ed: 14-08-25; Version: 2
//
ID   SDZ 12164-5361
AC   CVCL_E2XA
SY   San Diego Zoo 12164-5361
RX   PubMed=21518243;
CC   Group: Marsupial cell line.
CC   Senescence: Cells enter stasis at 4 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30668; ! Lasiorhinus latifrons (Southern hairy-nosed wombat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 12580-5673
AC   CVCL_E2XB
SY   San Diego Zoo 12580-5673
RX   PubMed=21518243;
CC   Group: Cetacean cell line.
CC   Senescence: Senesces at 19 PDL (PubMed=21518243).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 12582
AC   CVCL_E2XC
SY   San Diego Zoo 12582
RX   PubMed=21518243;
CC   Group: Marsupial cell line.
CC   Senescence: Cells enter stasis at 6 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=38626; ! Phascolarctos cinereus (Koala)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 12816-5837
AC   CVCL_E2XD
SY   San Diego Zoo 12816-5837
RX   PubMed=21518243;
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=77216; ! Pteropus rodricensis (Rodriguez flying fox)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 12900
AC   CVCL_E2XE
SY   San Diego Zoo 12900
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 3 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=319819; ! Setifer setosus (Greater hedgehog tenrec)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 13451
AC   CVCL_E2XF
SY   San Diego Zoo 13451
RX   PubMed=21518243;
CC   Group: Marsupial cell line.
CC   Senescence: Senesces at 24 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9321; ! Osphranter rufus (Red kangaroo)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 13568
AC   CVCL_E2XG
SY   San Diego Zoo 13568
RX   PubMed=21518243;
CC   Group: Endangered species/breed cell line.
CC   Senescence: Senesces at 64 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=439328; ! Giraffa tippelskirchi (Masai giraffe)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 13718
AC   CVCL_E2XH
SY   San Diego Zoo 13718
RX   PubMed=21518243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=77149; ! Mustela eversmannii (Steppe polecat)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 13791
AC   CVCL_E2XI
SY   San Diego Zoo 13791
RX   PubMed=21518243;
CC   Senescence: Senesces at 128 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=71006; ! Myrmecophaga tridactyla (Giant anteater)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 14068
AC   CVCL_E2XJ
SY   San Diego Zoo 14068
RX   PubMed=21518243;
CC   Group: Endangered species/breed cell line.
CC   Senescence: Senesces at 41 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73337; ! Ceratotherium simum simum (Southern white rhinoceros)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 14132
AC   CVCL_E2XK
SY   San Diego Zoo 14132
RX   PubMed=21518243;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=74534; ! Panthera tigris corbetti (Indochinese tiger)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 14309-6697
AC   CVCL_E2XL
SY   San Diego Zoo 14309-6697
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 4 PDL (PubMed=21518243).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 14446-6760
AC   CVCL_E2XM
SY   San Diego Zoo 14446-6760
RX   PubMed=21518243;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=56798; ! Hexaprotodon liberiensis (Pygmy hippopotamus)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 2242-248
AC   CVCL_E2XN
SY   San Diego Zoo 2242-248
RX   PubMed=21518243;
CC   Senescence: Senesces at 39 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=49271; ! Tachyglossus aculeatus aculeatus (Southeast Australian short-beaked echidna)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 3429
AC   CVCL_E2XP
SY   San Diego Zoo 3429
RX   PubMed=21518243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9785; ! Loxodonta africana (African elephant)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 3739
AC   CVCL_E2XQ
SY   San Diego Zoo 3739
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 6 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=42151; ! Galegeeska rufescens (East African rufous sengi)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 4256
AC   CVCL_E2XR
SY   San Diego Zoo 4256
RX   PubMed=21518243;
CC   Senescence: Senesces at 44 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9678; ! Crocuta crocuta (Spotted hyena)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 7576
AC   CVCL_E2XS
SY   San Diego Zoo 7576
RX   PubMed=21518243;
CC   Senescence: Senesces at 46 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9783; ! Elephas maximus (Indian elephant)
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SDZ 8372-2959
AC   CVCL_E2XT
SY   San Diego Zoo 8372-2959
RX   PubMed=21518243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=29082; ! Macroscelides proboscideus (Short-eared elephant shrew)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 8424-2982
AC   CVCL_E2XU
SY   San Diego Zoo 8424-2982
RX   PubMed=21518243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9802; ! Tapirus indicus (Asiatic tapir)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 9142
AC   CVCL_E2XV
SY   San Diego Zoo 9142
RX   PubMed=21518243;
CC   Senescence: Was still dividing at 143 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9838; ! Camelus dromedarius (Dromedary)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 9701-3639
AC   CVCL_E2XW
SY   San Diego Zoo 9701-3639
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 26 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9813; ! Procavia capensis (Rock hyrax)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 9765-3678
AC   CVCL_E2XX
SY   San Diego Zoo 9765-3678
RX   PubMed=21518243;
CC   Senescence: Cells enter stasis at 14 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=29073; ! Ursus maritimus (Polar bear)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 9793-3696
AC   CVCL_E2XY
SY   San Diego Zoo 9793-3696
RX   PubMed=21518243;
CC   Group: Cetacean cell line.
CC   Senescence: Cells enter stasis at 7 PDL (PubMed=21518243).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9764; ! Eschrichtius robustus (California gray whale)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZ 9893-3769
AC   CVCL_E2XZ
SY   San Diego Zoo 9893-3769
RX   PubMed=21518243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9358; ! Choloepus hoffmanni (Hoffmann's two-fingered sloth)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   SDZFYi001-A
AC   CVCL_A8ZY
DR   BioSamples; SAMEA9197488
DR   hPSCreg; SDZFYi001-A
DR   Wikidata; Q108821291
CC   From: Shandong Academy of Occupational Health and Occupational Medicine; Jinan; China.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SE
AC   CVCL_6D91
SY   Salmon Egg
DR   Wikidata; Q54952737
RX   CelloPub=CLPUB00103;
RX   DOI=10.2331/suisan.46.1203;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8018; ! Oncorhynchus keta (Chum salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 7
//
ID   Se Jac
AC   CVCL_U792
DR   ATCC; CRL-1178
DR   Wikidata; Q54952739
CC   Discontinued: ATCC; CRL-1178; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C72070; Systemic scleroderma
DI   ORDO; Orphanet_90291; Systemic sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Se Mar
AC   CVCL_U682
DR   ATCC; CRL-1134
DR   Wikidata; Q54952740
CC   Discontinued: ATCC; CRL-1134; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   Se Red
AC   CVCL_U686
DR   ATCC; CRL-1184
DR   Wikidata; Q54952741
CC   Discontinued: ATCC; CRL-1184; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85036; Pseudoxanthoma elasticum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   SE-1.3
AC   CVCL_G146
DR   CLO; CLO_0008979
DR   ATCC; HB-137
DR   Wikidata; Q54952743
CC   Monoclonal antibody isotype: IgE.
CC   Monoclonal antibody target: ChEBI; CHEBI_64449; Phenylarsonate.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   Se-Ax
AC   CVCL_5363
SY   SeAx; SeAX
DR   BTO; BTO_0004783
DR   Cosmic; 1551449
DR   Cosmic; 2402470
DR   Wikidata; Q54952744
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2460034;
RX   PubMed=3498444;
RX   PubMed=8045039;
CC   Characteristics: IL2 dependent.
CC   Doubling time: ~3 days (PubMed=3498444).
CC   Karyotypic information: Originally had a near-diploid karyotype but developed gradually into a near-tetraploid karyotype (PubMed=2460034).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   SE-R
AC   CVCL_0I78
DR   CCLV; CCLV-RIE 0174
DR   Wikidata; Q54952746
RX   PubMed=25565633;
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
AG   Fetus
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   Se21
AC   CVCL_B7PI
DR   Wikidata; Q112930370
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PJ ! SeA1
OI   CVCL_B7PK ! SeA2
OI   CVCL_B7PL ! SeD
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   Se301
AC   CVCL_Z520
SY   SE301
DR   ICLDB; se301
DR   Wikidata; Q54952747
RX   DOI=10.1139/m95-154;
RX   PubMed=10358729;
RX   PubMed=21830050;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
HI   CVCL_Z521 ! Se3FH
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Se3FH
AC   CVCL_Z521
DR   ICLDB; se3fh
DR   Wikidata; Q54952748
RX   DOI=10.1139/m95-154;
RX   PubMed=7726004;
RX   PubMed=8167910;
CC   Group: Insect cell line.
CC   Doubling time: 30.09 +- 4.97 hours (PubMed=8167910).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Se4FH
AC   CVCL_Z522
DR   ICLDB; se4fh
DR   Wikidata; Q54952750
RX   PubMed=8167910;
CC   Group: Insect cell line.
CC   Doubling time: 37.48 +- 6.15 hours (PubMed=8167910).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Se5FH
AC   CVCL_Z523
DR   ICLDB; se5fh
DR   Wikidata; Q54952751
RX   PubMed=8167910;
CC   Group: Insect cell line.
CC   Doubling time: 21.75 +- 6.69 hours (PubMed=8167910).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   SE686
AC   CVCL_IV33
DR   Wikidata; Q54952754
RX   PubMed=8515068;
RX   PubMed=9973220;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   Se6FHA
AC   CVCL_Z524
DR   ICLDB; se6fha
DR   Wikidata; Q54952755
RX   PubMed=8167910;
CC   Group: Insect cell line.
CC   Doubling time: 19.35 +- 2.78 hours (PubMed=8167910).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
OI   CVCL_Z525 ! Se6FHB
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   Se6FHB
AC   CVCL_Z525
DR   ICLDB; se6fhb
DR   Wikidata; Q54952756
RX   PubMed=8167910;
CC   Group: Insect cell line.
CC   Doubling time: 23.0 +- 4.7 hours (PubMed=8167910).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
OI   CVCL_Z524 ! Se6FHA
SX   Sex unspecified
AG   Embryo/neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   SeA1
AC   CVCL_B7PJ
SY   Seha A1
DR   Wikidata; Q112930371
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PI ! Se21
OI   CVCL_B7PK ! SeA2
OI   CVCL_B7PL ! SeD
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   SeA2
AC   CVCL_B7PK
DR   Wikidata; Q112930372
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PI ! Se21
OI   CVCL_B7PJ ! SeA1
OI   CVCL_B7PL ! SeD
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   SEAD
AC   CVCL_C1CQ
DR   Wikidata; Q114312985
RX   DOI=10.1155/NP.1991.285;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: Psi2 defective retrovirus adenovirus E1A.
CC   Derived from site: In situ; Peripheral nervous system, sciatic nerve; UBERON=UBERON_0001322.
CC   Cell type: Schwann cell; CL=CL_0002573.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1-10D
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   SEB-1
AC   CVCL_A2FF
DR   Wikidata; Q105511015
RX   PubMed=12787114;
RX   PubMed=18690467;
RX   PubMed=20224690;
RX   PubMed=29451719;
CC   Doubling time: 36 hours (PubMed=12787114).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Face, skin, sebaceous gland; UBERON=UBERON_0003487.
CC   Cell type: Sebocyte; CL=CL_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   Seb-E6E7
AC   CVCL_A2FG
DR   Wikidata; Q105511018
RX   PubMed=18308950;
RX   PubMed=18690467;
RX   PubMed=20224690;
RX   PubMed=29451719;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Face, skin, sebaceous gland; UBERON=UBERON_0003487.
CC   Cell type: Sebocyte; CL=CL_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   Seb Nev-1
AC   CVCL_VW47
DR   IBRC; C10572
DR   Wikidata; Q98129497
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C4678; Organoid nevus
DI   ORDO; Orphanet_2612; Linear nevus sebaceus syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   SEBO662
AC   CVCL_A2FH
DR   Wikidata; Q105511021
RX   PubMed=22417312;
RX   PubMed=25864624;
RX   PubMed=29451719;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Face, skin, sebaceous gland; UBERON=UBERON_0003487.
CC   Cell type: Sebocyte; CL=CL_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 8
//
ID   SEBO662 AR+
AC   CVCL_A2FI
SY   SEBO662AR
DR   Wikidata; Q105511024
RX   PubMed=25864624;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Face, skin, sebaceous gland; UBERON=UBERON_0003487.
CC   Cell type: Sebocyte; CL=CL_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2FH ! SEBO662
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   SEC
AC   CVCL_E825
DR   IHW; 9w 0804
DR   Wikidata; Q54952772
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*31; B*62; C*w01 (IHW=9w 0804).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   SeD
AC   CVCL_B7PL
DR   Wikidata; Q112930373
RX   PubMed=82971;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic lymphocytic leukemia.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7PI ! Se21
OI   CVCL_B7PJ ! SeA1
OI   CVCL_B7PK ! SeA2
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   SEES1
AC   CVCL_1Q89
SY   SEES-1; SEi-iku Embryonic Stem-1
DR   RCB; HES0006
DR   SKIP; SKIP001146
DR   Wikidata; Q54952773
RX   PubMed=31245438;
RX   PubMed=31245498;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   SEES2
AC   CVCL_1Q90
SY   SEES-2; SEi-iku Embryonic Stem-2
DR   RCB; HES0007
DR   SKIP; SKIP001147
DR   Wikidata; Q54952774
RX   PubMed=31245438;
RX   PubMed=31245498;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   SEES3
AC   CVCL_1Q91
SY   SEES-3; SEi-iku Embryonic Stem-3
DR   RCB; HES0008
DR   SKIP; SKIP001148
DR   Wikidata; Q54952776
RX   PubMed=31245438;
RX   PubMed=31245498;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   SEES3-1L
AC   CVCL_ZJ89
SY   1L
DR   Wikidata; Q98129498
RX   PubMed=32433964;
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q91 ! SEES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   SEES3-1V
AC   CVCL_ZJ91
SY   1V
DR   Wikidata; Q98129499
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q91 ! SEES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   SEES3-1V Emerald, clone1
AC   CVCL_ZK54
SY   1V-90515-6A
DR   Wikidata; Q98129500
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected Emerald (EmGFP) gene and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-EmGFP-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transposed human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   SEES3-1V Emerald, clone2
AC   CVCL_ZK55
SY   1V-90515-8D
DR   Wikidata; Q98129501
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected Emerald (EmGFP) gene and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-EmGFP-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transposed human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   SEES3-1V Emerald, clone3
AC   CVCL_ZK56
SY   1V-90515-2C
DR   Wikidata; Q98129502
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected Emerald (EmGFP) gene and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-EmGFP-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transposed human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   SEES3-1V human AATF, clone1
AC   CVCL_A0A0
SY   1V-91864-1A
DR   Wikidata; Q98129503
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19235; AATF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AATF, clone2
AC   CVCL_A0A1
SY   1V-91864-3B
DR   Wikidata; Q98129504
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19235; AATF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AATF, clone3
AC   CVCL_A0A2
SY   1V-91864-5C
DR   Wikidata; Q98129505
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19235; AATF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AES, clone1
AC   CVCL_A0A3
SY   1V-91630-2A
DR   Wikidata; Q98129506
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:307; TLE5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AES, clone2
AC   CVCL_A0A4
SY   1V-91630-3B
DR   Wikidata; Q98129507
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:307; TLE5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AES, clone3
AC   CVCL_A0A5
SY   1V-91630-6C
DR   Wikidata; Q98129508
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:307; TLE5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX1, clone1
AC   CVCL_A0A6
SY   1V-93068-2A
DR   Wikidata; Q98129509
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1494; ALX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX1, clone2
AC   CVCL_A0A7
SY   1V-93068-3B
DR   Wikidata; Q98129510
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1494; ALX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX1, clone3
AC   CVCL_A0A8
SY   1V-93068-4C
DR   Wikidata; Q98129511
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1494; ALX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX3, clone1
AC   CVCL_A0A9
SY   1V-93159-5A
DR   Wikidata; Q98129512
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:449; ALX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX3, clone2
AC   CVCL_A0B0
SY   1V-93159-2B
DR   Wikidata; Q98129513
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:449; ALX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX3, clone3
AC   CVCL_A0B1
SY   1V-93159-5C
DR   Wikidata; Q98129514
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:449; ALX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX4, clone1
AC   CVCL_A0B2
SY   1V-93354-4A
DR   Wikidata; Q98129515
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:450; ALX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX4, clone2
AC   CVCL_A0B3
SY   1V-93354-6B
DR   Wikidata; Q98129516
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:450; ALX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ALX4, clone3
AC   CVCL_A0B4
SY   1V-93354-5C
DR   Wikidata; Q98129517
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:450; ALX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ANKRD22, clone1
AC   CVCL_A0B5
SY   1V-91383-1A
DR   Wikidata; Q98129519
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28321; ANKRD22.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ANKRD22, clone2
AC   CVCL_A0B6
SY   1V-91383-3B
DR   Wikidata; Q98129520
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28321; ANKRD22.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ANKRD22, clone3
AC   CVCL_A0B7
SY   1V-91383-2C
DR   Wikidata; Q98129521
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28321; ANKRD22.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AR, clone1
AC   CVCL_A0B8
SY   1V-91631-4A
DR   Wikidata; Q98129522
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AR, clone2
AC   CVCL_A0B9
SY   1V-91631-6B
DR   Wikidata; Q98129523
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human AR, clone3
AC   CVCL_A0C0
SY   1V-91631-3C
DR   Wikidata; Q98129524
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:644; AR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARID3A, clone1
AC   CVCL_A0C1
SY   1V-91306-6A
DR   Wikidata; Q98129525
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3031; ARID3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARID3A, clone2
AC   CVCL_A0C2
SY   1V-91306-2B
DR   Wikidata; Q98129526
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3031; ARID3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARID3A, clone3
AC   CVCL_A0C3
SY   1V-91306-1C
DR   Wikidata; Q98129527
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3031; ARID3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARID3B, clone1
AC   CVCL_A0C4
SY   1V-92307-1A
DR   Wikidata; Q98129528
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14350; ARID3B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARID3B, clone2
AC   CVCL_A0C5
SY   1V-92307-3B
DR   Wikidata; Q98129529
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14350; ARID3B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARID3B, clone3
AC   CVCL_A0C6
SY   1V-92307-6C
DR   Wikidata; Q98129530
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14350; ARID3B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARNT2, clone1
AC   CVCL_A0C7
SY   1V-91242-1A
DR   Wikidata; Q98129531
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16876; ARNT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARNT2, clone2
AC   CVCL_A0C8
SY   1V-91242-3B
DR   Wikidata; Q98129533
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16876; ARNT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ARNT2, clone3
AC   CVCL_A0C9
SY   1V-91242-15D
DR   Wikidata; Q98129534
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16876; ARNT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASCL1, clone1
AC   CVCL_A0D0
SY   1V-91017-2A
DR   Wikidata; Q98129535
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:738; ASCL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASCL1, clone2
AC   CVCL_A0D1
SY   1V-91017-1B
DR   Wikidata; Q98129537
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:738; ASCL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASCL1, clone3
AC   CVCL_A0D2
SY   1V-91017-4C
DR   Wikidata; Q98129538
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:738; ASCL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASCL2, clone1
AC   CVCL_A0D3
SY   1V-90988-6A
DR   Wikidata; Q98129539
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:739; ASCL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASCL2, clone2
AC   CVCL_A0D4
SY   1V-90988-2B
DR   Wikidata; Q98129540
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:739; ASCL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASCL2, clone3
AC   CVCL_A0D5
SY   1V-90988-4C
DR   Wikidata; Q98129541
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:739; ASCL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASH2L, clone1
AC   CVCL_A0D6
SY   1V-91632-6A
DR   Wikidata; Q98129542
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:744; ASH2L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASH2L, clone2
AC   CVCL_A0D7
SY   1V-91632-1B
DR   Wikidata; Q98129543
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:744; ASH2L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ASH2L, clone3
AC   CVCL_A0D8
SY   1V-91632-2C
DR   Wikidata; Q98129544
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:744; ASH2L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF1, clone1
AC   CVCL_A0D9
SY   1V-91323-3A
DR   Wikidata; Q98129545
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:783; ATF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF1, clone2
AC   CVCL_A0E0
SY   1V-91323-4B
DR   Wikidata; Q98129548
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:783; ATF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF1, clone3
AC   CVCL_A0E1
SY   1V-91323-1C
DR   Wikidata; Q98129550
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:783; ATF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF2, clone1
AC   CVCL_A0E2
SY   1V-91271-3A
DR   Wikidata; Q98129553
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:784; ATF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF2, clone2
AC   CVCL_A0E3
SY   1V-91271-4B
DR   Wikidata; Q98129555
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:784; ATF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF2, clone3
AC   CVCL_A0E4
SY   1V-91271-11C
DR   Wikidata; Q98129558
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:784; ATF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF3, clone1
AC   CVCL_A0E5
SY   1V-90596-5A
DR   Wikidata; Q98129560
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:785; ATF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF3, clone2
AC   CVCL_A0E6
SY   1V-90596-2B
DR   Wikidata; Q98129562
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:785; ATF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF3, clone3
AC   CVCL_A0E7
SY   1V-90596-7C
DR   Wikidata; Q98129565
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:785; ATF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF4, clone1
AC   CVCL_A0E8
SY   1V-91928-2A
DR   Wikidata; Q98129567
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:786; ATF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF4, clone2
AC   CVCL_A0E9
SY   1V-91928-6C
DR   Wikidata; Q98129570
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:786; ATF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATF4, clone3
AC   CVCL_A0F0
SY   1V-91928-4D
DR   Wikidata; Q98129572
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:786; ATF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATOH1, clone1
AC   CVCL_A0F1
SY   1V-92298-1A
DR   Wikidata; Q98129575
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:797; ATOH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATOH1, clone2
AC   CVCL_A0F2
SY   1V-92298-4B
DR   Wikidata; Q98129578
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:797; ATOH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATOH1, clone3
AC   CVCL_A0F3
SY   1V-92298-6C
DR   Wikidata; Q98129580
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:797; ATOH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATOH7, clone1
AC   CVCL_A0F4
SY   1V-92177-1A
DR   Wikidata; Q98129582
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13907; ATOH7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATOH7, clone2
AC   CVCL_A0F5
SY   1V-92177-4B
DR   Wikidata; Q98129584
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13907; ATOH7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ATOH7, clone3
AC   CVCL_A0F6
SY   1V-92177-2C
DR   Wikidata; Q98129586
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13907; ATOH7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BACH1, clone1
AC   CVCL_A0F7
SY   1V-91471-4A
DR   Wikidata; Q98129589
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:935; BACH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BACH1, clone2
AC   CVCL_A0F8
SY   1V-91471-1B
DR   Wikidata; Q98129592
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:935; BACH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BACH1, clone3
AC   CVCL_A0F9
SY   1V-91471-8C
DR   Wikidata; Q98129595
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:935; BACH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BANP, clone1
AC   CVCL_A0G0
SY   1V-92192-1A
DR   Wikidata; Q98129597
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13450; BANP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BANP, clone2
AC   CVCL_A0G1
SY   1V-92192-5B
DR   Wikidata; Q98129600
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13450; BANP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BANP, clone3
AC   CVCL_A0G2
SY   1V-92192-6C
DR   Wikidata; Q98129603
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13450; BANP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BARHL2, clone1
AC   CVCL_A0G3
SY   1V-91472-4A
DR   Wikidata; Q98129605
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:954; BARHL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BARHL2, clone2
AC   CVCL_A0G4
SY   1V-91472-8B
DR   Wikidata; Q98129607
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:954; BARHL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BARHL2, clone3
AC   CVCL_A0G5
SY   1V-91472-1C
DR   Wikidata; Q98129609
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:954; BARHL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BARX2, clone1
AC   CVCL_A0G6
SY   1V-93069-2A
DR   Wikidata; Q98129612
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:956; BARX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BARX2, clone2
AC   CVCL_A0G7
SY   1V-93069-5B
DR   Wikidata; Q98129614
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:956; BARX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BARX2, clone3
AC   CVCL_A0G8
SY   1V-93069-4C
DR   Wikidata; Q98129616
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:956; BARX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BATF, clone1
AC   CVCL_A0G9
SY   1V-91389-5A
DR   Wikidata; Q98129620
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:958; BATF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BATF, clone2
AC   CVCL_A0H0
SY   1V-91389-4B
DR   Wikidata; Q98129622
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:958; BATF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BATF, clone3
AC   CVCL_A0H1
SY   1V-91389-1C
DR   Wikidata; Q98129625
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:958; BATF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BATF3, clone1
AC   CVCL_A0H2
SY   1V-91633-5A
DR   Wikidata; Q98129627
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28915; BATF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BATF3, clone2
AC   CVCL_A0H3
SY   1V-91633-1B
DR   Wikidata; Q98129629
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28915; BATF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BATF3, clone3
AC   CVCL_A0H4
SY   1V-91633-6C
DR   Wikidata; Q98129632
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28915; BATF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BCL11A, clone1
AC   CVCL_A0H5
SY   1V-91280-3A
DR   Wikidata; Q98129634
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13221; BCL11A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BCL11A, clone2
AC   CVCL_A0H6
SY   1V-91280-1C
DR   Wikidata; Q98129636
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13221; BCL11A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BCL11A, clone3
AC   CVCL_A0H7
SY   1V-91280-9D
DR   Wikidata; Q98129639
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13221; BCL11A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BCL6, clone1
AC   CVCL_A0H8
SY   1V-91187-2A
DR   Wikidata; Q98129642
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1001; BCL6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BCL6, clone2
AC   CVCL_A0H9
SY   1V-91187-6B
DR   Wikidata; Q98129644
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1001; BCL6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BCL6, clone3
AC   CVCL_A0I0
SY   1V-91187-5C
DR   Wikidata; Q98129646
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1001; BCL6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BHLHE40, clone1
AC   CVCL_A0I1
SY   1V-91473-4A
DR   Wikidata; Q98129649
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1046; BHLHE40.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BHLHE40, clone2
AC   CVCL_A0I2
SY   1V-91473-1B
DR   Wikidata; Q98129652
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1046; BHLHE40.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BHLHE40, clone3
AC   CVCL_A0I3
SY   1V-91473-6C
DR   Wikidata; Q98129655
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1046; BHLHE40.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BLZF1, clone1
AC   CVCL_A0I4
SY   1V-91908-4A
DR   Wikidata; Q98129657
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1065; BLZF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BLZF1, clone2
AC   CVCL_A0I5
SY   1V-91908-2B
DR   Wikidata; Q98129660
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1065; BLZF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BLZF1, clone3
AC   CVCL_A0I6
SY   1V-91908-3C
DR   Wikidata; Q98129663
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1065; BLZF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMI1, clone1
AC   CVCL_A0I7
SY   1V-91764-1A
DR   Wikidata; Q98129666
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMI1, clone3
AC   CVCL_A0I8
SY   1V-91764-4C
DR   Wikidata; Q98129669
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP2, clone1
AC   CVCL_A0I9
SY   1V-91929-3A
DR   Wikidata; Q98129671
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP2, clone2
AC   CVCL_A0J0
SY   1V-91929-1B
DR   Wikidata; Q98129673
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP2, clone3
AC   CVCL_A0J1
SY   1V-91929-2C
DR   Wikidata; Q98129677
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1069; BMP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP4, clone1
AC   CVCL_A0J2
SY   1V-91918-8F
DR   Wikidata; Q98129680
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1071; BMP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP4, clone2
AC   CVCL_A0J3
SY   1V-91918-10E
DR   Wikidata; Q98129682
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1071; BMP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP4, clone3
AC   CVCL_A0J4
SY   1V-91918-6C
DR   Wikidata; Q98129685
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1071; BMP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP7, clone1
AC   CVCL_A0J5
SY   1V-92145-5A
DR   Wikidata; Q98129687
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1074; BMP7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP7, clone2
AC   CVCL_A0J6
SY   1V-92145-2B
DR   Wikidata; Q98129691
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1074; BMP7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BMP7, clone3
AC   CVCL_A0J7
SY   1V-92145-3C
DR   Wikidata; Q98129693
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1074; BMP7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BRF1, clone1
AC   CVCL_A0J8
SY   1V-91636-3A
DR   Wikidata; Q98129695
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11551; BRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BRF1, clone2
AC   CVCL_A0J9
SY   1V-91636-4B
DR   Wikidata; Q98129697
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11551; BRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BRF1, clone3
AC   CVCL_A0K0
SY   1V-91636-5C
DR   Wikidata; Q98129699
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11551; BRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BRF2, clone1
AC   CVCL_A0K1
SY   1V-91266-3A
DR   Wikidata; Q98129702
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17298; BRF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BRF2, clone2
AC   CVCL_A0K2
SY   1V-91266-4B
DR   Wikidata; Q98129704
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17298; BRF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human BRF2, clone3
AC   CVCL_A0K3
SY   1V-91266-2C
DR   Wikidata; Q98129707
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17298; BRF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CARM1, clone1
AC   CVCL_A0K4
SY   1V-92224-4A
DR   Wikidata; Q98129709
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23393; CARM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CARM1, clone2
AC   CVCL_A0K5
SY   1V-92224-6B
DR   Wikidata; Q98129711
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23393; CARM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CARM1, clone3
AC   CVCL_A0K6
SY   1V-92224-3C
DR   Wikidata; Q98129714
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23393; CARM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBFB, clone1
AC   CVCL_A0K7
SY   1V-91873-7A
DR   Wikidata; Q98129716
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1539; CBFB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBFB, clone2
AC   CVCL_A0K8
SY   1V-91873-9D
DR   Wikidata; Q98129719
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1539; CBFB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBFB, clone3
AC   CVCL_A0K9
SY   1V-91873-8C
DR   Wikidata; Q98129721
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1539; CBFB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX2, clone1
AC   CVCL_A0L0
SY   1V-91298-4A
DR   Wikidata; Q98129723
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1552; CBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX2, clone2
AC   CVCL_A0L1
SY   1V-91298-5B
DR   Wikidata; Q98129725
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1552; CBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX2, clone3
AC   CVCL_A0L2
SY   1V-91298-1C
DR   Wikidata; Q98129728
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1552; CBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX3, clone1
AC   CVCL_A0L3
SY   1V-91336-4A
DR   Wikidata; Q98129730
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1553; CBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX3, clone2
AC   CVCL_A0L4
SY   1V-91336-3B
DR   Wikidata; Q98129733
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1553; CBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX3, clone3
AC   CVCL_A0L5
SY   1V-91336-2C
DR   Wikidata; Q98129734
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1553; CBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX8, clone1
AC   CVCL_A0L6
SY   1V-91329-1A
DR   Wikidata; Q98129735
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15962; CBX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX8, clone2
AC   CVCL_A0L7
SY   1V-91329-5B
DR   Wikidata; Q98129736
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15962; CBX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CBX8, clone3
AC   CVCL_A0L8
SY   1V-91329-2C
DR   Wikidata; Q98129737
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15962; CBX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CCNE1, clone1
AC   CVCL_A0L9
SY   1V-90748-6A
DR   Wikidata; Q98129739
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1589; CCNE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CCNE1, clone2
AC   CVCL_A0M0
SY   1V-90748-5B
DR   Wikidata; Q98129740
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1589; CCNE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CCNE1, clone3
AC   CVCL_A0M1
SY   1V-90748-4C
DR   Wikidata; Q98129741
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1589; CCNE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDK9, clone1
AC   CVCL_A0M2
SY   1V-90734-1A
DR   Wikidata; Q98129742
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1780; CDK9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDK9, clone2
AC   CVCL_A0M3
SY   1V-90734-2B
DR   Wikidata; Q98129743
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1780; CDK9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDK9, clone3
AC   CVCL_A0M4
SY   1V-90734-3C
DR   Wikidata; Q98129744
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1780; CDK9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDKN1B, clone1
AC   CVCL_A0M5
SY   1V-90723-3A
DR   Wikidata; Q98129745
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1785; CDKN1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDKN1B, clone2
AC   CVCL_A0M6
SY   1V-90723-2B
DR   Wikidata; Q98129747
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1785; CDKN1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDKN1B, clone3
AC   CVCL_A0M7
SY   1V-90723-4C
DR   Wikidata; Q98129748
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1785; CDKN1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDKN2D, clone1
AC   CVCL_A0M8
SY   1V-92100-3A
DR   Wikidata; Q98129749
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1790; CDKN2D.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDKN2D, clone2
AC   CVCL_A0M9
SY   1V-92100-1B
DR   Wikidata; Q98129750
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1790; CDKN2D.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDKN2D, clone3
AC   CVCL_A0N0
SY   1V-92100-2C
DR   Wikidata; Q98129751
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1790; CDKN2D.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDX2, clone1
AC   CVCL_A0N1
SY   1V-90597-4A
DR   RCB; HES0009
DR   Wikidata; Q98129752
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1806; CDX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDX2, clone2
AC   CVCL_A0N2
SY   1V-90597-2B
DR   RCB; HES0010
DR   Wikidata; Q98129753
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1806; CDX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDX2, clone3
AC   CVCL_A0N3
SY   1V-90597-6C
DR   Wikidata; Q98129754
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1806; CDX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDYL, clone1
AC   CVCL_A0N4
SY   1V-91637-1A
DR   Wikidata; Q98129755
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1811; CDYL.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDYL, clone2
AC   CVCL_A0N5
SY   1V-91637-8D
DR   Wikidata; Q98129756
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1811; CDYL.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDYL, clone3
AC   CVCL_A0N6
SY   1V-91637-9E
DR   Wikidata; Q98129757
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1811; CDYL.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDYL2, clone1
AC   CVCL_A0N7
SY   1V-90996-1A
DR   Wikidata; Q98129759
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23030; CDYL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDYL2, clone2
AC   CVCL_A0N8
SY   1V-90996-4B
DR   Wikidata; Q98129760
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23030; CDYL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CDYL2, clone3
AC   CVCL_A0N9
SY   1V-90996-6C
DR   Wikidata; Q98129761
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23030; CDYL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPA, clone1
AC   CVCL_A0P0
SY   1V-91474-4A
DR   Wikidata; Q98129762
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1833; CEBPA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPA, clone2
AC   CVCL_A0P1
SY   1V-91474-6B
DR   Wikidata; Q98129763
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1833; CEBPA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPA, clone3
AC   CVCL_A0P2
SY   1V-91474-3C
DR   Wikidata; Q98129764
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1833; CEBPA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPB, clone1
AC   CVCL_A0P3
SY   1V-91382-3A
DR   Wikidata; Q98129765
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1834; CEBPB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPB, clone2
AC   CVCL_A0P4
SY   1V-91382-4B
DR   Wikidata; Q98129766
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1834; CEBPB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPB, clone3
AC   CVCL_A0P5
SY   1V-91382-1C
DR   Wikidata; Q98129767
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1834; CEBPB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPD, clone1
AC   CVCL_A0P6
SY   1V-91475-5A
DR   Wikidata; Q98129768
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1835; CEBPD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPD, clone2
AC   CVCL_A0P7
SY   1V-91475-6B
DR   Wikidata; Q98129769
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1835; CEBPD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPD, clone3
AC   CVCL_A0P8
SY   1V-91475-2C
DR   Wikidata; Q98129771
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1835; CEBPD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPE, clone1
AC   CVCL_A0P9
SY   1V-91384-4A
DR   Wikidata; Q98129773
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1836; CEBPE.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPE, clone2
AC   CVCL_A0Q0
SY   1V-91384-8D
DR   Wikidata; Q98129776
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1836; CEBPE.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPE, clone3
AC   CVCL_A0Q1
SY   1V-91384-7E
DR   Wikidata; Q98129779
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1836; CEBPE.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPG, clone1
AC   CVCL_A0Q2
SY   1V-91922-3A
DR   Wikidata; Q98129781
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1837; CEBPG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPG, clone2
AC   CVCL_A0Q3
SY   1V-91922-2B
DR   Wikidata; Q98129784
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1837; CEBPG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CEBPG, clone3
AC   CVCL_A0Q4
SY   1V-91922-5C
DR   Wikidata; Q98129786
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1837; CEBPG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CERS2, clone1
AC   CVCL_A0Q5
SY   1V-91694-5A
DR   Wikidata; Q98129789
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14076; CERS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CERS2, clone2
AC   CVCL_A0Q6
SY   1V-91694-4B
DR   Wikidata; Q98129792
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14076; CERS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CERS2, clone3
AC   CVCL_A0Q7
SY   1V-91694-2C
DR   Wikidata; Q98129794
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14076; CERS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD1, clone1
AC   CVCL_A0Q8
SY   1V-91684-6A
DR   Wikidata; Q98129797
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1915; CHD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD1, clone2
AC   CVCL_A0Q9
SY   1V-91684-2B
DR   Wikidata; Q98129799
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1915; CHD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD1, clone3
AC   CVCL_A0R0
SY   1V-91684-5C
DR   Wikidata; Q98129802
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1915; CHD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD4, clone1
AC   CVCL_A0R1
SY   1V-91279-1A
DR   Wikidata; Q98129804
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1919; CHD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD4, clone2
AC   CVCL_A0R2
SY   1V-91279-4B
DR   Wikidata; Q98129807
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1919; CHD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD4, clone3
AC   CVCL_A0R3
SY   1V-91279-8D
DR   Wikidata; Q98129809
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1919; CHD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD5, clone1
AC   CVCL_A0R4
SY   1V-92101-1A
DR   Wikidata; Q98129811
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16816; CHD5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD5, clone2
AC   CVCL_A0R5
SY   1V-92101-5B
DR   Wikidata; Q98129814
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16816; CHD5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CHD5, clone3
AC   CVCL_A0R6
SY   1V-92101-2C
DR   Wikidata; Q98129816
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16816; CHD5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CITED1, clone1
AC   CVCL_A0R7
SY   1V-91913-3A
DR   Wikidata; Q98129818
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1986; CITED1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CITED1, clone2
AC   CVCL_A0R8
SY   1V-91913-4B
DR   Wikidata; Q98129820
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1986; CITED1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CITED1, clone3
AC   CVCL_A0R9
SY   1V-91913-5C
DR   Wikidata; Q98129823
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1986; CITED1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CREB1, clone1
AC   CVCL_A0S0
SY   1V-90733-1A
DR   Wikidata; Q98129825
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2345; CREB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CREB1, clone2
AC   CVCL_A0S1
SY   1V-90733-8D
DR   Wikidata; Q98129828
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2345; CREB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CREB1, clone3
AC   CVCL_A0S2
SY   1V-90733-2C
DR   Wikidata; Q98129830
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2345; CREB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CREB3, clone1
AC   CVCL_A0S3
SY   1V-93160-9D
DR   Wikidata; Q98129833
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2347; CREB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CREB3, clone2
AC   CVCL_A0S4
SY   1V-93160-3B
DR   Wikidata; Q98129837
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2347; CREB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CREB3, clone3
AC   CVCL_A0S5
SY   1V-93160-1C
DR   Wikidata; Q98129840
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2347; CREB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRX, clone1
AC   CVCL_A0S6
SY   1V-92159-1A
DR   Wikidata; Q98129842
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2383; CRX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRX, clone2
AC   CVCL_A0S7
SY   1V-92159-2B
DR   Wikidata; Q98129844
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2383; CRX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRX, clone3
AC   CVCL_A0S8
SY   1V-92159-5C
DR   Wikidata; Q98129846
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2383; CRX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRY1, clone1
AC   CVCL_A0S9
SY   1V-91374-6A
DR   Wikidata; Q98129849
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2384; CRY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRY1, clone2
AC   CVCL_A0T0
SY   1V-91374-4B
DR   Wikidata; Q98129851
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2384; CRY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRY1, clone3
AC   CVCL_A0T1
SY   1V-91374-2C
DR   Wikidata; Q98129854
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2384; CRY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRY2, clone1
AC   CVCL_A0T2
SY   1V-92311-3A
DR   Wikidata; Q98129856
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2385; CRY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRY2, clone2
AC   CVCL_A0T3
SY   1V-92311-1B
DR   Wikidata; Q98129858
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2385; CRY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CRY2, clone3
AC   CVCL_A0T4
SY   1V-92311-6C
DR   Wikidata; Q98129861
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2385; CRY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTBP1, clone1
AC   CVCL_A0T5
SY   1V-90738-1A
DR   Wikidata; Q98129863
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2494; CTBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTBP1, clone2
AC   CVCL_A0T6
SY   1V-90738-2B
DR   Wikidata; Q98129866
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2494; CTBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTBP1, clone3
AC   CVCL_A0T7
SY   1V-90738-6C
DR   Wikidata; Q98129868
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2494; CTBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTBP2, clone1
AC   CVCL_A0T8
SY   1V-91685-5A
DR   Wikidata; Q98129870
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2495; CTBP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTBP2, clone2
AC   CVCL_A0T9
SY   1V-91685-3B
DR   Wikidata; Q98129873
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2495; CTBP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTBP2, clone3
AC   CVCL_A0U0
SY   1V-91685-2C
DR   Wikidata; Q98129875
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2495; CTBP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTCF, clone1
AC   CVCL_A0U1
SY   1V-91219-3A
DR   Wikidata; Q98129877
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13723; CTCF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTCF, clone2
AC   CVCL_A0U2
SY   1V-91219-6B
DR   Wikidata; Q98129881
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13723; CTCF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTCF, clone3
AC   CVCL_A0U3
SY   1V-91219-8C
DR   Wikidata; Q98129883
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13723; CTCF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTCFL, clone1
AC   CVCL_A0U4
SY   1V-91340-1A
DR   Wikidata; Q98129885
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16234; CTCFL.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTCFL, clone2
AC   CVCL_A0U5
SY   1V-91340-2B
DR   Wikidata; Q98129889
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16234; CTCFL.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTCFL, clone3
AC   CVCL_A0U6
SY   1V-91340-3C
DR   Wikidata; Q98129890
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16234; CTCFL.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTGF, clone1
AC   CVCL_A0U7
SY   1V-93070-2A
DR   Wikidata; Q98129892
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2500; CCN2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTGF, clone2
AC   CVCL_A0U8
SY   1V-93070-4B
DR   Wikidata; Q98129896
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2500; CCN2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTGF, clone3
AC   CVCL_A0U9
SY   1V-93070-3C
DR   Wikidata; Q98129898
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2500; CCN2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTNNB1, clone1
AC   CVCL_A0V0
SY   1V-91312-5A
DR   Wikidata; Q98129900
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2514; CTNNB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTNNB1, clone2
AC   CVCL_A0V1
SY   1V-91312-6B
DR   Wikidata; Q98129903
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2514; CTNNB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CTNNB1, clone3
AC   CVCL_A0V2
SY   1V-91312-4C
DR   Wikidata; Q98129905
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2514; CTNNB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CUX1, clone1
AC   CVCL_A0V3
SY   1V-91269-3A
DR   Wikidata; Q98129908
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2557; CUX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CUX1, clone2
AC   CVCL_A0V4
SY   1V-91269-1B
DR   Wikidata; Q98129910
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2557; CUX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CUX1, clone3
AC   CVCL_A0V5
SY   1V-91269-5C
DR   Wikidata; Q98129913
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2557; CUX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CXXC5, clone1
AC   CVCL_A0V6
SY   1V-92102-1A
DR   Wikidata; Q98129915
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26943; CXXC5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CXXC5, clone2
AC   CVCL_A0V7
SY   1V-92102-6B
DR   Wikidata; Q98129918
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26943; CXXC5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human CXXC5, clone3
AC   CVCL_A0V8
SY   1V-92102-3C
DR   Wikidata; Q98129920
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26943; CXXC5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DBX1, clone1
AC   CVCL_A0V9
SY   1V-92209-2A
DR   Wikidata; Q98129924
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:33185; DBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DBX1, clone2
AC   CVCL_A0W0
SY   1V-92209-1B
DR   Wikidata; Q98129925
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:33185; DBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DBX1, clone3
AC   CVCL_A0W1
SY   1V-92209-5C
DR   Wikidata; Q98129927
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:33185; DBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DBX2, clone1
AC   CVCL_A0W2
SY   1V-93071-1A
DR   Wikidata; Q98129930
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:33186; DBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DBX2, clone2
AC   CVCL_A0W3
SY   1V-93071-2B
DR   Wikidata; Q98129932
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:33186; DBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DBX2, clone3
AC   CVCL_A0W4
SY   1V-93071-6C
DR   Wikidata; Q98129935
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:33186; DBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DCP1A, clone1
AC   CVCL_A0W5
SY   1V-91223-11A
DR   Wikidata; Q98129937
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18714; DCP1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DCP1A, clone2
AC   CVCL_A0W6
SY   1V-91223-12B
DR   Wikidata; Q98129939
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18714; DCP1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DCP1A, clone3
AC   CVCL_A0W7
SY   1V-91223-5C
DR   Wikidata; Q98129941
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18714; DCP1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DCT, clone1
AC   CVCL_A0W8
SY   1V-92173-3A
DR   Wikidata; Q98129942
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2709; DCT.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DCT, clone2
AC   CVCL_A0W9
SY   1V-92173-4B
DR   Wikidata; Q98129943
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2709; DCT.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DCT, clone3
AC   CVCL_A0X0
SY   1V-92173-2C
DR   Wikidata; Q98129944
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2709; DCT.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DEDD2, clone1
AC   CVCL_A0X1
SY   1V-91400-2A
DR   Wikidata; Q98129945
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24450; DEDD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DEDD2, clone2
AC   CVCL_A0X2
SY   1V-91400-3B
DR   Wikidata; Q98129946
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24450; DEDD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DEDD2, clone3
AC   CVCL_A0X3
SY   1V-91400-4C
DR   Wikidata; Q98129947
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24450; DEDD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLK1, clone1
AC   CVCL_A0X4
SY   1V-93161-6A
DR   Wikidata; Q98129949
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2907; DLK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLK1, clone2
AC   CVCL_A0X5
SY   1V-93161-5B
DR   Wikidata; Q98129950
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2907; DLK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLK1, clone3
AC   CVCL_A0X6
SY   1V-93161-5C
DR   Wikidata; Q98129951
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2907; DLK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX1, clone1
AC   CVCL_A0X7
SY   1V-91933-3A
DR   Wikidata; Q98129952
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2914; DLX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX1, clone2
AC   CVCL_A0X8
SY   1V-91933-2B
DR   Wikidata; Q98129953
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2914; DLX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX1, clone3
AC   CVCL_A0X9
SY   1V-91933-6C
DR   Wikidata; Q98129954
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2914; DLX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX2, clone1
AC   CVCL_A0Y0
SY   1V-91385-6A
DR   Wikidata; Q98129956
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2915; DLX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX2, clone2
AC   CVCL_A0Y1
SY   1V-91385-1B
DR   Wikidata; Q98129957
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2915; DLX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX2, clone3
AC   CVCL_A0Y2
SY   1V-91385-4C
DR   Wikidata; Q98129958
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2915; DLX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX3, clone1
AC   CVCL_A0Y3
SY   1V-90987-1A
DR   Wikidata; Q98129959
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2916; DLX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX3, clone2
AC   CVCL_A0Y4
SY   1V-90987-9D
DR   Wikidata; Q98129960
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2916; DLX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX3, clone3
AC   CVCL_A0Y5
SY   1V-90987-3C
DR   Wikidata; Q98129961
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2916; DLX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX4, clone1
AC   CVCL_A0Y6
SY   1V-91386-6A
DR   Wikidata; Q98129962
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2917; DLX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX4, clone2
AC   CVCL_A0Y7
SY   1V-91386-4B
DR   Wikidata; Q98129963
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2917; DLX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX4, clone3
AC   CVCL_A0Y8
SY   1V-91386-5C
DR   Wikidata; Q98129965
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2917; DLX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX5, clone1
AC   CVCL_A0Y9
SY   1V-93073-4A
DR   Wikidata; Q98129966
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2918; DLX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX5, clone2
AC   CVCL_A0Z0
SY   1V-93073-3B
DR   Wikidata; Q98129967
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2918; DLX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX5, clone3
AC   CVCL_A0Z1
SY   1V-93073-6C
DR   Wikidata; Q98129968
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2918; DLX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX6, clone1
AC   CVCL_A0Z2
SY   1V-91785-3A
DR   Wikidata; Q98129969
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2919; DLX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX6, clone2
AC   CVCL_A0Z3
SY   1V-91785-1B
DR   Wikidata; Q98129971
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2919; DLX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DLX6, clone3
AC   CVCL_A0Z4
SY   1V-91785-2C
DR   Wikidata; Q98129972
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2919; DLX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRT1, clone1
AC   CVCL_A0Z5
SY   1V-90985-1A
DR   Wikidata; Q98129973
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2934; DMRT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRT1, clone2
AC   CVCL_A0Z6
SY   1V-90985-4B
DR   Wikidata; Q98129974
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2934; DMRT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRT1, clone3
AC   CVCL_A0Z7
SY   1V-90985-6C
DR   Wikidata; Q98129976
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2934; DMRT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRT2, clone1
AC   CVCL_A0Z8
SY   1V-93111-4A
DR   Wikidata; Q98129977
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2935; DMRT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRT2, clone2
AC   CVCL_A0Z9
SY   1V-93111-3B
DR   Wikidata; Q98129978
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2935; DMRT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRT2, clone3
AC   CVCL_A1A0
SY   1V-93111-6C
DR   Wikidata; Q98129980
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2935; DMRT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRTC2, clone1
AC   CVCL_A1A1
SY   1V-91387-4A
DR   Wikidata; Q98129982
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13911; DMRTC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DMRTC2, clone2
AC   CVCL_A1A2
SY   1V-91387-1B
DR   Wikidata; Q98129983
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13911; DMRTC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DNMT3B, clone1
AC   CVCL_A1A3
SY   1V-91284-1A
DR   Wikidata; Q98129984
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2979; DNMT3B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DNMT3B, clone2
AC   CVCL_A1A4
SY   1V-91284-4B
DR   Wikidata; Q98129985
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2979; DNMT3B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DNMT3B, clone3
AC   CVCL_A1A5
SY   1V-91284-5C
DR   Wikidata; Q98129986
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2979; DNMT3B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DNMT3L, clone1
AC   CVCL_A1A6
SY   1V-91393-2A
DR   Wikidata; Q98129988
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2980; DNMT3L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DNMT3L, clone2
AC   CVCL_A1A7
SY   1V-91393-4B
DR   Wikidata; Q98129991
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2980; DNMT3L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DNMT3L, clone3
AC   CVCL_A1A8
SY   1V-91393-5C
DR   Wikidata; Q98129993
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2980; DNMT3L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DPF1, clone1
AC   CVCL_A1A9
SY   1V-93162-5A
DR   Wikidata; Q98129995
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20225; DPF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DPF1, clone2
AC   CVCL_A1B0
SY   1V-93162-6B
DR   Wikidata; Q98129998
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20225; DPF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DPF1, clone3
AC   CVCL_A1B1
SY   1V-93162-1C
DR   Wikidata; Q98130000
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20225; DPF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DUX4, clone1
AC   CVCL_A1B2
SY   1V-93074-1A
DR   Wikidata; Q98130003
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:50800; DUX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DUX4, clone2
AC   CVCL_A1B3
SY   1V-93074-2B
DR   Wikidata; Q98130005
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:50800; DUX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DUX4, clone3
AC   CVCL_A1B4
SY   1V-93074-3C
DR   Wikidata; Q98130008
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:50800; DUX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DVL2, clone1
AC   CVCL_A1B5
SY   1V-93497-1A
DR   Wikidata; Q98130010
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3086; DVL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DVL2, clone2
AC   CVCL_A1B6
SY   1V-93497-2B
DR   Wikidata; Q98130012
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3086; DVL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human DVL2, clone3
AC   CVCL_A1B7
SY   1V-93497-4C
DR   Wikidata; Q98130015
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3086; DVL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F1, clone1
AC   CVCL_A1B8
SY   1V-91320-5A
DR   Wikidata; Q98130017
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3113; E2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F1, clone2
AC   CVCL_A1B9
SY   1V-91320-3B
DR   Wikidata; Q98130019
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3113; E2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F1, clone3
AC   CVCL_A1C0
SY   1V-91320-1C
DR   Wikidata; Q98130021
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3113; E2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F3, clone1
AC   CVCL_A1C1
SY   1V-92210-4A
DR   Wikidata; Q98130024
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3115; E2F3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F3, clone2
AC   CVCL_A1C2
SY   1V-92210-5B
DR   Wikidata; Q98130026
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3115; E2F3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F3, clone3
AC   CVCL_A1C3
SY   1V-92210-2C
DR   Wikidata; Q98130028
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3115; E2F3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F4, clone1
AC   CVCL_A1C4
SY   1V-90732-3A
DR   Wikidata; Q98130031
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3118; E2F4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F4, clone2
AC   CVCL_A1C5
SY   1V-90732-6B
DR   Wikidata; Q98130033
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3118; E2F4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F4, clone3
AC   CVCL_A1C6
SY   1V-90732-4C
DR   Wikidata; Q98130036
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3118; E2F4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F5, clone1
AC   CVCL_A1C7
SY   1V-92205-3A
DR   Wikidata; Q98130038
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3119; E2F5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F5, clone2
AC   CVCL_A1C8
SY   1V-92205-6B
DR   Wikidata; Q98130041
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3119; E2F5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F5, clone3
AC   CVCL_A1C9
SY   1V-92205-4C
DR   Wikidata; Q98130043
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3119; E2F5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F6, clone1
AC   CVCL_A1D0
SY   1V-91300-1A
DR   Wikidata; Q98130045
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3120; E2F6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F6, clone2
AC   CVCL_A1D1
SY   1V-91300-3B
DR   Wikidata; Q98130048
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3120; E2F6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F6, clone3
AC   CVCL_A1D2
SY   1V-91300-5C
DR   Wikidata; Q98130050
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3120; E2F6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F7, clone1
AC   CVCL_A1D3
SY   1V-91686-1A
DR   Wikidata; Q98130052
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23820; E2F7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F7, clone2
AC   CVCL_A1D4
SY   1V-91686-6B
DR   Wikidata; Q98130055
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23820; E2F7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human E2F7, clone3
AC   CVCL_A1D5
SY   1V-91686-5C
DR   Wikidata; Q98130057
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23820; E2F7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EBF1, clone1
AC   CVCL_A1D6
SY   1V-91687-1A
DR   Wikidata; Q98130059
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3126; EBF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EBF1, clone2
AC   CVCL_A1D7
SY   1V-91687-4B
DR   Wikidata; Q98130062
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3126; EBF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EBF1, clone3
AC   CVCL_A1D8
SY   1V-91687-3C
DR   Wikidata; Q98130064
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3126; EBF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EDF1, clone1
AC   CVCL_A1D9
SY   1V-92157-4A
DR   Wikidata; Q98130067
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3164; EDF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EDF1, clone2
AC   CVCL_A1E0
SY   1V-92157-1B
DR   Wikidata; Q98130070
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3164; EDF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EDF1, clone3
AC   CVCL_A1E1
SY   1V-92157-5C
DR   Wikidata; Q98130072
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3164; EDF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EDN3, clone1
AC   CVCL_A1E2
SY   1V-93053-2A
DR   Wikidata; Q98130075
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3178; EDN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EDN3, clone2
AC   CVCL_A1E3
SY   1V-93053-3B
DR   Wikidata; Q98130077
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3178; EDN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EDN3, clone3
AC   CVCL_A1E4
SY   1V-93053-1C
DR   Wikidata; Q98130079
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3178; EDN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EED, clone1
AC   CVCL_A1E5
SY   1V-91476-5A
DR   Wikidata; Q98130082
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3188; EED.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EED, clone2
AC   CVCL_A1E6
SY   1V-91476-4B
DR   Wikidata; Q98130084
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3188; EED.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EED, clone3
AC   CVCL_A1E7
SY   1V-91476-2C
DR   Wikidata; Q98130087
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3188; EED.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EEF1A1, clone1
AC   CVCL_A1E8
SY   1V-90760-5A
DR   Wikidata; Q98130089
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3189; EEF1A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EEF1A1, clone2
AC   CVCL_A1E9
SY   1V-90760-3B
DR   Wikidata; Q98130091
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3189; EEF1A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EEF1A1, clone3
AC   CVCL_A1F0
SY   1V-90760-10C
DR   Wikidata; Q98130094
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3189; EEF1A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGFLAM, clone1
AC   CVCL_A1F1
SY   1V-91786-1A
DR   Wikidata; Q98130096
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26810; EGFLAM.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGFLAM, clone2
AC   CVCL_A1F2
SY   1V-91786-2B
DR   Wikidata; Q98130098
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26810; EGFLAM.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGFLAM, clone3
AC   CVCL_A1F3
SY   1V-91786-3C
DR   Wikidata; Q98130101
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26810; EGFLAM.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGR1, clone1
AC   CVCL_A1F4
SY   1V-91339-6A
DR   Wikidata; Q98130104
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3238; EGR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGR1, clone2
AC   CVCL_A1F5
SY   1V-91339-1B
DR   Wikidata; Q98130106
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3238; EGR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGR1, clone3
AC   CVCL_A1F6
SY   1V-91339-2C
DR   Wikidata; Q98130110
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3238; EGR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGR2, clone1
AC   CVCL_A1F7
SY   1V-91407-6A
DR   Wikidata; Q98130112
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3239; EGR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGR2, clone2
AC   CVCL_A1F8
SY   1V-91407-2B
DR   Wikidata; Q98130114
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3239; EGR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EGR2, clone3
AC   CVCL_A1F9
SY   1V-91407-4C
DR   Wikidata; Q98130117
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3239; EGR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EHF, clone1
AC   CVCL_A1G0
SY   1V-93103-6A
DR   Wikidata; Q98130118
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3246; EHF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EHF, clone2
AC   CVCL_A1G1
SY   1V-93103-2B
DR   Wikidata; Q98130122
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3246; EHF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EHF, clone3
AC   CVCL_A1G2
SY   1V-93103-4C
DR   Wikidata; Q98130124
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3246; EHF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EIF4E, clone1
AC   CVCL_A1G3
SY   1V-90728-1A
DR   Wikidata; Q98130127
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3287; EIF4E.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EIF4E, clone2
AC   CVCL_A1G4
SY   1V-90728-6B
DR   Wikidata; Q98130129
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3287; EIF4E.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EIF4E, clone3
AC   CVCL_A1G5
SY   1V-90728-5C
DR   Wikidata; Q98130132
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3287; EIF4E.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF1, clone1
AC   CVCL_A1G6
SY   1V-90726-2A
DR   Wikidata; Q98130134
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3316; ELF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF1, clone2
AC   CVCL_A1G7
SY   1V-90726-1B
DR   Wikidata; Q98130136
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3316; ELF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF1, clone3
AC   CVCL_A1G8
SY   1V-90726-6C
DR   Wikidata; Q98130139
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3316; ELF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF2, clone1
AC   CVCL_A1G9
SY   1V-92181-4A
DR   Wikidata; Q98130141
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3317; ELF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF2, clone2
AC   CVCL_A1H0
SY   1V-92181-2B
DR   Wikidata; Q98130143
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3317; ELF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF2, clone3
AC   CVCL_A1H1
SY   1V-92181-3C
DR   Wikidata; Q98130146
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3317; ELF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF3, clone1
AC   CVCL_A1H2
SY   1V-92187-5A
DR   Wikidata; Q98130148
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3318; ELF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF3, clone2
AC   CVCL_A1H3
SY   1V-92187-3B
DR   Wikidata; Q98130152
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3318; ELF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF3, clone3
AC   CVCL_A1H4
SY   1V-92187-4C
DR   Wikidata; Q98130155
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3318; ELF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF4, clone1
AC   CVCL_A1H5
SY   1V-92160-5A
DR   Wikidata; Q98130158
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3319; ELF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF4, clone2
AC   CVCL_A1H6
SY   1V-92160-2B
DR   Wikidata; Q98130161
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3319; ELF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF4, clone3
AC   CVCL_A1H7
SY   1V-92160-4C
DR   Wikidata; Q98130163
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3319; ELF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF5, clone1
AC   CVCL_A1H8
SY   1V-90551-1F
DR   Wikidata; Q98130165
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3320; ELF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF5, clone2
AC   CVCL_A1H9
SY   1V-90551-18G
DR   Wikidata; Q98130168
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3320; ELF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF5, clone3
AC   CVCL_A1I0
SY   1V-90551-17H
DR   Wikidata; Q98130170
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3320; ELF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF5, clone4
AC   CVCL_A1I1
SY   1V-90551-6A
DR   RCB; HES0015
DR   Wikidata; Q98130173
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3320; ELF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELF5, clone5
AC   CVCL_A1I2
SY   1V-90551-1B
DR   RCB; HES0016
DR   Wikidata; Q98130175
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3320; ELF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELK1, clone1
AC   CVCL_A1I3
SY   1V-91398-3A
DR   Wikidata; Q98130177
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3321; ELK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELK1, clone2
AC   CVCL_A1I4
SY   1V-91398-6B
DR   Wikidata; Q98130180
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3321; ELK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELK1, clone3
AC   CVCL_A1I5
SY   1V-91398-2C
DR   Wikidata; Q98130182
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3321; ELK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELK3, clone1
AC   CVCL_A1I6
SY   1V-91910-4A
DR   Wikidata; Q98130184
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3325; ELK3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELK3, clone2
AC   CVCL_A1I7
SY   1V-91910-2B
DR   Wikidata; Q98130186
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3325; ELK3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELK3, clone3
AC   CVCL_A1I8
SY   1V-91910-1C
DR   Wikidata; Q98130189
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3325; ELK3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELL2, clone1
AC   CVCL_A1I9
SY   1V-91237-1A
DR   Wikidata; Q98130190
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17064; ELL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELL2, clone2
AC   CVCL_A1J0
SY   1V-91237-3B
DR   Wikidata; Q98130191
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17064; ELL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ELL2, clone3
AC   CVCL_A1J1
SY   1V-91237-5C
DR   Wikidata; Q98130194
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17064; ELL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EMX2, clone1
AC   CVCL_A1J2
SY   1V-93107-3A
DR   Wikidata; Q98130197
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3341; EMX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EMX2, clone2
AC   CVCL_A1J3
SY   1V-93107-4B
DR   Wikidata; Q98130200
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3341; EMX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EMX2, clone3
AC   CVCL_A1J4
SY   1V-93107-5C
DR   Wikidata; Q98130202
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3341; EMX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EN1, clone1
AC   CVCL_A1J5
SY   1V-91765-1A
DR   Wikidata; Q98130204
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3342; EN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EN1, clone2
AC   CVCL_A1J6
SY   1V-91765-2D
DR   Wikidata; Q98130207
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3342; EN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EN1, clone3
AC   CVCL_A1J7
SY   1V-91765-4C
DR   Wikidata; Q98130209
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3342; EN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EOMES, clone1
AC   CVCL_A1J8
SY   1V-91688-4A
DR   RCB; HES0013
DR   Wikidata; Q98130211
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3372; EOMES.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EOMES, clone2
AC   CVCL_A1J9
SY   1V-91688-2B
DR   RCB; HES0014
DR   Wikidata; Q98130213
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3372; EOMES.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EOMES, clone3
AC   CVCL_A1K0
SY   1V-91688-7D
DR   Wikidata; Q98130215
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3372; EOMES.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ERG, clone1
AC   CVCL_A1K1
SY   1V-91373-1A
DR   Wikidata; Q98130218
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3446; ERG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ERG, clone2
AC   CVCL_A1K2
SY   1V-91373-3B
DR   Wikidata; Q98130220
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3446; ERG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ERG, clone3
AC   CVCL_A1K3
SY   1V-91373-4C
DR   Wikidata; Q98130222
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3446; ERG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESR1, clone1
AC   CVCL_A1K4
SY   1V-91477-4A
DR   Wikidata; Q98130225
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESR1, clone2
AC   CVCL_A1K5
SY   1V-91477-6B
DR   Wikidata; Q98130227
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESR1, clone3
AC   CVCL_A1K6
SY   1V-91477-2C
DR   Wikidata; Q98130228
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3467; ESR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESR2, clone1
AC   CVCL_A1K7
SY   1V-93360-7A
DR   Wikidata; Q98130229
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3468; ESR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESR2, clone2
AC   CVCL_A1K8
SY   1V-93360-8B
DR   Wikidata; Q98130232
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3468; ESR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESR2, clone3
AC   CVCL_A1K9
SY   1V-93360-12C
DR   Wikidata; Q98130233
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3468; ESR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRA, clone1
AC   CVCL_A1L0
SY   1V-91317-2A
DR   Wikidata; Q98130234
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3471; ESRRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRA, clone2
AC   CVCL_A1L1
SY   1V-91317-1B
DR   Wikidata; Q98130235
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3471; ESRRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRA, clone3
AC   CVCL_A1L2
SY   1V-91317-4C
DR   Wikidata; Q98130237
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3471; ESRRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRB, clone1
AC   CVCL_A1L3
SY   1V-90930-1A
DR   RCB; HES0011
DR   Wikidata; Q98130238
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3473; ESRRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRB, clone2
AC   CVCL_A1L4
SY   1V-90930-3B
DR   RCB; HES0012
DR   Wikidata; Q98130239
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3473; ESRRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRB, clone3
AC   CVCL_A1L5
SY   1V-90930-5C
DR   Wikidata; Q98130240
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3473; ESRRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRG, clone1
AC   CVCL_A1L6
SY   1V-91341-1A
DR   Wikidata; Q98130241
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3474; ESRRG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRG, clone2
AC   CVCL_A1L7
SY   1V-91341-3C
DR   Wikidata; Q98130242
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3474; ESRRG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESRRG, clone3
AC   CVCL_A1L8
SY   1V-91341-11D
DR   Wikidata; Q98130243
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3474; ESRRG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESX1, clone1
AC   CVCL_A1L9
SY   1V-90981-4A
DR   Wikidata; Q98130244
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14865; ESX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESX1, clone2
AC   CVCL_A1M0
SY   1V-90981-5B
DR   Wikidata; Q98130245
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14865; ESX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ESX1, clone3
AC   CVCL_A1M1
SY   1V-90981-2C
DR   Wikidata; Q98130246
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14865; ESX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETS1, clone1
AC   CVCL_A1M2
SY   1V-90997-3A
DR   Wikidata; Q98130247
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3488; ETS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETS1, clone2
AC   CVCL_A1M3
SY   1V-90997-1B
DR   Wikidata; Q98130248
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3488; ETS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETS1, clone3
AC   CVCL_A1M4
SY   1V-90997-4C
DR   Wikidata; Q98130249
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3488; ETS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETS2, clone1
AC   CVCL_A1M5
SY   1V-91249-3A
DR   Wikidata; Q98130250
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3489; ETS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETS2, clone2
AC   CVCL_A1M6
SY   1V-91249-1B
DR   Wikidata; Q98130252
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3489; ETS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETS2, clone3
AC   CVCL_A1M7
SY   1V-91249-7E
DR   Wikidata; Q98130253
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3489; ETS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV1, clone1
AC   CVCL_A1M8
SY   1V-93163-2A
DR   Wikidata; Q98130254
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3490; ETV1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV1, clone2
AC   CVCL_A1M9
SY   1V-93163-4B
DR   Wikidata; Q98130255
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3490; ETV1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV1, clone3
AC   CVCL_A1N0
SY   1V-93163-6C
DR   Wikidata; Q98130256
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3490; ETV1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV2, clone1
AC   CVCL_A1N1
SY   1V-93075-3A
DR   Wikidata; Q98130257
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3491; ETV2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV2, clone2
AC   CVCL_A1N2
SY   1V-93075-1B
DR   Wikidata; Q98130258
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3491; ETV2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV2, clone3
AC   CVCL_A1N3
SY   1V-93075-2C
DR   Wikidata; Q98130259
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3491; ETV2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV3, clone1
AC   CVCL_A1N4
SY   1V-91250-5A
DR   Wikidata; Q98130260
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3492; ETV3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV3, clone2
AC   CVCL_A1N5
SY   1V-91250-2B
DR   Wikidata; Q98130261
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3492; ETV3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV3, clone3
AC   CVCL_A1N6
SY   1V-91250-7D
DR   Wikidata; Q98130262
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3492; ETV3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV4, clone1
AC   CVCL_A1N7
SY   1V-92103-1A
DR   Wikidata; Q98130263
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3493; ETV4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV4, clone2
AC   CVCL_A1N8
SY   1V-92103-2B
DR   Wikidata; Q98130264
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3493; ETV4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV4, clone3
AC   CVCL_A1N9
SY   1V-92103-3C
DR   Wikidata; Q98130265
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3493; ETV4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV5, clone1
AC   CVCL_A1P0
SY   1V-91230-5A
DR   Wikidata; Q98130266
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3494; ETV5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV5, clone2
AC   CVCL_A1P1
SY   1V-91230-3B
DR   Wikidata; Q98130267
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3494; ETV5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV5, clone3
AC   CVCL_A1P2
SY   1V-91230-1C
DR   Wikidata; Q98130269
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3494; ETV5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV6, clone1
AC   CVCL_A1P3
SY   1V-93361-4A
DR   Wikidata; Q98130271
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3495; ETV6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV6, clone2
AC   CVCL_A1P4
SY   1V-93361-6B
DR   Wikidata; Q98130272
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3495; ETV6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ETV6, clone3
AC   CVCL_A1P5
SY   1V-93361-5C
DR   Wikidata; Q98130273
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3495; ETV6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EVX1, clone1
AC   CVCL_A1P6
SY   1V-93355-2A
DR   Wikidata; Q98130274
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3506; EVX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EVX1, clone2
AC   CVCL_A1P7
SY   1V-93355-3B
DR   Wikidata; Q98130275
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3506; EVX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EVX1, clone3
AC   CVCL_A1P8
SY   1V-93355-4C
DR   Wikidata; Q98130276
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3506; EVX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EYA1, clone1
AC   CVCL_A1P9
SY   1V-91787-5A
DR   Wikidata; Q98130277
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3519; EYA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EYA1, clone2
AC   CVCL_A1Q0
SY   1V-91787-12D
DR   Wikidata; Q98130278
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3519; EYA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EYA1, clone3
AC   CVCL_A1Q1
SY   1V-91787-10E
DR   Wikidata; Q98130279
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3519; EYA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EZH2, clone1
AC   CVCL_A1Q2
SY   1V-91267-12C
DR   Wikidata; Q98130280
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EZH2, clone2
AC   CVCL_A1Q3
SY   1V-91267-13D
DR   Wikidata; Q98130281
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human EZH2, clone3
AC   CVCL_A1Q4
SY   1V-91267-17E
DR   Wikidata; Q98130282
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3527; EZH2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FAM48A, clone1
AC   CVCL_A1Q5
SY   1V-90740-1A
DR   Wikidata; Q98130283
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20596; SUPT20H.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FAM48A, clone2
AC   CVCL_A1Q6
SY   1V-90740-3B
DR   Wikidata; Q98130284
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20596; SUPT20H.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FAM48A, clone3
AC   CVCL_A1Q7
SY   1V-90740-2C
DR   Wikidata; Q98130285
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20596; SUPT20H.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FBXO15, clone1
AC   CVCL_A1Q8
SY   1V-91274-2A
DR   Wikidata; Q98130286
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13617; FBXO15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FBXO15, clone2
AC   CVCL_A1Q9
SY   1V-91274-1B
DR   Wikidata; Q98130287
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13617; FBXO15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FBXO15, clone3
AC   CVCL_A1R0
SY   1V-91274-7C
DR   Wikidata; Q98130289
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13617; FBXO15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FEM1B, clone1
AC   CVCL_A1R1
SY   1V-93164-4A
DR   Wikidata; Q98130290
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3649; FEM1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FEM1B, clone2
AC   CVCL_A1R2
SY   1V-93164-3B
DR   Wikidata; Q98130291
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3649; FEM1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FEM1B, clone3
AC   CVCL_A1R3
SY   1V-93164-6C
DR   Wikidata; Q98130292
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3649; FEM1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FERD3L, clone1
AC   CVCL_A1R4
SY   1V-93080-5A
DR   Wikidata; Q98130293
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16660; FERD3L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FERD3L, clone2
AC   CVCL_A1R5
SY   1V-93080-6B
DR   Wikidata; Q98130294
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16660; FERD3L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FERD3L, clone3
AC   CVCL_A1R6
SY   1V-93080-3C
DR   Wikidata; Q98130296
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16660; FERD3L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FEV, clone1
AC   CVCL_A1R7
SY   1V-92168-2A
DR   Wikidata; Q98130297
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18562; FEV.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FEV, clone2
AC   CVCL_A1R8
SY   1V-92168-3B
DR   Wikidata; Q98130298
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18562; FEV.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FEV, clone3
AC   CVCL_A1R9
SY   1V-92168-1C
DR   Wikidata; Q98130299
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18562; FEV.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF1, clone1
AC   CVCL_A1S0
SY   1V-93046-5A
DR   Wikidata; Q98130300
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3665; FGF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF1, clone2
AC   CVCL_A1S1
SY   1V-93046-4B
DR   Wikidata; Q98130301
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3665; FGF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF1, clone3
AC   CVCL_A1S2
SY   1V-93046-6C
DR   Wikidata; Q98130302
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3665; FGF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF10, clone1
AC   CVCL_A1S3
SY   1V-91930-5D
DR   Wikidata; Q98130303
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3666; FGF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF10, clone2
AC   CVCL_A1S4
SY   1V-91930-11E
DR   Wikidata; Q98130304
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3666; FGF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF10, clone3
AC   CVCL_A1S5
SY   1V-91930-6F
DR   Wikidata; Q98130305
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3666; FGF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF18, clone1
AC   CVCL_A1S6
SY   1V-92144-1A
DR   Wikidata; Q98130306
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3674; FGF18.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF18, clone2
AC   CVCL_A1S7
SY   1V-92144-3B
DR   Wikidata; Q98130308
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3674; FGF18.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF18, clone3
AC   CVCL_A1S8
SY   1V-92144-6C
DR   Wikidata; Q98130309
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3674; FGF18.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF21, clone1
AC   CVCL_A1S9
SY   1V-92199-4A
DR   Wikidata; Q98130310
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3678; FGF21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF21, clone2
AC   CVCL_A1T0
SY   1V-92199-5B
DR   Wikidata; Q98130311
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3678; FGF21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF21, clone3
AC   CVCL_A1T1
SY   1V-92199-6C
DR   Wikidata; Q98130312
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3678; FGF21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF4, clone1
AC   CVCL_A1T2
SY   1V-92220-1A
DR   Wikidata; Q98130313
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3682; FGF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF4, clone2
AC   CVCL_A1T3
SY   1V-92220-2B
DR   Wikidata; Q98130314
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3682; FGF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF4, clone3
AC   CVCL_A1T4
SY   1V-92220-4C
DR   Wikidata; Q98130315
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3682; FGF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF7, clone1
AC   CVCL_A1T5
SY   1V-93047-4A
DR   Wikidata; Q98130316
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3685; FGF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF7, clone2
AC   CVCL_A1T6
SY   1V-93047-3B
DR   Wikidata; Q98130317
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3685; FGF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGF7, clone3
AC   CVCL_A1T7
SY   1V-93047-5C
DR   Wikidata; Q98130318
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3685; FGF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGFBP1, clone1
AC   CVCL_A1T8
SY   1V-91689-1A
DR   Wikidata; Q98130319
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19695; FGFBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGFBP1, clone2
AC   CVCL_A1T9
SY   1V-91689-3B
DR   Wikidata; Q98130320
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19695; FGFBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGFBP1, clone3
AC   CVCL_A1U0
SY   1V-91689-2C
DR   Wikidata; Q98130321
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19695; FGFBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGR, clone1
AC   CVCL_A1U1
SY   1V-93362-4A
DR   Wikidata; Q98130322
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3697; FGR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGR, clone2
AC   CVCL_A1U2
SY   1V-93362-2B
DR   Wikidata; Q98130323
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3697; FGR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FGR, clone3
AC   CVCL_A1U3
SY   1V-93362-3C
DR   Wikidata; Q98130325
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3697; FGR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FIGLA, clone1
AC   CVCL_A1U4
SY   1V-91868-2A
DR   Wikidata; Q98130326
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24669; FIGLA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FIGLA, clone2
AC   CVCL_A1U5
SY   1V-91868-6B
DR   Wikidata; Q98130327
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24669; FIGLA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FIGLA, clone3
AC   CVCL_A1U6
SY   1V-91868-1C
DR   Wikidata; Q98130328
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24669; FIGLA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FLI1, clone1
AC   CVCL_A1U7
SY   1V-91247-1A
DR   Wikidata; Q98130329
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3749; FLI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FLI1, clone2
AC   CVCL_A1U8
SY   1V-91247-4F
DR   Wikidata; Q98130330
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3749; FLI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FLI1, clone3
AC   CVCL_A1U9
SY   1V-91247-6E
DR   Wikidata; Q98130331
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3749; FLI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOS, clone1
AC   CVCL_A1V0
SY   1V-90747-1A
DR   Wikidata; Q98130332
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOS, clone2
AC   CVCL_A1V1
SY   1V-90747-3B
DR   Wikidata; Q98130333
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOS, clone3
AC   CVCL_A1V2
SY   1V-90747-6C
DR   Wikidata; Q98130334
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3796; FOS.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSB, clone1
AC   CVCL_A1V3
SY   1V-93076-2A
DR   Wikidata; Q98130335
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3797; FOSB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSB, clone2
AC   CVCL_A1V4
SY   1V-93076-5B
DR   Wikidata; Q98130336
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3797; FOSB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSB, clone3
AC   CVCL_A1V5
SY   1V-93076-4C
DR   Wikidata; Q98130337
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3797; FOSB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSL1, clone1
AC   CVCL_A1V6
SY   1V-90729-5A
DR   Wikidata; Q98130338
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13718; FOSL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSL1, clone2
AC   CVCL_A1V7
SY   1V-90729-4B
DR   Wikidata; Q98130339
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13718; FOSL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSL1, clone3
AC   CVCL_A1V8
SY   1V-90729-3C
DR   Wikidata; Q98130340
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13718; FOSL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSL2, clone1
AC   CVCL_A1V9
SY   1V-90598-5A
DR   Wikidata; Q98130341
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3798; FOSL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSL2, clone2
AC   CVCL_A1W0
SY   1V-90598-4B
DR   Wikidata; Q98130343
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3798; FOSL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOSL2, clone3
AC   CVCL_A1W1
SY   1V-90598-6C
DR   Wikidata; Q98130344
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3798; FOSL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXA1, clone1
AC   CVCL_A1W2
SY   1V-90599-4A
DR   Wikidata; Q98130345
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5021; FOXA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXA1, clone2
AC   CVCL_A1W3
SY   1V-90599-5B
DR   Wikidata; Q98130347
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5021; FOXA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXA1, clone3
AC   CVCL_A1W4
SY   1V-90599-1C
DR   Wikidata; Q98130348
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5021; FOXA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXA2, clone1
AC   CVCL_A1W5
SY   1V-91255-5A
DR   Wikidata; Q98130349
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5022; FOXA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXA2, clone2
AC   CVCL_A1W6
SY   1V-91255-3B
DR   Wikidata; Q98130350
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5022; FOXA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXA2, clone3
AC   CVCL_A1W7
SY   1V-91255-4C
DR   Wikidata; Q98130351
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5022; FOXA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXB1, clone1
AC   CVCL_A1W8
SY   1V-93077-2A
DR   Wikidata; Q98130352
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3799; FOXB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXB1, clone2
AC   CVCL_A1W9
SY   1V-93077-6B
DR   Wikidata; Q98130353
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3799; FOXB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXB1, clone3
AC   CVCL_A1X0
SY   1V-93077-4C
DR   Wikidata; Q98130354
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3799; FOXB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXC1, clone1
AC   CVCL_A1X1
SY   1V-91478-5A
DR   Wikidata; Q98130355
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3800; FOXC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXC1, clone2
AC   CVCL_A1X2
SY   1V-91478-6B
DR   Wikidata; Q98130356
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3800; FOXC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXC1, clone3
AC   CVCL_A1X3
SY   1V-91478-2C
DR   Wikidata; Q98130357
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3800; FOXC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXC2, clone1
AC   CVCL_A1X4
SY   1V-92104-3A
DR   Wikidata; Q98130358
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3801; FOXC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXC2, clone2
AC   CVCL_A1X5
SY   1V-92104-4B
DR   Wikidata; Q98130359
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3801; FOXC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXC2, clone3
AC   CVCL_A1X6
SY   1V-92104-6C
DR   Wikidata; Q98130360
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3801; FOXC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD1, clone1
AC   CVCL_A1X7
SY   1V-91945-4A
DR   Wikidata; Q98130361
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3802; FOXD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD1, clone2
AC   CVCL_A1X8
SY   1V-91945-2B
DR   Wikidata; Q98130362
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3802; FOXD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD1, clone3
AC   CVCL_A1X9
SY   1V-91945-6C
DR   Wikidata; Q98130363
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3802; FOXD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD3, clone1
AC   CVCL_A1Y0
SY   1V-93363-4A
DR   Wikidata; Q98130364
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3804; FOXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD3, clone2
AC   CVCL_A1Y1
SY   1V-93363-2B
DR   Wikidata; Q98130365
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3804; FOXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD3, clone3
AC   CVCL_A1Y2
SY   1V-93363-1C
DR   Wikidata; Q98130366
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3804; FOXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L1, clone1
AC   CVCL_A1Y3
SY   1V-92216-2A
DR   Wikidata; Q98130367
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18521; FOXD4L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L1, clone2
AC   CVCL_A1Y4
SY   1V-92216-3B
DR   Wikidata; Q98130368
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18521; FOXD4L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L3, clone1
AC   CVCL_A1Y5
SY   1V-92237-9A
DR   Wikidata; Q98130369
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18523; FOXD4L3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L3, clone2
AC   CVCL_A1Y6
SY   1V-92237-10B
DR   Wikidata; Q98130370
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18523; FOXD4L3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L3, clone3
AC   CVCL_A1Y7
SY   1V-92237-12C
DR   Wikidata; Q98130371
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18523; FOXD4L3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L4, clone1
AC   CVCL_A1Y8
SY   1V-92236-2A
DR   Wikidata; Q98130372
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23762; FOXD4L4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L4, clone2
AC   CVCL_A1Y9
SY   1V-92236-5C
DR   Wikidata; Q98130373
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23762; FOXD4L4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXD4L4, clone3
AC   CVCL_A1Z0
SY   1V-92236-3D
DR   Wikidata; Q98130374
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23762; FOXD4L4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXE1, clone1
AC   CVCL_A1Z1
SY   1V-93078-1A
DR   Wikidata; Q98130375
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3806; FOXE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXE1, clone2
AC   CVCL_A1Z2
SY   1V-93078-4B
DR   Wikidata; Q98130376
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3806; FOXE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXE1, clone3
AC   CVCL_A1Z3
SY   1V-93078-3C
DR   Wikidata; Q98130377
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3806; FOXE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXE3, clone1
AC   CVCL_A1Z4
SY   1V-92215-4A
DR   Wikidata; Q98130378
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3808; FOXE3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXE3, clone2
AC   CVCL_A1Z5
SY   1V-92215-3B
DR   Wikidata; Q98130379
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3808; FOXE3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXE3, clone3
AC   CVCL_A1Z6
SY   1V-92215-2C
DR   Wikidata; Q98130380
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3808; FOXE3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXF1, clone1
AC   CVCL_A1Z7
SY   1V-93091-6A
DR   Wikidata; Q98130381
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3809; FOXF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXF1, clone2
AC   CVCL_A1Z8
SY   1V-93091-5B
DR   Wikidata; Q98130382
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3809; FOXF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXF1, clone3
AC   CVCL_A1Z9
SY   1V-93091-3C
DR   Wikidata; Q98130383
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3809; FOXF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXG1, clone1
AC   CVCL_A2A0
SY   1V-90999-4A
DR   Wikidata; Q98130385
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3811; FOXG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXG1, clone2
AC   CVCL_A2A1
SY   1V-90999-5B
DR   Wikidata; Q98130386
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3811; FOXG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXG1, clone3
AC   CVCL_A2A2
SY   1V-90999-2C
DR   Wikidata; Q98130387
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3811; FOXG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXH1, clone1
AC   CVCL_A2A3
SY   1V-91220-5A
DR   Wikidata; Q98130388
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3814; FOXH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXH1, clone2
AC   CVCL_A2A4
SY   1V-91220-6B
DR   Wikidata; Q98130389
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3814; FOXH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXH1, clone3
AC   CVCL_A2A5
SY   1V-91220-3C
DR   Wikidata; Q98130390
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3814; FOXH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXJ1, clone1
AC   CVCL_A2A6
SY   1V-93364-2A
DR   Wikidata; Q98130391
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3816; FOXJ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXJ1, clone2
AC   CVCL_A2A7
SY   1V-93364-3B
DR   Wikidata; Q98130392
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3816; FOXJ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXJ1, clone3
AC   CVCL_A2A8
SY   1V-93364-5C
DR   Wikidata; Q98130393
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3816; FOXJ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXJ2, clone1
AC   CVCL_A2A9
SY   1V-92312-1A
DR   Wikidata; Q98130394
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24818; FOXJ2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXJ2, clone2
AC   CVCL_A2B0
SY   1V-92312-2B
DR   Wikidata; Q98130395
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24818; FOXJ2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXJ2, clone3
AC   CVCL_A2B1
SY   1V-92312-3C
DR   Wikidata; Q98130396
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24818; FOXJ2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXL1, clone1
AC   CVCL_A2B2
SY   1V-93079-2A
DR   Wikidata; Q98130397
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3817; FOXL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXL1, clone2
AC   CVCL_A2B3
SY   1V-93079-3B
DR   Wikidata; Q98130398
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3817; FOXL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXL1, clone3
AC   CVCL_A2B4
SY   1V-93079-5C
DR   Wikidata; Q98130399
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3817; FOXL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXL2, clone1
AC   CVCL_A2B5
SY   1V-90989-6A
DR   Wikidata; Q98130402
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1092; FOXL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXL2, clone2
AC   CVCL_A2B6
SY   1V-90989-2B
DR   Wikidata; Q98130403
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1092; FOXL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXL2, clone3
AC   CVCL_A2B7
SY   1V-90989-3C
DR   Wikidata; Q98130404
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1092; FOXL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXM1, clone1
AC   CVCL_A2B8
SY   1V-91326-2A
DR   Wikidata; Q98130405
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3818; FOXM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXM1, clone2
AC   CVCL_A2B9
SY   1V-91326-3B
DR   Wikidata; Q98130406
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3818; FOXM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXM1, clone3
AC   CVCL_A2C0
SY   1V-91326-4C
DR   Wikidata; Q98130408
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3818; FOXM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXN1, clone1
AC   CVCL_A2C1
SY   1V-92105-2A
DR   Wikidata; Q98130409
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12765; FOXN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXN1, clone2
AC   CVCL_A2C2
SY   1V-92105-3B
DR   Wikidata; Q98130410
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12765; FOXN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXN1, clone3
AC   CVCL_A2C3
SY   1V-92105-4C
DR   Wikidata; Q98130412
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12765; FOXN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXN3, clone1
AC   CVCL_A2C4
SY   1V-91270-2A
DR   Wikidata; Q98130413
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1928; FOXN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXN3, clone2
AC   CVCL_A2C5
SY   1V-91270-4B
DR   Wikidata; Q98130414
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1928; FOXN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXN3, clone3
AC   CVCL_A2C6
SY   1V-91270-1C
DR   Wikidata; Q98130415
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1928; FOXN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXO3, clone1
AC   CVCL_A2C7
SY   1V-93498-2A
DR   Wikidata; Q98130416
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXO3, clone2
AC   CVCL_A2C8
SY   1V-93498-4B
DR   Wikidata; Q98130417
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXO3, clone3
AC   CVCL_A2C9
SY   1V-93498-6C
DR   Wikidata; Q98130418
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXP1, clone1
AC   CVCL_A2D0
SY   1V-91311-6A
DR   Wikidata; Q98130419
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3823; FOXP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXP1, clone2
AC   CVCL_A2D1
SY   1V-91311-4B
DR   Wikidata; Q98130420
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3823; FOXP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXP1, clone3
AC   CVCL_A2D2
SY   1V-91311-3C
DR   Wikidata; Q98130421
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3823; FOXP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXP3, clone1
AC   CVCL_A2D3
SY   1V-91503-2A
DR   Wikidata; Q98130422
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXP3, clone2
AC   CVCL_A2D4
SY   1V-91503-1B
DR   Wikidata; Q98130423
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXP3, clone3
AC   CVCL_A2D5
SY   1V-91503-4C
DR   Wikidata; Q98130424
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXS1, clone1
AC   CVCL_A2D6
SY   1V-91923-3A
DR   Wikidata; Q98130425
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3735; FOXS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXS1, clone2
AC   CVCL_A2D7
SY   1V-91923-1B
DR   Wikidata; Q98130426
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3735; FOXS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FOXS1, clone3
AC   CVCL_A2D8
SY   1V-91923-5C
DR   Wikidata; Q98130427
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3735; FOXS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FUBP1, clone1
AC   CVCL_A2D9
SY   1V-92198-4A
DR   Wikidata; Q98130428
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4004; FUBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FUBP1, clone2
AC   CVCL_A2E0
SY   1V-92198-2B
DR   Wikidata; Q98130430
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4004; FUBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FUBP1, clone3
AC   CVCL_A2E1
SY   1V-92198-3C
DR   Wikidata; Q98130431
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4004; FUBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FXR1, clone1
AC   CVCL_A2E2
SY   1V-90722-4A
DR   Wikidata; Q98130432
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4023; FXR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FXR1, clone2
AC   CVCL_A2E3
SY   1V-90722-2B
DR   Wikidata; Q98130433
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4023; FXR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human FXR1, clone3
AC   CVCL_A2E4
SY   1V-90722-6C
DR   Wikidata; Q98130434
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4023; FXR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GABPA, clone1
AC   CVCL_A2E5
SY   1V-91304-5A
DR   Wikidata; Q98130435
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4071; GABPA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GABPA, clone2
AC   CVCL_A2E6
SY   1V-91304-3B
DR   Wikidata; Q98130436
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4071; GABPA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GABPA, clone3
AC   CVCL_A2E7
SY   1V-91304-2C
DR   Wikidata; Q98130437
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4071; GABPA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GADD45A, clone1
AC   CVCL_A2E8
SY   1V-90847-19A
DR   Wikidata; Q98130438
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4095; GADD45A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GADD45A, clone2
AC   CVCL_A2E9
SY   1V-90847-22B
DR   Wikidata; Q98130439
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4095; GADD45A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GADD45A, clone3
AC   CVCL_A2F0
SY   1V-90847-21C
DR   Wikidata; Q98130440
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4095; GADD45A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA1, clone1
AC   CVCL_A2F1
SY   1V-91479-4A
DR   Wikidata; Q98130441
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4170; GATA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA1, clone2
AC   CVCL_A2F2
SY   1V-91479-2B
DR   Wikidata; Q98130442
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4170; GATA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA1, clone3
AC   CVCL_A2F3
SY   1V-91479-3C
DR   Wikidata; Q98130443
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4170; GATA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA2, clone1
AC   CVCL_A2F4
SY   1V-90855-3A
DR   Wikidata; Q98130444
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA2, clone2
AC   CVCL_A2F5
SY   1V-90855-5B
DR   Wikidata; Q98130445
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA2, clone3
AC   CVCL_A2F6
SY   1V-90855-6C
DR   Wikidata; Q98130446
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4171; GATA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA3, clone1
AC   CVCL_A2F7
SY   1V-90995-3A
DR   Wikidata; Q98130447
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4172; GATA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA3, clone2
AC   CVCL_A2F8
SY   1V-90995-4B
DR   Wikidata; Q98130448
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4172; GATA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA3, clone3
AC   CVCL_A2F9
SY   1V-90995-1C
DR   Wikidata; Q98130449
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4172; GATA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA6, clone1
AC   CVCL_A2G0
SY   1V-92310-6A
DR   Wikidata; Q98130450
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4174; GATA6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA6, clone2
AC   CVCL_A2G1
SY   1V-92310-5B
DR   Wikidata; Q98130451
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4174; GATA6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GATA6, clone3
AC   CVCL_A2G2
SY   1V-92310-4C
DR   Wikidata; Q98130452
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4174; GATA6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GBX2, clone1
AC   CVCL_A2G3
SY   1V-91213-5A
DR   Wikidata; Q98130454
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4186; GBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GBX2, clone2
AC   CVCL_A2G4
SY   1V-91213-2B
DR   Wikidata; Q98130455
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4186; GBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GBX2, clone3
AC   CVCL_A2G5
SY   1V-91213-1C
DR   Wikidata; Q98130456
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4186; GBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLI1, clone1
AC   CVCL_A2G6
SY   1V-91394-4A
DR   Wikidata; Q98130457
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4317; GLI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLI1, clone2
AC   CVCL_A2G7
SY   1V-91394-1B
DR   Wikidata; Q98130458
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4317; GLI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLI1, clone3
AC   CVCL_A2G8
SY   1V-91394-6C
DR   Wikidata; Q98130459
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4317; GLI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLI4, clone1
AC   CVCL_A2G9
SY   1V-92154-1A
DR   Wikidata; Q98130460
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4320; GLI4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLI4, clone2
AC   CVCL_A2H0
SY   1V-92154-3B
DR   Wikidata; Q98130461
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4320; GLI4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLI4, clone3
AC   CVCL_A2H1
SY   1V-92154-4C
DR   Wikidata; Q98130462
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4320; GLI4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLIS2, clone1
AC   CVCL_A2H2
SY   1V-91342-4B
DR   Wikidata; Q98130464
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29450; GLIS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLIS2, clone2
AC   CVCL_A2H3
SY   1V-91342-4D
DR   Wikidata; Q98130465
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29450; GLIS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GLIS2, clone3
AC   CVCL_A2H4
SY   1V-91342-6E
DR   Wikidata; Q98130466
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29450; GLIS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GPBP1L1, clone1
AC   CVCL_A2H5
SY   1V-92197-4A
DR   Wikidata; Q98130467
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28843; GPBP1L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GPBP1L1, clone2
AC   CVCL_A2H6
SY   1V-92197-2B
DR   Wikidata; Q98130468
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28843; GPBP1L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GPBP1L1, clone3
AC   CVCL_A2H7
SY   1V-92197-3C
DR   Wikidata; Q98130469
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28843; GPBP1L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GRHL2, clone1
AC   CVCL_A2H8
SY   1V-90994-3A
DR   Wikidata; Q98130470
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2799; GRHL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GRHL2, clone2
AC   CVCL_A2H9
SY   1V-90994-2B
DR   Wikidata; Q98130471
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2799; GRHL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GRHL2, clone3
AC   CVCL_A2I0
SY   1V-90994-5C
DR   Wikidata; Q98130472
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2799; GRHL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GSC, clone1
AC   CVCL_A2I1
SY   1V-93054-5A
DR   Wikidata; Q98130473
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4612; GSC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GSC, clone2
AC   CVCL_A2I2
SY   1V-93054-2B
DR   Wikidata; Q98130474
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4612; GSC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GSC, clone3
AC   CVCL_A2I3
SY   1V-93054-6C
DR   Wikidata; Q98130475
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4612; GSC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2B, clone1
AC   CVCL_A2I4
SY   1V-91301-2A
DR   Wikidata; Q98130476
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4648; GTF2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2B, clone2
AC   CVCL_A2I5
SY   1V-91301-6B
DR   Wikidata; Q98130477
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4648; GTF2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2B, clone3
AC   CVCL_A2I6
SY   1V-91301-8D
DR   Wikidata; Q98130478
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4648; GTF2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2F1, clone1
AC   CVCL_A2I7
SY   1V-90737-5D
DR   Wikidata; Q98130479
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4652; GTF2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2F1, clone2
AC   CVCL_A2I8
SY   1V-90737-6E
DR   Wikidata; Q98130481
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4652; GTF2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2F1, clone3
AC   CVCL_A2I9
SY   1V-90737-4F
DR   Wikidata; Q98130482
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4652; GTF2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2H4, clone1
AC   CVCL_A2J0
SY   1V-92188-1A
DR   Wikidata; Q98130483
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4658; GTF2H4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2H4, clone2
AC   CVCL_A2J1
SY   1V-92188-2B
DR   Wikidata; Q98130484
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4658; GTF2H4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF2H4, clone3
AC   CVCL_A2J2
SY   1V-92188-5C
DR   Wikidata; Q98130485
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4658; GTF2H4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF3C2, clone1
AC   CVCL_A2J3
SY   1V-91290-2A
DR   Wikidata; Q98130487
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4665; GTF3C2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF3C2, clone2
AC   CVCL_A2J4
SY   1V-91290-1B
DR   Wikidata; Q98130488
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4665; GTF3C2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF3C2, clone3
AC   CVCL_A2J5
SY   1V-91290-4C
DR   Wikidata; Q98130489
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4665; GTF3C2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF3C5, clone1
AC   CVCL_A2J6
SY   1V-92149-4A
DR   Wikidata; Q98130490
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4668; GTF3C5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF3C5, clone2
AC   CVCL_A2J7
SY   1V-92149-6B
DR   Wikidata; Q98130491
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4668; GTF3C5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human GTF3C5, clone3
AC   CVCL_A2J8
SY   1V-92149-5C
DR   Wikidata; Q98130492
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4668; GTF3C5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFX, clone1
AC   CVCL_A2J9
SY   1V-93055-5A
DR   Wikidata; Q98130493
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4739; H2AX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFX, clone2
AC   CVCL_A2K0
SY   1V-93055-6B
DR   Wikidata; Q98130494
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4739; H2AX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFX, clone3
AC   CVCL_A2K1
SY   1V-93055-4C
DR   Wikidata; Q98130495
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4739; H2AX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFY, clone1
AC   CVCL_A2K2
SY   1V-93092-6A
DR   Wikidata; Q98130497
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4740; MACROH2A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFY, clone2
AC   CVCL_A2K3
SY   1V-93092-3B
DR   Wikidata; Q98130498
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4740; MACROH2A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFY, clone3
AC   CVCL_A2K4
SY   1V-93092-1C
DR   Wikidata; Q98130499
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4740; MACROH2A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFY2, clone1
AC   CVCL_A2K5
SY   1V-93082-4A
DR   Wikidata; Q98130500
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14453; MACROH2A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFY2, clone2
AC   CVCL_A2K6
SY   1V-93082-1B
DR   Wikidata; Q98130501
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14453; MACROH2A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFY2, clone3
AC   CVCL_A2K7
SY   1V-93082-3C
DR   Wikidata; Q98130502
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14453; MACROH2A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFZ, clone1
AC   CVCL_A2K8
SY   1V-90746-3A
DR   Wikidata; Q98130503
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4741; H2AZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFZ, clone2
AC   CVCL_A2K9
SY   1V-90746-6B
DR   Wikidata; Q98130504
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4741; H2AZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H2AFZ, clone3
AC   CVCL_A2L0
SY   1V-90746-2C
DR   Wikidata; Q98130505
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4741; H2AZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H3F3A, clone1
AC   CVCL_A2L1
SY   1V-92174-6A
DR   Wikidata; Q98130506
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4764; H3-3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H3F3A, clone2
AC   CVCL_A2L2
SY   1V-92174-4B
DR   Wikidata; Q98130507
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4764; H3-3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human H3F3A, clone3
AC   CVCL_A2L3
SY   1V-92174-2C
DR   Wikidata; Q98130508
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4764; H3-3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HCFC1, clone1
AC   CVCL_A2L4
SY   1V-93352-5A
DR   Wikidata; Q98130509
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4839; HCFC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HCFC1, clone2
AC   CVCL_A2L5
SY   1V-93352-4B
DR   Wikidata; Q98130510
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4839; HCFC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HCFC1, clone3
AC   CVCL_A2L6
SY   1V-93352-3C
DR   Wikidata; Q98130511
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4839; HCFC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC1, clone1
AC   CVCL_A2L7
SY   1V-92962-3A
DR   Wikidata; Q98130512
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4852; HDAC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC1, clone2
AC   CVCL_A2L8
SY   1V-92962-2B
DR   Wikidata; Q98130513
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4852; HDAC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC1, clone3
AC   CVCL_A2L9
SY   1V-92962-1C
DR   Wikidata; Q98130514
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4852; HDAC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC2, clone1
AC   CVCL_A2M0
SY   1V-91248-1A
DR   Wikidata; Q98130515
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4853; HDAC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC2, clone2
AC   CVCL_A2M1
SY   1V-91248-4B
DR   Wikidata; Q98130516
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4853; HDAC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC2, clone3
AC   CVCL_A2M2
SY   1V-91248-3C
DR   Wikidata; Q98130517
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4853; HDAC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC3, clone1
AC   CVCL_A2M3
SY   1V-91480-2A
DR   Wikidata; Q98130518
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4854; HDAC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC3, clone2
AC   CVCL_A2M4
SY   1V-91480-4B
DR   Wikidata; Q98130519
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4854; HDAC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC6, clone1
AC   CVCL_A2M5
SY   1V-91481-5A
DR   Wikidata; Q98130520
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14064; HDAC6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC6, clone2
AC   CVCL_A2M6
SY   1V-91481-6B
DR   Wikidata; Q98130521
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14064; HDAC6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC6, clone3
AC   CVCL_A2M7
SY   1V-91481-4C
DR   Wikidata; Q98130522
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14064; HDAC6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC8, clone1
AC   CVCL_A2M8
SY   1V-91330-2A
DR   Wikidata; Q98130524
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13315; HDAC8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC8, clone2
AC   CVCL_A2M9
SY   1V-91330-3B
DR   Wikidata; Q98130525
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13315; HDAC8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDAC8, clone3
AC   CVCL_A2N0
SY   1V-91330-6C
DR   Wikidata; Q98130526
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13315; HDAC8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDGF, clone1
AC   CVCL_A2N1
SY   1V-92166-1A
DR   Wikidata; Q98130527
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4856; HDGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDGF, clone2
AC   CVCL_A2N2
SY   1V-92166-3B
DR   Wikidata; Q98130529
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4856; HDGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HDGF, clone3
AC   CVCL_A2N3
SY   1V-92166-5C
DR   Wikidata; Q98130530
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4856; HDGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HES1, clone1
AC   CVCL_A2N4
SY   1V-91392-2A
DR   Wikidata; Q98130531
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5192; HES1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HES1, clone2
AC   CVCL_A2N5
SY   1V-91392-4B
DR   Wikidata; Q98130532
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5192; HES1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HES1, clone3
AC   CVCL_A2N6
SY   1V-91392-1C
DR   Wikidata; Q98130533
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5192; HES1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HES6, clone1
AC   CVCL_A2N7
SY   1V-93108-1A
DR   Wikidata; Q98130534
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18254; HES6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HES6, clone2
AC   CVCL_A2N8
SY   1V-93108-3B
DR   Wikidata; Q98130535
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18254; HES6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HES6, clone3
AC   CVCL_A2N9
SY   1V-93108-4C
DR   Wikidata; Q98130536
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18254; HES6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HESX1, clone1
AC   CVCL_A2P0
SY   1V-91504-17F
DR   Wikidata; Q98130537
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4877; HESX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HESX1, clone2
AC   CVCL_A2P1
SY   1V-91504-19G
DR   Wikidata; Q98130539
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4877; HESX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HESX1, clone3
AC   CVCL_A2P2
SY   1V-91504-8D
DR   Wikidata; Q98130540
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4877; HESX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HEY1, clone1
AC   CVCL_A2P3
SY   1V-91328-2A
DR   Wikidata; Q98130542
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4880; HEY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HEY1, clone2
AC   CVCL_A2P4
SY   1V-91328-1B
DR   Wikidata; Q98130543
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4880; HEY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HEY1, clone3
AC   CVCL_A2P5
SY   1V-91328-5C
DR   Wikidata; Q98130544
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4880; HEY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HEY2, clone1
AC   CVCL_A2P6
SY   1V-91343-1B
DR   Wikidata; Q98130545
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4881; HEY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HEY2, clone2
AC   CVCL_A2P7
SY   1V-91343-9D
DR   Wikidata; Q98130546
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4881; HEY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HEY2, clone3
AC   CVCL_A2P8
SY   1V-91343-8E
DR   Wikidata; Q98130547
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4881; HEY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HGF, clone1
AC   CVCL_A2P9
SY   1V-93056-4A
DR   Wikidata; Q98130548
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HGF, clone2
AC   CVCL_A2Q0
SY   1V-93056-2B
DR   Wikidata; Q98130549
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HGF, clone3
AC   CVCL_A2Q1
SY   1V-93056-6C
DR   Wikidata; Q98130550
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4893; HGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HHEX, clone1
AC   CVCL_A2Q2
SY   1V-91344-3A
DR   Wikidata; Q98130552
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4901; HHEX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HHEX, clone2
AC   CVCL_A2Q3
SY   1V-91344-2B
DR   Wikidata; Q98130553
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4901; HHEX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HHEX, clone3
AC   CVCL_A2Q4
SY   1V-91344-1C
DR   Wikidata; Q98130555
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4901; HHEX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIC2, clone1
AC   CVCL_A2Q5
SY   1V-92106-1A
DR   Wikidata; Q98130558
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18595; HIC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIC2, clone2
AC   CVCL_A2Q6
SY   1V-92106-8B
DR   Wikidata; Q98130559
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18595; HIC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIC2, clone3
AC   CVCL_A2Q7
SY   1V-92106-7C
DR   Wikidata; Q98130560
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18595; HIC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H2AC, clone1
AC   CVCL_A2Q8
SY   1V-93057-2A
DR   Wikidata; Q98130563
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4738; H2AC20.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H2AC, clone2
AC   CVCL_A2Q9
SY   1V-93057-5B
DR   Wikidata; Q98130565
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4738; H2AC20.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H2AC, clone3
AC   CVCL_A2R0
SY   1V-93057-6C
DR   Wikidata; Q98130568
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4738; H2AC20.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H3C, clone1
AC   CVCL_A2R1
SY   1V-91936-2A
DR   Wikidata; Q98130569
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20503; H3C14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H3C, clone2
AC   CVCL_A2R2
SY   1V-91936-3B
DR   Wikidata; Q98130571
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20503; H3C14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H3C, clone3
AC   CVCL_A2R3
SY   1V-91936-6C
DR   Wikidata; Q98130574
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20503; H3C14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H4A, clone1
AC   CVCL_A2R4
SY   1V-90721-1A
DR   Wikidata; Q98130578
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4794; H4C14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H4A, clone2
AC   CVCL_A2R5
SY   1V-90721-3B
DR   Wikidata; Q98130580
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4794; H4C14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HIST2H4A, clone3
AC   CVCL_A2R6
SY   1V-90721-4C
DR   Wikidata; Q98130582
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4794; H4C14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HLX, clone1
AC   CVCL_A2R7
SY   1V-92107-2A
DR   Wikidata; Q98130585
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4978; HLX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HLX, clone2
AC   CVCL_A2R8
SY   1V-92107-6B
DR   Wikidata; Q98130588
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4978; HLX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HLX, clone3
AC   CVCL_A2R9
SY   1V-92107-5C
DR   Wikidata; Q98130590
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4978; HLX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMG2L1, clone1
AC   CVCL_A2S0
SY   1V-92108-2A
DR   Wikidata; Q98130591
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5003; HMGXB4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMG2L1, clone2
AC   CVCL_A2S1
SY   1V-92108-6B
DR   Wikidata; Q98130592
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5003; HMGXB4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMG2L1, clone3
AC   CVCL_A2S2
SY   1V-92108-5C
DR   Wikidata; Q98130595
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5003; HMGXB4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGA1, clone1
AC   CVCL_A2S3
SY   1V-92146-4A
DR   Wikidata; Q98130598
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5010; HMGA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGA1, clone2
AC   CVCL_A2S4
SY   1V-92146-5B
DR   Wikidata; Q98130600
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5010; HMGA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGA1, clone3
AC   CVCL_A2S5
SY   1V-92146-6C
DR   Wikidata; Q98130601
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5010; HMGA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGA2, clone1
AC   CVCL_A2S6
SY   1V-91482-3A
DR   Wikidata; Q98130602
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5009; HMGA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGA2, clone2
AC   CVCL_A2S7
SY   1V-91482-1B
DR   Wikidata; Q98130603
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5009; HMGA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGA2, clone3
AC   CVCL_A2S8
SY   1V-91482-2C
DR   Wikidata; Q98130604
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5009; HMGA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGB1, clone1
AC   CVCL_A2S9
SY   1V-93048-5A
DR   Wikidata; Q98130605
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4983; HMGB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGB1, clone2
AC   CVCL_A2T0
SY   1V-93048-6B
DR   Wikidata; Q98130606
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4983; HMGB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGB1, clone3
AC   CVCL_A2T1
SY   1V-93048-3C
DR   Wikidata; Q98130607
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4983; HMGB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGB2, clone1
AC   CVCL_A2T2
SY   1V-91875-3A
DR   Wikidata; Q98130608
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5000; HMGB2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGB2, clone2
AC   CVCL_A2T3
SY   1V-91875-4B
DR   Wikidata; Q98130609
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5000; HMGB2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGB2, clone3
AC   CVCL_A2T4
SY   1V-91875-1C
DR   Wikidata; Q98130610
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5000; HMGB2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGN1, clone1
AC   CVCL_A2T5
SY   1V-90724-6A
DR   Wikidata; Q98130611
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4984; HMGN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGN1, clone2
AC   CVCL_A2T6
SY   1V-90724-4B
DR   Wikidata; Q98130612
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4984; HMGN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGN1, clone3
AC   CVCL_A2T7
SY   1V-90724-3C
DR   Wikidata; Q98130613
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4984; HMGN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGN3, clone1
AC   CVCL_A2T8
SY   1V-91690-5A
DR   Wikidata; Q98130614
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12312; HMGN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGN3, clone2
AC   CVCL_A2T9
SY   1V-91690-2B
DR   Wikidata; Q98130615
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12312; HMGN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMGN3, clone3
AC   CVCL_A2U0
SY   1V-91690-4C
DR   Wikidata; Q98130616
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12312; HMGN3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMX1, clone1
AC   CVCL_A2U1
SY   1V-91939-2A
DR   Wikidata; Q98130617
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5017; HMX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMX1, clone2
AC   CVCL_A2U2
SY   1V-91939-5B
DR   Wikidata; Q98130618
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5017; HMX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMX1, clone3
AC   CVCL_A2U3
SY   1V-91939-8D
DR   Wikidata; Q98130619
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5017; HMX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMX2, clone1
AC   CVCL_A2U4
SY   1V-93083-2A
DR   Wikidata; Q98130620
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5018; HMX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HMX2, clone2
AC   CVCL_A2U5
SY   1V-93083-1B
DR   Wikidata; Q98130621
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5018; HMX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF1A, clone1
AC   CVCL_A2U6
SY   1V-92305-4A
DR   Wikidata; Q98130622
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11621; HNF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF1A, clone2
AC   CVCL_A2U7
SY   1V-92305-9D
DR   Wikidata; Q98130623
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11621; HNF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF1A, clone3
AC   CVCL_A2U8
SY   1V-92305-1C
DR   Wikidata; Q98130624
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11621; HNF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF4A, clone1
AC   CVCL_A2U9
SY   1V-91181-6A
DR   Wikidata; Q98130625
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5024; HNF4A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF4A, clone2
AC   CVCL_A2V0
SY   1V-91181-3B
DR   Wikidata; Q98130626
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5024; HNF4A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF4A, clone3
AC   CVCL_A2V1
SY   1V-91181-1C
DR   Wikidata; Q98130627
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5024; HNF4A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF4G, clone1
AC   CVCL_A2V2
SY   1V-93365-3A
DR   Wikidata; Q98130628
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5026; HNF4G.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF4G, clone2
AC   CVCL_A2V3
SY   1V-93365-1B
DR   Wikidata; Q98130629
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5026; HNF4G.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNF4G, clone3
AC   CVCL_A2V4
SY   1V-93365-2C
DR   Wikidata; Q98130630
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5026; HNF4G.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNRNPD, clone1
AC   CVCL_A2V5
SY   1V-90757-3A
DR   Wikidata; Q98130631
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5036; HNRNPD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNRNPD, clone2
AC   CVCL_A2V6
SY   1V-90757-2B
DR   Wikidata; Q98130632
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5036; HNRNPD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HNRNPD, clone3
AC   CVCL_A2V7
SY   1V-90757-4C
DR   Wikidata; Q98130633
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5036; HNRNPD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOPX, clone1
AC   CVCL_A2V8
SY   1V-91911-1A
DR   Wikidata; Q98130634
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24961; HOPX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOPX, clone2
AC   CVCL_A2V9
SY   1V-91911-5B
DR   Wikidata; Q98130635
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24961; HOPX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOPX, clone3
AC   CVCL_A2W0
SY   1V-91911-7C
DR   Wikidata; Q98130636
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24961; HOPX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA1, clone1
AC   CVCL_A2W1
SY   1V-91917-1A
DR   Wikidata; Q98130637
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5099; HOXA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA1, clone2
AC   CVCL_A2W2
SY   1V-91917-3B
DR   Wikidata; Q98130638
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5099; HOXA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA1, clone3
AC   CVCL_A2W3
SY   1V-91917-2C
DR   Wikidata; Q98130639
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5099; HOXA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA10, clone1
AC   CVCL_A2W4
SY   1V-91912-1A
DR   Wikidata; Q98130640
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5100; HOXA10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA10, clone2
AC   CVCL_A2W5
SY   1V-91912-3B
DR   Wikidata; Q98130641
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5100; HOXA10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA10, clone3
AC   CVCL_A2W6
SY   1V-91912-5C
DR   Wikidata; Q98130642
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5100; HOXA10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA2, clone1
AC   CVCL_A2W7
SY   1V-91272-4A
DR   Wikidata; Q98130643
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5103; HOXA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA2, clone2
AC   CVCL_A2W8
SY   1V-91272-3B
DR   Wikidata; Q98130644
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5103; HOXA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA2, clone3
AC   CVCL_A2W9
SY   1V-91272-6C
DR   Wikidata; Q98130645
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5103; HOXA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA3, clone1
AC   CVCL_A2X0
SY   1V-91907-5A
DR   Wikidata; Q98130646
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5104; HOXA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA3, clone2
AC   CVCL_A2X1
SY   1V-91907-1B
DR   Wikidata; Q98130647
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5104; HOXA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA3, clone3
AC   CVCL_A2X2
SY   1V-91907-12C
DR   Wikidata; Q98130648
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5104; HOXA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA5, clone1
AC   CVCL_A2X3
SY   1V-92195-3A
DR   Wikidata; Q98130650
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5106; HOXA5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA5, clone2
AC   CVCL_A2X4
SY   1V-92195-4B
DR   Wikidata; Q98130651
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5106; HOXA5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA5, clone3
AC   CVCL_A2X5
SY   1V-92195-5C
DR   Wikidata; Q98130652
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5106; HOXA5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA7, clone1
AC   CVCL_A2X6
SY   1V-92109-2A
DR   Wikidata; Q98130653
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5108; HOXA7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA7, clone2
AC   CVCL_A2X7
SY   1V-92109-3B
DR   Wikidata; Q98130654
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5108; HOXA7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA7, clone3
AC   CVCL_A2X8
SY   1V-92109-5C
DR   Wikidata; Q98130655
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5108; HOXA7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA9, clone1
AC   CVCL_A2X9
SY   1V-90931-6A
DR   Wikidata; Q98130657
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXA9, clone2
AC   CVCL_A2Y0
SY   1V-90931-5C
DR   Wikidata; Q98130658
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5109; HOXA9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB1, clone1
AC   CVCL_A2Y1
SY   1V-91691-11D
DR   Wikidata; Q98130659
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5111; HOXB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB1, clone2
AC   CVCL_A2Y2
SY   1V-91691-2A
DR   Wikidata; Q98130660
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5111; HOXB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB1, clone3
AC   CVCL_A2Y3
SY   1V-91691-1B
DR   Wikidata; Q98130661
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5111; HOXB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB3, clone1
AC   CVCL_A2Y4
SY   1V-91925-3A
DR   Wikidata; Q98130662
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5114; HOXB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB3, clone2
AC   CVCL_A2Y5
SY   1V-91925-1B
DR   Wikidata; Q98130663
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5114; HOXB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB3, clone3
AC   CVCL_A2Y6
SY   1V-91925-2C
DR   Wikidata; Q98130664
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5114; HOXB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB4, clone1
AC   CVCL_A2Y7
SY   1V-91491-12D
DR   Wikidata; Q98130665
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5115; HOXB4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB4, clone2
AC   CVCL_A2Y8
SY   1V-91491-6B
DR   Wikidata; Q98130667
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5115; HOXB4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB4, clone3
AC   CVCL_A2Y9
SY   1V-91491-5C
DR   Wikidata; Q98130668
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5115; HOXB4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB6, clone1
AC   CVCL_A2Z0
SY   1V-91914-3A
DR   Wikidata; Q98130669
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5117; HOXB6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB6, clone2
AC   CVCL_A2Z1
SY   1V-91914-1B
DR   Wikidata; Q98130671
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5117; HOXB6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXB6, clone3
AC   CVCL_A2Z2
SY   1V-91914-2C
DR   Wikidata; Q98130672
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5117; HOXB6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC13, clone1
AC   CVCL_A2Z3
SY   1V-91391-1A
DR   Wikidata; Q98130673
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5125; HOXC13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC13, clone2
AC   CVCL_A2Z4
SY   1V-91391-2B
DR   Wikidata; Q98130674
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5125; HOXC13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC13, clone3
AC   CVCL_A2Z5
SY   1V-91391-6C
DR   Wikidata; Q98130675
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5125; HOXC13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC5, clone1
AC   CVCL_A2Z6
SY   1V-92110-6A
DR   Wikidata; Q98130676
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5127; HOXC5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC5, clone2
AC   CVCL_A2Z7
SY   1V-92110-3B
DR   Wikidata; Q98130677
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5127; HOXC5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC5, clone3
AC   CVCL_A2Z8
SY   1V-92110-5C
DR   Wikidata; Q98130678
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5127; HOXC5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC8, clone1
AC   CVCL_A2Z9
SY   1V-93049-2A
DR   Wikidata; Q98130679
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5129; HOXC8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC8, clone2
AC   CVCL_A3A0
SY   1V-93049-3B
DR   Wikidata; Q98130680
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5129; HOXC8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC8, clone3
AC   CVCL_A3A1
SY   1V-93049-6C
DR   Wikidata; Q98130681
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5129; HOXC8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC9, clone1
AC   CVCL_A3A2
SY   1V-91345-2A
DR   Wikidata; Q98130682
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5130; HOXC9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC9, clone2
AC   CVCL_A3A3
SY   1V-91345-1B
DR   Wikidata; Q98130683
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5130; HOXC9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXC9, clone3
AC   CVCL_A3A4
SY   1V-91345-3C
DR   Wikidata; Q98130684
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5130; HOXC9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD1, clone1
AC   CVCL_A3A5
SY   1V-91346-6A
DR   Wikidata; Q98130685
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5132; HOXD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD1, clone2
AC   CVCL_A3A6
SY   1V-91346-3B
DR   Wikidata; Q98130686
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5132; HOXD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD1, clone3
AC   CVCL_A3A7
SY   1V-91346-5C
DR   Wikidata; Q98130695
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5132; HOXD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD10, clone1
AC   CVCL_A3A8
SY   1V-93165-3A
DR   Wikidata; Q98130696
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5133; HOXD10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD10, clone2
AC   CVCL_A3A9
SY   1V-93165-2B
DR   Wikidata; Q98130697
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5133; HOXD10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD10, clone3
AC   CVCL_A3B0
SY   1V-93165-1C
DR   Wikidata; Q98130698
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5133; HOXD10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD13, clone1
AC   CVCL_A3B1
SY   1V-92208-3A
DR   Wikidata; Q98130699
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5136; HOXD13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD13, clone2
AC   CVCL_A3B2
SY   1V-92208-6B
DR   Wikidata; Q98130700
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5136; HOXD13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD13, clone3
AC   CVCL_A3B3
SY   1V-92208-5C
DR   Wikidata; Q98130701
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5136; HOXD13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD3, clone1
AC   CVCL_A3B4
SY   1V-91906-5A
DR   Wikidata; Q98130702
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5137; HOXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD3, clone2
AC   CVCL_A3B5
SY   1V-91906-3B
DR   Wikidata; Q98130703
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5137; HOXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HOXD3, clone3
AC   CVCL_A3B6
SY   1V-91906-1C
DR   Wikidata; Q98130704
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5137; HOXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSF1, clone1
AC   CVCL_A3B7
SY   1V-91183-6A
DR   Wikidata; Q98130705
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSF1, clone2
AC   CVCL_A3B8
SY   1V-91183-4D
DR   Wikidata; Q98130706
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSF1, clone3
AC   CVCL_A3B9
SY   1V-91183-5E
DR   Wikidata; Q98130707
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5224; HSF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSF4, clone1
AC   CVCL_A3C0
SY   1V-91866-7C
DR   Wikidata; Q98130708
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5227; HSF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSF4, clone2
AC   CVCL_A3C1
SY   1V-91866-8D
DR   Wikidata; Q98130710
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5227; HSF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSF4, clone3
AC   CVCL_A3C2
SY   1V-91866-9E
DR   Wikidata; Q98130711
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5227; HSF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSFX1, clone1
AC   CVCL_A3C3
SY   1V-92238-2A
DR   Wikidata; Q98130712
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29603; HSFX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSFX1, clone2
AC   CVCL_A3C4
SY   1V-92238-3B
DR   Wikidata; Q98130713
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29603; HSFX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSFX1, clone3
AC   CVCL_A3C5
SY   1V-92238-1C
DR   Wikidata; Q98130714
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29603; HSFX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSFY2, clone1
AC   CVCL_A3C6
SY   1V-92111-8A
DR   Wikidata; Q98130715
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23950; HSFY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSFY2, clone2
AC   CVCL_A3C7
SY   1V-92111-11B
DR   Wikidata; Q98130716
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23950; HSFY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human HSFY2, clone3
AC   CVCL_A3C8
SY   1V-92111-3C
DR   Wikidata; Q98130717
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23950; HSFY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ID1, clone1
AC   CVCL_A3C9
SY   1V-90849-4A
DR   Wikidata; Q98130718
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ID1, clone2
AC   CVCL_A3D0
SY   1V-90849-3B
DR   Wikidata; Q98130719
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ID1, clone3
AC   CVCL_A3D1
SY   1V-90849-2C
DR   Wikidata; Q98130720
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5360; ID1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ID3, clone1
AC   CVCL_A3D2
SY   1V-91239-1A
DR   Wikidata; Q98130721
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ID3, clone2
AC   CVCL_A3D3
SY   1V-91239-4B
DR   Wikidata; Q98130723
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ID3, clone3
AC   CVCL_A3D4
SY   1V-91239-3C
DR   Wikidata; Q98130724
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5362; ID3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IGF1, clone1
AC   CVCL_A3D5
SY   1V-93058-3A
DR   Wikidata; Q98130725
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IGF1, clone2
AC   CVCL_A3D6
SY   1V-93058-6B
DR   Wikidata; Q98130726
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IGF1, clone3
AC   CVCL_A3D7
SY   1V-93058-4C
DR   Wikidata; Q98130727
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IKZF1, clone1
AC   CVCL_A3D8
SY   1V-91692-8D
DR   Wikidata; Q98130728
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13176; IKZF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IKZF1, clone2
AC   CVCL_A3D9
SY   1V-91692-16E
DR   Wikidata; Q98130729
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13176; IKZF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IKZF1, clone3
AC   CVCL_A3E0
SY   1V-91692-15F
DR   Wikidata; Q98130731
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13176; IKZF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IKZF5, clone1
AC   CVCL_A3E1
SY   1V-92200-5A
DR   Wikidata; Q98130732
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14283; IKZF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IKZF5, clone2
AC   CVCL_A3E2
SY   1V-92200-6B
DR   Wikidata; Q98130733
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14283; IKZF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IKZF5, clone3
AC   CVCL_A3E3
SY   1V-92200-3C
DR   Wikidata; Q98130735
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14283; IKZF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ILF2, clone1
AC   CVCL_A3E4
SY   1V-90742-1A
DR   Wikidata; Q98130736
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6037; ILF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ILF2, clone2
AC   CVCL_A3E5
SY   1V-90742-6B
DR   Wikidata; Q98130737
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6037; ILF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ILF2, clone3
AC   CVCL_A3E6
SY   1V-90742-4C
DR   Wikidata; Q98130738
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6037; ILF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF1, clone1
AC   CVCL_A3E7
SY   1V-90745-3A
DR   Wikidata; Q98130739
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6116; IRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF1, clone2
AC   CVCL_A3E8
SY   1V-90745-2B
DR   Wikidata; Q98130740
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6116; IRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF1, clone3
AC   CVCL_A3E9
SY   1V-90745-5C
DR   Wikidata; Q98130741
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6116; IRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF2, clone1
AC   CVCL_A3F0
SY   1V-91006-3A
DR   Wikidata; Q98130742
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6117; IRF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF2, clone2
AC   CVCL_A3F1
SY   1V-91006-6B
DR   Wikidata; Q98130743
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6117; IRF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF2, clone3
AC   CVCL_A3F2
SY   1V-91006-5C
DR   Wikidata; Q98130744
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6117; IRF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF2BP2, clone1
AC   CVCL_A3F3
SY   1V-91940-4A
DR   Wikidata; Q98130745
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21729; IRF2BP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF2BP2, clone2
AC   CVCL_A3F4
SY   1V-91940-5B
DR   Wikidata; Q98130746
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21729; IRF2BP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF2BP2, clone3
AC   CVCL_A3F5
SY   1V-91940-6C
DR   Wikidata; Q98130747
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21729; IRF2BP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF3, clone1
AC   CVCL_A3F6
SY   1V-90741-2A
DR   Wikidata; Q98130748
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6118; IRF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF3, clone2
AC   CVCL_A3F7
SY   1V-90741-4B
DR   Wikidata; Q98130749
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6118; IRF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF3, clone3
AC   CVCL_A3F8
SY   1V-90741-5C
DR   Wikidata; Q98130750
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6118; IRF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF4, clone1
AC   CVCL_A3F9
SY   1V-91303-4A
DR   Wikidata; Q98130751
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6119; IRF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF4, clone2
AC   CVCL_A3G0
SY   1V-91303-5B
DR   Wikidata; Q98130752
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6119; IRF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF4, clone3
AC   CVCL_A3G1
SY   1V-91303-1C
DR   Wikidata; Q98130753
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6119; IRF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF5, clone1
AC   CVCL_A3G2
SY   1V-91253-6A
DR   Wikidata; Q98130754
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6120; IRF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF5, clone2
AC   CVCL_A3G3
SY   1V-91253-5B
DR   Wikidata; Q98130755
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6120; IRF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF5, clone3
AC   CVCL_A3G4
SY   1V-91253-3C
DR   Wikidata; Q98130756
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6120; IRF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF6, clone1
AC   CVCL_A3G5
SY   1V-93470-4A
DR   Wikidata; Q98130757
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6121; IRF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF6, clone2
AC   CVCL_A3G6
SY   1V-93470-5B
DR   Wikidata; Q98130758
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6121; IRF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF6, clone3
AC   CVCL_A3G7
SY   1V-93470-1C
DR   Wikidata; Q98130759
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6121; IRF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF7, clone1
AC   CVCL_A3G8
SY   1V-93471-2A
DR   Wikidata; Q98130760
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6122; IRF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF7, clone2
AC   CVCL_A3G9
SY   1V-93471-9D
DR   Wikidata; Q98130761
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6122; IRF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF7, clone3
AC   CVCL_A3H0
SY   1V-93471-7E
DR   Wikidata; Q98130762
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6122; IRF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF8, clone1
AC   CVCL_A3H1
SY   1V-93356-2A
DR   Wikidata; Q98130764
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5358; IRF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF8, clone2
AC   CVCL_A3H2
SY   1V-93356-1B
DR   Wikidata; Q98130765
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5358; IRF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF8, clone3
AC   CVCL_A3H3
SY   1V-93356-4C
DR   Wikidata; Q98130766
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5358; IRF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF9, clone1
AC   CVCL_A3H4
SY   1V-93166-1A
DR   Wikidata; Q98130767
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6131; IRF9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF9, clone2
AC   CVCL_A3H5
SY   1V-93166-5B
DR   Wikidata; Q98130768
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6131; IRF9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRF9, clone3
AC   CVCL_A3H6
SY   1V-93166-6C
DR   Wikidata; Q98130770
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6131; IRF9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRX1, clone1
AC   CVCL_A3H7
SY   1V-91946-4A
DR   Wikidata; Q98130771
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14358; IRX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRX1, clone2
AC   CVCL_A3H8
SY   1V-91946-1B
DR   Wikidata; Q98130772
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14358; IRX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRX1, clone3
AC   CVCL_A3H9
SY   1V-91946-6C
DR   Wikidata; Q98130773
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14358; IRX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRX2, clone1
AC   CVCL_A3I0
SY   1V-91291-4A
DR   Wikidata; Q98130774
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14359; IRX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRX2, clone2
AC   CVCL_A3I1
SY   1V-91291-6B
DR   Wikidata; Q98130776
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14359; IRX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human IRX2, clone3
AC   CVCL_A3I2
SY   1V-91291-2C
DR   Wikidata; Q98130777
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14359; IRX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ISL1, clone1
AC   CVCL_A3I3
SY   1V-91348-7A
DR   Wikidata; Q98130778
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6132; ISL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ISL1, clone2
AC   CVCL_A3I4
SY   1V-91348-8B
DR   Wikidata; Q98130779
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6132; ISL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ISL1, clone3
AC   CVCL_A3I5
SY   1V-91348-9C
DR   Wikidata; Q98130780
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6132; ISL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ISL2, clone1
AC   CVCL_A3I6
SY   1V-92300-4A
DR   Wikidata; Q98130781
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18524; ISL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ISL2, clone2
AC   CVCL_A3I7
SY   1V-92300-5B
DR   Wikidata; Q98130782
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18524; ISL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ISL2, clone3
AC   CVCL_A3I8
SY   1V-92300-6C
DR   Wikidata; Q98130783
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18524; ISL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JAG1, clone1
AC   CVCL_A3I9
SY   1V-91782-2A
DR   Wikidata; Q98130784
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6188; JAG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JAG1, clone2
AC   CVCL_A3J0
SY   1V-91782-6B
DR   Wikidata; Q98130785
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6188; JAG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JAG1, clone3
AC   CVCL_A3J1
SY   1V-91782-1C
DR   Wikidata; Q98130786
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6188; JAG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JARID2, clone1
AC   CVCL_A3J2
SY   1V-91492-6A
DR   Wikidata; Q98130787
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6196; JARID2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JARID2, clone2
AC   CVCL_A3J3
SY   1V-91492-4B
DR   Wikidata; Q98130788
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6196; JARID2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JARID2, clone3
AC   CVCL_A3J4
SY   1V-91492-1C
DR   Wikidata; Q98130789
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6196; JARID2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUN, clone1
AC   CVCL_A3J5
SY   1V-90998-8D
DR   Wikidata; Q98130790
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6204; JUN.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUN, clone2
AC   CVCL_A3J6
SY   1V-90998-3B
DR   Wikidata; Q98130793
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6204; JUN.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUN, clone3
AC   CVCL_A3J7
SY   1V-90998-4C
DR   Wikidata; Q98130794
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6204; JUN.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUNB, clone1
AC   CVCL_A3J8
SY   1V-90725-3A
DR   Wikidata; Q98130795
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6205; JUNB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUNB, clone2
AC   CVCL_A3J9
SY   1V-90725-4B
DR   Wikidata; Q98130796
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6205; JUNB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUNB, clone3
AC   CVCL_A3K0
SY   1V-90725-2C
DR   Wikidata; Q98130797
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6205; JUNB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUND, clone1
AC   CVCL_A3K1
SY   1V-91493-6A
DR   Wikidata; Q98130798
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6206; JUND.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUND, clone2
AC   CVCL_A3K2
SY   1V-91493-2B
DR   Wikidata; Q98130799
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6206; JUND.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human JUND, clone3
AC   CVCL_A3K3
SY   1V-91493-4C
DR   Wikidata; Q98130800
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6206; JUND.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT2A, clone1
AC   CVCL_A3K4
SY   1V-93167-2A
DR   Wikidata; Q98130801
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4201; KAT2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT2A, clone2
AC   CVCL_A3K5
SY   1V-93167-5B
DR   Wikidata; Q98130802
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4201; KAT2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT2A, clone3
AC   CVCL_A3K6
SY   1V-93167-4C
DR   Wikidata; Q98130803
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4201; KAT2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT6A, clone1
AC   CVCL_A3K7
SY   1V-91921-2A
DR   Wikidata; Q98130804
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13013; KAT6A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT6A, clone2
AC   CVCL_A3K8
SY   1V-91921-3B
DR   Wikidata; Q98130805
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13013; KAT6A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT6A, clone3
AC   CVCL_A3K9
SY   1V-91921-6C
DR   Wikidata; Q98130806
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13013; KAT6A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT8, clone1
AC   CVCL_A3L0
SY   1V-91257-4A
DR   Wikidata; Q98130807
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17933; KAT8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT8, clone2
AC   CVCL_A3L1
SY   1V-91257-1B
DR   Wikidata; Q98130808
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17933; KAT8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KAT8, clone3
AC   CVCL_A3L2
SY   1V-91257-2C
DR   Wikidata; Q98130809
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17933; KAT8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM1A, clone1
AC   CVCL_A3L3
SY   1V-93350-4A
DR   Wikidata; Q98130810
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29079; KDM1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM1A, clone2
AC   CVCL_A3L4
SY   1V-93350-3B
DR   Wikidata; Q98130811
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29079; KDM1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM1A, clone3
AC   CVCL_A3L5
SY   1V-93350-2C
DR   Wikidata; Q98130812
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29079; KDM1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM3A, clone1
AC   CVCL_A3L6
SY   1V-93106-3A
DR   Wikidata; Q98130813
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20815; KDM3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM3A, clone2
AC   CVCL_A3L7
SY   1V-93106-6B
DR   Wikidata; Q98130814
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20815; KDM3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM3A, clone3
AC   CVCL_A3L8
SY   1V-93106-2C
DR   Wikidata; Q98130815
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20815; KDM3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM4C, clone1
AC   CVCL_A3L9
SY   1V-91693-6A
DR   Wikidata; Q98130817
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17071; KDM4C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM4C, clone2
AC   CVCL_A3M0
SY   1V-91693-1B
DR   Wikidata; Q98130818
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17071; KDM4C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM4C, clone3
AC   CVCL_A3M1
SY   1V-91693-4C
DR   Wikidata; Q98130819
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17071; KDM4C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM5A, clone1
AC   CVCL_A3M2
SY   1V-90775-3A
DR   Wikidata; Q98130820
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9886; KDM5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM5A, clone2
AC   CVCL_A3M3
SY   1V-90775-9D
DR   Wikidata; Q98130821
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9886; KDM5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM5A, clone3
AC   CVCL_A3M4
SY   1V-90775-8E
DR   Wikidata; Q98130822
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9886; KDM5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM5B, clone1
AC   CVCL_A3M5
SY   1V-93353-2A
DR   Wikidata; Q98130823
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18039; KDM5B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM5B, clone2
AC   CVCL_A3M6
SY   1V-93353-5B
DR   Wikidata; Q98130825
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18039; KDM5B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KDM5B, clone3
AC   CVCL_A3M7
SY   1V-93353-4C
DR   Wikidata; Q98130826
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18039; KDM5B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KITLG, clone1
AC   CVCL_A3M8
SY   1V-93084-4A
DR   Wikidata; Q98130827
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6343; KITLG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KITLG, clone2
AC   CVCL_A3M9
SY   1V-93084-2B
DR   Wikidata; Q98130828
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6343; KITLG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KITLG, clone3
AC   CVCL_A3N0
SY   1V-93084-3C
DR   Wikidata; Q98130830
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6343; KITLG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF1, clone1
AC   CVCL_A3N1
SY   1V-93168-4A
DR   Wikidata; Q98130832
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF1, clone2
AC   CVCL_A3N2
SY   1V-93168-3B
DR   Wikidata; Q98130833
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF1, clone3
AC   CVCL_A3N3
SY   1V-93168-2C
DR   Wikidata; Q98130834
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6345; KLF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF10, clone1
AC   CVCL_A3N4
SY   1V-93366-2A
DR   Wikidata; Q98130835
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11810; KLF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF10, clone2
AC   CVCL_A3N5
SY   1V-93366-3B
DR   Wikidata; Q98130836
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11810; KLF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF10, clone3
AC   CVCL_A3N6
SY   1V-93366-4C
DR   Wikidata; Q98130837
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11810; KLF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF11, clone1
AC   CVCL_A3N7
SY   1V-93367-2A
DR   Wikidata; Q98130838
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11811; KLF11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF11, clone2
AC   CVCL_A3N8
SY   1V-93367-4B
DR   Wikidata; Q98130839
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11811; KLF11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF11, clone3
AC   CVCL_A3N9
SY   1V-93367-3C
DR   Wikidata; Q98130840
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11811; KLF11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF12, clone1
AC   CVCL_A3P0
SY   1V-91861-12A
DR   Wikidata; Q98130841
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6346; KLF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF12, clone2
AC   CVCL_A3P1
SY   1V-91861-15B
DR   Wikidata; Q98130842
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6346; KLF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF12, clone3
AC   CVCL_A3P2
SY   1V-91861-11C
DR   Wikidata; Q98130843
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6346; KLF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF14, clone1
AC   CVCL_A3P3
SY   1V-91941-14A
DR   Wikidata; Q98130845
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23025; KLF14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF14, clone2
AC   CVCL_A3P4
SY   1V-91941-9B
DR   Wikidata; Q98130846
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23025; KLF14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF14, clone3
AC   CVCL_A3P5
SY   1V-91941-8C
DR   Wikidata; Q98130847
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23025; KLF14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF15, clone1
AC   CVCL_A3P6
SY   1V-91880-1A
DR   Wikidata; Q98130848
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14536; KLF15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF15, clone2
AC   CVCL_A3P7
SY   1V-91880-2B
DR   Wikidata; Q98130850
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14536; KLF15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF15, clone3
AC   CVCL_A3P8
SY   1V-91880-3C
DR   Wikidata; Q98130851
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14536; KLF15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF16, clone1
AC   CVCL_A3P9
SY   1V-92223-5A
DR   Wikidata; Q98130852
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16857; KLF16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF16, clone2
AC   CVCL_A3Q0
SY   1V-92223-6B
DR   Wikidata; Q98130853
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16857; KLF16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF16, clone3
AC   CVCL_A3Q1
SY   1V-92223-4C
DR   Wikidata; Q98130854
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16857; KLF16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF2, clone1
AC   CVCL_A3Q2
SY   1V-93085-3A
DR   Wikidata; Q98130855
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6347; KLF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF2, clone2
AC   CVCL_A3Q3
SY   1V-93085-5B
DR   Wikidata; Q98130856
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6347; KLF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF2, clone3
AC   CVCL_A3Q4
SY   1V-93085-1C
DR   Wikidata; Q98130857
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6347; KLF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF3, clone1
AC   CVCL_A3Q5
SY   1V-90992-2A
DR   Wikidata; Q98130858
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16516; KLF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF3, clone2
AC   CVCL_A3Q6
SY   1V-90992-9D
DR   Wikidata; Q98130859
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16516; KLF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF3, clone3
AC   CVCL_A3Q7
SY   1V-90992-4C
DR   Wikidata; Q98130860
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16516; KLF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF4, clone1
AC   CVCL_A3Q8
SY   1V-90600-2A
DR   Wikidata; Q98130861
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF4, clone2
AC   CVCL_A3Q9
SY   1V-90600-5B
DR   Wikidata; Q98130862
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF4, clone3
AC   CVCL_A3R0
SY   1V-90600-6C
DR   Wikidata; Q98130863
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6348; KLF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF5, clone1
AC   CVCL_A3R1
SY   1V-92190-1A
DR   Wikidata; Q98130864
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6349; KLF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF5, clone2
AC   CVCL_A3R2
SY   1V-92190-2B
DR   Wikidata; Q98130866
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6349; KLF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF5, clone3
AC   CVCL_A3R3
SY   1V-92190-3C
DR   Wikidata; Q98130867
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6349; KLF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF6, clone1
AC   CVCL_A3R4
SY   1V-92135-5A
DR   Wikidata; Q98130868
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2235; KLF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF6, clone2
AC   CVCL_A3R5
SY   1V-92135-3B
DR   Wikidata; Q98130869
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2235; KLF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF6, clone3
AC   CVCL_A3R6
SY   1V-92135-4C
DR   Wikidata; Q98130870
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2235; KLF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF7, clone1
AC   CVCL_A3R7
SY   1V-93112-6A
DR   Wikidata; Q98130871
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6350; KLF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF7, clone2
AC   CVCL_A3R8
SY   1V-93112-1B
DR   Wikidata; Q98130872
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6350; KLF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF7, clone3
AC   CVCL_A3R9
SY   1V-93112-5C
DR   Wikidata; Q98130873
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6350; KLF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF8, clone1
AC   CVCL_A3S0
SY   1V-93169-2A
DR   Wikidata; Q98130874
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6351; KLF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF8, clone2
AC   CVCL_A3S1
SY   1V-93169-5B
DR   Wikidata; Q98130875
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6351; KLF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF8, clone3
AC   CVCL_A3S2
SY   1V-93169-1C
DR   Wikidata; Q98130876
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6351; KLF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF9, clone1
AC   CVCL_A3S3
SY   1V-91218-4A
DR   Wikidata; Q98130877
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1123; KLF9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF9, clone2
AC   CVCL_A3S4
SY   1V-91218-5B
DR   Wikidata; Q98130878
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1123; KLF9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLF9, clone3
AC   CVCL_A3S5
SY   1V-91218-6C
DR   Wikidata; Q98130879
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:1123; KLF9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLRG1, clone1
AC   CVCL_A3S6
SY   1V-92194-5A
DR   Wikidata; Q98130880
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6380; KLRG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLRG1, clone2
AC   CVCL_A3S7
SY   1V-92194-4B
DR   Wikidata; Q98130881
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6380; KLRG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KLRG1, clone3
AC   CVCL_A3S8
SY   1V-92194-3C
DR   Wikidata; Q98130882
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6380; KLRG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KRBA2, clone1
AC   CVCL_A3S9
SY   1V-91865-8B
DR   Wikidata; Q98130883
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26989; KRBA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KRBA2, clone2
AC   CVCL_A3T0
SY   1V-91865-9C
DR   Wikidata; Q98130884
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26989; KRBA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human KRBA2, clone3
AC   CVCL_A3T1
SY   1V-91865-10D
DR   Wikidata; Q98130885
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26989; KRBA2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human L3MBTL2, clone1
AC   CVCL_A3T2
SY   1V-91246-1A
DR   Wikidata; Q98130886
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18594; L3MBTL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human L3MBTL2, clone2
AC   CVCL_A3T3
SY   1V-91246-5C
DR   Wikidata; Q98130887
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18594; L3MBTL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human L3MBTL2, clone3
AC   CVCL_A3T4
SY   1V-91246-9D
DR   Wikidata; Q98130888
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18594; L3MBTL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LBX2, clone1
AC   CVCL_A3T5
SY   1V-93059-4A
DR   Wikidata; Q98130889
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15525; LBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LBX2, clone2
AC   CVCL_A3T6
SY   1V-93059-3B
DR   Wikidata; Q98130890
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15525; LBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LBX2, clone3
AC   CVCL_A3T7
SY   1V-93059-6C
DR   Wikidata; Q98130891
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15525; LBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LEF1, clone1
AC   CVCL_A3T8
SY   1V-93368-4A
DR   Wikidata; Q98130892
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6551; LEF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LEF1, clone2
AC   CVCL_A3T9
SY   1V-93368-5B
DR   Wikidata; Q98130893
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6551; LEF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LEF1, clone3
AC   CVCL_A3U0
SY   1V-93368-1C
DR   Wikidata; Q98130894
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6551; LEF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LFNG, clone1
AC   CVCL_A3U1
SY   1V-91817-2A
DR   Wikidata; Q98130895
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6560; LFNG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LFNG, clone2
AC   CVCL_A3U2
SY   1V-91817-7D
DR   Wikidata; Q98130896
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6560; LFNG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LFNG, clone3
AC   CVCL_A3U3
SY   1V-91817-9E
DR   Wikidata; Q98130897
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6560; LFNG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHFP, clone1
AC   CVCL_A3U4
SY   1V-91235-4A
DR   Wikidata; Q98130898
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6586; LHFPL6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHFP, clone2
AC   CVCL_A3U5
SY   1V-91235-2B
DR   Wikidata; Q98130899
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6586; LHFPL6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHFP, clone3
AC   CVCL_A3U6
SY   1V-91235-3C
DR   Wikidata; Q98130900
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6586; LHFPL6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX1, clone1
AC   CVCL_A3U7
SY   1V-92309-2A
DR   Wikidata; Q98130902
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6593; LHX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX1, clone2
AC   CVCL_A3U8
SY   1V-92309-3B
DR   Wikidata; Q98130903
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6593; LHX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX1, clone3
AC   CVCL_A3U9
SY   1V-92309-6C
DR   Wikidata; Q98130904
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6593; LHX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX2, clone1
AC   CVCL_A3V0
SY   1V-90854-2D
DR   Wikidata; Q98130905
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6594; LHX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX2, clone2
AC   CVCL_A3V1
SY   1V-90854-4E
DR   Wikidata; Q98130906
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6594; LHX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX2, clone3
AC   CVCL_A3V2
SY   1V-90854-6F
DR   Wikidata; Q98130907
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6594; LHX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX3, clone1
AC   CVCL_A3V3
SY   1V-91766-4A
DR   Wikidata; Q98130909
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6595; LHX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX3, clone2
AC   CVCL_A3V4
SY   1V-91766-6B
DR   Wikidata; Q98130910
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6595; LHX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX3, clone3
AC   CVCL_A3V5
SY   1V-91766-5C
DR   Wikidata; Q98130913
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6595; LHX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX4, clone1
AC   CVCL_A3V6
SY   1V-92151-6A
DR   Wikidata; Q98130915
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21734; LHX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX4, clone2
AC   CVCL_A3V7
SY   1V-92151-1B
DR   Wikidata; Q98130917
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21734; LHX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX4, clone3
AC   CVCL_A3V8
SY   1V-92151-2C
DR   Wikidata; Q98130920
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21734; LHX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX5, clone1
AC   CVCL_A3V9
SY   1V-93351-2A
DR   Wikidata; Q98130923
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14216; LHX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX5, clone2
AC   CVCL_A3W0
SY   1V-93351-5B
DR   Wikidata; Q98130924
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14216; LHX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX5, clone3
AC   CVCL_A3W1
SY   1V-93351-4C
DR   Wikidata; Q98130925
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14216; LHX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX6, clone1
AC   CVCL_A3W2
SY   1V-93170-1A
DR   Wikidata; Q98130926
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21735; LHX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX6, clone2
AC   CVCL_A3W3
SY   1V-93170-6B
DR   Wikidata; Q98130927
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21735; LHX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX6, clone3
AC   CVCL_A3W4
SY   1V-93170-4C
DR   Wikidata; Q98130928
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21735; LHX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX8, clone1
AC   CVCL_A3W5
SY   1V-93086-2A
DR   Wikidata; Q98130929
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28838; LHX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX8, clone2
AC   CVCL_A3W6
SY   1V-93086-1B
DR   Wikidata; Q98130930
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28838; LHX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX8, clone3
AC   CVCL_A3W7
SY   1V-93086-3C
DR   Wikidata; Q98130931
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28838; LHX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX9, clone1
AC   CVCL_A3W8
SY   1V-93171-5A
DR   Wikidata; Q98130932
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14222; LHX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX9, clone2
AC   CVCL_A3W9
SY   1V-93171-4B
DR   Wikidata; Q98130933
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14222; LHX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LHX9, clone3
AC   CVCL_A3X0
SY   1V-93171-3C
DR   Wikidata; Q98130935
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14222; LHX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LIF, clone1
AC   CVCL_A3X1
SY   1V-93050-3A
DR   Wikidata; Q98130936
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6596; LIF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LIF, clone2
AC   CVCL_A3X2
SY   1V-93050-4B
DR   Wikidata; Q98130937
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6596; LIF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LIF, clone3
AC   CVCL_A3X3
SY   1V-93050-5C
DR   Wikidata; Q98130938
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6596; LIF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LIN28, clone1
AC   CVCL_A3X4
SY   1V-91356-5A
DR   Wikidata; Q98130940
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15986; LIN28A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LIN28, clone2
AC   CVCL_A3X5
SY   1V-91356-3C
DR   Wikidata; Q98130942
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15986; LIN28A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LIN28, clone3
AC   CVCL_A3X6
SY   1V-91356-10D
DR   Wikidata; Q98130943
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15986; LIN28A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMO1, clone1
AC   CVCL_A3X7
SY   1V-91333-5A
DR   Wikidata; Q98130944
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6641; LMO1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMO1, clone2
AC   CVCL_A3X8
SY   1V-91333-6B
DR   Wikidata; Q98130945
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6641; LMO1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMO1, clone3
AC   CVCL_A3X9
SY   1V-91333-1C
DR   Wikidata; Q98130946
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6641; LMO1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMO2, clone1
AC   CVCL_A3Y0
SY   1V-91221-4A
DR   Wikidata; Q98130947
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6642; LMO2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMO2, clone2
AC   CVCL_A3Y1
SY   1V-91221-6B
DR   Wikidata; Q98130949
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6642; LMO2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMO2, clone3
AC   CVCL_A3Y2
SY   1V-91221-2C
DR   Wikidata; Q98130950
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6642; LMO2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMX1A, clone1
AC   CVCL_A3Y3
SY   1V-91357-11A
DR   Wikidata; Q98130951
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6653; LMX1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMX1A, clone2
AC   CVCL_A3Y4
SY   1V-91357-12B
DR   Wikidata; Q98130952
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6653; LMX1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMX1A, clone3
AC   CVCL_A3Y5
SY   1V-91357-8C
DR   Wikidata; Q98130953
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6653; LMX1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMX1B, clone1
AC   CVCL_A3Y6
SY   1V-93172-2A
DR   Wikidata; Q98130954
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6654; LMX1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMX1B, clone2
AC   CVCL_A3Y7
SY   1V-93172-3B
DR   Wikidata; Q98130955
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6654; LMX1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human LMX1B, clone3
AC   CVCL_A3Y8
SY   1V-93172-5C
DR   Wikidata; Q98130956
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6654; LMX1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L1, clone1
AC   CVCL_A3Y9
SY   1V-92172-5A
DR   Wikidata; Q98130957
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6757; MAB21L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L1, clone2
AC   CVCL_A3Z0
SY   1V-92172-3B
DR   Wikidata; Q98130958
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6757; MAB21L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L1, clone3
AC   CVCL_A3Z1
SY   1V-92172-6C
DR   Wikidata; Q98130959
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6757; MAB21L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L2, clone1
AC   CVCL_A3Z2
SY   1V-91818-2A
DR   Wikidata; Q98130960
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6758; MAB21L2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L2, clone2
AC   CVCL_A3Z3
SY   1V-91818-5B
DR   Wikidata; Q98130961
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6758; MAB21L2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L2, clone3
AC   CVCL_A3Z4
SY   1V-91818-4C
DR   Wikidata; Q98130962
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6758; MAB21L2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L3, clone1
AC   CVCL_A3Z5
SY   1V-91783-1A
DR   Wikidata; Q98130963
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26787; MAB21L3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L3, clone2
AC   CVCL_A3Z6
SY   1V-91783-4B
DR   Wikidata; Q98130964
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26787; MAB21L3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAB21L3, clone3
AC   CVCL_A3Z7
SY   1V-91783-5C
DR   Wikidata; Q98130965
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26787; MAB21L3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAFA, clone1
AC   CVCL_A3Z8
SY   1V-93557-1A
DR   Wikidata; Q98130966
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23145; MAFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAFA, clone2
AC   CVCL_A3Z9
SY   1V-93557-6B
DR   Wikidata; Q98130967
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23145; MAFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAFA, clone3
AC   CVCL_A4A0
SY   1V-93557-4C
DR   Wikidata; Q98130968
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23145; MAFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAFK, clone1
AC   CVCL_A4A1
SY   1V-91494-11D
DR   Wikidata; Q98130969
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6782; MAFK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAFK, clone2
AC   CVCL_A4A2
SY   1V-91494-12E
DR   Wikidata; Q98130970
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6782; MAFK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAFK, clone3
AC   CVCL_A4A3
SY   1V-91494-13F
DR   Wikidata; Q98130971
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6782; MAFK.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAX, clone1
AC   CVCL_A4A4
SY   1V-91316-1A
DR   Wikidata; Q98130972
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6913; MAX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAX, clone2
AC   CVCL_A4A5
SY   1V-91316-2B
DR   Wikidata; Q98130973
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6913; MAX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAX, clone3
AC   CVCL_A4A6
SY   1V-91316-3C
DR   Wikidata; Q98130974
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6913; MAX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAZ, clone1
AC   CVCL_A4A7
SY   1V-91495-10D
DR   Wikidata; Q98130975
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6914; MAZ.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAZ, clone2
AC   CVCL_A4A8
SY   1V-91495-12E
DR   Wikidata; Q98130976
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6914; MAZ.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MAZ, clone3
AC   CVCL_A4A9
SY   1V-91495-8F
DR   Wikidata; Q98130977
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6914; MAZ.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MBD3, clone1
AC   CVCL_A4B0
SY   1V-91358-2A
DR   Wikidata; Q98130979
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6918; MBD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MBD3, clone2
AC   CVCL_A4B1
SY   1V-91358-3B
DR   Wikidata; Q98130980
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6918; MBD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MBD3, clone3
AC   CVCL_A4B2
SY   1V-91358-7D
DR   Wikidata; Q98130982
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6918; MBD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MECOM, clone1
AC   CVCL_A4B3
SY   1V-91695-6A
DR   Wikidata; Q98130983
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3498; MECOM.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MECOM, clone2
AC   CVCL_A4B4
SY   1V-91695-3B
DR   Wikidata; Q98130984
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3498; MECOM.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MECOM, clone3
AC   CVCL_A4B5
SY   1V-91695-4C
DR   Wikidata; Q98130985
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3498; MECOM.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MED12, clone1
AC   CVCL_A4B6
SY   1V-93369-3A
DR   Wikidata; Q98130986
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11957; MED12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MED12, clone2
AC   CVCL_A4B7
SY   1V-93369-5B
DR   Wikidata; Q98130988
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11957; MED12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MED12, clone3
AC   CVCL_A4B8
SY   1V-93369-1C
DR   Wikidata; Q98130989
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11957; MED12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEF2A, clone1
AC   CVCL_A4B9
SY   1V-91334-3A
DR   Wikidata; Q98130990
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6993; MEF2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEF2A, clone2
AC   CVCL_A4C0
SY   1V-91334-1B
DR   Wikidata; Q98130991
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6993; MEF2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEF2A, clone3
AC   CVCL_A4C1
SY   1V-91334-2C
DR   Wikidata; Q98130992
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6993; MEF2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEF2C, clone1
AC   CVCL_A4C2
SY   1V-91190-3A
DR   Wikidata; Q98130993
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6996; MEF2C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEF2C, clone2
AC   CVCL_A4C3
SY   1V-91190-6B
DR   Wikidata; Q98130994
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6996; MEF2C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEF2C, clone3
AC   CVCL_A4C4
SY   1V-91190-2C
DR   Wikidata; Q98130995
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6996; MEF2C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEIS1, clone1
AC   CVCL_A4C5
SY   1V-91324-4A
DR   Wikidata; Q98130996
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7000; MEIS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEIS1, clone2
AC   CVCL_A4C6
SY   1V-91324-1B
DR   Wikidata; Q98130998
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7000; MEIS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEIS1, clone3
AC   CVCL_A4C7
SY   1V-91324-2C
DR   Wikidata; Q98130999
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7000; MEIS1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEIS2, clone1
AC   CVCL_A4C8
SY   1V-91359-1A
DR   Wikidata; Q98131000
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7001; MEIS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEIS2, clone2
AC   CVCL_A4C9
SY   1V-91359-2B
DR   Wikidata; Q98131001
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7001; MEIS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MEIS2, clone3
AC   CVCL_A4D0
SY   1V-91359-5C
DR   Wikidata; Q98131002
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7001; MEIS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human METTL5, clone1
AC   CVCL_A4D1
SY   1V-91278-10A
DR   Wikidata; Q98131003
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25006; METTL5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human METTL5, clone2
AC   CVCL_A4D2
SY   1V-91278-11B
DR   Wikidata; Q98131004
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25006; METTL5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human METTL5, clone3
AC   CVCL_A4D3
SY   1V-91278-1C
DR   Wikidata; Q98131005
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25006; METTL5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MIF4GD, clone1
AC   CVCL_A4D4
SY   1V-92179-5A
DR   Wikidata; Q98131006
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24030; MIF4GD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MIF4GD, clone2
AC   CVCL_A4D5
SY   1V-92179-4B
DR   Wikidata; Q98131007
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24030; MIF4GD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MIF4GD, clone3
AC   CVCL_A4D6
SY   1V-92179-12D
DR   Wikidata; Q98131008
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24030; MIF4GD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MITF, clone1
AC   CVCL_A4D7
SY   1V-93472-3A
DR   Wikidata; Q98131009
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7105; MITF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MITF, clone2
AC   CVCL_A4D8
SY   1V-93472-6B
DR   Wikidata; Q98131010
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7105; MITF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MITF, clone3
AC   CVCL_A4D9
SY   1V-93472-2C
DR   Wikidata; Q98131011
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7105; MITF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MKRN1, clone1
AC   CVCL_A4E0
SY   1V-91276-1A
DR   Wikidata; Q98131012
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7112; MKRN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MKRN1, clone2
AC   CVCL_A4E1
SY   1V-91276-3B
DR   Wikidata; Q98131013
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7112; MKRN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MKRN1, clone3
AC   CVCL_A4E2
SY   1V-91276-6C
DR   Wikidata; Q98131014
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7112; MKRN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MLLT1, clone1
AC   CVCL_A4E3
SY   1V-91926-1A
DR   Wikidata; Q98131015
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7134; MLLT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MLLT1, clone2
AC   CVCL_A4E4
SY   1V-91926-2B
DR   Wikidata; Q98131016
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7134; MLLT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MLLT1, clone3
AC   CVCL_A4E5
SY   1V-91926-3C
DR   Wikidata; Q98131017
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7134; MLLT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MNX1, clone1
AC   CVCL_A4E6
SY   1V-91767-2A
DR   Wikidata; Q98131018
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4979; MNX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MNX1, clone2
AC   CVCL_A4E7
SY   1V-91767-3B
DR   Wikidata; Q98131019
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4979; MNX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MNX1, clone3
AC   CVCL_A4E8
SY   1V-91767-4C
DR   Wikidata; Q98131020
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:4979; MNX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSC, clone1
AC   CVCL_A4E9
SY   1V-91496-4A
DR   Wikidata; Q98131021
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7321; MSC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSC, clone2
AC   CVCL_A4F0
SY   1V-91496-6B
DR   Wikidata; Q98131022
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7321; MSC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSC, clone3
AC   CVCL_A4F1
SY   1V-91496-3C
DR   Wikidata; Q98131023
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7321; MSC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSGN1, clone1
AC   CVCL_A4F2
SY   1V-92233-1A
DR   Wikidata; Q98131024
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14907; MSGN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSGN1, clone2
AC   CVCL_A4F3
SY   1V-92233-6B
DR   Wikidata; Q98131025
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14907; MSGN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSGN1, clone3
AC   CVCL_A4F4
SY   1V-92233-2C
DR   Wikidata; Q98131026
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14907; MSGN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSI1, clone1
AC   CVCL_A4F5
SY   1V-92113-4A
DR   Wikidata; Q98131028
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7330; MSI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSI1, clone2
AC   CVCL_A4F6
SY   1V-92113-3B
DR   Wikidata; Q98131029
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7330; MSI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSI1, clone3
AC   CVCL_A4F7
SY   1V-92113-1C
DR   Wikidata; Q98131030
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7330; MSI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSL3L1, clone1
AC   CVCL_A4F8
SY   1V-92114-1A
DR   Wikidata; Q98131031
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7370; MSL3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSL3L1, clone2
AC   CVCL_A4F9
SY   1V-92114-2B
DR   Wikidata; Q98131033
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7370; MSL3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSL3L1, clone3
AC   CVCL_A4G0
SY   1V-92114-6C
DR   Wikidata; Q98131034
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7370; MSL3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSX2, clone1
AC   CVCL_A4G1
SY   1V-92158-3A
DR   Wikidata; Q98131035
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7392; MSX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSX2, clone2
AC   CVCL_A4G2
SY   1V-92158-4B
DR   Wikidata; Q98131036
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7392; MSX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MSX2, clone3
AC   CVCL_A4G3
SY   1V-92158-5C
DR   Wikidata; Q98131037
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7392; MSX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MXD3, clone1
AC   CVCL_A4G4
SY   1V-92136-4A
DR   Wikidata; Q98131038
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14008; MXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MXD3, clone2
AC   CVCL_A4G5
SY   1V-92136-6B
DR   Wikidata; Q98131039
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14008; MXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MXD3, clone3
AC   CVCL_A4G6
SY   1V-92136-1C
DR   Wikidata; Q98131041
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14008; MXD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MXI1, clone1
AC   CVCL_A4G7
SY   1V-90731-1A
DR   Wikidata; Q98131044
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7534; MXI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MXI1, clone2
AC   CVCL_A4G8
SY   1V-90731-2B
DR   Wikidata; Q98131045
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7534; MXI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MXI1, clone3
AC   CVCL_A4G9
SY   1V-90731-6C
DR   Wikidata; Q98131046
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7534; MXI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYB, clone1
AC   CVCL_A4H0
SY   1V-91361-3A
DR   Wikidata; Q98131047
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYB, clone2
AC   CVCL_A4H1
SY   1V-91361-1B
DR   Wikidata; Q98131049
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYB, clone3
AC   CVCL_A4H2
SY   1V-91361-6C
DR   Wikidata; Q98131050
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7545; MYB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYBL2, clone1
AC   CVCL_A4H3
SY   1V-90753-2A
DR   Wikidata; Q98131051
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7548; MYBL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYBL2, clone2
AC   CVCL_A4H4
SY   1V-90753-5B
DR   Wikidata; Q98131052
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7548; MYBL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYBL2, clone3
AC   CVCL_A4H5
SY   1V-90753-4C
DR   Wikidata; Q98131053
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7548; MYBL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYC, clone1
AC   CVCL_A4H6
SY   1V-90980-1A
DR   Wikidata; Q98131054
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYC, clone2
AC   CVCL_A4H7
SY   1V-90980-10D
DR   Wikidata; Q98131056
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYC, clone3
AC   CVCL_A4H8
SY   1V-90980-4C
DR   Wikidata; Q98131057
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7553; MYC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYCN, clone1
AC   CVCL_A4H9
SY   1V-93051-2A
DR   Wikidata; Q98131058
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYCN, clone2
AC   CVCL_A4I0
SY   1V-93051-5B
DR   Wikidata; Q98131059
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYCN, clone3
AC   CVCL_A4I1
SY   1V-93051-4C
DR   Wikidata; Q98131061
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYF5, clone1
AC   CVCL_A4I2
SY   1V-91696-2A
DR   Wikidata; Q98131062
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7565; MYF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYF5, clone2
AC   CVCL_A4I3
SY   1V-91696-6B
DR   Wikidata; Q98131063
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7565; MYF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYF5, clone3
AC   CVCL_A4I4
SY   1V-91696-5C
DR   Wikidata; Q98131064
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7565; MYF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYF6, clone1
AC   CVCL_A4I5
SY   1V-92163-7A
DR   Wikidata; Q98131065
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7566; MYF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYF6, clone2
AC   CVCL_A4I6
SY   1V-92163-9B
DR   Wikidata; Q98131066
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7566; MYF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYF6, clone3
AC   CVCL_A4I7
SY   1V-92163-8C
DR   Wikidata; Q98131067
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7566; MYF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYOD1, clone1
AC   CVCL_A4I8
SY   1V-90982-1A
DR   Wikidata; Q98131068
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7611; MYOD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYOD1, clone2
AC   CVCL_A4I9
SY   1V-90982-2B
DR   Wikidata; Q98131069
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7611; MYOD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYOD1, clone3
AC   CVCL_A4J0
SY   1V-90982-5C
DR   Wikidata; Q98131070
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7611; MYOD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYT1, clone1
AC   CVCL_A4J1
SY   1V-91697-6C
DR   Wikidata; Q98131071
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7622; MYT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYT1, clone2
AC   CVCL_A4J2
SY   1V-91697-9D
DR   Wikidata; Q98131072
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7622; MYT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYT1, clone3
AC   CVCL_A4J3
SY   1V-91697-14E
DR   Wikidata; Q98131073
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7622; MYT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYT1L, clone1
AC   CVCL_A4J4
SY   1V-91768-4A
DR   Wikidata; Q98131074
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7623; MYT1L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYT1L, clone2
AC   CVCL_A4J5
SY   1V-91768-2C
DR   Wikidata; Q98131075
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7623; MYT1L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human MYT1L, clone3
AC   CVCL_A4J6
SY   1V-91768-11D
DR   Wikidata; Q98131076
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7623; MYT1L.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NANOG, clone1
AC   CVCL_A4J7
SY   1V-91000-4B
DR   Wikidata; Q98131077
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20857; NANOG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NANOG, clone2
AC   CVCL_A4J8
SY   1V-91000-3C
DR   Wikidata; Q98131078
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20857; NANOG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NANOG, clone3
AC   CVCL_A4J9
SY   1V-91000-9D
DR   Wikidata; Q98131079
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20857; NANOG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD1, clone1
AC   CVCL_A4K0
SY   1V-91769-3A
DR   Wikidata; Q98131081
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7762; NEUROD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD1, clone2
AC   CVCL_A4K1
SY   1V-91769-2B
DR   Wikidata; Q98131082
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7762; NEUROD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD1, clone3
AC   CVCL_A4K2
SY   1V-91769-4C
DR   Wikidata; Q98131083
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7762; NEUROD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD2, clone1
AC   CVCL_A4K3
SY   1V-91770-5A
DR   Wikidata; Q98131084
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7763; NEUROD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD2, clone2
AC   CVCL_A4K4
SY   1V-91770-3B
DR   Wikidata; Q98131085
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7763; NEUROD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD2, clone3
AC   CVCL_A4K5
SY   1V-91770-2C
DR   Wikidata; Q98131086
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7763; NEUROD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD4, clone1
AC   CVCL_A4K6
SY   1V-93087-3A
DR   Wikidata; Q98131088
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13802; NEUROD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD4, clone2
AC   CVCL_A4K7
SY   1V-93087-9C
DR   Wikidata; Q98131089
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13802; NEUROD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD4, clone3
AC   CVCL_A4K8
SY   1V-93087-13D
DR   Wikidata; Q98131090
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13802; NEUROD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD6, clone1
AC   CVCL_A4K9
SY   1V-93093-5A
DR   Wikidata; Q98131091
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13804; NEUROD6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD6, clone2
AC   CVCL_A4L0
SY   1V-93093-2B
DR   Wikidata; Q98131092
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13804; NEUROD6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROD6, clone3
AC   CVCL_A4L1
SY   1V-93093-3C
DR   Wikidata; Q98131093
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13804; NEUROD6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG1, clone1
AC   CVCL_A4L2
SY   1V-92299-1A
DR   Wikidata; Q98131094
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7764; NEUROG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG1, clone2
AC   CVCL_A4L3
SY   1V-92299-2B
DR   Wikidata; Q98131095
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7764; NEUROG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG1, clone3
AC   CVCL_A4L4
SY   1V-92299-3C
DR   Wikidata; Q98131096
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7764; NEUROG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG2, clone1
AC   CVCL_A4L5
SY   1V-91771-5A
DR   Wikidata; Q98131097
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG2, clone2
AC   CVCL_A4L6
SY   1V-91771-6B
DR   Wikidata; Q98131098
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG2, clone3
AC   CVCL_A4L7
SY   1V-91771-3C
DR   Wikidata; Q98131100
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG3, clone1
AC   CVCL_A4L8
SY   1V-91275-3A
DR   Wikidata; Q98131101
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13806; NEUROG3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG3, clone2
AC   CVCL_A4L9
SY   1V-91275-4B
DR   Wikidata; Q98131103
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13806; NEUROG3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NEUROG3, clone3
AC   CVCL_A4M0
SY   1V-91275-1C
DR   Wikidata; Q98131104
RX   PubMed=28610919;
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13806; NEUROG3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFATC1, clone1
AC   CVCL_A4M1
SY   1V-93173-3A
DR   Wikidata; Q98131105
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7775; NFATC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFATC1, clone2
AC   CVCL_A4M2
SY   1V-93173-1B
DR   Wikidata; Q98131106
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7775; NFATC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFATC1, clone3
AC   CVCL_A4M3
SY   1V-93173-6C
DR   Wikidata; Q98131107
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7775; NFATC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFE2L1, clone1
AC   CVCL_A4M4
SY   1V-92148-2A
DR   Wikidata; Q98131109
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7781; NFE2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFE2L1, clone2
AC   CVCL_A4M5
SY   1V-92148-4C
DR   Wikidata; Q98131110
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7781; NFE2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFE2L1, clone3
AC   CVCL_A4M6
SY   1V-92148-9D
DR   Wikidata; Q98131111
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7781; NFE2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIA, clone1
AC   CVCL_A4M7
SY   1V-92167-6A
DR   Wikidata; Q98131112
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7784; NFIA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIA, clone2
AC   CVCL_A4M8
SY   1V-92167-2B
DR   Wikidata; Q98131113
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7784; NFIA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIA, clone3
AC   CVCL_A4M9
SY   1V-92167-5C
DR   Wikidata; Q98131114
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7784; NFIA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIB, clone1
AC   CVCL_A4N0
SY   1V-91232-3A
DR   Wikidata; Q98131115
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7785; NFIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIB, clone2
AC   CVCL_A4N1
SY   1V-91232-2B
DR   Wikidata; Q98131117
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7785; NFIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIB, clone3
AC   CVCL_A4N2
SY   1V-91232-5C
DR   Wikidata; Q98131118
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7785; NFIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIC, clone1
AC   CVCL_A4N3
SY   1V-90758-3A
DR   Wikidata; Q98131119
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7786; NFIC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIC, clone2
AC   CVCL_A4N4
SY   1V-90758-4B
DR   Wikidata; Q98131121
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7786; NFIC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIL3, clone1
AC   CVCL_A4N5
SY   1V-91924-3A
DR   Wikidata; Q98131122
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7787; NFIL3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIL3, clone2
AC   CVCL_A4N6
SY   1V-91924-6B
DR   Wikidata; Q98131123
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7787; NFIL3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFIL3, clone3
AC   CVCL_A4N7
SY   1V-91924-2D
DR   Wikidata; Q98131124
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7787; NFIL3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFX1, clone1
AC   CVCL_A4N8
SY   1V-92152-5A
DR   Wikidata; Q98131125
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7803; NFX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFX1, clone2
AC   CVCL_A4N9
SY   1V-92152-3B
DR   Wikidata; Q98131127
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7803; NFX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFX1, clone3
AC   CVCL_A4P0
SY   1V-92152-4C
DR   Wikidata; Q98131129
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7803; NFX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFYA, clone1
AC   CVCL_A4P1
SY   1V-91354-7A
DR   Wikidata; Q98131130
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7804; NFYA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFYA, clone2
AC   CVCL_A4P2
SY   1V-91354-9C
DR   Wikidata; Q98131131
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7804; NFYA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFYA, clone3
AC   CVCL_A4P3
SY   1V-91354-11D
DR   Wikidata; Q98131132
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7804; NFYA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFYB, clone1
AC   CVCL_A4P4
SY   1V-90752-4A
DR   Wikidata; Q98131134
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7805; NFYB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFYB, clone2
AC   CVCL_A4P5
SY   1V-90752-6B
DR   Wikidata; Q98131137
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7805; NFYB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NFYB, clone3
AC   CVCL_A4P6
SY   1V-90752-5C
DR   Wikidata; Q98131140
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7805; NFYB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NGF, clone1
AC   CVCL_A4P7
SY   1V-93060-1A
DR   Wikidata; Q98131142
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7808; NGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NGF, clone2
AC   CVCL_A4P8
SY   1V-93060-2B
DR   Wikidata; Q98131144
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7808; NGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NGF, clone3
AC   CVCL_A4P9
SY   1V-93060-4C
DR   Wikidata; Q98131146
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7808; NGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-1, clone1
AC   CVCL_A4Q0
SY   1V-91293-3A
DR   Wikidata; Q98131148
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11825; NKX2-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-1, clone2
AC   CVCL_A4Q1
SY   1V-91293-6B
DR   Wikidata; Q98131151
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11825; NKX2-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-1, clone3
AC   CVCL_A4Q2
SY   1V-91293-1C
DR   Wikidata; Q98131152
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11825; NKX2-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-2, clone1
AC   CVCL_A4Q3
SY   1V-91772-6A
DR   Wikidata; Q98131154
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7835; NKX2-2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-2, clone2
AC   CVCL_A4Q4
SY   1V-91772-2B
DR   Wikidata; Q98131156
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7835; NKX2-2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-2, clone3
AC   CVCL_A4Q5
SY   1V-91772-9D
DR   Wikidata; Q98131159
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7835; NKX2-2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-5, clone1
AC   CVCL_A4Q6
SY   1V-90848-1A
DR   Wikidata; Q98131162
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2488; NKX2-5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-5, clone2
AC   CVCL_A4Q7
SY   1V-90848-3B
DR   Wikidata; Q98131164
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2488; NKX2-5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX2-5, clone3
AC   CVCL_A4Q8
SY   1V-90848-6C
DR   Wikidata; Q98131166
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2488; NKX2-5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-1, clone1
AC   CVCL_A4Q9
SY   1V-91773-1A
DR   Wikidata; Q98131168
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7839; NKX6-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-1, clone2
AC   CVCL_A4R0
SY   1V-91773-4B
DR   Wikidata; Q98131171
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7839; NKX6-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-1, clone3
AC   CVCL_A4R1
SY   1V-91773-2C
DR   Wikidata; Q98131173
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7839; NKX6-1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-2, clone1
AC   CVCL_A4R2
SY   1V-93088-2A
DR   Wikidata; Q98131174
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19321; NKX6-2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-2, clone2
AC   CVCL_A4R3
SY   1V-93088-5B
DR   Wikidata; Q98131176
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19321; NKX6-2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-2, clone3
AC   CVCL_A4R4
SY   1V-93088-1C
DR   Wikidata; Q98131177
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19321; NKX6-2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-3, clone1
AC   CVCL_A4R5
SY   1V-91258-2A
DR   Wikidata; Q98131178
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26328; NKX6-3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-3, clone2
AC   CVCL_A4R6
SY   1V-91258-1B
DR   Wikidata; Q98131180
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26328; NKX6-3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NKX6-3, clone3
AC   CVCL_A4R7
SY   1V-91258-4C
DR   Wikidata; Q98131182
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:26328; NKX6-3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NPAS2, clone1
AC   CVCL_A4R8
SY   1V-91698-17G
DR   Wikidata; Q98131183
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7895; NPAS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NPAS2, clone2
AC   CVCL_A4R9
SY   1V-91698-11E
DR   Wikidata; Q98131184
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7895; NPAS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NPAS2, clone3
AC   CVCL_A4S0
SY   1V-91698-10F
DR   Wikidata; Q98131185
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7895; NPAS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR0B2, clone1
AC   CVCL_A4S1
SY   1V-93174-6A
DR   Wikidata; Q98131186
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7961; NR0B2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR0B2, clone2
AC   CVCL_A4S2
SY   1V-93174-3B
DR   Wikidata; Q98131187
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7961; NR0B2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR0B2, clone3
AC   CVCL_A4S3
SY   1V-93174-2C
DR   Wikidata; Q98131188
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7961; NR0B2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1D1, clone1
AC   CVCL_A4S4
SY   1V-93499-6A
DR   Wikidata; Q98131190
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7962; NR1D1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1D1, clone2
AC   CVCL_A4S5
SY   1V-93499-5B
DR   Wikidata; Q98131191
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7962; NR1D1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1D1, clone3
AC   CVCL_A4S6
SY   1V-93499-2C
DR   Wikidata; Q98131193
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7962; NR1D1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1D2, clone1
AC   CVCL_A4S7
SY   1V-93500-6A
DR   Wikidata; Q98131195
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7963; NR1D2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1D2, clone2
AC   CVCL_A4S8
SY   1V-93500-4B
DR   Wikidata; Q98131197
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7963; NR1D2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1D2, clone3
AC   CVCL_A4S9
SY   1V-93500-3C
DR   Wikidata; Q98131198
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7963; NR1D2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H2, clone1
AC   CVCL_A4T0
SY   1V-92206-6A
DR   Wikidata; Q98131199
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7965; NR1H2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H2, clone2
AC   CVCL_A4T1
SY   1V-92206-4B
DR   Wikidata; Q98131201
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7965; NR1H2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H2, clone3
AC   CVCL_A4T2
SY   1V-92206-1C
DR   Wikidata; Q98131202
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7965; NR1H2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H3, clone1
AC   CVCL_A4T3
SY   1V-93370-1A
DR   Wikidata; Q98131204
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7966; NR1H3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H3, clone2
AC   CVCL_A4T4
SY   1V-93370-2B
DR   Wikidata; Q98131205
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7966; NR1H3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H3, clone3
AC   CVCL_A4T5
SY   1V-93370-3C
DR   Wikidata; Q98131207
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7966; NR1H3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H4, clone1
AC   CVCL_A4T6
SY   1V-93371-2A
DR   Wikidata; Q98131208
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7967; NR1H4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H4, clone2
AC   CVCL_A4T7
SY   1V-93371-3B
DR   Wikidata; Q98131209
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7967; NR1H4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1H4, clone3
AC   CVCL_A4T8
SY   1V-93371-6C
DR   Wikidata; Q98131210
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7967; NR1H4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1I2, clone1
AC   CVCL_A4T9
SY   1V-93473-5A
DR   Wikidata; Q98131211
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1I2, clone2
AC   CVCL_A4U0
SY   1V-93473-3B
DR   Wikidata; Q98131212
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1I2, clone3
AC   CVCL_A4U1
SY   1V-93473-1C
DR   Wikidata; Q98131213
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7968; NR1I2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1I3, clone1
AC   CVCL_A4U2
SY   1V-93089-1A
DR   Wikidata; Q98131214
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1I3, clone2
AC   CVCL_A4U3
SY   1V-93089-5B
DR   Wikidata; Q98131215
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR1I3, clone3
AC   CVCL_A4U4
SY   1V-93089-3C
DR   Wikidata; Q98131217
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7969; NR1I3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2C2, clone1
AC   CVCL_A4U5
SY   1V-91297-11D
DR   Wikidata; Q98131218
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7972; NR2C2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2C2, clone2
AC   CVCL_A4U6
SY   1V-91297-9E
DR   Wikidata; Q98131219
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7972; NR2C2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2C2, clone3
AC   CVCL_A4U7
SY   1V-91297-8F
DR   Wikidata; Q98131220
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7972; NR2C2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2E1, clone1
AC   CVCL_A4U8
SY   1V-93175-9D
DR   Wikidata; Q98131222
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7973; NR2E1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2E1, clone2
AC   CVCL_A4U9
SY   1V-93175-4B
DR   Wikidata; Q98131223
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7973; NR2E1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2E1, clone3
AC   CVCL_A4V0
SY   1V-93175-3C
DR   Wikidata; Q98131225
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7973; NR2E1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2E3, clone1
AC   CVCL_A4V1
SY   1V-93357-3A
DR   Wikidata; Q98131226
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7974; NR2E3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2E3, clone2
AC   CVCL_A4V2
SY   1V-93357-6B
DR   Wikidata; Q98131227
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7974; NR2E3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2E3, clone3
AC   CVCL_A4V3
SY   1V-93357-2C
DR   Wikidata; Q98131228
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7974; NR2E3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F1, clone1
AC   CVCL_A4V4
SY   1V-91497-3A
DR   Wikidata; Q98131229
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7975; NR2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F1, clone2
AC   CVCL_A4V5
SY   1V-91497-2B
DR   Wikidata; Q98131230
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7975; NR2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F1, clone3
AC   CVCL_A4V6
SY   1V-91497-5C
DR   Wikidata; Q98131231
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7975; NR2F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F2, clone1
AC   CVCL_A4V7
SY   1V-90986-4A
DR   Wikidata; Q98131233
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7976; NR2F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F2, clone2
AC   CVCL_A4V8
SY   1V-90986-5B
DR   Wikidata; Q98131234
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7976; NR2F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F2, clone3
AC   CVCL_A4V9
SY   1V-90986-6C
DR   Wikidata; Q98131235
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7976; NR2F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F6, clone1
AC   CVCL_A4W0
SY   1V-93372-3A
DR   Wikidata; Q98131236
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7977; NR2F6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F6, clone2
AC   CVCL_A4W1
SY   1V-93372-5B
DR   Wikidata; Q98131237
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7977; NR2F6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR2F6, clone3
AC   CVCL_A4W2
SY   1V-93372-4C
DR   Wikidata; Q98131239
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7977; NR2F6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR3C1, clone1
AC   CVCL_A4W3
SY   1V-91399-3A
DR   Wikidata; Q98131240
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR3C1, clone2
AC   CVCL_A4W4
SY   1V-91399-6B
DR   Wikidata; Q98131242
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR3C1, clone3
AC   CVCL_A4W5
SY   1V-91399-5C
DR   Wikidata; Q98131243
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A1, clone1
AC   CVCL_A4W6
SY   1V-90735-5A
DR   Wikidata; Q98131247
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7980; NR4A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A1, clone2
AC   CVCL_A4W7
SY   1V-90735-7D
DR   Wikidata; Q98131262
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7980; NR4A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A1, clone3
AC   CVCL_A4W8
SY   1V-90735-8E
DR   Wikidata; Q98131263
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7980; NR4A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A2, clone1
AC   CVCL_A4W9
SY   1V-91774-1A
DR   Wikidata; Q98131264
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7981; NR4A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A2, clone2
AC   CVCL_A4X0
SY   1V-91774-4B
DR   Wikidata; Q98131265
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7981; NR4A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A3, clone1
AC   CVCL_A4X1
SY   1V-93502-6A
DR   Wikidata; Q98131267
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7981; NR4A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A3, clone2
AC   CVCL_A4X2
SY   1V-93502-2B
DR   Wikidata; Q98131269
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7982; NR4A3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR4A3, clone3
AC   CVCL_A4X3
SY   1V-93502-1D
DR   Wikidata; Q98131270
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7982; NR4A3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR5A1, clone1
AC   CVCL_A4X4
SY   1V-93474-5A
DR   Wikidata; Q98131271
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7983; NR5A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR5A1, clone2
AC   CVCL_A4X5
SY   1V-93474-3B
DR   Wikidata; Q98131273
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7983; NR5A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR5A1, clone3
AC   CVCL_A4X6
SY   1V-93474-2C
DR   Wikidata; Q98131274
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7983; NR5A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR5A2, clone1
AC   CVCL_A4X7
SY   1V-91188-2C
DR   Wikidata; Q98131276
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7984; NR5A2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR6A1, clone1
AC   CVCL_A4X8
SY   1V-93475-2A
DR   Wikidata; Q98131278
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7985; NR6A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR6A1, clone2
AC   CVCL_A4X9
SY   1V-93475-4B
DR   Wikidata; Q98131279
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7985; NR6A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NR6A1, clone3
AC   CVCL_A4Y0
SY   1V-93475-1C
DR   Wikidata; Q98131280
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7985; NR6A1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NRF1, clone1
AC   CVCL_A4Y1
SY   1V-91308-4A
DR   Wikidata; Q98131281
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7996; NRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NRF1, clone2
AC   CVCL_A4Y2
SY   1V-91308-3B
DR   Wikidata; Q98131283
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7996; NRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NRF1, clone3
AC   CVCL_A4Y3
SY   1V-91308-6C
DR   Wikidata; Q98131284
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:7996; NRF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NSBP1, clone1
AC   CVCL_A4Y4
SY   1V-91369-3A
DR   Wikidata; Q98131285
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8013; HMGN5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NSBP1, clone2
AC   CVCL_A4Y5
SY   1V-91369-6B
DR   Wikidata; Q98131286
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8013; HMGN5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NSBP1, clone3
AC   CVCL_A4Y6
SY   1V-91369-4C
DR   Wikidata; Q98131287
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8013; HMGN5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NUPR1, clone1
AC   CVCL_A4Y7
SY   1V-91699-4A
DR   Wikidata; Q98131288
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29990; NUPR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NUPR1, clone2
AC   CVCL_A4Y8
SY   1V-91699-6B
DR   Wikidata; Q98131289
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29990; NUPR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human NUPR1, clone3
AC   CVCL_A4Y9
SY   1V-91699-1C
DR   Wikidata; Q98131291
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29990; NUPR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG1, clone1
AC   CVCL_A4Z0
SY   1V-91775-3A
DR   Wikidata; Q98131294
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16983; OLIG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG1, clone2
AC   CVCL_A4Z1
SY   1V-91775-4B
DR   Wikidata; Q98131295
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16983; OLIG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG1, clone3
AC   CVCL_A4Z2
SY   1V-91775-2C
DR   Wikidata; Q98131296
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16983; OLIG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG2, clone1
AC   CVCL_A4Z3
SY   1V-91294-4A
DR   Wikidata; Q98131297
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9398; OLIG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG2, clone2
AC   CVCL_A4Z4
SY   1V-91294-3B
DR   Wikidata; Q98131298
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9398; OLIG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG2, clone3
AC   CVCL_A4Z5
SY   1V-91294-1C
DR   Wikidata; Q98131299
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9398; OLIG2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG3, clone1
AC   CVCL_A4Z6
SY   1V-93090-2A
DR   Wikidata; Q98131301
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18003; OLIG3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG3, clone2
AC   CVCL_A4Z7
SY   1V-93090-5B
DR   Wikidata; Q98131302
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18003; OLIG3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OLIG3, clone3
AC   CVCL_A4Z8
SY   1V-93090-1C
DR   Wikidata; Q98131303
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18003; OLIG3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ONECUT1, clone1
AC   CVCL_A4Z9
SY   1V-93476-4A
DR   Wikidata; Q98131305
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8138; ONECUT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ONECUT1, clone2
AC   CVCL_A5A0
SY   1V-93476-3B
DR   Wikidata; Q98131307
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8138; ONECUT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ONECUT1, clone3
AC   CVCL_A5A1
SY   1V-93476-5C
DR   Wikidata; Q98131309
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8138; ONECUT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OSR1, clone1
AC   CVCL_A5A2
SY   1V-93094-2A
DR   Wikidata; Q98131311
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8111; OSR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OSR1, clone2
AC   CVCL_A5A3
SY   1V-93094-6B
DR   Wikidata; Q98131313
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8111; OSR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OSR1, clone3
AC   CVCL_A5A4
SY   1V-93094-1C
DR   Wikidata; Q98131314
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8111; OSR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OSTF1, clone1
AC   CVCL_A5A5
SY   1V-91390-3A
DR   Wikidata; Q98131315
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8510; OSTF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OSTF1, clone2
AC   CVCL_A5A6
SY   1V-91390-2B
DR   Wikidata; Q98131317
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8510; OSTF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OSTF1, clone3
AC   CVCL_A5A7
SY   1V-91390-5C
DR   Wikidata; Q98131318
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8510; OSTF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTP, clone1
AC   CVCL_A5A8
SY   1V-93095-6A
DR   Wikidata; Q98131320
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8518; OTP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTP, clone2
AC   CVCL_A5A9
SY   1V-93095-1B
DR   Wikidata; Q98131321
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8518; OTP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTP, clone3
AC   CVCL_A5B0
SY   1V-93095-2C
DR   Wikidata; Q98131323
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8518; OTP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTX1, clone1
AC   CVCL_A5B1
SY   1V-91005-7D
DR   Wikidata; Q98131324
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8521; OTX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTX1, clone2
AC   CVCL_A5B2
SY   1V-91005-4B
DR   Wikidata; Q98131325
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8521; OTX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTX1, clone3
AC   CVCL_A5B3
SY   1V-91005-3C
DR   Wikidata; Q98131326
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8521; OTX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTX2, clone1
AC   CVCL_A5B4
SY   1V-90850-8A
DR   Wikidata; Q98131329
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8522; OTX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTX2, clone2
AC   CVCL_A5B5
SY   1V-90850-9B
DR   Wikidata; Q98131330
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8522; OTX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OTX2, clone3
AC   CVCL_A5B6
SY   1V-90850-12C
DR   Wikidata; Q98131331
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8522; OTX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OVOL2, clone1
AC   CVCL_A5B7
SY   1V-91370-5A
DR   Wikidata; Q98131332
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15804; OVOL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OVOL2, clone2
AC   CVCL_A5B8
SY   1V-91370-2C
DR   Wikidata; Q98131333
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15804; OVOL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human OVOL2, clone3
AC   CVCL_A5B9
SY   1V-91370-9D
DR   Wikidata; Q98131334
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15804; OVOL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PA2G4, clone1
AC   CVCL_A5C0
SY   1V-91909-1A
DR   Wikidata; Q98131335
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8550; PA2G4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PA2G4, clone2
AC   CVCL_A5C1
SY   1V-91909-3B
DR   Wikidata; Q98131336
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8550; PA2G4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PA2G4, clone3
AC   CVCL_A5C2
SY   1V-91909-2C
DR   Wikidata; Q98131337
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8550; PA2G4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PABPC1, clone1
AC   CVCL_A5C3
SY   1V-90751-4A
DR   Wikidata; Q98131338
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8554; PABPC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PABPC1, clone2
AC   CVCL_A5C4
SY   1V-90751-5B
DR   Wikidata; Q98131339
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8554; PABPC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PABPC1, clone3
AC   CVCL_A5C5
SY   1V-90751-3C
DR   Wikidata; Q98131340
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8554; PABPC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PATZ1, clone1
AC   CVCL_A5C6
SY   1V-92115-4A
DR   Wikidata; Q98131341
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PATZ1, clone2
AC   CVCL_A5C7
SY   1V-92115-3B
DR   Wikidata; Q98131342
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PATZ1, clone3
AC   CVCL_A5C8
SY   1V-92115-2C
DR   Wikidata; Q98131344
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13071; PATZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX2, clone1
AC   CVCL_A5C9
SY   1V-92116-5A
DR   Wikidata; Q98131345
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8616; PAX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX2, clone2
AC   CVCL_A5D0
SY   1V-92116-6B
DR   Wikidata; Q98131347
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8616; PAX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX2, clone3
AC   CVCL_A5D1
SY   1V-92116-1C
DR   Wikidata; Q98131349
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8616; PAX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX3, clone1
AC   CVCL_A5D2
SY   1V-91498-5A
DR   Wikidata; Q98131351
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8617; PAX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX3, clone2
AC   CVCL_A5D3
SY   1V-91498-6B
DR   Wikidata; Q98131352
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8617; PAX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX3, clone3
AC   CVCL_A5D4
SY   1V-91498-1C
DR   Wikidata; Q98131353
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8617; PAX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX4, clone1
AC   CVCL_A5D5
SY   1V-93096-6A
DR   Wikidata; Q98131354
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8618; PAX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX4, clone2
AC   CVCL_A5D6
SY   1V-93096-1B
DR   Wikidata; Q98131356
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8618; PAX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX4, clone3
AC   CVCL_A5D7
SY   1V-93096-2C
DR   Wikidata; Q98131357
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8618; PAX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX5, clone1
AC   CVCL_A5D8
SY   1V-91499-2D
DR   Wikidata; Q98131359
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8619; PAX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX5, clone2
AC   CVCL_A5D9
SY   1V-91499-3B
DR   Wikidata; Q98131361
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8619; PAX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX5, clone3
AC   CVCL_A5E0
SY   1V-91499-4C
DR   Wikidata; Q98131362
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8619; PAX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX6, clone1
AC   CVCL_A5E1
SY   1V-90932-2A
DR   Wikidata; Q98131364
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8620; PAX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX6, clone2
AC   CVCL_A5E2
SY   1V-90932-4B
DR   Wikidata; Q98131365
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8620; PAX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX6, clone3
AC   CVCL_A5E3
SY   1V-90932-1C
DR   Wikidata; Q98131366
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8620; PAX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX8, clone1
AC   CVCL_A5E4
SY   1V-92184-2A
DR   Wikidata; Q98131368
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8622; PAX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX8, clone2
AC   CVCL_A5E5
SY   1V-92184-4B
DR   Wikidata; Q98131369
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8622; PAX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX8, clone3
AC   CVCL_A5E6
SY   1V-92184-6C
DR   Wikidata; Q98131371
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8622; PAX8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX9, clone1
AC   CVCL_A5E7
SY   1V-92117-6A
DR   Wikidata; Q98131372
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8623; PAX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX9, clone2
AC   CVCL_A5E8
SY   1V-92117-5B
DR   Wikidata; Q98131373
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8623; PAX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PAX9, clone3
AC   CVCL_A5E9
SY   1V-92117-3C
DR   Wikidata; Q98131374
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8623; PAX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PBX1, clone1
AC   CVCL_A5F0
SY   1V-91332-5A
DR   Wikidata; Q98131375
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8632; PBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PBX1, clone2
AC   CVCL_A5F1
SY   1V-91332-6B
DR   Wikidata; Q98131377
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8632; PBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PBX1, clone3
AC   CVCL_A5F2
SY   1V-91332-4C
DR   Wikidata; Q98131379
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8632; PBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PBX3, clone1
AC   CVCL_A5F3
SY   1V-91500-3B
DR   Wikidata; Q98131381
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8634; PBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PBX3, clone2
AC   CVCL_A5F4
SY   1V-91500-8D
DR   Wikidata; Q98131382
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8634; PBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PBX3, clone3
AC   CVCL_A5F5
SY   1V-91500-10E
DR   Wikidata; Q98131383
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8634; PBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PCDH1, clone1
AC   CVCL_A5F6
SY   1V-91819-4A
DR   Wikidata; Q98131386
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8655; PCDH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PCDH1, clone2
AC   CVCL_A5F7
SY   1V-91819-3B
DR   Wikidata; Q98131388
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8655; PCDH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PCDH1, clone3
AC   CVCL_A5F8
SY   1V-91819-5C
DR   Wikidata; Q98131389
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8655; PCDH1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDE4A, clone1
AC   CVCL_A5F9
SY   1V-92203-5A
DR   Wikidata; Q98131391
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8780; PDE4A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDE4A, clone2
AC   CVCL_A5G0
SY   1V-92203-2B
DR   Wikidata; Q98131392
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8780; PDE4A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDE4A, clone3
AC   CVCL_A5G1
SY   1V-92203-4C
DR   Wikidata; Q98131394
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8780; PDE4A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDGFA, clone1
AC   CVCL_A5G2
SY   1V-92118-1A
DR   Wikidata; Q98131395
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8799; PDGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDGFA, clone2
AC   CVCL_A5G3
SY   1V-92118-2B
DR   Wikidata; Q98131396
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8799; PDGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDGFA, clone3
AC   CVCL_A5G4
SY   1V-92118-5C
DR   Wikidata; Q98131397
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8799; PDGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDLIM1, clone1
AC   CVCL_A5G5
SY   1V-91700-9D
DR   Wikidata; Q98131399
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2067; PDLIM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDLIM1, clone2
AC   CVCL_A5G6
SY   1V-91700-8E
DR   Wikidata; Q98131400
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2067; PDLIM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDLIM1, clone3
AC   CVCL_A5G7
SY   1V-91700-7F
DR   Wikidata; Q98131401
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2067; PDLIM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDX1, clone1
AC   CVCL_A5G8
SY   1V-90933-2A
DR   Wikidata; Q98131402
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6107; PDX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDX1, clone2
AC   CVCL_A5G9
SY   1V-90933-4B
DR   Wikidata; Q98131403
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6107; PDX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PDX1, clone3
AC   CVCL_A5H0
SY   1V-90933-3C
DR   Wikidata; Q98131404
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6107; PDX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PGF, clone1
AC   CVCL_A5H1
SY   1V-92138-3A
DR   Wikidata; Q98131405
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8893; PGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PGF, clone2
AC   CVCL_A5H2
SY   1V-92138-5B
DR   Wikidata; Q98131406
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8893; PGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PGF, clone3
AC   CVCL_A5H3
SY   1V-92138-6C
DR   Wikidata; Q98131407
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8893; PGF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PGR, clone1
AC   CVCL_A5H4
SY   1V-93503-2A
DR   Wikidata; Q98131409
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8910; PGR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PGR, clone2
AC   CVCL_A5H5
SY   1V-93503-5B
DR   Wikidata; Q98131410
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8910; PGR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PGR, clone3
AC   CVCL_A5H6
SY   1V-93503-3C
DR   Wikidata; Q98131412
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8910; PGR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHF2, clone1
AC   CVCL_A5H7
SY   1V-93116-5A
DR   Wikidata; Q98131413
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8920; PHF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHF2, clone2
AC   CVCL_A5H8
SY   1V-93116-6B
DR   Wikidata; Q98131414
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8920; PHF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHF2, clone3
AC   CVCL_A5H9
SY   1V-93116-1C
DR   Wikidata; Q98131415
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8920; PHF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHF8, clone1
AC   CVCL_A5I0
SY   1V-91313-3A
DR   Wikidata; Q98131416
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20672; PHF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHF8, clone2
AC   CVCL_A5I1
SY   1V-91313-5B
DR   Wikidata; Q98131417
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20672; PHF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHF8, clone3
AC   CVCL_A5I2
SY   1V-91313-6C
DR   Wikidata; Q98131418
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20672; PHF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHOX2B, clone1
AC   CVCL_A5I3
SY   1V-92302-4A
DR   Wikidata; Q98131419
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9143; PHOX2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHOX2B, clone2
AC   CVCL_A5I4
SY   1V-92302-2B
DR   Wikidata; Q98131420
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9143; PHOX2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PHOX2B, clone3
AC   CVCL_A5I5
SY   1V-92302-3C
DR   Wikidata; Q98131421
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9143; PHOX2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PIAS2, clone1
AC   CVCL_A5I6
SY   1V-92156-5A
DR   Wikidata; Q98131423
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17311; PIAS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PIAS2, clone2
AC   CVCL_A5I7
SY   1V-92156-4B
DR   Wikidata; Q98131424
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17311; PIAS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PIAS2, clone3
AC   CVCL_A5I8
SY   1V-92156-6C
DR   Wikidata; Q98131425
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17311; PIAS2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX1, clone1
AC   CVCL_A5I9
SY   1V-91362-1A
DR   Wikidata; Q98131426
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9004; PITX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX1, clone2
AC   CVCL_A5J0
SY   1V-91362-4B
DR   Wikidata; Q98131427
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9004; PITX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX1, clone3
AC   CVCL_A5J1
SY   1V-91362-6C
DR   Wikidata; Q98131428
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9004; PITX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX2, clone1
AC   CVCL_A5J2
SY   1V-90934-6A
DR   Wikidata; Q98131429
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9005; PITX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX2, clone2
AC   CVCL_A5J3
SY   1V-90934-9B
DR   Wikidata; Q98131430
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9005; PITX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX2, clone3
AC   CVCL_A5J4
SY   1V-90934-4C
DR   Wikidata; Q98131431
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9005; PITX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX3, clone1
AC   CVCL_A5J5
SY   1V-91776-9E
DR   Wikidata; Q98131432
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9006; PITX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX3, clone2
AC   CVCL_A5J6
SY   1V-91776-2B
DR   Wikidata; Q98131433
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9006; PITX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PITX3, clone3
AC   CVCL_A5J7
SY   1V-91776-6C
DR   Wikidata; Q98131434
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9006; PITX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PKNOX2, clone1
AC   CVCL_A5J8
SY   1V-91371-15A
DR   Wikidata; Q98131436
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16714; PKNOX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PKNOX2, clone2
AC   CVCL_A5J9
SY   1V-91371-8B
DR   Wikidata; Q98131437
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16714; PKNOX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PKNOX2, clone3
AC   CVCL_A5K0
SY   1V-91371-11C
DR   Wikidata; Q98131438
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16714; PKNOX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PLAGL1, clone1
AC   CVCL_A5K1
SY   1V-93358-4A
DR   Wikidata; Q98131440
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9046; PLAGL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PLAGL1, clone2
AC   CVCL_A5K2
SY   1V-93358-1B
DR   Wikidata; Q98131441
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9046; PLAGL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PLAGL1, clone3
AC   CVCL_A5K3
SY   1V-93358-5C
DR   Wikidata; Q98131442
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9046; PLAGL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PLXNB3, clone1
AC   CVCL_A5K4
SY   1V-90776-3A
DR   Wikidata; Q98131443
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9105; PLXNB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PLXNB3, clone2
AC   CVCL_A5K5
SY   1V-90776-4B
DR   Wikidata; Q98131444
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9105; PLXNB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PLXNB3, clone3
AC   CVCL_A5K6
SY   1V-90776-6C
DR   Wikidata; Q98131445
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9105; PLXNB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PML, clone1
AC   CVCL_A5K7
SY   1V-91501-2A
DR   Wikidata; Q98131446
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9113; PML.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PML, clone2
AC   CVCL_A5K8
SY   1V-91501-6D
DR   Wikidata; Q98131447
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9113; PML.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PML, clone3
AC   CVCL_A5K9
SY   1V-91501-4C
DR   Wikidata; Q98131448
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9113; PML.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POLR3A, clone1
AC   CVCL_A5L0
SY   1V-91703-6A
DR   Wikidata; Q98131449
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30074; POLR3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POLR3A, clone2
AC   CVCL_A5L1
SY   1V-91703-4B
DR   Wikidata; Q98131450
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30074; POLR3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POLR3A, clone3
AC   CVCL_A5L2
SY   1V-91703-5C
DR   Wikidata; Q98131451
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30074; POLR3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU2AF1, clone1
AC   CVCL_A5L3
SY   1V-91872-3A
DR   Wikidata; Q98131452
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9211; POU2AF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU2AF1, clone2
AC   CVCL_A5L4
SY   1V-91872-5B
DR   Wikidata; Q98131453
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9211; POU2AF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU2AF1, clone3
AC   CVCL_A5L5
SY   1V-91872-6C
DR   Wikidata; Q98131454
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9211; POU2AF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU2F2, clone1
AC   CVCL_A5L6
SY   1V-91502-2A
DR   Wikidata; Q98131455
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9213; POU2F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU2F2, clone2
AC   CVCL_A5L7
SY   1V-91502-4B
DR   Wikidata; Q98131456
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9213; POU2F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU2F2, clone3
AC   CVCL_A5L8
SY   1V-91502-1C
DR   Wikidata; Q98131457
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9213; POU2F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU3F2, clone1
AC   CVCL_A5L9
SY   1V-91777-6A
DR   Wikidata; Q98131458
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9215; POU3F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU3F2, clone2
AC   CVCL_A5M0
SY   1V-91777-5B
DR   Wikidata; Q98131459
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9215; POU3F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU3F2, clone3
AC   CVCL_A5M1
SY   1V-91777-1C
DR   Wikidata; Q98131460
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9215; POU3F2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU3F4, clone1
AC   CVCL_A5M2
SY   1V-92119-5A
DR   Wikidata; Q98131462
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9217; POU3F4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU3F4, clone2
AC   CVCL_A5M3
SY   1V-92119-1B
DR   Wikidata; Q98131463
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9217; POU3F4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU3F4, clone3
AC   CVCL_A5M4
SY   1V-92119-2C
DR   Wikidata; Q98131464
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9217; POU3F4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU4F1, clone1
AC   CVCL_A5M5
SY   1V-92120-1A
DR   Wikidata; Q98131465
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9218; POU4F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU4F1, clone2
AC   CVCL_A5M6
SY   1V-92120-6B
DR   Wikidata; Q98131466
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9218; POU4F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU4F1, clone3
AC   CVCL_A5M7
SY   1V-92120-4C
DR   Wikidata; Q98131467
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9218; POU4F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU4F3, clone1
AC   CVCL_A5M8
SY   1V-93097-3A
DR   Wikidata; Q98131468
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9220; POU4F3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU4F3, clone2
AC   CVCL_A5M9
SY   1V-93097-5B
DR   Wikidata; Q98131470
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9220; POU4F3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU4F3, clone3
AC   CVCL_A5N0
SY   1V-93097-2C
DR   Wikidata; Q98131471
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9220; POU4F3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU5F1, clone1
AC   CVCL_A5N1
SY   1V-90990-1A
DR   Wikidata; Q98131472
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9221; POU5F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU5F1, clone2
AC   CVCL_A5N2
SY   1V-90990-4B
DR   Wikidata; Q98131473
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9221; POU5F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human POU5F1, clone3
AC   CVCL_A5N3
SY   1V-90990-3C
DR   Wikidata; Q98131474
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9221; POU5F1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARA, clone1
AC   CVCL_A5N4
SY   1V-92121-2A
DR   Wikidata; Q98131475
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9232; PPARA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARA, clone2
AC   CVCL_A5N5
SY   1V-92121-1B
DR   Wikidata; Q98131476
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9232; PPARA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARA, clone3
AC   CVCL_A5N6
SY   1V-92121-3C
DR   Wikidata; Q98131477
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9232; PPARA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARD, clone1
AC   CVCL_A5N7
SY   1V-93373-2A
DR   Wikidata; Q98131478
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9235; PPARD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARD, clone2
AC   CVCL_A5N8
SY   1V-93373-1B
DR   Wikidata; Q98131479
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9235; PPARD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARD, clone3
AC   CVCL_A5N9
SY   1V-93373-4C
DR   Wikidata; Q98131480
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9235; PPARD.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARG, clone1
AC   CVCL_A5P0
SY   1V-90935-9D
DR   Wikidata; Q98131481
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9236; PPARG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARG, clone2
AC   CVCL_A5P1
SY   1V-90935-4B
DR   Wikidata; Q98131482
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9236; PPARG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARG, clone3
AC   CVCL_A5P2
SY   1V-90935-1C
DR   Wikidata; Q98131483
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9236; PPARG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARGC1A, clone1
AC   CVCL_A5P3
SY   1V-91483-3A
DR   Wikidata; Q98131484
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARGC1A, clone2
AC   CVCL_A5P4
SY   1V-91483-2B
DR   Wikidata; Q98131485
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PPARGC1A, clone3
AC   CVCL_A5P5
SY   1V-91483-7D
DR   Wikidata; Q98131486
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9237; PPARGC1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM1, clone1
AC   CVCL_A5P6
SY   1V-91706-5A
DR   Wikidata; Q98131487
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9346; PRDM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM1, clone2
AC   CVCL_A5P7
SY   1V-91706-4B
DR   Wikidata; Q98131489
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9346; PRDM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM1, clone3
AC   CVCL_A5P8
SY   1V-91706-2C
DR   Wikidata; Q98131490
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9346; PRDM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM13, clone1
AC   CVCL_A5P9
SY   1V-92234-6A
DR   Wikidata; Q98131491
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13998; PRDM13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM13, clone2
AC   CVCL_A5Q0
SY   1V-92234-2B
DR   Wikidata; Q98131492
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13998; PRDM13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM13, clone3
AC   CVCL_A5Q1
SY   1V-92234-4C
DR   Wikidata; Q98131493
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13998; PRDM13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM2, clone1
AC   CVCL_A5Q2
SY   1V-92214-4A
DR   Wikidata; Q98131494
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9347; PRDM2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM2, clone2
AC   CVCL_A5Q3
SY   1V-92214-3B
DR   Wikidata; Q98131495
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9347; PRDM2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM2, clone3
AC   CVCL_A5Q4
SY   1V-92214-2C
DR   Wikidata; Q98131497
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9347; PRDM2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM4, clone1
AC   CVCL_A5Q5
SY   1V-91862-12A
DR   Wikidata; Q98131498
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9348; PRDM4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM4, clone2
AC   CVCL_A5Q6
SY   1V-91862-9B
DR   Wikidata; Q98131499
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9348; PRDM4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRDM4, clone3
AC   CVCL_A5Q7
SY   1V-91862-13D
DR   Wikidata; Q98131500
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9348; PRDM4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PREB, clone1
AC   CVCL_A5Q8
SY   1V-92122-4A
DR   Wikidata; Q98131501
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9356; PREB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PREB, clone2
AC   CVCL_A5Q9
SY   1V-92122-5B
DR   Wikidata; Q98131503
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9356; PREB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PREB, clone3
AC   CVCL_A5R0
SY   1V-92122-6C
DR   Wikidata; Q98131504
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9356; PREB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRICKLE1, clone1
AC   CVCL_A5R1
SY   1V-91366-1A
DR   Wikidata; Q98131505
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17019; PRICKLE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRICKLE1, clone2
AC   CVCL_A5R2
SY   1V-91366-6B
DR   Wikidata; Q98131506
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17019; PRICKLE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PRICKLE1, clone3
AC   CVCL_A5R3
SY   1V-91366-5C
DR   Wikidata; Q98131507
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17019; PRICKLE1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PTAFR, clone1
AC   CVCL_A5R4
SY   1V-91927-4A
DR   Wikidata; Q98131508
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PTAFR, clone2
AC   CVCL_A5R5
SY   1V-91927-5B
DR   Wikidata; Q98131509
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PTAFR, clone3
AC   CVCL_A5R6
SY   1V-91927-3C
DR   Wikidata; Q98131510
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PTF1A, clone1
AC   CVCL_A5R7
SY   1V-91277-4A
DR   Wikidata; Q98131511
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23734; PTF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PTF1A, clone2
AC   CVCL_A5R8
SY   1V-91277-6C
DR   Wikidata; Q98131512
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23734; PTF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human PTF1A, clone3
AC   CVCL_A5R9
SY   1V-91277-9D
DR   Wikidata; Q98131513
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23734; PTF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RAD21, clone1
AC   CVCL_A5S0
SY   1V-91315-4A
DR   Wikidata; Q98131514
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9811; RAD21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RAD21, clone2
AC   CVCL_A5S1
SY   1V-91315-3B
DR   Wikidata; Q98131515
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9811; RAD21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RAD21, clone3
AC   CVCL_A5S2
SY   1V-91315-6C
DR   Wikidata; Q98131516
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9811; RAD21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARA, clone1
AC   CVCL_A5S3
SY   1V-91240-2A
DR   Wikidata; Q98131517
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9864; RARA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARA, clone2
AC   CVCL_A5S4
SY   1V-91240-6B
DR   Wikidata; Q98131518
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9864; RARA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARA, clone3
AC   CVCL_A5S5
SY   1V-91240-3C
DR   Wikidata; Q98131519
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9864; RARA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARB, clone1
AC   CVCL_A5S6
SY   1V-93374-6A
DR   Wikidata; Q98131520
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9865; RARB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARB, clone2
AC   CVCL_A5S7
SY   1V-93374-2B
DR   Wikidata; Q98131521
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9865; RARB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARB, clone3
AC   CVCL_A5S8
SY   1V-93374-4C
DR   Wikidata; Q98131522
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9865; RARB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARG, clone1
AC   CVCL_A5S9
SY   1V-91296-4A
DR   Wikidata; Q98131523
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9866; RARG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARG, clone2
AC   CVCL_A5T0
SY   1V-91296-2B
DR   Wikidata; Q98131524
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9866; RARG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RARG, clone3
AC   CVCL_A5T1
SY   1V-91296-6C
DR   Wikidata; Q98131525
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9866; RARG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBBP5, clone1
AC   CVCL_A5T2
SY   1V-90750-6A
DR   Wikidata; Q98131526
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9888; RBBP5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBBP5, clone2
AC   CVCL_A5T3
SY   1V-90750-5B
DR   Wikidata; Q98131527
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9888; RBBP5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBBP5, clone3
AC   CVCL_A5T4
SY   1V-90750-2C
DR   Wikidata; Q98131528
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9888; RBBP5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBBP6, clone1
AC   CVCL_A5T5
SY   1V-92221-4C
DR   Wikidata; Q98131529
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9889; RBBP6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBBP6, clone2
AC   CVCL_A5T6
SY   1V-92221-7D
DR   Wikidata; Q98131530
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9889; RBBP6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBBP6, clone3
AC   CVCL_A5T7
SY   1V-92221-8E
DR   Wikidata; Q98131531
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9889; RBBP6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBPJ, clone1
AC   CVCL_A5T8
SY   1V-91281-3A
DR   Wikidata; Q98131533
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5724; RBPJ.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBPJ, clone2
AC   CVCL_A5T9
SY   1V-91281-2B
DR   Wikidata; Q98131534
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5724; RBPJ.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RBPJ, clone3
AC   CVCL_A5U0
SY   1V-91281-5C
DR   Wikidata; Q98131536
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:5724; RBPJ.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RCOR1, clone1
AC   CVCL_A5U1
SY   1V-93477-6A
DR   Wikidata; Q98131537
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17441; RCOR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RCOR1, clone2
AC   CVCL_A5U2
SY   1V-93477-2B
DR   Wikidata; Q98131538
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17441; RCOR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RCOR1, clone3
AC   CVCL_A5U3
SY   1V-93477-5C
DR   Wikidata; Q98131539
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17441; RCOR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RDBP, clone1
AC   CVCL_A5U4
SY   1V-91707-5A
DR   Wikidata; Q98131540
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13974; NELFE.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RDBP, clone2
AC   CVCL_A5U5
SY   1V-91707-6B
DR   Wikidata; Q98131541
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13974; NELFE.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RDBP, clone3
AC   CVCL_A5U6
SY   1V-91707-4C
DR   Wikidata; Q98131542
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13974; NELFE.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human REPIN1, clone1
AC   CVCL_A5U7
SY   1V-91307-6A
DR   Wikidata; Q98131543
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17922; REPIN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human REPIN1, clone2
AC   CVCL_A5U8
SY   1V-91307-5B
DR   Wikidata; Q98131544
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17922; REPIN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human REPIN1, clone3
AC   CVCL_A5U9
SY   1V-91307-4C
DR   Wikidata; Q98131545
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17922; REPIN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human REST, clone1
AC   CVCL_A5V0
SY   1V-91708-1A
DR   Wikidata; Q98131546
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9966; REST.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human REST, clone2
AC   CVCL_A5V1
SY   1V-91708-4B
DR   Wikidata; Q98131547
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9966; REST.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human REST, clone3
AC   CVCL_A5V2
SY   1V-91708-3C
DR   Wikidata; Q98131548
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9966; REST.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFX2, clone1
AC   CVCL_A5V3
SY   1V-91251-1A
DR   Wikidata; Q98131549
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9983; RFX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFX2, clone2
AC   CVCL_A5V4
SY   1V-91251-2B
DR   Wikidata; Q98131550
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9983; RFX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFX2, clone3
AC   CVCL_A5V5
SY   1V-91251-3C
DR   Wikidata; Q98131551
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9983; RFX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFX5, clone1
AC   CVCL_A5V6
SY   1V-90755-5A
DR   Wikidata; Q98131552
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9986; RFX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFX5, clone2
AC   CVCL_A5V7
SY   1V-90755-6B
DR   Wikidata; Q98131553
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9986; RFX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFX5, clone3
AC   CVCL_A5V8
SY   1V-90755-7D
DR   Wikidata; Q98131554
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9986; RFX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFXAP, clone1
AC   CVCL_A5V9
SY   1V-92171-3A
DR   Wikidata; Q98131555
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9988; RFXAP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFXAP, clone2
AC   CVCL_A5W0
SY   1V-92171-6B
DR   Wikidata; Q98131556
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9988; RFXAP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RFXAP, clone3
AC   CVCL_A5W1
SY   1V-92171-2C
DR   Wikidata; Q98131557
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:9988; RFXAP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RHOXF2, clone1
AC   CVCL_A5W2
SY   1V-91192-1A
DR   Wikidata; Q98131558
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30011; RHOXF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RHOXF2, clone2
AC   CVCL_A5W3
SY   1V-91192-2B
DR   Wikidata; Q98131559
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30011; RHOXF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RHOXF2, clone3
AC   CVCL_A5W4
SY   1V-91192-8D
DR   Wikidata; Q98131560
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30011; RHOXF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RNF2, clone1
AC   CVCL_A5W5
SY   1V-90856-5A
DR   Wikidata; Q98131562
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10061; RNF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RNF2, clone2
AC   CVCL_A5W6
SY   1V-90856-4B
DR   Wikidata; Q98131565
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10061; RNF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RNF2, clone3
AC   CVCL_A5W7
SY   1V-90856-6C
DR   Wikidata; Q98131568
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10061; RNF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RORB, clone1
AC   CVCL_A5W8
SY   1V-93375-5A
DR   Wikidata; Q98131570
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10259; RORB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RORB, clone2
AC   CVCL_A5W9
SY   1V-93375-1B
DR   Wikidata; Q98131573
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10259; RORB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RORB, clone3
AC   CVCL_A5X0
SY   1V-93375-4C
DR   Wikidata; Q98131576
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10259; RORB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RORC, clone1
AC   CVCL_A5X1
SY   1V-92176-1A
DR   Wikidata; Q98131579
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10260; RORC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RORC, clone2
AC   CVCL_A5X2
SY   1V-92176-2B
DR   Wikidata; Q98131582
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10260; RORC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RORC, clone3
AC   CVCL_A5X3
SY   1V-92176-4C
DR   Wikidata; Q98131585
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10260; RORC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RPS6KA1, clone1
AC   CVCL_A5X4
SY   1V-90754-5C
DR   Wikidata; Q98131587
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10430; RPS6KA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RPS6KA1, clone2
AC   CVCL_A5X5
SY   1V-90754-2D
DR   Wikidata; Q98131589
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10430; RPS6KA1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RREB1, clone1
AC   CVCL_A5X6
SY   1V-92231-3A
DR   Wikidata; Q98131592
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10449; RREB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RREB1, clone2
AC   CVCL_A5X7
SY   1V-92231-2B
DR   Wikidata; Q98131595
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10449; RREB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RREB1, clone3
AC   CVCL_A5X8
SY   1V-92231-1C
DR   Wikidata; Q98131598
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10449; RREB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RSPO1, clone1
AC   CVCL_A5X9
SY   1V-91784-3A
DR   Wikidata; Q98131601
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21679; RSPO1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RSPO1, clone2
AC   CVCL_A5Y0
SY   1V-91784-6B
DR   Wikidata; Q98131604
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21679; RSPO1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RSPO1, clone3
AC   CVCL_A5Y1
SY   1V-91784-4C
DR   Wikidata; Q98131608
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21679; RSPO1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX1, clone1
AC   CVCL_A5Y2
SY   1V-91484-1A
DR   Wikidata; Q98131611
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10471; RUNX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX1, clone2
AC   CVCL_A5Y3
SY   1V-91484-12D
DR   Wikidata; Q98131613
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10471; RUNX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX1, clone3
AC   CVCL_A5Y4
SY   1V-91484-8E
DR   Wikidata; Q98131616
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10471; RUNX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX2, clone1
AC   CVCL_A5Y5
SY   1V-91485-2A
DR   Wikidata; Q98131618
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10472; RUNX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX2, clone2
AC   CVCL_A5Y6
SY   1V-91485-5B
DR   Wikidata; Q98131621
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10472; RUNX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX2, clone3
AC   CVCL_A5Y7
SY   1V-91485-1C
DR   Wikidata; Q98131623
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10472; RUNX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX3, clone1
AC   CVCL_A5Y8
SY   1V-91319-2A
DR   Wikidata; Q98131626
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10473; RUNX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX3, clone2
AC   CVCL_A5Y9
SY   1V-91319-4B
DR   Wikidata; Q98131628
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10473; RUNX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUNX3, clone3
AC   CVCL_A5Z0
SY   1V-91319-6C
DR   Wikidata; Q98131631
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10473; RUNX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUVBL2, clone1
AC   CVCL_A5Z1
SY   1V-90743-5A
DR   Wikidata; Q98131633
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10475; RUVBL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUVBL2, clone2
AC   CVCL_A5Z2
SY   1V-90743-3B
DR   Wikidata; Q98131635
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10475; RUVBL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RUVBL2, clone3
AC   CVCL_A5Z3
SY   1V-90743-2C
DR   Wikidata; Q98131638
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10475; RUVBL2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRA, clone1
AC   CVCL_A5Z4
SY   1V-91214-5A
DR   Wikidata; Q98131641
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRA, clone2
AC   CVCL_A5Z5
SY   1V-91214-6B
DR   Wikidata; Q98131643
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRA, clone3
AC   CVCL_A5Z6
SY   1V-91214-3C
DR   Wikidata; Q98131645
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRB, clone1
AC   CVCL_A5Z7
SY   1V-93376-3A
DR   Wikidata; Q98131648
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10478; RXRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRB, clone2
AC   CVCL_A5Z8
SY   1V-93376-5B
DR   Wikidata; Q98131650
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10478; RXRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRB, clone3
AC   CVCL_A5Z9
SY   1V-93376-4C
DR   Wikidata; Q98131653
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10478; RXRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRG, clone1
AC   CVCL_A6A0
SY   1V-93377-5A
DR   Wikidata; Q98131656
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10479; RXRG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRG, clone2
AC   CVCL_A6A1
SY   1V-93377-2B
DR   Wikidata; Q98131658
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10479; RXRG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RXRG, clone3
AC   CVCL_A6A2
SY   1V-93377-3C
DR   Wikidata; Q98131660
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10479; RXRG.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RYBP, clone1
AC   CVCL_A6A3
SY   1V-92155-4A
DR   Wikidata; Q98131664
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10480; RYBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RYBP, clone2
AC   CVCL_A6A4
SY   1V-92155-1B
DR   Wikidata; Q98131666
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10480; RYBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human RYBP, clone3
AC   CVCL_A6A5
SY   1V-92155-2C
DR   Wikidata; Q98131668
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10480; RYBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SALL1, clone1
AC   CVCL_A6A6
SY   1V-91938-2A
DR   Wikidata; Q98131671
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10524; SALL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SALL1, clone2
AC   CVCL_A6A7
SY   1V-91938-5B
DR   Wikidata; Q98131673
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10524; SALL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SALL1, clone3
AC   CVCL_A6A8
SY   1V-91938-6C
DR   Wikidata; Q98131676
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10524; SALL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SALL4, clone1
AC   CVCL_A6A9
SY   1V-90991-6A
DR   Wikidata; Q98131679
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15924; SALL4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SALL4, clone2
AC   CVCL_A6B0
SY   1V-90991-5B
DR   Wikidata; Q98131682
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15924; SALL4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SALL4, clone3
AC   CVCL_A6B1
SY   1V-90991-3C
DR   Wikidata; Q98131685
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15924; SALL4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SAP30, clone1
AC   CVCL_A6B2
SY   1V-90601-5A
DR   Wikidata; Q98131687
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10532; SAP30.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SAP30, clone2
AC   CVCL_A6B3
SY   1V-90601-1B
DR   Wikidata; Q98131689
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10532; SAP30.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SAP30, clone3
AC   CVCL_A6B4
SY   1V-90601-10D
DR   Wikidata; Q98131692
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10532; SAP30.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SATB1, clone1
AC   CVCL_A6B5
SY   1V-92139-4A
DR   Wikidata; Q98131694
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10541; SATB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SATB1, clone2
AC   CVCL_A6B6
SY   1V-92139-5B
DR   Wikidata; Q98131697
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10541; SATB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SATB1, clone3
AC   CVCL_A6B7
SY   1V-92139-6C
DR   Wikidata; Q98131700
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10541; SATB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SETDB1, clone1
AC   CVCL_A6B8
SY   1V-91710-5A
DR   Wikidata; Q98131704
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10761; SETDB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SETDB1, clone2
AC   CVCL_A6B9
SY   1V-91710-6B
DR   Wikidata; Q98131706
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10761; SETDB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SETDB1, clone3
AC   CVCL_A6C0
SY   1V-91710-4C
DR   Wikidata; Q98131709
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10761; SETDB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SFRS6, clone1
AC   CVCL_A6C1
SY   1V-91711-3A
DR   Wikidata; Q98131712
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10788; SRSF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SFRS6, clone2
AC   CVCL_A6C2
SY   1V-91711-4B
DR   Wikidata; Q98131714
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10788; SRSF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SFRS6, clone3
AC   CVCL_A6C3
SY   1V-91711-5C
DR   Wikidata; Q98131717
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10788; SRSF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SHH, clone1
AC   CVCL_A6C4
SY   1V-93478-6A
DR   Wikidata; Q98131718
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10848; SHH.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SHH, clone2
AC   CVCL_A6C5
SY   1V-93478-4B
DR   Wikidata; Q98131719
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10848; SHH.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SHH, clone3
AC   CVCL_A6C6
SY   1V-93478-2C
DR   Wikidata; Q98131720
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10848; SHH.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SHOX, clone1
AC   CVCL_A6C7
SY   1V-92225-4A
DR   Wikidata; Q98131721
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10853; SHOX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SHOX, clone2
AC   CVCL_A6C8
SY   1V-92225-5B
DR   Wikidata; Q98131722
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10853; SHOX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SHOX, clone3
AC   CVCL_A6C9
SY   1V-92225-3C
DR   Wikidata; Q98131724
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10853; SHOX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIM1, clone1
AC   CVCL_A6D0
SY   1V-93504-6A
DR   Wikidata; Q98131726
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10882; SIM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIM1, clone2
AC   CVCL_A6D1
SY   1V-93504-5B
DR   Wikidata; Q98131729
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10882; SIM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIM1, clone3
AC   CVCL_A6D2
SY   1V-93504-3C
DR   Wikidata; Q98131732
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10882; SIM1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIN3A, clone1
AC   CVCL_A6D3
SY   1V-91712-5A
DR   Wikidata; Q98131735
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19353; SIN3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIN3A, clone2
AC   CVCL_A6D4
SY   1V-91712-3B
DR   Wikidata; Q98131738
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19353; SIN3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIN3A, clone3
AC   CVCL_A6D5
SY   1V-91712-4C
DR   Wikidata; Q98131740
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19353; SIN3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human S1PR1, clone1
AC   CVCL_A6D6
SY   1V-93176-5A
DR   Wikidata; Q98131743
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3165; S1PR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human S1PR1, clone2
AC   CVCL_A6D7
SY   1V-93176-6B
DR   Wikidata; Q98131746
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3165; S1PR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human S1PR1, clone3
AC   CVCL_A6D8
SY   1V-93176-1C
DR   Wikidata; Q98131748
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:3165; S1PR1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIRT3, clone1
AC   CVCL_A6D9
SY   1V-91395-5A
DR   Wikidata; Q98131751
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14931; SIRT3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIRT3, clone2
AC   CVCL_A6E0
SY   1V-91395-6B
DR   Wikidata; Q98131753
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14931; SIRT3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIRT3, clone3
AC   CVCL_A6E1
SY   1V-91395-1C
DR   Wikidata; Q98131756
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14931; SIRT3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIRT6, clone1
AC   CVCL_A6E2
SY   1V-90763-4A
DR   Wikidata; Q98131759
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14934; SIRT6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIRT6, clone2
AC   CVCL_A6E3
SY   1V-90763-8D
DR   Wikidata; Q98131762
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14934; SIRT6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIRT6, clone3
AC   CVCL_A6E4
SY   1V-90763-5C
DR   Wikidata; Q98131764
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:14934; SIRT6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX1, clone1
AC   CVCL_A6E5
SY   1V-91363-5A
DR   Wikidata; Q98131766
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10887; SIX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX1, clone2
AC   CVCL_A6E6
SY   1V-91363-4B
DR   Wikidata; Q98131769
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10887; SIX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX1, clone3
AC   CVCL_A6E7
SY   1V-91363-1C
DR   Wikidata; Q98131772
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10887; SIX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX2, clone1
AC   CVCL_A6E8
SY   1V-93098-6A
DR   Wikidata; Q98131774
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10888; SIX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX2, clone2
AC   CVCL_A6E9
SY   1V-93098-3B
DR   Wikidata; Q98131775
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10888; SIX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX2, clone3
AC   CVCL_A6F0
SY   1V-93098-1C
DR   Wikidata; Q98131776
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10888; SIX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX5, clone1
AC   CVCL_A6F1
SY   1V-91713-5A
DR   Wikidata; Q98131777
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10891; SIX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX5, clone2
AC   CVCL_A6F2
SY   1V-91713-4B
DR   Wikidata; Q98131778
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10891; SIX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX5, clone3
AC   CVCL_A6F3
SY   1V-91713-6C
DR   Wikidata; Q98131779
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10891; SIX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX6, clone1
AC   CVCL_A6F4
SY   1V-93061-3A
DR   Wikidata; Q98131782
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10892; SIX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX6, clone2
AC   CVCL_A6F5
SY   1V-93061-6B
DR   Wikidata; Q98131785
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10892; SIX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SIX6, clone3
AC   CVCL_A6F6
SY   1V-93061-1C
DR   Wikidata; Q98131787
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10892; SIX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SLBP, clone1
AC   CVCL_A6F7
SY   1V-90756-2A
DR   Wikidata; Q98131790
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10904; SLBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SLBP, clone2
AC   CVCL_A6F8
SY   1V-90756-4D
DR   Wikidata; Q98131792
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10904; SLBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SLBP, clone3
AC   CVCL_A6F9
SY   1V-90756-6C
DR   Wikidata; Q98131794
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10904; SLBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD1, clone1
AC   CVCL_A6G0
SY   1V-91233-2A
DR   Wikidata; Q98131797
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6767; SMAD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD1, clone2
AC   CVCL_A6G1
SY   1V-91233-1C
DR   Wikidata; Q98131800
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6767; SMAD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD1, clone3
AC   CVCL_A6G2
SY   1V-91233-7D
DR   Wikidata; Q98131803
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6767; SMAD1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD2, clone1
AC   CVCL_A6G3
SY   1V-91222-3A
DR   Wikidata; Q98131806
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6768; SMAD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD2, clone2
AC   CVCL_A6G4
SY   1V-91222-1B
DR   Wikidata; Q98131809
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6768; SMAD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD2, clone3
AC   CVCL_A6G5
SY   1V-91222-2C
DR   Wikidata; Q98131812
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6768; SMAD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD3, clone1
AC   CVCL_A6G6
SY   1V-91486-2B
DR   Wikidata; Q98131815
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6769; SMAD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD3, clone2
AC   CVCL_A6G7
SY   1V-91486-3C
DR   Wikidata; Q98131818
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6769; SMAD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD3, clone3
AC   CVCL_A6G8
SY   1V-91486-4D
DR   Wikidata; Q98131822
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6769; SMAD3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD4, clone1
AC   CVCL_A6G9
SY   1V-91184-8D
DR   Wikidata; Q98131825
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6770; SMAD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD4, clone2
AC   CVCL_A6H0
SY   1V-91184-2B
DR   Wikidata; Q98131828
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6770; SMAD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD4, clone3
AC   CVCL_A6H1
SY   1V-91184-3C
DR   Wikidata; Q98131831
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6770; SMAD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD5, clone1
AC   CVCL_A6H2
SY   1V-91375-15A
DR   Wikidata; Q98131834
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6771; SMAD5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD5, clone2
AC   CVCL_A6H3
SY   1V-91375-14B
DR   Wikidata; Q98131837
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6771; SMAD5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD5, clone3
AC   CVCL_A6H4
SY   1V-91375-10C
DR   Wikidata; Q98131840
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6771; SMAD5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD7, clone1
AC   CVCL_A6H5
SY   1V-91217-2A
DR   Wikidata; Q98131842
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6773; SMAD7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD7, clone2
AC   CVCL_A6H6
SY   1V-91217-3B
DR   Wikidata; Q98131845
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6773; SMAD7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMAD7, clone3
AC   CVCL_A6H7
SY   1V-91217-4C
DR   Wikidata; Q98131847
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:6773; SMAD7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCA4, clone1
AC   CVCL_A6H8
SY   1V-91714-4A
DR   Wikidata; Q98131850
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCA4, clone2
AC   CVCL_A6H9
SY   1V-91714-3B
DR   Wikidata; Q98131854
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCA4, clone3
AC   CVCL_A6I0
SY   1V-91714-2C
DR   Wikidata; Q98131858
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11100; SMARCA4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCB1, clone1
AC   CVCL_A6I1
SY   1V-90718-5A
DR   Wikidata; Q98131862
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11103; SMARCB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCB1, clone2
AC   CVCL_A6I2
SY   1V-90718-4B
DR   Wikidata; Q98131865
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11103; SMARCB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCB1, clone3
AC   CVCL_A6I3
SY   1V-90718-2C
DR   Wikidata; Q98131869
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11103; SMARCB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCC1, clone1
AC   CVCL_A6I4
SY   1V-91487-4A
DR   Wikidata; Q98131871
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11104; SMARCC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCC1, clone2
AC   CVCL_A6I5
SY   1V-91487-5B
DR   Wikidata; Q98131875
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11104; SMARCC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCC1, clone3
AC   CVCL_A6I6
SY   1V-91487-6C
DR   Wikidata; Q98131878
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11104; SMARCC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCC2, clone1
AC   CVCL_A6I7
SY   1V-90762-6A
DR   Wikidata; Q98131879
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11105; SMARCC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCC2, clone2
AC   CVCL_A6I8
SY   1V-90762-5B
DR   Wikidata; Q98131880
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11105; SMARCC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMARCC2, clone3
AC   CVCL_A6I9
SY   1V-90762-4C
DR   Wikidata; Q98131881
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11105; SMARCC2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMC1A, clone1
AC   CVCL_A6J0
SY   1V-93177-1A
DR   Wikidata; Q98131882
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11111; SMC1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMC1A, clone2
AC   CVCL_A6J1
SY   1V-93177-4B
DR   Wikidata; Q98131883
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11111; SMC1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMC1A, clone3
AC   CVCL_A6J2
SY   1V-93177-2C
DR   Wikidata; Q98131884
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11111; SMC1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMC3, clone1
AC   CVCL_A6J3
SY   1V-91715-4A
DR   Wikidata; Q98131885
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2468; SMC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMC3, clone2
AC   CVCL_A6J4
SY   1V-91715-5B
DR   Wikidata; Q98131886
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2468; SMC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SMC3, clone3
AC   CVCL_A6J5
SY   1V-91715-2C
DR   Wikidata; Q98131887
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:2468; SMC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI1, clone1
AC   CVCL_A6J6
SY   1V-91874-4A
DR   Wikidata; Q98131888
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11128; SNAI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI1, clone2
AC   CVCL_A6J7
SY   1V-91874-6B
DR   Wikidata; Q98131889
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11128; SNAI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI1, clone3
AC   CVCL_A6J8
SY   1V-91874-1C
DR   Wikidata; Q98131890
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11128; SNAI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI2, clone1
AC   CVCL_A6J9
SY   1V-93099-1A
DR   Wikidata; Q98131891
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11094; SNAI2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI2, clone2
AC   CVCL_A6K0
SY   1V-93099-2B
DR   Wikidata; Q98131892
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11094; SNAI2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI2, clone3
AC   CVCL_A6K1
SY   1V-93099-3C
DR   Wikidata; Q98131893
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11094; SNAI2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI3, clone1
AC   CVCL_A6K2
SY   1V-91716-8A
DR   Wikidata; Q98131894
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18411; SNAI3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI3, clone2
AC   CVCL_A6K3
SY   1V-91716-9B
DR   Wikidata; Q98131895
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18411; SNAI3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAI3, clone3
AC   CVCL_A6K4
SY   1V-91716-11C
DR   Wikidata; Q98131896
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18411; SNAI3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAPC1, clone1
AC   CVCL_A6K5
SY   1V-91878-2A
DR   Wikidata; Q98131897
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11134; SNAPC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAPC1, clone2
AC   CVCL_A6K6
SY   1V-91878-4B
DR   Wikidata; Q98131898
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11134; SNAPC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAPC1, clone3
AC   CVCL_A6K7
SY   1V-91878-5C
DR   Wikidata; Q98131899
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11134; SNAPC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAPC4, clone1
AC   CVCL_A6K8
SY   1V-92218-3A
DR   Wikidata; Q98131900
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11137; SNAPC4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAPC4, clone2
AC   CVCL_A6K9
SY   1V-92218-5B
DR   Wikidata; Q98131901
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11137; SNAPC4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SNAPC4, clone3
AC   CVCL_A6L0
SY   1V-92218-2C
DR   Wikidata; Q98131902
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11137; SNAPC4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX10, clone1
AC   CVCL_A6L1
SY   1V-91778-3A
DR   Wikidata; Q98131903
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11190; SOX10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX10, clone2
AC   CVCL_A6L2
SY   1V-91778-2B
DR   Wikidata; Q98131904
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11190; SOX10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX10, clone3
AC   CVCL_A6L3
SY   1V-91778-1C
DR   Wikidata; Q98131905
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11190; SOX10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX11, clone1
AC   CVCL_A6L4
SY   1V-91216-3A
DR   Wikidata; Q98131906
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11191; SOX11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX11, clone2
AC   CVCL_A6L5
SY   1V-91216-5B
DR   Wikidata; Q98131907
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11191; SOX11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX11, clone3
AC   CVCL_A6L6
SY   1V-91216-6C
DR   Wikidata; Q98131908
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11191; SOX11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX14, clone1
AC   CVCL_A6L7
SY   1V-93065-5A
DR   Wikidata; Q98131909
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11193; SOX14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX14, clone2
AC   CVCL_A6L8
SY   1V-93065-4B
DR   Wikidata; Q98131910
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11193; SOX14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX14, clone3
AC   CVCL_A6L9
SY   1V-93065-6C
DR   Wikidata; Q98131911
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11193; SOX14.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX15, clone1
AC   CVCL_A6M0
SY   1V-91231-2A
DR   Wikidata; Q98131912
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11196; SOX15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX15, clone2
AC   CVCL_A6M1
SY   1V-91231-4B
DR   Wikidata; Q98131913
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11196; SOX15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX15, clone3
AC   CVCL_A6M2
SY   1V-91231-5C
DR   Wikidata; Q98131914
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11196; SOX15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX17, clone1
AC   CVCL_A6M3
SY   1V-93378-3A
DR   Wikidata; Q98131915
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX17, clone2
AC   CVCL_A6M4
SY   1V-93378-6B
DR   Wikidata; Q98131916
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX17, clone3
AC   CVCL_A6M5
SY   1V-93378-5C
DR   Wikidata; Q98131917
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18122; SOX17.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX2, clone1
AC   CVCL_A6M6
SY   1V-90984-6A
DR   Wikidata; Q98131918
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX2, clone2
AC   CVCL_A6M7
SY   1V-90984-4B
DR   Wikidata; Q98131919
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX2, clone3
AC   CVCL_A6M8
SY   1V-90984-1C
DR   Wikidata; Q98131920
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11195; SOX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX5, clone1
AC   CVCL_A6M9
SY   1V-93505-5A
DR   Wikidata; Q98131921
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11201; SOX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX5, clone2
AC   CVCL_A6N0
SY   1V-93505-3B
DR   Wikidata; Q98131922
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11201; SOX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX5, clone3
AC   CVCL_A6N1
SY   1V-93505-2C
DR   Wikidata; Q98131923
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11201; SOX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX6, clone1
AC   CVCL_A6N2
SY   1V-93506-6C
DR   Wikidata; Q98131924
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16421; SOX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX6, clone2
AC   CVCL_A6N3
SY   1V-93506-1D
DR   Wikidata; Q98131925
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16421; SOX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX6, clone3
AC   CVCL_A6N4
SY   1V-93506-7E
DR   Wikidata; Q98131926
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16421; SOX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX7, clone1
AC   CVCL_A6N5
SY   1V-90853-5A
DR   Wikidata; Q98131927
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX7, clone2
AC   CVCL_A6N6
SY   1V-90853-1B
DR   Wikidata; Q98131928
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX7, clone3
AC   CVCL_A6N7
SY   1V-90853-2C
DR   Wikidata; Q98131929
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18196; SOX7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX9, clone1
AC   CVCL_A6N8
SY   1V-91016-1B
DR   Wikidata; Q98131930
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11204; SOX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX9, clone2
AC   CVCL_A6N9
SY   1V-91016-1C
DR   Wikidata; Q98131931
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11204; SOX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SOX9, clone3
AC   CVCL_A6P0
SY   1V-91016-8D
DR   Wikidata; Q98131932
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11204; SOX9.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SP4, clone1
AC   CVCL_A6P1
SY   1V-91751-8A
DR   Wikidata; Q98131933
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11209; SP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SP4, clone2
AC   CVCL_A6P2
SY   1V-91751-7B
DR   Wikidata; Q98131934
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11209; SP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SP4, clone3
AC   CVCL_A6P3
SY   1V-91751-6C
DR   Wikidata; Q98131935
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11209; SP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SP8, clone1
AC   CVCL_A6P4
SY   1V-93479-1A
DR   Wikidata; Q98131936
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19196; SP8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SP8, clone2
AC   CVCL_A6P5
SY   1V-93479-4B
DR   Wikidata; Q98131937
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19196; SP8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SP8, clone3
AC   CVCL_A6P6
SY   1V-93479-6C
DR   Wikidata; Q98131938
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19196; SP8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPI1, clone1
AC   CVCL_A6P7
SY   1V-91215-3A
DR   Wikidata; Q98131939
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11241; SPI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPI1, clone2
AC   CVCL_A6P8
SY   1V-91215-4B
DR   Wikidata; Q98131940
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11241; SPI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPI1, clone3
AC   CVCL_A6P9
SY   1V-91215-6C
DR   Wikidata; Q98131941
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11241; SPI1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPIB, clone1
AC   CVCL_A6Q0
SY   1V-93100-6A
DR   Wikidata; Q98131942
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11242; SPIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPIB, clone2
AC   CVCL_A6Q1
SY   1V-93100-4B
DR   Wikidata; Q98131943
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11242; SPIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPIB, clone3
AC   CVCL_A6Q2
SY   1V-93100-3C
DR   Wikidata; Q98131944
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11242; SPIB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPIC, clone1
AC   CVCL_A6Q3
SY   1V-91367-11D
DR   Wikidata; Q98131945
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29549; SPIC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPIC, clone2
AC   CVCL_A6Q4
SY   1V-91367-7E
DR   Wikidata; Q98131946
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29549; SPIC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPIC, clone3
AC   CVCL_A6Q5
SY   1V-91367-8F
DR   Wikidata; Q98131947
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29549; SPIC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPINT1, clone1
AC   CVCL_A6Q6
SY   1V-91934-6A
DR   Wikidata; Q98131948
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11246; SPINT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPINT1, clone2
AC   CVCL_A6Q7
SY   1V-91934-4D
DR   Wikidata; Q98131949
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11246; SPINT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPINT1, clone3
AC   CVCL_A6Q8
SY   1V-91934-6E
DR   Wikidata; Q98131950
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11246; SPINT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPRY2, clone1
AC   CVCL_A6Q9
SY   1V-93109-4A
DR   Wikidata; Q98131951
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11270; SPRY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPRY2, clone2
AC   CVCL_A6R0
SY   1V-93109-3B
DR   Wikidata; Q98131952
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11270; SPRY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPRY2, clone3
AC   CVCL_A6R1
SY   1V-93109-2C
DR   Wikidata; Q98131953
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11270; SPRY2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPZ1, clone1
AC   CVCL_A6R2
SY   1V-91241-1A
DR   Wikidata; Q98131954
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30721; SPZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPZ1, clone2
AC   CVCL_A6R3
SY   1V-91241-2B
DR   Wikidata; Q98131956
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30721; SPZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SPZ1, clone3
AC   CVCL_A6R4
SY   1V-91241-8C
DR   Wikidata; Q98131957
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30721; SPZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SRCAP, clone1
AC   CVCL_A6R5
SY   1V-92222-7A
DR   Wikidata; Q98131959
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16974; SRCAP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SRCAP, clone2
AC   CVCL_A6R6
SY   1V-92222-1B
DR   Wikidata; Q98131960
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16974; SRCAP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SRCAP, clone3
AC   CVCL_A6R7
SY   1V-92222-8C
DR   Wikidata; Q98131961
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16974; SRCAP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SREBF1, clone1
AC   CVCL_A6R8
SY   1V-91488-7A
DR   Wikidata; Q98131962
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11289; SREBF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SREBF1, clone2
AC   CVCL_A6R9
SY   1V-91488-8B
DR   Wikidata; Q98131963
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11289; SREBF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SREBF1, clone3
AC   CVCL_A6S0
SY   1V-91488-11C
DR   Wikidata; Q98131964
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11289; SREBF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SREBF2, clone1
AC   CVCL_A6S1
SY   1V-90719-3A
DR   Wikidata; Q98131965
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11290; SREBF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SREBF2, clone2
AC   CVCL_A6S2
SY   1V-90719-6B
DR   Wikidata; Q98131966
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11290; SREBF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SREBF2, clone3
AC   CVCL_A6S3
SY   1V-90719-5C
DR   Wikidata; Q98131967
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11290; SREBF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SRF, clone1
AC   CVCL_A6S4
SY   1V-93052-5A
DR   Wikidata; Q98131968
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11291; SRF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SRF, clone2
AC   CVCL_A6S5
SY   1V-93052-6B
DR   Wikidata; Q98131969
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11291; SRF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SRF, clone3
AC   CVCL_A6S6
SY   1V-93052-3C
DR   Wikidata; Q98131970
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11291; SRF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX1, clone1
AC   CVCL_A6S7
SY   1V-92137-6A
DR   Wikidata; Q98131971
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11335; SSX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX1, clone2
AC   CVCL_A6S8
SY   1V-92137-5B
DR   Wikidata; Q98131972
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11335; SSX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX1, clone3
AC   CVCL_A6S9
SY   1V-92137-1C
DR   Wikidata; Q98131973
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11335; SSX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX4B, clone1
AC   CVCL_A6T0
SY   1V-91870-6A
DR   Wikidata; Q98131974
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16880; SSX4B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX4B, clone2
AC   CVCL_A6T1
SY   1V-91870-2B
DR   Wikidata; Q98131975
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16880; SSX4B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX4B, clone3
AC   CVCL_A6T2
SY   1V-91870-1C
DR   Wikidata; Q98131976
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16880; SSX4B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX6, clone1
AC   CVCL_A6T3
SY   1V-91871-5A
DR   Wikidata; Q98131977
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19652; SSX6P.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX6, clone2
AC   CVCL_A6T4
SY   1V-91871-6B
DR   Wikidata; Q98131978
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19652; SSX6P.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SSX6, clone3
AC   CVCL_A6T5
SY   1V-91871-4C
DR   Wikidata; Q98131979
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19652; SSX6P.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ST18, clone1
AC   CVCL_A6T6
SY   1V-91752-3A
DR   Wikidata; Q98131980
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18695; ST18.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ST18, clone2
AC   CVCL_A6T7
SY   1V-91752-1B
DR   Wikidata; Q98131981
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18695; ST18.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ST18, clone3
AC   CVCL_A6T8
SY   1V-91752-7C
DR   Wikidata; Q98131982
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18695; ST18.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAG1, clone1
AC   CVCL_A6T9
SY   1V-91318-5A
DR   Wikidata; Q98131983
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11354; STAG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAG1, clone2
AC   CVCL_A6U0
SY   1V-91318-3B
DR   Wikidata; Q98131984
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11354; STAG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAG1, clone3
AC   CVCL_A6U1
SY   1V-91318-2C
DR   Wikidata; Q98131985
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11354; STAG1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT3, clone1
AC   CVCL_A6U2
SY   1V-91292-2A
DR   Wikidata; Q98131986
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT3, clone2
AC   CVCL_A6U3
SY   1V-91292-1B
DR   Wikidata; Q98131987
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT3, clone3
AC   CVCL_A6U4
SY   1V-91292-4C
DR   Wikidata; Q98131988
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT4, clone1
AC   CVCL_A6U5
SY   1V-91225-5A
DR   Wikidata; Q98131989
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11365; STAT4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT4, clone2
AC   CVCL_A6U6
SY   1V-91225-4B
DR   Wikidata; Q98131990
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11365; STAT4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT4, clone3
AC   CVCL_A6U7
SY   1V-91225-9D
DR   Wikidata; Q98131991
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11365; STAT4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT5A, clone1
AC   CVCL_A6U8
SY   1V-90730-2A
DR   Wikidata; Q98131992
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT5A, clone2
AC   CVCL_A6U9
SY   1V-90730-3B
DR   Wikidata; Q98131993
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STAT5A, clone3
AC   CVCL_A6V0
SY   1V-90730-1C
DR   Wikidata; Q98131994
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11366; STAT5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STRA13, clone1
AC   CVCL_A6V1
SY   1V-91252-6A
DR   Wikidata; Q98131995
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11422; CENPX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STRA13, clone2
AC   CVCL_A6V2
SY   1V-91252-3B
DR   Wikidata; Q98131996
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11422; CENPX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STRA13, clone3
AC   CVCL_A6V3
SY   1V-91252-4C
DR   Wikidata; Q98131997
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11422; CENPX.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STRA8, clone1
AC   CVCL_A6V4
SY   1V-91743-1A
DR   Wikidata; Q98131998
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30653; STRA8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STRA8, clone2
AC   CVCL_A6V5
SY   1V-91743-5B
DR   Wikidata; Q98131999
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30653; STRA8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human STRA8, clone3
AC   CVCL_A6V6
SY   1V-91743-6C
DR   Wikidata; Q98132000
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30653; STRA8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SUB1, clone1
AC   CVCL_A6V7
SY   1V-91364-6A
DR   Wikidata; Q98132001
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19985; SUB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SUB1, clone2
AC   CVCL_A6V8
SY   1V-91364-2B
DR   Wikidata; Q98132002
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19985; SUB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SUB1, clone3
AC   CVCL_A6V9
SY   1V-91364-1C
DR   Wikidata; Q98132003
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19985; SUB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SUZ12, clone1
AC   CVCL_A6W0
SY   1V-91381-2A
DR   Wikidata; Q98132004
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17101; SUZ12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SUZ12, clone2
AC   CVCL_A6W1
SY   1V-91381-6B
DR   Wikidata; Q98132005
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17101; SUZ12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human SUZ12, clone3
AC   CVCL_A6W2
SY   1V-91381-4C
DR   Wikidata; Q98132006
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17101; SUZ12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human T, clone1
AC   CVCL_A6W3
SY   1V-93081-4A
DR   Wikidata; Q98132007
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11515; TBXT.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human T, clone2
AC   CVCL_A6W4
SY   1V-93081-2B
DR   Wikidata; Q98132008
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11515; TBXT.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human T, clone3
AC   CVCL_A6W5
SY   1V-93081-3C
DR   Wikidata; Q98132009
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11515; TBXT.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAB1, clone1
AC   CVCL_A6W6
SY   1V-93480-5A
DR   Wikidata; Q98132010
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18157; TAB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAB1, clone2
AC   CVCL_A6W7
SY   1V-93480-6B
DR   Wikidata; Q98132011
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18157; TAB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAB1, clone3
AC   CVCL_A6W8
SY   1V-93480-3C
DR   Wikidata; Q98132012
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18157; TAB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF10, clone1
AC   CVCL_A6W9
SY   1V-93066-2A
DR   Wikidata; Q98132013
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11543; TAF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF10, clone2
AC   CVCL_A6X0
SY   1V-93066-6B
DR   Wikidata; Q98132014
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11543; TAF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF10, clone3
AC   CVCL_A6X1
SY   1V-93066-1C
DR   Wikidata; Q98132015
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11543; TAF10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF11, clone1
AC   CVCL_A6X2
SY   1V-93062-4A
DR   Wikidata; Q98132016
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11544; TAF11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF11, clone2
AC   CVCL_A6X3
SY   1V-93062-3B
DR   Wikidata; Q98132017
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11544; TAF11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF11, clone3
AC   CVCL_A6X4
SY   1V-93062-6C
DR   Wikidata; Q98132018
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11544; TAF11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF12, clone1
AC   CVCL_A6X5
SY   1V-92193-5A
DR   Wikidata; Q98132019
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11545; TAF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF12, clone2
AC   CVCL_A6X6
SY   1V-92193-4B
DR   Wikidata; Q98132020
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11545; TAF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF12, clone3
AC   CVCL_A6X7
SY   1V-92193-2C
DR   Wikidata; Q98132021
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11545; TAF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF13, clone1
AC   CVCL_A6X8
SY   1V-93063-4A
DR   Wikidata; Q98132022
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11546; TAF13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF13, clone2
AC   CVCL_A6X9
SY   1V-93063-2B
DR   Wikidata; Q98132023
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11546; TAF13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF13, clone3
AC   CVCL_A6Y0
SY   1V-93063-5C
DR   Wikidata; Q98132024
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11546; TAF13.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF1A, clone1
AC   CVCL_A6Y1
SY   1V-92153-3A
DR   Wikidata; Q98132025
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11532; TAF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF1A, clone2
AC   CVCL_A6Y2
SY   1V-92153-6B
DR   Wikidata; Q98132026
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11532; TAF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF1A, clone3
AC   CVCL_A6Y3
SY   1V-92153-8C
DR   Wikidata; Q98132027
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11532; TAF1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF3, clone1
AC   CVCL_A6Y4
SY   1V-92232-5A
DR   Wikidata; Q98132028
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17303; TAF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF3, clone2
AC   CVCL_A6Y5
SY   1V-92232-6B
DR   Wikidata; Q98132029
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17303; TAF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF3, clone3
AC   CVCL_A6Y6
SY   1V-92232-1C
DR   Wikidata; Q98132030
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17303; TAF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF5, clone1
AC   CVCL_A6Y7
SY   1V-93507-1A
DR   Wikidata; Q98132031
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11539; TAF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF5, clone2
AC   CVCL_A6Y8
SY   1V-93507-2B
DR   Wikidata; Q98132032
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11539; TAF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF5, clone3
AC   CVCL_A6Y9
SY   1V-93507-4C
DR   Wikidata; Q98132033
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11539; TAF5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF6, clone1
AC   CVCL_A6Z0
SY   1V-92164-11A
DR   Wikidata; Q98132034
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11540; TAF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF6, clone2
AC   CVCL_A6Z1
SY   1V-92164-8B
DR   Wikidata; Q98132035
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11540; TAF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF6, clone3
AC   CVCL_A6Z2
SY   1V-92164-10C
DR   Wikidata; Q98132036
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11540; TAF6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF7, clone1
AC   CVCL_A6Z3
SY   1V-90759-6A
DR   Wikidata; Q98132037
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11541; TAF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF7, clone2
AC   CVCL_A6Z4
SY   1V-90759-5B
DR   Wikidata; Q98132038
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11541; TAF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF7, clone3
AC   CVCL_A6Z5
SY   1V-90759-7D
DR   Wikidata; Q98132039
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11541; TAF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF8, clone1
AC   CVCL_A6Z6
SY   1V-93101-5A
DR   Wikidata; Q98132040
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17300; TAF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF8, clone2
AC   CVCL_A6Z7
SY   1V-93101-1B
DR   Wikidata; Q98132041
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17300; TAF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAF8, clone3
AC   CVCL_A6Z8
SY   1V-93101-2C
DR   Wikidata; Q98132042
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17300; TAF8.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAL1, clone1
AC   CVCL_A6Z9
SY   1V-91489-2A
DR   Wikidata; Q98132043
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAL1, clone2
AC   CVCL_A7A0
SY   1V-91489-5B
DR   Wikidata; Q98132044
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TAL1, clone3
AC   CVCL_A7A1
SY   1V-91489-6C
DR   Wikidata; Q98132045
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11556; TAL1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBP, clone1
AC   CVCL_A7A2
SY   1V-91490-1A
DR   Wikidata; Q98132046
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11588; TBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBP, clone2
AC   CVCL_A7A3
SY   1V-91490-2B
DR   Wikidata; Q98132047
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11588; TBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBP, clone3
AC   CVCL_A7A4
SY   1V-91490-4C
DR   Wikidata; Q98132048
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11588; TBP.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX2, clone1
AC   CVCL_A7A5
SY   1V-92301-3A
DR   Wikidata; Q98132049
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11597; TBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX2, clone2
AC   CVCL_A7A6
SY   1V-92301-5B
DR   Wikidata; Q98132050
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11597; TBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX2, clone3
AC   CVCL_A7A7
SY   1V-92301-7D
DR   Wikidata; Q98132051
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11597; TBX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX3, clone1
AC   CVCL_A7A8
SY   1V-90936-5A
DR   Wikidata; Q98132052
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11602; TBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX3, clone2
AC   CVCL_A7A9
SY   1V-90936-4B
DR   Wikidata; Q98132053
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11602; TBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX3, clone3
AC   CVCL_A8L5
SY   1V-90936-1C
DR   Wikidata; Q98132054
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11602; TBX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX4, clone1
AC   CVCL_A8L6
SY   1V-93481-4A
DR   Wikidata; Q98132055
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11603; TBX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX4, clone2
AC   CVCL_A8L7
SY   1V-93481-3B
DR   Wikidata; Q98132056
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11603; TBX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX4, clone3
AC   CVCL_A8L8
SY   1V-93481-2C
DR   Wikidata; Q98132057
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11603; TBX4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX5, clone1
AC   CVCL_A8L9
SY   1V-91007-4A
DR   Wikidata; Q98132058
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11604; TBX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX5, clone2
AC   CVCL_A8M0
SY   1V-91007-6B
DR   Wikidata; Q98132059
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11604; TBX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX5, clone3
AC   CVCL_A8M1
SY   1V-91007-3C
DR   Wikidata; Q98132060
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11604; TBX5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX6, clone1
AC   CVCL_A8M2
SY   1V-91365-5A
DR   Wikidata; Q98132061
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11605; TBX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX6, clone2
AC   CVCL_A8M3
SY   1V-91365-3B
DR   Wikidata; Q98132062
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11605; TBX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TBX6, clone3
AC   CVCL_A8M4
SY   1V-91365-1C
DR   Wikidata; Q98132063
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11605; TBX6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCEA3, clone1
AC   CVCL_A7B0
SY   1V-91261-4B
DR   Wikidata; Q98132064
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11615; TCEA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCEA3, clone2
AC   CVCL_A7B1
SY   1V-91261-6C
DR   Wikidata; Q98132065
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11615; TCEA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCEA3, clone3
AC   CVCL_A7B2
SY   1V-91261-9D
DR   Wikidata; Q98132066
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11615; TCEA3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCEB3, clone1
AC   CVCL_A7B3
SY   1V-92142-3A
DR   Wikidata; Q98132067
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11620; ELOA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCEB3, clone2
AC   CVCL_A7B4
SY   1V-92142-6B
DR   Wikidata; Q98132068
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11620; ELOA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCEB3, clone3
AC   CVCL_A7B5
SY   1V-92142-1C
DR   Wikidata; Q98132069
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11620; ELOA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF12, clone1
AC   CVCL_A7B6
SY   1V-91744-2A
DR   Wikidata; Q98132070
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11623; TCF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF12, clone2
AC   CVCL_A7B7
SY   1V-91744-3B
DR   Wikidata; Q98132071
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11623; TCF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF12, clone3
AC   CVCL_A7B8
SY   1V-91744-4C
DR   Wikidata; Q98132072
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11623; TCF12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF15, clone1
AC   CVCL_A7B9
SY   1V-91942-1A
DR   Wikidata; Q98132073
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11627; TCF15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF15, clone2
AC   CVCL_A7C0
SY   1V-91942-12C
DR   Wikidata; Q98132074
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11627; TCF15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF15, clone3
AC   CVCL_A7C1
SY   1V-91942-11D
DR   Wikidata; Q98132075
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11627; TCF15.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF19, clone1
AC   CVCL_A7C2
SY   1V-92186-2A
DR   Wikidata; Q98132076
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11629; TCF19.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF19, clone2
AC   CVCL_A7C3
SY   1V-92186-6B
DR   Wikidata; Q98132077
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11629; TCF19.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF19, clone3
AC   CVCL_A7C4
SY   1V-92186-4C
DR   Wikidata; Q98132078
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11629; TCF19.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF2, clone1
AC   CVCL_A7C5
SY   1V-91931-2A
DR   Wikidata; Q98132079
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11630; HNF1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF2, clone2
AC   CVCL_A7C6
SY   1V-91931-11F
DR   Wikidata; Q98132081
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11630; HNF1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF2, clone3
AC   CVCL_A7C7
SY   1V-91931-12G
DR   Wikidata; Q98132082
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11630; HNF1B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF20, clone1
AC   CVCL_A7C8
SY   1V-92213-5A
DR   Wikidata; Q98132083
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11631; TCF20.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF20, clone2
AC   CVCL_A7C9
SY   1V-92213-2B
DR   Wikidata; Q98132084
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11631; TCF20.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF20, clone3
AC   CVCL_A7D0
SY   1V-92213-3C
DR   Wikidata; Q98132085
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11631; TCF20.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF21, clone1
AC   CVCL_A7D1
SY   1V-93067-2A
DR   Wikidata; Q98132086
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11632; TCF21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF21, clone2
AC   CVCL_A7D2
SY   1V-93067-4B
DR   Wikidata; Q98132087
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11632; TCF21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF21, clone3
AC   CVCL_A7D3
SY   1V-93067-6C
DR   Wikidata; Q98132088
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11632; TCF21.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF23, clone1
AC   CVCL_A7D4
SY   1V-92306-6A
DR   Wikidata; Q98132089
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18602; TCF23.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF23, clone2
AC   CVCL_A7D5
SY   1V-92306-3B
DR   Wikidata; Q98132090
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18602; TCF23.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF23, clone3
AC   CVCL_A7D6
SY   1V-92306-4C
DR   Wikidata; Q98132091
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18602; TCF23.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF25, clone1
AC   CVCL_A7D7
SY   1V-93508-1A
DR   Wikidata; Q98132092
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29181; TCF25.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF25, clone2
AC   CVCL_A7D8
SY   1V-93508-2B
DR   Wikidata; Q98132094
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29181; TCF25.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF25, clone3
AC   CVCL_A7D9
SY   1V-93508-3C
DR   Wikidata; Q98132095
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29181; TCF25.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF3, clone1
AC   CVCL_A7E0
SY   1V-91505-5B
DR   Wikidata; Q98132097
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11633; TCF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF3, clone2
AC   CVCL_A7E1
SY   1V-91505-9D
DR   Wikidata; Q98132098
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11633; TCF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF3, clone3
AC   CVCL_A7E2
SY   1V-91505-12E
DR   Wikidata; Q98132099
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11633; TCF3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF4, clone1
AC   CVCL_A7E3
SY   1V-90852-6A
DR   Wikidata; Q98132100
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11634; TCF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF4, clone2
AC   CVCL_A7E4
SY   1V-90852-4B
DR   Wikidata; Q98132101
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11634; TCF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF4, clone3
AC   CVCL_A7E5
SY   1V-90852-8D
DR   Wikidata; Q98132102
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11634; TCF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF7, clone1
AC   CVCL_A7E6
SY   1V-93178-5A
DR   Wikidata; Q98132103
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11639; TCF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF7, clone2
AC   CVCL_A7E7
SY   1V-93178-2B
DR   Wikidata; Q98132104
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11639; TCF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF7, clone3
AC   CVCL_A7E8
SY   1V-93178-4C
DR   Wikidata; Q98132105
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11639; TCF7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF7L2, clone1
AC   CVCL_A7E9
SY   1V-91273-10A
DR   Wikidata; Q98132106
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11641; TCF7L2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF7L2, clone2
AC   CVCL_A7F0
SY   1V-91273-8B
DR   Wikidata; Q98132107
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11641; TCF7L2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCF7L2, clone3
AC   CVCL_A7F1
SY   1V-91273-7C
DR   Wikidata; Q98132108
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11641; TCF7L2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCL1A, clone1
AC   CVCL_A7F2
SY   1V-91506-5B
DR   Wikidata; Q98132109
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11648; TCL1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCL1A, clone2
AC   CVCL_A7F3
SY   1V-91506-3C
DR   Wikidata; Q98132110
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11648; TCL1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TCL1A, clone3
AC   CVCL_A7F4
SY   1V-91506-8D
DR   Wikidata; Q98132111
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11648; TCL1A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEAD2, clone1
AC   CVCL_A7F5
SY   1V-92124-3A
DR   Wikidata; Q98132112
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11715; TEAD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEAD2, clone2
AC   CVCL_A7F6
SY   1V-92124-4B
DR   Wikidata; Q98132114
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11715; TEAD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEAD2, clone3
AC   CVCL_A7F7
SY   1V-92124-2C
DR   Wikidata; Q98132115
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11715; TEAD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEAD4, clone1
AC   CVCL_A7F8
SY   1V-91314-1A
DR   Wikidata; Q98132116
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11717; TEAD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEAD4, clone2
AC   CVCL_A7F9
SY   1V-91314-3B
DR   Wikidata; Q98132117
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11717; TEAD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEAD4, clone3
AC   CVCL_A7G0
SY   1V-91314-4C
DR   Wikidata; Q98132118
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11717; TEAD4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEF, clone1
AC   CVCL_A7G1
SY   1V-92125-4A
DR   Wikidata; Q98132119
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11722; TEF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEF, clone2
AC   CVCL_A7G2
SY   1V-92125-2B
DR   Wikidata; Q98132120
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11722; TEF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TEF, clone3
AC   CVCL_A7G3
SY   1V-92125-5C
DR   Wikidata; Q98132121
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11722; TEF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2A, clone1
AC   CVCL_A7G4
SY   1V-90736-5A
DR   Wikidata; Q98132122
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11742; TFAP2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2A, clone2
AC   CVCL_A7G5
SY   1V-90736-2B
DR   Wikidata; Q98132123
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11742; TFAP2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2A, clone3
AC   CVCL_A7G6
SY   1V-90736-6C
DR   Wikidata; Q98132124
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11742; TFAP2A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2B, clone1
AC   CVCL_A7G7
SY   1V-92183-2A
DR   Wikidata; Q98132125
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11743; TFAP2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2B, clone2
AC   CVCL_A7G8
SY   1V-92183-5B
DR   Wikidata; Q98132126
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11743; TFAP2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2B, clone3
AC   CVCL_A7G9
SY   1V-92183-3C
DR   Wikidata; Q98132127
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11743; TFAP2B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2C, clone1
AC   CVCL_A7H0
SY   1V-90983-5D
DR   Wikidata; Q98132128
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11744; TFAP2C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2C, clone2
AC   CVCL_A7H1
SY   1V-90983-6E
DR   Wikidata; Q98132129
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11744; TFAP2C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP2C, clone3
AC   CVCL_A7H2
SY   1V-90983-2F
DR   Wikidata; Q98132130
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11744; TFAP2C.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP4, clone1
AC   CVCL_A7H3
SY   1V-91396-4A
DR   Wikidata; Q98132131
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11745; TFAP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP4, clone2
AC   CVCL_A7H4
SY   1V-91396-3B
DR   Wikidata; Q98132132
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11745; TFAP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFAP4, clone3
AC   CVCL_A7H5
SY   1V-91396-1C
DR   Wikidata; Q98132133
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11745; TFAP4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFCP2L1, clone1
AC   CVCL_A7H6
SY   1V-91161-2A
DR   Wikidata; Q98132134
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17925; TFCP2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFCP2L1, clone2
AC   CVCL_A7H7
SY   1V-91161-1A
DR   Wikidata; Q98132135
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17925; TFCP2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFCP2L1, clone3
AC   CVCL_A7H8
SY   1V-91161-9F
DR   Wikidata; Q98132136
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17925; TFCP2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFCP2L1, clone4
AC   CVCL_A7H9
SY   1V-91161-7D
DR   Wikidata; Q98132137
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17925; TFCP2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFCP2L1, clone5
AC   CVCL_A7I0
SY   1V-91161-8E
DR   Wikidata; Q98132138
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17925; TFCP2L1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFDP1, clone1
AC   CVCL_A7I1
SY   1V-92150-7B
DR   Wikidata; Q98132139
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11749; TFDP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFDP1, clone2
AC   CVCL_A7I2
SY   1V-92150-3C
DR   Wikidata; Q98132140
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11749; TFDP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFDP1, clone3
AC   CVCL_A7I3
SY   1V-92150-9D
DR   Wikidata; Q98132141
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11749; TFDP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFE3, clone1
AC   CVCL_A7I4
SY   1V-91388-5A
DR   Wikidata; Q98132142
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11752; TFE3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFE3, clone2
AC   CVCL_A7I5
SY   1V-91388-3B
DR   Wikidata; Q98132144
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11752; TFE3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TFE3, clone3
AC   CVCL_A7I6
SY   1V-91388-4C
DR   Wikidata; Q98132145
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11752; TFE3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFA, clone1
AC   CVCL_A7I7
SY   1V-93064-2A
DR   Wikidata; Q98132146
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11765; TGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFA, clone2
AC   CVCL_A7I8
SY   1V-93064-6B
DR   Wikidata; Q98132147
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11765; TGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFA, clone3
AC   CVCL_A7I9
SY   1V-93064-3C
DR   Wikidata; Q98132149
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11765; TGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFB1, clone1
AC   CVCL_A7J0
SY   1V-93179-6A
DR   Wikidata; Q98132150
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11766; TGFB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFB1, clone2
AC   CVCL_A7J1
SY   1V-93179-2B
DR   Wikidata; Q98132151
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11766; TGFB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFB1, clone3
AC   CVCL_A7J2
SY   1V-93179-5C
DR   Wikidata; Q98132152
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11766; TGFB1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFBR2, clone1
AC   CVCL_A7J3
SY   1V-93482-4A
DR   Wikidata; Q98132153
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11773; TGFBR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFBR2, clone2
AC   CVCL_A7J4
SY   1V-93482-2B
DR   Wikidata; Q98132154
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11773; TGFBR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGFBR2, clone3
AC   CVCL_A7J5
SY   1V-93482-3C
DR   Wikidata; Q98132155
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11773; TGFBR2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGIF1, clone1
AC   CVCL_A7J6
SY   1V-90550-5A
DR   Wikidata; Q98132156
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11776; TGIF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGIF1, clone2
AC   CVCL_A7J7
SY   1V-90550-1B
DR   Wikidata; Q98132157
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11776; TGIF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGIF1, clone3
AC   CVCL_A7J8
SY   1V-90550-3C
DR   Wikidata; Q98132158
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11776; TGIF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGIF2, clone1
AC   CVCL_A7J9
SY   1V-91915-4A
DR   Wikidata; Q98132159
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15764; TGIF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGIF2, clone2
AC   CVCL_A7K0
SY   1V-91915-2B
DR   Wikidata; Q98132160
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15764; TGIF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGIF2, clone3
AC   CVCL_A7K1
SY   1V-91915-1C
DR   Wikidata; Q98132161
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15764; TGIF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGM2, clone1
AC   CVCL_A7K2
SY   1V-91289-4A
DR   Wikidata; Q98132162
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11778; TGM2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGM2, clone2
AC   CVCL_A7K3
SY   1V-91289-5B
DR   Wikidata; Q98132163
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11778; TGM2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TGM2, clone3
AC   CVCL_A7K4
SY   1V-91289-2C
DR   Wikidata; Q98132164
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11778; TGM2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP1, clone1
AC   CVCL_A7K5
SY   1V-91260-4A
DR   Wikidata; Q98132165
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20856; THAP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP1, clone2
AC   CVCL_A7K6
SY   1V-91260-6B
DR   Wikidata; Q98132166
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20856; THAP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP1, clone3
AC   CVCL_A7K7
SY   1V-91260-1C
DR   Wikidata; Q98132167
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20856; THAP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP10, clone1
AC   CVCL_A7K8
SY   1V-92201-1A
DR   Wikidata; Q98132168
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23193; THAP10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP10, clone2
AC   CVCL_A7K9
SY   1V-92201-5B
DR   Wikidata; Q98132169
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23193; THAP10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP10, clone3
AC   CVCL_A7L0
SY   1V-92201-4C
DR   Wikidata; Q98132170
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23193; THAP10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP11, clone1
AC   CVCL_A7L1
SY   1V-91224-4A
DR   Wikidata; Q98132171
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23194; THAP11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP11, clone2
AC   CVCL_A7L2
SY   1V-91224-6B
DR   Wikidata; Q98132172
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23194; THAP11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP11, clone3
AC   CVCL_A7L3
SY   1V-91224-9D
DR   Wikidata; Q98132173
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23194; THAP11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP3, clone1
AC   CVCL_A7L4
SY   1V-92207-6A
DR   Wikidata; Q98132174
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20855; THAP3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP3, clone2
AC   CVCL_A7L5
SY   1V-92207-1B
DR   Wikidata; Q98132175
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20855; THAP3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP3, clone3
AC   CVCL_A7L6
SY   1V-92207-2C
DR   Wikidata; Q98132176
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20855; THAP3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP7, clone1
AC   CVCL_A7L7
SY   1V-92126-5A
DR   Wikidata; Q98132177
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23190; THAP7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP7, clone2
AC   CVCL_A7L8
SY   1V-92126-2B
DR   Wikidata; Q98132178
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23190; THAP7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THAP7, clone3
AC   CVCL_A7L9
SY   1V-92126-1C
DR   Wikidata; Q98132179
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23190; THAP7.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THOC1, clone1
AC   CVCL_A7M0
SY   1V-92147-2A
DR   Wikidata; Q98132180
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19070; THOC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THOC1, clone2
AC   CVCL_A7M1
SY   1V-92147-3B
DR   Wikidata; Q98132181
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19070; THOC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THOC1, clone3
AC   CVCL_A7M2
SY   1V-92147-5C
DR   Wikidata; Q98132182
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19070; THOC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THRA, clone1
AC   CVCL_A7M3
SY   1V-92134-1A
DR   Wikidata; Q98132183
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11796; THRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THRA, clone2
AC   CVCL_A7M4
SY   1V-92134-6B
DR   Wikidata; Q98132184
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11796; THRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THRA, clone3
AC   CVCL_A7M5
SY   1V-92134-5C
DR   Wikidata; Q98132185
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11796; THRA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THRB, clone1
AC   CVCL_A7M6
SY   1V-93379-6A
DR   Wikidata; Q98132186
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THRB, clone2
AC   CVCL_A7M7
SY   1V-93379-5B
DR   Wikidata; Q98132187
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human THRB, clone3
AC   CVCL_A7M8
SY   1V-93379-2C
DR   Wikidata; Q98132188
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11799; THRB.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TLK1, clone1
AC   CVCL_A7M9
SY   1V-91229-3A
DR   Wikidata; Q98132189
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11841; TLK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TLK1, clone2
AC   CVCL_A7N0
SY   1V-91229-1B
DR   Wikidata; Q98132190
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11841; TLK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TLK1, clone3
AC   CVCL_A7N1
SY   1V-91229-5C
DR   Wikidata; Q98132191
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11841; TLK1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TLX3, clone1
AC   CVCL_A7N2
SY   1V-92161-6A
DR   Wikidata; Q98132192
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13532; TLX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TLX3, clone2
AC   CVCL_A7N3
SY   1V-92161-1B
DR   Wikidata; Q98132193
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13532; TLX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TLX3, clone3
AC   CVCL_A7N4
SY   1V-92161-4C
DR   Wikidata; Q98132194
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13532; TLX3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TNF, clone1
AC   CVCL_A7N5
SY   1V-91876-2A
DR   Wikidata; Q98132195
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11892; TNF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TNF, clone2
AC   CVCL_A7N6
SY   1V-91876-3B
DR   Wikidata; Q98132196
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11892; TNF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TNF, clone3
AC   CVCL_A7N7
SY   1V-91876-5C
DR   Wikidata; Q98132197
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11892; TNF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TP53, clone1
AC   CVCL_A7N8
SY   1V-90744-6A
DR   Wikidata; Q98132198
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TP53, clone2
AC   CVCL_A7N9
SY   1V-90744-1B
DR   Wikidata; Q98132199
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TP53, clone3
AC   CVCL_A7P0
SY   1V-90744-2C
DR   Wikidata; Q98132200
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TP73, clone1
AC   CVCL_A7P1
SY   1V-91746-2A
DR   Wikidata; Q98132201
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12003; TP73.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TP73, clone2
AC   CVCL_A7P2
SY   1V-91746-1B
DR   Wikidata; Q98132202
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12003; TP73.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TP73, clone3
AC   CVCL_A7P3
SY   1V-91746-7C
DR   Wikidata; Q98132203
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12003; TP73.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRAF4, clone1
AC   CVCL_A7P4
SY   1V-92141-1A
DR   Wikidata; Q98132204
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12034; TRAF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRAF4, clone2
AC   CVCL_A7P5
SY   1V-92141-4B
DR   Wikidata; Q98132205
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12034; TRAF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRAF4, clone3
AC   CVCL_A7P6
SY   1V-92141-3C
DR   Wikidata; Q98132206
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12034; TRAF4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRIB2, clone1
AC   CVCL_A7P7
SY   1V-93105-2A
DR   Wikidata; Q98132207
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30809; TRIB2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRIB2, clone2
AC   CVCL_A7P8
SY   1V-93105-5B
DR   Wikidata; Q98132208
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30809; TRIB2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRIB2, clone3
AC   CVCL_A7P9
SY   1V-93105-6C
DR   Wikidata; Q98132209
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:30809; TRIB2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRIM28, clone1
AC   CVCL_A7Q0
SY   1V-91322-6A
DR   Wikidata; Q98132210
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16384; TRIM28.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRIM28, clone2
AC   CVCL_A7Q1
SY   1V-91322-3B
DR   Wikidata; Q98132212
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16384; TRIM28.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRIM28, clone3
AC   CVCL_A7Q2
SY   1V-91322-4C
DR   Wikidata; Q98132213
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16384; TRIM28.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRPV2, clone1
AC   CVCL_A7Q3
SY   1V-91236-1B
DR   Wikidata; Q98132214
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18082; TRPV2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRPV2, clone2
AC   CVCL_A7Q4
SY   1V-91236-3C
DR   Wikidata; Q98132215
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18082; TRPV2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TRPV2, clone3
AC   CVCL_A7Q5
SY   1V-91236-4D
DR   Wikidata; Q98132216
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18082; TRPV2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TSHZ1, clone1
AC   CVCL_A7Q6
SY   1V-91282-3A
DR   Wikidata; Q98132217
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10669; TSHZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TSHZ1, clone2
AC   CVCL_A7Q7
SY   1V-91282-6B
DR   Wikidata; Q98132218
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10669; TSHZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TSHZ1, clone3
AC   CVCL_A7Q8
SY   1V-91282-4C
DR   Wikidata; Q98132219
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:10669; TSHZ1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TWIST2, clone1
AC   CVCL_A7Q9
SY   1V-92178-1A
DR   Wikidata; Q98132220
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20670; TWIST2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TWIST2, clone2
AC   CVCL_A7R0
SY   1V-92178-4B
DR   Wikidata; Q98132221
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20670; TWIST2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TWIST2, clone3
AC   CVCL_A7R1
SY   1V-92178-2C
DR   Wikidata; Q98132222
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20670; TWIST2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TYR, clone1
AC   CVCL_A7R2
SY   1V-91821-1A
DR   Wikidata; Q98132223
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12442; TYR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TYR, clone2
AC   CVCL_A7R3
SY   1V-91821-3B
DR   Wikidata; Q98132224
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12442; TYR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TYR, clone3
AC   CVCL_A7R4
SY   1V-91821-5C
DR   Wikidata; Q98132225
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12442; TYR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TYRP1, clone1
AC   CVCL_A7R5
SY   1V-91822-1A
DR   Wikidata; Q98132226
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12450; TYRP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TYRP1, clone2
AC   CVCL_A7R6
SY   1V-91822-3B
DR   Wikidata; Q98132227
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12450; TYRP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human TYRP1, clone3
AC   CVCL_A7R7
SY   1V-91822-4C
DR   Wikidata; Q98132229
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12450; TYRP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human UBTF, clone1
AC   CVCL_A7R8
SY   1V-93180-2A
DR   Wikidata; Q98132230
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12511; UBTF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human UBTF, clone2
AC   CVCL_A7R9
SY   1V-93180-3B
DR   Wikidata; Q98132231
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12511; UBTF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human UBTF, clone3
AC   CVCL_A7S0
SY   1V-93180-4C
DR   Wikidata; Q98132233
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12511; UBTF.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human UGP2, clone1
AC   CVCL_A7S1
SY   1V-91397-1A
DR   Wikidata; Q98132234
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12527; UGP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human UGP2, clone2
AC   CVCL_A7S2
SY   1V-91397-3B
DR   Wikidata; Q98132235
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12527; UGP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human UGP2, clone3
AC   CVCL_A7S3
SY   1V-91397-2C
DR   Wikidata; Q98132236
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12527; UGP2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human USF1, clone1
AC   CVCL_A7S4
SY   1V-91327-3A
DR   Wikidata; Q98132237
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12593; USF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human USF1, clone2
AC   CVCL_A7S5
SY   1V-91327-5B
DR   Wikidata; Q98132238
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12593; USF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human USF1, clone3
AC   CVCL_A7S6
SY   1V-91327-2C
DR   Wikidata; Q98132240
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12593; USF1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human USF2, clone1
AC   CVCL_A7S7
SY   1V-91747-2A
DR   Wikidata; Q98132241
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12594; USF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human USF2, clone2
AC   CVCL_A7S8
SY   1V-91747-6B
DR   Wikidata; Q98132242
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12594; USF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human USF2, clone3
AC   CVCL_A7S9
SY   1V-91747-5C
DR   Wikidata; Q98132243
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12594; USF2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VAX1, clone1
AC   CVCL_A7T0
SY   1V-91823-2A
DR   Wikidata; Q98132244
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12660; VAX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VAX1, clone2
AC   CVCL_A7T1
SY   1V-91823-3B
DR   Wikidata; Q98132245
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12660; VAX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VAX1, clone3
AC   CVCL_A7T2
SY   1V-91823-4C
DR   Wikidata; Q98132246
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12660; VAX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VAX2, clone1
AC   CVCL_A7T3
SY   1V-93104-3A
DR   Wikidata; Q98132247
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12661; VAX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VAX2, clone2
AC   CVCL_A7T4
SY   1V-93104-1B
DR   Wikidata; Q98132248
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12661; VAX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VAX2, clone3
AC   CVCL_A7T5
SY   1V-93104-2C
DR   Wikidata; Q98132249
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12661; VAX2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VDR, clone1
AC   CVCL_A7T6
SY   1V-91302-5A
DR   Wikidata; Q98132250
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12679; VDR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VDR, clone2
AC   CVCL_A7T7
SY   1V-91302-6B
DR   Wikidata; Q98132251
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12679; VDR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VDR, clone3
AC   CVCL_A7T8
SY   1V-91302-2C
DR   Wikidata; Q98132252
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12679; VDR.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VEGFA, clone1
AC   CVCL_A7T9
SY   1V-92217-3A
DR   Wikidata; Q98132253
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12680; VEGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VEGFA, clone2
AC   CVCL_A7U0
SY   1V-92217-2B
DR   Wikidata; Q98132254
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12680; VEGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VEGFA, clone3
AC   CVCL_A7U1
SY   1V-92217-4C
DR   Wikidata; Q98132255
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12680; VEGFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VEGFC, clone1
AC   CVCL_A7U2
SY   1V-92182-2A
DR   Wikidata; Q98132256
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12682; VEGFC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VEGFC, clone2
AC   CVCL_A7U3
SY   1V-92182-3B
DR   Wikidata; Q98132258
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12682; VEGFC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VEGFC, clone3
AC   CVCL_A7U4
SY   1V-92182-4C
DR   Wikidata; Q98132259
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12682; VEGFC.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VPS72, clone1
AC   CVCL_A7U5
SY   1V-91879-4A
DR   Wikidata; Q98132260
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11644; VPS72.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VPS72, clone2
AC   CVCL_A7U6
SY   1V-91879-6B
DR   Wikidata; Q98132261
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11644; VPS72.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human VPS72, clone3
AC   CVCL_A7U7
SY   1V-91879-1C
DR   Wikidata; Q98132262
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11644; VPS72.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WHSC1, clone1
AC   CVCL_A7U8
SY   1V-91295-2A
DR   Wikidata; Q98132263
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12766; NSD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WHSC1, clone2
AC   CVCL_A7U9
SY   1V-91295-5B
DR   Wikidata; Q98132264
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12766; NSD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WHSC1, clone3
AC   CVCL_A7V0
SY   1V-91295-3C
DR   Wikidata; Q98132265
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12766; NSD2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WHSC2, clone1
AC   CVCL_A7V1
SY   1V-91182-1A
DR   Wikidata; Q98132266
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12768; NELFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WHSC2, clone2
AC   CVCL_A7V2
SY   1V-91182-3B
DR   Wikidata; Q98132267
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12768; NELFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WHSC2, clone3
AC   CVCL_A7V3
SY   1V-91182-4C
DR   Wikidata; Q98132268
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12768; NELFA.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT2, clone1
AC   CVCL_A7V4
SY   1V-92202-6A
DR   Wikidata; Q98132269
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12780; WNT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT2, clone2
AC   CVCL_A7V5
SY   1V-92202-7B
DR   Wikidata; Q98132270
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12780; WNT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT2, clone3
AC   CVCL_A7V6
SY   1V-92202-5C
DR   Wikidata; Q98132271
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12780; WNT2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT3A, clone1
AC   CVCL_A7V7
SY   1V-91824-2A
DR   Wikidata; Q98132272
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15983; WNT3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT3A, clone2
AC   CVCL_A7V8
SY   1V-91824-3B
DR   Wikidata; Q98132273
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15983; WNT3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT3A, clone3
AC   CVCL_A7V9
SY   1V-91824-4C
DR   Wikidata; Q98132274
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:15983; WNT3A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT5B, clone1
AC   CVCL_A7W0
SY   1V-92140-3A
DR   Wikidata; Q98132275
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16265; WNT5B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT5B, clone2
AC   CVCL_A7W1
SY   1V-92140-2B
DR   Wikidata; Q98132276
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16265; WNT5B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT5B, clone3
AC   CVCL_A7W2
SY   1V-92140-5C
DR   Wikidata; Q98132277
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16265; WNT5B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT6, clone1
AC   CVCL_A7W3
SY   1V-92143-5A
DR   Wikidata; Q98132279
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12785; WNT6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT6, clone2
AC   CVCL_A7W4
SY   1V-92143-4B
DR   Wikidata; Q98132280
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12785; WNT6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT6, clone3
AC   CVCL_A7W5
SY   1V-92143-2C
DR   Wikidata; Q98132281
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12785; WNT6.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT7A, clone1
AC   CVCL_A7W6
SY   1V-92191-5A
DR   Wikidata; Q98132282
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12786; WNT7A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT7A, clone2
AC   CVCL_A7W7
SY   1V-92191-4B
DR   Wikidata; Q98132284
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12786; WNT7A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT7A, clone3
AC   CVCL_A7W8
SY   1V-92191-1C
DR   Wikidata; Q98132285
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12786; WNT7A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT8B, clone1
AC   CVCL_A7W9
SY   1V-91943-5A
DR   Wikidata; Q98132286
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12789; WNT8B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT8B, clone2
AC   CVCL_A7X0
SY   1V-91943-2B
DR   Wikidata; Q98132287
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12789; WNT8B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WNT8B, clone3
AC   CVCL_A7X1
SY   1V-91943-1C
DR   Wikidata; Q98132288
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12789; WNT8B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WRNIP1, clone1
AC   CVCL_A7X2
SY   1V-90739-4A
DR   Wikidata; Q98132290
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20876; WRNIP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WRNIP1, clone2
AC   CVCL_A7X3
SY   1V-90739-2B
DR   Wikidata; Q98132292
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20876; WRNIP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WRNIP1, clone3
AC   CVCL_A7X4
SY   1V-90739-6C
DR   Wikidata; Q98132293
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20876; WRNIP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WT1, clone1
AC   CVCL_A7X5
SY   1V-93483-1A
DR   Wikidata; Q98132294
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12796; WT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WT1, clone2
AC   CVCL_A7X6
SY   1V-93483-6B
DR   Wikidata; Q98132295
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12796; WT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human WT1, clone3
AC   CVCL_A7X7
SY   1V-93483-2C
DR   Wikidata; Q98132296
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12796; WT1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XBP1, clone1
AC   CVCL_A7X8
SY   1V-91920-2A
DR   Wikidata; Q98132297
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XBP1, clone2
AC   CVCL_A7X9
SY   1V-91920-4B
DR   Wikidata; Q98132298
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XBP1, clone3
AC   CVCL_A7Y0
SY   1V-91920-3C
DR   Wikidata; Q98132299
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XDH, clone1
AC   CVCL_A7Y1
SY   1V-91944-3A
DR   Wikidata; Q98132300
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12805; XDH.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XDH, clone2
AC   CVCL_A7Y2
SY   1V-91944-5B
DR   Wikidata; Q98132301
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12805; XDH.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XDH, clone3
AC   CVCL_A7Y3
SY   1V-91944-2C
DR   Wikidata; Q98132302
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12805; XDH.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XRCC4, clone1
AC   CVCL_A7Y4
SY   1V-91337-1A
DR   Wikidata; Q98132303
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12831; XRCC4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XRCC4, clone2
AC   CVCL_A7Y5
SY   1V-91337-3B
DR   Wikidata; Q98132305
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12831; XRCC4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XRCC4, clone3
AC   CVCL_A7Y6
SY   1V-91337-6C
DR   Wikidata; Q98132306
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12831; XRCC4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XRN2, clone1
AC   CVCL_A7Y7
SY   1V-91355-4A
DR   Wikidata; Q98132307
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12836; XRN2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XRN2, clone2
AC   CVCL_A7Y8
SY   1V-91355-9D
DR   Wikidata; Q98132308
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12836; XRN2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human XRN2, clone3
AC   CVCL_A7Y9
SY   1V-91355-10E
DR   Wikidata; Q98132309
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12836; XRN2.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human YBX1, clone1
AC   CVCL_A7Z0
SY   1V-91863-3A
DR   Wikidata; Q98132310
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8014; YBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human YBX1, clone2
AC   CVCL_A7Z1
SY   1V-91863-1B
DR   Wikidata; Q98132311
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8014; YBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human YBX1, clone3
AC   CVCL_A7Z2
SY   1V-91863-11D
DR   Wikidata; Q98132312
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:8014; YBX1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human YY1, clone1
AC   CVCL_A7Z3
SY   1V-90727-1A
DR   Wikidata; Q98132313
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12856; YY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human YY1, clone2
AC   CVCL_A7Z4
SY   1V-90727-6B
DR   Wikidata; Q98132314
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12856; YY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human YY1, clone3
AC   CVCL_A7Z5
SY   1V-90727-3C
DR   Wikidata; Q98132315
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12856; YY1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBED4, clone1
AC   CVCL_A7Z6
SY   1V-92127-5A
DR   Wikidata; Q98132316
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20721; ZBED4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBED4, clone2
AC   CVCL_A7Z7
SY   1V-92127-4B
DR   Wikidata; Q98132317
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20721; ZBED4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBED4, clone3
AC   CVCL_A7Z8
SY   1V-92127-1C
DR   Wikidata; Q98132318
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20721; ZBED4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB3, clone1
AC   CVCL_A7Z9
SY   1V-92170-3A
DR   Wikidata; Q98132319
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:22918; ZBTB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB3, clone2
AC   CVCL_A8A0
SY   1V-92170-2B
DR   Wikidata; Q98132321
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:22918; ZBTB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB3, clone3
AC   CVCL_A8A1
SY   1V-92170-4C
DR   Wikidata; Q98132322
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:22918; ZBTB3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB33, clone1
AC   CVCL_A8A2
SY   1V-91310-5A
DR   Wikidata; Q98132323
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16682; ZBTB33.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB33, clone2
AC   CVCL_A8A3
SY   1V-91310-2B
DR   Wikidata; Q98132324
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16682; ZBTB33.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB33, clone3
AC   CVCL_A8A4
SY   1V-91310-5C
DR   Wikidata; Q98132325
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16682; ZBTB33.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB44, clone1
AC   CVCL_A8A5
SY   1V-92175-5A
DR   Wikidata; Q98132326
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25001; ZBTB44.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB44, clone2
AC   CVCL_A8A6
SY   1V-92175-2B
DR   Wikidata; Q98132327
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25001; ZBTB44.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB44, clone3
AC   CVCL_A8A7
SY   1V-92175-6C
DR   Wikidata; Q98132328
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25001; ZBTB44.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB45, clone1
AC   CVCL_A8A8
SY   1V-92304-9A
DR   Wikidata; Q98132329
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23715; ZBTB45.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB45, clone2
AC   CVCL_A8A9
SY   1V-92304-1B
DR   Wikidata; Q98132330
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23715; ZBTB45.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB45, clone3
AC   CVCL_A8B0
SY   1V-92304-3C
DR   Wikidata; Q98132331
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23715; ZBTB45.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB7A, clone1
AC   CVCL_A8B1
SY   1V-91748-2D
DR   Wikidata; Q98132332
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18078; ZBTB7A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB7A, clone2
AC   CVCL_A8B2
SY   1V-91748-1E
DR   Wikidata; Q98132333
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18078; ZBTB7A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZBTB7A, clone3
AC   CVCL_A8B3
SY   1V-91748-1C
DR   Wikidata; Q98132334
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18078; ZBTB7A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZC3H11A, clone1
AC   CVCL_A8B4
SY   1V-91507-4A
DR   Wikidata; Q98132335
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29093; ZC3H11A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZC3H11A, clone2
AC   CVCL_A8B5
SY   1V-91507-2B
DR   Wikidata; Q98132336
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29093; ZC3H11A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZC3H11A, clone3
AC   CVCL_A8B6
SY   1V-91507-1C
DR   Wikidata; Q98132337
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29093; ZC3H11A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZFAND3, clone1
AC   CVCL_A8B7
SY   1V-91238-4B
DR   Wikidata; Q98132338
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18019; ZFAND3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZFAND3, clone2
AC   CVCL_A8B8
SY   1V-91238-1C
DR   Wikidata; Q98132339
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18019; ZFAND3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZFAND3, clone3
AC   CVCL_A8B9
SY   1V-91238-5D
DR   Wikidata; Q98132340
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18019; ZFAND3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZFP57, clone1
AC   CVCL_A8C0
SY   1V-91254-1A
DR   Wikidata; Q98132341
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18791; ZFP57.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZFP57, clone2
AC   CVCL_A8C1
SY   1V-91254-2B
DR   Wikidata; Q98132342
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18791; ZFP57.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZFP57, clone3
AC   CVCL_A8C2
SY   1V-91254-3C
DR   Wikidata; Q98132343
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:18791; ZFP57.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZIC1, clone1
AC   CVCL_A8C3
SY   1V-90993-2A
DR   Wikidata; Q98132344
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12872; ZIC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZIC1, clone2
AC   CVCL_A8C4
SY   1V-90993-3B
DR   Wikidata; Q98132345
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12872; ZIC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZIC1, clone3
AC   CVCL_A8C5
SY   1V-90993-5C
DR   Wikidata; Q98132346
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12872; ZIC1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZIC3, clone1
AC   CVCL_A8C6
SY   1V-93484-4A
DR   Wikidata; Q98132347
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12874; ZIC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZIC3, clone2
AC   CVCL_A8C7
SY   1V-93484-1B
DR   Wikidata; Q98132348
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12874; ZIC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZIC3, clone3
AC   CVCL_A8C8
SY   1V-93484-6C
DR   Wikidata; Q98132349
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12874; ZIC3.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZKSCAN1, clone1
AC   CVCL_A8C9
SY   1V-91305-2A
DR   Wikidata; Q98132350
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13101; ZKSCAN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZKSCAN1, clone2
AC   CVCL_A8D0
SY   1V-91305-1B
DR   Wikidata; Q98132351
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13101; ZKSCAN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZKSCAN1, clone3
AC   CVCL_A8D1
SY   1V-91305-3C
DR   Wikidata; Q98132352
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13101; ZKSCAN1.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZKSCAN4, clone1
AC   CVCL_A8D2
SY   1V-92196-3A
DR   Wikidata; Q98132353
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13854; ZKSCAN4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZKSCAN4, clone2
AC   CVCL_A8D3
SY   1V-92196-2B
DR   Wikidata; Q98132354
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13854; ZKSCAN4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZKSCAN4, clone3
AC   CVCL_A8D4
SY   1V-92196-5C
DR   Wikidata; Q98132355
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13854; ZKSCAN4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMAT4, clone1
AC   CVCL_A8D5
SY   1V-91259-3A
DR   Wikidata; Q98132356
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25844; ZMAT4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMAT4, clone2
AC   CVCL_A8D6
SY   1V-91259-4B
DR   Wikidata; Q98132357
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25844; ZMAT4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMAT4, clone3
AC   CVCL_A8D7
SY   1V-91259-2C
DR   Wikidata; Q98132358
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:25844; ZMAT4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMAT5, clone1
AC   CVCL_A8D8
SY   1V-92128-3A
DR   Wikidata; Q98132359
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28046; ZMAT5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMAT5, clone2
AC   CVCL_A8D9
SY   1V-92128-5B
DR   Wikidata; Q98132360
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28046; ZMAT5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMAT5, clone3
AC   CVCL_A8E0
SY   1V-92128-4C
DR   Wikidata; Q98132361
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28046; ZMAT5.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND10, clone1
AC   CVCL_A8E1
SY   1V-93359-3A
DR   Wikidata; Q98132362
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19412; ZMYND10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND10, clone2
AC   CVCL_A8E2
SY   1V-93359-6B
DR   Wikidata; Q98132363
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19412; ZMYND10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND10, clone3
AC   CVCL_A8E3
SY   1V-93359-2C
DR   Wikidata; Q98132364
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:19412; ZMYND10.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND11, clone1
AC   CVCL_A8E4
SY   1V-92180-5A
DR   Wikidata; Q98132365
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16966; ZMYND11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND11, clone2
AC   CVCL_A8E5
SY   1V-92180-2B
DR   Wikidata; Q98132366
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16966; ZMYND11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND11, clone3
AC   CVCL_A8E6
SY   1V-92180-6C
DR   Wikidata; Q98132367
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:16966; ZMYND11.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND12, clone1
AC   CVCL_A8E7
SY   1V-92169-1A
DR   Wikidata; Q98132368
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21192; ZMYND12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND12, clone2
AC   CVCL_A8E8
SY   1V-92169-2B
DR   Wikidata; Q98132369
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21192; ZMYND12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZMYND12, clone3
AC   CVCL_A8E9
SY   1V-92169-4C
DR   Wikidata; Q98132370
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21192; ZMYND12.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF121, clone1
AC   CVCL_A8F0
SY   1V-92226-1A
DR   Wikidata; Q98132371
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12904; ZNF121.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF121, clone2
AC   CVCL_A8F1
SY   1V-92226-10B
DR   Wikidata; Q98132372
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12904; ZNF121.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF121, clone3
AC   CVCL_A8F2
SY   1V-92226-7C
DR   Wikidata; Q98132373
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:12904; ZNF121.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF217, clone1
AC   CVCL_A8F3
SY   1V-93181-2A
DR   Wikidata; Q98132374
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13009; ZNF217.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF217, clone2
AC   CVCL_A8F4
SY   1V-93181-3B
DR   Wikidata; Q98132375
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13009; ZNF217.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF217, clone3
AC   CVCL_A8F5
SY   1V-93181-1C
DR   Wikidata; Q98132376
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13009; ZNF217.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF263, clone1
AC   CVCL_A8F6
SY   1V-91750-1A
DR   Wikidata; Q98132377
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13056; ZNF263.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF263, clone2
AC   CVCL_A8F7
SY   1V-91750-3B
DR   Wikidata; Q98132379
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13056; ZNF263.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF263, clone3
AC   CVCL_A8F8
SY   1V-91750-10C
DR   Wikidata; Q98132380
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13056; ZNF263.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF274, clone1
AC   CVCL_A8F9
SY   1V-91335-5A
DR   Wikidata; Q98132382
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13068; ZNF274.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF274, clone2
AC   CVCL_A8G0
SY   1V-91335-6B
DR   Wikidata; Q98132383
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13068; ZNF274.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF274, clone3
AC   CVCL_A8G1
SY   1V-91335-2C
DR   Wikidata; Q98132384
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13068; ZNF274.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF280B, clone1
AC   CVCL_A8G2
SY   1V-91919-4A
DR   Wikidata; Q98132385
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23022; ZNF280B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF280B, clone2
AC   CVCL_A8G3
SY   1V-91919-6C
DR   Wikidata; Q98132386
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23022; ZNF280B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF280B, clone3
AC   CVCL_A8G4
SY   1V-91919-9D
DR   Wikidata; Q98132387
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23022; ZNF280B.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF281, clone1
AC   CVCL_A8G5
SY   1V-91256-5A
DR   Wikidata; Q98132388
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13075; ZNF281.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF281, clone2
AC   CVCL_A8G6
SY   1V-91256-1B
DR   Wikidata; Q98132389
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13075; ZNF281.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF281, clone3
AC   CVCL_A8G7
SY   1V-91256-2C
DR   Wikidata; Q98132390
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13075; ZNF281.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF382, clone1
AC   CVCL_A8G8
SY   1V-92229-2A
DR   Wikidata; Q98132391
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17409; ZNF382.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF382, clone2
AC   CVCL_A8G9
SY   1V-92229-5B
DR   Wikidata; Q98132392
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17409; ZNF382.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF382, clone3
AC   CVCL_A8H0
SY   1V-92229-3C
DR   Wikidata; Q98132393
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:17409; ZNF382.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF384, clone1
AC   CVCL_A8H1
SY   1V-92313-4A
DR   Wikidata; Q98132394
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11955; ZNF384.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF384, clone2
AC   CVCL_A8H2
SY   1V-92313-6B
DR   Wikidata; Q98132395
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11955; ZNF384.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF384, clone3
AC   CVCL_A8H3
SY   1V-92313-1C
DR   Wikidata; Q98132396
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:11955; ZNF384.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF426, clone1
AC   CVCL_A8H4
SY   1V-92185-2A
DR   Wikidata; Q98132397
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20725; ZNF426.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF426, clone2
AC   CVCL_A8H5
SY   1V-92185-6B
DR   Wikidata; Q98132398
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20725; ZNF426.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF426, clone3
AC   CVCL_A8H6
SY   1V-92185-3C
DR   Wikidata; Q98132399
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:20725; ZNF426.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF462, clone1
AC   CVCL_A8H7
SY   1V-92212-5A
DR   Wikidata; Q98132400
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21684; ZNF462.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF462, clone2
AC   CVCL_A8H8
SY   1V-92212-3B
DR   Wikidata; Q98132401
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21684; ZNF462.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF462, clone3
AC   CVCL_A8H9
SY   1V-92212-7D
DR   Wikidata; Q98132402
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:21684; ZNF462.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF480, clone1
AC   CVCL_A8I0
SY   1V-92165-3A
DR   Wikidata; Q98132403
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23305; ZNF480.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF480, clone2
AC   CVCL_A8I1
SY   1V-92165-5B
DR   Wikidata; Q98132404
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23305; ZNF480.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF480, clone3
AC   CVCL_A8I2
SY   1V-92165-1C
DR   Wikidata; Q98132405
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23305; ZNF480.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF496, clone1
AC   CVCL_A8I3
SY   1V-92189-5A
DR   Wikidata; Q98132406
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23713; ZNF496.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF496, clone2
AC   CVCL_A8I4
SY   1V-92189-4B
DR   Wikidata; Q98132407
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23713; ZNF496.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF496, clone3
AC   CVCL_A8I5
SY   1V-92189-3C
DR   Wikidata; Q98132408
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23713; ZNF496.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF521, clone1
AC   CVCL_A8I6
SY   1V-91779-4A
DR   Wikidata; Q98132409
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24605; ZNF521.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF521, clone2
AC   CVCL_A8I7
SY   1V-91779-5B
DR   Wikidata; Q98132410
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24605; ZNF521.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF521, clone3
AC   CVCL_A8I8
SY   1V-91779-6C
DR   Wikidata; Q98132411
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24605; ZNF521.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF559, clone1
AC   CVCL_A8I9
SY   1V-92129-3A
DR   Wikidata; Q98132412
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28197; ZNF559.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF559, clone2
AC   CVCL_A8J0
SY   1V-92129-7D
DR   Wikidata; Q98132413
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:28197; ZNF559.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF646, clone1
AC   CVCL_A8J1
SY   1V-91191-4A
DR   Wikidata; Q98132414
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29004; ZNF646.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF646, clone2
AC   CVCL_A8J2
SY   1V-91191-3B
DR   Wikidata; Q98132415
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29004; ZNF646.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF646, clone3
AC   CVCL_A8J3
SY   1V-91191-6C
DR   Wikidata; Q98132416
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:29004; ZNF646.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF70, clone1
AC   CVCL_A8J4
SY   1V-92131-1A
DR   Wikidata; Q98132417
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13140; ZNF70.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF70, clone2
AC   CVCL_A8J5
SY   1V-92131-3B
DR   Wikidata; Q98132418
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13140; ZNF70.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF70, clone3
AC   CVCL_A8J6
SY   1V-92131-6C
DR   Wikidata; Q98132419
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13140; ZNF70.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF706, clone1
AC   CVCL_A8J7
SY   1V-91189-4A
DR   Wikidata; Q98132420
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24992; ZNF706.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF706, clone2
AC   CVCL_A8J8
SY   1V-91189-5B
DR   Wikidata; Q98132421
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24992; ZNF706.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF706, clone3
AC   CVCL_A8J9
SY   1V-91189-2C
DR   Wikidata; Q98132422
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:24992; ZNF706.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF713, clone1
AC   CVCL_A8K0
SY   1V-91867-6A
DR   Wikidata; Q98132423
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:22043; ZNF713.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF713, clone2
AC   CVCL_A8K1
SY   1V-91867-5C
DR   Wikidata; Q98132424
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:22043; ZNF713.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF713, clone3
AC   CVCL_A8K2
SY   1V-91867-7D
DR   Wikidata; Q98132425
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:22043; ZNF713.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF74, clone1
AC   CVCL_A8K3
SY   1V-92132-3A
DR   Wikidata; Q98132426
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13144; ZNF74.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF74, clone2
AC   CVCL_A8K4
SY   1V-92132-4B
DR   Wikidata; Q98132427
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13144; ZNF74.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF74, clone3
AC   CVCL_A8K5
SY   1V-92132-2C
DR   Wikidata; Q98132428
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:13144; ZNF74.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF780A, clone1
AC   CVCL_A8K6
SY   1V-92230-1A
DR   Wikidata; Q98132429
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:27603; ZNF780A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF780A, clone2
AC   CVCL_A8K7
SY   1V-92230-2B
DR   Wikidata; Q98132430
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:27603; ZNF780A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZNF780A, clone3
AC   CVCL_A8K8
SY   1V-92230-6C
DR   Wikidata; Q98132431
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:27603; ZNF780A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZSCAN4, clone1
AC   CVCL_A8K9
SY   1V-90929-2A
DR   Wikidata; Q98132432
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23709; ZSCAN4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZSCAN4, clone2
AC   CVCL_A8L0
SY   1V-90929-3B
DR   Wikidata; Q98132433
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23709; ZSCAN4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZSCAN4, clone3
AC   CVCL_A8L1
SY   1V-90929-6C
DR   Wikidata; Q98132434
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23709; ZSCAN4.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZSCAN5A, clone1
AC   CVCL_A8L2
SY   1V-92133-2A
DR   Wikidata; Q98132435
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23710; ZSCAN5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04486; Human herpesvirus 1 VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZSCAN5A, clone2
AC   CVCL_A8L3
SY   1V-92133-1B
DR   Wikidata; Q98132436
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23710; ZSCAN5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-1V human ZSCAN5A, clone3
AC   CVCL_A8L4
SY   1V-92133-3C
DR   Wikidata; Q98132437
RX   PubMed=32433964;
CC   Characteristics: When doxycycline is added the transfected human gene (ORF) and lacZ are expressed.
CC   Characteristics: Transposed with a PB-PuroR-Ins-tetO2-ORF-IRES-bgeo-PB where PB is a piggyBac sequence, Ins is a chicken HS4 insulator, ORF is the transfected human gene and bgeo is a neo-LacZ fusion protein.
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=PiggyBac transposition; Gene=HGNC; HGNC:23710; ZSCAN5A.
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ91 ! SEES3-1V
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   SEES3-3L
AC   CVCL_ZJ90
SY   3L
DR   Wikidata; Q98132439
RX   PubMed=32433964;
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q91 ! SEES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   SEES3-5V
AC   CVCL_ZJ92
SY   5V
DR   Wikidata; Q98132440
RX   PubMed=32433964;
CC   Characteristics: Transfected with a pG-flox-CAGrtTA3G-IRES-Hyg-pA construct that contains a reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1Q91 ! SEES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   SEES4
AC   CVCL_RH08
SY   SEES-4; SEi-iku Embryonic Stem-4
DR   SKIP; SKIP001149
DR   Wikidata; Q54952777
RX   PubMed=31245438;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SEES5
AC   CVCL_RH09
SY   SEES-5; SEi-iku Embryonic Stem-5
DR   SKIP; SKIP001150
DR   Wikidata; Q54952779
RX   PubMed=31245438;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SEES6
AC   CVCL_RH10
SY   SEES-6; SEi-iku Embryonic Stem-6
DR   SKIP; SKIP001151
DR   Wikidata; Q54952780
RX   PubMed=31245438;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SEES7
AC   CVCL_RH11
SY   SEES-7; SEi-iku Embryonic Stem-7
DR   SKIP; SKIP001152
DR   Wikidata; Q54952782
RX   PubMed=31245438;
RX   PubMed=33225099;
CC   From: National Center for Child Health and Development (NCCHD); Tokyo; Japan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SEG-1
AC   CVCL_8113
SY   Seg-1; SEG1; Seg1
DR   BTO; BTO_0003430
DR   BioSample; SAMN03151859
DR   cancercelllines; CVCL_8113
DR   IARC_TP53; 21627
DR   Wikidata; Q54952784
RX   PubMed=9407969;
RX   PubMed=10078940;
RX   PubMed=16364037;
RX   PubMed=20075370;
RX   PubMed=23795680;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a NCI-H460 derivative (PubMed=20075370). Originally thought to originate from an esophageal Barrett adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00366.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=20075370
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 15,18
ST   D5S818: 9,10
ST   D7S820: 9,12
ST   D8S1179: 12
ST   FGA: 21,23
ST   Penta D: 11,13
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0459 ! NCI-H460
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SeGB
AC   CVCL_A7VF
SY   Sevenband Grouper Brain
DR   Wikidata; Q107116907
RX   DOI=10.3147/jsfp.56.22;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 15 to 32 Celsius (DOI=10.3147/jsfp.56.22).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=232417; ! Hyporthodus septemfasciatus (Convict grouper)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SeGE-12
AC   CVCL_A7VG
SY   Sevenband Grouper Embryo-12
DR   Wikidata; Q107116908
RX   DOI=10.3147/jsfp.56.22;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 25 to 32 Celsius (DOI=10.3147/jsfp.56.22).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=232417; ! Hyporthodus septemfasciatus (Convict grouper)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SeGE-22
AC   CVCL_A7VH
SY   Sevenband Grouper Embryo-22
DR   Wikidata; Q107116909
RX   DOI=10.3147/jsfp.56.22;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 25 to 32 Celsius (DOI=10.3147/jsfp.56.22).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=232417; ! Hyporthodus septemfasciatus (Convict grouper)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SeGF
AC   CVCL_A7VI
SY   Sevenband Grouper Fin
DR   Wikidata; Q107116911
RX   DOI=10.3147/jsfp.56.22;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 15 to 32 Celsius (DOI=10.3147/jsfp.56.22).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=232417; ! Hyporthodus septemfasciatus (Convict grouper)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SEH
AC   CVCL_R855
SY   Sake Embryo Head
DR   Wikidata; Q54952785
RX   CelloPub=CLPUB00103;
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8018; ! Oncorhynchus keta (Chum salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 11
//
ID   SeHe920-1a
AC   CVCL_AV40
SY   SeH920-1a
DR   ICLDB; sehe920-1a
DR   Wikidata; Q54952787
RX   PubMed=15638701;
CC   Group: Insect cell line.
CC   Doubling time: 28 hours (PubMed=15638701).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   SEIi001-A
AC   CVCL_UJ70
SY   SEIOA1#1
DR   hPSCreg; SEIi001-A
DR   Wikidata; Q98132441
RX   PubMed=30513407;
CC   From: UCLA Stein Eye Institute; Los Angeles; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20145; GPR143; Simple; c.885+748G>A (g.25288G>A); ClinVar=VCV001408135; Zygosity=Hemizygous; Note=Creates an acceptor splice site (PubMed=30513407).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118785; Ocular albinism type 1
DI   ORDO; Orphanet_54; X-linked recessive ocular albinism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   SEKI
AC   CVCL_3162
DR   BioSample; SAMN03472487
DR   cancercelllines; CVCL_3162
DR   Cell_Model_Passport; SIDM01344
DR   DepMap; ACH-001645
DR   JCRB; JCRB0620
DR   JCRB; JCRB1041
DR   JCRB; NIHS0312
DR   Wikidata; Q54952788
RX   CelloPub=CLPUB00112;
RX   CelloPub=CLPUB00113;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 4-5 days (CelloPub=CLPUB00112).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-001645).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: JCRB; JCRB0620; probable.
CC   Discontinued: JCRB; NIHS0312; true.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
ST   Source(s): DepMap=ACH-001645; JCRB=JCRB1041
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,10.1,11 (JCRB=JCRB1041)
ST   D16S539: 9,11 (DepMap=ACH-001645)
ST   D18S51: 14,22
ST   D21S11: 33.2
ST   D3S1358: 16,17
ST   D5S818: 9,11
ST   D7S820: 9,12
ST   D8S1179: 10,11,12
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   Seki
AC   CVCL_AS13
DR   TKG; TKG 0725
DR   Wikidata; Q54952789
RX   PubMed=2486607;
CC   Population: Japanese.
CC   Doubling time: 36.3 hours (PubMed=2486607).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   SEKI-45
AC   CVCL_JG84
DR   JCRB; KURB2687
DR   Wikidata; Q54952790
CC   Discontinued: JCRB; KURB2687; probable.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 6
//
ID   Sel Ger
AC   CVCL_0F69
DR   ATCC; CRL-1122
DR   Wikidata; Q54952793
CC   Discontinued: ATCC; CRL-1122; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 7
//
ID   SEM
AC   CVCL_0095
DR   EFO; EFO_0002326
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 1548
DR   BioSample; SAMN03473532
DR   BioSample; SAMN10988273
DR   cancercelllines; CVCL_0095
DR   Cell_Model_Passport; SIDM01424
DR   ChEMBL-Cells; CHEMBL4295399
DR   ChEMBL-Targets; CHEMBL4296493
DR   Cosmic; 1130254
DR   Cosmic; 2491076
DR   Cosmic; 2542839
DR   DepMap; ACH-000782
DR   DSMZ; ACC-546
DR   DSMZCellDive; ACC-546
DR   GEO; GSM887563
DR   GEO; GSM888646
DR   GEO; GSM5137743
DR   GEO; GSM5137744
DR   IARC_TP53; 28231
DR   IGRhCellID; SEM
DR   LiGeA; CCLE_736
DR   PharmacoDB; SEM_1363_2019
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_0095
DR   PubChem_Cell_line; CVCL_0095
DR   Wikidata; Q54952795
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7794749;
RX   PubMed=8199015;
RX   PubMed=9067587;
RX   PubMed=9881706;
RX   PubMed=14671638;
RX   PubMed=20215515;
RX   PubMed=21552520;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35354797;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (PubMed=8199015); 24 hours (PubMed=25984343); ~30 hours (DSMZ=ACC-546).
CC   HLA typing: A*01:01,32:01; B*08:01,15:01; C*03:03,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,32:01:01; B*08:01:01,15:01:01; C*03:03:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,02:01:02; DQA1*01:03:01,01:03:01; DQB1*03:01:01,06:03:01; DRA*01:01:01,01:02:02; DRB1*11:01:01,13:01:01 (DSMZCellDive=ACC-546).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (PubMed=14671638; PubMed=35354797).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (DepMap=ACH-000782).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (DepMap=ACH-000782).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.88%; Native American=0.05%; East Asian, North=2.53%; East Asian, South=0%; South Asian=0.07%; European, North=64.12%; European, South=32.35% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-546
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 8,10
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 29,30,31
ST   D2S1338: 17,24
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 21,25
ST   Penta D: 11,14
ST   Penta E: 10,11
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   SEM-1
AC   CVCL_T013
SY   SEM1; Seminoma-1
DR   ABM; T8021
DR   Cosmic; 1939514
DR   Wikidata; Q38147424
RX   DOI=10.25549/usctheses-c16-319395;
RX   PubMed=23374840;
CC   Population: Hispanic.
CC   Doubling time: 50 hours (PubMed=23374840).
CC   Derived from site: In situ; Mediastinum; UBERON=UBERON_0003728.
DI   NCIt; C6812; Mediastinal seminoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   Sema3Fc mAb
AC   CVCL_E8HN
RX   PubMed=29420136;
RX   PubMed=29474161;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q13275; Human SEMA3F.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SEMK2
AC   CVCL_S906
SY   SEM-K2
DR   cancercelllines; CVCL_S906
DR   Cell_Model_Passport; SIDM01627
DR   DepMap; ACH-001735
DR   Wikidata; Q54952797
RX   PubMed=7669664;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (DepMap=ACH-001735).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (DepMap=ACH-001735).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0095 ! SEM
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 21
//
ID   SEMK2-M1
AC   CVCL_S907
DR   cancercelllines; CVCL_S907
DR   Wikidata; Q54952798
RX   PubMed=12620411;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7135; AFF1 + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFF1, MLL-AFF1, ALL-1/AF4 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S906 ! SEMK2
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 19
//
ID   SEN11
AC   CVCL_JZ72
DR   Wikidata; Q54952799
RX   PubMed=1645566;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Human cluster-5A antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   SEN12
AC   CVCL_JZ73
DR   Wikidata; Q54952801
RX   PubMed=1645566;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human cluster-5A antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   Sen15C6
AC   CVCL_JZ77
DR   Wikidata; Q54952802
RX   Patent=US5217871;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10185.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Phaeosphaeria nodorum.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   SEN3
AC   CVCL_JZ74
DR   Wikidata; Q54952803
RX   PubMed=1645566;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human cluster-5A antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   SEN31
AC   CVCL_JZ75
DR   Wikidata; Q54952805
RX   PubMed=1645566;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human cluster-5A antigen on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   SEN7.2a.4
AC   CVCL_JZ71
SY   SEN.7.2a.4; SEN 7.2a.4
DR   Wikidata; Q54952807
RX   Patent=US5614373;
RX   PubMed=7684948;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2050.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13591; Human NCAM1/CD56.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   sEnd.1
AC   CVCL_6270
SY   sEnd-1; sEND1; skin-derived Endothelial cells.1
DR   BTO; BTO_0004507
DR   Wikidata; Q54952809
RX   PubMed=3345558;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   Senju-CCS
AC   CVCL_E2TM
RX   PubMed=28745431;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=28745431).
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SEP-K1
AC   CVCL_DR22
SY   SEPK1; SEPfk
DR   CCRID; 5301SWI-KCB88014ZJ
DR   KCB; KCB 88014KZJ
DR   Wikidata; Q54952811
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_A9FA ! SEP-L1
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   SEP-L1
AC   CVCL_A9FA
SY   SEPfl
DR   CCRID; 5301SWI-KCB8814LZJ
DR   KCB; KCB 88014LZJ
DR   Wikidata; Q108821292
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_DR22 ! SEP-K1
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SEP-L2
AC   CVCL_A9FB
SY   SEPml
DR   CCRID; 5301SWI-KCB88021ZJ
DR   KCB; KCB 88021ZJ
DR   Wikidata; Q108821293
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SEP2
AC   CVCL_5586
DR   CLO; CLO_0050260
DR   RCB; RCB0269
DR   Wikidata; Q54952810
CC   Discontinued: RCB; RCB0269; probable.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=9378; ! Suncus murinus (Asian house shrew)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Seraphina
AC   CVCL_M646
SY   SERAPHINA; Seraphine; SERAP; U-604 BL
DR   cancercelllines; CVCL_M646
DR   Cosmic; 931112
DR   Cosmic; 2297025
DR   GEO; GSM115813
DR   NCBI_Iran; C102
DR   Progenetix; CVCL_M646
DR   Wikidata; Q54952813
RX   PubMed=163717;
RX   PubMed=165156;
RX   PubMed=216485;
RX   PubMed=3026973;
RX   PubMed=3027441;
RX   PubMed=4122458;
RX   PubMed=4364259;
RX   PubMed=6231253;
RX   PubMed=6286514;
RX   PubMed=9473234;
RX   PubMed=16960149;
RX   PubMed=17254797;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 16,17
ST   D21S11: 27
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   TH01: 6,9
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   SerBob
AC   CVCL_2720
SY   Serum-adapted Bob
DR   ECACC; 10021101
DR   Wikidata; Q54952814
RX   PubMed=19544327;
CC   Characteristics: Adapted to growth in a medium containing serum.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): ECACC=10021101
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2317 ! Bob
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   SerW3
AC   CVCL_1669
SY   Ser-W3; SER-W3
DR   BTO; BTO_0004514
DR   CLO; CLO_0008982
DR   DSMZ; ACC-420
DR   DSMZCellDive; ACC-420
DR   Wikidata; Q54952815
RX   PubMed=9352123;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-420).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   17D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   SES-Bm-1 30
AC   CVCL_WK41
SY   SES-Bm-130
DR   ICLDB; ses-bm-1-30
DR   Wikidata; Q98132442
RX   CelloPub=CLPUB00498;
RX   CelloPub=CLPUB00537;
CC   Group: Insect cell line.
CC   Doubling time: 3-4 days (CelloPub=CLPUB00498).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: 1 30(pM, Ze, L, q).
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   SES-Bm-1 30A
AC   CVCL_Z696
DR   ICLDB; ses-bm-1-30a
DR   Wikidata; Q54952817
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: 1 30(pM, Ze, L, q).
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_WK41 ! SES-Bm-1 30
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SES-Bm-1 30R
AC   CVCL_Z697
SY   SES-Bm-130R
DR   ICLDB; ses-bm-1-30r
DR   Wikidata; Q54952818
RX   CelloPub=CLPUB00199;
RX   CelloPub=CLPUB00537;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: 1 30(pM, Ze, L, q).
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_WK41 ! SES-Bm-1 30
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-Bm-e 21
AC   CVCL_WK42
SY   SES-Bm-e21; Bm-e21
DR   ICLDB; ses-bm-e-21
DR   Wikidata; Q98132443
RX   CelloPub=CLPUB00199;
RX   CelloPub=CLPUB00498;
RX   CelloPub=CLPUB00537;
CC   Group: Insect cell line.
CC   Doubling time: 2-3 days (CelloPub=CLPUB00498).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: e21.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   SES-Bm-e 21-12
AC   CVCL_WK51
SY   Bm-e21-12
DR   ICLDB; ses-bm-e-21-12
DR   Wikidata; Q98132445
RX   PubMed=3467322;
CC   Group: Insect cell line.
CC   Doubling time: 2-3 days (PubMed=3467322).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: e21.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_WK42 ! SES-Bm-e 21
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SES-Bm-e 21A
AC   CVCL_Z698
DR   ICLDB; ses-bm-e-21a
DR   Wikidata; Q54952819
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: e21.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_WK42 ! SES-Bm-e 21
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SES-Bm-e 21B
AC   CVCL_Z699
DR   ICLDB; ses-bm-e-21b
DR   Wikidata; Q54952820
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: e21.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_WK42 ! SES-Bm-e 21
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SES-Bm-e 21R
AC   CVCL_Z700
DR   ICLDB; ses-bm-e-21r
DR   Wikidata; Q54952822
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: e21.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_WK42 ! SES-Bm-e 21
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SES-Bma-01
AC   CVCL_C2U5
DR   ICLDB; ses-bma-01
DR   Wikidata; Q114312986
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7092; ! Bombyx mandarina (Wild silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SES-Bma-01A
AC   CVCL_Z694
SY   Bma-01A; SES-Bma-O1A
DR   ICLDB; ses-bma-01a
DR   Wikidata; Q54952823
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7092; ! Bombyx mandarina (Wild silk moth)
HI   CVCL_C2U5 ! SES-Bma-01
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SES-Bma-01R
AC   CVCL_Z695
SY   Bma-01R; SES-Bma-O1R
DR   ICLDB; ses-bma-01r
DR   Wikidata; Q54952824
RX   CelloPub=CLPUB00199;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7092; ! Bombyx mandarina (Wild silk moth)
HI   CVCL_C2U5 ! SES-Bma-01
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SES-BoMo-15A
AC   CVCL_Z108
SY   SES-BoMo-15 A; BoMo-15 A; BoMo-15A
DR   ICLDB; ses-bomo-15a
DR   NISES; SK0029
DR   Wikidata; Q54952825
RX   CelloPub=CLPUB00184;
RX   CelloPub=CLPUB00372;
RX   CelloPub=CLPUB00498;
RX   CelloPub=CLPUB00537;
RX   DOI=10.11416/kontyushigen1930.53.108;
RX   DOI=10.1303/aez.23.8;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=15827172;
RX   PubMed=16756546;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Doubling time: 3 days (CelloPub=CLPUB00372).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kuroko.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 14
//
ID   SES-BoMo-15AII
AC   CVCL_Z419
SY   SES-BoMo-15 AII; BoMo-15 AII
DR   ICLDB; ses-bomo-15aii
DR   Wikidata; Q54952827
RX   CelloPub=CLPUB00184;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kuroko.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z108 ! SES-BoMo-15A
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-BoMo-C129
AC   CVCL_Z105
SY   SBC129
DR   ICLDB; ses-bomo-c129
DR   NISES; SK0030
DR   Wikidata; Q54952828
RX   CelloPub=CLPUB00534;
RX   DOI=10.11416/jibs.74.117;
RX   DOI=10.11416/kontyushigen1930.57.184;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Doubling time: 3.5 days (DOI=10.11416/kontyushigen1930.57.184).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C129.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-BoMo-J125
AC   CVCL_Z106
DR   ICLDB; ses-bomo-j125
DR   NISES; SK0028
DR   Wikidata; Q54952842
RX   CelloPub=CLPUB00193;
RX   CelloPub=CLPUB00534;
RX   DOI=10.11416/kontyushigen1930.57.184;
CC   Group: Insect cell line.
CC   Doubling time: 3.0 days (DOI=10.11416/kontyushigen1930.57.184).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J125.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-BoMo-J125K1
AC   CVCL_Z526
DR   ICLDB; ses-bomo-j125k1
DR   NISES; SK0020
DR   Wikidata; Q54952844
RX   CelloPub=CLPUB00193;
CC   Group: Insect cell line.
CC   Doubling time: 5.41 days (CelloPub=CLPUB00193).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J125.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z106 ! SES-BoMo-J125
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-BoMo-J125K2
AC   CVCL_Z527
SY   SES-BoMo-J125-K2
DR   ICLDB; ses-bomo-j125k2
DR   NISES; SK0019
DR   Wikidata; Q54952845
RX   CelloPub=CLPUB00193;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 1.96 days (CelloPub=CLPUB00193).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J125.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z106 ! SES-BoMo-J125
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-BoMo-J125K5
AC   CVCL_Z528
SY   SES-BoMo-J125-K5
DR   ICLDB; ses-bomo-j125k5
DR   NISES; SK0021
DR   Wikidata; Q54952846
RX   CelloPub=CLPUB00193;
RX   PubMed=15827172;
RX   PubMed=16756546;
CC   Group: Insect cell line.
CC   Doubling time: 4.12 days (CelloPub=CLPUB00193).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J125.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z106 ! SES-BoMo-J125
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-BoMo-J125K6
AC   CVCL_Z529
DR   ICLDB; ses-bomo-j125k6
DR   NISES; SK0022
DR   Wikidata; Q54952847
RX   CelloPub=CLPUB00193;
CC   Group: Insect cell line.
CC   Doubling time: 5.41 days (CelloPub=CLPUB00193).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: J125.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
HI   CVCL_Z106 ! SES-BoMo-J125
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   SES-MaBr-1
AC   CVCL_Z127
DR   CLO; CLO_0050499
DR   ICLDB; ses-mabr-1
DR   NISES; SK0003
DR   RCB; RCB0275
DR   Wikidata; Q54952848
RX   CelloPub=CLPUB00372;
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00532;
RX   DOI=10.1303/aez.20.496;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=1367489;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275014.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 14
//
ID   SES-MaBr-2
AC   CVCL_Z128
DR   ICLDB; ses-mabr-2
DR   NISES; SK0034
DR   Wikidata; Q54952850
RX   CelloPub=CLPUB00372;
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00532;
RX   DOI=10.1303/aez.20.496;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275015.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   SES-MaBr-3
AC   CVCL_Z129
DR   CLO; CLO_0050497
DR   ICLDB; ses-mabr-3
DR   NISES; SK0004
DR   RCB; RCB0276
DR   Wikidata; Q54952851
RX   CelloPub=CLPUB00372;
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00532;
RX   CelloPub=CLPUB00537;
RX   DOI=10.1303/aez.20.496;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=1367489;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275016.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 14
//
ID   SES-MaBr-4
AC   CVCL_Z130
DR   CLO; CLO_0050500
DR   ICLDB; ses-mabr-4
DR   NISES; SK0007
DR   RCB; RCB0404
DR   Wikidata; Q54952853
RX   CelloPub=CLPUB00372;
RX   CelloPub=CLPUB00492;
RX   CelloPub=CLPUB00532;
RX   DOI=10.1303/aez.20.496;
RX   PubMed=1367489;
RX   PubMed=9282311;
WW   Provider; NGRC Genebank; 275017; https://web.archive.org/web/20230326054300/https://www.gene.affrc.go.jp/databases-animal_celllines_detail.php?maff=275017
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275017.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   SES-MaBr-5
AC   CVCL_Z131
DR   CLO; CLO_0050498
DR   ICLDB; ses-mabr-5
DR   NISES; SK0011
DR   RCB; RCB0429
DR   Wikidata; Q54952854
RX   CelloPub=CLPUB00372;
RX   CelloPub=CLPUB00537;
RX   DOI=10.1303/aez.20.496;
RX   DOI=10.1303/aez.32.227;
RX   PubMed=9282311;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275018.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 14
//
ID   SESX
AC   CVCL_M778
DR   Cosmic; 922394
DR   Wikidata; Q54952856
RX   PubMed=3491924;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 6
//
ID   SET
AC   CVCL_WY71
DR   Wikidata; Q98132446
RX   CelloPub=CLPUB00103;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8018; ! Oncorhynchus keta (Chum salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 4
//
ID   SET-2
AC   CVCL_2187
SY   Set-2; Set2; SET2
DR   BTO; BTO_0004766
DR   EFO; EFO_0006486
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 804
DR   BioSample; SAMN03473274
DR   BioSample; SAMN10988088
DR   cancercelllines; CVCL_2187
DR   Cell_Model_Passport; SIDM00397
DR   ChEMBL-Cells; CHEMBL4523535
DR   ChEMBL-Targets; CHEMBL4523566
DR   Cosmic; 1012054
DR   Cosmic; 1519162
DR   Cosmic; 1633513
DR   Cosmic; 1943610
DR   Cosmic; 2306995
DR   Cosmic-CLP; 1659820
DR   DepMap; ACH-000195
DR   DSMZ; ACC-608
DR   DSMZCellDive; ACC-608
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GDSC; 1659820
DR   GEO; GSM887564
DR   GEO; GSM888647
DR   GEO; GSM1374868
DR   GEO; GSM1446764
DR   IARC_TP53; 28307
DR   LiGeA; CCLE_845
DR   Lonza; 1318
DR   PharmacoDB; Set2_1364_2019
DR   Progenetix; CVCL_2187
DR   PubChem_Cell_line; CVCL_2187
DR   Wikidata; Q54952857
RX   PubMed=10637490;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31739141;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=10637490); ~60-80 hours (DSMZ=ACC-608).
CC   HLA typing: A*02:01,33:03; B*40:02,44:03; C*03:03,14:03 (PubMed=26589293).
CC   HLA typing: A*02:01:01,33:03:01; B*40:02:01,44:03:01; C*03:03:01,14:03; DPA1*02:01:01,02:02:02; DPB1*09:01:01,05:01:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,06:09:01; DRA*01:01:01,01:02:02; DRB1*04:06:01,13:02:01 (DSMZCellDive=ACC-608).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882His (c.2645G>A); ClinVar=VCV000375881; Zygosity=Heterozygous (PubMed=31739141; DepMap=ACH-000195).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=16408098; Cosmic-CLP=1659820).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+2T>A; ClinVar=VCV000635391; Zygosity=Heterozygous; Note=Splice donor mutation (Cosmic-CLP=1659820; DepMap=ACH-000195).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (Cosmic-CLP=1659820; DepMap=ACH-000195).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=7.24%; Native American=0%; East Asian, North=78.39%; East Asian, South=9.7%; South Asian=0%; European, North=0%; European, South=4.67% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-608; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 18,23
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 10,11 (DSMZ=ACC-608)
ST   Penta D: 11 (PubMed=25877200)
ST   Penta E: 16,20
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SETDB-1(Z4601)
AC   CVCL_C5Z3
SY   Z4601
DR   RCB; RCB4392
DR   Wikidata; Q116050487
RX   PubMed=26296461;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15047; Human SETDB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SETDB-1(Z4606)
AC   CVCL_C5Z4
SY   Z4606
DR   RCB; RCB4393
DR   Wikidata; Q116050488
RX   PubMed=26296461;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15047; Human SETDB1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SETX-1RM
AC   CVCL_ZT66
DR   Wikidata; Q98132447
RX   PubMed=17562789;
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Unexplicit; Ex14-21del; Zygosity=Homozygous (PubMed=17562789).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   SETX-2RM
AC   CVCL_ZT67
DR   Wikidata; Q98132448
RX   PubMed=17347666;
RX   PubMed=17562789;
CC   Sequence variation: Mutation; HGNC; HGNC:445; SETX; Simple; c.7287+5G>A (IVS23+5G>A); Zygosity=Homozygous (PubMed=17562789).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165500; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2
DI   ORDO; Orphanet_64753; Spinocerebellar ataxia with axonal neuropathy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   SEWA
AC   CVCL_2188
DR   DSMZ; ACC-523
DR   DSMZCellDive; ACC-523
DR   Wikidata; Q54952859
RX   CelloPub=CLPUB00702;
RX   PubMed=77207;
RX   PubMed=39662063;
CC   Doubling time: ~28 hours (DSMZ=ACC-523).
CC   Karyotypic information: Near diploid karyotype. Has lost chromosome Y (PubMed=39662063).
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   SEWA-CL-3
AC   CVCL_1N79
SY   SEWA 1Rclone3:4R; SEWA1Rclone3:4R; Clone 3:4
DR   Wikidata; Q54952860
RX   PubMed=7129936;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JX62 ! SEWA1R
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   SEWA/Rec4
AC   CVCL_4Y75
SY   SEWA1Rrec4; SEWA1Rrec4R; Rec4; Rec 4
DR   Wikidata; Q54952861
RX   PubMed=7129936;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JX62 ! SEWA1R
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   SEWA/Rec4TC1
AC   CVCL_6C61
SY   Rec4TC1
DR   Wikidata; Q54952863
RX   PubMed=3078951;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4Y75 ! SEWA/Rec4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   SEWA/TC13
AC   CVCL_4Y76
SY   SEWA1RTC13R; TC13
DR   Wikidata; Q54952864
RX   PubMed=7129936;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JX62 ! SEWA1R
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   SEWA/TC13MTXr10
AC   CVCL_4Y77
SY   TC13MTXr10
DR   Wikidata; Q54952865
RX   PubMed=6668215;
RX   PubMed=7129936;
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4Y76 ! SEWA/TC13
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   SEWA1R
AC   CVCL_JX62
DR   Wikidata; Q54952866
RX   PubMed=77207;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Isolate 1956-11C).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: A.SW.
DI   NCIt; C24021; Mouse osteosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2188 ! SEWA
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   Sez-4
AC   CVCL_8330
SY   Sez 4; SeZ4; SZ-4
DR   Cell_Model_Passport; SIDM01389
DR   Wikidata; Q54952869
RX   PubMed=1987293;
RX   PubMed=11021758;
RX   PubMed=11737246;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3366; Sezary syndrome
DI   ORDO; Orphanet_3162; Sezary syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Sez507
AC   CVCL_A6TM
SY   Sez507(+)
DR   Wikidata; Q107116912
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   Sez627
AC   CVCL_5364
SY   Sez 627; SEZ 627; SEZ627; Sez627(+); Sez.627
DR   RCB; RCB3547
DR   Wikidata; Q54952868
RX   PubMed=3023492;
RX   PubMed=3263317;
RX   PubMed=16242045;
RX   PubMed=32210945;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Sez627
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Sez627(-)
AC   CVCL_A6TG
SY   Sez627C(-)
DR   RCB; RCB3548
DR   Wikidata; Q107116913
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5364 ! Sez627
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   SezM
AC   CVCL_A6TJ
DR   Wikidata; Q107116914
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TK ! SezM3
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SezM3
AC   CVCL_A6TK
SY   SezM3(+)
DR   RCB; RCB3543
DR   Wikidata; Q107116915
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TJ ! SezM
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SezM3(-)
AC   CVCL_A6TL
DR   RCB; RCB3544
DR   Wikidata; Q107116916
RX   PubMed=32210945;
CC   Population: Japanese.
CC   Characteristics: Lost its original IL2 dependency.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6TK ! SezM3
SX   Female
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SF [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC28
DR   Wikidata; Q98132449
RX   PubMed=20889926;
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   SF [Human fibroblast]
AC   CVCL_4790
DR   Wikidata; Q54952870
CC   Miscellaneous: Cell line no longer available; was distributed by Viromed.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   SF [Lates]
AC   CVCL_S008
SY   Seabass Fry
DR   Wikidata; Q54952871
RX   DOI=10.1016/S0044-8486(00)00465-8;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   Sf 1 Ep
AC   CVCL_3795
SY   Sf1Ep; sf1Ep; Sf 1Ep; Sf 1 Ep (NBL-11); NBL-11; CTEp
DR   CLO; CLO_0008983
DR   CLO; CLO_0008986
DR   CLDB; cl4275
DR   CLDB; cl4276
DR   ATCC; CCL-68
DR   ATCC; CRL-6502
DR   ECACC; 90092702
DR   IZSLER; BS CL 78
DR   Wikidata; Q54952873
RX   DOI=10.1007/BF02618370;
RX   PubMed=7989438;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9988; ! Sylvilagus floridanus (Cottontail rabbit)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SF 181
AC   CVCL_D682
DR   BCRJ; 0220
DR   Wikidata; Q54952874
ST   Source(s): BCRJ=0220
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C67383; Epidermolysis bullosa
DI   ORDO; Orphanet_79361; Inherited epidermolysis bullosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 7
//
ID   SF-003
AC   CVCL_A4MT
DR   Wikidata; Q105511026
RX   PubMed=27879207;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Tyr1124Thrfs*4 (c.3369delA); ClinVar=VCV000141444; Zygosity=Heterozygous (PubMed=27879207).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Tyr1252Glnfs*4 (c.3754_3756delTATinsCA); ClinVar=VCV000185042; Zygosity=Heterozygous (PubMed=27879207).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   Sf-21-CB
AC   CVCL_A7NB
SY   SF-21 CB; Sf21-CB
DR   Wikidata; Q107116917
RX   PubMed=22265860;
WW   Info; EMA; -; https://www.ema.europa.eu/en/documents/assessment-report/porcilis-pcv-id-epar-public-assessment-report_en.pdf
WW   Info; EMA; -; https://www.ema.europa.eu/en/documents/scientific-discussion/porcilis-pesti-epar-scientific-discussion_en.pdf
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Group: Vaccine production cell line.
CC   Biotechnology: Used for the production of the MSD Animal Health porcine circovirus type 2 (PCV2) vaccine Porcilis PCV. Used to produce the PCV2 ORF2 capsid protein.
CC   Biotechnology: Used for the production of the MSD Animal Health classical swine fever virus (CSFV) vaccine Porcilis Pesti. Used to produce the CSFV envelope glycoprotein E2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   Sf-9ET
AC   CVCL_1D71
SY   SF-9ET; Sf-9 Easy Titer; Sf-9 ET; Sf9-ET; Sf9-Easy Titer; Sf9 Easy Titer
DR   ATCC; CRL-3357
DR   Kerafast; ENH022-FP
DR   Wikidata; Q54952876
RX   PubMed=19852765;
WW   Provider; NCI TTC; TAB-4244/E-009-2008-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-4244
WW   Provider; NIH OTT; E-009-2008/0-55; https://web.archive.org/web/20150922071005/http://www.ott.nih.gov/erma/development-sf-9et-easy-titer-inset-determining-baculovirus-titers
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: The expression of the eGFP gene is under the control of the baculovirus polyhedrin promoter.
CC   Doubling time: 28-32 hours (ATCC=CRL-3357).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   SF-CMTI-2
AC   CVCL_HE69
DR   Millipore; SF-CMTI-2
DR   Wikidata; Q54952877
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Pre-adapted to serum-free and feeder-free cell culture conditions and is intended for use with the ESGRO cell culture system.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.Cg-Thy1<a>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K037 ! Bruce-4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   Sf-RVN
AC   CVCL_JF76
SY   Spodoptera frugiperda-RhabdoVirus Negative
DR   Sigma-Aldrich; SFRVN
DR   Wikidata; Q54952878
RX   Patent=US11473055;
RX   PubMed=26923062;
RX   PubMed=29133148;
RX   PubMed=34838817;
WW   Provider; GlycoBac; -; https://www.glycobac.com/sf-rvn-cells
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Virology: Devoid of SfRV rhabdovirus.
CC   Doubling time: ~20 hours (PubMed=26923062).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   Sf-RVNLec1
AC   CVCL_B5EE
SY   SfMgat1t4#
DR   Wikidata; Q110433215
RX   PubMed=34838817;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Produces immature, relatively minimally processed N-glycan precursors that can be removed from the polypeptide backbone using endo-beta-N-acetylglucosaminidase H (PubMed=34838817).
CC   Virology: Devoid of SfRV rhabdovirus (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; H2BEB9; Mgat1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_JF76 ! Sf-RVN
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   SF-TY
AC   CVCL_3163
DR   BioSample; SAMN03471063
DR   JCRB; JCRB0075
DR   JCRB; NIHS0016
DR   Wikidata; Q54952881
RX   PubMed=8320183;
CC   Doubling time: ~40 hours (Note=Lot 102198), ~1.5 days (Note=Lots 07092007 and 08082018), ~42 hours (Note=Lot 07162010), 34-54 hours (Note=Lot 10192015), ~52 hours (Note=Lot 03272017), ~41 hours (Note=Lot 12202021) (JCRB=JCRB0075).
CC   HLA typing: A*02,24; B*05,w22 (JCRB=JCRB0075).
CC   Discontinued: JCRB; NIHS0016; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0075
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   SF-xL
AC   CVCL_D590
SY   SFxl
DR   BTO; BTO_0005311
DR   cancercelllines; CVCL_D590
DR   Wikidata; Q54952882
RX   PubMed=19033189;
RX   PubMed=21555572;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:992; BCL2L1 (Note=Isoform Bcl-xL).
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6948 ! SF188
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SF1-1
AC   CVCL_Y495
SY   ESHyb
DR   EFO; EFO_0003972
DR   Wikidata; Q54952883
RX   PubMed=9584126;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA/Ca.
OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus (Hybrid mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   SF1-1.1.10
AC   CVCL_G147
DR   CLO; CLO_0008984
DR   ATCC; HB-159
DR   Wikidata; Q54952886
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   SF1-3
AC   CVCL_Y496
DR   Wikidata; Q54952887
RX   PubMed=9584126;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA/Ca.
OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus (Hybrid mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   SF1-8
AC   CVCL_Y497
DR   Wikidata; Q54952888
RX   PubMed=9584126;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA/Ca.
OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus (Hybrid mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   SF1-G
AC   CVCL_Y498
DR   Wikidata; Q54952889
RX   PubMed=9584126;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA/Ca.
OX   NCBI_TaxID=186842; ! Mus musculus x Mus spretus (Hybrid mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   SF126
AC   CVCL_1688
SY   SF-126; SF 126
DR   CLO; CLO_0009901
DR   EFO; EFO_0005450
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1009
DR   BioSample; SAMN03472774
DR   BioSample; SAMN10987624
DR   cancercelllines; CVCL_1688
DR   CCRID; 1101HUM-PUMC000049
DR   Cell_Model_Passport; SIDM00382
DR   CGH-DB; 153-1
DR   ChEMBL-Cells; CHEMBL3307444
DR   ChEMBL-Targets; CHEMBL614905
DR   CLS; 300608
DR   Cosmic; 909712
DR   Cosmic; 1175814
DR   Cosmic; 1217678
DR   Cosmic; 2367543
DR   Cosmic; 2516033
DR   Cosmic-CLP; 909712
DR   DepMap; ACH-000609
DR   EGA; EGAS00001000978
DR   GDSC; 909712
DR   GEO; GSM887565
DR   GEO; GSM888648
DR   GEO; GSM1670416
DR   IARC_TP53; 27572
DR   JCRB; IFO50286
DR   KCB; KCB 200818YJ
DR   LiGeA; CCLE_368
DR   LINCS_LDP; LCL-1388
DR   Millipore; SCC283
DR   PharmacoDB; SF126_1366_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1688
DR   PubChem_Cell_line; CVCL_1688
DR   Wikidata; Q54952891
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2829496;
RX   PubMed=3335022;
RX   PubMed=3708752;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=62
WW   Provider; UCSF; -; https://web.archive.org/web/20150905213317/btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 35 hours (PubMed=25984343); ~28 hours (Note=Lot 06202011) (JCRB=IFO50286).
CC   HLA typing: A*02:01,24:02; B*35:01,40:01; C*03:04,04:01; DRB1*11:09 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Arg1653Ter (c.4957C>T); ClinVar=VCV000224559; Zygosity=Heterozygous (Cosmic-CLP=909712; DepMap=ACH-000609).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Arg (c.385G>A); ClinVar=VCV000189484; Zygosity=Homozygous (Cosmic-CLP=909712; DepMap=ACH-000609).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro75Hisfs*13 (c.224_750del); Zygosity=Heterozygous (Cosmic-CLP=909712).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=1.63%; East Asian, South=0%; South Asian=2.77%; European, North=51.32%; European, South=44.04% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): CCRID=1101HUM-PUMC000049; Cosmic-CLP=909712; JCRB=IFO50286; Millipore=SCC283
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,19
ST   D19S433: 13,14
ST   D21S11: 27,32.2
ST   D2S1338: 16,17
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 21,24
ST   Penta D: 10,14
ST   Penta E: 12,13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   Sf158
AC   CVCL_2074
SY   SF158; Sf-158; SF-158; SF 158; Sf 158
DR   CLO; CLO_0008985
DR   DSMZ; ACC-292
DR   DSMZCellDive; ACC-292
DR   ICLDB; sf158
DR   Wikidata; Q54952892
RX   PubMed=2159542;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: ~70 hours (DSMZ=ACC-292).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   SF17
AC   CVCL_6947
DR   CCRID; 1101HUM-PUMC000084
DR   Wikidata; Q54952893
ST   Source(s): CCRID=1101HUM-PUMC000084
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 12,14
ST   D19S433: 13
ST   D21S11: 27,29
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 15,19
DI   NCIt; C2907; Brain neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 9
//
ID   SF172
AC   CVCL_V613
SY   SF-172
DR   BioSample; SAMN10988399
DR   cancercelllines; CVCL_V613
DR   Cell_Model_Passport; SIDM01351
DR   Cosmic; 2516034
DR   DepMap; ACH-000887
DR   PharmacoDB; SF172_1365_2019
DR   Progenetix; CVCL_V613
DR   Wikidata; Q54952895
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Probably misidentified/contaminated. Except of a loss of an allele of TH01 the STR profile of SF172 is identical to that of SF763. Furthermore we could not find in the literature any trace of the exact origin of SF172. According to the UCSF Biorepository, there is no record of SF172 in their system while SF763 is registered there (personal communication of Shai, Anny). The TP53 mutation recorded for SF763 is also identical to the one in SF172.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 24 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Homozygous (DepMap=ACH-000887).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=75.55%; Native American=0.48%; East Asian, North=4.1%; East Asian, South=0%; South Asian=0%; European, North=7%; European, South=12.87% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): DepMap=ACH-000887
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 10,12
ST   D16S539: 10
ST   D18S51: 16
ST   D21S11: 27,30
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 5,13
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6949 ! SF763
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 20
//
ID   SF180
AC   CVCL_A8X6
DR   GEO; GSM2392417
DR   Wikidata; Q102114904
RX   PubMed=28827786;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   SF188
AC   CVCL_6948
SY   SF-188; SF 188
DR   BTO; BTO_0002824
DR   EFO; EFO_0022665
DR   cancercelllines; CVCL_6948
DR   ChEMBL-Cells; CHEMBL3307445
DR   ChEMBL-Targets; CHEMBL614906
DR   Cosmic; 849884
DR   Cosmic; 1875113
DR   GEO; GSM2197886
DR   GEO; GSM2197887
DR   GEO; GSM2197888
DR   GEO; GSM2197889
DR   GEO; GSM2197890
DR   GEO; GSM2197891
DR   IARC_TP53; 5708
DR   Millipore; SCC282
DR   Progenetix; CVCL_6948
DR   PubChem_Cell_line; CVCL_6948
DR   Wikidata; Q54952896
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2829496;
RX   PubMed=3708752;
RX   PubMed=9614553;
RX   PubMed=10416987;
RX   PubMed=19033189;
RX   PubMed=19365568;
RX   PubMed=20215515;
RX   PubMed=22570425;
RX   PubMed=25628092;
RX   PubMed=29760046;
WW   Provider; UCSF; -; https://web.archive.org/web/20150905213317/btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC   Doubling time: 26 hours (PubMed=19365568).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Homozygous (PubMed=9614553; PubMed=10416987).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain, right frontal lobe; UBERON=UBERON_0002810.
ST   Source(s): Millipore=SCC282; PubMed=22570425; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 19
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 13,14
ST   D1S1656: 15,16
ST   D21S11: 31
ST   D22S1045: 11,17
ST   D2S1338: 17,22
ST   D2S441: 11
ST   D3S1358: 15,18
ST   D5S818: 11,14
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   DYS391: 11
ST   FGA: 22,22.2
ST   Penta D: 14
ST   Penta E: 10,13
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Sf21
AC   CVCL_0518
SY   SF21; Sf-21; SF-21; IPLB-SF-21-AE; IPLB-Sf21-AE; IPLB-SF21-AE; IPLB-SF 21AE; IPLB-Sf21AE; IPLB-SF21AE; IPLB-SF-21; IPLB-Sf-21; IPLB-SF 21; IPLB-Sf21; IPLB-SF21
DR   BTO; BTO_0001196
DR   CLO; CLO_0008987
DR   EFO; EFO_0022744
DR   MCCL; MCC:0000416
DR   CLDB; cl2906
DR   CCRID; 4201INS-CCTCC00020
DR   CCTCC; GDC0020
DR   ChEMBL-Cells; CHEMBL4106362
DR   DSMZ; ACC-119
DR   DSMZCellDive; ACC-119
DR   ECACC; 05022801
DR   ICLDB; iplb-sf21
DR   KCB; KCB 2010008YJ
DR   Lonza; 1183
DR   NCBI_Iran; C503
DR   PubChem_Cell_line; CVCL_0518
DR   Wikidata; Q2276068
RX   CelloPub=CLPUB00492;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   DOI=10.19603/j.cnki.1000-1190.1995.04.025;
RX   PubMed=68913;
RX   PubMed=1367489;
RX   PubMed=1369220;
RX   PubMed=8314732;
RX   PubMed=8799737;
RX   PubMed=10475266;
RX   PubMed=10585188;
RX   PubMed=10777062;
RX   PubMed=10852353;
RX   PubMed=12623313;
RX   PubMed=15038778;
RX   PubMed=15926859;
RX   PubMed=16346059;
RX   PubMed=16409117;
RX   PubMed=22797937;
RX   PubMed=24672045;
RX   PubMed=29133148;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-382.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-385.html
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/sp2userfiles/person/3489/sf21.pdf
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Sf21
WW   Provider; OET; -; https://oetltd.com/product/sf21-cells/
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 26-30 hours (PubMed=68913); 33 +- 1 hours (Note=In static culture), 26 +- 1 hours (Note=In suspension culture) (PubMed=10585188); ~3 days (DSMZ=ACC-119); 24 hours (ECACC=05022801).
CC   Misspelling: IPBL-SF-21AE; Note=Occasionally.
CC   Misspelling: IPBL-SF-21; Note=Occasionally.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   Sf21 TiterHigh AC free
AC   CVCL_JX37
DR   ECACC; 05030202
DR   Wikidata; Q54952913
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   Sf21-HT
AC   CVCL_A2IN
SY   Sf21-High Temperature
DR   Wikidata; Q105511032
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Able to grow at 37 Celsius.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SF210
AC   CVCL_M425
SY   SF-210; SF 210
DR   Wikidata; Q54952914
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2829496;
WW   Provider; UCSF; -; https://web.archive.org/web/20150905213317/btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC   Derived from site: In situ; Brain, left parietal lobe; UBERON=UBERON_0002802.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   SF268
AC   CVCL_1689
SY   SF-268; SF_268; SF.268; SF 268
DR   BTO; BTO_0003772
DR   CLO; CLO_0009902
DR   EFO; EFO_0005451
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471159
DR   BioSample; SAMN10989591
DR   cancercelllines; CVCL_1689
DR   Cell_Model_Passport; SIDM00085
DR   ChEMBL-Cells; CHEMBL3307499
DR   ChEMBL-Targets; CHEMBL613977
DR   Cosmic; 687581
DR   Cosmic; 905986
DR   Cosmic; 974239
DR   Cosmic; 1092629
DR   Cosmic; 1175815
DR   Cosmic; 1305358
DR   Cosmic; 1436039
DR   Cosmic; 1998472
DR   Cosmic; 2367544
DR   Cosmic; 2550357
DR   Cosmic-CLP; 905986
DR   DepMap; ACH-000655
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905986
DR   GEO; GSM2108
DR   GEO; GSM50175
DR   GEO; GSM50239
DR   GEO; GSM743435
DR   GEO; GSM750787
DR   GEO; GSM750790
DR   GEO; GSM799323
DR   GEO; GSM799386
DR   GEO; GSM844680
DR   GEO; GSM844681
DR   GEO; GSM847112
DR   GEO; GSM1153392
DR   GEO; GSM1178595
DR   GEO; GSM1178596
DR   GEO; GSM1181244
DR   GEO; GSM1181320
DR   GEO; GSM1670417
DR   GEO; GSM2124648
DR   IARC_TP53; 5710
DR   LiGeA; CCLE_636
DR   LINCS_LDP; LCL-1389
DR   NCI-DTP; SF-268
DR   PharmacoDB; SF268_1367_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1689
DR   PubChem_Cell_line; CVCL_1689
DR   SKY/M-FISH/CGH; 2819
DR   Wikidata; Q54952917
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2041050;
RX   PubMed=2829496;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19365568;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=59
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/sf-268-xenograft-model/
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 33.1 hours (NCI-DTP=SF-268).
CC   HLA typing: A*01:01:01,32:01; B*08:01,40:02; C*02:02:02,07; DPB1*04:01,06:01; DQB1*02:01,03:02; DRB1*03,04 (PubMed=15748285).
CC   HLA typing: A*01:01,32:01; B*08:01,40:02; C*02:02,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=9331090; PubMed=15900046; PubMed=17088437; PubMed=18277095).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=0.34%; East Asian, North=0.35%; East Asian, South=0%; South Asian=1.04%; European, North=65.25%; European, South=32.77% (PubMed=30894373).
CC   Misspelling: SP-268; Note=Occasionally.
CC   Derived from site: In situ; Brain, right parietal lobe; UBERON=UBERON_0002803.
ST   Source(s): Cosmic-CLP=905986; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 16
ST   D19S433: 13,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 19,24
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 12,14
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   SF295
AC   CVCL_1690
SY   SF-295; SF_295; SF.295; SF 295
DR   BTO; BTO_0004213
DR   EFO; EFO_0005452
DR   AddexBio; C0005005/415
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 380
DR   BioSample; SAMN10987772
DR   cancercelllines; CVCL_1690
DR   Cell_Model_Passport; SIDM00084
DR   ChEMBL-Cells; CHEMBL3307738
DR   ChEMBL-Targets; CHEMBL614908
DR   ChEMBL-Targets; CHEMBL614937
DR   Cosmic; 875897
DR   Cosmic; 897438
DR   Cosmic; 905985
DR   Cosmic; 974240
DR   Cosmic; 1044248
DR   Cosmic; 1092630
DR   Cosmic; 1175816
DR   Cosmic; 1305359
DR   Cosmic; 1436040
DR   Cosmic; 1998473
DR   Cosmic; 2367545
DR   Cosmic; 2516035
DR   Cosmic; 2550358
DR   Cosmic-CLP; 905985
DR   DepMap; ACH-000376
DR   EGA; EGAS00001000978
DR   GDSC; 905985
DR   GEO; GSM2138
DR   GEO; GSM50176
DR   GEO; GSM50240
DR   GEO; GSM743436
DR   GEO; GSM750783
DR   GEO; GSM799324
DR   GEO; GSM799387
DR   GEO; GSM844682
DR   GEO; GSM847113
DR   GEO; GSM887566
DR   GEO; GSM888649
DR   GEO; GSM1153393
DR   GEO; GSM1153394
DR   GEO; GSM1181245
DR   GEO; GSM1181260
DR   GEO; GSM1670418
DR   GEO; GSM2124649
DR   IARC_TP53; 18082
DR   LiGeA; CCLE_523
DR   Millipore; SCC289
DR   PharmacoDB; SF295_1368_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1690
DR   PubChem_Cell_line; CVCL_1690
DR   SKY/M-FISH/CGH; 2746
DR   Wikidata; Q54952919
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2041050;
RX   PubMed=2829496;
RX   PubMed=3335022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=17984197;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25984343;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=60
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/sf-295-xenograft-model/
WW   Provider; UCSF; -; https://web.archive.org/web/20150905213317/btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=25984343); 27.9 hours (PubMed=22628656); 31.5 hours (PubMed=17984197); 29.5 hours (NCI-DTP).
CC   HLA typing: A*01:01:01,26:01; B*07:02:01,55:01; C*03,07; DPB1*04:01; DQB1*05:03:01,06:02; DRB1*14,15 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=9331090; PubMed=15900046; PubMed=17088437; PubMed=18277095).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.31%; East Asian, South=0%; South Asian=0%; European, North=72.83%; European, South=25.86% (PubMed=30894373).
CC   Misspelling: SP-295; ChEMBL-Targets=CHEMBL614937.
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
ST   Source(s): AddexBio=C0005005/415; Cosmic-CLP=905985; Millipore=SCC289; PubMed=19372543; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D10S1248: 14
ST   D12S391: 21
ST   D13S317: 10
ST   D16S539: 12,13
ST   D18S51: 15,18
ST   D19S433: 12,15
ST   D1S1656: 12,14
ST   D21S11: 28,30
ST   D22S1045: 13,15
ST   D2S1338: 15,20
ST   D2S441: 11
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,13
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 13,14.4
ST   Penta E: 5,7
ST   TH01: 9.3 (Cosmic-CLP=905985)
ST   TH01: 9.3,10 (AddexBio=C0005005/415; Millipore=SCC289; PubMed=19372543; Technion Genomics Center)
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   SF295 MX10
AC   CVCL_LB68
DR   ABM; T8036
DR   cancercelllines; CVCL_LB68
DR   Wikidata; Q54952920
RX   PubMed=11406094;
RX   PubMed=11559526;
RX   PubMed=12642696;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 10 nM of mitoxantrone (PubMed=11559526).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 14
//
ID   SF295 MX100
AC   CVCL_E5T4
DR   ABM; T8039
RX   PubMed=15993268;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 100 nM of mitoxantrone (PubMed=15993268).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295 MX1000
AC   CVCL_E5T5
DR   ABM; T8042
CC   Population: Caucasian.
CC   Characteristics: Resistant to 1000 nM of mitoxantrone (ABM=T8042).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295 MX1500
AC   CVCL_E5T6
DR   ABM; T8043
CC   Population: Caucasian.
CC   Characteristics: Resistant to 1500 nM of mitoxantrone (ABM=T8043).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295 MX20
AC   CVCL_E5T7
DR   ABM; T8037
RX   PubMed=15993268;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295 MX250
AC   CVCL_E5T8
DR   ABM; T8040
RX   PubMed=15993268;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 250 nM of mitoxantrone (PubMed=15993268).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295 MX50
AC   CVCL_E5T9
DR   ABM; T8038
RX   PubMed=12642696;
RX   PubMed=15993268;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 50 nM of mitoxantrone (PubMed=15993268).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295 MX500
AC   CVCL_E5TA
DR   ABM; T8041
RX   PubMed=15993268;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 500 nM of mitoxantrone (PubMed=15993268).
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF295/BN50
AC   CVCL_WV57
DR   cancercelllines; CVCL_WV57
DR   Wikidata; Q98132450
RX   PubMed=17984197;
CC   Population: Caucasian.
CC   Doubling time: 99 hours (PubMed=17984197).
CC   Selected for resistance to: ChEBI; CHEBI_144046; Diflomotecan (BN80915).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   SF295/hCPT50
AC   CVCL_WV58
DR   cancercelllines; CVCL_WV58
DR   Wikidata; Q98132451
RX   PubMed=17984197;
CC   Population: Caucasian.
CC   Doubling time: 69 hours (PubMed=17984197).
CC   Selected for resistance to: ChEBI; CHEBI_144047; Homocamptothecin.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, left temporal lobe; UBERON=UBERON_0002808.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1690 ! SF295
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   SF3061
AC   CVCL_5892
SY   SF-3061; SF3061-Parental
DR   BTO; BTO_0004515
DR   Wikidata; Q54952921
RX   PubMed=16554968;
CC   Senescence: Has a finite life span like most meningioma-derived cell lines.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SF3061-hTERT
AC   CVCL_M426
DR   Wikidata; Q54952923
RX   PubMed=16554968;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5892 ! SF3061
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   SF4068
AC   CVCL_5893
SY   SF-4068; SF4068-Parental
DR   BTO; BTO_0004516
DR   Wikidata; Q54952925
RX   PubMed=16554968;
CC   Senescence: Has a finite life span like most meningioma-derived cell lines.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   SF4068-E6/E7-hTERT
AC   CVCL_M427
DR   Wikidata; Q54952926
RX   PubMed=16554968;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5893 ! SF4068
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   SF4433
AC   CVCL_5894
SY   SF-4433; SF4433-Parental
DR   BTO; BTO_0004517
DR   Wikidata; Q54952927
RX   PubMed=16554968;
CC   Senescence: Has a finite life span like most meningioma-derived cell lines.
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   SF4433-E6/E7-hTERT
AC   CVCL_M428
DR   Wikidata; Q54952928
RX   PubMed=16554968;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Brain, meninges; UBERON=UBERON_0010743.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5894 ! SF4433
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 17
//
ID   SF539
AC   CVCL_1691
AS   CVCL_F230
SY   SF-539; SF-539 BT; SF_539; SF.539; SF 539
DR   BTO; BTO_0004214
DR   CLO; CLO_0009903
DR   EFO; EFO_0005453
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1010
DR   BioSample; SAMN03471111
DR   BioSample; SAMN10989592
DR   cancercelllines; CVCL_1691
DR   Cell_Model_Passport; SIDM00083
DR   ChEMBL-Cells; CHEMBL3307721
DR   ChEMBL-Cells; CHEMBL3307833
DR   ChEMBL-Targets; CHEMBL613986
DR   ChEMBL-Targets; CHEMBL614860
DR   Cosmic; 687582
DR   Cosmic; 875893
DR   Cosmic; 905984
DR   Cosmic; 974238
DR   Cosmic; 1092631
DR   Cosmic; 1175817
DR   Cosmic; 1305360
DR   Cosmic; 1312342
DR   Cosmic; 1436041
DR   Cosmic; 1998474
DR   Cosmic; 2367546
DR   Cosmic; 2550359
DR   Cosmic-CLP; 905984
DR   DepMap; ACH-000273
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905984
DR   GEO; GSM2133
DR   GEO; GSM50177
DR   GEO; GSM50241
DR   GEO; GSM743437
DR   GEO; GSM750784
DR   GEO; GSM799325
DR   GEO; GSM799388
DR   GEO; GSM844683
DR   GEO; GSM844684
DR   GEO; GSM847114
DR   GEO; GSM1153395
DR   GEO; GSM1178602
DR   GEO; GSM1178603
DR   GEO; GSM1181246
DR   GEO; GSM1181261
DR   GEO; GSM1670419
DR   GEO; GSM2124682
DR   IARC_TP53; 21089
DR   LiGeA; CCLE_033
DR   LINCS_LDP; LCL-1390
DR   NCI-DTP; SF-539
DR   PharmacoDB; SF539_1369_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1691
DR   PubChem_Cell_line; CVCL_1691
DR   SKY/M-FISH/CGH; 2744
DR   Wikidata; Q54952931
RX   PubMed=2041050;
RX   PubMed=3019542;
RX   PubMed=3335022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=61
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/sf-539-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (Note=At 5th passage) (PubMed=3019542); 35.4 hours (NCI-DTP=SF-539).
CC   HLA typing: A*02:01:01; B*08,35; C*04,07; DPB1*01:01:01,04:01; DQB1*02:01,03:01:01; DRB1*03:01:01,12 (PubMed=15748285).
CC   HLA typing: A*02:01,02:01; B*08:01,35:03; C*04:01,07:01; DRB1*11:07,11:07 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Thr116Leufs*8 (c.346_349delACTT); Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905984; DepMap=ACH-000273).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Glufs*3 (c.1024delC); ClinVar=VCV000428885; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905984; DepMap=ACH-000273).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.47%; Native American=1.68%; East Asian, North=1.5%; East Asian, South=2.04%; South Asian=6.93%; European, North=25.95%; European, South=60.44% (PubMed=30894373).
CC   Misspelling: ISF-539; ChEMBL-Targets=CHEMBL613986; ChEMBL-Cells=CHEMBL3307833.
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
ST   Source(s): Cosmic-CLP=905984; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11,13 (Cosmic-CLP=905984)
ST   CSF1PO: 11,13 (PubMed=19372543; PubMed=25877200)
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 20
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 14
ST   D7S820: 11
ST   D8S1179: 15,17
ST   FGA: 20,21
ST   Penta D: 10
ST   Penta E: 12,15
ST   TH01: 7,8 (PubMed=19372543; PubMed=25877200)
ST   TH01: 7,8,9 (Cosmic-CLP=905984)
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 48
//
ID   SF65
AC   CVCL_C2T3
DR   ICLDB; sf65
DR   Wikidata; Q114312987
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   SF763
AC   CVCL_6949
SY   SF-763; SF 763
DR   BTO; BTO_0004215
DR   cancercelllines; CVCL_6949
DR   CCRID; 1101HUM-PUMC000050
DR   Cosmic; 849885
DR   Cosmic; 1175818
DR   Cosmic; 1217677
DR   Cosmic; 2367500
DR   Wikidata; Q54952932
RX   PubMed=10416987;
RX   PubMed=22570425;
WW   Provider; UCSF; -; https://web.archive.org/web/20150905213317/btrctissuecore.ucsf.edu/tbank/Cell_Line%20Notice.html
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Unspecified (PubMed=10416987).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CCRID=1101HUM-PUMC000050; PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 9 (PubMed=22570425)
ST   CSF1PO: 9,10 (CCRID=1101HUM-PUMC000050)
ST   D13S317: 10,12
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 27,30
ST   D2S1338: 19
ST   D3S1358: 15 (PubMed=22570425)
ST   D3S1358: 15,20 (CCRID=1101HUM-PUMC000050)
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 11,12
ST   Penta E: 5,13
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SF767
AC   CVCL_6950
SY   SF-767; SF 767
DR   BTO; BTO_0001557
DR   BioGRID_ORCS_Cell_line; 306
DR   BioSample; SAMN03151844
DR   BioSample; SAMN10988409
DR   cancercelllines; CVCL_6950
DR   Cell_Model_Passport; SIDM00626
DR   Cosmic; 849886
DR   Cosmic; 2036688
DR   Cosmic; 2367501
DR   Cosmic; 2516036
DR   DepMap; ACH-000490
DR   IARC_TP53; 26925
DR   PharmacoDB; SF767_1370_2019
DR   Wikidata; Q54952933
RX   PubMed=10416987;
RX   PubMed=20593219;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a ME-180 derivative (PubMed=22570425).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00452.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (DepMap=ACH-000490).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=1.45%; Native American=0.35%; East Asian, North=2.49%; East Asian, South=0%; South Asian=0%; European, North=61.71%; European, South=33.99% (PubMed=30894373).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000051). It was one of the sources for the STR profile of this entry.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): CCRID; PubMed=22570425
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D21S11: 30,31
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9,14
ST   Penta E: 12,14
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SF7761
AC   CVCL_IT45
DR   Cosmic; 1925952
DR   GEO; GSM1508943
DR   GEO; GSM1508944
DR   GEO; GSM1508945
DR   GEO; GSM1508946
DR   GEO; GSM1508947
DR   GEO; GSM1508948
DR   GEO; GSM1508951
DR   GEO; GSM4969604
DR   GEO; GSM4969605
DR   GEO; GSM4969606
DR   GEO; GSM4969607
DR   GEO; GSM4969620
DR   GEO; GSM4969649
DR   GEO; GSM4969650
DR   GEO; GSM4969651
DR   GEO; GSM5356023
DR   GEO; GSM5434618
DR   GEO; GSM5434619
DR   GEO; GSM5434620
DR   GEO; GSM5434621
DR   GEO; GSM5434622
DR   GEO; GSM5434623
DR   GEO; GSM5434624
DR   GEO; GSM5434625
DR   GEO; GSM5434626
DR   GEO; GSM5434627
DR   GEO; GSM5434628
DR   GEO; GSM5434629
DR   Millipore; SCC126
DR   Wikidata; Q54952936
RX   PubMed=22983601;
RX   PubMed=23603901;
RX   PubMed=25401693;
RX   PubMed=25939062;
RX   PubMed=26115193;
RX   PubMed=32229503;
RX   PubMed=34078608;
RX   PubMed=34732238;
CC   Doubling time: 48 hours (PubMed=22983601).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=23603901; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Glu540Ter (c.1618G>T); Zygosity=Unspecified (PubMed=32229503; PubMed=34732238).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): Millipore=SCC126; PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 12 (PubMed=34732238)
ST   CSF1PO: 13 (Millipore=SCC126)
ST   D13S317: 8,9
ST   D16S539: 11
ST   D18S51: 19,22
ST   D21S11: 28,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 20
ST   Penta D: 13
ST   Penta E: 14,17
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   SF7761-luc
AC   CVCL_E3G3
RX   PubMed=22983601;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Glu540Ter (c.1618G>T); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IT45 ! SF7761
SX   Female
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   SF828
AC   CVCL_A8X7
DR   GEO; GSM2392413
DR   Wikidata; Q102114905
RX   PubMed=28827786;
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   SF829
AC   CVCL_A8X8
DR   GEO; GSM2392414
DR   Wikidata; Q102114906
RX   PubMed=28827786;
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   SF830
AC   CVCL_A8X9
DR   GEO; GSM2392415
DR   Wikidata; Q102114907
RX   PubMed=28827786;
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   SF831
AC   CVCL_A8Y1
DR   GEO; GSM2392416
DR   Wikidata; Q102114908
RX   PubMed=28827786;
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   SF8402
AC   CVCL_K062
DR   CLO; CLO_0050657
DR   BioSample; SAMN03472292
DR   RCB; RCB0580
DR   Wikidata; Q54952937
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 36 PDL (PubMed=17395773).
CC   Donor information: Established from a nonexposed individual with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0580
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K066 ! SF8410
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8403
AC   CVCL_RK68
DR   RCB; RCB0581
DR   Wikidata; Q54952938
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 34 PDL (PubMed=17395773).
CC   Discontinued: RCB; RCB0581; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SF8404
AC   CVCL_K063
SY   SF A-2; SFA2
DR   CLO; CLO_0050658
DR   BioSample; SAMN03472293
DR   RCB; RCB0582
DR   Wikidata; Q54952939
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0582
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8405
AC   CVCL_K064
SY   SF A-3; SFA3
DR   CLO; CLO_0050688
DR   BioSample; SAMN03472294
DR   RCB; RCB0583
DR   Wikidata; Q54952940
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0583
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8406
AC   CVCL_K065
SY   SF A-4; SFA4
DR   CLO; CLO_0050659
DR   BioSample; SAMN03472295
DR   RCB; RCB0584
DR   Wikidata; Q54952942
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=38639832;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0584
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 17
//
ID   SF8410
AC   CVCL_K066
DR   CLO; CLO_0050678
DR   BioSample; SAMN03472261
DR   RCB; RCB0635
DR   Wikidata; Q54952943
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0635
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 7,9,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K062 ! SF8402
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8413
AC   CVCL_K067
SY   SF A-8; SFA8
DR   CLO; CLO_0050677
DR   BioSample; SAMN03472260
DR   RCB; RCB0634
DR   Wikidata; Q54952945
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual with chest cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0634
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 11,13
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8414
AC   CVCL_K068
SY   SF B-12; SFB12
DR   CLO; CLO_0050676
DR   BioSample; SAMN03472259
DR   RCB; RCB0633
DR   Wikidata; Q54952947
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0633
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8416
AC   CVCL_K069
SY   SF D2-12; SFD212
DR   CLO; CLO_0050675
DR   BioSample; SAMN03472257
DR   RCB; RCB0631
DR   Wikidata; Q54952948
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 14 PDL (PubMed=17395773).
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0631
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 10,11,12
ST   D7S820: 8,12
ST   TH01: 7,9,9.3
ST   TPOX: 9
ST   vWA: 14,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8425
AC   CVCL_K070
DR   CLO; CLO_0050674
DR   BioSample; SAMN03472256
DR   RCB; RCB0624
DR   Wikidata; Q54952949
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0624
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 8,10
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K071 ! SF8428
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8428
AC   CVCL_K071
DR   CLO; CLO_0050673
DR   BioSample; SAMN03472255
DR   RCB; RCB0621
DR   Wikidata; Q54952951
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 28 PDL (PubMed=17395773).
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0621
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9,12
ST   D16S539: 8,10
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K070 ! SF8425
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8429
AC   CVCL_K072
SY   SF D2-13; SFD213
DR   CLO; CLO_0050672
DR   BioSample; SAMN03472254
DR   RCB; RCB0620
DR   Wikidata; Q54952952
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 38 PDL (PubMed=17395773).
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0620
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D5S818: 10,12,13
ST   D7S820: 8,13
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8433
AC   CVCL_K073
SY   SF D1-2; SFD12
DR   CLO; CLO_0050671
DR   BioSample; SAMN03472253
DR   RCB; RCB0617
DR   Wikidata; Q54952953
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 36 PDL (PubMed=17395773).
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0617
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   TH01: 7,9,9.3
ST   TPOX: 8,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF848
AC   CVCL_A8Z3
DR   GEO; GSM2644521
DR   Wikidata; Q102114909
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (from child cell line STBCi042-A).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   SF8536
AC   CVCL_K074
SY   SF C2-7; SFC27
DR   CLO; CLO_0050670
DR   BioSample; SAMN03472252
DR   RCB; RCB0614
DR   Wikidata; Q54952955
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 38 PDL (PubMed=17395773).
CC   Donor information: Established from an atomic bomb survivor without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0614
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8538
AC   CVCL_K075
SY   SF B-11; SFB11
DR   CLO; CLO_0050669
DR   BioSample; SAMN03472251
DR   RCB; RCB0613
DR   Wikidata; Q54952956
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 32 PDL (PubMed=17395773).
CC   Donor information: Established from a nonexposed individual with breast cancer.
CC   Discontinued: RCB; RCB0613; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0613
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   TH01: 7,9,9.3
ST   TPOX: 8,11
ST   vWA: 15,16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8541
AC   CVCL_K076
SY   SF A-10; SFA10
DR   CLO; CLO_0050668
DR   BioSample; SAMN03472250
DR   RCB; RCB0610
DR   Wikidata; Q54952958
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 34 PDL (PubMed=17395773).
CC   Donor information: Established from a nonexposed individual with uterus cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0610
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11,12
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8543
AC   CVCL_K077
SY   SF B-14; SFB14
DR   CLO; CLO_0050667
DR   BioSample; SAMN03472249
DR   RCB; RCB0608
DR   Wikidata; Q54952961
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=17395773;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Senescence: Senesces at 44 PDL (PubMed=17395773).
CC   Donor information: Established from a nonexposed individual with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0608
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 10,11,12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8546
AC   CVCL_K078
SY   SF A-11; SFA11
DR   CLO; CLO_0050693
DR   RCB; RCB0605
DR   Wikidata; Q54952962
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   SF856
AC   CVCL_A8Y2
DR   GEO; GSM2392427
DR   Wikidata; Q102114910
RX   PubMed=28827786;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   SF8628
AC   CVCL_IT46
SY   SF-8628
DR   cancercelllines; CVCL_IT46
DR   Cosmic; 1925953
DR   GEO; GSE59366
DR   GEO; GSE59496
DR   GEO; GSM1508949
DR   GEO; GSM1508952
DR   GEO; GSM4969608
DR   GEO; GSM4969609
DR   GEO; GSM4969610
DR   GEO; GSM4969611
DR   GEO; GSM4969616
DR   GEO; GSM4969646
DR   GEO; GSM4969647
DR   GEO; GSM4969648
DR   Millipore; SCC127
DR   Wikidata; Q54952963
RX   PubMed=23603901;
RX   PubMed=24305702;
RX   PubMed=25401693;
RX   PubMed=29760046;
RX   PubMed=34078608;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=23603901).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): Millipore=SCC127
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 19,22
ST   Penta D: 11,12
ST   Penta E: 11,13
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   SF8647
AC   CVCL_K079
SY   SF D1-5; SFD15
DR   CLO; CLO_0050692
DR   RCB; RCB0604
DR   Wikidata; Q54952965
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   SF8649
AC   CVCL_K080
SY   SF D1-6; SFD16
DR   CLO; CLO_0050666
DR   BioSample; SAMN03472248
DR   RCB; RCB0603
DR   Wikidata; Q54952966
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0603
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8650
AC   CVCL_K081
SY   SF D1-7; SFD17
DR   CLO; CLO_0050665
DR   BioSample; SAMN03472246
DR   RCB; RCB0602
DR   Wikidata; Q54952967
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0602
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9
ST   D5S818: 10
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8653
AC   CVCL_K082
SY   SF C2-6; SFC26
DR   CLO; CLO_0050716
DR   BioSample; SAMN03472245
DR   RCB; RCB0600
DR   Wikidata; Q54952969
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with thyroid cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0600
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8655
AC   CVCL_K083
SY   SF C2-9; SFC29
DR   CLO; CLO_0050691
DR   BioSample; SAMN03472244
DR   RCB; RCB0598
DR   Wikidata; Q54952971
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0598
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8656
AC   CVCL_K084
SY   SF A-13; SFA13
DR   CLO; CLO_0050664
DR   BioSample; SAMN03472243
DR   RCB; RCB0597
DR   Wikidata; Q54952972
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual with thyroid and colon cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0597
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 11,13
ST   D5S818: 10,13
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8657
AC   CVCL_K085
SY   SF A-14; SFA14
DR   CLO; CLO_0050660
DR   BioSample; SAMN03472297
DR   BioSample; SAMN10989580
DR   Cell_Model_Passport; SIDM01865
DR   DepMap; ACH-001187
DR   PharmacoDB; SF8657_1371_2019
DR   RCB; RCB0585
DR   Wikidata; Q54952991
RX   PubMed=1762123;
RX   PubMed=2354455;
RX   PubMed=31068700;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Donor information: Established from a nonexposed individual with stomach cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0585
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   SF871
AC   CVCL_A8Z2
DR   GEO; GSM2644519
DR   Wikidata; Q102114911
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (from child cell line STBCi084-A).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   SF8758
AC   CVCL_K086
SY   SF D2-16; SFD216
DR   CLO; CLO_0050663
DR   BioSample; SAMN03472242
DR   RCB; RCB0596
DR   Wikidata; Q54952992
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0596
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 10,12
ST   D7S820: 8,13
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8759
AC   CVCL_K087
SY   SF D1-9; SFD19
DR   CLO; CLO_0050661
DR   BioSample; SAMN03472298
DR   RCB; RCB0587
DR   Wikidata; Q54952993
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0587
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8760
AC   CVCL_K088
SY   SF D2-17; SFD217
DR   CLO; CLO_0050689
DR   BioSample; SAMN03472299
DR   RCB; RCB0588
DR   Wikidata; Q54952996
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0588
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8761
AC   CVCL_K089
SY   SF B-6; SFB6
DR   CLO; CLO_0050690
DR   BioSample; SAMN03472300
DR   RCB; RCB0589
DR   Wikidata; Q54952997
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from a nonexposed individual without cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0589
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SF8762
AC   CVCL_K090
SY   SF D1-10; SFD110
DR   CLO; CLO_0050662
DR   BioSample; SAMN03472241
DR   RCB; RCB0590
DR   Wikidata; Q54952998
RX   PubMed=1762123;
RX   PubMed=2354455;
CC   Part of: Ban's atomic bomb survivor-derived skin fibroblast library.
CC   Population: Japanese.
CC   Donor information: Established from an atomic bomb survivor with breast cancer.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0590
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   Sf9
AC   CVCL_0549
SY   SF9; sf9; SF-9; Sf-9; sf-9; Sf 9; Spodoptera frugiperda clone 9; Sf clone 9; IPLB-Sf-9AE; IPLB-SF-9AE; IPLB-SF-9; IPLB-Sf-9; IPLB-Sf9
DR   BTO; BTO_0001240
DR   CLO; CLO_0008988
DR   CLO; CLO_0008989
DR   CLO; CLO_0008990
DR   EFO; EFO_0022745
DR   MCCL; MCC:0000450
DR   CLDB; cl4277
DR   CLDB; cl4278
DR   CLDB; cl4279
DR   ATCC; CRL-1711
DR   BCRC; 60011
DR   CCLV; CCLV-RIE 0352
DR   CCRID; 1101INS-PUMC000117
DR   CCRID; 1102INS-NIFDC00107
DR   CCRID; 4201INS-CCTCC00008
DR   CCTCC; GDC0008
DR   ChEMBL-Cells; CHEMBL3308860
DR   CLS; 604328
DR   DSMZ; ACC-125
DR   DSMZCellDive; ACC-125
DR   ECACC; 89070101
DR   IBRC; C10127
DR   ICLDB; sf9
DR   IZSLER; BS CL 157
DR   KCB; KCB 200807YJ
DR   KCB; KCB 92018YJ
DR   Lonza; 1014
DR   MeSH; D061987
DR   NCBI_Iran; C425
DR   NISES; SK0002
DR   PubChem_Cell_line; CVCL_0549
DR   RCB; RCB0563
DR   TOKU-E; 3107
DR   Wikidata; Q7459700
RX   DOI=10.1111/j.1439-0418.2010.01574.x;
RX   DOI=10.11416/jibs2001.71.25;
RX   DOI=10.3923/jas.2007.4040.4043;
RX   PubMed=1367489;
RX   PubMed=1369220;
RX   PubMed=7615077;
RX   PubMed=8050503;
RX   PubMed=8314732;
RX   PubMed=8799737;
RX   PubMed=10718368;
RX   PubMed=10777062;
RX   PubMed=12052082;
RX   PubMed=14668217;
RX   PubMed=15926859;
RX   PubMed=19003226;
RX   PubMed=19941903;
RX   PubMed=20300881;
RX   PubMed=21667340;
RX   PubMed=23891577;
RX   PubMed=24375231;
RX   PubMed=24672045;
RX   PubMed=28423032;
RX   PubMed=28839023;
RX   PubMed=29038528;
RX   PubMed=29133148;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-1711
WW   Info; The Scientist; -; https://www.the-scientist.com/virus-found-in-sf9-cell-line-37454
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-311.html
WW   Info; USDA-ARS; -; https://www.ars.usda.gov/sp2userfiles/person/3489/sf9.pdf
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Sf9_(cells)
WW   Provider; OET; -; https://oetltd.com/product/sf9-cells/
WW   Provider; Thermo Fisher; B82501; https://www.thermofisher.com/order/catalog/product/B82501
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Group: Space-flown cell line (cellonaut).
CC   Group: Vaccine production cell line.
CC   Biotechnology: Used for the production of the Novavax SARS-CoV-2 (COVID-19) vaccine (Trade name: NVX-CoV2373) (DrugBank=DB15810). The cell line is used to produce the recombinant SARS-CoV-2 spike protein rSARS-CoV-2 which is the active part of the vaccine formulation.
CC   Doubling time: 25.2 +- 2.8 hours (Note=At 28 Celsius) (PubMed=10718368); 27 hours (PubMed=21667340); ~50 hours (DSMZ=ACC-125).
CC   Karyotypic information: Heterogeneous, contains a mixture of diploid and tetraploid cells.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; ESTs sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Anecdotal: Have been flown in space on shuttle flights STS-50 (USML-1), STS-54 and STS-57 (Spacehab-1) to study growth in microgravity (PubMed=8050503).
CC   Caution: The SfRV rhabdovirus found in Sf9 cells of ATCC CRL-1711 lot 5807852 (PubMed=24672045) does not seem to be expressed in CRL-1711 lot 5814 from 1987 (PubMed=28423032). The SfRV genome is integrated in the Sf9 genome.
CC   Discontinued: RCB; RCB0563; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0518 ! Sf21
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   Sf9 SARS-CoV-2 Spike S1
AC   CVCL_A8DC
SY   SARS-CoV-2 Spike Glycoprotein S1 SF9
DR   ABM; T6797
DR   Wikidata; Q107116918
CC   Group: Insect cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) (Note=AA 1-685; S1).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   Sf9 SARS-CoV-2 Spike S2
AC   CVCL_A8DD
SY   SARS-CoV-2 Spike Glycoprotein S2 SF9
DR   ABM; T6798
DR   Wikidata; Q107116919
CC   Group: Insect cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0DTC2; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) (Note=AA 816-1273; S2).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   Sf9 TiterHigh AC free
AC   CVCL_JX36
DR   ECACC; 05011001
DR   Wikidata; Q54953001
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   Sf9-GFP
AC   CVCL_B6BV
DR   Wikidata; Q112044534
RX   PubMed=28365799;
CC   Group: Insect cell line.
CC   Characteristics: Expresses GFP at the cell surface. Transfected with a vector containing a fused AcMNPV gp64-GFP construct (PubMed=28365799).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17501; Autographa californica nuclear polyhedrosis virus (AcMNPV) GP64.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   Sf9-HT
AC   CVCL_A2IM
SY   Sf9-High Temperature
DR   Wikidata; Q105511035
RX   PubMed=10718368;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Able to grow at 37 Celsius.
CC   Doubling time: 33.6 hours (Note=At 28 Celsius), 21.4 +- 2.5 hours (Note=At 37 Celsius) (PubMed=10718368).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   sf9-ht33
AC   CVCL_UF23
DR   Wikidata; Q98132452
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Adapted to growth at 33 Celsius.
CC   Doubling time: 26 hours (PubMed=21667340).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   sf9-ht35
AC   CVCL_UF24
DR   Wikidata; Q98132453
RX   PubMed=21667340;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Adapted to growth at 35 Celsius.
CC   Doubling time: 23 hours (PubMed=21667340).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   Sf9-JD31
AC   CVCL_D4ZH
DR   CCRID; 4201PAT-CCTCC02478
DR   Wikidata; Q127384289
RX   Patent=CN117050928B;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023184.
CC   Virology: Devoid of SfRV rhabdovirus (Patent=CN117050928B).
CC   Doubling time: 28 hours (Patent=CN117050928B).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   Sf9-P35AcV5-1
AC   CVCL_Z457
DR   Wikidata; Q54953002
RX   Patent=US7405038;
RX   PubMed=11513084;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3099.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08160; Autographa californica nuclear polyhedrosis virus (AcMNPV) p35.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   Sf9-P35AcV5-3
AC   CVCL_Z458
DR   Wikidata; Q54953004
RX   Patent=US7405038;
RX   PubMed=11513084;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3100.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08160; Autographa californica nuclear polyhedrosis virus (AcMNPV) p35.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   Sf9/TPS4
AC   CVCL_C3IH
DR   ICLDB; sf9tps4
DR   Wikidata; Q114312988
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6JD73; Maize 7-epi-sesquithujene synthase (TPS4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   Sf900+
AC   CVCL_4U10
SY   expresSF+; expressSF+; express SF+; Express Sf+; Sf+
DR   Wikidata; Q54953005
RX   Patent=US6103526;
RX   PubMed=18304705;
RX   PubMed=19453397;
RX   PubMed=22265860;
RX   PubMed=23848607;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12579.
CC   Biotechnology: Used for the production of the influenza virus vaccine FluBlok. Used to produce the hemagglutinin (HA) of influenza A subtype H1N1, H3N2 and of influenza B (PubMed=19453397).
CC   Biotechnology: Used for the production of the porcine circovirus 2 (PCV2) vaccine CircoFLEX. Used to produce the PCV2 ORF2 capsid protein (PubMed=29133148).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 13
//
ID   SF9012
AC   CVCL_E5GA
RX   PubMed=25401693;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Unspecified (PubMed=25401693).
CC   Derived from site: In situ; Brain, fronto-parietal lobe.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF9402
AC   CVCL_E5GB
DR   GEO; GSM4969612
DR   GEO; GSM4969618
DR   GEO; GSM4969643
DR   GEO; GSM4969644
DR   GEO; GSM4969645
DR   GEO; GSM5356024
RX   PubMed=25401693;
RX   PubMed=34078608;
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SF9427
AC   CVCL_E5GC
DR   GEO; GSM4969613
DR   GEO; GSM4969614
DR   GEO; GSM4969621
DR   GEO; GSM4969640
DR   GEO; GSM4969641
DR   GEO; GSM4969642
DR   GEO; GSM4969659
DR   GEO; GSM5356025
RX   PubMed=25401693;
RX   PubMed=34078608;
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C39750; Glioblastoma, IDH-wildtype
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Sf9S
AC   CVCL_Z459
SY   Sf9s; Sf-9S
DR   Wikidata; Q54953007
RX   Patent=US7041500;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4047.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   SFA1.2B4
AC   CVCL_C4BC
SY   SFA1-2B4
DR   Wikidata; Q116050489
RX   PubMed=8627808;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P48509; Human CD151.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SFAF-PI 38
AC   CVCL_9V84
DR   NCBI_Iran; C465
DR   Wikidata; Q54953008
CC   Derived from site: In situ; Fetal abdomen; UBERON=UBERON_0000916.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   SFAT-3
AC   CVCL_1N75
SY   Spleen Focus-derived Ascites Tumor-3
DR   Wikidata; Q54953009
RX   PubMed=5973415;
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 4
//
ID   sfAWRamos
AC   CVCL_C5DM
SY   serum free AW Ramos
DR   Wikidata; Q116050490
RX   CelloPub=CLPUB00725;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV from P3HR-1 cell line (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2702 ! Ramos-AW
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   SFB
AC   CVCL_YE21
SY   Swordtail Fish Brain
DR   Wikidata; Q98132454
RX   DOI=10.3724/SP.J.1231.2013.38402;
CC   Group: Fish cell line.
CC   Doubling time: 43.048 hours (Note=At 65th passage) (DOI=10.3724/SP.J.1231.2013.38402).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8084; ! Xiphophorus hellerii (Green swordtail)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   Sfbeta4GalT
AC   CVCL_Z364
DR   Wikidata; Q54953011
RX   PubMed=9597545;
RX   PubMed=11181556;
RX   PubMed=12475259;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   Sfbeta4GalT/ST6
AC   CVCL_Z365
DR   Wikidata; Q54953012
RX   PubMed=11181556;
RX   PubMed=12475259;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3676; St6gal1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_Z364 ! Sfbeta4GalT
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   SFBF-PI 39
AC   CVCL_9V85
DR   NCBI_Iran; C467
DR   Wikidata; Q54953014
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 7
//
ID   SFBF-PI 41
AC   CVCL_9V86
DR   NCBI_Iran; C469
DR   Wikidata; Q54953017
CC   Derived from site: In situ; Fetal bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   sfBIT
AC   CVCL_WS54
SY   serum-free B95-8 requiring Insulin and Transferrin
DR   Wikidata; Q98132455
RX   PubMed=2824833;
RX   PubMed=2841494;
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Grows in serum-free RPMI 1640 medium supplemented with insulin, transferrin and selenium.
CC   Doubling time: 2.5 days (PubMed=2841494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
HI   CVCL_1953 ! B95-8
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   sfBJAB
AC   CVCL_C5DJ
SY   serum free BJAB
DR   Wikidata; Q116050491
RX   CelloPub=CLPUB00725;
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   sfBT
AC   CVCL_WS55
SY   serum-free B95-8 requiring Transferrin
DR   Wikidata; Q98132456
RX   CelloPub=CLPUB00725;
RX   PubMed=2841494;
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Grows in serum-free RPMI 1640 medium supplemented with transferrin and selenium.
CC   Doubling time: 2.8 days (PubMed=2841494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
HI   CVCL_WS54 ! sfBIT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   SFC6-iPS#3.1
AC   CVCL_YM97
SY   SFC6-iPSC#3.1
DR   Wikidata; Q98132457
RX   PubMed=26411903;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SFC6-iPS+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/SFC6-iPS%2520Anexo%2520I.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.633+1G>A; dbSNP=rs528466699; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26411903).
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; p.Leu473Pro (c.1418T>C) (p.Leu445Pro, c.1334T>C); Zygosity=Heterozygous (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D21S11: 29,30
ST   D5S818: 11,14
ST   D7S820: 12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM98 ! SFC6-iPS#3.2
OI   CVCL_A9W5 ! SFC6-iPS#4.6
OI   CVCL_A9W6 ! SFC6-iPS#4.7
SX   Female
AG   4Y7M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   SFC6-iPS#3.2
AC   CVCL_YM98
SY   SFC6-iPSC#3.2
DR   Wikidata; Q98132458
RX   PubMed=26411903;
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.633+1G>A; dbSNP=rs528466699; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26411903).
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; p.Leu473Pro (c.1418T>C) (p.Leu445Pro, c.1334T>C); Zygosity=Heterozygous (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM97 ! SFC6-iPS#3.1
OI   CVCL_A9W5 ! SFC6-iPS#4.6
OI   CVCL_A9W6 ! SFC6-iPS#4.7
SX   Female
AG   4Y7M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   SFC6-iPS#4.6
AC   CVCL_A9W5
DR   Wikidata; Q102114912
RX   PubMed=26411903;
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.633+1G>A; dbSNP=rs528466699; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26411903).
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; p.Leu473Pro (c.1418T>C) (p.Leu445Pro, c.1334T>C); Zygosity=Heterozygous (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM97 ! SFC6-iPS#3.1
OI   CVCL_YM98 ! SFC6-iPS#3.2
OI   CVCL_A9W6 ! SFC6-iPS#4.7
SX   Female
AG   4Y7M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   SFC6-iPS#4.7
AC   CVCL_A9W6
DR   Wikidata; Q102114914
RX   PubMed=26411903;
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.633+1G>A; dbSNP=rs528466699; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26411903).
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; p.Leu473Pro (c.1418T>C) (p.Leu445Pro, c.1334T>C); Zygosity=Heterozygous (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM97 ! SFC6-iPS#3.1
OI   CVCL_YM98 ! SFC6-iPS#3.2
OI   CVCL_A9W5 ! SFC6-iPS#4.6
SX   Female
AG   4Y7M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   SFC7-iPS#3.1
AC   CVCL_YM99
SY   SFC7-iPSC#3.1
DR   Wikidata; Q98132459
RX   PubMed=26411903;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SFC7-iPS+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/SFC7-iPS%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.372-2A>G; ClinVar=VCV000001236; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 27,31.2
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN00 ! SFC7-iPS#3.2
OI   CVCL_A9W7 ! SFC7-iPS#4.8
OI   CVCL_A9W8 ! SFC7-iPS#4.9
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   SFC7-iPS#3.2
AC   CVCL_YN00
SY   SFC7-iPSC#3.2
DR   Wikidata; Q98132460
RX   PubMed=26411903;
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.372-2A>G; ClinVar=VCV000001236; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM99 ! SFC7-iPS#3.1
OI   CVCL_A9W7 ! SFC7-iPS#4.8
OI   CVCL_A9W8 ! SFC7-iPS#4.9
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   SFC7-iPS#4.8
AC   CVCL_A9W7
DR   Wikidata; Q102114915
RX   PubMed=26411903;
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.372-2A>G; ClinVar=VCV000001236; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM99 ! SFC7-iPS#3.1
OI   CVCL_YN00 ! SFC7-iPS#3.2
OI   CVCL_A9W8 ! SFC7-iPS#4.9
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   SFC7-iPS#4.9
AC   CVCL_A9W8
DR   Wikidata; Q102114916
RX   PubMed=26411903;
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple; c.372-2A>G; ClinVar=VCV000001236; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26411903).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YM99 ! SFC7-iPS#3.1
OI   CVCL_YN00 ! SFC7-iPS#3.2
OI   CVCL_A9W7 ! SFC7-iPS#4.8
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   SFCC
AC   CVCL_JX15
DR   Wikidata; Q54953018
RX   PubMed=2472868;
CC   Population: Japanese.
CC   Doubling time: 67.6 hours (PubMed=2472868).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C6344; Cervical clear cell adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   SFCI-SCC-09ko
AC   CVCL_E7HC
WW   Provider; OHSU; -; https://apps.ohsu.edu/research/fanconi-anemia/uploads/material_datasheet/cell_line/download/sfci-scc-09-6222a9d4f3797875140876.pdf
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Glyfs*20 (c.822_853del); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
ST   Source(s): OHSU
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1685 ! SCC-9
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SFCI-SCC-09ko+Tg
AC   CVCL_E7HD
WW   Provider; OHSU; -; https://apps.ohsu.edu/research/fanconi-anemia/uploads/material_datasheet/cell_line/download/sfci-scc-09-6222a9d4f3797875140876.pdf
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 FANCA was introduced at the chromosome 4 SHS231 safe locus (OHSU).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Glyfs*20 (c.822_853del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:3582; FANCA.
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
ST   Source(s): OHSU
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7HC ! SFCI-SCC-09ko
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SFCi55
AC   CVCL_UL47
SY   SFC i55; EDi020-A
DR   BioSamples; SAMEA12362311
DR   hPSCreg; EDi020-A
DR   Wikidata; Q98132461
RX   PubMed=28026072;
RX   PubMed=29786554;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   SFCi55-ZsGr
AC   CVCL_UL48
SY   SFCi55-ZsGreen; SFCi55-ZsG; SFCi55ZsG
DR   Wikidata; Q98132462
RX   PubMed=29786554;
CC   Characteristics: Using ZFN the fluorescent reporter gene ZsGreen1 has been inserted at the AAVS1 safe harbor locus.
CC   Genetic integration: Method=ZFN; Gene=FPbase; 51H85; ZsGreen1 (Note=Green fluorescent protein derived from ZsGreen).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL47 ! SFCi55
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   SFDH
AC   CVCL_D6UR
RX   PubMed=10600235;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Spontaneously transformed. Forms dense, multicellular spheroids at high density. These spheroids detach from the growth surface (PubMed=10600235).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SFE-HA-831
AC   CVCL_YA23
DR   ICLDB; sfe-ha-831
DR   Wikidata; Q98132463
RX   DOI=10.1016/B978-0-12-470255-4.50027-4;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Helicoverpa armigera cytoplasmic polyhedrosis virus (HaCPV) (DOI=10.1016/B978-0-12-470255-4.50027-4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   SFEC
AC   CVCL_IM35
SY   Southern Flounder Embryonic Cell line
DR   Wikidata; Q54953019
RX   CelloPub=CLPUB00053;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=141886; ! Paralichthys lethostigma (Southern flounder)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 27-11-25; Version: 7
//
ID   SFH-R
AC   CVCL_0I79
DR   CCLV; CCLV-RIE 0042
DR   Wikidata; Q54953021
RX   PubMed=25565633;
CC   Senescence: Senesces at 40 PDL (CCLV=CCLV-RIE 0042).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   SFIF-PI 44
AC   CVCL_9V87
DR   NCBI_Iran; C472
DR   Wikidata; Q54953023
CC   Derived from site: In situ; Fetal intestine; UBERON=UBERON_0000160.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   sfJiyoye
AC   CVCL_C5DK
SY   serum free Jiyoye
DR   Wikidata; Q116050492
RX   CelloPub=CLPUB00725;
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Gln (c.394A>C); ClinVar=VCV000376628; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1317 ! Jiyoye
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   SFK
AC   CVCL_R925
SY   Southern Flounder Kidney
DR   Wikidata; Q54953024
RX   PubMed=21210550;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=141886; ! Paralichthys lethostigma (Southern flounder)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   SFKF-PI 37
AC   CVCL_9V88
DR   NCBI_Iran; C464
DR   Wikidata; Q54953025
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SFL [Astyanax]
AC   CVCL_C0VW
SY   Surface Fish Livers
DR   GEO; GSM5856818
DR   GEO; GSM5856819
DR   GEO; GSM5856820
DR   Wikidata; Q114312989
RX   PubMed=35710938;
CC   Group: Fish cell line.
CC   Doubling time: 1.5 days (PubMed=35710938).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Surface morph.
OX   NCBI_TaxID=7994; ! Astyanax mexicanus (Blind cave fish)
SX   Sex unspecified
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   SFL [Kareius]
AC   CVCL_B6XJ
SY   Stone Flounder Liver
DR   Wikidata; Q112044535
RX   DOI=10.1111/j.1749-7345.2010.00445.x;
CC   Group: Fish cell line.
CC   Characteristics: The optimal growth temperature is 22 Celsius (DOI=10.1111/j.1749-7345.2010.00445.x).
CC   Doubling time: 38.8 hours (DOI=10.1111/j.1749-7345.2010.00445.x).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=143345; ! Kareius bicoloratus (Stone flounder)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   SFLF-PI 35
AC   CVCL_9V89
DR   NCBI_Iran; C460
DR   Wikidata; Q54953026
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SFLSF-PI 36
AC   CVCL_9V90
DR   NCBI_Iran; C462
DR   Wikidata; Q54953027
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Derived from site: In situ; Fetal spleen; UBERON=UBERON_0006293.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SFM1
AC   CVCL_C7RU
SY   Serum Free Mesothelial 1
DR   Wikidata; Q117704868
RX   PubMed=9733279;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 38 hours (PubMed=9733279).
CC   Derived from site: In situ; Lung, parietal pleura; UBERON=UBERON_0002400.
CC   Cell type: Mesothelial cell; CL=CL_0000077.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7RR ! NRM 2
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   SFMUi001-A
AC   CVCL_C1WG
DR   BioSamples; SAMEA110645264
DR   hPSCreg; SFMUi001-A
DR   Wikidata; Q114312990
RX   PubMed=37126974;
CC   From: Shandong First Medical University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Ser180Pro (c.538T>C); ClinVar=VCV000554033; Zygosity=Heterozygous (PubMed=37126974).
CC   Sequence variation: Mutation; HGNC; HGNC:12601; USH2A; Simple; p.Cys934Trp (c.2802T>G); ClinVar=VCV000143179; Zygosity=Heterozygous (PubMed=37126974).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126328; Usher syndrome type 2
DI   ORDO; Orphanet_231178; Usher syndrome type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SFN-R
AC   CVCL_XH20
DR   CCLV; CCLV-RIE 0039
DR   Wikidata; Q98132464
RX   PubMed=25565633;
CC   Senescence: Senesces at 40 PDL (CCLV=CCLV-RIE 0039).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   sfP3HR-1
AC   CVCL_C5DN
SY   serum free P3HR-1
DR   Wikidata; Q116050493
RX   CelloPub=CLPUB00725;
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   SFPHi001-A
AC   CVCL_C9LX
SY   GD09031
DR   BioSamples; SAMEA113414143
DR   hPSCreg; SFPHi001-A
DR   Wikidata; Q123033476
RX   PubMed=37385134;
CC   From: Shanghai Fifth People's Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:775; SERPINC1; Simple; p.Arg79His (c.236G>A); ClinVar=VCV000018014; Zygosity=Heterozygous (PubMed=37385134).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98815; Antithrombin III deficiency
DI   ORDO; Orphanet_82; Hereditary thrombophilia due to congenital antithrombin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SFR1-Myco 1
AC   CVCL_F0WN
RX   PubMed=6698819;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycoplasmopsis fermentans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SFR1-Myco 2
AC   CVCL_F0WP
RX   PubMed=6698819;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Mycoplasmopsis fermentans.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SFR3-DR5
AC   CVCL_9237
DR   CLO; CLO_0008992
DR   ATCC; HB-151
DR   IZSLER; BS Hy 14
DR   Wikidata; Q54953029
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   SFR8-B6
AC   CVCL_9238
DR   CLO; CLO_0008993
DR   ATCC; HB-152
DR   Wikidata; Q54953030
RX   PubMed=6176653;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes HLA-Bw6 epitope).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   sfRaji
AC   CVCL_C5DL
SY   serum free Raji
DR   Wikidata; Q116050494
RX   CelloPub=CLPUB00725;
CC   Group: Serum/protein free medium cell line.
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   sfRamos
AC   CVCL_WS53
SY   serum free Ramos
DR   Wikidata; Q98132465
RX   CelloPub=CLPUB00725;
RX   PubMed=1572277;
RX   PubMed=1850347;
RX   PubMed=7678796;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Asp (c.760_761AT>GA); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0597 ! Ramos
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   SFSF-PI 45
AC   CVCL_9V91
DR   NCBI_Iran; C473
DR   Wikidata; Q54953031
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SfSWT-1
AC   CVCL_Z366
SY   Sf SWT1; SfSWT1; Mimic; Mimic Sf9
DR   Wikidata; Q54953032
RX   PubMed=12475259;
RX   PubMed=12626399;
RX   PubMed=20574041;
WW   Provider; Thermo Fisher; 12552014; https://tools.thermofisher.com/content/sfs/manuals/mimic_cell_man.pdf
WW   Provider; Thermo Fisher; 12552014; https://www.thermofisher.com/order/catalog/product/12552014
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Has been engineered to stably express a variety of mammalian glycosyltransferases thus allowing for production of biantennary, terminally sialyated N-glycans from insect cells. Can be used to produce more mammalian-like proteins in both baculovirus and stable insect expression systems (Thermo Fisher).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7044; MGAT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7045; MGAT2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1316743; St3gal4.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3676; St6gal1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_Z364 ! Sfbeta4GalT
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   SfSWT-3
AC   CVCL_Z367
SY   Sf SWT3; SfSWT3
DR   Wikidata; Q54953033
RX   PubMed=12626399;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7044; MGAT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7045; MGAT2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1337124; Cmas.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2149820; Nans.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1316743; St3gal4.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3676; St6gal1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_Z366 ! SfSWT-1
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   SfSWT-4
AC   CVCL_C3MD
DR   Wikidata; Q116050495
RX   PubMed=23065352;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Capable of producing terminally sialylated N-glycans when cultured in serum-free media supplemented with N-acetylmannosamine (PubMed=23065352).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7045; MGAT2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1337124; Cmas.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2149820; Nans.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1316659; St3gal3.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3676; St6gal1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   SfSWT-5
AC   CVCL_C3ME
DR   Wikidata; Q116050496
RX   PubMed=22042767;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Capable of producing terminally sialylated N-glycans under the transcriptional control of a doxycycline-inducible cytomegalovirus promoter (PubMed=22042767).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7045; MGAT2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1337124; Cmas.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2149820; Nans.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1316659; St3gal3.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3676; St6gal1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   SfSWT-6
AC   CVCL_C3MF
DR   Wikidata; Q116050497
RX   PubMed=23065352;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Capable of producing terminally sialylated N-glycans when cultured in serum-free media supplemented with N-acetylmannosamine (PubMed=23065352).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7045; MGAT2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11021; SLC35A1.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1337124; Cmas.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2149820; Nans.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1316659; St3gal3.
CC   Genetic integration: Method=Transfection; Gene=RGD; 3676; St6gal1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C3MD ! SfSWT-4
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   SfSWT-7
AC   CVCL_C3MG
DR   Wikidata; Q116050498
RX   Patent=US9045778;
RX   PubMed=23848607;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Can produce sulfated complex N-glycans. The expression of the carbohydrate modidying enzymes is under the transcriptional control of baculovirus immediate early 1 (ie1) promoter and homologous region 5 (hr5) enhancer elements.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7045; MGAT2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1891160; Chst2.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:2685834; Gal3st2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:26388; Bovine B4GALT1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_4U10 ! Sf900+
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   SFT
AC   CVCL_B0CD
DR   ATCC; CRL-3469
DR   cancercelllines; CVCL_B0CD
DR   Wikidata; Q108821294
RX   PubMed=23843634;
RX   PubMed=29091757;
CC   Population: Caucasian.
CC   Virology: Can be used to evaluate the infectious entry of polyomaviruses (BKPyV, JCPyV, SV40) and human papillomaviruses. Pathogenic variants of the JCPyV virus previously believed to be non-infectious can infect this cell line, especially in the presence of the chemical 3Fax-Peracetyl Neu5Ac (3Fax) (ATCC=CRL-3469).
CC   Doubling time: ~30 hours (ATCC=CRL-3469).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Thr116Leufs*8 (c.346_349delACTT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Glufs*3 (c.1024delC); ClinVar=VCV000428885; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3796; Gliosarcoma
DI   ORDO; Orphanet_251576; Gliosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1691 ! SF539
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   SFT-8606
AC   CVCL_IS67
SY   SFT8606
DR   Wikidata; Q54953035
RX   PubMed=8908166;
RX   PubMed=10929770;
RX   PubMed=16557275;
RX   PubMed=19756736;
CC   Population: Japanese.
CC   Derived from site: In situ; Elbow; UBERON=UBERON_0001461.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SFT-R
AC   CVCL_Y470
SY   SFTR
DR   CCLV; CCLV-RIE 0043
DR   Wikidata; Q54953037
RX   PubMed=19941903;
RX   PubMed=24973239;
RX   PubMed=25565633;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   SFT-S1
AC   CVCL_D4AC
DR   Wikidata; Q127384291
RX   PubMed=38070062;
CC   Doubling time: ~2 weeks (PubMed=38070062).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 3 fused to STAT6 exon 18 (PubMed=38070062).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
ST   Source(s): PubMed=38070062
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 17,20
ST   D13S317: 8,12
ST   D16S539: 8,11
ST   D18S51: 14
ST   D19S433: 12,15
ST   D1S1656: 12,14
ST   D21S11: 28,31.2
ST   D22S1045: 11
ST   D2S1338: 18,22
ST   D2S441: 11
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,14
ST   D8S1179: 12,16
ST   FGA: 20,24
ST   Penta D: 10,11
ST   Penta E: 9,17
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4457; Pleural solitary fibrous tumor
DI   ORDO; Orphanet_2126; Solitary fibrous tumour/hemangiopericytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   SFT-T1
AC   CVCL_C6JI
DR   Wikidata; Q116050499
RX   PubMed=36428694;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 4 fused to STAT6 exon 2 (PubMed=36428694).
CC   Miscellaneous: STR profile from personal communication of Baier, Dina.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,14
ST   D18S51: 12,16
ST   D21S11: 28,31
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 19,23
ST   Penta D: 10,13
ST   Penta E: 7,14
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4457; Pleural solitary fibrous tumor
DI   ORDO; Orphanet_2126; Solitary fibrous tumour/hemangiopericytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   SFT-T2
AC   CVCL_C6JJ
DR   Wikidata; Q116050500
RX   PubMed=36428694;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7627; NAB2 + HGNC; HGNC:11368; STAT6; Name(s)=NAB2-STAT6; Note=NAB2 exon 4 fused to STAT6 exon 2 (PubMed=36428694).
CC   Miscellaneous: STR profile from personal communication of Baier, Dina.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 28
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   Penta D: 11,13
ST   Penta E: 10,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4457; Pleural solitary fibrous tumor
DI   ORDO; Orphanet_2126; Solitary fibrous tumour/hemangiopericytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   SFTF-PI 40
AC   CVCL_9V92
DR   NCBI_Iran; C468
DR   Wikidata; Q54953039
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V93 ! SFTF-PI 42
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SFTF-PI 42
AC   CVCL_9V93
DR   NCBI_Iran; C470
DR   Wikidata; Q54953041
CC   Derived from site: In situ; Fetal tail; UBERON=UBERON_0002415.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V35 ! SFTF-PI 43
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SFTF-PI 43
AC   CVCL_9V35
SY   SFTF-PI43
DR   NCBI_Iran; C471
DR   Wikidata; Q54953042
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
OI   CVCL_9V84 ! SFAF-PI 38
OI   CVCL_9V85 ! SFBF-PI 39
OI   CVCL_9V86 ! SFBF-PI 41
OI   CVCL_9V87 ! SFIF-PI 44
OI   CVCL_9V88 ! SFKF-PI 37
OI   CVCL_9V89 ! SFLF-PI 35
OI   CVCL_9V90 ! SFLSF-PI 36
OI   CVCL_9V91 ! SFSF-PI 45
OI   CVCL_9V92 ! SFTF-PI 40
OI   CVCL_9V93 ! SFTF-PI 42
SX   Male
AG   2FM
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   SfTPS4-10
AC   CVCL_C3II
DR   ICLDB; sftps4-10
DR   Wikidata; Q114312992
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6JD73; Maize 7-epi-sesquithujene synthase (TPS4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C3IH ! Sf9/TPS4
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   SfTPS4-2-1
AC   CVCL_C3IJ
DR   ICLDB; sftps4-2-1
DR   Wikidata; Q114312993
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6JD73; Maize 7-epi-sesquithujene synthase (TPS4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C3IH ! Sf9/TPS4
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   SfTPS4-3
AC   CVCL_C3IK
DR   ICLDB; sftps4-3
DR   Wikidata; Q114312994
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6JD73; Maize 7-epi-sesquithujene synthase (TPS4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C3IH ! Sf9/TPS4
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   SfTPS4-3A2
AC   CVCL_C3IL
DR   ICLDB; sftps4-3a2
DR   Wikidata; Q114312995
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6JD73; Maize 7-epi-sesquithujene synthase (TPS4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C3IH ! Sf9/TPS4
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   SfTPS4-7
AC   CVCL_C3IM
DR   ICLDB; sftps4-7
DR   Wikidata; Q114312996
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6JD73; Maize 7-epi-sesquithujene synthase (TPS4).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_C3IH ! Sf9/TPS4
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   SG
AC   CVCL_M617
DR   Wikidata; Q54953043
RX   PubMed=8689637;
CC   Karyotypic information: Diploid with a 9p23del (PubMed=8689637).
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   SG0002
AC   CVCL_5G99
DR   ECACC; 00040402
DR   Wikidata; Q54953044
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00040402; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0003
AC   CVCL_5H00
DR   ECACC; 00040403
DR   Wikidata; Q54953046
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00040403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0004
AC   CVCL_5H01
DR   ECACC; 00040404
DR   Wikidata; Q54953047
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00040404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0005
AC   CVCL_5H02
DR   ECACC; 00040405
DR   Wikidata; Q54953048
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00040405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0008
AC   CVCL_5H03
DR   ECACC; 00040408
DR   Wikidata; Q54953065
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00040408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0010
AC   CVCL_5H04
DR   ECACC; 00040410
DR   Wikidata; Q54953066
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00040410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0015
AC   CVCL_5H05
DR   ECACC; 00041910
DR   Wikidata; Q54953067
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0018
AC   CVCL_5H06
DR   ECACC; 00041913
DR   Wikidata; Q54953068
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041913; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0020
AC   CVCL_5H07
DR   ECACC; 00041915
DR   Wikidata; Q54953069
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041915; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0022
AC   CVCL_5H08
DR   ECACC; 00041917
DR   Wikidata; Q54953070
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041917; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0024
AC   CVCL_5H09
DR   ECACC; 00041919
DR   Wikidata; Q54953071
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041919; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0026
AC   CVCL_5H10
DR   ECACC; 00041921
DR   Wikidata; Q54953072
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00041921; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0030
AC   CVCL_5H11
DR   ECACC; 00042213
DR   Wikidata; Q54953073
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00042213; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0034
AC   CVCL_5H12
DR   ECACC; 00051819
DR   Wikidata; Q54953074
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051819; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0035
AC   CVCL_5H13
DR   ECACC; 00051820
DR   Wikidata; Q54953075
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051820; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0038
AC   CVCL_5H14
DR   ECACC; 00051823
DR   Wikidata; Q54953076
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051823; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0040
AC   CVCL_5H15
DR   ECACC; 00051825
DR   Wikidata; Q54953077
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051825; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0041
AC   CVCL_5H16
DR   ECACC; 00051826
DR   Wikidata; Q54953078
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051826; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0042
AC   CVCL_5H17
DR   ECACC; 00051827
DR   Wikidata; Q54953079
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00051827; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0046
AC   CVCL_5H18
DR   ECACC; 00052307
DR   Wikidata; Q54953080
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052307; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0052
AC   CVCL_5H19
DR   ECACC; 00052313
DR   Wikidata; Q54953081
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052313; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0054
AC   CVCL_5H20
DR   ECACC; 00052315
DR   Wikidata; Q54953082
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052315; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0055
AC   CVCL_5H21
DR   ECACC; 00052401
DR   Wikidata; Q54953083
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052401; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0057
AC   CVCL_5H22
DR   ECACC; 00052403
DR   Wikidata; Q54953084
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052403; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0058
AC   CVCL_5H23
DR   ECACC; 00052404
DR   Wikidata; Q54953085
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052404; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0059
AC   CVCL_5H24
DR   ECACC; 00052405
DR   Wikidata; Q54953086
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052405; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0060
AC   CVCL_5H25
DR   ECACC; 00052406
DR   Wikidata; Q54953088
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052406; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0062
AC   CVCL_5H26
DR   ECACC; 00052408
DR   Wikidata; Q54953089
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0063
AC   CVCL_5H27
DR   ECACC; 00052409
DR   Wikidata; Q54953090
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052409; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0064
AC   CVCL_5H28
DR   ECACC; 00052410
DR   Wikidata; Q54953092
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0066
AC   CVCL_5H29
DR   ECACC; 00052512
DR   Wikidata; Q54953093
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052512; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0067
AC   CVCL_5H30
DR   ECACC; 00052514
DR   Wikidata; Q54953094
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052514; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0069
AC   CVCL_5H31
DR   ECACC; 00052516
DR   Wikidata; Q54953095
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052516; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0070
AC   CVCL_5H32
DR   ECACC; 00052517
DR   Wikidata; Q54953096
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052517; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0071
AC   CVCL_5H33
DR   ECACC; 00052518
DR   Wikidata; Q54953097
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052518; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0072
AC   CVCL_5H34
DR   ECACC; 00052519
DR   Wikidata; Q54953098
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052519; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0073
AC   CVCL_5H35
DR   ECACC; 00052520
DR   Wikidata; Q54953099
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052520; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0074
AC   CVCL_5H36
DR   ECACC; 00052521
DR   Wikidata; Q54953100
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052521; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0077
AC   CVCL_5H37
DR   ECACC; 00052524
DR   Wikidata; Q54953101
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052524; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0078
AC   CVCL_5H38
DR   ECACC; 00052525
DR   Wikidata; Q54953102
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052525; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0080
AC   CVCL_5H39
DR   ECACC; 00052527
DR   Wikidata; Q54953103
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052527; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0081
AC   CVCL_5H40
DR   ECACC; 00052528
DR   Wikidata; Q54953104
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052528; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0082
AC   CVCL_5H41
DR   ECACC; 00052529
DR   Wikidata; Q54953106
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052529; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0084
AC   CVCL_5H42
DR   ECACC; 00052531
DR   Wikidata; Q54953107
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052531; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0086
AC   CVCL_5H43
DR   ECACC; 00052533
DR   Wikidata; Q54953127
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052533; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0088
AC   CVCL_5H44
DR   ECACC; 00052535
DR   Wikidata; Q54953128
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052535; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0089
AC   CVCL_5H45
DR   ECACC; 00052536
DR   Wikidata; Q54953129
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052536; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0090
AC   CVCL_5H46
DR   ECACC; 00052537
DR   Wikidata; Q54953130
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052537; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0094
AC   CVCL_5H47
DR   ECACC; 00052541
DR   Wikidata; Q54953131
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052541; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0095
AC   CVCL_5H48
DR   ECACC; 00052542
DR   Wikidata; Q54953132
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052542; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0097
AC   CVCL_5H49
DR   ECACC; 00052544
DR   Wikidata; Q54953133
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052544; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0099
AC   CVCL_5H50
DR   ECACC; 00052546
DR   Wikidata; Q54953134
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052546; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG01
AC   CVCL_VP30
SY   SubGlottis 01
DR   CancerTools; 153460
DR   ECACC; 17100230
DR   Wikidata; Q98132466
DR   Ximbio; 153460
RX   DOI=10.1177/0194599815593290e;
RX   PubMed=30623447;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100230; true.
CC   Derived from site: In situ; Larynx, subglottis; UBERON=UBERON_0036068.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   SG0100
AC   CVCL_5H51
DR   ECACC; 00052447
DR   Wikidata; Q54953135
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052447; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0101
AC   CVCL_5H52
DR   ECACC; 00052413
DR   Wikidata; Q54953136
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0102
AC   CVCL_5H53
DR   ECACC; 00052414
DR   Wikidata; Q54953137
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052414; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0104
AC   CVCL_5H54
DR   ECACC; 00052416
DR   Wikidata; Q54953138
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052416; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0105
AC   CVCL_5H55
DR   ECACC; 00052417
DR   Wikidata; Q54953139
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052417; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0107
AC   CVCL_5H56
DR   ECACC; 00052419
DR   Wikidata; Q54953140
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052419; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0109
AC   CVCL_5H57
DR   ECACC; 00052548
DR   Wikidata; Q54953142
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052548; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0111
AC   CVCL_5H58
DR   ECACC; 00052550
DR   Wikidata; Q54953143
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052550; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0112
AC   CVCL_5H59
DR   ECACC; 00052551
DR   Wikidata; Q54953144
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052551; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0114
AC   CVCL_5H60
DR   ECACC; 00052553
DR   Wikidata; Q54953145
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052553; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0115
AC   CVCL_5H61
DR   ECACC; 00052554
DR   Wikidata; Q54953148
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052554; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0117
AC   CVCL_5H62
DR   ECACC; 00052556
DR   Wikidata; Q54953149
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052556; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0118
AC   CVCL_5H63
DR   ECACC; 00052557
DR   Wikidata; Q54953150
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052557; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0120
AC   CVCL_5H64
DR   ECACC; 00052559
DR   Wikidata; Q54953151
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052559; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0121
AC   CVCL_5H65
DR   ECACC; 00052560
DR   Wikidata; Q54953153
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052560; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG0125
AC   CVCL_5H66
DR   ECACC; 00052564
DR   Wikidata; Q54953155
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 00052564; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   SG141R
AC   CVCL_B7C6
DR   Wikidata; Q112930374
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 62 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SG143(CF)R
AC   CVCL_B7C7
DR   Wikidata; Q112930375
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 59 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SG146S
AC   CVCL_B7C8
DR   Wikidata; Q112930376
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 74 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SG1D12D10
AC   CVCL_F1DF
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni egg/larvae surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SG1D12D8
AC   CVCL_F1DG
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni egg/larvae surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SG1D12E12
AC   CVCL_F1DH
SY   SG1D12.E12
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Schistosoma mansoni egg surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SG209(CF)S
AC   CVCL_B7C9
DR   Wikidata; Q112930377
RX   PubMed=1693627;
CC   Characteristics: Seems to be immortalized (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   SG223(CF)S
AC   CVCL_B7CA
DR   Wikidata; Q112930378
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 67 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SG224(CF)S
AC   CVCL_B7CB
DR   Wikidata; Q112930379
RX   PubMed=1693627;
CC   Characteristics: Seems to be immortalized (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   SG231
AC   CVCL_0519
SY   PCI:SG231; PCI-SG231; PCI:SG-231
DR   BTO; BTO_0002935
DR   EFO; EFO_0022554
DR   MCCL; MCC:0000417
DR   ATCC; CRL-2126
DR   BioSample; SAMN03472551
DR   cancercelllines; CVCL_0519
DR   Cell_Model_Passport; SIDM01852
DR   DepMap; ACH-001857
DR   Wikidata; Q54953156
RX   CelloPub=CLPUB00275;
RX   PubMed=2176543;
RX   PubMed=27231123;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr125Pro (c.373A>C); ClinVar=VCV000376666; Zygosity=Unspecified (DepMap=ACH-001857).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: ATCC; CRL-2126; true.
ST   Source(s): ATCC=CRL-2126; DepMap=ACH-001857
ST   Amelogenin: X
ST   CSF1PO: 10 (ATCC=CRL-2126)
ST   CSF1PO: 10,11 (DepMap=ACH-001857)
ST   D13S317: 9,10
ST   D16S539: 9,14 (DepMap=ACH-001857)
ST   D16S539: 14 (ATCC=CRL-2126)
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21,21.2
ST   Penta D: 12,15
ST   Penta E: 10,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SG237R
AC   CVCL_B7CC
DR   Wikidata; Q112930380
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 38 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7CD ! SG237S
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SG237S
AC   CVCL_B7CD
DR   Wikidata; Q112930381
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 78 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland, secretory coil; UBERON=UBERON_8480064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7CC ! SG237R
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SG27
AC   CVCL_A0QK
DR   Wikidata; Q108821295
RX   Patent=US10683364;
RX   Patent=US10730945;
RX   PubMed=22615450;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SG3
AC   CVCL_Y569
SY   SpermatoGonial cell line from i3 medaka
DR   Wikidata; Q38123319
RX   PubMed=15141090;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Spermatogonium; CL=CL_0000020.
CC   Breed/subspecies: Albino strain i3; VBO=VBO_0017502.
OX   NCBI_TaxID=8090; ! Oryzias latipes (Japanese rice fish)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 10
//
ID   Sg4
AC   CVCL_Z707
SY   Sf4; SF4
DR   EFO; EFO_0005839
DR   DGRC; 179
DR   ENCODE; ENCBS418XCA
DR   FlyBase_Cell_line; FBtc0000179
DR   Wikidata; Q54953157
RX   PubMed=21177962;
RX   PubMed=24434506;
RX   PubMed=24985917;
RX   PubMed=25262759;
RX   PubMed=26772746;
WW   Info; FlyBase; -; http://flybase.org/reports/FBrf0205934.html
CC   Group: Insect cell line.
CC   Part of: modENCODE project cell lines.
CC   Doubling time: 28 hours (DGRC=179).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z232 ! Schneider 2
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 12
//
ID   Sg4-PP-27F
AC   CVCL_5I18
DR   DGRC; 238
DR   FlyBase_Cell_line; FBtc0000238
DR   Wikidata; Q54953160
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z707 ! Sg4
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Sg4-PP-3A
AC   CVCL_5I19
DR   DGRC; 237
DR   FlyBase_Cell_line; FBtc0000237
DR   Wikidata; Q54953161
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z707 ! Sg4
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Sg4-PP-49B
AC   CVCL_5I20
DR   DGRC; 239
DR   FlyBase_Cell_line; FBtc0000239
DR   Wikidata; Q54953162
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z707 ! Sg4
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Sg4-PP-57B
AC   CVCL_5I21
DR   DGRC; 241
DR   FlyBase_Cell_line; FBtc0000241
DR   Wikidata; Q54953163
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z707 ! Sg4
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Sg4-PP-70F
AC   CVCL_5I22
DR   DGRC; 242
DR   FlyBase_Cell_line; FBtc0000242
DR   Wikidata; Q54953164
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z707 ! Sg4
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   Sg4-PP-84E
AC   CVCL_5I23
DR   DGRC; 240
DR   FlyBase_Cell_line; FBtc0000240
DR   Wikidata; Q54953165
RX   PubMed=26450921;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Oregon-R; FlyBase_Strain=FBsn0000276.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
HI   CVCL_Z707 ! Sg4
SX   Male
AG   Late embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   SG43B11E8
AC   CVCL_F1DI
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni egg surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SG5-1.13
AC   CVCL_U457
DR   Wikidata; Q54953166
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   SG5-2
AC   CVCL_U458
DR   Wikidata; Q54953167
RX   PubMed=12514093;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_U450 ! G5
SX   Male
AG   6D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   SG568
AC   CVCL_A1ZU
DR   IARC_TP53; 7402
DR   Wikidata; Q105511038
RX   PubMed=8402660;
RX   PubMed=9563901;
CC   Virology: EBV-negative.
CC   Doubling time: 23 hours (PubMed=8402660).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.522_523ins3; Zygosity=Unspecified (PubMed=8402660).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   SG5B11
AC   CVCL_XE98
DR   Wikidata; Q98132467
RX   Patent=CN1580247A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200309.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on esophageal carcinoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   SG5B7
AC   CVCL_XF00
DR   Wikidata; Q98132468
RX   Patent=CN1580247A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200311.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on esophageal carcinoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   SG5B8
AC   CVCL_XE97
DR   Wikidata; Q98132469
RX   Patent=CN1580247A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200308.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on esophageal carcinoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   SG5E12C8
AC   CVCL_F1DJ
SY   SG5E12.C8
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni egg surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SG5E12D11
AC   CVCL_F1DK
SY   SG5E12.D11
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni egg surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SG87
AC   CVCL_B7C5
DR   Wikidata; Q112930382
RX   PubMed=1693627;
CC   Senescence: Ad-5-SV40 transformed but with a finite life span. Senesces after 63 PDL (PubMed=1693627).
CC   Transformant: Ad5-SV40 hybrid virus (Note=1613 ori-).
CC   Derived from site: In situ; Skin, eccrine sweat gland; UBERON=UBERON_0000423.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 7
//
ID   SGA
AC   CVCL_YJ31
SY   Skin Gambusia Affinis
DR   Wikidata; Q98132470
RX   DOI=10.1016/j.aquaculture.2019.734778;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by betanodaviruses.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=33528; ! Gambusia affinis (Western mosquitofish)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   SGB3B4
AC   CVCL_B0D3
DR   Wikidata; Q108821296
RX   Patent=US5217870;
RX   Patent=US6307025;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10879.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10205.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human 150 kDa protein 'CDX'.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SGBS
AC   CVCL_GS28
SY   Simpson Golabi Behmel Syndrome cell strain
DR   ChEMBL-Cells; CHEMBL4482992
DR   ChEMBL-Targets; CHEMBL4483278
DR   GEO; GSM1543665
DR   GEO; GSM1543666
DR   GEO; GSM1543667
DR   PRIDE; PXD000012
DR   PRIDE; PXD006341
DR   PRIDE; PXD023227
DR   PRIDE; PXD023266
DR   PubChem_Cell_line; CVCL_GS28
DR   Wikidata; Q54953168
RX   PubMed=11244452;
RX   PubMed=20054179;
RX   PubMed=22645513;
RX   PubMed=25925588;
RX   PubMed=35986215;
CC   Characteristics: Versatile in vitro model to study all aspects of human adipocyte biology (PubMed=35986215).
CC   Characteristics: Has a capacity for adipogenic differentiation. Once differentiated, the cells function and behave as mature adipocytes.
CC   Senescence: Ability for adipogenic differentiation is preserved for up to 50 PDL (PubMed=35986215).
CC   Doubling time: 38.4 +- 1.0 hours (Note=In 10% FCS) (PubMed=11244452).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Stromal cell; CL=CL_0000499.
DI   NCIt; C118787; Simpson Golabi Behmel syndrome type 1
DI   ORDO; Orphanet_373; Simpson-Golabi-Behmel syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   SGC-7901
AC   CVCL_0520
SY   SGC 7901; SGC7901
DR   BTO; BTO_0002392
DR   EFO; EFO_0006293
DR   MCCL; MCC:0000418
DR   CCTCC; GDC0150
DR   ChEMBL-Cells; CHEMBL3307739
DR   ChEMBL-Targets; CHEMBL614909
DR   GEO; GSM844685
DR   GEO; GSM1374869
DR   PubChem_Cell_line; CVCL_0520
DR   TOKU-E; 3764
DR   Wikidata; Q54953170
RX   DOI=10.1007/978-4-431-68252-3_114;
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   DOI=10.11569/wcjd.v19.i12.1219;
RX   DOI=10.1360/sb1982-27-12-1355;
RX   PubMed=6443274;
RX   PubMed=16038636;
RX   PubMed=16525997;
RX   PubMed=22576950;
RX   PubMed=26116706;
RX   PubMed=27917905;
RX   PubMed=28498440;
RX   PubMed=28851942;
RX   PubMed=29717028;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/sgc-7901-xenograft-model/
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from the lymph node of a 56 year old female patient with a gastric carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00577.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Formerly the CCRID database had 2 entries describing this cell line (3111C0001CCC000236, 3131C0001000700046). They were one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706; PubMed=28851942; PubMed=29717028
ST   Amelogenin: X
ST   CSF1PO: 9,10 (PubMed=26116706; PubMed=29717028)
ST   CSF1PO: 10 (CCRID; PubMed=28851942)
ST   D12S391: 20,25
ST   D13S317: 12,13.3 (PubMed=26116706; PubMed=29717028)
ST   D13S317: 13.3 (CCRID; PubMed=28851942)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13 (CCRID; PubMed=28851942)
ST   D19S433: 13,14 (PubMed=26116706; PubMed=29717028)
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18 (CCRID; PubMed=26116706; PubMed=29717028)
ST   D3S1358: 16,18 (PubMed=28851942)
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12 (PubMed=26116706; PubMed=29717028)
ST   D7S820: 12 (CCRID; PubMed=28851942)
ST   D8S1179: 12 (CCRID; PubMed=28851942)
ST   D8S1179: 12,13 (PubMed=26116706; PubMed=29717028)
ST   FGA: 18,21 (CCRID; PubMed=28851942)
ST   FGA: 21 (PubMed=26116706; PubMed=29717028)
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12 (PubMed=26116706; PubMed=29717028)
ST   TPOX: 12 (CCRID; PubMed=28851942)
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SGC-7901/B1
AC   CVCL_RK37
DR   Wikidata; Q54953171
RX   PubMed=27917905;
CC   Problematic cell line: Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0520 ! SGC-7901
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   SGC-7901/B2
AC   CVCL_RK36
DR   Wikidata; Q54953172
RX   PubMed=27917905;
CC   Problematic cell line: Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Characteristics: Has high metastatic potential.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0520 ! SGC-7901
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   SGC-996
AC   CVCL_M737
SY   SGC996
DR   Wikidata; Q54953174
RX   CelloPub=CLPUB00379;
RX   PubMed=22387537;
CC   Population: Chinese.
CC   Doubling time: ~48 hours (CelloPub=CLPUB00379).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   SGC7901/ADR
AC   CVCL_VU57
SY   SGC7901/Adr
DR   Wikidata; Q98132471
RX   PubMed=22576950;
RX   PubMed=28498440;
CC   Problematic cell line: Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0520 ! SGC-7901
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   SGC7901/OXA
AC   CVCL_B0A1
DR   Wikidata; Q108821297
RX   DOI=10.11569/wcjd.v19.i12.1219;
CC   Problematic cell line: Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0520 ! SGC-7901
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   SGC7901/VCR
AC   CVCL_VU58
DR   Wikidata; Q98132472
RX   PubMed=16038636;
RX   PubMed=16525997;
RX   PubMed=28498440;
CC   Problematic cell line: Contaminated. Parent cell line (SGC-7901) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0520 ! SGC-7901
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 7
//
ID   SGD5
AC   CVCL_XE99
DR   Wikidata; Q98132473
RX   Patent=CN1580247A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200310.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human antigen on esophageal carcinoma cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   SGDC-1D10
AC   CVCL_B7BU
SY   SGDC-SV40T 1D10; 1D10
DR   Wikidata; Q112930383
RX   CelloPub=CLPUB00693;
RX   PubMed=35262932;
CC   Doubling time: 30-35 hours (PubMed=35262932).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, eccrine sweat gland, duct; UBERON=UBERON_0035073.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   SGE-1
AC   CVCL_2189
SY   SGE1
DR   CLO; CLO_0008999
DR   DSMZ; ACC-343
DR   DSMZCellDive; ACC-343
DR   Wikidata; Q54953175
RX   DOI=10.11418/jtca1981.15.2_141;
RX   DOI=10.11418/jtca1981.8.2_48;
RX   PubMed=2570695;
RX   PubMed=3242847;
CC   Doubling time: 21.6 hours (PubMed=3242847); ~33 hours (DSMZ=ACC-343).
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular epithelial cell; CL=CL_1000510.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   3W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   SGE-RC
AC   CVCL_X538
DR   Cosmic; 849368
DR   Wikidata; Q54953183
RX   PubMed=11146448;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   SGF-3
AC   CVCL_A1RU
DR   Wikidata; Q105511042
RX   DOI=10.5833/jjgs.14.1646;
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=2312501;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Doubling time: 33 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SGF-4
AC   CVCL_A1RV
DR   Wikidata; Q105511048
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=9183632;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Doubling time: 26 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Caution: Indicated as originating from a 66 year old male patient in DOI=10.5833/jjgs.28.615 and from a 64 year old male patient in PubMed=10937344.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SGF-5
AC   CVCL_A1RW
DR   Wikidata; Q105511051
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=2312501;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Doubling time: 30 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Caution: Indicated as originating from a 78 year old male patient in DOI=10.5833/jjgs.28.615 and from a 71 year old male patient in PubMed=10937344.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   SGF-7
AC   CVCL_A1RX
DR   Wikidata; Q105511054
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Doubling time: 35 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Caution: Indicated as originating from a 78 year old male patient in DOI=10.5833/jjgs.28.615 and from a 71 year old male patient in PubMed=10937344.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SGF-8
AC   CVCL_A1RY
DR   Wikidata; Q105511057
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft transplanted into BALB/c,nu/nu mice.
CC   Doubling time: 38.5 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Caution: Indicated as originating from a 56 year old male patient in DOI=10.5833/jjgs.28.615 and from a 52 year old male patient in PubMed=10937344.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 6
//
ID   SGF-9
AC   CVCL_A1RZ
DR   Wikidata; Q105511061
RX   DOI=10.5833/jjgs.28.615;
RX   PubMed=10937344;
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft transplanted into BALB/c,nu/nu mice.
CC   Doubling time: 28 hours (DOI=10.5833/jjgs.28.615; PubMed=10937344).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SGHPL-2
AC   CVCL_VM44
SY   Saint Georges Hospital Placental cell Line-2
DR   Wikidata; Q98132474
RX   PubMed=11723542;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <12FW
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   SGHPL-3
AC   CVCL_VM45
SY   Saint Georges Hospital Placental cell Line-3
DR   Wikidata; Q98132475
RX   PubMed=11723542;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <12FW
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 8
//
ID   SGHPL-4
AC   CVCL_0521
SY   SGHPL4; CTB-CL-MC4; MC4; Saint Georges Hospital Placental cell Line-4
DR   BTO; BTO_0003980
DR   MCCL; MCC:0000419
DR   Lonza; 1281
DR   Wikidata; Q54953186
RX   PubMed=9804259;
RX   PubMed=10498850;
RX   PubMed=11723542;
RX   PubMed=19223288;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Misspelling: SHGPL-4; Note=Once in text of PubMed 24103555.
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <12FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   SGHPL-4sG1
AC   CVCL_WN35
DR   Wikidata; Q98132476
RX   PubMed=19223288;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4964; HLA-G (Note=Soluble isoform).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0521 ! SGHPL-4
SX   Male
AG   <12FW
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   SGHPL-5
AC   CVCL_D727
SY   SGHPL5; Saint Georges Hospital Placental cell Line-5
DR   Wikidata; Q54953187
RX   PubMed=11723542;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Misspelling: SHGPL-5; Note=Occasionally.
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <12FW
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   SGM1
AC   CVCL_VS32
SY   St. George's Melanoma 1
DR   Wikidata; Q98132477
RX   PubMed=21418545;
CC   Characteristics: Long lived but not immortal.
CC   Doubling time: 9.2 days (PubMed=21418545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   SGM2
AC   CVCL_VS33
SY   St. George's Melanoma 2
DR   cancercelllines; CVCL_VS33
DR   Wikidata; Q98132478
RX   PubMed=21418545;
CC   Doubling time: 2.8 days (PubMed=21418545).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21418545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   SGM3
AC   CVCL_VS34
SY   St. George's Melanoma 3
DR   cancercelllines; CVCL_VS34
DR   Wikidata; Q98132479
RX   PubMed=21418545;
CC   Doubling time: 4.9 days (PubMed=21418545).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21418545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   SGM4
AC   CVCL_VS35
SY   St. George's Melanoma 4
DR   cancercelllines; CVCL_VS35
DR   Wikidata; Q98132480
RX   PubMed=21418545;
CC   Doubling time: 3.8 days (PubMed=21418545).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21418545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   SGM5
AC   CVCL_VS36
SY   St. George's Melanoma 5
DR   cancercelllines; CVCL_VS36
DR   Wikidata; Q98132481
RX   PubMed=21418545;
CC   Doubling time: 2.5 days (PubMed=21418545).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21418545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   SGM6
AC   CVCL_VS37
SY   St. George's Melanoma 6
DR   Wikidata; Q98132482
RX   PubMed=21418545;
CC   Doubling time: 6.3 days (PubMed=21418545).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   SGP
AC   CVCL_6F88
SY   Snakeskin Gourami caudal Peduncle
DR   Wikidata; Q54953188
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
RX   PubMed=1717644;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=313238; ! Trichopodus pectoralis (Snakeskin gourami)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   SGP-2
AC   CVCL_YB67
SY   Snakeskin Gourami caudal Peduncle-2
DR   Wikidata; Q98132484
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=313238; ! Trichopodus pectoralis (Snakeskin gourami)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   SGS
AC   CVCL_4007
SY   Sarcoma Galliera strain; SGS-2
DR   BTO; BTO_0001210
DR   CLO; CLO_0009000
DR   CLDB; cl4284
DR   Wikidata; Q54953189
RX   DOI=10.1007/978-1-4612-5008-1_23;
RX   PubMed=652394;
RX   PubMed=2982624;
CC   Breed/subspecies: Galliera.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   SGS/3A
AC   CVCL_F738
DR   CLO; CLO_0009001
DR   CLDB; cl4285
DR   Wikidata; Q54953190
CC   Breed/subspecies: Galliera.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4007 ! SGS
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   SGS/4A
AC   CVCL_L436
DR   Wikidata; Q54953191
RX   PubMed=10832101;
CC   Breed/subspecies: Galliera.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4007 ! SGS
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   SGT11 1T3.1D9
AC   CVCL_WS36
SY   1D9
DR   Wikidata; Q98132485
RX   Patent=US9534233;
RX   PubMed=25943527;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3134.
CC   Characteristics: Can be used for adenoviral vector production under serum-free conditions.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS35 ! SGT11 1T3.1G3
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   SGT11 1T3.1G3
AC   CVCL_WS35
SY   1G3
DR   FCS-free; 167-2-310-1-4-12
DR   Wikidata; Q98132486
RX   Patent=US9534233;
RX   PubMed=25943527;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3135.
CC   Characteristics: Can be used for adenoviral vector production under serum-free conditions.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03281; Human adenovirus C serotype 5 pIX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WS36 ! SGT11 1T3.1D9
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   SGW-R
AC   CVCL_A3AN
DR   CCLV; CCLV-RIE 0565
DR   Wikidata; Q105511063
RX   PubMed=25565633;
CC   Derived from site: In situ; Brainstem; UBERON=UBERON_0002298.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Weaned
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   SGZ1D4E5
AC   CVCL_F1DL
RX   PubMed=6538899;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Schistosoma mansoni egg/larvae surface membrane antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SH [Acipenser]
AC   CVCL_S945
SY   Sturgeon Heart
DR   Wikidata; Q54953193
RX   DOI=10.1139/z85-427;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=36177; ! Acipenser oxyrinchus (Atlantic sturgeon)
SX   Male
AG   Mature
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   SH [Dog hemangiosarcoma]
AC   CVCL_GY96
DR   GEO; GSM1122231
DR   Wikidata; Q54953192
RX   PubMed=24582862;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   Sh #1
AC   CVCL_1E45
SY   SH #1; SH 1
DR   Wikidata; Q54953194
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=4524119;
RX   PubMed=5030962;
CC   Doubling time: 30 hours (Note=At 41th passage), 31 hours (Note=At 142th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   SH-10-TC
AC   CVCL_5167
SY   SH10TC; SH-10
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 709
DR   BioSample; SAMN10987814
DR   cancercelllines; CVCL_5167
DR   Cell_Model_Passport; SIDM01343
DR   Cosmic; 889109
DR   Cosmic; 1187292
DR   DepMap; ACH-000764
DR   GEO; GSM887567
DR   GEO; GSM888650
DR   IARC_TP53; 28235
DR   LiGeA; CCLE_568
DR   PharmacoDB; SH10TC_1372_2019
DR   Progenetix; CVCL_5167
DR   RCB; RCB1940
DR   TKG; TKG 0338
DR   TKG; TKG 0412
DR   Wikidata; Q54953195
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (DepMap=ACH-000764).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (DepMap=ACH-000764).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=64.56%; East Asian, South=34.04%; South Asian=0%; European, North=0%; European, South=1.4% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): RCB=RCB1940; TKG=TKG 0412
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C5248; Gastric mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SH-2 [Human contaminated breast cancer]
AC   CVCL_M622
SY   SH2
DR   BioSample; SAMN03151757
DR   Wikidata; Q54953196
RX   CelloPub=CLPUB00114;
RX   CelloPub=CLPUB00262;
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from the pleural effusion of a Caucasian female patient with a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00086.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   SH-2 [Human leukemia]
AC   CVCL_2190
DR   BioSample; SAMN03473457
DR   cancercelllines; CVCL_2190
DR   DSMZ; ACC-643
DR   DSMZCellDive; ACC-643
DR   GEO; GSM1446761
DR   Wikidata; Q54953197
RX   PubMed=18715689;
RX   PubMed=19954598;
CC   Population: Chinese.
CC   Doubling time: ~80 hours (DSMZ=ACC-643).
CC   Karyotypic information: Has lost chromosome Y (PubMed=18715689; PubMed=19954598).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192His (c.576G>T); ClinVar=VCV000922531; Zygosity=Hemizygous (PubMed=18715689; PubMed=19954598).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-643; PubMed=18715689
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 9
ST   D18S51: 13,22
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 23,25
ST   Penta D: 9
ST   Penta E: 15,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SH-224
AC   CVCL_S708
DR   Cosmic; 1493302
DR   Wikidata; Q54953198
RX   PubMed=21372829;
WW   Provider; BRICS; BRICS0083; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3896
CC   Population: Chinese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   SH-289
AC   CVCL_S709
DR   Cosmic; 1493303
DR   Wikidata; Q54953200
RX   PubMed=21372829;
WW   Provider; BRICS; BRICS0084; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3897
CC   Population: Chinese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   SH-3
AC   CVCL_M383
SY   SH3
DR   BioSample; SAMN03151758
DR   Wikidata; Q54953201
RX   CelloPub=CLPUB00114;
RX   CelloPub=CLPUB00262;
RX   PubMed=72600;
RX   PubMed=1246601;
RX   PubMed=1260689;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from the pleural effusion of a 73 year old Caucasian female patient with a breast carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00087.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   SH-34
AC   CVCL_F764
DR   CLO; CLO_0009004
DR   ATCC; CRL-2405
DR   Wikidata; Q54953202
RX   PubMed=3614206;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_27938; Asialo-GM1 ganglioside.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   SH-39-HOM
AC   CVCL_C585
DR   ESTDAB; ESTDAB-060
DR   Wikidata; Q54953203
RX   PubMed=15592718;
WW   Info; ESTDAB; ESTDAB-060; https://web.archive.org/web/20160416070743/http://www.ebi.ac.uk/cgi-bin/ipd/estdab/print_cell.cgi?ESTDAB-060
CC   Problematic cell line: Probably contaminated. The STR profile and HLA typing information are nearly identical to that of the A-549 cell line. Originally thought to originate from a melanoma patient along with a sister cell line, RE-25-HOM (Cellosaurus=CVCL_C577).
CC   Population: Caucasian.
CC   HLA typing: A*25:01,30:01; B*18:01,44:03:01; C*12:03,16:01; DPB1*03:01,16:01; DQB1*03:01:01,02:01; DRB1*11:03:01,07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ESTDAB=ESTDAB-060
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 10
//
ID   SH-4
AC   CVCL_1692
SY   SH4
DR   CLO; CLO_0009006
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7724
DR   BCRJ; 0337
DR   BioSample; SAMN03471142
DR   BioSample; SAMN10987692
DR   cancercelllines; CVCL_1692
DR   Cell_Model_Passport; SIDM01079
DR   ChEMBL-Cells; CHEMBL3308177
DR   ChEMBL-Targets; CHEMBL2366309
DR   Cosmic; 687440
DR   Cosmic; 909713
DR   Cosmic; 2159447
DR   Cosmic-CLP; 909713
DR   DepMap; ACH-000441
DR   EGA; EGAS00001000978
DR   GDSC; 909713
DR   GEO; GSM887568
DR   GEO; GSM888651
DR   GEO; GSM1670420
DR   IARC_TP53; 27573
DR   IGRhCellID; SH4
DR   LiGeA; CCLE_307
DR   LINCS_LDP; LCL-1280
DR   PharmacoDB; SH4_1373_2019
DR   PRIDE; PXD007265
DR   PRIDE; PXD022992
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1692
DR   PubChem_Cell_line; CVCL_1692
DR   Wikidata; Q54953204
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1176156;
RX   PubMed=3518877;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29275043;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Doubling time: 31 +- 1.1 hours (PubMed=29275043).
CC   HLA typing: A*02:01,26:01; B*51:01,56:01; C*01:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=909713; DepMap=ACH-000441).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.19%; Native American=0.74%; East Asian, North=4.52%; East Asian, South=0%; South Asian=0%; European, North=64.08%; European, South=28.47% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-7724; Cosmic-CLP=909713
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 16,20
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 13
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   Penta D: 12
ST   Penta E: 10,18
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SH-405
AC   CVCL_S710
DR   Cosmic; 1493308
DR   Wikidata; Q54953205
RX   PubMed=21372829;
CC   Population: Chinese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   SH-416
AC   CVCL_S711
DR   cancercelllines; CVCL_S711
DR   Cosmic; 1493305
DR   Wikidata; Q54953206
RX   PubMed=21372829;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Thr751del (c.2240_2254delTAAGAGAAGCAACAT); ClinVar=VCV000177649; Zygosity=Unspecified (PubMed=21372829).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   SH-437
AC   CVCL_S712
DR   cancercelllines; CVCL_S712
DR   Cosmic; 1493307
DR   Wikidata; Q54953207
RX   PubMed=21372829;
WW   Provider; BRICS; BRICS0086; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3899
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro848Leu (c.2543C>T); ClinVar=VCV000045282; Zygosity=Unspecified (PubMed=21372829).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   SH-450
AC   CVCL_S713
DR   Cosmic; 1493306
DR   Wikidata; Q54953208
RX   PubMed=21372829;
WW   Provider; BRICS; BRICS0087; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3900
CC   Population: Chinese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   SH-498
AC   CVCL_S714
DR   Cosmic; 1493309
DR   Wikidata; Q54953209
RX   PubMed=21372829;
WW   Provider; BRICS; BRICS0090; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3903
CC   Population: Chinese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   SH-543
AC   CVCL_S715
DR   Cosmic; 1493304
DR   Wikidata; Q54953210
RX   PubMed=21372829;
WW   Provider; BRICS; BRICS0088; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3901
CC   Population: Chinese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 9
//
ID   SH-75
AC   CVCL_B6CN
DR   Wikidata; Q112041706
RX   PubMed=22359170;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SH-76
AC   CVCL_B6CP
DR   Wikidata; Q112041707
RX   PubMed=1368811;
RX   PubMed=22359170;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SH-77
AC   CVCL_B6CQ
DR   Wikidata; Q112041708
RX   PubMed=22359170;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SH-78
AC   CVCL_B6CR
DR   Wikidata; Q112041709
RX   PubMed=22359170;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SH-83
AC   CVCL_B6CS
DR   Wikidata; Q112041710
RX   PubMed=22359170;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SH-9 [Human hybridoma against poly(dT)]
AC   CVCL_B6CJ
DR   Wikidata; Q112041711
RX   PubMed=3804938;
RX   PubMed=22359119;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_73300; Poly(deoxythymidylic acid) (poly(dT)).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SH-9 [Mouse hybridoma against human MUC16]
AC   CVCL_B6CA
DR   Wikidata; Q112041712
RX   PubMed=1694212;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SH-A
AC   CVCL_0C25
DR   Cosmic; 2239085
DR   Wikidata; Q54953211
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 10
//
ID   SH-EP
AC   CVCL_0524
SY   SHEP
DR   BTO; BTO_0005397
DR   EFO; EFO_0006294
DR   MCCL; MCC:0000423
DR   cancercelllines; CVCL_0524
DR   Cosmic; 1212535
DR   Cosmic; 2393640
DR   GEO; GSM1622295
DR   IARC_TP53; 23600
DR   Progenetix; CVCL_0524
DR   Wikidata; Q54953212
RX   PubMed=1354203;
RX   PubMed=2535691;
RX   PubMed=6137586;
RX   PubMed=24466371;
RX   PubMed=27517323;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-530.html
CC   Population: Caucasian.
CC   Doubling time: 17.9 +- 1.4 hours (PubMed=27517323).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 32
//
ID   SH-EP007
AC   CVCL_0522
SY   SH-EP 007 SH-EPII
DR   MCCL; MCC:0000420
DR   cancercelllines; CVCL_0522
DR   Wikidata; Q54953213
RX   PubMed=2364393;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   SH-EP1
AC   CVCL_0F47
SY   SH-EPi
DR   BTO; BTO_0005788
DR   EFO; EFO_0022343
DR   ATCC; CRL-2269
DR   cancercelllines; CVCL_0F47
DR   Wikidata; Q54953217
RX   PubMed=6137586;
RX   PubMed=6582512;
RX   PubMed=15720811;
RX   PubMed=17506115;
RX   PubMed=26342562;
CC   Population: Caucasian.
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=15720811).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-2269; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2269
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 8,13
ST   D5S818: 12
ST   D7S820: 7,10
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 20
//
ID   SH-EP1-pCEP4-ha7
AC   CVCL_F0SS
SY   SH-EP1-pCEP4-halpha7
RX   PubMed=15590768;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1960; CHRNA7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F47 ! SH-EP1
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SH-F
AC   CVCL_IY16
SY   SK-N-SH-F
DR   cancercelllines; CVCL_IY16
DR   Wikidata; Q54953218
RX   PubMed=3026862;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 13
//
ID   SH-FE
AC   CVCL_W973
DR   cancercelllines; CVCL_W973
DR   Wikidata; Q54953219
RX   PubMed=6137586;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 16
//
ID   SH-IN
AC   CVCL_W974
DR   cancercelllines; CVCL_W974
DR   Wikidata; Q54953220
RX   PubMed=1354203;
RX   PubMed=2535691;
RX   PubMed=6137586;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 19
//
ID   SH-J1
AC   CVCL_HE82
DR   Wikidata; Q54953221
RX   PubMed=11850072;
CC   Population: Korean.
CC   Karyotypic information: Has lost chromosome Y.
DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 6
//
ID   SH-N
AC   CVCL_IY17
SY   SK-N-SH-N
DR   cancercelllines; CVCL_IY17
DR   Wikidata; Q54953222
RX   PubMed=3026862;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 13
//
ID   SH-SY5Y
AC   CVCL_0019
SY   SH-Sy5y; SHSY5Y; SHSY-5Y; SK-SH-SY5Y; SY5Y; SH-SY5Y Parental
DR   BTO; BTO_0000793
DR   CLO; CLO_0009015
DR   EFO; EFO_0002717
DR   MCCL; MCC:0000421
DR   CLDB; cl4287
DR   CLDB; cl4288
DR   CLDB; cl4289
DR   CLDB; cl4290
DR   Abcam; ab275475
DR   AddexBio; C0005004/63
DR   ATCC; CRL-2266
DR   BCRJ; 0223
DR   BioGRID_ORCS_Cell_line; 1228
DR   BioSample; SAMN10987717
DR   cancercelllines; CVCL_0019
DR   CancerTools; 161932
DR   CCRID; 1101HUM-PUMC000026
DR   CCRID; 3101HUMSCSP5014
DR   CCRID; 3101HUMTCHu97
DR   CCRID; 4201HUM-CCTCC00210
DR   CCRID; 4201PAT-CCTCC00086
DR   CCRID; 5301HUM-KCB06107YJ
DR   CCTCC; GDC0210
DR   Cell_Model_Passport; SIDM01236
DR   CGH-DB; 63-1
DR   ChEMBL-Cells; CHEMBL3307740
DR   ChEMBL-Targets; CHEMBL614910
DR   CLS; 300154
DR   Cosmic; 688084
DR   Cosmic; 1019933
DR   Cosmic; 1167410
DR   Cosmic; 1212536
DR   Cosmic; 2058109
DR   Cosmic; 2239470
DR   Cosmic; 2393641
DR   DepMap; ACH-001188
DR   DSMZ; ACC-209
DR   DSMZCellDive; ACC-209
DR   ECACC; 94030304
DR   ENCODE; ENCBS264AAA
DR   GEO; GSM231608
DR   GEO; GSM231609
DR   GEO; GSM231610
DR   GEO; GSM231611
DR   GEO; GSM231612
DR   GEO; GSM231613
DR   GEO; GSM231614
DR   GEO; GSM231615
DR   GEO; GSM231616
DR   GEO; GSM231617
DR   GEO; GSM231618
DR   GEO; GSM231619
DR   GEO; GSM231620
DR   GEO; GSM231621
DR   GEO; GSM231622
DR   GEO; GSM231623
DR   GEO; GSM231624
DR   GEO; GSM231625
DR   GEO; GSM231626
DR   GEO; GSM231627
DR   GEO; GSM231628
DR   GEO; GSM231629
DR   GEO; GSM231630
DR   GEO; GSM231631
DR   GEO; GSM231632
DR   GEO; GSM231633
DR   GEO; GSM231634
DR   GEO; GSM231635
DR   GEO; GSM231636
DR   GEO; GSM231637
DR   GEO; GSM231638
DR   GEO; GSM231639
DR   GEO; GSM231640
DR   GEO; GSM231641
DR   GEO; GSM231642
DR   GEO; GSM231643
DR   GEO; GSM231644
DR   GEO; GSM231645
DR   GEO; GSM231646
DR   GEO; GSM231647
DR   GEO; GSM231648
DR   GEO; GSM231649
DR   GEO; GSM231650
DR   GEO; GSM231651
DR   GEO; GSM231652
DR   GEO; GSM231653
DR   GEO; GSM231654
DR   GEO; GSM231655
DR   GEO; GSM231656
DR   GEO; GSM231657
DR   GEO; GSM231658
DR   GEO; GSM231659
DR   GEO; GSM231660
DR   GEO; GSM231661
DR   GEO; GSM231662
DR   GEO; GSM231663
DR   GEO; GSM231664
DR   GEO; GSM231665
DR   GEO; GSM231666
DR   GEO; GSM231667
DR   GEO; GSM231668
DR   GEO; GSM231669
DR   GEO; GSM231670
DR   GEO; GSM231671
DR   GEO; GSM231672
DR   GEO; GSM231673
DR   GEO; GSM692874
DR   GEO; GSM887570
DR   GEO; GSM888653
DR   GEO; GSM1622294
DR   GEO; GSM2371253
DR   GEO; GSM2394368
DR   GEO; GSM7701455
DR   GEO; GSM7701459
DR   IARC_TP53; 23599
DR   ICLC; HTL95013
DR   IZSLER; BS TCL 232
DR   KCB; KCB 2006107YJ
DR   KCLB; 22266
DR   Kerafast; ECP004
DR   LINCS_LDP; LCL-2000
DR   Lonza; 132
DR   MetaboLights; MTBLS455
DR   NCBI_Iran; C611
DR   PharmacoDB; SHSY5Y_1374_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD003914
DR   PRIDE; PXD004452
DR   PRIDE; PXD010005
DR   PRIDE; PXD010027
DR   PRIDE; PXD010776
DR   PRIDE; PXD014381
DR   PRIDE; PXD020389
DR   PRIDE; PXD029012
DR   Progenetix; CVCL_0019
DR   PubChem_Cell_line; CVCL_0019
DR   TOKU-E; 3118
DR   Ubigene; YC-D014
DR   Wikidata; Q7390126
RX   PubMed=1354203;
RX   PubMed=2535691;
RX   PubMed=2846152;
RX   PubMed=3968181;
RX   PubMed=4748425;
RX   PubMed=6137586;
RX   PubMed=7687927;
RX   PubMed=10630978;
RX   PubMed=11668190;
RX   PubMed=12505268;
RX   PubMed=14676279;
RX   PubMed=15150091;
RX   PubMed=15720811;
RX   PubMed=16120276;
RX   PubMed=16822308;
RX   PubMed=16957166;
RX   PubMed=17506115;
RX   PubMed=18957096;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=23421552;
RX   PubMed=24466371;
RX   PubMed=25182563;
RX   PubMed=25730103;
RX   PubMed=25884760;
RX   PubMed=26342562;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=28118852;
RX   PubMed=28350380;
RX   PubMed=28601559;
RX   PubMed=29468137;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35893584;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-2266
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/sh-sy5y/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/SH-SY5Y_Farnham_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-101.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/SH-SY5Y
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sh-sy5y
CC   Problematic cell line: Partially contaminated. Some laboratories that are redistributing this cell line are in fact redistributing a contaminated cell line of mouse origin (PubMed=25182563).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 810.
CC   Population: Caucasian.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Characteristics: There seem to be differences in the retinoic acid (RA)-induced neuronal phenotype of SH-SY5Y cells from ATCC and ECACC. After 5 days of RA treatment, ECACC cells are slightly larger in size and contains significant amount of neuroblastic (N-type) cells and a small fraction of epithelial (S-type) cells (PubMed=18957096).
CC   Characteristics: Particularly suitable for research in neurodegenerative diseases due to the fact that it has a specific uptake of norepinephrine (NA), expresses bona fide neurofilament proteins, and shows activity of enzymes involved in catecholaminergic systems (tyrosine and dopamine-beta-hydroxylases) (PubMed=35893584).
CC   Virology: Low susceptibility to infection by Zika virus (ZIKV) (PubMed=29468137).
CC   Doubling time: 67.3 +- 5.8 hours (PubMed=35893584); >55 hours (DSMZ=ACC-209).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=28350380).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
CC   Omics: Proteomics; Subcellular; Mitochondrion; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.17%; East Asian, North=0.35%; East Asian, South=0.1%; South Asian=0.08%; European, North=69.09%; European, South=29.2% (PubMed=30894373).
CC   Misspelling: SH-SY5; Note=Occasionally.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2266; CCRID; CLS=300154; DSMZ=ACC-209; ECACC=94030304; KCLB=22266; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14
ST   D12S391: 18,22
ST   D13S317: 11
ST   D16S539: 8,13
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D1S1656: 12
ST   D21S11: 31,31.2
ST   D22S1045: 16,17
ST   D2S1338: 17,19
ST   D2S441: 11,11.3
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D6S1043: 12,18
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 23.2,24
ST   Penta D: 10,12
ST   Penta E: 7,11
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   SH-SY5Y DNAJC5 KD
AC   CVCL_C8UQ
SY   SH-SY5Y-DNAJC5-KD
DR   Wikidata; Q123033477
RX   PubMed=36626307;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:16235; DNAJC5.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SH-SY5Y Rho0 64/5
AC   CVCL_U924
SY   Rho0 64/5
DR   cancercelllines; CVCL_U924
DR   Wikidata; Q54953224
RX   PubMed=8863494;
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   SH-SY5Y TagGFP2-SNCA
AC   CVCL_YK67
SY   TagGFP2-alpha-synuclein SH-SY5Y
DR   cancercelllines; CVCL_YK67
DR   Innoprot; P30707
DR   Wikidata; Q98132487
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11138; SNCA.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   SH-SY5Y TSC1 +/-
AC   CVCL_E9DD
SY   TSC1 +/- SH-SY5Y
RX   PubMed=28828560;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SH-SY5Y-A4CT
AC   CVCL_E4WN
SY   SH-SY5Y A4CT; SHSY5Y-A4CT; A4CT
RX   PubMed=8243673;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=With p.Met1_Lys60del = A4CT).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SH-SY5Y-FLAG-NGB
AC   CVCL_C0U0
DR   cancercelllines; CVCL_C0U0
DR   PRIDE; PXD029012
DR   Wikidata; Q112930384
RX   PubMed=34943907;
RX   PubMed=35128003;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14077; NGB (Note=With a C-terminal 3xFLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SH-SY5Y-HFE
AC   CVCL_5I52
DR   cancercelllines; CVCL_5I52
DR   Kerafast; EQ1001
DR   Wikidata; Q54953225
RX   PubMed=17194693;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4886; HFE (Note=With a FLAG tag).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   SH-SY5Y-HFE C282Y
AC   CVCL_5I53
DR   cancercelllines; CVCL_5I53
DR   Kerafast; EQ1003
DR   Wikidata; Q54953226
RX   PubMed=17194693;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4886; HFE (Note=With p.Cys282Tyr (c.845G>A) and a FLAG tag).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   SH-SY5Y-HFE H63D
AC   CVCL_5I54
DR   cancercelllines; CVCL_5I54
DR   Kerafast; EQ1002
DR   Wikidata; Q54953227
RX   PubMed=17194693;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4886; HFE (Note=With p.His63Asp (c.187C>G) and a FLAG tag).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 15
//
ID   SH-SY5Y-Luc
AC   CVCL_C8XY
DR   Ubigene; YC-D014-Luc-P
DR   Wikidata; Q123033479
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SH-SY5Y-parkin clone 1
AC   CVCL_C3I6
SY   SH-Parkin 1
DR   cancercelllines; CVCL_C3I6
DR   Wikidata; Q114312997
RX   PubMed=16278233;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   SH-SY5Y-parkin clone 2
AC   CVCL_C3I7
SY   SH-Parkin 2
DR   cancercelllines; CVCL_C3I7
DR   Wikidata; Q114312998
RX   PubMed=16278233;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   SH-SY5Y-parkin clone 6
AC   CVCL_C3I8
SY   SH-Parkin 6
DR   cancercelllines; CVCL_C3I8
DR   Wikidata; Q114312999
RX   PubMed=16278233;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   SH-SY5Y-parkin p.A82E
AC   CVCL_C3I9
SY   SH-Parkin A82E; SH-A82E
DR   cancercelllines; CVCL_C3I9
DR   Wikidata; Q114313000
RX   PubMed=16278233;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With p.Ala82Glu (c.245C>A) and a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   SH-SY5Y-parkin p.T240R
AC   CVCL_C3IA
SY   SH-Parkin A82E; SH-T240R
DR   cancercelllines; CVCL_C3IA
DR   Wikidata; Q114313001
RX   PubMed=16278233;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8607; PRKN (Note=With p.Thr240Arg and a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   SH-SY5Y-pCEP4-ra7
AC   CVCL_F0ST
SY   SH-SY5Y-pCEP4-ralpha7
RX   PubMed=15590768;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2348; Chrna7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SH-SY5Y-pLNCX2 empty vector
AC   CVCL_UJ96
DR   cancercelllines; CVCL_UJ96
DR   Kerafast; ECP005
DR   Wikidata; Q98132488
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Kerafast=ECP005).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   SH-SY5Y-SPA4CT
AC   CVCL_0523
SY   SH-SY5Y SPA4CT; SHSY5Y-SPA4CT; SPA4CT
DR   MCCL; MCC:0000422
DR   cancercelllines; CVCL_0523
DR   Wikidata; Q54953228
RX   PubMed=8243673;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:620; APP (Note=With p.Val20_Met671del = SPA4CT).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   SH-SY5Y-TrkA, clone P23A
AC   CVCL_UJ94
SY   SH-SY5Y-TrkA, P23A
DR   cancercelllines; CVCL_UJ94
DR   Kerafast; ECP006
DR   Wikidata; Q98132489
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Kerafast=ECP006).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8031; NTRK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   SH-SY5Y-TrkB, clone BR6
AC   CVCL_UJ95
SY   SY5Y-TrkB, clone BR6; SH-SY5Y-TrkB, BR6
DR   cancercelllines; CVCL_UJ95
DR   Kerafast; ECP007
DR   Wikidata; Q98132490
RX   PubMed=25684664;
RX   PubMed=26797418;
CC   Population: Caucasian.
CC   Doubling time: 18-24 hours (Kerafast=ECP007).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8032; NTRK2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   SH-SY5Y-vector control
AC   CVCL_E1GZ
DR   Kerafast; EQ1004
RX   PubMed=17194693;
CC   Population: Caucasian.
CC   Characteristics: Transfected with an empty pcDNA 3.1 vector. Control cell line for SH-SY5Y-HFE (Cellosaurus=CVCL_5I52), SH-SY5Y-HFE C282Y (Cellosaurus=CVCL_5I53) and SH-SY5Y-HFE H63D (Cellosaurus=CVCL_5I54).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   SH-SY5Y/Cas9-hyg
AC   CVCL_C9F2
DR   GeneCopoeia; SL550
DR   Wikidata; Q123033480
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL550).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SH-SY5Y/VCR
AC   CVCL_ZL49
DR   cancercelllines; CVCL_ZL49
DR   Wikidata; Q98132491
RX   PubMed=2566379;
RX   PubMed=3968181;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   SH-SY5YrCDDP200
AC   CVCL_RR81
DR   cancercelllines; CVCL_RR81
DR   Wikidata; Q54953229
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SH-SY5YrCDDP500
AC   CVCL_RS23
DR   cancercelllines; CVCL_RS23
DR   Wikidata; Q54953239
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SH-SY5YrDOX10
AC   CVCL_RS80
AS   CVCL_RS8O
DR   cancercelllines; CVCL_RS80
DR   Wikidata; Q54953240
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   SH-SY5YrDOX20
AC   CVCL_RS81
DR   cancercelllines; CVCL_RS81
DR   Wikidata; Q54953241
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SH-SY5YrVCR10
AC   CVCL_RR53
DR   cancercelllines; CVCL_RR53
DR   Wikidata; Q54953242
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   Sh01
AC   CVCL_VY53
DR   IBRC; C10030
DR   Wikidata; Q98132492
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SH101
AC   CVCL_RT29
DR   Wikidata; Q54953244
RX   PubMed=8473041;
RX   PubMed=8507543;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   SH101-P4
AC   CVCL_A669
SY   SH101P4; SH-101-P4
DR   CGH-DB; 130-1
DR   CGH-DB; 9018-4
DR   Cosmic; 877039
DR   Cosmic; 897531
DR   Cosmic; 1122339
DR   Cosmic; 1187291
DR   Cosmic; 1518240
DR   JCRB; JCRB1944
DR   Wikidata; Q54953245
RX   PubMed=8242641;
RX   PubMed=15723654;
CC   Population: Japanese.
CC   Doubling time: 18 hours (PubMed=8242641).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1944
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT29 ! SH101
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 11
//
ID   SH1a
AC   CVCL_JX27
DR   Wikidata; Q54953246
RX   PubMed=2795680;
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Belgian Malinois; VBO=VBO_0200147.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_JX28 ! SH2 [Dog mammary carcinoma]
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   SH1b
AC   CVCL_JX25
SY   SH1
DR   Wikidata; Q54953247
RX   PubMed=2795680;
RX   PubMed=9042250;
CC   Doubling time: 19 hours (Note=In FCS medium), 20 hours (Note=In SH-FCS medium) (PubMed=2795680).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Belgian Malinois; VBO=VBO_0200147.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_JX27 ! SH1a
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   SH2 [Dog mammary carcinoma]
AC   CVCL_JX28
DR   Wikidata; Q54953248
RX   PubMed=2795680;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Belgian Malinois; VBO=VBO_0200147.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_JX27 ! SH1a
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   SH2 [Mouse hybridoma]
AC   CVCL_7700
DR   CLO; CLO_0009002
DR   ATCC; HB-10743
DR   CCRID; 1101MOU-PUMC000204
DR   Wikidata; Q54953249
RX   Patent=US5486359;
RX   PubMed=1316137;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10743.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human marrow-derived mesenchymal cells surface antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   SH3 [Dog mammary carcinoma]
AC   CVCL_JX26
DR   Wikidata; Q54953250
RX   PubMed=2795680;
RX   PubMed=9042250;
CC   Doubling time: 27 hours (Note=In FCS medium), 32 hours (Note=In SH-FCS medium) (PubMed=2795680).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Bouvier des Flandres; VBO=VBO_0200208.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 6
//
ID   SH3 [Mouse hybridoma]
AC   CVCL_7701
DR   CLO; CLO_0009003
DR   ATCC; HB-10744
DR   CCRID; 1101MOU-PUMC000205
DR   Wikidata; Q54953251
RX   Patent=US5486359;
RX   PubMed=1316137;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10744.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human marrow-derived mesenchymal cells surface antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   SH4
AC   CVCL_7702
DR   CLO; CLO_0009005
DR   EFO; EFO_0002327
DR   ATCC; HB-10745
DR   Wikidata; Q54953252
RX   Patent=US5486359;
RX   PubMed=1316137;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10745.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human marrow-derived mesenchymal cells surface antigens.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   ShA
AC   CVCL_B7LM
DR   Wikidata; Q112930385
RX   PubMed=9536093;
CC   Population: Druze.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Pro12Argfs (c.35insGCGGGCG) (151ins7(GCGGGCG)fs329X); Zygosity=Homozygous (PubMed=9536093).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SHA1
AC   CVCL_C1JF
DR   Wikidata; Q114313003
RX   PubMed=4333769;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic myeloid leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1JG ! SHA2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SHA2
AC   CVCL_C1JG
DR   Wikidata; Q114313004
RX   PubMed=4333769;
RX   PubMed=7316467;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from chronic myeloid leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1JF ! SHA1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SHAC
AC   CVCL_D522
SY   Shac
DR   BTO; BTO_0003763
DR   Wikidata; Q54953253
RX   PubMed=3284824;
RX   PubMed=3374507;
DI   NCIt; C6605; Soft tissue fibrosarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 10
//
ID   Shadow
AC   CVCL_0D17
SY   SHADOW; SHA
DR   Wikidata; Q54953254
RX   PubMed=11467477;
RX   PubMed=12944992;
RX   PubMed=26842912;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   Shamba
AC   CVCL_R797
DR   Wikidata; Q54953256
RX   PubMed=1690682;
RX   PubMed=8891732;
WW   Info; -; -; https://zooatlanta.org/remembering-shamba/
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   SHAMUi001-A
AC   CVCL_A1DL
DR   hPSCreg; SHAMUi001-A
DR   Wikidata; Q102114917
RX   PubMed=32979630;
CC   From: The Second Affiliated Hospital of Army Medical University; Chongqing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:29186; ANKRD26; Simple; c.-128G>T; ClinVar=VCV000812728; Zygosity=Heterozygous (PubMed=32979630).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=32979630
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,19
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 14,20
ST   D19S433: 13,14.2
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 24,27
ST   Penta D: 8,13
ST   Penta E: 5
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C129035; Thrombocytopenia 2
DI   ORDO; Orphanet_268322; Hereditary thrombocytopenia with normal platelets
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   Shay
AC   CVCL_6018
DR   JCRB; JCRB0241
DR   Wikidata; Q54953257
RX   PubMed=6585112;
CC   Doubling time: 49 hours (PubMed=6585112).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   ShB02
AC   CVCL_VZ43
DR   IBRC; C10014
DR   Wikidata; Q98132493
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB03
AC   CVCL_VZ44
DR   IBRC; C10015
DR   Wikidata; Q98132494
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   1Y3M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB04
AC   CVCL_VZ45
DR   IBRC; C10016
DR   Wikidata; Q98132495
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   7Y5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB05
AC   CVCL_VZ46
DR   IBRC; C10017
DR   Wikidata; Q98132496
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   6Y5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB06
AC   CVCL_VZ47
DR   IBRC; C10726
DR   Wikidata; Q98132497
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB07
AC   CVCL_VZ48
DR   IBRC; C10727
DR   Wikidata; Q98132498
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB08
AC   CVCL_VZ49
DR   IBRC; C10728
DR   Wikidata; Q98132499
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShB09
AC   CVCL_VZ50
DR   IBRC; C10739
DR   Wikidata; Q98132500
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Baluchi; VBO=VBO_0001313.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   sHCC29
AC   CVCL_HE83
DR   Wikidata; Q54953258
RX   DOI=10.1158/1538-7445.AM2014-3622;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 5
//
ID   sHCC63
AC   CVCL_HE84
DR   Wikidata; Q54953260
RX   DOI=10.1158/1538-7445.AM2014-3622;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 5
//
ID   sHCC74
AC   CVCL_HE85
DR   Wikidata; Q54953262
RX   DOI=10.1158/1538-7445.AM2014-3622;
CC   Population: Chinese.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C43627; Sarcomatoid hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 21-03-23; Version: 5
//
ID   SHCDCLi001-A
AC   CVCL_C1W8
DR   hPSCreg; SHCDCLi001-A
DR   Wikidata; Q114313005
CC   From: Department of Central Laboratory, Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43532; MIR5004.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SHCDCLi001-B
AC   CVCL_C0JW
SY   MIR5004KO-2
DR   BioSamples; SAMEA12814054
DR   hPSCreg; SHCDCLi001-B
DR   Wikidata; Q112930386
RX   PubMed=35576811;
CC   From: Department of Central Laboratory, Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:43532; MIR5004.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8HA ! RC01001-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SHCDNi001-A
AC   CVCL_YT40
SY   SHCDN001
DR   BioSamples; SAMEA6880588
DR   hPSCreg; SHCDNi001-A
DR   SKIP; SKIP005801
DR   Wikidata; Q98132501
RX   PubMed=32416579;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:13601; FBXL4; Simple; p.Leu332Thrfs*3 (c.993dupA); Zygosity=Homozygous (PubMed=32416579).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172095; Mitochondrial DNA depletion syndrome 13
DI   ORDO; Orphanet_369897; Mitochondrial DNA depletion syndrome, encephalomyopathic form with variable craniofacial anomalies
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   SHCDNi002-A
AC   CVCL_YZ99
SY   SHCDN002
DR   BioSamples; SAMEA6878082
DR   hPSCreg; SHCDNi002-A
DR   SKIP; SKIP005751
DR   Wikidata; Q98132502
RX   PubMed=32505899;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11957; MED12; Simple; c.1249-1G>C; ClinVar=VCV001210232; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=32505899).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171270; FG syndrome type 1
DI   ORDO; Orphanet_93932; FG syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SHCDNi003-A
AC   CVCL_ZL96
SY   SHCDN003
DR   BioSamples; SAMEA7044788
DR   hPSCreg; SHCDNi003-A
DR   Wikidata; Q98132503
RX   PubMed=32603881;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10923; SLC16A2; Simple; c.1026+1G>A; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=32603881).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118843; Allan-Herndon-Dudley syndrome
DI   ORDO; Orphanet_59; Allan-Herndon-Dudley syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   SHCDNi004-A
AC   CVCL_A1WV
SY   SHCDN004
DR   hPSCreg; SHCDNi004-A
DR   Wikidata; Q105511067
RX   PubMed=33774333;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5996; IL1RAPL1; Simple; p.Leu349Serfs*7 (c.1043_1044dup); Zygosity=Hemizygous; Note=De novo mutation (PubMed=33774333).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179707; Intellectual developmental disorder, X-linked 21/34
DI   ORDO; Orphanet_777; X-linked non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 7
//
ID   SHCDNi005-A
AC   CVCL_A7IQ
SY   SHCDN005
DR   hPSCreg; SHCDNi005-A
DR   Wikidata; Q107116920
RX   PubMed=34968892;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:18060; ARX; Simple; p.Gln503Alafs*28 (c.1507_1508del); Zygosity=Hemizygous (PubMed=34968892).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179866; Developmental and epileptic encephalopathy 1
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SHCDNi006-A
AC   CVCL_B5RS
SY   SHCDN006
DR   BioSamples; SAMEA14207087
DR   hPSCreg; SHCDNi006-A
DR   Wikidata; Q112041713
RX   PubMed=35537242;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:18865; KCNT1; Simple; p.Ala934Thr (c.2800G>A); ClinVar=VCV000039594; Zygosity=Heterozygous; Note=De novo mutation (PubMed=35537242).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C188141; Developmental and epileptic encephalopathy 14
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SHCDNi007-A
AC   CVCL_C0JI
SY   20210812SLQZZ-C1-P6
DR   BioSamples; SAMEA13182979
DR   hPSCreg; SHCDNi007-A
DR   Wikidata; Q112930387
RX   PubMed=36508859;
CC   From: Shanghai Children's Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8636; PC; Simple; p.Ile61Thr (c.182T>C); Zygosity=Heterozygous (PubMed=36508859).
CC   Sequence variation: Mutation; HGNC; HGNC:8636; PC; Simple; p.Val861Met (c.2581G>A); Zygosity=Heterozygous (PubMed=36508859).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85040; Pyruvate carboxylase deficiency
DI   ORDO; Orphanet_3008; Pyruvate carboxylase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SHCDNRi001-A
AC   CVCL_ZA37
SY   IPS-51
DR   BioSamples; SAMEA6762569
DR   hPSCreg; SHCDNRi001-A
DR   SKIP; SKIP005799
DR   Wikidata; Q98132504
RX   PubMed=32416580;
CC   From: Department of Nephrology and Rheumatology, Shanghai Children's Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly409Ser (c.1225G>A); ClinVar=VCV000975073; Zygosity=Heterozygous (PubMed=32416580).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SHCE
AC   CVCL_6E72
SY   SV40-immortalized Human Corneal Epithelial cells
DR   Wikidata; Q54953263
RX   PubMed=26631824;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SHCHNDi001-A
AC   CVCL_B5FV
DR   BioSamples; SAMEA9097531
DR   hPSCreg; SHCHNDi001-A
DR   Wikidata; Q110433217
CC   From: Shanghai Children's Hospital; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SHCMDLi001-A
AC   CVCL_A8PJ
DR   hPSCreg; SHCMDLi001-A
DR   Wikidata; Q108821300
RX   PubMed=34088006;
CC   From: Shanghai Children's Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:20456; TRAF7; Simple; p.Arg655Gln (c.1964G>A); ClinVar=VCV000587685; Zygosity=Heterozygous; Note=De novo mutation (PubMed=34088006).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179868; Cardiac, facial, and digital anomalies with developmental delay
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   SHCMDLi002-A
AC   CVCL_A8PK
DR   hPSCreg; SHCMDLi002-A
DR   Wikidata; Q108821301
RX   PubMed=34088006;
CC   From: Shanghai Children's Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SHED clone B-2
AC   CVCL_F1H7
RX   PubMed=36713359;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SHEE10
AC   CVCL_4M96
SY   SHEE; H5E973; HFEE973
DR   Wikidata; Q54953264
RX   PubMed=11712078;
RX   PubMed=12439909;
RX   PubMed=12569775;
RX   PubMed=16364037;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=E6E7AAV).
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   SHEE100
AC   CVCL_4N01
SY   H5E973 at passage 100
DR   Wikidata; Q54953266
RX   PubMed=16364037;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=E6E7AAV).
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4N00 ! SHEE85
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   SHEE31
AC   CVCL_4M97
DR   Wikidata; Q54953267
RX   PubMed=11712078;
RX   PubMed=12439909;
RX   PubMed=12569775;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=E6E7AAV).
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M96 ! SHEE10
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   SHEE61
AC   CVCL_4M98
SY   H5E973 at passage 61
DR   Wikidata; Q54953268
RX   PubMed=11712078;
RX   PubMed=12439909;
RX   PubMed=12569775;
RX   PubMed=16364037;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=E6E7AAV).
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M97 ! SHEE31
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   SHEE61A
AC   CVCL_4M99
DR   Wikidata; Q54953271
RX   PubMed=11712078;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=E6E7AAV).
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M98 ! SHEE61
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   SHEE85
AC   CVCL_4N00
SY   H5E973 at passage 85
DR   Wikidata; Q54953272
RX   PubMed=12015026;
RX   PubMed=12439909;
RX   PubMed=12851721;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18) (Note=E6E7AAV).
CC   Derived from site: In situ; Fetal esophagus; UBERON=UBERON_0001043.
CC   Cell type: Epithelial cell of esophagus; CL=CL_0002252.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M98 ! SHEE61
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 9
//
ID   Shef-DDLPS 01
AC   CVCL_C8VC
SY   Shef-DDLPS01; STS 09/10 w2; Sheffield De-differentiated Liposarcoma Cell Line 01
DR   Wikidata; Q123033481
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 49.5 hours (Note=At 35th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,14
ST   D16S539: 9,10
ST   D21S11: 29,32
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-DDLPS 02
AC   CVCL_C8VD
SY   Shef-DDLPS02; STS 20/11; Sheffield De-differentiated Liposarcoma Cell Line 02
DR   Wikidata; Q123033482
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 58.22 hours (Note=At 23th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lower limb, hypodermis; UBERON=UBERON_0002103+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 14
ST   D16S539: 12
ST   D21S11: 29
ST   D5S818: 9
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 20
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-LMS 01 w1 variant
AC   CVCL_C8VE
SY   Shef-LMS01 w1; STS 02/11 w1; Sheffield Leiomyosarcoma Cell Line 01 (w1 variant)
DR   Wikidata; Q123033483
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 27.44 hours (Note=At 54th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pelvis, hypodermis; UBERON=UBERON_0002355+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 11
ST   D21S11: 27,30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8VF ! Shef-LMS 01 ws variant
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-LMS 01 ws variant
AC   CVCL_C8VF
SY   Shef-LMS01 ws; STS 02/11 ws; Sheffield Leiomyosarcoma Cell Line 01 (ws variant)
DR   Wikidata; Q123033484
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 44.62 hours (Note=At 63th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pelvis, hypodermis; UBERON=UBERON_0002355+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 11
ST   D21S11: 27,30
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8VE ! Shef-LMS 01 w1 variant
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 4
//
ID   Shef-MFS 01 w1 variant
AC   CVCL_C8VG
SY   Shef-MFS01 w1; STS 21/11 w1; Sheffield Myxofibrosarcoma Cell Line 01 (w1 variant)
DR   Wikidata; Q123033485
RX   PubMed=27560552;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 59.93 hours (Note=At 35th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, hypodermis; UBERON=UBERON_0001460+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8VH ! Shef-MFS 01 w2 variant
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-MFS 01 w2 variant
AC   CVCL_C8VH
SY   Shef-MFS01 w2; STS 21/11 w2; Sheffield Myxofibrosarcoma Cell Line 01 (w2 variant)
DR   Wikidata; Q123033486
RX   PubMed=27560552;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 56.30 hours (Note=At 31th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Arm, hypodermis; UBERON=UBERON_0001460+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 30,31.2
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8VG ! Shef-MFS 01 w1 variant
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-MFS 02
AC   CVCL_C8X1
SY   Sheffield Myxofibrosarcoma Cell Line 02
DR   Wikidata; Q123033487
RX   PubMed=29853780;
CC   Miscellaneous: Cell line is unavailable. It didn't develop much further beyond p2 (personal communication of Birkett, Ashley J.).
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   Shef-UPS 01
AC   CVCL_C8V9
SY   Shef-UPS01; STS 14/10; Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 01
DR   Wikidata; Q123033488
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 40.55 hours (Note=At 70th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lower limb, hypodermis; UBERON=UBERON_0002103+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 14
ST   D21S11: 27,30
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-UPS 02
AC   CVCL_C8VA
SY   Shef-UPS02; STS 06/11; Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 02
DR   Wikidata; Q123033489
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 35.38 hours (Note=At 91th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lower limb, hypodermis; UBERON=UBERON_0002103+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 11
ST   D21S11: 29,31
ST   D5S818: 9,13
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-UPS 03
AC   CVCL_C8VB
SY   Shef-UPS03; STS 09/11; Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 03
DR   Wikidata; Q123033490
RX   PubMed=27560552;
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 63.97 hours (Note=At 35th passage) (PubMed=27560552).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Lower limb, hypodermis; UBERON=UBERON_0002103+UBERON_0002072.
ST   Source(s): PubMed=27560552
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9
ST   D21S11: 28,31.2
ST   D5S818: 9,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   Shef-UPS 04
AC   CVCL_C8VI
SY   Shef-UPS04; STS 13/12; Sheffield Undifferentiated Pleomorphic Sarcoma Cell Line 04
DR   Wikidata; Q123033491
RX   PubMed=29853780;
WW   Provider; UOS; -; https://licensing.sheffield.ac.uk/product/sarcoma-cell-lines
CC   Doubling time: 43.49 hours (Direct_author_submission).
CC   Miscellaneous: Age/sex of donor, STR profile, doubling time and sampling site from personal communication of Birkett, Ashley J.
CC   Derived from site: In situ; Leg, hypodermis; UBERON=UBERON_0000978+UBERON_0002072.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 31.2,33.2
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   Shef1
AC   CVCL_9788
SY   SHEF1; Shef-1; SHEF-1; Shef 1; SHEFF-1; AXORe001-A
DR   EFO; EFO_0005454
DR   GEO; GSM569201
DR   GEO; GSM569202
DR   hPSCreg; AXORe001-A
DR   SKIP; SKIP001873
DR   Wikidata; Q54953274
RX   PubMed=15345125;
RX   PubMed=17287758;
RX   PubMed=17572666;
RX   PubMed=20224972;
RX   PubMed=20736931;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/shef-1.aspx
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-007, Steering comm. appl. SCSC04-28(1).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   Shef2
AC   CVCL_9789
SY   SHEF2; Shef-2; SHEF-2; Shef 2; SHEFF-2; AXORe002-A
DR   EFO; EFO_0005456
DR   GEO; GSM755490
DR   GEO; GSM755493
DR   hPSCreg; AXORe002-A
DR   SKIP; SKIP001874
DR   Wikidata; Q54953275
RX   PubMed=17572666;
RX   PubMed=20224972;
RX   PubMed=20736931;
RX   PubMed=21936705;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/shef-2.aspx
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-028, Steering comm. appl. SCSC04-28(2).
CC   Misspelling: SHEP-2; EFO=EFO_0005456.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   Shef3
AC   CVCL_9790
SY   SHEF3; Shef-3; SHEF-3; Shef 3; SHEFF-3; Sheff3; AXORe003-A; UOSe003-A
DR   EFO; EFO_0005455
DR   BioSamples; SAMEA104628042
DR   hPSCreg; UOSe003-A
DR   Lonza; 1393
DR   NIHhESC; NIHhESC-10-0077
DR   SKIP; SKIP001875
DR   Wikidata; Q54953277
RX   PubMed=17572666;
RX   PubMed=20224972;
RX   PubMed=20736931;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/shef-3.aspx
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0077.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-008, Steering comm. appl. SCSC04-29.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Shef3.2
AC   CVCL_BW72
SY   Shef 3-2
DR   Wikidata; Q54953278
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0059.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-003, Steering comm. appl. SCSC14-34.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9790 ! Shef3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   Shef4
AC   CVCL_9791
SY   SHEF4; Shef-4; SHEF-4; Shef 4; AXORe004-A
DR   hPSCreg; AXORe004-A
DR   SKIP; SKIP001876
DR   Wikidata; Q54953279
RX   PubMed=17287758;
RX   PubMed=20224972;
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0095.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-029, Steering comm. appl. SCSC05-22.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   Shef5
AC   CVCL_9792
SY   SHEF5; Shef-5; SHEF-5; Shef 5; AXORe005-A
DR   hPSCreg; AXORe005-A
DR   SKIP; SKIP001877
DR   Wikidata; Q54953281
RX   PubMed=17287758;
RX   PubMed=20224972;
RX   PubMed=27829140;
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-030, Steering comm. appl. SCSC05-22.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   Shef6
AC   CVCL_9793
SY   SHEF6; Shef-6; SHEF-6; Shef 6; AXORe006-A; UOSe006-A
DR   BioSamples; SAMEA104628040
DR   hPSCreg; UOSe006-A
DR   NIHhESC; NIHhESC-10-0078
DR   SKIP; SKIP001878
DR   Wikidata; Q54953282
RX   PubMed=20224972;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/shef-6.aspx
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0078.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-031, Steering comm. appl. SCSC05-23.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   Shef6.1
AC   CVCL_BW73
SY   Shef 6-1
DR   Wikidata; Q54953283
RX   PubMed=26607962;
RX   PubMed=28445466;
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0060.
CC   Registration: UK Stem Cell Bank (UKSCB); C-18-002, Steering comm. appl. SCSC14-35.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9793 ! Shef6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   Shef6EOS
AC   CVCL_C0VY
SY   S6EOS
DR   Wikidata; Q114313008
RX   PubMed=25215486;
RX   PubMed=28765214;
CC   Characteristics: Transduced with a EOS-C(3+)-GFP/puroR construct. EOS (ETn, Oct-4 and Sox2) combines a highly active promoter from a mouse early transposon (ETn) that is specific for undifferentiated pluripotent stem cells and combined it with Oct-4 (Pou5f1) and Sox2-binding motifs. EOS regulates an enhanced green fluorescent protein (eGFP), an internal ribosome entry site (IRES) and a puromycin resistance gene to allow live-cell visualization and antibiotic selection simultaneously.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9793 ! Shef6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   Shef7
AC   CVCL_9794
SY   SHEF7; Shef-7; SHEF-7; Shef 7; AXORe007-A
DR   hPSCreg; AXORe007-A
DR   SKIP; SKIP001879
DR   Wikidata; Q54953284
RX   PubMed=20224972;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/shef-7.aspx
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   From: Pfizer, Inc.; New York; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-004, Steering comm. appl. SCSC06-30.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   Shef8
AC   CVCL_9795
SY   SHEF8; Shef-8; Shef 8
DR   Wikidata; Q54953286
RX   PubMed=20224972;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/shef-8.aspx
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   From: Pfizer, Inc.; New York; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); R-08-015, Steering comm. appl. SCSC07-31.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   SHEFP-1
AC   CVCL_Z071
DR   Wikidata; Q54953315
RX   DOI=10.1007/BF01404489;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   SHEHDNi001-A
AC   CVCL_WT13
DR   BioSamples; SAMEA5796126
DR   hPSCreg; SHEHDNi001-A
DR   Wikidata; Q98132505
CC   From: Department of Neurology, Shanghai East Hospital; Shanghai; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   SHEHDNi002-A
AC   CVCL_A3BX
SY   KY03AP
DR   BioSamples; SAMEA7895017
DR   hPSCreg; SHEHDNi002-A
DR   Wikidata; Q105511072
RX   PubMed=38219303;
CC   From: Department of Neurology, Shanghai East Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple; p.Asn526Ser (c.1577A>G); ClinVar=VCV000706821; Zygosity=Heterozygous (PubMed=38219303).
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2385Arg (c.7153G>A); ClinVar=VCV000001943; Zygosity=Heterozygous (PubMed=38219303).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   SHEHi001-A
AC   CVCL_UK99
SY   KY02AO
DR   hPSCreg; SHEHi001-A
DR   Wikidata; Q98132506
CC   From: Shanghai East Hospital; Shanghai; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   SHEHi002-A
AC   CVCL_YX74
SY   5426; iPS36
DR   BioSamples; SAMEA6233350
DR   hPSCreg; SHEHi002-A
DR   SKIP; SKIP005822
DR   Wikidata; Q98132507
RX   PubMed=32062134;
CC   From: Shanghai East Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Arg858His (c.2573G>A); ClinVar=VCV000190653; Zygosity=Heterozygous (PubMed=32062134).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   SHEP-SF
AC   CVCL_2A38
SY   SH-EP/SF
DR   EFO; EFO_0002857
DR   cancercelllines; CVCL_2A38
DR   Wikidata; Q54953287
RX   PubMed=15150091;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 14
//
ID   SHEP-TR-miR-17-92
AC   CVCL_EI12
DR   cancercelllines; CVCL_EI12
DR   PRIDE; PRD000321
DR   Wikidata; Q54953289
RX   PubMed=21145484;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Tet-on system to induce the oncogenic miR-17-92 cluster with the addition of tetracycline to the culture medium.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 15
//
ID   SHEPrCDDP1000
AC   CVCL_RR78
DR   cancercelllines; CVCL_RR78
DR   Wikidata; Q54953291
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SHEPrDOX100
AC   CVCL_RS82
DR   cancercelllines; CVCL_RS82
DR   Wikidata; Q54953306
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SHEPrETO100
AC   CVCL_RR79
DR   cancercelllines; CVCL_RR79
DR   Wikidata; Q54953307
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SHEPrSNS-032_2000nM
AC   CVCL_RS18
SY   SHEPrSNS-032(2000nM)
DR   cancercelllines; CVCL_RS18
DR   Wikidata; Q54953308
RX   PubMed=27517323;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 17.9 +- 0.6 hours (PubMed=27517323).
CC   Selected for resistance to: ChEBI; CHEBI_91399; N-[5-[(5-tert-butyl-2-oxazolyl)methylthio]-2-thiazolyl]-4-piperidinecarboxamide (SNS-032; BMS-387032).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   SHEPrVCR1
AC   CVCL_RR80
DR   cancercelllines; CVCL_RR80
DR   Wikidata; Q54953310
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SHEPrVCR10
AC   CVCL_RS83
DR   cancercelllines; CVCL_RS83
DR   Wikidata; Q54953311
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SHEPrVCR20
AC   CVCL_RS84
DR   cancercelllines; CVCL_RS84
DR   Wikidata; Q54953312
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0524 ! SH-EP
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SHER-I
AC   CVCL_M782
SY   SHER-1
DR   Cosmic; 1590842
DR   Wikidata; Q54953314
RX   CelloPub=CLPUB00412;
RX   PubMed=15126569;
RX   PubMed=17786610;
RX   PubMed=19424640;
RX   PubMed=22038905;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   SHETi001-A
AC   CVCL_A1TF
SY   SHCHjhj-2A
DR   BioSamples; SAMEA7655489
DR   hPSCreg; SHETi001-A
DR   Wikidata; Q105511074
RX   PubMed=33517121;
CC   From: Department of Cardiology, Shanghai Children's Hospital, Shanghai Jiaotong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16974; SRCAP; Simple; p.Phe151Cysfs*71 (c.452_453del); Zygosity=Heterozygous (PubMed=33517121).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175241; Floating-Harbor syndrome
DI   ORDO; Orphanet_2044; Floating-Harbor syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SHETi002-A
AC   CVCL_A1TE
DR   BioSamples; SAMEA7683807
DR   hPSCreg; SHETi002-A
DR   Wikidata; Q105511078
RX   PubMed=33497884;
CC   From: Department of Cardiology, Shanghai Children's Hospital, Shanghai Jiaotong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2511; CTNNA3; Simple; p.Met737Ile (c.2211G>C); ClinVar=VCV000643288; Zygosity=Heterozygous (PubMed=33497884).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176008; Familial arrhythmogenic right ventricular dysplasia 13
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SHETi003-A
AC   CVCL_C1WH
DR   BioSamples; SAMEA12941516
DR   hPSCreg; SHETi003-A
DR   Wikidata; Q114313010
RX   PubMed=35679758;
CC   From: Department of Cardiology, Shanghai Children's Hospital, Shanghai Jiaotong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:27365; TECRL; Simple; p.Arg196Gln (c.587G>A); ClinVar=VCV000372284; Zygosity=Heterozygous (PubMed=35679758).
CC   Sequence variation: Mutation; HGNC; HGNC:27365; TECRL; Simple; c.918+3T>G; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35679758).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C189278; Catecholaminergic polymorphic ventricular tachycardia type 3
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SHETi004-A
AC   CVCL_D0LM
DR   BioSamples; SAMEA114221411
DR   hPSCreg; SHETi004-A
DR   Wikidata; Q123033492
RX   PubMed=37931536;
CC   From: Department of Cardiology, Shanghai Children's Hospital, Shanghai Jiaotong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2770; DES; Simple; p.Thr453Ile (c.1358C>T); ClinVar=VCV000066401; Zygosity=Heterozygous (PubMed=37931536).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=37931536
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 13,14
ST   D12S391: 23,24
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D19S433: 12,15.2
ST   D21S11: 28,30
ST   D2S1338: 16,23
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D6S1043: 11,14
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 20,24
ST   Penta D: 9,11
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C206515; Myofibrillar myopathy 1
DI   ORDO; Orphanet_98909; Desminopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   SHF-1
AC   CVCL_6F89
SY   SheepsHead Fin-1
DR   Wikidata; Q54953316
RX   DOI=10.1139/f78-081;
RX   DOI=10.2307/1444537;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 26 Celsius (DOI=10.1139/f78-081).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=119682; ! Archosargus probatocephalus (Sheepshead)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 8
//
ID   SHFDi001-A
AC   CVCL_ZR88
SY   SHFD-1
DR   BioSamples; SAMEA6963224
DR   hPSCreg; SHFDi001-A
DR   SKIP; SKIP005765
DR   Wikidata; Q98132508
RX   PubMed=32570173;
CC   From: Shanghai Stomatological Hospital, Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   SHFDi002-A
AC   CVCL_C1WI
DR   hPSCreg; SHFDi002-A
DR   Wikidata; Q114313011
CC   From: Shanghai Stomatological Hospital, Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SHG [Channa]
AC   CVCL_6F90
SY   SnakeHead Gonad
DR   Wikidata; Q54953317
RX   CelloPub=CLPUB00305;
WW   Provider; AAHL; -; https://aahl.res.in/snakehead-fish-channa-striatus-kidney-shk-gill-shg-and-heart-shh-cell-lines/
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gonad; UBERON=UBERON_0000991.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   SHG [Verasper]
AC   CVCL_IN54
SY   Spotted Halibut Gill
DR   Wikidata; Q54953319
RX   DOI=10.16441/j.cnki.hdxb.2010.09.012;
CC   Group: Fish cell line.
CC   Doubling time: 43.6 hours (DOI=10.16441/j.cnki.hdxb.2010.09.012).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=82366; ! Verasper variegatus (Spotted flounder)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   ShG
AC   CVCL_B7LN
DR   Wikidata; Q112930388
RX   PubMed=9536093;
CC   Population: Druze.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Pro12Argfs (c.35insGCGGGCG) (151ins7(GCGGGCG)fs329X); Zygosity=Homozygous (PubMed=9536093).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SHG-139
AC   CVCL_2H28
SY   SHG139; Suzhou Human Glioma-139
DR   Wikidata; Q54953320
RX   PubMed=25879429;
RX   PubMed=25975682;
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=25879429
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 12,15
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 9,12
ST   vWA: 17,18
DI   NCIt; C4322; Fibrillary astrocytoma
DI   ORDO; Orphanet_251601; Fibrillary astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   SHG-140
AC   CVCL_A0XC
SY   SHG140; Suzhou Human Glioma-140
DR   cancercelllines; CVCL_A0XC
DR   Wikidata; Q108821302
RX   PubMed=33391433;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Homozygous (PubMed=33391433).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg1968Ter (c.5902C>T) (p.Arg1947Ter, c.5839C>T); ClinVar=VCV000000343; Zygosity=Homozygous (PubMed=33391433).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.950_953delTACT) (p.VL317fs) (V317fs*3); Zygosity=Homozygous (PubMed=33391433).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=33391433).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=33391433
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 17,20
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 21
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D6S1043: 19
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 24,25
ST   Penta D: 9,13
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SHG-44
AC   CVCL_6728
SY   SHG 44; SHG44; Suzhou Human Glioma-44
DR   BTO; BTO_0003231
DR   Wikidata; Q54953321
RX   DOI=10.3321/j.issn:1000-5404.2001.03.006;
RX   PubMed=6525937;
RX   PubMed=19091570;
RX   PubMed=22038279;
RX   PubMed=25333456;
CC   Population: Chinese.
CC   Doubling time: 26.67 hours (PubMed=25333456).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: SGH-44; Note=Occasionally.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SHG-44/ADM
AC   CVCL_HF68
DR   Wikidata; Q54953323
RX   PubMed=25333456;
CC   Population: Chinese.
CC   Doubling time: 32.22 hours (PubMed=25333456).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Misspelling: SGH-44/ADM; PubMed=25333456; Note=In abstract and many parts of the text.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6728 ! SHG-44
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   SHGE-1
AC   CVCL_JE70
SY   SV40-transformed Human Gingival Epithelial cell line-1
DR   Wikidata; Q54953324
RX   PubMed=15088874;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   SHGE-2
AC   CVCL_JE71
SY   SV40-transformed Human Gingival Epithelial cell line-2
DR   Wikidata; Q54953325
RX   PubMed=15088874;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Epithelial cell of gingiva; CL=CL_0002621.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   SHH [Snakehead heart Japan]
AC   CVCL_R856
SY   SnakeHead Heart
DR   Wikidata; Q54953326
RX   CelloPub=CLPUB00103;
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   SHH [Snakehead heart Philippine]
AC   CVCL_6F91
SY   SnakeHead Heart
DR   Wikidata; Q54953328
RX   CelloPub=CLPUB00305;
WW   Provider; AAHL; -; https://aahl.res.in/snakehead-fish-channa-striatus-kidney-shk-gill-shg-and-heart-shh-cell-lines/
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   Shh Light
AC   CVCL_E8AK
SY   Shh-LIGHT
RX   PubMed=10984056;
CC   Characteristics: Useful for the quantitative assay of biologically active hedgehog proteins (PubMed=10984056).
CC   Characteristics: Transfected with a GLI-responsive firefly luciferase reporter as well as a constitutive (TK promoter driven) Renilla-luciferase reporter (PubMed=10984056).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Shh Light II
AC   CVCL_2721
SY   Shh-Light II; Shh Light 2; Shh LIGHT 2; Shh-LIGHT2; Shh Light2; Shh-Light2; Shh-L2
DR   CLO; CLO_0009010
DR   ATCC; CRL-2795
DR   ATCC; JHU-68
DR   ChEMBL-Cells; CHEMBL3430863
DR   ChEMBL-Targets; CHEMBL3430862
DR   PubChem_Cell_line; CVCL_2721
DR   Wikidata; Q54953329
RX   PubMed=10984056;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/6088-Shh-Light2-Cells.html
WW   Provider; JHTV; C04409; https://jhu.technologypublisher.com/technology/16328
CC   Characteristics: Useful for the quantitative assay of biologically active hedgehog proteins (PubMed=10984056).
CC   Characteristics: Transfected with a GLI-responsive firefly luciferase reporter as well as a constitutive (TK promoter driven) Renilla-luciferase reporter (PubMed=10984056).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Discontinued: ATCC; CRL-2795; true.
CC   Discontinued: ATCC; JHU-68; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   SHH-1
AC   CVCL_IQ83
SY   ShowChwan-Hwang-Hu-1
DR   Wikidata; Q54953330
RX   PubMed=17554590;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 36 hours (PubMed=17554590).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SHhES1
AC   CVCL_C732
SY   SJTUe001-A
DR   hPSCreg; SJTUe001-A
DR   SKIP; SKIP002256
DR   Wikidata; Q54953332
RX   PubMed=16319131;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SHhES2
AC   CVCL_C733
DR   Wikidata; Q54953334
RX   PubMed=19679563;
RX   PubMed=20186511;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=19679563
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   FGA: 21,24
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   SHhES3
AC   CVCL_C734
DR   Wikidata; Q54953335
RX   PubMed=20186511;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
ID   SHhES4
AC   CVCL_C735
DR   Wikidata; Q54953336
RX   PubMed=20186511;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
ID   SHHT
AC   CVCL_S148
SY   SnakeHead HearT
DR   Wikidata; Q54953337
RX   PubMed=15801161;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   SHI-1
AC   CVCL_2191
SY   shi-1; SHI1
DR   BTO; BTO_0005745
DR   BioSample; SAMN03473459
DR   cancercelllines; CVCL_2191
DR   Cell_Model_Passport; SIDM01787
DR   Cosmic; 1601065
DR   Cosmic; 1604864
DR   DepMap; ACH-001647
DR   DSMZ; ACC-645
DR   DSMZCellDive; ACC-645
DR   GEO; GSM1446762
DR   IARC_TP53; 21615
DR   Wikidata; Q54953339
RX   PubMed=15921626;
RX   PubMed=15951289;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Chinese.
CC   Doubling time: ~36 hours (PubMed=15951289); ~60-70 hours (DSMZ=ACC-645).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7137; AFDN + HGNC; HGNC:7132; KMT2A; Name(s)=KMT2A-AFDN, MLL-MLLT4, MLL-AF6 (PubMed=15921626; PubMed=15951289).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (DepMap=ACH-001647).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (DepMap=ACH-001647).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DepMap=ACH-001647; DSMZ=ACC-645
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 15,17
ST   D21S11: 30,30.2
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 11,14
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   NCIt; C132105; Acute myeloid leukemia with t(6;11)(q27;q23) KMT2A-MLLT4
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   Shi/FeT-1C
AC   CVCL_V314
DR   Wikidata; Q54953340
RX   Patent=US5846825;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11976.
CC   Characteristics: IL2 dependent.
CC   Virology: Persistently infected by feline immunodeficiency virus (FIV) isolate Shi.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_3686 ! FeT-1C
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Shimozuma-1
AC   CVCL_F748
DR   Wikidata; Q54953341
RX   PubMed=2579855;
CC   Virology: Infected by porcine retrovirus Tsukuba-1.
DI   NCIt; C134786; Porcine lymphoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 9
//
ID   SHIN-3
AC   CVCL_A670
SY   SHIN3; Shin3
DR   cancercelllines; CVCL_A670
DR   Cosmic; 877481
DR   Cosmic; 945374
DR   Cosmic; 1152561
DR   Cosmic; 1526883
DR   Cosmic; 2482713
DR   GEO; GSM459739
DR   Progenetix; CVCL_A670
DR   Wikidata; Q54953343
RX   CelloPub=CLPUB00115;
RX   DOI=10.5795/jjscc.27.926;
RX   PubMed=2314830;
RX   PubMed=2469292;
RX   PubMed=8718548;
RX   PubMed=8980248;
RX   PubMed=15677628;
CC   Population: Japanese.
CC   Doubling time: 48.3 hours (Note=At 12th passage), 26.7 hours (Note=At 20th passage) (PubMed=2314830).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=8980248).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (PubMed=8980248).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   SHIN-3/PTEN
AC   CVCL_W128
DR   cancercelllines; CVCL_W128
DR   Wikidata; Q54953344
RX   PubMed=18347155;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9588; PTEN.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A670 ! SHIN-3
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   SHIPMi001-A
AC   CVCL_B0JP
SY   SHIi001
DR   BioSamples; SAMEA9676225
DR   hPSCreg; SHIPMi001-A
DR   Wikidata; Q108821303
RX   PubMed=34785479;
CC   From: Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Leu460Trpfs*6 (c.1377delC); ClinVar=VCV000188548; Zygosity=Heterozygous (PubMed=34785479).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SHIPMi002-A
AC   CVCL_B0JQ
SY   SHIi002
DR   BioSamples; SAMEA9716845
DR   hPSCreg; SHIPMi002-A
DR   Wikidata; Q108821304
RX   PubMed=34785479;
CC   From: Shanghai Institute of Precision Medicine, Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   ShiPS-miFF1
AC   CVCL_1E69
SY   ShiPS-MIFF1; MIFF1; MIFF-1; mRNA Induced Foreskin Fibroblast-1; UOSi001-A
DR   BioSamples; SAMEA5573424
DR   hPSCreg; UOSi001-A
DR   SKIP; SKIP002473
DR   Wikidata; Q54953345
RX   PubMed=26810087;
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   ShiPS-miFF3
AC   CVCL_1E70
SY   ShiPS-MIFF3; MIFF3; MIFF-3; mRNA Induced Foreskin Fibroblast-3; UOSi001-B
DR   BioSamples; SAMEA5424900
DR   hPSCreg; UOSi001-B
DR   SKIP; SKIP002499
DR   Wikidata; Q54953347
RX   PubMed=26810087;
CC   From: University of Sheffield; Sheffield; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   ShispAEC.B-2
AC   CVCL_RW86
SY   Sigmodon hispidus Airway Epithelial Cells B subclone 2
DR   Wikidata; Q54953348
RX   PubMed=27142375;
CC   Virology: Susceptible to infection by vesicular stomatitis virus strain Indiana, Rift Valley fever virus (RVFV) clone 13, West Nile virus (WNV) strain New York and tick-borne encephalitis virus (TBEV) strain K23.
CC   Virology: Not susceptible to infection by Moussa virus, Ferak virus and Cavally virus.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
OX   NCBI_TaxID=42415; ! Sigmodon hispidus (Hispid cotton rat)
OI   CVCL_RW87 ! ShispREC.B-6
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 10
//
ID   ShispREC.B-6
AC   CVCL_RW87
SY   Sigmodon hispidus Renal Epithelial Cells B subclone 6
DR   Wikidata; Q54953349
RX   PubMed=27142375;
CC   Virology: Susceptible to infection by vesicular stomatitis virus (VSV) strain Indiana, Rift Valley fever virus (RVFV) clone 13, West Nile virus (WNV) strain New York and tick-borne encephalitis virus (TBEV) strain K23.
CC   Virology: Not susceptible to infection by Moussa virus, Ferak virus and Cavally virus.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=42415; ! Sigmodon hispidus (Hispid cotton rat)
OI   CVCL_RW86 ! ShispAEC.B-2
SX   Male
AG   3M
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 9
//
ID   SHJO
AC   CVCL_E827
SY   SH.JO; SMJ
DR   dbMHC; 49018
DR   ECACC; 94022547
DR   IHW; IHW09239
DR   IPD-IMGT/HLA; 11384
DR   Wikidata; Q54953350
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*23:01:01,24:02:01:01; B*50:01:01,42:01:01; C*06:02:01:02,17:01:01:02; DPA1*01:03:01:02,03:01; DPB1*03:01,04:02; DQA1*02:01,03:03:01; DQB1*02:02:01:01; DRB1*07:01:01; DRB4*01:01:01:01,01:03:01 (IPD-IMGT/HLA=11384).
CC   HLA typing: A*23:01:01,24:02:01:01; B*50:01:01,42:01:01; C*06:02:01:02;17:01:01:02; DPA1*01:03:01:02,03:01; DPB1*104:01(124:01),105:01(463:01); DQA1*02:01:01,03:03:01:01; DQB1*02:02:01:01; DRB1*07:01:01; DRB4*01:01:01:01,01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   SHK [Channa]
AC   CVCL_6F92
SY   SnakeHead Kidney
DR   Wikidata; Q54953353
RX   CelloPub=CLPUB00305;
WW   Provider; AAHL; -; https://aahl.res.in/snakehead-fish-channa-striatus-kidney-shk-gill-shg-and-heart-shh-cell-lines/
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   SHK [Verasper]
AC   CVCL_W850
SY   Spotted Halibut Kidney
DR   Wikidata; Q54953352
RX   DOI=10.1007/s11802-010-0162-1;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=82366; ! Verasper variegatus (Spotted flounder)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 05-10-23; Version: 10
//
ID   ShK
AC   CVCL_B3QN
DR   Wikidata; Q110433218
RX   PubMed=11572760;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5853; IGL; Name(s)=IGL-BCL2 (PubMed=12967475).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=12967475).
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 4
//
ID   SHK-1
AC   CVCL_4299
SY   SHK1; Salmon Head Kidney-1
DR   CCLV; CCLV-RIE 0489
DR   ECACC; 97111106
DR   Wikidata; Q54953354
RX   DOI=10.1006/fsim.1996.0076;
RX   PubMed=7782764;
RX   PubMed=15825496;
RX   PubMed=19162334;
RX   PubMed=30537062;
RX   PubMed=31049989;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious salmon anaemia virus (ISAV).
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
ID   SHL
AC   CVCL_6F93
SY   SnakeHead Liver
DR   Wikidata; Q54953355
RX   CelloPub=CLPUB00305;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   ShLb01
AC   CVCL_VZ09
DR   IBRC; C10019
DR   Wikidata; Q98132509
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb02
AC   CVCL_VZ10
DR   IBRC; C10020
DR   Wikidata; Q98132510
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4-5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb03
AC   CVCL_VZ11
DR   IBRC; C10021
DR   Wikidata; Q98132511
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb04
AC   CVCL_VZ12
DR   IBRC; C10022
DR   Wikidata; Q98132512
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb05
AC   CVCL_VZ13
DR   IBRC; C10023
DR   Wikidata; Q98132513
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb06
AC   CVCL_VZ14
DR   IBRC; C10024
DR   Wikidata; Q98132514
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb07
AC   CVCL_VZ15
DR   IBRC; C10025
DR   Wikidata; Q98132516
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   4-5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb08
AC   CVCL_VZ16
DR   IBRC; C10026
DR   Wikidata; Q98132518
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShLb09
AC   CVCL_VZ17
DR   IBRC; C10027
DR   Wikidata; Q98132521
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Lori-Bakhtiari; VBO=VBO_0016082.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4-5M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   SHM-A6
AC   CVCL_9088
AS   CVCL_KR27
SY   SHM A6; A6; A-6
DR   CLO; CLO_0001602
DR   ATCC; CRL-8192
DR   Wikidata; Q54607070
RX   Patent=US4574116;
RX   PubMed=6316357;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8192.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
HI   CVCL_J236 ! FU-266 clone E1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   SHM-D33
AC   CVCL_3419
SY   SHMD-33; SHMD33; D-33
DR   CLO; CLO_0009011
DR   CLDB; cl4294
DR   CLDB; cl4295
DR   ATCC; CRL-1668
DR   ICLC; ATL94001
DR   RCB; RCB0267
DR   TKG; TKG 0246
DR   Wikidata; Q54953378
RX   PubMed=6316357;
RX   PubMed=18514220;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: RCB; RCB0267; true.
CC   Discontinued: TKG; TKG 0246; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
HI   CVCL_J236 ! FU-266 clone E1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   SHM-D33S
AC   CVCL_E8WS
RX   PubMed=3084658;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3419 ! SHM-D33
CA   Hybrid cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ShM1
AC   CVCL_VZ18
DR   IBRC; C10040
DR   Wikidata; Q98132524
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM10
AC   CVCL_VZ19
DR   IBRC; C10036
DR   Wikidata; Q98132527
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM11
AC   CVCL_VZ20
DR   IBRC; C10033
DR   Wikidata; Q98132528
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM12
AC   CVCL_VZ21
DR   IBRC; C10044
DR   Wikidata; Q98132529
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM13
AC   CVCL_VZ22
DR   IBRC; C10042
DR   Wikidata; Q98132531
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM14
AC   CVCL_VZ23
DR   IBRC; C10034
DR   Wikidata; Q98132533
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM15
AC   CVCL_VZ24
DR   IBRC; C10045
DR   Wikidata; Q98132534
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM2
AC   CVCL_VZ25
DR   IBRC; C10041
DR   Wikidata; Q98132535
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM3
AC   CVCL_VZ26
DR   IBRC; C10043
DR   Wikidata; Q98132536
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM4
AC   CVCL_VZ27
DR   IBRC; C10039
DR   Wikidata; Q98132537
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM5
AC   CVCL_VZ28
DR   IBRC; C10037
DR   Wikidata; Q98132538
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM6
AC   CVCL_VZ29
DR   IBRC; C10046
DR   Wikidata; Q98132539
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM7
AC   CVCL_VZ30
DR   IBRC; C10047
DR   Wikidata; Q98132541
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM8
AC   CVCL_VZ31
DR   IBRC; C10038
DR   Wikidata; Q98132542
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShM9
AC   CVCL_VZ32
DR   IBRC; C10035
DR   Wikidata; Q98132543
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mehrabani; VBO=VBO_0016093.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   Shmac 1
AC   CVCL_AR57
DR   ECACC; 11102001
DR   Wikidata; Q54953379
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ECACC=11102001
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 7,10
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 13
//
ID   Shmac 2
AC   CVCL_F280
DR   Wikidata; Q54953380
RX   PubMed=17163777;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   Shmac 3
AC   CVCL_F281
DR   Wikidata; Q54953381
RX   PubMed=17163777;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   Shmac 4
AC   CVCL_2722
DR   DepMap; ACH-001648
DR   ECACC; 10112302
DR   Wikidata; Q54953384
RX   PubMed=17163777;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): DepMap=ACH-001648; ECACC=10112302
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,14
ST   D18S51: 15
ST   D21S11: 30,31.2
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   D8S1179: 9,12
ST   FGA: 21
ST   Penta D: 11,12
ST   Penta E: 7
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   Shmac 5
AC   CVCL_2723
SY   SHMAC5
DR   DepMap; ACH-001649
DR   ECACC; 10112303
DR   Wikidata; Q54953385
RX   PubMed=17163777;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): DepMap=ACH-001649; ECACC=10112303
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 12,14
ST   D7S820: 7,12
ST   D8S1179: 11,14
ST   FGA: 22.2
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 15 (DepMap=ACH-001649)
ST   vWA: 15,17 (ECACC=10112303)
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   Shmac 6
AC   CVCL_F282
DR   Wikidata; Q54953386
RX   PubMed=17163777;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   SHMS
AC   CVCL_S149
SY   SnakeHead MuScle
DR   Wikidata; Q54953387
RX   PubMed=15801161;
CC   Group: Fish cell line.
CC   Doubling time: 39 hours (Note=At 20-25 Celsius), ~33 hours (Note=With 20% FBS at 30 Celsius), ~48 hours (Note=With 10% FBS at 30 Celsius) (PubMed=15801161).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   SHO
AC   CVCL_A1ZT
DR   Wikidata; Q105511082
RX   PubMed=8402660;
RX   PubMed=9192833;
CC   Doubling time: 21 hours (PubMed=8402660).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 02-05-24; Version: 4
//
ID   SHOK
AC   CVCL_3164
SY   Syrian Hamster Osaka-Kanazawa cells
DR   CLO; CLO_0009012
DR   CLDB; cl4296
DR   ECACC; 90071805
DR   JCRB; IFO50367
DR   RCB; RCB0453
DR   Wikidata; Q54953389
RX   PubMed=2181436;
RX   PubMed=3148601;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_8153 ! GHE-L
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   SHOV4
AC   CVCL_XJ63
DR   CCRID; 4201PAT-CCTCC01300
DR   Wikidata; Q98132544
RX   Patent=CN109486767B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018195.
CC   Population: Chinese; Han.
CC   Doubling time: ~48 hours (Patent=CN109486767B).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Patent=CN109486767B
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D12S391: 21,22
ST   D13S317: 8,11,12
ST   D16S539: 11,12
ST   D18S51: 15,16,17
ST   D19S433: 14,14.2
ST   D21S11: 29,30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta D: 12,13
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 8
//
ID   Shox2
AC   CVCL_2Z99
DR   ATCC; CRL-3256
DR   Wikidata; Q54953390
RX   PubMed=23877224;
CC   Characteristics: Transfected with a vector containing a Shox2 promoter (PubMed=23877224).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: 129S1/SvImJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C316 ! CJ7
SX   Male
AG   Blastocyst stage
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   SHP-77
AC   CVCL_1693
SY   SHP77; Shadyside Hospital Pittsburgh-77
DR   BTO; BTO_0003726
DR   CLO; CLO_0009013
DR   EFO; EFO_0002328
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2195
DR   BioSample; SAMN03472563
DR   BioSample; SAMN10988529
DR   cancercelllines; CVCL_1693
DR   Cell_Model_Passport; SIDM01078
DR   ChEMBL-Cells; CHEMBL3308363
DR   ChEMBL-Targets; CHEMBL612569
DR   Cosmic; 724872
DR   Cosmic; 844577
DR   Cosmic; 877392
DR   Cosmic; 1152487
DR   Cosmic; 1759309
DR   Cosmic; 1995626
DR   Cosmic; 2125288
DR   Cosmic; 2239081
DR   Cosmic-CLP; 724872
DR   DepMap; ACH-000790
DR   ECACC; 98110201
DR   EGA; EGAS00001000978
DR   GDSC; 724872
DR   GEO; GSM169447
DR   GEO; GSM887569
DR   GEO; GSM888652
DR   GEO; GSM1374870
DR   GEO; GSM1887913
DR   GEO; GSM1887995
DR   IARC_TP53; 27237
DR   IGRhCellID; SHP77
DR   LiGeA; CCLE_667
DR   LINCS_LDP; LCL-1823
DR   NCI-DTP; SHP-77
DR   PharmacoDB; SHP77_1375_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1693
DR   PubChem_Cell_line; CVCL_1693
DR   Ubigene; YC-B049
DR   Wikidata; Q54953391
RX   PubMed=212181;
RX   PubMed=2985251;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=12068308;
RX   PubMed=17426248;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=39154123;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 85 hours (PubMed=212181); 96 hours (PubMed=2985251).
CC   HLA typing: A*02:01,24:02; B*40:08,54:01; C*03:08,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (Cosmic-CLP=724872; DepMap=ACH-000790).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=724872; DepMap=ACH-000790).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (Cosmic-CLP=724872; DepMap=ACH-000790).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (Cosmic-CLP=724872; DepMap=ACH-000790).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.14%; Native American=0.63%; East Asian, North=3.39%; East Asian, South=0%; South Asian=0%; European, North=49.1%; European, South=43.74% (PubMed=30894373).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
ST   Source(s): ATCC=CRL-2195; Cosmic-CLP=724872; ECACC=98110201; Ubigene=YC-B049
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14,14.1
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 19
ST   Penta D: 13
ST   Penta E: 10
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   SHP-77 DLL3 KO clone 2B1
AC   CVCL_E8SN
SY   SHP77-DLL3-KO-2B1
DR   KYinno; KC-4352
CC   Population: Caucasian.
CC   Doubling time: ~85 hours (KYinno=KC-4352).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1693 ! SHP-77
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SHP-77 DLL3 KO clone 2C3
AC   CVCL_E8SP
SY   SHP77-DLL3-KO-2C3
DR   KYinno; KC-4353
CC   Population: Caucasian.
CC   Doubling time: ~85 hours (KYinno=KC-4353).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1693 ! SHP-77
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SHP-77/Luciferase
AC   CVCL_E8SS
SY   SHP-77 / Luciferase
WW   Provider; GenTarget; SC085-Luc; https://www.gentarget.com/product/human-shp-77-luciferase-stable-cell-line/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-Rsv-PuroR construct (GenTarget=SC085-Luc).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1693 ! SHP-77
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SHP-77/Luciferase-2A-GFP
AC   CVCL_E8ST
SY   SHP-77 / Luciferase & GFP
WW   Provider; GenTarget; SC085-LG; https://www.gentarget.com/product/human-shp-77-luciferase-gfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-GFP-Rsv-PuroR construct (GenTarget=SC085-LG).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1693 ! SHP-77
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SHP-77/Luciferase-2A-RFP
AC   CVCL_E8SU
SY   SHP-77 / Luciferase & RFP
WW   Provider; GenTarget; SC085-LR; https://www.gentarget.com/product/human-shp-77-luciferase-rfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-RFP-Rsv-PuroR construct (GenTarget=SC085-LR).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1693 ! SHP-77
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SHP-77/RFP
AC   CVCL_E8SV
SY   SHP-77 / RFP
WW   Provider; GenTarget; SC085-R; https://www.gentarget.com/product/human-shp-77-rfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-RFP-Rsv-PuroR construct (GenTarget=SC085-R).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Val1128Glu (c.3383T>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Tyr32Cys (c.95A>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Trp (c.528C>G); ClinVar=VCV000376572; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, left upper lobe; UBERON=UBERON_0008952.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1693 ! SHP-77
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   sHPT-1
AC   CVCL_0I22
DR   Wikidata; Q54953393
RX   PubMed=17126301;
RX   PubMed=26973719;
CC   Doubling time: ~72 hours (PubMed=17126301).
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
DI   NCIt; C3630; Benign parathyroid gland neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   sHPT-1/TET1
AC   CVCL_A8V1
DR   Wikidata; Q102114918
RX   PubMed=26973719;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29484; TET1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Parathyroid gland; UBERON=UBERON_0001132.
DI   NCIt; C3630; Benign parathyroid gland neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0I22 ! sHPT-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   Shs
AC   CVCL_UF03
DR   CLO; CLO_0009014
DR   CLDB; cl4297
DR   Wikidata; Q98132545
CC   Derived from site: In situ; Fetal thyroid gland; UBERON=UBERON_0003091.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   SHS
AC   CVCL_6F94
SY   SnakeHead Spleen
DR   Wikidata; Q54953394
RX   CelloPub=CLPUB00305;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   SHSB
AC   CVCL_S150
SY   SnakeHead Swim Bladder
DR   Wikidata; Q54953395
RX   PubMed=15801161;
CC   Group: Fish cell line.
CC   Doubling time: 43 hours (PubMed=15801161).
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   SHSY-5Y Tet-On SNCA
AC   CVCL_A7QJ
SY   SHSY-5Y Tet-On Inducible Alpha-Synuclein
DR   cancercelllines; CVCL_A7QJ
DR   Millipore; SCC291
DR   Wikidata; Q107116922
CC   Population: Caucasian.
CC   Characteristics: Inducible expression of SNCA upon treatment with doxycycline. Serves as a model for both dopaminergic neuronal biology and a-synuclein pathology (Millipore=SCC291).
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11138; SNCA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Millipore=SCC291
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 8,13
ST   D18S51: 13,16
ST   D21S11: 31,31.2
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 23.2,24
ST   Penta D: 10,12
ST   Penta E: 7,11
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   SHSY5Y-B7H6
AC   CVCL_VA24
DR   cancercelllines; CVCL_VA24
DR   Wikidata; Q54953398
RX   PubMed=29453518;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:42400; NCR3LG1.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   SHSY5Y#15 rho-0
AC   CVCL_D7J8
DR   CancerTools; 162188
DR   Kerafast; ESA125
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SHT-1
AC   CVCL_IQ81
SY   ShowChwan-Hwang-Tsai-1
DR   Wikidata; Q54953400
RX   PubMed=17554590;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 39 hours (PubMed=17554590).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SHT290
AC   CVCL_G213
SY   Stromal Human TERT 290
DR   ABM; T0739
DR   Kerafast; ENC017
DR   Wikidata; Q54953401
RX   PubMed=15772261;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   SHTCMi001-A
AC   CVCL_D6J8
DR   BioSamples; SAMEA114861130
DR   hPSCreg; SHTCMi001-A
DR   Wikidata; Q127384293
CC   From: Affiliated Hospital of Shandong University of Traditional Chinese Medicine; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SHTUi001-A
AC   CVCL_C1WJ
DR   hPSCreg; SHTUi001-A
DR   Wikidata; Q114313012
CC   From: ShanghaiTech University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SHTUi002-A
AC   CVCL_C1WK
DR   hPSCreg; SHTUi002-A
DR   Wikidata; Q114313013
CC   From: ShanghaiTech University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SHUPLi001-A
AC   CVCL_ZI84
SY   IPS-14
DR   BioSamples; SAMEA7044755
DR   hPSCreg; SHUPLi001-A
DR   SKIP; SKIP005771
DR   Wikidata; Q98132546
RX   PubMed=32592952;
CC   From: Shanghai University of Political Science and Law; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   SHUPLi002-A
AC   CVCL_C1WL
SY   iPS-26
DR   hPSCreg; SHUPLi002-A
DR   Wikidata; Q114313014
RX   PubMed=38631181;
CC   From: Shanghai University of Political Science and Law; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 02-05-24; Version: 4
//
ID   SHY
AC   CVCL_E828
DR   dbMHC; 49019
DR   IHW; IHW09379
DR   IPD-IMGT/HLA; 25988
DR   Wikidata; Q54953402
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   HLA typing: A*29; B*41; C*02; DRB1*10 (IPD-IMGT/HLA=25988).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   SHZ-88
AC   CVCL_7163
DR   CCRID; 3101RATTCR5
DR   CLS; 305209
DR   Wikidata; Q54953403
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   ShZ01
AC   CVCL_VZ33
DR   IBRC; C10052
DR   Wikidata; Q98132547
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ02
AC   CVCL_VZ34
DR   IBRC; C10058
DR   Wikidata; Q98132548
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ03
AC   CVCL_VZ35
DR   IBRC; C10059
DR   Wikidata; Q98132549
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ04
AC   CVCL_VZ36
DR   IBRC; C10056
DR   Wikidata; Q98132550
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ05
AC   CVCL_VZ37
DR   IBRC; C10054
DR   Wikidata; Q98132551
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ06
AC   CVCL_VZ38
DR   IBRC; C10053
DR   Wikidata; Q98132552
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   1Y2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ07
AC   CVCL_VZ39
DR   IBRC; C10051
DR   Wikidata; Q98132553
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   1Y4M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ08
AC   CVCL_VZ40
DR   IBRC; C10061
DR   Wikidata; Q98132554
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ09
AC   CVCL_VZ41
DR   IBRC; C10055
DR   Wikidata; Q98132555
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   ShZ10
AC   CVCL_VZ42
DR   IBRC; C10057
DR   Wikidata; Q98132556
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Zandi; VBO=VBO_0016101.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   SI #1
AC   CVCL_C7S8
SY   SI I; Siggins I
DR   Wikidata; Q117704869
RX   PubMed=1066320;
RX   PubMed=4524119;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7S9 ! SI #2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SI #2
AC   CVCL_C7S9
SY   SI II
DR   Wikidata; Q117704870
RX   PubMed=4524119;
CC   Derived from site: In situ; Bone, left leg; UBERON=UBERON_0005893.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7S8 ! SI #1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   Si-1
AC   CVCL_3165
DR   JCRB; JCRB1369
DR   Wikidata; Q54953406
RX   PubMed=6122826;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Si-2
AC   CVCL_3166
DR   JCRB; JCRB1321
DR   Wikidata; Q54953408
RX   PubMed=6309601;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9543; ! Macaca fuscata fuscata (Japanese macaque)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Si-IIA
AC   CVCL_X690
SY   SiIIA
DR   Wikidata; Q54953410
RX   PubMed=2118885;
RX   PubMed=7928626;
RX   PubMed=9284968;
RX   PubMed=10971128;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 114769; Cynomolgus Epstein-Barr Virus Si-IIA.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   SI-PMEC
AC   CVCL_W953
SY   Spontaneously Immortalized-Porcine Mammary Epithelial Cell line
DR   Wikidata; Q54953411
RX   PubMed=16919976;
CC   Doubling time: 20-22 hours (PubMed=16919976).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 10
//
ID   Si-TGCT-1
AC   CVCL_C6ML
SY   Siriraj-Tenosynovial Giant Cell Tumor-1
DR   Wikidata; Q116050501
RX   PubMed=36456782;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 141.92 +- 0.85 hours (Note=In 1% FBS), 78.87 +- 2.39 hours (Note=In 10% FBS) (PubMed=36456782).
CC   Derived from site: In situ; Knee, tendon sheath; UBERON=UBERON_0001465+UBERON_0000304.
ST   Source(s): PubMed=36456782
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D10S1248: 13,16
ST   D12S391: 18,20
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D18S51: 12,18
ST   D19S433: 12,15.2
ST   D1S1656: 13,15
ST   D21S11: 30,31.2
ST   D22S1045: 11
ST   D2S1338: 17,20
ST   D2S441: 12,15
ST   D3S1358: 16,18
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 13,15
ST   DYS391: 10
ST   DYS570: 17
ST   DYS576: 20
ST   FGA: 21.2,24
ST   Penta D: 9,13
ST   Penta E: 11,18
ST   SE33: 28.2
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C6535; Malignant tenosynovial giant cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Si-TGCT-2
AC   CVCL_C6MM
SY   Siriraj-Tenosynovial Giant Cell Tumor-2
DR   Wikidata; Q116050502
RX   PubMed=36456782;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 271.38 +- 1.53 hours (Note=In 1% FBS), 51.03 +- 3.52 hours (Note=In 10% FBS) (PubMed=36456782).
CC   Derived from site: In situ; Ankle, tendon sheath; UBERON=UBERON_0001488+UBERON_0000304.
ST   Source(s): PubMed=36456782
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 19
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 14,16.2
ST   D1S1656: 14,18.3
ST   D21S11: 29,33.2
ST   D22S1045: 16
ST   D2S1338: 19,23
ST   D2S441: 11,12
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 10,14
ST   DYS391: 10
ST   DYS570: 17
ST   DYS576: 21
ST   FGA: 19,23
ST   Penta D: 8,9
ST   Penta E: 11
ST   SE33: 22,31.2
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C6535; Malignant tenosynovial giant cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Si-TGCT-3
AC   CVCL_C6MN
SY   Siriraj-Tenosynovial Giant Cell Tumor-3
DR   Wikidata; Q116050503
RX   PubMed=36456782;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 136.87 +- 1.86 hours (Note=In 1% FBS), 52.89 +- 1.13 hours (Note=In 10% FBS) (PubMed=36456782).
CC   Derived from site: In situ; Hip, tendon sheath; UBERON=UBERON_0001486+UBERON_0000304.
ST   Source(s): PubMed=36456782
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D10S1248: 12,14
ST   D12S391: 19,21
ST   D13S317: 8
ST   D16S539: 13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D1S1656: 15,16
ST   D21S11: 30
ST   D22S1045: 16
ST   D2S1338: 20
ST   D2S441: 11,12
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 24,26
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   SE33: 19,21
ST   TH01: 7,10
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C6535; Malignant tenosynovial giant cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Si-TGCT-4
AC   CVCL_C6MP
SY   Siriraj-Tenosynovial Giant Cell Tumor-4
DR   Wikidata; Q116050504
RX   PubMed=36456782;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 92.60 +- 1.80 hours (Note=In 1% FBS), 45.34 +- 1.17 hours (Note=In 10% FBS) (PubMed=36456782).
CC   Derived from site: In situ; Knee, tendon sheath; UBERON=UBERON_0001465+UBERON_0000304.
ST   Source(s): PubMed=36456782
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 16,17
ST   D12S391: 15,18
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15.2,16.2
ST   D1S1656: 15,17
ST   D21S11: 32,33.2
ST   D22S1045: 11,17
ST   D2S1338: 17,18
ST   D2S441: 11.3,15
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   DYS391: 10
ST   DYS570: 20
ST   DYS576: 17
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 12,14
ST   SE33: 21,28.2
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C6535; Malignant tenosynovial giant cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SIA
AC   CVCL_F582
SY   TER197
DR   IPD-IMGT/HLA; 12184
DR   Wikidata; Q54953412
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,02:01; B*08:01,53:06; C*02:02,07:01 (IPD-IMGT/HLA=12184).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   SIAC1
AC   CVCL_VJ92
SY   Small Intestinal AdenoCarcinoma 1
DR   Cosmic; 2646092
DR   Wikidata; Q98132557
RX   PubMed=25478808;
CC   Population: Japanese.
CC   Microsatellite instability: Instable (MSI-high) (PubMed=25478808).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Unexplicit; Ex3-4del; Zygosity=Heterozygous (PubMed=25478808).
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
DI   NCIt; C7888; Small intestinal adenocarcinoma
DI   ORDO; Orphanet_104075; Adenocarcinoma of the small instestine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   SIAISi001-A
AC   CVCL_YK99
SY   RJ1901ZWF
DR   BioSamples; SAMEA6500875
DR   hPSCreg; SIAISi001-A
DR   SKIP; SKIP005813
DR   Wikidata; Q98132559
RX   PubMed=32007762;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=32007762).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32007762
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 15,15.2
ST   D1S1656: 15
ST   D21S11: 28,29
ST   D2S1338: 18,25
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D6S1043: 14,17
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 19,23
ST   Penta D: 12,13
ST   Penta E: 12,22
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   SIAISi002-A
AC   CVCL_YK98
SY   RJ1902LXM
DR   BioSamples; SAMEA6504182
DR   hPSCreg; SIAISi002-A
DR   Wikidata; Q98132560
RX   PubMed=32339902;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=32339902).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SIAISi003-A
AC   CVCL_ZA27
SY   15F0006
DR   BioSamples; SAMEA6877859
DR   hPSCreg; SIAISi003-A
DR   SKIP; SKIP005825
DR   Wikidata; Q98132561
RX   PubMed=32822964;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=32822964).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SIAISi004-A
AC   CVCL_ZA28
SY   ZYF
DR   BioSamples; SAMEA6880592
DR   hPSCreg; SIAISi004-A
DR   Wikidata; Q98132562
RX   PubMed=34450529;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=34450529).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   SIAISi005-A
AC   CVCL_ZA29
SY   JBQ
DR   hPSCreg; SIAISi005-A
DR   Wikidata; Q98132563
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   SIAISi006-A
AC   CVCL_ZA30
SY   JJY
DR   BioSamples; SAMEA7762095
DR   hPSCreg; SIAISi006-A
DR   Wikidata; Q98132564
RX   PubMed=33472125;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=33472125).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SIAISi007-A
AC   CVCL_ZA31
SY   ZSJ
DR   BioSamples; SAMEA6880593
DR   hPSCreg; SIAISi007-A
DR   Wikidata; Q98132565
RX   PubMed=33472125;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=33472125).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SIAISi008-A
AC   CVCL_ZA32
SY   ZMY
DR   BioSamples; SAMEA6880594
DR   hPSCreg; SIAISi008-A
DR   Wikidata; Q98132567
RX   PubMed=33472125;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=33472125).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SIAISi009-A
AC   CVCL_ZA33
SY   YJP
DR   BioSamples; SAMEA7893610
DR   hPSCreg; SIAISi009-A
DR   Wikidata; Q98132568
RX   PubMed=33524675;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=33524675).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   SIAISi010-A
AC   CVCL_ZA34
SY   16F0040; LJM
DR   BioSamples; SAMEA7762136
DR   hPSCreg; SIAISi010-A
DR   Wikidata; Q98132570
RX   PubMed=33799282;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   SIAISi011-A
AC   CVCL_ZA35
SY   15F0003; NZM
DR   BioSamples; SAMEA7764247
DR   hPSCreg; SIAISi011-A
DR   Wikidata; Q98132571
RX   PubMed=33465532;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   SIAISi012-A
AC   CVCL_ZA36
SY   QHL
DR   BioSamples; SAMEA7895014
DR   hPSCreg; SIAISi012-A
DR   Wikidata; Q98132572
RX   PubMed=33610016;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   SIAISi013-A
AC   CVCL_A7GJ
DR   hPSCreg; SIAISi013-A
DR   Wikidata; Q107116923
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   SIAISi014-A
AC   CVCL_B3S0
DR   hPSCreg; SIAISi014-A
DR   Wikidata; Q110433220
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   SIAISi015-A
AC   CVCL_B3S1
DR   hPSCreg; SIAISi015-A
DR   Wikidata; Q110433221
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   SIAISi016-A
AC   CVCL_B3S2
SY   ZYY
DR   BioSamples; SAMEA14366679
DR   hPSCreg; SIAISi016-A
DR   Wikidata; Q110433222
RX   PubMed=37148820;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=37148820).
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Heterozygous; Note=ApoE2 allele (PubMed=37148820).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 8
//
ID   SIAISi017-A
AC   CVCL_B3S3
SY   ZY
DR   BioSamples; SAMEA9697105
DR   hPSCreg; SIAISi017-A
DR   Wikidata; Q110433223
RX   PubMed=35093714;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese/Asian ethnic group: Hui.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   SIAISi018-A
AC   CVCL_B3S4
SY   GSX
DR   BioSamples; SAMEA9717412
DR   hPSCreg; SIAISi018-A
DR   Wikidata; Q110433224
RX   PubMed=35124538;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   SIAISi019-A
AC   CVCL_B7EA
SY   SJZF
DR   BioSamples; SAMEA13370869
DR   hPSCreg; SIAISi019-A
DR   Wikidata; Q112930389
RX   PubMed=35853414;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35853414).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SIAISi020-A
AC   CVCL_B7EB
SY   XLM
DR   BioSamples; SAMEA13371398
DR   hPSCreg; SIAISi020-A
DR   Wikidata; Q112930390
RX   PubMed=35853414;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35853414).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97250; Intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SIAISi021-A
AC   CVCL_C1W9
SY   JRM
DR   BioSamples; SAMEA110107467
DR   hPSCreg; SIAISi021-A
DR   Wikidata; Q114313015
RX   PubMed=35843023;
CC   From: Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=35843023).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SIB-1
AC   CVCL_S924
DR   Wikidata; Q54953413
RX   PubMed=8039117;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   SIB186
AC   CVCL_F406
DR   CLO; CLO_0051119
DR   RCB; HSC0096
DR   Wikidata; Q54953415
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Sibundoy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   SiBBE
AC   CVCL_A2HP
DR   Wikidata; Q105511084
RX   PubMed=33033327;
CC   Population: Southeast Asian; Thai.
CC   Doubling time: 17 hours (PubMed=33033327).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.His3His (c.9T>C); ClinVar=VCV000193106; Zygosity=Heterozygous (PubMed=33033327).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu27Lys (c.79G>A) (E26K); ClinVar=VCV000015161; Zygosity=Heterozygous (PubMed=33033327).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.315+16G>C; ClinVar=VCV000256345; Zygosity=Heterozygous (PubMed=33033327).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-185C>T; ClinVar=VCV000036316; Zygosity=Homozygous (PubMed=33033327).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mononuclear cell; CL=CL_0000842.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   SIC
AC   CVCL_XZ73
DR   KCB; KCB 85022
DR   Wikidata; Q98132573
RX   PubMed=22086079;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=94196; ! Viverricula indica (Small Indian civet)
SX   Female
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   SICE
AC   CVCL_R922
SY   Sahul Indian Catla Eye
DR   NRFC; NRFC018
DR   Wikidata; Q54953416
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1111/j.1095-8649.2008.01851.x;
WW   Provider; AAHL; -; https://aahl.res.in/catla-catla-catla-heart-sich-brain-cb-gill-icg-and-eye-sice-cell-lines/
WW   Provider; NRFC; NRFC018; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC018.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   SICH
AC   CVCL_R811
SY   Sahul Indian Catla Heart
DR   NRFC; NRFC019
DR   Wikidata; Q54953417
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1016/j.aquaculture.2009.05.012;
WW   Provider; AAHL; -; https://aahl.res.in/catla-catla-catla-heart-sich-brain-cb-gill-icg-and-eye-sice-cell-lines/
WW   Provider; NRFC; NRFC019; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC019.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=72446; ! Labeo catla (Catla)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   SIE-EO-801
AC   CVCL_AV41
DR   Wikidata; Q54953419
RX   CelloPub=CLPUB00312;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=248899; ! Ectropis obliqua (Tea geometrid moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   SIE-EO-803
AC   CVCL_AV42
DR   Wikidata; Q54953421
RX   CelloPub=CLPUB00312;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=248899; ! Ectropis obliqua (Tea geometrid moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   SIE-Ha-798
AC   CVCL_Z954
DR   ICLDB; sie-ha-798
DR   Wikidata; Q54953422
RX   CelloPub=CLPUB00212;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SIE-Ha-806
AC   CVCL_Z955
DR   ICLDB; sie-ha-806
DR   Wikidata; Q54953423
RX   CelloPub=CLPUB00212;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=29058; ! Helicoverpa armigera (Cotton bollworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SIE-MSH-805
AC   CVCL_B3NG
SY   SIE-Ls-805
DR   Wikidata; Q110433225
RX   CelloPub=CLPUB00654;
RX   PubMed=34599689;
CC   Group: Insect cell line.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   SIE-MSH-805-F
AC   CVCL_B3NJ
SY   MSH-F
DR   Wikidata; Q110433226
RX   PubMed=2273288;
CC   Group: Insect cell line.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
HI   CVCL_B3NG ! SIE-MSH-805
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   SIE-MSH-805-At
AC   CVCL_B3NK
SY   MSAH-At
DR   Wikidata; Q110433227
RX   PubMed=2273288;
CC   Group: Insect cell line.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
HI   CVCL_B3NG ! SIE-MSH-805
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   SIG-M5
AC   CVCL_1694
SY   SigM5; SIGM5
DR   CLO; CLO_0009016
DR   EFO; EFO_0006751
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473111
DR   BioSample; SAMN03473559
DR   BioSample; SAMN10989556
DR   cancercelllines; CVCL_1694
DR   Cell_Model_Passport; SIDM00396
DR   ChEMBL-Cells; CHEMBL3308248
DR   ChEMBL-Targets; CHEMBL2366251
DR   Cosmic; 787476
DR   Cosmic; 909715
DR   Cosmic; 975299
DR   Cosmic; 1012117
DR   Cosmic; 1281352
DR   Cosmic; 1465968
DR   Cosmic; 2131558
DR   Cosmic; 2306238
DR   Cosmic; 2750871
DR   Cosmic-CLP; 909715
DR   DepMap; ACH-000112
DR   DSMZ; ACC-468
DR   DSMZCellDive; ACC-468
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909715
DR   GEO; GSM887571
DR   GEO; GSM888654
DR   GEO; GSM1374871
DR   GEO; GSM1670421
DR   IARC_TP53; 27574
DR   LiGeA; CCLE_115
DR   LINCS_LDP; LCL-1071
DR   PharmacoDB; SIGM5_1376_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1694
DR   PubChem_Cell_line; CVCL_1694
DR   Wikidata; Q54953425
RX   PubMed=10848831;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 50-60 hours (PubMed=10848831); ~72 hours (DSMZ=ACC-468).
CC   HLA typing: A*01:01,24:02; B*07:02,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=909715; DepMap=ACH-000112).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.46%; Native American=0%; East Asian, North=4.98%; East Asian, South=0%; South Asian=0%; European, North=48.84%; European, South=43.72% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=909715; DSMZ=ACC-468; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 15,16,18
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 19,20
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 14,16
ST   FGA: 22,26
ST   Penta D: 10,13
ST   Penta E: 7,19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SIGC
AC   CVCL_6729
SY   Spontaneously Immortalized Granulosa Cell line
DR   Wikidata; Q54953426
RX   PubMed=1845958;
RX   PubMed=15541573;
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
CC   Breed/subspecies: Berlin-Druckrey IV (BD-IV); RS=RS_0000089.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   45D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SIGE
AC   CVCL_R923
SY   Sahul Indian Grouper Eye
DR   NRFC; NRFC016
DR   Wikidata; Q54953427
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=17216384;
WW   Provider; AAHL; -; https://aahl.res.in/grouper-epinephelus-coioides-eye-sige-kidney-gk-heart-gh-and-brain-gb-cell-lines/
WW   Provider; NRFC; NRFC016; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC016.
CC   Virology: Susceptible to infection by marine birnaviru isolate NC-1 (MABV NC-1) and marine birnavirus isolate Y-6 (MABV Y-6).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=94232; ! Epinephelus coioides (Orange-spotted grouper)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   SIGi001-A
AC   CVCL_EE38
SY   iPSC0028; IPSC0028; Sigma iPSC 0028; Si28; iPSC Epithelial-1; iPSC EPITHELIAL-1
DR   BioSamples; SAMEA4447455
DR   EBiSC; SIGi001-A
DR   ECACC; 66540499
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A
DR   Sigma-Aldrich; IPSC0028
DR   Wikidata; Q54953429
RX   PubMed=35689659;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; SIGi001-A; true.
CC   Discontinued: ECACC; 66540499; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=35689659; Sigma-Aldrich=IPSC0028
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   Penta D: 8,11
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   SIGi001-A-1
AC   CVCL_EF83
SY   iPSC0028 SLC17A7/GFP E3
DR   BioSamples; SAMEA4451096
DR   EBiSC; SIGi001-A-1
DR   ECACC; 66540356
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-1
DR   SKIP; SKIP002822
DR   Wikidata; Q54953430
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a T2A-GFP construct was integrated in the SLC17a7 gene (hPSCreg=SIGi001-A-1).
CC   Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540356; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   SIGi001-A-10
AC   CVCL_II92
SY   iPSC0028 MAPT P301S+Ex10+16/Clone 7G4A8
DR   BioSamples; SAMEA4451117
DR   EBiSC; SIGi001-A-10
DR   ECACC; 66540358
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-10
DR   SKIP; SKIP002831
DR   Wikidata; Q54953431
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-10).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-10).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540358; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   SIGi001-A-11
AC   CVCL_LE50
SY   IPSC0028 MAPT P301S+Ex10+16/Clone 7C6A4
DR   BioSamples; SAMEA4451118
DR   EBiSC; SIGi001-A-11
DR   ECACC; 66540359
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-11
DR   Wikidata; Q54953432
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-11).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-11).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540359; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   SIGi001-A-12
AC   CVCL_LL41
SY   iPSC0028 BiAllelic MAPT_Ex10+16T/Clone 1F5-D12
DR   BioSamples; SAMEA104237570
DR   EBiSC; SIGi001-A-12
DR   ECACC; 66540611
DR   hPSCreg; SIGi001-A-12
DR   Wikidata; Q54953434
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-12).
CC   Discontinued: ECACC; 66540611; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   SIGi001-A-13
AC   CVCL_LL42
SY   iPSC0028 MonoAllelic MAPT_Ex10+16T/Clone 1D01-11
DR   BioSamples; SAMEA104386250
DR   EBiSC; SIGi001-A-13
DR   ECACC; 66540631
DR   hPSCreg; SIGi001-A-13
DR   Wikidata; Q54953456
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Heterozygous; Note=By method not specified (EBiSC=SIGi001-A-13).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-13).
CC   Discontinued: ECACC; 66540631; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 14
//
ID   SIGi001-A-14
AC   CVCL_A7GS
SY   SIGi001-A Bi-Allelic MAPT HA-tag; BIONi039-A-14
DR   BioSamples; SAMEA6080813
DR   EBiSC; SIGi001-A-14
DR   ECACC; 66541213
DR   hPSCreg; SIGi001-A-14
DR   Wikidata; Q107116924
CC   Population: Caucasian.
CC   Characteristics: Contains a HA tag at the C-terminal of both alleles of MAPT (hPSCreg=SIGi001-A-14).
CC   Discontinued: ECACC; 66541213; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 8
//
ID   SIGi001-A-16
AC   CVCL_A7GT
SY   SIGi001-A-9 Bi-Allelic MAPT HA-tag; BIONi039-A-16
DR   BioSamples; SAMEA6080815
DR   EBiSC; SIGi001-A-16
DR   ECACC; 66541215
DR   hPSCreg; SIGi001-A-16
DR   Wikidata; Q107116926
CC   Population: Caucasian.
CC   Characteristics: Contains a HA tag at the C-terminal of both alleles of MAPT (hPSCreg=SIGi001-A-16).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Homozygous; Note=By method not specified (hPSCreg=SIGi001-A-16).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-16).
CC   Discontinued: ECACC; 66541215; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EF90 ! SIGi001-A-9
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 9
//
ID   SIGi001-A-2
AC   CVCL_II91
SY   iPSC0028 SLC17A7/GFP C3
DR   BioSamples; SAMEA4451116
DR   EBiSC; SIGi001-A-2
DR   ECACC; 66540357
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-2
DR   SKIP; SKIP002823
DR   Wikidata; Q54953457
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a T2A-GFP construct was integrated in the SLC17a7 gene (hPSCreg=SIGi001-A-2).
CC   Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540357; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 13
//
ID   SIGi001-A-20
AC   CVCL_C1U6
SY   Sigma-SOX9; KULi002-A-20
DR   BioSamples; SAMEA6703233
DR   hPSCreg; SIGi001-A-20
DR   Wikidata; Q114313016
RX   PubMed=33982246;
CC   From: KU Leuven; Leuven; Belgium.
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a cassette containing a Tet-ON SOX9 construct framed by FRT and FRT3 sites was introduced in the AAVS1 safe harbor locus (PubMed=33982246).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:11204; SOX9.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   SIGi001-A-21
AC   CVCL_C1U5
SY   SIGi001-AAVS1-FRT; KULi002-A-21
DR   BioSamples; SAMEA111379999
DR   hPSCreg; SIGi001-A-21
DR   Wikidata; Q114313017
CC   From: KU Leuven; Leuven; Belgium.
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a FRT-Hyg-TK-FRT construct was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 6
//
ID   SIGi001-A-3
AC   CVCL_EF84
SY   iPSC0028 MAPT P301L C4
DR   BioSamples; SAMEA4448571
DR   EBiSC; SIGi001-A-3
DR   ECACC; 66540331
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-3
DR   SKIP; SKIP002824
DR   Wikidata; Q54953458
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous; Note=By method not specified (EBiSC=SIGi001-A-3).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540331; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   SIGi001-A-4
AC   CVCL_EF85
SY   iPSC0028 MAPT P301L D4
DR   BioSamples; SAMEA4448632
DR   EBiSC; SIGi001-A-4
DR   ECACC; 66540332
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-4
DR   SKIP; SKIP002825
DR   Wikidata; Q54953459
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Leu (c.902C>T) (P618L, c.1853C>T or P636L, c.1907C>T); ClinVar=VCV000014245; Zygosity=Heterozygous; Note=By method not specified (EBiSC=SIGi001-A-4).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540332; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   SIGi001-A-5
AC   CVCL_EF86
SY   iPSC0028 MAPT P301S 1C9C4
DR   BioSamples; SAMEA4448708
DR   EBiSC; SIGi001-A-5
DR   ECACC; 66540333
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-5
DR   SKIP; SKIP002826
DR   Wikidata; Q54953461
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Heterozygous; Note=By method not specified (EBiSC=SIGi001-A-5).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540333; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   SIGi001-A-6
AC   CVCL_EF87
SY   iPSC0028 MAPT P301S 1B9C9
DR   BioSamples; SAMEA4447426
DR   EBiSC; SIGi001-A-6
DR   ECACC; 66540326
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-6
DR   SKIP; SKIP002827
DR   Wikidata; Q54953463
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-6).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540326; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   SIGi001-A-7
AC   CVCL_EF88
SY   iPSC0028 MAPT P301S 2G2B7
DR   BioSamples; SAMEA4448730
DR   EBiSC; SIGi001-A-7
DR   ECACC; 66540334
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-7
DR   SKIP; SKIP002828
DR   Wikidata; Q54953464
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Heterozygous; Note=By method not specified (EBiSC=SIGi001-A-7).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540334; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   SIGi001-A-8
AC   CVCL_EF89
SY   iPSC0028 MAPT P301S+Ex10+16/Clone 7D11A7
DR   BioSamples; SAMEA4448777
DR   EBiSC; SIGi001-A-8
DR   ECACC; 66540335
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-8
DR   SKIP; SKIP002829
DR   Wikidata; Q54953467
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Heterozygous; Note=By method not specified (EBiSC=SIGi001-A-8).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-8).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540335; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   SIGi001-A-9
AC   CVCL_EF90
SY   iPSC0028 MAPT P301S+Ex10+16/Clone 7H6A1
DR   BioSamples; SAMEA4447499
DR   EBiSC; SIGi001-A-9
DR   ECACC; 66540327
DR   EGA; EGAS00001002755
DR   hPSCreg; SIGi001-A-9
DR   SKIP; SKIP002830
DR   Wikidata; Q54953468
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; p.Pro301Ser (c.901C>T) (P618S, c.1852C>T or P636S, c.1906C>T); ClinVar=VCV000014256; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-9).
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple_edited; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Homozygous; Note=By method not specified (EBiSC=SIGi001-A-9).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540327; true.
CC   Cell type: Epithelial cell; CL=CL_0000066.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 16
//
ID   Sigma-NGN1
AC   CVCL_D3XQ
SY   Si28-NGN1
DR   Wikidata; Q127384295
RX   PubMed=35689659;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a TurboRFP-2A-NGN1 construct. Expresses NEUROG1/NGN1 upon induction by doxycycline (PubMed=35689659).
CC   Genetic integration: Method=Transduction; Gene=FPbase; AHNXC; TurboRFP (Note=Orange fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7764; NEUROG1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): PubMed=35689659
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 10,14
ST   FGA: 22,25
ST   Penta D: 8,11
ST   Penta E: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE38 ! SIGi001-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   SiHa
AC   CVCL_0032
SY   Siha; SIHA
DR   BTO; BTO_0002210
DR   CLO; CLO_0009017
DR   EFO; EFO_0002379
DR   MCCL; MCC:0000451
DR   CLDB; cl4298
DR   CLDB; cl4299
DR   CLDB; cl4900
DR   AddexBio; C0008002/372
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-35
DR   BioGRID_ORCS_Cell_line; 1796
DR   BioSample; SAMN03473215
DR   BioSample; SAMN10989623
DR   cancercelllines; CVCL_0032
DR   CCRID; 1101HUM-PUMC000294
DR   CCRID; 1102HUM-NIFDC00092
DR   CCRID; 3101HUMSCSP5058
DR   CCRID; 3101HUMTCHu113
DR   CCRID; 4201HUM-CCTCC00110
DR   CCTCC; GDC0110
DR   Cell_Model_Passport; SIDM01093
DR   ChEMBL-Cells; CHEMBL3307968
DR   ChEMBL-Targets; CHEMBL612542
DR   CLS; 305023
DR   Cosmic; 760220
DR   Cosmic; 809229
DR   Cosmic; 846184
DR   Cosmic; 877467
DR   Cosmic; 925356
DR   Cosmic; 928911
DR   Cosmic; 930297
DR   Cosmic; 1019306
DR   Cosmic; 1131517
DR   Cosmic; 1193028
DR   Cosmic; 1201773
DR   Cosmic; 1324212
DR   Cosmic; 1995627
DR   Cosmic; 2301542
DR   Cosmic; 2660193
DR   Cosmic; 2791018
DR   Cosmic; 2816217
DR   Cosmic-CLP; 930297
DR   DepMap; ACH-000556
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 930297
DR   GEO; GSM113866
DR   GEO; GSM226740
DR   GEO; GSM226876
DR   GEO; GSM253302
DR   GEO; GSM675738
DR   GEO; GSM685444
DR   GEO; GSM722576
DR   GEO; GSM722577
DR   GEO; GSM723057
DR   GEO; GSM723058
DR   GEO; GSM1670422
DR   GEO; GSM1716411
DR   GEO; GSM1716412
DR   GEO; GSM1716413
DR   GEO; GSM1716414
DR   GEO; GSM1716415
DR   GEO; GSM1716416
DR   GEO; GSM1716423
DR   GEO; GSM1716424
DR   GEO; GSM1716425
DR   GEO; GSM1716426
DR   GEO; GSM7701382
DR   IARC_TP53; 21696
DR   ICLC; HTL98017
DR   IGRhCellID; SiHa
DR   IZSLER; BS TCL 112
DR   KCB; KCB 2013026YJ
DR   KCLB; 30035
DR   LINCS_LDP; LCL-1542
DR   PharmacoDB; SiHa_1377_2019
DR   PRIDE; PXD001806
DR   PRIDE; PXD005466
DR   PRIDE; PXD029773
DR   PRIDE; PXD030304
DR   PRIDE; PXD030885
DR   Progenetix; CVCL_0032
DR   PubChem_Cell_line; CVCL_0032
DR   TOKU-E; 3119
DR   Wikidata; Q54953470
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1394225;
RX   PubMed=2990217;
RX   PubMed=3029430;
RX   PubMed=3029760;
RX   PubMed=3518877;
RX   PubMed=5529598;
RX   PubMed=10423141;
RX   PubMed=15531914;
RX   PubMed=16957166;
RX   PubMed=17311676;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20429727;
RX   PubMed=21439369;
RX   PubMed=22412903;
RX   PubMed=23881600;
RX   PubMed=24134916;
RX   PubMed=24201445;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28261610;
RX   PubMed=29156801;
RX   PubMed=30760827;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35198691;
RX   PubMed=35421932;
RX   PubMed=35692560;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-22.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Japanese.
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (PubMed=24201445).
CC   Doubling time: 2.6 days (PubMed=29156801); 17 hours (Note=In 10% FBS), 21 hours (Note=In 5% FBS) (PubMed=30760827).
CC   HLA typing: A*24:02,24:02; B*40:02,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=84.36%; East Asian, South=15.4%; South Asian=0%; European, North=0%; European, South=0.24% (PubMed=30894373).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): AddexBio=C0008002/372; ATCC=HTB-35; CCRID; Cosmic-CLP=930297; KCLB=30035; PubMed=25877200; PubMed=29156801
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 8,12 (PubMed=29156801)
ST   D16S539: 12 (AddexBio=C0008002/372; ATCC=HTB-35; CCRID; Cosmic-CLP=930297; KCLB=30035; PubMed=25877200)
ST   D18S51: 15
ST   D19S433: 14.2
ST   D21S11: 29,31
ST   D2S1338: 24
ST   D3S1358: 16,17
ST   D5S818: 9
ST   D7S820: 10
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 8 (AddexBio=C0008002/372; ATCC=HTB-35; CCRID; Cosmic-CLP=930297; KCLB=30035; PubMed=25877200)
ST   TPOX: 8,9 (PubMed=29156801)
ST   vWA: 14,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   SiHa fat-1
AC   CVCL_E6ZA
SY   f-SiHa
DR   ABM; T6261
RX   DOI=10.1136/esmoopen-2018-EACR25.164;
CC   Population: Japanese.
CC   Characteristics: Applicable for studies investigating the effects of endogenous omega3-polyunsaturated fatty acids (ABM=T6261).
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (from parent cell line).
CC   Doubling time: 30-40 hours (ABM=T6261).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9NEQ0; Caenorhabditis elegans omega-3 fatty acid desaturase fat-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SiHa-APOA1
AC   CVCL_C0TY
DR   PRIDE; PXD030885
DR   Wikidata; Q112930391
RX   PubMed=35421932;
CC   Population: Japanese.
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:600; APOA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   SiHa-NTRpuro
AC   CVCL_X529
DR   Wikidata; Q54953472
RX   PubMed=14997211;
CC   Population: Japanese.
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P38489; Escherichia coli nitroreductase nfnB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 14
//
ID   SiHa/cDDP
AC   CVCL_K031
DR   CCRID; 4201PAT-CCTCC00271
DR   Wikidata; Q54953473
RX   Patent=CN101503674B;
RX   PubMed=22650020;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200903.
CC   Population: Japanese.
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (from parent cell line).
CC   Doubling time: 45.82 +- 3.69 hours (PubMed=22650020).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 20
//
ID   SiHa/VP16
AC   CVCL_XB80
DR   CCRID; 4201PAT-CCTCC00272
DR   Wikidata; Q98132574
RX   Patent=CN101503673B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200904.
CC   Population: Japanese.
CC   Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   SIHN-005A
AC   CVCL_W318
DR   Wikidata; Q54953474
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 38.0 +- 1.1 hours (PubMed=11497283).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W319 ! SIHN-005B
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   SIHN-005B
AC   CVCL_W319
DR   Wikidata; Q54953475
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 45.9 +- 1.4 hours (PubMed=11497283).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W318 ! SIHN-005A
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   SIHN-006
AC   CVCL_H947
SY   SI-HN-006; HN006
DR   ChEMBL-Cells; CHEMBL3308668
DR   ChEMBL-Targets; CHEMBL614827
DR   PubChem_Cell_line; CVCL_H947
DR   Wikidata; Q54953476
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=15197768;
CC   Doubling time: 35.1 +- 1.7 hours (PubMed=11497283).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SIHN-008
AC   CVCL_W320
DR   Wikidata; Q54953477
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 31.1 +- 2.5 hours (PubMed=11497283).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   SIHN-011A
AC   CVCL_W321
DR   Wikidata; Q54953478
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 40.1 +- 1.5 hours (PubMed=11497283).
CC   Derived from site: In situ; Pharynx, hypopharynx, pyriform sinus; UBERON=UBERON_8480022.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W322 ! SIHN-011B
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   SIHN-011B
AC   CVCL_W322
DR   Wikidata; Q54953479
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 36.8 +- 1.9 hours (PubMed=11497283).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W321 ! SIHN-011A
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 10
//
ID   SIHN-013
AC   CVCL_W323
DR   Wikidata; Q54953480
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 40.6 +- 0.6 hours (PubMed=11497283).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W325 ! SIHN-013/2
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   SIHN-013/2
AC   CVCL_W325
SY   SIHN-13/2
DR   Wikidata; Q54953481
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 76.3 +- 1.5 hours (PubMed=11497283).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W323 ! SIHN-013
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   SIHN-015B
AC   CVCL_W324
DR   Wikidata; Q54953482
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 47.6 +- 1.3 hours (PubMed=11497283).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   SIHN-034B
AC   CVCL_W326
DR   Wikidata; Q54953484
RX   PubMed=10760816;
RX   PubMed=11497283;
RX   PubMed=12124801;
CC   Doubling time: 57.5 +- 1.6 hours (PubMed=11497283).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   SIK
AC   CVCL_D525
DR   Wikidata; Q54953485
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=7949178;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   SIKR
AC   CVCL_5T83
DR   Wikidata; Q54953487
RX   PubMed=4416368;
RX   PubMed=4672577;
CC   Breed/subspecies: 129/Sv-SlJ-CP.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4277 ! PSA1
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   SIKR-OSB
AC   CVCL_5T84
DR   Wikidata; Q54953488
RX   PubMed=650144;
CC   Breed/subspecies: 129/Sv-SlJ-CP.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5T83 ! SIKR
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   SIL-6/1
AC   CVCL_U118
DR   CLO; CLO_0050547
DR   RCB; RCB1792
DR   Wikidata; Q54953489
CC   Characteristics: IL6 or KITLG dependent.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_N545 ! A-6
SX   Male
AG   Blastocyst stage
CA   Factor-dependent cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Silfere
AC   CVCL_W936
SY   NK9; NK-9; NK 9; NK9c
DR   CGH-DB; 9202-4
DR   Cosmic; 931133
DR   Wikidata; Q54953491
RX   PubMed=2985879;
RX   PubMed=3026973;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4174339;
RX   PubMed=4178827;
RX   PubMed=4320167;
RX   PubMed=4321974;
RX   PubMed=4878906;
RX   PubMed=5786183;
RX   PubMed=6286514;
RX   PubMed=9473234;
RX   PubMed=11515428;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 12
//
ID   Silvanus
AC   CVCL_QW70
SY   SILVANUS
DR   Wikidata; Q54953492
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7919343;
RX   PubMed=9444937;
CC   Doubling time: 2-3 days (PubMed=9444937).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   SIM-A9
AC   CVCL_5I31
SY   Spontaneously Immortalized Microglia-A9
DR   ABM; T0247
DR   ATCC; CRL-3265
DR   ChEMBL-Cells; CHEMBL4879541
DR   Kerafast; END001
DR   Wikidata; Q54953493
RX   PubMed=24975292;
RX   PubMed=32287325;
CC   Doubling time: 2-3 days (Kerafast=END001).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   SIM.2
AC   CVCL_1Y14
DR   BEI_Resources; ARP-511
DR   Wikidata; Q54953495
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 6
//
ID   SIM.4
AC   CVCL_1Y15
DR   BEI_Resources; ARP-512
DR   Wikidata; Q54953496
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P01730; Human CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 6
//
ID   SIM/EW27
AC   CVCL_0097
SY   SIM(EW27); SIM-EW27; SIMON; Simon; SIM
DR   Cosmic; 721018
DR   Wikidata; Q54953494
CC   From: Delattre, Olivier; Institut Curie; Paris; France.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   SiMa
AC   CVCL_1695
SY   SIMA
DR   CLO; CLO_0009018
DR   CLDB; cl4300
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 469
DR   BioSample; SAMN03470930
DR   BioSample; SAMN10988579
DR   cancercelllines; CVCL_1695
DR   Cell_Model_Passport; SIDM00395
DR   ChEMBL-Cells; CHEMBL3308828
DR   ChEMBL-Targets; CHEMBL2366067
DR   Cosmic; 753620
DR   Cosmic; 2485949
DR   Cosmic-CLP; 753620
DR   DepMap; ACH-000099
DR   DSMZ; ACC-164
DR   DSMZCellDive; ACC-164
DR   EGA; EGAS00001000978
DR   GDSC; 753620
DR   GEO; GSM563363
DR   GEO; GSM887572
DR   GEO; GSM888655
DR   GEO; GSM1366410
DR   GEO; GSM1670423
DR   IARC_TP53; 27575
DR   LiGeA; CCLE_027
DR   LINCS_LDP; LCL-1979
DR   PharmacoDB; SIMA_1378_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1695
DR   PubChem_Cell_line; CVCL_1695
DR   Wikidata; Q54953497
RX   PubMed=10686945;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23185348;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Biotechnology: Used in a bioassay to measure botulinum toxin serotype A (BoNT/B) activity. Together with the monoclonal antibody produced by hybridoma 2E2A6 (Cellosaurus=CVCL_RA98).
CC   Doubling time: 48-100 hours (PubMed=10686945); ~34-100 hours (Note=Highly variable) (DSMZ=ACC-164).
CC   HLA typing: A*03:01,03:01; B*40:01,51:01; C*06:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.65%; Native American=0%; East Asian, North=2.52%; East Asian, South=0%; South Asian=1.24%; European, North=63.44%; European, South=32.14% (PubMed=30894373).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Cosmic-CLP=753620; DSMZ=ACC-164; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 19,21
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 14
ST   Penta E: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SiMa APEX2-VAMP2
AC   CVCL_E8EB
SY   APEX2-VAMP2 SiMa
RX   PubMed=29170639;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12643; VAMP2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q76LA6; Glycine max L-ascorbate peroxidase apx2 (Note=Engineered to be used for proximity labeling = APEX2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1695 ! SiMa
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SiMa GFP-VAMP2
AC   CVCL_RG05
SY   GFP-VAMP2 SiMa
DR   Wikidata; Q54953498
RX   PubMed=29170639;
WW   Info; UKRI; -; https://gtr.ukri.org/projects?ref=NC%2FN001516%2F1
CC   Population: Caucasian.
CC   Biotechnology: Used in a bioassay to measure botulinum toxin serotype B (BoNT/B) activity (PubMed=29170639).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12643; VAMP2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1695 ! SiMa
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   SiMa NanoLuc-VAMP2
AC   CVCL_E8EC
SY   NanoLuc-VAMP2 SiMa
RX   PubMed=29170639;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12643; VAMP2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1695 ! SiMa
SX   Male
AG   1Y8M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SIMH
AC   CVCL_R924
SY   Sahul Indian Milkfish Heart
DR   Wikidata; Q54953499
RX   CelloPub=CLPUB00463;
RX   PubMed=17216384;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=29144; ! Chanos chanos (Milkfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   simLSEC
AC   CVCL_LF80
SY   spontaneously immortalized mouse Liver Sinusoidal Endothelial Cell line
DR   Wikidata; Q54953502
RX   PubMed=25585915;
CC   Doubling time: 4.01 days (Note=At 20th passage), 3.50 days (Note=At 21th passage) (PubMed=25585915).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
CC   Breed/subspecies: Kunming White.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   Simplicon
AC   CVCL_A2BQ
DR   Millipore; SCC271
DR   Wikidata; Q105511088
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Simsim
AC   CVCL_VL64
DR   Wikidata; Q98132575
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9595; ! Gorilla gorilla gorilla (Western lowland gorilla)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   siNEC
AC   CVCL_A2GJ
SY   swine immortalized Nasal Epithelial Cells
DR   Wikidata; Q105511090
RX   PubMed=32967961;
CC   Doubling time: ~50 hours (PubMed=32967961).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Nose, nasal cavity, epithelium; UBERON=UBERON_0005384.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   SINJ
AC   CVCL_M783
SY   SIN-J
DR   Cosmic; 1590843
DR   Wikidata; Q54953503
RX   CelloPub=CLPUB00412;
RX   PubMed=12089864;
RX   PubMed=15126569;
RX   PubMed=17786610;
RX   PubMed=21573635;
RX   PubMed=22038905;
CC   Doubling time: 3 days (PubMed=21573635).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3879; Thyroid gland medullary carcinoma
DI   ORDO; Orphanet_1332; Medullary thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 13
//
ID   Sipanc-1076
AC   CVCL_E4BY
SY   sipanc-1076
RX   Patent=CN109321528A;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   Sipanc-187
AC   CVCL_E4BX
SY   sipanc-187
RX   Patent=CN108384756A;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   SIPDi001-A
AC   CVCL_C1WU
DR   BioSamples; SAMEA12936824
DR   hPSCreg; SIPDi001-A
DR   Wikidata; Q114313019
RX   PubMed=37478672;
CC   From: Shaanxi Institute of Pediatric Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:20344; UBR7; Simple; p.Ser19Argfs*42 (c.35_54dup); ClinVar=VCV001294425; Zygosity=Heterozygous (PubMed=37478672).
CC   Sequence variation: Mutation; HGNC; HGNC:20344; UBR7; Simple; p.Leu288Pro (c.863T>C); ClinVar=VCV001292050; Zygosity=Heterozygous (PubMed=37478672).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201589; Li-Campeau syndrome
DI   ORDO; Orphanet_528084; Non-specific syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SIPS
AC   CVCL_DF10
SY   Spontaneously Immortalized Pancreatic Stellate cell line
DR   Wikidata; Q54953504
RX   PubMed=14669327;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic stellate cell; CL=CL_0002410.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   SIR2-P
AC   CVCL_E8AX
RX   DOI=10.4314/ujas.v22i1.3;
CC   Virology: Susceptible to infection by African swine fever virus (AFSV) (DOI=10.4314/ujas.v22i1.3).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SIRC
AC   CVCL_2724
SY   Sirc; Statens Seruminstitut Rabbit Cornea
DR   BTO; BTO_0004495
DR   CLO; CLO_0009019
DR   CLO; CLO_0009020
DR   CLO; CLO_0050407
DR   CLDB; cl4301
DR   CLDB; cl4302
DR   CLDB; cl4304
DR   CLDB; cl4305
DR   CLDB; cl4306
DR   CLDB; cl4307
DR   ATCC; CCL-60
DR   ATCC; CRL-6595
DR   BCRC; 60093
DR   BCRJ; 0224
DR   ECACC; 89090404
DR   ICLC; AL96001
DR   IZSLER; BS CL 79
DR   JCRB; IFO50020
DR   JCRB; JCRB9122
DR   Lonza; 1197
DR   RCB; RCB1835
DR   TOKU-E; 3120
DR   Wikidata; Q54953505
RX   DOI=10.1007/BF02618370;
RX   PubMed=2228906;
RX   PubMed=5918951;
RX   PubMed=6500159;
RX   PubMed=7989438;
RX   PubMed=14331182;
RX   PubMed=29653143;
RX   PubMed=34737324;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Characteristics: Expresses a mix of epithelial and fibroblastic markers (PubMed=29653143).
CC   Virology: Can be used for isolation and growth of rubella virus.
CC   Virology: Not susceptible to infection by bovine viral diarrhea virus (BVDV) (PubMed=7989438).
CC   Doubling time: ~31 hours (Note=Lot 11132012), ~1.5 days (Note=Lot 10272017) (JCRB=JCRB9122).
CC   Discontinued: ATCC; CRL-6595; true.
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   SIRC-CD4
AC   CVCL_E3FC
RX   PubMed=9621031;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_2724 ! SIRC
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   SIRC-CD4/CCR5
AC   CVCL_E3KV
RX   PubMed=9621031;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_E3FC ! SIRC-CD4
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   SIRMu-1
AC   CVCL_UW38
SY   Spontaneously Immortalized Rat Muller cell line-1
DR   CancerTools; 154858
DR   GEO; GSM3497791
DR   GEO; GSM3497792
DR   GEO; GSM3497793
DR   GEO; GSM3497794
DR   GEO; GSM3497795
DR   Wikidata; Q98132576
RX   PubMed=30677389;
RX   PubMed=31372389;
CC   Characteristics: Displays key characteristics of primary Muller cells, including the expression of an array of well-characterized Muller cells marker proteins (PubMed=30677389).
CC   Doubling time: 36 hours (Note=In 10% FBS), 30 hours (Note=In 20% FBS) (PubMed=30677389).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   SIS
AC   CVCL_C4JE
DR   Wikidata; Q116050507
RX   PubMed=8608235;
RX   PubMed=16827800;
CC   Virology: Contains an EBV genome in an episomal form (PubMed=8608235).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C162687; Severe chronic active EBV infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SISE
AC   CVCL_S946
SY   Sahul India Seabass Embryonic
DR   Wikidata; Q54953506
RX   CelloPub=CLPUB00463;
RX   PubMed=16919787;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 25 to 32 Celsius, with an optimal growth temperature of 28 Celsius (PubMed=16919787).
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   SISK
AC   CVCL_M424
SY   Sahul India Seabass Kidney
DR   NRFC; NRFC014
DR   Wikidata; Q54953519
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1016/j.aquaculture.2006.01.011;
WW   Provider; AAHL; -; https://aahl.res.in/asian-sea-bass-lates-calcarifer-kidney-sisk-and-spleen-siss-cell-lines/
WW   Provider; NRFC; NRFC014; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC014.
CC   Characteristics: Capable of growing from 20 to 32 Celsius, the optimal temperature is 28 Celsius (DOI=10.1016/j.aquaculture.2006.01.011).
CC   Doubling time: 36 hours (DOI=10.1016/j.aquaculture.2006.01.011).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 17
//
ID   SiSo
AC   CVCL_2193
SY   SISO
DR   CLO; CLO_0009021
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470956
DR   BioSample; SAMN03473350
DR   cancercelllines; CVCL_2193
DR   Cell_Model_Passport; SIDM00394
DR   ChEMBL-Cells; CHEMBL3307272
DR   ChEMBL-Targets; CHEMBL613527
DR   Cosmic; 1995628
DR   Cosmic-CLP; 1240212
DR   DepMap; ACH-001650
DR   DSMZ; ACC-327
DR   DSMZCellDive; ACC-327
DR   EGA; EGAS00001000978
DR   GDSC; 1240212
DR   GEO; GSM1670424
DR   LINCS_LDP; LCL-1514
DR   PharmacoDB; SISO_1379_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_2193
DR   Wikidata; Q54953520
RX   PubMed=21556646;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35692560;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=21556646); ~35 hours (DSMZ=ACC-327).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (Cosmic-CLP=1240212; DepMap=ACH-001650).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser834Ter (c.2501C>G); ClinVar=VCV000428733; Zygosity=Homozygous (Cosmic-CLP=1240212; DepMap=ACH-001650).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=3.91%; Native American=0.11%; East Asian, North=79.2%; East Asian, South=9.59%; South Asian=0%; European, North=0%; European, South=7.19% (PubMed=30894373).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): Cosmic-CLP=1240212; DepMap=ACH-001650; DSMZ=ACC-327; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 14 (DSMZ=ACC-327)
ST   D19S433: 14,16.2 (PubMed=25877200)
ST   D21S11: 30,31
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 11,13
ST   Penta E: 11,13
ST   TH01: 7 (PubMed=25877200)
ST   TH01: 7,9 (Cosmic-CLP=1240212; DepMap=ACH-001650; DSMZ=ACC-327)
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SISS
AC   CVCL_R812
SY   Sahul Indian Seabass Spleen
DR   NRFC; NRFC015
DR   Wikidata; Q54953521
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.1016/j.aquaculture.2006.07.034;
WW   Provider; AAHL; -; https://aahl.res.in/asian-sea-bass-lates-calcarifer-kidney-sisk-and-spleen-siss-cell-lines/
WW   Provider; NRFC; NRFC015; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC015.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8187; ! Lates calcarifer (Barramundi)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   siTEC
AC   CVCL_A2GK
SY   swine immortalized Tracheal Epithelial Cells
DR   Wikidata; Q105511092
RX   PubMed=32967961;
CC   Doubling time: ~50 hours (PubMed=32967961).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SJ-89
AC   CVCL_S860
DR   Wikidata; Q54953523
RX   PubMed=11229593;
CC   Group: Serum/protein free medium cell line.
CC   Population: Chinese.
CC   Doubling time: ~33 hours (PubMed=11229593).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   SJ-DIPGX29c
AC   CVCL_C1NF
SY   SJHGG013322_C2
DR   cancercelllines; CVCL_C1NF
DR   GEO; GSM4600831
DR   Wikidata; Q114313020
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29964/baker/SJHGG013322/SJ-DIPGX29/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 9.0 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 22
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 11
ST   Penta E: 12,16
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11-12Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SJ-DIPGX37c
AC   CVCL_C1NG
SY   SJHGG015756_C35
DR   cancercelllines; CVCL_C1NG
DR   Wikidata; Q114313021
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29966/baker/SJHGG015756/SJ-DIPGX37/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 9.0 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Homozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Tyr452_Asn453Tyr (c.1356_1358delTAA); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu513fs (c.1539dupT); Zygosity=Heterozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 12,16
ST   D21S11: 28,29
ST   D3S1358: 14,16
ST   D5S818: 12,14
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 7,17
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8-9Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SJ-DIPGX7c
AC   CVCL_C1NH
SY   SJHGG00101_C2
DR   cancercelllines; CVCL_C1NH
DR   Wikidata; Q114313022
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29956/baker/SJHGG000101/SJ-DIPGX7/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 6.1 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Thr200_Leu201fs (c.600_603delGCCA); Zygosity=Homozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Homozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 17
ST   D21S11: 31,31.2
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 22,23
ST   Penta D: 8,11
ST   Penta E: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17-18Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SJ-DIPGX9c
AC   CVCL_C1NI
SY   SJHGG010327_C3
DR   cancercelllines; CVCL_C1NI
DR   Wikidata; Q114313023
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29962/baker/SJHGG010327/SJ-DIPGX9/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 9.1 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Gly328Glu (c.983G>A); ClinVar=VCV000029595; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,13
ST   D16S539: 12,14
ST   D18S51: 18,19
ST   D21S11: 27,30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 12
ST   Penta E: 14,17
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SJ-GBM1
AC   CVCL_C8E8
SY   SG-G1
DR   Wikidata; Q123033493
RX   CelloPub=CLPUB00738;
RX   PubMed=10402232;
CC   Senescence: Undergoes crisis at approximately passage 17 (CelloPub=CLPUB00738).
CC   Misspelling: SJ-A1; PubMed=10402232.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SJ-GBM2
AC   CVCL_M141
SY   SJ-GBM-2; SJGBM2; SJ-G2; SJG2
DR   BTO; BTO_0006332
DR   cancercelllines; CVCL_M141
DR   IARC_TP53; 24985
DR   Wikidata; Q54953524
RX   CelloPub=CLPUB00738;
RX   PubMed=7634381;
RX   PubMed=9220028;
RX   PubMed=9802058;
RX   PubMed=10402232;
RX   PubMed=10933967;
RX   PubMed=11306486;
RX   PubMed=20922763;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Brain/SJ-GBM2.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Brain.php
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 29 hours (PubMed=20922763).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (CelloPub=CLPUB00738; PubMed=9802058).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): COG; PubMed=20922763
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16,17
ST   D19S433: 12,14
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 8,12
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   SJ-GBM3
AC   CVCL_A8SF
SY   SJ-G3
DR   cancercelllines; CVCL_A8SF
DR   IARC_TP53; 24986
DR   Wikidata; Q108821305
RX   CelloPub=CLPUB00738;
RX   PubMed=9802058;
RX   PubMed=10402232;
RX   PubMed=10933967;
RX   PubMed=11306486;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Unspecified (PubMed=9802058).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SJ-GBM4
AC   CVCL_C8E7
SY   SJ-G4
DR   Wikidata; Q123033494
RX   CelloPub=CLPUB00738;
RX   PubMed=10402232;
CC   Senescence: Undergoes crisis at approximately passage 23 (CelloPub=CLPUB00738).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (CelloPub=CLPUB00738).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8SE ! SJ-GBM5
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 3
//
ID   SJ-GBM5
AC   CVCL_A8SE
SY   SJ-G5
DR   cancercelllines; CVCL_A8SE
DR   IARC_TP53; 24987
DR   Wikidata; Q108821306
RX   CelloPub=CLPUB00738;
RX   PubMed=8603418;
RX   PubMed=9802058;
RX   PubMed=10402232;
CC   Senescence: Undergoes crisis at approximately passage 35 (CelloPub=CLPUB00738).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (CelloPub=CLPUB00738; PubMed=9802058).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8E7 ! SJ-GBM4
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SJ-HGGX2c
AC   CVCL_C1NJ
SY   SJHGG009024_C2
DR   cancercelllines; CVCL_C1NJ
DR   Wikidata; Q114313024
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29958/baker/SJHGG009024/SJ-HGGX2/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 8.2 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Asn659Lys (c.1977C>G); ClinVar=VCV000375902; Zygosity=Homozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Trp (c.405C>G); ClinVar=VCV000376561; Zygosity=Homozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 24,25
ST   Penta D: 2.2,5
ST   Penta E: 8
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4-5Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SJ-HGGX39c
AC   CVCL_C1NK
SY   SJHGG015760_C2
DR   cancercelllines; CVCL_C1NK
DR   Wikidata; Q114313025
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29969/baker/SJHGG015760/SJ-HGGX39/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 3.7 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Gly1429_Thr1431fs (c.4286_4293delCCAGAGCG); Zygosity=Homozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser1045Phe (c.3134C>T); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=34215733).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 17
ST   D21S11: 29,30
ST   D3S1358: 12,16
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 7,12
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 14,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-11Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SJ-HGGX42c
AC   CVCL_C1NL
SY   SJHGG054830_C2
DR   cancercelllines; CVCL_C1NL
DR   Wikidata; Q114313026
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29986/baker/SJHGG059115/SJ-HGGX42/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 6.1 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Ser177fs (c.529_530delAG); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Arg (c.103G>A) (H3.3G34R); ClinVar=VCV000438766; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu265del (c.792_794delTCT); Zygosity=Heterozygous (PubMed=34215733).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 9,11
ST   D18S51: 12,18
ST   D21S11: 29,30
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13-14Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   SJ-HGGX6c
AC   CVCL_C1NM
SY   SJHGG009103_C8
DR   cancercelllines; CVCL_C1NM
DR   Wikidata; Q114313027
RX   PubMed=34215733;
WW   Provider; PBTP; -; https://pbtp.stjude.cloud/sample-details/29960/baker/SJHGG009103/SJ-HGGX6/Cell%20Line
CC   Characteristics: Derived from a patient-derived xenograft.
CC   Doubling time: 5.6 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Thr1582fs (c.4745delA); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Gly35Arg (c.103G>A) (H3.3G34R); ClinVar=VCV000438766; Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:25311; H3C13; Simple; p.Ser88Pro (c.262T>C); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Asp583_Trp586del (c.1749_1760del); Zygosity=Heterozygous (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=34215733).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
ST   Source(s): PubMed=34215733
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D21S11: 32.2
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,14
ST   D8S1179: 10,15
ST   FGA: 23,25
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16-17Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   SJ-N-CG
AC   CVCL_Y141
SY   NCG
DR   CGH-DB; 76-1
DR   CGH-DB; 9102-4
DR   Wikidata; Q54953525
RX   PubMed=2981159;
RX   PubMed=6610792;
RX   PubMed=11129446;
RX   PubMed=12702577;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   SJ-N-KP
AC   CVCL_4608
SY   NKP
DR   CLO; CLO_0009029
DR   CLDB; cl4308
DR   CGH-DB; 60-1
DR   CGH-DB; 9092-4
DR   Wikidata; Q54953526
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=2981159;
RX   PubMed=6610792;
RX   PubMed=12702577;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   SJ-S5A
AC   CVCL_C8E5
DR   Wikidata; Q123033496
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8E6 ! SJ-S5B
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SJ-S5B
AC   CVCL_C8E6
DR   Wikidata; Q123033497
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8E5 ! SJ-S5A
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SJ-S6
AC   CVCL_AQ32
DR   Wikidata; Q54953528
RX   PubMed=9220028;
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   SJ-S7
AC   CVCL_C8E4
DR   Wikidata; Q123033498
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SJ3.6
AC   CVCL_B463
DR   Wikidata; Q54953529
RX   PubMed=9819136;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Conditionally immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   SJCRH30 POLG Y955C
AC   CVCL_C1D0
DR   cancercelllines; CVCL_C1D0
DR   Wikidata; Q114313028
RX   PubMed=35760101;
CC   Population: Caucasian.
CC   Doubling time: 45.7 +- 5.6 hours (PubMed=35760101).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3819; FOXO1 + HGNC; HGNC:8617; PAX3; Name(s)=PAX3-FOXO1, PAX3-FKHR (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9179; POLG; Simple_edited; p.Tyr955Cys (c.2864A>G); ClinVar=VCV000013495; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35760101).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Pro9Leu (c.26C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Cys (c.614A>G); ClinVar=VCV000376681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0041 ! Rh30
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SJD.1
AC   CVCL_5895
SY   SJD1
DR   CLO; CLO_0009022
DR   ATCC; CRL-2296
DR   Wikidata; Q54953530
RX   PubMed=9891354;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Breed/subspecies: SJD; VBO=VBO_0017497.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   SJES-1
AC   CVCL_5168
SY   SJES1
DR   cancercelllines; CVCL_5168
DR   Cosmic; 1104563
DR   GEO; GSM393029
DR   IGRhCellID; SJES1%20GEO
DR   Progenetix; CVCL_5168
DR   Wikidata; Q54953532
RX   PubMed=7536457;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   SJES-2
AC   CVCL_5169
DR   cancercelllines; CVCL_5169
DR   Cosmic; 801763
DR   Cosmic; 1104564
DR   GEO; GSM393030
DR   IGRhCellID; SJES2%20GEO
DR   Progenetix; CVCL_5169
DR   Wikidata; Q54953533
RX   PubMed=7536457;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   SJES-3
AC   CVCL_5170
DR   cancercelllines; CVCL_5170
DR   Cosmic; 801764
DR   Cosmic; 1104565
DR   GEO; GSM393031
DR   IGRhCellID; SJES3%20GEO
DR   Progenetix; CVCL_5170
DR   Wikidata; Q54953534
RX   PubMed=7536457;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   SJES-4
AC   CVCL_A459
SY   SJES4
DR   Cosmic; 1104566
DR   IGRhCellID; SJES4%20GEO
DR   Wikidata; Q54953535
RX   PubMed=7536457;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   SJES-5
AC   CVCL_5171
SY   SJES5
DR   cancercelllines; CVCL_5171
DR   Cosmic; 801765
DR   Cosmic; 1104567
DR   GEO; GSM393032
DR   IGRhCellID; SJES5%20GEO
DR   Progenetix; CVCL_5171
DR   Wikidata; Q54953537
RX   PubMed=7536457;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   SJES-6
AC   CVCL_5172
DR   cancercelllines; CVCL_5172
DR   Cosmic; 801766
DR   Cosmic; 1104568
DR   GEO; GSM393033
DR   IGRhCellID; SJES6%20GEO
DR   Progenetix; CVCL_5172
DR   Wikidata; Q54953539
RX   PubMed=7536457;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   SJES-7
AC   CVCL_5173
DR   cancercelllines; CVCL_5173
DR   Cosmic; 801767
DR   GEO; GSM393034
DR   IGRhCellID; SJES7%20GEO
DR   Progenetix; CVCL_5173
DR   Wikidata; Q54953540
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   SJES-8
AC   CVCL_5174
DR   cancercelllines; CVCL_5174
DR   Cosmic; 801768
DR   GEO; GSM393035
DR   IGRhCellID; SJES8%20GEO
DR   Progenetix; CVCL_5174
DR   Wikidata; Q54953542
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   SJG-1
AC   CVCL_WV25
SY   SJG-001
DR   Wikidata; Q98132577
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-12
AC   CVCL_WV30
SY   SJG-012
DR   Wikidata; Q98132579
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-13
AC   CVCL_WV10
SY   SJG-013
DR   cancercelllines; CVCL_WV10
DR   Wikidata; Q98132581
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:1509; CASP8; Simple; p.Ser115Ter (c.698C>A) (p.Ser174Ter, c.521C>A); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012602; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Asp (c.658T>G); ClinVar=VCV000376689; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259His (c.775G>C); ClinVar=VCV001349622; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,18
ST   D21S11: 29
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 13
//
ID   SJG-14
AC   CVCL_WV31
SY   SJG-014
DR   Wikidata; Q98132584
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-15
AC   CVCL_WV24
SY   SJG-015; SJG15
DR   Wikidata; Q98132585
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=22564525;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-16
AC   CVCL_WV32
SY   SJG-016
DR   Wikidata; Q98132587
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-17
AC   CVCL_WV11
SY   SJG-017
DR   Wikidata; Q98132589
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Thr968Met (c.2903C>T); ClinVar=VCV001494610; Zygosity=Heterozygous (CelloPub=CLPUB00517; PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258fs (c.773_774insG); Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 18,19
ST   D21S11: 28,29
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 11,12
ST   FGA: 21
ST   Penta D: 11,14
ST   Penta E: 11,17
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   SJG-18
AC   CVCL_WV12
SY   SJG-018
DR   Wikidata; Q98132591
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:1509; CASP8; Simple; p.Lys148Thr (c.443A>C) (p.Lys207Thr, c.620A>C); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; c.9854-1G>C; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Gln (c.770T>A); ClinVar=VCV000012372; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Ter (c.772G>T); ClinVar=VCV000486557; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 31,31.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21,25
ST   Penta D: 13
ST   Penta E: 15,17
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   SJG-19
AC   CVCL_WV33
SY   SJG-019
DR   Wikidata; Q98132593
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-2
AC   CVCL_WV26
SY   SJG-002
DR   Wikidata; Q98132596
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-20
AC   CVCL_WV34
SY   SJG-020
DR   Wikidata; Q98132598
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-21
AC   CVCL_WV35
SY   SJG-021
DR   Wikidata; Q98132599
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-22
AC   CVCL_WV36
SY   SJG-022
DR   Wikidata; Q98132601
RX   CelloPub=CLPUB00518;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 4
//
ID   SJG-23
AC   CVCL_WV37
SY   SJG-023
DR   Wikidata; Q98132602
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-24
AC   CVCL_WV38
SY   SJG-024
DR   Wikidata; Q98132603
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-25
AC   CVCL_WV39
SY   SJG-025
DR   Wikidata; Q98132604
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-26
AC   CVCL_WV13
SY   SJG-026
DR   Wikidata; Q98132605
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 17,20
ST   D21S11: 28,31
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   SJG-27
AC   CVCL_WV14
SY   SJG-027
DR   Wikidata; Q98132606
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 14,15
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   Penta D: 7,11
ST   Penta E: 5,17
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 19,20
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   SJG-28
AC   CVCL_WV15
SY   SJG-028
DR   Wikidata; Q98132608
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13,14
ST   D16S539: 8,11
ST   D18S51: 11,13
ST   D21S11: 29,31
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 11,14
ST   FGA: 18,23
ST   Penta D: 13
ST   Penta E: 7,15
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   SJG-29
AC   CVCL_WV46
SY   SJG-029
DR   Wikidata; Q98132609
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-3
AC   CVCL_WV06
SY   SJG-003
DR   Wikidata; Q98132610
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D21S11: 28,32.2
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 10,14
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   SJG-30
AC   CVCL_WV45
SY   SJG-030
DR   Wikidata; Q98132611
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-31
AC   CVCL_WV16
SY   SJG-031
DR   Wikidata; Q98132614
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13,14
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 5,15
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   SJG-32
AC   CVCL_WV17
SY   SJG-032
DR   Wikidata; Q98132616
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Gly2470fs (c.7408_7409delCC); Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 13,17
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 10,15
ST   FGA: 20,23
ST   Penta D: 13
ST   Penta E: 10,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   SJG-33
AC   CVCL_WV18
SY   SJG-033
DR   cancercelllines; CVCL_WV18
DR   Wikidata; Q98132618
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Val (c.736A>G); ClinVar=VCV000100815; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Gly (c.773A>G); ClinVar=VCV000406590; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 15,16
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   SJG-34
AC   CVCL_WV47
SY   SJG-034
DR   Wikidata; Q98132621
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-35
AC   CVCL_WV48
SY   SJG-035
DR   Wikidata; Q98132622
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-36
AC   CVCL_WV49
SY   SJG-036
DR   Wikidata; Q98132623
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-37
AC   CVCL_WV19
SY   SJG-037
DR   Wikidata; Q98132624
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 7,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   SJG-38
AC   CVCL_WV50
SY   SJG-038
DR   Wikidata; Q98132626
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-39
AC   CVCL_WV51
SY   SJG-039
DR   Wikidata; Q98132628
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-4
AC   CVCL_WV07
SY   SJG-004
DR   Wikidata; Q98132629
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 9,10
ST   FGA: 22,25
ST   Penta D: 9,13
ST   Penta E: 12,19
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   SJG-40
AC   CVCL_WV52
SY   SJG-040
DR   Wikidata; Q98132630
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-41
AC   CVCL_WV20
SY   SJG-041
DR   Wikidata; Q98132631
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Arg1279His (c.3836G>A); ClinVar=VCV000134930; Zygosity=Heterozygous (CelloPub=CLPUB00517; PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr73fs (c.218_219insT); Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D18S51: 15,18
ST   D21S11: 30
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 13,14
ST   Penta E: 11,15
ST   TH01: 9,9.3
ST   TPOX: 11,12
ST   vWA: 17,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   SJG-42
AC   CVCL_WV21
SY   SJG-042
DR   Wikidata; Q98132632
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,18
ST   D21S11: 29
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   Penta D: 9,10
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   SJG-43
AC   CVCL_WV53
SY   SJG-043
DR   Wikidata; Q98132633
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-44
AC   CVCL_WV54
SY   SJG-044
DR   Wikidata; Q98132634
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-5
AC   CVCL_WV27
SY   SJG-005
DR   Wikidata; Q98132635
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-6
AC   CVCL_WV08
SY   SJG-006
DR   cancercelllines; CVCL_WV08
DR   Wikidata; Q98132636
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:1509; CASP8; Simple; p.His278Tyr (c.832C>T); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Glu833Ter (c.2497G>T); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Ser3065Ter (c.9194C>G); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Gln3524Ter (c.10570C>T); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Cys312Ter (c.936C>A); Zygosity=Heterozygous (CelloPub=CLPUB00517; PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Trp1843Ter (c.5529G>A); Zygosity=Heterozygous (CelloPub=CLPUB00517; PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln171Ter (c.511C>T); ClinVar=VCV000189411; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu201Gln (c.601G>C); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly209Glu (c.626G>A); Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 15,16
ST   D21S11: 29,30
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19,24
ST   Penta D: 10,12
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 17,19
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   SJG-7
AC   CVCL_WV28
SY   SJG-007
DR   Wikidata; Q98132637
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJG-8
AC   CVCL_WV09
SY   SJG-008
DR   cancercelllines; CVCL_WV09
DR   Wikidata; Q98132638
RX   CelloPub=CLPUB00517;
RX   CelloPub=CLPUB00518;
RX   PubMed=27693639;
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Thr677fs (c.2029_2036delACACCAGT); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Asp154His (c.460G>C); Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.159G>A); ClinVar=VCV000420659; Zygosity=Unspecified (PubMed=27693639).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=27693639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile from personal communication of Broad, Simon.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 12,16
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 9
ST   D8S1179: 10,13
ST   FGA: 21
ST   Penta D: 8,9
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 12
//
ID   SJG-9
AC   CVCL_WV29
SY   SJG-009
DR   Wikidata; Q98132639
RX   CelloPub=CLPUB00518;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-09-24; Version: 5
//
ID   SJHi001-A
AC   CVCL_C0HQ
SY   010
DR   hPSCreg; SJHi001-A
DR   Wikidata; Q112930392
RX   PubMed=35381520;
CC   From: Shengjing Hospital of China Medical University; Shenyang; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4192; GCGR; Simple; p.Trp83Ter (c.248G>A); Zygosity=Heterozygous (PubMed=35381520).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_183625; Rare genetic diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SJHi002-A
AC   CVCL_C0HR
SY   008
DR   hPSCreg; SJHi002-A
DR   Wikidata; Q112930393
RX   PubMed=35381520;
CC   From: Shengjing Hospital of China Medical University; Shenyang; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   SJHi003-A
AC   CVCL_C1WM
SY   009
DR   hPSCreg; SJHi003-A
DR   Wikidata; Q114313029
CC   From: Shengjing Hospital of China Medical University; Shenyang; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   SJK-132-20
AC   CVCL_4300
SY   SJK 132-20
DR   CLO; CLO_0009023
DR   ATCC; CRL-1640
DR   ATCC; TIB-177
DR   ECACC; 88041903
DR   Wikidata; Q54953544
RX   PubMed=7085672;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
CC   Discontinued: ATCC; TIB-177; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   SJK-237-71
AC   CVCL_4301
SY   SJK 237-71
DR   CLO; CLO_0009024
DR   ATCC; CRL-1645
DR   ATCC; TIB-178
DR   JCRB; JCRB9032
DR   Wikidata; Q54953546
RX   PubMed=7085672;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
CC   Discontinued: ATCC; TIB-178; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   SJK-287-38
AC   CVCL_4302
SY   SJK 287-38
DR   CLO; CLO_0009025
DR   ATCC; CRL-1644
DR   ATCC; TIB-179
DR   ECACC; 90112228
DR   Wikidata; Q54953547
RX   PubMed=7085672;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
CC   Discontinued: ATCC; TIB-179; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   SJL/JA
AC   CVCL_S359
DR   ATCC; CRL-6451
DR   Wikidata; Q54953549
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6451; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   SJL/JB
AC   CVCL_5896
DR   CLO; CLO_0009026
DR   ATCC; CRL-6452
DR   Wikidata; Q54953550
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6452; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   SJL/JC
AC   CVCL_5897
DR   CLO; CLO_0009027
DR   ATCC; CRL-6453
DR   Wikidata; Q54953551
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6453; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: SJL/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 7
//
ID   SJMRF
AC   CVCL_4303
DR   CLO; CLO_0009028
DR   CLDB; cl4309
DR   ATCC; CRL-6072
DR   ECACC; 92020421
DR   Wikidata; Q54953552
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6072; true.
OX   NCBI_TaxID=9901; ! Bison bison (American bison)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   SJNB-1
AC   CVCL_8812
SY   SJ-NB-1; SJ-NB1; SJNB1; SJNB-1(EB); NB1
DR   BTO; BTO_0006053
DR   cancercelllines; CVCL_8812
DR   ChEMBL-Cells; CHEMBL3308822
DR   ChEMBL-Targets; CHEMBL2366284
DR   Cosmic; 947712
DR   Cosmic; 1037331
DR   Cosmic; 1099128
DR   Cosmic; 1109106
DR   Cosmic; 1153792
DR   Cosmic; 1518073
DR   Cosmic; 1526641
DR   Cosmic; 2131598
DR   Cosmic; 2239468
DR   GEO; GSM314019
DR   GEO; GSM333806
DR   GEO; GSM692870
DR   IARC_TP53; 23605
DR   Progenetix; CVCL_8812
DR   PubChem_Cell_line; CVCL_8812
DR   Wikidata; Q54953553
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7838528;
RX   PubMed=8516298;
RX   PubMed=10933967;
RX   PubMed=10935473;
RX   PubMed=11550280;
RX   PubMed=18923524;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   SJNB-10
AC   CVCL_1441
SY   SJ-NB-10; SJ-NB10; SJNB10; NB10; NB10-DH; NB 90-9; NB90-9
DR   BTO; BTO_0006052
DR   CLO; CLO_0037083
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 946
DR   cancercelllines; CVCL_1441
DR   Cell_Model_Passport; SIDM00259
DR   ChEMBL-Cells; CHEMBL3308172
DR   ChEMBL-Targets; CHEMBL2366243
DR   Cosmic; 688069
DR   Cosmic; 949171
DR   Cosmic; 1109121
DR   Cosmic; 1518076
DR   Cosmic; 1526644
DR   Cosmic; 1543770
DR   Cosmic; 2239458
DR   Cosmic-CLP; 949171
DR   DepMap; ACH-002278
DR   EGA; EGAS00001000978
DR   GDSC; 949171
DR   GEO; GSM692861
DR   GEO; GSM1670146
DR   IARC_TP53; 27181
DR   LINCS_LDP; LCL-1989
DR   PharmacoDB; NB10_985_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1441
DR   Wikidata; Q54953554
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8490657;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=20164919;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Partial deletion; Zygosity=Homozygous (PubMed=20655465).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.93%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=1.43%; European, North=66.44%; European, South=31.2% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949171
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SJNB-11
AC   CVCL_8813
SY   SJNB11; NB11; NB11-DH
DR   Cosmic; 688070
DR   Wikidata; Q54953555
RX   PubMed=10935473;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   SJNB-12
AC   CVCL_1442
SY   SJ-NB-12; SJ-NB12; SJNB12; NB12
DR   BTO; BTO_0006056
DR   CLO; CLO_0037084
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1442
DR   Cell_Model_Passport; SIDM00258
DR   ChEMBL-Cells; CHEMBL3308173
DR   ChEMBL-Targets; CHEMBL2366285
DR   Cosmic; 949172
DR   Cosmic; 1109107
DR   Cosmic; 1518077
DR   Cosmic; 1526645
DR   Cosmic; 2239457
DR   Cosmic-CLP; 949172
DR   DepMap; ACH-002279
DR   EGA; EGAS00001000978
DR   GDSC; 949172
DR   GEO; GSM692857
DR   GEO; GSM1670147
DR   IARC_TP53; 27182
DR   LINCS_LDP; LCL-1990
DR   PharmacoDB; NB12_986_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1442
DR   Wikidata; Q54953556
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7838528;
RX   PubMed=9516836;
RX   PubMed=10935473;
RX   PubMed=11550280;
RX   PubMed=20164919;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.78%; Native American=0%; East Asian, North=1.75%; East Asian, South=0%; South Asian=0%; European, North=67.42%; European, South=30.06% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=949172
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SJNB-13
AC   CVCL_1443
SY   SJNB13; NB13; NB13-DH
DR   CLO; CLO_0037085
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 947
DR   cancercelllines; CVCL_1443
DR   Cell_Model_Passport; SIDM00257
DR   ChEMBL-Cells; CHEMBL3308174
DR   ChEMBL-Targets; CHEMBL2366225
DR   Cosmic; 688071
DR   Cosmic; 949177
DR   Cosmic; 1526634
DR   Cosmic-CLP; 949177
DR   DepMap; ACH-002280
DR   EGA; EGAS00001000978
DR   GDSC; 949177
DR   GEO; GSM1670148
DR   IARC_TP53; 27177
DR   LINCS_LDP; LCL-1991
DR   PharmacoDB; NB13_987_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1443
DR   Wikidata; Q54953557
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=15892104;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:20893; BCOR; Simple; p.Tyr869Ilefs*10 (c.2605delT); Zygosity=Heterozygous (Cosmic-CLP=949177; DepMap=ACH-002280).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Met (c.517G>A); ClinVar=VCV000233951; Zygosity=Homozygous (Cosmic-CLP=949177; DepMap=ACH-002280).
CC   Sequence variation: Mutation; HGNC; HGNC:18410; ZNF292; Simple; p.Glu1009Ter (c.3025G>T); Zygosity=Heterozygous (Cosmic-CLP=949177; DepMap=ACH-002280).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=68.95%; Native American=0.52%; East Asian, North=1.69%; East Asian, South=0%; South Asian=0.75%; European, North=16.7%; European, South=11.4% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949177
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   SJNB-14
AC   CVCL_1444
SY   SJNB14; NB14; NB14-DH; NCC
DR   BTO; BTO_0005073
DR   CLO; CLO_0037086
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1444
DR   Cell_Model_Passport; SIDM00256
DR   ChEMBL-Cells; CHEMBL3308827
DR   ChEMBL-Targets; CHEMBL2366212
DR   Cosmic; 688072
DR   Cosmic; 922663
DR   Cosmic; 949178
DR   Cosmic; 1526635
DR   Cosmic-CLP; 949178
DR   DepMap; ACH-002281
DR   EGA; EGAS00001000978
DR   GDSC; 949178
DR   GEO; GSM1670149
DR   IARC_TP53; 27178
DR   LINCS_LDP; LCL-1992
DR   PharmacoDB; NB14_988_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1444
DR   Wikidata; Q54953558
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=922665;
RX   PubMed=6171342;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=15892104;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>T; ClinVar=VCV001210292; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=949178).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.42%; Native American=0.13%; East Asian, North=0%; East Asian, South=0.23%; South Asian=5.64%; European, North=50.65%; European, South=42.92% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949178
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 12
ST   TH01: 9.3
ST   TPOX: 10
ST   vWA: 16,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   SJNB-15
AC   CVCL_8814
SY   SJNB15; NB15
DR   Wikidata; Q54953559
RX   PubMed=10935473;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   SJNB-16
AC   CVCL_8815
SY   SJNB16; NB16; NB16-DH; NKP
DR   Cosmic; 688073
DR   Wikidata; Q54953560
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=6171342;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=15892104;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   SJNB-17
AC   CVCL_1445
SY   SJNB17; NB17; NB17-DH
DR   CLO; CLO_0037087
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 948
DR   cancercelllines; CVCL_1445
DR   Cell_Model_Passport; SIDM00255
DR   ChEMBL-Cells; CHEMBL3308175
DR   ChEMBL-Targets; CHEMBL2366064
DR   Cosmic; 688075
DR   Cosmic; 922664
DR   Cosmic; 949175
DR   Cosmic-CLP; 949175
DR   DepMap; ACH-002282
DR   EGA; EGAS00001000978
DR   GDSC; 949175
DR   GEO; GSM1670150
DR   IARC_TP53; 27700
DR   LINCS_LDP; LCL-1994
DR   PharmacoDB; NB17_989_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1445
DR   Wikidata; Q54953562
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=10935473;
RX   PubMed=15892104;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.11%; Native American=0.8%; East Asian, North=1.46%; East Asian, South=0.35%; South Asian=0%; European, North=66.06%; European, South=30.22% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949175
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   SJNB-18
AC   CVCL_8816
SY   SJNB18; NB18
DR   Wikidata; Q54953563
RX   PubMed=10935473;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   SJNB-19
AC   CVCL_8817
SY   SJNB19; NB19; NB19-DH
DR   Cosmic; 688076
DR   Wikidata; Q54953564
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=15892104;
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   SJNB-2
AC   CVCL_8818
SY   SJNB2; NB2; N0303L
DR   cancercelllines; CVCL_8818
DR   Cosmic; 947713
DR   Cosmic; 1037332
DR   Cosmic; 1099129
DR   Cosmic; 1153793
DR   Cosmic; 2131584
DR   GEO; GSM314020
DR   GEO; GSM333807
DR   Progenetix; CVCL_8818
DR   Wikidata; Q54953566
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=18923524;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   SJNB-20
AC   CVCL_8819
SY   SJNB20; NB20; NB20-DH
DR   Cosmic; 688078
DR   Cosmic; 922665
DR   Wikidata; Q54953567
RX   PubMed=10935473;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   SJNB-3
AC   CVCL_8820
SY   SJNB3; NB3; N1003L
DR   cancercelllines; CVCL_8820
DR   Cosmic; 947714
DR   Cosmic; 1037333
DR   Cosmic; 1099130
DR   Cosmic; 1153794
DR   GEO; GSM314021
DR   GEO; GSM333808
DR   Progenetix; CVCL_8820
DR   Wikidata; Q54953568
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=18923524;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   SJNB-4
AC   CVCL_8821
SY   SJNB4; SJNB-4(SD); NB4; NB4-DH
DR   cancercelllines; CVCL_8821
DR   Cosmic; 688079
DR   Cosmic; 801747
DR   Cosmic; 947715
DR   Cosmic; 1037334
DR   Cosmic; 1099131
DR   Cosmic; 1153795
DR   Cosmic; 2131585
DR   GEO; GSM314022
DR   GEO; GSM333809
DR   IARC_TP53; 15545
DR   Progenetix; CVCL_8821
DR   Wikidata; Q54953569
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8516298;
RX   PubMed=10933967;
RX   PubMed=10935473;
RX   PubMed=15892104;
RX   PubMed=18923524;
RX   PubMed=20164919;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (IARC_TP53=15545).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   SJNB-5
AC   CVCL_8822
AS   CVCL_1446
SY   SJNB5; SJ-NB5; NB5; NB5-DH; NJF
DR   BTO; BTO_0005072
DR   CLO; CLO_0037088
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 949
DR   cancercelllines; CVCL_8822
DR   Cell_Model_Passport; SIDM00254
DR   ChEMBL-Cells; CHEMBL3308156
DR   ChEMBL-Targets; CHEMBL2366328
DR   Cosmic; 688080
DR   Cosmic; 922662
DR   Cosmic; 947716
DR   Cosmic; 949176
DR   Cosmic; 1037335
DR   Cosmic; 1099132
DR   Cosmic; 1153796
DR   Cosmic; 1526633
DR   Cosmic; 2131586
DR   Cosmic-CLP; 949176
DR   DepMap; ACH-002283
DR   EGA; EGAS00001000978
DR   GDSC; 949176
DR   GEO; GSM314023
DR   GEO; GSM333810
DR   GEO; GSM1670152
DR   IARC_TP53; 27183
DR   LINCS_LDP; LCL-1995
DR   PharmacoDB; NB5_991_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_8822
DR   PubChem_Cell_line; CVCL_8822
DR   Wikidata; Q54953577
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=6171342;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: African American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=87.26%; Native American=0%; East Asian, North=2.17%; East Asian, South=0%; South Asian=0.49%; European, North=5.14%; European, South=4.93% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=949176
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9,10
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 37
//
ID   SJNB-6
AC   CVCL_8823
AS   CVCL_1447
SY   SJ-NB-6; SJ-NB6; SJNB6; NB6; NB6-DH; N2307L
DR   BTO; BTO_0006054
DR   CLO; CLO_0037089
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 950
DR   cancercelllines; CVCL_8823
DR   Cell_Model_Passport; SIDM00253
DR   ChEMBL-Cells; CHEMBL3308157
DR   ChEMBL-Targets; CHEMBL2366318
DR   Cosmic; 688082
DR   Cosmic; 949173
DR   Cosmic; 1037336
DR   Cosmic; 1099133
DR   Cosmic; 1109117
DR   Cosmic; 1153797
DR   Cosmic; 1518074
DR   Cosmic; 1526642
DR   Cosmic-CLP; 949173
DR   DepMap; ACH-002284
DR   EGA; EGAS00001000978
DR   GDSC; 949173
DR   GEO; GSM314024
DR   GEO; GSM333811
DR   GEO; GSM692877
DR   GEO; GSM1670153
DR   IARC_TP53; 27179
DR   LINCS_LDP; LCL-1996
DR   PharmacoDB; NB6_992_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_8823
DR   PubChem_Cell_line; CVCL_8823
DR   Wikidata; Q54953578
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7838528;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=11550280;
RX   PubMed=15892104;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (Cosmic-CLP=949173; DepMap=ACH-002284).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.42%; Native American=0%; East Asian, North=0.32%; East Asian, South=0.64%; South Asian=4.28%; European, North=52.61%; European, South=41.73% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949173
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 8,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 38
//
ID   SJNB-7
AC   CVCL_8824
AS   CVCL_1449
SY   SJ-NB-7; SJNB7; NB7; NB7-DH; NCG; SJ-NCG
DR   BTO; BTO_0003439
DR   CLO; CLO_0037090
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 952
DR   cancercelllines; CVCL_8824
DR   Cell_Model_Passport; SIDM00156
DR   ChEMBL-Cells; CHEMBL3308158
DR   ChEMBL-Targets; CHEMBL2366345
DR   Cosmic; 688083
DR   Cosmic; 801748
DR   Cosmic; 947717
DR   Cosmic; 949174
DR   Cosmic; 1037337
DR   Cosmic; 1099134
DR   Cosmic; 1153798
DR   Cosmic; 2131587
DR   Cosmic-CLP; 949174
DR   DepMap; ACH-002285
DR   EGA; EGAS00001000978
DR   GDSC; 949174
DR   GEO; GSM314025
DR   GEO; GSM333812
DR   GEO; GSM1670155
DR   IARC_TP53; 27180
DR   LINCS_LDP; LCL-1997
DR   PharmacoDB; NB7_994_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_8824
DR   PubChem_Cell_line; CVCL_8824
DR   Wikidata; Q54953579
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=6171342;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=15892104;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Heterozygous (Cosmic-CLP=949174; DepMap=ACH-002285).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.35%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=68.16%; European, South=31.49% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=949174
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 8,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 37
//
ID   SJNB-8
AC   CVCL_8825
SY   SJ-NB-8; SJ-NB8; SJNB8; NB8; N1108L
DR   BTO; BTO_0006055
DR   cancercelllines; CVCL_8825
DR   Cosmic; 947718
DR   Cosmic; 1037338
DR   Cosmic; 1099135
DR   Cosmic; 1109115
DR   Cosmic; 1153799
DR   Cosmic; 1518075
DR   Cosmic; 1526643
DR   Cosmic; 1543778
DR   Cosmic; 2131588
DR   GEO; GSM314026
DR   GEO; GSM333813
DR   GEO; GSM692860
DR   Progenetix; CVCL_8825
DR   Wikidata; Q54953580
RX   PubMed=7838528;
RX   PubMed=8516298;
RX   PubMed=9516836;
RX   PubMed=10935473;
RX   PubMed=11550280;
RX   PubMed=18923524;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   SJNB-9
AC   CVCL_8826
SY   SJNB9; NB9
DR   Wikidata; Q54953582
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=8516298;
RX   PubMed=10935473;
RX   PubMed=15892104;
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   SJO
AC   CVCL_0T73
DR   ATCC; CRL-2293
DR   BioSample; SAMN03471860
DR   Wikidata; Q54953583
RX   PubMed=1538137;
RX   PubMed=1852002;
RX   PubMed=2299498;
RX   PubMed=7615790;
RX   PubMed=7744245;
RX   PubMed=8106283;
RX   PubMed=9806546;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Ser78Argfs*7 (c.234delCTCAG); Zygosity=Homozygous (PubMed=7744245).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-2293; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=CRL-2293
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   SJPL
AC   CVCL_1T04
SY   St. Jude Porcine Lung; St-Jude Porcine Lung
DR   BioSample; SAMN03152028
DR   Wikidata; Q54953584
RX   Patent=WO2009059411A1;
RX   PubMed=11533214;
RX   PubMed=20200241;
RX   PubMed=23148668;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Problematic cell line: Misidentified. Originally thought to be of pig origin but found to be from Chlorocebus aethiops (PubMed=20200241).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00367.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3256.
CC   Doubling time: 32.57 +- 2.58 hours (PubMed=23148668).
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 13
//
ID   SJSA-1
AC   CVCL_1697
SY   SJSA1; SJSA; OsA-CL; OSA-CL; OsACL; OSACL; Os-A; OSA; OsA
DR   BTO; BTO_0004216
DR   CLO; CLO_0009031
DR   EFO; EFO_0002330
DR   AddexBio; C0004004/64
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2098
DR   BioGRID_ORCS_Cell_line; 468
DR   BioSample; SAMN03472540
DR   BioSample; SAMN10987778
DR   cancercelllines; CVCL_1697
DR   CCTCC; GDC0257
DR   Cell_Model_Passport; SIDM01112
DR   ChEMBL-Cells; CHEMBL3308885
DR   ChEMBL-Targets; CHEMBL2366298
DR   CLS; 305096
DR   Cosmic; 687931
DR   Cosmic; 909717
DR   Cosmic; 931911
DR   Cosmic; 1070843
DR   Cosmic; 1074396
DR   Cosmic; 1097756
DR   Cosmic; 1188476
DR   Cosmic; 1529912
DR   Cosmic-CLP; 909717
DR   DepMap; ACH-000748
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS327EZG
DR   ENCODE; ENCBS489PLT
DR   GDSC; 909717
DR   GEO; GSM320826
DR   GEO; GSM879221
DR   GEO; GSM887574
DR   GEO; GSM888657
DR   GEO; GSM1670426
DR   GEO; GSM1676316
DR   GEO; GSM1701650
DR   IARC_TP53; 27705
DR   IGRhCellID; SJSA1
DR   LiGeA; CCLE_243
DR   LINCS_LDP; LCL-1433
DR   PharmacoDB; SJSA1_1382_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1697
DR   PubChem_Cell_line; CVCL_1697
DR   Wikidata; Q54953586
RX   PubMed=2766305;
RX   PubMed=8275086;
RX   PubMed=12645653;
RX   PubMed=15150091;
RX   PubMed=17354236;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21519327;
RX   PubMed=22460905;
RX   PubMed=23144859;
RX   PubMed=25984343;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30214690;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/sarcoma-xenograft/sjsa1-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: African American.
CC   Doubling time: 31 hours (PubMed=25984343); ~24 hours (PubMed=21519327).
CC   HLA typing: A*30:02,74:01; B*07:06,57:03; C*15:05,18:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (PubMed=19787792).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Heterozygous (Cosmic-CLP=909717; DepMap=ACH-000748).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=909717; DepMap=ACH-000748).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=90.72%; Native American=0%; East Asian, North=1.2%; East Asian, South=0%; South Asian=0%; European, North=2.05%; European, South=6.03% (PubMed=30894373).
CC   Misspelling: SISA; Cosmic=1529912.
CC   Misspelling: SJSA2; Cosmic=1097756.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
ST   Source(s): ATCC=CRL-2098; Cosmic-CLP=909717; PubMed=19787792
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,10
ST   D18S51: 15,17
ST   D19S433: 14.2,15 (ATCC=CRL-2098)
ST   D19S433: 15 (PubMed=19787792)
ST   D21S11: 28,33.2
ST   D2S1338: 21,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 2.2,10
ST   Penta E: 11,14
ST   SE33: 21.2,27.2
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SJSC
AC   CVCL_B7RZ
DR   GEO; GSM2033135
DR   GEO; GSM2033136
DR   GEO; GSM2033137
DR   GEO; GSM2033138
DR   GEO; GSM2033139
DR   GEO; GSM2033140
DR   Wikidata; Q112930394
RX   PubMed=8818656;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C96847; Extrarenal rhabdoid tumor of the liver
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   SJTUGHi001-A
AC   CVCL_D6J9
DR   BioSamples; SAMEA115376234
DR   hPSCreg; SJTUGHi001-A
DR   Wikidata; Q127384297
RX   PubMed=38507880;
CC   From: Shanghai Jiao Tong University School of Medicine, Shanghai General Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:18286; RAX2; Simple; p.Pro28Leu (c.77C>T); Zygosity=Heterozygous (PubMed=38507880).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SJTUGHi002-A
AC   CVCL_D6NM
DR   BioSamples; SAMEA114765760
DR   hPSCreg; SJTUGHi002-A
RX   PubMed=38340451;
CC   From: Shanghai Jiao Tong University School of Medicine, Shanghai General Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2148; CNGA1; Simple; p.Leu85Phefs*4 (c.253delC) (p.Leu89Phefs*4, c.265delC); ClinVar=VCV000225315; Zygosity=Homozygous (PubMed=38340451).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SJTUGHi003-A
AC   CVCL_D6NN
DR   BioSamples; SAMEA115084141
DR   hPSCreg; SJTUGHi003-A
RX   PubMed=38640637;
CC   From: Shanghai Jiao Tong University School of Medicine, Shanghai General Hospital; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11822; TIMP3; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001511267; Zygosity=Heterozygous (PubMed=38640637).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206110; Sorsby fundus dystrophy
DI   ORDO; Orphanet_59181; Sorsby pseudoinflammatory fundus dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SJTUi001-A
AC   CVCL_YR17
DR   hPSCreg; SJTUi001-A
DR   SKIP; SKIP005618
DR   Wikidata; Q98132640
RX   PubMed=32155459;
CC   From: Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8980; PIK3R2; Simple; p.Arg89Cys (c.265C>T); ClinVar=VCV001534490; Zygosity=Heterozygous (PubMed=32155459).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32155459
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D21S11: 29,33.2
ST   D5S818: 10
ST   D7S820: 12
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   SJTUi002-A
AC   CVCL_YT41
DR   hPSCreg; SJTUi002-A
DR   Wikidata; Q98132641
CC   From: Shanghai Jiao Tong University School of Medicine; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   SJTUi003-A
AC   CVCL_B7EC
DR   BioSamples; SAMEA113578710
DR   hPSCreg; SJTUi003-A
DR   Wikidata; Q112930395
RX   PubMed=37343430;
CC   From: Shanghai Jiao Tong University School of Medicine; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=ApoE4 allele (PubMed=37343430).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SJTUi004-A
AC   CVCL_D0LN
DR   hPSCreg; SJTUi004-A
DR   Wikidata; Q123033499
CC   From: Shanghai Jiao Tong University School of Medicine; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SJTUXHi001-A
AC   CVCL_C0F8
DR   BioSamples; SAMEA11567036
DR   hPSCreg; SJTUXHi001-A
DR   Wikidata; Q112930396
RX   PubMed=35358829;
CC   From: Shanghai Xinhua Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:13315; HDAC8; Simple; p.Pro359Ser (c.1075C>T); Zygosity=Heterozygous (PubMed=35358829).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y6M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SJTUXHi002-A
AC   CVCL_C0F7
DR   BioSamples; SAMEA11567037
DR   hPSCreg; SJTUXHi002-A
DR   Wikidata; Q112930397
RX   PubMed=35134694;
CC   From: Shanghai Xinhua Hospital, Shanghai Jiao Tong University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4572; GRIA2; Simple; c.1998delT; Zygosity=Heterozygous (PubMed=35134694).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SJU-1
AC   CVCL_B7QB
DR   Wikidata; Q112930398
RX   DOI=10.1111/j.1095-8649.1973.tb04461.x;
RX   PubMed=235493;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious pancreatic necrosis virus (IPNV) (DOI=10.1111/j.1095-8649.1973.tb04461.x).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   SK [Channa]
AC   CVCL_WY76
SY   Snakehead Kidney
DR   Wikidata; Q98132642
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=188791; ! Channa maculata (Blotched snakehead)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   SK [Scatophagus]
AC   CVCL_CV33
SY   Scatophagus Kidney
DR   Wikidata; Q54953588
RX   PubMed=26911257;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=75038; ! Scatophagus argus (Spotted scat)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   SK 37-7
AC   CVCL_B6QL
SY   37-7
DR   Wikidata; Q112041714
RX   PubMed=6159966;
WW   Provider; Wistar; -; https://web.archive.org/web/20221204232513/https://wistar.org/sites/default/files/2017-11/Herlyn%20Lab%20-%20Monoclonal%20Antibodies%20-%202017.pdf
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human HLA-DR + HLA-DQ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 4
//
ID   SK 7
AC   CVCL_L697
SY   SK7
DR   ATCC; HB-8584
DR   Wikidata; Q54953589
RX   Patent=US4665032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8584.
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L699 ! KE 37.3.2
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   SK 8
AC   CVCL_L698
SY   SK8
DR   ATCC; HB-8585
DR   Wikidata; Q54953591
RX   Patent=US4665032;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8585.
CC   Characteristics: T-cell hybridoma.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L699 ! KE 37.3.2
CA   Hybridoma
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   SK-1
AC   CVCL_JL40
SY   SK1
DR   Wikidata; Q54953592
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   SK-4
AC   CVCL_JL41
SY   SK4
DR   Wikidata; Q54953593
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   SK-5
AC   CVCL_5H87
SY   SK5
DR   ChEMBL-Cells; CHEMBL3307446
DR   ChEMBL-Targets; CHEMBL614911
DR   PubChem_Cell_line; CVCL_5H87
DR   Wikidata; Q54953594
RX   PubMed=2536714;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   SK-6
AC   CVCL_D296
SY   SK6; Swine Kidney-6
DR   BTO; BTO_0005887
DR   BCRJ; 0225
DR   CCLV; CCLV-RIE 0262
DR   Wikidata; Q54953596
RX   PubMed=4336054;
RX   PubMed=19941903;
RX   PubMed=24973239;
RX   PubMed=34737324;
CC   Virology: Susceptible to infection by a wide variety of viruses including porcine adenoviruses, vaccinia and swinepox viruses (PubMed=4336054).
CC   Discontinued: BCRJ; 0225; probable.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   SK-9
AC   CVCL_D593
SY   SK9
DR   cancercelllines; CVCL_D593
DR   Wikidata; Q54953597
RX   PubMed=20471447;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=20471447).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Thr315Ile (c.944C>T) (c.1001C>T); ClinVar=VCV000012624; Zygosity=Unspecified (PubMed=20471447).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Lys361Gln (c.1081A>C); ClinVar=VCV001088249; Zygosity=Heterozygous (PubMed=35124168).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   SK-Ala-1
AC   CVCL_8591
SY   SKAla-1
DR   Wikidata; Q54953599
RX   PubMed=9717829;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-Ala-10
AC   CVCL_8592
SY   SKAla-10
DR   Wikidata; Q54953601
RX   PubMed=17513613;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-Ala-14
AC   CVCL_8593
SY   SKAla-14
DR   Wikidata; Q54953602
RX   PubMed=17513613;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-Ala-2
AC   CVCL_8594
SY   SKAla-2
DR   Wikidata; Q54953603
RX   PubMed=9717829;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-Ala-21
AC   CVCL_8595
SY   SKAla-21
DR   Wikidata; Q54953605
RX   PubMed=17513613;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-Ala-3
AC   CVCL_8596
SY   SKAla-3
DR   Wikidata; Q54953606
RX   PubMed=9717829;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Val143Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-AO2
AC   CVCL_8567
SY   SKAO2; AO2
DR   Wikidata; Q54953607
RX   PubMed=2964515;
RX   PubMed=6182568;
RX   PubMed=8943096;
RX   PubMed=9070656;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SK-astrocyte-IDH1
AC   CVCL_Z595
DR   Wikidata; Q54953609
RX   PubMed=22343889;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2012-113.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5382; IDH1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3G4 ! NHA E6/E7/hTERT/Ras
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   SK-astrocyte-IDH1-R132H
AC   CVCL_Z596
DR   Wikidata; Q54953610
RX   PubMed=22343889;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2012-113.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132His).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3G4 ! NHA E6/E7/hTERT/Ras
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   SK-beta2.7
AC   CVCL_J125
DR   cancercelllines; CVCL_J125
DR   Wikidata; Q54953612
RX   PubMed=8977199;
CC   Problematic cell line: Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2197 ! SKW-3
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   SK-BR-1 II
AC   CVCL_LK78
SY   Lev II; Lev-II
DR   Wikidata; Q54953614
RX   PubMed=4329447;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   SK-BR-1 III
AC   CVCL_T283
SY   SK-BR-1-III; SK-Br-1 III; Lev III; Lev-III
DR   ATCC; HTB-28
DR   Wikidata; Q54953615
RX   PubMed=212193;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4329447;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: ATCC; HTB-28; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LK78 ! SK-BR-1 II
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   SK-BR-2 III
AC   CVCL_T284
SY   SK-BR-2-III; SK-Br-2 III; SK-BR-2/III; Sal III; Sal-III
DR   ATCC; HTB-29
DR   Wikidata; Q54953617
RX   PubMed=212193;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4329447;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: ATCC; HTB-29; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   SK-BR-3
AC   CVCL_0033
SY   SK-Br-3; Sk-Br-3; SK BR 03; SKBR-3; SKBr-3; SK-BR3; SKBr3; SkBr3; SKBR3
DR   BTO; BTO_0002419
DR   CLO; CLO_0009034
DR   CLO; CLO_0037295
DR   EFO; EFO_0001236
DR   MCCL; MCC:0000424
DR   CLDB; cl4310
DR   CLDB; cl7143
DR   AddexBio; C0006007/65
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-30
DR   BCRJ; 0226
DR   BioGRID_ORCS_Cell_line; 378
DR   BioSample; SAMN01821597
DR   BioSample; SAMN03471462
DR   BioSample; SAMN10987910
DR   cancercelllines; CVCL_0033
DR   CancerTools; 161911
DR   CCRID; 1101HUM-PUMC000085
DR   CCRID; 3101HUMTCHu225
DR   CCRID; 4201HUM-CCTCC00286
DR   CCTCC; GDC0286
DR   Cell_Model_Passport; SIDM00897
DR   ChEMBL-Cells; CHEMBL3308062
DR   ChEMBL-Targets; CHEMBL613834
DR   CLS; 300333
DR   Cosmic; 687499
DR   Cosmic; 755294
DR   Cosmic; 759896
DR   Cosmic; 871159
DR   Cosmic; 894090
DR   Cosmic; 897742
DR   Cosmic; 904385
DR   Cosmic; 921974
DR   Cosmic; 923062
DR   Cosmic; 934531
DR   Cosmic; 944297
DR   Cosmic; 979713
DR   Cosmic; 991329
DR   Cosmic; 997935
DR   Cosmic; 1000127
DR   Cosmic; 1010922
DR   Cosmic; 1018478
DR   Cosmic; 1044209
DR   Cosmic; 1046958
DR   Cosmic; 1129655
DR   Cosmic; 1136357
DR   Cosmic; 1176645
DR   Cosmic; 1287914
DR   Cosmic; 1289405
DR   Cosmic; 1308997
DR   Cosmic; 1434957
DR   Cosmic; 1524342
DR   Cosmic; 1571789
DR   Cosmic; 1609462
DR   Cosmic; 2036669
DR   Cosmic; 2165013
DR   Cosmic; 2301535
DR   Cosmic; 2318379
DR   Cosmic; 2361351
DR   DepMap; ACH-000017
DR   DSMZ; ACC-736
DR   DSMZCellDive; ACC-736
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM69195
DR   GEO; GSM73742
DR   GEO; GSM115115
DR   GEO; GSM149978
DR   GEO; GSM149986
DR   GEO; GSM149994
DR   GEO; GSM152556
DR   GEO; GSM152557
DR   GEO; GSM152558
DR   GEO; GSM152559
DR   GEO; GSM154096
DR   GEO; GSM154097
DR   GEO; GSM154098
DR   GEO; GSM154099
DR   GEO; GSM154100
DR   GEO; GSM154101
DR   GEO; GSM154102
DR   GEO; GSM154104
DR   GEO; GSM154107
DR   GEO; GSM155215
DR   GEO; GSM170624
DR   GEO; GSM170625
DR   GEO; GSM170626
DR   GEO; GSM170627
DR   GEO; GSM170630
DR   GEO; GSM170631
DR   GEO; GSM170633
DR   GEO; GSM170634
DR   GEO; GSM183440
DR   GEO; GSM183441
DR   GEO; GSM186457
DR   GEO; GSM186458
DR   GEO; GSM217596
DR   GEO; GSM274644
DR   GEO; GSM274663
DR   GEO; GSM344357
DR   GEO; GSM344407
DR   GEO; GSM350501
DR   GEO; GSM378146
DR   GEO; GSM421883
DR   GEO; GSM481334
DR   GEO; GSM590106
DR   GEO; GSM595617
DR   GEO; GSM783927
DR   GEO; GSM827582
DR   GEO; GSM844686
DR   GEO; GSM844687
DR   GEO; GSM845399
DR   GEO; GSM847432
DR   GEO; GSM847499
DR   GEO; GSM887575
DR   GEO; GSM888658
DR   GEO; GSM1008913
DR   GEO; GSM1038850
DR   GEO; GSM1038851
DR   GEO; GSM1038852
DR   GEO; GSM1038853
DR   GEO; GSM1038854
DR   GEO; GSM1053720
DR   GEO; GSM1172895
DR   GEO; GSM1172989
DR   GEO; GSM1214572
DR   GEO; GSM1238124
DR   GEO; GSM1264069
DR   GEO; GSM1264074
DR   GEO; GSM1264111
DR   GEO; GSM1264116
DR   GEO; GSM1374872
DR   GEO; GSM1374873
DR   GEO; GSM1374874
DR   GEO; GSM1401659
DR   GEO; GSM1661988
DR   GEO; GSM1833627
DR   GEO; GSM2258794
DR   GEO; GSM2258795
DR   GEO; GSM2258796
DR   GEO; GSM2258797
DR   GEO; GSM2258798
DR   GEO; GSM2258799
DR   GEO; GSM2258800
DR   GEO; GSM2258801
DR   GEO; GSM2258802
DR   GEO; GSM2258803
DR   GEO; GSM2258804
DR   GEO; GSM2258805
DR   GEO; GSM2258806
DR   GEO; GSM2258807
DR   GEO; GSM2258808
DR   GEO; GSM2258809
DR   GEO; GSM2258810
DR   GEO; GSM2258811
DR   GEO; GSM2258950
DR   GEO; GSM2258951
DR   GEO; GSM2258952
DR   GEO; GSM7701439
DR   GEO; GSM7701440
DR   IARC_TP53; 580
DR   IBRC; C10147
DR   ICLC; HTL03005
DR   IPD-IMGT/HLA; 12368
DR   IZSLER; BS TCL 156
DR   KCB; KCB 200723YJ
DR   KCLB; 30030
DR   LiGeA; CCLE_391
DR   LINCS_HMS; 50057
DR   LINCS_LDP; LCL-1475
DR   Lonza; 70
DR   NCBI_Iran; C207
DR   PharmacoDB; SKBR3_1383_2019
DR   PRIDE; PXD000691
DR   PRIDE; PXD002053
DR   PRIDE; PXD002057
DR   PRIDE; PXD002281
DR   PRIDE; PXD002486
DR   PRIDE; PXD005390
DR   PRIDE; PXD008222
DR   Progenetix; CVCL_0033
DR   PubChem_Cell_line; CVCL_0033
DR   RCB; RCB2132
DR   SLKBase; 3618
DR   TKG; TKG 0592
DR   TOKU-E; 3129
DR   Ubigene; YC-C048
DR   Wikidata; Q7390592
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1013510;
RX   PubMed=1961733;
RX   PubMed=3518877;
RX   PubMed=6401685;
RX   PubMed=6500159;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=9671407;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11343771;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=16957166;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=19727395;
RX   PubMed=20070913;
RX   PubMed=20215515;
RX   PubMed=20407441;
RX   PubMed=21247443;
RX   PubMed=21378333;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23151021;
RX   PubMed=23601657;
RX   PubMed=23671654;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24389870;
RX   PubMed=24456987;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=25960936;
RX   PubMed=26055192;
RX   PubMed=26378940;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=29954844;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32942617;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-and-growth-of-sk-br-3-htb-30-cells
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/sk-br-3.htm
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-57.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/SKBR3
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-breast-cell-line-sk-br-3
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 808.
CC   Population: Caucasian.
CC   Doubling time: 37.4 hours (PubMed=24389870); ~30 hours (CLS=300333); ~2-3 days (DSMZ=ACC-736); 56.19 hours (JWGray panel).
CC   HLA typing: A*02:01,02:01; B*14:02,39/50/55; C*03:04,03:04; DQB1*02:02,06:04 (PubMed=25960936).
CC   HLA typing: A*02:01,11:01; B*14:02,35:21; C*03:04,03:04; DQB1*06:04,06:04; DRB1*01:05,01:05 (PubMed=26589293).
CC   HLA typing: DPB1*03:01; DRB1*13:02 (IPD-IMGT/HLA=12368).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (PubMed=17334996; PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=1961733; PubMed=16541312; PubMed=28889351; ATCC=HTB-30; DepMap=ACH-000017).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.7%; Native American=0%; East Asian, North=2.13%; East Asian, South=0%; South Asian=0.26%; European, North=63.89%; European, South=33.02% (PubMed=30894373).
CC   Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870).
CC   Misspelling: SKBR3B; PubMed=26378940.
CC   Discontinued: RCB; RCB2132; true.
CC   Discontinued: TKG; TKG 0592; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006007/65; ATCC=HTB-30; CCRID; CLS=300333; DSMZ=ACC-736; KCLB=30030; MSKCC; PubMed=25877200; PubMed=28889351; RCB=RCB2132; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11 (Technion Genomics Center)
ST   D13S317: 11,12 (AddexBio=C0006007/65; ATCC=HTB-30; CCRID; CLS=300333; DSMZ=ACC-736; KCLB=30030; MSKCC; PubMed=25877200; PubMed=28889351; RCB=RCB2132)
ST   D16S539: 9
ST   D18S51: 10,13
ST   D19S433: 14
ST   D21S11: 30,30.2
ST   D2S1338: 20,25
ST   D3S1358: 17
ST   D5S818: 9 (MSKCC)
ST   D5S818: 9,12 (AddexBio=C0006007/65; ATCC=HTB-30; CCRID; CLS=300333; DSMZ=ACC-736; KCLB=30030; PubMed=25877200; PubMed=28889351; RCB=RCB2132; Technion Genomics Center)
ST   D7S820: 9,12
ST   D8S1179: 11,12 (CLS=300333)
ST   D8S1179: 12 (ATCC=HTB-30; CCRID; DSMZ=ACC-736; MSKCC; PubMed=25877200; Technion Genomics Center)
ST   FGA: 20
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1074 ! AU565
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   SK-BR-3 shPARG
AC   CVCL_RA92
SY   shPARG SK-BR-3
DR   cancercelllines; CVCL_RA92
DR   Wikidata; Q54953619
RX   PubMed=29166620;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   SK-BR-3 shWDR12-4
AC   CVCL_YJ28
SY   SKBR-3 shWDR12-4
DR   cancercelllines; CVCL_YJ28
DR   Wikidata; Q98132643
RX   CelloPub=CLPUB00550;
CC   Population: Caucasian.
CC   Doubling time: 36-39 hours (CelloPub=CLPUB00550).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:14098; WDR12.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SK-BR-3-EGFP
AC   CVCL_C8WI
DR   Ubigene; YC-C048-EGFP-P
DR   Wikidata; Q123033500
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SK-BR-3-LR
AC   CVCL_4V52
DR   cancercelllines; CVCL_4V52
DR   Wikidata; Q54953621
RX   PubMed=23811285;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   SK-BR-3-Luc [JCRB]
AC   CVCL_4Y11
DR   cancercelllines; CVCL_4Y11
DR   JCRB; JCRB1627.1
DR   JCRB; NIHS0735
DR   Wikidata; Q54953622
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0735; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1627.1
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 9,12
ST   D7S820: 9,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   SK-BR-3-Luc [Ubigene]
AC   CVCL_C8WJ
DR   Ubigene; YC-C048-Luc-P
DR   Wikidata; Q123033502
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SK-BR-3/nab-P
AC   CVCL_B6Y6
SY   SK-BR-3/nab-Paclitaxel resistant
DR   cancercelllines; CVCL_B6Y6
DR   Wikidata; Q112041715
RX   DOI=10.4314/tjpr.v20i12.6;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   SK-BR-3/Cas9-hyg
AC   CVCL_C9CH
DR   GeneCopoeia; SL535
DR   Wikidata; Q123033503
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL535).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SK-BR-3/PacR
AC   CVCL_B7P8
DR   cancercelllines; CVCL_B7P8
DR   Wikidata; Q112930399
RX   PubMed=27664577;
RX   PubMed=29625142;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line no longer available (personal communication of Daniel, Petr).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   SK-BR-5
AC   CVCL_5217
SY   SK-Br-5; SKBR-5; SKBr5; SkBr5; SKBR5
DR   cancercelllines; CVCL_5217
DR   Cosmic; 997936
DR   Cosmic; 1046938
DR   Cosmic; 1287912
DR   Cosmic; 1289406
DR   DepMap; ACH-002329
DR   GEO; GSM421884
DR   GEO; GSM1661989
DR   IARC_TP53; 24347
DR   PharmacoDB; SKBR5_1384_2019
DR   Wikidata; Q54953625
RX   PubMed=6582512;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=23601657;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; c.532-1G>C; ClinVar=VCV000406644; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Asp (c.482C>A); ClinVar=VCV000422295; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SK-BR-7
AC   CVCL_5218
SY   SK-Br-7; SK BR 07; SKBR-7; SKBr7; SKBR7
DR   cancercelllines; CVCL_5218
DR   Cosmic; 1046946
DR   Cosmic; 1287927
DR   Cosmic; 1289407
DR   DepMap; ACH-002330
DR   GEO; GSM75171
DR   GEO; GSM217597
DR   GEO; GSM219966
DR   GEO; GSM421885
DR   IARC_TP53; 24337
DR   PharmacoDB; SKBR7_1385_2019
DR   Progenetix; CVCL_5218
DR   Wikidata; Q54953626
RX   PubMed=11044355;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=23601657;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/sk-br-7.htm
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=19593635).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 15,15.2
ST   D21S11: 29,31
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SK-ChA-1
AC   CVCL_6952
SY   SK-CHA-1; SK-ChA1; SkChA-1; SkChA1; WITT; WITT-1
DR   BTO; BTO_0004655
DR   Cosmic; 924011
DR   Cosmic; 927191
DR   Cosmic; 2674050
DR   Wikidata; Q54953627
RX   CelloPub=CLPUB00275;
RX   PubMed=4056357;
RX   PubMed=9824643;
RX   PubMed=21533411;
RX   PubMed=26486326;
RX   PubMed=26956050;
RX   PubMed=35640676;
CC   Doubling time: ~48 hours (Note=At 55-60th passages) (PubMed=4056357); 26 hours (PubMed=9824643).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-CO-1
AC   CVCL_0626
SY   SKCO-1; SKCO 1; SKCO1; SKCol1; SK-Col-1; SK Col 1
DR   CLO; CLO_0009035
DR   EFO; EFO_0006752
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-39
DR   BioSample; SAMN03472359
DR   BioSample; SAMN03472743
DR   BioSample; SAMN10988030
DR   cancercelllines; CVCL_0626
DR   CancerTools; 161933
DR   Cell_Model_Passport; SIDM01096
DR   ChEMBL-Cells; CHEMBL3308784
DR   ChEMBL-Targets; CHEMBL1075576
DR   ColonAtlas; SKCO1
DR   Cosmic; 724846
DR   Cosmic; 876726
DR   Cosmic; 909718
DR   Cosmic; 948125
DR   Cosmic; 948852
DR   Cosmic; 986016
DR   Cosmic; 995402
DR   Cosmic; 1071892
DR   Cosmic; 1175844
DR   Cosmic; 1176593
DR   Cosmic; 1187318
DR   Cosmic; 1312310
DR   Cosmic; 1466820
DR   Cosmic; 1479586
DR   Cosmic; 1482520
DR   Cosmic; 1676740
DR   Cosmic; 1805265
DR   Cosmic; 2302006
DR   Cosmic; 2647531
DR   Cosmic-CLP; 909718
DR   DepMap; ACH-000400
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909718
DR   GEO; GSM206541
DR   GEO; GSM274769
DR   GEO; GSM274770
DR   GEO; GSM513919
DR   GEO; GSM514306
DR   GEO; GSM741251
DR   GEO; GSM827412
DR   GEO; GSM887576
DR   GEO; GSM888659
DR   GEO; GSM1346852
DR   GEO; GSM1374875
DR   GEO; GSM1374876
DR   GEO; GSM1374877
DR   GEO; GSM1448193
DR   GEO; GSM1670427
DR   IARC_TP53; 21767
DR   LiGeA; CCLE_559
DR   LINCS_LDP; LCL-1184
DR   PharmacoDB; SKCO1_1386_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0626
DR   PubChem_Cell_line; CVCL_0626
DR   SKY/M-FISH/CGH; 5015
DR   Wikidata; Q54953629
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6582512;
RX   PubMed=7017212;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-colorectal-adenocarcinoma-cell-line-sk-co-1
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-072.
CC   Population: Caucasian.
CC   Doubling time: 46.56 hours (PubMed=25944804); 46 hours (PubMed=25984343).
CC   HLA typing: A*01:01,02:01; B*35:08,58:05; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Phe1089fs*37 (c.3266delT); Zygosity=Heterozygous (ATCC=HTB-39; Cosmic-CLP=909718; DepMap=ACH-000400).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Pro1443fs*30 (c.4328delC); Zygosity=Heterozygous (ATCC=HTB-39; Cosmic-CLP=909718; DepMap=ACH-000400).
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple; p.Arg201Cys (c.601C>T); ClinVar=VCV000015933; Zygosity=Heterozygous (Cosmic-CLP=909718; DepMap=ACH-000400).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; Cosmic-CLP=909718; DepMap=ACH-000400).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.04%; Native American=0.56%; East Asian, North=2.24%; East Asian, South=0%; South Asian=0%; European, North=68.7%; European, South=28.45% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=HTB-39; Cosmic-CLP=909718; PubMed=25877200; PubMed=25926053; Technion Genomics Center
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (ATCC=HTB-39; Cosmic-CLP=909718; PubMed=25926053; Technion Genomics Center)
ST   CSF1PO: 13
ST   D10S1248: 13,14
ST   D12S391: 18
ST   D13S317: 14
ST   D16S539: 13
ST   D18S51: 19
ST   D19S433: 12,13
ST   D1S1656: 13,18.3
ST   D21S11: 28,30
ST   D22S1045: 15
ST   D2S1338: 17,21
ST   D2S441: 10,15
ST   D3S1358: 17,18
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   Penta D: 11
ST   Penta E: 13,16
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SK-CO-10
AC   CVCL_GS25
DR   Wikidata; Q54953630
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 4
//
ID   SK-CO-15
AC   CVCL_A337
SY   SK CO-15; SKCO-15; SKCO 15; SK-CO15; SKCO15; SKco15
DR   BTO; BTO_0005068
DR   EFO; EFO_0022715
DR   Wikidata; Q54953631
RX   PubMed=2687880;
RX   PubMed=22556145;
WW   Provider; Beyotime; C6834; https://www.beyotime.com/Manual/C6834%20SKCO-15%20(Human%20Colorectal%20Cancer%20Cells).pdf
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Caution: Beyotime seems to distribute a cell line under the designation 'SKCO-15' whose STR profile is 100% identical to that of the Caco-2 cell line and is thus contaminated. MSKCC is in possession of original stocks and thus the STR profile shown in this entry is that of the original stock.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,14
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 15,16
ST   D21S11: 28,31
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,14
ST   D8S1179: 10,14
ST   FGA: 25.2
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   SK-DHL2A
AC   CVCL_E051
SY   SK-DHL2a; SKDHL2A; Manca; MANCA
DR   ChEMBL-Cells; CHEMBL3307363
DR   ChEMBL-Targets; CHEMBL614320
DR   PubChem_Cell_line; CVCL_E051
DR   Wikidata; Q54953634
RX   PubMed=3921823;
RX   PubMed=6160588;
RX   PubMed=6608987;
CC   Doubling time: 17.9 +- 2.6 hours (PubMed=6608987).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   SK-DHL2B
AC   CVCL_E052
SY   SK-DHL2b; SKDHL2B
DR   Wikidata; Q54953635
RX   PubMed=6608987;
CC   Doubling time: 17.1 +- 2.1 hours (PubMed=6608987).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E051 ! SK-DHL2A
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   SK-DSRCT1
AC   CVCL_B5EF
SY   SK-DSRCT-1
DR   Wikidata; Q110433229
RX   PubMed=34841430;
CC   Doubling time: 23.4 hours (PubMed=34841430).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex10-WT1 Ex8 fusion (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Met1634Ter (c.4899delC); Zygosity=Unspecified (PubMed=34841430).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C27373; Adult desmoplastic small round cell tumor
DI   ORDO; Orphanet_83469; Desmoplastic small round cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   SK-DSRCT2
AC   CVCL_B5EG
SY   SK-DSRCT-2
DR   cancercelllines; CVCL_B5EG
DR   Wikidata; Q110433230
RX   PubMed=34841430;
CC   Doubling time: 59.5 hours (PubMed=34841430).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:12796; WT1; Name(s)=EWSR1-WT1, EWS-WT1; Note=EWSR1 Ex9-WT1 Ex8 fusion (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Asn564Asp (c.1690A>G); ClinVar=VCV000376261; Zygosity=Unspecified (PubMed=34841430).
CC   Sequence variation: Mutation; HGNC; HGNC:9949; RECQL4; Simple; p.Val767Glyfs*76; Zygosity=Unspecified (PubMed=34841430).
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C27373; Adult desmoplastic small round cell tumor
DI   ORDO; Orphanet_83469; Desmoplastic small round cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   SK-EPD-2-R
AC   CVCL_IX46
DR   Wikidata; Q54953652
RX   PubMed=1326305;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C115203; Childhood embryonal tumor with multilayered rosettes, C19MC-altered
DI   ORDO; Orphanet_251870; Central nervous system embryonal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y5M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 6
//
ID   SK-ES-1
AC   CVCL_0627
SY   Sk-Es-1; Sk-ES-1; SK ES 01; SK-ES1; SKES-1; SKES1; SK-ES
DR   CLO; CLO_0009036
DR   EFO; EFO_0002858
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-86
DR   BCRJ; 0266
DR   BioGRID_ORCS_Cell_line; 195
DR   BioSample; SAMN03472758
DR   BioSample; SAMN03473516
DR   BioSample; SAMN10987953
DR   cancercelllines; CVCL_0627
DR   Cell_Model_Passport; SIDM01111
DR   ChEMBL-Cells; CHEMBL3307826
DR   ChEMBL-Targets; CHEMBL613970
DR   CLS; 300435
DR   Cosmic; 684072
DR   Cosmic; 759888
DR   Cosmic; 1078385
DR   Cosmic; 1082505
DR   Cosmic; 1085904
DR   Cosmic; 1388894
DR   Cosmic; 1718430
DR   Cosmic; 1995629
DR   Cosmic; 2060800
DR   Cosmic; 2228231
DR   Cosmic; 2250467
DR   Cosmic-CLP; 684072
DR   DepMap; ACH-000087
DR   DSMZ; ACC-518
DR   DSMZCellDive; ACC-518
DR   EGA; EGAS00001000978
DR   GDSC; 684072
DR   GEO; GSM393027
DR   GEO; GSM510008
DR   GEO; GSM510017
DR   GEO; GSM510018
DR   GEO; GSM827589
DR   GEO; GSM887577
DR   GEO; GSM888660
DR   GEO; GSM1670428
DR   GEO; GSM1676343
DR   GEO; GSM1701674
DR   GEO; GSM5359694
DR   GEO; GSM5359695
DR   GEO; GSM5359696
DR   GEO; GSM5359697
DR   GEO; GSM5359698
DR   GEO; GSM5359699
DR   GEO; GSM5362957
DR   GEO; GSM5362958
DR   GEO; GSM5362959
DR   GEO; GSM5362960
DR   GEO; GSM5362961
DR   GEO; GSM5362962
DR   GEO; GSM5364001
DR   GEO; GSM5364002
DR   GEO; GSM5364003
DR   GEO; GSM5364004
DR   GEO; GSM5364005
DR   IARC_TP53; 710
DR   IGRhCellID; SKES%20%20GEO
DR   LiGeA; CCLE_862
DR   LINCS_LDP; LCL-1434
DR   PharmacoDB; SKES1_1387_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0627
DR   PubChem_Cell_line; CVCL_0627
DR   Wikidata; Q54953654
RX   DOI=10.5282/edoc.27750;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=8040301;
RX   PubMed=8221663;
RX   PubMed=8378080;
RX   PubMed=8617485;
RX   PubMed=9738976;
RX   PubMed=11423975;
RX   PubMed=11891184;
RX   PubMed=12054564;
RX   PubMed=18082704;
RX   PubMed=18160777;
RX   PubMed=19787792;
RX   PubMed=20215515;
RX   PubMed=21822310;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=25010205;
RX   PubMed=25223734;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29464090;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-es-1-human-ewing-sarcoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-542.
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (DSMZ=ACC-518).
CC   HLA typing: A*11:01,11:01; B*07:06,44:02; C*05:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777; PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=8040301; PubMed=9738976; PubMed=11423975; PubMed=11891184; PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln735Ter (c.2203C>T); Zygosity=Unspecified (PubMed=25010205; PubMed=25223734).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=8221663; PubMed=8378080; PubMed=19787792; PubMed=25010205; PubMed=25223734; PubMed=26428435).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.13%; Native American=0%; East Asian, North=0.63%; East Asian, South=0%; South Asian=1.64%; European, North=63.44%; European, South=34.15% (PubMed=30894373).
CC   Miscellaneous: The signal for the amelogenin "Y" allele is quite weak (MSKCC).
ST   Source(s): ATCC=HTB-86; CLS=300435; Cosmic-CLP=684072; DSMZ=ACC-518; MSKCC; PubMed=19787792; PubMed=25877200; PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,9
ST   D16S539: 11 (ATCC=HTB-86; CLS=300435; Cosmic-CLP=684072; MSKCC; PubMed=19787792; PubMed=25877200; PubMed=30879952)
ST   D16S539: 12 (DSMZ=ACC-518)
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 11
ST   SE33: 18,20
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SK-ES-2
AC   CVCL_T285
DR   ATCC; HTB-87
DR   Wikidata; Q54953655
RX   PubMed=327080;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: ATCC; HTB-87; true.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 10
//
ID   SK-GT-1
AC   CVCL_9585
SY   SKGT1
DR   IARC_TP53; 4077
DR   Wikidata; Q54953658
RX   PubMed=7665247;
RX   PubMed=8334620;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=8334620).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.169_185del17; Zygosity=Unspecified (PubMed=7665247).
CC   Derived from site: In situ; Stomach, cardia; UBERON=UBERON_0001162.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   SK-GT-2
AC   CVCL_2194
SY   SKGT2
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473450
DR   cancercelllines; CVCL_2194
DR   Cell_Model_Passport; SIDM00393
DR   Cosmic-CLP; 1503364
DR   DepMap; ACH-001653
DR   DSMZ; ACC-702
DR   DSMZCellDive; ACC-702
DR   ECACC; 11012008
DR   EGA; EGAS00001000978
DR   GDSC; 1503364
DR   GEO; GSM1670430
DR   IARC_TP53; 4078
DR   PharmacoDB; SKGT2_1388_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54953659
RX   PubMed=7665247;
RX   PubMed=8334620;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Hispanic.
CC   Doubling time: 44 hours (PubMed=8334620); ~48 hours (DSMZ=ACC-702); ~44 hours (ECACC=11012008).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=7665247; Cosmic-CLP=1503364; DepMap=ACH-001653).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=20.34%; Native American=14.81%; East Asian, North=2.09%; East Asian, South=0%; South Asian=0%; European, North=30.94%; European, South=31.83% (PubMed=30894373).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
ST   Source(s): Cosmic-CLP=1503364; DepMap=ACH-001653; DSMZ=ACC-702; ECACC=11012008
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 12
ST   D21S11: 32 (DSMZ=ACC-702)
ST   D21S11: 32.2 (DepMap=ACH-001653)
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 15,17
ST   TH01: 8,9
ST   TPOX: 9,12
ST   vWA: 15,18
DI   NCIt; C8398; Gastric fundus carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SK-GT-3
AC   CVCL_9584
SY   SKGT3
DR   Wikidata; Q54953660
RX   PubMed=8334620;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 58 hours (PubMed=8334620).
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
DI   NCIt; C8398; Gastric fundus carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SK-GT-4
AC   CVCL_2195
SY   SKGT4; SK4
DR   EFO; EFO_0001237
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1011
DR   BioSample; SAMN03473395
DR   cancercelllines; CVCL_2195
DR   Cell_Model_Passport; SIDM00483
DR   Cosmic; 1599346
DR   Cosmic-CLP; 1503365
DR   DepMap; ACH-001654
DR   DSMZ; ACC-712
DR   DSMZCellDive; ACC-712
DR   ECACC; 11012007
DR   EGA; EGAS00001000978
DR   GDSC; 1503365
DR   GEO; GSE2144
DR   GEO; GSE13376
DR   GEO; GSM1374878
DR   GEO; GSM1670431
DR   IARC_TP53; 4079
DR   PharmacoDB; SKGT4_1389_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54953662
RX   PubMed=7665247;
RX   PubMed=8334620;
RX   PubMed=11520067;
RX   PubMed=20075370;
RX   PubMed=20139130;
RX   PubMed=23795680;
RX   PubMed=26317542;
RX   PubMed=27397505;
RX   PubMed=27594985;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 39 hours (PubMed=8334620); ~30-35 hours (DSMZ=ACC-712).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=27594985; Cosmic-CLP=1503365; DepMap=ACH-001654).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (Cosmic-CLP=1503365; DepMap=ACH-001654).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln100Ter (c.298C>T); ClinVar=VCV000634707; Zygosity=Homozygous (PubMed=20075370; Cosmic-CLP=1503365; DepMap=ACH-001654).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=2.11%; Native American=1.08%; East Asian, North=1.62%; East Asian, South=0%; South Asian=7.99%; European, North=27.72%; European, South=59.48% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at p.Arg175His (c.524G>A) in PubMed=7665247.
CC   Misspelling: SJGT4; GEO=GSM337727.
CC   Derived from site: In situ; Esophagus, distal; UBERON=UBERON_0013473.
ST   Source(s): Cosmic-CLP=1503365; DepMap=ACH-001654; DSMZ=ACC-712; PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 11,15
ST   D13S317: 9,10
ST   D16S539: 11,12,13
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 16,19
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 7,11
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 7
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 17,19
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SK-GT-5
AC   CVCL_8114
SY   SKGT5
DR   BioSample; SAMN03151916
DR   cancercelllines; CVCL_8114
DR   IARC_TP53; 4080
DR   Wikidata; Q54953663
RX   PubMed=7665247;
RX   PubMed=8334620;
RX   PubMed=20075370;
RX   PubMed=23795680;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SK-GT-2 derivative (PubMed=20075370). Originally thought to originate from a 67 year old male patient with an esophageal adenocarcinoma.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00368.
CC   Population: Hispanic.
CC   Doubling time: 41 hours (PubMed=8334620).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Caution: TP53 mutation indicated incorrectly as being at p.Asp281Glu (c.843C>G) in PubMed=7665247.
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
ST   Source(s): PubMed=20075370
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 32.2
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 26
ST   Penta D: 9
ST   Penta E: 15,17
ST   TH01: 8,9
ST   TPOX: 9,12
ST   vWA: 15,18
DI   NCIt; C8398; Gastric fundus carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2194 ! SK-GT-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SK-HD-1
AC   CVCL_1E50
DR   Wikidata; Q54953664
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   SK-HEP-1
AC   CVCL_0525
SY   SK-Hep-1; SK HEP-1; SK HEP 01; SK-Hep1; Sk-Hep1; SK Hep 1; SK Hep1; SKHEP-1; SKHEP1; SKHep1; SK_HEP1
DR   BTO; BTO_0003477
DR   CLO; CLO_0009037
DR   MCCL; MCC:0000425
DR   CLDB; cl4312
DR   CLDB; cl4313
DR   CLDB; cl4314
DR   CLDB; cl4315
DR   CLDB; cl7214
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-52
DR   BioGRID_ORCS_Cell_line; 467
DR   BioSample; SAMN01821598
DR   BioSample; SAMN01821664
DR   BioSample; SAMN03472884
DR   BioSample; SAMN10988022
DR   cancercelllines; CVCL_0525
DR   CancerTools; 161934
DR   CCRID; 1101HUM-PUMC000677
DR   CCRID; 1102HUM-NIFDC00060
DR   CCRID; 3101HUMTCHu109
DR   CCRID; 4201HUM-CCTCC00145
DR   CCTCC; GDC0145
DR   Cell_Model_Passport; SIDM01110
DR   CGH-DB; 9071-4
DR   ChEMBL-Cells; CHEMBL3307741
DR   ChEMBL-Targets; CHEMBL614912
DR   CLS; 300334
DR   Cosmic; 684195
DR   Cosmic; 735607
DR   Cosmic; 873394
DR   Cosmic; 909719
DR   Cosmic; 928139
DR   Cosmic; 932990
DR   Cosmic; 979728
DR   Cosmic; 1187333
DR   Cosmic; 1518231
DR   Cosmic; 2162539
DR   Cosmic; 2321042
DR   Cosmic; 2668284
DR   Cosmic-CLP; 909719
DR   DepMap; ACH-000361
DR   DSMZ; ACC-141
DR   DSMZCellDive; ACC-141
DR   ECACC; 91091816
DR   EGA; EGAS00001000978
DR   FCS-free; 174-2-331-1-4-3
DR   GDSC; 909719
DR   GEO; GSM481451
DR   GEO; GSM501784
DR   GEO; GSM565878
DR   GEO; GSM887578
DR   GEO; GSM888661
DR   GEO; GSM936776
DR   GEO; GSM1374879
DR   GEO; GSM1670432
DR   GEO; GSM2551582
DR   IARC_TP53; 27577
DR   ICLC; HTL10001
DR   KCB; KCB 2013038YJ
DR   KCLB; 30052
DR   LiGeA; CCLE_110
DR   LINCS_LDP; LCL-1941
DR   PharmacoDB; SKHEP1_1390_2019
DR   PRIDE; PXD002957
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0525
DR   PubChem_Cell_line; CVCL_0525
DR   TOKU-E; 3132
DR   Ubigene; YC-C007
DR   Wikidata; Q54953666
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1371504;
RX   PubMed=2439335;
RX   PubMed=3431441;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=8224613;
RX   PubMed=8389256;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=11416159;
RX   PubMed=12029633;
RX   PubMed=12068308;
RX   PubMed=20069059;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25574106;
RX   PubMed=25822314;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31938418;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-397.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/sk-hep1-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-hep-1-human-hepatic-adenocarcinoma-cell-line
CC   Problematic cell line: Misclassified. Originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells (PubMed=1371504; PubMed=31938418).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-535.
CC   Population: Caucasian.
CC   Doubling time: 46.7 +- 10.3 hours, 94.2 hours (Note=In CDM4-CHO medium), 289.8 hours (Note=In 293 SFM II medium) (PubMed=25822314); ~30 hours (DSMZ=ACC-141).
CC   HLA typing: A*02:01,24:02; B*35:04,44:03:01; C*04:01; DQA1*01:02; DQB1*05:02,06.04; DRB1*13:02,16:02 (PubMed=9178645).
CC   HLA typing: A*02:01,24:02; B*35:02,44:03; C*04:01,04:01 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (ATCC=HTB-52).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; ATCC=HTB-52; Cosmic-CLP=909719; DepMap=ACH-000361).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.65%; Native American=1.18%; East Asian, North=0%; East Asian, South=2.22%; South Asian=8.09%; European, North=23.66%; European, South=64.2% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): ATCC=HTB-52; CCRID; CLS=300334; Cosmic-CLP=909719; DSMZ=ACC-141; ECACC=91091816; KCLB=30052; MSKCC; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12 (DSMZ=ACC-141)
ST   D19S433: 12,15.2 (ATCC=HTB-52; CCRID; CLS=300334; MSKCC; PubMed=25877200)
ST   D21S11: 29,31
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta D: 13,14
ST   Penta E: 13 (PubMed=25877200)
ST   Penta E: 13,21 (ATCC=HTB-52; CCRID; CLS=300334; DSMZ=ACC-141)
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SK-HEP-1-Cas9-726
AC   CVCL_XD84
DR   cancercelllines; CVCL_XD84
DR   CCRID; 1101HUM-PUMC000726
DR   Wikidata; Q98132644
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000726
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-727
AC   CVCL_XD85
DR   cancercelllines; CVCL_XD85
DR   CCRID; 1101HUM-PUMC000727
DR   Wikidata; Q98132645
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000727
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-728
AC   CVCL_XD86
DR   cancercelllines; CVCL_XD86
DR   CCRID; 1101HUM-PUMC000728
DR   Wikidata; Q98132647
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000728
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-729
AC   CVCL_XD87
DR   cancercelllines; CVCL_XD87
DR   CCRID; 1101HUM-PUMC000729
DR   Wikidata; Q98132648
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000729
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-730
AC   CVCL_XD88
DR   cancercelllines; CVCL_XD88
DR   CCRID; 1101HUM-PUMC000730
DR   Wikidata; Q98132649
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000730
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-731
AC   CVCL_XD89
DR   cancercelllines; CVCL_XD89
DR   CCRID; 1101HUM-PUMC000731
DR   Wikidata; Q98132650
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000731
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-732
AC   CVCL_XD90
DR   cancercelllines; CVCL_XD90
DR   CCRID; 1101HUM-PUMC000732
DR   Wikidata; Q98132651
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000732
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-733
AC   CVCL_XD91
DR   cancercelllines; CVCL_XD91
DR   CCRID; 1101HUM-PUMC000733
DR   Wikidata; Q98132654
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000733
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-734
AC   CVCL_XD92
DR   cancercelllines; CVCL_XD92
DR   CCRID; 1101HUM-PUMC000734
DR   Wikidata; Q98132655
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000734
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-Cas9-735
AC   CVCL_XD93
DR   cancercelllines; CVCL_XD93
DR   CCRID; 1101HUM-PUMC000735
DR   Wikidata; Q98132656
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-PuroR construct.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
ST   Source(s): CCRID=1101HUM-PUMC000735
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 12,15.2
ST   D21S11: 29,31,32
ST   D2S1338: 20,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D6S1043: 11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 17
ST   Penta E: 13,21
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 16
//
ID   SK-HEP-1-FIX
AC   CVCL_AU01
SY   SK-Hep-1-FIX
DR   cancercelllines; CVCL_AU01
DR   Wikidata; Q54953667
RX   PubMed=26802680;
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3551; F9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   SK-HEP-1-Luc
AC   CVCL_C8XK
DR   Ubigene; YC-C007-Luc-P
DR   Wikidata; Q123033504
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SK-Hep-1-NIS
AC   CVCL_6019
SY   SK-Hep1-NIS
DR   cancercelllines; CVCL_6019
DR   Wikidata; Q54953669
RX   PubMed=15347726;
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   SK-HEP-1/Cas9-hyg
AC   CVCL_C9DI
DR   GeneCopoeia; SL557
DR   Wikidata; Q123033505
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL557).
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SK-Hep-1/CDDP
AC   CVCL_M182
SY   SK-Hep1/DDP
DR   cancercelllines; CVCL_M182
DR   Wikidata; Q54953671
RX   PubMed=20109345;
RX   PubMed=20458768;
CC   Problematic cell line: Misclassified. Parent cell line (SK-HEP-1) was originally described as originating from an adenocarcinoma of liver and thus classified as hepatocellular carcinoma. Later studies show that it most probably has arisen from endothelial cells.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Caution: PubMed=20458768 describes SK-Hep-1/CDDP and does not cite PubMed=20109345 which describes SK-Hep1/DDP. As the two papers are from the same authors and that the described cell lines have identical characteristics it is probable that they are identical.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Endothelial cell; CL=CL_0000115.
DI   NCIt; C7106; Liver and intrahepatic bile duct epithelial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0525 ! SK-HEP-1
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   SK-HNF-5
AC   CVCL_LL62
SY   SK-HNF-5a
DR   Wikidata; Q54953672
RX   PubMed=3518877;
RX   PubMed=12058748;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 8
//
ID   SK-JHRCC-12
AC   CVCL_Z029
SY   JHRCC12 cell line
DR   Wikidata; Q54953673
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK-JHRCC-12.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SK-JHRCC-120
AC   CVCL_Z030
DR   Wikidata; Q54953675
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK-JHRCC-120.
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SK-JHRCC-219
AC   CVCL_B3PV
SY   JHRCC219 cell line; RMC219
DR   Wikidata; Q110433231
RX   PubMed=28753786;
RX   PubMed=32359397;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=32359397).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SK-JHRCC-228
AC   CVCL_B3PT
SY   JHRCC228 cell line
DR   Wikidata; Q110433232
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SK-JHRCC-3
AC   CVCL_Z031
SY   JHRCC3 cell line
DR   Wikidata; Q54953676
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK-JHRCC-3.
CC   Population: Caucasian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SK-JHRCC-62-LN
AC   CVCL_B3PU
SY   JHRCC62-LN cell line
DR   Wikidata; Q110433233
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 5
//
ID   SK-JHRCC-92
AC   CVCL_Z032
DR   Wikidata; Q54953678
RX   PubMed=28753786;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK-JHRCC-92.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SK-L1
AC   CVCL_IU60
SY   SK-LI; SKL-1; SKL 1; SKL1
DR   Wikidata; Q54953680
RX   PubMed=170370;
RX   PubMed=4169243;
RX   PubMed=4170382;
RX   PubMed=4325933;
RX   PubMed=5229350;
RX   PubMed=5229525;
RX   PubMed=5640868;
RX   PubMed=7316467;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 30 hours (PubMed=5229525).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 11
//
ID   SK-L10
AC   CVCL_LK92
SY   SKL-10; SKL10
DR   Wikidata; Q54953681
RX   PubMed=4894370;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7463; Acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 7
//
ID   SK-L2
AC   CVCL_LK80
SY   SKL-2; SKL 2; SKL2
DR   Wikidata; Q54953682
RX   PubMed=4169243;
RX   PubMed=4170382;
RX   PubMed=4866767;
RX   PubMed=4894370;
RX   PubMed=5229350;
RX   PubMed=5229525;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 23 hours (PubMed=5229525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   SK-L3
AC   CVCL_LK81
SY   SKL-3; SKL 3; SKL3
DR   Wikidata; Q54953684
RX   PubMed=3518877;
RX   PubMed=4169243;
RX   PubMed=4170382;
RX   PubMed=4866767;
RX   PubMed=5229525;
RX   PubMed=5640868;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 26 hours (PubMed=5229525).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   SK-L4
AC   CVCL_LK82
SY   SKL-4; SKL 4; SKL4
DR   Wikidata; Q54953685
RX   PubMed=4169243;
RX   PubMed=4170382;
RX   PubMed=4866767;
RX   PubMed=4894370;
RX   PubMed=5229525;
RX   PubMed=5640868;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   SK-L5
AC   CVCL_LK83
SY   SKL-5; SKL 5; SKL5
DR   Wikidata; Q54953686
RX   PubMed=3518877;
RX   PubMed=4169243;
RX   PubMed=4170382;
RX   PubMed=4866767;
RX   PubMed=5229525;
RX   PubMed=5640868;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   SK-L6
AC   CVCL_LK84
SY   SKL-6; SKL 6; SKL6
DR   Wikidata; Q54953687
RX   PubMed=4170382;
RX   PubMed=4894370;
RX   PubMed=5229525;
RX   PubMed=5640868;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   SK-L7
AC   CVCL_LK85
SY   SKL-7; SKL 7; SKL7
DR   Wikidata; Q54953689
RX   PubMed=3518877;
RX   PubMed=4169243;
RX   PubMed=4170382;
RX   PubMed=4866767;
RX   PubMed=4894370;
RX   PubMed=5229525;
RX   PubMed=5640868;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7970; Childhood acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   SK-L8
AC   CVCL_UH48
SY   SKL-8; SKL8
DR   Wikidata; Q98132657
RX   PubMed=4170382;
RX   PubMed=5229525;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   SK-L9
AC   CVCL_LK93
SY   SKL-9; SKL9
DR   Wikidata; Q54953690
RX   PubMed=3518877;
RX   PubMed=4170382;
RX   PubMed=4894370;
RX   PubMed=5229525;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   SK-la
AC   CVCL_CV34
SY   Scatophagus Kidney-low-osmolarity adapted
DR   Wikidata; Q54953691
RX   PubMed=26911257;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=75038; ! Scatophagus argus (Spotted scat)
HI   CVCL_CV33 ! SK [Scatophagus]
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 8
//
ID   SK-LC-1
AC   CVCL_5458
SY   SK-LC-01
DR   Wikidata; Q54953693
RX   PubMed=2784858;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=8385084;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Miscellaneous: STR profile, age/sex of donor and ethnicity from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14,14.2
ST   D21S11: 27,31.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 24,25
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
ID   SK-LC-10
AC   CVCL_5459
SY   SK-Luci-10; Sk-Luci-10; SkLuci 10; Luci-10; Luci 10; Luci10
DR   Cosmic; 934463
DR   Wikidata; Q54953694
RX   CelloPub=CLPUB00586;
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=1778766;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=7834619;
RX   PubMed=8384671;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C9133; Lung adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-LC-11
AC   CVCL_5460
DR   Wikidata; Q54953695
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SK-LC-12
AC   CVCL_5461
DR   Cosmic; 923381
DR   Wikidata; Q54953697
RX   PubMed=1409687;
RX   PubMed=3518877;
RX   PubMed=6208122;
RX   PubMed=6582512;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SK-LC-13
AC   CVCL_5462
SY   SKLC-13; SK-Luci-13; SkLuci 13; Luci-13; Luci 13
DR   cancercelllines; CVCL_5462
DR   GEO; GSM784225
DR   Progenetix; CVCL_5462
DR   Wikidata; Q54953698
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=1778766;
RX   PubMed=3518877;
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   SK-LC-14
AC   CVCL_5463
DR   Wikidata; Q54953699
RX   PubMed=3518877;
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SK-LC-15
AC   CVCL_5464
DR   Wikidata; Q54953702
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SK-LC-16
AC   CVCL_5465
DR   BTO; BTO_0003229
DR   Wikidata; Q54953703
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   SK-LC-17
AC   CVCL_5466
SY   SK LC 17; SKLC17
DR   cancercelllines; CVCL_5466
DR   GEO; GSM784221
DR   Progenetix; CVCL_5466
DR   Wikidata; Q54953704
RX   PubMed=1409687;
RX   PubMed=2540905;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 10,13
ST   D18S51: 12,13
ST   D19S433: 12,15.2
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 20,23
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 17
//
ID   SK-LC-19
AC   CVCL_5467
DR   Wikidata; Q54953706
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   SK-LC-2
AC   CVCL_5468
SY   SK LC 02; SK-LC2
DR   Cosmic; 1089233
DR   IARC_TP53; 18799
DR   Wikidata; Q54953709
RX   PubMed=2540905;
RX   PubMed=2784858;
RX   PubMed=3518877;
RX   PubMed=6208122;
RX   PubMed=6582512;
RX   PubMed=9636188;
RX   PubMed=12794755;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro85fs (c.253delC); Zygosity=Unspecified (PubMed=12794755).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   SK-LC-20
AC   CVCL_5469
DR   Wikidata; Q54953710
RX   PubMed=3518877;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   SK-LC-21
AC   CVCL_5470
DR   Wikidata; Q54953728
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   SK-LC-3
AC   CVCL_5471
SY   Luci-3; LUCI-3; Luci3
DR   cancercelllines; CVCL_5471
DR   CGH-DB; 209-1
DR   CGH-DB; 9171-4
DR   Cosmic; 1089219
DR   GEO; GSM784256
DR   Progenetix; CVCL_5471
DR   Wikidata; Q54953730
RX   PubMed=3518877;
RX   PubMed=6208122;
RX   PubMed=6582512;
RX   PubMed=14581340;
RX   PubMed=15746151;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-LC-4
AC   CVCL_5472
DR   Wikidata; Q54953731
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=8385084;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   SK-LC-5
AC   CVCL_5473
SY   SK-LC5
DR   EFO; EFO_0022359
DR   Wikidata; Q54953733
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=8385084;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SK-LC-6
AC   CVCL_5474
SY   SKLC6; SK-Luci-6; Sk-Luci-6; SK-LuCi6; Luci-6; Luci6
DR   cancercelllines; CVCL_5474
DR   Cosmic; 923380
DR   Cosmic; 1089232
DR   Cosmic; 2696406
DR   IARC_TP53; 18794
DR   NCBI_Iran; C566
DR   Wikidata; Q54953735
RX   PubMed=2535957;
RX   PubMed=3518877;
RX   PubMed=6208122;
RX   PubMed=6582512;
RX   PubMed=7116286;
RX   PubMed=8384671;
RX   PubMed=12794755;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Unspecified (PubMed=12794755).
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   SK-LC-7
AC   CVCL_5475
SY   SK-Luci-7; Luci-7; Luci 7
DR   Wikidata; Q54953736
RX   DOI=10.2995/jacsurg1987.4.6_755;
RX   PubMed=1778766;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=8385084;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   SK-LC-8
AC   CVCL_5476
DR   BTO; BTO_0003228
DR   Wikidata; Q54953738
RX   PubMed=3518877;
RX   PubMed=6208122;
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SK-LC-9
AC   CVCL_5477
DR   Wikidata; Q54953739
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=9636188;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SK-LMS-1
AC   CVCL_0628
SY   SK-LMS-01; SKLMS-1; SKLMS1
DR   BTO; BTO_0002607
DR   CLO; CLO_0009038
DR   EFO; EFO_0002331
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-88
DR   BioSample; SAMN03472759
DR   BioSample; SAMN10988181
DR   cancercelllines; CVCL_0628
DR   CancerTools; 161912
DR   Cell_Model_Passport; SIDM01109
DR   ChEMBL-Cells; CHEMBL3308552
DR   ChEMBL-Targets; CHEMBL2366096
DR   CLS; 300125
DR   Cosmic; 687594
DR   Cosmic; 909720
DR   Cosmic; 1834891
DR   Cosmic-CLP; 909720
DR   DepMap; ACH-000145
DR   EGA; EGAS00001000978
DR   GDSC; 909720
DR   GEO; GSM887579
DR   GEO; GSM888662
DR   GEO; GSM1670433
DR   GEO; GSM1676326
DR   GEO; GSM1701659
DR   IARC_TP53; 769
DR   IARC_TP53; 21704
DR   IGRhCellID; SKLMS1
DR   LiGeA; CCLE_739
DR   LINCS_HMS; 50042
DR   LINCS_LDP; LCL-1286
DR   PharmacoDB; SKLMS1_1391_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0628
DR   PubChem_Cell_line; CVCL_0628
DR   Wikidata; Q54953741
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1385192;
RX   PubMed=2216456;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=7459858;
RX   PubMed=16142349;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29853780;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-476.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,32:01; B*07:02,51:01; C*07:02,15:02; DQA1*01:02,01:02; DRB1*11:14,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Lys (c.710T>A); ClinVar=VCV000376636; Zygosity=Unspecified (PubMed=2216456; PubMed=16142349).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=2216456; PubMed=16142349).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.76%; East Asian, South=0%; South Asian=1.17%; European, North=66.04%; European, South=31.02% (PubMed=30894373).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
ST   Source(s): ATCC=HTB-88; CLS=300125; Cosmic-CLP=909720
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12 (Cosmic-CLP=909720)
ST   D13S317: 12 (ATCC=HTB-88; CLS=300125)
ST   D16S539: 8,11
ST   D18S51: 14,19
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18 (CLS=300125)
ST   vWA: 18,20 (ATCC=HTB-88; Cosmic-CLP=909720)
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SK-LN1
AC   CVCL_LK94
SY   SKLN1
DR   Wikidata; Q54953745
RX   PubMed=4170382;
RX   PubMed=4894370;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3093; Hemophilia
DI   ORDO; Orphanet_448; Hemophilia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 7
//
ID   SK-LU-1
AC   CVCL_0629
SY   SK-Lu-1; SK LU 1; SK-Lu1; SK-LU1; SKLU-1; SKLU1; SKLU01
DR   BTO; BTO_0003029
DR   CLO; CLO_0009032
DR   CLO; CLO_0009039
DR   EFO; EFO_0022536
DR   CLDB; cl4317
DR   CLDB; cl4318
DR   CLDB; cl4319
DR   AddexBio; C0016049/5014
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-57
DR   BioSample; SAMN03472748
DR   BioSample; SAMN10987792
DR   cancercelllines; CVCL_0629
DR   CancerTools; 161913
DR   CCRID; 1101HUM-PUMC000237
DR   Cell_Model_Passport; SIDM01108
DR   ChEMBL-Cells; CHEMBL3307447
DR   ChEMBL-Targets; CHEMBL614913
DR   CLS; 300335
DR   Cosmic; 724877
DR   Cosmic; 909721
DR   Cosmic; 929967
DR   Cosmic; 932920
DR   Cosmic; 933576
DR   Cosmic; 1089218
DR   Cosmic; 1146944
DR   Cosmic; 1434960
DR   Cosmic; 1733129
DR   Cosmic; 1995631
DR   Cosmic-CLP; 909721
DR   DepMap; ACH-000309
DR   ECACC; 93120835
DR   EGA; EGAS00001000978
DR   GDSC; 909721
DR   GEO; GSM385525
DR   GEO; GSM385536
DR   GEO; GSM434291
DR   GEO; GSM513973
DR   GEO; GSM514560
DR   GEO; GSM784226
DR   GEO; GSM794407
DR   GEO; GSM827413
DR   GEO; GSM887580
DR   GEO; GSM888663
DR   GEO; GSM1670434
DR   IARC_TP53; 121
DR   ICLC; HTL96023
DR   IGRhCellID; SK-LU-1%20GEO
DR   IZSLER; BS TCL 81
DR   KCLB; 30057
DR   LiGeA; CCLE_197
DR   LINCS_LDP; LCL-1659
DR   PharmacoDB; SKLU1_1392_2019
DR   PRIDE; PXD002556
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0629
DR   PubChem_Cell_line; CVCL_0629
DR   Wikidata; Q54953746
RX   CelloPub=CLPUB00712;
RX   PubMed=833871;
RX   PubMed=1855224;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=9636188;
RX   PubMed=12068308;
RX   PubMed=12794755;
RX   PubMed=19935656;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24135919;
RX   PubMed=26361996;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-lu-1-human-lung-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2005-049.
CC   Population: Caucasian.
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   HLA typing: A*24:02,24:02; B*40:02,40:02; C*02:02,02:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asn1253fs*16 (c.3753delC); Zygosity=Heterozygous (Cosmic-CLP=909721; DepMap=ACH-000309).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=1855224; PubMed=12068308; PubMed=12794755; Cosmic-CLP=909721; DepMap=ACH-000309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=1855224; PubMed=12794755; Cosmic-CLP=909721; DepMap=ACH-000309).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.44%; Native American=0%; East Asian, North=1.91%; East Asian, South=0%; South Asian=0%; European, North=66.14%; European, South=31.5% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016049/5014; ATCC=HTB-57; CCRID=1101HUM-PUMC000237; CLS=300335; Cosmic-CLP=909721; ECACC=93120835; KCLB=30057
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 8
ST   D18S51: 18
ST   D19S433: 15
ST   D21S11: 29,30.2
ST   D2S1338: 16,17
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 10
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SK-LU-1b
AC   CVCL_IV51
SY   SK-LU-1B
DR   cancercelllines; CVCL_IV51
DR   Wikidata; Q54953748
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7459858;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asn1253fs*16 (c.3753delC); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0629 ! SK-LU-1
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   SK-LY-16
AC   CVCL_GS22
SY   SK-Ly-16; SKLY-16; SKLy-16; SKLY16
DR   Wikidata; Q54953749
RX   PubMed=6193516;
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   SK-LY-18
AC   CVCL_GS23
SY   SK-Ly-18; SKLY-18; SKLY18
DR   Wikidata; Q54953750
RX   PubMed=2939141;
RX   PubMed=6193516;
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   HLA typing: A*33; B*04,27 (PubMed=2939141).
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 6
//
ID   SK-MBL-10
AC   CVCL_IX47
DR   Wikidata; Q54953752
RX   PubMed=1326305;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 6
//
ID   SK-MEL-1
AC   CVCL_0068
SY   SK-Mel-1; SK Mel 1; SK-Mel 1; SK-Mel1; SKMEL-1; SkMEL-1; SKMEL1; SK 1
DR   BTO; BTO_0002129
DR   CLO; CLO_0009040
DR   CLO; CLO_0037292
DR   EFO; EFO_0002332
DR   AddexBio; C0020006/4979
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-67
DR   BioSample; SAMN01821599
DR   BioSample; SAMN01821665
DR   BioSample; SAMN03473224
DR   BioSample; SAMN10987654
DR   cancercelllines; CVCL_0068
DR   CancerTools; 161914
DR   CCRID; 1101HUM-PUMC000052
DR   Cell_Model_Passport; SIDM01107
DR   ChEMBL-Cells; CHEMBL3308365
DR   ChEMBL-Targets; CHEMBL614916
DR   CLS; 300424
DR   Cosmic; 688052
DR   Cosmic; 888065
DR   Cosmic; 909723
DR   Cosmic; 928696
DR   Cosmic; 1022279
DR   Cosmic; 1303052
DR   Cosmic; 1459639
DR   Cosmic; 1669128
DR   Cosmic; 1995632
DR   Cosmic-CLP; 909723
DR   DepMap; ACH-000465
DR   DSMZ; ACC-303
DR   DSMZCellDive; ACC-303
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909723
DR   GEO; GSM784507
DR   GEO; GSM827506
DR   GEO; GSM887582
DR   GEO; GSM888665
DR   GEO; GSM1670436
DR   IARC_TP53; 27578
DR   IGRhCellID; SKMEL1
DR   KCB; KCB 200724YJ
DR   KCLB; 30067
DR   LiGeA; CCLE_788
DR   LINCS_LDP; LCL-1265
DR   PharmacoDB; SKMEL1_1393_2019
DR   PRIDE; PXD022992
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0068
DR   PubChem_Cell_line; CVCL_0068
DR   Wikidata; Q54953753
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=4879578;
RX   PubMed=6220172;
RX   PubMed=6895502;
RX   PubMed=8755562;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21725359;
RX   PubMed=22460905;
RX   PubMed=24576830;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-1
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2004-052.
CC   Population: Caucasian.
CC   Doubling time: ~100 hours (DSMZ=ACC-303).
CC   HLA typing: A*26:01,26:01; B*38:01,67:02; C*04:01,12:03; DQA1*03:02,03:02; DQB1*06:01,06:01; DRB1*14:76,14:76 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21725359; PubMed=24576830; Cosmic-CLP=909723; DepMap=ACH-000465).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Cys (c.98C>G); ClinVar=VCV000376231; Zygosity=Heterozygous (ATCC=HTB-67; Cosmic-CLP=909723; DepMap=ACH-000465).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.29%; Native American=0%; East Asian, North=4.27%; East Asian, South=0%; South Asian=9.23%; European, North=23.14%; European, South=62.08% (PubMed=30894373).
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
ST   Source(s): AddexBio=C0020006/4979; ATCC=HTB-67; CCRID=1101HUM-PUMC000052; CLS=300424; Cosmic-CLP=909723; DSMZ=ACC-303; KCLB=30067; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D19S433: 15 (DSMZ=ACC-303)
ST   D19S433: 15,16.2 (ATCC=HTB-67; CCRID=1101HUM-PUMC000052)
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13,16 (ATCC=HTB-67; CLS=300424; DSMZ=ACC-303; PubMed=25877200)
ST   D8S1179: 16 (CCRID=1101HUM-PUMC000052)
ST   FGA: 17,20 (DSMZ=ACC-303)
ST   FGA: 18,20 (ATCC=HTB-67; CCRID=1101HUM-PUMC000052; CLS=300424; PubMed=25877200)
ST   Penta D: 11,13
ST   Penta E: 7,21
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SK-MEL-10
AC   CVCL_6020
SY   SK-MEL 10; SK-Mel 10; SKMEL10
DR   cancercelllines; CVCL_6020
DR   Wikidata; Q54953755
RX   DOI=10.1007/BF00199208;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=27533468;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:3689; FGFR2; Simple; p.Arg625Gln (c.1874G>A) (p.Arg626Gln, c.1877G>A); Zygosity=Unspecified (PubMed=27533468).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=27533468).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-100
AC   CVCL_6067
SY   SK-Mel-100; SK-MEL 100; SK-Mel 100; SKMEL-100; SKMEL100; DY-Mel
DR   cancercelllines; CVCL_6067
DR   Cosmic; 685206
DR   Cosmic; 721848
DR   Cosmic; 1122257
DR   Cosmic; 1507611
DR   Cosmic; 1669160
DR   Cosmic; 2233670
DR   Cosmic; 2440476
DR   GEO; GSM555126
DR   GEO; GSM555179
DR   GEO; GSM784522
DR   Lonza; 1336
DR   Progenetix; CVCL_6067
DR   Wikidata; Q54953756
RX   PubMed=2983346;
RX   PubMed=6933476;
RX   PubMed=7747814;
RX   PubMed=15299072;
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814; PubMed=18505964).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   SK-MEL-101
AC   CVCL_6068
SY   DZ-Mel
DR   Cosmic; 923391
DR   Wikidata; Q54953757
RX   PubMed=6933476;
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.329G>A); ClinVar=VCV000376304; Zygosity=Unspecified (PubMed=7747814).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-MEL-102
AC   CVCL_4U05
DR   Wikidata; Q54953759
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-103
AC   CVCL_6069
SY   SK-Mel-103; SKMEL-103; SkMel103; SKMEL103
DR   cancercelllines; CVCL_6069
DR   ChEMBL-Cells; CHEMBL4483143
DR   ChEMBL-Targets; CHEMBL4483267
DR   Cosmic; 685207
DR   Cosmic; 1054850
DR   Cosmic; 1122258
DR   Cosmic; 1507613
DR   Cosmic; 1669161
DR   GEO; GSM555127
DR   GEO; GSM555180
DR   GEO; GSM784512
DR   GEO; GSM3039513
DR   Lonza; 1337
DR   Millipore; SCC439
DR   Progenetix; CVCL_6069
DR   PubChem_Cell_line; CVCL_6069
DR   Wikidata; Q54953761
RX   PubMed=7747814;
RX   PubMed=17308088;
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Millipore=SCC439
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 13
ST   D18S51: 13,15
ST   D21S11: 31.2
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 20
ST   Penta D: 12
ST   Penta E: 10,12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SK-MEL-104
AC   CVCL_4U06
DR   Wikidata; Q54953762
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-105
AC   CVCL_6070
SY   SK-Mel-105; SKMEL-105
DR   cancercelllines; CVCL_6070
DR   Cosmic; 1669162
DR   GEO; GSM784523
DR   Progenetix; CVCL_6070
DR   Wikidata; Q54953764
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-106
AC   CVCL_6071
SY   EE-Mel
DR   Wikidata; Q54953765
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-108
AC   CVCL_6072
DR   Wikidata; Q54953767
RX   PubMed=7017212;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-109
AC   CVCL_6073
SY   SK-Mel-109; SK-MEL109; SKMEL-109
DR   cancercelllines; CVCL_6073
DR   Cosmic; 1669163
DR   GEO; GSM784518
DR   Progenetix; CVCL_6073
DR   Wikidata; Q54953769
RX   PubMed=3005411;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-11
AC   CVCL_D702
SY   SK-Mel-11; SKMEL-11; AF-Mel
DR   cancercelllines; CVCL_D702
DR   Cosmic; 1669132
DR   GEO; GSM784514
DR   Progenetix; CVCL_D702
DR   Wikidata; Q54953770
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   SK-MEL-110
AC   CVCL_3875
SY   SK-Mel-110; SK-Mel 110; SKMEL-110; EI-Mel
DR   BTO; BTO_0004994
DR   cancercelllines; CVCL_3875
DR   Cosmic; 1669164
DR   Wikidata; Q54953772
RX   PubMed=1716514;
RX   PubMed=2983346;
RX   PubMed=6864164;
RX   PubMed=7175440;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Glu63Lys (c.187G>A); ClinVar=VCV002498256; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-111
AC   CVCL_U938
SY   SK-Mel-111; EJ-Mel
DR   Wikidata; Q54953774
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 6
//
ID   SK-MEL-112
AC   CVCL_6963
SY   SK-Mel-112; EK-Mel
DR   Cosmic; 923392
DR   Wikidata; Q54953775
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-113
AC   CVCL_6074
SY   SK-Mel-113; SKMEL-113; EL-Mel
DR   cancercelllines; CVCL_6074
DR   Cosmic; 721830
DR   Cosmic; 1060421
DR   Cosmic; 1669165
DR   GEO; GSM784519
DR   Progenetix; CVCL_6074
DR   Wikidata; Q54953776
RX   PubMed=2983346;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-114
AC   CVCL_U936
DR   Wikidata; Q54953778
RX   PubMed=7017212;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 6
//
ID   SK-MEL-115
AC   CVCL_8075
DR   Cosmic; 1507602
DR   Wikidata; Q54953779
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-117
AC   CVCL_6075
SY   SK-Mel-117; SKMEL-117
DR   cancercelllines; CVCL_6075
DR   Cosmic; 1669166
DR   Wikidata; Q54953780
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-118
AC   CVCL_6076
SY   SK-Mel-118; SK-mel-118; SKMEL-118; EQ-Mel
DR   cancercelllines; CVCL_6076
DR   Cosmic; 1669167
DR   GEO; GSM784524
DR   Progenetix; CVCL_6076
DR   Wikidata; Q54953782
RX   PubMed=3518877;
RX   PubMed=6864164;
RX   PubMed=7175440;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-119
AC   CVCL_6077
SY   SK-Mel-119; SK-mel-119; SK Mel 119; SKMEL-119; SKMEL119
DR   cancercelllines; CVCL_6077
DR   Cosmic; 706089
DR   Cosmic; 721807
DR   Cosmic; 851034
DR   Cosmic; 888833
DR   Cosmic; 897473
DR   Cosmic; 1054853
DR   Cosmic; 1507604
DR   Cosmic; 1669168
DR   Cosmic; 2233669
DR   Wikidata; Q54953784
RX   PubMed=3518877;
RX   PubMed=7747814;
RX   PubMed=9598804;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=17308088;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=10766161; PubMed=15009714; PubMed=24576830).
CC   Misspelling: SK-ME-119; Cosmic=2233669.
CC   Misspelling: SK-NEL-119; Note=In a IARC_TP53 document: handbook of p53 mutations in cell lines.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   SK-MEL-12
AC   CVCL_6021
SY   SK-Mel-12; SKMEL-12; AG-Mel
DR   cancercelllines; CVCL_6021
DR   Cosmic; 923384
DR   Cosmic; 1669133
DR   GEO; GSM784515
DR   Progenetix; CVCL_6021
DR   Wikidata; Q54953785
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=7747814;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   SK-MEL-122
AC   CVCL_4U00
DR   Wikidata; Q54953787
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-123
AC   CVCL_4U01
DR   Wikidata; Q54953788
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-124
AC   CVCL_8076
DR   Cosmic; 923393
DR   Wikidata; Q54953790
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-125
AC   CVCL_4U02
DR   Wikidata; Q54953808
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-127
AC   CVCL_6078
SY   SK-Mel-127; SK MEL 127; SKMEL-127; EZ-Mel
DR   cancercelllines; CVCL_6078
DR   Cosmic; 721814
DR   Cosmic; 1669169
DR   Wikidata; Q54953809
RX   PubMed=1716514;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=7175440;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-128
AC   CVCL_6079
DR   Wikidata; Q54953810
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-129
AC   CVCL_4U03
DR   Wikidata; Q54953811
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-13
AC   CVCL_6022
SY   SK-Mel-13; SK-MEL 13; SK-MEL13; SKMEL-13; SKMEL13; Mel13; AH-Mel
DR   cancercelllines; CVCL_6022
DR   Cosmic; 721822
DR   Cosmic; 889040
DR   Cosmic; 928711
DR   Cosmic; 1669134
DR   GEO; GSM170980
DR   Wikidata; Q54953813
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1697409;
RX   PubMed=1716514;
RX   PubMed=2784858;
RX   PubMed=2983346;
RX   PubMed=3518877;
RX   PubMed=3756862;
RX   PubMed=3972469;
RX   PubMed=6220172;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=9354451;
RX   PubMed=9598804;
RX   PubMed=15048078;
RX   PubMed=17516929;
RX   PubMed=21725359;
RX   PubMed=23039341;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SK-MEL-130
AC   CVCL_6080
SY   SK-Mel-130; SKMEL-130
DR   cancercelllines; CVCL_6080
DR   Cosmic; 933131
DR   Cosmic; 1507605
DR   Cosmic; 1669170
DR   Cosmic; 2233671
DR   GEO; GSM784525
DR   Progenetix; CVCL_6080
DR   Wikidata; Q54953814
RX   PubMed=6582512;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SK-MEL-131
AC   CVCL_6081
SY   SK-Mel-131; SK-mel-131; SK-Mel 131; SK Mel 131; Sk Mel131; SKMEL-131; FD-Mel
DR   cancercelllines; CVCL_6081
DR   Cosmic; 706112
DR   Cosmic; 721849
DR   Cosmic; 851055
DR   Cosmic; 888847
DR   Cosmic; 923394
DR   Cosmic; 933132
DR   Cosmic; 1020273
DR   Cosmic; 1060428
DR   Cosmic; 1507595
DR   Cosmic; 1669171
DR   Cosmic; 2233672
DR   Wikidata; Q54953816
RX   PubMed=2453881;
RX   PubMed=2983346;
RX   PubMed=6864164;
RX   PubMed=7175440;
RX   PubMed=7509835;
RX   PubMed=7747814;
RX   PubMed=9598804;
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714; PubMed=21725359; PubMed=24576830).
DI   NCIt; C4633; Amelanotic cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   SK-MEL-132
AC   CVCL_4U04
DR   Wikidata; Q54953817
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-133
AC   CVCL_6082
SY   SK-Mel-133; SK-Mel 133; SKMEL-133; FF-MEL; FF-Mel
DR   cancercelllines; CVCL_6082
DR   Cosmic; 1669172
DR   Wikidata; Q54953819
RX   PubMed=2983346;
RX   PubMed=3518877;
RX   PubMed=7814883;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-135
AC   CVCL_6083
DR   Wikidata; Q54953821
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-136
AC   CVCL_8077
DR   Cosmic; 721812
DR   Wikidata; Q54953823
RX   PubMed=1716514;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-139
AC   CVCL_4U07
DR   Wikidata; Q54953825
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-14
AC   CVCL_6023
SY   SK-Mel-14; AI-Mel
DR   Wikidata; Q54953827
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 15
//
ID   SK-MEL-140
AC   CVCL_U907
SY   SK-MEL 140
DR   Wikidata; Q54953828
RX   PubMed=1716514;
RX   PubMed=3972469;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 8
//
ID   SK-MEL-144
AC   CVCL_6084
SY   SK-Mel-144
DR   Wikidata; Q54953829
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-145
AC   CVCL_8078
DR   Cosmic; 923395
DR   Wikidata; Q54953830
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-146
AC   CVCL_6085
SY   SK-Mel-146; SKMEL-146
DR   cancercelllines; CVCL_6085
DR   Cosmic; 721805
DR   Cosmic; 933118
DR   Cosmic; 1669173
DR   Wikidata; Q54953833
RX   PubMed=1716514;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-147
AC   CVCL_3876
SY   SK-Mel-147; SK MEL 147; SKMEL-147; SkMel147; SKMEL147; SK-147; FT-Mel
DR   cancercelllines; CVCL_3876
DR   ChEMBL-Cells; CHEMBL4630606
DR   ChEMBL-Targets; CHEMBL4630706
DR   Cosmic; 685208
DR   Cosmic; 721808
DR   Cosmic; 933133
DR   Cosmic; 1054851
DR   Cosmic; 1122259
DR   Cosmic; 1247853
DR   Cosmic; 1507623
DR   Cosmic; 1669174
DR   Cosmic; 2233673
DR   GEO; GSM555128
DR   GEO; GSM555181
DR   GEO; GSM1507943
DR   GEO; GSM5466407
DR   GEO; GSM5466408
DR   GEO; GSM5466409
DR   Lonza; 1338
DR   Millipore; SCC440
DR   PRIDE; PXD007000
DR   Progenetix; CVCL_3876
DR   PubChem_Cell_line; CVCL_3876
DR   Wikidata; Q54953834
RX   PubMed=1716514;
RX   PubMed=6864164;
RX   PubMed=7747814;
RX   PubMed=9598804;
RX   PubMed=17308088;
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
RX   PubMed=25502142;
RX   PubMed=25728708;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Unspecified (PubMed=9598804; PubMed=7747814).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830; PubMed=25728708).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Millipore=SCC440
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 13,17
ST   D21S11: 30,31
ST   D3S1358: 17,18
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   D8S1179: 12,17
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   SK-MEL-15
AC   CVCL_6964
SY   SK-Mel-15; SKMEL-15; BO-Mel
DR   cancercelllines; CVCL_6964
DR   Cosmic; 1669135
DR   Wikidata; Q54953835
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=3518877;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   SK-MEL-150
AC   CVCL_8079
DR   Cosmic; 923396
DR   Wikidata; Q54953837
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-152
AC   CVCL_IY53
DR   Wikidata; Q54953839
RX   PubMed=2784858;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-153
AC   CVCL_6087
SY   SK-Mel-153; SKMEL-153
DR   cancercelllines; CVCL_6087
DR   Cosmic; 721831
DR   Cosmic; 1507627
DR   Cosmic; 1669175
DR   Cosmic; 2233674
DR   Wikidata; Q54953840
RX   PubMed=6582512;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-158
AC   CVCL_8080
DR   Cosmic; 923397
DR   Wikidata; Q54953842
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-16
AC   CVCL_1E23
SY   SK-Mel-16
DR   Wikidata; Q54953843
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 6
//
ID   SK-MEL-161
AC   CVCL_6088
SY   SK-Mel-161; SKMEL-161
DR   Cosmic; 721833
DR   Cosmic; 1669176
DR   Wikidata; Q54953844
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-162
AC   CVCL_4U08
DR   Wikidata; Q54953847
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-163
AC   CVCL_U940
DR   Wikidata; Q54953848
RX   PubMed=7175440;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-165
AC   CVCL_J708
SY   GL-Mel
DR   Wikidata; Q54953850
RX   PubMed=6864164;
RX   PubMed=7175440;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-166
AC   CVCL_8081
DR   Cosmic; 721834
DR   Wikidata; Q54953852
RX   PubMed=6864164;
RX   PubMed=7175440;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-168
AC   CVCL_U941
DR   Wikidata; Q54953854
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-169
AC   CVCL_U942
DR   Wikidata; Q54953855
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-17
AC   CVCL_6024
SY   SK-Mel-17; AJ-Mel
DR   Cosmic; 721809
DR   Wikidata; Q54953856
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
ID   SK-MEL-170
AC   CVCL_6089
SY   SK-Mel-170; SKMEL-170
DR   cancercelllines; CVCL_6089
DR   Cosmic; 933117
DR   Cosmic; 1669177
DR   Wikidata; Q54953858
RX   PubMed=3081645;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-172
AC   CVCL_J709
DR   Wikidata; Q54953859
RX   PubMed=7175440;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   SK-MEL-173
AC   CVCL_6090
SY   SK-Mel-173; SKMEL-173; SKMEL173
DR   cancercelllines; CVCL_6090
DR   Cosmic; 685209
DR   Cosmic; 933115
DR   Cosmic; 1054847
DR   Cosmic; 1122260
DR   Cosmic; 1155285
DR   Cosmic; 1507628
DR   Cosmic; 1669178
DR   Cosmic; 2233675
DR   GEO; GSM555129
DR   GEO; GSM555182
DR   GEO; GSM784511
DR   Lonza; 1339
DR   Progenetix; CVCL_6090
DR   Wikidata; Q54953860
RX   PubMed=7175440;
RX   PubMed=7747814;
RX   PubMed=9598804;
RX   PubMed=17308088;
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
RX   PubMed=25645078;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814; PubMed=9598804; PubMed=18505964).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Asp32Gly (c.95A>G); ClinVar=VCV000017578; Zygosity=Unspecified (PubMed=25645078).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830; PubMed=25645078).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   SK-MEL-174
AC   CVCL_6091
SY   SK-Mel-174; SKMEL-174
DR   cancercelllines; CVCL_6091
DR   Cosmic; 1669179
DR   Wikidata; Q54953862
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-176
AC   CVCL_6092
SY   SK-Mel-176; SK-MEL 176; SKMEL-176
DR   Cosmic; 1669180
DR   Wikidata; Q54953864
RX   PubMed=3972469;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-177
AC   CVCL_4U09
SY   SK-MEL 177
DR   Wikidata; Q54953866
RX   PubMed=3972469;
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 6
//
ID   SK-MEL-178
AC   CVCL_6093
SY   SK-Mel-178; SK-MEL 178; SKMEL-178
DR   cancercelllines; CVCL_6093
DR   Cosmic; 923398
DR   Cosmic; 1669181
DR   GEO; GSM784526
DR   Progenetix; CVCL_6093
DR   Wikidata; Q54953868
RX   PubMed=3972469;
RX   PubMed=7747814;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Unspecified (PubMed=7747814).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   SK-MEL-179
AC   CVCL_C5UD
SY   SK-MEL 179
DR   Wikidata; Q116050508
RX   PubMed=3972469;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   SK-MEL-18
AC   CVCL_U933
SY   SK-Mel-18; AK-Mel
DR   Wikidata; Q54953869
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1067619;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   SK-MEL-181
AC   CVCL_6094
SY   SK-Mel-181; SKMEL-181
DR   cancercelllines; CVCL_6094
DR   Cosmic; 1507597
DR   Cosmic; 1669182
DR   Cosmic; 2233676
DR   Wikidata; Q54953888
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-182
AC   CVCL_6095
SY   SK-Mel-182; SKMEL-182
DR   cancercelllines; CVCL_6095
DR   Cosmic; 1669183
DR   Wikidata; Q54953889
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-186
AC   CVCL_6096
SY   SK-Mel-186; SK-Mel 186; SKMEL-186
DR   cancercelllines; CVCL_6096
DR   Cosmic; 721813
DR   Cosmic; 923399
DR   Cosmic; 1507614
DR   Cosmic; 1669184
DR   Cosmic; 2233677
DR   Wikidata; Q54953890
RX   PubMed=1716514;
RX   PubMed=7747814;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-187
AC   CVCL_6097
SY   SK-Mel-187; SKMEL-187; SKMEL187
DR   cancercelllines; CVCL_6097
DR   Cosmic; 685210
DR   Cosmic; 1054845
DR   Cosmic; 1122261
DR   Cosmic; 1507593
DR   Cosmic; 1669185
DR   Cosmic; 2233678
DR   GEO; GSM555130
DR   GEO; GSM555183
DR   GEO; GSM784527
DR   Lonza; 1340
DR   Progenetix; CVCL_6097
DR   Wikidata; Q54953892
RX   PubMed=7747814;
RX   PubMed=17308088;
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-188
AC   CVCL_6098
SY   SK-Mel-188; SKMEL-188; SKMEL188
DR   cancercelllines; CVCL_6098
DR   Cosmic; 933116
DR   Cosmic; 1669186
DR   Wikidata; Q54953893
RX   PubMed=7509835;
RX   PubMed=9598804;
RX   PubMed=10614864;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-19
AC   CVCL_6025
SY   SK-Mel-19; SKMEL-19; SkMEL-19; SK-MEL19; SK-Mel19; Sk Mel19; SKMEL19; AL-Mel
DR   cancercelllines; CVCL_6025
DR   Cell_Model_Passport; SIDM01423
DR   ChEMBL-Cells; CHEMBL3307448
DR   ChEMBL-Targets; CHEMBL614915
DR   Cosmic; 685202
DR   Cosmic; 721841
DR   Cosmic; 886830
DR   Cosmic; 923385
DR   Cosmic; 933126
DR   Cosmic; 1047686
DR   Cosmic; 1060427
DR   Cosmic; 1122255
DR   Cosmic; 1669136
DR   DepMap; ACH-002005
DR   GEO; GSM156032
DR   GEO; GSM555122
DR   GEO; GSM555175
DR   GEO; GSM784508
DR   IARC_TP53; 26112
DR   Lonza; 1332
DR   Progenetix; CVCL_6025
DR   PubChem_Cell_line; CVCL_6025
DR   Wikidata; Q54953894
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=2499655;
RX   PubMed=2784858;
RX   PubMed=2983346;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=17260012;
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Characteristics: Pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=21725359; PubMed=24576830; DepMap=ACH-002005).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Homozygous (PubMed=9598804; PubMed=18505964; DepMap=ACH-002005).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn131Lys (c.393C>A); ClinVar=VCV000246429; Zygosity=Unspecified (DepMap=ACH-002005).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): DepMap=ACH-002005
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 12
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 24,25
ST   Penta D: 12,14
ST   Penta E: 9,12
ST   TH01: 8,9.3
ST   TPOX: 9
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SK-MEL-190
AC   CVCL_6099
SY   SK-Mel-190; SKMEL-190
DR   cancercelllines; CVCL_6099
DR   Cosmic; 1507617
DR   Cosmic; 1669187
DR   Cosmic; 2233679
DR   Wikidata; Q54953896
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-191
AC   CVCL_6100
SY   SK-Mel-191; SKMEL-191
DR   cancercelllines; CVCL_6100
DR   Cosmic; 1669188
DR   Wikidata; Q54953897
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-192
AC   CVCL_6101
SY   SK-Mel-192; SKMEL-192; SKMEL192
DR   cancercelllines; CVCL_6101
DR   Cosmic; 685211
DR   Cosmic; 1122262
DR   Cosmic; 1669189
DR   GEO; GSM555131
DR   GEO; GSM555184
DR   Lonza; 1341
DR   Progenetix; CVCL_6101
DR   Wikidata; Q54953899
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   SK-MEL-196
AC   CVCL_6102
SY   SK-Mel-196; SKMEL-196
DR   cancercelllines; CVCL_6102
DR   Cosmic; 933134
DR   Cosmic; 1669190
DR   GEO; GSM784528
DR   Progenetix; CVCL_6102
DR   Wikidata; Q54953900
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   SK-MEL-197
AC   CVCL_8082
SY   SK-Mel-197; SK-MEL 197; SK-Mel 197; SKMEL-197; SKMEL197
DR   cancercelllines; CVCL_8082
DR   Cosmic; 685212
DR   Cosmic; 1122263
DR   GEO; GSM555132
DR   GEO; GSM555185
DR   Lonza; 1342
DR   Progenetix; CVCL_8082
DR   Wikidata; Q54953901
RX   PubMed=18505964;
RX   PubMed=21343389;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18505964).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SK-MEL-198
AC   CVCL_6103
DR   Wikidata; Q54953903
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-199
AC   CVCL_6104
SY   SK-Mel-199; SKMEL-199; SK-MEL-199A; SK-MEL-199 (adhesion); SK-MEL-199S; SK-MEL-199 (suspension)
DR   cancercelllines; CVCL_6104
DR   Cosmic; 1669192
DR   Cosmic; 1669193
DR   GEO; GSM784529
DR   GEO; GSM784530
DR   Progenetix; CVCL_6104
DR   Wikidata; Q54953904
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-2
AC   CVCL_0069
SY   SK-Mel-2; SK-Mel 2; SK-mel-2; SK-MEL2; SK.MEL.2; SK Mel 2; SK MEL 2; SKMEL-2; SKMEL2; SKmel2; SK-ML2; SKml2
DR   BTO; BTO_0003476
DR   CLO; CLO_0009041
DR   EFO; EFO_0002079
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-68
DR   BioGRID_ORCS_Cell_line; 1012
DR   BioSample; SAMN03471882
DR   BioSample; SAMN03472752
DR   BioSample; SAMN05292464
DR   BioSample; SAMN10988256
DR   cancercelllines; CVCL_0069
DR   CancerTools; 161915
DR   Cell_Model_Passport; SIDM00082
DR   CGH-DB; 9322-4
DR   ChEMBL-Cells; CHEMBL3307743
DR   ChEMBL-Targets; CHEMBL614917
DR   CLS; 300423
DR   Cosmic; 724824
DR   Cosmic; 875885
DR   Cosmic; 897468
DR   Cosmic; 905235
DR   Cosmic; 905955
DR   Cosmic; 974073
DR   Cosmic; 974257
DR   Cosmic; 1006555
DR   Cosmic; 1022288
DR   Cosmic; 1044266
DR   Cosmic; 1045411
DR   Cosmic; 1067222
DR   Cosmic; 1092632
DR   Cosmic; 1132585
DR   Cosmic; 1155283
DR   Cosmic; 1175871
DR   Cosmic; 1303053
DR   Cosmic; 1305367
DR   Cosmic; 1458964
DR   Cosmic; 1459662
DR   Cosmic; 1477419
DR   Cosmic; 1669129
DR   Cosmic; 1995633
DR   Cosmic; 1998475
DR   Cosmic; 2159450
DR   Cosmic; 2479250
DR   Cosmic-CLP; 905955
DR   DepMap; ACH-001190
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905955
DR   GEO; GSM2109
DR   GEO; GSM50204
DR   GEO; GSM50266
DR   GEO; GSM188225
DR   GEO; GSM188255
DR   GEO; GSM188314
DR   GEO; GSM743467
DR   GEO; GSM750824
DR   GEO; GSM799356
DR   GEO; GSM799419
DR   GEO; GSM844688
DR   GEO; GSM844689
DR   GEO; GSM847115
DR   GEO; GSM887585
DR   GEO; GSM888668
DR   GEO; GSM1153426
DR   GEO; GSM1181281
DR   GEO; GSM1181359
DR   GEO; GSM1670437
DR   GEO; GSM1671997
DR   GEO; GSM1672003
DR   GEO; GSM1672044
DR   GEO; GSM1672075
DR   GEO; GSM1672083
DR   GEO; GSM1672088
DR   GEO; GSM1672104
DR   GEO; GSM1672117
DR   GEO; GSM1672126
DR   GEO; GSM2124650
DR   IARC_TP53; 18086
DR   KCLB; 30068
DR   LINCS_LDP; LCL-1256
DR   NCI-DTP; SK-MEL-2
DR   PharmacoDB; SKMEL2_1394_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030206
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0069
DR   PubChem_Cell_line; CVCL_0069
DR   SKY/M-FISH/CGH; 2820
DR   Wikidata; Q54953905
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   DOI=10.1007/BF00199208;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2041050;
RX   PubMed=2784858;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=8631022;
RX   PubMed=8755562;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12068308;
RX   PubMed=14871852;
RX   PubMed=15467732;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=19727395;
RX   PubMed=20164919;
RX   PubMed=21725359;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23285177;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24576830;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25728708;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27533468;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=45
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544462
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/sk-mel-2-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-2
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 779.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (PubMed=7718330); >50 hours (PubMed=8631022); 45.5 hours (NCI-DTP=SK-MEL-2); ~56 hours (PBCF).
CC   HLA typing: A*03,26; B*35,38; C*04,12:03:01; DPB1*02:01:02,04:01; DQB1*03:01:01,06:03; DRB1*04:02,13:01:01 (PubMed=15748285).
CC   HLA typing: A*03:01,26:01; B*35:08,38:01; C*04:01,12:03; DQA1*03:02,03:02; DQB1*06:11,06:11; DRB1*04:02,13:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=17088437; PubMed=21725359; PubMed=24576830; PubMed=25728708; PubMed=27533468).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; PubMed=21912889; PubMed=27533468).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.43%; Native American=0%; East Asian, North=2.36%; East Asian, South=1.87%; South Asian=7.21%; European, North=28.23%; European, South=58.89% (PubMed=30894373).
CC   Misspelling: SKm12; Note=Occasionally.
CC   Derived from site: Metastatic; Thigh, skin; UBERON=UBERON_0004262.
ST   Source(s): ATCC=HTB-68; Cosmic-CLP=905955; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 8,9
ST   D18S51: 15,16
ST   D19S433: 12,13,15 (ATCC=HTB-68)
ST   D19S433: 12,15 (PubMed=19372543)
ST   D21S11: 29,30
ST   D2S1338: 21,24
ST   D3S1358: 14,16
ST   D5S818: 11,12,13 (ATCC=HTB-68)
ST   D5S818: 12,13 (Cosmic-CLP=905955; PubMed=19372543; PubMed=25877200)
ST   D7S820: 11,12
ST   D8S1179: 11,12,13 (ATCC=HTB-68)
ST   D8S1179: 12,13 (PubMed=19372543)
ST   FGA: 19,25
ST   Penta D: 10,15
ST   Penta E: 7,16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17 (ATCC=HTB-68)
ST   vWA: 17 (Cosmic-CLP=905955; PubMed=19372543; PubMed=25877200)
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 49
//
ID   SK-MEL-2-Luc
AC   CVCL_J266
DR   cancercelllines; CVCL_J266
DR   JCRB; JCRB1393
DR   JCRB; NIHS0640
DR   Wikidata; Q54953907
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0640; true.
CC   Derived from site: Metastatic; Thigh, skin; UBERON=UBERON_0004262.
ST   Source(s): JCRB=JCRB1393
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 8,9
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0069 ! SK-MEL-2
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 25
//
ID   SK-MEL-20
AC   CVCL_U925
SY   SK-Mel-20; AM-Mel
DR   Wikidata; Q54953908
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=833871;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=7017212;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   SK-MEL-200
AC   CVCL_6105
SY   SK-Mel-200; SKMEL-200
DR   cancercelllines; CVCL_6105
DR   Cosmic; 1669194
DR   GEO; GSM784531
DR   Progenetix; CVCL_6105
DR   Wikidata; Q54953910
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-202
AC   CVCL_6106
SY   SK-Mel-202; SKMEL-202
DR   cancercelllines; CVCL_6106
DR   Cosmic; 1669195
DR   Wikidata; Q54953912
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-203
AC   CVCL_U908
DR   Wikidata; Q54953915
RX   PubMed=1716514;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 6
//
ID   SK-MEL-204
AC   CVCL_U909
DR   Wikidata; Q54953916
RX   PubMed=1716514;
RX   PubMed=7509835;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   SK-MEL-205
AC   CVCL_6107
SY   SK-Mel-205; SKMEL-205
DR   cancercelllines; CVCL_6107
DR   Cosmic; 1669196
DR   Wikidata; Q54953918
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-207
AC   CVCL_6108
SY   SK-Mel-207; SKMEL-207
DR   cancercelllines; CVCL_6108
DR   Cosmic; 1669197
DR   Wikidata; Q54953919
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-208
AC   CVCL_6109
SY   SK-Mel-208; SKMEL-208
DR   cancercelllines; CVCL_6109
DR   Cosmic; 1669198
DR   GEO; GSM784532
DR   Progenetix; CVCL_6109
DR   Wikidata; Q54953921
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly466Glu (c.1397G>A); ClinVar=VCV000376073; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-209
AC   CVCL_6110
SY   SK-Mel-209; SKMEL-209
DR   cancercelllines; CVCL_6110
DR   Cosmic; 1669199
DR   Wikidata; Q54953922
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-21
AC   CVCL_3877
SY   SK-Mel-21; SK MEL 21; SK-MEL21; AN-Mel
DR   BTO; BTO_0002966
DR   cancercelllines; CVCL_3877
DR   Cosmic; 897471
DR   Cosmic; 923386
DR   Cosmic; 933127
DR   Cosmic; 1669137
DR   Wikidata; Q54953923
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   Patent=US4591572;
RX   PubMed=327080;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=6197381;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7747814;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Very highly pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg58Ter (c.172C>T) (p.Pro72Leu, c.215C>T); ClinVar=VCV000376310; Zygosity=Unspecified (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   SK-MEL-210-3
AC   CVCL_D772
SY   SKMEL-210-3; SK-Mel-210
DR   cancercelllines; CVCL_D772
DR   Cosmic; 1669200
DR   Wikidata; Q54953925
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   SK-MEL-215-1
AC   CVCL_U911
SY   SKMEL-215-1; SK-Mel-215
DR   cancercelllines; CVCL_U911
DR   Cosmic; 1669201
DR   Wikidata; Q54953926
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn581Ser (c.1742A>G); ClinVar=VCV000177776; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-217
AC   CVCL_6111
SY   SK-Mel-217; SKMEL-217
DR   cancercelllines; CVCL_6111
DR   Cosmic; 1669202
DR   GEO; GSM784533
DR   Progenetix; CVCL_6111
DR   Wikidata; Q54953927
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   SK-MEL-22
AC   CVCL_6026
SY   SK-Mel-22; SKMEL-22; SK-MEL-022; AO-Mel
DR   cancercelllines; CVCL_6026
DR   Cosmic; 1669138
DR   GEO; GSM784520
DR   Progenetix; CVCL_6026
DR   Wikidata; Q54953930
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   SK-MEL-222
AC   CVCL_6112
SY   SK-Mel-222; SKMEL-222
DR   cancercelllines; CVCL_6112
DR   Cosmic; 1669203
DR   Wikidata; Q54953931
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-227
AC   CVCL_6113
SY   SK-Mel-227; SKMEL-227
DR   cancercelllines; CVCL_6113
DR   Cosmic; 1669204
DR   Wikidata; Q54953932
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-228
AC   CVCL_6114
SY   SK-Mel-228; SKMEL-228
DR   cancercelllines; CVCL_6114
DR   Cosmic; 1669205
DR   Wikidata; Q54953934
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-229
AC   CVCL_6115
SY   SK-Mel-229; SKMEL-229
DR   cancercelllines; CVCL_6115
DR   Cosmic; 1669206
DR   Wikidata; Q54953936
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-23
AC   CVCL_6027
SY   SK-Mel-23; SK-Mel 23; SK-mel-23; SK MEL 23; SK Mel 23; Sk Mel23; SKMEL-23; SKMEL23; SKmel23; SK23-MEL; SK23-mel; SK23; AP-Mel
DR   BTO; BTO_0005333
DR   EFO; EFO_0006490
DR   BioSample; SAMN03470872
DR   BioSample; SAMN03473194
DR   cancercelllines; CVCL_6027
DR   CGH-DB; 9318-4
DR   Cosmic; 706107
DR   Cosmic; 721823
DR   Cosmic; 851051
DR   Cosmic; 876705
DR   Cosmic; 888852
DR   Cosmic; 897493
DR   Cosmic; 905231
DR   Cosmic; 1060423
DR   Cosmic; 1303054
DR   Cosmic; 1507594
DR   Cosmic; 1669139
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM206542
DR   GEO; GSM784516
DR   Lonza; 1343
DR   PharmacoDB; SK23_1416_2019
DR   Progenetix; CVCL_6027
DR   Wikidata; Q54953937
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   Patent=US4591572;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=6197381;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7175440;
RX   PubMed=7509835;
RX   PubMed=7646526;
RX   PubMed=9670966;
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=15467732;
RX   PubMed=17308088;
RX   PubMed=21725359;
RX   PubMed=22178978;
RX   PubMed=24576830;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Characteristics: Very highly pigmented.
CC   HLA typing: A*01,02:01; B*07,08 (PubMed=9670966).
CC   HLA typing: A*01:01,02:01; B*08:01,37:04; C*07:01,07:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=10766161; PubMed=15009714).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D21S11: 26,29
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 10,11
ST   FGA: 18,22,23
ST   Penta D: 9.1,11,12
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   SK-MEL-23-neoR
AC   CVCL_VS13
DR   Wikidata; Q98132658
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
CC   Population: Caucasian.
CC   Characteristics: Very highly pigmented (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6027 ! SK-MEL-23
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   SK-MEL-230
AC   CVCL_6116
SY   SK-Mel-230; SKMEL-230
DR   cancercelllines; CVCL_6116
DR   Cosmic; 1669207
DR   Wikidata; Q54953939
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-232
AC   CVCL_6117
SY   SK-Mel-232; SKMEL-232
DR   cancercelllines; CVCL_6117
DR   Cosmic; 1669208
DR   Wikidata; Q54953940
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-233
AC   CVCL_6118
SY   SK-Mel-233; SKMEL-233
DR   cancercelllines; CVCL_6118
DR   Cosmic; 1669209
DR   Wikidata; Q54953941
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-234
AC   CVCL_6119
SY   SK-Mel-234; SKMEL-234
DR   cancercelllines; CVCL_6119
DR   Cosmic; 933139
DR   Cosmic; 1669210
DR   Wikidata; Q54953943
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-235
AC   CVCL_4Z29
SY   SKMEL-235
DR   Cosmic; 2233680
DR   Wikidata; Q54953944
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-237
AC   CVCL_6120
SY   SK-Mel-237; SKMEL-237
DR   cancercelllines; CVCL_6120
DR   Cosmic; 1669211
DR   Wikidata; Q54953945
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-238
AC   CVCL_6121
SY   SK-Mel-238; SKMEL-238
DR   cancercelllines; CVCL_6121
DR   Cosmic; 1669212
DR   GEO; GSM784534
DR   Progenetix; CVCL_6121
DR   Wikidata; Q54953966
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-239
AC   CVCL_6122
SY   SK-Mel-239; SKMEL-239
DR   cancercelllines; CVCL_6122
DR   Cosmic; 1507603
DR   Cosmic; 1669213
DR   GEO; GSM784535
DR   Progenetix; CVCL_6122
DR   Wikidata; Q54953967
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   SK-MEL-24
AC   CVCL_0599
SY   Sk-Mel-24; SK Mel 24; SKMEL-24; SK-MEL24; SK-Mel24; SKMEL24; SKMel24; AQ-Mel
DR   BTO; BTO_0005861
DR   CLO; CLO_0009042
DR   EFO; EFO_0006487
DR   CLDB; cl7124
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-71
DR   BioGRID_ORCS_Cell_line; 466
DR   BioSample; SAMN03473230
DR   BioSample; SAMN10988223
DR   cancercelllines; CVCL_0599
DR   CancerTools; 161916
DR   Cell_Model_Passport; SIDM01106
DR   ChEMBL-Cells; CHEMBL3308324
DR   ChEMBL-Targets; CHEMBL2366314
DR   Cosmic; 687441
DR   Cosmic; 851405
DR   Cosmic; 909725
DR   Cosmic; 932997
DR   Cosmic; 1022274
DR   Cosmic; 1054858
DR   Cosmic; 1102581
DR   Cosmic; 1155265
DR   Cosmic; 1458965
DR   Cosmic; 1459651
DR   Cosmic; 1507625
DR   Cosmic; 1669140
DR   Cosmic; 1995634
DR   Cosmic-CLP; 909725
DR   DepMap; ACH-000822
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909725
DR   GEO; GSM784509
DR   GEO; GSM887583
DR   GEO; GSM888666
DR   GEO; GSM1670438
DR   GEO; GSM1671959
DR   GEO; GSM1671965
DR   GEO; GSM1671966
DR   GEO; GSM1671972
DR   GEO; GSM1671978
DR   GEO; GSM1671998
DR   GEO; GSM1672008
DR   GEO; GSM1672014
DR   GEO; GSM1672015
DR   GEO; GSM1672019
DR   GEO; GSM1672022
DR   GEO; GSM1672023
DR   GEO; GSM1672025
DR   GEO; GSM1672035
DR   GEO; GSM1672038
DR   GEO; GSM1672040
DR   GEO; GSM1672048
DR   GEO; GSM1672055
DR   IARC_TP53; 27579
DR   ICLC; HTL02001
DR   LiGeA; CCLE_246
DR   LINCS_LDP; LCL-1281
DR   PharmacoDB; SKMEL24_1395_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0599
DR   PubChem_Cell_line; CVCL_0599
DR   Wikidata; Q54953969
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=10709110;
RX   PubMed=12068308;
RX   PubMed=17308088;
RX   PubMed=20164919;
RX   PubMed=21654344;
RX   PubMed=21725359;
RX   PubMed=22460905;
RX   PubMed=24576830;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26405815;
RX   PubMed=26589293;
RX   PubMed=26673621;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-24
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2003-078.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*14:01,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=26405815; DepMap=ACH-000822).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=909725; DepMap=ACH-000822).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.73%; Native American=0.82%; East Asian, North=1.82%; East Asian, South=0%; South Asian=0%; European, North=60.41%; European, South=35.21% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-71; Cosmic-CLP=909725; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SK-MEL-241
AC   CVCL_8083
DR   Cosmic; 933140
DR   Wikidata; Q54953970
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-243
AC   CVCL_6123
SY   SK-Mel-243; SKMEL-243
DR   cancercelllines; CVCL_6123
DR   Cosmic; 1669214
DR   Wikidata; Q54953971
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-244
AC   CVCL_6124
SY   SK-Mel-244; SKMEL-244
DR   cancercelllines; CVCL_6124
DR   Cosmic; 1669215
DR   Wikidata; Q54953973
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-245
AC   CVCL_6125
SY   SK-Mel-245
DR   Wikidata; Q54953975
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-246
AC   CVCL_6126
SY   SK-Mel-246; SKMEL-246
DR   cancercelllines; CVCL_6126
DR   Cosmic; 1669216
DR   Wikidata; Q54953976
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Ala (c.1406G>C); ClinVar=VCV000013971; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-249
AC   CVCL_6961
SY   JU-MEL
DR   Wikidata; Q54953978
RX   PubMed=7814883;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-25
AC   CVCL_6028
SY   SK-Mel-25; SK-Mel 25; SK Mel 25; SK 25; AR-Mel
DR   ChEMBL-Cells; CHEMBL3308005
DR   ChEMBL-Targets; CHEMBL612706
DR   CLS; 300336
DR   PubChem_Cell_line; CVCL_6028
DR   Wikidata; Q54953979
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   DOI=10.1007/BF00199208;
RX   DOI=10.1007/BF00205883;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=6555061;
RX   PubMed=6895502;
RX   PubMed=7646526;
RX   PubMed=22970293;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: CLS; 300336; true.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 22
//
ID   SK-MEL-25 subclone-5
AC   CVCL_B5AE
SY   Mel S-5; S-5
DR   Wikidata; Q110433234
RX   PubMed=6555061;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6028 ! SK-MEL-25
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SK-MEL-250
AC   CVCL_6962
DR   Wikidata; Q54953981
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-252
AC   CVCL_6127
SY   SK-Mel-252; SKMEL-252
DR   cancercelllines; CVCL_6127
DR   Cosmic; 1669217
DR   Wikidata; Q54953983
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-256
AC   CVCL_6128
SY   SK-Mel-256; SKMEL-256; JX-MEL
DR   cancercelllines; CVCL_6128
DR   Cosmic; 1669218
DR   Wikidata; Q54953984
RX   PubMed=7814883;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-257
AC   CVCL_D3F1
DR   Wikidata; Q127384299
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   SK-MEL-258
AC   CVCL_6129
DR   Cosmic; 933112
DR   Wikidata; Q54953986
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-26
AC   CVCL_6029
SY   SK-Mel-26; SKMEL-26; AS-Mel
DR   cancercelllines; CVCL_6029
DR   Cosmic; 1669141
DR   Wikidata; Q54953987
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=327080;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=21725359;
RX   PubMed=24576830;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-26-human-melanoma-cell-line
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-546.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SK-MEL-263
AC   CVCL_6130
SY   SKMEL-263
DR   Cosmic; 1669219
DR   Wikidata; Q54953988
RX   PubMed=17308088;
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-264
AC   CVCL_6131
SY   SK-Mel-264; SKMEL-264
DR   cancercelllines; CVCL_6131
DR   Cosmic; 1669220
DR   Wikidata; Q54953990
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp594Gly (c.1781A>G); ClinVar=VCV000013972; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-265
AC   CVCL_6132
SY   SK-Mel-265; SKMEL-265
DR   Cosmic; 1669221
DR   Wikidata; Q54953991
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-266
AC   CVCL_6133
SY   SK-Mel-266; SKMEL-266
DR   Cosmic; 1669222
DR   Wikidata; Q54953992
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-267
AC   CVCL_6134
SY   SK-Mel-267; SKMEL-267; SK-Mel 267
DR   cancercelllines; CVCL_6134
DR   Cosmic; 1669223
DR   Wikidata; Q54953994
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-268
AC   CVCL_6135
SY   SK-Mel-268; SKMEL-268
DR   cancercelllines; CVCL_6135
DR   Cosmic; 1669224
DR   Wikidata; Q54953995
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-269
AC   CVCL_6136
SY   SK-Mel-269; SKMEL-269
DR   cancercelllines; CVCL_6136
DR   Cosmic; 1669225
DR   Wikidata; Q54953997
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-27
AC   CVCL_6030
SY   SK-Mel-27; SK-Mel/27; AT-Mel
DR   cancercelllines; CVCL_6030
DR   Cosmic; 1507592
DR   GEO; GSM784517
DR   Progenetix; CVCL_6030
DR   Wikidata; Q54953998
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=327080;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=6933476;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   SK-MEL-27-1
AC   CVCL_U913
SY   SKMEL-27-1
DR   cancercelllines; CVCL_U913
DR   Cosmic; 1669142
DR   Wikidata; Q54954000
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6030 ! SK-MEL-27
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   SK-MEL-27-2
AC   CVCL_U914
SY   SKMEL-27-2
DR   cancercelllines; CVCL_U914
DR   Cosmic; 1669143
DR   Wikidata; Q54954002
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6030 ! SK-MEL-27
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   SK-MEL-271
AC   CVCL_6137
SY   SK-Mel-271; SKMEL-271
DR   cancercelllines; CVCL_6137
DR   Cosmic; 1669226
DR   Wikidata; Q54954004
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-272
AC   CVCL_6138
SY   SK-Mel-272; SKMEL-272
DR   cancercelllines; CVCL_6138
DR   Cosmic; 1669227
DR   Wikidata; Q54954006
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-275
AC   CVCL_6139
SY   SK-Mel-275; SKMEL-275
DR   cancercelllines; CVCL_6139
DR   Cosmic; 1669228
DR   Wikidata; Q54954008
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-276
AC   CVCL_6140
SY   SK-Mel-276; SKMEL-276
DR   cancercelllines; CVCL_6140
DR   Cosmic; 1669229
DR   Wikidata; Q54954009
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-279
AC   CVCL_6141
SY   SK-Mel-279; SKMEL-279
DR   cancercelllines; CVCL_6141
DR   Cosmic; 1669230
DR   Wikidata; Q54954012
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-28
AC   CVCL_0526
SY   SK-Mel-28; SK.MEL.28; SK-MEL 28; SK MEL-28; SK MEL 28; SK Mel 28; SKMel-28; SKMEL-28; SK-MEL28; SK-Mel28; SK Mel28; SKMEL28; SKMel28; SKmel28; SKML-28; SK28; AU-Mel; P-36; P36
DR   BTO; BTO_0002131
DR   CLO; CLO_0009043
DR   EFO; EFO_0003081
DR   MCCL; MCC:0000426
DR   CLDB; cl4321
DR   CLDB; cl4954
DR   AddexBio; C0020001/66
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-72
DR   BCRJ; 0289
DR   BioSample; SAMN03470899
DR   BioSample; SAMN03472092
DR   BioSample; SAMN03472754
DR   BioSample; SAMN10987689
DR   cancercelllines; CVCL_0526
DR   CancerTools; 161917
DR   Cell_Model_Passport; SIDM00081
DR   CGH-DB; 9317-4
DR   ChEMBL-Cells; CHEMBL3308494
DR   ChEMBL-Targets; CHEMBL614919
DR   CLS; 300337
DR   Cosmic; 686472
DR   Cosmic; 686476
DR   Cosmic; 687442
DR   Cosmic; 706106
DR   Cosmic; 721824
DR   Cosmic; 851050
DR   Cosmic; 874384
DR   Cosmic; 874446
DR   Cosmic; 875887
DR   Cosmic; 886831
DR   Cosmic; 888846
DR   Cosmic; 897491
DR   Cosmic; 898252
DR   Cosmic; 905230
DR   Cosmic; 905954
DR   Cosmic; 928748
DR   Cosmic; 932712
DR   Cosmic; 933135
DR   Cosmic; 974072
DR   Cosmic; 974262
DR   Cosmic; 1006554
DR   Cosmic; 1007156
DR   Cosmic; 1022271
DR   Cosmic; 1045407
DR   Cosmic; 1047687
DR   Cosmic; 1054859
DR   Cosmic; 1067227
DR   Cosmic; 1092633
DR   Cosmic; 1102386
DR   Cosmic; 1109809
DR   Cosmic; 1132589
DR   Cosmic; 1155280
DR   Cosmic; 1155570
DR   Cosmic; 1175872
DR   Cosmic; 1183772
DR   Cosmic; 1187579
DR   Cosmic; 1221590
DR   Cosmic; 1238109
DR   Cosmic; 1295337
DR   Cosmic; 1303055
DR   Cosmic; 1305368
DR   Cosmic; 1312350
DR   Cosmic; 1425350
DR   Cosmic; 1458966
DR   Cosmic; 1459645
DR   Cosmic; 1477319
DR   Cosmic; 1477408
DR   Cosmic; 1507598
DR   Cosmic; 1598350
DR   Cosmic; 1665022
DR   Cosmic; 1669144
DR   Cosmic; 1995635
DR   Cosmic; 1998476
DR   Cosmic; 2159448
DR   Cosmic; 2479251
DR   Cosmic; 2560253
DR   Cosmic; 2651877
DR   Cosmic-CLP; 905954
DR   DepMap; ACH-000615
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905954
DR   GEO; GSM2115
DR   GEO; GSM50205
DR   GEO; GSM50267
DR   GEO; GSM156050
DR   GEO; GSM171012
DR   GEO; GSM188226
DR   GEO; GSM188256
DR   GEO; GSM188315
DR   GEO; GSM206543
DR   GEO; GSM228378
DR   GEO; GSM274690
DR   GEO; GSM276739
DR   GEO; GSM743468
DR   GEO; GSM750825
DR   GEO; GSM784506
DR   GEO; GSM799357
DR   GEO; GSM799420
DR   GEO; GSM844690
DR   GEO; GSM847116
DR   GEO; GSM887584
DR   GEO; GSM888667
DR   GEO; GSM952581
DR   GEO; GSM1138790
DR   GEO; GSM1153427
DR   GEO; GSM1153428
DR   GEO; GSM1181282
DR   GEO; GSM1181283
DR   GEO; GSM1588919
DR   GEO; GSM1670439
DR   GEO; GSM1671969
DR   GEO; GSM1671970
DR   GEO; GSM1671974
DR   GEO; GSM1671983
DR   GEO; GSM1671986
DR   GEO; GSM1671991
DR   GEO; GSM1671996
DR   GEO; GSM1672002
DR   GEO; GSM1672006
DR   GEO; GSM1672032
DR   GEO; GSM1672043
DR   GEO; GSM1672047
DR   GEO; GSM1672049
DR   GEO; GSM1672050
DR   GEO; GSM1672054
DR   GEO; GSM1672056
DR   GEO; GSM1672060
DR   GEO; GSM1672061
DR   GEO; GSM2124651
DR   GEO; GSM3039512
DR   IARC_TP53; 26113
DR   ICLC; HTL99010
DR   LiGeA; CCLE_529
DR   LINCS_HMS; 51101
DR   LINCS_LDP; LCL-2092
DR   NCI-DTP; SK-MEL-28
DR   PharmacoDB; SKMEL28_1396_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD007000
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0526
DR   PubChem_Cell_line; CVCL_0526
DR   RCB; RCB1930
DR   SKY/M-FISH/CGH; 2745
DR   TKG; TKG 0333
DR   Wikidata; Q54954013
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   Patent=US4591572;
RX   PubMed=313568;
RX   PubMed=327080;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1716514;
RX   PubMed=2041050;
RX   PubMed=2068080;
RX   PubMed=2983346;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6197381;
RX   PubMed=6203018;
RX   PubMed=6349783;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=7718330;
RX   PubMed=7999427;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=9354451;
RX   PubMed=9466661;
RX   PubMed=9598804;
RX   PubMed=10700174;
RX   PubMed=10766161;
RX   PubMed=11016658;
RX   PubMed=11121133;
RX   PubMed=12068308;
RX   PubMed=12479222;
RX   PubMed=14692828;
RX   PubMed=14871852;
RX   PubMed=15009714;
RX   PubMed=15299072;
RX   PubMed=15467732;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17260012;
RX   PubMed=17308088;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=18277095;
RX   PubMed=18790768;
RX   PubMed=19147755;
RX   PubMed=19372543;
RX   PubMed=19799798;
RX   PubMed=20041153;
RX   PubMed=20164919;
RX   PubMed=20406486;
RX   PubMed=21424129;
RX   PubMed=21725359;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23285177;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24576830;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25950383;
RX   PubMed=25960936;
RX   PubMed=26405815;
RX   PubMed=26589293;
RX   PubMed=26673621;
RX   PubMed=27087056;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29492214;
RX   PubMed=30674989;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=47
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/melanoma-xenograft/skmel28-xenograft-model/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-28
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-524.
CC   Population: Caucasian.
CC   Characteristics: Lightly pigmented.
CC   Doubling time: 27 hours (PubMed=7718330); 36 hours (PubMed=8631022); 72 hours (PubMed=12479222); 26.9 hours (PubMed=20406486); 35.1 hours (NCI-DTP=SK-MEL-28).
CC   HLA typing: A*11:01:01; B*40:01; C*03:04:01; DPB1*03:01:01; DQB1*03:02; DRB1*04:04 (PubMed=15748285).
CC   HLA typing: A*11:01,11:01; B*40:01,40:01; C*03:03,03:03; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*04:04,04:04 (PubMed=25960936).
CC   HLA typing: A*11:01,11:01; B*40:01,40:01; C*03:04,03:04; DQA1*03:02,05:02; DQB1*03:02,03:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=15467732; PubMed=17088437; PubMed=17260012; PubMed=17363583; PubMed=19799798; PubMed=24576830; PubMed=26405815; PubMed=29492214; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=9598804; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (PubMed=10766161; PubMed=17260012; PubMed=17363583; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (PubMed=17088437; PubMed=17260012; PubMed=18277095; Cosmic-CLP=905954; DepMap=ACH-000615).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.75%; Native American=0.56%; East Asian, North=3%; East Asian, South=1.38%; South Asian=8.29%; European, North=20.11%; European, South=64.91% (PubMed=30894373).
CC   Discontinued: RCB; RCB1930; true.
CC   Discontinued: TKG; TKG 0333; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB=RCB1930; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10 (PubMed=19372543; PubMed=25877200)
ST   CSF1PO: 10,12 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   D10S1248: 16
ST   D12S391: 15,19
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D19S433: 14
ST   D1S1656: 12
ST   D21S11: 28,29
ST   D22S1045: 11,15
ST   D2S1338: 18
ST   D2S441: 10,11
ST   D3S1358: 16,18
ST   D5S818: 11,13 (AddexBio=C0020001/66; ATCC=HTB-72; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   D5S818: 13 (CLS=300337; PubMed=19372543; PubMed=25877200)
ST   D7S820: 9.3,10 (AddexBio=C0020001/66; ATCC=HTB-72)
ST   D7S820: 10 (CLS=300337; Cosmic-CLP=905954; PubMed=19372543; PubMed=25877200; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 9,10
ST   Penta E: 8,12
ST   TH01: 7
ST   TPOX: 8,12 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   TPOX: 12 (PubMed=19372543; PubMed=25877200)
ST   vWA: 16,19 (AddexBio=C0020001/66; ATCC=HTB-72; CLS=300337; Cosmic-CLP=905954; PubMed=25877200; PubMed=27087056; RCB=RCB1930; Technion Genomics Center)
ST   vWA: 19 (PubMed=19372543)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   SK-MEL-28-Luc
AC   CVCL_J267
DR   cancercelllines; CVCL_J267
DR   JCRB; JCRB1376
DR   JCRB; NIHS0641
DR   Wikidata; Q54954015
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0641; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
ST   Source(s): JCRB=JCRB1376
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 9.3,10
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 26
//
ID   SK-MEL-28-VR
AC   CVCL_AP99
DR   cancercelllines; CVCL_AP99
DR   Wikidata; Q54954017
RX   PubMed=26497853;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 17
//
ID   SK-MEL-281
AC   CVCL_6142
DR   Wikidata; Q54954018
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-282
AC   CVCL_6143
SY   SK-Mel-282; SKMEL-282
DR   cancercelllines; CVCL_6143
DR   Cosmic; 1669231
DR   Wikidata; Q54954020
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-283
AC   CVCL_6144
SY   SK-Mel-283; SKMEL-283
DR   cancercelllines; CVCL_6144
DR   Cosmic; 1669232
DR   Wikidata; Q54954021
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-284
AC   CVCL_6145
SY   SK-Mel-284; SKMEL-284
DR   cancercelllines; CVCL_6145
DR   Cosmic; 1669233
DR   Wikidata; Q54954024
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-285
AC   CVCL_6146
SY   SK-Mel-285; SKMEL-285
DR   cancercelllines; CVCL_6146
DR   Cosmic; 1669234
DR   Wikidata; Q54954026
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-28DDR1-PLXAZD
AC   CVCL_IM75
SY   SkMel28DDR1-PLXAZD
DR   cancercelllines; CVCL_IM75
DR   GEO; GSM1588921
DR   Wikidata; Q54954028
RX   PubMed=26359985;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   SK-MEL-28R1-PLX
AC   CVCL_IM76
SY   SkMel28R1-PLX
DR   cancercelllines; CVCL_IM76
DR   GEO; GSM1588920
DR   Wikidata; Q54954029
RX   PubMed=26359985;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 16
//
ID   SK-MEL-29
AC   CVCL_6031
SY   SK-Mel-29; SKMEL-29; SKMEL29; Skmel29; SK29-MEL; AV-Mel
DR   cancercelllines; CVCL_6031
DR   Cosmic; 685203
DR   Cosmic; 933136
DR   Cosmic; 1669145
DR   GEO; GSM555123
DR   GEO; GSM555176
DR   GEO; GSM784513
DR   Lonza; 1333
DR   Progenetix; CVCL_6031
DR   Wikidata; Q54954048
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=2784858;
RX   PubMed=2983346;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=7652577;
RX   PubMed=9598804;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-29-human-melanoma-cell-line
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-525.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=7652577; PubMed=9598804).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D3F2 ! SK29-EBV-B
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SK-MEL-29.1
AC   CVCL_IY54
SY   SK29-MEL-1
DR   cancercelllines; CVCL_IY54
DR   CLS; 300429
DR   Wikidata; Q54954050
RX   PubMed=2784858;
RX   PubMed=7652577;
RX   PubMed=9605759;
CC   Population: Caucasian.
CC   HLA typing: A*02,28; B*44,w45; C*w5,w6 (PubMed=9605759).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (PubMed=7652577).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6031 ! SK-MEL-29
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   SK-MEL-29.1.22
AC   CVCL_D3EZ
DR   Wikidata; Q127384301
RX   PubMed=9605759;
CC   Population: Caucasian.
CC   HLA typing: A*28; B*44,w45; C*w5,w6 (PubMed=9605759).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4931; HLA-A; Zygosity=Heterozygous (PubMed=9605759).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY54 ! SK-MEL-29.1
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SK-MEL-29.1.29
AC   CVCL_D3F0
DR   Wikidata; Q127384303
RX   PubMed=9605759;
CC   Population: Caucasian.
CC   HLA typing: A*28; B*w45; C*w6 (PubMed=9605759).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4931; HLA-A; Zygosity=Heterozygous (PubMed=9605759).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4932; HLA-B; Zygosity=Heterozygous (PubMed=9605759).
CC   Sequence variation: Gene deletion; HGNC; HGNC:4933; HLA-C; Zygosity=Heterozygous (PubMed=9605759).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IY54 ! SK-MEL-29.1
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   SK-MEL-29.2
AC   CVCL_IY55
DR   cancercelllines; CVCL_IY55
DR   Wikidata; Q54954051
RX   PubMed=2784858;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6031 ! SK-MEL-29
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   SK-MEL-29.3
AC   CVCL_IY56
DR   cancercelllines; CVCL_IY56
DR   Wikidata; Q54954053
RX   PubMed=2784858;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6031 ! SK-MEL-29
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   SK-MEL-29.4
AC   CVCL_IY57
DR   cancercelllines; CVCL_IY57
DR   Wikidata; Q54954054
RX   PubMed=2784858;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6031 ! SK-MEL-29
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   SK-MEL-29.5
AC   CVCL_IY58
DR   cancercelllines; CVCL_IY58
DR   Wikidata; Q54954055
RX   PubMed=2784858;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6031 ! SK-MEL-29
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 10
//
ID   SK-MEL-3
AC   CVCL_0550
SY   SK-Mel-3; Sk-mel-3; SK-MEL3; SK-Mel3; SKMEL3
DR   BTO; BTO_0002132
DR   CLO; CLO_0009044
DR   EFO; EFO_0002333
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-69
DR   BioSample; SAMN03472882
DR   BioSample; SAMN10988234
DR   cancercelllines; CVCL_0550
DR   CancerTools; 161918
DR   Cell_Model_Passport; SIDM01105
DR   ChEMBL-Cells; CHEMBL3307449
DR   ChEMBL-Targets; CHEMBL614920
DR   Cosmic; 687443
DR   Cosmic; 874445
DR   Cosmic; 888063
DR   Cosmic; 909724
DR   Cosmic; 1022286
DR   Cosmic; 1047688
DR   Cosmic; 1459671
DR   Cosmic; 1995636
DR   Cosmic; 2159449
DR   Cosmic-CLP; 909724
DR   DepMap; ACH-000423
DR   DSMZ; ACC-321
DR   DSMZCellDive; ACC-321
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909724
DR   GEO; GSM156045
DR   GEO; GSM827519
DR   GEO; GSM887588
DR   GEO; GSM888671
DR   GEO; GSM1670440
DR   IARC_TP53; 26114
DR   IGRhCellID; SKMEL3
DR   KCLB; 30069
DR   LiGeA; CCLE_928
DR   LINCS_LDP; LCL-1266
DR   NCBI_Iran; C458
DR   PharmacoDB; SKMEL3_1397_2019
DR   PRIDE; PXD022992
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0550
DR   PubChem_Cell_line; CVCL_0550
DR   Wikidata; Q54954057
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=8755562;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=17260012;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23285177;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-3
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-523.
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-321).
CC   HLA typing: A*24:02,24:02; B*44:03,51:01; C*04:01,15:04; DQA1*01:02,01:02; DQB1*04:01,04:01; DRB1*03:17,14:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=17260012; ATCC=HTB-69; Cosmic-CLP=909724; DepMap=ACH-000423).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Homozygous (PubMed=17260012; ATCC=HTB-69; Cosmic-CLP=909724; DepMap=ACH-000423).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.51%; Native American=0%; East Asian, North=2.94%; East Asian, South=0%; South Asian=8.82%; European, North=24.17%; European, South=62.57% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-69; Cosmic-CLP=909724; DSMZ=ACC-321; KCLB=30069; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 10,18
ST   D19S433: 17
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 11,15
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SK-MEL-30
AC   CVCL_0039
SY   SK-Mel-30; SK Mel 30; SKMEL-30; Sk Mel30; SKMEL30; AW-Mel
DR   BTO; BTO_0002133
DR   CLO; CLO_0009045
DR   EFO; EFO_0006488
DR   CLDB; cl4323
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 465
DR   BioSample; SAMN03473251
DR   BioSample; SAMN10988313
DR   cancercelllines; CVCL_0039
DR   Cell_Model_Passport; SIDM00392
DR   ChEMBL-Cells; CHEMBL3308128
DR   ChEMBL-Targets; CHEMBL1075577
DR   Cosmic; 706090
DR   Cosmic; 721825
DR   Cosmic; 851035
DR   Cosmic; 888061
DR   Cosmic; 888834
DR   Cosmic; 909726
DR   Cosmic; 933128
DR   Cosmic; 1022283
DR   Cosmic; 1060425
DR   Cosmic; 1669146
DR   Cosmic-CLP; 909726
DR   DepMap; ACH-000810
DR   DSMZ; ACC-151
DR   DSMZCellDive; ACC-151
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909726
DR   GEO; GSM784510
DR   GEO; GSM887586
DR   GEO; GSM888669
DR   GEO; GSM1670441
DR   GEO; GSM7701406
DR   GEO; GSM7701407
DR   IARC_TP53; 27239
DR   LiGeA; CCLE_671
DR   LINCS_LDP; LCL-1257
DR   PharmacoDB; SKMEL30_1398_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0039
DR   PubChem_Cell_line; CVCL_0039
DR   Wikidata; Q54954059
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1716514;
RX   PubMed=3081645;
RX   PubMed=3473501;
RX   PubMed=3518877;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7175440;
RX   PubMed=7509835;
RX   PubMed=9598804;
RX   PubMed=10766161;
RX   PubMed=11668190;
RX   PubMed=15009714;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=21725359;
RX   PubMed=22460905;
RX   PubMed=24576830;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mel-30-human-melanoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-526.
CC   Population: Caucasian.
CC   Characteristics: Pigmented.
CC   Doubling time: ~30 hours (DSMZ=ACC-151).
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly1339Arg (c.4015G>C); ClinVar=VCV000233611; Zygosity=Heterozygous (Cosmic-CLP=909726; DepMap=ACH-000810).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1406Ter (c.4216C>T); ClinVar=VCV000142519; Zygosity=Heterozygous (Cosmic-CLP=909726; DepMap=ACH-000810).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341C>T) (p.Ala128Ala, c.384C>T); ClinVar=VCV000077637; Zygosity=Homozygous (PubMed=9598804; Cosmic-CLP=909726; DepMap=ACH-000810).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=10766161; PubMed=15009714; PubMed=21725359; PubMed=24576830; Cosmic-CLP=909726; DepMap=ACH-000810).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr284Argfs*21 (c.851_852delCA) (p.R283fs, c.849_850del2); Zygosity=Heterozygous (Cosmic-CLP=909726; DepMap=ACH-000810).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.6%; East Asian, South=0%; South Asian=0%; European, North=62.41%; European, South=35.99% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=909726; DSMZ=ACC-151; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 8,11
ST   D18S51: 12,14 (DSMZ=ACC-151)
ST   D18S51: 13,15 (PubMed=25877200)
ST   D19S433: 14,15
ST   D21S11: 29,31.2
ST   D2S1338: 19,21
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   D8S1179: 8,14
ST   FGA: 20,21
ST   Penta D: 12
ST   Penta E: 5,14
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 47
//
ID   SK-MEL-301
AC   CVCL_6147
SY   SK-Mel-301; SKMEL-301
DR   cancercelllines; CVCL_6147
DR   Cosmic; 1669235
DR   Wikidata; Q54954061
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-304
AC   CVCL_6148
SY   SK-Mel-304; SKMEL-304
DR   Cosmic; 1669236
DR   Wikidata; Q54954062
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-306
AC   CVCL_6149
SY   SK-Mel-306; SKMEL-306
DR   cancercelllines; CVCL_6149
DR   Cosmic; 1669237
DR   Wikidata; Q54954063
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-307
AC   CVCL_6150
SY   SK-Mel-307; SKMEL-307
DR   cancercelllines; CVCL_6150
DR   Cosmic; 1669238
DR   Wikidata; Q54954065
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-309B
AC   CVCL_U912
SY   SKMEL-309B; SK-Mel-309
DR   Cosmic; 1669239
DR   Wikidata; Q54954066
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-31
AC   CVCL_0600
SY   Sk-Mel-31; SKMEL-31; SKMel-31; SkMel31; SKMEL31; AX-Mel
DR   CLO; CLO_0009046
DR   EFO; EFO_0006489
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-73
DR   BioSample; SAMN03472881
DR   BioSample; SAMN10988127
DR   cancercelllines; CVCL_0600
DR   CancerTools; 161919
DR   Cell_Model_Passport; SIDM01104
DR   Cosmic; 688054
DR   Cosmic; 851406
DR   Cosmic; 932998
DR   Cosmic; 933113
DR   Cosmic; 1022273
DR   Cosmic; 1047689
DR   Cosmic; 1102384
DR   Cosmic; 1459643
DR   Cosmic; 1669147
DR   Cosmic; 2159444
DR   Cosmic; 2479254
DR   Cosmic-CLP; 909727
DR   DepMap; ACH-000640
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909727
DR   GEO; GSM156033
DR   GEO; GSM276762
DR   GEO; GSM887587
DR   GEO; GSM888670
DR   GEO; GSM1670442
DR   IARC_TP53; 26115
DR   KCLB; 30073
DR   LiGeA; CCLE_731
DR   Lonza; 1344
DR   PharmacoDB; SKMEL31_1399_2019
DR   Progenetix; CVCL_0600
DR   Wikidata; Q54954067
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=2784858;
RX   PubMed=3335022;
RX   PubMed=3473501;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=17260012;
RX   PubMed=21725359;
RX   PubMed=22460905;
RX   PubMed=23285177;
RX   PubMed=24576830;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-31
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-527.
CC   Population: Caucasian.
CC   Characteristics: Non-pigmented (PubMed=3473501).
CC   HLA typing: A*01:01,31:01; B*40:01,53:01; C*03:04,04:01; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*04:04,14:103 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804; PubMed=17260012).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17260012; Cosmic-CLP=909727; DepMap=ACH-000640).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.89%; Native American=0.03%; East Asian, North=4.7%; East Asian, South=0%; South Asian=4.17%; European, North=26.77%; European, South=60.44% (PubMed=30894373).
CC   Discontinued: KCLB; 30073; probable.
ST   Source(s): ATCC=HTB-73; Cosmic-CLP=909727; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 13,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 18,20
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 12,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SK-MEL-313
AC   CVCL_1T59
SY   SK-Mel-313
DR   Wikidata; Q54954069
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-315-02
AC   CVCL_E090
SY   SK-Mel-315-02; SKMEL-315-02
DR   Cosmic; 1669240
DR   Wikidata; Q54954070
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E091 ! SK-MEL-315-03
OI   CVCL_E092 ! SK-MEL-315-05
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-315-03
AC   CVCL_E091
SY   SKMEL-315-03
DR   Cosmic; 1669241
DR   Wikidata; Q54954071
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E090 ! SK-MEL-315-02
OI   CVCL_E092 ! SK-MEL-315-05
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   SK-MEL-315-05
AC   CVCL_E092
SY   SK-Mel-315-05; SKMEL-315-05
DR   Cosmic; 1669242
DR   Wikidata; Q54954073
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E090 ! SK-MEL-315-02
OI   CVCL_E091 ! SK-MEL-315-03
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-316
AC   CVCL_6151
SY   SK-Mel-316
DR   Cosmic; 1669243
DR   Wikidata; Q54954074
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-318
AC   CVCL_1T60
SY   SK-Mel-318
DR   Wikidata; Q54954075
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-32
AC   CVCL_6032
SY   SK-Mel-32; SKMEL-32; SK-Mel 32; AY-Mel
DR   cancercelllines; CVCL_6032
DR   Cosmic; 1669148
DR   Wikidata; Q54954077
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   SK-MEL-321A
AC   CVCL_D771
SY   SK-Mel-321A; SKMEL-321A
DR   cancercelllines; CVCL_D771
DR   Cosmic; 1669244
DR   Wikidata; Q54954078
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E089 ! SK-MEL-321B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   SK-MEL-321B
AC   CVCL_E089
SY   SK-Mel-321B; SKMEL-321B
DR   Cosmic; 1669245
DR   Wikidata; Q54954079
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D771 ! SK-MEL-321A
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-323
AC   CVCL_6152
SY   SK-Mel-323; SKMEL-323
DR   Cosmic; 1669246
DR   Wikidata; Q54954081
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-325
AC   CVCL_6153
SY   SK-Mel-325; SKMEL-325
DR   cancercelllines; CVCL_6153
DR   Cosmic; 1669247
DR   Wikidata; Q54954082
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-326
AC   CVCL_6154
SY   SK-Mel-326; SKMEL-326
DR   Cosmic; 1669248
DR   Wikidata; Q54954084
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-33
AC   CVCL_6033
SY   SK-Mel-33; AZ-Mel
DR   Cosmic; 923387
DR   Wikidata; Q54954086
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=2983346;
RX   PubMed=3518877;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=8432869;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Asp96Metfs*6 (c.286delG); Zygosity=Unspecified (PubMed=8432869).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   SK-MEL-330
AC   CVCL_6155
SY   SK-Mel-330; SKMEL-330
DR   cancercelllines; CVCL_6155
DR   Cosmic; 1669249
DR   Wikidata; Q54954087
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-332
AC   CVCL_1T61
SY   SK-Mel-332
DR   Wikidata; Q54954088
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-334
AC   CVCL_6156
SY   SK-Mel-334; SKMEL-334
DR   cancercelllines; CVCL_6156
DR   Cosmic; 1669250
DR   Wikidata; Q54954090
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-339
AC   CVCL_6157
SY   SK-Mel-339; SKMEL-339
DR   cancercelllines; CVCL_6157
DR   Cosmic; 1669251
DR   Wikidata; Q54954091
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-34
AC   CVCL_8084
SY   SK-Mel-34; BA-Mel
DR   Cosmic; 721842
DR   Wikidata; Q54954092
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
ID   SK-MEL-341
AC   CVCL_6158
SY   SKMEL-341
DR   Cosmic; 1669252
DR   Wikidata; Q54954094
RX   PubMed=21725359;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-346
AC   CVCL_6159
SY   SK-Mel-346; SKMEL-346
DR   Cosmic; 1669253
DR   Wikidata; Q54954096
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-35
AC   CVCL_6034
SY   SK-Mel-35; SKMEL-35; BB-Mel
DR   Cosmic; 1669149
DR   Wikidata; Q54954098
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 15
//
ID   SK-MEL-351
AC   CVCL_6160
SY   SK-Mel-351; SKMEL-351
DR   Cosmic; 1669254
DR   Wikidata; Q54954099
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-359
AC   CVCL_6161
SY   SK-Mel-359; SKMEL-359
DR   cancercelllines; CVCL_6161
DR   Cosmic; 1669255
DR   Wikidata; Q54954100
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-36
AC   CVCL_6035
SY   SK-Mel-36; SKMEL-36; BC-Mel
DR   Cosmic; 1669150
DR   Wikidata; Q54954102
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1778766;
RX   PubMed=3518877;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
ID   SK-MEL-364
AC   CVCL_6162
SY   SK-Mel-364; SKMEL-364
DR   cancercelllines; CVCL_6162
DR   Cosmic; 1669256
DR   Wikidata; Q54954103
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-366
AC   CVCL_6163
SY   SK-Mel-366; SKMEL-366
DR   Cosmic; 1669257
DR   Wikidata; Q54954104
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-367
AC   CVCL_6164
SY   SK-Mel-367; SKMEL-367
DR   cancercelllines; CVCL_6164
DR   Cosmic; 1669258
DR   Wikidata; Q54954124
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-369
AC   CVCL_6165
SY   SK-Mel-369; SKMEL-369
DR   cancercelllines; CVCL_6165
DR   Cosmic; 1669259
DR   Wikidata; Q54954126
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SK-MEL-37
AC   CVCL_3878
SY   SK-Mel-37; SK-MEL37; SK-Mel 37; SK MEL 37; Sk Mel37; SKMEL-37; SK-37; SK37-MEL; BD-Mel
DR   BTO; BTO_0002967
DR   EFO; EFO_0022424
DR   cancercelllines; CVCL_3878
DR   Cosmic; 706102
DR   Cosmic; 721826
DR   Cosmic; 851046
DR   Cosmic; 888842
DR   Cosmic; 933137
DR   Cosmic; 1303056
DR   Cosmic; 1669151
DR   Millipore; SCC262
DR   Wikidata; Q54954130
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=1778766;
RX   PubMed=2784858;
RX   PubMed=2983346;
RX   PubMed=3081645;
RX   PubMed=3518877;
RX   PubMed=6197381;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714; PubMed=21725359; PubMed=24576830).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (PubMed=9692547).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Millipore=SCC262
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,14
ST   D18S51: 12,16
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 12,15
ST   FGA: 19,23
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4633; Amelanotic cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 32
//
ID   SK-MEL-38
AC   CVCL_U926
SY   SK-Mel-38; BE-Mel
DR   Wikidata; Q54954132
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SK-MEL-380
AC   CVCL_6166
SY   SK-Mel-380; SKMEL-380
DR   Cosmic; 1669260
DR   Wikidata; Q54954133
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-381
AC   CVCL_6167
SY   SK-Mel-381; SKMEL-381
DR   Cosmic; 1669261
DR   Wikidata; Q54954134
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-39
AC   CVCL_6036
SY   SK-Mel-39; SK-Mel 39; SK Mel 39; Sk Mel39; SKMEL-39; BF-Mel
DR   cancercelllines; CVCL_6036
DR   Cosmic; 706098
DR   Cosmic; 851042
DR   Cosmic; 888840
DR   Cosmic; 897487
DR   Cosmic; 933138
DR   Cosmic; 1669152
DR   Wikidata; Q54954136
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=9598804;
RX   PubMed=9692547;
RX   PubMed=10766161;
RX   PubMed=15009714;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714; PubMed=21725359; PubMed=24576830).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Unspecified (PubMed=9692547).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys183fs*7 (c.546_547insA); Zygosity=Unspecified (PubMed=9692547; PubMed=10766161).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   SK-MEL-390
AC   CVCL_6168
SY   SK-Mel-390; SKMEL-390
DR   cancercelllines; CVCL_6168
DR   Cosmic; 1669262
DR   Wikidata; Q54954138
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-391
AC   CVCL_1T62
SY   SK-Mel-391
DR   Wikidata; Q54954140
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-393
AC   CVCL_1T63
SY   SK-Mel-393
DR   Wikidata; Q54954142
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-394
AC   CVCL_1T64
SY   SK-Mel-394
DR   cancercelllines; CVCL_1T64
DR   Wikidata; Q54954143
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   SK-MEL-398
AC   CVCL_1T65
SY   SK-Mel-398
DR   Wikidata; Q54954146
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-3rCDDP1000
AC   CVCL_RS85
DR   cancercelllines; CVCL_RS85
DR   Wikidata; Q54954148
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0550 ! SK-MEL-3
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   SK-MEL-3rDACARB20
AC   CVCL_RS86
DR   cancercelllines; CVCL_RS86
DR   Wikidata; Q54954149
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0550 ! SK-MEL-3
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   SK-MEL-40
AC   CVCL_6037
SY   SK-Mel-40; SKMEL-40; BG-Mel
DR   cancercelllines; CVCL_6037
DR   Cosmic; 721844
DR   Cosmic; 1669153
DR   Wikidata; Q54954150
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1067619;
RX   PubMed=1778766;
RX   PubMed=2784858;
RX   PubMed=6933476;
RX   PubMed=7017212;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   SK-MEL-400
AC   CVCL_1T66
SY   SK-Mel-400
DR   Wikidata; Q54954152
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-406
AC   CVCL_1T67
SY   SK-Mel-406
DR   Wikidata; Q54954154
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-408
AC   CVCL_1T68
SY   SK-Mel-408
DR   Wikidata; Q54954155
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-41
AC   CVCL_6038
SY   SK-Mel-41; SKMEL-41; BH-Mel
DR   cancercelllines; CVCL_6038
DR   Cosmic; 1669154
DR   Wikidata; Q54954157
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=1067619;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   SK-MEL-410
AC   CVCL_1T69
SY   SK-Mel-410
DR   cancercelllines; CVCL_1T69
DR   Wikidata; Q54954158
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   SK-MEL-411
AC   CVCL_1T70
SY   SK-Mel-411
DR   Wikidata; Q54954160
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-412Parotid
AC   CVCL_1T71
SY   SK-Mel-412Parotid
DR   Wikidata; Q54954162
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-413-2
AC   CVCL_1T72
SY   SK-Mel-413-2
DR   cancercelllines; CVCL_1T72
DR   Wikidata; Q54954163
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-42
AC   CVCL_6039
SY   SK-Mel-42; BR-Mel
DR   Wikidata; Q54954164
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   SK-MEL-423A
AC   CVCL_1T73
SY   SK-Mel-423A
DR   Wikidata; Q54954165
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T74 ! SK-MEL-423B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-423B
AC   CVCL_1T74
SY   SK-Mel-423B
DR   Wikidata; Q54954169
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T73 ! SK-MEL-423A
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-426
AC   CVCL_1T75
SY   SK-Mel-426
DR   cancercelllines; CVCL_1T75
DR   Wikidata; Q54954170
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-427
AC   CVCL_1T76
SY   SK-Mel-427
DR   Wikidata; Q54954171
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-428
AC   CVCL_1T77
SY   SK-Mel-428
DR   Wikidata; Q54954173
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-43
AC   CVCL_U927
SY   Sk-Mel-43; BS-Mel
DR   Wikidata; Q54954175
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SK-MEL-430
AC   CVCL_1T78
SY   SK-Mel-430
DR   Wikidata; Q54954176
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-431
AC   CVCL_1T79
SY   SK-Mel-431
DR   Wikidata; Q54954178
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-432
AC   CVCL_1T80
SY   SK-Mel-432
DR   Wikidata; Q54954179
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-435
AC   CVCL_1T81
SY   SK-Mel-435
DR   Wikidata; Q54954181
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-439
AC   CVCL_1T82
SY   SK-Mel-439
DR   Wikidata; Q54954184
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-44
AC   CVCL_6040
SY   SK-Mel 44; BT-Mel
DR   Cosmic; 721827
DR   Wikidata; Q54954185
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=2983346;
RX   PubMed=6933476;
RX   PubMed=22970293;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   SK-MEL-441
AC   CVCL_1T83
SY   SK-Mel-441
DR   cancercelllines; CVCL_1T83
DR   Wikidata; Q54954187
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-444
AC   CVCL_1T84
SY   SK-Mel-444
DR   Wikidata; Q54954188
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-445
AC   CVCL_1T85
SY   SK-Mel-445
DR   Wikidata; Q54954190
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-446
AC   CVCL_1T86
SY   SK-Mel-446
DR   Wikidata; Q54954191
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-447
AC   CVCL_1T87
SY   SK-Mel-447
DR   cancercelllines; CVCL_1T87
DR   Wikidata; Q54954220
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-45
AC   CVCL_U928
SY   SK-Mel-45; BU-Mel
DR   Wikidata; Q54954221
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SK-MEL-451
AC   CVCL_1T88
SY   SK-Mel-451
DR   Wikidata; Q54954222
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-452
AC   CVCL_1T89
SY   SK-Mel-452
DR   Wikidata; Q54954223
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-455
AC   CVCL_1T90
SY   SK-Mel-455
DR   cancercelllines; CVCL_1T90
DR   Wikidata; Q54954225
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   SK-MEL-457
AC   CVCL_1T91
SY   SK-Mel-457
DR   cancercelllines; CVCL_1T91
DR   Wikidata; Q54954228
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-459
AC   CVCL_1T92
SY   SK-Mel-459
DR   Wikidata; Q54954229
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-46
AC   CVCL_U929
SY   SK-Mel-46; BV-Mel
DR   Wikidata; Q54954231
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SK-MEL-462
AC   CVCL_1T93
SY   SK-Mel-462
DR   cancercelllines; CVCL_1T93
DR   Wikidata; Q54954232
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-464A
AC   CVCL_1T94
SY   SK-Mel-464a
DR   Wikidata; Q54954233
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T95 ! SK-MEL-464B
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-464B
AC   CVCL_1T95
SY   SK-Mel-464b
DR   Wikidata; Q54954235
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T94 ! SK-MEL-464A
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-47
AC   CVCL_U930
SY   SK-Mel-47; BW-Mel
DR   Wikidata; Q54954236
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SK-MEL-479
AC   CVCL_1T96
SY   SK-Mel-479
DR   cancercelllines; CVCL_1T96
DR   Wikidata; Q54954238
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-48
AC   CVCL_U931
SY   SK-Mel-48; BX-Mel
DR   Wikidata; Q54954240
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SK-MEL-481
AC   CVCL_1T97
SY   SK-Mel-481
DR   Wikidata; Q54954242
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-483
AC   CVCL_1T98
SY   SK-Mel-483
DR   cancercelllines; CVCL_1T98
DR   Wikidata; Q54954243
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-49
AC   CVCL_6229
SY   SK-Mel-49; BZ-Mel
DR   Wikidata; Q54954244
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-495
AC   CVCL_1T99
SY   SK-Mel-495
DR   cancercelllines; CVCL_1T99
DR   Wikidata; Q54954246
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-498
AC   CVCL_1U00
SY   SK-Mel-498
DR   cancercelllines; CVCL_1U00
DR   Wikidata; Q54954247
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-5
AC   CVCL_0527
SY   SK-Mel-5; SK MEL 5; SK.MEL.5; SK-MEL5; SKMel-5; SKMEL-5; SKMEL5; SKMel5; SKmel5; AA-Mel
DR   BTO; BTO_0002134
DR   CLO; CLO_0009047
DR   EFO; EFO_0005720
DR   MCCL; MCC:0000427
DR   CLDB; cl7123
DR   4DN; 4DNSRTEP2XSG
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-70
DR   BioSample; SAMN03472753
DR   BioSample; SAMN10988351
DR   cancercelllines; CVCL_0527
DR   CancerTools; 161920
DR   Cell_Model_Passport; SIDM00080
DR   CGH-DB; 9316-4
DR   ChEMBL-Cells; CHEMBL3307744
DR   ChEMBL-Targets; CHEMBL614922
DR   CLS; 300157
DR   Cosmic; 686475
DR   Cosmic; 688055
DR   Cosmic; 875886
DR   Cosmic; 905229
DR   Cosmic; 905956
DR   Cosmic; 932996
DR   Cosmic; 974074
DR   Cosmic; 974258
DR   Cosmic; 1022282
DR   Cosmic; 1092634
DR   Cosmic; 1132588
DR   Cosmic; 1175873
DR   Cosmic; 1247851
DR   Cosmic; 1303057
DR   Cosmic; 1305369
DR   Cosmic; 1312351
DR   Cosmic; 1458967
DR   Cosmic; 1459648
DR   Cosmic; 1477410
DR   Cosmic; 1481415
DR   Cosmic; 1507626
DR   Cosmic; 1669130
DR   Cosmic; 1998477
DR   Cosmic; 2159434
DR   Cosmic; 2479253
DR   Cosmic-CLP; 905956
DR   DepMap; ACH-000730
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS029HXQ
DR   ENCODE; ENCBS324XRL
DR   ENCODE; ENCBS398HNX
DR   ENCODE; ENCBS465YNJ
DR   ENCODE; ENCBS518AAA
DR   ENCODE; ENCBS519AAA
DR   ENCODE; ENCBS524EJL
DR   ENCODE; ENCBS697RNA
DR   ENCODE; ENCBS981ZNI
DR   GDSC; 905956
DR   GEO; GSM2094
DR   GEO; GSM50206
DR   GEO; GSM50268
DR   GEO; GSM171011
DR   GEO; GSM188227
DR   GEO; GSM188257
DR   GEO; GSM188316
DR   GEO; GSM226866
DR   GEO; GSM743469
DR   GEO; GSM750826
DR   GEO; GSM799358
DR   GEO; GSM799421
DR   GEO; GSM844691
DR   GEO; GSM847117
DR   GEO; GSM887589
DR   GEO; GSM888672
DR   GEO; GSM1138791
DR   GEO; GSM1153429
DR   GEO; GSM1181267
DR   GEO; GSM1181310
DR   GEO; GSM1670443
DR   GEO; GSM2124683
DR   IARC_TP53; 21090
DR   ICLC; HTL01023
DR   KCLB; 30070
DR   LiGeA; CCLE_242
DR   LINCS_LDP; LCL-1282
DR   Lonza; 1202
DR   NCI-DTP; SK-MEL-5
DR   PharmacoDB; SKMEL5_1400_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0527
DR   PubChem_Cell_line; CVCL_0527
DR   SKY/M-FISH/CGH; 2821
DR   Wikidata; Q54954250
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=313568;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1067619;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=7017212;
RX   PubMed=7718330;
RX   PubMed=7747814;
RX   PubMed=7999427;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=11016658;
RX   PubMed=14871852;
RX   PubMed=15299072;
RX   PubMed=15467732;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17363583;
RX   PubMed=17516929;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=21725359;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24576830;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27600516;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=46
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-melanoma-cell-line-sk-mel-5
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-522.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=7718330); 26 hours (PubMed=8631022); 70 hours (PubMed=25984343); 25.2 hours (NCI-DTP=SK-MEL-5).
CC   HLA typing: A*02:01:01,11:01:01; B*07,40; C*03:04:01,07:02:01; DPB1*03:01:01,16:01; DQB1*03:02,06:03; DRB1*04:01:01,13:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,11:01; B*40:01,40:01; C*03:03,03:03; DQA1*01:03,03:02; DQB1*03:02,06:11; DRB1*04:01,13:02 (PubMed=25960936).
CC   HLA typing: A*02:01,11:01; B*07:02,40:01; C*03:04,07:02; DQA1*01:02,03:02; DQB1*03:03,06:13; DRB1*04:01,13:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15467732; PubMed=17088437; PubMed=17363583; PubMed=24576830; Cosmic-CLP=905956; DepMap=ACH-000730).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=905956; DepMap=ACH-000730).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.41%; Native American=0%; East Asian, North=3.5%; East Asian, South=0%; South Asian=0%; European, North=60.03%; European, South=35.06% (PubMed=30894373).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ATCC=HTB-70; CLS=300157; Cosmic-CLP=905956; KCLB=30070; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 12,15
ST   FGA: 20.2,22.2
ST   Penta D: 9,11
ST   Penta E: 5,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14 (PubMed=19372543)
ST   vWA: 14,18 (ATCC=HTB-70; CLS=300157; Cosmic-CLP=905956; KCLB=30070)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   SK-MEL-50
AC   CVCL_U935
SY   SK-Mel-50; CA-Mel
DR   Wikidata; Q54954251
RX   PubMed=313568;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-506
AC   CVCL_1U01
SY   SK-Mel-506
DR   cancercelllines; CVCL_1U01
DR   Wikidata; Q54954252
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-507
AC   CVCL_1U02
SY   SK-Mel-507
DR   cancercelllines; CVCL_1U02
DR   Wikidata; Q54954254
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-509
AC   CVCL_1U03
SY   SK-Mel-509
DR   Wikidata; Q54954256
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-51
AC   CVCL_6041
SY   SK-Mel-51; CB-Mel
DR   Wikidata; Q54954257
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-513
AC   CVCL_1U04
SY   SK-Mel-513
DR   cancercelllines; CVCL_1U04
DR   Wikidata; Q54954259
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-52
AC   CVCL_8085
SY   Sk-Mel-52; CC-Mel
DR   Cosmic; 721828
DR   Wikidata; Q54954262
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-524
AC   CVCL_1U05
SY   SK-Mel-524
DR   Wikidata; Q54954263
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-529
AC   CVCL_1U06
SY   SK-Mel-529
DR   cancercelllines; CVCL_1U06
DR   Wikidata; Q54954264
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   SK-MEL-534
AC   CVCL_1U07
SY   SK-Mel-534; SK-Mel-534A
DR   cancercelllines; CVCL_1U07
DR   Wikidata; Q54954267
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   SK-MEL-538
AC   CVCL_1U08
SY   SK-Mel-538
DR   cancercelllines; CVCL_1U08
DR   Wikidata; Q54954268
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 10
//
ID   SK-MEL-55
AC   CVCL_6042
SY   CF-Mel
DR   Wikidata; Q54954269
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=7017212;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-56
AC   CVCL_6046
SY   CG-Mel
DR   Wikidata; Q54954271
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-57
AC   CVCL_6043
SY   CH-Mel
DR   Wikidata; Q54954272
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-59
AC   CVCL_VA39
SY   CJ-Mel
DR   Wikidata; Q54954273
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 5
//
ID   SK-MEL-6
AC   CVCL_U932
SY   SK-Mel-6; AB-Mel
DR   Wikidata; Q54954275
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=833871;
RX   PubMed=1067619;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   SK-MEL-60
AC   CVCL_6047
SY   CK-Mel
DR   Wikidata; Q54954276
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-61
AC   CVCL_6044
SY   SK-Mel-61; CL-Mel
DR   Cosmic; 721836
DR   Cosmic; 923388
DR   Cosmic; 933129
DR   Wikidata; Q54954277
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=2983346;
RX   PubMed=6933476;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly89Ser (c.265G>A) (p.Gly103Glu, c.308G>A); ClinVar=VCV000009408; Zygosity=Unspecified (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SK-MEL-62
AC   CVCL_8086
SY   CM-Mel
DR   Cosmic; 721837
DR   Wikidata; Q54954279
RX   DOI=10.1007/978-1-4615-7228-2_39;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-63
AC   CVCL_6045
SY   SK-Mel-63; Sk Mel 63; SKMEL63; Sk Mel63; SkMel63; CN-Mel
DR   cancercelllines; CVCL_6045
DR   Cosmic; 706095
DR   Cosmic; 721811
DR   Cosmic; 851040
DR   Cosmic; 888838
DR   Cosmic; 897477
DR   Cosmic; 933130
DR   Cosmic; 1054852
DR   Wikidata; Q54954280
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=1716514;
RX   PubMed=2784858;
RX   PubMed=6933476;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=10766161;
RX   PubMed=15009714;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg112Pro (c.335G>C) (p.Pro126Pro, c.378G>C); ClinVar=VCV001730600; Zygosity=Unspecified (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=10766161; PubMed=15009714).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SK-MEL-64
AC   CVCL_6048
SY   SK-Mel-64; SKMEL-64; SK64-MEL; CO-Mel
DR   cancercelllines; CVCL_6048
DR   Cosmic; 721838
DR   Cosmic; 1669155
DR   Wikidata; Q54954303
RX   PubMed=2784858;
RX   PubMed=2983346;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   SK-MEL-65
AC   CVCL_6050
SY   SK-Mel-65
DR   Cosmic; 721815
DR   Wikidata; Q54954305
RX   PubMed=7175440;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-68
AC   CVCL_6051
SY   CR-Mel
DR   Wikidata; Q54954306
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-69
AC   CVCL_6058
SY   CS-Mel
DR   Wikidata; Q54954308
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-7
AC   CVCL_D854
SY   SK-Mel-7; SK-Mel 7; SKMEL-7; AC-Mel
DR   cancercelllines; CVCL_D854
DR   Cosmic; 1669131
DR   Wikidata; Q54954309
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   DOI=10.1007/BF00199208;
RX   PubMed=327080;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   SK-MEL-72
AC   CVCL_6052
SY   SK-Mel-72
DR   Cosmic; 721839
DR   Cosmic; 923389
DR   Wikidata; Q54954310
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-73
AC   CVCL_6053
SY   SK-Mel-73; SKMEL-73
DR   cancercelllines; CVCL_6053
DR   Cosmic; 721840
DR   Cosmic; 1669156
DR   Wikidata; Q54954312
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-75
AC   CVCL_6054
SY   SK-Mel-75; SKMEL-75
DR   Cosmic; 721829
DR   Cosmic; 933114
DR   Cosmic; 1060424
DR   Cosmic; 1669157
DR   Wikidata; Q54954313
RX   PubMed=6582512;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=9598804;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   SK-MEL-76
AC   CVCL_6221
DR   Wikidata; Q54954314
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-78
AC   CVCL_6056
SY   SK-Mel-78; SKMEL78; DC-Mel
DR   Cosmic; 721845
DR   Cosmic; 1507606
DR   Cosmic; 2233681
DR   Wikidata; Q54954316
RX   PubMed=2983346;
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-79
AC   CVCL_6222
SY   DD-Mel
DR   Wikidata; Q54954318
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-8
AC   CVCL_6960
SY   SK-Mel-8; AD-Mel
DR   Wikidata; Q54954320
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=978138;
RX   PubMed=1067619;
RX   PubMed=3518877;
RX   PubMed=22970293;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 16
//
ID   SK-MEL-80
AC   CVCL_6057
DR   Wikidata; Q54954321
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-81
AC   CVCL_6223
DR   Cosmic; 721846
DR   Wikidata; Q54954323
RX   PubMed=1716514;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-83
AC   CVCL_6059
SY   DH-Mel
DR   Wikidata; Q54954324
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-85
AC   CVCL_6224
SY   SK-Mel-85; SK-MEL 85; SKMEL-85; SKMEL85; SK-MEL-085; DJ-Mel
DR   cancercelllines; CVCL_6224
DR   Cosmic; 685204
DR   Cosmic; 1669158
DR   GEO; GSM555124
DR   GEO; GSM555177
DR   GEO; GSM784521
DR   Lonza; 1334
DR   Progenetix; CVCL_6224
DR   Wikidata; Q54954325
RX   PubMed=7747814;
RX   PubMed=21343389;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=7747814).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Ser (c.1405_1406delGGinsTC); ClinVar=VCV000376072; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   SK-MEL-86
AC   CVCL_6225
SY   SK-Mel-86; DK-Mel
DR   Cosmic; 923390
DR   Wikidata; Q54954328
RX   PubMed=6933476;
RX   PubMed=7747814;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   SK-MEL-87
AC   CVCL_6060
SY   DL-Mel
DR   Wikidata; Q54954329
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-88
AC   CVCL_6049
SY   SK-Mel-88; SKMEL88; DM-Mel
DR   Cosmic; 721847
DR   Wikidata; Q54954331
RX   PubMed=2784858;
RX   PubMed=2983346;
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-MEL-89
AC   CVCL_6226
SY   DN-Mel
DR   Wikidata; Q54954332
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-9
AC   CVCL_U934
SY   SK-Mel-9; AE-Mel
DR   Wikidata; Q54954333
RX   DOI=10.1007/978-1-4615-7228-2_39;
RX   PubMed=327080;
RX   PubMed=1067619;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   SK-MEL-90
AC   CVCL_6227
SY   SK-Mel-90; SKMEL-90; DO-Mel
DR   cancercelllines; CVCL_6227
DR   Cosmic; 1669159
DR   Wikidata; Q54954335
RX   PubMed=3518877;
RX   PubMed=6864164;
RX   PubMed=6933476;
RX   PubMed=21725359;
RX   PubMed=24576830;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=21725359; PubMed=24576830).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   SK-MEL-91
AC   CVCL_6228
SY   DP-Mel
DR   Wikidata; Q54954336
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-93 DX-1
AC   CVCL_5651
AS   CVCL_3879; CVCL_U902
SY   SK-MEL-93-DX-1; SK-MEL-93 DX1; SK-MEL-93 (DX1); DX-1; DX1; SK-MEL-93(1); SK-MEL-93-1; SK-MEL-93; SK-Mel-93; SK-MEL93; SKMel-93; SKMEL93; SKMel93
DR   BTO; BTO_0002968
DR   Cosmic; 721816
DR   Cosmic; 926000
DR   Cosmic; 933119
DR   Cosmic; 1060426
DR   Wikidata; Q54954338
RX   PubMed=2886213;
RX   PubMed=6864164;
RX   PubMed=6976407;
RX   PubMed=7017212;
RX   PubMed=7175440;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Derived from site: Metastatic; Left thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5652 ! SK-MEL-93 DX-2
OI   CVCL_5650 ! SK-MEL-93 DX-3
OI   CVCL_A432 ! SK-MEL-93 DX-4
OI   CVCL_A433 ! SK-MEL-93 DX-5
OI   CVCL_A434 ! SK-MEL-93 DX-6
OI   CVCL_A435 ! SK-MEL-93 DX-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   SK-MEL-93 DX-2
AC   CVCL_5652
AS   CVCL_6062
SY   SK-MEL-93-DX-2; SK-MEL-93 DX2; SK-MEL-93 (DX2); DX-2; DX2; SK-MEL-93(2); SK-MEL-93-2; DX-Mel-2
DR   Cosmic; 721817
DR   Cosmic; 926001
DR   Cosmic; 933120
DR   Wikidata; Q54954340
RX   PubMed=1716514;
RX   PubMed=2886213;
RX   PubMed=2983346;
RX   PubMed=3081645;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6976407;
RX   PubMed=7017212;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5651 ! SK-MEL-93 DX-1
OI   CVCL_5650 ! SK-MEL-93 DX-3
OI   CVCL_A432 ! SK-MEL-93 DX-4
OI   CVCL_A433 ! SK-MEL-93 DX-5
OI   CVCL_A434 ! SK-MEL-93 DX-6
OI   CVCL_A435 ! SK-MEL-93 DX-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-MEL-93 DX-3
AC   CVCL_5650
AS   CVCL_U903
SY   SK-MEL-93-DX-3; SK-MEL-93 DX3; SK-MEL-93 (DX3); DX-3; DX3; SK-MEL-93(3); SK-MEL-93-3; DX-Mel-3
DR   BTO; BTO_0003988
DR   Cosmic; 721806
DR   Cosmic; 926002
DR   Cosmic; 932703
DR   Cosmic; 933121
DR   KCLB; 80012
DR   Wikidata; Q54954341
RX   PubMed=1716514;
RX   PubMed=2060182;
RX   PubMed=2297053;
RX   PubMed=2886213;
RX   PubMed=2983346;
RX   PubMed=6582512;
RX   PubMed=6744277;
RX   PubMed=6976407;
RX   PubMed=7017212;
RX   PubMed=7780963;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5651 ! SK-MEL-93 DX-1
OI   CVCL_5652 ! SK-MEL-93 DX-2
OI   CVCL_A432 ! SK-MEL-93 DX-4
OI   CVCL_A433 ! SK-MEL-93 DX-5
OI   CVCL_A434 ! SK-MEL-93 DX-6
OI   CVCL_A435 ! SK-MEL-93 DX-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-MEL-93 DX-4
AC   CVCL_A432
AS   CVCL_U904
SY   SK-MEL-93-DX-4; SK-MEL-93 DX4; SK-MEL-93 (DX4); DX-4; DX4; SK-MEL-93(4); DX-Mel-4
DR   Cosmic; 721818
DR   Cosmic; 926003
DR   Cosmic; 933122
DR   Wikidata; Q54954342
RX   PubMed=1716514;
RX   PubMed=2886213;
RX   PubMed=2983346;
RX   PubMed=6976407;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5651 ! SK-MEL-93 DX-1
OI   CVCL_5652 ! SK-MEL-93 DX-2
OI   CVCL_5650 ! SK-MEL-93 DX-3
OI   CVCL_A433 ! SK-MEL-93 DX-5
OI   CVCL_A434 ! SK-MEL-93 DX-6
OI   CVCL_A435 ! SK-MEL-93 DX-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   SK-MEL-93 DX-5
AC   CVCL_A433
AS   CVCL_U905
SY   SK-MEL-93-DX-5; SK-MEL-93 DX5; SK-MEL-93 (DX5); DX-5; DX5; SK-MEL-93(5)
DR   Cosmic; 721819
DR   Cosmic; 926004
DR   Cosmic; 933123
DR   Wikidata; Q54954345
RX   PubMed=2886213;
RX   PubMed=6976407;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5651 ! SK-MEL-93 DX-1
OI   CVCL_5652 ! SK-MEL-93 DX-2
OI   CVCL_5650 ! SK-MEL-93 DX-3
OI   CVCL_A432 ! SK-MEL-93 DX-4
OI   CVCL_A434 ! SK-MEL-93 DX-6
OI   CVCL_A435 ! SK-MEL-93 DX-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   SK-MEL-93 DX-6
AC   CVCL_A434
AS   CVCL_U906
SY   SK-MEL-93-DX-6; SK-MEL-93 DX 6; SK-MEL-93 DX6; SK-MEL-93 (DX6); DX-6; DX6; SK-MEL-93(6); DX-Mel-6
DR   Cosmic; 721820
DR   Cosmic; 926005
DR   Cosmic; 933124
DR   Wikidata; Q54954346
RX   PubMed=1716514;
RX   PubMed=2886213;
RX   PubMed=2983346;
RX   PubMed=6976407;
RX   PubMed=9598804;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly35Glu (c.104G>A); ClinVar=VCV000188292; Zygosity=Unspecified (PubMed=9598804).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5651 ! SK-MEL-93 DX-1
OI   CVCL_5652 ! SK-MEL-93 DX-2
OI   CVCL_5650 ! SK-MEL-93 DX-3
OI   CVCL_A432 ! SK-MEL-93 DX-4
OI   CVCL_A433 ! SK-MEL-93 DX-5
OI   CVCL_A435 ! SK-MEL-93 DX-B
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   SK-MEL-93 DX-B
AC   CVCL_A435
SY   DX-B; DX B
DR   Wikidata; Q54954347
RX   PubMed=2886213;
RX   PubMed=6976407;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5651 ! SK-MEL-93 DX-1
OI   CVCL_5652 ! SK-MEL-93 DX-2
OI   CVCL_5650 ! SK-MEL-93 DX-3
OI   CVCL_A432 ! SK-MEL-93 DX-4
OI   CVCL_A433 ! SK-MEL-93 DX-5
OI   CVCL_A434 ! SK-MEL-93 DX-6
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SK-MEL-94
AC   CVCL_3880
SY   SK-Mel-94; SKMEL94
DR   cancercelllines; CVCL_3880
DR   Cosmic; 685205
DR   Cosmic; 1122256
DR   GEO; GSM555125
DR   GEO; GSM555178
DR   Lonza; 1335
DR   Progenetix; CVCL_3880
DR   Wikidata; Q54954349
RX   PubMed=7747814;
RX   PubMed=18505964;
RX   PubMed=21343389;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=18505964).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-MEL-95
AC   CVCL_6064
SY   DT-Mel
DR   Wikidata; Q54954350
RX   PubMed=6933476;
RX   PubMed=7017212;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-96
AC   CVCL_U939
DR   Wikidata; Q54954352
RX   PubMed=7175440;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   SK-MEL-97
AC   CVCL_6065
DR   Wikidata; Q54954353
RX   PubMed=2784858;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MEL-98
AC   CVCL_6066
SY   DW-Mel
DR   Wikidata; Q54954356
RX   PubMed=6933476;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SK-MES-1
AC   CVCL_0630
AS   CVCL_8913
SY   SK MES 1; SKMES-1; SK-Mes-1; SK-MES1; SKMES1; SK-MES; SKMES
DR   BTO; BTO_0002203
DR   CLO; CLO_0009033
DR   CLO; CLO_0009048
DR   CLO; CLO_0009049
DR   EFO; EFO_0002334
DR   CLDB; cl4325
DR   CLDB; cl4326
DR   CLDB; cl4329
DR   AddexBio; C0016029/4989
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-58
DR   BioGRID_ORCS_Cell_line; 464
DR   BioSample; SAMN03473164
DR   BioSample; SAMN10987781
DR   cancercelllines; CVCL_0630
DR   CancerTools; 161935
DR   CCRID; 1101HUM-PUMC000262
DR   CCRID; 3101HUMSCSP5010
DR   CCRID; 3101HUMTCHu110
DR   CCRID; 4201HUM-CCTCC00619
DR   Cell_Model_Passport; SIDM01103
DR   CGH-DB; 191-1
DR   CGH-DB; 9180-4
DR   ChEMBL-Cells; CHEMBL3307450
DR   ChEMBL-Targets; CHEMBL614923
DR   CLS; 300339
DR   Cosmic; 687832
DR   Cosmic; 909728
DR   Cosmic; 933577
DR   Cosmic; 934464
DR   Cosmic; 1006538
DR   Cosmic; 1071896
DR   Cosmic; 1089225
DR   Cosmic; 1176620
DR   Cosmic; 1219089
DR   Cosmic; 1239912
DR   Cosmic; 1434962
DR   Cosmic; 1995637
DR   Cosmic; 2060529
DR   Cosmic; 2125289
DR   Cosmic; 2696402
DR   Cosmic; 2772162
DR   Cosmic-CLP; 909728
DR   DepMap; ACH-000665
DR   DSMZ; ACC-353
DR   DSMZCellDive; ACC-353
DR   ECACC; 91091804
DR   ECACC; 93120837
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909728
DR   GEO; GSM62971
DR   GEO; GSM206544
DR   GEO; GSM274789
DR   GEO; GSM274819
DR   GEO; GSM513971
DR   GEO; GSM514561
DR   GEO; GSM784266
DR   GEO; GSM827318
DR   GEO; GSM887590
DR   GEO; GSM888673
DR   GEO; GSM1374881
DR   GEO; GSM1670444
DR   IARC_TP53; 8201
DR   IARC_TP53; 18793
DR   ICLC; HTL95004
DR   IGRhCellID; SKMES1
DR   IZSLER; BS TCL 72
DR   KCB; KCB 200821YJ
DR   KCLB; 30058
DR   LiGeA; CCLE_382
DR   LINCS_HMS; 50043
DR   LINCS_LDP; LCL-1583
DR   NCBI_Iran; C562
DR   NCI-DTP; SK-MES-1
DR   PharmacoDB; SKMES1_1401_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0630
DR   PubChem_Cell_line; CVCL_0630
DR   TOKU-E; 3142
DR   Ubigene; YC-C019
DR   Wikidata; Q54954357
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=833871;
RX   PubMed=2990217;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=4005855;
RX   PubMed=6935474;
RX   PubMed=7017212;
RX   PubMed=7736387;
RX   PubMed=8385084;
RX   PubMed=11583962;
RX   PubMed=12794755;
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=16187286;
RX   PubMed=18083107;
RX   PubMed=19472407;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-mes-1-lung-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2009-091.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-353).
CC   HLA typing: A*03:01,03:01; B*07:02,07:02; C*07:02,07:02 (PubMed=26589293).
CC   HLA typing: A*03:01:01; B*07:02:01; C*07:02:01; DPB1*04:01:01; DQA1*01:02:02; DQB1*05:02:01; DRB1*16:01:01 (CLS=300339).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (PubMed=12794755; PubMed=20557307; Cosmic-CLP=909728; DepMap=ACH-000665).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.88%; Native American=0%; East Asian, North=1.52%; East Asian, South=0%; South Asian=0%; European, North=64.63%; European, South=32.97% (PubMed=30894373).
CC   Discontinued: ECACC; 91091804; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0016029/4989; ATCC=HTB-58; CLS=300339; Cosmic-CLP=909728; DSMZ=ACC-353; KCLB=30058; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,19 (ATCC=HTB-58)
ST   D2S1338: 19 (CLS=300339)
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 11,12 (DSMZ=ACC-353)
ST   Penta D: 12,13 (ATCC=HTB-58; CLS=300339; PubMed=25877200)
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   SK-MES-1-Luc
AC   CVCL_C8XL
DR   Ubigene; YC-C019-Luc-P
DR   Wikidata; Q123033506
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0630 ! SK-MES-1
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SK-MG-1
AC   CVCL_1698
SY   SKMG1; SKMG; AJ
DR   BTO; BTO_0005396
DR   CLO; CLO_0009904
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1013
DR   BioSample; SAMN03151837
DR   BioSample; SAMN03472786
DR   cancercelllines; CVCL_1698
DR   Cell_Model_Passport; SIDM00379
DR   ChEMBL-Cells; CHEMBL3308547
DR   ChEMBL-Targets; CHEMBL2366151
DR   Cosmic; 909729
DR   Cosmic; 2367547
DR   Cosmic-CLP; 909729
DR   DepMap; ACH-002304
DR   EGA; EGAS00001000978
DR   GDSC; 909729
DR   GEO; GSM1670445
DR   IARC_TP53; 27240
DR   JCRB; IFO50344
DR   LINCS_LDP; LCL-1391
DR   PharmacoDB; SKMG1_1402_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1698
DR   Wikidata; Q54954358
RX   PubMed=6182568;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; JCRB; -; https://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC   Problematic cell line: Contaminated. Shown to be a Marcus derivative (PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00345.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg2635Ter (c.7903C>T); ClinVar=VCV000196692; Zygosity=Heterozygous (Cosmic-CLP=909729; DepMap=ACH-002304).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Homozygous (Cosmic-CLP=909729; DepMap=ACH-002304).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.66%; Native American=0.87%; East Asian, North=0.78%; East Asian, South=2.54%; South Asian=8.48%; European, North=25.75%; European, South=58.92% (PubMed=30894373).
CC   Discontinued: JCRB; IFO50344; probable.
ST   Source(s): Cosmic-CLP=909729; JCRB=IFO50344
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9 (JCRB=IFO50344)
ST   D7S820: 9,11 (Cosmic-CLP=909729)
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3019 ! Marcus
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SK-MG-10
AC   CVCL_8568
DR   Wikidata; Q54954362
RX   PubMed=6182568;
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SK-MG-11
AC   CVCL_8569
DR   Wikidata; Q54954363
RX   PubMed=6182568;
RX   PubMed=6582512;
RX   PubMed=8934553;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   SK-MG-12
AC   CVCL_8570
DR   Wikidata; Q54954364
RX   PubMed=6182568;
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SK-MG-13
AC   CVCL_8571
DR   Wikidata; Q54954387
RX   PubMed=6182568;
RX   PubMed=6864164;
RX   PubMed=8934553;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   SK-MG-14
AC   CVCL_GS21
DR   Wikidata; Q54954388
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   SK-MG-15
AC   CVCL_8572
DR   Wikidata; Q54954389
RX   PubMed=6582512;
RX   PubMed=8934553;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SK-MG-16
AC   CVCL_8573
DR   cancercelllines; CVCL_8573
DR   IARC_TP53; 8290
DR   Wikidata; Q54954391
RX   PubMed=6864164;
RX   PubMed=8934553;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>C); ClinVar=VCV002185665; Zygosity=Unspecified (PubMed=8934553).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   SK-MG-17
AC   CVCL_8574
SY   SK-MG 17
DR   Cosmic; 1038408
DR   Wikidata; Q54954393
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   SK-MG-2
AC   CVCL_8575
DR   Wikidata; Q54954394
RX   PubMed=6182568;
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SK-MG-21
AC   CVCL_Y195
DR   IARC_TP53; 8291
DR   Wikidata; Q54954395
RX   PubMed=8934553;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Ile (c.765C>T); ClinVar=VCV001532094; Zygosity=Unspecified (PubMed=8934553).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 8
//
ID   SK-MG-26
AC   CVCL_D701
SY   SK-MG 26; SKMG26
DR   Cosmic; 1038414
DR   Cosmic; 1672407
DR   Wikidata; Q54954397
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   SK-MG-3
AC   CVCL_8576
SY   SKMG-3; SKMG3
DR   Cosmic; 847808
DR   Cosmic; 1175819
DR   Cosmic; 1217676
DR   Cosmic; 2550360
DR   Wikidata; Q54954398
RX   PubMed=2994648;
RX   PubMed=6182568;
RX   PubMed=6582512;
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   SK-MG-4
AC   CVCL_8577
SY   SKMG4; SK-MG4
DR   Wikidata; Q54954399
RX   PubMed=6182568;
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SK-MG-5
AC   CVCL_GS19
DR   Wikidata; Q54954401
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   SK-MG-6
AC   CVCL_GS20
DR   Wikidata; Q54954402
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 5
//
ID   SK-MG-7
AC   CVCL_8578
DR   Wikidata; Q54954403
RX   PubMed=6182568;
RX   PubMed=6864164;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SK-MG-8
AC   CVCL_Y196
DR   IARC_TP53; 8292
DR   Wikidata; Q54954404
RX   PubMed=6582512;
RX   PubMed=8934553;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Met (c.765C>G); Zygosity=Unspecified (PubMed=8934553).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 9
//
ID   SK-MG-9
AC   CVCL_8579
SY   SK-MG 9
DR   Cosmic; 1038409
DR   Wikidata; Q54954406
RX   PubMed=6182568;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   SK-MM-1
AC   CVCL_A478
SY   SK-MM1; SKMM-1; SKMM1; SK-MY-1; SK-My-1
DR   BTO; BTO_0006521
DR   EFO; EFO_0005457
DR   BioSample; SAMN03470877
DR   cancercelllines; CVCL_A478
DR   Cosmic; 720782
DR   Cosmic; 760399
DR   Cosmic; 2081407
DR   Cosmic; 2302414
DR   Cosmic; 2367273
DR   Cosmic; 2391803
DR   DSMZ; ACC-758
DR   DSMZCellDive; ACC-758
DR   GEO; GSM143343
DR   SKY/M-FISH/CGH; 2544
DR   Wikidata; Q54954407
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2506399;
RX   PubMed=6582512;
RX   PubMed=8943038;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=11429052;
RX   PubMed=12886255;
RX   PubMed=17171682;
RX   PubMed=17229644;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=25877200;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-multiple-myeloma-cell-line-sk-mm-1
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 440.
CC   Characteristics: Produces Ig kappa.
CC   Doubling time: 32 hours (PubMed=2506399); ~48 hours (DSMZ=ACC-758).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (PubMed=11157491).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): DSMZ=ACC-758; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 13,14
ST   D18S51: 16,17
ST   D19S433: 13
ST   D21S11: 28,32
ST   D2S1338: 22,26
ST   D3S1358: 14,17
ST   D5S818: 8,11
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 2.2,13 (PubMed=25877200)
ST   Penta D: 3,13 (DSMZ=ACC-758)
ST   Penta E: 10,12
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 28
//
ID   SK-MM-2
AC   CVCL_1699
SY   SK-MM2; SKMM-2; SKMM2
DR   CLO; CLO_0009050
DR   EFO; EFO_0005458
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-937
DR   BioSample; SAMN03472942
DR   BioSample; SAMN10988476
DR   cancercelllines; CVCL_1699
DR   Cell_Model_Passport; SIDM00391
DR   ChEMBL-Cells; CHEMBL3308277
DR   ChEMBL-Targets; CHEMBL2366232
DR   Cosmic; 720793
DR   Cosmic; 753612
DR   Cosmic; 2081408
DR   Cosmic; 2159573
DR   Cosmic; 2302409
DR   Cosmic; 2367263
DR   Cosmic; 2809766
DR   Cosmic-CLP; 753612
DR   DepMap; ACH-000363
DR   DSMZ; ACC-430
DR   DSMZCellDive; ACC-430
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 753612
DR   GEO; GSM887591
DR   GEO; GSM888674
DR   GEO; GSM1374882
DR   GEO; GSM1670446
DR   IARC_TP53; 27241
DR   IARC_TP53; 28509
DR   LiGeA; CCLE_323
DR   LINCS_LDP; LCL-2051
DR   PharmacoDB; SKMM2_1403_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1699
DR   PubChem_Cell_line; CVCL_1699
DR   Wikidata; Q54954410
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2506399;
RX   PubMed=8695815;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=20164919;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-multiple-myeloma-cell-line-sk-mm-2
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1989-002.
CC   Population: Caucasian.
CC   Characteristics: Produces Ig kappa.
CC   Doubling time: 60 hours (PubMed=2506399); 85 hours (PubMed=25984343); ~100 hours (DSMZ=ACC-430).
CC   HLA typing: A*30,68; B*49,51; C*07,07 (PubMed=25688540).
CC   HLA typing: A*30:01,68:01; B*49:01,51:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1582; CCND1 + HGNC; HGNC:5477; IGH; Name(s)=IGH-CCND1 (PubMed=8695815).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (PubMed=21173094; Cosmic-CLP=753612; DepMap=ACH-000363).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.65%; Native American=0%; East Asian, North=2.84%; East Asian, South=0%; South Asian=3.06%; European, North=38.09%; European, South=52.35% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): Cosmic-CLP=753612; DSMZ=ACC-430; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 11 (PubMed=25877200)
ST   D18S51: 11,16 (DSMZ=ACC-430)
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 11,15
ST   Penta E: 10,20
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,20
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   SK-N-AS
AC   CVCL_1700
SY   SKN-AS; SKNAS
DR   BTO; BTO_0002827
DR   CLO; CLO_0009051
DR   EFO; EFO_0002859
DR   CLDB; cl4330
DR   CLDB; cl4331
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-6654
DR   ATCC; CRL-2137
DR   BioGRID_ORCS_Cell_line; 376
DR   BioSample; SAMN03473210
DR   BioSample; SAMN10987940
DR   cancercelllines; CVCL_1700
DR   Cell_Model_Passport; SIDM01101
DR   CGH-DB; 61-1
DR   CGH-DB; 9098-4
DR   ChEMBL-Cells; CHEMBL3308785
DR   ChEMBL-Targets; CHEMBL1075578
DR   CLS; 305272
DR   Cosmic; 724828
DR   Cosmic; 848935
DR   Cosmic; 930074
DR   Cosmic; 1019941
DR   Cosmic; 1109104
DR   Cosmic; 1162002
DR   Cosmic; 1167418
DR   Cosmic; 1518070
DR   Cosmic; 1526646
DR   Cosmic; 1543772
DR   Cosmic; 2058112
DR   Cosmic; 2239472
DR   Cosmic; 2393642
DR   Cosmic; 2485950
DR   Cosmic-CLP; 724828
DR   DepMap; ACH-000260
DR   ECACC; 94092302
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724828
DR   GEO; GSM563352
DR   GEO; GSM692855
DR   GEO; GSM887592
DR   GEO; GSM888675
DR   GEO; GSM1670449
DR   GEO; GSM2371254
DR   GEO; GSM2394379
DR   GEO; GSM4104591
DR   GEO; GSM4104592
DR   GEO; GSM4104635
DR   GEO; GSM4104636
DR   GEO; GSM4105338
DR   GEO; GSM4105339
DR   GEO; GSM4105340
DR   GEO; GSM4105341
DR   GEO; GSM4105342
DR   IARC_TP53; 23597
DR   ICLC; HTL95026
DR   IGRhCellID; SKNAS
DR   LiGeA; CCLE_394
DR   LINCS_LDP; LCL-1969
DR   Lonza; 447
DR   Lonza; 1617
DR   MetaboLights; MTBLS541
DR   PharmacoDB; SKNAS_1404_2019
DR   PRIDE; PXD010745
DR   PRIDE; PXD011187
DR   PRIDE; PXD023088
DR   PRIDE; PXD024551
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1700
DR   PubChem_Cell_line; CVCL_1700
DR   Wikidata; Q54954411
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.1159/000407025;
RX   PubMed=2987426;
RX   PubMed=6610792;
RX   PubMed=7838528;
RX   PubMed=9283597;
RX   PubMed=11550280;
RX   PubMed=12068308;
RX   PubMed=12702577;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=17506115;
RX   PubMed=18082704;
RX   PubMed=18534018;
RX   PubMed=18724359;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=23202128;
RX   PubMed=24466371;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28192521;
RX   PubMed=28350380;
RX   PubMed=30459281;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=33921066;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SK-N-AS
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-509.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/sk-n-as-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,26:01; B*14:01,40:01; C*03:04,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724828; DepMap=ACH-000260).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.49%; Native American=0%; East Asian, North=2.41%; East Asian, South=0%; South Asian=2.58%; European, North=53.12%; European, South=40.39% (PubMed=30894373).
CC   Misspelling: SK-NA-S; PubMed=15892104.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2137; Cosmic-CLP=724828; ECACC=94092302; PubMed=25877200; PubMed=28192521
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 14
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 32.2,33.2
ST   D2S1338: 17,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SK-N-AS RET KO clone C17
AC   CVCL_C0QD
SY   SK-N-AS C17
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0QD
DR   PRIDE; PXD024551
DR   Wikidata; Q112930400
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SK-N-AS RET KO clone C19
AC   CVCL_C0QE
SY   SK-N-AS C19
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0QE
DR   PRIDE; PXD024551
DR   Wikidata; Q112930401
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SK-N-AS RET KO clone C2
AC   CVCL_C0QA
SY   SK-N-AS C2
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0QA
DR   PRIDE; PXD024551
DR   Wikidata; Q112930402
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SK-N-AS RET KO clone C5
AC   CVCL_C0QB
SY   SK-N-AS C5
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0QB
DR   PRIDE; PXD024551
DR   Wikidata; Q112930403
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SK-N-AS RET KO clone C9
AC   CVCL_C0QC
SY   SK-N-AS C9
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0QC
DR   PRIDE; PXD024551
DR   Wikidata; Q112930404
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SK-N-AS RET overexpressing clone C1
AC   CVCL_C0Q9
SY   SK-N-AS C1
DR   ArrayExpress; E-MTAB-10032
DR   cancercelllines; CVCL_C0Q9
DR   PRIDE; PXD024551
DR   Wikidata; Q112930405
RX   PubMed=33921066;
CC   Population: Caucasian.
CC   Characteristics: Was engineered using CRISPR/Cas9 to be a RET KO cell line, but unexpectedly expresses a high level of RET due to a mutation in intron 1 of the RET gene (PubMed=33921066).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   SK-N-AS THAP1 clone 10
AC   CVCL_E5VB
DR   ABM; T3305
RX   PubMed=32112337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20856; THAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-N-AS THAP1 F81L clone 35
AC   CVCL_E5VC
DR   ABM; T3307
RX   PubMed=32112337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20856; THAP1 (Note=With p.Phe81Leu (c.241T>C)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-N-AS THAP1 L180S clone 8
AC   CVCL_E5VD
DR   ABM; T3308
RX   PubMed=32112337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20856; THAP1 (Note=With p.Leu180Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-N-AS THAP1 S21T clone 9
AC   CVCL_E5VE
DR   ABM; T3306
RX   PubMed=32112337;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:20856; THAP1 (Note=With p.Ser21Thr).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-N-ASrCARBO2000
AC   CVCL_RS87
DR   cancercelllines; CVCL_RS87
DR   Wikidata; Q54954414
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrCDDP1000
AC   CVCL_RS88
DR   cancercelllines; CVCL_RS88
DR   Wikidata; Q54954416
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrCDDP500
AC   CVCL_RS24
DR   cancercelllines; CVCL_RS24
DR   Wikidata; Q54954418
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrDACARB16
AC   CVCL_RS89
DR   cancercelllines; CVCL_RS89
DR   Wikidata; Q54954420
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   SK-N-ASrDOCE10
AC   CVCL_RS90
DR   cancercelllines; CVCL_RS90
DR   Wikidata; Q54954421
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrDOX10
AC   CVCL_RS91
DR   cancercelllines; CVCL_RS91
DR   Wikidata; Q54954423
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrETO100
AC   CVCL_RS92
DR   cancercelllines; CVCL_RS92
DR   Wikidata; Q54954424
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrETO200
AC   CVCL_RS93
DR   cancercelllines; CVCL_RS93
DR   Wikidata; Q54954425
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrGEMCI10
AC   CVCL_RS94
DR   cancercelllines; CVCL_RS94
DR   Wikidata; Q54954427
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrIRINO500
AC   CVCL_RS95
DR   cancercelllines; CVCL_RS95
DR   Wikidata; Q54954428
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrMEL1000
AC   CVCL_RS96
DR   cancercelllines; CVCL_RS96
DR   Wikidata; Q54954429
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrOXALI4000
AC   CVCL_RR29
DR   cancercelllines; CVCL_RR29
DR   Wikidata; Q54954430
RX   PubMed=28192521;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=28192521
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 14
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrOXALI4000(-)
AC   CVCL_RS97
DR   cancercelllines; CVCL_RS97
DR   Wikidata; Q54954432
RX   PubMed=28192521;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrPCL20
AC   CVCL_RS98
DR   cancercelllines; CVCL_RS98
DR   Wikidata; Q54954433
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrTOPO20
AC   CVCL_RS99
DR   cancercelllines; CVCL_RS99
DR   Wikidata; Q54954434
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrVCR20
AC   CVCL_RR31
DR   cancercelllines; CVCL_RR31
DR   Wikidata; Q54954435
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrVINB10
AC   CVCL_RT00
DR   cancercelllines; CVCL_RT00
DR   Wikidata; Q54954437
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-ASrVINOR20
AC   CVCL_RT01
DR   cancercelllines; CVCL_RT01
DR   Wikidata; Q54954438
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SK-N-BE(1)
AC   CVCL_9898
SY   SK-N-Be(1); SKNBE(1); SKNBE-1; SKNBE1
DR   Wikidata; Q54954440
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=29704;
RX   PubMed=2535691;
RX   PubMed=11507071;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SK-N-BE1_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: ~4 days (PubMed=29704); 96 hours (COG).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0528 ! SK-N-BE(2)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   SK-N-BE(1)n
AC   CVCL_A8RV
SY   SKNBE(1)N; SKNBE(1n); SKNBE1n
DR   IARC_TP53; 23829
DR   Wikidata; Q108821307
RX   PubMed=2535691;
RX   PubMed=11196202;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Karyotypic information: 46,XY,del(1)(p32),der(3)t(3;17)(p21;q21),der(4)t(1;4)(q21;q3?5),dmin (PubMed=11196202).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=11196202).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9898 ! SK-N-BE(1)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SK-N-BE(1)s
AC   CVCL_A8RW
DR   Wikidata; Q108821308
RX   PubMed=2535691;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9898 ! SK-N-BE(1)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SK-N-BE(2)
AC   CVCL_0528
SY   SK-N-BE2; SK-N-BE-2; SKNBE(2); SKNBE-2; SKNBE2; SK-N-BE; SKNBE
DR   BTO; BTO_0002696
DR   CLO; CLO_0009052
DR   EFO; EFO_0022401
DR   MCCL; MCC:0000505
DR   CLDB; cl4332
DR   CLDB; cl4333
DR   Abcam; ab275476
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2271
DR   BCRJ; 0381
DR   BioGRID_ORCS_Cell_line; 375
DR   BioSample; SAMN03472880
DR   BioSample; SAMN03473451
DR   BioSample; SAMN10988136
DR   cancercelllines; CVCL_0528
DR   CancerTools; 161921
DR   CCRID; 3101HUMTCHu200
DR   Cell_Model_Passport; SIDM00894
DR   CLS; 305058
DR   Cosmic; 1019928
DR   Cosmic; 2485941
DR   DepMap; ACH-000312
DR   DSMZ; ACC-632
DR   DSMZCellDive; ACC-632
DR   ECACC; 95011815
DR   GEO; GSM554389
DR   GEO; GSM563358
DR   GEO; GSM692869
DR   GEO; GSM827352
DR   GEO; GSM887593
DR   GEO; GSM888676
DR   GEO; GSM1366411
DR   GEO; GSM1670450
DR   GEO; GSM2371255
DR   GEO; GSM2394375
DR   IARC_TP53; 30154
DR   ICLC; HTL96015
DR   KCB; KCB 2011099YJ
DR   LiGeA; CCLE_929
DR   LINCS_LDP; LCL-1980
DR   MetaboLights; MTBLS104
DR   PharmacoDB; SKNBE_2_1405_2019
DR   PRIDE; PXD002635
DR   Progenetix; CVCL_0528
DR   Wikidata; Q54954442
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=29704;
RX   PubMed=62055;
RX   PubMed=2535691;
RX   PubMed=6582512;
RX   PubMed=7838528;
RX   PubMed=11507071;
RX   PubMed=11550280;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=20215515;
RX   PubMed=20631050;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=24792489;
RX   PubMed=25877200;
RX   PubMed=25884760;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-565.html
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SK-N-BE2_Cell_Line_Data_Sheet_COGcell_org.pdf
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-human-neuroblastoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-530.
CC   Population: Caucasian.
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=15720811).
CC   Doubling time: 27 hours (PubMed=29704); ~36 hours (DSMZ=ACC-632).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from child cell line SK-N-BE(2)-C).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (PubMed=11507071; DepMap=ACH-000312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.71%; Native American=0.88%; East Asian, North=1.41%; East Asian, South=0%; South Asian=7.87%; European, North=24.66%; European, South=63.46% (PubMed=30894373).
CC   Discontinued: Abcam; ab275476; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2271; CCRID=3101HUMTCHu200; COG; DSMZ=ACC-632; PubMed=25877200
ST   Amelogenin: X (DSMZ=ACC-632)
ST   Amelogenin: X,Y (ATCC=CRL-2271; CCRID=3101HUMTCHu200; COG; PubMed=25877200)
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14 (DSMZ=ACC-632)
ST   D18S51: 14,16 (ATCC=CRL-2271; CCRID=3101HUMTCHu200; PubMed=25877200)
ST   D18S51: 16 (COG)
ST   D19S433: 12,13
ST   D21S11: 30,31,32.2 (ATCC=CRL-2271; CCRID=3101HUMTCHu200; PubMed=25877200)
ST   D21S11: 30,32.2 (COG; DSMZ=ACC-632)
ST   D2S1338: 17,23
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 13,14
ST   Penta E: 14,18
ST   TH01: 6 (DSMZ=ACC-632)
ST   TH01: 6,7 (ATCC=CRL-2271; CCRID=3101HUMTCHu200; COG; PubMed=25877200)
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9898 ! SK-N-BE(1)
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SK-N-BE(2)-C
AC   CVCL_0529
SY   SK-N-BE(2)C; SK-N-BE-2c; SK-N-BE2(c); SK-N-BE(2C); SK-N-BE(2c); SK-N-BE2C; SK_N_BE2C; SKNBE2C; SKNBE(2c); BE(2)-C; BE(2)C; Be(2)C; BE2-C; BE2_C; Be2-C; BE2C; Be2C
DR   BTO; BTO_0004782
DR   CLO; CLO_0001915
DR   CLO; CLO_0009053
DR   EFO; EFO_0005725
DR   MCCL; MCC:0000428
DR   CLDB; cl413
DR   CLDB; cl4334
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-2268
DR   BioSample; SAMN03471855
DR   cancercelllines; CVCL_0529
DR   CancerTools; 161922
DR   Cell_Model_Passport; SIDM01232
DR   ChEMBL-Cells; CHEMBL4482984
DR   ChEMBL-Targets; CHEMBL4483229
DR   Cosmic; 688061
DR   Cosmic; 922659
DR   Cosmic; 1162003
DR   Cosmic; 1167421
DR   Cosmic; 1526648
DR   ECACC; 95011817
DR   ENCODE; ENCBS271SFD
DR   ENCODE; ENCBS403ENC
DR   ENCODE; ENCBS427ENC
DR   ENCODE; ENCBS982TUR
DR   GEO; GSM651567
DR   GEO; GSM651568
DR   GEO; GSM923434
DR   GEO; GSM945241
DR   GEO; GSM945283
DR   GEO; GSM1022648
DR   GEO; GSM1022650
DR   GEO; GSM1022653
DR   GEO; GSM2371256
DR   GEO; GSM2394383
DR   GEO; GSM3145614
DR   GEO; GSM3145690
DR   GEO; GSM4104593
DR   GEO; GSM4104594
DR   GEO; GSM4105343
DR   GEO; GSM4105344
DR   GEO; GSM4105345
DR   GEO; GSM4105346
DR   GEO; GSM4105347
DR   IARC_TP53; 15544
DR   ICLC; HTL96018
DR   IGRhCellID; BE2C
DR   LINCS_LDP; LCL-1963
DR   NCBI_Iran; C577
DR   PRIDE; PXD003596
DR   Progenetix; CVCL_0529
DR   PubChem_Cell_line; CVCL_0529
DR   Wikidata; Q54954443
RX   PubMed=1985865;
RX   PubMed=2535691;
RX   PubMed=6582512;
RX   PubMed=8665486;
RX   PubMed=10630978;
RX   PubMed=11196202;
RX   PubMed=15150552;
RX   PubMed=15390183;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=18724359;
RX   PubMed=19147553;
RX   PubMed=20215515;
RX   PubMed=23202128;
RX   PubMed=23325432;
RX   PubMed=24466371;
RX   PubMed=26342562;
RX   PubMed=28350380;
RX   PubMed=33525507;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/BE2-C_Myers_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/b/cell-lines-detail-162.html
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-c-human-neuroblastoma-cell-line
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-532.
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   Characteristics: MYCN-amplified NBL cell line.
CC   Doubling time: ~18 hours (ATCC=CRL-2268).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=11196202).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (PubMed=11196202).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2268; ECACC=95011817
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 23
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 13,14
ST   Penta E: 14,18
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0528 ! SK-N-BE(2)
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   SK-N-BE(2)-M17
AC   CVCL_0167
SY   BE(2)-M17; BE(2)M17; BE(2)M-17; BE2-M17; BE2M17
DR   BTO; BTO_0002104
DR   CLO; CLO_0001916
DR   MCCL; MCC:0000059
DR   CLDB; cl407
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2267
DR   BioGRID_ORCS_Cell_line; 833
DR   BioSample; SAMN03471024
DR   BioSample; SAMN03472366
DR   cancercelllines; CVCL_0167
DR   CCRID; 1101HUM-PUMC000076
DR   Cell_Model_Passport; SIDM01229
DR   ChEMBL-Cells; CHEMBL4295394
DR   ChEMBL-Targets; CHEMBL4296494
DR   Cosmic; 753616
DR   Cosmic; 1167416
DR   Cosmic-CLP; 753616
DR   DepMap; ACH-002217
DR   ECACC; 95011816
DR   EGA; EGAS00001000978
DR   GDSC; 753616
DR   GEO; GSM1669614
DR   JCRB; JCRB9131
DR   JCRB; NIHS0221
DR   LINCS_LDP; LCL-1972
DR   Lonza; 1236
DR   NCBI_Iran; C614
DR   PharmacoDB; BE2M17_85_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_0167
DR   Wikidata; Q54954446
RX   PubMed=2535691;
RX   PubMed=10485488;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=17506115;
RX   PubMed=25877200;
RX   PubMed=26342562;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-be-2-m17-human-neuroblastoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-531.
CC   Population: Caucasian.
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Doubling time: 20-24 hours (ECACC=95011816).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (Cosmic-CLP=753616).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=3.92%; Native American=1.22%; East Asian, North=3.24%; East Asian, South=0%; South Asian=6.24%; European, North=21.38%; European, South=64% (PubMed=30894373).
CC   Discontinued: JCRB; JCRB9131; true.
CC   Discontinued: JCRB; NIHS0221; true.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2267; CCRID=1101HUM-PUMC000076; Cosmic-CLP=753616; ECACC=95011816; JCRB=JCRB9131; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,11 (CCRID=1101HUM-PUMC000076)
ST   D16S539: 11 (ATCC=CRL-2267; Cosmic-CLP=753616; ECACC=95011816; JCRB=JCRB9131; PubMed=25877200)
ST   D18S51: 14 (ATCC=CRL-2267; PubMed=25877200)
ST   D18S51: 16,26 (CCRID=1101HUM-PUMC000076)
ST   D19S433: 12,13
ST   D21S11: 30,32.2
ST   D2S1338: 17,23 (ATCC=CRL-2267; PubMed=25877200)
ST   D2S1338: 23 (CCRID=1101HUM-PUMC000076)
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 13,14
ST   Penta E: 14,18
ST   TH01: 6
ST   TPOX: 8,11 (ATCC=CRL-2267; Cosmic-CLP=753616; ECACC=95011816; JCRB=JCRB9131; PubMed=25877200)
ST   TPOX: 11 (CCRID=1101HUM-PUMC000076)
ST   vWA: 17,18 (Cosmic-CLP=753616; JCRB=JCRB9131)
ST   vWA: 18 (ATCC=CRL-2267; CCRID=1101HUM-PUMC000076; ECACC=95011816; PubMed=25877200)
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0528 ! SK-N-BE(2)
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SK-N-DZ
AC   CVCL_1701
SY   SKNDZ
DR   BTO; BTO_0004217
DR   CLO; CLO_0009054
DR   EFO; EFO_0005721
DR   CLDB; cl4335
DR   4DN; 4DNSRPJISWJY
DR   AddexBio; C0005020/5011
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2149
DR   BioGRID_ORCS_Cell_line; 463
DR   BioSample; SAMN03473093
DR   BioSample; SAMN10988189
DR   cancercelllines; CVCL_1701
DR   Cell_Model_Passport; SIDM01100
DR   CGH-DB; 77-1
DR   CGH-DB; 9094-4
DR   ChEMBL-Cells; CHEMBL3308474
DR   ChEMBL-Targets; CHEMBL1075579
DR   Cosmic; 688086
DR   Cosmic; 897447
DR   Cosmic; 930076
DR   Cosmic; 1019931
DR   Cosmic; 1109370
DR   Cosmic; 1162004
DR   Cosmic; 1167415
DR   Cosmic; 2058115
DR   Cosmic; 2485951
DR   Cosmic-CLP; 688086
DR   DepMap; ACH-000366
DR   ECACC; 94092305
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS373BOT
DR   ENCODE; ENCBS439FDS
DR   ENCODE; ENCBS478IFE
DR   ENCODE; ENCBS514GVM
DR   ENCODE; ENCBS520AAA
DR   ENCODE; ENCBS521AAA
DR   ENCODE; ENCBS580YYW
DR   ENCODE; ENCBS707BMT
DR   ENCODE; ENCBS715HTH
DR   ENCODE; ENCBS773LCT
DR   ENCODE; ENCBS893THB
DR   GDSC; 688086
DR   GEO; GSM887594
DR   GEO; GSM888677
DR   GEO; GSM1366412
DR   GEO; GSM1670451
DR   GEO; GSM2371257
DR   GEO; GSM2394372
DR   IARC_TP53; 27242
DR   IGRhCellID; SKNDZ
DR   LiGeA; CCLE_236
DR   LINCS_LDP; LCL-1970
DR   Lonza; 1190
DR   PharmacoDB; SKNDZ_1406_2019
DR   PRIDE; PXD010745
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1701
DR   PubChem_Cell_line; CVCL_1701
DR   Wikidata; Q54954471
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.1159/000407025;
RX   PubMed=2987426;
RX   PubMed=6610792;
RX   PubMed=12702577;
RX   PubMed=16822308;
RX   PubMed=18082704;
RX   PubMed=18724359;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian and Native North American.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (Cosmic-CLP=688086; DepMap=ACH-000366).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.63%; Native American=20.53%; East Asian, North=2.39%; East Asian, South=0%; South Asian=0.6%; European, North=47.7%; European, South=27.16% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): AddexBio=C0005020/5011; ATCC=CRL-2149; Cosmic-CLP=688086; ECACC=94092305; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 14.2,16
ST   D21S11: 29,31
ST   D2S1338: 21,22,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 12,13
ST   FGA: 18,22
ST   Penta D: 9,14
ST   Penta E: 7,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SK-N-ER
AC   CVCL_WH10
DR   Wikidata; Q98132659
RX   PubMed=10485488;
RX   PubMed=15720811;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   SK-N-FI
AC   CVCL_1702
SY   SK_N_FI; SKNFI; SK-N-F1; SKNF1
DR   BTO; BTO_0004218
DR   CLO; CLO_0009056
DR   CLO; CLO_0009057
DR   EFO; EFO_0002338
DR   CLDB; cl4336
DR   CLDB; cl4337
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2142
DR   BioGRID_ORCS_Cell_line; 374
DR   BioSample; SAMN03473095
DR   BioSample; SAMN10987939
DR   cancercelllines; CVCL_1702
DR   Cell_Model_Passport; SIDM01099
DR   ChEMBL-Cells; CHEMBL3308278
DR   ChEMBL-Targets; CHEMBL2366120
DR   Cosmic; 688087
DR   Cosmic; 930077
DR   Cosmic; 965555
DR   Cosmic; 1019946
DR   Cosmic; 1109102
DR   Cosmic; 1162005
DR   Cosmic; 1212540
DR   Cosmic; 1518064
DR   Cosmic; 1526649
DR   Cosmic; 1543769
DR   Cosmic; 2058111
DR   Cosmic; 2393644
DR   Cosmic-CLP; 688087
DR   DepMap; ACH-000341
DR   ECACC; 94092304
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 688087
DR   GEO; GSM393037
DR   GEO; GSM692854
DR   GEO; GSM827414
DR   GEO; GSM887595
DR   GEO; GSM888678
DR   GEO; GSM1670453
DR   GEO; GSM2371258
DR   GEO; GSM2394387
DR   GEO; GSM4104595
DR   GEO; GSM4104596
DR   GEO; GSM4105348
DR   GEO; GSM4105349
DR   GEO; GSM4105350
DR   GEO; GSM4105351
DR   GEO; GSM4105352
DR   IARC_TP53; 27244
DR   ICLC; HTL97020
DR   IGRhCellID; SKNFI
DR   IGRhCellID; SKNFI%20GEO
DR   LiGeA; CCLE_677
DR   LINCS_LDP; LCL-1981
DR   Lonza; 1196
DR   PharmacoDB; SKNFI_1407_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1702
DR   PubChem_Cell_line; CVCL_1702
DR   Wikidata; Q54954472
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.1159/000407025;
RX   PubMed=2987426;
RX   PubMed=6610792;
RX   PubMed=7838528;
RX   PubMed=11550280;
RX   PubMed=15150091;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=23202128;
RX   PubMed=24792489;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31631027;
RX   PubMed=35839778;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SK-N-FI_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,23:01; B*08:01,44:02; C*04:01,07:01; DQA1*01:02,04:01; DQB1*02:01,03:04; DRB1*01:02,13:67 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Partial deletion; Zygosity=Homozygous (PubMed=20655465).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Arg (c.737T>G); ClinVar=VCV000127822; Zygosity=Homozygous (Cosmic-CLP=688087; DepMap=ACH-000341).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=24.58%; Native American=8.08%; East Asian, North=2.3%; East Asian, South=0.57%; South Asian=1.35%; European, North=35.17%; European, South=27.95% (PubMed=30894373).
CC   Misspelling: SN-N-FI; Cosmic=2393644.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2142; COG; Cosmic-CLP=688087; ECACC=94092304; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 12
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 16,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 11,12
ST   FGA: 22
ST   Penta D: 2.2,13
ST   Penta E: 11,20
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SK-N-FI ACE KO
AC   CVCL_C7SN
DR   Wikidata; Q117704872
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2707; ACE.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Unexplicit; Partial deletion; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Arg (c.737T>G); ClinVar=VCV000127822; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1702 ! SK-N-FI
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   SK-N-HM
AC   CVCL_WH11
DR   Wikidata; Q98132660
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   SK-N-JD
AC   CVCL_WH12
DR   Wikidata; Q98132661
RX   PubMed=9815755;
RX   PubMed=15720811;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SK-N-LE
AC   CVCL_5G80
DR   Wikidata; Q54954475
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2987426;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   SK-N-LO
AC   CVCL_4569
SY   SK-N-L0; SKN-LO; SKNLO
DR   BTO; BTO_0004787
DR   cancercelllines; CVCL_4569
DR   CLS; 300400
DR   Cosmic; 1078368
DR   Cosmic; 1212539
DR   GEO; GSM393039
DR   IGRhCellID; SKNLO%20GEO
DR   Progenetix; CVCL_4569
DR   Wikidata; Q54954476
RX   DOI=10.1159/000407025;
RX   PubMed=2987426;
RX   PubMed=6610792;
RX   PubMed=7591257;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=7591257).
CC   Caution: It is not certain if this is a neuroblastoma cell line as indicated by CLS or an Ewing sarcoma cell line as indicated in PubMed=7591257.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): CLS=300400; COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 16,20
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 20,25 (COG)
ST   FGA: 25 (CLS=300400)
ST   Penta D: 9,13
ST   Penta E: 7
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 24
//
ID   SK-N-LP
AC   CVCL_WH13
DR   Wikidata; Q98132663
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Characteristics: Intermediate type (I-type) (PubMed=15720811).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   SK-N-MC
AC   CVCL_0530
SY   SKNMC; SK-NM-C; SK-NMC
DR   BTO; BTO_0002914
DR   CLO; CLO_0009058
DR   EFO; EFO_0002860
DR   MCCL; MCC:0000429
DR   CLDB; cl4338
DR   CLDB; cl4339
DR   CLDB; cl4340
DR   CLDB; cl4341
DR   CLDB; cl4342
DR   CLDB; cl4343
DR   4DN; 4DNSRW6BI5JA
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-10
DR   BioGRID_ORCS_Cell_line; 462
DR   BioSample; SAMN01821666
DR   BioSample; SAMN03151999
DR   BioSample; SAMN10987896
DR   cancercelllines; CVCL_0530
DR   CancerTools; 161936
DR   CCRID; 1101HUM-PUMC000263
DR   CCRID; 3101HUMTCHu50
DR   Cell_Model_Passport; SIDM00634
DR   ChEMBL-Cells; CHEMBL3307551
DR   ChEMBL-Targets; CHEMBL614163
DR   CLS; 300340
DR   Cosmic; 753613
DR   Cosmic; 897448
DR   Cosmic; 922655
DR   Cosmic; 1078367
DR   Cosmic; 1078391
DR   Cosmic; 1082511
DR   Cosmic; 1084314
DR   Cosmic; 2228233
DR   Cosmic; 2250468
DR   Cosmic; 2301579
DR   DepMap; ACH-000039
DR   DSMZ; ACC-203
DR   DSMZCellDive; ACC-203
DR   ECACC; 90022302
DR   ENCODE; ENCBS203EZT
DR   ENCODE; ENCBS255ORK
DR   ENCODE; ENCBS273LIC
DR   ENCODE; ENCBS357PJT
DR   ENCODE; ENCBS366AET
DR   ENCODE; ENCBS387QLW
DR   ENCODE; ENCBS400ENC
DR   ENCODE; ENCBS423QPB
DR   ENCODE; ENCBS426ENC
DR   ENCODE; ENCBS556HGY
DR   ENCODE; ENCBS734TWP
DR   FANTOM5_SSTAR; 10728-110A8
DR   GEO; GSM393038
DR   GEO; GSM510009
DR   GEO; GSM824868
DR   GEO; GSM824869
DR   GEO; GSM887596
DR   GEO; GSM888679
DR   GEO; GSM945247
DR   GEO; GSM945264
DR   GEO; GSM1022638
DR   GEO; GSM1676318
DR   GEO; GSM1701651
DR   GEO; GSM5359700
DR   GEO; GSM5359701
DR   GEO; GSM5359702
DR   GEO; GSM5359703
DR   GEO; GSM5359704
DR   GEO; GSM5359705
DR   GEO; GSM5362882
DR   GEO; GSM5362883
DR   GEO; GSM5362890
DR   GEO; GSM5362891
DR   GEO; GSM5362898
DR   GEO; GSM5362899
DR   GEO; GSM5364006
DR   GEO; GSM5364007
DR   GEO; GSM5364008
DR   GEO; GSM5364009
DR   GEO; GSM5364010
DR   IARC_TP53; 23586
DR   IGRhCellID; SKNMC%20GEO
DR   IZSLER; BS TCL 93
DR   KCB; KCB 2012033YJ
DR   KCLB; 30010
DR   LiGeA; CCLE_596
DR   Lonza; 82
DR   NCBI_Iran; C535
DR   PharmacoDB; SKNMC_1408_2019
DR   Progenetix; CVCL_0530
DR   PubChem_Cell_line; CVCL_0530
DR   TOKU-E; 3148
DR   Wikidata; Q54954478
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.5282/edoc.27750;
RX   PubMed=29704;
RX   PubMed=62055;
RX   PubMed=327080;
RX   PubMed=856461;
RX   PubMed=2784858;
RX   PubMed=2987426;
RX   PubMed=3518877;
RX   PubMed=4748425;
RX   PubMed=6582512;
RX   PubMed=7037175;
RX   PubMed=7459858;
RX   PubMed=7591257;
RX   PubMed=8040301;
RX   PubMed=8378080;
RX   PubMed=8570170;
RX   PubMed=8617485;
RX   PubMed=8665486;
RX   PubMed=9121763;
RX   PubMed=11668190;
RX   PubMed=15390183;
RX   PubMed=18160777;
RX   PubMed=19787792;
RX   PubMed=20143388;
RX   PubMed=21822310;
RX   PubMed=22460905;
RX   PubMed=23325432;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=25223734;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=26589293;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=36476851;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/SK-N-MC_protocol.pdf
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-97.html
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-human-neuroblastoma-cell-line
CC   Problematic cell line: Misclassified. Originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor (PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00267.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 776.
CC   Population: Caucasian.
CC   Doubling time: 32 hours (PubMed=4748425); 23 +- 5 hours (PubMed=856461); 23 hours (PubMed=24312454); ~32 hours (CLS=300340); ~48 hours (DSMZ=ACC-203).
CC   HLA typing: A*01:01,25:01; B*08:01,08:01; C*07:01,07:01; DQA1*05:02,05:02; DQB1*02:02,05:01; DRB1*03:38,12:27 (PubMed=26589293).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=7591257; PubMed=8040301; PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (PubMed=19787792; PubMed=26428435).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.84%; Native American=0%; East Asian, North=0.61%; East Asian, South=0%; South Asian=0.27%; European, North=67.85%; European, South=29.43% (PubMed=30894373).
CC   Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088.
ST   Source(s): ATCC=HTB-10; CCRID; CLS=300340; COG; DSMZ=ACC-203; KCLB=30010; PubMed=19787792; PubMed=24312454; PubMed=25010205; PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13,14 (ATCC=HTB-10; CCRID; CLS=300340; DSMZ=ACC-203; PubMed=24312454; PubMed=25010205)
ST   D18S51: 14 (PubMed=19787792)
ST   D19S433: 13,15.2 (ATCC=HTB-10; CCRID; PubMed=19787792; PubMed=24312454; PubMed=25010205)
ST   D19S433: 13,16 (DSMZ=ACC-203)
ST   D21S11: 30,31.2 (ATCC=HTB-10; CLS=300340; COG; DSMZ=ACC-203; PubMed=19787792; PubMed=24312454; PubMed=25010205)
ST   D21S11: 30,31.2,32.2 (CCRID)
ST   D2S1338: 17,21
ST   D3S1358: 15 (ATCC=HTB-10; CLS=300340; KCLB=30010; PubMed=19787792; PubMed=30879952)
ST   D3S1358: 15,16 (CCRID; DSMZ=ACC-203; PubMed=24312454; PubMed=25010205)
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 10
ST   FGA: 21,25
ST   Penta D: 8,9,13 (DSMZ=ACC-203)
ST   Penta D: 9,13 (ATCC=HTB-10; CLS=300340)
ST   Penta E: 16,18
ST   SE33: 16
ST   TH01: 9.3
ST   TPOX: 9,11 (ATCC=HTB-10; CCRID; CLS=300340; COG; DSMZ=ACC-203; KCLB=30010; PubMed=24312454; PubMed=25010205; PubMed=30879952)
ST   TPOX: 11 (PubMed=19787792)
ST   vWA: 17,18
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 47
//
ID   SK-N-MC-IXC
AC   CVCL_1398
SY   MC-IXC; MCIXC
DR   BTO; BTO_0005372
DR   CLO; CLO_0007615
DR   EFO; EFO_0002230
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-2270
DR   BioGRID_ORCS_Cell_line; 939
DR   BioSample; SAMN03472918
DR   cancercelllines; CVCL_1398
DR   Cell_Model_Passport; SIDM01246
DR   ChEMBL-Cells; CHEMBL3308758
DR   ChEMBL-Targets; CHEMBL1075495
DR   Cosmic; 688068
DR   Cosmic; 908118
DR   Cosmic-CLP; 908118
DR   DepMap; ACH-002160
DR   GDSC; 908118
DR   GEO; GSM1670077
DR   IGRhCellID; MCIXC
DR   LINCS_LDP; LCL-1967
DR   PharmacoDB; MCIXC_886_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1398
DR   PubChem_Cell_line; CVCL_1398
DR   TOKU-E; 4055
DR   Wikidata; Q54954480
RX   PubMed=4748425;
RX   PubMed=15892104;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-n-mc-ixc-human-neuroblastoma-cell-line
CC   Problematic cell line: Misclassified. Parent cell line (SK-N-MC) was originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-067.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=0%; European, North=74.37%; European, South=25.63% (PubMed=30894373).
CC   Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088.
ST   Source(s): ATCC=CRL-2270; Cosmic-CLP=908118; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13,14,15
ST   D19S433: 13,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 10
ST   FGA: 21,25
ST   Penta D: 9,13
ST   Penta E: 16,18
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0530 ! SK-N-MC
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   SK-N-MC-IXC/VCR
AC   CVCL_B0FD
SY   MC-IXC/VCR
DR   Wikidata; Q108821309
RX   PubMed=2566379;
CC   Problematic cell line: Misclassified. Grand-parent cell line (SK-N-MC) was originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1398 ! SK-N-MC-IXC
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   SK-N-MM
AC   CVCL_C8G1
SY   SKNMM
DR   DepMap; ACH-002922
DR   Wikidata; Q123033507
RX   PubMed=9815755;
RX   PubMed=31631027;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Lys1367Ter (c.4099A>T); Zygosity=Heterozygous (PubMed=31631027; DepMap=ACH-002922).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Unexplicit; Ex1-11del; Zygosity=Heterozygous (PubMed=31631027).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Homozygous (DepMap=ACH-002922).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   SK-N-PI
AC   CVCL_S664
SY   SK-N-P1
DR   cancercelllines; CVCL_S664
DR   Cosmic; 1078366
DR   GEO; GSM393036
DR   IGRhCellID; SKNPI%20GEO
DR   Progenetix; CVCL_S664
DR   Wikidata; Q54954481
RX   PubMed=7591257;
CC   Miscellaneous: Only mentioned as a Ewing sarcoma cell line in PubMed=7591257.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 11
//
ID   SK-N-RA
AC   CVCL_AQ53
DR   IARC_TP53; 23823
DR   Wikidata; Q54954483
RX   DOI=10.1159/000407025;
RX   PubMed=11507071;
RX   PubMed=24792489;
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the SK-N-AS cell line. Originally thought to originate from a neuroblastoma but the sex and age of the patient has not been reported.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 14
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 32.2,33.2
ST   D2S1338: 17,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1700 ! SK-N-AS
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 11
//
ID   SK-N-SH
AC   CVCL_0531
SY   SK N SH; SKN-SH; SK-NSH; SKNSH; NSH
DR   BTO; BTO_0001620
DR   CLO; CLO_0009059
DR   CLO; CLO_0050268
DR   EFO; EFO_0003072
DR   MCCL; MCC:0000430
DR   CLDB; cl4345
DR   CLDB; cl4347
DR   CLDB; cl4348
DR   CLDB; cl4349
DR   CLDB; cl4351
DR   CLDB; cl4352
DR   AddexBio; C0005006/4924
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-11
DR   BioGRID_ORCS_Cell_line; 1014
DR   BioSample; SAMN01821600
DR   BioSample; SAMN03472879
DR   BioSample; SAMN10987849
DR   cancercelllines; CVCL_0531
DR   CancerTools; 161937
DR   CCRID; 1101HUM-PUMC000086
DR   CCRID; 3101HUMSCSP5029
DR   CCRID; 3101HUMTCHu51
DR   CCRID; 4201HUM-CCTCC00047
DR   CCTCC; GDC0047
DR   Cell_Model_Passport; SIDM01098
DR   CGH-DB; 62-1
DR   CGH-DB; 9093-4
DR   ChEMBL-Cells; CHEMBL3307745
DR   ChEMBL-Targets; CHEMBL614924
DR   CLS; 305028
DR   Cosmic; 697284
DR   Cosmic; 717431
DR   Cosmic; 801743
DR   Cosmic; 848936
DR   Cosmic; 922656
DR   Cosmic; 923830
DR   Cosmic; 930078
DR   Cosmic; 947706
DR   Cosmic; 1019929
DR   Cosmic; 1037355
DR   Cosmic; 1078393
DR   Cosmic; 1082519
DR   Cosmic; 1099151
DR   Cosmic; 1109108
DR   Cosmic; 1109371
DR   Cosmic; 1153800
DR   Cosmic; 1153806
DR   Cosmic; 1162006
DR   Cosmic; 1167420
DR   Cosmic; 1167993
DR   Cosmic; 1518079
DR   Cosmic; 1526640
DR   Cosmic; 2058116
DR   Cosmic; 2131595
DR   Cosmic; 2239469
DR   Cosmic; 2393645
DR   Cosmic; 2485952
DR   Cosmic-CLP; 717431
DR   DepMap; ACH-000149
DR   ECACC; 86012802
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS007RAH
DR   ENCODE; ENCBS018DDZ
DR   ENCODE; ENCBS061YYT
DR   ENCODE; ENCBS324TZB
DR   ENCODE; ENCBS360ENC
DR   ENCODE; ENCBS361ENC
DR   ENCODE; ENCBS362ENC
DR   ENCODE; ENCBS363ENC
DR   ENCODE; ENCBS364ENC
DR   ENCODE; ENCBS365ENC
DR   ENCODE; ENCBS376ENC
DR   ENCODE; ENCBS387WHS
DR   ENCODE; ENCBS428ENC
DR   ENCODE; ENCBS433ENC
DR   ENCODE; ENCBS434ENC
DR   ENCODE; ENCBS435ENC
DR   ENCODE; ENCBS436ENC
DR   ENCODE; ENCBS437ENC
DR   ENCODE; ENCBS438ENC
DR   ENCODE; ENCBS439KOM
DR   ENCODE; ENCBS489AAA
DR   ENCODE; ENCBS490AAA
DR   ENCODE; ENCBS491AAA
DR   ENCODE; ENCBS492AAA
DR   ENCODE; ENCBS495AAA
DR   ENCODE; ENCBS500EWH
DR   ENCODE; ENCBS526AQV
DR   ENCODE; ENCBS592MTQ
DR   GDSC; 717431
DR   GEO; GSM231674
DR   GEO; GSM231675
DR   GEO; GSM231676
DR   GEO; GSM231677
DR   GEO; GSM231678
DR   GEO; GSM231679
DR   GEO; GSM231680
DR   GEO; GSM231681
DR   GEO; GSM231682
DR   GEO; GSM231683
DR   GEO; GSM231684
DR   GEO; GSM231685
DR   GEO; GSM231686
DR   GEO; GSM231687
DR   GEO; GSM231688
DR   GEO; GSM231689
DR   GEO; GSM231690
DR   GEO; GSM231691
DR   GEO; GSM231692
DR   GEO; GSM231693
DR   GEO; GSM314027
DR   GEO; GSM333814
DR   GEO; GSM563357
DR   GEO; GSM692864
DR   GEO; GSM803335
DR   GEO; GSM887597
DR   GEO; GSM888680
DR   GEO; GSM923419
DR   GEO; GSM923441
DR   GEO; GSM1003626
DR   GEO; GSM1003627
DR   GEO; GSM1003628
DR   GEO; GSM1003629
DR   GEO; GSM1003630
DR   GEO; GSM1003631
DR   GEO; GSM1003632
DR   GEO; GSM1003633
DR   GEO; GSM1008585
DR   GEO; GSM1010735
DR   GEO; GSM1010738
DR   GEO; GSM1010739
DR   GEO; GSM1010750
DR   GEO; GSM1010751
DR   GEO; GSM1010763
DR   GEO; GSM1010767
DR   GEO; GSM1010773
DR   GEO; GSM1010799
DR   GEO; GSM1010806
DR   GEO; GSM1010816
DR   GEO; GSM1010817
DR   GEO; GSM1010834
DR   GEO; GSM1010835
DR   GEO; GSM1010840
DR   GEO; GSM1010858
DR   GEO; GSM1010880
DR   GEO; GSM1010887
DR   GEO; GSM1010897
DR   GEO; GSM1010900
DR   GEO; GSM1010901
DR   GEO; GSM1622296
DR   GEO; GSM1670454
DR   GEO; GSM2371259
DR   GEO; GSM2394365
DR   GEO; GSM2824362
DR   GEO; GSM2824363
DR   GEO; GSM4104597
DR   GEO; GSM4104598
DR   GEO; GSM4104637
DR   GEO; GSM4104638
DR   IARC_TP53; 23584
DR   ICLC; HTL96019
DR   IZSLER; BS TCL 143
DR   KCB; KCB 200426YJ
DR   KCLB; 30011
DR   LINCS_LDP; LCL-1971
DR   Lonza; 80
DR   PharmacoDB; SKNSH_1409_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0531
DR   PubChem_Cell_line; CVCL_0531
DR   RCB; RCB0426
DR   TOKU-E; 3149
DR   Ubigene; YC-C027
DR   Wikidata; Q28308636
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.1159/000407025;
RX   PubMed=29704;
RX   PubMed=62055;
RX   PubMed=833871;
RX   PubMed=856461;
RX   PubMed=922665;
RX   PubMed=1354203;
RX   PubMed=2535691;
RX   PubMed=2846152;
RX   PubMed=2987426;
RX   PubMed=3518877;
RX   PubMed=4748425;
RX   PubMed=6304521;
RX   PubMed=6582512;
RX   PubMed=6610792;
RX   PubMed=6888561;
RX   PubMed=6935474;
RX   PubMed=7037175;
RX   PubMed=7838528;
RX   PubMed=8040301;
RX   PubMed=8069455;
RX   PubMed=8490657;
RX   PubMed=8617485;
RX   PubMed=8665486;
RX   PubMed=10074188;
RX   PubMed=10630978;
RX   PubMed=11550280;
RX   PubMed=12702577;
RX   PubMed=15390183;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=18923523;
RX   PubMed=18923524;
RX   PubMed=18957096;
RX   PubMed=22213050;
RX   PubMed=22460905;
RX   PubMed=23325432;
RX   PubMed=24466371;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28350380;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/SK-N-SH_Myers_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-398.html
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-neuroblastoma-cell-line-sk-n-sh
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-529.
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=4748425); 36 +- 8 hours (PubMed=856461).
CC   HLA typing: A*01:01,24:02; B*18:01,49:01; C*07:06,07:06 (PubMed=25960936).
CC   HLA typing: A*01:01,24:02; B*18:01,49:01; C*07:06,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18724359; PubMed=18923523; PubMed=28350380; Cosmic-CLP=717431; DepMap=ACH-000149).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=717431; DepMap=ACH-000149).
CC   Omics: Genomics; ChIP-seq.
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0.07%; East Asian, North=1.63%; East Asian, South=0%; South Asian=0%; European, North=66.77%; European, South=31.16% (PubMed=30894373).
CC   Anecdotal: One of the 3 cell lines (HT-1080, RD and SK-N-SH) where the NRAS oncogene was first identified (PubMed=6304521).
CC   Misspelling: SK-N-CH; Note=Occasionally.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): AddexBio=C0005006/4924; ATCC=HTB-11; CCRID; Cosmic-CLP=717431; ECACC=86012802; KCLB=30011; PubMed=25877200; RCB=RCB0426; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 14
ST   D12S391: 18,22
ST   D13S317: 11
ST   D16S539: 8,13
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D1S1656: 12
ST   D21S11: 31,31.2
ST   D22S1045: 16,17
ST   D2S1338: 17,19
ST   D2S441: 11,11.3
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 7,10
ST   D8S1179: 15
ST   FGA: 23.2,24
ST   Penta D: 10,12
ST   Penta E: 7,11
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   SK-N-SH D
AC   CVCL_B0GN
SY   SK-N-SHD
DR   cancercelllines; CVCL_B0GN
DR   Wikidata; Q108821310
RX   Patent=US10591466;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-5010.
CC   Population: Caucasian.
CC   Characteristics: Can naturally differentiate as neuron-like cells (Patent=US10591466).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   SK-N-SH-RA
AC   CVCL_D044
SY   SK-N-SH_RA; SK-N-SH Retinoic acid
DR   CLO; CLO_0037234
DR   EFO; EFO_0002802
DR   cancercelllines; CVCL_D044
DR   ENCODE; ENCBS172JMM
DR   ENCODE; ENCBS366ENC
DR   ENCODE; ENCBS367ENC
DR   ENCODE; ENCBS404ENC
DR   ENCODE; ENCBS606NNZ
DR   ENCODE; ENCBS718MJZ
DR   ENCODE; ENCBS767VYD
DR   ENCODE; ENCBS799ICU
DR   GEO; GSM472912
DR   GEO; GSM472913
DR   GEO; GSM472917
DR   GEO; GSM749667
DR   GEO; GSM749693
DR   GEO; GSM749700
DR   GEO; GSM945202
DR   GEO; GSM945209
DR   GEO; GSM945210
DR   GEO; GSM945317
DR   Wikidata; Q54954485
RX   PubMed=23325432;
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   SK-N-WD
AC   CVCL_C8G2
DR   Wikidata; Q123033508
RX   PubMed=9815755;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SK-Neo
AC   CVCL_8597
SY   SKNeo
DR   cancercelllines; CVCL_8597
DR   Wikidata; Q54954486
RX   PubMed=9717829;
RX   PubMed=17513613;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Lys (c.710T>A); ClinVar=VCV000376636; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   SK-NEP-1
AC   CVCL_0631
SY   SKNEP-1; SKNEP1; SKNEP
DR   CLO; CLO_0009055
DR   EFO; EFO_0002337
DR   CLDB; cl4353
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-48
DR   BioSample; SAMN03472745
DR   BioSample; SAMN10989620
DR   cancercelllines; CVCL_0631
DR   CCRID; 3101HUMTCHu164
DR   Cell_Model_Passport; SIDM00027
DR   ChEMBL-Cells; CHEMBL3308141
DR   ChEMBL-Targets; CHEMBL1075580
DR   CLS; 300341
DR   Cosmic; 688125
DR   Cosmic; 909730
DR   Cosmic; 1112129
DR   Cosmic; 1196558
DR   Cosmic; 2060801
DR   Cosmic; 2228232
DR   Cosmic; 2294587
DR   Cosmic-CLP; 909730
DR   DepMap; ACH-001192
DR   EGA; EGAS00001000978
DR   GDSC; 909730
DR   GEO; GSM827180
DR   GEO; GSM844692
DR   GEO; GSM845556
DR   GEO; GSM1670452
DR   IARC_TP53; 27243
DR   IGRhCellID; SKNEP1
DR   IZSLER; BS TCL 61
DR   LINCS_LDP; LCL-1802
DR   PharmacoDB; SKNEP1_1410_2019
DR   Progenetix; CVCL_0631
DR   PubChem_Cell_line; CVCL_0631
DR   Wikidata; Q54954488
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=7459858;
RX   PubMed=17154184;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25010205;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=30924592;
RX   PubMed=31006967;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-nep-1-human-ewing-sarcoma-cell-line
CC   Problematic cell line: Misclassified. Originally thought to be a Wilm's tumor cell line but shown to be from an Ewing sarcoma (PubMed=17154184; PubMed=30924592).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2008-052.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=17154184; PubMed=25010205; DepMap=ACH-001192).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=25010205; DepMap=ACH-001192).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.75%; East Asian, South=0%; South Asian=1.81%; European, North=66.07%; European, South=31.37% (PubMed=30894373).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=HTB-48; CLS=300341; Cosmic-CLP=909730; PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15,17
ST   D19S433: 12,14
ST   D21S11: 29,31
ST   D2S1338: 19,20
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 24
ST   Penta D: 11,12
ST   Penta E: 7,18
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SK-OS-10
AC   CVCL_1E47
DR   ATCC; HTB-90
DR   Wikidata; Q54954489
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: ATCC; HTB-90; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   SK-OS-3B
AC   CVCL_1E41
SY   OS3B
DR   Wikidata; Q54954490
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4329447;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 7
//
ID   SK-OS-5
AC   CVCL_LK69
DR   ATCC; HTB-89
DR   Wikidata; Q54954492
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Discontinued: ATCC; HTB-89; true.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   SK-OV-1
AC   CVCL_X208
SY   SKOV-1; SKOV1
DR   BTO; BTO_0006361
DR   GEO; GSM743492
DR   Wikidata; Q54954494
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=833871;
RX   PubMed=1013510;
RX   PubMed=3518877;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   SK-OV-3
AC   CVCL_0532
SY   SKOV-3; SK-OV3; SK.OV.3; SKOV3; Skov3; SKO3; SKOV3 (S)
DR   BTO; BTO_0000948
DR   CLO; CLO_0009063
DR   EFO; EFO_0002340
DR   MCCL; MCC:0000431
DR   CLDB; cl4354
DR   CLDB; cl4355
DR   CLDB; cl4356
DR   AddexBio; C0017008/5024
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-77
DR   BCRJ; 0409
DR   BioGRID_ORCS_Cell_line; 372
DR   BioSample; SAMN03471310
DR   BioSample; SAMN05292466
DR   BioSample; SAMN10987874
DR   cancercelllines; CVCL_0532
DR   CancerTools; 161938
DR   CCRID; 1101HUM-PUMC000027
DR   CCRID; 3101HUMTCHu185
DR   CCRID; 4201HUM-CCTCC00114
DR   CCTCC; GDC0114
DR   Cell_Model_Passport; SIDM00079
DR   ChEMBL-Cells; CHEMBL3307746
DR   ChEMBL-Targets; CHEMBL614925
DR   CLS; 300342
DR   Cosmic; 687925
DR   Cosmic; 688110
DR   Cosmic; 755846
DR   Cosmic; 809115
DR   Cosmic; 844348
DR   Cosmic; 849611
DR   Cosmic; 875858
DR   Cosmic; 897436
DR   Cosmic; 897739
DR   Cosmic; 905959
DR   Cosmic; 906578
DR   Cosmic; 920359
DR   Cosmic; 923106
DR   Cosmic; 924150
DR   Cosmic; 927563
DR   Cosmic; 932983
DR   Cosmic; 947358
DR   Cosmic; 948289
DR   Cosmic; 949228
DR   Cosmic; 991320
DR   Cosmic; 1044243
DR   Cosmic; 1057759
DR   Cosmic; 1066218
DR   Cosmic; 1070900
DR   Cosmic; 1071897
DR   Cosmic; 1092635
DR   Cosmic; 1093556
DR   Cosmic; 1102817
DR   Cosmic; 1113276
DR   Cosmic; 1129658
DR   Cosmic; 1139226
DR   Cosmic; 1175886
DR   Cosmic; 1176622
DR   Cosmic; 1305333
DR   Cosmic; 1312193
DR   Cosmic; 1312359
DR   Cosmic; 1436037
DR   Cosmic; 1482526
DR   Cosmic; 1523762
DR   Cosmic; 1524361
DR   Cosmic; 1707561
DR   Cosmic; 1708388
DR   Cosmic; 1709249
DR   Cosmic; 1998478
DR   Cosmic; 2301586
DR   Cosmic; 2464670
DR   Cosmic; 2560252
DR   Cosmic; 2582807
DR   Cosmic; 2668296
DR   Cosmic-CLP; 905959
DR   DepMap; ACH-000811
DR   ECACC; 91091004
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905959
DR   GEO; GSM2110
DR   GEO; GSM50223
DR   GEO; GSM50287
DR   GEO; GSM183338
DR   GEO; GSM183341
DR   GEO; GSM274701
DR   GEO; GSM313702
DR   GEO; GSM459638
DR   GEO; GSM459643
DR   GEO; GSM459644
DR   GEO; GSM459645
DR   GEO; GSM659405
DR   GEO; GSM711713
DR   GEO; GSM743478
DR   GEO; GSM743500
DR   GEO; GSM750833
DR   GEO; GSM784565
DR   GEO; GSM799368
DR   GEO; GSM799431
DR   GEO; GSM827322
DR   GEO; GSM847159
DR   GEO; GSM851940
DR   GEO; GSM887598
DR   GEO; GSM888681
DR   GEO; GSM1001423
DR   GEO; GSM1001424
DR   GEO; GSM1001486
DR   GEO; GSM1153439
DR   GEO; GSM1181272
DR   GEO; GSM1181301
DR   GEO; GSM1291150
DR   GEO; GSM1340593
DR   GEO; GSM1374883
DR   GEO; GSM1670455
DR   GEO; GSM2124684
DR   GEO; GSM2475005
DR   IARC_TP53; 21123
DR   ICLC; HTL01014
DR   IGRhCellID; SKOV3
DR   IZSLER; BS TCL 84
DR   KCB; KCB 200810YJ
DR   KCLB; 30077
DR   LiGeA; CCLE_824
DR   LINCS_HMS; 50044
DR   LINCS_LDP; LCL-1517
DR   Lonza; 133
DR   NCBI_Iran; C209
DR   NCI-DTP; SK-OV-3
DR   PharmacoDB; SKOV3_1411_2019
DR   PRIDE; PXD001402
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD007615
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0532
DR   PubChem_Cell_line; CVCL_0532
DR   SKY/M-FISH/CGH; 1438
DR   Wikidata; Q50432263
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1423261;
RX   PubMed=1892748;
RX   PubMed=2041050;
RX   PubMed=2653399;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=3804493;
RX   PubMed=4016745;
RX   PubMed=6582512;
RX   PubMed=7459858;
RX   PubMed=7718330;
RX   PubMed=8557231;
RX   PubMed=9041185;
RX   PubMed=9331090;
RX   PubMed=9554442;
RX   PubMed=9698466;
RX   PubMed=10318951;
RX   PubMed=10700174;
RX   PubMed=10972993;
RX   PubMed=11416159;
RX   PubMed=11565033;
RX   PubMed=11789735;
RX   PubMed=11793438;
RX   PubMed=12080474;
RX   PubMed=12417041;
RX   PubMed=12960427;
RX   PubMed=15748285;
RX   PubMed=16380993;
RX   PubMed=17088437;
RX   PubMed=17726699;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20204287;
RX   PubMed=20215515;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22328975;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=23415752;
RX   PubMed=23839242;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24023729;
RX   PubMed=24279929;
RX   PubMed=24434149;
RX   PubMed=24670534;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26169745;
RX   PubMed=26589293;
RX   PubMed=26668597;
RX   PubMed=26925792;
RX   PubMed=27235858;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=32612269;
RX   PubMed=33519462;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=27
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544449
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-19.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/SK-OV-3
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/ovarian-cancer-xenograft/sk-ov-3-xenograft-model/
WW   Provider; BRICS; BRICS0100; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3906
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/human-ovarian-cell-line-sk-ov-3
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-528.
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=7718330); 19 hours (PubMed=2653399); 28 +- 2 hours (PubMed=3804493); 28.8 hours (PubMed=4016745); 75 hours (PubMed=25984343); 48.7 hours (NCI-DTP=SK-OV-3); ~35 hours (PBCF); 33.29 hours (JWGray panel).
CC   HLA typing: A*03,68; B*18,35; C*04,05; DPB1*02:01:02,04:01; DQB1*02:01,05:01:01; DRB1*01,03:01:01 (PubMed=15748285).
CC   HLA typing: A*03:01,68:01; B*18:01,35:01; C*04:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (PubMed=11565033; PubMed=25846456).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=17088437; PubMed=22705003; PubMed=25846456; PubMed=28273451).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (PubMed=17088437; PubMed=20204287).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=0%; East Asian, North=1.76%; East Asian, South=0%; South Asian=1.14%; European, North=59.05%; European, South=36.53% (PubMed=30894373).
CC   Misspelling: SCOV-3; Note=Occasionally.
CC   Misspelling: SCOV3; Note=Occasionally.
CC   Misspelling: SKVO3; Note=Occasionally.
CC   Discontinued: ICLC; HTL01014; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): AddexBio=C0017008/5024; ATCC=HTB-77; CCRID; CLS=300342; Cosmic-CLP=905959; ECACC=91091004; KCLB=30077; PubMed=11416159; PubMed=19372543; PubMed=25230021; PubMed=25877200; PubMed=30485824; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,16,17
ST   D12S391: 21,22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,17 (ATCC=HTB-77; ECACC=91091004; PubMed=19372543; PubMed=25877200)
ST   D18S51: 16,17,18 (CCRID; CLS=300342; PubMed=11416159; Technion Genomics Center)
ST   D18S51: 16,18 (PubMed=25230021)
ST   D19S433: 14,14.2
ST   D1S1656: 11,17.3
ST   D21S11: 30,31,31.2 (CLS=300342; PubMed=11416159; PubMed=30485824)
ST   D21S11: 30,31.2 (ATCC=HTB-77; CCRID; PubMed=19372543; PubMed=25230021; PubMed=25877200; Technion Genomics Center)
ST   D22S1045: 11,16
ST   D2S1338: 18,23
ST   D2S441: 10,11.3
ST   D3S1358: 13,14 (PubMed=19372543)
ST   D3S1358: 14 (ATCC=HTB-77; CCRID; CLS=300342; PubMed=25230021; PubMed=25877200; Technion Genomics Center)
ST   D5S818: 11
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 23,24,25 (ATCC=HTB-77; ECACC=91091004; Technion Genomics Center)
ST   FGA: 24,25 (CCRID; KCLB=30077; PubMed=25230021; PubMed=25877200)
ST   FGA: 24,25,26 (CLS=300342; PubMed=11416159)
ST   Penta D: 12,13
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17 (PubMed=25230021)
ST   vWA: 17,18 (AddexBio=C0017008/5024; ATCC=HTB-77; CCRID; CLS=300342; Cosmic-CLP=905959; ECACC=91091004; KCLB=30077; PubMed=11416159; PubMed=25877200; PubMed=30485824; Technion Genomics Center)
ST   vWA: 18 (PubMed=19372543)
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   SK-OV-3 SK23a
AC   CVCL_E8BP
SY   SK23a
RX   PubMed=8152906;
CC   Population: Caucasian.
CC   Characteristics: Transfected with mouse Trp53 p53Val135, a temperature sensitive variant that assume a wild-type configuration at 32 Celsius and transforms cells at 37 Celsius (PubMed=8152906).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala135Val = p53Val135).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-OV-3 SK9
AC   CVCL_E8BQ
SY   SK9
RX   PubMed=8152906;
CC   Population: Caucasian.
CC   Characteristics: Transfected with mouse Trp53 p53Val135, a temperature sensitive variant that assume a wild-type configuration at 32 Celsius and transforms cells at 37 Celsius (PubMed=8152906).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:98834; Trp53 (Note=With p.Ala135Val = p53Val135).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-OV-3 SKN
AC   CVCL_E8BR
SY   SKN
RX   PubMed=8152906;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for SK23a (Cellosaurus=CVCL_E8BP) and SK9 (Cellosaurus=CVCL_E8BQ) (PubMed=8152906).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SK-OV-3-Cas9-560
AC   CVCL_XB82
DR   cancercelllines; CVCL_XB82
DR   CCRID; 1101HUM-PUMC000560
DR   Wikidata; Q98132664
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000560
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 14,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   SK-OV-3-Cas9-561
AC   CVCL_XB83
DR   cancercelllines; CVCL_XB83
DR   CCRID; 1101HUM-PUMC000561
DR   Wikidata; Q98132665
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000561
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,18,26
ST   D19S433: 14,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   SK-OV-3-Cas9-562
AC   CVCL_XB84
DR   cancercelllines; CVCL_XB84
DR   CCRID; 1101HUM-PUMC000562
DR   Wikidata; Q98132666
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000562
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,17,18
ST   D19S433: 14,14.2
ST   D21S11: 30,31,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,26
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   SK-OV-3-Cas9-563
AC   CVCL_XB85
DR   cancercelllines; CVCL_XB85
DR   CCRID; 1101HUM-PUMC000563
DR   Wikidata; Q98132667
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000563
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 14,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 11
ST   D6S1043: 12
ST   D7S820: 15
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   SK-OV-3-Cas9-564
AC   CVCL_XB86
DR   cancercelllines; CVCL_XB86
DR   CCRID; 1101HUM-PUMC000564
DR   Wikidata; Q98132668
CC   Population: Caucasian.
CC   Characteristics: Transduced with a Cas9-FLAG-Neo construct.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With a C-terminal FLAG tag).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CCRID=1101HUM-PUMC000564
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 22
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 16,17,18
ST   D19S433: 14,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D6S1043: 12
ST   D7S820: 13,14
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   Penta E: 5,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 14
//
ID   SK-OV-3-hCD271
AC   CVCL_YU10
SY   SK-OV-3-CD271
DR   cancercelllines; CVCL_YU10
DR   Wikidata; Q98132669
RX   PubMed=32069133;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7809; NGFR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   SK-OV-3-Luc
AC   CVCL_4Y20
DR   cancercelllines; CVCL_4Y20
DR   JCRB; JCRB1549
DR   JCRB; NIHS0737
DR   Wikidata; Q54954498
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0737; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1549
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   SK-OV-3/Cas9-hyg
AC   CVCL_C9F9
DR   GeneCopoeia; SL580
DR   Wikidata; Q123033509
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL580).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SK-OV-3/CBP
AC   CVCL_D621
SY   SKOV3/CBP; S-car
DR   cancercelllines; CVCL_D621
DR   Wikidata; Q54954499
RX   PubMed=15254775;
RX   PubMed=17269733;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   SK-OV-3/CDDP
AC   CVCL_D622
SY   SKOV3/CDDP
DR   cancercelllines; CVCL_D622
DR   Wikidata; Q54954500
RX   PubMed=17269733;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   SK-OV-3/CMV-Luc
AC   CVCL_4Y19
DR   cancercelllines; CVCL_4Y19
DR   JCRB; JCRB1594
DR   JCRB; NIHS0736
DR   Wikidata; Q54954502
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=JCRB1594).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0736; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1594
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 13,14
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 20
//
ID   SK-OV-3/pVgRXR
AC   CVCL_E3E8
SY   SK-OV-3 Zeo(R); SK-OV-3 ZeoR
RX   PubMed=15755800;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR (PubMed=15755800).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   SK-OV-3/pVgRXR/pIND
AC   CVCL_E3E9
RX   PubMed=15755800;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for SK-OV-3/pVgRXR/pINDp53wt (Cellosaurus=CVCL_E3EA) (PubMed=15755800).
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR. Also transfected with an empty pIND vector (PubMed=15755800).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3E8 ! SK-OV-3/pVgRXR
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   SK-OV-3/pVgRXR/pINDp53wt
AC   CVCL_E3EA
RX   PubMed=15755800;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the pVgRXR vector that contains the VgEcR fusion protein under the control of a CMV promoter and RXRA under the control of a RSV promoter as well as BleoR. Also transfected with pINDp53wt (PubMed=15755800).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FlyBase_Gene; FBgn0000546; EcR (Note=With p.Met1_Val221del, as 2nd part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10477; RXRA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Thr412del, as 1st part of VgECR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3E8 ! SK-OV-3/pVgRXR
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   SK-OV-4
AC   CVCL_X008
SY   SKOV-4; SKOV4
DR   BioSample; SAMN03151613
DR   cancercelllines; CVCL_X008
DR   GEO; GSM851941
DR   Wikidata; Q54954503
RX   PubMed=6582512;
RX   PubMed=22710073;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00469.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1094 ! C-33 A
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 24
//
ID   SK-OV-6
AC   CVCL_A457
SY   SKOV-6; SKOV6
DR   BioSample; SAMN03151614
DR   cancercelllines; CVCL_A457
DR   Cosmic; 923107
DR   Cosmic; 1709253
DR   GEO; GSM851942
DR   GEO; GSM1291151
DR   Wikidata; Q54954504
RX   PubMed=6582512;
RX   PubMed=22328975;
RX   PubMed=22710073;
RX   PubMed=25230021;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a C-33 A derivative (PubMed=22710073).
CC   Part of: OCCP ovarian cancer cell line panel.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00470.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1094 ! C-33 A
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   SK-OV-8
AC   CVCL_A458
SY   SKOV-8; SKOV8
DR   Cosmic; 1709254
DR   Wikidata; Q54954507
RX   PubMed=8349167;
RX   PubMed=22328975;
RX   PubMed=22710073;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SK-p53-1
AC   CVCL_8598
SY   SKp53-1
DR   Wikidata; Q54954508
RX   PubMed=9717829;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-p53-2
AC   CVCL_8599
SY   SKp53-2
DR   Wikidata; Q54954510
RX   PubMed=9717829;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-p53-3
AC   CVCL_8600
SY   SKp53-3
DR   Wikidata; Q54954512
RX   PubMed=9717829;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SK-PBL-1-R
AC   CVCL_IX48
DR   Wikidata; Q54954513
RX   PubMed=1326305;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C114812; Childhood pineoblastoma
DI   ORDO; Orphanet_251909; Pineoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 6
//
ID   SK-PC-1
AC   CVCL_4054
SY   SK-PC1; PC1
DR   BTO; BTO_0002823
DR   cancercelllines; CVCL_4054
DR   Cosmic; 710871
DR   Cosmic; 948737
DR   IARC_TP53; 3386
DR   IARC_TP53; 16744
DR   Wikidata; Q54954514
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=7723277;
RX   PubMed=8026879;
RX   PubMed=9665481;
RX   PubMed=11169957;
RX   PubMed=11787853;
RX   PubMed=22585861;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 51.8 hours (PubMed=7723277).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=8026879; PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Leu (c.845G>T); ClinVar=VCV000182938; Zygosity=Unspecified (PubMed=11787853).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   SK-PC-3
AC   CVCL_4055
SY   PC3
DR   cancercelllines; CVCL_4055
DR   Cosmic; 948729
DR   Wikidata; Q54954517
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=7723277;
RX   PubMed=8026879;
RX   PubMed=9665481;
RX   PubMed=22585861;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 59.5 hours (PubMed=7723277).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (PubMed=8026879).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): PubMed=22585861
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-PN-AG
AC   CVCL_M167
DR   Wikidata; Q54954518
RX   PubMed=3024811;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   SK-PN-DW
AC   CVCL_1703
SY   SKPNDW
DR   CLO; CLO_0009064
DR   CLDB; cl4358
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2139
DR   BioGRID_ORCS_Cell_line; 1015
DR   BioSample; SAMN03472556
DR   BioSample; SAMN10989621
DR   cancercelllines; CVCL_1703
DR   Cell_Model_Passport; SIDM01097
DR   ChEMBL-Cells; CHEMBL3308886
DR   ChEMBL-Targets; CHEMBL2366108
DR   Cosmic; 684073
DR   Cosmic; 909731
DR   Cosmic; 1078390
DR   Cosmic; 1718431
DR   Cosmic-CLP; 909731
DR   DepMap; ACH-001193
DR   ECACC; 94092301
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10719-109I8
DR   GDSC; 909731
DR   GEO; GSM1670456
DR   IARC_TP53; 27245
DR   LINCS_LDP; LCL-1048
DR   PharmacoDB; SKPNDW_1412_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1703
DR   Wikidata; Q54954519
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.5282/edoc.27750;
RX   PubMed=2987426;
RX   PubMed=3024811;
RX   PubMed=8040301;
RX   PubMed=20164919;
RX   PubMed=22142829;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31046733;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-2139
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Karyotypic information: Has lost chromosome Y as well as one copy each of chromosomes 11, 13, 17 and 18 (PubMed=31046733).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=8040301).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Trp78Ter (c.234G>A); ClinVar=VCV001456015; Zygosity=Homozygous (Cosmic-CLP=909731; DepMap=ACH-001193).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Homozygous (Cosmic-CLP=909731; DepMap=ACH-001193).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.81%; East Asian, South=0%; South Asian=0%; European, North=62.77%; European, South=35.42% (PubMed=30894373).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): ATCC=CRL-2139; Cosmic-CLP=909731; ECACC=94092301
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 29,31
ST   D2S1338: 17,25
ST   D3S1358: 14,16
ST   D5S818: 13,14
ST   D7S820: 8,14
ST   D8S1179: 13,15
ST   FGA: 19,22
ST   Penta D: 10,11
ST   Penta E: 14,16
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   SK-PN-LI
AC   CVCL_A748
SY   SK-PNET-Li; SKPNETLI
DR   cancercelllines; CVCL_A748
DR   Cosmic; 1078389
DR   Cosmic; 2228234
DR   Wikidata; Q54954520
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2987426;
RX   PubMed=3024811;
RX   PubMed=8040301;
RX   PubMed=25010205;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=8040301; PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Ser704fs; Zygosity=Unspecified (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>T); ClinVar=VCV000012358; Zygosity=Unspecified (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 16,20
ST   D19S433: 14,16
ST   D21S11: 33.2
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   SK-PN-WA
AC   CVCL_M168
DR   Wikidata; Q54954522
RX   PubMed=3024811;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   SK-RC-1
AC   CVCL_4017
SY   SK-RC 1; SK RC 1; SK RC 01; SKRC-1
DR   BTO; BTO_0003193
DR   Wikidata; Q53996683
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6946460;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 42 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and metastatic site from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Renal fascia; UBERON=UBERON_0016851.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 16,24
ST   D3S1358: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-10
AC   CVCL_6175
SY   SK RC 10; SKRC-10
DR   Wikidata; Q54954526
RX   PubMed=479762;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 30,31.2
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6178 ! SK-RC-13
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-RC-11
AC   CVCL_6176
SY   SK RC 11; SK-RC11
DR   Wikidata; Q54954528
RX   PubMed=479762;
RX   PubMed=1717605;
RX   PubMed=2784858;
RX   PubMed=6864164;
RX   PubMed=6946460;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 24,25
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,14
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 17
//
ID   SK-RC-12
AC   CVCL_6177
SY   SK RC 12; SKRC-12
DR   Cosmic; 945057
DR   Wikidata; Q54954529
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=6582512;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and metastatic site from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-RC-13
AC   CVCL_6178
SY   SK RC 13
DR   Cosmic; 737185
DR   Wikidata; Q54954530
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 42 hours (PubMed=2386958).
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 12,13
ST   D21S11: 30,31.2
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6175 ! SK-RC-10
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   SK-RC-14
AC   CVCL_6179
SY   SK RC 14; SKRC-14
DR   Cosmic; 945058
DR   Wikidata; Q54954533
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 30,31
ST   D2S1338: 17
ST   D3S1358: 19
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   TH01: 8,9
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   SK-RC-15
AC   CVCL_6180
SY   SK RC 15
DR   Wikidata; Q54954535
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile, exact cancer type and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,14
ST   D18S51: 13,21
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-RC-16
AC   CVCL_GS24
SY   SK RC 16
DR   Wikidata; Q54954537
RX   PubMed=6582512;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 21,24
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 7,8
ST   D8S1179: 10,11
ST   FGA: 22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 7
//
ID   SK-RC-17
AC   CVCL_4018
SY   SK-RC 17; SK RC 17; SKRC-17
DR   BTO; BTO_0003196
DR   Cosmic; 737186
DR   Cosmic; 945059
DR   Wikidata; Q54954539
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile, metastatic site and sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D16S539: 13,14
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 10
ST   FGA: 20
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SK-RC-18
AC   CVCL_6181
SY   SK RC 18; SKRC18; SKRC-18; SKRC 18
DR   Wikidata; Q54954557
RX   PubMed=2386958;
RX   PubMed=2784858;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 42 hours (PubMed=2386958).
CC   Miscellaneous: STR profile, metastatic site and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 12,13
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10,13
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SK-RC-2
AC   CVCL_6169
SY   SK RC 02; SKRC-02
DR   Cosmic; 737183
DR   Wikidata; Q54954558
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6946460;
RX   PubMed=7017212;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 60 hours (PubMed=2386958).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 12,19
ST   D19S433: 12,13
ST   D21S11: 28,30
ST   D2S1338: 16,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 8,15
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-20
AC   CVCL_V605
SY   SK RC 20; SKRC-20; SKRC20
DR   BioSample; SAMN10988408
DR   Cell_Model_Passport; SIDM01863
DR   DepMap; ACH-000385
DR   PharmacoDB; SKRC20_1414_2019
DR   Wikidata; Q54954559
RX   PubMed=25984343;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 55 hours (PubMed=25984343).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D16S539: 11,12
ST   D19S433: 14,15
ST   D21S11: 32.2
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   SK-RC-21
AC   CVCL_6182
SY   SK RC 21; SKRC-21
DR   Wikidata; Q54954560
RX   PubMed=2386958;
RX   PubMed=6946460;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 38 hours (PubMed=2386958).
CC   Miscellaneous: STR profile, metastatic site and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Bone, lumbar vertebra; UBERON=UBERON_0002414.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 12,15
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-22
AC   CVCL_VR18
SY   SK RC 22
DR   Wikidata; Q98132670
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
ID   SK-RC-24
AC   CVCL_VR19
SY   SK RC 24
DR   Wikidata; Q98132671
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 8,10
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 14,17
ST   D19S433: 12,16.2
ST   D21S11: 28,30
ST   D2S1338: 16,20
ST   D3S1358: 17
ST   D5S818: 9,10
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 19,24
ST   TH01: 8,9.3
ST   TPOX: 10,12
ST   vWA: 15,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
ID   SK-RC-25
AC   CVCL_VR20
SY   SK RC 25
DR   Wikidata; Q98132672
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,11
ST   D18S51: 15,18
ST   D19S433: 14,16.2
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 20,22
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
ID   SK-RC-26A
AC   CVCL_6183
SY   SK-RC-26a; SK RC 26a
DR   Wikidata; Q54954562
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 15.2
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 20
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3120 ! SK-RC-26B
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-26B
AC   CVCL_3120
SY   SK-RC-26b; SK-RC 26B; SK RC 26b; SKRC-26B; SK-RC26b; RCC 26b; RCC26b
DR   BTO; BTO_0004781
DR   IARC_TP53; 26508
DR   Wikidata; Q54954563
RX   PubMed=2386958;
RX   PubMed=15026329;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 15.2
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 20
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6183 ! SK-RC-26A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-28
AC   CVCL_6184
SY   SK RC 28; SKRC28
DR   Cosmic; 972918
DR   Wikidata; Q54954564
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6946460;
RX   PubMed=7915601;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Pro86His (c.257C>A); Zygosity=Unspecified (PubMed=7915601).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14,15.2
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 12,13,14
ST   FGA: 22,23
ST   TH01: 6,10
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SK-RC-29
AC   CVCL_4019
SY   SK-RC 29; SK RC 29; SKRC-29
DR   BTO; BTO_0003197
DR   cancercelllines; CVCL_4019
DR   Cosmic; 737187
DR   Cosmic; 945060
DR   GEO; GSM374462
DR   Progenetix; CVCL_4019
DR   Wikidata; Q54954565
RX   PubMed=2386958;
RX   PubMed=6864164;
RX   PubMed=6946460;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 36 hours (PubMed=2386958).
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-3
AC   CVCL_6170
SY   SK-RC 3; SK RC 03
DR   Wikidata; Q54954569
RX   PubMed=479762;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 14
//
ID   SK-RC-30
AC   CVCL_6185
SY   SK RC 30
DR   Wikidata; Q54954571
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 22,24
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   SK-RC-31
AC   CVCL_6186
SY   SK-RC 31; SK RC 31; SKRC-31; SKRC31
DR   cancercelllines; CVCL_6186
DR   Cell_Model_Passport; SIDM01839
DR   DepMap; ACH-001194
DR   GEO; GSM374463
DR   PharmacoDB; SKRC31_1413_2019
DR   Progenetix; CVCL_6186
DR   Wikidata; Q54954573
RX   PubMed=2386958;
RX   PubMed=25984343;
RX   PubMed=27993170;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Doubling time: 120 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Homozygous (DepMap=ACH-001194).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gly (c.637C>G); ClinVar=VCV000376651; Zygosity=Homozygous (DepMap=ACH-001194).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser111Gly (c.331A>G); ClinVar=VCV000633016; Zygosity=Hemizygous (DepMap=ACH-001194).
CC   Genome ancestry: African=3.19%; Native American=0.01%; East Asian, North=7.38%; East Asian, South=0%; South Asian=3.18%; European, North=19.72%; European, South=66.52% (PubMed=30894373).
CC   Miscellaneous: STR profile and sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 20
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8,13
ST   D8S1179: 12,16
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SK-RC-33
AC   CVCL_6187
SY   SK RC 33; SKRC-33; SKRC33
DR   Wikidata; Q54954575
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 18
ST   D5S818: 9,10
ST   D7S820: 8,9
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   SK-RC-34
AC   CVCL_VR21
SY   SK RC 34
DR   Wikidata; Q98132673
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 16
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,16
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 6
//
ID   SK-RC-35
AC   CVCL_4020
SY   SK-RC 35; SK RC 35; SKRC-35
DR   BTO; BTO_0003198
DR   Cosmic; 737180
DR   Wikidata; Q54954576
RX   PubMed=2386958;
RX   PubMed=6582512;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 30 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 12,19
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 11,13,14
ST   FGA: 21,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-36
AC   CVCL_VR22
SY   SK RC 36
DR   Wikidata; Q98132674
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile, metastatic site and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Femoral neck, hypodermis; UBERON=UBERON_0007119+UBERON_0002072.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 14,16
ST   D21S11: 31
ST   D2S1338: 18,24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,15
ST   FGA: 25
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   SK-RC-37
AC   CVCL_6188
SY   SK RC 37; SKRC37
DR   Cosmic; 737181
DR   Cosmic; 972885
DR   Wikidata; Q54954577
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 29,33.2
ST   D2S1338: 16,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-RC-38
AC   CVCL_6189
SY   SK-RC 38; SKRC-38; SKRC38
DR   cancercelllines; CVCL_6189
DR   GEO; GSM374464
DR   Progenetix; CVCL_6189
DR   Wikidata; Q54954578
RX   PubMed=2386958;
RX   PubMed=6864164;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SK-RC-39
AC   CVCL_4021
SY   SK-RC 39; SKRC-39; SKRC 39
DR   BTO; BTO_0003199
DR   Wikidata; Q54954580
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 42 hours (PubMed=2386958).
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-4
AC   CVCL_6171
SY   SK RC 04
DR   Wikidata; Q54954581
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=6946460;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and metastatic site from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 8,12
ST   D18S51: 12,20
ST   D19S433: 14.2,15
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-RC-40
AC   CVCL_6190
SY   SK RC 40
DR   Wikidata; Q54954583
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-RC-41
AC   CVCL_6191
SY   SK RC 41
DR   Wikidata; Q54954587
RX   PubMed=2386958;
RX   PubMed=6864164;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-RC-42
AC   CVCL_6192
SY   SK-RC 42; SKRC-42
DR   cancercelllines; CVCL_6192
DR   Cosmic; 737188
DR   GEO; GSM374465
DR   Progenetix; CVCL_6192
DR   Wikidata; Q54954588
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=2386958).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-44
AC   CVCL_4022
SY   SK-RC 44; SK RC 44; SKRC-44
DR   BTO; BTO_0003200
DR   Wikidata; Q54954589
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4016 ! SK-RC-45
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-RC-45
AC   CVCL_4016
SY   SK-RC 45; SK RC 45; SKRC-45; SKRC45; RCC 45; RCC45
DR   BTO; BTO_0003201
DR   Cosmic; 737189
DR   IARC_TP53; 26509
DR   Wikidata; Q54954591
RX   PubMed=2386958;
RX   PubMed=12670922;
RX   PubMed=15026329;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 14,16
ST   D21S11: 27,28
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4022 ! SK-RC-44
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SK-RC-46
AC   CVCL_6193
SY   SK RC 46
DR   Cosmic; 737190
DR   Wikidata; Q54954592
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile, metastatic site and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Bone, shoulder; UBERON=UBERON_0003461.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,14
ST   D12S391: 22,24
ST   D13S317: 10
ST   D16S539: 10,14
ST   D18S51: 12
ST   D19S433: 15,16.2
ST   D1S1656: 17.3,18.3
ST   D21S11: 29,31.2
ST   D22S1045: 16
ST   D2S1338: 19,22
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 9,11
ST   Penta E: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SK-RC-47
AC   CVCL_6194
SY   SK-RC 47; SK RC 47; SKRC 47
DR   Wikidata; Q54954593
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SK-RC-48
AC   CVCL_6195
SY   SK RC 48; SKRC48
DR   Cosmic; 972919
DR   Wikidata; Q54954595
RX   PubMed=2386958;
RX   PubMed=7915601;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu135Tyrfs*24 (c.404delT); Zygosity=Unspecified (PubMed=7915601).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 12,16
ST   D21S11: 28,30
ST   D2S1338: 20
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 20
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-49
AC   CVCL_6196
SY   SKRC-49; SKRC49
DR   Wikidata; Q54954596
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 42 hours (PubMed=2386958).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SK-RC-5
AC   CVCL_6172
DR   Wikidata; Q54954597
RX   PubMed=479762;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   SK-RC-51
AC   CVCL_6197
DR   Wikidata; Q54954598
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SK-RC-52
AC   CVCL_6198
SY   SK-RC 52; SK RC 52; SKRC-52
DR   cancercelllines; CVCL_6198
DR   Cosmic; 945061
DR   GEO; GSM374466
DR   Progenetix; CVCL_6198
DR   Wikidata; Q54954600
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 36 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Mediastinum; UBERON=UBERON_0003728.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,13
ST   D18S51: 15
ST   D19S433: 15,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-53
AC   CVCL_6199
DR   Wikidata; Q54954601
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SK-RC-54
AC   CVCL_6200
SY   SK RC 54; SKRC-54; RCC 54; RCC54
DR   IARC_TP53; 26510
DR   Wikidata; Q54954602
RX   PubMed=2386958;
RX   PubMed=15026329;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,14
ST   D12S391: 22,24
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 15.3
ST   D21S11: 29,32
ST   D22S1045: 15,16
ST   D2S1338: 23
ST   D2S441: 11
ST   D3S1358: 14,15
ST   D5S818: 12,14
ST   D7S820: 7,9
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 21,23
ST   Penta D: 11,14
ST   Penta E: 5,12
ST   TH01: 6
ST   TPOX: 12
ST   vWA: 16,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SK-RC-54V
AC   CVCL_6201
DR   Wikidata; Q54954603
RX   PubMed=16818659;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6200 ! SK-RC-54
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   SK-RC-55
AC   CVCL_6202
DR   Wikidata; Q54954605
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SK-RC-56
AC   CVCL_6203
SY   SK RC 56; SKRC56
DR   Cosmic; 972886
DR   Wikidata; Q54954606
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D16S539: 9,13
ST   D18S51: 16
ST   D19S433: 12,15
ST   D21S11: 31
ST   D2S1338: 16,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   SK-RC-57
AC   CVCL_6204
DR   Wikidata; Q54954607
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=2386958).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-RC-58
AC   CVCL_6205
SY   SK-RC 58; SK RC 58; SKRC58
DR   Cosmic; 972887
DR   Wikidata; Q54954608
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 36 hours (PubMed=2386958).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-RC-59
AC   CVCL_6206
SY   SKRC-59; SKRC59
DR   Cosmic; 945062
DR   Cosmic; 972888
DR   Wikidata; Q54954610
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 36 hours (PubMed=2386958).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SK-RC-6
AC   CVCL_4023
SY   SK-RC 6; SK RC 06; SKRC-6; SKRC6
DR   BTO; BTO_0003194
DR   Wikidata; Q54954611
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=2784858;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6946460;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 60 hours (PubMed=2386958).
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 20,26
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SK-RC-60
AC   CVCL_6207
DR   Wikidata; Q54954612
RX   PubMed=2386958;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SK-RC-61
AC   CVCL_6208
SY   SK RC 61; SKRC61
DR   cancercelllines; CVCL_6208
DR   Cosmic; 972920
DR   Wikidata; Q54954614
RX   PubMed=2386958;
RX   PubMed=7915601;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 48 hours (PubMed=2386958).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val130Leu (c.388G>C); ClinVar=VCV000002229; Zygosity=Unspecified (PubMed=7915601).
CC   Miscellaneous: STR profile, metastatic site and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-62
AC   CVCL_6209
SY   SK RC 62; SKRC62
DR   cancercelllines; CVCL_6209
DR   Cosmic; 972921
DR   Wikidata; Q54954637
RX   PubMed=2386958;
RX   PubMed=7915601;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 96 hours (PubMed=2386958).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Cys162Tyr (c.485G>A); ClinVar=VCV000223225; Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SK-RC-63
AC   CVCL_VR23
SY   SK RC 63
DR   Wikidata; Q98132675
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 28,29
ST   D2S1338: 23,25
ST   D3S1358: 13
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 24
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   SK-RC-7
AC   CVCL_4024
SY   SK-RC 7; SK RC 07; SKRC-7
DR   BTO; BTO_0003195
DR   Wikidata; Q54954640
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=2784858;
RX   PubMed=6582512;
RX   PubMed=6946460;
RX   PubMed=7017212;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 8
ST   D18S51: 20
ST   D19S433: 14.2,15
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-8
AC   CVCL_6173
SY   SK RC 08; SKRC-8; SKRC-08; SKRC8
DR   Cosmic; 972916
DR   Wikidata; Q54954641
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6946460;
RX   PubMed=7915601;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-p-primary-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Arg120Lysfs*39 (c.359del); Zygosity=Unspecified (PubMed=7915601).
CC   Miscellaneous: STR profile, metastatic site and exact cancer type from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): MSKCC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 17,20
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 23,25
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SK-RC-9
AC   CVCL_6174
SY   SK-RC-09; SK RC 09; SKRC-9; SK-RC9; SKRC9M
DR   Cosmic; 737184
DR   Cosmic; 972917
DR   Wikidata; Q54954642
RX   PubMed=479762;
RX   PubMed=2386958;
RX   PubMed=6582512;
RX   PubMed=6864164;
RX   PubMed=6946460;
RX   PubMed=7915601;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu89Arg (c.266T>G); Zygosity=Unspecified (PubMed=7915601).
CC   Miscellaneous: STR profile from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,14
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 10,15
ST   D21S11: 30
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 20
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SK-RC-99
AC   CVCL_4025
SY   SK-RC 99; SKRC-99
DR   BTO; BTO_0003202
DR   Wikidata; Q54954644
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   SK-RCS1
AC   CVCL_LK88
DR   Wikidata; Q54954646
RX   PubMed=4170382;
RX   PubMed=4180348;
RX   PubMed=4329447;
RX   PubMed=4894370;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 2-3 days (PubMed=4180348).
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   SK-RST
AC   CVCL_K279
SY   Swine Kidney-RST
DR   ATCC; CRL-2842
DR   Wikidata; Q54954647
RX   PubMed=19508353;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   SK-SC-1
AC   CVCL_1E48
DR   Wikidata; Q54954649
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   SK-UT-1
AC   CVCL_0533
SY   SK UT 1; SKUT-1; SKUT1; Skut1
DR   BTO; BTO_0002034
DR   CLO; CLO_0009065
DR   EFO; EFO_0002341
DR   MCCL; MCC:0000432
DR   AddexBio; C0017007/5008
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-114
DR   BioSample; SAMN03471095
DR   BioSample; SAMN10987664
DR   cancercelllines; CVCL_0533
DR   CancerTools; 161923
DR   Cell_Model_Passport; SIDM01113
DR   ChEMBL-Cells; CHEMBL3308848
DR   ChEMBL-Targets; CHEMBL2366316
DR   CLS; 300455
DR   Cosmic; 687595
DR   Cosmic; 848888
DR   Cosmic; 909732
DR   Cosmic; 923382
DR   Cosmic; 1071895
DR   Cosmic; 1091504
DR   Cosmic; 1176619
DR   Cosmic; 1622903
DR   Cosmic-CLP; 909732
DR   DepMap; ACH-000939
DR   EGA; EGAS00001000978
DR   GDSC; 909732
DR   GEO; GSM887599
DR   GEO; GSM888682
DR   GEO; GSM1670457
DR   GEO; GSM1676327
DR   GEO; GSM1701660
DR   IARC_TP53; 770
DR   IGRhCellID; SKUT1
DR   LiGeA; CCLE_357
DR   LINCS_LDP; LCL-1508
DR   PharmacoDB; SKUT1_1415_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0533
DR   PubChem_Cell_line; CVCL_0533
DR   Wikidata; Q54954650
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=2216456;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29853780;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-329.html
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-ut-1-human-uterine-leiomyosarcoma-cell-line
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK1980-537.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*44:02,55:01; C*01:02,05:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1096Ter (c.3286C>T); ClinVar=VCV000156475; Zygosity=Heterozygous (ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg88Gln (c.263G>A); ClinVar=VCV000376049; Zygosity=Heterozygous (ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323fs*2 (c.968_969insA); Zygosity=Heterozygous (ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Homozygous (ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (PubMed=2216456; ATCC=HTB-114).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=2216456; ATCC=HTB-114).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.59%; Native American=1.42%; East Asian, North=0%; East Asian, South=1.64%; South Asian=7.64%; European, North=32.8%; European, South=54.91% (PubMed=30894373).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): AddexBio=C0017007/5008; ATCC=HTB-114; CLS=300455; Cosmic-CLP=909732
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 13,14
ST   D18S51: 11,16
ST   D19S433: 12,13
ST   D21S11: 29,32.2
ST   D2S1338: 18,19,21
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 22,24
ST   Penta D: 11,14,15 (ATCC=HTB-114)
ST   Penta D: 11,15 (CLS=300455)
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C6340; Uterine corpus leiomyosarcoma
DI   ORDO; Orphanet_213625; Leiomyosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SK-UT-1B
AC   CVCL_2250
SY   SKUT1B; SK-UT 1B; SKUT-1B; Skut1B
DR   BTO; BTO_0003725
DR   CLO; CLO_0009066
DR   CLDB; cl4359
DR   ATCC; HTB-115
DR   BioSample; SAMN03471096
DR   BioSample; SAMN03472878
DR   cancercelllines; CVCL_2250
DR   CancerTools; 161939
DR   ChEMBL-Cells; CHEMBL3307682
DR   ChEMBL-Targets; CHEMBL614678
DR   CLS; 300406
DR   Cosmic; 713478
DR   Cosmic; 871555
DR   Cosmic; 889118
DR   Cosmic; 1007164
DR   Cosmic; 1066227
DR   Cosmic; 1091505
DR   GEO; GSM185152
DR   GEO; GSM185153
DR   GEO; GSM844693
DR   GEO; GSM844694
DR   GEO; GSM1676334
DR   GEO; GSM1701666
DR   IGRhCellID; SKUT1B
DR   IZSLER; BS TCL 210
DR   Progenetix; CVCL_2250
DR   PubChem_Cell_line; CVCL_2250
DR   Wikidata; Q54954651
RX   PubMed=327080;
RX   PubMed=2372783;
RX   PubMed=2766249;
RX   PubMed=3383166;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=9541971;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-ut-1b-human-uterine-leiomyosarcoma-cell-line
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK2010-071.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1096Ter (c.3286C>T); ClinVar=VCV000156475; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg88Gln (c.263G>A); ClinVar=VCV000376049; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr319fs*1 (c.955_958delACTT) (p.VL317fs) (V317fs*3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asn323fs*2 (c.968_969insA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Val654Cysfs*4 (c.1959delA); ClinVar=VCV002724056; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): ATCC=HTB-115; CLS=300406; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 12,14
ST   D18S51: 11,17
ST   D19S433: 12,13
ST   D21S11: 29,32.2
ST   D2S1338: 19,21
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 22,23
ST   Penta D: 11,14
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 5,8 (PubMed=25877200)
ST   TPOX: 8 (ATCC=HTB-115; CLS=300406)
ST   vWA: 16
DI   NCIt; C6340; Uterine corpus leiomyosarcoma
DI   ORDO; Orphanet_213625; Leiomyosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0533 ! SK-UT-1
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   SK-UT-2
AC   CVCL_IW37
SY   SKUT2
DR   EFO; EFO_0022638
DR   Cosmic; 1576465
DR   Wikidata; Q54954653
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   SK/IFN-gamma
AC   CVCL_B7TE
DR   cancercelllines; CVCL_B7TE
DR   Wikidata; Q112930406
RX   PubMed=15150552;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5438; IFNG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   SK/neo
AC   CVCL_B7TF
DR   cancercelllines; CVCL_B7TF
DR   Wikidata; Q112930407
RX   PubMed=15150552;
CC   Population: Caucasian.
CC   Characteristics: Intermediate type (I-type) (from parent cell line).
CC   Characteristics: MYCN-amplified NBL cell line (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0529 ! SK-N-BE(2)-C
SX   Male
AG   2Y2M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   SK11
AC   CVCL_RU22
SY   PureStem SK11, NCr-fac progenitor; ACTC250
DR   Wikidata; Q54954654
RX   Patent=US8685386;
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-250; https://web.archive.org/web/20141202091603/http://www.esibio.com/purestemr-sk11-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-11152.
CC   Characteristics: Undergoes osteochondral differentiation in a facial neural crest progenitor. Used for studies of related degenerative diseases.
CC   Senescence: Can undergo >50 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SK19-1E10
AC   CVCL_C3LQ
SY   1E10
DR   Wikidata; Q116050509
RX   Patent=US9862772;
RX   PubMed=25263193;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
CC   Misspelling: SK-1E10; PubMed=25263193; Note=Once in supplementary material.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SK19-2E8
AC   CVCL_C3LR
SY   2E8
DR   Wikidata; Q116050510
RX   Patent=US9862772;
RX   PubMed=25263193;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
CC   Misspelling: SK-2E8; PubMed=25263193; Note=Once in supplementary material.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SK19-4C9
AC   CVCL_C3LP
SY   4C9
DR   Wikidata; Q116050511
RX   Patent=US9862772;
RX   PubMed=25263193;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SK19-4G11
AC   CVCL_C3LS
SY   4G11
DR   Wikidata; Q116050513
RX   Patent=US9862772;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SK2
AC   CVCL_IY59
SY   SK-2
DR   cancercelllines; CVCL_IY59
DR   Cosmic; 716175
DR   Cosmic; 748116
DR   Wikidata; Q54954655
RX   PubMed=6087347;
RX   PubMed=6667830;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (PubMed=6087347).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   SK24
AC   CVCL_4V70
DR   Wikidata; Q54954657
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Defective in Pex2 (PubMed=10771091).
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Characteristics: Transfected with a GFP C-terminally tagged with peroxisomal PTS1 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3DU ! CHOPS1a
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   SK29-EBV-B
AC   CVCL_D3F2
DR   Wikidata; Q127384305
RX   PubMed=7652577;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6031 ! SK-MEL-29
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SK3/VP16
AC   CVCL_Y203
DR   CGH-DB; 9124-4
DR   Wikidata; Q54954658
RX   PubMed=14973057;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7005 ! ACC-LC-172
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 11
//
ID   SK32
AC   CVCL_4708
DR   BTO; BTO_0003220
DR   Wikidata; Q54954659
RX   PubMed=10771091;
RX   PubMed=11330054;
CC   Characteristics: Defective in Pex5 (PubMed=10771091).
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Characteristics: Transfected with a GFP C-terminally tagged with peroxisomal PTS1 signal (PubMed=10771091).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E3DU ! CHOPS1a
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   SK4-Rf
AC   CVCL_C0X0
DR   cancercelllines; CVCL_C0X0
DR   Wikidata; Q114313030
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln100Ter (c.298C>T); ClinVar=VCV000634707; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus, distal; UBERON=UBERON_0013473.
DI   NCIt; C4025; Esophageal adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2195 ! SK-GT-4
SX   Male
AG   89Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SK6-MxLuc
AC   CVCL_RW95
DR   CCLV; CCLV-RIE 1272
DR   Wikidata; Q54954661
RX   PubMed=19812146;
CC   Characteristics: The expression of the luciferase reporter gene is under control of the mouse Mx1 gene promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_D296 ! SK-6
SX   Female
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   SKA
AC   CVCL_UD55
DR   Wikidata; Q98132676
RX   PubMed=1997098;
RX   PubMed=2789934;
RX   PubMed=3182331;
CC   Doubling time: 48 hours (PubMed=3182331).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 4
//
ID   Ska-3-68
AC   CVCL_S488
DR   Cosmic; 688109
DR   Wikidata; Q54954662
RX   PubMed=12068308;
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   SKB
AC   CVCL_C7WI
SY   Spotted Knifejaw Brain
DR   Wikidata; Q123033510
RX   PubMed=36966380;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by largemouth bass virus, red grouper nervous necrosis virus (RGNNV), infectious spleen and kidney necrosis virus (ISKNV), Singapore grouper iridovirus (SGIV) and spotted knifejaw iridovirus isolate TJ (SKIV-TJ) (PubMed=36966380).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=163135; ! Oplegnathus punctatus (Spotted knifejaw)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SKBR-3-OE
AC   CVCL_A2FE
DR   cancercelllines; CVCL_A2FE
DR   Wikidata; Q105511095
RX   PubMed=33123265;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a construct containing a CAG promoter-driven IGF2R gene was introduced in the AAVS1 safe harbor locus.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:5467; IGF2R.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   SKBR3 A3
AC   CVCL_YX81
DR   cancercelllines; CVCL_YX81
DR   Wikidata; Q98132677
RX   PubMed=20386540;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 11
//
ID   SKBR3-AZDRa
AC   CVCL_EI04
DR   cancercelllines; CVCL_EI04
DR   Wikidata; Q54954663
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132986; Sapitinib (AZD8931).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   SKBR3-AZDRb
AC   CVCL_EI05
DR   cancercelllines; CVCL_EI05
DR   Wikidata; Q54954665
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132986; Sapitinib (AZD8931).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   SKBR3-AZDRc
AC   CVCL_EI06
DR   cancercelllines; CVCL_EI06
DR   PRIDE; PXD002057
DR   Wikidata; Q54954666
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_132986; Sapitinib (AZD8931).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   SKBR3-LAP[r]
AC   CVCL_4V68
DR   cancercelllines; CVCL_4V68
DR   Wikidata; Q54954667
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Miscellaneous: Cell line is no longer available (personal communication of Dowding, Charles).
CC   Discontinued: ChemoScreen; Catalog number 10031C.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 14
//
ID   SKBR3-LAPRa
AC   CVCL_EI07
DR   cancercelllines; CVCL_EI07
DR   Wikidata; Q54954670
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   SKBR3-LAPRb
AC   CVCL_EI08
DR   cancercelllines; CVCL_EI08
DR   Wikidata; Q54954671
RX   PubMed=26883193;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 12
//
ID   SKBR3-LR
AC   CVCL_LG17
DR   cancercelllines; CVCL_LG17
DR   Wikidata; Q54954672
RX   PubMed=24876102;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_49603; Lapatinib (Tykerb; Tyverb).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   SKBR3-NR
AC   CVCL_LG18
DR   cancercelllines; CVCL_LG18
DR   Wikidata; Q54954674
RX   PubMed=24876102;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_61397; Neratinib (Nerlynx; HKI-272).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   SKBR3-PR
AC   CVCL_EQ69
SY   SKBR3 PR
DR   cancercelllines; CVCL_EQ69
DR   GEO; GSM183442
DR   GEO; GSM183443
DR   Wikidata; Q54954676
RX   PubMed=17560336;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 12
//
ID   SKBR3-TR
AC   CVCL_LG19
DR   cancercelllines; CVCL_LG19
DR   Wikidata; Q54954677
RX   PubMed=24876102;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00072; Trastuzumab (Herceptin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   SKBR3/TDR
AC   CVCL_B3MN
DR   cancercelllines; CVCL_B3MN
DR   Wikidata; Q110433236
RX   CelloPub=CLPUB00650;
RX   PubMed=28821558;
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB05773; Trastuzumab emtansine (T-DM1).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   SkCa1
AC   CVCL_HC05
DR   GEO; GSM29836
DR   GEO; GSM29837
DR   GEO; GSM29838
DR   Wikidata; Q54954681
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa10
AC   CVCL_HC14
DR   GEO; GSM29863
DR   GEO; GSM29864
DR   GEO; GSM29865
DR   Wikidata; Q54954682
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa11
AC   CVCL_HC15
DR   GEO; GSM29866
DR   GEO; GSM29867
DR   GEO; GSM29868
DR   Wikidata; Q54954683
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa12
AC   CVCL_HC16
DR   GEO; GSM29869
DR   GEO; GSM29870
DR   GEO; GSM29871
DR   Wikidata; Q54954684
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa13
AC   CVCL_HC17
DR   GEO; GSM29872
DR   GEO; GSM29873
DR   GEO; GSM29874
DR   Wikidata; Q54954685
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa14
AC   CVCL_HC18
DR   GEO; GSM29875
DR   GEO; GSM29876
DR   GEO; GSM29877
DR   Wikidata; Q54954687
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa15
AC   CVCL_HC19
DR   GEO; GSM29878
DR   GEO; GSM29879
DR   GEO; GSM29880
DR   Wikidata; Q54954688
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa2
AC   CVCL_HC06
DR   GEO; GSM29839
DR   GEO; GSM29840
DR   GEO; GSM29841
DR   Wikidata; Q54954689
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa3
AC   CVCL_HC07
DR   GEO; GSM29842
DR   GEO; GSM29843
DR   GEO; GSM29844
DR   Wikidata; Q54954691
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa4
AC   CVCL_HC08
DR   GEO; GSM29845
DR   GEO; GSM29846
DR   GEO; GSM29847
DR   Wikidata; Q54954693
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa5
AC   CVCL_HC09
DR   GEO; GSM29848
DR   GEO; GSM29849
DR   GEO; GSM29850
DR   Wikidata; Q54954695
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa6
AC   CVCL_HC10
DR   GEO; GSM29851
DR   GEO; GSM29852
DR   GEO; GSM29853
DR   Wikidata; Q54954696
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa7
AC   CVCL_HC11
DR   GEO; GSM29854
DR   GEO; GSM29855
DR   GEO; GSM29856
DR   Wikidata; Q54954715
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa8
AC   CVCL_HC12
DR   GEO; GSM29857
DR   GEO; GSM29858
DR   GEO; GSM29859
DR   Wikidata; Q54954716
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCa9
AC   CVCL_HC13
DR   GEO; GSM29860
DR   GEO; GSM29861
DR   GEO; GSM29862
DR   Wikidata; Q54954718
RX   PubMed=15096622;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 7
//
ID   SkCEFi
AC   CVCL_B6MP
SY   Skin-derived CEF immortal
DR   Wikidata; Q112041716
RX   PubMed=11237869;
RX   PubMed=11420679;
RX   PubMed=11513975;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SKE-hTERT
AC   CVCL_Z586
DR   Wikidata; Q54954720
RX   PubMed=16621759;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_Z587 ! SKE-Spon
OI   CVCL_Z588 ! SKE-SV40LT
SX   Sex unspecified
AG   1W
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   SKE-Spon
AC   CVCL_Z587
DR   Wikidata; Q54954721
RX   PubMed=16621759;
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_Z586 ! SKE-hTERT
OI   CVCL_Z588 ! SKE-SV40LT
SX   Sex unspecified
AG   1W
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 8
//
ID   SKE-SV40LT
AC   CVCL_Z588
DR   Wikidata; Q54954722
RX   PubMed=16621759;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Breed/subspecies: Large White; VBO=VBO_0001163.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_Z586 ! SKE-hTERT
OI   CVCL_Z587 ! SKE-Spon
SX   Sex unspecified
AG   1W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   SKF-9
AC   CVCL_IZ43
SY   Spotted Knifejaw Fry-9
DR   Wikidata; Q54954723
RX   DOI=10.1016/j.aquaculture.2017.02.027;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious spleen and kidney necrosis virus (ISKNV) and red sea bream iridovirus (RSIV) (DOI=10.1016/j.aquaculture.2017.02.027).
CC   Doubling time: ~1-2 days (DOI=10.1016/j.aquaculture.2017.02.027).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=163135; ! Oplegnathus punctatus (Spotted knifejaw)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 6
//
ID   SKF5
AC   CVCL_WY49
SY   SKF-5
DR   Wikidata; Q98132678
RX   PubMed=8570170;
RX   PubMed=9121763;
CC   Problematic cell line: Misclassified. Parent cell line (SK-N-MC) was originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu682_Ala1210del; HERRet fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9967; RET (Note=With p.Met1_Lys662del; HERRet fusion).
CC   Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0530 ! SK-N-MC
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   SKF6
AC   CVCL_WY50
SY   SKF-6
DR   Wikidata; Q98132679
RX   PubMed=8570170;
RX   PubMed=9121763;
CC   Problematic cell line: Misclassified. Parent cell line (SK-N-MC) was originally thought to be a neuroblastoma cell line but shown to be from an Askin tumor.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.170_572del; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Leu682_Ala1210del; HERRet fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9967; RET (Note=With p.Met1_Lys662del; HERRet fusion).
CC   Derived from site: Metastatic; Orbital region; UBERON=UBERON_0004088.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0530 ! SK-N-MC
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   SKG-I
AC   CVCL_2793
SY   SKG-1; SKG1; SKGI
DR   BioSample; SAMN03472778
DR   Cell_Model_Passport; SIDM01853
DR   Cosmic; 877459
DR   Cosmic; 1152537
DR   DepMap; ACH-001651
DR   JCRB; IFO50308
DR   Wikidata; Q54954725
RX   CelloPub=CLPUB00481;
RX   PubMed=3029293;
RX   PubMed=6163305;
RX   PubMed=6174649;
RX   PubMed=7196935;
RX   PubMed=9436037;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 35 (Note=At 20th passage), 42 hours (At 68th passage) (PubMed=7196935).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DepMap=ACH-001651; JCRB=IFO50308
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10
ST   D18S51: 15
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   SKG-I/TS
AC   CVCL_4J75
SY   SKG-I-TS
DR   Cell_Model_Passport; SIDM01918
DR   Wikidata; Q54954726
RX   PubMed=12845668;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2793 ! SKG-I
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 12
//
ID   SKG-II
AC   CVCL_2794
SY   SKGII; SKG-2; SKG2
DR   BioSample; SAMN03470893
DR   BioSample; SAMN03472779
DR   Cell_Model_Passport; SIDM01854
DR   Cosmic; 877460
DR   Cosmic; 1152538
DR   DepMap; ACH-001652
DR   JCRB; IFO50309
DR   JCRB; JCRB0171
DR   Wikidata; Q54954727
RX   CelloPub=CLPUB00434;
RX   CelloPub=CLPUB00481;
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=3029293;
RX   PubMed=9023415;
RX   PubMed=9436037;
RX   PubMed=9573483;
RX   PubMed=10457904;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 31 hours (PubMed=10457904).
CC   HLA typing: A*24:02 (PubMed=9023415).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Unspecified (DepMap=ACH-001652).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: JCRB; JCRB0171; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): DepMap=ACH-001652; JCRB=IFO50309; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 14,16.2
ST   D21S11: 28
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 12
ST   TH01: 7,9 (DepMap=ACH-001652; JCRB=IFO50309)
ST   TH01: 9 (PubMed=25877200)
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VI91 ! SKG-IIB
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   SKG-II-SF
AC   CVCL_8159
SY   SKG-II SF; SKG-II-Serum Free
DR   CLO; CLO_0050918
DR   Cell_Model_Passport; SIDM01917
DR   FANTOM5_SSTAR; 10692-109F8
DR   RCB; RCB0685
DR   Wikidata; Q54954728
RX   PubMed=9573483;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB0685
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2794 ! SKG-II
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SKG-II/LUC
AC   CVCL_4J76
SY   SKG-II-LUC; SKG-II/luciferase
DR   Cell_Model_Passport; SIDM01915
DR   Wikidata; Q54954729
RX   PubMed=12239455;
RX   PubMed=12845668;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2794 ! SKG-II
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 16
//
ID   SKG-II/TS
AC   CVCL_4J77
SY   SKG-II-TS
DR   Cell_Model_Passport; SIDM01914
DR   Wikidata; Q54954731
RX   PubMed=12239455;
RX   PubMed=12845668;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12441; TYMS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2794 ! SKG-II
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 27-11-25; Version: 14
//
ID   SKG-IIB
AC   CVCL_VI91
SY   SKG-2B
DR   Cell_Model_Passport; SIDM01840
DR   Wikidata; Q98132680
RX   CelloPub=CLPUB00434;
CC   Population: Japanese.
CC   Doubling time: 28 hours (Note=At 40th passage) (CelloPub=CLPUB00434).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2794 ! SKG-II
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   SKG-IIIa
AC   CVCL_1704
SY   SKG-IIIA; SKG IIIa; SKGIIIA; SKG-3a; SKG3A; SKG3a
DR   CLO; CLO_0050923
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN01821739
DR   BioSample; SAMN03470894
DR   BioSample; SAMN03471660
DR   cancercelllines; CVCL_1704
DR   Cell_Model_Passport; SIDM00381
DR   ChEMBL-Cells; CHEMBL3308786
DR   ChEMBL-Targets; CHEMBL1075581
DR   Cosmic; 877461
DR   Cosmic; 930298
DR   Cosmic; 1152539
DR   Cosmic; 1995630
DR   Cosmic-CLP; 930298
DR   DepMap; ACH-002020
DR   EGA; EGAS00001000978
DR   GDSC; 930298
DR   GEO; GSM1670429
DR   IARC_TP53; 27576
DR   JCRB; IFO50310
DR   JCRB; JCRB0232
DR   LINCS_LDP; LCL-1804
DR   PharmacoDB; SKGIIIa_1417_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1704
DR   RCB; RCB1892
DR   TKG; TKG 0462
DR   Wikidata; Q54954734
RX   CelloPub=CLPUB00481;
RX   PubMed=6600963;
RX   PubMed=6699456;
RX   PubMed=8380785;
RX   PubMed=9290701;
RX   PubMed=15099960;
RX   PubMed=20164919;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35692560;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>C); ClinVar=VCV000376624; Zygosity=Heterozygous (Cosmic-CLP=930298; DepMap=ACH-002020).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.18%; Native American=0%; East Asian, North=84.88%; East Asian, South=14.94%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): Cosmic-CLP=930298; JCRB=IFO50310; JCRB=JCRB0232; PubMed=25877200; RCB=RCB1892; TKG=TKG 0462
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,26
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 10 (JCRB=JCRB0232)
ST   D7S820: 10,12 (Cosmic-CLP=930298; PubMed=25877200; JCRB=IFO50310; RCB=RCB1892; TKG=TKG 0462)
ST   D8S1179: 11,15
ST   FGA: 21,22
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2795 ! SKG-IIIb
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SKG-IIIb
AC   CVCL_2795
SY   SKG-3b; SKG3B; SKG3b
DR   CLO; CLO_0009931
DR   BioSample; SAMN03470895
DR   BioSample; SAMN03472780
DR   cancercelllines; CVCL_2795
DR   Cosmic; 1152540
DR   GEO; GSM827212
DR   JCRB; FDSC0026
DR   JCRB; IFO50311
DR   JCRB; JCRB0232.1
DR   LINCS_LDP; LCL-1543
DR   Progenetix; CVCL_2795
DR   Wikidata; Q54954736
RX   CelloPub=CLPUB00481;
RX   PubMed=3029293;
RX   PubMed=6600963;
RX   PubMed=6699456;
RX   PubMed=8380785;
RX   PubMed=15099960;
RX   PubMed=20215515;
RX   PubMed=25877200;
RX   PubMed=35692560;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; FDSC0026; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): JCRB=IFO50311; JCRB=JCRB0232.1; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 31.2
ST   D2S1338: 26
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1704 ! SKG-IIIa
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SKH-R
AC   CVCL_0I62
DR   CCLV; CCLV-RIE 0483
DR   Wikidata; Q54954737
RX   PubMed=19941903;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=31138; ! Trachemys scripta elegans (Red-eared slider turtle)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SKH1 [Human leukemia]
AC   CVCL_C124
SY   SKH-1
DR   Cosmic; 919117
DR   Cosmic; 947370
DR   Cosmic; 1012118
DR   Wikidata; Q54954739
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8313895;
RX   PubMed=9510473;
RX   PubMed=10576511;
RX   PubMed=15156182;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=8313895; PubMed=10576511).
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   SKH1 [Mouse hybridoma against human 40 kDa cytokeratin]
AC   CVCL_B5Y2
DR   Wikidata; Q112041717
RX   PubMed=2668356;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Human 40 kDa cytokeratin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SKI-DLCL-1
AC   CVCL_E053
SY   SKI-DLBCL1; SKI; SKI-DCLC; GM20259
DR   CLO; CLO_0027837
DR   EFO; EFO_0005460
DR   Coriell; GM20259
DR   Cosmic; 1945191
DR   Wikidata; Q54954741
RX   PubMed=11426565;
RX   PubMed=23292937;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   SKII.4
AC   CVCL_A0AQ
DR   Wikidata; Q108821311
RX   PubMed=15034010;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P15151; Human PVR/CD155.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Skin.2.6A2.1A8
AC   CVCL_B7CU
SY   SKIN2
DR   Wikidata; Q112930408
RX   Patent=US9574007;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4245.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 4
//
ID   SKiPSc1
AC   CVCL_GQ04
DR   Wikidata; Q54954743
RX   PubMed=27558616;
CC   From: King Abdulaziz City for Science and Technology (KACST); Riyadh; Saudi Arabia.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   SKK-1
AC   CVCL_S607
SY   SKK1
DR   cancercelllines; CVCL_S607
DR   Cosmic; 1465963
DR   GEO; GSM2124118
DR   Progenetix; CVCL_S607
DR   Wikidata; Q54954745
RX   PubMed=15996938;
RX   PubMed=27750403;
RX   PubMed=28751768;
RX   PubMed=34707142;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=15996938).
CC   Karyotypic information: Has a chromosome 8 trisomy. 47,XY,add(4)(p16),+8,add(12)(p13) (PubMed=15996938).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:8033; NTRK3; Name(s)=ETV6-NTRK3, TEL-TRKC; Note=In frame (PubMed=28751768; PubMed=34707142).
CC   Sequence variation: Mutation; HGNC; HGNC:12453; U2AF1; Simple; p.Ser34Phe (c.101C>T); ClinVar=VCV000376025; Zygosity=Heterozygous (PubMed=27750403).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Diesch, Jeannine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29,32
ST   D2S1338: 19,20
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 17
//
ID   SKLOi001-A
AC   CVCL_YT42
DR   hPSCreg; SKLOi001-A
DR   SKIP; SKIP005730
DR   Wikidata; Q98132681
RX   PubMed=32278302;
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2020; CLCN2; Simple; p.Arg753Ter (c.2257C>T); ClinVar=VCV002418913; Zygosity=Homozygous (PubMed=32278302).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C171603; Leukoencephalopathy with ataxia
DI   ORDO; Orphanet_363540; Leukoencephalopathy with mild cerebellar ataxia and edema of the white matter
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   SKLOi002-A
AC   CVCL_C1WN
DR   hPSCreg; SKLOi002-A
DR   Wikidata; Q114313031
RX   PubMed=36191543;
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9454; PROM1; Simple; p.Glu207Ter (c.619G>T); Zygosity=Homozygous (PubMed=36191543).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C85078; Stargardt disease
DI   ORDO; Orphanet_827; Stargardt disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SKLOi003-A
AC   CVCL_C1WP
DR   hPSCreg; SKLOi003-A
DR   Wikidata; Q114313032
RX   PubMed=36191543;
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9454; PROM1; Simple; p.Glu207Ter (c.619G>T); Zygosity=Heterozygous (PubMed=36191543).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SKLOi004-A
AC   CVCL_C9GU
DR   BioSamples; SAMEA114299543
DR   hPSCreg; SKLOi004-A
DR   Wikidata; Q123033511
RX   PubMed=37708614;
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GV ! SKLOi004-B
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SKLOi004-B
AC   CVCL_C9GV
DR   BioSamples; SAMEA114302067
DR   hPSCreg; SKLOi004-B
DR   Wikidata; Q123033512
RX   PubMed=37708614;
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Eye, conjunctiva; UBERON=UBERON_0001811.
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GU ! SKLOi004-A
SX   Male
AG   1Y9M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SKLOi005-A
AC   CVCL_C9GW
DR   hPSCreg; SKLOi005-A
DR   Wikidata; Q123033513
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GX ! SKLOi005-B
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SKLOi005-B
AC   CVCL_C9GX
DR   hPSCreg; SKLOi005-B
DR   Wikidata; Q123033514
CC   From: State Key Laboratory of Ophthalmology, Sun Yat-sen University; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GW ! SKLOi005-A
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SKLRMe001-A
AC   CVCL_B5RY
DR   BioSamples; SAMEA10315460
DR   hPSCreg; SKLRMe001-A
DR   Wikidata; Q112041719
RX   PubMed=34952435;
CC   From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C185244; Y-linked spermatogenic failure-2
DI   ORDO; Orphanet_1646; Partial chromosome Y deletion
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SKLRMe002-A
AC   CVCL_C0JX
SY   hEPS1-iCas9-B
DR   hPSCreg; SKLRMe002-A
DR   Wikidata; Q112930409
RX   PubMed=35617843;
CC   From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China.
CC   Characteristics: Using CRISPR/Cas9 two different constructs were introduced in the two alleles of the AAVS1 safe harbor locus. In one allele a doxycycline inducible PuroR-Cas9 cassette was introduced while in the other alleles a constitutive reverse tetracycline trans-activator (M2rtTA) expression cassette Neo-M2rtTA was introduced (PubMed=35617843).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   SKLRMe005-A
AC   CVCL_D0LP
DR   BioSamples; SAMEA111482387
DR   hPSCreg; SKLRMe005-A
DR   Wikidata; Q123033515
RX   PubMed=36805323;
CC   From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4174; GATA6; Simple; p.Ser208Alafs*77 (c.620_647del); Zygosity=Heterozygous (PubMed=36805323).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_156532; Rare syndrome with cardiac malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SKLRMi001-A
AC   CVCL_YT43
DR   BioSamples; SAMEA6649903
DR   hPSCreg; SKLRMi001-A
DR   SKIP; SKIP005783
DR   Wikidata; Q98132682
RX   PubMed=32505105;
CC   From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Val904Met (c.2710G>A); ClinVar=VCV002138590; Zygosity=Hemizygous (PubMed=32505105).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120192; Partial androgen insensitivity syndrome
DI   ORDO; Orphanet_90797; Partial androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   SKLRMi001-A-1
AC   CVCL_D0LQ
SY   AR repaired iPSCs
DR   BioSamples; SAMEA112648452
DR   hPSCreg; SKLRMi001-A-1
DR   Wikidata; Q123033516
RX   PubMed=37148822;
CC   From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple_corrected; p.Val904Met (c.2710G>A); ClinVar=VCV002138590; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=37148822).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120192; Partial androgen insensitivity syndrome
DI   ORDO; Orphanet_90797; Partial androgen insensitivity syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YT43 ! SKLRMi001-A
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SKM-1
AC   CVCL_0098
SY   SKM1
DR   BTO; BTO_0006520
DR   CLO; CLO_0037289
DR   EFO; EFO_0006753
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 218
DR   BioSample; SAMN03470798
DR   BioSample; SAMN03473113
DR   BioSample; SAMN10988125
DR   cancercelllines; CVCL_0098
DR   Cell_Model_Passport; SIDM00380
DR   ChEMBL-Cells; CHEMBL3308216
DR   ChEMBL-Targets; CHEMBL2366085
DR   Cosmic; 787477
DR   Cosmic; 909722
DR   Cosmic; 975300
DR   Cosmic; 1012119
DR   Cosmic; 1078731
DR   Cosmic; 1465964
DR   Cosmic; 1551462
DR   Cosmic; 2131566
DR   Cosmic; 2750855
DR   Cosmic-CLP; 909722
DR   DepMap; ACH-000373
DR   DSMZ; ACC-547
DR   DSMZCellDive; ACC-547
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10772-110F7
DR   GDSC; 909722
DR   GEO; GSM482513
DR   GEO; GSM887581
DR   GEO; GSM888664
DR   GEO; GSM1374880
DR   GEO; GSM1446741
DR   GEO; GSM1670435
DR   GEO; GSM2124121
DR   IARC_TP53; 27238
DR   JCRB; JCRB0118
DR   JCRB; NIHS0147
DR   LiGeA; CCLE_537
DR   PharmacoDB; SKM1_1418_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0098
DR   PubChem_Cell_line; CVCL_0098
DR   Wikidata; Q54954746
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8136267;
RX   PubMed=8580805;
RX   PubMed=16408098;
RX   PubMed=20164919;
RX   PubMed=21989985;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27750403;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=8136267); ~48 hours (DSMZ=ACC-547).
CC   HLA typing: A*02:07,33:03; B*40:01,59:01; C*01:02,03:04; DQA1*01:02,03:02; DQB1*04:02,06:01; DRB1*04:05,08:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Tyr591Ter (c.1773C>A); ClinVar=VCV000451016; Zygosity=Homozygous (PubMed=27750403).
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; c.4619-1G>A; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=21989985; PubMed=27750403; Cosmic-CLP=909722; DepMap=ACH-000373).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr646Cys (c.1937A>G); Zygosity=Heterozygous (Cosmic-CLP=909722; DepMap=ACH-000373).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Lys117Asn (c.351A>C); ClinVar=VCV000375965; Zygosity=Homozygous (Cosmic-CLP=909722; DepMap=ACH-000373).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=27750403; Cosmic-CLP=909722; DepMap=ACH-000373).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.67%; East Asian, North=75.52%; East Asian, South=22.98%; South Asian=0%; European, North=0.33%; European, South=0.5% (PubMed=30894373).
CC   Caution: TP53 mutation indicated incorrectly as being at p.Tyr327His (c.981T>C) in PubMed=8136267.
CC   Discontinued: JCRB; NIHS0147; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=909722; DSMZ=ACC-547; JCRB=JCRB0118; PubMed=25877200
ST   Amelogenin: X (Cosmic-CLP=909722; JCRB=JCRB0118)
ST   Amelogenin: X,Y (DSMZ=ACC-547; PubMed=25877200)
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 31.2,32.2
ST   D2S1338: 19,23
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 15,19 (DSMZ=ACC-547)
ST   Penta E: 15,20 (PubMed=25877200)
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SKM-1/HHT
AC   CVCL_IM24
DR   cancercelllines; CVCL_IM24
DR   Wikidata; Q54954747
RX   PubMed=22967374;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_71019; Omacetaxine mepesuccinate (Homoharringtonine; HHT).
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; c.4619-1G>A; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Lys117Asn (c.351A>C); ClinVar=VCV000375965; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   NCIt; C3247; Myelodysplastic syndrome
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0098 ! SKM-1
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   SKMEL28-SLC13A3-KO-c3
AC   CVCL_D4WQ
SY   CE05P4-N
DR   Wikidata; Q127384307
WW   Info; RESOLUTE; CE05P4-N; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14430; SLC13A3.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   SKMEL28-SLC13A3-KO-c4
AC   CVCL_D4WR
SY   CE05P5-H
DR   Wikidata; Q127384309
WW   Info; RESOLUTE; CE05P5-H; https://re-solute.eu/resources/reagents
CC   Part of: Research Empowerment on Solute Carriers (RESOLUTE) KO cell line panel.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14430; SLC13A3.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Pro753Ser (c.2257C>T); ClinVar=VCV000376081; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Thr167Ala (c.499A>G); ClinVar=VCV001686107; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.-57A>C (c.161A>C) (A161C); ClinVar=VCV000242210; Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu145Arg (c.434T>G); ClinVar=VCV001027110; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0526 ! SK-MEL-28
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   SKMEL5/R
AC   CVCL_IW12
DR   cancercelllines; CVCL_IW12
DR   Wikidata; Q54954749
RX   PubMed=26365896;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90295; PLX-4720 (PLX4720).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0527 ! SK-MEL-5
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   SKMES-1-Taxol
AC   CVCL_X336
DR   cancercelllines; CVCL_X336
DR   Wikidata; Q54954751
RX   PubMed=18503785;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0630 ! SK-MES-1
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   SKMES-1-Taxotere
AC   CVCL_X337
DR   cancercelllines; CVCL_X337
DR   Wikidata; Q54954752
RX   PubMed=18503785;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0630 ! SK-MES-1
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   SKN
AC   CVCL_3167
DR   CLO; CLO_0050881
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470820
DR   BioSample; SAMN03472277
DR   cancercelllines; CVCL_3167
DR   Cell_Model_Passport; SIDM00377
DR   Cosmic; 1330908
DR   Cosmic-CLP; 1240215
DR   DepMap; ACH-001655
DR   EGA; EGAS00001000978
DR   GDSC; 1240215
DR   GEO; GSM827211
DR   GEO; GSM1670447
DR   JCRB; FDSC0031
DR   JCRB; IFO50314
DR   JCRB; JCRB0173
DR   PharmacoDB; SKN_1419_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3167
DR   RCB; RCB0513
DR   Wikidata; Q54954754
RX   CelloPub=CLPUB00481;
RX   PubMed=556976;
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=9436037;
RX   PubMed=9573483;
RX   PubMed=10457904;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 36 hours (Note=At 29th passage) (PubMed=556976).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=0%; East Asian, North=0%; East Asian, South=87.84%; South Asian=7.96%; European, North=0%; European, South=3.89% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0031; true.
ST   Source(s): Cosmic-CLP=1240215; DepMap=ACH-001655; JCRB=IFO50314; JCRB=JCRB0173; RCB=RCB0513
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13,15
ST   D21S11: 31.2
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9
ST   Penta E: 5
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C6340; Uterine corpus leiomyosarcoma
DI   ORDO; Orphanet_213625; Leiomyosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SKN [Human T-cell]
AC   CVCL_C4JF
DR   Wikidata; Q116050514
RX   PubMed=8608235;
RX   PubMed=16827800;
CC   Virology: Contains an EBV genome in an episomal form (PubMed=8608235).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C162687; Severe chronic active EBV infection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SKN-3
AC   CVCL_3168
SY   SKN3
DR   CLO; CLO_0009953
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1016
DR   BioSample; SAMN03472486
DR   cancercelllines; CVCL_3168
DR   Cell_Model_Passport; SIDM00375
DR   CGH-DB; 370-2
DR   Cosmic; 1530758
DR   Cosmic; 1530759
DR   Cosmic-CLP; 1299059
DR   DepMap; ACH-002305
DR   EGA; EGAS00001000978
DR   GDSC; 1299059
DR   GEO; GSM827179
DR   GEO; GSM1670448
DR   JCRB; JCRB1039
DR   LINCS_LDP; LCL-1211
DR   PharmacoDB; SKN3_1420_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3168
DR   Wikidata; Q54954755
RX   PubMed=17599052;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from a xenograft established in nude mice.
CC   Doubling time: ~40 hours (Note=Lot 09012008) (JCRB=JCRB1039).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.03%; East Asian, North=76.9%; East Asian, South=21.66%; South Asian=0.86%; European, North=0.55%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1299059; JCRB=JCRB1039
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,12
ST   D5S818: 9
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 18,20
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SKNO-1
AC   CVCL_2196
SY   Skno-1; SKNO1
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473440
DR   BioSample; SAMN10989585
DR   cancercelllines; CVCL_2196
DR   Cell_Model_Passport; SIDM01864
DR   Cosmic; 787478
DR   Cosmic; 975301
DR   Cosmic; 1149337
DR   Cosmic; 1281353
DR   Cosmic; 1524841
DR   Cosmic; 2306239
DR   Cosmic; 2690678
DR   DepMap; ACH-001656
DR   DSMZ; ACC-690
DR   DSMZCellDive; ACC-690
DR   GEO; GSM236805
DR   GEO; GSM236841
DR   IARC_TP53; 16154
DR   JCRB; JCRB1170
DR   Wikidata; Q54954758
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7772516;
RX   PubMed=9738977;
RX   PubMed=10637496;
RX   PubMed=11753612;
RX   PubMed=15843827;
RX   PubMed=18385756;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=36982453;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Doubling time: 48-72 hours (PubMed=7772516); 24 hours (PubMed=25984343); ~35-50 hours (DSMZ=ACC-690); ~38 hours (Note=Lot 06112012), 52-57 hours (Note=Lot 02032016) (JCRB=JCRB1170).
CC   HLA typing: A*02:06:01,31:01:02; B*40:02:01,46:01:01; C*01:02:01,03:04:01; DRA*01:01:01,01:02:02; DRB1*14:02:01,14:02:01 (DSMZCellDive=ACC-690).
CC   Sequence variation: Gene fusion; HGNC; HGNC:10471; RUNX1 + HGNC; HGNC:1535; RUNX1T1; Name(s)=RUNX1-RUNX1T1, AML1-ETO (PubMed=11753612; PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Homozygous (PubMed=18385756; DepMap=ACH-001656).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=7772516; DepMap=ACH-001656).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His368Arg (c.1103G>A); Zygosity=Homozygous (PubMed=7772516; DepMap=ACH-001656).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=1.83%; Native American=0%; East Asian, North=90.65%; East Asian, South=3.5%; South Asian=1.23%; European, North=0.2%; European, South=2.59% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-690; JCRB=JCRB1170
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 13,14
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   SKO-007
AC   CVCL_4974
SY   SKO007; U-226AR1; U-266 AR1
DR   CLO; CLO_0009061
DR   EFO; EFO_0002339
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-8033-1
DR   cancercelllines; CVCL_4974
DR   Cosmic; 2159572
DR   IGRhCellID; SKO007
DR   Progenetix; CVCL_4974
DR   Wikidata; Q54954759
RX   PubMed=6159646;
RX   PubMed=6864164;
RX   PubMed=20215515;
CC   Group: Hybridoma fusion partner cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8033.
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ATCC=CRL-8033-1
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 12,14
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 18
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   SKO-007 clone J3
AC   CVCL_4975
SY   Clone J3 of SKO-007
DR   CLO; CLO_0009062
DR   ATCC; CRL-8033-2
DR   cancercelllines; CVCL_4975
DR   Wikidata; Q54954760
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ATCC=CRL-8033-2
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4974 ! SKO-007
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   SKOV-3/BCRP
AC   CVCL_ZZ42
DR   cancercelllines; CVCL_ZZ42
DR   Wikidata; Q102114919
RX   PubMed=15695404;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Myc-tagged ABCG2/BCRP.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:74; ABCG2.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   SKOV-3/GFP-Luc
AC   CVCL_JY94
DR   cancercelllines; CVCL_JY94
DR   Cell_Biolabs; AKR-225
DR   Wikidata; Q54954761
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Cell_Biolabs; AKR-225; probable.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 17
//
ID   SKOV-3/Luc
AC   CVCL_M089
DR   cancercelllines; CVCL_M089
DR   Cell_Biolabs; AKR-232
DR   Wikidata; Q54954763
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 23
//
ID   SKOV-3/RFP
AC   CVCL_M090
DR   cancercelllines; CVCL_M090
DR   Cell_Biolabs; AKR-253
DR   Wikidata; Q54954764
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Cell_Biolabs; AKR-253; probable.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 23
//
ID   SKOV-3TR
AC   CVCL_4V89
DR   cancercelllines; CVCL_4V89
DR   Wikidata; Q54954765
RX   PubMed=10095106;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   SKOV3 (R)
AC   CVCL_C8XP
DR   Wikidata; Q123033517
RX   PubMed=33519462;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SKOV3-A2
AC   CVCL_VS41
DR   cancercelllines; CVCL_VS41
DR   Wikidata; Q98132683
WW   Provider; UNC OTC; 17-0029; https://web.archive.org/web/20171016202123/http://technologies.unc.edu/technologies/17-0029_cell-line-skov3-a2
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   SKOV3-CisR
AC   CVCL_UI88
DR   cancercelllines; CVCL_UI88
DR   Wikidata; Q98132684
RX   PubMed=21372221;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   SKOV3-GFP-HER2
AC   CVCL_C3C2
DR   cancercelllines; CVCL_C3C2
DR   Sigma-Aldrich; CLL1135
DR   Wikidata; Q114313033
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the C-terminus of the ERBB2 gene (Sigma-Aldrich=CLL1135).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   SKOV3-GFP-HER2 RFP-EGFR
AC   CVCL_C3C3
DR   cancercelllines; CVCL_C3C3
DR   Sigma-Aldrich; CLL1143
DR   Wikidata; Q114313034
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the ERBB2 locus to insert a TagGFP2 construct at the C-terminus of the gene and at the EGFR locus to insert a TagRFP construct at the C-terminus of the gene (Sigma-Aldrich=CLL1143).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3C2 ! SKOV3-GFP-HER2
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   SKOV3-GFP-STAT3
AC   CVCL_C3C1
DR   cancercelllines; CVCL_C3C1
DR   Sigma-Aldrich; CLL1139
DR   Wikidata; Q114313035
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the N-terminus of the STAT3 gene (Sigma-Aldrich=CLL1139).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   SKOV3-luc-D3
AC   CVCL_5J38
SY   SKOV-3-luc-D3
DR   cancercelllines; CVCL_5J38
DR   Revvity/PerkinElmer; 119276
DR   Wikidata; Q54954766
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Revvity/PerkinElmer; 119276; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   SKOV3-Red-FLuc
AC   CVCL_5J11
SY   SKOV3 Red-FLuc; Bioware Brite SKOV3 Red-FLuc; IVISbrite SKOV3 Red F-luc
DR   cancercelllines; CVCL_5J11
DR   Revvity/PerkinElmer; BW119276
DR   Wikidata; Q54954769
CC   Population: Caucasian.
CC   Doubling time: 35 hours (Revvity/PerkinElmer=BW119276).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   SKOV3-TAX/CBP
AC   CVCL_B0WE
DR   cancercelllines; CVCL_B0WE
DR   Wikidata; Q108821312
RX   PubMed=34535163;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SKOV3.A2.1E4
AC   CVCL_E7IY
SY   SKOV3.A2
RX   PubMed=7539040;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02.01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SKOV3.ip1
AC   CVCL_0C84
SY   SKOV3-ip1; Skov3-ip1; SKOV3ip1; SKOV3IP1; SKOV3IP
DR   BTO; BTO_0006557
DR   cancercelllines; CVCL_0C84
DR   PRIDE; PXD003668
DR   Wikidata; Q54954770
RX   PubMed=8094034;
RX   PubMed=23552738;
RX   PubMed=27561551;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 20
//
ID   SKOV3.ip1 PEA-15-AA
AC   CVCL_C4J9
SY   SKOV3.ip1-AA
DR   Wikidata; Q116050515
RX   PubMed=23552738;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8822; PEA15 (Note=With p.Ser104Ala and p.Ser116Ala and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C84 ! SKOV3.ip1
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SKOV3.ip1 PEA-15-DD
AC   CVCL_C4JA
SY   SKOV3.ip1-DD
DR   Wikidata; Q116050516
RX   PubMed=23552738;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8822; PEA15 (Note=With p.Ser104Asp and p.Ser116Asp and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C84 ! SKOV3.ip1
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SKOV3.ip1 PEA-15-WT
AC   CVCL_C4JB
DR   Wikidata; Q116050517
RX   PubMed=23552738;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8822; PEA15 (Note=With a N-terminal HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0C84 ! SKOV3.ip1
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SKOV3/MRP7
AC   CVCL_B3Q0
DR   cancercelllines; CVCL_B3Q0
DR   Wikidata; Q110433238
RX   PubMed=34631561;
CC   Population: Caucasian.
CC   Doubling time: 68.19 +- 1.53 hours (PubMed=34631561).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:52; ABCC10.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   SKOV3/TR
AC   CVCL_HF69
DR   cancercelllines; CVCL_HF69
DR   Wikidata; Q54954771
RX   PubMed=25815442;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKOV3/VP
AC   CVCL_Y280
DR   cancercelllines; CVCL_Y280
DR   CGH-DB; 9125-4
DR   Wikidata; Q54954774
RX   PubMed=7911742;
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 18
//
ID   SKOV3/VP16
AC   CVCL_XB81
DR   cancercelllines; CVCL_XB81
DR   CCRID; 4201PAT-CCTCC00273
DR   Wikidata; Q98132685
RX   Patent=CN101503675B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200905.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   SKP17
AC   CVCL_D5JQ
DR   TKG; TKG 0808
DR   Wikidata; Q127384311
RX   PubMed=19320554;
CC   Derived from site: In situ; Back, skin, dermis; UBERON=UBERON_0001068+UBERON_0002067.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Somatic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   SKPT-0193 Cl.1
AC   CVCL_R942
DR   Wikidata; Q54954775
RX   PubMed=8807581;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R943 ! SKPT-0193 Cl.2
OI   CVCL_R944 ! SKPT-0193 Cl.5
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   SKPT-0193 Cl.2
AC   CVCL_R943
DR   Wikidata; Q54954792
RX   PubMed=8807581;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R942 ! SKPT-0193 Cl.1
OI   CVCL_R944 ! SKPT-0193 Cl.5
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   SKPT-0193 Cl.5
AC   CVCL_R944
DR   Wikidata; Q54954794
RX   PubMed=8807581;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R942 ! SKPT-0193 Cl.1
OI   CVCL_R943 ! SKPT-0193 Cl.2
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   SKPT-1092 Cl.1
AC   CVCL_R945
DR   Wikidata; Q54954795
RX   PubMed=8807581;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R946 ! SKPT-1092 Cl.2
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   SKPT-1092 Cl.2
AC   CVCL_R946
DR   Wikidata; Q54954796
RX   PubMed=8807581;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Spontaneously hypertensive rat (SHR); RS=RS_0000015.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R945 ! SKPT-1092 Cl.1
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   SKR1
AC   CVCL_G366
DR   TKG; TKG 0700
DR   Wikidata; Q54954797
RX   PubMed=9183637;
CC   Population: Japanese.
CC   Doubling time: 28 hours (Note=At 50th passage) (PubMed=9183637).
CC   Caution: The age/sex of donor of this cell line and that of NKK1 (Cellosaurus=CVCL_G365), both described in PubMed=9183637 are inverted in the abstract of that paper. We believe that the information in the material and methods section is the correct one as it is corroborated by the karyotype information in the same paper.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): TKG=TKG 0700
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 16
//
ID   SKS
AC   CVCL_S989
DR   IARC_TP53; 17912
DR   Wikidata; Q54954799
RX   PubMed=11408806;
CC   Population: Japanese.
CC   Doubling time: 44 hours (PubMed=11408806).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn131del (c.390_392delCAA); Zygosity=Unspecified (PubMed=11408806).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7982; Cervical small cell carcinoma
DI   ORDO; Orphanet_213777; High-grade neuroendocrine carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   SKT-1A
AC   CVCL_Y112
DR   Wikidata; Q54954800
RX   PubMed=2972890;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y113 ! SKT-1B
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 9
//
ID   SKT-1B
AC   CVCL_Y113
SY   SKT1B
DR   Cosmic; 919150
DR   Wikidata; Q54954801
RX   PubMed=2972890;
RX   PubMed=9510473;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y112 ! SKT-1A
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   SKVCR0.015
AC   CVCL_IN06
SY   SK VCR 0.015; SKVCR (0.015)
DR   cancercelllines; CVCL_IN06
DR   Wikidata; Q54954802
RX   PubMed=2565764;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKVCR0.1
AC   CVCL_IN07
SY   SK VCR 0.1
DR   cancercelllines; CVCL_IN07
DR   Wikidata; Q54954804
RX   PubMed=2565764;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKVCR0.25
AC   CVCL_IN08
SY   SK VCR 0.25
DR   cancercelllines; CVCL_IN08
DR   Wikidata; Q54954805
RX   PubMed=2565764;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKVCR2.0
AC   CVCL_IN09
SY   SKVCR 2.0; SK VCR 2
DR   cancercelllines; CVCL_IN09
DR   GEO; GSM183342
DR   GEO; GSM183344
DR   Wikidata; Q54954807
RX   PubMed=2565764;
RX   PubMed=17726699;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   SKVLB0.03
AC   CVCL_IN03
SY   SK VLB 0.03; SKVLB (0.03)
DR   cancercelllines; CVCL_IN03
DR   Wikidata; Q54954808
RX   PubMed=2565764;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKVLB0.06
AC   CVCL_IN04
SY   SK VLB 0.06; SKVLB (0.06)
DR   cancercelllines; CVCL_IN04
DR   Wikidata; Q54954809
RX   PubMed=2565764;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKVLB1
AC   CVCL_IN05
SY   SKVLB 1; SKVLB-1; SK VLB 1; SKVLB (1.0); SKVLB
DR   cancercelllines; CVCL_IN05
DR   Wikidata; Q54954810
RX   PubMed=2565764;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 15
//
ID   SKW 6.4
AC   CVCL_3796
SY   SKW6.4; Skw6.4; SKW 6-4; SKW6-Cl4; SKW6-CL4; SKW6 clone 4; SKW6-4
DR   BTO; BTO_0001936
DR   CLO; CLO_0009067
DR   ATCC; TIB-215
DR   ChEMBL-Cells; CHEMBL3307453
DR   ChEMBL-Targets; CHEMBL614928
DR   Lonza; 83
DR   PubChem_Cell_line; CVCL_3796
DR   Wikidata; Q54954813
RX   Patent=US4730036;
RX   PubMed=305004;
RX   PubMed=6339249;
RX   PubMed=6605913;
RX   PubMed=8509142;
RX   PubMed=19220422;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SKW6-Cl4
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a WIL2-A3 derivative (ICLAC). Based on the STR profile. The exact WIL2 derivative has been arbitrarily chosen to be WIL2-A3 because this cell line was used in the lab where SKW 6.4 was derived (PubMed=305004). Originally thought to originate from the Daudi cell line.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00617.
CC   Population: Caucasian.
CC   Characteristics: Produces and secretes IgM.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly59_Thr125del (c.175_375del199); Zygosity=Heterozygous (PubMed=19220422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=TIB-215
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11,16
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 5,7
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7TT ! WIL2-A3
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SKW-3
AC   CVCL_2197
SY   SKW3
DR   BTO; BTO_0006057
DR   CLO; CLO_0009068
DR   CLO; CLO_0051007
DR   CLDB; cl4362
DR   BioSample; SAMN03151818
DR   BioSample; SAMN03473523
DR   cancercelllines; CVCL_2197
DR   CLS; 300343
DR   Cosmic; 913412
DR   Cosmic; 919156
DR   Cosmic; 933546
DR   Cosmic; 1524820
DR   Cosmic; 1641385
DR   DSMZ; ACC-53
DR   DSMZCellDive; ACC-53
DR   FANTOM5_SSTAR; 10416-106C2
DR   NCBI_Iran; C182
DR   RCB; RCB1168
DR   TKG; TKG 0247
DR   Wikidata; Q108821313
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=7849311;
RX   PubMed=8127147;
RX   PubMed=8641406;
RX   PubMed=9510473;
RX   PubMed=9933131;
RX   PubMed=15472075;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/skw-3-ke-37/
CC   Problematic cell line: Contaminated. Shown to be a KE-37 derivative (PubMed=20143388). Originally thought to originate from the peripheral blood of a 61 year old male patient with T cell chronic lymphocytic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00346.
CC   Population: Caucasian.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-53); ~30 hours (CLS=300343).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (PubMed=15472075).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
ST   Source(s): CLS=300343; DSMZ=ACC-53; RCB=RCB1168; TKG=TKG 0247
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 19,22
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D19S433: 13,15
ST   D1S1656: 15.3,16
ST   D21S11: 28,29,30 (CLS=300343)
ST   D21S11: 28,30 (DSMZ=ACC-53)
ST   D2S1338: 19,25
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D6S1043: 18,21
ST   D7S820: 8,12
ST   D8S1179: 11,14
ST   FGA: 24,25
ST   Penta D: 11,15
ST   Penta E: 5,14
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1327 ! KE-37
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   SKW-4
AC   CVCL_A477
SY   SKW4; SKW 4
DR   Cosmic; 999779
DR   Wikidata; Q54954815
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6160588;
RX   PubMed=6329938;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=6329938).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SKW3/Clo
AC   CVCL_4V58
DR   cancercelllines; CVCL_4V58
DR   Wikidata; Q54954817
RX   PubMed=25461250;
CC   Problematic cell line: Contaminated. Parent cell line (SKW-3) has been shown to be a KE-37 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_681569; Clofarabine (CAFdA).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gln2459Ter (c.7375C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg571Gln (c.1712G>A); ClinVar=VCV000819886; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Gly310Glu (c.929G>A); ClinVar=VCV000237678; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2197 ! SKW-3
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   SKX
AC   CVCL_VP43
DR   cancercelllines; CVCL_VP43
DR   IARC_TP53; 17653
DR   Wikidata; Q98132686
RX   CelloPub=CLPUB00439;
RX   PubMed=11799138;
RX   PubMed=19038467;
CC   Characteristics: Established from a xenograft developed by serial transplantation of the original tumor in nude mice (CelloPub=CLPUB00439).
CC   Characteristics: Defective in double-strand break (DSB) DNA repair. Highly radiosensitive, has a TCD50 value of 19.8 Gy (PubMed=19038467).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Unspecified (CelloPub=CLPUB00439; PubMed=11799138).
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   83Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 11
//
ID   Sky
AC   CVCL_A0WZ
DR   Wikidata; Q108821314
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, proximal femur; UBERON=UBERON_0004412.
CC   Breed/subspecies: Boxer; VBO=VBO_0200210.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 6
//
ID   SL-1-TC
AC   CVCL_AS19
SY   SL-1
DR   TKG; TKG 0136
DR   TKG; TKG 0639
DR   Wikidata; Q54954818
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: ACI/N; RS=RS_0000023.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   SL-15
AC   CVCL_Y285
DR   cancercelllines; CVCL_Y285
DR   DSMZ; ACC-955
DR   GEO; GSM866165
DR   Progenetix; CVCL_Y285
DR   Wikidata; Q54954819
RX   PubMed=16049984;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=16049984); ~30-40 hours (DSMZ=ACC-955).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:8619; PAX5; Name(s)=PAX5-IGH (PubMed=16049984).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-955
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 13,15
ST   D19S433: 12,15
ST   D21S11: 30,31.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   SL-29
AC   CVCL_5587
DR   CLO; CLO_0009072
DR   ATCC; CRL-1590
DR   BCRJ; 0367
DR   Wikidata; Q54954820
CC   Group: Bird cell line.
CC   Senescence: Can undergo 35 PDL (ATCC=CRL-1590).
CC   Discontinued: BCRJ; 0367; probable.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: White Leghorn SPAFAS.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   11FD
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   SL-ZSU-1
AC   CVCL_Z321
SY   SL-zsu-1; ZSU-SL-1
DR   ICLDB; sl-zsu-1
DR   Wikidata; Q54954822
RX   CelloPub=CLPUB00174;
RX   DOI=10.3923/jas.2007.4040.4043;
RX   PubMed=21335011;
CC   Group: Insect cell line.
CC   Doubling time: 100-144 hours (CelloPub=CLPUB00174).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   Sl/Sl4
AC   CVCL_6525
DR   CLO; CLO_0009069
DR   ATCC; CRL-2452
DR   TKG; TKG 0736
DR   Wikidata; Q54954824
RX   PubMed=1380155;
RX   PubMed=7507105;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: WBB6 F1 Sl/Sl(d).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   Sl/Sl4 hSCF220
AC   CVCL_6526
SY   Sl/Sl4 hSCF220-3; Sl/Sl4-hSCF200
DR   CLO; CLO_0009070
DR   ATCC; CRL-2453
DR   Wikidata; Q54954825
RX   PubMed=1380155;
RX   PubMed=7507105;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6343; KITLG (Note=Isoform SCF220).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: WBB6 F1 Sl/Sl(d).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6525 ! Sl/Sl4
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Sl/Sl4 hSCF248
AC   CVCL_6527
SY   Sl/Sl4 hSCF248-1
DR   CLO; CLO_0009071
DR   ATCC; CRL-2454
DR   Wikidata; Q54954826
RX   PubMed=1380155;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6343; KITLG (Note=Isoform SCF248).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: WBB6 F1 Sl/Sl(d).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6525 ! Sl/Sl4
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Sl/Sl4-mSCF220
AC   CVCL_UZ97
SY   Sl/Sl4-mSCF-m220
DR   TKG; TKG 0735
DR   Wikidata; Q98132688
RX   PubMed=7507105;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96974; Kitl (Note=Isoform SCF220).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: WBB6 F1 Sl/Sl(d).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6525 ! Sl/Sl4
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   Sl/Sl4-mSCF248
AC   CVCL_C4TG
DR   Wikidata; Q116050518
RX   PubMed=7507105;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96974; Kitl (Note=Isoform SCF248).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: WBB6 F1 Sl/Sl(d).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6525 ! Sl/Sl4
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 5
//
ID   SL0003
AC   CVCL_TZ89
SY   A549 E1Adl01/07-4-E1B-55K-2
DR   cancercelllines; CVCL_TZ89
DR   Wikidata; Q54954828
RX   Patent=US7851218;
RX   PubMed=16246392;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6231.
CC   Population: Caucasian.
CC   Characteristics: Useful for the production of E1-deleted adenovirus (rAd) vectors.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein (Note=With p.Ile4_Glu25del and p.Ser111_Thr123del = dl01/07).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03243; Human adenovirus C serotype 5 E1B 55 kDa protein.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 14
//
ID   SL0006
AC   CVCL_TZ90
DR   cancercelllines; CVCL_TZ90
DR   Wikidata; Q54954829
RX   Patent=US7851218;
RX   PubMed=16246392;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-6663.
CC   Population: Caucasian.
CC   Characteristics: Useful for the production of E1-deleted adenovirus (rAd) vectors.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04495; Human adenovirus C serotype 5 DNA polymerase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein (Note=With p.Ile4_Glu25del and p.Ser111_Thr123del = dl01/07).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03246; Human adenovirus C serotype 5 E1B 19 kDa protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03243; Human adenovirus C serotype 5 E1B 55 kDa protein.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 15
//
ID   SL1
AC   CVCL_X934
SY   SL-1
DR   CGH-DB; 9206-4
DR   Wikidata; Q54954831
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4169243;
RX   PubMed=4321974;
RX   PubMed=4366935;
RX   PubMed=4866767;
RX   PubMed=4894370;
RX   PubMed=5894364;
RX   PubMed=6018567;
RX   PubMed=14293797;
CC   Population: African; Nigerian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 13
//
ID   SL12
AC   CVCL_F832
DR   Wikidata; Q54954833
RX   PubMed=6201262;
CC   Breed/subspecies: AKR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   SL12.1
AC   CVCL_F833
DR   Wikidata; Q54954835
RX   PubMed=6201262;
CC   Breed/subspecies: AKR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F832 ! SL12
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   SL12.4
AC   CVCL_F834
DR   Wikidata; Q54954836
RX   PubMed=6201262;
CC   Breed/subspecies: AKR.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F832 ! SL12
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   SL221
AC   CVCL_RQ41
DR   GEO; GSE68037
DR   ICLDB; sl221
DR   Wikidata; Q54954837
RX   PubMed=26840182;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   SL4
AC   CVCL_D7FA
RX   PubMed=16320114;
CC   Characteristics: Highly metastatic to the liver. Established by 4 successive passage of the parent cell line into the spleen of C57BL/6J female mice (PubMed=16320114).
CC   Doubling time: 16 hours (PubMed=16320114).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 3
//
ID   SL4-1
AC   CVCL_D7FB
RX   PubMed=16320114;
CC   Characteristics: Highly metastatic to the liver (PubMed=16320114).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7FA ! SL4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   SL4-2
AC   CVCL_D7FC
RX   PubMed=16320114;
CC   Characteristics: Highly metastatic to the liver (PubMed=16320114).
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7FA ! SL4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   SL4c
AC   CVCL_U294
DR   Wikidata; Q54954840
RX   PubMed=2414213;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   SLB-1
AC   CVCL_RT63
SY   S-LB1
DR   EFO; EFO_0022363
DR   Wikidata; Q54954841
RX   PubMed=6331549;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 9
//
ID   SLC
AC   CVCL_5365
SY   Sato Lung Cancer; Sato Lung Carcinoma
DR   CLO; CLO_0050828
DR   RCB; RCB2862
DR   TKG; TKG 0135
DR   Wikidata; Q54954842
CC   Breed/subspecies: Donryu; RS=RS_0000253.
DI   NCIt; C64112; Carcinoma of the rat lung
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   SLC-11
AC   CVCL_C8J9
DR   Wikidata; Q123033518
RX   PubMed=2145064;
RX   PubMed=2148162;
RX   PubMed=2470094;
RX   PubMed=8518426;
CC   Doubling time: 17 hours (PubMed=2148162; PubMed=2470094).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein.
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SLC-12
AC   CVCL_C8JA
DR   Wikidata; Q123033519
RX   PubMed=2148162;
RX   PubMed=8518426;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein.
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8J9 ! SLC-11
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SLC-12T
AC   CVCL_C8JB
DR   Wikidata; Q123033520
RX   PubMed=2148162;
RX   PubMed=8518426;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03254; Human adenovirus C serotype 2 E1A protein.
CC   Transformant: NCBI_TaxID; 10515; Human adenovirus C serotype 2.
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8JA ! SLC-12
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SLC-21
AC   CVCL_C8JC
DR   Wikidata; Q123033521
RX   PubMed=2470094;
RX   PubMed=8518426;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SLC-41
AC   CVCL_C8JD
DR   Wikidata; Q123033522
RX   PubMed=2148162;
RX   PubMed=2470094;
RX   PubMed=8518426;
CC   Doubling time: 24 hours (PubMed=2148162).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV40 LP-pUC13).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SLC-44
AC   CVCL_C8JE
DR   Wikidata; Q123033524
RX   PubMed=2148162;
RX   PubMed=8518426;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV40 LP-pUC13).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8JD ! SLC-41
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SLC-44H
AC   CVCL_C8JG
DR   Wikidata; Q123033526
RX   PubMed=8253353;
CC   Characteristics: Control cell line for SCL-44MT (Cellosaurus=CVCL_C8JH) and SLC-44T (Cellosaurus=CVCL_C8JF) (PubMed=8253353).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV40 LP-pUC13).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8JE ! SLC-44
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SLC-44MT
AC   CVCL_C8JH
DR   Wikidata; Q123033527
RX   PubMed=8253353;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV40 LP-pUC13).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8JE ! SLC-44
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SLC-44T
AC   CVCL_C8JF
DR   Wikidata; Q123033530
RX   PubMed=2148162;
RX   PubMed=8253353;
RX   PubMed=8518426;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV40 LP-pUC13).
CC   Derived from site: In situ; Fetal small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C8JE ! SLC-44
SX   Female
AG   19FD
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   Sld1
AC   CVCL_E235
DR   Wikidata; Q54954843
RX   PubMed=3595763;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (WC x C57BL/6)-Sl/Sld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8M
CA   Stromal cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   Sld2
AC   CVCL_E236
DR   Wikidata; Q54954844
RX   PubMed=3595763;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (WC x C57BL/6)-Sl/Sld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8M
CA   Stromal cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   Sld3
AC   CVCL_E237
DR   Wikidata; Q54954846
RX   PubMed=3595763;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: (WC x C57BL/6)-Sl/Sld.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8M
CA   Stromal cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 7
//
ID   SLE005
AC   CVCL_E829
SY   SLE-005; SLE
DR   dbMHC; 49020
DR   ECACC; 88052059
DR   IHW; IHW09059
DR   IPD-IMGT/HLA; 11391
DR   Wikidata; Q54954847
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*40:01:02:01; C*03:04:01:01; DPB1*03:01:01; DQA1*01:02; DQB1*06:04:01; DRB1*13:02:01; DRB3*03:01 (IPD-IMGT/HLA=11391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   SLE#100H
AC   CVCL_A4QH
DR   SKIP; SKIP000920
DR   Wikidata; Q105511098
RX   PubMed=22142803;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QI ! SLE#20J
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SLE#20J
AC   CVCL_A4QI
DR   SKIP; SKIP000921
DR   Wikidata; Q105511101
RX   PubMed=22142803;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QH ! SLE#100H
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   SLET-1
AC   CVCL_F756
SY   Sheep Lymphatic Endothelial Transformed-1
DR   Wikidata; Q54954864
RX   PubMed=10100190;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=776).
CC   Derived from site: In situ; Mesenteric lymphatic vessel; UBERON=UBERON_8480006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   SLF [Leiostomus]
AC   CVCL_S947
SY   Spot Liver Fibroblastic
DR   Wikidata; Q54954865
RX   DOI=10.1016/0044-8486(94)00382-X;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=59837; ! Leiostomus xanthurus (Spot)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   SLF [Rat]
AC   CVCL_IQ78
SY   Spiral Ligament Fibrocyte
DR   Wikidata; Q54954866
RX   PubMed=17214269;
CC   Doubling time: 28.0 +- 8.2 hours (PubMed=17214269).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Ear, inner ear, cochlea, spiral ligament; UBERON=UBERON_0006725.
CC   Cell type: Fibrocyte; CL=CL_0000135.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   5D
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   SLK
AC   CVCL_9569
SY   KS-SLK
DR   BEI_Resources; ARP-9402
DR   BioSample; SAMN03151616
DR   SKY/M-FISH/CGH; 3862
DR   Wikidata; Q54954867
RX   DOI=10.1007/0-306-46861-1_10;
RX   PubMed=7520247;
RX   PubMed=22987579;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Caki-1 derivative (PubMed=22987579). Originally thought to originate from a 28 year old male patient with HIV-1 negative Kaposi sarcoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00477.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (PubMed=7520247).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Leu98Pro (c.293T>C); ClinVar=VCV001502192; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=22987579
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0234 ! Caki-1
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   SLMT-1
AC   CVCL_E305
SY   SLMT1
DR   TOKU-E; 3591
DR   Wikidata; Q54954868
RX   PubMed=11165320;
RX   PubMed=15885884;
CC   Population: Chinese.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: ~31 hours (PubMed=11165320).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   SLN
AC   CVCL_S948
DR   Wikidata; Q54954869
RX   DOI=10.1016/0044-8486(94)00382-X;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=59837; ! Leiostomus xanthurus (Spot)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   SLR20
AC   CVCL_V606
SY   SLR 20
DR   BioGRID_ORCS_Cell_line; 707
DR   BioSample; SAMN10988419
DR   cancercelllines; CVCL_V606
DR   Cell_Model_Passport; SIDM01341
DR   DepMap; ACH-000127
DR   GEO; GSM374467
DR   PharmacoDB; SLR20_1421_2019
DR   Progenetix; CVCL_V606
DR   Wikidata; Q54954870
RX   PubMed=12907621;
RX   PubMed=19470766;
RX   PubMed=19690146;
RX   PubMed=25984343;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (ICLAC). Originally thought to originate from a clear cell renal cell carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00573.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 24 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (DepMap=ACH-000127).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (DepMap=ACH-000127).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0%; Native American=0.52%; East Asian, North=2.35%; East Asian, South=0%; South Asian=0%; European, North=72.79%; European, South=24.34% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D21S11: 29
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 24
//
ID   SLR20.A2
AC   CVCL_UY80
DR   cancercelllines; CVCL_UY80
DR   Wikidata; Q98132689
RX   PubMed=19690146;
CC   Problematic cell line: Contaminated. Parent cell line (SLR20) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*02:01).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V606 ! SLR20
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   SLR21
AC   CVCL_V607
SY   SLR 21
DR   BioSample; SAMN10988415
DR   cancercelllines; CVCL_V607
DR   Cell_Model_Passport; SIDM01862
DR   Cosmic; 2520630
DR   DepMap; ACH-000016
DR   GEO; GSM374468
DR   PharmacoDB; SLR21_1422_2019
DR   Progenetix; CVCL_V607
DR   Wikidata; Q54954872
RX   PubMed=12907621;
RX   PubMed=19470766;
RX   PubMed=22949125;
RX   PubMed=25984343;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 60 hours (PubMed=25984343).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.09%; Native American=0.64%; East Asian, North=0%; East Asian, South=0.43%; South Asian=1.26%; European, North=66.35%; European, South=31.24% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12,14
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D21S11: 28,29
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 8,15
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   SLR22
AC   CVCL_V608
SY   SLR 22
DR   cancercelllines; CVCL_V608
DR   Cosmic; 2520634
DR   GEO; GSM374469
DR   Progenetix; CVCL_V608
DR   Wikidata; Q54954873
RX   PubMed=19470766;
RX   PubMed=19690146;
RX   PubMed=22949125;
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 16,18
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 11,15
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 12
//
ID   SLR23
AC   CVCL_V609
SY   SLR 23
DR   BioGRID_ORCS_Cell_line; 706
DR   BioSample; SAMN10988389
DR   cancercelllines; CVCL_V609
DR   Cell_Model_Passport; SIDM01340
DR   Cosmic; 2520635
DR   DepMap; ACH-000246
DR   GEO; GSM374470
DR   PharmacoDB; SLR23_1423_2019
DR   Progenetix; CVCL_V609
DR   Wikidata; Q54954874
RX   PubMed=12907621;
RX   PubMed=19470766;
RX   PubMed=22949125;
RX   PubMed=25984343;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Heterozygous (DepMap=ACH-000246).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Trp88Ter (c.264G>A); ClinVar=VCV000936684; Zygosity=Heterozygous (DepMap=ACH-000246).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0%; Native American=0.14%; East Asian, North=0.79%; East Asian, South=0%; South Asian=0%; European, North=67.65%; European, South=31.41% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12,16
ST   D21S11: 30,31.2
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,14
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 12,13
ST   Penta E: 13,15
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 23
//
ID   SLR24
AC   CVCL_V610
SY   SLR 24
DR   BioSample; SAMN10988394
DR   cancercelllines; CVCL_V610
DR   Cell_Model_Passport; SIDM01339
DR   Cell_Model_Passport; SIDM01919
DR   Cosmic; 2520643
DR   DepMap; ACH-000272
DR   GEO; GSM374471
DR   PharmacoDB; SLR24_1424_2019
DR   Progenetix; CVCL_V610
DR   Wikidata; Q54954875
RX   PubMed=12907621;
RX   PubMed=19470766;
RX   PubMed=22949125;
RX   PubMed=25984343;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RCC4 derivative (ICLAC).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00574.
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Trp (c.194C>G); ClinVar=VCV000043597; Zygosity=Hemizygous (DepMap=ACH-000272).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=2.8%; East Asian, South=0%; South Asian=0%; European, North=55.96%; European, South=41% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 8
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0498 ! RCC4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   SLR25
AC   CVCL_V611
SY   SLR 25
DR   BioSample; SAMN10988404
DR   cancercelllines; CVCL_V611
DR   Cell_Model_Passport; SIDM01861
DR   Cosmic; 2520639
DR   DepMap; ACH-000300
DR   GEO; GSM374472
DR   PharmacoDB; SLR25_1425_2019
DR   Progenetix; CVCL_V611
DR   Wikidata; Q54954876
RX   PubMed=12907621;
RX   PubMed=19470766;
RX   PubMed=22949125;
RX   PubMed=25984343;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 80 hours (PubMed=25984343).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=0.9%; Native American=0%; East Asian, North=3.02%; East Asian, South=0%; South Asian=0.26%; European, North=57.41%; European, South=38.41% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 28,30
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   SLR26
AC   CVCL_V612
SY   SLR 26
DR   BioGRID_ORCS_Cell_line; 705
DR   BioSample; SAMN10988407
DR   cancercelllines; CVCL_V612
DR   Cell_Model_Passport; SIDM01338
DR   Cosmic; 2520644
DR   DepMap; ACH-000600
DR   GEO; GSM374473
DR   GEO; GSM482712
DR   PharmacoDB; SLR26_1426_2019
DR   Progenetix; CVCL_V612
DR   Wikidata; Q54954877
RX   PubMed=12907621;
RX   PubMed=19470766;
RX   PubMed=22949125;
RX   PubMed=25984343;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 55 hours (PubMed=25984343).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=1.17%; Native American=0%; East Asian, North=1.33%; East Asian, South=1.5%; South Asian=0%; European, North=65.36%; European, South=30.63% (PubMed=30894373).
CC   Miscellaneous: STR profile from personal communication of von Teichman, Adriana.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 28,31
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 15
ST   Penta E: 10,13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   SLU-L
AC   CVCL_RX43
DR   CCLV; CCLV-RIE 0151
DR   Wikidata; Q54954878
RX   PubMed=25565633;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C147532; Sheep lung adenocarcinoma
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SLUGEO
AC   CVCL_F723
DR   IPD-IMGT/HLA; 11392
DR   Wikidata; Q54954879
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:13,11:01; B*35,44:02; C*04,05:01; DPB1*02:01:02,11:01:01 (IPD-IMGT/HLA=11392).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   SLW
AC   CVCL_S949
DR   Wikidata; Q54954881
RX   DOI=10.1016/0044-8486(94)00382-X;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=59837; ! Leiostomus xanthurus (Spot)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   Sly-1
AC   CVCL_E2UX
DR   BTO; BTO_0005617
DR   RIKEN_BRC_EPD; rpc00012
RX   DOI=10.1016/0031-9422(95)00162-Z;
RX   PubMed=10734215;
RX   PubMed=12715150;
CC   Group: Plant cell line.
CC   Caution: According to RIKEN_BRC_EPD=rpc00012, it was first reported in DOI=10.1016/0031-9422(95)00162-Z. But that paper while mentioning cultured tomato cells does not provide any information.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
OX   NCBI_TaxID=4081; ! Solanum lycopersicum (Tomato)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SM [Human B-cell IHW]
AC   CVCL_E830
SY   S.M.
DR   dbMHC; 49021
DR   ECACC; 94061621
DR   IHW; IHW09353
DR   IPD-IMGT/HLA; 11350
DR   Wikidata; Q54954882
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01:01:01,26:03:01; B*39:01:01:03,51:01:01; C*07:02:01:01,03:04:01:02; DPA1*02:02:02; DPB1*05:01:01; DQA1*01:03:01:01,03:01:01; DQB1*03:02:01,06:01:01; DRB1*04:07:01,08:03:02; DRB4*01:03:01 (IPD-IMGT/HLA=11350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   SM [Human chondrosarcoma]
AC   CVCL_M607
DR   Wikidata; Q54954883
RX   PubMed=16039953;
CC   Doubling time: 36 hours (PubMed=16039953).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   SM-1
AC   CVCL_IU19
SY   SM1
DR   EFO; EFO_0002706
DR   BioSamples; SAMEA365986
DR   BioSamples; SAMEA366011
DR   GEO; GSM38808
DR   GEO; GSM38809
DR   Wikidata; Q54954884
RX   PubMed=10554028;
RX   PubMed=15613351;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8285; AIDS-related immunoblastic lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   SM-AP1
AC   CVCL_D117
DR   Wikidata; Q54954886
RX   PubMed=19622142;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=19622142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=19622142).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D118 ! SM-AP2
OI   CVCL_D119 ! SM-AP3
OI   CVCL_D120 ! SM-AP4
OI   CVCL_D121 ! SM-AP5
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SM-AP2
AC   CVCL_D118
DR   Wikidata; Q54954887
RX   PubMed=19622142;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=19622142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=19622142).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D117 ! SM-AP1
OI   CVCL_D119 ! SM-AP3
OI   CVCL_D120 ! SM-AP4
OI   CVCL_D121 ! SM-AP5
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SM-AP3
AC   CVCL_D119
DR   Wikidata; Q54954888
RX   PubMed=19622142;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=19622142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=19622142).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D117 ! SM-AP1
OI   CVCL_D118 ! SM-AP2
OI   CVCL_D120 ! SM-AP4
OI   CVCL_D121 ! SM-AP5
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SM-AP4
AC   CVCL_D120
DR   Wikidata; Q54954890
RX   PubMed=19622142;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=19622142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=19622142).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D117 ! SM-AP1
OI   CVCL_D118 ! SM-AP2
OI   CVCL_D119 ! SM-AP3
OI   CVCL_D121 ! SM-AP5
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SM-AP5
AC   CVCL_D121
DR   Wikidata; Q54954892
RX   PubMed=19622142;
CC   Population: Japanese.
CC   Doubling time: ~31 hours (PubMed=19622142).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=19622142).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D117 ! SM-AP1
OI   CVCL_D118 ! SM-AP2
OI   CVCL_D119 ! SM-AP3
OI   CVCL_D120 ! SM-AP4
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SM-E
AC   CVCL_0C26
DR   Wikidata; Q54954893
RX   PubMed=7736387;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SM-MI-1
AC   CVCL_W283
DR   CGH-DB; 9285-4
DR   Cosmic; 905199
DR   Wikidata; Q54954894
RX   PubMed=15467732;
CC   Population: Japanese.
CC   Misspelling: SM-M1-1; CGH-DB=9285-4.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   Sm-MT
AC   CVCL_5588
SY   SmMT
DR   Wikidata; Q54954895
RX   PubMed=4060590;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C134951; Suncus murinus mammary tumor
OX   NCBI_TaxID=9378; ! Suncus murinus (Asian house shrew)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   SM-S1
AC   CVCL_A9IG
SY   SMS1
DR   CCRID; 5301MAM-KCB04041ZJ
DR   KCB; KCB 200441ZJ
DR   Wikidata; Q108821315
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=415933; ! Myotis altarium (Szechwan myotis)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SM1/9
AC   CVCL_0A33
DR   Wikidata; Q54954897
RX   PubMed=7570575;
CC   Doubling time: 18 hours (PubMed=7570575).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Bone, jaw, mandible, condyle; UBERON=UBERON_0004657.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   SM190.2
AC   CVCL_C8VQ
DR   Wikidata; Q123033531
RX   PubMed=12839934;
CC   Characteristics: Pigmented. Obtained from a pigmented tumor established from a tumor (SM190) transplanted into a syngeneic SCID mouse (PubMed=12839934).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (PubMed=12839934).
CC   Transformant: ChEBI; CHEBI_16236; Ethanol.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Dorsal, skin; UBERON=UBERON_3010006.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8VR ! SM190.626
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SM190.626
AC   CVCL_C8VR
DR   Wikidata; Q123033532
RX   PubMed=12839934;
CC   Characteristics: Amelanotic. Obtained from a pigmented tumor established from a tumor (SM190) transplanted into a syngeneic SCID mouse (PubMed=12839934).
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (PubMed=12839934).
CC   Transformant: ChEBI; CHEBI_16236; Ethanol.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Dorsal, skin; UBERON=UBERON_3010006.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C8VQ ! SM190.2
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   SM2-1
AC   CVCL_H200
DR   Cosmic; 2144976
DR   Wikidata; Q54954899
RX   PubMed=19035443;
RX   PubMed=22578220;
CC   From: Department of Dermatology, Shinshu University; Matsumoto; Japan.
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Hypodermis; Note=In-transit between skin and lymph node; UBERON=UBERON_0002072.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   SM22
AC   CVCL_RU23
SY   PureStem SM22 progenitor; ACTC156
DR   Wikidata; Q54954901
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-156; https://web.archive.org/web/20141202044024/http://www.esibio.com/products/product-category/purestemr-progenitor-sm22/
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   SM25/3
AC   CVCL_0A34
DR   Wikidata; Q54954902
RX   PubMed=7570575;
CC   Doubling time: 13 hours (PubMed=7570575).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Bone, jaw, mandible, condyle; UBERON=UBERON_0004657.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   SM27-1045
AC   CVCL_F765
DR   CLO; CLO_0009078
DR   ATCC; HB-11917
DR   Wikidata; Q54954903
RX   Patent=US6127135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11917.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human stem and progenitor cells marker EM10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   SM28
AC   CVCL_RU24
SY   ACTC150
DR   Millipore; SCC125
DR   Millipore; SCR225
DR   Wikidata; Q54954904
RX   PubMed=18462054;
CC   Discontinued: Millipore; SCC125; true.
CC   Discontinued: Millipore; SCR225; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   SM3
AC   CVCL_H202
DR   cancercelllines; CVCL_H202
DR   Wikidata; Q54954905
RX   PubMed=19035443;
RX   PubMed=22578220;
CC   From: Department of Dermatology, Shinshu University; Matsumoto; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp820Tyr (c.2458G>T); ClinVar=VCV000375928; Zygosity=Unspecified (PubMed=19035443).
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   SM30
AC   CVCL_RV29
SY   PureStem SM30, NCr-fac progenitor; ACTC256
DR   Wikidata; Q54954906
RX   Patent=US8685386;
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-256; https://web.archive.org/web/20141202111942/http://www.esibio.com/purestemr-sm30-progenitor/
CC   Group: Patented cell line.
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10232.
CC   Characteristics: Used to study robust osteochondral differentiation in a facial neural crest progenitor with low levels of hypertrophic marker COL10A1.
CC   Senescence: Can undergo >50 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SM5
AC   CVCL_D158
SY   SM-5
DR   BTO; BTO_0004275
DR   Wikidata; Q54954907
RX   PubMed=15051493;
RX   PubMed=18544163;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Omics: Proteomics; 2DE-MS.
CC   Breed/subspecies: C57BL/6J-Trp53tm1Tyj.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   SM5-1
AC   CVCL_UW40
DR   ATCC; HB-12588
DR   Wikidata; Q98132690
RX   Patent=US7666609;
RX   PubMed=11214818;
RX   PubMed=16405722;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12588.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02751; Human FN1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 5
//
ID   SM7
AC   CVCL_D159
SY   SM-7
DR   BTO; BTO_0004276
DR   Wikidata; Q54954908
RX   PubMed=15051493;
RX   PubMed=18544163;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Omics: Proteomics; 2DE-MS.
CC   Breed/subspecies: C57BL/6J-Trp53tm1Tyj.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   SMA-01
AC   CVCL_WB07
SY   SMA-1; Spinal Muscular Atrophy-01
DR   IBRC; C10591
DR   Wikidata; Q98132691
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y1M
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SMA-02
AC   CVCL_WB08
SY   SMA-2; Spinal Muscular Atrophy-02
DR   IBRC; C10631
DR   Wikidata; Q98132692
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SMA-03
AC   CVCL_WB09
SY   SMA-3; Spinal Muscular Atrophy-03
DR   IBRC; C10632
DR   Wikidata; Q98132694
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SMA-04
AC   CVCL_WB10
SY   SMA-4; Spinal Muscular Atrophy-04
DR   IBRC; C10633
DR   Wikidata; Q98132695
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SMA-05
AC   CVCL_WB11
SY   SMA-5; Spinal Muscular Atrophy-05
DR   IBRC; C10634
DR   Wikidata; Q98132697
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SMA-06
AC   CVCL_WB12
SY   Spinal Muscular Atrophy-06
DR   IBRC; C10700
DR   Wikidata; Q98132698
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   SMA-497
AC   CVCL_6E76
SY   P497
DR   Wikidata; Q54954909
RX   PubMed=3806112;
RX   PubMed=7435141;
RX   PubMed=10493969;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: VM/Dk.
DI   NCIt; C21932; Mouse astrocytic tumours
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6E75 ! SMA-540
OI   CVCL_8580 ! SMA-560
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   SMA-540
AC   CVCL_6E75
SY   P540
DR   Wikidata; Q54954910
RX   PubMed=3806112;
RX   PubMed=7435141;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: VM/Dk.
DI   NCIt; C21932; Mouse astrocytic tumours
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6E76 ! SMA-497
OI   CVCL_8580 ! SMA-560
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   SMA-560
AC   CVCL_8580
SY   SMA 560; SMA560; P560
DR   Millipore; SCC179
DR   PRIDE; PXD000589
DR   Wikidata; Q54954917
RX   PubMed=3806112;
RX   PubMed=7435141;
RX   PubMed=9402588;
RX   PubMed=25894527;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: VM/Dk.
ST   Source(s): Millipore=SCC179
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 18.3
ST   Mouse STR 5-5: 15
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 11
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 18.1
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 14
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26,27
DI   NCIt; C21932; Mouse astrocytic tumours
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6E76 ! SMA-497
OI   CVCL_6E75 ! SMA-540
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   SMA-iPS1
AC   CVCL_L670
DR   SKIP; SKIP005475
DR   Wikidata; Q54954920
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*24,26; B*60,55 (PubMed=22673189).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7del; Zygosity=Unspecified (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 22,23
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 18,22
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 10,13
ST   D7S820: 11,12
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 12,14
ST   Penta E: 14
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L671 ! SMA-iPS2
SX   Female
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   SMA-iPS2
AC   CVCL_L671
DR   SKIP; SKIP005476
DR   Wikidata; Q54954921
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*24,26; B*60,55 (PubMed=22673189).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7del; Zygosity=Unspecified (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 22,23
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13,15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 18,22
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 10,13
ST   D7S820: 11,12
ST   D8S1179: 14,16
ST   FGA: 22
ST   Penta D: 12,14
ST   Penta E: 14
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C85075; Spinal muscular atrophy
DI   ORDO; Orphanet_70; Proximal spinal muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L670 ! SMA-iPS1
SX   Female
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   SMa0006
AC   CVCL_VB74
DR   ECACC; 15102995
DR   Wikidata; Q54954922
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SMa0008
AC   CVCL_VB75
DR   ECACC; 15082822
DR   Wikidata; Q54954923
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SMa0020
AC   CVCL_VB76
DR   ECACC; 15082823
DR   Wikidata; Q54954925
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SMa0031
AC   CVCL_VB77
DR   ECACC; 15102996
DR   Wikidata; Q54954926
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SMa0078
AC   CVCL_VB78
DR   ECACC; 15082824
DR   Wikidata; Q54954927
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SMa0166
AC   CVCL_VB79
DR   ECACC; 15102997
DR   Wikidata; Q54954929
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SMa0211
AC   CVCL_VB80
DR   ECACC; 15082825
DR   Wikidata; Q54954931
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SMa0232
AC   CVCL_VB81
DR   ECACC; 15092925
DR   Wikidata; Q54954932
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SMab-1
AC   CVCL_D3EB
DR   Wikidata; Q127384313
RX   PubMed=21352804;
RX   PubMed=22396072;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O75874; Human IDH1 (Note=With p.Arg132Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   SMab-2
AC   CVCL_D3EC
DR   Wikidata; Q127384315
RX   PubMed=25753205;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2 (Note=With p.Arg172Ser).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   Smac.4M
AC   CVCL_1E65
DR   Wikidata; Q54954933
WW   Provider; Axiogenesis; -; https://web.archive.org/web/20150509040332/http://axiogenesis.com/products/murine-smooth-muscle-cells/smac-4m.html
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Cell type: Smooth muscle cell; CL=CL_0000192.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 7
//
ID   SMAP1dm
AC   CVCL_F960
SY   SMAP1-deficient macrophage
DR   TKG; TKG 0661
DR   Wikidata; Q54954934
CC   Knockout cell: Method=KO mouse; MGI; MGI:2138261; Smap1.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   SMAT1
AC   CVCL_U449
SY   SMAT-1
DR   Wikidata; Q54954935
RX   PubMed=9510068;
RX   PubMed=15541572;
RX   PubMed=15897891;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: (B6.D2 x B6.CBA) F2 AMH-SV40 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6-7D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   SMB [Human]
AC   CVCL_S863
SY   SIM-1
DR   cancercelllines; CVCL_S863
DR   Cosmic; 1388896
DR   IARC_TP53; 23650
DR   Wikidata; Q54954936
RX   PubMed=2844401;
RX   PubMed=8378080;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8378080).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C8776; Peripheral primitive neuroectodermal tumor of bone
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   SMB [Scophthalmus]
AC   CVCL_A9LE
SY   Scophthalmus Maximus Brain
DR   Wikidata; Q108821316
RX   DOI=10.3969/j.issn.1674-7968.2017.05.014;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
ID   SMBCi001-A
AC   CVCL_VF04
SY   trisomy 18 iPSCs; 18T-iPSCs
DR   BioSamples; SAMEA4675130
DR   hPSCreg; SMBCi001-A
DR   Wikidata; Q54954937
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   SMBCi002-A
AC   CVCL_YC54
DR   BioSamples; SAMEA5945659
DR   hPSCreg; SMBCi002-A
DR   SKIP; SKIP005640
DR   Wikidata; Q98132699
RX   PubMed=31986484;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5109; HOXA9; Simple; chr7:g.27165663A>C (g.4868T>C); dbSNP=rs3801776; Zygosity=Homozygous (PubMed=31986484).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C84641; Clubfoot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SMBCi003-A
AC   CVCL_YC55
DR   BioSamples; SAMEA5781308
DR   hPSCreg; SMBCi003-A
DR   SKIP; SKIP005768
DR   Wikidata; Q98132700
RX   PubMed=32554297;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Val166Leufs*7 (c.496_497delGT); ClinVar=VCV000431562; Zygosity=Heterozygous (PubMed=32554297).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC56 ! SMBCi003-B
OI   CVCL_YC57 ! SMBCi003-C
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SMBCi003-B
AC   CVCL_YC56
DR   hPSCreg; SMBCi003-B
DR   SKIP; SKIP005769
DR   Wikidata; Q98132701
RX   PubMed=32554297;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Val166Leufs*7 (c.496_497delGT); ClinVar=VCV000431562; Zygosity=Heterozygous (PubMed=32554297).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC55 ! SMBCi003-A
OI   CVCL_YC57 ! SMBCi003-C
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   SMBCi003-C
AC   CVCL_YC57
DR   hPSCreg; SMBCi003-C
DR   Wikidata; Q98132702
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Val166Leufs*7 (c.496_497delGT); ClinVar=VCV000431562; Zygosity=Heterozygous (from autologous cell lines SMBCi003-A; SMBCi003-B).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YC55 ! SMBCi003-A
OI   CVCL_YC56 ! SMBCi003-B
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SMBCi004-A
AC   CVCL_ZL97
DR   hPSCreg; SMBCi004-A
DR   Wikidata; Q98132703
RX   PubMed=32977293;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (PubMed=32977293).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   SMBCi005-A
AC   CVCL_ZL98
DR   hPSCreg; SMBCi005-A
DR   Wikidata; Q98132704
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   SMBCi006-A
AC   CVCL_A1MZ
DR   BioSamples; SAMEA7361094
DR   hPSCreg; SMBCi006-A
DR   Wikidata; Q102114920
RX   PubMed=33039803;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1NA ! SMBCi006-B
OI   CVCL_A1NB ! SMBCi006-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SMBCi006-B
AC   CVCL_A1NA
DR   hPSCreg; SMBCi006-B
DR   Wikidata; Q102114921
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1MZ ! SMBCi006-A
OI   CVCL_A1NB ! SMBCi006-C
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SMBCi006-C
AC   CVCL_A1NB
DR   hPSCreg; SMBCi006-C
DR   Wikidata; Q102114922
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1MZ ! SMBCi006-A
OI   CVCL_A1NA ! SMBCi006-B
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   SMBCi008-A
AC   CVCL_A8PX
DR   hPSCreg; SMBCi008-A
DR   Wikidata; Q108821317
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SMBCi009-A
AC   CVCL_A1YZ
SY   FH-C3
DR   BioSamples; SAMEA7710160
DR   hPSCreg; SMBCi009-A
DR   Wikidata; Q105511103
RX   PubMed=34974203;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.His583Tyr (c.1747C>T); ClinVar=VCV000200921; Zygosity=Heterozygous (PubMed=34974203).
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Glu650Argfs*15 (c.1948delG); Zygosity=Heterozygous (PubMed=34974203).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   SMBCi010-A
AC   CVCL_A1NC
DR   BioSamples; SAMEA7543834
DR   hPSCreg; SMBCi010-A
DR   Wikidata; Q102114923
RX   PubMed=33360848;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3512; EXT1; Simple; c.1883+1G>T; ClinVar=VCV000961767; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=33360848).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
DI   NCIt; C5183; Hereditary multiple exostoses
DI   ORDO; Orphanet_321; Multiple osteochondromas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   SMBCi011-A
AC   CVCL_B3SI
DR   BioSamples; SAMEA10468112
DR   hPSCreg; SMBCi011-A
DR   Wikidata; Q110433239
RX   PubMed=35203049;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   SMBCi013-A
AC   CVCL_B3SJ
SY   WD-iPSC
DR   BioSamples; SAMEA10107503
DR   hPSCreg; SMBCi013-A
DR   Wikidata; Q110433240
RX   PubMed=34995846;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Ser975Tyr (c.2924C>A) (p.Ser768Tyr, c.2303C>A); ClinVar=VCV000862055; Zygosity=Heterozygous (PubMed=34995846).
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Arg1319Ter (c.3955C>T) (p.Arg1112Ter, c.3334C>T); ClinVar=VCV000035728; Zygosity=Heterozygous (PubMed=34995846).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SMBCi014-A
AC   CVCL_B7E2
DR   BioSamples; SAMEA13603429
DR   hPSCreg; SMBCi014-A
DR   Wikidata; Q112930410
RX   PubMed=35660813;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Pro817Leufs*291 (c.2450delC); ClinVar=VCV000035912; Zygosity=Heterozygous (PubMed=35660813).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SMBCi015-A
AC   CVCL_C0JL
SY   TACH
DR   hPSCreg; SMBCi015-A
DR   Wikidata; Q112930411
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   SMBCi016-A
AC   CVCL_C0JM
DR   hPSCreg; SMBCi016-A
DR   Wikidata; Q112930412
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   SMBCi017-A
AC   CVCL_C0JN
DR   hPSCreg; SMBCi017-A
DR   Wikidata; Q112930413
RX   PubMed=35872524;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SMBCi018-A
AC   CVCL_C0JK
DR   BioSamples; SAMEA14366882
DR   hPSCreg; SMBCi018-A
DR   Wikidata; Q112930414
RX   PubMed=35605480;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9004; PITX1; Simple; p.Gly299Ala (c.896G>C); ClinVar=VCV000286868; Zygosity=Unspecified; Note=De novo mutation (PubMed=35605480).
CC   Caution: Indicated in PubMed=35605480 both as being established from a 12 year old and a 29 year old patient.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C188148; Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly
DI   ORDO; Orphanet_293150; Familial clubfoot due to PITX1 point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SMBCi019-A
AC   CVCL_C0JP
DR   hPSCreg; SMBCi019-A
DR   Wikidata; Q112930415
RX   PubMed=35660814;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp203Ter (c.609G>A); ClinVar=VCV000030800; Zygosity=Heterozygous (PubMed=35660814).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SMBCi020-A
AC   CVCL_C1WA
DR   hPSCreg; SMBCi020-A
DR   Wikidata; Q114313036
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   SMBCi021-A
AC   CVCL_D0LR
DR   hPSCreg; SMBCi021-A
DR   Wikidata; Q123033533
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SMC-1
AC   CVCL_J121
DR   Wikidata; Q54954939
RX   PubMed=3159086;
CC   Population: Chinese.
CC   Doubling time: ~32 hours (PubMed=3159086).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   SMC-L001
AC   CVCL_X018
DR   cancercelllines; CVCL_X018
DR   Cosmic; 2563250
DR   Wikidata; Q54954940
RX   PubMed=24569940;
CC   Population: Korean.
CC   Doubling time: 70 hours (PubMed=24569940).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=24569940).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=24569940).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=24569940
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 18,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 12
//
ID   SmcMF
AC   CVCL_T067
DR   Wikidata; Q54954941
RX   PubMed=23674870;
CC   Doubling time: 17.2 hours (PubMed=23674870).
CC   Derived from site: In situ; Colon, mucosa; UBERON=UBERON_0000317.
CC   Cell type: Myofibroblast; CL=CL_0000186.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   SMCPGHi001-A
AC   CVCL_A1WW
SY   SMCPGHi-ABCA3; SMCPGi001-A
DR   BioSamples; SAMEA7462439
DR   hPSCreg; SMCPGHi001-A
DR   Wikidata; Q105511106
RX   PubMed=33839547;
CC   From: The Seven Medical Center of PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:33; ABCA3; Simple; p.Ala1046Val (c.3137C>T); ClinVar=VCV003366688; Zygosity=Heterozygous (PubMed=33839547).
CC   Sequence variation: Mutation; HGNC; HGNC:33; ABCA3; Simple; p.Arg1333Glyfs*24 (c.3997_3998delAG); ClinVar=VCV001317554; Zygosity=Heterozygous (PubMed=33839547).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33839547
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 19,22
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 14
ST   D1S1656: 15,16
ST   D21S11: 30
ST   D2S1338: 20,22
ST   D3S1358: 17,18
ST   D5S818: 7,9
ST   D6S1043: 14,20
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 20,21.2
ST   Penta D: 9,15
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C99070; Pulmonary surfactant metabolism dysfunction-3
DI   ORDO; Orphanet_440402; Interstitial lung disease due to ABCA3 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 9
//
ID   SMCPGi001-A
AC   CVCL_B3SK
SY   SMCPGHi-HNRNPH2
DR   Wikidata; Q110433241
RX   PubMed=34763229;
CC   From: The Seven Medical Center of PLA General Hospital; Beijing; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:5042; HNRNPH2; Simple; p.Arg206Trp (c.616C>T); ClinVar=VCV000225760; Zygosity=Heterozygous; Note=De novo mutation (PubMed=34763229).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183311; Intellectual developmental disorder, X-linked, syndromic, Bain type
DI   ORDO; Orphanet_777; X-linked non-syndromic intellectual disability
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   SME-1
AC   CVCL_T726
SY   Silurus Meridionalis Embryo-1
DR   Wikidata; Q54954943
RX   CelloPub=CLPUB00253;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=175797; ! Silurus meridionalis (Southern catfish)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 27-11-25; Version: 9
//
ID   SME1.Lu
AC   CVCL_UH27
DR   ATCC; CRL-6454
DR   Wikidata; Q98132705
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6454; true.
CC   Derived from site: In situ; Embryonic lung, bronchus; UBERON=UBERON_0002185.
CC   Derived from site: In situ; Embryonic lung; Note=Uncertainty of sampling site; UBERON=UBERON_0005597.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   16FD
CA   Undefined cell line type
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   SME2.Lu
AC   CVCL_UH28
DR   ATCC; CRL-6455
DR   Wikidata; Q98132706
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6455; true.
CC   Derived from site: In situ; Embryonic lung, bronchus; UBERON=UBERON_0002185.
CC   Derived from site: In situ; Embryonic lung; Note=Uncertainty of sampling site; UBERON=UBERON_0005597.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Undefined cell line type
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   SME3.Lu
AC   CVCL_UH29
DR   ATCC; CRL-6456
DR   Wikidata; Q98132707
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6456; true.
CC   Derived from site: In situ; Embryonic lung, bronchus; UBERON=UBERON_0002185.
CC   Derived from site: In situ; Embryonic lung; Note=Uncertainty of sampling site; UBERON=UBERON_0005597.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   20FD
CA   Undefined cell line type
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 7
//
ID   SMF No.12
AC   CVCL_0H75
DR   SKIP; SKIP000569
DR   Wikidata; Q54954944
RX   PubMed=24859480;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SMF No.15
AC   CVCL_0H76
DR   SKIP; SKIP000570
DR   Wikidata; Q54954945
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   SMF No.16
AC   CVCL_0H77
DR   SKIP; SKIP000571
DR   Wikidata; Q54954946
RX   PubMed=24859480;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SMF No.17
AC   CVCL_0H78
DR   SKIP; SKIP000572
DR   Wikidata; Q54954947
RX   PubMed=24859480;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SMF No.20
AC   CVCL_0H79
DR   SKIP; SKIP000573
DR   Wikidata; Q54954948
RX   PubMed=24859480;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SMF No.21
AC   CVCL_0H80
DR   SKIP; SKIP000574
DR   Wikidata; Q54954949
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   SMF No.5
AC   CVCL_0H70
DR   SKIP; SKIP000565
DR   Wikidata; Q54954950
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   SMF No.6
AC   CVCL_0H71
DR   SKIP; SKIP000566
DR   Wikidata; Q54954951
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   SMF No.7
AC   CVCL_0H72
DR   SKIP; SKIP000567
DR   Wikidata; Q54954952
RX   PubMed=24859480;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SMF No.8
AC   CVCL_0H73
DR   SKIP; SKIP000568
DR   Wikidata; Q54954953
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H74 ! SMF No.9
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   SMF No.9
AC   CVCL_0H74
DR   Wikidata; Q54954954
RX   PubMed=24859480;
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=24859480).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C27701; Secondary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H70 ! SMF No.5
OI   CVCL_0H71 ! SMF No.6
OI   CVCL_0H72 ! SMF No.7
OI   CVCL_0H73 ! SMF No.8
OI   CVCL_0H75 ! SMF No.12
OI   CVCL_0H76 ! SMF No.15
OI   CVCL_0H77 ! SMF No.16
OI   CVCL_0H78 ! SMF No.17
OI   CVCL_0H79 ! SMF No.20
OI   CVCL_0H80 ! SMF No.21
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   SMG
AC   CVCL_E9WY
SY   Scophthalmus Maximus Gill
RX   PubMed=40058675;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 16 to 28 Celsius, the optimal temperature is 24 Celsius (PubMed=40058675).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SMG-B3
AC   CVCL_B6FM
DR   Wikidata; Q112041720
RX   PubMed=22358741;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   SMG-BD9
AC   CVCL_B6FP
DR   Wikidata; Q112041721
RX   PubMed=22358741;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   SMG-C10
AC   CVCL_6953
SY   SMG C10; SMGC10; Submandibular C10; C10
DR   Wikidata; Q54954955
RX   PubMed=9112124;
RX   PubMed=9825893;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Salivary gland acinar cell; CL=CL_0002623.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   21-42D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SMG-C6
AC   CVCL_6954
SY   SMG C6; SMGC6; Submandibular C6; C6
DR   BTO; BTO_0004220
DR   Wikidata; Q54954956
RX   PubMed=9112124;
RX   PubMed=9825893;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Salivary gland acinar cell; CL=CL_0002623.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   21-42D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SMG-F3
AC   CVCL_B6FN
DR   Wikidata; Q112041722
RX   PubMed=22358741;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   SMG-G10
AC   CVCL_B6FS
DR   Wikidata; Q112041723
RX   PubMed=22358741;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   SMG-G4
AC   CVCL_B6FQ
DR   Wikidata; Q112041724
RX   PubMed=22358741;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   SMG-G9
AC   CVCL_B6FR
DR   Wikidata; Q112041725
RX   PubMed=22358741;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_9185; Solamargine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 4
//
ID   SMG-hu-1
AC   CVCL_B3NC
DR   Wikidata; Q110433242
RX   CelloPub=CLPUB00653;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
ST   Source(s): CelloPub=CLPUB00653
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 13
ST   D7S820: 9,10
ST   TH01: 7.9
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SMI
AC   CVCL_E7B4
RX   PubMed=36809593;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 16 to 32 Celsius, the optimal temperature is 24 Celsius (PubMed=36809593).
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SMIE
AC   CVCL_9Y73
SY   RSMG 2C-2; 2C-2
DR   Wikidata; Q54954957
RX   PubMed=2164809;
RX   PubMed=9426293;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A).
CC   Miscellaneous: Assignment of SMIE to RSMG 2C-2 from personal communication of Tabak, Lawrence A.
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   sMISK
AC   CVCL_W333
DR   Wikidata; Q54954958
RX   PubMed=7531680;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W332 ! MISK81-5
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   SMITH
AC   CVCL_W397
DR   Wikidata; Q54954959
RX   CelloPub=CLPUB00019;
RX   PubMed=10936422;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   SMKT-R1
AC   CVCL_A749
SY   SMKT-R-1; SMKTR1
DR   Wikidata; Q54954961
RX   PubMed=1433606;
RX   PubMed=2051699;
RX   PubMed=2815432;
RX   PubMed=8620516;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Doubling time: 180 hours (PubMed=2815432).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SMKT-R2
AC   CVCL_A750
SY   SMKT-R-2; SMKT R2; SMKTR2
DR   Cosmic; 849380
DR   Wikidata; Q54954962
RX   PubMed=1433606;
RX   PubMed=2051699;
RX   PubMed=2815432;
RX   PubMed=11146448;
RX   PubMed=24477694;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Characteristics: Established from a xenotransplantable tumor at passage 2 in a nude mouse (PubMed=2815432).
CC   Doubling time: 56.4 hours (PubMed=2815432).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SMKT-R3
AC   CVCL_A751
SY   SMKT-R-3; SMKT R3; SMKTR3
DR   Cosmic; 849381
DR   Wikidata; Q54954964
RX   PubMed=1433606;
RX   PubMed=2051699;
RX   PubMed=2815432;
RX   PubMed=8620516;
RX   PubMed=11146448;
RX   PubMed=24477694;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Characteristics: Established from a xenotransplantable tumor at passage 1 in a nude mouse (PubMed=2815432).
CC   Doubling time: 55.7 hours (PubMed=2815432).
CC   Misspelling: SMTK-R3; Note=Occasionally.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   SMKT-R4
AC   CVCL_A752
SY   SMKT-R-4; SMKTR4
DR   Wikidata; Q54954965
RX   PubMed=1433606;
RX   PubMed=2051699;
RX   PubMed=8620516;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SML, clone 4D8
AC   CVCL_6446
SY   SML; 4D8; Squirrel Monkey Lymphoblastic cell line
DR   CLO; CLO_0009090
DR   ATCC; CRL-2311
DR   Wikidata; Q54954975
RX   PubMed=10090044;
WW   Info; KCCMR; -; https://web.archive.org/web/20110829112150/http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   SMMC-7721
AC   CVCL_0534
AS   CVCL_B400
SY   SMMC 7721; SMMC7721; H7721; H-7721
DR   BTO; BTO_0003227
DR   MCCL; MCC:0000433
DR   ChEMBL-Cells; CHEMBL3308059
DR   ChEMBL-Targets; CHEMBL613831
DR   Cosmic; 852773
DR   Cosmic; 1060081
DR   Cosmic; 1499248
DR   Cosmic; 2773184
DR   GEO; GSM501779
DR   GEO; GSM936777
DR   GEO; GSM1374884
DR   PubChem_Cell_line; CVCL_0534
DR   Ubigene; YC-C056
DR   Wikidata; Q54954976
RX   PubMed=12717835;
RX   PubMed=17552011;
RX   PubMed=23505090;
RX   PubMed=26116706;
RX   PubMed=28807831;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-587.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/smmc-7721-xenograft-model/
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28807831). Originally thought to originate from a hepatocellular carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00554.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Formerly the CCRID database had 3 entries describing this cell line (3111C0001CCC000087, 3131C0001000700052, 3142C0001000000063). They were one of the sources for the STR profile of this entry.
CC   Misspelling: SMMU-7721; Note=Occasionally.
CC   Misspelling: SMCC-7721; Note=Occasionally.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 20,25,26
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   SMMU-1
AC   CVCL_DG22
SY   SMMUneg
DR   Wikidata; Q54954978
RX   PubMed=7511044;
RX   PubMed=8755562;
RX   PubMed=11214818;
RX   PubMed=16405722;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG23 ! SMMU-2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   SMMU-2
AC   CVCL_DG23
SY   SMMU2; SMMUpos
DR   Wikidata; Q54954979
RX   PubMed=7511044;
RX   PubMed=8755562;
RX   PubMed=11214818;
RX   PubMed=16405722;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG22 ! SMMU-1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   SmoA1 Light
AC   CVCL_E8AL
SY   SmoA1-LIGHT
RX   PubMed=10984056;
CC   Characteristics: Transfected with a GLI-responsive firefly luciferase reporter as well as a constitutive (TK promoter driven) Renilla-luciferase reporter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:108075; Smo (Note=With p.Trp539Leu = SmoA1; Activated).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_E8AK ! Shh Light
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SMOV-1
AC   CVCL_S916
SY   SMOV1
DR   Wikidata; Q54954980
RX   DOI=10.1007/BF02492857;
CC   Population: Japanese.
CC   Doubling time: 61.4 hours (DOI=10.1007/BF02492857).
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   SMOV-2
AC   CVCL_S920
SY   SMOV2
DR   Cosmic; 2482701
DR   GEO; GSM416683
DR   Wikidata; Q54954981
RX   PubMed=10695021;
RX   PubMed=20081105;
CC   Population: Japanese.
CC   Doubling time: 48.2 hours (PubMed=10695021).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   SMRC-1
AC   CVCL_5898
DR   Wikidata; Q54954982
RX   PubMed=11737483;
CC   Population: Japanese.
CC   Doubling time: ~6 days (PubMed=11737483).
CC   Karyotypic information: The number of chromosomes varies from 92 to 100 and the modal number is 95 (PubMed=11737483).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SMRC-3
AC   CVCL_5899
DR   Wikidata; Q54954983
RX   PubMed=11737483;
CC   Population: Japanese.
CC   Doubling time: ~2 days (PubMed=11737483).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SMS-CTR
AC   CVCL_A770
SY   SMS_CTR; SMSCTR
DR   cancercelllines; CVCL_A770
DR   Cell_Model_Passport; SIDM01337
DR   Cosmic; 802048
DR   Cosmic; 1097752
DR   Cosmic; 1718105
DR   Cosmic; 2355930
DR   DepMap; ACH-001196
DR   Wikidata; Q54954985
RX   CelloPub=CLPUB00569;
RX   PubMed=2302710;
RX   PubMed=8275086;
RX   PubMed=21948088;
RX   PubMed=22142829;
RX   PubMed=23882450;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Reynolds, Charles Patrick; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Homozygous (PubMed=22142829; DepMap=ACH-001196).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
ST   Source(s): COG; PubMed=21948088
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,31.2
ST   D2S1338: 24
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 10,12
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   SMS-KAN
AC   CVCL_7131
SY   sms-KAN
DR   CGH-DB; 9096-4
DR   Cosmic; 717425
DR   Cosmic; 848932
DR   Cosmic; 922671
DR   Cosmic; 923826
DR   Cosmic; 930079
DR   Cosmic; 1019938
DR   Cosmic; 1526650
DR   GEO; GSM2371260
DR   GEO; GSM2394371
DR   IARC_TP53; 23596
DR   Wikidata; Q54954986
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=8665486;
RX   PubMed=12702577;
RX   PubMed=15390183;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=24792489;
RX   PubMed=28350380;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SMS-KAN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Doubling time: ~95 hours (PubMed=3456456).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 17,21
ST   D19S433: 12
ST   D21S11: 28,30
ST   D2S1338: 18,19
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,9
ST   D8S1179: 14,16
ST   FGA: 19,21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7132 ! SMS-KANR
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SMS-KANR
AC   CVCL_7132
DR   Cosmic; 922672
DR   Cosmic; 1890105
DR   Wikidata; Q54954988
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=8665486;
RX   PubMed=23202128;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SMS-KANR_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: ~69 hours (PubMed=3456456).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 17,21
ST   D19S433: 12
ST   D21S11: 28,30
ST   D2S1338: 18,19
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,9
ST   D8S1179: 14,16
ST   FGA: 19,21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7131 ! SMS-KAN
SX   Female
AG   3Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   SMS-KCL
AC   CVCL_AQ28
DR   Wikidata; Q54954989
RX   PubMed=7037175;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,22
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7133 ! SMS-KCN
OI   CVCL_7134 ! SMS-KCNR
SX   Male
AG   11M
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   SMS-KCN
AC   CVCL_7133
SY   KCN; SMS-KCNs; NB07C
DR   BTO; BTO_0003548
DR   EFO; EFO_0022537
DR   cancercelllines; CVCL_7133
DR   CGH-DB; 71-1
DR   CGH-DB; 9091-4
DR   Cosmic; 717426
DR   Cosmic; 848940
DR   Cosmic; 923827
DR   Cosmic; 1019932
DR   Cosmic; 1162007
DR   Cosmic; 1890077
DR   Cosmic; 2393632
DR   GEO; GSM3145570
DR   GEO; GSM3145730
DR   Wikidata; Q54954990
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2019470;
RX   PubMed=2535691;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=12702577;
RX   PubMed=15150091;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=23202128;
RX   PubMed=24792489;
RX   PubMed=25884760;
RX   PubMed=26342562;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SMS-KCN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=15720811).
CC   Doubling time: ~109 hours (PubMed=3456456).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (PubMed=18724359).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,22
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ28 ! SMS-KCL
OI   CVCL_7134 ! SMS-KCNR
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   SMS-KCN-69n
AC   CVCL_RK69
SY   SMS-KCN69n; KCN-69n; SMS-KCN (69n)
DR   cancercelllines; CVCL_RK69
DR   Wikidata; Q54954991
RX   PubMed=10485488;
RX   PubMed=15720811;
RX   PubMed=26342562;
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7133 ! SMS-KCN
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   SMS-KCN-A
AC   CVCL_WM95
DR   cancercelllines; CVCL_WM95
DR   Wikidata; Q98132708
RX   PubMed=25884760;
CC   Characteristics: Adherent phenotype. Selected by culturing parent cells on collagen coated plates and removing floating cell spheres.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; PTM; Tyrosine phosphorylation.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7133 ! SMS-KCN
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   SMS-KCN11s
AC   CVCL_WZ30
SY   KCN11s
DR   cancercelllines; CVCL_WZ30
DR   Wikidata; Q98132709
RX   PubMed=2019470;
CC   Characteristics: Substrate-adherent type (S-type) (PubMed=2019470).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7133 ! SMS-KCN
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   SMS-KCN5n
AC   CVCL_WZ31
SY   KCN5n
DR   cancercelllines; CVCL_WZ31
DR   Wikidata; Q98132710
RX   PubMed=2019470;
CC   Characteristics: Neuroblastic type (N-type) (PubMed=2019470).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Arg1275Gln (c.3824G>A); ClinVar=VCV000018083; Zygosity=Unspecified (from parent cell line).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7133 ! SMS-KCN
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   SMS-KCNR
AC   CVCL_7134
SY   sms-KCNR; SMSKCNR; KCNR; KCN-R
DR   cancercelllines; CVCL_7134
DR   CGH-DB; 9100-4
DR   Cosmic; 848941
DR   Cosmic; 922673
DR   Cosmic; 1019950
DR   Cosmic; 1109112
DR   Cosmic; 1153804
DR   Cosmic; 1167413
DR   Cosmic; 1518067
DR   Cosmic; 1526651
DR   Cosmic; 2239460
DR   Cosmic; 2393633
DR   GEO; GSM692866
DR   Wikidata; Q54954992
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=7838528;
RX   PubMed=8665486;
RX   PubMed=9283597;
RX   PubMed=11507071;
RX   PubMed=12702577;
RX   PubMed=15390183;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18923523;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SMS-KCNR_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: ~72 hours (PubMed=3456456).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (PubMed=18923523).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,22
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ28 ! SMS-KCL
OI   CVCL_7133 ! SMS-KCN
SX   Male
AG   11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SMS-LHN
AC   CVCL_9539
DR   Cosmic; 717429
DR   Cosmic; 848931
DR   IARC_TP53; 23821
DR   Wikidata; Q54954993
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7037175;
RX   PubMed=8242562;
RX   PubMed=11507071;
RX   PubMed=15720811;
RX   PubMed=15892104;
RX   PubMed=24792489;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SMS-LHN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Characteristics: Neuroblastic type (N-type) (PubMed=15720811).
CC   Doubling time: 216 hours (COG).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,13
ST   D16S539: 8,9
ST   D18S51: 16,19
ST   D19S433: 15
ST   D21S11: 27,28
ST   D2S1338: 17,19
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   TH01: 9.3,10
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   SMS-MSN
AC   CVCL_7135
DR   Cosmic; 930080
DR   Wikidata; Q54954995
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=15892104;
CC   Doubling time: ~85 hours (PubMed=3456456).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SMS-SAL
AC   CVCL_AQ29
DR   Wikidata; Q54954996
RX   PubMed=7037175;
RX   PubMed=11986953;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 16,19
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 19
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7136 ! SMS-SAN
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   SMS-SAN
AC   CVCL_7136
SY   sms-SAN; SMS SAN
DR   cancercelllines; CVCL_7136
DR   Cosmic; 717428
DR   Cosmic; 848933
DR   Cosmic; 1019951
DR   Cosmic; 1162008
DR   Cosmic; 1890107
DR   GEO; GSM2371261
DR   GEO; GSM2394374
DR   GEO; GSM3145589
DR   GEO; GSM3145731
DR   Wikidata; Q54954998
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-008304-6.50015-4;
RX   PubMed=3456456;
RX   PubMed=7037175;
RX   PubMed=11507071;
RX   PubMed=15390183;
RX   PubMed=15892104;
RX   PubMed=16822308;
RX   PubMed=18724359;
RX   PubMed=23202128;
RX   PubMed=24792489;
RX   PubMed=28350380;
WW   Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/SMS-SAN_Cell_Line_Data_Sheet_COGcell_org.pdf
CC   Doubling time: ~71 hours (PubMed=3456456).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (PubMed=18724359; PubMed=28350380).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Pro252fs*144 (c.753_763del11); Zygosity=Unspecified (PubMed=23202128).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 16,19
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,11
ST   FGA: 19
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AQ29 ! SMS-SAL
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   SMS-SB
AC   CVCL_AQ30
SY   SMS/SB; SB
DR   Cosmic; 922680
DR   Cosmic; 1226861
DR   Cosmic; 2361361
DR   Cosmic; 2491100
DR   Wikidata; Q54955000
RX   PubMed=6778921;
RX   PubMed=8547074;
RX   PubMed=9067587;
RX   PubMed=9207458;
RX   PubMed=11986953;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/SMS-SB%20Cell%20Line%20Data%20Sheet.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): COG
ST   Amelogenin: X
ST   CSF1PO: 7,10
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 16,17
ST   D19S433: 12,15
ST   D21S11: 28,30
ST   D2S1338: 19,22
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 18.2,21
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18,21
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 11
//
ID   SMSP
AC   CVCL_C8NG
SY   Scophthalmus Maximus SPleen
DR   CCRID; 4201PAT-CCTCC02208
DR   Wikidata; Q123033534
RX   Patent=CN115651902A;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2022229.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   6M
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SMT/2A LNM
AC   CVCL_3601
DR   CLO; CLO_0009091
DR   ATCC; CRL-6602
DR   Wikidata; Q54955001
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_Y904 ! Rama 900
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SMTC2
AC   CVCL_VZ64
SY   Sub Media Testis Cat 2
DR   IBRC; C11091
DR   Wikidata; Q98132711
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_VZ63 ! ATTC2
OI   CVCL_VY52 ! EPTC2
OI   CVCL_VZ65 ! VTTC2
SX   Male
AG   6Y6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   SMTK-1
AC   CVCL_GS48
DR   Wikidata; Q54955002
RX   PubMed=15160996;
CC   From: Shinsu University School of Medicine; Matsumoto; Japan.
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 6
//
ID   SMU-DDCS
AC   CVCL_D1GI
SY   Sapporo Medical University hospital-DeDifferentiated ChondroSarcoma
DR   Wikidata; Q127384317
RX   PubMed=37454032;
CC   Population: Japanese.
CC   Doubling time: ~16.8 hours (PubMed=37454032).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (PubMed=37454032).
CC   Derived from site: In situ; Proximal femur, cartilage; UBERON=UBERON_0010129.
ST   Source(s): PubMed=37454032
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 10,13
ST   D18S51: 13
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 10
ST   Penta E: 5,18
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   SMU-MFS
AC   CVCL_E6MG
SY   Sapporo Medical University hospital-MyxoFibroSarcoma
RX   PubMed=39625530;
CC   Population: Japanese.
CC   Characteristics: Tumorigenic (PubMed=39625530).
CC   Doubling time: ~24 hours (PubMed=39625530).
CC   Derived from site: In situ; Left forearm, hypodermis; UBERON=UBERON_0002386+UBERON_0002072.
ST   Source(s): PubMed=39625530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 29,33.2
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 19
ST   Penta D: 10,12
ST   Penta E: 9
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C6496; Myxofibrosarcoma
DI   ORDO; Orphanet_79105; Myxofibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SMU1-10
AC   CVCL_IN93
DR   ABM; T0651
DR   Wikidata; Q54955003
RX   PubMed=9170108;
CC   Characteristics: At the permissive temperature (33 Celsius) grow continuously. At the restrictive temperature (39 Celsius) stop dividing and ultimately die within 3 weeks (PubMed=9170108).
CC   Doubling time: ~26 hours (PubMed=9170108).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Discontinued: ABM; T0651; true.
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
CC   Cell type: Uterine smooth muscle cell; CL=CL_0002601.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   4W
CA   Conditionally immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   SMUSHi001-A
AC   CVCL_A8NV
SY   iPSC-SRS
DR   hPSCreg; SMUSHi001-A
DR   Wikidata; Q108821318
RX   PubMed=34098200;
CC   From: Southern Medical University, Shenzhen Hospital; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Karyotypic information: 46,XX.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179867; 46,XX sex reversal 1
DI   ORDO; Orphanet_393; 46,XX testicular disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SMUSHi002-A
AC   CVCL_C6SQ
SY   FUS iPSC
DR   BioSamples; SAMEA114638876
DR   hPSCreg; SMUSHi002-A
DR   Wikidata; Q117704874
RX   PubMed=38141357;
CC   From: Southern Medical University, Shenzhen Hospital; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg521His (c.1562G>A); ClinVar=VCV000016225; Zygosity=Heterozygous (PubMed=38141357).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   SMUSHi003-A
AC   CVCL_D0LS
DR   BioSamples; SAMEA113600920
DR   hPSCreg; SMUSHi003-A
DR   Wikidata; Q123033535
RX   PubMed=38412658;
CC   From: Southern Medical University, Shenzhen Hospital; Shenzhen; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C37308; Focal segmental glomerulosclerosis
DI   ORDO; Orphanet_656; Genetic steroid-resistant nephrotic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   SMUSHi004-A
AC   CVCL_D0LT
DR   hPSCreg; SMUSHi004-A
DR   Wikidata; Q123033536
CC   From: Southern Medical University, Shenzhen Hospital; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SMUSHi005-A
AC   CVCL_D0LU
DR   BioSamples; SAMEA114397770
DR   hPSCreg; SMUSHi005-A
DR   Wikidata; Q123033537
CC   From: Southern Medical University, Shenzhen Hospital; Shenzhen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SMYM-PRGP
AC   CVCL_H199
DR   Cosmic; 2144973
DR   Wikidata; Q54955005
RX   PubMed=17488338;
RX   PubMed=19035443;
RX   PubMed=22578220;
CC   Population: Japanese.
CC   Doubling time: 2-4 days (PubMed=17488338).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Sole, skin; UBERON=UBERON_0013778.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   SMZ-1
AC   CVCL_RL84
SY   SMZ1
DR   cancercelllines; CVCL_RL84
DR   Cell_Model_Passport; SIDM01784
DR   DepMap; ACH-001197
DR   Wikidata; Q54955007
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1316225;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 34 hours (PubMed=1316225).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Ser (c.338T>C); ClinVar=VCV000823709; Zygosity=Unspecified (DepMap=ACH-001197).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   SN-1
AC   CVCL_B075
DR   Cosmic; 996312
DR   Cosmic; 998747
DR   Cosmic; 1037663
DR   Cosmic; 2393017
DR   Wikidata; Q54955009
RX   PubMed=10233379;
RX   PubMed=10706136;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=14671638;
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=10706136).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
ID   SN-512
AC   CVCL_8759
DR   CLO; CLO_0051544
DR   BioSample; SAMN03472137
DR   RCB; RCB1429
DR   Wikidata; Q54955010
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): RCB=RCB1429
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   SN-56/OBR
AC   CVCL_4457
DR   BTO; BTO_0003557
DR   Wikidata; Q54955011
RX   PubMed=10806392;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6554; LEPR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4456 ! SN56
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   SN-Mel
AC   CVCL_7137
DR   cancercelllines; CVCL_7137
DR   Cosmic; 1109810
DR   Cosmic; 1295342
DR   Cosmic; 2647644
DR   Wikidata; Q54955013
RX   PubMed=11121133;
RX   PubMed=11851879;
RX   PubMed=18384130;
RX   PubMed=19799798;
RX   PubMed=21424129;
RX   PubMed=29492214;
CC   Microsatellite instability: Stable (MSS) (PubMed=11851879).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SN-Ow1
AC   CVCL_RN47
DR   Wikidata; Q54955014
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690048;
CC   Population: Japanese.
DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   SN-SY-1
AC   CVCL_N584
DR   Cosmic; 1206121
DR   Wikidata; Q54955015
RX   PubMed=9378564;
CC   Population: Japanese.
CC   Doubling time: ~167 hours (PubMed=9378564).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=9378564).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   SN1
AC   CVCL_C7J9
DR   Wikidata; Q117704875
RX   PubMed=2440562;
RX   PubMed=6600841;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P41732; Human TSPAN7/CD231.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN12A1
AC   CVCL_D105
DR   NCI-DTP; SN12A1
DR   Wikidata; Q54955017
RX   PubMed=3731078;
CC   Population: Caucasian.
CC   Characteristics: Established after implementation of tumor cells in nude mice and culture of a resulting ascitic tumor (PubMed=3731078).
CC   Doubling time: 30.0 hours (PubMed=3731078).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1705 ! SN12C
OI   CVCL_D106 ! SN12K1
OI   CVCL_D107 ! SN12L1
OI   CVCL_D108 ! SN12S1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   SN12C
AC   CVCL_1705
SY   SN-12C; SN12 C
DR   BTO; BTO_0004221
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1705
DR   Cell_Model_Passport; SIDM00094
DR   ChEMBL-Cells; CHEMBL3307518
DR   ChEMBL-Targets; CHEMBL614054
DR   Cosmic; 687942
DR   Cosmic; 849372
DR   Cosmic; 897464
DR   Cosmic; 905979
DR   Cosmic; 974307
DR   Cosmic; 1044262
DR   Cosmic; 1092636
DR   Cosmic; 1175852
DR   Cosmic; 1305377
DR   Cosmic; 1312365
DR   Cosmic; 1998479
DR   Cosmic-CLP; 905979
DR   DepMap; ACH-002199
DR   EGA; EGAS00001000978
DR   GDSC; 905979
DR   GEO; GSM2097
DR   GEO; GSM50230
DR   GEO; GSM50294
DR   GEO; GSM579204
DR   GEO; GSM579205
DR   GEO; GSM579404
DR   GEO; GSM743485
DR   GEO; GSM750840
DR   GEO; GSM799376
DR   GEO; GSM799439
DR   GEO; GSM844695
DR   GEO; GSM844696
DR   GEO; GSM847160
DR   GEO; GSM1153449
DR   GEO; GSM1178609
DR   GEO; GSM1178610
DR   GEO; GSM1181307
DR   GEO; GSM1181325
DR   GEO; GSM1670459
DR   GEO; GSM2124685
DR   IARC_TP53; 18075
DR   KCLB; 80025
DR   NCI-DTP; SN12C
DR   PharmacoDB; SN12C_1428_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1705
DR   PubChem_Cell_line; CVCL_1705
DR   SKY/M-FISH/CGH; 2804
DR   Wikidata; Q54955018
RX   PubMed=2041050;
RX   PubMed=2706827;
RX   PubMed=3335022;
RX   PubMed=3731078;
RX   PubMed=8053494;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=11146448;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20952505;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=36
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 25.9 hours (PubMed=3731078); 29.5 hours (NCI-DTP=SN12C).
CC   HLA typing: A*03,24; B*07,44; C*05,07:02:01; DQB1*03,06:02; DRB1*04:01:01,15:01:01 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Homozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; Cosmic-CLP=905979; DepMap=ACH-002199).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.58%; Native American=1.06%; East Asian, North=0.47%; East Asian, South=0%; South Asian=1.82%; European, North=64.97%; European, South=31.1% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=905979; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D105 ! SN12A1
OI   CVCL_D106 ! SN12K1
OI   CVCL_D107 ! SN12L1
OI   CVCL_D108 ! SN12S1
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
ID   SN12C-PM6
AC   CVCL_9549
SY   SN12CPM6; SN12-PM6; SN12PM6; PM6; LM1
DR   cancercelllines; CVCL_9549
DR   GEO; GSM374474
DR   GEO; GSM579206
DR   GEO; GSM579401
DR   KCLB; 80026
DR   Progenetix; CVCL_9549
DR   Wikidata; Q54955020
RX   PubMed=2706827;
RX   PubMed=8053494;
RX   PubMed=10987313;
RX   PubMed=20952505;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1705 ! SN12C
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   SN12C-PM6-2
AC   CVCL_DG80
SY   LM2
DR   GEO; GSM579207
DR   GEO; GSM579208
DR   GEO; GSM579402
DR   GEO; GSM579403
DR   Wikidata; Q54955021
RX   PubMed=20952505;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu336Ter (c.1006G>T); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9549 ! SN12C-PM6
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   SN12K1
AC   CVCL_D106
SY   SN12 K1
DR   ChEMBL-Cells; CHEMBL3307784
DR   ChEMBL-Targets; CHEMBL1909241
DR   NCI-DTP; SN12K1
DR   PubChem_Cell_line; CVCL_D106
DR   Wikidata; Q54955022
RX   PubMed=3335022;
RX   PubMed=3731078;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Population: Caucasian.
CC   Characteristics: Established after implementation of tumor cells in nude mice and culture of a resulting kidney tumor (PubMed=3731078).
CC   Doubling time: 30.0 hours (PubMed=3731078).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D105 ! SN12A1
OI   CVCL_1705 ! SN12C
OI   CVCL_D107 ! SN12L1
OI   CVCL_D108 ! SN12S1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   SN12L1
AC   CVCL_D107
DR   NCI-DTP; SN12L1
DR   Wikidata; Q54955023
RX   PubMed=3731078;
CC   Population: Caucasian.
CC   Characteristics: Established after implementation of tumor cells in nude mice and culture of a resulting liver tumor (PubMed=3731078).
CC   Doubling time: 30.5 hours (PubMed=3731078).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D105 ! SN12A1
OI   CVCL_1705 ! SN12C
OI   CVCL_D106 ! SN12K1
OI   CVCL_D108 ! SN12S1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   SN12S1
AC   CVCL_D108
DR   NCI-DTP; SN12S1
DR   Wikidata; Q54955024
RX   PubMed=3731078;
CC   Population: Caucasian.
CC   Characteristics: Established after subcutaneous implementation of tumor cells in nude mice and culture of the resulting tumor (PubMed=3731078).
CC   Doubling time: 29.5 hours (PubMed=3731078).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D105 ! SN12A1
OI   CVCL_1705 ! SN12C
OI   CVCL_D106 ! SN12K1
OI   CVCL_D107 ! SN12L1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 11
//
ID   SN161
AC   CVCL_5U32
DR   Wikidata; Q54955033
RX   PubMed=1855225;
RX   PubMed=2185890;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: 129 x NIH Swiss.
DI   NCIt; C21609; Mouse squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 9
//
ID   SN1a
AC   CVCL_C7JA
DR   Wikidata; Q117704876
RX   PubMed=2440562;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P41732; Human TSPAN7/CD231.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN1b
AC   CVCL_C7JB
DR   Wikidata; Q117704877
RX   PubMed=2440562;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P41732; Human TSPAN7/CD231.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN2
AC   CVCL_C7JC
SY   N6; N6-D11
DR   Wikidata; Q117704878
RX   PubMed=3489164;
RX   PubMed=6607954;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Gp37/CD165.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN2a
AC   CVCL_C7JD
DR   Wikidata; Q117704879
RX   PubMed=3489164;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Gp37/CD165.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN2b
AC   CVCL_C7JE
DR   Wikidata; Q117704880
RX   PubMed=3489164;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Gp37/CD165.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN3
AC   CVCL_C7JF
SY   A5-2H10
DR   Wikidata; Q117704881
RX   PubMed=3489635;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN36
AC   CVCL_F954
SY   SN-36
DR   TKG; TKG 0171
DR   Wikidata; Q54955034
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   SN3a
AC   CVCL_C7JG
SY   J3-3D3
DR   Wikidata; Q117704882
RX   PubMed=3489635;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN3b
AC   CVCL_C7JH
SY   N6-3G5-2G1
DR   Wikidata; Q117704883
RX   PubMed=3489635;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P25063; Human CD24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN4
AC   CVCL_C7JI
SY   C3-3A2; SN4 C3-3A2
DR   Wikidata; Q117704884
RX   PubMed=2783384;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P21926; Human CD9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN4741
AC   CVCL_S466
DR   BTO; BTO_0006140
DR   Wikidata; Q54955035
RX   PubMed=9870933;
RX   PubMed=22863662;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, substantia nigra; UBERON=UBERON_0006238+UBERON_0002038.
CC   Cell type: Dopaminergic neuron; CL=CL_0000700.
CC   Breed/subspecies: (CBA/J x C57BL/6) F2 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Conditionally immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   SN48
AC   CVCL_VI62
SY   SN-48
DR   Wikidata; Q98132713
RX   PubMed=2331789;
RX   PubMed=8254366;
CC   Characteristics: Hybrid of septal neuronal cells from postnatal day 21 mice with the N18TG2 neuroblastoma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 4
//
ID   SN5
AC   CVCL_C7JJ
SY   N6-5D2-F10
DR   Wikidata; Q117704885
RX   PubMed=2435407;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN56
AC   CVCL_4456
SY   SN-56; SN56.B5.G4; SN56 B5 G4
DR   BTO; BTO_0003556
DR   EFO; EFO_0002081
DR   Wikidata; Q54955036
RX   PubMed=2331789;
CC   Characteristics: Hybrid of septal neuronal cells from postnatal day 21 mice with the N18TG2 neuroblastoma.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2132 ! N18TG2
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   SN5a
AC   CVCL_C7JK
SY   M6-2E3
DR   Wikidata; Q117704886
RX   PubMed=2435407;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN5b
AC   CVCL_C7JL
SY   I3-3C2
DR   Wikidata; Q117704887
RX   PubMed=2435407;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN5c
AC   CVCL_C7JM
SY   L4-1A1
DR   Wikidata; Q117704888
RX   PubMed=2435407;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08473; Human MME/CD10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN6
AC   CVCL_C7JN
SY   N1-3A1
DR   Wikidata; Q117704890
RX   PubMed=3464004;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN6j
AC   CVCL_E9ZV
SY   Y4-2F1
DR   ABCD; ABCD_AA785
RX   PubMed=10037187;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SN6k
AC   CVCL_E9ZW
SY   P3-2G8
RX   PubMed=10037187;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SN8
AC   CVCL_C7JP
SY   3A2-2E7-1F5
DR   Wikidata; Q117704891
RX   PubMed=8417805;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40259; Human CD79B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN8a
AC   CVCL_C7JQ
SY   3B3-1D2-1A2
DR   Wikidata; Q117704892
RX   PubMed=8417805;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40259; Human CD79B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SN8b
AC   CVCL_C7JR
SY   46-1D5-C6
DR   Wikidata; Q117704893
RX   PubMed=8417805;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40259; Human CD79B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SNA-BLL
AC   CVCL_E831
SY   SNANI-BLL; SNA
DR   dbMHC; 49022
DR   ECACC; 94050325
DR   IHW; IHW09245
DR   IPD-IMGT/HLA; 11394
DR   Wikidata; Q54955037
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Moroccan; Berber.
CC   HLA typing: A*03:01,68:02; B*78:01,07:02; C*16:01,07:02; DPB1*04:01 (IPD-IMGT/HLA=11394).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   SNB-1
AC   CVCL_A1IU
SY   LM; Case 35; Surgical Neurology Branch-1
DR   Wikidata; Q102114924
RX   PubMed=2086734;
RX   PubMed=6088716;
RX   PubMed=6275048;
RX   PubMed=6578368;
RX   PubMed=7459816;
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   SNB-19
AC   CVCL_0535
SY   SNB.19; SNB19; Surgical Neurology Branch-19
DR   BTO; BTO_0003761
DR   CLO; CLO_0009093
DR   EFO; EFO_0002342
DR   MCCL; MCC:0000434
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-2219
DR   BioGRID_ORCS_Cell_line; 1486
DR   BioSample; SAMN03151977
DR   BioSample; SAMN03471000
DR   BioSample; SAMN03472567
DR   cancercelllines; CVCL_0535
DR   Cell_Model_Passport; SIDM00109
DR   ChEMBL-Cells; CHEMBL3307552
DR   ChEMBL-Targets; CHEMBL614164
DR   Cosmic; 875894
DR   Cosmic; 897439
DR   Cosmic; 905966
DR   Cosmic; 974241
DR   Cosmic; 1044249
DR   Cosmic; 1092637
DR   Cosmic; 1305361
DR   Cosmic; 1312343
DR   Cosmic; 1746950
DR   Cosmic; 1998480
DR   Cosmic; 2302333
DR   Cosmic; 2367548
DR   Cosmic; 2550361
DR   DepMap; ACH-001198
DR   DSMZ; ACC-325
DR   DSMZCellDive; ACC-325
DR   GEO; GSM2090
DR   GEO; GSM50178
DR   GEO; GSM50242
DR   GEO; GSM326246
DR   GEO; GSM743438
DR   GEO; GSM750785
DR   GEO; GSM799326
DR   GEO; GSM799389
DR   GEO; GSM844697
DR   GEO; GSM847161
DR   GEO; GSM887600
DR   GEO; GSM888683
DR   GEO; GSM1153396
DR   GEO; GSM1181304
DR   GEO; GSM1181321
DR   GEO; GSM2124686
DR   IARC_TP53; 2511
DR   IARC_TP53; 18084
DR   IGRhCellID; SNB19
DR   JCRB; NIHS0294
DR   LINCS_LDP; LCL-1363
DR   NCI-DTP; SNB-19
DR   PharmacoDB; SNB19_1429_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   Progenetix; CVCL_0535
DR   PubChem_Cell_line; CVCL_0535
DR   SKY/M-FISH/CGH; 2822
DR   Wikidata; Q54955038
RX   CelloPub=CLPUB00261;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2041050;
RX   PubMed=3121170;
RX   PubMed=3335022;
RX   PubMed=8528516;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18304946;
RX   PubMed=19372543;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24335698;
RX   PubMed=24670534;
RX   PubMed=25877200;
RX   PubMed=27377824;
RX   PubMed=27807467;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=38861359;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/u251_snb-19.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=55
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-111.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/snb-19-xenograft-model/
CC   Problematic cell line: Contaminated. Shown to be a U-251MG derivative (PubMed=18304946; PubMed=20143388; PubMed=22570425). Originally thought to originate from a 47 year old patient with a left parieto-occipital glioblastoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI-60 cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00268.
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (DSMZ=ACC-325); 34.6 hours (NCI-DTP=SNB-19).
CC   HLA typing: A*02:01:01; B*18; C*05; DPB1*04:02; DQB1*02:01; DRB1*03:01:01 (PubMed=15748285).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Homozygous (PubMed=17088437).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=9331090; PubMed=17088437).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.48%; Native American=0%; East Asian, North=2.88%; East Asian, South=0%; South Asian=0%; European, North=78.25%; European, South=18.39% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-2219; true.
CC   Discontinued: JCRB; NIHS0294; true.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): ATCC=CRL-2219; DSMZ=ACC-325; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (ATCC=CRL-2219; DSMZ=ACC-325; PubMed=19372543)
ST   CSF1PO: 11,12 (ATCC=CRL-2219; DSMZ=ACC-325; PubMed=25877200)
ST   CSF1PO: 12 (PubMed=19372543)
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 22,24
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10 (PubMed=19372543)
ST   D7S820: 10,12 (ATCC=CRL-2219; DSMZ=ACC-325; PubMed=25877200)
ST   D8S1179: 13,15
ST   FGA: 21 (PubMed=19372543)
ST   FGA: 21,25 (DSMZ=ACC-325; PubMed=25877200)
ST   Penta D: 12
ST   Penta E: 7,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   SNB-2
AC   CVCL_A1IT
SY   Surgical Neurology Branch-2
DR   Wikidata; Q102114925
RX   PubMed=6578368;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
ID   SNB-3
AC   CVCL_A1IV
SY   Surgical Neurology Branch-3
DR   Wikidata; Q102114926
RX   PubMed=2086734;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
ID   SNB-4
AC   CVCL_A1IW
SY   Surgical Neurology Branch-4
DR   Wikidata; Q102114927
RX   PubMed=2086734;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 4
//
ID   SNB-44
AC   CVCL_YA90
SY   SNB44; Surgical Neurology Branch-44
DR   Wikidata; Q98132714
RX   PubMed=3335022;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   SNB-56
AC   CVCL_B320
SY   SNB56; Surgical Neurology Branch-56
DR   Wikidata; Q54955040
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=3121170;
RX   PubMed=3335022;
CC   Doubling time: 33 +- 3 hours (PubMed=3121170).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   SNB-7
AC   CVCL_IZ73
SY   SNB7; Surgical Neurology Branch-7
DR   ChEMBL-Cells; CHEMBL3308418
DR   ChEMBL-Targets; CHEMBL614930
DR   NCI-DTP; SNB-7
DR   PubChem_Cell_line; CVCL_IZ73
DR   Wikidata; Q54955041
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   SNB-75
AC   CVCL_1706
SY   SNB.75; SNB75; Surgical Neurology Branch-75
DR   BTO; BTO_0004222
DR   CLO; CLO_0009905
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1017
DR   BioSample; SAMN10989593
DR   cancercelllines; CVCL_1706
DR   Cell_Model_Passport; SIDM00095
DR   ChEMBL-Cells; CHEMBL3307616
DR   ChEMBL-Targets; CHEMBL614451
DR   Cosmic; 687583
DR   Cosmic; 875895
DR   Cosmic; 905982
DR   Cosmic; 974242
DR   Cosmic; 1092638
DR   Cosmic; 1175820
DR   Cosmic; 1305362
DR   Cosmic; 1312344
DR   Cosmic; 1436042
DR   Cosmic; 1998481
DR   Cosmic; 2367549
DR   Cosmic-CLP; 905982
DR   DepMap; ACH-000504
DR   EGA; EGAS00001000978
DR   GDSC; 905982
DR   GEO; GSM2141
DR   GEO; GSM50179
DR   GEO; GSM50243
DR   GEO; GSM743439
DR   GEO; GSM750786
DR   GEO; GSM799327
DR   GEO; GSM799390
DR   GEO; GSM844698
DR   GEO; GSM844699
DR   GEO; GSM844700
DR   GEO; GSM847162
DR   GEO; GSM1153397
DR   GEO; GSM1181270
DR   GEO; GSM1181313
DR   GEO; GSM1670460
DR   GEO; GSM2124687
DR   IARC_TP53; 18083
DR   IARC_TP53; 21124
DR   LiGeA; CCLE_047
DR   LINCS_HMS; 50045
DR   LINCS_LDP; LCL-1346
DR   NCI-DTP; SNB-75
DR   PharmacoDB; SNB75_1430_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1706
DR   PubChem_Cell_line; CVCL_1706
DR   SKY/M-FISH/CGH; 2823
DR   Wikidata; Q54955042
RX   PubMed=2041050;
RX   PubMed=3121170;
RX   PubMed=3335022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=56
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/snb-75-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 58 +- 2 hours (PubMed=3121170); 62.8 hours (NCI-DTP=SNB-75).
CC   HLA typing: A*02:01:01,11:01:01; B*35,39; C*04,12:03:01; DPB1*04:01,04:02; DQB1*03,05:01:01; DRB1*01:03,11 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Lys (c.772G>A); ClinVar=VCV000012348; Zygosity=Homozygous (PubMed=9331090; PubMed=15900046; PubMed=17088437; PubMed=18277095).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.77%; Native American=0.06%; East Asian, North=2.51%; East Asian, South=0%; South Asian=0.24%; European, North=57.46%; European, South=38.96% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Cosmic-CLP=905982; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9 (PubMed=19372543)
ST   D7S820: 9,11 (Cosmic-CLP=905982)
ST   D8S1179: 12
ST   FGA: 19,23
ST   TH01: 6,9 (Cosmic-CLP=905982)
ST   TH01: 9 (PubMed=19372543)
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
ID   SNB-78
AC   CVCL_B321
SY   SNB78; Surgical Neurology Branch-78
DR   ChEMBL-Cells; CHEMBL3307969
DR   ChEMBL-Targets; CHEMBL612543
DR   Cosmic; 1436043
DR   IARC_TP53; 21646
DR   NCI-DTP; SNB-78
DR   PubChem_Cell_line; CVCL_B321
DR   Wikidata; Q54955043
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2041050;
RX   PubMed=3121170;
RX   PubMed=15900046;
RX   PubMed=22336246;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC   Part of: JFCR39 cancer cell line panel.
CC   Doubling time: 50 +- 2 hours (PubMed=3121170).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Ala (c.667C>G); Zygosity=Unspecified (PubMed=15900046).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   SNc0031
AC   CVCL_VB82
DR   ECACC; 15102998
DR   Wikidata; Q54955045
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNc0041
AC   CVCL_VB83
DR   ECACC; 15092926
DR   Wikidata; Q54955046
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SNc0063
AC   CVCL_VB84
DR   ECACC; 15102999
DR   Wikidata; Q54955047
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNc0080
AC   CVCL_VB85
DR   ECACC; 15103001
DR   Wikidata; Q54955048
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SNc0106
AC   CVCL_VB86
DR   ECACC; 15092927
DR   Wikidata; Q54955049
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SNc0125
AC   CVCL_VB87
DR   ECACC; 15092928
DR   Wikidata; Q54955050
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SNc0189
AC   CVCL_VB88
DR   ECACC; 15103002
DR   Wikidata; Q54955051
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNc0202
AC   CVCL_VB89
DR   ECACC; 15103003
DR   Wikidata; Q54955052
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNc0204
AC   CVCL_VB90
DR   ECACC; 15103004
DR   Wikidata; Q54955053
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNc0214
AC   CVCL_VB91
DR   ECACC; 15082826
DR   Wikidata; Q54955054
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNE 1
AC   CVCL_B5YE
DR   Wikidata; Q112041726
RX   PubMed=230517;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5YF ! SNE 2
OI   CVCL_B5YH ! SNE 3
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SNE 2
AC   CVCL_B5YF
DR   Wikidata; Q112041727
RX   PubMed=230517;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5YE ! SNE 1
OI   CVCL_B5YH ! SNE 3
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SNE 3
AC   CVCL_B5YH
DR   Wikidata; Q112041728
RX   PubMed=230517;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5YE ! SNE 1
OI   CVCL_B5YF ! SNE 2
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SNEC-MI
AC   CVCL_9481
DR   Wikidata; Q54955055
RX   PubMed=15218315;
CC   Population: Japanese.
CC   Doubling time: ~70.4 hours (PubMed=15218315).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C116318; Sinonasal small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   sNF02.2
AC   CVCL_K280
SY   sNF02-2
DR   ATCC; CRL-2885
DR   BioSample; SAMN03471811
DR   Cosmic; 1644554
DR   Wikidata; Q54955056
RX   PubMed=14762442;
RX   PubMed=22346343;
RX   PubMed=28469964;
RX   PubMed=32642732;
WW   Provider; UF Innovate; 11276; https://web.archive.org/web/20150618074550/http://technologylicensing.research.ufl.edu/technologies/11276_human-schwann-cell-like-cell-line-snf02-2
CC   Doubling time: ~26 hours (ATCC=CRL-2885).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=CRL-2885
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 12.3,15.3
ST   D19S433: 13,15.2
ST   D21S11: 31.2
ST   D2S1338: 20,23
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 22,23
ST   Penta D: 13
ST   Penta E: 16,18
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   sNF94.3
AC   CVCL_K164
DR   ABM; T8272
DR   ATCC; CRL-2886
DR   BioSample; SAMN03471812
DR   Wikidata; Q54955057
RX   PubMed=14762442;
RX   PubMed=32642732;
WW   Provider; UF Innovate; 11277; https://web.archive.org/web/20150905204458/http://technologylicensing.research.ufl.edu/technologies/11277_human-schwann-cell-like-cell-line-snf94-3
CC   Doubling time: ~43 hours (ATCC=CRL-2886).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-2886
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 28,31
ST   D2S1338: 24,25
ST   D3S1358: 16,19
ST   D5S818: 10,12
ST   D7S820: 9,14
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 9,11
ST   Penta E: 10,14
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 17,18
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   sNF96.2
AC   CVCL_K281
SY   SNF96.2; sNF96-2
DR   ATCC; CRL-2884
DR   BioSample; SAMN03471810
DR   Cosmic; 1644553
DR   Wikidata; Q54955059
RX   PubMed=14762442;
RX   PubMed=17876295;
RX   PubMed=22346343;
RX   PubMed=28469964;
RX   PubMed=32076030;
RX   PubMed=32642732;
RX   PubMed=34059954;
RX   PubMed=36818284;
WW   Provider; UF Innovate; 11278; https://web.archive.org/web/20150905200621/http://technologylicensing.research.ufl.edu/technologies/11278_human-schwann-cell-like-cell-line-snf96-2
CC   Doubling time: ~33 hours (ATCC=CRL-2884).
CC   Karyotypic information: Average ploidy of 2.02 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Asn1229Metfs*11 (c.3683delC); Zygosity=Heterozygous; Note=Germline (PubMed=17876295).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, lower leg nerve; UBERON=UBERON_0004218.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): ATCC=CRL-2884; PubMed=32076030; PubMed=36818284
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 16 (ATCC=CRL-2884; PubMed=36818284)
ST   D3S1358: 16,21 (PubMed=32076030)
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 14
ST   Penta E: 15
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,19 (ATCC=CRL-2884; PubMed=36818284)
ST   vWA: 17,19,20 (PubMed=32076030)
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 22
//
ID   SNG-II
AC   CVCL_3170
SY   SNGII; SNG-2
DR   BioSample; SAMN03472781
DR   Cosmic; 1241343
DR   Cosmic; 2030482
DR   JCRB; IFO50312
DR   JCRB; JCRB0175
DR   Wikidata; Q54955060
RX   CelloPub=CLPUB00481;
RX   PubMed=2478021;
RX   PubMed=3295079;
RX   PubMed=12893190;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 62 hours (Note=At 9th passage) (PubMed=2478021); 30-41 hours (Note=Lot 09102015) (JCRB=IFO50312).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Discontinued: JCRB; JCRB0175; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=IFO50312
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D5S818: 6,12
ST   D7S820: 9,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,16,17
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   SNG-M
AC   CVCL_1707
SY   SNGM
DR   CLO; CLO_0037165
DR   EFO; EFO_0022497
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 460
DR   BioSample; SAMN03470892
DR   BioSample; SAMN03472782
DR   BioSample; SAMN10987627
DR   cancercelllines; CVCL_1707
DR   Cell_Model_Passport; SIDM00373
DR   ChEMBL-Cells; CHEMBL3308466
DR   ChEMBL-Targets; CHEMBL1075582
DR   Cosmic; 909735
DR   Cosmic; 1152552
DR   Cosmic; 1241347
DR   Cosmic; 2030483
DR   Cosmic-CLP; 909735
DR   DepMap; ACH-000974
DR   EGA; EGAS00001000978
DR   GDSC; 909735
DR   GEO; GSM827242
DR   GEO; GSM887601
DR   GEO; GSM888684
DR   GEO; GSM1670461
DR   IARC_TP53; 27580
DR   JCRB; FDSC0030
DR   JCRB; IFO50313
DR   JCRB; JCRB0179
DR   LiGeA; CCLE_345
DR   LINCS_LDP; LCL-1503
DR   PharmacoDB; SNGM_1431_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1707
DR   PubChem_Cell_line; CVCL_1707
DR   Wikidata; Q54955061
RX   CelloPub=CLPUB00481;
RX   PubMed=858140;
RX   PubMed=2429643;
RX   PubMed=2448191;
RX   PubMed=9436037;
RX   PubMed=10457904;
RX   PubMed=12893190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Possibly contaminated. HHUA (distributed by RCB) and SNG-M (distributed by JCRB) share similar STR profiles and have been established by the same research group. While HHUA was described in 1984 and SNG-M in 1977 it has not been possible to establish which of the two cell lines are derived from each other. Thus it has been decided to consider them as being sister cell lines originating from the same donor.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00632.
CC   Population: Japanese.
CC   Doubling time: 30 hours (Note=At 50th passage) (PubMed=858140).
CC   HLA typing: A*11:01,26:03; B*51:01,54:01; C*01:02,03:04 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Tyr46fs*10 (c.136_137delTA); Zygosity=Heterozygous (Cosmic-CLP=909735; DepMap=ACH-000974).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Thr93fs*2 (c.276_277insC); Zygosity=Heterozygous (Cosmic-CLP=909735; DepMap=ACH-000974).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (Cosmic-CLP=909735; DepMap=ACH-000974).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Arg88Gln (c.263G>A); ClinVar=VCV000376049; Zygosity=Heterozygous (Cosmic-CLP=909735; DepMap=ACH-000974).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.03%; East Asian, North=75.48%; East Asian, South=24.49%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; FDSC0030; true.
CC   Derived from site: Metastatic; Obturator lymph node; UBERON=UBERON_0035171.
ST   Source(s): Cosmic-CLP=909735; JCRB=IFO50313; JCRB=JCRB0179; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10,11 (JCRB=IFO50313; JCRB=JCRB0179)
ST   D13S317: 8,11 (Cosmic-CLP=909735; PubMed=25877200)
ST   D16S539: 10,11,12 (JCRB=IFO50313; PubMed=25877200)
ST   D16S539: 10,12 (Cosmic-CLP=909735; JCRB=JCRB0179)
ST   D18S51: 12,18,19
ST   D19S433: 13.2,14,15
ST   D21S11: 29,30
ST   D2S1338: 19,24,25
ST   D3S1358: 13,14,15
ST   D5S818: 9,13
ST   D7S820: 10,11 (JCRB=IFO50313)
ST   D7S820: 10,11,12 (JCRB=JCRB0179; PubMed=25877200)
ST   D7S820: 10,12,13 (Cosmic-CLP=909735)
ST   D8S1179: 11,13
ST   FGA: 22
ST   Penta D: 8,11
ST   Penta E: 11,14
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17,18,20 (JCRB=JCRB0179)
ST   vWA: 17,18,20 (JCRB=IFO50313)
ST   vWA: 17,20 (Cosmic-CLP=909735; PubMed=25877200)
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3866 ! HHUA
OI   CVCL_S914 ! SNG-P
SX   Female
AG   52-54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SNG-P
AC   CVCL_S914
DR   Cell_Model_Passport; SIDM00372
DR   Wikidata; Q54955062
RX   PubMed=858140;
CC   Population: Japanese.
CC   Doubling time: 33 hours (Note=At 45th passage) (PubMed=858140).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3866 ! HHUA
OI   CVCL_1707 ! SNG-M
SX   Female
AG   52-54Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 11
//
ID   SNK-1
AC   CVCL_A671
SY   SNK1
DR   Cosmic; 1542073
DR   GEO; GSM472003
DR   Wikidata; Q54955063
RX   PubMed=11881730;
RX   PubMed=12780797;
RX   PubMed=19194464;
RX   PubMed=21052088;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   SNK-10
AC   CVCL_A672
SY   SNK10
DR   Cosmic; 1534878
DR   Cosmic; 2025328
DR   GEO; GSM472004
DR   GEO; GSM472005
DR   Wikidata; Q54955064
RX   PubMed=12780797;
RX   PubMed=21052088;
RX   PubMed=22102884;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   SNK-57
AC   CVCL_3923
SY   SNK57
DR   BTO; BTO_0003480
DR   TKG; TKG 0701
DR   Wikidata; Q54955065
RX   PubMed=9183630;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=9183630).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): TKG=TKG 0701
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   SNK-6
AC   CVCL_A673
SY   SNK6
DR   cancercelllines; CVCL_A673
DR   Cosmic; 1534873
DR   Cosmic; 1542074
DR   Cosmic; 2025327
DR   Cosmic; 2390118
DR   Cosmic; 2785206
DR   GEO; GSM472006
DR   GEO; GSM3021083
DR   Progenetix; CVCL_A673
DR   Wikidata; Q54955067
RX   PubMed=11157488;
RX   PubMed=12780797;
RX   PubMed=16827800;
RX   PubMed=19194464;
RX   PubMed=21052088;
RX   PubMed=22102884;
RX   PubMed=25586472;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Unexplicit; Ex29-34del; Zygosity=Heterozygous (PubMed=16827800).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
CC   Cell type: NK T-cell; CL=CL_0000814.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   SNL 76/7
AC   CVCL_K227
SY   SNL76/7; STO-Neo-LIF clone 76/7
DR   ATCC; SCRC-1049
DR   Cell_Biolabs; CBA-316
DR   ECACC; 07032801
DR   Wikidata; Q54955068
RX   PubMed=2205396;
CC   Characteristics: Used as a feeder layer to support the growth of mouse ESCs and iPSCs.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96787; Lif.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3420 ! STO
SX   Mixed sex
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   SNLH9
AC   CVCL_JZ07
DR   Wikidata; Q54955069
RX   PubMed=1508665;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96787; Lif.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K227 ! SNL 76/7
SX   Mixed sex
AG   Embryo
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 9
//
ID   SNLP 76/7-4
AC   CVCL_K228
SY   SNLP76/7-4; SNLP76.7-4
DR   ATCC; SCRC-1050
DR   Wikidata; Q54955070
RX   PubMed=17576687;
CC   Characteristics: Used as a feeder layer to support the growth of mouse ESCs and iPSCs.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_17939; Puromycin.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96787; Lif.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_K227 ! SNL 76/7
SX   Mixed sex
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   SNO
AC   CVCL_M848
SY   SN; SN original
DR   Wikidata; Q54955008
RX   CelloPub=CLPUB00771;
RX   CelloPub=CLPUB00772;
RX   PubMed=174997;
RX   PubMed=3167823;
RX   PubMed=12153764;
RX   PubMed=16643659;
RX   PubMed=16895604;
RX   PubMed=21734802;
CC   Population: African; Zulu.
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex5del; Zygosity=Homozygous (PubMed=16895604).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   SNO(RES)
AC   CVCL_D7FS
RX   CelloPub=CLPUB00772;
CC   Population: African; Zulu.
CC   Characteristics: EGF-resistanct (CelloPub=CLPUB00772).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex5del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M848 ! SNO
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SNO(T4)
AC   CVCL_M849
SY   SN-T4
DR   Wikidata; Q54955016
RX   CelloPub=CLPUB00772;
RX   PubMed=3167823;
CC   Population: African; Zulu.
CC   Characteristics: Established after 4 tumor passages of parent cell line in nude mice (CelloPub=CLPUB00772; PubMed=3167823).
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex5del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M848 ! SNO
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   Snow leopard iPS
AC   CVCL_VA25
DR   Wikidata; Q54955071
RX   PubMed=22079579;
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=29064; ! Panthera uncia (Snow leopard)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SNP
AC   CVCL_IP76
DR   TKG; TKG 0730
DR   Wikidata; Q54955072
RX   PubMed=26726024;
CC   Doubling time: 26.2 hours (PubMed=26726024).
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C124249; Canine mammary carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 6
//
ID   SNT-13
AC   CVCL_A674
SY   SNT13
DR   Cosmic; 2390217
DR   GEO; GSM349852
DR   GEO; GSM349853
DR   GEO; GSM472007
DR   Wikidata; Q54955073
RX   PubMed=12780797;
RX   PubMed=20132662;
RX   PubMed=21052088;
RX   PubMed=25586472;
RX   PubMed=36094314;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   SNT-15
AC   CVCL_A675
SY   SNT15
DR   Cosmic; 2390122
DR   GEO; GSM349854
DR   GEO; GSM349855
DR   GEO; GSM472008
DR   Wikidata; Q54955074
RX   PubMed=12780797;
RX   PubMed=20132662;
RX   PubMed=21052088;
RX   PubMed=22102884;
RX   PubMed=25586472;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   SNT-16
AC   CVCL_A676
SY   SNT16
DR   Wikidata; Q54955076
RX   PubMed=12780797;
RX   PubMed=22102884;
RX   PubMed=36094314;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C126348; Chronic active EBV disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   SNT-8
AC   CVCL_A677
SY   SNT8
DR   cancercelllines; CVCL_A677
DR   Cosmic; 2390121
DR   GEO; GSM349850
DR   GEO; GSM349851
DR   GEO; GSM472009
DR   GEO; GSM3021088
DR   GEO; GSM3021089
DR   Progenetix; CVCL_A677
DR   Wikidata; Q54955077
RX   PubMed=11157488;
RX   PubMed=12780797;
RX   PubMed=16827800;
RX   PubMed=20132662;
RX   PubMed=21052088;
RX   PubMed=22102884;
RX   PubMed=25586472;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Nose, nasal cavity; UBERON=UBERON_0001707.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   SNU-1
AC   CVCL_0099
SY   SNU1; NCI-SNU-1
DR   BTO; BTO_0005786
DR   CLO; CLO_0009094
DR   EFO; EFO_0002343
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5971
DR   BCRC; 60210
DR   BioGRID_ORCS_Cell_line; 370
DR   BioSample; SAMN03472628
DR   BioSample; SAMN10988139
DR   cancercelllines; CVCL_0099
DR   CCRID; 3101HUMTCHu230
DR   Cell_Model_Passport; SIDM01146
DR   ChEMBL-Cells; CHEMBL3307455
DR   ChEMBL-Targets; CHEMBL614931
DR   CLS; 305076
DR   Cosmic; 685584
DR   Cosmic; 724854
DR   Cosmic; 737362
DR   Cosmic; 848136
DR   Cosmic; 887260
DR   Cosmic; 908444
DR   Cosmic; 921595
DR   Cosmic; 1090450
DR   Cosmic; 1154647
DR   Cosmic; 1187294
DR   Cosmic; 1294954
DR   Cosmic; 1528871
DR   Cosmic; 1995595
DR   Cosmic; 2069772
DR   Cosmic; 2373749
DR   Cosmic; 2484960
DR   Cosmic; 2646585
DR   Cosmic-CLP; 908444
DR   DepMap; ACH-000932
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908444
DR   GEO; GSM267421
DR   GEO; GSM267428
DR   GEO; GSM267435
DR   GEO; GSM267442
DR   GEO; GSM552372
DR   GEO; GSM562406
DR   GEO; GSM827406
DR   GEO; GSM844701
DR   GEO; GSM887614
DR   GEO; GSM888698
DR   GEO; GSM1237679
DR   GEO; GSM1237704
DR   GEO; GSM1374885
DR   GEO; GSM1670273
DR   GEO; GSM1670462
DR   IARC_TP53; 21581
DR   IARC_TP53; 30155
DR   IGRhCellID; SNU1
DR   KCLB; 00001
DR   LiGeA; CCLE_775
DR   LINCS_LDP; LCL-1888
DR   PharmacoDB; SNU1_1432_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0099
DR   PubChem_Cell_line; CVCL_0099
DR   Wikidata; Q54955083
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1676761;
RX   PubMed=2158397;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=10674020;
RX   PubMed=12068308;
RX   PubMed=18804159;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 26 hours (ATCC=CRL-5971; PubMed=2158397; PubMed=29435981).
CC   HLA typing: A*02:07,30:04; B*14:01,51:01; C*08:05,01:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*02:265,30:04; B*14:01,14:01; C*01:02,08:02; DQB1*06:04,06:04 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (Cosmic-CLP=908444; DepMap=ACH-000932).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (Cosmic-CLP=908444; DepMap=ACH-000932).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=12068308; DepMap=ACH-000932).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1676761).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.88%; East Asian, North=57.18%; East Asian, South=41.93%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): ATCC=CRL-5971; Cosmic-CLP=908444; KCLB=00001
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13 (ATCC=CRL-5971; Cosmic-CLP=908444)
ST   CSF1PO: 12,14 (KCLB=00001)
ST   D13S317: 11,14 (ATCC=CRL-5971; Cosmic-CLP=908444)
ST   D13S317: 12,14 (KCLB=00001)
ST   D16S539: 9,12
ST   D18S51: 14,22
ST   D19S433: 13,14.2
ST   D21S11: 29,32.2
ST   D2S1338: 23,24
ST   D3S1358: 16 (ATCC=CRL-5971)
ST   D3S1358: 16,17 (KCLB=00001)
ST   D5S818: 12,13 (ATCC=CRL-5971; Cosmic-CLP=908444)
ST   D5S818: 13 (KCLB=00001)
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 22 (KCLB=00001)
ST   FGA: 22,23 (ATCC=CRL-5971)
ST   Penta D: 10,11
ST   Penta E: 11,14
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   SNU-1-DOX
AC   CVCL_L042
DR   cancercelllines; CVCL_L042
DR   Wikidata; Q54955084
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0099 ! SNU-1
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   SNU-1/Cas9-hyg
AC   CVCL_C9DK
DR   GeneCopoeia; SL526
DR   Wikidata; Q123033538
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL526).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Leu1154fs*12 (c.3457_3458insT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6190; JAK1; Simple; p.Lys860Asnfs*16 (c.2580delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0099 ! SNU-1
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SNU-1000
AC   CVCL_5000
SY   SNU1000
DR   KCLB; 01000
DR   Wikidata; Q54955086
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Has both integrated and episomal forms of HPV16.
CC   Doubling time: 96 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=01000
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   FGA: 22.2
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-1005
AC   CVCL_5001
SY   SNU1005
DR   KCLB; 01005
DR   Wikidata; Q54955087
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV16 genome.
CC   Doubling time: 48 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=01005
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   FGA: 24
ST   TH01: 9,10
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-1033
AC   CVCL_5002
SY   SNU1033
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987752
DR   cancercelllines; CVCL_5002
DR   Cell_Model_Passport; SIDM00192
DR   ColonAtlas; SNU1033
DR   Cosmic; 738855
DR   Cosmic; 2612379
DR   Cosmic; 2651858
DR   DepMap; ACH-000286
DR   GEO; GSM1448078
DR   IARC_TP53; 10837
DR   KCLB; 01033
DR   LiGeA; CCLE_623
DR   PharmacoDB; SNU1033_1433_2019
DR   Wikidata; Q54955088
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=10362137).
CC   HLA typing: A*24:02,24:02; B*40:01,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=10362137; DepMap=ACH-000286).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leu (c.569C>T); ClinVar=VCV000418517; Zygosity=Homozygous (PubMed=10362137; DepMap=ACH-000286).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=18.67%; Native American=0%; East Asian, North=56.8%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=24.53% (PubMed=30894373).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=01033; PubMed=25926053; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 13,15
ST   D12S391: 18,21
ST   D13S317: 10
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,14
ST   D1S1656: 13
ST   D21S11: 29,30
ST   D22S1045: 17
ST   D2S1338: 18,26
ST   D2S441: 10,12
ST   D3S1358: 14,17 (KCLB=01033)
ST   D3S1358: 17 (Technion Genomics Center)
ST   D5S818: 13
ST   D7S820: 11,12 (PubMed=25926053; Technion Genomics Center)
ST   D7S820: 12 (KCLB=01033)
ST   D8S1179: 12,13
ST   FGA: 23
ST   Penta D: 11,12
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SNU-1040
AC   CVCL_5003
SY   SNU1040; NCI-SNU-1040
DR   CLO; CLO_0037283
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988065
DR   cancercelllines; CVCL_5003
DR   Cell_Model_Passport; SIDM00217
DR   ColonAtlas; SNU1040
DR   Cosmic; 738857
DR   Cosmic; 848830
DR   Cosmic; 2612380
DR   Cosmic; 2651859
DR   Cosmic-CLP; 1659823
DR   DepMap; ACH-000999
DR   EGA; EGAS00001000978
DR   GDSC; 1659823
DR   GEO; GSM887602
DR   GEO; GSM888685
DR   GEO; GSM1448189
DR   GEO; GSM1670463
DR   IARC_TP53; 10838
DR   KCLB; 01040
DR   LiGeA; CCLE_351
DR   PharmacoDB; SNU1040_1434_2019
DR   PRIDE; PXD005235
DR   Progenetix; CVCL_5003
DR   Wikidata; Q54955089
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 63 hours (PubMed=10362137).
CC   HLA typing: A*24:02,24:02; B*38:02,51:01; C*07:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=10362137).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.04%; East Asian, North=58.5%; East Asian, South=40.46%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=1659823; KCLB=01040; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (Cosmic-CLP=1659823)
ST   CSF1PO: 12 (KCLB=01040; PubMed=25926053)
ST   D13S317: 12
ST   D16S539: 9 (PubMed=25926053)
ST   D16S539: 9,10 (Cosmic-CLP=1659823)
ST   D21S11: 28,29,32
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 11,13
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18,19 (Cosmic-CLP=1659823)
ST   vWA: 17,19 (KCLB=01040)
ST   vWA: 17,19,20 (PubMed=25926053)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SNU-1041
AC   CVCL_L085
SY   SNU 1041; SNU1041
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987966
DR   cancercelllines; CVCL_L085
DR   Cell_Model_Passport; SIDM00173
DR   DepMap; ACH-000618
DR   IARC_TP53; 30156
DR   KCLB; 01041
DR   LiGeA; CCLE_264
DR   PharmacoDB; SNU1041_1435_2019
DR   Wikidata; Q54955090
RX   CelloPub=CLPUB00001;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   HLA typing: A*02:01,02:01; B*15:01,27:05; C*01:02,04:01; DQA1*05:02,05:02; DQB1*05:01,05:01; DRB1*11:01,11:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Homozygous (DepMap=ACH-000618).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): KCLB=01041
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 8,12
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 24
//
ID   SNU-1047
AC   CVCL_5004
SY   SNU1047
DR   cancercelllines; CVCL_5004
DR   ColonAtlas; SNU1047
DR   Cosmic; 738858
DR   Cosmic; 848831
DR   Cosmic; 875423
DR   Cosmic; 2612381
DR   Cosmic; 2651860
DR   GEO; GSM1448085
DR   IARC_TP53; 10839
DR   KCLB; 01047
DR   Wikidata; Q54955091
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=10362137).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Thr (c.761T>C); ClinVar=VCV001759844; Zygosity=Unspecified (PubMed=10362137).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=01047; PubMed=25926053
ST   CSF1PO: 9,11
ST   D13S317: 10,11
ST   D16S539: 9
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 8,12
ST   D7S820: 8,10
ST   FGA: 18,21
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,21
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SNU-1066
AC   CVCL_5005
SY   SNU1066
DR   BTO; BTO_0005924
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987965
DR   Cell_Model_Passport; SIDM00170
DR   Cosmic; 934176
DR   DepMap; ACH-000682
DR   IARC_TP53; 11324
DR   KCLB; 01066
DR   LiGeA; CCLE_560
DR   PharmacoDB; SNU1066_1436_2019
DR   Wikidata; Q54955092
RX   PubMed=10369293;
RX   PubMed=19956504;
RX   PubMed=26589293;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=10369293).
CC   HLA typing: A*02:06,24:02; B*15:01,27:05; C*01:02,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp92fs*54 (c.274delG); Zygosity=Homozygous (PubMed=10369293; DepMap=ACH-000682).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.514_559del46; Zygosity=Homozygous (PubMed=10369293; DepMap=ACH-000682).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): KCLB=01066
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D3S1358: 17
ST   D5S818: 9,11
ST   D7S820: 12
ST   FGA: 23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-1076
AC   CVCL_5006
SY   SNU1076; NCI-SNU-1076
DR   BTO; BTO_0005922
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988066
DR   cancercelllines; CVCL_5006
DR   Cell_Model_Passport; SIDM00168
DR   Cosmic; 934177
DR   DepMap; ACH-000549
DR   GEO; GSM887603
DR   GEO; GSM888686
DR   IARC_TP53; 30157
DR   KCLB; 01076
DR   LiGeA; CCLE_803
DR   PharmacoDB; SNU1076_1437_2019
DR   Progenetix; CVCL_5006
DR   Wikidata; Q54955093
RX   PubMed=10369293;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=10369293).
CC   HLA typing: A*01:01,02:01; B*13:01,13:01; C*03:04,06:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114His (c.341C>A) (p.Ala128Ala, c.384C>A); ClinVar=VCV000376383; Zygosity=Unspecified (PubMed=10369293).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (DepMap=ACH-000549).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.88%; Native American=0%; East Asian, North=66.81%; East Asian, South=28.32%; South Asian=0%; European, North=0%; European, South=1.99% (PubMed=30894373).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): KCLB=01076; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13
ST   D12S391: 19,20
ST   D13S317: 8,10
ST   D16S539: 13
ST   D18S51: 14
ST   D19S433: 15.2
ST   D1S1656: 15
ST   D21S11: 30
ST   D22S1045: 15,17
ST   D2S1338: 19,24
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   DYS391: 11
ST   FGA: 24,25
ST   Penta D: 9,10
ST   Penta E: 12,22
ST   TH01: 6 (Technion Genomics Center)
ST   TH01: 6,7 (KCLB=01076)
ST   TPOX: 8,11
ST   vWA: 15,16 (KCLB=01076)
ST   vWA: 16 (Technion Genomics Center)
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SNU-1077
AC   CVCL_5007
SY   SNU1077
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987741
DR   cancercelllines; CVCL_5007
DR   Cell_Model_Passport; SIDM00166
DR   DepMap; ACH-000302
DR   GEO; GSM887604
DR   GEO; GSM888687
DR   IARC_TP53; 28344
DR   KCLB; 01077
DR   LiGeA; CCLE_902
DR   PharmacoDB; SNU1077_1438_2019
DR   Progenetix; CVCL_5007
DR   Wikidata; Q54955095
RX   PubMed=9299262;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 43 hours (PubMed=9299262).
CC   HLA typing: A*02:06,24:02; B*40:06,67:01; C*07:02,08:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Ser (c.584T>G); ClinVar=VCV000376619; Zygosity=Homozygous (DepMap=ACH-000302).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.64%; Native American=0%; East Asian, North=64.52%; East Asian, South=33.3%; South Asian=0%; European, North=0%; European, South=1.53% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): KCLB=01077
ST   Amelogenin: X
ST   D13S317: 12
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8
ST   FGA: 24,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-1079
AC   CVCL_5008
SY   SNU1079; SNU 1079; NCI-SNU-1079
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988073
DR   cancercelllines; CVCL_5008
DR   Cell_Model_Passport; SIDM00164
DR   Cosmic; 738874
DR   Cosmic; 2674047
DR   DepMap; ACH-000209
DR   GEO; GSM887605
DR   GEO; GSM888688
DR   IARC_TP53; 30158
DR   KCLB; 01079
DR   LiGeA; CCLE_763
DR   PharmacoDB; SNU1079_1439_2019
DR   Progenetix; CVCL_5008
DR   Wikidata; Q54955096
RX   CelloPub=CLPUB00275;
RX   PubMed=12107841;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27231123;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 72 hours (PubMed=12107841).
CC   HLA typing: A*31:01,33:03; B*44:03,48:01; C*03:03,14:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (PubMed=27231123; DepMap=ACH-000209).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=64.18%; East Asian, South=34.91%; South Asian=0%; European, North=0%; European, South=0.66% (PubMed=30894373).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): KCLB=01079
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   FGA: 22
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SNU-1103
AC   CVCL_5009
SY   SNU1103
DR   Wikidata; Q54955097
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a rectal carcinoma.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SNU-1105
AC   CVCL_5010
SY   SNU1105; NCI-SNU-1105
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988078
DR   cancercelllines; CVCL_5010
DR   Cell_Model_Passport; SIDM01336
DR   Cosmic; 2516037
DR   DepMap; ACH-000368
DR   GEO; GSM887606
DR   GEO; GSM888689
DR   IARC_TP53; 28368
DR   KCLB; 01105
DR   LiGeA; CCLE_081
DR   PharmacoDB; SNU1105_1440_2019
DR   Progenetix; CVCL_5010
DR   Wikidata; Q54955098
RX   PubMed=11776963;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 84 hours (PubMed=11776963); 73 hours (PubMed=25984343).
CC   HLA typing: A*11:01,24:02; B*35:01,51:01; C*08:01,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Gly (c.472C>G); ClinVar=VCV000856171; Zygosity=Homozygous (DepMap=ACH-000368).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.33%; Native American=1.43%; East Asian, North=63.75%; East Asian, South=34.48%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=01105
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,11
ST   FGA: 24,25
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SNU-1118
AC   CVCL_5011
SY   SNU1118
DR   Cell_Model_Passport; SIDM01440
DR   KCLB; 01118
DR   Wikidata; Q54955099
RX   PubMed=11776963;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 78 hours (PubMed=11776963).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=01118
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D3S1358: 14,15
ST   D5S818: 9,12
ST   D7S820: 8
ST   FGA: 23,25
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   SNU-1160
AC   CVCL_5012
SY   SNU1160
DR   KCLB; 01160
DR   Wikidata; Q54955100
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV18 genome.
CC   Doubling time: 54 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   SNU-1181
AC   CVCL_5013
SY   SNU1181
DR   cancercelllines; CVCL_5013
DR   ColonAtlas; SNU1181
DR   Cosmic; 1322287
DR   GEO; GSM1448219
DR   IARC_TP53; 28473
DR   KCLB; 01181
DR   Wikidata; Q54955102
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 52 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Lys1370Ter (c.4108A>T); Zygosity=Homozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=01181; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,12
ST   D18S51: 17
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 25
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 10,12
ST   FGA: 18,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SNU-119
AC   CVCL_5014
SY   SNU119; NCI-SNU-119
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987751
DR   cancercelllines; CVCL_5014
DR   Cell_Model_Passport; SIDM01771
DR   DepMap; ACH-000635
DR   GEO; GSM887608
DR   GEO; GSM888691
DR   IARC_TP53; 28379
DR   KCLB; 00119
DR   LiGeA; CCLE_813
DR   PharmacoDB; SNU119_1441_2019
DR   PRIDE; PXD003668
DR   Progenetix; CVCL_5014
DR   Wikidata; Q54955103
RX   PubMed=9299249;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=26589293;
RX   PubMed=27561551;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 53 hours (PubMed=9299249).
CC   HLA typing: A*31:01,31:01; B*35:01,51:01; C*14:02,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ala (c.451C>G); ClinVar=VCV000376641; Zygosity=Homozygous (PubMed=9299249; DepMap=ACH-000635).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.1%; Native American=0%; East Asian, North=63.25%; East Asian, South=31.5%; South Asian=0%; European, North=0%; European, South=3.15% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00119
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   FGA: 25
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SNU-1196
AC   CVCL_5015
SY   SNU1196
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988072
DR   cancercelllines; CVCL_5015
DR   Cell_Model_Passport; SIDM00163
DR   Cosmic; 738876
DR   Cosmic; 2674049
DR   DepMap; ACH-000461
DR   GEO; GSM887607
DR   GEO; GSM888690
DR   IARC_TP53; 17162
DR   KCLB; 01196
DR   LiGeA; CCLE_002
DR   PharmacoDB; SNU1196_1442_2019
DR   Progenetix; CVCL_5015
DR   Wikidata; Q54955104
RX   CelloPub=CLPUB00275;
RX   PubMed=12107841;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27231123;
RX   PubMed=28883618;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=12107841).
CC   HLA typing: A*24:02,24:02; B*54:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=12107841; DepMap=ACH-000461).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=0%; East Asian, North=61.64%; East Asian, South=37.54%; South Asian=0%; European, North=0%; European, South=0.51% (PubMed=30894373).
CC   Derived from site: In situ; Bile duct, common hepatic duct; UBERON=UBERON_0001175.
ST   Source(s): KCLB=01196
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8,11
ST   FGA: 24,25
ST   TH01: 5,7
ST   TPOX: 10,11
ST   vWA: 14,16
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   SNU-1196/GR
AC   CVCL_C1L2
DR   Wikidata; Q114313037
RX   PubMed=28883618;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: In situ; Bile duct, common hepatic duct; UBERON=UBERON_0001175.
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5015 ! SNU-1196
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   SNU-1197
AC   CVCL_5016
SY   SNU1197
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987710
DR   cancercelllines; CVCL_5016
DR   Cell_Model_Passport; SIDM00171
DR   ColonAtlas; SNU1197
DR   Cosmic; 738859
DR   Cosmic; 2612382
DR   Cosmic; 2651861
DR   DepMap; ACH-000412
DR   IARC_TP53; 10840
DR   KCLB; 01197
DR   LiGeA; CCLE_185
DR   PharmacoDB; SNU1197_1443_2019
DR   Progenetix; CVCL_5016
DR   Wikidata; Q54955105
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 60 hours (PubMed=10362137).
CC   HLA typing: A*24:02,24:02; B*48:01,55:02; C*03:03,08:01; DQA1*04:01,04:01; DQB1*03:01,03:01; DRB1*03:38,12:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg232Ter (c.694C>T); ClinVar=VCV000042248; Zygosity=Heterozygous (DepMap=ACH-000412).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Homozygous (DepMap=ACH-000412).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=10362137; DepMap=ACH-000412).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=10362137; DepMap=ACH-000412).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=1.84%; Native American=0.35%; East Asian, North=62.22%; East Asian, South=34.04%; South Asian=0%; European, North=0%; European, South=1.55% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=01197
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   FGA: 23
ST   TH01: 8,9
ST   TPOX: 7,8
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SNU-1214
AC   CVCL_5017
SY   SNU1214; NCI-SNU-1214
DR   BTO; BTO_0005923
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987707
DR   cancercelllines; CVCL_5017
DR   Cell_Model_Passport; SIDM00167
DR   Cosmic; 934178
DR   DepMap; ACH-000715
DR   GEO; GSM887609
DR   GEO; GSM888692
DR   IARC_TP53; 28366
DR   KCLB; 01214
DR   LiGeA; CCLE_188
DR   PharmacoDB; SNU1214_1444_2019
DR   Progenetix; CVCL_5017
DR   Wikidata; Q54955106
RX   PubMed=10369293;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 96 hours (PubMed=10369293).
CC   HLA typing: A*11:01,11:01; B*13:01,13:01; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (PubMed=10369293; DepMap=ACH-000715).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Pro (c.475G>C); ClinVar=VCV000182929; Zygosity=Homozygous (DepMap=ACH-000715).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.38%; Native American=0%; East Asian, North=61.21%; East Asian, South=37.41%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): KCLB=01214
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D3S1358: 16
ST   D5S818: 9,10
ST   D7S820: 8,9
ST   FGA: 19
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SNU-1235
AC   CVCL_5018
SY   SNU1235
DR   cancercelllines; CVCL_5018
DR   ColonAtlas; SNU1235
DR   Cosmic; 1322288
DR   GEO; GSM1448190
DR   IARC_TP53; 28474
DR   KCLB; 01235
DR   Wikidata; Q54955107
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): KCLB=01235; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13
ST   D16S539: 9,12 (PubMed=20176655)
ST   D16S539: 12 (PubMed=25926053)
ST   D18S51: 13
ST   D19S433: 14.2,15.2
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12,16
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SNU-1245
AC   CVCL_5019
SY   SNU1245
DR   KCLB; 01245
DR   Wikidata; Q54955108
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an episomal HPV18 genome.
CC   Doubling time: 54 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=01245
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   FGA: 22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   SNU-1272
AC   CVCL_8788
AS   CVCL_5020
SY   SNU1272; NCI-SNU-1272
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987719
DR   cancercelllines; CVCL_8788
DR   Cell_Model_Passport; SIDM01335
DR   DepMap; ACH-000513
DR   GEO; GSM887610
DR   GEO; GSM888693
DR   IARC_TP53; 30159
DR   KCLB; 01272
DR   LiGeA; CCLE_309
DR   PharmacoDB; SNU1272_1445_2019
DR   Progenetix; CVCL_8788
DR   Wikidata; Q54955109
RX   PubMed=10619961;
RX   PubMed=14634222;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27993170;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 153 hours (PubMed=10619961).
CC   HLA typing: A*02:06,26:02; B*40:06,55:02; C*08:01,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.64%; Native American=0.63%; East Asian, North=63.53%; East Asian, South=33.83%; South Asian=0%; European, North=0%; European, South=0.37% (PubMed=30894373).
CC   Misspelling: SNU-1271; PubMed=19956504.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=01272
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-1299
AC   CVCL_5021
SY   SNU1299
DR   KCLB; 01299
DR   Wikidata; Q54955110
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV16 genome.
CC   Doubling time: 48 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=01299
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D3S1358: 15,16
ST   D5S818: 7,11
ST   D7S820: 11
ST   FGA: 22
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   SNU-1327
AC   CVCL_5022
SY   SNU1327
DR   Cosmic; 1484499
DR   DepMap; ACH-002526
DR   KCLB; 01327
DR   Wikidata; Q54955112
RX   PubMed=21290211;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=21290211).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Gln160Ter (c.478C>T); Zygosity=Homozygous (DepMap=ACH-002526).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Val (c.461G>T); ClinVar=VCV000651769; Zygosity=Homozygous (DepMap=ACH-002526).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=01327
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,13
ST   FGA: 18
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   SNU-1330
AC   CVCL_5023
SY   SNU1330
DR   Cosmic; 1484500
DR   KCLB; 01330
DR   Wikidata; Q54955113
RX   PubMed=21290211;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 39 hours (PubMed=21290211).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=01330
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   SNU-1406
AC   CVCL_5024
SY   SNU1406
DR   Cosmic; 1322289
DR   GEO; GSM1448191
DR   IARC_TP53; 28476
DR   KCLB; 01406
DR   Wikidata; Q54955114
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 25 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): KCLB=01406; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 13,20
ST   D19S433: 14.2,16.2
ST   D21S11: 30,33.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14,16
ST   FGA: 21,22
ST   TH01: 6,9 (KCLB=01406; PubMed=20176655)
ST   TH01: 6,9.3 (PubMed=25926053)
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SNU-1411
AC   CVCL_5025
SY   SNU1411
DR   cancercelllines; CVCL_5025
DR   ColonAtlas; SNU1411
DR   Cosmic; 1322290
DR   GEO; GSM1448157
DR   IARC_TP53; 28477
DR   KCLB; 01411
DR   Wikidata; Q54955115
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 38 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser94Ter (c.281C>A); Zygosity=Homozygous (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=01411; PubMed=20176655; PubMed=25926053; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13
ST   D12S391: 19
ST   D13S317: 10 (PubMed=25926053)
ST   D13S317: 10,11 (KCLB=01411; PubMed=20176655; Technion Genomics Center)
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 14
ST   D1S1656: 16,17.3
ST   D21S11: 30
ST   D22S1045: 16,17
ST   D2S1338: 19,24
ST   D2S441: 10,11
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 15 (PubMed=20176655)
ST   D8S1179: 15,16 (Technion Genomics Center)
ST   FGA: 23,24
ST   Penta D: 5,12
ST   Penta E: 16,18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SNU-1460
AC   CVCL_5026
SY   SNU1460
DR   cancercelllines; CVCL_5026
DR   ColonAtlas; SNU1460
DR   Cosmic; 1322291
DR   GEO; GSM1448158
DR   IARC_TP53; 28478
DR   KCLB; 01460
DR   Wikidata; Q54955116
RX   PubMed=20176655;
RX   PubMed=25926053;
RX   PubMed=31228769;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 67 hours (PubMed=20176655); 48 hours (PubMed=31228769).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): KCLB=01460; PubMed=20176655; PubMed=25926053; PubMed=31228769; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 15
ST   D12S391: 17,19
ST   D13S317: 9,12
ST   D16S539: 10
ST   D18S51: 13
ST   D19S433: 13,14.2
ST   D1S1656: 16,17
ST   D21S11: 30.2,31
ST   D22S1045: 16
ST   D2S1338: 23,24
ST   D2S441: 11
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 10,11
ST   Penta E: 13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SNU-1528
AC   CVCL_T037
DR   Cosmic; 2068084
DR   KCLB; 01528
DR   Wikidata; Q54955118
RX   PubMed=24141649;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 110 hours (PubMed=24141649).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): KCLB=01528; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 9,11
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 30,30.2
ST   D2S1338: 25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 16
//
ID   SNU-1544
AC   CVCL_5027
SY   SNU1544
DR   cancercelllines; CVCL_5027
DR   Cell_Model_Passport; SIDM01838
DR   ColonAtlas; SNU1544
DR   Cosmic; 1322292
DR   DepMap; ACH-001786
DR   GEO; GSM1448192
DR   IARC_TP53; 28480
DR   KCLB; 01544
DR   Wikidata; Q54955119
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=20176655).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ser2Leu (c.5C>T); ClinVar=VCV000182533; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): DepMap=ACH-001786; KCLB=01544; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12 (KCLB=01544; PubMed=20176655; PubMed=25926053)
ST   CSF1PO: 11.1,12 (DepMap=ACH-001786)
ST   D13S317: 9,11
ST   D16S539: 8,14
ST   D18S51: 12,17
ST   D19S433: 14.2,16.2
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 20,23,24 (DepMap=ACH-001786)
ST   FGA: 20,24 (PubMed=20176655)
ST   Penta D: 8,12
ST   Penta E: 9,16
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,19,20,21 (DepMap=ACH-001786)
ST   vWA: 14,20 (KCLB=01544; PubMed=20176655)
ST   vWA: 14,20,21 (PubMed=25926053)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-1553
AC   CVCL_T038
DR   Cosmic; 2068085
DR   KCLB; 01553
DR   Wikidata; Q54955120
RX   PubMed=24141649;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 89 hours (PubMed=24141649).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=01553; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 12
ST   FGA: 22,23
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 16
//
ID   SNU-1566
AC   CVCL_ZE50
DR   cancercelllines; CVCL_ZE50
DR   KCLB; 01566
DR   Wikidata; Q98132715
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.856 days (PubMed=32321971).
CC   Microsatellite instability: Instable (MSI) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Heterozygous (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=01566; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12,16
ST   D21S11: 31,32
ST   D2S1338: 16,24
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   TH01: 9
ST   TPOX: 7,8
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-1581
AC   CVCL_T039
DR   Cosmic; 2068086
DR   KCLB; 01581
DR   Wikidata; Q54955121
RX   PubMed=24141649;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 47 hours (PubMed=24141649).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
ST   Source(s): KCLB=01581; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 10
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,32.2
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 16
ST   FGA: 19,24
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 16
//
ID   SNU-16
AC   CVCL_0076
SY   SNU16; NCI-SNU-16
DR   BTO; BTO_0004987
DR   CLO; CLO_0009095
DR   EFO; EFO_0002344
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5974
DR   BCRC; 60212
DR   BioGRID_ORCS_Cell_line; 1018
DR   BioSample; SAMN03473127
DR   BioSample; SAMN10987911
DR   cancercelllines; CVCL_0076
DR   Cell_Model_Passport; SIDM01145
DR   ChEMBL-Cells; CHEMBL3307273
DR   ChEMBL-Targets; CHEMBL613529
DR   CLS; 305273
DR   Cosmic; 685588
DR   Cosmic; 687558
DR   Cosmic; 737365
DR   Cosmic; 848138
DR   Cosmic; 887247
DR   Cosmic; 908446
DR   Cosmic; 921597
DR   Cosmic; 1067204
DR   Cosmic; 1090452
DR   Cosmic; 1154649
DR   Cosmic; 1187295
DR   Cosmic; 1294962
DR   Cosmic; 1528873
DR   Cosmic; 1995596
DR   Cosmic; 2069774
DR   Cosmic; 2373751
DR   Cosmic; 2443799
DR   Cosmic; 2484966
DR   Cosmic; 2646590
DR   Cosmic; 2807644
DR   Cosmic-CLP; 908446
DR   DepMap; ACH-000581
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908446
DR   GEO; GSM267423
DR   GEO; GSM267430
DR   GEO; GSM267437
DR   GEO; GSM267444
DR   GEO; GSM552373
DR   GEO; GSM562407
DR   GEO; GSM827556
DR   GEO; GSM828829
DR   GEO; GSM844702
DR   GEO; GSM887611
DR   GEO; GSM888695
DR   GEO; GSM1237680
DR   GEO; GSM1237705
DR   GEO; GSM1374886
DR   GEO; GSM1670274
DR   IARC_TP53; 306
DR   IARC_TP53; 30160
DR   IGRhCellID; SNU16
DR   KCLB; 00016
DR   LiGeA; CCLE_312
DR   LINCS_LDP; LCL-1889
DR   PharmacoDB; SNU16_1446_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0076
DR   PubChem_Cell_line; CVCL_0076
DR   Wikidata; Q54955122
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1676761;
RX   PubMed=2158397;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=10674020;
RX   PubMed=14720123;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23637631;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=34466148;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/snu-16-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 27 hours (ATCC=CRL-5974; PubMed=2158397; PubMed=29435981).
CC   HLA typing: A*24:02,33:03; B*52:01,55:01; C*01:02,01:02; DQB1*06:13,06:13; DRB1*13:02,13:02 (PubMed=25960936).
CC   HLA typing: A*24:02,33:03; B*52:01,55:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (Cosmic-CLP=908446; DepMap=ACH-000581).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000581).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000581).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (PubMed=1676761; Cosmic-CLP=908446; DepMap=ACH-000581).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.14%; Native American=0.82%; East Asian, North=65.94%; East Asian, South=27.38%; South Asian=0%; European, North=0%; European, South=2.71% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-5974; Cosmic-CLP=908446; KCLB=00016; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 29,33.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   SNU-16 CDH17 KO clone 1C1
AC   CVCL_E8SI
SY   SNU-16-CDH17-KO-1C1
DR   KYinno; KC-4258
CC   Population: Korean.
CC   Doubling time: ~27 hours (KYinno=KC-4258).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1756; CDH17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SNU-16 CDH17 KO clone 2A1
AC   CVCL_E8SJ
SY   SNU-16-CDH17-KO-2A1
DR   KYinno; KC-4259
CC   Population: Korean.
CC   Doubling time: ~27 hours (KYinno=KC-4259).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1756; CDH17.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SNU-16 human PDL1
AC   CVCL_E8SK
SY   SNU-16-PDL1
DR   KYinno; KC-2868
CC   Population: Korean.
CC   Doubling time: ~27 hours (KYinno=KC-2868).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:17635; CD274.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SNU-16-DOX
AC   CVCL_L043
DR   cancercelllines; CVCL_L043
DR   Wikidata; Q54955124
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 21
//
ID   SNU-16/Cas9-hyg
AC   CVCL_C9DM
DR   GeneCopoeia; SL545
DR   Wikidata; Q123033539
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL545).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SNU-1684
AC   CVCL_5028
SY   SNU1684
DR   cancercelllines; CVCL_5028
DR   ColonAtlas; SNU1684
DR   Cosmic; 1322293
DR   GEO; GSM1448205
DR   IARC_TP53; 28481
DR   KCLB; 01684
DR   Wikidata; Q54955125
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 53 hours (PubMed=20176655).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg554Ter (c.1660C>T); ClinVar=VCV000000807; Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ile1557fs*1 (c.4669_4670delAT); Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): KCLB=01684; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 12
ST   D19S433: 14,15.2
ST   D21S11: 28
ST   D2S1338: 18,23
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 9,13
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SNU-16Ad
AC   CVCL_WY37
SY   SNU16Ad; SNU-16 Adherent
DR   cancercelllines; CVCL_WY37
DR   Wikidata; Q98132716
RX   PubMed=14720123;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   SNU-16alpha5
AC   CVCL_WY38
SY   SNU16alpha5; SNU16a5
DR   cancercelllines; CVCL_WY38
DR   Wikidata; Q98132717
RX   PubMed=14720123;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1681; CD44 + HGNC; HGNC:10940; SLC1A2; Name(s)=CD44-SLC1A2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Lys1358fs*2 (c.4065_4066insTTGA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Arg5Trp (c.13C>T); ClinVar=VCV003765045; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Phe39Leu (c.117T>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205Phe (c.614A>T); ClinVar=VCV000376682; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6141; ITGA5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0076 ! SNU-16
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   SNU-17
AC   CVCL_5029
SY   SNU17
DR   KCLB; 00017
DR   Wikidata; Q54955126
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV16 genome.
CC   Doubling time: 48 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=00017
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 9
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-1746
AC   CVCL_5030
SY   SNU1746
DR   cancercelllines; CVCL_5030
DR   ColonAtlas; SNU1746
DR   Cosmic; 1322294
DR   GEO; GSM1448206
DR   IARC_TP53; 28483
DR   KCLB; 01746
DR   Wikidata; Q54955128
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=20176655).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr562fs*19 (c.1682_1683insA); Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1429Ter (c.4285C>T); ClinVar=VCV000376063; Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Glu523Lys (c.1567G>A); Zygosity=Homozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): KCLB=01746; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 7,9
ST   D13S317: 9
ST   D16S539: 9,14
ST   D18S51: 13,18
ST   D19S433: 13,17.2
ST   D21S11: 28,33
ST   D2S1338: 18,24
ST   D3S1358: 14,17
ST   D5S818: 11,12,13 (KCLB=01746)
ST   D5S818: 11,12,13,14 (PubMed=25926053)
ST   D5S818: 12,13 (PubMed=20176655)
ST   D7S820: 8,11
ST   D8S1179: 11
ST   FGA: 17,22
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 15,18 (KCLB=01746; PubMed=20176655)
ST   vWA: 18 (PubMed=25926053)
DI   NCIt; C7967; Colon signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-175
AC   CVCL_5031
SY   SNU175; NCI-SNU-175
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988067
DR   cancercelllines; CVCL_5031
DR   Cell_Model_Passport; SIDM00216
DR   ColonAtlas; SNU175
DR   Cosmic; 738861
DR   Cosmic; 848826
DR   Cosmic; 2302007
DR   Cosmic; 2612375
DR   Cosmic; 2651852
DR   Cosmic-CLP; 1659928
DR   DepMap; ACH-000989
DR   EGA; EGAS00001000978
DR   GDSC; 1659928
DR   GEO; GSM887612
DR   GEO; GSM888696
DR   GEO; GSM1346853
DR   GEO; GSM1448216
DR   GEO; GSM1670464
DR   IARC_TP53; 30161
DR   KCLB; 00175
DR   LiGeA; CCLE_792
DR   PharmacoDB; SNU175_1447_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5031
DR   Wikidata; Q54955129
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 33 hours (PubMed=10362137).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=24755471; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg232Ter (c.694C>T); ClinVar=VCV000042248; Zygosity=Heterozygous (Cosmic-CLP=1659928; DepMap=ACH-000989).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gly1499Ter (c.4495G>T); ClinVar=VCV000217983; Zygosity=Heterozygous (Cosmic-CLP=1659928; DepMap=ACH-000989).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous (PubMed=10362137; Cosmic-CLP=1659928; DepMap=ACH-000989).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0.33%; East Asian, North=60.01%; East Asian, South=39.42%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): Cosmic-CLP=1659928; KCLB=00175; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D21S11: 30,32.2
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 11
ST   FGA: 19,21
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   SNU-1750
AC   CVCL_8914
DR   cancercelllines; CVCL_8914
DR   Cosmic; 1661032
DR   KCLB; 01750
DR   Wikidata; Q54955139
RX   PubMed=22361929;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 74 hours (PubMed=22361929).
CC   Microsatellite instability: Stable (MSS) (PubMed=22361929).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Pro (c.818G>C); ClinVar=VCV000231060; Zygosity=Unspecified (PubMed=22361929).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): KCLB=01750; PubMed=22361929
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 7,14
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 24
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 14,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   SNU-182
AC   CVCL_0090
SY   SNU182; NCI-SNU-182
DR   BTO; BTO_0003760
DR   CLO; CLO_0009096
DR   EFO; EFO_0002345
DR   AddexBio; C0015003/4954
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2235
DR   BioSample; SAMN03473221
DR   BioSample; SAMN10987895
DR   cancercelllines; CVCL_0090
DR   CCRID; 3101HUMSCSP5047
DR   Cell_Model_Passport; SIDM01151
DR   ChEMBL-Cells; CHEMBL4295423
DR   ChEMBL-Targets; CHEMBL4296495
DR   CLS; 305119
DR   Cosmic; 684198
DR   Cosmic; 873399
DR   Cosmic; 928141
DR   Cosmic; 1995638
DR   Cosmic; 2162540
DR   Cosmic; 2321040
DR   Cosmic-CLP; 1240216
DR   DepMap; ACH-000483
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240216
DR   GEO; GSM481446
DR   GEO; GSM565919
DR   GEO; GSM887613
DR   GEO; GSM888697
DR   GEO; GSM936778
DR   GEO; GSM1670465
DR   GEO; GSM2551583
DR   IARC_TP53; 6304
DR   IGRhCellID; SNU182
DR   KCLB; 00182
DR   LiGeA; CCLE_348
DR   LIMORE; SNU182
DR   LINCS_LDP; LCL-1932
DR   PharmacoDB; SNU182_1448_2019
DR   Progenetix; CVCL_0090
DR   PubChem_Cell_line; CVCL_0090
DR   Wikidata; Q54955141
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=19956504;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU182
WW   Provider; BRICS; BRICS0081; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3895
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 46 hours (PubMed=7543080); 37.62 hours (PubMed=31378681).
CC   HLA typing: A*11:01,30:01; B*13:02,55:02; C*01:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Unspecified (PubMed=8824565; PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.29%; Native American=0%; East Asian, North=65.62%; East Asian, South=30.85%; South Asian=0%; European, North=0%; European, South=2.24% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): AddexBio=C0015003/4954; ATCC=CRL-2235; Cosmic-CLP=1240216; KCLB=00182; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14 (AddexBio=C0015003/4954; ATCC=CRL-2235; Cosmic-CLP=1240216; PubMed=25877200; PubMed=31378681)
ST   D13S317: 14 (KCLB=00182)
ST   D16S539: 11,13
ST   D18S51: 16
ST   D21S11: 29,34.2
ST   D3S1358: 16,18 (PubMed=25877200)
ST   D3S1358: 17 (KCLB=00182)
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 10
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17 (AddexBio=C0015003/4954; ATCC=CRL-2235; Cosmic-CLP=1240216; PubMed=25877200; PubMed=31378681)
ST   vWA: 17,18 (KCLB=00182)
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SNU-1826
AC   CVCL_WW16
SY   SNU1826
DR   KCLB; 01826
DR   Wikidata; Q98132718
RX   PubMed=31228769;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=31228769).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): KCLB=01826; PubMed=31228769
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 11.2,14
ST   D21S11: 32,32.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   SNU-1958
AC   CVCL_T040
DR   cancercelllines; CVCL_T040
DR   Cosmic; 2068087
DR   KCLB; 01958
DR   Wikidata; Q54955142
RX   PubMed=24141649;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a LS513 derivative (ICLAC). Originally thought to originate from the ascitic fluid of a 55 year old female patient with triple-negative breast carcinoma.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00539.
CC   Population: Caucasian.
CC   Doubling time: 53 hours (PubMed=24141649).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Misspelling: SNU-1598; Cosmic=2068087.
CC   Derived from site: In situ; Intestine, ileocecal valve; UBERON=UBERON_0000569.
ST   Source(s): KCLB=01958; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,10
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   FGA: 19,21
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1386 ! LS513
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 23
//
ID   SNU-1967
AC   CVCL_8915
DR   Cosmic; 1661033
DR   KCLB; 01967
DR   Wikidata; Q54955143
RX   PubMed=22361929;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 49 hours (PubMed=22361929).
CC   Microsatellite instability: Stable (MSS) (PubMed=22361929).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=01967; PubMed=22361929
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 14.2
ST   D21S11: 30,31
ST   D2S1338: 17,18
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 12,13
ST   D8S1179: 10,16
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   SNU-1983
AC   CVCL_ZE51
DR   cancercelllines; CVCL_ZE51
DR   KCLB; 01983
DR   Wikidata; Q98132719
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 35.4 hours (PubMed=32321971).
CC   Microsatellite instability: Instable (MSI) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Trp666Ter (c.1997G>A); ClinVar=VCV000265246; Zygosity=Heterozygous (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys164Argfs*3 (c.491delA); ClinVar=VCV000189448; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.437G>A); ClinVar=VCV000634785; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=01983; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 10,12
ST   D18S51: 12,23
ST   D19S433: 12,14
ST   D21S11: 28,35.2
ST   D2S1338: 20,23
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 12,13
ST   D8S1179: 12,17
ST   FGA: 20,22
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 20,22
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   SNU-20
AC   CVCL_5032
SY   SNU20
DR   Wikidata; Q54955144
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a stomach cancer.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-201
AC   CVCL_5033
SY   SNU201; NCI-SNU-201
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 704
DR   BioSample; SAMN10988069
DR   cancercelllines; CVCL_5033
DR   Cell_Model_Passport; SIDM00158
DR   Cosmic; 2516038
DR   DepMap; ACH-000623
DR   GEO; GSM887615
DR   GEO; GSM888699
DR   IARC_TP53; 28277
DR   KCLB; 00201
DR   LiGeA; CCLE_119
DR   PharmacoDB; SNU201_1449_2019
DR   Progenetix; CVCL_5033
DR   Wikidata; Q54955145
RX   PubMed=11776963;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 61 hours (PubMed=11776963); 58 hours (PubMed=25984343).
CC   HLA typing: A*24:02,33:03; B*40:01,40:01; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Heterozygous; Note=Splice acceptor mutation (DepMap=ACH-000623).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Asn (c.841G>A); ClinVar=VCV000376586; Zygosity=Heterozygous (DepMap=ACH-000623).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.24%; Native American=2.29%; East Asian, North=64.8%; East Asian, South=30.66%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=00201
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 15,16
ST   D5S818: 9,10
ST   D7S820: 8,11
ST   FGA: 18,25
ST   TH01: 6,8
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SNU-213
AC   CVCL_5034
SY   SNU213; NCI-SNU-213
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 703
DR   BioSample; SAMN10987743
DR   cancercelllines; CVCL_5034
DR   Cell_Model_Passport; SIDM01372
DR   Cosmic; 707181
DR   DepMap; ACH-000266
DR   GEO; GSM887616
DR   GEO; GSM888700
DR   IARC_TP53; 16868
DR   KCLB; 00213
DR   LiGeA; CCLE_377
DR   PharmacoDB; SNU213_1450_2019
DR   Progenetix; CVCL_5034
DR   Wikidata; Q54955147
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=12037578;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=12037578).
CC   HLA typing: A*02:01,33:03; B*44:02,51:01; C*07:01,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=12037578; DepMap=ACH-000266).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=12037578).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Homozygous (DepMap=ACH-000266).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.77%; Native American=0%; East Asian, North=68.61%; East Asian, South=29.21%; South Asian=0%; European, North=0%; European, South=0.41% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=00213
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SNU-216
AC   CVCL_3946
SY   SNU216; NCI-SNU-216
DR   BTO; BTO_0004988
DR   EFO; EFO_0006754
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473182
DR   BioSample; SAMN10988071
DR   cancercelllines; CVCL_3946
DR   Cell_Model_Passport; SIDM01393
DR   CGH-DB; 124-1
DR   CGH-DB; 9012-4
DR   Cosmic; 685589
DR   Cosmic; 848139
DR   Cosmic; 1067205
DR   Cosmic; 1090453
DR   Cosmic; 1151969
DR   Cosmic; 1528874
DR   Cosmic; 2484970
DR   DepMap; ACH-000466
DR   EGA; EGAS00001000610
DR   GEO; GSM887617
DR   GEO; GSM888701
DR   GEO; GSM1374887
DR   IARC_TP53; 7418
DR   KCLB; 00216
DR   LiGeA; CCLE_434
DR   PharmacoDB; SNU216_1451_2019
DR   Progenetix; CVCL_3946
DR   Wikidata; Q54955148
RX   PubMed=9033653;
RX   PubMed=15723654;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=29435981).
CC   HLA typing: A*24:02,24:02; B*51:01,52:01; C*12:02,12:02; DRB1*15:02,15:02 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*52:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Homozygous (PubMed=9033653; DepMap=ACH-000466).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.54%; Native American=0%; East Asian, North=69.93%; East Asian, South=26.25%; South Asian=0%; European, North=0%; European, South=1.27% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): KCLB=00216; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 10,13
ST   D18S51: 16
ST   D21S11: 30,33.2
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 5
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 14,20
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SNU-2172
AC   CVCL_ZE52
DR   cancercelllines; CVCL_ZE52
DR   KCLB; 02172
DR   Wikidata; Q98132720
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.122 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02172; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 21
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   SNU-228
AC   CVCL_5035
SY   SNU228
DR   KCLB; 00228
DR   Wikidata; Q54955149
RX   PubMed=10619961;
RX   PubMed=19956504;
RX   PubMed=27993170;
RX   PubMed=34560848;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00228
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   FGA: 23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   SNU-2292
AC   CVCL_5036
SY   SNU2292
DR   Cosmic; 1484501
DR   KCLB; 02292
DR   Wikidata; Q54955150
RX   PubMed=21290211;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 72 hours (PubMed=21290211).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=02292
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11
ST   FGA: 23,24
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   SNU-2297
AC   CVCL_ZE53
DR   cancercelllines; CVCL_ZE53
DR   KCLB; 02297
DR   Wikidata; Q98132722
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 41.3 hours (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gly386Asp (c.1157G>A); ClinVar=VCV000008545; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02297; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 25
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2303
AC   CVCL_ZE54
DR   cancercelllines; CVCL_ZE54
DR   KCLB; 02303
DR   Wikidata; Q98132723
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 47.6 hours (PubMed=32321971).
CC   Microsatellite instability: Instable (MSI) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Leu574Pro (c.1721T>C); ClinVar=VCV000089846; Zygosity=Heterozygous (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02303; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10,11 (PubMed=32321971)
ST   CSF1PO: 9,11 (KCLB=02303)
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 11,13
ST   D19S433: 12,13
ST   D21S11: 29,35.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2315
AC   CVCL_5037
SY   SNU2315
DR   Cosmic; 1484502
DR   KCLB; 02315
DR   Wikidata; Q54955151
RX   PubMed=21290211;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 141 hours (PubMed=21290211).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): KCLB=02315
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   FGA: 23,25
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   SNU-2335A
AC   CVCL_UR60
SY   SNU-2335A1
DR   cancercelllines; CVCL_UR60
DR   KCLB; 02335A1
DR   Wikidata; Q98132724
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg302Ter (c.904C>T) (R284*); ClinVar=VCV000000798; Zygosity=Unspecified (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02335A1; PubMed=30114595
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 14,16.2
ST   D2S1338: 19,22
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 26
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR61 ! SNU-2335D
OI   CVCL_UR62 ! SNU-2335E
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   SNU-2335D
AC   CVCL_UR61
DR   cancercelllines; CVCL_UR61
DR   KCLB; 02335D
DR   Wikidata; Q98132726
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg302Ter (c.904C>T) (R284*); ClinVar=VCV000000798; Zygosity=Unspecified (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): KCLB=02335D; PubMed=30114595
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 14,16.2
ST   D2S1338: 19,22
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 26
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR60 ! SNU-2335A
OI   CVCL_UR62 ! SNU-2335E
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2335E
AC   CVCL_UR62
DR   cancercelllines; CVCL_UR62
DR   Wikidata; Q98132727
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 40 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=30114595
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 14,16.2
ST   D2S1338: 19,22
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 12
ST   D8S1179: 10,15
ST   FGA: 26
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3153; Krukenberg tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR60 ! SNU-2335A
OI   CVCL_UR61 ! SNU-2335D
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   SNU-2353B
AC   CVCL_ZE55
DR   KCLB; 02353B
DR   Wikidata; Q98132728
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 3.157 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): KCLB=02353B; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 15,16
ST   D19S433: 13,14.2
ST   D21S11: 29
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   SNU-2359
AC   CVCL_ZE56
DR   cancercelllines; CVCL_ZE56
DR   KCLB; 02359
DR   Wikidata; Q98132729
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.937 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02359; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 14,15
ST   D19S433: 13
ST   D21S11: 28.2,30
ST   D2S1338: 23
ST   D3S1358: 14,15
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2372
AC   CVCL_T041
DR   Cosmic; 2068088
DR   KCLB; 02372
DR   Wikidata; Q54955152
RX   PubMed=24141649;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 78 hours (PubMed=24141649).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=02372; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D3S1358: 15.2,18.2
ST   D5S818: 12
ST   D7S820: 11
ST   FGA: 25
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 16
//
ID   SNU-2373B
AC   CVCL_ZE57
DR   cancercelllines; CVCL_ZE57
DR   KCLB; 02373B
DR   Wikidata; Q98132731
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.335 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val147Asp (c.440T>A); ClinVar=VCV001351017; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,14
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 31.2
ST   D2S1338: 22
ST   D3S1358: 15,17
ST   D5S818: 14
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 19,21
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2404A
AC   CVCL_UR63
DR   cancercelllines; CVCL_UR63
DR   KCLB; 02404A
DR   Wikidata; Q98132732
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 55 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg302Ter (c.904C>T) (R284*); ClinVar=VCV000000798; Zygosity=Unspecified (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): KCLB=02404A; PubMed=30114595
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR64 ! SNU-2404B
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   SNU-2404B
AC   CVCL_UR64
DR   cancercelllines; CVCL_UR64
DR   KCLB; 02404B
DR   Wikidata; Q98132733
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 67 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): KCLB=02404B; PubMed=30114595
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR63 ! SNU-2404A
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2407
AC   CVCL_ZE58
DR   cancercelllines; CVCL_ZE58
DR   KCLB; 02407
DR   Wikidata; Q98132734
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 3.031 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=02407; PubMed=32321971
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 13,16.2
ST   D21S11: 30,31
ST   D2S1338: 22,23
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 24
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2414A
AC   CVCL_UR65
DR   KCLB; 02414A
DR   Wikidata; Q98132735
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1444Ter (c.4330C>T); Zygosity=Unspecified (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): KCLB=02414A; PubMed=30114595
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR66 ! SNU-2414B
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2414B
AC   CVCL_UR66
DR   KCLB; 02414B
DR   Wikidata; Q98132736
RX   PubMed=30114595;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=30114595).
CC   Microsatellite instability: Stable (MSS) (PubMed=30114595).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1444Ter (c.4330C>T); Zygosity=Unspecified (PubMed=30114595).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): KCLB=02414B; PubMed=30114595
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14,14.2
ST   D21S11: 29
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17 (KCLB=02414B)
ST   vWA: 17,18 (PubMed=30114595)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UR65 ! SNU-2414A
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2423
AC   CVCL_ZE59
DR   cancercelllines; CVCL_ZE59
DR   KCLB; 02423
DR   Wikidata; Q98132737
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.296 days (PubMed=32321971).
CC   Microsatellite instability: Instable (MSI) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Leu574Pro (c.1721T>C); ClinVar=VCV000089846; Zygosity=Heterozygous (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Colon, serosa; UBERON=UBERON_0003335.
ST   Source(s): KCLB=02423; PubMed=32321971
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 10,21
ST   D19S433: 12,14.2
ST   D21S11: 28,30
ST   D2S1338: 17,19
ST   D3S1358: 14,17
ST   D5S818: 10,14
ST   D7S820: 11
ST   D8S1179: 10,16
ST   FGA: 21,24
ST   TH01: 8,9
ST   TPOX: 9
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2431
AC   CVCL_ZE60
DR   cancercelllines; CVCL_ZE60
DR   KCLB; 02431
DR   Wikidata; Q98132738
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 5.759 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln442Ter (c.1324C>T); ClinVar=VCV000529907; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg337Cys (c.1009C>T); ClinVar=VCV000142536; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02431; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 13.2,15
ST   D21S11: 31
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 12,15
ST   FGA: 20,21
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2446
AC   CVCL_WW17
SY   SNU2446
DR   KCLB; 02446
DR   Wikidata; Q98132739
RX   PubMed=31228769;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 82 hours (PubMed=31228769).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon, descending; UBERON=UBERON_0001158.
ST   Source(s): KCLB=02446; PubMed=31228769
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 19
ST   D19S433: 13
ST   D21S11: 29,34
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 24
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14
DI   NCIt; C43585; Colorectal mucinous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-245
AC   CVCL_5038
SY   SNU245; NCI-SNU-245
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988083
DR   cancercelllines; CVCL_5038
DR   Cell_Model_Passport; SIDM00162
DR   Cosmic; 738866
DR   Cosmic; 2674052
DR   DepMap; ACH-000268
DR   GEO; GSM887618
DR   GEO; GSM888702
DR   IARC_TP53; 28357
DR   KCLB; 00245
DR   LiGeA; CCLE_733
DR   PharmacoDB; SNU245_1452_2019
DR   Progenetix; CVCL_5038
DR   Wikidata; Q54955153
RX   CelloPub=CLPUB00275;
RX   PubMed=12107841;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27231123;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 54 hours (PubMed=12107841).
CC   HLA typing: A*02:01,33:03; B*35:01,44:03; C*03:03,14:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (DepMap=ACH-000268).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=0.55%; East Asian, North=65.45%; East Asian, South=33.11%; South Asian=0%; European, North=0%; European, South=0.05% (PubMed=30894373).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): KCLB=00245
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,13
ST   D16S539: 9,13
ST   D18S51: 16
ST   D19S433: 14,15.2
ST   D21S11: 27,30
ST   D2S1338: 18,19
ST   D3S1358: 17,19
ST   D5S818: 7
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 21.2,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SNU-2465
AC   CVCL_ZE61
DR   cancercelllines; CVCL_ZE61
DR   KCLB; 02465
DR   Wikidata; Q98132740
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.133 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02465; PubMed=32321971
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 10,15
ST   D7S820: 9,12
ST   D8S1179: 11,12
ST   FGA: 23,26
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2466
AC   CVCL_YI70
DR   cancercelllines; CVCL_YI70
DR   KCLB; 02466
DR   Wikidata; Q98132743
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Thr18_Ala20del (c.51_59delCACGGCCGC); Zygosity=Homozygous (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His168Arg (c.503A>G); ClinVar=VCV000428866; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02466; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D18S51: 13
ST   D19S433: 13,14.2
ST   D21S11: 29,31.2
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 8,13
ST   D8S1179: 12,13
ST   FGA: 22
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2469
AC   CVCL_YI71
DR   cancercelllines; CVCL_YI71
DR   KCLB; 02469
DR   Wikidata; Q98132746
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe328fs (c.982_983insA); Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02469; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9,14
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 14,16
ST   D5S818: 7,10
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,20
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-247
AC   CVCL_5039
SY   SNU247
DR   Wikidata; Q54955154
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a ureter cancer.
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-2485
AC   CVCL_YI72
DR   cancercelllines; CVCL_YI72
DR   KCLB; 02485
DR   Wikidata; Q98132747
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro70_Asn71del (c.208_213delCCCAAC); Zygosity=Homozygous (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>A; ClinVar=VCV000634769; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02485; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 23
ST   TH01: 6.2,8,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SNU-2491
AC   CVCL_YI73
DR   cancercelllines; CVCL_YI73
DR   KCLB; 02491
DR   Wikidata; Q98132748
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02491; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 13
ST   D19S433: 14.2,15.2
ST   D21S11: 29
ST   D2S1338: 18,24
ST   D3S1358: 14,15
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2493
AC   CVCL_ZE62
DR   cancercelllines; CVCL_ZE62
DR   KCLB; 02493
DR   Wikidata; Q98132749
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.113 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser106Arg (c.318C>G); ClinVar=VCV000492752; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=02493; PubMed=32321971
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 13.2,14
ST   D21S11: 32.2
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 26
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 11
//
ID   SNU-251
AC   CVCL_5040
SY   SNU251
DR   EFO; EFO_0022583
DR   cancercelllines; CVCL_5040
DR   KCLB; 00251
DR   Wikidata; Q54955155
RX   PubMed=9299249;
RX   PubMed=19956504;
RX   PubMed=22710073;
RX   PubMed=23415752;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 46 hours (PubMed=9299249).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Trp1815Ter (c.5445G>A); ClinVar=VCV000055581; Zygosity=Hemizygous or homozygous (PubMed=9299249).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ala723Asp (c.2168C>A); Zygosity=Heterozygous (PubMed=9299249).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00251; PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13.2,14.2
ST   D21S11: 30,31.2
ST   D2S1338: 19,22
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20
ST   TH01: 8
ST   TPOX: 12
ST   vWA: 15,18
DI   NCIt; C36100; BRCA1 syndrome
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-2535
AC   CVCL_R756
DR   cancercelllines; CVCL_R756
DR   Cosmic; 1859888
DR   DepMap; ACH-002531
DR   KCLB; 02535
DR   Wikidata; Q54955156
RX   CelloPub=CLPUB00546;
RX   PubMed=23344087;
RX   PubMed=35852680;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Characteristics: Resistant to crizotinib (PubMed=23344087).
CC   Doubling time: 61 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546; PubMed=35852680).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Gly1269Ala (c.3806G>C); ClinVar=VCV000376132; Zygosity=Heterozygous (CelloPub=CLPUB00546; PubMed=35852680; DepMap=ACH-002531).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=02535; CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 10.2,14
ST   D21S11: 28,29
ST   D2S1338: 20,23
ST   D3S1358: 14,15 (CelloPub=CLPUB00546)
ST   D3S1358: 15 (KCLB=02535)
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 24,27
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   SNU-2535LR
AC   CVCL_C5TR
DR   Wikidata; Q116050519
RX   PubMed=35852680;
CC   Population: Korean.
CC   Characteristics: Resistant to crizotinib (from parent cell line).
CC   Characteristics: Has lost the ALK p.Gly1269Ala mutation of the parent cell line (PubMed=35852680).
CC   Selected for resistance to: ChEBI; CHEBI_143117; Lorlatinib (Lorbrena; Lorviqua; PF-6463922).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=35852680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Val (c.854A>T); ClinVar=VCV000012384; Zygosity=Homozygous (PubMed=35852680).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R756 ! SNU-2535
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   SNU-2536C
AC   CVCL_ZE63
DR   cancercelllines; CVCL_ZE63
DR   KCLB; 02536C
DR   Wikidata; Q98132750
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 3.305 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=02536C; PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,14.2
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 8
ST   D8S1179: 15
ST   FGA: 22
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-254
AC   CVCL_5041
SY   SNU254
DR   cancercelllines; CVCL_5041
DR   ColonAtlas; SNU254
DR   Cosmic; 1322283
DR   GEO; GSM1448207
DR   IARC_TP53; 28469
DR   KCLB; 00254
DR   Wikidata; Q54955157
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 50 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1488Tyrfs*19 (c.4463delT); ClinVar=VCV000428136; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Unspecified (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=00254; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 12,15.2
ST   D21S11: 31
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 11,13 (KCLB=00254; PubMed=20176655)
ST   D7S820: 13 (PubMed=25926053)
ST   D8S1179: 13,15
ST   FGA: 24,25
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SNU-2543
AC   CVCL_YI74
DR   cancercelllines; CVCL_YI74
DR   KCLB; 02543
DR   Wikidata; Q98132751
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 55 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+2T>A (IVS9+2T>A); Zygosity=Unspecified; Note=Splice donor mutation (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02543; PubMed=31688591
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   SNU-2550
AC   CVCL_YD22
DR   Wikidata; Q98132752
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 32 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 8,17
ST   D19S433: 12,15,15.2
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2550CR
AC   CVCL_YD49
DR   Wikidata; Q98132753
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YD22 ! SNU-2550
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2553
AC   CVCL_YD23
DR   Wikidata; Q98132754
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 61 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30.2,31
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,24
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2556
AC   CVCL_YD24
DR   Wikidata; Q98132755
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 35 hours (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 13.2,15
ST   D21S11: 28,29
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 11,15
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   SNU-2563
AC   CVCL_YD25
DR   cancercelllines; CVCL_YD25
DR   Wikidata; Q98132756
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 47 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14,14.2
ST   D21S11: 29,32.2
ST   D2S1338: 20,26
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SNU-2563CR
AC   CVCL_YD50
DR   cancercelllines; CVCL_YD50
DR   Wikidata; Q98132757
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YD25 ! SNU-2563
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SNU-2564
AC   CVCL_YI75
DR   cancercelllines; CVCL_YI75
DR   KCLB; 02564
DR   Wikidata; Q98132758
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 58 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02564; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 9,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 14,15
ST   FGA: 23,26
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2570
AC   CVCL_YI76
DR   cancercelllines; CVCL_YI76
DR   KCLB; 02570
DR   Wikidata; Q98132759
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 49 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02570; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 18,19
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 15,16
ST   FGA: 24,25
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2571
AC   CVCL_YI77
DR   cancercelllines; CVCL_YI77
DR   KCLB; 02571
DR   Wikidata; Q98132760
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02571; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 12,16.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 15 (KCLB=02571)
ST   D3S1358: 15,20 (PubMed=31688591)
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2585
AC   CVCL_YD26
DR   cancercelllines; CVCL_YD26
DR   Wikidata; Q98132761
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 31 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D18S51: 13,18
ST   D19S433: 13
ST   D21S11: 31,31.2
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12,16
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2588
AC   CVCL_YD27
DR   Wikidata; Q98132763
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 39 hours (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 13,17
ST   D19S433: 13.2,15
ST   D21S11: 32.2
ST   D2S1338: 24,25
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 24
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   SNU-2589
AC   CVCL_YD28
DR   cancercelllines; CVCL_YD28
DR   Wikidata; Q98132765
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 33 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146Ter (c.438G>A); ClinVar=VCV000428890; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13,14
ST   D19S433: 13,17.2
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 21,22
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2606
AC   CVCL_YD29
DR   cancercelllines; CVCL_YD29
DR   Wikidata; Q98132766
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 28 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9
ST   D16S539: 8,9
ST   D18S51: 16
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 24,26
ST   D3S1358: 15
ST   D5S818: 9,13
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 21,26
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SNU-2608
AC   CVCL_YI78
DR   cancercelllines; CVCL_YI78
DR   KCLB; 02608
DR   Wikidata; Q98132767
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02608; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 10
ST   D18S51: 16
ST   D19S433: 11,13
ST   D21S11: 31
ST   D2S1338: 20
ST   D3S1358: 15,17
ST   D5S818: 11 (PubMed=31688591)
ST   D5S818: 11,13 (KCLB=02608)
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   TH01: 9,9.3 (KCLB=02608)
ST   TH01: 9.3 (PubMed=31688591)
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SNU-2612A
AC   CVCL_YD30
DR   Wikidata; Q98132768
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 39 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6324; KIF5B + HGNC; HGNC:9967; RET; Name(s)=KIF5B-RET (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,21
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 18,21
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2617
AC   CVCL_YI79
DR   cancercelllines; CVCL_YI79
DR   KCLB; 02617
DR   Wikidata; Q98132769
RX   PubMed=31688591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 17 hours (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=31688591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=31688591).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=02617; PubMed=31688591
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 18
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 16
ST   D5S818: 7,13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 22 (KCLB=02617)
ST   FGA: 22,25 (PubMed=31688591)
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 14,15
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SNU-2621B
AC   CVCL_ZE64
DR   cancercelllines; CVCL_ZE64
DR   KCLB; 02621B
DR   Wikidata; Q98132770
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 32.3 hours (PubMed=32321971).
CC   Microsatellite instability: Instable (MSI) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Arg74Ter (c.220C>T); ClinVar=VCV000239891; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Arg800Alafs*16 (c.2398delC); ClinVar=VCV000156497; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gly163Ser (c.487G>A); Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe328fs (c.980_981dupAT); Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D18S51: 15,19
ST   D19S433: 13,14
ST   D21S11: 28,32
ST   D2S1338: 21,25
ST   D3S1358: 15,19
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 20,23
ST   TH01: 7,9
ST   TPOX: 7,9
ST   vWA: 15,22
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   SNU-2627
AC   CVCL_YD31
DR   Wikidata; Q98132771
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 40 hours (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 21
ST   D19S433: 13,14.2
ST   D21S11: 30,32.2
ST   D2S1338: 25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   SNU-2637
AC   CVCL_YD32
DR   Wikidata; Q98132772
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 30 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 13,21
ST   D19S433: 14.2,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 18,23
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18,19,20
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2641
AC   CVCL_YD33
DR   Wikidata; Q98132773
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 44 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:9668; PTPRD; Simple; p.Cys1668Ter (c.5004T>A); Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,10
ST   D16S539: 10,13
ST   D18S51: 14,15
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 17,21
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-2643
AC   CVCL_YD34
DR   cancercelllines; CVCL_YD34
DR   Wikidata; Q98132774
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 27 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 20
ST   D19S433: 13.2,15
ST   D21S11: 29,31
ST   D2S1338: 19,24
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 22,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-265
AC   CVCL_5042
SY   SNU265
DR   Wikidata; Q54955158
RX   PubMed=9542645;
RX   PubMed=11507201;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
ID   SNU-2657
AC   CVCL_YD35
DR   cancercelllines; CVCL_YD35
DR   Wikidata; Q98132775
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 27 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 13,22
ST   D19S433: 13,15
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-267
AC   CVCL_5043
SY   SNU267
DR   KCLB; 00267
DR   Wikidata; Q54955159
RX   PubMed=10619961;
RX   PubMed=19956504;
RX   PubMed=27993170;
RX   PubMed=34560848;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00267
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   FGA: 24,25
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   SNU-2681
AC   CVCL_YD36
DR   cancercelllines; CVCL_YD36
DR   Wikidata; Q98132776
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 34 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14,15.2
ST   D21S11: 29.2,30
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2689
AC   CVCL_YD37
DR   cancercelllines; CVCL_YD37
DR   Wikidata; Q98132777
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 25 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 14,17
ST   D19S433: 14.2,15.2
ST   D21S11: 30
ST   D2S1338: 22
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 20
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2693
AC   CVCL_YD38
DR   Wikidata; Q98132778
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 34 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:8592; PAK3; Simple; p.Glu480Ter (c.1438G>T); Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 18,24
ST   D3S1358: 15,18
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 27
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   SNU-2708.1
AC   CVCL_YD39
DR   Wikidata; Q98132779
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 24
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 20,23
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   SNU-2727
AC   CVCL_YD40
DR   cancercelllines; CVCL_YD40
DR   Wikidata; Q98132780
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 102 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,14
ST   D8S1179: 11
ST   FGA: 23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2741
AC   CVCL_YD41
DR   cancercelllines; CVCL_YD41
DR   Wikidata; Q98132781
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 55 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Thr751del (c.2240_2254delTAAGAGAAGCAACAT); ClinVar=VCV000177649; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 10.2,14
ST   D21S11: 30,32.2
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2749
AC   CVCL_YD42
DR   cancercelllines; CVCL_YD42
DR   Wikidata; Q98132782
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 31 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 14
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2778
AC   CVCL_YD43
DR   Wikidata; Q98132784
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 35 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6324; KIF5B + HGNC; HGNC:9967; RET; Name(s)=KIF5B-RET (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,10
ST   D18S51: 20
ST   D19S433: 14,15.2
ST   D21S11: 32.2
ST   D2S1338: 23,26
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 13,16
ST   FGA: 22,23
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-283
AC   CVCL_5044
SY   SNU283; NCI-SNU-283
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988079
DR   cancercelllines; CVCL_5044
DR   Cell_Model_Passport; SIDM00215
DR   ColonAtlas; SNU283
DR   Cosmic; 738862
DR   Cosmic; 2302008
DR   Cosmic; 2612376
DR   Cosmic; 2651853
DR   Cosmic-CLP; 1659929
DR   DepMap; ACH-000708
DR   EGA; EGAS00001000978
DR   GEO; GSM887619
DR   GEO; GSM888703
DR   GEO; GSM1346854
DR   GEO; GSM1448123
DR   GEO; GSM1670466
DR   KCLB; 00283
DR   PharmacoDB; SNU283_1453_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5044
DR   Wikidata; Q54955161
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=10362137).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=24755471; PubMed=25926053; Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.3%; Native American=0.52%; East Asian, North=60.74%; East Asian, South=36.27%; South Asian=0%; European, North=0%; European, South=1.16% (PubMed=30894373).
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Cosmic-CLP=1659929; KCLB=00283; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 9
ST   D7S820: 11
ST   FGA: 23,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SNU-2832
AC   CVCL_YD44
DR   Wikidata; Q98132785
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 25 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 10,11
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 30,31
ST   D2S1338: 18,24
ST   D3S1358: 15,19
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 15,16
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SNU-285
AC   CVCL_5045
SY   SNU285
DR   Wikidata; Q54955163
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-2867
AC   CVCL_YD45
DR   cancercelllines; CVCL_YD45
DR   Wikidata; Q98132786
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 87 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu747_Ser752del (c.2239_2256delTTAAGAGAAGCAACATCT); ClinVar=VCV000177647; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 15
ST   FGA: 24
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 20
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-2887
AC   CVCL_YD46
DR   Wikidata; Q98132787
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 102 hours (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 16.2
ST   D21S11: 29,31
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 24,25
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   SNU-291
AC   CVCL_5046
SY   SNU291; SNU-291BL; SNU-291EBV
DR   KCLB; 00291EBV
DR   Wikidata; Q54955164
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
ID   SNU-2964
AC   CVCL_YD47
DR   Wikidata; Q98132788
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 46 hours (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 29.2,30
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,22.2,23.2
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 5
//
ID   SNU-2972-1
AC   CVCL_UD98
SY   NMC1
DR   EGA; EGAD00001003117
DR   KCLB; 02972-1
DR   Wikidata; Q98132789
RX   PubMed=28203693;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 11 fused to NUTM1 exon 2 (PubMed=28203693).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=02972-1
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   SNU-299
AC   CVCL_5047
SY   SNU299
DR   Wikidata; Q54955166
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-3023
AC   CVCL_YD48
DR   cancercelllines; CVCL_YD48
DR   Wikidata; Q98132790
RX   CelloPub=CLPUB00546;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 29 hours (CelloPub=CLPUB00546).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (CelloPub=CLPUB00546).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): CelloPub=CLPUB00546
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 19,25
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 15,16
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SNU-306
AC   CVCL_T042
DR   Cosmic; 2068082
DR   KCLB; 00306
DR   Wikidata; Q54955168
RX   PubMed=24141649;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 152 hours (PubMed=24141649).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): KCLB=00306; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 14
//
ID   SNU-308
AC   CVCL_5048
SY   SNU308; NCI-SNU-308
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988081
DR   cancercelllines; CVCL_5048
DR   Cell_Model_Passport; SIDM00161
DR   ChEMBL-Cells; CHEMBL3307456
DR   ChEMBL-Targets; CHEMBL614932
DR   Cosmic; 738869
DR   Cosmic; 2674056
DR   DepMap; ACH-000141
DR   GEO; GSM887620
DR   GEO; GSM888704
DR   IARC_TP53; 28334
DR   KCLB; 00308
DR   LiGeA; CCLE_685
DR   PharmacoDB; SNU308_1454_2019
DR   Progenetix; CVCL_5048
DR   PubChem_Cell_line; CVCL_5048
DR   Wikidata; Q54955169
RX   CelloPub=CLPUB00275;
RX   PubMed=12107841;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27231123;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32899426;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=12107841).
CC   HLA typing: A*24:02,33:03; B*48:01,58:01; C*03:02,08:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val217Gly (c.650T>G); Zygosity=Homozygous (DepMap=ACH-000141).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.26%; Native American=0%; East Asian, North=62.71%; East Asian, South=35.2%; South Asian=0%; European, North=0%; European, South=1.83% (PubMed=30894373).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): KCLB=00308
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D3S1358: 16
ST   D5S818: 9
ST   D7S820: 7,12
ST   FGA: 25,26
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SNU-315
AC   CVCL_5049
SY   SNU315
DR   Wikidata; Q54955170
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a esophageal cancer.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-3178S
AC   CVCL_UD99
SY   NMC2
DR   EGA; EGAD00001003117
DR   KCLB; 03178S
DR   Wikidata; Q98132791
RX   PubMed=28203693;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1104; BRD3 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD3-NUTM1, BRD3-NUT; Note=BRD3 exon 10 fused to NUTM1 exon 5 (PubMed=28203693).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): KCLB=03178S
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 11
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   SNU-321
AC   CVCL_5050
SY   SNU321
DR   Wikidata; Q54955171
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a lymphoma.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SNU-324
AC   CVCL_5051
SY   SNU324; NCI-SNU-324
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987733
DR   cancercelllines; CVCL_5051
DR   Cell_Model_Passport; SIDM01451
DR   Cosmic; 707182
DR   DepMap; ACH-000933
DR   GEO; GSM887621
DR   GEO; GSM888705
DR   IARC_TP53; 30163
DR   KCLB; 00324
DR   LiGeA; CCLE_769
DR   PharmacoDB; SNU324_1455_2019
DR   Progenetix; CVCL_5051
DR   Wikidata; Q54955172
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=12037578;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 52 hours (PubMed=12037578).
CC   HLA typing: A*24:02,26:02; B*40:06,40:06; C*03:03,03:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (DepMap=ACH-000933).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=60.53%; East Asian, South=39.47%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): KCLB=00324
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11
ST   FGA: 21,22
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SNU-328
AC   CVCL_5052
SY   SNU328
DR   Wikidata; Q54955173
RX   PubMed=10619961;
RX   PubMed=19956504;
RX   PubMed=27993170;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 120 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   SNU-333
AC   CVCL_5053
SY   SNU333
DR   KCLB; 00333
DR   Wikidata; Q54955174
RX   PubMed=10619961;
RX   PubMed=19956504;
RX   PubMed=27993170;
RX   PubMed=34490820;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 76 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00333
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,13
ST   FGA: 22,23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   SNU-334
AC   CVCL_T043
DR   Cosmic; 2068083
DR   KCLB; 00334
DR   Wikidata; Q54955176
RX   PubMed=24141649;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 80 hours (PubMed=24141649).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): KCLB=00334; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 14,15
ST   D19S433: 14,14.2
ST   D21S11: 30,32
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 20
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 14
//
ID   SNU-349
AC   CVCL_5054
SY   SNU349; NCI-SNU-349
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 702
DR   BioSample; SAMN10988037
DR   cancercelllines; CVCL_5054
DR   Cell_Model_Passport; SIDM01394
DR   DepMap; ACH-000907
DR   GEO; GSM888706
DR   IARC_TP53; 30164
DR   KCLB; 00349
DR   LiGeA; CCLE_577
DR   PharmacoDB; SNU349_1456_2019
DR   Progenetix; CVCL_5054
DR   Wikidata; Q54955177
RX   PubMed=10619961;
RX   PubMed=14634222;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27993170;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 120 hours (PubMed=10619961).
CC   HLA typing: A*02:01,24:02; B*39:01,51:01; C*14:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=10619961; PubMed=31068700).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.29%; Native American=0.68%; East Asian, North=61.84%; East Asian, South=37.03%; South Asian=0%; European, North=0.16%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00349
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D3S1358: 14
ST   D5S818: 10,11,13
ST   D7S820: 10,11
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-354
AC   CVCL_3947
SY   SNU354
DR   BTO; BTO_0003190
DR   ChEMBL-Cells; CHEMBL3307310
DR   ChEMBL-Targets; CHEMBL614165
DR   Cosmic; 2023865
DR   GEO; GSM1374888
DR   GEO; GSM2551584
DR   KCLB; 00354
DR   LIMORE; SNU354
DR   PubChem_Cell_line; CVCL_3947
DR   Wikidata; Q54955178
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=16616112;
RX   PubMed=19956504;
RX   PubMed=31063779;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU354
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 34 hours (PubMed=7543080); 39.48 hours (PubMed=31378681).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Ala1090Cysfs*5 (c.3267dupT); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Gly1424Valfs*5 (c.4271delG); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Lys515Ter (c.1543A>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00354; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 8,11
ST   D13S317: 10,11
ST   D16S539: 10
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 7,11
ST   FGA: 21,22
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SNU-368
AC   CVCL_3948
SY   SNU368
DR   BTO; BTO_0003169
DR   cancercelllines; CVCL_3948
DR   Cosmic; 2023866
DR   GEO; GSM1374889
DR   GEO; GSM2551585
DR   IARC_TP53; 6305
DR   KCLB; 00368
DR   LIMORE; SNU368
DR   Wikidata; Q54955179
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=16616112;
RX   PubMed=19956504;
RX   PubMed=31063779;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU368
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 41 hours (PubMed=7543080); 42.77 hours (PubMed=31378681).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Leu1607Profs*41 (c.4817dupT); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Gln184Ter (c.550C>T); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser106Arg (c.318C>G); ClinVar=VCV000492752; Zygosity=Unspecified (PubMed=8824565; PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00368; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,9
ST   D16S539: 12
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 11,12
ST   FGA: 25
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SNU-371
AC   CVCL_5055
SY   SNU371
DR   Cosmic; 1484497
DR   Wikidata; Q54955180
RX   PubMed=21290211;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 98 hours (PubMed=21290211).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3732; Pulmonary blastoma
DI   ORDO; Orphanet_64741; Pulmonary blastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   SNU-373
AC   CVCL_5056
SY   SNU373
DR   cancercelllines; CVCL_5056
DR   Cosmic; 1024885
DR   Cosmic; 1065284
DR   IARC_TP53; 24494
DR   Wikidata; Q54955181
RX   PubMed=17134824;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 41 hours (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Homozygous (PubMed=17134824).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   SNU-374
AC   CVCL_5057
SY   SNU374; SNU-374BL; SNU-374EBV
DR   KCLB; 00374EBV
DR   Wikidata; Q54955182
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a stomach cancer.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): KCLB=00374EBV
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   FGA: 22,26
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-387
AC   CVCL_0250
SY   SNU387; NCI-SNU-387
DR   BTO; BTO_0003191
DR   CLO; CLO_0009097
DR   EFO; EFO_0002346
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2237
DR   BioGRID_ORCS_Cell_line; 812
DR   BioSample; SAMN03471848
DR   BioSample; SAMN03473190
DR   BioSample; SAMN10987947
DR   cancercelllines; CVCL_0250
DR   CCRID; 3101HUMSCSP5046
DR   Cell_Model_Passport; SIDM01180
DR   ChEMBL-Cells; CHEMBL3308817
DR   ChEMBL-Targets; CHEMBL1075583
DR   CLS; 305124
DR   Cosmic; 684199
DR   Cosmic; 873397
DR   Cosmic; 909736
DR   Cosmic; 928142
DR   Cosmic; 1995639
DR   Cosmic; 2023867
DR   Cosmic; 2162530
DR   Cosmic; 2321035
DR   Cosmic-CLP; 909736
DR   DepMap; ACH-000478
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10706-109H4
DR   GDSC; 909736
DR   GEO; GSM481453
DR   GEO; GSM565921
DR   GEO; GSM887622
DR   GEO; GSM888707
DR   GEO; GSM936779
DR   GEO; GSM1670467
DR   GEO; GSM2551586
DR   IARC_TP53; 6306
DR   IGRhCellID; SNU387
DR   KCLB; 00387
DR   LiGeA; CCLE_883
DR   LIMORE; SNU387
DR   LINCS_LDP; LCL-1933
DR   PharmacoDB; SNU387_1457_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0250
DR   PubChem_Cell_line; CVCL_0250
DR   Ubigene; YC-B001
DR   Wikidata; Q54955183
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=16616112;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU387
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; BRICS; BRICS0057; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3872
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 61 hours (PubMed=7543080); 30.81 hours (PubMed=31378681).
CC   HLA typing: A*02:06,02:06; B*15:27,35:14; C*03:03,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=909736; DepMap=ACH-000478).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (PubMed=8824565; PubMed=31378681; Cosmic-CLP=909736; DepMap=ACH-000478).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0.32%; East Asian, North=64.77%; East Asian, South=33.73%; South Asian=0%; European, North=0%; European, South=0.87% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-2237; Cosmic-CLP=909736; KCLB=00387; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 31
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 8
ST   Penta E: 16
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14 (PubMed=25877200)
ST   vWA: 14,16 (ATCC=CRL-2237; Cosmic-CLP=909736; KCLB=00387; PubMed=31378681)
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SNU-387-Luc
AC   CVCL_C8V2
DR   Ubigene; YC-B001-Luc-P
DR   Wikidata; Q123033540
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0250 ! SNU-387
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SNU-387/Cas9-hyg
AC   CVCL_C9G8
DR   GeneCopoeia; SL537
DR   Wikidata; Q123033541
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL537).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys164Ter (c.490A>T); ClinVar=VCV000935480; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0250 ! SNU-387
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SNU-398
AC   CVCL_0077
SY   SNU398; NCI-SNU-398
DR   BTO; BTO_0003170
DR   CLO; CLO_0009098
DR   EFO; EFO_0002347
DR   MCCL; MCC:0000435
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2233
DR   BioGRID_ORCS_Cell_line; 368
DR   BioSample; SAMN03473191
DR   BioSample; SAMN10987942
DR   cancercelllines; CVCL_0077
DR   Cell_Model_Passport; SIDM01181
DR   ChEMBL-Cells; CHEMBL3307619
DR   ChEMBL-Targets; CHEMBL614454
DR   CLS; 305274
DR   Cosmic; 873393
DR   Cosmic; 928143
DR   Cosmic; 1187337
DR   Cosmic; 1995640
DR   Cosmic; 2009538
DR   Cosmic; 2023868
DR   Cosmic; 2162531
DR   Cosmic; 2321036
DR   Cosmic; 2771606
DR   Cosmic-CLP; 1240217
DR   DepMap; ACH-000221
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240217
DR   GEO; GSM481448
DR   GEO; GSM565922
DR   GEO; GSM827415
DR   GEO; GSM887623
DR   GEO; GSM888708
DR   GEO; GSM936780
DR   GEO; GSM1374890
DR   GEO; GSM1670468
DR   GEO; GSM2551587
DR   IARC_TP53; 6307
DR   IGRhCellID; SNU398
DR   KCLB; 00398
DR   LiGeA; CCLE_422
DR   LIMORE; SNU398
DR   LINCS_LDP; LCL-1934
DR   PharmacoDB; SNU398_1458_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0077
DR   PubChem_Cell_line; CVCL_0077
DR   Wikidata; Q54955184
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=19956504;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU398
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/liver-cancer-xenograft/snu-398-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 39 hours (PubMed=7543080); 25.49 hours (PubMed=31378681).
CC   HLA typing: A*02:01,24:02; B*15:32,40:02; C*01:02,04:01 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Cys (c.110C>G); ClinVar=VCV000017579; Zygosity=Heterozygous (PubMed=31378681; Cosmic-CLP=1240217; DepMap=ACH-000221).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Heterozygous (PubMed=8824565).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.33%; Native American=0.85%; East Asian, North=66.35%; East Asian, South=28.86%; South Asian=0%; European, North=0%; European, South=2.61% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-2233; Cosmic-CLP=1240217; KCLB=00398; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 10,14
ST   D18S51: 15 (PubMed=25877200)
ST   D18S51: 15,19 (ATCC=CRL-2233)
ST   D19S433: 14,14.1
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 22,23 (KCLB=00398)
ST   FGA: 23 (ATCC=CRL-2233; PubMed=25877200)
ST   Penta D: 14
ST   Penta E: 12
ST   TH01: 7,9 (ATCC=CRL-2233; Cosmic-CLP=1240217; PubMed=25877200)
ST   TH01: 8,9 (KCLB=00398)
ST   TH01: 9 (PubMed=31378681)
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   SNU-407
AC   CVCL_5058
SY   SNU407; NCI-SNU-407
DR   AddexBio; C0009016/377
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10988068
DR   cancercelllines; CVCL_5058
DR   Cell_Model_Passport; SIDM00214
DR   ColonAtlas; SNU407
DR   Cosmic; 738863
DR   Cosmic; 848827
DR   Cosmic; 875422
DR   Cosmic; 2612377
DR   Cosmic; 2651854
DR   Cosmic-CLP; 1660034
DR   DepMap; ACH-000955
DR   EGA; EGAS00001000978
DR   GDSC; 1660034
DR   GEO; GSM887624
DR   GEO; GSM888709
DR   GEO; GSM1448217
DR   GEO; GSM1670469
DR   IARC_TP53; 30165
DR   KCLB; 00407
DR   LiGeA; CCLE_766
DR   PharmacoDB; SNU407_1459_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5058
DR   PubChem_Cell_line; CVCL_5058
DR   Wikidata; Q54955187
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=10362137).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=10674020; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Lys1169del (c.3505_3507delAAG); Zygosity=Heterozygous (Cosmic-CLP=1660034; DepMap=ACH-000955).
CC   Sequence variation: Mutation; HGNC; HGNC:2768; DEK; Simple; p.Leu98fs*1 (c.291delT); Zygosity=Heterozygous (Cosmic-CLP=1660034).
CC   Sequence variation: Mutation; HGNC; HGNC:3512; EXT1; Simple; p.Ser478Profs*10 (c.1431delC); ClinVar=VCV000947295; Zygosity=Heterozygous (Cosmic-CLP=1660034).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=10362137; Cosmic-CLP=1660034).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Heterozygous (Cosmic-CLP=1660034).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.29%; Native American=0.4%; East Asian, North=66.65%; East Asian, South=29.61%; South Asian=0%; European, North=0%; European, South=2.05% (PubMed=30894373).
CC   Derived from site: Metastatic; Buttock; UBERON=UBERON_0013691.
ST   Source(s): AddexBio=C0009016/377; Cosmic-CLP=1660034; KCLB=00407; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D3S1358: 15,18
ST   D5S818: 10 (Cosmic-CLP=1660034; PubMed=25926053)
ST   D5S818: 10,11 (AddexBio=C0009016/377; KCLB=00407)
ST   D7S820: 8,10
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 7,8
ST   vWA: 14,16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 37
//
ID   SNU-410
AC   CVCL_5059
SY   SNU410; NCI-SNU-410
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 701
DR   BioSample; SAMN10988085
DR   cancercelllines; CVCL_5059
DR   Cell_Model_Passport; SIDM01449
DR   Cosmic; 707183
DR   DepMap; ACH-000517
DR   GEO; GSM887625
DR   GEO; GSM888710
DR   IARC_TP53; 28388
DR   KCLB; 00410
DR   LiGeA; CCLE_879
DR   PharmacoDB; SNU410_1460_2019
DR   Progenetix; CVCL_5059
DR   Wikidata; Q54955196
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=12037578;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 72 hours (PubMed=12037578).
CC   HLA typing: A*02:01,33:03; B*07:02,59:01; C*01:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap=ACH-000517).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser127Phe (c.380C>T); ClinVar=VCV000182928; Zygosity=Homozygous (DepMap=ACH-000517).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.52%; Native American=0%; East Asian, North=66.58%; East Asian, South=32.02%; South Asian=0%; European, North=0%; European, South=0.89% (PubMed=30894373).
CC   Caution: KRAS mutation indicated incorrectly as being p.Gly12Val in PubMed=12037578.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00410
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12,14
ST   FGA: 23
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SNU-4210
AC   CVCL_C0WL
DR   Wikidata; Q114313038
RX   PubMed=35278143;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=35278143).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   SNU-4210 #11
AC   CVCL_C0WM
SY   SNU-4210 subclone #11
DR   Wikidata; Q114313039
RX   PubMed=35278143;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=35278143).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WL ! SNU-4210
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   SNU-4210 #5
AC   CVCL_C0WN
SY   SNU-4210 subclone #5
DR   Wikidata; Q114313040
RX   PubMed=35278143;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=35278143).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0WL ! SNU-4210
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   SNU-423
AC   CVCL_0366
SY   SNU423; NCI-SNU-423
DR   BTO; BTO_0003187
DR   CLO; CLO_0009099
DR   EFO; EFO_0002348
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2238
DR   BioGRID_ORCS_Cell_line; 813
DR   BioSample; SAMN03471849
DR   BioSample; SAMN03473132
DR   BioSample; SAMN10987943
DR   cancercelllines; CVCL_0366
DR   Cell_Model_Passport; SIDM01199
DR   ChEMBL-Cells; CHEMBL3308367
DR   ChEMBL-Targets; CHEMBL1075584
DR   Cosmic; 871513
DR   Cosmic; 909737
DR   Cosmic; 1177681
DR   Cosmic; 1995641
DR   Cosmic; 2023869
DR   Cosmic; 2162532
DR   Cosmic; 2321037
DR   Cosmic-CLP; 909737
DR   DepMap; ACH-000493
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909737
DR   GEO; GSM565923
DR   GEO; GSM887626
DR   GEO; GSM888711
DR   GEO; GSM936781
DR   GEO; GSM1670470
DR   GEO; GSM2551588
DR   IARC_TP53; 6308
DR   IGRhCellID; SNU423
DR   KCLB; 00423
DR   LiGeA; CCLE_063
DR   LIMORE; SNU423
DR   LINCS_LDP; LCL-1935
DR   PharmacoDB; SNU423_1461_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0366
DR   PubChem_Cell_line; CVCL_0366
DR   Wikidata; Q54955197
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=19956504;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU423
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 72 hours (PubMed=7543080); 36.62 hours (PubMed=31378681).
CC   HLA typing: A*11:01,33:03; B*15:02,58:01; C*03:02,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700; PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-2A>G; ClinVar=VCV000186236; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=8824565; PubMed=31378681; DepMap=ACH-000493).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.82%; East Asian, North=62.68%; East Asian, South=36.24%; South Asian=0%; European, North=0%; European, South=0.26% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-2238; Cosmic-CLP=909737; KCLB=00423; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (ATCC=CRL-2238; KCLB=00423; PubMed=25877200; PubMed=31378681)
ST   CSF1PO: 11,12,13 (Cosmic-CLP=909737)
ST   D13S317: 10,13
ST   D16S539: 9
ST   D18S51: 12,13
ST   D19S433: 14,16.2
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 17 (PubMed=25877200)
ST   D3S1358: 17,18 (ATCC=CRL-2238; KCLB=00423)
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 11,16
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 6,9 (ATCC=CRL-2238; Cosmic-CLP=909737)
ST   TH01: 9 (KCLB=00423; PubMed=25877200; PubMed=31378681)
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SNU-423/Cas9-hyg
AC   CVCL_C9DG
DR   GeneCopoeia; SL538
DR   Wikidata; Q123033542
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL538).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-2A>G; ClinVar=VCV000186236; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0366 ! SNU-423
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 6
//
ID   SNU-444
AC   CVCL_5060
SY   SNU444
DR   Wikidata; Q54955198
RX   PubMed=11776963;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=11776963).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   SNU-445
AC   CVCL_5061
SY   SNU445
DR   Wikidata; Q54955199
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-447
AC   CVCL_5062
SY   SNU447
DR   Wikidata; Q54955200
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-449
AC   CVCL_0454
SY   SNU449; NCI-SNU-449
DR   BTO; BTO_0003188
DR   CLO; CLO_0009100
DR   EFO; EFO_0002349
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2234
DR   BioGRID_ORCS_Cell_line; 367
DR   BioSample; SAMN03471847
DR   BioSample; SAMN03473133
DR   BioSample; SAMN10987611
DR   cancercelllines; CVCL_0454
DR   Cell_Model_Passport; SIDM01194
DR   ChEMBL-Cells; CHEMBL3308480
DR   ChEMBL-Targets; CHEMBL1075585
DR   CLS; 305429
DR   Cosmic; 684200
DR   Cosmic; 871511
DR   Cosmic; 873396
DR   Cosmic; 909738
DR   Cosmic; 928144
DR   Cosmic; 1187338
DR   Cosmic; 1995642
DR   Cosmic; 2009539
DR   Cosmic; 2023870
DR   Cosmic; 2162541
DR   Cosmic; 2321041
DR   Cosmic-CLP; 909738
DR   DepMap; ACH-000420
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909738
DR   GEO; GSM481452
DR   GEO; GSM565924
DR   GEO; GSM887627
DR   GEO; GSM888712
DR   GEO; GSM936782
DR   GEO; GSM1374891
DR   GEO; GSM1670471
DR   GEO; GSM2551589
DR   IARC_TP53; 6309
DR   IARC_TP53; 21142
DR   IGRhCellID; SNU449
DR   KCLB; 00449
DR   LiGeA; CCLE_155
DR   LIMORE; SNU449
DR   LINCS_LDP; LCL-1936
DR   PharmacoDB; SNU449_1462_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0454
DR   PubChem_Cell_line; CVCL_0454
DR   Wikidata; Q54955201
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=16616112;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU449
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=7543080); 27.74 hours (PubMed=31378681).
CC   HLA typing: A*11:01,31:01; B*39:01,67:01; C*07:02,07:02 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Glu2250Argfs*28 (c.6747dupA); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg712Ter (c.2134C>T); Zygosity=Homozygous (PubMed=31378681; DepMap=ACH-000420).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Arg (c.416A>G); ClinVar=VCV001500748; Zygosity=Unspecified (PubMed=8824565).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=8824565; DepMap=ACH-000420).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0.29%; East Asian, North=60.93%; East Asian, South=36.75%; South Asian=0%; European, North=0%; European, South=1.66% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-2234; Cosmic-CLP=909738; KCLB=00449; PubMed=25877200; PubMed=31378681; Technion Genomics Center
ST   Amelogenin: X (Cosmic-CLP=909738; PubMed=25877200; Technion Genomics Center)
ST   Amelogenin: X,Y (ATCC=CRL-2234; KCLB=00449; PubMed=31378681)
ST   CSF1PO: 11
ST   D10S1248: 12,15
ST   D12S391: 17,18
ST   D13S317: 9
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 15.2,17.2
ST   D1S1656: 15,17
ST   D21S11: 29,31
ST   D22S1045: 17
ST   D2S1338: 19
ST   D2S441: 12
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 8,13
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 10,11
ST   Penta E: 10,15
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SNU-449/Cas9-hyg
AC   CVCL_C9G7
DR   GeneCopoeia; SL530
DR   Wikidata; Q123033543
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL530).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Glu2250Argfs*28 (c.6747dupA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg712Ter (c.2134C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Arg (c.416A>G); ClinVar=VCV001500748; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0454 ! SNU-449
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SNU-46
AC   CVCL_5063
SY   SNU46
DR   BTO; BTO_0005927
DR   BioSample; SAMN10988080
DR   cancercelllines; CVCL_5063
DR   Cell_Model_Passport; SIDM01448
DR   Cosmic; 934173
DR   DepMap; ACH-000500
DR   GEO; GSM887629
DR   GEO; GSM888714
DR   IARC_TP53; 11322
DR   KCLB; 00046
DR   PharmacoDB; SNU46_1463_2019
DR   Progenetix; CVCL_5063
DR   Wikidata; Q54955202
RX   CelloPub=CLPUB00001;
RX   PubMed=10369293;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=10369293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114His (c.341C>A) (p.Ala128Ala, c.384C>A); ClinVar=VCV000376383; Zygosity=Homozygous (PubMed=10369293; DepMap=ACH-000500).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Homozygous (PubMed=10369293; DepMap=ACH-000500).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.74%; Native American=0%; East Asian, North=68.94%; East Asian, South=24.69%; South Asian=0%; European, North=0%; European, South=4.64% (PubMed=30894373).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): KCLB=00046
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SNU-466
AC   CVCL_5064
SY   SNU466; NCI-SNU-466
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988076
DR   cancercelllines; CVCL_5064
DR   Cell_Model_Passport; SIDM01447
DR   DepMap; ACH-000289
DR   GEO; GSM887628
DR   GEO; GSM888713
DR   IARC_TP53; 30166
DR   KCLB; 00466
DR   LiGeA; CCLE_270
DR   PharmacoDB; SNU466_1464_2019
DR   Progenetix; CVCL_5064
DR   Wikidata; Q54955203
RX   PubMed=11776963;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 54 hours (PubMed=11776963).
CC   HLA typing: A*02:01,11:01; B*39:01,40:01; C*07:02,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg159Ser (c.477G>T); ClinVar=VCV000375959; Zygosity=Homozygous (DepMap=ACH-000289).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.92%; Native American=0%; East Asian, North=61.85%; East Asian, South=36.86%; South Asian=0%; European, North=0%; European, South=0.36% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=00466
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D3S1358: 15,18
ST   D5S818: 7,12
ST   D7S820: 10,12
ST   FGA: 22,24
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SNU-475
AC   CVCL_0497
SY   SNU475; NCI-SNU-475
DR   BTO; BTO_0003189
DR   CLO; CLO_0009101
DR   EFO; EFO_0002350
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2236
DR   BioGRID_ORCS_Cell_line; 811
DR   BioSample; SAMN03471846
DR   BioSample; SAMN03473134
DR   BioSample; SAMN10987958
DR   cancercelllines; CVCL_0497
DR   Cell_Model_Passport; SIDM01196
DR   ChEMBL-Cells; CHEMBL3308787
DR   ChEMBL-Targets; CHEMBL1075586
DR   Cosmic; 684201
DR   Cosmic; 871512
DR   Cosmic; 873403
DR   Cosmic; 909739
DR   Cosmic; 928145
DR   Cosmic; 2023871
DR   Cosmic; 2162533
DR   Cosmic; 2321038
DR   Cosmic-CLP; 909739
DR   DepMap; ACH-000422
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909739
DR   GEO; GSM481449
DR   GEO; GSM565920
DR   GEO; GSM887630
DR   GEO; GSM888715
DR   GEO; GSM936783
DR   GEO; GSM1670472
DR   GEO; GSM2551590
DR   IARC_TP53; 6310
DR   IARC_TP53; 21143
DR   IGRhCellID; SNU475
DR   KCLB; 00475
DR   LiGeA; CCLE_299
DR   LIMORE; SNU475
DR   LINCS_LDP; LCL-1937
DR   Lonza; 452
DR   PharmacoDB; SNU475_1465_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0497
DR   PubChem_Cell_line; CVCL_0497
DR   Wikidata; Q54955204
RX   PubMed=7543080;
RX   PubMed=8824565;
RX   PubMed=16616112;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23505090;
RX   PubMed=23887712;
RX   PubMed=25485619;
RX   PubMed=25574106;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
RX   PubMed=35839778;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU475
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 66 hours (PubMed=7543080); 35.6 hours (PubMed=31378681).
CC   HLA typing: A*02:01,11:01; B*40:02,54:01; C*03:04,03:04 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (PubMed=8824565; Cosmic-CLP=909739; DepMap=ACH-000422).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262Asp (c.785G>A); Zygosity=Heterozygous (Cosmic-CLP=909739; DepMap=ACH-000422).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Arg (c.823T>C); ClinVar=VCV000376584; Zygosity=Unspecified (PubMed=8824565).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn288Ser (c.863A>G); Zygosity=Unspecified (PubMed=8824565).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.39%; Native American=0%; East Asian, North=63.9%; East Asian, South=34.56%; South Asian=0%; European, North=0%; European, South=1.15% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-2236; Cosmic-CLP=909739; KCLB=00475; PubMed=25877200; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 14.2
ST   D21S11: 28,30
ST   D2S1338: 17,23
ST   D3S1358: 14
ST   D5S818: 10,13
ST   D7S820: 7 (PubMed=25877200)
ST   D7S820: 7,12 (ATCC=CRL-2236; Cosmic-CLP=909739; KCLB=00475; PubMed=31378681)
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 5,16
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SNU-475/Cas9-hyg
AC   CVCL_C9G6
DR   GeneCopoeia; SL522
DR   Wikidata; Q123033544
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL522).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239Asp (c.715A>G); ClinVar=VCV000234036; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262Asp (c.785G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Arg (c.823T>C); ClinVar=VCV000376584; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn288Ser (c.863A>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0497 ! SNU-475
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SNU-478
AC   CVCL_5065
SY   SNU478; NCI-SNU-478
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988084
DR   cancercelllines; CVCL_5065
DR   Cell_Model_Passport; SIDM00160
DR   Cosmic; 738871
DR   Cosmic; 2674053
DR   DepMap; ACH-000377
DR   GEO; GSM887631
DR   GEO; GSM888716
DR   IARC_TP53; 17160
DR   KCLB; 00478
DR   LiGeA; CCLE_048
DR   PharmacoDB; SNU478_1466_2019
DR   PRIDE; PXD002657
DR   Progenetix; CVCL_5065
DR   Wikidata; Q54955205
RX   CelloPub=CLPUB00275;
RX   PubMed=12107841;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=26951071;
RX   PubMed=27231123;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=32899426;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 52 hours (PubMed=12107841).
CC   HLA typing: A*11:01,33:03; B*52:01,58:01; C*03:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12107841).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266fs*4 (c.797_801delGACGG); Zygosity=Homozygous (PubMed=12107841; DepMap=ACH-000377).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.85%; East Asian, North=60.73%; East Asian, South=37.41%; South Asian=0%; European, North=0%; European, South=1.02% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): KCLB=00478
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SNU-479
AC   CVCL_5066
SY   SNU479
DR   cancercelllines; CVCL_5066
DR   Cosmic; 1322284
DR   GEO; GSM1448208
DR   IARC_TP53; 28470
DR   KCLB; 00479
DR   Wikidata; Q54955208
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 44 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile162Phe (c.484A>T); ClinVar=VCV000948225; Zygosity=Unspecified (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00479; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X (PubMed=25926053)
ST   Amelogenin: X,Y (PubMed=20176655)
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 32.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 10,12
ST   FGA: 22,24
ST   TH01: 6,7
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C43584; Rectosigmoid adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SNU-482
AC   CVCL_5067
SY   SNU482
DR   KCLB; 00482
DR   Wikidata; Q54955209
RX   PubMed=10619961;
RX   PubMed=14634222;
RX   PubMed=19956504;
RX   PubMed=27993170;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 60 hours (PubMed=10619961).
CC   Microsatellite instability: Stable (MSS) (PubMed=10619961).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): KCLB=00482
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 11
ST   FGA: 22,23
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-484
AC   CVCL_0100
SY   SNU484
DR   BTO; BTO_0003479
DR   EFO; EFO_0006755
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473176
DR   cancercelllines; CVCL_0100
DR   CGH-DB; 125-1
DR   CGH-DB; 9013-4
DR   Cosmic; 685590
DR   Cosmic; 848140
DR   Cosmic; 921598
DR   Cosmic; 1067206
DR   Cosmic; 1090454
DR   Cosmic; 1294958
DR   Cosmic; 1528875
DR   Cosmic; 2484965
DR   Cosmic; 2646591
DR   Cosmic; 2807646
DR   EGA; EGAS00001000610
DR   GEO; GSM1374892
DR   IARC_TP53; 7419
DR   KCLB; 00484
DR   PharmacoDB; SNU484_1467_2019
DR   Wikidata; Q54955211
RX   PubMed=9033653;
RX   PubMed=10812166;
RX   PubMed=15723654;
RX   PubMed=18804159;
RX   PubMed=19956504;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29435981;
RX   PubMed=32028591;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 34 hours (PubMed=29435981).
CC   HLA typing: A*24:02,24:02; B*44:05,51:01; C*05:01,14:02; DQB1*04:01,04:01 (PubMed=25960936).
CC   HLA typing: A*24:02,30:01; B*44:02,51:01; C*05:01,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Homozygous (PubMed=9033653).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): KCLB=00484; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 19,23
ST   Penta D: 12
ST   Penta E: 22
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   SNU-484 Ola-R
AC   CVCL_C1NA
SY   SNU-484/olaparib-resistant; Olaparib-resistant SNU-484
DR   cancercelllines; CVCL_C1NA
DR   Wikidata; Q114313041
RX   PubMed=32028591;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_83766; Olaparib.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0100 ! SNU-484
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SNU-487
AC   CVCL_5068
SY   SNU487
DR   KCLB; 00487
DR   Wikidata; Q54955212
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV18 genome.
CC   Doubling time: 52 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=00487
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,13
ST   FGA: 23
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   SNU-489
AC   CVCL_5069
SY   SNU489; NCI-SNU-489
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988061
DR   cancercelllines; CVCL_5069
DR   Cell_Model_Passport; SIDM01446
DR   DepMap; ACH-000543
DR   GEO; GSM888717
DR   IARC_TP53; 28254
DR   KCLB; 00489
DR   LiGeA; CCLE_278
DR   PharmacoDB; SNU489_1468_2019
DR   Progenetix; CVCL_5069
DR   Wikidata; Q54955213
RX   PubMed=11776963;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=11776963).
CC   HLA typing: A*11:01,33:03; B*40:06,44:03; C*07:06,08:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.994-1G>C; ClinVar=VCV000232659; Zygosity=Homozygous; Note=Splice acceptor mutation (DepMap=ACH-000543).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.11%; Native American=0.3%; East Asian, North=61.65%; East Asian, South=37.93%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=00489
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D3S1358: 15,17
ST   D5S818: 10,13
ST   D7S820: 7,11
ST   FGA: 21,23
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SNU-494
AC   CVCL_5070
SY   SNU494
DR   cancercelllines; CVCL_5070
DR   Cosmic; 707184
DR   IARC_TP53; 16869
DR   Wikidata; Q54955214
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=12037578;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 120 hours (PubMed=12037578).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=12037578).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Tyr (c.713G>A); ClinVar=VCV000182935; Zygosity=Unspecified (PubMed=12037578).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   SNU-5
AC   CVCL_0078
SY   SNU5; NCI-SNU-5
DR   BTO; BTO_0004986
DR   CLO; CLO_0009102
DR   EFO; EFO_0002351
DR   MCCL; MCC:0000436
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5973
DR   BCRC; 60213
DR   BioSample; SAMN03470906
DR   BioSample; SAMN10987957
DR   cancercelllines; CVCL_0078
DR   Cell_Model_Passport; SIDM01144
DR   ChEMBL-Cells; CHEMBL3307458
DR   ChEMBL-Targets; CHEMBL614934
DR   Cosmic; 685587
DR   Cosmic; 687559
DR   Cosmic; 737363
DR   Cosmic; 848137
DR   Cosmic; 868237
DR   Cosmic; 908445
DR   Cosmic; 921596
DR   Cosmic; 1066231
DR   Cosmic; 1067203
DR   Cosmic; 1090451
DR   Cosmic; 1154648
DR   Cosmic; 1187293
DR   Cosmic; 1294960
DR   Cosmic; 1329187
DR   Cosmic; 1482072
DR   Cosmic; 1528872
DR   Cosmic; 1995597
DR   Cosmic; 2069773
DR   Cosmic; 2373750
DR   Cosmic; 2484972
DR   Cosmic; 2646589
DR   Cosmic-CLP; 908445
DR   DepMap; ACH-000303
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 908445
DR   GEO; GSM267422
DR   GEO; GSM267429
DR   GEO; GSM267436
DR   GEO; GSM267443
DR   GEO; GSM552374
DR   GEO; GSM562408
DR   GEO; GSM827398
DR   GEO; GSM828830
DR   GEO; GSM844703
DR   GEO; GSM887634
DR   GEO; GSM888720
DR   GEO; GSM1237681
DR   GEO; GSM1237706
DR   GEO; GSM1374893
DR   GEO; GSM1670275
DR   GEO; GSM1670473
DR   IARC_TP53; 307
DR   IARC_TP53; 21582
DR   IGRhCellID; SNU5
DR   KCLB; 00005
DR   LiGeA; CCLE_263
DR   LINCS_LDP; LCL-1890
DR   PharmacoDB; SNU5_1469_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0078
DR   PubChem_Cell_line; CVCL_0078
DR   Wikidata; Q54955215
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1676761;
RX   PubMed=2158397;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25343454;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/gastric-xenograft-model/snu5-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Characteristics: MET-amplified, contains 8-9 copies of the gene (PubMed=29435981).
CC   Doubling time: 34 hours (PubMed=2158397; PubMed=29435981).
CC   HLA typing: A*24:02,26:01; B*35:01,40:05; C*03:03,03:03; DQA1*05:01,05:01; DQB1*03:09,03:09; DRB1*11:01,12:01 (PubMed=25960936).
CC   HLA typing: A*24:02,26:01; B*35:01,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (DepMap=ACH-000303).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262_Ser269delGlyAsnLeuLeuGlyArgAsnSer (c.784_807del24); Zygosity=Unspecified (PubMed=1676761).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=65.54%; East Asian, South=33.69%; South Asian=0%; European, North=0%; European, South=0.76% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-5973; Cosmic-CLP=908445; KCLB=00005; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8 (KCLB=00005)
ST   D13S317: 8,9 (ATCC=CRL-5973; Cosmic-CLP=908445; PubMed=25877200)
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13.2,15
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 18,19
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SNU-503
AC   CVCL_5071
SY   SNU503; NCI-SNU-503
DR   AddexBio; C0009015/378
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 699
DR   BioSample; SAMN10988087
DR   cancercelllines; CVCL_5071
DR   Cell_Model_Passport; SIDM00497
DR   ColonAtlas; SNU503
DR   Cosmic; 738864
DR   Cosmic; 2612378
DR   Cosmic; 2651855
DR   DepMap; ACH-000683
DR   GEO; GSM887632
DR   GEO; GSM888718
DR   GEO; GSM1448209
DR   IARC_TP53; 10836
DR   KCLB; 00503
DR   LiGeA; CCLE_446
DR   PharmacoDB; SNU503_1470_2019
DR   Progenetix; CVCL_5071
DR   Wikidata; Q54955216
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 64 hours (PubMed=10362137).
CC   HLA typing: A*33:03,33:03; B*51:01,51:01; C*14:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=10362137; DepMap=ACH-000683).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=62.02%; East Asian, South=37.59%; South Asian=0%; European, North=0%; European, South=0.39% (PubMed=30894373).
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
ST   Source(s): KCLB=00503; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10
ST   D16S539: 11,12
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 10 (KCLB=00503)
ST   D7S820: 10,11 (PubMed=25926053)
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SNU-520
AC   CVCL_5072
SY   SNU520; NCI-SNU-520
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987747
DR   cancercelllines; CVCL_5072
DR   Cell_Model_Passport; SIDM01770
DR   Cosmic; 685591
DR   Cosmic; 2373752
DR   DepMap; ACH-000908
DR   GEO; GSM887633
DR   GEO; GSM888719
DR   IARC_TP53; 30167
DR   KCLB; 00520
DR   LiGeA; CCLE_828
DR   PharmacoDB; SNU520_1471_2019
DR   Progenetix; CVCL_5072
DR   Wikidata; Q54955217
RX   PubMed=9033653;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   HLA typing: A*24:02,30:01; B*50,53; C*05:01,06:02; DQB1*06:13,06:13 (PubMed=25960936).
CC   HLA typing: A*24:02,30:01; B*07:17,35:01; C*05:01,06:02; DQB1*06:11,06:11; DRB1*11:01,13:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Unspecified (DepMap=ACH-000908).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9033653).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=57.76%; East Asian, South=42.23%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): KCLB=00520
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D3S1358: 14,15
ST   D5S818: 10,13
ST   D7S820: 9,11
ST   FGA: 21
ST   TH01: 8,9
ST   TPOX: 7,8
ST   vWA: 17,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SNU-523
AC   CVCL_5073
SY   SNU523
DR   KCLB; 00523
DR   Wikidata; Q54955218
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an episomal HPV16 genome.
CC   Doubling time: 72 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: KCLB; 00523; probable.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   SNU-538
AC   CVCL_5074
SY   SNU538; SNU-538BL; SNU-538EBV
DR   KCLB; 00538EBV
DR   Wikidata; Q54955219
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a stomach cancer.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): KCLB=00538EBV
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-539
AC   CVCL_5075
SY   SNU539
DR   KCLB; 00539
DR   Wikidata; Q54955221
RX   PubMed=9299262;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 46 hours (PubMed=9299262).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): KCLB=00539
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 8
ST   FGA: 23,26
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   SNU-55
AC   CVCL_E107
SY   SNU55; NCI-SNU-55
DR   IARC_TP53; 308
DR   Wikidata; Q54955222
RX   PubMed=1676761;
RX   PubMed=8806092;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143fs (c.427delC); Zygosity=Unspecified (PubMed=1676761).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   SNU-563
AC   CVCL_5076
SY   SNU563
DR   cancercelllines; CVCL_5076
DR   KCLB; 00563
DR   Wikidata; Q54955223
RX   PubMed=9299249;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 67 hours (PubMed=9299249).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Gly (c.844C>G); ClinVar=VCV000140821; Zygosity=Unspecified (PubMed=9299249).
CC   Discontinued: KCLB; 00563; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   SNU-585
AC   CVCL_5077
SY   SNU585
DR   BTO; BTO_0005926
DR   cancercelllines; CVCL_5077
DR   Cosmic; 934174
DR   IARC_TP53; 11323
DR   KCLB; 00585
DR   Wikidata; Q54955225
RX   CelloPub=CLPUB00001;
RX   PubMed=10369293;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 54 hours (PubMed=10369293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gln50Arg (c.149A>G); ClinVar=VCV000232304; Zygosity=Unspecified (PubMed=10369293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp153Tyr (c.457G>T); ClinVar=VCV000216035; Zygosity=Unspecified (PubMed=10369293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=10369293).
CC   Discontinued: KCLB; 00585; probable.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   SNU-601
AC   CVCL_0101
SY   SNU601; NCI-SNU-601
DR   EFO; EFO_0006756
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473177
DR   BioSample; SAMN10988047
DR   cancercelllines; CVCL_0101
DR   Cell_Model_Passport; SIDM01445
DR   CGH-DB; 126-1
DR   CGH-DB; 9014-4
DR   CLS; 305282
DR   Cosmic; 685585
DR   Cosmic; 848141
DR   Cosmic; 869513
DR   Cosmic; 921599
DR   Cosmic; 1090455
DR   Cosmic; 1294955
DR   Cosmic; 1528876
DR   Cosmic; 2484961
DR   Cosmic; 2646592
DR   Cosmic; 2807648
DR   DepMap; ACH-000736
DR   EGA; EGAS00001000610
DR   GEO; GSM888721
DR   GEO; GSM1374894
DR   IARC_TP53; 7420
DR   KCLB; 00601
DR   LiGeA; CCLE_780
DR   PharmacoDB; SNU601_1472_2019
DR   Progenetix; CVCL_0101
DR   Wikidata; Q54955227
RX   PubMed=9033653;
RX   PubMed=10812166;
RX   PubMed=15723654;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=32028591;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=29435981).
CC   HLA typing: A*11:01,26:01; B*15:01,40:01; C*04:01,15:02; DQB1*06:02,06:02 (PubMed=25960936).
CC   HLA typing: A*11:01,26:01; B*15:01,40:01; C*04:01,15:02; DQB1*06:02,06:02; DRB1*13:05,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=9033653; DepMap=ACH-000736).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (DepMap=ACH-000736).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=9033653; DepMap=ACH-000736).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.93%; Native American=0.43%; East Asian, North=63.23%; East Asian, South=33.73%; South Asian=0%; European, North=0%; European, South=0.68% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00601; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 8,15
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   SNU-601 Ola-R
AC   CVCL_C1NB
SY   SNU-601/olaparib-resistant; Olaparib-resistant SNU-601
DR   cancercelllines; CVCL_C1NB
DR   Wikidata; Q114313042
RX   PubMed=32028591;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_83766; Olaparib.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:18884; TDP1; Simple; p.Ala520Asp; Zygosity=Unspecified (PubMed=32028591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0101 ! SNU-601
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SNU-61
AC   CVCL_5078
SY   SNU61; NCI-SNU-61
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1019
DR   BioSample; SAMN10987731
DR   cancercelllines; CVCL_5078
DR   Cell_Model_Passport; SIDM00194
DR   ColonAtlas; SNU61
DR   Cosmic; 738860
DR   Cosmic; 2612373
DR   Cosmic; 2651850
DR   Cosmic-CLP; 1660035
DR   DepMap; ACH-000532
DR   EGA; EGAS00001000978
DR   GDSC; 1660035
DR   GEO; GSM887635
DR   GEO; GSM888722
DR   GEO; GSM1448086
DR   GEO; GSM1670474
DR   IARC_TP53; 10835
DR   KCLB; 00061
DR   LiGeA; CCLE_400
DR   PharmacoDB; SNU61_1473_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5078
DR   Wikidata; Q54955228
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 39 hours (PubMed=10362137).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Homozygous (Cosmic-CLP=1660035; DepMap=ACH-000532).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=10362137; Cosmic-CLP=1660035; DepMap=ACH-000532).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=10362137; Cosmic-CLP=1660035; DepMap=ACH-000532).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.54%; Native American=0.17%; East Asian, North=63.73%; East Asian, South=33.22%; South Asian=0%; European, North=0%; European, South=1.34% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=1660035; KCLB=00061; PubMed=25926053
ST   Amelogenin: X (Cosmic-CLP=1660035; PubMed=25926053)
ST   Amelogenin: X,Y (KCLB=00061)
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 9,11 (KCLB=00061)
ST   D5S818: 11 (Cosmic-CLP=1660035; PubMed=25926053)
ST   D7S820: 8
ST   FGA: 22,26
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SNU-620
AC   CVCL_5079
SY   SNU620; NCI-SNU-620
DR   BTO; BTO_0005171
DR   EFO; EFO_0006757
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473178
DR   BioSample; SAMN10987759
DR   cancercelllines; CVCL_5079
DR   Cell_Model_Passport; SIDM01781
DR   Cosmic; 685592
DR   Cosmic; 848142
DR   Cosmic; 921600
DR   Cosmic; 1090456
DR   Cosmic; 1528877
DR   Cosmic; 2484958
DR   Cosmic; 2807649
DR   DepMap; ACH-000325
DR   EGA; EGAS00001000610
DR   GEO; GSM887636
DR   GEO; GSM888723
DR   GEO; GSM1374895
DR   IARC_TP53; 30168
DR   KCLB; 00620
DR   LiGeA; CCLE_322
DR   PharmacoDB; SNU620_1474_2019
DR   Progenetix; CVCL_5079
DR   Wikidata; Q54955229
RX   PubMed=9033653;
RX   PubMed=10812166;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Characteristics: MET-amplified, contains 20-21 copies of the gene (PubMed=29435981).
CC   Doubling time: 31 hours (PubMed=29435981).
CC   HLA typing: A*33:03,33:03; B*44:07,58:01; C*03:02,07:01; DQB1*06:05,06:05; DRB1*13:02,14:05 (PubMed=25960936).
CC   HLA typing: A*33:03,33:03; B*44:03,58:01; C*03:02,07:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=9033653).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=1.1%; East Asian, North=58.94%; East Asian, South=38.87%; South Asian=0%; European, North=0.05%; European, South=0.67% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00620; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 14,15
ST   D21S11: 31,32,32.2
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 13
ST   D8S1179: 13
ST   FGA: 19,24 (PubMed=25877200)
ST   FGA: 24 (KCLB=00620)
ST   Penta D: 11,13
ST   Penta E: 15,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17,18 (PubMed=25877200)
ST   vWA: 16,18 (KCLB=00620)
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SNU-620-5FU
AC   CVCL_L044
SY   SNU-620R-5-FU/1000
DR   KCLB; 00620-5FU
DR   Wikidata; Q54955230
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5079 ! SNU-620
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   SNU-620-ADR
AC   CVCL_L084
SY   SNU-620-ADR/300
DR   KCLB; 00620-ADR
DR   Wikidata; Q54955231
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00620-ADR
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 13
ST   FGA: 19,24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17,18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5079 ! SNU-620
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   SNU-620-CIS
AC   CVCL_L045
SY   SNU-620R-CIS/2000
DR   Wikidata; Q54955232
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5079 ! SNU-620
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   SNU-620-DOX
AC   CVCL_L046
SY   SNU-620R-DOX/300
DR   Wikidata; Q54955233
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5079 ! SNU-620
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   SNU-620/5-FUR
AC   CVCL_E2UA
RX   PubMed=30015846;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5079 ! SNU-620
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   SNU-626
AC   CVCL_5080
SY   SNU626; NCI-SNU-626
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988090
DR   cancercelllines; CVCL_5080
DR   Cell_Model_Passport; SIDM01444
DR   DepMap; ACH-000370
DR   GEO; GSM887637
DR   GEO; GSM888724
DR   IARC_TP53; 28319
DR   KCLB; 00626
DR   LiGeA; CCLE_810
DR   PharmacoDB; SNU626_1475_2019
DR   Progenetix; CVCL_5080
DR   Wikidata; Q54955234
RX   PubMed=11776963;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 92 hours (PubMed=11776963).
CC   HLA typing: A*24:02,29:01; B*07:06,15:01; C*01:02,15:05 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129Arg (c.385G>A); ClinVar=VCV000189484; Zygosity=Homozygous (DepMap=ACH-000370).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Ser (c.713G>C); ClinVar=VCV000376575; Zygosity=Heterozygous (DepMap=ACH-000370).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.03%; Native American=0%; East Asian, North=63.88%; East Asian, South=35.09%; South Asian=0.99%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=00626
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D3S1358: 17
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   FGA: 19
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SNU-638
AC   CVCL_0102
SY   SNU638
DR   BTO; BTO_0003478
DR   EFO; EFO_0006758
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473180
DR   cancercelllines; CVCL_0102
DR   Cell_Model_Passport; SIDM01769
DR   CGH-DB; 127-1
DR   CGH-DB; 9015-4
DR   ChEMBL-Cells; CHEMBL3307747
DR   ChEMBL-Targets; CHEMBL614935
DR   Cosmic; 685583
DR   Cosmic; 848143
DR   Cosmic; 869511
DR   Cosmic; 921601
DR   Cosmic; 1067207
DR   Cosmic; 1090457
DR   Cosmic; 1294961
DR   Cosmic; 1528878
DR   Cosmic; 2036662
DR   Cosmic; 2373753
DR   Cosmic; 2484959
DR   Cosmic; 2646587
DR   Cosmic; 2807650
DR   DepMap; ACH-001664
DR   EGA; EGAS00001000610
DR   GEO; GSM1374896
DR   IARC_TP53; 7421
DR   KCLB; 00638
DR   PharmacoDB; SNU638_1476_2019
DR   PubChem_Cell_line; CVCL_0102
DR   Wikidata; Q54955236
RX   PubMed=9033653;
RX   PubMed=10812166;
RX   PubMed=10974411;
RX   PubMed=15723654;
RX   PubMed=19956504;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29435981;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 25 hours (PubMed=29435981).
CC   HLA typing: A*03:19,24:02; B*44:02,52:01; C*05:01,12:02; DQB1*06:02,06:02; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*03:19,24:02; B*44:02,52:01; C*05:01,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Unspecified (PubMed=29435981).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (PubMed=9033653).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001664; KCLB=00638; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 11,13 (KCLB=00638; PubMed=25877200)
ST   D16S539: 11,13,14 (DepMap=ACH-001664)
ST   D18S51: 14,16
ST   D21S11: 30.2,31
ST   D3S1358: 15
ST   D5S818: 10,13,14,15 (PubMed=25877200)
ST   D5S818: 10,13,14,15,16 (DepMap=ACH-001664)
ST   D5S818: 10,14 (KCLB=00638)
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 17,26,27 (DepMap=ACH-001664)
ST   FGA: 17,27 (PubMed=25877200)
ST   Penta D: 9
ST   Penta E: 14,18
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SNU-638-5FU
AC   CVCL_L047
SY   SNU-638R-5-FU/50000
DR   cancercelllines; CVCL_L047
DR   Wikidata; Q54955238
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0102 ! SNU-638
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   SNU-638-CIS
AC   CVCL_L048
SY   SNU-638R-CIS/400
DR   cancercelllines; CVCL_L048
DR   Wikidata; Q54955240
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0102 ! SNU-638
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   SNU-668
AC   CVCL_5081
SY   SNU668; NCI-SNU-668
DR   EFO; EFO_0006759
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473141
DR   BioSample; SAMN10988049
DR   cancercelllines; CVCL_5081
DR   Cell_Model_Passport; SIDM01443
DR   CGH-DB; 128-1
DR   CGH-DB; 9016-4
DR   Cosmic; 685593
DR   Cosmic; 921602
DR   Cosmic; 1066232
DR   Cosmic; 1294956
DR   Cosmic; 1528879
DR   Cosmic; 2373754
DR   Cosmic; 2484962
DR   Cosmic; 2646593
DR   Cosmic; 2807651
DR   DepMap; ACH-000344
DR   EGA; EGAS00001000610
DR   GEO; GSM888725
DR   GEO; GSM1374897
DR   IARC_TP53; 7422
DR   KCLB; 00668
DR   LiGeA; CCLE_350
DR   PharmacoDB; SNU668_1477_2019
DR   Progenetix; CVCL_5081
DR   Wikidata; Q54955241
RX   PubMed=9033653;
RX   PubMed=10812166;
RX   PubMed=15723654;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32028591;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 26 hours (PubMed=29435981).
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03 (PubMed=25960936).
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03; DQA1*05:02,05:02; DQB1*06:01,06:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Homozygous (PubMed=9033653; DepMap=ACH-000344).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Homozygous (PubMed=9033653; DepMap=ACH-000344).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.18%; Native American=0%; East Asian, North=71.14%; East Asian, South=25.86%; South Asian=0%; European, North=0%; European, South=1.82% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00668; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,19
ST   TH01: 8
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SNU-668 Ola-R
AC   CVCL_C1NC
SY   SNU-668/olaparib-resistant; Olaparib-resistant SNU-668
DR   cancercelllines; CVCL_C1NC
DR   Wikidata; Q114313043
RX   PubMed=32028591;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_83766; Olaparib.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5081 ! SNU-668
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   SNU-668-5FU
AC   CVCL_L049
SY   SNU-668R-5-FU/4000
DR   cancercelllines; CVCL_L049
DR   Wikidata; Q54955242
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5081 ! SNU-668
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   SNU-668-CIS
AC   CVCL_L050
SY   SNU-668R-CIS/400
DR   cancercelllines; CVCL_L050
DR   Wikidata; Q54955243
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5081 ! SNU-668
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   SNU-668-DOX
AC   CVCL_L051
SY   SNU-668R-DOX/50
DR   cancercelllines; CVCL_L051
DR   Wikidata; Q54955244
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000177777; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Asn (c.644G>A); ClinVar=VCV000376662; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5081 ! SNU-668
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   SNU-682
AC   CVCL_5082
SY   SNU682
DR   KCLB; 00682
DR   Wikidata; Q54955249
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=00682
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   FGA: 24
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   SNU-685
AC   CVCL_5083
SY   SNU685; NCI-SNU-685
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 697
DR   BioSample; SAMN10988056
DR   cancercelllines; CVCL_5083
DR   Cell_Model_Passport; SIDM00165
DR   DepMap; ACH-000407
DR   GEO; GSM888726
DR   GEO; GSM3161726
DR   GEO; GSM3161727
DR   IARC_TP53; 28262
DR   KCLB; 00685
DR   LiGeA; CCLE_719
DR   PharmacoDB; SNU685_1478_2019
DR   Progenetix; CVCL_5083
DR   Wikidata; Q54955250
RX   PubMed=9299262;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 20 hours (PubMed=9299262).
CC   HLA typing: A*02:01,33:03; B*44:02,54:01; C*14:03,14:03; DQA1*04:01,04:01; DQB1*03:23,03:23; DRB1*04:03,13:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>T (IVS8+1G>T); ClinVar=VCV000495326; Zygosity=Homozygous; Note=Splice donor mutation (DepMap=ACH-000407).
CC   Omics: Genomics; Chromatin accessibility; ATAC-seq.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.15%; Native American=0.59%; East Asian, North=63.21%; East Asian, South=35.03%; South Asian=0%; European, North=0%; European, South=0.02% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): KCLB=00685
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8,12
ST   FGA: 21
ST   TH01: 6,9.3
ST   TPOX: 9
ST   vWA: 17,19
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SNU-70
AC   CVCL_5084
SY   SNU70
DR   cancercelllines; CVCL_5084
DR   ColonAtlas; SNU70
DR   Cosmic; 1322282
DR   GEO; GSM1448210
DR   IARC_TP53; 28468
DR   KCLB; 00070
DR   Wikidata; Q54955252
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 118 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1294Ter (c.3880C>T); ClinVar=VCV000469942; Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282fs (c.845delG); Zygosity=Homozygous (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=00070; PubMed=20176655
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 21
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   SNU-703
AC   CVCL_5085
SY   SNU703
DR   KCLB; 00703
DR   Wikidata; Q54955253
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV16 genome.
CC   Doubling time: 48 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=00703
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 12,13
ST   FGA: 22,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-719
AC   CVCL_5086
SY   SNU719; NCI-SNU-719
DR   BTO; BTO_0006482
DR   EFO; EFO_0006760
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473188
DR   BioSample; SAMN10988060
DR   cancercelllines; CVCL_5086
DR   Cell_Model_Passport; SIDM01450
DR   CGH-DB; 129-1
DR   CGH-DB; 9017-4
DR   Cosmic; 685594
DR   Cosmic; 848144
DR   Cosmic; 869512
DR   Cosmic; 921603
DR   Cosmic; 1090458
DR   Cosmic; 1294959
DR   Cosmic; 1528880
DR   Cosmic; 2646594
DR   Cosmic; 2807652
DR   DepMap; ACH-000898
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM552375
DR   GEO; GSM888727
DR   IARC_TP53; 30169
DR   KCLB; 00719
DR   LiGeA; CCLE_869
DR   PharmacoDB; SNU719_1479_2019
DR   Progenetix; CVCL_5086
DR   Wikidata; Q54955255
RX   PubMed=9033653;
RX   PubMed=10812166;
RX   PubMed=15016554;
RX   PubMed=15723654;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24807215;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26889033;
RX   PubMed=29435981;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34466148;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains a complete EBV genome (strain SNU-719) which has been sequenced (PubMed=26889033).
CC   Doubling time: 43 hours (PubMed=29435981).
CC   HLA typing: A*24:02,24:02; B*07:02,52:01; C*07:02,12:02; DQB1*05:01,05:01; DRB1*01:01,15:02 (PubMed=25960936).
CC   HLA typing: A*24:02,24:02; B*07:02,52:01; C*07:02,12:02; DQA1*05:02,05:02; DQB1*05:01,05:01; DRB1*01:01,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (DepMap=ACH-000898).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asp153Ala (c.458A>C); Zygosity=Heterozygous (PubMed=29435981; DepMap=ACH-000898).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (DepMap=ACH-000898).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro104Arg (c.311C>G); ClinVar=VCV001480334; Zygosity=Heterozygous (DepMap=ACH-000898).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Ala61Val (c.182C>T); Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000898).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9033653).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.31%; East Asian, North=60.01%; East Asian, South=38.67%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): KCLB=00719; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 13,15
ST   D21S11: 29,30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 21,23
ST   Penta D: 10,11
ST   Penta E: 11,16
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   SNU-719-5FU
AC   CVCL_L052
SY   SNU-719R-5-FU/600
DR   cancercelllines; CVCL_L052
DR   Wikidata; Q54955256
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asp153Ala (c.458A>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro104Arg (c.311C>G); ClinVar=VCV001480334; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Ala61Val (c.182C>T); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5086 ! SNU-719
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 19
//
ID   SNU-719-DOX
AC   CVCL_L053
SY   SNU-719R-DOX/100
DR   cancercelllines; CVCL_L053
DR   Wikidata; Q54955257
RX   PubMed=14734480;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asp153Ala (c.458A>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro104Arg (c.311C>G); ClinVar=VCV001480334; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Ala61Val (c.182C>T); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5086 ! SNU-719
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 19
//
ID   SNU-738
AC   CVCL_5087
SY   SNU738; NCI-SNU-738
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988089
DR   cancercelllines; CVCL_5087
DR   Cell_Model_Passport; SIDM01442
DR   DepMap; ACH-000807
DR   GEO; GSM887638
DR   GEO; GSM888728
DR   IARC_TP53; 28349
DR   KCLB; 00738
DR   LiGeA; CCLE_158
DR   PharmacoDB; SNU738_1480_2019
DR   Progenetix; CVCL_5087
DR   Wikidata; Q54955259
RX   PubMed=11776963;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 56 hours (PubMed=11776963).
CC   HLA typing: A*02:06,24:02; B*35:01,52:01; C*03:03,12:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (DepMap=ACH-000807).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.32%; Native American=0%; East Asian, North=64.14%; East Asian, South=32.96%; South Asian=0%; European, North=0%; European, South=1.57% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=00738
ST   Amelogenin: Y
ST   CSF1PO: 10
ST   D13S317: 8
ST   D3S1358: 16
ST   D5S818: 13
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SNU-739
AC   CVCL_5088
SY   SNU739
DR   cancercelllines; CVCL_5088
DR   Cell_Model_Passport; SIDM01438
DR   DepMap; ACH-002523
DR   GEO; GSM1374898
DR   GEO; GSM2551591
DR   IARC_TP53; 6311
DR   KCLB; 00739
DR   LIMORE; SNU739
DR   Wikidata; Q54955260
RX   PubMed=8824565;
RX   PubMed=11819450;
RX   PubMed=19956504;
RX   PubMed=31063779;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU739
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 20 hours (PubMed=11819450); 24.99 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Gln149Serfs*83 (c.444dupT); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Arg3384Ter (c.10150C>T); ClinVar=VCV000051049; Zygosity=Homozygous (DepMap=ACH-002523).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.645T>G); ClinVar=VCV000376661; Zygosity=Unspecified (PubMed=8824565; PubMed=31378681; DepMap=ACH-002523).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00739; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   FGA: 24
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SNU-761
AC   CVCL_5089
SY   SNU761; NCI-SNU-761
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987730
DR   cancercelllines; CVCL_5089
DR   Cell_Model_Passport; SIDM01439
DR   Cosmic; 2771601
DR   DepMap; ACH-000537
DR   GEO; GSM887639
DR   GEO; GSM888729
DR   GEO; GSM1374899
DR   GEO; GSM2551592
DR   IARC_TP53; 6312
DR   KCLB; 00761
DR   LiGeA; CCLE_397
DR   LIMORE; SNU761
DR   PharmacoDB; SNU761_1481_2019
DR   Progenetix; CVCL_5089
DR   Wikidata; Q54955261
RX   PubMed=8824565;
RX   PubMed=11819450;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU761
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=11819450); 24.32 hours (PubMed=31378681).
CC   HLA typing: A*11:01,11:01; B*13:01,13:01; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser313Glyfs*13 (c.937_968delAGCTCCTCTCCCCAGCCAAAGAAGAAACCACT); Zygosity=Unspecified (PubMed=8824565; PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=0%; East Asian, North=59.84%; East Asian, South=38.16%; South Asian=0%; European, North=0%; European, South=1.38% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00761; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 11
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 9
ST   FGA: 23,24
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   SNU-769A
AC   CVCL_5090
SY   SNU769A
DR   Cosmic; 738865
DR   Cosmic; 848828
DR   Cosmic; 2612371
DR   Cosmic; 2651856
DR   Wikidata; Q54955262
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=10362137).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5091 ! SNU-769B
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 18
//
ID   SNU-769B
AC   CVCL_5091
SY   SNU769B
DR   Cosmic; 738854
DR   Cosmic; 848829
DR   Cosmic; 2612372
DR   Cosmic; 2651857
DR   GEO; GSM1448218
DR   KCLB; 00769B
DR   Wikidata; Q54955263
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 42 hours (PubMed=10362137).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=00769B; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 8,12 (KCLB=00769B)
ST   D13S317: 9,12 (PubMed=25926053)
ST   D16S539: 12
ST   D21S11: 29,31
ST   D3S1358: 13,15
ST   D5S818: 14
ST   D7S820: 11.3,13
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5090 ! SNU-769A
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   SNU-778
AC   CVCL_5092
SY   SNU778
DR   KCLB; 00778
DR   Wikidata; Q54955264
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=00778
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   FGA: 23.2
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   SNU-790
AC   CVCL_5093
SY   SNU790
DR   cancercelllines; CVCL_5093
DR   Cosmic; 1024886
DR   Cosmic; 1065285
DR   Cosmic; 1151968
DR   IARC_TP53; 24495
DR   KCLB; 00790
DR   Wikidata; Q54955267
RX   PubMed=17134824;
RX   PubMed=38225447;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 33 hours (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17134824).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): KCLB=00790
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   FGA: 20,25
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SNU-791
AC   CVCL_5094
SY   SNU791
DR   Wikidata; Q54955268
RX   PubMed=11776963;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 60 hours (PubMed=11776963).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   SNU-796
AC   CVCL_5095
SY   SNU796
DR   cancercelllines; CVCL_5095
DR   ColonAtlas; SNU796
DR   Cosmic; 1322285
DR   IARC_TP53; 28471
DR   KCLB; 00796
DR   Wikidata; Q54955269
RX   PubMed=20176655;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 121 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg554Ter (c.1660C>T); ClinVar=VCV000000807; Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1364fs*11 (c.4090_4091insA); Zygosity=Heterozygous (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=20176655).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=00796; PubMed=20176655
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   D8S1179: 10
ST   FGA: 22,23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   SNU-8
AC   CVCL_5096
SY   SNU8
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 696
DR   BioSample; SAMN10988094
DR   cancercelllines; CVCL_5096
DR   Cell_Model_Passport; SIDM01437
DR   DepMap; ACH-000460
DR   IARC_TP53; 28385
DR   KCLB; 00008
DR   LiGeA; CCLE_353
DR   PharmacoDB; SNU8_1482_2019
DR   Progenetix; CVCL_5096
DR   Wikidata; Q54955270
RX   PubMed=9299249;
RX   PubMed=19956504;
RX   PubMed=23839242;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 44 hours (PubMed=9299249).
CC   HLA typing: A*02:06,24:02; B*39:01,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000460).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro142fs (c.425_426delCT); Zygosity=Homozygous (DepMap=ACH-000460).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0.06%; Native American=0.79%; East Asian, North=58.48%; East Asian, South=40.21%; South Asian=0%; European, North=0.01%; European, South=0.45% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=00008
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,9
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   FGA: 20,26
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SNU-80
AC   CVCL_5097
SY   SNU80
DR   cancercelllines; CVCL_5097
DR   Cosmic; 1024884
DR   Cosmic; 1065283
DR   IARC_TP53; 24493
DR   KCLB; 00080
DR   Wikidata; Q54955272
RX   PubMed=17134824;
RX   PubMed=38225447;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 37 hours (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Arg (c.1405G>C); ClinVar=VCV000013970; Zygosity=Unspecified (PubMed=17134824).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (PubMed=17134824).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): KCLB=00080
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 12,13
ST   FGA: 20,23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SNU-81
AC   CVCL_5098
SY   SNU81; NCI-SNU-81
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1020
DR   BioSample; SAMN10988062
DR   cancercelllines; CVCL_5098
DR   Cell_Model_Passport; SIDM00193
DR   ColonAtlas; SNU81
DR   Cosmic; 738853
DR   Cosmic; 2612374
DR   Cosmic; 2651851
DR   Cosmic-CLP; 1660036
DR   DepMap; ACH-000991
DR   EGA; EGAS00001000978
DR   GDSC; 1660036
DR   GEO; GSM888730
DR   GEO; GSM1448159
DR   GEO; GSM1670475
DR   IARC_TP53; 28338
DR   KCLB; 00081
DR   LiGeA; CCLE_695
DR   PharmacoDB; SNU81_1483_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5098
DR   Wikidata; Q54955273
RX   PubMed=10362137;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 30 hours (PubMed=10362137).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1392Ter (c.4175C>A); ClinVar=VCV000188240; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2204Ter (c.6610C>T); ClinVar=VCV000236632; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Gln (c.389G>A); ClinVar=VCV000007829; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu299Ter (c.895G>T); ClinVar=VCV000428263; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:11602; TBX3; Simple; p.Glu111Ter (c.331G>T); Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:11602; TBX3; Simple; c.942-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Thr (c.395A>C); ClinVar=VCV000376627; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Heterozygous (Cosmic-CLP=1660036; DepMap=ACH-000991).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.37%; East Asian, North=56.62%; East Asian, South=42%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): Cosmic-CLP=1660036; KCLB=00081; PubMed=25926053
ST   Amelogenin: X (Cosmic-CLP=1660036; PubMed=25926053)
ST   Amelogenin: X,Y (KCLB=00081)
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 9,12
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 12
ST   FGA: 19,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   SNU-817
AC   CVCL_5099
SY   SNU817; SNU-817BL; SNU-817EBV
DR   KCLB; 00817EBV
DR   Wikidata; Q54955275
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a stomach cancer.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): KCLB=00817EBV
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 10
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11,13
ST   FGA: 20,21
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 12,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-840
AC   CVCL_5100
SY   SNU840; NCI-SNU-840
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 695
DR   BioSample; SAMN10988093
DR   cancercelllines; CVCL_5100
DR   Cell_Model_Passport; SIDM01436
DR   DepMap; ACH-000280
DR   GEO; GSM887640
DR   GEO; GSM888731
DR   IARC_TP53; 30170
DR   KCLB; 00840
DR   LiGeA; CCLE_690
DR   PharmacoDB; SNU840_1484_2019
DR   Progenetix; CVCL_5100
DR   Wikidata; Q54955276
RX   PubMed=9299249;
RX   PubMed=10748297;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=23839242;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 40 hours (PubMed=9299249); 36 hours (PubMed=25984343).
CC   HLA typing: A*03:01,31:01; B*15:07,44:02; C*03:03,05:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (DepMap=ACH-000280).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.49%; Native American=0%; East Asian, North=68.16%; East Asian, South=24.79%; South Asian=0%; European, North=0%; European, South=3.57% (PubMed=30894373).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): KCLB=00840
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 12
ST   FGA: 26,51.2
ST   TH01: 7,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C4270; Malignant ovarian Brenner tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SNU-869
AC   CVCL_5101
SY   SNU869
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988091
DR   cancercelllines; CVCL_5101
DR   Cell_Model_Passport; SIDM00159
DR   Cosmic; 738872
DR   Cosmic; 2674054
DR   DepMap; ACH-000182
DR   IARC_TP53; 17161
DR   KCLB; 00869
DR   LiGeA; CCLE_931
DR   PharmacoDB; SNU869_1485_2019
DR   PRIDE; PXD002657
DR   Wikidata; Q54955278
RX   CelloPub=CLPUB00275;
RX   PubMed=12107841;
RX   PubMed=19956504;
RX   PubMed=26589293;
RX   PubMed=26951071;
RX   PubMed=27231123;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=12107841).
CC   HLA typing: A*33:03,33:03; B*44:03,44:03; C*14:03,14:03 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (DepMap=ACH-000182).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (DepMap=ACH-000182).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp48Gly (c.143A>G); Zygosity=Unspecified (PubMed=12107841).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=15.94%; Native American=0%; East Asian, North=64.53%; East Asian, South=0%; South Asian=0%; European, North=0%; European, South=19.53% (PubMed=30894373).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): KCLB=00869
ST   CSF1PO: 10
ST   D13S317: 12
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   FGA: 23
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   SNU-878
AC   CVCL_5102
SY   SNU878; NCI-SNU-878
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988092
DR   cancercelllines; CVCL_5102
DR   Cell_Model_Passport; SIDM01435
DR   CLS; 305285
DR   Cosmic; 2771605
DR   DepMap; ACH-000686
DR   GEO; GSM887641
DR   GEO; GSM888732
DR   GEO; GSM1374900
DR   GEO; GSM2551593
DR   IARC_TP53; 6313
DR   KCLB; 00878
DR   LiGeA; CCLE_727
DR   LIMORE; SNU878
DR   PharmacoDB; SNU878_1486_2019
DR   PRIDE; PXD002486
DR   Progenetix; CVCL_5102
DR   Wikidata; Q54955280
RX   PubMed=8824565;
RX   PubMed=11819450;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU878
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 25 hours (PubMed=11819450); 40.35 hours (PubMed=31378681).
CC   HLA typing: A*33:03,33:03; B*58:01,58:01; C*03:02,03:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Asn (c.752T>A); ClinVar=VCV000528254; Zygosity=Homozygous (PubMed=8824565; PubMed=31378681; DepMap=ACH-000686).
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Ser1514Ter (c.4541C>G); ClinVar=VCV000620335; Zygosity=Homozygous (PubMed=31378681; DepMap=ACH-000686).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.81%; Native American=0%; East Asian, North=66.98%; East Asian, South=21.49%; South Asian=0%; European, North=0%; European, South=5.72% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00878; PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10
ST   D3S1358: 15
ST   D5S818: 9,12 (KCLB=00878)
ST   D5S818: 15 (PubMed=31378681)
ST   D7S820: 9,11
ST   FGA: 23,26
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SNU-886
AC   CVCL_5103
SY   SNU886; NCI-SNU-886
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988057
DR   cancercelllines; CVCL_5103
DR   Cell_Model_Passport; SIDM01434
DR   Cosmic; 2771604
DR   DepMap; ACH-000316
DR   GEO; GSM888733
DR   GEO; GSM1374901
DR   GEO; GSM2551594
DR   IARC_TP53; 6314
DR   KCLB; 00886
DR   LiGeA; CCLE_720
DR   LIMORE; SNU886
DR   PharmacoDB; SNU886_1487_2019
DR   Progenetix; CVCL_5103
DR   Wikidata; Q54955282
RX   PubMed=8824565;
RX   PubMed=11819450;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31063779;
RX   PubMed=31068700;
RX   PubMed=31378681;
WW   Info; LCCL; -; https://lccl.zucmanlab.com/hcc/cellLines/SNU886
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=11819450); 25.19 hours (PubMed=31378681).
CC   HLA typing: A*24:02,33:03; B*13:02,44:03; C*06:02,07:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220fs*27 (c.655delC) (p.P219Lfs); Zygosity=Homozygous (PubMed=8824565; DepMap=ACH-000316).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.56%; Native American=0.92%; East Asian, North=64.25%; East Asian, South=33.26%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): KCLB=00886; PubMed=31378681
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 10
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11,12
ST   FGA: 21,24
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,20
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SNU-889
AC   CVCL_5104
SY   SNU889
DR   Wikidata; Q54955283
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a rectal carcinoma.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   SNU-899
AC   CVCL_5105
SY   SNU899; NCI-SNU-899
DR   BTO; BTO_0005925
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988086
DR   cancercelllines; CVCL_5105
DR   Cell_Model_Passport; SIDM00169
DR   Cosmic; 934175
DR   DepMap; ACH-000692
DR   GEO; GSM887642
DR   GEO; GSM888734
DR   IARC_TP53; 30171
DR   KCLB; 00899
DR   LiGeA; CCLE_315
DR   PharmacoDB; SNU899_1488_2019
DR   Progenetix; CVCL_5105
DR   Wikidata; Q54955284
RX   CelloPub=CLPUB00001;
RX   CelloPub=CLPUB00626;
RX   PubMed=10369293;
RX   PubMed=17923759;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=10369293).
CC   HLA typing: A*02:06,02:06; B*15:01,15:01; C*04:01,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Heterozygous (DepMap=ACH-000692).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.85%; East Asian, North=62.64%; East Asian, South=35.88%; South Asian=0%; European, North=0%; European, South=0.63% (PubMed=30894373).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): KCLB=00899
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,13
ST   FGA: 21
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   SNU-899 R1
AC   CVCL_A6IV
DR   cancercelllines; CVCL_A6IV
DR   Wikidata; Q107116947
RX   CelloPub=CLPUB00626;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5105 ! SNU-899
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SNU-9
AC   CVCL_5106
SY   SNU9
DR   Wikidata; Q54955285
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a leukemia.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SNU-902
AC   CVCL_5107
SY   SNU902
DR   KCLB; 00902
DR   Wikidata; Q54955286
RX   PubMed=9219839;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Virology: Contains an integrated HPV16 genome.
CC   Doubling time: 52 hours (PubMed=9219839).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): KCLB=00902
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   SNU-963
AC   CVCL_5108
SY   SNU963
DR   Cosmic; 1484498
DR   Wikidata; Q54955288
RX   PubMed=21290211;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 149 hours (PubMed=21290211).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SNU-977
AC   CVCL_5109
SY   SNU977
DR   cancercelllines; CVCL_5109
DR   ColonAtlas; SNU977
DR   Cosmic; 1322286
DR   GEO; GSM1448211
DR   IARC_TP53; 28472
DR   KCLB; 00977
DR   Wikidata; Q54955289
RX   PubMed=20176655;
RX   PubMed=25926053;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 63 hours (PubMed=20176655).
CC   Microsatellite instability: Stable (MSS) (PubMed=20176655; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1355fs*20 (c.4063_4064insT); Zygosity=Unspecified (PubMed=20176655).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=20176655).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): KCLB=00977; PubMed=20176655; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11 (KCLB=00977; PubMed=20176655)
ST   CSF1PO: 11,12 (PubMed=25926053)
ST   D13S317: 11 (PubMed=25926053)
ST   D13S317: 11,12 (KCLB=00977; PubMed=20176655)
ST   D16S539: 10
ST   D18S51: 15
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 19,22
ST   D3S1358: 16
ST   D5S818: 11 (KCLB=00977; PubMed=20176655)
ST   D5S818: 11,12 (PubMed=25926053)
ST   D7S820: 10,12
ST   D8S1179: 10
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,17,18 (PubMed=25926053)
ST   vWA: 16,18 (KCLB=00977; PubMed=20176655)
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   SNU-99
AC   CVCL_5110
SY   SNU99
DR   Wikidata; Q54955290
RX   PubMed=9542645;
RX   PubMed=19956504;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a rectal carcinoma.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SNU-C1
AC   CVCL_1708
SY   Snu-C1; SNUC1; NCI-SNU-C1
DR   CLO; CLO_0009103
DR   EFO; EFO_0006761
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5972
DR   BioGRID_ORCS_Cell_line; 1021
DR   BioSample; SAMN03472966
DR   BioSample; SAMN10988188
DR   cancercelllines; CVCL_1708
DR   Cell_Model_Passport; SIDM01197
DR   ChEMBL-Cells; CHEMBL3308249
DR   ChEMBL-Targets; CHEMBL2366304
DR   ColonAtlas; SNUC1
DR   Cosmic; 687539
DR   Cosmic; 910905
DR   Cosmic; 1187319
DR   Cosmic; 1995643
DR   Cosmic; 2302009
DR   Cosmic-CLP; 910905
DR   DepMap; ACH-000722
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910905
DR   GEO; GSM844704
DR   GEO; GSM887643
DR   GEO; GSM888735
DR   GEO; GSM1346855
DR   GEO; GSM1448115
DR   GEO; GSM1670476
DR   GEO; GSM3258550
DR   IARC_TP53; 27246
DR   KCB; KCB 2016028YJ-A
DR   KCLB; 0000C1
DR   LiGeA; CCLE_859
DR   LINCS_LDP; LCL-1194
DR   PharmacoDB; SNUC1_1489_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1708
DR   PubChem_Cell_line; CVCL_1708
DR   Wikidata; Q54955291
RX   PubMed=3479249;
RX   PubMed=8556707;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23637631;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 31 hours (PubMed=25984343).
CC   HLA typing: A*02:06,11:01; B*15:01,54:01; C*01:02,03:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:17581; APIP + HGNC; HGNC:10940; SLC1A2; Name(s)=APIP-SLC1A2; Note=In frame (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser166Ter (c.497C>A); Zygosity=Homozygous (Cosmic-CLP=910905; DepMap=ACH-000722).
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.6%; Native American=0%; East Asian, North=70.54%; East Asian, South=21.43%; South Asian=0%; European, North=0%; European, South=4.43% (PubMed=30894373).
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): ATCC=CRL-5972; Cosmic-CLP=910905; KCLB=0000C1; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 13,16
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   SNU-C1/Cas9-hyg
AC   CVCL_C9G9
DR   GeneCopoeia; SL551
DR   Wikidata; Q123033545
CC   Population: Korean.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL551).
CC   Sequence variation: Gene fusion; HGNC; HGNC:17581; APIP + HGNC; HGNC:10940; SLC1A2; Name(s)=APIP-SLC1A2; Note=In frame (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser166Ter (c.497C>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1708 ! SNU-C1
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   SNU-C2A
AC   CVCL_1709
SY   SNUC2A; NCI-SNU-C2A; C2A
DR   CLO; CLO_0009104
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-250.1
DR   BioSample; SAMN03471382
DR   BioSample; SAMN10987650
DR   cancercelllines; CVCL_1709
DR   Cell_Model_Passport; SIDM00780
DR   ColonAtlas; SNUC2A
DR   Cosmic; 687540
DR   Cosmic; 848824
DR   Cosmic; 2651862
DR   DepMap; ACH-000967
DR   GEO; GSM887644
DR   GEO; GSM888736
DR   GEO; GSM1448096
DR   IARC_TP53; 28285
DR   KCLB; 0000C2A
DR   LiGeA; CCLE_489
DR   PharmacoDB; SNUC2A_1490_2019
DR   Progenetix; CVCL_1709
DR   PubChem_Cell_line; CVCL_1709
DR   Wikidata; Q54955292
RX   PubMed=3479249;
RX   PubMed=8806095;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Characteristics: Established from a nude mouse xenograft.
CC   Doubling time: 50 hours (PubMed=25984343).
CC   HLA typing: A*24:02,26:01; B*07:02,48:01; C*08:03,14:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=25926053; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000967).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (DepMap=ACH-000967).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (DepMap=ACH-000967).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=0%; East Asian, North=62.55%; East Asian, South=35.74%; South Asian=0%; European, North=0.97%; European, South=0.14% (PubMed=30894373).
CC   Misspelling: SUN-C2A; Note=Occasionally.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): ATCC=CCL-250.1; KCLB=0000C2A; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 9,12
ST   D16S539: 8,9
ST   D18S51: 15,16
ST   D19S433: 12
ST   D21S11: 29
ST   D2S1338: 18
ST   D3S1358: 13
ST   D5S818: 8,9
ST   D7S820: 13,16
ST   D8S1179: 11,13
ST   FGA: 20,22 (KCLB=0000C2A)
ST   FGA: 20,22,23 (ATCC=CCL-250.1)
ST   Penta D: 10
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,19 (KCLB=0000C2A; PubMed=25926053)
ST   vWA: 15,19,20 (ATCC=CCL-250.1)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1710 ! SNU-C2B
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SNU-C2B
AC   CVCL_1710
SY   SNUC2B; NCI-SNU-C2B
DR   CLO; CLO_0009105
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-250
DR   BioSample; SAMN03471381
DR   cancercelllines; CVCL_1710
DR   Cell_Model_Passport; SIDM00781
DR   ChEMBL-Cells; CHEMBL3308279
DR   ChEMBL-Targets; CHEMBL2366279
DR   ColonAtlas; SNUC2B
DR   Cosmic; 687541
DR   Cosmic; 909740
DR   Cosmic; 1218880
DR   Cosmic; 1312311
DR   Cosmic; 1479583
DR   Cosmic; 1995644
DR   Cosmic; 2302010
DR   Cosmic-CLP; 909740
DR   DepMap; ACH-001199
DR   ECACC; 96020932
DR   EGA; EGAS00001000978
DR   GDSC; 909740
DR   GEO; GSM741262
DR   GEO; GSM1346856
DR   GEO; GSM1374902
DR   GEO; GSM1448087
DR   GEO; GSM1670477
DR   IARC_TP53; 21744
DR   KCLB; 0000C2B
DR   LINCS_LDP; LCL-1341
DR   PharmacoDB; SNUC2B_1491_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1710
DR   Wikidata; Q54955293
RX   PubMed=8806092;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19956504;
RX   PubMed=20164919;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 49.51 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=24755471; PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (PubMed=16418264).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.36%; East Asian, North=60.61%; East Asian, South=39.03%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): ATCC=CCL-250; Cosmic-CLP=909740; ECACC=96020932; KCLB=0000C2B; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,13,14 (ATCC=CCL-250)
ST   CSF1PO: 11,14 (Cosmic-CLP=909740; ECACC=96020932; KCLB=0000C2B; PubMed=25926053)
ST   D13S317: 9,10 (ECACC=96020932; KCLB=0000C2B; PubMed=25926053)
ST   D13S317: 9,10,11 (ATCC=CCL-250; Cosmic-CLP=909740)
ST   D16S539: 8,9
ST   D18S51: 15,17
ST   D19S433: 11,12
ST   D21S11: 29
ST   D2S1338: 18
ST   D3S1358: 13
ST   D5S818: 8,9
ST   D7S820: 12,13 (ECACC=96020932)
ST   D7S820: 13,16 (ATCC=CCL-250; Cosmic-CLP=909740; KCLB=0000C2B; PubMed=25926053)
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   Penta D: 10
ST   Penta E: 12,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18 (KCLB=0000C2B; PubMed=25926053)
ST   vWA: 15,18,19 (ATCC=CCL-250; Cosmic-CLP=909740)
ST   vWA: 15,19 (ECACC=96020932)
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1709 ! SNU-C2A
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SNU-C4
AC   CVCL_5111
SY   SNU C4; SNUC4; NCI-SNU-C4; C4
DR   CLO; CLO_0037284
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987757
DR   cancercelllines; CVCL_5111
DR   Cell_Model_Passport; SIDM00500
DR   ChEMBL-Cells; CHEMBL3307457
DR   ChEMBL-Targets; CHEMBL614933
DR   ColonAtlas; SNUC4
DR   Cosmic; 848825
DR   Cosmic; 2302011
DR   Cosmic; 2651863
DR   DepMap; ACH-000959
DR   GEO; GSM887645
DR   GEO; GSM888737
DR   GEO; GSM1448127
DR   IARC_TP53; 28310
DR   KCLB; 0000C4
DR   LiGeA; CCLE_420
DR   PharmacoDB; SNUC4_1492_2019
DR   Progenetix; CVCL_5111
DR   PubChem_Cell_line; CVCL_5111
DR   Wikidata; Q54955294
RX   PubMed=3479249;
RX   PubMed=8556707;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=10674020;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=24755471;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Characteristics: Established from a nude mouse xenograft.
CC   HLA typing: A*02:01,24:02; B*35:12,48:01; C*03:04,08:03 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=24755471; PubMed=25926053; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (PubMed=10674020).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu288fs*3 (c.863delA); Zygosity=Heterozygous (DepMap=ACH-000959).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=10674020).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (DepMap=ACH-000959).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.62%; East Asian, North=57.31%; East Asian, South=42.07%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: SNU-4c; Note=Occasionally.
ST   Source(s): KCLB=0000C4; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D21S11: 28,30
ST   D3S1358: 16,20
ST   D5S818: 8,9
ST   D7S820: 7.3,11,12 (PubMed=25926053)
ST   D7S820: 8 (KCLB=0000C4)
ST   FGA: 20,21
ST   TH01: 7,8 (PubMed=25926053)
ST   TH01: 7,9 (KCLB=0000C4)
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SNU-C5
AC   CVCL_5112
SY   SNUC5; NCI-SNU-C5; SNU-C5/WT
DR   CLO; CLO_0037285
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1023
DR   BioSample; SAMN10987753
DR   cancercelllines; CVCL_5112
DR   Cell_Model_Passport; SIDM00498
DR   ColonAtlas; SNUC5
DR   Cosmic-CLP; 1674021
DR   DepMap; ACH-000970
DR   EGA; EGAS00001000978
DR   GDSC; 1674021
DR   GEO; GSM887646
DR   GEO; GSM888738
DR   GEO; GSM1448131
DR   GEO; GSM1670478
DR   IARC_TP53; 5453
DR   KCLB; 0000C5
DR   LiGeA; CCLE_017
DR   PharmacoDB; SNUC5_1493_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD018763
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_5112
DR   PubChem_Cell_line; CVCL_5112
DR   Wikidata; Q54955295
RX   PubMed=3479249;
RX   PubMed=8556707;
RX   PubMed=8806092;
RX   PubMed=8806095;
RX   PubMed=19956504;
RX   PubMed=22460905;
RX   PubMed=25926053;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Characteristics: Established from a nude mouse xenograft.
CC   HLA typing: A*02:07,24:22; B*15:05,46:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=25926053; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=1674021; DepMap=ACH-000970).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (Cosmic-CLP=1674021; DepMap=ACH-000970).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Leu (c.652G>T); Zygosity=Heterozygous (PubMed=8556707; Cosmic-CLP=1674021; DepMap=ACH-000970).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (PubMed=8556707; Cosmic-CLP=1674021; DepMap=ACH-000970).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.84%; East Asian, North=58.4%; East Asian, South=40.75%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): Cosmic-CLP=1674021; KCLB=0000C5; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 8,13
ST   D21S11: 29,31.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 12 (Cosmic-CLP=1674021; PubMed=25926053)
ST   D7S820: 12,13 (KCLB=0000C5)
ST   FGA: 19,23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SNU-C5/5FU-R
AC   CVCL_V482
DR   cancercelllines; CVCL_V482
DR   Wikidata; Q54955296
RX   PubMed=17845510;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Leu (c.652G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5112 ! SNU-C5
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   SNU-C5/IRT-R
AC   CVCL_V483
DR   cancercelllines; CVCL_V483
DR   Wikidata; Q54955298
RX   PubMed=17845510;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Leu (c.652G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5112 ! SNU-C5
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   SNU-C5/OXT-R
AC   CVCL_V484
DR   cancercelllines; CVCL_V484
DR   Wikidata; Q54955299
RX   PubMed=17845510;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Leu (c.652G>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5112 ! SNU-C5
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   SNU-NCC-19
AC   CVCL_8897
SY   NCC-19
DR   cancercelllines; CVCL_8897
DR   Cosmic; 1661028
DR   KCLB; 50019
DR   Wikidata; Q54907594
RX   PubMed=22361929;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Doubling time: 59 hours (PubMed=22361929).
CC   Microsatellite instability: Stable (MSS) (PubMed=22361929).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=22361929).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): KCLB=50019; PubMed=22361929
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 9
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 18,19
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 20,23
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   SNU-NCC-20
AC   CVCL_8898
SY   NCC-20
DR   Cosmic; 1661029
DR   KCLB; 50020
DR   Wikidata; Q54907595
RX   PubMed=22361929;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Doubling time: 135 hours (PubMed=22361929).
CC   Microsatellite instability: Stable (MSS) (PubMed=22361929).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=50020; PubMed=22361929
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 31
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 14
//
ID   SNU-NCC-24
AC   CVCL_8899
SY   NCC-24
DR   cancercelllines; CVCL_8899
DR   Cosmic; 1661030
DR   KCLB; 50024
DR   Wikidata; Q54907596
RX   PubMed=22361929;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Doubling time: 47 hours (PubMed=22361929).
CC   Microsatellite instability: Stable (MSS) (PubMed=22361929).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Arg (c.796G>C); ClinVar=VCV000376605; Zygosity=Unspecified (PubMed=22361929).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=22361929).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): KCLB=50024; PubMed=22361929
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 19,20
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 19,22
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   SNU-NCC-376
AC   CVCL_ZE65
DR   cancercelllines; CVCL_ZE65
DR   Wikidata; Q98132792
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 3.147 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 31,32.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D7S820: 13
ST   D8S1179: 13
ST   FGA: 19,21
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   SNU-NCC-377
AC   CVCL_ZE66
DR   cancercelllines; CVCL_ZE66
DR   Wikidata; Q98132793
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 2.449 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 32.2
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 12,16
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   SNU-NCC-59
AC   CVCL_8900
SY   NCC-59
DR   cancercelllines; CVCL_8900
DR   Cosmic; 1661031
DR   GEO; GSM2267429
DR   KCLB; 50059
DR   Progenetix; CVCL_8900
DR   Wikidata; Q54907597
RX   PubMed=22361929;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Doubling time: 50 hours (PubMed=22361929).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=22361929).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=22361929).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Unspecified (PubMed=22361929).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): KCLB=50059; PubMed=22361929
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 8,9
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 24,27
ST   D3S1358: 14,15
ST   D5S818: 12,14
ST   D7S820: 11,13
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C5473; Gastric tubular adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   SNU-NCC-61
AC   CVCL_ZE67
DR   cancercelllines; CVCL_ZE67
DR   Wikidata; Q98132794
RX   PubMed=32321971;
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Population: Korean.
CC   Doubling time: 3.283 days (PubMed=32321971).
CC   Microsatellite instability: Stable (MSS) (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=32321971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu11Gln (c.31G>C); ClinVar=VCV000041723; Zygosity=Unspecified (PubMed=32321971).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=32321971
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 17
ST   D19S433: 14.2,15
ST   D21S11: 30
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,15
ST   FGA: 22,23
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   SNU_MM1393_BM
AC   CVCL_IW63
SY   SNU MM1393 BM; Seoul National University-Multiple Myeloma 1393-Bone Marrow
DR   ABM; T8214
DR   Wikidata; Q54955300
RX   PubMed=25343143;
CC   Population: Korean.
CC   Characteristics: Established from a bone marrow tumor in a NRG/SCID mice injected with the patient cancer cells (PubMed=25343143).
CC   Characteristics: Produces IgA kappa (PubMed=25343143).
CC   Characteristics: IL6 dependent (PubMed=25343143).
CC   Doubling time: ~48 hours (PubMed=25343143).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=25343143).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW64 ! SNU_MM1393_SC
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 10
//
ID   SNU_MM1393_SC
AC   CVCL_IW64
SY   SNU MM1393 SC; Seoul National University-Multiple Myeloma 1393-SubCutis
DR   ABM; T8215
DR   Wikidata; Q54955309
RX   PubMed=25343143;
CC   Population: Korean.
CC   Characteristics: Established from a subcutis tumor in a NRG/SCID mice injected with the patient cancer cells (PubMed=25343143).
CC   Characteristics: Produces IgA kappa (PubMed=25343143).
CC   Characteristics: IL6 independent (PubMed=25343143).
CC   Doubling time: ~48 hours (PubMed=25343143).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=25343143).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW63 ! SNU_MM1393_BM
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 8
//
ID   SNUARTe003
AC   CVCL_B5FL
SY   ES-OR6
DR   Wikidata; Q110433243
RX   PubMed=34861590;
CC   Characteristics: Contains a porcine OCT4 upstream region-derived dual reporter system composed of two constructs, pOCT4-deltaPE-eGFP and pOCT4-deltaDE-DsRed2 (PubMed=34861590).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TXLFX; DsRed2 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: Landrace x Yorkshire x Duroc; VBO=VBO_0001161+VBO_0001212+VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   SNUCML-02
AC   CVCL_D773
SY   Seoul National University Chronic Myeloid Leukemia-02
DR   Cosmic; 1429043
DR   Wikidata; Q54955310
RX   PubMed=20438801;
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=20438801).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=20438801).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   SNUe003-A-1
AC   CVCL_A5MV
DR   hPSCreg; SNUe003-A-1
DR   SKIP; SKIP002454
DR   Wikidata; Q107116948
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Karyotypic information: 47,XY,+12 (hPSCreg=SNUe003-A-1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9949 ! SNUhES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SNUe003-A-2
AC   CVCL_A5MW
SY   B-mC-KI-SE-3; IRMPe004-A-2
DR   BioSamples; SAMEA7513374
DR   hPSCreg; SNUe003-A-2
DR   Wikidata; Q107116949
RX   PubMed=33878708;
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 a T2A-mCherry-polyA-PGKp-Neo-polyA construct was introduced at the C-terminus of one allele of Brachyury (PubMed=33878708).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9949 ! SNUhES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   SNUe003-A-3
AC   CVCL_A0MK
SY   SNUhES3-alphaMHC-EGFP; A-eG-KI-SE-3; IRMPe004-A-3
DR   BioSamples; SAMEA9403864
DR   hPSCreg; SNUe003-A-3
DR   Wikidata; Q108821319
RX   PubMed=35427904;
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 a T2A-EGFP-polyA-PGKp-PuroR-polyA construct was introduced at the C-terminus of MYH6 (PubMed=35427904).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9949 ! SNUhES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   SNUe003-A-4
AC   CVCL_D0QP
SY   SNUhES3-TUBB3-mCherry; T-mC-KI-SE-3; IRMPe004-A-4
DR   BioSamples; SAMEA12504963
DR   hPSCreg; SNUe003-A-4
DR   Wikidata; Q123033546
RX   PubMed=36913849;
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Characteristics: Using CRISPR/Cas9 a T2A-mCherry-polyA-PGKp-Neo-polyA construct was introduced at the C-terminus of one allele of TUBB3 (PubMed=36913849).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9949 ! SNUhES3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   SNUe004-A-1
AC   CVCL_A5MT
DR   hPSCreg; SNUe004-A-1
DR   SKIP; SKIP002455
DR   Wikidata; Q107116950
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9950 ! SNUhES4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SNUe004-A-2
AC   CVCL_A5MU
SY   A-eG-KI-SE-4; IRMPe005-A-2
DR   BioSamples; SAMEA7543700
DR   hPSCreg; SNUe004-A-2
DR   Wikidata; Q107116951
CC   From: Seoul National University; Seoul; South Korea.
CC   Population: Korean.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9950 ! SNUhES4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   SNUhES1
AC   CVCL_9945
SY   SNUhES 1; Kor-hES16; SNUe001-A
DR   hPSCreg; SNUe001-A
DR   SKIP; SKIP002068
DR   Wikidata; Q54955311
RX   PubMed=15671144;
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SNUhES10
AC   CVCL_B998
SY   SNUhES 10; Kor-hES21
DR   Wikidata; Q54955312
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010010.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUhES11
AC   CVCL_9946
SY   SNUhES 11; Kor-hES3; SNUe005-A
DR   hPSCreg; SNUe005-A
DR   SKIP; SKIP002274
DR   Wikidata; Q54955313
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010011.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SNUhES12
AC   CVCL_B995
SY   SNUhES 12; Kor-hES22
DR   Wikidata; Q54955314
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010012.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUhES14
AC   CVCL_B996
SY   SNUhES 14; Kor-hES23
DR   Wikidata; Q54955315
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010013.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUhES16
AC   CVCL_9947
SY   SNUhES 16; Kor-hES4; SNUe006-A
DR   hPSCreg; SNUe006-A
DR   SKIP; SKIP002275
DR   Wikidata; Q54955316
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010014.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SNUhES18
AC   CVCL_L116
SY   SNUhES 18; Kor-hES24
DR   Wikidata; Q54955317
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010025.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   SNUhES19
AC   CVCL_B997
SY   SNUhES 19; Kor-hES25
DR   Wikidata; Q54955318
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010015.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUhES2
AC   CVCL_9948
SY   SNUhES 2; Kor-hES17; SNUe002-A
DR   hPSCreg; SNUe002-A
DR   SKIP; SKIP002069
DR   Wikidata; Q54955319
RX   PubMed=15671144;
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   SNUhES3
AC   CVCL_9949
SY   SNUhES 3; SNUhES#3; Kor-hES1; SNUe003-A
DR   BioSamples; SAMEA7543704
DR   hPSCreg; SNUe003-A
DR   SKIP; SKIP002070
DR   Wikidata; Q54955321
RX   PubMed=15671144;
RX   PubMed=24159464;
RX   PubMed=33714852;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010005.
CC   Population: Korean.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   SNUhES31
AC   CVCL_L117
SY   SNUhES 31; Kor-hES26; SNUe007-A
DR   BioSamples; SAMEA7543702
DR   hPSCreg; SNUe007-A
DR   Wikidata; Q54955322
RX   PubMed=24159464;
RX   PubMed=33714852;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010037.
CC   Population: Korean.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   SNUhES32
AC   CVCL_L118
SY   SNUhES 32; Kor-hES27
DR   Wikidata; Q54955323
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010051.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   SNUhES33
AC   CVCL_L119
SY   SNUhES 33; Kor-hES50
DR   Wikidata; Q54955324
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   SNUhES34
AC   CVCL_L120
SY   SNUhES 34; Kor-hES51
DR   Wikidata; Q54955325
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   SNUhES35
AC   CVCL_L121
SY   SNUhES 35; Kor-hES52
DR   Wikidata; Q54955326
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   SNUhES36
AC   CVCL_Y990
DR   Wikidata; Q54955327
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12012009.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   SNUhES37
AC   CVCL_L122
SY   SNUhES 37; Kor-hES53
DR   Wikidata; Q54955328
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   SNUhES38
AC   CVCL_L123
SY   SNUhES 38; Kor-hES54
DR   Wikidata; Q54955329
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12011005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   SNUhES39
AC   CVCL_Y991
DR   Wikidata; Q54955330
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SNUhES4
AC   CVCL_9950
SY   SNUhES 4; SNUhES-4; Kor-hES2; SNUe004-A
DR   hPSCreg; SNUe004-A
DR   SKIP; SKIP002273
DR   Wikidata; Q54955331
RX   PubMed=24159464;
RX   PubMed=33714852;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010006.
CC   Population: Korean.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   SNUhES40
AC   CVCL_Y992
DR   Wikidata; Q54955332
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   SNUhES41
AC   CVCL_IS20
DR   Wikidata; Q54955333
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12014003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SNUhES42
AC   CVCL_IS10
DR   Wikidata; Q54955334
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12015001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SNUhES43
AC   CVCL_IS11
DR   Wikidata; Q54955335
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12015002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SNUhES44
AC   CVCL_IS12
DR   Wikidata; Q54955336
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12016005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SNUhES45
AC   CVCL_B3V8
DR   Wikidata; Q110433244
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SNUhES46
AC   CVCL_B3V9
DR   Wikidata; Q110433245
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SNUhES47
AC   CVCL_B3VA
DR   Wikidata; Q110433246
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SNUhES48
AC   CVCL_B3VB
DR   Wikidata; Q110433248
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017007.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SNUhES49
AC   CVCL_B3VC
DR   Wikidata; Q110433250
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12017008.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SNUhES5
AC   CVCL_B999
SY   SNUhES 5; Kor-hES18
DR   Wikidata; Q54955337
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010007.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUhES6
AC   CVCL_C000
SY   SNUhES 6; Kor-hES19
DR   Wikidata; Q54955338
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010008.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUhES7
AC   CVCL_C001
SY   SNUhES 7; Kor-hES20
DR   Wikidata; Q54955339
RX   PubMed=24159464;
CC   From: Seoul National University; Seoul; South Korea.
CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010009.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SNUOT-Rb1
AC   CVCL_6210
SY   SNUOT-RB1
DR   BTO; BTO_0003759
DR   Wikidata; Q54955340
RX   PubMed=17671685;
RX   PubMed=18799932;
CC   Population: Korean.
CC   Doubling time: 24 hours (PubMed=17671685).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   SNUOT-Rb4
AC   CVCL_IQ57
SY   SNUOT-RB4
DR   Wikidata; Q54955341
RX   PubMed=18799932;
CC   Population: Korean.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   SO-4
AC   CVCL_VN48
SY   SO4
DR   Cosmic; 2765437
DR   IARC_TP53; 26996
DR   Wikidata; Q98132795
RX   PubMed=7803265;
RX   PubMed=9172809;
RX   PubMed=9596675;
RX   PubMed=10190897;
RX   PubMed=10863977;
RX   PubMed=12207908;
RX   PubMed=15638862;
RX   PubMed=19220422;
RX   PubMed=19710698;
RX   PubMed=27193821;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223His (c.668C>A); Zygosity=Unspecified (PubMed=19710698; PubMed=19220422).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Caution: It is uncertain if cell line SD-4 (Cellosaurus=CVCL_0G04) is not a misspelling of SO-4.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   So-G1-1
AC   CVCL_C4R6
DR   Wikidata; Q116050520
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-G2a-1
AC   CVCL_C4R7
DR   Wikidata; Q116050521
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-G2a-2
AC   CVCL_C4R8
DR   Wikidata; Q116050522
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-G2b-1
AC   CVCL_C4R9
DR   Wikidata; Q116050523
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-G3-1
AC   CVCL_C4RA
DR   Wikidata; Q116050524
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-G3-2
AC   CVCL_C4RB
DR   Wikidata; Q116050525
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-G3-3
AC   CVCL_C4RC
DR   Wikidata; Q116050526
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   So-M-1
AC   CVCL_C4RD
DR   Wikidata; Q116050527
RX   PubMed=3657786;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_9195; Soman.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   SO-MI
AC   CVCL_4764
DR   Wikidata; Q54955342
RX   PubMed=12772193;
CC   Population: Japanese.
CC   Doubling time: 52-72 hours (PubMed=12772193).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C6766; Prostate small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   SO-Rb50
AC   CVCL_D543
SY   SO-RB50; So-Rb50; SO-Rb 50; Sun Yat-sen university Ophtalmic center-Retinoblastoma 50
DR   EFO; EFO_0022681
DR   Wikidata; Q54955344
RX   CelloPub=CLPUB00236;
RX   PubMed=2086157;
RX   PubMed=8253182;
RX   PubMed=9639853;
RX   PubMed=11877168;
CC   Population: Chinese.
CC   Doubling time: 44.32 hours (CelloPub=CLPUB00236).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M3W
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   SO-Rb50/CBP
AC   CVCL_0U08
DR   Wikidata; Q54955345
RX   CelloPub=CLPUB00236;
CC   Population: Chinese.
CC   Doubling time: 50.9 hours (CelloPub=CLPUB00236).
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D543 ! SO-Rb50
SX   Female
AG   1M3W
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   SO-Rb70
AC   CVCL_W459
SY   Sun Yat-sen university Ophtalmic center-Retinoblastoma 70
DR   Wikidata; Q54955346
RX   PubMed=9639853;
RX   PubMed=11877168;
RX   PubMed=12580037;
CC   Population: Chinese.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   SOB-15
AC   CVCL_6447
DR   BTO; BTO_0005474
DR   CLO; CLO_0009106
DR   ATCC; CRL-2301
DR   Wikidata; Q54955348
RX   PubMed=7543343;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Shasta.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   SOCS3-/- ESC
AC   CVCL_AW04
SY   SOCS-3-Null ES Cells
DR   Wikidata; Q54955349
RX   PubMed=16123385;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1201791; Socs3.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 7
//
ID   SODk1
AC   CVCL_6448
SY   SODK1; SODK1293
DR   CLO; CLO_0009107
DR   ATCC; CRL-12386
DR   Wikidata; Q54955351
RX   Patent=US6218181;
RX   PubMed=9847362;
CC   Group: Patented cell line.
CC   Group: Retrovirus packaging cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12386.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: ATCC; CRL-12386; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-12386
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9
ST   D5S818: 8,9
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SOE00363IN
AC   CVCL_E206
DR   Wikidata; Q54955352
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   SOE00364IN
AC   CVCL_E207
DR   Wikidata; Q54955362
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   SOE00365IN
AC   CVCL_E208
DR   Wikidata; Q54955363
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   SOE00366IN
AC   CVCL_E209
DR   Wikidata; Q54955364
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   SOE00367IN
AC   CVCL_E210
DR   Wikidata; Q54955366
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   SOE00368IN
AC   CVCL_E211
DR   Wikidata; Q54955367
WW   Provider; INPRIMAT; -; http://www.biologia.uniba.it/primates/cell_lines.html
CC   Group: Non-human primate cell line.
CC   Part of: INPRIMAT consortium primate cell line collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   Sog9
AC   CVCL_D242
SY   sog9
DR   CCLV; CCLV-RIE 0297
DR   Wikidata; Q54955368
RX   PubMed=7745676;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D241 ! Gro2C
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   SOgE
AC   CVCL_Y592
DR   Wikidata; Q54955369
RX   PubMed=12124462;
RX   PubMed=25903999;
CC   Group: Bird cell line.
CC   Group: Vaccine production cell line.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C134950; Quail fibrosarcoma
OX   NCBI_TaxID=93934; ! Coturnix japonica (Japanese quail)
HI   CVCL_3450 ! QM7
SX   Sex unspecified
AG   1-3W
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 15
//
ID   SOJ
AC   CVCL_B464
DR   Wikidata; Q54955370
RX   PubMed=2083222;
CC   Population: Japanese.
CC   Doubling time: 50-70 hours (PubMed=2083222).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   SOJ-3
AC   CVCL_WI59
DR   Wikidata; Q98132796
RX   PubMed=2083222;
CC   Population: Japanese.
CC   Doubling time: 50-70 hours (PubMed=2083222).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B464 ! SOJ
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SOJ-4
AC   CVCL_WI60
DR   Wikidata; Q98132798
RX   PubMed=2083222;
CC   Population: Japanese.
CC   Doubling time: 70-90 hours (PubMed=2083222).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B464 ! SOJ
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SOJ-6
AC   CVCL_B465
DR   Wikidata; Q54955372
RX   PubMed=2083222;
CC   Population: Japanese.
CC   Doubling time: 40-50 hours (PubMed=2083222).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B464 ! SOJ
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   SOL,CA
AC   CVCL_E832
SY   SOL, CA
DR   dbMHC; 49023
DR   ECACC; 94082252
DR   IHW; IHW09152
DR   IPD-IMGT/HLA; 11695
DR   Wikidata; Q54955373
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*11,33; B*50:01,55; C*03:03; DPB1*02:02,03:01; DQA1*05:01,02:01; DQB1*02:01; DRB1*03:01,07:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11695).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Sol8
AC   CVCL_6449
SY   sol8; Soleus clone 8
DR   CLO; CLO_0009108
DR   ATCC; CRL-2174
DR   BCRC; 60512
DR   Wikidata; Q54955375
RX   PubMed=2456580;
RX   PubMed=2894633;
RX   PubMed=11162846;
RX   PubMed=35682977;
CC   Characteristics: Will differentiate into myotubes with serum deprivation (ATCC=CRL-2174).
CC   Doubling time: ~16-18 hours (ATCC=CRL-2174).
CC   Derived from site: In situ; Leg, skeletal muscle, soleus; UBERON=UBERON_0001389.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4W
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   Sol8 Gaa DeltaATG_14
AC   CVCL_F1BB
RX   PubMed=35682977;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95609; Gaa.
CC   Derived from site: In situ; Leg, skeletal muscle, soleus; UBERON=UBERON_0001389.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6449 ! Sol8
SX   Sex unspecified
AG   4W
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Sol8 Gaa E2_1
AC   CVCL_F1BC
RX   PubMed=35682977;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95609; Gaa (Note=Mutated in exon 2, produces a truncated protein).
CC   Derived from site: In situ; Leg, skeletal muscle, soleus; UBERON=UBERON_0001389.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6449 ! Sol8
SX   Sex unspecified
AG   4W
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Sol8 Gaa E5_6
AC   CVCL_F1BD
RX   PubMed=35682977;
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95609; Gaa (Note=Mutated in exon 5, produces a truncated protein).
CC   Derived from site: In situ; Leg, skeletal muscle, soleus; UBERON=UBERON_0001389.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6449 ! Sol8
SX   Sex unspecified
AG   4W
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Sol8 Gaa E7_1
AC   CVCL_F1BE
RX   PubMed=35682977;
CC   Sequence variation: Mutation; MGI; MGI:95609; Gaa; Simple_edited; p.Arg393_Thr394del (c.1177_1182del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=35682977).
CC   Derived from site: In situ; Leg, skeletal muscle, soleus; UBERON=UBERON_0001389.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6449 ! Sol8
SX   Sex unspecified
AG   4W
CA   Finite cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SOM 157d
AC   CVCL_C8VM
SY   157d
DR   Wikidata; Q123033547
RX   PubMed=20960562;
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   SOM 196b
AC   CVCL_C8VN
SY   SOM-196b; 196b
DR   Wikidata; Q123033548
RX   PubMed=12036969;
RX   PubMed=20960562;
RX   PubMed=29853780;
CC   Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SOM-4D10
AC   CVCL_2198
DR   CLO; CLO_0009109
DR   DSMZ; ACC-480
DR   DSMZCellDive; ACC-480
DR   Wikidata; Q54955376
CC   Doubling time: ~20-30 hours (DSMZ=ACC-480).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   SoMG
AC   CVCL_A1VT
SY   Sitophilus Oryzae MidGut
DR   Wikidata; Q105511109
RX   PubMed=33146860;
CC   Group: Insect cell line.
CC   Doubling time: 72.3 +- 4.3 hours (PubMed=33146860).
CC   Derived from site: In situ; Midgut; UBERON=UBERON_0001045.
OX   NCBI_TaxID=7048; ! Sitophilus oryzae (Rice weevil)
SX   Male
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   Sora
AC   CVCL_WH26
DR   Wikidata; Q98132799
RX   PubMed=28283079;
RX   PubMed=30246405;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   SORMi001-A
AC   CVCL_RX15
SY   PhiPSC
DR   hPSCreg; SORMi001-A
DR   Wikidata; Q54955377
RX   PubMed=29291511;
CC   From: School of Regenerative Medicine, Manipal University; Bengaluru; India.
CC   Population: Indian.
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
CC   Cell type: Mesenchymal stem cell; CL=CL_0000134.
ST   Source(s): PubMed=29291511
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D10S1248: 16
ST   D12S391: 18,22
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 12,13
ST   D19S433: 13
ST   D21S11: 30
ST   D22S1045: 15
ST   D2S1338: 18,24
ST   D2S441: 11,12
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 14,18
ST   FGA: 19,23
ST   SE33: 19,20.2
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   SORMi002-A
AC   CVCL_XI82
DR   hPSCreg; SORMi002-A
DR   SKIP; SKIP005558
DR   Wikidata; Q98132800
RX   PubMed=31454679;
CC   From: School of Regenerative Medicine, Manipal University; Bengaluru; India.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   SOSP-9607
AC   CVCL_4V80
DR   EFO; EFO_0022623
DR   Wikidata; Q54955378
RX   PubMed=20016965;
RX   PubMed=25017716;
CC   Population: Chinese.
CC   Doubling time: 29.79 +- 0.57 hours (PubMed=25017716).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 9
//
ID   SOSP-9607/CDDP
AC   CVCL_4V81
DR   Wikidata; Q54955379
RX   PubMed=25017716;
CC   Population: Chinese.
CC   Doubling time: 45.11 +- 2.37 hours (PubMed=25017716).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V80 ! SOSP-9607
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   SOSP-9607/F4
AC   CVCL_4V82
SY   F4
DR   Wikidata; Q54955381
RX   PubMed=20016965;
CC   Population: Chinese.
CC   Doubling time: 31 +- 3 hours (PubMed=20016965).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V80 ! SOSP-9607
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   SOSP-9607/F5M2
AC   CVCL_4V83
SY   F5M2
DR   Wikidata; Q54955382
RX   PubMed=20016965;
CC   Population: Chinese.
CC   Doubling time: 20 +- 2 hours (PubMed=20016965).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4V80 ! SOSP-9607
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   SP
AC   CVCL_C4PJ
DR   Wikidata; Q116050528
RX   PubMed=198669;
RX   PubMed=2580779;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_194097; 3,5-dinitro-4-hydroxyphenylacetic acid (NNP).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   SP+
AC   CVCL_1Y11
SY   SP (HTLV); SP
DR   BEI_Resources; ARP-3059
DR   Wikidata; Q54955383
RX   PubMed=7564472;
RX   PubMed=8105609;
RX   PubMed=12920029;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Donor information: Established from a patient suffering from adult T-cell leukemia/lymphoma (ATLL).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 11
//
ID   SP-01-CL
AC   CVCL_E5GM
RX   PubMed=37798904;
CC   Population: Caucasian; Spanish.
CC   Characteristics: Tumorigenic (PubMed=37798904).
CC   Doubling time: 1.53 days (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple; p.Arg612Trp (c.1834C>T); Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Heterozygous (PubMed=37798904).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GN ! SP-01-OT-CL
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SP-01-OT-CL
AC   CVCL_E5GN
RX   PubMed=37798904;
CC   Population: Caucasian; Spanish.
CC   Characteristics: Established from the athymic nude mice SP-01-OT orthotopic xenograft (PubMed=37798904).
CC   Doubling time: 2.72 days (PubMed=37798904).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple; p.Arg612Trp (c.1834C>T); Zygosity=Heterozygous (PubMed=37798904).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Heterozygous (PubMed=37798904).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GM ! SP-01-CL
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SP-1
AC   CVCL_R987
SY   Silver Perch-1
DR   Wikidata; Q54955384
RX   PubMed=407147;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 26 Celsius (PubMed=407147).
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=331523; ! Bairdiella chrysoura (Silver perch)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 10
//
ID   SP-2 [Bairdiella]
AC   CVCL_R988
SY   Silver Perch-2
DR   Wikidata; Q54955385
RX   DOI=10.1007/BF02618106;
RX   DOI=10.2307/1444537;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 26 Celsius (DOI=10.1007/BF02618106).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=331523; ! Bairdiella chrysoura (Silver perch)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 11
//
ID   SP-2 [Mouse hybridoma against human LGALS3BP]
AC   CVCL_B5AD
DR   Wikidata; Q110433251
RX   PubMed=3516389;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q08380; Human LGALS3BP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SP-49
AC   CVCL_D022
SY   Sp-49; SP49
DR   cancercelllines; CVCL_D022
DR   Cosmic; 1070709
DR   Cosmic; 2296991
DR   GEO; GSM115806
DR   GEO; GSM1266773
DR   GEO; GSM1266774
DR   Progenetix; CVCL_D022
DR   Wikidata; Q54955386
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3121553;
RX   PubMed=9738977;
RX   PubMed=16960149;
RX   PubMed=19358282;
RX   PubMed=24362935;
RX   PubMed=25960936;
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=3121553).
CC   HLA typing: A*02:06,24:02; B*56:01,40:02; C*04:01,03:04; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*04:05,08:02 (PubMed=25960936).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C121 ! SP-50B
OI   CVCL_M655 ! SP-52EB
OI   CVCL_C122 ! SP-53
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   SP-50B
AC   CVCL_C121
DR   Wikidata; Q54955387
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2548699;
RX   PubMed=8971032;
RX   PubMed=11061568;
CC   Population: Japanese.
CC   Virology: Contains an EBV genome in a circular episomal form.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D022 ! SP-49
OI   CVCL_M655 ! SP-52EB
OI   CVCL_C122 ! SP-53
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SP-52EB
AC   CVCL_M655
SY   SP-52-EB
DR   Wikidata; Q54955388
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2548699;
RX   PubMed=8971032;
RX   PubMed=9738977;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D022 ! SP-49
OI   CVCL_C121 ! SP-50B
OI   CVCL_C122 ! SP-53
SX   Female
AG   58Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   SP-53
AC   CVCL_C122
SY   SP53; DBsp53; DB-sp53
DR   cancercelllines; CVCL_C122
DR   Cosmic; 1070710
DR   Cosmic; 2296998
DR   GEO; GSM119539
DR   Progenetix; CVCL_C122
DR   Wikidata; Q54955389
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2548699;
RX   PubMed=8971032;
RX   PubMed=9738977;
RX   PubMed=11061568;
RX   PubMed=12683869;
RX   PubMed=16960149;
RX   PubMed=26194763;
RX   PubMed=29666304;
CC   Population: Japanese.
CC   Doubling time: 57 hours (PubMed=11061568).
CC   HLA typing: A*02,24; B*40,56; C*03,04 (Direct_author_submission).
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D022 ! SP-49
OI   CVCL_C121 ! SP-50B
OI   CVCL_M655 ! SP-52EB
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   SP-53 EBV-infected
AC   CVCL_UW48
SY   EBV-carrying SP53
DR   Wikidata; Q98132802
RX   PubMed=11061568;
CC   Population: Japanese.
CC   Doubling time: 73 hours (PubMed=11061568).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C122 ! SP-53
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 7
//
ID   SP-6.5
AC   CVCL_7997
SY   SP 6.5; SP6.5; SP6_5
DR   BTO; BTO_0002737
DR   cancercelllines; CVCL_7997
DR   Cosmic; 986620
DR   Cosmic; 1628411
DR   Wikidata; Q54955390
RX   PubMed=9154388;
RX   PubMed=10892885;
RX   PubMed=15645125;
RX   PubMed=15714118;
RX   PubMed=17487557;
RX   PubMed=22236444;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=22236444).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SP-8.0
AC   CVCL_W928
SY   SP8.0
DR   Wikidata; Q54955391
RX   PubMed=10892885;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   Sp-E-HNU11
AC   CVCL_0A19
DR   ICLDB; sp-e-hnu11
DR   Wikidata; Q54955392
RX   DOI=10.16380/j.kcxb.2011.05.007;
CC   Group: Insect cell line.
CC   Doubling time: 42 hours (DOI=10.16380/j.kcxb.2011.05.007).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7386; ! Sarcophaga peregrina (Flesh fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SP-R
AC   CVCL_0I80
DR   CCLV; CCLV-RIE 0279
DR   Wikidata; Q54955393
RX   PubMed=25565633;
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   SP01.1
AC   CVCL_RI42
DR   SKIP; SKIP000936
DR   Wikidata; Q54955394
RX   PubMed=22407749;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI43 ! SP01.4
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   SP01.4
AC   CVCL_RI43
DR   SKIP; SKIP000937
DR   Wikidata; Q54955395
RX   PubMed=22407749;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI42 ! SP01.1
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   SP02.1
AC   CVCL_V201
SY   SP02#1; ESi001-A
DR   BioSamples; SAMEA3302942
DR   EBiSC; ESi001-A
DR   ECACC; 66540063
DR   hPSCreg; ESi001-A
DR   SKIP; SKIP000938
DR   SKIP; SKIP002419
DR   Wikidata; Q54955397
RX   PubMed=22407749;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/pdf_SP_2_1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_SP02_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Discontinued: ECACC; 66540063; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI45 ! SP02.2
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   SP02.2
AC   CVCL_RI45
DR   SKIP; SKIP000939
DR   Wikidata; Q54955398
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V201 ! SP02.1
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP04.1
AC   CVCL_RI46
DR   SKIP; SKIP000940
DR   Wikidata; Q54955399
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI47 ! SP04.2
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP04.2
AC   CVCL_RI47
DR   SKIP; SKIP000941
DR   Wikidata; Q54955401
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI46 ! SP04.1
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP05.1
AC   CVCL_RI48
DR   SKIP; SKIP000951
DR   Wikidata; Q54955402
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI49 ! SP05.2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP05.2
AC   CVCL_RI49
DR   SKIP; SKIP000952
DR   Wikidata; Q54955403
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI48 ! SP05.1
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP06.1
AC   CVCL_RI50
DR   SKIP; SKIP000953
DR   Wikidata; Q54955404
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI51 ! SP06.2
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP06.2
AC   CVCL_RI51
DR   SKIP; SKIP000954
DR   Wikidata; Q54955405
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI50 ! SP06.1
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP08.1
AC   CVCL_V202
SY   SP08#1; ESi002-A
DR   BioSamples; SAMEA3303008
DR   EBiSC; ESi002-A
DR   ECACC; 66540067
DR   hPSCreg; ESi002-A
DR   SKIP; SKIP000942
DR   SKIP; SKIP002420
DR   Wikidata; Q54955406
RX   PubMed=22407749;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/pdf_SP_8_1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_SP08_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Discontinued: ECACC; 66540067; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI53 ! SP08.2
OI   CVCL_RI54 ! SP08.3
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 17
//
ID   SP08.2
AC   CVCL_RI53
DR   SKIP; SKIP000943
DR   Wikidata; Q54955407
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V202 ! SP08.1
OI   CVCL_RI54 ! SP08.3
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP08.3
AC   CVCL_RI54
DR   SKIP; SKIP000944
DR   Wikidata; Q54955412
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V202 ! SP08.1
OI   CVCL_RI53 ! SP08.2
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP09.2
AC   CVCL_RI55
DR   SKIP; SKIP000929
DR   Wikidata; Q54955413
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI56 ! SP09.4
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP09.4
AC   CVCL_RI56
DR   SKIP; SKIP000926
DR   Wikidata; Q54955414
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI55 ! SP09.2
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP1
AC   CVCL_AZ65
SY   SPI
DR   Wikidata; Q54955438
RX   PubMed=1317363;
RX   PubMed=3191495;
CC   Breed/subspecies: CBA/J.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 4
//
ID   SP1-3M
AC   CVCL_AZ66
DR   Wikidata; Q54955439
RX   PubMed=1317363;
CC   Caution: Could be identical to AC2M2 (Cellosaurus=CVCL_AZ67).
CC   Breed/subspecies: CBA/J.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AZ65 ! SP1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 4
//
ID   SP1.D8
AC   CVCL_C7H5
DR   DSHB; SP1-D8
DR   Wikidata; Q117704894
RX   PubMed=6190652;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5P481; Sheep COL1A1 (Note=Also reacts with bovine, human and chicken).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 3
//
ID   Sp1/7-2
AC   CVCL_A6PE
SY   Sp-1/7-2
DR   Wikidata; Q107116952
RX   PubMed=825377;
RX   PubMed=1172191;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
CC   Anecdotal: Together with Sp2/3-3 (Cellosaurus=CVCL_A6PD) these are the first hybridomas to have been created.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Sp1/HL
AC   CVCL_A6PF
SY   SP1-HL
DR   Wikidata; Q107116953
RX   PubMed=825377;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6PE ! Sp1/7-2
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   SP10
AC   CVCL_D6TF
RX   PubMed=7685234;
RX   PubMed=11884350;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P23763; Human VAMP1.
CC   Monoclonal antibody target: UniProtKB; P63027; Human VAMP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP10.1
AC   CVCL_RI57
DR   SKIP; SKIP000945
DR   Wikidata; Q54955415
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI58 ! SP10.2
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP10.2
AC   CVCL_RI58
DR   SKIP; SKIP000946
DR   Wikidata; Q54955417
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI57 ! SP10.1
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP11
AC   CVCL_D6TG
RX   PubMed=7685234;
RX   PubMed=10334480;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P23763; Human VAMP1.
CC   Monoclonal antibody target: UniProtKB; P63027; Human VAMP2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP11.1
AC   CVCL_RI59
SY   SP11#1; ESi081-A
DR   BioSamples; SAMEA7178022
DR   hPSCreg; ESi081-A
DR   SKIP; SKIP000927
DR   Wikidata; Q54955418
RX   PubMed=22407749;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento%2520de%2520Deposito_SP11-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_deposito_SP11-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D21S11: 28,30
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9,9.3
ST   TPOX: 10,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI60 ! SP11.4
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   SP11.4
AC   CVCL_RI60
DR   SKIP; SKIP000928
DR   Wikidata; Q54955420
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI59 ! SP11.1
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP12
AC   CVCL_D6TH
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=Isoforms SNAP-25a and SNAP-25b. Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP12.3
AC   CVCL_RI61
DR   SKIP; SKIP000955
DR   Wikidata; Q54955421
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI62 ! SP12.4
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP12.4
AC   CVCL_RI62
DR   SKIP; SKIP000956
DR   Wikidata; Q54955423
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI61 ! SP12.3
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP13.2
AC   CVCL_RI63
DR   SKIP; SKIP000957
DR   Wikidata; Q54955424
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V203 ! SP13.4
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   SP13.4
AC   CVCL_V203
AS   CVCL_RI64
SY   SP13#4; ESi006-A
DR   BioSamples; SAMEA3303225
DR   EBiSC; ESi006-A
DR   ECACC; 66540068
DR   hPSCreg; ESi006-A
DR   SKIP; SKIP000958
DR   SKIP; SKIP002423
DR   Wikidata; Q54955440
RX   PubMed=22407749;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/pdf_SP_13_4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexos_SP13_4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=22407749).
CC   Discontinued: ECACC; 66540068; true.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI63 ! SP13.2
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 21
//
ID   SP14
AC   CVCL_D6TI
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P60880; Human SNAP25 (Note=Isoforms SNAP-25a and SNAP-25b. Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP14.1
AC   CVCL_RI65
DR   SKIP; SKIP000947
DR   Wikidata; Q54955428
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI66 ! SP14.2
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP14.2
AC   CVCL_RI66
DR   SKIP; SKIP000948
DR   Wikidata; Q54955429
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI65 ! SP14.1
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP15
AC   CVCL_D6TJ
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP (Note=Also reacts with rat, hamster and pig).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP15.2
AC   CVCL_RI67
DR   SKIP; SKIP000930
DR   Wikidata; Q54955430
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI68 ! SP15.3
OI   CVCL_RI69 ! SP15.4
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP15.3
AC   CVCL_RI68
DR   SKIP; SKIP000931
DR   Wikidata; Q54955431
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI67 ! SP15.2
OI   CVCL_RI69 ! SP15.4
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP15.4
AC   CVCL_RI69
DR   SKIP; SKIP000932
DR   Wikidata; Q54955432
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI67 ! SP15.2
OI   CVCL_RI68 ! SP15.3
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP16
AC   CVCL_D6TK
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP16.2
AC   CVCL_RI70
DR   SKIP; SKIP000949
DR   Wikidata; Q54955433
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI71 ! SP16.3
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP16.3
AC   CVCL_RI71
DR   SKIP; SKIP000950
DR   Wikidata; Q54955434
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI70 ! SP16.2
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   SP17
AC   CVCL_D6TL
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP17.1
AC   CVCL_RI72
DR   SKIP; SKIP000933
DR   Wikidata; Q54955435
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI73 ! SP17.2
OI   CVCL_RI74 ! SP17.3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP17.2
AC   CVCL_RI73
DR   SKIP; SKIP000934
DR   Wikidata; Q54955436
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI72 ! SP17.1
OI   CVCL_RI74 ! SP17.3
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP17.3
AC   CVCL_RI74
DR   SKIP; SKIP000935
DR   Wikidata; Q54955437
RX   PubMed=22407749;
CC   From: Institut de Bioenginyeria de Catalunya (IBEC); Barcelona; Spain.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI72 ! SP17.1
OI   CVCL_RI73 ! SP17.2
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   SP18
AC   CVCL_D6TM
RX   PubMed=7685234;
RX   PubMed=9760144;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99719; Human SEPTIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP19
AC   CVCL_D6TN
RX   PubMed=7685234;
RX   PubMed=9760144;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99719; Human SEPTIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Sp1K
AC   CVCL_4304
SY   Sp1K (NBL-10); Sp 1 K (NBL-10); Sp 1 K; SP 1 K; Sp1.K; NBL-10
DR   CLO; CLO_0009110
DR   CLDB; cl4380
DR   ATCC; CCL-78
DR   ATCC; CRL-6262
DR   ECACC; 89120705
DR   Wikidata; Q54955441
RX   PubMed=6988327;
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CCL-78; true.
CC   Discontinued: ATCC; CRL-6262; true.
CC   Discontinued: ECACC; 89120705; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=103590; ! Stenella frontalis (Atlantic spotted dolphin)
SX   Male
AG   Adolescent
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   SP2/0 mIL-6 A9
AC   CVCL_F1LD
RX   PubMed=15345310;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Expresses high levels of mouse Il6 (PubMed=15345310).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96559; Il6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SP2/0 MP
AC   CVCL_F1LE
RX   PubMed=15345310;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Control cell line for SP2/0 mIL-6 A9 (Cellosaurus=CVCL_F1LD) (PubMed=15345310).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SP2/0-01-SPINK1-SUN
AC   CVCL_A0US
DR   CCRID; 4201PAT-CCTCC01311
DR   Wikidata; Q108821320
RX   Patent=WO2020073593A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018213.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P00995; Human SPINK1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SP2/0-02-AREG-SUN
AC   CVCL_B0UC
DR   CCRID; 4201PAT-CCTCC01312
DR   Wikidata; Q108821321
RX   Patent=WO2020073594A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2018214.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P15514; Human AREG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Sp2/0-Ag14
AC   CVCL_2199
SY   SP2/0-Ag14; SP2/0-AG14; SP2/0-ag14; Sp2/O-Ag14; SP2/O-Ag14; Sp2/0-Ag-14; SP2-0-Ag14; SP2/0 Ag-14; SP-2/0-AG14; Sp 2/0-Ag 14; SP2/0AG14; Sp2/0; SP2/0; Sp2/O; SP2/O; SP-2; SP2; GM03569; GM3569; GM03569B; GM3569B; GM03569D
DR   BTO; BTO_0002291
DR   CLO; CLO_0009112
DR   CLO; CLO_0009113
DR   CLO; CLO_0009114
DR   CLO; CLO_0009115
DR   CLO; CLO_0017241
DR   CLO; CLO_0050178
DR   CLDB; cl4382
DR   CLDB; cl4383
DR   CLDB; cl4384
DR   CLDB; cl4385
DR   CLDB; cl4386
DR   AddexBio; C0033005/4967
DR   ATCC; CRL-1581
DR   ATCC; CRL-8287
DR   BCRC; 60034
DR   BCRJ; 0227
DR   BioSample; SAMN11397630
DR   CCRID; 1101MOU-PUMC000054
DR   CCRID; 1102MOU-NIFDC00011
DR   CCRID; 3101MOUTCM18
DR   CCRID; 3101MOUTCM42
DR   CCRID; 4201MOU-CCTCC00019
DR   CCRID; 5301MOU-KCB92021YJ
DR   CCRID; 6101MOU-CERC000118
DR   CCTCC; GDC0019
DR   CLS; 400481
DR   Coriell; GM03569
DR   DSMZ; ACC-146
DR   DSMZCellDive; ACC-146
DR   ECACC; 85072401
DR   IBRC; C10106
DR   JCRB; JCRB9084
DR   KCB; KCB 92021YJ
DR   KCLB; 21581
DR   Lonza; 329
DR   NCBI_Iran; C129
DR   RCB; RCB0209
DR   TKG; TKG 0248
DR   Wikidata; Q54955446
RX   CelloPub=CLPUB00447;
RX   PubMed=714156;
RX   PubMed=1373425;
RX   PubMed=6769123;
RX   PubMed=31220119;
CC   Group: Hybridoma fusion partner cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8287.
CC   Doubling time: ~30-40 hours (DSMZ=ACC-146).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Misspelling: SP2/0-Ag15; Note=Occasionally.
CC   Misspelling: Sp20; PubMed=25723277.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,16,17
ST   Mouse STR 1-2: 16,17,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 13,14
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 17,18,19
ST   Mouse STR 6-7: 11,12
ST   Mouse STR 7-1: 26.2,28
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 15,16,17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3,23.3
ST   Mouse STR 17-2: 16,17
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 25
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   Sp2/0-Ag14 (serum free)
AC   CVCL_JX38
SY   SP2/0-Ag14 (AC-Free)
DR   ECACC; 08060101
DR   Wikidata; Q54955447
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   Sp2/0-Ag14 (serum-free Celox)
AC   CVCL_JX59
DR   ATCC; CRL-1581.1
DR   Wikidata; Q54955448
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Discontinued: ATCC; CRL-1581.1; true.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   Sp2/0-Ag14 hEPO
AC   CVCL_B0H2
DR   Wikidata; Q108821322
RX   DOI=10.1023/A:1018328801615;
CC   Characteristics: Produces human EPO with full in vitro biological activity, but low in vivo biological activity.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   Sp2/0-Ag14-K13
AC   CVCL_C4CP
SY   Sp2/0-Ag14-k13
DR   Wikidata; Q116050529
RX   PubMed=1279746;
RX   PubMed=8150984;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   Sp2/0-Ag14-Turbodoma
AC   CVCL_G697
DR   ECACC; 03092501
DR   Wikidata; Q54955449
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Serum/protein free medium cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   Sp2/01-Ag
AC   CVCL_6450
DR   CLO; CLO_0009111
DR   ATCC; CRL-8006
DR   Wikidata; Q54955450
CC   Group: Hybridoma fusion partner cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8006.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   Sp2/08A2
AC   CVCL_J171
SY   SP2/08A2; Sp2/08AZ; SP2/08AZ
DR   Wikidata; Q54955451
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   Sp2/3-3
AC   CVCL_A6PD
SY   Sp-2/3-3
DR   Wikidata; Q107116954
RX   PubMed=825377;
RX   PubMed=1172191;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
CC   Anecdotal: Together with Sp1/7-2 (Cellosaurus=CVCL_A6PE) these are the first hybridomas to have been created.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   Sp2/5
AC   CVCL_D037
DR   Wikidata; Q54955452
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   Sp2/HL
AC   CVCL_VT73
SY   Sp 2/HL
DR   Wikidata; Q98132803
RX   PubMed=825377;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6PD ! Sp2/3-3
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   Sp2/HL-BU
AC   CVCL_VT74
SY   Sp2HL/BU
DR   Wikidata; Q98132804
RX   PubMed=2108149;
RX   PubMed=6769123;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_VT73 ! Sp2/HL
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 4
//
ID   Sp2/mIL-6
AC   CVCL_C561
SY   Sp2/MIL6; SP2-IL6
DR   CLO; CLO_0009116
DR   ATCC; CRL-2016
DR   Wikidata; Q54955453
RX   PubMed=1373425;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96559; Il6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 17
//
ID   Sp2/mIL-6 (hTERT)
AC   CVCL_F1LF
SY   Sp2/mIL-6 MPT
RX   PubMed=15345310;
RX   PubMed=18514220;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:96559; Il6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C561 ! Sp2/mIL-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Sp2/neo
AC   CVCL_B0G8
DR   Wikidata; Q108821323
RX   PubMed=1373425;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 8
//
ID   SP20
AC   CVCL_D6TP
RX   PubMed=7685234;
RX   PubMed=9760144;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q99719; Human SEPTIN5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP212
AC   CVCL_WN80
DR   Wikidata; Q98132805
RX   PubMed=28965766;
CC   Sequence variation: Mutation; HGNC; HGNC:10801; SFTPB; Simple; p.Pro121Glufs*95 (c.361delCinsGAA) (121ins2); ClinVar=VCV000013201; Zygosity=Homozygous (PubMed=28965766).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99068; Pulmonary surfactant metabolism dysfunction-1
DI   ORDO; Orphanet_217563; Neonatal acute respiratory distress due to SP-B deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   SP212Corr
AC   CVCL_WN81
DR   Wikidata; Q98132806
RX   PubMed=28965766;
CC   Sequence variation: Mutation; HGNC; HGNC:10801; SFTPB; Simple_corrected; p.Pro121Glufs*95 (c.361delCinsGAA) (121ins2); ClinVar=VCV000013201; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=28965766).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99068; Pulmonary surfactant metabolism dysfunction-1
DI   ORDO; Orphanet_217563; Neonatal acute respiratory distress due to SP-B deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN80 ! SP212
SX   Female
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   Sp2ab
AC   CVCL_Z067
SY   SP2ab
DR   Wikidata; Q54955443
RX   PubMed=19187782;
WW   Provider; Enzo; ENZ-70008-0001; https://web.archive.org/web/20210128031238/http://www.enzolifesciences.com/ENZ-70008/sp2ab-myeloma-fusion-partner/
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Discontinued: Enzo; Catalog number ENZ-70008-0001.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   SP3
AC   CVCL_D6T9
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP3006
AC   CVCL_VB92
DR   ECACC; 15103005
DR   Wikidata; Q54955454
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3033
AC   CVCL_VB93
DR   ECACC; 15103006
DR   Wikidata; Q54955455
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3063
AC   CVCL_VB94
DR   ECACC; 15103007
DR   Wikidata; Q54955456
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3068
AC   CVCL_VB95
DR   ECACC; 15082827
DR   Wikidata; Q54955457
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3070
AC   CVCL_VB96
DR   ECACC; 15103008
DR   Wikidata; Q54955459
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85026; Progressive bulbar palsy
DI   ORDO; Orphanet_206707; Bulbospinal muscular atrophy of adult
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3089
AC   CVCL_VB97
DR   ECACC; 15103009
DR   Wikidata; Q54955460
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3118
AC   CVCL_VB98
DR   ECACC; 15103010
DR   Wikidata; Q54955467
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3127
AC   CVCL_VB99
DR   ECACC; 15103011
DR   Wikidata; Q54955468
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3148
AC   CVCL_VC00
DR   ECACC; 15082828
DR   Wikidata; Q54955469
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3154
AC   CVCL_VC01
DR   ECACC; 15082829
DR   Wikidata; Q54955470
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3202
AC   CVCL_VC02
DR   ECACC; 15103012
DR   Wikidata; Q54955471
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3216
AC   CVCL_VC03
DR   ECACC; 15082830
DR   Wikidata; Q54955472
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3218
AC   CVCL_VC04
DR   ECACC; 15082831
DR   Wikidata; Q54955473
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3277
AC   CVCL_VC05
DR   ECACC; 15082832
DR   Wikidata; Q54955474
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3303
AC   CVCL_VC06
DR   ECACC; 15082833
DR   Wikidata; Q54955475
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3325
AC   CVCL_VC07
DR   ECACC; 15103013
DR   Wikidata; Q54955476
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3331
AC   CVCL_VC08
DR   ECACC; 15082834
DR   Wikidata; Q54955477
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3462
AC   CVCL_VC09
DR   ECACC; 15103014
DR   Wikidata; Q54955478
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3474
AC   CVCL_VC10
DR   ECACC; 15082835
DR   Wikidata; Q54955479
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3508
AC   CVCL_VC11
DR   ECACC; 15103015
DR   Wikidata; Q54955481
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3526
AC   CVCL_VC12
DR   ECACC; 15082836
DR   Wikidata; Q54955482
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3528
AC   CVCL_VC13
DR   ECACC; 15082837
DR   Wikidata; Q54955483
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3534
AC   CVCL_VC14
DR   ECACC; 15103016
DR   Wikidata; Q54955484
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3547
AC   CVCL_VC15
DR   ECACC; 15082838
DR   Wikidata; Q54955486
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3560
AC   CVCL_VC16
DR   ECACC; 15103017
DR   Wikidata; Q54955487
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3590
AC   CVCL_VC17
DR   ECACC; 15082839
DR   Wikidata; Q54955488
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3610
AC   CVCL_VC18
DR   ECACC; 15103018
DR   Wikidata; Q54955489
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3643
AC   CVCL_VC19
DR   ECACC; 15103019
DR   Wikidata; Q54955490
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3650
AC   CVCL_VC20
DR   ECACC; 15103020
DR   Wikidata; Q54955491
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3659
AC   CVCL_VC21
DR   ECACC; 15082840
DR   Wikidata; Q54955493
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3668
AC   CVCL_VC22
DR   ECACC; 15103021
DR   Wikidata; Q54955494
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3670
AC   CVCL_VC23
DR   ECACC; 15103022
DR   Wikidata; Q54955495
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3702
AC   CVCL_VC24
DR   ECACC; 15103023
DR   Wikidata; Q54955496
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3769
AC   CVCL_VC25
DR   ECACC; 15082841
DR   Wikidata; Q54955497
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3779
AC   CVCL_VC26
DR   ECACC; 15103024
DR   Wikidata; Q54955498
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3783
AC   CVCL_VC27
DR   ECACC; 15103025
DR   Wikidata; Q54955499
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP3796
AC   CVCL_VC28
DR   ECACC; 15103026
DR   Wikidata; Q54955500
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SP4
AC   CVCL_D6TA
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP5
AC   CVCL_D6TB
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16623; Human STX1A (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP6
AC   CVCL_D6TC
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16623; Human STX1A (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP7
AC   CVCL_D6TD
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q16623; Human STX1A.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SP8
AC   CVCL_D6TE
RX   PubMed=7685234;
RX   PubMed=9135092;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q16623; Human STX1A (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6972 ! FO [Mouse myeloma]
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SPA255-22
AC   CVCL_6G03
DR   Wikidata; Q54955501
RX   PubMed=205873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G04 ! SPA255-23
OI   CVCL_6G05 ! SPA255-24
OI   CVCL_6G06 ! SPA255-25
OI   CVCL_6G07 ! SPA255-26
OI   CVCL_6G08 ! SPA255-27
OI   CVCL_6G09 ! SPA255-28
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   SPA255-23
AC   CVCL_6G04
DR   Wikidata; Q54955502
RX   PubMed=205873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G03 ! SPA255-22
OI   CVCL_6G05 ! SPA255-24
OI   CVCL_6G06 ! SPA255-25
OI   CVCL_6G07 ! SPA255-26
OI   CVCL_6G08 ! SPA255-27
OI   CVCL_6G09 ! SPA255-28
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   SPA255-24
AC   CVCL_6G05
DR   Wikidata; Q54955505
RX   PubMed=205873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G03 ! SPA255-22
OI   CVCL_6G04 ! SPA255-23
OI   CVCL_6G06 ! SPA255-25
OI   CVCL_6G07 ! SPA255-26
OI   CVCL_6G08 ! SPA255-27
OI   CVCL_6G09 ! SPA255-28
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   SPA255-25
AC   CVCL_6G06
DR   Wikidata; Q54955506
RX   PubMed=205873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G03 ! SPA255-22
OI   CVCL_6G04 ! SPA255-23
OI   CVCL_6G05 ! SPA255-24
OI   CVCL_6G07 ! SPA255-26
OI   CVCL_6G08 ! SPA255-27
OI   CVCL_6G09 ! SPA255-28
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   SPA255-26
AC   CVCL_6G07
SY   SPA 255-26; SPA-26
DR   Wikidata; Q54955507
RX   PubMed=205873;
RX   PubMed=1327521;
RX   PubMed=6265484;
RX   PubMed=6603411;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G03 ! SPA255-22
OI   CVCL_6G04 ! SPA255-23
OI   CVCL_6G05 ! SPA255-24
OI   CVCL_6G06 ! SPA255-25
OI   CVCL_6G08 ! SPA255-27
OI   CVCL_6G09 ! SPA255-28
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   SPA255-27
AC   CVCL_6G08
DR   Wikidata; Q54955509
RX   PubMed=205873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G03 ! SPA255-22
OI   CVCL_6G04 ! SPA255-23
OI   CVCL_6G05 ! SPA255-24
OI   CVCL_6G06 ! SPA255-25
OI   CVCL_6G07 ! SPA255-26
OI   CVCL_6G09 ! SPA255-28
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   SPA255-28
AC   CVCL_6G09
DR   Wikidata; Q54955511
RX   PubMed=205873;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA255).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6G03 ! SPA255-22
OI   CVCL_6G04 ! SPA255-23
OI   CVCL_6G05 ! SPA255-24
OI   CVCL_6G06 ! SPA255-25
OI   CVCL_6G07 ! SPA255-26
OI   CVCL_6G08 ! SPA255-27
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   SPAC-1-L
AC   CVCL_IW47
SY   SPAC-1L; SPAC1L
DR   Wikidata; Q54955512
RX   PubMed=8063244;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 27.4 hours (PubMed=8063244).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW48 ! SPAC-1-S
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   SPAC-1-S
AC   CVCL_IW48
SY   SPAC-1S; SPAC1S
DR   Wikidata; Q54955513
RX   PubMed=8063244;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 66.5 hours (PubMed=8063244).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IW47 ! SPAC-1-L
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   SPACH
AC   CVCL_E833
SY   SPACHECO; SPL
DR   dbMHC; 49024
DR   dbMHC; 49026
DR   ECACC; 95042725
DR   IHW; IHW09072
DR   IHW; IHW09101
DR   IPD-IMGT/HLA; 11396
DR   IPD-IMGT/HLA; 11397
DR   Wikidata; Q54955518
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Native South American; Warao.
CC   HLA typing: A*31:01:02:01; B*15:01:01:01; C*01:02:30; DPA1*01:03:01:15; DPB1*04:02:01:02; DQA1*04:01:01:07; DQB1*04:02:01:04; DRA*01:02:02; DRB1*08:02:01:01 (IPD-IMGT/HLA=11396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Discontinued: ECACC; 95042725; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   SPAM-8
AC   CVCL_9V20
DR   Wikidata; Q54955519
RX   PubMed=1651784;
RX   PubMed=7590790;
RX   PubMed=7756584;
CC   Group: Hybridoma fusion partner cell line.
CC   Characteristics: Heteromyeloma produced by the fusion of Sp2/0-Ag14 mouse myeloma with human peripheral blood lymphocytes (PubMed=1651784).
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 7
//
ID   SPan-1
AC   CVCL_ZX66
SY   Span-1; Span 1; SPan1
DR   Wikidata; Q102114929
RX   PubMed=2454732;
RX   PubMed=3476183;
RX   PubMed=3821718;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human mucin-like antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   SPARKY
AC   CVCL_U015
DR   Wikidata; Q54955520
RX   Patent=US7220891;
RX   PubMed=12492292;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2919.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
DI   NCIt; C134559; Feline bronchioloalveolar lung carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 11
//
ID   SPAZ-4
AC   CVCL_JJ88
SY   SPAZ 4
DR   Wikidata; Q54955521
RX   PubMed=2032733;
RX   PubMed=6678802;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 5
//
ID   SPB
AC   CVCL_6E01
SY   Snubnose Pompano Brain
DR   Wikidata; Q43376820
RX   PubMed=20167281;
RX   PubMed=23305502;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by chum salmon virus (CSV), giant seaperch iridovirus (GSIV-K1) and red sea bream iridovirus (RSIV-Ku). Refractory to infection by grouper nervous necrosis virus (GNNV-K1) and eel herpesvirus (HVA) (PubMed=23305502).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   SPB/p35L-DsRed
AC   CVCL_YC96
DR   Wikidata; Q98132807
RX   PubMed=23305502;
CC   Group: Fish cell line.
CC   Characteristics: Transfected with GSIV ORF35L-RFP fusion transcript.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; L7YBE4; Giant seaperch iridovirus ORF35L.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
HI   CVCL_6E01 ! SPB
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   SPB/pEGFP-B1
AC   CVCL_YC97
DR   Wikidata; Q98132808
RX   PubMed=23305502;
CC   Group: Fish cell line.
CC   Characteristics: Transfected with GNNV-K1 protein B1-eGFP fusion transcript.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; L7YAM6; Redspotted grouper nervous necrosis virus protein B1.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
HI   CVCL_6E01 ! SPB
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   SPB/pEGFP-B2
AC   CVCL_YC98
DR   Wikidata; Q98132809
RX   PubMed=23305502;
CC   Group: Fish cell line.
CC   Characteristics: Transfected with GNNV-K1 protein B2-eGFP fusion transcript.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; L7Y5K1; Redspotted grouper nervous necrosis virus protein B2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
HI   CVCL_6E01 ! SPB
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 7
//
ID   SPC-A-1BM
AC   CVCL_YP05
DR   Wikidata; Q98132810
RX   PubMed=19324277;
CC   Problematic cell line: Contaminated. Parent cell line (SPC-A1) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Characteristics: Bone metastatic phenotype. Obtained after 8 serial passages of the parent cell line by injection into the left cardiac ventricle of NIH-Beige-Nude-XID immunodeficient mice and retrieval of the bone metastatic lesions.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6955 ! SPC-A1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   SPC-A1
AC   CVCL_6955
SY   SPC-A-1; SPCA-1; SPCA1
DR   BTO; BTO_0006512
DR   CCTCC; GDC0050
DR   Cosmic; 1515871
DR   Cosmic; 2664119
DR   TOKU-E; 3573
DR   Wikidata; Q54955522
RX   PubMed=22862169;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (CCRID; PubMed=26116706). Originally thought to be a lung adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00608.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Formerly the CCRID database had 3 entries describing this cell line (3111C0001CCC000387, 3131C0001000700053, 3142C0001000000050). They were one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   SPC-A1/DTX
AC   CVCL_W217
SY   SPC-A1/docetaxel
DR   Wikidata; Q54955523
RX   PubMed=22460125;
RX   PubMed=23035364;
CC   Problematic cell line: Contaminated. Parent cell line (SPC-A1) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6955 ! SPC-A1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   SPC-A4
AC   CVCL_1B41
DR   BTO; BTO_0006285
DR   ChEMBL-Cells; CHEMBL3307459
DR   ChEMBL-Targets; CHEMBL614938
DR   PubChem_Cell_line; CVCL_1B41
DR   Wikidata; Q54955524
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 6
//
ID   SPC-BM-36
AC   CVCL_Z327
SY   SPC BM 36; SPC Bm 36; SPC Bm-36; SPC-Bm36; S.P.C.Bm36; S.P.C. Bm36; S.P.C. Bm 36; SPCBm36; Bm36
DR   CLO; CLO_0009119
DR   CLDB; cl4388
DR   DSMZ; ACC-186
DR   DSMZCellDive; ACC-186
DR   NISES; SK0035
DR   Wikidata; Q54955525
RX   CelloPub=CLPUB00172;
RX   CelloPub=CLPUB00496;
RX   CelloPub=CLPUB00498;
RX   CelloPub=CLPUB00537;
RX   PubMed=3467322;
RX   PubMed=21335011;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Insect cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be from a Bombyx mori chrysalid but found to be from Spodoptera frugiperda (DSMZ=ACC-186).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00584.
CC   Doubling time: 72-80 hours (CelloPub=CLPUB00496); ~50-100 hours (DSMZ=ACC-186).
CC   Misspelling: SPC Bin36; Note=Occasionally.
CC   Discontinued: DSMZ; ACC-186; true.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   SPC-Gl-13
AC   CVCL_Z326
SY   SPC Gl 13
DR   Wikidata; Q29581166
RX   DOI=10.1007/BF02623290;
CC   Group: Insect cell line.
CC   Misspelling: SPC G1 13; Note=Occasionally.
CC   Derived from site: In situ; Dorsal vessel; UBERON=UBERON_0015231.
OX   NCBI_TaxID=231263; ! Gromphadorhina laevigata (Madagascar hissing cockroach)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 02-05-24; Version: 9
//
ID   SPC-Gm-17
AC   CVCL_A8KG
SY   SPC-Gm 17; SPC Gm 17
DR   Wikidata; Q108821324
RX   PubMed=12762839;
CC   Group: Insect cell line.
CC   Doubling time: 2.4 days (PubMed=12762839).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7137; ! Galleria mellonella (Greater wax moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   SPC-Ld-135
AC   CVCL_Z262
SY   SPC Ld 135; SC-LD 135; SCLd 135
DR   ICLDB; spc-ld-135
DR   Wikidata; Q54955527
RX   CelloPub=CLPUB00173;
RX   PubMed=8919823;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=13123; ! Lymantria dispar (Gypsy moth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SPC-Mb-92
AC   CVCL_VT61
SY   SPC-Mb 92; spc-mb92
DR   ICLDB; spc-mb-92
DR   Wikidata; Q98132811
RX   DOI=10.1016/B978-0-7506-1845-8.50054-5;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 8
//
ID   SPC-Mb-92-C6
AC   CVCL_VT62
SY   SPCMb-92-C6
DR   ICLDB; spc-mb-92-c6
DR   Wikidata; Q98132812
RX   PubMed=9837949;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=55057; ! Mamestra brassicae (Cabbage moth)
HI   CVCL_VT61 ! SPC-Mb-92
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   SPC-PL-40
AC   CVCL_Z324
SY   SPC-PL 40
DR   ICLDB; spc-pl-40
DR   Wikidata; Q54955528
RX   PubMed=8919823;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   SPC-PL-65
AC   CVCL_Z325
SY   SPC-PL 65; SPC PL65
DR   ICLDB; spc-pl-65
DR   Wikidata; Q54955530
RX   PubMed=8919823;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SPC-PL-65 P1
AC   CVCL_A2SY
SY   P1
DR   Wikidata; Q105511112
RX   PubMed=32659903;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by deformed wing virus (DWV).
CC   Doubling time: ~40 hours (PubMed=32659903).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
HI   CVCL_Z325 ! SPC-PL-65
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 6
//
ID   SPC-Sl-48
AC   CVCL_Z263
SY   SPC Sl 48; SPC SL-48
DR   ICLDB; spc-sl-48
DR   Wikidata; Q54955531
RX   DOI=10.1007/BF02372123;
CC   Group: Insect cell line.
CC   Doubling time: ~72 hours (DOI=10.1007/BF02372123).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Female
AG   Chrysalid
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SPC-Sl-52
AC   CVCL_Z264
SY   SPC Sl 52; SPC-SL 52; SPC-SL52
DR   ICLDB; spc-sl-52
DR   Wikidata; Q54955532
RX   DOI=10.1007/BF02372123;
RX   PubMed=8919823;
CC   Group: Insect cell line.
CC   Doubling time: ~48 hours (DOI=10.1007/BF02372123).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Female
AG   Chrysalid
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SPC111
AC   CVCL_D311
DR   ECACC; 11120716
DR   Wikidata; Q54955533
RX   PubMed=1373705;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 50 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=11120716
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   SPC212
AC   CVCL_D312
DR   ECACC; 11120717
DR   Wikidata; Q54955534
RX   PubMed=1373705;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 58 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): ECACC=11120717
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   SPC78
AC   CVCL_T736
DR   Wikidata; Q54955535
RX   PubMed=1373705;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 145 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   SPCC-OU1
AC   CVCL_T598
DR   Wikidata; Q54955536
RX   PubMed=6204901;
RX   PubMed=18766641;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   SPD-1-iChon
AC   CVCL_RJ23
DR   SKIP; SKIP001227
DR   Wikidata; Q54955537
RX   PubMed=25187577;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2200; COL2A1; Simple; p.Lys1447Cysfs*18 (c.4337dupG); Zygosity=Heterozygous (PubMed=25187577).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C135088; Spondyloperipheral dysplasia
DI   ORDO; Orphanet_1856; Spondyloperipheral dysplasia-short ulna syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JX72 ! GM11902
SX   Male
AG   2M2W
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   SPE
AC   CVCL_B5P4
SY   Snubnose Pompano Eye
DR   Wikidata; Q112041729
RX   PubMed=34609743;
CC   Group: Fish cell line.
CC   Doubling time: 34 hours (Note=At 72th passage) (PubMed=34609743).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SPE,G
AC   CVCL_E834
SY   SPE, G
DR   dbMHC; 49025
DR   ECACC; 94082235
DR   IHW; IHW09136
DR   IPD-IMGT/HLA; 11679
DR   Wikidata; Q54955538
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*11:01:01,30:02; B*18:01:01,35:01:01; C*04,05; DPB1*02:02,04:01; DQA1*01:01,05:01; DQB1*05:01:01,02:01; DRB1*01:01:01,03:01; DRB3*02:02 (IPD-IMGT/HLA=11679).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   SpEBr-5
AC   CVCL_JX60
SY   spEBR-5
DR   Wikidata; Q54955539
RX   PubMed=7900209;
RX   PubMed=14678650;
CC   Group: Hybridoma fusion partner cell line.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 6
//
ID   SPEC-1
AC   CVCL_A678
SY   SPEC1; Serous Papillary Endometrial Carcinoma-1
DR   Cosmic; 713491
DR   Wikidata; Q54955540
RX   PubMed=2722053;
CC   Population: African American.
CC   Doubling time: 48 hours (PubMed=2722053).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SPEC-2
AC   CVCL_A679
SY   SPEC2; Serous Papillary Endometrial Carcinoma-2
DR   Cosmic; 713492
DR   Wikidata; Q54955541
RX   PubMed=1696575;
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   SPEC-3
AC   CVCL_A680
SY   SPEC3; Serous Papillary Endometrial Carcinoma-3
DR   Cosmic; 713496
DR   Wikidata; Q54955542
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   Speedy
AC   CVCL_6730
DR   Wikidata; Q54955543
RX   PubMed=22083648;
CC   Group: Amphibian cell line.
CC   Doubling time: ~24 hours (PubMed=22083648).
CC   Karyotypic information: Diploid with a trisomy of chromosome 10 (PubMed=22083648).
CC   Derived from site: In situ; Hindlimb; UBERON=UBERON_0002103.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8364; ! Xenopus tropicalis (Western clawed frog)
HI   CVCL_6559 ! 91.1.F1
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   SpEEE
AC   CVCL_WS47
SY   SpEEE #87-29; 87-29
DR   Wikidata; Q98132813
RX   Patent=US7608425;
RX   PubMed=21473000;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   SPEL
AC   CVCL_IU20
DR   Wikidata; Q54955544
RX   PubMed=27536332;
CC   Population: Japanese.
CC   Characteristics: Has a gourd-shaped form with a polarized nucleus.
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SpESF
AC   CVCL_WS48
SY   SpEEE Serum-Free
DR   Wikidata; Q98132814
RX   Patent=US7608425;
RX   PubMed=21473000;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WS47 ! SpEEE
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   SpESFX
AC   CVCL_WS49
SY   SpESF-X
DR   Wikidata; Q98132815
RX   Patent=US7608425;
RX   PubMed=21473000;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WS48 ! SpESF
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   SpESFX-10
AC   CVCL_WS50
SY   SpESF-X10; SpESFX clone 10
DR   FCS-free; 137-17-240-3-4-12
DR   Wikidata; Q98132816
RX   Patent=US7608425;
RX   PubMed=21473000;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WS49 ! SpESFX
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   SpESFX-2
AC   CVCL_WS51
SY   SpESF-X2; SpESFX clone 2
DR   Wikidata; Q98132817
RX   Patent=US7608425;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WS49 ! SpESFX
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 8
//
ID   SPEV
AC   CVCL_4625
DR   CLO; CLO_0009120
DR   CLDB; cl4389
DR   CLDB; cl4390
DR   CLDB; cl4391
DR   CCLV; CCLV-RIE 0008
DR   Wikidata; Q54955545
RX   PubMed=19941903;
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   SPEV-13-D5-TK-
AC   CVCL_4921
SY   PK-13-D5-TC
DR   CLO; CLO_0009121
DR   CLDB; cl4392
DR   Wikidata; Q54955546
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_6433 ! PK-13
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   SPF [Lateolabrax]
AC   CVCL_A2JQ
SY   Sea Perch Fry
DR   Wikidata; Q105511116
RX   DOI=10.1016/j.aquaculture.2020.736127;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by sea perch iridovirus (SPIV), Singapore grouper iridovirus (SGIV), and red-spotted grouper nervous necrosis virus (RGNNV).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 27-11-25; Version: 6
//
ID   SPF [Trachinotus]
AC   CVCL_B5P5
SY   Snubnose Pompano Fin
DR   Wikidata; Q112041730
RX   PubMed=34609743;
CC   Group: Fish cell line.
CC   Doubling time: 27 hours (Note=At 55th passage) (PubMed=34609743).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SPG
AC   CVCL_B5P6
SY   Snubnose Pompano Gill
DR   Wikidata; Q112041731
RX   PubMed=34609743;
CC   Group: Fish cell line.
CC   Doubling time: 29 hours (Note=At 45th passage) (PubMed=34609743).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   SPG FiPS2-Ep6F-8
AC   CVCL_E7SZ
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+SPG+FiPS2-Ep6F-8+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/SPG%2520FiPS2-Ep6F-8%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:575; AP4S1; Simple; p.Arg97Ter (c.289C>T); ClinVar=VCV000234924; Zygosity=Homozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 10,12
ST   D16S539: 11
ST   D21S11: 28,31.2
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C212890; Spastic paraplegia 52, autosomal recessive
DI   ORDO; Orphanet_280763; Severe intellectual disability and progressive spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SPG-1
AC   CVCL_SA47
DR   Wikidata; Q54955547
RX   PubMed=823042;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C134766; Baboon lymphoma
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
OI   CVCL_SA46 ! KMPG-1
SX   Female
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 4
//
ID   SPG11-11
AC   CVCL_VE48
DR   SKIP; SKIP001198
DR   Wikidata; Q54955548
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Tyr1012Ter (c.3036C>A); ClinVar=VCV001344088; Zygosity=Heterozygous (PubMed=26971897).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Ala1933Valfs*18 (c.5798delC); ClinVar=VCV000041328; Zygosity=Heterozygous (PubMed=26971897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE49 ! SPG11-12
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   SPG11-12
AC   CVCL_VE49
DR   SKIP; SKIP001199
DR   Wikidata; Q54955549
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Tyr1012Ter (c.3036C>A); ClinVar=VCV001344088; Zygosity=Heterozygous (PubMed=26971897).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Ala1933Valfs*18 (c.5798delC); ClinVar=VCV000041328; Zygosity=Heterozygous (PubMed=26971897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE48 ! SPG11-11
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   SPG11-21
AC   CVCL_VE50
DR   SKIP; SKIP001200
DR   Wikidata; Q54955550
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Tyr1012Ter (c.3036C>A); ClinVar=VCV001344088; Zygosity=Heterozygous (PubMed=26971897).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Ala1933Valfs*18 (c.5798delC); ClinVar=VCV000041328; Zygosity=Heterozygous (PubMed=26971897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE51 ! SPG11-22
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   SPG11-22
AC   CVCL_VE51
DR   SKIP; SKIP001201
DR   Wikidata; Q54955551
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Tyr1012Ter (c.3036C>A); ClinVar=VCV001344088; Zygosity=Heterozygous (PubMed=26971897).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Ala1933Valfs*18 (c.5798delC); ClinVar=VCV000041328; Zygosity=Heterozygous (PubMed=26971897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE50 ! SPG11-21
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   SPG11-31
AC   CVCL_VE52
DR   SKIP; SKIP001202
DR   Wikidata; Q54955552
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Trp89Ter (c.267G>A); ClinVar=VCV000041294; Zygosity=Heterozygous (PubMed=26971897).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; c.1457-2A>G; ClinVar=VCV000041272; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=26971897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE53 ! SPG11-32
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   SPG11-32
AC   CVCL_VE53
DR   SKIP; SKIP001203
DR   Wikidata; Q54955553
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; p.Trp89Ter (c.267G>A); ClinVar=VCV000041294; Zygosity=Heterozygous (PubMed=26971897).
CC   Sequence variation: Mutation; HGNC; HGNC:11226; SPG11; Simple; c.1457-2A>G; ClinVar=VCV000041272; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=26971897).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148317; Spastic paraplegia 11
DI   ORDO; Orphanet_2822; Autosomal recessive spastic paraplegia type 11
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE52 ! SPG11-31
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   SPG11-CTRL-12
AC   CVCL_VE54
SY   CTRL-12
DR   SKIP; SKIP001204
DR   Wikidata; Q54955554
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE55 ! SPG11-CTRL-13
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPG11-CTRL-13
AC   CVCL_VE55
SY   CTRL-13
DR   SKIP; SKIP001205
DR   Wikidata; Q54955555
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE54 ! SPG11-CTRL-12
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPG11-CTRL-21
AC   CVCL_VE56
SY   CTRL-21
DR   SKIP; SKIP001206
DR   Wikidata; Q54955556
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE57 ! SPG11-CTRL-22
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPG11-CTRL-22
AC   CVCL_VE57
SY   CTRL-22
DR   SKIP; SKIP001207
DR   Wikidata; Q54955557
RX   CelloPub=CLPUB00424;
RX   PubMed=26971897;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VE56 ! SPG11-CTRL-21
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SpG213Dc
AC   CVCL_CW60
DR   Wikidata; Q54955558
RX   PubMed=26382919;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; B2RUZ4; Human SMIM1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   SPH [Human pancreatic adenocarcinoma]
AC   CVCL_0A29
DR   Wikidata; Q54955559
RX   PubMed=17560620;
RX   PubMed=17632328;
CC   Population: Japanese.
CC   Doubling time: ~35 hours (PubMed=17560620).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SPH [Lateolabrax]
AC   CVCL_R926
SY   Sea Perch Heart
DR   Wikidata; Q54955567
RX   DOI=10.1016/S0044-8486(98)00329-9;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   SPH [Trachinotus]
AC   CVCL_B5P7
SY   Snubnose Pompano Heart
DR   Wikidata; Q112041732
RX   PubMed=34609743;
CC   Group: Fish cell line.
CC   Doubling time: 36 hours (Note=At 61th passage) (PubMed=34609743).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SPH-7(T)
AC   CVCL_W384
DR   Wikidata; Q54955569
RX   PubMed=7842161;
CC   Group: Non-human primate cell line.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
DI   NCIt; C134766; Baboon lymphoma
OX   NCBI_TaxID=9557; ! Papio hamadryas (Hamadryas baboon)
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   SPHi001-A
AC   CVCL_A4UA
SY   SLEi002HZY
DR   BioSamples; SAMEA7976390
DR   hPSCreg; SPHi001-A
DR   Wikidata; Q107116955
RX   PubMed=33516123;
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SPI-801
AC   CVCL_2200
DR   CLO; CLO_0009122
DR   CLDB; cl4393
DR   BioSample; SAMN03151814
DR   BioSample; SAMN03473405
DR   Cosmic; 787507
DR   DSMZ; ACC-86
DR   DSMZCellDive; ACC-86
DR   Wikidata; Q54955572
RX   PubMed=6958338;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00160.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: DSMZ; ACC-86; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-86
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SPI-802
AC   CVCL_2201
DR   CLO; CLO_0009123
DR   CLDB; cl4394
DR   BioSample; SAMN03151815
DR   Cosmic; 787508
DR   DSMZ; ACC-92
DR   DSMZCellDive; ACC-92
DR   Wikidata; Q54955573
RX   PubMed=6958338;
RX   PubMed=10508494;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=10508494; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00161.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Discontinued: DSMZ; ACC-92; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-92
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SPIBL-I
AC   CVCL_LH75
SY   SPontaneous ImmunoBLastoid cell line-I
DR   Wikidata; Q54955575
RX   PubMed=23880011;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH76 ! SPIBL-II
OI   CVCL_LH77 ! SPIBL-III
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   SPIBL-II
AC   CVCL_LH76
SY   SPontaneous ImmunoBLastoid cell line-II
DR   Wikidata; Q54955577
RX   PubMed=23880011;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH75 ! SPIBL-I
OI   CVCL_LH77 ! SPIBL-III
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   SPIBL-III
AC   CVCL_LH77
SY   SPontaneous ImmunoBLastoid cell line-III
DR   Wikidata; Q54955578
RX   PubMed=23880011;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7224; Plasmablastic lymphoma
DI   ORDO; Orphanet_289666; Plasmablastic lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LH75 ! SPIBL-I
OI   CVCL_LH76 ! SPIBL-II
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   SPK
AC   CVCL_B5P8
SY   Snubnose Pompano Kidney
DR   Wikidata; Q112041733
RX   PubMed=34609743;
CC   Group: Fish cell line.
CC   Doubling time: 30 hours (Note=At 66th passage) (PubMed=34609743).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=435999; ! Trachinotus blochii (Snubnose pompano)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SPL.IID2
AC   CVCL_B5CY
SY   IID2
DR   Wikidata; Q110433252
RX   Patent=US4619895;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SPL.IID2A2
AC   CVCL_B5D1
SY   IID2A2
DR   Wikidata; Q110433253
RX   Patent=US4619895;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5CY ! SPL.IID2
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SPL.IVA5
AC   CVCL_B5D0
SY   IVA5
DR   Wikidata; Q110433254
RX   Patent=US4619895;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SPL.IVA5A1
AC   CVCL_B5D3
SY   IVA5A1
DR   Wikidata; Q110433255
RX   Patent=US4619895;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8535.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5D0 ! SPL.IVA5
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SPL.IVB5
AC   CVCL_B5CZ
SY   IVB5
DR   Wikidata; Q110433256
RX   Patent=US4619895;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SPL.IVB5A1
AC   CVCL_B5D2
SY   IVB5A1
DR   Wikidata; Q110433258
RX   Patent=US4619895;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human low density lipoprotein (LDL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B5CZ ! SPL.IVB5
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   Spli-B
AC   CVCL_B5ZK
DR   Wikidata; Q112041734
RX   CelloPub=CLPUB00678;
RX   CelloPub=CLPUB00679;
RX   PubMed=28127700;
RX   PubMed=31069609;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Spodoptera littoralis multicapsid nucleopolyhedrovirus (SpliMNPV) (CelloPub=CLPUB00678; CelloPub=CLPUB00679; PubMed=31069609).
CC   Doubling time: 44.5 hours (Note=At 19th passage), 32 hours (Note=At 120th passage) (CelloPub=CLPUB00678; CelloPub=CLPUB00679).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   Spli-C
AC   CVCL_B5ZL
DR   Wikidata; Q112041735
RX   CelloPub=CLPUB00678;
RX   CelloPub=CLPUB00679;
RX   PubMed=28127700;
RX   PubMed=31069609;
CC   Group: Insect cell line.
CC   Virology: Highly susceptible to infection by Spodoptera littoralis multicapsid nucleopolyhedrovirus (SpliMNPV) (CelloPub=CLPUB00678; CelloPub=CLPUB00679; PubMed=31069609).
CC   Doubling time: 30.5 hours (Note=At 19th passage), 26 hours (Note=At 120th passage) (CelloPub=CLPUB00678; CelloPub=CLPUB00679).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   Spli-S
AC   CVCL_B5ZM
DR   Wikidata; Q112041736
RX   CelloPub=CLPUB00678;
RX   CelloPub=CLPUB00679;
RX   PubMed=28127700;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Spodoptera littoralis multicapsid nucleopolyhedrovirus (SpliMNPV) (CelloPub=CLPUB00678; CelloPub=CLPUB00679).
CC   Doubling time: 31 hours (Note=At 19th passage), 27 hours (Note=At 120th passage) (CelloPub=CLPUB00678; CelloPub=CLPUB00679).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   SPLW-R
AC   CVCL_A3AP
DR   CCLV; CCLV-RIE 0150
DR   Wikidata; Q105511118
RX   PubMed=25565633;
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
AG   Lamb
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   SPM4-0
AC   CVCL_9V21
SY   SPM4-O; SPM 4-0
DR   NCBI_Iran; C490
DR   Wikidata; Q54955579
RX   PubMed=2391499;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   SPNE1
AC   CVCL_B7IW
DR   Wikidata; Q112930416
RX   PubMed=35394261;
CC   Population: Chinese.
CC   Doubling time: ~140 hours (PubMed=35394261).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): PubMed=35394261
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19,23
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14,15.2
ST   D21S11: 29
ST   D7S820: 11,12
ST   D8S1179: 12,15
ST   Penta D: 9
ST   vWA: 14,19
DI   NCIt; C172814; Pancreatic neuroendocrine tumor G3
DI   ORDO; Orphanet_97253; Neuroendocrine tumor of pancreas
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   SPO010
AC   CVCL_E835
SY   SP0010; SPO 010; SPO; SPO-H
DR   dbMHC; 49027
DR   ECACC; 88052036
DR   IHW; IHW09036
DR   IPD-IMGT/HLA; 11398
DR   Wikidata; Q54955580
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=29660261;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*02:01:01:01; B*44:02:01:01; C*05:01:01:02; DPA1*01; DPB1*02:01:02/02:01:19; DQA1*01:02:02; DQB1*05:02:01; DRA*01:01; DRB1*11:01:01; DRB3*02:02 (IPD-IMGT/HLA=11398).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   SPOC1
AC   CVCL_F847
SY   SPOC-1; SPOntaneously derived in Complete serum-free medium 1
DR   ABM; T0733
DR   Wikidata; Q54955582
RX   PubMed=7535063;
RX   PubMed=8630264;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-331.html
CC   Doubling time: ~24 hours (PubMed=7535063).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: Fischer 344/NCr; RS=RS_0003877.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10-14W
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   SPPHIi001-A
AC   CVCL_A4CV
SY   SPPH-1; KXD-0
DR   hPSCreg; SPPHIi001-A
DR   Wikidata; Q105511120
RX   PubMed=33429129;
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[49] (c.52CAG(49)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=33429129).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SPPHIi002-A
AC   CVCL_A4CW
SY   SPPH-2; KY-4
DR   hPSCreg; SPPHIi002-A
DR   Wikidata; Q105511123
RX   PubMed=33429129;
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[59] (c.52CAG(59)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=33429129).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   SPPHIi003-A
AC   CVCL_C1WB
SY   SPPH-3
DR   BioSamples; SAMEA12816503
DR   hPSCreg; SPPHIi003-A
DR   Wikidata; Q114313044
RX   PubMed=35933956;
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Asp252Val (c.755A>T) (p.Asp177Val, c.530A>T); Zygosity=Heterozygous (PubMed=35933956).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SPPHIi004-A
AC   CVCL_C1WC
SY   SPPH-4
DR   BioSamples; SAMEA12841754
DR   hPSCreg; SPPHIi004-A
DR   Wikidata; Q114313045
RX   PubMed=35933956;
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; p.Pro215Ser (c.643C>T) (p.Pro140Ser, c.418C>T); ClinVar=VCV000706054; Zygosity=Heterozygous (PubMed=35933956).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   SPPHIi005-A
AC   CVCL_D1G6
DR   hPSCreg; SPPHIi005-A
DR   Wikidata; Q127384320
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SPPHIi006-A
AC   CVCL_D1G7
DR   hPSCreg; SPPHIi006-A
DR   Wikidata; Q127384322
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SPPHIi007-A
AC   CVCL_D1G8
DR   hPSCreg; SPPHIi007-A
DR   Wikidata; Q127384324
CC   From: Sichuan Academy of Medical Science & Sichuan Provincial People's Hospital; Chengdu; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SpR
AC   CVCL_L986
SY   SPR; SP
DR   BioSample; SAMN03151878
DR   Wikidata; Q54955583
RX   PubMed=68093;
RX   PubMed=265539;
RX   PubMed=7005696;
RX   PubMed=7192801;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=29533902;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; NYT; -; https://www.nytimes.com/1981/01/22/us/cells-in-disease-study-said-to-come-from-monkeys.html
CC   Group: Non-human primate cell line.
CC   Problematic cell line: Misidentified/contaminated. Originally thought to be of human origin but found to derive from Aotus trivirgatus OMK-210 (PubMed=7192801; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00088.
CC   Anecdotal: Part of a set of 4 cell lines that were fraudulently stated to originate from Hodgkin lymphoma (PubMed=265539).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9505; ! Aotus trivirgatus (Three-striped night monkey)
HI   CVCL_L983 ! OMK-210
SX   Female
CA   Undefined cell line type
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   SPr0026
AC   CVCL_VC29
DR   ECACC; 15103027
DR   Wikidata; Q54955584
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPr0059
AC   CVCL_VC30
DR   ECACC; 15103028
DR   Wikidata; Q54955585
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPr0079
AC   CVCL_VC31
DR   ECACC; 15103029
DR   Wikidata; Q54955586
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85027; Progressive muscular atrophy
DI   ORDO; Orphanet_454706; Progressive muscular atrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPr0080
AC   CVCL_VC32
DR   ECACC; 15092929
DR   Wikidata; Q54955587
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SPr0085
AC   CVCL_VC33
DR   ECACC; 15082842
DR   Wikidata; Q54955588
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SPr0086
AC   CVCL_VC34
DR   ECACC; 15092930
DR   Wikidata; Q54955589
CC   Part of: Motor Neurone Disease (MND) collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   Spry-STS
AC   CVCL_0D05
DR   Wikidata; Q54955590
WW   Provider; UMN; -; https://web.archive.org/web/20100613061254/http://www.cvm.umn.edu/accr/research/modianolab/scientificresources/reagentsandscientificresources/home.html
CC   Miscellaneous: Cell line no longer available (personal communication of Modiano, Jaime F.).
DI   NCIt; C132276; Canine soft tissue sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   SPS
AC   CVCL_R927
SY   Sea Perch Spleen
DR   Wikidata; Q54955591
RX   DOI=10.1016/S0044-8486(98)00329-9;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8164; ! Lateolabrax japonicus (Japanese sea perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   SPSK
AC   CVCL_F1BG
SY   Schizothorax Prenanti SKin
RX   PubMed=40459177;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by spring viraemia of carp virus (SVCV) (PubMed=40459177).
CC   Donor information: Fish collected from the Dadu River, Luding County, Sichuan province, China (PubMed=40459177).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=75362; ! Schizothorax prenanti (Ya-fish)
SX   Sex unspecified
AG   10M
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   SPV-L3
AC   CVCL_JY72
SY   SPV L3; SPVL-3; SPVL3; SPvL3
DR   Wikidata; Q54955592
RX   PubMed=6332061;
RX   PubMed=6609821;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   SPY3-2
AC   CVCL_5366
DR   Wikidata; Q54955593
RX   PubMed=7538817;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SPY3-2
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8-12W
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   SPYMEG
AC   CVCL_VG38
DR   Wikidata; Q54955594
RX   Patent=US8173425;
RX   PubMed=29669959;
WW   Provider; MBL; -; https://www.mblbio.com/e/ir/2010/img/press100112.pdf
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-10761.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0425 ! MEG-01
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybrid cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   Sq-1
AC   CVCL_4900
SY   SQ-1; SQ1; Sq1
DR   CLO; CLO_0050049
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472088
DR   BioSample; SAMN10988374
DR   cancercelllines; CVCL_4900
DR   Cell_Model_Passport; SIDM01767
DR   CGH-DB; 192-1
DR   CGH-DB; 9181-4
DR   Cosmic; 889087
DR   Cosmic; 946075
DR   Cosmic; 1048222
DR   Cosmic; 1066172
DR   Cosmic; 1219090
DR   Cosmic; 1239913
DR   Cosmic; 2060523
DR   DepMap; ACH-000553
DR   GEO; GSM887647
DR   GEO; GSM888739
DR   IARC_TP53; 28446
DR   IARC_TP53; 30172
DR   LiGeA; CCLE_756
DR   PharmacoDB; Sq1_1494_2019
DR   Progenetix; CVCL_4900
DR   RCB; RCB1905
DR   TKG; TKG 0301
DR   Wikidata; Q54955595
RX   PubMed=9023415;
RX   PubMed=9416778;
RX   PubMed=9538136;
RX   PubMed=14581340;
RX   PubMed=15746151;
RX   PubMed=16105816;
RX   PubMed=17511773;
RX   PubMed=19472407;
RX   PubMed=20557307;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*11:01,24:02; B*15:01,52:01; C*04:01,12:02 (PubMed=9023415).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=In 10% of cells (PubMed=16105816).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+2T>C (IVS4+2T>C); ClinVar=VCV000439316; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=20557307; DepMap=ACH-000553).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.4%; Native American=0%; East Asian, North=81.37%; East Asian, South=17.66%; South Asian=0.56%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): RCB=RCB1905; TKG=TKG 0301
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Sq-19
AC   CVCL_6998
SY   SQ-19; Sq19
DR   Cosmic; 889088
DR   Cosmic; 946077
DR   Cosmic; 1066173
DR   Wikidata; Q54955596
RX   PubMed=9416778;
RX   PubMed=16105816;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   Sq-1979
AC   CVCL_6541
SY   Sq1979
DR   CLO; CLO_0050767
DR   RCB; RCB0284
DR   Wikidata; Q54955597
RX   DOI=10.4103/ctm.ctm_34_17;
RX   PubMed=6424091;
RX   PubMed=28405677;
RX   PubMed=29435078;
CC   Doubling time: 10.1 +- 0.2 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Sq-1979-1
AC   CVCL_A1JC
DR   Wikidata; Q102114930
RX   PubMed=29435078;
CC   Doubling time: 11.0 +- 3.3 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979-2
AC   CVCL_A1JD
DR   Wikidata; Q102114931
RX   PubMed=29435078;
CC   Doubling time: 11.8 +- 1.0 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979-3
AC   CVCL_A1JE
DR   Wikidata; Q102114932
RX   PubMed=29435078;
CC   Doubling time: 11.6 +- 0.8 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 233-1
AC   CVCL_A1JF
SY   233-1
DR   Wikidata; Q102114934
RX   PubMed=29435078;
CC   Characteristics: Established from the primary tumor of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 12.7 +- 0.5 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 233-11
AC   CVCL_A1JG
SY   233-11
DR   Wikidata; Q102114936
RX   DOI=10.4103/ctm.ctm_34_17;
RX   PubMed=29435078;
CC   Characteristics: Established from the primary tumor of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 16.0 +- 4.8 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 L2-3
AC   CVCL_A1JH
SY   L2-3
DR   Wikidata; Q102114938
RX   PubMed=29435078;
CC   Characteristics: Established from the metastastic lymph nodes of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 12.1 +- 0.3 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 L3-5
AC   CVCL_A1JI
SY   L3-5
DR   Wikidata; Q102114939
RX   DOI=10.4103/ctm.ctm_34_17;
RX   PubMed=29435078;
CC   Characteristics: Established from the metastastic lymph nodes of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 11.6 +- 1.1 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 L5-11
AC   CVCL_A1JJ
SY   L5-11
DR   Wikidata; Q102114940
RX   DOI=10.4103/ctm.ctm_34_17;
RX   PubMed=28405677;
RX   PubMed=29435078;
CC   Characteristics: Established from the metastastic lymph nodes of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 15.4 +- 1.2 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 L6-8
AC   CVCL_A1JK
SY   L6-8
DR   Wikidata; Q102114941
RX   DOI=10.4103/ctm.ctm_34_17;
RX   PubMed=29435078;
CC   Characteristics: Established from the metastastic lymph nodes of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 14.1 +- 0.4 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Sq-1979 L6-9
AC   CVCL_A1JL
SY   L6-9
DR   Wikidata; Q102114942
RX   PubMed=29435078;
CC   Characteristics: Established from the metastastic lymph nodes of male C3H/HeN mice subcutaneously injected with the parent cell line into the posterior neck area.
CC   Doubling time: 18.6 +- 2.5 hours (PubMed=29435078).
CC   Breed/subspecies: C3H.
DI   NCIt; C23049; Squamous cell carcinoma of the mouse oral cavity
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6541 ! Sq-1979
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   SQ-20B
AC   CVCL_7138
SY   SQ20B; SQ20-B
DR   cancercelllines; CVCL_7138
DR   ChEMBL-Cells; CHEMBL3307460
DR   ChEMBL-Targets; CHEMBL614939
DR   Cosmic; 1122674
DR   Cosmic; 1530760
DR   Cosmic; 1530761
DR   GEO; GSM1524316
DR   GEO; GSM1524317
DR   GEO; GSM1524318
DR   IARC_TP53; 6406
DR   Millipore; SCC287
DR   PubChem_Cell_line; CVCL_7138
DR   TOKU-E; 4134
DR   Wikidata; Q54955598
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1423286;
RX   PubMed=1574572;
RX   PubMed=2380097;
RX   PubMed=2466340;
RX   PubMed=2573646;
RX   PubMed=3182330;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=3616625;
RX   PubMed=7938462;
RX   PubMed=8339273;
RX   PubMed=17312569;
RX   PubMed=17848307;
RX   PubMed=25888065;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=8339273).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: SQ2013; Cosmic=1530760.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SQ-29
AC   CVCL_7139
SY   SQ29
DR   Wikidata; Q54955600
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SQ-31
AC   CVCL_7140
SY   SQ31
DR   Wikidata; Q54955601
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=8339273;
RX   PubMed=17312569;
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   SQ-38
AC   CVCL_7141
SY   SQ38
DR   cancercelllines; CVCL_7141
DR   IARC_TP53; 1689
DR   Wikidata; Q54955602
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1423286;
RX   PubMed=1574572;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=1423286).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   SQ-39
AC   CVCL_7142
SY   SQ39
DR   Wikidata; Q54955603
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2394610;
RX   PubMed=2573646;
RX   PubMed=3458227;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   SQ-43
AC   CVCL_7143
SY   SQ43
DR   Wikidata; Q54955604
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   SQ-5
AC   CVCL_8273
SY   Sq-5; SQ5
DR   EFO; EFO_0002861
DR   BioSample; SAMN03151759
DR   Cosmic; 946076
DR   Cosmic; 1219091
DR   Cosmic; 1239914
DR   Cosmic; 1571743
DR   RCB; RCB0110
DR   Wikidata; Q54955605
RX   PubMed=10358721;
RX   PubMed=16105816;
RX   PubMed=16643607;
RX   PubMed=19472407;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a lung carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00269.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: RCB; RCB0110; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   SQ-9G
AC   CVCL_7144
SY   SQ9G
DR   Cosmic; 1530762
DR   IARC_TP53; 6407
DR   Wikidata; Q54955607
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1423286;
RX   PubMed=1574572;
RX   PubMed=2573646;
RX   PubMed=3417487;
RX   PubMed=3458227;
RX   PubMed=8339273;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Argfs*110 (c.811delG); Zygosity=Unspecified (PubMed=1423286; PubMed=8339273).
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   SQ-Mitox-BCRP
AC   CVCL_4U25
SY   DLKP-SQ-Mitox-BCRP
DR   Wikidata; Q54955608
RX   CelloPub=CLPUB00266;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H740 ! DLKP-SQ
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   SQ-Mitox-MDR
AC   CVCL_4U26
SY   DLKP-SQ-Mitox-MDR
DR   Wikidata; Q54955609
RX   CelloPub=CLPUB00266;
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H737 ! DLKP
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   SQ4
AC   CVCL_WH55
DR   Wikidata; Q98132818
RX   PubMed=30268330;
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   SqCC/Y1
AC   CVCL_0551
SY   SqCC-Y1; SQCCY1
DR   MCCL; MCC:0000452
DR   ATCC; CRL-2980
DR   Cosmic; 948040
DR   Cosmic; 2131856
DR   Cosmic; 2513918
DR   Cosmic; 2602602
DR   Cosmic; 2646651
DR   GEO; GSM190621
DR   GEO; GSM190622
DR   GEO; GSM966940
DR   GEO; GSM966941
DR   GEO; GSM966946
DR   Wikidata; Q54955611
RX   CelloPub=CLPUB00346;
RX   PubMed=3858572;
RX   PubMed=11377230;
RX   PubMed=18186669;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-2980; true.
ST   Source(s): ATCC=CRL-2980; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SQD9
AC   CVCL_D774
DR   cancercelllines; CVCL_D774
DR   Cosmic; 1466802
DR   Wikidata; Q54955612
RX   PubMed=7938462;
CC   Doubling time: ~36 hours (PubMed=7938462).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7138 ! SQ-20B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   SQG6
AC   CVCL_D775
DR   cancercelllines; CVCL_D775
DR   Wikidata; Q54955613
RX   PubMed=7938462;
CC   Doubling time: ~36 hours (PubMed=7938462).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7138 ! SQ-20B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   SQM1
AC   CVCL_C8DJ
DR   Wikidata; Q123033549
RX   PubMed=3894247;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P17568; Human NDUFB7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   SQMK-FP
AC   CVCL_6451
SY   Pindak cells
DR   CLO; CLO_0009125
DR   ATCC; CRL-2762
DR   Wikidata; Q54955614
RX   PubMed=12418921;
WW   Info; KCCMR; -; https://web.archive.org/web/20110829112150/http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   SqMkLu/68
AC   CVCL_E930
DR   Wikidata; Q54955616
RX   PubMed=11528123;
WW   Info; KCCMR; -; https://web.archive.org/web/20110829112150/http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=39432; ! Saimiri boliviensis boliviensis (Bolivian squirrel monkey)
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   SR
AC   CVCL_1711
AS   CVCL_2203
SY   SR-786; SR786
DR   BTO; BTO_0003585
DR   CLO; CLO_0009126
DR   CLO; CLO_0009129
DR   EFO; EFO_0002352
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2262
DR   BioSample; SAMN03471620
DR   BioSample; SAMN03473321
DR   BioSample; SAMN10988434
DR   cancercelllines; CVCL_1711
DR   Cell_Model_Passport; SIDM00096
DR   ChEMBL-Cells; CHEMBL3307586
DR   ChEMBL-Targets; CHEMBL614300
DR   Cosmic; 687852
DR   Cosmic; 850201
DR   Cosmic; 875868
DR   Cosmic; 897453
DR   Cosmic; 905965
DR   Cosmic; 974254
DR   Cosmic; 1044251
DR   Cosmic; 1086366
DR   Cosmic; 1092639
DR   Cosmic; 1305341
DR   Cosmic; 1312327
DR   Cosmic; 1998482
DR   Cosmic; 2060807
DR   Cosmic; 2674497
DR   Cosmic-CLP; 905965
DR   DepMap; ACH-000338
DR   DepMap; ACH-001665
DR   DSMZ; ACC-369
DR   DSMZCellDive; ACC-369
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905965
DR   GEO; GSM2102
DR   GEO; GSM50199
DR   GEO; GSM50911
DR   GEO; GSM743462
DR   GEO; GSM750815
DR   GEO; GSM799350
DR   GEO; GSM799413
DR   GEO; GSM827416
DR   GEO; GSM887648
DR   GEO; GSM888740
DR   GEO; GSM1153420
DR   GEO; GSM1178626
DR   GEO; GSM1178627
DR   GEO; GSM1178628
DR   GEO; GSM1181290
DR   GEO; GSM1181362
DR   GEO; GSM1670479
DR   GEO; GSM2124688
DR   IARC_TP53; 21092
DR   IARC_TP53; 28377
DR   IGRhCellID; SR
DR   LiGeA; CCLE_367
DR   LINCS_LDP; LCL-1129
DR   NCI-DTP; SR
DR   PharmacoDB; SR_1495_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1711
DR   PubChem_Cell_line; CVCL_1711
DR   SKY/M-FISH/CGH; 2805
DR   Wikidata; Q54955622
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2041050;
RX   PubMed=2313723;
RX   PubMed=2456698;
RX   PubMed=8558920;
RX   PubMed=9331090;
RX   PubMed=9787181;
RX   PubMed=10700174;
RX   PubMed=15356658;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29899875;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=34
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (DSMZ=ACC-369); 28.7 hours (NCI-DTP=SR).
CC   HLA typing: A*02,03; B*37:01,39:01; C*06:02,12:03:01; DPB1*04:01; DQB1*05:01:01,05:02:01; DRB1*01,16:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,03:01; B*37:01,39:01; C*06:02,12:03; DQA1*01:01,01:01; DQB1*05:02,05:02; DRB1*01:01,16:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01,03:01:01; B*37:01:01,39:01:01; C*06:02:01,12:03:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:01:01; DQA1*01:02:02,01:01:01; DQB1*05:01:01,05:02:01; DRA*01:01:01,01:01:01; DRB1*01:01:01,16:01:01 (DSMZCellDive=ACC-369).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=25485619; PubMed=29899875).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=3.12%; East Asian, South=0%; South Asian=0%; European, North=62.78%; European, South=34.1% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-001665; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2262; Cosmic-CLP=905965; DSMZ=ACC-369; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X (DSMZ=ACC-369)
ST   Amelogenin: X,Y (ATCC=CRL-2262; Cosmic-CLP=905965; PubMed=19372543; PubMed=25877200)
ST   CSF1PO: 14,15
ST   D13S317: 11 (ATCC=CRL-2262; Cosmic-CLP=905965; PubMed=19372543; PubMed=25877200)
ST   D13S317: 11,13 (DSMZ=ACC-369)
ST   D16S539: 11 (Cosmic-CLP=905965)
ST   D16S539: 11,13 (ATCC=CRL-2262; DSMZ=ACC-369; PubMed=19372543; PubMed=25877200)
ST   D18S51: 13,14 (ATCC=CRL-2262; PubMed=19372543; PubMed=25877200)
ST   D18S51: 14 (DSMZ=ACC-369)
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 24
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 9,13
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   SR DU-145
AC   CVCL_4901
SY   SR DU 145; SR DU145
DR   cancercelllines; CVCL_4901
DR   Wikidata; Q54955623
RX   PubMed=9923549;
RX   PubMed=15643172;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45906; Suramin.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Tyr (c.250G>T) (p.Arg98Leu, c.293G>T); ClinVar=VCV000376306; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Lys715Ter (c.2143A>T); ClinVar=VCV001786615; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Lys178fs*86 (c.532_536delAAGCC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0105 ! DU145
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   SR-1
AC   CVCL_J389
DR   Wikidata; Q54955624
RX   PubMed=15381372;
CC   Population: Korean.
CC   Doubling time: ~24 hours (PubMed=15381372).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SR-3Y1-1
AC   CVCL_8115
DR   BTO; BTO_0002377
DR   RCB; RCB0353
DR   Wikidata; Q54955626
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SR-3Y1-2
AC   CVCL_8116
DR   BTO; BTO_0002377
DR   JCRB; JCRB0742
DR   RCB; RCB0354
DR   Wikidata; Q54955627
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   SR-3Y1-3
AC   CVCL_6E97
DR   Wikidata; Q54955628
RX   PubMed=2961438;
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   SR-4987
AC   CVCL_2202
SY   SR4987
DR   CLO; CLO_0009127
DR   CLO; CLO_0009128
DR   CLDB; cl4395
DR   CLDB; cl4397
DR   CLDB; cl4948
DR   ATCC; CRL-2028
DR   DSMZ; ACC-323
DR   DSMZCellDive; ACC-323
DR   ECACC; 94102704
DR   ICLC; ATL99005
DR   IZSLER; BS CL 175
DR   Wikidata; Q54955629
RX   PubMed=1382506;
RX   PubMed=21190129;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SR-4987
CC   Doubling time: 14.7 hours (PubMed=1382506); 24.5 +- 5.4 hours (PubMed=21190129); ~24-36 hours (DSMZ=ACC-323).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   5M
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   SR-91
AC   CVCL_8441
DR   BioSample; SAMN03151611
DR   cancercelllines; CVCL_8441
DR   Wikidata; Q54955630
RX   PubMed=8180609;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a AML-193 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 22 year old male patient with acute lymphoblastic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00270.
CC   Population: African American and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25657; BCORL1; Simple; p.Arg784Ter (c.2350C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Val (c.38G>T); ClinVar=VCV000375876; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+2T>G (IVS9+2T>G); ClinVar=VCV000635384; Zygosity=Unspecified; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1071 ! AML-193
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   SR-CDF1 DBT
AC   CVCL_4W75
SY   SR-CDF1-DBT; SR-CDF1; DBT
DR   JCRB; JCRB1580
DR   Wikidata; Q54955631
RX   PubMed=209230;
RX   PubMed=4301953;
RX   PubMed=8593285;
RX   PubMed=21538303;
CC   Virology: Used for propagation and assay of mouse hepatitis virus (MHV) (PubMed=209230; PubMed=21538303).
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c x DBA/2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   SR-fibroblasts
AC   CVCL_C7WM
DR   Wikidata; Q123033550
RX   PubMed=36388963;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: 19 hours (PubMed=36388963).
CC   Donor information: Established from a rhinoceros named Kertam, the last male Malaysian rhinoceros who died in 2019.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89632; ! Dicerorhinus sumatrensis (Sumatran rhinoceros)
SX   Male
AG   32-37Y
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   SR-iPSC #14
AC   CVCL_C7WQ
DR   Wikidata; Q123033551
RX   PubMed=36388963;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Kertam, the last male Malaysian rhinoceros who died in 2019.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89632; ! Dicerorhinus sumatrensis (Sumatran rhinoceros)
HI   CVCL_C7WM ! SR-fibroblasts
SX   Male
AG   32-37Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   SR-iPSC #8
AC   CVCL_C7WN
DR   Wikidata; Q123033553
RX   PubMed=36388963;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Kertam, the last male Malaysian rhinoceros who died in 2019.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89632; ! Dicerorhinus sumatrensis (Sumatran rhinoceros)
HI   CVCL_C7WM ! SR-fibroblasts
SX   Male
AG   32-37Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   SR-iPSC #9
AC   CVCL_C7WP
DR   Wikidata; Q123033554
RX   PubMed=36388963;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Kertam, the last male Malaysian rhinoceros who died in 2019.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89632; ! Dicerorhinus sumatrensis (Sumatran rhinoceros)
HI   CVCL_C7WM ! SR-fibroblasts
SX   Male
AG   32-37Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 3
//
ID   SR2
AC   CVCL_Y625
DR   Wikidata; Q54955633
RX   PubMed=21861759;
RX   PubMed=23954875;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0440 ! MRC-5
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   SR8
AC   CVCL_JL55
DR   Wikidata; Q54955634
RX   PubMed=8695226;
RX   PubMed=10540202;
CC   Doubling time: 29 hours (PubMed=8695226; PubMed=10540202).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   SR8CT
AC   CVCL_JL56
DR   Wikidata; Q54955635
RX   PubMed=10540202;
CC   Characteristics: Derived from parent cell line by adding cholera-toxin to the medium.
CC   Doubling time: 39 hours (PubMed=10540202).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JL55 ! SR8
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 6
//
ID   SRA01/01
AC   CVCL_A9KN
SY   SRA 01/01
DR   Wikidata; Q108821325
RX   Patent=US5885832;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5858.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-B-T Ag).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7157 ! SRA01/04
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   SRA01/04
AC   CVCL_7157
SY   SRA 01/04; HLEC-SRA 01/04; HLE-SRA-01/04; SRA01/04 (HLE)
DR   BTO; BTO_0003071
DR   CLO; CLO_0051565
DR   BioSample; SAMN03472107
DR   FANTOM5_SSTAR; 10647-109A8
DR   RCB; RCB1591
DR   Wikidata; Q54955637
RX   Patent=US5885832;
RX   PubMed=9878220;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-590.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-5454.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-B-T Ag).
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000206). It was one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
ST   Source(s): CCRID; RCB=RCB1591
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13,15
ST   D13S317: 10
ST   D16S539: 10
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 27,28,31
ST   D2S1338: 23,24
ST   D3S1358: 14,15
ST   D5S818: 11,12,13
ST   D7S820: 10,11,13
ST   D8S1179: 14,15
ST   FGA: 19,20,22.2
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9KN ! SRA01/01
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SRB-1
AC   CVCL_AT72
SY   SRB1
DR   Wikidata; Q54955638
RX   PubMed=21868764;
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 3
//
ID   SRB-12
AC   CVCL_AT73
SY   SRB12
DR   Wikidata; Q54955639
RX   PubMed=21868764;
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 14
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 3
//
ID   SRBC-F12-1-19
AC   CVCL_J487
DR   JCRB; JCRB1358.04
DR   Wikidata; Q54955640
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-F12-18-7
AC   CVCL_J488
DR   JCRB; JCRB1358.05
DR   Wikidata; Q54955641
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-F23-20-22
AC   CVCL_J489
DR   JCRB; JCRB1358.06
DR   Wikidata; Q54955642
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-F31-19-1
AC   CVCL_J490
DR   JCRB; JCRB1358.08
DR   Wikidata; Q54955643
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-F31-2-11
AC   CVCL_J491
DR   JCRB; JCRB1358.07
DR   Wikidata; Q54955644
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-P13-7-3
AC   CVCL_J492
DR   JCRB; JCRB1358.01
DR   Wikidata; Q54955645
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-P18-3-8
AC   CVCL_J493
DR   JCRB; JCRB1358.02
DR   Wikidata; Q54955646
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-P20-13-13
AC   CVCL_J494
DR   JCRB; JCRB1358.03
DR   Wikidata; Q54955647
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-RF29-1-3
AC   CVCL_J495
DR   JCRB; JCRB1358.11
DR   Wikidata; Q54955648
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-RP8-18-15
AC   CVCL_J496
DR   JCRB; JCRB1358.10
DR   Wikidata; Q54955649
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SRBC-RP8-2-4
AC   CVCL_J497
DR   JCRB; JCRB1358.09
DR   Wikidata; Q54955650
RX   PubMed=3250645;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Sheep red blood cells (SRBC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   Src++
AC   CVCL_6492
DR   CLO; CLO_0009132
DR   ATCC; CRL-2497
DR   Wikidata; Q54955651
RX   PubMed=10228160;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   SRCF
AC   CVCL_0A27
SY   SRF; Schizothorax Richardsonii Caudal Fin
DR   NRFC; NRFC002
DR   Wikidata; Q54955652
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.4194/1303-2712-v21_2_05;
RX   PubMed=23545061;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC002.
CC   Doubling time: 48 hours (PubMed=23545061).
CC   Miscellaneous: Cell line no longer available; due to technical problems (DOI=10.4194/1303-2712-v21_2_05).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=183910; ! Schizothorax richardsonii (Snowtrout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   SRD-1
AC   CVCL_E040
SY   Sterol Regulatory Defective-1
DR   Wikidata; Q54955654
RX   PubMed=2570073;
RX   PubMed=7744865;
RX   PubMed=7958866;
CC   Sequence variation: Gene fusion; UniProtKB; Q60429; Srebf2 + UniProtKB; G3IJJ1; Xrcc6; Name(s)=Srebf2-Xrcc6, Srebp2-Xrcc6, Srebp-2/Ku p70; Note=Out of frame (PubMed=7744865).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   SRD-12A
AC   CVCL_2H50
SY   Sterol Regulatory Defective-12A
DR   Wikidata; Q54955655
RX   PubMed=9774448;
CC   Characteristics: Has a defect in the site 1 cleavage reaction.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15455; MBTPS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2H49 ! CHO/pS2P
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   SRD-12B
AC   CVCL_2H51
SY   SRD12B; Sterol Regulatory Defective-12B
DR   Wikidata; Q54955656
RX   PubMed=9774448;
CC   Characteristics: Has a defect in the site 1 cleavage reaction.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15455; MBTPS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2H49 ! CHO/pS2P
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   SRD-13A
AC   CVCL_2H52
SY   SRD13A; Sterol Regulatory Defective-13A
DR   Wikidata; Q54955658
RX   PubMed=10497220;
RX   PubMed=12482938;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15455; MBTPS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2H49 ! CHO/pS2P
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   SRD-14
AC   CVCL_B7PA
SY   Sterol Regulatory Defective-14
DR   Wikidata; Q112930417
RX   PubMed=15247248;
RX   PubMed=15866869;
CC   Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813).
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (PubMed=15247248).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SRD-14/pInsig-1
AC   CVCL_B7PB
DR   Wikidata; Q112930418
RX   PubMed=15247248;
CC   Characteristics: Transfected with INSIG1 followed by 6 tandem copies of the Myc epitope.
CC   Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813).
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (PubMed=15247248).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6083; INSIG1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7PA ! SRD-14
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   SRD-14/pInsig-2
AC   CVCL_B7PC
DR   Wikidata; Q112930419
RX   PubMed=15247248;
CC   Characteristics: Transfected with INSIG2 followed by 6 tandem copies of the Myc epitope.
CC   Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813).
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (PubMed=15247248).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:20452; INSIG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7PA ! SRD-14
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   SRD-15
AC   CVCL_B7PD
SY   Sterol Regulatory Defective-15
DR   Wikidata; Q112930420
RX   PubMed=15866869;
CC   Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813).
CC   Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol.
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (from parent cell line).
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA5; Insig2; Zygosity=Heterozygous (PubMed=15866869).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7PA ! SRD-14
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   SRD-15/pInsig-1
AC   CVCL_B7PE
DR   Wikidata; Q112930421
RX   PubMed=15866869;
CC   Characteristics: Transfected with INSIG1 followed by 6 tandem copies of the Myc epitope (PubMed=15866869).
CC   Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813).
CC   Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol.
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (from parent cell line).
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA5; Insig2; Zygosity=Heterozygous (PubMed=15866869).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6083; INSIG1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7PD ! SRD-15
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SRD-15/pInsig-2
AC   CVCL_B7PF
DR   Wikidata; Q112930422
RX   PubMed=15866869;
CC   Characteristics: Transfected with INSIG2 followed by 6 tandem copies of the Myc epitope (PubMed=15866869).
CC   Selected for resistance to: ChEBI; CHEBI_77317; 4-[2,2-bis(diethoxyphosphoryl)ethenyl]-2,6-ditert-butylphenol] (SR12813).
CC   Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol.
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA6; Insig1; Zygosity=Heterozygous; Note=The 2nd allele has a loss of function (from parent cell line).
CC   Sequence variation: Gene deletion; UniProtKB; Q8CFA5; Insig2; Zygosity=Heterozygous (PubMed=15866869).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:20452; INSIG2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B7PD ! SRD-15
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SRD-2
AC   CVCL_E041
SY   Sterol Regulatory Defective-2
DR   Wikidata; Q54955660
RX   PubMed=1673968;
RX   PubMed=2570073;
RX   PubMed=7744865;
CC   Sequence variation: Gene fusion; UniProtKB; G3HX69; Lima1 + UniProtKB; Q60429; Srebf2; Name(s)=Srebf2-Lima1, Srebp2-Lima1; Note=In frame (PubMed=7744865).
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   SRD-3
AC   CVCL_DC36
SY   Sterol Regulatory Defective-3
DR   Wikidata; Q54955661
RX   PubMed=1673968;
RX   PubMed=7744865;
CC   Sequence variation: Mutation; UniProtKB; Q60429; Srebf2; Simple; p.Pro462_Ser1139del; Zygosity=Heterozygous (PubMed=7744865).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 13
//
ID   SRD-4
AC   CVCL_DA09
SY   SRD 4; Sterol Regulatory Defective-4
DR   Wikidata; Q54955662
RX   PubMed=1712025;
RX   PubMed=8662991;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   SRD-5
AC   CVCL_B7PG
SY   Sterol Regulatory Defective-5
DR   Wikidata; Q112930423
RX   PubMed=12482938;
CC   Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol.
CC   Sequence variation: Mutation; UniProtKB; P97260; Scap; Simple; p.Leu315Phe (c.943C>T); Zygosity=Heterozygous (PubMed=12482938).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SRD-6A
AC   CVCL_D894
SY   Sterol Regulatory Defective-6A
DR   Wikidata; Q54955663
RX   PubMed=8102788;
CC   Selected for resistance to: ChEBI; CHEBI_2682; Amphotericin B.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   SRD-6B
AC   CVCL_D895
SY   Sterol Regulatory Defective-6B
DR   Wikidata; Q54955664
RX   PubMed=8102788;
CC   Selected for resistance to: ChEBI; CHEBI_2682; Amphotericin B.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   SRD-6C
AC   CVCL_D896
SY   Sterol Regulatory Defective-6C
DR   Wikidata; Q54955666
RX   PubMed=8102788;
CC   Selected for resistance to: ChEBI; CHEBI_2682; Amphotericin B.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   SRD-6D
AC   CVCL_D897
SY   Sterol Regulatory Defective-6D
DR   Wikidata; Q54955667
RX   PubMed=8102788;
CC   Selected for resistance to: ChEBI; CHEBI_2682; Amphotericin B.
CC   Transformant: NCIt; C129643; Cesium-137 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   SRD-9
AC   CVCL_DA10
SY   Sterol Regulatory Defective-9
DR   Wikidata; Q54955674
RX   PubMed=9789003;
RX   PubMed=12482938;
CC   Selected for resistance to: ChEBI; CHEBI_42977; 25-hydroxycholesterol.
CC   Sequence variation: Mutation; UniProtKB; P97260; Scap; Simple; p.Tyr298Cys (c.893A>G); Zygosity=Heterozygous (PubMed=9789003).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D893 ! CHO-7
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
ID   SREM-1
AC   CVCL_A2YW
SY   SRE; Schizothorax Richardsonii Eye Muscle-1
DR   NRFC; NRFC060
DR   Wikidata; Q105511125
RX   DOI=10.4194/1303-2712-v21_2_05;
WW   Provider; NRFC; NRFC060; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC060.
CC   Characteristics: Can grow at temperatures ranging from 20 to 32 Celsius with an optimum temperature of 28 Celsius (DOI=10.4194/1303-2712-v21_2_05).
CC   Doubling time: ~34 hours (DOI=10.4194/1303-2712-v21_2_05).
CC   Derived from site: In situ; Eye, muscle; UBERON=UBERON_0004277.
OX   NCBI_TaxID=183910; ! Schizothorax richardsonii (Snowtrout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   SRH
AC   CVCL_A0XB
DR   cancercelllines; CVCL_A0XB
DR   Wikidata; Q108821326
RX   PubMed=33322555;
CC   Doubling time: 34.3 +- 2.5 hours (PubMed=33322555).
CC   Sequence variation: Mutation; HGNC; HGNC:7611; MYOD1; Simple; p.Leu122Arg (c.365T>G); Zygosity=Homozygous (PubMed=33322555).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=33322555).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Unspecified (PubMed=33322555).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Left leg, skeletal muscle; UBERON=UBERON_0001383.
ST   Source(s): PubMed=33322555
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D21S11: 29,31.2
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C121654; Spindle cell/sclerosing rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   SRIK-NKL
AC   CVCL_IP68
DR   Wikidata; Q54955675
RX   PubMed=15927673;
CC   Population: Caucasian.
CC   Doubling time: 36-48 hours (PubMed=15927673).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: NK T-cell; CL=CL_0000814.
ST   Source(s): PubMed=15927673
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16-17Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 5
//
ID   SRM
AC   CVCL_W497
DR   Wikidata; Q54955677
RX   PubMed=8343449;
CC   Population: Japanese.
CC   Doubling time: 23 hours (PubMed=8343449).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   SRM-1
AC   CVCL_E5JV
SY   Schizothorax richardsonii Muscle-1
DR   NRFC; NRFC079
WW   Provider; NRFC; NRFC079; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC079.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=183910; ! Schizothorax richardsonii (Snowtrout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SRP2070
AC   CVCL_D3Q8
DR   Wikidata; Q127384326
RX   Patent=US11773161;
RX   PubMed=32669569;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P0ABE7; Escherichia coli cybC (Note=AA 23-128 with p.Met29Trp, p.His124Ile and p.Arg128Leu = BRIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SRS-82
AC   CVCL_XA35
DR   Wikidata; Q98132820
RX   CelloPub=CLPUB00530;
RX   CelloPub=CLPUB00531;
RX   DOI=10.1007/BF02997220;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   SRT
AC   CVCL_L420
DR   Wikidata; Q54955678
RX   PubMed=2957013;
CC   Doubling time: ~18 hours (PubMed=2957013).
CC   Derived from site: In situ; Paranasal sinus; UBERON=UBERON_0001825.
DI   NCIt; C134781; Ovine sinus tumor
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   SRT-1
AC   CVCL_VK53
SY   SRT 1; SRT clone No.1
DR   Wikidata; Q98132823
RX   PubMed=2957013;
CC   Derived from site: In situ; Paranasal sinus; UBERON=UBERON_0001825.
DI   NCIt; C134781; Ovine sinus tumor
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_L420 ! SRT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   SRT-2
AC   CVCL_VK40
SY   SRT 2; SRT clone No.2
DR   Wikidata; Q98132824
RX   PubMed=2957013;
CC   Derived from site: In situ; Paranasal sinus; UBERON=UBERON_0001825.
DI   NCIt; C134781; Ovine sinus tumor
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
HI   CVCL_L420 ! SRT
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   SRTF
AC   CVCL_A8VU
SY   Standard Ryukin Takafumi Fin
DR   Wikidata; Q108821327
RX   PubMed=23999703;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by cyprinid herpesvirus 2 (CyHV-2) (PubMed=23999703).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Breed/subspecies: Standard Ryukin Takafumi.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   Ss
AC   CVCL_B7LQ
SY   SS
DR   Wikidata; Q112930424
RX   PubMed=7951244;
RX   PubMed=9536093;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9536093).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SS-1
AC   CVCL_W375
DR   Wikidata; Q54955679
RX   PubMed=20712709;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=20712709).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   SS-2
AC   CVCL_YD51
DR   RCB; RCB5663
DR   Wikidata; Q98132825
RX   PubMed=31648389;
CC   Population: Japanese.
CC   Derived from site: In situ; Colon, ascending; UBERON=UBERON_0001156.
ST   Source(s): PubMed=31648389
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8
ST   D16S539: 10,11
ST   D21S11: 30
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C6761; Colon small cell neuroendocrine carcinoma
DI   ORDO; Orphanet_100080; Neuroendocrine tumor of the colon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 8
//
ID   SS-A3-1
AC   CVCL_5367
DR   CLO; CLO_0050836
DR   RCB; RCB1518
DR   Wikidata; Q54955680
RX   PubMed=9428931;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_T754 ! SS-P
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   SS-ES-1
AC   CVCL_A681
DR   Cosmic; 1483097
DR   Wikidata; Q54955681
RX   PubMed=20962673;
CC   Population: Iranian.
CC   Doubling time: 35 hours (PubMed=20962673).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=20962673).
CC   Derived from site: In situ; Chest, soft tissue; UBERON=UBERON_0001443+UBERON_0034929.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   SS-P
AC   CVCL_T754
DR   Wikidata; Q54955682
RX   PubMed=9428931;
CC   Breed/subspecies: Fischer 344/DuCrj; RS=RS_0000305.
DI   NCIt; C60403; Rat fibrosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   SS1C
AC   CVCL_6E61
SY   Solea Senegalensis 1C
DR   Wikidata; Q54955683
RX   DOI=10.1111/jai.12539;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone, vertebra; UBERON=UBERON_0002412.
OX   NCBI_TaxID=28829; ! Solea senegalensis (Senegalese sole)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   SS23
AC   CVCL_RY76
DR   JCRB; JCRB1710
DR   Wikidata; Q54955684
RX   PubMed=3391611;
RX   PubMed=10200052;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.68-1G>C; ClinVar=VCV000251005; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=10200052).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1710
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   SS713
AC   CVCL_F583
SY   SS76; TER127; Extract 335
DR   IPD-IMGT/HLA; 11400
DR   Wikidata; Q54955685
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,25:01; B*15:14,18:01; C*03:03,12:03 (IPD-IMGT/HLA=11400).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 12
//
ID   SS78
AC   CVCL_X166
DR   Cosmic; 972927
DR   Wikidata; Q54955686
RX   PubMed=7319533;
RX   PubMed=7915601;
CC   Population: Caucasian.
CC   Doubling time: 1.5 days (Note=At 29th passage) (PubMed=7319533).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly144Aspfs*15 (c.431delG); ClinVar=VCV000223209; Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   SS9;22
AC   CVCL_A682
SY   SS9:22; SS9-22; SS 9:22
DR   CGH-DB; 9217-4
DR   Cosmic; 998759
DR   Cosmic; 1037679
DR   Cosmic; 2089674
DR   Wikidata; Q54955687
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   SSB
AC   CVCL_B7QD
SY   Silky Shark Brain
DR   Wikidata; Q112930425
RX   CelloPub=CLPUB00705;
RX   DOI=10.1007/BF02631047;
CC   Group: Fish cell line.
CC   Characteristics: Can grow at temperatures ranging from 20 to 37 Celsius with an optimum temperature of 29-30 Celsius (DOI=10.1007/BF02631047).
CC   Doubling time: 67 hours (Note=At 30th passage) (CelloPub=CLPUB00705; DOI=10.1007/BF02631047).
CC   Derived from site: In situ; Embryonic brain; UBERON=UBERON_0006238.
OX   NCBI_TaxID=202609; ! Carcharhinus falciformis (Silky shark)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   SSC-S1
AC   CVCL_XC02
DR   CCRID; 5301SWI-KCB00015ZJ
DR   KCB; KCB 200015ZJ
DR   Wikidata; Q98132826
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   SSC-S2
AC   CVCL_WZ61
DR   CCRID; 5301SWI-KCB02015ZJ
DR   KCB; KCB 200215ZJ
DR   Wikidata; Q98132827
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Wuzhishan miniature pig; VBO=VBO_0012869.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 8
//
ID   SSC-S3
AC   CVCL_A9FM
DR   CCRID; 5301SWI-KCB11084ZJ
DR   KCB; KCB 2011084ZJ
DR   Wikidata; Q108821328
CC   Group: Endangered species/breed cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Changbai Mountains wild boar.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SSC-S4
AC   CVCL_A9FN
DR   CCRID; 5301SWI-KCB15023ZJ
DR   KCB; KCB 2015023ZJ
DR   Wikidata; Q108821329
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SSC-S5
AC   CVCL_A9FP
DR   CCRID; 5301SWI-KCB1521SZJ
DR   KCB; KCB 2015021SZJ
DR   Wikidata; Q108821330
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SSE-30
AC   CVCL_R823
SY   Sockeye Salmon Embryo-30
DR   Wikidata; Q54955688
RX   PubMed=6542066;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8023; ! Oncorhynchus nerka (Sockeye salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   SSE-5
AC   CVCL_4305
SY   SSE 5; Sockeye Salmon Embryo-5
DR   CLO; CLO_0009138
DR   CLO; CLO_0009139
DR   CLDB; cl4402
DR   ECACC; 95122021
DR   IZSLER; BS CL 80
DR   Wikidata; Q54955689
RX   CelloPub=CLPUB00703;
RX   PubMed=6542066;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) (CelloPub=CLPUB00703).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8023; ! Oncorhynchus nerka (Sockeye salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   SSF-1
AC   CVCL_L009
AS   CVCL_XE37
SY   SSF-VIEV-1; SSF (VIEV)-1; Siberian Sturgeon Fin-1
DR   Wikidata; Q54955690
RX   CelloPub=CLPUB00301;
RX   CelloPub=CLPUB00445;
RX   DOI=10.1088/1755-1315/315/7/072006;
RX   Patent=RU2488632;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 76.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   SSF-2
AC   CVCL_L010
SY   SSF-VIEV-2; SSF (VIEV)-2; Siberian Sturgeon Fin-2
DR   Wikidata; Q54955691
RX   CelloPub=CLPUB00301;
RX   CelloPub=CLPUB00445;
RX   DOI=10.1088/1755-1315/315/7/072006;
RX   PubMed=20066954;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   SSF-3
AC   CVCL_A2SW
SY   SSF-VIEV-3; SSF (VIEV)-3; Siberian Sturgeon Fin-3
DR   Wikidata; Q105511128
RX   DOI=10.1088/1755-1315/315/7/072006;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   ssf-MDCK
AC   CVCL_WL76
DR   FCS-free; 41-14-426-2-3-4
DR   Wikidata; Q98132828
RX   PubMed=21848001;
CC   Group: Serum/protein free medium cell line.
CC   Characteristics: Adapted to growth in suspension in MDCK-SFM medium.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 8
//
ID   SSH-S1
AC   CVCL_WI04
AS   CVCL_XZ99
SY   SSHS1; KCB 200220
DR   CCRID; 5301OVI-KCB02020ZJ
DR   KCB; KCB 200220ZJ
DR   Wikidata; Q94337314
RX   PubMed=15973503;
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=56194; ! Ovis nivicola (Snow sheep)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   SSH23
AC   CVCL_F839
DR   Wikidata; Q54955692
RX   PubMed=1322670;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   ssHUDEP2
AC   CVCL_YT59
DR   Wikidata; Q98132831
RX   DOI=10.1182/blood-2019-127330;
CC   Population: Japanese.
CC   Characteristics: Expression of the HPV16 E6 and E7 genes is induced by tetracycline (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple_edited; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous; Note=By CRISPR/Cas9 (DOI=10.1182/blood-2019-127330).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Erythroid progenitor cell; CL=CL_0000038.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VI06 ! HUDEP-2
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 11
//
ID   SSI
AC   CVCL_B7M6
DR   Wikidata; Q112930426
RX   PubMed=10395672;
CC   Population: Caucasian; Dutch and Indonesian.
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln321Ter (c.961C>T); Zygosity=Homozygous (PubMed=10395672).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   SSILY
AC   CVCL_M362
DR   Wikidata; Q54955693
RX   PubMed=19067762;
CC   Population: Japanese.
CC   Characteristics: ER-negative, PR-positive and ERBB2-positive.
CC   Doubling time: ~20 hours (PubMed=19067762).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7362; Breast scirrhous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   SsJ1
AC   CVCL_6E05
SY   Salmo salar Jaw 1
DR   Wikidata; Q54955694
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone, jaw; UBERON=UBERON_0001708.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   SSK
AC   CVCL_A8VX
SY   Striped Snakehead Kidney
DR   Wikidata; Q108821331
RX   DOI=10.21077/ijf.2017.64.special-issue.76212-14;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 28 Celsius (DOI=10.21077/ijf.2017.64.special-issue.76212-14).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   SSK-HY-23-42
AC   CVCL_J614
DR   TKG; TKG 0386
DR   Wikidata; Q54955696
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J604 ! TKHMY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   SSK-HY-A3-22
AC   CVCL_J615
DR   TKG; TKG 0384
DR   Wikidata; Q54955697
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J604 ! TKHMY
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   SSK41
AC   CVCL_C123
SY   SSK-41
DR   cancercelllines; CVCL_C123
DR   Cosmic; 1291154
DR   Cosmic; 2297033
DR   Cosmic; 2590021
DR   GEO; GSM115988
DR   GEO; GSM866166
DR   GEO; GSM1035347
DR   GEO; GSM1035348
DR   Progenetix; CVCL_C123
DR   Wikidata; Q54955698
RX   PubMed=1712020;
RX   PubMed=2518730;
RX   PubMed=7849311;
RX   PubMed=16960149;
CC   Characteristics: Expresses surface IgM but can spontaneously switch to the production of IgG1 or IgG3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Originally assigned to be from a follicular lymphoma.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   SSKWB
AC   CVCL_VC39
DR   Wikidata; Q54955699
RX   PubMed=1712020;
CC   Characteristics: Expresses both surface IgM and IgG1.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C123 ! SSK41
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   SSL-1
AC   CVCL_6295
SY   SSL 1; Splenic Stromal cell Line-1
DR   Wikidata; Q54955700
RX   PubMed=8799619;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SSL%201
CC   Group: Bird cell line.
CC   Transformant: NCBI_TaxID; 11889; Rous sarcoma virus (strain Schmidt-Ruppin).
CC   Derived from site: In situ; Embryonic spleen; UBERON=UBERON_0006293.
CC   Cell type: Stromal cell; CL=CL_0000499.
CC   Breed/subspecies: Australorp x White Leghorn; VBO=VBO_0000448+VBO_0000646.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   16FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   SSM-1
AC   CVCL_W289
DR   Wikidata; Q54955701
RX   DOI=10.1007/BF01545086;
RX   DOI=10.5794/jjoms.42.51;
RX   PubMed=8583160;
CC   Population: Japanese.
CC   Doubling time: 70 hours (DOI=10.5794/jjoms.42.51).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C5915; Oral cavity mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   SSMUe001-A
AC   CVCL_C722
SY   SH1
DR   hPSCreg; SSMUe001-A
DR   SKIP; SKIP002071
DR   Wikidata; Q54955702
RX   PubMed=15955827;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 35 hours (Note=Grown on EDF), 33 hours (Note=Grown on MEF) (PubMed=15955827).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   SSMUe002-A
AC   CVCL_C723
SY   SH2
DR   hPSCreg; SSMUe002-A
DR   SKIP; SKIP002072
DR   Wikidata; Q54955703
RX   PubMed=15955827;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 37 hours (Note=Grown on EDF), 38 hours (Note=Grown on MEF) (PubMed=15955827).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   SSMUe003-A
AC   CVCL_C725
SY   SH7
DR   hPSCreg; SSMUe003-A
DR   SKIP; SKIP002073
DR   Wikidata; Q54955705
RX   PubMed=15955827;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SSMUe004-A
AC   CVCL_C724
SY   SH4
DR   hPSCreg; SSMUe004-A
DR   SKIP; SKIP002282
DR   Wikidata; Q54955706
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 32 +- 2 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SSMUe005-A
AC   CVCL_C726
SY   SH28
DR   hPSCreg; SSMUe005-A
DR   SKIP; SKIP002283
DR   Wikidata; Q54955707
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 30 +- 3 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SSMUe006-A
AC   CVCL_C727
SY   SH35; SSMUe007-A
DR   hPSCreg; SSMUe006-A
DR   SKIP; SKIP002284
DR   Wikidata; Q54955708
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 36 +- 1 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   SSMUe006-A-1
AC   CVCL_C728
SY   SH35a; SSMUe007-A
DR   SKIP; SKIP002285
DR   Wikidata; Q54955709
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 33 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C727 ! SSMUe006-A
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   SSMUe008-A
AC   CVCL_C729
SY   SH38
DR   hPSCreg; SSMUe008-A
DR   SKIP; SKIP002286
DR   Wikidata; Q54955710
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 32 +- 3 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SSMUe009-A
AC   CVCL_C730
SY   SH39
DR   hPSCreg; SSMUe009-A
DR   SKIP; SKIP002287
DR   Wikidata; Q54955711
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 39 +- 3 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SSMUe010-A
AC   CVCL_C731
SY   SH42
DR   hPSCreg; SSMUe010-A
DR   SKIP; SKIP002288
DR   Wikidata; Q54955713
RX   PubMed=15916726;
CC   From: Shanghai Second Medical University; Shanghai; China.
CC   Doubling time: 34 +- 2 hours (PubMed=15916726).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 11
//
ID   SSN-1
AC   CVCL_4306
DR   CLO; CLO_0009140
DR   ECACC; 96082808
DR   Wikidata; Q54955714
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/are.12095;
RX   DOI=10.1111/j.1365-2761.1989.tb01290.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
RX   DOI=10.3147/jsfp.34.213;
RX   PubMed=1717644;
RX   PubMed=11145456;
RX   PubMed=19401229;
CC   Group: Fish cell line.
CC   Virology: Persistently infected with snakehead retrovirus (SnRV).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   SSN-1 clone A-6
AC   CVCL_YD10
SY   A-6
DR   Wikidata; Q98132832
RX   PubMed=11145456;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 20 and 25 Celsius (PubMed=11145456).
CC   Virology: Highly susceptible to infection by redspotted grouper nervous necrosis virus (RGNNV) and striped jack nervous necrosis virus (SJNNV). Also susceptible but to a less extent to infection by barfin flounder nervous necrosis virus (BFNNV) and tiger puffer nervous necrosis virus (TPNNV).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
HI   CVCL_4306 ! SSN-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   SSN-1 clone B-7
AC   CVCL_YD11
SY   B-7
DR   Wikidata; Q98132833
RX   PubMed=11145456;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 20 and 25 Celsius (PubMed=11145456).
CC   Virology: Not susceptible to infection by barfin flounder nervous necrosis virus (BFNNV), redspotted grouper nervous necrosis virus (RGNNV), striped jack nervous necrosis virus (SJNNV) and tiger puffer nervous necrosis virus (TPNNV) (PubMed=11145456).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
HI   CVCL_4306 ! SSN-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   SSN-1 clone C-3
AC   CVCL_YD12
SY   C-3
DR   Wikidata; Q98132834
RX   PubMed=11145456;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 25 Celsius but not at 20 Celsius (PubMed=11145456).
CC   Virology: Highly susceptible to infection by redspotted grouper nervous necrosis virus (RGNNV) and striped jack nervous necrosis virus (SJNNV). Not susceptible to infection by barfin flounder nervous necrosis virus (BFNNV) and tiger puffer nervous necrosis virus (TPNNV) (PubMed=11145456).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
HI   CVCL_4306 ! SSN-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   SSN-1 clone E-11
AC   CVCL_4168
AS   CVCL_YD13
SY   E-11; E11
DR   ECACC; 01110916
DR   Wikidata; Q54831638
RX   PubMed=11145456;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 20 and 25 Celsius (PubMed=11145456).
CC   Virology: Persistently infected with snakehead retrovirus (SnRV).
CC   Virology: Highly susceptible to infection by redspotted grouper nervous necrosis virus (RGNNV) and striped jack nervous necrosis virus (SJNNV). Also susceptible but to a less extent to infection by barfin flounder nervous necrosis virus (BFNNV) and tiger puffer nervous necrosis virus (TPNNV) (PubMed=11145456).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
HI   CVCL_4306 ! SSN-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 13
//
ID   SSN-1 clone E-2
AC   CVCL_YD14
SY   E-2
DR   Wikidata; Q98132836
RX   PubMed=11145456;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 20 and 25 Celsius (PubMed=11145456).
CC   Virology: Highly susceptible to infection by redspotted grouper nervous necrosis virus (RGNNV) and striped jack nervous necrosis virus (SJNNV). Also susceptible but to a less extent to infection by barfin flounder nervous necrosis virus (BFNNV) and tiger puffer nervous necrosis virus (TPNNV) (PubMed=11145456).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
HI   CVCL_4306 ! SSN-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   SSN-1 clone E-9
AC   CVCL_YD15
SY   E-9
DR   Wikidata; Q98132837
RX   PubMed=11145456;
CC   Group: Fish cell line.
CC   Characteristics: Grows at 20 and 25 Celsius (PubMed=11145456).
CC   Virology: Highly susceptible to infection by redspotted grouper nervous necrosis virus (RGNNV) and striped jack nervous necrosis virus (SJNNV). Also susceptible but to a less extent to infection by barfin flounder nervous necrosis virus (BFNNV) and tiger puffer nervous necrosis virus (TPNNV) (PubMed=11145456).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
HI   CVCL_4306 ! SSN-1
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 8
//
ID   SSN-2
AC   CVCL_YB43
DR   Wikidata; Q98132838
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
RX   DOI=10.1111/j.1365-2761.1994.tb00246.x;
RX   PubMed=1717644;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   SSN-3
AC   CVCL_S950
DR   Wikidata; Q54955715
RX   PubMed=1717644;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal peduncle; UBERON=UBERON_2000178.
OX   NCBI_TaxID=64152; ! Channa striata (Snakehead murrel)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   SSO-1
AC   CVCL_UC79
SY   Siberian Sturgeon Organs-1
DR   Wikidata; Q98132839
RX   CelloPub=CLPUB00445;
CC   Group: Fish cell line.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 4
//
ID   SSO-2
AC   CVCL_6E45
SY   Siberian Sturgeon Organs-2
DR   Wikidata; Q54955716
RX   CelloPub=CLPUB00445;
RX   PubMed=20066954;
CC   Group: Fish cell line.
OX   NCBI_TaxID=27689; ! Acipenser baerii (Siberian sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 7
//
ID   SSP-25
AC   CVCL_4902
SY   SSP25
DR   CLO; CLO_0050849
DR   BioSample; SAMN03472126
DR   Cell_Model_Passport; SIDM00275
DR   Cosmic; 1187339
DR   Cosmic; 1571786
DR   Cosmic; 2629287
DR   DepMap; ACH-001858
DR   RCB; RCB1293
DR   Wikidata; Q54955717
RX   CelloPub=CLPUB00275;
RX   PubMed=9358283;
RX   PubMed=15767549;
RX   PubMed=27231123;
RX   PubMed=31077409;
RX   PubMed=35640676;
RX   PubMed=39026794;
WW   Info; RCB; -; https://cell.brc.riken.jp/en/rcb/rbessp-25_announce
CC   Problematic cell line: Contaminated. Shown to be a ETK-1 derivative (RCB=RCB1293). Originally thought to originate from a 64 year old female patient with an intrahepatic cholangiocarcinoma.
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: 64 hours (PubMed=9358283).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001858; RCB=RCB1293
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 21
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 19,25
ST   Penta D: 14
ST   Penta E: 15
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1206 ! ETK-1
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SSP-9
AC   CVCL_Y083
SY   Salmo Salar Pronephros-9
DR   Wikidata; Q54955721
RX   PubMed=25230295;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 10
//
ID   SST-2-P-Lu
AC   CVCL_D3X5
DR   TKG; TKG 0813
DR   Wikidata; Q127384329
CC   Characteristics: Established from cancer cell transplanted into rat and metastasized to the lung (TKG=TKG 0813).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 3
//
ID   SST125
AC   CVCL_C8GQ
DR   Wikidata; Q123033555
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   HLA typing: A*01,02; B*18,37; C*06,07 (PubMed=15585611).
CC   Derived from site: Metastatic; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SST140
AC   CVCL_C8GR
DR   Wikidata; Q123033556
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   HLA typing: A*11,26; B*35; C*04 (PubMed=15585611).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SST207
AC   CVCL_C8GS
DR   Wikidata; Q123033557
RX   PubMed=18698046;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SST548
AC   CVCL_C8HJ
DR   Wikidata; Q123033558
RX   PubMed=22892449;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SSTO
AC   CVCL_E836
DR   dbMHC; 49028
DR   ECACC; 86112002
DR   IHW; IHW09302
DR   IPD-IMGT/HLA; 11403
DR   Wikidata; Q54955722
RX   PubMed=18193213;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Amish.
CC   HLA typing: A*32:01:01:01; B*44:02:01:01; C*05:01:01:02; DPA1*01:03; DPB1*04:01:01; DQA1*03:01:01; DQB1*03:05:01; DRB1*04:03:01 (IPD-IMGT/HLA=11403).
CC   HLA typing: A*32:01:01; B*44:02:01:01; C*05:01:01:02; DPA1*01:03:01:04; DPB1*04:01:01:01; DQA1*03:01:01; DQB1*03:05:01; DRB1*04:03:01; DRB4*01:03:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   SSTW
AC   CVCL_T739
DR   Wikidata; Q54955723
RX   PubMed=8391386;
RX   PubMed=19818766;
CC   Population: Japanese.
CC   HLA typing: A*24:01,26:01; B*15:01,46:01; C*01:02,03:03 (PubMed=19818766).
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 8
//
ID   SSTW-9
AC   CVCL_WK59
DR   Wikidata; Q98132841
RX   PubMed=9023415;
RX   PubMed=9178645;
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*15:01,46:01; C*01:02,03:03 (PubMed=9023415).
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T739 ! SSTW
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   SsV2
AC   CVCL_6E06
SY   Salmo salar Vertebra 2
DR   Wikidata; Q54955724
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone, vertebra; UBERON=UBERON_0002412.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   ST [Human leukemia]
AC   CVCL_U347
DR   CLO; CLO_0050980
DR   BioSample; SAMN03472170
DR   cancercelllines; CVCL_U347
DR   Cell_Model_Passport; SIDM01238
DR   RCB; RCB1181
DR   Wikidata; Q54955725
RX   PubMed=7538617;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Thr (c.737T>C); ClinVar=VCV000428886; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1181
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1852 ! Tanoue
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 20
//
ID   ST [Pig testis]
AC   CVCL_2204
SY   Swine Testis; STOMA24; Stoma 24; ST-IOWA; ATCC-ST
DR   BTO; BTO_0004921
DR   CLO; CLO_0009141
DR   CLDB; cl4403
DR   AddexBio; P0028002/4941
DR   ATCC; CRL-1746
DR   BCRC; 60481
DR   CCLV; CCLV-RIE 0606
DR   CCRID; 1102SWI-NIFDC00090
DR   CCRID; 4201SWI-CCTCC00007
DR   CCTCC; GDC0007
DR   CLS; 305214
DR   DSMZ; ACC-641
DR   DSMZCellDive; ACC-641
DR   ECACC; 92040221
DR   IZSLER; BS CL 121
DR   Wikidata; Q54955726
RX   PubMed=4224292;
RX   PubMed=15140978;
RX   PubMed=17005704;
RX   PubMed=19508353;
RX   PubMed=19941903;
RX   PubMed=26744029;
RX   PubMed=31667881;
CC   Virology: Useful for the propagation, assay and isolation of porcine parvovirus (PPV), transmissible gastroenteritis virus (TGEV) and swine enteroviruses (ATCC=CRL-1746).
CC   Doubling time: ~30-40 hours (DSMZ=ACC-641).
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 28
//
ID   ST 13
AC   CVCL_8581
SY   ST-13; ST13
DR   JCRB; JCRB1413
DR   Wikidata; Q54955727
RX   PubMed=6998859;
CC   Breed/subspecies: ddN.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   ST IRF3 KO
AC   CVCL_D3XG
DR   Wikidata; Q127384330
RX   PubMed=38047496;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:89206; IRF3.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   ST IRF3/7 KO
AC   CVCL_D3XI
DR   Wikidata; Q127384332
RX   PubMed=38047496;
CC   Virology: Compared to the parent ST cell line supports a higher level of replication for several types of viruses, such as coronavirus (PEDV), picornavirus (SVA), paramyxovirus (PIV5), and alphavirus (GETV). This is due to the reduced production of interferon alphas and betas and related antiviral factors (PubMed=38047496).
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:89206; IRF3.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:89210; IRF7.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_D3XG ! ST IRF3 KO
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   ST IRF7 KO
AC   CVCL_D3XH
DR   Wikidata; Q127384334
RX   PubMed=38047496;
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:89210; IRF7.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   ST-1 [Human leukemia]
AC   CVCL_0G05
SY   ST1
DR   EFO; EFO_0022625
DR   CGH-DB; 9033-4
DR   IARC_TP53; 26997
DR   Wikidata; Q54955728
RX   PubMed=9172809;
RX   PubMed=9596675;
RX   PubMed=10025895;
RX   PubMed=10190897;
RX   PubMed=10570904;
RX   PubMed=10863977;
RX   PubMed=15638862;
RX   PubMed=19220422;
RX   PubMed=19710698;
RX   PubMed=27193821;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   ST-1 [Human liver]
AC   CVCL_5229
DR   Wikidata; Q54955729
RX   PubMed=3257968;
RX   PubMed=3514636;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=ST-1
CC   Doubling time: 30 hours (PubMed=3514636).
CC   Derived from site: In situ; Fetal liver, stroma; UBERON=UBERON_0016478.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   20FW
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 8
//
ID   ST-1 [Mouse kidney]
AC   CVCL_0536
DR   MCCL; MCC:0000437
DR   Wikidata; Q54955730
RX   CelloPub=CLPUB00231;
RX   PubMed=7503239;
RX   PubMed=10198422;
CC   Derived from site: In situ; Kidney, nephron, thick ascending limb of loop of Henle; UBERON=UBERON_0001291.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 6
//
ID   St-2
AC   CVCL_E3YP
RX   PubMed=8641169;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ZipSV40-6).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   ST-2014S
AC   CVCL_XI68
DR   CCRID; 4201PAT-CCTCC00698
DR   Wikidata; Q98132842
RX   Patent=CN105112352B;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201567.
CC   Characteristics: Adapted to growth in suspension.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 9
//
ID   St-4
AC   CVCL_H265
DR   ChEMBL-Cells; CHEMBL3307553
DR   ChEMBL-Targets; CHEMBL614166
DR   Cosmic; 1436022
DR   IARC_TP53; 21647
DR   PubChem_Cell_line; CVCL_H265
DR   Wikidata; Q54955732
RX   PubMed=2170010;
RX   PubMed=15767549;
RX   PubMed=15900046;
RX   PubMed=22336246;
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205del (c.613_615delTAT); Zygosity=Unspecified (PubMed=15900046).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   ST-4
AC   CVCL_H267
DR   Cosmic; 1086321
DR   Wikidata; Q54955733
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3257718;
RX   PubMed=8558920;
WW   Info; DSMZ; -; https://www.dsmz.de/fileadmin/Bereiche/HumanandAnimalCellLines/False_LL_Cell_Lines.pdf
CC   Problematic cell line: Contaminated. Shown to be a PF-382 derivative. Originally thought to originate from the axillary lymph node biopsy of a 12 year old boy with a T-cell malignant lymphoma.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2493fs*67 (c.7476_7477ins11); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1641 ! PF-382
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   St-4/cDDP
AC   CVCL_Y176
SY   St/DDP
DR   CGH-DB; 9109-4
DR   Wikidata; Q54955734
RX   PubMed=9816187;
RX   PubMed=14973057;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H265 ! St-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 7
//
ID   St-4/CPT
AC   CVCL_H266
SY   St-4 / CPT
DR   CGH-DB; 9108-4
DR   Wikidata; Q54955735
RX   PubMed=2170010;
RX   PubMed=14973057;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27656; Camptothecin (CPT).
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H265 ! St-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 10
//
ID   ST-EAH
AC   CVCL_DP20
DR   Wikidata; Q54955736
RX   PubMed=7517574;
RX   PubMed=10074495;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:44; TAP2; Simple; p.Arg273Ter (c.817C>T) (R253*); ClinVar=VCV000013727; Zygosity=Heterozygous (from familial inference of ST-EMO).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   ST-EMO
AC   CVCL_DP21
DR   Wikidata; Q54955737
RX   PubMed=7517574;
RX   PubMed=10074495;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:44; TAP2; Simple; p.Arg273Ter (c.817C>T) (R253*); ClinVar=VCV000013727; Zygosity=Homozygous (PubMed=7517574).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171267; Bare lymphocyte syndrome type 1
DI   ORDO; Orphanet_34592; Immunodeficiency by defective expression of MHC class I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NE ! STF-1
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   ST-IOWA GGTA1+/-
AC   CVCL_C7HW
SY   ST-IOWA+/-
DR   Wikidata; Q117704895
RX   PubMed=15140978;
CC   Knockout cell: Method=Homologous recombination; VGNC; VGNC:112761; GGTA1 (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   ST-IOWA GGTA1-/-
AC   CVCL_C7HX
SY   ST-IOWA-/-
DR   Wikidata; Q117704896
RX   PubMed=15140978;
CC   Knockout cell: Method=Homologous recombination; VGNC; VGNC:112761; GGTA1 (Note=1 of 2 alleles. The second allele was spontaneously deleted).
CC   Sequence variation: Gene deletion; VGNC; VGNC:112761; GGTA1; Zygosity=Heterozygous (PubMed=15140978).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_C7HW ! ST-IOWA GGTA1+/-
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   ST-IOWA/PERV-C(1312)
AC   CVCL_YE73
DR   Wikidata; Q98132843
RX   PubMed=17005704;
RX   PubMed=31667881;
CC   Virology: Infected with porcine endogenous retrovirus PERV-C(1312).
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ST-IOWA/PERV-C(5683)
AC   CVCL_YE74
DR   Wikidata; Q98132844
RX   PubMed=31667881;
CC   Virology: Infected with porcine endogenous retrovirus PERV-C(5683).
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   ST-Mel
AC   CVCL_7145
DR   cancercelllines; CVCL_7145
DR   Cosmic; 1295331
DR   Wikidata; Q54955738
RX   PubMed=11121133;
RX   PubMed=19799798;
RX   PubMed=29492214;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly466Glu (c.1397G>A); ClinVar=VCV000376073; Zygosity=Unspecified (PubMed=19799798; PubMed=29492214).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   St-T1b
AC   CVCL_0G06
DR   ECACC; 09102901
DR   Wikidata; Q54955739
RX   PubMed=19619280;
CC   Doubling time: ~24 hours (PubMed=19619280).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: ECACC; 09102901; true.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 14
//
ID   ST/aut
AC   CVCL_D678
SY   ST/AUT
DR   BCRJ; 0228
DR   Wikidata; Q54955740
RX   PubMed=3507390;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=452646; ! Neovison vison (American mink)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   ST03
AC   CVCL_XF14
DR   ABCD; ABCD_AM345
DR   CCRID; 4201PAT-CCTCC00433
DR   Wikidata; Q98132845
RX   Patent=US9176136;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013187.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: ChEBI; CHEBI_18227; Sterigmatocystin (ST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   ST1
AC   CVCL_Y456
DR   ATCC; CRL-6552
DR   Wikidata; Q54955741
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6552; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=62906; ! Sorex trowbridgii (Trowbridge's shrew)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   ST14A
AC   CVCL_M588
DR   Wikidata; Q54955742
RX   PubMed=9671979;
RX   PubMed=11161610;
RX   PubMed=18853328;
RX   PubMed=22863662;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/animal-stem-cells-catalogue-isenet.pdf
CC   Characteristics: At the permissive temperature (33 Celsius) proliferates. At the restrictive temperature (39 Celsius) has reduced proliferation, decreased expression of nestin and differentiates into neuronal cells.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   ST14A HTT-Q120
AC   CVCL_DN68
SY   CHDI-90000065-2; CH01137; N548 mutant cells
DR   Coriell; CH01137
DR   Wikidata; Q54955744
RX   PubMed=17195849;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4851; HTT (Note=AA 1-548 region with 120-Q run).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M588 ! ST14A
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   ST14A HTT-Q120 High
AC   CVCL_DN69
SY   CHDI-90000067; CH00067
DR   Coriell; CH00067
DR   Wikidata; Q54955745
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4851; HTT (Note=AA 1-548 region with 120-Q run).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M588 ! ST14A
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   ST14A HTT-Q15
AC   CVCL_DN70
SY   CHDI-90000066; CH00066
DR   Coriell; CH00066
DR   Wikidata; Q54955747
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4851; HTT (Note=AA 1-548 region with 15-Q run).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M588 ! ST14A
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 13
//
ID   ST14A HTT-Q15 High
AC   CVCL_DN71
SY   CHDI-90000068; CH00068
DR   Coriell; CH00068
DR   Wikidata; Q54955748
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4851; HTT (Note=AA 1-548 region with 15-Q run).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_M588 ! ST14A
SX   Sex unspecified
AG   14FD
CA   Conditionally immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 14
//
ID   ST15A
AC   CVCL_0537
SY   St15A
DR   MCCL; MCC:0000438
DR   Wikidata; Q54955749
RX   Patent=US5270191;
RX   PubMed=2065021;
RX   PubMed=2856096;
CC   Characteristics: At the permissive temperature (33 Celsius) proliferates. At the restrictive temperature (39 Celsius) has reduced proliferation and the cells can differentiate into either neurons or glial cells depending on the culture conditions.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2D
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   St16
AC   CVCL_RM01
SY   ST16
DR   Wikidata; Q54955750
RX   PubMed=1846553;
RX   PubMed=8194883;
RX   PubMed=10562577;
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   ST2
AC   CVCL_2205
SY   ST-2
DR   BTO; BTO_0005997
DR   CLO; CLO_0009142
DR   CLO; CLO_0051025
DR   DSMZ; ACC-333
DR   DSMZCellDive; ACC-333
DR   RCB; RCB0224
DR   Wikidata; Q54955731
RX   PubMed=2787384;
RX   PubMed=3261687;
RX   PubMed=3264531;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=ST2
CC   Characteristics: Can differentiate into osteoblasts, adipocytes and hematopoietic supporting cells.
CC   Doubling time: ~30-50 hours (DSMZ=ACC-333).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BC8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   ST2-BA-1.1-07E04-02B07-02G06
AC   CVCL_A0GQ
SY   7E4
DR   Wikidata; Q108821332
RX   Patent=US10745484;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10431.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   ST2-BA-1.1-09F08-02D04-01F05
AC   CVCL_A0GR
SY   9F8
DR   Wikidata; Q108821333
RX   Patent=US10745484;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-10432.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 02-05-24; Version: 4
//
ID   ST2-S10
AC   CVCL_WX24
SY   ST2-s10
DR   Wikidata; Q98132846
RX   PubMed=1708811;
RX   PubMed=3264531;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BC8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2205 ! ST2
SX   Sex unspecified
AG   Age unspecified
CA   Stromal cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   ST38c
AC   CVCL_E6BU
DR   ABM; T0652
RX   PubMed=24440575;
CC   Characteristics: Expresses functional androgen receptors (PubMed=24440575).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Tg(VIM-Tag)3Pau transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   St42
AC   CVCL_RM00
SY   ST42
DR   Cosmic; 1460705
DR   Wikidata; Q54955751
RX   PubMed=1846553;
RX   PubMed=8194883;
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   ST42B/H7
AC   CVCL_E9UU
SY   ST42B
RX   PubMed=16046671;
WW   Info; EuroMAbNet; -; https://www.euromabnet.com/monoclonal-antibodies/bcl6/44.html
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P41182; Human BCL6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ST486
AC   CVCL_1712
SY   ST 486
DR   CLO; CLO_0009143
DR   EFO; EFO_0002353
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1647
DR   BioSample; SAMN03471412
DR   BioSample; SAMN10988193
DR   cancercelllines; CVCL_1712
DR   Cell_Model_Passport; SIDM01198
DR   ChEMBL-Cells; CHEMBL3308887
DR   ChEMBL-Targets; CHEMBL2366293
DR   Cosmic; 687853
DR   Cosmic; 910906
DR   Cosmic; 931134
DR   Cosmic; 2808232
DR   Cosmic-CLP; 910906
DR   DepMap; ACH-000567
DR   EGA; EGAS00001000978
DR   GDSC; 910906
DR   GEO; GSM887649
DR   GEO; GSM888741
DR   GEO; GSM1670480
DR   IARC_TP53; 182
DR   IARC_TP53; 27043
DR   IGRhCellID; ST486
DR   LiGeA; CCLE_392
DR   LINCS_LDP; LCL-2026
DR   PharmacoDB; ST486_1497_2019
DR   Progenetix; CVCL_1712
DR   PubChem_Cell_line; CVCL_1712
DR   Wikidata; Q54955752
RX   PubMed=1325212;
RX   PubMed=2052620;
RX   PubMed=3026973;
RX   PubMed=3080238;
RX   PubMed=3100061;
RX   PubMed=3921823;
RX   PubMed=6243721;
RX   PubMed=6243722;
RX   PubMed=6265077;
RX   PubMed=6286763;
RX   PubMed=6328505;
RX   PubMed=7757991;
RX   PubMed=8176200;
RX   PubMed=8220424;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=8515068;
RX   PubMed=8568269;
RX   PubMed=9192833;
RX   PubMed=9473234;
RX   PubMed=9643977;
RX   PubMed=9973220;
RX   PubMed=11587216;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24590883;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MYC genetic alteration cell panel (ATCC TCP-1035).
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: 20 hours (PubMed=8402660); 19-20 hours (ATCC=CRL-1647).
CC   HLA typing: A*02:11,25:01; B*18:01,52:01; C*12:03,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=6328505; PubMed=9643977; PubMed=11587216).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Unspecified (PubMed=2052620; PubMed=8344493).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.3%; Native American=2.43%; East Asian, North=1.27%; East Asian, South=0%; South Asian=1.74%; European, North=54.96%; European, South=39.3% (PubMed=30894373).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-1647; Cosmic-CLP=910906
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 18,25
ST   D3S1358: 14,20
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   D8S1179: 10,11
ST   FGA: 19,22
ST   Penta D: 10,15
ST   Penta E: 10,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   ST821
AC   CVCL_C6MD
SY   ST 821
DR   Wikidata; Q116050530
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8241
AC   CVCL_C6ME
SY   ST 8241
DR   Wikidata; Q116050531
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8246
AC   CVCL_C6KQ
SY   ST/8246; ST 8246
DR   Wikidata; Q116050532
RX   PubMed=1431313;
RX   PubMed=6235882;
RX   PubMed=8386866;
CC   Characteristics: Produces extracellular, membrane-associated and cytoplasmic IgM (PubMed=1431313).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a patient suffering from a traumatic rupture of the spleen.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8251
AC   CVCL_C6MF
SY   ST 8251
DR   Wikidata; Q116050533
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8252
AC   CVCL_C6MG
SY   ST 8252
DR   Wikidata; Q116050535
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8363
AC   CVCL_C6MH
SY   ST 8363
DR   Wikidata; Q116050536
RX   PubMed=6235882;
CC   Karyotypic information: Hypotetraploid (PubMed=6235882).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8367
AC   CVCL_C6MI
SY   ST 8367
DR   Wikidata; Q116050537
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST8368
AC   CVCL_C6MJ
SY   ST 8368
DR   Wikidata; Q116050538
RX   PubMed=6235882;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST87/MHT1
AC   CVCL_C6KR
DR   Wikidata; Q116050539
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y9M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST88-14
AC   CVCL_8916
SY   ST88.14; ST 88-14; ST-8814; ST8814; 88-14; NF188-14
DR   EFO; EFO_0006295
DR   cancercelllines; CVCL_8916
DR   Cosmic; 1132063
DR   Cosmic; 1644550
DR   Cosmic; 1801814
DR   Cosmic; 2307729
DR   GEO; GSM1676331
DR   GEO; GSM1701663
DR   Wikidata; Q54955754
RX   PubMed=1568246;
RX   PubMed=1906341;
RX   PubMed=7627966;
RX   PubMed=9766530;
RX   PubMed=10791998;
RX   PubMed=16239399;
RX   PubMed=16510576;
RX   PubMed=18650488;
RX   PubMed=21084276;
RX   PubMed=22346343;
RX   PubMed=23437333;
RX   PubMed=24726063;
RX   PubMed=26351324;
RX   PubMed=28469964;
RX   PubMed=28556483;
RX   PubMed=32076030;
RX   PubMed=32642732;
RX   PubMed=34059954;
RX   PubMed=36818284;
RX   PubMed=37798904;
CC   Doubling time: ~24 hours (PubMed=21084276); 1.59 days (PubMed=37798904).
CC   Karyotypic information: Average ploidy of 2.60 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous; Note=By translocation (PubMed=34059954).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg304Ter (c.910C>T); ClinVar=VCV000187722; Zygosity=Heterozygous; Note=Germline (PubMed=32642732; PubMed=36818284).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): PubMed=28556483; PubMed=32076030; PubMed=36818284
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15 (PubMed=28556483)
ST   D3S1358: 15,18 (PubMed=32076030; PubMed=36818284)
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 9,13
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 16
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   ST88-3
AC   CVCL_IU70
SY   88-3; NF188-3
DR   Wikidata; Q54955755
RX   PubMed=1568246;
RX   PubMed=1906341;
RX   PubMed=10791998;
RX   PubMed=16510576;
RX   PubMed=28469964;
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 6
//
ID   ST88/MHT2
AC   CVCL_C6KS
DR   Wikidata; Q116050540
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6L2 ! ST90/MHT7
OI   CVCL_C6L3 ! ST90/MHT8
SX   Female
AG   32Y9M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST89/MGH3
AC   CVCL_C6KT
DR   Wikidata; Q116050541
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KX ! ST90/MGH9
OI   CVCL_C6KY ! ST90/MGH10
OI   CVCL_C6KZ ! ST90/MGH11
OI   CVCL_C6L0 ! ST90/MGH12
OI   CVCL_C6L1 ! ST90/MGH13
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST89/MHT4
AC   CVCL_C6KU
DR   Wikidata; Q116050542
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KV ! ST89/MHT5
OI   CVCL_C6L5 ! ST90/MHT15
OI   CVCL_C6L6 ! ST90/MHT16
OI   CVCL_C6L7 ! ST90/MHT17
OI   CVCL_C6L8 ! ST90/MHT18
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST89/MHT5
AC   CVCL_C6KV
DR   Wikidata; Q116050543
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KU ! ST89/MHT4
OI   CVCL_C6L5 ! ST90/MHT15
OI   CVCL_C6L6 ! ST90/MHT16
OI   CVCL_C6L7 ! ST90/MHT17
OI   CVCL_C6L8 ! ST90/MHT18
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST89/MHT6
AC   CVCL_C6KW
SY   ST89/MGH6
DR   Wikidata; Q116050544
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6L9 ! ST90/MHT19
OI   CVCL_C6LA ! ST90/MHT20
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MGH9
AC   CVCL_C6KX
DR   Wikidata; Q116050545
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KT ! ST89/MGH3
OI   CVCL_C6KY ! ST90/MGH10
OI   CVCL_C6KZ ! ST90/MGH11
OI   CVCL_C6L0 ! ST90/MGH12
OI   CVCL_C6L1 ! ST90/MGH13
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MGH10
AC   CVCL_C6KY
DR   Wikidata; Q116050546
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KT ! ST89/MGH3
OI   CVCL_C6KX ! ST90/MGH9
OI   CVCL_C6KZ ! ST90/MGH11
OI   CVCL_C6L0 ! ST90/MGH12
OI   CVCL_C6L1 ! ST90/MGH13
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MGH11
AC   CVCL_C6KZ
DR   Wikidata; Q116050547
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KT ! ST89/MGH3
OI   CVCL_C6KX ! ST90/MGH9
OI   CVCL_C6KY ! ST90/MGH10
OI   CVCL_C6L0 ! ST90/MGH12
OI   CVCL_C6L1 ! ST90/MGH13
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MGH12
AC   CVCL_C6L0
DR   Wikidata; Q116050548
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KT ! ST89/MGH3
OI   CVCL_C6KX ! ST90/MGH9
OI   CVCL_C6KY ! ST90/MGH10
OI   CVCL_C6KZ ! ST90/MGH11
OI   CVCL_C6L1 ! ST90/MGH13
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MGH13
AC   CVCL_C6L1
DR   Wikidata; Q116050549
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KT ! ST89/MGH3
OI   CVCL_C6KX ! ST90/MGH9
OI   CVCL_C6KY ! ST90/MGH10
OI   CVCL_C6KZ ! ST90/MGH11
OI   CVCL_C6L0 ! ST90/MGH12
SX   Female
AG   29Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT7
AC   CVCL_C6L2
DR   Wikidata; Q116050550
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KS ! ST88/MHT2
OI   CVCL_C6L3 ! ST90/MHT8
SX   Female
AG   32Y9M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT8
AC   CVCL_C6L3
DR   Wikidata; Q116050551
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KS ! ST88/MHT2
OI   CVCL_C6L2 ! ST90/MHT7
SX   Female
AG   32Y9M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT14
AC   CVCL_C6L4
DR   Wikidata; Q116050552
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y3M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT15
AC   CVCL_C6L5
DR   Wikidata; Q116050553
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KU ! ST89/MHT4
OI   CVCL_C6KV ! ST89/MHT5
OI   CVCL_C6L6 ! ST90/MHT16
OI   CVCL_C6L7 ! ST90/MHT17
OI   CVCL_C6L8 ! ST90/MHT18
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT16
AC   CVCL_C6L6
DR   Wikidata; Q116050554
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KU ! ST89/MHT4
OI   CVCL_C6KV ! ST89/MHT5
OI   CVCL_C6L5 ! ST90/MHT15
OI   CVCL_C6L7 ! ST90/MHT17
OI   CVCL_C6L8 ! ST90/MHT18
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT17
AC   CVCL_C6L7
DR   Wikidata; Q116050556
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KU ! ST89/MHT4
OI   CVCL_C6KV ! ST89/MHT5
OI   CVCL_C6L5 ! ST90/MHT15
OI   CVCL_C6L6 ! ST90/MHT16
OI   CVCL_C6L8 ! ST90/MHT18
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT18
AC   CVCL_C6L8
DR   Wikidata; Q116050557
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KU ! ST89/MHT4
OI   CVCL_C6KV ! ST89/MHT5
OI   CVCL_C6L5 ! ST90/MHT15
OI   CVCL_C6L6 ! ST90/MHT16
OI   CVCL_C6L7 ! ST90/MHT17
SX   Female
AG   51Y6M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT19
AC   CVCL_C6L9
DR   Wikidata; Q116050558
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KW ! ST89/MHT6
OI   CVCL_C6LA ! ST90/MHT20
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT20
AC   CVCL_C6LA
DR   Wikidata; Q116050559
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6KW ! ST89/MHT6
OI   CVCL_C6L9 ! ST90/MHT19
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT21
AC   CVCL_C6LB
DR   Wikidata; Q116050560
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LC ! ST90/MHT22
OI   CVCL_C6LD ! ST90/MHT23
OI   CVCL_C6LE ! ST90/MHT24
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT22
AC   CVCL_C6LC
DR   Wikidata; Q116050561
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LB ! ST90/MHT21
OI   CVCL_C6LD ! ST90/MHT23
OI   CVCL_C6LE ! ST90/MHT24
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT23
AC   CVCL_C6LD
DR   Wikidata; Q116050562
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LB ! ST90/MHT21
OI   CVCL_C6LC ! ST90/MHT22
OI   CVCL_C6LE ! ST90/MHT24
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT24
AC   CVCL_C6LE
DR   Wikidata; Q116050563
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LB ! ST90/MHT21
OI   CVCL_C6LC ! ST90/MHT22
OI   CVCL_C6LD ! ST90/MHT23
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST90/MHT25
AC   CVCL_C6LF
DR   Wikidata; Q116050564
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT26
AC   CVCL_C6LG
DR   Wikidata; Q116050565
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LK ! ST91/MHT30
SX   Female
AG   30Y11M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT27
AC   CVCL_C6LH
DR   Wikidata; Q116050567
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LI ! ST91/MHT28
OI   CVCL_C6LJ ! ST91/MHT29
SX   Female
AG   19Y2M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT28
AC   CVCL_C6LI
DR   Wikidata; Q116050568
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LH ! ST91/MHT27
OI   CVCL_C6LJ ! ST91/MHT29
SX   Female
AG   19Y2M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT29
AC   CVCL_C6LJ
DR   Wikidata; Q116050569
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LH ! ST91/MHT27
OI   CVCL_C6LI ! ST91/MHT28
SX   Female
AG   19Y2M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT30
AC   CVCL_C6LK
DR   Wikidata; Q116050570
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6LG ! ST91/MHT26
SX   Female
AG   30Y11M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT31
AC   CVCL_C6LL
DR   Wikidata; Q116050572
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y8M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT32
AC   CVCL_C6LM
DR   Wikidata; Q116050573
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y11M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT33
AC   CVCL_C6LN
DR   Wikidata; Q116050574
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y3M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT34
AC   CVCL_C6LP
DR   Wikidata; Q116050575
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y7M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ST91/MHT35
AC   CVCL_C6LQ
DR   Wikidata; Q116050576
RX   PubMed=8386866;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C60989; Myasthenia gravis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y11M
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   STA
AC   CVCL_X372
SY   Soft-shelled Turtle Artery
DR   Wikidata; Q54955756
RX   DOI=10.3147/jsfp.48.126;
CC   Group: Reptilian cell line.
CC   Virology: Susceptible to infection by soft-shelled turtle iridovirus (STIV).
CC   Derived from site: In situ; Carotid artery; UBERON=UBERON_0005396.
OX   NCBI_TaxID=13735; ! Pelodiscus sinensis (Chinese softshell turtle)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 9
//
ID   STA-BT-1
AC   CVCL_B466
DR   Wikidata; Q54955757
RX   PubMed=17084022;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   STA-BT-15
AC   CVCL_B467
DR   Wikidata; Q54955758
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   STA-BT-3
AC   CVCL_B468
DR   Wikidata; Q54955759
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   STA-BT-6
AC   CVCL_B469
DR   Wikidata; Q54955760
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   STA-ET-1
AC   CVCL_9681
SY   STA-ET1; STAET1; St. Anna Kinderspital-Ewing Tumor-1
DR   EFO; EFO_0002862
DR   cancercelllines; CVCL_9681
DR   Cosmic; 2250473
DR   GEO; GSM510010
DR   IARC_TP53; 23641
DR   Progenetix; CVCL_9681
DR   Wikidata; Q54955761
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21822310;
RX   PubMed=25223734;
RX   PubMed=26428435;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792; PubMed=25223734).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=9393981).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 12
ST   D18S51: 14,18
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D8S1179: 8,15
ST   FGA: 21,24
ST   SE33: 14,16
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S862 ! SAL1
OI   CVCL_F122 ! SAL2
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   STA-ET-10
AC   CVCL_9682
SY   STAET10; ET10; St. Anna Kinderspital-Ewing Tumor-10
DR   cancercelllines; CVCL_9682
DR   GEO; GSM510012
DR   IARC_TP53; 27039
DR   Progenetix; CVCL_9682
DR   Wikidata; Q54955763
RX   PubMed=9393981;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21822310;
RX   PubMed=26428435;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:18562; FEV; Name(s)=EWSR1-FEV, EWS-FEV (PubMed=9393981).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X
ST   D16S539: 10,14
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 21,22
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D8S1179: 13,14
ST   FGA: 22.2,25
ST   SE33: 19,28.2
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   STA-ET-11
AC   CVCL_9683
SY   STAET11; St. Anna Kinderspital-Ewing Tumor-11
DR   Wikidata; Q54955764
RX   PubMed=9393981;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=9393981).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   STA-ET-12
AC   CVCL_9684
SY   St. Anna Kinderspital-Ewing Tumor-12
DR   Wikidata; Q54955769
RX   PubMed=9393981;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   STA-ET-14
AC   CVCL_9685
SY   St. Anna Kinderspital-Ewing Tumor-14
DR   Wikidata; Q54955770
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   STA-ET-2.1
AC   CVCL_9686
SY   STA-ET2.1; STA-ET-2_1; STAET2.1; St. Anna Kinderspital-Ewing Tumor-2.1
DR   EFO; EFO_0002863
DR   cancercelllines; CVCL_9686
DR   Cosmic; 1388902
DR   GEO; GSM510011
DR   IARC_TP53; 80
DR   IARC_TP53; 23643
DR   Progenetix; CVCL_9686
DR   Wikidata; Q54955771
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21822310;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=9393981).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Tyr (c.830G>A); ClinVar=VCV000185722; Zygosity=Unspecified (PubMed=8378080; PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 12,14
ST   D21S11: 30.2,31.2
ST   D2S1338: 16,19
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D8S1179: 12,13
ST   FGA: 22,27
ST   SE33: 17,27.2
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 15,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9687 ! STA-ET-2.2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   STA-ET-2.2
AC   CVCL_9687
SY   St. Anna Kinderspital-Ewing Tumor-2.2
DR   cancercelllines; CVCL_9687
DR   Wikidata; Q54955772
RX   PubMed=8378080;
RX   PubMed=9393981;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Tyr (c.830G>A); ClinVar=VCV000185722; Zygosity=Unspecified (PubMed=8378080).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9686 ! STA-ET-2.1
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   STA-ET-3
AC   CVCL_9688
SY   St. Anna Kinderspital-Ewing Tumor-3
DR   Cosmic; 2250475
DR   IARC_TP53; 23644
DR   Wikidata; Q54955773
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=25223734;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   STA-ET-4
AC   CVCL_9689
SY   St. Anna Kinderspital-Ewing Tumor-4
DR   IARC_TP53; 23645
DR   Wikidata; Q54955774
RX   PubMed=8378080;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   STA-ET-5
AC   CVCL_9690
SY   St. Anna Kinderspital-Ewing Tumor-5
DR   IARC_TP53; 23646
DR   Wikidata; Q54955775
RX   PubMed=8378080;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   STA-ET-6
AC   CVCL_9691
SY   St. Anna Kinderspital-Ewing Tumor-6
DR   IARC_TP53; 23647
DR   Wikidata; Q54955776
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   STA-ET-7.1
AC   CVCL_9692
SY   STA-ET-7_1; St. Anna Kinderspital-Ewing Tumor-7.1
DR   cancercelllines; CVCL_9692
DR   Cosmic; 1388898
DR   IARC_TP53; 711
DR   Wikidata; Q54955777
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=11507040;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8378080).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9693 ! STA-ET-7.2
OI   CVCL_9694 ! STA-ET-7.3
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   STA-ET-7.2
AC   CVCL_9693
SY   STA-ET-7_2; St. Anna Kinderspital-Ewing Tumor-7.2
DR   cancercelllines; CVCL_9693
DR   Cosmic; 1388899
DR   IARC_TP53; 23648
DR   Wikidata; Q54955778
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=11507040;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8378080).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9692 ! STA-ET-7.1
OI   CVCL_9694 ! STA-ET-7.3
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   STA-ET-7.3
AC   CVCL_9694
SY   St. Anna Kinderspital-Ewing Tumor-7.3
DR   Wikidata; Q54955780
RX   PubMed=9393981;
RX   PubMed=11507040;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9692 ! STA-ET-7.1
OI   CVCL_9693 ! STA-ET-7.2
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   STA-ET-8.1
AC   CVCL_9695
SY   STA-ET-8; St. Anna Kinderspital-Ewing Tumor-8.1
DR   Cosmic; 2250478
DR   IARC_TP53; 23649
DR   Wikidata; Q54955781
RX   PubMed=8378080;
RX   PubMed=9393981;
RX   PubMed=25223734;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro152Thr (c.454C>A); Zygosity=Unspecified (PubMed=25223734).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9696 ! STA-ET-8.2
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   STA-ET-8.2
AC   CVCL_9696
SY   St. Anna Kinderspital-Ewing Tumor-8.2
DR   Wikidata; Q54955782
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9695 ! STA-ET-8.1
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   STA-ET-9
AC   CVCL_9697
SY   St. Anna Kinderspital-Ewing Tumor-9
DR   Wikidata; Q54955783
RX   PubMed=9393981;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   STA-NB-1.1
AC   CVCL_9883
SY   St. Anna Kinderspital-Neuroblastoma-1.1
DR   Wikidata; Q54955784
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=18165268;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9884 ! STA-NB-1.2
SX   Male
AG   3Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   STA-NB-1.2
AC   CVCL_9884
SY   St. Anna Kinderspital-Neuroblastoma-1.2
DR   Wikidata; Q54955785
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9883 ! STA-NB-1.1
SX   Male
AG   3Y9M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   STA-NB-10
AC   CVCL_9885
SY   STANB10; St. Anna Kinderspital-Neuroblastoma-10
DR   cancercelllines; CVCL_9885
DR   Cosmic; 1526655
DR   GEO; GSM563364
DR   GEO; GSM1366415
DR   Progenetix; CVCL_9885
DR   Wikidata; Q54955787
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 12
//
ID   STA-NB-10/dmin
AC   CVCL_DG49
SY   STA-NB-10DM
DR   cancercelllines; CVCL_DG49
DR   GEO; GSM554385
DR   Progenetix; CVCL_DG49
DR   Wikidata; Q54955788
RX   PubMed=20631050;
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9885 ! STA-NB-10
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   STA-NB-10/hsr
AC   CVCL_DG50
SY   STA-NB-10HSR
DR   cancercelllines; CVCL_DG50
DR   GEO; GSM554386
DR   Progenetix; CVCL_DG50
DR   Wikidata; Q54955790
RX   PubMed=20631050;
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9885 ! STA-NB-10
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   STA-NB-11
AC   CVCL_9886
SY   St. Anna Kinderspital-Neuroblastoma-11
DR   Wikidata; Q54955791
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   STA-NB-12
AC   CVCL_A450
SY   St. Anna Kinderspital-Neuroblastoma-12
DR   Cosmic; 1526656
DR   Wikidata; Q54955792
RX   PubMed=11550280;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8-9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   STA-NB-13
AC   CVCL_A451
SY   STA-NB13; St. Anna Kinderspital-Neuroblastoma-13
DR   cancercelllines; CVCL_A451
DR   GEO; GSM554387
DR   Progenetix; CVCL_A451
DR   Wikidata; Q54955793
RX   PubMed=18165268;
RX   PubMed=20631050;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   STA-NB-15
AC   CVCL_A452
SY   STA-NB15; St. Anna Kinderspital-Neuroblastoma-15
DR   cancercelllines; CVCL_A452
DR   GEO; GSM554388
DR   Progenetix; CVCL_A452
DR   Wikidata; Q54955794
RX   PubMed=18165268;
RX   PubMed=20631050;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   STA-NB-2
AC   CVCL_9887
SY   St. Anna Kinderspital-Neuroblastoma-2
DR   Wikidata; Q54955795
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   STA-NB-3
AC   CVCL_9888
SY   STA-NB3; St. Anna Kinderspital-Neuroblastoma-3
DR   cancercelllines; CVCL_9888
DR   Cosmic; 1526652
DR   GEO; GSM554382
DR   Progenetix; CVCL_9888
DR   Wikidata; Q54955797
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
RX   PubMed=20631050;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   STA-NB-4
AC   CVCL_9889
SY   STA-NB4; St. Anna Kinderspital-Neuroblastoma-4
DR   cancercelllines; CVCL_9889
DR   GEO; GSM554383
DR   Progenetix; CVCL_9889
DR   Wikidata; Q54955798
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
RX   PubMed=20631050;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   STA-NB-5
AC   CVCL_9890
SY   St. Anna Kinderspital-Neuroblastoma-5
DR   Wikidata; Q54955799
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   STA-NB-6
AC   CVCL_9891
SY   STA-NB6; St. Anna Kinderspital-Neuroblastoma-6
DR   Wikidata; Q54955800
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y1M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   STA-NB-7
AC   CVCL_9892
SY   STA-N-B7; STANB7; St. Anna Kinderspital-Neuroblastoma-7
DR   cancercelllines; CVCL_9892
DR   Cosmic; 2485953
DR   GEO; GSM563359
DR   GEO; GSM1366414
DR   Progenetix; CVCL_9892
DR   Wikidata; Q54955801
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y7M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 15
//
ID   STA-NB-8
AC   CVCL_9893
SY   STA-NB8; St. Anna Kinderspital-Neuroblastoma-8
DR   cancercelllines; CVCL_9893
DR   Cosmic; 1526653
DR   GEO; GSM554384
DR   Progenetix; CVCL_9893
DR   Wikidata; Q54955802
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
RX   PubMed=20631050;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   STA-NB-9
AC   CVCL_9894
SY   St. Anna Kinderspital-Neuroblastoma-9
DR   Cosmic; 1526654
DR   Wikidata; Q54955803
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=9516850;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   STA-OS-1
AC   CVCL_6D50
SY   St. Anna Kinderspital-Osteosarcoma-1
DR   Wikidata; Q54955804
RX   PubMed=10862039;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   STA-OS-2
AC   CVCL_6D51
SY   St. Anna Kinderspital-Osteosarcoma-2
DR   Wikidata; Q54955805
RX   PubMed=10862039;
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   STA-OS-3
AC   CVCL_6D52
SY   St. Anna Kinderspital-Osteosarcoma-3
DR   Wikidata; Q54955806
RX   PubMed=10862039;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   STA-OS-5
AC   CVCL_6D53
SY   St. Anna Kinderspital-Osteosarcoma-5
DR   Wikidata; Q54955807
RX   PubMed=10862039;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17-18Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   STA-OS-6
AC   CVCL_6D54
SY   St. Anna Kinderspital-Osteosarcoma-6
DR   Wikidata; Q54955809
RX   PubMed=10862039;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13-14Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   STA-WT-1
AC   CVCL_6D82
SY   STA-WT1; WT; St. Anna Kinderspital-Wilms Tumor-1
DR   Cosmic; 802241
DR   Wikidata; Q54955810
RX   PubMed=9671307;
RX   PubMed=10397258;
RX   PubMed=11782423;
RX   PubMed=16945155;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Gly317Aspfs*3 (c.950delG); Zygosity=Heterozygous (PubMed=9671307; PubMed=16945155).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   STA-WT-3
AC   CVCL_6D49
SY   St. Anna Kinderspital-Wilms Tumor-3
DR   Wikidata; Q54955811
RX   PubMed=18165268;
CC   From: Children's Cancer Research Institute; Vienna; Austria.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   STA5
AC   CVCL_XF78
SY   STA 5
DR   Wikidata; Q98132847
RX   PubMed=7588596;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   STAN001i-047-1
AC   CVCL_EL73
DR   SKIP; SKIP005093
DR   WiCell; stan001i-047-1
DR   Wikidata; Q54955812
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN002i-161-1
AC   CVCL_EL74
DR   SKIP; SKIP005096
DR   WiCell; stan002i-161-1
DR   Wikidata; Q54955813
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL75 ! STAN003i-161-2
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN003i-161-2
AC   CVCL_EL75
DR   SKIP; SKIP005097
DR   WiCell; stan003i-161-2
DR   Wikidata; Q54955818
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL74 ! STAN002i-161-1
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN004i-147-1
AC   CVCL_EL76
DR   SKIP; SKIP005115
DR   WiCell; stan004i-147-1
DR   Wikidata; Q54955819
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL77 ! STAN005i-147-2
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN005i-147-2
AC   CVCL_EL77
DR   SKIP; SKIP005114
DR   WiCell; stan005i-147-2
DR   Wikidata; Q54955820
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL76 ! STAN004i-147-1
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN006i-148-1
AC   CVCL_EL78
DR   SKIP; SKIP005117
DR   WiCell; stan006i-148-1
DR   Wikidata; Q54955821
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL79 ! STAN007i-148-2
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN007i-148-2
AC   CVCL_EL79
DR   SKIP; SKIP005116
DR   WiCell; stan007i-148-2
DR   Wikidata; Q54955822
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL78 ! STAN006i-148-1
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN008i-165-1
AC   CVCL_EL80
DR   SKIP; SKIP005123
DR   WiCell; stan008i-165-1
DR   Wikidata; Q54955823
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL81 ! STAN009i-165-2
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN009i-165-2
AC   CVCL_EL81
DR   SKIP; SKIP005122
DR   WiCell; stan009i-165-2
DR   Wikidata; Q54955824
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL80 ! STAN008i-165-1
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN010i-041-2
AC   CVCL_EL82
DR   SKIP; SKIP005129
DR   WiCell; stan010i-041-2
DR   Wikidata; Q54955825
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN011i-123-1
AC   CVCL_EL83
DR   SKIP; SKIP005132
DR   WiCell; stan011i-123-1
DR   Wikidata; Q54955827
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121946; Drug- and toxin-induced pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL84 ! STAN012i-123-2
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN012i-123-2
AC   CVCL_EL84
DR   SKIP; SKIP005133
DR   WiCell; stan012i-123-2
DR   Wikidata; Q54955828
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121946; Drug- and toxin-induced pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL83 ! STAN011i-123-1
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN013i-121-1
AC   CVCL_EL85
DR   SKIP; SKIP005139
DR   WiCell; stan013i-121-1
DR   Wikidata; Q54955829
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL86 ! STAN014i-121-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN014i-121-2
AC   CVCL_EL86
DR   SKIP; SKIP005138
DR   WiCell; stan014i-121-2
DR   Wikidata; Q54955830
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL85 ! STAN013i-121-1
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN015i-178-1
AC   CVCL_EL87
DR   SKIP; SKIP005146
DR   WiCell; stan015i-178-1
DR   Wikidata; Q54955831
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121946; Drug- and toxin-induced pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL88 ! STAN016i-178-2
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN016i-178-2
AC   CVCL_EL88
DR   SKIP; SKIP005147
DR   WiCell; stan016i-178-2
DR   Wikidata; Q54955833
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121946; Drug- and toxin-induced pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL87 ! STAN015i-178-1
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN017i-171-1
AC   CVCL_EL89
DR   SKIP; SKIP005149
DR   WiCell; stan017i-171-1
DR   Wikidata; Q54955834
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL90 ! STAN018i-171-2
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN018i-171-2
AC   CVCL_EL90
DR   SKIP; SKIP005148
DR   WiCell; stan018i-171-2
DR   Wikidata; Q54955835
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL89 ! STAN017i-171-1
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN019i-177-1
AC   CVCL_EL91
DR   SKIP; SKIP005152
DR   WiCell; stan019i-177-1
DR   Wikidata; Q54955836
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL92 ! STAN020i-177-2
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN020i-177-2
AC   CVCL_EL92
DR   SKIP; SKIP005153
DR   WiCell; stan020i-177-2
DR   Wikidata; Q54955837
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL91 ! STAN019i-177-1
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN021i-170-1
AC   CVCL_EL93
DR   SKIP; SKIP005161
DR   WiCell; stan021i-170-1
DR   Wikidata; Q54955838
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL94 ! STAN022i-170-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN022i-170-2
AC   CVCL_EL94
DR   SKIP; SKIP005160
DR   WiCell; stan022i-170-2
DR   Wikidata; Q54955839
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL93 ! STAN021i-170-1
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN023i-41-1
AC   CVCL_EL95
DR   SKIP; SKIP005128
DR   WiCell; stan023i-41-1
DR   Wikidata; Q54955840
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN024i-29-1
AC   CVCL_EL96
DR   SKIP; SKIP005102
DR   WiCell; stan024i-29-1
DR   Wikidata; Q54955841
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL97 ! STAN025i-29-2
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN025i-29-2
AC   CVCL_EL97
DR   SKIP; SKIP005103
DR   WiCell; stan025i-29-2
DR   Wikidata; Q54955842
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL96 ! STAN024i-29-1
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN026i-30-1
AC   CVCL_EL98
DR   SKIP; SKIP005126
DR   WiCell; stan026i-30-1
DR   Wikidata; Q54955844
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL99 ! STAN027i-30-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN027i-30-2
AC   CVCL_EL99
DR   SKIP; SKIP005127
DR   WiCell; stan027i-30-2
DR   Wikidata; Q54955845
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EL98 ! STAN026i-30-1
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN028i-42-1
AC   CVCL_EM00
DR   SKIP; SKIP005131
DR   WiCell; stan028i-42-1
DR   Wikidata; Q54955846
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM01 ! STAN029i-42-2
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN029i-42-2
AC   CVCL_EM01
DR   SKIP; SKIP005130
DR   WiCell; stan029i-42-2
DR   Wikidata; Q54955847
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM00 ! STAN028i-42-1
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN030i-46-1
AC   CVCL_EM02
DR   SKIP; SKIP005162
DR   WiCell; stan030i-46-1
DR   Wikidata; Q54955848
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Arg491Trp (c.1471C>T); ClinVar=VCV000008802; Zygosity=Heterozygous (WiCell=stan030i-46-1).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174219; Primary pulmonary hypertension-1
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM03 ! STAN031i-46-2
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   STAN031i-46-2
AC   CVCL_EM03
DR   SKIP; SKIP005163
DR   WiCell; stan031i-46-2
DR   Wikidata; Q54955849
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:1078; BMPR2; Simple; p.Arg491Trp (c.1471C>T); ClinVar=VCV000008802; Zygosity=Heterozygous (WiCell=stan031i-46-2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174219; Primary pulmonary hypertension-1
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM02 ! STAN030i-46-1
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 17
//
ID   STAN032i-48-1
AC   CVCL_EM04
DR   SKIP; SKIP005106
DR   WiCell; stan032i-48-1
DR   Wikidata; Q54955850
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM05 ! STAN034i-48-2
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN034i-48-2
AC   CVCL_EM05
DR   SKIP; SKIP005107
DR   WiCell; stan034i-48-2
DR   Wikidata; Q54955852
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM04 ! STAN032i-48-1
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN035i-49-1
AC   CVCL_EM06
DR   SKIP; SKIP005108
DR   WiCell; stan035i-49-1
DR   Wikidata; Q54955853
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM07 ! STAN036i-49-2
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN036i-49-2
AC   CVCL_EM07
DR   SKIP; SKIP005109
DR   WiCell; stan036i-49-2
DR   Wikidata; Q54955854
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM06 ! STAN035i-49-1
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN037i-118-1
AC   CVCL_EM08
DR   SKIP; SKIP005134
DR   WiCell; stan037i-118-1
DR   Wikidata; Q54955855
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM09 ! STAN038i-118-2
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN038i-118-2
AC   CVCL_EM09
DR   SKIP; SKIP005135
DR   WiCell; stan038i-118-2
DR   Wikidata; Q54955856
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM08 ! STAN037i-118-1
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN039i-119-1
AC   CVCL_EM10
DR   SKIP; SKIP005104
DR   WiCell; stan039i-119-1
DR   Wikidata; Q54955857
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM11 ! STAN040i-119-2
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN040i-119-2
AC   CVCL_EM11
DR   SKIP; SKIP005105
DR   WiCell; stan040i-119-2
DR   Wikidata; Q54955858
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM10 ! STAN039i-119-1
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN041i-122-1
AC   CVCL_EM12
DR   SKIP; SKIP005141
DR   WiCell; stan041i-122-1
DR   Wikidata; Q54955859
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM13 ! STAN042i-122-2
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN042i-122-2
AC   CVCL_EM13
DR   SKIP; SKIP005140
DR   WiCell; stan042i-122-2
DR   Wikidata; Q54955860
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM12 ! STAN041i-122-1
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN043i-124-1
AC   CVCL_EM14
DR   SKIP; SKIP005137
DR   WiCell; stan043i-124-1
DR   Wikidata; Q54955861
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
DI   NCIt; C84390; Eisenmenger syndrome
DI   ORDO; Orphanet_97214; Eisenmenger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM15 ! STAN044i-124-2
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN044i-124-2
AC   CVCL_EM15
DR   SKIP; SKIP005136
DR   WiCell; stan044i-124-2
DR   Wikidata; Q54955877
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
DI   NCIt; C84390; Eisenmenger syndrome
DI   ORDO; Orphanet_97214; Eisenmenger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM14 ! STAN043i-124-1
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN045i-125-1
AC   CVCL_EM16
DR   SKIP; SKIP005159
DR   WiCell; stan045i-125-1
DR   Wikidata; Q54955878
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
DI   NCIt; C84390; Eisenmenger syndrome
DI   ORDO; Orphanet_97214; Eisenmenger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM17 ! STAN046i-125-2
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN046i-125-2
AC   CVCL_EM17
DR   SKIP; SKIP005158
DR   WiCell; stan046i-125-2
DR   Wikidata; Q54955879
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97147; Associated pulmonary arterial hypertension
DI   NCIt; C84390; Eisenmenger syndrome
DI   ORDO; Orphanet_97214; Eisenmenger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM16 ! STAN045i-125-1
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN047i-126-1
AC   CVCL_EM18
DR   SKIP; SKIP005110
DR   WiCell; stan047i-126-1
DR   Wikidata; Q54955880
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM19 ! STAN048i-126-2
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN048i-126-2
AC   CVCL_EM19
DR   SKIP; SKIP005111
DR   WiCell; stan048i-126-2
DR   Wikidata; Q54955881
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM18 ! STAN047i-126-1
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN051i-146-1
AC   CVCL_EM20
DR   SKIP; SKIP005112
DR   WiCell; stan051i-146-1
DR   Wikidata; Q54955882
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM21 ! STAN052i-146-2
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN052i-146-2
AC   CVCL_EM21
DR   SKIP; SKIP005113
DR   WiCell; stan052i-146-2
DR   Wikidata; Q54955883
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM20 ! STAN051i-146-1
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN053i-149-1
AC   CVCL_EM22
DR   SKIP; SKIP005119
DR   WiCell; stan053i-149-1
DR   Wikidata; Q54955884
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM23 ! STAN054i-149-2
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN054i-149-2
AC   CVCL_EM23
DR   SKIP; SKIP005118
DR   WiCell; stan054i-149-2
DR   Wikidata; Q54955885
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM22 ! STAN053i-149-1
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN055i-160-1
AC   CVCL_EM24
DR   SKIP; SKIP005095
DR   WiCell; stan055i-160-1
DR   Wikidata; Q54955886
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM25 ! STAN056i-160-2
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN056i-160-2
AC   CVCL_EM25
DR   SKIP; SKIP005094
DR   WiCell; stan056i-160-2
DR   Wikidata; Q54955887
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM24 ! STAN055i-160-1
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN057i-162-1
AC   CVCL_EM26
DR   SKIP; SKIP005098
DR   WiCell; stan057i-162-1
DR   Wikidata; Q54955888
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM27 ! STAN058i-162-2
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN058i-162-2
AC   CVCL_EM27
DR   SKIP; SKIP005099
DR   WiCell; stan058i-162-2
DR   Wikidata; Q54955889
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM26 ! STAN057i-162-1
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN059i-163-1
AC   CVCL_EM28
DR   SKIP; SKIP005101
DR   WiCell; stan059i-163-1
DR   Wikidata; Q54955891
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM29 ! STAN060i-163-2
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN060i-163-2
AC   CVCL_EM29
DR   SKIP; SKIP005100
DR   WiCell; stan060i-163-2
DR   Wikidata; Q54955893
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM28 ! STAN059i-163-1
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN061i-164-1
AC   CVCL_EM30
DR   SKIP; SKIP005120
DR   WiCell; stan061i-164-1
DR   Wikidata; Q54955894
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM31 ! STAN062i-164-2
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN062i-164-2
AC   CVCL_EM31
DR   SKIP; SKIP005121
DR   WiCell; stan062i-164-2
DR   Wikidata; Q54955895
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM30 ! STAN061i-164-1
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN063i-166-1
AC   CVCL_EM32
DR   SKIP; SKIP005124
DR   WiCell; stan063i-166-1
DR   Wikidata; Q54955896
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM33 ! STAN064i-166-2
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN064i-166-2
AC   CVCL_EM33
DR   SKIP; SKIP005125
DR   WiCell; stan064i-166-2
DR   Wikidata; Q54955898
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM32 ! STAN063i-166-1
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN065i-167-1
AC   CVCL_EM34
DR   SKIP; SKIP005143
DR   WiCell; stan065i-167-1
DR   Wikidata; Q54955900
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM35 ! STAN066i-167-2
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN066i-167-2
AC   CVCL_EM35
DR   SKIP; SKIP005142
DR   WiCell; stan066i-167-2
DR   Wikidata; Q54955901
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM34 ! STAN065i-167-1
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN067i-168-1
AC   CVCL_EM36
DR   SKIP; SKIP005144
DR   WiCell; stan067i-168-1
DR   Wikidata; Q54955902
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM37 ! STAN068i-168-2
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN068i-168-2
AC   CVCL_EM37
DR   SKIP; SKIP005145
DR   WiCell; stan068i-168-2
DR   Wikidata; Q54955903
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM36 ! STAN067i-168-1
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN069i-169-1
AC   CVCL_EM38
DR   SKIP; SKIP005157
DR   WiCell; stan069i-169-1
DR   Wikidata; Q54955904
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121946; Drug- and toxin-induced pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN070i-169-2
AC   CVCL_EM39
DR   SKIP; SKIP005156
DR   WiCell; stan070i-169-2
DR   Wikidata; Q54955905
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121946; Drug- and toxin-induced pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN071i-179-1
AC   CVCL_EM40
DR   SKIP; SKIP005150
DR   WiCell; stan071i-179-1
DR   Wikidata; Q54955906
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM41 ! STAN072i-179-2
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN072i-179-2
AC   CVCL_EM41
DR   SKIP; SKIP005151
DR   WiCell; stan072i-179-2
DR   Wikidata; Q54955907
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121945; Heritable pulmonary arterial hypertension
DI   ORDO; Orphanet_275777; Heritable pulmonary arterial hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM40 ! STAN071i-179-1
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   STAN073i-180-1
AC   CVCL_EM42
DR   SKIP; SKIP005155
DR   WiCell; stan073i-180-1
DR   Wikidata; Q54955908
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM43 ! STAN074i-180-2
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN074i-180-2
AC   CVCL_EM43
DR   SKIP; SKIP005154
DR   WiCell; stan074i-180-2
DR   Wikidata; Q54955909
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Rabinovitch, Marlene; Stanford University; Stanford; USA.
CC   Population: Caucasian and Latino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97119; Idiopathic pulmonary hypertension
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EM42 ! STAN073i-180-1
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   STAN076i-004C1
AC   CVCL_JQ61
SY   ISMMS 004i C1
DR   SKIP; SKIP005179
DR   WiCell; stan076i-004c1
DR   Wikidata; Q54955910
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ62 ! STAN077i-004C2
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN077i-004C2
AC   CVCL_JQ62
SY   ISMMS 004i C2
DR   SKIP; SKIP005178
DR   WiCell; stan077i-004c2
DR   Wikidata; Q54955911
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ61 ! STAN076i-004C1
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN078i-018C2
AC   CVCL_JQ63
SY   ISMMS 018i C2; 018_2
DR   GEO; GSM2099959
DR   WiCell; stan078i-018c2
DR   Wikidata; Q54955912
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ64 ! STAN079i-018C3
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN079i-018C3
AC   CVCL_JQ64
SY   ISMMS 018i C3; 018_3
DR   GEO; GSM2099960
DR   WiCell; stan079i-018c3
DR   Wikidata; Q54955913
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ63 ! STAN078i-018C2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN080i-023C2
AC   CVCL_JQ65
SY   ISMMS 023i C2; 023_2
DR   GEO; GSM2099962
DR   WiCell; stan080i-023c2
DR   Wikidata; Q54955914
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ66 ! STAN081i-023C3
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN081i-023C3
AC   CVCL_JQ66
SY   ISMMS 023i C3; 023_3
DR   GEO; GSM2099963
DR   WiCell; stan081i-023c3
DR   Wikidata; Q54955917
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ65 ! STAN080i-023C2
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN082i-024C1
AC   CVCL_JQ67
SY   ISMMS 024i C1; 024_1
DR   GEO; GSM2099965
DR   SKIP; SKIP005180
DR   WiCell; stan082i-024c1
DR   Wikidata; Q54955918
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ68 ! STAN083i-024C4
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN083i-024C4
AC   CVCL_JQ68
SY   ISMMS 024i C4; 024_4
DR   GEO; GSM2099966
DR   SKIP; SKIP005181
DR   WiCell; stan083i-024c4
DR   Wikidata; Q54955919
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ67 ! STAN082i-024C1
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN084i-041C1
AC   CVCL_JQ69
SY   ISMMS 041i C1
DR   SKIP; SKIP005182
DR   WiCell; stan084i-041c1
DR   Wikidata; Q54955920
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ70 ! STAN085i-041C3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN085i-041C3
AC   CVCL_JQ70
SY   ISMMS 041i C3
DR   SKIP; SKIP005183
DR   WiCell; stan085i-041c3
DR   Wikidata; Q54955921
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ69 ! STAN084i-041C1
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN086i-054C1
AC   CVCL_JQ71
SY   ISMMS 054i C1; 054_1
DR   GEO; GSM2099968
DR   SKIP; SKIP005185
DR   WiCell; stan086i-054c1
DR   Wikidata; Q54955922
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ72 ! STAN087i-054C2
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN087i-054C2
AC   CVCL_JQ72
SY   ISMMS 054i C2; 054_2
DR   GEO; GSM2099969
DR   SKIP; SKIP005184
DR   WiCell; stan087i-054c2
DR   Wikidata; Q54955943
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ71 ! STAN086i-054C1
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN088i-060C1
AC   CVCL_JQ73
SY   ISMMS 060i C1; 060_1
DR   GEO; GSM2099971
DR   SKIP; SKIP005187
DR   WiCell; stan088i-060c1
DR   Wikidata; Q54955944
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN089i-070C2
AC   CVCL_JQ74
SY   ISMMS 070i C2
DR   SKIP; SKIP005188
DR   WiCell; stan089i-070c2
DR   Wikidata; Q54955946
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ75 ! STAN090i-070C4
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN090i-070C4
AC   CVCL_JQ75
SY   ISMMS 070i C4
DR   SKIP; SKIP005189
DR   WiCell; stan090i-070c4
DR   Wikidata; Q54955948
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ74 ! STAN089i-070C2
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN091i-071C2
AC   CVCL_JQ76
SY   ISMMS 071i C2; 071_2
DR   GEO; GSM2099976
DR   SKIP; SKIP005190
DR   WiCell; stan091i-071c2
DR   Wikidata; Q54955949
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   STAN093i-081C1
AC   CVCL_JQ77
SY   ISMMS 081 C1
DR   SKIP; SKIP005192
DR   WiCell; stan093i-081c1
DR   Wikidata; Q54955950
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ78 ! STAN094i-081C2
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN094i-081C2
AC   CVCL_JQ78
SY   ISMMS 081 C2
DR   SKIP; SKIP005191
DR   WiCell; stan094i-081c2
DR   Wikidata; Q54955951
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ77 ! STAN093i-081C1
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN095i-102C4
AC   CVCL_JQ79
SY   ISMMS 102i C4; 102_4
DR   GEO; GSM2099985
DR   SKIP; SKIP005196
DR   WiCell; stan095i-102c4
DR   Wikidata; Q54955952
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ80 ! STAN096i-102C6
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN096i-102C6
AC   CVCL_JQ80
SY   ISMMS 102i C6; 102_6
DR   GEO; GSM2099986
DR   SKIP; SKIP005195
DR   WiCell; stan096i-102c6
DR   Wikidata; Q54955953
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ79 ! STAN095i-102C4
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN097i-107C3
AC   CVCL_JQ81
SY   ISMMS 107i C3; 107_3
DR   GEO; GSM2099987
DR   SKIP; SKIP005197
DR   WiCell; stan097i-107c3
DR   Wikidata; Q54955954
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ82 ! STAN098i-107C4
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN098i-107C4
AC   CVCL_JQ82
SY   ISMMS 107i C4; 107_4
DR   GEO; GSM2099988
DR   SKIP; SKIP005198
DR   WiCell; stan098i-107c4
DR   Wikidata; Q54955955
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ81 ! STAN097i-107C3
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN099i-108C2
AC   CVCL_JQ83
SY   ISMMS 108i C2
DR   SKIP; SKIP005200
DR   WiCell; stan099i-108c2
DR   Wikidata; Q54955956
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ84 ! STAN100i-108C4
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN100i-108C4
AC   CVCL_JQ84
SY   ISMMS 108i C4
DR   SKIP; SKIP005199
DR   WiCell; stan100i-108c4
DR   Wikidata; Q54955957
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ83 ! STAN099i-108C2
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN101i-110C3
AC   CVCL_YZ02
SY   ISMMS 110i C3; 110_3
DR   GEO; GSM2099991
DR   WiCell; stan101i-110c3
DR   Wikidata; Q98132848
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   STAN104i-120C3
AC   CVCL_JQ85
SY   ISMMS 120i C3; 120_3
DR   GEO; GSM2099993
DR   SKIP; SKIP005201
DR   WiCell; stan104i-120c3
DR   Wikidata; Q54955958
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Latino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN106i-121C1
AC   CVCL_JQ86
SY   ISMMS 121i C1
DR   SKIP; SKIP005202
DR   WiCell; stan106i-121c1
DR   Wikidata; Q54955959
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ87 ! STAN107i-121C2
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN107i-121C2
AC   CVCL_JQ87
SY   ISMMS 121i C2
DR   SKIP; SKIP005203
DR   WiCell; stan107i-121c2
DR   Wikidata; Q54955960
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ86 ! STAN106i-121C1
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN108i-123C2
AC   CVCL_JQ88
SY   ISMMS 123i C2; 123_2
DR   GEO; GSM2099999
DR   SKIP; SKIP005205
DR   WiCell; stan108i-123c2
DR   Wikidata; Q54955961
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ89 ! STAN109i-123C3
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN109i-123C3
AC   CVCL_JQ89
SY   ISMMS 123i C3; 123_3
DR   GEO; GSM2100000
DR   SKIP; SKIP005204
DR   WiCell; stan109i-123c3
DR   Wikidata; Q54955962
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ88 ! STAN108i-123C2
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN111i-125C4
AC   CVCL_JQ90
SY   ISMMS 125i C4
DR   SKIP; SKIP005206
DR   WiCell; stan111i-125c4
DR   Wikidata; Q54955963
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN114i-135C2
AC   CVCL_JQ91
SY   ISMMS 135i C2
DR   SKIP; SKIP005207
DR   WiCell; stan114i-135c2
DR   Wikidata; Q54955965
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN115i-148C2
AC   CVCL_JQ92
SY   ISMMS 148i C2
DR   SKIP; SKIP005209
DR   WiCell; stan115i-148c2
DR   Wikidata; Q54955966
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ93 ! STAN116i-148C4
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN116i-148C4
AC   CVCL_JQ93
SY   ISMMS 148i C4
DR   SKIP; SKIP005208
DR   WiCell; stan116i-148c4
DR   Wikidata; Q54955967
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ92 ! STAN115i-148C2
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN117i-182C4
AC   CVCL_JQ94
SY   ISMMS 182i C4; 182_4
DR   GEO; GSM2100011
DR   SKIP; SKIP005212
DR   WiCell; stan117i-182c4
DR   Wikidata; Q54955968
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ95 ! STAN118i-182C7
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN118i-182C7
AC   CVCL_JQ95
SY   ISMMS 182i C7; 182_7
DR   GEO; GSM2100012
DR   SKIP; SKIP005211
DR   WiCell; stan118i-182c7
DR   Wikidata; Q54955970
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ94 ! STAN117i-182C4
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN119i-192C1
AC   CVCL_JQ96
SY   ISMMS 192i C1
DR   SKIP; SKIP005215
DR   WiCell; stan119i-192c1
DR   Wikidata; Q54955971
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ97 ! STAN120i-192C2
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN120i-192C2
AC   CVCL_JQ97
SY   ISMMS 192i C2
DR   SKIP; SKIP005214
DR   WiCell; stan120i-192c2
DR   Wikidata; Q54955972
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ96 ! STAN119i-192C1
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN121i-193C2
AC   CVCL_JQ98
SY   ISMMS 193i C2
DR   SKIP; SKIP005216
DR   WiCell; stan121i-193c2
DR   Wikidata; Q54955973
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ99 ! STAN122i-193C1
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN122i-193C1
AC   CVCL_JQ99
SY   ISMMS 193i C1
DR   SKIP; SKIP005217
DR   WiCell; stan122i-193c1
DR   Wikidata; Q54955974
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JQ98 ! STAN121i-193C2
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN125i-202C2
AC   CVCL_JR00
SY   ISMMS 202i C2
DR   SKIP; SKIP005219
DR   WiCell; stan125i-202c2
DR   Wikidata; Q54955975
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR01 ! STAN126i-202C3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN126i-202C3
AC   CVCL_JR01
SY   ISMMS 202i C3
DR   SKIP; SKIP005218
DR   WiCell; stan126i-202c3
DR   Wikidata; Q54955976
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR00 ! STAN125i-202C2
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN128i-211C2
AC   CVCL_JR02
SY   ISMMS 211i C2; 211_2
DR   GEO; GSM2100018
DR   SKIP; SKIP005220
DR   WiCell; stan128i-211c2
DR   Wikidata; Q54955977
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN129i-212C2
AC   CVCL_JR03
SY   ISMMS 212i C2
DR   SKIP; SKIP005222
DR   WiCell; stan129i-212c2
DR   Wikidata; Q54955978
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR04 ! STAN130i-212C4
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN130i-212C4
AC   CVCL_JR04
SY   ISMMS 212i C4
DR   SKIP; SKIP005221
DR   WiCell; stan130i-212c4
DR   Wikidata; Q54955979
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR03 ! STAN129i-212C2
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN131i-214C3
AC   CVCL_JR05
SY   ISMMS 214i C3; 214_3
DR   GEO; GSM2100021
DR   SKIP; SKIP005224
DR   WiCell; stan131i-214c3
DR   Wikidata; Q54955981
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR06 ! STAN132i-214C4
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN132i-214C4
AC   CVCL_JR06
SY   ISMMS 214i C4; 214_4
DR   GEO; GSM2100022
DR   SKIP; SKIP005223
DR   WiCell; stan132i-214c4
DR   Wikidata; Q54955982
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR05 ! STAN131i-214C3
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN133i-215C1
AC   CVCL_JR07
SY   ISMMS 215i C1; 215_1
DR   GEO; GSM2100023
DR   SKIP; SKIP005225
DR   WiCell; stan133i-215c1
DR   Wikidata; Q54955983
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR08 ! STAN134i-215C2
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN134i-215C2
AC   CVCL_JR08
SY   ISMMS 215i C2; 215_2
DR   GEO; GSM2100024
DR   SKIP; SKIP005226
DR   WiCell; stan134i-215c2
DR   Wikidata; Q54955984
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR07 ! STAN133i-215C1
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN135i-230C1
AC   CVCL_JR09
SY   ISMMS 230i C1
DR   SKIP; SKIP005228
DR   WiCell; stan135i-230c1
DR   Wikidata; Q54955985
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR10 ! STAN136i-230C2
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN136i-230C2
AC   CVCL_JR10
SY   ISMMS 230i C2
DR   SKIP; SKIP005227
DR   WiCell; stan136i-230c2
DR   Wikidata; Q54955986
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR09 ! STAN135i-230C1
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN137i-231C3
AC   CVCL_JR11
SY   ISMMS 231i C3; 231_3
DR   GEO; GSM2100027
DR   SKIP; SKIP005229
DR   WiCell; stan137i-231c3
DR   Wikidata; Q54955987
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN138i-239C3
AC   CVCL_JR12
SY   ISMMS 239i C3; 239_3
DR   GEO; GSM2100029
DR   SKIP; SKIP005230
DR   WiCell; stan138i-239c3
DR   Wikidata; Q54956002
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR13 ! STAN139i-239C5
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN139i-239C5
AC   CVCL_JR13
SY   ISMMS 239i C5; 239_5
DR   GEO; GSM2100030
DR   SKIP; SKIP005231
DR   WiCell; stan139i-239c5
DR   Wikidata; Q54956004
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR12 ! STAN138i-239C3
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN140i-243C1
AC   CVCL_JR14
SY   ISMMS 243i C1; 243_1
DR   GEO; GSM2100032
DR   SKIP; SKIP005232
DR   WiCell; stan140i-243c1
DR   Wikidata; Q54956005
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN141i-250C4
AC   CVCL_JR15
SY   ISMMS 250i C4; 250_4
DR   GEO; GSM2100036
DR   SKIP; SKIP005233
DR   WiCell; stan141i-250c4
DR   Wikidata; Q54956006
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN142i-255C1
AC   CVCL_JR16
SY   ISMMS 255i C1; 255_1
DR   GEO; GSM2100038
DR   SKIP; SKIP005234
DR   WiCell; stan142i-255c1
DR   Wikidata; Q54956007
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Latino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN144i-285C3
AC   CVCL_JR17
SY   ISMMS 285i C3
DR   SKIP; SKIP005236
DR   WiCell; stan144i-285c3
DR   Wikidata; Q54956008
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN145i-286C1
AC   CVCL_JR18
SY   ISMMS 286i C1
DR   SKIP; SKIP005237
DR   WiCell; stan145i-286c1
DR   Wikidata; Q54956009
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR19 ! STAN146i-286C2
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN146i-286C2
AC   CVCL_JR19
SY   ISMMS 286i C2
DR   SKIP; SKIP005238
DR   WiCell; stan146i-286c2
DR   Wikidata; Q54956010
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR18 ! STAN145i-286C1
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN148i-291C3
AC   CVCL_JR20
SY   ISMMS 291i C3; 291_3
DR   GEO; GSM2100047
DR   SKIP; SKIP005239
DR   WiCell; stan148i-291c3
DR   Wikidata; Q54956011
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN149i-298C1
AC   CVCL_JR21
SY   ISMMS 298i C1
DR   SKIP; SKIP005242
DR   WiCell; stan149i-298c1
DR   Wikidata; Q54956012
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN150i-337C1
AC   CVCL_JR22
SY   ISMMS 337i C1
DR   SKIP; SKIP005252
DR   WiCell; stan150i-337c1
DR   Wikidata; Q54956013
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN151i-303C3
AC   CVCL_JR23
SY   ISMMS 303i C3; 303_3
DR   GEO; GSM2100050
DR   SKIP; SKIP005243
DR   WiCell; stan151i-303c3
DR   Wikidata; Q54956014
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN152i-307C2
AC   CVCL_JR24
SY   ISMMS 307i C2; 307_2
DR   GEO; GSM2100052
DR   SKIP; SKIP005245
DR   WiCell; stan152i-307c2
DR   Wikidata; Q54956015
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR25 ! STAN153i-307C3
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN153i-307C3
AC   CVCL_JR25
SY   ISMMS 307i C3; 307_3
DR   GEO; GSM2100053
DR   SKIP; SKIP005244
DR   WiCell; stan153i-307c3
DR   Wikidata; Q54956016
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR24 ! STAN152i-307C2
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN154i-312C1
AC   CVCL_JR26
SY   ISMMS 312i C1
DR   SKIP; SKIP005246
DR   WiCell; stan154i-312c1
DR   Wikidata; Q54956017
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN155i-313C2
AC   CVCL_JR27
SY   ISMMS 313i C2; 313_2
DR   GEO; GSM2100056
DR   SKIP; SKIP005247
DR   WiCell; stan155i-313c2
DR   Wikidata; Q54956018
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN156i-334C1
AC   CVCL_JR28
SY   ISMMS 334i C1; 334_1
DR   GEO; GSM2100058
DR   SKIP; SKIP005248
DR   WiCell; stan156i-334c1
DR   Wikidata; Q54956019
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR29 ! STAN157i-334C2
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN157i-334C2
AC   CVCL_JR29
SY   ISMMS 334i C2; 334_2
DR   GEO; GSM2100059
DR   SKIP; SKIP005249
DR   WiCell; stan157i-334c2
DR   Wikidata; Q54956021
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR28 ! STAN156i-334C1
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN158i-336C2
AC   CVCL_JR30
SY   ISMMS 336i C2; 336_2
DR   GEO; GSM2100061
DR   SKIP; SKIP005251
DR   WiCell; stan158i-336c2
DR   Wikidata; Q54956022
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR31 ! STAN159i-336C3
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN159i-336C3
AC   CVCL_JR31
SY   ISMMS 336i C3; 336_3
DR   GEO; GSM2100062
DR   SKIP; SKIP005250
DR   WiCell; stan159i-336c3
DR   Wikidata; Q54956024
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR30 ! STAN158i-336C2
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN160i-341C4
AC   CVCL_JR32
SY   ISMMS 341i C4
DR   SKIP; SKIP005254
DR   WiCell; stan160i-341c4
DR   Wikidata; Q54956026
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR33 ! STAN161i-341C5
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN161i-341C5
AC   CVCL_JR33
SY   ISMMS 341i C5
DR   SKIP; SKIP005253
DR   WiCell; stan161i-341c5
DR   Wikidata; Q54956027
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR32 ! STAN160i-341C4
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN162i-345C2
AC   CVCL_JR34
SY   ISMMS 345i C2; 345_2
DR   GEO; GSM2100066
DR   SKIP; SKIP005255
DR   WiCell; stan162i-345c2
DR   Wikidata; Q54956028
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR35 ! STAN163i-345C5
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN163i-345C5
AC   CVCL_JR35
SY   ISMMS 345i C5; 345_5
DR   GEO; GSM2100067
DR   SKIP; SKIP005256
DR   WiCell; stan163i-345c5
DR   Wikidata; Q54956029
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR34 ! STAN162i-345C2
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN164i-352C1
AC   CVCL_JR36
SY   ISMMS 352i C1; 352_1
DR   GEO; GSM2100069
DR   SKIP; SKIP005257
DR   WiCell; stan164i-352c1
DR   Wikidata; Q54956030
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR37 ! STAN165i-352C5
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN165i-352C5
AC   CVCL_JR37
SY   ISMMS 352i C5; 352_5
DR   GEO; GSM2100070
DR   SKIP; SKIP005258
DR   WiCell; stan165i-352c5
DR   Wikidata; Q54956031
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR36 ! STAN164i-352C1
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN166i-356C4
AC   CVCL_JR38
SY   ISMMS 356i C4; 356_4
DR   GEO; GSM2100072
DR   SKIP; SKIP005260
DR   WiCell; stan166i-356c4
DR   Wikidata; Q54956033
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR39 ! STAN167i-356C6
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN167i-356C6
AC   CVCL_JR39
SY   ISMMS 356i C6; 356_6
DR   GEO; GSM2100073
DR   SKIP; SKIP005259
DR   WiCell; stan167i-356c6
DR   Wikidata; Q54956034
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR38 ! STAN166i-356C4
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN168i-358C1
AC   CVCL_JR40
SY   ISMMS 358i C1; 358_1
DR   GEO; GSM2100075
DR   SKIP; SKIP005262
DR   WiCell; stan168i-358c1
DR   Wikidata; Q54956035
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR41 ! STAN169i-358C4
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN169i-358C4
AC   CVCL_JR41
SY   ISMMS 358i C4; 358_4
DR   GEO; GSM2100078
DR   SKIP; SKIP005261
DR   WiCell; stan169i-358c4
DR   Wikidata; Q54956036
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR40 ! STAN168i-358C1
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN170i-364C3
AC   CVCL_JR42
SY   ISMMS 364i C3
DR   SKIP; SKIP005264
DR   WiCell; stan170i-364c3
DR   Wikidata; Q54956037
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR43 ! STAN171i-364C4
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN171i-364C4
AC   CVCL_JR43
SY   ISMMS 364i C4
DR   SKIP; SKIP005263
DR   WiCell; stan171i-364c4
DR   Wikidata; Q54956039
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR42 ! STAN170i-364C3
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN173i-368C2
AC   CVCL_JR44
SY   ISMMS 368i C2; 368_2
DR   GEO; GSM2100082
DR   SKIP; SKIP005265
DR   WiCell; stan173i-368c2
DR   Wikidata; Q54956040
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN174i-371C3
AC   CVCL_JR45
SY   ISMMS 371i C3; 371_3
DR   GEO; GSM2100084
DR   SKIP; SKIP005266
DR   WiCell; stan174i-371c3
DR   Wikidata; Q54956041
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN175i-373C4
AC   CVCL_JR46
SY   ISMMS 373i C4
DR   SKIP; SKIP005268
DR   WiCell; stan175i-373c4
DR   Wikidata; Q54956042
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR47 ! STAN176i-373C6
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN176i-373C6
AC   CVCL_JR47
SY   ISMMS 373i C6
DR   SKIP; SKIP005267
DR   WiCell; stan176i-373c6
DR   Wikidata; Q54956043
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR46 ! STAN175i-373C4
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN179i-400C2
AC   CVCL_JR48
SY   ISMMS 400i C2
DR   SKIP; SKIP005270
DR   WiCell; stan179i-400c2
DR   Wikidata; Q54956044
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN180i-408C2
AC   CVCL_JR49
SY   ISMMS 408i C2; 408_2
DR   GEO; GSM2100086
DR   SKIP; SKIP005272
DR   WiCell; stan180i-408c2
DR   Wikidata; Q54956045
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR50 ! STAN181i-408C4
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN181i-408C4
AC   CVCL_JR50
SY   ISMMS 408i C4; 408_4
DR   GEO; GSM2100087
DR   SKIP; SKIP005271
DR   WiCell; stan181i-408c4
DR   Wikidata; Q54956046
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR49 ! STAN180i-408C2
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN182i-410C3
AC   CVCL_JR51
SY   ISMMS 410i C3
DR   SKIP; SKIP005274
DR   WiCell; stan182i-410c3
DR   Wikidata; Q54956047
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR52 ! STAN183i-410C4
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN183i-410C4
AC   CVCL_JR52
SY   ISMMS 410i C4; 410_4
DR   GEO; GSM2100089
DR   SKIP; SKIP005273
DR   WiCell; stan183i-410c4
DR   Wikidata; Q54956053
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR51 ! STAN182i-410C3
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN187i-420C6
AC   CVCL_JR53
SY   ISMMS 420i C6; 420_6
DR   GEO; GSM2100101
DR   SKIP; SKIP005277
DR   WiCell; stan187i-420c6
DR   Wikidata; Q54956054
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN190i-424C2
AC   CVCL_JR54
SY   ISMMS 424i C2
DR   SKIP; SKIP005278
DR   WiCell; stan190i-424c2
DR   Wikidata; Q54956056
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN191i-429C2
AC   CVCL_JR55
SY   ISMMS 429i C2 P11
DR   SKIP; SKIP005279
DR   WiCell; stan191i-429c2
DR   Wikidata; Q54956058
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR56 ! STAN192i-429C3
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN192i-429C3
AC   CVCL_JR56
SY   ISMMS 429i C3 P11
DR   SKIP; SKIP005280
DR   WiCell; stan192i-429c3
DR   Wikidata; Q54956059
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR55 ! STAN191i-429C2
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN193i-432C1
AC   CVCL_JR57
SY   ISMMS 432i C1; 432_1
DR   GEO; GSM2100214
DR   WiCell; stan193i-432c1
DR   Wikidata; Q54956061
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: WiCell; stan193i-432c1; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR58 ! STAN194i-432C3
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN194i-432C3
AC   CVCL_JR58
SY   ISMMS 432i C3; 432_3
DR   GEO; GSM2100215
DR   WiCell; stan194i-432c3
DR   Wikidata; Q54956062
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: WiCell; stan194i-432c3; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR57 ! STAN193i-432C1
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN195i-434C3
AC   CVCL_JR59
SY   ISMMS 434i C3; 434_3
DR   GEO; GSM2100197
DR   WiCell; stan195i-434c3
DR   Wikidata; Q54956063
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: WiCell; stan195i-434c3; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN197i-441C1
AC   CVCL_JR60
SY   ISMMS 441i C1 P20; 441_1
DR   GEO; GSM2100111
DR   WiCell; stan197i-441c1
DR   Wikidata; Q54956064
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR61 ! STAN198i-441C2
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN198i-441C2
AC   CVCL_JR61
SY   ISMMS 441i C2; 441_2
DR   GEO; GSM2100112
DR   SKIP; SKIP005282
DR   WiCell; stan198i-441c2
DR   Wikidata; Q54956065
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR60 ! STAN197i-441C1
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN200i-444C1
AC   CVCL_JR62
SY   ISMMS 444i C1
DR   SKIP; SKIP005284
DR   WiCell; stan200i-444c1
DR   Wikidata; Q54956066
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR63 ! STAN201i-444C2
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN201i-444C2
AC   CVCL_JR63
SY   ISMMS 444i C2
DR   SKIP; SKIP005283
DR   WiCell; stan201i-444c2
DR   Wikidata; Q54956067
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR62 ! STAN200i-444C1
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN202i-445C1
AC   CVCL_JR64
SY   ISMMS 445i C1
DR   SKIP; SKIP005285
DR   WiCell; stan202i-445c1
DR   Wikidata; Q54956068
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR65 ! STAN203i-445C2
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN203i-445C2
AC   CVCL_JR65
SY   ISMMS 445i C2
DR   SKIP; SKIP005286
DR   WiCell; stan203i-445c2
DR   Wikidata; Q54956069
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR64 ! STAN202i-445C1
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN204i-448C1
AC   CVCL_JR66
SY   ISMMS 448i C1; 448_1
DR   GEO; GSM2100122
DR   SKIP; SKIP005287
DR   WiCell; stan204i-448c1
DR   Wikidata; Q54956070
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR67 ! STAN205i-448C2
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN205i-448C2
AC   CVCL_JR67
SY   ISMMS 448i C2; 448_2
DR   GEO; GSM2100123
DR   SKIP; SKIP005288
DR   WiCell; stan205i-448c2
DR   Wikidata; Q54956071
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR66 ! STAN204i-448C1
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN206i-459C1
AC   CVCL_JR68
SY   ISMMS 459i C1; 459_1
DR   GEO; GSM2100125
DR   SKIP; SKIP005289
DR   WiCell; stan206i-459c1
DR   Wikidata; Q54956072
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR69 ! STAN207i-459C2
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN207i-459C2
AC   CVCL_JR69
SY   ISMMS 459i C2; 459_2
DR   GEO; GSM2100126
DR   SKIP; SKIP005290
DR   WiCell; stan207i-459c2
DR   Wikidata; Q54956073
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR68 ! STAN206i-459C1
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN208i-460C2
AC   CVCL_JR70
SY   ISMMS 460i C2; 460_2
DR   GEO; GSM2100128
DR   SKIP; SKIP005291
DR   WiCell; stan208i-460c2
DR   Wikidata; Q54956074
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR71 ! STAN209i-460C6
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN209i-460C6
AC   CVCL_JR71
SY   ISMMS 460i C6; 460_6
DR   GEO; GSM2100130
DR   SKIP; SKIP005292
DR   WiCell; stan209i-460c6
DR   Wikidata; Q54956077
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR70 ! STAN208i-460C2
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN210i-468C1
AC   CVCL_JR72
SY   ISMMS 468i C1
DR   SKIP; SKIP005294
DR   WiCell; stan210i-468c1
DR   Wikidata; Q54956079
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 12
//
ID   STAN211i-475C1
AC   CVCL_JR73
SY   ISMMS 475i C1; 475_1
DR   GEO; GSM2100131
DR   SKIP; SKIP005295
DR   WiCell; stan211i-475c1
DR   Wikidata; Q54956080
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN212i-488C2
AC   CVCL_JR74
SY   ISMMS 488i C2
DR   SKIP; SKIP005297
DR   WiCell; stan212i-488c2
DR   Wikidata; Q54956081
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR75 ! STAN213i-488C3
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN213i-488C3
AC   CVCL_JR75
SY   ISMMS 488i C3
DR   SKIP; SKIP005296
DR   WiCell; stan213i-488c3
DR   Wikidata; Q54956082
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR74 ! STAN212i-488C2
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN215i-490C3
AC   CVCL_YZ03
SY   ISMMS 490i C3
DR   WiCell; stan215i-490c3
DR   Wikidata; Q98132849
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   STAN216i-496C1
AC   CVCL_JR76
SY   ISMMS 496i C1; 496_1
DR   GEO; GSM2100134
DR   SKIP; SKIP005299
DR   WiCell; stan216i-496c1
DR   Wikidata; Q54956083
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR77 ! STAN217i-496C2
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN217i-496C2
AC   CVCL_JR77
SY   ISMMS 4968 C2; 496_2
DR   GEO; GSM2100136
DR   SKIP; SKIP005298
DR   WiCell; stan217i-496c2
DR   Wikidata; Q54956084
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR76 ! STAN216i-496C1
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN218i-501C5
AC   CVCL_JR78
SY   ISMMS 501i C5
DR   SKIP; SKIP005300
DR   WiCell; stan218i-501c5
DR   Wikidata; Q54956085
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR79 ! STAN219i-501C6
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN219i-501C6
AC   CVCL_JR79
SY   ISMMS 501i C6
DR   SKIP; SKIP005301
DR   WiCell; stan219i-501c6
DR   Wikidata; Q54956086
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR78 ! STAN218i-501C5
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN220i-504C2
AC   CVCL_JR80
SY   ISMMS 504i C2; 504_2
DR   GEO; GSM2100138
DR   SKIP; SKIP005302
DR   WiCell; stan220i-504c2
DR   Wikidata; Q54956087
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN222i-509C2
AC   CVCL_JR81
SY   ISMMS 509i C2; 509_2
DR   GEO; GSM2100140
DR   SKIP; SKIP005304
DR   WiCell; stan222i-509c2
DR   Wikidata; Q54956088
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR82 ! STAN223i-509C3
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN223i-509C3
AC   CVCL_JR82
SY   ISMMS 509i C3; 509_3
DR   GEO; GSM2100141
DR   SKIP; SKIP005303
DR   WiCell; stan223i-509c3
DR   Wikidata; Q54956089
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR81 ! STAN222i-509C2
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN224i-514C3
AC   CVCL_JR83
SY   ISMMS 514i C3; 514_3
DR   GEO; GSM2100143
DR   SKIP; SKIP005306
DR   WiCell; stan224i-514c3
DR   Wikidata; Q54956091
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR84 ! STAN225i-514C4
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN225i-514C4
AC   CVCL_JR84
SY   ISMMS 514i C4; 514_4
DR   GEO; GSM2100144
DR   SKIP; SKIP005305
DR   WiCell; stan225i-514c4
DR   Wikidata; Q54956092
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR83 ! STAN224i-514C3
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN226i-516C3
AC   CVCL_JR85
SY   ISMMS 516i C3; 516_3
DR   GEO; GSM2100146
DR   SKIP; SKIP005308
DR   WiCell; stan226i-516c3
DR   Wikidata; Q54956093
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR86 ! STAN227i-516C5
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN227i-516C5
AC   CVCL_JR86
SY   ISMMS 516i C5; 516_5
DR   GEO; GSM2100147
DR   SKIP; SKIP005307
DR   WiCell; stan227i-516c5
DR   Wikidata; Q54956094
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR85 ! STAN226i-516C3
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN228i-523C1
AC   CVCL_JR87
SY   ISMMS 523i C1
DR   SKIP; SKIP005311
DR   WiCell; stan228i-523c1
DR   Wikidata; Q54956096
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR88 ! STAN229i-523C2
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN229i-523C2
AC   CVCL_JR88
SY   ISMMS 523i C2
DR   SKIP; SKIP005310
DR   WiCell; stan229i-523c2
DR   Wikidata; Q54956098
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR87 ! STAN228i-523C1
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN230i-533C1
AC   CVCL_JR89
SY   ISMMS 533i C1
DR   SKIP; SKIP005313
DR   WiCell; stan230i-533c1
DR   Wikidata; Q54956099
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR90 ! STAN231i-533C2
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN231i-533C2
AC   CVCL_JR90
SY   ISMMS 533i C2
DR   SKIP; SKIP005314
DR   WiCell; stan231i-533c2
DR   Wikidata; Q54956100
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR89 ! STAN230i-533C1
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN232i-541C2
AC   CVCL_JR91
SY   ISMMS 541i C2; 541_2
DR   GEO; GSM2100152
DR   SKIP; SKIP005315
DR   WiCell; stan232i-541c2
DR   Wikidata; Q54956102
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR92 ! STAN233i-541C5
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN233i-541C5
AC   CVCL_JR92
SY   ISMMS 541i C5; 541_5
DR   GEO; GSM2100154
DR   SKIP; SKIP005316
DR   WiCell; stan233i-541c5
DR   Wikidata; Q54956113
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR91 ! STAN232i-541C2
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN234i-546C1
AC   CVCL_JR93
SY   ISMMS 546i C1; 546_1
DR   GEO; GSM2100155
DR   SKIP; SKIP005318
DR   WiCell; stan234i-546c1
DR   Wikidata; Q54956114
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR94 ! STAN235i-546C2
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN235i-546C2
AC   CVCL_JR94
SY   ISMMS 546i C2; 546_2
DR   GEO; GSM2100156
DR   SKIP; SKIP005317
DR   WiCell; stan235i-546c2
DR   Wikidata; Q54956115
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR93 ! STAN234i-546C1
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN236i-551C1
AC   CVCL_JR95
SY   ISMMS 551i C1; 551_1
DR   GEO; GSM2100158
DR   SKIP; SKIP005319
DR   WiCell; stan236i-551c1
DR   Wikidata; Q54956116
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR96 ! STAN237i-551C2
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN237i-551C2
AC   CVCL_JR96
SY   ISMMS 551i C2; 551_2
DR   GEO; GSM2100159
DR   SKIP; SKIP005320
DR   WiCell; stan237i-551c2
DR   Wikidata; Q54956117
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR95 ! STAN236i-551C1
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN238i-553C5
AC   CVCL_JR97
SY   ISMMS 553i C5; 553_5
DR   GEO; GSM2100161
DR   SKIP; SKIP005321
DR   WiCell; stan238i-553c5
DR   Wikidata; Q54956118
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Latino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR98 ! STAN239i-553C8
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN239i-553C8
AC   CVCL_JR98
SY   ISMMS 553i C8; 553_8
DR   GEO; GSM2100162
DR   SKIP; SKIP005322
DR   WiCell; stan239i-553c8
DR   Wikidata; Q54956119
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Latino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR97 ! STAN238i-553C5
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN240i-558C3
AC   CVCL_JR99
SY   ISMMS 558i C3; 558_3
DR   GEO; GSM2100166
DR   SKIP; SKIP005324
DR   WiCell; stan240i-558c3
DR   Wikidata; Q54956120
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS00 ! STAN241i-558C4
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN241i-558C4
AC   CVCL_JS00
SY   ISMMS 558i C4
DR   SKIP; SKIP005323
DR   WiCell; stan241i-558c4
DR   Wikidata; Q54956121
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JR99 ! STAN240i-558C3
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN242i-573C2
AC   CVCL_JS01
SY   ISMMS 573i C2
DR   SKIP; SKIP005327
DR   WiCell; stan242i-573c2
DR   Wikidata; Q54956122
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN243i-589C3
AC   CVCL_JS02
SY   ISMMS 589i C3; 589_3
DR   GEO; GSM2100169
DR   SKIP; SKIP005328
DR   WiCell; stan243i-589c3
DR   Wikidata; Q54956123
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS03 ! STAN244i-589C4
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN244i-589C4
AC   CVCL_JS03
SY   ISMMS 589i C4
DR   SKIP; SKIP005329
DR   WiCell; stan244i-589c4
DR   Wikidata; Q54956124
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS02 ! STAN243i-589C3
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN245i-601C4
AC   CVCL_JS04
SY   ISMMS 601i C4; 601_4
DR   GEO; GSM2100170
DR   SKIP; SKIP005331
DR   WiCell; stan245i-601c4
DR   Wikidata; Q54956126
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS05 ! STAN246i-601C5
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN246i-601C5
AC   CVCL_JS05
SY   ISMMS 601i C5; 601_5
DR   GEO; GSM2100171
DR   SKIP; SKIP005330
DR   WiCell; stan246i-601c5
DR   Wikidata; Q54956127
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS04 ! STAN245i-601C4
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN247i-614C2
AC   CVCL_JS06
SY   ISMMS 614i C2; 614_2
DR   GEO; GSM2100173
DR   SKIP; SKIP005332
DR   WiCell; stan247i-614c2
DR   Wikidata; Q54956128
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN248i-617C1
AC   CVCL_JS07
SY   ISMMS 617i C1; 617_1
DR   GEO; GSM2100176
DR   SKIP; SKIP005334
DR   WiCell; stan248i-617c1
DR   Wikidata; Q54956129
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS08 ! STAN249i-617C2
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN249i-617C2
AC   CVCL_JS08
SY   ISMMS 617i C2; 617_2
DR   GEO; GSM2100177
DR   SKIP; SKIP005333
DR   WiCell; stan249i-617c2
DR   Wikidata; Q54956130
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS07 ! STAN248i-617C1
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN250i-622C2
AC   CVCL_JS09
SY   ISMMS 622i C2
DR   SKIP; SKIP005335
DR   WiCell; stan250i-622c2
DR   Wikidata; Q54956131
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN251i-637C1
AC   CVCL_JS10
SY   ISMMS 637i C1
DR   SKIP; SKIP005337
DR   WiCell; stan251i-637c1
DR   Wikidata; Q54956133
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS11 ! STAN252i-637C2
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN252i-637C2
AC   CVCL_JS11
SY   ISMMS 637i C2
DR   SKIP; SKIP005338
DR   WiCell; stan252i-637c2
DR   Wikidata; Q54956134
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS10 ! STAN251i-637C1
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN253i-647C1
AC   CVCL_JS12
SY   ISMMS 647i C1
DR   SKIP; SKIP005340
DR   WiCell; stan253i-647c1
DR   Wikidata; Q54956136
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS13 ! STAN254i-647C3
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN254i-647C3
AC   CVCL_JS13
SY   ISMMS 647i C3
DR   SKIP; SKIP005339
DR   WiCell; stan254i-647c3
DR   Wikidata; Q54956138
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS12 ! STAN253i-647C1
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN255i-649C1
AC   CVCL_JS14
SY   ISMMS 649i C1; 649_1
DR   GEO; GSM2100179
DR   SKIP; SKIP005341
DR   WiCell; stan255i-649c1
DR   Wikidata; Q54956140
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS15 ! STAN256i-649C2
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN256i-649C2
AC   CVCL_JS15
SY   ISMMS 649i C2; 649_2
DR   GEO; GSM2100180
DR   SKIP; SKIP005342
DR   WiCell; stan256i-649c2
DR   Wikidata; Q54956141
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS14 ! STAN255i-649C1
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN257i-685C3
AC   CVCL_JS16
SY   ISMMS 685i C3
DR   SKIP; SKIP005345
DR   WiCell; stan257i-685c3
DR   Wikidata; Q54956142
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS17 ! STAN258i-685C4
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN258i-685C4
AC   CVCL_JS17
SY   ISMMS 685i C4
DR   SKIP; SKIP005346
DR   WiCell; stan258i-685c4
DR   Wikidata; Q54956143
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS16 ! STAN257i-685C3
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN259i-688C1
AC   CVCL_JS18
SY   ISMMS 688i C1; 688_1
DR   GEO; GSM2100185
DR   SKIP; SKIP005348
DR   WiCell; stan259i-688c1
DR   Wikidata; Q54956144
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS19 ! STAN260i-688C3
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN260i-688C3
AC   CVCL_JS19
SY   ISMMS 688i C3; 688_3
DR   GEO; GSM2100186
DR   SKIP; SKIP005347
DR   WiCell; stan260i-688c3
DR   Wikidata; Q54956146
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS18 ! STAN259i-688C1
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN261i-698C5
AC   CVCL_JS20
SY   ISMMS 698i C5; 698_5
DR   GEO; GSM2100217
DR   SKIP; SKIP005350
DR   WiCell; stan261i-698c5
DR   Wikidata; Q54956148
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN263i-703C1
AC   CVCL_JS21
SY   ISMMS 703i C1; 703_1
DR   GEO; GSM2100102
DR   SKIP; SKIP005351
DR   WiCell; stan263i-703c1
DR   Wikidata; Q54956149
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS22 ! STAN264i-703C2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN264i-703C2
AC   CVCL_JS22
SY   ISMMS 703i C2; 703_2
DR   GEO; GSM2100103
DR   SKIP; SKIP005352
DR   WiCell; stan264i-703c2
DR   Wikidata; Q54956151
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS21 ! STAN263i-703C1
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN265i-707C1
AC   CVCL_JS23
SY   ISMMS 707i C1; 707_1
DR   GEO; GSM2100194
DR   SKIP; SKIP005353
DR   WiCell; stan265i-707c1
DR   Wikidata; Q54956152
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS24 ! STAN266i-707C4
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN266i-707C4
AC   CVCL_JS24
SY   ISMMS 707i C4; 707_4
DR   GEO; GSM2100195
DR   SKIP; SKIP005354
DR   WiCell; stan266i-707c4
DR   Wikidata; Q54956153
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS23 ! STAN265i-707C1
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN269i-720C2
AC   CVCL_JS25
SY   ISMMS 720i C2
DR   SKIP; SKIP005356
DR   WiCell; stan269i-720c2
DR   Wikidata; Q54956155
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS26 ! STAN270i-720C3
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN270i-720C3
AC   CVCL_JS26
SY   ISMMS 720i C3
DR   SKIP; SKIP005355
DR   WiCell; stan270i-720c3
DR   Wikidata; Q54956156
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS25 ! STAN269i-720C2
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN271i-726C3
AC   CVCL_JS27
SY   ISMMS 726i C3
DR   SKIP; SKIP005357
DR   WiCell; stan271i-726c3
DR   Wikidata; Q54956157
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS28 ! STAN272i-726C4
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN272i-726C4
AC   CVCL_JS28
SY   ISMMS 726i C4
DR   SKIP; SKIP005358
DR   WiCell; stan272i-726c4
DR   Wikidata; Q54956158
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS27 ! STAN271i-726C3
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN273i-729C1
AC   CVCL_JS29
SY   ISMMS 729i C1
DR   SKIP; SKIP005359
DR   WiCell; stan273i-729c1
DR   Wikidata; Q54956159
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS30 ! STAN274i-729C2
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN274i-729C2
AC   CVCL_JS30
SY   ISMMS 729i C2
DR   SKIP; SKIP005360
DR   WiCell; stan274i-729c2
DR   Wikidata; Q54956161
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian and Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS29 ! STAN273i-729C1
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN275i-732C1
AC   CVCL_JS31
SY   ISMMS 732i C1
DR   SKIP; SKIP005361
DR   WiCell; stan275i-732c1
DR   Wikidata; Q54956162
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN276i-756C4
AC   CVCL_JS32
SY   ISMMS 756i C4; 756_4
DR   GEO; GSM2100200
DR   SKIP; SKIP005363
DR   WiCell; stan276i-756c4
DR   Wikidata; Q54956182
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS33 ! STAN277i-756C5
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN277i-756C5
AC   CVCL_JS33
SY   ISMMS 756i C5; 756_5
DR   GEO; GSM2100201
DR   SKIP; SKIP005362
DR   WiCell; stan277i-756c5
DR   Wikidata; Q54956183
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: 756_6; GEO=GSM2100201.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS32 ! STAN276i-756C4
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN278i-767C2
AC   CVCL_JS34
SY   ISMMS 767i C2; 767_2
DR   GEO; GSM2100205
DR   SKIP; SKIP005366
DR   WiCell; stan278i-767c2
DR   Wikidata; Q54956184
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS35 ! STAN279i-767C3
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN279i-767C3
AC   CVCL_JS35
SY   ISMMS 767i C3; 767_3
DR   GEO; GSM2100206
DR   SKIP; SKIP005365
DR   WiCell; stan279i-767c3
DR   Wikidata; Q54956185
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS34 ! STAN278i-767C2
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN280i-770C1
AC   CVCL_JS36
SY   ISMMS 770i C1
DR   SKIP; SKIP005367
DR   WiCell; stan280i-770c1
DR   Wikidata; Q54956186
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS37 ! STAN281i-770C2
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN281i-770C2
AC   CVCL_JS37
SY   ISMMS 770i C2
DR   SKIP; SKIP005368
DR   WiCell; stan281i-770c2
DR   Wikidata; Q54956188
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS36 ! STAN280i-770C1
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN282i-771C3
AC   CVCL_JS38
SY   ISMMS 771i C3
DR   SKIP; SKIP005369
DR   WiCell; stan282i-771c3
DR   Wikidata; Q54956189
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS39 ! STAN283i-771C4
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN283i-771C4
AC   CVCL_JS39
SY   ISMMS 771i C4; 771_4
DR   GEO; GSM2100209
DR   SKIP; SKIP005370
DR   WiCell; stan283i-771c4
DR   Wikidata; Q54956190
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Asian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS38 ! STAN282i-771C3
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN284i-780C1
AC   CVCL_JS40
SY   ISMMS 780i C1; 780_1
DR   GEO; GSM2100211
DR   SKIP; SKIP005372
DR   WiCell; stan284i-780c1
DR   Wikidata; Q54956191
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS41 ! STAN285i-780C2
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN285i-780C2
AC   CVCL_JS41
SY   ISMMS 780i C2; 780_2
DR   GEO; GSM2100212
DR   SKIP; SKIP005371
DR   WiCell; stan285i-780c2
DR   Wikidata; Q54956192
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS40 ! STAN284i-780C1
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN286i-799C2
AC   CVCL_JS42
SY   ISMMS 799i C2; 799_2
DR   GEO; GSM2100106
DR   SKIP; SKIP005374
DR   WiCell; stan286i-799c2
DR   Wikidata; Q54956193
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: WiCell; stan286i-799c2; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN287i-810C1
AC   CVCL_JS43
SY   ISMMS 810i C1
DR   SKIP; SKIP005376
DR   WiCell; stan287i-810c1
DR   Wikidata; Q54956194
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS44 ! STAN288i-810C3
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN288i-810C3
AC   CVCL_JS44
SY   ISMMS 810i C3
DR   SKIP; SKIP005375
DR   WiCell; stan288i-810c3
DR   Wikidata; Q54956195
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS43 ! STAN287i-810C1
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN291i-827C1
AC   CVCL_JS45
SY   ISMMS 827i C1; 827_1
DR   GEO; GSM2100220
DR   SKIP; SKIP005378
DR   WiCell; stan291i-827c1
DR   Wikidata; Q54956197
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS46 ! STAN292i-827C2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN292i-827C2
AC   CVCL_JS46
SY   ISMMS 827i C2; 827_2
DR   GEO; GSM2100221
DR   SKIP; SKIP005377
DR   WiCell; stan292i-827c2
DR   Wikidata; Q54956198
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS45 ! STAN291i-827C1
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN293i-835C1
AC   CVCL_JS47
SY   ISMMS 835i C1; 835_1
DR   GEO; GSM2100223
DR   SKIP; SKIP005380
DR   WiCell; stan293i-835c1
DR   Wikidata; Q54956199
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS48 ! STAN294i-835C5
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN294i-835C5
AC   CVCL_JS48
SY   ISMMS 835i C5; 835_5
DR   GEO; GSM2100224
DR   SKIP; SKIP005379
DR   WiCell; stan294i-835c5
DR   Wikidata; Q54956201
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS47 ! STAN293i-835C1
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN295i-836C1
AC   CVCL_JS49
SY   ISMMS 836i C1
DR   SKIP; SKIP005381
DR   WiCell; stan295i-836c1
DR   Wikidata; Q54956202
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS50 ! STAN296i-836C2
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN296i-836C2
AC   CVCL_JS50
SY   ISMMS 836i C2
DR   SKIP; SKIP005382
DR   WiCell; stan296i-836c2
DR   Wikidata; Q54956203
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS49 ! STAN295i-836C1
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN297i-839C1
AC   CVCL_JS51
SY   ISMMS 839i C1; 839_1
DR   GEO; GSM2100229
DR   SKIP; SKIP005383
DR   WiCell; stan297i-839c1
DR   Wikidata; Q54956204
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Latino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS52 ! STAN298i-839C5
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN298i-839C5
AC   CVCL_JS52
SY   ISMMS 839i C5; 839_5
DR   GEO; GSM2100230
DR   SKIP; SKIP005384
DR   WiCell; stan298i-839c5
DR   Wikidata; Q54956205
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Latino.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS51 ! STAN297i-839C1
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN299i-843C5
AC   CVCL_JS53
SY   ISMMS 843i C5
DR   SKIP; SKIP005386
DR   WiCell; stan299i-843c5
DR   Wikidata; Q54956206
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS54 ! STAN300i-843C6
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN300i-843C6
AC   CVCL_JS54
SY   ISMMS 843i C6
DR   SKIP; SKIP005385
DR   WiCell; stan300i-843c6
DR   Wikidata; Q54956207
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS53 ! STAN299i-843C5
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN301i-845AC2
AC   CVCL_JS55
SY   ISMMS 845Ai C2; 845A_2
DR   GEO; GSM2100236
DR   WiCell; stan301i-845ac2
DR   Wikidata; Q54956209
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS56 ! STAN302i-845AC4
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN302i-845AC4
AC   CVCL_JS56
SY   ISMMS 845Ai C4; 845A_4
DR   GEO; GSM2100237
DR   WiCell; stan302i-845ac4
DR   Wikidata; Q54956210
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS55 ! STAN301i-845AC2
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   STAN303i-864C2
AC   CVCL_JS57
SY   ISMMS 864i C2; 864_2
DR   GEO; GSM2100241
DR   SKIP; SKIP005390
DR   WiCell; stan303i-864c2
DR   Wikidata; Q54956211
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS58 ! STAN304i-864C5
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN304i-864C5
AC   CVCL_JS58
SY   ISMMS 864i C5; 864_5
DR   GEO; GSM2100243
DR   SKIP; SKIP005389
DR   WiCell; stan304i-864c5
DR   Wikidata; Q54956212
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS57 ! STAN303i-864C2
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN305i-865C2
AC   CVCL_JS59
SY   ISMMS 865i C2; 865_2
DR   GEO; GSM2100244
DR   SKIP; SKIP005392
DR   WiCell; stan305i-865c2
DR   Wikidata; Q54956213
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS60 ! STAN306i-865C3
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN306i-865C3
AC   CVCL_JS60
SY   ISMMS 865i C3; 865_3
DR   GEO; GSM2100245
DR   SKIP; SKIP005391
DR   WiCell; stan306i-865c3
DR   Wikidata; Q54956214
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS59 ! STAN305i-865C2
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN307i-871C2
AC   CVCL_JS61
SY   ISMMS 871i C2
DR   SKIP; SKIP005395
DR   WiCell; stan307i-871c2
DR   Wikidata; Q54956215
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS62 ! STAN308i-871C3
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN308i-871C3
AC   CVCL_JS62
SY   ISMMS 871i C3
DR   SKIP; SKIP005394
DR   WiCell; stan308i-871c3
DR   Wikidata; Q54956216
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS61 ! STAN307i-871C2
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN311i-906C1
AC   CVCL_JS63
SY   ISMMS 906i C1; 906_1
DR   GEO; GSM2100247
DR   SKIP; SKIP005400
DR   WiCell; stan311i-906c1
DR   Wikidata; Q54956217
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS64 ! STAN312i-906C3
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN312i-906C3
AC   CVCL_JS64
SY   ISMMS 906i C3; 906_3
DR   GEO; GSM2100248
DR   SKIP; SKIP005399
DR   WiCell; stan312i-906c3
DR   Wikidata; Q54956219
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS63 ! STAN311i-906C1
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN313i-907C1
AC   CVCL_JS65
SY   ISMMS 907i C1
DR   SKIP; SKIP005402
DR   WiCell; stan313i-907c1
DR   Wikidata; Q54956220
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS66 ! STAN314i-907C4
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN314i-907C4
AC   CVCL_JS66
SY   ISMMS 907i C4
DR   SKIP; SKIP005401
DR   WiCell; stan314i-907c4
DR   Wikidata; Q54956221
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS65 ! STAN313i-907C1
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN315i-909C1
AC   CVCL_JS67
SY   ISMMS 909i C1; 909_1
DR   GEO; GSM2100250
DR   SKIP; SKIP005403
DR   WiCell; stan315i-909c1
DR   Wikidata; Q54956222
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS68 ! STAN316i-909C2
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN316i-909C2
AC   CVCL_JS68
SY   ISMMS 909i C2; 909_2
DR   GEO; GSM2100251
DR   SKIP; SKIP005404
DR   WiCell; stan316i-909c2
DR   Wikidata; Q54956223
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS67 ! STAN315i-909C1
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN317i-910C2
AC   CVCL_JS69
SY   ISMMS 910i C2
DR   SKIP; SKIP005405
DR   WiCell; stan317i-910c2
DR   Wikidata; Q54956224
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS70 ! STAN318i-910C3
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN318i-910C3
AC   CVCL_JS70
SY   ISMMS 910i C3
DR   SKIP; SKIP005406
DR   WiCell; stan318i-910c3
DR   Wikidata; Q54956225
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS69 ! STAN317i-910C2
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN319i-922C1
AC   CVCL_JS71
SY   ISMMS 922i C1
DR   SKIP; SKIP005407
DR   WiCell; stan319i-922c1
DR   Wikidata; Q54956226
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN321i-924C1
AC   CVCL_JS72
SY   ISMMS 924i C1
DR   SKIP; SKIP005408
DR   WiCell; stan321i-924c1
DR   Wikidata; Q54956233
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS73 ! STAN322i-924C2
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN322i-924C2
AC   CVCL_JS73
SY   ISMMS 924i C2
DR   SKIP; SKIP005409
DR   WiCell; stan322i-924c2
DR   Wikidata; Q54956234
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS72 ! STAN321i-924C1
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN323i-928C2
AC   CVCL_JS74
SY   ISMMS 928i C2; 928_2
DR   GEO; GSM2100256
DR   SKIP; SKIP005410
DR   WiCell; stan323i-928c2
DR   Wikidata; Q54956235
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS75 ! STAN324i-928C6
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN324i-928C6
AC   CVCL_JS75
SY   ISMMS 928i C6; 928_6
DR   GEO; GSM2100258
DR   SKIP; SKIP005411
DR   WiCell; stan324i-928c6
DR   Wikidata; Q54956236
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS74 ! STAN323i-928C2
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN327i-940C2
AC   CVCL_JS76
SY   ISMMS 940i C2
DR   SKIP; SKIP005412
DR   WiCell; stan327i-940c2
DR   Wikidata; Q54956237
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN328i-946C2
AC   CVCL_JS77
SY   ISMMS 946i C2
DR   SKIP; SKIP005413
DR   WiCell; stan328i-946c2
DR   Wikidata; Q54956238
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN329i-949C3
AC   CVCL_JS78
SY   ISMMS 949i C3
DR   SKIP; SKIP005414
DR   WiCell; stan329i-949c3
DR   Wikidata; Q54956239
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS79 ! STAN330i-949C4
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN330i-949C4
AC   CVCL_JS79
SY   ISMMS 949i C4
DR   SKIP; SKIP005415
DR   WiCell; stan330i-949c4
DR   Wikidata; Q54956240
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS78 ! STAN329i-949C3
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN331i-952C3
AC   CVCL_JS80
SY   ISMMS 952i C3; 952_3
DR   GEO; GSM2100260
DR   SKIP; SKIP005416
DR   WiCell; stan331i-952c3
DR   Wikidata; Q54956241
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS81 ! STAN332i-952C5
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN332i-952C5
AC   CVCL_JS81
SY   ISMMS 952i C5; 952_5
DR   GEO; GSM2100261
DR   SKIP; SKIP005417
DR   WiCell; stan332i-952c5
DR   Wikidata; Q54956242
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS80 ! STAN331i-952C3
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN333i-955C1
AC   CVCL_JS82
SY   ISMMS 955i C1
DR   SKIP; SKIP005419
DR   WiCell; stan333i-955c1
DR   Wikidata; Q54956243
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS83 ! STAN334i-955C2
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN334i-955C2
AC   CVCL_JS83
SY   ISMMS 955i C2
DR   SKIP; SKIP005418
DR   WiCell; stan334i-955c2
DR   Wikidata; Q54956244
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS82 ! STAN333i-955C1
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN336i-963C1
AC   CVCL_JS84
SY   ISMMS 963i C1; 963_1
DR   GEO; GSM2100265
DR   SKIP; SKIP005422
DR   WiCell; stan336i-963c1
DR   Wikidata; Q54956246
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS85 ! STAN337i-963C3
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN337i-963C3
AC   CVCL_JS85
SY   ISMMS 963i C3; 963_3
DR   GEO; GSM2100266
DR   SKIP; SKIP005421
DR   WiCell; stan337i-963c3
DR   Wikidata; Q54956247
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS84 ! STAN336i-963C1
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN338i-975C1
AC   CVCL_JS86
SY   ISMMS 975i C1
DR   SKIP; SKIP005424
DR   WiCell; stan338i-975c1
DR   Wikidata; Q54956248
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS87 ! STAN339i-975C3
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN339i-975C3
AC   CVCL_JS87
SY   ISMMS 975i C3
DR   SKIP; SKIP005423
DR   WiCell; stan339i-975c3
DR   Wikidata; Q54956249
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Latino.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS86 ! STAN338i-975C1
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN340i-981C1
AC   CVCL_JS88
SY   ISMMS 981i C1
DR   SKIP; SKIP005425
DR   WiCell; stan340i-981c1
DR   Wikidata; Q54956250
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN341i-994C1
AC   CVCL_JS89
SY   ISMMS 994i C1
DR   SKIP; SKIP005426
DR   WiCell; stan341i-994c1
DR   Wikidata; Q54956251
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS90 ! STAN342i-994C3
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN342i-994C3
AC   CVCL_JS90
SY   ISMMS 994i C3
DR   SKIP; SKIP005427
DR   WiCell; stan342i-994c3
DR   Wikidata; Q54956252
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS89 ! STAN341i-994C1
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN343i-998C1
AC   CVCL_JS91
SY   ISMMS 998i C1; 998_1
DR   GEO; GSM2100271
DR   SKIP; SKIP005428
DR   WiCell; stan343i-998c1
DR   Wikidata; Q54956253
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN345i-390C3
AC   CVCL_JS92
SY   ISMMS 390i C3
DR   SKIP; SKIP005269
DR   WiCell; stan345i-390c3
DR   Wikidata; Q54956254
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN346i-59C2
AC   CVCL_JS93
SY   ISMMS 059i C2
DR   SKIP; SKIP005176
DR   WiCell; stan346i-59c2
DR   Wikidata; Q54956255
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN347i-66C3
AC   CVCL_JS94
SY   ISMMS 066i C3
DR   SKIP; SKIP005177
DR   WiCell; stan347i-66c3
DR   Wikidata; Q54956256
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN348i-851C1
AC   CVCL_JS95
SY   ISMMS 851i C1
DR   SKIP; SKIP005388
DR   WiCell; stan348i-851c1
DR   Wikidata; Q54956257
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN349i-762C3
AC   CVCL_JS96
SY   ISMMS 762i C3; 762_3
DR   GEO; GSM2100204
DR   SKIP; SKIP005364
DR   WiCell; stan349i-762c3
DR   Wikidata; Q54956258
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: African American.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN350i-694C5
AC   CVCL_JS97
SY   ISMMS 694i C5; 694_5
DR   GEO; GSM2100190
DR   SKIP; SKIP005349
DR   WiCell; stan350i-694c5
DR   Wikidata; Q54956259
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN351i-631C1
AC   CVCL_JS98
SY   ISMMS 631i C1
DR   SKIP; SKIP005336
DR   WiCell; stan351i-631c1
DR   Wikidata; Q54956262
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN357i-298C2
AC   CVCL_JS99
SY   ISMMS 298Bi C2
DR   SKIP; SKIP005241
DR   WiCell; stan357i-298c2
DR   Wikidata; Q54956263
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JT00 ! STAN358i-298C3
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN358i-298C3
AC   CVCL_JT00
SY   ISMMS 298Bi C3
DR   SKIP; SKIP005240
DR   WiCell; stan358i-298c3
DR   Wikidata; Q54956264
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JS99 ! STAN357i-298C2
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN359i-442C11
AC   CVCL_JT01
SY   ISMMS 442i C11; 442_11
DR   GEO; GSM2100114
DR   SKIP; SKIP005281
DR   WiCell; stan359i-442c11
DR   Wikidata; Q54956265
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN360i-465C2
AC   CVCL_JT02
SY   ISMMS 465i C2
DR   SKIP; SKIP005293
DR   WiCell; stan360i-465c2
DR   Wikidata; Q54956266
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN361i-531C6
AC   CVCL_JT03
SY   ISMMS 531i C6
DR   SKIP; SKIP005312
DR   WiCell; stan361i-531c6
DR   Wikidata; Q54956267
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN362i-178C1
AC   CVCL_JT04
SY   ISMMS 178i C1
DR   SKIP; SKIP005210
DR   WiCell; stan362i-178c1
DR   Wikidata; Q54956268
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN363i-845C5
AC   CVCL_JT05
SY   ISMMS 845i C5
DR   SKIP; SKIP005387
DR   WiCell; stan363i-845c5
DR   Wikidata; Q54956269
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN364i-055C2
AC   CVCL_JT06
SY   ISMMS 055i C2
DR   SKIP; SKIP005186
DR   WiCell; stan364i-055c2
DR   Wikidata; Q54956270
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN365i-664C1
AC   CVCL_JT07
SY   ISMMS 664i C1
DR   SKIP; SKIP005344
DR   WiCell; stan365i-664c1
DR   Wikidata; Q54956271
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN366i-282C2
AC   CVCL_JT08
SY   ISMMS 282i C2
DR   SKIP; SKIP005235
DR   WiCell; stan366i-282c2
DR   Wikidata; Q54956272
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN367i-894C1
AC   CVCL_JT09
SY   ISMMS 894i C1
DR   SKIP; SKIP005397
DR   WiCell; stan367i-894c1
DR   Wikidata; Q54956274
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JT10 ! STAN368i-894C2
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN368i-894C2
AC   CVCL_JT10
SY   ISMMS 894i C2
DR   SKIP; SKIP005398
DR   WiCell; stan368i-894c2
DR   Wikidata; Q54956275
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JT09 ! STAN367i-894C1
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN369i-088C3
AC   CVCL_JT11
SY   ISMMS 088i C3
DR   SKIP; SKIP005193
DR   WiCell; stan369i-088c3
DR   Wikidata; Q54956276
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN370i-190C3
AC   CVCL_JT12
SY   ISMMS 190i C3
DR   SKIP; SKIP005213
DR   WiCell; stan370i-190c3
DR   Wikidata; Q54956297
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN371i-868C5
AC   CVCL_JT13
SY   ISMMS 868i C5
DR   SKIP; SKIP005393
DR   WiCell; stan371i-868c5
DR   Wikidata; Q54956298
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN372i-411C8
AC   CVCL_JT14
SY   ISMMS 411i C8
DR   SKIP; SKIP005275
DR   WiCell; stan372i-411c8
DR   Wikidata; Q54956299
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN373i-412C4
AC   CVCL_JT15
SY   ISMMS 412i C4
DR   SKIP; SKIP005276
DR   WiCell; stan373i-412c4
DR   Wikidata; Q54956300
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN374i-565C4
AC   CVCL_JT16
SY   ISMMS 565i C4
DR   SKIP; SKIP005325
DR   WiCell; stan374i-565c4
DR   Wikidata; Q54956302
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN375i-961C1
AC   CVCL_JT17
SY   ISMMS 961i C1; 961_1
DR   GEO; GSM2100262
DR   SKIP; SKIP005420
DR   WiCell; stan375i-961c1
DR   Wikidata; Q54956303
RX   PubMed=28017796;
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 10
//
ID   STAN376i-518C2
AC   CVCL_JT18
SY   ISMMS 518i C2
DR   SKIP; SKIP005309
DR   WiCell; stan376i-518c2
DR   Wikidata; Q54956304
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN377i-572C5
AC   CVCL_JT19
SY   ISMMS 572i C5
DR   SKIP; SKIP005326
DR   WiCell; stan377i-572c5
DR   Wikidata; Q54956305
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN378i-886C4
AC   CVCL_JT20
SY   ISMMS 886i C4
DR   SKIP; SKIP005396
DR   WiCell; stan378i-886c4
DR   Wikidata; Q54956307
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN379i-783C6
AC   CVCL_JT21
SY   ISMMS 783i C6
DR   SKIP; SKIP005373
DR   WiCell; stan379i-783c6
DR   Wikidata; Q54956309
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN380i-092C2
AC   CVCL_JT22
SY   ISMMS 092i C2
DR   SKIP; SKIP005194
DR   WiCell; stan380i-092c2
DR   Wikidata; Q54956310
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAN381i-652C1
AC   CVCL_JT23
SY   ISMMS 652i C1
DR   SKIP; SKIP005343
DR   WiCell; stan381i-652c1
DR   Wikidata; Q54956311
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Quertermous, Thomas; Stanford University; Stanford; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-09-24; Version: 10
//
ID   STAR [HEK293T derivative]
AC   CVCL_AR73
DR   ECACC; 04072119
DR   Wikidata; Q54956312
RX   PubMed=12679787;
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   STAR [Human renal cell carcinoma]
AC   CVCL_C8GT
DR   Wikidata; Q123033559
RX   PubMed=15585611;
RX   PubMed=18698046;
CC   From: Childs, Richard W.; National Heart, Lung, and Blood Institute, National Institutes of Health; Bethesda; USA.
CC   HLA typing: A*03; B*07,15 (PubMed=15585611).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   STAR-A
AC   CVCL_AR74
DR   ECACC; 04072118
DR   Wikidata; Q54956314
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=04072118
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 8
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR73 ! STAR [HEK293T derivative]
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   STAR-A-HV#2
AC   CVCL_AR75
DR   ECACC; 04072115
DR   Wikidata; Q54956316
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR74 ! STAR-A
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   STAR-G+
AC   CVCL_AR76
DR   ECACC; 04072116
DR   Wikidata; Q54956317
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR73 ! STAR [HEK293T derivative]
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   STAR-G+-HV#2
AC   CVCL_AR77
DR   ECACC; 04072113
DR   Wikidata; Q54956318
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR76 ! STAR-G+
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   STAR-RDpro
AC   CVCL_AR78
SY   STAR-Rdpro
DR   ECACC; 04072117
DR   Wikidata; Q54956320
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR73 ! STAR [HEK293T derivative]
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   STAR-RDpro-HV#1
AC   CVCL_AR79
DR   ECACC; 04072114
DR   Wikidata; Q54956321
CC   Group: Retrovirus packaging cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AR78 ! STAR-RDpro
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 11
//
ID   STAT1 KO (129/SvEV)
AC   CVCL_C0LC
SY   STAT1 KO (129/SvEV) Macrophage Cell Line
DR   Kerafast; ENH182-FP
DR   Wikidata; Q112930427
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:103063; Stat1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: 129/SvEV.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   STAT2 KO (129)
AC   CVCL_C0LD
SY   STAT2 KO (129) Macrophage Cell Line
DR   Kerafast; ENH183-FP
DR   Wikidata; Q112930428
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:103039; Stat2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   STAT6 KO (BalbC)
AC   CVCL_C0LE
SY   STAT6 KO (BalbC) Macrophage Cell Line
DR   Kerafast; ENH184-FP
DR   Wikidata; Q112930429
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:103034; Stat6.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   STAV-AB
AC   CVCL_7998
DR   BTO; BTO_0003758
DR   Wikidata; Q54956323
RX   PubMed=2790824;
RX   PubMed=7662316;
RX   PubMed=9310181;
RX   PubMed=23840376;
RX   PubMed=33567673;
CC   Characteristics: Grows with an epithelial phenotype in the presence of the AB medium (PubMed=2790824).
CC   Doubling time: 45 hours (PubMed=23840376).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7999 ! STAV-FCS
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   STAV-FCS
AC   CVCL_7999
DR   BTO; BTO_0003756
DR   Wikidata; Q54956324
RX   PubMed=2790824;
RX   PubMed=7662316;
RX   PubMed=9310181;
RX   PubMed=23840376;
RX   PubMed=33567673;
CC   Characteristics: Grows with a fibroblast-like morphology in the presence of the FCS medium (PubMed=2790824).
CC   Doubling time: 90 hours (PubMed=23840376).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7998 ! STAV-AB
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   STB-S2
AC   CVCL_A9IH
SY   STBS2
DR   CCRID; 5301MAM-KCB05010ZJ
DR   KCB; KCB 200510ZJ
DR   Wikidata; Q108821334
CC   Group: Bat cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=188568; ! Aselliscus stoliczkanus (Stoliczka's Asian trident bat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   STB5 Gill
AC   CVCL_B7N0
SY   STickleBack 5 Gill
DR   Wikidata; Q112930430
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=69293; ! Gasterosteus aculeatus (Three-spined stickleback)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   STB6 Gill
AC   CVCL_B7N1
SY   STickleBack 6 Gill
DR   Wikidata; Q112930431
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=69293; ! Gasterosteus aculeatus (Three-spined stickleback)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   STBH
AC   CVCL_B7MZ
SY   STickleBack Heart
DR   Wikidata; Q112930432
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=69293; ! Gasterosteus aculeatus (Three-spined stickleback)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   STBCi004-A
AC   CVCL_RB34
SY   SFC832-03-19
DR   BioSamples; SAMEA104026350
DR   EBiSC; STBCi004-A
DR   ECACC; 66540582
DR   hPSCreg; STBCi004-A
DR   Wikidata; Q54956325
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (EBiSC=STBCi004-A).
CC   Discontinued: ECACC; 66540582; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB35 ! STBCi004-B
OI   CVCL_RB36 ! STBCi004-C
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi004-B
AC   CVCL_RB35
SY   SFC832-03-06
DR   BioSamples; SAMEA104615892
DR   EBiSC; STBCi004-B
DR   ECACC; 66540905
DR   hPSCreg; STBCi004-B
DR   Wikidata; Q54956326
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=32359446).
CC   Discontinued: EBiSC; STBCi004-B; true.
CC   Discontinued: ECACC; 66540905; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB34 ! STBCi004-A
OI   CVCL_RB36 ! STBCi004-C
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi004-B-1
AC   CVCL_A8X1
SY   SFC832-03-06 LRRK2WT/WT C47
DR   BioSamples; SAMEA5859478
DR   EBiSC; STBCi004-B-1
DR   ECACC; 66541204
DR   hPSCreg; STBCi004-B-1
DR   Wikidata; Q102114943
RX   PubMed=32359446;
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32359446).
CC   Discontinued: ECACC; 66541204; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB35 ! STBCi004-B
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   STBCi004-C
AC   CVCL_RB36
SY   SFC832-03-07
DR   BioSamples; SAMEA104615895
DR   EBiSC; STBCi004-C
DR   ECACC; 66540906
DR   hPSCreg; STBCi004-C
DR   Wikidata; Q54956327
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (EBiSC=STBCi004-C).
CC   Discontinued: ECACC; 66540906; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB34 ! STBCi004-A
OI   CVCL_RB35 ! STBCi004-B
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi005-A
AC   CVCL_RB37
SY   SFC833-03-01
DR   BioSamples; SAMEA104129750
DR   EBiSC; STBCi005-A
DR   ECACC; 66540583
DR   hPSCreg; STBCi005-A
DR   Wikidata; Q54956329
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (EBiSC=STBCi005-A).
CC   Discontinued: ECACC; 66540583; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB38 ! STBCi005-B
OI   CVCL_RB39 ! STBCi005-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi005-B
AC   CVCL_RB38
SY   SFC833-03-05
DR   BioSamples; SAMEA104615893
DR   EBiSC; STBCi005-B
DR   ECACC; 66540907
DR   hPSCreg; STBCi005-B
DR   Wikidata; Q54956330
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (EBiSC=STBCi005-B).
CC   Discontinued: ECACC; 66540907; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB37 ! STBCi005-A
OI   CVCL_RB39 ! STBCi005-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi005-C
AC   CVCL_RB39
SY   SFC833-03-14
DR   BioSamples; SAMEA104615894
DR   EBiSC; STBCi005-C
DR   ECACC; 66540908
DR   hPSCreg; STBCi005-C
DR   Wikidata; Q54956331
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (EBiSC=STBCi005-C).
CC   Discontinued: ECACC; 66540908; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB37 ! STBCi005-A
OI   CVCL_RB38 ! STBCi005-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi006-A
AC   CVCL_RB40
SY   SFC140-04-01
DR   BioSamples; SAMEA104133818
DR   EBiSC; STBCi006-A
DR   ECACC; 66540598
DR   hPSCreg; STBCi006-A
DR   Wikidata; Q54956332
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (EBiSC=STBCi006-A).
CC   Discontinued: ECACC; 66540598; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi006-A-1
AC   CVCL_RM80
SY   ApoE KO
DR   BioSamples; SAMEA104243170
DR   EBiSC; STBCi006-A-1
DR   ECACC; 66540613
DR   hPSCreg; STBCi006-A-1
DR   Wikidata; Q54956333
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Discontinued: ECACC; 66540613; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB40 ! STBCi006-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   STBCi006-A-2
AC   CVCL_YC58
SY   ApoE 2/2
DR   BioSamples; SAMEA104243171
DR   EBiSC; STBCi006-A-2
DR   ECACC; 66540614
DR   hPSCreg; STBCi006-A-2
DR   Wikidata; Q98132851
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: EBiSC; STBCi006-A-2; true.
CC   Discontinued: ECACC; 66540614; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB40 ! STBCi006-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 8
//
ID   STBCi006-A-3
AC   CVCL_RX82
SY   ApoE 3/3
DR   BioSamples; SAMEA104243172
DR   EBiSC; STBCi006-A-3
DR   ECACC; 66540615
DR   hPSCreg; STBCi006-A-3
DR   Wikidata; Q54956334
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540615; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB40 ! STBCi006-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi006-A-4
AC   CVCL_RM81
SY   ApoE 3/4
DR   BioSamples; SAMEA104243173
DR   EBiSC; STBCi006-A-4
DR   ECACC; 66540616
DR   hPSCreg; STBCi006-A-4
DR   Wikidata; Q54956336
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Discontinued: ECACC; 66540616; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB40 ! STBCi006-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi007-A
AC   CVCL_RB41
SY   SFC855-03-06
DR   BioSamples; SAMEA104129752
DR   EBiSC; STBCi007-A
DR   ECACC; 66540584
DR   hPSCreg; STBCi007-A
DR   Wikidata; Q54956337
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (EBiSC=STBCi007-A).
CC   Discontinued: ECACC; 66540584; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB42 ! STBCi007-B
OI   CVCL_RB43 ! STBCi007-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi007-B
AC   CVCL_RB42
SY   SFC855-03-08
DR   BioSamples; SAMEA104615901
DR   EBiSC; STBCi007-B
DR   ECACC; 66540909
DR   hPSCreg; STBCi007-B
DR   Wikidata; Q54956339
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (EBiSC=STBCi007-B).
CC   Discontinued: ECACC; 66540909; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB41 ! STBCi007-A
OI   CVCL_RB43 ! STBCi007-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi007-C
AC   CVCL_RB43
SY   SFC855-03-01
DR   BioSamples; SAMEA104616122
DR   EBiSC; STBCi007-C
DR   ECACC; 66540917
DR   hPSCreg; STBCi007-C
DR   Wikidata; Q54956340
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (EBiSC=STBCi007-C).
CC   Discontinued: ECACC; 66540917; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB41 ! STBCi007-A
OI   CVCL_RB42 ! STBCi007-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi009-A
AC   CVCL_RB44
SY   SFC801-03-01
DR   BioSamples; SAMEA104491370
DR   EBiSC; STBCi009-A
DR   ECACC; 66540649
DR   hPSCreg; STBCi009-A
DR   Wikidata; Q54956341
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Pro264Leu (c.791C>T); ClinVar=VCV000098080; Zygosity=Unspecified (EBiSC=STBCi009-A).
CC   Discontinued: ECACC; 66540649; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB45 ! STBCi009-B
OI   CVCL_RB46 ! STBCi009-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi009-B
AC   CVCL_RB45
SY   SFC801-03-02
DR   BioSamples; SAMEA104493602
DR   EBiSC; STBCi009-B
DR   ECACC; 66540650
DR   hPSCreg; STBCi009-B
DR   Wikidata; Q54956343
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Pro264Leu (c.791C>T); ClinVar=VCV000098080; Zygosity=Unspecified (EBiSC=STBCi009-B).
CC   Discontinued: ECACC; 66540650; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB44 ! STBCi009-A
OI   CVCL_RB46 ! STBCi009-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi009-C
AC   CVCL_RB46
SY   SFC801-03-03
DR   BioSamples; SAMEA104493603
DR   EBiSC; STBCi009-C
DR   ECACC; 66540651
DR   hPSCreg; STBCi009-C
DR   Wikidata; Q54956344
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Pro264Leu (c.791C>T); ClinVar=VCV000098080; Zygosity=Unspecified (EBiSC=STBCi009-C).
CC   Discontinued: ECACC; 66540651; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB44 ! STBCi009-A
OI   CVCL_RB45 ! STBCi009-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi010-A
AC   CVCL_RB47
SY   SFC802-03-06
DR   BioSamples; SAMEA104493604
DR   EBiSC; STBCi010-A
DR   ECACC; 66540652
DR   hPSCreg; STBCi010-A
DR   Wikidata; Q54956345
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Glu184Asp (c.552A>C); ClinVar=VCV000098049; Zygosity=Unspecified (EBiSC=STBCi010-A).
CC   Discontinued: ECACC; 66540652; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi011-A
AC   CVCL_RB48
SY   SFC803-03-01
DR   BioSamples; SAMEA104493606
DR   EBiSC; STBCi011-A
DR   ECACC; 66540653
DR   hPSCreg; STBCi011-A
DR   Wikidata; Q54956346
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Unspecified (EBiSC=STBCi011-A).
CC   Discontinued: ECACC; 66540653; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB49 ! STBCi011-B
OI   CVCL_RB50 ! STBCi011-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi011-B
AC   CVCL_RB49
SY   SFC803-03-02
DR   BioSamples; SAMEA104493608
DR   EBiSC; STBCi011-B
DR   ECACC; 66540654
DR   hPSCreg; STBCi011-B
DR   Wikidata; Q54956347
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Unspecified (EBiSC=STBCi011-B).
CC   Discontinued: ECACC; 66540654; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB48 ! STBCi011-A
OI   CVCL_RB50 ! STBCi011-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi011-C
AC   CVCL_RB50
SY   SFC803-03-08
DR   BioSamples; SAMEA104493609
DR   EBiSC; STBCi011-C
DR   ECACC; 66540655
DR   hPSCreg; STBCi011-C
DR   Wikidata; Q54956361
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met146Ile (c.438G>A); ClinVar=VCV000018137; Zygosity=Unspecified (EBiSC=STBCi011-C).
CC   Discontinued: ECACC; 66540655; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB48 ! STBCi011-A
OI   CVCL_RB49 ! STBCi011-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi012-A
AC   CVCL_RB51
SY   SFC805-03-01
DR   BioSamples; SAMEA104493610
DR   EBiSC; STBCi012-A
DR   ECACC; 66540656
DR   hPSCreg; STBCi012-A
DR   Wikidata; Q54956362
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met139Val (c.415A>G); ClinVar=VCV000018128; Zygosity=Unspecified (EBiSC=STBCi012-A).
CC   Discontinued: ECACC; 66540656; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB52 ! STBCi012-B
OI   CVCL_RB53 ! STBCi012-C
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi012-B
AC   CVCL_RB52
SY   SFC805-03-02
DR   BioSamples; SAMEA104493612
DR   EBiSC; STBCi012-B
DR   ECACC; 66540657
DR   hPSCreg; STBCi012-B
DR   Wikidata; Q54956363
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met139Val (c.415A>G); ClinVar=VCV000018128; Zygosity=Unspecified (EBiSC=STBCi012-B).
CC   Discontinued: ECACC; 66540657; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB51 ! STBCi012-A
OI   CVCL_RB53 ! STBCi012-C
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi012-C
AC   CVCL_RB53
SY   SFC805-03-03
DR   BioSamples; SAMEA104493613
DR   EBiSC; STBCi012-C
DR   ECACC; 66540658
DR   hPSCreg; STBCi012-C
DR   Wikidata; Q54956364
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Met139Val (c.415A>G); ClinVar=VCV000018128; Zygosity=Unspecified (EBiSC=STBCi012-C).
CC   Discontinued: EBiSC; STBCi012-C; true.
CC   Discontinued: ECACC; 66540658; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB51 ! STBCi012-A
OI   CVCL_RB52 ! STBCi012-B
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi013-A
AC   CVCL_RB54
SY   SFC807-03-01
DR   BioSamples; SAMEA104493614
DR   EBiSC; STBCi013-A
DR   ECACC; 66540659
DR   hPSCreg; STBCi013-A
DR   Wikidata; Q54956365
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Tyr115Cys (c.344A>G); ClinVar=VCV000098015; Zygosity=Unspecified (EBiSC=STBCi013-A).
CC   Discontinued: ECACC; 66540659; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB55 ! STBCi013-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi013-B
AC   CVCL_RB55
SY   SFC807-03-04
DR   BioSamples; SAMEA104493616
DR   EBiSC; STBCi013-B
DR   ECACC; 66540660
DR   hPSCreg; STBCi013-B
DR   Wikidata; Q54956367
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Tyr115Cys (c.344A>G); ClinVar=VCV000098015; Zygosity=Unspecified (EBiSC=STBCi013-B).
CC   Discontinued: ECACC; 66540660; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB54 ! STBCi013-A
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi014-A
AC   CVCL_RB56
SY   SFC808-03-03
DR   BioSamples; SAMEA104493617
DR   EBiSC; STBCi014-A
DR   ECACC; 66540661
DR   hPSCreg; STBCi014-A
DR   Wikidata; Q54956369
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; c.338+1delG (p.Leu113_Ile114insThr) (int4del); ClinVar=VCV000098013; Zygosity=Heterozygous (EBiSC=STBCi014-A).
CC   Discontinued: ECACC; 66540661; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB57 ! STBCi014-B
OI   CVCL_RB58 ! STBCi014-C
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi014-B
AC   CVCL_RB57
SY   SFC808-03-04; SB808-03-04
DR   BioSamples; SAMEA104493619
DR   EBiSC; STBCi014-B
DR   ECACC; 66540662
DR   hPSCreg; STBCi014-B
DR   Wikidata; Q54956370
RX   PubMed=30245212;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; c.338+1delG (p.Leu113_Ile114insThr) (int4del); ClinVar=VCV000098013; Zygosity=Heterozygous (EBiSC=STBCi014-B).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540662; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB56 ! STBCi014-A
OI   CVCL_RB58 ! STBCi014-C
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi014-B-1
AC   CVCL_C1WV
SY   AZi324-A-1
DR   hPSCreg; STBCi014-B-1
DR   Wikidata; Q114313046
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_corrected; c.338+1delG (p.Leu113_Ile114insThr) (int4del); ClinVar=VCV000098013; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=STBCi014-B-1).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB57 ! STBCi014-B
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   STBCi014-C
AC   CVCL_RB58
SY   SFC808-03-06
DR   BioSamples; SAMEA104493620
DR   EBiSC; STBCi014-C
DR   ECACC; 66540663
DR   hPSCreg; STBCi014-C
DR   Wikidata; Q54956371
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; c.338+1delG (p.Leu113_Ile114insThr) (int4del); ClinVar=VCV000098013; Zygosity=Heterozygous (EBiSC=STBCi014-C).
CC   Discontinued: ECACC; 66540663; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB56 ! STBCi014-A
OI   CVCL_RB57 ! STBCi014-B
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   STBCi015-A
AC   CVCL_RB59
SY   SFC809-03-01
DR   BioSamples; SAMEA104493621
DR   EBiSC; STBCi015-A
DR   ECACC; 66540664
DR   hPSCreg; STBCi015-A
DR   Wikidata; Q54956372
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Unspecified (EBiSC=STBCi015-A).
CC   Discontinued: ECACC; 66540664; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB60 ! STBCi015-B
OI   CVCL_RB61 ! STBCi015-C
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   STBCi015-B
AC   CVCL_RB60
SY   SFC809-03-03
DR   BioSamples; SAMEA104493623
DR   EBiSC; STBCi015-B
DR   ECACC; 66540665
DR   hPSCreg; STBCi015-B
DR   Wikidata; Q54956373
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Unspecified (EBiSC=STBCi015-B).
CC   Discontinued: ECACC; 66540665; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB59 ! STBCi015-A
OI   CVCL_RB61 ! STBCi015-C
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   STBCi015-C
AC   CVCL_RB61
SY   SFC809-03-04
DR   BioSamples; SAMEA104493624
DR   EBiSC; STBCi015-C
DR   ECACC; 66540666
DR   hPSCreg; STBCi015-C
DR   Wikidata; Q54956374
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Unspecified (EBiSC=STBCi015-C).
CC   Discontinued: ECACC; 66540666; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB59 ! STBCi015-A
OI   CVCL_RB60 ! STBCi015-B
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   STBCi016-A
AC   CVCL_RB62
SY   SFC810-03-01
DR   BioSamples; SAMEA104493625
DR   EBiSC; STBCi016-A
DR   ECACC; 66540667
DR   hPSCreg; STBCi016-A
DR   Wikidata; Q54956375
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi016-A; true.
CC   Discontinued: ECACC; 66540667; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB63 ! STBCi016-B
OI   CVCL_RB64 ! STBCi016-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi016-B
AC   CVCL_RB63
SY   SFC810-03-02
DR   BioSamples; SAMEA104493627
DR   EBiSC; STBCi016-B
DR   ECACC; 66540668
DR   hPSCreg; STBCi016-B
DR   Wikidata; Q54956377
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi016-B; true.
CC   Discontinued: ECACC; 66540668; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB62 ! STBCi016-A
OI   CVCL_RB64 ! STBCi016-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi016-C
AC   CVCL_RB64
SY   SFC810-03-03
DR   BioSamples; SAMEA104493628
DR   EBiSC; STBCi016-C
DR   ECACC; 66540669
DR   hPSCreg; STBCi016-C
DR   Wikidata; Q54956379
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi016-C; true.
CC   Discontinued: ECACC; 66540669; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB62 ! STBCi016-A
OI   CVCL_RB63 ! STBCi016-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi017-A
AC   CVCL_RB65
SY   SFC811-03-01
DR   BioSamples; SAMEA104493629
DR   EBiSC; STBCi017-A
DR   ECACC; 66540670
DR   hPSCreg; STBCi017-A
DR   Wikidata; Q54956380
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Arg841Ter (c.2521C>T) (p.Arg830Ter, c.2488C>T); ClinVar=VCV000440257; Zygosity=Heterozygous (EBiSC=STBCi017-A).
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Glu1784Glyfs*14 (c.5351delA) (p.Glu1773Glyfs, c.5318delA); ClinVar=VCV000471143; Zygosity=Heterozygous (EBiSC=STBCi017-A).
CC   Discontinued: ECACC; 66540670; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB66 ! STBCi017-B
OI   CVCL_RB67 ! STBCi017-C
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   STBCi017-A-1
AC   CVCL_C1WW
SY   AZi326-A-1
DR   hPSCreg; STBCi017-A-1
DR   Wikidata; Q114313047
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple_corrected; p.Arg841Ter (c.2521C>T) (p.Arg830Ter, c.2488C>T); ClinVar=VCV000440257; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=STBCi017-A-1).
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple_corrected; p.Glu1784Glyfs*14 (c.5351delA) (p.Glu1773Glyfs, c.5318delA); ClinVar=VCV000471143; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=STBCi017-A-1).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB65 ! STBCi017-A
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   STBCi017-B
AC   CVCL_RB66
SY   SFC811-03-04
DR   BioSamples; SAMEA104493631
DR   EBiSC; STBCi017-B
DR   ECACC; 66540671
DR   hPSCreg; STBCi017-B
DR   Wikidata; Q54956381
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Arg841Ter (c.2521C>T) (p.Arg830Ter, c.2488C>T); ClinVar=VCV000440257; Zygosity=Heterozygous (EBiSC=STBCi017-B).
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Glu1784Glyfs*14 (c.5351delA) (p.Glu1773Glyfs, c.5318delA); ClinVar=VCV000471143; Zygosity=Heterozygous (EBiSC=STBCi017-B).
CC   Discontinued: ECACC; 66540671; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB65 ! STBCi017-A
OI   CVCL_RB67 ! STBCi017-C
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   STBCi017-C
AC   CVCL_RB67
SY   SFC811-03-05
DR   BioSamples; SAMEA104493632
DR   EBiSC; STBCi017-C
DR   ECACC; 66540672
DR   hPSCreg; STBCi017-C
DR   Wikidata; Q54956382
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Arg841Ter (c.2521C>T) (p.Arg830Ter, c.2488C>T); ClinVar=VCV000440257; Zygosity=Heterozygous (EBiSC=STBCi017-C).
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Glu1784Glyfs*14 (c.5351delA) (p.Glu1773Glyfs, c.5318delA); ClinVar=VCV000471143; Zygosity=Heterozygous (EBiSC=STBCi017-C).
CC   Discontinued: ECACC; 66540672; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB65 ! STBCi017-A
OI   CVCL_RB66 ! STBCi017-B
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi018-A
AC   CVCL_RB68
SY   SFC815-03-06
DR   BioSamples; SAMEA104493633
DR   EBiSC; STBCi018-A
DR   ECACC; 66540673
DR   hPSCreg; STBCi018-A
DR   Wikidata; Q54956384
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Ser635Leu (c.1904C>T) (S581L); ClinVar=VCV000209157; Zygosity=Unspecified (EBiSC=STBCi018-A).
CC   Discontinued: ECACC; 66540673; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB69 ! STBCi018-B
OI   CVCL_RB70 ! STBCi018-C
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi018-B
AC   CVCL_RB69
SY   SFC815-03-08
DR   BioSamples; SAMEA104493635
DR   EBiSC; STBCi018-B
DR   ECACC; 66540674
DR   hPSCreg; STBCi018-B
DR   Wikidata; Q54956385
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Ser635Leu (c.1904C>T) (S581L); ClinVar=VCV000209157; Zygosity=Unspecified (EBiSC=STBCi018-B).
CC   Discontinued: ECACC; 66540674; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB68 ! STBCi018-A
OI   CVCL_RB70 ! STBCi018-C
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi018-C
AC   CVCL_RB70
SY   SFC815-03-02
DR   BioSamples; SAMEA104493636
DR   EBiSC; STBCi018-C
DR   ECACC; 66540675
DR   hPSCreg; STBCi018-C
DR   Wikidata; Q54956386
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Ser635Leu (c.1904C>T) (S581L); ClinVar=VCV000209157; Zygosity=Unspecified (EBiSC=STBCi018-C).
CC   Discontinued: ECACC; 66540675; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB68 ! STBCi018-A
OI   CVCL_RB69 ! STBCi018-B
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi019-A
AC   CVCL_RB71
SY   SFC828-03-06; A53T1.2
DR   BioSamples; SAMEA104493637
DR   EBiSC; STBCi019-A
DR   ECACC; 66540676
DR   GEO; GSM2392421
DR   GEO; GSM2392482
DR   hPSCreg; STBCi019-A
DR   Wikidata; Q54956388
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540676; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X7 ! SF828
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi019-B
AC   CVCL_RB72
SY   SFC828-03-09
DR   BioSamples; SAMEA104493639
DR   EBiSC; STBCi019-B
DR   ECACC; 66540677
DR   hPSCreg; STBCi019-B
DR   Wikidata; Q54956389
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (EBiSC=STBCi019-B).
CC   Discontinued: EBiSC; STBCi019-B; true.
CC   Discontinued: ECACC; 66540677; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X7 ! SF828
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi019-C
AC   CVCL_RB73
SY   SFC828-03-04; A53T1.1
DR   BioSamples; SAMEA104493708
DR   EBiSC; STBCi019-C
DR   ECACC; 66540678
DR   GEO; GSM2392420
DR   GEO; GSM2392481
DR   hPSCreg; STBCi019-C
DR   Wikidata; Q54956392
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540678; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X7 ! SF828
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi020-A
AC   CVCL_RB74
SY   SFC800-03-03
DR   BioSamples; SAMEA104493640
DR   EBiSC; STBCi020-A
DR   ECACC; 66540679
DR   hPSCreg; STBCi020-A
DR   Wikidata; Q54956393
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540679; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB75 ! STBCi020-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi020-B
AC   CVCL_RB75
SY   SFC800-03-01
DR   BioSamples; SAMEA104493642
DR   EBiSC; STBCi020-B
DR   ECACC; 66540680
DR   hPSCreg; STBCi020-B
DR   Wikidata; Q54956394
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540680; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB74 ! STBCi020-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi023-A
AC   CVCL_RB76
SY   SFC829-03-02
DR   BioSamples; SAMEA104493648
DR   EBiSC; STBCi023-A
DR   ECACC; 66540685
DR   hPSCreg; STBCi023-A
DR   Wikidata; Q54956396
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (EBiSC=STBCi023-A).
CC   Discontinued: ECACC; 66540685; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X8 ! SF829
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi023-B
AC   CVCL_RB77
SY   SFC829-03-04; A53T2.1
DR   BioSamples; SAMEA104493650
DR   EBiSC; STBCi023-B
DR   ECACC; 66540686
DR   GEO; GSM2392422
DR   GEO; GSM2392483
DR   hPSCreg; STBCi023-B
DR   Wikidata; Q54956397
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540686; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X8 ! SF829
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi023-C
AC   CVCL_RB78
SY   SFC829-03-06; A53T2.2
DR   BioSamples; SAMEA104493651
DR   EBiSC; STBCi023-C
DR   ECACC; 66540687
DR   GEO; GSM2392423
DR   GEO; GSM2392484
DR   hPSCreg; STBCi023-C
DR   Wikidata; Q54956398
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540687; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X8 ! SF829
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi024-A
AC   CVCL_RB79
SY   SFC831-03-01; TPL1.1
DR   BioSamples; SAMEA104493652
DR   EBiSC; STBCi024-A
DR   ECACC; 66540688
DR   GEO; GSM2392424
DR   GEO; GSM2392487
DR   hPSCreg; STBCi024-A
DR   Wikidata; Q54956400
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540688; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y1 ! SF831
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi024-B
AC   CVCL_RB80
SY   SFC831-03-03; TPL1.2
DR   BioSamples; SAMEA104493654
DR   EBiSC; STBCi024-B
DR   ECACC; 66540689
DR   GEO; GSM2392425
DR   GEO; GSM2392488
DR   hPSCreg; STBCi024-B
DR   Wikidata; Q54956401
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540689; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y1 ! SF831
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi024-C
AC   CVCL_RB81
SY   SFC831-03-05; TPL1.3
DR   BioSamples; SAMEA104493655
DR   EBiSC; STBCi024-C
DR   ECACC; 66540690
DR   GEO; GSM2392426
DR   GEO; GSM2392489
DR   hPSCreg; STBCi024-C
DR   Wikidata; Q54956402
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540690; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y1 ! SF831
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi025-A
AC   CVCL_RB82
SY   SFC834-03-01
DR   BioSamples; SAMEA104493656
DR   EBiSC; STBCi025-A
DR   ECACC; 66540691
DR   hPSCreg; STBCi025-A
DR   Wikidata; Q54956405
RX   PubMed=26905200;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=26905200).
CC   Discontinued: ECACC; 66540691; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB83 ! STBCi025-B
OI   CVCL_RB84 ! STBCi025-C
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   STBCi025-B
AC   CVCL_RB83
SY   SFC834-03-03
DR   BioSamples; SAMEA104493658
DR   EBiSC; STBCi025-B
DR   ECACC; 66540692
DR   hPSCreg; STBCi025-B
DR   Wikidata; Q54956406
RX   PubMed=26905200;
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=26905200).
CC   Discontinued: ECACC; 66540692; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB82 ! STBCi025-A
OI   CVCL_RB84 ! STBCi025-C
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   STBCi025-C
AC   CVCL_RB84
SY   SFC834-03-10
DR   BioSamples; SAMEA104493659
DR   EBiSC; STBCi025-C
DR   ECACC; 66540693
DR   hPSCreg; STBCi025-C
DR   Wikidata; Q54956407
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (EBiSC=STBCi025-C).
CC   Discontinued: ECACC; 66540693; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB82 ! STBCi025-A
OI   CVCL_RB83 ! STBCi025-B
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   STBCi026-A
AC   CVCL_RB85
SY   SFC840-03-03; AH017-13; AH017, iPSc clone 13; iPS AH017-13; CTL2.1; Ctrl3#2
DR   BioSamples; SAMEA104493660
DR   EBiSC; STBCi026-A
DR   ECACC; 66540694
DR   GEO; GSM1831382
DR   GEO; GSM1831590
DR   hPSCreg; STBCi026-A
DR   Wikidata; Q54956408
RX   PubMed=26905200;
RX   PubMed=28591653;
RX   PubMed=28827786;
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540694; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB86 ! STBCi026-B
OI   CVCL_RB87 ! STBCi026-C
OI   CVCL_RB88 ! STBCi026-D
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi026-A-1
AC   CVCL_A8Z8
SY   SFC840-03-03 LRRK2-/- D10
DR   BioSamples; SAMEA5859479
DR   EBiSC; STBCi026-A-1
DR   ECACC; 66541205
DR   hPSCreg; STBCi026-A-1
DR   Wikidata; Q102114944
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Discontinued: ECACC; 66541205; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB85 ! STBCi026-A
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   STBCi026-A-2
AC   CVCL_A8Z9
SY   SFC840-03-03 LRRK2-/- C11
DR   BioSamples; SAMEA5859480
DR   EBiSC; STBCi026-A-2
DR   ECACC; 66541206
DR   hPSCreg; STBCi026-A-2
DR   Wikidata; Q102114946
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18618; LRRK2.
CC   Discontinued: ECACC; 66541206; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB85 ! STBCi026-A
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   STBCi026-A-3
AC   CVCL_A9A0
SY   SFC840-03-03 LRRK2 WT/R1441C H3
DR   BioSamples; SAMEA5859481
DR   EBiSC; STBCi026-A-3
DR   ECACC; 66541207
DR   hPSCreg; STBCi026-A-3
DR   Wikidata; Q102114947
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Arg1441Cys (c.4321C>T); ClinVar=VCV000001938; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (EBiSC=STBCi026-A-3).
CC   Discontinued: ECACC; 66541207; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB85 ! STBCi026-A
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   STBCi026-A-4
AC   CVCL_A4YP
SY   SFC840-03-03-PITX3-GFP
DR   BioSamples; SAMEA5859482
DR   EBiSC; STBCi026-A-4
DR   ECACC; 66541208
DR   hPSCreg; STBCi026-A-4
DR   Wikidata; Q107116956
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Characteristics: Using CRISPR/Cas9 a GFP tag was introduced at the C-terminus of PITX3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: ECACC; 66541208; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB85 ! STBCi026-A
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 8
//
ID   STBCi026-B
AC   CVCL_RB86
SY   SFC840-03-01; AH017-11; Ctrl3#1
DR   BioSamples; SAMEA104493717
DR   EBiSC; STBCi026-B
DR   ECACC; 66540695
DR   hPSCreg; STBCi026-B
DR   Wikidata; Q54956409
RX   PubMed=26905200;
RX   PubMed=28591653;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540695; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB85 ! STBCi026-A
OI   CVCL_RB87 ! STBCi026-C
OI   CVCL_RB88 ! STBCi026-D
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi026-C
AC   CVCL_RB87
SY   SFC840-03-05; CTL2.2
DR   BioSamples; SAMEA104493718
DR   EBiSC; STBCi026-C
DR   ECACC; 66540696
DR   GEO; GSM2392418
DR   GEO; GSM2392478
DR   hPSCreg; STBCi026-C
DR   Wikidata; Q54956410
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540696; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB85 ! STBCi026-A
OI   CVCL_RB86 ! STBCi026-B
OI   CVCL_RB88 ! STBCi026-D
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi026-D
AC   CVCL_RB88
SY   SFC840-03-06; CTL2.3
DR   BioSamples; SAMEA104493719
DR   EBiSC; STBCi026-D
DR   ECACC; 66540697
DR   GEO; GSM2392419
DR   GEO; GSM2392479
DR   hPSCreg; STBCi026-D
DR   Wikidata; Q54956411
RX   PubMed=28827786;
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540697; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB85 ! STBCi026-A
OI   CVCL_RB86 ! STBCi026-B
OI   CVCL_RB87 ! STBCi026-C
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi027-A
AC   CVCL_RB89
SY   SFC017-03-01
DR   BioSamples; SAMEA104493662
DR   EBiSC; STBCi027-A
DR   ECACC; 66540698
DR   hPSCreg; STBCi027-A
DR   Wikidata; Q54956412
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540698; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB90 ! STBCi027-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi027-B
AC   CVCL_RB90
SY   SFC017-03-02
DR   BioSamples; SAMEA104493664
DR   EBiSC; STBCi027-B
DR   ECACC; 66540699
DR   hPSCreg; STBCi027-B
DR   Wikidata; Q54956427
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540699; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB89 ! STBCi027-A
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi028-A
AC   CVCL_RB91
SY   SFC018-03-01; SFC018 clone 03-01
DR   BioSamples; SAMEA104493665
DR   EBiSC; STBCi028-A
DR   ECACC; 66540700
DR   hPSCreg; STBCi028-A
DR   Wikidata; Q54956428
RX   PubMed=30222766;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Heterozygous (from child cell line STBCi028-A-1).
CC   Discontinued: ECACC; 66540700; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB92 ! STBCi028-B
OI   CVCL_RB93 ! STBCi028-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   STBCi028-A-1
AC   CVCL_C1WX
SY   AZi325-A-1
DR   hPSCreg; STBCi028-A-1
DR   Wikidata; Q114313048
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple_corrected; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=STBCi028-A-1).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB91 ! STBCi028-A
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   STBCi028-B
AC   CVCL_RB92
SY   SFC018-03-02
DR   BioSamples; SAMEA104493667
DR   EBiSC; STBCi028-B
DR   ECACC; 66540701
DR   hPSCreg; STBCi028-B
DR   Wikidata; Q54956429
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Heterozygous (from autologous cell line STBCi028-A).
CC   Discontinued: ECACC; 66540701; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB91 ! STBCi028-A
OI   CVCL_RB93 ! STBCi028-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   STBCi028-C
AC   CVCL_RB93
SY   SFC018-03-04
DR   BioSamples; SAMEA104493668
DR   EBiSC; STBCi028-C
DR   ECACC; 66540702
DR   hPSCreg; STBCi028-C
DR   Wikidata; Q54956430
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Simple; p.Arg582Gln (c.1745G>A) (p.Arg583Gln, c.1748G>A); ClinVar=VCV000008505; Zygosity=Heterozygous (from autologous cell line STBCi028-A).
CC   Discontinued: ECACC; 66540702; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C189277; Familial hemiplegic migraine-1
DI   ORDO; Orphanet_569; Familial or sporadic hemiplegic migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB91 ! STBCi028-A
OI   CVCL_RB92 ! STBCi028-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi029-A
AC   CVCL_RB94
SY   SFC020-03-02
DR   BioSamples; SAMEA104493669
DR   EBiSC; STBCi029-A
DR   ECACC; 66540703
DR   hPSCreg; STBCi029-A
DR   Wikidata; Q54956431
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540703; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB95 ! STBCi029-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi029-B
AC   CVCL_RB95
SY   SFC020-03-03
DR   BioSamples; SAMEA104493671
DR   EBiSC; STBCi029-B
DR   ECACC; 66540704
DR   hPSCreg; STBCi029-B
DR   Wikidata; Q54956432
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540704; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB94 ! STBCi029-A
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi030-A
AC   CVCL_RB96
SY   SFC023-03-24
DR   BioSamples; SAMEA104493672
DR   EBiSC; STBCi030-A
DR   ECACC; 66540705
DR   hPSCreg; STBCi030-A
DR   Wikidata; Q54956434
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540705; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB97 ! STBCi030-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi030-B
AC   CVCL_RB97
SY   SFC023-03-43
DR   BioSamples; SAMEA104493674
DR   EBiSC; STBCi030-B
DR   ECACC; 66540706
DR   hPSCreg; STBCi030-B
DR   Wikidata; Q54956435
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540706; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB96 ! STBCi030-A
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi031-A
AC   CVCL_RB98
SY   SFC024-04-02
DR   BioSamples; SAMEA104493675
DR   EBiSC; STBCi031-A
DR   ECACC; 66540707
DR   hPSCreg; STBCi031-A
DR   Wikidata; Q54956436
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540707; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB99 ! STBCi031-B
OI   CVCL_RC00 ! STBCi031-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi031-B
AC   CVCL_RB99
SY   SFC024-04-03
DR   BioSamples; SAMEA104493677
DR   EBiSC; STBCi031-B
DR   ECACC; 66540708
DR   hPSCreg; STBCi031-B
DR   Wikidata; Q54956437
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540708; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB98 ! STBCi031-A
OI   CVCL_RC00 ! STBCi031-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi031-C
AC   CVCL_RC00
SY   SFC024-04-01
DR   BioSamples; SAMEA104493699
DR   EBiSC; STBCi031-C
DR   ECACC; 66540709
DR   hPSCreg; STBCi031-C
DR   Wikidata; Q54956438
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540709; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RB98 ! STBCi031-A
OI   CVCL_RB99 ! STBCi031-B
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi032-A
AC   CVCL_RC01
SY   SFC042-03-01
DR   BioSamples; SAMEA104493678
DR   EBiSC; STBCi032-A
DR   ECACC; 66540710
DR   hPSCreg; STBCi032-A
DR   Wikidata; Q54956440
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540710; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC02 ! STBCi032-B
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi032-B
AC   CVCL_RC02
SY   SFC042-03-03
DR   BioSamples; SAMEA104493680
DR   EBiSC; STBCi032-B
DR   ECACC; 66540711
DR   hPSCreg; STBCi032-B
DR   Wikidata; Q54956441
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540711; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC01 ! STBCi032-A
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi033-A
AC   CVCL_RC03
SY   SFC084-03-01
DR   BioSamples; SAMEA104493681
DR   EBiSC; STBCi033-A
DR   ECACC; 66540712
DR   hPSCreg; STBCi033-A
DR   Wikidata; Q54956442
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540712; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC04 ! STBCi033-B
OI   CVCL_RC05 ! STBCi033-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi033-B
AC   CVCL_RC04
SY   SFC084-03-02
DR   BioSamples; SAMEA104493683
DR   EBiSC; STBCi033-B
DR   ECACC; 66540713
DR   hPSCreg; STBCi033-B
DR   Wikidata; Q54956443
RX   PubMed=32516804;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540713; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC03 ! STBCi033-A
OI   CVCL_RC05 ! STBCi033-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   STBCi033-C
AC   CVCL_RC05
SY   SFC084-03-03
DR   BioSamples; SAMEA104493684
DR   EBiSC; STBCi033-C
DR   ECACC; 66540714
DR   hPSCreg; STBCi033-C
DR   Wikidata; Q54956444
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540714; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC03 ! STBCi033-A
OI   CVCL_RC04 ! STBCi033-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi034-A
AC   CVCL_RC06
SY   SFC091-04-03
DR   BioSamples; SAMEA104493685
DR   EBiSC; STBCi034-A
DR   ECACC; 66540715
DR   hPSCreg; STBCi034-A
DR   Wikidata; Q54956445
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540715; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC07 ! STBCi034-B
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi034-B
AC   CVCL_RC07
SY   SFC091-04-01
DR   BioSamples; SAMEA104493747
DR   EBiSC; STBCi034-B
DR   ECACC; 66540716
DR   hPSCreg; STBCi034-B
DR   Wikidata; Q54956446
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540716; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC06 ! STBCi034-A
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi035-A
AC   CVCL_RC08
SY   SFC813-03-09
DR   BioSamples; SAMEA104493687
DR   EBiSC; STBCi035-A
DR   ECACC; 66540717
DR   hPSCreg; STBCi035-A
DR   Wikidata; Q54956448
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Leu869Phe (c.2605C>T) (p.Leu858Phe, c.2572C>T); ClinVar=VCV000006364; Zygosity=Heterozygous (EBiSC=STBCi035-A).
CC   Discontinued: ECACC; 66540717; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125383; Primary erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC09 ! STBCi035-B
OI   CVCL_RC10 ! STBCi035-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi035-B
AC   CVCL_RC09
SY   SFC813-03-03
DR   BioSamples; SAMEA104493869
DR   EBiSC; STBCi035-B
DR   ECACC; 66540718
DR   hPSCreg; STBCi035-B
DR   Wikidata; Q54956449
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Leu869Phe (c.2605C>T) (p.Leu858Phe, c.2572C>T); ClinVar=VCV000006364; Zygosity=Heterozygous (EBiSC=STBCi035-B).
CC   Discontinued: ECACC; 66540718; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125383; Primary erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC08 ! STBCi035-A
OI   CVCL_RC10 ! STBCi035-C
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi035-C
AC   CVCL_RC10
SY   SFC813-03-07
DR   BioSamples; SAMEA104493870
DR   EBiSC; STBCi035-C
DR   ECACC; 66540719
DR   hPSCreg; STBCi035-C
DR   Wikidata; Q54956450
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Leu869Phe (c.2605C>T) (p.Leu858Phe, c.2572C>T); ClinVar=VCV000006364; Zygosity=Heterozygous (EBiSC=STBCi035-C).
CC   Discontinued: ECACC; 66540719; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125383; Primary erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC08 ! STBCi035-A
OI   CVCL_RC09 ! STBCi035-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   STBCi036-A
AC   CVCL_RC11
SY   SFC814-03-01
DR   BioSamples; SAMEA104493689
DR   EBiSC; STBCi036-A
DR   ECACC; 66540720
DR   hPSCreg; STBCi036-A
DR   Wikidata; Q54956451
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Unexplicit; Not described; Zygosity=Unspecified (EBiSC=STBCi036-A).
CC   Discontinued: ECACC; 66540720; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125383; Primary erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   STBCi037-A
AC   CVCL_RC12
SY   SFC816-03-02
DR   BioSamples; SAMEA104493691
DR   EBiSC; STBCi037-A
DR   ECACC; 66540721
DR   hPSCreg; STBCi037-A
DR   Wikidata; Q54956452
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Ser635Leu (c.1904C>T) (S581L); ClinVar=VCV000209157; Zygosity=Unspecified (EBiSC=STBCi037-A).
CC   Discontinued: EBiSC; STBCi037-A; true.
CC   Discontinued: ECACC; 66540721; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC13 ! STBCi037-B
OI   CVCL_RC14 ! STBCi037-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi037-B
AC   CVCL_RC13
SY   SFC816-03-08
DR   BioSamples; SAMEA104493693
DR   EBiSC; STBCi037-B
DR   ECACC; 66540722
DR   hPSCreg; STBCi037-B
DR   Wikidata; Q54956453
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Ser635Leu (c.1904C>T) (S581L); ClinVar=VCV000209157; Zygosity=Unspecified (EBiSC=STBCi037-B).
CC   Discontinued: ECACC; 66540722; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC12 ! STBCi037-A
OI   CVCL_RC14 ! STBCi037-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi037-C
AC   CVCL_RC14
SY   SFC816-03-13
DR   BioSamples; SAMEA104493694
DR   EBiSC; STBCi037-C
DR   ECACC; 66540723
DR   hPSCreg; STBCi037-C
DR   Wikidata; Q54956455
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4162; GARS1; Simple; p.Ser635Leu (c.1904C>T) (S581L); ClinVar=VCV000209157; Zygosity=Unspecified (EBiSC=STBCi037-C).
CC   Discontinued: ECACC; 66540723; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C122659; Charcot-Marie-Tooth disease type 2D
DI   ORDO; Orphanet_99938; Autosomal dominant Charcot-Marie-Tooth disease type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC12 ! STBCi037-A
OI   CVCL_RC13 ! STBCi037-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   STBCi038-A
AC   CVCL_RC15
SY   SFC011-04-01
DR   BioSamples; SAMEA104493695
DR   EBiSC; STBCi038-A
DR   ECACC; 66540724
DR   hPSCreg; STBCi038-A
DR   Wikidata; Q54956456
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540724; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC16 ! STBCi038-B
OI   CVCL_RC17 ! STBCi038-C
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi038-B
AC   CVCL_RC16
SY   SFC011-04-02
DR   BioSamples; SAMEA104493697
DR   EBiSC; STBCi038-B
DR   ECACC; 66540725
DR   hPSCreg; STBCi038-B
DR   Wikidata; Q54956457
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540725; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC15 ! STBCi038-A
OI   CVCL_RC17 ! STBCi038-C
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi038-C
AC   CVCL_RC17
SY   SFC011-04-03
DR   BioSamples; SAMEA104493698
DR   EBiSC; STBCi038-C
DR   ECACC; 66540726
DR   hPSCreg; STBCi038-C
DR   Wikidata; Q54956458
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540726; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC15 ! STBCi038-A
OI   CVCL_RC16 ! STBCi038-B
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi039-A
AC   CVCL_RC18
SY   SFC062-03-02
DR   BioSamples; SAMEA104493700
DR   EBiSC; STBCi039-A
DR   ECACC; 66540727
DR   hPSCreg; STBCi039-A
DR   Wikidata; Q54956459
RX   PubMed=32516804;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540727; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC19 ! STBCi039-B
OI   CVCL_RC20 ! STBCi039-C
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   STBCi039-B
AC   CVCL_RC19
SY   SFC062-03-03
DR   BioSamples; SAMEA104493702
DR   EBiSC; STBCi039-B
DR   ECACC; 66540728
DR   hPSCreg; STBCi039-B
DR   Wikidata; Q54956460
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540728; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC18 ! STBCi039-A
OI   CVCL_RC20 ! STBCi039-C
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi039-C
AC   CVCL_RC20
SY   SFC062-03-01
DR   BioSamples; SAMEA104493754
DR   EBiSC; STBCi039-C
DR   ECACC; 66540729
DR   hPSCreg; STBCi039-C
DR   Wikidata; Q54956461
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540729; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC18 ! STBCi039-A
OI   CVCL_RC19 ! STBCi039-B
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi040-A
AC   CVCL_RC21
SY   SFC029-03-04
DR   BioSamples; SAMEA104493703
DR   EBiSC; STBCi040-A
DR   ECACC; 66540730
DR   hPSCreg; STBCi040-A
DR   Wikidata; Q54956462
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540730; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC22 ! STBCi040-B
OI   CVCL_RC23 ! STBCi040-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi040-B
AC   CVCL_RC22
SY   SFC029-03-08
DR   BioSamples; SAMEA104493705
DR   EBiSC; STBCi040-B
DR   ECACC; 66540731
DR   hPSCreg; STBCi040-B
DR   Wikidata; Q54956463
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540731; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC21 ! STBCi040-A
OI   CVCL_RC23 ! STBCi040-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi040-C
AC   CVCL_RC23
SY   SFC029-03-01
DR   BioSamples; SAMEA104493799
DR   EBiSC; STBCi040-C
DR   ECACC; 66540732
DR   hPSCreg; STBCi040-C
DR   Wikidata; Q54956465
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540732; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC21 ! STBCi040-A
OI   CVCL_RC22 ! STBCi040-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi041-A
AC   CVCL_RC24
SY   SFC081-03-02
DR   BioSamples; SAMEA104493706
DR   EBiSC; STBCi041-A
DR   ECACC; 66540733
DR   hPSCreg; STBCi041-A
DR   Wikidata; Q54956466
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540733; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC25 ! STBCi041-B
OI   CVCL_WU52 ! STBCi041-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi041-B
AC   CVCL_RC25
SY   SFC081-03-04
DR   BioSamples; SAMEA104493854
DR   EBiSC; STBCi041-B
DR   ECACC; 66540734
DR   hPSCreg; STBCi041-B
DR   Wikidata; Q54956467
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540734; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC24 ! STBCi041-A
OI   CVCL_WU52 ! STBCi041-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi041-C
AC   CVCL_WU52
SY   SFC081-03-07
DR   BioSamples; SAMEA5859485
DR   EBiSC; STBCi041-C
DR   ECACC; 66541209
DR   hPSCreg; STBCi041-C
DR   Wikidata; Q98132852
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541209; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC24 ! STBCi041-A
OI   CVCL_RC25 ! STBCi041-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   STBCi042-A
AC   CVCL_RC26
SY   SFC848-03-02
DR   BioSamples; SAMEA104493710
DR   EBiSC; STBCi042-A
DR   ECACC; 66540735
DR   GEO; GSM2644522
DR   hPSCreg; STBCi042-A
DR   Wikidata; Q54956468
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (EBiSC=STBCi042-A).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540735; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z3 ! SF848
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi042-B
AC   CVCL_RC27
SY   SFC848-03-04
DR   BioSamples; SAMEA104493712
DR   EBiSC; STBCi042-B
DR   ECACC; 66540736
DR   hPSCreg; STBCi042-B
DR   Wikidata; Q54956469
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (EBiSC=STBCi042-B).
CC   Discontinued: ECACC; 66540736; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z3 ! SF848
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi042-C
AC   CVCL_RC28
SY   SFC848-03-06
DR   BioSamples; SAMEA104493713
DR   EBiSC; STBCi042-C
DR   ECACC; 66540737
DR   hPSCreg; STBCi042-C
DR   Wikidata; Q54956471
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (EBiSC=STBCi042-C).
CC   Discontinued: ECACC; 66540737; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z3 ! SF848
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi043-A
AC   CVCL_RC29
SY   SFC120-03-03
DR   BioSamples; SAMEA104493714
DR   EBiSC; STBCi043-A
DR   ECACC; 66540738
DR   hPSCreg; STBCi043-A
DR   Wikidata; Q54956472
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540738; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC30 ! STBCi043-B
OI   CVCL_RC31 ! STBCi043-C
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi043-B
AC   CVCL_RC30
SY   SFC120-03-04
DR   BioSamples; SAMEA104493716
DR   EBiSC; STBCi043-B
DR   ECACC; 66540739
DR   hPSCreg; STBCi043-B
DR   Wikidata; Q54956481
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540739; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC29 ! STBCi043-A
OI   CVCL_RC31 ! STBCi043-C
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi043-C
AC   CVCL_RC31
SY   SFC120-03-02
DR   BioSamples; SAMEA104493855
DR   EBiSC; STBCi043-C
DR   ECACC; 66540740
DR   hPSCreg; STBCi043-C
DR   Wikidata; Q54956482
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540740; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC29 ! STBCi043-A
OI   CVCL_RC30 ! STBCi043-B
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi044-A
AC   CVCL_RC32
SY   SFC841-03-01; CTL3
DR   BioSamples; SAMEA104493720
DR   EBiSC; STBCi044-A
DR   ECACC; 66540741
DR   hPSCreg; STBCi044-A
DR   Wikidata; Q54956483
RX   PubMed=28827786;
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540741; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC33 ! STBCi044-B
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi044-B
AC   CVCL_RC33
SY   SFC841-03-02
DR   BioSamples; SAMEA104493722
DR   EBiSC; STBCi044-B
DR   ECACC; 66540742
DR   hPSCreg; STBCi044-B
DR   Wikidata; Q54956484
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540742; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC32 ! STBCi044-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi045-A
AC   CVCL_RC34
SY   SFC039-03-01
DR   BioSamples; SAMEA104493723
DR   EBiSC; STBCi045-A
DR   ECACC; 66540743
DR   hPSCreg; STBCi045-A
DR   Wikidata; Q54956486
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540743; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC35 ! STBCi045-B
OI   CVCL_RC36 ! STBCi045-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi045-B
AC   CVCL_RC35
SY   SFC039-03-02
DR   BioSamples; SAMEA104493733
DR   EBiSC; STBCi045-B
DR   ECACC; 66540744
DR   hPSCreg; STBCi045-B
DR   Wikidata; Q54956487
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540744; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC34 ! STBCi045-A
OI   CVCL_RC36 ! STBCi045-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi045-C
AC   CVCL_RC36
SY   SFC039-03-03
DR   BioSamples; SAMEA104493756
DR   EBiSC; STBCi045-C
DR   ECACC; 66540745
DR   hPSCreg; STBCi045-C
DR   Wikidata; Q54956488
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540745; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC34 ! STBCi045-A
OI   CVCL_RC35 ! STBCi045-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi046-A
AC   CVCL_RC37
SY   SFC021-03-01
DR   BioSamples; SAMEA104493725
DR   EBiSC; STBCi046-A
DR   ECACC; 66540746
DR   hPSCreg; STBCi046-A
DR   Wikidata; Q54956489
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540746; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC38 ! STBCi046-B
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi046-B
AC   CVCL_RC38
SY   SFC021-03-02
DR   BioSamples; SAMEA104493781
DR   EBiSC; STBCi046-B
DR   ECACC; 66540747
DR   hPSCreg; STBCi046-B
DR   Wikidata; Q54956490
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540747; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC37 ! STBCi046-A
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi047-A
AC   CVCL_RC39
SY   SFC043-03-01
DR   BioSamples; SAMEA104493727
DR   EBiSC; STBCi047-A
DR   ECACC; 66540748
DR   hPSCreg; STBCi047-A
DR   Wikidata; Q54956491
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540748; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC40 ! STBCi047-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi047-B
AC   CVCL_RC40
SY   SFC043-03-13
DR   BioSamples; SAMEA104493778
DR   EBiSC; STBCi047-B
DR   ECACC; 66540749
DR   hPSCreg; STBCi047-B
DR   Wikidata; Q54956492
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540749; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC39 ! STBCi047-A
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi048-A
AC   CVCL_RC41
SY   SFC014-03-01
DR   BioSamples; SAMEA104493729
DR   EBiSC; STBCi048-A
DR   ECACC; 66540750
DR   hPSCreg; STBCi048-A
DR   Wikidata; Q54956493
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540750; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC42 ! STBCi048-B
OI   CVCL_RC43 ! STBCi048-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi048-B
AC   CVCL_RC42
SY   SFC014-03-02
DR   BioSamples; SAMEA104493731
DR   EBiSC; STBCi048-B
DR   ECACC; 66540751
DR   hPSCreg; STBCi048-B
DR   Wikidata; Q54956495
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540751; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC41 ! STBCi048-A
OI   CVCL_RC43 ! STBCi048-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi048-C
AC   CVCL_RC43
SY   SFC014-03-03
DR   BioSamples; SAMEA104493732
DR   EBiSC; STBCi048-C
DR   ECACC; 66540752
DR   hPSCreg; STBCi048-C
DR   Wikidata; Q54956496
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540752; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC41 ! STBCi048-A
OI   CVCL_RC42 ! STBCi048-B
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi049-A
AC   CVCL_RC44
SY   SFC040-03-02
DR   BioSamples; SAMEA104493734
DR   EBiSC; STBCi049-A
DR   ECACC; 66540753
DR   hPSCreg; STBCi049-A
DR   Wikidata; Q54956498
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540753; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC45 ! STBCi049-B
OI   CVCL_RC46 ! STBCi049-C
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi049-B
AC   CVCL_RC45
SY   SFC040-03-03
DR   BioSamples; SAMEA104493736
DR   EBiSC; STBCi049-B
DR   ECACC; 66540754
DR   hPSCreg; STBCi049-B
DR   Wikidata; Q54956499
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540754; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC44 ! STBCi049-A
OI   CVCL_RC46 ! STBCi049-C
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi049-C
AC   CVCL_RC46
SY   SFC040-03-01
DR   BioSamples; SAMEA104493757
DR   EBiSC; STBCi049-C
DR   ECACC; 66540755
DR   hPSCreg; STBCi049-C
DR   Wikidata; Q54956500
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540755; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC44 ! STBCi049-A
OI   CVCL_RC45 ! STBCi049-B
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi050-A
AC   CVCL_RC47
SY   SFC041-04-01
DR   BioSamples; SAMEA104493737
DR   EBiSC; STBCi050-A
DR   ECACC; 66540756
DR   hPSCreg; STBCi050-A
DR   Wikidata; Q54956501
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540756; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC48 ! STBCi050-B
OI   CVCL_RC49 ! STBCi050-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi050-B
AC   CVCL_RC48
SY   SFC041-04-02
DR   BioSamples; SAMEA104493755
DR   EBiSC; STBCi050-B
DR   ECACC; 66540757
DR   hPSCreg; STBCi050-B
DR   Wikidata; Q54956503
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540757; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC47 ! STBCi050-A
OI   CVCL_RC49 ! STBCi050-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi050-C
AC   CVCL_RC49
SY   SFC041-04-03
DR   BioSamples; SAMEA104493758
DR   EBiSC; STBCi050-C
DR   ECACC; 66540758
DR   hPSCreg; STBCi050-C
DR   Wikidata; Q54956504
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540758; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC47 ! STBCi050-A
OI   CVCL_RC48 ! STBCi050-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi051-A
AC   CVCL_RC50
SY   SFC056-04-03
DR   BioSamples; SAMEA104493739
DR   EBiSC; STBCi051-A
DR   ECACC; 66540759
DR   hPSCreg; STBCi051-A
DR   Wikidata; Q54956505
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540759; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC51 ! STBCi051-B
OI   CVCL_RC52 ! STBCi051-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi051-B
AC   CVCL_RC51
SY   SFC056-04-01
DR   BioSamples; SAMEA104493782
DR   EBiSC; STBCi051-B
DR   ECACC; 66540760
DR   hPSCreg; STBCi051-B
DR   Wikidata; Q54956506
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540760; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC50 ! STBCi051-A
OI   CVCL_RC52 ! STBCi051-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi051-C
AC   CVCL_RC52
SY   SFC056-04-02
DR   BioSamples; SAMEA104493783
DR   EBiSC; STBCi051-C
DR   ECACC; 66540761
DR   hPSCreg; STBCi051-C
DR   Wikidata; Q54956508
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540761; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC50 ! STBCi051-A
OI   CVCL_RC51 ! STBCi051-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi052-A
AC   CVCL_RC53
SY   SFC086-03-01
DR   BioSamples; SAMEA104493741
DR   EBiSC; STBCi052-A
DR   ECACC; 66540762
DR   hPSCreg; STBCi052-A
DR   Wikidata; Q54956510
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540762; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC54 ! STBCi052-B
OI   CVCL_RC55 ! STBCi052-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi052-B
AC   CVCL_RC54
SY   SFC086-03-02
DR   BioSamples; SAMEA104493743
DR   EBiSC; STBCi052-B
DR   ECACC; 66540763
DR   hPSCreg; STBCi052-B
DR   Wikidata; Q54956511
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540763; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC53 ! STBCi052-A
OI   CVCL_RC55 ! STBCi052-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi052-C
AC   CVCL_RC55
SY   SFC086-03-03
DR   BioSamples; SAMEA104493744
DR   EBiSC; STBCi052-C
DR   ECACC; 66540764
DR   hPSCreg; STBCi052-C
DR   Wikidata; Q54956513
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540764; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC53 ! STBCi052-A
OI   CVCL_RC54 ! STBCi052-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi053-A
AC   CVCL_RC56
SY   SFC089-03-07
DR   BioSamples; SAMEA104493745
DR   EBiSC; STBCi053-A
DR   ECACC; 66540765
DR   hPSCreg; STBCi053-A
DR   Wikidata; Q54956514
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540765; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC57 ! STBCi053-B
OI   CVCL_RC58 ! STBCi053-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi053-B
AC   CVCL_RC57
SY   SFC089-03-55
DR   BioSamples; SAMEA104493765
DR   EBiSC; STBCi053-B
DR   ECACC; 66540766
DR   hPSCreg; STBCi053-B
DR   Wikidata; Q54956515
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540766; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC56 ! STBCi053-A
OI   CVCL_RC58 ! STBCi053-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi053-C
AC   CVCL_RC58
SY   SFC089-03-06
DR   BioSamples; SAMEA104493784
DR   EBiSC; STBCi053-C
DR   ECACC; 66540767
DR   hPSCreg; STBCi053-C
DR   Wikidata; Q54956516
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540767; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC56 ! STBCi053-A
OI   CVCL_RC57 ! STBCi053-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi054-A
AC   CVCL_RC59
SY   SFC010-03-01
DR   BioSamples; SAMEA104493748
DR   EBiSC; STBCi054-A
DR   ECACC; 66540768
DR   hPSCreg; STBCi054-A
DR   Wikidata; Q54956517
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540768; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC60 ! STBCi054-B
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi054-B
AC   CVCL_RC60
SY   SFC010-03-02
DR   BioSamples; SAMEA104493750
DR   EBiSC; STBCi054-B
DR   ECACC; 66540769
DR   hPSCreg; STBCi054-B
DR   Wikidata; Q54956518
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540769; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC59 ! STBCi054-A
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi055-A
AC   CVCL_RC61
SY   SFC026-04-03
DR   BioSamples; SAMEA104493751
DR   EBiSC; STBCi055-A
DR   ECACC; 66540770
DR   hPSCreg; STBCi055-A
DR   Wikidata; Q54956519
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540770; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC62 ! STBCi055-B
OI   CVCL_RC63 ! STBCi055-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi055-B
AC   CVCL_RC62
SY   SFC026-04-10
DR   BioSamples; SAMEA104493753
DR   EBiSC; STBCi055-B
DR   ECACC; 66540771
DR   hPSCreg; STBCi055-B
DR   Wikidata; Q54956520
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540771; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC61 ! STBCi055-A
OI   CVCL_RC63 ! STBCi055-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi055-C
AC   CVCL_RC63
SY   SFC026-04-04
DR   BioSamples; SAMEA104615898
DR   EBiSC; STBCi055-C
DR   ECACC; 66540910
DR   hPSCreg; STBCi055-C
DR   Wikidata; Q54956521
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540910; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC61 ! STBCi055-A
OI   CVCL_RC62 ! STBCi055-B
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi056-A
AC   CVCL_RC64
SY   SFC064-03-39
DR   BioSamples; SAMEA104493759
DR   EBiSC; STBCi056-A
DR   ECACC; 66540772
DR   hPSCreg; STBCi056-A
DR   Wikidata; Q54956522
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi056-A; true.
CC   Discontinued: ECACC; 66540772; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC65 ! STBCi056-B
OI   CVCL_RC66 ! STBCi056-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi056-B
AC   CVCL_RC65
SY   SFC064-03-42
DR   BioSamples; SAMEA104493761
DR   EBiSC; STBCi056-B
DR   ECACC; 66540773
DR   hPSCreg; STBCi056-B
DR   Wikidata; Q54956523
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi056-B; true.
CC   Discontinued: ECACC; 66540773; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC64 ! STBCi056-A
OI   CVCL_RC66 ! STBCi056-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi056-C
AC   CVCL_RC66
SY   SFC064-03-09
DR   BioSamples; SAMEA104493779
DR   EBiSC; STBCi056-C
DR   ECACC; 66540774
DR   hPSCreg; STBCi056-C
DR   Wikidata; Q54956525
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540774; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC64 ! STBCi056-A
OI   CVCL_RC65 ! STBCi056-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi057-A
AC   CVCL_RC67
SY   SFC065-03-03
DR   BioSamples; SAMEA104493762
DR   EBiSC; STBCi057-A
DR   ECACC; 66540775
DR   hPSCreg; STBCi057-A
DR   Wikidata; Q54956526
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540775; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC68 ! STBCi057-B
OI   CVCL_RC69 ! STBCi057-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi057-B
AC   CVCL_RC68
SY   SFC065-03-05
DR   BioSamples; SAMEA104493764
DR   EBiSC; STBCi057-B
DR   ECACC; 66540776
DR   hPSCreg; STBCi057-B
DR   Wikidata; Q54956527
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540776; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC67 ! STBCi057-A
OI   CVCL_RC69 ! STBCi057-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi057-C
AC   CVCL_RC69
SY   SFC065-03-06
DR   BioSamples; SAMEA104493780
DR   EBiSC; STBCi057-C
DR   ECACC; 66540777
DR   hPSCreg; STBCi057-C
DR   Wikidata; Q54956529
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540777; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC67 ! STBCi057-A
OI   CVCL_RC68 ! STBCi057-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi058-A
AC   CVCL_RC70
SY   SFC012-04-20
DR   BioSamples; SAMEA104493766
DR   EBiSC; STBCi058-A
DR   ECACC; 66540778
DR   hPSCreg; STBCi058-A
DR   Wikidata; Q54956541
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540778; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC71 ! STBCi058-B
OI   CVCL_RC72 ! STBCi058-C
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi058-B
AC   CVCL_RC71
SY   SFC012-04-30
DR   BioSamples; SAMEA104493768
DR   EBiSC; STBCi058-B
DR   ECACC; 66540779
DR   hPSCreg; STBCi058-B
DR   Wikidata; Q54956542
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540779; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC70 ! STBCi058-A
OI   CVCL_RC72 ! STBCi058-C
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi058-C
AC   CVCL_RC72
SY   SFC012-04-31
DR   BioSamples; SAMEA104493769
DR   EBiSC; STBCi058-C
DR   ECACC; 66540780
DR   hPSCreg; STBCi058-C
DR   Wikidata; Q54956543
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540780; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC70 ! STBCi058-A
OI   CVCL_RC71 ! STBCi058-B
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi059-A
AC   CVCL_RC73
SY   SFC015-01-05
DR   BioSamples; SAMEA104493770
DR   EBiSC; STBCi059-A
DR   ECACC; 66540781
DR   hPSCreg; STBCi059-A
DR   Wikidata; Q54956545
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540781; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC74 ! STBCi059-B
OI   CVCL_RC75 ! STBCi059-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi059-B
AC   CVCL_RC74
SY   SFC015-01-06
DR   BioSamples; SAMEA104493772
DR   EBiSC; STBCi059-B
DR   ECACC; 66540782
DR   hPSCreg; STBCi059-B
DR   Wikidata; Q54956546
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540782; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC73 ! STBCi059-A
OI   CVCL_RC75 ! STBCi059-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi059-C
AC   CVCL_RC75
SY   SFC015-01-10
DR   BioSamples; SAMEA104493773
DR   EBiSC; STBCi059-C
DR   ECACC; 66540783
DR   hPSCreg; STBCi059-C
DR   Wikidata; Q54956548
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540783; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC73 ! STBCi059-A
OI   CVCL_RC74 ! STBCi059-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi060-A
AC   CVCL_RC76
SY   SFC038-07-05
DR   BioSamples; SAMEA104493774
DR   EBiSC; STBCi060-A
DR   ECACC; 66540784
DR   hPSCreg; STBCi060-A
DR   Wikidata; Q54956550
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540784; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC77 ! STBCi060-B
OI   CVCL_RC78 ! STBCi060-C
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi060-B
AC   CVCL_RC77
SY   SFC038-07-06
DR   BioSamples; SAMEA104493776
DR   EBiSC; STBCi060-B
DR   ECACC; 66540785
DR   hPSCreg; STBCi060-B
DR   Wikidata; Q54956551
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540785; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC76 ! STBCi060-A
OI   CVCL_RC78 ! STBCi060-C
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi060-C
AC   CVCL_RC78
SY   SFC038-07-07
DR   BioSamples; SAMEA104493777
DR   EBiSC; STBCi060-C
DR   ECACC; 66540786
DR   hPSCreg; STBCi060-C
DR   Wikidata; Q54956552
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540786; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC76 ! STBCi060-A
OI   CVCL_RC77 ! STBCi060-B
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi061-A
AC   CVCL_RC79
SY   SFC850-03-01
DR   BioSamples; SAMEA104493785
DR   EBiSC; STBCi061-A
DR   ECACC; 66540787
DR   hPSCreg; STBCi061-A
DR   Wikidata; Q54956553
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540787; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi062-A
AC   CVCL_RC80
SY   SFC851-03-04
DR   BioSamples; SAMEA104493787
DR   EBiSC; STBCi062-A
DR   ECACC; 66540788
DR   hPSCreg; STBCi062-A
DR   Wikidata; Q54956554
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540788; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi063-A
AC   CVCL_RC81
SY   SFC856-03-04; CTL4
DR   BioSamples; SAMEA104493789
DR   EBiSC; STBCi063-A
DR   ECACC; 66540789
DR   GEO; GSM2392429
DR   GEO; GSM2392480
DR   hPSCreg; STBCi063-A
DR   Wikidata; Q54956555
RX   PubMed=28591653;
RX   PubMed=28827786;
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540789; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y2 ! SF856
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi063-B
AC   CVCL_RC82
SY   SFC856-03-07
DR   BioSamples; SAMEA104493791
DR   EBiSC; STBCi063-B
DR   ECACC; 66540790
DR   hPSCreg; STBCi063-B
DR   Wikidata; Q54956556
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540790; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y2 ! SF856
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi063-C
AC   CVCL_RC83
SY   SFC856-03-08
DR   BioSamples; SAMEA104493792
DR   EBiSC; STBCi063-C
DR   ECACC; 66540791
DR   hPSCreg; STBCi063-C
DR   Wikidata; Q54956557
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540791; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y2 ! SF856
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi064-A
AC   CVCL_RC84
SY   SFC180-01-01; CTL1
DR   BioSamples; SAMEA104493793
DR   EBiSC; STBCi064-A
DR   ECACC; 66540792
DR   GEO; GSM2392428
DR   GEO; GSM2392477
DR   hPSCreg; STBCi064-A
DR   Wikidata; Q54956558
RX   PubMed=28591653;
RX   PubMed=28827786;
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540792; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X6 ! SF180
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   STBCi065-A
AC   CVCL_RC85
SY   SFC853-03-03
DR   BioSamples; SAMEA104493795
DR   EBiSC; STBCi065-A
DR   ECACC; 66540793
DR   hPSCreg; STBCi065-A
DR   Wikidata; Q54956559
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540793; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi066-A
AC   CVCL_RC86
SY   SFC854-03-02; CTL6
DR   BioSamples; SAMEA104493797
DR   EBiSC; STBCi066-A
DR   ECACC; 66540794
DR   hPSCreg; STBCi066-A
DR   Wikidata; Q54956560
RX   PubMed=28827786;
RX   PubMed=32359446;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540794; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi067-A
AC   CVCL_D0LV
SY   SFC855-03-08
DR   BioSamples; SAMEA104493800
DR   EBiSC; STBCi067-A
DR   ECACC; 66540795
DR   hPSCreg; STBCi067-A
DR   Wikidata; Q123033560
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Unspecified (hPSCreg=STBCi067-A).
CC   Discontinued: ECACC; 66540795; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   STBCi068-A
AC   CVCL_RC87
SY   SFC035-03-01
DR   BioSamples; SAMEA104493802
DR   EBiSC; STBCi068-A
DR   ECACC; 66540797
DR   hPSCreg; STBCi068-A
DR   Wikidata; Q54956561
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540797; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC88 ! STBCi068-B
OI   CVCL_RC89 ! STBCi068-C
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi068-B
AC   CVCL_RC88
SY   SFC035-03-02
DR   BioSamples; SAMEA104493804
DR   EBiSC; STBCi068-B
DR   ECACC; 66540798
DR   hPSCreg; STBCi068-B
DR   Wikidata; Q54956562
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540798; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC87 ! STBCi068-A
OI   CVCL_RC89 ! STBCi068-C
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi068-C
AC   CVCL_RC89
SY   SFC035-03-03
DR   BioSamples; SAMEA104493805
DR   EBiSC; STBCi068-C
DR   ECACC; 66540799
DR   hPSCreg; STBCi068-C
DR   Wikidata; Q54956563
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540799; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC87 ! STBCi068-A
OI   CVCL_RC88 ! STBCi068-B
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi069-A
AC   CVCL_RC90
SY   SFC050-03-21
DR   BioSamples; SAMEA104493806
DR   EBiSC; STBCi069-A
DR   ECACC; 66540800
DR   hPSCreg; STBCi069-A
DR   Wikidata; Q54956564
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540800; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC91 ! STBCi069-B
OI   CVCL_RC92 ! STBCi069-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi069-B
AC   CVCL_RC91
SY   SFC050-03-22
DR   BioSamples; SAMEA104493808
DR   EBiSC; STBCi069-B
DR   ECACC; 66540801
DR   hPSCreg; STBCi069-B
DR   Wikidata; Q54956565
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540801; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC90 ! STBCi069-A
OI   CVCL_RC92 ! STBCi069-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi069-C
AC   CVCL_RC92
SY   SFC050-03-20
DR   BioSamples; SAMEA104493843
DR   EBiSC; STBCi069-C
DR   ECACC; 66540802
DR   hPSCreg; STBCi069-C
DR   Wikidata; Q54956568
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540802; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC90 ! STBCi069-A
OI   CVCL_RC91 ! STBCi069-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi070-A
AC   CVCL_RC93
SY   SFC052-03-03
DR   BioSamples; SAMEA104493809
DR   EBiSC; STBCi070-A
DR   ECACC; 66540803
DR   hPSCreg; STBCi070-A
DR   Wikidata; Q54956569
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540803; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC94 ! STBCi070-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi070-B
AC   CVCL_RC94
SY   SFC052-03-02
DR   BioSamples; SAMEA104493844
DR   EBiSC; STBCi070-B
DR   ECACC; 66540804
DR   hPSCreg; STBCi070-B
DR   Wikidata; Q54956571
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540804; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC93 ! STBCi070-A
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi071-A
AC   CVCL_RC95
SY   SFC057-07-03
DR   BioSamples; SAMEA104493811
DR   EBiSC; STBCi071-A
DR   ECACC; 66540805
DR   hPSCreg; STBCi071-A
DR   Wikidata; Q54956572
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540805; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC96 ! STBCi071-B
OI   CVCL_RC97 ! STBCi071-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi071-B
AC   CVCL_RC96
SY   SFC057-07-01
DR   BioSamples; SAMEA104493876
DR   EBiSC; STBCi071-B
DR   ECACC; 66540806
DR   hPSCreg; STBCi071-B
DR   Wikidata; Q54956573
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540806; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC95 ! STBCi071-A
OI   CVCL_RC97 ! STBCi071-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi071-C
AC   CVCL_RC97
SY   SFC057-07-02
DR   BioSamples; SAMEA104493896
DR   EBiSC; STBCi071-C
DR   ECACC; 66540807
DR   hPSCreg; STBCi071-C
DR   Wikidata; Q54956574
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540807; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC95 ! STBCi071-A
OI   CVCL_RC96 ! STBCi071-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi072-A
AC   CVCL_RC98
SY   SFC058-03-01
DR   BioSamples; SAMEA104493813
DR   EBiSC; STBCi072-A
DR   ECACC; 66540808
DR   hPSCreg; STBCi072-A
DR   Wikidata; Q54956576
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540808; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC99 ! STBCi072-B
OI   CVCL_RD00 ! STBCi072-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi072-B
AC   CVCL_RC99
SY   SFC058-03-02
DR   BioSamples; SAMEA104493815
DR   EBiSC; STBCi072-B
DR   ECACC; 66540809
DR   hPSCreg; STBCi072-B
DR   Wikidata; Q54956577
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540809; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC98 ! STBCi072-A
OI   CVCL_RD00 ! STBCi072-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi072-C
AC   CVCL_RD00
SY   SFC058-03-03
DR   BioSamples; SAMEA104493816
DR   EBiSC; STBCi072-C
DR   ECACC; 66540810
DR   hPSCreg; STBCi072-C
DR   Wikidata; Q54956578
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540810; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RC98 ! STBCi072-A
OI   CVCL_RC99 ! STBCi072-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi073-A
AC   CVCL_RD01
SY   SFC106-03-02
DR   BioSamples; SAMEA104493817
DR   EBiSC; STBCi073-A
DR   ECACC; 66540811
DR   hPSCreg; STBCi073-A
DR   Wikidata; Q54956579
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540811; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD02 ! STBCi073-B
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi073-B
AC   CVCL_RD02
SY   SFC106-03-03
DR   BioSamples; SAMEA104493819
DR   EBiSC; STBCi073-B
DR   ECACC; 66540812
DR   hPSCreg; STBCi073-B
DR   Wikidata; Q54956580
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540812; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD01 ! STBCi073-A
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi074-A
AC   CVCL_RD03
SY   SFC109-03-02
DR   BioSamples; SAMEA104493820
DR   EBiSC; STBCi074-A
DR   ECACC; 66540813
DR   hPSCreg; STBCi074-A
DR   Wikidata; Q54956581
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540813; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD04 ! STBCi074-B
OI   CVCL_RD05 ! STBCi074-C
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi074-B
AC   CVCL_RD04
SY   SFC109-03-12
DR   BioSamples; SAMEA104493822
DR   EBiSC; STBCi074-B
DR   ECACC; 66540814
DR   hPSCreg; STBCi074-B
DR   Wikidata; Q54956582
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540814; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD03 ! STBCi074-A
OI   CVCL_RD05 ! STBCi074-C
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi074-C
AC   CVCL_RD05
SY   SFC109-03-01
DR   BioSamples; SAMEA104493901
DR   EBiSC; STBCi074-C
DR   ECACC; 66540815
DR   hPSCreg; STBCi074-C
DR   Wikidata; Q54956583
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540815; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD03 ! STBCi074-A
OI   CVCL_RD04 ! STBCi074-B
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi075-A
AC   CVCL_RD06
SY   SFC129-03-02
DR   BioSamples; SAMEA104493823
DR   EBiSC; STBCi075-A
DR   ECACC; 66540816
DR   hPSCreg; STBCi075-A
DR   Wikidata; Q54956584
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540816; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD07 ! STBCi075-B
OI   CVCL_RD08 ! STBCi075-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi075-B
AC   CVCL_RD07
SY   SFC129-03-03
DR   BioSamples; SAMEA104493825
DR   EBiSC; STBCi075-B
DR   ECACC; 66540817
DR   hPSCreg; STBCi075-B
DR   Wikidata; Q54956585
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540817; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD06 ! STBCi075-A
OI   CVCL_RD08 ! STBCi075-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi075-C
AC   CVCL_RD08
SY   SFC129-03-01
DR   BioSamples; SAMEA104493845
DR   EBiSC; STBCi075-C
DR   ECACC; 66540818
DR   hPSCreg; STBCi075-C
DR   Wikidata; Q54956586
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540818; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD06 ! STBCi075-A
OI   CVCL_RD07 ! STBCi075-B
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi076-A
AC   CVCL_RD09
SY   SFC134-03-01
DR   BioSamples; SAMEA104493826
DR   EBiSC; STBCi076-A
DR   ECACC; 66540819
DR   hPSCreg; STBCi076-A
DR   Wikidata; Q54956588
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540819; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi077-A
AC   CVCL_RD10
SY   SFC136-03-02
DR   BioSamples; SAMEA104493828
DR   EBiSC; STBCi077-A
DR   ECACC; 66540820
DR   hPSCreg; STBCi077-A
DR   Wikidata; Q54956594
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540820; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD11 ! STBCi077-B
OI   CVCL_RD12 ! STBCi077-C
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi077-B
AC   CVCL_RD11
SY   SFC136-03-03
DR   BioSamples; SAMEA104493830
DR   EBiSC; STBCi077-B
DR   ECACC; 66540821
DR   hPSCreg; STBCi077-B
DR   Wikidata; Q54956596
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540821; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD10 ! STBCi077-A
OI   CVCL_RD12 ! STBCi077-C
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi077-C
AC   CVCL_RD12
SY   SFC136-03-01
DR   BioSamples; SAMEA104493846
DR   EBiSC; STBCi077-C
DR   ECACC; 66540822
DR   hPSCreg; STBCi077-C
DR   Wikidata; Q54956597
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540822; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD10 ! STBCi077-A
OI   CVCL_RD11 ! STBCi077-B
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi078-A
AC   CVCL_RD13
SY   SFC013-07-01
DR   BioSamples; SAMEA104493831
DR   EBiSC; STBCi078-A
DR   ECACC; 66540823
DR   hPSCreg; STBCi078-A
DR   Wikidata; Q54970162
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540823; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD14 ! STBCi078-B
OI   CVCL_RD15 ! STBCi078-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi078-B
AC   CVCL_RD14
SY   SFC013-07-02
DR   BioSamples; SAMEA104493833
DR   EBiSC; STBCi078-B
DR   ECACC; 66540824
DR   hPSCreg; STBCi078-B
DR   Wikidata; Q54970163
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540824; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD13 ! STBCi078-A
OI   CVCL_RD15 ! STBCi078-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi078-C
AC   CVCL_RD15
SY   SFC013-07-03
DR   BioSamples; SAMEA104493834
DR   EBiSC; STBCi078-C
DR   ECACC; 66540825
DR   hPSCreg; STBCi078-C
DR   Wikidata; Q54970164
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540825; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD13 ! STBCi078-A
OI   CVCL_RD14 ! STBCi078-B
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi079-A
AC   CVCL_RD16
SY   SFC045-03-01
DR   BioSamples; SAMEA104493835
DR   EBiSC; STBCi079-A
DR   ECACC; 66540826
DR   hPSCreg; STBCi079-A
DR   Wikidata; Q54970166
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540826; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD17 ! STBCi079-B
OI   CVCL_RD18 ! STBCi079-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi079-B
AC   CVCL_RD17
SY   SFC045-03-02
DR   BioSamples; SAMEA104493837
DR   EBiSC; STBCi079-B
DR   ECACC; 66540827
DR   hPSCreg; STBCi079-B
DR   Wikidata; Q54970167
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540827; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD16 ! STBCi079-A
OI   CVCL_RD18 ! STBCi079-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi079-C
AC   CVCL_RD18
SY   SFC045-03-03
DR   BioSamples; SAMEA104493838
DR   EBiSC; STBCi079-C
DR   ECACC; 66540828
DR   hPSCreg; STBCi079-C
DR   Wikidata; Q54970168
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540828; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD16 ! STBCi079-A
OI   CVCL_RD17 ! STBCi079-B
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi080-A
AC   CVCL_RD19
SY   SFC047-03-01
DR   BioSamples; SAMEA104493839
DR   EBiSC; STBCi080-A
DR   ECACC; 66540829
DR   hPSCreg; STBCi080-A
DR   Wikidata; Q54970169
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540829; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD20 ! STBCi080-B
OI   CVCL_RD21 ! STBCi080-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi080-B
AC   CVCL_RD20
SY   SFC047-03-02
DR   BioSamples; SAMEA104493841
DR   EBiSC; STBCi080-B
DR   ECACC; 66540830
DR   hPSCreg; STBCi080-B
DR   Wikidata; Q54970170
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540830; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD19 ! STBCi080-A
OI   CVCL_RD21 ! STBCi080-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi080-C
AC   CVCL_RD21
SY   SFC047-03-03
DR   BioSamples; SAMEA104493842
DR   EBiSC; STBCi080-C
DR   ECACC; 66540831
DR   hPSCreg; STBCi080-C
DR   Wikidata; Q54970171
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540831; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD19 ! STBCi080-A
OI   CVCL_RD20 ! STBCi080-B
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi081-A
AC   CVCL_RD22
SY   SFC170-03-01
DR   BioSamples; SAMEA104493847
DR   EBiSC; STBCi081-A
DR   ECACC; 66540832
DR   hPSCreg; STBCi081-A
DR   Wikidata; Q54970172
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540832; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD23 ! STBCi081-B
OI   CVCL_RD24 ! STBCi081-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi081-B
AC   CVCL_RD23
SY   SFC170-03-03
DR   BioSamples; SAMEA104493849
DR   EBiSC; STBCi081-B
DR   ECACC; 66540833
DR   hPSCreg; STBCi081-B
DR   Wikidata; Q54970173
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540833; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD22 ! STBCi081-A
OI   CVCL_RD24 ! STBCi081-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi081-C
AC   CVCL_RD24
SY   SFC170-03-02
DR   BioSamples; SAMEA104493892
DR   EBiSC; STBCi081-C
DR   ECACC; 66540834
DR   hPSCreg; STBCi081-C
DR   Wikidata; Q54970175
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540834; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD22 ! STBCi081-A
OI   CVCL_RD23 ! STBCi081-B
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi082-A
AC   CVCL_RD25
SY   SFC888-07-01
DR   BioSamples; SAMEA104493850
DR   EBiSC; STBCi082-A
DR   ECACC; 66540835
DR   hPSCreg; STBCi082-A
DR   Wikidata; Q54970176
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540835; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD26 ! STBCi082-B
OI   CVCL_RD27 ! STBCi082-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi082-B
AC   CVCL_RD26
SY   SFC888-07-02
DR   BioSamples; SAMEA104493852
DR   EBiSC; STBCi082-B
DR   ECACC; 66540836
DR   hPSCreg; STBCi082-B
DR   Wikidata; Q54970177
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540836; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD25 ! STBCi082-A
OI   CVCL_RD27 ! STBCi082-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi082-C
AC   CVCL_RD27
SY   SFC888-07-03
DR   BioSamples; SAMEA104493853
DR   EBiSC; STBCi082-C
DR   ECACC; 66540837
DR   hPSCreg; STBCi082-C
DR   Wikidata; Q54970178
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540837; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD25 ! STBCi082-A
OI   CVCL_RD26 ! STBCi082-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi083-A
AC   CVCL_RD28
SY   SFC830-04-09; A53T3.2
DR   BioSamples; SAMEA104493856
DR   EBiSC; STBCi083-A
DR   ECACC; 66540838
DR   GEO; GSM2392431
DR   GEO; GSM2392486
DR   hPSCreg; STBCi083-A
DR   Wikidata; Q54970179
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540838; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X9 ! SF830
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi083-B
AC   CVCL_RD29
SY   SFC830-04-08; A53T3.1
DR   BioSamples; SAMEA104493877
DR   EBiSC; STBCi083-B
DR   ECACC; 66540839
DR   GEO; GSM2392430
DR   GEO; GSM2392485
DR   hPSCreg; STBCi083-B
DR   Wikidata; Q54970180
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540839; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8X9 ! SF830
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   STBCi084-A
AC   CVCL_RD30
SY   SFC871-03-12
DR   BioSamples; SAMEA104493859
DR   EBiSC; STBCi084-A
DR   ECACC; 66540840
DR   hPSCreg; STBCi084-A
DR   Wikidata; Q54970181
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (EBiSC=STBCi084-A).
CC   Discontinued: ECACC; 66540840; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z2 ! SF871
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi084-B
AC   CVCL_RD31
SY   SFC871-03-04
DR   BioSamples; SAMEA104493863
DR   EBiSC; STBCi084-B
DR   ECACC; 66540841
DR   hPSCreg; STBCi084-B
DR   Wikidata; Q54970183
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (EBiSC=STBCi084-B).
CC   Discontinued: ECACC; 66540841; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z2 ! SF871
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi084-C
AC   CVCL_RD32
SY   SFC871-03-09
DR   BioSamples; SAMEA104493864
DR   EBiSC; STBCi084-C
DR   ECACC; 66540842
DR   GEO; GSM2644520
DR   hPSCreg; STBCi084-C
DR   Wikidata; Q54970184
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (EBiSC=STBCi084-C).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540842; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z2 ! SF871
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi085-A
AC   CVCL_RD33
SY   SFC866-03-06
DR   BioSamples; SAMEA104493861
DR   EBiSC; STBCi085-A
DR   ECACC; 66540843
DR   hPSCreg; STBCi085-A
DR   Wikidata; Q54970185
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (EBiSC=STBCi085-A).
CC   Discontinued: ECACC; 66540843; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD34 ! STBCi085-B
OI   CVCL_RD35 ! STBCi085-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi085-B
AC   CVCL_RD34
SY   SFC866-03-02
DR   BioSamples; SAMEA104493865
DR   EBiSC; STBCi085-B
DR   ECACC; 66540844
DR   hPSCreg; STBCi085-B
DR   Wikidata; Q54970186
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (EBiSC=STBCi085-B).
CC   Discontinued: ECACC; 66540844; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD33 ! STBCi085-A
OI   CVCL_RD35 ! STBCi085-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi085-C
AC   CVCL_RD35
SY   SFC866-03-05
DR   BioSamples; SAMEA104493875
DR   EBiSC; STBCi085-C
DR   ECACC; 66540845
DR   hPSCreg; STBCi085-C
DR   Wikidata; Q54970187
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (EBiSC=STBCi085-C).
CC   Discontinued: ECACC; 66540845; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD33 ! STBCi085-A
OI   CVCL_RD34 ! STBCi085-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 16
//
ID   STBCi086-A
AC   CVCL_RD36
SY   SFC842-03-02
DR   BioSamples; SAMEA104493866
DR   EBiSC; STBCi086-A
DR   ECACC; 66540846
DR   hPSCreg; STBCi086-A
DR   Wikidata; Q54970189
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540846; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD37 ! STBCi086-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi086-B
AC   CVCL_RD37
SY   SFC842-03-07
DR   BioSamples; SAMEA104493868
DR   EBiSC; STBCi086-B
DR   ECACC; 66540847
DR   hPSCreg; STBCi086-B
DR   Wikidata; Q54970190
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540847; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD36 ! STBCi086-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi087-A
AC   CVCL_RD38
SY   SFC845-03-05
DR   BioSamples; SAMEA104493871
DR   EBiSC; STBCi087-A
DR   ECACC; 66540848
DR   hPSCreg; STBCi087-A
DR   Wikidata; Q54970191
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540848; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD39 ! STBCi087-B
OI   CVCL_RD40 ! STBCi087-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi087-B
AC   CVCL_RD39
SY   SFC845-03-09
DR   BioSamples; SAMEA104493873
DR   EBiSC; STBCi087-B
DR   ECACC; 66540849
DR   hPSCreg; STBCi087-B
DR   Wikidata; Q54970192
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540849; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD38 ! STBCi087-A
OI   CVCL_RD40 ! STBCi087-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi087-C
AC   CVCL_RD40
SY   SFC845-03-11
DR   BioSamples; SAMEA104493874
DR   EBiSC; STBCi087-C
DR   ECACC; 66540850
DR   hPSCreg; STBCi087-C
DR   Wikidata; Q54970193
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540850; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD38 ! STBCi087-A
OI   CVCL_RD39 ! STBCi087-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi088-A
AC   CVCL_RD41
SY   SFC872-03-05
DR   BioSamples; SAMEA104493878
DR   EBiSC; STBCi088-A
DR   ECACC; 66540851
DR   hPSCreg; STBCi088-A
DR   Wikidata; Q54970194
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (EBiSC=STBCi088-A).
CC   Discontinued: ECACC; 66540851; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD42 ! STBCi088-B
OI   CVCL_RD43 ! STBCi088-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   STBCi088-B
AC   CVCL_RD42
SY   SFC872-03-02
DR   BioSamples; SAMEA104493880
DR   EBiSC; STBCi088-B
DR   ECACC; 66540852
DR   hPSCreg; STBCi088-B
DR   Wikidata; Q54970195
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (EBiSC=STBCi088-B).
CC   Discontinued: ECACC; 66540852; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD41 ! STBCi088-A
OI   CVCL_RD43 ! STBCi088-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   STBCi088-C
AC   CVCL_RD43
SY   SFC872-03-03
DR   BioSamples; SAMEA104493881
DR   EBiSC; STBCi088-C
DR   ECACC; 66540853
DR   hPSCreg; STBCi088-C
DR   Wikidata; Q54970196
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Unspecified (EBiSC=STBCi088-C).
CC   Discontinued: ECACC; 66540853; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD41 ! STBCi088-A
OI   CVCL_RD42 ! STBCi088-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   STBCi089-A
AC   CVCL_RD44
SY   SFC868-03-05
DR   BioSamples; SAMEA104493882
DR   EBiSC; STBCi089-A
DR   ECACC; 66540854
DR   hPSCreg; STBCi089-A
DR   Wikidata; Q54970197
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540854; true.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD45 ! STBCi089-B
OI   CVCL_RD46 ! STBCi089-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   STBCi089-B
AC   CVCL_RD45
SY   SFC868-03-08
DR   BioSamples; SAMEA104493884
DR   EBiSC; STBCi089-B
DR   ECACC; 66540855
DR   hPSCreg; STBCi089-B
DR   Wikidata; Q54970198
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540855; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD44 ! STBCi089-A
OI   CVCL_RD46 ! STBCi089-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi089-C
AC   CVCL_RD46
SY   SFC868-03-10
DR   BioSamples; SAMEA104493885
DR   EBiSC; STBCi089-C
DR   ECACC; 66540856
DR   hPSCreg; STBCi089-C
DR   Wikidata; Q54970199
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540856; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD44 ! STBCi089-A
OI   CVCL_RD45 ! STBCi089-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi090-A
AC   CVCL_RD47
SY   SFC867-04-09
DR   BioSamples; SAMEA104493886
DR   EBiSC; STBCi090-A
DR   ECACC; 66540857
DR   hPSCreg; STBCi090-A
DR   Wikidata; Q54970200
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540857; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD48 ! STBCi090-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi090-B
AC   CVCL_RD48
SY   SFC867-04-12
DR   BioSamples; SAMEA104493900
DR   EBiSC; STBCi090-B
DR   ECACC; 66540858
DR   hPSCreg; STBCi090-B
DR   Wikidata; Q54970201
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540858; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD47 ! STBCi090-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi091-A
AC   CVCL_RD49
SY   SFC126-03-01
DR   BioSamples; SAMEA104493888
DR   EBiSC; STBCi091-A
DR   ECACC; 66540859
DR   hPSCreg; STBCi091-A
DR   Wikidata; Q54970202
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540859; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD50 ! STBCi091-B
OI   CVCL_RD51 ! STBCi091-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi091-B
AC   CVCL_RD50
SY   SFC126-03-02
DR   BioSamples; SAMEA104493890
DR   EBiSC; STBCi091-B
DR   ECACC; 66540860
DR   hPSCreg; STBCi091-B
DR   Wikidata; Q54970203
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540860; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD49 ! STBCi091-A
OI   CVCL_RD51 ! STBCi091-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi091-C
AC   CVCL_RD51
SY   SFC126-03-03
DR   BioSamples; SAMEA104493891
DR   EBiSC; STBCi091-C
DR   ECACC; 66540861
DR   hPSCreg; STBCi091-C
DR   Wikidata; Q54970204
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540861; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD49 ! STBCi091-A
OI   CVCL_RD50 ! STBCi091-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi092-A
AC   CVCL_RD52
SY   SFC049-03-04
DR   BioSamples; SAMEA104493893
DR   EBiSC; STBCi092-A
DR   ECACC; 66540862
DR   hPSCreg; STBCi092-A
DR   Wikidata; Q54970205
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540862; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD53 ! STBCi092-B
OI   CVCL_RD54 ! STBCi092-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi092-B
AC   CVCL_RD53
SY   SFC049-03-10
DR   BioSamples; SAMEA104493895
DR   EBiSC; STBCi092-B
DR   ECACC; 66540863
DR   hPSCreg; STBCi092-B
DR   Wikidata; Q54970222
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540863; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD52 ! STBCi092-A
OI   CVCL_RD54 ! STBCi092-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi092-C
AC   CVCL_RD54
SY   SFC049-03-13
DR   BioSamples; SAMEA104493902
DR   EBiSC; STBCi092-C
DR   ECACC; 66540864
DR   hPSCreg; STBCi092-C
DR   Wikidata; Q54970223
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540864; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
DI   ORDO; Orphanet_181376; Rare diabetes mellitus type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD52 ! STBCi092-A
OI   CVCL_RD53 ! STBCi092-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi093-A
AC   CVCL_RD55
SY   SFC893-07-06
DR   BioSamples; SAMEA104493897
DR   ECACC; 66540865
DR   hPSCreg; STBCi093-A
DR   Wikidata; Q54970224
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540865; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD56 ! STBCi093-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi093-B
AC   CVCL_RD56
SY   SFC893-07-09
DR   BioSamples; SAMEA104493899
DR   EBiSC; STBCi093-B
DR   ECACC; 66540866
DR   hPSCreg; STBCi093-B
DR   Wikidata; Q54970225
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540866; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD55 ! STBCi093-A
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi094-A
AC   CVCL_RD57
SY   BPC321-01-06
DR   BioSamples; SAMEA104493903
DR   EBiSC; STBCi094-A
DR   ECACC; 66540867
DR   hPSCreg; STBCi094-A
DR   Wikidata; Q54970226
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540867; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84427; Drug induced liver injury
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD58 ! STBCi094-B
OI   CVCL_RD59 ! STBCi094-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi094-B
AC   CVCL_RD58
SY   BPC321-01-07
DR   BioSamples; SAMEA104493905
DR   EBiSC; STBCi094-B
DR   ECACC; 66540868
DR   hPSCreg; STBCi094-B
DR   Wikidata; Q54970227
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540868; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84427; Drug induced liver injury
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD57 ! STBCi094-A
OI   CVCL_RD59 ! STBCi094-C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi094-C
AC   CVCL_RD59
SY   BPC321-01-09
DR   BioSamples; SAMEA104493906
DR   EBiSC; STBCi094-C
DR   ECACC; 66540869
DR   hPSCreg; STBCi094-C
DR   Wikidata; Q54970228
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540869; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84427; Drug induced liver injury
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD57 ! STBCi094-A
OI   CVCL_RD58 ! STBCi094-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi095-A
AC   CVCL_RD60
SY   BPC339-03-01
DR   BioSamples; SAMEA104493907
DR   EBiSC; STBCi095-A
DR   ECACC; 66540870
DR   hPSCreg; STBCi095-A
DR   Wikidata; Q54970229
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540870; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C84427; Drug induced liver injury
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi096-A
AC   CVCL_RD61
SY   BPC340-03-06
DR   BioSamples; SAMEA104493909
DR   EBiSC; STBCi096-A
DR   ECACC; 66540871
DR   hPSCreg; STBCi096-A
DR   Wikidata; Q54970232
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540871; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C34786; Long QT syndrome
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi097-A
AC   CVCL_RD62
SY   SFC055-04-02
DR   BioSamples; SAMEA104615896
DR   EBiSC; STBCi097-A
DR   ECACC; 66540911
DR   hPSCreg; STBCi097-A
DR   Wikidata; Q54970233
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540911; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD63 ! STBCi097-B
OI   CVCL_RD64 ! STBCi097-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi097-B
AC   CVCL_RD63
SY   SFC055-04-01
DR   BioSamples; SAMEA104615899
DR   EBiSC; STBCi097-B
DR   ECACC; 66540912
DR   hPSCreg; STBCi097-B
DR   Wikidata; Q54970234
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540912; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD62 ! STBCi097-A
OI   CVCL_RD64 ! STBCi097-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi097-C
AC   CVCL_RD64
SY   SFC055-04-03
DR   BioSamples; SAMEA104615900
DR   EBiSC; STBCi097-C
DR   ECACC; 66540913
DR   hPSCreg; STBCi097-C
DR   Wikidata; Q54970235
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540913; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD62 ! STBCi097-A
OI   CVCL_RD63 ! STBCi097-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi098-A
AC   CVCL_RD65
SY   SFC048-07-14
DR   BioSamples; SAMEA104615906
DR   EBiSC; STBCi098-A
DR   ECACC; 66540914
DR   hPSCreg; STBCi098-A
DR   Wikidata; Q54970236
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540914; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD66 ! STBCi098-B
OI   CVCL_RD67 ! STBCi098-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi098-B
AC   CVCL_RD66
SY   SFC048-07-18
DR   BioSamples; SAMEA104615908
DR   EBiSC; STBCi098-B
DR   ECACC; 66540915
DR   hPSCreg; STBCi098-B
DR   Wikidata; Q54970237
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540915; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD65 ! STBCi098-A
OI   CVCL_RD67 ! STBCi098-C
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi098-C
AC   CVCL_RD67
SY   SFC048-07-17
DR   BioSamples; SAMEA104616150
DR   EBiSC; STBCi098-C
DR   ECACC; 66540918
DR   hPSCreg; STBCi098-C
DR   Wikidata; Q54970238
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540918; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD65 ! STBCi098-A
OI   CVCL_RD66 ! STBCi098-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi099-A
AC   CVCL_RD68
SY   SFC059-03-01
DR   BioSamples; SAMEA104615909
DR   EBiSC; STBCi099-A
DR   ECACC; 66540916
DR   hPSCreg; STBCi099-A
DR   Wikidata; Q54970239
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540916; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD69 ! STBCi099-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi099-B
AC   CVCL_RD69
SY   SFC059-03-02
DR   BioSamples; SAMEA104616191
DR   EBiSC; STBCi099-B
DR   ECACC; 66540919
DR   hPSCreg; STBCi099-B
DR   Wikidata; Q54970240
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi099-B; true.
CC   Discontinued: ECACC; 66540919; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD68 ! STBCi099-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi100-A
AC   CVCL_RD70
SY   SFC117-03-01
DR   BioSamples; SAMEA104616123
DR   EBiSC; STBCi100-A
DR   ECACC; 66540920
DR   hPSCreg; STBCi100-A
DR   Wikidata; Q54970241
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540920; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi101-A
AC   CVCL_RD71
SY   SFC156-03-01
DR   BioSamples; SAMEA104616125
DR   EBiSC; STBCi101-A
DR   ECACC; 66540921
DR   hPSCreg; STBCi101-A
DR   Wikidata; Q54970242
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540921; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi102-A
AC   CVCL_RD72
SY   SFC163-03-01
DR   BioSamples; SAMEA104616127
DR   EBiSC; STBCi102-A
DR   ECACC; 66540922
DR   hPSCreg; STBCi102-A
DR   Wikidata; Q54970244
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540922; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi103-A
AC   CVCL_RD73
SY   SFC294-03-01
DR   BioSamples; SAMEA104616129
DR   EBiSC; STBCi103-A
DR   ECACC; 66540923
DR   hPSCreg; STBCi103-A
DR   Wikidata; Q54970245
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540923; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi104-A
AC   CVCL_RD74
SY   SFC836-03-01
DR   BioSamples; SAMEA104616131
DR   EBiSC; STBCi104-A
DR   ECACC; 66540924
DR   hPSCreg; STBCi104-A
DR   Wikidata; Q54970246
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540924; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi105-A
AC   CVCL_RD75
SY   SFC067-03-01
DR   BioSamples; SAMEA104616133
DR   EBiSC; STBCi105-A
DR   ECACC; 66540925
DR   hPSCreg; STBCi105-A
DR   Wikidata; Q54970247
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540925; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi106-A
AC   CVCL_RD76
SY   SFC068-03-01
DR   BioSamples; SAMEA104616135
DR   EBiSC; STBCi106-A
DR   ECACC; 66540926
DR   hPSCreg; STBCi106-A
DR   Wikidata; Q54970248
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540926; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi107-A
AC   CVCL_RD77
SY   SFC104-03-01
DR   BioSamples; SAMEA104616137
DR   EBiSC; STBCi107-A
DR   ECACC; 66540927
DR   hPSCreg; STBCi107-A
DR   Wikidata; Q54970249
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540927; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi108-A
AC   CVCL_RD78
SY   SFC110-03-01
DR   BioSamples; SAMEA104616139
DR   EBiSC; STBCi108-A
DR   ECACC; 66540928
DR   hPSCreg; STBCi108-A
DR   Wikidata; Q54970251
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540928; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi109-A
AC   CVCL_RD79
SY   SFC113-03-01
DR   BioSamples; SAMEA104616141
DR   EBiSC; STBCi109-A
DR   ECACC; 66540929
DR   hPSCreg; STBCi109-A
DR   Wikidata; Q54970252
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540929; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi110-A
AC   CVCL_RD80
SY   SFC116-03-01
DR   BioSamples; SAMEA104616143
DR   EBiSC; STBCi110-A
DR   ECACC; 66540930
DR   hPSCreg; STBCi110-A
DR   Wikidata; Q54970253
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204C>T); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=STBCi110-A).
CC   Discontinued: ECACC; 66540930; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C174215; Age-related macular degeneration-4
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT97 ! UNEWi026-A
OI   CVCL_IT98 ! UNEWi026-B
OI   CVCL_IT99 ! UNEWi026-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   STBCi111-A
AC   CVCL_RD81
SY   SFC131-03-01
DR   BioSamples; SAMEA104616144
DR   EBiSC; STBCi111-A
DR   ECACC; 66540931
DR   hPSCreg; STBCi111-A
DR   Wikidata; Q54970254
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540931; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi112-A
AC   CVCL_RD82
SY   SFC177-03-01
DR   BioSamples; SAMEA104616146
DR   EBiSC; STBCi112-A
DR   ECACC; 66540932
DR   hPSCreg; STBCi112-A
DR   Wikidata; Q54970255
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540932; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi113-A
AC   CVCL_RD83
SY   SFC178-03-01
DR   BioSamples; SAMEA104616148
DR   EBiSC; STBCi113-A
DR   ECACC; 66540933
DR   hPSCreg; STBCi113-A
DR   Wikidata; Q54970256
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540933; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi114-A
AC   CVCL_RD84
SY   SFC034-03-01
DR   BioSamples; SAMEA104616151
DR   EBiSC; STBCi114-A
DR   ECACC; 66540934
DR   hPSCreg; STBCi114-A
DR   Wikidata; Q54970257
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540934; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi115-A
AC   CVCL_RD85
SY   SFC162-03-01
DR   BioSamples; SAMEA104616153
DR   EBiSC; STBCi115-A
DR   ECACC; 66540935
DR   hPSCreg; STBCi115-A
DR   Wikidata; Q54970258
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540935; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi116-A
AC   CVCL_RD86
SY   SFC164-03-01
DR   BioSamples; SAMEA104616155
DR   EBiSC; STBCi116-A
DR   ECACC; 66540936
DR   hPSCreg; STBCi116-A
DR   Wikidata; Q54970259
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540936; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi117-A
AC   CVCL_RD87
SY   SFC246-03-01
DR   BioSamples; SAMEA104616157
DR   EBiSC; STBCi117-A
DR   ECACC; 66540937
DR   hPSCreg; STBCi117-A
DR   Wikidata; Q54970260
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540937; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi118-A
AC   CVCL_RD88
SY   SFC037-03-01
DR   BioSamples; SAMEA104616159
DR   EBiSC; STBCi118-A
DR   ECACC; 66540938
DR   hPSCreg; STBCi118-A
DR   Wikidata; Q54970261
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540938; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi119-A
AC   CVCL_RD89
SY   SFC044-03-01
DR   BioSamples; SAMEA104616161
DR   EBiSC; STBCi119-A
DR   ECACC; 66540939
DR   hPSCreg; STBCi119-A
DR   Wikidata; Q54970262
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540939; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi120-A
AC   CVCL_RD90
SY   SFC046-03-01
DR   BioSamples; SAMEA104616163
DR   EBiSC; STBCi120-A
DR   ECACC; 66540940
DR   hPSCreg; STBCi120-A
DR   Wikidata; Q54970263
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540940; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi121-A
AC   CVCL_RD91
SY   SFC112-03-01
DR   BioSamples; SAMEA104616165
DR   EBiSC; STBCi121-A
DR   ECACC; 66540941
DR   hPSCreg; STBCi121-A
DR   Wikidata; Q54970265
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540941; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi122-A
AC   CVCL_RD92
SY   SFC115-03-01
DR   BioSamples; SAMEA104616167
DR   EBiSC; STBCi122-A
DR   ECACC; 66540942
DR   hPSCreg; STBCi122-A
DR   Wikidata; Q54970266
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540942; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi123-A
AC   CVCL_RD93
SY   SFC053-03-01
DR   BioSamples; SAMEA104616169
DR   EBiSC; STBCi123-A
DR   ECACC; 66540943
DR   hPSCreg; STBCi123-A
DR   Wikidata; Q54970280
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540943; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi124-A
AC   CVCL_RD94
SY   SFC135-03-01
DR   BioSamples; SAMEA104616171
DR   EBiSC; STBCi124-A
DR   ECACC; 66540944
DR   hPSCreg; STBCi124-A
DR   Wikidata; Q54970281
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540944; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi125-A
AC   CVCL_RD95
SY   SFC175-03-01
DR   BioSamples; SAMEA104616173
DR   EBiSC; STBCi125-A
DR   ECACC; 66540945
DR   hPSCreg; STBCi125-A
DR   Wikidata; Q54970282
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540945; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi126-A
AC   CVCL_RD96
SY   SFC105-03-01
DR   BioSamples; SAMEA104616175
DR   EBiSC; STBCi126-A
DR   ECACC; 66540946
DR   hPSCreg; STBCi126-A
DR   Wikidata; Q54970283
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540946; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi127-A
AC   CVCL_RD97
SY   SFC107-03-01
DR   BioSamples; SAMEA104616177
DR   EBiSC; STBCi127-A
DR   ECACC; 66540947
DR   hPSCreg; STBCi127-A
DR   Wikidata; Q54970284
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540947; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi128-A
AC   CVCL_RD98
SY   SFC108-03-01
DR   BioSamples; SAMEA104616179
DR   EBiSC; STBCi128-A
DR   ECACC; 66540948
DR   hPSCreg; STBCi128-A
DR   Wikidata; Q54970285
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540948; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi129-A
AC   CVCL_RD99
SY   SFC137-03-01
DR   BioSamples; SAMEA104616181
DR   EBiSC; STBCi129-A
DR   ECACC; 66540949
DR   hPSCreg; STBCi129-A
DR   Wikidata; Q54970286
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540949; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi130-A
AC   CVCL_RE00
SY   SFC172-03-01
DR   BioSamples; SAMEA104616183
DR   EBiSC; STBCi130-A
DR   ECACC; 66540950
DR   hPSCreg; STBCi130-A
DR   Wikidata; Q54970287
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540950; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi131-A
AC   CVCL_RE01
SY   SFC295-03-01
DR   BioSamples; SAMEA104616185
DR   EBiSC; STBCi131-A
DR   ECACC; 66540951
DR   hPSCreg; STBCi131-A
DR   Wikidata; Q54970289
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540951; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi132-A
AC   CVCL_RE02
SY   SFC301-01-01
DR   BioSamples; SAMEA104616187
DR   EBiSC; STBCi132-A
DR   ECACC; 66540952
DR   hPSCreg; STBCi132-A
DR   Wikidata; Q54970291
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540952; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi133-A
AC   CVCL_RE03
SY   SFC302-01-01
DR   BioSamples; SAMEA104616189
DR   EBiSC; STBCi133-A
DR   ECACC; 66540953
DR   hPSCreg; STBCi133-A
DR   Wikidata; Q54970292
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540953; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi134-A
AC   CVCL_RE04
SY   SFC019-03-01
DR   BioSamples; SAMEA104616192
DR   EBiSC; STBCi134-A
DR   ECACC; 66540954
DR   hPSCreg; STBCi134-A
DR   Wikidata; Q54970293
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi134-A; true.
CC   Discontinued: ECACC; 66540954; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi135-A
AC   CVCL_RE05
SY   SFC033-03-01
DR   BioSamples; SAMEA104616194
DR   EBiSC; STBCi135-A
DR   ECACC; 66540955
DR   hPSCreg; STBCi135-A
DR   Wikidata; Q54970294
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi135-A; true.
CC   Discontinued: ECACC; 66540955; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi136-A
AC   CVCL_RE06
SY   SFC036-03-01
DR   BioSamples; SAMEA104616196
DR   EBiSC; STBCi136-A
DR   ECACC; 66540956
DR   hPSCreg; STBCi136-A
DR   Wikidata; Q54970295
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi136-A; true.
CC   Discontinued: ECACC; 66540956; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi137-A
AC   CVCL_RE07
SY   SFC076-03-01
DR   BioSamples; SAMEA104616198
DR   EBiSC; STBCi137-A
DR   ECACC; 66540957
DR   hPSCreg; STBCi137-A
DR   Wikidata; Q54970296
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540957; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi138-A
AC   CVCL_RE08
SY   SFC079-03-01
DR   BioSamples; SAMEA104616200
DR   EBiSC; STBCi138-A
DR   ECACC; 66540958
DR   hPSCreg; STBCi138-A
DR   Wikidata; Q54970297
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540958; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi139-A
AC   CVCL_RE09
SY   SFC101-03-01
DR   BioSamples; SAMEA104616202
DR   EBiSC; STBCi139-A
DR   ECACC; 66540959
DR   hPSCreg; STBCi139-A
DR   Wikidata; Q54970298
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540959; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi140-A
AC   CVCL_RE10
SY   SFC102-03-01
DR   BioSamples; SAMEA104616204
DR   EBiSC; STBCi140-A
DR   ECACC; 66540960
DR   hPSCreg; STBCi140-A
DR   Wikidata; Q54970299
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi140-A; true.
CC   Discontinued: ECACC; 66540960; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi141-A
AC   CVCL_RE11
SY   SFC103-03-01
DR   BioSamples; SAMEA104616206
DR   EBiSC; STBCi141-A
DR   ECACC; 66540961
DR   hPSCreg; STBCi141-A
DR   Wikidata; Q54970300
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540961; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi142-A
AC   CVCL_RE12
SY   SFC118-03-01
DR   BioSamples; SAMEA104616208
DR   EBiSC; STBCi142-A
DR   ECACC; 66540962
DR   hPSCreg; STBCi142-A
DR   Wikidata; Q54970301
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi142-A; true.
CC   Discontinued: ECACC; 66540962; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi143-A
AC   CVCL_RE13
SY   SFC122-03-01
DR   BioSamples; SAMEA104616210
DR   EBiSC; STBCi143-A
DR   ECACC; 66540963
DR   hPSCreg; STBCi143-A
DR   Wikidata; Q54970303
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi143-A; true.
CC   Discontinued: ECACC; 66540963; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi144-A
AC   CVCL_RE14
SY   SFC123-03-01
DR   BioSamples; SAMEA104616212
DR   EBiSC; STBCi144-A
DR   ECACC; 66540964
DR   hPSCreg; STBCi144-A
DR   Wikidata; Q54970304
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi144-A; true.
CC   Discontinued: ECACC; 66540964; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi145-A
AC   CVCL_RE15
SY   SFC125-03-01
DR   BioSamples; SAMEA104616214
DR   EBiSC; STBCi145-A
DR   ECACC; 66540965
DR   hPSCreg; STBCi145-A
DR   Wikidata; Q54970305
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi145-A; true.
CC   Discontinued: ECACC; 66540965; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi146-A
AC   CVCL_RE16
SY   SFC127-03-01
DR   BioSamples; SAMEA104616216
DR   EBiSC; STBCi146-A
DR   ECACC; 66540966
DR   hPSCreg; STBCi146-A
DR   Wikidata; Q54970306
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi146-A; true.
CC   Discontinued: ECACC; 66540966; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi147-A
AC   CVCL_RE17
SY   SFC128-03-01
DR   BioSamples; SAMEA104616218
DR   EBiSC; STBCi147-A
DR   ECACC; 66540967
DR   hPSCreg; STBCi147-A
DR   Wikidata; Q54970308
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi147-A; true.
CC   Discontinued: ECACC; 66540967; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi148-A
AC   CVCL_RE18
SY   SFC130-03-01
DR   BioSamples; SAMEA104616220
DR   EBiSC; STBCi148-A
DR   ECACC; 66540968
DR   hPSCreg; STBCi148-A
DR   Wikidata; Q54970309
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi148-A; true.
CC   Discontinued: ECACC; 66540968; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi149-A
AC   CVCL_RE19
SY   SFC132-03-01
DR   BioSamples; SAMEA104616222
DR   EBiSC; STBCi149-A
DR   ECACC; 66540969
DR   hPSCreg; STBCi149-A
DR   Wikidata; Q54970310
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi149-A; true.
CC   Discontinued: ECACC; 66540969; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi150-A
AC   CVCL_RE20
SY   SFC133-03-01
DR   BioSamples; SAMEA104616224
DR   EBiSC; STBCi150-A
DR   ECACC; 66540970
DR   hPSCreg; STBCi150-A
DR   Wikidata; Q54970311
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi150-A; true.
CC   Discontinued: ECACC; 66540970; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi151-A
AC   CVCL_RE21
SY   SFC145-03-01
DR   BioSamples; SAMEA104616226
DR   EBiSC; STBCi151-A
DR   ECACC; 66540971
DR   hPSCreg; STBCi151-A
DR   Wikidata; Q54970312
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi151-A; true.
CC   Discontinued: ECACC; 66540971; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi152-A
AC   CVCL_RE22
SY   SFC146-03-01
DR   BioSamples; SAMEA104616228
DR   EBiSC; STBCi152-A
DR   ECACC; 66540972
DR   hPSCreg; STBCi152-A
DR   Wikidata; Q54970313
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi152-A; true.
CC   Discontinued: ECACC; 66540972; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi153-A
AC   CVCL_RE23
SY   SFC147-03-01
DR   BioSamples; SAMEA104616230
DR   EBiSC; STBCi153-A
DR   ECACC; 66540973
DR   hPSCreg; STBCi153-A
DR   Wikidata; Q54970314
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi153-A; true.
CC   Discontinued: ECACC; 66540973; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi154-A
AC   CVCL_RE24
SY   SFC148-03-01
DR   BioSamples; SAMEA104616232
DR   EBiSC; STBCi154-A
DR   ECACC; 66540974
DR   hPSCreg; STBCi154-A
DR   Wikidata; Q54970315
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi154-A; true.
CC   Discontinued: ECACC; 66540974; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi155-A
AC   CVCL_RE25
SY   SFC149-03-01
DR   BioSamples; SAMEA104616234
DR   EBiSC; STBCi155-A
DR   ECACC; 66540975
DR   hPSCreg; STBCi155-A
DR   Wikidata; Q54970316
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi155-A; true.
CC   Discontinued: ECACC; 66540975; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi156-A
AC   CVCL_RE26
SY   SFC150-03-01
DR   BioSamples; SAMEA104616236
DR   EBiSC; STBCi156-A
DR   ECACC; 66540976
DR   hPSCreg; STBCi156-A
DR   Wikidata; Q54970318
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540976; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi157-A
AC   CVCL_RE27
SY   SFC154-03-01
DR   BioSamples; SAMEA104616238
DR   EBiSC; STBCi157-A
DR   ECACC; 66540977
DR   hPSCreg; STBCi157-A
DR   Wikidata; Q54970319
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi157-A; true.
CC   Discontinued: ECACC; 66540977; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi158-A
AC   CVCL_RE28
SY   SFC155-03-01
DR   BioSamples; SAMEA104616240
DR   EBiSC; STBCi158-A
DR   ECACC; 66540978
DR   hPSCreg; STBCi158-A
DR   Wikidata; Q54970320
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi158-A; true.
CC   Discontinued: ECACC; 66540978; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi159-A
AC   CVCL_RE29
SY   SFC158-03-01
DR   BioSamples; SAMEA104616242
DR   EBiSC; STBCi159-A
DR   ECACC; 66540979
DR   hPSCreg; STBCi159-A
DR   Wikidata; Q54970321
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi159-A; true.
CC   Discontinued: ECACC; 66540979; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi160-A
AC   CVCL_RE30
SY   SFC159-03-01
DR   BioSamples; SAMEA104616244
DR   EBiSC; STBCi160-A
DR   ECACC; 66540980
DR   hPSCreg; STBCi160-A
DR   Wikidata; Q54970322
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540980; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi161-A
AC   CVCL_RE31
SY   SFC160-03-01
DR   BioSamples; SAMEA104616246
DR   EBiSC; STBCi161-A
DR   ECACC; 66540981
DR   hPSCreg; STBCi161-A
DR   Wikidata; Q54970324
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540981; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi162-A
AC   CVCL_RE32
SY   SFC161-03-01
DR   BioSamples; SAMEA104616248
DR   EBiSC; STBCi162-A
DR   ECACC; 66540982
DR   hPSCreg; STBCi162-A
DR   Wikidata; Q54970325
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540982; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi163-A
AC   CVCL_RE33
SY   SFC165-03-01
DR   BioSamples; SAMEA104616250
DR   EBiSC; STBCi163-A
DR   ECACC; 66540983
DR   hPSCreg; STBCi163-A
DR   Wikidata; Q54970341
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540983; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi164-A
AC   CVCL_RE34
SY   SFC166-03-01
DR   BioSamples; SAMEA104616252
DR   EBiSC; STBCi164-A
DR   ECACC; 66540984
DR   hPSCreg; STBCi164-A
DR   Wikidata; Q54970342
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540984; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi165-A
AC   CVCL_RE35
SY   SFC168-03-01
DR   BioSamples; SAMEA104616254
DR   EBiSC; STBCi165-A
DR   ECACC; 66540985
DR   hPSCreg; STBCi165-A
DR   Wikidata; Q54970343
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi165-A; true.
CC   Discontinued: ECACC; 66540985; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi166-A
AC   CVCL_RE36
SY   SFC169-03-01
DR   BioSamples; SAMEA104616256
DR   EBiSC; STBCi166-A
DR   ECACC; 66540986
DR   hPSCreg; STBCi166-A
DR   Wikidata; Q54970345
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi166-A; true.
CC   Discontinued: ECACC; 66540986; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi167-A
AC   CVCL_RE37
SY   SFC174-03-01
DR   BioSamples; SAMEA104616258
DR   EBiSC; STBCi167-A
DR   ECACC; 66540987
DR   hPSCreg; STBCi167-A
DR   Wikidata; Q54970346
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540987; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi168-A
AC   CVCL_RE38
SY   SFC176-03-01
DR   BioSamples; SAMEA104616260
DR   EBiSC; STBCi168-A
DR   ECACC; 66540988
DR   hPSCreg; STBCi168-A
DR   Wikidata; Q54970347
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi168-A; true.
CC   Discontinued: ECACC; 66540988; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi169-A
AC   CVCL_RE39
SY   SFC179-03-01
DR   BioSamples; SAMEA104616262
DR   EBiSC; STBCi169-A
DR   ECACC; 66540989
DR   hPSCreg; STBCi169-A
DR   Wikidata; Q54970349
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540989; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi170-A
AC   CVCL_RE40
SY   SFC190-03-01
DR   BioSamples; SAMEA104616264
DR   EBiSC; STBCi170-A
DR   ECACC; 66540990
DR   hPSCreg; STBCi170-A
DR   Wikidata; Q54970350
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi170-A; true.
CC   Discontinued: ECACC; 66540990; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi171-A
AC   CVCL_RE41
SY   SFC191-03-01
DR   BioSamples; SAMEA104616266
DR   EBiSC; STBCi171-A
DR   ECACC; 66540991
DR   hPSCreg; STBCi171-A
DR   Wikidata; Q54970351
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi171-A; true.
CC   Discontinued: ECACC; 66540991; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi172-A
AC   CVCL_RE42
SY   SFC192-03-01
DR   BioSamples; SAMEA104616268
DR   EBiSC; STBCi172-A
DR   ECACC; 66540992
DR   hPSCreg; STBCi172-A
DR   Wikidata; Q54970352
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi172-A; true.
CC   Discontinued: ECACC; 66540992; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi173-A
AC   CVCL_RE43
SY   SFC193-03-01
DR   BioSamples; SAMEA104616270
DR   EBiSC; STBCi173-A
DR   ECACC; 66540993
DR   hPSCreg; STBCi173-A
DR   Wikidata; Q54970353
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi173-A; true.
CC   Discontinued: ECACC; 66540993; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi174-A
AC   CVCL_RE44
SY   SFC194-03-01
DR   BioSamples; SAMEA104616272
DR   EBiSC; STBCi174-A
DR   ECACC; 66540994
DR   hPSCreg; STBCi174-A
DR   Wikidata; Q54970354
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540994; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi175-A
AC   CVCL_RE45
SY   SFC195-03-01
DR   BioSamples; SAMEA104616274
DR   EBiSC; STBCi175-A
DR   ECACC; 66540995
DR   hPSCreg; STBCi175-A
DR   Wikidata; Q54970356
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540995; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi176-A
AC   CVCL_RE46
SY   SFC196-03-01
DR   BioSamples; SAMEA104616276
DR   EBiSC; STBCi176-A
DR   ECACC; 66540996
DR   hPSCreg; STBCi176-A
DR   Wikidata; Q54970357
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi176-A; true.
CC   Discontinued: ECACC; 66540996; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi177-A
AC   CVCL_RE47
SY   SFC197-03-01
DR   BioSamples; SAMEA104616278
DR   EBiSC; STBCi177-A
DR   ECACC; 66540997
DR   hPSCreg; STBCi177-A
DR   Wikidata; Q54970358
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540997; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi178-A
AC   CVCL_RE48
SY   SFC198-03-01
DR   BioSamples; SAMEA104616280
DR   EBiSC; STBCi178-A
DR   ECACC; 66540998
DR   hPSCreg; STBCi178-A
DR   Wikidata; Q54970359
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi178-A; true.
CC   Discontinued: ECACC; 66540998; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi179-A
AC   CVCL_RE49
SY   SFC243-03-01
DR   BioSamples; SAMEA104616282
DR   EBiSC; STBCi179-A
DR   ECACC; 66540999
DR   hPSCreg; STBCi179-A
DR   Wikidata; Q54970360
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66540999; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi180-A
AC   CVCL_RE50
SY   SFC242-03-07
DR   BioSamples; SAMEA104616284
DR   EBiSC; STBCi180-A
DR   ECACC; 66541000
DR   hPSCreg; STBCi180-A
DR   Wikidata; Q54970361
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541000; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi181-A
AC   CVCL_RE51
SY   SFC247-03-01
DR   BioSamples; SAMEA104616286
DR   EBiSC; STBCi181-A
DR   ECACC; 66541001
DR   hPSCreg; STBCi181-A
DR   Wikidata; Q54970362
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541001; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi182-A
AC   CVCL_RE52
SY   SFC248-03-01
DR   BioSamples; SAMEA104616288
DR   EBiSC; STBCi182-A
DR   ECACC; 66541002
DR   hPSCreg; STBCi182-A
DR   Wikidata; Q54970363
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541002; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi183-A
AC   CVCL_RE53
SY   SFC250-03-01
DR   BioSamples; SAMEA104616290
DR   EBiSC; STBCi183-A
DR   ECACC; 66541003
DR   hPSCreg; STBCi183-A
DR   Wikidata; Q54970365
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541003; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi184-A
AC   CVCL_RE54
SY   SFC251-03-01
DR   BioSamples; SAMEA104616292
DR   EBiSC; STBCi184-A
DR   ECACC; 66541004
DR   hPSCreg; STBCi184-A
DR   Wikidata; Q54970366
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541004; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi185-A
AC   CVCL_RE55
SY   SFC253-03-01
DR   BioSamples; SAMEA104616294
DR   EBiSC; STBCi185-A
DR   ECACC; 66541005
DR   hPSCreg; STBCi185-A
DR   Wikidata; Q54970367
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi185-A; true.
CC   Discontinued: ECACC; 66541005; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi186-A
AC   CVCL_RE56
SY   SFC255-03-01
DR   BioSamples; SAMEA104616296
DR   EBiSC; STBCi186-A
DR   ECACC; 66541006
DR   hPSCreg; STBCi186-A
DR   Wikidata; Q54970369
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541006; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi187-A
AC   CVCL_RE57
SY   SFC256-03-01
DR   BioSamples; SAMEA104616298
DR   EBiSC; STBCi187-A
DR   ECACC; 66541007
DR   hPSCreg; STBCi187-A
DR   Wikidata; Q54970371
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541007; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi188-A
AC   CVCL_RE58
SY   SFC257-04-01
DR   BioSamples; SAMEA104616300
DR   EBiSC; STBCi188-A
DR   ECACC; 66541008
DR   hPSCreg; STBCi188-A
DR   Wikidata; Q54970372
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi188-A; true.
CC   Discontinued: ECACC; 66541008; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi189-A
AC   CVCL_RE59
SY   SFC258-04-01
DR   BioSamples; SAMEA104616302
DR   EBiSC; STBCi189-A
DR   ECACC; 66541009
DR   hPSCreg; STBCi189-A
DR   Wikidata; Q54970373
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi189-A; true.
CC   Discontinued: ECACC; 66541009; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi190-A
AC   CVCL_RE60
SY   SFC259-03-01
DR   BioSamples; SAMEA104616304
DR   EBiSC; STBCi190-A
DR   ECACC; 66541010
DR   hPSCreg; STBCi190-A
DR   Wikidata; Q54970375
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi190-A; true.
CC   Discontinued: ECACC; 66541010; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi191-A
AC   CVCL_RE61
SY   SFC260-03-01
DR   BioSamples; SAMEA104616306
DR   EBiSC; STBCi191-A
DR   ECACC; 66541011
DR   hPSCreg; STBCi191-A
DR   Wikidata; Q54970376
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541011; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi192-A
AC   CVCL_RE62
SY   SFC261-03-01
DR   BioSamples; SAMEA104616308
DR   EBiSC; STBCi192-A
DR   ECACC; 66541012
DR   hPSCreg; STBCi192-A
DR   Wikidata; Q54970377
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi192-A; true.
CC   Discontinued: ECACC; 66541012; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi193-A
AC   CVCL_RE63
SY   SFC262-03-01
DR   BioSamples; SAMEA104616310
DR   EBiSC; STBCi193-A
DR   ECACC; 66541013
DR   hPSCreg; STBCi193-A
DR   Wikidata; Q54970378
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541013; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi194-A
AC   CVCL_RE64
SY   SFC263-03-01
DR   BioSamples; SAMEA104616312
DR   EBiSC; STBCi194-A
DR   ECACC; 66541014
DR   hPSCreg; STBCi194-A
DR   Wikidata; Q54970379
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541014; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi195-A
AC   CVCL_RE65
SY   SFC286-03-01
DR   BioSamples; SAMEA104616314
DR   EBiSC; STBCi195-A
DR   ECACC; 66541015
DR   hPSCreg; STBCi195-A
DR   Wikidata; Q54970380
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541015; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi196-A
AC   CVCL_RE66
SY   SFC287-03-01
DR   BioSamples; SAMEA104616316
DR   EBiSC; STBCi196-A
DR   ECACC; 66541016
DR   hPSCreg; STBCi196-A
DR   Wikidata; Q54970383
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi196-A; true.
CC   Discontinued: ECACC; 66541016; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi197-A
AC   CVCL_RE67
SY   SFC288-03-01
DR   BioSamples; SAMEA104616318
DR   EBiSC; STBCi197-A
DR   ECACC; 66541017
DR   hPSCreg; STBCi197-A
DR   Wikidata; Q54970384
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi197-A; true.
CC   Discontinued: ECACC; 66541017; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi198-A
AC   CVCL_RE68
SY   SFC289-03-01
DR   BioSamples; SAMEA104616320
DR   EBiSC; STBCi198-A
DR   ECACC; 66541018
DR   hPSCreg; STBCi198-A
DR   Wikidata; Q54970385
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi198-A; true.
CC   Discontinued: ECACC; 66541018; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi199-A
AC   CVCL_RE69
SY   SFC290-04-01
DR   BioSamples; SAMEA104616322
DR   EBiSC; STBCi199-A
DR   ECACC; 66541019
DR   hPSCreg; STBCi199-A
DR   Wikidata; Q54970386
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi199-A; true.
CC   Discontinued: ECACC; 66541019; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi200-A
AC   CVCL_RE70
SY   SFC291-03-01
DR   BioSamples; SAMEA104616324
DR   EBiSC; STBCi200-A
DR   ECACC; 66541020
DR   hPSCreg; STBCi200-A
DR   Wikidata; Q54970387
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi200-A; true.
CC   Discontinued: ECACC; 66541020; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi201-A
AC   CVCL_RE71
SY   SFC292-03-02
DR   BioSamples; SAMEA104616326
DR   EBiSC; STBCi201-A
DR   ECACC; 66541021
DR   hPSCreg; STBCi201-A
DR   Wikidata; Q54970388
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541021; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi202-A
AC   CVCL_RE72
SY   SFC293-03-01
DR   BioSamples; SAMEA104616328
DR   EBiSC; STBCi202-A
DR   ECACC; 66541022
DR   hPSCreg; STBCi202-A
DR   Wikidata; Q54970389
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541022; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi203-A
AC   CVCL_RE73
SY   SFC296-03-01
DR   BioSamples; SAMEA104616330
DR   EBiSC; STBCi203-A
DR   ECACC; 66541023
DR   hPSCreg; STBCi203-A
DR   Wikidata; Q54970400
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541023; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi204-A
AC   CVCL_RE74
SY   SFC297-03-01
DR   BioSamples; SAMEA104616332
DR   EBiSC; STBCi204-A
DR   ECACC; 66541024
DR   hPSCreg; STBCi204-A
DR   Wikidata; Q54970401
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541024; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi205-A
AC   CVCL_RE75
SY   SFC298-03-01
DR   BioSamples; SAMEA104616334
DR   EBiSC; STBCi205-A
DR   ECACC; 66541025
DR   hPSCreg; STBCi205-A
DR   Wikidata; Q54970402
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi205-A; true.
CC   Discontinued: ECACC; 66541025; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi206-A
AC   CVCL_RE76
SY   SFC299-03-01
DR   BioSamples; SAMEA104616336
DR   EBiSC; STBCi206-A
DR   ECACC; 66541026
DR   hPSCreg; STBCi206-A
DR   Wikidata; Q54970403
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi206-A; true.
CC   Discontinued: ECACC; 66541026; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi207-A
AC   CVCL_RE77
SY   SFC300-03-01
DR   BioSamples; SAMEA104616338
DR   EBiSC; STBCi207-A
DR   ECACC; 66541027
DR   hPSCreg; STBCi207-A
DR   Wikidata; Q54970404
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541027; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi208-A
AC   CVCL_RE78
SY   SFC303-04-01
DR   BioSamples; SAMEA104616340
DR   EBiSC; STBCi208-A
DR   ECACC; 66541028
DR   hPSCreg; STBCi208-A
DR   Wikidata; Q54970405
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi208-A; true.
CC   Discontinued: ECACC; 66541028; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi209-A
AC   CVCL_RE79
SY   SFC304-04-01
DR   BioSamples; SAMEA104616342
DR   EBiSC; STBCi209-A
DR   ECACC; 66541029
DR   hPSCreg; STBCi209-A
DR   Wikidata; Q54970406
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi209-A; true.
CC   Discontinued: ECACC; 66541029; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi210-A
AC   CVCL_RE80
SY   SFC305-03-01
DR   BioSamples; SAMEA104616344
DR   EBiSC; STBCi210-A
DR   ECACC; 66541030
DR   hPSCreg; STBCi210-A
DR   Wikidata; Q54970407
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541030; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi211-A
AC   CVCL_RE81
SY   SFC306-04-01
DR   BioSamples; SAMEA104616346
DR   EBiSC; STBCi211-A
DR   ECACC; 66541031
DR   hPSCreg; STBCi211-A
DR   Wikidata; Q54970408
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi211-A; true.
CC   Discontinued: ECACC; 66541031; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi212-A
AC   CVCL_RE82
SY   SFC312-03-01
DR   BioSamples; SAMEA104616348
DR   EBiSC; STBCi212-A
DR   ECACC; 66541032
DR   hPSCreg; STBCi212-A
DR   Wikidata; Q54970410
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi212-A; true.
CC   Discontinued: ECACC; 66541032; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi213-A
AC   CVCL_RE83
SY   SFC313-03-01
DR   BioSamples; SAMEA104616350
DR   EBiSC; STBCi213-A
DR   ECACC; 66541033
DR   hPSCreg; STBCi213-A
DR   Wikidata; Q54970411
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi213-A; true.
CC   Discontinued: ECACC; 66541033; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi214-A
AC   CVCL_RE84
SY   SFC314-03-01
DR   BioSamples; SAMEA104616352
DR   EBiSC; STBCi214-A
DR   ECACC; 66541034
DR   hPSCreg; STBCi214-A
DR   Wikidata; Q54970412
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi214-A; true.
CC   Discontinued: ECACC; 66541034; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi215-A
AC   CVCL_RE85
SY   SFC318-03-01
DR   BioSamples; SAMEA104616354
DR   EBiSC; STBCi215-A
DR   ECACC; 66541035
DR   hPSCreg; STBCi215-A
DR   Wikidata; Q54970413
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi215-A; true.
CC   Discontinued: ECACC; 66541035; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi216-A
AC   CVCL_RE86
SY   SFC319-03-01
DR   BioSamples; SAMEA104616356
DR   EBiSC; STBCi216-A
DR   ECACC; 66541036
DR   hPSCreg; STBCi216-A
DR   Wikidata; Q54970414
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi216-A; true.
CC   Discontinued: ECACC; 66541036; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi217-A
AC   CVCL_RE87
SY   SFC320-03-01
DR   BioSamples; SAMEA104616358
DR   EBiSC; STBCi217-A
DR   ECACC; 66541037
DR   hPSCreg; STBCi217-A
DR   Wikidata; Q54970415
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi217-A; true.
CC   Discontinued: ECACC; 66541037; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi218-A
AC   CVCL_RE88
SY   SFC357-03-01
DR   BioSamples; SAMEA104616360
DR   EBiSC; STBCi218-A
DR   ECACC; 66541038
DR   hPSCreg; STBCi218-A
DR   Wikidata; Q54970416
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi218-A; true.
CC   Discontinued: ECACC; 66541038; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi219-A
AC   CVCL_RE89
SY   SFC358-03-01
DR   BioSamples; SAMEA104616362
DR   EBiSC; STBCi219-A
DR   ECACC; 66541039
DR   hPSCreg; STBCi219-A
DR   Wikidata; Q54970417
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541039; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi220-A
AC   CVCL_RE90
SY   SFC359-03-01
DR   BioSamples; SAMEA104616364
DR   EBiSC; STBCi220-A
DR   ECACC; 66541040
DR   hPSCreg; STBCi220-A
DR   Wikidata; Q54970418
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi220-A; true.
CC   Discontinued: ECACC; 66541040; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi221-A
AC   CVCL_RE91
SY   SFC360-03-01
DR   BioSamples; SAMEA104616366
DR   EBiSC; STBCi221-A
DR   ECACC; 66541041
DR   hPSCreg; STBCi221-A
DR   Wikidata; Q54970419
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi221-A; true.
CC   Discontinued: ECACC; 66541041; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi222-A
AC   CVCL_RE92
SY   SFC361-03-01
DR   BioSamples; SAMEA104616368
DR   EBiSC; STBCi222-A
DR   ECACC; 66541042
DR   hPSCreg; STBCi222-A
DR   Wikidata; Q54970420
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi222-A; true.
CC   Discontinued: ECACC; 66541042; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi223-A
AC   CVCL_RE93
SY   SFC363-04-01
DR   BioSamples; SAMEA104616370
DR   EBiSC; STBCi223-A
DR   ECACC; 66541043
DR   hPSCreg; STBCi223-A
DR   Wikidata; Q54970423
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541043; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi224-A
AC   CVCL_RE94
SY   SFC364-03-01
DR   BioSamples; SAMEA104616372
DR   EBiSC; STBCi224-A
DR   ECACC; 66541044
DR   hPSCreg; STBCi224-A
DR   Wikidata; Q54970424
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541044; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi225-A
AC   CVCL_RE95
SY   SFC365-03-01
DR   BioSamples; SAMEA104616374
DR   EBiSC; STBCi225-A
DR   ECACC; 66541045
DR   hPSCreg; STBCi225-A
DR   Wikidata; Q54970426
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541045; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi226-A
AC   CVCL_RE96
SY   SFC366-03-01
DR   BioSamples; SAMEA104616376
DR   EBiSC; STBCi226-A
DR   ECACC; 66541046
DR   hPSCreg; STBCi226-A
DR   Wikidata; Q54970427
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541046; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi227-A
AC   CVCL_RE97
SY   SFC367-03-01
DR   BioSamples; SAMEA104616378
DR   EBiSC; STBCi227-A
DR   ECACC; 66541047
DR   hPSCreg; STBCi227-A
DR   Wikidata; Q54970428
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541047; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi228-A
AC   CVCL_RE98
SY   SFC368-03-01
DR   BioSamples; SAMEA104616380
DR   EBiSC; STBCi228-A
DR   ECACC; 66541048
DR   hPSCreg; STBCi228-A
DR   Wikidata; Q54970429
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541048; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi229-A
AC   CVCL_RE99
SY   SFC369-03-01
DR   BioSamples; SAMEA104616382
DR   EBiSC; STBCi229-A
DR   ECACC; 66541049
DR   hPSCreg; STBCi229-A
DR   Wikidata; Q54970430
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi229-A; true.
CC   Discontinued: ECACC; 66541049; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi230-A
AC   CVCL_RF00
SY   SFC372-03-01
DR   BioSamples; SAMEA104616384
DR   EBiSC; STBCi230-A
DR   ECACC; 66541050
DR   hPSCreg; STBCi230-A
DR   Wikidata; Q54970431
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541050; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi231-A
AC   CVCL_RF01
SY   SFC374-03-01
DR   BioSamples; SAMEA104616386
DR   EBiSC; STBCi231-A
DR   ECACC; 66541051
DR   hPSCreg; STBCi231-A
DR   Wikidata; Q54970432
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541051; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi232-A
AC   CVCL_RF02
SY   SFC375-03-01
DR   BioSamples; SAMEA104616388
DR   EBiSC; STBCi232-A
DR   ECACC; 66541052
DR   hPSCreg; STBCi232-A
DR   Wikidata; Q54970433
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541052; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4731; Neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi233-A
AC   CVCL_RF03
SY   SFC873-03-01
DR   BioSamples; SAMEA104616390
DR   EBiSC; STBCi233-A
DR   ECACC; 66541053
DR   hPSCreg; STBCi233-A
DR   Wikidata; Q54970434
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi233-A; true.
CC   Discontinued: ECACC; 66541053; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi234-A
AC   CVCL_RF04
SY   SFC874-03-01
DR   BioSamples; SAMEA104616392
DR   EBiSC; STBCi234-A
DR   ECACC; 66541054
DR   hPSCreg; STBCi234-A
DR   Wikidata; Q54970435
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541054; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi235-A
AC   CVCL_RF05
SY   SFC879-03-01
DR   BioSamples; SAMEA104616394
DR   EBiSC; STBCi235-A
DR   ECACC; 66541055
DR   hPSCreg; STBCi235-A
DR   Wikidata; Q54970436
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541055; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi236-A
AC   CVCL_RF06
SY   SFC880-03-01
DR   BioSamples; SAMEA104616396
DR   EBiSC; STBCi236-A
DR   ECACC; 66541056
DR   hPSCreg; STBCi236-A
DR   Wikidata; Q54970437
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541056; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi237-A
AC   CVCL_RF07
SY   SFC881-03-01
DR   BioSamples; SAMEA104616398
DR   EBiSC; STBCi237-A
DR   ECACC; 66541057
DR   hPSCreg; STBCi237-A
DR   Wikidata; Q54970438
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541057; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi238-A
AC   CVCL_RF08
SY   SFC882-03-01
DR   BioSamples; SAMEA104616400
DR   EBiSC; STBCi238-A
DR   ECACC; 66541058
DR   hPSCreg; STBCi238-A
DR   Wikidata; Q54970440
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541058; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi239-A
AC   CVCL_RF09
SY   SFC883-03-01
DR   BioSamples; SAMEA104616402
DR   EBiSC; STBCi239-A
DR   ECACC; 66541059
DR   hPSCreg; STBCi239-A
DR   Wikidata; Q54970441
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi239-A; true.
CC   Discontinued: ECACC; 66541059; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi240-A
AC   CVCL_RF10
SY   SFC884-03-01
DR   BioSamples; SAMEA104616404
DR   EBiSC; STBCi240-A
DR   ECACC; 66541060
DR   hPSCreg; STBCi240-A
DR   Wikidata; Q54970442
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi240-A; true.
CC   Discontinued: ECACC; 66541060; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi241-A
AC   CVCL_RF11
SY   SFC885-03-01
DR   BioSamples; SAMEA104616406
DR   EBiSC; STBCi241-A
DR   ECACC; 66541061
DR   hPSCreg; STBCi241-A
DR   Wikidata; Q54970443
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541061; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi242-A
AC   CVCL_RF12
SY   SFC886-03-01
DR   BioSamples; SAMEA104616408
DR   EBiSC; STBCi242-A
DR   ECACC; 66541062
DR   hPSCreg; STBCi242-A
DR   Wikidata; Q54970444
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi242-A; true.
CC   Discontinued: ECACC; 66541062; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi243-A
AC   CVCL_RF13
SY   SFC991-03-01
DR   BioSamples; SAMEA104616410
DR   EBiSC; STBCi243-A
DR   ECACC; 66541063
DR   hPSCreg; STBCi243-A
DR   Wikidata; Q54970452
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi243-A; true.
CC   Discontinued: ECACC; 66541063; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi244-A
AC   CVCL_RF14
SY   SFC993-03-01
DR   BioSamples; SAMEA104616412
DR   EBiSC; STBCi244-A
DR   ECACC; 66541064
DR   hPSCreg; STBCi244-A
DR   Wikidata; Q54970453
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi244-A; true.
CC   Discontinued: ECACC; 66541064; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi245-A
AC   CVCL_RF15
SY   SFC994-03-01
DR   BioSamples; SAMEA104616414
DR   EBiSC; STBCi245-A
DR   ECACC; 66541065
DR   hPSCreg; STBCi245-A
DR   Wikidata; Q54970454
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi245-A; true.
CC   Discontinued: ECACC; 66541065; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi246-A
AC   CVCL_RF16
SY   SFC995-03-01
DR   BioSamples; SAMEA104616416
DR   EBiSC; STBCi246-A
DR   ECACC; 66541066
DR   hPSCreg; STBCi246-A
DR   Wikidata; Q54970455
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi246-A; true.
CC   Discontinued: ECACC; 66541066; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   STBCi247-A
AC   CVCL_RF17
SY   SFC996-03-01
DR   BioSamples; SAMEA104616418
DR   EBiSC; STBCi247-A
DR   ECACC; 66541067
DR   hPSCreg; STBCi247-A
DR   Wikidata; Q54970456
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi247-A; true.
CC   Discontinued: ECACC; 66541067; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi248-A
AC   CVCL_RF18
SY   SFC999-01-01
DR   BioSamples; SAMEA104618960
DR   EBiSC; STBCi248-A
DR   ECACC; 66541069
DR   hPSCreg; STBCi248-A
DR   Wikidata; Q54970458
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541069; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi249-A
AC   CVCL_RF19
SY   SFC171-03-01
DR   BioSamples; SAMEA104618962
DR   EBiSC; STBCi249-A
DR   ECACC; 66541070
DR   hPSCreg; STBCi249-A
DR   Wikidata; Q54970459
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541070; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi250-A
AC   CVCL_RF20
SY   SFC997-01-01
DR   BioSamples; SAMEA104618964
DR   EBiSC; STBCi250-A
DR   ECACC; 66541071
DR   hPSCreg; STBCi250-A
DR   Wikidata; Q54970460
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541071; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi251-A
AC   CVCL_RF21
SY   SFC998-01-01
DR   BioSamples; SAMEA104618966
DR   EBiSC; STBCi251-A
DR   ECACC; 66541072
DR   hPSCreg; STBCi251-A
DR   Wikidata; Q54970461
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541072; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi252-A
AC   CVCL_RF22
SY   SFC254-03-01
DR   BioSamples; SAMEA104618968
DR   EBiSC; STBCi252-A
DR   ECACC; 66541073
DR   hPSCreg; STBCi252-A
DR   Wikidata; Q54970462
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi252-A; true.
CC   Discontinued: ECACC; 66541073; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi253-A
AC   CVCL_RF23
SY   SFC184-01-04
DR   BioSamples; SAMEA104620632
DR   EBiSC; STBCi253-A
DR   ECACC; 66541079
DR   hPSCreg; STBCi253-A
DR   Wikidata; Q54970465
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541079; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi254-A
AC   CVCL_RF24
SY   SFC143-03-08
DR   BioSamples; SAMEA104620634
DR   EBiSC; STBCi254-A
DR   ECACC; 66541080
DR   hPSCreg; STBCi254-A
DR   Wikidata; Q54970466
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541080; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi255-A
AC   CVCL_RF25
SY   SFC183-01-07
DR   BioSamples; SAMEA104620636
DR   EBiSC; STBCi255-A
DR   ECACC; 66541081
DR   hPSCreg; STBCi255-A
DR   Wikidata; Q54970467
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541081; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi256-A
AC   CVCL_RF26
SY   SFC144-03-02
DR   BioSamples; SAMEA104620638
DR   EBiSC; STBCi256-A
DR   ECACC; 66541082
DR   hPSCreg; STBCi256-A
DR   Wikidata; Q54970469
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541082; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi257-A
AC   CVCL_RF27
SY   SFC185-01-11
DR   BioSamples; SAMEA104620640
DR   EBiSC; STBCi257-A
DR   ECACC; 66541083
DR   hPSCreg; STBCi257-A
DR   Wikidata; Q54970470
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541083; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi258-A
AC   CVCL_RF28
SY   SFC090-03-07
DR   BioSamples; SAMEA104620642
DR   EBiSC; STBCi258-A
DR   ECACC; 66541084
DR   hPSCreg; STBCi258-A
DR   Wikidata; Q54970471
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541084; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi259-A
AC   CVCL_RF29
SY   SFC032-03-07
DR   BioSamples; SAMEA104620644
DR   EBiSC; STBCi259-A
DR   ECACC; 66541085
DR   hPSCreg; STBCi259-A
DR   Wikidata; Q54970472
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541085; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi260-A
AC   CVCL_RF30
SY   SFC279-03-02
DR   BioSamples; SAMEA104620646
DR   EBiSC; STBCi260-A
DR   ECACC; 66541086
DR   hPSCreg; STBCi260-A
DR   Wikidata; Q54970473
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541086; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi261-A
AC   CVCL_RF31
SY   SFC186-01-07
DR   BioSamples; SAMEA104620648
DR   EBiSC; STBCi261-A
DR   ECACC; 66541087
DR   hPSCreg; STBCi261-A
DR   Wikidata; Q54970474
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541087; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi262-A
AC   CVCL_RF32
SY   SFC271-03-06
DR   BioSamples; SAMEA104620650
DR   EBiSC; STBCi262-A
DR   ECACC; 66541088
DR   hPSCreg; STBCi262-A
DR   Wikidata; Q54970475
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541088; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi263-A
AC   CVCL_RF33
SY   SFC268-03-02
DR   BioSamples; SAMEA104620652
DR   EBiSC; STBCi263-A
DR   ECACC; 66541089
DR   hPSCreg; STBCi263-A
DR   Wikidata; Q54970476
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541089; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi264-A
AC   CVCL_RF34
SY   SFC142-03-01
DR   BioSamples; SAMEA104620654
DR   EBiSC; STBCi264-A
DR   ECACC; 66541090
DR   hPSCreg; STBCi264-A
DR   Wikidata; Q54970477
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541090; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi265-A
AC   CVCL_RF35
SY   SFC121-03-02
DR   BioSamples; SAMEA104620656
DR   EBiSC; STBCi265-A
DR   ECACC; 66541091
DR   hPSCreg; STBCi265-A
DR   Wikidata; Q54970480
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541091; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi266-A
AC   CVCL_RF36
SY   SFC072-03-06
DR   BioSamples; SAMEA104620658
DR   EBiSC; STBCi266-A
DR   ECACC; 66541092
DR   hPSCreg; STBCi266-A
DR   Wikidata; Q54970481
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541092; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi267-A
AC   CVCL_RF37
SY   SFC027-03-02
DR   BioSamples; SAMEA104620660
DR   EBiSC; STBCi267-A
DR   ECACC; 66541093
DR   hPSCreg; STBCi267-A
DR   Wikidata; Q54970482
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541093; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi268-A
AC   CVCL_RF38
SY   SFC077-03-04
DR   BioSamples; SAMEA104620662
DR   EBiSC; STBCi268-A
DR   ECACC; 66541094
DR   hPSCreg; STBCi268-A
DR   Wikidata; Q54970483
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541094; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi269-A
AC   CVCL_RF39
SY   BPC943-03-03
DR   BioSamples; SAMEA104620664
DR   EBiSC; STBCi269-A
DR   ECACC; 66541095
DR   hPSCreg; STBCi269-A
DR   Wikidata; Q54970484
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541095; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi270-A
AC   CVCL_RF40
SY   BPC944-03-04
DR   BioSamples; SAMEA104620666
DR   EBiSC; STBCi270-A
DR   ECACC; 66541096
DR   hPSCreg; STBCi270-A
DR   Wikidata; Q54970485
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541096; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi271-A
AC   CVCL_RF41
SY   BPC936-03-07
DR   BioSamples; SAMEA104620668
DR   EBiSC; STBCi271-A
DR   ECACC; 66541097
DR   hPSCreg; STBCi271-A
DR   Wikidata; Q54970486
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541097; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi272-A
AC   CVCL_RF42
SY   BPC930-03-08
DR   BioSamples; SAMEA104620670
DR   EBiSC; STBCi272-A
DR   ECACC; 66541098
DR   hPSCreg; STBCi272-A
DR   Wikidata; Q54970487
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541098; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi273-A
AC   CVCL_RF43
SY   BPC928-03-07
DR   BioSamples; SAMEA104620672
DR   EBiSC; STBCi273-A
DR   ECACC; 66541099
DR   hPSCreg; STBCi273-A
DR   Wikidata; Q54970488
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541099; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi274-A
AC   CVCL_RF44
SY   BPC935-03-05
DR   BioSamples; SAMEA104620674
DR   EBiSC; STBCi274-A
DR   ECACC; 66541100
DR   hPSCreg; STBCi274-A
DR   Wikidata; Q54970489
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541100; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi275-A
AC   CVCL_RF45
SY   BPC937-03-06
DR   BioSamples; SAMEA104620676
DR   EBiSC; STBCi275-A
DR   ECACC; 66541101
DR   hPSCreg; STBCi275-A
DR   Wikidata; Q54970490
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541101; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi276-A
AC   CVCL_RF46
SY   BPC933-03-12
DR   BioSamples; SAMEA104620678
DR   EBiSC; STBCi276-A
DR   ECACC; 66541102
DR   hPSCreg; STBCi276-A
DR   Wikidata; Q54970491
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541102; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi277-A
AC   CVCL_RF47
SY   BPC934-03-02
DR   BioSamples; SAMEA104620680
DR   EBiSC; STBCi277-A
DR   ECACC; 66541103
DR   hPSCreg; STBCi277-A
DR   Wikidata; Q54970492
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541103; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi278-A
AC   CVCL_RF48
SY   SFC245-03-08
DR   BioSamples; SAMEA104620682
DR   EBiSC; STBCi278-A
DR   ECACC; 66541104
DR   hPSCreg; STBCi278-A
DR   Wikidata; Q54970493
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541104; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi279-A
AC   CVCL_RF49
SY   SFC063-03-01
DR   BioSamples; SAMEA104620684
DR   EBiSC; STBCi279-A
DR   ECACC; 66541105
DR   hPSCreg; STBCi279-A
DR   Wikidata; Q54970494
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541105; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi280-A
AC   CVCL_RF50
SY   SFC066-03-01
DR   BioSamples; SAMEA104620686
DR   EBiSC; STBCi280-A
DR   ECACC; 66541106
DR   hPSCreg; STBCi280-A
DR   Wikidata; Q54970495
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541106; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi281-A
AC   CVCL_RF51
SY   SFC167-03-04
DR   BioSamples; SAMEA104620688
DR   EBiSC; STBCi281-A
DR   ECACC; 66541107
DR   hPSCreg; STBCi281-A
DR   Wikidata; Q54970497
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541107; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi282-A
AC   CVCL_RF52
SY   SFC138-03-05
DR   BioSamples; SAMEA104620690
DR   EBiSC; STBCi282-A
DR   ECACC; 66541108
DR   hPSCreg; STBCi282-A
DR   Wikidata; Q54970498
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541108; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi283-A
AC   CVCL_RF53
SY   SFC073-03-08
DR   BioSamples; SAMEA104620692
DR   EBiSC; STBCi283-A
DR   ECACC; 66541109
DR   hPSCreg; STBCi283-A
DR   Wikidata; Q54970514
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541109; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi284-A
AC   CVCL_RF54
SY   BPC939-03-01
DR   BioSamples; SAMEA104620694
DR   EBiSC; STBCi284-A
DR   ECACC; 66541110
DR   hPSCreg; STBCi284-A
DR   Wikidata; Q54970515
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541110; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi285-A
AC   CVCL_RF55
SY   BPC940-03-08
DR   BioSamples; SAMEA104620696
DR   EBiSC; STBCi285-A
DR   ECACC; 66541111
DR   hPSCreg; STBCi285-A
DR   Wikidata; Q54970516
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541111; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi286-A
AC   CVCL_RF56
SY   BPC929-03-07
DR   BioSamples; SAMEA104620698
DR   EBiSC; STBCi286-A
DR   ECACC; 66541112
DR   hPSCreg; STBCi286-A
DR   Wikidata; Q54970517
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541112; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi287-A
AC   CVCL_RF57
SY   BPC946-04-10
DR   BioSamples; SAMEA104620700
DR   EBiSC; STBCi287-A
DR   ECACC; 66541113
DR   hPSCreg; STBCi287-A
DR   Wikidata; Q54970518
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541113; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi288-A
AC   CVCL_RF58
SY   SFC028-03-08
DR   BioSamples; SAMEA104620702
DR   EBiSC; STBCi288-A
DR   ECACC; 66541114
DR   hPSCreg; STBCi288-A
DR   Wikidata; Q54970520
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541114; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi289-A
AC   CVCL_RF59
SY   SFC030-03-02
DR   BioSamples; SAMEA104620704
DR   EBiSC; STBCi289-A
DR   ECACC; 66541115
DR   hPSCreg; STBCi289-A
DR   Wikidata; Q54970521
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541115; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi290-A
AC   CVCL_RF60
SY   SFC069-03-01
DR   BioSamples; SAMEA104620706
DR   EBiSC; STBCi290-A
DR   ECACC; 66541116
DR   hPSCreg; STBCi290-A
DR   Wikidata; Q54970522
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541116; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi291-A
AC   CVCL_RF61
SY   SFC080-03-04
DR   BioSamples; SAMEA104620708
DR   EBiSC; STBCi291-A
DR   ECACC; 66541117
DR   hPSCreg; STBCi291-A
DR   Wikidata; Q54970523
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541117; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi292-A
AC   CVCL_RF62
SY   SFC139-03-06
DR   BioSamples; SAMEA104620710
DR   EBiSC; STBCi292-A
DR   ECACC; 66541118
DR   hPSCreg; STBCi292-A
DR   Wikidata; Q54970524
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541118; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi293-A
AC   CVCL_RF63
SY   SFC843-03-09
DR   BioSamples; SAMEA104620712
DR   EBiSC; STBCi293-A
DR   ECACC; 66541119
DR   hPSCreg; STBCi293-A
DR   Wikidata; Q54970525
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541119; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi294-A
AC   CVCL_RF64
SY   SFC844-03-12
DR   BioSamples; SAMEA104620714
DR   EBiSC; STBCi294-A
DR   ECACC; 66541120
DR   hPSCreg; STBCi294-A
DR   Wikidata; Q54970526
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541120; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi295-A
AC   CVCL_RF65
SY   SFC847-03-05
DR   BioSamples; SAMEA104620716
DR   EBiSC; STBCi295-A
DR   ECACC; 66541121
DR   hPSCreg; STBCi295-A
DR   Wikidata; Q54970528
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541121; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WU53 ! STBCi295-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi295-B
AC   CVCL_WU53
SY   SFC847-03-08
DR   BioSamples; SAMEA5859486
DR   EBiSC; STBCi255-B
DR   ECACC; 66541210
DR   hPSCreg; STBCi295-B
DR   Wikidata; Q98132853
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541210; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RF65 ! STBCi295-A
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   STBCi296-A
AC   CVCL_RF66
SY   SFC864-03-02
DR   BioSamples; SAMEA104620718
DR   EBiSC; STBCi296-A
DR   ECACC; 66541122
DR   hPSCreg; STBCi296-A
DR   Wikidata; Q54970529
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541122; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi297-A
AC   CVCL_RF67
SY   SFC061-03-07
DR   BioSamples; SAMEA104620720
DR   EBiSC; STBCi297-A
DR   ECACC; 66541123
DR   hPSCreg; STBCi297-A
DR   Wikidata; Q54970530
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541123; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi298-A
AC   CVCL_RF68
SY   SFC865-03-07
DR   BioSamples; SAMEA104620722
DR   EBiSC; STBCi298-A
DR   ECACC; 66541124
DR   hPSCreg; STBCi298-A
DR   Wikidata; Q54970531
RX   PubMed=30503143;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541124; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi299-A
AC   CVCL_RF69
SY   BPC931-01-08
DR   BioSamples; SAMEA104620724
DR   EBiSC; STBCi299-A
DR   ECACC; 66541125
DR   hPSCreg; STBCi299-A
DR   Wikidata; Q54970532
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541125; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi300-A
AC   CVCL_RF70
SY   BPC932-03-03
DR   BioSamples; SAMEA104620726
DR   EBiSC; STBCi300-A
DR   ECACC; 66541126
DR   hPSCreg; STBCi300-A
DR   Wikidata; Q54970534
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541126; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi301-A
AC   CVCL_RF71
SY   BPC949-04-11
DR   BioSamples; SAMEA104620728
DR   EBiSC; STBCi301-A
DR   ECACC; 66541127
DR   hPSCreg; STBCi301-A
DR   Wikidata; Q54970535
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541127; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi302-A
AC   CVCL_RF72
SY   BPC945-03-01
DR   BioSamples; SAMEA104620730
DR   EBiSC; STBCi302-A
DR   ECACC; 66541128
DR   hPSCreg; STBCi302-A
DR   Wikidata; Q54970536
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541128; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi303-A
AC   CVCL_RF73
SY   SFC071-03-09
DR   BioSamples; SAMEA104620732
DR   EBiSC; STBCi303-A
DR   ECACC; 66541129
DR   hPSCreg; STBCi303-A
DR   Wikidata; Q54970537
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541129; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi304-A
AC   CVCL_RF74
SY   SFC074-03-03
DR   BioSamples; SAMEA104620734
DR   EBiSC; STBCi304-A
DR   ECACC; 66541130
DR   hPSCreg; STBCi304-A
DR   Wikidata; Q54970539
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541130; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi305-A
AC   CVCL_RF75
SY   SFC083-03-10; SFC083-07-10
DR   BioSamples; SAMEA104620736
DR   EBiSC; STBCi305-A
DR   ECACC; 66541131
DR   hPSCreg; STBCi305-A
DR   Wikidata; Q54970540
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541131; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi306-A
AC   CVCL_RF76
SY   SFC087-03-04; SFC087-07-04
DR   BioSamples; SAMEA104620738
DR   EBiSC; STBCi306-A
DR   ECACC; 66541132
DR   hPSCreg; STBCi306-A
DR   Wikidata; Q54970541
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541132; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   STBCi307-A
AC   CVCL_RF77
SY   SFC088-03-05
DR   BioSamples; SAMEA104620740
DR   EBiSC; STBCi307-A
DR   ECACC; 66541133
DR   hPSCreg; STBCi307-A
DR   Wikidata; Q54970542
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541133; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi308-A
AC   CVCL_RF78
SY   SFC249-03-06
DR   BioSamples; SAMEA104620742
DR   EBiSC; STBCi308-A
DR   ECACC; 66541134
DR   hPSCreg; STBCi308-A
DR   Wikidata; Q54970543
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541134; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi309-A
AC   CVCL_RF79
SY   SFC391-03-03
DR   BioSamples; SAMEA104620744
DR   EBiSC; STBCi309-A
DR   ECACC; 66541135
DR   hPSCreg; STBCi309-A
DR   Wikidata; Q54970544
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541135; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi310-A
AC   CVCL_RF80
SY   SFC846-03-02
DR   BioSamples; SAMEA104620746
DR   EBiSC; STBCi310-A
DR   ECACC; 66541136
DR   hPSCreg; STBCi310-A
DR   Wikidata; Q54970545
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541136; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   STBCi311-A
AC   CVCL_RF81
SY   BPC941-03-12
DR   BioSamples; SAMEA104620748
DR   EBiSC; STBCi311-A
DR   ECACC; 66541137
DR   hPSCreg; STBCi311-A
DR   Wikidata; Q54970546
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541137; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C89715; Migraine
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi312-A
AC   CVCL_RF82
SY   BPC333-03-09
DR   BioSamples; SAMEA104620750
DR   EBiSC; STBCi312-A
DR   ECACC; 66541138
DR   hPSCreg; STBCi312-A
DR   Wikidata; Q54970547
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541138; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi313-A
AC   CVCL_RF83
SY   BPC334-03-06
DR   BioSamples; SAMEA104620752
DR   EBiSC; STBCi313-A
DR   ECACC; 66541139
DR   hPSCreg; STBCi313-A
DR   Wikidata; Q54970548
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541139; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi314-A
AC   CVCL_RF84
SY   BPC335-03-08
DR   BioSamples; SAMEA104620754
DR   EBiSC; STBCi314-A
DR   ECACC; 66541140
DR   hPSCreg; STBCi314-A
DR   Wikidata; Q54970549
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541140; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi315-A
AC   CVCL_RF85
SY   BPC336-03-03
DR   BioSamples; SAMEA104620756
DR   EBiSC; STBCi315-A
DR   ECACC; 66541141
DR   hPSCreg; STBCi315-A
DR   Wikidata; Q54970551
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541141; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi316-A
AC   CVCL_RF86
SY   SFC244-03-01
DR   BioSamples; SAMEA104620758
DR   EBiSC; STBCi316-A
DR   ECACC; 66541142
DR   hPSCreg; STBCi316-A
DR   Wikidata; Q54970552
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi316-A; true.
CC   Discontinued: ECACC; 66541142; true.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 8
//
ID   STBCi317-A
AC   CVCL_RF87
SY   SFC241-03-01
DR   BioSamples; SAMEA104620760
DR   EBiSC; STBCi317-A
DR   ECACC; 66541143
DR   hPSCreg; STBCi317-A
DR   Wikidata; Q54970553
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi317-A; true.
CC   Discontinued: ECACC; 66541143; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi318-A
AC   CVCL_RF88
SY   SFC200-03-01
DR   BioSamples; SAMEA104620762
DR   EBiSC; STBCi318-A
DR   ECACC; 66541144
DR   hPSCreg; STBCi318-A
DR   Wikidata; Q54970554
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi318-A; true.
CC   Discontinued: ECACC; 66541144; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 10
//
ID   STBCi319-A
AC   CVCL_RF89
SY   SFC199-03-01
DR   BioSamples; SAMEA104620764
DR   EBiSC; STBCi319-A
DR   ECACC; 66541145
DR   hPSCreg; STBCi319-A
DR   Wikidata; Q54970555
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi319-A; true.
CC   Discontinued: ECACC; 66541145; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 9
//
ID   STBCi320-A
AC   CVCL_WU51
SY   SFC031-03-03
DR   BioSamples; SAMEA5859484
DR   EBiSC; STBCi320-A
DR   ECACC; 66541211
DR   hPSCreg; STBCi320-A
DR   Wikidata; Q98132854
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66541211; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   STBCi321-A
AC   CVCL_ZX54
SY   SFC-AD2-01; SB-AD2c1; AD2c1; SBAD02-01; SBAD2-01; SBAD0201; SB AD2.1; SBAD2 clone 1
DR   BioSamples; SAMEA7020163
DR   EBiSC; STBCi321-A
DR   ECACC; 66770002
DR   hPSCreg; STBCi321-A
DR   Wikidata; Q102114948
RX   PubMed=30222766;
RX   PubMed=32359446;
RX   PubMed=38115090;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: ECACC; 66770002; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   STBCi322-A
AC   CVCL_ZX55
SY   SFC-AD3-01; SB-AD3c1; AD3c1; SBAD03-01; SBAD3-01; SBAD3-1; SB AD3.1; SB Ad3.1; SBAD3 clone 1; UOXFi012-A
DR   hPSCreg; STBCi322-A
DR   hPSCreg; UOXFi012-A
DR   Wikidata; Q102114949
RX   PubMed=28591653;
RX   PubMed=29734117;
RX   PubMed=30222766;
RX   PubMed=30245212;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   STBCi322-A-1
AC   CVCL_C1XW
SY   NKX6.1-GFP reporter line; NKX6.1-GFP clone 1a-10-3; AZi323-A-1
DR   hPSCreg; STBCi322-A-1
DR   Wikidata; Q114313049
RX   PubMed=29734117;
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Characteristics: Using CRISPR/Cas9 a T2A-GFP-LoxP-PGKp-Neo-LoxP construct was introduced at the C-terminus of NKX6-1. Subsequently the LoxP-PGKp-Neo-LoxP sequence was removed by Cre-mediated excision (PubMed=29734117).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX55 ! STBCi322-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   STBCi322-A-4
AC   CVCL_C3LE
SY   ABCB1 KO; AZi323-A-4
DR   hPSCreg; STBCi322-A-4
DR   Wikidata; Q114313051
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX55 ! STBCi322-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   STBCi322-A-5
AC   CVCL_C3LF
SY   ABCB11 KO; AZi323-A-5
DR   hPSCreg; STBCi322-A-5
DR   Wikidata; Q114313052
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:42; ABCB11.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX55 ! STBCi322-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   STBCi322-A-6
AC   CVCL_C3LG
SY   SLC47A1 KO; AZi323-A-6
DR   hPSCreg; STBCi322-A-6
DR   Wikidata; Q114313053
CC   From: AstraZeneca; Cambridge; United Kingdom.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25588; SLC47A1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX55 ! STBCi322-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   STBCi323-A
AC   CVCL_ZX56
SY   SFC-AD4-01; SB-AD4c1; AD4c1; SBAD04-01
DR   BioSamples; SAMEA7023539
DR   EBiSC; STBCi323-A
DR   ECACC; 66770003
DR   hPSCreg; STBCi323-A
DR   Wikidata; Q102114950
RX   PubMed=28591653;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Discontinued: EBiSC; STBCi323-A; true.
CC   Discontinued: ECACC; 66770003; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   STC 1
AC   CVCL_3171
SY   STC-1; STC1
DR   CLO; CLO_0037044
DR   BioSample; SAMN03472491
DR   cancercelllines; CVCL_3171
DR   GEO; GSM784283
DR   GEO; GSM827380
DR   JCRB; JCRB1053
DR   LINCS_LDP; LCL-1878
DR   Progenetix; CVCL_3171
DR   PubChem_Cell_line; CVCL_3171
DR   Wikidata; Q54970556
RX   DOI=10.2482/haigan.32.223;
RX   PubMed=1484432;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Doubling time: 28 hours (DOI=10.2482/haigan.32.223); ~50 hours (Note=Lot 04212010), ~18 hours (Note=Lot 05202019) (JCRB=JCRB1053).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   STC 6-14
AC   CVCL_J404
SY   STC6-14
DR   Wikidata; Q54970557
RX   PubMed=7653549;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P68835; Murine polyomavirus (strain A2) (MPyV) small T antigen (PyST).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Breed/subspecies: C57BL/6J double transgenic RIP1Tag2/Rip2pyST1.
DI   NCIt; C22150; Neuroendocrine adenoma of the mouse intestinal tract
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J405 ! STC-1
SX   Sex unspecified
AG   10-13W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 15
//
ID   STC-1
AC   CVCL_J405
DR   BTO; BTO_0003584
DR   ATCC; CRL-3254
DR   Wikidata; Q54970558
RX   PubMed=1654206;
RX   PubMed=2162628;
RX   PubMed=18708196;
RX   PubMed=22538498;
RX   PubMed=28870797;
RX   PubMed=29787051;
CC   Doubling time: 54 hours (PubMed=29787051).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P68835; Murine polyomavirus (strain A2) (MPyV) small T antigen (PyST).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Breed/subspecies: C57BL/6J double transgenic RIP1Tag2/Rip2pyST1.
DI   NCIt; C22150; Neuroendocrine adenoma of the mouse intestinal tract
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-13W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   STC-1 pGIP/Neo
AC   CVCL_C6ND
SY   pGIP/Neo STC-1; pGIP/Neo
DR   Wikidata; Q116050577
RX   PubMed=12124779;
RX   PubMed=22768997;
RX   PubMed=28870797;
CC   Characteristics: Expression of the neo gene is driven by a rat GIP promoter (PubMed=12124779).
CC   Characteristics: Compared to parent cell line secrete 3-6 times more GIP and substantially less CCK and PYY (PubMed=22768997).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P68835; Murine polyomavirus (strain A2) (MPyV) small T antigen (PyST).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Breed/subspecies: C57BL/6J double transgenic RIP1Tag2/Rip2pyST1.
DI   NCIt; C22150; Neuroendocrine adenoma of the mouse intestinal tract
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J405 ! STC-1
SX   Sex unspecified
AG   10-13W
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   STC1/CDDP
AC   CVCL_1F88
DR   Wikidata; Q54970570
RX   DOI=10.2482/haigan.32.223;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3171 ! STC 1
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 10
//
ID   STE-137
AC   CVCL_4308
SY   STE 137; Steelhead Trout Embryo-137
DR   CLO; CLO_0009147
DR   ECACC; 95122020
DR   Wikidata; Q54970571
RX   CelloPub=CLPUB00103;
RX   CelloPub=CLPUB00703;
RX   DOI=10.1016/S1873-0140(05)80005-0;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3354/dao001209;
RX   PubMed=6542066;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by infectious haematopoetic necrosis virus (IHNV) and infectious pancreatic necrosis virus (IPNV) (CelloPub=CLPUB00703).
CC   Doubling time: ~72 hours (ECACC=95122020).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   Steele
AC   CVCL_AT90
DR   cancercelllines; CVCL_AT90
DR   Cosmic; 888866
DR   Wikidata; Q54970572
RX   PubMed=15009714;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15009714).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   STEINLIN
AC   CVCL_E837
DR   dbMHC; 49029
DR   ECACC; 88052087
DR   IHW; IHW09087
DR   IPD-IMGT/HLA; 11648
DR   PRIDE; PXD001205
DR   PRIDE; PXD017682
DR   Wikidata; Q54970574
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*01:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*01; DPB1*03:01:01,04:01:01; DQA1*05:01:01; DQB1*02:01:01; DRA*01:02; DRB1*03:01:01; DRB3*01:01 (IPD-IMGT/HLA=11648).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   sTERT-SSF
AC   CVCL_E7B1
RX   PubMed=39918276;
CC   Doubling time: 9.81 hours (Note=At 6th passage), 10.59 hours (Note=At 16th passage), 14.00 hours (Note=At 26th passage), 18.61 hours (Note=At 36th passage) (PubMed=39918276).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; A9QMB4; Sheep TERT.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Mongolian; VBO=VBO_0001514.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   STF-1
AC   CVCL_A5NE
DR   Wikidata; Q107116958
RX   PubMed=10074495;
RX   PubMed=10229096;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:44; TAP2; Simple; p.Arg273Ter (c.817C>T) (R253*); ClinVar=VCV000013727; Zygosity=Homozygous (from autologous cell line ST-EMO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171267; Bare lymphocyte syndrome type 1
DI   ORDO; Orphanet_34592; Immunodeficiency by defective expression of MHC class I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DP21 ! ST-EMO
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   STF-4
AC   CVCL_A5NH
DR   Wikidata; Q107116961
RX   PubMed=10229096;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   STF-5
AC   CVCL_A5NI
DR   Wikidata; Q107116963
RX   PubMed=10229096;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   STF-6
AC   CVCL_A5NG
DR   Wikidata; Q107116965
RX   PubMed=10074495;
RX   PubMed=10229096;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   STF1-169
AC   CVCL_F744
SY   STF1.169
DR   BTO; BTO_0003755
DR   Wikidata; Q54970575
RX   PubMed=17977821;
RX   PubMed=18802093;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:44; TAP2; Simple; p.Arg273Ter (c.817C>T) (R253*); ClinVar=VCV000013727; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171267; Bare lymphocyte syndrome type 1
DI   ORDO; Orphanet_34592; Immunodeficiency by defective expression of MHC class I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5NE ! STF-1
SX   Male
AG   6Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   STF34
AC   CVCL_1F99
DR   Wikidata; Q54970576
RX   PubMed=24845938;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: 24 hours (PubMed=24845938).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=74533; ! Panthera tigris altaica (Siberian tiger)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 8
//
ID   STF3a
AC   CVCL_C6NQ
DR   Wikidata; Q117704897
RX   PubMed=19022675;
CC   Characteristics: Stably express high levels of murine Wnt3a (PubMed=19022675).
CC   Characteristics: Responds to activation of the canonical Wnt signaling pathway by increasing expression of firefly luciferase. Luciferase reporter gene expression is under the control of a promoter with 7 LEF/TCF binding sites (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98956; Wnt3a.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AQ26 ! HEK 293 STF
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   STFO3416AN
AC   CVCL_V382
DR   IPD-IMGT/HLA; 14470
DR   Wikidata; Q54970577
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:RPH,03:BKS; B*07:XV,44:AMUT; C*05:ANJN,07:02; DQA1*01:03,03:MN; DQB1*03:AF,06:08:02; DRB1*04:01:01,13:01:01 (IPD-IMGT/HLA=14470).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   STH4
AC   CVCL_B4IL
DR   Wikidata; Q110433259
RX   PubMed=2422659;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4IM ! YTA1
OI   CVCL_B4IN ! YTH3
OI   CVCL_B4IP ! YTH5
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   STHdhQ109
AC   CVCL_M589
SY   STHdhQ109/Q109
DR   Wikidata; Q54970578
RX   PubMed=21985783;
CC   Characteristics: From a transgenic mouse containing homozygous HTT loci with a humanized exon 1 containing 109 polyglutamine repeats (PubMed=21985783).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, forebrain, striatum; UBERON=UBERON_0002435.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   14FD
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   STHdhQ111
AC   CVCL_M591
SY   STHdh(Q111); STHdhQ111/Q111; Q111; ST HDH Q111/111; CHDI-90000071; CH00095
DR   Coriell; CH00095
DR   Wikidata; Q54970579
RX   PubMed=11092756;
RX   PubMed=21985783;
RX   PubMed=30256717;
CC   Characteristics: From a transgenic mouse containing homozygous HTT loci with a humanized exon 1 containing 111 polyglutamine repeats (Coriell=CH00095).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   14FD
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 14
//
ID   STHdhQ7
AC   CVCL_M590
SY   STHdhQ7/Q7; Q7; ST HDH Q7/7; CHDI-90000073; CH00097
DR   Coriell; CH00097
DR   Wikidata; Q54970580
CC   Characteristics: From a transgenic mouse containing homozygous HTT loci with a humanized exon 1 containing 7 polyglutamine repeats (Coriell=CH00097).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, forebrain, striatum; UBERON=UBERON_0002435.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   14FD
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   STHdhQ7/111
AC   CVCL_DN41
SY   ST HDH Q7/111; CHDI-90000072; CH00096
DR   Coriell; CH00096
DR   Wikidata; Q54970581
CC   Characteristics: From a transgenic mouse containing an heterozygous HTT loci with a humanized exon 1 containing 7 polyglutamine repeats and an heterozygous HTT loci with a humanized exon 1 containing 111 polyglutamine repeats (Coriell=CH00096).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, forebrain, striatum; UBERON=UBERON_0002435.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   14FD
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   STIP-1
AC   CVCL_W221
SY   STIP 1; Sturgeon Iris Pigmented-1
DR   Wikidata; Q54970582
RX   Patent=JP4065150;
RX   Patent=US7217564;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8421.
CC   Doubling time: 38.9 hours (Patent=US7217564).
CC   Derived from site: In situ; Eye, iris; UBERON=UBERON_0001769.
OX   NCBI_TaxID=328639; ! Acipenser ruthenus x Huso huso (Bester sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 12
//
ID   STIP-2
AC   CVCL_JF75
SY   STIP 2; Sturgeon Iris Pigmented-2
DR   Wikidata; Q54970583
RX   Patent=JP5702092;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11274.
CC   Doubling time: ~80 hours (Patent=JP5702092).
CC   Derived from site: In situ; Eye, iris; UBERON=UBERON_0001769.
OX   NCBI_TaxID=328639; ! Acipenser ruthenus x Huso huso (Bester sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   STIP-3
AC   CVCL_W222
SY   STIP 3; Sturgeon Iris Pigmented-3
DR   Wikidata; Q54970584
RX   Patent=JP4065150;
RX   Patent=US7217564;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8422.
CC   Doubling time: 74.9 hours (Patent=US7217564).
CC   Derived from site: In situ; Eye, iris; UBERON=UBERON_0001769.
OX   NCBI_TaxID=328639; ! Acipenser ruthenus x Huso huso (Bester sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 11
//
ID   STiPS A3
AC   CVCL_X733
DR   SKIP; SKIP004440
DR   Wikidata; Q54970585
CC   From: Harvard University; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X734 ! STiPS A4
OI   CVCL_X735 ! STiPS A5
OI   CVCL_X736 ! STiPS A6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   STiPS A4
AC   CVCL_X734
DR   SKIP; SKIP004441
DR   Wikidata; Q54970586
CC   From: Harvard University; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X733 ! STiPS A3
OI   CVCL_X735 ! STiPS A5
OI   CVCL_X736 ! STiPS A6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   STiPS A5
AC   CVCL_X735
DR   SKIP; SKIP004442
DR   Wikidata; Q54970587
CC   From: Harvard University; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X733 ! STiPS A3
OI   CVCL_X734 ! STiPS A4
OI   CVCL_X736 ! STiPS A6
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   STiPS A6
AC   CVCL_X736
DR   SKIP; SKIP004443
DR   Wikidata; Q54970588
CC   From: Harvard University; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X733 ! STiPS A3
OI   CVCL_X734 ! STiPS A4
OI   CVCL_X735 ! STiPS A5
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   STiPS O-XX1
AC   CVCL_X728
DR   SKIP; SKIP004445
DR   Wikidata; Q54970590
CC   From: Harvard University; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X729 ! STiPS O-XX2
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   STiPS O-XX2
AC   CVCL_X729
DR   SKIP; SKIP004444
DR   Wikidata; Q54970592
CC   From: Harvard University; Boston; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X728 ! STiPS O-XX1
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 6
//
ID   STiPS-B004
AC   CVCL_VF00
DR   Wikidata; Q54970589
RX   CelloPub=CLPUB00425;
CC   From: STEMCELL Technologies, Inc.; Vancouver; Canada.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   STJUDEi001-A
AC   CVCL_YT44
SY   AD2000MEMS00
DR   hPSCreg; STJUDEi001-A
DR   Wikidata; Q98132855
RX   PubMed=32485644;
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Leu215Pro (c.644T>C); ClinVar=VCV000393239; Zygosity=Heterozygous (PubMed=32485644).
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Val217Met (c.649G>A); ClinVar=VCV000002449; Zygosity=Heterozygous (PubMed=32485644).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   STJUDEi002-A
AC   CVCL_YT45
SY   GSL079
DR   hPSCreg; STJUDEi002-A
DR   Wikidata; Q98132856
RX   PubMed=32485644;
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Tyr370Cys (c.1109A>G); ClinVar=VCV000986732; Zygosity=Homozygous (PubMed=32485644).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_87876; Sialidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   STJUDEi003-A
AC   CVCL_YT46
SY   279
DR   hPSCreg; STJUDEi003-A
DR   Wikidata; Q98132857
RX   PubMed=32485644;
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.Gly227Arg (c.679G>A); ClinVar=VCV000430342; Zygosity=Heterozygous (PubMed=32485644).
CC   Sequence variation: Mutation; HGNC; HGNC:7758; NEU1; Simple; p.His399_Tyr400dup (c.1195_1200dup); Zygosity=Heterozygous (PubMed=32485644).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_812; Sialidosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 9
//
ID   STJUDEi004-A
AC   CVCL_C6ST
SY   INS3
DR   BioSamples; SAMEA111437013
DR   hPSCreg; STJUDEi004-A
DR   Wikidata; Q117704898
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10402; RPS19; Simple; p.Leu64Pro (c.191T>C); ClinVar=VCV001782649; Zygosity=Heterozygous (hPSCreg=STJUDEi004-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   STJUDEi004-A-1
AC   CVCL_C6SU
SY   INS3 Isogenic
DR   BioSamples; SAMEA111437015
DR   hPSCreg; STJUDEi004-A-1
DR   Wikidata; Q117704899
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10402; RPS19; Simple_corrected; p.Leu64Pro (c.191T>C); ClinVar=VCV001782649; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=STJUDEi004-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6ST ! STJUDEi004-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   STJUDEi005-A
AC   CVCL_C6SV
SY   INS14
DR   BioSamples; SAMEA111437016
DR   hPSCreg; STJUDEi005-A
DR   Wikidata; Q117704900
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10402; RPS19; Simple; p.Arg62Trp (c.184C>T); ClinVar=VCV000006314; Zygosity=Heterozygous (hPSCreg=STJUDEi005-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   STJUDEi005-A-1
AC   CVCL_C6SW
SY   INS14 Isogenic
DR   BioSamples; SAMEA111437018
DR   hPSCreg; STJUDEi005-A-1
DR   Wikidata; Q117704901
CC   From: St. Jude Children's Research Hospital; Memphis; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:10402; RPS19; Simple_corrected; p.Arg62Trp (c.184C>T); ClinVar=VCV000006314; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=STJUDEi005-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C61236; Congenital pure red cell aplasia
DI   ORDO; Orphanet_124; Blackfan-Diamond anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6SV ! STJUDEi005-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   STK 1
AC   CVCL_8513
SY   STK1
DR   CLO; CLO_0009148
DR   ATCC; CRL-1652
DR   JCRB; JCRB9033
DR   Wikidata; Q54970593
RX   PubMed=7085672;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09884; Human POLA1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   STKM-1
AC   CVCL_M569
SY   ST-KM-1; STKM1
DR   BTO; BTO_0005430
DR   ChEMBL-Cells; CHEMBL3307828
DR   ChEMBL-Targets; CHEMBL613972
DR   PubChem_Cell_line; CVCL_M569
DR   Wikidata; Q54970594
RX   PubMed=1888706;
RX   PubMed=8018449;
RX   PubMed=9290701;
RX   PubMed=9849464;
RX   PubMed=24324061;
CC   Population: Japanese.
CC   Doubling time: 31.4 hours (Note=At 30th passage) (PubMed=1888706).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 13
//
ID   STKM-1 clone R3
AC   CVCL_RX84
SY   R3
DR   Wikidata; Q54970596
RX   PubMed=9849464;
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M569 ! STKM-1
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   STKM-1 clone S4
AC   CVCL_RX85
SY   S4
DR   Wikidata; Q54970597
CC   Population: Japanese.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M569 ! STKM-1
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   STKM-2
AC   CVCL_M570
SY   STKM2
DR   BTO; BTO_0005443
DR   Wikidata; Q54970598
RX   PubMed=9290701;
CC   From: Yanoma, Shunsuke; Kanagawa Cancer Center; Yokohama; Japan.
CC   Population: Japanese.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   STL-C1
AC   CVCL_XE86
DR   CCRID; 4201PAT-CCTCC00843
DR   Wikidata; Q98132858
RX   Patent=CN105861441B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201630.
CC   Population: Chinese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 9
//
ID   STL-C2
AC   CVCL_XE87
DR   CCRID; 4201PAT-CCTCC00844
DR   Wikidata; Q98132859
CC   Population: Chinese.
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 7
//
ID   STLE
AC   CVCL_A2SX
SY   Salmo Trutta Linneus Embryo
DR   Wikidata; Q105511131
RX   DOI=10.1088/1755-1315/315/7/072006;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8032; ! Salmo trutta (Brown trout)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   STM38
AC   CVCL_RY77
DR   JCRB; JCRB1714
DR   Wikidata; Q54970599
RX   PubMed=1446662;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Asp433His (c.1297G>C); ClinVar=VCV000003732; Zygosity=Heterozygous (PubMed=1446662).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1714
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   STM91-01
AC   CVCL_8000
SY   STM-91-01; STM9101
DR   BioSample; SAMN10989622
DR   Cell_Model_Passport; SIDM01860
DR   Cosmic; 801777
DR   Cosmic; 1063889
DR   Cosmic; 2144788
DR   DepMap; ACH-001200
DR   GEO; GSM2033129
DR   GEO; GSM2033130
DR   GEO; GSM2033131
DR   GEO; GSM2033132
DR   GEO; GSM2033133
DR   GEO; GSM2033134
DR   TOKU-E; 4152
DR   Wikidata; Q54970600
RX   PubMed=8385567;
RX   PubMed=8818656;
RX   PubMed=9559292;
RX   PubMed=9920784;
RX   PubMed=11557780;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=14662021;
RX   PubMed=16557275;
RX   PubMed=24418192;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=11921280).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): DepMap=ACH-001200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 22,26
ST   Penta D: 10,17
ST   Penta E: 5,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   STO
AC   CVCL_3420
DR   CLO; CLO_0009149
DR   CLO; CLO_0050530
DR   CLDB; cl4406
DR   CLDB; cl4407
DR   CLDB; cl4408
DR   AddexBio; P0011006/4964
DR   ATCC; CRL-1503
DR   BCRC; 60003
DR   BioSample; SAMN11397628
DR   CCRID; 3101MOUSCSP519
DR   CCRID; 4201MOU-CCTCC00013
DR   CCTCC; GDC0013
DR   ChEMBL-Cells; CHEMBL4483000
DR   CLS; 400165
DR   ECACC; 86032003
DR   IZSLER; BS CL 81
DR   NCBI_Iran; C537
DR   PubChem_Cell_line; CVCL_3420
DR   RCB; RCB0536
DR   TOKU-E; 3192
DR   Wikidata; Q54970601
RX   PubMed=1055416;
RX   PubMed=31220119;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 12
ST   Mouse STR 1-2: 16
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 15.3
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 19
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 13
ST   Mouse STR 18-3: 19
ST   Mouse STR 19-2: 12
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Mixed sex
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   STO-SNL2
AC   CVCL_N792
SY   STO-SNL/2; STO SNL2
DR   ATCC; CRL-2225
DR   Wikidata; Q54970602
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: ATCC; CRL-2225; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3420 ! STO
SX   Mixed sex
AG   Embryo
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   STOSE
AC   CVCL_HP92
SY   Spontaneously Transformed Ovarian Surface Epithelial
DR   GEO; GSM1320309
DR   GEO; GSM1320310
DR   GEO; GSM1320311
DR   Wikidata; Q54970603
RX   PubMed=24672774;
CC   Doubling time: 13 hours (PubMed=24672774).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: FVB/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HP91 ! M0505
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   STP-1
AC   CVCL_RW71
DR   BTO; BTO_0002961
DR   Wikidata; Q54970605
RX   PubMed=16585582;
CC   Miscellaneous: Only mentioned as a melanoma cell line in PubMed=16585582.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   STP54
AC   CVCL_UY58
DR   Wikidata; Q98132860
RX   PubMed=19419948;
CC   Doubling time: 68 hours (PubMed=19419948).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   STPDL
AC   CVCL_B6BM
SY   SV40T-Ag and TERT immortalized PerioDontal Ligament cells
DR   Wikidata; Q112041737
RX   PubMed=34590290;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   STPDLDS
AC   CVCL_B6BN
SY   SV40T-Ag and TERT immortalized PerioDontal Ligament Down Syndrome cells
DR   Wikidata; Q112041738
RX   PubMed=34590290;
CC   Population: Japanese.
CC   Karyotypic information: Has a large number of abnormal chromosomes (PubMed=34590290).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
ST   Source(s): PubMed=34590290
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,14
ST   D21S11: 29,31.2
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   STPLF-fE
AC   CVCL_C0WB
SY   SV40 and TERT-immortalized Periodontal Ligament Fibroblast-female E
DR   Wikidata; Q114313054
RX   PubMed=16408200;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   STPLF-fF
AC   CVCL_C0WC
SY   SV40 and TERT-immortalized Periodontal Ligament Fibroblast-female F
DR   Wikidata; Q114313055
RX   PubMed=16408200;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   STPLF-mB
AC   CVCL_C0WD
SY   SV40 and TERT-immortalized Periodontal Ligament Fibroblast-male B
DR   Wikidata; Q114313056
RX   PubMed=16408200;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth, periodontal ligament; UBERON=UBERON_0008266.
CC   Cell type: Fibroblast of periodontal ligament; CL=CL_2000017.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   STR-428
AC   CVCL_8533
DR   JCRB; JCRB1384
DR   Wikidata; Q54970606
RX   PubMed=17368758;
RX   PubMed=34584567;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=17368758).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=17368758).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1384
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53-54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   STR-I-155-HD
AC   CVCL_C082
SY   STR-155-HD; INSERMe003-A; INSRMe003-A
DR   hPSCreg; INSRMe003-A
DR   SKIP; SKIP002317
DR   Wikidata; Q54970607
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_155_hd.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE07-051-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   STR-I-171-GLA
AC   CVCL_C083
SY   STR-171-GLA; INSERMe004-A; INSRMe004-A
DR   hPSCreg; INSRMe004-A
DR   SKIP; SKIP002318
DR   Wikidata; Q54970609
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_171_gla.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-056-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   STR-I-189-FRAXA
AC   CVCL_C084
SY   STR-189-FRAXA; INSERMe005-A; INSRMe005-A
DR   hPSCreg; INSRMe005-A
DR   SKIP; SKIP002319
DR   Wikidata; Q54970610
RX   PubMed=20217271;
RX   PubMed=27690107;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_189_fraxa.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-065-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   STR-I-203-CFTR
AC   CVCL_C085
SY   STR-203-CFTR; INSERMe008-A; INSRMe008-A
DR   hPSCreg; INSRMe008-A
DR   SKIP; SKIP002322
DR   Wikidata; Q54970611
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_203_cftr.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-072-L1.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Arg347Pro (c.1040G>C); ClinVar=VCV000007110; Zygosity=Heterozygous (PubMed=20217271).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=20217271).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   STR-I-209-MEN2a
AC   CVCL_C086
SY   STR-209-MEN2a; INSERMe006-A; INSRMe006-A
DR   hPSCreg; INSRMe006-A
DR   SKIP; SKIP002320
DR   Wikidata; Q54970612
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_209_men2a.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-075-L1.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys634Arg (c.1900T>C); ClinVar=VCV000013917; Zygosity=Unspecified (PubMed=20217271).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3226; Multiple endocrine neoplasia type 2A
DI   ORDO; Orphanet_247698; Multiple endocrine neoplasia type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   STR-I-211-MEN2a
AC   CVCL_C087
SY   STR-211-MEN2a; INSERMe007-A; INSRMe007-A
DR   hPSCreg; INSRMe007-A
DR   SKIP; SKIP002321
DR   Wikidata; Q54970613
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_211_men2a.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-076-L1.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys634Arg (c.1900T>C); ClinVar=VCV000013917; Zygosity=Unspecified (PubMed=20217271).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3226; Multiple endocrine neoplasia type 2A
DI   ORDO; Orphanet_247698; Multiple endocrine neoplasia type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   STR-I-221-Sca2
AC   CVCL_C088
SY   STR-I-221-SCA2; STR-221-SCA2; INSERMe010-A; INSRMe010-A
DR   hPSCreg; INSRMe010-A
DR   SKIP; SKIP002324
DR   Wikidata; Q54970615
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_221_sca2.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-081-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C148315; Spinocerebellar ataxia type 2
DI   ORDO; Orphanet_98756; Spinocerebellar ataxia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   STR-I-229-MTMX
AC   CVCL_C089
SY   STR-229-MTMX; INSERMe011-A; INSRMe011-A
DR   hPSCreg; INSRMe011-A
DR   SKIP; SKIP002325
DR   Wikidata; Q54970623
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_229_mtmx.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-085-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   STR-I-231-MTMX
AC   CVCL_C090
SY   STR-231-MTMX; INSERMe012-A; INSRMe012-A
DR   hPSCreg; INSRMe012-A
DR   SKIP; SKIP002326
DR   Wikidata; Q54970624
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_231_mtmx.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-086-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118781; X-linked centronuclear myopathy
DI   ORDO; Orphanet_596; X-linked centronuclear myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   STR-I-233-FRAXA
AC   CVCL_C091
SY   STR-233-FRAXA; INSERMe002-A; INSRMe002-A
DR   hPSCreg; INSRMe002-A
DR   SKIP; SKIP002309
DR   Wikidata; Q54970625
RX   PubMed=20217271;
RX   PubMed=27690107;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_233_fraxa.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE08-087-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   STR-I-251-CFTR
AC   CVCL_C092
SY   STR-251-CFTR; INSERMe009-A; INSRMe009-A
DR   hPSCreg; INSRMe009-A
DR   SKIP; SKIP002323
DR   Wikidata; Q54970626
RX   PubMed=20217271;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_251_cftr.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-046-L1.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20217271).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   STR-I-301-MFS
AC   CVCL_C093
SY   INSERMe013-A; INSRMe013-A
DR   hPSCreg; INSRMe013-A
DR   SKIP; SKIP002327
DR   Wikidata; Q54970627
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_301_mfs.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-071-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   STR-I-305-APC
AC   CVCL_C094
SY   INSERMe014-A; INSRMe014-A
DR   hPSCreg; INSRMe014-A
DR   SKIP; SKIP002328
DR   Wikidata; Q54970628
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_305_apc.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-073-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   STR-I-315-CMT1a
AC   CVCL_C095
SY   INSERMe015-A; INSRMe015-A
DR   hPSCreg; INSRMe015-A
DR   SKIP; SKIP002329
DR   Wikidata; Q54970629
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_315_cmt1a.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-078-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   STR-I-347-FRAXA
AC   CVCL_C096
SY   INSERMe016-A; INSRMe016-A
DR   hPSCreg; INSRMe016-A
DR   SKIP; SKIP002330
DR   Wikidata; Q54970630
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_347_fraxa.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-094-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   STR-I-355-APC
AC   CVCL_C097
SY   INSERMe017-A; INSRMe017-A
DR   hPSCreg; INSRMe017-A
DR   SKIP; SKIP002331
DR   Wikidata; Q54970631
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_355_apc.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-271-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   STR-I-359-APC
AC   CVCL_C098
SY   INSERMe018-A; INSRMe018-A
DR   hPSCreg; INSRMe018-A
DR   SKIP; SKIP002332
DR   Wikidata; Q54970632
CC   From: INSERM; Paris; France.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3339; Familial adenomatous polyposis
DI   ORDO; Orphanet_733; Familial adenomatous polyposis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   STR-I-437-NF1
AC   CVCL_Y599
DR   Wikidata; Q54970633
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_437_nf1.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-313-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   STR-I-441-NF1
AC   CVCL_Y600
DR   Wikidata; Q54970635
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_441_nf1.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-315-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   STR-I-443-NF1
AC   CVCL_Y601
DR   Wikidata; Q54970636
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/inserm_str_i_443_nf1.pdf
CC   From: INSERM; Paris; France.
CC   Registration: French Agence de la Biomedecine; FE09-316-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   STR0C05
AC   CVCL_9T01
SY   STROC05
DR   Lonza; 1062
DR   Wikidata; Q54970637
RX   Patent=US7666672;
RX   PubMed=18635871;
CC   Group: Patented cell line.
CC   From: ReNeuron, Ltd; Pencoed; United Kingdom.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 04110301.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7553; MYC.
CC   Misspelling: Stroco5; Lonza=1062.
CC   Derived from site: In situ; Fetal brain, forebrain, striatum; UBERON=UBERON_0006240+UBERON_0002435.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12FW
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   STRlar1
AC   CVCL_F1C9
SY   Salmo TRutta larva 1
RX   PubMed=40863973;
CC   Group: Fish cell line.
CC   Biotechnology: Used for ecotoxicological assessments. Has been tested with ethanol, isopropanol, DMSO, and acetone (PubMed=40863973).
CC   Donor information: Obtained from a pool of 5 larvae (PubMed=40863973).
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8032; ! Salmo trutta (Brown trout)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   STRlar2
AC   CVCL_F1CA
SY   Salmo TRutta larva 2
RX   PubMed=40863973;
CC   Group: Fish cell line.
CC   Biotechnology: Used for ecotoxicological assessments. Has been tested with ethanol, isopropanol, DMSO, and acetone (PubMed=40863973).
CC   Donor information: Obtained from a pool of 12 larvae (PubMed=40863973).
CC   Derived from site: In situ; Whole larva; UBERON=UBERON_0002548.
OX   NCBI_TaxID=8032; ! Salmo trutta (Brown trout)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   StromaNKtert
AC   CVCL_4667
DR   CLO; CLO_0051546
DR   BioSample; SAMN03471967
DR   FANTOM5_SSTAR; 10686-109F2
DR   RCB; RCB2350
DR   Wikidata; Q54970638
RX   PubMed=12393449;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Discontinued: RCB; RCB2350; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
ST   Source(s): RCB=RCB2350
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   STS
AC   CVCL_YB15
DR   Wikidata; Q98132861
RX   Patent=US20190300863;
CC   Group: Serum/protein free medium cell line.
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3308.
CC   Derived from site: In situ; Fetal testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2204 ! ST [Pig testis]
SX   Male
AG   80-90FD
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   STS-0421
AC   CVCL_X508
SY   STS 0421; STS0421
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00041
DR   Cosmic-CLP; 1299061
DR   DepMap; ACH-002306
DR   EGA; EGAS00001000978
DR   GDSC; 1299061
DR   PharmacoDB; STS0421_1498_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54970639
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.99%; Native American=0.12%; East Asian, North=0.8%; East Asian, South=0%; South Asian=1.87%; European, North=67.02%; European, South=29.19% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1299061
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 18
//
ID   STS-26T
AC   CVCL_8917
SY   STS-26 T; STS26T; STS26
DR   BTO; BTO_0003226
DR   EFO; EFO_0006296
DR   Cosmic; 1644551
DR   Cosmic; 1801813
DR   Cosmic; 2307728
DR   DepMap; ACH-002695
DR   Wikidata; Q54970640
RX   PubMed=8094415;
RX   PubMed=9766530;
RX   PubMed=16239399;
RX   PubMed=16510576;
RX   PubMed=21084276;
RX   PubMed=22346343;
RX   PubMed=23437333;
RX   PubMed=24726063;
RX   PubMed=28469964;
RX   PubMed=28556483;
RX   PubMed=32076030;
RX   PubMed=32642732;
RX   PubMed=33707600;
RX   PubMed=34059954;
RX   PubMed=36818284;
RX   PubMed=37798904;
CC   Problematic cell line: Misclassified. Originally thought to be a malignant peripheral nerve sheath tumor (MPNST) but shown to be from a melanoma (PubMed=36818284). This is based on a number of criteria such as the result of a methylome-based classifier, immunofluorescence of cell identity markers (SOX9, SOX10, S100B) the presence of a functional PRC2 complex and of the BRAF V600E mutation. It also exhibits a much higher mutation frequency than other MPNST cell lines.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Characteristics: Tumorigenic (PubMed=37798904).
CC   Doubling time: ~16 hours (PubMed=21084276), 0.80 day (PubMed=37798904).
CC   Karyotypic information: Average ploidy of 4.05 (PubMed=36818284).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=21084276).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=36818284).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro114Leu (c.341_342delinsTT) (p.Arg129Cys, c.384_385delinsTT); Zygosity=Heterozygous (PubMed=34059954).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone, left scapula; UBERON=UBERON_0006849.
ST   Source(s): PubMed=28556483; PubMed=32076030; PubMed=33707600; PubMed=36818284
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,10
ST   D16S539: 12,13
ST   D18S51: 17,18
ST   D19S433: 14
ST   D21S11: 30,31 (PubMed=28556483; PubMed=32076030; PubMed=36818284)
ST   D21S11: 31 (PubMed=33707600)
ST   D2S1338: 20
ST   D3S1358: 14 (PubMed=28556483; PubMed=32076030; PubMed=36818284)
ST   D3S1358: 14,20 (PubMed=33707600)
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   Penta D: 8,12
ST   Penta E: 12,13
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   STS255
AC   CVCL_N585
SY   SS255; Bax
DR   Cosmic; 1217469
DR   Wikidata; Q54970641
RX   PubMed=1338692;
RX   PubMed=2704557;
RX   PubMed=7539744;
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=2704557; PubMed=7539744).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   STSA-1
AC   CVCL_D274
SY   STSA_1
DR   ChEMBL-Cells; CHEMBL3307911
DR   ChEMBL-Targets; CHEMBL614303
DR   GEO; GSM1974799
DR   PubChem_Cell_line; CVCL_D274
DR   Wikidata; Q54970642
RX   PubMed=22615950;
RX   PubMed=27197945;
RX   PubMed=27257868;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 40 hours (PubMed=27257868).
CC   Sequence variation: Mutation; VGNC; VGNC:43761; NF1; Simple; p.Met877fs (c.2626dupT); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Transcriptomics; Microarray.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235
ST   Dog FHC2054: 156,164
ST   Dog FHC2079: 271,275
ST   Dog PEZ1: 115,119
ST   Dog PEZ3: 121
ST   Dog PEZ5: 107,111
ST   Dog PEZ6: 179
ST   Dog PEZ8: 228,232
ST   Dog PEZ12: 274,285
ST   Dog PEZ20: 176,184
DI   NCIt; C132276; Canine soft tissue sarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   STSAR-10
AC   CVCL_U567
SY   STSAR10; Soft Tissue SARcoma-10
DR   Wikidata; Q54970644
RX   PubMed=1845955;
RX   PubMed=2573646;
RX   PubMed=3182333;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-100
AC   CVCL_U568
SY   Soft Tissue SARcoma-100
DR   Wikidata; Q54970645
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-104
AC   CVCL_U569
SY   STSAR104; Soft Tissue SARcoma-104
DR   Wikidata; Q54970646
RX   PubMed=1845955;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-11
AC   CVCL_U570
SY   STSAR 11; STSAR11; Soft Tissue SARcoma-11
DR   Wikidata; Q54970647
RX   PubMed=1574572;
RX   PubMed=1845955;
RX   PubMed=2380097;
RX   PubMed=2573646;
RX   PubMed=3182330;
RX   PubMed=3182333;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-13
AC   CVCL_U571
SY   Soft Tissue SARcoma-13
DR   Wikidata; Q54970649
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=2602359;
RX   PubMed=7607972;
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-14
AC   CVCL_U572
SY   STSAR14; Soft Tissue SARcoma-14
DR   Wikidata; Q54970650
RX   PubMed=1845955;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-169
AC   CVCL_U573
SY   Soft Tissue SARcoma-169
DR   Wikidata; Q54970652
RX   PubMed=7607972;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-19
AC   CVCL_U574
SY   STSAR19; Soft Tissue SARcoma-19
DR   Wikidata; Q54970653
RX   PubMed=1845955;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-198
AC   CVCL_U575
SY   Soft Tissue SARcoma-198
DR   Wikidata; Q54970654
RX   PubMed=7607972;
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-2
AC   CVCL_U576
SY   Soft Tissue SARcoma-2
DR   Wikidata; Q54970655
RX   PubMed=2573646;
RX   PubMed=3182333;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-20
AC   CVCL_U577
SY   Soft Tissue SARcoma-20
DR   Wikidata; Q54970656
RX   PubMed=2573646;
RX   PubMed=3182333;
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-21
AC   CVCL_U578
SY   Soft Tissue SARcoma-21
DR   Wikidata; Q54970657
RX   PubMed=2573646;
RX   PubMed=3182333;
DI   NCIt; C3158; Leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-210
AC   CVCL_U579
SY   Soft Tissue SARcoma-210
DR   Wikidata; Q54970658
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-217
AC   CVCL_U580
SY   Soft Tissue SARcoma-217
DR   Wikidata; Q54970659
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   STSAR-22
AC   CVCL_U581
SY   Soft Tissue SARcoma-22
DR   Wikidata; Q54970660
RX   PubMed=2573646;
RX   PubMed=3182333;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-23
AC   CVCL_U582
SY   Soft Tissue SARcoma-23
DR   Wikidata; Q54970661
RX   PubMed=2573646;
RX   PubMed=3182333;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-255
AC   CVCL_U583
SY   Soft Tissue SARcoma-255
DR   Wikidata; Q54970663
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-26
AC   CVCL_U584
SY   Soft Tissue SARcoma-26
DR   Wikidata; Q54970664
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
CC   Derived from site: In situ; Muscle, left triceps brachii; UBERON=UBERON_0001509.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 10
//
ID   STSAR-28
AC   CVCL_U585
SY   Stsar 28; Soft Tissue SARcoma-28
DR   Wikidata; Q54970665
RX   PubMed=1933904;
RX   PubMed=2253180;
RX   PubMed=3182333;
CC   Donor information: Established from a patient originally treated by radiation therapy for a Hodgkin lymphoma (PubMed=2253180).
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 9
//
ID   STSAR-33
AC   CVCL_U586
SY   Soft Tissue SARcoma-33
DR   Wikidata; Q54970667
RX   PubMed=1574572;
RX   PubMed=2380097;
RX   PubMed=2573646;
RX   PubMed=2602359;
RX   PubMed=3182333;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-34
AC   CVCL_U587
SY   Soft Tissue SARcoma-34
DR   Wikidata; Q54970668
RX   PubMed=2573646;
RX   PubMed=3182333;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-35
AC   CVCL_U588
SY   Soft Tissue SARcoma-35
DR   Wikidata; Q54970676
RX   PubMed=2573646;
RX   PubMed=3182333;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-43
AC   CVCL_U589
SY   Soft Tissue SARcoma-43
DR   Wikidata; Q54970677
RX   PubMed=2380097;
RX   PubMed=2573646;
RX   PubMed=2602359;
RX   PubMed=3182333;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-48
AC   CVCL_U590
SY   Soft Tissue SARcoma-48
DR   Wikidata; Q54970678
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2380097;
RX   PubMed=2394610;
RX   PubMed=2602359;
RX   PubMed=7607972;
DI   NCIt; C3269; Schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   STSAR-49
AC   CVCL_U591
SY   Soft Tissue SARcoma-49
DR   Wikidata; Q54970679
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
CC   Derived from site: In situ; Muscle, left biceps brachii; UBERON=UBERON_0001507.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 30-01-24; Version: 11
//
ID   STSAR-5
AC   CVCL_U592
SY   Stsar 5; Soft Tissue SARcoma-5
DR   Wikidata; Q54970680
RX   PubMed=1574572;
RX   PubMed=1933904;
RX   PubMed=2253180;
RX   PubMed=2380097;
RX   PubMed=2602359;
RX   PubMed=3182330;
RX   PubMed=3182333;
CC   Donor information: Established from a patient originally treated by radiation therapy for a breast carcinoma (PubMed=2253180).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 10
//
ID   STSAR-6
AC   CVCL_U593
SY   Soft Tissue SARcoma-6
DR   Wikidata; Q54970681
RX   PubMed=2573646;
RX   PubMed=3182333;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-64
AC   CVCL_U594
SY   Soft Tissue SARcoma-64
DR   Wikidata; Q54970682
RX   PubMed=2573646;
RX   PubMed=3182333;
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-7
AC   CVCL_U595
SY   Soft Tissue SARcoma-7
DR   Wikidata; Q54970683
RX   PubMed=2573646;
RX   PubMed=3182333;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-75
AC   CVCL_U596
SY   Soft Tissue SARcoma-75
DR   Wikidata; Q54970684
RX   PubMed=2380097;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-8
AC   CVCL_U597
SY   Soft Tissue SARcoma-8
DR   Wikidata; Q54970686
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-84
AC   CVCL_U598
SY   Soft Tissue SARcoma-84
DR   Wikidata; Q54970688
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSAR-88
AC   CVCL_U599
SY   STSAR88; Soft Tissue SARcoma-88
DR   Wikidata; Q54970689
RX   PubMed=1845955;
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   STSAR-90
AC   CVCL_U600
SY   STSAR 90; STSAR90; Soft Tissue SARcoma-90
DR   Wikidata; Q54970691
RX   PubMed=1574572;
RX   PubMed=1845955;
RX   PubMed=2380097;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   STSAR-91
AC   CVCL_U601
SY   Soft Tissue SARcoma-91
DR   Wikidata; Q54970692
RX   DOI=10.1007/978-1-4615-2023-8_7;
RX   PubMed=2394610;
RX   PubMed=7607972;
DI   NCIt; C9306; Soft tissue sarcoma
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   STSW-01
AC   CVCL_C5TX
DR   Wikidata; Q116050578
RX   PubMed=35732500;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=35732500).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=35732500).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Trp60Cysfs*62 (c.180delG); Zygosity=Heterozygous; Note=Germline (PubMed=35732500).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Glu122Ter (c.364G>T); ClinVar=VCV001076272; Zygosity=Heterozygous; Note=Germline (PubMed=35732500).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C6557; Schwannomatosis
DI   ORDO; Orphanet_93921; Schwannomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   STSW-01-LUC
AC   CVCL_C5TY
DR   Wikidata; Q116050579
RX   PubMed=35732500;
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Heterozygous (PubMed=35732500).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=35732500).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Trp60Cysfs*62 (c.180delG); Zygosity=Heterozygous; Note=Germline (PubMed=35732500).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Glu122Ter (c.364G>T); ClinVar=VCV001076272; Zygosity=Heterozygous; Note=Germline (PubMed=35732500).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C6557; Schwannomatosis
DI   ORDO; Orphanet_93921; Schwannomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5TX ! STSW-01
SX   Sex unspecified
AG   32Y
CA   Telomerase immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   STUC
AC   CVCL_ZP47
DR   Wikidata; Q98132862
RX   PubMed=24986372;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Glu55Ter (c.163G>T); ClinVar=VCV000975158; Zygosity=Homozygous (PubMed=24986372).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   STW-1
AC   CVCL_W828
DR   cancercelllines; CVCL_W828
DR   Wikidata; Q54970693
RX   DOI=10.6342/NTU.2004.01000;
CC   Population: Chinese; Taiwan.
CC   Characteristics: Produces IgD lambda.
CC   Karyotypic information: Near pseudodiploid with monosomy 13 karyotype (DOI=10.6342/NTU.2004.01000).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1582; CCND1 + HGNC; HGNC:5477; IGH; Name(s)=IGH-CCND1 (DOI=10.6342/NTU.2004.01000).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000045117; Zygosity=Unspecified (DOI=10.6342/NTU.2004.01000).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu221Asp (c.663G>T); Zygosity=Unspecified (DOI=10.6342/NTU.2004.01000).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Unspecified (DOI=10.6342/NTU.2004.01000).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 17
//
ID   STY51
AC   CVCL_S993
SY   Sty51
DR   BioSamples; SAMEA101016
DR   cancercelllines; CVCL_S993
DR   Cosmic; 1522769
DR   Cosmic; 1963333
DR   GEO; GSM726283
DR   Progenetix; CVCL_S993
DR   Wikidata; Q54970694
RX   PubMed=21642991;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 12
//
ID   SU
AC   CVCL_W201
DR   Wikidata; Q54970695
RX   PubMed=3164747;
RX   PubMed=6963945;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Su Mor
AC   CVCL_F121
DR   ATCC; CRL-1150
DR   Wikidata; Q54970697
CC   Discontinued: ATCC; CRL-1150; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII
DI   ORDO; Orphanet_1899; Arthrochalasia Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   SU-1
AC   CVCL_B6CB
DR   Wikidata; Q112041739
RX   DOI=10.1080/00021369.1986.10867575;
RX   PubMed=1368811;
RX   PubMed=3804938;
RX   PubMed=22359119;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Nucleic acids: dsDNA, ssDNA and RNA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z045 ! HO-323
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   SU-211-10
AC   CVCL_XJ92
DR   CCRID; 4201PAT-CCTCC00240
DR   Wikidata; Q98132863
RX   Patent=CN101393218A;
RX   PubMed=21315921;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200813.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_30958; Sudan I (CI Solvent Yellow 14).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   Su-2E4
AC   CVCL_D6DB
DR   Wikidata; Q127384337
RX   PubMed=2460104;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P08621; Human SNRNP70.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C84892; Mixed connective tissue disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 3
//
ID   SU-ALL-1
AC   CVCL_IV39
SY   Stanford University-Acute Lymphoblastic Leukemia-1
DR   Wikidata; Q54970698
RX   PubMed=83902;
RX   PubMed=371794;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SU-ALL-2
AC   CVCL_IV40
SY   Stanford University-Acute Lymphoblastic Leukemia-2
DR   Wikidata; Q54970699
RX   PubMed=83902;
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 05-10-23; Version: 5
//
ID   SU-AmB-1
AC   CVCL_IV29
SY   SU-AMB-1; SUAmB1; Stanford University-American Burkitt-1
DR   Wikidata; Q54970700
RX   PubMed=83902;
RX   PubMed=174098;
RX   PubMed=371794;
RX   PubMed=6804087;
CC   Virology: EBV-negative.
CC   Derived from site: Metastatic; Peritoneal effusion; UBERON=UBERON_0001268.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   SU-AmB-2
AC   CVCL_IV30
SY   SU-AMB-2; SUAmB2; Stanford University-American Burkitt-2; Switzer
DR   Wikidata; Q54970702
RX   PubMed=83902;
RX   PubMed=174098;
RX   PubMed=205666;
RX   PubMed=371794;
RX   PubMed=3026973;
RX   PubMed=6804087;
RX   PubMed=24590883;
CC   Virology: Contains mutliple copies of integrated and non-integrated (circular) copies of EBV genome.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 8
//
ID   SU-AmB-3
AC   CVCL_IV31
SY   SU-AMB-3; Stanford University-American Burkitt-3
DR   Wikidata; Q54970703
RX   PubMed=83902;
RX   PubMed=6804087;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_100; Ataxia telangiectasia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 7
//
ID   SU-CCS-1
AC   CVCL_B470
SY   Su-ccs-1; Su CCS-1; SU-CCS1; SUCCS1
DR   ATCC; CRL-2971
DR   Cosmic; 1092866
DR   EGA; EGAD00001008611
DR   Wikidata; Q54970704
RX   PubMed=6362860;
RX   PubMed=7753552;
RX   PubMed=12966428;
RX   PubMed=15150091;
RX   PubMed=16766266;
RX   PubMed=28745431;
RX   PubMed=36959380;
CC   Population: Caucasian.
CC   Doubling time: ~52 hours (PubMed=6362860).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 1: EWSR1 exon 8 fused to ATF1 exon 4 (PubMed=7753552; PubMed=15150091; PubMed=28745431).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2971; PubMed=36959380
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 16,20
ST   D3S1358: 15,18
ST   D5S818: 12,14
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 22.2,24
ST   Penta D: 9,12
ST   Penta E: 12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   SU-DHL-1
AC   CVCL_0538
SY   SU-DHL1; SUDHL1; SUDHL-1; SuDHL-1; SuDHL 1; Stanford University-Diffuse Histiocytic Lymphoma-1
DR   BTO; BTO_0005058
DR   CLO; CLO_0009160
DR   EFO; EFO_0005461
DR   MCCL; MCC:0000439
DR   AddexBio; C0003020/4894
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2955
DR   BioSample; SAMN03471710
DR   BioSample; SAMN10988544
DR   cancercelllines; CVCL_0538
DR   Cell_Model_Passport; SIDM00390
DR   ChEMBL-Cells; CHEMBL3308303
DR   ChEMBL-Targets; CHEMBL2366200
DR   Cosmic; 909742
DR   Cosmic; 946364
DR   Cosmic; 1086003
DR   Cosmic; 1086367
DR   Cosmic; 1086753
DR   Cosmic; 1152235
DR   Cosmic; 1995646
DR   Cosmic; 2361379
DR   Cosmic; 2674496
DR   Cosmic-CLP; 909742
DR   DepMap; ACH-000664
DR   DSMZ; ACC-356
DR   DSMZCellDive; ACC-356
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909742
DR   GEO; GSM887652
DR   GEO; GSM888744
DR   GEO; GSM1217155
DR   GEO; GSM1670482
DR   IARC_TP53; 27247
DR   LiGeA; CCLE_319
DR   LINCS_LDP; LCL-1918
DR   PharmacoDB; SUDHL1_1499_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0538
DR   PubChem_Cell_line; CVCL_0538
DR   Wikidata; Q54970705
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.1159/000415060;
RX   PubMed=83902;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=2525056;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=3881165;
RX   PubMed=4140017;
RX   PubMed=7824924;
RX   PubMed=8547074;
RX   PubMed=8558920;
RX   PubMed=9121481;
RX   PubMed=9738977;
RX   PubMed=11021758;
RX   PubMed=11494142;
RX   PubMed=15356658;
RX   PubMed=16596703;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=20922763;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26657151;
RX   PubMed=27397505;
RX   PubMed=29899875;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-356).
CC   HLA typing: A*02:01,68:02; B*55:01,55:01; C*03:03,06:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,68:02:01; B*55:01:01,55:01:01; C*03:03:01,06:02:01 (DSMZCellDive=ACC-356).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=7824924; PubMed=9121481; PubMed=25485619; PubMed=26657151; PubMed=29899875).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (Cosmic-CLP=909742).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.76%; Native American=22.55%; East Asian, North=5.57%; East Asian, South=0%; South Asian=0%; European, North=43.3%; European, South=24.81% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0003020/4894; ATCC=CRL-2955; COG; Cosmic-CLP=909742; DSMZ=ACC-356; PubMed=20922763; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 12,16
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 15 (COG; DSMZ=ACC-356; PubMed=25877200)
ST   D3S1358: 15,16 (PubMed=20922763)
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 11
ST   FGA: 21
ST   Penta D: 14
ST   Penta E: 11,15
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SU-DHL-10
AC   CVCL_1889
SY   Su-DHL-10; SUDHL10; Sudhl10; SUDHL-10; SuDHL 10; Stanford University-Diffuse Histiocytic Lymphoma-10; DHL10
DR   CLO; CLO_0037059
DR   EFO; EFO_0002354
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2963
DR   BioGRID_ORCS_Cell_line; 1024
DR   BioSample; SAMN03471872
DR   BioSample; SAMN10988471
DR   cancercelllines; CVCL_1889
DR   CCTCC; GDC0217
DR   Cell_Model_Passport; SIDM00389
DR   ChEMBL-Cells; CHEMBL4483178
DR   ChEMBL-Targets; CHEMBL4483268
DR   Cosmic; 850207
DR   Cosmic; 1067460
DR   Cosmic; 1079257
DR   Cosmic; 1517644
DR   Cosmic; 1541914
DR   Cosmic; 1636685
DR   Cosmic; 2276343
DR   Cosmic; 2361377
DR   Cosmic-CLP; 1331033
DR   DepMap; ACH-000271
DR   DSMZ; ACC-576
DR   DSMZCellDive; ACC-576
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1331033
DR   GEO; GSM380143
DR   GEO; GSM552468
DR   GEO; GSM887651
DR   GEO; GSM888743
DR   GEO; GSM1035312
DR   GEO; GSM1059808
DR   GEO; GSM1374904
DR   GEO; GSM1670483
DR   IARC_TP53; 28255
DR   IGRhCellID; SUDHL10
DR   LiGeA; CCLE_214
DR   LINCS_LDP; LCL-1134
DR   PharmacoDB; SUDHL10_1500_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1889
DR   PubChem_Cell_line; CVCL_1889
DR   Wikidata; Q54970706
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83902;
RX   PubMed=177185;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=1465024;
RX   PubMed=3881165;
RX   PubMed=8547074;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20054396;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=23257783;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~15-30 hours (DSMZ=ACC-576).
CC   HLA typing: A*31:01,31:01; B*40:01,40:01; C*03:04,03:04 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr68His (c.202T>C); ClinVar=VCV000189474; Zygosity=Homozygous (PubMed=9787181; Cosmic-CLP=1331033; DepMap=ACH-000271).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp162His (c.484G>C); Zygosity=Homozygous (PubMed=9787181; Cosmic-CLP=1331033; DepMap=ACH-000271).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.994-1G>A; ClinVar=VCV000142161; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=1331033; DepMap=ACH-000271).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.75%; Native American=0%; East Asian, North=4.02%; East Asian, South=0%; South Asian=0%; European, North=61.61%; European, South=31.62% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2963; Cosmic-CLP=1331033; DSMZ=ACC-576; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 31
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 8
ST   FGA: 22,23
ST   Penta D: 9,11
ST   Penta E: 16,17
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SU-DHL-11
AC   CVCL_W958
SY   SUDHL11; Stanford University-Diffuse Histiocytic Lymphoma-11; DHL-11
DR   Wikidata; Q54970707
RX   PubMed=83902;
RX   PubMed=3881165;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   SU-DHL-12
AC   CVCL_W959
SY   SUDHL12; Stanford University-Diffuse Histiocytic Lymphoma-12; DHL-12
DR   Wikidata; Q54970708
RX   PubMed=83902;
RX   PubMed=3881165;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   SU-DHL-13
AC   CVCL_H736
SY   SUDHL13; Stanford University-Diffuse Histiocytic Lymphoma-13; DHL-13
DR   Wikidata; Q54970709
RX   PubMed=3881165;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   SU-DHL-14
AC   CVCL_W960
SY   SUDHL14; Stanford University-Diffuse Histiocytic Lymphoma-14; DHL-14
DR   Wikidata; Q54970710
RX   PubMed=3881165;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   SU-DHL-15
AC   CVCL_W961
SY   SUDHL15; Stanford University-Diffuse Histiocytic Lymphoma-15; DHL-15
DR   Wikidata; Q54970711
RX   PubMed=3881165;
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   SU-DHL-16
AC   CVCL_1890
SY   SUDHL16; SuDHL16; SUDHL-16; Stanford University-Diffuse Histiocytic Lymphoma-16; DHL-16
DR   CLO; CLO_0037060
DR   EFO; EFO_0002355
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2964
DR   BioSample; SAMN03472751
DR   cancercelllines; CVCL_1890
DR   Cell_Model_Passport; SIDM00404
DR   ChEMBL-Cells; CHEMBL4523528
DR   ChEMBL-Targets; CHEMBL4523559
DR   Cosmic; 1070713
DR   Cosmic-CLP; 1331034
DR   DepMap; ACH-002307
DR   DSMZ; ACC-577
DR   DSMZCellDive; ACC-577
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1331034
DR   GEO; GSM380144
DR   GEO; GSM1035310
DR   GEO; GSM1670484
DR   GEO; GSM3150256
DR   IGRhCellID; SUDHL16
DR   IZSLER; BS TCL 226
DR   LINCS_LDP; LCL-1135
DR   PharmacoDB; SUDHL16_1501_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1890
DR   PubChem_Cell_line; CVCL_1890
DR   Wikidata; Q54970713
RX   PubMed=19278952;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (DSMZ=ACC-577).
CC   HLA typing: A*01:01,01:01; B*08:01,08:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.78%; Native American=0.75%; East Asian, North=0%; East Asian, South=0%; South Asian=2.95%; European, North=66.22%; European, South=29.29% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2964; Cosmic-CLP=1331034; DSMZ=ACC-577; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,13
ST   D19S433: 12,13
ST   D21S11: 30,31
ST   D2S1338: 26
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 20,21
ST   Penta D: 10,13
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SU-DHL-2
AC   CVCL_9550
SY   SUDHL2; SUDHL-2; Su-DHL-2; SU-DHL2; SuDHL 2; Stanford University-Diffuse Histiocytic Lymphoma-2; DHL-2
DR   BTO; BTO_0006463
DR   EFO; EFO_0007611
DR   ATCC; CRL-2956
DR   ChEMBL-Cells; CHEMBL4523529
DR   ChEMBL-Targets; CHEMBL4523560
DR   Cosmic; 1289989
DR   Cosmic; 1486588
DR   Cosmic; 1517653
DR   Cosmic; 1550339
DR   Cosmic; 1636686
DR   Cosmic; 2361374
DR   DSMZ; ACC-902
DR   DSMZCellDive; ACC-902
DR   ENCODE; ENCBS354PZC
DR   ENCODE; ENCBS446LEC
DR   ENCODE; ENCBS621PAH
DR   ENCODE; ENCBS775VGT
DR   GEO; GSM1374905
DR   PubChem_Cell_line; CVCL_9550
DR   Wikidata; Q54970715
RX   PubMed=83902;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=4140017;
RX   PubMed=8547074;
RX   PubMed=15356658;
RX   PubMed=21179087;
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (DSMZ=ACC-902).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Ser209Arg (c.627T>G) (p.Ser222Arg, c.666T>G) (S222R); Zygosity=Heterozygous (PubMed=21179087).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2956; DSMZ=ACC-902
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 14
ST   D18S51: 11
ST   D19S433: 12
ST   D21S11: 30
ST   D2S1338: 17,24
ST   D3S1358: 14,19
ST   D5S818: 13
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 21,26
ST   Penta D: 13
ST   Penta E: 7,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 28
//
ID   SU-DHL-3
AC   CVCL_W769
SY   SU-DHL-3 (clone 1); Stanford University-Diffuse Histiocytic Lymphoma-3; DHL-3
DR   Wikidata; Q54970716
RX   PubMed=83902;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=4140017;
CC   Population: Asian.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   SU-DHL-4
AC   CVCL_0539
SY   SUDHL4; Sudhl4; SUDHL-4; Sudhl-4; SuDHL 4; SUD-4; SUD4; SU4; Stanford University-Diffuse Histiocytic Lymphoma-4; DHL-4; DHL4
DR   BTO; BTO_0006462
DR   CLO; CLO_0037061
DR   EFO; EFO_0006492
DR   MCCL; MCC:0000440
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2957
DR   BioGRID_ORCS_Cell_line; 742
DR   BioSample; SAMN03473232
DR   BioSample; SAMN10988472
DR   cancercelllines; CVCL_0539
DR   CCRID; 3101HUMSCSP5048
DR   Cell_Model_Passport; SIDM00405
DR   ChEMBL-Cells; CHEMBL3308053
DR   ChEMBL-Targets; CHEMBL613711
DR   CLS; 305106
DR   Cosmic; 850203
DR   Cosmic; 932763
DR   Cosmic; 999780
DR   Cosmic; 1067443
DR   Cosmic; 1079254
DR   Cosmic; 1517656
DR   Cosmic; 1541909
DR   Cosmic; 1636687
DR   Cosmic; 1714160
DR   Cosmic; 1945192
DR   Cosmic; 2276338
DR   Cosmic; 2361375
DR   Cosmic; 2437313
DR   Cosmic-CLP; 1331035
DR   DepMap; ACH-000365
DR   DSMZ; ACC-495
DR   DSMZCellDive; ACC-495
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS265MKB
DR   ENCODE; ENCBS980NLV
DR   GDSC; 1331035
DR   GEO; GSM274842
DR   GEO; GSM380145
DR   GEO; GSM499735
DR   GEO; GSM552463
DR   GEO; GSM562826
DR   GEO; GSM887653
DR   GEO; GSM888745
DR   GEO; GSM1035322
DR   GEO; GSM1374906
DR   GEO; GSM1670485
DR   IARC_TP53; 25031
DR   IARC_TP53; 28236
DR   ICLC; HTL10002
DR   LiGeA; CCLE_386
DR   LINCS_LDP; LCL-1136
DR   Lonza; 270
DR   PharmacoDB; SUDHL4_1502_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0539
DR   PubChem_Cell_line; CVCL_0539
DR   Ubigene; YC-C082
DR   Wikidata; Q54970717
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   DOI=10.11418/jtca1981.15.4_211;
RX   PubMed=83902;
RX   PubMed=177185;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=2875799;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=3881165;
RX   PubMed=8547074;
RX   PubMed=8957066;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=12169673;
RX   PubMed=17363600;
RX   PubMed=18357372;
RX   PubMed=19278952;
RX   PubMed=20054396;
RX   PubMed=20628145;
RX   PubMed=20889926;
RX   PubMed=22460905;
RX   PubMed=23292937;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28356514;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30165192;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (DSMZ=ACC-495).
CC   HLA typing: A*02:01,03:01; B*15:01,15:01; C*03:04,03:04 (PubMed=26589293).
CC   HLA typing: A*02:01:01,02:01:01; B*15:01:01,15:01:01; C*03:04:01,03:04:01; DPA1*02:01:02,02:01:02; DPB1*01:01:01,01:01:01; DQA1*01:02:01,01:02:01; DQB1*06:02:01,06:02:01; DRA*01:02:03,01:02:03; DRB1*15:01:01,15:01:01 (DSMZCellDive=ACC-495).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=2875799).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr646Ser (c.1937A>C) (Y641S); ClinVar=VCV000376218; Zygosity=Heterozygous (Cosmic-CLP=1331035; DepMap=ACH-000365).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr666Asn (c.1996T>A) (Y661N); Zygosity=Heterozygous (Cosmic-CLP=1331035; DepMap=ACH-000365).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=17363600; Cosmic-CLP=1331035; DepMap=ACH-000365).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.07%; East Asian, North=0%; East Asian, South=0.49%; South Asian=0%; European, North=60.53%; European, South=37.92% (PubMed=30894373).
CC   Discontinued: ICLC; HTL10002; true.
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): ATCC=CRL-2957; Cosmic-CLP=1331035; DSMZ=ACC-495; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 19,21
ST   Penta D: 9,14
ST   Penta E: 7,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   SU-DHL-4/12V
AC   CVCL_KU32
SY   DHL-4/12V
DR   cancercelllines; CVCL_KU32
DR   Wikidata; Q54970719
RX   PubMed=18357372;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr646Ser (c.1937A>C) (Y641S); ClinVar=VCV000376218; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr666Asn (c.1996T>A) (Y661N); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0539 ! SU-DHL-4
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   SU-DHL-5
AC   CVCL_1735
SY   Su-DHL-5; SUDHL5; SUDHL-5; SU-DH-L5; SuDHL 5; Stanford University-Diffuse Histiocytic Lymphoma-5; DHL-5; DHL5
DR   CLO; CLO_0037062
DR   EFO; EFO_0002356
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-4956
DR   ATCC; CRL-2958
DR   BioGRID_ORCS_Cell_line; 1025
DR   BioSample; SAMN03472762
DR   BioSample; SAMN10989557
DR   cancercelllines; CVCL_1735
DR   Cell_Model_Passport; SIDM00406
DR   ChEMBL-Cells; CHEMBL4523530
DR   ChEMBL-Targets; CHEMBL4523561
DR   Cosmic; 850204
DR   Cosmic; 1079255
DR   Cosmic; 1517657
DR   Cosmic; 1541910
DR   Cosmic; 2276339
DR   Cosmic; 2361380
DR   Cosmic; 2437314
DR   Cosmic-CLP; 1331036
DR   DepMap; ACH-000660
DR   DSMZ; ACC-571
DR   DSMZCellDive; ACC-571
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1331036
DR   GEO; GSM1962
DR   GEO; GSM380146
DR   GEO; GSM552464
DR   GEO; GSM887654
DR   GEO; GSM888746
DR   GEO; GSM1035317
DR   GEO; GSM1151287
DR   GEO; GSM1374907
DR   GEO; GSM1670486
DR   IARC_TP53; 30173
DR   IGRhCellID; SUDHL5
DR   LiGeA; CCLE_716
DR   LINCS_LDP; LCL-1137
DR   PharmacoDB; SUDHL5_1503_2019
DR   Progenetix; CVCL_1735
DR   PubChem_Cell_line; CVCL_1735
DR   Wikidata; Q54970720
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83902;
RX   PubMed=177185;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=8547074;
RX   PubMed=9787181;
RX   PubMed=10676951;
RX   PubMed=19278952;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=27566572;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572).
CC   Doubling time: ~40 hours (DSMZ=ACC-571).
CC   HLA typing: A*03:01,24:02; B*07:02,52:01; C*07:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.37%; Native American=0%; East Asian, North=1.36%; East Asian, South=0%; South Asian=1.05%; European, North=63.92%; European, South=32.3% (PubMed=30894373).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-2958; Cosmic-CLP=1331036; DSMZ=ACC-571; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 5,19
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SU-DHL-6
AC   CVCL_2206
SY   SUDHL6; SuDHL6; SU-DHL6; SUDHL-6; SuDHL-6; Sudhl-6; SUD6; Stanford University-Diffuse Histiocytic Lymphoma-6; DHL-6; DHL6
DR   CLO; CLO_0037063
DR   EFO; EFO_0002357
DR   AddexBio; C0003011/4672
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2959
DR   BioSample; SAMN03471138
DR   BioSample; SAMN10989551
DR   cancercelllines; CVCL_2206
DR   CCRID; 5301HUM-KCB1629YJA
DR   CCTCC; GDC0164
DR   Cell_Model_Passport; SIDM00407
DR   ChEMBL-Cells; CHEMBL4295461
DR   Cosmic; 687854
DR   Cosmic; 850205
DR   Cosmic; 1070712
DR   Cosmic; 1329089
DR   Cosmic; 1517640
DR   Cosmic; 1541911
DR   Cosmic; 1629935
DR   Cosmic; 1636688
DR   Cosmic; 1714158
DR   Cosmic; 2276340
DR   Cosmic; 2297009
DR   Cosmic; 2437315
DR   Cosmic-CLP; 1331037
DR   DepMap; ACH-000611
DR   DSMZ; ACC-572
DR   DSMZCellDive; ACC-572
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ENCODE; ENCBS107PVI
DR   ENCODE; ENCBS136LHJ
DR   ENCODE; ENCBS401ZBX
DR   ENCODE; ENCBS782RBW
DR   GDSC; 1331037
DR   GEO; GSM1955
DR   GEO; GSM115975
DR   GEO; GSM201348
DR   GEO; GSM380147
DR   GEO; GSM552465
DR   GEO; GSM887655
DR   GEO; GSM888747
DR   GEO; GSM1035311
DR   GEO; GSM1374908
DR   GEO; GSM1670487
DR   IARC_TP53; 28323
DR   IGRhCellID; SUDHL6
DR   KCB; KCB 2016029YJ-A
DR   LiGeA; CCLE_578
DR   LINCS_LDP; LCL-1138
DR   Lonza; 942
DR   MetaboLights; MTBLS774
DR   PharmacoDB; SUDHL6_1504_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2206
DR   PubChem_Cell_line; CVCL_2206
DR   Wikidata; Q54970721
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83902;
RX   PubMed=177185;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=7849311;
RX   PubMed=9738977;
RX   PubMed=9787181;
RX   PubMed=10676951;
RX   PubMed=12169673;
RX   PubMed=15122589;
RX   PubMed=16960149;
RX   PubMed=19278952;
RX   PubMed=20054396;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=20889926;
RX   PubMed=22460905;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: ~35-40 hours (DSMZ=ACC-572).
CC   HLA typing: A*11 (PubMed=25960936).
CC   HLA typing: A*02:01,23:01; B*15:01,49:01; C*03:03,07:06 (PubMed=26589293).
CC   HLA typing: A*02:01:01,23:01:01; B*15:01:01,49:01:01; C*03:03:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:02:01,04:01:01; DQA1*01:02:01,03:01:01; DQB1*03:02:01,05:02:01; DRA*01:01:01,01:01:02; DRB1*01:01:01,04:01:01 (DSMZCellDive=ACC-572).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (DSMZ=ACC-572).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr646Ser (c.1937A>C) (Y641S); ClinVar=VCV000376218; Zygosity=Heterozygous (Cosmic-CLP=1331037; DepMap=ACH-000611).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln211Ter (c.631C>T); Zygosity=Heterozygous (Cosmic-CLP=1331037; DepMap=ACH-000611).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu4712Ter (c.14134G>T); Zygosity=Heterozygous (Cosmic-CLP=1331037; DepMap=ACH-000611).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>C (IVS6-2A>C); ClinVar=VCV000635387; Zygosity=Heterozygous; Note=Splice acceptor mutation (Cosmic-CLP=1331037; DepMap=ACH-000611).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Heterozygous (Cosmic-CLP=1331037; DepMap=ACH-000611).
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.74%; Native American=0%; East Asian, North=1.8%; East Asian, South=0%; South Asian=0%; European, North=59.44%; European, South=36.02% (PubMed=30894373).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
ST   Source(s): AddexBio=C0003011/4672; ATCC=CRL-2959; CCRID=5301HUM-KCB1629YJA; Cosmic-CLP=1331037; DSMZ=ACC-572; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 18,19
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 20,24
ST   Penta D: 8,10
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   SU-DHL-7
AC   CVCL_4380
SY   SUDHL7; SUDHL-7; SuDHL 7; Stanford University-Diffuse Histiocytic Lymphoma-7; DHL-7; DHL7
DR   cancercelllines; CVCL_4380
DR   Cosmic; 850206
DR   Cosmic; 1290018
DR   Cosmic; 1517608
DR   Cosmic; 1541912
DR   Cosmic; 1945193
DR   Cosmic; 2276341
DR   Cosmic; 2361373
DR   DSMZ; ACC-903
DR   DSMZCellDive; ACC-903
DR   GEO; GSM380148
DR   GEO; GSM552466
DR   GEO; GSM1035335
DR   Progenetix; CVCL_4380
DR   Wikidata; Q54970722
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83902;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=8547074;
RX   PubMed=9787181;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20628145;
RX   PubMed=23292937;
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00557.
CC   Doubling time: ~50 hours (DSMZ=ACC-903).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Caution: Was reported in Cellosaurus and the ICLAC Register (from 2018 to early 2022) to be a SU-DHL-8 contaminated cell line but there seem to have been an issue with the sample tested. DSMZ has obtained original stock from Epstein A.L. and SU-DHL-7 is a genuine non-problematic cell line.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-903
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 32.2
ST   D2S1338: 16,20
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 20,25
ST   Penta D: 13
ST   Penta E: 12,15
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   SU-DHL-8
AC   CVCL_2207
SY   SUDHL8; SUDHL-8; SuDHL 8; Stanford University-Diffuse Histiocytic Lymphoma-8; DHL-8; DHL8
DR   CLO; CLO_0037064
DR   EFO; EFO_0006493
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2961
DR   BioGRID_ORCS_Cell_line; 1026
DR   BioSample; SAMN03471060
DR   BioSample; SAMN10988104
DR   cancercelllines; CVCL_2207
DR   Cell_Model_Passport; SIDM00423
DR   ChEMBL-Cells; CHEMBL4523531
DR   ChEMBL-Targets; CHEMBL4523562
DR   Cosmic; 1067442
DR   Cosmic; 1079256
DR   Cosmic; 1295511
DR   Cosmic; 1517639
DR   Cosmic; 1541913
DR   Cosmic; 1636689
DR   Cosmic; 2276342
DR   Cosmic; 2361381
DR   Cosmic; 2437316
DR   Cosmic-CLP; 1331038
DR   DepMap; ACH-000656
DR   DSMZ; ACC-573
DR   DSMZCellDive; ACC-573
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1331038
DR   GEO; GSM380149
DR   GEO; GSM552467
DR   GEO; GSM887656
DR   GEO; GSM888748
DR   GEO; GSM1035316
DR   GEO; GSM1374909
DR   GEO; GSM1670488
DR   IARC_TP53; 28301
DR   LiGeA; CCLE_179
DR   LINCS_LDP; LCL-1139
DR   PharmacoDB; SUDHL8_1505_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2207
DR   PubChem_Cell_line; CVCL_2207
DR   Wikidata; Q54970731
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83902;
RX   PubMed=177185;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=8547074;
RX   PubMed=19278952;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~48-72 hours (DSMZ=ACC-573).
CC   HLA typing: A*03:01,03:01; B*44:02,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Pro648Thrfs*2 (c.1940dupC) (c.1940_1941insC); ClinVar=VCV000432829; Zygosity=Heterozygous (Cosmic-CLP=1331038; DepMap=ACH-000656).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Asn (c.700T>A); ClinVar=VCV000376692; Zygosity=Heterozygous (Cosmic-CLP=1331038; DepMap=ACH-000656).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Heterozygous (Cosmic-CLP=1331038; DepMap=ACH-000656).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.67%; Native American=0%; East Asian, North=0.1%; East Asian, South=0%; South Asian=2.54%; European, North=64.1%; European, South=32.58% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2961; Cosmic-CLP=1331038; DSMZ=ACC-573; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 14,19
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 17,20
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 13 (PubMed=25877200)
ST   D8S1179: 13,18 (DSMZ=ACC-573)
ST   FGA: 25
ST   Penta D: 11,12
ST   Penta E: 14,17
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SU-DHL-9
AC   CVCL_4379
SY   SUDHL9; SUDHL-9; SuDHL 9; Stanford University-Diffuse Histiocytic Lymphoma-9; DHL-9; DHL9
DR   BTO; BTO_0001617
DR   cancercelllines; CVCL_4379
DR   Cosmic; 2361382
DR   GEO; GSM380150
DR   Wikidata; Q54970733
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=83902;
RX   PubMed=177185;
RX   PubMed=214220;
RX   PubMed=371794;
RX   PubMed=3881165;
RX   PubMed=8547074;
RX   PubMed=9738977;
RX   PubMed=19278952;
RX   PubMed=23699601;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SU-DHL-8 derivative (ICLAC). Originally thought to originate from a 64 year old female patient with a diffuse large B-cell lymphoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00558.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Pro648Thrfs*2 (c.1940dupC) (c.1940_1941insC); ClinVar=VCV000432829; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Asn (c.700T>A); ClinVar=VCV000376692; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Gly (c.745A>G); ClinVar=VCV000376654; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ICLAC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D5S818: 11,13
ST   D7S820: 8
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2207 ! SU-DHL-8
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   SU-DIPG-IV
AC   CVCL_IT39
AS   CVCL_IP14
SY   SUDIPGIV; SU-DIPG-4; SUDIPG4; DIPG IV; DIPGIV; DIPG 4; DIPG-4; DIPG4; SJHGG054832; Stanford University-Diffuse Intrinsic Pontine Glioma-IV
DR   BTO; BTO_0005955
DR   cancercelllines; CVCL_IT39
DR   GEO; GSM4969586
DR   GEO; GSM4969587
DR   GEO; GSM4969588
DR   GEO; GSM4969589
DR   GEO; GSM4969615
DR   GEO; GSM4969637
DR   GEO; GSM4969638
DR   GEO; GSM4969639
DR   Wikidata; Q54970734
RX   PubMed=25366336;
RX   PubMed=25939062;
RX   PubMed=28823557;
RX   PubMed=31439867;
RX   PubMed=33319914;
RX   PubMed=34078608;
RX   PubMed=34215733;
CC   Doubling time: 3.0 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Gly328Val (c.983G>T); ClinVar=VCV000376363; Zygosity=Unspecified (PubMed=28823557).
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Unspecified (PubMed=25939062).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062; PubMed=28823557
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 7,12
ST   D16S539: 9,12
ST   D21S11: 29,31
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2-3Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 13
//
ID   SU-DIPG-VI
AC   CVCL_IT40
AS   CVCL_IP15
SY   SU-DIPGVI; SUDIPGVI; SU-DIPG-6; DIPG 6; DIPG-6; DIPG6; SJHGG042550; Stanford University-Diffuse Intrinsic Pontine Glioma-VI
DR   BTO; BTO_0005954
DR   cancercelllines; CVCL_IT40
DR   Wikidata; Q54970735
RX   PubMed=24777482;
RX   PubMed=25366336;
RX   PubMed=25939062;
RX   PubMed=28823557;
RX   PubMed=33319914;
RX   PubMed=34215733;
RX   PubMed=34732238;
WW   Info; -; -; https://mckennaclairefoundation.org/
CC   Doubling time: 5.8 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu198Ter (c.592G>T); ClinVar=VCV000634704; Zygosity=Unspecified (PubMed=34732238).
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from a sample taken just after the death at age 7 of McKenna Wetzel. When McKenna died, the Wetzels donated to researchers at Stanford University the tissues that allowed this cell line to be derived. They also created the McKenna Claire Foundation's whose mission is to help cure pediatric brain cancer by raising awareness, increasing community involvement and funding research.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062; PubMed=28823557; PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 9,10 (PubMed=28823557)
ST   CSF1PO: 10,11 (PubMed=25939062; PubMed=34732238)
ST   D13S317: 11
ST   D16S539: 8,13 (PubMed=25939062; PubMed=28823557)
ST   D16S539: 13 (PubMed=34732238)
ST   D21S11: 29,30,31 (PubMed=34732238)
ST   D21S11: 29,31 (PubMed=25939062; PubMed=28823557)
ST   D5S818: 10,12
ST   D7S820: 8,9
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18 (PubMed=25939062; PubMed=28823557)
ST   vWA: 18 (PubMed=34732238)
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 16
//
ID   SU-DIPG-XIII
AC   CVCL_IT41
SY   SU DIPG XIII; SU-DIPGXIII; SU-DIPG-13; DIPG XIII; DIPGXIII; SJHGG054833; Stanford University-Diffuse Intrinsic Pontine Glioma-XIII
DR   cancercelllines; CVCL_IT41
DR   GEO; GSM4969590
DR   GEO; GSM4969591
DR   GEO; GSM4969592
DR   GEO; GSM4969593
DR   GEO; GSM4969619
DR   GEO; GSM4969628
DR   GEO; GSM4969629
DR   GEO; GSM4969630
DR   GEO; GSM4969657
DR   GEO; GSM5356026
DR   Wikidata; Q54970736
RX   PubMed=25939062;
RX   PubMed=26115193;
RX   PubMed=28823557;
RX   PubMed=31439867;
RX   PubMed=33319914;
RX   PubMed=34078608;
RX   PubMed=34215733;
RX   PubMed=34732238;
CC   Doubling time: 6.6 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Unspecified (PubMed=34732238).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=25939062; PubMed=28823557; PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11 (PubMed=34732238)
ST   D13S317: 11,12 (PubMed=25939062; PubMed=28823557)
ST   D16S539: 11,12
ST   D21S11: 30 (PubMed=25939062; PubMed=28823557)
ST   D21S11: 30,31 (PubMed=34732238)
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 6 (PubMed=34732238)
ST   TH01: 6,7 (PubMed=25939062; PubMed=28823557)
ST   TPOX: 8 (PubMed=25939062; PubMed=28823557)
ST   TPOX: 8,9 (PubMed=34732238)
ST   vWA: 13,18 (PubMed=25939062; PubMed=28823557)
ST   vWA: 18,19 (PubMed=34732238)
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 15
//
ID   SU-DIPG-XIX
AC   CVCL_C1MV
SY   SU-DIPG-19; SJHGG054835; Stanford University-Diffuse Intrinsic Pontine Glioma-XIX
DR   cancercelllines; CVCL_C1MV
DR   Wikidata; Q114313057
RX   PubMed=28823557;
RX   PubMed=33319914;
RX   PubMed=34215733;
CC   Doubling time: 4.6 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 9,13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XLVIII
AC   CVCL_C1N7
SY   SU-DIPG-48; Stanford University-Diffuse Intrinsic Pontine Glioma-XLVIII
DR   Wikidata; Q114313058
RX   PubMed=33319914;
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 5
//
ID   SU-DIPG-XVII
AC   CVCL_C1MW
SY   SU-DIPG-17; SJHGG054834; Stanford University-Diffuse Intrinsic Pontine Glioma-XVII
DR   cancercelllines; CVCL_C1MW
DR   Wikidata; Q114313059
RX   PubMed=28823557;
RX   PubMed=31439867;
RX   PubMed=33319914;
RX   PubMed=34215733;
CC   Doubling time: 5.8 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 9,12
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XXI
AC   CVCL_C1MX
SY   SU-DIPG-21; SJHGG054836; Stanford University-Diffuse Intrinsic Pontine Glioma-XXI
DR   Wikidata; Q114313060
RX   PubMed=28823557;
RX   PubMed=33319914;
RX   PubMed=34215733;
CC   Doubling time: 4.6 days (PubMed=34215733).
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 10
ST   D21S11: 30,32
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 16,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   SU-DIPG-XXIV
AC   CVCL_C1MY
SY   SU-DIPG-24; Stanford University-Diffuse Intrinsic Pontine Glioma-XXIV
DR   cancercelllines; CVCL_C1MY
DR   Wikidata; Q114313061
RX   PubMed=28823557;
RX   PubMed=33319914;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 30,31
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XXIX
AC   CVCL_C1MZ
SY   SU-DIPG-29; Stanford University-Diffuse Intrinsic Pontine Glioma-XXIX
DR   cancercelllines; CVCL_C1MZ
DR   Wikidata; Q114313062
RX   PubMed=28823557;
RX   PubMed=34215733;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D21S11: 28,32.2
ST   D5S818: 12,14
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XXV
AC   CVCL_C1N0
SY   SU-DIPG-25; Stanford University-Diffuse Intrinsic Pontine Glioma-XXV
DR   cancercelllines; CVCL_C1N0
DR   Wikidata; Q114313063
RX   PubMed=28823557;
RX   PubMed=33319914;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D21S11: 30,35
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 7,8
ST   vWA: 14,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XXVII
AC   CVCL_C1N1
SY   SU-DIPG-27; Stanford University-Diffuse Intrinsic Pontine Glioma-XXVII
DR   cancercelllines; CVCL_C1N1
DR   Wikidata; Q114313064
RX   PubMed=28823557;
RX   PubMed=33319914;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=28823557).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D21S11: 30,33.2
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XXXIII
AC   CVCL_C1N4
SY   SU-DIPG-33; Stanford University-Diffuse Intrinsic Pontine Glioma-XXXIII
DR   Wikidata; Q114313065
RX   PubMed=33319914;
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Unspecified (PubMed=33319914).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   SU-DIPG-XXXV
AC   CVCL_C1MJ
SY   SU-DIPG-35; SU-DIPG 35; Stanford University-Diffuse Intrinsic Pontine Glioma-XXXV
DR   cancercelllines; CVCL_C1MJ
DR   Wikidata; Q114313066
RX   PubMed=31439867;
RX   PubMed=33319914;
RX   PubMed=34732238;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Ser432Ter; Zygosity=Unspecified (PubMed=34732238).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D21S11: 31.2,32.2
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   SU-DIPG-XXXVI
AC   CVCL_C1N5
SY   SU-DIPG-36; Stanford University-Diffuse Intrinsic Pontine Glioma-XXXVI
DR   Wikidata; Q114313067
RX   PubMed=33319914;
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Unspecified (PubMed=33319914).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   SU-DIPG-XXXVIII
AC   CVCL_C1N6
SY   SU-DIPG-38; Stanford University-Diffuse Intrinsic Pontine Glioma-XXXVIII
DR   Wikidata; Q114313068
RX   PubMed=33319914;
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Unspecified (PubMed=33319914).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 6
//
ID   SU-DUL-1
AC   CVCL_IV41
SY   Stanford University-Diffuse Undifferentiated Lymphoma-1
DR   Wikidata; Q54970737
RX   PubMed=83902;
RX   PubMed=6804087;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SU-DUL-2
AC   CVCL_IV42
SY   Stanford University-Diffuse Undifferentiated Lymphoma-2
DR   Wikidata; Q54970738
RX   PubMed=83902;
RX   PubMed=6804087;
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SU-DUL-3
AC   CVCL_IV43
SY   Stanford University-Diffuse Undifferentiated Lymphoma-3
DR   Wikidata; Q54970739
RX   PubMed=83902;
RX   PubMed=6804087;
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   SU-iPS-1
AC   CVCL_E4G8
RX   PubMed=31495903;
CC   From: The Third Affiliated Hospital of Guangzhou Medical College; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4824; HBA2; Simple; p.Ter143Glnext*32 (c.427T>C); ClinVar=VCV000015624; Zygosity=Homozygous; Note=Hb Constant Spring (PubMed=31495903).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31495903
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D18S51: 11,14
ST   D19S433: 12,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   SU-LB-1
AC   CVCL_IV34
SY   Stanford University-LymphoBlastoid-1
DR   Wikidata; Q54970740
RX   PubMed=83902;
RX   PubMed=4140017;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 3
//
ID   SU-LB-2
AC   CVCL_IV35
SY   Stanford University-LymphoBlastoid-2
DR   Wikidata; Q54970741
RX   PubMed=83902;
RX   PubMed=174098;
RX   PubMed=214220;
RX   PubMed=371794;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SU-LB-3
AC   CVCL_IV36
SY   Stanford University-LymphoBlastoid-3
DR   Wikidata; Q54970744
RX   PubMed=83902;
RX   PubMed=214220;
RX   PubMed=371794;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SU-LB-4
AC   CVCL_IV37
SY   Stanford University-LymphoBlastoid-4
DR   Wikidata; Q54970745
RX   PubMed=83902;
RX   PubMed=174098;
RX   PubMed=214220;
RX   PubMed=371794;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SU-LB-5
AC   CVCL_IV38
SY   Stanford University-LymphoBlastoid-5
DR   Wikidata; Q54970746
RX   PubMed=83902;
RX   PubMed=174098;
RX   PubMed=214220;
RX   PubMed=371794;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SU-LL-1
AC   CVCL_B5D7
DR   Wikidata; Q110433260
RX   PubMed=8432193;
CC   Karyotypic information: 49,XY,+ 1,-2,-5,+der(5)t(2;5)(p23;q35),+7,-21,+der(21q),+3mar (PubMed=8432193).
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   SU-LyB.1
AC   CVCL_B5D8
DR   Wikidata; Q110433261
RX   PubMed=8432193;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   SU-pcGBM-2
AC   CVCL_IT42
SY   SU-pcGBM2
DR   Wikidata; Q54970747
RX   PubMed=25939062;
RX   PubMed=28823557;
RX   PubMed=33319914;
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
ST   Source(s): PubMed=25939062; PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D21S11: 28,30.2
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   SU-pGBM3
AC   CVCL_C1N8
DR   Wikidata; Q114313069
RX   PubMed=28823557;
CC   Derived from site: In situ; Brain, left frontal lobe; UBERON=UBERON_0002811.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,15,16
ST   D16S539: 9,14
ST   D21S11: 30,31
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SU-Ph2
AC   CVCL_UI50
SY   SuPh2
DR   Wikidata; Q98132864
RX   PubMed=18783828;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 30-48 hours (PubMed=18783828).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=18783828).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   SU-pSCG-1
AC   CVCL_C1N9
SY   SU-pSCG1; Stanford University-pediatric Spinal Cord Glioma-1
DR   Wikidata; Q114313070
RX   PubMed=28823557;
CC   Derived from site: In situ; Spinal cord; UBERON=UBERON_0002240.
ST   Source(s): PubMed=28823557
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4534; Spinal cord glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SU.86.86
AC   CVCL_3881
SY   Su.86.86; SU 86.86; SU-86-86; Su-86-86; SU86.86; SU86-86; SU86_86; Su86_86; SU8686; SU.86
DR   BTO; BTO_0001904
DR   CLO; CLO_0009150
DR   EFO; EFO_0006494
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1837
DR   BioGRID_ORCS_Cell_line; 196
DR   BioSample; SAMN03472014
DR   BioSample; SAMN10987701
DR   cancercelllines; CVCL_3881
DR   Cell_Model_Passport; SIDM01188
DR   CGH-DB; 183-1
DR   CGH-DB; 9282-4
DR   ChEMBL-Cells; CHEMBL4630607
DR   ChEMBL-Targets; CHEMBL4630707
DR   Cosmic; 707252
DR   Cosmic; 868244
DR   Cosmic; 873003
DR   Cosmic; 913314
DR   Cosmic; 922250
DR   Cosmic; 923172
DR   Cosmic; 932522
DR   Cosmic; 949237
DR   Cosmic; 1006362
DR   Cosmic; 1066203
DR   Cosmic; 1122349
DR   Cosmic; 1218879
DR   Cosmic; 1358486
DR   Cosmic; 1518237
DR   Cosmic; 1644315
DR   Cosmic; 1995645
DR   Cosmic; 2434090
DR   Cosmic-CLP; 1240218
DR   DepMap; ACH-000114
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240218
DR   GEO; GSM206545
DR   GEO; GSM621901
DR   GEO; GSM784693
DR   GEO; GSM887650
DR   GEO; GSM888742
DR   GEO; GSM1024414
DR   GEO; GSM1374903
DR   GEO; GSM1435693
DR   GEO; GSM1435694
DR   GEO; GSM1435695
DR   GEO; GSM1670481
DR   IARC_TP53; 2860
DR   IZSLER; BS TCL 180
DR   LiGeA; CCLE_401
DR   LINCS_LDP; LCL-1747
DR   PharmacoDB; SU_86_86_1506_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3881
DR   PubChem_Cell_line; CVCL_3881
DR   SKY/M-FISH/CGH; 2000
DR   Wikidata; Q54970749
RX   PubMed=3264833;
RX   PubMed=10027410;
RX   PubMed=11115575;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=16912165;
RX   PubMed=18380791;
RX   PubMed=20037478;
RX   PubMed=20418756;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 77 hours (PubMed=3264833); 48 hours (PubMed=25984343).
CC   HLA typing: A*29:02,32:01; B*44:02,44:02; C*05:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Hemizygous (PubMed=11115575).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=11115575).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.25%; Native American=1.63%; East Asian, North=1.94%; East Asian, South=0%; South Asian=0%; European, North=53.02%; European, South=43.16% (PubMed=30894373).
CC   Misspelling: Su_86_96; Cosmic=913314.
CC   Misspelling: SU-88-86; Cosmic=873003.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): ATCC=CRL-1837; Cosmic-CLP=1240218; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 9
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 14,19
ST   D5S818: 7,13
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SU/RH-HD-1
AC   CVCL_M692
SY   SU/RH-HD1; SU-RH-HD-1
DR   Wikidata; Q54970748
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2690233;
RX   PubMed=6332936;
RX   PubMed=29533902;
CC   Doubling time: ~4-5 days (PubMed=6332936).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   SU/SR
AC   CVCL_UI51
DR   cancercelllines; CVCL_UI51
DR   Wikidata; Q98132865
RX   PubMed=18783828;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=18783828).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Thr315Ile (c.944C>T) (c.1001C>T); ClinVar=VCV000012624; Zygosity=Unspecified (PubMed=18783828).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UI50 ! SU-Ph2
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   SU042-1
AC   CVCL_RK73
DR   SKIP; SKIP001714
DR   Wikidata; Q54970750
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val2193Ile (c.6577G>A); ClinVar=VCV000231987; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Ser837Ter (c.2510C>G); Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:30045; SMG1; Simple; p.Leu250Val; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Thr1673Ser; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK79 ! SU42T-4
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   SU042-2
AC   CVCL_RK74
DR   SKIP; SKIP001715
DR   Wikidata; Q54970751
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val2193Ile (c.6577G>A); ClinVar=VCV000231987; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Ser837Ter (c.2510C>G); Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:30045; SMG1; Simple; p.Leu250Val; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Thr1673Ser; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK79 ! SU42T-4
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   SU042-3
AC   CVCL_RK75
DR   SKIP; SKIP001716
DR   Wikidata; Q54970752
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val2193Ile (c.6577G>A); ClinVar=VCV000231987; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Ser837Ter (c.2510C>G); Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:30045; SMG1; Simple; p.Leu250Val; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Thr1673Ser; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Miscellaneous: Lacks the KRAS p.Gly13Asp mutations found in other clones.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK79 ! SU42T-4
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   SU042-4
AC   CVCL_RK76
DR   SKIP; SKIP001717
DR   Wikidata; Q54970753
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val2193Ile (c.6577G>A); ClinVar=VCV000231987; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Ser837Ter (c.2510C>G); Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:30045; SMG1; Simple; p.Leu250Val; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Thr1673Ser; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK79 ! SU42T-4
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   SU042-5
AC   CVCL_RK77
DR   SKIP; SKIP001718
DR   Wikidata; Q54970754
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Val2193Ile (c.6577G>A); ClinVar=VCV000231987; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Ser837Ter (c.2510C>G); Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:30045; SMG1; Simple; p.Leu250Val; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:17575; SPEN; Simple; p.Thr1673Ser; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK79 ! SU42T-4
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   SU1
AC   CVCL_RQ43
SY   SU-1
DR   Wikidata; Q54970755
RX   PubMed=18940013;
CC   Group: Cancer stem cell line.
CC   Population: Chinese.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RQ44 ! SU2
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   SU2
AC   CVCL_RQ44
SY   SU-2
DR   Wikidata; Q54970756
RX   PubMed=18940013;
RX   PubMed=22360855;
CC   Group: Cancer stem cell line.
CC   Population: Chinese.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, right temporal lobe; UBERON=UBERON_0002809.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RQ43 ! SU1
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   SU223-A2
AC   CVCL_RK83
DR   SKIP; SKIP001719
DR   Wikidata; Q54970757
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:10729; SEMA4A; Simple; p.Tyr589His (c.1765T>C); ClinVar=VCV001418371; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   SU223-A4
AC   CVCL_RK84
DR   SKIP; SKIP001720
DR   Wikidata; Q54970759
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:10729; SEMA4A; Simple; p.Tyr589His (c.1765T>C); ClinVar=VCV001418371; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   SU223-A7
AC   CVCL_RK85
DR   SKIP; SKIP001721
DR   Wikidata; Q54970760
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:10729; SEMA4A; Simple; p.Tyr589His (c.1765T>C); ClinVar=VCV001418371; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   SU223-B3
AC   CVCL_RK86
DR   SKIP; SKIP001722
DR   Wikidata; Q54970761
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:10729; SEMA4A; Simple; p.Tyr589His (c.1765T>C); ClinVar=VCV001418371; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   SU223-B5
AC   CVCL_RK87
DR   SKIP; SKIP001723
DR   Wikidata; Q54970763
RX   PubMed=28089908;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
CC   Sequence variation: Mutation; HGNC; HGNC:10729; SEMA4A; Simple; p.Tyr589His (c.1765T>C); ClinVar=VCV001418371; Zygosity=Unspecified; Note=Somatic (PubMed=28089908).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   SU223T-4
AC   CVCL_RK88
DR   SKIP; SKIP001711
DR   Wikidata; Q54970764
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK89 ! SU223T-5
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   SU223T-5
AC   CVCL_RK89
DR   SKIP; SKIP001712
DR   Wikidata; Q54970765
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK90 ! SU223T-6
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   SU223T-6
AC   CVCL_RK90
DR   SKIP; SKIP001713
DR   Wikidata; Q54970766
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK83 ! SU223-A2
OI   CVCL_RK84 ! SU223-A4
OI   CVCL_RK85 ! SU223-A7
OI   CVCL_RK86 ! SU223-B3
OI   CVCL_RK87 ! SU223-B5
OI   CVCL_RK88 ! SU223T-4
OI   CVCL_RK89 ! SU223T-5
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   SU3
AC   CVCL_RQ45
DR   Wikidata; Q54970768
RX   PubMed=22360855;
RX   PubMed=29390972;
CC   Group: Cancer stem cell line.
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   SU3-ihDCTC
AC   CVCL_RQ46
SY   SU3-induced host Dendritic Cells Transformed Cell
DR   Wikidata; Q54970769
RX   PubMed=29390972;
CC   Characteristics: Dendritic cells transformed by co-cultivation with SU3 (Cellosaurus=CVCL_RQ45) glioma stem cells.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: Transgenic EGFP.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   SU42T-2
AC   CVCL_RK78
DR   SKIP; SKIP001724
DR   Wikidata; Q54970770
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK79 ! SU42T-4
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   SU42T-4
AC   CVCL_RK79
DR   SKIP; SKIP001709
DR   Wikidata; Q54970771
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK80 ! SU42T-5
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 3
//
ID   SU42T-5
AC   CVCL_RK80
DR   SKIP; SKIP001710
DR   Wikidata; Q54970772
RX   PubMed=28089908;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RK73 ! SU042-1
OI   CVCL_RK74 ! SU042-2
OI   CVCL_RK75 ! SU042-3
OI   CVCL_RK76 ! SU042-4
OI   CVCL_RK77 ! SU042-5
OI   CVCL_RK78 ! SU42T-2
OI   CVCL_RK79 ! SU42T-4
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   SU511
AC   CVCL_W082
SY   Su511
DR   BioSamples; SAMEA101001
DR   cancercelllines; CVCL_W082
DR   Cosmic; 1522784
DR   GEO; GSM726284
DR   Progenetix; CVCL_W082
DR   Wikidata; Q54970773
RX   PubMed=21642991;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   SU706A
AC   CVCL_S719
DR   SKY/M-FISH/CGH; 3861
DR   Wikidata; Q54970774
DI   NCIt; C6339; Uterine corpus sarcoma
DI   ORDO; Orphanet_213620; Sarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   Su9T01
AC   CVCL_B7P5
SY   SU9T01
DR   GEO; GSE168558
DR   Wikidata; Q112930433
RX   PubMed=1472476;
RX   PubMed=1719236;
RX   PubMed=9357968;
RX   PubMed=34794206;
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   Sua-5B-IE8
AC   CVCL_B3N2
DR   DGRC; 333
DR   Wikidata; Q110433263
RX   PubMed=34819517;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase.
CC   Doubling time: ~20 hours (DGRC=333).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
HI   CVCL_RQ24 ! Sua5B
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 7
//
ID   Sua-5B-IE8-Act::Cas9-2A-Neo
AC   CVCL_B3N3
DR   DGRC; 334
DR   Wikidata; Q110433264
RX   PubMed=34819517;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Characteristics: Modified using a Minos mediated integration cassette (MiMIC) to deliver a recombination-mediated cassette (RMCE) acceptor, to add a docking site for recombination via the bacteriophage FC31 integrase.
CC   Characteristics: A N-3xFLAG-spCas9-T2A-Neo construct was integrated in the Act5C locus (PubMed=34819517).
CC   Doubling time: ~20 hours (DGRC=334).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
HI   CVCL_B3N2 ! Sua-5B-IE8
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   Sua1.1
AC   CVCL_Z626
DR   BTO; BTO_0002635
DR   Wikidata; Q54970776
RX   PubMed=12626708;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   Sua1B
AC   CVCL_Z627
SY   SuaB.1
DR   Wikidata; Q54970778
RX   PubMed=9326640;
RX   PubMed=23382679;
RX   PubMed=23891577;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   Sua4.0
AC   CVCL_Z629
SY   Sua 4.0; Suakoko 4
DR   BEI_Resources; MRA-921
DR   Wikidata; Q54970786
RX   PubMed=10681436;
RX   PubMed=23382679;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   Sua5.1*
AC   CVCL_Z630
SY   Sua 5.1*; Sua 5.1; Sua5.1
DR   BEI_Resources; MRA-922
DR   Wikidata; Q54970787
RX   PubMed=10681436;
RX   PubMed=23382679;
RX   PubMed=27365445;
RX   PubMed=35477969;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: BEI_Resources; MRA-922; probable.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
SX   Female
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   Sua5B
AC   CVCL_RQ24
SY   Sua-5B; Sua 5B
DR   Wikidata; Q54970789
RX   PubMed=17028229;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_1c16f776df
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_5d6ca2547f
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
HI   CVCL_Z627 ! Sua1B
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   Sua5B wAlbB+
AC   CVCL_RQ25
DR   Wikidata; Q54970790
RX   PubMed=17028229;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_1c16f776df
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_5d6ca2547f
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Characteristics: Infected by Wolbachia pipientis strain wAlbB.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
HI   CVCL_RQ24 ! Sua5B
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   Sua5B wMel+
AC   CVCL_RQ26
DR   Wikidata; Q54970791
RX   PubMed=17028229;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_1c16f776df
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Characteristics: Infected by Wolbachia pipientis strain wMel.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
HI   CVCL_RQ24 ! Sua5B
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   SuaE.1
AC   CVCL_Z628
SY   SuaE1; SuaE
DR   BEI_Resources; MRA-924
DR   Wikidata; Q54970792
RX   PubMed=23382679;
CC   Group: Insect cell line.
CC   Group: Malaria research cell line.
CC   Omics: Transcriptomics; RNAseq.
CC   Breed/subspecies: Suakoko 2La.
OX   NCBI_TaxID=1518534; ! Anopheles coluzzii (African malaria mosquito)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   Subclone 707 BUF
AC   CVCL_4309
DR   CLO; CLO_0009151
DR   CLDB; cl4411
DR   ECACC; 91112122
DR   Wikidata; Q54970794
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   Subclone 707 DAP1
AC   CVCL_8918
SY   707 DAP1
DR   Wikidata; Q54970795
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP10
AC   CVCL_8919
SY   707 DAP10; 707DAP10
DR   CLO; CLO_0001466
DR   CLDB; cl121
DR   ECACC; 91112130
DR   Wikidata; Q54970796
RX   PubMed=1986259;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112130; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 12
//
ID   Subclone 707 DAP2
AC   CVCL_8920
SY   707 DAP2
DR   Wikidata; Q54970797
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP3
AC   CVCL_8921
SY   707 DAP3
DR   Wikidata; Q54970798
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP4
AC   CVCL_8922
SY   707 DAP4; 707DAP4
DR   Wikidata; Q54970799
RX   PubMed=3116422;
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP5
AC   CVCL_8923
SY   707 DAP5
DR   Wikidata; Q54970800
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP6
AC   CVCL_8924
SY   707 DAP6
DR   Wikidata; Q54970801
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP7
AC   CVCL_8925
SY   707 DAP7
DR   Wikidata; Q54970802
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   Subclone 707 DAP8
AC   CVCL_4310
SY   707 DAP8; 707DAP8
DR   CLO; CLO_0009152
DR   CLDB; cl4412
DR   ECACC; 91112129
DR   Wikidata; Q54970804
RX   PubMed=1986259;
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   Subclone 707 DAP9
AC   CVCL_4Y34
SY   707 DAP9
DR   Wikidata; Q54970805
RX   PubMed=3477692;
CC   Selected for resistance to: ChEBI; CHEBI_38001; 2,6-diaminopurine (2,6-DAP).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 6
//
ID   Subclone 707 DK 4.8
AC   CVCL_8291
DR   CLO; CLO_0009153
DR   CLDB; cl4413
DR   ECACC; 91112119
DR   Wikidata; Q54970807
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112119; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   Subclone 707 DKA
AC   CVCL_8292
DR   CLO; CLO_0009154
DR   CLDB; cl4414
DR   ECACC; 91112117
DR   Wikidata; Q54970808
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112117; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Subclone 707 DKE
AC   CVCL_8293
DR   CLO; CLO_0009155
DR   CLDB; cl4415
DR   ECACC; 91112132
DR   Wikidata; Q54970809
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112132; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Subclone 707 DKH
AC   CVCL_8294
DR   CLO; CLO_0009156
DR   CLDB; cl4416
DR   ECACC; 91112131
DR   Wikidata; Q54970810
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112131; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Subclone 707 DKJ
AC   CVCL_8295
DR   CLO; CLO_0009157
DR   CLDB; cl4417
DR   ECACC; 91112118
DR   Wikidata; Q54970811
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112118; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   Subclone 707 TG1
AC   CVCL_8296
DR   CLO; CLO_0009158
DR   CLDB; cl4418
DR   ECACC; 91112127
DR   Wikidata; Q54970812
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112127; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   Subclone 707 TG2
AC   CVCL_8297
DR   CLO; CLO_0009159
DR   CLDB; cl4419
DR   ECACC; 91112128
DR   Wikidata; Q54970813
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Discontinued: ECACC; 91112128; true.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4145 ! Clone 707
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   SuBK12-08
AC   CVCL_YZ71
DR   Wikidata; Q98132866
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=24131711;
RX   PubMed=26605499;
RX   PubMed=30718752;
CC   Group: Bat cell line.
CC   Virology: Highly susceptible to infection by Lloviu virus (LLOV) (PubMed=24131711).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9433; ! Miniopterus schreibersii (Schreibers's long-fingered bat)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   SUBL
AC   CVCL_M554
DR   Wikidata; Q54970814
RX   PubMed=7506636;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=7506636).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   SubP14.36.1
AC   CVCL_C4ZD
DR   Wikidata; Q116050580
RX   PubMed=1726160;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20366; Human TAC1 (Note=AA 58-68 = Substance P).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 10-09-24; Version: 4
//
ID   Sufu-KO-LIGHT
AC   CVCL_C8QR
DR   CLO; CLO_0037222
DR   Wikidata; Q123033561
RX   PubMed=32268014;
CC   Characteristics: Used to discover small-molecule antagonists of Gli function. Exhibits constitutive Hh pathway activity driven by endogenous Gli factors (PubMed=32268014).
CC   Characteristics: Transfected with a firefly luciferase reporter driven by eight Gli binding sites and a delta-crystallin basal promoter (8XGHBS-FL) and with a SV40 promoter-driven Renilla luciferase reporter (PubMed=32268014).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1345643; Sufu.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SUHC-1
AC   CVCL_HE76
SY   Shinshu University Hepatocellular Carcinoma-1
DR   Wikidata; Q54970815
RX   PubMed=1328123;
RX   PubMed=8280838;
RX   PubMed=9737568;
CC   Population: Japanese.
CC   Characteristics: Although established from a patient suffering from persistent HCC infection, HCV-RNA is not detected.
CC   Doubling time: ~24 hours (PubMed=1328123).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 8
//
ID   SUHi001-A
AC   CVCL_D0LW
SY   RES143
DR   BioSamples; SAMEA114319061
DR   hPSCreg; SUHi001-A
DR   Wikidata; Q123033562
CC   From: Sahlgrenska University Hospital; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SUHi002-A
AC   CVCL_D0LX
SY   RES145
DR   BioSamples; SAMEA114335237
DR   hPSCreg; SUHi002-A
DR   Wikidata; Q123033563
CC   From: Sahlgrenska University Hospital; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SUHi003-A
AC   CVCL_D0LY
SY   RES146
DR   BioSamples; SAMEA114335968
DR   hPSCreg; SUHi003-A
DR   Wikidata; Q123033564
CC   From: Sahlgrenska University Hospital; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SUHi004-A
AC   CVCL_D0LZ
SY   RES152
DR   BioSamples; SAMEA114336525
DR   hPSCreg; SUHi004-A
DR   Wikidata; Q123033565
CC   From: Sahlgrenska University Hospital; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26780; Gastritis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SUHi005-A
AC   CVCL_D0M0
SY   RES165
DR   BioSamples; SAMEA114338263
DR   hPSCreg; SUHi005-A
DR   Wikidata; Q123033566
CC   From: Sahlgrenska University Hospital; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SUHi006-A
AC   CVCL_D0M1
SY   RES169
DR   BioSamples; SAMEA114338264
DR   hPSCreg; SUHi006-A
DR   Wikidata; Q123033567
CC   From: Sahlgrenska University Hospital; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SUi001-A
AC   CVCL_A4YQ
SY   iPSC-SZ-HU-MO 1
DR   hPSCreg; SUi001-A
DR   Wikidata; Q107116967
RX   PubMed=33503521;
CC   From: Semmelweis University; Budapest; Hungary.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YR ! SUi001-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SUi001-B
AC   CVCL_A4YR
SY   iPSC-SZ-HU-MO 2
DR   hPSCreg; SUi001-B
DR   Wikidata; Q107116969
CC   From: Semmelweis University; Budapest; Hungary.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YQ ! SUi001-A
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SUi002-A
AC   CVCL_A4YS
SY   iPSC-SZ-HU-FA 1
DR   hPSCreg; SUi002-A
DR   Wikidata; Q107116972
RX   PubMed=33503521;
CC   From: Semmelweis University; Budapest; Hungary.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YT ! SUi002-B
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SUi002-B
AC   CVCL_A4YT
SY   iPSC-SZ-HU-FA 2
DR   hPSCreg; SUi002-B
DR   Wikidata; Q107116975
CC   From: Semmelweis University; Budapest; Hungary.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YS ! SUi002-A
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   SUi003-A
AC   CVCL_A4YU
SY   iPSC-SZ-HU-PROB 1
DR   hPSCreg; SUi003-A
DR   Wikidata; Q107116977
RX   PubMed=33503521;
CC   From: Semmelweis University; Budapest; Hungary.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6316; KHSRP; Simple; p.Gly403Cys (c.1207G>T) (chr19:g.6416869C>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521).
CC   Sequence variation: Mutation; HGNC; HGNC:6329; KIR2DL1; Simple; c.412A>T (chr19:g.55286658A>T); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521).
CC   Sequence variation: Mutation; HGNC; HGNC:18531; LRRC7; Simple; p.Val1158Ile (c.3472G>A) (chr1:g.70505093G>A); Zygosity=Heterozygous; Note=De novo mutation (PubMed=33503521).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YV ! SUi003-B
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SUi003-B
AC   CVCL_A4YV
SY   iPSC-SZ-HU-PROB 2
DR   hPSCreg; SUi003-B
DR   Wikidata; Q107116979
CC   From: Semmelweis University; Budapest; Hungary.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6316; KHSRP; Simple; p.Gly403Cys (c.1207G>T) (chr19:g.6416869C>A); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A).
CC   Sequence variation: Mutation; HGNC; HGNC:6329; KIR2DL1; Simple; c.412A>T (chr19:g.55286658A>T); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A).
CC   Sequence variation: Mutation; HGNC; HGNC:18531; LRRC7; Simple; p.Val1158Ile (c.3472G>A) (chr1:g.70505093G>A); Zygosity=Heterozygous; Note=De novo mutation (from autologous cell line SUi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YU ! SUi003-A
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   Sui65
AC   CVCL_UM50
DR   cancercelllines; CVCL_UM50
DR   GEO; GSM4767163
DR   IARC_TP53; 26967
DR   JCRB; JCRB1882
DR   Wikidata; Q98132867
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 65Taco1 SCID nude mouse xenograft.
CC   Doubling time: 48.6 hours (PubMed=18691340); 40.3 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala148fs*9 (c.441delC); Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): JCRB=JCRB1882
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui66
AC   CVCL_UM51
DR   cancercelllines; CVCL_UM51
DR   GEO; GSM4767164
DR   IARC_TP53; 26968
DR   JCRB; JCRB1900
DR   Wikidata; Q98132868
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 66Taco2 SCID nude mouse xenograft.
CC   Doubling time: 41.2 hours (PubMed=18691340); 38.2 hours (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala100fs*18 (c.299_303delCCGGG); Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Unspecified (PubMed=18691340).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1900
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   Sui67
AC   CVCL_UM52
DR   cancercelllines; CVCL_UM52
DR   GEO; GSM4767165
DR   IARC_TP53; 26969
DR   JCRB; JCRB1907
DR   Wikidata; Q98132869
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 67Taco4 SCID nude mouse xenograft.
CC   Doubling time: 35.1 hours (PubMed=18691340); 33.5 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Was originally (PubMed=18691340) indicated to originate from a female patient but is from a male patint.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1907
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 8,13
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui68
AC   CVCL_UM53
DR   cancercelllines; CVCL_UM53
DR   GEO; GSM4767166
DR   IARC_TP53; 26970
DR   JCRB; JCRB1910
DR   Wikidata; Q98132870
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 68Taco5 SCID nude mouse xenograft.
CC   Doubling time: 43.3 hours (PubMed=18691340); 41.5 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1910
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui69
AC   CVCL_UM54
DR   cancercelllines; CVCL_UM54
DR   GEO; GSM4767167
DR   IARC_TP53; 26971
DR   JCRB; JCRB1919
DR   Wikidata; Q98132872
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 69Taco6 SCID nude mouse xenograft.
CC   Senescence: Has a finite life span (JCRB=JCRB1919).
CC   Doubling time: 55.2 hours (PubMed=18691340); 35.5 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1919
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui70
AC   CVCL_UM55
DR   cancercelllines; CVCL_UM55
DR   GEO; GSM4767168
DR   IARC_TP53; 26972
DR   JCRB; JCRB1917
DR   Wikidata; Q98132873
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 70Taco7 SCID nude mouse xenograft.
CC   Doubling time: 20.8 hours (PubMed=18691340); 22.3 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1917
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui71
AC   CVCL_UM56
DR   cancercelllines; CVCL_UM56
DR   GEO; GSM4767169
DR   IARC_TP53; 26973
DR   JCRB; JCRB1922
DR   Wikidata; Q98132874
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 71Taco12 SCID nude mouse xenograft.
CC   Doubling time: 24.1 hours (PubMed=18691340); 24.7 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr253Pro (c.757A>C); Zygosity=Unspecified (PubMed=18691340).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1922
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui72
AC   CVCL_UM57
DR   cancercelllines; CVCL_UM57
DR   GEO; GSM4767170
DR   IARC_TP53; 26974
DR   JCRB; JCRB1924
DR   Wikidata; Q98132875
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 72Taco13 SCID nude mouse xenograft.
CC   Doubling time: 27.8 hours (PubMed=18691340); 27.8 hours (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Homozygous (PubMed=18691340; PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1924
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 10
ST   D5S818: 9
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   Sui73
AC   CVCL_UM58
DR   GEO; GSM4767171
DR   IARC_TP53; 26975
DR   JCRB; JCRB1923
DR   Wikidata; Q98132876
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 73Taco15 SCID nude mouse xenograft.
CC   Doubling time: 23.5 hours (PubMed=18691340); 24.6 hours (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Ser32Ter (c.89_89delGA); Zygosity=Heterozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18691340).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1923
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D5S818: 10,12
ST   D7S820: 7.3,8
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 9
//
ID   Sui74
AC   CVCL_UM59
DR   cancercelllines; CVCL_UM59
DR   GEO; GSM4767172
DR   IARC_TP53; 26976
DR   JCRB; JCRB1931
DR   Wikidata; Q98132877
RX   PubMed=18691340;
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 74Taco16 SCID nude mouse xenograft.
CC   Doubling time: 47.5 hours (PubMed=18691340); 34.5 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:12637; KDM6A; Simple; p.Asn236fs*26 (c.705_706delGA) (c.702_703delAG); ClinVar=VCV002429725; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=18691340; PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.His528fs*25 (c.1582_1583delCA); Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18691340).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1931
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   Sui75
AC   CVCL_C7UK
DR   GEO; GSM4767173
DR   JCRB; JCRB1925
DR   Wikidata; Q123033568
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 75Taco21 SCID nude mouse xenograft.
CC   Doubling time: 30.3 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Gly1611fs*15 (c.4830_4833delGGGC); Zygosity=Heterozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr231fs*8 (c.691_692delAC); Zygosity=Homozygous (PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
ST   Source(s): JCRB=JCRB1925
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 8,11
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 17,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7UL ! Sui76
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   Sui76
AC   CVCL_C7UL
DR   GEO; GSM4767174
DR   JCRB; JCRB1928
DR   Wikidata; Q123033569
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 76Taco22 SCID nude mouse xenograft.
CC   Doubling time: 28.2 hours (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Gly1611fs*15 (c.4830_4833delGGGC); Zygosity=Heterozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr231fs*8 (c.691_692delAC); Zygosity=Homozygous (PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1928
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9
ST   vWA: 17,19
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C7UK ! Sui75
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   Sui77
AC   CVCL_C7UM
DR   GEO; GSM4767175
DR   JCRB; JCRB1929
DR   Wikidata; Q123033570
RX   PubMed=35272288;
CC   Population: Japanese.
CC   Characteristics: Established from the 77Taco23 SCID nude mouse xenograft.
CC   Doubling time: 38.7 hours (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Homozygous (PubMed=35272288).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp148Ilefs*22 (c.441delT); Zygosity=Homozygous (PubMed=35272288).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1929
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   SUIT-2
AC   CVCL_3172
SY   Suit-2; SUIT 2; SUIT2; Suit2; SUIzo Tumor-2
DR   BTO; BTO_0003493
DR   CLO; CLO_0037114
DR   EFO; EFO_0006495
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 365
DR   BioSample; SAMN03472902
DR   BioSample; SAMN10988018
DR   cancercelllines; CVCL_3172
DR   Cell_Model_Passport; SIDM00371
DR   Cosmic; 710872
DR   Cosmic; 755300
DR   Cosmic; 808161
DR   Cosmic; 918051
DR   Cosmic; 1108340
DR   Cosmic; 1320464
DR   Cosmic; 1534322
DR   Cosmic; 1995647
DR   Cosmic; 2664046
DR   Cosmic-CLP; 1240219
DR   DepMap; ACH-000652
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10797-110I5
DR   GDSC; 1240219
DR   GEO; GSM244426
DR   GEO; GSM244427
DR   GEO; GSM827218
DR   GEO; GSM887657
DR   GEO; GSM888749
DR   GEO; GSM1588615
DR   GEO; GSM1588627
DR   GEO; GSM1670489
DR   IARC_TP53; 16745
DR   JCRB; JCRB1094
DR   LiGeA; CCLE_481
DR   LINCS_LDP; LCL-1729
DR   Lonza; 1079
DR   PharmacoDB; SUIT2_1507_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3172
DR   TKG; TKG 0705
DR   Wikidata; Q54970817
RX   PubMed=1391733;
RX   PubMed=3102439;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=11854916;
RX   PubMed=12800145;
RX   PubMed=19077451;
RX   PubMed=20215515;
RX   PubMed=21607521;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/SUIT-2.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~38.2 hours (PubMed=3102439); 29.1 hours (PubMed=1391733); 15.64 hours (JWGray panel).
CC   HLA typing: A*02:06,24:02; B*07:02,59:01; C*01:02,07:02; DQA1*02:01,02:01; DQB1*06:13,06:13; DRB1*11:04,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.His83Tyr (c.247C>T) (p.Ala97Val, c.290C>T); ClinVar=VCV000376307; Zygosity=Unspecified (PubMed=11787853).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853; PubMed=21607521).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=11169959; PubMed=11787853; PubMed=21607521).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.31%; East Asian, North=81.51%; East Asian, South=17.16%; South Asian=0.02%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Cosmic-CLP=1240219; JCRB=JCRB1094; PubMed=25877200; TKG=TKG 0705
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 16
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 20,23
ST   Penta D: 11
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SUIT-4
AC   CVCL_9280
SY   Suit4; SUIzo Tumor-4
DR   cancercelllines; CVCL_9280
DR   Wikidata; Q54970818
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=15452375;
CC   Population: Japanese.
CC   Doubling time: 43.9 hours (PubMed=15452375).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=15452375).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   SUIT-58
AC   CVCL_1Y17
SY   SUIzo Tumor-58
DR   Wikidata; Q54970819
RX   PubMed=26141632;
RX   PubMed=32780825;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=26141632).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=26141632
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D21S11: 31
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   SUK 2
AC   CVCL_KR91
DR   DSHB; SUK-2
DR   Wikidata; Q54970820
RX   PubMed=2974459;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35978; Strongylocentrotus purpuratus kinesin heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   SUK 4
AC   CVCL_KR92
DR   DSHB; SUK-4
DR   Wikidata; Q54970822
RX   PubMed=2974459;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P35978; Strongylocentrotus purpuratus kinesin heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   SUK 5
AC   CVCL_KR93
DR   DSHB; SUK-5
DR   Wikidata; Q54970823
RX   PubMed=2974459;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P35978; Strongylocentrotus purpuratus kinesin heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   Sulubo
AC   CVCL_IU22
SY   Solubo; Solubu
DR   Wikidata; Q54970824
RX   PubMed=3026973;
RX   PubMed=4122458;
RX   PubMed=4142009;
RX   PubMed=4347031;
RX   PubMed=4364259;
RX   PubMed=24590883;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   SUm/C
AC   CVCL_JH10
DR   JCRB; JCRB1470
DR   Wikidata; Q54970825
RX   PubMed=16489088;
RX   PubMed=16832412;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Thoracic lymph duct; UBERON=UBERON_0007644.
ST   Source(s): JCRB=JCRB1470
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 7
//
ID   SUM102PT
AC   CVCL_3421
SY   SUM-102PT; SUM 102PT; SUM-102; SUM 102; SUM102; Sum102; 102PT
DR   BTO; BTO_0005387
DR   cancercelllines; CVCL_3421
DR   Cell_Model_Passport; SIDM01837
DR   Cosmic; 904388
DR   Cosmic; 997922
DR   Cosmic; 1046939
DR   Cosmic; 1287928
DR   Cosmic; 1289410
DR   DepMap; ACH-001388
DR   GEO; GSM217598
DR   GEO; GSM350537
DR   GEO; GSM421888
DR   GEO; GSM1008914
DR   GEO; GSM1172990
DR   GEO; GSM1215255
DR   GEO; GSM1401675
DR   IARC_TP53; 24338
DR   LINCS_HMS; 51120
DR   PharmacoDB; SUM102PT_1514_2019
DR   Progenetix; CVCL_3421
DR   SLKBase; 241
DR   Wikidata; Q54970826
RX   PubMed=9041204;
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=32715085;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Doubling time: 112.71 hours (JWGray panel).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=19593635).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DepMap=ACH-001388
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 24,27
ST   Penta D: 10,11
ST   Penta E: 13,16
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SUM1315MO2
AC   CVCL_5589
SY   SUM1315M02; SUM1315-MO2; SUM-1315M02; SUM 1315M02; SUM-1315; SUM 1315; SUM1315; 1315M02
DR   BTO; BTO_0005933
DR   CLO; CLO_0009916
DR   EFO; EFO_0001239
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-TABM-157
DR   BioSample; SAMN03471829
DR   cancercelllines; CVCL_5589
DR   Cell_Model_Passport; SIDM01836
DR   Cosmic; 904394
DR   Cosmic; 997924
DR   Cosmic; 1046961
DR   Cosmic; 1287925
DR   Cosmic; 1289417
DR   Cosmic; 1460228
DR   DepMap; ACH-001389
DR   EGA; EGAS00001000610
DR   GEO; GSM217599
DR   GEO; GSM421893
DR   GEO; GSM1008915
DR   GEO; GSM1053733
DR   GEO; GSM1172896
DR   GEO; GSM1172991
DR   GEO; GSM1214566
DR   GEO; GSM1374910
DR   IARC_TP53; 24341
DR   LINCS_HMS; 51081
DR   LINCS_LDP; LCL-2066
DR   PharmacoDB; SUM1315M02_1508_2019
DR   Progenetix; CVCL_5589
DR   SLKBase; 1106
DR   Wikidata; Q54970827
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=22032724;
RX   PubMed=23151021;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=32715085;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Characteristics: Established from tumor tissue after two passages in nude mice.
CC   Characteristics: EGF dependent.
CC   Doubling time: 94.59 hours (JWGray panel).
CC   HLA typing: A*31:01,32:01; B*39:01,40:01; C*03:04,12:03; DQA1*01:02,05:02; DQB1*03:02,06:04; DRB1*15:01,04 (PubMed=25960936).
CC   HLA typing: A*31:01,32:01; B*39:01,40:01; C*03:04,12:03 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Hemizygous (PubMed=16397213; PubMed=19593635; PubMed=22032724).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): DepMap=ACH-001389; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28,29
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 25
ST   Penta D: 13,15
ST   Penta E: 5
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SUM149-Luc
AC   CVCL_DH44
DR   cancercelllines; CVCL_DH44
DR   GEO; GSM1463862
DR   Wikidata; Q54970828
RX   PubMed=20229045;
RX   PubMed=25279830;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro724Leufs*12 (c.2169delT) (p.Asn723fs*13) (2288delT); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.4025+26_4025+30 (c.5224+28del3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3422 ! SUM149PT
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 18
//
ID   SUM149-Luc/MA1
AC   CVCL_DH45
SY   MA1
DR   cancercelllines; CVCL_DH45
DR   GEO; GSM1463860
DR   GEO; GSM1463863
DR   Wikidata; Q54970829
RX   PubMed=25279830;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro724Leufs*12 (c.2169delT) (p.Asn723fs*13) (2288delT); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.4025+26_4025+30 (c.5224+28del3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH44 ! SUM149-Luc
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 18
//
ID   SUM149-Luc/MA2
AC   CVCL_DH46
SY   MA2
DR   cancercelllines; CVCL_DH46
DR   GEO; GSM1463861
DR   GEO; GSM1463864
DR   Wikidata; Q54970831
RX   PubMed=25279830;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro724Leufs*12 (c.2169delT) (p.Asn723fs*13) (2288delT); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.4025+26_4025+30 (c.5224+28del3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH44 ! SUM149-Luc
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 17
//
ID   SUM149PT
AC   CVCL_3422
SY   SUM-149PT; SUM 149PT; SUM149-PT; SUM149; SUM-149; SUM 149; 149 PT; 149PT; BrCL12
DR   BTO; BTO_0005475
DR   CLO; CLO_0009917
DR   EFO; EFO_0001240
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-11134
DR   ArrayExpress; E-TABM-157
DR   BioGRID_ORCS_Cell_line; 1311
DR   BioSample; SAMN03472959
DR   cancercelllines; CVCL_3422
DR   Cell_Model_Passport; SIDM01441
DR   ChEMBL-Cells; CHEMBL4295448
DR   ChEMBL-Targets; CHEMBL4296497
DR   CLS; 300609
DR   Cosmic; 1044208
DR   Cosmic; 1046959
DR   Cosmic; 1136379
DR   Cosmic; 1176631
DR   Cosmic; 1287929
DR   Cosmic; 1289411
DR   Cosmic; 1460239
DR   Cosmic; 1523966
DR   Cosmic; 1603224
DR   Cosmic; 2036674
DR   DepMap; ACH-001390
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM115105
DR   GEO; GSM217600
DR   GEO; GSM350549
DR   GEO; GSM421889
DR   GEO; GSM481335
DR   GEO; GSM501233
DR   GEO; GSM501234
DR   GEO; GSM501235
DR   GEO; GSM501237
DR   GEO; GSM501238
DR   GEO; GSM844705
DR   GEO; GSM847433
DR   GEO; GSM847500
DR   GEO; GSM1008916
DR   GEO; GSM1053736
DR   GEO; GSM1172897
DR   GEO; GSM1172992
DR   GEO; GSM1214568
DR   GEO; GSM1215280
DR   GEO; GSM1238140
DR   GEO; GSM1374911
DR   GEO; GSM1401669
DR   GEO; GSM3145734
DR   IARC_TP53; 24356
DR   LINCS_HMS; 51082
DR   LINCS_LDP; LCL-2067
DR   PharmacoDB; SUM149PT_1509_2019
DR   PRIDE; PXD005295
DR   Progenetix; CVCL_3422
DR   PubChem_Cell_line; CVCL_3422
DR   SLKBase; 249
DR   Wikidata; Q54970832
RX   DOI=10.4172/2161-0681.1000119;
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10700188;
RX   PubMed=10969801;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=15857504;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=22032724;
RX   PubMed=23151021;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=23784380;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26495931;
RX   PubMed=26589293;
RX   PubMed=26735014;
RX   PubMed=28287265;
RX   PubMed=32416067;
RX   PubMed=32715085;
RX   PubMed=35042871;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Characteristics: Derived from a mouse xenograft of a transplanted primary human invasive infiltrating ductal carcinoma metastatic nodule.
CC   Doubling time: 33.95 hours (JWGray panel).
CC   HLA typing: A*68:01,68:01; B*53:01,78:01; C*06:02,16:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro724Leufs*12 (c.2169delT) (p.Asn723fs*13) (2288delT); Zygosity=Hemizygous (PubMed=16397213; PubMed=19593635; PubMed=22032724).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.4025+26_4025+30 (c.5224+28del3); Zygosity=Heterozygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): CLS=300609; DepMap=ACH-001390; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 15,18
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 28,31.2
ST   D2S1338: 20
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 18
ST   D7S820: 11
ST   D8S1179: 14,16
ST   FGA: 29
ST   Penta D: 8,9
ST   Penta E: 11
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   SUM149R
AC   CVCL_C9AM
SY   SUM-149PT(R)
DR   BioGRID_ORCS_Cell_line; 1395
DR   Wikidata; Q123033571
RX   PubMed=26735014;
RX   PubMed=32416067;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Selected for resistance to: ChEBI; CHEBI_137113; JQ1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro724Leufs*12 (c.2169delT) (p.Asn723fs*13) (2288delT); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; c.4025+26_4025+30 (c.5224+28del3); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (from parent cell line).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3422 ! SUM149PT
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SUM159PT
AC   CVCL_5423
AS   CVCL_5590
SY   SUM-159-PT; SUM-159PT; SUM 159PT; SUM-159; SUM 159; SUM159; 159 PT; 159PT
DR   BTO; BTO_0004928
DR   CLO; CLO_0009918
DR   EFO; EFO_0001241
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-11134
DR   ArrayExpress; E-TABM-157
DR   BioGRID_ORCS_Cell_line; 1394
DR   BioSample; SAMN03472960
DR   cancercelllines; CVCL_5423
DR   Cell_Model_Passport; SIDM01452
DR   ChEMBL-Cells; CHEMBL4483124
DR   ChEMBL-Targets; CHEMBL4483269
DR   CLS; 305116
DR   Cosmic; 904389
DR   Cosmic; 1046944
DR   Cosmic; 1136380
DR   Cosmic; 1287924
DR   Cosmic; 1289412
DR   Cosmic; 1460240
DR   DepMap; ACH-001391
DR   EGA; EGAS00001000610
DR   GEO; GSM75170
DR   GEO; GSM217601
DR   GEO; GSM412074
DR   GEO; GSM412089
DR   GEO; GSM412092
DR   GEO; GSM412105
DR   GEO; GSM412114
DR   GEO; GSM412117
DR   GEO; GSM421890
DR   GEO; GSM474278
DR   GEO; GSM474279
DR   GEO; GSM476481
DR   GEO; GSM476482
DR   GEO; GSM476483
DR   GEO; GSM478318
DR   GEO; GSM478319
DR   GEO; GSM478323
DR   GEO; GSM478324
DR   GEO; GSM844706
DR   GEO; GSM844707
DR   GEO; GSM847434
DR   GEO; GSM847501
DR   GEO; GSM967817
DR   GEO; GSM967822
DR   GEO; GSM1008917
DR   GEO; GSM1053735
DR   GEO; GSM1172993
DR   GEO; GSM1214567
DR   GEO; GSM1401652
DR   GEO; GSM3145737
DR   IARC_TP53; 24342
DR   LINCS_HMS; 51083
DR   LINCS_LDP; LCL-2068
DR   PharmacoDB; SUM159PT_1510_2019
DR   Progenetix; CVCL_5423
DR   PubChem_Cell_line; CVCL_5423
DR   SLKBase; 256
DR   Wikidata; Q54970841
RX   DOI=10.25904/1912/1434;
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=23151021;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26735014;
RX   PubMed=28889351;
RX   PubMed=32416067;
RX   PubMed=32715085;
RX   PubMed=34320349;
RX   PubMed=35042871;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/SUM-159.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Doubling time: 21.73 hours (JWGray panel).
CC   HLA typing: A*02:01,24:02; B*15:01,51:01; C*03:03,15:02 (PubMed=25960936).
CC   HLA typing: A*02:01,24:02; B*15:01,51:01; C*03:03,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=15677628).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (PubMed=19593635; PubMed=28889351).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (PubMed=19593635; PubMed=28889351).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157_Arg158insLeu (c.472_473ins3); Zygosity=Unspecified (PubMed=16541312; PubMed=28889351).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: SUM152; Note=Occasionally.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DepMap=ACH-001391; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 10,11 (DepMap=ACH-001391)
ST   CSF1PO: 11 (PubMed=25877200; PubMed=28889351)
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12,14 (PubMed=25877200)
ST   D18S51: 12,14,15 (DepMap=ACH-001391)
ST   D21S11: 28
ST   D3S1358: 11,16 (PubMed=25877200)
ST   D3S1358: 11,16,17 (DepMap=ACH-001391)
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 17
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C5161; Breast pleomorphic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   SUM159PT shPARG
AC   CVCL_RA93
SY   shPARG SUM159
DR   cancercelllines; CVCL_RA93
DR   Wikidata; Q54970842
RX   PubMed=29166620;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157_Arg158insLeu (c.472_473ins3); Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C5161; Breast pleomorphic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5423 ! SUM159PT
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   SUM159R
AC   CVCL_C9AN
SY   SUM-159PT(R)
DR   BioGRID_ORCS_Cell_line; 1396
DR   Wikidata; Q123033572
RX   PubMed=26735014;
RX   PubMed=32416067;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Selected for resistance to: ChEBI; CHEBI_137113; JQ1.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012612; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157_Arg158insLeu (c.472_473ins3); Zygosity=Unspecified (from parent cell line).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C5161; Breast pleomorphic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5423 ! SUM159PT
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SUM16LN
AC   CVCL_Y469
SY   SUM-16LN
DR   Wikidata; Q54970843
RX   PubMed=8018955;
RX   PubMed=8425198;
CC   Senescence: Has a finite life span. Senesces at 15 to 20 PDL (PubMed=8018955).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 10
//
ID   SUM185PE
AC   CVCL_5591
SY   SUM-185PE; SUM 185PE; SUM-185; SUM 185; SUM185; 185PE
DR   BTO; BTO_0005476
DR   CLO; CLO_0009919
DR   EFO; EFO_0001242
DR   ArrayExpress; E-TABM-157
DR   cancercelllines; CVCL_5591
DR   Cell_Model_Passport; SIDM01430
DR   ChEMBL-Cells; CHEMBL4632324
DR   ChEMBL-Targets; CHEMBL4632331
DR   Cosmic; 904390
DR   Cosmic; 1046940
DR   Cosmic; 1136381
DR   Cosmic; 1176642
DR   Cosmic; 1287898
DR   Cosmic; 1289413
DR   Cosmic; 1460241
DR   DepMap; ACH-001392
DR   GEO; GSM421891
DR   GEO; GSM844708
DR   GEO; GSM847435
DR   GEO; GSM847502
DR   GEO; GSM1053738
DR   GEO; GSM1172994
DR   IARC_TP53; 24365
DR   LINCS_HMS; 51084
DR   LINCS_LDP; LCL-2069
DR   PharmacoDB; SUM185PE_1515_2019
DR   PRIDE; PXD005390
DR   PubChem_Cell_line; CVCL_5591
DR   SLKBase; 115
DR   Wikidata; Q54970844
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=28287265;
RX   PubMed=32715085;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Doubling time: 92.43 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001392
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SUM190PT
AC   CVCL_3423
SY   SUM-190PT; SUM 190PT; SUM-190; SUM 190; SUM190; 190PT
DR   BTO; BTO_0005477
DR   EFO; EFO_0001243
DR   ArrayExpress; E-MTAB-11134
DR   ArrayExpress; E-TABM-157
DR   BioSample; SAMN03471033
DR   cancercelllines; CVCL_3423
DR   Cosmic; 904391
DR   Cosmic; 1046941
DR   Cosmic; 1287899
DR   Cosmic; 1289414
DR   Cosmic; 1460244
DR   Cosmic; 1603225
DR   DepMap; ACH-001393
DR   GEO; GSM217602
DR   GEO; GSM350534
DR   GEO; GSM847436
DR   GEO; GSM847503
DR   GEO; GSM1008918
DR   GEO; GSM1053734
DR   GEO; GSM1215269
DR   GEO; GSM1238141
DR   IARC_TP53; 24367
DR   LINCS_HMS; 51121
DR   PharmacoDB; SUM190_1511_2019
DR   Progenetix; CVCL_3423
DR   SLKBase; 263
DR   Wikidata; Q54970845
RX   DOI=10.4172/2161-0681.1000119;
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=23151021;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=23784380;
RX   PubMed=24162158;
RX   PubMed=25877200;
RX   PubMed=28196595;
RX   PubMed=32715085;
RX   PubMed=35042871;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive.
CC   Doubling time: 310.16 hours (JWGray panel).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Ter (c.949C>T); ClinVar=VCV000450344; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): DepMap=ACH-001393; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 12
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 22
ST   Penta D: 10,11
ST   Penta E: 18,19
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SUM206CWN
AC   CVCL_5592
SY   SUM-206CWN; SUM-206cwn; SUM-206 Chest Wall Nodule; SUM206; SUM-206
DR   Wikidata; Q54970846
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=23401782;
WW   Info; -; -; https://web.archive.org/web/20040421014855/http://www.cancer.med.umich.edu/breast_cell/Production/sumlines/SUM-206CWN.html
CC   Senescence: Has a finite life span. Senesces at about 20 PDL (personal communication of Ethier, Stephen P.).
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: Cell line not distributed (personal communication of Ethier, Stephen P.).
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   SUM225CWN
AC   CVCL_5593
SY   SUM-225CWN; SUM-225cwn; SUM 225CWN; SUM-225 Chest Wall Nodule; SUM-225; SUM 225; SUM225; Sum225; 225CWN
DR   BTO; BTO_0005478
DR   CLO; CLO_0009920
DR   EFO; EFO_0001244
DR   ArrayExpress; E-TABM-157
DR   cancercelllines; CVCL_5593
DR   Cosmic; 904392
DR   Cosmic; 1046960
DR   Cosmic; 1136359
DR   Cosmic; 1287900
DR   Cosmic; 1289415
DR   Cosmic; 1460242
DR   DepMap; ACH-001397
DR   GEO; GSM320177
DR   GEO; GSM844709
DR   GEO; GSM844710
DR   GEO; GSM847437
DR   GEO; GSM847504
DR   GEO; GSM1053732
DR   GEO; GSM1172901
DR   GEO; GSM1172995
DR   IARC_TP53; 24360
DR   LINCS_HMS; 51085
DR   LINCS_LDP; LCL-2070
DR   PharmacoDB; SUM225CWN_1516_2019
DR   Progenetix; CVCL_5593
DR   SLKBase; 284
DR   Wikidata; Q54970848
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19593635;
RX   PubMed=23151021;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=25960936;
RX   PubMed=28196595;
RX   PubMed=32715085;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 73.20 hours (JWGray panel).
CC   HLA typing: A*01:01,02:01; B*08:01,39:01; C*07:01,12:03; DQB1*05:01,05:01; DRB1*16:05,16:05 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu265Pro (c.794T>C); ClinVar=VCV000245777; Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
ST   Source(s): DepMap=ACH-001397
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D21S11: 30,33.2
ST   D3S1358: 16,19
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SUM229PE
AC   CVCL_5594
SY   SUM-229PE; SUM 229PE; SUM-229; SUM 229; SUM229; 229PE
DR   BTO; BTO_0005479
DR   CLO; CLO_0009921
DR   EFO; EFO_0006762
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03471035
DR   cancercelllines; CVCL_5594
DR   Cell_Model_Passport; SIDM01461
DR   Cosmic; 904393
DR   Cosmic; 997923
DR   Cosmic; 1046949
DR   Cosmic; 1287930
DR   Cosmic; 1289416
DR   Cosmic; 1460243
DR   Cosmic; 1479523
DR   DepMap; ACH-001394
DR   EGA; EGAS00001000610
DR   GEO; GSM421892
DR   GEO; GSM1172902
DR   GEO; GSM1172996
DR   IARC_TP53; 24363
DR   LINCS_HMS; 51086
DR   LINCS_LDP; LCL-2065
DR   PharmacoDB; SUM229PE_1512_2019
DR   PRIDE; PXD005295
DR   SLKBase; 295
DR   Wikidata; Q54970849
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28287265;
RX   PubMed=32715085;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Problematic cell line: Partially misidentified. For a period of time Asterand (now BioIVT) mistakenly distributed SUM149PT (Cellosaurus=CVCL_3422) under the designation of SUM229PE. This leads to the publication of a STR profile (PubMed=25877200) which was almost identical to that of SUM149PT.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00548.
CC   Doubling time: 42.27 hours (JWGray panel).
CC   HLA typing: A*02:01,11:01; B*40:02,44:02; C*02:02,03:04; DQB1*05:01,05:01; DRB1*01:01,15:01 (PubMed=25960936).
CC   HLA typing: A*68:01,68:01; B*53:02,78:01; C*06:02,16:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=19593635; DepMap=ACH-001394).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=16541312; DepMap=ACH-001394).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): BioIVT/Asterand
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D5S818: 9,12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SUM44PE
AC   CVCL_3424
SY   Sum44PE; SUM-44PE; SUM 44PE; SUM-44 PE; SUM-44; SUM 44; SUM44; Sum44; 44PE
DR   BTO; BTO_0005389
DR   EFO; EFO_0001245
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   cancercelllines; CVCL_3424
DR   Cell_Model_Passport; SIDM01835
DR   Cosmic; 997937
DR   Cosmic; 1289408
DR   Cosmic; 1460237
DR   DepMap; ACH-001395
DR   GEO; GSM115108
DR   GEO; GSM217603
DR   GEO; GSM320179
DR   GEO; GSM350531
DR   GEO; GSM421886
DR   GEO; GSM481300
DR   GEO; GSM847438
DR   GEO; GSM847505
DR   GEO; GSM984233
DR   GEO; GSM1053740
DR   GEO; GSM1172997
DR   GEO; GSM1226542
DR   GEO; GSM1226543
DR   GEO; GSM1226544
DR   GEO; GSM1226545
DR   GEO; GSM1226546
DR   GEO; GSM1226547
DR   GEO; GSM1226548
DR   GEO; GSM1226549
DR   GEO; GSM1226550
DR   GEO; GSM1226551
DR   GEO; GSM1226552
DR   GEO; GSM1226553
DR   GEO; GSM1226554
DR   GEO; GSM1226555
DR   GEO; GSM1226556
DR   GEO; GSM1226557
DR   GEO; GSM1226558
DR   GEO; GSM1226559
DR   GEO; GSM1226560
DR   GEO; GSM1226561
DR   GEO; GSM1661990
DR   IARC_TP53; 24364
DR   LINCS_HMS; 51122
DR   PharmacoDB; SUM44PE_1517_2019
DR   Progenetix; CVCL_3424
DR   SLKBase; 219
DR   Wikidata; Q54970850
RX   PubMed=8425198;
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=24425047;
RX   PubMed=25757734;
RX   PubMed=25960936;
RX   PubMed=30228172;
RX   PubMed=32715085;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Characteristics: ER-positive, PR-negative and ERBB2-negative.
CC   Doubling time: 85.10 hours (JWGray panel).
CC   HLA typing: B*14:02,56:29; C*08:04,08:04 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Phe423Leufs*8 (c.1269delT); ClinVar=VCV002035493; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu28fs*16 (c.82_84del3insCA); Zygosity=Unspecified (PubMed=16541312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001395
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 17
ST   D21S11: 32.2
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 10,18
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SUM52PE
AC   CVCL_3425
SY   SUM-52PE; SUM 52PE; SUM-52-PE; SUM-52; SUM 52; SUM52; 52PE
DR   BTO; BTO_0005390
DR   CLO; CLO_0037189
DR   EFO; EFO_0001246
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-TABM-157
DR   BioSample; SAMN03472911
DR   cancercelllines; CVCL_3425
DR   Cell_Model_Passport; SIDM01422
DR   Cosmic; 904387
DR   Cosmic; 1046962
DR   Cosmic; 1176647
DR   Cosmic; 1287897
DR   Cosmic; 1289409
DR   Cosmic; 1460238
DR   DepMap; ACH-001396
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM115109
DR   GEO; GSM217604
DR   GEO; GSM219890
DR   GEO; GSM320178
DR   GEO; GSM350524
DR   GEO; GSM421887
DR   GEO; GSM481330
DR   GEO; GSM844711
DR   GEO; GSM844712
DR   GEO; GSM847439
DR   GEO; GSM847506
DR   GEO; GSM1053739
DR   GEO; GSM1172903
DR   GEO; GSM1172998
DR   GEO; GSM1374912
DR   IARC_TP53; 24366
DR   LINCS_HMS; 51087
DR   LINCS_LDP; LCL-2071
DR   Lonza; 1253
DR   PharmacoDB; SUM52PE_1513_2019
DR   Progenetix; CVCL_3425
DR   SLKBase; 231
DR   Wikidata; Q54970851
RX   PubMed=10424408;
RX   PubMed=10604729;
RX   PubMed=10969801;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=21778573;
RX   PubMed=23401782;
RX   PubMed=23601657;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26759240;
RX   PubMed=32715085;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SUM-52PE
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/SUM52.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/sum-breast-cancer-cell-lines/
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Doubling time: 55.21 hours (JWGray panel).
CC   HLA typing: A*32:01,32:01; B*07:02,15:01; C*03:03,07:02; DQB1*06:04,05:01; DRB1*15:01,15:01 (PubMed=25960936).
CC   HLA typing: A*32:01,32:01; B*07:02,15:01; C*03:03,07:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68Val (c.203C>T); ClinVar=VCV000406701; Zygosity=Homozygous (PubMed=19593635; DepMap=ACH-001396).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=16541312; DepMap=ACH-001396).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001396; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 12,14 (DepMap=ACH-001396)
ST   D7S820: 14 (PubMed=25877200)
ST   D8S1179: 13
ST   FGA: 21 (PubMed=25877200)
ST   FGA: 21,22 (DepMap=ACH-001396)
ST   Penta D: 9,12
ST   Penta E: 13,17
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SUM52PE GDC-0941_resistant
AC   CVCL_A1FM
DR   cancercelllines; CVCL_A1FM
DR   Cosmic; 2787233
DR   Wikidata; Q102114951
RX   PubMed=26759240;
CC   Selected for resistance to: ChEBI; CHEBI_65326; Pictrelisib (Pictilisib; GDC-0941).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68Val (c.203C>T); ClinVar=VCV000406701; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3425 ! SUM52PE
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   SUNE1
AC   CVCL_6946
SY   SUNE-1; SUNE 1
DR   BTO; BTO_0006009
DR   ChEMBL-Cells; CHEMBL4483126
DR   ChEMBL-Targets; CHEMBL4483270
DR   Cosmic; 755507
DR   Cosmic; 1193458
DR   Cosmic; 1322950
DR   Cosmic; 2366882
DR   PubChem_Cell_line; CVCL_6946
DR   Wikidata; Q54970853
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile (PubMed=26116706) it seems to be a hybrid of HeLa and of cell line of unknown origin. Originally thought to originate from a patient with a nasopharyngeal carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00595.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 11,14,18
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 17
ST   TH01: 9
ST   TPOX: 8,9,12
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SUNE2
AC   CVCL_6956
SY   SUNE-2
DR   ABM; T8020
DR   Wikidata; Q54970854
RX   PubMed=22176775;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. On the basis of the STR profile (PubMed=26116706) it seems to be a hybrid of HeLa and of cell line of unknown origin. Originally thought to originate from a 38 year old female patient with a nasopharyngeal carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00598.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 20,21
ST   D13S317: 10,12,13.3
ST   D16S539: 9,10
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 27,30
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 11,12,13
ST   D6S1043: 11,14,18
ST   D7S820: 10,12
ST   D8S1179: 12,13,17
ST   FGA: 18,21
ST   Penta D: 9,12
ST   Penta E: 17,20
ST   TH01: 6,7,9
ST   TPOX: 8,9
ST   vWA: 14,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SUP-B1
AC   CVCL_A309
DR   Wikidata; Q54970856
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 6
//
ID   SUP-B12
AC   CVCL_A319
DR   Wikidata; Q54970857
RX   PubMed=2541219;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 9
//
ID   SUP-B13
AC   CVCL_A308
SY   SUPB13
DR   Cosmic; 2348805
DR   Wikidata; Q54970858
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1434795;
RX   PubMed=1967982;
RX   PubMed=3162827;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8704231;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=10071072;
CC   Population: Caucasian.
CC   Doubling time: ~35 hours (PubMed=1434795; PubMed=3162827).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=3162827; PubMed=10071072).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0103 ! SUP-B15
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   SUP-B15
AC   CVCL_0103
SY   Sup-B15; SUPB-15; SUPB15; SupB15; SupB15W; SupB15WT
DR   CLO; CLO_0009161
DR   EFO; EFO_0006763
DR   AddexBio; C0003019/4892
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1929
DR   BCRJ; 0229
DR   BioSample; SAMN03473114
DR   BioSample; SAMN10987666
DR   cancercelllines; CVCL_0103
DR   CCRID; 3101HUMTCHu190
DR   Cell_Model_Passport; SIDM01176
DR   ChEMBL-Cells; CHEMBL4295393
DR   ChEMBL-Targets; CHEMBL4296498
DR   Cosmic; 1012120
DR   Cosmic; 1130245
DR   Cosmic; 1498420
DR   Cosmic; 1524821
DR   Cosmic; 1630017
DR   Cosmic; 2491077
DR   Cosmic-CLP; 1247871
DR   DepMap; ACH-000059
DR   DSMZ; ACC-389
DR   DSMZCellDive; ACC-389
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1247871
DR   GEO; GSM236806
DR   GEO; GSM236842
DR   GEO; GSM887658
DR   GEO; GSM888750
DR   GEO; GSM1374913
DR   GEO; GSM1670490
DR   GEO; GSM5137745
DR   GEO; GSM5137767
DR   IARC_TP53; 30174
DR   IZSLER; BS TCL 238
DR   LiGeA; CCLE_418
DR   LINCS_LDP; LCL-1041
DR   PharmacoDB; SUPB15_1518_2019
DR   PRIDE; PXD000394
DR   PRIDE; PXD023662
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0103
DR   PubChem_Cell_line; CVCL_0103
DR   Wikidata; Q54970859
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3162827;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8704231;
RX   PubMed=9067587;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15843827;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25576301;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35354797;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~18 hours (PubMed=3162827); ~60 hours (DSMZ=ACC-389).
CC   HLA typing: A*03:01,11:01; B*51:02,52:01; C*12:02,14:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=3162827; PubMed=10071072; PubMed=10576511; PubMed=15843827; PubMed=25485619; PubMed=35354797; DepMap=ACH-000059).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.5%; East Asian, North=0.25%; East Asian, South=0.2%; South Asian=1.01%; European, North=70.33%; European, South=27.71% (PubMed=30894373).
CC   Discontinued: AddexBio; C0003019/4892; probable.
CC   Discontinued: BCRJ; 0229; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-1929; Cosmic-CLP=1247871; DSMZ=ACC-389; PubMed=25877200; PubMed=30879952
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,14
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28,31
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 19,20
ST   Penta D: 9,12
ST   Penta E: 21
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A308 ! SUP-B13
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   SUP-B15/RI
AC   CVCL_S642
SY   SUP-B15-RI
DR   Cosmic; 1630018
DR   Wikidata; Q54970860
RX   PubMed=22285507;
RX   PubMed=23230732;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0103 ! SUP-B15
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   SUP-B16
AC   CVCL_A310
DR   Wikidata; Q54970861
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: Caucasian.
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A321 ! SUP-B19
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   SUP-B17
AC   CVCL_A322
DR   Wikidata; Q54970862
RX   PubMed=2541219;
RX   PubMed=8231254;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 10
//
ID   SUP-B19
AC   CVCL_A321
AS   CVCL_A311
DR   Wikidata; Q54970863
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: Caucasian.
CC   Misspelling: SUP-B18; PubMed=8704231.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A310 ! SUP-B16
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 12
//
ID   SUP-B2
AC   CVCL_A312
DR   Wikidata; Q54970864
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1434795;
RX   PubMed=2875799;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=9087565;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (PubMed=1434795).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:50866; RNF217-AS1; Name(s)=ETV6-RNF217-AS1, ETV6-STL (PubMed=9087565).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   SUP-B24
AC   CVCL_A313
DR   Wikidata; Q54970866
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1434795;
RX   PubMed=8231254;
CC   Population: Caucasian.
CC   Doubling time: ~72 hours (PubMed=1434795).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A317 ! SUP-B31
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SUP-B26
AC   CVCL_A314
SY   AT-1; AT1
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   cancercelllines; CVCL_A314
DR   Cosmic; 1524790
DR   GEO; GSM236778
DR   GEO; GSM236814
DR   Wikidata; Q54970868
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=12127395;
RX   PubMed=34940123;
CC   Population: Caucasian and Pacific; Polynesian.
CC   Doubling time: ~5 days (PubMed=12127395).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1; Note=ETV6 exon 5/RUNX1 exon 4 and RUNX1 exon 3/ETV6 exon 6 fusions (PubMed=8704231; PubMed=12127395; PubMed=34940123).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous; Note=In 15% of the reads (PubMed=34940123).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous; Note=In 35% of the reads (PubMed=34940123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Ryan, Russell James Hubbard.
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 19,24
ST   D3S1358: 16,18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 20,24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A316 ! SUP-B28
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   SUP-B27
AC   CVCL_A315
DR   Cosmic; 2396140
DR   Cosmic; 2491078
DR   Wikidata; Q54970869
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1967982;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=9067587;
RX   PubMed=10490826;
CC   Population: Caucasian.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 15
//
ID   SUP-B28
AC   CVCL_A316
AS   CVCL_DI26
SY   AT-2; AT2
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   cancercelllines; CVCL_A316
DR   Wikidata; Q54750826
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=12127395;
RX   PubMed=34940123;
CC   Population: Caucasian and Pacific; Polynesian.
CC   Doubling time: ~3 days (PubMed=12127395).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1; Note=ETV6 exon 5/RUNX1 exon 4 and RUNX1 exon 3/ETV6 exon 6 fusions (PubMed=8704231; PubMed=12127395; PubMed=34940123).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous; Note=In 50% of the reads (PubMed=34940123).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000040468; Zygosity=Heterozygous; Note=In 3% of the reads (PubMed=34940123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: STR profile from personal communication of Ryan, Russell James Hubbard.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 19,24
ST   D3S1358: 16,18
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 20,24
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A314 ! SUP-B26
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   SUP-B31
AC   CVCL_A317
DR   Wikidata; Q54970871
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A313 ! SUP-B24
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   SUP-B6
AC   CVCL_A320
DR   Wikidata; Q54970872
RX   PubMed=2875799;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   SUP-B7
AC   CVCL_A318
DR   Wikidata; Q54970873
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1434795;
RX   PubMed=3469019;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8704231;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Doubling time: ~100 hours (PubMed=1434795); 7 days (PubMed=3469019).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SUP-B8
AC   CVCL_1713
SY   SupB8; SUPB8
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_1713
DR   Cell_Model_Passport; SIDM01177
DR   Cosmic; 910209
DR   Cosmic-CLP; 910209
DR   DepMap; ACH-002308
DR   EGA; EGAS00001000978
DR   GDSC; 910209
DR   GEO; GSM1670491
DR   IARC_TP53; 27248
DR   PharmacoDB; SUPB8_1519_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54970874
RX   PubMed=2541219;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Arg1192Cys (c.3574C>T); ClinVar=VCV000570308; Zygosity=Heterozygous (Cosmic-CLP=910209; DepMap=ACH-002308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Homozygous (DepMap=ACH-002308).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.05%; Native American=0%; East Asian, North=0.63%; East Asian, South=0.05%; South Asian=1.61%; European, North=69.66%; European, South=28% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=910209
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   SUP-HD1
AC   CVCL_2208
SY   Sup-HD1; SUP-HD-1; SUPHD1
DR   CLO; CLO_0037190
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473483
DR   BioSample; SAMN10988468
DR   cancercelllines; CVCL_2208
DR   Cell_Model_Passport; SIDM00422
DR   Cosmic; 1086360
DR   Cosmic; 1278831
DR   Cosmic; 1432043
DR   Cosmic-CLP; 1331039
DR   DepMap; ACH-001203
DR   DSMZ; ACC-574
DR   DSMZCellDive; ACC-574
DR   EGA; EGAS00001000978
DR   GDSC; 1331039
DR   GEO; GSM552469
DR   GEO; GSM887659
DR   GEO; GSM888751
DR   GEO; GSM1670492
DR   IARC_TP53; 30175
DR   LINCS_LDP; LCL-2014
DR   PharmacoDB; SUPHD1_1520_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2208
DR   Wikidata; Q54970875
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2554995;
RX   PubMed=8558920;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=29533902;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 3-4 days (PubMed=2554995); ~40-80 hours (DSMZ=ACC-574).
CC   HLA typing: A*01:01:01,01:01:71; B*38:01:01,38:01:01; C*12:03:01,12:03:01; DPA1*02:02:02,02:02:02; DPB1*02:01:02,02:01:02; DQA1*01:03:01,01:03:01; DQB1*06:03:01,06:03:01; DRA*01:02:02,01:02:02; DRB1*13:01:01,13:01:01 (DSMZCellDive=ACC-574).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=31068700; Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.43%; Native American=0%; East Asian, North=4.61%; East Asian, South=0%; South Asian=0.02%; European, North=49.35%; European, South=40.59% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1331039; DSMZ=ACC-574
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10
ST   D18S51: 13,16,17
ST   D19S433: 13,15
ST   D21S11: 28
ST   D2S1338: 16,24,25
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11,12 (DSMZ=ACC-574)
ST   D7S820: 10,12 (Cosmic-CLP=1331039)
ST   D8S1179: 12
ST   FGA: 23
ST   Penta D: 11
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   SUP-M2
AC   CVCL_2209
SY   Sup-M2; SUPM2
DR   BTO; BTO_0004775
DR   CLO; CLO_0037065
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioGRID_ORCS_Cell_line; 458
DR   BioSample; SAMN03473512
DR   BioSample; SAMN10988021
DR   cancercelllines; CVCL_2209
DR   Cell_Model_Passport; SIDM00421
DR   Cosmic; 1086004
DR   Cosmic; 1152615
DR   Cosmic; 1995648
DR   Cosmic-CLP; 1331040
DR   DepMap; ACH-000226
DR   DSMZ; ACC-509
DR   DSMZCellDive; ACC-509
DR   EGA; EGAS00001000978
DR   GDSC; 1331040
DR   GEO; GSM887660
DR   GEO; GSM888752
DR   GEO; GSM1670493
DR   IARC_TP53; 30176
DR   LiGeA; CCLE_582
DR   LINCS_LDP; LCL-1919
DR   PharmacoDB; SUPM2_1521_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2209
DR   Wikidata; Q54970876
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2525056;
RX   PubMed=7824924;
RX   PubMed=9121481;
RX   PubMed=15356658;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-509).
CC   HLA typing: A*02:01:01,02:01:01; B*44:03:01,50:01:01; C*06:02:01,16:01:01; DPA1*01:03:01,02:01:01; DPB1*11:01:01,04:01:01; DQA1*02:01:01,02:01:01; DQB1*02:01:01,02:02:01; DRA*01:01:01,01:02:02; DRB1*03:01:01,07:01:01 (DSMZCellDive=ACC-509).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=7824924; PubMed=9121481).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.59%; Native American=1.22%; East Asian, North=2.73%; East Asian, South=0%; South Asian=0%; European, North=54.77%; European, South=38.68% (PubMed=30894373).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
ST   Source(s): Cosmic-CLP=1331040; DSMZ=ACC-509
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 11,12
ST   Penta E: 7,16
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   SUP-M2-CR03
AC   CVCL_V405
SY   SUPM2CR03
DR   Cosmic; 1849570
DR   Wikidata; Q54970878
RX   PubMed=23239810;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (from parent cell line).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2209 ! SUP-M2
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   Sup-M2-TS
AC   CVCL_B228
SY   Sup-M2TS; TS
DR   BTO; BTO_0004867
DR   cancercelllines; CVCL_B228
DR   GEO; GSM1217149
DR   Progenetix; CVCL_B228
DR   Wikidata; Q54970879
RX   PubMed=26657151;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=26657151).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2209 ! SUP-M2
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   SUP-T1
AC   CVCL_1714
SY   Sup-T1; SUPT-1; SupT-1; Sup T-1; SUP T-1; SUP T1; Sup T1; SupT1; SUPT1; Tsup-1; VB; Stanford University Pediatric T-cell line 1
DR   BTO; BTO_0003582
DR   CLO; CLO_0009164
DR   EFO; EFO_0022582
DR   CLDB; cl4420
DR   CLDB; cl4421
DR   CLDB; cl4422
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1942
DR   BCRC; 60191
DR   BEI_Resources; ARP-100
DR   BEI_Resources; ARP-150
DR   BioGRID_ORCS_Cell_line; 456
DR   BioSample; SAMN03471266
DR   BioSample; SAMN03473416
DR   BioSample; SAMN10987655
DR   cancercelllines; CVCL_1714
DR   Cell_Model_Passport; SIDM01154
DR   ChEMBL-Cells; CHEMBL3308368
DR   ChEMBL-Targets; CHEMBL614940
DR   Cosmic; 687855
DR   Cosmic; 909743
DR   Cosmic; 1086322
DR   Cosmic; 1281384
DR   Cosmic; 1330493
DR   Cosmic; 1524822
DR   Cosmic; 1664528
DR   Cosmic; 1760532
DR   Cosmic; 2165716
DR   Cosmic; 2602931
DR   Cosmic-CLP; 909743
DR   DepMap; ACH-000953
DR   DSMZ; ACC-140
DR   DSMZCellDive; ACC-140
DR   ECACC; 95013123
DR   EGA; EGAS00001000978
DR   GDSC; 909743
DR   GEO; GSM482493
DR   GEO; GSM887662
DR   GEO; GSM888754
DR   GEO; GSM1670494
DR   ICLC; HTL96007
DR   LiGeA; CCLE_331
DR   LINCS_LDP; LCL-1023
DR   Lonza; 293
DR   PharmacoDB; SUPT1_1522_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1714
DR   PubChem_Cell_line; CVCL_1714
DR   Wikidata; Q54970880
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3004618;
RX   PubMed=3010463;
RX   PubMed=3036367;
RX   PubMed=3107838;
RX   PubMed=3935328;
RX   PubMed=6437672;
RX   PubMed=6438800;
RX   PubMed=7849311;
RX   PubMed=8558920;
RX   PubMed=9933131;
RX   PubMed=11264379;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22292511;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=25355872;
RX   PubMed=27397505;
RX   PubMed=29304865;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=32938764;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/comprehensivetable/sup-t1/
WW   Provider; HHV-6 Foundation; -; https://hhv-6foundation.org/wp-content/uploads/2016/11/SupT-1-Cells-data-sheet.pdf
WW   Provider; NIBSC; 0024; http://www.nibsc.org/Default.aspx?pageid=597&id=0024&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Characteristics: Has chromosomal translocations involving the genes for the alpha and beta subunits of TCR thus preventing surface expression of the endogenous TCR complex.
CC   Virology: Useful for studies of cell fusion and cytopathic effects of HIV-1 as well as cytopathic isolates of HIV-2.
CC   Virology: Susceptible to infection by herpesvirus 6B (HHV-6B) strain Z29 (PubMed=29304865).
CC   Doubling time: 28 hours (PubMed=3004618); ~30 hours (DSMZ=ACC-140); ~24-36 hours (BEI_Resources=ARP-100).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743; DepMap=ACH-000953).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=909743).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.14%; Native American=1.61%; East Asian, North=0%; East Asian, South=0%; South Asian=9.49%; European, North=46.77%; European, South=41.99% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-1942; Cosmic-CLP=909743; DSMZ=ACC-140; PubMed=32938764
ST   Amelogenin: X (DSMZ=ACC-140)
ST   Amelogenin: X,Y (ATCC=CRL-1942; Cosmic-CLP=909743; PubMed=32938764)
ST   CSF1PO: 10,11 (ATCC=CRL-1942; Cosmic-CLP=909743; DSMZ=ACC-140)
ST   CSF1PO: 10,11,12 (PubMed=32938764)
ST   D13S317: 10,11,12 (DSMZ=ACC-140; PubMed=32938764)
ST   D13S317: 11,12 (ATCC=CRL-1942; Cosmic-CLP=909743)
ST   D16S539: 9,10,11,13 (DSMZ=ACC-140)
ST   D16S539: 9,11,12 (ATCC=CRL-1942; Cosmic-CLP=909743)
ST   D16S539: 9,12 (PubMed=32938764)
ST   D18S51: 13,14
ST   D19S433: 13,27
ST   D21S11: 28,29,32.2,33.2 (DSMZ=ACC-140)
ST   D21S11: 28,31,32,33 (PubMed=32938764)
ST   D2S1338: 25,26
ST   D3S1358: 16,17,18,19 (PubMed=32938764)
ST   D3S1358: 17 (DSMZ=ACC-140)
ST   D5S818: 10,11,12 (DSMZ=ACC-140)
ST   D5S818: 11 (PubMed=32938764)
ST   D5S818: 11,12 (ATCC=CRL-1942; Cosmic-CLP=909743)
ST   D7S820: 11
ST   D8S1179: 13,14 (PubMed=32938764)
ST   D8S1179: 13,14,15 (DSMZ=ACC-140)
ST   FGA: 19,20,21 (PubMed=32938764)
ST   FGA: 20,21 (DSMZ=ACC-140)
ST   Penta D: 12
ST   Penta E: 13,14,16 (PubMed=32938764)
ST   Penta E: 14,16 (DSMZ=ACC-140)
ST   TH01: 9.3
ST   TPOX: 8,9 (DSMZ=ACC-140)
ST   TPOX: 9 (ATCC=CRL-1942; Cosmic-CLP=909743; PubMed=32938764)
ST   vWA: 16,17,18,19 (PubMed=32938764)
ST   vWA: 16,18 (ATCC=CRL-1942; Cosmic-CLP=909743)
ST   vWA: 16,18,19 (DSMZ=ACC-140)
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   Sup-T1 CCR5+ H6
AC   CVCL_A9NU
SY   Sup-T1 CCR5+ Cells (H6)
DR   BEI_Resources; ARP-13783
DR   cancercelllines; CVCL_A9NU
DR   Wikidata; Q108821336
CC   Population: Caucasian.
CC   Characteristics: Expresses high level of CCR5 (BEI_Resources=ARP-13783).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   Sup-T1 CCR5+ L23
AC   CVCL_A9NV
SY   Sup-T1 CCR5+ Cells (L23)
DR   BEI_Resources; ARP-13784
DR   cancercelllines; CVCL_A9NV
DR   Wikidata; Q108821337
CC   Population: Caucasian.
CC   Characteristics: Expresses low level of CCR5 (BEI_Resources=ARP-13784).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   Sup-T1 CCR5+ M10
AC   CVCL_A9NW
SY   Sup-T1 CCR5+ Cells (M10)
DR   BEI_Resources; ARP-13782
DR   cancercelllines; CVCL_A9NW
DR   Wikidata; Q108821338
CC   Population: Caucasian.
CC   Characteristics: Expresses medium level of CCR5 (BEI_Resources=ARP-13782).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 10
//
ID   Sup-T1 Nef-ER 31
AC   CVCL_1H35
SY   Nef-ER 31; Nef-ER #31; Nef-ER #31 Clone; Nef-ER Expressing Sup-T1 Cells (Clone 31)
DR   BEI_Resources; ARP-6453
DR   cancercelllines; CVCL_1H35
DR   Wikidata; Q54930388
RX   PubMed=11134296;
CC   Population: Caucasian.
CC   Characteristics: Expresses a chimeric Nef-estrogen receptor hormone-binding domain (Nef-ER) protein. Nef-ER is kept in an inactive state due to steric hindrance, and addition of the membrane-permeable drug 4-hydroxytamoxifen (4-HT), which binds to the ER domain, leads to inducible activation of Nef-ER within cells (PubMed=11134296).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1352467; Esr1 (Note=With p.Met1_Asp484del and p.Ile486_Ile599del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q90VU7; HIV-1 isolate NL4-3 nef.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 17
//
ID   Sup-T1-CCR5
AC   CVCL_X633
SY   SupT1/CCR5; SupT1-CCR5
DR   cancercelllines; CVCL_X633
DR   Wikidata; Q54970881
RX   PubMed=11264379;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Miscellaneous: STR profile from personal communication of Fernandez, Melissa Victoria.
CC   Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 11,12
ST   D16S539: 9,12,13
ST   D18S51: 13,14
ST   D21S11: 27,28,32,33
ST   D3S1358: 16,17,18,19,20
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 19,20,21
ST   Penta D: 12
ST   Penta E: 14,16
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 16,17,18,19
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 18
//
ID   Sup-T1/JI
AC   CVCL_M773
SY   SUP-T1/JI
DR   BEI_Resources; ARP-12184
DR   cancercelllines; CVCL_M773
DR   Wikidata; Q54970882
WW   Provider; HHV-6 Foundation; -; https://hhv-6foundation.org/wp-content/uploads/2016/12/hhv-7-ji-strain-in-supt-1-cell-line.pdf
CC   Population: Caucasian.
CC   Virology: Infected by human herpesvirus 7 (HHV-7) strain JI (HHV-6 Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 20
//
ID   SUP-T1/Z29
AC   CVCL_M772
SY   SUPT-1 / Z29
DR   BEI_Resources; ARP-12183
DR   cancercelllines; CVCL_M772
DR   Wikidata; Q54970884
RX   PubMed=11689646;
WW   Provider; HHV-6 Foundation; -; https://hhv-6foundation.org/reagent/hhv-6b-z29-strain-in-supt-1-cells
CC   Population: Caucasian.
CC   Virology: Infected by human herpesvirus 6B (HHV-6B) strain Z29 (HHV-6 Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Caution: Was discontinued from BEI_Resources because the cell line seemed to have also been infected by HIV-1 (personal communication of Rashid, Sujatha).
CC   Discontinued: BEI_Resources; ARP-12183; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   SUP-T10
AC   CVCL_F689
SY   Stanford University Pediatric T-cell line 10
DR   Wikidata; Q54970885
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SUP-T11
AC   CVCL_2210
SY   SupT11; SUPT11; SUPT-11; Stanford University Pediatric T-cell line 11
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473500
DR   BioSample; SAMN10988463
DR   cancercelllines; CVCL_2210
DR   Cell_Model_Passport; SIDM01859
DR   Cosmic; 913418
DR   Cosmic; 1115599
DR   Cosmic; 1151792
DR   Cosmic; 1524823
DR   Cosmic; 2602932
DR   DepMap; ACH-000122
DR   DSMZ; ACC-605
DR   DSMZCellDive; ACC-605
DR   GEO; GSM887661
DR   GEO; GSM888753
DR   IARC_TP53; 28336
DR   LiGeA; CCLE_855
DR   PharmacoDB; SUPT11_1523_2019
DR   Progenetix; CVCL_2210
DR   Wikidata; Q54970886
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
RX   PubMed=15472075;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~35-45 hours (DSMZ=ACC-605).
CC   HLA typing: A*01:01,33:01; B*08:01,14:02; C*07:01,08:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (DepMap=ACH-000122).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Ser (c.747G>C); ClinVar=VCV000406598; Zygosity=Homozygous (DepMap=ACH-000122).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.38%; Native American=0%; East Asian, North=3.57%; East Asian, South=0%; South Asian=0%; European, North=62.17%; European, South=31.87% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-605
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 17,18
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 14,18
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   Penta D: 11,14
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SUP-T12
AC   CVCL_F691
SY   Stanford University Pediatric T-cell line 12
DR   Wikidata; Q54970887
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SUP-T13
AC   CVCL_9973
SY   Sup-T13; SupT13; SUPT13; SUPT-13; Stanford University Pediatric T-cell line 13
DR   cancercelllines; CVCL_9973
DR   Cosmic; 913417
DR   Cosmic; 1115600
DR   Cosmic; 1151793
DR   Cosmic; 1760533
DR   Cosmic; 2165709
DR   Wikidata; Q54970894
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1720549;
RX   PubMed=2786436;
RX   PubMed=14671638;
RX   PubMed=15472075;
RX   PubMed=22675565;
RX   PubMed=23637631;
CC   Sequence variation: Gene fusion; HGNC; HGNC:19124; FIP1L1 + HGNC; HGNC:8803; PDGFRA; Name(s)=FIP1L1-PDGFRA (PubMed=23637631).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu57Trp (c.170T>G); ClinVar=VCV000185713; Zygosity=Unspecified (PubMed=22675565).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 24
//
ID   SUP-T14
AC   CVCL_F692
SY   Stanford University Pediatric T-cell line 14
DR   Wikidata; Q54970895
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   SUP-T19
AC   CVCL_9974
SY   Sup-T19; SUPT19; SupT19; Stanford University Pediatric T-cell line 19
DR   Wikidata; Q54970896
RX   PubMed=1720549;
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   SUP-T2
AC   CVCL_F693
SY   Stanford University Pediatric T-cell line 2
DR   Wikidata; Q54970897
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3004618;
RX   PubMed=6437672;
CC   Doubling time: 130 hours (PubMed=3004618).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   SUP-T3
AC   CVCL_F694
SY   Supt3; Stanford University Pediatric T-cell line 3
DR   Wikidata; Q54970898
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3004618;
RX   PubMed=6437672;
RX   PubMed=17170727;
CC   Doubling time: 61 hours (PubMed=3004618).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SUP-T4
AC   CVCL_F695
SY   Stanford University Pediatric T-cell line 4
DR   Wikidata; Q54970899
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3004618;
RX   PubMed=6437672;
RX   PubMed=6438800;
CC   Doubling time: 33 hours (PubMed=3004618).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7226; Adult T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   SUP-T5
AC   CVCL_F686
SY   Stanford University Pediatric T-cell line 5
DR   Wikidata; Q54970901
RX   PubMed=2786436;
CC   Miscellaneous: Cell line has been lost (PubMed=2786436).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9360; Lymphoblastic lymphoma
DI   ORDO; Orphanet_547; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   SUP-T6
AC   CVCL_F687
SY   Stanford University Pediatric T-cell line 6
DR   Wikidata; Q54970902
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SUP-T7
AC   CVCL_A449
SY   SUPT-7; SUPT7; SupT7; Stanford University Pediatric T-cell line 7
DR   Cosmic; 1115595
DR   Cosmic; 1151794
DR   Cosmic; 2396143
DR   Wikidata; Q54970903
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1967982;
RX   PubMed=2786436;
RX   PubMed=3162254;
RX   PubMed=15472075;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 16
//
ID   SUP-T8
AC   CVCL_F685
SY   Stanford University Pediatric T-cell line 8
DR   Wikidata; Q54970904
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
RX   PubMed=2875799;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SUP-T9
AC   CVCL_F688
SY   Stanford University Pediatric T-cell line 9
DR   Wikidata; Q54970906
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2786436;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   SUP1
AC   CVCL_ZW09
DR   Wikidata; Q102114952
RX   PubMed=2166533;
CC   Characteristics: Established from the transplantable tumor 7315a.
CC   Transformant: ChEBI; CHEBI_82545; 2,4,6-trimethylaniline (TMA).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: Buffalo; RS=RS_0000163.
DI   NCIt; C132194; Rat pituitary gland neoplasm
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_ZW08 ! P11
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   SupB15RT
AC   CVCL_DR65
DR   PRIDE; PXD000394
DR   Wikidata; Q54970907
RX   PubMed=25576301;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (from parent cell line).
CC   Omics: Proteomics; HLA class I peptidome.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0103 ! SUP-B15
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   Super Dome
AC   CVCL_6452
SY   MDCK superdome; SuperDome
DR   ATCC; CRL-2286
DR   CCRID; 1101CAN-PUMC000225
DR   Wikidata; Q54970908
RX   PubMed=8749715;
RX   PubMed=21982418;
CC   Characteristics: Dome-forming clone of MDCK.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   Super Tube
AC   CVCL_6453
SY   MDCK supertube; SuperTube
DR   ATCC; CRL-2285
DR   CCRID; 3101CANGNO29
DR   CLS; 305004
DR   Wikidata; Q54970909
RX   PubMed=8749715;
RX   PubMed=21982418;
CC   Characteristics: Tubule-forming clone of MDCK.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 18
//
ID   Super-CHO C1
AC   CVCL_IR03
SY   Super-CHO clone C1; CHO-IGF/Tf C1
DR   Wikidata; Q54970910
RX   Patent=US6797515;
RX   PubMed=22358924;
CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter (PubMed=22358924).
CC   Doubling time: 18 hours (PubMed=22358924).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   Super-CHO C2
AC   CVCL_IR04
SY   Super-CHO clone C2; CHO-IGF/Tf C2
DR   Wikidata; Q54970911
RX   Patent=US6797515;
RX   PubMed=22358924;
CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter (PubMed=22358924).
CC   Doubling time: 21 hours (PubMed=22358924).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   Super-CHO C2.8
AC   CVCL_IR05
SY   Super-CHO clone C2.8; C2.8
DR   Wikidata; Q54970912
RX   DOI=10.1002/jctb.1670;
RX   PubMed=19003411;
CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter (from parent cell line).
CC   Doubling time: 24 hours (PubMed=19003411).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_IR04 ! Super-CHO C2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   Super-CHO ISS9
AC   CVCL_IR06
SY   Super-CHO clone ISS9; ISS9
DR   Wikidata; Q54970913
RX   PubMed=19003411;
CC   Characteristics: IGF1 expression is under control of the CMV promoter and TF expression is under control of the SV40 early promoter.
CC   Doubling time: >35 hours (PubMed=19003411).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5464; IGF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11740; TF.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   SuperSOST C9
AC   CVCL_SA52
DR   Wikidata; Q54970914
RX   PubMed=24913258;
CC   Population: Caucasian.
CC   Characteristics: Expresses SOST mRNA at 10x higher level than parental cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   SuperSOST G5
AC   CVCL_SA53
DR   Wikidata; Q54970917
RX   PubMed=24913258;
CC   Population: Caucasian.
CC   Characteristics: Expresses SOST mRNA at 10x higher level than parental cell line.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0548 ! SaOS-2
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   SupT1-CIITA
AC   CVCL_C6JB
SY   SupT1-CIITA B5; SupT1.CIITA
DR   PRIDE; PXD013015
DR   Wikidata; Q116050582
RX   PubMed=21041720;
RX   PubMed=31020640;
CC   Population: Caucasian.
CC   Virology: Has an enhanced susceptibility to infection by HIV-1 (PubMed=21041720).
CC   Virology: Susceptible to infection by herpesvirus 6B (HHV-6B) strain Z29 (PubMed=31020640).
CC   HLA typing: DRB1*03:01,13:01; DRB3*01:01,02:02 (PubMed=31020640).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7067; CIITA.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   SupT1-R5
AC   CVCL_WU89
SY   SupT1-CCR5
DR   cancercelllines; CVCL_WU89
DR   Wikidata; Q98132878
RX   PubMed=24162716;
RX   PubMed=25253335;
RX   PubMed=28233807;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 14
//
ID   SupT1.CCR5
AC   CVCL_WU88
DR   cancercelllines; CVCL_WU88
DR   Wikidata; Q98132879
RX   PubMed=15169555;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Caution: There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 13
//
ID   SupT1/Blam
AC   CVCL_WV22
SY   SupT1/Beta-lactamase
DR   cancercelllines; CVCL_WV22
DR   Wikidata; Q98132880
RX   PubMed=11884576;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1714 ! SUP-T1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 13
//
ID   SupT1/CCR5/Blam
AC   CVCL_WU94
DR   cancercelllines; CVCL_WU94
DR   Wikidata; Q98132881
RX   PubMed=11884576;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys251Tyr (c.752G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Arg177His (c.530G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg191Trp (c.571C>T); ClinVar=VCV000568557; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Asp (c.1635G>T); ClinVar=VCV000217293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu970Lys (c.2908G>A); ClinVar=VCV001057635; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9585; PTCH1; Simple; p.Arg682Cys (c.2044C>T); ClinVar=VCV000237466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:15533; SPRY4; Simple; p.Arg25Trp (c.73C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Leu (c.800G>T); ClinVar=VCV000852206; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7210; Childhood T lymphoblastic lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WV22 ! SupT1/Blam
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 14
//
ID   SURE CHO-M
AC   CVCL_R728
SY   CHO-M; CHOM
DR   Wikidata; Q54970918
RX   Patent=US20190194694;
WW   Provider; Selexis; -; https://www.kbibiopharma.com/capabilities/mammalian/sure-cho-m
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Biotechnology: Used for high yield production of therapeutic proteins and antibodies (Selexis).
CC   Doubling time: 15.7 hours (Selexis).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   SuSa
AC   CVCL_L280
SY   SUSA
DR   cancercelllines; CVCL_L280
DR   Cell_Model_Passport; SIDM01833
DR   DepMap; ACH-001668
DR   DSMZ; ACC-747
DR   DSMZCellDive; ACC-747
DR   GEO; GSM863899
DR   GEO; GSM7701395
DR   GEO; GSM7701396
DR   Progenetix; CVCL_L280
DR   Wikidata; Q54970919
RX   PubMed=593370;
RX   PubMed=2144165;
RX   PubMed=3518877;
RX   PubMed=6169654;
RX   PubMed=11416159;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 27.7 +- 1.3 hours (PubMed=2144165); ~48-72 hours (DSMZ=ACC-747).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
ST   Source(s): DepMap=ACH-001668; DSMZ=ACC-747; PubMed=11416159
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 21,21.2
ST   Penta D: 9
ST   Penta E: 11,18
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   SuSa-CP
AC   CVCL_B7BN
SY   SuSa cisR
DR   Wikidata; Q112930434
RX   PubMed=2144165;
CC   Doubling time: 29.8 +- 0.8 hours (PubMed=2144165).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3877; Testicular teratoma
DI   ORDO; Orphanet_363483; Testicular teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L280 ! SuSa
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SUSM-1
AC   CVCL_4903
SY   SUSM1
DR   CLO; CLO_0050043
DR   BioSample; SAMN03472342
DR   IARC_TP53; 5360
DR   RCB; RCB0174
DR   Wikidata; Q54970920
RX   CelloPub=CLPUB00712;
RX   DOI=10.11418/jtca1981.12.4_313;
RX   DOI=10.11418/jtca1981.16.3_173;
RX   PubMed=3140712;
RX   PubMed=3413074;
RX   PubMed=7705936;
RX   PubMed=8105370;
RX   PubMed=8148305;
RX   PubMed=8557247;
RX   PubMed=8744932;
RX   PubMed=8790940;
RX   PubMed=9175740;
RX   PubMed=9290701;
RX   PubMed=9359923;
RX   PubMed=19935656;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Heterozygous (PubMed=8790940).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): RCB=RCB0174
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M811 ! HSF-412
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   SUSM-1/p53-1
AC   CVCL_VE91
SY   SUSM-1/P53-1
DR   Wikidata; Q54970921
RX   PubMed=7705936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4903 ! SUSM-1
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   SUSM-1/p53-6
AC   CVCL_VE92
SY   SUSM-1/P53-6
DR   Wikidata; Q54970922
RX   PubMed=7705936;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53 (Note=With p.Arg273His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4903 ! SUSM-1
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   SUSM-1/RAS
AC   CVCL_WH84
DR   Wikidata; Q98132882
RX   DOI=10.11418/jtca1981.12.4_313;
RX   PubMed=8148305;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gln61Leu).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4903 ! SUSM-1
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   SUSMi001-A
AC   CVCL_UM29
SY   RY3
DR   BioSamples; SAMEA4909539
DR   hPSCreg; SUSMi001-A
DR   Wikidata; Q98132883
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   SUSMi001-A-1
AC   CVCL_UM30
SY   128Lp1
DR   BioSamples; SAMEA4909543
DR   hPSCreg; SUSMi001-A-1
DR   Wikidata; Q98132885
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UM29 ! SUSMi001-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   SUSMi002-A
AC   CVCL_UM31
SY   02-005
DR   BioSamples; SAMEA4909541
DR   hPSCreg; SUSMi002-A
DR   Wikidata; Q98132886
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   SUSMi003-A
AC   CVCL_B5FW
SY   0524-1
DR   BioSamples; SAMEA9197492
DR   hPSCreg; SUSMi003-A
DR   Wikidata; Q110433265
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   SUSMi005-A-1.1
AC   CVCL_C0GS
SY   SNCA3X 0KO C1
DR   BioSamples; SAMEA12312965
DR   hPSCreg; SUSMi005-A-1
DR   Wikidata; Q112930435
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SUSMi005-A-1.2
AC   CVCL_C0GT
SY   SNCA3X 0KO C2
DR   BioSamples; SAMEA12312965
DR   hPSCreg; SUSMi005-A-1
DR   Wikidata; Q112930436
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   SUSMi005-A-2.1
AC   CVCL_C0GU
SY   SNCA3X 1KO C1
DR   BioSamples; SAMEA12312966
DR   hPSCreg; SUSMi005-A-2
DR   Wikidata; Q112930437
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-2.2
AC   CVCL_C0GV
SY   SNCA3X 1KO C2
DR   BioSamples; SAMEA12312966
DR   hPSCreg; SUSMi005-A-2
DR   Wikidata; Q112930438
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-3.1
AC   CVCL_C0GW
SY   SNCA3X 2KO C1
DR   BioSamples; SAMEA12312967
DR   hPSCreg; SUSMi005-A-3
DR   Wikidata; Q112930439
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=2 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-3.2
AC   CVCL_C0GX
SY   SNCA3X 2KO C2
DR   BioSamples; SAMEA12312967
DR   hPSCreg; SUSMi005-A-3
DR   Wikidata; Q112930440
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=2 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-4.1
AC   CVCL_C0GY
SY   SNCA3X 3KO C1
DR   BioSamples; SAMEA12312968
DR   hPSCreg; SUSMi005-A-4
DR   Wikidata; Q112930441
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=3 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-4.2
AC   CVCL_C0GZ
SY   SNCA3X 3KO C2
DR   BioSamples; SAMEA12312968
DR   hPSCreg; SUSMi005-A-4
DR   Wikidata; Q112930442
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=3 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-5.1
AC   CVCL_C0H0
SY   SNCA3X 4KO C1
DR   BioSamples; SAMEA12312969
DR   hPSCreg; SUSMi005-A-5
DR   Wikidata; Q112930443
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=4 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUSMi005-A-5.2
AC   CVCL_C0H1
SY   SNCA3X 4KO C2
DR   BioSamples; SAMEA12312969
DR   hPSCreg; SUSMi005-A-5
DR   Wikidata; Q112930444
RX   PubMed=35263701;
CC   From: Stanford University School of Medicine; Stanford; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=4 of 4 alleles).
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   SUTCMi001-A
AC   CVCL_C1XC
DR   BioSamples; SAMEA13959287
DR   hPSCreg; SUTCMi001-A
DR   Wikidata; Q114313071
RX   PubMed=35843020;
CC   From: Shandong University of Traditional Chinese Medicine; Jinan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Suzanna
AC   CVCL_VL66
SY   Suzanne
DR   Wikidata; Q98132887
RX   PubMed=1690682;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   SV
AC   CVCL_E938
DR   JCRB; JCRB1207
DR   Wikidata; Q54970923
RX   PubMed=27844419;
CC   Problematic cell line: Contaminated/misidentified. Not from strain C57BL/6 as originally assigned but from a C57BL/6 x CBA cross (PubMed=27844419).
CC   Knockout cell: Method=KO mouse; MGI; MGI:88151; Glb1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   4D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   SV-2b2b5
AC   CVCL_C6EG
DR   Wikidata; Q116050583
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-3Y1-C66
AC   CVCL_F822
SY   SV-3Y1
DR   JCRB; JCRB0735
DR   RCB; RCB0343
DR   Wikidata; Q54970924
RX   PubMed=2961438;
RX   PubMed=3533570;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   SV-4b4b2
AC   CVCL_C6EH
DR   Wikidata; Q116050584
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-4b6a
AC   CVCL_C6EI
DR   Wikidata; Q116050585
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-4b6b
AC   CVCL_C6EJ
DR   Wikidata; Q116050586
RX   PubMed=12762836;
CC   Doubling time: ~24 hours (PubMed=12762836).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-4e7a
AC   CVCL_C6EK
DR   Wikidata; Q116050587
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-589
AC   CVCL_RW34
SY   SV589
DR   Wikidata; Q54970925
RX   PubMed=6091915;
RX   PubMed=32690708;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   SV-6c4a1a
AC   CVCL_C6EL
DR   Wikidata; Q116050588
RX   PubMed=12762836;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-6c4a1b
AC   CVCL_C6EM
DR   Wikidata; Q116050589
RX   PubMed=12762836;
CC   Doubling time: ~24 hours (PubMed=12762836).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Vagina, lower part; UBERON=UBERON_0015243.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Prepubertal
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-A3
AC   CVCL_0540
DR   MCCL; MCC:0000441
DR   Wikidata; Q54970926
RX   PubMed=11387343;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   SV-AL/N
AC   CVCL_L813
SY   SVS AL/N; SV-S-AL/N
DR   Wikidata; Q54970927
RX   PubMed=174816;
RX   PubMed=4302577;
RX   PubMed=4331720;
RX   PubMed=4564284;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AL/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6312 ! AL/N
SX   Sex unspecified
AG   10FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 9
//
ID   SV-BB-1
AC   CVCL_B3RC
DR   Wikidata; Q110433266
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   SV-BB-2
AC   CVCL_B3RD
DR   Wikidata; Q110433268
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   SV-BB-3
AC   CVCL_B3RE
DR   Wikidata; Q110433269
RX   PubMed=2995424;
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   SV-BB-4
AC   CVCL_B3RF
DR   Wikidata; Q110433270
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   SV-BB-5
AC   CVCL_B3RG
SY   RB-W-531-2
DR   Wikidata; Q110433271
RX   PubMed=6309870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=SV68C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/cAnN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-09-24; Version: 6
//
ID   SV-BEC
AC   CVCL_C3X9
SY   SV40 transformed-Bovine Endothelial Cells
DR   Wikidata; Q116050590
RX   Patent=WO1993006222A1;
RX   PubMed=1683665;
RX   PubMed=12958429;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-1143.
CC   Doubling time: ~12 hours (PubMed=1683665).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   SV-BR-1
AC   CVCL_4U12
SY   SV-BR1
DR   Wikidata; Q54970928
RX   Patent=US7674456;
RX   PubMed=16958969;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7812.
CC   Characteristics: ER/PR-negative and ERBB2-positive.
CC   Doubling time: 48 hours (Patent=US7674456).
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 8
//
ID   SV-BR-1-GM
AC   CVCL_4U13
SY   SVBR-1-GM
DR   Wikidata; Q54970930
RX   Patent=US7674456;
RX   PubMed=16958969;
RX   PubMed=29867922;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7813.
CC   Characteristics: ER/PR-negative and ERBB2-positive.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2434; CSF2.
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U12 ! SV-BR-1
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 9
//
ID   SV-C3H
AC   CVCL_C4K5
SY   SVC3H
DR   Wikidata; Q116050591
RX   PubMed=191529;
RX   PubMed=2991384;
RX   PubMed=6286762;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-C3H-V4
AC   CVCL_C4K6
SY   V4
DR   Wikidata; Q116050592
RX   PubMed=2991384;
RX   PubMed=6286762;
CC   Characteristics: Weakly oncogenic. Produced after 4 consecutive passages of the parent cell line through irradiated syngeneic recipients.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4K5 ! SV-C3H
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-C3H-V5
AC   CVCL_C4K8
SY   V5
DR   Wikidata; Q116050593
RX   PubMed=2991384;
RX   PubMed=6286762;
CC   Characteristics: Highly oncogenic. Produced after a passage of the parent cell line through irradiated syngeneic recipients.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4K6 ! SV-C3H-V4
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-C3H-V5B
AC   CVCL_C4KB
DR   Wikidata; Q116050594
RX   PubMed=2991384;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4K8 ! SV-C3H-V5
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-C3H-V6
AC   CVCL_C4KC
DR   Wikidata; Q116050595
RX   PubMed=2991384;
CC   Characteristics: Derived by culturing cells from a growing SV-C3H-V5 tumor 14 days after inoculation (PubMed=2991384).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4K8 ! SV-C3H-V5
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-COL
AC   CVCL_C4KD
DR   Wikidata; Q116050596
RX   PubMed=87414;
RX   PubMed=2991384;
RX   PubMed=3027416;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.OL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-COL-E8
AC   CVCL_C4KE
SY   SV-COL clone E8; E8
DR   Wikidata; Q116050597
RX   PubMed=2991384;
RX   PubMed=3027416;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.OL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4KD ! SV-COL
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-COL-F5
AC   CVCL_C4KF
SY   SV-COL clone F5; F5
DR   Wikidata; Q116050598
RX   PubMed=2991384;
RX   PubMed=3027416;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.OL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C4KD ! SV-COL
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-E
AC   CVCL_0C27
DR   Cosmic; 2239091
DR   Wikidata; Q54970931
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=10100721;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   SV-HCEC
AC   CVCL_DQ72
SY   SVHCEC; SV40-transformed Human Capillary/microvascular Endothelial Cells
DR   Wikidata; Q54970932
RX   PubMed=9367354;
RX   PubMed=11032886;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Brain, temporal lobe, endothelium; UBERON=UBERON_0001871+UBERON_0013694.
CC   Cell type: Brain microvascular endothelial cell; CL=CL_2000044.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 10
//
ID   SV-HFO
AC   CVCL_4T85
SY   SVHFO; SV40-transformed Human Fetal Osteoblastic cells
DR   Wikidata; Q54970933
RX   DOI=10.15114/tr.28.41;
RX   PubMed=8387478;
RX   PubMed=15072557;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal bone; UBERON=UBERON_0002481.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 8
//
ID   SV-HGEC-1
AC   CVCL_WL99
SY   SV40-immortalized Human Glomerular Endothelial Cell Line-1
DR   BTO; BTO_0003580
DR   Wikidata; Q98132888
RX   PubMed=15637427;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Miscellaneous: The paper indicates that 3 SV-HGEC cell lines have been established but do not name them. We have therefore arbitrarly named them SV-HGEC-1 to -3.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular endothelial cell; CL=CL_0002188.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WM00 ! SV-HGEC-2
OI   CVCL_WM01 ! SV-HGEC-3
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SV-HGEC-2
AC   CVCL_WM00
SY   SV40-immortalized Human Glomerular Endothelial Cell Line-2
DR   Wikidata; Q98132889
RX   PubMed=15637427;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Miscellaneous: The paper indicates that 3 SV-HGEC cell lines have been established but do not name them. We have therefore arbitrarly named them SV-HGEC-1 to -3.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular endothelial cell; CL=CL_0002188.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL99 ! SV-HGEC-1
OI   CVCL_WM01 ! SV-HGEC-3
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   SV-HGEC-3
AC   CVCL_WM01
SY   SV40-immortalized Human Glomerular Endothelial Cell Line-3
DR   Wikidata; Q98132890
RX   PubMed=15637427;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Miscellaneous: The paper indicates that 3 SV-HGEC cell lines have been established but do not name them. We have therefore arbitrarly named them SV-HGEC-1 to -3.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Glomerular endothelial cell; CL=CL_0002188.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WL99 ! SV-HGEC-1
OI   CVCL_WM00 ! SV-HGEC-2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   SV-HUC-1
AC   CVCL_3798
SY   HUC-1; SV-HUC; SVHUC
DR   BTO; BTO_0003908
DR   CLO; CLO_0009177
DR   ATCC; CRL-9520
DR   BCRC; 60358
DR   BioSample; SAMN03471218
DR   CCRID; 3101HUMTCHu169
DR   CLS; 305075
DR   Cosmic; 687554
DR   KCB; KCB 2012112YJ
DR   Wikidata; Q54970934
RX   Patent=US4980290;
RX   PubMed=1311637;
RX   PubMed=1767334;
RX   PubMed=2822239;
RX   PubMed=2835156;
RX   PubMed=2841047;
RX   PubMed=15846775;
RX   PubMed=27270441;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9520.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-9520; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 14,17
ST   D5S818: 12,14
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 21,22
ST   Penta D: 13
ST   Penta E: 10,20
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SV-HUC-2
AC   CVCL_G006
DR   Wikidata; Q54970935
RX   PubMed=2822239;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   SV-HUC-MAr
AC   CVCL_A0BS
DR   Wikidata; Q123033573
RX   PubMed=1767334;
CC   Selected for resistance to: ChEBI; CHEBI_168396; Mycophenolic acid.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SV-HUC-TGr/Gr
AC   CVCL_A0BZ
DR   Wikidata; Q123033574
RX   PubMed=1311637;
RX   PubMed=1767334;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SV-HUC/ras-A
AC   CVCL_IP92
SY   SV-HUC/ras clone A; EJ/ras-A
DR   Wikidata; Q54970936
RX   PubMed=1316224;
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-HUC/ras-B
AC   CVCL_IP93
SY   SV-HUC/ras clone B
DR   Wikidata; Q54970937
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-HUC/ras-C
AC   CVCL_IP94
SY   SV-HUC/ras clone C
DR   Wikidata; Q54970938
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-HUC/ras-D
AC   CVCL_IP95
SY   SV-HUC/ras clone D
DR   Wikidata; Q54970945
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-HUC/ras-E
AC   CVCL_IP96
SY   SV-HUC/ras clone E
DR   Wikidata; Q54970946
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-HUC/ras-F
AC   CVCL_IP97
SY   SV-HUC/ras clone F
DR   Wikidata; Q54970948
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-HUC/ras-G
AC   CVCL_IP98
SY   SV-HUC/ras clone G
DR   Wikidata; Q54970949
RX   PubMed=2164447;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ureter; UBERON=UBERON_0000056.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3798 ! SV-HUC-1
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SV-JD
AC   CVCL_H239
SY   SVJD
DR   Wikidata; Q54970950
RX   PubMed=8212552;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   SV-Mm-11
AC   CVCL_V317
DR   Wikidata; Q54970951
RX   PubMed=217958;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_V316 ! Mm-2K
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SV-Mm-12
AC   CVCL_V318
DR   Wikidata; Q54970953
RX   PubMed=217958;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_V316 ! Mm-2K
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SV-Mm-12A
AC   CVCL_V319
DR   Wikidata; Q54970954
RX   PubMed=217958;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_V318 ! SV-Mm-12
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SV-Mm-13
AC   CVCL_V320
DR   Wikidata; Q54970955
RX   PubMed=217958;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_V316 ! Mm-2K
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SV-Mm-21
AC   CVCL_V321
DR   Wikidata; Q54970956
RX   PubMed=217958;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_V316 ! Mm-2K
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SV-SW
AC   CVCL_C4K7
DR   Wikidata; Q116050599
RX   PubMed=191529;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H.SW/SnJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   SV-T2
AC   CVCL_4554
SY   BALB 3T3 SV-T2; SVT2
DR   CLO; CLO_0009181
DR   CLDB; cl4423
DR   CLDB; cl4424
DR   CLDB; cl4425
DR   ATCC; CCL-163.1
DR   ChEMBL-Cells; CHEMBL3307978
DR   ChEMBL-Targets; CHEMBL612564
DR   ECACC; 90030801
DR   IZSLER; BS CL 106
DR   JCRB; JCRB9099
DR   PubChem_Cell_line; CVCL_4554
DR   Wikidata; Q54970957
RX   PubMed=174085;
RX   PubMed=1260760;
RX   PubMed=4359949;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   SV-TGo
AC   CVCL_T958
DR   Wikidata; Q54970958
RX   PubMed=208961;
RX   PubMed=212573;
CC   Population: Caucasian.
CC   Senescence: SV40-transformed but with a finite life span.
CC   Doubling time: ~22 hours (PubMed=208961).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Parapharyngeal space; UBERON=UBERON_0035618.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   SV/HF-5/39
AC   CVCL_G293
SY   SV/HF-5 Cl39
DR   Wikidata; Q54970959
RX   PubMed=2823105;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Fibroblast of bone marrow; CL=CL_0002240.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N626 ! Hs 74.Bm
SX   Female
AG   3-4FM
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   SV1-LOHG
AC   CVCL_LI13
DR   Wikidata; Q54970960
RX   PubMed=15753990;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C5394; Solitary adult fibroma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LI09 ! LOHG-F
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   SV19
AC   CVCL_LH63
DR   ATCC; HB-8557
DR   Wikidata; Q54970961
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8557.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human choriocarcinoma tumor cell 40 kDa glycoprotein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   SV2-61
AC   CVCL_LJ58
DR   Wikidata; Q54970963
RX   PubMed=2565325;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   SV2-61r
AC   CVCL_LJ59
DR   Wikidata; Q54970964
RX   PubMed=1671001;
CC   Characteristics: Isotype switched derivative of SV2-61.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_LJ58 ! SV2-61
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   SV3T3B
AC   CVCL_4311
DR   CLO; CLO_0009166
DR   CLDB; cl4427
DR   ECACC; 85011409
DR   Wikidata; Q54970965
RX   PubMed=4284655;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: SIM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   SV40 MES 13
AC   CVCL_5368
SY   SV40-MES-13; SV40-MES13; MES-13; MES 13; MES13
DR   CLO; CLO_0009167
DR   ATCC; CRL-1927
DR   BCRC; 60366
DR   CCRID; 3101MOUGNM21
DR   CLS; 305183
DR   GEO; GSE2557
DR   Wikidata; Q54970966
RX   PubMed=2835539;
RX   PubMed=17178593;
RX   PubMed=25277546;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=MES-13
CC   Doubling time: 26 hours (ATCC=CRL-1927).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
CC   Breed/subspecies: C57BL/6J x SJL/J transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   7-10W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SV40 OFPAE
AC   CVCL_6G13
SY   SV40-transformed Ovine FetoPlacental Artery Endothelial cells
DR   Wikidata; Q54970967
RX   PubMed=17005940;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRNS-1).
CC   Derived from site: In situ; Placenta, arterial endothelium; UBERON=UBERON_8480005.
CC   Cell type: Endothelial cell of artery; CL=CL_1000413.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   SV40-BIEC
AC   CVCL_UZ25
DR   Wikidata; Q98132891
RX   PubMed=30600465;
CC   Doubling time: 14.26 hours (PubMed=30600465).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_UZ22 ! BIEC-c4
SX   Male
AG   2D
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   SV40-iISEMF
AC   CVCL_WW33
SY   SV40-immortalized ISEMF; SV40-immortalized Intestinal Sub-Epithelial MyoFibroblast
DR   Wikidata; Q98132892
RX   PubMed=31183683;
CC   Characteristics: Useful as a model to study ISEMF's origin, physiology and functions (PubMed=31183683).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Myofibroblast; CL=CL_0000186.
CC   Breed/subspecies: Holstein; VBO=VBO_0000237.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Male
AG   2D
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   SV40-NPE
AC   CVCL_B7GQ
DR   Wikidata; Q112930445
RX   PubMed=1478280;
RX   PubMed=2166638;
RX   PubMed=8262911;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=8-4).
CC   Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778.
CC   Cell type: Non-pigmented ciliary epithelial cell; CL=CL_0002304.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_B7GR ! SV40-PE
SX   Sex unspecified
AG   1W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   SV40-PE
AC   CVCL_B7GR
DR   Wikidata; Q112930446
RX   PubMed=1478280;
RX   PubMed=2166638;
RX   PubMed=8262911;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=8-4).
CC   Derived from site: In situ; Eye, ciliary body, ciliary epithelium; UBERON=UBERON_0001778.
CC   Cell type: Pigmented ciliary epithelial cell; CL=CL_0002303.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_B7GQ ! SV40-NPE
SX   Sex unspecified
AG   1W
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   SV40-T2
AC   CVCL_WN19
SY   SV40T2
DR   Wikidata; Q98132895
RX   PubMed=1716583;
RX   PubMed=8841424;
RX   PubMed=20135361;
CC   Doubling time: 22 hours (PubMed=1716583).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 10
//
ID   SV40-tsA58 OMCD
AC   CVCL_6B06
DR   Wikidata; Q54970969
RX   PubMed=8852699;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the immortalization technique and the primary cell type name.
CC   Derived from site: In situ; Kidney, outer medullary collecting duct; UBERON=UBERON_0004204.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   SV40-tsA58 S1
AC   CVCL_6B07
DR   Wikidata; Q54970971
RX   PubMed=8595391;
RX   PubMed=8852699;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the immortalization technique and the primary cell type name.
CC   Derived from site: In situ; Kidney, proximal convoluted tubule; UBERON=UBERON_0001287.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   SV40-tsA58 S3
AC   CVCL_6B08
DR   Wikidata; Q54970972
RX   PubMed=8852699;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Miscellaneous: As no cell line name was provided in the papers, we assigned the name based on the immortalization technique and the primary cell type name.
CC   Derived from site: In situ; Kidney, proximal straight tubule; UBERON=UBERON_0001290.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 14
//
ID   SV40imMyo
AC   CVCL_C5Q3
SY   SV40-immortalized Myoblast; Clone 1
DR   Wikidata; Q116050600
RX   PubMed=26111090;
CC   Characteristics: Capable of differentiation into multinucleated myotubes (PubMed=26111090).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pNIT-TAg).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: Thoroughbred; VBO=VBO_0001083.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 8
//
ID   SV40LT-SMC Clone HEP-SA
AC   CVCL_6454
DR   CLO; CLO_0009169
DR   EFO; EFO_0022812
DR   ATCC; CRL-2018
DR   BCRC; 60523
DR   Wikidata; Q54970973
RX   PubMed=2154504;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SV40RH1
AC   CVCL_B6EG
DR   Wikidata; Q112041740
RX   PubMed=22358532;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SV40T PEF
AC   CVCL_JJ69
SY   SV40 large T transformed Pig Embryonic Fibroblasts
DR   Wikidata; Q54970974
RX   PubMed=22785463;
CC   Characteristics: The SV40 large T gene is flanked by two loxP sites that allow the excision of the transforming gene by transient expression of the Cre recombinase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   45FD
CA   Conditionally immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   SV40T-DPC
AC   CVCL_T950
SY   SV40TDPC; SV40 large T-transformed Dermal Papilla Cells
DR   Wikidata; Q54970975
RX   PubMed=17560084;
CC   Population: Korean.
CC   Senescence: SV40-transformed but with a finite life span.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Scalp, skin, dermis, dermal papilla; UBERON=UBERON_0000412.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   SV40T-hTERT-DPC
AC   CVCL_T951
DR   Wikidata; Q54970976
RX   PubMed=21871174;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Scalp, skin, dermis, dermal papilla; UBERON=UBERON_0000412.
CC   Cell type: Hair follicle dermal papilla cell; CL=CL_0000346.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T950 ! SV40T-DPC
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 16
//
ID   SV40T-YREC-hTERT
AC   CVCL_C0X1
DR   CCRID; 4201PAT-CCTCC01878
DR   Wikidata; Q114313072
RX   Patent=CN114058592B;
RX   PubMed=35368868;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021245.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Rumen; UBERON=UBERON_0007365.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=30521; ! Bos mutus grunniens (Wild yak)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   SV589j
AC   CVCL_C8YJ
DR   BioGRID_ORCS_Cell_line; 1386
DR   Wikidata; Q123033576
RX   PubMed=32690708;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Phenotyping; CRISPR screening.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW34 ! SV-589
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   SV6
AC   CVCL_0E03
SY   SPAML/SV6
DR   ATCC; CRL-2427
DR   Wikidata; Q54970977
RX   PubMed=11485907;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: ATCC; CRL-2427; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C3888; Kidney angiomyolipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J654 ! SV7
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   SV6-1 Bam/HFK
AC   CVCL_H240
SY   SV6-1 BAM/HFK; SV61 Bam/HFK
DR   Wikidata; Q54970978
RX   PubMed=2423124;
RX   PubMed=2447927;
RX   PubMed=6191883;
RX   PubMed=6319304;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 13
//
ID   SV63
AC   CVCL_F768
DR   CLO; CLO_0009170
DR   ATCC; HB-8766
DR   Wikidata; Q54970979
RX   Patent=US4851332;
RX   PubMed=2580800;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8766.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human choriocarcinoma tumor cell 68 kDa glycoprotein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SV68c-IS
AC   CVCL_M084
SY   SV68 c-IS
DR   BTO; BTO_0003529
DR   Wikidata; Q54970980
RX   PubMed=11123759;
RX   PubMed=17760834;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: ICR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6W
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   SV7
AC   CVCL_J654
SY   SPAML/SV7
DR   BTO; BTO_0004391
DR   ATCC; CRL-2428
DR   Wikidata; Q54970981
RX   PubMed=11485907;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: ATCC; CRL-2428; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C3888; Kidney angiomyolipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0E03 ! SV6
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   SV7tert
AC   CVCL_3602
SY   SV7 tert
DR   BTO; BTO_0004390
DR   CLO; CLO_0009171
DR   ATCC; CRL-2461
DR   BioSample; SAMN03471581
DR   Cosmic; 2777739
DR   Wikidata; Q54970982
RX   PubMed=11485907;
RX   PubMed=15509531;
RX   PubMed=15695519;
RX   PubMed=17592550;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: ATCC; CRL-2461; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2461
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3888; Kidney angiomyolipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J654 ! SV7
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   SV7tert PDGF
AC   CVCL_0F39
DR   ATCC; CRL-4007
DR   Wikidata; Q54970985
RX   PubMed=15695519;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8800; PDGFB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: ATCC; CRL-4007; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C3888; Kidney angiomyolipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3602 ! SV7tert
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 14
//
ID   SV7tert PDGFtu1
AC   CVCL_C573
SY   SV7tert PDGF tumor-1
DR   ATCC; CRL-4008
DR   Wikidata; Q54970987
RX   PubMed=15695519;
CC   Characteristics: The parent cell line was implanted into nude mice and formed tumors from which the cell line was derived (PubMed=15695519).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8800; PDGFB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-4008
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 21,24
ST   Penta D: 8,13
ST   Penta E: 7,23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3888; Kidney angiomyolipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F39 ! SV7tert PDGF
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   SV7tert PDGFtu2
AC   CVCL_0F40
SY   SV7tert PDGF tumor-2
DR   ATCC; CRL-4009
DR   Wikidata; Q54970988
RX   PubMed=15695519;
CC   Characteristics: The parent cell line was implanted into nude mice and formed tumors from which the cell line was derived (PubMed=15695519).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8800; PDGFB.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: ATCC; CRL-4009; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-4009
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3888; Kidney angiomyolipoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0F39 ! SV7tert PDGF
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   SV80
AC   CVCL_0541
SY   SV-80; SV 80; SV-A clone 80; SV clone 80; Simian virus 80
DR   MCCL; MCC:0000442
DR   ATCC; CRL-7725
DR   CLS; 300345
DR   Wikidata; Q54970989
RX   PubMed=68015;
RX   PubMed=174085;
RX   PubMed=1260760;
RX   PubMed=4129832;
RX   PubMed=4288245;
RX   PubMed=4359949;
RX   PubMed=4370249;
RX   PubMed=6328024;
RX   PubMed=14086148;
CC   Problematic cell line: Probably misidentified. Said to originate from fibroblasts of the lung of a male black individual (CLS=300345), but in reality seems to be established from skin fibroblast of an adult female (strain A). Note that some papers have probably missasigned it to be from a Fanconi anemia patient.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-7725; true.
ST   Source(s): CLS=300345
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 15,20
ST   D21S11: 28,30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 11,15
ST   FGA: 21,27
ST   Penta D: 9
ST   Penta E: 11,12
ST   TH01: 9
ST   TPOX: 10,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   SVCT
AC   CVCL_2718
DR   CLO; CLO_0009172
DR   CancerTools; 152701
DR   CCRID; 5301HUM-KCB15018YJ
DR   ECACC; 94122105
DR   KCB; KCB 2015018YJ
DR   Wikidata; Q54970990
DR   Ximbio; 152701
RX   DOI=10.25904/1912/1434;
RX   PubMed=2423124;
RX   PubMed=28889351;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 94122105; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): CCRID=5301HUM-KCB15018YJ; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D21S11: 29,35
ST   D5S818: 12,13 (PubMed=28889351)
ST   D5S818: 13 (CCRID=5301HUM-KCB15018YJ)
ST   D7S820: 8,11
ST   TH01: 8,9 (CCRID=5301HUM-KCB15018YJ)
ST   TH01: 9 (PubMed=28889351)
ST   TPOX: 8,12
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   SVCT-MI2
AC   CVCL_2719
SY   SVCT-M12
DR   CancerTools; 152596
DR   ECACC; 98031105
DR   Wikidata; Q54970991
DR   Ximbio; 152596
CC   Characteristics: Tumorigenic in nude mice (ECACC=98031105).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 98031105; true.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2718 ! SVCT
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   SVD-2
AC   CVCL_6E59
DR   Wikidata; Q54970992
RX   PubMed=6190988;
CC   Virology: Transfected with two copies of the genome of human papillomavirus type 1 (HPV1).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Trunk, skin, epidermis; UBERON=UBERON_0001085+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18FW
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   SVDC
AC   CVCL_6C14
DR   Wikidata; Q54971001
RX   PubMed=15598888;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVE3
AC   CVCL_Y908
DR   Wikidata; Q54971002
RX   PubMed=1708370;
RX   PubMed=2478401;
CC   Doubling time: 12 hours (Note=In routine medium), 12 hours (Note=In growth medium) (PubMed=2478401).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   SVEC4-10
AC   CVCL_4393
SY   SVEC 4-10
DR   BTO; BTO_0002826
DR   CLO; CLO_0009173
DR   EFO; EFO_0022793
DR   ATCC; CRL-2181
DR   BCRC; 60220
DR   CCTCC; GDC0212
DR   CLS; 305180
DR   Lonza; 1373
DR   Wikidata; Q54971004
RX   PubMed=2153170;
RX   PubMed=8496612;
CC   Doubling time: ~24-30 hours (ATCC=CRL-2181).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   SVEC4-10EE2
AC   CVCL_4394
DR   CLO; CLO_0009174
DR   ATCC; CRL-2167
DR   Wikidata; Q54971005
RX   PubMed=8496612;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4393 ! SVEC4-10
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   SVEC4-10EHR1
AC   CVCL_4395
DR   CLO; CLO_0009175
DR   ATCC; CRL-2161
DR   Wikidata; Q54971006
RX   PubMed=8496612;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4393 ! SVEC4-10
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   sVero p66
AC   CVCL_JX48
SY   sVero; Vero E6 AGS
DR   Wikidata; Q54971007
RX   Patent=US20090203112;
RX   PubMed=19559123;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2791.
CC   Characteristics: Adapted to suspension growth in serum-free media.
CC   Doubling time: 24 hours (Patent=US20090203112).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 8
//
ID   SVG
AC   CVCL_5G14
SY   SV40 immortalized Glial cell
DR   Wikidata; Q54971008
RX   PubMed=2983332;
RX   PubMed=8689028;
RX   PubMed=10845756;
RX   PubMed=24052414;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 12
//
ID   SVG p12
AC   CVCL_3797
SY   SVGp12; SVG(P12)
DR   BTO; BTO_0005184
DR   CLO; CLO_0009176
DR   AddexBio; T0005008/4960
DR   ATCC; CRL-8621
DR   BCRC; 60371
DR   BioSample; SAMN03471204
DR   IZSLER; BS CL 200
DR   LINCS_LDP; LCL-2079
DR   Wikidata; Q54971009
RX   Patent=US4707448;
RX   PubMed=24052414;
RX   PubMed=24760884;
RX   PubMed=25288626;
RX   PubMed=25288627;
WW   Info; The Scientist; -; https://www.the-scientist.com/virus-detected-in-human-cell-line-37377
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8621.
CC   Virology: Contaminated with BK polyomavirus strain UT (PubMed=24760884; PubMed=25288626).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
ST   Source(s): AddexBio=T0005008/4960; ATCC=CRL-8621
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 8,13,14
ST   D16S539: 10,11,12
ST   D18S51: 14,15,16,18
ST   D19S433: 13,14.2,15
ST   D21S11: 29,30
ST   D2S1338: 19,21,22,24
ST   D3S1358: 15,16,17
ST   D5S818: 11,12,14
ST   D7S820: 10,12,13
ST   D8S1179: 12,13,14
ST   FGA: 22,24,25
ST   Penta D: 7,11,12,13
ST   Penta E: 11,12,14,18
ST   TH01: 6,7,9,9.3 (AddexBio=T0005008/4960)
ST   TH01: 6,7,9.3 (ATCC=CRL-8621)
ST   TPOX: 8,10,11
ST   vWA: 15,16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G14 ! SVG
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   SVG-10B1
AC   CVCL_D5B6
SY   10B1
DR   Wikidata; Q127384339
RX   PubMed=24052414;
RX   PubMed=25288626;
CC   Virology: Highly permissive for JC virus (JCV) DNA replication and gene expression and supported persistent and stable JCV infection over months in culture (PubMed=24052414).
CC   Caution: In contrast to SVG p12 (Cellosaurus=CVCL_3797), this cell line is not contaminated with BK polyomavirus (PubMed=25288626).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G14 ! SVG
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SVG-5F4
AC   CVCL_D5B7
SY   5F4
DR   Wikidata; Q127384341
RX   PubMed=24052414;
RX   PubMed=25288626;
CC   Virology: More resistant to productive JC virus (JCV) infection than the parent cell line (PubMed=24052414).
CC   Caution: In contrast to SVG p12 (Cellosaurus=CVCL_3797), this cell line is not contaminated with BK polyomavirus (PubMed=25288626).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G14 ! SVG
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   SVG-A
AC   CVCL_5G13
DR   BTO; BTO_0006555
DR   CancerTools; 153563
DR   GEO; GSM189708
DR   GEO; GSM189709
DR   GEO; GSM189710
DR   GEO; GSM189714
DR   GEO; GSM189715
DR   GEO; GSM189716
DR   Wikidata; Q54971010
DR   Ximbio; 153563
RX   PubMed=11517388;
RX   PubMed=14517064;
RX   PubMed=16945950;
RX   PubMed=17555786;
RX   PubMed=17881653;
RX   PubMed=24760884;
RX   PubMed=25288626;
RX   PubMed=28973443;
RX   PubMed=30044992;
CC   Characteristics: Used to study trinucleotide repeat (TNR) expansion as these cells support expansiosns in culture.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: In contrast to SVG p12 (Cellosaurus=CVCL_3797), this cell line is not contaminated with BK polyomavirus (PubMed=24760884).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G14 ! SVG
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   SVG-A CHMP1A null
AC   CVCL_C3HJ
DR   Wikidata; Q114313073
RX   PubMed=30044992;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8740; CHMP1A.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G13 ! SVG-A
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   SVG-A Msh3 1.7X
AC   CVCL_VP19
DR   CancerTools; 153691
DR   Wikidata; Q98132898
DR   Ximbio; 153691
RX   PubMed=28973443;
CC   Characteristics: Compared to wild-type SVG-A, has a 1.7 times expression level of MSH3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7326; MSH3.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VP18 ! SVG-A Msh3-/-
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   SVG-A Msh3-/-
AC   CVCL_VP18
SY   Msh3-/- SVG-A
DR   CancerTools; 153562
DR   Wikidata; Q98132899
DR   Ximbio; 153562
RX   PubMed=28973443;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7326; MSH3.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G13 ! SVG-A
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   SVG-TH
AC   CVCL_5F78
DR   Wikidata; Q54971012
RX   PubMed=8689028;
RX   PubMed=10845756;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11782; TH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G14 ! SVG
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   SVGR2
AC   CVCL_IM78
DR   GEO; GSM189711
DR   GEO; GSM189712
DR   GEO; GSM189713
DR   GEO; GSM189717
DR   GEO; GSM189718
DR   GEO; GSM189719
DR   Wikidata; Q54971014
RX   PubMed=14517064;
RX   PubMed=17555786;
CC   Virology: Not susceptible to infection by human polyomavirus JCV.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5G13 ! SVG-A
SX   Male
AG   8-12FW
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   SVHep B4
AC   CVCL_B6ES
SY   SVHepB4
DR   Wikidata; Q112041741
RX   PubMed=1681808;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=Strain LP).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   SVI
AC   CVCL_5943
DR   CLS; 400495
DR   Wikidata; Q54971015
RX   PubMed=15200416;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   SVK-1
AC   CVCL_D805
SY   SV-k1; Stria Vascularis K-1
DR   ABM; T0784
DR   Wikidata; Q54971016
RX   CelloPub=CLPUB00246;
RX   PubMed=12382283;
CC   Characteristics: At the permissive temperature (33 Celsius) capable of rapid proliferation in the presence of interferon gamma (IFNG). At the restrictive temperature (39 Celsius) have the potential to differentiate in the absence of IFNG.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, stria vascularis; UBERON=UBERON_0002282.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   SVK-2
AC   CVCL_D806
SY   Stria Vascularis K-2
DR   Wikidata; Q54971017
RX   CelloPub=CLPUB00246;
RX   PubMed=12382283;
CC   Characteristics: At the permissive temperature (33 Celsius) capable of rapid proliferation in the presence of interferon gamma (IFNG). At the restrictive temperature (39 Celsius) have the potential to differentiate in the absence of IFNG.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, stria vascularis; UBERON=UBERON_0002282.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   SVK-CR2
AC   CVCL_YD67
DR   Wikidata; Q98132901
RX   PubMed=1312681;
RX   PubMed=8553585;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2336; CR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z59 ! SVK14
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   SVK-Neo
AC   CVCL_YD68
DR   Wikidata; Q98132903
RX   PubMed=1312681;
RX   PubMed=8553585;
CC   Characteristics: Control cell line for SVK-CR2 (Cellosaurus=CVCL_YD67) (PubMed=1312681).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z59 ! SVK14
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 8
//
ID   SVK14
AC   CVCL_4Z59
SY   SVK-14; SVK 14; SVK
DR   Wikidata; Q54971018
RX   PubMed=2423124;
RX   PubMed=6180835;
RX   PubMed=8612705;
CC   Doubling time: 23 hours (PubMed=8612705).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 10
//
ID   SVM84
AC   CVCL_9127
SY   SVM
DR   Wikidata; Q54971019
RX   CelloPub=CLPUB00768;
RX   PubMed=2157503;
RX   PubMed=3013792;
RX   PubMed=3023994;
CC   Characteristics: Hypersensitive to UV radiation (PubMed=3013792).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9888; ! Muntiacus muntjak (Barking deer)
HI   CVCL_9126 ! DM87
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 12
//
ID   SVMC-a
AC   CVCL_6C25
DR   Wikidata; Q54971020
RX   PubMed=16822814;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVMC-c
AC   CVCL_6C26
DR   Wikidata; Q54971021
RX   PubMed=16822814;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVMC-E
AC   CVCL_6C27
DR   Wikidata; Q54971022
RX   PubMed=16822814;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-1
AC   CVCL_6C28
SY   SVNK 1
DR   Wikidata; Q54971023
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C34 ! SVNK-9
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-10
AC   CVCL_6C35
SY   SVNK 10
DR   Wikidata; Q54971024
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C34 ! SVNK-9
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-2
AC   CVCL_6C29
SY   SVNK 2
DR   Wikidata; Q54971025
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C34 ! SVNK-9
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-3
AC   CVCL_6C30
SY   SVNK 3
DR   Wikidata; Q54971026
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C34 ! SVNK-9
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-4
AC   CVCL_6C31
SY   SVNK 4
DR   Wikidata; Q54971027
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C34 ! SVNK-9
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-6
AC   CVCL_6C32
SY   SVNK 6
DR   Wikidata; Q54971028
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C34 ! SVNK-9
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-8
AC   CVCL_6C33
SY   SVNK 8
DR   Wikidata; Q54971029
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C34 ! SVNK-9
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVNK-9
AC   CVCL_6C34
SY   SVNK 9
DR   Wikidata; Q54971030
RX   PubMed=16845125;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Natural killer cell; CL=CL_0000623.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6C28 ! SVNK-1
OI   CVCL_6C29 ! SVNK-2
OI   CVCL_6C30 ! SVNK-3
OI   CVCL_6C31 ! SVNK-4
OI   CVCL_6C32 ! SVNK-6
OI   CVCL_6C33 ! SVNK-8
OI   CVCL_6C35 ! SVNK-10
SX   Female
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVOG-3e
AC   CVCL_IN98
SY   SVOG3e
DR   BTO; BTO_0005892
DR   Wikidata; Q54971032
RX   PubMed=26408257;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=PX-8).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 9
//
ID   SVOG-4m
AC   CVCL_E241
SY   SVOG-4M
DR   Wikidata; Q54971033
RX   PubMed=8832577;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=PX-8).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E242 ! SVOG-4o
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   SVOG-4o
AC   CVCL_E242
SY   SVOG-4O
DR   Wikidata; Q54971034
RX   PubMed=8832577;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=PX-8).
CC   Misspelling: SVOG-40; Note=Occasionally.
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Granulosa cell; CL=CL_0000501.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E241 ! SVOG-4m
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   SVP
AC   CVCL_WJ16
SY   Super-Vero-Porcine; Super Vero porcine
DR   CCRID; 4201MON-CCTCC00062
DR   CCTCC; GDC0062
DR   Wikidata; Q98132905
RX   PubMed=6298990;
CC   Group: Non-human primate cell line.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 8
//
ID   SVpgC2a
AC   CVCL_DG34
DR   GEO; GSM190619
DR   GEO; GSM190620
DR   GEO; GSM298193
DR   GEO; GSM966935
DR   GEO; GSM966936
DR   GEO; GSM966937
DR   Wikidata; Q54971035
RX   CelloPub=CLPUB00346;
RX   PubMed=7586160;
RX   PubMed=11377230;
RX   PubMed=15651925;
RX   PubMed=18186669;
RX   PubMed=19287496;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   SVpgC2a-FOXM1B
AC   CVCL_DH25
DR   cancercelllines; CVCL_DH25
DR   GEO; GSM298194
DR   Progenetix; CVCL_DH25
DR   Wikidata; Q54971036
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DG34 ! SVpgC2a
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   SVpgC2a-FOXM1B/SVFN1
AC   CVCL_DH26
SY   SVFN1
DR   cancercelllines; CVCL_DH26
DR   GEO; GSM298195
DR   Progenetix; CVCL_DH26
DR   Wikidata; Q54971037
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN2
AC   CVCL_DH27
SY   SVFN2
DR   cancercelllines; CVCL_DH27
DR   GEO; GSM298196
DR   Progenetix; CVCL_DH27
DR   Wikidata; Q54971039
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN3
AC   CVCL_DH28
SY   SVFN3
DR   cancercelllines; CVCL_DH28
DR   GEO; GSM298197
DR   Progenetix; CVCL_DH28
DR   Wikidata; Q54971040
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN4
AC   CVCL_DH29
SY   SVFN4
DR   cancercelllines; CVCL_DH29
DR   GEO; GSM298198
DR   Progenetix; CVCL_DH29
DR   Wikidata; Q54971041
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN5
AC   CVCL_DH30
SY   SVFN5
DR   cancercelllines; CVCL_DH30
DR   GEO; GSM298199
DR   Progenetix; CVCL_DH30
DR   Wikidata; Q54971042
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN6
AC   CVCL_DH31
SY   SVFN6
DR   cancercelllines; CVCL_DH31
DR   GEO; GSM298200
DR   Progenetix; CVCL_DH31
DR   Wikidata; Q54971043
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN7
AC   CVCL_DH32
SY   SVFN7
DR   cancercelllines; CVCL_DH32
DR   GEO; GSM298201
DR   Progenetix; CVCL_DH32
DR   Wikidata; Q54971044
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVpgC2a-FOXM1B/SVFN8
AC   CVCL_DH33
SY   SVFN8
DR   cancercelllines; CVCL_DH33
DR   GEO; GSM298202
DR   Progenetix; CVCL_DH33
DR   Wikidata; Q54971045
RX   PubMed=19287496;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3818; FOXM1 (Note=Isoform FoxM1B).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DH25 ! SVpgC2a-FOXM1B
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   SVR
AC   CVCL_6455
SY   SVEN 1 ras
DR   CLO; CLO_0009178
DR   ATCC; CRL-2280
DR   BCRC; 60219
DR   ChEMBL-Cells; CHEMBL3307724
DR   ChEMBL-Targets; CHEMBL614869
DR   JCRB; NIHS0317
DR   PubChem_Cell_line; CVCL_6455
DR   Wikidata; Q54971053
RX   PubMed=9023347;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-127.html
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Discontinued: JCRB; NIHS0317; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6502 ! Mile Sven 1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   SVR A221a
AC   CVCL_6456
SY   SVRA221a
DR   CLO; CLO_0009179
DR   ATCC; CRL-2386
DR   JCRB; NIHS0316
DR   Wikidata; Q54971055
RX   PubMed=11106566;
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1346866; Map2k1 (Note=With p.Ser222Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Discontinued: JCRB; NIHS0316; true.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6455 ! SVR
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   SVR bag4
AC   CVCL_6457
SY   SVRbag4
DR   CLO; CLO_0009180
DR   ATCC; CRL-2387
DR   Wikidata; Q54971056
RX   PubMed=11106566;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58-3).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6455 ! SVR
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   SVS24
AC   CVCL_6A93
SY   SVS 24
DR   Wikidata; Q54971057
RX   PubMed=9281449;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVS30
AC   CVCL_6A94
SY   SVS 30
DR   Wikidata; Q54971058
RX   PubMed=9281449;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   SVts7-1
AC   CVCL_W844
DR   Wikidata; Q54971060
RX   PubMed=1851674;
CC   Population: Japanese and Korean.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 11
//
ID   SVts8
AC   CVCL_3173
SY   SVts-8; TIG-3 SVts8
DR   GEO; GSM827591
DR   JCRB; JCRB0506.1
DR   Wikidata; Q54971061
RX   PubMed=1851674;
RX   PubMed=9290701;
RX   PubMed=10050041;
RX   PubMed=20215515;
CC   Population: Japanese and Korean.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   SVU-H1
AC   CVCL_A9FU
DR   CCRID; 5301MAM-KCB1124HZJ
DR   KCB; KCB 2011024HZJ
DR   Wikidata; Q108821339
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=55149; ! Sciurus vulgaris (Eurasian red squirrel)
OI   CVCL_A9FV ! SVU-K1
OI   CVCL_A9FW ! SVU-L1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SVU-K1
AC   CVCL_A9FV
DR   CCRID; 5301MAM-KCB1124KZJ
DR   KCB; KCB 2011024KZJ
DR   Wikidata; Q108821340
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=55149; ! Sciurus vulgaris (Eurasian red squirrel)
OI   CVCL_A9FU ! SVU-H1
OI   CVCL_A9FW ! SVU-L1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SVU-L1
AC   CVCL_A9FW
DR   CCRID; 5301MAM-KCB1124LZJ
DR   KCB; KCB 2011024LZJ
DR   Wikidata; Q108821341
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=55149; ! Sciurus vulgaris (Eurasian red squirrel)
OI   CVCL_A9FU ! SVU-H1
OI   CVCL_A9FV ! SVU-K1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   SW-8
AC   CVCL_IR35
DR   Wikidata; Q54971062
RX   PubMed=3745952;
RX   PubMed=6095297;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   SW-OH1
AC   CVCL_S868
DR   Wikidata; Q54971063
RX   PubMed=12904596;
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   SW1-C-CD83
AC   CVCL_C8SM
DR   Wikidata; Q123033577
RX   PubMed=15051893;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1328316; Cd83.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8S5 ! K1735-SW1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SW1-P2
AC   CVCL_C8SL
SY   SW1-ATF2(50-100)
DR   Wikidata; Q123033578
RX   PubMed=12208865;
RX   PubMed=15051893;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:784; ATF2 (Note=With p.Met1_His49del and p.Glu101_Ser505del and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8S5 ! K1735-SW1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SW1-P2-CD83
AC   CVCL_C8SN
DR   Wikidata; Q123033579
RX   PubMed=15051893;
CC   Sequence variation: Mutation; MGI; MGI:97376; Nras; Simple; p.Gly13Asp (c.38G>A); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1328316; Cd83.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:784; ATF2 (Note=With p.Met1_His49del and p.Glu101_Ser505del and a N-terminal HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8SL ! SW1-P2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   SW10
AC   CVCL_6458
DR   CLO; CLO_0009207
DR   ATCC; CRL-2766
DR   BCRC; 60550
DR   Wikidata; Q54971064
RX   PubMed=12210843;
RX   PubMed=25277546;
CC   Characteristics: At the permissive temperature (33 Celsius) proliferates. Does not proliferate at the restrictive temperature (37 Celsius).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   SW10#20A
AC   CVCL_B5RA
SY   SW10 #20A
DR   Wikidata; Q112041742
RX   PubMed=22308265;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RB ! SW10#5P
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SW10#5P
AC   CVCL_B5RB
SY   SW10 #5P
DR   Wikidata; Q112041743
RX   PubMed=22308265;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RA ! SW10#20A
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SW1007
AC   CVCL_1E30
SY   SW-1007; SW 1007
DR   Wikidata; Q54971065
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6935474;
RX   PubMed=7459858;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 11
//
ID   SW1016
AC   CVCL_1E29
SY   SW-1016; SW 1016
DR   Wikidata; Q54971067
RX   PubMed=327080;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW1045
AC   CVCL_7164
SY   SW-1045; SW 1045
DR   Wikidata; Q54971069
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   SW1083
AC   CVCL_L215
SY   SW-1083; SW 1083
DR   Wikidata; Q54971070
RX   PubMed=286328;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=1778766;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 142 hours (Note=At 6th passage) (PubMed=1000501).
CC   Derived from site: Metastatic; Perineum; UBERON=UBERON_0002356.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 14
//
ID   SW1088
AC   CVCL_1715
SY   SW-1088; SW 1088
DR   BTO; BTO_0000296
DR   CLO; CLO_0009182
DR   EFO; EFO_0002358
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-12
DR   BioGRID_ORCS_Cell_line; 1027
DR   BioSample; SAMN03471100
DR   BioSample; SAMN10988151
DR   cancercelllines; CVCL_1715
DR   Cell_Model_Passport; SIDM01155
DR   ChEMBL-Cells; CHEMBL3307573
DR   ChEMBL-Targets; CHEMBL614243
DR   Cosmic; 687584
DR   Cosmic; 897442
DR   Cosmic; 909745
DR   Cosmic; 1036335
DR   Cosmic; 2367550
DR   Cosmic; 2731175
DR   Cosmic-CLP; 909745
DR   DepMap; ACH-000437
DR   EGA; EGAS00001000978
DR   GDSC; 909745
DR   GEO; GSM101667
DR   GEO; GSM101668
DR   GEO; GSM887663
DR   GEO; GSM888755
DR   GEO; GSM1374914
DR   GEO; GSM1670495
DR   IARC_TP53; 27249
DR   IGRhCellID; SW1088
DR   IZSLER; BS TCL 129
DR   LiGeA; CCLE_853
DR   LINCS_LDP; LCL-1398
DR   PharmacoDB; SW1088_1527_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1715
DR   PubChem_Cell_line; CVCL_1715
DR   Wikidata; Q54971072
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=286328;
RX   PubMed=327080;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=11414198;
RX   PubMed=16697959;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*01,03; B*08,44; DRB1*04,13 (IZSLER=BS TCL 129).
CC   HLA typing: A*01:01,03:01; B*08:01,44:02; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (Cosmic-CLP=909745; DepMap=ACH-000437).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (ATCC=HTB-12; Cosmic-CLP=909745; DepMap=ACH-000437).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.6%; East Asian, North=1.08%; East Asian, South=0.34%; South Asian=0%; European, North=68.27%; European, South=29.71% (PubMed=30894373).
ST   Source(s): ATCC=HTB-12; Cosmic-CLP=909745
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 14,18
ST   D19S433: 15
ST   D21S11: 29,33.2
ST   D2S1338: 17,23
ST   D3S1358: 13,16
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13,15
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 5,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SW1116
AC   CVCL_0544
SY   SW-1116; SW 1116
DR   BTO; BTO_0001599
DR   CLO; CLO_0009183
DR   CLO; CLO_0009208
DR   EFO; EFO_0002359
DR   MCCL; MCC:0000445
DR   CLDB; cl4429
DR   AddexBio; C0009019/4909
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-233
DR   BCRC; 60307
DR   BioSample; SAMN03473185
DR   BioSample; SAMN10987597
DR   cancercelllines; CVCL_0544
DR   CCRID; 3101HUMTCHu174
DR   CCTCC; GDC0258
DR   Cell_Model_Passport; SIDM00835
DR   ChEMBL-Cells; CHEMBL3308495
DR   ChEMBL-Targets; CHEMBL614942
DR   CLS; 300348
DR   ColonAtlas; SW1116
DR   Cosmic; 711271
DR   Cosmic; 719678
DR   Cosmic; 724847
DR   Cosmic; 733171
DR   Cosmic; 887241
DR   Cosmic; 889526
DR   Cosmic; 909746
DR   Cosmic; 948834
DR   Cosmic; 1122331
DR   Cosmic; 1187320
DR   Cosmic; 1223147
DR   Cosmic; 1310939
DR   Cosmic; 1312312
DR   Cosmic; 1479569
DR   Cosmic; 1609499
DR   Cosmic; 1676732
DR   Cosmic; 1805266
DR   Cosmic; 1995649
DR   Cosmic; 2267317
DR   Cosmic; 2302012
DR   Cosmic; 2433753
DR   Cosmic-CLP; 909746
DR   DepMap; ACH-000489
DR   ECACC; 87071006
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909746
DR   GEO; GSM206546
DR   GEO; GSM513920
DR   GEO; GSM514307
DR   GEO; GSM741267
DR   GEO; GSM784013
DR   GEO; GSM827441
DR   GEO; GSM887664
DR   GEO; GSM888756
DR   GEO; GSM1006225
DR   GEO; GSM1006226
DR   GEO; GSM1006227
DR   GEO; GSM1346887
DR   GEO; GSM1374915
DR   GEO; GSM1374916
DR   GEO; GSM1374917
DR   GEO; GSM1448114
DR   GEO; GSM1670496
DR   GEO; GSM2550012
DR   IARC_TP53; 1559
DR   IGRhCellID; SW1116
DR   IZSLER; BS TCL 96
DR   KCLB; 10233
DR   LiGeA; CCLE_653
DR   LINCS_LDP; LCL-1200
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C481
DR   PharmacoDB; SW1116_1528_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0544
DR   PubChem_Cell_line; CVCL_0544
DR   Wikidata; Q54971073
RX   PubMed=286328;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=1778766;
RX   PubMed=3335022;
RX   PubMed=3349466;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7104989;
RX   PubMed=7651727;
RX   PubMed=8422623;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11414198;
RX   PubMed=11526487;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23932154;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=24840470;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 163 hours (PubMed=1000501); 68.70 hours (PubMed=25944804).
CC   HLA typing: A*23:01,23:01; B*44:03,44:03; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln264Ter (c.790C>T); ClinVar=VCV001761174; Zygosity=Heterozygous (PubMed=24755471; ATCC=CCL-233).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1429fs*41 (c.4287_4296delAACCATGCCA); Zygosity=Heterozygous (PubMed=24755471; ATCC=CCL-233).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala159Asp (c.476C>A); ClinVar=VCV001026335; Zygosity=Homozygous (PubMed=7651727; PubMed=9000147; PubMed=16418264; PubMed=24042735; PubMed=24755471; PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Glycomics; O-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.32%; Native American=0%; East Asian, North=3.41%; East Asian, South=0%; South Asian=0%; European, North=62.64%; European, South=32.62% (PubMed=30894373).
CC   Misspelling: SW116; Cosmic=1122331; Cosmic=1676732.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009019/4909; ATCC=CCL-233; CLS=300348; Cosmic-CLP=909746; ECACC=87071006; KCLB=10233; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 28,29
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12 (ECACC=87071006)
ST   D7S820: 12 (AddexBio=C0009019/4909; ATCC=CCL-233; CLS=300348; Cosmic-CLP=909746; KCLB=10233; PubMed=25877200; PubMed=25926053)
ST   D8S1179: 10,11
ST   FGA: 21,22
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6 (AddexBio=C0009019/4909; ATCC=CCL-233; CLS=300348; Cosmic-CLP=909746; ECACC=87071006; PubMed=25877200; PubMed=25926053)
ST   TH01: 7 (KCLB=10233)
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   SW1222
AC   CVCL_3886
SY   SW-1222; SW 1222
DR   BTO; BTO_0003105
DR   cancercelllines; CVCL_3886
DR   CancerTools; 152434
DR   ColonAtlas; SW1222
DR   Cosmic; 876714
DR   Cosmic; 948833
DR   Cosmic; 985653
DR   Cosmic; 986017
DR   Cosmic; 995398
DR   Cosmic; 1043827
DR   Cosmic; 1223148
DR   Cosmic; 1312313
DR   Cosmic; 1479605
DR   Cosmic; 1482523
DR   Cosmic; 1524330
DR   Cosmic; 1803950
DR   Cosmic; 2302013
DR   Cosmic; 2760073
DR   Cosmic; 2800578
DR   ECACC; 12022910
DR   GEO; GSM1346888
DR   GEO; GSM1374918
DR   GEO; GSM1448088
DR   GEO; GSM3145613
DR   GEO; GSM3145738
DR   IARC_TP53; 21761
DR   Wikidata; Q54971074
DR   Ximbio; 152434
RX   PubMed=286328;
RX   PubMed=924690;
RX   PubMed=1778766;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6582512;
RX   PubMed=8464898;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=16418264;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=24755471;
RX   PubMed=25926053;
CC   From: Scott and White Clinic; Temple; USA.
CC   HLA typing: A*01 (PubMed=8464898).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu1306Ter (c.3916G>T) (E1288*, c.3862G>T); ClinVar=VCV000376059; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Val (c.437C>T); ClinVar=VCV000375962; Zygosity=Unspecified (PubMed=20570890).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu540Arg (c.1619T>G); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Ex1 113 bp del; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 12022910; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ECACC=12022910; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9 (PubMed=25926053)
ST   D13S317: 9,13 (ECACC=12022910)
ST   D16S539: 9,10
ST   D21S11: 29
ST   D5S818: 9
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 10
ST   vWA: 18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 35
//
ID   SW1231
AC   CVCL_WS74
SY   SW-1231; SW 1231
DR   Wikidata; Q98132907
RX   PubMed=924690;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 05-10-23; Version: 5
//
ID   SW1271
AC   CVCL_1716
SY   SW-1271; SW 1271
DR   CLO; CLO_0009184
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2177
DR   BioSample; SAMN03472877
DR   BioSample; SAMN10987907
DR   cancercelllines; CVCL_1716
DR   Cell_Model_Passport; SIDM01156
DR   Cosmic; 701079
DR   Cosmic; 929966
DR   Cosmic; 932919
DR   Cosmic; 1925844
DR   Cosmic-CLP; 1299062
DR   DepMap; ACH-000890
DR   EGA; EGAS00001000978
DR   GDSC; 1299062
DR   GEO; GSM169452
DR   GEO; GSM170724
DR   GEO; GSM170725
DR   GEO; GSM887665
DR   GEO; GSM888757
DR   GEO; GSM986181
DR   GEO; GSM1670497
DR   GEO; GSM1887959
DR   GEO; GSM1888036
DR   IARC_TP53; 122
DR   LiGeA; CCLE_662
DR   LINCS_LDP; LCL-1824
DR   PharmacoDB; SW1271_1524_2019
DR   PRIDE; PXD011896
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1716
DR   Wikidata; Q54971075
RX   PubMed=1855224;
RX   PubMed=3518877;
RX   PubMed=17426248;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27247353;
RX   PubMed=27397505;
RX   PubMed=28766886;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32586373;
RX   PubMed=35839778;
RX   PubMed=38180245;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,26:01; B*07:02,13:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=1855224; ATCC=CRL-2177; Cosmic-CLP=1299062; DepMap=ACH-000890).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Asn774Lys (c.2322C>A); Zygosity=Homozygous (DepMap=ACH-000123).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Homozygous (PubMed=1855224; Cosmic-CLP=1299062; DepMap=ACH-000890).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.42%; Native American=1.29%; East Asian, North=2.56%; East Asian, South=0%; South Asian=0%; European, North=63.53%; European, South=32.2% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-2177; Cosmic-CLP=1299062; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D10S1248: 13,16
ST   D12S391: 18,20
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14
ST   D1S1656: 15
ST   D21S11: 29,31.2
ST   D22S1045: 15
ST   D2S1338: 23
ST   D2S441: 11
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 20
ST   Penta D: 10,12
ST   Penta E: 5,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   SW13
AC   CVCL_0542
SY   SW-13; SW 13; Scott and White No. 13
DR   CLO; CLO_0009185
DR   CLO; CLO_0009209
DR   MCCL; MCC:0000444
DR   CLDB; cl4435
DR   CLDB; cl4436
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-105
DR   BCRC; 60483
DR   BCRJ; 0300
DR   BioSample; SAMN03472418
DR   BioSample; SAMN03472692
DR   cancercelllines; CVCL_0542
DR   CCRID; 1101HUM-PUMC000055
DR   CCRID; 3101HUMTCHu221
DR   Cell_Model_Passport; SIDM00814
DR   ChEMBL-Cells; CHEMBL3308467
DR   ChEMBL-Targets; CHEMBL1075587
DR   CLS; 300349
DR   Cosmic; 684683
DR   Cosmic; 909744
DR   Cosmic; 1024274
DR   Cosmic; 1179077
DR   Cosmic; 1622872
DR   Cosmic; 2239456
DR   Cosmic-CLP; 909744
DR   DepMap; ACH-001401
DR   ECACC; 87031801
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10810-111A9
DR   GDSC; 909744
DR   GEO; GSM827353
DR   GEO; GSM1670498
DR   IARC_TP53; 2946
DR   IZSLER; BS TCL 62
DR   JCRB; JCRB9069
DR   KCB; KCB 200780YJ
DR   KCLB; 10105
DR   LINCS_LDP; LCL-1676
DR   PharmacoDB; SW13_1529_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0542
DR   PubChem_Cell_line; CVCL_0542
DR   TOKU-E; 3228
DR   Wikidata; Q54971076
RX   CelloPub=CLPUB00337;
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1516062;
RX   PubMed=3518877;
RX   PubMed=4765382;
RX   PubMed=6244232;
RX   PubMed=6988327;
RX   PubMed=7459858;
RX   PubMed=11414198;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21924324;
RX   PubMed=22266826;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=SW-13
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-332.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Gln164Ter (c.490C>T); ClinVar=VCV001436624; Zygosity=Heterozygous (Cosmic-CLP=909744; DepMap=ACH-001401).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Homozygous (ATCC=CCL-105; Cosmic-CLP=909744; DepMap=ACH-001401).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.01%; Native American=0%; East Asian, North=0%; East Asian, South=0.61%; South Asian=0.44%; European, North=72.28%; European, South=24.66% (PubMed=30894373).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): ATCC=CCL-105; CCRID; CLS=300349; Cosmic-CLP=909744; DepMap=ACH-001401; ECACC=87031801; IZSLER=BS TCL 62; JCRB=JCRB9069; KCLB=10105
ST   Amelogenin: X
ST   CSF1PO: 11,12 (ATCC=CCL-105; Cosmic-CLP=909744; DepMap=ACH-001401; KCLB=10105)
ST   CSF1PO: 12 (CCRID; CLS=300349; ECACC=87031801; IZSLER=BS TCL 62; JCRB=JCRB9069)
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 14,15
ST   D21S11: 31,32.2
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 11,12 (CCRID; CLS=300349; DepMap=ACH-001401; IZSLER=BS TCL 62; JCRB=JCRB9069; KCLB=10105)
ST   D5S818: 12 (ATCC=CCL-105; Cosmic-CLP=909744; ECACC=87031801)
ST   D7S820: 8,10
ST   D8S1179: 10
ST   FGA: 20
ST   Penta D: 10,13
ST   Penta E: 7,15
ST   TH01: 7 (JCRB=JCRB9069)
ST   TH01: 7,8 (ATCC=CCL-105; CCRID; CLS=300349; Cosmic-CLP=909744; DepMap=ACH-001401; ECACC=87031801; IZSLER=BS TCL 62; KCLB=10105)
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   SW13/cl.1 vim+
AC   CVCL_WY51
SY   SW13 Cl.1 Vim+; SW-13/cl.1 vim+; SW13 Vim+
DR   cancercelllines; CVCL_WY51
DR   Wikidata; Q98132908
RX   PubMed=1696263;
RX   PubMed=10388528;
CC   Population: Caucasian.
CC   Characteristics: Expresses vimentin.
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Gln164Ter (c.490C>T); ClinVar=VCV001436624; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0542 ! SW13
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   SW13/cl.2 vim-
AC   CVCL_WY52
SY   SW13 Cl.2 Vim-; SW-13/cl.2 vim-; SW13 Vim-
DR   EFO; EFO_0022566
DR   cancercelllines; CVCL_WY52
DR   Wikidata; Q98132909
RX   PubMed=1696263;
RX   PubMed=10388528;
CC   Population: Caucasian.
CC   Characteristics: Does not express vimentin.
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Gln164Ter (c.490C>T); ClinVar=VCV001436624; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0542 ! SW13
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   SW1318
AC   CVCL_6G40
SY   SW-1318; SW 1318
DR   Wikidata; Q54971077
RX   PubMed=571047;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=7459858;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   SW1353
AC   CVCL_0543
SY   SW-1353; SW 1353
DR   BTO; BTO_0002003
DR   CLO; CLO_0009186
DR   CLO; CLO_0009210
DR   EFO; EFO_0002360
DR   MCCL; MCC:0000443
DR   CLDB; cl4957
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7466
DR   ATCC; HTB-94
DR   BCRC; 60548
DR   BCRJ; 0382
DR   BioSample; SAMN03472765
DR   BioSample; SAMN10988195
DR   cancercelllines; CVCL_0543
DR   CCRID; 3101HUMTCHu128
DR   Cell_Model_Passport; SIDM01766
DR   ChEMBL-Cells; CHEMBL3307462
DR   ChEMBL-Targets; CHEMBL614944
DR   CLS; 300440
DR   Cosmic; 923378
DR   Cosmic; 1602475
DR   Cosmic; 1992321
DR   DepMap; ACH-000418
DR   FANTOM5_SSTAR; 10700-109G7
DR   GEO; GSM887666
DR   GEO; GSM888758
DR   GEO; GSM1670499
DR   GEO; GSM1676319
DR   GEO; GSM1701652
DR   IARC_TP53; 27036
DR   ICLC; HTL99008
DR   IGRhCellID; SW1353
DR   IZSLER; BS TCL 213
DR   LiGeA; CCLE_285
DR   Lonza; 85
DR   NCBI_Iran; C571
DR   PharmacoDB; SW1353_1525_2019
DR   PRIDE; PXD012985
DR   PRIDE; PXD024953
DR   Progenetix; CVCL_0543
DR   PubChem_Cell_line; CVCL_0543
DR   TOKU-E; 3213
DR   Ubigene; YC-C105
DR   Wikidata; Q54971078
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=3518877;
RX   PubMed=15950496;
RX   PubMed=19787792;
RX   PubMed=20215515;
RX   PubMed=22057234;
RX   PubMed=22460905;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27231123;
RX   PubMed=28196595;
RX   PubMed=29853780;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31300557;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*24:02,29:02; B*44:02,44:02; C*02:02,16:01 (PubMed=26589293).
CC   Karyotypic information: Hyperdiploid, 47,XX,+7 (ATCC=HTB-94).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple; p.Arg172Ser (c.516G>C); ClinVar=VCV000375985; Zygosity=Heterozygous (PubMed=22057234; DepMap=ACH-000418).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val203Leu (c.607G>C); ClinVar=VCV000482235; Zygosity=Heterozygous (PubMed=19787792; DepMap=ACH-000418).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Ribosome profiling; Ribo-Seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=2.24%; East Asian, South=0%; South Asian=0%; European, North=66.16%; European, South=31.35% (PubMed=30894373).
CC   Derived from site: In situ; Bone, right humerus; UBERON=UBERON_0000976.
ST   Source(s): ATCC=HTB-94; CLS=300440; IZSLER=BS TCL 213; PubMed=19787792; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,16
ST   D12S391: 22,23
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 13,17
ST   D19S433: 14
ST   D1S1656: 11,17.3
ST   D21S11: 30,32.2
ST   D22S1045: 15,17
ST   D2S1338: 19,24
ST   D2S441: 11,14
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 12,14
ST   SE33: 19,21
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7155; Primary central chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   SW1370
AC   CVCL_6G41
SY   SW-1370; SW 1370
DR   Wikidata; Q54971079
RX   PubMed=571047;
RX   PubMed=6244232;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   SW1398
AC   CVCL_3885
SY   SW-1398; SW 1398
DR   BTO; BTO_0003746
DR   MetaboLights; MTBLS227
DR   PRIDE; PXD001550
DR   Wikidata; Q54971080
RX   PubMed=25841592;
RX   PubMed=26537799;
CC   From: Scott and White Clinic; Temple; USA.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics; PTM; Phosphorylation.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   SW1417
AC   CVCL_1717
SY   SW-1417; SW 1417
DR   BTO; BTO_0001536
DR   CLO; CLO_0009187
DR   CLO; CLO_0009211
DR   EFO; EFO_0002361
DR   CLDB; cl4430
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-238
DR   BioSample; SAMN03471478
DR   BioSample; SAMN03471575
DR   BioSample; SAMN10988333
DR   cancercelllines; CVCL_1717
DR   Cell_Model_Passport; SIDM00812
DR   ChEMBL-Cells; CHEMBL3308129
DR   ChEMBL-Targets; CHEMBL1075588
DR   ColonAtlas; SW1417
DR   Cosmic; 685869
DR   Cosmic; 909747
DR   Cosmic; 948838
DR   Cosmic; 986018
DR   Cosmic; 995413
DR   Cosmic; 1043826
DR   Cosmic; 1090352
DR   Cosmic; 1187321
DR   Cosmic; 1310940
DR   Cosmic; 1312314
DR   Cosmic; 1466825
DR   Cosmic; 1479614
DR   Cosmic; 1609491
DR   Cosmic; 1708405
DR   Cosmic; 1995650
DR   Cosmic; 2302014
DR   Cosmic; 2760075
DR   Cosmic; 2800577
DR   Cosmic-CLP; 909747
DR   DepMap; ACH-000236
DR   ECACC; 90102543
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909747
DR   GEO; GSM206547
DR   GEO; GSM513921
DR   GEO; GSM514308
DR   GEO; GSM741248
DR   GEO; GSM827354
DR   GEO; GSM887667
DR   GEO; GSM888759
DR   GEO; GSM1346857
DR   GEO; GSM1374919
DR   GEO; GSM1374920
DR   GEO; GSM1448089
DR   GEO; GSM1670500
DR   IARC_TP53; 21762
DR   ICLC; HTL00005
DR   IGRhCellID; SW1417
DR   LiGeA; CCLE_528
DR   LINCS_LDP; LCL-1185
DR   PharmacoDB; SW1417_1530_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1717
DR   PubChem_Cell_line; CVCL_1717
DR   Wikidata; Q54971081
RX   PubMed=924690;
RX   PubMed=1778766;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7104989;
RX   PubMed=7459858;
RX   PubMed=7651727;
RX   PubMed=8464898;
RX   PubMed=9294210;
RX   PubMed=9331070;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/SW1417.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 68 hours (PubMed=25984343).
CC   HLA typing: A*03 (PubMed=8464898).
CC   HLA typing: A*03:01,24:02; B*35:01,35:01; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Homozygous (ATCC=CCL-238; Cosmic-CLP=909747; DepMap=ACH-000236).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; ATCC=CCL-238; Cosmic-CLP=909747; DepMap=ACH-000236).
CC   Sequence variation: Mutation; HGNC; HGNC:6844; MAP2K4; Simple; p.Arg274Gly (c.820A>G); Zygosity=Homozygous (PubMed=9331070; Cosmic-CLP=909747; DepMap=ACH-000236).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Hisfs*21 (c.712_725delTGTAACAGTTCCTG); Zygosity=Heterozygous (Cosmic-CLP=909747; DepMap=ACH-000236).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.13%; East Asian, South=0%; South Asian=0.86%; European, North=62.18%; European, South=34.82% (PubMed=30894373).
CC   Discontinued: ICLC; HTL00005; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-238; Cosmic-CLP=909747; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12 (ATCC=CCL-238; Cosmic-CLP=909747)
ST   D13S317: 12 (PubMed=25877200; PubMed=25926053)
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 12
ST   D21S11: 29,32.2,33.2
ST   D2S1338: 24,25
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 8
ST   FGA: 23
ST   Penta D: 9,12
ST   Penta E: 8
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SW1463
AC   CVCL_1718
SY   SW-1463; SW 1463
DR   CLO; CLO_0009188
DR   CLO; CLO_0009212
DR   EFO; EFO_0002362
DR   CLDB; cl4431
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-234
DR   BCRC; 60521
DR   BioGRID_ORCS_Cell_line; 454
DR   BioSample; SAMN03471489
DR   BioSample; SAMN10987771
DR   cancercelllines; CVCL_1718
DR   Cell_Model_Passport; SIDM00834
DR   ChEMBL-Cells; CHEMBL3308788
DR   ChEMBL-Targets; CHEMBL1075589
DR   CLS; 300623
DR   ColonAtlas; SW1463
DR   Cosmic; 724851
DR   Cosmic; 909748
DR   Cosmic; 983735
DR   Cosmic; 1071894
DR   Cosmic; 1176595
DR   Cosmic; 1310937
DR   Cosmic; 1708416
DR   Cosmic; 1995651
DR   Cosmic; 2302015
DR   Cosmic; 2647532
DR   Cosmic-CLP; 909748
DR   DepMap; ACH-000470
DR   ECACC; 90112713
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909748
DR   GEO; GSM206548
DR   GEO; GSM513922
DR   GEO; GSM514309
DR   GEO; GSM827417
DR   GEO; GSM887668
DR   GEO; GSM888760
DR   GEO; GSM1006228
DR   GEO; GSM1006229
DR   GEO; GSM1006230
DR   GEO; GSM1346858
DR   GEO; GSM1448113
DR   GEO; GSM1670501
DR   GEO; GSM2550013
DR   IARC_TP53; 27250
DR   IGRhCellID; SW1463
DR   IZSLER; BS TCL 220
DR   LiGeA; CCLE_589
DR   LINCS_LDP; LCL-1291
DR   MetaboLights; MTBLS227
DR   PharmacoDB; SW1463_1531_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1718
DR   PubChem_Cell_line; CVCL_1718
DR   Wikidata; Q54971083
RX   PubMed=924690;
RX   PubMed=7104989;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23932154;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,02:01; B*08:01,44:02; C*05:01,07:06 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Val452Serfs*7 (c.1348_1349GT[3]) (c.1354_1355delGT); ClinVar=VCV000537527; Zygosity=Homozygous (ATCC=CCL-234; Cosmic-CLP=909748; DepMap=ACH-000470).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Gln (c.1436G>A); ClinVar=VCV000376419; Zygosity=Heterozygous (Cosmic-CLP=909748; DepMap=ACH-000470).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=12068308; PubMed=28683746; ATCC=CCL-234; Cosmic-CLP=909748; DepMap=ACH-000470).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=28683746; ATCC=CCL-234; Cosmic-CLP=909748; DepMap=ACH-000470).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.61%; Native American=0%; East Asian, North=8.03%; East Asian, South=0%; South Asian=0%; European, North=41.75%; European, South=44.61% (PubMed=30894373).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ATCC=CCL-234; CLS=300623; Cosmic-CLP=909748; ECACC=90112713; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 17
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,18
ST   D3S1358: 16,17
ST   D5S818: 13,14
ST   D6S1043: 12,18
ST   D7S820: 9
ST   D8S1179: 11,15
ST   FGA: 23,28
ST   Penta D: 9,12
ST   Penta E: 17
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SW1494
AC   CVCL_LK66
SY   SW-1494
DR   ATCC; HTB-116
DR   Wikidata; Q54971084
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Scott and White Clinic; Temple; USA.
CC   Discontinued: ATCC; HTB-116; true.
DI   NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   SW1503
AC   CVCL_LK67
SY   SW-1503
DR   Wikidata; Q54971085
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   SW156
AC   CVCL_1719
SY   SW-156; SW 156
DR   CLO; CLO_0009189
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2175
DR   BioSample; SAMN03472558
DR   cancercelllines; CVCL_1719
DR   Cell_Model_Passport; SIDM01162
DR   Cosmic; 687943
DR   Cosmic; 1995652
DR   Cosmic-CLP; 1240220
DR   DepMap; ACH-001398
DR   EGA; EGAS00001000978
DR   GDSC; 1240220
DR   GEO; GSM374475
DR   GEO; GSM827270
DR   GEO; GSM1670502
DR   LINCS_LDP; LCL-1758
DR   PharmacoDB; SW156_1532_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1719
DR   Wikidata; Q54971086
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=20215515;
RX   PubMed=22949125;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Microsatellite instability: Stable (MSS) (PubMed=31068700; Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2175; Cosmic-CLP=1240220; DepMap=ACH-001398
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 12,14
ST   D21S11: 27,32.2 (ATCC=CRL-2175)
ST   D21S11: 27,32.2,33.2 (DepMap=ACH-001398)
ST   D2S1338: 19,20
ST   D3S1358: 14
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 10,12
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   SW1573
AC   CVCL_1720
SY   SW-1573; SW 1573
DR   BTO; BTO_0003016
DR   CLO; CLO_0009190
DR   EFO; EFO_0002363
DR   AddexBio; C0016009/4862
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2170
DR   BioGRID_ORCS_Cell_line; 1028
DR   BioSample; SAMN03473239
DR   BioSample; SAMN10988028
DR   cancercelllines; CVCL_1720
DR   Cell_Model_Passport; SIDM01163
DR   ChEMBL-Cells; CHEMBL3307980
DR   ChEMBL-Targets; CHEMBL612570
DR   Cosmic; 724878
DR   Cosmic; 1017831
DR   Cosmic; 1802305
DR   Cosmic; 2060538
DR   Cosmic-CLP; 724878
DR   DepMap; ACH-000677
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   FANTOM5_SSTAR; 10708-109H6
DR   GDSC; 724878
DR   GEO; GSM206549
DR   GEO; GSM274788
DR   GEO; GSM274818
DR   GEO; GSM385526
DR   GEO; GSM385537
DR   GEO; GSM827193
DR   GEO; GSM887669
DR   GEO; GSM888761
DR   GEO; GSM1670503
DR   IARC_TP53; 27581
DR   IGRhCellID; SW1573
DR   LiGeA; CCLE_030
DR   LINCS_LDP; LCL-1799
DR   PharmacoDB; SW1573_1533_2019
DR   PRIDE; PXD011315
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1720
DR   PubChem_Cell_line; CVCL_1720
DR   Wikidata; Q54971087
RX   CelloPub=CLPUB00485;
RX   PubMed=1353703;
RX   PubMed=1974823;
RX   PubMed=2566376;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=9256160;
RX   PubMed=12068308;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30710758;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=9256160).
CC   HLA typing: A*02:01,24:02; B*44:02,44:02; C*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (ATCC=CRL-2170).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (ATCC=CRL-2170).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (ATCC=CRL-2170; Cosmic-CLP=724878).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=12068308; ATCC=CRL-2170; Cosmic-CLP=724878).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (ATCC=CRL-2170; Cosmic-CLP=724878).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (Cosmic-CLP=724878).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Secretome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.36%; Native American=0.18%; East Asian, North=0.45%; East Asian, South=0%; South Asian=0%; European, North=66.92%; European, South=32.09% (PubMed=30894373).
CC   Misspelling: SW1753; Note=Occasionally.
CC   Misspelling: SW-1753; Note=Occasionally.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0016009/4862; ATCC=CRL-2170; Cosmic-CLP=724878; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12,14
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 11
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 5,13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 20
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SW1573/1R10000
AC   CVCL_WG69
SY   SW-1573/1R10000; SW-1573/10000; SW1573/10000; 1R10000
DR   cancercelllines; CVCL_WG69
DR   Wikidata; Q98132912
RX   PubMed=1353703;
RX   PubMed=1974823;
RX   PubMed=2566376;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/1R50
AC   CVCL_WG67
SY   SW-1573/1R50; SW-1573/50; SW1573/50; 1R50; 1R50b
DR   cancercelllines; CVCL_WG67
DR   Wikidata; Q98132914
RX   PubMed=1348862;
RX   PubMed=1353703;
RX   PubMed=1974823;
RX   PubMed=2566376;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/1R500
AC   CVCL_WG68
SY   SW-1573/1R500; SW-1573/500; SW1573/500; 1R500; 1R500b
DR   cancercelllines; CVCL_WG68
DR   Wikidata; Q98132916
RX   PubMed=1353703;
RX   PubMed=1974823;
RX   PubMed=2566376;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/2R120
AC   CVCL_WG70
SY   SW-1573/2R120; 2R120
DR   cancercelllines; CVCL_WG70
DR   Wikidata; Q98132917
RX   CelloPub=CLPUB00485;
RX   PubMed=1353703;
RX   PubMed=1974823;
RX   PubMed=9256160;
CC   Population: Caucasian.
CC   Doubling time: 42 hours (PubMed=9256160).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/2R160
AC   CVCL_WG71
SY   SW-1573/2R160; 2R160
DR   cancercelllines; CVCL_WG71
DR   Wikidata; Q98132920
RX   CelloPub=CLPUB00485;
RX   PubMed=1353703;
RX   PubMed=1974823;
RX   PubMed=9256160;
CC   Population: Caucasian.
CC   Doubling time: 30 hours (PubMed=9256160).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG76 ! SW1573/2R80
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/2R250
AC   CVCL_WG77
SY   SW-1573/2R250; 2R250
DR   cancercelllines; CVCL_WG77
DR   Wikidata; Q98132921
RX   CelloPub=CLPUB00485;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG71 ! SW1573/2R160
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/2R50
AC   CVCL_WG75
SY   SW-1573/2R50; 2R50
DR   cancercelllines; CVCL_WG75
DR   Wikidata; Q98132922
RX   CelloPub=CLPUB00485;
RX   PubMed=1348862;
RX   PubMed=1353703;
RX   PubMed=1974823;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/2R80
AC   CVCL_WG76
SY   SW-1573/2R80; 2R80
DR   cancercelllines; CVCL_WG76
DR   Wikidata; Q98132924
RX   CelloPub=CLPUB00485;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WG75 ! SW1573/2R50
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/3R80
AC   CVCL_WG72
SY   SW-1573/3R80; 3R80
DR   cancercelllines; CVCL_WG72
DR   Wikidata; Q98132925
RX   PubMed=1348862;
RX   PubMed=1353703;
RX   PubMed=1974823;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 9
//
ID   SW1573/S1
AC   CVCL_A5BA
SY   SW-1573/S1; S1
DR   BTO; BTO_0006275
DR   cancercelllines; CVCL_A5BA
DR   Wikidata; Q107116980
RX   PubMed=1348862;
RX   PubMed=1353703;
RX   PubMed=7644478;
RX   PubMed=7809167;
RX   PubMed=12093475;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1720 ! SW1573
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   SW1573/S1(MDR1)
AC   CVCL_A5BB
SY   S1(MDR1); S1(1.1); S1 1.1
DR   cancercelllines; CVCL_A5BB
DR   Wikidata; Q107116982
RX   PubMed=1348862;
RX   PubMed=7644478;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:40; ABCB1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SW1573/S1(MRP)
AC   CVCL_A5BC
SY   S1(MRP)
DR   cancercelllines; CVCL_A5BC
DR   Wikidata; Q107116983
RX   PubMed=7644478;
RX   PubMed=7809167;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:51; ABCC1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   SW1573/S1neo
AC   CVCL_A5BD
SY   S1neo
DR   cancercelllines; CVCL_A5BD
DR   Wikidata; Q107116985
RX   PubMed=7809167;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   SW1573/S1ou
AC   CVCL_A5BE
SY   S1ou
DR   cancercelllines; CVCL_A5BE
DR   Wikidata; Q107116987
RX   PubMed=1348862;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Lys111Glu (c.331A>G); ClinVar=VCV000376482; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; c.362+1G>C; ClinVar=VCV000582116; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88105; Atp1a1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5BA ! SW1573/S1
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SW161
AC   CVCL_1E52
SY   SW-161; SW 161
DR   Wikidata; Q54971088
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C2923; Minimally invasive lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   SW1614
AC   CVCL_LK68
SY   SW-1614; SW 1614
DR   Wikidata; Q54971089
RX   PubMed=286328;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   SW1687
AC   CVCL_B0T2
SY   SW-1687; SW 1687
DR   Wikidata; Q108821342
RX   PubMed=286328;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SW1694
AC   CVCL_B0T3
SY   SW-1694; SW 1694
DR   Wikidata; Q108821343
RX   PubMed=286328;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SW1710
AC   CVCL_1721
SY   SW-1710; SW 1710
DR   CLO; CLO_0009213
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473594
DR   BioSample; SAMN10988432
DR   cancercelllines; CVCL_1721
DR   Cell_Model_Passport; SIDM00420
DR   ChEMBL-Cells; CHEMBL3308804
DR   ChEMBL-Targets; CHEMBL1075590
DR   Cosmic; 715750
DR   Cosmic; 760483
DR   Cosmic; 845572
DR   Cosmic; 909749
DR   Cosmic; 1016890
DR   Cosmic; 1046685
DR   Cosmic; 1285129
DR   Cosmic; 1285989
DR   Cosmic; 2037957
DR   Cosmic; 2050463
DR   Cosmic; 2057458
DR   Cosmic; 2444251
DR   Cosmic; 2686115
DR   Cosmic-CLP; 909749
DR   DepMap; ACH-000566
DR   DSMZ; ACC-426
DR   DSMZCellDive; ACC-426
DR   EGA; EGAS00001000978
DR   GDSC; 909749
DR   GEO; GSM136258
DR   GEO; GSM763023
DR   GEO; GSM827181
DR   GEO; GSM887670
DR   GEO; GSM888762
DR   GEO; GSM1374921
DR   GEO; GSM1574554
DR   GEO; GSM1670504
DR   IARC_TP53; 6606
DR   LiGeA; CCLE_831
DR   LINCS_LDP; LCL-1719
DR   PharmacoDB; SW1710_1534_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1721
DR   PubChem_Cell_line; CVCL_1721
DR   Wikidata; Q54971090
RX   PubMed=3518877;
RX   PubMed=6744315;
RX   PubMed=6935474;
RX   PubMed=11921286;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: ~25-32 hours (DSMZ=ACC-426).
CC   HLA typing: A*02:01,24:02; B*07:02,44:02; C*05:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=909749; DepMap=ACH-000566).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.06%; Native American=0%; East Asian, North=1.26%; East Asian, South=0%; South Asian=1.43%; European, North=65.29%; European, South=31.96% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=909749; DSMZ=ACC-426; PubMed=27270441; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 12,17
ST   D12S391: 20,22
ST   D13S317: 12
ST   D16S539: 8,11
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D1S1656: 15
ST   D21S11: 28,30
ST   D22S1045: 15,16
ST   D2S1338: 19,20
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 9,12
ST   FGA: 25
ST   Penta D: 9,11
ST   Penta E: 7,14
ST   TH01: 7,8,9.3 (DSMZ=ACC-426)
ST   TH01: 7,9.3 (PubMed=27270441; Technion Genomics Center)
ST   TH01: 7,10 (Cosmic-CLP=909749)
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SW1736
AC   CVCL_3883
SY   SW-1736; SW 1736
DR   BTO; BTO_0001611
DR   EFO; EFO_0022676
DR   cancercelllines; CVCL_3883
DR   ChEMBL-Cells; CHEMBL3307699
DR   ChEMBL-Targets; CHEMBL614773
DR   CLS; 300453
DR   Cosmic; 886549
DR   Cosmic; 1068627
DR   Cosmic; 1239961
DR   Cosmic; 1280048
DR   Cosmic; 1507375
DR   Cosmic; 1533551
DR   Cosmic; 1536128
DR   Cosmic; 1889006
DR   Cosmic; 2050366
DR   Cosmic; 2054081
DR   Cosmic; 2319853
DR   Cosmic; 2786689
DR   Cosmic; 2791084
DR   IARC_TP53; 27015
DR   IBRC; C10311
DR   PubChem_Cell_line; CVCL_3883
DR   Wikidata; Q29964497
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=14522906;
RX   PubMed=17465858;
RX   PubMed=18713817;
RX   PubMed=21868764;
RX   PubMed=23833040;
RX   PubMed=24825855;
RX   PubMed=25365311;
RX   PubMed=26958598;
RX   PubMed=30737244;
CC   From: Scott and White Clinic; Temple; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:12373; TSHR; Simple; p.Ile486Phe (c.1456A>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): CLS=300453; PubMed=17465858; PubMed=18713817; PubMed=21868764; PubMed=25365311; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 29,31 (CLS=300453; PubMed=18713817; PubMed=30737244)
ST   D21S11: 29,31.2 (PubMed=17465858)
ST   D3S1358: 16,17 (CLS=300453; PubMed=18713817; PubMed=30737244)
ST   D3S1358: 17,18 (PubMed=17465858)
ST   D5S818: 12,13
ST   D7S820: 8 (PubMed=17465858)
ST   D7S820: 8,11 (CLS=300453; PubMed=18713817; PubMed=21868764; PubMed=25365311; PubMed=30737244)
ST   D8S1179: 13 (CLS=300453)
ST   D8S1179: 13,14 (PubMed=17465858; PubMed=18713817; PubMed=30737244)
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 11,17
ST   TH01: 6 (CLS=300453; PubMed=21868764)
ST   TH01: 6,9.3 (PubMed=25365311; PubMed=30737244)
ST   TPOX: 11
ST   vWA: 16,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   SW1736 eGFP-H2B
AC   CVCL_IY89
DR   cancercelllines; CVCL_IY89
DR   Wikidata; Q54971091
RX   PubMed=26958598;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12373; TSHR; Simple; p.Ile486Phe (c.1456A>T); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=Human histone H2B (Note=But which of the H2B genes is not specified).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3883 ! SW1736
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 20
//
ID   SW1738
AC   CVCL_A683
SY   SW-1738; SW 1738
DR   Wikidata; Q54971094
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6744315;
RX   PubMed=29732388;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   SW1783
AC   CVCL_1722
SY   SW-1783; SW 1783
DR   CLO; CLO_0009191
DR   EFO; EFO_0002364
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-13
DR   BioSample; SAMN03472711
DR   BioSample; SAMN10987670
DR   cancercelllines; CVCL_1722
DR   Cell_Model_Passport; SIDM01164
DR   ChEMBL-Cells; CHEMBL3308369
DR   ChEMBL-Targets; CHEMBL1075591
DR   Cosmic; 687585
DR   Cosmic; 897443
DR   Cosmic; 909750
DR   Cosmic; 2367551
DR   Cosmic; 2516039
DR   Cosmic-CLP; 909750
DR   DepMap; ACH-000883
DR   EGA; EGAS00001000978
DR   GDSC; 909750
DR   GEO; GSM887671
DR   GEO; GSM888763
DR   GEO; GSM1374922
DR   GEO; GSM1670505
DR   IARC_TP53; 27251
DR   IGRhCellID; SW1783
DR   IZSLER; BS TCL 193
DR   LiGeA; CCLE_797
DR   LINCS_LDP; LCL-1399
DR   PharmacoDB; SW1783_1535_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1722
DR   PubChem_Cell_line; CVCL_1722
DR   Wikidata; Q54971095
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=286328;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=11414198;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 55 hours (PubMed=25984343).
CC   HLA typing: A*29:02,32:01; B*44:02,49:01; C*05:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Homozygous (ATCC=HTB-13; Cosmic-CLP=909750; DepMap=ACH-000883).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (ATCC=HTB-13; Cosmic-CLP=909750; DepMap=ACH-000883).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (ATCC=HTB-13; Cosmic-CLP=909750; DepMap=ACH-000883).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.24%; East Asian, North=1.93%; East Asian, South=1.02%; South Asian=0%; European, North=65.97%; European, South=30.84% (PubMed=30894373).
ST   Source(s): ATCC=HTB-13; Cosmic-CLP=909750
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 9,11
ST   D16S539: 12
ST   D18S51: 10,12,13
ST   D19S433: 15
ST   D21S11: 29,31
ST   D2S1338: 21,25
ST   D3S1358: 14,15
ST   D5S818: 12 (Cosmic-CLP=909750)
ST   D5S818: 12,13 (ATCC=HTB-13)
ST   D7S820: 9,13
ST   D8S1179: 10,11
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 7,16
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SW193
AC   CVCL_UE97
SY   SW-193; SW 193
DR   Wikidata; Q98132928
RX   DOI=10.1007/978-1-4757-1647-4_2;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   SW1990
AC   CVCL_1723
SY   SW-1990; SW 1990
DR   BTO; BTO_0003491
DR   CLO; CLO_0009192
DR   CLO; CLO_0009194
DR   EFO; EFO_0002365
DR   CLDB; cl4438
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2172
DR   BioGRID_ORCS_Cell_line; 1029
DR   BioSample; SAMN03472179
DR   BioSample; SAMN10987630
DR   cancercelllines; CVCL_1723
DR   CCRID; 1101HUM-PUMC000472
DR   CCRID; 3101HUMTCHu201
DR   CCRID; 4201HUM-CCTCC00246
DR   CCTCC; GDC0246
DR   Cell_Model_Passport; SIDM01165
DR   CGH-DB; 184-1
DR   CGH-DB; 9275-4
DR   ChEMBL-Cells; CHEMBL3308789
DR   ChEMBL-Targets; CHEMBL1075592
DR   CLS; 305068
DR   Cosmic; 724871
DR   Cosmic; 910907
DR   Cosmic; 913312
DR   Cosmic; 1609543
DR   Cosmic; 2434093
DR   Cosmic-CLP; 910907
DR   DepMap; ACH-000155
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910907
DR   GEO; GSE79953
DR   GEO; GSM206550
DR   GEO; GSM621893
DR   GEO; GSM784708
DR   GEO; GSM887672
DR   GEO; GSM888764
DR   GEO; GSM1024415
DR   GEO; GSM1670506
DR   IARC_TP53; 27582
DR   IGRhCellID; SW1990
DR   KCB; KCB 2012113YJ
DR   LiGeA; CCLE_709
DR   LINCS_LDP; LCL-1750
DR   MetaboLights; MTBLS9288
DR   PharmacoDB; SW1990_1536_2019
DR   PRIDE; PXD003198
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1723
DR   PubChem_Cell_line; CVCL_1723
DR   TOKU-E; 3217
DR   Ubigene; YC-C124
DR   Wikidata; Q54971096
RX   PubMed=6871872;
RX   PubMed=12068308;
RX   PubMed=15126341;
RX   PubMed=15688027;
RX   PubMed=17217822;
RX   PubMed=18380791;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21054984;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27067801;
RX   PubMed=27259358;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31452783;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; BRICS; BRICS0124; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3927
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 72 hours (PubMed=25984343); 35.8 +- 4.4 hours (PubMed=27067801).
CC   HLA typing: A*26:01,26:01; B*27:05,38:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (Cosmic-CLP=910907; DepMap=ACH-000155).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=910907; DepMap=ACH-000155).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (Cosmic-CLP=910907; DepMap=ACH-000155).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.49%; Native American=0.78%; East Asian, North=2.9%; East Asian, South=0%; South Asian=0%; European, North=60.78%; European, South=35.04% (PubMed=30894373).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
ST   Source(s): ATCC=CRL-2172; CCRID; Cosmic-CLP=910907; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 31
ST   D2S1338: 23
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 26
ST   Penta D: 11
ST   Penta E: 5,7
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 44
//
ID   SW1990-GZ
AC   CVCL_ZW95
SY   SW1990/gemcitabine; SW1990-gemcitabine
DR   cancercelllines; CVCL_ZW95
DR   Wikidata; Q102114953
RX   PubMed=31452783;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   SW1990/ADM
AC   CVCL_ZW96
DR   cancercelllines; CVCL_ZW96
DR   Wikidata; Q102114954
RX   PubMed=17217822;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   SW1990/FU
AC   CVCL_ZW97
DR   cancercelllines; CVCL_ZW97
DR   Wikidata; Q102114955
RX   PubMed=17217822;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   SW1990/GEM
AC   CVCL_ZW98
DR   cancercelllines; CVCL_ZW98
DR   Wikidata; Q102114956
RX   PubMed=17217822;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   SW1990/GZ
AC   CVCL_WS12
DR   cancercelllines; CVCL_WS12
DR   Wikidata; Q98132932
RX   PubMed=21054984;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   SW1990/GFP (Bsd)
AC   CVCL_E8T0
SY   SW1990 / GFP (Bsd)
WW   Provider; GenTarget; SC074-GB; https://www.gentarget.com/product/human-sw1990-gfp-bsd-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-eGFP-Rsv-Bsd construct (GenTarget=SC074-GB).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SW1990/GFP (Puro)
AC   CVCL_E8T1
SY   SW1990 / GFP (Puro)
WW   Provider; GenTarget; SC074-GP; https://www.gentarget.com/product/human-sw1990-gfp-puro-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-eGFP-Rsv-PuroR construct (GenTarget=SC074-GP).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SW1990/Luciferase
AC   CVCL_E8T2
SY   SW1990 / Luciferase
WW   Provider; GenTarget; SC074-Luc; https://www.gentarget.com/product/human-sw1990-luciferase-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-Rsv-PuroR construct (GenTarget=SC074-Luc).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SW1990/Luciferase-2A-GFP
AC   CVCL_E8T3
SY   SW1990 / Luciferase & GFP
WW   Provider; GenTarget; SC074-LG; https://www.gentarget.com/product/human-sw1990-luciferase-gfp-stable-cells/
CC   Population: Caucasian.
CC   Characteristics: Transduced by lentivirus with a EF1a-Luc-2A-eGFP-Rsv-PuroR construct (GenTarget=SC074-LG).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.Gln533Ter (c.1597C>T); ClinVar=VCV000096480; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro191del (c.569_571CTC[1]) (c.572_574delCTC); ClinVar=VCV000458551; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell of pancreas; CL=CL_0000083.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1723 ! SW1990
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SW2
AC   CVCL_R777
SY   SW-2
DR   BTO; BTO_0005501
DR   CLS; 300396
DR   Wikidata; Q54971097
RX   PubMed=2155434;
CC   Discontinued: CLS; 300396; true.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   SW210.5
AC   CVCL_S185
DR   Wikidata; Q54971098
RX   PubMed=11414198;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   SW213
AC   CVCL_1E93
SY   SW-213; SW 213
DR   Wikidata; Q54971099
RX   DOI=10.1007/978-1-4757-1647-4_2;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW267
AC   CVCL_1E53
SY   SW-267; SW 267
DR   Wikidata; Q54971100
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C5328; Extra-adrenal retroperitoneal paraganglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW3#B
AC   CVCL_B5RC
SY   SW3 #B; ND1 LV#b
DR   Wikidata; Q112041744
RX   PubMed=22308265;
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   SW4#N1
AC   CVCL_B5RD
SY   SW4 #N1; ND2 LV#NI
DR   Wikidata; Q112041745
RX   PubMed=22308265;
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RE ! SW4#SE
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   SW4#SE
AC   CVCL_B5RE
SY   SW4 #SE
DR   Wikidata; Q112041746
RX   PubMed=22308265;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RD ! SW4#N1
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SW403
AC   CVCL_0545
SY   SW-403; SW 403
DR   BTO; BTO_0000033
DR   CLO; CLO_0009193
DR   CLO; CLO_0009214
DR   CLO; CLO_0009215
DR   EFO; EFO_0002366
DR   MCCL; MCC:0000446
DR   CLDB; cl4432
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-230
DR   BCRC; 60258
DR   BioGRID_ORCS_Cell_line; 364
DR   BioSample; SAMN01821601
DR   BioSample; SAMN01821667
DR   BioSample; SAMN03473184
DR   BioSample; SAMN10988328
DR   cancercelllines; CVCL_0545
DR   Cell_Model_Passport; SIDM00836
DR   CLS; 300350
DR   ColonAtlas; SW403
DR   Cosmic; 724848
DR   Cosmic; 738937
DR   Cosmic; 876718
DR   Cosmic; 910908
DR   Cosmic; 934566
DR   Cosmic; 948128
DR   Cosmic; 948831
DR   Cosmic; 983731
DR   Cosmic; 986019
DR   Cosmic; 995394
DR   Cosmic; 1071893
DR   Cosmic; 1176594
DR   Cosmic; 1184097
DR   Cosmic; 1187322
DR   Cosmic; 1310938
DR   Cosmic; 1312315
DR   Cosmic; 1479587
DR   Cosmic; 1609502
DR   Cosmic; 1676749
DR   Cosmic; 1708408
DR   Cosmic; 1805267
DR   Cosmic; 2302016
DR   Cosmic; 2647530
DR   Cosmic; 2668258
DR   Cosmic; 2760091
DR   Cosmic; 2800583
DR   Cosmic; 2811048
DR   Cosmic-CLP; 910908
DR   DepMap; ACH-000820
DR   DSMZ; ACC-294
DR   DSMZCellDive; ACC-294
DR   ECACC; 87071008
DR   EGA; EGAS00001000610
DR   GDSC; 910908
DR   GEO; GSM206551
DR   GEO; GSM274724
DR   GEO; GSM513923
DR   GEO; GSM514310
DR   GEO; GSM741263
DR   GEO; GSM887673
DR   GEO; GSM888765
DR   GEO; GSM1006231
DR   GEO; GSM1006232
DR   GEO; GSM1006233
DR   GEO; GSM1346889
DR   GEO; GSM1374923
DR   GEO; GSM1374924
DR   GEO; GSM1448194
DR   GEO; GSM2550014
DR   IARC_TP53; 21752
DR   IGRhCellID; SW403
DR   KCLB; 10230
DR   LiGeA; CCLE_932
DR   LINCS_LDP; LCL-1195
DR   PharmacoDB; SW403_1537_2019
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Progenetix; CVCL_0545
DR   Wikidata; Q54971109
RX   PubMed=286328;
RX   PubMed=327080;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6582512;
RX   PubMed=7104989;
RX   PubMed=7972006;
RX   PubMed=8464898;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26589293;
RX   PubMed=28179481;
RX   PubMed=28683746;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-ccl-230-morphology-and-growth
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/SW403.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 79 hours (Note=At 31th passage) (PubMed=1000501); 38.19 hours (PubMed=25944804); ~40-50 hours (DSMZ=ACC-294).
CC   HLA typing: A*02,03 (PubMed=8464898).
CC   HLA typing: A*02:05,03:01; B*07:02,49:01; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Asn125Lys (c.375T>G); Zygosity=Heterozygous (PubMed=24755471; PubMed=28179481; Cosmic-CLP=910908; DepMap=ACH-000820).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1198Glnfs*67 (c.3591delC); Zygosity=Heterozygous (PubMed=24755471; PubMed=28179481; Cosmic-CLP=910908; DepMap=ACH-000820).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1278Ter (c.3833C>A); Zygosity=Heterozygous (PubMed=24755471; PubMed=28179481; Cosmic-CLP=910908; DepMap=ACH-000820).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746; Cosmic-CLP=910908; DepMap=ACH-000820).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Lys (c.1636C>A); ClinVar=VCV000013657; Zygosity=Heterozygous (PubMed=24755471; Cosmic-CLP=910908; DepMap=ACH-000820).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu51Ter (c.151G>T); ClinVar=VCV000568781; Zygosity=Homozygous (PubMed=16418264; PubMed=28683746; Cosmic-CLP=910908; DepMap=ACH-000820).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.6%; Native American=0.4%; East Asian, North=0.5%; East Asian, South=0%; South Asian=3.26%; European, North=62.34%; European, South=32.9% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-230; CLS=300350; DSMZ=ACC-294; ECACC=87071008; KCLB=10230; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 10,12
ST   D18S51: 17
ST   D19S433: 16,18.2 (ATCC=CCL-230)
ST   D19S433: 17 (DSMZ=ACC-294)
ST   D21S11: 28,29
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 11 (CLS=300350)
ST   D8S1179: 11,14 (ATCC=CCL-230; PubMed=25877200)
ST   D8S1179: 12 (DSMZ=ACC-294)
ST   FGA: 19
ST   Penta D: 9
ST   Penta E: 5
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   SW409
AC   CVCL_1E94
SY   SW-409; SW 409
DR   Wikidata; Q54971110
RX   DOI=10.1007/978-1-4757-1647-4_2;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   SW419
AC   CVCL_1E95
SY   SW-419; SW 419
DR   Wikidata; Q54971111
RX   DOI=10.1007/978-1-4757-1647-4_2;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   SW451
AC   CVCL_1E55
SY   SW-451; SW 451
DR   Wikidata; Q54971112
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   SW47
AC   CVCL_1E54
SY   SW-47; SW 47
DR   Wikidata; Q54971113
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6935474;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   SW48
AC   CVCL_1724
SY   SW-48; SW 48
DR   BTO; BTO_0001535
DR   CLO; CLO_0009216
DR   EFO; EFO_0002367
DR   CLDB; cl4971
DR   AddexBio; C0009014/373
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-231
DR   BCRC; 60311
DR   BioGRID_ORCS_Cell_line; 362
DR   BioSample; SAMN03470827
DR   BioSample; SAMN03471477
DR   BioSample; SAMN10988325
DR   cancercelllines; CVCL_1724
DR   Cell_Model_Passport; SIDM00837
DR   ChEMBL-Cells; CHEMBL3307292
DR   ChEMBL-Targets; CHEMBL614055
DR   CLS; 305235
DR   ColonAtlas; SW48
DR   Cosmic; 687544
DR   Cosmic; 711258
DR   Cosmic; 870450
DR   Cosmic; 873705
DR   Cosmic; 876645
DR   Cosmic; 876707
DR   Cosmic; 887225
DR   Cosmic; 889527
DR   Cosmic; 909751
DR   Cosmic; 948122
DR   Cosmic; 948855
DR   Cosmic; 986000
DR   Cosmic; 995399
DR   Cosmic; 1043828
DR   Cosmic; 1057753
DR   Cosmic; 1122330
DR   Cosmic; 1132563
DR   Cosmic; 1132688
DR   Cosmic; 1175846
DR   Cosmic; 1184089
DR   Cosmic; 1184332
DR   Cosmic; 1374624
DR   Cosmic; 1466821
DR   Cosmic; 1479633
DR   Cosmic; 1552177
DR   Cosmic; 1571771
DR   Cosmic; 1609488
DR   Cosmic; 1676725
DR   Cosmic; 1708409
DR   Cosmic; 1805268
DR   Cosmic; 1995653
DR   Cosmic; 2036657
DR   Cosmic; 2052594
DR   Cosmic; 2302017
DR   Cosmic; 2389571
DR   Cosmic; 2667883
DR   Cosmic; 2667978
DR   Cosmic; 2668254
DR   Cosmic; 2727480
DR   Cosmic; 2760064
DR   Cosmic; 2787543
DR   Cosmic; 2820498
DR   Cosmic-CLP; 909751
DR   DepMap; ACH-000958
DR   ECACC; 89012702
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909751
DR   GEO; GSM513924
DR   GEO; GSM514311
DR   GEO; GSM741252
DR   GEO; GSM827355
DR   GEO; GSM844713
DR   GEO; GSM887675
DR   GEO; GSM888767
DR   GEO; GSM1346890
DR   GEO; GSM1374925
DR   GEO; GSM1374926
DR   GEO; GSM1374927
DR   GEO; GSM1448165
DR   GEO; GSM1670507
DR   GEO; GSM2550015
DR   IARC_TP53; 4556
DR   IARC_TP53; 21768
DR   ICLC; HTL99020
DR   IGRhCellID; SW48
DR   LiGeA; CCLE_034
DR   LINCS_LDP; LCL-1186
DR   Lonza; 86
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C480
DR   PharmacoDB; SW48_1538_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1724
DR   PubChem_Cell_line; CVCL_1724
DR   SKY/M-FISH/CGH; 2838
DR   Ubigene; YC-C126
DR   Wikidata; Q54971115
RX   CelloPub=CLPUB00337;
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=327080;
RX   PubMed=793708;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6652615;
RX   PubMed=7104989;
RX   PubMed=7459858;
RX   PubMed=7651727;
RX   PubMed=8197130;
RX   PubMed=8422623;
RX   PubMed=8464898;
RX   PubMed=9000572;
RX   PubMed=9294210;
RX   PubMed=9515795;
RX   PubMed=10612807;
RX   PubMed=10737795;
RX   PubMed=11314036;
RX   PubMed=11526487;
RX   PubMed=12615714;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 70 hours (Note=At 63th passage) (PubMed=1000501); 42.33 hours (PubMed=25944804); 33 hours (PubMed=25984343).
CC   HLA typing: A*24:02,24:02; B*44:02,44:02; C*05:01,07:06 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=9000572; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (PubMed=8197130).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (PubMed=8197130).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (PubMed=9294210; PubMed=24755471; ATCC=CCL-231).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16418264).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.09%; Native American=0%; East Asian, North=0%; East Asian, South=1.44%; South Asian=0%; European, North=69.25%; European, South=29.21% (PubMed=30894373).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009014/373; ATCC=CCL-231; Cosmic-CLP=909751; ECACC=89012702; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 19,26,27
ST   D3S1358: 13,14,15
ST   D5S818: 10,14
ST   D7S820: 9,10
ST   D8S1179: 13,14 (ATCC=CCL-231)
ST   D8S1179: 13,14,15 (PubMed=25877200)
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 12,13 (PubMed=25877200)
ST   Penta E: 12,13,14 (ATCC=CCL-231)
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 18,19,20,21 (ATCC=CCL-231)
ST   vWA: 18,20 (Cosmic-CLP=909751; ECACC=89012702; PubMed=25877200; PubMed=25926053)
ST   vWA: 18,20,21 (AddexBio=C0009014/373)
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   SW48 BRAF (V600E/+/+/+)
AC   CVCL_LD77
SY   BRAF (V600E/+/+/+) SW48
DR   cancercelllines; CVCL_LD77
DR   Horizon_Discovery; HD+103-003
DR   Wikidata; Q54971116
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a BRAF activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple_edited; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-003).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   SW48 EGFR (I491M/+/+)
AC   CVCL_LD11
SY   EGFR (I491M/+/+) SW48
DR   cancercelllines; CVCL_LD11
DR   Horizon_Discovery; HD+103-042
DR   Wikidata; Q54971117
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a EGFR mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Ile491Met (c.1473A>G); ClinVar=VCV001404733; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-042).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 16
//
ID   SW48 EGFR (L65V/+/+)
AC   CVCL_LD12
SY   EGFR (L65V/+/+) SW48
DR   cancercelllines; CVCL_LD12
DR   Horizon_Discovery; HD+103-046
DR   Wikidata; Q54971118
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a EGFR mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu65Val (c.193T>G); Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-046).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 EGFR (L858R/+/+)
AC   CVCL_LD13
SY   EGFR (L858R/+/+) SW48
DR   cancercelllines; CVCL_LD13
DR   Horizon_Discovery; HD+103-045
DR   Wikidata; Q54971119
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a EGFR activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-045).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 EGFR (S492R/+/+)
AC   CVCL_LD14
SY   EGFR (S492R/+/+) SW48
DR   cancercelllines; CVCL_LD14
DR   Horizon_Discovery; HD+103-044
DR   Wikidata; Q54971121
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a EGFR mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple_edited; p.Ser492Arg (c.1476C>A); ClinVar=VCV000376341; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-044).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 GNAS (R201C/+)
AC   CVCL_LD78
SY   GNAS (R201C/+) SW48
DR   cancercelllines; CVCL_LD78
DR   Horizon_Discovery; HD+103-040
DR   Wikidata; Q54971122
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a GNAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple_edited; p.Arg201Cys (c.601C>T); ClinVar=VCV000015933; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-040).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 HRAS (G12V/+)
AC   CVCL_LC87
SY   HRAS (G12V/+) SW48
DR   cancercelllines; CVCL_LC87
DR   Horizon_Discovery; HD+103-034
DR   Wikidata; Q54971123
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a HRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-034).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 JAK2 (V617F/+)
AC   CVCL_LD79
SY   JAK2 (V617F/+) SW48
DR   cancercelllines; CVCL_LD79
DR   Horizon_Discovery; HD+103-027
DR   Wikidata; Q54971124
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a JAK2 activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_edited; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-027).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   SW48 KRAS (A146T/+)
AC   CVCL_LC88
SY   KRAS (A146T/+) SW48
DR   cancercelllines; CVCL_LC88
DR   Horizon_Discovery; HD+103-036
DR   Wikidata; Q54971125
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-036).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (A59T/+)
AC   CVCL_LC89
SY   KRAS (A59T/+) SW48
DR   cancercelllines; CVCL_LC89
DR   Horizon_Discovery; HD+103-067
DR   Wikidata; Q54971126
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Ala59Thr (c.175G>A); ClinVar=VCV000012581; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-067).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G12A/+)
AC   CVCL_LC90
SY   KRAS (G12A/+) SW48
DR   cancercelllines; CVCL_LC90
DR   Horizon_Discovery; HD+103-009
DR   Wikidata; Q54971127
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-009).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G12C/+)
AC   CVCL_LC91
SY   KRAS (G12C/+) SW48
DR   cancercelllines; CVCL_LC91
DR   Horizon_Discovery; HD+103-006
DR   Wikidata; Q54971128
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-006).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G12D/+)
AC   CVCL_LC92
SY   KRAS (G12D/+) SW48
DR   cancercelllines; CVCL_LC92
DR   Horizon_Discovery; HD+103-011
DR   Wikidata; Q54971129
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-011).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G12R/+)
AC   CVCL_LC94
SY   KRAS (G12R/+) SW48
DR   cancercelllines; CVCL_LC94
DR   Horizon_Discovery; HD+103-010
DR   Wikidata; Q54971130
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-010).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G12S/+)
AC   CVCL_LC93
SY   KRAS (G12S/+) SW48
DR   cancercelllines; CVCL_LC93
DR   Horizon_Discovery; HD+103-013
DR   Wikidata; Q54971132
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-013).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G12V/+)
AC   CVCL_LC95
SY   KRAS (G12V/+) SW48
DR   cancercelllines; CVCL_LC95
DR   Horizon_Discovery; HD+103-007
DR   Wikidata; Q54971134
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-007).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (G13D/+)
AC   CVCL_LC96
SY   KRAS (G13D/+) SW48
DR   cancercelllines; CVCL_LC96
DR   Horizon_Discovery; HD+103-002
DR   Wikidata; Q54971135
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-002).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 KRAS (Q61H/+)
AC   CVCL_LC97
SY   KRAS (Q61H/+) SW48
DR   cancercelllines; CVCL_LC97
DR   Horizon_Discovery; HD+103-053
DR   Wikidata; Q54971136
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a KRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-053).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (A59T/+)
AC   CVCL_LC98
SY   NRAS (A59T/+) SW48
DR   cancercelllines; CVCL_LC98
DR   Horizon_Discovery; HD+103-060
DR   Wikidata; Q54971137
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Ala59Thr (c.175G>A); ClinVar=VCV000040473; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-060).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (G12D/+)
AC   CVCL_LD00
SY   NRAS (G12D/+) SW48
DR   cancercelllines; CVCL_LD00
DR   Horizon_Discovery; HD+103-062
DR   Wikidata; Q54971139
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-062).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (G12V/+)
AC   CVCL_A2PP
SY   NRAS (G12V/+) SW48
DR   cancercelllines; CVCL_A2PP
DR   Horizon_Discovery; HD+103-039
DR   Wikidata; Q105511133
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000040470; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-039).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   SW48 NRAS (K117N/+)
AC   CVCL_LC99
SY   NRAS (K117N/+) SW48
DR   cancercelllines; CVCL_LC99
DR   Horizon_Discovery; HD+103-061
DR   Wikidata; Q54971138
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Lys117Asn (c.351G>T); Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-061).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (Q61H/+)
AC   CVCL_LD01
SY   NRAS (Q61H/+) SW48
DR   cancercelllines; CVCL_LD01
DR   Horizon_Discovery; HD+103-035
DR   Wikidata; Q54971140
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-035).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (Q61K/+)
AC   CVCL_LD03
SY   NRAS (Q61K/+) SW48
DR   cancercelllines; CVCL_LD03
DR   Horizon_Discovery; HD+103-017
DR   Wikidata; Q54971143
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-017).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (Q61L/+)
AC   CVCL_LD02
SY   NRAS (Q61L/+) SW48
DR   cancercelllines; CVCL_LD02
DR   Horizon_Discovery; HD+103-038
DR   Wikidata; Q54971142
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-038).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 NRAS (Q61R/+)
AC   CVCL_LD04
SY   NRAS (Q61R/+) SW48
DR   cancercelllines; CVCL_LD04
DR   Horizon_Discovery; HD+103-022
DR   Wikidata; Q54971144
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a NRAS activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple_edited; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-022).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 PIK3CA (E542K/+)
AC   CVCL_LD80
SY   PIK3CA (E542K/+) SW48
DR   cancercelllines; CVCL_LD80
DR   Horizon_Discovery; HD+103-016
DR   Wikidata; Q54971146
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a PIK3CA helix domain activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-016).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   SW48 PIK3CA (E545K/+)
AC   CVCL_LD81
SY   PIK3CA (E545K/+) SW48
DR   cancercelllines; CVCL_LD81
DR   Horizon_Discovery; HD+103-001
DR   Wikidata; Q54971147
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a PIK3CA helix domain activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-001).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   SW48 PIK3CA (H1047R/+)
AC   CVCL_LD56
SY   PIK3CA (H1047R/+) SW48
DR   cancercelllines; CVCL_LD56
DR   Horizon_Discovery; HD+103-005
DR   Wikidata; Q54971149
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a PIK3CA kinase domain activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-005).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 15
//
ID   SW48 RAC1 (Q61L/+/+)
AC   CVCL_LD82
SY   RAC1 (Q61L/+/+) SW48
DR   cancercelllines; CVCL_LD82
DR   Horizon_Discovery; HD+103-014
DR   Wikidata; Q54971150
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a RAC1 mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple_edited; p.Gln61Leu (c.182A>T); Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-014).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   SW48 TP53 (R273H/+)
AC   CVCL_LD83
SY   TP53 (R273H/+) SW48
DR   cancercelllines; CVCL_LD83
DR   Horizon_Discovery; HD+103-008
DR   Wikidata; Q54971152
CC   Population: Caucasian.
CC   Characteristics: Heterozygous knockin of a TP53 mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple_edited; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+103-008).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   SW48 TP53(+/-)
AC   CVCL_HE26
SY   TP53 (+/-) SW48
DR   cancercelllines; CVCL_HE26
DR   Horizon_Discovery; HD+R06-001
DR   Wikidata; Q54971153
RX   PubMed=19225112;
CC   Population: Caucasian.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:11998; TP53 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   SW48 TP53(-/-)
AC   CVCL_HE27
SY   TP53 (-/-) SW48
DR   cancercelllines; CVCL_HE27
DR   Horizon_Discovery; HD+103-004
DR   Wikidata; Q54971154
RX   PubMed=19225112;
CC   Population: Caucasian.
CC   Knockout cell: Method=Recombinant Adeno-Associated Virus; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2714Cys (c.8140C>T); ClinVar=VCV000231255; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Ser14fs*29 (c.41_44delCTCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Glu67fs (c.200delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Tyr (c.98C>A); ClinVar=VCV000017577; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1724 ! SW48
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   SW480
AC   CVCL_0546
SY   SW-480; SW 480; SW480E
DR   BTO; BTO_0000038
DR   BTO; BTO_0006552
DR   CLO; CLO_0009195
DR   CLO; CLO_0009217
DR   CLO; CLO_0009218
DR   EFO; EFO_0002083
DR   MCCL; MCC:0000447
DR   CLDB; cl4440
DR   CLDB; cl4441
DR   CLDB; cl4966
DR   Abcam; ab271146
DR   AddexBio; C0009001/43
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CCL-228
DR   BCRC; 60249
DR   BCRJ; 0411
DR   BioSample; SAMN01821602
DR   BioSample; SAMN03481110
DR   BioSample; SAMN05292431
DR   BioSample; SAMN07709984
DR   BioSample; SAMN07709985
DR   BioSample; SAMN07709986
DR   BioSample; SAMN07709987
DR   BioSample; SAMN07709988
DR   BioSample; SAMN07709989
DR   BioSample; SAMN07709990
DR   BioSample; SAMN10987646
DR   cancercelllines; CVCL_0546
DR   CCRID; 1101HUM-PUMC000166
DR   CCRID; 3101HUMSCSP5033
DR   CCRID; 3101HUMTCHu172
DR   CCRID; 4201HUM-CCTCC00306
DR   CCTCC; GDC0065
DR   CCTCC; GDC0306
DR   Cell_Model_Passport; SIDM00840
DR   ChEMBL-Cells; CHEMBL3307758
DR   ChEMBL-Targets; CHEMBL612544
DR   CLS; 300302
DR   ColonAtlas; SW480
DR   Cosmic; 709847
DR   Cosmic; 711272
DR   Cosmic; 716169
DR   Cosmic; 720332
DR   Cosmic; 875293
DR   Cosmic; 876719
DR   Cosmic; 887240
DR   Cosmic; 889536
DR   Cosmic; 902791
DR   Cosmic; 905006
DR   Cosmic; 913892
DR   Cosmic; 948827
DR   Cosmic; 983732
DR   Cosmic; 985652
DR   Cosmic; 990302
DR   Cosmic; 995393
DR   Cosmic; 1043829
DR   Cosmic; 1057764
DR   Cosmic; 1066212
DR   Cosmic; 1071888
DR   Cosmic; 1122332
DR   Cosmic; 1132573
DR   Cosmic; 1132693
DR   Cosmic; 1154645
DR   Cosmic; 1176589
DR   Cosmic; 1184095
DR   Cosmic; 1184328
DR   Cosmic; 1187323
DR   Cosmic; 1223149
DR   Cosmic; 1310935
DR   Cosmic; 1332007
DR   Cosmic; 1374642
DR   Cosmic; 1466822
DR   Cosmic; 1479588
DR   Cosmic; 1482524
DR   Cosmic; 1486130
DR   Cosmic; 1524329
DR   Cosmic; 1552183
DR   Cosmic; 1571768
DR   Cosmic; 1609479
DR   Cosmic; 1676750
DR   Cosmic; 1708398
DR   Cosmic; 1803951
DR   Cosmic; 2036653
DR   Cosmic; 2145577
DR   Cosmic; 2156941
DR   Cosmic; 2267318
DR   Cosmic; 2301547
DR   Cosmic; 2302018
DR   Cosmic; 2433752
DR   Cosmic; 2646770
DR   Cosmic; 2651869
DR   Cosmic; 2664054
DR   Cosmic; 2668252
DR   Cosmic; 2727482
DR   Cosmic; 2760071
DR   Cosmic; 2787551
DR   Cosmic; 2800590
DR   Cosmic; 2823492
DR   DepMap; ACH-000842
DR   DSMZ; ACC-313
DR   DSMZCellDive; ACC-313
DR   ECACC; 87092801
DR   EGA; EGAS00001000610
DR   ENCODE; ENCBS211HGL
DR   ENCODE; ENCBS421AQW
DR   FCS-free; 180-2-342-3-16-3
DR   GEO; GSM206552
DR   GEO; GSM274771
DR   GEO; GSM274772
DR   GEO; GSM513930
DR   GEO; GSM514312
DR   GEO; GSM741258
DR   GEO; GSM784022
DR   GEO; GSM861349
DR   GEO; GSM861350
DR   GEO; GSM861351
DR   GEO; GSM861352
DR   GEO; GSM887674
DR   GEO; GSM888766
DR   GEO; GSM1006234
DR   GEO; GSM1006235
DR   GEO; GSM1346891
DR   GEO; GSM1374928
DR   GEO; GSM1374929
DR   GEO; GSM1374930
DR   GEO; GSM1448166
DR   GEO; GSM1670508
DR   GEO; GSM1862124
DR   GEO; GSM1862125
DR   GEO; GSM1862126
DR   GEO; GSM2299788
DR   GEO; GSM2550016
DR   GEO; GSM3258549
DR   GEO; GSM3399745
DR   GEO; GSM3399746
DR   GEO; GSM3591767
DR   IARC_TP53; 96
DR   IARC_TP53; 23572
DR   ICLC; HTL99017
DR   IGRhCellID; SW480
DR   KCB; KCB 200848YJ
DR   KCLB; 10228
DR   LiGeA; CCLE_461
DR   Lonza; 816
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C506
DR   PharmacoDB; SW480_1539_2019
DR   PRIDE; PXD000089
DR   PRIDE; PXD000230
DR   PRIDE; PXD001550
DR   PRIDE; PXD002793
DR   PRIDE; PXD003708
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD006662
DR   PRIDE; PXD019478
DR   PRIDE; PXD019479
DR   Progenetix; CVCL_0546
DR   PubChem_Cell_line; CVCL_0546
DR   RCB; RCB1959
DR   SKY/M-FISH/CGH; 2839
DR   SKY/M-FISH/CGH; 3982
DR   TKG; TKG 0505
DR   TOKU-E; 3233
DR   Ubigene; YC-C057
DR   Wikidata; Q28472974
RX   PubMed=286328;
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=1389533;
RX   PubMed=1458472;
RX   PubMed=1778766;
RX   PubMed=3349466;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=7104989;
RX   PubMed=7459858;
RX   PubMed=7651727;
RX   PubMed=7824277;
RX   PubMed=8422623;
RX   PubMed=8895552;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=9715273;
RX   PubMed=10612807;
RX   PubMed=10674020;
RX   PubMed=10737795;
RX   PubMed=10773689;
RX   PubMed=11113861;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11526487;
RX   PubMed=11668190;
RX   PubMed=16418264;
RX   PubMed=16854228;
RX   PubMed=19927377;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=20831567;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=24840470;
RX   PubMed=25485619;
RX   PubMed=25841592;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=25984343;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27987026;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=29101300;
RX   PubMed=29131639;
RX   PubMed=30894373;
RX   PubMed=31059103;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=32172478;
RX   PubMed=39246444;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-ccl-228-growth-and-morphology
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/SW480.html
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544587
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-54.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/sw480-xenograft-model/
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 50 hours (Note=At 73th passage) (PubMed=1000501); 28.2 hours (PubMed=1458472); 30.74 hours (PubMed=25944804); 24 hours (PubMed=25984343); 20-25 hours (CLS=300302); ~25-30 hours (DSMZ=ACC-313); ~38 hours (PBCF).
CC   HLA typing: A*02:01,24:02; B*07:02,15:18; C*07:04,07:04; DQA1*03:02,03:02; DQB1*05:01,06:11; DRB1*13:27,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (PubMed=24755471; DepMap=ACH-000842).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=20570890; PubMed=24755471; PubMed=28683746; DepMap=ACH-000842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=7651727; PubMed=9000147; PubMed=9715273; PubMed=16418264; PubMed=24755471; PubMed=28683746; DepMap=ACH-000842).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (PubMed=7651727; PubMed=9000147; PubMed=9715273; PubMed=16418264; PubMed=24755471; PubMed=28683746; DepMap=ACH-000842).
CC   Omics: Genomics; Chromosome conformation analysis; Hi-C.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Glycomics; O-glycan profiling.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Nucleus.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.55%; East Asian, North=1.14%; East Asian, South=0.1%; South Asian=0.15%; European, North=58.36%; European, South=39.69% (PubMed=30894373).
CC   Misspelling: WE-480; Note=Occasionally.
CC   Misspelling: WE480; Note=Occasionally.
CC   Misspelling: SW80; Note=Occasionally.
CC   Misspelling: SWH80; BTO=BTO_0006552.
CC   Discontinued: RCB; RCB1959; true.
CC   Discontinued: TKG; TKG 0505; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): AddexBio=C0009001/43; ATCC=CCL-228; CCRID; CLS=300302; DSMZ=ACC-313; ECACC=87092801; KCLB=10228; PubMed=11416159; PubMed=25877200; PubMed=25926053; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D10S1248: 13,14
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 13,14
ST   D21S11: 30,30.2
ST   D22S1045: 16
ST   D2S1338: 17,24
ST   D2S441: 10,15
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,15
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 51
//
ID   SW480 EGFP clone 1
AC   CVCL_E5FX
SY   SW480 GFP-alone 1; SW480/cntl 1
DR   CancerTools; 162203
RX   PubMed=18714339;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP clone 2
AC   CVCL_E5FY
SY   SW480 GFP-alone 2; SW480/cntl 2
DR   CancerTools; 162204
RX   PubMed=18714339;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-emerin clone 1
AC   CVCL_E5FZ
SY   SW480 GFP-emerin 1
DR   CancerTools; 162200
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3331; EMD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-emerin clone 2
AC   CVCL_E5G0
SY   SW480 GFP-emerin 2
DR   CancerTools; 162201
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3331; EMD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-emerin clone 3
AC   CVCL_E5G1
SY   SW480 GFP-emerin 3
DR   CancerTools; 162202
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3331; EMD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-lamin A clone 11
AC   CVCL_E5G2
SY   SW480 GFP-lamin A clone 11
DR   CancerTools; 162195
RX   PubMed=18714339;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6636; LMNA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-lamin A clone 12
AC   CVCL_E5G3
SY   SW480 GFP-lamin A clone 12
DR   CancerTools; 162198
RX   PubMed=18714339;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6636; LMNA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-lamin A clone 1A3
AC   CVCL_E5G4
SY   SW480 GFP-lamin A clone 1A3
DR   CancerTools; 162194
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6636; LMNA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-lamin A clone 1B4
AC   CVCL_E5G5
SY   SW480 GFP-lamin A clone 1B4
DR   CancerTools; 162197
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6636; LMNA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-lamin A clone 2bb3
AC   CVCL_E5G6
SY   SW480 GFP-lamin A clone 2bb3
DR   CancerTools; 162199
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6636; LMNA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 EGFP-lamin A clone 2c3
AC   CVCL_E5G7
SY   SW480 GFP-lamin A clone 2c3
DR   CancerTools; 162196
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6636; LMNA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   SW480 M13OE
AC   CVCL_C8D6
SY   SW480 MUC13 OverExpressing
DR   Wikidata; Q123033580
RX   PubMed=24097071;
CC   Population: Caucasian.
CC   Characteristics: Transfected with GFP-tagged MUC13 (PubMed=24097071).
CC   Doubling time: 29.4 hours (PubMed=24097071).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7511; MUC13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   SW480-EGFP
AC   CVCL_A9MF
DR   cancercelllines; CVCL_A9MF
DR   CCRID; 1101HUM-PUMC000833
DR   Ubigene; YC-C057-EGFP-P
DR   Wikidata; Q108821344
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000833
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   SW480-Luc
AC   CVCL_C8Y1
DR   Ubigene; YC-C057-Luc-P
DR   Wikidata; Q123033581
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   SW480-Luc2
AC   CVCL_A4BX
DR   ATCC; CCL-228-LUC2
DR   cancercelllines; CVCL_A4BX
DR   Wikidata; Q105511136
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CCL-228-LUC2).
CC   Doubling time: ~55 hours (ATCC=CCL-228-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-228-LUC2
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 11
//
ID   SW480-Luc2-tdT
AC   CVCL_A9MG
DR   cancercelllines; CVCL_A9MG
DR   CCRID; 1101HUM-PUMC000836
DR   Wikidata; Q108821345
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000836
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   SW480-mCherry
AC   CVCL_A9MH
DR   cancercelllines; CVCL_A9MH
DR   CCRID; 1101HUM-PUMC000834
DR   Wikidata; Q108821346
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000834
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   SW480-tdT
AC   CVCL_A9MI
DR   cancercelllines; CVCL_A9MI
DR   CCRID; 1101HUM-PUMC000835
DR   Wikidata; Q108821347
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): CCRID=1101HUM-PUMC000835
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   SW480/5FUR
AC   CVCL_AU16
DR   cancercelllines; CVCL_AU16
DR   Wikidata; Q54971156
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   SW480/BEVA
AC   CVCL_AU17
DR   cancercelllines; CVCL_AU17
DR   Wikidata; Q54971157
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: DrugBank; DB00112; Bevacizumab (Avastin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   SW480/CMV-Luc
AC   CVCL_4Y13
SY   SW-480/CMV-Luc
DR   cancercelllines; CVCL_4Y13
DR   JCRB; NIHS0738
DR   Wikidata; Q54971168
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter (JCRB=NIHS0738).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; NIHS0738; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   SW480/nkR
AC   CVCL_AT66
DR   cancercelllines; CVCL_AT66
DR   Wikidata; Q54971169
RX   Patent=US7989001;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   SW480/nkS
AC   CVCL_AT65
DR   cancercelllines; CVCL_AT65
DR   Wikidata; Q54971170
RX   Patent=US7989001;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 15
//
ID   SW480/OXR
AC   CVCL_AU18
DR   cancercelllines; CVCL_AU18
DR   Wikidata; Q54971171
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Characterized%20Cell%20Line%20Core%20Facility/CCLC%20Cell%20Line%20List%20to%20Distribute.pdf
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   SW480_6244R
AC   CVCL_C3GM
DR   cancercelllines; CVCL_C3GM
DR   GEO; GSM3591768
DR   Wikidata; Q114313074
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   SW480E
AC   CVCL_AT67
SY   SW480 E8; E8; SW480 Epithelial-type clone 8
DR   cancercelllines; CVCL_AT67
DR   KCLB; 60067
DR   Wikidata; Q54971172
RX   Patent=US7989001;
RX   PubMed=1458472;
CC   Population: Caucasian.
CC   Doubling time: 32.6 hours (PubMed=1458472).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=1458472).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): KCLB=60067
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 17
//
ID   SW480R
AC   CVCL_AT68
SY   SW480 R2; R2; SW480 Round-type clone 2
DR   cancercelllines; CVCL_AT68
DR   Wikidata; Q54971174
RX   Patent=US7989001;
RX   PubMed=1458472;
CC   Population: Caucasian.
CC   Doubling time: 15.6 hours (PubMed=1458472).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=1458472).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 16
//
ID   SW489
AC   CVCL_1E89
SY   SW-489; SW 489
DR   Wikidata; Q54971176
RX   DOI=10.1007/BF00199208;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 26 hours (Note=At 10th passage) (PubMed=994214).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 9
//
ID   SW527
AC   CVCL_3799
SY   SW-527; SW 527
DR   CLO; CLO_0009219
DR   EFO; EFO_0005462
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CRL-7940
DR   BioSample; SAMN03151930
DR   BioSample; SAMN03481115
DR   cancercelllines; CVCL_3799
DR   Cosmic; 1047713
DR   DepMap; ACH-001825
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   LINCS_HMS; 50046
DR   LINCS_LDP; LCL-1474
DR   PharmacoDB; SW527_1526_2019
DR   PRIDE; PXD008222
DR   Wikidata; Q54971177
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=20143388;
RX   PubMed=22585861;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25892236;
RX   PubMed=26589293;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 70 year old female patient with a metastatic breast carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00089.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*07:02,15:18; C*07:04,07:04; DQA1*01:02,01:02; DQB1*05:01,05:01; DRB1*01:03,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-7940; DepMap=ACH-001825; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,15
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   SW534
AC   CVCL_1E56
SY   SW-534; SW 534
DR   Wikidata; Q54971178
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW579
AC   CVCL_3603
SY   SW-579; SW 579
DR   CLO; CLO_0009220
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; HTB-107
DR   BCRC; 60412
DR   BioSample; SAMN10988339
DR   cancercelllines; CVCL_3603
DR   CCRID; 1101HUM-PUMC000264
DR   CCRID; 3101HUMTCHu125
DR   Cell_Model_Passport; SIDM01167
DR   CLS; 300346
DR   Cosmic; 1005454
DR   Cosmic; 1006467
DR   Cosmic; 1017791
DR   Cosmic; 1041672
DR   Cosmic; 1094773
DR   Cosmic; 1339924
DR   DepMap; ACH-000163
DR   GEO; GSM887676
DR   GEO; GSM888768
DR   GEO; GSM1374931
DR   GEO; GSM1374932
DR   IARC_TP53; 1308
DR   IGRhCellID; SW579
DR   IZSLER; BS TCL 121
DR   KCB; KCB 2013004YJ
DR   LiGeA; CCLE_771
DR   PharmacoDB; SW579_1540_2019
DR   Progenetix; CVCL_3603
DR   Wikidata; Q54971179
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1516062;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=29066502;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31443247;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:43,51:01; C*15:02,15:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Ser (c.764T>G); ClinVar=VCV000376622; Zygosity=Homozygous (PubMed=1516062; DepMap=ACH-000163).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.11%; Native American=1.95%; East Asian, North=0.43%; East Asian, South=0%; South Asian=0.91%; European, North=63.94%; European, South=32.66% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): ATCC=HTB-107; CCRID; CLS=300346; IZSLER=BS TCL 121
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 15,17,18
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,18
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 21,24
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C46008; Thyroid gland squamous cell carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SW594
AC   CVCL_1E57
SY   SW-594; SW 594
DR   Wikidata; Q54971180
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   SW598
AC   CVCL_F649
SY   SW-598; SW 598
DR   ATCC; CRL-2176
DR   BioSample; SAMN03151931
DR   cancercelllines; CVCL_F649
DR   Wikidata; Q54971181
RX   PubMed=288927;
RX   PubMed=833871;
RX   PubMed=20143388;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/sw-598-sw-598-sw598-atcc-crl-2176
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 63 year old female patient with a meningioma.
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00090.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2176; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CRL-2176
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 13
ST   D7S820: 8
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 30
//
ID   SW608
AC   CVCL_F653
SY   SW-608; SW 608
DR   BioSample; SAMN03151932
DR   cancercelllines; CVCL_F653
DR   Wikidata; Q54971182
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 55 year old female patient with a fibrillary astrocytoma.
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00091.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 29
//
ID   SW613
AC   CVCL_F650
SY   SW-613; SW 613
DR   ATCC; CRL-2146
DR   BioSample; SAMN03151933
DR   cancercelllines; CVCL_F650
DR   ChEMBL-Cells; CHEMBL3307463
DR   ChEMBL-Targets; CHEMBL614945
DR   PubChem_Cell_line; CVCL_F650
DR   Wikidata; Q54971183
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 86 year old female patient with a breast adenocarcinoma.
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00092.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-2146; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 30
//
ID   SW620
AC   CVCL_0547
SY   SW-620; SW_620; SW 620; SW.620
DR   BTO; BTO_0000675
DR   CLO; CLO_0009196
DR   CLO; CLO_0009221
DR   EFO; EFO_0002368
DR   MCCL; MCC:0000448
DR   CLDB; cl4443
DR   CLDB; cl4444
DR   CLDB; cl4969
DR   AddexBio; C0009002/68
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-227
DR   BCRC; 60343
DR   BioGRID_ORCS_Cell_line; 361
DR   BioSample; SAMN03481108
DR   BioSample; SAMN05292430
DR   BioSample; SAMN07709977
DR   BioSample; SAMN07709978
DR   BioSample; SAMN07709979
DR   BioSample; SAMN07709980
DR   BioSample; SAMN07709981
DR   BioSample; SAMN07709982
DR   BioSample; SAMN07709983
DR   BioSample; SAMN10988250
DR   cancercelllines; CVCL_0547
DR   CCRID; 1101HUM-PUMC000207
DR   CCRID; 3101HUMTCHu101
DR   Cell_Model_Passport; SIDM00841
DR   ChEMBL-Cells; CHEMBL3307944
DR   ChEMBL-Targets; CHEMBL612262
DR   CLS; 300466
DR   ColonAtlas; SW620
DR   Cosmic; 719676
DR   Cosmic; 724849
DR   Cosmic; 873706
DR   Cosmic; 875294
DR   Cosmic; 875900
DR   Cosmic; 876720
DR   Cosmic; 887243
DR   Cosmic; 889525
DR   Cosmic; 897460
DR   Cosmic; 905962
DR   Cosmic; 934561
DR   Cosmic; 948828
DR   Cosmic; 974248
DR   Cosmic; 983733
DR   Cosmic; 986020
DR   Cosmic; 990304
DR   Cosmic; 1071889
DR   Cosmic; 1092640
DR   Cosmic; 1122333
DR   Cosmic; 1154646
DR   Cosmic; 1175845
DR   Cosmic; 1176590
DR   Cosmic; 1183768
DR   Cosmic; 1184083
DR   Cosmic; 1187324
DR   Cosmic; 1219446
DR   Cosmic; 1223150
DR   Cosmic; 1305357
DR   Cosmic; 1310936
DR   Cosmic; 1312341
DR   Cosmic; 1466823
DR   Cosmic; 1479589
DR   Cosmic; 1524325
DR   Cosmic; 1552181
DR   Cosmic; 1609505
DR   Cosmic; 1676751
DR   Cosmic; 1708397
DR   Cosmic; 1995654
DR   Cosmic; 1998483
DR   Cosmic; 2156943
DR   Cosmic; 2302019
DR   Cosmic; 2389570
DR   Cosmic; 2668250
DR   Cosmic; 2727483
DR   Cosmic; 2760070
DR   Cosmic; 2823493
DR   Cosmic-CLP; 905962
DR   DepMap; ACH-000651
DR   ECACC; 87051203
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905962
DR   GEO; GSM2107
DR   GEO; GSM50192
DR   GEO; GSM50256
DR   GEO; GSM206553
DR   GEO; GSM274773
DR   GEO; GSM274774
DR   GEO; GSM513819
DR   GEO; GSM513867
DR   GEO; GSM514313
DR   GEO; GSM514314
DR   GEO; GSM741270
DR   GEO; GSM743447
DR   GEO; GSM750800
DR   GEO; GSM784023
DR   GEO; GSM799335
DR   GEO; GSM799398
DR   GEO; GSM847163
DR   GEO; GSM887677
DR   GEO; GSM888769
DR   GEO; GSM1006236
DR   GEO; GSM1006237
DR   GEO; GSM1006238
DR   GEO; GSM1153405
DR   GEO; GSM1178644
DR   GEO; GSM1178645
DR   GEO; GSM1178646
DR   GEO; GSM1181305
DR   GEO; GSM1181343
DR   GEO; GSM1346892
DR   GEO; GSM1374933
DR   GEO; GSM1374934
DR   GEO; GSM1374935
DR   GEO; GSM1448212
DR   GEO; GSM1862127
DR   GEO; GSM1862128
DR   GEO; GSM1862129
DR   GEO; GSM2124652
DR   GEO; GSM2299789
DR   GEO; GSM2550017
DR   GEO; GSM3591769
DR   IARC_TP53; 20
DR   ICLC; HTL99015
DR   IGRhCellID; SW620
DR   KCB; KCB 2011098YJ
DR   KCLB; 10227
DR   KCLB; 60068
DR   LiGeA; CCLE_536
DR   LINCS_HMS; 50047
DR   LINCS_LDP; LCL-1157
DR   Lonza; 543
DR   MetaboLights; MTBLS227
DR   NCI-DTP; SW-620
DR   PharmacoDB; SW620_1541_2019
DR   PRIDE; PXD000089
DR   PRIDE; PXD003539
DR   PRIDE; PXD003708
DR   PRIDE; PXD004079
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD006662
DR   PRIDE; PXD030304
DR   PRIDE; PXD037651
DR   Progenetix; CVCL_0547
DR   PubChem_Cell_line; CVCL_0547
DR   SKY/M-FISH/CGH; 2806
DR   SKY/M-FISH/CGH; 5075
DR   Wikidata; Q28519412
RX   PubMed=286328;
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=6582512;
RX   PubMed=7972006;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=9294210;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=10773689;
RX   PubMed=11113861;
RX   PubMed=11226274;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=12107847;
RX   PubMed=15748285;
RX   PubMed=16854228;
RX   PubMed=17088437;
RX   PubMed=18258742;
RX   PubMed=19188929;
RX   PubMed=19372543;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23272949;
RX   PubMed=23631600;
RX   PubMed=23856246;
RX   PubMed=23932154;
RX   PubMed=23933261;
RX   PubMed=24042735;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24755471;
RX   PubMed=24840470;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27470641;
RX   PubMed=27807467;
RX   PubMed=27987026;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29131639;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32172478;
RX   PubMed=35839778;
RX   PubMed=36648961;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/SW620.html
WW   Info; Quora; -; https://www.quora.com/What-is-the-full-form-of-SW-in-case-of-SW620-cell-line
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=18
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544588
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-333.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/sw620-xenograft-model/
WW   Provider; BRICS; BRICS0101; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3907
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: NCI-60 cancer cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 37.06 hours (PubMed=25944804); 20.4 hours (NCI-DTP=SW-620); ~26 hours (PBCF).
CC   HLA typing: A*02:01,24:02; B*07:02,15:18; C*07:02,07:04 (PubMed=9178645).
CC   HLA typing: A*02,24; B*07,15; C*07:02:01,07; DPB1*01:01:01,04:01; DQB1*05:01:01,06:03; DRB1*01:03,13:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,24:02; B*07:13,37:04; C*07:04,07:04; DQB1*05:01,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (PubMed=17088437; PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (PubMed=12068308; PubMed=17088437; PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=9331090; PubMed=17088437; PubMed=21912889; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (PubMed=17088437; PubMed=21912889; PubMed=24755471; PubMed=28683746).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Glycomics; O-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Extracellular vesicles.
CC   Omics: Proteomics; Subcellular; Nucleus.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.02%; Native American=0%; East Asian, North=4.3%; East Asian, South=0%; South Asian=0%; European, North=50.01%; European, South=43.67% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): AddexBio=C0009002/68; ATCC=CCL-227; CCRID; CLS=300466; Cosmic-CLP=905962; ECACC=87051203; KCLB=10227; KCLB=60068; PubMed=11416159; PubMed=19372543; PubMed=25877200; PubMed=25926053; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D10S1248: 13
ST   D12S391: 17
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 13,14
ST   D21S11: 30,30.2
ST   D22S1045: 16
ST   D2S1338: 17,24
ST   D2S441: 10,15
ST   D3S1358: 16
ST   D5S818: 13
ST   D6S1043: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 24
ST   Penta D: 9,15
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   SW620 M13KD
AC   CVCL_C8D7
SY   SW620 MUC13 KnockDown
DR   Wikidata; Q123033582
RX   PubMed=24097071;
CC   Population: Caucasian.
CC   Doubling time: 20.5 hours (PubMed=24097071).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7511; MUC13.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 5
//
ID   SW620-EGFP
AC   CVCL_A9MJ
DR   cancercelllines; CVCL_A9MJ
DR   CCRID; 1101HUM-PUMC000837
DR   Wikidata; Q108821348
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000837
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   SW620-FX-R
AC   CVCL_C4RZ
DR   Wikidata; Q116050601
RX   PubMed=36230735;
CC   Population: Caucasian.
CC   Characteristics: Resistant to FOLFOXIRI, the combination of 5-FU, folinic acic, oxaliplatin and SN-38.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Selected for resistance to: ChEBI; CHEBI_15640; 5-formyltetrahydrofolic acid (Folinic acid; Leucovorin).
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Selected for resistance to: ChEBI; CHEBI_8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   SW620-hrGFP
AC   CVCL_E9DT
SY   SW620-GFP
RX   PubMed=32591581;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a CAG-hrGFP-PuroR construct was introduced in the AAVS1 safe harbor locus (PubMed=32591581).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 84CGO; rrGFP (Note=hrGFP; luorescent protein published in 2007, green fluorescent protein derived from R.reniformis).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SW620-Luc
AC   CVCL_J268
DR   cancercelllines; CVCL_J268
DR   JCRB; JCRB1399
DR   JCRB; NIHS0648
DR   Wikidata; Q54971186
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0648; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1399
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 8,9
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 25
//
ID   SW620-Luc2-tdT
AC   CVCL_A9MK
DR   cancercelllines; CVCL_A9MK
DR   CCRID; 1101HUM-PUMC000840
DR   Wikidata; Q108821349
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000840
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 11
//
ID   SW620-Lv-T7 R1C11
AC   CVCL_B7Q5
DR   cancercelllines; CVCL_B7Q5
DR   Wikidata; Q112930447
RX   PubMed=33592218;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SW620-Lv-T7 R3C5
AC   CVCL_B7Q6
DR   cancercelllines; CVCL_B7Q6
DR   Wikidata; Q112930448
RX   PubMed=33592218;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SW620-Lv-T7 R3E6
AC   CVCL_B7Q7
DR   cancercelllines; CVCL_B7Q7
DR   Wikidata; Q112930449
RX   PubMed=33592218;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector pLv-T7 containing T7-RNAP gene, puroR and mCherry.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00573; Bacteriophage T7 DNA-directed RNA polymerase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   SW620-mCherry
AC   CVCL_A9ML
DR   cancercelllines; CVCL_A9ML
DR   CCRID; 1101HUM-PUMC000838
DR   Wikidata; Q108821350
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000838
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   SW620-OX
AC   CVCL_4V76
DR   cancercelllines; CVCL_4V76
DR   Wikidata; Q54971187
RX   PubMed=24761924;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   SW620-tdT
AC   CVCL_A9MM
DR   cancercelllines; CVCL_A9MM
DR   CCRID; 1101HUM-PUMC000839
DR   Wikidata; Q108821351
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000839
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,30.2
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 9
//
ID   SW620/AD300
AC   CVCL_ZZ39
SY   SW620/AD-300; SW620/Ad300; SW620 Ad300; Ad300
DR   cancercelllines; CVCL_ZZ39
DR   ChEMBL-Cells; CHEMBL4630768
DR   ChEMBL-Targets; CHEMBL4630776
DR   PubChem_Cell_line; CVCL_ZZ39
DR   Wikidata; Q102114957
RX   PubMed=14871996;
RX   PubMed=34977876;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 11
//
ID   SW620/Ad300-ABCB1ko
AC   CVCL_B6Y0
DR   cancercelllines; CVCL_B6Y0
DR   Wikidata; Q112041747
RX   PubMed=34977876;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZZ39 ! SW620/AD300
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   SW620/L-OHP
AC   CVCL_4V77
DR   cancercelllines; CVCL_4V77
DR   Wikidata; Q54971189
RX   PubMed=20591218;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 17
//
ID   SW620(MDR1/3)
AC   CVCL_C7SP
SY   SW620MDR1/3
DR   Wikidata; Q117704902
RX   PubMed=19188929;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_91367; Barasertib-HQPA (AZD1152-HQPA).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   SW620_6244R
AC   CVCL_C3GN
DR   cancercelllines; CVCL_C3GN
DR   GEO; GSM3591770
DR   Wikidata; Q114313075
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90227; Selumetinib (AZD6244).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   SW626
AC   CVCL_1725
AS   CVCL_IW65
SY   SW-626; SW 626
DR   BTO; BTO_0001881
DR   CLO; CLO_0009197
DR   CLO; CLO_0009222
DR   CLDB; cl4446
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-78
DR   BioGRID_ORCS_Cell_line; 1030
DR   BioSample; SAMN03472756
DR   BioSample; SAMN03472876
DR   cancercelllines; CVCL_1725
DR   CCRID; 4201HUM-CCTCC00112
DR   CCTCC; GDC0112
DR   Cell_Model_Passport; SIDM01168
DR   ChEMBL-Cells; CHEMBL3308130
DR   ChEMBL-Targets; CHEMBL1075593
DR   CLS; 305093
DR   Cosmic; 724882
DR   Cosmic; 844346
DR   Cosmic; 849608
DR   Cosmic; 867865
DR   Cosmic; 897437
DR   Cosmic; 909753
DR   Cosmic; 920358
DR   Cosmic; 948285
DR   Cosmic; 949229
DR   Cosmic; 1044244
DR   Cosmic; 1093559
DR   Cosmic; 1113284
DR   Cosmic; 1312194
DR   Cosmic; 1707572
DR   Cosmic; 2582804
DR   Cosmic; 2674699
DR   Cosmic-CLP; 909753
DR   DepMap; ACH-001399
DR   ECACC; 91091203
DR   EGA; EGAS00001000978
DR   GDSC; 909753
DR   GEO; GSM186459
DR   GEO; GSM186460
DR   GEO; GSM313714
DR   GEO; GSM659406
DR   GEO; GSM784571
DR   GEO; GSM1670509
DR   IARC_TP53; 27252
DR   KCB; KCB 2013039YJ
DR   LINCS_LDP; LCL-1529
DR   PharmacoDB; SW626_1542_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1725
DR   PubChem_Cell_line; CVCL_1725
DR   Wikidata; Q54971190
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6582512;
RX   PubMed=9698466;
RX   PubMed=10433623;
RX   PubMed=11314036;
RX   PubMed=12068308;
RX   PubMed=20106510;
RX   PubMed=20164919;
RX   PubMed=23415752;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Misclassified. Although established from a surgical specimen from a cystadenocarcinoma of the ovary in a 46 year old female Caucasian, it now seems likely that it was established from an ovarian metastasis of a colonic carcinoma (PubMed=10433623).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg976fs*9 (c.2926_2927insA); Zygosity=Homozygous (ATCC=HTB-78; Cosmic-CLP=909753; DepMap=ACH-001399).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=12068308; PubMed=25846456; Cosmic-CLP=909753; DepMap=ACH-001399).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (PubMed=25846456; Cosmic-CLP=909753; DepMap=ACH-001399).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly262Val (c.785G>T); ClinVar=VCV000428889; Zygosity=Homozygous (Cosmic-CLP=909753; DepMap=ACH-001399).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.06%; Native American=0.08%; East Asian, North=0.77%; East Asian, South=0%; South Asian=2.55%; European, North=65.38%; European, South=31.17% (PubMed=30894373).
CC   Misspelling: SWS-26; PubMed=20106510.
CC   Discontinued: CLS; 305093; true.
CC   Derived from site: Metastatic; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=HTB-78; Cosmic-CLP=909753; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11 (ATCC=HTB-78; PubMed=25877200)
ST   D13S317: 11,12 (Cosmic-CLP=909753)
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 27,29
ST   D2S1338: 25
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,12 (ATCC=HTB-78; Cosmic-CLP=909753)
ST   D7S820: 12 (PubMed=25877200)
ST   D8S1179: 11
ST   FGA: 21,23
ST   Penta D: 9,13
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   SW684
AC   CVCL_1726
SY   SW-684; SW 684
DR   CLO; CLO_0009198
DR   CLO; CLO_0037070
DR   EFO; EFO_0002369
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-91
DR   BioSample; SAMN03472761
DR   cancercelllines; CVCL_1726
DR   Cell_Model_Passport; SIDM01175
DR   ChEMBL-Cells; CHEMBL3308217
DR   ChEMBL-Targets; CHEMBL2366143
DR   CLS; 300422
DR   Cosmic; 684075
DR   Cosmic; 909754
DR   Cosmic; 923379
DR   Cosmic-CLP; 909754
DR   DepMap; ACH-002309
DR   EGA; EGAS00001000978
DR   GDSC; 909754
DR   GEO; GSM185154
DR   GEO; GSM185155
DR   GEO; GSM1670510
DR   GEO; GSM1676320
DR   GEO; GSM1701653
DR   IARC_TP53; 27253
DR   IGRhCellID; SW684
DR   LINCS_LDP; LCL-1490
DR   PharmacoDB; SW684_1543_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1726
DR   PubChem_Cell_line; CVCL_1726
DR   Wikidata; Q54971192
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=26351324;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3432; ERBB4; Simple; p.Glu452Lys (c.1354G>A); ClinVar=VCV000091898; Zygosity=Heterozygous (Cosmic-CLP=909754; DepMap=ACH-002309).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Homozygous (Cosmic-CLP=909754; DepMap=ACH-002309).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.49%; Native American=0.15%; East Asian, North=1.06%; East Asian, South=1.15%; South Asian=0.61%; European, North=67.56%; European, South=28.98% (PubMed=30894373).
ST   Source(s): ATCC=HTB-91; CLS=300422; Cosmic-CLP=909754
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 14,19
ST   D19S433: 13,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 20,25
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 7,10
ST   D8S1179: 14
ST   FGA: 20,22
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SW690
AC   CVCL_1E24
SY   SW-690; SW 690
DR   Wikidata; Q54971194
RX   PubMed=286328;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=994214;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 34 hours (Note=At 11th passage) (PubMed=994214).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   SW691
AC   CVCL_0L89
SY   SW-691; SW 691
DR   Wikidata; Q54971195
RX   PubMed=286328;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3020539;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   SW707
AC   CVCL_6230
SY   SW-707; SW 707
DR   EFO; EFO_0022504
DR   CLS; 300351
DR   Cosmic; 889528
DR   Wikidata; Q54971197
RX   PubMed=286328;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=7459858;
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 47 hours (Note=At 43th passage) (PubMed=1000501).
CC   Discontinued: CLS; 300351; true.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 21
//
ID   SW73.2
AC   CVCL_J774
DR   ECACC; 93113021
DR   Wikidata; Q54971198
RX   PubMed=2431999;
RX   PubMed=8223864;
CC   Monoclonal antibody isotype: IgG2a (PubMed=2431999); IgG2b (ECACC=93113021).
CC   Monoclonal antibody target: Sheep MHC class II beta chain.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 5
//
ID   SW732
AC   CVCL_F651
SY   SW-732; SW 732
DR   BioSample; SAMN03151934
DR   cancercelllines; CVCL_F651
DR   Wikidata; Q54971200
RX   PubMed=77569;
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 67 year old female patient with a cervical squamous cell carcinoma metastasized to the lung.
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00093.
CC   Population: Caucasian.
CC   HLA typing: A*02,09; B*07,w22; C*w03,w06 (PubMed=77569).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 29
//
ID   SW733
AC   CVCL_F652
SY   SW-733; SW 733
DR   BioSample; SAMN03151935
DR   cancercelllines; CVCL_F652
DR   Wikidata; Q54971201
RX   PubMed=288927;
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=6244232;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927; PubMed=20143388). Originally thought to originate from a 69 year old female patient with a urinary bladder transitional cell carcinoma.
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00093.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 31
//
ID   SW742
AC   CVCL_3884
SY   SW-742; SW 742
DR   BTO; BTO_0002825
DR   NCBI_Iran; C146
DR   Wikidata; Q54971202
RX   PubMed=1000501;
RX   PubMed=17254797;
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 273 hours (Note=At 2nd passage) (PubMed=1000501).
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 14
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   SW756
AC   CVCL_1727
SY   SW-756; SW 756
DR   CLO; CLO_0009223
DR   EFO; EFO_0002370
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3584
DR   ATCC; CRL-10302
DR   BioSample; SAMN03471299
DR   cancercelllines; CVCL_1727
DR   Cell_Model_Passport; SIDM01174
DR   ChEMBL-Cells; CHEMBL3308790
DR   ChEMBL-Targets; CHEMBL1075594
DR   Cosmic; 724839
DR   Cosmic; 925359
DR   Cosmic; 1131522
DR   Cosmic; 1193032
DR   Cosmic; 2660194
DR   Cosmic-CLP; 724839
DR   DepMap; ACH-001402
DR   EGA; EGAS00001000978
DR   GDSC; 724839
DR   GEO; GSM113867
DR   GEO; GSM253303
DR   GEO; GSM675739
DR   GEO; GSM685443
DR   GEO; GSM1670511
DR   IARC_TP53; 27583
DR   IGRhCellID; SW756
DR   IGRhCellID; SW756GEO
DR   LINCS_LDP; LCL-1544
DR   PharmacoDB; SW756_1544_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1727
DR   PubChem_Cell_line; CVCL_1727
DR   Wikidata; Q54971203
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3029760;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7129487;
RX   PubMed=12068308;
RX   PubMed=15531914;
RX   PubMed=20215515;
RX   PubMed=24134916;
RX   PubMed=27397505;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=35692560;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10302.
CC   Population: Caucasian.
CC   Virology: Contains a complete HPV18 genome.
CC   Doubling time: 1.6 days (PubMed=29156801).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724839; DepMap=ACH-001402).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.44%; Native American=0%; East Asian, North=3.59%; East Asian, South=0%; South Asian=0.36%; European, North=58.26%; European, South=34.34% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-10302; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CRL-3584; Cosmic-CLP=724839; DepMap=ACH-001402; PubMed=29156801
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,17
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SW780
AC   CVCL_1728
SY   SW-780; SW 780
DR   BTO; BTO_0006307
DR   CLO; CLO_0009199
DR   EFO; EFO_0002371
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2169
DR   BioSample; SAMN03473242
DR   BioSample; SAMN10988174
DR   cancercelllines; CVCL_1728
DR   CCRID; 3101HUMTCHu219
DR   Cell_Model_Passport; SIDM01160
DR   ChEMBL-Cells; CHEMBL3308468
DR   ChEMBL-Targets; CHEMBL1075595
DR   CLS; 305098
DR   Cosmic; 687457
DR   Cosmic; 1285128
DR   Cosmic; 1285990
DR   Cosmic; 1819323
DR   Cosmic; 2037958
DR   Cosmic; 2050464
DR   Cosmic; 2057457
DR   Cosmic; 2444257
DR   Cosmic; 2686117
DR   Cosmic; 2700998
DR   Cosmic-CLP; 687457
DR   DepMap; ACH-000384
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 687457
DR   GEO; GSM136235
DR   GEO; GSM827294
DR   GEO; GSM887678
DR   GEO; GSM888770
DR   GEO; GSM1374936
DR   GEO; GSM1574556
DR   GEO; GSM1670512
DR   GEO; GSM2143918
DR   GEO; GSM2143919
DR   GEO; GSM2143920
DR   IARC_TP53; 27584
DR   IGRhCellID; SW780
DR   LiGeA; CCLE_886
DR   LINCS_LDP; LCL-1718
DR   PharmacoDB; SW780_1545_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1728
DR   PubChem_Cell_line; CVCL_1728
DR   Ubigene; YC-C138
DR   Wikidata; Q54971204
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6744315;
RX   PubMed=7459858;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=27189164;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/other-bladder-cervical/sw780-xenograft-model/
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,23:01; B*07:02,41:02; C*07:02,17:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.52%; Native American=0.16%; East Asian, North=0.43%; East Asian, South=0.73%; South Asian=3.11%; European, North=68.95%; European, South=26.09% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-2169; Cosmic-CLP=687457; PubMed=25877200; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 19,22
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 19,20
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16 (PubMed=27270441)
ST   vWA: 16,19 (ATCC=CRL-2169; Cosmic-CLP=687457; PubMed=25877200)
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   SW780 FOXP3
AC   CVCL_C3GV
DR   GEO; GSM2143924
DR   GEO; GSM2143925
DR   GEO; GSM2143926
DR   Wikidata; Q114313076
RX   PubMed=27189164;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1728 ! SW780
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   SW780 FOXP3Delta3
AC   CVCL_C3GW
SY   SW780 FOXP3 Delta 3
DR   GEO; GSM2143921
DR   GEO; GSM2143922
DR   GEO; GSM2143923
DR   Wikidata; Q114313077
RX   PubMed=27189164;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6106; FOXP3 (Note=Isoform Delta3).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1728 ! SW780
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   SW8#20I
AC   CVCL_B5RF
SY   SW8 #20I
DR   Wikidata; Q112041749
RX   PubMed=22308265;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RG ! SW8#5P
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   SW8#5P
AC   CVCL_B5RG
SY   SW8 #5P
DR   Wikidata; Q112041750
RX   PubMed=22308265;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RF ! SW8#20I
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SW80
AC   CVCL_1E58
SY   SW-80; SW 80
DR   Wikidata; Q54971206
RX   DOI=10.1007/978-1-4757-1647-4_2;
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW800
AC   CVCL_A684
SY   SW-800; SW 800
DR   Cosmic; 715816
DR   Cosmic; 1016883
DR   Cosmic; 2037959
DR   GEO; GSM1567855
DR   GEO; GSM1574555
DR   Wikidata; Q54971207
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6744315;
RX   PubMed=6935474;
RX   PubMed=16885334;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   From: Scott and White Clinic; Temple; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   SW802
AC   CVCL_L214
SY   SW-802; SW 802
DR   Wikidata; Q54971209
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   From: Scott and White Clinic; Temple; USA.
CC   Doubling time: 58 hours (Note=At 19th passage) (PubMed=1000501).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   SW837
AC   CVCL_1729
SY   SW-837; SW 837
DR   CLO; CLO_0009200
DR   CLO; CLO_0009224
DR   EFO; EFO_0002372
DR   CLDB; cl4447
DR   CLDB; cl4448
DR   CLDB; cl4972
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-235
DR   BioGRID_ORCS_Cell_line; 453
DR   BioSample; SAMN03472312
DR   BioSample; SAMN10987996
DR   cancercelllines; CVCL_1729
DR   Cell_Model_Passport; SIDM00833
DR   ChEMBL-Cells; CHEMBL3308361
DR   ChEMBL-Targets; CHEMBL1075596
DR   ColonAtlas; SW837
DR   Cosmic; 724852
DR   Cosmic; 873707
DR   Cosmic; 909755
DR   Cosmic; 948839
DR   Cosmic; 983734
DR   Cosmic; 985589
DR   Cosmic; 986021
DR   Cosmic; 995397
DR   Cosmic; 1043830
DR   Cosmic; 1122334
DR   Cosmic; 1132696
DR   Cosmic; 1184090
DR   Cosmic; 1310943
DR   Cosmic; 1312316
DR   Cosmic; 1374627
DR   Cosmic; 1479571
DR   Cosmic; 1676728
DR   Cosmic; 1708404
DR   Cosmic; 1805269
DR   Cosmic; 1995655
DR   Cosmic; 2302020
DR   Cosmic; 2664051
DR   Cosmic; 2760072
DR   Cosmic; 2800571
DR   Cosmic-CLP; 909755
DR   DepMap; ACH-000421
DR   ECACC; 91031104
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909755
DR   GEO; GSM817
DR   GEO; GSM206554
DR   GEO; GSM383864
DR   GEO; GSM513925
DR   GEO; GSM514315
DR   GEO; GSM741265
DR   GEO; GSM827281
DR   GEO; GSM887679
DR   GEO; GSM888771
DR   GEO; GSM1006239
DR   GEO; GSM1006240
DR   GEO; GSM1006241
DR   GEO; GSM1346893
DR   GEO; GSM1374937
DR   GEO; GSM1448195
DR   GEO; GSM1670513
DR   GEO; GSM2550018
DR   IARC_TP53; 95
DR   IARC_TP53; 23571
DR   ICLC; HTL99021
DR   IGRhCellID; SW837
DR   JCRB; JCRB9115
DR   LiGeA; CCLE_838
DR   LINCS_LDP; LCL-1292
DR   Lonza; 1348
DR   NCBI_Iran; C510
DR   PharmacoDB; SW837_1546_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1729
DR   PubChem_Cell_line; CVCL_1729
DR   SKY/M-FISH/CGH; 2849
DR   Wikidata; Q54971210
RX   PubMed=286328;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=6652615;
RX   PubMed=7104989;
RX   PubMed=7651727;
RX   PubMed=7824277;
RX   PubMed=8464898;
RX   PubMed=9715273;
RX   PubMed=10612807;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11687795;
RX   PubMed=12068308;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=23932154;
RX   PubMed=24755471;
RX   PubMed=24840470;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/SW837.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 169 hours (Note=At 5th passage) (PubMed=1000501); 40.60 hours (PubMed=25944804).
CC   HLA typing: A*32:01,32:01; B*35:01,35:01; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1450Ter (c.4348C>T); ClinVar=VCV000194585; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Leu403fs*34 (c.1208_1209insT); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Hemizygous (PubMed=7651727; PubMed=9715273; PubMed=16418264; PubMed=24755471; PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Glycomics; O-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.4%; Native American=0%; East Asian, North=1.12%; East Asian, South=0.53%; South Asian=0%; European, North=65.15%; European, South=30.8% (PubMed=30894373).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): ATCC=CCL-235; Cosmic-CLP=909755; ECACC=91031104; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 28,31.2
ST   D2S1338: 24
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 8,14
ST   FGA: 25
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   SW839
AC   CVCL_3604
SY   SW-839; SW 839
DR   ATCC; HTB-49
DR   BioSample; SAMN03472746
DR   IZSLER; BS TCL 219
DR   RCB; RCB2131
DR   TKG; TKG 0582
DR   Wikidata; Q54971211
RX   PubMed=571047;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6244232;
RX   PubMed=6935474;
RX   PubMed=7459858;
CC   From: Scott and White Clinic; Temple; USA.
CC   Discontinued: ATCC; HTB-49; true.
CC   Discontinued: RCB; RCB2131; true.
CC   Discontinued: TKG; TKG 0582; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=HTB-49
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9.3,10
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 21
//
ID   SW843
AC   CVCL_1E59
SY   SW-843; SW 843
DR   Wikidata; Q54971213
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW850
AC   CVCL_A424
SY   SW-850; SW 850
DR   Cosmic; 736278
DR   Cosmic; 933518
DR   GEO; GSM1567856
DR   Wikidata; Q54971214
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1906154;
RX   PubMed=6220172;
RX   PubMed=8426738;
RX   PubMed=9472115;
RX   PubMed=11787853;
RX   PubMed=25997541;
RX   PubMed=26621286;
CC   Problematic cell line: Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (Cellosaurus=CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2A and DPC4 often found in pancreatic adenocarcinoma. Considered by PubMed=25997541 to be a bladder carcinoma cell line.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   From: Scott and White Clinic; Temple; USA.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   SW872
AC   CVCL_1730
SY   SW-872; SW 872
DR   BTO; BTO_0003743
DR   CLO; CLO_0009201
DR   CLO; CLO_0037071
DR   EFO; EFO_0002373
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-92
DR   BCRC; 60432
DR   BioSample; SAMN03472763
DR   cancercelllines; CVCL_1730
DR   Cell_Model_Passport; SIDM01159
DR   ChEMBL-Cells; CHEMBL3308837
DR   ChEMBL-Targets; CHEMBL2366302
DR   CLS; 300405
DR   Cosmic; 684521
DR   Cosmic; 909756
DR   Cosmic; 923383
DR   Cosmic; 2009544
DR   Cosmic; 2307722
DR   Cosmic; 2560246
DR   Cosmic; 2800532
DR   Cosmic-CLP; 909756
DR   DepMap; ACH-002310
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10726-110A6
DR   GDSC; 909756
DR   GEO; GSM185156
DR   GEO; GSM185157
DR   GEO; GSM482514
DR   GEO; GSM1543668
DR   GEO; GSM1543669
DR   GEO; GSM1670514
DR   IARC_TP53; 24518
DR   IGRhCellID; SW872
DR   IZSLER; BS TCL 119
DR   LINCS_LDP; LCL-1459
DR   Lonza; 88
DR   NCBI_Iran; C638
DR   PharmacoDB; SW872_1547_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1730
DR   PubChem_Cell_line; CVCL_1730
DR   Wikidata; Q54971215
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=12068308;
RX   PubMed=16888811;
RX   PubMed=17354236;
RX   PubMed=17426441;
RX   PubMed=17431109;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22911243;
RX   PubMed=24726063;
RX   PubMed=24758355;
RX   PubMed=26643872;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=16888811).
CC   HLA typing: A*02:01:01G; B*27:05:02,40:01:02; C*01:02:01,03:04:01; DPB1*02:01:02; DQA1*04:01:01,05:05:01; DQB1*03:01:01,04:02:01; DRB1*08:01:01;13:03:01 (CLS=300405).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (ATCC=HTB-92).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=12068308; PubMed=26643872; ATCC=HTB-92; Cosmic-CLP=909756; DepMap=ACH-002310).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (PubMed=26643872; ATCC=HTB-92; Cosmic-CLP=909756; DepMap=ACH-002310).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Asn (c.752T>A); ClinVar=VCV000528254; Zygosity=Homozygous (PubMed=16888811; PubMed=26643872; Cosmic-CLP=909756; DepMap=ACH-002310).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.25%; Native American=0%; East Asian, North=2.4%; East Asian, South=0.14%; South Asian=1.73%; European, North=69.64%; European, South=24.84% (PubMed=30894373).
CC   Misspelling: SW672; PubMed=17431109.
ST   Source(s): ATCC=HTB-92; CLS=300405; Cosmic-CLP=909756
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D21S11: 27,31.2
ST   D2S1338: 17,21
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 21.2,23
ST   Penta D: 9,10
ST   Penta E: 5,10
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   SW897
AC   CVCL_1E60
SY   SW-897; SW 897
DR   Wikidata; Q54971216
RX   PubMed=833871;
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 6
//
ID   SW900
AC   CVCL_1731
SY   SW-900; SW 900
DR   BTO; BTO_0004611
DR   CLO; CLO_0009202
DR   EFO; EFO_0002374
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-59
DR   BioSample; SAMN03472972
DR   BioSample; SAMN10987793
DR   cancercelllines; CVCL_1731
DR   Cell_Model_Passport; SIDM01158
DR   ChEMBL-Cells; CHEMBL3308819
DR   ChEMBL-Targets; CHEMBL1075597
DR   Cosmic; 724879
DR   Cosmic; 933582
DR   Cosmic; 1071890
DR   Cosmic; 1176591
DR   Cosmic; 1608837
DR   Cosmic; 1995656
DR   Cosmic; 2060528
DR   Cosmic-CLP; 724879
DR   DepMap; ACH-000669
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724879
DR   GEO; GSM63352
DR   GEO; GSM784255
DR   GEO; GSM827522
DR   GEO; GSM887680
DR   GEO; GSM888772
DR   GEO; GSM1670515
DR   IARC_TP53; 27254
DR   IGRhCellID; SW900
DR   KCLB; 30059
DR   LiGeA; CCLE_258
DR   LINCS_LDP; LCL-1593
DR   PharmacoDB; SW900_1548_2019
DR   Progenetix; CVCL_1731
DR   PubChem_Cell_line; CVCL_1731
DR   Wikidata; Q54971217
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=7736387;
RX   PubMed=12068308;
RX   PubMed=16187286;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24002593;
RX   PubMed=24135919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*33:01,33:01; B*14:02,14:02; C*08:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=12068308; Cosmic-CLP=724879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln167Ter (c.499C>T); ClinVar=VCV000528250; Zygosity=Homozygous (Cosmic-CLP=724879).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.45%; Native American=0%; East Asian, North=1.4%; East Asian, South=0%; South Asian=1.83%; European, North=65.68%; European, South=30.63% (PubMed=30894373).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=HTB-59; Cosmic-CLP=724879; KCLB=30059; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 19
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 20,27
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 11,16
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 14,15
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   SW948
AC   CVCL_0632
SY   SW-948; SW 948
DR   BTO; BTO_0001534
DR   CLO; CLO_0009203
DR   CLO; CLO_0009225
DR   CLO; CLO_0009226
DR   EFO; EFO_0002375
DR   CLDB; cl4449
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CCL-237
DR   BCRC; 60318
DR   BioSample; SAMN03473187
DR   BioSample; SAMN10988334
DR   cancercelllines; CVCL_0632
DR   CCRID; 3101HUMSCSP572
DR   Cell_Model_Passport; SIDM00832
DR   ChEMBL-Cells; CHEMBL3308131
DR   ChEMBL-Targets; CHEMBL1075598
DR   CLS; 300347
DR   ColonAtlas; SW948
DR   Cosmic; 724850
DR   Cosmic; 876721
DR   Cosmic; 909757
DR   Cosmic; 934565
DR   Cosmic; 948832
DR   Cosmic; 995395
DR   Cosmic; 1043831
DR   Cosmic; 1184094
DR   Cosmic; 1223151
DR   Cosmic; 1310941
DR   Cosmic; 1312317
DR   Cosmic; 1466824
DR   Cosmic; 1479599
DR   Cosmic; 1609501
DR   Cosmic; 1676730
DR   Cosmic; 1708413
DR   Cosmic; 1803952
DR   Cosmic; 1995657
DR   Cosmic; 2302021
DR   Cosmic; 2800589
DR   Cosmic-CLP; 909757
DR   DepMap; ACH-000680
DR   DSMZ; ACC-326
DR   DSMZCellDive; ACC-326
DR   ECACC; 91030714
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909757
DR   GEO; GSM206555
DR   GEO; GSM513926
DR   GEO; GSM514316
DR   GEO; GSM741243
DR   GEO; GSM784024
DR   GEO; GSM887681
DR   GEO; GSM888773
DR   GEO; GSM1346894
DR   GEO; GSM1374938
DR   GEO; GSM1374939
DR   GEO; GSM1448213
DR   GEO; GSM1670516
DR   GEO; GSM2550019
DR   GEO; GSM2983081
DR   GEO; GSM2983082
DR   GEO; GSM2983083
DR   GEO; GSM2983084
DR   IARC_TP53; 21763
DR   IGRhCellID; SW948
DR   LiGeA; CCLE_724
DR   LINCS_LDP; LCL-1187
DR   MetaboLights; MTBLS227
DR   NCBI_Iran; C499
DR   PharmacoDB; SW948_1549_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0632
DR   PubChem_Cell_line; CVCL_0632
DR   Ubigene; YC-C128
DR   Wikidata; Q54971218
RX   PubMed=286328;
RX   PubMed=924690;
RX   PubMed=1000501;
RX   PubMed=3518877;
RX   PubMed=7104989;
RX   PubMed=7972006;
RX   PubMed=9294210;
RX   PubMed=10737795;
RX   PubMed=11668190;
RX   PubMed=12068308;
RX   PubMed=12584437;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24042735;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28683746;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=34466148;
RX   PubMed=35839778;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Doubling time: 120 hours (Note=At 8th passage) (PubMed=1000501); 42.45 hours (PubMed=25944804); 2-4 days (DSMZ=ACC-326).
CC   HLA typing: A*01:01,01:01; B*08:01,58:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=24755471; PubMed=25926053; PubMed=28683746; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000045116; Zygosity=Heterozygous (PubMed=12068308; PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=20570890; PubMed=24755471; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Gly17Glu (c.50G>A); Zygosity=Heterozygous (PubMed=34466148; DepMap=ACH-000680).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp537Tyr (c.1609G>T); ClinVar=VCV000376000; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr118Glnfs*5 (c.351delG) (p.G117fs); Zygosity=Unspecified (PubMed=28683746).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.47%; East Asian, North=0%; East Asian, South=0%; South Asian=1.25%; European, North=63.91%; European, South=33.37% (PubMed=30894373).
CC   Misspelling: SW984; Cosmic=1184094.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-237; CLS=300347; Cosmic-CLP=909757; DSMZ=ACC-326; ECACC=91030714; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 19
ST   D19S433: 13,15
ST   D21S11: 25.2,29
ST   D2S1338: 17,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   SW954
AC   CVCL_1732
SY   SW-954; SW 954
DR   CLO; CLO_0009204
DR   CLO; CLO_0037166
DR   EFO; EFO_0002376
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-117
DR   BioSample; SAMN03471097
DR   cancercelllines; CVCL_1732
DR   Cell_Model_Passport; SIDM01157
DR   ChEMBL-Cells; CHEMBL3307461
DR   ChEMBL-Targets; CHEMBL614943
DR   Cosmic; 924247
DR   Cosmic-CLP; 924247
DR   DepMap; ACH-001400
DR   EGA; EGAS00001000978
DR   GDSC; 924247
DR   GEO; GSM1670517
DR   IARC_TP53; 27255
DR   IGRhCellID; SW954
DR   LINCS_LDP; LCL-1295
DR   PharmacoDB; SW954_1550_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1732
DR   PubChem_Cell_line; CVCL_1732
DR   Wikidata; Q54971219
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158His (c.473G>A); ClinVar=VCV000141963; Zygosity=Homozygous (Cosmic-CLP=924247; DepMap=ACH-001400).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.24%; Native American=0%; East Asian, North=0.14%; East Asian, South=0.57%; South Asian=1.33%; European, North=70.36%; European, South=27.38% (PubMed=30894373).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
ST   Source(s): ATCC=HTB-117; Cosmic-CLP=924247; DepMap=ACH-001400
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 20
ST   D19S433: 14,15
ST   D21S11: 30,31
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 9,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   SW962
AC   CVCL_1733
SY   SW-962; SW 962
DR   CLO; CLO_0009205
DR   CLO; CLO_0037167
DR   EFO; EFO_0002377
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-118
DR   BioSample; SAMN03471098
DR   cancercelllines; CVCL_1733
DR   Cell_Model_Passport; SIDM01178
DR   ChEMBL-Cells; CHEMBL3307274
DR   ChEMBL-Targets; CHEMBL613530
DR   Cosmic; 909758
DR   Cosmic-CLP; 909758
DR   DepMap; ACH-002200
DR   EGA; EGAS00001000978
DR   GDSC; 909758
DR   GEO; GSM1670518
DR   IARC_TP53; 27256
DR   IGRhCellID; SW962
DR   IZSLER; BS TCL 211
DR   LINCS_LDP; LCL-1152
DR   PharmacoDB; SW962_1551_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1733
DR   PubChem_Cell_line; CVCL_1733
DR   Wikidata; Q54971227
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=327080;
RX   PubMed=924690;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Val (c.797G>T); ClinVar=VCV000233303; Zygosity=Heterozygous (Cosmic-CLP=909758; DepMap=ACH-002200).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.03%; Native American=0.7%; East Asian, North=4.56%; East Asian, South=0%; South Asian=0%; European, North=58.72%; European, South=31.99% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=HTB-118; Cosmic-CLP=909758
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 30,32
ST   D2S1338: 20
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 11,13
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C4866; Vulvar carcinoma
DI   ORDO; Orphanet_494418; Vulvar carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   SW979
AC   CVCL_4057
SY   SW-979; SW 979
DR   Cosmic; 736279
DR   Cosmic; 922261
DR   Cosmic; 933520
DR   Wikidata; Q54971228
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6935474;
RX   PubMed=8026879;
RX   PubMed=8426738;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12800145;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/SW-979.html
CC   Problematic cell line: Possibly misidentified/contaminated. Reported by PubMed=11787853 to contain the same HPV18 sequences as the cervix carcinoma cell line C-4-I (Cellosaurus=CVCL_2253) and to lack mutations in KRAS, TP53, CDKN2 and DPC4 often found in pancreatic adenocarcinoma.
CC   From: Scott and White Clinic; Temple; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (PubMed=8026879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8026879).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   SW982
AC   CVCL_1734
SY   SW-982; SW 982
DR   BTO; BTO_0006386
DR   CLO; CLO_0009206
DR   CLO; CLO_0037072
DR   EFO; EFO_0002378
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-93
DR   BCRC; 60535
DR   BioSample; SAMN03471376
DR   BioSample; SAMN03472764
DR   cancercelllines; CVCL_1734
DR   CCRID; 3101HUMTCHu209
DR   Cell_Model_Passport; SIDM01161
DR   ChEMBL-Cells; CHEMBL3308534
DR   ChEMBL-Targets; CHEMBL2366238
DR   CLS; 300404
DR   Cosmic; 909759
DR   Cosmic; 1933188
DR   Cosmic; 2009545
DR   Cosmic-CLP; 909759
DR   DepMap; ACH-001274
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909759
DR   GEO; GSM1670519
DR   GEO; GSM1676321
DR   GEO; GSM1701654
DR   IARC_TP53; 27585
DR   IGRhCellID; SW982
DR   LINCS_LDP; LCL-1880
DR   PharmacoDB; SW982_1552_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1734
DR   PubChem_Cell_line; CVCL_1734
DR   Wikidata; Q54971230
RX   DOI=10.1007/978-94-011-3550-4_4;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=15038780;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Scott and White Clinic; Temple; USA.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,02:01; B*07:02,49:01; C*07:01,07:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7208; MPDZ; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=909759; DepMap=ACH-001274).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.11%; East Asian, North=0%; East Asian, South=0%; South Asian=2.82%; European, North=67.54%; European, South=29.52% (PubMed=30894373).
CC   Caution: Stated to originate from a patient with a biphasic synovial sarcoma, however does not contain the SST-SSX1/SSX2 translocation which is typical of synovial sarcoma.
CC   Derived from site: In situ; Synovium; UBERON=UBERON_0007616.
ST   Source(s): ATCC=HTB-93; CLS=300404; Cosmic-CLP=909759; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12,13 (CLS=300404)
ST   D13S317: 12,13 (ATCC=HTB-93; Cosmic-CLP=909759; PubMed=25877200)
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 12,15
ST   D21S11: 28,30
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11,13 (ATCC=HTB-93; CLS=300404; Cosmic-CLP=909759)
ST   D5S818: 13 (PubMed=25877200)
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 21,24
ST   Penta D: 10,13
ST   Penta E: 13,15
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 19,20
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   SW999
AC   CVCL_LK63
SY   SW-999
DR   Wikidata; Q54971231
RX   PubMed=3518877;
CC   From: Scott and White Clinic; Temple; USA.
DI   NCIt; C3230; Meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 6
//
ID   SWA11
AC   CVCL_D3L4
DR   Wikidata; Q127384344
RX   Patent=EP0356397A2;
RX   PubMed=2539173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 88080301.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human glycoprotein antigen sGP45 on membrane of lung small cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SWA20
AC   CVCL_JZ76
SY   SWA-20
DR   Wikidata; Q54971232
RX   DOI=10.1016/S0169-5002(88)80032-1;
RX   Patent=EP0323802A2;
RX   PubMed=2839290;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 88030201.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Human cluster-5A antigen (sGP100) on small cell lung cancer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 5
//
ID   SWA21
AC   CVCL_D3L5
DR   Wikidata; Q127384346
RX   DOI=10.1016/S0169-5002(88)80032-1;
RX   Patent=EP0356397A2;
RX   PubMed=2539173;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human glycoprotein antigen sGP45 on membrane of lung small cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SWA22
AC   CVCL_D3L6
DR   Wikidata; Q127384348
RX   DOI=10.1016/S0169-5002(88)80032-1;
RX   Patent=EP0356397A2;
RX   PubMed=2539173;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human glycoprotein antigen sGP45 on membrane of lung small cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SWA23
AC   CVCL_D3L7
DR   Wikidata; Q127384351
RX   DOI=10.1016/S0169-5002(88)80032-1;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human sialoglycoprotein antigen sGP90-135 on membrane of lung small cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   SWA4
AC   CVCL_D3L8
DR   Wikidata; Q127384353
RX   DOI=10.1016/S0169-5002(88)80032-1;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human sialoglycoprotein antigen sGP90-135 on membrane of lung small cell carcinoma.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Swan 71
AC   CVCL_D855
SY   SWAN 71; SWAN-71; Swan-71; Swan71; Sw.71
DR   ABM; T0532
DR   Wikidata; Q54971233
RX   PubMed=19766308;
RX   PubMed=28454693;
RX   PubMed=33810901;
WW   Provider; Beyotime; C6926; https://www.beyotime.com/Manual/C6926%20SWAN%2071%20(Human%20Trophoblast%20Cells).pdf
CC   Doubling time: 14-24 hours (ABM=T0532).
CC   Karyotypic information: Near pentaploid karyotype (PubMed=28454693).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
ST   Source(s): Beyotime; PubMed=28454693; PubMed=33810901
ST   Amelogenin: X
ST   CSF1PO: 10,11,12
ST   D10S1248: 13,14,15
ST   D12S391: 15,18,19,23
ST   D13S317: 11,12
ST   D16S539: 9,11,12,13
ST   D18S51: 12,14,20
ST   D19S433: 12,14,16.2
ST   D1S1656: 15,17.3
ST   D21S11: 28,29,30
ST   D22S1045: 15,16
ST   D2S1338: 17,18,20,22
ST   D2S441: 11,14
ST   D3S1358: 15,16,17
ST   D5S818: 11,12,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 20,21,25
ST   Penta D: 8,9,11,13 (Beyotime; PubMed=28454693)
ST   Penta D: 8,9,13 (PubMed=33810901)
ST   Penta E: 5,7,9,14
ST   SE33: 18,28.2
ST   TH01: 8,9,9.3
ST   TPOX: 6,8,11 (Beyotime; PubMed=28454693)
ST   TPOX: 6,11 (PubMed=33810901)
ST   vWA: 14,15,16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7FW
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   SWEIG007
AC   CVCL_E838
SY   SWEIG 007; SWEIG-H; SWEIG-4H; SWEIG; Sweig; Swei
DR   dbMHC; 49030
DR   ECACC; 88052037
DR   IHW; IHW09037
DR   IPD-IMGT/HLA; 11414
DR   PRIDE; PXD001205
DR   Wikidata; Q54971234
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=25502872;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*29:02:01:01; B*40:02:01:01; C*02:02:02:01; DPA1*01:03; DPB1*04:02:01; DQA1*05:05; DQB1*03:01:01; DRB1*11:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=11414).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 21
//
ID   SWH-R
AC   CVCL_XH38
DR   CCLV; CCLV-RIE 0033
DR   Wikidata; Q98132933
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryonic heart; UBERON=UBERON_0003084.
OX   NCBI_TaxID=8869; ! Cygnus olor (Mute swan)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   SWI3a-26
AC   CVCL_A5ZP
DR   Wikidata; Q107116990
RX   PubMed=22174749;
RX   PubMed=25804355;
CC   Biotechnology: Cell line for recombinase mediated cassette exchange (RMCE) that was generated by random integration of a FRT-flanked GFP reporter. It contains a single copy of the GFP reporter transgene at a genetic locus that is protected from silencing. The integrated GFP cassette contains a selection trap that allows for selection of recombinant cells upon RMCE (PubMed=25804355).
CC   Characteristics: Transduced with the pEFFS-EGFP-dneo vector that contains eGFP under the control of the EF1a promoter. The eGFP gene is flanked by a wild type FRT site and a synthetic variant (F3). A selection trap, an ATG-deleted, promoterless neo (Dneo) gene is located downstream of eGFP. When eGFP is exchanged by Flp-mediated recombination against a cassette including a promoter and start codon, Dneo becomes complemented and the cell becomes resistant against the antibiotic G418, thus allowing for selection of recombinant cells (PubMed=22174749).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_K173 ! Lec3.2.8.1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   Swiss SFME
AC   CVCL_6459
SY   Swiss Serum Free Mouse Embryo
DR   CLO; CLO_0009228
DR   ATCC; CRL-9391
DR   Wikidata; Q54971236
RX   Patent=US5602025;
RX   PubMed=3494308;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9391.
CC   Discontinued: ATCC; CRL-9391; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   16FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Swiss-LAPA
AC   CVCL_0552
SY   Swiss-LAP-A
DR   MCCL; MCC:0000453
DR   Wikidata; Q54971237
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Swiss19
AC   CVCL_1Y75
SY   Swiss 19
DR   EFO; EFO_0006297
DR   Wikidata; Q54971238
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss2
AC   CVCL_1Y76
SY   Swiss 2
DR   EFO; EFO_0006298
DR   Wikidata; Q54971239
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss20
AC   CVCL_1Y77
SY   Swiss 20
DR   Wikidata; Q54971241
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss22
AC   CVCL_1Y78
SY   Swiss 22
DR   EFO; EFO_0006299
DR   Wikidata; Q54971242
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss27
AC   CVCL_1Y79
SY   Swiss 27
DR   Wikidata; Q54971243
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss3
AC   CVCL_1Y80
SY   Swiss 3
DR   EFO; EFO_0006300
DR   Wikidata; Q54971244
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss30
AC   CVCL_1Y81
SY   Swiss 30
DR   Wikidata; Q54971245
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss38
AC   CVCL_1Y82
SY   Swiss 38
DR   Wikidata; Q54971246
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss5
AC   CVCL_1Y83
SY   Swiss 5
DR   EFO; EFO_0006301
DR   Wikidata; Q54971247
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss8
AC   CVCL_1Y84
SY   Swiss 8
DR   EFO; EFO_0006302
DR   Wikidata; Q54971249
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   Swiss9
AC   CVCL_1Y85
SY   Swiss 9
DR   EFO; EFO_0006303
DR   Wikidata; Q54971251
RX   PubMed=20200519;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   SWLA1
AC   CVCL_2725
DR   CLO; CLO_0009229
DR   ATCC; HB-12559
DR   Wikidata; Q54971252
RX   Patent=US6231857;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12559.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   SWLA2
AC   CVCL_2726
DR   CLO; CLO_0009230
DR   ATCC; HB-12560
DR   Wikidata; Q54971253
RX   Patent=US6231857;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12560.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   SWLA3
AC   CVCL_2727
DR   CLO; CLO_0009231
DR   ATCC; HB-12558
DR   Wikidata; Q54971254
RX   Patent=US6231857;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12558.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   SWR 21328 iPSC-c560
AC   CVCL_B6U1
SY   21328-c560
DR   Wikidata; Q112041751
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Amani that lives in San Diego Zoo Safari Park.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73337; ! Ceratotherium simum simum (Southern white rhinoceros)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SWR 21409 iPSC-c5156
AC   CVCL_B6U2
SY   21409-c5156
DR   Wikidata; Q112041752
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Wallis that lives in San Diego Zoo Safari Park.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73337; ! Ceratotherium simum simum (Southern white rhinoceros)
OI   CVCL_B6U3 ! SWR 21409 iPSC-c550
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SWR 21409 iPSC-c550
AC   CVCL_B6U3
SY   21409-c550; Wallis-c550
DR   Wikidata; Q112041753
RX   PubMed=33406994;
CC   Group: Endangered species/breed cell line.
CC   Donor information: Established from a rhinoceros named Wallis that lives in San Diego Zoo Safari Park.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=73337; ! Ceratotherium simum simum (Southern white rhinoceros)
OI   CVCL_B6U2 ! SWR 21409 iPSC-c5156
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   SwR-100
AC   CVCL_DD10
SY   SwR
DR   Wikidata; Q54971255
RX   Patent=US5272070;
RX   PubMed=2105319;
RX   PubMed=2267628;
RX   PubMed=2521484;
CC   Selected for resistance to: ChEBI; CHEBI_9367; Swainsonine (Sw).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   SWR/J.Li
AC   CVCL_S360
DR   ATCC; CRL-6457
DR   Wikidata; Q54971256
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6457; true.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: SWR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6460 ! SWR/J.We
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   SWR/J.We
AC   CVCL_6460
DR   CLO; CLO_0009232
DR   ATCC; CRL-6458
DR   Wikidata; Q54971257
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6458; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: SWR/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S360 ! SWR/J.Li
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   SWT
AC   CVCL_S951
SY   SWordTail
DR   Wikidata; Q54971258
RX   PubMed=4760587;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 26 to 30 Celsius, fails to grow at 16 and 37 Celsius.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=8084; ! Xiphophorus hellerii (Green swordtail)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   SWT-1
AC   CVCL_4W76
DR   Wikidata; Q54971260
RX   PubMed=8760591;
CC   Population: Japanese.
CC   Doubling time: 16.4 +- 2.2 hours (PubMed=8760591).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-2Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   SWT-2
AC   CVCL_4W77
DR   Wikidata; Q54971261
RX   PubMed=8760591;
CC   Population: Japanese.
CC   Doubling time: 18.7 +- 1.9 hours (PubMed=8760591).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   SXC1
AC   CVCL_D677
SY   SXC-1; SXC 1
DR   BCRJ; 0230
DR   Wikidata; Q54971265
RX   PubMed=2145365;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P18893; Mouse Il10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   SXC2
AC   CVCL_J096
SY   SXC-2; SXC 2
DR   Wikidata; Q54971266
RX   PubMed=2145365;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P18893; Mouse Il10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   SXMUi001-A
AC   CVCL_B3RZ
SY   SXMUi002-A-1; HB-iPSCs; HIPS-F9
DR   BioSamples; SAMEA10422684
DR   hPSCreg; SXMUi001-A
DR   Wikidata; Q110433273
RX   Patent=CN113881637B;
RX   PubMed=35121195;
CC   Group: Patented cell line.
CC   From: Shanxi Medical University; Taiyuan; China.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.22359.
CC   Sequence variation: Mutation; HGNC; HGNC:3551; F9; Simple; p.Arg75Ter (c.223C>T); ClinVar=VCV000010572; Zygosity=Hemizygous (Patent=CN113881637B; PubMed=35121195).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): Patent=CN113881637B; PubMed=35121195
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 9,10
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 13
ST   D1S1656: 14,17
ST   D21S11: 28,31.2
ST   D2S1338: 23,35
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D6S1043: 12,17
ST   D7S820: 11
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   Penta D: 9
ST   Penta E: 17,18
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C26721; Hemophilia B
DI   ORDO; Orphanet_98879; Hemophilia B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   SXMUi002-A
AC   CVCL_C0F5
SY   F8-hiPSC; HIPS-F8; SXMUi001-A-1
DR   BioSamples; SAMEA11645415
DR   hPSCreg; SXMUi002-A
DR   Wikidata; Q112930450
RX   Patent=CN114350614B;
RX   PubMed=35123343;
CC   Group: Patented cell line.
CC   From: Shanxi Medical University; Taiyuan; China.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.23095.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Simple; p.Arg814Ter (c.2440C>T); ClinVar=VCV000993607; Zygosity=Hemizygous (PubMed=35123343).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): Patent=CN114350614B; PubMed=35123343
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D19S433: 13,14
ST   D1S1656: 13,17
ST   D21S11: 31,33.2
ST   D2S1338: 19,21
ST   D3S1358: 14,17
ST   D5S818: 7,11
ST   D6S1043: 18,19
ST   D7S820: 10,11
ST   D8S1179: 12
ST   FGA: 19,22
ST   Penta D: 9
ST   Penta E: 20
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   SXR-01
AC   CVCL_WD15
SY   SeX Reversal-01
DR   IBRC; C10648
DR   Wikidata; Q98132934
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103186; Sexual differentiation disorder
DI   ORDO; Orphanet_90771; Disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SXR-02
AC   CVCL_WD16
SY   SeX Reversal-02
DR   IBRC; C10725
DR   Wikidata; Q98132936
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103186; Sexual differentiation disorder
DI   ORDO; Orphanet_90771; Disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SXR-03
AC   CVCL_WD17
SY   SeX Reversal-03
DR   IBRC; C10747
DR   Wikidata; Q98132937
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103186; Sexual differentiation disorder
DI   ORDO; Orphanet_90771; Disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SXR-04
AC   CVCL_WD18
SY   SeX Reversal-04
DR   IBRC; C11031
DR   Wikidata; Q98132941
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C103186; Sexual differentiation disorder
DI   ORDO; Orphanet_90771; Disorder of sex development
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   SY38
AC   CVCL_D6T8
RX   PubMed=3924408;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08247; Human SYP (Note=Also reacts with rat).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SY90575
AC   CVCL_VI16
DR   Wikidata; Q54971285
RX   PubMed=9230208;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1165Ter (c.3493C>T); ClinVar=VCV000005445; Zygosity=Homozygous (PubMed=9230208).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   SY90576
AC   CVCL_VI17
DR   Wikidata; Q54971286
RX   PubMed=9230208;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1165Ter (c.3493C>T); ClinVar=VCV000005445; Zygosity=Heterozygous (from familial inference of SY90575).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   SYF
AC   CVCL_6461
SY   src-/- yes-/- fyn-/-
DR   CLO; CLO_0009233
DR   ATCC; CRL-2459
DR   CCRID; 4201MOU-CCTCC00158
DR   CCTCC; GDC0158
DR   Wikidata; Q54971267
RX   PubMed=10228160;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95602; Fyn.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98397; Src.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99147; Yes1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   9-10FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   SYF + c-Src
AC   CVCL_8976
DR   CLO; CLO_0009234
DR   ATCC; CRL-2498
DR   Wikidata; Q54971268
RX   PubMed=10228160;
CC   Knockout cell: Method=KO mouse; MGI; MGI:95602; Fyn.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98397; Src.
CC   Knockout cell: Method=KO mouse; MGI; MGI:99147; Yes1.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:98397; Src.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6461 ! SYF
SX   Sex unspecified
AG   9-10FD
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   SYM-1
AC   CVCL_VK48
DR   Cosmic; 1085905
DR   Wikidata; Q98132944
RX   PubMed=9738976;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=9738976).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   SYM-I
AC   CVCL_M718
DR   Wikidata; Q54971269
RX   PubMed=6208314;
CC   From: Sekiguchi, Morimasa; Institute of Medical Science, University of Tokyo; Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   SYM-I clone K-104
AC   CVCL_M719
SY   SYM-I (clone K-104); K-104
DR   Wikidata; Q54899206
RX   PubMed=6208314;
CC   Population: Japanese.
CC   Characteristics: Produces beta-interferon (PubMed=6208314).
CC   Virology: Can be persistently infected by rabies virus (PubMed=6208314).
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M718 ! SYM-I
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   SYN-1
AC   CVCL_W498
DR   Wikidata; Q54971270
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SYNb-1
AC   CVCL_W499
DR   Wikidata; Q54971272
RX   PubMed=12237927;
CC   Derived from site: In situ; Forearm, synovium; UBERON=UBERON_0002386+UBERON_0007616.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W500 ! SYNb-2
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 8
//
ID   SYNb-2
AC   CVCL_W500
DR   Wikidata; Q54971273
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W499 ! SYNb-1
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   SYO-1
AC   CVCL_7146
SY   SYO-I; SYO1
DR   EFO; EFO_0022505
DR   cancercelllines; CVCL_7146
DR   Cell_Model_Passport; SIDM01453
DR   Cosmic; 1211854
DR   Cosmic; 1319812
DR   Cosmic; 2307725
DR   DepMap; ACH-001275
DR   GEO; GSM482570
DR   GEO; GSM1676335
DR   GEO; GSM1701667
DR   GEO; GSM2887622
DR   GEO; GSM2887623
DR   PharmacoDB; SYO1_1553_2019
DR   Progenetix; CVCL_7146
DR   Wikidata; Q54971281
RX   PubMed=14744540;
RX   PubMed=24726063;
RX   PubMed=26351324;
RX   PubMed=27353471;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=14744540).
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11336; SSX2; Name(s)=SS18-SSX2 (PubMed=14744540; DepMap=ACH-001275).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Val (c.101G>T); ClinVar=VCV000017582; Zygosity=Unspecified (DepMap=ACH-001275).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Duan, Zhen-Feng through ICLAC.
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
ST   Source(s): ICLAC
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 9,13
ST   D18S51: 15,19
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 11
ST   D8S1179: 12,24
ST   FGA: 19,24
ST   Penta D: 9,12
ST   Penta E: 5,15
ST   TH01: 6,7
ST   TPOX: 9,12
ST   vWA: 17
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   SYR10009
AC   CVCL_VI13
SY   SYR 10009
DR   Wikidata; Q54971282
RX   PubMed=10606667;
CC   Population: Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1229fs*1246 (c.3688_3691delACAG); Zygosity=Heterozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   SYR10010
AC   CVCL_VI14
SY   SYR 10010
DR   Wikidata; Q54971283
RX   PubMed=10606667;
CC   Population: Syrian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   SYR10011
AC   CVCL_VI15
SY   SYR 10011
DR   Wikidata; Q54971284
RX   PubMed=10606667;
CC   Population: Syrian.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1229fs*1246 (c.3688_3691delACAG); Zygosity=Homozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   SYRUP
AC   CVCL_WH56
DR   Wikidata; Q98132946
RX   PubMed=30268330;
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
DI   NCIt; C132823; Canine oral squamous cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   SYS FiPS120-mR6F-2
AC   CVCL_E7TG
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS120_ANEXO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS120_signedSBSB_signed.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Departament de Genetica de la Facultat de Biologia de la Universidad de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SYS FiPS132-mR6F-4
AC   CVCL_E7TH
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS132_ANEXO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS132_signedSBSB_signed.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Departament de Genetica de la Facultat de Biologia de la Universidad de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:6814; MAGEL2; Simple; p.Gln1007Ter (c.3019C>T); Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215157; Schaaf-Yang syndrome
DI   ORDO; Orphanet_398069; Schaaf-Yang syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SYS FiPS135-mR6F-5
AC   CVCL_E7TI
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS135_ANEXO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS135_signedSBSB_signed.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Departament de Genetica de la Facultat de Biologia de la Universidad de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SYS FiPS66-mR6F-1
AC   CVCL_E7TE
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS66+ANEXO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS66_signedSBSB_signed.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Departament de Genetica de la Facultat de Biologia de la Universidad de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:6814; MAGEL2; Simple; p.Gln666Profs*47 (c.1996dupC); ClinVar=VCV000190122; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215157; Schaaf-Yang syndrome
DI   ORDO; Orphanet_398069; Schaaf-Yang syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SYS FiPS68-mR6F-3
AC   CVCL_E7TF
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS68+ANEXO.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_Linea_iPSC-SYS+FiPS68_signedSBSB_signed.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Departament de Genetica de la Facultat de Biologia de la Universidad de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:6814; MAGEL2; Simple; p.Gln666Profs*47 (c.1996dupC); ClinVar=VCV000190122; Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215157; Schaaf-Yang syndrome
DI   ORDO; Orphanet_398069; Schaaf-Yang syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   SYSU-OfHe-C
AC   CVCL_ZF35
DR   Wikidata; Q98132948
RX   PubMed=24513271;
CC   Group: Insect cell line.
CC   Doubling time: 2.37 days (PubMed=24513271).
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=93504; ! Ostrinia furnacalis (Asian corn borer)
SX   Sex unspecified
AG   Fourth-fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   SYSUe001-A
AC   CVCL_C067
SY   SYSU-1
DR   hPSCreg; SYSUe001-A
DR   SKIP; SKIP002046
DR   Wikidata; Q54971287
RX   PubMed=17442208;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   SYSUe002-A
AC   CVCL_C068
SY   SYSU-2
DR   hPSCreg; SYSUe002-A
DR   SKIP; SKIP002047
DR   Wikidata; Q54971288
RX   PubMed=17442208;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   SYSUe003-A
AC   CVCL_C808
SY   CHES-1
DR   hPSCreg; SYSUe003-A
DR   SKIP; SKIP002268
DR   Wikidata; Q54971289
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   SYSUe004-A
AC   CVCL_C111
SY   CHE-1; CHE1
DR   hPSCreg; SYSUe004-A
DR   SKIP; SKIP002278
DR   Wikidata; Q54971290
RX   PubMed=12509934;
RX   PubMed=17341453;
CC   From: Sun Yat-sen University Second Affiliated Hospital; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SYSUe005-A
AC   CVCL_C112
SY   CHE-2; CHE2
DR   hPSCreg; SYSUe005-A
DR   SKIP; SKIP002279
DR   Wikidata; Q54971291
RX   PubMed=12509934;
RX   PubMed=17341453;
CC   From: Sun Yat-sen University Second Affiliated Hospital; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SYSUe006-A
AC   CVCL_C113
SY   CHE-3; CHE3
DR   hPSCreg; SYSUe006-A
DR   SKIP; SKIP002280
DR   Wikidata; Q54971292
RX   PubMed=12509934;
RX   PubMed=17341453;
CC   From: Sun Yat-sen University Second Affiliated Hospital; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   SYSUe008-A
AC   CVCL_A7IT
SY   SYSUe-008-A; H1-GPAM-/-
DR   hPSCreg; SYSUe008-A
DR   Wikidata; Q107116992
RX   PubMed=33831647;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24865; GPAM.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   SYSUe009-A
AC   CVCL_C7FZ
SY   SYSUe-009-A
DR   hPSCreg; SYSUe009-A
DR   Wikidata; Q117704904
RX   PubMed=36630838;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 NANOS3 has been endogenously tagged at the C-terminus with mCherry (PubMed=36630838).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 10-09-24; Version: 3
//
ID   SYSUe011-A-1
AC   CVCL_B5G9
DR   BioSamples; SAMEA10332181
DR   hPSCreg; SYSUe011-A-1
DR   Wikidata; Q110433274
RX   PubMed=34856466;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2892; DKK2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   SYSUi001-A
AC   CVCL_UK98
SY   iPSC-ADM01
DR   hPSCreg; SYSUi001-A
DR   Wikidata; Q98132949
RX   PubMed=30797990;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 7
//
ID   SYSUi002-A
AC   CVCL_YC59
SY   CSFPhiPSC01.1
DR   BioSamples; SAMEA5781305
DR   hPSCreg; SYSUi002-A
DR   SKIP; SKIP005592
DR   Wikidata; Q98132951
RX   PubMed=31783296;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165530; Coronary slow flow phenomenon
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   SYSUi003-A
AC   CVCL_YJ61
SY   SYSUi-003-A; GRIN2A+/L611Q iPSC
DR   hPSCreg; SYSUi003-A
DR   SKIP; SKIP005643
DR   Wikidata; Q98132952
RX   PubMed=32036246;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:4585; GRIN2A; Simple; p.Leu611Gln (c.1832T>A); ClinVar=VCV001325863; Zygosity=Heterozygous; Note=De novo mutation (PubMed=32036246).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168598; Epilepsy, focal, with speech disorder and with or without intellectual developmental disorder
DI   ORDO; Orphanet_289266; Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   SYSUi004-A
AC   CVCL_YT13
SY   SYSUi-004-A
DR   hPSCreg; SYSUi004-A
DR   SKIP; SKIP005745
DR   SKIP; SKIP005788
DR   Wikidata; Q98132954
RX   PubMed=32279010;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:25598; TYW1; Simple; p.Arg206Cys (c.616C>T); Zygosity=Heterozygous (PubMed=32279010).
CC   Sequence variation: Mutation; HGNC; HGNC:25598; TYW1; Simple; p.Arg389Gln (c.1166G>A); Zygosity=Heterozygous (PubMed=32279010).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85874; Microcephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   SYSUi005-A
AC   CVCL_B0W6
DR   BioSamples; SAMEA10129971
DR   hPSCreg; SYSUi005-A
DR   Wikidata; Q108821352
RX   PubMed=34942479;
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Pro77Ser (c.229C>T); Zygosity=Heterozygous (PubMed=34942479).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142892; Familial hypertrophic cardiomyopathy type 2
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   SYSUi006-A
AC   CVCL_B0W7
DR   BioSamples; SAMEA10129970
DR   hPSCreg; SYSUi006-A
DR   Wikidata; Q108821353
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 4
//
ID   SYSUi007-A
AC   CVCL_D0M2
DR   BioSamples; SAMEA114266905
DR   hPSCreg; SYSUi007-A
DR   Wikidata; Q123033583
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SYSUIMi001-A
AC   CVCL_B6XT
SY   MOVLD-1
DR   hPSCreg; SYSUIMi001-A
DR   Wikidata; Q112041754
RX   PubMed=35091306;
CC   From: Sun Yat-sen University Fifth Affiliated Hospital; Zhuhai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:13266; DDX24; Simple; p.Glu271Lys (c.811G>A); Zygosity=Heterozygous (PubMed=35091306).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35091306
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 20,21
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D1S1656: 14,15
ST   D21S11: 28,29,30
ST   D2S1338: 19,26
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D6S1043: 13,20
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 19,24
ST   Penta D: 9,11
ST   Penta E: 11,15
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,19
DI   NCIt; C186307; Multiorgan venous and lymphatic defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SYSUIMi002-A
AC   CVCL_B6XU
SY   MOVLD-2
DR   hPSCreg; SYSUIMi002-A
DR   Wikidata; Q112041755
RX   PubMed=35091306;
CC   From: Sun Yat-sen University Fifth Affiliated Hospital; Zhuhai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:13266; DDX24; Simple; p.Glu271Lys (c.811G>A); Zygosity=Heterozygous (PubMed=35091306).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35091306
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D12S391: 20,21
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D1S1656: 11,13
ST   D21S11: 28,29
ST   D2S1338: 23,26
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D6S1043: 19,20
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 9
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 9,12
ST   vWA: 14,17
DI   NCIt; C186307; Multiorgan venous and lymphatic defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SYSUIMi003-A
AC   CVCL_B6XV
SY   MOVLD-3
DR   hPSCreg; SYSUIMi003-A
DR   Wikidata; Q112041756
RX   PubMed=35091306;
CC   From: Sun Yat-sen University Fifth Affiliated Hospital; Zhuhai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:13266; DDX24; Simple; p.Glu271Lys (c.811G>A); Zygosity=Heterozygous (PubMed=35091306).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35091306
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 21,22
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 13,14
ST   D19S433: 13
ST   D1S1656: 14,16
ST   D21S11: 30
ST   D2S1338: 24,26
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D6S1043: 11,19
ST   D7S820: 10,12
ST   D8S1179: 13,16
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 11,17
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C186307; Multiorgan venous and lymphatic defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   SYSUSCi001-A
AC   CVCL_B5FX
SY   CC-hiPSCs
DR   BioSamples; SAMEA9927008
DR   hPSCreg; SYSUSCi001-A
DR   Wikidata; Q110433275
RX   PubMed=34995847;
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1040; BFSP1; Simple; p.Glu269Lys (c.805G>A); Zygosity=Heterozygous (PubMed=34995847).
CC   Sequence variation: Mutation; HGNC; HGNC:10012; RHO; Simple; p.Leu125Pro (c.374T>C); Zygosity=Heterozygous (PubMed=34995847).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98888; Congenital cataract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   SYSUSCi002-A
AC   CVCL_B5FY
SY   FNAIT-hiPSCs
DR   BioSamples; SAMEA10888742
DR   hPSCreg; SYSUSCi002-A
DR   Wikidata; Q110433277
RX   PubMed=35305469;
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1663; CD36; Simple; p.Thr111Serfs*22 (c.332_333delCA) (c.329_330delAC); ClinVar=VCV000225309; Zygosity=Homozygous (PubMed=35305469).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C101200; Neonatal alloimmune thrombocytopenia
DI   ORDO; Orphanet_853; Fetal and neonatal alloimmune thrombocytopenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   SYSUSCi004-A
AC   CVCL_D0M3
SY   IMO-hiPSCs
DR   BioSamples; SAMEA114184492
DR   hPSCreg; SYSUSCi004-A
DR   Wikidata; Q123033584
RX   PubMed=38335662;
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; p.Pro81Argfs*85 (c.242delC); ClinVar=VCV000551450; Zygosity=Heterozygous (PubMed=38335662).
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; p.Gln372Ter (c.1114C>T); ClinVar=VCV000830066; Zygosity=Heterozygous (PubMed=38335662).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C167215; Autosomal recessive osteopetrosis 1
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   SYSUSHi001-A
AC   CVCL_D6JA
SY   IPS-AML1-C1
DR   hPSCreg; SYSUSHi001-A
DR   Wikidata; Q127384356
RX   PubMed=38608356;
CC   From: Sun Yat-sen University Seventh Affiliated Hospital; Shenzhen; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:26144; PALB2; Simple; p.Thr1099Met (c.3296C>T); ClinVar=VCV000410162; Zygosity=Heterozygous (PubMed=38608356).
CC   Sequence variation: Mutation; HGNC; HGNC:12825; XPO1; Simple; c.591-4_591-3dupTT; dbSNP=rs372688892; Zygosity=Heterozygous (PubMed=38608356).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SYSUSHi002-A
AC   CVCL_D6JB
SY   IPS-AML2-C3
DR   hPSCreg; SYSUSHi002-A
DR   Wikidata; Q127384357
RX   PubMed=37890328;
CC   From: Sun Yat-sen University Seventh Affiliated Hospital; Shenzhen; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Heterozygous (PubMed=37890328).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   SYSUTFi001-A
AC   CVCL_C1XG
DR   BioSamples; SAMEA14300243
DR   hPSCreg; SYSUTFi001-A
DR   Wikidata; Q114313078
RX   PubMed=36375283;
CC   From: Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese.
CC   Donor information: Established from a patient suffering from hepatocellular carcinoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Cytotoxic T-cell; CL=CL_0000910.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   SZ-117
AC   CVCL_A7NH
SY   SZ117
DR   Wikidata; Q107116993
RX   PubMed=22142190;
RX   PubMed=22741587;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08253; Human MMP2 (Note=Also recognizes filamin A).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   SZ-123
AC   CVCL_B0EX
DR   Wikidata; Q108821354
RX   PubMed=17723136;
RX   PubMed=18788616;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SZ-125
AC   CVCL_B0EY
DR   Wikidata; Q108821355
RX   PubMed=17723136;
RX   PubMed=18788616;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SZ-163
AC   CVCL_B0EZ
DR   CCRID; 4201PAT-CCTCC00827
DR   Wikidata; Q108821356
RX   Patent=CN105754953B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201613.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SZ-168
AC   CVCL_B0F0
DR   CCRID; 4201PAT-CCTCC00828
DR   Wikidata; Q108821357
RX   Patent=CN105754953B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2015185.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q86YL7; Human PDPN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SZ-176
AC   CVCL_B0EV
SY   SZ176(3C1); SZ176
DR   Wikidata; Q108821358
RX   Patent=CN113087803B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2019273.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 4
//
ID   SZ-179
AC   CVCL_B0EW
DR   Wikidata; Q108821359
RX   PubMed=28166803;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04275; Human VWF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   SZ-189
AC   CVCL_E8H7
RX   PubMed=29939835;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9P126; Human CLEC1B.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   SZ-21
AC   CVCL_C5E8
DR   ABCD; ABCD_AI578
DR   Wikidata; Q116050602
RX   DOI=10.1055/s-0038-1643700;
RX   PubMed=12031828;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05106; Human ITGB3/CD61.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SZ-22
AC   CVCL_C5E9
DR   Wikidata; Q116050603
RX   DOI=10.1055/s-0038-1643700;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08514; Human ITGA2B/CD41.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SZ-32
AC   CVCL_M633
SY   sz-32; CHL-5
DR   IPD-IMGT/HLA; 16475
DR   Wikidata; Q54971294
RX   PubMed=19845917;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:07,31:01:02; B*46:01,55:02; C*01:02:01,03:61; DRB1*09:01,16:02 (IPD-IMGT/HLA=16475).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   SZ-51
AC   CVCL_C5EA
DR   Wikidata; Q116050604
RX   PubMed=1705321;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   SZ-ALS1
AC   CVCL_YL00
SY   SZ-ALS1 PGD; ALS#1
DR   NIHhESC; NIHhESC-20-0483
DR   Wikidata; Q98132956
RX   PubMed=27773700;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0483.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=27773700).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-ALS3
AC   CVCL_YL01
SY   SZ-ALS3 PGD; ALS#3
DR   NIHhESC; NIHhESC-20-0484
DR   Wikidata; Q98132957
RX   PubMed=27773700;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0484.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=27773700).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-ATRX7
AC   CVCL_YX92
SY   ATRX#7
DR   Wikidata; Q98132959
CC   Sequence variation: Mutation; HGNC; HGNC:886; ATRX; Simple; p.Arg37Ter (c.109C>T); ClinVar=VCV000011742; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118631; Alpha thalassemia X-linked intellectual disability syndrome
DI   ORDO; Orphanet_847; Alpha-thalassemia-X-linked intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 27-11-25; Version: 8
//
ID   SZ-beta-thal8
AC   CVCL_YL02
SY   SZ-beta-thal8 PGD; b-thal#8
DR   NIHhESC; NIHhESC-20-0462
DR   Wikidata; Q98132962
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0462.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Trp38Ter (c.114G>A) (W37*); ClinVar=VCV000015405; Zygosity=Homozygous (NIHhESC=NIHhESC-20-0462).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-BOR1
AC   CVCL_Y322
SY   SZ-BOR1 PGD; BOR#1
DR   NIHhESC; NIHhESC-20-0436
DR   Wikidata; Q54971295
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0436.
CC   Sequence variation: Mutation; HGNC; HGNC:3519; EYA1; Simple; c.433delG; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98983; Melnick-Fraser syndrome
DI   ORDO; Orphanet_107; BOR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   SZ-BOR2
AC   CVCL_YL04
SY   SZ-BOR2 PGD; BOR#2
DR   NIHhESC; NIHhESC-20-0437
DR   Wikidata; Q98132964
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0437.
CC   Sequence variation: Mutation; HGNC; HGNC:3519; EYA1; Simple; c.433delG; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98983; Melnick-Fraser syndrome
DI   ORDO; Orphanet_107; BOR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-BRCA1-1
AC   CVCL_YL06
SY   SZ-BRCA1-1 PGD; BRCA1#1
DR   NIHhESC; NIHhESC-20-0456
DR   Wikidata; Q98132965
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0456.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu23Valfs*17 (c.68_69delAG) (c.66_67AG[1]) (185delAG); ClinVar=VCV000017662; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SZ-BRCA1-4
AC   CVCL_Y323
SY   SZ-BRCA1-4 PGD; SZ-BRCA1; BRCA1#4
DR   NIHhESC; NIHhESC-20-0455
DR   Wikidata; Q54971297
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0455.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Gln1756Profs*74 (c.5266dupC) (5382insC); ClinVar=VCV000017677; Zygosity=Unspecified (PubMed=21585244).
CC   Miscellaneous: Identity of SZ-BRCA1-4 with SZ-BRCA1 of PubMed=21585244 from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 17
//
ID   SZ-BRCA2-1
AC   CVCL_YL07
SY   SZ-BRCA2-1 PGD; BRCA2#1
DR   NIHhESC; NIHhESC-20-0470
DR   Wikidata; Q98132966
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0470.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0470).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SZ-BRCA2-6
AC   CVCL_YL08
SY   SZ-BRCA2-6 PGD; BRCA2#6
DR   NIHhESC; NIHhESC-20-0469
DR   Wikidata; Q98132968
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0469.
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ser1982Argfs*22 (c.5946delT) (6174delT); ClinVar=VCV000009325; Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0469).
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 13
//
ID   SZ-CF12
AC   CVCL_YL09
SY   SZ-CF12 PGD; CF#12
DR   NIHhESC; NIHhESC-20-0466
DR   Wikidata; Q98132970
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0466.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Trp1282Ter (c.3846G>A); ClinVar=VCV000007129; Zygosity=Homozygous (NIHhESC=NIHhESC-20-0466).
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SZ-CIPA1
AC   CVCL_Y324
SY   SZ-CIPA1 PGD; CIPA#1
DR   NIHhESC; NIHhESC-20-0415
DR   Wikidata; Q54971298
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0415.
CC   Sequence variation: Mutation; HGNC; HGNC:8031; NTRK1; Simple; p.Pro621Serfs*12 (c.1860_1861insT) (1926insT) (p.Pro585fs, c.1752_1753insT); ClinVar=VCV000021306; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118633; Neuropathy, hereditary sensory and autonomic, type IV
DI   ORDO; Orphanet_642; Hereditary sensory and autonomic neuropathy type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   SZ-CMT
AC   CVCL_YL11
SY   SZ-CMT PGD; CMT
DR   NIHhESC; NIHhESC-20-0461
DR   Wikidata; Q98132971
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0461.
CC   Sequence variation: Mutation; HGNC; HGNC:4283; GJB1; Simple; p.Arg75Trp (c.223C>T); ClinVar=VCV000021082; Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0461).
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C129068; Charcot-Marie-Tooth neuropathy X type 1
DI   ORDO; Orphanet_101075; X-linked Charcot-Marie-Tooth disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SZ-DC10
AC   CVCL_YL12
SY   SZ-DC10 PGD; DC#10
DR   NIHhESC; NIHhESC-20-0480
DR   Wikidata; Q98132973
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0480.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Arg631Gln (c.1892G>A); ClinVar=VCV000029899; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-DC2
AC   CVCL_YL13
SY   SZ-DC2 PGD; DC#2
DR   NIHhESC; NIHhESC-20-0478
DR   Wikidata; Q98132976
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0478.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Arg631Gln (c.1892G>A); ClinVar=VCV000029899; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-DC3
AC   CVCL_YL14
SY   SZ-DC3 PGD; DC#3
DR   NIHhESC; NIHhESC-20-0479
DR   Wikidata; Q98132977
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0479.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; p.Arg631Gln (c.1892G>A); ClinVar=VCV000029899; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C111802; Dyskeratosis congenita
DI   ORDO; Orphanet_1775; Dyskeratosis congenita
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-DM1
AC   CVCL_Y325
SY   SZ-DM1 PGD; DM#1
DR   NIHhESC; NIHhESC-20-0421
DR   Wikidata; Q54971299
RX   PubMed=21585244;
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0421.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   SZ-DM11
AC   CVCL_YL16
SY   SZ-DM11 PGD; DM#11
DR   NIHhESC; NIHhESC-20-0429
DR   Wikidata; Q98132980
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0429.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~500] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DM12
AC   CVCL_YL17
SY   SZ-DM12 PGD; DM#12
DR   NIHhESC; NIHhESC-20-0430
DR   Wikidata; Q98132981
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0430.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~630] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DM14
AC   CVCL_YL18
SY   SZ-DM14 PGD; DM#14
DR   NIHhESC; NIHhESC-20-0431
DR   Wikidata; Q98132983
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0431.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~2000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DM15
AC   CVCL_YL19
SY   SZ-DM15 PGD; DM#15
DR   NIHhESC; NIHhESC-20-0432
DR   Wikidata; Q98132984
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0432.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   SZ-DM16
AC   CVCL_YL20
SY   SZ-DM16 PGD; DM#16
DR   NIHhESC; NIHhESC-20-0433
DR   Wikidata; Q98132986
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0433.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   SZ-DM2
AC   CVCL_Y326
SY   SZ-DM2 PGD; DM#2
DR   NIHhESC; NIHhESC-20-0422
DR   Wikidata; Q54971300
RX   PubMed=21585244;
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0422.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~430-1000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   SZ-DM20
AC   CVCL_YL22
SY   SZ-DM20 PGD; DM#20
DR   NIHhESC; NIHhESC-20-0425
DR   Wikidata; Q98132987
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0425.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~300] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DM21
AC   CVCL_YL23
SY   SZ-DM21 PGD; DM#21
DR   NIHhESC; NIHhESC-20-0426
DR   Wikidata; Q98132988
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0426.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   SZ-DM3
AC   CVCL_YL03
DR   Wikidata; Q98132989
RX   PubMed=26190529;
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~2000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   SZ-DM4
AC   CVCL_Y327
SY   SZ-DM4 PGD; DM#4
DR   NIHhESC; NIHhESC-20-0420
DR   Wikidata; Q54971301
RX   PubMed=21585244;
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0420.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~180] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   SZ-DM5
AC   CVCL_Y328
DR   Wikidata; Q54971302
RX   PubMed=21585244;
RX   PubMed=26190529;
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~300] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 10
//
ID   SZ-DM6
AC   CVCL_YL25
SY   SZ-DM6 PGD; DM#6
DR   NIHhESC; NIHhESC-20-0427
DR   Wikidata; Q98132991
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0427.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1060] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DM7
AC   CVCL_Y329
SY   SZ-DM7 PGD; DM#7
DR   NIHhESC; NIHhESC-20-0423
DR   Wikidata; Q54971303
RX   PubMed=21585244;
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0423.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~300] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   SZ-DM8
AC   CVCL_YL27
SY   SZ-DM8 PGD; DM#8
DR   NIHhESC; NIHhESC-20-0424
DR   Wikidata; Q98132992
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0424.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~400-2000] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DM9
AC   CVCL_YL28
SY   SZ-DM9 PGD; DM#9
DR   NIHhESC; NIHhESC-20-0428
DR   Wikidata; Q98132993
RX   PubMed=26190529;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0428.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~180] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=26190529).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-DMD2
AC   CVCL_YL29
SY   SZ-DMD2 PGD; DMD#2
DR   NIHhESC; NIHhESC-20-0475
DR   Wikidata; Q98132995
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0475.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex8dup; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-ED5
AC   CVCL_YL30
SY   SZ-ED5 PGD; ED#5
DR   NIHhESC; NIHhESC-20-0481
DR   Wikidata; Q98132996
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0481.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Unexplicit; 4bp deletion within exon 6; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84685; Emery-Dreifuss muscular dystrophy
DI   ORDO; Orphanet_261; Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-Fanconi C
AC   CVCL_YL31
SY   SZ-Fanconi C PGD
DR   NIHhESC; NIHhESC-20-0476
DR   Wikidata; Q98132998
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0476.
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; c.456+4A>T (IVS4+4A>T); ClinVar=VCV000012045; Zygosity=Unspecified; Note=Splice donor mutation (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-FX1
AC   CVCL_Y330
SY   SZ-FX1 PGD; FX#1
DR   NIHhESC; NIHhESC-20-0440
DR   Wikidata; Q54971304
RX   PubMed=21585244;
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0440.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[75]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   SZ-FX10
AC   CVCL_Y331
SY   SZ-FX10 PGD; FX#10
DR   NIHhESC; NIHhESC-20-0442
DR   Wikidata; Q54971305
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0442.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[75]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   SZ-FX11
AC   CVCL_YL34
SY   SZ-FX11 PGD; FX#11
DR   NIHhESC; NIHhESC-20-0447
DR   Wikidata; Q98132999
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0447.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[80]; ClinVar=VCV000009972; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-FX12
AC   CVCL_YL35
SY   SZ-FX12 PGD; FX#12
DR   NIHhESC; NIHhESC-20-0448
DR   Wikidata; Q98133000
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0448.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[150-300]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-FX13
AC   CVCL_YL36
SY   SZ-FX13 PGD; FX#13
DR   NIHhESC; NIHhESC-20-0449
DR   Wikidata; Q98133001
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0449.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[75]; ClinVar=VCV000009972; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-FX14
AC   CVCL_YL37
SY   SZ-FX14 PGD; FX#14
DR   NIHhESC; NIHhESC-20-0450
DR   Wikidata; Q98133002
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0450.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[290-600]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-FX16
AC   CVCL_YL38
SY   SZ-FX16 PGD; FX#16
DR   NIHhESC; NIHhESC-20-0452
DR   Wikidata; Q98133004
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0452.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[180]; ClinVar=VCV000009972; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-FX17
AC   CVCL_YL39
SY   SZ-FX17 PGD; FX#17
DR   NIHhESC; NIHhESC-20-0453
DR   Wikidata; Q98133005
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0453.
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SZ-FX18
AC   CVCL_YL40
SY   SZ-FX18 PGD; FX#18
DR   NIHhESC; NIHhESC-20-0454
DR   Wikidata; Q98133006
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0454.
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SZ-FX2
AC   CVCL_Y332
DR   Wikidata; Q54971306
RX   PubMed=21585244;
CC   Problematic cell line: Contaminated. Cell line withdrawn from distribution by the Shaare Zedek Medical Center.
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[70]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=21585244).
CC   Miscellaneous: Information on contamination from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 12
//
ID   SZ-FX22
AC   CVCL_YL41
SY   SZ-FX22 PGD; FX#22
DR   NIHhESC; NIHhESC-20-0451
DR   Wikidata; Q98133007
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0451.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[74]; ClinVar=VCV000009972; Zygosity=Hemizygous (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-FX3
AC   CVCL_Y333
SY   SZ-FX3 PGD; FX#3
DR   NIHhESC; NIHhESC-20-0439
DR   Wikidata; Q54971307
RX   PubMed=21585244;
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0439.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[100-300]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   SZ-FX4
AC   CVCL_YL43
SY   SZ-FX4 PGD; FX#4
DR   NIHhESC; NIHhESC-20-0444
DR   Wikidata; Q98133009
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0444.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[75]; ClinVar=VCV000009972; Zygosity=Hemizygous (Direct_author_submission).
CC   Miscellaneous: Sex of donor and sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-FX5
AC   CVCL_Y334
SY   SZ-FX5 PGD; FX#5
DR   NIHhESC; NIHhESC-20-0441
DR   Wikidata; Q54971308
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0441.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[75]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   SZ-FX6
AC   CVCL_Y335
SY   SZ-FX6 PGD; FX#6
DR   NIHhESC; NIHhESC-20-0443
DR   Wikidata; Q54971311
RX   PubMed=21585244;
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0443.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[170]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   SZ-FX7
AC   CVCL_YL46
SY   SZ-FX7 PGD; FX#7
DR   NIHhESC; NIHhESC-20-0445
DR   Wikidata; Q98133010
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0445.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[200-300]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-FX8
AC   CVCL_YL47
SY   SZ-FX8 PGD; FX#8
DR   NIHhESC; NIHhESC-20-0446
DR   Wikidata; Q98133011
RX   PubMed=27690107;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0446.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[200-600]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-Gaucher4
AC   CVCL_YL48
SY   SZ-Gaucher4 PGD; Gaucher#4
DR   NIHhESC; NIHhESC-20-0457
DR   Wikidata; Q98133012
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0457.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu29Alafs*18 (c.84dupG) (c.84_85insG) (84GG); ClinVar=VCV000004311; Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0457).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg535His (c.1604G>A) (R496H); ClinVar=VCV000004311; Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0457).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-HED11
AC   CVCL_YL49
SY   SZ-HED11 PGD; HED#11
DR   NIHhESC; NIHhESC-20-0435
DR   Wikidata; Q98133013
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0435.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Asp50Asn (c.148G>A); ClinVar=VCV000017020; Zygosity=Unspecified (NIHhESC=NIHhESC-20-0435).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-HED7
AC   CVCL_Y336
SY   SZ-HED7 PGD; HED#7
DR   NIHhESC; NIHhESC-20-0434
DR   Wikidata; Q54971312
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0434.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Asp50Asn (c.148G>A); ClinVar=VCV000017020; Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   SZ-HNPCC3
AC   CVCL_YL51
SY   SZ-HNPCC3 PGD; HNPCC#3
DR   NIHhESC; NIHhESC-20-0477
DR   Wikidata; Q98133014
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0477.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C120083; Hereditary nonpolyposis colorectal cancer syndrome
DI   ORDO; Orphanet_443909; Hereditary nonpolyposis colon cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   SZ-HTT210
AC   CVCL_YL52
SY   SZ-HTT210 PGD; HTT#210
DR   NIHhESC; NIHhESC-20-0472
DR   Wikidata; Q98133016
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0472.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[42] (c.52CAG(42)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-HTT3
AC   CVCL_YL53
SY   SZ-HTT3 PGD; HTT#3
DR   NIHhESC; NIHhESC-20-0471
DR   Wikidata; Q98133017
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0471.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[32] (c.52CAG(32)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-Hunter4
AC   CVCL_Y337
SY   SZ-Hunter4 PGD; SZ-Hun4; SZ-Hunter; Hunter#4
DR   NIHhESC; NIHhESC-20-0438
DR   Wikidata; Q54971313
RX   PubMed=21585244;
RX   PubMed=23320174;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0438.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Unexplicit; Ex4-7del; Zygosity=Unspecified (PubMed=21585244; PubMed=23320174).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   SZ-Kennedy
AC   CVCL_Y341
SY   SZ-Kennedy PGD; SZ-SBMA
DR   NIHhESC; NIHhESC-20-0459
DR   Wikidata; Q54971317
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0459.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Repeat_expansion; (CAG)>40 (c.172_174CAG(10_36)); ClinVar=VCV000009818; Zygosity=Unspecified (NIHhESC=NIHhESC-20-0459).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   SZ-Marfan7
AC   CVCL_YL56
SY   SZ-Marfan7 PGD; Marfan#7
DR   NIHhESC; NIHhESC-20-0458
DR   Wikidata; Q98133019
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0458.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Gln1813Ter (c.5437C>T); ClinVar=VCV000042383; Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0458).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-NF1
AC   CVCL_YL57
SY   SZ-NF1 PGD; NF#1
DR   NIHhESC; NIHhESC-20-0463
DR   Wikidata; Q98133021
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0463.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.4332+1G>C (c.4269+1G>C); ClinVar=VCV001457886; Zygosity=Unspecified; Note=Splice donor mutation (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SZ-NF2
AC   CVCL_YL58
SY   SZ-NF2 PGD; NF#2
DR   NIHhESC; NIHhESC-20-0464
DR   Wikidata; Q98133025
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0464.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.4332+1G>C (c.4269+1G>C); ClinVar=VCV00145788; Zygosity=Unspecified; Note=Splice donor mutation (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SZ-NF4
AC   CVCL_YL59
SY   SZ-NF4 PGD; NF#4
DR   NIHhESC; NIHhESC-20-0465
DR   Wikidata; Q98133028
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0465.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.4332+1G>C (c.4269+1G>C); ClinVar=VCV001457886; Zygosity=Unspecified; Note=Splice donor mutation (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SZ-NF6
AC   CVCL_YY00
SY   NF#6
DR   Wikidata; Q98133031
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; c.4332+1G>C (c.4269+1G>C); ClinVar=VCV001457886; Zygosity=Unspecified; Note=Splice donor mutation (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   SZ-OI8
AC   CVCL_YL60
SY   SZ-OI8 PGD; OI#8
DR   NIHhESC; NIHhESC-20-0460
DR   Wikidata; Q98133034
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0460.
CC   Sequence variation: Mutation; HGNC; HGNC:2197; COL1A1; Simple; p.Arg361Ter (c.1081C>T); ClinVar=VCV000425593; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SZ-PKD1
AC   CVCL_YL61
SY   SZ-PKD1 PGD; PKD#1
DR   NIHhESC; NIHhESC-20-0473
DR   Wikidata; Q98133038
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0473.
CC   Sequence variation: Mutation; HGNC; HGNC:9008; PKD1; Simple; c.8433_8438delinsGCCC; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Misspelling: SZ-PDK1; NIHhESC=NIHhESC-20-0473; Note=Prior to 2022.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   SZ-Pompe4
AC   CVCL_YL62
SY   SZ-Pompe4 PGD; Pompe#4
DR   NIHhESC; NIHhESC-20-0474
DR   Wikidata; Q98133040
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0474.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg819Pro (c.2456G>C); ClinVar=VCV001693550; Zygosity=Homozygous (NIHhESC=NIHhESC-20-0474).
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   SZ-Rb18
AC   CVCL_Y338
SY   SZ-Rb18 PGD; Rb#18
DR   NIHhESC; NIHhESC-20-0417
DR   Wikidata; Q54971314
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0417.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ala525Lysfs*7 (c.1572insAA); Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   SZ-Rb2
AC   CVCL_Y339
SY   SZ-Rb2 PGD; Rb#2
DR   NIHhESC; NIHhESC-20-0418
DR   Wikidata; Q54971315
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0418.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ala525Lysfs*7 (c.1572insAA); Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   SZ-Rb26
AC   CVCL_Y340
SY   SZ-Rb26 PGD; Rb#26
DR   NIHhESC; NIHhESC-20-0416
DR   Wikidata; Q54971316
RX   PubMed=21585244;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0416.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ala525Lysfs*7 (c.1572insAA); Zygosity=Unspecified (PubMed=21585244).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 14
//
ID   SZ-Rb4
AC   CVCL_YL66
SY   SZ-Rb4 PGD; Rb#4
DR   NIHhESC; NIHhESC-20-0419
DR   Wikidata; Q98133043
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0419.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ala525Lysfs*7 (c.1572insAA); Zygosity=Heterozygous (NIHhESC=NIHhESC-20-0419).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ-SMA5
AC   CVCL_YL67
SY   SZ-SMA5 PGD; SMA#5
DR   NIHhESC; NIHhESC-20-0467
DR   Wikidata; Q98133046
RX   PubMed=26473610;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0467.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (PubMed=26473610).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   SZ-SMA6
AC   CVCL_YL68
SY   SZ-SMA6 PGD; SMA#6
DR   NIHhESC; NIHhESC-20-0468
DR   Wikidata; Q98133049
RX   PubMed=26473610;
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0468.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7del; Zygosity=Homozygous (NIHhESC=NIHhESC-20-0468).
CC   Miscellaneous: Sex of donor from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   SZ-VHL1
AC   CVCL_YL69
SY   SZ-VHL1 PGD; VHL#1
DR   NIHhESC; NIHhESC-20-0482
DR   Wikidata; Q98133051
WW   Provider; SZMC; -; https://www.szmc.org.il/UploadFiles/12_2016/HESC.pdf
CC   From: Shaare Zedek Medical Center, The Hebrew University; Jerusalem; Israel.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-20-0482.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Arg64Pro (c.191G>C); ClinVar=VCV000002226; Zygosity=Unspecified (Direct_author_submission).
CC   Miscellaneous: Sequence variation from personal communication of Eiges, Rachel.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   SZ95
AC   CVCL_9803
SY   SZ-95; SZ 95
DR   BTO; BTO_0003484
DR   FCS-free; 31-2-33-2-4-3
DR   GEO; GSE57571
DR   Lonza; 489
DR   Wikidata; Q54971318
RX   Patent=US20160237406;
RX   PubMed=10594745;
RX   PubMed=18308950;
RX   PubMed=18690467;
RX   PubMed=20224690;
RX   PubMed=25061872;
RX   PubMed=25828468;
RX   PubMed=29451719;
RX   PubMed=29927962;
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Where-can-I-obtain-immortalized-human-sebocyte-cell-line-SZ95
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2383.
CC   Doubling time: 52.4 +- 1.6 hours (PubMed=10594745).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVT).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Face, skin, sebaceous gland; UBERON=UBERON_0003487.
CC   Cell type: Sebocyte; CL=CL_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   SZBKi001-A
AC   CVCL_D0M4
DR   BioSamples; SAMEA112769078
DR   hPSCreg; SZBKi001-A
DR   Wikidata; Q123033585
RX   PubMed=37099933;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0M5 ! SZBKi001-B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SZBKi001-B
AC   CVCL_D0M5
DR   BioSamples; SAMEA112770753
DR   hPSCreg; SZBKi001-B
DR   Wikidata; Q123033587
RX   PubMed=37099933;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0M4 ! SZBKi001-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SZBKi002-A
AC   CVCL_D0M6
DR   BioSamples; SAMEA112770754
DR   hPSCreg; SZBKi002-A
DR   Wikidata; Q123033588
RX   PubMed=37099933;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0M7 ! SZBKi002-B
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SZBKi002-B
AC   CVCL_D0M7
DR   BioSamples; SAMEA112770756
DR   hPSCreg; SZBKi002-B
DR   Wikidata; Q123033589
RX   PubMed=37099933;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0M6 ! SZBKi002-A
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   SZBKi003-A
AC   CVCL_D6R5
DR   BioSamples; SAMEA114863095
DR   hPSCreg; SZBKi003-A
RX   PubMed=38636268;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SZBKi004-A
AC   CVCL_D6R6
DR   BioSamples; SAMEA114863097
DR   hPSCreg; SZBKi004-A
RX   PubMed=38636268;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SZBKi005-A
AC   CVCL_D6R7
DR   BioSamples; SAMEA114863123
DR   hPSCreg; SZBKi005-A
RX   PubMed=38636268;
CC   From: Shenzhen Beike Biotechnology Co. Ltd; Shenzhen; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   SZCIQASFV1
AC   CVCL_XC07
DR   CCRID; 4201PAT-CCTCC00543
DR   Wikidata; Q98133053
RX   Patent=CN104497137B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014212.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q65194; African swine fever virus envelope protein p54 (Note=Also reacts with many isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   SZCIQASFV2
AC   CVCL_XC08
DR   CCRID; 4201PAT-CCTCC00544
DR   Wikidata; Q98133055
RX   Patent=CN104497136B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014213.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q65194; African swine fever virus envelope protein p54 (Note=Also reacts with many isolates).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   SZGJMSi001-A
AC   CVCL_C6SX
SY   ZLP-2
DR   BioSamples; SAMEA111342284
DR   hPSCreg; SZGJMSi001-A
DR   Wikidata; Q117704905
RX   PubMed=36502622;
CC   From: Research Center of Biological Psychiatry, Suzhou Guangji Hospital; Suzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SZGJMSi002-A
AC   CVCL_C6SY
SY   TSQ-1
DR   BioSamples; SAMEA111351696
DR   hPSCreg; SZGJMSi002-A
DR   Wikidata; Q117704906
RX   PubMed=36502622;
CC   From: Research Center of Biological Psychiatry, Suzhou Guangji Hospital; Suzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88411; Obsessive compulsive disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SZGJMSi003-A
AC   CVCL_C6SZ
SY   TSH-2
DR   BioSamples; SAMEA111351709
DR   hPSCreg; SZGJMSi003-A
DR   Wikidata; Q117704907
RX   PubMed=36502622;
CC   From: Research Center of Biological Psychiatry, Suzhou Guangji Hospital; Suzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   SZGJMSi004-A
AC   CVCL_D0M8
SY   WJM-1
DR   BioSamples; SAMEA112294709
DR   hPSCreg; SZGJMSi004-A
DR   Wikidata; Q123033590
RX   PubMed=38696853;
CC   From: Research Center of Biological Psychiatry, Suzhou Guangji Hospital; Suzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35094; Unipolar depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   SZGSQ-12
AC   CVCL_9T35
DR   IPD-IMGT/HLA; 25445
DR   Wikidata; Q54971319
RX   PubMed=22077627;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,26:01; B*15:02,46:01; DRB1*09:01,12:02 (IPD-IMGT/HLA=25445).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   SZGT-31
AC   CVCL_B7RU
SY   Sydney Zoology Goldfish Testis-31 degree
DR   Wikidata; Q112930451
RX   DOI=10.1016/B978-0-12-427150-0.50040-1;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 31 Celsius.
CC   Doubling time: ~18 hours (DOI=10.1016/B978-0-12-427150-0.50040-1).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   SZGT-37
AC   CVCL_B7RV
SY   Sydney Zoology Goldfish Testis-37 degree
DR   Wikidata; Q112930452
RX   DOI=10.1016/B978-0-12-427150-0.50040-1;
CC   Group: Fish cell line.
CC   Characteristics: Adapted to growth at 37 Celsius.
CC   Doubling time: ~18 hours (DOI=10.1016/B978-0-12-427150-0.50040-1).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7957; ! Carassius auratus (Goldfish)
HI   CVCL_B7RU ! SZGT-31
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   T 174
AC   CVCL_U955
DR   ATCC; CRL-7726
DR   Wikidata; Q54971322
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7726; true.
ST   Source(s): ATCC=CRL-7726
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   T HESCs
AC   CVCL_C464
SY   THESCs
DR   ATCC; CRL-4003
DR   BioSample; SAMN03471714
DR   Wikidata; Q54971321
RX   PubMed=14726435;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
CC   Cell type: Stromal cell of endometrium; CL=CL_0002255.
ST   Source(s): ATCC=CRL-4003
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 12,14
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 8
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 20,21
ST   Penta D: 10,11
ST   Penta E: 5,7
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   T-1
AC   CVCL_M858
SY   T1
DR   BioSample; SAMN03151761
DR   Wikidata; Q54971324
RX   CelloPub=CLPUB00262;
RX   DOI=10.2172/4683311;
RX   PubMed=1167420;
RX   PubMed=4288260;
RX   PubMed=5660764;
RX   PubMed=7394535;
RX   PubMed=13545791;
RX   PubMed=13686930;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=7394535; PubMed=20143388). Originally thought to originate from the kidney of a 8 year old boy.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00095.
CC   Population: African American.
CC   Doubling time: ~22-24 hours (DOI=10.2172/4683311).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   t-1
AC   CVCL_F1I6
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   t-10
AC   CVCL_F1IB
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   t-11
AC   CVCL_F1IC
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-13
AC   CVCL_D5GU
DR   RIKEN_BRC_EPD; rpc00009
DR   Wikidata; Q127384358
RX   PubMed=10808071;
RX   PubMed=16662301;
CC   Group: Plant cell line.
CC   Characteristics: Produces coumarin (PubMed=10808071; PubMed=16662301).
CC   Characteristics: Can be used to prepare protoplasts (PubMed=10808071).
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Bright Yellow.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   t-13
AC   CVCL_F1ID
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-1387
AC   CVCL_F244
DR   CLO; CLO_0009240
DR   CLDB; cl4453
DR   Wikidata; Q54971325
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   t-14
AC   CVCL_F1IE
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-143
AC   CVCL_E2VP
SY   143
RX   PubMed=8288271;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9V20 ! SPAM-8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   T-147
AC   CVCL_E2VQ
SY   147
RX   PubMed=7756584;
RX   PubMed=8288271;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04958; Clostridium tetani tetanus toxin (tetX).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_EY25 ! CLB-Hu-TT-1
HI   CVCL_9V20 ! SPAM-8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   t-15
AC   CVCL_F1IF
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   t-17
AC   CVCL_F1IG
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   t-18
AC   CVCL_F1IH
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   t-19
AC   CVCL_F1II
SY   t 19 clone
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-199
AC   CVCL_B7RX
DR   Wikidata; Q112930453
RX   PubMed=2743322;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on the cell surface of neuroectodermally derived tumors.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   t-2
AC   CVCL_F1I7
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   t-22
AC   CVCL_F1IJ
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-23
AC   CVCL_5595
DR   CLO; CLO_0050007
DR   RCB; RCB1861
DR   Wikidata; Q54971326
RX   PubMed=3331674;
CC   Doubling time: 18-19 hours (PubMed=3331674).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=37347; ! Tupaia belangeri (Common tree shrew)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   t-23
AC   CVCL_F1IK
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-23 clone 8
AC   CVCL_5596
SY   T-238
DR   JCRB; JCRB0745
DR   Wikidata; Q54971334
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=37347; ! Tupaia belangeri (Common tree shrew)
HI   CVCL_5595 ! T-23
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   T-289
AC   CVCL_8760
SY   289
DR   BTO; BTO_0004618
DR   Wikidata; Q54971335
RX   PubMed=3652009;
RX   PubMed=8752169;
RX   PubMed=9205073;
RX   PubMed=10661763;
CC   Characteristics: Established from a xenograft maintained in nude mice.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   T-289/DPP3
AC   CVCL_GZ32
SY   289 DPP3
DR   Wikidata; Q54583795
RX   PubMed=8752169;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8760 ! T-289
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 5
//
ID   T-289/TAM6
AC   CVCL_GZ33
SY   289/TAM6; 289 TAM6
DR   Wikidata; Q54583797
RX   PubMed=8752169;
RX   PubMed=9205073;
RX   PubMed=10661763;
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8760 ! T-289
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 5
//
ID   T-3-Cl-2
AC   CVCL_4312
AS   CVCL_F515
SY   T-3-CI-2; T3-C12; T3-CI2; T3Cl2; T3CL2; GM00979; GM-979; GM0979; GM00979B
DR   CLO; CLO_0029501
DR   Coriell; GM00979
DR   Wikidata; Q54971336
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1071084;
RX   PubMed=4509323;
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N76 ! TSFAT-3
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   T-3-Cl-2-0.fl
AC   CVCL_4313
SY   T-3-CI-2-0.fl
DR   CLO; CLO_0050784
DR   ECACC; 99072804
DR   RCB; RCB0561
DR   Wikidata; Q54971337
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4312 ! T-3-Cl-2
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   T-33
AC   CVCL_8427
DR   BioSample; SAMN03151816
DR   Wikidata; Q54971338
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3167860;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from the peripheral blood of a 62 year old female patient with chronic myelogenous leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00271.
CC   Population: Caucasian.
CC   Doubling time: 24-36 hours (PubMed=3167860).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 31
//
ID   T-37
AC   CVCL_E7BQ
RX   PubMed=23428061;
RX   PubMed=39326941;
CC   From: IMBICE Cell Repository, La Plata; Buenos Aires; Argentina.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   T-4
AC   CVCL_D1L8
DR   Wikidata; Q127384359
RX   PubMed=4288260;
RX   PubMed=13545791;
CC   Donor information: Established from a patient suffering from a pneumonic form of primary reticulosarcoma (PubMed=13545791).
CC   Derived from site: In situ; Lung, right middle lobe; UBERON=UBERON_0002174.
DI   NCIt; C3200; Lung neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   T-40
AC   CVCL_LM78
DR   Wikidata; Q54971339
RX   PubMed=3518877;
RX   PubMed=4350029;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   T-47
AC   CVCL_3945
SY   T47
DR   BTO; BTO_0003741
DR   Wikidata; Q54971340
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   T-47D
AC   CVCL_0553
SY   T-47-D; T47-D; T47D:A; T47D
DR   BTO; BTO_0001248
DR   CLO; CLO_0009251
DR   EFO; EFO_0001247
DR   MCCL; MCC:0000454
DR   CLDB; cl4454
DR   CLDB; cl4455
DR   CLDB; cl4923
DR   4DN; 4DNSRULKRD7P
DR   ABM; T8987
DR   AddexBio; C0006001/69
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; HTB-133
DR   BCRC; 60250
DR   BCRJ; 0323
DR   BioGRID_ORCS_Cell_line; 198
DR   BioSample; SAMN03472872
DR   BioSample; SAMN05292455
DR   BioSample; SAMN07710019
DR   BioSample; SAMN07710020
DR   BioSample; SAMN07710021
DR   BioSample; SAMN07710022
DR   BioSample; SAMN07710023
DR   BioSample; SAMN07710024
DR   BioSample; SAMN07710025
DR   BioSample; SAMN10987684
DR   cancercelllines; CVCL_0553
DR   CCRID; 1101HUM-PUMC000265
DR   CCRID; 3101HUMTCHu87
DR   CCRID; 4201HUM-CCTCC00045
DR   CCTCC; GDC0045
DR   Cell_Model_Passport; SIDM00097
DR   ChEMBL-Cells; CHEMBL3307606
DR   ChEMBL-Targets; CHEMBL614361
DR   CLS; 300353
DR   Cosmic; 687500
DR   Cosmic; 755296
DR   Cosmic; 871150
DR   Cosmic; 875882
DR   Cosmic; 877451
DR   Cosmic; 894091
DR   Cosmic; 897428
DR   Cosmic; 904395
DR   Cosmic; 905945
DR   Cosmic; 934538
DR   Cosmic; 944295
DR   Cosmic; 947353
DR   Cosmic; 949193
DR   Cosmic; 979711
DR   Cosmic; 991330
DR   Cosmic; 997925
DR   Cosmic; 1000126
DR   Cosmic; 1010918
DR   Cosmic; 1017169
DR   Cosmic; 1018470
DR   Cosmic; 1019311
DR   Cosmic; 1027050
DR   Cosmic; 1044203
DR   Cosmic; 1044220
DR   Cosmic; 1046942
DR   Cosmic; 1047715
DR   Cosmic; 1092641
DR   Cosmic; 1136342
DR   Cosmic; 1152529
DR   Cosmic; 1175835
DR   Cosmic; 1176629
DR   Cosmic; 1287901
DR   Cosmic; 1289418
DR   Cosmic; 1305387
DR   Cosmic; 1308999
DR   Cosmic; 1312373
DR   Cosmic; 1434958
DR   Cosmic; 1524350
DR   Cosmic; 1565732
DR   Cosmic; 1603226
DR   Cosmic; 1609473
DR   Cosmic; 1995658
DR   Cosmic; 1998484
DR   Cosmic; 2162162
DR   Cosmic; 2165027
DR   Cosmic; 2301534
DR   Cosmic; 2318373
DR   Cosmic; 2437466
DR   Cosmic; 2560247
DR   Cosmic; 2564833
DR   Cosmic; 2668277
DR   Cosmic; 2750524
DR   Cosmic-CLP; 905945
DR   DepMap; ACH-000147
DR   DSMZ; ACC-739
DR   DSMZCellDive; ACC-739
DR   ECACC; 85102201
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS323FFY
DR   ENCODE; ENCBS440ENC
DR   ENCODE; ENCBS441ENC
DR   ENCODE; ENCBS442ENC
DR   ENCODE; ENCBS597ENC
DR   ENCODE; ENCBS598ENC
DR   ENCODE; ENCBS599ENC
DR   ENCODE; ENCBS600ENC
DR   ENCODE; ENCBS601ENC
DR   ENCODE; ENCBS602ENC
DR   ENCODE; ENCBS603ENC
DR   ENCODE; ENCBS604ENC
DR   ENCODE; ENCBS610MSM
DR   ENCODE; ENCBS620AAA
DR   ENCODE; ENCBS622AAA
DR   ENCODE; ENCBS624AAA
DR   ENCODE; ENCBS625AAA
DR   ENCODE; ENCBS626AAA
DR   ENCODE; ENCBS627AAA
DR   ENCODE; ENCBS754KLC
DR   ENCODE; ENCBS805DMB
DR   ENCODE; ENCBS816QUZ
DR   ENCODE; ENCBS943ULT
DR   ENCODE; ENCBS979PGB
DR   GDSC; 905945
DR   GEO; GSM818
DR   GEO; GSM2098
DR   GEO; GSM50185
DR   GEO; GSM50249
DR   GEO; GSM69196
DR   GEO; GSM73762
DR   GEO; GSM115116
DR   GEO; GSM149980
DR   GEO; GSM149988
DR   GEO; GSM149996
DR   GEO; GSM186461
DR   GEO; GSM186462
DR   GEO; GSM186463
DR   GEO; GSM217605
DR   GEO; GSM274651
DR   GEO; GSM274652
DR   GEO; GSM274664
DR   GEO; GSM344358
DR   GEO; GSM344408
DR   GEO; GSM350514
DR   GEO; GSM378141
DR   GEO; GSM388215
DR   GEO; GSM421894
DR   GEO; GSM459712
DR   GEO; GSM481305
DR   GEO; GSM559637
DR   GEO; GSM750782
DR   GEO; GSM783929
DR   GEO; GSM799322
DR   GEO; GSM799385
DR   GEO; GSM816673
DR   GEO; GSM827326
DR   GEO; GSM839035
DR   GEO; GSM844714
DR   GEO; GSM844715
DR   GEO; GSM844716
DR   GEO; GSM847164
DR   GEO; GSM847440
DR   GEO; GSM847507
DR   GEO; GSM887685
DR   GEO; GSM888777
DR   GEO; GSM923428
DR   GEO; GSM923429
DR   GEO; GSM923431
DR   GEO; GSM923436
DR   GEO; GSM967820
DR   GEO; GSM1008576
DR   GEO; GSM1008919
DR   GEO; GSM1053715
DR   GEO; GSM1153391
DR   GEO; GSM1172904
DR   GEO; GSM1173000
DR   GEO; GSM1181243
DR   GEO; GSM1181259
DR   GEO; GSM1214577
DR   GEO; GSM1238136
DR   GEO; GSM1374950
DR   GEO; GSM1374951
DR   GEO; GSM1374952
DR   GEO; GSM1401654
DR   GEO; GSM1670521
DR   GEO; GSM1833628
DR   GEO; GSM2124689
DR   GEO; GSM7701426
DR   GEO; GSM7701444
DR   IARC_TP53; 98
DR   IBRC; C10103
DR   ICLC; HTL98003
DR   KCB; KCB 2011116YJ
DR   KCLB; 30133
DR   LiGeA; CCLE_903
DR   LINCS_HMS; 50541
DR   LINCS_LDP; LCL-1486
DR   Lonza; 748
DR   NCBI_Iran; C203
DR   NCI-DTP; T-47D
DR   PharmacoDB; T47D_1559_2019
DR   PRIDE; PXD002104
DR   PRIDE; PXD003539
DR   PRIDE; PXD005390
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0553
DR   PubChem_Cell_line; CVCL_0553
DR   SKY/M-FISH/CGH; 2824
DR   SLKBase; 3622
DR   TOKU-E; 3260
DR   TOKU-E; 3775
DR   Wikidata; Q54971341
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   DOI=10.4172/2157-7145.S2-005;
RX   PubMed=228940;
RX   PubMed=1961733;
RX   PubMed=8562478;
RX   PubMed=8824553;
RX   PubMed=9331090;
RX   PubMed=9671407;
RX   PubMed=9815641;
RX   PubMed=10700174;
RX   PubMed=10862037;
RX   PubMed=11044355;
RX   PubMed=11343771;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11687795;
RX   PubMed=12353263;
RX   PubMed=12661003;
RX   PubMed=12800145;
RX   PubMed=15748285;
RX   PubMed=15767549;
RX   PubMed=16142302;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=17088437;
RX   PubMed=17157791;
RX   PubMed=17254797;
RX   PubMed=18277095;
RX   PubMed=18516279;
RX   PubMed=19372543;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=19727395;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21378333;
RX   PubMed=21912889;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=22628656;
RX   PubMed=23151021;
RX   PubMed=23325432;
RX   PubMed=23601657;
RX   PubMed=23671654;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24279929;
RX   PubMed=24456987;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27378269;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29718670;
RX   PubMed=30787054;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=32576280;
RX   PubMed=34320349;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/T47D_StamandMyers_protocol.pdf
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/t-47d.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=5
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544491
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-41.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/T-47D
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/t-47d-xenograft-model/
WW   Provider; BRICS; BRICS0116; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3920
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: NCI-7 clinical proteomics reference material cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 1.6 days (PubMed=9671407); 59.7 hours, 33.8 hours (Note=With 17-beta-estradiol) (PubMed=32576280); 49.2 hours (PubMed=8562478; PubMed=9815641); 32 hours (CLS=300353); ~30-40 hours (DSMZ=ACC-739); 45.5 hours (NCI-DTP=T-47D); ~43 hours (PBCF); 55.80 hours (JWGray panel).
CC   HLA typing: A*33:01; B*14:02; C*08:02; DPB1*02:01:02,04:01; DQB1*05:01:01; DRB1*01:02:01 (PubMed=15748285).
CC   HLA typing: A*33:01,33:01; B*14:02,14:02; C*08:02,08:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=25960936).
CC   HLA typing: A*33:03,33:03; B*14:02,14:02; C*08:02,08:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=12661003; PubMed=23671654; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=17088437; PubMed=19593635; PubMed=28889351).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (PubMed=1961733; PubMed=9331090; PubMed=16541312; PubMed=17088437; PubMed=18277095; PubMed=21912889; PubMed=28889351).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.86%; Native American=1.2%; East Asian, North=3.03%; East Asian, South=1.59%; South Asian=8.04%; European, North=22.59%; European, South=62.69% (PubMed=30894373).
CC   Misspelling: T470; Cosmic=877451; Cosmic=1152529.
CC   Misspelling: T74D; Cosmic=1027050.
CC   Misspelling: T-47D-RU; Cosmic=1175835.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0006001/69; ATCC=HTB-133; CCRID; CLS=300353; Cosmic-CLP=905945; DSMZ=ACC-739; ECACC=85102201; KCLB=30133; DOI=10.4172/2157-7145.S2-005; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D10S1248: 17
ST   D12S391: 19
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D19S433: 14
ST   D1S1656: 15,16
ST   D21S11: 28,31
ST   D22S1045: 15
ST   D2S1338: 24
ST   D2S441: 14
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3945 ! T-47
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 52
//
ID   T-47D Control-PEROXO
AC   CVCL_ZM08
SY   T47D Control-PEROXO
DR   cancercelllines; CVCL_ZM08
DR   Wikidata; Q98133056
RX   PubMed=32417403;
CC   Population: Caucasian.
CC   Characteristics: Expresses Control-PEROXO-Tag, a chimeric protein consisting of three Myc epitopes attached to the N-terminus of mEGFP and a segment of PEX26 fused to the EGFP C-terminus.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:22965; PEX26 (Note=With p.Met1_Val236del).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   T-47D HA-PEROXO
AC   CVCL_ZM09
SY   T47D HA-PEROXO
DR   cancercelllines; CVCL_ZM09
DR   Wikidata; Q98133057
RX   PubMed=32417403;
CC   Population: Caucasian.
CC   Characteristics: Expresses PEROXO-Tag, a chimeric protein consisting of three HA epitopes attached to the N-terminus of mEGFP and a segment of PEX26 fused to the EGFP C-terminus. This tag allows for localization to and insertion into the peroxisomal membrane.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:22965; PEX26 (Note=With p.Met1_Val236del).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   T-47D shPARG
AC   CVCL_RA94
SY   shPARG T47D
DR   cancercelllines; CVCL_RA94
DR   Wikidata; Q54971342
RX   PubMed=29166620;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T-47D SimpleCell O-GalNAc
AC   CVCL_S034
SY   T47D SimpleCell; T47D SC
DR   cancercelllines; CVCL_S034
DR   Wikidata; Q54971343
RX   PubMed=23584533;
CC   Population: Caucasian.
CC   Characteristics: Cell engineered to produce only truncated GalNAc or NeuAc-alpha-2-6-GalNAc O-glycans.
CC   Knockout cell: Method=ZFN; HGNC; HGNC:24338; C1GALT1C1.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   T-47D Tam1
AC   CVCL_A4AN
DR   ATCC; CRL-3436
DR   cancercelllines; CVCL_A4AN
DR   Wikidata; Q105511140
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~1-2 weeks (ATCC=CRL-3436).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   T-47D Tam2
AC   CVCL_A4AP
DR   ATCC; CRL-3437
DR   cancercelllines; CVCL_A4AP
DR   Wikidata; Q105511143
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~1-2 weeks (ATCC=CRL-3437).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3437
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   T-47D Tet-Off
AC   CVCL_KU40
DR   cancercelllines; CVCL_KU40
DR   Wikidata; Q54971345
CC   Population: Caucasian.
CC   Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630924.
CC   Discontinued: Takara/Clontech; Catalog number 631145.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   T-47D Tet-On
AC   CVCL_V334
DR   cancercelllines; CVCL_V334
DR   Wikidata; Q54971346
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Discontinued: Takara/Clontech; Catalog number 630923.
CC   Discontinued: Takara/Clontech; Catalog number 631144.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 19
//
ID   T-47D-Luc
AC   CVCL_AS01
DR   JCRB; JCRB1374
DR   JCRB; NIHS0639
DR   Wikidata; Q54971347
CC   Problematic cell line: Contaminated. Shown to be a DLD-1 derivative (STR profile). Was originally thought to originate from T-47D (Cellosaurus=CVCL_0553).
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: JCRB; JCRB1374; probable.
CC   Discontinued: JCRB; NIHS0639; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
ST   Source(s): JCRB=JCRB1374
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0248 ! DLD-1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 14
//
ID   T-47D/BCRP
AC   CVCL_ZZ43
DR   cancercelllines; CVCL_ZZ43
DR   Wikidata; Q102114958
RX   PubMed=15695404;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Myc-tagged ABCG2/BCRP.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:74; ABCG2.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   T-47Daro
AC   CVCL_9582
DR   cancercelllines; CVCL_9582
DR   Wikidata; Q54971348
RX   PubMed=9449203;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 21
//
ID   t-6
AC   CVCL_F1I8
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-60
AC   CVCL_JX99
DR   Wikidata; Q54971349
RX   PubMed=10214354;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   T-67
AC   CVCL_QW79
DR   Wikidata; Q54971350
RX   PubMed=3518877;
RX   PubMed=6220172;
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 3
//
ID   t-7
AC   CVCL_F1I9
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-77
AC   CVCL_LK90
DR   Wikidata; Q54971351
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
CC   Donor information: Established from a patient suffering from 'reticulum cell sarcoma'.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   t-8
AC   CVCL_F1IA
RX   PubMed=6201727;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P06454; Human PTMA (Note=AA 2-20 = Thymosin alpha-1. Also reacts with bovine and other species as this peptide is 100% conserved across mammals).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   T-82
AC   CVCL_LK91
DR   Wikidata; Q54971353
RX   PubMed=833871;
RX   PubMed=3518877;
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 5
//
ID   T-85
AC   CVCL_IX02
DR   Wikidata; Q54971354
RX   PubMed=8581142;
CC   Population: Japanese.
CC   Characteristics: Produces high quantity of IL6 (PubMed=8581142).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   T-88
AC   CVCL_5369
SY   T88
DR   Wikidata; Q54971356
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=2624778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=T88
CC   Characteristics: IL3 or IL5 dependent.
CC   Caution: Not from strain DBA/2J as originally published but from strain C3H/He (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2-3W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   T-9
AC   CVCL_M092
SY   T9
DR   BioSample; SAMN03151762
DR   Wikidata; Q54971358
RX   PubMed=1246601;
RX   PubMed=4472134;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=4472134; PubMed=20143388). Originally thought to be a derivative of WI-38.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00096.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 19
//
ID   T-Ag-MOSE
AC   CVCL_C562
SY   T-Antigen-carrying Mouse Ovarian Surface Epithelium
DR   JCRB; JCRB0151
DR   JCRB; NIHS0214
DR   Wikidata; Q54971360
RX   PubMed=9820870;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: JCRB; NIHS0214; true.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   8W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   T-AL/N
AC   CVCL_6334
SY   T AL/N; TAL/N
DR   CLO; CLO_0009266
DR   ATCC; CRL-6514
DR   Wikidata; Q54971361
RX   PubMed=174816;
RX   PubMed=4302577;
RX   PubMed=4331720;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6514; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AL/N.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6312 ! AL/N
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   T-CDS17
AC   CVCL_WJ32
SY   T-CDS-17
DR   ABM; T8287
DR   cancercelllines; CVCL_WJ32
DR   Wikidata; Q98133060
RX   PubMed=30987403;
CC   Characteristics: Established from a xenograft obtained by subcutaneous inoculation of parent cell line in immunodeficient mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple; p.Arg172Gly (c.514A>G); ClinVar=VCV000376439; Zygosity=Heterozygous (PubMed=30987403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Arg (c.645T>G); ClinVar=VCV000376661; Zygosity=Homozygous (PubMed=30987403).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Cartilage; UBERON=UBERON_0002418.
ST   Source(s): PubMed=30987403
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 14,16
DI   NCIt; C6476; Dedifferentiated chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WJ31 ! CDS17
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   T-cell-iPSC
AC   CVCL_E7ST
RX   PubMed=26500142;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+Dep%C3%B3sito+de+iPSC+human+T-cell.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Josep Carreras Leukemia Research Institute; Barcelona; Spain.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   T-HEECs
AC   CVCL_0F63
SY   T HEECs; THEECs
DR   ATCC; CRL-4026
DR   BioSample; SAMN03471729
DR   Wikidata; Q54971362
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ATCC; CRL-4026; true.
CC   Derived from site: In situ; Endometrium, epithelium; UBERON=UBERON_0004811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-4026
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,10,12
ST   D16S539: 9,12
ST   D5S818: 11,12,13
ST   D7S820: 9,10,11,12
ST   TH01: 7,8,9
ST   TPOX: 8,10
ST   vWA: 14,15,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 12
//
ID   T-HSC/Cl-6
AC   CVCL_M083
DR   BTO; BTO_0003527
DR   Wikidata; Q54971363
RX   PubMed=12753423;
RX   PubMed=17760834;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   t-HUE1
AC   CVCL_UY91
DR   cancercelllines; CVCL_UY91
DR   Wikidata; Q98133061
RX   PubMed=1817644;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 30 hours (PubMed=1817644).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2029 ! ECV-304
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   t-HUE2
AC   CVCL_J427
DR   cancercelllines; CVCL_J427
DR   Wikidata; Q54971364
RX   PubMed=1817644;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Parent cell line (ECV-304) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 35 hours (PubMed=1817644).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2029 ! ECV-304
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   t-HUE4
AC   CVCL_J428
DR   cancercelllines; CVCL_J428
DR   Wikidata; Q54971366
RX   PubMed=1817644;
CC   Group: Serum/protein free medium cell line.
CC   Problematic cell line: Contaminated. Grand-parent cell line (ECV-304) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 45 hours (PubMed=1817644).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J427 ! t-HUE2
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   T-MNU-1
AC   CVCL_A9K0
DR   Wikidata; Q102114959
RX   PubMed=29288005;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60691; Rat urinary system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   >35W
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   T-REx Tango GHSR-bla U2OS
AC   CVCL_ZK27
DR   Wikidata; Q98133062
WW   Provider; Thermo Fisher; K1819; https://www.thermofisher.com/order/catalog/product/K1819
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4267; GHSR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   T-REx Tango P2RY14-bla U2OS
AC   CVCL_ZK28
DR   Wikidata; Q98133063
WW   Provider; Thermo Fisher; K1858; https://www.thermofisher.com/order/catalog/product/K1858
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16442; P2RY14.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   T-REx-293
AC   CVCL_D585
SY   T-REx 293; T-REx293; TRex-293; TREx293; T-REx-HEK293; T-REx HEK 293; HEK293-T-REx; HEK293-Trex
DR   BTO; BTO_0005238
DR   CLO; CLO_0037238
DR   Wikidata; Q54971367
WW   Info; EMA; -; https://www.ema.europa.eu/en/documents/assessment-report/vaxzevria-previously-covid-19-vaccine-astrazeneca-epar-public-assessment-report_en.pdf
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/T-REx-HEK293_Farnham_protocol.pdf
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-410.html
WW   Provider; Thermo Fisher; R71007; https://www.thermofisher.com/order/catalog/product/R71007
CC   Group: Vaccine production cell line.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Biotechnology: Used for the production of the AstraZeneca SARS-CoV-2 (COVID-19) vaccine (Trade name: Vaxzevria; also known as ChAdOx1-SARS-COV-2 or AZD1222) (DrugBank=DB15656). In the context of the vaccine production, the tetR repressor blocks the expression of the SARS-CoV-2 spike protein gene during production of the recombinant adenoviral vector, thereby optimising vector production.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 26
//
ID   T-REx-293-MSR
AC   CVCL_KS19
SY   T-REx 293-MSR; T-REx 293 MSR; 293 MSR tetR
DR   Wikidata; Q54971368
RX   Patent=US7217566;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-5079.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7376; MSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U428 ! GripTite 293 MSR
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 11
//
ID   T-REx-CHO
AC   CVCL_D586
SY   T-REX-CHO; T-REx CHO; T-REx-CHO-K1; CHO-T-Rex
DR   Wikidata; Q54971369
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-599.html
WW   Provider; Thermo Fisher; R71807; https://www.thermofisher.com/order/catalog/product/R71807
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   T-REx-HeLa
AC   CVCL_D587
SY   T-REx HeLa; HeLa T-REx
DR   EFO; EFO_0022683
DR   TOKU-E; 3542
DR   Wikidata; Q54971370
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-598.html
WW   Provider; Thermo Fisher; R71407; https://www.thermofisher.com/order/catalog/product/R71407
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   T-REx-Jurkat
AC   CVCL_D588
SY   T-REx Jurkat
DR   cancercelllines; CVCL_D588
DR   Wikidata; Q54971371
WW   Provider; Thermo Fisher; R72207; https://www.thermofisher.com/order/catalog/product/R72207
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   T-tag MEC
AC   CVCL_E7GM
SY   T-antigen Mammary Epithelial Cells
RX   PubMed=39322983;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
CC   Breed/subspecies: East Friesian x Hu; VBO=VBO_0001404+VBO_0015749.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   T-YFP-SF1
AC   CVCL_F703
DR   Wikidata; Q54971372
RX   PubMed=21959845;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Doubling time: 27.27 hours (Note=In 15% FBS), 29.4 hours (Note=In 10% FBS) (PubMed=21959845).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Tail lobe, skin; UBERON=UBERON_8480071.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1706337; ! Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise)
HI   CVCL_F702 ! YFP-SF1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   T.T
AC   CVCL_3174
SY   T-T; T_T_; T. T; tdott; TT
DR   CLO; CLO_0009935
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1031
DR   BioSample; SAMN03470960
DR   BioSample; SAMN10988191
DR   cancercelllines; CVCL_3174
DR   Cell_Model_Passport; SIDM00322
DR   ChEMBL-Cells; CHEMBL3989362
DR   Cosmic; 923184
DR   Cosmic-CLP; 1299064
DR   DepMap; ACH-000561
DR   EGA; EGAS00001000978
DR   GDSC; 1299064
DR   GEO; GSM827520
DR   GEO; GSM887713
DR   GEO; GSM888806
DR   GEO; GSM1670549
DR   IARC_TP53; 21664
DR   JCRB; JCRB0262
DR   LiGeA; CCLE_660
DR   LINCS_LDP; LCL-1561
DR   PharmacoDB; T_T_1555_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3174
DR   PubChem_Cell_line; CVCL_3174
DR   Wikidata; Q54971374
RX   DOI=10.5794/jjoms.36.307;
RX   PubMed=9290701;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 27 hours (Note=At 50th passage) (DOI=10.5794/jjoms.36.307); 40 hours (PubMed=25984343); ~1.2 days (Note=Lot 09262006), 28-38 hours (Note=Lot 10132015) (JCRB=JCRB0262).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Unspecified (PubMed=9290701).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.13%; Native American=0%; East Asian, North=82.54%; East Asian, South=14.89%; South Asian=0%; European, North=0%; European, South=2.44% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone, jaw, mandible; UBERON=UBERON_0001684.
ST   Source(s): Cosmic-CLP=1299064; JCRB=JCRB0262; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 8,10
ST   D7S820: 11
ST   D8S1179: 15,16
ST   FGA: 18
ST   Penta D: 12
ST   Penta E: 16,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3175 ! T.Tn
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   T.Tn
AC   CVCL_3175
SY   T_Tn; T-Tn; TTn; T Tn; T-Tn6; TTN
DR   CLO; CLO_0009936
DR   BioSample; SAMN03471669
DR   cancercelllines; CVCL_3175
DR   Cosmic; 873391
DR   Cosmic; 923185
DR   Cosmic; 1612902
DR   GEO; GSM827521
DR   GEO; GSM1374967
DR   IARC_TP53; 21668
DR   JCRB; JCRB0261
DR   LINCS_LDP; LCL-1562
DR   Progenetix; CVCL_3175
DR   Wikidata; Q54971375
RX   DOI=10.5794/jjoms.36.307;
RX   PubMed=9290701;
RX   PubMed=15885884;
RX   PubMed=20215515;
CC   Population: Japanese.
CC   Characteristics: Established from the original tumor through transplantation in nude mice.
CC   Doubling time: 27 hours (Note=At 52th passage) (DOI=10.5794/jjoms.36.307); 32-35 hours (Note=Lot 01212003), ~28 hours (Note=Lot 01262015) (JCRB=JCRB0261).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (PubMed=9290701).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Bone, jaw, mandible; UBERON=UBERON_0001684.
ST   Source(s): JCRB=JCRB0261
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 8,10
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3174 ! T.T
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   T/C28a2
AC   CVCL_6850
SY   T/C-28a2; T/C-28 a2; TC28a2; C28A2; T/C-28
DR   BTO; BTO_0003860
DR   EFO; EFO_0022684
DR   GEO; GSM297603
DR   GEO; GSM297604
DR   Lonza; 121
DR   Lonza; 1423
DR   Millipore; SCC042
DR   PRIDE; PXD025187
DR   Wikidata; Q54971376
RX   PubMed=7989586;
RX   PubMed=14673991;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
ST   Source(s): Millipore=SCC042
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 16,19
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 20
ST   Penta D: 14
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   T/C28a4
AC   CVCL_M776
SY   T/C-28a4
DR   BTO; BTO_0005558
DR   Wikidata; Q54971377
RX   PubMed=14673991;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Rib, costal cartilage; UBERON=UBERON_0002236.
CC   Cell type: Chondrocyte; CL=CL_0000138.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6850 ! T/C28a2
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   T/G HA-VSMC
AC   CVCL_4009
SY   T/G HA VSMC; T/G HA-vSMC; T/GHA-VSMC; TGHAVSMC; T/G Human Aortic Vascular Smooth Muscle Cells
DR   BTO; BTO_0001962
DR   CLO; CLO_0009237
DR   CLDB; cl4470
DR   ATCC; CRL-1999
DR   BioSample; SAMN03471275
DR   CCRID; 4201HUM-CCTCC00632
DR   ECACC; 94102702
DR   IZSLER; BS CL 149
DR   Lonza; 1084
DR   NCBI_Iran; C591
DR   Wikidata; Q54971378
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-and-growth-of-the-cell-line-t-g-ha-vsmc-atcc-crl-1999
CC   Population: Caucasian.
CC   Discontinued: ECACC; 94102702; true.
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
ST   Source(s): ATCC=CRL-1999; IZSLER=BS CL 149
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 18,22
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 20
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 12,13
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   T0033
AC   CVCL_VG47
SY   Immortalized Human Skeletal Muscle Myoblasts
DR   ABM; T0033
DR   Wikidata; Q54971379
CC   Population: Caucasian.
CC   Doubling time: 30-40 hours (ABM=T0033).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
ST   Source(s): ABM=T0033
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 13
ST   D21S11: 30,31
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   T0034
AC   CVCL_VG48
SY   Immortalized Human Skeletal Muscle Cells
DR   ABM; T0034
DR   Wikidata; Q54971380
CC   Doubling time: 30-40 hours (ABM=T0034).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
ST   Source(s): ABM=T0034
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   T1
AC   CVCL_7904
SY   T1 (174 x CEM.T1); T1(174 x CEM.T1); 174xCEM.T1; 174xCEM; CEMx174; CEM x 174
DR   BTO; BTO_0006566
DR   CLO; CLO_0009238
DR   EFO; EFO_0022421
DR   ATCC; CRL-1991
DR   BEI_Resources; ARP-272
DR   BioSample; SAMN03471270
DR   Wikidata; Q54971392
RX   PubMed=3872841;
ST   Source(s): ATCC=CRL-1991
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 12,13,17
ST   D19S433: 12,14,15
ST   D21S11: 28,30,34.2
ST   D2S1338: 18,24,25
ST   D3S1358: 14,15,16
ST   D5S818: 12,14
ST   D7S820: 10,11,15
ST   D8S1179: 10,13,14
ST   FGA: 23,24
ST   Penta D: 11,12,14
ST   Penta E: 5,12,14
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6260 ! LCL 721.174
HI   CVCL_7905 ! CEMR.3
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   T1 [Human contaminated neural stem cell]
AC   CVCL_1U15
DR   BioSample; SAMN03151760
DR   Wikidata; Q54971393
RX   PubMed=21814484;
RX   PubMed=22949886;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=22949886).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00453.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   T1 [Rat mesothelioma]
AC   CVCL_C1IK
DR   Wikidata; Q114313079
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T1 1Cr NKX2.1 Pt 1
AC   CVCL_D3C4
SY   T1; T1-1Cr4
DR   Wikidata; Q127384360
RX   PubMed=26593959;
WW   Provider; CReM; 590; https://stemcellbank.bu.edu/Catalog/Item/Details/590
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11825; NKX2-1; Simple; p.Pro129Glyfs (c.384_391delGCCGTACC); Zygosity=Unspecified (PubMed=26593959).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202546; Choreoathetosis, hypothyroidism, and neonatal respiratory distress
DI   ORDO; Orphanet_209905; Brain-lung-thyroid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   T1-107
AC   CVCL_C5LV
DR   ABCD; ABCD_AE145
DR   Wikidata; Q116050605
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T1-18
AC   CVCL_LK87
DR   Wikidata; Q54971394
RX   Patent=US4870163;
RX   PubMed=3863119;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8887.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P01375; Human TNF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-11-17; Last updated: 21-03-23; Version: 4
//
ID   T1-73
AC   CVCL_3605
AS   CVCL_1772
SY   TI-73; T173
DR   CLO; CLO_0009241
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7943
DR   BioSample; SAMN03471127
DR   BioSample; SAMN10987677
DR   cancercelllines; CVCL_3605
DR   Cell_Model_Passport; SIDM01765
DR   ChEMBL-Cells; CHEMBL3308222
DR   ChEMBL-Targets; CHEMBL2366158
DR   Cosmic; 687932
DR   Cosmic; 910696
DR   DepMap; ACH-000529
DR   GDSC; 910696
DR   GEO; GSM185158
DR   GEO; GSM185159
DR   GEO; GSM827271
DR   GEO; GSM887682
DR   GEO; GSM888774
DR   IARC_TP53; 27709
DR   IARC_TP53; 30177
DR   LiGeA; CCLE_417
DR   PharmacoDB; TI73_1594_2019
DR   Progenetix; CVCL_3605
DR   PubChem_Cell_line; CVCL_3605
DR   Wikidata; Q54971395
RX   DOI=10.1101/166199;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a osteosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000529).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,01:01; B*08:01,44:05; C*02:02,07:06; DRB1*13:86,16:05 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.88%; Native American=0.25%; East Asian, North=0.51%; East Asian, South=0%; South Asian=3.27%; European, North=53.75%; European, South=41.34% (PubMed=30894373).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7943
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 12,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,24
ST   D3S1358: 17,19
ST   D5S818: 8,12
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 19,24
ST   Penta D: 9,14
ST   Penta E: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N340 ! F1-73
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   T1-A
AC   CVCL_6C57
DR   ABM; T8144
DR   Wikidata; Q54971396
RX   PubMed=26254261;
CC   Characteristics: Highly tumorigenic. Obtained by subcutaneous hind quarter injection of parent cell line (GhrasT-NIH/3T3) in NIH Swiss mice and selection of cells from a hind quarter tumor.
CC   Doubling time: 17.5 hours (PubMed=26254261).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_WS34 ! GhrasT-NIH/Swiss
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   T1-LOHG
AC   CVCL_LI14
DR   Wikidata; Q54971398
RX   PubMed=15753990;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Thr215Serfs*13 (c.643_646delACAG); ClinVar=VCV000200997; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   NCIt; C5394; Solitary adult fibroma
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LI09 ! LOHG-F
SX   Male
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   T1.7
AC   CVCL_K255
DR   CLO; CLO_0050389
DR   RCB; RCB2307
DR   Wikidata; Q54971399
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P18266; Rat Gsk3b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   T1/CUHK
AC   CVCL_E317
SY   Tongue 1/Chinese University of Hong Kong
DR   Wikidata; Q54971400
RX   PubMed=1280031;
RX   PubMed=7788927;
CC   Population: Chinese.
CC   Doubling time: 26 hours (PubMed=7788927).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   T1/HCVcon
AC   CVCL_B334
DR   Wikidata; Q54971402
RX   PubMed=15914852;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7904 ! T1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   T1/NS3-4A
AC   CVCL_B335
DR   Wikidata; Q54971403
RX   PubMed=15914852;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7904 ! T1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 5
//
ID   T10 [Human iPSC]
AC   CVCL_RL56
DR   SKIP; SKIP000907
DR   Wikidata; Q54971404
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   T10 [Rat mesothelioma]
AC   CVCL_C1IL
DR   Wikidata; Q114313080
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T10-1
AC   CVCL_C5LW
DR   Wikidata; Q116050606
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T10-5
AC   CVCL_C5LX
DR   ABCD; ABCD_AE146
DR   Wikidata; Q116050607
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T1000
AC   CVCL_M809
DR   Cosmic; 2800530
DR   Wikidata; Q54971405
RX   PubMed=22911243;
RX   PubMed=26643872;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 10
//
ID   T101 [Human retinoblastoma]
AC   CVCL_ZF13
DR   Wikidata; Q98133064
RX   PubMed=23498719;
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; None_reported; -; Zygosity=- (PubMed=23498719).
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   T101 [Mouse hybridoma against human bladder carcinomas]
AC   CVCL_N333
DR   ATCC; HB-8273
DR   Wikidata; Q54971406
RX   Patent=US4643971;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8273.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   T101 [Mouse hybridoma against human CD5]
AC   CVCL_DC79
DR   Wikidata; Q54971407
RX   CelloPub=CLPUB00335;
RX   Patent=US4675386;
RX   PubMed=6993560;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8023.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.
CC   Anecdotal: The T101 mAb was one of the earliest mAbs to be tested in clinical trials against cutaneous T cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   T101-iPSC
AC   CVCL_DD61
DR   Wikidata; Q54971408
RX   PubMed=27191603;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X,Y
ST   CSF1PO: 10,14
ST   D13S317: 9,11
ST   D16S539: 12
ST   D21S11: 28,31
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD53 ! ND31630
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 13
//
ID   T103p53i
AC   CVCL_E3FY
RX   PubMed=16829690;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   T105
AC   CVCL_C7VZ
DR   Wikidata; Q123033591
RX   PubMed=27723895;
CC   Doubling time: 29.64 +- 2.04 hours (Note=At 6-11th passages), 16.55 +- 0.15 hours (Note=At 60-62th passages) (PubMed=27723895).
CC   Karyotypic information: Trisomy of chromosome 8 (PubMed=27723895).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=27723895).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=27723895
ST   Amelogenin: X
ST   D10S1248: 14
ST   D12S391: 18,21
ST   D19S433: 17,18
ST   D1S1656: 14,15
ST   D22S1045: 16
ST   D2S1338: 19
ST   D2S441: 12,15
ST   D6S1043: 11
ST   TH01: 7,9.3
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   T11 [Human ESC]
AC   CVCL_RL57
DR   SKIP; SKIP000908
DR   Wikidata; Q54971409
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   T11 [Human glioblastoma]
AC   CVCL_8926
DR   Wikidata; Q54971410
RX   PubMed=19886054;
CC   Doubling time: 74 hours (PubMed=19886054).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   T11 [Rat mesothelioma]
AC   CVCL_C1IM
DR   Wikidata; Q114313081
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T110 [Human B-cell IHW]
AC   CVCL_6G70
DR   IPD-IMGT/HLA; 12647
DR   Wikidata; Q54971411
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:09,23:01; B*44:15,81:01; C*04:07,18:AB (IPD-IMGT/HLA=12647).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   T110 [Mouse hybridoma]
AC   CVCL_N334
SY   URO6
DR   Wikidata; Q54971412
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8278.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   T11D7e2
AC   CVCL_F769
SY   T11D7
DR   CLO; CLO_0009239
DR   AddexBio; C0033001/4938
DR   ATCC; TIB-103
DR   BCRC; 60471
DR   ECACC; 92021209
DR   ECACC; 92021210
DR   Wikidata; Q54971414
RX   PubMed=393521;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90 (Note=Allotype 1.1).
CC   Discontinued: ECACC; 92021209; true.
CC   Discontinued: ECACC; 92021210; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   T12
AC   CVCL_C1IN
DR   Wikidata; Q114313082
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T122
AC   CVCL_C7W0
DR   Wikidata; Q123033594
RX   PubMed=27723895;
CC   Doubling time: 27.86 +- 3.71 hours (Note=At 6-11th passages), 20.47 +- 2.23 hours (Note=At 60-62th passages) (PubMed=27723895).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=27723895
ST   Amelogenin: X
ST   D10S1248: 14
ST   D12S391: 19
ST   D19S433: 14,15
ST   D1S1656: 11,12
ST   D22S1045: 15
ST   D2S1338: 19
ST   D2S441: 11
ST   D6S1043: 11
ST   TH01: 6,7
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   T127
AC   CVCL_C7W1
DR   Wikidata; Q123033595
RX   PubMed=27723895;
CC   Doubling time: 28.40 +- 0.32 hours (Note=At 6-11th passages), 20.71 +- 2.48 hours (Note=At 60-62th passages) (PubMed=27723895).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   T13
AC   CVCL_C1IP
DR   Wikidata; Q114313083
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T130
AC   CVCL_C7W2
DR   Wikidata; Q123033596
RX   PubMed=27723895;
CC   Doubling time: 23.65 +- 0.35 hours (Note=At 6-11th passages), 16.70 +- 0.15 hours (Note=At 60-62th passages) (PubMed=27723895).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   T137p53i
AC   CVCL_E3FZ
RX   PubMed=16829690;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   T138
AC   CVCL_N335
SY   EC1
DR   ATCC; HB-8277
DR   Wikidata; Q54971417
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8277.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   T142
AC   CVCL_C7W3
DR   GEO; GSM1499916
DR   GEO; GSM1499917
DR   GEO; GSM1499918
DR   Wikidata; Q123033597
RX   PubMed=27723895;
CC   Doubling time: 34.32 +- 3.46 hours (Note=At 6-11th passages), 14.46 +- 1.06 hours (Note=At 60-62th passages) (PubMed=27723895).
CC   Karyotypic information: Monosomy of chromosome 3 and trisomy of chromosome 8 (PubMed=27723895).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=27723895).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=27723895
ST   Amelogenin: X
ST   D10S1248: 14
ST   D12S391: 21
ST   D19S433: Not_detected
ST   D1S1656: 14,15
ST   D22S1045: 16
ST   D2S1338: 19
ST   D2S441: 15
ST   D6S1043: Not_detected
ST   TH01: 7,9.3
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   T143
AC   CVCL_C7W4
DR   GEO; GSM1499920
DR   GEO; GSM1499921
DR   GEO; GSM1499922
DR   Wikidata; Q123033599
RX   PubMed=27723895;
CC   Doubling time: 27.17 +- 0.97 hours (Note=At 6-11th passages), 16.12 +- 1.45 hours (Note=At 60-62th passages) (PubMed=27723895).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=27723895
ST   Amelogenin: X
ST   D10S1248: 14,15
ST   D12S391: 20,21
ST   D19S433: 16,17,18
ST   D1S1656: 14,15,16.3
ST   D22S1045: 16
ST   D2S1338: 19,20
ST   D2S441: 12,15
ST   D6S1043: 11
ST   TH01: 7,9.3
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 3
//
ID   T14c
AC   CVCL_HF47
DR   Wikidata; Q54971418
RX   PubMed=2583278;
CC   Doubling time: ~24 hours (PubMed=2583278).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Cheek pouch; Note=From a granulomatous inflammation; UBERON=UBERON_0008802.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 6
//
ID   T151p53i
AC   CVCL_E3G0
RX   PubMed=16829690;
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   T16
AC   CVCL_N336
SY   URO5
DR   Wikidata; Q54971419
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=1459581;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8279.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   T1682
AC   CVCL_D023
DR   GEO; GSM577205
DR   Wikidata; Q54971421
RX   PubMed=18360827;
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Mediastinum; UBERON=UBERON_0003728.
DI   NCIt; C6887; Thymoma type B1
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   T17-17703A
AC   CVCL_JF17
DR   Wikidata; Q54971422
RX   Patent=US8513018;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Transgene SA; Illkirch-Graffenstaden; France.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 09070703.
CC   Doubling time: 47 hours (Patent=US8513018).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; B7S5K9; Cairina moschata TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
HI   CVCL_JF18 ! DuckCelt-T17
SX   Sex unspecified
AG   Embryo
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   T17-17703B
AC   CVCL_JF15
DR   Wikidata; Q54971423
RX   Patent=US8513018;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Transgene SA; Illkirch-Graffenstaden; France.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 09070701.
CC   Doubling time: 35 hours (Patent=US8513018).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; B7S5K9; Cairina moschata TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
HI   CVCL_JF18 ! DuckCelt-T17
SX   Sex unspecified
AG   Embryo
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   T17-17703B2
AC   CVCL_JF16
DR   Wikidata; Q54971424
RX   Patent=US8513018;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   From: Transgene SA; Illkirch-Graffenstaden; France.
CC   Registration: International Depositary Authority, European Collection of Cell Cultures (ECACC); 09070702.
CC   Doubling time: 30 hours (Patent=US8513018).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; B7S5K9; Cairina moschata TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03255; Human adenovirus C serotype 5 E1A protein.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A).
OX   NCBI_TaxID=8855; ! Cairina moschata (Muscovy duck)
HI   CVCL_JF18 ! DuckCelt-T17
SX   Sex unspecified
AG   Embryo
CA   Telomerase immortalized cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   T1889
AC   CVCL_D024
SY   TC1889; T-1889; 1889c
DR   Cosmic; 1498256
DR   GEO; GSM577204
DR   Wikidata; Q54971425
RX   PubMed=18360827;
RX   PubMed=34781947;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Ile (c.738G>T); ClinVar=VCV000968639; Zygosity=Homozygous (PubMed=34781947).
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C35718; Thymic undifferentiated carcinoma
DI   ORDO; Orphanet_99868; Thymic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   T1D HKLV#2
AC   CVCL_B5RH
SY   T1D LV2
DR   Wikidata; Q112041757
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=23197849
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 20,23
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RI ! T1D HKSV#D
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   T1D HKSV#D
AC   CVCL_B5RI
SY   T1D SV#D
DR   Wikidata; Q112041759
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=23197849
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D3S1358: 14,18
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 20,23
ST   TPOX: 8,10
ST   vWA: 14,17
DI   NCIt; C2986; Type 1 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5RH ! T1D HKLV#2
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   t1E4
AC   CVCL_D3ET
DR   Wikidata; Q127384361
RX   PubMed=27608665;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   T1SV2
AC   CVCL_E3G9
RX   PubMed=12096332;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=776).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Theca cell; CL=CL_0000503.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_6630 ! G1SV1
OI   CVCL_E3GA ! T1SV3
SX   Female
AG   3-6Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   T1SV3
AC   CVCL_E3GA
RX   PubMed=12096332;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=776).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Theca cell; CL=CL_0000503.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
OI   CVCL_6630 ! G1SV1
OI   CVCL_E3G9 ! T1SV2
SX   Female
AG   3-6Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   T2
AC   CVCL_2211
SY   T2 (174 x CEM.T2); T2(174 x CEM.T2); 174xCEM.T2; CEMx721.174.T2
DR   BTO; BTO_0003771
DR   CLO; CLO_0009242
DR   CLO; CLO_0050160
DR   EFO; EFO_0022680
DR   ATCC; CRL-1992
DR   BioSample; SAMN03471271
DR   BioSample; SAMN03472034
DR   CLS; 305228
DR   DSMZ; ACC-598
DR   DSMZCellDive; ACC-598
DR   Lonza; 926
DR   NCBI_Iran; C509
DR   RCB; RCB1932
DR   TKG; TKG 0599
DR   TOKU-E; 3251
DR   Wikidata; Q54971430
RX   PubMed=1373173;
RX   PubMed=3872841;
CC   Doubling time: ~40-60 hours (DSMZ=ACC-598).
ST   Source(s): ATCC=CRL-1992; DSMZ=ACC-598; RCB=RCB1932; TKG=TKG 0599
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 12,13,17
ST   D19S433: 12,14
ST   D21S11: 28,30,34.2
ST   D2S1338: 18,24,25
ST   D3S1358: 14,16
ST   D5S818: 12,14
ST   D7S820: 10,11 (RCB=RCB1932; TKG=TKG 0599)
ST   D7S820: 10,11,15 (ATCC=CRL-1992; DSMZ=ACC-598)
ST   D8S1179: 10,13,14
ST   FGA: 23,24
ST   Penta D: 11,12,14
ST   Penta E: 5,12,14
ST   TH01: 6,7,9.3
ST   TPOX: 8,12
ST   vWA: 14,17,20 (ATCC=CRL-1992; DSMZ=ACC-598; TKG=TKG 0599)
ST   vWA: 17,19 (RCB=RCB1932)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7904 ! T1
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   T2 [Rat mesothelioma]
AC   CVCL_C1IQ
DR   Wikidata; Q114313084
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T2-150
AC   CVCL_C5LY
DR   ABCD; ABCD_AE149
DR   Wikidata; Q116050608
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T2-A
AC   CVCL_6C58
DR   ABM; T8145
DR   Wikidata; Q54971431
RX   PubMed=26254261;
CC   Characteristics: Obtained by intravenous injection of parent cell line (T1-A) in the tail vein of NIH Swiss mice and selection of cells from a local metastasis.
CC   Doubling time: 15.5 hours (PubMed=26254261).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6C57 ! T1-A
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   T2.5
AC   CVCL_E5MG
DR   ABCD; ABCD_AX059
RX   PubMed=15146245;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O60603; Human TLR2 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   T2.A3
AC   CVCL_S602
SY   T2-A3; T2/A3
DR   Wikidata; Q54971433
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4931; HLA-A (Note=Allele A*03).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2211 ! T2
CA   Hybrid cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 9
//
ID   T2.DR3
AC   CVCL_9W17
SY   T2/DR3; T2DR3
DR   Wikidata; Q54971434
RX   PubMed=1373173;
RX   PubMed=7600288;
RX   PubMed=8195723;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DRB1*03:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2211 ! T2
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   T2.DR3/DM
AC   CVCL_9W18
DR   Wikidata; Q54971436
RX   PubMed=7600288;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4934; HLA-DMA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4935; HLA-DMB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DRB1*03:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W17 ! T2.DR3
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   T2.DR4
AC   CVCL_9W15
SY   T2.DR4w4; T2-DR4; T2DR4
DR   NCBI_Iran; C529
DR   Wikidata; Q54971437
RX   PubMed=8195723;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DRB1*04:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2211 ! T2
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 6
//
ID   T2.DR4/DM
AC   CVCL_9W16
SY   T2-DR4-DM; T2DR4.DM
DR   Wikidata; Q54971445
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4934; HLA-DMA.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4935; HLA-DMB.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4948; HLA-DRB1 (Note=Allele DRB1*04:01).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W15 ! T2.DR4
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 7
//
ID   T2/CUHK
AC   CVCL_E318
SY   Tongue 2/Chinese University of Hong Kong
DR   Wikidata; Q54971446
RX   PubMed=1280031;
RX   PubMed=7788927;
CC   Population: Chinese.
CC   Doubling time: 31 hours (PubMed=7788927).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   T201
AC   CVCL_V486
DR   Wikidata; Q54971447
RX   PubMed=11251167;
CC   Doubling time: 48 hours (Note=At 35th passage) (PubMed=11251167).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   T21-iPSC#1
AC   CVCL_B3LY
DR   Wikidata; Q110433278
RX   PubMed=30760866;
CC   Karyotypic information: 47,XX,+21 (PubMed=30760866).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3LZ ! T21-iPSC#5
OI   CVCL_B3M0 ! T21-iPSC#6
OI   CVCL_B3M1 ! T21-iPSC#9
OI   CVCL_B3M2 ! T21-iPSC#12
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   T21-iPSC#12
AC   CVCL_B3M2
DR   Wikidata; Q110433280
RX   PubMed=30760866;
CC   Karyotypic information: 47,XX,+21 (PubMed=30760866).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): PubMed=30760866
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 30,31,32
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 9,10,11
ST   Penta E: 12,19
ST   TH01: 6,7
ST   TPOX: 10,12
ST   vWA: 14,19
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3LY ! T21-iPSC#1
OI   CVCL_B3LZ ! T21-iPSC#5
OI   CVCL_B3M0 ! T21-iPSC#6
OI   CVCL_B3M1 ! T21-iPSC#9
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   T21-iPSC#5
AC   CVCL_B3LZ
DR   Wikidata; Q110433281
RX   PubMed=30760866;
CC   Karyotypic information: 47,XX,+21 (PubMed=30760866).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3LY ! T21-iPSC#1
OI   CVCL_B3M0 ! T21-iPSC#6
OI   CVCL_B3M1 ! T21-iPSC#9
OI   CVCL_B3M2 ! T21-iPSC#12
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   T21-iPSC#6
AC   CVCL_B3M0
SY   AF-T21-iPS#6
DR   JCRB; JCRB1839
DR   Wikidata; Q110433282
RX   PubMed=30760866;
CC   Karyotypic information: 47,XX,+21 (PubMed=30760866).
CC   Karyotypic information: At 66th passage: 46,X0,+21 (JCRB=JCRB1839).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
ST   Source(s): JCRB=JCRB1839
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 10,12
ST   vWA: 14,19
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3LY ! T21-iPSC#1
OI   CVCL_B3LZ ! T21-iPSC#5
OI   CVCL_B3M1 ! T21-iPSC#9
OI   CVCL_B3M2 ! T21-iPSC#12
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   T21-iPSC#9
AC   CVCL_B3M1
DR   Wikidata; Q110433283
RX   PubMed=30760866;
CC   Karyotypic information: 47,XX,+21 (PubMed=30760866).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3LY ! T21-iPSC#1
OI   CVCL_B3LZ ! T21-iPSC#5
OI   CVCL_B3M0 ! T21-iPSC#6
OI   CVCL_B3M2 ! T21-iPSC#12
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   T21-KC-K4DT
AC   CVCL_B3M3
DR   Wikidata; Q110433284
RX   PubMed=30760866;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B3M2 ! T21-iPSC#12
SX   Female
AG   Fetus
CA   Telomerase immortalized cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   T21C1
AC   CVCL_1E83
SY   ND50026
DR   NHCDR; ND50026
DR   SKIP; SKIP001644
DR   Wikidata; Q54971448
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   T21C5
AC   CVCL_1E84
SY   ND50027
DR   NHCDR; ND50027
DR   SKIP; SKIP001645
DR   Wikidata; Q54971449
WW   Provider; RUCDR; -; https://www.commonfund.nih.gov/stemcells/stem-cell-lines-scl
CC   From: NIH Center for Regenerative Medicine (CRM); Bethesda; USA.
CC   Population: Caucasian.
CC   Karyotypic information: Lost the third copy of chromosome 21.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X867 ! AG06872
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   T21M
AC   CVCL_B6QM
DR   Wikidata; Q112041760
RX   PubMed=4194655;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3D
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   T222
AC   CVCL_S811
DR   ChEMBL-Cells; CHEMBL3307464
DR   ChEMBL-Targets; CHEMBL614947
DR   PubChem_Cell_line; CVCL_S811
DR   Wikidata; Q54971450
RX   PubMed=6318979;
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   T23
AC   CVCL_N337
DR   Wikidata; Q54971451
RX   Patent=US4643971;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8271.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   T235
AC   CVCL_6478
SY   ATC235
DR   cancercelllines; CVCL_6478
DR   Cosmic; 1239957
DR   Cosmic; 2054078
DR   Cosmic; 2186781
DR   Wikidata; Q54971452
RX   PubMed=17406368;
RX   PubMed=18713817;
RX   PubMed=23833040;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 13,19
ST   D21S11: 29
ST   D3S1358: 14
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 21,23
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   T238
AC   CVCL_6299
DR   cancercelllines; CVCL_6299
DR   Cosmic; 1239958
DR   Cosmic; 2036696
DR   Cosmic; 2054089
DR   Cosmic; 2186788
DR   Wikidata; Q54971453
RX   PubMed=17406368;
RX   PubMed=18713817;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=26680454;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu63Arg (c.188T>G); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser183Ter (c.548C>G); ClinVar=VCV000634701; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817; PubMed=25365311; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 10,17
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 9,11 (PubMed=25365311)
ST   D5S818: 11 (PubMed=18713817; PubMed=30737244)
ST   D7S820: 11,13
ST   D8S1179: 12
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   T24
AC   CVCL_0554
SY   T-24; T 24
DR   BTO; BTO_0001345
DR   CLO; CLO_0009235
DR   CLO; CLO_0009245
DR   CLO; CLO_0050843
DR   CLO; CLO_0050844
DR   EFO; EFO_0002864
DR   MCCL; MCC:0000455
DR   CLDB; cl4452
DR   ABM; T8988
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-4
DR   BCRC; 60062
DR   BCRJ; 0231
DR   BioGRID_ORCS_Cell_line; 360
DR   BioSample; SAMN03472744
DR   BioSample; SAMN03473324
DR   BioSample; SAMN10987918
DR   cancercelllines; CVCL_0554
DR   CCLV; CCLV-RIE 0062
DR   CCRID; 1101HUM-PUMC000295
DR   CCRID; 3101HUMSCSP536
DR   CCRID; 3101HUMTCHu55
DR   CCRID; 4201HUM-CCTCC00078
DR   CCRID; 5301HUM-KCB92027YJ
DR   CCTCC; GDC0078
DR   Cell_Model_Passport; SIDM01184
DR   ChEMBL-Cells; CHEMBL3307700
DR   ChEMBL-Targets; CHEMBL614774
DR   CLS; 300352
DR   Cosmic; 716174
DR   Cosmic; 724812
DR   Cosmic; 755400
DR   Cosmic; 845561
DR   Cosmic; 846275
DR   Cosmic; 925832
DR   Cosmic; 928817
DR   Cosmic; 943742
DR   Cosmic; 1001664
DR   Cosmic; 1016880
DR   Cosmic; 1046673
DR   Cosmic; 1285130
DR   Cosmic; 1285985
DR   Cosmic; 1302355
DR   Cosmic; 1927302
DR   Cosmic; 1938698
DR   Cosmic; 2037960
DR   Cosmic; 2050465
DR   Cosmic; 2057459
DR   Cosmic; 2444230
DR   Cosmic; 2686118
DR   Cosmic; 2700999
DR   Cosmic-CLP; 724812
DR   DepMap; ACH-000018
DR   DSMZ; ACC-376
DR   DSMZCellDive; ACC-376
DR   EGA; EGAS00001000978
DR   GDSC; 724812
DR   GEO; GSM136233
DR   GEO; GSM492493
DR   GEO; GSM887683
DR   GEO; GSM888775
DR   GEO; GSM1374940
DR   GEO; GSM1574571
DR   GEO; GSM1670520
DR   IARC_TP53; 3722
DR   IARC_TP53; 21131
DR   IARC_TP53; 30178
DR   JCRB; JCRB0711
DR   KCB; KCB 92027YJ
DR   KCLB; 30004
DR   LiGeA; CCLE_255
DR   LINCS_HMS; 50048
DR   LINCS_LDP; LCL-1709
DR   Lonza; 862
DR   PharmacoDB; T24_1554_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0554
DR   PubChem_Cell_line; CVCL_0554
DR   RCB; RCB0431
DR   RCB; RCB2536
DR   TKG; TKG 0443
DR   TOKU-E; 3252
DR   Ubigene; YC-C044
DR   Wikidata; Q54971454
RX   CelloPub=CLPUB00543;
RX   DOI=10.11418/jtca1981.18.4_329;
RX   PubMed=77569;
RX   PubMed=571047;
RX   PubMed=651066;
RX   PubMed=663932;
RX   PubMed=833871;
RX   PubMed=864752;
RX   PubMed=870558;
RX   PubMed=2607719;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=4133950;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=6823318;
RX   PubMed=6826254;
RX   PubMed=7017212;
RX   PubMed=7185004;
RX   PubMed=7787250;
RX   PubMed=8873383;
RX   PubMed=9247707;
RX   PubMed=9290701;
RX   PubMed=9850064;
RX   PubMed=11416159;
RX   PubMed=11921286;
RX   PubMed=12068308;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=19105184;
RX   PubMed=19375735;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=24376083;
RX   PubMed=24459064;
RX   PubMed=25997541;
RX   PubMed=26055179;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29732388;
RX   PubMed=30193179;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=T24
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Quora; -; https://www.quora.com/What-is-the-duplication-time-of-T24-cell-line-that-I-can-depend-on-for-MTT-assay
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-335.html
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 19 hours (PubMed=4133950); 21 hours (PubMed=3708594); 23.2 hours (PubMed=26055179); ~48 hours (DSMZ=ACC-376); ~1 day (Note=Lot 02052018) (JCRB=JCRB0711).
CC   HLA typing: A*01,03; B*08,18; C*w02,w06 (PubMed=77569).
CC   HLA typing: A*01:01,01:01; B*18:01,18:01; C*05:01,05:01 (PubMed=26589293).
CC   HLA typing: A*01,03; B*18,w35; C*w04 (ATCC=HTB-4).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (PubMed=12068308; ATCC=HTB-4).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (PubMed=7787250; ATCC=HTB-4).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.35%; Native American=0.28%; East Asian, North=4.67%; East Asian, South=0%; South Asian=0%; European, North=65.79%; European, South=27.92% (PubMed=30894373).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=HTB-4; CCRID; CLS=300352; Cosmic-CLP=724812; DSMZ=ACC-376; JCRB=JCRB0711; KCLB=30004; PubMed=11416159; PubMed=27270441; RCB=RCB0431; RCB=RCB2536; TKG=TKG 0443
ST   Amelogenin: X
ST   CSF1PO: 10,12 (ATCC=HTB-4; CCRID; CLS=300352; Cosmic-CLP=724812; DSMZ=ACC-376; JCRB=JCRB0711; KCLB=30004; PubMed=27270441; RCB=RCB2536; TKG=TKG 0443)
ST   CSF1PO: 12 (RCB=RCB0431)
ST   D12S391: 17,18
ST   D13S317: 9,12 (DSMZ=ACC-376)
ST   D13S317: 12 (ATCC=HTB-4; CCRID; CLS=300352; Cosmic-CLP=724812; JCRB=JCRB0711; KCLB=30004; PubMed=27270441; RCB=RCB0431; RCB=RCB2536; TKG=TKG 0443)
ST   D16S539: 9
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D1S1656: 12,15
ST   D21S11: 29
ST   D2S1338: 20,23
ST   D3S1358: 16 (ATCC=HTB-4; CCRID; DSMZ=ACC-376; KCLB=30004)
ST   D3S1358: 16,21 (CLS=300352)
ST   D5S818: 10 (RCB=RCB0431)
ST   D5S818: 10,12 (ATCC=HTB-4; CCRID; CLS=300352; Cosmic-CLP=724812; DSMZ=ACC-376; JCRB=JCRB0711; KCLB=30004; PubMed=27270441; RCB=RCB2536; TKG=TKG 0443)
ST   D6S1043: 11
ST   D7S820: 10,11
ST   D8S1179: 9,14 (CLS=300352)
ST   D8S1179: 14 (ATCC=HTB-4; CCRID; DSMZ=ACC-376; PubMed=11416159)
ST   FGA: 17,22
ST   Penta D: 11,15
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17 (ATCC=HTB-4; CCRID; Cosmic-CLP=724812; JCRB=JCRB0711; RCB=RCB0431; RCB=RCB2536; TKG=TKG 0443)
ST   vWA: 17,19 (CLS=300352; DSMZ=ACC-376; KCLB=30004; PubMed=11416159; PubMed=27270441)
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 50
//
ID   T24 FOXP3
AC   CVCL_C3GX
DR   cancercelllines; CVCL_C3GX
DR   Wikidata; Q114313085
RX   PubMed=27189164;
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6106; FOXP3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   T24 FOXP3Delta3
AC   CVCL_C3GY
DR   cancercelllines; CVCL_C3GY
DR   Wikidata; Q114313086
RX   PubMed=27189164;
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6106; FOXP3 (Note=Isoform Delta3).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   T24/83
AC   CVCL_2728
DR   CLO; CLO_0009246
DR   CLDB; cl4473
DR   cancercelllines; CVCL_2728
DR   ECACC; 85061107
DR   Wikidata; Q54971455
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   T24/Cas9-hyg
AC   CVCL_C9F3
DR   GeneCopoeia; SL560
DR   Wikidata; Q123033600
CC   Population: Caucasian; Swedish.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL560).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   T24/DDP10
AC   CVCL_Y181
DR   cancercelllines; CVCL_Y181
DR   CGH-DB; 9115-4
DR   Wikidata; Q54971457
RX   PubMed=8205547;
RX   PubMed=14973057;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   T24/DDP5
AC   CVCL_Y182
DR   cancercelllines; CVCL_Y182
DR   CGH-DB; 9113-4
DR   Wikidata; Q54971458
RX   PubMed=8205547;
RX   PubMed=14973057;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   T24/DDP7
AC   CVCL_Y183
DR   cancercelllines; CVCL_Y183
DR   CGH-DB; 9114-4
DR   Wikidata; Q54971459
RX   PubMed=8205547;
RX   PubMed=14973057;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   T24/MMC
AC   CVCL_XX49
DR   cancercelllines; CVCL_XX49
DR   Wikidata; Q98133065
RX   CelloPub=CLPUB00543;
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   T241
AC   CVCL_M975
SY   ATC241
DR   Cosmic; 1239979
DR   Cosmic; 2054112
DR   Cosmic; 2186784
DR   Wikidata; Q54971460
RX   PubMed=17406368;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Asp252fs (c.756delT); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25365311; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 19
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   T243
AC   CVCL_M976
DR   cancercelllines; CVCL_M976
DR   Cosmic; 2186785
DR   Wikidata; Q54971461
RX   PubMed=17406368;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:2681; DAXX; Simple; p.Arg318Ter (c.952C>T); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Pro723fs (c.2167delC); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11957; MED12; Simple; p.Arg282Ter (c.844C>T); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Gln130Valfs*2 (c.388_389delCA); ClinVar=VCV000091090; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Arg604Ter (c.1810C>T); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr103Thrfs*20 (c.306delC) (p.Thr102fs); Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 9,10,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 15,16,17
ST   D21S11: 32.2
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   T24M [Human bladder carcinoma]
AC   CVCL_VL60
DR   cancercelllines; CVCL_VL60
DR   Wikidata; Q98133066
RX   PubMed=19105184;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Established from T24 by cycles of subcutaneous injections into SCID mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   T24M [Rat thymus]
AC   CVCL_B6QN
DR   Wikidata; Q112041761
RX   PubMed=4194655;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   2-3D
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   T24R1
AC   CVCL_E9W9
RX   CelloPub=CLPUB00806;
CC   Population: Caucasian; Swedish.
CC   Doubling time: 26.5 +- 2.7 hours (CelloPub=CLPUB00806).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T24R2
AC   CVCL_E9WA
RX   CelloPub=CLPUB00806;
CC   Population: Caucasian; Swedish.
CC   Doubling time: 28.2 +- 2.8 hours (CelloPub=CLPUB00806).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T24rCDDP1000
AC   CVCL_RR21
DR   cancercelllines; CVCL_RR21
DR   Wikidata; Q54971462
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 24.7 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   T24rGEMCI20
AC   CVCL_RR22
DR   cancercelllines; CVCL_RR22
DR   Wikidata; Q54971464
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 25.9 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   T24rVINB20
AC   CVCL_RR23
SY   T24rVBL20
DR   cancercelllines; CVCL_RR23
DR   Wikidata; Q54971466
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   T24rYM155_20nM
AC   CVCL_RS42
SY   T24rYM155(20nM)
DR   cancercelllines; CVCL_RS42
DR   Wikidata; Q54971467
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian; Swedish.
CC   Selected for resistance to: ChEBI; CHEBI_139608; Sepantronium bromide (YM155).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
ID   T24T
AC   CVCL_M892
DR   cancercelllines; CVCL_M892
DR   Millipore; SCC468
DR   Wikidata; Q54971468
RX   PubMed=10679914;
RX   PubMed=12460916;
RX   PubMed=15520187;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   T24T FL1
AC   CVCL_M895
SY   FL1
DR   cancercelllines; CVCL_M895
DR   Wikidata; Q54971470
RX   PubMed=15520187;
RX   PubMed=19147813;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M892 ! T24T
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   T24T FL2
AC   CVCL_M896
SY   FL2
DR   cancercelllines; CVCL_M896
DR   Wikidata; Q54971471
RX   PubMed=15520187;
RX   PubMed=19147813;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M895 ! T24T FL1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   T24T FL3
AC   CVCL_M897
SY   FL3
DR   cancercelllines; CVCL_M897
DR   GEO; GSM136264
DR   Wikidata; Q54971472
RX   PubMed=15520187;
RX   PubMed=19147813;
RX   PubMed=24376083;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Forms metastasis in the lung of mice. Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M896 ! T24T FL2
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 17
//
ID   T24T FL4
AC   CVCL_RN62
SY   FL4
DR   cancercelllines; CVCL_RN62
DR   Wikidata; Q54971473
RX   PubMed=19147813;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Forms metastasis in the lung of mice. Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M897 ! T24T FL3
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   T24T SL1
AC   CVCL_RN63
SY   SL1
DR   cancercelllines; CVCL_RN63
DR   Wikidata; Q54971474
RX   PubMed=19147813;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M892 ! T24T
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   T24T SL2
AC   CVCL_RN64
SY   SL2
DR   cancercelllines; CVCL_RN64
DR   Wikidata; Q54971475
RX   PubMed=19147813;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RN63 ! T24T SL1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   T24T SL3
AC   CVCL_RN65
SY   SL3
DR   cancercelllines; CVCL_RN65
DR   Wikidata; Q54971476
RX   PubMed=19147813;
RX   PubMed=29732388;
CC   Population: Caucasian; Swedish.
CC   Characteristics: Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RN64 ! T24T SL2
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   T24T SLT4
AC   CVCL_3922
SY   SLT4; SL4
DR   BTO; BTO_0004892
DR   cancercelllines; CVCL_3922
DR   GEO; GSM136257
DR   Wikidata; Q54971478
RX   PubMed=19147813;
RX   PubMed=24376083;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Forms metastasis in the liver of mice. Produced by passage of the parent cell line through nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Subcellular; Exosome.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RN65 ! T24T SL3
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   T265
AC   CVCL_S805
SY   T265-2c; T265-2C; T265p21
DR   EFO; EFO_0006304
DR   Cosmic; 1644552
DR   Cosmic; 1801808
DR   Cosmic; 2307730
DR   Wikidata; Q54971479
RX   PubMed=9766530;
RX   PubMed=16429615;
RX   PubMed=16510576;
RX   PubMed=21084276;
RX   PubMed=22346343;
RX   PubMed=24726063;
RX   PubMed=28469964;
RX   PubMed=32642732;
RX   PubMed=36818284;
CC   Problematic cell line: Contaminated. Shown to be a ST88-14 derivative (PubMed=36818284).
CC   Doubling time: ~28 hours (PubMed=21084276).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous; Note=By translocation (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7765; NF1; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Arg304Ter (c.910C>T); ClinVar=VCV000187722; Zygosity=Heterozygous; Note=Germline (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): PubMed=36818284
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 21
ST   TH01: 9
ST   TPOX: 11,12
ST   vWA: 16
DI   NCIt; C3798; Malignant peripheral nerve sheath tumor
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_3148; Malignant peripheral nerve sheath tumor
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8916 ! ST88-14
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   T27A
AC   CVCL_3606
DR   CLO; CLO_0009247
DR   ATCC; TIB-57
DR   Wikidata; Q54971481
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   T27A1
AC   CVCL_AZ72
DR   Wikidata; Q54971482
RX   PubMed=7583324;
RX   PubMed=10516297;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: PVG; RS=RS_0000224.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   T29
AC   CVCL_2G67
DR   Wikidata; Q54971483
RX   PubMed=14996724;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5535 ! IOSE-29
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 10
//
ID   T29/33
AC   CVCL_DC80
DR   Wikidata; Q54971485
RX   Patent=US4582797;
RX   PubMed=6336985;
RX   PubMed=6968338;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8036.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
ID   T29H
AC   CVCL_2G69
DR   Wikidata; Q54971486
RX   PubMed=14996724;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G67 ! T29
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   T29K
AC   CVCL_2G74
DR   Wikidata; Q54971487
RX   PubMed=14996724;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G67 ! T29
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   T2D001A
AC   CVCL_A9K4
DR   Wikidata; Q102114960
CC   Miscellaneous: Cell line information from personal communication of Maxwell, Kristina G.
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 5
//
ID   T2D1 HKSV#A
AC   CVCL_B5RJ
SY   T2D1 SV#A
DR   Wikidata; Q112041762
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=23197849
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D3S1358: 14,15
ST   D5S818: 12,13
ST   D7S820: 7,10
ST   D8S1179: 10,16
ST   FGA: 18,21
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   T2D2 HKSV#i
AC   CVCL_B5RK
SY   T2D2 SV#i
DR   Wikidata; Q112041764
RX   PubMed=23197849;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): PubMed=23197849
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 13,17
ST   D3S1358: 15,18
ST   D5S818: 10,11
ST   D7S820: 9,13
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   T2LT3
AC   CVCL_E3KW
RX   PubMed=12096332;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, ovarian follicle, granulosa cell layer; UBERON=UBERON_0005170.
CC   Cell type: Theca cell; CL=CL_0000503.
OX   NCBI_TaxID=9483; ! Callithrix jacchus (White-tufted-ear marmoset)
SX   Female
AG   3-6Y
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   T3 [Human LCL]
AC   CVCL_A6TY
DR   Wikidata; Q107116996
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 46,XX,add(19)(p13) (PubMed=15262425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=15262425
ST   Amelogenin: X
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 6,7
ST   vWA: 17
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TZ ! T3-2 [Human type 2 diabetes]
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   T3 [Rat mesothelioma]
AC   CVCL_C1IR
DR   Wikidata; Q114313087
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T3 2Cr NKX2.1 Pt 3
AC   CVCL_D3C5
SY   T3; T3-2Cr3
DR   Wikidata; Q127384362
RX   PubMed=26593959;
WW   Provider; CReM; 591; https://stemcellbank.bu.edu/Catalog/Item/Details/591
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11825; NKX2-1; Zygosity=Unspecified (PubMed=26593959).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202546; Choreoathetosis, hypothyroidism, and neonatal respiratory distress
DI   ORDO; Orphanet_209905; Brain-lung-thyroid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   T3-1C12
AC   CVCL_J130
DR   Wikidata; Q54971488
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9030.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-1C9
AC   CVCL_J131
DR   Wikidata; Q54971489
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9033.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-1D8
AC   CVCL_J132
DR   Wikidata; Q54971490
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9032.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-1E10
AC   CVCL_J133
DR   Wikidata; Q54971499
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9060.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-1E5
AC   CVCL_J134
DR   Wikidata; Q54971500
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9029.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-1E7
AC   CVCL_J135
DR   Wikidata; Q54971501
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9055.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-2 [Human type 2 diabetes]
AC   CVCL_A6TZ
DR   Wikidata; Q107116999
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=15262425
ST   Amelogenin: X
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15
ST   D8S1179: 11,14
ST   FGA: 23
ST   TH01: 6,7
ST   vWA: 17,18
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6TY ! T3 [Human LCL]
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   T3-2 [Rat tooth germ]
AC   CVCL_A7PA
DR   Wikidata; Q107117000
RX   PubMed=11904297;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
CC   Cell type: Odontoblast; CL=CL_0000060.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   3-5D
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   T3-2A9
AC   CVCL_J136
DR   Wikidata; Q54971502
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9028.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-2B1
AC   CVCL_J137
DR   Wikidata; Q54971503
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9057.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-2D2
AC   CVCL_J138
DR   Wikidata; Q54971504
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9061.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-2G4
AC   CVCL_J139
DR   Wikidata; Q54971505
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9058.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-2H5
AC   CVCL_J140
DR   Wikidata; Q54971506
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9056.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-2H6
AC   CVCL_J141
DR   Wikidata; Q54971507
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9062.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-3A1
AC   CVCL_F770
SY   T3 3A1; 3A1
DR   CLO; CLO_0009248
DR   ATCC; HB-2
DR   NCBI_Iran; H158
DR   Wikidata; Q54971508
RX   PubMed=6156457;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   T3-3F11
AC   CVCL_J142
DR   Wikidata; Q54971510
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9059.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-3H1
AC   CVCL_J143
DR   Wikidata; Q54971511
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9064.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-4A7
AC   CVCL_J144
DR   Wikidata; Q54971512
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9063.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-4C11
AC   CVCL_J145
DR   Wikidata; Q54971513
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9031.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-5E9
AC   CVCL_G093
SY   5E9C11
DR   CLO; CLO_0001436
DR   ATCC; HB-21
DR   Wikidata; Q54971515
RX   PubMed=6787129;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   T3-8B8
AC   CVCL_J146
DR   Wikidata; Q54971516
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9066.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-8F5
AC   CVCL_J147
DR   Wikidata; Q54971517
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9067.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-9E7
AC   CVCL_J148
DR   Wikidata; Q54971518
RX   Patent=US5071759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9065.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P16154; Clostridioides difficile toxA.
CC   Monoclonal antibody target: UniProtKB; P18177; Clostridioides difficile toxB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   T3-HA
AC   CVCL_6C59
DR   ABM; T8147
DR   Wikidata; Q54971519
RX   PubMed=26254261;
CC   Characteristics: Obtained by intravenous injection of parent cell line (T2-A) in the tail vein of nude NIH Swiss mice and selection of cells from a liver metastasis.
CC   Doubling time: 17.5 hours (PubMed=26254261).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6C58 ! T2-A
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   T3-HEP-W1
AC   CVCL_4Z94
DR   Wikidata; Q54971520
RX   DOI=10.2957/kanzo.28.1135;
RX   PubMed=3338696;
CC   Doubling time: 24 hours (Note=At 20th passage) (PubMed=3338696).
CC   Transformant: NCBI_TaxID; 35269; Woodchuck hepatitis virus.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C124251; Woodchuck hepatocellular carcinoma
OX   NCBI_TaxID=9995; ! Marmota monax (Woodchuck)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   T3-MAAB
AC   CVCL_E9XC
RX   PubMed=8054865;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Anti-idiotypic against antibodies recognizing triiodothyronine (T3).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T3-PA
AC   CVCL_WR51
DR   ABM; T8146
DR   Wikidata; Q98133067
RX   PubMed=26254261;
CC   Characteristics: Obtained by intravenous injection of parent cell line (T2-A) in the tail vein of nude NIH Swiss mice and selection of cells from a lung metastasis.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6C58 ! T2-A
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   T311
AC   CVCL_XX94
DR   Wikidata; Q98133068
RX   PubMed=7667256;
RX   PubMed=10782467;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P14679; Human TYR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   T34 [Human lymphoma]
AC   CVCL_J352
DR   Wikidata; Q54971521
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3261629;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3261629).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3467; Primary cutaneous T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171901; Primary cutaneous T-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 14
//
ID   T34 [Rabbit spleen]
AC   CVCL_A3AQ
DR   CCLV; CCLV-RIE 0830
DR   Wikidata; Q105511147
RX   PubMed=25565633;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
AG   Adult
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   T34-2
AC   CVCL_AZ71
DR   Wikidata; Q54971523
RX   PubMed=7583324;
RX   PubMed=10516297;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, cerebral cortex; UBERON=UBERON_0000956.
CC   Cell type: Astrocyte of cerebral cortex; CL=CL_0002605.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 10
//
ID   T351
AC   CVCL_M977
SY   ATC351
DR   cancercelllines; CVCL_M977
DR   Cosmic; 1239980
DR   Cosmic; 2054118
DR   Cosmic; 2186786
DR   Wikidata; Q54971524
RX   PubMed=17406368;
RX   PubMed=23833040;
RX   PubMed=25365311;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln28Ter (c.82C>T); ClinVar=VCV000429015; Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn29Thrfs*15 (c.86delA); ClinVar=VCV000528243; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: ACT351; PubMed=25365311; Note=In supplementary table 1.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=25365311; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 17
ST   D21S11: 30,32.2
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 20,26
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   T36274
AC   CVCL_6335
SY   T3 6274
DR   CLO; CLO_0009249
DR   ATCC; CRL-2012
DR   Wikidata; Q54971527
RX   PubMed=2985973;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0361 ! JB6 Cl 30-7b
SX   Sex unspecified
AG   Newborn
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   T37i
AC   CVCL_S893
DR   EFO; EFO_0022805
DR   Millipore; SCC250
DR   Wikidata; Q54971528
RX   PubMed=9502766;
RX   PubMed=12482590;
CC   Characteristics: Can differentiate into brown adipocytes when incubated with triiodothyronine (T3) and insulin over 3-6 days. Differentiation can also be induced by incubation with steroid hormones such as aldosterone, which induces differentiation through its interaction with mineralocorticoid receptor (MR) (Millipore=SCC250).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Breed/subspecies: C57BL/6 x DBA/2 SV40TAg transgenic.
ST   Source(s): Millipore=SCC250
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14.2
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 13
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,16
ST   Mouse STR 7-1: 26.2
ST   Mouse STR 8-1: 16,17
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 26
DI   NCIt; C21634; Mouse hibernoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   2W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 14
//
ID   t3H3
AC   CVCL_D3EU
DR   Wikidata; Q127384363
RX   PubMed=27608665;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   T3M-1
AC   CVCL_8289
DR   Wikidata; Q54971529
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=308840;
RX   PubMed=2474371;
CC   Population: Japanese.
CC   Doubling time: ~17 hours (PubMed=308840).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8663 ! CJM [Human OCSCC]
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   T3M-1 Cl-10
AC   CVCL_8761
SY   T3M-1 Clone10; T3M-1 clone-10
DR   CLO; CLO_0050090
DR   BioSample; SAMN03472203
DR   Cosmic; 2009525
DR   RCB; RCB1017
DR   Wikidata; Q54971530
RX   PubMed=14733907;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB1017
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8289 ! T3M-1
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   T3M-1 Cl-2
AC   CVCL_8762
SY   T3M-1 Clone2; T3M-1 clone-2
DR   CLO; CLO_0050091
DR   BioSample; SAMN03472202
DR   RCB; RCB1015
DR   Wikidata; Q54971531
RX   PubMed=14733907;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB1015
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8289 ! T3M-1
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   T3M-10
AC   CVCL_8067
SY   T3M10
DR   CLO; CLO_0050071
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472206
DR   BioSample; SAMN10988110
DR   cancercelllines; CVCL_8067
DR   Cell_Model_Passport; SIDM01764
DR   DepMap; ACH-000813
DR   IARC_TP53; 28362
DR   LiGeA; CCLE_753
DR   PharmacoDB; T3M10_1556_2019
DR   RCB; RCB1020
DR   Wikidata; Q54971532
RX   PubMed=6088016;
RX   PubMed=6091874;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=38639832;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Chinese; Taiwan.
CC   HLA typing: A*11:01,24:02; B*40:01,46:01; C*01:03,03:10; DQA1*01:03,05:02; DQB1*03:04,06:01; DRB1*08:03,11:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (DepMap=ACH-000813).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (DepMap=ACH-000813).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=1.75%; Native American=0%; East Asian, North=84.13%; East Asian, South=11.41%; South Asian=0%; European, North=0%; European, South=2.71% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1020
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 11,14
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   T3M-11
AC   CVCL_8066
SY   T3M11
DR   CLO; CLO_0050046
DR   BioSample; SAMN03472208
DR   RCB; RCB1022
DR   Wikidata; Q54971533
RX   PubMed=6091874;
RX   PubMed=7730145;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB1022
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   T3M-12
AC   CVCL_4058
SY   T3M12
DR   CLO; CLO_0050060
DR   BioSample; SAMN03471951
DR   RCB; RCB1019
DR   RCB; RCB2281
DR   Wikidata; Q54971534
RX   PubMed=20143388;
RX   PubMed=38639832;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Partially contaminated. Some stocks (such as RCB1019) were contaminated by T3M-1 (PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00355.
CC   Population: Chinese/Asian ethnic group; Hakka.
CC   Discontinued: RCB; RCB1019; true.
ST   Source(s): RCB=RCB2281
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   T3M-15
AC   CVCL_Y007
DR   Wikidata; Q54971535
RX   PubMed=6091874;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   T3M-3
AC   CVCL_8065
SY   T3M3
DR   CLO; CLO_0050641
DR   BioSample; SAMN03472204
DR   DepMap; ACH-002021
DR   FANTOM5_SSTAR; 10618-108G6
DR   RCB; RCB1018
DR   Wikidata; Q54971536
RX   DOI=10.1007/0-306-46861-1_8;
RX   PubMed=6603906;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Characteristics: Established from a xenotransplanted choriocarcinoma grown in nude mice.
ST   Source(s): RCB=RCB1018
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   T3M-4
AC   CVCL_4056
SY   T3M4; Panc89; Panc-89; PANC-89; Panc 89
DR   BTO; BTO_0002864
DR   CLO; CLO_0050113
DR   EFO; EFO_0002714
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 452
DR   BioSample; SAMN03472207
DR   BioSample; SAMN10988105
DR   cancercelllines; CVCL_4056
DR   CCRID; 1101HUM-PUMC000815
DR   Cell_Model_Passport; SIDM01469
DR   Cosmic; 710873
DR   Cosmic; 724641
DR   Cosmic; 736281
DR   Cosmic; 922257
DR   Cosmic; 922263
DR   Cosmic; 933528
DR   Cosmic; 2546061
DR   Cosmic; 2546062
DR   DepMap; ACH-000085
DR   GEO; GSM887684
DR   GEO; GSM888776
DR   GEO; GSM1374814
DR   GEO; GSM1374815
DR   GEO; GSM1374816
DR   IARC_TP53; 1561
DR   IARC_TP53; 16746
DR   LiGeA; CCLE_195
DR   PharmacoDB; T3M4_1557_2019
DR   Progenetix; CVCL_4056
DR   RCB; RCB1021
DR   Wikidata; Q54971538
RX   PubMed=6821838;
RX   PubMed=8426738;
RX   PubMed=11169959;
RX   PubMed=11787853;
RX   PubMed=12692724;
RX   PubMed=18298655;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/PancCellLineDescriptions/T3M-4.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: KuDOS 95 cell line panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Heterozygous (PubMed=8426738; DepMap=ACH-000085).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=8426738; PubMed=11169959; PubMed=11787853; DepMap=ACH-000085).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.38%; Native American=0.38%; East Asian, North=79.41%; East Asian, South=19.66%; South Asian=0%; European, North=0%; European, South=0.16% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000815; RCB=RCB1021; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D10S1248: 17
ST   D12S391: 20,21,24
ST   D13S317: 10,13 (RCB=RCB1021; Technion Genomics Center)
ST   D13S317: 13 (CCRID=1101HUM-PUMC000815)
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 14
ST   D1S1656: 14,19.3
ST   D21S11: 32.2,33.2
ST   D22S1045: 15,16
ST   D2S1338: 17,25
ST   D2S441: 11,14
ST   D3S1358: 14 (Technion Genomics Center)
ST   D3S1358: 14,15 (CCRID=1101HUM-PUMC000815)
ST   D5S818: 11
ST   D6S1043: 10,11
ST   D7S820: 12
ST   D8S1179: 16
ST   FGA: 25
ST   Penta D: 10
ST   Penta E: 11,12
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 18,19,21
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   T3M-5
AC   CVCL_8064
SY   T3M5
DR   CLO; CLO_0050948
DR   BioSample; SAMN03472201
DR   cancercelllines; CVCL_8064
DR   Cosmic; 2009526
DR   DepMap; ACH-002042
DR   FANTOM5_SSTAR; 10616-108G4
DR   RCB; RCB1012
DR   Wikidata; Q54971539
RX   PubMed=6982994;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 22 hours (Note=At 60th passage) (PubMed=6982994).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (DepMap=ACH-002042).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly108Val (c.323G>T); ClinVar=VCV001729287; Zygosity=Unspecified (DepMap=ACH-002042).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): RCB=RCB1012
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D5S818: 11,13
ST   D7S820: 13
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C46008; Thyroid gland squamous cell carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   T4
AC   CVCL_C1IS
DR   Wikidata; Q114313088
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T4 32Cr NKX2.1 Pt 4
AC   CVCL_D3C6
SY   T4; T4-32Cr2
DR   Wikidata; Q127384364
RX   PubMed=26593959;
WW   Provider; CReM; 592; https://stemcellbank.bu.edu/Catalog/Item/Details/592
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11825; NKX2-1; Simple; p.Pro185Alafs (c.552_556delCCCGC); ClinVar=VCV002506915; Zygosity=Unspecified (PubMed=26593959).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C202546; Choreoathetosis, hypothyroidism, and neonatal respiratory distress
DI   ORDO; Orphanet_209905; Brain-lung-thyroid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-2Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   T4 clone 3
AC   CVCL_DA07
DR   Wikidata; Q54971540
RX   Patent=US4636478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8499.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI_18332; L-thyroxine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 5
//
ID   T4 Clone 5 (10-0101, 0062-83)
AC   CVCL_F771
DR   CLO; CLO_0009250
DR   ATCC; HB-8500
DR   Wikidata; Q54971541
RX   Patent=US4636478;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8500.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_18332; L-thyroxine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   T4-4
AC   CVCL_0E54
DR   Wikidata; Q54971542
RX   PubMed=11904297;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
CC   Cell type: Odontoblast; CL=CL_0000060.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   3-5D
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 11
//
ID   T4-57
AC   CVCL_C5LZ
DR   ABCD; ABCD_AE136
DR   Wikidata; Q116050609
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T4-PA
AC   CVCL_6C60
DR   ABM; T8148
DR   Wikidata; Q54971543
RX   PubMed=26254261;
CC   Characteristics: Highly metastatic. Produces widespread metastatic lesions throughout the bodies of nude NIH Swiss mice when injected intravenously. Obtained by injection of parent cell line (T3-HA) in the tail vein of nude NIH Swiss mice and selection of cells from a lung metastasis.
CC   Doubling time: 18.5 hours (PubMed=26254261).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6C59 ! T3-HA
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 12
//
ID   T404
AC   CVCL_1T20
DR   BioSample; SAMN03151954
DR   Wikidata; Q54971552
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00425.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_4910 ! Tu 138
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   T406 [Human glioblastoma]
AC   CVCL_4570
SY   T-406
DR   CLS; 300361
DR   Wikidata; Q54971553
RX   PubMed=3759084;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): CLS=300361
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 13,18
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 10,13
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 23,26
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   T406 [Human HNSCC]
AC   CVCL_1T19
DR   BioSample; SAMN03151955
DR   Wikidata; Q54971555
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00426.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_4910 ! Tu 138
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   T409
AC   CVCL_1Q88
SY   T-409
DR   BioSample; SAMN03151991
DR   Cosmic; 1530764
DR   Wikidata; Q54971556
RX   PubMed=18234965;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00427.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   T43
AC   CVCL_N338
SY   URO10
DR   ATCC; HB-8275
DR   Wikidata; Q54971557
RX   Patent=US4643971;
RX   Patent=US4935344;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8275.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen URO10 on bladder cancer cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   T449
AC   CVCL_M807
SY   93449; LPS449
DR   Cosmic; 2307716
DR   TOKU-E; 4077
DR   Wikidata; Q54971558
RX   PubMed=17354236;
RX   PubMed=22911243;
RX   PubMed=24726063;
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M808 ! T778
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 10
//
ID   T45
AC   CVCL_JY66
DR   cancercelllines; CVCL_JY66
DR   Wikidata; Q54971559
RX   PubMed=1846646;
RX   PubMed=7633286;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Homozygous (PubMed=7633286).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 8
//
ID   T47D Ad12
AC   CVCL_ZZ24
DR   cancercelllines; CVCL_ZZ24
DR   Wikidata; Q102114962
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 68.2 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   T47D Ad60
AC   CVCL_ZZ25
DR   cancercelllines; CVCL_ZZ25
DR   Wikidata; Q102114963
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 86.0 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   T47D HER2
AC   CVCL_XZ63
SY   T47D-ERBB2
DR   cancercelllines; CVCL_XZ63
DR   KYinno; KC-0136
DR   Wikidata; Q98133069
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-0136).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   T47D P95HER2
AC   CVCL_XZ64
SY   T47D-P95ERBB2
DR   cancercelllines; CVCL_XZ64
DR   KYinno; KC-0137
DR   Wikidata; Q98133071
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-0137).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2 (Note=Isoform CTF-611/P95HER2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   T47D RB1 KO clone 1A1
AC   CVCL_E8SE
SY   T47D-RB1-KO-1A1
DR   KYinno; KC-4409
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (KYinno=KC-4409).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T47D RB1 KO clone 1A2
AC   CVCL_E8SF
SY   T47D-RB1-KO-1A2
DR   KYinno; KC-4410
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (KYinno=KC-4410).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T47D-E2J
AC   CVCL_HG14
SY   T47D E2J; E2J
DR   cancercelllines; CVCL_HG14
DR   CancerTools; 153169
DR   Wikidata; Q54971560
DR   Ximbio; 153169
RX   PubMed=11118434;
RX   PubMed=16319059;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4203; GCNT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   T47D-KBluc
AC   CVCL_K229
SY   T47D-KBLUC; T47D Kbluc; T47D_KBluc; T47DKBluc; T47DKBLUC
DR   CLO; CLO_0037191
DR   ATCC; CRL-2865
DR   cancercelllines; CVCL_K229
DR   GEO; GSM1172905
DR   GEO; GSM1173001
DR   LINCS_HMS; 51091
DR   LINCS_LDP; LCL-2064
DR   Wikidata; Q54971561
RX   PubMed=15166400;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Used to screen chemicals for estrogenic or anti-estrogenic activity. Selected for responsiveness to 17-beta-estradiol. Transfected with a pGL2.TATA.Inr.luc.neo plasmid which contains three estrogen responsive elements upstream of the luciferase reporter gene (PubMed=15166400).
CC   Doubling time: 70.61 hours (JWGray panel).
CC   HLA typing: A*33:01,33:01; B*14:02,14:02; C*08:02,08:02; DQA1*01:02,01:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2865
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 24
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 27
//
ID   T47D-LTED
AC   CVCL_YX85
SY   T47D LTED; T47D-Long Term Estrogen-Deprived
DR   cancercelllines; CVCL_YX85
DR   Wikidata; Q98133073
RX   PubMed=26116361;
CC   Population: Caucasian.
CC   Characteristics: Derived from parent cell line by long-term culture in the presence of RPMI 1640 medium containing 10% dextran charcoal stripped serum (DCC) (PubMed=26116361).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   T47D-Luc2
AC   CVCL_E8SH
DR   KYinno; KC-2427
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-2427).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T47D-PalR
AC   CVCL_E8SG
DR   KYinno; KC-1404
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (KYinno=KC-1404).
CC   Selected for resistance to: ChEBI; CHEBI_85993; Palbociclib (Ibrance).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T47D-ST3
AC   CVCL_HG15
SY   T47D 3STMYC
DR   cancercelllines; CVCL_HG15
DR   Wikidata; Q54971564
RX   PubMed=9182658;
RX   PubMed=16319059;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10862; ST3GAL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   T47D-ST3-STn
AC   CVCL_HG17
DR   cancercelllines; CVCL_HG17
DR   Wikidata; Q54971566
RX   PubMed=16319059;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:10862; ST3GAL1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23614; ST6GALNAC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HG15 ! T47D-ST3
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   T47D-StN
AC   CVCL_HG16
SY   T47D-E2J-StN
DR   cancercelllines; CVCL_HG16
DR   CancerTools; 153170
DR   Wikidata; Q54971567
DR   Ximbio; 153170
RX   PubMed=16319059;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4203; GCNT1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:23614; ST6GALNAC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HG14 ! T47D-E2J
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   T47D-Y
AC   CVCL_1H30
DR   EFO; EFO_0022460
DR   cancercelllines; CVCL_1H30
DR   TOKU-E; 3661
DR   Wikidata; Q54971568
RX   PubMed=8033109;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   T47D-YA
AC   CVCL_1H31
DR   cancercelllines; CVCL_1H31
DR   Wikidata; Q54971569
RX   PubMed=8033109;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H30 ! T47D-Y
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   T47D-YB
AC   CVCL_1H32
DR   cancercelllines; CVCL_1H32
DR   Wikidata; Q54971570
RX   PubMed=8033109;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1H30 ! T47D-Y
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   T47D/182R-1
AC   CVCL_1D34
SY   T47D-182R1; 182R-1
DR   cancercelllines; CVCL_1D34
DR   CancerTools; 151891
DR   ECACC; 16022507
DR   Wikidata; Q54971571
DR   Ximbio; 151891
RX   PubMed=24513268;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 16022507; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022507
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D21S11: 28,31
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D46 ! T47D/S5
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   T47D/182R-2
AC   CVCL_1D35
SY   T47D-182R2; 182R-2
DR   cancercelllines; CVCL_1D35
DR   CancerTools; 151890
DR   ECACC; 16022508
DR   Wikidata; Q54971572
DR   Ximbio; 151890
RX   PubMed=24513268;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31638; Fulvestrant (ICI 182780).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 16022508; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022508
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D21S11: 28,31
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D46 ! T47D/S5
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   T47D/A1-2
AC   CVCL_0I95
SY   T47D(A1-2); T47D A1-2; A1-2
DR   cancercelllines; CVCL_0I95
DR   GEO; GSE141834
DR   Wikidata; Q54971573
RX   PubMed=2550815;
RX   PubMed=32170217;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2741; Nr3c1.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   T47D/Cas9-hyg
AC   CVCL_C9CG
DR   GeneCopoeia; SL517
DR   Wikidata; Q123033601
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL517).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   T47D/GFP
AC   CVCL_JY86
DR   cancercelllines; CVCL_JY86
DR   Cell_Biolabs; AKR-208
DR   Wikidata; Q54971574
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   T47D/S2
AC   CVCL_1D45
DR   cancercelllines; CVCL_1D45
DR   CancerTools; 152109
DR   ECACC; 16022512
DR   Wikidata; Q54971575
DR   Ximbio; 152109
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 16022512; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022512
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D21S11: 28,31
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   T47D/S5
AC   CVCL_1D46
DR   cancercelllines; CVCL_1D46
DR   CancerTools; 152111
DR   ECACC; 16022511
DR   Wikidata; Q54971576
DR   Ximbio; 152111
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 16022511; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022511
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D21S11: 28,31
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   T47D/TR-1
AC   CVCL_1D36
DR   cancercelllines; CVCL_1D36
DR   CancerTools; 152108
DR   ECACC; 16022513
DR   Wikidata; Q54971577
DR   Ximbio; 152108
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ECACC; 16022513; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=16022513
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 17
ST   D21S11: 28,31
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 23
ST   Penta D: 10,12
ST   Penta E: 7,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D45 ! T47D/S2
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   T47D/TR-2
AC   CVCL_1D37
DR   cancercelllines; CVCL_1D37
DR   CancerTools; 152110
DR   Wikidata; Q54971578
DR   Ximbio; 152110
RX   PubMed=25362855;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D45 ! T47D/S2
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   T47D/XBP1
AC   CVCL_C4MA
DR   Wikidata; Q116050610
RX   PubMed=17660348;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12801; XBP1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   T47D:A18
AC   CVCL_GY01
SY   A18
DR   EFO; EFO_0022637
DR   cancercelllines; CVCL_GY01
DR   Wikidata; Q54971580
RX   PubMed=2224859;
RX   PubMed=8883409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   T47D:C4
AC   CVCL_GY02
DR   cancercelllines; CVCL_GY02
DR   Wikidata; Q54971581
RX   PubMed=2224859;
RX   PubMed=2632259;
RX   PubMed=8883409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0553 ! T-47D
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   T47D:C4:2
AC   CVCL_GY03
SY   T47D:C42; T47DC42; C4:2
DR   cancercelllines; CVCL_GY03
DR   TOKU-E; 4085
DR   Wikidata; Q54971582
RX   PubMed=8883409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Phe (c.580C>T); ClinVar=VCV000127817; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GY02 ! T47D:C4
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   T49-25
AC   CVCL_A6ZU
SY   P3-X63-Ag8-U/hEphB6-T49-25
DR   RCB; RCB5378
DR   Wikidata; Q107117002
RX   PubMed=10831073;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O15197; Human EPHB6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   T5 [Human LCL]
AC   CVCL_A6UA
DR   Wikidata; Q107117004
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 46,Y,add(X)(p22) (PubMed=15262425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=15262425
ST   Amelogenin: X,Y
ST   D16S539: 11
ST   D18S51: 15,21
ST   D19S433: 14.2,15.2
ST   D21S11: 31.2,32.2
ST   D2S1338: 24
ST   D3S1358: 15
ST   D8S1179: 13,17
ST   FGA: 23,24
ST   TH01: 7,9
ST   vWA: 16,17
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   T5 [Rat mesothelioma]
AC   CVCL_C1IT
DR   Wikidata; Q114313089
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T5-1
AC   CVCL_E839
AS   CVCL_H270
SY   T5-1 (3.1.0); T51; T51 LCL; PGLC 33H(T5-1)
DR   EFO; EFO_0022350
DR   dbMHC; 49031
DR   ECACC; 94071434
DR   IHW; IHW09284
DR   IPD-IMGT/HLA; 11419
DR   Wikidata; Q54971583
RX   PubMed=62390;
RX   PubMed=75508;
RX   PubMed=4504337;
RX   PubMed=4599625;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*02:01:01:01; B*08,27; DPA1*01:03:01 (IPD-IMGT/HLA=11419).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C34726; Infectious mononucleosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JA31 ! L33-6-1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   T5-131
AC   CVCL_C5M0
DR   ABCD; ABCD_AE147
DR   Wikidata; Q116050611
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T5-224
AC   CVCL_C5M1
DR   ABCD; ABCD_AE148
DR   Wikidata; Q116050612
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T5-314
AC   CVCL_C5M2
DR   ABCD; ABCD_AE143
DR   Wikidata; Q116050613
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T5-334
AC   CVCL_C5M3
DR   ABCD; ABCD_AE141
DR   Wikidata; Q116050614
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T5-58
AC   CVCL_C5M4
DR   ABCD; ABCD_AE142
DR   Wikidata; Q116050615
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T5-626
AC   CVCL_C5M5
DR   ABCD; ABCD_AE150
DR   Wikidata; Q116050616
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T5-86
AC   CVCL_A0IR
DR   Wikidata; Q108821360
RX   Patent=US9670287;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11254.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   T508
AC   CVCL_W136
DR   Wikidata; Q54971584
RX   PubMed=3759084;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   T51
AC   CVCL_WY61
DR   Wikidata; Q98133075
RX   CelloPub=CLPUB00524;
RX   PubMed=282624;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   T51B
AC   CVCL_WY59
DR   Wikidata; Q98133076
RX   CelloPub=CLPUB00524;
RX   PubMed=282624;
RX   PubMed=1283740;
RX   PubMed=1374614;
RX   PubMed=2480838;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WY61 ! T51
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   T51B-Ni
AC   CVCL_WY60
SY   T51B Clone 4
DR   Wikidata; Q98133077
RX   PubMed=1374614;
RX   PubMed=2480838;
CC   Transformant: ChEBI; CHEBI_144804; Nickel subsulfide.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_WY59 ! T51B
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 9
//
ID   T529-15D3-18-1A3-1B7
AC   CVCL_F773
SY   1B7; 41.6-1B7; CTCC 10752
DR   CLO; CLO_0009252
DR   ATCC; HB-10500
DR   Wikidata; Q54971585
RX   Patent=US5959084;
RX   Patent=US6143873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10500.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F772 ! 443-15D3-2F12
HI   CVCL_J227 ! 3G8 [Mouse hybridoma against human FCGR3A]
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   T529-15D3-2E5-4G12-1
AC   CVCL_F774
SY   1A7; 34.5-1A7; CTCC 10753
DR   CLO; CLO_0009253
DR   ATCC; HB-10501
DR   Wikidata; Q54971586
RX   Patent=US5959084;
RX   Patent=US6143873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10501.
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F772 ! 443-15D3-2F12
HI   CVCL_J227 ! 3G8 [Mouse hybridoma against human FCGR3A]
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   T56/14
AC   CVCL_DC69
DR   Wikidata; Q54971588
RX   Patent=US4626507;
RX   PubMed=6265934;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8035.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02786; Human TFRC/CD71.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4696 ! S194/5.XXO.BU.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   T560
AC   CVCL_F724
DR   Wikidata; Q54971587
RX   PubMed=1535783;
CC   Breed/subspecies: B10 x B10.H-2aH-4b.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   T560.1
AC   CVCL_F725
DR   Wikidata; Q54971589
RX   PubMed=1535783;
CC   Characteristics: ~38 hours (PubMed=1535783).
CC   Breed/subspecies: B10 x B10.H-2aH-4b.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F724 ! T560
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   T560.1.C11
AC   CVCL_E9W5
RX   PubMed=1535783;
CC   Breed/subspecies: B10 x B10.H-2aH-4b.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F725 ! T560.1
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   T560.2
AC   CVCL_F726
DR   Wikidata; Q54971590
RX   PubMed=1535783;
CC   Characteristics: ~19 hours (PubMed=1535783).
CC   Breed/subspecies: B10 x B10.H-2aH-4b.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F724 ! T560
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   T560.2.F7
AC   CVCL_F727
DR   Wikidata; Q54971591
RX   PubMed=1535783;
RX   PubMed=10433101;
RX   PubMed=11683378;
CC   Characteristics: Secretes polyreactive IgG2a antibodies whose known ligands include phosphorylcholine, 2,4,6,trinitrophenyl-determinant, human TNF-beta and polystyrene. Can switches spontaneously from IgG2a to IgA (PubMed=10433101; PubMed=11683378).
CC   Breed/subspecies: B10 x B10.H-2aH-4b.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F726 ! T560.2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   T560.2.G4
AC   CVCL_F728
DR   Wikidata; Q54971593
RX   PubMed=1535783;
CC   Breed/subspecies: B10 x B10.H-2aH-4b.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F726 ! T560.2
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   T567
AC   CVCL_W135
DR   Wikidata; Q54971594
RX   PubMed=3759084;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   t5a11
AC   CVCL_D3EV
DR   Wikidata; Q127384365
RX   PubMed=27608665;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   T6 [Human LCL]
AC   CVCL_A6UB
DR   Wikidata; Q107117005
RX   PubMed=15262425;
CC   Population: Japanese.
CC   Karyotypic information: 47,XX,+2 (PubMed=15262425).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=15262425
ST   Amelogenin: X
ST   D16S539: 9,10
ST   D18S51: 14,15
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D8S1179: 11,17
ST   FGA: 23
ST   TH01: 7,9
ST   vWA: 16,17
DI   NCIt; C26747; Type 2 diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   T6 [Rat mesothelioma]
AC   CVCL_C1IU
DR   Wikidata; Q114313090
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_46664; Chrysotile asbestos.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T6-112
AC   CVCL_C5M6
DR   Wikidata; Q116050617
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T6-16
AC   CVCL_A0IS
DR   Wikidata; Q108821361
RX   Patent=US9670287;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-11346.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   T6-19
AC   CVCL_C5M7
DR   ABCD; ABCD_AE144
DR   Wikidata; Q116050618
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T6-416
AC   CVCL_C5M8
DR   Wikidata; Q116050619
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T6-510
AC   CVCL_C5M9
DR   ABCD; ABCD_AE151
DR   Wikidata; Q116050620
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T6-626
AC   CVCL_C5MA
DR   ABCD; ABCD_AE138
DR   Wikidata; Q116050621
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T61577
AC   CVCL_J123
DR   Wikidata; Q54971595
RX   PubMed=7448785;
CC   Transformant: ChEBI; CHEBI_91112; N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C64146; Squamous cell carcinoma of the rat urinary bladder
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   T67
AC   CVCL_M033
DR   Wikidata; Q54971596
RX   PubMed=3485879;
RX   PubMed=7519632;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   T68
AC   CVCL_C6JV
DR   Wikidata; Q116050622
RX   DOI=10.21037/tcr.2018.12.12;
CC   Population: Chinese.
CC   Characteristics: Tumorigenic.
CC   Doubling time: 37 hours (DOI=10.21037/tcr.2018.12.12).
CC   Derived from site: In situ; Mediastinum; UBERON=UBERON_0003728.
DI   NCIt; C6885; Thymoma type AB
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   T7 [Mouse lung]
AC   CVCL_4314
DR   ECACC; 07021402
DR   Wikidata; Q54971597
RX   PubMed=10949996;
CC   Characteristics: Proliferates at permissive temperature (33-35 Celsius) in the presence of IFNG, terminally differentiates at restrictive temperature (39 Celsius) in the absence of IFNG.
CC   Doubling time: 48 hours (ECACC=07021402).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 2 pneumocyte; CL=CL_0002063.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   T7 [Rat mesothelioma]
AC   CVCL_C1IV
DR   Wikidata; Q114313091
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T7-4
AC   CVCL_C5MB
DR   ABCD; ABCD_AE137
DR   Wikidata; Q116050623
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T70
AC   CVCL_M034
DR   Wikidata; Q54971606
RX   PubMed=3485879;
RX   PubMed=7519632;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   T705
AC   CVCL_W137
DR   Wikidata; Q54971607
RX   PubMed=3759084;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   T7526
AC   CVCL_E840
DR   dbMHC; 49032
DR   ECACC; 94082238
DR   IHW; IHW09076
DR   IPD-IMGT/HLA; 11420
DR   Wikidata; Q54971608
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=1363422;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Chinese.
CC   HLA typing: A*02:06:01:01,02:07:01; B*46:01:01; C*01:02:01,08:01:01; DPA1*04:01; DPB1*13:01:01/107:01; DQA1*03:02; DQB1*03:03:02; DRA*01:01; DRB1*09:01:02/09:21; DRB4*01:03:01:01 (IPD-IMGT/HLA=11420).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   T7527
AC   CVCL_E841
DR   dbMHC; 49033
DR   ECACC; 94070716
DR   IHW; IHW09077
DR   IPD-IMGT/HLA; 11421
DR   Wikidata; Q54971609
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Chinese.
CC   HLA typing: A*02:07:01,02:01:01:27; B*46:01:01; C*01:02:01; DPB1*05:01:01,21:01; DQA1*03:01,06:01; DQB1*03:01:01,03:03:02; DRB1*09:01:02/09:21,12:02:01; DRB3*03:01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=11421).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   T7643-3
AC   CVCL_RM56
SY   7643-3
DR   GEO; GSM627811
DR   Wikidata; Q54971610
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM58 ! T7643-5
OI   CVCL_RM59 ! T7643-7
OI   CVCL_RM57 ! T7643-32
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T7643-32
AC   CVCL_RM57
SY   7643-32
DR   GEO; GSM627818
DR   SKIP; SKIP000791
DR   Wikidata; Q54971612
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM56 ! T7643-3
OI   CVCL_RM58 ! T7643-5
OI   CVCL_RM59 ! T7643-7
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T7643-5
AC   CVCL_RM58
SY   7643-5
DR   GEO; GSM627825
DR   SKIP; SKIP000787
DR   Wikidata; Q54971614
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM56 ! T7643-3
OI   CVCL_RM59 ! T7643-7
OI   CVCL_RM57 ! T7643-32
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T7643-7
AC   CVCL_RM59
SY   7643-7
DR   GEO; GSM627831
DR   SKIP; SKIP000789
DR   Wikidata; Q54971615
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM56 ! T7643-3
OI   CVCL_RM58 ! T7643-5
OI   CVCL_RM57 ! T7643-32
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T778
AC   CVCL_M808
SY   94778; 778
DR   Cosmic; 2307717
DR   Cosmic; 2800531
DR   Wikidata; Q54971617
RX   PubMed=17354236;
RX   PubMed=22911243;
RX   PubMed=24726063;
RX   PubMed=26643872;
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M807 ! T449
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   T78-1
AC   CVCL_X527
SY   V79puro
DR   ChEMBL-Cells; CHEMBL3307256
DR   ChEMBL-Targets; CHEMBL613095
DR   PubChem_Cell_line; CVCL_X527
DR   Wikidata; Q54971618
RX   PubMed=9111301;
RX   PubMed=14997211;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P38489; Escherichia coli nitroreductase nfnB.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 14
//
ID   T79-A3
AC   CVCL_X528
SY   V79-NTRpuro
DR   Wikidata; Q54971619
RX   PubMed=9111301;
RX   PubMed=14997211;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P38489; Escherichia coli nitroreductase nfnB.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 13
//
ID   T7CC
AC   CVCL_ZZ86
SY   T7 Co-Culture
DR   Wikidata; Q102114965
RX   PubMed=7474117;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=40843; ! Macaca tonkeana (Tonkean macaque)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   t7e3
AC   CVCL_D3EW
DR   Wikidata; Q127384366
RX   PubMed=27608665;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   T8
AC   CVCL_C1IW
DR   Wikidata; Q114313092
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T8-2
AC   CVCL_C5MC
DR   Wikidata; Q116050624
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T8-3
AC   CVCL_C5MD
DR   Wikidata; Q116050625
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T80
AC   CVCL_2G68
DR   Wikidata; Q54971620
RX   PubMed=14996724;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5546 ! IOSE-80
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 10
//
ID   T80-4
AC   CVCL_5631
DR   Wikidata; Q54971621
RX   PubMed=6504058;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5634 ! Don D-6
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   T80-6
AC   CVCL_5632
DR   Wikidata; Q54971622
RX   PubMed=6504058;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5634 ! Don D-6
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   T80-7
AC   CVCL_5633
DR   Wikidata; Q54971623
RX   PubMed=6504058;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5634 ! Don D-6
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   T80H
AC   CVCL_2G70
DR   Wikidata; Q54971624
RX   PubMed=14996724;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G68 ! T80
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 12
//
ID   T80K
AC   CVCL_2G75
DR   Wikidata; Q54971625
RX   PubMed=14996724;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Val (c.35G>T)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2G68 ! T80
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 11
//
ID   T84
AC   CVCL_0555
SY   T-84; T 84
DR   BTO; BTO_0002032
DR   CLO; CLO_0009254
DR   EFO; EFO_0002084
DR   MCCL; MCC:0000456
DR   CLDB; cl4474
DR   CLDB; cl4475
DR   AddexBio; C0009008/70
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-4194
DR   ATCC; CCL-248
DR   BCRC; 60149
DR   BCRJ; 0232
DR   BioGRID_ORCS_Cell_line; 358
DR   BioSample; SAMN03471378
DR   BioSample; SAMN03473196
DR   BioSample; SAMN10988370
DR   cancercelllines; CVCL_0555
DR   CCRID; 1101HUM-PUMC000056
DR   CCRID; 3101HUMTCHu211
DR   Cell_Model_Passport; SIDM00782
DR   ChEMBL-Cells; CHEMBL3307275
DR   ChEMBL-Targets; CHEMBL613531
DR   CLS; 300354
DR   ColonAtlas; T84
DR   Cosmic; 887245
DR   Cosmic; 889532
DR   Cosmic; 909761
DR   Cosmic; 983742
DR   Cosmic; 995406
DR   Cosmic; 1043832
DR   Cosmic; 1122335
DR   Cosmic; 1184103
DR   Cosmic; 1187325
DR   Cosmic; 1479590
DR   Cosmic; 1537487
DR   Cosmic; 1609494
DR   Cosmic; 1676743
DR   Cosmic; 1708411
DR   Cosmic; 1803953
DR   Cosmic; 1888953
DR   Cosmic; 2301548
DR   Cosmic; 2302022
DR   Cosmic; 2647528
DR   Cosmic; 2760074
DR   Cosmic-CLP; 909761
DR   DepMap; ACH-000381
DR   ECACC; 88021101
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909761
DR   GEO; GSM206556
DR   GEO; GSM741255
DR   GEO; GSM827303
DR   GEO; GSM887686
DR   GEO; GSM888778
DR   GEO; GSM1346895
DR   GEO; GSM1374953
DR   GEO; GSM1448090
DR   GEO; GSM1670522
DR   IARC_TP53; 21756
DR   IARC_TP53; 23495
DR   ICLC; HTL95022
DR   IGRhCellID; T84
DR   IZSLER; BS TCL 154
DR   LiGeA; CCLE_014
DR   LINCS_LDP; LCL-1166
DR   Lonza; 958
DR   MetaboLights; MTBLS227
DR   PharmacoDB; T84_1561_2019
DR   PRIDE; PXD005235
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0555
DR   PubChem_Cell_line; CVCL_0555
DR   SKY/M-FISH/CGH; 2853
DR   Wikidata; Q54971626
RX   CelloPub=CLPUB00574;
RX   PubMed=2110452;
RX   PubMed=6141741;
RX   PubMed=8464898;
RX   PubMed=10612807;
RX   PubMed=10737795;
RX   PubMed=15484219;
RX   PubMed=16418264;
RX   PubMed=16612624;
RX   PubMed=18258742;
RX   PubMed=19927377;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=22460905;
RX   PubMed=23272949;
RX   PubMed=24755471;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28854368;
RX   PubMed=29101300;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft produced by subcutaneous injection of the tumor cells into BALB/c nude mice.
CC   Doubling time: 33.90 hours (PubMed=25944804).
CC   HLA typing: A*02,09 (PubMed=8464898).
CC   HLA typing: A*02:01,24:02; B*18:01,35:01; C*04:01,07:01 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471; PubMed=25926053; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1488Phefs*19 (c.4464delA); Zygosity=Homozygous (PubMed=24755471; ATCC=CCL-248; Cosmic-CLP=909761; DepMap=ACH-000381).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (PubMed=20570890; PubMed=24755471; Cosmic-CLP=909761; DepMap=ACH-000381).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (PubMed=20570890; PubMed=24755471; Cosmic-CLP=909761; DepMap=ACH-000381).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Lys340Asn (c.1020G>C); Zygosity=Homozygous (PubMed=24755471; Cosmic-CLP=909761; DepMap=ACH-000381).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>T; ClinVar=VCV003148249; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=16418264; Cosmic-CLP=909761; DepMap=ACH-000381).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.33%; Native American=0%; East Asian, North=3.37%; East Asian, South=0%; South Asian=0%; European, North=57.21%; European, South=37.09% (PubMed=30894373).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): AddexBio=C0009008/70; ATCC=CCL-248; CCRID; CLS=300354; Cosmic-CLP=909761; ECACC=88021101; PubMed=25877200; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 10,11
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 23,26
ST   D3S1358: 19
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 14
ST   TH01: 6,9
ST   TPOX: 8 (CLS=300354; ECACC=88021101; PubMed=25877200)
ST   TPOX: 8,11 (AddexBio=C0009008/70; ATCC=CCL-248; CCRID; Cosmic-CLP=909761; PubMed=25926053)
ST   vWA: 17,18
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   T84/Cas9-hyg
AC   CVCL_C9EU
DR   GeneCopoeia; SL541
DR   Wikidata; Q123033602
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL541).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1488Phefs*19 (c.4464delA); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Lys340Asn (c.1020G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>T; ClinVar=VCV003148249; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0555 ! T84
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   T84.66A3.1A.1F2
AC   CVCL_F775
SY   T84.66.A3.1-H-11; T84.66
DR   CLO; CLO_0009255
DR   ABCD; ABCD_AC854
DR   ATCC; HB-8747
DR   Wikidata; Q54971627
RX   Patent=US4873313;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8747.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 7
//
ID   T84SF
AC   CVCL_C4S3
DR   Wikidata; Q116050626
RX   PubMed=15484219;
RX   PubMed=16612624;
CC   Population: Caucasian.
CC   Characteristics: Metastatic. Selected by repetitive plating on TNFalpha-activated human endothelial cells and subsequent selection for adherent cells (PubMed=15484219).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Leu1488Phefs*19 (c.4464delA); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Lys340Asn (c.1020G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>T; ClinVar=VCV003148249; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0555 ! T84
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   T87 [A.thaliana]
AC   CVCL_D5GW
DR   EFO; EFO_0006305
DR   GEO; GSE23301
DR   GEO; GSE28600
DR   GEO; GSE52468
DR   GEO; GSE94348
DR   GEO; GSM539889
DR   GEO; GSM539890
DR   GEO; GSM539891
DR   PRIDE; PXD041996
DR   RIKEN_BRC_EPD; rpc00008
DR   Wikidata; Q127384367
RX   CelloPub=CLPUB00764;
RX   PubMed=12668783;
RX   PubMed=15388974;
RX   PubMed=24709077;
RX   PubMed=30770845;
RX   PubMed=37253723;
WW   Provider; ABRC; CCL84839; https://abrc.osu.edu/stocks/3
CC   Group: Plant cell line.
CC   Characteristics: Partial chloroplast development under light conditions (https://abrc.osu.edu/stocks/3).
CC   Characteristics: Active Cre recombinase can be delivered by electroporation (PubMed=30770845).
CC   Characteristics: Can be used to prepare protoplasts (PubMed=15388974).
CC   Characteristics: Photoautotrophic growth (PubMed=24709077).
CC   Doubling time: ~95 hours (CelloPub=CLPUB00764).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Columbia.
OX   NCBI_TaxID=3702; ! Arabidopsis thaliana (Mouse-ear cress)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   T87 [Mouse hybridoma against human 60 kDa glycoprotein]
AC   CVCL_N339
DR   ATCC; HB-8274
DR   Wikidata; Q54971628
RX   Patent=US4643971;
RX   PubMed=6364135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8274.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown 60 kDa glycoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 7
//
ID   T87/rc
AC   CVCL_M671
DR   Wikidata; Q54971629
RX   PubMed=1692307;
CC   Characteristics: Established from a xenograft maintained in nude mice (PubMed=1692307).
CC   Doubling time: 38 +- 3 hours (Note=At 40th passage) (PubMed=1692307).
CC   Derived from site: In situ; Pharynx, epiglottis; UBERON=UBERON_0000388.
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 8
//
ID   T88-M
AC   CVCL_6542
SY   T88M
DR   CLO; CLO_0051533
DR   RCB; RCB0792
DR   Wikidata; Q54971631
RX   DOI=10.4051/ibc.2010.2.4.0014;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=T88-M
CC   Characteristics: IL3 or IL5 dependent.
CC   Caution: Not from strain DBA/2J as originally published but from strain C3H/He (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5369 ! T-88
SX   Female
AG   2-3W
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   T8993G iPSC clone 1
AC   CVCL_A4QJ
DR   SKIP; SKIP000985
DR   Wikidata; Q105511151
RX   PubMed=27008180;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Unspecified (PubMed=27008180).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8A61 ! GM13411
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   T8993G iPSC clone 2
AC   CVCL_A4QK
DR   SKIP; SKIP000986
DR   Wikidata; Q105511154
RX   PubMed=27008180;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Unspecified (PubMed=27008180).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8A61 ! GM13411
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   T8993G iPSC clone 3
AC   CVCL_A4QL
DR   SKIP; SKIP000987
DR   Wikidata; Q105511157
RX   PubMed=27008180;
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu156Arg (m.8993T>G); ClinVar=VCV000009641; Zygosity=Unspecified (PubMed=27008180).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8A61 ! GM13411
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   t8E4
AC   CVCL_D3EX
DR   Wikidata; Q127384368
RX   PubMed=27608665;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   t8G12
AC   CVCL_D3EY
DR   Wikidata; Q127384369
RX   PubMed=27608665;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P14210; Human HGF.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   T9
AC   CVCL_C1IX
DR   Wikidata; Q114313093
RX   PubMed=2545605;
CC   Transformant: ChEBI; CHEBI_82272; Erionite.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60453; Rat malignant mesothelioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 7
//
ID   T9-1
AC   CVCL_C5ME
DR   Wikidata; Q116050627
RX   PubMed=1908510;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA) (Note=With p.Gly241Asp = PR8(Asp225)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   T91M
AC   CVCL_A5XX
DR   Wikidata; Q107117007
RX   DOI=10.2172/4683311;
RX   PubMed=5660764;
CC   Problematic cell line: Contaminated. Parent cell line (T-1) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Characteristics: Derived from parent cell line after 800 rads of X-radiation (PubMed=5660764).
CC   Doubling time: 27-28 hours (DOI=10.2172/4683311).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M858 ! T-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   T921
AC   CVCL_T057
DR   Wikidata; Q54971633
RX   Patent=CN102344910A;
RX   PubMed=23813186;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201180.
CC   Population: Chinese.
CC   Doubling time: 48-72 hours (PubMed=23813186).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   T9305
AC   CVCL_D6VU
SY   Immortalized Mouse Hypothalamic Neurons - SV40T
DR   ABM; T9305
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, hypothalamus; UBERON=UBERON_0001898.
CC   Cell type: Neuron; CL=CL_0000540.
ST   Source(s): ABM=T9305
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 15,16
ST   Mouse STR 6-4: 16,18
ST   Mouse STR 6-7: 12,14
ST   Mouse STR 12-1: 16
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 18-3: 20,21
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   T95-45D
AC   CVCL_M081
DR   Wikidata; Q54971634
RX   PubMed=12209986;
CC   From: Center for Medical Genetics; Ghent; Belgium.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   T98
AC   CVCL_B368
SY   T-98
DR   BTO; BTO_0006123
DR   ChEMBL-Cells; CHEMBL4630770
DR   ChEMBL-Targets; CHEMBL4630778
DR   GEO; GSM101669
DR   GEO; GSM101670
DR   PubChem_Cell_line; CVCL_B368
DR   Wikidata; Q54971635
RX   PubMed=222778;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=16697959;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   T9862-35
AC   CVCL_RM60
SY   9862-35
DR   GEO; GSM627834
DR   Wikidata; Q54971636
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM64 ! T9862-5
OI   CVCL_RM61 ! T9862-40
OI   CVCL_RM62 ! T9862-41
OI   CVCL_RM63 ! T9862-42
OI   CVCL_RM65 ! T9862-61
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T9862-40
AC   CVCL_RM61
SY   9862-40
DR   GEO; GSM627835
DR   Wikidata; Q54971637
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM64 ! T9862-5
OI   CVCL_RM60 ! T9862-35
OI   CVCL_RM62 ! T9862-41
OI   CVCL_RM63 ! T9862-42
OI   CVCL_RM65 ! T9862-61
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T9862-41
AC   CVCL_RM62
SY   9862-41
DR   GEO; GSM627836
DR   Wikidata; Q54971638
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM64 ! T9862-5
OI   CVCL_RM60 ! T9862-35
OI   CVCL_RM61 ! T9862-40
OI   CVCL_RM63 ! T9862-42
OI   CVCL_RM65 ! T9862-61
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T9862-42
AC   CVCL_RM63
SY   9862-42
DR   GEO; GSM627838
DR   SKIP; SKIP000788
DR   Wikidata; Q54971639
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM64 ! T9862-5
OI   CVCL_RM60 ! T9862-35
OI   CVCL_RM61 ! T9862-40
OI   CVCL_RM62 ! T9862-41
OI   CVCL_RM65 ! T9862-61
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T9862-5
AC   CVCL_RM64
SY   9862-5
DR   GEO; GSM627839
DR   Wikidata; Q54971640
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM60 ! T9862-35
OI   CVCL_RM61 ! T9862-40
OI   CVCL_RM62 ! T9862-41
OI   CVCL_RM63 ! T9862-42
OI   CVCL_RM65 ! T9862-61
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T9862-61
AC   CVCL_RM65
SY   9862-61
DR   GEO; GSM627840
DR   SKIP; SKIP000790
DR   Wikidata; Q54971641
RX   PubMed=21307850;
RX   PubMed=22120178;
CC   Sequence variation: Mutation; HGNC; HGNC:1390; CACNA1C; Simple; p.Gly406Arg (c.1216G>A); ClinVar=VCV000017632; Zygosity=Unspecified (PubMed=21307850).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142894; Long QT syndrome 8
DI   ORDO; Orphanet_65283; Timothy syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM64 ! T9862-5
OI   CVCL_RM60 ! T9862-35
OI   CVCL_RM61 ! T9862-40
OI   CVCL_RM62 ! T9862-41
OI   CVCL_RM63 ! T9862-42
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   T98G
AC   CVCL_0556
SY   T 98 G; T-98G; T98 G; T98-G
DR   BTO; BTO_0001583
DR   CLO; CLO_0009236
DR   CLO; CLO_0009258
DR   CLO; CLO_0050636
DR   EFO; EFO_0002085
DR   MCCL; MCC:0000457
DR   CLDB; cl4478
DR   CLDB; cl4480
DR   CLDB; cl4481
DR   CLDB; cl4482
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1690
DR   BCRJ; 0406
DR   BioGRID_ORCS_Cell_line; 357
DR   BioSample; SAMN01821603
DR   BioSample; SAMN01821719
DR   BioSample; SAMN01821740
DR   BioSample; SAMN03473051
DR   BioSample; SAMN05292443
DR   BioSample; SAMN07710005
DR   BioSample; SAMN07710006
DR   BioSample; SAMN07710007
DR   BioSample; SAMN07710008
DR   BioSample; SAMN07710009
DR   BioSample; SAMN07710010
DR   BioSample; SAMN07710011
DR   BioSample; SAMN10988244
DR   cancercelllines; CVCL_0556
DR   Cell_Model_Passport; SIDM01171
DR   CGH-DB; 154-1
DR   ChEMBL-Cells; CHEMBL3307777
DR   ChEMBL-Targets; CHEMBL614775
DR   CLS; 305030
DR   Cosmic; 687586
DR   Cosmic; 759898
DR   Cosmic; 849847
DR   Cosmic; 850740
DR   Cosmic; 897444
DR   Cosmic; 1175821
DR   Cosmic; 1217675
DR   Cosmic; 1294953
DR   Cosmic; 1610748
DR   Cosmic; 1746960
DR   Cosmic; 2302325
DR   Cosmic; 2367552
DR   Cosmic; 2491103
DR   Cosmic; 2516040
DR   Cosmic; 2701088
DR   Cosmic; 2731176
DR   Cosmic; 2732519
DR   Cosmic-CLP; 687586
DR   DepMap; ACH-000571
DR   ECACC; 92090213
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10485-107A8
DR   GDSC; 687586
DR   GEO; GSM326205
DR   GEO; GSM887687
DR   GEO; GSM888779
DR   GEO; GSM1374954
DR   GEO; GSM1638664
DR   GEO; GSM1638665
DR   GEO; GSM1638666
DR   GEO; GSM1670523
DR   GEO; GSM2113432
DR   GEO; GSM2113433
DR   GEO; GSM2113434
DR   GEO; GSM2113435
DR   IARC_TP53; 2574
DR   IZSLER; BS TCL 63
DR   JCRB; IFO50303
DR   JCRB; JCRB9041
DR   KCLB; 21690
DR   LiGeA; CCLE_712
DR   LINCS_LDP; LCL-1357
DR   PharmacoDB; T98G_1562_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD002192
DR   PRIDE; PXD003790
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0556
DR   PubChem_Cell_line; CVCL_0556
DR   RCB; RCB1954
DR   TKG; TKG 0471
DR   Wikidata; Q52609889
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=222778;
RX   PubMed=3413074;
RX   PubMed=9090379;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=10560660;
RX   PubMed=11414198;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=14961077;
RX   PubMed=16232199;
RX   PubMed=17595512;
RX   PubMed=18445040;
RX   PubMed=19435942;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20587068;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25984343;
RX   PubMed=26496030;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27412690;
RX   PubMed=28464039;
RX   PubMed=30188626;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=33385022;
RX   PubMed=35839778;
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544555
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-574.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/T98G
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Doubling time: 22 hours (PubMed=9842975); 40 hours (PubMed=25984343); 26-36 hours (PubMed=30188626); ~28 hours (PBCF).
CC   HLA typing: A*02:01,02:01; B*35:03,39:06; C*04:01,07:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01; B*36:06:02; C*07:02:01 (PubMed=27412690).
CC   Karyotypic information: Hyperpentaploid karyotype. Has almost twice as many chromosomes as its parental cell line (T98) (PubMed=222778).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-20del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu42Arg (c.125T>G); Zygosity=Unspecified (PubMed=9090379; PubMed=10560660; PubMed=28464039).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (PubMed=10416987; PubMed=14614447).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.56%; Native American=0.16%; East Asian, North=4.73%; East Asian, South=0%; South Asian=6.52%; European, North=26.22%; European, South=60.81% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-1690; COG; Cosmic-CLP=687586; ECACC=92090213; JCRB=IFO50303; JCRB=JCRB9041; KCLB=21690; PubMed=22570425; PubMed=25877200; RCB=RCB1954; Technion Genomics Center; TKG=TKG 0471
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 14
ST   D12S391: 17,18
ST   D13S317: 13
ST   D16S539: 13
ST   D18S51: 13,16
ST   D19S433: 12,13
ST   D1S1656: 14,17
ST   D21S11: 28,32.2
ST   D22S1045: 15,16
ST   D2S1338: 19,24
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   DYS391: 9
ST   FGA: 21 (PubMed=22570425; PubMed=25877200)
ST   FGA: 21,22 (ATCC=CRL-1690; COG; KCLB=21690; Technion Genomics Center)
ST   Penta D: 10,11
ST   Penta E: 16
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B368 ! T98
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   TA-02
AC   CVCL_C1D2
SY   Tilapia Astrocyte clone 02
DR   Wikidata; Q114313094
RX   PubMed=35758189;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Astrocyte; CL=CL_0000127.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   TA-1 [Human leukemia]
AC   CVCL_QX04
DR   Wikidata; Q54971644
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8395908;
CC   Population: Japanese.
CC   Doubling time: 96-120 hours (PubMed=8395908).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   TA-1 [Mouse hybridoma against human ERBB2]
AC   CVCL_F777
DR   CLO; CLO_0009260
DR   ATCC; HB-10206
DR   Wikidata; Q54971645
RX   Patent=US5604107;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10206.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04626; Human ERBB2/CD340.
CC   Discontinued: ATCC; HB-10206; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   TA-85B5
AC   CVCL_2212
DR   DSMZ; ACC-624
DR   DSMZCellDive; ACC-624
DR   Wikidata; Q54971646
CC   Doubling time: ~60-70 hours (DSMZ=ACC-624).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Wistar-AF/Han.
DI   NCIt; C60682; Rat digestive system neoplasms
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Ta288
AC   CVCL_6D38
SY   T.a 288
DR   Wikidata; Q54971647
RX   PubMed=1979317;
CC   Characteristics: Infected by Theileria annulaza isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TA3
AC   CVCL_4315
DR   ChEMBL-Cells; CHEMBL3307258
DR   ChEMBL-Targets; CHEMBL613285
DR   Lonza; 1032
DR   PubChem_Cell_line; CVCL_4315
DR   Wikidata; Q54971649
RX   PubMed=4934423;
RX   PubMed=13709454;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-145.html
CC   Breed/subspecies: A/HeHa.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   TA3/Ha
AC   CVCL_4321
SY   TA3-Ha; TA3Ha; TA3 Hauschka
DR   CLO; CLO_0009262
DR   CLDB; cl4484
DR   ECACC; 85061102
DR   Wikidata; Q54971650
RX   PubMed=460789;
RX   PubMed=4934423;
CC   Breed/subspecies: A/HeHa.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4315 ! TA3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 7
//
ID   TA3/St
AC   CVCL_4316
SY   TA3-St; TA3 Stockholm; TA3K1
DR   TOKU-E; 4019
DR   Wikidata; Q54971651
RX   PubMed=460789;
RX   PubMed=4934423;
CC   Breed/subspecies: A/HeHa.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4315 ! TA3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   Ta363
AC   CVCL_6D39
DR   Wikidata; Q54971653
RX   PubMed=1979317;
CC   Characteristics: Infected by Theileria annulaza isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TA99
AC   CVCL_F776
SY   TA 99
DR   CLO; CLO_0009259
DR   ABCD; ABCD_AF499
DR   ATCC; HB-8704
DR   Wikidata; Q54971654
RX   Patent=US4798790;
RX   Patent=US5160723;
RX   PubMed=3473501;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/anti-trp1-mouse-monoclonal-antibody-clone-ta99
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8704.
CC   Registration: Memorial Sloan Kettering Cancer Center Office of Technology Development; SK 413.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P17643; Human TYRP1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 10
//
ID   TaA2
AC   CVCL_B6P0
DR   Wikidata; Q112041765
RX   PubMed=1569131;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TaA2 clone C9
AC   CVCL_B6P1
SY   C9
DR   Wikidata; Q112041766
RX   PubMed=1569131;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_B6P0 ! TaA2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TaA2 clone D3
AC   CVCL_B6P3
SY   D3
DR   Wikidata; Q112041767
RX   PubMed=1569131;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_B6P0 ! TaA2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TaA2 clone D7
AC   CVCL_B6P4
SY   D7; TaD7
DR   Wikidata; Q112041768
RX   CelloPub=CLPUB00682;
RX   PubMed=1569131;
RX   PubMed=11426947;
RX   PubMed=15075278;
RX   PubMed=18573257;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_B6P0 ! TaA2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TaA2 clone D7B12
AC   CVCL_B6P5
SY   D7B12; D7/B12; TaD7B12
DR   Wikidata; Q112041769
RX   CelloPub=CLPUB00682;
RX   PubMed=11426947;
RX   PubMed=18573257;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_B6P4 ! TaA2 clone D7
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TaA2 clone E3
AC   CVCL_B6P2
SY   E3
DR   Wikidata; Q112041770
RX   PubMed=1569131;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_B6P0 ! TaA2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TaA46
AC   CVCL_WI95
SY   Ta A46
DR   Wikidata; Q98133078
RX   PubMed=1461683;
CC   Characteristics: Infected by Theileria annulata isolate Ankara.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_WI96 ! TaH46
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TAB089
AC   CVCL_E842
SY   TAB 089; TAB
DR   dbMHC; 49034
DR   ECACC; 88052066
DR   IHW; IHW09066
DR   IPD-IMGT/HLA; 11424
DR   Wikidata; Q54971660
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:07:01,02:01:01:01; B*46:01:01; C*01:02:01; DPA1*02:02:02; DPB1*02:02; DQA1*01:03; DQB1*06:01:01/06:01:15; DRA*01:02; DRB1*08:03:02 (IPD-IMGT/HLA=11424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   TAB1
AC   CVCL_GZ67
SY   TAB-1
DR   Wikidata; Q54971661
RX   PubMed=12579318;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent. Requires bone marrow stromal cells for growth.
CC   Doubling time: ~72 hours (PubMed=12579318).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   TAB1/C2-2
AC   CVCL_JJ76
SY   C2-2
DR   Wikidata; Q54971662
RX   PubMed=12579318;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: Does not require bone marrow stromal cells for growth.
CC   Doubling time: ~30 hours (PubMed=12579318).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GZ67 ! TAB1
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   TAC-1
AC   CVCL_3468
SY   Tamarin Adenocarcinoma of the Colon-1
DR   CLO; CLO_0009263
DR   Wikidata; Q54971663
RX   Patent=US5093259;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10632.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C134964; Tamarin colon adenocarcinoma
OX   NCBI_TaxID=9490; ! Saguinus oedipus (Cotton-top tamarin)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TAC-2
AC   CVCL_G954
SY   TAC2; TubuloAlveolar Colony-2
DR   Wikidata; Q54971664
RX   PubMed=7768990;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Namru.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0075 ! NMuMG
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   TaC12
AC   CVCL_2G84
SY   TaC 12
DR   Wikidata; Q54971665
RX   PubMed=18573257;
RX   PubMed=20927361;
CC   Characteristics: Infected by Theileria annulata.
CC   Miscellaneous: The exact nature of this cell line is not clear, it could be derived from the TaA2 (Cellosaurus=CVCL_B6P0) cell line.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   TaD-1
AC   CVCL_5635
SY   TaD1
DR   JCRB; IFO50112
DR   Wikidata; Q54971666
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   TaD-1-2
AC   CVCL_M863
SY   TaD1-2
DR   Wikidata; Q54971667
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TaD-1-3
AC   CVCL_5636
SY   TaD1-3
DR   JCRB; IFO50120
DR   Wikidata; Q54971668
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   TaD-1-4
AC   CVCL_M864
SY   TaD1-4
DR   Wikidata; Q54971669
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TaD-1-5
AC   CVCL_M865
SY   TaD1-5
DR   Wikidata; Q54971671
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TaD-1-6
AC   CVCL_M866
SY   TaD1-6
DR   Wikidata; Q54971672
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TaD-1-7
AC   CVCL_M867
SY   TaD1-7
DR   Wikidata; Q54971673
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TaD-1-8
AC   CVCL_5637
SY   TaD1-8
DR   Wikidata; Q54971674
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna x Buffalo/Mna; RS=RS_0000030+RS_0000165.
DI   NCIt; C60470; Rat malignant thymoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5635 ! TaD-1
SX   Male
AG   2Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   TAD-2
AC   CVCL_5370
SY   TAD2
DR   BTO; BTO_0004770
DR   ATCC; CRL-2855
DR   BioSample; SAMN03471804
DR   Wikidata; Q54971675
RX   PubMed=1973649;
RX   PubMed=16778181;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Discontinued: ATCC; CRL-2855; true.
CC   Derived from site: In situ; Fetal thyroid gland; UBERON=UBERON_0003091.
ST   Source(s): ATCC=CRL-2855
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 7,8
ST   vWA: 13,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   TAF11
AC   CVCL_A7ML
SY   TAF-11
DR   Wikidata; Q107117008
RX   PubMed=33070101;
RX   PubMed=33619287;
CC   Population: Caucasian.
CC   Karyotypic information: 46,XY,r(8)(p23;q24.3); 45,XY,-8 (PubMed=33070101).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175705; Ring chromosome 8 syndrome
DI   ORDO; Orphanet_1450; Ring chromosome 8 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y4M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   TAF12
AC   CVCL_A7MS
SY   TAF-12
DR   Wikidata; Q107117010
RX   PubMed=33212351;
RX   PubMed=33619287;
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C175706; Ring chromosome 18 syndrome
DI   ORDO; Orphanet_1442; Ring chromosome 18 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   TAF5
AC   CVCL_A9Q1
SY   TAF-5
DR   Wikidata; Q102114967
RX   PubMed=29736186;
RX   PubMed=30144655;
RX   PubMed=33619287;
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   NCIt; C179702; Ring chromosome 22 syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
DI   ORDO; Orphanet_1446; Ring chromosome 22 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   TAF6
AC   CVCL_A9Q2
SY   TAF-6
DR   Wikidata; Q102114968
RX   PubMed=30500678;
RX   PubMed=33619287;
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C116942; Developmental delay
DI   NCIt; C179703; Ring chromosome 13 syndrome
DI   ORDO; Orphanet_96176; Ring chromosome 13 syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   TAg58
AC   CVCL_D1L9
SY   TAg
DR   ABM; T0716
DR   Wikidata; Q127384370
RX   Patent=US10400217;
RX   PubMed=25895553;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3218.
CC   Doubling time: 9.60 +- 2.29 hours (Note=At 7th passage), 12.34 +- 3.09 hours (Note=At 9th passage), 31.85 +- 10.49 hours (Note=At 10th passage) (PubMed=25895553).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone, periosteum, pericranium; UBERON=UBERON_0013687.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   TAH-11
AC   CVCL_D4BC
SY   TilApia Heart-11
DR   Wikidata; Q127384371
RX   DOI=10.3390/fishes8030167;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 16 to 37 Celsius (DOI=10.3390/fishes8030167).
CC   Virology: Susceptible to infection by Chinese giant salamander iridovirus (CGSIV). CGSIV cause cytopathic effects (DOI=10.3390/fishes8030167).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   TaH46
AC   CVCL_WI96
SY   Ta H46; Tah46; TAH46
DR   Wikidata; Q98133079
RX   PubMed=1461683;
RX   PubMed=2421227;
CC   Characteristics: In vitro infected by Theileria annulata isolate Hissar.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_WI95 ! TaA46
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   Tahr87
AC   CVCL_A398
SY   TAHR-87; Tahr-87; Tahr 87
DR   Cosmic; 999767
DR   Cosmic; 1281354
DR   Cosmic; 2491092
DR   Wikidata; Q54971676
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7688832;
RX   PubMed=9067587;
RX   PubMed=9680106;
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   TAI034
AC   CVCL_E843
SY   TAI 034
DR   dbMHC; 49035
DR   ECACC; 94082210
DR   IHW; IHW09111
DR   IPD-IMGT/HLA; 11656
DR   Wikidata; Q54971677
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*11:01:01,33:01; B*14:02,52:01:01; C*08:02; DPB1*04:01; DQA1*01:01,01:03; DQB1*05:01,06:01; DRB1*01:02,15:02; DRB5*01:02 (IPD-IMGT/HLA=11656).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   TAK-N
AC   CVCL_VG89
DR   Wikidata; Q54971678
RX   PubMed=3658923;
CC   Population: Japanese.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   TAK3
AC   CVCL_2729
SY   TAK 3
DR   CLO; CLO_0009264
DR   CLDB; cl4485
DR   ECACC; 93093004
DR   Wikidata; Q54971679
RX   PubMed=6438434;
RX   PubMed=6817143;
WW   Info; IMGT; -; https://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC   Population: Tunisian; Berber.
CC   Characteristics: Homozygous for deletion of IGH G1-EP1-A1-GP-G2-G4.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5523; IGHEP1; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5525; IGHG1; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5526; IGHG2; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5528; IGHG4; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5529; IGHGP; Zygosity=Homozygous (PubMed=6438434; PubMed=6817143).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   TAKA
AC   CVCL_UW36
DR   Wikidata; Q98133080
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   TAKA-1
AC   CVCL_T061
DR   Wikidata; Q54971680
RX   PubMed=7728976;
RX   PubMed=8581919;
CC   Doubling time: 33 hours (Note=At 17th passage), 20 hours (Note=At 30th passage) (PubMed=8581919); 37.4 hours (Note=At 11th passage), 33 hours (Note=At 17th passage), 20.4 hours (Note=At 31th passage) (PubMed=7728976).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic ductal cell; CL=CL_0002079.
CC   Breed/subspecies: Eppley colony; VBO=VBO_0017486.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Male
AG   8-10W
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   Takigawa
AC   CVCL_3176
DR   BioSample; SAMN03473263
DR   CGH-DB; 137-1
DR   Cosmic; 1122340
DR   Cosmic; 1187296
DR   GEO; GSM552376
DR   JCRB; JCRB0124
DR   JCRB; NIHS0182
DR   PharmacoDB; Takigawa_1563_2019
DR   Wikidata; Q54971681
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=8574330;
RX   PubMed=25877200;
CC   Population: Japanese.
CC   Characteristics: Produces high level of AFP.
CC   Doubling time: 152 hours (Note=At 58th passage) (PubMed=8574330); ~2 weeks (Note=Lot 09022004), ~10 days (Note=Lot 06282011) (JCRB=JCRB0124).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0182; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB0124; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 14
ST   D18S51: 22
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 23
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Tal Jo
AC   CVCL_3469
DR   CLO; CLO_0009265
DR   ATCC; CRL-1267
DR   Wikidata; Q54971682
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TALH SVE.1
AC   CVCL_4317
AS   CVCL_U960
SY   TALH-SVE.1; TALH,SVE.1; TALH; Thick Ascending Limb of Henle's loop pSVE immortalized 1
DR   BTO; BTO_0004609
DR   Wikidata; Q54971684
RX   PubMed=1504097;
RX   PubMed=1847303;
RX   PubMed=2427348;
RX   PubMed=9312212;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, nephron, thick ascending limb of loop of Henle; UBERON=UBERON_0001291.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_E3F4 ! TALH SVE.2
OI   CVCL_E3F5 ! TALH SVE2.1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   TALH SVE.2
AC   CVCL_E3F4
SY   TALH-SVE.2; TALH,SVE.2; Thick Ascending Limb of Henle's loop pSVE immortalized 2
RX   PubMed=2427348;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, nephron, thick ascending limb of loop of Henle; UBERON=UBERON_0001291.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_4317 ! TALH SVE.1
OI   CVCL_E3F5 ! TALH SVE2.1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   TALH SVE2.1
AC   CVCL_E3F5
SY   TALH-SVE2.1; TALH,SVE2.1; Thick Ascending Limb of Henle's loop pSVE2 immortalized 1
RX   PubMed=2427348;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, nephron, thick ascending limb of loop of Henle; UBERON=UBERON_0001291.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_4317 ! TALH SVE.1
OI   CVCL_E3F4 ! TALH SVE.2
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   TALL-1 [Human adult T-ALL]
AC   CVCL_1736
SY   TALL 1; TALL1; T-ALL-1; T-ALL 1; T-ALL1; T-cell Acute Lymphoblastic Leukemia-1
DR   BTO; BTO_0003739
DR   CLO; CLO_0051547
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472057
DR   BioSample; SAMN03473519
DR   BioSample; SAMN10987755
DR   cancercelllines; CVCL_1736
DR   Cell_Model_Passport; SIDM00370
DR   ChEMBL-Cells; CHEMBL3308541
DR   ChEMBL-Targets; CHEMBL2366254
DR   Cosmic; 909762
DR   Cosmic; 1375581
DR   Cosmic; 1641379
DR   Cosmic; 1760534
DR   Cosmic; 1760556
DR   Cosmic; 2165721
DR   Cosmic-CLP; 909762
DR   DepMap; ACH-000197
DR   DSMZ; ACC-521
DR   DSMZCellDive; ACC-521
DR   GDSC; 909762
DR   GEO; GSM887688
DR   GEO; GSM888780
DR   IARC_TP53; 10564
DR   IARC_TP53; 27257
DR   JCRB; JCRB0086
DR   LiGeA; CCLE_866
DR   LINCS_LDP; LCL-1024
DR   PharmacoDB; TALL1_1564_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1736
DR   PubChem_Cell_line; CVCL_1736
DR   RCB; RCB2084
DR   TKG; TKG 0251
DR   Wikidata; Q54971685
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=197412;
RX   PubMed=305872;
RX   PubMed=2140233;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6966589;
RX   PubMed=8127147;
RX   PubMed=8957066;
RX   PubMed=9290701;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15472075;
RX   PubMed=16408098;
RX   PubMed=17170727;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22675565;
RX   PubMed=27397505;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; T-ALL cell lines db; -; https://humantallcelllines.wordpress.com/additionalcells/tall-1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 73 hours (PubMed=305872); ~50-70 hours (DSMZ=ACC-521); 36.2 hours (Note=Lot 062994), ~2 days (Note=Lot 08072008), ~41 hours (Note=Lot 12172015), ~39 hours (Note=Lot 11112021) (JCRB=JCRB0086).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=10071127; PubMed=22675565; Cosmic-CLP=909762; DepMap=ACH-000197).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Heterozygous (Cosmic-CLP=909762; DepMap=ACH-000197).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (Cosmic-CLP=909762; DepMap=ACH-000197).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.7%; East Asian, North=75.83%; East Asian, South=19.85%; South Asian=1.99%; European, North=0%; European, South=1.62% (PubMed=30894373).
CC   Caution: TP53 mutation indicated to be at p.Arg175His (c.524G>A) in PubMed=10071127.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): Cosmic-CLP=909762; DSMZ=ACC-521; JCRB=JCRB0086; RCB=RCB2084; TKG=TKG 0251
ST   Amelogenin: X (RCB=RCB2084; TKG=TKG 0251)
ST   Amelogenin: X,Y (Cosmic-CLP=909762; DSMZ=ACC-521; JCRB=JCRB0086)
ST   CSF1PO: 11,13
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 15
ST   D21S11: 29,31.2
ST   D2S1338: 22,23
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,24
ST   Penta D: 13
ST   Penta E: 10,14
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   TALL-1 [Human childhood T-ALL]
AC   CVCL_LK52
DR   Wikidata; Q54971686
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3496132;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Derived from site: In situ; Peripheral blood; Note=Uncertainty of sampling site; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   TALL-101
AC   CVCL_4922
DR   Cosmic; 721701
DR   Cosmic; 913408
DR   Cosmic; 933549
DR   Cosmic; 1012121
DR   Cosmic; 1115586
DR   Cosmic; 1151795
DR   Cosmic; 1330504
DR   Cosmic; 1524824
DR   Wikidata; Q54971688
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1706955;
RX   PubMed=2656885;
RX   PubMed=2953797;
RX   PubMed=3496132;
RX   PubMed=9195772;
CC   Characteristics: CSF2 dependent.
CC   Caution: Indicated as originating from a 3 year old boy in PubMed=1706955 and from a 9 year old boy in PubMed=3496132.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   TALL-103
AC   CVCL_4923
AS   CVCL_L799
SY   TALL-103/3
DR   Wikidata; Q54971689
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1706955;
RX   PubMed=2246514;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   TALL-103/2
AC   CVCL_4805
DR   Wikidata; Q54971690
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5272082;
RX   PubMed=1706955;
RX   PubMed=2246514;
RX   PubMed=2351825;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TALL-103
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4923 ! TALL-103
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TALL-104
AC   CVCL_2771
DR   BTO; BTO_0003740
DR   CLO; CLO_0009267
DR   AddexBio; C0003027/NA
DR   ATCC; CRL-11386
DR   BioSample; SAMN03471335
DR   Cosmic; 683541
DR   Cosmic; 2602910
DR   GEO; GSM5137746
DR   PRIDE; PXD023662
DR   Wikidata; Q54971691
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5272082;
RX   PubMed=1706955;
RX   PubMed=2039829;
RX   PubMed=11059767;
RX   PubMed=15361874;
RX   PubMed=17170727;
RX   PubMed=35354797;
WW   Provider; Galileo Research; -; https://web.archive.org/web/20181130194601/http://www.galileoresearch.it/en/pipeline/TALL-104.html
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11386.
CC   Characteristics: IL2 dependent.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:8064; NUP214; Name(s)=NUP214-ABL1; Note=NUP214 exon 32 fused to ABL1 exon 2 (PubMed=15361874; PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose.
CC   Discontinued: AddexBio; C0003027/NA; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-11386; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 13,14
ST   D12S391: 22,23
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 12,13
ST   D19S433: 14.2,15
ST   D1S1656: 16
ST   D21S11: 30,31
ST   D22S1045: 11,16
ST   D2S1338: 20,25
ST   D2S441: 11
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 7,13
ST   D8S1179: 11,14
ST   DYS391: 10
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 5,7
ST   SE33: 16,19
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   TALL-105
AC   CVCL_L800
DR   Wikidata; Q54971693
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1706955;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TALL-106
AC   CVCL_L801
DR   Wikidata; Q54971694
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1706955;
RX   PubMed=2039829;
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   TALL-107
AC   CVCL_8464
DR   Wikidata; Q54971695
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   Patent=US5272082;
RX   PubMed=8490180;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   TalphaT1
AC   CVCL_U355
SY   T-alpha-T1
DR   Wikidata; Q54971697
RX   PubMed=8898243;
RX   PubMed=15541569;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6 x BALB/c transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_U463 ! AlphaT1-1
SX   Sex unspecified
AG   67D
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 10
//
ID   TALS9-11.2
AC   CVCL_FA04
SY   ND50008
DR   NHCDR; ND50008
DR   SKIP; SKIP001611
DR   Wikidata; Q54971698
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50008).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease (mutation in C9orf72).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 16
//
ID   TALS9-12.3
AC   CVCL_FA05
SY   ND50009
DR   NHCDR; ND50009
DR   SKIP; SKIP001612
DR   Wikidata; Q54971699
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50009).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   TALS9-8.1
AC   CVCL_EZ97
SY   ND50002
DR   NHCDR; ND50002
DR   SKIP; SKIP001580
DR   Wikidata; Q54971700
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ98 ! TALS9-8.6
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   TALS9-8.6
AC   CVCL_EZ98
SY   ND50011
DR   NHCDR; ND50011
DR   SKIP; SKIP001581
DR   Wikidata; Q54971701
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ97 ! TALS9-8.1
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   TALS9-9.3
AC   CVCL_EZ95
SY   ND50000
DR   NHCDR; ND50000
DR   SKIP; SKIP001578
DR   Wikidata; Q54971702
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50000).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ96 ! TALS9-9.5
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   TALS9-9.5
AC   CVCL_EZ96
SY   ND50001
DR   NHCDR; ND50001
DR   SKIP; SKIP001579
DR   Wikidata; Q54971703
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (NHCDR=ND50001).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EZ95 ! TALS9-9.3
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   TALSCTRL11.5
AC   CVCL_EZ99
SY   ND50003; FA0000010; CUIMCi001-A
DR   BioSamples; SAMEA113466677
DR   hPSCreg; CUIMCi001-A
DR   NHCDR; ND50003
DR   SKIP; SKIP001606
DR   Wikidata; Q54971704
RX   PubMed=32738631;
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT90 ! NH50276
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   TALSCTRL15.12
AC   CVCL_FA00
SY   ND50004; FA0000011; CUIMCi002-A
DR   BioSamples; SAMEA113467953
DR   hPSCreg; CUIMCi002-A
DR   NHCDR; ND50004
DR   SKIP; SKIP001607
DR   Wikidata; Q54971715
RX   PubMed=32738631;
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UX40 ! NH50162
OI   CVCL_UX41 ! NH50163
OI   CVCL_YP76 ! NH50286
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   Talsky
AC   CVCL_DN31
DR   Wikidata; Q54971720
RX   PubMed=26842912;
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   TALSSOD1A4V-39.7
AC   CVCL_FA06
SY   ND50010
DR   NHCDR; ND50010
DR   SKIP; SKIP001613
DR   Wikidata; Q54971716
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ala5Val (c.14C>T) (A4V); ClinVar=VCV000014763; Zygosity=Unspecified (NHCDR=ND50010).
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   TALSSPO16.2
AC   CVCL_FA01
SY   ND50005
DR   NHCDR; ND50005
DR   SKIP; SKIP001608
DR   Wikidata; Q54971717
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   TALSSPO21.21
AC   CVCL_FA02
SY   ND50006
DR   NHCDR; ND50006
DR   SKIP; SKIP001609
DR   Wikidata; Q54971718
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Donor information: At sampling donor was not affected with amyotrophic lateral sclerosis but at risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   TALSTDP-47.10
AC   CVCL_FA03
SY   ND50007
DR   NHCDR; ND50007
DR   SKIP; SKIP001610
DR   Wikidata; Q54971719
WW   Info; Target ALS; -; https://www.targetals.org/resource/stem-cell-core/
CC   From: Target ALS Foundation; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   TAM-1
AC   CVCL_B7V1
DR   Wikidata; Q112930454
RX   PubMed=2939141;
CC   HLA typing: A*02; B*06,27 (PubMed=2939141).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7V2 ! TAM-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 5
//
ID   TAM-6
AC   CVCL_B7V2
DR   Wikidata; Q112930455
RX   PubMed=2939141;
CC   HLA typing: A*02; B*06,27 (PubMed=2939141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7V1 ! TAM-1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   TAM.T
AC   CVCL_4008
DR   CLO; CLO_0009268
DR   ATCC; CRL-6001
DR   Wikidata; Q54971721
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6001; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=48850; ! Tamandua tetradactyla (Southern anteater)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TAMH
AC   CVCL_B471
SY   TGF-Alpha overexpressing Mouse Hepatocytes
DR   BTO; BTO_0004226
DR   ChEMBL-Cells; CHEMBL4483164
DR   ChEMBL-Targets; CHEMBL4483280
DR   PubChem_Cell_line; CVCL_B471
DR   Wikidata; Q54971722
RX   PubMed=7525051;
WW   Info; Quora; -; https://www.quora.com/How-does-the-L-02-cell-line-compare-with-the-TAMH-cell-line-How-closely-do-these-two-cell-lines-resemble-actual-human-hepatocytes
CC   Doubling time: 15 hours (PubMed=7525051).
CC   Karyotypic information: Quasi-tetraploid karyotype.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2-3M
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   Tango ADORA1-bla U2OS
AC   CVCL_ZK53
DR   Wikidata; Q98133081
WW   Provider; Thermo Fisher; K1445; https://www.thermofisher.com/order/catalog/product/K1445
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:262; ADORA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango ADORA3-bla U2OS
AC   CVCL_ZJ94
DR   Wikidata; Q98133082
WW   Provider; Thermo Fisher; K1484; https://www.thermofisher.com/order/catalog/product/K1484
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:268; ADORA3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango ADRA2A-bla U2OS
AC   CVCL_ZJ95
DR   Wikidata; Q98133083
WW   Provider; Thermo Fisher; K1604; https://www.thermofisher.com/order/catalog/product/K1604
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:281; ADRA2A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango AGTR1-bla U2OS
AC   CVCL_ZJ96
DR   Wikidata; Q98133084
WW   Provider; Thermo Fisher; K1443; https://www.thermofisher.com/order/catalog/product/K1443
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:336; AGTR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango AGTRL1-bla U2OS
AC   CVCL_ZJ97
DR   Wikidata; Q98133086
WW   Provider; Thermo Fisher; K1754; https://www.thermofisher.com/order/catalog/product/K1754
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:339; APLNR.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR1-bla U2OS
AC   CVCL_ZJ98
DR   Wikidata; Q98133088
WW   Provider; Thermo Fisher; K1787; https://www.thermofisher.com/order/catalog/product/K1787
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1602; CCR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR2-bla U2OS
AC   CVCL_ZJ99
DR   Wikidata; Q98133090
WW   Provider; Thermo Fisher; K1809; https://www.thermofisher.com/order/catalog/product/K1809
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1603; CCR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR3-bla U2OS
AC   CVCL_ZK00
DR   Wikidata; Q98133091
WW   Provider; Thermo Fisher; K1815; https://www.thermofisher.com/order/catalog/product/K1815
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR4-bla U2OS
AC   CVCL_ZK01
DR   Wikidata; Q98133092
WW   Provider; Thermo Fisher; K1799; https://www.thermofisher.com/order/catalog/product/K1799
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1605; CCR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR5-bla U2OS
AC   CVCL_ZK02
DR   Wikidata; Q98133093
WW   Provider; Thermo Fisher; K1788; https://www.thermofisher.com/order/catalog/product/K1788
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR6-bla U2OS
AC   CVCL_ZK03
DR   Wikidata; Q98133094
WW   Provider; Thermo Fisher; K1761; https://www.thermofisher.com/order/catalog/product/K1761
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1607; CCR6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CCR7-bla U2OS
AC   CVCL_ZK04
DR   Wikidata; Q98133095
WW   Provider; Thermo Fisher; K1531; https://www.thermofisher.com/order/catalog/product/K1531
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1608; CCR7.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CHRM2-bla U2OS
AC   CVCL_ZK05
DR   Wikidata; Q98133096
WW   Provider; Thermo Fisher; K1564; https://www.thermofisher.com/order/catalog/product/K1564
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1951; CHRM2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CMKLR1-bla U2OS
AC   CVCL_ZK06
DR   Wikidata; Q98133097
WW   Provider; Thermo Fisher; K1527; https://www.thermofisher.com/order/catalog/product/K1527
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2121; CMKLR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CNR1-bla U2OS
AC   CVCL_ZK07
DR   Wikidata; Q98133098
WW   Provider; Thermo Fisher; K1513; https://www.thermofisher.com/order/catalog/product/K1513
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2159; CNR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CNR2-bla U2OS
AC   CVCL_ZK08
DR   Wikidata; Q98133099
WW   Provider; Thermo Fisher; K1512; https://www.thermofisher.com/order/catalog/product/K1512
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2160; CNR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CXCR1-bla U2OS
AC   CVCL_ZK09
DR   Wikidata; Q98133101
WW   Provider; Thermo Fisher; K1807; https://www.thermofisher.com/order/catalog/product/K1807
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6026; CXCR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CXCR2-bla U2OS
AC   CVCL_ZK10
DR   Wikidata; Q98133102
WW   Provider; Thermo Fisher; K1521; https://www.thermofisher.com/order/catalog/product/K1521
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6027; CXCR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CXCR3-bla U2OS
AC   CVCL_ZK11
DR   Wikidata; Q98133103
WW   Provider; Thermo Fisher; K1829; https://www.thermofisher.com/order/catalog/product/K1829
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CXCR4-bla U2OS
AC   CVCL_ZK12
DR   Wikidata; Q98133105
WW   Provider; Thermo Fisher; K1779; https://www.thermofisher.com/order/catalog/product/K1779
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CXCR6-bla U2OS
AC   CVCL_ZK13
DR   Wikidata; Q98133107
WW   Provider; Thermo Fisher; K1563; https://www.thermofisher.com/order/catalog/product/K1563
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:16647; CXCR6.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango CXCR7-bla U2OS
AC   CVCL_ZK14
DR   Wikidata; Q98133108
WW   Provider; Thermo Fisher; K1832; https://www.thermofisher.com/order/catalog/product/K1832
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:23692; ACKR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango DRD1-bla U2OS
AC   CVCL_ZK15
DR   Wikidata; Q98133109
WW   Provider; Thermo Fisher; K1485; https://www.thermofisher.com/order/catalog/product/K1485
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3020; DRD1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG1-bla U2OS
AC   CVCL_ZK16
DR   Wikidata; Q98133110
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1520; https://www.thermofisher.com/order/catalog/product/K1520
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3165; S1PR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG2-bla U2OS
AC   CVCL_ZK17
DR   Wikidata; Q98133111
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1519; https://www.thermofisher.com/order/catalog/product/K1519
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3166; LPAR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG3-bla U2OS
AC   CVCL_ZK18
DR   Wikidata; Q98133112
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1848; https://www.thermofisher.com/order/catalog/product/K1848
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3167; S1PR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG4-bla U2OS
AC   CVCL_ZK37
DR   Wikidata; Q98133114
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1442; https://www.thermofisher.com/order/catalog/product/K1442
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3168; LPAR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG5-bla U2OS
AC   CVCL_ZK38
DR   Wikidata; Q98133115
RX   PubMed=19726785;
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3169; S1PR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG6-bla U2OS
AC   CVCL_ZK30
DR   Wikidata; Q98133116
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1622B; https://www.thermofisher.com/order/catalog/product/K1622B
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3170; S1PR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG7-bla U2OS
AC   CVCL_ZK32
DR   Wikidata; Q98133117
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1849; https://www.thermofisher.com/order/catalog/product/K1849
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:14298; LPAR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango EDG8-bla U2OS
AC   CVCL_ZK33
DR   Wikidata; Q98133119
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1518; https://www.thermofisher.com/order/catalog/product/K1518
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:14299; S1PR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango F2RL1-bla U2OS
AC   CVCL_ZL09
DR   Wikidata; Q98133120
WW   Provider; Thermo Fisher; K1830; https://www.thermofisher.com/order/catalog/product/K1830
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3538; F2RL1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GALR2-bla U2OS
AC   CVCL_ZL03
DR   Wikidata; Q98133121
WW   Provider; Thermo Fisher; K1811; https://www.thermofisher.com/order/catalog/product/K1811
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4133; GALR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GLP2R-bla U2OS
AC   CVCL_ZK95
DR   Wikidata; Q98133122
WW   Provider; Thermo Fisher; K1543; https://www.thermofisher.com/order/catalog/product/K1543
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4325; GLP2R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPCR-bla U2OS
AC   CVCL_ZJ93
SY   Tango GPCR U2OS
DR   Wikidata; Q98133124
RX   PubMed=19726785;
CC   Population: Caucasian.
CC   Characteristics: This is the parental cell line for all other ThermoFisher Tango cell lines. It is not distributed.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   Tango GPR1-bla U2OS
AC   CVCL_ZL12
DR   Wikidata; Q98133125
WW   Provider; Thermo Fisher; K1839; https://www.thermofisher.com/order/catalog/product/K1839
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4463; CMKLR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 12
//
ID   Tango GPR109A-bla U2OS
AC   CVCL_ZL11
DR   Wikidata; Q98133126
WW   Provider; Thermo Fisher; K1791; https://www.thermofisher.com/order/catalog/product/K1791
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24827; HCAR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR119-bla U2OS
AC   CVCL_ZL13
DR   Wikidata; Q98133128
WW   Provider; Thermo Fisher; K1777; https://www.thermofisher.com/order/catalog/product/K1777
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:19060; GPR119.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR120-bla U2OS
AC   CVCL_ZK31
DR   Wikidata; Q98133130
WW   Provider; Thermo Fisher; K1845; https://www.thermofisher.com/order/catalog/product/K1845
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:19061; FFAR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR23-bla U2OS
AC   CVCL_ZK34
DR   Wikidata; Q98133132
RX   PubMed=19726785;
WW   Provider; Thermo Fisher; K1841; https://www.thermofisher.com/order/catalog/product/K1841
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4478; LPAR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR35-bla U2OS
AC   CVCL_ZL10
DR   Wikidata; Q98133133
WW   Provider; Thermo Fisher; K1872; https://www.thermofisher.com/order/catalog/product/K1872
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4492; GPR35.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR44 (CRTH2)-bla U2OS
AC   CVCL_ZL14
DR   Wikidata; Q98133134
WW   Provider; Thermo Fisher; K1859; https://www.thermofisher.com/order/catalog/product/K1859
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR8-bla U2OS
AC   CVCL_ZK29
DR   Wikidata; Q98133136
WW   Provider; Thermo Fisher; K1478; https://www.thermofisher.com/order/catalog/product/K1478
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4530; NPBWR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR87-bla U2OS
AC   CVCL_ZK36
DR   Wikidata; Q98133138
RX   PubMed=19726785;
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4538; GPR87.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango GPR92-bla U2OS
AC   CVCL_ZK35
DR   Wikidata; Q98133139
RX   PubMed=19726785;
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13307; LPAR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Discontinued: Thermo Fisher/Invitrogen; Catalog number K1843.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango HTR1A-bla U2OS
AC   CVCL_ZL06
DR   Wikidata; Q98133140
WW   Provider; Thermo Fisher; K1857; https://www.thermofisher.com/order/catalog/product/K1857
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5286; HTR1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango HTR1D-bla U2OS
AC   CVCL_ZK94
DR   Wikidata; Q98133141
WW   Provider; Thermo Fisher; K1524; https://www.thermofisher.com/order/catalog/product/K1524
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5289; HTR1D.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango HTR2A-bla U2OS
AC   CVCL_ZK96
DR   Wikidata; Q98133142
WW   Provider; Thermo Fisher; K1562; https://www.thermofisher.com/order/catalog/product/K1562
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5293; HTR2A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango M1-bla U2OS
AC   CVCL_ZL05
DR   Wikidata; Q98133143
WW   Provider; Thermo Fisher; K1861; https://www.thermofisher.com/order/catalog/product/K1861
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango M4-bla U2OS
AC   CVCL_ZL04
DR   Wikidata; Q98133145
WW   Provider; Thermo Fisher; K1818; https://www.thermofisher.com/order/catalog/product/K1818
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1953; CHRM4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango MTNR1B-bla U2OS
AC   CVCL_ZL00
DR   Wikidata; Q98133146
WW   Provider; Thermo Fisher; K1753; https://www.thermofisher.com/order/catalog/product/K1753
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7464; MTNR1B.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango NPY1R-bla U2OS
AC   CVCL_ZL02
DR   Wikidata; Q98133147
WW   Provider; Thermo Fisher; K1803; https://www.thermofisher.com/order/catalog/product/K1803
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7956; NPY1R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango NPY2R-bla U2OS
AC   CVCL_ZK92
DR   Wikidata; Q98133149
WW   Provider; Thermo Fisher; K1479; https://www.thermofisher.com/order/catalog/product/K1479
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7957; NPY2R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango NPY5R-bla U2OS
AC   CVCL_ZL01
DR   Wikidata; Q98133151
WW   Provider; Thermo Fisher; K1782; https://www.thermofisher.com/order/catalog/product/K1782
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7958; NPY5R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango OPRD1-bla U2OS
AC   CVCL_ZL07
DR   Wikidata; Q98133152
WW   Provider; Thermo Fisher; K1778; https://www.thermofisher.com/order/catalog/product/K1778
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8153; OPRD1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango OPRK1-bla U2OS
AC   CVCL_ZK97
DR   Wikidata; Q98133153
WW   Provider; Thermo Fisher; K1576; https://www.thermofisher.com/order/catalog/product/K1576
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8154; OPRK1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango OPRL1-bla U2OS
AC   CVCL_ZL08
DR   Wikidata; Q98133154
WW   Provider; Thermo Fisher; K1786; https://www.thermofisher.com/order/catalog/product/K1786
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8155; OPRL1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango OPRM1-bla U2OS
AC   CVCL_ZK93
DR   Wikidata; Q98133155
WW   Provider; Thermo Fisher; K1523; https://www.thermofisher.com/order/catalog/product/K1523
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8156; OPRM1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango PTAFR-bla U2OS
AC   CVCL_ZK19
DR   Wikidata; Q98133156
WW   Provider; Thermo Fisher; K1789; https://www.thermofisher.com/order/catalog/product/K1789
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9582; PTAFR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango RLN3R1-bla U2OS
AC   CVCL_ZK20
DR   Wikidata; Q98133157
WW   Provider; Thermo Fisher; K1569; https://www.thermofisher.com/order/catalog/product/K1569
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24883; RXFP3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango SSTR1-bla U2OS
AC   CVCL_ZK21
DR   Wikidata; Q98133160
WW   Provider; Thermo Fisher; K1570; https://www.thermofisher.com/order/catalog/product/K1570
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11330; SSTR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango SSTR2-bla U2OS
AC   CVCL_ZK22
DR   Wikidata; Q98133161
WW   Provider; Thermo Fisher; K1582; https://www.thermofisher.com/order/catalog/product/K1582
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11331; SSTR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango SSTR5-bla U2OS
AC   CVCL_ZK23
DR   Wikidata; Q98133163
WW   Provider; Thermo Fisher; K1575; https://www.thermofisher.com/order/catalog/product/K1575
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11334; SSTR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango TACR1-bla U2OS
AC   CVCL_ZK24
DR   Wikidata; Q98133164
WW   Provider; Thermo Fisher; K1801; https://www.thermofisher.com/order/catalog/product/K1801
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11526; TACR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango TACR3-bla U2OS
AC   CVCL_ZK25
DR   Wikidata; Q98133165
WW   Provider; Thermo Fisher; K1603; https://www.thermofisher.com/order/catalog/product/K1603
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11528; TACR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   Tango TBXA2R-bla U2OS
AC   CVCL_ZK26
DR   Wikidata; Q98133166
WW   Provider; Thermo Fisher; K1549; https://www.thermofisher.com/order/catalog/product/K1549
CC   Population: Caucasian.
CC   Characteristics: The target GPCR is linked to a TEV protease cleavage site and a GAL4-VP16 transcription factor. When activated the GPCR recruits the beta-arrestin/TEV protease fusion protein, the TEV protease cleaves off the transcription factor that translocates to the nucleus to activate the expression of the bla gene.
CC   Characteristics: Stably expresses a beta-arrestin/TEV protease fusion protein and a beta-lactamase reporter gene under the control of an upstream activator sequence (UAS).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:712; ARRB2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11608; TBXA2R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P62593; Escherichia coli beta-lactamase bla (Note=With p.Met1_Phe22del, p.Ala23Met, p.Val82Ile and p.Met184Val).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04517; Tobacco etch virus (TEV) protease (Note=AA 2038-2279).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZJ93 ! Tango GPCR-bla U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 11
//
ID   TANI
AC   CVCL_UW37
DR   Wikidata; Q98133167
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   Tank
AC   CVCL_0E95
SY   TANK; CHIMP,TANK
DR   ATCC; CRL-1847
DR   Wikidata; Q54971723
RX   PubMed=1690682;
RX   PubMed=8307784;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ATCC; CRL-1847; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   Tanoue
AC   CVCL_1852
SY   TANOUE
DR   CLO; CLO_0009269
DR   CLO; CLO_0050979
DR   EFO; EFO_0002380
DR   ArrayExpress; E-MTAB-38
DR   BioGRID_ORCS_Cell_line; 1759
DR   BioSample; SAMN03472169
DR   BioSample; SAMN03473578
DR   cancercelllines; CVCL_1852
DR   Cell_Model_Passport; SIDM00288
DR   Cosmic; 1012122
DR   Cosmic; 1130258
DR   Cosmic; 1281385
DR   DepMap; ACH-001669
DR   DSMZ; ACC-399
DR   DSMZCellDive; ACC-399
DR   GEO; GSM5137747
DR   IARC_TP53; 21631
DR   IGRhCellID; TANOUE
DR   LINCS_LDP; LCL-1095
DR   PRIDE; PXD023662
DR   Progenetix; CVCL_1852
DR   RCB; RCB1180
DR   Wikidata; Q54971725
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7538617;
RX   PubMed=15843827;
RX   PubMed=15901131;
RX   PubMed=16408098;
RX   PubMed=20215515;
RX   PubMed=24590883;
RX   PubMed=28196595;
RX   PubMed=35354797;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=7538617); ~40 hours (DSMZ=ACC-399).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met246Thr (c.737T>C); ClinVar=VCV000428886; Zygosity=Heterozygous (PubMed=15901131; DepMap=ACH-001669).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DepMap=ACH-001669; DSMZ=ACC-399; RCB=RCB1180
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,12,13,14 (DepMap=ACH-001669)
ST   D16S539: 12,13 (DSMZ=ACC-399; RCB=RCB1180)
ST   D18S51: 13,14
ST   D19S433: 15,16
ST   D21S11: 29,30
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 10,11,12 (DepMap=ACH-001669; RCB=RCB1180)
ST   D5S818: 11,12 (DSMZ=ACC-399)
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 14,22,23 (DSMZ=ACC-399)
ST   FGA: 19,22,23 (DepMap=ACH-001669)
ST   Penta D: 11,13
ST   Penta E: 14,18,19
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 14,18,19 (DepMap=ACH-001669; RCB=RCB1180)
ST   vWA: 14,19 (DSMZ=ACC-399)
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   tao BpRc1
AC   CVCL_3800
SY   Tao BpRc1; tao BpRcl; TAOc1BPrc1
DR   CLO; CLO_0009270
DR   ATCC; CRL-2218
DR   Wikidata; Q54971726
RX   PubMed=6300048;
CC   Characteristics: Defective in aryl hydrocarbon receptor (AhR) function.
CC   Doubling time: 12-24 hours (ATCC=CRL-2218).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3492 ! BpRc1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   TAOV
AC   CVCL_U987
DR   BTO; BTO_0004922
DR   Wikidata; Q54971727
RX   PubMed=12019149;
CC   Population: Japanese.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 8
//
ID   TARL-2
AC   CVCL_0557
DR   MCCL; MCC:0000458
DR   Wikidata; Q54971728
RX   PubMed=2880789;
RX   PubMed=3001699;
RX   PubMed=6323614;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   TARS-1
AC   CVCL_D322
DR   Wikidata; Q54971730
RX   PubMed=2880789;
RX   PubMed=2892480;
RX   PubMed=6323614;
CC   Virology: HTLV-1 producing cell line.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   TART-1
AC   CVCL_D323
DR   Wikidata; Q54971731
RX   PubMed=2880789;
RX   PubMed=6323614;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Wistar King Aptekman/Hok (WKA/Hok); RS=RS_0001595.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   TAS-5
AC   CVCL_8484
DR   JCRB; JCRB1370
DR   Wikidata; Q54971733
RX   PubMed=8660794;
RX   PubMed=9893044;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q00651; Mouse Itga4/Cd49d.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   TASH
AC   CVCL_WT34
DR   Wikidata; Q98133168
RX   PubMed=6749281;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 4
//
ID   TASK1
AC   CVCL_3177
DR   CLO; CLO_0037092
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470806
DR   cancercelllines; CVCL_3177
DR   Cell_Model_Passport; SIDM00026
DR   Cosmic-CLP; 1299067
DR   DepMap; ACH-001670
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10774-110F9
DR   GDSC; 1299067
DR   GEO; GSM827197
DR   GEO; GSM1670524
DR   JCRB; JCRB0139
DR   JCRB; NIHS0202
DR   LINCS_LDP; LCL-1114
DR   PharmacoDB; TASK1_1565_2019
DR   Progenetix; CVCL_3177
DR   Wikidata; Q54971734
RX   PubMed=9661044;
RX   PubMed=20215515;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 38 hours (PubMed=9661044).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=9661044).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.94%; Native American=0.97%; East Asian, North=86.4%; East Asian, South=7.58%; South Asian=0.24%; European, North=0%; European, South=2.87% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0202; true.
CC   Derived from site: In situ; Chest wall; UBERON=UBERON_0016435.
ST   Source(s): Cosmic-CLP=1299067; DepMap=ACH-001670; JCRB=JCRB0139
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 14
ST   D21S11: 30,31
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 10
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 5,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   Tat-1
AC   CVCL_M789
SY   TAT-1
DR   Wikidata; Q54971735
RX   PubMed=11840295;
RX   PubMed=26727417;
CC   Doubling time: 72 hours (PubMed=11840295).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3209; Follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   TAT1
AC   CVCL_T980
SY   TAT-1
DR   ECACC; 00020911
DR   Wikidata; Q54971736
RX   PubMed=2606940;
CC   Monoclonal antibody isotype: IgG2a+IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q4GYY5; Trypanosoma brucei brucei tubulin alpha-chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 6
//
ID   TAT2SF
AC   CVCL_F611
SY   GM09607; GM9607
DR   CLO; CLO_0026603
DR   EFO; EFO_0022373
DR   Coriell; GM09607
DR   Wikidata; Q54843879
RX   CelloPub=CLPUB00447;
RX   PubMed=2903889;
RX   PubMed=2987007;
RX   PubMed=9357546;
RX   PubMed=11172010;
RX   PubMed=24142626;
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe1774Lysfs*17 (c.5320_5326del) (c.5320del7); Zygosity=Heterozygous (Coriell=GM09607).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2769Ter (c.8307G>A); ClinVar=VCV000189104; Zygosity=Heterozygous (Coriell=GM09607).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V575 ! AT2SF
SX   Female
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 24
//
ID   TAT2SF T4
AC   CVCL_C1HK
SY   T4
DR   Wikidata; Q114313095
RX   PubMed=9357546;
CC   Characteristics: Transfected with a pSXneo-1.6-T2AG3 plasmid that contains 1.6 kb of telomeric repeat sequences (PubMed=9357546).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe1774Lysfs*17 (c.5320_5326del) (c.5320del7); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2769Ter (c.8307G>A); ClinVar=VCV000189104; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F611 ! TAT2SF
SX   Female
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   TAT2SF T4-B
AC   CVCL_C1HL
SY   T4-B subclone
DR   Wikidata; Q114313096
RX   PubMed=9357546;
CC   Characteristics: Transfected with a pSXneo-1.6-T2AG3 plasmid that contains 1.6 kb of telomeric repeat sequences (PubMed=9357546).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe1774Lysfs*17 (c.5320_5326del) (c.5320del7); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2769Ter (c.8307G>A); ClinVar=VCV000189104; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F611 ! TAT2SF
SX   Female
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   TAT2SF T4-F
AC   CVCL_C1HM
SY   T4-F subclone
DR   Wikidata; Q114313097
RX   PubMed=9357546;
CC   Characteristics: Transfected with a pSXneo-1.6-T2AG3 plasmid that contains 1.6 kb of telomeric repeat sequences (PubMed=9357546).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Phe1774Lysfs*17 (c.5320_5326del) (c.5320del7); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Trp2769Ter (c.8307G>A); ClinVar=VCV000189104; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1HK ! TAT2SF T4
SX   Female
CA   Transformed cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   Tau RD P301S FRET Biosensor
AC   CVCL_DA04
DR   ATCC; CRL-3275
DR   Wikidata; Q54971737
RX   PubMed=25261551;
RX   PubMed=37553663;
CC   Characteristics: Transduced with 2 separate lentivirus constructs encoding the tau repeat domain (RD) with the disease-associated p.Pro301Ser (p.Pro636Ser) mutation fused to either CFP or YFP (ATCC=CRL-3275).
CC   Characteristics: Tau seeds introduced into the culture media of this cell line can nucleate the aggregation of the reporter proteins. This aggregation produces a FRET signal which can be measured via microscopy, microplate readers or flow cytometry (ATCC=CRL-3275).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRLU4; CFP (Note=Cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-3275
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 12
//
ID   Tau RD P301L FRET Sensitive Biosensor
AC   CVCL_C8YL
SY   HEK293T clone 18
DR   Wikidata; Q123033603
RX   PubMed=37553663;
CC   Characteristics: Transduced with a lentivirus construct EF1a-TauRD(P301L)-RLinker-mTurquoise2-T2A-TauRD(P301L)-RLinker-mNeonGreen-WPRE where TauRD(P301L) is the tau repeat domain (RD) with the disease-associated p.Pro301Leu (p.Pro636Leu) mutation and Rlinker is a (EAAAK)3 rigid linker (PubMed=37553663).
CC   Characteristics: Shows a high sensitivity in detecting bioactive tau seeds. These seeds can nucleate the aggregation of the reporter proteins. This aggregation produces a FRET signal (PubMed=37553663).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZRKRV; mNeonGreen (Note=Derivative of Branchiostoma lanceolatum LanYFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 7AV5G; mTurquoise2 (Note=Tq2, cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   TAUi001-A
AC   CVCL_ZA77
SY   UTA.09703.HCMJp
DR   BioSamples; SAMEA6880673
DR   hPSCreg; TAUi001-A
DR   Wikidata; Q98133169
CC   From: University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14202; JPH2; Simple; p.Thr161Lys (c.482C>A); ClinVar=VCV000155800; Zygosity=Heterozygous (hPSCreg=TAUi001-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172093; Familial hypertrophic cardiomyopathy type 17
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TAUi001-A-1
AC   CVCL_ZA78
SY   JPH2
DR   BioSamples; SAMEA6880675
DR   hPSCreg; TAUi001-A-1
DR   Wikidata; Q98133171
CC   From: University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14202; JPH2; Simple_corrected; p.Thr161Lys (c.482C>A); Zygosity=Heterozygous; Note=By method not specified (hPSCreg=TAUi001-A-1).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172093; Familial hypertrophic cardiomyopathy type 17
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZA77 ! TAUi001-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TAUi008-A
AC   CVCL_C1JP
SY   TAU2106C1.MS
DR   BioSamples; SAMEA14263389
DR   hPSCreg; TAUi008-A
DR   Wikidata; Q114313098
RX   PubMed=35843021;
CC   From: University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   TAW-925
AC   CVCL_Z044
DR   Wikidata; Q54971738
RX   Patent=EP0305960A2;
RX   Patent=EP0336405B1;
RX   PubMed=3030301;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50095.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   TAYA
AC   CVCL_M717
DR   cancercelllines; CVCL_M717
DR   Wikidata; Q54971740
RX   PubMed=11914605;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=11914605).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Glu (c.394A>G); ClinVar=VCV000376626; Zygosity=Unspecified (PubMed=11914605).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   TB [Human]
AC   CVCL_4Z67
DR   Wikidata; Q54971741
RX   PubMed=10320710;
CC   Doubling time: 18 +- 2 hours (PubMed=10320710).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C6891; Meningeal melanomatosis
DI   ORDO; Orphanet_252031; Diffuse leptomeningeal melanocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   TB [Mouse]
AC   CVCL_VT15
DR   ATCC; CRL-6459
DR   Wikidata; Q98133172
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6459; true.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   Tb 1 Lu
AC   CVCL_2730
SY   Tb 1 Lu (NBL-12); NBL-12; TB1 Lu; Tb 1-Lu; TB-1 Lu; Tb1.Lu; Tb1Lu; Bat lung; Tadarida brasiliensis 1 lung
DR   CLO; CLO_0009271
DR   CLO; CLO_0009272
DR   CLO; CLO_0009274
DR   CLO; CLO_0009275
DR   CLDB; cl392
DR   CLDB; cl4486
DR   CLDB; cl4487
DR   CLDB; cl4488
DR   ATCC; CCL-88
DR   ATCC; CRL-6564
DR   CCLV; CCLV-RIE 0072
DR   CCRID; 4201MAM-CCTCC00190
DR   CCTCC; GDC0190
DR   ECACC; 90020805
DR   ICLC; ATL96010
DR   IZSLER; BS CL 84
DR   Wikidata; Q54971742
RX   DOI=10.1007/BF02618370;
RX   PubMed=7065527;
RX   PubMed=19941903;
RX   PubMed=33389257;
CC   Group: Bat cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Discontinued: ATCC; CRL-6564; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9438; ! Tadarida brasiliensis (Brazilian free-tailed bat)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 18
//
ID   TB 28-2
AC   CVCL_F778
DR   CLO; CLO_0009273
DR   ATCC; HB-61
DR   Wikidata; Q54971744
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human Ig kappa light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   TB-6c
AC   CVCL_M351
SY   Toad Bladder-6c
DR   Wikidata; Q54971745
RX   PubMed=226998;
RX   PubMed=6267945;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=8386; ! Rhinella marina (Cane toad)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   TB/SVTERT350
AC   CVCL_F0RC
DR   Evercyte; CLHT-070-0350
CC   Doubling time: ~45 hours (Evercyte=CLHT-070-0350).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Miscellaneous: STR profile from personal communication of Evercyte.
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
ST   Source(s): Evercyte=CLHT-070-0350
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,20
ST   D19S433: 12,14
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 14,17
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 8.8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TB13
AC   CVCL_A0DD
DR   Wikidata; Q108821362
RX   Patent=EP0265847B1;
RX   PubMed=2440025;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04401; Mouse Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   TB1A2
AC   CVCL_1D84
DR   Wikidata; Q54971747
RX   PubMed=8691151;
WW   Provider; NIH OTT; E-342-2008/0-49; https://web.archive.org/web/20150922074851/http://www.ott.nih.gov/erma/tb1a2-cells-are-defective-protein-tyrosine-kinase-syk-immunoglobulin-ige-receptor-induced
CC   Characteristics: Deficient in the expression of SYK (PubMed=8691151).
CC   Transformant: ChEBI; CHEBI_232042; Beta-chloro-N-isopropyl-2-naphthaleneethanamine hydrochloride (ICI 42464).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil; CL=CL_0000767.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60428; Rat leukemia
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0591 ! RBL-2H3
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   TB2
AC   CVCL_Y570
SY   Tilapia Brain 2
DR   Wikidata; Q54971748
RX   PubMed=18096421;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus (Hybrid tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 07-11-14; Last updated: 05-10-23; Version: 9
//
ID   TBC34836
AC   CVCL_V383
DR   IPD-IMGT/HLA; 14461
DR   Wikidata; Q54971749
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02; B*40:02,54:01; C*01:02,03:29; DRB1*04:05 (IPD-IMGT/HLA=14461).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   TBC60311
AC   CVCL_V384
DR   IPD-IMGT/HLA; 14460
DR   Wikidata; Q54971750
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,26:01; B*40:01; C*03:28,04:01; DRB1*09:01,15:01 (IPD-IMGT/HLA=14460).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   TBCN-1
AC   CVCL_0T71
DR   Wikidata; Q54971751
RX   PubMed=9824643;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 54 hours (PubMed=9824643).
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   TBCN-6
AC   CVCL_H710
SY   TBCN6
DR   Wikidata; Q54971752
RX   CelloPub=CLPUB00275;
RX   PubMed=15645130;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 28 +- 0.2 hours (PubMed=15645130).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   TBD-a1
AC   CVCL_C6FF
DR   Wikidata; Q116050628
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-a2
AC   CVCL_C6FG
DR   Wikidata; Q116050629
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-a3
AC   CVCL_C6FH
DR   Wikidata; Q116050630
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-a4
AC   CVCL_C6FI
DR   Wikidata; Q116050631
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-a5
AC   CVCL_C6FJ
DR   Wikidata; Q116050632
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-a6
AC   CVCL_C6FK
DR   Wikidata; Q116050634
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-a7
AC   CVCL_C6FL
DR   Wikidata; Q116050635
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-b1
AC   CVCL_C6FM
DR   Wikidata; Q116050636
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FN ! TBD-b2
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-b2
AC   CVCL_C6FN
DR   Wikidata; Q116050637
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-c
AC   CVCL_C6FP
DR   Wikidata; Q116050638
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_C6FF ! TBD-a1
OI   CVCL_C6FG ! TBD-a2
OI   CVCL_C6FH ! TBD-a3
OI   CVCL_C6FI ! TBD-a4
OI   CVCL_C6FJ ! TBD-a5
OI   CVCL_C6FK ! TBD-a6
OI   CVCL_C6FL ! TBD-a7
OI   CVCL_C6FM ! TBD-b1
OI   CVCL_C6FN ! TBD-b2
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBD-c1
AC   CVCL_C6FQ
DR   Wikidata; Q116050639
RX   PubMed=21437573;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Oral cavity, tongue, taste bud; UBERON=UBERON_0014451.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C6FP ! TBD-c
SX   Sex unspecified
AG   12D
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   TBE-1 [Human bronchial epithelial]
AC   CVCL_R813
DR   Wikidata; Q54971753
RX   PubMed=2538323;
RX   PubMed=3975607;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: v-Ha-Ras.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 11
//
ID   TBE-1 [Scophthalmus]
AC   CVCL_R814
SY   TurBot Epithelial-1
DR   Wikidata; Q54971754
RX   PubMed=8856337;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   TBE-1SA
AC   CVCL_JF05
SY   TBE-1 Soft Agar
DR   Wikidata; Q54971756
RX   PubMed=2538323;
RX   PubMed=3975607;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).
CC   Transformant: v-Ha-Ras.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R813 ! TBE-1 [Human bronchial epithelial]
SX   Female
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   TBJ
AC   CVCL_L429
DR   Wikidata; Q54971757
RX   PubMed=8749920;
CC   Characteristics: Less immunogenic and more metastatic than the parent cell line (PubMed=8749920).
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4343 ! C-1300
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   TBK1-DEF
AC   CVCL_4W78
DR   JCRB; JCRB1535
DR   Wikidata; Q54971758
CC   Knockout cell: Method=KO mouse; MGI; MGI:1929658; Tbk1.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   TBL.Cl2
AC   CVCL_D7CG
SY   TBL CL2; TBLC2
RX   PubMed=4660932;
RX   PubMed=4932229;
RX   PubMed=11378348;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   TBL.Cl2.Pt
AC   CVCL_D7CH
SY   TBL.Cl2 Pt; TBL.Cl2 PT
RX   PubMed=11378348;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CG ! TBL.Cl2
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   TBL20
AC   CVCL_2G83
SY   TaH/BL20; TaBL 20
DR   Wikidata; Q54971759
RX   PubMed=1461683;
RX   PubMed=2421227;
RX   PubMed=7770085;
RX   PubMed=16441438;
RX   PubMed=23840536;
CC   Characteristics: In vitro infected by Theileria annulata isolate Hissar.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bronchial lymph node; UBERON=UBERON_0016481.
CC   Breed/subspecies: Holstein Friesian; VBO=VBO_0003171.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_L859 ! BL20
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 11
//
ID   TBLC2RC
AC   CVCL_D7CI
RX   PubMed=4932229;
CC   Virology: Infected with Rauscher murine leukemia virus RCL- strain (PubMed=4932229).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CG ! TBL.Cl2
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   TBLC2RR
AC   CVCL_D7CJ
RX   PubMed=4932229;
CC   Virology: Infected with Rauscher murine leukemia virus RRL+ strain (PubMed=4932229).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21603; Mouse sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D7CG ! TBL.Cl2
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   TBL3
AC   CVCL_2G82
SY   TaH/BL3
DR   Wikidata; Q54971760
RX   PubMed=1461683;
RX   PubMed=7770085;
RX   PubMed=16441438;
CC   Characteristics: In vitro infected by Theileria annulata isolate Hissar.
CC   Breed/subspecies: Hereford; VBO=VBO_0000232.
DI   NCIt; C131469; Bovine leukemia
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
HI   CVCL_3454 ! BL-3 [Bovine leukemia]
SX   Male
AG   3M
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 10
//
ID   TBM-54
AC   CVCL_5654
SY   TB-M; Toad Bladder-M
DR   CLO; CLO_0009278
DR   ATCC; CRL-2051
DR   Wikidata; Q54971761
RX   PubMed=226998;
RX   PubMed=6267945;
RX   PubMed=17941892;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=8386; ! Rhinella marina (Cane toad)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   TBN
AC   CVCL_A5GX
SY   TBNC; Tilapia Brain Neural
DR   BioSample; SAMN14785096
DR   Wikidata; Q107117012
RX   PubMed=33258111;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 32 Celsius. Does not grow at 16 Celsius.
CC   Doubling time: 4.84 days (Note=In 2.5% FBS), 2.66 days (Note=In 7.5% FBS), 2.44 days (Note=In 10% FBS), 2.59 days (Note=In 15% FBS), 4.84 days (Note=In 20% FBS) (PubMed=33258111).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Neural cell; CL=CL_0002319.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   TBR-B
AC   CVCL_6A91
SY   TBRB
DR   Wikidata; Q54971768
RX   PubMed=7796878;
RX   PubMed=10996322;
RX   PubMed=11520047;
RX   PubMed=11776976;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   TBR10-1
AC   CVCL_F961
SY   TBR 10-1; TBR10
DR   TKG; TKG 0622
DR   Wikidata; Q54971769
RX   PubMed=9638976;
RX   PubMed=11776976;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   TBR31-1
AC   CVCL_5371
SY   TBR 31-1
DR   Wikidata; Q54971770
RX   DOI=10.2745/dds.18.86;
RX   PubMed=9224657;
RX   PubMed=9638976;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_6A86 ! TBR31-2
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   TBR31-2
AC   CVCL_6A86
SY   TBR 31-2
DR   Wikidata; Q54971771
RX   PubMed=7796878;
RX   PubMed=9638976;
RX   PubMed=10679225;
RX   PubMed=11520047;
RX   PubMed=11776976;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5371 ! TBR31-1
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TBR52
AC   CVCL_6A92
SY   TBR 52
DR   Wikidata; Q54971772
RX   PubMed=7796878;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TBR59
AC   CVCL_5372
SY   TBR 59
DR   Wikidata; Q54971773
RX   DOI=10.2745/dds.18.86;
RX   PubMed=7796878;
RX   PubMed=9224657;
RX   PubMed=9638976;
RX   PubMed=10378898;
RX   PubMed=11520047;
RX   PubMed=17233813;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TBR59
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   TBY2-31/ST
AC   CVCL_D5GQ
DR   RIKEN_BRC_EPD; rpc00091
DR   Wikidata; Q127384372
RX   PubMed=22740633;
RX   PubMed=28839076;
CC   Group: Plant cell line.
CC   Characteristics: Used to visualize the cis-Golgi network and trans-Golgi network thanks to the integration of two fusion constructs GFP-AtSYP31 and ST52-mRFP (PubMed=22740633; PubMed=28839076).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3676; St6gal1 (Note=With p.Met53_Cys403del = ST52 Cyto+TM).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9FFK1; Arabidopsis thaliana SYP31.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GT ! TBY2-R31
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   TBY2-41/ST
AC   CVCL_D5GR
DR   RIKEN_BRC_EPD; rpc00093
DR   Wikidata; Q127384374
RX   PubMed=28339924;
CC   Group: Plant cell line.
CC   Characteristics: Used to visualize the trans-Golgi network thanks to the integration of two fusion constructs GFP-AtSYP41 and ST52-mRFP (PubMed=28339924).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 3676; St6gal1 (Note=With p.Met53_Cys403del = ST52 Cyto+TM).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; O65359; Arabidopsis thaliana SYP41.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GM ! BY-2
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   TBY2-AtRER1B
AC   CVCL_D5GS
DR   RIKEN_BRC_EPD; rpc00042
DR   Wikidata; Q127384375
RX   PubMed=12182707;
RX   PubMed=28839076;
CC   Group: Plant cell line.
CC   Characteristics: Used to visualize Golgi apparatus thanks to the integration of the fusion construct GFP-AtRer1B (PubMed=12182707; PubMed=28839076).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; O48671; Arabidopsis thaliana RER1B.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GM ! BY-2
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   TBY2-R31
AC   CVCL_D5GT
DR   RIKEN_BRC_EPD; rpc00095
DR   Wikidata; Q127384376
RX   PubMed=22740633;
RX   PubMed=28839076;
CC   Group: Plant cell line.
CC   Characteristics: Used to visualize the cis-Golgi network thanks to the integration of the fusion construct GFP-AtSYP31 (PubMed=22740633; PubMed=28839076).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9FFK1; Arabidopsis thaliana SYP31.
CC   Derived from site: In situ; Seedling; PO=PO_0008037.
CC   Breed/subspecies: Cultivar Bright Yellow 2.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GM ! BY-2
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   TC 178
AC   CVCL_N709
SY   T.C. 178; TC178; Tissue Culture 178
DR   Wikidata; Q54971774
RX   CelloPub=CLPUB00278;
RX   PubMed=195435;
RX   PubMed=467167;
RX   PubMed=13766343;
RX   PubMed=13856118;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   TC 224
AC   CVCL_N710
SY   Tissue Culture 224
DR   Wikidata; Q54971775
RX   PubMed=13766343;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   TC 314
AC   CVCL_5H67
SY   TC314; Tissue Culture 314
DR   Wikidata; Q54971776
RX   CelloPub=CLPUB00278;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   TC 379
AC   CVCL_5G75
SY   TC379; Tissue Culture 379
DR   Wikidata; Q54971777
RX   CelloPub=CLPUB00278;
RX   PubMed=467167;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 5
//
ID   TC 396
AC   CVCL_5G74
SY   Tissue Culture 396
DR   Wikidata; Q54971779
RX   CelloPub=CLPUB00278;
RX   PubMed=467167;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   TC 491
AC   CVCL_5G76
SY   TC491; Tissue Culture 491
DR   Wikidata; Q54971780
RX   PubMed=5578746;
CC   Miscellaneous: Cell line has been lost (PubMed=5578746).
CC   Derived from site: Metastatic; Brain, cerebellum; UBERON=UBERON_0002037.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 11
//
ID   TC 501
AC   CVCL_N711
SY   TC501; Tissue Culture 501
DR   Wikidata; Q54971781
RX   CelloPub=CLPUB00278;
RX   PubMed=195435;
RX   PubMed=467167;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N712 ! TC 526
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   TC 526
AC   CVCL_N712
SY   TC526; Tissue Culture 526
DR   Wikidata; Q54971782
RX   CelloPub=CLPUB00278;
RX   PubMed=195435;
RX   PubMed=467167;
RX   PubMed=3288483;
CC   Characteristics: Established after a few passages of the original tumor in the anterior chamber of the eye of guinea pigs.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N711 ! TC 501
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   TC 593
AC   CVCL_N713
SY   TC593; Tissue Culture 593
DR   Wikidata; Q54971783
RX   CelloPub=CLPUB00278;
RX   PubMed=195435;
RX   PubMed=467167;
RX   PubMed=3192213;
RX   PubMed=3288483;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   TC 620
AC   CVCL_N714
SY   TC-620; TC620; Tissue Culture 620
DR   Wikidata; Q54971784
RX   CelloPub=CLPUB00278;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=195435;
RX   PubMed=467167;
RX   PubMed=3142218;
RX   PubMed=3192213;
RX   PubMed=3288483;
RX   PubMed=8416742;
CC   Doubling time: 24 hours (PubMed=8416742).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   TC 691
AC   CVCL_5G73
SY   Tissue Culture 691
DR   Wikidata; Q54971785
RX   CelloPub=CLPUB00278;
RX   PubMed=3288483;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   TC-1 [Human renal cell carcinoma]
AC   CVCL_M349
DR   Wikidata; Q54971786
RX   PubMed=1479760;
CC   Population: Indian; Bengali.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   TC-1 [Mouse lung]
AC   CVCL_4699
SY   TC-1[JHU-1]; Tissue Culture-1
DR   BTO; BTO_0004795
DR   CLO; CLO_0009279
DR   ATCC; CRL-2785
DR   ATCC; JHU-1
DR   NCBI_Iran; C569
DR   Wikidata; Q54971787
RX   PubMed=8548765;
RX   PubMed=12559790;
RX   PubMed=31638243;
CC   Doubling time: 18.2 hours (PubMed=12559790); 18.5 hours (PubMed=31638243).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: ATCC; CRL-2785; true.
CC   Discontinued: ATCC; JHU-1; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   TC-1/A9
AC   CVCL_ZW99
SY   A9
DR   Wikidata; Q102114969
RX   PubMed=12559790;
RX   PubMed=31638243;
CC   Characteristics: Lacks MHC class I expression. Established from tumors produced by subcutaneous injection of parent cell line (PubMed=12559790).
CC   Doubling time: 17.5 hours (PubMed=12559790); 16.2 hours (PubMed=31638243).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4699 ! TC-1 [Mouse lung]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   TC-1/D11
AC   CVCL_ZX00
SY   D11
DR   Wikidata; Q102114970
RX   PubMed=12559790;
CC   Characteristics: Has reduced MHC class I expression. Established from tumors produced by subcutaneous injection of parent cell line (PubMed=12559790).
CC   Doubling time: 16.5 hours (PubMed=12559790).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4699 ! TC-1 [Mouse lung]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   TC-1/dB2m
AC   CVCL_ZX01
DR   Wikidata; Q102114971
RX   PubMed=31638243;
CC   Characteristics: Irreversible MHC class I downregulation and has a reduced proliferation rate and tumor growth (PubMed=31638243).
CC   Doubling time: 27.9 hours (PubMed=31638243).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4699 ! TC-1 [Mouse lung]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   TC-1/E2
AC   CVCL_B6PJ
DR   Wikidata; Q112041771
RX   PubMed=17638915;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4699 ! TC-1 [Mouse lung]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   TC-106
AC   CVCL_F531
SY   TC106
DR   cancercelllines; CVCL_F531
DR   Cell_Model_Passport; SIDM01468
DR   Cosmic; 2228235
DR   DepMap; ACH-001283
DR   GEO; GSM5359706
DR   GEO; GSM5359707
DR   GEO; GSM5359708
DR   GEO; GSM5359709
DR   GEO; GSM5359710
DR   GEO; GSM5359711
DR   GEO; GSM5362910
DR   GEO; GSM5362911
DR   GEO; GSM5362918
DR   GEO; GSM5362919
DR   GEO; GSM5362920
DR   GEO; GSM5362921
DR   GEO; GSM5364021
DR   GEO; GSM5364022
DR   GEO; GSM5364023
DR   GEO; GSM5364024
DR   GEO; GSM5364025
DR   Wikidata; Q54971788
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.5282/edoc.27750;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=25010205;
RX   PubMed=28196595;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG; Note=EWSR1 exon 7 with ERG exon 6 (PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys3326Ter (c.9976A>T) (10204A>T); ClinVar=VCV000038266; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; ChIP-seq; ERG.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Scalp; UBERON=UBERON_0000403.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,11
ST   D16S539: 13
ST   D18S51: 17,18
ST   D19S433: 12
ST   D21S11: 29,31.2
ST   D2S1338: 24,26
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 26
//
ID   TC-12
AC   CVCL_WP00
DR   Wikidata; Q98133174
RX   PubMed=9845376;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on T-cell leukemia cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   TC-131
AC   CVCL_7147
SY   TC-131T
DR   Cosmic; 1091066
DR   Wikidata; Q54971791
RX   PubMed=3004699;
RX   PubMed=7882340;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   TC-135
AC   CVCL_9698
SY   TC135
DR   Wikidata; Q54971794
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   TC-138
AC   CVCL_4Z30
SY   TC138
DR   Cell_Model_Passport; SIDM01467
DR   Cosmic; 2228236
DR   DepMap; ACH-001430
DR   Wikidata; Q54971795
RX   PubMed=25010205;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 4 fusion (Ex10/Ex5) (PubMed=25010205).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,23
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   TC-140
AC   CVCL_C8XB
DR   Wikidata; Q123033604
RX   PubMed=8395773;
RX   PubMed=35692560;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TC-140/7
AC   CVCL_C8XC
DR   Wikidata; Q123033605
RX   PubMed=7785967;
RX   PubMed=8395773;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8XB ! TC-140
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TC-146A
AC   CVCL_C8XD
DR   Wikidata; Q123033606
RX   PubMed=7785967;
RX   PubMed=8395773;
RX   PubMed=35692560;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8XE ! TC-146B
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TC-146B
AC   CVCL_C8XE
DR   Wikidata; Q123033607
RX   PubMed=7785967;
RX   PubMed=8395773;
RX   PubMed=35692560;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8XD ! TC-146A
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TC-174
AC   CVCL_7148
DR   Cosmic; 1091067
DR   Wikidata; Q54971796
RX   PubMed=7882340;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   TC-205
AC   CVCL_4Z31
SY   TC205
DR   Cell_Model_Passport; SIDM01466
DR   Cosmic; 2228237
DR   DepMap; ACH-001431
DR   Wikidata; Q54971797
RX   DOI=10.5282/edoc.27750;
RX   PubMed=25010205;
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:18562; FEV; Name(s)=EWSR1-FEV, EWS-FEV; Note=EWSR1 exon 7 fused to FEV exon 3 (DOI=10.5282/edoc.27750).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 14,17.2
ST   D21S11: 28,30
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 21,23
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   TC-206
AC   CVCL_7149
DR   Cosmic; 1091068
DR   Wikidata; Q54971798
RX   CelloPub=CLPUB00569;
RX   PubMed=7882340;
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   TC-212
AC   CVCL_S867
SY   TC212
DR   Wikidata; Q54971799
RX   CelloPub=CLPUB00569;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Derived from site: Metastatic; Testis; UBERON=UBERON_0000473.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,11
ST   FGA: 20,24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   TC-215
AC   CVCL_4Z32
DR   cancercelllines; CVCL_4Z32
DR   Cosmic; 2228238
DR   Wikidata; Q54971800
RX   PubMed=25010205;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 2 fusion (Ex7/Ex5) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Cys (c.377A>G); ClinVar=VCV000458541; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 28,34.2
ST   D2S1338: 16,26
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 12,16
ST   FGA: 19,22
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   TC-240
AC   CVCL_4Z33
DR   cancercelllines; CVCL_4Z33
DR   Cosmic; 2228239
DR   Wikidata; Q54971802
RX   PubMed=25010205;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 3 fusion (Ex10/Ex6) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Arg216Ter (c.646C>T); Zygosity=Unspecified (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 20,24
ST   D3S1358: 18
ST   D5S818: 11,13
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   TC-244
AC   CVCL_4Z34
DR   Cosmic; 2228240
DR   Wikidata; Q54971803
RX   PubMed=25010205;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=25010205).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 23,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 14,16
ST   FGA: 21,27
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   TC-248
AC   CVCL_4Z35
SY   TC248
DR   cancercelllines; CVCL_4Z35
DR   Cosmic; 2228241
DR   Wikidata; Q54971804
RX   PubMed=25010205;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Tyr (c.775G>T); ClinVar=VCV000634680; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 19,20.2
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   TC-249
AC   CVCL_4Z36
DR   Cosmic; 2228242
DR   Wikidata; Q54971806
RX   PubMed=25010205;
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,20
ST   D19S433: 15.2,16
ST   D21S11: 29,31
ST   D2S1338: 19,24
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 9,13
ST   FGA: 20,26
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 7
//
ID   TC-252
AC   CVCL_S866
SY   TC 252; TC252
DR   Cosmic; 2060802
DR   IARC_TP53; 23655
DR   Wikidata; Q54971807
RX   PubMed=8378080;
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 10
//
ID   TC-253
AC   CVCL_7150
DR   cancercelllines; CVCL_7150
DR   Cosmic; 1091070
DR   Cosmic; 2228243
DR   Wikidata; Q54971808
RX   PubMed=7882340;
RX   PubMed=25010205;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 3 fusion (Ex10/Ex6) (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Asn842fs; Zygosity=Unspecified (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,10
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 24
ST   TH01: 7,8
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   TC-268
AC   CVCL_F532
DR   Wikidata; Q54971809
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=2841669;
RX   PubMed=8577710;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=8577710).
CC   Derived from site: Metastatic; Paraspinal mass; UBERON=UBERON_8480060.
DI   NCIt; C3789; Olfactory neuroblastoma
DI   ORDO; Orphanet_1957; Esthesioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   TC-280
AC   CVCL_S871
DR   Wikidata; Q54971811
RX   CelloPub=CLPUB00569;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 9
//
ID   TC-32
AC   CVCL_7151
SY   TC32
DR   BTO; BTO_0004227
DR   BioGRID_ORCS_Cell_line; 199
DR   cancercelllines; CVCL_7151
DR   Cell_Model_Passport; SIDM01465
DR   ChEMBL-Cells; CHEMBL4295485
DR   ChEMBL-Targets; CHEMBL4296499
DR   Cosmic; 759891
DR   Cosmic; 1078387
DR   Cosmic; 1084513
DR   Cosmic; 1718432
DR   Cosmic; 2060803
DR   Cosmic; 2228244
DR   Cosmic; 2294588
DR   DepMap; ACH-001205
DR   GEO; GSM1676322
DR   GEO; GSM1701655
DR   GEO; GSM1899423
DR   GEO; GSM5359712
DR   GEO; GSM5359713
DR   GEO; GSM5359714
DR   GEO; GSM5359715
DR   GEO; GSM5359716
DR   GEO; GSM5359717
DR   GEO; GSM5362928
DR   GEO; GSM5362929
DR   GEO; GSM5362936
DR   GEO; GSM5362937
DR   GEO; GSM5362944
DR   GEO; GSM5362945
DR   GEO; GSM5364011
DR   GEO; GSM5364012
DR   GEO; GSM5364013
DR   GEO; GSM5364014
DR   GEO; GSM5364015
DR   PharmacoDB; TC32_1566_2019
DR   Progenetix; CVCL_7151
DR   PubChem_Cell_line; CVCL_7151
DR   Wikidata; Q54971813
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   DOI=10.5282/edoc.27750;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=8040301;
RX   PubMed=16631476;
RX   PubMed=22142829;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=25984343;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=26979953;
RX   PubMed=28196595;
RX   PubMed=29464090;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Ewings/TC-32.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=24312454); 36 hours (PubMed=25984343).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=8040301; PubMed=25010205; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Tyr636fs; Zygosity=Unspecified (PubMed=25010205; DepMap=ACH-001205).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=0.13%; Native American=0.3%; East Asian, North=1.12%; East Asian, South=0%; South Asian=0.2%; European, North=67.6%; European, South=30.65% (PubMed=30894373).
CC   Derived from site: In situ; Bone, left ilium; UBERON=UBERON_0001273.
ST   Source(s): PubMed=24312454; PubMed=25010205; PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 10,12
ST   D16S539: 13,14
ST   D18S51: 11,19
ST   D19S433: 12,14
ST   D21S11: 27,28
ST   D2S1338: 17,19
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   TC-4C
AC   CVCL_4Z37
DR   cancercelllines; CVCL_4Z37
DR   Cosmic; 2228245
DR   Wikidata; Q54971814
RX   PubMed=25010205;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Unexplicit; Ex5-12del; Zygosity=Hemizygous (PubMed=25010205).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 9,11
ST   D18S51: 12,17
ST   D19S433: 14,16.2
ST   D21S11: 29
ST   D2S1338: 19,26
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 20,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C27291; Ewing sarcoma/peripheral primitive neuroectodermal tumor
DI   ORDO; Orphanet_223727; Bone sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   TC-71
AC   CVCL_2213
SY   TC71; GM11654
DR   BTO; BTO_0002604
DR   CLO; CLO_0009879
DR   CLO; CLO_0021329
DR   EFO; EFO_0002865
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 200
DR   BioSample; SAMN03473241
DR   BioSample; SAMN10987608
DR   cancercelllines; CVCL_2213
DR   Cell_Model_Passport; SIDM00419
DR   Coriell; GM11654
DR   Cosmic; 1078383
DR   Cosmic; 1082507
DR   Cosmic; 1112132
DR   Cosmic; 1718433
DR   Cosmic; 2228246
DR   Cosmic; 2250474
DR   Cosmic; 2294589
DR   Cosmic-CLP; 1240221
DR   DepMap; ACH-000424
DR   DSMZ; ACC-516
DR   DSMZCellDive; ACC-516
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1240221
DR   GEO; GSM510013
DR   GEO; GSM887689
DR   GEO; GSM888781
DR   GEO; GSM1670525
DR   GEO; GSM1676323
DR   GEO; GSM1701656
DR   GEO; GSM4368464
DR   GEO; GSM5359718
DR   GEO; GSM5359719
DR   GEO; GSM5359720
DR   GEO; GSM5359721
DR   GEO; GSM5359722
DR   GEO; GSM5359723
DR   GEO; GSM5362946
DR   GEO; GSM5362947
DR   GEO; GSM5362954
DR   GEO; GSM5362956
DR   GEO; GSM5362963
DR   GEO; GSM5362964
DR   GEO; GSM5364016
DR   GEO; GSM5364017
DR   GEO; GSM5364018
DR   GEO; GSM5364019
DR   GEO; GSM5364020
DR   IARC_TP53; 15970
DR   IARC_TP53; 27040
DR   LiGeA; CCLE_900
DR   LINCS_LDP; LCL-1438
DR   PharmacoDB; TC71_1567_2019
DR   PRIDE; PXD012680
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2213
DR   Wikidata; Q54971816
RX   DOI=10.5282/edoc.27750;
RX   PubMed=3004699;
RX   PubMed=3390826;
RX   PubMed=8040301;
RX   PubMed=8617485;
RX   PubMed=9823299;
RX   PubMed=11891184;
RX   PubMed=15150091;
RX   PubMed=18160777;
RX   PubMed=19787792;
RX   PubMed=20197622;
RX   PubMed=20922763;
RX   PubMed=21822310;
RX   PubMed=22142829;
RX   PubMed=22460905;
RX   PubMed=24312454;
RX   PubMed=25010205;
RX   PubMed=25223734;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26351324;
RX   PubMed=26428435;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29464090;
RX   PubMed=30879952;
RX   PubMed=30894373;
RX   PubMed=30962207;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36476851;
WW   Info; ESCLA; -; https://hgserver1.amc.nl/cgi-bin/r2/main.cgi?option=about_dscope
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/Ewings/TC-71.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Ewings.php
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Ewing Sarcoma Cell Line Atlas (ESCLA).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 15 hours (PubMed=20922763); 21 hours (PubMed=24312454); 26 hours (PubMed=25984343); ~24 hours (DSMZ=ACC-516).
CC   HLA typing: A*02:01,68:01; B*15:07,44:02; C*03:03,05:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18160777; PubMed=19787792; PubMed=25010205; PubMed=25223734).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=8040301; PubMed=11891184; PubMed=25010205; PubMed=25485619; PubMed=36476851).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=19787792; PubMed=25010205; PubMed=25223734; DepMap=ACH-000424).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=25010205).
CC   Omics: Genomics; ChIP-seq; FLI1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.1%; Native American=0.12%; East Asian, North=1.75%; East Asian, South=0%; South Asian=0.97%; European, North=65.4%; European, South=31.66% (PubMed=30894373).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
ST   Source(s): COG; Cosmic-CLP=1240221; DSMZ=ACC-516; PubMed=19787792; PubMed=20922763; PubMed=24312454; PubMed=25010205; PubMed=25877200; PubMed=30879952
ST   Amelogenin: X (PubMed=25877200)
ST   Amelogenin: X,Y (COG; Cosmic-CLP=1240221; DSMZ=ACC-516; PubMed=19787792; PubMed=20922763; PubMed=24312454; PubMed=25010205; PubMed=30879952)
ST   CSF1PO: 10 (PubMed=25010205)
ST   CSF1PO: 10,11 (COG; Cosmic-CLP=1240221; DSMZ=ACC-516; PubMed=20922763; PubMed=24312454; PubMed=30879952)
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 12,15
ST   D19S433: 14 (DSMZ=ACC-516; PubMed=19787792; PubMed=25010205)
ST   D19S433: 14,16.2 (PubMed=24312454)
ST   D21S11: 29,30
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 10 (DSMZ=ACC-516; PubMed=19787792)
ST   D8S1179: 10,12 (PubMed=20922763; PubMed=24312454; PubMed=25010205; PubMed=25877200)
ST   FGA: 24,26
ST   Penta D: 11,14
ST   Penta E: 12
ST   SE33: 21,30.2
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17 (COG; DSMZ=ACC-516; PubMed=20922763; PubMed=24312454; PubMed=25010205; PubMed=25877200)
ST   vWA: 17,18 (PubMed=19787792; PubMed=30879952)
ST   vWA: 17,19 (Cosmic-CLP=1240221)
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   TC-71 EHD1 KO
AC   CVCL_D6TX
SY   EHD1-KO TC71
RX   PubMed=37474760;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3242; EHD1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2213 ! TC-71
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   TC-78
AC   CVCL_Y006
SY   TC78
DR   Wikidata; Q54971817
RX   PubMed=2474371;
RX   PubMed=9177455;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   TC-797
AC   CVCL_C8YZ
SY   TC797; NMC 797; NMC797; 797
DR   Wikidata; Q123033608
RX   PubMed=12796605;
RX   PubMed=17934517;
RX   PubMed=20871596;
RX   PubMed=21447744;
RX   PubMed=29348827;
RX   PubMed=30135075;
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT (PubMed=21447744; PubMed=29348827).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45716; NUT carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   TC-83
AC   CVCL_9716
DR   Wikidata; Q54971824
RX   PubMed=11004677;
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   TC-CD99-shRNA#1
AC   CVCL_QW72
DR   cancercelllines; CVCL_QW72
DR   GEO; GSM278143
DR   GEO; GSM278144
DR   Wikidata; Q54971825
RX   PubMed=20197622;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7082; CD99.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2213 ! TC-71
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   TC-CD99-shRNA#2
AC   CVCL_QW73
DR   cancercelllines; CVCL_QW73
DR   GEO; GSM278145
DR   GEO; GSM278146
DR   Wikidata; Q54971826
RX   PubMed=20197622;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:7082; CD99.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2213 ! TC-71
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   TC-CTR-shRNA
AC   CVCL_QW71
DR   cancercelllines; CVCL_QW71
DR   GEO; GSM278141
DR   GEO; GSM278142
DR   Wikidata; Q54971827
RX   PubMed=20197622;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2213 ! TC-71
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   TC-YIK
AC   CVCL_1737
SY   TCYIK
DR   CLO; CLO_0050913
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472316
DR   Cell_Model_Passport; SIDM00234
DR   ChEMBL-Cells; CHEMBL3308250
DR   ChEMBL-Targets; CHEMBL2366324
DR   Cosmic; 946357
DR   Cosmic; 1995659
DR   Cosmic-CLP; 946357
DR   DepMap; ACH-002201
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10589-108D4
DR   GDSC; 946357
DR   GEO; GSM1670527
DR   IARC_TP53; 27258
DR   PharmacoDB; TCYIK_1568_2019
DR   PubChem_Cell_line; CVCL_1737
DR   RCB; RCB0443
DR   Wikidata; Q54971829
RX   PubMed=1849445;
RX   PubMed=10391092;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Characteristics: Established from the YIK-1 xenograft which was obtained by mutliple serial transplantation of the original tumor in nude mice.
CC   Doubling time: ~21.6 hours (Note=At 119th passage) (PubMed=1849445).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9885; ARID4A; Simple; p.Glu565Ter (c.1693G>T); Zygosity=Heterozygous (Cosmic-CLP=946357; DepMap=ACH-002201).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=74.47%; East Asian, South=25.52%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=946357; RCB=RCB0443
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C7982; Cervical small cell carcinoma
DI   ORDO; Orphanet_213777; High-grade neuroendocrine carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   TC1 [Mouse ESC]
AC   CVCL_M350
SY   TC-1
DR   BTO; BTO_0004888
DR   Wikidata; Q54971830
RX   PubMed=8601314;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTacfBR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   TC1 [Mouse hybridoma against P.aeruginosa eta]
AC   CVCL_G561
SY   TC-1
DR   ATCC; CRL-2493
DR   Wikidata; Q54971831
RX   PubMed=6425217;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   TC10
AC   CVCL_0558
DR   MCCL; MCC:0000459
DR   Wikidata; Q54971832
RX   PubMed=8274453;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Breed/subspecies: MT-PLVT transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   TC106
AC   CVCL_F720
DR   IPD-IMGT/HLA; 11433
DR   Wikidata; Q54971833
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:02,32:01; B*44:03,51:01; C*14:02:01,16:01:01; DRB1*07,15 (IPD-IMGT/HLA=11433).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   TC11-3782
AC   CVCL_A3YM
DR   Wikidata; Q105511160
RX   PubMed=25732146;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   TC289
AC   CVCL_IS68
SY   TC-289
DR   Wikidata; Q54971834
RX   PubMed=11115567;
RX   PubMed=11557780;
RX   PubMed=16557275;
CC   Population: Japanese.
CC   Doubling time: 48 hours (Note=At 20th passage) (PubMed=11115567).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   TC31
AC   CVCL_G562
SY   TC-31; TC-31.4
DR   ATCC; CRL-2494
DR   Wikidata; Q54971835
RX   PubMed=6425217;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P11439; Pseudomonas aeruginosa exotoxin A (eta).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   TC587
AC   CVCL_ZV62
DR   cancercelllines; CVCL_ZV62
DR   Wikidata; Q98133175
RX   PubMed=32014918;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=32014918).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Tyr (c.2446G>T); ClinVar=VCV000013860; Zygosity=Unspecified (PubMed=32014918).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000013901; Zygosity=Unspecified (PubMed=32014918).
CC   Sequence variation: Mutation; HGNC; HGNC:18118; RSF1; Simple; p.Pro1133Leu (c.3398C>T); Zygosity=Unspecified (PubMed=32014918).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala347Asp (c.1040C>A); ClinVar=VCV000043587; Zygosity=Unspecified (PubMed=32014918).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C8107; Ovarian yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TC6
AC   CVCL_6A95
SY   TC 6; T immortalized chondrocyte-like cell 6
DR   Wikidata; Q54971837
RX   PubMed=8915772;
RX   PubMed=9224657;
RX   PubMed=10502305;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Joint articular cartilage; UBERON=UBERON_0010996.
CC   Cell type: Chondrocyte; CL=CL_0000138.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TC616
AC   CVCL_RL78
DR   Wikidata; Q54971838
RX   PubMed=26560505;
CC   Population: Japanese.
DI   NCIt; C6619; Mediastinal leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   TC620 1.0
AC   CVCL_UJ23
SY   TC620 clone 1.0
DR   Wikidata; Q98133177
RX   PubMed=3142218;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N714 ! TC 620
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   TC620 1.3
AC   CVCL_UJ24
SY   TC620 subclone 1.3
DR   Wikidata; Q98133179
RX   PubMed=3142218;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UJ23 ! TC620 1.0
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   TC620.6A2
AC   CVCL_5G72
DR   Wikidata; Q54971840
RX   PubMed=8530186;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3288; Oligodendroglioma
DI   ORDO; Orphanet_251627; Oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N714 ! TC 620
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   TC7
AC   CVCL_S881
DR   Cosmic; 711260
DR   Cosmic; 887224
DR   Wikidata; Q54971841
RX   PubMed=9000572;
RX   PubMed=10732766;
RX   PubMed=11526487;
RX   PubMed=24042735;
CC   Microsatellite instability: Instable (MSI) (PubMed=9000572).
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 8,10,11
ST   D16S539: 10,11
ST   D18S51: 16,17,18
ST   D19S433: 12,15
ST   D21S11: 29,30
ST   D2S1338: 21,23
ST   D3S1358: 13,17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 11
//
ID   TC71
AC   CVCL_S882
DR   cancercelllines; CVCL_S882
DR   ColonAtlas; TC71
DR   Cosmic; 711259
DR   Cosmic; 887221
DR   Cosmic; 1132567
DR   Cosmic; 1479584
DR   GEO; GSM2550020
DR   Wikidata; Q54971843
RX   PubMed=9000572;
RX   PubMed=10732766;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=25944804;
RX   PubMed=28683746;
CC   Doubling time: 28.52 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI) (PubMed=9000572; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=20570890; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg233Ter (c.697C>T); ClinVar=VCV000007813; Zygosity=Heterozygous (PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=28683746).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: In situ; Colon, sigmoid; UBERON=UBERON_0001159.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X
ST   CSF1PO: 10,15
ST   D13S317: 9,12,13
ST   D16S539: 11
ST   D18S51: 10,11,15
ST   D19S433: 13
ST   D21S11: 29,32.2
ST   D2S1338: 16,17
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 10,13
ST   FGA: 18,19
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   TC78
AC   CVCL_QX05
DR   Wikidata; Q54971844
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3866123;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 6
//
ID   Tc81
AC   CVCL_Z277
DR   ICLDB; tc81
DR   Wikidata; Q54971845
RX   PubMed=23535851;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7070; ! Tribolium castaneum (Red flour beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   TC86-1530
AC   CVCL_A3YN
DR   Wikidata; Q105511162
RX   PubMed=25732146;
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   TC95-2711
AC   CVCL_C2A9
DR   Wikidata; Q114313099
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 9,12
ST   D7S820: 10
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC95-2806
AC   CVCL_C2AA
DR   Wikidata; Q114313101
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 13
ST   D5S818: 12,14
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC95-2817
AC   CVCL_C2AB
DR   Wikidata; Q114313102
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2824
AC   CVCL_C2AC
DR   Wikidata; Q114313103
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 6,11
ST   vWA: 15,16
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2827
AC   CVCL_C2AD
DR   Wikidata; Q114313104
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2831
AC   CVCL_C2AE
DR   Wikidata; Q114313105
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 13,14
ST   D5S818: 7,11
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2832
AC   CVCL_C2AF
DR   Wikidata; Q114313107
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2837
AC   CVCL_C2AG
DR   Wikidata; Q114313108
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,14
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2860
AC   CVCL_C2AH
DR   Wikidata; Q114313109
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 8,9.3
ST   TPOX: 11,12
ST   vWA: 15,18
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2865
AC   CVCL_C2AI
DR   Wikidata; Q114313110
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 13,14
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2873
AC   CVCL_C2AJ
DR   Wikidata; Q114313111
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 10,11
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC96-2906
AC   CVCL_C2AK
DR   Wikidata; Q114313112
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Quadruplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 10,12
ST   vWA: 16,17
DI   NCIt; C118847; Spinal muscular atrophy type 3
DI   ORDO; Orphanet_83419; Proximal spinal muscular atrophy type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC97-2922
AC   CVCL_C2AL
DR   Wikidata; Q114313113
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (PubMed=28284873).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 18,19
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC97-2923
AC   CVCL_C2AM
DR   Wikidata; Q114313114
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC97-2932
AC   CVCL_C2AN
DR   Wikidata; Q114313115
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 11
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   TC97-2947
AC   CVCL_C2AP
DR   Wikidata; Q114313117
RX   PubMed=28284873;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 8,13
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   Tca8113
AC   CVCL_6851
SY   TCA8113; Tca-8113
DR   BTO; BTO_0006058
DR   Cosmic; 851222
DR   KCB; KCB 93034YJ
DR   Wikidata; Q54971846
RX   PubMed=3464389;
RX   PubMed=26116706;
RX   PubMed=28851942;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28851942). Originally thought to originate from a female patient with a tongue squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00578.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: Formerly the CCRID database had 3 entries describing this cell line (3111C0001CCC000296, 3131C0001000700077, 3142C0001000000067). They were one of the sources for the STR profile of this entry.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): CCRID; PubMed=26116706; PubMed=28851942
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18,19
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Tca8113-P160
AC   CVCL_7906
SY   Tca8113P160
DR   Wikidata; Q54971847
CC   Problematic cell line: Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6851 ! Tca8113
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   Tca8113-P60
AC   CVCL_7907
SY   Tca8113P60
DR   Wikidata; Q54971848
CC   Problematic cell line: Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6851 ! Tca8113
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   Tca8113/CBP [Chengdu]
AC   CVCL_9U53
DR   Wikidata; Q54971849
RX   PubMed=21365850;
CC   Problematic cell line: Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6851 ! Tca8113
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   Tca8113/CBP [Chongqing]
AC   CVCL_T058
DR   Wikidata; Q54971850
RX   CelloPub=CLPUB00004;
CC   Problematic cell line: Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6851 ! Tca8113
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   Tca8113/PYM [Changsha]
AC   CVCL_9U54
DR   Wikidata; Q54971851
RX   DOI=10.1016/j.cellbi.2008.01.124;
RX   PubMed=21040473;
CC   Problematic cell line: Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_78160; Bleomycin A5 (Pingyangmycin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6851 ! Tca8113
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   Tca8113/PYM [Chengdu]
AC   CVCL_9U55
DR   Wikidata; Q54971852
RX   PubMed=21365850;
CC   Problematic cell line: Contaminated. Parent cell line (Tca8113) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_78160; Bleomycin A5 (Pingyangmycin).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6851 ! Tca8113
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TCAF
AC   CVCL_K592
DR   ChEMBL-Cells; CHEMBL3307350
DR   ChEMBL-Targets; CHEMBL614244
DR   PubChem_Cell_line; CVCL_K592
DR   Wikidata; Q54971853
RX   PubMed=1589797;
CC   Characteristics: No information is available on this cell line.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TCAF-DAX
AC   CVCL_K692
SY   TCAFDAX
DR   ChEMBL-Cells; CHEMBL3307465
DR   ChEMBL-Targets; CHEMBL615009
DR   PubChem_Cell_line; CVCL_K692
DR   Wikidata; Q54971855
RX   PubMed=1589797;
CC   Characteristics: No information is available on this cell line apart that it is multidrug-resistant.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K592 ! TCAF
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TCam-2
AC   CVCL_T012
SY   TCAM-2; TCam 2; T-CAM2; TCam2; T-CAM
DR   EFO; EFO_0022718
DR   Cosmic; 1449155
DR   Cosmic; 2077183
DR   Cosmic; 2163764
DR   Cosmic; 2806820
DR   Cosmic; 2807076
DR   GEO; GSM5209339
DR   GEO; GSM5209340
DR   GEO; GSM5209341
DR   GEO; GSM5209342
DR   GEO; GSM5209343
DR   GEO; GSM5209344
DR   GEO; GSM5209345
DR   GEO; GSM5209346
DR   Wikidata; Q54971858
RX   PubMed=8394948;
RX   PubMed=18008088;
RX   PubMed=18050305;
RX   PubMed=20607849;
RX   PubMed=21668453;
RX   PubMed=23374840;
RX   PubMed=24812411;
RX   PubMed=34153645;
RX   PubMed=36899312;
CC   Population: Japanese.
CC   Doubling time: 55.3 hours (Note=At 10th passage) (PubMed=8394948).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C7328; Testicular seminoma
DI   ORDO; Orphanet_842; Testicular seminomatous germ cell tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 18
//
ID   TCC-GC1-C1
AC   CVCL_E7AZ
RX   PubMed=39894565;
CC   Population: Japanese.
CC   Doubling time: ~41 hours (PubMed=39894565).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
ST   Source(s): PubMed=39894565
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9
ST   D18S51: 20
ST   D21S11: 28,30
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,12
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TCC-MESO-1
AC   CVCL_E263
SY   Tochigi Cancer Center-MESOthelioma-1
DR   JCRB; JCRB1894
DR   Wikidata; Q54971859
RX   PubMed=19876922;
CC   Population: Japanese.
CC   Doubling time: 24.5 hours (PubMed=19876922).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): JCRB=JCRB1894
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E264 ! TCC-MESO-2
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   TCC-MESO-2
AC   CVCL_E264
SY   Tochigi Cancer Center-MESOthelioma-2
DR   JCRB; JCRB1898
DR   Wikidata; Q54971860
RX   PubMed=19876922;
CC   Population: Japanese.
CC   Doubling time: 26.2 hours (PubMed=19876922).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): JCRB=JCRB1898
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E263 ! TCC-MESO-1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   TCC-MESO-3
AC   CVCL_E265
SY   Tochigi Cancer Center-MESOthelioma-3
DR   JCRB; JCRB1909
DR   Wikidata; Q54971861
RX   PubMed=19876922;
CC   Population: Japanese.
CC   Doubling time: 31.3 hours (PubMed=19876922).
CC   Donor information: No history of asbestos exposure (PubMed=19876922).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): JCRB=JCRB1909
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 12
//
ID   TCC-NECT-2
AC   CVCL_WS42
DR   cancercelllines; CVCL_WS42
DR   JCRB; JCRB1916
DR   Wikidata; Q98133180
RX   PubMed=29765522;
RX   PubMed=30559933;
CC   Population: Japanese.
CC   Doubling time: ~31.4 hours (PubMed=30559933).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=30559933).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783-1G>A; ClinVar=VCV000458565; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=30559933).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1916
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C135080; Duodenal neuroendocrine tumor
DI   ORDO; Orphanet_100076; Duodenal neuroendocrine tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 11
//
ID   TCC-Pan2
AC   CVCL_3178
SY   TCC-PAN2; TCCPAN2
DR   EFO; EFO_0006764
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 451
DR   BioSample; SAMN03472903
DR   BioSample; SAMN10988353
DR   cancercelllines; CVCL_3178
DR   Cell_Model_Passport; SIDM01464
DR   DepMap; ACH-000502
DR   EGA; EGAS00001000610
DR   GEO; GSM887690
DR   GEO; GSM888782
DR   GEO; GSM1588616
DR   GEO; GSM1588628
DR   IARC_TP53; 28256
DR   JCRB; JCRB1072
DR   JCRB; JCRB1921
DR   LiGeA; CCLE_741
DR   PharmacoDB; TCCPAN2_1569_2019
DR   Progenetix; CVCL_3178
DR   Wikidata; Q54971862
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=30747829;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=32782605;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~26 hours (PubMed=30747829).
CC   HLA typing: A*11:01,24:02; B*52:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=30747829).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Heterozygous (PubMed=30747829; DepMap=ACH-000502).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>A (IVS9+1G>A); ClinVar=VCV000528261; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=30747829; DepMap=ACH-000502).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.68%; Native American=0%; East Asian, North=89.24%; East Asian, South=5.56%; South Asian=0%; European, North=0%; European, South=3.52% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1921; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11
ST   D18S51: 16
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 19
ST   TH01: 6,7
ST   TPOX: 11,12
ST   vWA: 17
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   TCC-S
AC   CVCL_W386
SY   TCCS; Tochigi Cancer Center-S
DR   Wikidata; Q54971863
RX   PubMed=11264164;
RX   PubMed=16130897;
CC   Population: Japanese.
CC   Doubling time: 27.96 +- 0.97 hours (PubMed=16130897); 25 +- 2 hours (PubMed=11264164).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=16130897).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   TCC-SUPrCDDP1000
AC   CVCL_RR24
DR   cancercelllines; CVCL_RR24
DR   Wikidata; Q54971864
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 31.2 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1738 ! TCCSUP
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   TCC-SUPrGEMCI20
AC   CVCL_RR25
DR   cancercelllines; CVCL_RR25
DR   Wikidata; Q54971865
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Doubling time: 117.8 hours (PubMed=26055179).
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1738 ! TCCSUP
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   TCC-SUPrVINB20
AC   CVCL_RR26
SY   TCC-SUPrVBL20
DR   cancercelllines; CVCL_RR26
DR   Wikidata; Q54971866
RX   PubMed=26055179;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1738 ! TCCSUP
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   TCC-Y
AC   CVCL_D3Z4
SY   TCC-Y / wr; TCCY; Tochigi Cancer Center-Y
DR   Wikidata; Q127384377
RX   Patent=WO2004094628A1;
RX   PubMed=11264164;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 36 +- 3 hours (PubMed=11264164).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=11264164).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Thr531Tyrfs*10 (c.1589dup) (p.Thr532Tyrfs*10, c.1592dup); Zygosity=Homozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Val1003Ile (c.3007G>A); Zygosity=Heterozygous (PubMed=35124168).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   TCC-Y/sr
AC   CVCL_D3Z5
SY   TCC-Y / sr
DR   Wikidata; Q127384378
RX   Patent=WO2004094628A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8531.
CC   Population: Japanese.
CC   Doubling time: 34 +- 4 hours (Patent=WO2004094628A1).
CC   Selected for resistance to: ChEBI; CHEBI_45783; Imatinib (Gleevec; STI571).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Thr315Ile (c.944C>T) (c.1001C>T); ClinVar=VCV000012624; Zygosity=Unspecified (Patent=WO2004094628A1).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D3Z4 ! TCC-Y
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   TCC56
AC   CVCL_UD60
DR   Wikidata; Q98133181
RX   PubMed=25672256;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9H3R2; Human MUC13.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 3
//
ID   TCCSUP
AC   CVCL_1738
SY   TCCSuP; TCC-SUP; TCC Sup
DR   BTO; BTO_0006308
DR   CLO; CLO_0009283
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-5
DR   BioGRID_ORCS_Cell_line; 450
DR   BioSample; SAMN03472747
DR   BioSample; SAMN03473325
DR   BioSample; SAMN10988046
DR   cancercelllines; CVCL_1738
DR   CCRID; 3101HUMSCSP571
DR   Cell_Model_Passport; SIDM01190
DR   ChEMBL-Cells; CHEMBL3307466
DR   ChEMBL-Targets; CHEMBL615010
DR   CLS; 305073
DR   Cosmic; 687459
DR   Cosmic; 755398
DR   Cosmic; 925833
DR   Cosmic; 943734
DR   Cosmic; 1046692
DR   Cosmic; 1285131
DR   Cosmic; 1286003
DR   Cosmic; 2037961
DR   Cosmic; 2050466
DR   Cosmic; 2057460
DR   Cosmic; 2444246
DR   Cosmic; 2685942
DR   Cosmic-CLP; 687459
DR   DepMap; ACH-000720
DR   DSMZ; ACC-377
DR   DSMZCellDive; ACC-377
DR   EGA; EGAS00001000978
DR   GDSC; 687459
DR   GEO; GSM136227
DR   GEO; GSM142308
DR   GEO; GSM142311
DR   GEO; GSM142312
DR   GEO; GSM827282
DR   GEO; GSM888783
DR   GEO; GSM1374955
DR   GEO; GSM1374956
DR   GEO; GSM1574563
DR   GEO; GSM1670526
DR   IARC_TP53; 3724
DR   LiGeA; CCLE_887
DR   LINCS_LDP; LCL-1720
DR   PharmacoDB; TCCSUP_1570_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1738
DR   PubChem_Cell_line; CVCL_1738
DR   Wikidata; Q54971867
RX   PubMed=571047;
RX   PubMed=836756;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=6823318;
RX   PubMed=6826254;
RX   PubMed=7787250;
RX   PubMed=9850064;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25984343;
RX   PubMed=25997541;
RX   PubMed=26055179;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=3708594); 46 hours (PubMed=25984343); 49.2 hours (PubMed=26055179); ~30-40 hours (DSMZ=ACC-377).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Homozygous (PubMed=7787250; PubMed=9850064; PubMed=27270441).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.27%; East Asian, South=0.03%; South Asian=1.48%; European, North=68.68%; European, South=28.53% (PubMed=30894373).
CC   Misspelling: JCCSUP; PubMed=6582512.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=HTB-5; Cosmic-CLP=687459; DSMZ=ACC-377; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11 (DSMZ=ACC-377)
ST   D13S317: 11,14 (ATCC=HTB-5; Cosmic-CLP=687459; PubMed=27270441)
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 27,31.2
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 11
ST   Penta E: 12,14
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   TCCUB
AC   CVCL_WH27
DR   Wikidata; Q98133182
RX   PubMed=28283079;
RX   PubMed=30246405;
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   TCG 580
AC   CVCL_RQ32
SY   TCG580
DR   Wikidata; Q54971868
RX   PubMed=7551341;
RX   PubMed=29084941;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   TcHMC-1
AC   CVCL_H204
DR   Wikidata; Q54971870
RX   PubMed=3488124;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2949 ! HMC-1-8
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   TCIERi001-A
AC   CVCL_WU27
SY   IER-EK1
DR   BioSamples; SAMEA5859252
DR   hPSCreg; TCIERi001-A
DR   Wikidata; Q98133184
RX   PubMed=31683100;
CC   From: Institute of Eye Research, Hualien Tzu Chi Hospital; Hualien; Taiwan.
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   TCL-1
AC   CVCL_5373
SY   Trophoblast Cell Line-1
DR   Wikidata; Q54971871
RX   PubMed=8730883;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TCL-1
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ZipSV40-6).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   TCL-598
AC   CVCL_B6EB
SY   TCL 598; TCL598
DR   Wikidata; Q112041773
RX   DOI=10.1038/nbt0784-628;
RX   PubMed=8182078;
RX   PubMed=22359153;
CC   Characteristics: Produces and secretes pro-urokinase (DOI=10.1038/nbt0784-628).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C3150; Kidney neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   TCL-As
AC   CVCL_G008
DR   Wikidata; Q54971879
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F909 ! ILT-As
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   TCL-Haz
AC   CVCL_G009
DR   Wikidata; Q54971881
RX   PubMed=2981920;
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   TCL-Fuj3
AC   CVCL_B6MG
DR   Wikidata; Q112041774
RX   PubMed=2981920;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6MH ! TCL-Fuj4
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TCL-Fuj4
AC   CVCL_B6MH
DR   Wikidata; Q112041775
RX   PubMed=2981920;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6MG ! TCL-Fuj3
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TCL-Kan
AC   CVCL_G010
DR   RCB; RCB2085
DR   TKG; TKG 0285
DR   Wikidata; Q54971882
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB2085; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   TCL-Mor
AC   CVCL_G011
DR   Wikidata; Q54971883
RX   PubMed=2981920;
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F910 ! ILT-Mor
OI   CVCL_UG48 ! LCL-Mor8
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   TCL-Na1
AC   CVCL_6852
SY   TCL-NA1; TCL-Na-1; TCLNa1; Na1
DR   Wikidata; Q54971884
RX   PubMed=2981920;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Na1
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   TCL-Sug2
AC   CVCL_B6MI
DR   Wikidata; Q112041776
RX   PubMed=2981920;
RX   PubMed=6088403;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TCL-Tan
AC   CVCL_B6MJ
DR   Wikidata; Q112041777
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TCL-Ter
AC   CVCL_G012
DR   Wikidata; Q54971885
RX   PubMed=2981920;
RX   PubMed=6088403;
RX   PubMed=6189906;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F914 ! ILT-Ter
OI   CVCL_UH25 ! LCL-Ter50
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   TCMK-1
AC   CVCL_2772
SY   TCMK1; Transformed C3H Mouse Kidney-1
DR   BTO; BTO_0004231
DR   CLO; CLO_0009284
DR   CLDB; cl4493
DR   ATCC; CCL-139
DR   ECACC; 90050802
DR   KCLB; 10139
DR   Wikidata; Q54971886
RX   PubMed=14120333;
RX   PubMed=14206435;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Discontinued: ECACC; 90050802; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: C3H/Mai.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1-2M
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   TCNT1
AC   CVCL_K095
DR   RCB; AES0127
DR   RCB; RCB2701
DR   SKIP; SKIP001670
DR   Wikidata; Q54971887
CC   Discontinued: RCB; RCB2701; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x 129.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   TCO
AC   CVCL_HE32
DR   ColonAtlas; TCO
DR   Cosmic; 905004
DR   Wikidata; Q54971888
RX   PubMed=7601562;
RX   PubMed=15729718;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   TCO-1 [Human cervical carcinoma]
AC   CVCL_3179
DR   BioSample; SAMN03151962
DR   ChEMBL-Cells; CHEMBL3308791
DR   ChEMBL-Targets; CHEMBL1075599
DR   Cosmic; 877475
DR   Cosmic; 1152549
DR   PubChem_Cell_line; CVCL_3179
DR   RCB; RCB0640
DR   Wikidata; Q54971889
RX   PubMed=1607768;
RX   PubMed=16643607;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a TCS derivative (PubMed=16643607; PubMed=20143388). Originally thought to originate from a 34 year old patient with an uterine cervical adenocarcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00272.
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=1607768).
CC   Discontinued: RCB; RCB0640; true.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C40187; Cervical keratinizing squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8160 ! TCS
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   TCO-1 [Human thyroid carcinoma]
AC   CVCL_M839
SY   TCO-I
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03471663
DR   cancercelllines; CVCL_M839
DR   CGH-DB; 59-1
DR   Cosmic; 909763
DR   Cosmic; 2054090
DR   FANTOM5_SSTAR; 10783-110G9
DR   GEO; GSM827182
DR   IARC_TP53; 27018
DR   JCRB; FDSC0019
DR   JCRB; JCRB0239
DR   Progenetix; CVCL_M839
DR   Wikidata; Q54971891
RX   PubMed=1516062;
RX   PubMed=2181436;
RX   PubMed=3986962;
RX   PubMed=9177455;
RX   PubMed=9290701;
RX   PubMed=16924234;
RX   PubMed=20215515;
RX   PubMed=23833040;
RX   PubMed=30737244;
CC   Population: Japanese.
CC   Doubling time: ~26 hours (Note=Lot 11032003) (JCRB=JCRB0239).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Tyr101Ter (c.303T>A); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Homozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; FDSC0019; true.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): JCRB=JCRB0239; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 17
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 18
ST   TH01: 6,7
ST   TPOX: 12
ST   vWA: 17,19
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 29
//
ID   TCO-2
AC   CVCL_3630
DR   CLO; CLO_0050920
DR   BioSample; SAMN03472216
DR   Cosmic; 877476
DR   Cosmic; 1152550
DR   RCB; RCB0689
DR   Wikidata; Q54971892
RX   PubMed=1607768;
RX   PubMed=24403450;
CC   Population: Japanese.
CC   Doubling time: 93 hours (PubMed=1607768); 69 hours (PubMed=24403450).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): RCB=RCB0689
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 9,12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,19,20
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   TCO-3
AC   CVCL_A1JV
DR   Wikidata; Q102114972
RX   PubMed=2181436;
RX   PubMed=3148601;
CC   Population: Japanese.
DI   NCIt; C4815; Thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   TCO-4
AC   CVCL_M840
DR   Wikidata; Q54971893
RX   PubMed=2181436;
RX   PubMed=3148601;
CC   Population: Japanese.
DI   NCIt; C4815; Thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TCO-5
AC   CVCL_A1JW
DR   Wikidata; Q102114973
RX   PubMed=2181436;
RX   PubMed=3148601;
CC   Population: Japanese.
DI   NCIt; C4815; Thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   TcOSC-20
AC   CVCL_WW78
DR   Wikidata; Q98133203
RX   PubMed=9119748;
RX   PubMed=12716470;
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3087 ! OSC-20
SX   Female
AG   59Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   tCPC-12
AC   CVCL_0E88
SY   tCPC 12; tCPC clone 12; transformed Calf Papilla Cells-12
DR   Wikidata; Q54971894
RX   PubMed=10973559;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_0E89 ! tCPC-B
OI   CVCL_0E90 ! tCPC-C
OI   CVCL_0E91 ! tCPC-D
SX   Sex unspecified
AG   6M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   tCPC-B
AC   CVCL_0E89
SY   tCPC B; tCPC clone B; transformed Calf Papilla Cells-B
DR   Wikidata; Q54971896
RX   PubMed=10973559;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_0E88 ! tCPC-12
OI   CVCL_0E90 ! tCPC-C
OI   CVCL_0E91 ! tCPC-D
SX   Sex unspecified
AG   6M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   tCPC-C
AC   CVCL_0E90
SY   tCPC C; tCPC clone C; transformed Calf Papilla Cells-C
DR   Wikidata; Q54971897
RX   PubMed=10973559;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_0E88 ! tCPC-12
OI   CVCL_0E89 ! tCPC-B
OI   CVCL_0E91 ! tCPC-D
SX   Sex unspecified
AG   6M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   tCPC-D
AC   CVCL_0E91
SY   tCPC D; tCPC clone D; transformed Calf Papilla Cells-D
DR   Wikidata; Q54971898
RX   PubMed=10973559;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Tooth bud, dental papilla, molar; UBERON=UBERON_0015844.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
OI   CVCL_0E88 ! tCPC-12
OI   CVCL_0E89 ! tCPC-B
OI   CVCL_0E90 ! tCPC-C
SX   Sex unspecified
AG   6M
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   TCPH-MM01
AC   CVCL_WZ32
SY   MM1
DR   Wikidata; Q98133204
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ37 ! TCPH-MM01-pleural
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   TCPH-MM01-pleural
AC   CVCL_WZ37
SY   MM1-pleural
DR   Wikidata; Q98133205
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WZ32 ! TCPH-MM01
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   TCPH-MM02
AC   CVCL_WZ33
SY   MM2
DR   Wikidata; Q98133206
RX   PubMed=31038674;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45664; Pleural desmoplastic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   TCPH-MM03
AC   CVCL_M193
SY   MM3; MM1081
DR   Wikidata; Q54906040
RX   PubMed=23516439;
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: No history of asbestos exposure (PubMed=31038674).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   TCPH-MM04
AC   CVCL_M192
SY   MM4; MM05
DR   Wikidata; Q54906034
RX   PubMed=23516439;
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   TCPH-MM05
AC   CVCL_WZ34
SY   MM5
DR   Wikidata; Q98133207
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Omics: Genomics; Whole genome sequencing.
CC   Donor information: No history of asbestos exposure (PubMed=31038674).
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   TCPH-MM07
AC   CVCL_WZ35
SY   MM7
DR   Wikidata; Q98133209
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   TCPH-MM08
AC   CVCL_WZ36
SY   MM8
DR   Wikidata; Q98133210
RX   PubMed=31038674;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31038674).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   TCPH-MM10
AC   CVCL_WZ38
SY   MM10
DR   Wikidata; Q98133212
RX   PubMed=31038674;
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   TCPH-MM11
AC   CVCL_M191
SY   MM04
DR   Wikidata; Q54906032
RX   PubMed=23516439;
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45664; Pleural desmoplastic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TCPH-MM12
AC   CVCL_M194
SY   MM12
DR   Wikidata; Q54906043
RX   PubMed=23516439;
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TCPH-MM13
AC   CVCL_M195
SY   MM13
DR   Wikidata; Q54906045
RX   PubMed=23516439;
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TCPH-MM14
AC   CVCL_M196
SY   PF1038
DR   Wikidata; Q54947245
RX   PubMed=23516439;
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TCS
AC   CVCL_8160
SY   TC-S
DR   CLO; CLO_0050938
DR   BioSample; SAMN03472262
DR   RCB; RCB0638
DR   Wikidata; Q54971900
RX   PubMed=6520483;
CC   Population: Japanese.
CC   Doubling time: 29.8 hours (PubMed=6520483).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): RCB=RCB0638
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 8,10,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 11,12,13
ST   TH01: 7
ST   TPOX: 8,11,12
ST   vWA: 14,18,19
DI   NCIt; C40187; Cervical keratinizing squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   TCTMAB
AC   CVCL_E7QJ
RX   PubMed=20568996;
RX   PubMed=28636499;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Toxocara cati second stage larvae antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD
AC   CVCL_5M22
DR   Wikidata; Q54971901
RX   PubMed=4735239;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_5M20 ! KF
OI   CVCL_5M21 ! MB
OI   CVCL_5M23 ! WE
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   TD-02
AC   CVCL_C0KT
SY   TD02
DR   Wikidata; Q112930456
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   TD-03
AC   CVCL_C0KS
SY   TD03
DR   Wikidata; Q112930457
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34287353
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D21S11: 28,30
ST   D5S818: 9,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0KR ! AJD002-3
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   TD-06
AC   CVCL_E6KX
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2385Arg (c.7153G>A); ClinVar=VCV000001943; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-06 corrected
AC   CVCL_E6KY
SY   TD-06 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_corrected; p.Gly2385Arg (c.7153G>A); ClinVar=VCV000001943; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6KX ! TD-06
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-07
AC   CVCL_E6L1
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-08
AC   CVCL_E6L2
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-09
AC   CVCL_E6L3
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu363Ile (L324I); Zygosity=Unspecified (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-10
AC   CVCL_C0KU
SY   TD10
DR   Wikidata; Q112930458
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: South Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   TD-15
AC   CVCL_E6KV
RX   PubMed=34500068;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Heterozygous (PubMed=34500068).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34500068
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-15 corrected clone H02
AC   CVCL_E6KW
SY   TD-15 (isogenic correction)
RX   PubMed=34500068;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_corrected; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34500068).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34500068
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 28,31.2
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6KV ! TD-15
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-16
AC   CVCL_E6L4
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-17
AC   CVCL_E6LB
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-19
AC   CVCL_E6L5
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-2
AC   CVCL_A6UC
SY   TD2
DR   Wikidata; Q107117015
RX   PubMed=12454861;
RX   PubMed=14555993;
RX   PubMed=16230077;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   TD-2 fLuc
AC   CVCL_A6UD
DR   Wikidata; Q107117018
RX   PubMed=16230077;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6UC ! TD-2
SX   Male
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   TD-2 fLuc-CCR7
AC   CVCL_A6UE
DR   Wikidata; Q107117020
RX   PubMed=16230077;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:103011; Ccr7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6UC ! TD-2
SX   Male
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   TD-2 fLuc-CXCR4
AC   CVCL_A6UF
DR   Wikidata; Q107117023
RX   PubMed=16230077;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:109563; Cxcr4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A6UC ! TD-2
SX   Male
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   TD-20
AC   CVCL_E6L6
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-21
AC   CVCL_E6LC
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-22
AC   CVCL_C0KV
SY   TD22
DR   Wikidata; Q112930459
RX   PubMed=34287353;
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   TD-25
AC   CVCL_E6L7
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Ile114Thr (c.341T>C) (I113T); ClinVar=VCV000197145; Zygosity=Heterozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-26
AC   CVCL_E6LD
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-28
AC   CVCL_E6KZ
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple; p.Met393Thr (c.1178T>C); ClinVar=VCV001246424; Zygosity=Homozygous (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD-28 corrected
AC   CVCL_E6L0
SY   TD-28 (isogenic correction)
WW   Provider; C-BIG; -; https://cbigr-open.loris.ca/C-BIG_ipsc_catalog_august_2023.pdf
CC   From: Clinical Biospecimen Imaging and Genetic (C-BIG) Repository, Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:28709; TMEM175; Simple_corrected; p.Met393Thr (c.1178T>C); ClinVar=VCV001246424; Zygosity=Homozygous; Note=By CRISPR/Cas9 (C-BIG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6KZ ! TD-28
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TD.1
AC   CVCL_F779
DR   CLO; CLO_0009285
DR   ATCC; CRL-2232
DR   Wikidata; Q54971902
RX   PubMed=1547490;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P49951; Bovine CLTC (Note=Also reacts with human).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TD1-10749-2
AC   CVCL_RJ28
DR   SKIP; SKIP000813
DR   Wikidata; Q54971903
RX   PubMed=25231866;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (PubMed=25231866).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0Q23 ! GM10749
SX   Male
AG   3D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TD1-315H-2
AC   CVCL_RJ29
DR   SKIP; SKIP000814
DR   Wikidata; Q54971904
RX   PubMed=25231866;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (PubMed=25231866).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TD1-714-3
AC   CVCL_RJ27
DR   SKIP; SKIP000812
DR   Wikidata; Q54971905
RX   PubMed=25231866;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Arg248Cys (c.742C>T); ClinVar=VCV000016332; Zygosity=Heterozygous (PubMed=25231866).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85187; Thanatophoric dysplasia
DI   ORDO; Orphanet_2655; Thanatophoric dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P85 ! GM00714
SX   Male
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TD3
AC   CVCL_ZZ87
DR   Wikidata; Q102114974
RX   PubMed=7474117;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=40843; ! Macaca tonkeana (Tonkean macaque)
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   TD55-c15
AC   CVCL_RI82
DR   SKIP; SKIP001255
DR   Wikidata; Q54971906
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI80 ! TD55-c5
OI   CVCL_RI81 ! TD55-c6
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   TD55-c5
AC   CVCL_RI80
DR   SKIP; SKIP001253
DR   Wikidata; Q54971908
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI81 ! TD55-c6
OI   CVCL_RI82 ! TD55-c15
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   TD55-c6
AC   CVCL_RI81
DR   SKIP; SKIP001254
DR   Wikidata; Q54971909
RX   PubMed=27509850;
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI80 ! TD55-c5
OI   CVCL_RI82 ! TD55-c15
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TD59-c1
AC   CVCL_RI83
DR   SKIP; SKIP001256
DR   Wikidata; Q54971910
RX   PubMed=27509850;
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI84 ! TD59-c2
OI   CVCL_RI85 ! TD59-c4
SX   Male
AG   9Y10M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TD59-c2
AC   CVCL_RI84
DR   SKIP; SKIP001257
DR   Wikidata; Q54971912
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI83 ! TD59-c1
OI   CVCL_RI85 ! TD59-c4
SX   Male
AG   9Y10M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TD59-c4
AC   CVCL_RI85
DR   SKIP; SKIP001258
DR   Wikidata; Q54971913
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI83 ! TD59-c1
OI   CVCL_RI84 ! TD59-c2
SX   Male
AG   9Y10M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   TD63-c1
AC   CVCL_RI86
DR   SKIP; SKIP001259
DR   Wikidata; Q54971914
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI87 ! TD63-c3
OI   CVCL_RI88 ! TD63-c6
SX   Female
AG   19Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TD63-c3
AC   CVCL_RI87
DR   SKIP; SKIP001260
DR   Wikidata; Q54971915
RX   PubMed=27509850;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI86 ! TD63-c1
OI   CVCL_RI88 ! TD63-c6
SX   Female
AG   19Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TD63-c6
AC   CVCL_RI88
DR   SKIP; SKIP001261
DR   Wikidata; Q54971916
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI86 ! TD63-c1
OI   CVCL_RI87 ! TD63-c3
SX   Female
AG   19Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   TD70-c2
AC   CVCL_RI89
DR   SKIP; SKIP001262
DR   Wikidata; Q54971917
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI90 ! TD70-c4
OI   CVCL_RI91 ! TD70-c5
SX   Male
AG   9Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   TD70-c4
AC   CVCL_RI90
DR   SKIP; SKIP001263
DR   Wikidata; Q54971918
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI89 ! TD70-c2
OI   CVCL_RI91 ! TD70-c5
SX   Male
AG   9Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TD70-c5
AC   CVCL_RI91
DR   SKIP; SKIP001264
DR   Wikidata; Q54971919
RX   PubMed=27509850;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI89 ! TD70-c2
OI   CVCL_RI90 ! TD70-c4
SX   Male
AG   9Y3M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
ID   TDA2.3
AC   CVCL_B7EP
SY   HHUi001-A
DR   hPSCreg; HHUi001-A
DR   Wikidata; Q112930460
RX   PubMed=28132834;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C186788; Mitochondrial complex V (ATP synthase) deficiency, mitochondrial type 1
DI   ORDO; Orphanet_254913; Isolated ATP synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7EQ ! TFA2
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   TDA3.1
AC   CVCL_B7ER
SY   HHUi001-A
DR   hPSCreg; HHUi002-A
DR   Wikidata; Q112930461
RX   PubMed=28132834;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C186788; Mitochondrial complex V (ATP synthase) deficiency, mitochondrial type 1
DI   ORDO; Orphanet_254913; Isolated ATP synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   TDC2
AC   CVCL_LB92
SY   T-ALL derived Dendritic Cell line-2
DR   Wikidata; Q54971920
RX   Patent=EP2669367A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3168.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Dendritic cell; CL=CL_0000451.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   TDH6
AC   CVCL_A0QL
DR   Wikidata; Q108821363
RX   Patent=US10683364;
RX   Patent=US10730945;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   TDII,IAA11
AC   CVCL_B0C6
SY   TDII, IAA11
DR   Wikidata; Q108821364
RX   Patent=US5514553;
RX   PubMed=8020250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9966.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: Treponema denticola (strain ATCC 33520).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   TDIII,IIIBB2
AC   CVCL_B0C7
SY   TDIII, IIIBB2; TDIII IIIBB2
DR   Wikidata; Q108821365
RX   Patent=US4959304;
RX   PubMed=8020250;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9967.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: Treponema denticola (strain ATCC 33520).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   TDL-1
AC   CVCL_8428
DR   BioSample; SAMN03151883
DR   cancercelllines; CVCL_8428
DR   Wikidata; Q54971922
RX   PubMed=6248453;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a male patient with recurrent exudative tonsillitis.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00097.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   TDL-2
AC   CVCL_8429
DR   BioSample; SAMN03151884
DR   cancercelllines; CVCL_8429
DR   Wikidata; Q54971924
RX   PubMed=6248453;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a P3HR-1 derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a female patient with recurrent exudative tonsillitis.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00098.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163His (c.487T>C); ClinVar=VCV000376680; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu287Ter (c.859G>T); Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2676 ! P3HR-1
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   TDL-3
AC   CVCL_8430
DR   BioSample; SAMN03151909
DR   Wikidata; Q54971925
RX   PubMed=6248453;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RPMI-1788 derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a male patient with recurrent exudative tonsillitis.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00099.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2710 ! RPMI-1788
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   TDL-4
AC   CVCL_8431
DR   BioSample; SAMN03151900
DR   cancercelllines; CVCL_8431
DR   Cell_Model_Passport; SIDM00843
DR   Wikidata; Q54971926
RX   PubMed=6248453;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Raji derivative (PubMed=6248453; PubMed=20143388). Originally thought to be a tonsillar lymphoid cell line from a female patient with recurrent exudative tonsillitis.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00100.
CC   Population: African; Nigerian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   TDMM1
AC   CVCL_GS49
DR   Wikidata; Q54971938
RX   PubMed=15160996;
CC   From: Japanese Red Cross Medical Center; Tokyo; Japan.
CC   Population: Japanese.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 5
//
ID   TE
AC   CVCL_YD05
SY   Tilapia Eye
DR   Wikidata; Q98133213
RX   PubMed=31515819;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 25 to 32 Celsius, the optimal growth temperature is 28 Celsius.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   TE 112.T
AC   CVCL_S335
DR   ATCC; CRL-7742
DR   Wikidata; Q54971939
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7742; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   TE 114.T
AC   CVCL_S336
DR   ATCC; CRL-7743
DR   Wikidata; Q54971940
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7743; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   TE 115.T
AC   CVCL_1739
DR   CLO; CLO_0009288
DR   ATCC; CRL-7744
DR   BioSample; SAMN03471144
DR   Wikidata; Q54971941
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7744; true.
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7744
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   TE 125.T
AC   CVCL_1740
SY   TE-125-T; TE125T
DR   CLO; CLO_0009289
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7945
DR   ATCC; CRL-7945_FL
DR   BioSample; SAMN10988446
DR   cancercelllines; CVCL_1740
DR   Cell_Model_Passport; SIDM01763
DR   DepMap; ACH-000079
DR   LiGeA; CCLE_274
DR   PharmacoDB; TE125_T_1571_2019
DR   Progenetix; CVCL_1740
DR   Wikidata; Q54971943
RX   DOI=10.1101/166199;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a rhabdomyosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000079).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   HLA typing: A*02:06,11:01; B*35:21,51:01; C*04:01,15:09; DQA1*01:02,01:02; DRB1*13:02,15:66 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=5.57%; Native American=41.29%; East Asian, North=1.9%; East Asian, South=0.18%; South Asian=0%; European, North=25.13%; European, South=25.92% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7945; true.
CC   Discontinued: ATCC; CRL-7945_FL; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   TE 127.T
AC   CVCL_S337
DR   ATCC; CRL-7745
DR   Wikidata; Q54971944
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7745; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TE 130.T
AC   CVCL_1741
SY   TE 130_T
DR   CLO; CLO_0009290
DR   ATCC; CRL-7746
DR   BioSample; SAMN03471145
DR   Wikidata; Q54971945
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone, coccyx; UBERON=UBERON_0001350.
ST   Source(s): ATCC=CRL-7746
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13,14
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 12,15
ST   D21S11: 30,31.2
ST   D2S1338: 16,24
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 21,22.2
ST   Penta D: 12,13
ST   Penta E: 5,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C99055; Sacrococcygeal teratoma
DI   ORDO; Orphanet_494421; Sacrococcygeal teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   TE 131.T
AC   CVCL_S338
DR   ATCC; CRL-7747
DR   Wikidata; Q54971947
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7747; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 8
//
ID   TE 138.T
AC   CVCL_S262
DR   ATCC; CRL-7946
DR   Wikidata; Q54971948
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7946; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   TE 139.T
AC   CVCL_S339
DR   ATCC; CRL-7748
DR   Wikidata; Q54971949
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7748; true.
DI   NCIt; C3403; Teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TE 141.T
AC   CVCL_S340
DR   ATCC; CRL-7749
DR   Wikidata; Q54971950
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7749; true.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 143.T
AC   CVCL_S341
DR   ATCC; CRL-7750
DR   Wikidata; Q54971951
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7750; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   TE 149.T
AC   CVCL_1742
DR   CLO; CLO_0009291
DR   ATCC; CRL-7751
DR   Wikidata; Q54971952
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7751; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   TE 159.T
AC   CVCL_1743
SY   TE-159-T; TE-159.T; TE159T
DR   CLO; CLO_0009292
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7752
DR   BioSample; SAMN03471147
DR   BioSample; SAMN10988169
DR   cancercelllines; CVCL_1743
DR   Cell_Model_Passport; SIDM01761
DR   Cosmic; 686755
DR   DepMap; ACH-000175
DR   IARC_TP53; 30179
DR   LiGeA; CCLE_329
DR   PharmacoDB; TE159_T_1572_2019
DR   Progenetix; CVCL_1743
DR   Wikidata; Q54971953
RX   DOI=10.1101/166199;
RX   PubMed=12068308;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a rhabdomyosarcoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000175).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*02:01,11:01; B*15:01,52:01; C*04:01,12:02; DRB1*01:03,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=12068308).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175Leu (c.524G>T); ClinVar=VCV000182963; Zygosity=Unspecified (DepMap=ACH-000175).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Genome ancestry: African=1.8%; Native American=21.64%; East Asian, North=2.4%; East Asian, South=0%; South Asian=1.76%; European, North=45.27%; European, South=27.14% (PubMed=30894373).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): ATCC=CRL-7752
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D18S51: 16,21
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 19,23
ST   D3S1358: 14,15
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 23
ST   Penta D: 10
ST   Penta E: 12,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   TE 161.T
AC   CVCL_1744
SY   TE-161-T
DR   CLO; CLO_0009293
DR   ArrayExpress; E-MTAB-783
DR   ATCC; CRL-7753
DR   BioSample; SAMN03471146
DR   Cosmic; 909765
DR   IARC_TP53; 27706
DR   Wikidata; Q54971954
RX   PubMed=20164919;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; CRL-7753; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-7753
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 8,11
ST   D5S818: 12,13
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   TE 170.M
AC   CVCL_1745
DR   CLO; CLO_0009294
DR   ATCC; CRL-7754
DR   Wikidata; Q54971955
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7754; true.
CC   Derived from site: In situ; Fascia; UBERON=UBERON_0008982.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   TE 175.T
AC   CVCL_1746
SY   TE-175-T
DR   CLO; CLO_0009295
DR   ATCC; CRL-7755
DR   Cosmic; 683662
DR   Wikidata; Q54971956
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7755; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 10
//
ID   TE 189.T
AC   CVCL_S261
DR   ATCC; CRL-7947
DR   BioSample; SAMN03471128
DR   Wikidata; Q54971957
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7947; true.
ST   Source(s): ATCC=CRL-7947
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 8
//
ID   TE 193.T
AC   CVCL_S403
DR   ATCC; CRL-7756
DR   Wikidata; Q54971958
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7756; true.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 199.T
AC   CVCL_1747
DR   CLO; CLO_0009296
DR   ATCC; CRL-7757
DR   Wikidata; Q54971959
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7757; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   TE 206.T
AC   CVCL_1748
SY   TE-206-T
DR   CLO; CLO_0009297
DR   ATCC; CRL-7758
DR   Cosmic; 688124
DR   Cosmic; 909766
DR   IARC_TP53; 27707
DR   Wikidata; Q54971961
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7758; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   TE 210.T
AC   CVCL_N531
DR   ATCC; CRL-7759
DR   Wikidata; Q54971962
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7759; true.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 211.T
AC   CVCL_N532
DR   ATCC; CRL-7760
DR   Wikidata; Q54971963
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7760; true.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 353.Sk
AC   CVCL_1749
SY   TE 353.SK
DR   BTO; BTO_0005290
DR   CLO; CLO_0009298
DR   ATCC; CRL-7761
DR   BioSample; SAMN03471149
DR   Wikidata; Q54971964
RX   PubMed=21517135;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/origins-of-crl-7761-and-crl-7762
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7761
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 21
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 19,25
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1750 ! TE 354.T
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TE 354.T
AC   CVCL_1750
SY   TE354.T; TE354T
DR   CLO; CLO_0009299
DR   ATCC; CRL-7762
DR   BCRJ; 0290
DR   FANTOM5_SSTAR; 10702-109G9
DR   Wikidata; Q54971965
RX   PubMed=21517135;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/crl-7762-growth-and-morphology
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/origins-of-crl-7761-and-crl-7762
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Doubling time: Slow growth (Note=Recover slowly from cryopreservation and may take as long as 10-14 days to recover completely) (ATCC=CRL-7762).
CC   Discontinued: BCRJ; 0290; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7762
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 21
ST   D3S1358: 16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 19,25
ST   Penta D: 12,13
ST   Penta E: 7,13
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C2921; Skin basal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1749 ! TE 353.Sk
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   TE 381.T
AC   CVCL_1751
SY   TE-381-T; TE381T; RD114-B
DR   CLO; CLO_0009300
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CRL-7763
DR   cancercelllines; CVCL_1751
DR   Cosmic; 1309332
DR   IGRhCellID; TE381T
DR   Progenetix; CVCL_1751
DR   Wikidata; Q54971966
RX   PubMed=20215515;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Characteristics: Established through passage of the parent cell line in a fetal cat (ATCC=CRL-7763).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Omics: Variations; SNP array analysis.
CC   Caution: Wrongly indicated by ATCC to originate from a 7 week old female donor. Older product sheets of ATCC correctly indicated it originates from a 7 year old female.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): ATCC=CRL-7763
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13,18
ST   D19S433: 11
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TE 415.T
AC   CVCL_N279
DR   ATCC; CRL-7764
DR   Wikidata; Q54971967
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7764; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   TE 417.T
AC   CVCL_1752
DR   CLO; CLO_0009301
DR   ATCC; CRL-7765
DR   Wikidata; Q54971968
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7765; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TE 418.T
AC   CVCL_1753
DR   CLO; CLO_0009302
DR   ATCC; CRL-7766
DR   Wikidata; Q54971969
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7766; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TE 441.T
AC   CVCL_1754
SY   TE-441-T; TE441T
DR   CLO; CLO_0009303
DR   CLO; CLO_0037077
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7767
DR   BioSample; SAMN03471150
DR   BioSample; SAMN10988530
DR   cancercelllines; CVCL_1754
DR   Cell_Model_Passport; SIDM01173
DR   ChEMBL-Cells; CHEMBL3308304
DR   ChEMBL-Targets; CHEMBL2366268
DR   Cosmic; 687966
DR   Cosmic; 924248
DR   Cosmic; 1309327
DR   Cosmic-CLP; 924248
DR   DepMap; ACH-000772
DR   EGA; EGAS00001000978
DR   GDSC; 924248
DR   GEO; GSM887696
DR   GEO; GSM888789
DR   GEO; GSM1670534
DR   IARC_TP53; 27708
DR   LiGeA; CCLE_001
DR   LINCS_LDP; LCL-1413
DR   PharmacoDB; TE441_T_1573_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1754
DR   PubChem_Cell_line; CVCL_1754
DR   Wikidata; Q54971970
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: African American.
CC   HLA typing: A*03:01,24:02; B*15:01,44:03; C*02:02,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=87.48%; Native American=0.35%; East Asian, North=1.73%; East Asian, South=0%; South Asian=0.48%; European, North=4.76%; European, South=5.2% (PubMed=30894373).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
ST   Source(s): ATCC=CRL-7767; Cosmic-CLP=924248
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13,23
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 21,22
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 23,25
ST   Penta D: 2.2,8
ST   Penta E: 16
ST   TH01: 7,9
ST   TPOX: 7,8
ST   vWA: 15,16
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   TE 449.T
AC   CVCL_N603
DR   ATCC; CRL-7948
DR   Wikidata; Q54971971
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7948; true.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 453.T
AC   CVCL_S397
DR   ATCC; CRL-7768
DR   Wikidata; Q54971972
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7768; true.
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 491.T
AC   CVCL_S395
DR   ATCC; CRL-7769
DR   Wikidata; Q54971974
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7769; true.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 501.T
AC   CVCL_S394
DR   ATCC; CRL-7770
DR   Wikidata; Q54971975
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7770; true.
CC   Derived from site: In situ; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3167; Acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   TE 543.T
AC   CVCL_S396
DR   ATCC; CRL-7771
DR   Wikidata; Q54971976
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7771; true.
CC   Derived from site: In situ; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3211; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   TE 567.T
AC   CVCL_S404
DR   ATCC; CRL-7772
DR   Wikidata; Q54971977
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7772; true.
CC   Derived from site: In situ; Bone, coccyx; UBERON=UBERON_0001350.
DI   NCIt; C99055; Sacrococcygeal teratoma
DI   ORDO; Orphanet_494421; Sacrococcygeal teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   TE 585.T
AC   CVCL_S260
DR   ATCC; CRL-7949
DR   Wikidata; Q54971978
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7949; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   TE 596.T
AC   CVCL_S259
DR   ATCC; CRL-7950
DR   Wikidata; Q54971979
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7950; true.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 10
//
ID   TE 615.T
AC   CVCL_S098
DR   ATCC; CRL-7773
DR   Wikidata; Q54971980
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7773; true.
DI   NCIt; C3790; Ganglioneuroblastoma
DI   ORDO; Orphanet_251877; Ganglioneuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 617.T
AC   CVCL_1755
SY   TE-617-T; TE617T
DR   CLO; CLO_0009304
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7774
DR   BioSample; SAMN03471151
DR   BioSample; SAMN10988150
DR   cancercelllines; CVCL_1755
DR   Cell_Model_Passport; SIDM01760
DR   Cosmic; 1309328
DR   DepMap; ACH-000051
DR   GEO; GSM219749
DR   GEO; GSM887699
DR   GEO; GSM888792
DR   IARC_TP53; 30180
DR   LiGeA; CCLE_711
DR   PharmacoDB; TE617_T_1574_2019
DR   Progenetix; CVCL_1755
DR   Wikidata; Q54971981
RX   PubMed=19235922;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*24:03,24:03; B*07:02,51:09; C*01:02,01:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.43%; East Asian, North=0%; East Asian, South=0%; South Asian=2.79%; European, North=65.86%; European, South=29.92% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7774; true.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
ST   Source(s): ATCC=CRL-7774
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 13
ST   D5S818: 9,13
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   TE 671
AC   CVCL_1756
SY   TE-671; TE671; TE671/RD
DR   BTO; BTO_0002605
DR   CLO; CLO_0009305
DR   CLO; CLO_0009317
DR   CLDB; cl4495
DR   CLDB; cl4496
DR   CLDB; cl4497
DR   ATCC; HTB-139
DR   BioSample; SAMN03151901
DR   cancercelllines; CVCL_1756
DR   ChEMBL-Cells; CHEMBL3307468
DR   ChEMBL-Targets; CHEMBL615012
DR   CLS; 300355
DR   Cosmic; 970091
DR   DSMZ; ACC-263
DR   DSMZCellDive; ACC-263
DR   ECACC; 89071904
DR   IZSLER; BS TCL 64
DR   NCBI_Iran; C436
DR   PubChem_Cell_line; CVCL_1756
DR   Wikidata; Q54971989
RX   PubMed=892931;
RX   PubMed=2650908;
RX   PubMed=2739733;
RX   PubMed=2911385;
RX   PubMed=3335022;
RX   PubMed=6113887;
RX   PubMed=11416159;
RX   PubMed=11668190;
RX   PubMed=20143388;
RX   PubMed=24335698;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/te671-atcc-htb-139
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a RD derivative (PubMed=2650908; PubMed=2739733; PubMed=2911385; PubMed=20143388). Originally thought to originate from a 6 year old female patient with a medulloblastoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00101.
CC   Population: Caucasian.
CC   Doubling time: ~70-80 hours (DSMZ=ACC-263).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; HTB-139; true.
CC   Discontinued: DSMZ; ACC-263; true.
CC   Discontinued: ECACC; 89071904; true.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): ATCC=HTB-139; CLS=300355; DSMZ=ACC-263; PubMed=11416159
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 11,14
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1649 ! RD
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   TE 671 Subline No.2
AC   CVCL_2731
SY   TE671 Subline No.2; TE671 Subline 2; TE671 Line, subline 2
DR   CLO; CLO_0009318
DR   CLDB; cl4499
DR   CLDB; cl4500
DR   ATCC; CRL-8805
DR   BCRC; 60324
DR   BioSample; SAMN03151902
DR   cancercelllines; CVCL_2731
DR   CCRID; 1101HUM-PUMC000266
DR   ECACC; 94052610
DR   ICLC; HTL97021
DR   KCLB; 28805
DR   Wikidata; Q54971991
RX   Patent=US4789640;
RX   PubMed=2739733;
RX   PubMed=2911385;
RX   PubMed=2993532;
RX   PubMed=20143388;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/te671-sub-line-2-atcc-crl-8805
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00347.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8805.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=2993532).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-8805; true.
CC   Discontinued: BCRC; 60324; true.
CC   Discontinued: ECACC; 94052610; true.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): ATCC=CRL-8805; CCRID=1101HUM-PUMC000266
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 11,14
ST   D21S11: 28,29
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1756 ! TE 671
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
ID   TE 76.T
AC   CVCL_1757
DR   CLO; CLO_0009306
DR   ATCC; CRL-7732
DR   Wikidata; Q54971993
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7732; true.
CC   Derived from site: In situ; Bone, coccyx; UBERON=UBERON_0001350.
DI   NCIt; C99055; Sacrococcygeal teratoma
DI   ORDO; Orphanet_494421; Sacrococcygeal teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TE 79.T
AC   CVCL_S333
DR   ATCC; CRL-7733
DR   Wikidata; Q54971994
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7733; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   TE 84.T
AC   CVCL_1758
DR   CLO; CLO_0009307
DR   ATCC; CRL-7944
DR   Wikidata; Q54971995
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7944; true.
DI   NCIt; C8110; Ovarian teratoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   TE 86.T
AC   CVCL_S334
DR   ATCC; CRL-7736
DR   Wikidata; Q54971996
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7736; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Undefined cell line type
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 5
//
ID   TE 87.T
AC   CVCL_N533
DR   ATCC; CRL-7737
DR   Wikidata; Q54971997
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7737; true.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TE 89.T
AC   CVCL_N535
SY   TE-89
DR   ATCC; CRL-7738
DR   Wikidata; Q54971999
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7738; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   TE 90.Sk
AC   CVCL_2775
DR   CLO; CLO_0009308
DR   ATCC; CRL-7739
DR   BioSample; SAMN03471143
DR   Wikidata; Q54972000
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   Misspelling: TE9OSK; BioSample=SAMN03471143.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7739
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 22,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21,22.2
ST   Penta D: 10,12
ST   Penta E: 7,16
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   TE 91.Sk
AC   CVCL_2773
DR   CLO; CLO_0009309
DR   ATCC; CRL-7740
DR   Wikidata; Q54972002
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7740; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   TE 98.T
AC   CVCL_2774
DR   CLO; CLO_0009310
DR   ATCC; CRL-7741
DR   Wikidata; Q54972003
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7741; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   TE-1
AC   CVCL_1759
SY   TE1
DR   BTO; BTO_0004601
DR   CLO; CLO_0051369
DR   EFO; EFO_0022658
DR   ABM; T9161
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0371
DR   BioGRID_ORCS_Cell_line; 356
DR   BioSample; SAMN03472084
DR   BioSample; SAMN10988294
DR   cancercelllines; CVCL_1759
DR   CCRID; 3101HUMTCHu89
DR   Cell_Model_Passport; SIDM00369
DR   CGH-DB; 305-1
DR   CGH-DB; 9254-4
DR   ChEMBL-Cells; CHEMBL3308178
DR   ChEMBL-Targets; CHEMBL2366092
DR   CLS; 305060
DR   Cosmic; 730296
DR   Cosmic; 735780
DR   Cosmic; 753621
DR   Cosmic; 801322
DR   Cosmic; 923173
DR   Cosmic; 926097
DR   Cosmic; 983713
DR   Cosmic; 1043226
DR   Cosmic; 1123318
DR   Cosmic; 1612896
DR   Cosmic; 2650636
DR   Cosmic; 2698418
DR   Cosmic-CLP; 753621
DR   DepMap; ACH-000647
DR   EGA; EGAS00001000978
DR   GDSC; 753621
DR   GEO; GSM301571
DR   GEO; GSM887695
DR   GEO; GSM888788
DR   GEO; GSM1508955
DR   GEO; GSM1508959
DR   GEO; GSM1670528
DR   IARC_TP53; 6329
DR   KCB; KCB 200737YJ
DR   LiGeA; CCLE_791
DR   LINCS_LDP; LCL-1564
DR   PharmacoDB; TE1_1575_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1759
DR   PubChem_Cell_line; CVCL_1759
DR   RCB; RCB1894
DR   TKG; TKG 0252
DR   Wikidata; Q54972007
RX   DOI=10.1155/2014/376541;
RX   PubMed=520749;
RX   PubMed=1778766;
RX   PubMed=2302677;
RX   PubMed=2420787;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=8509434;
RX   PubMed=9096669;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=18973137;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28224081;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=36090890;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=520749).
CC   HLA typing: A*24:02,26:01; B*35:01,39:01; C*03:03,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (PubMed=9096669).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.32%; Native American=0%; East Asian, North=85.61%; East Asian, South=11.65%; South Asian=0%; European, North=0%; European, South=2.41% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): CCRID=3101HUMTCHu89; Cosmic-CLP=753621; RCB=RCB1894; TKG=TKG 0252
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 17
ST   D19S433: 14,15.2
ST   D21S11: 28
ST   D2S1338: 19,20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11 (CCRID=3101HUMTCHu89; Cosmic-CLP=753621; RCB=RCB1894)
ST   D7S820: 11 (TKG=TKG 0252)
ST   D8S1179: 11,13
ST   FGA: 24
ST   TH01: 7
ST   TPOX: 8,11 (Cosmic-CLP=753621; RCB=RCB1894; TKG=TKG 0252)
ST   TPOX: 11 (CCRID=3101HUMTCHu89)
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   TE-10
AC   CVCL_1760
SY   TE10
DR   CLO; CLO_0051372
DR   EFO; EFO_0022667
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1032
DR   BioSample; SAMN03472062
DR   BioSample; SAMN10987688
DR   cancercelllines; CVCL_1760
DR   CCRID; 3101HUMTCHu90
DR   Cell_Model_Passport; SIDM00349
DR   CGH-DB; 313-1
DR   CGH-DB; 9262-4
DR   ChEMBL-Cells; CHEMBL3308218
DR   ChEMBL-Targets; CHEMBL2366308
DR   Cosmic; 730351
DR   Cosmic; 735789
DR   Cosmic; 753622
DR   Cosmic; 923179
DR   Cosmic; 926106
DR   Cosmic; 947598
DR   Cosmic; 983722
DR   Cosmic; 1043232
DR   Cosmic; 1123327
DR   Cosmic; 1571760
DR   Cosmic; 1608836
DR   Cosmic; 2698425
DR   Cosmic-CLP; 753622
DR   DepMap; ACH-000318
DR   EGA; EGAS00001000978
DR   GDSC; 753622
DR   GEO; GSM887691
DR   GEO; GSM888784
DR   GEO; GSM1374957
DR   GEO; GSM1670529
DR   IARC_TP53; 6330
DR   LiGeA; CCLE_675
DR   LINCS_LDP; LCL-1565
DR   PharmacoDB; TE10_1576_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1760
DR   PubChem_Cell_line; CVCL_1760
DR   RCB; RCB2099
DR   TKG; TKG 0261
DR   Wikidata; Q54972008
RX   PubMed=8509434;
RX   PubMed=9023415;
RX   PubMed=9096669;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=11115554;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=20515944;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=25984343).
CC   HLA typing: A*02,24:02; C*01:02,03:02 (PubMed=9178645).
CC   HLA typing: A*02:19,24:02; B*51:01,56:01; C*01:02,14:02; DQB1*03:02,03:02; DRB1*01:01,13:17 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Tyr (c.725G>A); ClinVar=VCV000012354; Zygosity=Unspecified (PubMed=9096669).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=5.82%; Native American=0%; East Asian, North=81.86%; East Asian, South=7.66%; South Asian=0%; European, North=0%; European, South=4.65% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753622; RCB=RCB2099; TKG=TKG 0261
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 13
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   TE-11
AC   CVCL_1761
SY   TE11; Te11
DR   CLO; CLO_0051373
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472004
DR   BioSample; SAMN10988291
DR   cancercelllines; CVCL_1761
DR   CCRID; 3101HUMTCHu91
DR   Cell_Model_Passport; SIDM00348
DR   CGH-DB; 314-1
DR   CGH-DB; 9263-4
DR   ChEMBL-Cells; CHEMBL3308219
DR   ChEMBL-Targets; CHEMBL2366166
DR   Cosmic; 735827
DR   Cosmic; 923180
DR   Cosmic; 926107
DR   Cosmic; 946354
DR   Cosmic; 947599
DR   Cosmic; 1043233
DR   Cosmic; 1123328
DR   Cosmic; 1571761
DR   Cosmic; 2698426
DR   Cosmic-CLP; 946354
DR   DepMap; ACH-000488
DR   EGA; EGAS00001000978
DR   GDSC; 946354
DR   GEO; GSM887692
DR   GEO; GSM888785
DR   GEO; GSM1670530
DR   IARC_TP53; 21663
DR   LiGeA; CCLE_167
DR   LINCS_LDP; LCL-1566
DR   PharmacoDB; TE11_1577_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1761
DR   PubChem_Cell_line; CVCL_1761
DR   RCB; RCB2100
DR   TKG; TKG 0262
DR   Wikidata; Q54972009
RX   PubMed=7732013;
RX   PubMed=8509434;
RX   PubMed=9023415;
RX   PubMed=9096669;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=10741724;
RX   PubMed=11115554;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; C*14:01 (PubMed=9178645).
CC   HLA typing: A*24:02,24:02; B*51:01,51:01; C*03:04,03:04; DQB1*06:07,06:07 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Leu (c.329G>T); ClinVar=VCV000406597; Zygosity=Unspecified (PubMed=7732013; PubMed=10741724).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=89.62%; East Asian, South=10.38%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=946354; RCB=RCB2100; TKG=TKG 0262
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 10
ST   D16S539: 10,11
ST   D5S818: 8,14
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   TE-12
AC   CVCL_1762
SY   TE12
DR   CLO; CLO_0009937
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03151963
DR   Cell_Model_Passport; SIDM00023
DR   ChEMBL-Cells; CHEMBL3308220
DR   ChEMBL-Targets; CHEMBL2366278
DR   Cosmic; 735790
DR   Cosmic; 801329
DR   Cosmic; 923181
DR   Cosmic; 926108
DR   Cosmic; 946356
DR   Cosmic; 947600
DR   Cosmic; 1043234
DR   Cosmic; 1123329
DR   Cosmic-CLP; 946356
DR   DepMap; ACH-002311
DR   EGA; EGAS00001000978
DR   GDSC; 946356
DR   GEO; GSM1374958
DR   GEO; GSM1670531
DR   IARC_TP53; 27586
DR   LINCS_LDP; LCL-1567
DR   PharmacoDB; TE12_1578_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1762
DR   TKG; TKG 0263
DR   Wikidata; Q54972010
RX   PubMed=8509434;
RX   PubMed=9290701;
RX   PubMed=17804709;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00273.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.13%; East Asian, North=76.19%; East Asian, South=22.61%; South Asian=0.51%; European, North=0.56%; European, South=0% (PubMed=30894373).
CC   Discontinued: TKG; TKG 0263; probable.
ST   Source(s): Cosmic-CLP=946356
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4455 ! TE-2
OI   CVCL_9971 ! TE-3
OI   CVCL_9972 ! TE-7
OI   CVCL_4463 ! TE-13
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   TE-13
AC   CVCL_4463
SY   TE13
DR   BTO; BTO_0004599
DR   BioSample; SAMN03151964
DR   Cell_Model_Passport; SIDM00076
DR   CGH-DB; 315-1
DR   CGH-DB; 9264-4
DR   Cosmic; 730362
DR   Cosmic; 735791
DR   Cosmic; 923182
DR   Cosmic; 926109
DR   Cosmic; 947601
DR   Cosmic; 1043235
DR   Cosmic; 1123330
DR   Cosmic; 1612899
DR   Cosmic; 2698427
DR   TKG; TKG 0264
DR   Wikidata; Q54972011
RX   PubMed=8509434;
RX   PubMed=9096669;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00274.
CC   Population: Japanese.
CC   Discontinued: TKG; TKG 0264; probable.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4455 ! TE-2
OI   CVCL_9971 ! TE-3
OI   CVCL_9972 ! TE-7
OI   CVCL_1762 ! TE-12
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   TE-14
AC   CVCL_3336
SY   TE14
DR   CLO; CLO_0051374
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472005
DR   BioSample; SAMN10987745
DR   cancercelllines; CVCL_3336
DR   Cell_Model_Passport; SIDM01762
DR   CGH-DB; 316-1
DR   Cosmic; 983723
DR   Cosmic; 1043236
DR   Cosmic; 1123331
DR   Cosmic; 2698428
DR   DepMap; ACH-000726
DR   GEO; GSM887693
DR   GEO; GSM888786
DR   IARC_TP53; 28340
DR   LiGeA; CCLE_147
DR   PharmacoDB; TE14_1579_2019
DR   Progenetix; CVCL_3336
DR   RCB; RCB2101
DR   TKG; TKG 0265
DR   Wikidata; Q54972012
RX   PubMed=8509434;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*11:01,11:01; B*07:02,48:01; C*08:01,08:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (DepMap=ACH-000726).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (DepMap=ACH-000726).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.44%; Native American=0%; East Asian, North=83.33%; East Asian, South=9.3%; South Asian=0%; European, North=0%; European, South=3.92% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): RCB=RCB2101; TKG=TKG 0265
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 10
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   TE-15
AC   CVCL_1763
SY   TE15; Te15
DR   BTO; BTO_0004598
DR   CLO; CLO_0051370
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472042
DR   BioSample; SAMN10988301
DR   cancercelllines; CVCL_1763
DR   Cell_Model_Passport; SIDM00249
DR   CGH-DB; 317-1
DR   CGH-DB; 9266-4
DR   ChEMBL-Cells; CHEMBL3308221
DR   ChEMBL-Targets; CHEMBL2366086
DR   Cosmic; 753614
DR   Cosmic; 923183
DR   Cosmic; 983724
DR   Cosmic; 1043237
DR   Cosmic; 1123332
DR   Cosmic; 1612900
DR   Cosmic; 2698429
DR   Cosmic-CLP; 753614
DR   DepMap; ACH-000353
DR   EGA; EGAS00001000978
DR   GDSC; 753614
DR   GEO; GSM887694
DR   GEO; GSM888787
DR   GEO; GSM1670532
DR   IARC_TP53; 6332
DR   LiGeA; CCLE_057
DR   LINCS_LDP; LCL-1568
DR   PharmacoDB; TE15_1580_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1763
DR   PubChem_Cell_line; CVCL_1763
DR   RCB; RCB1951
DR   TKG; TKG 0266
DR   Wikidata; Q54972013
RX   PubMed=8509434;
RX   PubMed=9096669;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>A; ClinVar=VCV000634769; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=9096669).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.86%; East Asian, South=15.31%; South Asian=0.83%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753614; RCB=RCB1951; TKG=TKG 0266
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 9
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 15,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   TE-1R
AC   CVCL_C3M0
DR   Wikidata; Q116050640
RX   PubMed=36090890;
CC   Population: Japanese.
CC   Characteristics: Radioresistant. Was irradiated at 1 Gy three times, at 2 Gy three times and 4 Gy three times (PubMed=36090890).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Met (c.814G>A); ClinVar=VCV000185814; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1759 ! TE-1
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   TE-2
AC   CVCL_4455
SY   TE2
DR   BTO; BTO_0002866
DR   BioSample; SAMN03151965
DR   cancercelllines; CVCL_4455
DR   Cell_Model_Passport; SIDM00022
DR   CGH-DB; 306-1
DR   CGH-DB; 9255-4
DR   ChEMBL-Cells; CHEMBL3307467
DR   ChEMBL-Targets; CHEMBL615011
DR   Cosmic; 730307
DR   Cosmic; 735782
DR   Cosmic; 801323
DR   Cosmic; 923174
DR   Cosmic; 926098
DR   Cosmic; 947595
DR   Cosmic; 983714
DR   Cosmic; 1123319
DR   Cosmic; 1612897
DR   Cosmic; 2650637
DR   Cosmic; 2698419
DR   GEO; GSM301572
DR   Progenetix; CVCL_4455
DR   PubChem_Cell_line; CVCL_4455
DR   RCB; RCB1948
DR   TKG; TKG 0253
DR   Wikidata; Q54972015
RX   PubMed=520749;
RX   PubMed=1778766;
RX   PubMed=2302677;
RX   PubMed=2420787;
RX   PubMed=2990217;
RX   PubMed=3518877;
RX   PubMed=8509434;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=18973137;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388). TE-2 was originally thought to originate from the primary tumor of the intrathoracic esophagus of a 57 year old Japanese male.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00275.
CC   Population: Japanese.
CC   Doubling time: 72 hours (PubMed=520749).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: RCB; RCB1948; true.
CC   Discontinued: TKG; TKG 0253; true.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9971 ! TE-3
OI   CVCL_9972 ! TE-7
OI   CVCL_1762 ! TE-12
OI   CVCL_4463 ! TE-13
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   TE-3
AC   CVCL_9971
SY   TE3
DR   BioSample; SAMN03151966
DR   cancercelllines; CVCL_9971
DR   Cell_Model_Passport; SIDM00021
DR   CGH-DB; 9256-4
DR   Cosmic; 730318
DR   Cosmic; 735783
DR   Cosmic; 801324
DR   Cosmic; 923175
DR   Cosmic; 926099
DR   Cosmic; 932977
DR   Cosmic; 947596
DR   Cosmic; 983715
DR   Cosmic; 1043227
DR   Cosmic; 1123320
DR   Cosmic; 2650638
DR   GEO; GSM301573
DR   GEO; GSM1374959
DR   Progenetix; CVCL_9971
DR   TKG; TKG 0254
DR   Wikidata; Q54972016
RX   PubMed=1778766;
RX   PubMed=2302677;
RX   PubMed=2420787;
RX   PubMed=8509434;
RX   PubMed=9096669;
RX   PubMed=9290701;
RX   PubMed=17804709;
RX   PubMed=18973137;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00276.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Misspelling: TIE-3; Note=Occasionally. And more specifically in a number of papers that seem to be produced by paper mills.
CC   Discontinued: TKG; TKG 0254; probable.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4455 ! TE-2
OI   CVCL_9972 ! TE-7
OI   CVCL_1762 ! TE-12
OI   CVCL_4463 ! TE-13
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   TE-4
AC   CVCL_3337
SY   TE4
DR   CLO; CLO_0051377
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1033
DR   BioSample; SAMN03472060
DR   BioSample; SAMN10987722
DR   cancercelllines; CVCL_3337
DR   Cell_Model_Passport; SIDM00250
DR   CGH-DB; 307-1
DR   CGH-DB; 9257-4
DR   Cosmic; 735828
DR   Cosmic; 801325
DR   Cosmic; 926100
DR   Cosmic; 983716
DR   Cosmic; 1123321
DR   Cosmic; 1571757
DR   Cosmic; 2546865
DR   Cosmic; 2650639
DR   Cosmic; 2698420
DR   Cosmic-CLP; 1503371
DR   DepMap; ACH-000917
DR   EGA; EGAS00001000978
DR   GDSC; 1503371
DR   GEO; GSM887697
DR   GEO; GSM888790
DR   GEO; GSM1670533
DR   IARC_TP53; 28308
DR   LiGeA; CCLE_429
DR   PharmacoDB; TE4_1581_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3337
DR   RCB; RCB2097
DR   TKG; TKG 0255
DR   Wikidata; Q54972017
RX   PubMed=2420787;
RX   PubMed=8509434;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17325662;
RX   PubMed=17804709;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   HLA typing: A*02:07,11:01; B*46:01,54:01; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ter404Leuext*8 (c.1211G>T); Zygosity=Homozygous (Cosmic-CLP=1503371; DepMap=ACH-000917).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Homozygous (Cosmic-CLP=1503371; DepMap=ACH-000917).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.46%; Native American=0%; East Asian, North=82.3%; East Asian, South=12.31%; South Asian=0%; European, North=0%; European, South=2.93% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=1503371; RCB=RCB2097; TKG=TKG 0255
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   TE-5
AC   CVCL_1764
SY   TE5
DR   CLO; CLO_0051375
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 449
DR   BioSample; SAMN03472039
DR   BioSample; SAMN10988298
DR   cancercelllines; CVCL_1764
DR   Cell_Model_Passport; SIDM00347
DR   CGH-DB; 308-1
DR   CGH-DB; 9258-4
DR   ChEMBL-Cells; CHEMBL3308179
DR   ChEMBL-Targets; CHEMBL2366245
DR   Cosmic; 735784
DR   Cosmic; 801326
DR   Cosmic; 923176
DR   Cosmic; 926101
DR   Cosmic; 947597
DR   Cosmic; 983717
DR   Cosmic; 1043228
DR   Cosmic; 1123322
DR   Cosmic; 2650640
DR   Cosmic; 2698421
DR   Cosmic-CLP; 735784
DR   DepMap; ACH-000408
DR   EGA; EGAS00001000978
DR   GDSC; 735784
DR   GEO; GSM887698
DR   GEO; GSM888791
DR   GEO; GSM1508956
DR   GEO; GSM1508960
DR   GEO; GSM1670535
DR   IARC_TP53; 21662
DR   LiGeA; CCLE_067
DR   LINCS_LDP; LCL-1569
DR   PharmacoDB; TE5_1582_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1764
DR   PubChem_Cell_line; CVCL_1764
DR   RCB; RCB1949
DR   TKG; TKG 0256
DR   Wikidata; Q54972018
RX   DOI=10.1155/2014/376541;
RX   PubMed=7732013;
RX   PubMed=8509434;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=27397505;
RX   PubMed=28224081;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val272Leu (c.814G>T); ClinVar=VCV000012358; Zygosity=Unspecified (PubMed=7732013).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.34%; Native American=0.66%; East Asian, North=86.45%; East Asian, South=11.83%; South Asian=0.36%; European, North=0%; European, South=0.36% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=735784; RCB=RCB1949; TKG=TKG 0256
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 10
ST   D16S539: 9,10
ST   D5S818: 9
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   TE-6
AC   CVCL_1765
SY   TE6
DR   BTO; BTO_0002867
DR   CLO; CLO_0051376
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BCRJ; 0372
DR   BioSample; SAMN03472040
DR   BioSample; SAMN10987703
DR   cancercelllines; CVCL_1765
DR   Cell_Model_Passport; SIDM00328
DR   CGH-DB; 309-1
DR   CGH-DB; 9259-4
DR   ChEMBL-Cells; CHEMBL3308180
DR   ChEMBL-Targets; CHEMBL2366144
DR   Cosmic; 735785
DR   Cosmic; 801327
DR   Cosmic; 926102
DR   Cosmic; 946355
DR   Cosmic; 983718
DR   Cosmic; 1123323
DR   Cosmic; 1571758
DR   Cosmic; 2698422
DR   Cosmic-CLP; 946355
DR   DepMap; ACH-000605
DR   EGA; EGAS00001000978
DR   GDSC; 946355
DR   GEO; GSM887700
DR   GEO; GSM888793
DR   GEO; GSM1670536
DR   LiGeA; CCLE_742
DR   LINCS_LDP; LCL-1570
DR   PharmacoDB; TE6_1583_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1765
DR   PubChem_Cell_line; CVCL_1765
DR   RCB; RCB1950
DR   TKG; TKG 0257
DR   Wikidata; Q54972019
RX   PubMed=8509434;
RX   PubMed=9096669;
RX   PubMed=9290701;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*40:06,40:06; C*03:03,08:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.98%; Native American=0%; East Asian, North=84.09%; East Asian, South=13.31%; South Asian=0%; European, North=0%; European, South=1.62% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=946355; RCB=RCB1950; TKG=TKG 0257
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 12
ST   vWA: 17,19
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   TE-6/Hypo
AC   CVCL_8325
DR   Wikidata; Q54972020
RX   PubMed=21965748;
CC   Population: Japanese.
CC   Characteristics: Hypoxia-resistant.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1765 ! TE-6
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   TE-7
AC   CVCL_9972
SY   TE7
DR   BioSample; SAMN03151967
DR   cancercelllines; CVCL_9972
DR   Cell_Model_Passport; SIDM00066
DR   CGH-DB; 310-1
DR   Cosmic; 735786
DR   Cosmic; 926103
DR   Cosmic; 983719
DR   Cosmic; 1043229
DR   Cosmic; 1123324
DR   Cosmic; 1571759
DR   GEO; GSM482500
DR   GEO; GSM827183
DR   GEO; GSM1374960
DR   Progenetix; CVCL_9972
DR   RCB; RCB1893
DR   TKG; TKG 0258
DR   Wikidata; Q54972021
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=8509434;
RX   PubMed=9096669;
RX   PubMed=9290701;
RX   PubMed=11520067;
RX   PubMed=16364037;
RX   PubMed=17804709;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=23795680;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. TE-2, TE-3, TE-7, TE-12 and TE-13 have been shown to be identical (PubMed=17804709; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00277.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: RCB; RCB1893; true.
CC   Discontinued: TKG; TKG 0258; true.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4455 ! TE-2
OI   CVCL_9971 ! TE-3
OI   CVCL_1762 ! TE-12
OI   CVCL_4463 ! TE-13
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   TE-71
AC   CVCL_D3RA
DR   Wikidata; Q127384379
RX   PubMed=1374092;
RX   PubMed=1402691;
RX   PubMed=2467751;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6W
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   TE-75
AC   CVCL_D3RB
DR   Wikidata; Q127384380
RX   PubMed=2467751;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6W
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   TE-8
AC   CVCL_1766
SY   TE8
DR   BTO; BTO_0004600
DR   CLO; CLO_0051371
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1035
DR   BioSample; SAMN03472061
DR   BioSample; SAMN10987746
DR   cancercelllines; CVCL_1766
DR   Cell_Model_Passport; SIDM00326
DR   CGH-DB; 311-1
DR   CGH-DB; 9260-4
DR   ChEMBL-Cells; CHEMBL3308525
DR   ChEMBL-Targets; CHEMBL2366182
DR   Cosmic; 730329
DR   Cosmic; 735787
DR   Cosmic; 753623
DR   Cosmic; 801328
DR   Cosmic; 923177
DR   Cosmic; 926104
DR   Cosmic; 983720
DR   Cosmic; 1043230
DR   Cosmic; 1123325
DR   Cosmic; 1612898
DR   Cosmic; 2546866
DR   Cosmic; 2698423
DR   Cosmic-CLP; 753623
DR   DepMap; ACH-000452
DR   EGA; EGAS00001000978
DR   GDSC; 753623
DR   GEO; GSM887701
DR   GEO; GSM888794
DR   GEO; GSM1508957
DR   GEO; GSM1508961
DR   GEO; GSM1670537
DR   IARC_TP53; 27259
DR   LiGeA; CCLE_475
DR   LINCS_LDP; LCL-1571
DR   PharmacoDB; TE8_1584_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1766
DR   PubChem_Cell_line; CVCL_1766
DR   RCB; RCB2098
DR   TKG; TKG 0259
DR   Wikidata; Q54972022
RX   DOI=10.1155/2014/376541;
RX   PubMed=8509434;
RX   PubMed=9023415;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=11115554;
RX   PubMed=15172977;
RX   PubMed=17325662;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=20515944;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28224081;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:01; B*55; C*01:02 (PubMed=9178645).
CC   HLA typing: A*26:01,26:01; B*55:02,55:02; C*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (DepMap=ACH-000452).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Homozygous (Cosmic-CLP=753623; DepMap=ACH-000452).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.28%; Native American=0%; East Asian, North=88.72%; East Asian, South=6.31%; South Asian=0%; European, North=0%; European, South=3.7% (PubMed=30894373).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Cosmic-CLP=753623; RCB=RCB2098; TKG=TKG 0259
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 8,9 (RCB=RCB2098; TKG=TKG 0259)
ST   TPOX: 9 (Cosmic-CLP=753623)
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   TE-85-SF
AC   CVCL_YE14
DR   cancercelllines; CVCL_YE14
DR   Wikidata; Q98133214
RX   PubMed=6575958;
CC   Group: Serum/protein free medium cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0439 ! MNNG/HOS Cl #5
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 12
//
ID   TE-9
AC   CVCL_1767
SY   TE9; Te9
DR   CLO; CLO_0051379
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1036
DR   BioSample; SAMN03472053
DR   BioSample; SAMN10987930
DR   cancercelllines; CVCL_1767
DR   Cell_Model_Passport; SIDM00325
DR   CGH-DB; 312-1
DR   CGH-DB; 9261-4
DR   ChEMBL-Cells; CHEMBL3308181
DR   ChEMBL-Targets; CHEMBL2366147
DR   Cosmic; 730340
DR   Cosmic; 735788
DR   Cosmic; 923178
DR   Cosmic; 926105
DR   Cosmic; 946353
DR   Cosmic; 983721
DR   Cosmic; 1043231
DR   Cosmic; 1123326
DR   Cosmic; 2698424
DR   Cosmic-CLP; 946353
DR   DepMap; ACH-000694
DR   EGA; EGAS00001000978
DR   GDSC; 946353
DR   GEO; GSM887702
DR   GEO; GSM888795
DR   GEO; GSM1670538
DR   LiGeA; CCLE_624
DR   LINCS_LDP; LCL-1572
DR   PharmacoDB; TE9_1585_2019
DR   PRIDE; PXD002486
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1767
DR   PubChem_Cell_line; CVCL_1767
DR   RCB; RCB1988
DR   TKG; TKG 0260
DR   TKG; TKG 0572
DR   Wikidata; Q54972023
RX   PubMed=8509434;
RX   PubMed=9023415;
RX   PubMed=9096669;
RX   PubMed=9178645;
RX   PubMed=9290701;
RX   PubMed=11115554;
RX   PubMed=15172977;
RX   PubMed=17804709;
RX   PubMed=20164919;
RX   PubMed=20515944;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 25 hours (PubMed=25984343).
CC   HLA typing: A*33:02; B*15:03 (PubMed=9023415).
CC   HLA typing: A*24:02,24:02; B*15:07,40:06; C*03:03,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.49%; East Asian, North=84.82%; East Asian, South=14.68%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Discontinued: TKG; TKG 0572; probable.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=946353; RCB=RCB1988; TKG=TKG 0260
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   TE-FLY-A8
AC   CVCL_9U63
SY   TEFLY-A8; TEFLY A8; TEFLYA8
DR   cancercelllines; CVCL_9U63
DR   Wikidata; Q54972025
CC   Group: Retrovirus packaging cell line.
CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1756 ! TE 671
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   TE-FLY-GALV
AC   CVCL_9U64
SY   TE-FLYGALV
DR   cancercelllines; CVCL_9U64
DR   Wikidata; Q54972026
RX   PubMed=10022544;
CC   Group: Retrovirus packaging cell line.
CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P21415; Gibbon ape leukemia virus (GALV) env.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1756 ! TE 671
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   TE1
AC   CVCL_C6K3
DR   ABCD; ABCD_AF115
DR   Wikidata; Q116050641
RX   PubMed=8958042;
CC   Monoclonal antibody isotype: IgE, kappa.
CC   Monoclonal antibody target: UniProtKB; P09989; Trichosanthes kirilowii ribosome-inactivating protein alpha-trichosanthin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TE110
AC   CVCL_A1FS
DR   Cosmic; 2808233
DR   Wikidata; Q102114975
RX   PubMed=8220424;
RX   PubMed=8344493;
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 4
//
ID   TE15
AC   CVCL_F780
SY   TE-15; 18G3.cl 1
DR   CLO; CLO_0009311
DR   ATCC; HB-206
DR   Wikidata; Q54972028
RX   PubMed=2578044;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on Hassall's corpuscles.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   TE16
AC   CVCL_F781
SY   TE-16; 8F11.cl 2
DR   CLO; CLO_0009312
DR   ATCC; HB-210
DR   Wikidata; Q54972029
RX   PubMed=2578044;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human antigen on Hassall's corpuscles.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   TE19
AC   CVCL_F782
SY   TE-19; 11G8.cl 2-1.8
DR   CLO; CLO_0009313
DR   ATCC; HB-211
DR   Wikidata; Q54972030
RX   PubMed=2578044;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on Hassall's corpuscles.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   TE2
AC   CVCL_C6K4
DR   ABCD; ABCD_AF112
DR   Wikidata; Q116050642
RX   PubMed=8958042;
CC   Monoclonal antibody isotype: IgE, kappa.
CC   Monoclonal antibody target: UniProtKB; P09989; Trichosanthes kirilowii ribosome-inactivating protein alpha-trichosanthin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TE3 [Mouse hybridoma against human thymic antigen]
AC   CVCL_F783
SY   TE3A; TE-3A
DR   CLO; CLO_0009314
DR   ATCC; HB-209
DR   Wikidata; Q54972032
RX   PubMed=6205074;
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: Human thymic cortical epithelium antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   TE3 [Mouse hybridoma against T.kirilowii trichosanthin]
AC   CVCL_C6K5
SY   1G4
DR   Wikidata; Q116050643
RX   PubMed=8958042;
CC   Monoclonal antibody isotype: IgE, kappa.
CC   Monoclonal antibody target: UniProtKB; P09989; Trichosanthes kirilowii ribosome-inactivating protein alpha-trichosanthin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Te39
AC   CVCL_3801
SY   Te-39
DR   CLO; CLO_0009315
DR   ATCC; HB-8577
DR   Wikidata; Q54972033
RX   Patent=US4695538;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8577.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   TE4 [Macaca LCL]
AC   CVCL_ZZ88
DR   Wikidata; Q102114976
RX   PubMed=7474117;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=40843; ! Macaca tonkeana (Tonkean macaque)
SX   Female
AG   3Y
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   TE4 [Mouse hybridoma against human thymic antigen]
AC   CVCL_F784
SY   TE-4
DR   CLO; CLO_0009316
DR   ATCC; HB-207
DR   Wikidata; Q54972034
RX   PubMed=6200562;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human thymic endocrine epithelium antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   TE4 [Mouse hybridoma against T.kirilowii trichosanthin]
AC   CVCL_C6K6
SY   4C8
DR   ABCD; ABCD_AF113
DR   Wikidata; Q116050644
RX   PubMed=8958042;
CC   Monoclonal antibody isotype: IgE, kappa.
CC   Monoclonal antibody target: UniProtKB; P09989; Trichosanthes kirilowii ribosome-inactivating protein alpha-trichosanthin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TE7
AC   CVCL_F785
SY   TE-7
DR   CLO; CLO_0009319
DR   ATCC; HB-208
DR   Wikidata; Q54972035
RX   PubMed=6200562;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human thymic stroma antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   TE8
AC   CVCL_F786
SY   TE-8; 10A3.cl 1
DR   CLO; CLO_0009320
DR   ATCC; HB-212
DR   Wikidata; Q54972036
RX   PubMed=2578044;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human antigen on Hassall's corpuscles.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   TEC
AC   CVCL_J026
SY   Turbot Embryonic Cell line
DR   Wikidata; Q54972044
RX   CelloPub=CLPUB00053;
RX   DOI=10.1016/j.aquaculture.2005.01.031;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gastrula; UBERON=UBERON_0004734.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   TEC-11
AC   CVCL_A0RT
SY   2G11; TEC11; Tumor endothelial cell antibody 11
DR   Wikidata; Q108821366
RX   Patent=US5660827;
RX   Patent=US5877289;
RX   PubMed=9815965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12311.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   TEC-4
AC   CVCL_A0RU
SY   1G4; TEC4; Tumor endothelial cell antibody 4
DR   ATCC; HB-12312
DR   Wikidata; Q108821367
RX   Patent=US5660827;
RX   Patent=US5877289;
RX   PubMed=9815965;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12312.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P17813; Human ENG/CD105.
CC   Caution: The myeloma fusion partner is indicated to be Sp2/0-Ag14 in Patent=US5660827 and Patent=US5877289 and to be P3X63Ag8.653 (Cellosaurus=CVCL_4032) in PubMed=9815965.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 30-01-24; Version: 4
//
ID   TEC-84
AC   CVCL_E7D2
RX   PubMed=21296124;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   TEC-Dl1
AC   CVCL_E7GS
RX   PubMed=21296124;
CC   Characteristics: Transduced with a retroviral construct Dll1-IRES-eGFP thereby allowing bicistronic expression of Dll1 and eGFP (PubMed=21296124).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104659; Dll1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7D2 ! TEC-84
SX   Sex unspecified
AG   Children
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   TEC1-2
AC   CVCL_A8V8
DR   Wikidata; Q102114977
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   TEC1-2C1
AC   CVCL_A8V9
DR   Wikidata; Q102114978
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A8V8 ! TEC1-2
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1-2C2
AC   CVCL_A8W0
DR   Wikidata; Q102114979
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A8V8 ! TEC1-2
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1-3
AC   CVCL_A8W1
DR   Wikidata; Q102114980
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1-4
AC   CVCL_A8W2
DR   Wikidata; Q102114982
RX   PubMed=1988159;
RX   PubMed=8343964;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1-4C18
AC   CVCL_A8W3
SY   TEC 1-4C18
DR   Wikidata; Q102114983
RX   PubMed=1534114;
RX   PubMed=8343964;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A8W2 ! TEC1-4
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1C5
AC   CVCL_A8W4
DR   Wikidata; Q102114984
RX   PubMed=1988159;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   TEC1C6
AC   CVCL_A8W5
SY   TEC 1C6
DR   Wikidata; Q102114985
RX   PubMed=1534114;
RX   PubMed=1988159;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1C8
AC   CVCL_A8W6
DR   RCB; RCB4566
DR   Wikidata; Q102114986
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC1C9
AC   CVCL_A8W7
DR   Wikidata; Q102114988
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Cortical thymic epithelial cell; CL=CL_0002364.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC2-3
AC   CVCL_A8W8
DR   RCB; RCB4568
DR   Wikidata; Q102114989
RX   PubMed=1534114;
RX   PubMed=1988159;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC3-10
AC   CVCL_A8W9
DR   RCB; RCB4569
DR   Wikidata; Q102114990
RX   PubMed=1534114;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   0-2W
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TEC61
AC   CVCL_7167
DR   BioSample; SAMN03151803
DR   ECACC; 06031505
DR   Wikidata; Q54972045
RX   PubMed=12388152;
RX   PubMed=19625678;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a JEG-3 derivative (PubMed=20143388). Originally thought to be a thyroid endothelial cell.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00364.
CC   Population: Caucasian.
CC   Caution: PubMed=19625678 is a retractation of PubMed=12388152.
CC   Discontinued: ECACC; 06031505; true.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0363 ! JEG-3
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   TEK
AC   CVCL_F245
SY   Timus Embrion Korova
DR   CLO; CLO_0009321
DR   CLDB; cl4502
DR   CCLV; CCLV-RIE 0063
DR   Wikidata; Q54972046
CC   Derived from site: In situ; Fetal thymus; UBERON=UBERON_0005562.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   TEL-2
AC   CVCL_JZ63
DR   Wikidata; Q54972047
RX   PubMed=1968393;
RX   PubMed=8742694;
CC   Doubling time: ~20 hours (PubMed=1968393).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2W
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 6
//
ID   Tel12
AC   CVCL_EE25
SY   Tel#12; Telomerase 12; HFF TEL 12
DR   Wikidata; Q54972048
RX   PubMed=11044129;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Telomerase immortalized cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 8
//
ID   Tel2 F/- P53 -/- (#9136-1)
AC   CVCL_UE16
SY   Tel2 F/- P53 -/-(#9136-1)
DR   ATCC; CRL-3324
DR   Wikidata; Q98133215
CC   Characteristics: Has loxP sites on both sides of the second coding exon of mouse Tel2. Tel2 knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3324).
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   TELac2
AC   CVCL_9U65
SY   TElac2
DR   cancercelllines; CVCL_9U65
DR   Wikidata; Q54972050
RX   PubMed=7494248;
RX   PubMed=10022544;
CC   Group: Retrovirus packaging cell line.
CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1756 ! TE 671
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   TELCeB6
AC   CVCL_9U66
DR   cancercelllines; CVCL_9U66
DR   Wikidata; Q54972051
RX   PubMed=7494248;
RX   PubMed=10022544;
CC   Group: Retrovirus packaging cell line.
CC   Problematic cell line: Contaminated. Grand-parent cell line (TE 671) has been shown to be a RD derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03355; Moloney murine leukemia virus (MoMLV) gag-pol.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9U65 ! TELac2
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 16
//
ID   TelCOFS02MA
AC   CVCL_U606
DR   ATCC; CRL-4005
DR   BioSample; SAMN03471716
DR   Wikidata; Q54972052
RX   PubMed=10739753;
CC   Population: Native American; Saulteaux.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys1239Glufs*1; Zygosity=Homozygous (PubMed=10739753).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-4005
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 12,23
ST   D19S433: 14,15.2
ST   D21S11: 29,31
ST   D2S1338: 19,22
ST   D3S1358: 16
ST   D5S818: 7,13
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 18,20
ST   Penta D: 9,12
ST   Penta E: 12,16
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 16,17
DI   NCIt; C173085; Cerebrooculofacioskeletal syndrome 1
DI   ORDO; Orphanet_1466; COFS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4-6Y
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   TelCOFS03MA
AC   CVCL_U607
DR   ATCC; CRL-4006
DR   BioSample; SAMN03471717
DR   Wikidata; Q54972054
RX   PubMed=10739753;
CC   Population: Native American; Saulteaux.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Lys1239Glufs*1; Zygosity=Homozygous (PubMed=10739753).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: ATCC; CRL-4006; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-4006
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C173085; Cerebrooculofacioskeletal syndrome 1
DI   ORDO; Orphanet_1466; COFS syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <11Y
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   TeLFBASAF
AC   CVCL_9U67
SY   TELFBASAF
DR   cancercelllines; CVCL_9U67
DR   Wikidata; Q54972055
RX   PubMed=10022544;
CC   Group: Retrovirus packaging cell line.
CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1756 ! TE 671
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   TeloHAEC
AC   CVCL_Z065
DR   ATCC; CRL-4052
DR   Wikidata; Q54972056
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
ST   Source(s): ATCC=CRL-4052
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   TeloHAEC-GFP
AC   CVCL_Z066
DR   ATCC; CRL-4054
DR   Wikidata; Q54972057
CC   Characteristics: Stably expresses emerald GFP (emGFP) under the control of the EF1a promoter (ATCC=CRL-4054).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Caution: Indicated as originating from a 34 year old female donor in ATCC but for the parent cell line the age is indicated as being 23 year old.
CC   Derived from site: In situ; Thoracic aorta; UBERON=UBERON_0001515.
CC   Cell type: Endothelial cell of thoracic aorta; CL=CL_0002545.
ST   Source(s): ATCC=CRL-4054
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Z065 ! TeloHAEC
SX   Female
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   TEM
AC   CVCL_E844
DR   dbMHC; 49036
DR   ECACC; 88052057
DR   IHW; IHW09057
DR   IPD-IMGT/HLA; 11438
DR   Wikidata; Q54972058
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Jewish.
CC   HLA typing: A*66:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01; DPB1*04:01:01; DQA1*01:04; DQB1*05:03:01; DRA*01:01; DRB1*14:01:01; DRB3*02:01 (IPD-IMGT/HLA=11438).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   TEMF
AC   CVCL_UC82
SY   TEtraploid Misgurnus Fin
DR   Wikidata; Q98133216
RX   Patent=CN103555657B;
RX   PubMed=25721100;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013111.
CC   Doubling time: 41.45 hours (Note=At 50th passage) (PubMed=25721100).
CC   Karyotypic information: Tetraploid karyotype.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75329; ! Misgurnus anguillicaudatus (Oriental weatherloach)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 11
//
ID   TEN
AC   CVCL_E063
DR   CLO; CLO_0050884
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 693
DR   BioSample; SAMN03472138
DR   BioSample; SAMN10987928
DR   cancercelllines; CVCL_E063
DR   Cell_Model_Passport; SIDM01463
DR   DepMap; ACH-000397
DR   FANTOM5_SSTAR; 10636-108I6
DR   GEO; GSM887703
DR   GEO; GSM888796
DR   IARC_TP53; 28253
DR   LiGeA; CCLE_209
DR   PharmacoDB; TEN_1586_2019
DR   Progenetix; CVCL_E063
DR   RCB; RCB1433
DR   Wikidata; Q54972059
RX   PubMed=9436040;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 47.1 hours (Note=At 31th passage), 59.3 hours (Note=At 22th passage) (PubMed=9436040).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Thr74Pro (c.220A>C); ClinVar=VCV000929160; Zygosity=Heterozygous (DepMap=ACH-000397).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (DepMap=ACH-000397).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0%; East Asian, North=76.96%; East Asian, South=22.41%; South Asian=0.11%; European, North=0%; European, South=0.3% (PubMed=30894373).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB1433
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 26
//
ID   Ten12
AC   CVCL_4765
SY   TEN12; TEN/12
DR   Cosmic; 2585154
DR   Wikidata; Q54972061
RX   CelloPub=CLPUB00117;
RX   PubMed=9316653;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   TEN12C
AC   CVCL_K060
DR   Wikidata; Q54972062
RX   PubMed=14673948;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4765 ! Ten12
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   TEN12F
AC   CVCL_K061
DR   Wikidata; Q54972063
RX   PubMed=14673948;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4765 ! Ten12
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   tEnd.1
AC   CVCL_6272
SY   thymus-derived Endothelial cells.1
DR   Wikidata; Q54972064
RX   PubMed=2379237;
RX   PubMed=3345558;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03077; Murine polyomavirus (strain A2) (MPyV) middle T antigen (PyMT).
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   TENN
AC   CVCL_Y378
DR   ColonAtlas; TENN
DR   Cosmic; 1131689
DR   Wikidata; Q54972066
RX   PubMed=17363507;
RX   PubMed=23623571;
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 4
//
ID   teno-iPSC1
AC   CVCL_WW90
DR   Wikidata; Q98133217
RX   PubMed=31277043;
CC   Derived from site: In situ; Tendon; UBERON=UBERON_0000043.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_WW91 ! teno-iPSC2
OI   CVCL_WW92 ! teno-iPSC3
SX   Sex unspecified
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   teno-iPSC2
AC   CVCL_WW91
DR   Wikidata; Q98133218
RX   PubMed=31277043;
CC   Derived from site: In situ; Tendon; UBERON=UBERON_0000043.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_WW90 ! teno-iPSC1
OI   CVCL_WW92 ! teno-iPSC3
SX   Sex unspecified
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   teno-iPSC3
AC   CVCL_WW92
DR   Wikidata; Q98133219
RX   PubMed=31277043;
CC   Derived from site: In situ; Tendon; UBERON=UBERON_0000043.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
OI   CVCL_WW90 ! teno-iPSC1
OI   CVCL_WW91 ! teno-iPSC2
SX   Sex unspecified
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   Tep Be
AC   CVCL_3802
DR   CLO; CLO_0009322
DR   ATCC; CRL-1336
DR   BioSample; SAMN03471353
DR   JCRB; KURB1915
DR   Wikidata; Q54972067
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1336
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 11,20
ST   D19S433: 13.2,14
ST   D21S11: 28
ST   D2S1338: 17,20
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,15
ST   FGA: 22
ST   Penta D: 12
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   TEPC-1165
AC   CVCL_6731
SY   TEPC 1165; TEPC1165; T1165; T1165tc
DR   Wikidata; Q54972068
RX   PubMed=3261383;
RX   PubMed=3726549;
RX   PubMed=9419351;
RX   PubMed=17764563;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=T1165
CC   Characteristics: IL6 dependent.
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   TEPC-1198
AC   CVCL_RP65
SY   TEPC 1198; TEPC1198; T1198; T1198tc
DR   Wikidata; Q54972069
RX   PubMed=3726549;
RX   PubMed=9419351;
CC   Characteristics: IL6 dependent.
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   TEPC-2027
AC   CVCL_RP66
SY   TEPC 2027; TEPC2027; T2027; T2027tc
DR   Wikidata; Q54972070
RX   PubMed=3726549;
RX   PubMed=9002945;
RX   PubMed=9419351;
RX   PubMed=17764563;
CC   Characteristics: Produces IgG1.
CC   Characteristics: IL6 dependent.
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/cAnPt.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   TEPC-2372
AC   CVCL_RP76
SY   TEPC 2373; TEPC2372
DR   Wikidata; Q54972071
RX   PubMed=11166031;
CC   Characteristics: Produces IgG2b lambda.
CC   Transformant: ChEBI; CHEBI_53181; Pristane.
CC   Breed/subspecies: BALB/c.lambdaLIZ.
DI   NCIt; C21631; Mouse plasmacytoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 4
//
ID   Ter Loy
AC   CVCL_X716
DR   ATCC; CRL-1147
DR   Wikidata; Q54972072
CC   Discontinued: ATCC; CRL-1147; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 02-05-24; Version: 7
//
ID   TER-119
AC   CVCL_8432
DR   JCRB; JCRB1353
DR   Wikidata; Q54972074
RX   PubMed=8660794;
RX   PubMed=10848813;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TER-119
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: Mouse 52 kDa antigen on erythroid cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   TER-3
AC   CVCL_U375
DR   Wikidata; Q54972075
RX   PubMed=12064461;
RX   PubMed=19344951;
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   TER-ND
AC   CVCL_E846
SY   TER ND; RAIN-TER; RAI
DR   dbMHC; 49038
DR   ECACC; 88072602
DR   IHW; IHW09303
DR   IPD-IMGT/HLA; 11449
DR   Wikidata; Q54972076
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Irish.
CC   HLA typing: A*02,11; B*44:03:01,35; C*04,16:01; DPA1*01; DPB1*02:01,04:01; DQA1*01:01; DRB1*01:03 (IPD-IMGT/HLA=11449).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   TER111
AC   CVCL_JD05
SY   TER-111; Ter 111; TER151; TER-151; Ter 151; TER322; TER-322; Ter 322; TER494; TER-494; Ter-494; Ter 494
DR   IPD-IMGT/HLA; 14092
DR   Wikidata; Q54972077
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/376cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*01:01,17:01; DQA1*04:01,01:02; DQB1*05:01,03:01; DRB1*13:02:01,08:04:01; DRB3*03:01 (IPD-IMGT/HLA=14092).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER1132
AC   CVCL_JD15
SY   TER532; TER-532; Ter-532; Extract 242; Extract 428
DR   IPD-IMGT/HLA; 12913
DR   Wikidata; Q54972079
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX395Report.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*24:37,34:01; B*15:21,15:35; C*04:03,07:02; DPB1*01:01:01,05:01; DRB1*04:03:01,15:01 (IPD-IMGT/HLA=12913).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER119
AC   CVCL_JC68
SY   TER-119; Ter 119; TER458; TER-458; Ter 458
DR   Wikidata; Q54972080
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/359cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER120
AC   CVCL_JD51
SY   TER-120; Ter 120; TER400; TER-400; Ter 400
DR   Wikidata; Q54972082
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/330cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER121
AC   CVCL_JE02
SY   TER-121; Ter 121; TER285; TER-286; Ter-285
DR   Wikidata; Q54972083
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   TER135
AC   CVCL_JD02
SY   TER-135; Ter 135; TER488; TER-488; Ter 488
DR   Wikidata; Q54972084
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/374cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER144
AC   CVCL_JC95
SY   14034; TER-144; Ter 144; TER196; TER-196; Ter 196; TER374; TER-374; Ter 374; TER534; TER-534; Ter-534
DR   IPD-IMGT/HLA; 13126
DR   Wikidata; Q54972085
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX396reportF.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11,68; B*40,55; DPB1*02:02,26:01; DQA1*05:05:01,05:09; DQB1*03:01; DRB1*11:11:01,12:01:01; DRB3*01:01,02:02 (IPD-IMGT/HLA=13126).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER146
AC   CVCL_JD28
SY   TER-146; Ter 146; TER275; TER-275; Ter 275; TER434; TER-434; Ter 434
DR   IPD-IMGT/HLA; 14097
DR   Wikidata; Q54972086
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/346cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*39:01,40:01; DQA1*01:02,02:01; DQB1*06:02,02:02; DRB1*15:03,13:03:01; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=14097).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER172
AC   CVCL_JD22
SY   TER-172; Ter 172; TER286; TER-286; Ter 286; TER498; TER-498; Ter-498; Ter 498; Extract 67; Extract 171
DR   Wikidata; Q54972087
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/378cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER181
AC   CVCL_JD31
SY   TER-181; Ter 181; TER345; TER-345; Ter 345; TER429; TER-429; Ter-429; Ter 429
DR   Wikidata; Q54972088
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/344cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER215
AC   CVCL_JD16
SY   TER-215; Ter 215; TER340; TER-340; Ter 340; TER442; TER-442; Ter 442; Extract 107; Extract 187; Extract 399
DR   Wikidata; Q54972089
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/328cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/351cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER230
AC   CVCL_JD42
SY   TER-230; Ter 230; TER296; TER-296; Ter 296; TER410; TER-410; Ter 410
DR   Wikidata; Q54972090
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/335cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER248
AC   CVCL_JD27
SY   TER-248; Ter 248; TER312; TER-312; Ter 312; TER431; TER-431; Ter 431; Extract 106
DR   Wikidata; Q54972101
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/346cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER257
AC   CVCL_JD25
SY   TER-257; Ter 257; TER510; TER-510; Ter-510; Ter 510
DR   Wikidata; Q54972103
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/384cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER259
AC   CVCL_E845
SY   TER-259; Ter-259; Ter 259; TER366; TER-366; Ter 366
DR   dbMHC; 49037
DR   IHW; IHW09401
DR   IPD-IMGT/HLA; 26005
DR   Wikidata; Q54972104
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*32:01,68:02; B*08:01,44:02:01:01; C*01:02,07; DPB1*03:01:01,04:01:01; DQA1*03:01,05:01; DQB1*02:01,03:02; DRB1*03:01,04:26; DRB3*01:01; DRB4*01:03 (IPD-IMGT/HLA=26005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   TER261
AC   CVCL_JC40
SY   TER-261; Ter 261; TER500; TER-500; Ter-500; Ter 500; Extract 169
DR   Wikidata; Q54972105
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/380cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER264
AC   CVCL_JD04
SY   TER-264; Ter 264; TER342; TER-342; Ter 342; TER492; TER-492; Ter 492
DR   Wikidata; Q54972106
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/375cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER268
AC   CVCL_JD03
SY   TER-268; Ter 268; TER318; TER-318; Ter 318; TER341; TER-341; Ter 341; TER491; TER-491; Ter 491; Extract 150; Extract 324; Extract 457
DR   Wikidata; Q54972107
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/375cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER271
AC   CVCL_JD34
SY   TER-271; Ter 271; TER423; TER-423; Ter-423; Ter 423
DR   Wikidata; Q54972108
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/342cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER276
AC   CVCL_JD10
SY   TER-276; Ter 276; TER521; TER-521; Ter-521; Ter 521; Extract 112; Extract 279
DR   Wikidata; Q54972109
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX390reportFinal.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER278
AC   CVCL_JC98
SY   TER-278; Ter 278; TER217; TER-217; Ter 217; TER298; TER-298; Ter 298; TER483; TER-483; Ter 483
DR   IPD-IMGT/HLA; 14096
DR   Wikidata; Q54972111
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/372cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,24:02; B*08:01,15:01; C*03:03,07:01; DPB1*01:01,03:01; DQA1*05:01,05:05; DQB1*02:01,03:01; DRB1*03:01:01,11:19:01; DRB3*01:01,02:02 (IPD-IMGT/HLA=14096).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER283
AC   CVCL_JD35
SY   TER-283; Ter 283; TER247; TER-247; Ter 247; TER422; TER-422; Ter 422; Extract 119
DR   IPD-IMGT/HLA; 14105
DR   Wikidata; Q54972112
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/341cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,33:03; B*18:01,52:01; C*07:02,07:04; DPB1*01:01,05:01; DQA1*01:01,01:04; DQB1*05:01,05:03; DRB1*15:02:01,14:10; DRB3*02:02; DRB5*01:02 (IPD-IMGT/HLA=14105).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER293
AC   CVCL_JC38
SY   TER-293; Ter 293; Ter293; TER375; TER-375; Ter 375; TER505; TER-505; Ter-505; Ter 505; Extract 173; Extract 441
DR   IPD-IMGT/HLA; 14047
DR   Wikidata; Q54972113
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/339cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/382cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:BDDU,23:RRF; B*44:03:01,35:28; C*04:01:01:01/04:01:01:02/04:09N,16:01:01; DPB1*04:02,14:01; DQA1*01:04,04:01; DQB1*05:03:01,04:02; DRB1*08:02:01,14:54; DRB3*02:02 (IPD-IMGT/HLA=14047).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER295
AC   CVCL_JC30
SY   TER-295; Ter 295; TER409; TER-409; Ter 409; TER526; TER-526; Ter-526; Ter 526
DR   Wikidata; Q54972114
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/335cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX392report_Final.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER297
AC   CVCL_JD07
SY   TER-297; Ter 297; TER408; TER-408; Ter-408; Ter 408; TER502; TER-502; Ter-502; Ter 502
DR   Wikidata; Q54972115
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/334cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/381cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER299
AC   CVCL_JD41
SY   TER-299; Ter 299; Extract 434
DR   IPD-IMGT/HLA; 12916
DR   Wikidata; Q54972116
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/337cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:01,26:01; B*08:01,38:09; C*07:AG,12:03 (IPD-IMGT/HLA=12916).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER300
AC   CVCL_JD47
SY   TER-300; Ter 300; TER404; TER-404; Ter 404
DR   Wikidata; Q54972118
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/332cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER308
AC   CVCL_JD57
SY   TER-308; Ter 308; TER216; TER-216; Ter 216; TER394; TER-394; Ter 394
DR   IPD-IMGT/HLA; 14087
DR   Wikidata; Q54972119
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/327cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian.
CC   HLA typing: DPB1*04:02; DQA1*01:01,03:01; DQB1*05:01,03:02; DRB1*01:01:01,04:15; DRB4*01:03 (IPD-IMGT/HLA=14087).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER311
AC   CVCL_JD01
SY   TER-311; Ter 311; TER413; TER-413; Ter 413; TER487; TER-487; Ter 487; Extract 556
DR   Wikidata; Q54972120
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/336cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/374cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER313
AC   CVCL_JE00
SY   TER-313; Ter 313; TER240; TER-240; Ter 240; Extract 88; Extract 195
DR   IPD-IMGT/HLA; 14103
DR   Wikidata; Q54972121
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,31:01:02; B*15:01,67:01; C*07:02; DPB1*02:01,05:01; DQA1*05:03; DQB1*03:01; DRB1*14:03:01,14:06; DRB3*01:01,02:02 (IPD-IMGT/HLA=14103).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 9
//
ID   TER320
AC   CVCL_JD08
SY   TER-320; Ter 320; TER395; TER-395; Ter 395; TER503; TER-503; Ter-503; Ter 503
DR   IPD-IMGT/HLA; 14101
DR   Wikidata; Q54972122
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/327cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/381cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:02,03:01; DQA1*01:02,05:01; DQB1*02:01,06:04; DRB1*03:01:01,13:29; DRB3*02:02,03:01 (IPD-IMGT/HLA=14101).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER327
AC   CVCL_JC99
SY   TER-327; Ter 327; TER436; TER-436; Ter 436; TER484; TER-484; Ter 484
DR   IPD-IMGT/HLA; 14095
DR   Wikidata; Q54972123
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/348cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/372cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:02,04:01; DQA1*01:04,05:01; DQB1*02:01,05:03; DRB1*03:01:01,11:13; DRB3*02:02 (IPD-IMGT/HLA=14095).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER329
AC   CVCL_JC78
SY   TER-329; Ter 329; TER378; TER-378; Ter 378; TER481; TER-481; Ter-481; Ter 481
DR   Wikidata; Q54972124
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/370cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER331
AC   CVCL_JD11
SY   TER-331; Ter 331; Ter331; TER406; TER-406; Ter 406; TER527; TER-527; Ter-527; Ter 527
DR   IPD-IMGT/HLA; 14098
DR   Wikidata; Q54972125
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/333cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX393report_Final.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*01:01,03:01; DQA1*01:03,05:01; DQB1*02:01,06:03; DRB1*03:01:01,13:06; DRB3*01:01 (IPD-IMGT/HLA=14098).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER336
AC   CVCL_JD18
SY   TER-336; Ter 336; TER439; TER-439; Ter 439
DR   IPD-IMGT/HLA; 14084
DR   Wikidata; Q54972126
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/350cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caucasian.
CC   HLA typing: DPB1*04:02; DQA1*01:03,05:01; DQB1*02:01,06:03; DRB1*03:04,13:01:01; DRB3*01:01,02:02 (IPD-IMGT/HLA=14084).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER337
AC   CVCL_JC72
SY   TER-337; Ter 337; TER449; TER-449; Ter 449
DR   IPD-IMGT/HLA; 14086
DR   Wikidata; Q54972127
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/354cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*03:01,04:02; DQA1*03:01,05:05; DQB1*03:01,03:02; DRB1*04:03:02,11:04:01; DRB3*02:02; DRB4*01:03 (IPD-IMGT/HLA=14086).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TER343
AC   CVCL_JD72
SY   TER-343; Ter 343; TER220; TER-220; Ter 220
DR   IPD-IMGT/HLA; 14099
DR   Wikidata; Q54972128
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:01; DQA1*01:03,01:04; DQB1*05:03,06:03; DRB1*13:10,14:05; DRB3*01:01,02:02 (IPD-IMGT/HLA=14099).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 9
//
ID   TER347
AC   CVCL_JD17
SY   TER-347; Ter 347; TER432; TER-432; Ter-432; Ter 432; TER441; TER-441; Ter 441
DR   Wikidata; Q54972130
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/346cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/351cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER356
AC   CVCL_JC39
SY   TER-356; Ter 356; TER444; TER-444; Ter 444; TER506; TER-506; Ter-506; Ter 506; Extract 270; Extract 426
DR   Wikidata; Q54972131
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/335cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/351cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/382cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER361
AC   CVCL_JD55
SY   TER-361; Ter 361; TER397; TER-397; Ter 397
DR   Wikidata; Q54972132
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/328cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER362
AC   CVCL_JC66
SY   TER-362; Ter 362; TER398; TER-398; Ter 398; TER468; TER-468; Ter 468
DR   Wikidata; Q54972133
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/328cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/364cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER363
AC   CVCL_JD24
SY   TER-363; Ter 363; TER466; TER-466; Ter 466
DR   Wikidata; Q54972134
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/362cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER364
AC   CVCL_JC67
SY   TER-364; Ter 364; TER457; TER-457; Ter 457; Extract 480
DR   Wikidata; Q54972135
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/348cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/359cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER365
AC   CVCL_JD21
SY   TER-365; Ter 365; TER438; TER-438; Ter 438
DR   Wikidata; Q54972136
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/349cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER367
AC   CVCL_JD46
SY   TER-367; Ter 367; TER403; TER-403; Ter 403
DR   Wikidata; Q54972138
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/332cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER368
AC   CVCL_JC41
SY   TER-368; Ter 368; TER430; TER-430; Ter 430; TER496; TER-496; Ter-496; Ter 496
DR   Wikidata; Q54972140
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/344cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/378cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER381
AC   CVCL_JC65
SY   TER-381; Ter 381; TER470; TER-470; Ter 470
DR   Wikidata; Q54972141
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/365cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER385
AC   CVCL_JC33
SY   TER-385; Ter 385; TER517; TER-517; Ter-517; Ter 517; TER524; TER-524; Ter-524; Ter 524
DR   Wikidata; Q54972142
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/1CX391.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX388F.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER388
AC   CVCL_JD62
SY   TER-388; Ter 388; Extract 390
DR   Wikidata; Q54972143
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/324cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER392
AC   CVCL_JC60
SY   TER-392; Ter 392; TER478; TER-478; Ter 478
DR   Wikidata; Q54972144
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/326cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/368cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER393
AC   CVCL_JD56
SY   TER-393; Ter 393; TER482; TER-482; Ter 482
DR   Wikidata; Q54972145
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/327cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/370cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*02:01,05:01; DQA1*01:02,03:03; DQB1*05:02; DRB1*04:10,15:01 (UCLA International Cell Exchange).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER401
AC   CVCL_JC63
SY   TER-401; Ter 401; TER471; TER-471; Ter 471; Extract 414
DR   Wikidata; Q54972146
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/330cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/366cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER415
AC   CVCL_JD38
SY   TER-415; Ter 415
DR   Wikidata; Q54972165
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Caribbean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER416
AC   CVCL_JC34
SY   TER-416; Ter 416; TER519; TER-519; Ter-519; Ter 519; Extract 561
DR   Wikidata; Q54972166
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/369cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX389F.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: Chinese.
CC   HLA typing: DRB1*07:01,08:09 (UCLA International Cell Exchange).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER417
AC   CVCL_JC94
SY   TER-417; Ter 417; TER533; TER-533; Ter-533
DR   Wikidata; Q54972167
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX396reportF.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER418
AC   CVCL_JD13
SY   TER-418; Ter 418; TER530; TER-530; Ter-530; Ter 530; Extract 493
DR   Wikidata; Q54972168
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/338cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX394Report.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER419
AC   CVCL_JD36
SY   TER-419; Ter 419
DR   Wikidata; Q54972169
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/340cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER420
AC   CVCL_JD37
SY   TER-420; Ter 420
DR   Wikidata; Q54972170
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/340cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER473
AC   CVCL_JC61
SY   TER-473; Ter 473
DR   Wikidata; Q54972171
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/367cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER512
AC   CVCL_JC36
SY   TER-512; Ter-512; Ter 512; Extract 418
DR   Wikidata; Q54972172
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/385cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER525
AC   CVCL_JC29
SY   TER-525; Ter-525; Ter 525
DR   Wikidata; Q54972174
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX392report_Final.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER529
AC   CVCL_JD12
SY   TER-529; Ter-529; Ter 529; Extract 261; Extract 329; Extract 530
DR   Wikidata; Q54972175
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX394Report.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER67
AC   CVCL_JD00
SY   TER-67; Ter 67; TER177; TER-177; Ter 177; TER486; TER-486; Ter 486
DR   Wikidata; Q54972176
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/373cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER69
AC   CVCL_JD68
SY   TER-69; Ter 69; TER192; TER-192; Ter 192; TER489; TER-489; Ter 489
DR   Wikidata; Q54972177
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/375cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER73
AC   CVCL_JD23
SY   TER-73; Ter 73; TER270; TER-270; Ter 270; TER509; TER-509; Ter-509; Ter 509
DR   Wikidata; Q54972178
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/384cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER75
AC   CVCL_JC69
SY   TER-75; Ter 75; TER141; TER-141; Ter 141; TER460; TER-460; Ter 460
DR   Wikidata; Q54972179
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/359cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   TER85
AC   CVCL_JD50
SY   TER-85; Ter 85; TER132; TER-132; Ter 132; TER399; TER-399; Ter 399
DR   Wikidata; Q54972180
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/330cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   Tera-1
AC   CVCL_2776
SY   TERA-1; TERA1; Tera I
DR   CLO; CLO_0009323
DR   ATCC; HTB-105
DR   BioSample; SAMN03471091
DR   Cosmic; 687053
DR   Cosmic; 971769
DR   Cosmic; 2163763
DR   Cosmic; 2816210
DR   GDSC; 1331043
DR   KCLB; 30105
DR   LINCS_LDP; LCL-1902
DR   PharmacoDB; Tera1_1587_2019
DR   Wikidata; Q54972181
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6173755;
RX   PubMed=6202829;
RX   PubMed=6244232;
RX   PubMed=24812411;
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=HTB-105; KCLB=30105
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 15,16
ST   D19S433: 14,15
ST   D21S11: 29,32.2,33.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 11,15
ST   FGA: 21,25
ST   Penta D: 10,13
ST   Penta E: 7,15
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 25
//
ID   Tera-2
AC   CVCL_2777
SY   TERA-2; Tera 2; Tera II
DR   BTO; BTO_0002573
DR   CLO; CLO_0009324
DR   ATCC; HTB-106
DR   CancerTools; 161909
DR   Cell_Model_Passport; SIDM01142
DR   Cosmic; 971770
DR   Cosmic; 2816211
DR   DepMap; ACH-001672
DR   Wikidata; Q28248633
RX   DOI=10.1007/978-1-4757-1647-4_5;
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3293662;
RX   PubMed=3518877;
RX   PubMed=6169654;
RX   PubMed=6202829;
RX   PubMed=6244232;
RX   PubMed=6694356;
RX   PubMed=6935474;
RX   PubMed=31500094;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ATCC=HTB-106
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11,12,13
ST   D18S51: 14
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 22,25
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Tera-2_CDDP
AC   CVCL_XI45
DR   Wikidata; Q98133220
RX   PubMed=31500094;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2777 ! Tera-2
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   TERA-C3H
AC   CVCL_AV91
DR   CLS; 400360
DR   Wikidata; Q54972185
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Breed/subspecies: C3H.
DI   NCIt; C30037; Mouse malignant ovarian neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1-2Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   Tera-CP
AC   CVCL_A5AF
DR   Wikidata; Q107117025
RX   PubMed=8242627;
RX   PubMed=12093475;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3752; Embryonal carcinoma
DI   ORDO; Orphanet_180226; Embryonal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3407 ! NT2-D1
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   TerC
AC   CVCL_DE18
SY   Teratoma C; TerC74
DR   Wikidata; Q54972186
RX   CelloPub=CLPUB00342;
RX   PubMed=379868;
RX   PubMed=4365513;
RX   PubMed=6958907;
RX   PubMed=7135164;
CC   Breed/subspecies: 129/Sv.
DI   NCIt; C128123; Mouse testicular teratoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 3
//
ID   TERT-hBA
AC   CVCL_VU19
SY   TERT-immortalized human Brown Adipocyte cell line
DR   Wikidata; Q98133222
RX   PubMed=28957413;
CC   Characteristics: Recapitulate the gene expression profile of brown adipocytes. UCP1-positive and responsive to beta-adrenergic stimulation.
CC   Doubling time: ~1-2 days (PubMed=28957413).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU20 ! TERT-hWA
SX   Female
AG   48Y
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   TERT-hWA
AC   CVCL_VU20
SY   TERT-immortalized human White Adipocyte cell line
DR   Wikidata; Q98133223
RX   PubMed=28957413;
CC   Characteristics: Recapitulate the gene expression profile of white adipocytes.
CC   Doubling time: ~1-2 days (PubMed=28957413).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; White adipose tissue; UBERON=UBERON_0001347.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VU19 ! TERT-hBA
SX   Female
AG   48Y
CA   Telomerase immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   TERT-NHUC A
AC   CVCL_JX41
SY   TERT NHUC A; hTERT-NHUC A; TERT-Normal Human Urothelial Cells A
DR   Wikidata; Q54972188
RX   PubMed=16619045;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Telomerase immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   TERT-NHUC B
AC   CVCL_JX42
SY   TERT NHUC B; hTERT-NHUC B; TERT-Normal Human Urothelial Cells B
DR   Wikidata; Q54972189
RX   PubMed=16619045;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Telomerase immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   TERT-NHUC N
AC   CVCL_JX43
SY   TERT NHUC N; hTERT-NHUC N; TERT-Normal Human Urothelial Cells N
DR   Wikidata; Q54972190
RX   PubMed=16619045;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Telomerase immortalized cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 10
//
ID   Tes Man
AC   CVCL_Y128
DR   ATCC; CRL-1154
DR   Wikidata; Q54972191
CC   Discontinued: ATCC; CRL-1154; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   TES1
AC   CVCL_VM17
SY   TES-1
DR   GEO; GSM1238142
DR   Wikidata; Q98133224
RX   DOI=10.1158/1538-7445.AM2016-57;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM18 ! TES2b
OI   CVCL_VM19 ! TESPE
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 7
//
ID   TES101
AC   CVCL_A8ED
DR   Wikidata; Q107117026
RX   PubMed=11207211;
RX   PubMed=18620756;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   TES2b
AC   CVCL_VM18
SY   TES-2b
DR   GEO; GSM1238143
DR   Wikidata; Q98133225
RX   DOI=10.1158/1538-7445.AM2016-57;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM17 ! TES1
OI   CVCL_VM19 ! TESPE
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 6
//
ID   TES7
AC   CVCL_A0QM
DR   Wikidata; Q108821368
RX   Patent=US10683364;
RX   Patent=US10730945;
RX   PubMed=22615450;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q5ZPR3; Human CD276.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Tesi
AC   CVCL_IN51
DR   GEO; GSE10508
DR   Wikidata; Q54972192
RX   PubMed=9420268;
RX   PubMed=18276843;
CC   Characteristics: Immortalized using a tetracycline-repressible HTLV-1 Tax gene.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1) (Note=Tax).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   TESPE
AC   CVCL_VM19
DR   GEO; GSM1238144
DR   Wikidata; Q98133227
RX   DOI=10.1158/1538-7445.AM2016-57;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4001; Breast inflammatory carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VM17 ! TES1
OI   CVCL_VM18 ! TES2b
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 7
//
ID   Tet-293/Ins6
AC   CVCL_A6AC
SY   tet-293/Ins6; tet293/Ins6
DR   Wikidata; Q107117028
RX   PubMed=11925627;
CC   Characteristics: Secretes insulin induced by doxycyclin.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6081; INS.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_KS31 ! HEK 293 Tet-On
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   Tet-iNOS-293
AC   CVCL_8117
SY   Tet-iNOS 293; Tet-iNOS293
DR   BTO; BTO_0003282
DR   Wikidata; Q54972193
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   Tet2
AC   CVCL_HF70
SY   TET2; SHEP-2; SHEP2
DR   cancercelllines; CVCL_HF70
DR   GEO; GSM692875
DR   Wikidata; Q54972194
RX   PubMed=8761302;
RX   PubMed=17506115;
RX   PubMed=22213050;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2A38 ! SHEP-SF
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   Tet21N
AC   CVCL_9812
SY   TET21/N; Tet21/N; Tet-21/N; SHEP-21/N; SHEP-21N; SHEP21N
DR   BTO; BTO_0004654
DR   cancercelllines; CVCL_9812
DR   GEO; GSM692858
DR   Wikidata; Q54972195
RX   PubMed=8761302;
RX   PubMed=17506115;
RX   PubMed=22213050;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7559; MYCN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2A38 ! SHEP-SF
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   Teth-CRFK
AC   CVCL_WL54
DR   Wikidata; Q98133228
RX   PubMed=23585909;
CC   Group: Vaccine production cell line.
CC   Characteristics: Has a reduced risk of RD-114 contamination by suppressing the release of infectious RD-114 from cells by the antiviral action of BST2/tetherin.
CC   Virology: Persistently infected by feline endogenous virus RD-114.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1119; BST2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
HI   CVCL_2426 ! CRFK
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   TEV-1
AC   CVCL_E8U8
SY   Trophoblast ExtraVillous-1
RX   PubMed=15866109;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Trophoblast, extravillous; UBERON=UBERON_0000426.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <12FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TEX
AC   CVCL_A5CF
DR   BTO; BTO_0006359
DR   GEO; GSM838425
DR   GEO; GSM838426
DR   GEO; GSM838427
DR   Wikidata; Q107117030
RX   PubMed=16094415;
RX   PubMed=22160482;
CC   Characteristics: Expresses a transfected FUS-ERG (TLS-ERG) fusion protein. Mimics the features of primary human acute myeloid leukemia and of leukemia-initiating cells (LIC) and are more than 90% CD34+. Underwent step-wise transformation and immortalization through acquisition of additional genetic changes, such as expression of TERT, expression of LIC markers CD34, CD44 and CD123 and the stem cell gene BMI1 (PubMed=16094415; PubMed=22160482).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3446; ERG (Note=FUS-ERG fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4010; FUS (Note=FUS-ERG fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   TF [Scophthalmus fin China]
AC   CVCL_8274
SY   Turbot Fin
DR   Wikidata; Q54972196
RX   PubMed=20502962;
CC   Group: Fish cell line.
CC   Caution: There are two turbot fin cell lines that were established and that were given the same name, TF, one by UK group in the 1980's (Cellosaurus=CVCL_A3AZ) and one from a Chines lab in 2010 (Cellosaurus=CVCL_8274).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   TF [Scophthalmus fin UK]
AC   CVCL_A3AZ
DR   Wikidata; Q105511166
RX   DOI=10.1046/j.1365-2761.2002.00371.x;
RX   PubMed=2591197;
RX   PubMed=12911061;
CC   Group: Fish cell line.
CC   From: Hill, Barry J.; MAFF Fish Diseases Laboratory; Weymouth; United Kingdom.
CC   Characteristics: Optimal growth temperature is 25 Celsius (DOI=10.1046/j.1365-2761.2002.00371.x).
CC   Caution: There are two turbot fin cell lines that were established and that were given the same name, TF, one by UK group in the 1980's (Cellosaurus=CVCL_A3AZ) and one from a Chines lab in 2010 (Cellosaurus=CVCL_8274).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 8
//
ID   TF-1
AC   CVCL_0559
SY   TF1; MFD-1
DR   BTO; BTO_0004760
DR   CLO; CLO_0009325
DR   CLO; CLO_0009326
DR   EFO; EFO_0022398
DR   MCCL; MCC:0000460
DR   CLDB; cl4503
DR   CLDB; cl7163
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-2003
DR   BCRC; 60323
DR   BCRJ; 0233
DR   BioGRID_ORCS_Cell_line; 219
DR   BioSample; SAMN03470850
DR   BioSample; SAMN10988443
DR   cancercelllines; CVCL_0559
DR   CCRID; 1101HUM-PUMC000118
DR   CCRID; 1102HUM-NIFDC00101
DR   CCTCC; GDC0196
DR   Cell_Model_Passport; SIDM01470
DR   ChEMBL-Cells; CHEMBL3307972
DR   ChEMBL-Targets; CHEMBL612552
DR   CLS; 300434
DR   Cosmic; 787479
DR   Cosmic; 919129
DR   Cosmic; 924041
DR   Cosmic; 975302
DR   Cosmic; 1012123
DR   Cosmic; 1127259
DR   Cosmic; 1281355
DR   Cosmic; 2089658
DR   Cosmic; 2306240
DR   DepMap; ACH-000387
DR   DSMZ; ACC-334
DR   DSMZCellDive; ACC-334
DR   ECACC; 93022307
DR   GDSC; 1331044
DR   GEO; GSM743414
DR   GEO; GSM887704
DR   GEO; GSM888797
DR   GEO; GSM1374961
DR   IARC_TP53; 2197
DR   ICLC; HTL05001
DR   LiGeA; CCLE_592
DR   LINCS_LDP; LCL-1077
DR   Lonza; 1015
DR   NCBI_Iran; C602
DR   PharmacoDB; TF1_1588_2019
DR   Progenetix; CVCL_0559
DR   PubChem_Cell_line; CVCL_0559
DR   Wikidata; Q54972197
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=2656885;
RX   PubMed=2663885;
RX   PubMed=9096695;
RX   PubMed=9510473;
RX   PubMed=11021758;
RX   PubMed=11414198;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TF-1
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: Proliferatively responsive to many growth factors.
CC   Characteristics: IL3 or CSF2 dependent.
CC   Doubling time: 39 +- 6 hours (PubMed=9096695); 22 hours (ATCC=CRL-2003); ~70 hours (DSMZ=ACC-334).
CC   HLA typing: A*02:01,33:03; B*08:20,51:01; C*01:02,14:03 (PubMed=26589293).
CC   HLA typing: A*02:01:01,33:03:01; B*44:03:01;51:01:01; C*01:02:01;14:03; DPA1*01:03:01,02:02:02; DPB1*04:01:01,02:01:02; DQA1*01:02:01,03:02; DQB1*06:09:01,06:09:01; DRA*01:01:01,01:02:02; DRB1*09:01:02,13:02:01 (DSMZCellDive=ACC-334).
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (DepMap=ACH-000387).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (PubMed=1571549).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.64%; Native American=0.04%; East Asian, North=79.7%; East Asian, South=18.49%; South Asian=0%; European, North=0%; European, South=1.13% (PubMed=30894373).
CC   Discontinued: BCRJ; 0233; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2003; CCRID; CLS=300434; DSMZ=ACC-334; ECACC=93022307; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 13 (CCRID; CLS=300434; DSMZ=ACC-334; ECACC=93022307)
ST   CSF1PO: 13,14 (ATCC=CRL-2003; PubMed=25877200)
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 18,19
ST   Penta D: 10,13 (ATCC=CRL-2003; CCRID; CLS=300434; PubMed=25877200)
ST   Penta D: 13 (DSMZ=ACC-334)
ST   Penta E: 5,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   TF-1 BCR/ABL
AC   CVCL_J294
SY   TF-1 BCR-ABL
DR   BTO; BTO_0004761
DR   cancercelllines; CVCL_J294
DR   Wikidata; Q54972198
RX   PubMed=18829496;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:76; ABL1 (Note=BCR-ABL1 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1014; BCR (Note=BCR-ABL1 fusion).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   TF-1 D2
AC   CVCL_8059
SY   D2
DR   cancercelllines; CVCL_8059
DR   Wikidata; Q54817182
RX   PubMed=9038380;
CC   Population: Japanese.
CC   Characteristics: Growth factor independent clone of TF-1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   TF-1 D8
AC   CVCL_8060
SY   D8
DR   cancercelllines; CVCL_8060
DR   Wikidata; Q54817252
RX   PubMed=9038380;
CC   Population: Japanese.
CC   Characteristics: Growth factor independent clone of TF-1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   TF-1 IDH2 p.R140Q
AC   CVCL_UE10
SY   IDH2 mutant-TF-1 Isogenic Cell Line
DR   ATCC; CRL-2003IG
DR   cancercelllines; CVCL_UE10
DR   Wikidata; Q98133229
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/idh2-mutant-tf-1-isogenic-cell-line-atcc-crl-2003ig
CC   Population: Japanese.
CC   Characteristics: Compared to the parent cell line, has elevated intra- and extracellular D-2-hydroxyglutarate (D-2HG) levels (ATCC=CRL-2003IG).
CC   Doubling time: ~24.8 hours (ATCC=CRL-2003IG).
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple_edited; p.Arg140Gln (c.419G>A); ClinVar=VCV000014716; Zygosity=Homozygous; Note=By CRISPR/Cas9 (ATCC=CRL-2003IG).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2003IG
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 8
ST   TPOX: 7,9
ST   vWA: 15,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 14
//
ID   TF-1 IDH2 p.R140Q-Luc2
AC   CVCL_A4BL
SY   IDH2 mutant-TF-1 Isogenic-Luc2
DR   ATCC; CRL-2003IG-LUC2
DR   cancercelllines; CVCL_A4BL
DR   Wikidata; Q105511170
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter.
CC   Doubling time: ~30 hours (ATCC=CRL-2003IG-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5383; IDH2; Simple_edited; p.Arg140Gln (c.419G>A); ClinVar=VCV000014716; Zygosity=Homozygous; Note=By CRISPR/Cas9 (ATCC=CRL-2003IG-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2003IG-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 8
ST   TPOX: 7,9
ST   vWA: 15,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UE10 ! TF-1 IDH2 p.R140Q
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   TF-1-Luc2
AC   CVCL_A4BP
DR   ATCC; CRL-2003-LUC2
DR   cancercelllines; CVCL_A4BP
DR   Wikidata; Q105511173
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-2003-LUC2).
CC   Doubling time: ~19 hours (ATCC=CRL-2003-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2003-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   TF-1.CN5a.1
AC   CVCL_3607
DR   CLO; CLO_0009327
DR   ATCC; CRL-2512
DR   cancercelllines; CVCL_3607
DR   LINCS_LDP; LCL-1078
DR   Wikidata; Q54972200
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2170; CNTFR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2512
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 18,19
ST   Penta D: 10,13
ST   Penta E: 5,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   TF-1/TPO
AC   CVCL_RM06
DR   cancercelllines; CVCL_RM06
DR   Wikidata; Q54972199
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096695;
CC   Population: Japanese.
CC   Characteristics: TPO dependent.
CC   Doubling time: 74 +- 5 hours (PubMed=9096695).
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   TF-1a
AC   CVCL_3608
DR   CLO; CLO_0009328
DR   ATCC; CRL-2451
DR   BCRC; 60440
DR   BioSample; SAMN03471582
DR   cancercelllines; CVCL_3608
DR   LINCS_LDP; LCL-1079
DR   Wikidata; Q54972201
RX   PubMed=9716013;
CC   Population: Japanese.
CC   Characteristics: Growth factor independent clone of TF-1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:15868; ABHD12 + HGNC; HGNC:1537; CBFA2T3; Name(s)=CBFA2T3-ABHD12 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Pro (c.182A>C); ClinVar=VCV000280409; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile251Thrfs*94 (c.752delT); ClinVar=VCV001759367; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2451
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 13
ST   D19S433: 14,16
ST   D21S11: 30
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 18,19
ST   Penta D: 10,13
ST   Penta E: 5,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0559 ! TF-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   TF173B
AC   CVCL_B5P2
DR   Wikidata; Q112041778
RX   PubMed=35076391;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TF228.1.16
AC   CVCL_1G52
DR   BEI_Resources; ARP-11481
DR   cancercelllines; CVCL_1G52
DR   Wikidata; Q54972202
RX   PubMed=8094000;
CC   Population: African; Kenyan.
CC   Virology: EBV-negative.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Groin; UBERON=UBERON_0008337.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5711 ! BJAB
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   TF42
AC   CVCL_F1HG
RX   PubMed=2471746;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HE ! CV19
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF53.1
AC   CVCL_F1HH
RX   PubMed=2471746;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HF ! G24
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.1
AC   CVCL_F1HJ
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.12
AC   CVCL_F1HN
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.19
AC   CVCL_F1HP
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.20
AC   CVCL_F1HQ
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.3
AC   CVCL_F1HK
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.6
AC   CVCL_F1HL
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF54.8
AC   CVCL_F1HM
RX   PubMed=3428925;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3896 ! BW5147
HI   CVCL_F1HI ! G45
CA   Hybrid cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TF8-11D12
AC   CVCL_B6N4
DR   Wikidata; Q112041779
RX   Patent=US5622931;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF8-5C4
AC   CVCL_B6N5
DR   Wikidata; Q112041780
RX   Patent=US5622931;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF8-5G9
AC   CVCL_B6N6
DR   ATCC; HB-9382
DR   Wikidata; Q112041781
RX   Patent=US5622931;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9382.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF9-10H10
AC   CVCL_B6N7
DR   ATCC; HB-9383
DR   Wikidata; Q112041782
RX   Patent=US5622931;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9383.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF9-1B8
AC   CVCL_B6N8
DR   Wikidata; Q112041783
RX   Patent=US5622931;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF9-2C4
AC   CVCL_B6N9
DR   Wikidata; Q112041784
RX   Patent=US5622931;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF9-5B7
AC   CVCL_B6NA
DR   Wikidata; Q112041785
RX   Patent=US5622931;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TF9-6B4
AC   CVCL_B6NB
DR   ATCC; HB-9381
DR   Wikidata; Q112041786
RX   Patent=US5622931;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9381.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13726; Human F3/CD142.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2HZ ! P3X63Ag8.653.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TFA-11
AC   CVCL_H250
DR   Wikidata; Q54972203
RX   PubMed=6932214;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TFA1.4
AC   CVCL_B7EN
DR   Wikidata; Q112930463
RX   PubMed=28132834;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C186788; Mitochondrial complex V (ATP synthase) deficiency, mitochondrial type 1
DI   ORDO; Orphanet_254913; Isolated ATP synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   TFA2
AC   CVCL_B7EQ
DR   Wikidata; Q112930465
RX   PubMed=28132834;
CC   Sequence variation: Mutation; HGNC; HGNC:7414; MT-ATP6; Simple; p.Leu220Pro (m.9185T>C); ClinVar=VCV000009647; Zygosity=Homoplasmic (PubMed=28132834).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C186788; Mitochondrial complex V (ATP synthase) deficiency, mitochondrial type 1
DI   ORDO; Orphanet_254913; Isolated ATP synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7EP ! TDA2.3
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   TFK-1
AC   CVCL_2214
SY   TFK1
DR   CLO; CLO_0009330
DR   CLO; CLO_0050010
DR   BioSample; SAMN03471922
DR   BioSample; SAMN03473356
DR   cancercelllines; CVCL_2214
DR   Cell_Model_Passport; SIDM01462
DR   Cosmic; 927187
DR   Cosmic; 1122354
DR   Cosmic; 1373550
DR   Cosmic; 2674051
DR   DepMap; ACH-001673
DR   DSMZ; ACC-344
DR   DSMZCellDive; ACC-344
DR   FANTOM5_SSTAR; 10496-107C1
DR   RCB; RCB2537
DR   TKG; TKG 0367
DR   Wikidata; Q54972205
RX   CelloPub=CLPUB00275;
RX   PubMed=8693487;
RX   PubMed=9290701;
RX   PubMed=22490663;
RX   PubMed=27231123;
RX   PubMed=31077409;
RX   PubMed=32899426;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~37 hours (Note=At 40th passage) (PubMed=8693487); ~40 hours (DSMZ=ACC-344).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Homozygous (DepMap=ACH-001673).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: TFKK-1; PubMed=22490663; Note=In supplementary figure 2.
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): DepMap=ACH-001673; DSMZ=ACC-344; RCB=RCB2537; TKG=TKG 0367
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 14
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 18,22
ST   D3S1358: 17,18
ST   D5S818: 9,12
ST   D7S820: 10 (DSMZ=ACC-344)
ST   D7S820: 10,11 (DepMap=ACH-001673; RCB=RCB2537; TKG=TKG 0367)
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 13,14
ST   Penta E: 5,18 (DepMap=ACH-001673)
ST   Penta E: 18 (DSMZ=ACC-344)
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   TFK12 (DNAVEC)
AC   CVCL_RH52
SY   TFK12 [DNAVEC]; TFK12(DNAVEC)
DR   SKIP; SKIP000842
DR   Wikidata; Q54972206
RX   PubMed=26905201;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH51 ! TFK7 (DNAVEC)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TFK7 (DNAVEC)
AC   CVCL_RH51
SY   TFK7 [DNAVEC]; TFK7(DNAVEC)
DR   SKIP; SKIP000841
DR   Wikidata; Q54972207
RX   PubMed=26905201;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RH52 ! TFK12 (DNAVEC)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TFL-001
AC   CVCL_E2QX
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-016
AC   CVCL_E2QY
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-033
AC   CVCL_E2QZ
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-034
AC   CVCL_E2R0
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-041
AC   CVCL_E2R1
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-042
AC   CVCL_E2R2
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-043
AC   CVCL_E2R3
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-047
AC   CVCL_E2R4
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-056
AC   CVCL_E2R5
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-073
AC   CVCL_E2R6
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-074
AC   CVCL_E2R7
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-081
AC   CVCL_E2R8
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-109
AC   CVCL_E2R9
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-110
AC   CVCL_E2RA
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: Not determined.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-125
AC   CVCL_E2RB
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-126
AC   CVCL_E2RC
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-144
AC   CVCL_E2RD
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-145
AC   CVCL_E2RE
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-147
AC   CVCL_E2RF
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-148
AC   CVCL_E2RG
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-184
AC   CVCL_E2RH
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-185
AC   CVCL_E2RI
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-186
AC   CVCL_E2RJ
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-254
AC   CVCL_E2RK
RX   PubMed=26090591;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13747; Human HLA-E.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TFL-21-7G
AC   CVCL_A7BN
SY   P3-X63-Ag8-U/hZC3H12D.TFL-21-7G
DR   RCB; RCB5379
DR   Wikidata; Q107117032
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; A2A288; Human ZC3H12D.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   TFP-10
AC   CVCL_H251
SY   TFP10; TFP 10
DR   Wikidata; Q54972208
RX   PubMed=6932214;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TFS-1
AC   CVCL_JX83
DR   Wikidata; Q54972209
RX   PubMed=6091874;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human surface antigen on lung small cell carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   TFS-2
AC   CVCL_J858
DR   CLO; CLO_0050356
DR   RCB; RCB2203
DR   Wikidata; Q54972210
RX   PubMed=6091874;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human surface antigen on lung small cell carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   TFS-3
AC   CVCL_JX84
DR   Wikidata; Q54972220
RX   PubMed=6091874;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human surface antigen on lung small cell carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 4
//
ID   TFS-4
AC   CVCL_J859
DR   CLO; CLO_0050357
DR   RCB; RCB2204
DR   Wikidata; Q54972222
RX   PubMed=6091874;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human surface antigen on lung small cell carcinoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   TFTA1
AC   CVCL_D036
SY   TFT A1; 3721.95.161.4
DR   CLO; CLO_0009331
DR   ATCC; CRL-1771
DR   Wikidata; Q54972224
RX   PubMed=3957927;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D037 ! Sp2/5
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 8
//
ID   TFTB1
AC   CVCL_2732
SY   TFT B1; 3916.120.15
DR   CLO; CLO_0009332
DR   ATCC; CRL-1759
DR   ECACC; 94102701
DR   Wikidata; Q54972225
RX   PubMed=3957927;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 315-576 = B chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D037 ! Sp2/5
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 9
//
ID   TG
AC   CVCL_YD06
SY   Tilapia Gill
DR   Wikidata; Q98133230
RX   PubMed=31515819;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 25 to 32 Celsius, the optimal growth temperature is 28 Celsius.
CC   Virology: Highly susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   TG-1
AC   CVCL_0P34
SY   TG1
DR   Wikidata; Q54972226
RX   PubMed=1378830;
RX   PubMed=2424598;
DI   NCIt; C8000; Testicular yolk sac tumor
DI   ORDO; Orphanet_876; Yolk sac tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0P33 ! JTG-1
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 4
//
ID   TG-3
AC   CVCL_A2IZ
SY   TG3
DR   Wikidata; Q105511176
RX   Patent=US5811310;
RX   PubMed=9349554;
WW   Provider; AlzForum; -; https://www.alzforum.org/antibodies/tau-tg-3
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11744.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   TG-4
AC   CVCL_A2JA
SY   TG4
DR   Wikidata; Q105511180
RX   Patent=US5811310;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11745.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   TG-5
AC   CVCL_A2JB
SY   TG5
DR   Wikidata; Q105511182
RX   Patent=US5811310;
RX   PubMed=9130141;
WW   Provider; AlzForum; -; https://www.alzforum.org/antibodies/tau-tg-5
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11746.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   TG1
AC   CVCL_8555
DR   JCRB; JCRB0626
DR   Wikidata; Q54972227
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   TG102
AC   CVCL_C3T0
DR   Wikidata; Q116050645
RX   PubMed=2827804;
RX   PubMed=6320770;
RX   PubMed=6325164;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08666; Human herpesvirus 2 (HHV-2) glycoprotein B (gB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TG14
AC   CVCL_C3T1
DR   Wikidata; Q116050646
RX   PubMed=6320770;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P89452; Human herpesvirus 2 (HHV-2) major DNA-binding protein (DBP) (Note=Also reacts with HHV-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TG18
AC   CVCL_C3T2
DR   Wikidata; Q116050647
RX   PubMed=6320770;
RX   PubMed=6325164;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P89452; Human herpesvirus 2 (HHV-2) major DNA-binding protein (DBP) (Note=Also reacts with HHV-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TG180
AC   CVCL_C5PY
DR   Wikidata; Q116050648
RX   PubMed=2040563;
RX   PubMed=10733751;
RX   PubMed=34737324;
CC   Characteristics: Susceptible to infection by Toxoplasma gondii.
CC   Breed/subspecies: Swiss Webster (CFW).
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2874 ! CCRF S-180 II
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   Tg1.K
AC   CVCL_S182
DR   ATCC; CRL-6263
DR   Wikidata; Q54972228
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6263; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_S183 ! Tg1.Sp
OI   CVCL_S184 ! Tg1.Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Tg1.Sp
AC   CVCL_S183
DR   ATCC; CRL-6264
DR   Wikidata; Q54972229
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6264; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_S182 ! Tg1.K
OI   CVCL_S184 ! Tg1.Thy
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Tg1.Thy
AC   CVCL_S184
DR   ATCC; CRL-6265
DR   Wikidata; Q54972230
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6265; true.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_S182 ! Tg1.K
OI   CVCL_S183 ! Tg1.Sp
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   TG2
AC   CVCL_F231
SY   TG-2; GM00345; GM-345; GM345
DR   CLO; CLO_0025561
DR   Coriell; GM00345
DR   Wikidata; Q54972231
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=5062896;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   TG512
AC   CVCL_C3T3
DR   Wikidata; Q116050649
RX   PubMed=6320770;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P89452; Human herpesvirus 2 (HHV-2) major DNA-binding protein (DBP) (Note=Also reacts with HHV-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TG5E
AC   CVCL_C3T4
DR   Wikidata; Q116050650
RX   PubMed=2827804;
RX   PubMed=6541125;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P63018; Rat Hspa8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TGBC-47
AC   CVCL_H709
DR   Wikidata; Q54972232
RX   CelloPub=CLPUB00275;
RX   PubMed=14532968;
RX   PubMed=15645130;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 38 +- 0.3 hours (PubMed=15645130).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 16
//
ID   TGBC11TKB
AC   CVCL_1768
SY   TGBC-11-TKB; TGBC11T
DR   CLO; CLO_0050801
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472160
DR   BioSample; SAMN10987739
DR   cancercelllines; CVCL_1768
DR   Cell_Model_Passport; SIDM00251
DR   ChEMBL-Cells; CHEMBL3308557
DR   ChEMBL-Targets; CHEMBL2366374
DR   Cosmic; 909770
DR   Cosmic; 1187297
DR   Cosmic; 1518259
DR   Cosmic-CLP; 909770
DR   DepMap; ACH-000949
DR   EGA; EGAS00001000978
DR   GDSC; 909770
DR   GEO; GSM887705
DR   GEO; GSM888798
DR   GEO; GSM1670539
DR   IARC_TP53; 27260
DR   LiGeA; CCLE_473
DR   LINCS_LDP; LCL-1892
DR   PharmacoDB; TGBC11TKB_1589_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1768
DR   PubChem_Cell_line; CVCL_1768
DR   RCB; RCB1148
DR   Wikidata; Q54972233
RX   PubMed=11416159;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   HLA typing: A*26:01,26:01; B*35:10,35:10; C*03:03,03:03; DQA1*01:02,05:02; DRB1*13:60,13:60 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Microsatellite instability: Instable (MSI) (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (Cosmic-CLP=909770; DepMap=ACH-000949).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Heterozygous (Cosmic-CLP=909770; DepMap=ACH-000949).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys382Asnfs*40 (c.1146delA); ClinVar=VCV001408583; Zygosity=Heterozygous (Cosmic-CLP=909770; DepMap=ACH-000949).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=81.43%; East Asian, South=18.57%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=909770; PubMed=11416159; RCB=RCB1148
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 11,19
ST   D21S11: 29,30
ST   D5S818: 8,12
ST   D7S820: 10,11
ST   D8S1179: 15,16
ST   FGA: 20,21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,19,20 (RCB=RCB1148)
ST   vWA: 18,20,21 (Cosmic-CLP=909770; PubMed=11416159)
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   TGBC14TKB
AC   CVCL_3340
SY   TGBC-14-TKB; TGBC-14
DR   CLO; CLO_0050016
DR   BioSample; SAMN03472174
DR   Cosmic; 2629293
DR   Cosmic; 2674057
DR   FANTOM5_SSTAR; 10470-106I2
DR   RCB; RCB1186
DR   Wikidata; Q54972235
RX   PubMed=21451941;
RX   PubMed=27231123;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Population: Japanese.
CC   Characteristics: Established from a tumor passaged through a nude mice (RCB=RCB1186).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): RCB=RCB1186
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 14
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   TGBC18TKB
AC   CVCL_3338
SY   TGBC-18-TKB; TGBC-18TKB; UcFu
DR   CLO; CLO_0051538
DR   BioSample; SAMN03472165
DR   Cosmic; 2674055
DR   DepMap; ACH-002023
DR   FANTOM5_SSTAR; 10417-106C3
DR   RCB; RCB1169
DR   Wikidata; Q54972237
RX   PubMed=11416159;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
ST   Source(s): PubMed=11416159; RCB=RCB1169
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 15
ST   D21S11: 31.2,32.2
ST   D5S818: 12,14
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   TGBC1TKB
AC   CVCL_1769
SY   TGBC-1-TKB; TGBC-1TKB; TGBC1-TKB; TGBC-1; TGBC1
DR   CLO; CLO_0050019
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472156
DR   Cell_Model_Passport; SIDM00252
DR   ChEMBL-Cells; CHEMBL3308852
DR   ChEMBL-Targets; CHEMBL2366089
DR   Cosmic; 909769
DR   Cosmic-CLP; 909769
DR   DepMap; ACH-001861
DR   EGA; EGAS00001000978
DR   GDSC; 909769
DR   GEO; GSM1670540
DR   IARC_TP53; 27261
DR   LINCS_LDP; LCL-1343
DR   PharmacoDB; TGBC1TKB_1590_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1769
DR   RCB; RCB1129
DR   Wikidata; Q54972238
RX   PubMed=9824643;
RX   PubMed=20164919;
RX   PubMed=21451941;
RX   PubMed=21533411;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=32293552;
RX   PubMed=32899426;
RX   PubMed=35839778;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 41 hours (PubMed=9824643); 45 hours (PubMed=32293552).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176fs*6 (c.525_526insGCGC); Zygosity=Heterozygous (Cosmic-CLP=909769; DepMap=ACH-001861).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.16%; East Asian, North=75.35%; East Asian, South=24.48%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=909769; DepMap=ACH-001861; RCB=RCB1129
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8 (DepMap=ACH-001861)
ST   D13S317: 8,11 (Cosmic-CLP=909769; RCB=RCB1129)
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,13
ST   D8S1179: 14,16
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9167; Gallbladder undifferentiated carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3339 ! TGBC2TKB
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   TGBC24TKB
AC   CVCL_1770
SY   TGBC-24-TKB; YoMi
DR   CLO; CLO_0050018
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472177
DR   cancercelllines; CVCL_1770
DR   Cell_Model_Passport; SIDM00267
DR   ChEMBL-Cells; CHEMBL3308856
DR   ChEMBL-Targets; CHEMBL2366093
DR   Cosmic; 910695
DR   Cosmic; 2629285
DR   Cosmic-CLP; 910695
DR   DepMap; ACH-002312
DR   EGA; EGAS00001000978
DR   GDSC; 910695
DR   GEO; GSM1670541
DR   IARC_TP53; 27262
DR   LINCS_LDP; LCL-1344
DR   PharmacoDB; TGBC24TKB_1591_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1770
DR   RCB; RCB1196
DR   Wikidata; Q54972239
RX   PubMed=20164919;
RX   PubMed=21451941;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=32899426;
RX   PubMed=35839778;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Alafs*5 (c.723delC) (p.S241fs); ClinVar=VCV001074338; Zygosity=Homozygous (Cosmic-CLP=910695; DepMap=ACH-002312).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=75.8%; East Asian, South=23.94%; South Asian=0%; European, North=0.26%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=910695; RCB=RCB1196
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   TGBC2TKB
AC   CVCL_3339
SY   TGBC-2-TKB; TGBC-2TKB; TGBC-2; TGBC2
DR   CLO; CLO_0050015
DR   Cell_Model_Passport; SIDM00268
DR   Cosmic; 2629292
DR   Cosmic; 2674059
DR   FANTOM5_SSTAR; 10415-106C1
DR   RCB; RCB1130
DR   Wikidata; Q54972240
RX   PubMed=21451941;
RX   PubMed=21533411;
RX   PubMed=32293552;
RX   PubMed=32899426;
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=32293552).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1130
ST   Amelogenin: X
ST   CSF1PO: 14
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 9,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9167; Gallbladder undifferentiated carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1769 ! TGBC1TKB
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   TGBC41TKB
AC   CVCL_E144
SY   TGBC-41-TKB
DR   RCB; RCB1254
DR   Wikidata; Q54972241
CC   Population: Japanese.
CC   Discontinued: RCB; RCB1254; true.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 9
//
ID   TGBC44TKB
AC   CVCL_E145
SY   TGBC-44-TKB; TGBC-44TKB; TGBC-44
DR   RCB; RCB1259
DR   Wikidata; Q54972242
RX   PubMed=9824643;
RX   PubMed=14532968;
RX   PubMed=21533411;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=9824643).
CC   Discontinued: RCB; RCB1259; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7356; Gallbladder adenosquamous carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   TGBC50TKB
AC   CVCL_H693
DR   CLO; CLO_0050114
DR   BioSample; SAMN03472123
DR   PRIDE; PXD002657
DR   RCB; RCB1280
DR   Wikidata; Q54972244
RX   PubMed=26951071;
CC   Population: Japanese.
CC   Omics: Proteomics.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): RCB=RCB1280
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H694 ! TGBC51TKB
OI   CVCL_H695 ! TGBC52TKB
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   TGBC51TKB
AC   CVCL_H694
SY   TGBC-51TKB; TGBC-51
DR   CLO; CLO_0050116
DR   RCB; RCB1281
DR   Wikidata; Q54972245
RX   CelloPub=CLPUB00275;
RX   PubMed=9824643;
RX   PubMed=15645130;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=9824643); 94 +- 0.1 hours (PubMed=15645130).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): RCB=RCB1281
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 9,11
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H693 ! TGBC50TKB
OI   CVCL_H695 ! TGBC52TKB
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 17
//
ID   TGBC52TKB
AC   CVCL_H695
DR   CLO; CLO_0050115
DR   DepMap; ACH-001862
DR   RCB; RCB1282
DR   Wikidata; Q54972246
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): DepMap=ACH-001862; RCB=RCB1282
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10
ST   D18S51: 13
ST   D21S11: 29,32.2
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 10 (DepMap=ACH-001862)
ST   D7S820: 10,11 (RCB=RCB1282)
ST   D8S1179: 15
ST   FGA: 22
ST   Penta D: 9,10
ST   Penta E: 19
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C27418; Ampulla of Vater adenosquamous carcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H693 ! TGBC50TKB
OI   CVCL_H694 ! TGBC51TKB
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   TGBG3
AC   CVCL_B472
DR   Wikidata; Q54972247
RX   CelloPub=CLPUB00145;
CC   Population: Japanese.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C9166; Gallbladder adenocarcinoma
DI   ORDO; Orphanet_424991; Adenocarcinoma of the gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   TGE-R
AC   CVCL_0I63
SY   TGE
DR   CCLV; CCLV-RIE 0256
DR   Wikidata; Q54972248
RX   PubMed=19941903;
CC   Group: Bird cell line.
OX   NCBI_TaxID=8932; ! Columba livia (Rock dove)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 6
//
ID   TGI
AC   CVCL_F584
SY   TER218; TER-218; Ter 218; TER282; TER-282; Ter 282; TER344; TER-344; Ter 344; TER448; TER-448; Ter 448; Extract 53
DR   IPD-IMGT/HLA; 11452
DR   Wikidata; Q54972250
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/354cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,03:01; B*44:02,57:01; C*05:01,06:02; DPB1*04:01; DQA1*01:03,02:01; DQB1*06:03,03:03; DRB1*14:21,07:01; DRB3*01:01; DRB4*01:03:01:02N (IPD-IMGT/HLA=11452).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   tGM24
AC   CVCL_7703
SY   hTERT-GM00024; HTERT-GM00024
DR   Wikidata; Q54972251
RX   PubMed=16140041;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7269 ! GM00024
SX   Male
AG   31Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   TgMab-2
AC   CVCL_D2TF
DR   Wikidata; Q127384381
RX   PubMed=33900817;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q495A1; Human TIGIT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   TGP47
AC   CVCL_4318
SY   TGP 47
DR   CLO; CLO_0009338
DR   ATCC; CRL-2141
DR   Wikidata; Q54972252
RX   PubMed=7904904;
RX   PubMed=12006552;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34036; Mouse pancreatic acinar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   TGP48
AC   CVCL_IV01
SY   TGP 48
DR   Wikidata; Q54972253
RX   PubMed=7904904;
RX   PubMed=12006552;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34050; Mouse islet cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   TGP49
AC   CVCL_4319
SY   TGP 49
DR   CLO; CLO_0009334
DR   CLO; CLO_0009339
DR   CLDB; cl4504
DR   ATCC; CRL-2136
DR   ECACC; 94022427
DR   Wikidata; Q54972254
RX   PubMed=7904904;
RX   PubMed=12006552;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34036; Mouse pancreatic acinar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   TGP50
AC   CVCL_IV02
DR   Wikidata; Q54972255
RX   PubMed=7904904;
RX   PubMed=12006552;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34050; Mouse islet cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 7
//
ID   TGP51
AC   CVCL_IV03
DR   Wikidata; Q54972256
RX   PubMed=7904904;
RX   PubMed=12006552;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34036; Mouse pancreatic acinar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 8
//
ID   TGP52
AC   CVCL_4320
SY   TGP 52
DR   CLO; CLO_0009335
DR   CLO; CLO_0009340
DR   CLDB; cl4505
DR   ATCC; CRL-2140
DR   ECACC; 94022429
DR   Wikidata; Q54972258
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34050; Mouse islet cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   TGP54
AC   CVCL_4307
SY   TGP 54
DR   CLO; CLO_0009336
DR   CLDB; cl4506
DR   ECACC; 94022430
DR   Wikidata; Q54972259
RX   PubMed=7904904;
RX   PubMed=12006552;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34050; Mouse islet cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   26W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   TGP55
AC   CVCL_4322
SY   TGP 55
DR   CLO; CLO_0009337
DR   CLO; CLO_0009341
DR   CLDB; cl4507
DR   ATCC; CRL-2150
DR   ECACC; 95062833
DR   Wikidata; Q54972260
RX   PubMed=7904904;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   7-8M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   TGP61
AC   CVCL_4323
SY   TGP 61
DR   CLO; CLO_0009342
DR   ATCC; CRL-2135
DR   Wikidata; Q54972261
RX   PubMed=7904904;
CC   Characteristics: Expresses but does not secrete somatostatin.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Breed/subspecies: Tg(E1a-1-SV40E)Bri18 transgenic.
DI   NCIt; C34050; Mouse islet cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   26W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 11
//
ID   TGR-1
AC   CVCL_T955
DR   TOKU-E; 3592
DR   Wikidata; Q54972262
RX   PubMed=8455944;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0492 ! Rat1
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   TgSVA
AC   CVCL_U966
DR   Wikidata; Q54972263
RX   PubMed=8389915;
CC   Virology: Highly susceptible to infection by poliovirus (PubMed=8389915).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:9705; PVR.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: ICR-PVRTg1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   TgSVB
AC   CVCL_U967
DR   Wikidata; Q54972265
RX   PubMed=8389915;
CC   Virology: Highly susceptible to infection by poliovirus (PubMed=8389915).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:9705; PVR.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: ICR-PVRTg1 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   TGW
AC   CVCL_1771
SY   TOG; TGW-nu; TGW-I-nu; TGW-nu-1
DR   CLO; CLO_0009830
DR   EFO; EFO_0022441
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1037
DR   BioSample; SAMN03471635
DR   cancercelllines; CVCL_1771
DR   Cell_Model_Passport; SIDM00324
DR   ChEMBL-Cells; CHEMBL3308792
DR   ChEMBL-Targets; CHEMBL1075600
DR   Cosmic; 801749
DR   Cosmic; 910780
DR   Cosmic; 920238
DR   Cosmic; 947703
DR   Cosmic; 1037349
DR   Cosmic; 1099146
DR   Cosmic; 1153801
DR   Cosmic; 2131589
DR   Cosmic-CLP; 910780
DR   DepMap; ACH-001674
DR   EGA; EGAS00001000978
DR   GDSC; 910780
DR   GEO; GSM314028
DR   GEO; GSM333815
DR   GEO; GSM1670542
DR   JCRB; JCRB0618
DR   LINCS_LDP; LCL-1962
DR   Lonza; 1191
DR   PharmacoDB; TGW_1592_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1771
DR   PubChem_Cell_line; CVCL_1771
DR   Wikidata; Q54972266
RX   PubMed=2335222;
RX   PubMed=12210830;
RX   PubMed=15892104;
RX   PubMed=18923524;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-424.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 32 hours (Note=Lot 06012007), ~27 hours (Note=Lot 04172014) (JCRB=JCRB0618).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=71.87%; East Asian, South=26.74%; South Asian=0.97%; European, North=0.42%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Cosmic-CLP=910780; DepMap=ACH-001674; JCRB=JCRB0618
ST   Amelogenin: X
ST   CSF1PO: 15
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 14
ST   D21S11: 30,33.2
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   TGW.P3
AC   CVCL_3180
DR   BioSample; SAMN03471636
DR   JCRB; JCRB0618.1
DR   JCRB; NIHS0371
DR   Wikidata; Q54972268
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0371; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): JCRB=JCRB0618.1
ST   Amelogenin: X
ST   CSF1PO: 15
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1771 ! TGW
SX   Male
AG   1Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   TH [Human esophageal squamous cell carcinoma]
AC   CVCL_VH05
DR   Wikidata; Q54972276
RX   DOI=10.1093/oxfordjournals.jjco.a038751;
CC   Population: Japanese.
CC   Doubling time: ~17 hours (DOI=10.1093/oxfordjournals.jjco.a038751).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 7
//
ID   TH [Human plasma cell myeloma]
AC   CVCL_M528
DR   Cosmic; 720794
DR   Cosmic; 760395
DR   Cosmic; 2302419
DR   Wikidata; Q54972277
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1958480;
RX   PubMed=8943038;
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=11157491;
CC   Characteristics: Produces IgG3 kappa.
CC   Doubling time: ~24 hours (PubMed=1958480).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   TH [Tilapia]
AC   CVCL_YD07
SY   Tilapia Heart
DR   Wikidata; Q98133232
RX   PubMed=31515819;
CC   Group: Fish cell line.
CC   Characteristics: Grows well from 25 to 32 Celsius, the optimal growth temperature is 28 Celsius.
CC   Virology: Highly susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 6
//
ID   TH-1
AC   CVCL_G000
DR   TKG; TKG 0270
DR   Wikidata; Q54972279
RX   PubMed=2562090;
CC   Population: Japanese.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): TKG=TKG 0270
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y11M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 11
//
ID   TH-1 subline B1
AC   CVCL_4324
SY   TH-1, Subline B1; TH-1, Sub B1; TH-1B1; TH-1; Terrapene Heart-1
DR   CLO; CLO_0009343
DR   CLDB; cl4508
DR   CLDB; cl4509
DR   ATCC; CCL-50
DR   CCLV; CCLV-RIE 1131
DR   ECACC; 90102528
DR   Wikidata; Q54972280
RX   DOI=10.1007/BF02618370;
RX   PubMed=4295486;
RX   PubMed=4344303;
RX   PubMed=6082587;
RX   PubMed=19941903;
CC   Group: Reptilian cell line.
CC   Discontinued: ECACC; 90102528; true.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=158814; ! Terrapene carolina (Eastern box turtle)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   TH-111
AC   CVCL_WP01
DR   Wikidata; Q98133233
RX   PubMed=9845376;
RX   PubMed=22879978;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P40200; Human CD96.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   TH-4
AC   CVCL_UA24
SY   TH4; Terrapene Heart-4
DR   Wikidata; Q98133235
RX   PubMed=4344303;
RX   PubMed=6082587;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=158814; ! Terrapene carolina (Eastern box turtle)
OI   CVCL_UA25 ! TH-4W
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   TH-4W
AC   CVCL_UA25
SY   TH4W; Terrapene Heart-4W
DR   Wikidata; Q98133236
RX   PubMed=4344303;
RX   PubMed=6082587;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=158814; ! Terrapene carolina (Eastern box turtle)
OI   CVCL_UA24 ! TH-4
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   TH-5
AC   CVCL_UA26
SY   TH5; Terrapene Heart-5
DR   Wikidata; Q98133237
RX   PubMed=4344303;
RX   PubMed=6082587;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=158814; ! Terrapene carolina (Eastern box turtle)
OI   CVCL_UA27 ! TH-5W
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   TH-5W
AC   CVCL_UA27
SY   TH5W; Terrapene Heart-5W
DR   Wikidata; Q98133238
RX   PubMed=6082587;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=158814; ! Terrapene carolina (Eastern box turtle)
OI   CVCL_UA26 ! TH-5
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   TH-69
AC   CVCL_WP02
SY   TH 69; TH69
DR   ABCD; ABCD_AD355
DR   Wikidata; Q98133239
RX   CelloPub=CLPUB00509;
RX   PubMed=8904888;
RX   PubMed=12019163;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   TH-EM1
AC   CVCL_VU66
DR   Wikidata; Q98133240
RX   PubMed=30819050;
CC   Doubling time: 96 hours (PubMed=30819050).
DI   NCIt; C158138; Thoracic endometriosis
DI   ORDO; Orphanet_137820; Extrapelvic endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   TH-mOrange hiPSC
AC   CVCL_C3PH
SY   SP11#1 TH rep
DR   Wikidata; Q116050651
RX   PubMed=31048719;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/ANEXO+2_SP11-wild+type+TH+rep.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_SP11-wild+type+TH-rep.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Barcelona; Spain.
CC   Characteristics: Using CRISPR/Cas9 P2A-mOrange construct was integrated after the stop codon of TH in both alleles (PubMed=31048719).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; G6HDH; mOrange (Note=Bright orange fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   TH01: 9,10
ST   TPOX: 10,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RI59 ! SP11.1
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   TH::GFP
AC   CVCL_JJ81
DR   Wikidata; Q54972281
RX   PubMed=28413000;
CC   Characteristics: Expresses GFP under the control of the rat TH promoter.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 8
//
ID   TH::GFP;PrP::hSNCAA53T
AC   CVCL_JJ82
DR   Wikidata; Q54972282
RX   PubMed=28413000;
CC   Characteristics: Expresses GFP under the control of the rat TH promoter and human mutant SNCA p.Ala53Thr under the control of the mouse prion (PrP) promoter.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11138; SNCA (Note=With p.Ala53Thr).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x B6;C3-Tg(Prnp-SNCA*A53T)83Vle/J transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   TH1
AC   CVCL_5J51
DR   Kerafast; ECH001
DR   Wikidata; Q54972283
RX   Patent=US20050136539;
RX   PubMed=15208689;
CC   Group: Patented cell line.
CC   Characteristics: Reversible immortalized. The transduced hTERT and SV40 Tag genes are flanked by loxP sites. Transient Cre expression in this cell line leads to deletion of the two genes thus leading to a decrease in the rate of cell proliferation and ultimately to cell senescence (PubMed=15208689).
CC   Doubling time: 40-48 hours (PubMed=15208689).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5J52 ! TH7
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   TH202
AC   CVCL_AS73
DR   Wikidata; Q54972284
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 13,17
ST   D19S433: 15,15.2
ST   D21S11: 28,29
ST   D2S1338: 20,25
ST   D3S1358: 14,18
ST   D5S818: 7,10
ST   D7S820: 8,10
ST   D8S1179: 11,14
ST   FGA: 20
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 7
//
ID   TH4-7-5
AC   CVCL_B7RA
DR   Wikidata; Q112930468
RX   Patent=DE3940527C2;
RX   Patent=WO1990015150A1;
RX   PubMed=1373627;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-861.
CC   Virology: In vitro persistently infected by HIV-1. Produces substantial amounts of Nef (PubMed=1373627).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B7R9 ! 85HG-66
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 5
//
ID   TH4B
AC   CVCL_B7RC
DR   Wikidata; Q112930471
RX   PubMed=1454825;
RX   PubMed=3183586;
RX   PubMed=9415422;
RX   PubMed=10194417;
RX   PubMed=25740486;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Hindlimb, thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
OX   NCBI_TaxID=8316; ! Notophthalmus viridescens (Eastern newt)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   TH6
AC   CVCL_E5R5
RX   PubMed=21056889;
RX   PubMed=29558682;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; Q76ZQ3; Vaccinia virus virion membrane protein OPG140 (A14L).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TH7
AC   CVCL_5J52
DR   Wikidata; Q54972285
RX   Patent=US20050136539;
RX   PubMed=15208689;
CC   Group: Patented cell line.
CC   Characteristics: Reversible immortalized. The transduced hTERT and SV40 Tag genes are flanked by loxP sites. Transient Cre expression in this cell line leads to deletion of the two genes thus leading to a decrease in the rate of cell proliferation and ultimately to cell senescence (PubMed=15208689).
CC   Doubling time: 40-48 hours (PubMed=15208689).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5J51 ! TH1
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   THA
AC   CVCL_E847
SY   TER332; TER-332; Ter 332; TER425; TER-425; Ter 425
DR   dbMHC; 49039
DR   ECACC; 94050318
DR   IHW; IHW09327
DR   IPD-IMGT/HLA; 11456
DR   Wikidata; Q54972287
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/343cx.pdf
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: African American.
CC   HLA typing: A*03:01:01:01,31:01:02:01; B*35:03,15:18:01:02; C*04:01:01:01,07:04:01; DPA1*01:03:01:04,01:03:01:02; DPB1*04:01:01; DQA1*01:03:01:01,01:04:01; DQB1*05:03:01,06:01:01; DRB1*13:08,15:02:02; DRB3*02:02:01; DRB5*01:02 (IPD-IMGT/HLA=11456).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   THAI742
AC   CVCL_E848
SY   THAI 742; Extract 336
DR   dbMHC; 49040
DR   ECACC; 94022548
DR   IHW; IHW09253
DR   IPD-IMGT/HLA; 11472
DR   Wikidata; Q54972288
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Southeast Asian; Thai.
CC   HLA typing: A*24:03,33:03; B*46:01:01,15:12; C*01:02,03:03; DPB1*04:02,05:01; DQB1*03:01:01,03:02:01; DRB1*04:06,12:02:01; DRB3*03:01:01; DRB4*01:03:01:01 (IPD-IMGT/HLA=11472).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   THB-5
AC   CVCL_2215
SY   HB-5; HB5
DR   CLO; CLO_0009344
DR   CLDB; cl4510
DR   ABCD; ABCD_AI497
DR   ATCC; HB-135
DR   DSMZ; ACC-88
DR   DSMZCellDive; ACC-88
DR   Wikidata; Q54972289
CC   Doubling time: ~50 hours (DSMZ=ACC-88).
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P20023; Human CR2/CD21.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   THB-7
AC   CVCL_D038
SY   HB-7; HB7
DR   CLO; CLO_0009345
DR   ABCD; ABCD_AG338
DR   ATCC; HB-136
DR   Wikidata; Q54972290
RX   PubMed=6440308;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P28907; Human CD38.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   THC-252
AC   CVCL_6732
SY   THC 252
DR   BTO; BTO_0004336
DR   Wikidata; Q54972291
RX   PubMed=2684401;
RX   PubMed=2990676;
CC   Characteristics: Established by intraperitoneal transplantation of primary tumors.
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   THC-252.2
AC   CVCL_C0DR
SY   THC 252.2
DR   Wikidata; Q112930474
RX   PubMed=2684401;
RX   PubMed=2990676;
CC   Characteristics: Substrate adherent.
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6732 ! THC-252
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   THC-253
AC   CVCL_6733
SY   THC 253; THC253
DR   Wikidata; Q54972292
RX   PubMed=2684401;
RX   PubMed=2990676;
CC   Characteristics: Established by subcutaneous transplantation of primary tumors.
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   THC-253.1
AC   CVCL_C0DS
SY   THC 253.1
DR   Wikidata; Q112930475
RX   PubMed=2684401;
RX   PubMed=2990676;
CC   Transformant: ChEBI; CHEBI_17356; 2-acetamidofluorene (2AAF).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: ACI; RS=RS_0000012.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_6733 ! THC-253
SX   Male
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   THC10A
AC   CVCL_XF15
SY   THC-10A; THC-KLH-CH1
DR   CCRID; 4201PAT-CCTCC00282
DR   Wikidata; Q98133241
RX   Patent=CN101580544B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200915.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_66964; Delta(9)-tetrahydrocannabinol (THC).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   THG1-24
AC   CVCL_J775
DR   ECACC; 87120202
DR   Wikidata; Q54972295
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
CC   Discontinued: ECACC; 87120202; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   THG3-B5-13
AC   CVCL_J094
DR   ECACC; 88022402
DR   Wikidata; Q54972297
RX   PubMed=3500259;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   THG3-MP-2-19-3-8
AC   CVCL_J095
DR   ECACC; 88012701
DR   Wikidata; Q54972299
RX   PubMed=3500259;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   THJ-11T
AC   CVCL_W919
SY   THJ11T
DR   ABM; T8251
DR   cancercelllines; CVCL_W919
DR   Cosmic; 2054093
DR   Wikidata; Q54972300
RX   PubMed=20810568;
RX   PubMed=23724124;
RX   PubMed=23833040;
CC   Doubling time: 30 hours (PubMed=20810568).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=20810568; PubMed=23833040).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040).
CC   Miscellaneous: STR profile and age of donor from personal communication of Marlow, Laura A.
CC   Caution: Cell line wrongly indicated as being female in figure 2A of PubMed=20810568.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D18S51: 12,14
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 5,6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 19
//
ID   THJ-16T
AC   CVCL_W920
SY   THJ16T
DR   ABM; T8252
DR   cancercelllines; CVCL_W920
DR   Cosmic; 2054100
DR   Wikidata; Q54972301
RX   PubMed=20810568;
RX   PubMed=23724124;
RX   PubMed=23833040;
RX   PubMed=25675381;
RX   PubMed=26680454;
RX   PubMed=30737244;
CC   Doubling time: 27 hours (PubMed=20810568).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1097; BRAF + HGNC; HGNC:7112; MKRN1; Name(s)=MKRN1-BRAF; Note=In frame (PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Ser799Phefs*5 (c.2396delC); Zygosity=Homozygous (PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (PubMed=23833040; PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Glu90Lys (c.268G>A); Zygosity=Heterozygous (PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 10,11
ST   D16S539: 9,12
ST   D18S51: 17,19
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 23,27
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 19
//
ID   THJ-21T
AC   CVCL_W921
SY   THJ21T
DR   ABM; T8253
DR   cancercelllines; CVCL_W921
DR   Cosmic; 2054082
DR   Wikidata; Q54972302
RX   PubMed=20810568;
RX   PubMed=23724124;
RX   PubMed=23833040;
RX   PubMed=26680454;
RX   PubMed=30737244;
CC   Doubling time: 43 hours (PubMed=20810568).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=23833040; PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 11,15
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13,15
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 9,14
ST   FGA: 24
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 20
//
ID   THJ-29T
AC   CVCL_W922
SY   THJ29T
DR   ABM; T8254
DR   cancercelllines; CVCL_W922
DR   Cosmic; 2054113
DR   Wikidata; Q54972303
RX   PubMed=20810568;
RX   PubMed=23724124;
RX   PubMed=23833040;
RX   PubMed=25675381;
RX   PubMed=26680454;
RX   PubMed=30737244;
CC   Doubling time: 35 hours (PubMed=20810568).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3689; FGFR2 + HGNC; HGNC:8124; OGDH; Name(s)=FGFR2-OGDH; Note=In frame (PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gln70Serfs*102 (c.207delG) (G55fs); Zygosity=Homozygous (PubMed=26680454; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:18128; HDAC10; Simple; p.His134Thrfs*19 (c.399delG); dbSNP=rs759210981; Zygosity=Heterozygous (PubMed=26680454).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 15
ST   D21S11: 28,32,33
ST   D3S1358: 16,18
ST   D5S818: 11,14
ST   D7S820: 10
ST   D8S1179: 14,16
ST   FGA: 22,26
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 19
//
ID   THJ529
AC   CVCL_RP39
DR   ABM; T8261
DR   cancercelllines; CVCL_RP39
DR   Wikidata; Q54972304
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Cys (c.722C>G); ClinVar=VCV000177791; Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D21S11: 31.2,32.2
ST   D3S1358: 15,19
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 24,24.2
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C6040; Poorly differentiated thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   THJ560
AC   CVCL_RP40
DR   ABM; T8262
DR   cancercelllines; CVCL_RP40
DR   Wikidata; Q54972305
RX   PubMed=29846633;
RX   PubMed=30737244;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=29846633; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Homozygous (PubMed=29846633; PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=29846633; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 9,14
ST   D18S51: 15
ST   D21S11: 29,32.2
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 15
//
ID   THK [Hamster]
AC   CVCL_U475
SY   Transformed Hamster Kidney
DR   CLO; CLO_0051402
DR   RCB; RCB1832
DR   Wikidata; Q54972306
RX   PubMed=7288919;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   THK [Tilapia]
AC   CVCL_DE02
SY   Tilapia Head Kidney
DR   Wikidata; Q54972307
RX   PubMed=26806163;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 7
//
ID   THK 22A Cl 1
AC   CVCL_D5D4
SY   Transformed Hamster Kidney 22 clone A subclone 1
DR   Wikidata; Q127384383
RX   PubMed=171845;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D5D5 ! THK 22E Cl 1
OI   CVCL_D5D6 ! THK 22G Cl 1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22A Cl 1.1
AC   CVCL_D5D7
SY   Transformed Hamster Kidney 22 clone A subclone 1.1
DR   Wikidata; Q127384384
RX   PubMed=171845;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D5D4 ! THK 22A Cl 1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22A Cl 1.1 AP1
AC   CVCL_D5DA
SY   Transformed Hamster Kidney 22 clone A subclone 1.1 Animal Passage 1
DR   Wikidata; Q127384385
RX   PubMed=171845;
CC   Characteristics: Derived from the parent cell line through transplantation in an hamster (PubMed=171845).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D5D7 ! THK 22A Cl 1.1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22E Cl 1
AC   CVCL_D5D5
SY   Transformed Hamster Kidney 22 clone E subclone 1
DR   Wikidata; Q127384386
RX   PubMed=171845;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D5D4 ! THK 22A Cl 1
OI   CVCL_D5D6 ! THK 22G Cl 1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22E Cl 1.1
AC   CVCL_D5D8
SY   Transformed Hamster Kidney 22 clone A subclone 1.1
DR   Wikidata; Q127384388
RX   PubMed=171845;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D5D5 ! THK 22E Cl 1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22E Cl 1.1 AP1
AC   CVCL_D5DB
SY   Transformed Hamster Kidney 22 clone E subclone 1.1 Animal Passage 1
DR   Wikidata; Q127384389
RX   PubMed=171845;
CC   Characteristics: Derived from the parent cell line through transplantation in an hamster (PubMed=171845).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D5D8 ! THK 22E Cl 1.1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22G Cl 1
AC   CVCL_D5D6
SY   Transformed Hamster Kidney 22 clone G subclone 1
DR   Wikidata; Q127384390
RX   PubMed=171845;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_D5D4 ! THK 22A Cl 1
OI   CVCL_D5D5 ! THK 22E Cl 1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22G Cl 1.1
AC   CVCL_D5D9
SY   Transformed Hamster Kidney 22 clone G subclone 1.1
DR   Wikidata; Q127384391
RX   PubMed=171845;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D5D6 ! THK 22G Cl 1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK 22G Cl 1.1 AP1
AC   CVCL_D5DC
SY   Transformed Hamster Kidney 22 clone G subclone 1.1 Animal Passage 1
DR   Wikidata; Q127384392
RX   PubMed=171845;
CC   Characteristics: Derived from the parent cell line through transplantation in an hamster (PubMed=171845).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: LSH/SsLak; VBO=VBO_0017489.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D5D9 ! THK 22G Cl 1.1
SX   Sex unspecified
AG   Weaned
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   THK-1
AC   CVCL_DE00
SY   Transformed Hamster Kidney-1
DR   Wikidata; Q54972309
RX   PubMed=14077486;
RX   PubMed=14206435;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
SX   Sex unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   THK-72
AC   CVCL_UI39
DR   Wikidata; Q98133242
RX   CelloPub=CLPUB00456;
CC   Population: Japanese.
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: ~40-80 hours (CelloPub=CLPUB00456).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 8
//
ID   THLE-2
AC   CVCL_3803
SY   THLE2; Transformed Human Liver Epithelial-2
DR   CLO; CLO_0009346
DR   AddexBio; T0015001/4912
DR   ATCC; CRL-2706
DR   BioSample; SAMN03471297
DR   ChEMBL-Cells; CHEMBL4295456
DR   ChEMBL-Targets; CHEMBL4296500
DR   Cosmic; 2162542
DR   IARC_TP53; 23553
DR   IZSLER; BS CL 194
DR   PubChem_Cell_line; CVCL_3803
DR   Wikidata; Q54972310
RX   DOI=10.1007/978-1-4612-0411-4_31;
RX   Patent=US5529920;
RX   Patent=US5759765;
RX   PubMed=7685115;
RX   PubMed=8504475;
RX   PubMed=23887712;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10149.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): AddexBio=T0015001/4912; ATCC=CRL-2706; IZSLER=BS CL 194
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,23
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 10,13
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 25
//
ID   THLE-3
AC   CVCL_3804
SY   THLE3; Transformed Human Liver Epithelial-3
DR   CLO; CLO_0009347
DR   AddexBio; T0015002/4913
DR   ATCC; CRL-3583
DR   ATCC; CRL-11233
DR   BioSample; SAMN03471331
DR   CCRID; 3101HUMGNHu40
DR   CCRID; 5301HUM-KCB19018YJ
DR   Cosmic; 2162543
DR   IARC_TP53; 23554
DR   KCB; KCB 2019018YJ
DR   Wikidata; Q54972311
RX   DOI=10.1007/978-1-4612-0411-4_31;
RX   Patent=US5759765;
RX   PubMed=7685115;
RX   PubMed=8504475;
RX   PubMed=23887712;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11233.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ATCC; CRL-11233; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): AddexBio=T0015002/4913; ATCC=CRL-3583
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 13
ST   D7S820: 8,10
ST   TH01: 8,9.3
ST   TPOX: 6,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
ID   THLE-5B
AC   CVCL_M209
SY   THLE-5b; THLE5B; THLE-5; Transformed Human Liver Epithelial-5B
DR   BTO; BTO_0005782
DR   ArrayExpress; E-MTAB-7847
DR   Wikidata; Q54972313
RX   DOI=10.1007/978-1-4612-0411-4_31;
RX   Patent=US5506131;
RX   PubMed=7972006;
RX   PubMed=16962796;
RX   PubMed=18157683;
RX   PubMed=33495943;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11113.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   THLE-5B-1A1
AC   CVCL_IQ12
DR   Wikidata; Q54972314
RX   Patent=US5506131;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 7
//
ID   THLE-5B-1A2
AC   CVCL_IQ13
DR   Wikidata; Q54972315
RX   Patent=US5506131;
RX   PubMed=22851615;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-5B-2A6
AC   CVCL_IQ14
DR   Wikidata; Q54972316
RX   Patent=US5506131;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-5B-2B6
AC   CVCL_IQ15
DR   Wikidata; Q54972317
RX   Patent=US5506131;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2615; CYP2B6.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-5B-2C19
AC   CVCL_IQ16
DR   Wikidata; Q54972318
RX   PubMed=22851615;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2621; CYP2C19.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-5B-2C9
AC   CVCL_IQ17
DR   Wikidata; Q54972319
RX   Patent=US5506131;
RX   PubMed=22851615;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2623; CYP2C9.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-5B-2D6
AC   CVCL_IQ18
DR   Wikidata; Q54972320
RX   Patent=US5506131;
RX   PubMed=22851615;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2625; CYP2D6.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-5B-2E1
AC   CVCL_IQ19
SY   THLE-2E1
DR   Wikidata; Q54972321
RX   Patent=US5506131;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THLE-B5-3A4
AC   CVCL_IQ20
DR   Wikidata; Q54972322
RX   Patent=US5506131;
RX   PubMed=22851615;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M209 ! THLE-5B
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 9
//
ID   THM 7.3.5
AC   CVCL_J092
DR   ECACC; 87120201
DR   Wikidata; Q54972331
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_53793; (4-hydroxy-3-nitrophenyl)acetyl group (NP).
CC   Discontinued: ECACC; 87120201; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3949 ! J558L
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   Thm-1
AC   CVCL_E7XQ
WW   Info; KAKEN; 06454392; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-06454392/
CC   Population: Japanese.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
DI   NCIt; C3411; Thymoma
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   tHmf-e
AC   CVCL_0A61
DR   Wikidata; Q54972332
RX   PubMed=3515628;
CC   Doubling time: ~40 hours (PubMed=3515628).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0A60 ! tHmf-f
SX   Male
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   tHmf-f
AC   CVCL_0A60
DR   Wikidata; Q54972333
RX   PubMed=3515628;
CC   Doubling time: ~17 hours (PubMed=3515628).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Myofibroblast; CL=CL_0000186.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   THO
AC   CVCL_E849
DR   IHW; 9w 1406
DR   Wikidata; Q54972335
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*02,03; B*60; C*w03 (IHW=9w 1406).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   THO,MA
AC   CVCL_E850
SY   THO, MA
DR   dbMHC; 49041
DR   ECACC; 94082258
DR   IHW; IHW09158
DR   IPD-IMGT/HLA; 11701
DR   Wikidata; Q54972336
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,11; B*07,27; C*02,07; DPB1*04:01; DQA1*01:02,03; DQB1*03:01,06:02; DRB1*04:01,15:01; DRB4*01:01; DRB5*01:01 (IPD-IMGT/HLA=11701).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   ThoCu
AC   CVCL_U958
DR   Wikidata; Q54972338
RX   PubMed=14490970;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   Thomas
AC   CVCL_UB96
SY   THOMAS
DR   Cosmic; 2814543
DR   GEO; GSM862847
DR   GEO; GSM862848
DR   GEO; GSM862849
DR   GEO; GSM862850
DR   GEO; GSM960121
DR   GEO; GSM960122
DR   GEO; GSM960123
DR   GEO; GSM960124
DR   Wikidata; Q98133243
RX   PubMed=22885699;
RX   PubMed=25960936;
CC   HLA typing: A*02:11,25:01; B*52:01,18:01; C*15:02,12:03; DQA1*05:01,02:01; DQB1*03:01,02:01; DRB1*07:01,14:02 (PubMed=25960936).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   THP-1
AC   CVCL_0006
SY   THP1; THP 1; THPI; THP-1(ATCC); THP-1-O; O-THP-1; Tohoku Hospital Pediatrics-1
DR   BTO; BTO_0001370
DR   CLO; CLO_0009348
DR   CLO; CLO_0050999
DR   EFO; EFO_0001253
DR   MCCL; MCC:0000461
DR   CLDB; cl4513
DR   CLDB; cl4514
DR   CLDB; cl4515
DR   CLDB; cl4517
DR   Abcam; ab271147
DR   Abcam; ab275477
DR   Abcam; ab281894
DR   AddexBio; C0003024/4956
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; TIB-202
DR   BCRC; 60430
DR   BCRJ; 0234
DR   BEI_Resources; ARP-9942
DR   BioGRID_ORCS_Cell_line; 220
DR   BioSample; SAMN03470795
DR   BioSample; SAMN03473256
DR   BioSample; SAMN03473419
DR   BioSample; SAMN10987847
DR   cancercelllines; CVCL_0006
DR   CCRID; 1101HUM-PUMC000057
DR   CCRID; 1102HUM-NIFDC00058
DR   CCRID; 3101HUMSCSP567
DR   CCRID; 3101HUMTCHu57
DR   CCRID; 4201HUM-CCTCC00100
DR   CCTCC; GDC0100
DR   Cell_Model_Passport; SIDM01172
DR   ChEMBL-Cells; CHEMBL3307574
DR   ChEMBL-Targets; CHEMBL614245
DR   CLS; 300356
DR   Cosmic; 717684
DR   Cosmic; 724818
DR   Cosmic; 787480
DR   Cosmic; 909771
DR   Cosmic; 919122
DR   Cosmic; 924051
DR   Cosmic; 947361
DR   Cosmic; 975303
DR   Cosmic; 991556
DR   Cosmic; 996316
DR   Cosmic; 998748
DR   Cosmic; 1012124
DR   Cosmic; 1037666
DR   Cosmic; 1070694
DR   Cosmic; 1078722
DR   Cosmic; 1089517
DR   Cosmic; 1150901
DR   Cosmic; 1176587
DR   Cosmic; 1181604
DR   Cosmic; 1187864
DR   Cosmic; 1197931
DR   Cosmic; 1278779
DR   Cosmic; 1281356
DR   Cosmic; 1319551
DR   Cosmic; 1476425
DR   Cosmic; 1519163
DR   Cosmic; 1524842
DR   Cosmic; 1601064
DR   Cosmic; 1604863
DR   Cosmic; 2089655
DR   Cosmic; 2131559
DR   Cosmic; 2306241
DR   Cosmic; 2392976
DR   Cosmic-CLP; 909771
DR   DepMap; ACH-000146
DR   DSMZ; ACC-16
DR   DSMZCellDive; ACC-16
DR   ECACC; 88081201
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS248PAQ
DR   ENCODE; ENCBS443IYN
DR   ENCODE; ENCBS461BPB
DR   ENCODE; ENCBS615XLU
DR   ENCODE; ENCBS913QYS
DR   ENCODE; ENCBS980LBL
DR   FANTOM5_SSTAR; 10399-106A3
DR   FANTOM5_SSTAR; 10400-106A4
DR   FANTOM5_SSTAR; 10405-106A9
DR   GDSC; 909771
DR   GEO; GSM236807
DR   GEO; GSM236843
DR   GEO; GSM482495
DR   GEO; GSM838432
DR   GEO; GSM838433
DR   GEO; GSM887706
DR   GEO; GSM888799
DR   GEO; GSM1374962
DR   GEO; GSM1446742
DR   GEO; GSM1670543
DR   GEO; GSM2141952
DR   GEO; GSM2141956
DR   GEO; GSM2141958
DR   GEO; GSM2141959
DR   GEO; GSM2141962
DR   GEO; GSM2141968
DR   GEO; GSM2141972
DR   GEO; GSM2141974
DR   GEO; GSM2141979
DR   GEO; GSM2141986
DR   GEO; GSM2141987
DR   GEO; GSM2141993
DR   GEO; GSM2141995
DR   GEO; GSM2141998
DR   GEO; GSM2141999
DR   GEO; GSM2142000
DR   GEO; GSM2142004
DR   GEO; GSM2142005
DR   GEO; GSM2142009
DR   GEO; GSM2142011
DR   GEO; GSM2142015
DR   GEO; GSM2142016
DR   GEO; GSM2142019
DR   GEO; GSM2142021
DR   GEO; GSM2142023
DR   GEO; GSM2142024
DR   GEO; GSM2142028
DR   GEO; GSM2142029
DR   GEO; GSM2142030
DR   GEO; GSM2142031
DR   GEO; GSM2142036
DR   GEO; GSM2142037
DR   GEO; GSM2142039
DR   GEO; GSM2142048
DR   GEO; GSM2142049
DR   GEO; GSM2142052
DR   GEO; GSM2142053
DR   GEO; GSM2142055
DR   GEO; GSM2142059
DR   GEO; GSM2142060
DR   GEO; GSM7701404
DR   GEO; GSM7701405
DR   IARC_TP53; 2198
DR   ICLC; HTL97014
DR   IGRhCellID; THP1
DR   IZSLER; BS TCL 138
DR   JCRB; JCRB0112
DR   JCRB; JCRB0112.1
DR   KCB; KCB 200549YJ
DR   KCLB; 40202
DR   LiGeA; CCLE_181
DR   LINCS_HMS; 50861
DR   LINCS_LDP; LCL-1072
DR   Lonza; 134
DR   MeSH; D000074084
DR   NCBI_Iran; C563
DR   PharmacoDB; THP1_1593_2019
DR   PRIDE; PRD000345
DR   PRIDE; PXD000328
DR   PRIDE; PXD000953
DR   PRIDE; PXD004034
DR   PRIDE; PXD008516
DR   PRIDE; PXD011690
DR   PRIDE; PXD015039
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0006
DR   PubChem_Cell_line; CVCL_0006
DR   RCB; RCB1189
DR   RCB; RCB3686
DR   TKG; TKG 0267
DR   Ubigene; YC-D011
DR   Wikidata; Q7670282
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=1915666;
RX   PubMed=2633408;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6091813;
RX   PubMed=6949641;
RX   PubMed=6970727;
RX   PubMed=8558913;
RX   PubMed=9290701;
RX   PubMed=9379676;
RX   PubMed=9510473;
RX   PubMed=9738977;
RX   PubMed=10223614;
RX   PubMed=10739008;
RX   PubMed=11066077;
RX   PubMed=11226526;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=12068308;
RX   PubMed=14504097;
RX   PubMed=14671638;
RX   PubMed=15843827;
RX   PubMed=16311011;
RX   PubMed=16337770;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=19220422;
RX   PubMed=19377474;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22481983;
RX   PubMed=22645513;
RX   PubMed=22674354;
RX   PubMed=23097634;
RX   PubMed=23955599;
RX   PubMed=24368162;
RX   PubMed=25130606;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26421875;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28109323;
RX   PubMed=28196595;
RX   PubMed=28404994;
RX   PubMed=29169185;
RX   PubMed=29787063;
RX   PubMed=29901211;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=32387766;
RX   PubMed=33389257;
RX   PubMed=35373342;
RX   PubMed=35839778;
RX   PubMed=36982453;
WW   Info; -; -; http://www.bowdish.ca/lab/wp-content/uploads/2011/07/THP-1-propagation-culture.pdf
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; OECD; -; https://read.oecd-ilibrary.org/environment/test-no-442e-in-vitro-skin-sensitisation_9789264264359-en
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=78
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-444.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/THP-1_cell_line
CC   Group: Space-flown cell line (cellonaut).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Japanese.
CC   Biotechnology: Used in the human Cell Line Activation Test (h-CLAT), an in vitro skin sensitization test (PubMed=16311011; PubMed=16337770; PubMed=29901211).
CC   Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: 60-70 hours (PubMed=6970727); 26 hours (PubMed=25984343); ~35-50 hours (DSMZ=ACC-16).
CC   HLA typing: A*02; B*15:11; C*03; DQB1*05,06; DRB1*01,15; DRB5*01/02 (PubMed=22674354).
CC   HLA typing: A*02:01,02:01; B*15:11,15:11; C*03:03,03:03 (PubMed=26589293).
CC   HLA typing: A*02:01:01; B*15:11:01; C*03:03:01; DPB1*02:01:02G,04:02:01G; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:02:01; DRB1*01:01:01,15:01:01 (CLS=300356).
CC   HLA typing: A*02:01:01,24:02:01; B*15:11:01,35:01:01; C*03:03:01,03:03:01; DPA1*01:03:01,02:02:02; DPB1*02:01:02,04:02:01; DQB1*05:01:01,06:02:01; DRA*01:01:01,01:01:01; DRB1*01:01:01,15:01:01 (DSMZCellDive=ACC-16).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (PubMed=31160637).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=11066077; PubMed=15843827).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=12068308; ATCC=TIB-202; Cosmic-CLP=909771; DepMap=ACH-000146).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (PubMed=1571549; PubMed=19220422; DepMap=ACH-000146).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.3%; East Asian, North=77.63%; East Asian, South=20.4%; South Asian=1.67%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Anecdotal: Have been flown in space on Cosmos-2044 to study the inhibition of phorbol ester-induced cell activation in microgravity (PubMed=1915666).
CC   Caution: NRAS mutation indicated incorrectly as being p.Gly12Ser in PubMed=9379676.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): AddexBio=C0003024/4956; ATCC=TIB-202; CCRID; CLS=300356; Cosmic-CLP=909771; DSMZ=ACC-16; ECACC=88081201; ICLC=HTL97014; JCRB=JCRB0112; JCRB=JCRB0112.1; KCLB=40202; PubMed=11416159; PubMed=25877200; PubMed=35373342; RCB=RCB1189; Technion Genomics Center; TKG=TKG 0267
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D10S1248: 14
ST   D12S391: 18,19
ST   D13S317: 8,13 (CCRID; DSMZ=ACC-16; JCRB=JCRB0112; RCB=RCB1189; TKG=TKG 0267)
ST   D13S317: 13 (AddexBio=C0003024/4956; ATCC=TIB-202; CLS=300356; Cosmic-CLP=909771; ECACC=88081201; JCRB=JCRB0112.1; KCLB=40202; PubMed=25877200; Technion Genomics Center)
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 12.2,13 (ATCC=TIB-202; Technion Genomics Center)
ST   D19S433: 12.2,13,14 (CCRID)
ST   D19S433: 13 (DSMZ=ACC-16)
ST   D1S1656: 16,17
ST   D21S11: 30,31.2
ST   D22S1045: 11,15
ST   D2S1338: 17,18
ST   D2S441: 10,11
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   DYS391: 10
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 11,15
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16 (AddexBio=C0003024/4956; ATCC=TIB-202; CCRID; CLS=300356; Cosmic-CLP=909771; ECACC=88081201; ICLC=HTL97014; JCRB=JCRB0112.1; KCLB=40202; PubMed=11416159; PubMed=25877200; Technion Genomics Center)
ST   vWA: 16,17 (DSMZ=ACC-16; JCRB=JCRB0112; RCB=RCB1189; TKG=TKG 0267)
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 53
//
ID   THP-1 AP1-Luc2
AC   CVCL_A4CA
DR   ATCC; TIB-202-AP1-LUC2
DR   cancercelllines; CVCL_A4CA
DR   Wikidata; Q105511185
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the AP-1 promoter (ATCC=TIB-202-AP1-LUC2).
CC   Doubling time: ~72 hours (ATCC=TIB-202-AP1-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-202-AP1-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   THP-1 CRE-Luc2
AC   CVCL_A4CB
DR   ATCC; TIB-202-CRE-LUC2
DR   cancercelllines; CVCL_A4CB
DR   Wikidata; Q105511186
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the cAMP response element (CRE) (ATCC=TIB-202-CRE-LUC2).
CC   Doubling time: ~72 hours (ATCC=TIB-202-CRE-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-202-CRE-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   THP-1 GAS-Luc2
AC   CVCL_A4CD
DR   ATCC; TIB-202-GAS-LUC2
DR   cancercelllines; CVCL_A4CD
DR   Wikidata; Q105511189
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the gamma-activated site (GAS) promoter (ATCC=TIB-202-GAS-LUC2).
CC   Doubling time: ~72 hours (ATCC=TIB-202-GAS-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-202-GAS-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   THP-1 IQAD biosensor
AC   CVCL_E7CQ
SY   THP-1 caspase-1 biosensor
RX   PubMed=31562211;
CC   Population: Japanese.
CC   Characteristics: Transduced with a firefly luciferase reporter circularly permuted in which the N- and C-terminal domains are physically separated by a flexible hinge region containing a caspase-1 cleaving site (IQADSGPIG) (PubMed=31562211).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=Circ. permuted with an IQAD caspase-1 site).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP-1 ISRE-Luc2
AC   CVCL_A4CC
DR   ATCC; TIB-202-ISRE-LUC2
DR   cancercelllines; CVCL_A4CC
DR   Wikidata; Q105511193
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the interferon-sensitive response element (ISRE) (ATCC=TIB-202-ISRE-LUC2).
CC   Doubling time: ~72 hours (ATCC=TIB-202-ISRE-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-202-ISRE-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   THP-1 K5 P/A
AC   CVCL_F1K5
RX   PubMed=21490960;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Pro167Ala, p.Arg169Ala, p.Pro171Ala and p.Pro174Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   THP-1 K5 WT
AC   CVCL_F1K6
SY   WT K5-THP-1
RX   PubMed=21490960;
CC   Population: Japanese.
CC   Doubling time: ~15 hours (PubMed=21490960).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   THP-1 K5 Y/A
AC   CVCL_F1K7
RX   PubMed=21490960;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P90489; Human herpesvirus 8 type P (isolate GK18) E3 ubiquitin-protein ligase MIR2 (K5) (Note=With p.Tyr156Ala).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   THP-1 NF-kb-Luc2 reporter
AC   CVCL_XZ65
SY   THP-1 NF-kb luciferase reporter
DR   cancercelllines; CVCL_XZ65
DR   KYinno; KC-1216
DR   Wikidata; Q98133244
CC   Population: Japanese.
CC   Characteristics: The luciferase reporter gene is under the control of the NF-kappaB response element (KYinno=KC-1216).
CC   Doubling time: ~48 hours (KYinno=KC-1216).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: KYinno; KC-1216; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   THP-1 NF-kB-Luc2
AC   CVCL_A4CE
DR   ATCC; TIB-202-NFkB-LUC2
DR   cancercelllines; CVCL_A4CE
DR   Wikidata; Q105511199
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the NF-kappaB response element (ATCC=TIB-202-NFkB-LUC2).
CC   Doubling time: ~72 hours (ATCC=TIB-202-NFkB-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-202-NFkB-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   THP-1 NFAT-Luc2
AC   CVCL_B5NS
DR   ATCC; TIB-202-NFAT-LUC2
DR   Wikidata; Q123033609
CC   Population: Japanese.
CC   Characteristics: Stably expresses firefly luciferase under the control of the NFAT response element (ATCC=TIB-202-NFAT-LUC2).
CC   Doubling time: ~72 hours (ATCC=TIB-202-NFAT-LUC2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ATCC=TIB-202-NFAT-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 6
//
ID   THP-1 NF-kappaB-eGFP
AC   CVCL_E2QQ
DR   Millipore; SCC223
RX   PubMed=28542462;
CC   Population: Japanese.
CC   Characteristics: Expresses eGFP under the control of the NF-kappaB response element (PubMed=28542462).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Millipore=SCC223
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D21S11: 30,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   Penta D: 10,12
ST   Penta E: 11,15
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   THP-1 NucLight Red
AC   CVCL_DF52
DR   cancercelllines; CVCL_DF52
DR   Wikidata; Q54972340
CC   Population: Japanese.
CC   Characteristics: Stably expresses a non-perturbing nuclear restricted red fluorescent label.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: Sartorius/Essen Bioscience; Catalog number 4612.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 20
//
ID   THP-1 PSMB9-eGFP-His
AC   CVCL_E7B2
RX   PubMed=39044591;
CC   Population: Japanese.
CC   Characteristics: Transduced with a PSMB9-eGFP-His construct (PubMed=39044591).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9546; PSMB9.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP-1 Safe Harbor Landing Pad
AC   CVCL_C3EW
DR   cancercelllines; CVCL_C3EW
DR   Sigma-Aldrich; CLL1223
DR   Wikidata; Q114313119
CC   Population: Japanese.
CC   Characteristics: Using ZFN a fluorescent mKATE2 tag flanked by Cre-lox sites (LoxN-EF1a-Lox2272-mKATE2-LoxP) was introduced in the AAVS1 safe harbor locus. The mKATE2 tag can be exchanged for a payload of the user's choice using Cre recombinase and a targeting vector with appropriate lox sites (Sigma-Aldrich=CLL1223).
CC   Doubling time: ~24 hours (Sigma-Aldrich).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; DBBO8; mKate2 (Note=Bright red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   THP-1 TLR4-CD14 NFkappaB-eGFP
AC   CVCL_E2QR
RX   PubMed=28542462;
CC   Population: Japanese.
CC   Characteristics: Expresses eGFP under the control of the NF-kappaB response element (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11850; TLR4.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E2QQ ! THP-1 NF-kappaB-eGFP
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   THP-1 TLR9 mCherry
AC   CVCL_XI47
DR   cancercelllines; CVCL_XI47
DR   Wikidata; Q98133245
RX   CelloPub=CLPUB00539;
RX   CelloPub=CLPUB00540;
CC   Population: Japanese.
CC   Characteristics: Transfected with a Tet-on system so as to induce the expression of a TLR9-mCherry fusion protein with the addition of doxycycline to the culture medium.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   THP-1-EGFP
AC   CVCL_C8WG
DR   Ubigene; YC-D011-EGFP-P
DR   Wikidata; Q123033610
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   THP-1-Luc
AC   CVCL_C8WH
DR   Ubigene; YC-D011-Luc-P
DR   Wikidata; Q123033611
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   THP-1(NCI)
AC   CVCL_0R25
SY   THP-1NCI
DR   BEI_Resources; ARP-9949
DR   cancercelllines; CVCL_0R25
DR   Wikidata; Q54972344
RX   PubMed=14972530;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   THP-1(NCI)/DC-SIGN
AC   CVCL_0R26
SY   THP-1NCI/DC-SIGN; THP-1 NCI DC-SIGN+
DR   BEI_Resources; ARP-9950
DR   cancercelllines; CVCL_0R26
DR   Wikidata; Q54972346
RX   PubMed=14972530;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (BEI_Resources=ARP-9950).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0R25 ! THP-1(NCI)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   THP-1-Cs5
AC   CVCL_C0YT
DR   cancercelllines; CVCL_C0YT
DR   Wikidata; Q114313120
RX   PubMed=3476218;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   THP-1-R
AC   CVCL_C0YQ
DR   cancercelllines; CVCL_C0YQ
DR   Wikidata; Q114313121
RX   PubMed=3476218;
RX   PubMed=6949641;
CC   Population: Japanese.
CC   Characteristics: Cultured continuously for 26 months (PubMed=6949641).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   THP-1/AR
AC   CVCL_WI26
SY   TAR
DR   cancercelllines; CVCL_WI26
DR   Wikidata; Q98133247
RX   PubMed=24368162;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_2038; 5-azacytidine (5-azaC).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 10
//
ID   THP-1/ara-C
AC   CVCL_4V22
DR   cancercelllines; CVCL_4V22
DR   Wikidata; Q54972341
RX   PubMed=21290089;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   THP-1/DC-SIGN
AC   CVCL_0R21
SY   THP-1(ATCC)/DC-SIGN; THP-1ATCC/DC-SIGN; THP-1 DC-SIGN+
DR   BEI_Resources; ARP-9943
DR   cancercelllines; CVCL_0R21
DR   Wikidata; Q54972342
RX   PubMed=14972530;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   THP-1/E
AC   CVCL_A1RT
DR   cancercelllines; CVCL_A1RT
DR   Wikidata; Q105511202
RX   PubMed=2633408;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   THP-1/IL15
AC   CVCL_XD94
DR   cancercelllines; CVCL_XD94
DR   Wikidata; Q98133248
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5977; IL15.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000462). It was the sole source of information for this entry.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): CCRID
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D12S391: 19
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 12.2,13
ST   D21S11: 30,32.2
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D6S1043: 14
ST   D7S820: 10
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   Penta E: 11,15
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   THP-1/IL21
AC   CVCL_XD95
DR   cancercelllines; CVCL_XD95
DR   Wikidata; Q98133250
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6005; IL21.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   THP-1h
AC   CVCL_3426
SY   THP-1 h
DR   CLDB; cl7171
DR   cancercelllines; CVCL_3426
DR   ICLC; HTL05008
DR   Wikidata; Q54972347
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ICLC=HTL05008
ST   Amelogenin: X,Y
ST   D18S51: 13,14
ST   D21S11: 30,31.2
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   TH01: 8,9.3
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   THP-1l
AC   CVCL_3427
SY   THP-1 l
DR   CLDB; cl7172
DR   cancercelllines; CVCL_3427
DR   ICLC; HTL05009
DR   Wikidata; Q54972348
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ICLC=HTL05009
ST   Amelogenin: X,Y
ST   D18S51: 13,14
ST   D21S11: 30,31.2
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   TH01: 8,9.3
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   THP-2
AC   CVCL_9252
SY   THP-2-B; Tohoku Hospital Pediatrics-2
DR   Wikidata; Q54972349
RX   PubMed=6314596;
RX   PubMed=6949641;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 24 hours (PubMed=6314596).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 16
//
ID   THP-3-1
AC   CVCL_9250
SY   Tohoku Hospital Pediatrics-3-1
DR   Wikidata; Q54972350
RX   PubMed=6605598;
CC   Population: Japanese.
CC   Doubling time: 50-60 hours (PubMed=6605598).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9251 ! THP-3-2
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   THP-3-2
AC   CVCL_9251
SY   Tohoku Hospital Pediatrics-3-2
DR   Wikidata; Q54972352
RX   PubMed=6605598;
CC   Population: Japanese.
CC   Doubling time: 50-60 hours (PubMed=6605598).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3168; Childhood acute lymphoblastic leukemia
DI   ORDO; Orphanet_513; Acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9250 ! THP-3-1
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   THP-4
AC   CVCL_9247
SY   THP4; Tohoku Hospital Pediatrics-4
DR   Cosmic; 1037728
DR   Wikidata; Q54972353
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2954268;
RX   PubMed=8558913;
RX   PubMed=15182431;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 52 hours (PubMed=2954268).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=15182431).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Thr1150Ala (c.3448A>G); dbSNP=rs1726911919; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   THP-5
AC   CVCL_A441
SY   Tohoku Hospital Pediatrics-5
DR   Cosmic; 1037729
DR   Wikidata; Q54972354
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=6232734;
RX   PubMed=8558913;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 42 hours (PubMed=6232734).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Ser377Leufs*5 (c.1129del); Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Lys361Gln (c.1081A>C); ClinVar=VCV001088249; Zygosity=Heterozygous (PubMed=35124168).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   THP-6
AC   CVCL_4686
SY   Tohoku Hospital Pediatrics-6
DR   BTO; BTO_0004926
DR   cancercelllines; CVCL_4686
DR   Cosmic; 721719
DR   Cosmic; 801718
DR   Cosmic; 998732
DR   Cosmic; 1037684
DR   Cosmic; 1375584
DR   IARC_TP53; 10574
DR   Wikidata; Q54972355
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2954268;
RX   PubMed=3130528;
RX   PubMed=8558913;
RX   PubMed=10071127;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=15472075;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=2954268).
CC   Microsatellite instability: Instable (MSI) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=10071127).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10071127).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=10071127).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   THP-7
AC   CVCL_9248
SY   Tohoku Hospital Pediatrics-7
DR   Cosmic; 1037730
DR   Wikidata; Q54972356
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2954268;
RX   PubMed=8558913;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=2954268).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 15
//
ID   THP-8
AC   CVCL_4687
SY   Tohoku Hospital Pediatrics-8
DR   BTO; BTO_0004927
DR   Cosmic; 710462
DR   Cosmic; 801719
DR   Cosmic; 998705
DR   Cosmic; 1037731
DR   Wikidata; Q54972357
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2954268;
RX   PubMed=7727782;
RX   PubMed=8558913;
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: 68 hours (PubMed=2954268).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   THP-9
AC   CVCL_9249
SY   Tohoku Hospital Pediatrics-9
DR   Wikidata; Q54972358
RX   PubMed=2954268;
RX   PubMed=8558913;
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=2954268).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5165; Childhood lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   THP-G1b
AC   CVCL_D5JL
DR   TKG; TKG 0805
DR   Wikidata; Q127384393
RX   PubMed=24603311;
RX   PubMed=29594315;
CC   Population: Japanese.
CC   Characteristics: Part of an immunotoxicity assay system, the MultiImmunoTox Assay (MITA) (PubMed=24603311).
CC   Characteristics: Transfected with two constructs, one expressing green-light luciferase (SLG) under the control of an IL1B promoter, the other expressing red-light luciferase (SLR) under the control of a GAPDH promoter (PubMed=29594315).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9U4U8; Phrixothrix hirtus green luciferase (Note=SLG).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q9U4U7; Phrixothrix hirtus red luciferase (Note=SLR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0805
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   THP-G8
AC   CVCL_D5JK
DR   TKG; TKG 0809
DR   Wikidata; Q127384395
RX   PubMed=21920952;
RX   PubMed=24603311;
RX   PubMed=29594315;
WW   Info; OECD; -; https://read.oecd-ilibrary.org/environment/test-no-442e-in-vitro-skin-sensitisation_9789264264359-en
CC   Population: Japanese.
CC   Characteristics: Used for the interleukin-8 reporter gene assay (IL-8 Luc assay) (PubMed=21920952).
CC   Characteristics: Part of an immunotoxicity assay system, the MultiImmunoTox Assay (MITA) (PubMed=24603311).
CC   Characteristics: Transfected with two constructs, one expressing orange-light luciferase (SLO) under the control of an IL8 promoter, the other expressing red-light luciferase (SLR) under the control of a GAPDH promoter (PubMed=21920952).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9U4U8; Phrixothrix hirtus green luciferase (Note=With p.Thr226Asn = SLO, orange).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9U4U7; Phrixothrix hirtus red luciferase (Note=SLR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0809
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 27-11-25; Version: 6
//
ID   THP1 GFP-PEAK3
AC   CVCL_C0QX
DR   cancercelllines; CVCL_C0QX
DR   Wikidata; Q112930476
RX   PubMed=34944965;
CC   Population: Japanese.
CC   Characteristics: Transfected with a pBABE-GFP-PEAK3 construct that contains a GFP-PEAK3 fusion.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24793; PEAK3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 10
//
ID   THP1 ST-PEAK3
AC   CVCL_C0QY
DR   cancercelllines; CVCL_C0QY
DR   PRIDE; PXD029417
DR   Wikidata; Q112930477
RX   PubMed=34944965;
CC   Population: Japanese.
CC   Characteristics: Transfected with a pSBbi-PuroR-ST-PEAK3 that contains a N-terminally Strep-tagged PEAK3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24793; PEAK3 (Note=With a N-terminal Strep tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   THP1-ASC-GFP
AC   CVCL_A8AT
DR   cancercelllines; CVCL_A8AT
DR   InvivoGen; thp-ascgfp
DR   Wikidata; Q107117039
CC   Population: Japanese.
CC   Characteristics: Stably expresses a PYCARD-GFP construct under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thp-ascgfp).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16608; PYCARD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   THP1-Blue ISG
AC   CVCL_X588
DR   cancercelllines; CVCL_X588
DR   InvivoGen; thp-isg
DR   Wikidata; Q54972360
RX   PubMed=25130606;
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE (InvivoGen=thp-isg).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 18
//
ID   THP1-Blue ISG-KD-STING
AC   CVCL_X589
DR   cancercelllines; CVCL_X589
DR   InvivoGen; thp-kdstg
DR   Wikidata; Q54972361
WW   Provider; InvivoGen; thp-kdstg; https://web.archive.org/web/20170618070500/www.invivogen.com/thp1-blue-isg-kd-sting
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an ISG54 promoter enhanced by a multimeric ISRE (InvivoGen=thp-kdstg).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: InvivoGen; thp-kdstg; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 19
//
ID   THP1-Blue KI-IP10
AC   CVCL_A8CC
SY   THP1-Blue KI-IP10-Lucia
DR   cancercelllines; CVCL_A8CC
DR   InvivoGen; thpb-ip10kilc
DR   Wikidata; Q107117042
CC   Population: Japanese.
CC   Characteristics: The coding sequence of CXCL10 has been replaced with the Lucia luciferase reporter gene under the control of the endogenous promoter and thus allows the direct study of CXCL10 induction (InvivoGen=thpb-ip10kilc).
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 copies of the NF-kappaB consensus TRE and 3 copies of the c-Rel binding site (InvivoGen=thpb-ip10kilc).
CC   Knockout cell: Method=Homologous recombination; HGNC; HGNC:10637; CXCL10.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Homologous recombination; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X585 ! THP1-Blue NF-kappaB
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   THP1-Blue NF-kappaB
AC   CVCL_X585
DR   cancercelllines; CVCL_X585
DR   InvivoGen; thp-nfkb
DR   Wikidata; Q54972362
RX   PubMed=25130606;
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 copies of the NF-kappaB consensus TRE and 3 copies of the c-Rel binding site (InvivoGen=thp-nfkb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Discontinued: InvivoGen; thp-nfkb; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   THP1-Blue NF-kappaB v2
AC   CVCL_E8F3
DR   InvivoGen; thp-nfkbv2
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 copies of the NF-kappaB consensus TRE and 3 copies of the c-Rel binding site (InvivoGen=thp-nfkbv2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-defASC
AC   CVCL_X598
DR   cancercelllines; CVCL_X598
DR   InvivoGen; thp-dasc
DR   Wikidata; Q54972363
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:16608; PYCARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X601 ! THP1-Null
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   THP1-defCASP1
AC   CVCL_5I76
DR   cancercelllines; CVCL_5I76
DR   InvivoGen; thp-dcasp1
DR   Wikidata; Q54972364
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:1499; CASP1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X601 ! THP1-Null
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 16
//
ID   THP1-defNLRP3
AC   CVCL_X600
DR   cancercelllines; CVCL_X600
DR   InvivoGen; thp-dnlp
DR   Wikidata; Q54972366
CC   Population: Japanese.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:16400; NLRP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X601 ! THP1-Null
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   THP1-Difluo hLC3
AC   CVCL_A8BZ
DR   cancercelllines; CVCL_A8BZ
DR   InvivoGen; thpdf-hlc3
DR   Wikidata; Q107117044
CC   Population: Japanese.
CC   Characteristics: Allows monitoring of autophagic flux in real time by detecting the appearance of dual red and green RFP:GFP:LC3 puncta or single red RFP:LC3 puncta by fluorescence microscopy. Early in autophagy, both RFP and GFP signals are detected. As the fusion of the autophagosomes with the lysosomes progresses, the GFP fluorescence diminishes, leaving only the RFP fluorescence visible. The percentages of RFP-GFP positive and of RFP positive cells can be determined and these values can be used to assess autophagic flux (InvivoGen=thpdf-hlc3).
CC   Characteristics: Stably expresses a RFP-GFP-MAP1LC3B construct (InvivoGen=thpdf-hlc3).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13352; MAP1LC3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X601 ! THP1-Null
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   THP1-Dual
AC   CVCL_X599
DR   cancercelllines; CVCL_X599
DR   InvivoGen; thpd-nfis
DR   Wikidata; Q54972368
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-nfis).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   THP1-Dual hTLR3
AC   CVCL_E8FA
DR   InvivoGen; thpd-htlr3
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-htlr3).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11849; TLR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual hTLR7
AC   CVCL_E8FB
DR   InvivoGen; thpd-htlr7
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-htlr7).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15631; TLR7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual hTLR8
AC   CVCL_E8FC
DR   InvivoGen; thpd-htlr8
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-htlr8).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15632; TLR8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual hTLR9
AC   CVCL_E8FD
DR   InvivoGen; thpd-htlr9
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-htlr9).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:15633; TLR9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual KI-hSTING-A162
AC   CVCL_A8BF
DR   cancercelllines; CVCL_A8BF
DR   InvivoGen; thpd-a162
DR   Wikidata; Q107117045
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-a162).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Ser162Ala).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AH ! THP1-Dual KO-STING
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KI-hSTING-H232
AC   CVCL_A8BG
DR   cancercelllines; CVCL_A8BG
DR   InvivoGen; thpd-h232
DR   Wikidata; Q107117047
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-h232).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Arg232His).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AH ! THP1-Dual KO-STING
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KI-hSTING-M155
AC   CVCL_A8BH
DR   cancercelllines; CVCL_A8BH
DR   InvivoGen; thpd-m155
DR   Wikidata; Q107117049
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-m155).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Val155Met).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AH ! THP1-Dual KO-STING
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KI-hSTING-R232
AC   CVCL_A8BI
DR   cancercelllines; CVCL_A8BI
DR   InvivoGen; thpd-r232
DR   Wikidata; Q107117051
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-r232).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AH ! THP1-Dual KO-STING
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KI-hSTING-S154
AC   CVCL_A8BJ
DR   cancercelllines; CVCL_A8BJ
DR   InvivoGen; thpd-s154
DR   Wikidata; Q107117053
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-s154).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27962; STING1 (Note=With p.Asn154Ser).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AH ! THP1-Dual KO-STING
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KI-mSTING
AC   CVCL_A8BD
DR   cancercelllines; CVCL_A8BD
DR   InvivoGen; thpd-mstg
DR   Wikidata; Q107117054
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-mstg).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1919762; Sting1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AH ! THP1-Dual KO-STING
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-cGAS
AC   CVCL_A8AI
DR   cancercelllines; CVCL_A8AI
DR   InvivoGen; thpd-kocgas
DR   Wikidata; Q107117056
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kocgas).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:21367; CGAS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-DNase2
AC   CVCL_E8F4
DR   InvivoGen; thpd-kodnase2
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kodnase2).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:2960; DNASE2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual KO-IFI16
AC   CVCL_A8AU
DR   cancercelllines; CVCL_A8AU
DR   InvivoGen; thpd-koifi16
DR   Wikidata; Q107117058
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koifi16).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:5395; IFI16.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-IFNAR2
AC   CVCL_A8AL
DR   cancercelllines; CVCL_A8AL
DR   InvivoGen; thpd-koifnar2
DR   Wikidata; Q107117059
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koifnar2).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:5433; IFNAR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-IKKepsilon
AC   CVCL_A8AZ
DR   cancercelllines; CVCL_A8AZ
DR   InvivoGen; thpd-koikke
DR   Wikidata; Q107117061
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koikke).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-IRF1
AC   CVCL_E8F5
DR   InvivoGen; thpd-koirf1
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koirf1).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:6116; IRF1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual KO-IRF3
AC   CVCL_A8AV
DR   cancercelllines; CVCL_A8AV
DR   InvivoGen; thpd-koirf3
DR   Wikidata; Q107117063
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koirf3).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-IRF5
AC   CVCL_E8F6
DR   InvivoGen; thpd-koirf5
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koirf5).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:6120; IRF5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual KO-IRF7
AC   CVCL_E8F7
DR   InvivoGen; thpd-koirf7
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-koirf7).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:6122; IRF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual KO-MAVS
AC   CVCL_A8BA
DR   cancercelllines; CVCL_A8BA
DR   InvivoGen; thpd-komavs
DR   Wikidata; Q107117065
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-komavs).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-MDA5
AC   CVCL_A8BB
DR   cancercelllines; CVCL_A8BB
DR   InvivoGen; thpd-komda5
DR   Wikidata; Q107117066
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-komda5).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:18873; IFIH1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-MyD
AC   CVCL_5J54
SY   THP1-Dual KO-MyD88
DR   cancercelllines; CVCL_5J54
DR   InvivoGen; thpd-komyd
DR   Wikidata; Q54972369
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-komyd).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 19
//
ID   THP1-Dual KO-RIG-I
AC   CVCL_A8BC
DR   cancercelllines; CVCL_A8BC
DR   InvivoGen; thpd-korigi
DR   Wikidata; Q107117068
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-korigi).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:19102; RIGI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-SAMHD1
AC   CVCL_E8F8
DR   InvivoGen; thpd-kosamhd1
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kosamhd1).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:15925; SAMHD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual KO-STING
AC   CVCL_A8AH
DR   cancercelllines; CVCL_A8AH
DR   InvivoGen; thpd-kostg
DR   Wikidata; Q107117071
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kostg).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-TBK1
AC   CVCL_A8AY
DR   cancercelllines; CVCL_A8AY
DR   InvivoGen; thpd-kotbk
DR   Wikidata; Q107117072
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotbk).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-TLR2
AC   CVCL_A8AW
DR   cancercelllines; CVCL_A8AW
DR   InvivoGen; thpd-kotlr2
DR   Wikidata; Q107117074
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotlr2).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-TLR4
AC   CVCL_A8AX
DR   cancercelllines; CVCL_A8AX
DR   InvivoGen; thpd-kotlr4
DR   Wikidata; Q107117076
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotlr4).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-TLR8
AC   CVCL_A8BW
DR   cancercelllines; CVCL_A8BW
DR   InvivoGen; thpd-kotlr8
DR   Wikidata; Q107117078
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotlr8).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:15632; TLR8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-TREX1
AC   CVCL_A8AJ
DR   cancercelllines; CVCL_A8AJ
DR   InvivoGen; thpd-kotrex
DR   Wikidata; Q107117079
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotrex).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:12269; TREX1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual KO-TRIF
AC   CVCL_A8AM
DR   cancercelllines; CVCL_A8AM
DR   InvivoGen; thpd-kotrif
DR   Wikidata; Q107117082
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-kotrif).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:18348; TICAM1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   THP1-Dual MD2-CD14 KO-TLR4
AC   CVCL_E8FF
DR   InvivoGen; thpd-mckotlr4
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-mckotlr4).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-Dual MD2-CD14-TLR4
AC   CVCL_E8FE
DR   InvivoGen; thpd-mctlr4
CC   Population: Japanese.
CC   Characteristics: Stably expresses two reporter genes: SEAP (secreted ALPP) and the Lucia luciferase. In this cell line SEAP is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 C-Rel binding sites. The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpd-mctlr4).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11850; TLR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X599 ! THP1-Dual
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-HMGB1-Lucia
AC   CVCL_A8BE
DR   cancercelllines; CVCL_A8BE
DR   InvivoGen; thp-gb1lc
DR   Wikidata; Q107117083
CC   Population: Japanese.
CC   Characteristics: Designed to monitor ferroptosis, a form of non-apoptotic cell death. Stably express an HMGB1::Lucia luciferase fusion protein in the cytoplasm, following ferroptosis activation, the cell membrane ruptures and HMGB1::Lucia is released in the extracellular milieu (InvivoGen=thp1-gb1lc).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4983; HMGB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   THP1-KO-ASC
AC   CVCL_A8AN
DR   cancercelllines; CVCL_A8AN
DR   InvivoGen; thp-koascz
DR   Wikidata; Q107117084
CC   Population: Japanese.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:16608; PYCARD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AK ! THP1-Null2
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   THP1-KO-CASP4
AC   CVCL_A8AP
DR   cancercelllines; CVCL_A8AP
DR   InvivoGen; thp-kocasp4z
DR   Wikidata; Q107117085
CC   Population: Japanese.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:1505; CASP4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AK ! THP1-Null2
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   THP1-KO-GSDMD
AC   CVCL_A8AQ
DR   cancercelllines; CVCL_A8AQ
DR   InvivoGen; thp-kogsdmdz
DR   Wikidata; Q107117086
CC   Population: Japanese.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:25697; GSDMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AK ! THP1-Null2
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   THP1-KO-NLRC4
AC   CVCL_A8AR
DR   cancercelllines; CVCL_A8AR
DR   InvivoGen; thp-konlrc4z
DR   Wikidata; Q107117087
CC   Population: Japanese.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:16412; NLRC4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AK ! THP1-Null2
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   THP1-KO-NLRP3
AC   CVCL_A8AS
DR   cancercelllines; CVCL_A8AS
DR   InvivoGen; thp-konlrp3z
DR   Wikidata; Q107117088
CC   Population: Japanese.
CC   Knockout cell: Method=Not specified; HGNC; HGNC:16400; NLRP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8AK ! THP1-Null2
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   THP1-Lucia ISG
AC   CVCL_X587
DR   cancercelllines; CVCL_X587
DR   InvivoGen; thpl-isg
DR   Wikidata; Q54972370
CC   Population: Japanese.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an ISG54 minimal promoter in conjunction with 5 IFN-stimulated response elements (ISRE) (InvivoGen=thpl-isg).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   THP1-Lucia NF-kappaB
AC   CVCL_X590
SY   THP1-Lucia-NFKB; THP1-Lucia NF-kB; THP-1-Lucia-NFKB
DR   cancercelllines; CVCL_X590
DR   InvivoGen; thpl-nfkb
DR   Wikidata; Q54972371
CC   Population: Japanese.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites (InvivoGen=thpl-nfkb).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Discontinued: InvivoGen; thpl-nfkb; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 20
//
ID   THP1-Lucia NF-kappaB v2
AC   CVCL_E8F9
DR   InvivoGen; thpl-nfkbv2
CC   Population: Japanese.
CC   Characteristics: The Lucia luciferase reporter gene is under the control of an IFN-beta minimal promoter fused to 5 NF-kappaB binding sites and 3 c-Rel binding sites (InvivoGen=thpl-nfkbv2).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transfection; Gene=Synthetic construct Lucia luciferase (Note=Synthetic gene designed on natural secreted luciferase genes from marine copepods).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   THP1-NLRC4
AC   CVCL_5I77
DR   cancercelllines; CVCL_5I77
DR   InvivoGen; thp-nlrc4
DR   Wikidata; Q54972373
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:16412; NLRC4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   THP1-Null
AC   CVCL_X601
DR   cancercelllines; CVCL_X601
DR   InvivoGen; thp-null
DR   Wikidata; Q54972374
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   THP1-Null2
AC   CVCL_A8AK
DR   cancercelllines; CVCL_A8AK
DR   InvivoGen; thp-nullz
DR   Wikidata; Q107117089
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   THP1-XBlue
AC   CVCL_X582
DR   cancercelllines; CVCL_X582
DR   InvivoGen; thpx-sp
DR   Wikidata; Q54972375
RX   PubMed=25130606;
WW   Provider; InvivoGen; thpx-sp; https://web.archive.org/web/20180506155619/http://www.invivogen.com/thp1-xblue-cell
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=thpx-sp).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: InvivoGen; thpx-sp; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 18
//
ID   THP1-XBlue-CD14
AC   CVCL_X583
DR   cancercelllines; CVCL_X583
DR   InvivoGen; thpx-cd14sp
DR   Wikidata; Q54972376
RX   PubMed=25130606;
WW   Provider; InvivoGen; thpx-cd14sp; https://web.archive.org/web/20180324004727/http://www.invivogen.com/thp1-xblue-cd14-cell
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=thpx-cd14sp).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: InvivoGen; thpx-cd14sp; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X582 ! THP1-XBlue
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   THP1-XBlue-defMyD
AC   CVCL_X586
SY   MyD88-/- THP-1
DR   cancercelllines; CVCL_X586
DR   InvivoGen; thpx-dmyd
DR   Wikidata; Q54972377
RX   PubMed=25130606;
WW   Provider; InvivoGen; thpx-dmyd; https://web.archive.org/web/20170705151443/http://www.invivogen.com/thp1-xblue-defmyd-cell
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=thpx-dmyd).
CC   Knockout cell: Method=Not specified; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: InvivoGen; thpx-dmyd; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X582 ! THP1-XBlue
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 19
//
ID   THP1-XBlue-MD2-CD14
AC   CVCL_X584
DR   cancercelllines; CVCL_X584
DR   InvivoGen; thpx-mdcdsp
DR   Wikidata; Q54972378
RX   PubMed=25130606;
WW   Provider; InvivoGen; thpx-mdcdsp; https://web.archive.org/web/20180324004831/https://www.invivogen.com/thp1-xblue-md2cd14-cell
CC   Population: Japanese.
CC   Characteristics: SEAP (secreted ALPP) reporter cell line, in this cell line SEAP is under the control of a NF-KappaB/AP-1 promoter (InvivoGen=thpx-mdcdsp).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:439; ALPP.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1628; CD14.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:17156; LY96.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: InvivoGen; thpx-mdcdsp; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X582 ! THP1-XBlue
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 19
//
ID   THP18
AC   CVCL_A0HA
DR   cancercelllines; CVCL_A0HA
DR   Wikidata; Q108821369
RX   PubMed=31544853;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   THP18-deltaA3A
AC   CVCL_A0HB
DR   cancercelllines; CVCL_A0HB
DR   Wikidata; Q108821370
RX   PubMed=31544853;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0HA ! THP18
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   THP18-deltaA3A/B
AC   CVCL_A0HC
DR   cancercelllines; CVCL_A0HC
DR   Wikidata; Q108821371
RX   PubMed=31544853;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17343; APOBEC3A.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0HA ! THP18
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   THR
AC   CVCL_1M76
SY   GM06820; GM06820B
DR   CLO; CLO_0036526
DR   Coriell; GM06820
DR   Wikidata; Q54972379
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 12
//
ID   Thr.C1-PI 33
AC   CVCL_9V38
DR   NCBI_Iran; C443
DR   Wikidata; Q54972380
RX   PubMed=17254797;
CC   Population: Iranian.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=17254797
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 27,30
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 24
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4815; Thyroid gland carcinoma
DI   ORDO; Orphanet_100088; Thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 10
//
ID   THS119
AC   CVCL_5435
SY   THS-119; THS 119
DR   Wikidata; Q54972392
RX   DOI=10.2745/dds.18.86;
RX   PubMed=10378898;
RX   PubMed=11520047;
RX   PubMed=17233813;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=THS119
CC   Characteristics: Requires feeder cells. Maintenance of THS119 depends on the presence of cell line TBR59 (Cellosaurus=CVCL_5372).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   THSJTUi001-A
AC   CVCL_A1XC
SY   LZH-C3
DR   hPSCreg; THSJTUi001-A
DR   Wikidata; Q105511206
RX   PubMed=33096383;
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Arg778Leu (c.2333G>T); ClinVar=VCV000003852; Zygosity=Homozygous (PubMed=33096383).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   THUEC
AC   CVCL_XX84
SY   Transduced Human Urethral Epithelial Cells
DR   Wikidata; Q98133251
RX   PubMed=12228311;
RX   PubMed=17644708;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Urethra epithelium; UBERON=UBERON_0002325.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   THX
AC   CVCL_D556
DR   Cosmic; 922395
DR   Wikidata; Q54972393
RX   PubMed=3491924;
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 7
//
ID   Thy0517
AC   CVCL_2Z85
DR   Wikidata; Q54972394
RX   PubMed=26273358;
CC   Population: Chinese.
CC   Doubling time: 37 hours (PubMed=26273358).
CC   Derived from site: In situ; Thymus, anterior mediastinum; UBERON=UBERON_0008820.
DI   NCIt; C60989; Myasthenia gravis
DI   NCIt; C6885; Thymoma type AB
DI   ORDO; Orphanet_589; Myasthenia gravis
DI   ORDO; Orphanet_99867; Thymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 9
//
ID   Thy16
AC   CVCL_2Z87
SY   Thymoma line No. 16.3
DR   Wikidata; Q54972395
RX   PubMed=219598;
RX   PubMed=6543243;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 3
//
ID   Thy19
AC   CVCL_J304
SY   Thy-19; Thy 19
DR   Wikidata; Q54972396
RX   PubMed=219598;
RX   PubMed=6543243;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   THY28
AC   CVCL_HF48
DR   Wikidata; Q54972397
RX   PubMed=27811013;
CC   Population: Chinese.
CC   Doubling time: 56 hours (PubMed=27811013).
CC   Derived from site: Metastatic; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   ThyL-6
AC   CVCL_2Z86
DR   Wikidata; Q54972399
RX   PubMed=18691242;
CC   Population: Japanese.
CC   Doubling time: 26.3 hours (PubMed=18691242).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C35718; Thymic undifferentiated carcinoma
DI   ORDO; Orphanet_99868; Thymic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   TI-1 [Human leukemia]
AC   CVCL_L806
DR   BioSample; SAMN03151817
DR   Wikidata; Q54972401
RX   PubMed=1611097;
RX   PubMed=11871388;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a K-562 derivative (PubMed=11871388; PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00278.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 26
//
ID   TI-1 [Mouse hybridoma]
AC   CVCL_2216
DR   CLO; CLO_0009349
DR   DSMZ; ACC-285
DR   DSMZCellDive; ACC-285
DR   Wikidata; Q54972402
RX   PubMed=2777792;
CC   Doubling time: ~50 hours (DSMZ=ACC-285).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02646; Rabbit TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   TI-1 [Thysanoplusia]
AC   CVCL_Z344
DR   Wikidata; Q54972403
RX   DOI=10.1303/aez.2000.245;
CC   Group: Insect cell line.
CC   Doubling time: 36 hours (DOI=10.1303/aez.2000.245).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=254425; ! Thysanoplusia intermixta (Moth)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   TI-3
AC   CVCL_B7NK
DR   Wikidata; Q112930478
RX   PubMed=2777792;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08057; Bovine TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   TI-4
AC   CVCL_2217
DR   CLO; CLO_0009350
DR   DSMZ; ACC-286
DR   DSMZCellDive; ACC-286
DR   Wikidata; Q54972404
RX   PubMed=2777792;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08057; Bovine TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   TI56
AC   CVCL_C3T5
DR   Wikidata; Q116050652
RX   PubMed=2827804;
RX   PubMed=6325164;
CC   Monoclonal antibody isotype: Not specified.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TI81
AC   CVCL_C3T6
DR   Wikidata; Q116050654
RX   PubMed=2437255;
RX   PubMed=6320770;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04296; Human herpesvirus 1 (HHV-1) major DNA-binding protein (DBP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TiB
AC   CVCL_YC99
SY   Tilapia Brain
DR   ABM; T5404
DR   Wikidata; Q98133252
RX   PubMed=30320411;
CC   Group: Fish cell line.
CC   Characteristics: Capable of growing from 15 to 32 Celsius, the optimal growth temperature is 27 Celsius.
CC   Virology: Susceptible to infection by Tilapia lake virus (TiLV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 30-01-24; Version: 7
//
ID   TiB7-4
AC   CVCL_IS69
SY   TiB7.4
DR   Wikidata; Q54972405
RX   PubMed=17724450;
RX   PubMed=20221450;
CC   Derived from site: In situ; Tail, skin; UBERON=UBERON_0003534.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   TiBC
AC   CVCL_YD00
SY   Tilapia Brain Cells
DR   CCRID; 4201PAT-CCTCC01160
DR   Wikidata; Q98133253
RX   Patent=CN108865974B;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201829.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 9
//
ID   Tic-FX
AC   CVCL_RY73
DR   JCRB; JCRB1331.01
DR   Wikidata; Q54972406
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB1331.01
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8433 ! MRC-iPS-25
SX   Male
AG   14FW
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   TIE/LULS54
AC   CVCL_E1IB
RX   PubMed=36292854;
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: LSHTM laboratory colony.
OX   NCBI_TaxID=30076; ! Triatoma infestans (Assassin bug)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   TIEC1
AC   CVCL_B5WB
DR   Wikidata; Q112041787
RX   PubMed=30603916;
CC   Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
SX   Sex unspecified
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   TIEC2
AC   CVCL_B5WC
DR   Wikidata; Q112041788
RX   PubMed=30603916;
CC   Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
SX   Sex unspecified
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   TIEC3
AC   CVCL_B5WD
DR   Wikidata; Q112041789
RX   PubMed=30603916;
CC   Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Small intestine; UBERON=UBERON_0002108.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
SX   Sex unspecified
AG   2D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   TIFRe001-A
AC   CVCL_C752
SY   FCNCBS1; NC01
DR   hPSCreg; TIFRe001-A
DR   SKIP; SKIP002016
DR   Wikidata; Q54972407
CC   From: Tata Institute of Fundamental Research; Bangalore; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   TIFRe002-A
AC   CVCL_C753
SY   FCNCBS2; NC02
DR   hPSCreg; TIFRe002-A
DR   SKIP; SKIP002017
DR   Wikidata; Q54972408
CC   From: Tata Institute of Fundamental Research; Bangalore; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   TIFRe003-A
AC   CVCL_C754
SY   FCNCBS3; NC03
DR   hPSCreg; TIFRe003-A
DR   SKIP; SKIP002018
DR   Wikidata; Q54972409
CC   From: Tata Institute of Fundamental Research; Bangalore; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   TIG-1
AC   CVCL_0560
SY   TIG1; Tokyo Institute of Gerontology-1; AG06173; AG06173A
DR   BTO; BTO_0006358
DR   CLO; CLO_0035248
DR   MCCL; MCC:0000462
DR   Coriell; AG06173
DR   RCB; RCB4467
DR   Wikidata; Q54972410
RX   CelloPub=CLPUB00597;
RX   PubMed=1756776;
RX   PubMed=3361969;
RX   PubMed=4083160;
RX   PubMed=7389832;
RX   PubMed=7421303;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 55 to 79 PDL (Coriell=AG06173); 82 PDL (PubMed=4083160); 67 PDL (PubMed=3361969); 68 PDL (PubMed=7421303).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU09 ! TIG-1H
OI   CVCL_IU10 ! TIG-1L
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   TIG-1 iPSC clone K1
AC   CVCL_U502
DR   Wikidata; Q54972411
RX   PubMed=21562774;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   TIG-1 iPSC clone K2
AC   CVCL_U503
DR   Wikidata; Q54972413
RX   PubMed=21562774;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   TIG-1 iPSC clone K3
AC   CVCL_U504
DR   Wikidata; Q54972414
RX   PubMed=21562774;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   TIG-1 iPSC clone K4
AC   CVCL_U505
DR   Wikidata; Q54972415
RX   PubMed=21562774;
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   TIG-1-20
AC   CVCL_3181
DR   ChEMBL-Cells; CHEMBL3307469
DR   ChEMBL-Targets; CHEMBL615014
DR   JCRB; JCRB0501
DR   PubChem_Cell_line; CVCL_3181
DR   RCB; RCB1983
DR   TKG; TKG 0276
DR   Wikidata; Q54972416
CC   Population: Japanese.
CC   Senescence: Senesces at 67 PDL (JCRB=JCRB0501).
CC   Doubling time: ~1.5 days (Note=Lots 01202006 and 08172010), 32 hours (Note=Lot 01302008), ~21 hours (Note=Lot 01132009), ~1 day (Note=Lots 06142016, 05302017 and 07092018) (JCRB=JCRB0501).
CC   Discontinued: RCB; RCB1983; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB0501; TKG=TKG 0276
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D21S11: 28,30
ST   D3S1358: 16,17
ST   D5S818: 9,10
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 22,28
ST   Penta D: 9,11
ST   Penta E: 12,21
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   TIG-1-30
AC   CVCL_3182
DR   JCRB; JCRB0502
DR   Wikidata; Q54972418
CC   Population: Japanese.
CC   Doubling time: ~1.5 days (Note=Lot 02072006) (JCRB=JCRB0502).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   TIG-1-40
AC   CVCL_3183
DR   JCRB; JCRB0503
DR   Wikidata; Q54972420
CC   Population: Japanese.
CC   Doubling time: ~1.9 days (Note=Lot 02172006), ~33 hours (Note=Lot 02062015) (JCRB=JCRB0503).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB0503
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 9,10
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   TIG-1-50
AC   CVCL_3184
DR   JCRB; JCRB0504
DR   Wikidata; Q54972421
CC   Population: Japanese.
CC   Doubling time: ~1.5 days (Note=Lot 03082006), ~26 hours (Note=Lot 08222018) (JCRB=JCRB0504).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   TIG-1-60
AC   CVCL_3185
SY   TIG-1 (PDL62)
DR   JCRB; JCRB0505
DR   Wikidata; Q54972422
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Doubling time: ~4 days (Note=Lot 04102006), ~38 hours (Note=Lot 05262015) (JCRB=JCRB0505).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB0505
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 9,10
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   TIG-101
AC   CVCL_3186
SY   TIG101; Tokyo Institute of Gerontology-101
DR   JCRB; JCRB0526
DR   Wikidata; Q54972423
CC   Population: Japanese.
CC   Doubling time: ~3-4 days (Note=Lot 06042007) (JCRB=JCRB0526).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0526
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 15,19
ST   D21S11: 28,30
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 11,18
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   TIG-102
AC   CVCL_3187
SY   TIG102; Tokyo Institute of Gerontology-102
DR   JCRB; JCRB0527
DR   PRIDE; PXD032925
DR   Wikidata; Q54972424
CC   Population: Japanese.
CC   Doubling time: ~70 hours (Note=Lot 05232007) (JCRB=JCRB0527).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0527
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 16,17
ST   D21S11: 30
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 12,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   97Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   TIG-103
AC   CVCL_3188
SY   TIG103; Tokyo Institute of Gerontology-103
DR   JCRB; JCRB0528
DR   Wikidata; Q54972425
RX   PubMed=19956543;
CC   Population: Japanese.
CC   Doubling time: ~2.6 days (Note=Lot 06262006) (JCRB=JCRB0528).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0528
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 11,14
ST   D18S51: 14
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 11,12
ST   FGA: 23
ST   Penta D: 9,13
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   TIG-104
AC   CVCL_3189
SY   TIG104; Tokyo Institute of Gerontology-104
DR   JCRB; JCRB0529
DR   Wikidata; Q54972426
RX   PubMed=7556460;
CC   Population: Japanese.
CC   Caution: Indicated to be from a female donor in PubMed=7556460.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   TIG-105
AC   CVCL_3190
SY   TIG105; Tokyo Institute of Gerontology-105
DR   JCRB; JCRB0530
DR   Wikidata; Q54972427
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   TIG-106
AC   CVCL_3191
SY   TIG106; Tokyo Institute of Gerontology-106
DR   JCRB; JCRB0531
DR   Wikidata; Q54972428
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   TIG-107
AC   CVCL_3192
SY   TIG107; Tokyo Institute of Gerontology-107
DR   GEO; GSM1493707
DR   GEO; GSM1899754
DR   JCRB; JCRB0532
DR   Wikidata; Q54972429
RX   PubMed=19956543;
CC   Population: Japanese.
CC   Doubling time: 45 hours (Note=Lot 01182008), 29-63 hours (Note=Lot 11202015) (JCRB=JCRB0532).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0532
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13
ST   D18S51: 17
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 9,10
ST   Penta E: 11,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   TIG-108
AC   CVCL_3193
SY   TIG108; Tokyo Institute of Gerontology-108
DR   JCRB; JCRB0537
DR   Wikidata; Q54972430
RX   PubMed=15900046;
CC   Population: Japanese.
CC   Doubling time: ~51 hours (Note=Lot 10122010), ~31 hours (Note=Lot 10262015) (JCRB=JCRB0537).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   TIG-109
AC   CVCL_3194
SY   TIG109; Tokyo Institute of Gerontology-109
DR   JCRB; JCRB0538
DR   Wikidata; Q54972431
RX   PubMed=15900046;
CC   Population: Japanese.
CC   Doubling time: ~42 hours (Note=Lot 02122010) (JCRB=JCRB0538).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   TIG-110
AC   CVCL_3195
SY   TIG110; Tokyo Institute of Gerontology-110
DR   JCRB; JCRB0543
DR   Wikidata; Q54972432
CC   Population: Japanese.
CC   Doubling time: ~45 hours (Note=Lot 12032015) (JCRB=JCRB0543).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   TIG-111
AC   CVCL_3196
SY   TIG111; Tokyo Institute of Gerontology-111
DR   JCRB; JCRB0541
DR   Wikidata; Q54972433
CC   Population: Japanese.
CC   Doubling time: ~31 hours (Note=Lot 08152014) (JCRB=JCRB0541).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   TIG-112
AC   CVCL_3197
SY   TIG112; Tokyo Institute of Gerontology-112
DR   JCRB; JCRB0533
DR   Wikidata; Q54972435
RX   PubMed=19956543;
CC   Population: Japanese.
CC   Doubling time: ~58 hours (Note=Lot 08302010) (JCRB=JCRB0533).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0533
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 16
ST   D21S11: 30,32.2
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 10
ST   FGA: 23,24
ST   Penta D: 9,13
ST   Penta E: 5,16
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   TIG-113
AC   CVCL_3198
SY   TIG113; Tokyo Institute of Gerontology-113
DR   JCRB; JCRB0539
DR   Wikidata; Q54972436
RX   PubMed=7556460;
CC   Population: Japanese.
CC   Doubling time: 1.7 days (Note=Lot 04162008), ~41 hours (Note=Lot 01282013), ~45 hours (Note=Lot 11082018) (JCRB=JCRB0539).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   TIG-114
AC   CVCL_3199
SY   TIG114; Tokyo Institute of Gerontology-114
DR   JCRB; JCRB0534
DR   JCRB; NIHS0207
DR   Wikidata; Q54972437
RX   PubMed=7556460;
RX   PubMed=15900046;
RX   PubMed=19956543;
CC   Population: Japanese.
CC   Doubling time: 2.5-3.6 days (Note=Lot 12012010), ~56 hours (Note=Lot 10112012) (JCRB=JCRB0534).
CC   Discontinued: JCRB; NIHS0207; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 19
//
ID   TIG-118
AC   CVCL_3200
SY   TIG118; Tokyo Institute of Gerontology-118
DR   JCRB; JCRB0535
DR   Wikidata; Q54972445
CC   Population: Japanese.
CC   Doubling time: ~24 hours (Note=Lot 10182010), ~25 hours (Note=Lot 10182018) (JCRB=JCRB0535).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   TIG-119
AC   CVCL_3201
SY   TIG119; Tokyo Institute of Gerontology-119
DR   JCRB; JCRB0540
DR   Wikidata; Q54972446
RX   PubMed=7556460;
CC   Population: Japanese.
CC   Senescence: Senesces at 48 PDL (JCRB=JCRB0540).
CC   Doubling time: ~29 hours (Note=Lot 10162009), 53-65 hours (Note=Lot 06052013), ~23 hours (Note=Lot 09022016) (JCRB=JCRB0540).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   TIG-120
AC   CVCL_3202
SY   TIG120; Tig120; Tokyo Institute of Gerontology-120
DR   GEO; GSM1493703
DR   JCRB; JCRB0542
DR   PRIDE; PXD000071
DR   Wikidata; Q54972447
RX   PubMed=7556460;
RX   PubMed=19956543;
RX   PubMed=23210603;
CC   Population: Japanese.
CC   Doubling time: ~45 hours (Note=Lot 08202010), ~2 days (Note=Lot 07122011), 26-48 hours (Note=Lot 04152013) (JCRB=JCRB0542).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0542
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 12
ST   D5S818: 9,11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   TIG-121
AC   CVCL_3203
SY   TIG121; Tokyo Institute of Gerontology-121
DR   JCRB; JCRB0536
DR   Wikidata; Q54972448
CC   Population: Japanese.
CC   Doubling time: ~42 hours (Note=Lot 09272010) (JCRB=JCRB0536).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   TIG-1H
AC   CVCL_IU09
SY   Tokyo Institute of Gerontology-1 Heart
DR   Wikidata; Q54972450
RX   PubMed=7421303;
CC   Population: Japanese.
CC   Senescence: Senesces at 50 PDL (PubMed=7421303).
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0560 ! TIG-1
OI   CVCL_IU10 ! TIG-1L
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 11
//
ID   TIG-1L
AC   CVCL_IU10
SY   Tokyo Institute of Gerontology-1 Liver
DR   Wikidata; Q54972451
RX   PubMed=7421303;
CC   Population: Japanese.
CC   Senescence: Senesces at 65 PDL (PubMed=7421303).
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0560 ! TIG-1
OI   CVCL_IU09 ! TIG-1H
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 11
//
ID   TIG-2
AC   CVCL_IU07
SY   TIG2; Tokyo Institute of Gerontology-2
DR   Wikidata; Q54972452
RX   PubMed=7421303;
CC   Population: Japanese.
CC   Senescence: Senesces at 58 PDL (PubMed=7421303).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3204 ! TIG-2M-30
OI   CVCL_IU08 ! TIG-2S
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 12
//
ID   TIG-2M-30
AC   CVCL_3204
SY   TIG-2M; Tokyo Institute of Gerontology-2 Muscle
DR   JCRB; JCRB0525
DR   Wikidata; Q54972454
RX   PubMed=7421303;
CC   Population: Japanese.
CC   Senescence: Senesces at 63 PDL (PubMed=7421303).
CC   Doubling time: ~43 hours (Note=Lot 10132009), ~3 days (Note=Lot 11022015) (JCRB=JCRB0525).
CC   Derived from site: In situ; Fetal muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
ST   Source(s): JCRB=JCRB0525
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D21S11: 29,31
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 12,13
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU07 ! TIG-2
OI   CVCL_IU08 ! TIG-2S
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   TIG-2S
AC   CVCL_IU08
SY   Tokyo Institute of Gerontology-2 Skin
DR   Wikidata; Q54972456
RX   PubMed=7421303;
RX   PubMed=7556460;
CC   Population: Japanese.
CC   Senescence: Senesces at 56 PDL (PubMed=7421303).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU07 ! TIG-2
OI   CVCL_3204 ! TIG-2M-30
SX   Female
AG   13FW
CA   Finite cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 11
//
ID   TIG-3
AC   CVCL_E939
SY   TIG3; Tig3; Tokyo Institute of Gerontology-3
DR   BTO; BTO_0006282
DR   EFO; EFO_0022556
DR   Cell_Model_Passport; SIDM01886
DR   ChEMBL-Cells; CHEMBL4295477
DR   ChEMBL-Targets; CHEMBL4296501
DR   PRIDE; PXD000523
DR   PRIDE; PXD001068
DR   PRIDE; PXD001499
DR   PubChem_Cell_line; CVCL_E939
DR   RCB; RCB4468
DR   Wikidata; Q54972457
RX   PubMed=7053395;
RX   PubMed=9548301;
RX   PubMed=15900046;
RX   PubMed=38639832;
WW   Info; -; -; https://web.archive.org/web/20170722184019/http://proteome.tmig.or.jp/2D/Fibro/humfb_menu.html
CC   Population: Japanese and Korean.
CC   Senescence: Senesces at 83.8 PDL (PubMed=7053395).
CC   Doubling time: 18-24 hours (PubMed=7053395).
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3210 ! TIG-3S
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   TIG-3 iPSC #10-2
AC   CVCL_IN43
SY   TIG-3 #10-2
DR   GEO; GSM1519867
DR   Wikidata; Q54972458
RX   PubMed=25390333;
CC   Population: Japanese and Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   TIG-3 TD
AC   CVCL_V617
SY   TIG3 TD; TIG3TD
DR   BioSample; SAMN10988398
DR   Cell_Model_Passport; SIDM01924
DR   DepMap; ACH-001207
DR   PharmacoDB; TIG3TD_1595_2019
DR   Progenetix; CVCL_V617
DR   Wikidata; Q54972459
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Genomics; Whole exome sequencing.
CC   Genome ancestry: African=0%; Native American=0.91%; East Asian, North=74.91%; East Asian, South=24.18%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   TIG-3-20
AC   CVCL_3205
SY   TIG 3-20; TIG3-20; TIG-3 (PDL23)
DR   BTO; BTO_0004521
DR   JCRB; JCRB0506
DR   TKG; TKG 0488
DR   Wikidata; Q54972460
RX   PubMed=2468421;
RX   PubMed=9290701;
CC   Population: Japanese and Korean.
CC   Senescence: Senesces at 84 PDL (JCRB=JCRB0506).
CC   Doubling time: 1.5 days (Note=Lots 09122003 and 02192019), ~1 day (Note=Lot 06272008), ~52 hours (Note=Lot 11272014), ~30 hours (Note=Lot 07262017) (JCRB=JCRB0506).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): TKG=TKG 0488
ST   Amelogenin: X,Y
ST   D13S317: 9,12
ST   D16S539: 10
ST   D5S818: 13
ST   TH01: 7,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   TIG-3-30
AC   CVCL_3206
DR   JCRB; JCRB0507
DR   Wikidata; Q54972461
CC   Population: Japanese and Korean.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   TIG-3-40
AC   CVCL_3207
DR   JCRB; JCRB0508
DR   Wikidata; Q54972462
CC   Population: Japanese and Korean.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   TIG-3-50
AC   CVCL_3208
DR   JCRB; JCRB0509
DR   Wikidata; Q54972463
CC   Population: Japanese and Korean.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   TIG-3-60
AC   CVCL_3209
SY   TIG-3 (PDL60)
DR   JCRB; JCRB0510
DR   Wikidata; Q54972464
RX   PubMed=9290701;
CC   Population: Japanese and Korean.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   TIG-3S
AC   CVCL_3210
SY   Tokyo Institute of Gerontology-3 Skin
DR   Cell_Model_Passport; SIDM01899
DR   JCRB; JCRB0544
DR   Wikidata; Q54972466
RX   PubMed=7421303;
RX   PubMed=7556460;
CC   Population: Japanese and Korean.
CC   Senescence: Senesces at 67 PDL (JCRB=JCRB0544).
CC   Doubling time: ~35 hours (Note=Lot 11042010) (JCRB=JCRB0544).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E939 ! TIG-3
SX   Male
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   TIG-7
AC   CVCL_E940
SY   Tokyo Institute of Gerontology-7
DR   BTO; BTO_0005634
DR   RCB; RCB4469
DR   Wikidata; Q54972468
RX   PubMed=1756776;
RX   PubMed=1800129;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Senescence: Senesces at 73 +- 7 PDL (PubMed=1800129); 66-80 PDL (RCB=RCB4469).
CC   Doubling time: 23 hours (Note=At 65th passage), 62 hours (Note=At 75th passage) (PubMed=1800129).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   TIG-7-20
AC   CVCL_3211
DR   JCRB; JCRB0511
DR   Wikidata; Q54972469
CC   Population: Japanese.
CC   Doubling time: ~27 hours (Note=Lot 03162012) (JCRB=JCRB0511).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E940 ! TIG-7
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   TIG-7-30
AC   CVCL_3212
DR   JCRB; JCRB0512
DR   Wikidata; Q54972470
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E940 ! TIG-7
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   TIG-7-40
AC   CVCL_3213
DR   JCRB; JCRB0513
DR   Wikidata; Q54972471
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E940 ! TIG-7
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   TIG-7-50
AC   CVCL_3214
DR   JCRB; JCRB0514
DR   Wikidata; Q54972472
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E940 ! TIG-7
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   TIG-7-60
AC   CVCL_3215
DR   JCRB; JCRB0515
DR   Wikidata; Q54972473
CC   Population: Japanese.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E940 ! TIG-7
SX   Male
AG   11FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   TIGE-9
AC   CVCL_RH80
DR   Wikidata; Q54972474
RX   PubMed=26626025;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3199 ! TIG-114
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TIGEF
AC   CVCL_JL66
SY   T-Immortalized Goat Embryonic Fibroblasts
DR   Wikidata; Q54972475
RX   PubMed=9185961;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pMK16-SV40(ori-)).
CC   Derived from site: In situ; Fetal synovial membrane; UBERON=UBERON_0002018.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
OI   CVCL_JL67 ! mMTSV-54
OI   CVCL_JL68 ! mMTSV-93
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 10
//
ID   TIGETi001-A
AC   CVCL_A5GD
SY   ND1.2
DR   BioSamples; SAMEA7807675
DR   hPSCreg; TIGETi001-A
DR   Wikidata; Q107117090
CC   From: San Raffaele Telethon Institute for Gene Therapy, Ospedale San Raffaele; Milan; Italy.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   TIGETi003-A
AC   CVCL_A5GE
SY   GLD1.3
DR   BioSamples; SAMEA7807679
DR   hPSCreg; TIGETi003-A
DR   Wikidata; Q107117092
CC   From: San Raffaele Telethon Institute for Gene Therapy, Ospedale San Raffaele; Milan; Italy.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61254; Krabbe disease
DI   ORDO; Orphanet_487; Krabbe disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   TIGMEC-1
AC   CVCL_5374
SY   TIGMEC1; T-antigen Immortalized Goat Milk Epithelial Cells-1
DR   Wikidata; Q54972477
RX   PubMed=11592613;
CC   Doubling time: 24-48 hours (PubMed=11592613).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16-SV40-(ori)).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   TIGMEC-2
AC   CVCL_5375
SY   TIGMEC2; T-antigen Immortalized Goat Milk Epithelial Cells-2
DR   Wikidata; Q54972479
RX   PubMed=11592613;
CC   Doubling time: 24-48 hours (PubMed=11592613).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16-SV40-(ori)).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   TIGMEC-3
AC   CVCL_5376
SY   TIGMEC3; T-antigen Immortalized Goat Milk Epithelial Cells-3
DR   Wikidata; Q54972480
RX   PubMed=11592613;
CC   Doubling time: 24-48 hours (PubMed=11592613).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen (Note=pMK16-SV40-(ori)).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Milk; UBERON=UBERON_0001913.
CC   Cell type: Lactiferous duct luminal epithelial cell; CL=CL_0002662.
CC   Breed/subspecies: Saanen; VBO=VBO_0000827.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 15
//
ID   TiHo-0906
AC   CVCL_VQ58
SY   TiHoCMglAdcar0906
DR   Wikidata; Q98133254
RX   PubMed=30185896;
CC   Doubling time: 28.9 hours (Note=At low passages), 27.4 hours (Note=At high passages) (PubMed=30185896).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: British shorthair; VBO=VBO_0100052.
DI   NCIt; C132274; Feline mammary carcinoma
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 6
//
ID   TihoDProAdcarc0846
AC   CVCL_ZV54
SY   DT08/46; Adcarc0846; 0846
DR   GEO; GSM5720792
DR   GEO; GSM5720793
DR   GEO; GSM5720794
DR   GEO; GSM5720795
DR   GEO; GSM5720796
DR   GEO; GSM5720797
DR   GEO; GSM5720798
DR   GEO; GSM5720799
DR   Wikidata; Q98133255
RX   PubMed=24324078;
RX   PubMed=26774145;
RX   PubMed=32168360;
RX   PubMed=34972712;
RX   PubMed=35109825;
CC   Doubling time: 26.2 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: German Roughhaired Pointer; VBO=VBO_0200575.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   TihoDProAdcarc1258
AC   CVCL_W737
SY   CT1258; CT-1258; Adcarc1258
DR   GEO; GSM4962601
DR   GEO; GSM4962602
DR   GEO; GSM4962603
DR   GEO; GSM4962604
DR   GEO; GSM4962605
DR   GEO; GSM4962606
DR   GEO; GSM4962607
DR   GEO; GSM4962608
DR   GEO; GSM4962609
DR   Wikidata; Q28872894
RX   PubMed=15994418;
RX   PubMed=18706092;
RX   PubMed=24324078;
RX   PubMed=24914948;
RX   PubMed=26774145;
RX   PubMed=32168360;
RX   PubMed=32368185;
RX   PubMed=35109825;
CC   Doubling time: 21.6 hours (PubMed=32168360); 29.2 hours (PubMed=32368185).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Briard; VBO=VBO_0200234.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   TihoDProAdcarc1508
AC   CVCL_ZV55
SY   DT15/08; Adcarc1508
DR   GEO; GSM5720812
DR   GEO; GSM5720813
DR   GEO; GSM5720814
DR   GEO; GSM5720815
DR   GEO; GSM5720816
DR   GEO; GSM5720817
DR   GEO; GSM5720818
DR   GEO; GSM5720819
DR   GEO; GSM5720820
DR   GEO; GSM5720821
DR   GEO; GSM5720822
DR   GEO; GSM5720823
DR   Wikidata; Q98133256
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 18.2 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   TihoDProAdcarc1511.1
AC   CVCL_ZV56
SY   Adcarc1511.1
DR   GEO; GSM5720836
DR   GEO; GSM5720837
DR   GEO; GSM5720838
DR   GEO; GSM5720839
DR   GEO; GSM5720840
DR   GEO; GSM5720841
DR   GEO; GSM5720842
DR   GEO; GSM5720843
DR   GEO; GSM5720844
DR   GEO; GSM5720845
DR   GEO; GSM5720846
DR   GEO; GSM5720847
DR   Wikidata; Q98133257
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 27.9 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_ZV57 ! TihoDProMetadcarc1511.2
OI   CVCL_ZV58 ! TihoDProMetadcarc1511.3
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   TihoDProCarc/TCC0840
AC   CVCL_ZV59
SY   DT08/40; TCC0840; 0840
DR   GEO; GSM5720784
DR   GEO; GSM5720785
DR   GEO; GSM5720786
DR   GEO; GSM5720787
DR   GEO; GSM5720788
DR   GEO; GSM5720789
DR   GEO; GSM5720790
DR   GEO; GSM5720791
DR   Wikidata; Q98133258
RX   PubMed=24324078;
RX   PubMed=26774145;
RX   PubMed=32168360;
RX   PubMed=34972712;
RX   PubMed=35109825;
CC   Doubling time: 28.6 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Pitbull Terrier; VBO=VBO_0200054.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   TihoDProMetadcarc1511.2
AC   CVCL_ZV57
SY   Metadcarc1511.2
DR   GEO; GSM5720848
DR   GEO; GSM5720849
DR   GEO; GSM5720850
DR   GEO; GSM5720851
DR   GEO; GSM5720852
DR   GEO; GSM5720853
DR   GEO; GSM5720854
DR   GEO; GSM5720855
DR   GEO; GSM5720856
DR   GEO; GSM5720857
DR   GEO; GSM5720858
DR   GEO; GSM5720859
DR   Wikidata; Q98133259
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 37.9 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Sublumbar lymph node; UBERON=UBERON_8470001.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_ZV56 ! TihoDProAdcarc1511.1
OI   CVCL_ZV58 ! TihoDProMetadcarc1511.3
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   TihoDProMetadcarc1511.3
AC   CVCL_ZV58
SY   Metadcarc1511.3
DR   GEO; GSM5720860
DR   GEO; GSM5720861
DR   GEO; GSM5720862
DR   GEO; GSM5720863
DR   GEO; GSM5720864
DR   GEO; GSM5720865
DR   GEO; GSM5720866
DR   GEO; GSM5720867
DR   GEO; GSM5720868
DR   GEO; GSM5720869
DR   GEO; GSM5720870
DR   GEO; GSM5720871
DR   Wikidata; Q98133261
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 38.5 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Sublumbar lymph node; UBERON=UBERON_8470001.
CC   Breed/subspecies: Doberman Pinscher; VBO=VBO_0200442.
DI   NCIt; C128122; Canine prostate carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_ZV56 ! TihoDProAdcarc1511.1
OI   CVCL_ZV57 ! TihoDProMetadcarc1511.2
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   TihoDProTCC1509
AC   CVCL_ZV60
SY   DT15/09; TCC1509
DR   GEO; GSM5720824
DR   GEO; GSM5720825
DR   GEO; GSM5720826
DR   GEO; GSM5720827
DR   GEO; GSM5720828
DR   GEO; GSM5720829
DR   GEO; GSM5720830
DR   GEO; GSM5720831
DR   GEO; GSM5720832
DR   GEO; GSM5720833
DR   GEO; GSM5720834
DR   GEO; GSM5720835
DR   Wikidata; Q98133262
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 19.9 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: Bolonka Zwetna; VBO=VBO_0201147.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   TihoDUrtTCC1506
AC   CVCL_ZV61
SY   DT15/06; TCC1506
DR   GEO; GSM5720800
DR   GEO; GSM5720801
DR   GEO; GSM5720802
DR   GEO; GSM5720803
DR   GEO; GSM5720804
DR   GEO; GSM5720805
DR   GEO; GSM5720806
DR   GEO; GSM5720807
DR   GEO; GSM5720808
DR   GEO; GSM5720809
DR   GEO; GSM5720810
DR   GEO; GSM5720811
DR   Wikidata; Q98133263
RX   PubMed=32168360;
RX   PubMed=35109825;
CC   Doubling time: 21.3 hours (PubMed=32168360).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   Til-1
AC   CVCL_C8KC
DR   Wikidata; Q123033612
RX   PubMed=16332115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_195409; Tilmicosin (TIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Til-2
AC   CVCL_C8KD
DR   Wikidata; Q123033613
RX   PubMed=16332115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_195409; Tilmicosin (TIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Til-3
AC   CVCL_C8KE
DR   Wikidata; Q123033614
RX   PubMed=16332115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_195409; Tilmicosin (TIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Til-4
AC   CVCL_C8KF
DR   Wikidata; Q123033615
RX   PubMed=16332115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_195409; Tilmicosin (TIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Til-5
AC   CVCL_C8KG
DR   Wikidata; Q123033616
RX   PubMed=16332115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_195409; Tilmicosin (TIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Til-6
AC   CVCL_C8KH
DR   Wikidata; Q123033617
RX   PubMed=16332115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_195409; Tilmicosin (TIL).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   TIME
AC   CVCL_0047
SY   Telomerase-Immortalized human Microvascular Endothelial cells
DR   ATCC; CRL-4025
DR   BioGRID_ORCS_Cell_line; 1380
DR   BioSample; SAMN03471728
DR   GEO; GSM7701377
DR   Wikidata; Q27653709
RX   PubMed=11795943;
RX   PubMed=16957166;
RX   PubMed=33937098;
WW   Info; ATCC; -; https://www.atcc.org/-/media/resources/application-notes/telomerase-immortalized-microvascular-endothelial-cells.pdf?rev=1b6ac96d7e8a4778978ebb808a68b1a5
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339.
ST   Source(s): ATCC=CRL-4025; PubMed=33937098
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 18,20
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 19,25
ST   Penta D: 9,13
ST   Penta E: 7,16
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   TIME-GFP
AC   CVCL_S878
DR   ATCC; CRL-4045
DR   Wikidata; Q54972481
CC   Characteristics: Stably expresses emerald GFP (emGFP) under the control of the CMV promoter.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339.
ST   Source(s): ATCC=CRL-4045
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0047 ! TIME
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 18
//
ID   TIME.219
AC   CVCL_B6YR
DR   Wikidata; Q112041790
RX   PubMed=33937098;
CC   Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter.
CC   Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219.
CC   Genetic integration: Method=Transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin, dermis, microvascular endothelium; UBERON=UBERON_0001471+UBERON_0008339.
ST   Source(s): PubMed=33937098
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0047 ! TIME
SX   Male
AG   <1M
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 10
//
ID   TIMI.4
AC   CVCL_3609
SY   T1M1.4
DR   CLO; CLO_0009351
DR   ATCC; TIB-37
DR   Wikidata; Q54972483
RX   PubMed=4541304;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11787; Radiation murine leukemia virus.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   TIMI.4G.1.3
AC   CVCL_5900
SY   T1M1.4G.1.3
DR   CLO; CLO_0009352
DR   ATCC; TIB-38
DR   Wikidata; Q54972484
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 11787; Radiation murine leukemia virus.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3609 ! TIMI.4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   TIMJ2-C15
AC   CVCL_0P79
SY   Tumor-Infiltrated Macrophage J2-immortalized-Clone 15
DR   Wikidata; Q54972485
RX   PubMed=1879973;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   TIMJ2-C4
AC   CVCL_0P80
SY   Tumor-Infiltrated Macrophage J2-immortalized-Clone 4
DR   Wikidata; Q54972487
RX   PubMed=1879973;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   TIMJ2-C7
AC   CVCL_0P81
SY   Tumor-Infiltrated Macrophage J2-immortalized-Clone 7
DR   Wikidata; Q54972490
RX   PubMed=1879973;
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   TIN2 F/F
AC   CVCL_JM07
DR   ATCC; CRL-3318
DR   Wikidata; Q54972491
RX   PubMed=22099311;
CC   Characteristics: Embryonic fibroblasts that have loxP sites on both sides of the 1st coding exon of mouse Terf1 gene. Terf1 knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3318).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 9
//
ID   TISI
AC   CVCL_E851
DR   dbMHC; 49042
DR   ECACC; 88052042
DR   IHW; IHW09042
DR   IPD-IMGT/HLA; 11649
DR   Wikidata; Q54972492
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*24:02:01:01; B*35:08:01; C*04:01:01:06; DPA1*01:03; DPB1*04:02:01; DQA1*05:05; DQB1*03:01:01; DRA*01:01; DRB1*11:03:01; DRB3*02:02 (IPD-IMGT/HLA=11649).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   TISSUi001-A
AC   CVCL_WU56
SY   StemUse101; SU101; HUMIMIC101
DR   BioSamples; SAMEA5909229
DR   hPSCreg; TISSUi001-A
DR   Wikidata; Q98133264
RX   DOI=10.1101/376970;
RX   PubMed=31704539;
CC   From: TissUse GmbH; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   TISSUi002-A
AC   CVCL_WU57
SY   StemUse102; SU102; HUMIMIC102
DR   BioSamples; SAMEA5928134
DR   hPSCreg; TISSUi002-A
DR   Wikidata; Q98133265
RX   PubMed=31704539;
CC   From: TissUse GmbH; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   TISSUi003-A
AC   CVCL_WU58
SY   StemUse103; SU103; HUMIMIC103
DR   BioSamples; SAMEA5928368
DR   hPSCreg; TISSUi003-A
DR   Wikidata; Q98133267
RX   PubMed=31704539;
CC   From: TissUse GmbH; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   TISSUi004-A
AC   CVCL_WU59
DR   hPSCreg; TISSUi004-A
DR   Wikidata; Q98133268
CC   From: TissUse GmbH; Berlin; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   TISSUi005-A
AC   CVCL_WU60
SY   StemUse105; SU105; HUMIMIC105
DR   BioSamples; SAMEA5928370
DR   hPSCreg; TISSUi005-A
DR   Wikidata; Q98133269
RX   PubMed=31704539;
CC   From: TissUse GmbH; Berlin; Germany.
CC   Population: Caucasian.
CC   Donor information: Established from a patient suffering from leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   TISSUi006-A
AC   CVCL_WU61
SY   StemUse106; SU106; HUMIMIC106
DR   BioSamples; SAMEA7258623
DR   hPSCreg; TISSUi006-A
DR   Wikidata; Q98133270
RX   PubMed=33901815;
RX   PubMed=34136596;
CC   From: TissUse GmbH; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   TISSUi007-A
AC   CVCL_WU62
SY   StemUse107; SU107; HUMIMIC107
DR   BioSamples; SAMEA7258625
DR   hPSCreg; TISSUi007-A
DR   Wikidata; Q98133271
RX   PubMed=33901815;
RX   PubMed=34136596;
CC   From: TissUse GmbH; Berlin; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   TIVE
AC   CVCL_2G60
SY   Telomerase-Immortalized human umbilical Vein Endothelial cells
DR   EFO; EFO_0002086
DR   GEO; GSM1265861
DR   GEO; GSM1265862
DR   GEO; GSM1265863
DR   GEO; GSM1265864
DR   GEO; GSM1265865
DR   GEO; GSM1265866
DR   GEO; GSM1265867
DR   Wikidata; Q54972493
RX   PubMed=16641275;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 14
//
ID   TJ-GBC2
AC   CVCL_IU75
SY   TongJi-GallBladder Cancer-2
DR   Wikidata; Q54972494
RX   PubMed=28194091;
CC   Population: Chinese.
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
ID   TJ1
AC   CVCL_LB73
DR   Wikidata; Q54972505
RX   PubMed=11876747;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P25189; Human MPZ.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3996; Monoclonal gammopathy of undetermined significance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LB74 ! TJ2
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   TJ2
AC   CVCL_LB74
DR   Wikidata; Q54972506
RX   PubMed=11876747;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P25189; Human MPZ.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3996; Monoclonal gammopathy of undetermined significance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LB73 ! TJ1
SX   Female
AG   71Y
CA   Transformed cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 5
//
ID   TJ8510
AC   CVCL_B265
DR   Wikidata; Q54972507
RX   CelloPub=CLPUB00118;
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B266 ! TJ861
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   TJ861
AC   CVCL_B266
DR   Wikidata; Q54972510
RX   CelloPub=CLPUB00118;
CC   Population: Chinese.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B265 ! TJ8510
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   TJ899
AC   CVCL_B264
SY   Tj-899
DR   Wikidata; Q54972511
RX   CelloPub=CLPUB00119;
RX   PubMed=19781350;
CC   Population: Chinese.
CC   Omics: Proteomics; 2DE.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   TJ905
AC   CVCL_6975
AS   CVCL_XX33
SY   Tj-905
DR   CCRID; 1101HUM-PUMC000267
DR   Wikidata; Q54972512
RX   CelloPub=CLPUB00119;
RX   PubMed=19781350;
RX   PubMed=29679856;
CC   Population: Chinese.
CC   Doubling time: 41.03 hours (CCRID=1101HUM-PUMC000267).
CC   Omics: Proteomics; 2DE.
CC   Misspelling: TG-905; PubMed=29679856.
ST   Source(s): CCRID=1101HUM-PUMC000267
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 15.2,16
ST   D21S11: 30
ST   D2S1338: 22,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 25
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   TJCi001-A
AC   CVCL_A0YN
SY   BM-iPSC
DR   hPSCreg; TJCi001-A
DR   Wikidata; Q108821372
RX   PubMed=34371346;
CC   From: TJC Life; Seoul; South Korea.
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   TJPH-1
AC   CVCL_F0KZ
RX   PubMed=20355246;
CC   Characteristics: Transduced with the retroviral vector SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites (PubMed=20355246).
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype (PubMed=20355246).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Miniature pig.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TJU-UM001
AC   CVCL_B6PW
SY   UM001; Thomas Jefferson University-Uveal Melanoma 001
DR   cancercelllines; CVCL_B6PW
DR   Wikidata; Q112041791
RX   PubMed=24354797;
RX   PubMed=25952648;
RX   PubMed=26613897;
RX   PubMed=32430489;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (PubMed=24354797; PubMed=25952648).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   TJU-UM001-tdTomato
AC   CVCL_B6PZ
SY   UM001-tdTomato
DR   cancercelllines; CVCL_B6PZ
DR   Wikidata; Q112041792
RX   PubMed=26613897;
CC   Doubling time: ~72 hours (PubMed=26613897).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6PW ! TJU-UM001
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   TJU-UM003
AC   CVCL_B6PX
SY   UM003; Thomas Jefferson University-Uveal Melanoma 003
DR   cancercelllines; CVCL_B6PX
DR   Wikidata; Q112041793
RX   PubMed=24354797;
RX   PubMed=25952648;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Heterozygous (PubMed=24354797; PubMed=25952648).
CC   Derived from site: Metastatic; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   TJU-UM004
AC   CVCL_B6PY
SY   UM004; Thomas Jefferson University-Uveal Melanoma 004
DR   cancercelllines; CVCL_B6PY
DR   Wikidata; Q112041794
RX   PubMed=25952648;
RX   PubMed=32430489;
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Homozygous (PubMed=25952648).
CC   Derived from site: Metastatic; Eye socket; UBERON=UBERON_0001697.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   TK [Human B-cell lymphoma]
AC   CVCL_3216
SY   Tk
DR   CLO; CLO_0037066
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_3216
DR   Cell_Model_Passport; SIDM00323
DR   Cosmic-CLP; 1331045
DR   DepMap; ACH-002313
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1331045
DR   GEO; GSM827272
DR   GEO; GSM1670544
DR   JCRB; JCRB0157
DR   JCRB; NIHS0245
DR   LINCS_LDP; LCL-1953
DR   PharmacoDB; TK_1596_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3216
DR   Wikidata; Q54972513
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10354143;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 5.3 days (PubMed=10354143); 30-40 hours (Note=Lot 08032007) (JCRB=JCRB0157).
CC   HLA typing: A*02:06,02:06; B*52:01,52:01; C*12:02,12:02; DQA1*01:01,01:01; DQB1*05:01,05:01; DRB1*01:01,01:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu180Asp (c.540G>T); ClinVar=VCV001521256; Zygosity=Unspecified (PubMed=10354143).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.67%; Native American=0%; East Asian, North=79.08%; East Asian, South=19.03%; South Asian=0.83%; European, North=0.39%; European, South=0% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0245; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1331045
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9,11
ST   D5S818: 10,12
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3457; B-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171915; B-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   TK [Human brain lymphoma]
AC   CVCL_E941
SY   Tk
DR   BioSample; SAMN03472435
DR   JCRB; JCRB1206
DR   JCRB; NIHS0524
DR   Wikidata; Q54972514
RX   PubMed=6450513;
RX   PubMed=7059907;
RX   PubMed=30993483;
RX   PubMed=31510952;
CC   Population: Japanese.
CC   Doubling time: 34 hours (PubMed=7059907).
CC   Anecdotal: Cell line name corresponds to the initials of the patient from which it was established.
CC   Discontinued: JCRB; NIHS0524; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): JCRB=JCRB1206
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C9301; Central nervous system lymphoma
DI   ORDO; Orphanet_46135; Primary central nervous system lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 27-11-25; Version: 17
//
ID   TK [Human cholangiocarcinoma]
AC   CVCL_4Z42
SY   TanKan-gann
DR   Wikidata; Q54972515
RX   CelloPub=CLPUB00275;
RX   PubMed=10718366;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 29 hours (Note=At 13th passage) (PubMed=10718366).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   TK [Scophthalmus]
AC   CVCL_R815
SY   Turbot Kidney
DR   Wikidata; Q54972516
RX   PubMed=20496112;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   TK 173
AC   CVCL_C8FA
SY   Tk 173; TK-173; tNKF; transformed Normal Kidney Fibroblasts
DR   Wikidata; Q123033618
RX   PubMed=7773632;
RX   PubMed=11702000;
RX   PubMed=12684791;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Renal interstitial fibroblast; CL=CL_1000692.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   TK 188
AC   CVCL_C8FB
SY   Tk 188; tFKIF; transformed Fibroblasts from Kidney with Interstitial Fibrosis
DR   Wikidata; Q123033619
RX   PubMed=7773632;
RX   PubMed=12684791;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-gpt).
CC   Donor information: Established from a patient suffering from tubulointerstitial fibrosis.
CC   Derived from site: In situ; Kidney; Note=Fibrotic; UBERON=UBERON_0002113.
CC   Cell type: Renal interstitial fibroblast; CL=CL_1000692.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   TK#1
AC   CVCL_6528
DR   CLO; CLO_0009355
DR   ATCC; CRL-11383
DR   Wikidata; Q54972534
RX   Patent=US5675059;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11383.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96591; Irf2.
CC   Discontinued: ATCC; CRL-11383; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   TK-1 [Human astrocytoma]
AC   CVCL_B325
DR   BioSample; SAMN03151978
DR   cancercelllines; CVCL_B325
DR   Cosmic; 687587
DR   JCRB; JCRB0128
DR   JCRB; NIHS0181
DR   Wikidata; Q54972517
RX   PubMed=9183640;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-251MG derivative. Originally thought to originate from a 22 year old female patient with a glioblastoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00348.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Discontinued: JCRB; NIHS0181; true.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): JCRB=JCRB0128
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 27
//
ID   TK-1 [Human myeloid leukemia]
AC   CVCL_B326
DR   Wikidata; Q54972518
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3457771;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3457771).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   TK-1 [Mouse lymphoma]
AC   CVCL_3217
DR   CLO; CLO_0009356
DR   ATCC; CRL-2396
DR   Wikidata; Q54972521
CC   Breed/subspecies: AKR/Cum.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   TK-1 [Tilapia]
AC   CVCL_R879
SY   Tilapia Kidney-1
DR   Wikidata; Q54972522
RX   CelloPub=CLPUB00008;
RX   CelloPub=CLPUB00022;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 31 Celsius (CelloPub=CLPUB00008).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus (Hybrid tilapia)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   TK-10
AC   CVCL_1773
SY   TK.10; TK_10; TK 10; TK10
DR   BTO; BTO_0004283
DR   CLO; CLO_0009983
DR   EFO; EFO_0006765
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473277
DR   cancercelllines; CVCL_1773
DR   Cell_Model_Passport; SIDM00113
DR   ChEMBL-Cells; CHEMBL3308453
DR   ChEMBL-Targets; CHEMBL614056
DR   Cosmic; 687944
DR   Cosmic; 845925
DR   Cosmic; 905980
DR   Cosmic; 974308
DR   Cosmic; 1092642
DR   Cosmic; 1305378
DR   Cosmic; 1312366
DR   Cosmic; 1998485
DR   Cosmic-CLP; 905980
DR   DepMap; ACH-001208
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905980
DR   GEO; GSM2119
DR   GEO; GSM50231
DR   GEO; GSM50295
DR   GEO; GSM743486
DR   GEO; GSM750807
DR   GEO; GSM799440
DR   GEO; GSM844717
DR   GEO; GSM847165
DR   GEO; GSM1153450
DR   GEO; GSM1181308
DR   GEO; GSM1181326
DR   GEO; GSM1670545
DR   GEO; GSM2124690
DR   IARC_TP53; 18078
DR   LINCS_LDP; LCL-1771
DR   NCI-DTP; TK-10
DR   PharmacoDB; TK10_1597_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1773
DR   PubChem_Cell_line; CVCL_1773
DR   SKY/M-FISH/CGH; 2807
DR   Wikidata; Q54972524
RX   PubMed=2041050;
RX   PubMed=3594443;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=10723130;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=18277095;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=27993170;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=42
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Doubling time: 25 hours (Note=At 155th passage) (PubMed=3594443); 51.3 hours (NCI-DTP=TK-10).
CC   HLA typing: A*33:01; B*14:02; C*08:02; DPB1*04:02; DQB1*05:01:01; DRB1*01:02:01 (PubMed=15748285).
CC   HLA typing: A*33:01,33:01; B*14:02,14:02; C*08:02,08:02; DQB1*05:01,05:01; DRB1*01:02,01:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu264Arg (c.791T>G); Zygosity=Heterozygous (PubMed=9331090; PubMed=17088437; PubMed=18277095; Cosmic-CLP=905980; DepMap=ACH-001208).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.52%; Native American=2.2%; East Asian, North=0.11%; East Asian, South=1.52%; South Asian=12.26%; European, North=9%; European, South=73.4% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=905980; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X (PubMed=19372543)
ST   Amelogenin: X,Y (Cosmic-CLP=905980; PubMed=25877200)
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 16 (PubMed=19372543)
ST   D18S51: 16,17 (PubMed=25877200)
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 15,16
ST   FGA: 18,22
ST   Penta D: 10
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 11
ST   vWA: 18,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 43
//
ID   TK-140
AC   CVCL_WF16
DR   IBRC; C10235
DR   Wikidata; Q98133272
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-142
AC   CVCL_WF17
DR   IBRC; C10272
DR   Wikidata; Q98133274
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-144
AC   CVCL_WF18
DR   IBRC; C10269
DR   Wikidata; Q98133275
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-145
AC   CVCL_WF19
DR   IBRC; C10247
DR   Wikidata; Q98133276
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-146
AC   CVCL_WF20
DR   IBRC; C10255
DR   Wikidata; Q98133277
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-148
AC   CVCL_WF21
DR   IBRC; C10248
DR   Wikidata; Q98133278
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-150
AC   CVCL_WF22
DR   IBRC; C10362
DR   Wikidata; Q98133279
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-151
AC   CVCL_WF23
DR   IBRC; C10256
DR   Wikidata; Q98133280
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-152
AC   CVCL_WF24
DR   IBRC; C10315
DR   Wikidata; Q98133281
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-153
AC   CVCL_WF25
DR   IBRC; C10357
DR   Wikidata; Q98133282
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-155
AC   CVCL_WF26
DR   IBRC; C10249
DR   Wikidata; Q98133283
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-156
AC   CVCL_WF27
DR   IBRC; C10270
DR   Wikidata; Q98133286
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-159
AC   CVCL_WF28
DR   IBRC; C10363
DR   Wikidata; Q98133287
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-160
AC   CVCL_WF29
DR   IBRC; C10250
DR   Wikidata; Q98133288
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-164
AC   CVCL_8324
SY   TK 164; TK164
DR   BTO; BTO_0004284
DR   Cosmic; 845928
DR   Wikidata; Q54972525
RX   PubMed=3594443;
RX   PubMed=27993170;
CC   Doubling time: 43 hours (PubMed=3594443).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   TK-165
AC   CVCL_WF30
DR   IBRC; C10251
DR   Wikidata; Q98133289
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-173
AC   CVCL_WF31
DR   IBRC; C10240
DR   Wikidata; Q98133290
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-177
AC   CVCL_WF32
DR   IBRC; C10228
DR   Wikidata; Q98133291
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-180
AC   CVCL_WF33
DR   IBRC; C10243
DR   Wikidata; Q98133292
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-181
AC   CVCL_WF34
SY   Tk-181
DR   IBRC; C10230
DR   Wikidata; Q98133293
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-182
AC   CVCL_WF35
DR   IBRC; C10244
DR   Wikidata; Q98133294
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-183
AC   CVCL_WF36
DR   IBRC; C10245
DR   Wikidata; Q98133295
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-191
AC   CVCL_WF37
DR   IBRC; C10374
DR   Wikidata; Q98133296
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-193
AC   CVCL_WF38
DR   IBRC; C10361
DR   Wikidata; Q98133298
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-197
AC   CVCL_WF39
DR   IBRC; C10364
DR   Wikidata; Q98133299
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-198
AC   CVCL_WF40
DR   IBRC; C10367
DR   Wikidata; Q98133300
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-1B
AC   CVCL_B331
DR   Cosmic; 787481
DR   Cosmic; 975304
DR   DSMZ; ACC-946
DR   Wikidata; Q54972527
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3457771;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3457771); ~48-72 hours (DSMZ=ACC-946).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-946
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 15,21
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B326 ! TK-1 [Human myeloid leukemia]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   TK-1D
AC   CVCL_B327
DR   Wikidata; Q54972528
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3457771;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=3457771).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B326 ! TK-1 [Human myeloid leukemia]
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   TK-20
AC   CVCL_WF41
DR   IBRC; C10119
DR   Wikidata; Q98133301
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-211
AC   CVCL_WF42
DR   IBRC; C10384
DR   Wikidata; Q98133302
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-213
AC   CVCL_WF43
DR   IBRC; C10386
DR   Wikidata; Q98133303
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-217
AC   CVCL_WF44
DR   IBRC; C10390
DR   Wikidata; Q98133304
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-221
AC   CVCL_WF45
DR   IBRC; C10394
DR   Wikidata; Q98133305
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-23
AC   CVCL_WF46
DR   IBRC; C10121
DR   Wikidata; Q98133306
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-256
AC   CVCL_WF47
DR   IBRC; C10545
DR   Wikidata; Q98133307
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-28
AC   CVCL_WF48
DR   IBRC; C10122
DR   Wikidata; Q98133308
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-291
AC   CVCL_WF49
DR   IBRC; C10640
DR   Wikidata; Q98133309
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-292
AC   CVCL_WF50
DR   IBRC; C10641
DR   Wikidata; Q98133310
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-293
AC   CVCL_WF51
DR   IBRC; C10805
DR   Wikidata; Q98133311
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-294
AC   CVCL_WF52
DR   IBRC; C10699
DR   Wikidata; Q98133313
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-296
AC   CVCL_WF53
DR   IBRC; C10711
DR   Wikidata; Q98133314
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-303
AC   CVCL_WF54
DR   IBRC; C10793
DR   Wikidata; Q98133315
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-304
AC   CVCL_WF55
DR   IBRC; C10813
DR   Wikidata; Q98133316
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-307
AC   CVCL_WF56
DR   IBRC; C10811
DR   Wikidata; Q98133317
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-309
AC   CVCL_WF57
DR   IBRC; C10803
DR   Wikidata; Q98133318
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-313
AC   CVCL_WF58
DR   IBRC; C10808
DR   Wikidata; Q98133319
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-314
AC   CVCL_WF59
DR   IBRC; C10810
DR   Wikidata; Q98133320
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-316
AC   CVCL_WF60
DR   IBRC; C10767
DR   Wikidata; Q98133323
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-317
AC   CVCL_WF61
DR   IBRC; C10801
DR   Wikidata; Q98133324
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-319
AC   CVCL_WF62
DR   IBRC; C10800
DR   Wikidata; Q98133327
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-32
AC   CVCL_WF63
DR   IBRC; C10125
DR   Wikidata; Q98133328
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-327
AC   CVCL_WF64
DR   IBRC; C10769
DR   Wikidata; Q98133329
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-330
AC   CVCL_WF65
DR   IBRC; C10797
DR   Wikidata; Q98133330
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-333
AC   CVCL_WF66
DR   IBRC; C10773
DR   Wikidata; Q98133331
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-335
AC   CVCL_WF67
DR   IBRC; C10755
DR   Wikidata; Q98133332
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-342
AC   CVCL_WF68
DR   IBRC; C10752
DR   Wikidata; Q98133333
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-343
AC   CVCL_WF69
SY   Tk-343
DR   IBRC; C10754
DR   Wikidata; Q98133335
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-36
AC   CVCL_WF70
SY   Tk-36
DR   IBRC; C10129
DR   Wikidata; Q98133336
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-44
AC   CVCL_WF71
DR   IBRC; C10168
DR   Wikidata; Q98133337
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-46
AC   CVCL_WF72
DR   IBRC; C10172
DR   Wikidata; Q98133338
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-47
AC   CVCL_WF73
DR   IBRC; C10170
DR   Wikidata; Q98133340
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-48
AC   CVCL_WF74
DR   IBRC; C10171
DR   Wikidata; Q98133341
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-5
AC   CVCL_WF75
DR   IBRC; C10115
DR   Wikidata; Q98133342
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-50
AC   CVCL_WF76
DR   IBRC; C10176
DR   Wikidata; Q98133343
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-51
AC   CVCL_WF77
DR   IBRC; C10194
DR   Wikidata; Q98133344
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-52
AC   CVCL_WF78
DR   IBRC; C10173
DR   Wikidata; Q98133345
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-53
AC   CVCL_WF79
DR   IBRC; C10174
DR   Wikidata; Q98133346
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-54
AC   CVCL_WF80
DR   IBRC; C10175
DR   Wikidata; Q98133348
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-56
AC   CVCL_WF81
DR   IBRC; C10177
DR   Wikidata; Q98133349
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-6 [Human EBV-transformed]
AC   CVCL_WF82
DR   IBRC; C10116
DR   Wikidata; Q98133350
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TK-6 [Human leukemia]
AC   CVCL_X907
SY   TK6
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473400
DR   CGH-DB; 9213-4
DR   Cosmic; 1483366
DR   DSMZ; ACC-723
DR   DSMZCellDive; ACC-723
DR   Wikidata; Q54972529
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7475285;
RX   PubMed=9737692;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=31160637;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~60-72 hours (DSMZ=ACC-723).
CC   HLA typing: A*02:06:01,33:03:01; B*40:02:01,44:03:01; C*03:04:01;14:03 (DSMZCellDive=ACC-723).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=31160637).
CC   Sequence variation: Gene fusion; HGNC; HGNC:28904; AIF1L + HGNC; HGNC:6871; MAPK1; Name(s)=MAPK1-AIF1L (PubMed=31160637).
CC   Sequence variation: Mutation; HGNC; HGNC:7545; MYB; Unexplicit; Rearranged and truncated; Zygosity=Unspecified (PubMed=9737692).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-723
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 12,14
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 19,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 23,25
ST   Penta D: 11,12
ST   Penta E: 10,19
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 20
//
ID   TK-7
AC   CVCL_WF83
DR   IBRC; C10117
DR   Wikidata; Q98133351
RX   PubMed=32358742;
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-84
AC   CVCL_WF84
DR   IBRC; C10178
DR   Wikidata; Q98133353
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-86
AC   CVCL_WF85
DR   IBRC; C10179
DR   Wikidata; Q98133354
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-88
AC   CVCL_WF86
DR   IBRC; C10180
DR   Wikidata; Q98133355
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-89
AC   CVCL_WF87
DR   IBRC; C10185
DR   Wikidata; Q98133356
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-90
AC   CVCL_WF88
DR   IBRC; C10181
DR   Wikidata; Q98133357
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-92
AC   CVCL_WF89
DR   IBRC; C10182
DR   Wikidata; Q98133359
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-93
AC   CVCL_WF90
DR   IBRC; C10183
DR   Wikidata; Q98133360
CC   Population: Iranian; Azerbaijanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TK-ALCL1
AC   CVCL_E2T4
RX   PubMed=38755432;
CC   Population: Japanese.
CC   Doubling time: 26.9 +- 0.4 hours (PubMed=38755432).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=38755432).
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): PubMed=38755432
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D21S11: 32,32.2
ST   D5S818: 12
ST   D7S820: 9.3,10,10.3,11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,19,20
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   TK-SA
AC   CVCL_A1RJ
DR   Wikidata; Q105511209
RX   PubMed=7570584;
CC   Population: Japanese.
CC   Doubling time: 100.4 hours (PubMed=7570584).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   TK-ST
AC   CVCL_E4DH
SY   Tursiops Kidney - SV40 TERT
DR   ABM; T0434
RX   PubMed=37524977;
CC   Group: Cetacean cell line.
CC   Virology: Susceptible to infection by dolphin morbillivirus (DMV) (PubMed=37524977).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   TK-TS 13
AC   CVCL_4325
SY   TK TS 13; tk-ts13; tk. ts13; tk- ts13; tk^(-)ts13
DR   CLO; CLO_0009353
DR   CLO; CLO_0009354
DR   CLO; CLO_0009360
DR   CLO; CLO_0051412
DR   CLDB; cl4521
DR   CLDB; cl4522
DR   ATCC; CRL-1632
DR   BCRC; 60208
DR   ECACC; 93120838
DR   IZSLER; BS CL 85
DR   RCB; RCB0286
DR   Wikidata; Q54972532
RX   PubMed=6294505;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   TK6
AC   CVCL_0561
SY   TK-6; H2BT
DR   BTO; BTO_0003707
DR   CLO; CLO_0009357
DR   MCCL; MCC:0000463
DR   CLDB; cl4519
DR   ArrayExpress; E-TOXM-7
DR   ATCC; CRL-8015
DR   BCRC; 60107
DR   BCRJ; 0410
DR   BioSample; SAMN03471129
DR   ChEMBL-Cells; CHEMBL4295397
DR   ChEMBL-Targets; CHEMBL4296502
DR   CLS; 300357
DR   ECACC; 95111735
DR   GEO; GSE65477
DR   GEO; GSM260653
DR   GEO; GSM260654
DR   GEO; GSM260655
DR   GEO; GSM260656
DR   IARC_TP53; 21695
DR   PubChem_Cell_line; CVCL_0561
DR   Wikidata; Q54972535
RX   Patent=US4302535;
RX   PubMed=214074;
RX   PubMed=3012798;
RX   PubMed=3745200;
RX   PubMed=7565900;
RX   PubMed=7744731;
RX   PubMed=7859358;
RX   PubMed=8316623;
RX   PubMed=9258685;
RX   PubMed=10397247;
RX   PubMed=11221843;
RX   PubMed=15033590;
RX   PubMed=18805990;
RX   PubMed=22042714;
RX   PubMed=22525470;
RX   PubMed=26774668;
RX   PubMed=27692294;
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8015.
CC   Population: Caucasian.
CC   Doubling time: 12.2 hours (PubMed=7744731).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=7859358).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=7744731; PubMed=11221843).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8015; CLS=300357; ECACC=95111735
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11,16
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 5,7
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X906 ! HH4
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   TK6 (IVGT)
AC   CVCL_AR68
SY   TK6(IVGT)
DR   ECACC; 13051501
DR   GEO; GSM4288410
DR   JCRB; JCRB1435
DR   Wikidata; Q54972536
RX   PubMed=27692294;
RX   PubMed=29892436;
RX   PubMed=33198927;
CC   Part of: In Vitro Genetic Toxicity (IVGT) cell line panel.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (PubMed=33198927).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=33198927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ECACC=13051501; JCRB=JCRB1435
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0561 ! TK6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   TK6TGR
AC   CVCL_2733
SY   TK6 TGr.p1
DR   CLO; CLO_0009358
DR   CLDB; cl4520
DR   ECACC; 87020507
DR   Wikidata; Q54972537
RX   PubMed=22359172;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ECACC=87020507
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0561 ! TK6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   TK765
AC   CVCL_F544
SY   TER250; TER-250; Ter 250; Extract 109; Extract 397
DR   IPD-IMGT/HLA; 11480
DR   Wikidata; Q54972538
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/328cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*25:01,68:01; B*55:01,15:23; C*03:03,07:12; DPB1*04:01,03:01; DQA1*03:01,03:03; DQB1*03:01,03:02; DRB1*04:01,04:08; DRB4*01:03 (IPD-IMGT/HLA=11480).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   TK91
AC   CVCL_RN48
DR   Wikidata; Q54972539
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690048;
CC   Population: Japanese.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   TKA14 (DNAVEC)
AC   CVCL_RH53
SY   TKA14 [DNAVEC]; TKA14(DNAVEC); TiPS_TKA14(DNAVEC); dTKA14
DR   GEO; GSM2038546
DR   SKIP; SKIP000785
DR   SKIP; SKIP000833
DR   Wikidata; Q54972540
RX   PubMed=26905201;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   TKA4 (AIST)
AC   CVCL_RH54
SY   TKA4 [AIST]; TKA4(AIST); TiPS_TKA4(AIST); TKA4; aTKA4; T-cell(KA)-derived iPSC, clone #4
DR   GEO; GSM2038543
DR   GEO; GSM2038563
DR   GEO; GSM2185127
DR   SKIP; SKIP000782
DR   SKIP; SKIP000831
DR   Wikidata; Q54972542
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   TKA7 (DNAVEC)
AC   CVCL_RH55
SY   TKA7 [DNAVEC]; TKA7(DNAVEC); TiPS_TKA7(DNAVEC); dTKA7
DR   GEO; GSM2038545
DR   SKIP; SKIP000784
DR   SKIP; SKIP000834
DR   Wikidata; Q54972544
RX   PubMed=26905201;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   TKA9 (AIST)
AC   CVCL_RH56
SY   TKA9 [AIST]; TKA9(AIST); TiPS_TKA9(AIST); TKA9; aTKA9; T-cell(KA)-derived iPSC, clone #9
DR   GEO; GSM2038544
DR   GEO; GSM2038564
DR   GEO; GSM2185128
DR   SKIP; SKIP000783
DR   SKIP; SKIP000832
DR   Wikidata; Q54972545
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX87 ! KA(T-cell)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   TKB-1
AC   CVCL_S125
SY   TKB1
DR   Wikidata; Q54972546
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 11
//
ID   TKB-101
AC   CVCL_A1RM
SY   TKB101
DR   Wikidata; Q105511213
RX   PubMed=2430695;
CC   Population: Japanese.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   TKB-102
AC   CVCL_A1RN
SY   TKB102
DR   Wikidata; Q105511216
RX   PubMed=2430695;
CC   Population: Japanese.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   TKB-11
AC   CVCL_A1RK
SY   TKB11
DR   Wikidata; Q105511219
RX   PubMed=2430695;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   TKB-12
AC   CVCL_S126
SY   TKB12
DR   Wikidata; Q54972547
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TKB-13
AC   CVCL_A1RL
SY   TKB13
DR   Wikidata; Q105511223
RX   PubMed=2430695;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   TKB-14
AC   CVCL_S140
SY   TKB14
DR   Wikidata; Q54972549
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TKB-15
AC   CVCL_S127
SY   TKB15
DR   Wikidata; Q54972550
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TKB-16
AC   CVCL_S128
SY   TKB16
DR   Wikidata; Q54972551
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TKB-17
AC   CVCL_S129
SY   TKB17
DR   Wikidata; Q54972552
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TKB-2
AC   CVCL_S130
SY   TKB2
DR   Wikidata; Q54972553
RX   PubMed=2430695;
RX   PubMed=2548713;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   TKB-20
AC   CVCL_S131
SY   TKB20
DR   Wikidata; Q54972554
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TKB-21
AC   CVCL_S139
SY   TKB21
DR   Wikidata; Q54972556
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TKB-3
AC   CVCL_S138
SY   TKB3
DR   Wikidata; Q54972557
RX   PubMed=2430695;
RX   PubMed=2548713;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TKB-34
AC   CVCL_S137
SY   TKB34
DR   Wikidata; Q54972569
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TKB-4
AC   CVCL_S132
SY   TKB4
DR   Wikidata; Q54972570
RX   PubMed=2430695;
RX   PubMed=2548713;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TKB-5
AC   CVCL_S133
SY   TKB5
DR   Wikidata; Q54972571
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TKB-6
AC   CVCL_S134
SY   TKB6
DR   Wikidata; Q54972572
RX   PubMed=2430695;
RX   PubMed=2548713;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TKB-7
AC   CVCL_S135
SY   TKB7
DR   Wikidata; Q54972574
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TKB-8
AC   CVCL_S136
SY   TKB8
DR   Wikidata; Q54972575
RX   PubMed=2430695;
RX   PubMed=10365094;
CC   Population: Japanese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TKB-MEN2
AC   CVCL_E6MH
RX   PubMed=39612090;
CC   Population: Japanese.
CC   Doubling time: 28.2 hours (PubMed=39612090).
CC   Derived from site: In situ; Brain, falx cerebri; UBERON=UBERON_0006059.
ST   Source(s): PubMed=39612090
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 10,15
ST   FGA: 23,25
ST   Penta D: 9,10
ST   Penta E: 10,16
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4333; Transitional meningioma
DI   ORDO; Orphanet_2495; Meningioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TKC2
AC   CVCL_5597
SY   TKC-2
DR   JCRB; IFO50373
DR   TKG; TKG 0354
DR   Wikidata; Q54972577
RX   PubMed=1663919;
RX   PubMed=7641784;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Doubling time: ~27 hours (Note=Lot 04192002) (JCRB=IFO50373).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   TkCB7-2
AC   CVCL_DP88
SY   TKCB7-2
DR   GEO; GSM1040273
DR   GEO; GSM1040343
DR   Wikidata; Q54972578
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DP89 ! TkCBV4-2
OI   CVCL_DP90 ! TkCBV5-6
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   TkCBV4-2
AC   CVCL_DP89
SY   TKCBV4-2
DR   GEO; GSM1040271
DR   GEO; GSM1040341
DR   Wikidata; Q54972579
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DP88 ! TkCB7-2
OI   CVCL_DP90 ! TkCBV5-6
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   TkCBV5-6
AC   CVCL_DP90
SY   TKCBV5-6
DR   GEO; GSM1040272
DR   GEO; GSM1040342
DR   Wikidata; Q54972580
RX   PubMed=22802639;
RX   PubMed=24259714;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DP88 ! TkCB7-2
OI   CVCL_DP89 ! TkCBV4-2
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   TKD2
AC   CVCL_5598
DR   CLO; CLO_0050786
DR   JCRB; IFO50374
DR   RCB; RCB0752
DR   Wikidata; Q54972581
RX   PubMed=1663919;
CC   Doubling time: ~33 hours (Note=Lot 04152002), ~32 hours (Note=Lot 02252021) (JCRB=IFO50374).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, renal tubule; UBERON=UBERON_0009773.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   TkDA3-1
AC   CVCL_RJ52
DR   SKIP; SKIP001702
DR   Wikidata; Q54972582
RX   PubMed=21098095;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ53 ! TkDA3-2
OI   CVCL_RJ54 ! TkDA3-4
OI   CVCL_RJ55 ! TkDA3-5
OI   CVCL_RJ56 ! TkDA3-9
OI   CVCL_RJ57 ! TkDA3-20
OI   CVCL_RJ58 ! TkDN4-M
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TkDA3-2
AC   CVCL_RJ53
DR   SKIP; SKIP001703
DR   Wikidata; Q54972584
RX   PubMed=21098095;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ52 ! TkDA3-1
OI   CVCL_RJ54 ! TkDA3-4
OI   CVCL_RJ55 ! TkDA3-5
OI   CVCL_RJ56 ! TkDA3-9
OI   CVCL_RJ57 ! TkDA3-20
OI   CVCL_RJ58 ! TkDN4-M
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TkDA3-20
AC   CVCL_RJ57
DR   SKIP; SKIP001707
DR   Wikidata; Q54972588
RX   PubMed=21098095;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ52 ! TkDA3-1
OI   CVCL_RJ53 ! TkDA3-2
OI   CVCL_RJ54 ! TkDA3-4
OI   CVCL_RJ55 ! TkDA3-5
OI   CVCL_RJ56 ! TkDA3-9
OI   CVCL_RJ58 ! TkDN4-M
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TkDA3-4
AC   CVCL_RJ54
SY   TKDA3-4
DR   SKIP; SKIP001704
DR   Wikidata; Q54972585
RX   PubMed=21098095;
RX   PubMed=28089908;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ52 ! TkDA3-1
OI   CVCL_RJ53 ! TkDA3-2
OI   CVCL_RJ55 ! TkDA3-5
OI   CVCL_RJ56 ! TkDA3-9
OI   CVCL_RJ57 ! TkDA3-20
OI   CVCL_RJ58 ! TkDN4-M
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TkDA3-5
AC   CVCL_RJ55
DR   SKIP; SKIP001705
DR   Wikidata; Q54972586
RX   PubMed=21098095;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ52 ! TkDA3-1
OI   CVCL_RJ53 ! TkDA3-2
OI   CVCL_RJ54 ! TkDA3-4
OI   CVCL_RJ56 ! TkDA3-9
OI   CVCL_RJ57 ! TkDA3-20
OI   CVCL_RJ58 ! TkDN4-M
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TkDA3-9
AC   CVCL_RJ56
DR   SKIP; SKIP001706
DR   Wikidata; Q54972587
RX   PubMed=21098095;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ52 ! TkDA3-1
OI   CVCL_RJ53 ! TkDA3-2
OI   CVCL_RJ54 ! TkDA3-4
OI   CVCL_RJ55 ! TkDA3-5
OI   CVCL_RJ57 ! TkDA3-20
OI   CVCL_RJ58 ! TkDN4-M
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TkDN4-M
AC   CVCL_RJ58
SY   TkDN4M
DR   SKIP; SKIP001708
DR   Wikidata; Q54972589
RX   PubMed=21098095;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ52 ! TkDA3-1
OI   CVCL_RJ53 ! TkDA3-2
OI   CVCL_RJ54 ! TkDA3-4
OI   CVCL_RJ55 ! TkDA3-5
OI   CVCL_RJ56 ! TkDA3-9
OI   CVCL_RJ57 ! TkDA3-20
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TKE2
AC   CVCL_AR53
DR   ECACC; 11033107
DR   Wikidata; Q54972590
RX   PubMed=18318692;
RX   PubMed=19593795;
CC   Characteristics: Progenitor cell isolated from the basal layer of the limbal epithelium.
CC   Characteristics: Has applications in the cell biology of corneal epithelial cells, toxicity, and differentiation (ECACC=11033107).
CC   Characteristics: Can be induced to differentiate into stratified epithelium on increasing the calcium concentration and addition of FBS (ECACC=11033107).
CC   Doubling time: 34.2 hours (PubMed=18318692).
CC   Derived from site: In situ; Eye, cornea, epithelium; UBERON=UBERON_0001772.
CC   Cell type: Epithelial cell of cornea; CL=CL_0000575.
CC   Breed/subspecies: CD-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 5
//
ID   TKHMY
AC   CVCL_J604
DR   Wikidata; Q54972591
RX   PubMed=7822823;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6416 ! LTR228
CA   Hybrid cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   TKKK
AC   CVCL_5599
DR   CLO; CLO_0050852
DR   BioSample; SAMN03472090
DR   Cell_Model_Passport; SIDM01832
DR   Cosmic; 2629290
DR   Cosmic; 2674048
DR   DepMap; ACH-001863
DR   RCB; RCB1907
DR   TKG; TKG 0456
DR   Wikidata; Q54972593
RX   PubMed=21451941;
RX   PubMed=27231123;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
ST   Source(s): DepMap=ACH-001863; RCB=RCB1907; TKG=TKG 0456
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 17
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 21
ST   Penta D: 9
ST   Penta E: 14,17
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   TKM47
AC   CVCL_JG60
DR   JCRB; JCRB1720
DR   Wikidata; Q54972594
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Asp433His (c.1297G>C); ClinVar=VCV000003732; Zygosity=Heterozygous (JCRB=JCRB1720).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1720
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11,14
ST   D5S818: 11,14
ST   D7S820: 10,11
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   TKPTS
AC   CVCL_UJ13
DR   ATCC; CRL-3361
DR   Wikidata; Q98133361
RX   PubMed=7653514;
CC   Doubling time: ~12 hours (ATCC=CRL-3361).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Sex of donor and STR profile from personal communication of Rodriguez-Tarduchy Segovia, Gemma.
CC   Misspelling: TKTPS; Note=Occasionally.
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: C57BL/6J Tg(SV40E)Bri/7 transgenic.
ST   Source(s): Direct_author_submission
ST   Mouse STR 1-1: 10,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.2,20.3
ST   Mouse STR 5-5: 14,17
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 25.2,26.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 13,15
ST   Mouse STR 18-3: 16,17
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 28
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 9
//
ID   TKS-1
AC   CVCL_8465
DR   Wikidata; Q54972595
RX   PubMed=7967745;
RX   PubMed=10803505;
CC   Population: Japanese.
CC   Miscellaneous: Cell line has been lost (PubMed=10803505).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   TL [Human B-cell IHW]
AC   CVCL_E852
DR   dbMHC; 49043
DR   ECACC; 94050310
DR   IHW; IHW09270
DR   IPD-IMGT/HLA; 11481
DR   Wikidata; Q54972596
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*35:08:01,13:02; C*04:01,06:02; DQA1*02:01,05:01; DQB1*02:01; DRB1*07:01,03:01 (IPD-IMGT/HLA=11481).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   TL [Human SiHa contaminated cell line]
AC   CVCL_WU75
SY   Trophoblast-Like
DR   BCRC; 60528
DR   Wikidata; Q98133362
RX   PubMed=3581066;
RX   PubMed=11089925;
RX   PubMed=11409691;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a Siha derivative (BCRC=60528). Originally thought to originate from the placenta of a 29 year old woman donor.
CC   Population: Japanese.
CC   Doubling time: ~34 hours (PubMed=3581066).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: BCRC; 60528; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0032 ! SiHa
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 7
//
ID   TL-1
AC   CVCL_B371
SY   TL1
DR   CLO; CLO_0050020
DR   BioSample; SAMN03472078
DR   DepMap; ACH-002055
DR   RCB; RCB1871
DR   TKG; TKG 0607
DR   Wikidata; Q54972597
RX   PubMed=2486610;
RX   PubMed=6268866;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: ~36 hours (PubMed=2486610; PubMed=6268866).
CC   Sequence variation: Mutation; HGNC; HGNC:5362; ID3; Simple; p.Glu53Ter (c.157G>T); Zygosity=Heterozygous (DepMap=ACH-002055).
CC   Sequence variation: Mutation; HGNC; HGNC:7672; NCOR1; Simple; p.Ile1927fs (c.5779_5780delAT); Zygosity=Heterozygous (DepMap=ACH-002055).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Ser (c.707A>C); ClinVar=VCV000182966; Zygosity=Homozygous (DepMap=ACH-002055).
CC   Derived from site: In situ; Ileocecal lymph node; UBERON=UBERON_8480054.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): RCB=RCB1871; TKG=TKG 0607
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,19
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   TL-Hir
AC   CVCL_G014
DR   RCB; RCB1987
DR   TKG; TKG 0176
DR   TKG; TKG 0288
DR   Wikidata; Q54972599
RX   PubMed=6088403;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB1987; true.
CC   Discontinued: TKG; TKG 0176; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   TL-Mat
AC   CVCL_G015
DR   RCB; RCB1969
DR   TKG; TKG 0287
DR   Wikidata; Q54972600
RX   PubMed=6088403;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB1969; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A782 ! ILT-Mat
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   TL-Mor
AC   CVCL_0074
DR   CLO; CLO_0050080
DR   BioSample; SAMN03472082
DR   RCB; RCB1881
DR   TKG; TKG 0369
DR   Wikidata; Q54972602
CC   Population: Japanese.
CC   Characteristics: IL2 independent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): RCB=RCB1881; TKG=TKG 0369
ST   Amelogenin: X,Y
ST   CSF1PO: 7,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F910 ! ILT-Mor
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   TL-My
AC   CVCL_UG47
DR   Wikidata; Q98133363
RX   PubMed=6088403;
CC   Population: Japanese.
CC   Characteristics: IL2 independent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F911 ! ILT-My
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TL-Om1
AC   CVCL_B473
SY   TL-om1; TL-OM1; TLom1; TLOM1; TL-OML
DR   RCB; RCB2086
DR   TKG; TKG 0289
DR   Wikidata; Q54972603
RX   PubMed=2981920;
RX   PubMed=6088403;
RX   PubMed=7662981;
RX   PubMed=10706122;
RX   PubMed=25502533;
RX   PubMed=30125970;
CC   Population: Japanese.
CC   Biotechnology: Used as a reference cell line to standardize the qPCR of HTLV-1 (PubMed=25502533; PubMed=30125970).
CC   Characteristics: IL2 dependent.
CC   Virology: The HTLV-1 provirus is monoclonally integrated in chromosome 1 (PubMed=25502533).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB2086; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 17
//
ID   TL-Su
AC   CVCL_G013
DR   RCB; RCB1986
DR   TKG; TKG 0290
DR   Wikidata; Q54972604
RX   PubMed=1765142;
RX   PubMed=2981920;
RX   PubMed=6088403;
RX   PubMed=7662981;
CC   Population: Japanese.
CC   Characteristics: IL2 independent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Discontinued: RCB; RCB1986; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F913 ! ILT-Su
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   TL1
AC   CVCL_RP60
SY   TL-1
DR   Wikidata; Q54972605
RX   PubMed=19115345;
RX   PubMed=25277546;
CC   From: Hogan, Brigid L.M.; Duke University; Durham; USA.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTAC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   TLBR-1
AC   CVCL_L177
SY   TLBR 1; TLBR1; T-cell Lymphoma BReast-1
DR   ATCC; CRL-3027
DR   Cosmic; 2814460
DR   DSMZ; ACC-904
DR   DSMZCellDive; ACC-904
DR   GEO; GSM2527949
DR   Wikidata; Q54972607
RX   PubMed=21425149;
RX   PubMed=22791880;
RX   PubMed=28356514;
CC   Doubling time: 55 hours (PubMed=21425149); ~30-40 hours (DSMZ=ACC-904).
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Ser614Arg (c.1842C>G); Zygosity=Unspecified (PubMed=28356514).
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ATCC; CRL-3027; true.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ATCC=CRL-3027; DSMZ=ACC-904
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 28,29,30
ST   D2S1338: 17,26
ST   D3S1358: 17,18
ST   D5S818: 11,13 (ATCC=CRL-3027)
ST   D5S818: 11,13,14 (DSMZ=ACC-904)
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 10,11
ST   Penta E: 14,19
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   TLBR-2
AC   CVCL_A1EY
SY   TLBR 2; TLBR2; T-cell Lymphoma BReast-2
DR   cancercelllines; CVCL_A1EY
DR   Cosmic; 2814461
DR   DSMZ; ACC-905
DR   DSMZCellDive; ACC-905
DR   GEO; GSM2527950
DR   Wikidata; Q102114991
RX   PubMed=22791880;
RX   PubMed=28356514;
CC   Doubling time: 37 hours (PubMed=22791880); ~24-30 hours (DSMZ=ACC-905).
CC   Sequence variation: Mutation; HGNC; HGNC:11364; STAT3; Simple; p.Asp661Tyr (c.1981G>T); ClinVar=VCV000928790; Zygosity=Unspecified (PubMed=28356514).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-905
ST   Amelogenin: X
ST   CSF1PO: 11,12,13
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 15,16
ST   D19S433: 12,13
ST   D21S11: 31,32.2
ST   D2S1338: 16,24
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 12,16
ST   FGA: 21
ST   Penta D: 10,11
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 11
//
ID   TLBR-3
AC   CVCL_A1EZ
SY   TLBR 3; TLBR3; T-cell Lymphoma BReast-3
DR   DSMZ; ACC-906
DR   DSMZCellDive; ACC-906
DR   GEO; GSM2527951
DR   Wikidata; Q102114992
RX   PubMed=22791880;
RX   PubMed=28356514;
CC   Doubling time: 77 hours (PubMed=22791880); ~20-50 hours (DSMZ=ACC-906).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ=ACC-906
ST   Amelogenin: X
ST   CSF1PO: 8,12
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 12,13
ST   D19S433: 13
ST   D21S11: 29,31.2
ST   D2S1338: 18,23
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 8
ST   FGA: 21,23
ST   Penta D: 11,12,13
ST   Penta E: 12,17
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 15,16
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 8
//
ID   TLBR-4
AC   CVCL_A1FA
SY   TLBR 4; TLBR4; T-cell Lymphoma BReast-4
DR   DSMZCellDive; TLBR-4
DR   GEO; GSM2527952
DR   Wikidata; Q102114993
RX   PubMed=28356514;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 11,15
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 26,31.2
ST   D2S1338: 19,23
ST   D3S1358: 13,14
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,16
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 2,7
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C37194; Anaplastic large cell lymphoma, ALK-negative
DI   ORDO; Orphanet_300903; ALK-negative anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   TLE1-464-G04
AC   CVCL_A4PC
DR   Wikidata; Q105511226
RX   PubMed=27879218;
CC   From: Broad Institute of MIT and Harvard; Cambridge; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   TLE3-447-D08-A01
AC   CVCL_A4VH
DR   Wikidata; Q107117093
RX   PubMed=27879221;
CC   From: Broad Institute of MIT and Harvard; Cambridge; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   TLM1
AC   CVCL_0C83
SY   TLM-1
DR   Kerafast; EMN005-FP
DR   Wikidata; Q54972608
RX   PubMed=9539362;
RX   PubMed=11467477;
RX   PubMed=12944992;
CC   Doubling time: ~20 hours (Kerafast=EMN005-FP).
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Gordon Setter; VBO=VBO_0200613.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 13
//
ID   TLNC-1
AC   CVCL_6F00
SY   Transformed Lymph Node Cells-1
DR   Wikidata; Q54972609
RX   PubMed=4098902;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TLNC-2
AC   CVCL_6E98
SY   Transformed Lymph Node Cells-2
DR   Wikidata; Q54972610
RX   PubMed=4098902;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TLNC-3
AC   CVCL_6E99
SY   Transformed Lymph Node Cells-3
DR   Wikidata; Q54972611
RX   PubMed=4098902;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TLNC-4
AC   CVCL_6F01
SY   Transformed Lymph Node Cells-4
DR   Wikidata; Q54972612
RX   PubMed=4098902;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TLouaR
AC   CVCL_WU76
DR   BCRC; 60529
DR   Wikidata; Q98133364
RX   PubMed=11089925;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (BCRC=60529). Originally thought to originate from the TL cell line (Cellosaurus=CVCL_WU75) which was supposed to originate from the placenta of a 29 year old woman but is a SiHa contaminated cell line.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: BCRC; 60529; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   TLR1
AC   CVCL_F955
DR   TKG; TKG 0351
DR   Wikidata; Q54972613
RX   PubMed=1655502;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TLR2
AC   CVCL_5600
DR   CLO; CLO_0050768
DR   JCRB; IFO50379
DR   RCB; RCB0750
DR   Wikidata; Q54972614
RX   PubMed=1655502;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   TLR3
AC   CVCL_5601
DR   JCRB; IFO50380
DR   TKG; TKG 0352
DR   Wikidata; Q54972616
RX   PubMed=1655502;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   TLR4
AC   CVCL_F956
DR   TKG; TKG 0353
DR   Wikidata; Q54972632
RX   PubMed=1655502;
RX   PubMed=9224657;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TLS-1
AC   CVCL_WB46
SY   ThaLaSsemia-1
DR   IBRC; C10456
DR   Wikidata; Q98133365
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-10
AC   CVCL_WB47
SY   ThaLaSsemia-10
DR   IBRC; C10566
DR   Wikidata; Q98133367
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2869; Anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-11
AC   CVCL_WB48
SY   ThaLaSsemia-11
DR   IBRC; C10567
DR   Wikidata; Q98133368
CC   Population: Iranian; Turk.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-12
AC   CVCL_WB49
SY   ThaLaSsemia-12
DR   IBRC; C10568
DR   Wikidata; Q98133369
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-13
AC   CVCL_WB50
SY   TL-13; ThaLaSsemia-13
DR   IBRC; C10569
DR   Wikidata; Q98133370
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-14
AC   CVCL_WB51
SY   ThaLaSsemia-14
DR   IBRC; C10574
DR   Wikidata; Q98133372
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-15
AC   CVCL_WB52
SY   ThaLaSsemia-15
DR   IBRC; C10575
DR   Wikidata; Q98133374
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-16
AC   CVCL_WB53
SY   ThaLaSsemia-16
DR   IBRC; C10576
DR   Wikidata; Q98133375
CC   Population: Iranian; Kurd.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-17
AC   CVCL_WB54
SY   ThaLaSsemia-17
DR   IBRC; C10577
DR   Wikidata; Q98133376
CC   Population: Iranian; Mazanderanis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-18
AC   CVCL_WB55
SY   ThaLaSsemia-18
DR   IBRC; C10578
DR   Wikidata; Q98133377
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-19
AC   CVCL_WB56
SY   ThaLaSsemia-19
DR   IBRC; C10579
DR   Wikidata; Q98133378
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-2
AC   CVCL_WB57
SY   ThaLaSsemia-2
DR   IBRC; C10457
DR   Wikidata; Q98133380
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-20
AC   CVCL_WB58
SY   ThaLaSsemia-20
DR   IBRC; C10580
DR   Wikidata; Q98133381
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-21
AC   CVCL_WB59
SY   ThaLaSsemia-21
DR   IBRC; C10581
DR   Wikidata; Q98133382
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-22
AC   CVCL_WB60
SY   ThaLaSsemia-22
DR   IBRC; C10584
DR   Wikidata; Q98133383
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-23
AC   CVCL_WB61
SY   ThaLaSsemia-23
DR   IBRC; C10585
DR   Wikidata; Q98133384
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-24
AC   CVCL_WB62
SY   ThaLaSsemia-24
DR   IBRC; C10586
DR   Wikidata; Q98133385
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-25
AC   CVCL_WB63
SY   ThaLaSsemia-25
DR   IBRC; C10587
DR   Wikidata; Q98133386
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-26
AC   CVCL_WB64
SY   ThaLaSsemia-26
DR   IBRC; C10588
DR   Wikidata; Q98133387
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-27
AC   CVCL_WB65
SY   ThaLaSsemia-27
DR   IBRC; C10589
DR   Wikidata; Q98133388
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-28
AC   CVCL_WB66
SY   ThaLaSsemia-28
DR   IBRC; C10590
DR   Wikidata; Q98133389
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-29
AC   CVCL_WB67
SY   ThaLaSsemia-29
DR   IBRC; C10592
DR   Wikidata; Q98133391
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-3
AC   CVCL_WB68
SY   ThaLaSsemia-3
DR   IBRC; C10490
DR   Wikidata; Q98133392
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34368; Alpha thalassemia
DI   ORDO; Orphanet_846; Alpha-thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-30
AC   CVCL_WB69
SY   ThaLaSsemia-30
DR   IBRC; C10593
DR   Wikidata; Q98133395
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-31
AC   CVCL_WB70
SY   ThaLaSsemia-31
DR   IBRC; C10594
DR   Wikidata; Q98133396
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-32
AC   CVCL_WB71
SY   ThaLaSsemia-32
DR   IBRC; C10595
DR   Wikidata; Q98133397
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-33
AC   CVCL_WB72
SY   ThaLaSsemia-33
DR   IBRC; C10596
DR   Wikidata; Q98133398
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-34
AC   CVCL_WB73
SY   ThaLaSsemia-34
DR   IBRC; C10597
DR   Wikidata; Q98133399
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-35
AC   CVCL_WB74
SY   ThaLaSsemia-35
DR   IBRC; C10598
DR   Wikidata; Q98133400
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-36
AC   CVCL_WB75
SY   ThaLaSsemia-36
DR   IBRC; C10599
DR   Wikidata; Q98133401
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-37
AC   CVCL_WB76
SY   ThaLaSsemia-37
DR   IBRC; C10610
DR   Wikidata; Q98133402
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-38
AC   CVCL_WB77
SY   ThaLaSsemia-38
DR   IBRC; C10611
DR   Wikidata; Q98133403
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-39
AC   CVCL_WB78
SY   ThaLaSsemia-39
DR   IBRC; C10612
DR   Wikidata; Q98133404
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-4
AC   CVCL_WB79
SY   ThaLaSsemia-4
DR   IBRC; C10559
DR   Wikidata; Q98133406
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-40
AC   CVCL_WB80
SY   ThaLaSsemia-40
DR   IBRC; C10600
DR   Wikidata; Q98133407
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-41
AC   CVCL_WB81
SY   ThaLaSsemia-41
DR   IBRC; C10601
DR   Wikidata; Q98133408
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-42
AC   CVCL_WB82
SY   ThaLaSsemia-42
DR   IBRC; C10602
DR   Wikidata; Q98133409
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-43
AC   CVCL_WB83
SY   ThaLaSsemia-43
DR   IBRC; C10603
DR   Wikidata; Q98133411
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-44
AC   CVCL_WB84
SY   ThaLaSsemia-44
DR   IBRC; C10604
DR   Wikidata; Q98133412
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-45
AC   CVCL_WB85
SY   ThaLaSsemia-45
DR   IBRC; C10605
DR   Wikidata; Q98133413
CC   Population: Iranian; Lurs.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-46
AC   CVCL_WB86
SY   ThaLaSsemia-46
DR   IBRC; C10606
DR   Wikidata; Q98133414
CC   Population: Iranian; Gilaks.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-47
AC   CVCL_WB87
SY   ThaLaSsemia-47
DR   IBRC; C10613
DR   Wikidata; Q98133416
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-48
AC   CVCL_WB88
SY   ThaLaSsemia-48
DR   IBRC; C10614
DR   Wikidata; Q98133417
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-49
AC   CVCL_WB89
SY   ThaLaSsemia-49
DR   IBRC; C10615
DR   Wikidata; Q98133418
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-5
AC   CVCL_WB90
SY   ThaLaSsemia-5
DR   IBRC; C10560
DR   Wikidata; Q98133419
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-50
AC   CVCL_WB91
SY   ThaLaSsemia-50
DR   IBRC; C10616
DR   Wikidata; Q98133420
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-51
AC   CVCL_WB92
SY   ThaLaSsemia-51
DR   IBRC; C10617
DR   Wikidata; Q98133422
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-52
AC   CVCL_WB93
SY   ThaLaSsemia-52
DR   IBRC; C10618
DR   Wikidata; Q98133423
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-53
AC   CVCL_WB94
SY   ThaLaSsemia-53
DR   IBRC; C10619
DR   Wikidata; Q98133424
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-54
AC   CVCL_WB95
SY   ThaLaSsemia-54
DR   IBRC; C10620
DR   Wikidata; Q98133425
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-55
AC   CVCL_WB96
SY   ThaLaSsemia-55
DR   IBRC; C10621
DR   Wikidata; Q98133427
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-56
AC   CVCL_WB97
SY   ThaLaSsemia-56
DR   IBRC; C10622
DR   Wikidata; Q98133428
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-57
AC   CVCL_WB98
SY   ThaLaSsemia-57
DR   IBRC; C10623
DR   Wikidata; Q98133429
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-58
AC   CVCL_WB99
SY   ThaLaSsemia-58
DR   IBRC; C10624
DR   Wikidata; Q98133430
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-59
AC   CVCL_WC00
SY   ThaLaSsemia-59
DR   IBRC; C10625
DR   Wikidata; Q98133431
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-6
AC   CVCL_WC01
SY   ThaLaSsemia-6
DR   IBRC; C10561
DR   Wikidata; Q98133432
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-60
AC   CVCL_WC02
SY   ThaLaSsemia-60
DR   IBRC; C10626
DR   Wikidata; Q98133434
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-61
AC   CVCL_WC03
SY   ThaLaSsemia-61
DR   IBRC; C10627
DR   Wikidata; Q98133435
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-62
AC   CVCL_WC04
SY   ThaLaSsemia-62
DR   IBRC; C10628
DR   Wikidata; Q98133436
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-63
AC   CVCL_WC05
SY   ThaLaSsemia-63
DR   IBRC; C10629
DR   Wikidata; Q98133437
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-64
AC   CVCL_WC06
SY   ThaLaSsemia-64
DR   IBRC; C10630
DR   Wikidata; Q98133438
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-65
AC   CVCL_WC07
SY   ThaLaSsemia-65
DR   IBRC; C10643
DR   Wikidata; Q98133439
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-66
AC   CVCL_WC08
SY   ThaLaSsemia-66
DR   IBRC; C10706
DR   Wikidata; Q98133441
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-67
AC   CVCL_WC09
SY   ThaLaSsemia-67
DR   IBRC; C10853
DR   Wikidata; Q98133442
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-68
AC   CVCL_WC10
SY   ThaLaSsemia-68
DR   IBRC; C11114
DR   Wikidata; Q98133443
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-69
AC   CVCL_WC11
SY   ThaLaSsemia-69
DR   IBRC; C11115
DR   Wikidata; Q98133444
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-7
AC   CVCL_WC12
SY   ThaLaSsemia-7
DR   IBRC; C10562
DR   Wikidata; Q98133446
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-70
AC   CVCL_WC13
SY   ThaLaSsemia-70
DR   IBRC; C11116
DR   Wikidata; Q98133447
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-71
AC   CVCL_WC14
SY   ThaLaSsemia-71
DR   IBRC; C11117
DR   Wikidata; Q98133448
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-72
AC   CVCL_WC15
SY   ThaLaSsemia-72
DR   IBRC; C11118
DR   Wikidata; Q98133449
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-73
AC   CVCL_WC16
SY   ThaLaSsemia-73
DR   IBRC; C11119
DR   Wikidata; Q98133450
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-74
AC   CVCL_WC17
SY   ThaLaSsemia-74
DR   IBRC; C11097
DR   Wikidata; Q98133451
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-75
AC   CVCL_WC18
SY   ThaLaSsemia-75
DR   IBRC; C11100
DR   Wikidata; Q98133453
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-76
AC   CVCL_WC19
SY   ThaLaSsemia-76
DR   IBRC; C11101
DR   Wikidata; Q98133454
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-77
AC   CVCL_WC20
SY   ThaLaSsemia-77
DR   IBRC; C11111
DR   Wikidata; Q98133455
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-78
AC   CVCL_WC21
SY   ThaLaSsemia-78
DR   IBRC; C11112
DR   Wikidata; Q98133457
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-79
AC   CVCL_WC22
SY   ThaLaSsemia-79
DR   IBRC; C11113
DR   Wikidata; Q98133459
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-8
AC   CVCL_WC23
SY   ThaLaSsemia-8
DR   IBRC; C10564
DR   Wikidata; Q98133460
CC   Population: Iranian; Persian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-80
AC   CVCL_WC24
SY   ThaLaSsemia-80
DR   IBRC; C11121
DR   Wikidata; Q98133461
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-81
AC   CVCL_WC25
SY   ThaLaSsemia-81
DR   IBRC; C11123
DR   Wikidata; Q98133462
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-82
AC   CVCL_WC26
SY   ThaLaSsemia-82
DR   IBRC; C11137
DR   Wikidata; Q98133463
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-83
AC   CVCL_WC27
SY   ThaLaSsemia-83
DR   IBRC; C11138
DR   Wikidata; Q98133464
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-84
AC   CVCL_WC28
SY   ThaLaSsemia-84
DR   IBRC; C11139
DR   Wikidata; Q98133465
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-85
AC   CVCL_WC29
SY   ThaLaSsemia-85
DR   IBRC; C11140
DR   Wikidata; Q98133466
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-86
AC   CVCL_WC30
SY   ThaLaSsemia-86
DR   IBRC; C11142
DR   Wikidata; Q98133469
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-87
AC   CVCL_WC31
SY   ThaLaSsemia-87
DR   IBRC; C11143
DR   Wikidata; Q98133470
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-88
AC   CVCL_WC32
SY   ThaLaSsemia-88
DR   IBRC; C11145
DR   Wikidata; Q98133471
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-89
AC   CVCL_WC33
SY   ThaLaSsemia-89
DR   IBRC; C11154
DR   Wikidata; Q98133473
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-9
AC   CVCL_WC34
SY   ThaLaSsemia-9
DR   IBRC; C10565
DR   Wikidata; Q98133474
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TLS-90
AC   CVCL_WC35
SY   ThaLaSsemia-90
DR   IBRC; C11151
DR   Wikidata; Q98133475
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-91
AC   CVCL_WC36
SY   ThaLaSsemia-91
DR   IBRC; C11152
DR   Wikidata; Q98133476
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLS-92
AC   CVCL_WC37
SY   ThaLaSsemia-92
DR   IBRC; C11157
DR   Wikidata; Q98133477
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35069; Thalassemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TLT
AC   CVCL_6C16
DR   Wikidata; Q54972639
RX   PubMed=20444515;
RX   PubMed=24454965;
RX   PubMed=28239090;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   TLX5
AC   CVCL_N032
SY   TLX-5; TLX/5
DR   ChEMBL-Cells; CHEMBL3307470
DR   ChEMBL-Targets; CHEMBL615015
DR   PubChem_Cell_line; CVCL_N032
DR   Wikidata; Q54972640
RX   PubMed=5487248;
CC   Breed/subspecies: CBA.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TM
AC   CVCL_E853
SY   T.M.
DR   dbMHC; 49044
DR   IHW; IHW09355
DR   IPD-IMGT/HLA; 11415
DR   Wikidata; Q54972641
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*26:03; B*62; C*09; DRB1*04:03,15:01 (IPD-IMGT/HLA=11415).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   TM 902
AC   CVCL_F246
SY   TM902
DR   CLO; CLO_0009362
DR   CLDB; cl4525
DR   Wikidata; Q54972642
RX   PubMed=1429033;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   TM 903
AC   CVCL_F247
SY   TM903
DR   CLO; CLO_0009363
DR   CLDB; cl4526
DR   Wikidata; Q54972643
RX   PubMed=1429033;
CC   Monoclonal antibody isotype: IgG2a, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 6
//
ID   TM#1
AC   CVCL_N781
DR   Wikidata; Q54972658
RX   Patent=US5731490;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11380.
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:96590; Irf1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S2/SvPas.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4378 ! ES-D3
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   TM-1 [Human astrocytoma]
AC   CVCL_M032
DR   Wikidata; Q54972644
RX   PubMed=1917778;
WW   Info; KAKEN; 62570650; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-62570650/
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=1917778).
CC   Derived from site: In situ; Brain, frontal lobe; UBERON=UBERON_0016525.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 11
//
ID   TM-1 [Human leukemia]
AC   CVCL_A6KK
DR   Wikidata; Q107117094
RX   PubMed=19003328;
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Adult
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TM-1 [Human melanoma]
AC   CVCL_A1RP
DR   Wikidata; Q105511228
RX   PubMed=494244;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (PubMed=494244).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   TM-1 [Human trabecular meshwork]
AC   CVCL_5G36
SY   TM1
DR   Wikidata; Q54972645
RX   PubMed=11773026;
RX   PubMed=12789541;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, trabecular meshwork; UBERON=UBERON_0005969.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   30Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   TM-28
AC   CVCL_4979
SY   TM-28 [Mutatect]
DR   CLO; CLO_0009365
DR   ATCC; CRL-2803
DR   Wikidata; Q54972647
RX   PubMed=11228549;
CC   Discontinued: ATCC; CRL-2803; true.
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4978 ! MT-6
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   TM-31
AC   CVCL_6735
SY   TM31
DR   CLO; CLO_0050635
DR   ArrayExpress; E-MTAB-2770
DR   BCRJ; 0379
DR   BioSample; SAMN03472072
DR   BioSample; SAMN10987718
DR   cancercelllines; CVCL_6735
DR   Cell_Model_Passport; SIDM01460
DR   DepMap; ACH-000592
DR   FANTOM5_SSTAR; 10425-106D2
DR   GEO; GSM887707
DR   GEO; GSM888800
DR   IARC_TP53; 14834
DR   LiGeA; CCLE_306
DR   PharmacoDB; TM31_1598_2019
DR   Progenetix; CVCL_6735
DR   RCB; RCB1731
DR   Wikidata; Q54972649
RX   PubMed=11213969;
RX   PubMed=11213978;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 65 hours (Note=At 50th passage), 62 hours (Note=At 220th passage) (PubMed=11213969).
CC   HLA typing: A*24:02,24:02; B*07:02,51:01; C*07:02,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Gly (c.712T>G); ClinVar=VCV000376577; Zygosity=Homozygous (PubMed=11213969; DepMap=ACH-000592).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.8%; Native American=0%; East Asian, North=80.56%; East Asian, South=14.37%; South Asian=0%; European, North=0%; European, South=3.26% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): RCB=RCB1731
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 9,12
ST   D5S818: 10
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C60781; Astrocytoma
DI   NCIt; C3273; Neurofibromatosis type 1
DI   ORDO; Orphanet_94; Astrocytoma
DI   ORDO; Orphanet_636; Neurofibromatosis type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   TM-34
AC   CVCL_4980
SY   TM-34 [Mutatect]
DR   CLO; CLO_0009367
DR   ATCC; CRL-2801
DR   Wikidata; Q54972650
RX   PubMed=11228549;
CC   Discontinued: ATCC; CRL-2801; true.
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4978 ! MT-6
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   TM-7
AC   CVCL_4981
SY   TM-7 [Mutatect]
DR   CLO; CLO_0009369
DR   ATCC; CRL-2798
DR   Wikidata; Q54972651
RX   PubMed=11228549;
CC   Discontinued: ATCC; CRL-2798; true.
CC   Breed/subspecies: C57BL/10.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4978 ! MT-6
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   TM-791
AC   CVCL_5939
SY   TM 791; TM791
DR   CLS; 300358
DR   Wikidata; Q54972652
CC   Discontinued: CLS; 300358; true.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   TM-BBB1
AC   CVCL_6C09
DR   Wikidata; Q54972653
RX   PubMed=11741243;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TM-BBB2
AC   CVCL_6C10
DR   Wikidata; Q54972654
RX   PubMed=11741243;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TM-BBB3
AC   CVCL_6C11
DR   Wikidata; Q54972655
RX   PubMed=11741243;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TM-BBB4
AC   CVCL_6C12
DR   Wikidata; Q54972656
RX   PubMed=11741243;
RX   PubMed=12958429;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   TM-BBB5
AC   CVCL_6C13
DR   Wikidata; Q54972657
RX   PubMed=11741243;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, capillary; UBERON=UBERON_8480001.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TM01
AC   CVCL_6A96
SY   TM 01
DR   Wikidata; Q54972659
RX   PubMed=9706400;
RX   PubMed=11520047;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TM02-3
AC   CVCL_6A97
SY   TM 02-3
DR   Wikidata; Q54972660
RX   PubMed=9706400;
RX   PubMed=11520047;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Trachea, epithelium; UBERON=UBERON_0001901.
CC   Cell type: Epithelial cell of trachea; CL=CL_0000307.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   6-8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TM1 [Mouse hybridoma]
AC   CVCL_F787
DR   CLO; CLO_0009364
DR   ATCC; HB-169
DR   ECACC; 92100624
DR   Wikidata; Q54972661
RX   Patent=US4471056;
RX   PubMed=6601099;
CC   Biotechnology: Used for an assay to perform HLA-DR typing (Patent=US4471056; PubMed=6601099).
CC   Characteristics: Produces an antibody cytotoxic to T-cells (PubMed=6601099).
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J171 ! Sp2/08A2
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 8
//
ID   TM1 [Mouse mammary tumor]
AC   CVCL_D7CF
RX   PubMed=5157849;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TM10
AC   CVCL_HE75
SY   TM 10
DR   Wikidata; Q54972663
RX   PubMed=2888776;
RX   PubMed=4084981;
CC   Doubling time: 17.7 hours (PubMed=4084981).
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   3-5D
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 5
//
ID   TM2
AC   CVCL_E8V8
RX   PubMed=2412619;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P16284; Human PECAM1/CD31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TM3 [Mouse hybridoma against human PECAM1]
AC   CVCL_E8V9
RX   PubMed=2412619;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16284; Human PECAM1/CD31.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TM3 [Mouse testis]
AC   CVCL_4326
SY   TM-3
DR   BTO; BTO_0004523
DR   CLO; CLO_0009366
DR   CLDB; cl4527
DR   AddexBio; T0028002/5057
DR   ATCC; CRL-1714
DR   BCRC; 60475
DR   CCRID; 1101MOU-PUMC000297
DR   CCRID; 3101MOUGNM24
DR   ChEMBL-Cells; CHEMBL4482999
DR   ChEMBL-Targets; CHEMBL4483272
DR   CLS; 305167
DR   ECACC; 91060526
DR   KCLB; 21714
DR   NCBI_Iran; C514
DR   PubChem_Cell_line; CVCL_4326
DR   Ubigene; YC-D021
DR   Wikidata; Q54972665
RX   PubMed=6774781;
RX   PubMed=7046561;
RX   PubMed=15541572;
RX   PubMed=16786125;
CC   Doubling time: 16 hours (PubMed=7046561).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/c.
ST   Source(s): Ubigene=YC-D021
ST   Mouse STR 4-2: 19.3
ST   Mouse STR 5-5: 12
ST   Mouse STR 6-4: 16.3,17.3
ST   Mouse STR 6-7: 15
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 15-3: 20.3,22.3
ST   Mouse STR 18-3: 18
ST   Mouse STR X-1: 24
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   11-13D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   TM3-SF
AC   CVCL_B6PE
SY   TM3-Serum Free
DR   Wikidata; Q112041795
RX   PubMed=16786125;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: ~4-5 days (PubMed=16786125).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4326 ! TM3 [Mouse testis]
SX   Male
AG   11-13D
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 5
//
ID   TM4
AC   CVCL_4327
SY   TM-4
DR   BTO; BTO_0004230
DR   CLO; CLO_0009368
DR   CLDB; cl4528
DR   ATCC; CRL-1715
DR   BCRC; 60254
DR   CCRID; 1101MOU-PUMC000298
DR   CCRID; 4201MOU-CCTCC00624
DR   CLS; 305170
DR   ECACC; 88111401
DR   KCLB; 21715
DR   NCBI_Iran; C513
DR   Wikidata; Q54972666
RX   PubMed=6544874;
RX   PubMed=6774781;
RX   PubMed=7046561;
RX   PubMed=15541572;
RX   PubMed=26900862;
CC   Doubling time: 18 hours (PubMed=7046561).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   11-13D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   Tm87-16
AC   CVCL_8001
SY   TM87-16; TM 87-16; TM87; TM
DR   BioSample; SAMN10989624
DR   Cell_Model_Passport; SIDM01887
DR   Cosmic; 801769
DR   Cosmic; 802049
DR   Cosmic; 802247
DR   Cosmic; 1063887
DR   Cosmic; 2144782
DR   DepMap; ACH-000172
DR   GEO; GSM3145578
DR   GEO; GSM3145739
DR   PharmacoDB; TM8716_1599_2019
DR   TOKU-E; 4151
DR   Wikidata; Q54972667
RX   PubMed=1747867;
RX   PubMed=8385567;
RX   PubMed=8818656;
RX   PubMed=9559292;
RX   PubMed=9671307;
RX   PubMed=9920784;
RX   PubMed=10397258;
RX   PubMed=10602515;
RX   PubMed=11557780;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=14662021;
RX   PubMed=16557275;
RX   PubMed=24418192;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=1747867).
CC   Karyotypic information: 46,XY,t(11;22)(p15.5;q11.23) (PubMed=1747867).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=9671307; PubMed=10602515; PubMed=11921280).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   TMA-1
AC   CVCL_1R69
DR   RCB; AES0055
DR   RCB; RCB2542
DR   Wikidata; Q54972668
CC   Discontinued: RCB; RCB2542; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-16
AC   CVCL_1R71
DR   Wikidata; Q54972669
RX   PubMed=7514525;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-2
AC   CVCL_1R70
DR   RCB; AES0056
DR   RCB; RCB2543
DR   Wikidata; Q54972670
RX   PubMed=7514525;
CC   Discontinued: RCB; RCB2543; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C3H/He x T37H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-29
AC   CVCL_1R72
DR   Wikidata; Q54972671
RX   PubMed=7514525;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-30
AC   CVCL_1R73
DR   Wikidata; Q54972672
RX   PubMed=7514525;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-32
AC   CVCL_1R74
DR   Wikidata; Q54972673
RX   PubMed=7514525;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-45
AC   CVCL_1R75
DR   Wikidata; Q54972674
RX   PubMed=7514525;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv x C3H/HeHa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMA-46
AC   CVCL_1R76
DR   Wikidata; Q54972675
RX   PubMed=7514525;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv x C3H/HeHa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 5
//
ID   TMab-6
AC   CVCL_D3EE
DR   Wikidata; Q127384396
RX   PubMed=29723111;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   TmB
AC   CVCL_6F95
SY   Tilapia mossambica Bulbus arteriosus
DR   Wikidata; Q54972676
RX   DOI=10.1111/j.1365-2761.1985.tb01283.x;
RX   PubMed=24797371;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152.
OX   NCBI_TaxID=8127; ! Oreochromis mossambicus (Mozambique tilapia)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 9
//
ID   TMBL-1
AC   CVCL_A1UB
DR   cancercelllines; CVCL_A1UB
DR   IARC_TP53; 18838
DR   Wikidata; Q105511231
RX   PubMed=12802925;
CC   Population: Japanese.
CC   Doubling time: 96 hours (PubMed=12802925).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=12802925).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C4673; Acute biphenotypic leukemia
DI   ORDO; Orphanet_530995; Mixed phenotype acute leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   TMC-1
AC   CVCL_9475
SY   TMC1
DR   BTO; BTO_0003284
DR   BCRC; 60379
DR   cancercelllines; CVCL_9475
DR   Wikidata; Q54972678
RX   PubMed=15237194;
RX   PubMed=17022644;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (BCRC=60379). Originally thought to originate from the lymph nodes of a 67 year old female patient with a gastric carcinoma.
CC   Population: Caucasian.
CC   Doubling time: ~15 hours (PubMed=15237194).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Proteomics; Quantitative.
CC   Discontinued: BCRC; 60379; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   TMC16
AC   CVCL_A9A1
DR   Wikidata; Q102114995
RX   PubMed=10934646;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   TMCC-1
AC   CVCL_IM28
DR   Wikidata; Q54972687
RX   CelloPub=CLPUB00397;
RX   PubMed=8380785;
RX   PubMed=8631546;
RX   PubMed=8931502;
CC   Population: Japanese.
CC   Doubling time: 53 hours (CelloPub=CLPUB00397).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 9
//
ID   TMCC-2
AC   CVCL_6736
DR   BTO; BTO_0006336
DR   Wikidata; Q54972688
RX   PubMed=1888705;
RX   PubMed=1890355;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=1888705; PubMed=1890355).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   TMCC-2.U
AC   CVCL_6737
DR   Wikidata; Q54972690
RX   PubMed=1888705;
CC   Population: Japanese.
CC   Doubling time: 14 hours (PubMed=1888705).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C8028; Endometrial clear cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6736 ! TMCC-2
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TMD12
AC   CVCL_D5KS
SY   Tokyo Medical and Dental university 12
DR   Wikidata; Q127384397
RX   PubMed=36191884;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (PubMed=36191884).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196Asn (c.586T>A); Zygosity=Heterozygous (PubMed=36191884).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar= VCV000037055; Zygosity=Heterozygous (PubMed=36191884).
CC   Sequence variation: Mutation; HGNC; HGNC:8986; PIM1; Simple; c.880+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=36191884).
CC   Sequence variation: Mutation; HGNC; HGNC:12825; XPO1; Simple; p.Glu571Lys (c.1711G>A); ClinVar=VCV000376695; Zygosity=Heterozygous (PubMed=36191884).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   TMD2
AC   CVCL_5377
SY   Tokyo Medical and Dental university 2
DR   Wikidata; Q54972691
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1283544;
RX   PubMed=1912566;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TMD2
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   TMD5
AC   CVCL_3218
SY   Tokyo Medical and Dental university 5
DR   BioSample; SAMN03472802
DR   GEO; GSM5137748
DR   GEO; GSM5137768
DR   JCRB; IFO50516
DR   PRIDE; PXD023662
DR   Wikidata; Q54972692
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10071072;
RX   PubMed=10071078;
RX   PubMed=35124168;
RX   PubMed=35354797;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=10071078).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072; PubMed=10071078; PubMed=35354797).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Leo, Isabelle Rose.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=IFO50516; Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D10S1248: 12,16
ST   D12S391: 18,24
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 14,15
ST   D19S433: 12,14.2
ST   D1S1656: 11,18.3
ST   D21S11: 30
ST   D22S1045: 11,17
ST   D2S1338: 17,19
ST   D2S441: 10,12
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   DYS391: 10
ST   FGA: 21,23
ST   SE33: 22,29.2
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   TMD7
AC   CVCL_5378
SY   TMD-7; Tokyo Medical and Dental university 7
DR   Cosmic; 975305
DR   Wikidata; Q54972693
RX   PubMed=11972520;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TMD7
CC   Population: Japanese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7600; Acute myeloid leukemia with myelodysplasia-related changes
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   TMD8
AC   CVCL_A442
SY   TMD-8; Tokyo Medical and Dental university 8
DR   EFO; EFO_0006496
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-4956
DR   BioGRID_ORCS_Cell_line; 748
DR   cancercelllines; CVCL_A442
DR   ChEMBL-Cells; CHEMBL4295480
DR   ChEMBL-Targets; CHEMBL4296503
DR   Cosmic; 1486587
DR   Cosmic; 1945194
DR   Cosmic; 2129635
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM1059801
DR   GEO; GSM1374963
DR   GEO; GSM1527304
DR   GEO; GSM1527305
DR   GEO; GSM1527306
DR   GEO; GSM1527307
DR   GEO; GSM1527308
DR   GEO; GSM1527309
DR   GEO; GSM1890021
DR   GEO; GSM1890022
DR   GEO; GSM1890023
DR   GEO; GSM1890024
DR   GEO; GSM2037048
DR   GEO; GSM2037049
DR   PharmacoDB; TMD8_1600_2019
DR   Progenetix; CVCL_A442
DR   PubChem_Cell_line; CVCL_A442
DR   Wikidata; Q54972694
RX   PubMed=16780947;
RX   PubMed=20054396;
RX   PubMed=21179087;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=26787899;
RX   PubMed=27566572;
RX   PubMed=29416618;
RX   PubMed=29666304;
CC   Population: Japanese.
CC   Characteristics: Genetically heterogeneous, consists of 3 subclones (PubMed=27566572).
CC   Doubling time: ~30 hours (PubMed=16780947).
CC   HLA typing: A*02:07,02:07; B*15:01,46:01; C*01:02,01:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (PubMed=20054396).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (PubMed=21179087).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Gachova, Daniela.
CC   Misspelling: TDM8; PubMed=23292937.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11,12
ST   D16S539: 9,11
ST   D18S51: 13,20
ST   D19S433: 12.2,13.2
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 17,23
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 33
//
ID   TMD8-BTK-A428D-KI-1B4
AC   CVCL_E8IZ
DR   KYinno; KC-4533
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4533).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Ala428Asp (c.1283C>A); Zygosity=Hemizygous (KYinno=KC-4533).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-C481F-KI
AC   CVCL_E8J0
SY   TMD8-BTK-C481F-KI-1#
DR   KYinno; KC-4527
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4527).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Cys481Phe (c.1442G>T); Zygosity=Hemizygous (KYinno=KC-4527).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-C481S-KI-1B3
AC   CVCL_E8J1
DR   KYinno; KC-4717
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Cys481Ser (c.1441T>A); ClinVar=VCV000376204; Zygosity=Hemizygous (KYinno=KC-4717).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-C481S-KI-1C6
AC   CVCL_E8J2
DR   KYinno; KC-4718
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Cys481Ser (c.1441T>A); ClinVar=VCV000376204; Zygosity=Hemizygous (KYinno=KC-4718).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-C481Y-KI-1A2
AC   CVCL_E8J3
DR   KYinno; KC-4871
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Cys481Tyr (c.1442G>A); Zygosity=Hemizygous (KYinno=KC-4871).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-C481Y-KI-1B2
AC   CVCL_E8J4
DR   KYinno; KC-4872
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4872).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Cys481Tyr (c.1442G>A); Zygosity=Hemizygous (KYinno=KC-4872).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-HiBiT-KI-1B1
AC   CVCL_E8J5
DR   KYinno; KC-4700
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 a C-terminal HiBiT tag was introduced at the C-terminal of the sole allele of BTK (KYinno=KC-4700).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-L528W-KI
AC   CVCL_E8J6
SY   TMD8-BTK-L528W-KI-1#
DR   KYinno; KC-4601
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Leu528Trp (c.1583T>G); Zygosity=Hemizygous (KYinno=KC-4601).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-T474I-KI-1A1
AC   CVCL_E8J7
DR   KYinno; KC-4715
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4715).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Thr474Ile (c.1421C>T); Zygosity=Hemizygous (KYinno=KC-4715).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-T474I-KI-1C1
AC   CVCL_E8J8
DR   KYinno; KC-4716
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4716).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Thr474Ile (c.1421C>T); Zygosity=Hemizygous (KYinno=KC-4716).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-V416L-KI-1A3
AC   CVCL_E8J9
DR   KYinno; KC-4702
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4702).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Val416Leu; Zygosity=Hemizygous (KYinno=KC-4702).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-BTK-V416L-KI-1B1
AC   CVCL_E8JA
DR   KYinno; KC-4701
CC   Population: Japanese.
CC   Doubling time: ~30 hours (KYinno=KC-4701).
CC   Sequence variation: Mutation; HGNC; HGNC:1133; BTK; Simple_edited; p.Val416Leu; Zygosity=Hemizygous (KYinno=KC-4701).
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMD8-Luc2
AC   CVCL_E8GT
DR   KYinno; KC-2906
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:1699; CD79B; Simple; p.Tyr196His (c.586T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7562; MYD88; Simple; p.Leu252Pro (c.755T>C) (p.Leu265Pro, c.794T>C) (L265P); ClinVar=VCV000037055; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A442 ! TMD8
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TMDNG2
AC   CVCL_XE20
DR   ATCC; HB-10491
DR   Wikidata; Q98133479
RX   Patent=US5654158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10491.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human nephropathy-related immunoglobulin-like protein (NRIg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   TMDNM3
AC   CVCL_XE19
DR   ATCC; HB-10490
DR   Wikidata; Q98133480
RX   Patent=US5654158;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10490.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human nephropathy-related immunoglobulin-like protein (NRIg).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   TMF
AC   CVCL_WC96
SY   Turbot Muscle Fibroblasts
DR   Wikidata; Q98133481
RX   PubMed=30888578;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth temperature is 24 Celsius (PubMed=30888578).
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=52904; ! Scophthalmus maximus (Turbot)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   TMG-L
AC   CVCL_W391
DR   BTO; BTO_0006335
DR   Wikidata; Q54972695
RX   PubMed=12971623;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (Note=At 25th passage) (PubMed=12971623).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C7558; Endometrial carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   TMH-1
AC   CVCL_3219
DR   BioSample; SAMN03151799
DR   BioSample; SAMN03472499
DR   cancercelllines; CVCL_3219
DR   Cell_Model_Passport; SIDM00601
DR   JCRB; JCRB1078
DR   JCRB; NIHS0267
DR   Wikidata; Q54972696
RX   PubMed=11686581;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a IHH-4 derivative (PubMed=20143388). Originally thought to originate from a 79 year old female patient with a thyroid gland anaplastic carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00349.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:391; AKT1; Simple; p.Glu17Lys (c.49G>A); ClinVar=VCV000013983; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Trp592Ter (c.1776G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14281; CRLF2; Simple; p.Trp255Ter (c.765G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Arg1312Ter (c.3934C>T); ClinVar=VCV000545969; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Asp11Glu (c.33C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (from parent cell line).
CC   Discontinued: JCRB; NIHS0267; true.
CC   Derived from site: Metastatic; Left cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): JCRB=JCRB1078
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,13
ST   D16S539: 9,11
ST   D5S818: 9,13
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2960 ! IHH-4
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   TMhep39
AC   CVCL_B6DP
SY   TMHepTG3960 x 2984 x 4912 39; TMHepTG3960 x 2984 x 4912 line 39
DR   Wikidata; Q112041797
RX   Patent=US5814716;
RX   PubMed=1369183;
CC   Characteristics: Established from a triple transgenic mice that contains 1) a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1, 2) a human SERPINA1 promoter driving the expression of SV40 T-antigen and 3) a human F9 promoter driving the expression of F9 (PubMed=1369183).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3551; F9.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: Myc.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x SJL transgenic TG3960 x TG2984 x TG4912.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   TMhep48
AC   CVCL_B6DQ
SY   TMHepTG3960 x 2984 x 4912 48; TMHepTG3960 x 2984 x 4912 line 48
DR   Wikidata; Q112041798
RX   Patent=US5814716;
RX   PubMed=1369183;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-989.
CC   Characteristics: Established from a triple transgenic mice that contains 1) a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1, 2) a human SERPINA1 promoter driving the expression of SV40 T-antigen and 3) a human F9 promoter driving the expression of F9 (PubMed=1369183).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:3551; F9.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: Myc.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x SJL transgenic TG3960 x TG2984 x TG4912.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   TMHepTG2984 2
AC   CVCL_B6DM
SY   TMHepTG2984 line 2; TM hep TG 2984/2
DR   Wikidata; Q112041799
RX   PubMed=1369183;
RX   PubMed=1711473;
CC   Characteristics: Established from a transgenic mice that contains a human SERPINA1 promoter driving the expression of a mouse Myc as well as a second SERPINA1 promoter in front of a full copy of SERPINA1 (PubMed=1369183).
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:8941; SERPINA1.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:97250; Myc.
CC   Transformant: Myc.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x SJL transgenic TG2984.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   TMHepTG4912 10
AC   CVCL_B6DN
SY   TMHepTG4912 line 10; TM hep TG 4912/10
DR   Wikidata; Q112041800
RX   PubMed=1369183;
RX   PubMed=1711473;
CC   Characteristics: Established from a transgenic mice that contains a human SERPINA1 promoter driving the expression of SV40 T-antigen (PubMed=1369183).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57BL/6 x SJL transgenic TG4912.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   TMK-1
AC   CVCL_4384
SY   TMK1
DR   BTO; BTO_0003219
DR   EFO; EFO_0002867
DR   BioGRID_ORCS_Cell_line; 1038
DR   cancercelllines; CVCL_4384
DR   Cell_Model_Passport; SIDM00040
DR   ChEMBL-Cells; CHEMBL4295469
DR   ChEMBL-Targets; CHEMBL4296504
DR   Cosmic; 887251
DR   Cosmic; 888829
DR   Cosmic; 897537
DR   Cosmic; 922689
DR   Cosmic; 926110
DR   Cosmic; 1093301
DR   Cosmic; 1122341
DR   Cosmic; 1187298
DR   Cosmic; 1223585
DR   Cosmic; 1460701
DR   Cosmic; 1482078
DR   Cosmic; 1518245
DR   Cosmic; 1571762
DR   Cosmic-CLP; 1299069
DR   DepMap; ACH-002202
DR   GDSC; 1299069
DR   GEO; GSM552377
DR   GEO; GSM562397
DR   IARC_TP53; 974
DR   PharmacoDB; TMK1_1601_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_4384
DR   PubChem_Cell_line; CVCL_4384
DR   TOKU-E; 4022
DR   Wikidata; Q54972697
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=1370612;
RX   PubMed=1933850;
RX   PubMed=3003017;
RX   PubMed=11107048;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: ~34.9 hours (PubMed=3003017).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Met (c.517G>A); ClinVar=VCV000233951; Zygosity=Unspecified (PubMed=1370612; PubMed=1933850; PubMed=11107048).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.05%; Native American=0.49%; East Asian, North=70.76%; East Asian, South=27.97%; South Asian=0%; European, North=0.73%; European, South=0% (PubMed=30894373).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Cosmic-CLP=1299069
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F953 ! SC-6-JCK
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   TMM
AC   CVCL_1894
DR   CLO; CLO_0009376
DR   CLDB; cl4533
DR   BioSample; SAMN03151631
DR   BioSample; SAMN03473406
DR   DSMZ; ACC-95
DR   DSMZCellDive; ACC-95
DR   Wikidata; Q54972699
RX   PubMed=3478106;
RX   PubMed=10516762;
RX   PubMed=20143388;
RX   PubMed=20454443;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misclassified. Originally thought to be a leukemia cell line from a patient with myelodysplastic syndrome but is a B-lymphoblastoid cell line (PubMed=10516762; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00279.
CC   Doubling time: ~20-40 hours (DSMZ=ACC-95).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): DSMZ=ACC-95
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 10,12
ST   D18S51: 13,16
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 17.3,23
ST   Penta D: 11,12
ST   Penta E: 7
ST   TH01: 8,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   TMMR-1
AC   CVCL_A5LN
DR   Wikidata; Q107117096
RX   PubMed=2293550;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   TMMR-2
AC   CVCL_A5LP
DR   Wikidata; Q107117097
RX   PubMed=2293550;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human 26 kDa protein on osteosarcoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   TMMR-3
AC   CVCL_A5LQ
DR   Wikidata; Q107117098
RX   PubMed=2293550;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human 97 kDa protein on osteosarcoma cell lines.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   TMNK-1
AC   CVCL_4W79
SY   TMNK1
DR   JCRB; JCRB1564
DR   Wikidata; Q54972700
RX   Patent=WO2008066199A1;
RX   PubMed=15167590;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8017.
CC   Characteristics: Because it has been transduced by two constructs containing LoxP sites, transfection with the Cre recombinase eliminates both the SV40 T gene and TERT thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with two retroviral vectors: 1) SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by two loxP sites and 2) SSR#69 (MoMLV/LTR-LoxP-HygroR-HSV/TK-IRES-SV40T-LoxP-Neo-MoMLV/LTR) expressing HygroR, HSV-1 TK and SV40 T-antigen flanked by two loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q9QNF7; Human herpesvirus 1 TK.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
ST   Source(s): JCRB=JCRB1564
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 11,13
ST   TH01: 6,7
ST   TPOX: 9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 18
//
ID   TMO-399
AC   CVCL_V385
DR   IPD-IMGT/HLA; 14458
DR   Wikidata; Q54972702
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,02:11; B*07:02,40:68; C*03:04,07:02; DQB1*03:02,06:02; DRB1*04:07,15:01 (IPD-IMGT/HLA=14458).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   TMOi001-A-1
AC   CVCL_UL03
SY   hiPSC-CD34-GFP-3G6; Clone 3G6; Reporter line 3G6; 3G6; CCRIi001-A-1
DR   BioSamples; SAMEA104619935
DR   hPSCreg; TMOi001-A-1
DR   Wikidata; Q98133482
RX   PubMed=30009677;
CC   From: St. Anna Kinderkrebsforschung GmbH; Vienna; Austria.
CC   Characteristics: CRISPR/Cas9-mediated knock-in of a IRES-GFP-NLS-PuroR construct at the 3'UTR of CD34 (PubMed=30009677).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   TMOi001-A-10
AC   CVCL_D0MX
SY   TTBK2 Het; UNCi010-A-10
DR   hPSCreg; TMOi001-A-10
DR   Wikidata; Q123033620
RX   PubMed=37059819;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19141; TTBK2 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   TMOi001-A-11
AC   CVCL_D0MY
SY   INSRMi017-A-11
DR   BioSamples; SAMEA114304151
DR   hPSCreg; TMOi001-A-11
DR   Wikidata; Q123033621
RX   PubMed=38035530;
CC   From: INSERM; Paris; France.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24466; SYNM.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   TMOi001-A-3
AC   CVCL_B0PI
SY   2B10; NIHi002-A-3
DR   hPSCreg; TMOi001-A-3
DR   Wikidata; Q108821373
RX   PubMed=34419745;
CC   From: National Institutes of Health; Bethesda; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; p.Ala111Leufs*7 (c.331delG); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34419745).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TMOi001-A-4
AC   CVCL_A8SW
SY   SPG11-HA; SPG11_HA; UKERi008-A-4
DR   BioSamples; SAMEA7807684
DR   hPSCreg; TMOi001-A-4
DR   Wikidata; Q108821374
RX   PubMed=34479069;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Characteristics: Using CRISPR/Cas9 a HA tag was integrated at the C-terminus of SPG11 (PubMed=34479069).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
ST   Source(s): PubMed=34479069
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 9,15
ST   FGA: 22,25
ST   Penta D: 2.2,11
ST   Penta E: 12,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   TMOi001-A-5
AC   CVCL_C4PM
SY   DISC1 Ex2 D5; NMIi013-A-5
DR   BioSamples; SAMEA110247825
DR   hPSCreg; TMOi001-A-5
DR   Wikidata; Q116050655
RX   PubMed=36154917;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2888; DISC1 (Note=1 of 2 alleles).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 7
//
ID   TMOi001-A-6
AC   CVCL_C4PN
SY   DISC1 Ex2 C4; NMIi013-A-6
DR   BioSamples; SAMEA110360471
DR   hPSCreg; TMOi001-A-6
DR   Wikidata; Q116050656
RX   PubMed=36154917;
CC   From: Natural and Medical Sciences Institute, University of Tubingen; Tubingen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2888; DISC1.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   TMOi001-A-9
AC   CVCL_D0MW
SY   TTBK2 KO; UNCi010-A-9
DR   hPSCreg; TMOi001-A-9
DR   Wikidata; Q123033622
RX   PubMed=37059819;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19141; TTBK2.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RM92 ! CBiPSC6.2
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   TMPi001-A
AC   CVCL_A7JH
SY   KO-001 c6; K001 c6
DR   hPSCreg; TMPi001-A
DR   Wikidata; Q107117099
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JI ! TMPi001-B
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi001-B
AC   CVCL_A7JI
SY   KO-001 c9; K001 c9
DR   hPSCreg; TMPi001-B
DR   Wikidata; Q107117101
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JH ! TMPi001-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi002-A
AC   CVCL_A7JJ
SY   KO-003 c14; K003 c14
DR   hPSCreg; TMPi002-A
DR   Wikidata; Q107117102
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JK ! TMPi002-B
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi002-B
AC   CVCL_A7JK
SY   KO-003 c20; K003 c20
DR   hPSCreg; TMPi002-B
DR   Wikidata; Q107117103
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JJ ! TMPi002-A
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi003-A
AC   CVCL_A7JL
SY   KO-005 c12; K005 c12
DR   hPSCreg; TMPi003-A
DR   Wikidata; Q107117104
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JM ! TMPi003-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi003-B
AC   CVCL_A7JM
SY   KO-005 c13; K005 c13
DR   hPSCreg; TMPi003-B
DR   Wikidata; Q107117105
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JL ! TMPi003-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi004-A
AC   CVCL_A7JN
SY   KO-008 c13; K008 c13
DR   hPSCreg; TMPi004-A
DR   Wikidata; Q107117107
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JP ! TMPi004-B
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi004-B
AC   CVCL_A7JP
SY   KO-008 c44; K008 c44
DR   hPSCreg; TMPi004-B
DR   Wikidata; Q107117109
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JN ! TMPi004-A
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi005-A
AC   CVCL_A7JQ
SY   KO-011 c6; K011 c6
DR   hPSCreg; TMPi005-A
DR   Wikidata; Q107117110
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JR ! TMPi005-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi005-B
AC   CVCL_A7JR
SY   KO-011 c10; K011 c10
DR   hPSCreg; TMPi005-B
DR   Wikidata; Q107117111
RX   PubMed=33667761;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JQ ! TMPi005-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi006-A
AC   CVCL_A7JS
SY   MR001 c3
DR   hPSCreg; TMPi006-A
DR   Wikidata; Q107117112
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JT ! TMPi006-B
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi006-B
AC   CVCL_A7JT
SY   MR001 c15
DR   hPSCreg; TMPi006-B
DR   Wikidata; Q107117113
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JS ! TMPi006-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   TMPi007-A
AC   CVCL_A7JU
SY   MR-010 c3; MR010 c3
DR   hPSCreg; TMPi007-A
DR   Wikidata; Q107117115
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JV ! TMPi007-B
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   TMPi007-B
AC   CVCL_A7JV
SY   MR-010 c18; MR010 c18
DR   hPSCreg; TMPi007-B
DR   Wikidata; Q107117116
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JU ! TMPi007-A
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   TMPi008-A
AC   CVCL_A7JW
SY   MR-013 c3; MR013 c3
DR   hPSCreg; TMPi008-A
DR   Wikidata; Q107117117
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6T0 ! TMPi008-B
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   TMPi008-B
AC   CVCL_C6T0
SY   MR-013 c13; MR013 c13
DR   hPSCreg; TMPi008-B
DR   Wikidata; Q117704908
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JW ! TMPi008-A
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 05-10-23; Version: 3
//
ID   TMPi009-A
AC   CVCL_A7JX
SY   MR014 c12.1.1
DR   hPSCreg; TMPi009-A
DR   Wikidata; Q107117119
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JY ! TMPi009-B
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   TMPi009-B
AC   CVCL_A7JY
SY   MR014 c27
DR   hPSCreg; TMPi009-B
DR   Wikidata; Q107117120
RX   PubMed=33662736;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7JX ! TMPi009-A
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   TMPi010-A
AC   CVCL_D0M9
SY   KO-013 c20; K013 c20
DR   BioSamples; SAMEA112772276
DR   hPSCreg; TMPi010-A
DR   Wikidata; Q123033624
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0MA ! TMPi010-B
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TMPi010-B
AC   CVCL_D0MA
SY   KO-013 c39; K013 c39
DR   BioSamples; SAMEA112772789
DR   hPSCreg; TMPi010-B
DR   Wikidata; Q123033625
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0M9 ! TMPi010-A
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TMPi011-A
AC   CVCL_D0MB
SY   KO-015 c1; K015 c1
DR   BioSamples; SAMEA112776312
DR   hPSCreg; TMPi011-A
DR   Wikidata; Q123033626
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0MC ! TMPi011-B
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TMPi011-B
AC   CVCL_D0MC
SY   KO-015 c9; K015 c9
DR   BioSamples; SAMEA112776316
DR   hPSCreg; TMPi011-B
DR   Wikidata; Q123033628
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0MB ! TMPi011-A
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TMPi012-A
AC   CVCL_D0MD
SY   MR-023 c17; MR023 c17
DR   BioSamples; SAMEA112782515
DR   hPSCreg; TMPi012-A
DR   Wikidata; Q123033629
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0ME ! TMPi012-B
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TMPi012-B
AC   CVCL_D0ME
SY   MR-023 c22; MR023 c22
DR   BioSamples; SAMEA112783670
DR   hPSCreg; TMPi012-B
DR   Wikidata; Q123033630
RX   PubMed=37004448;
CC   From: Translational Molecular Psychiatry, Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Zurich; Zurich; Switzerland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0MD ! TMPi012-A
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TMs7311
AC   CVCL_A8XM
DR   Wikidata; Q108821375
RX   DOI=10.1007/BF02899643;
CC   Group: Insect cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08160; Autographa californica nuclear polyhedrosis virus (AcMNPV) p35.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=271217; ! Mythimna separata (Oriental armyworm)
HI   CVCL_IM41 ! NEAU-Ms-927311
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   TMT-081MS
AC   CVCL_L174
SY   TMT-081-MS; TMT-081.MS
DR   KCLB; 60021
DR   Wikidata; Q54972704
RX   PubMed=6662551;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_L175 ! TMT-081NM
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   TMT-081NM
AC   CVCL_L175
SY   TMT-081-NM; NM-081
DR   KCLB; 60023
DR   Wikidata; Q54972705
RX   PubMed=6662551;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_L174 ! TMT-081MS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 11
//
ID   TMT-50
AC   CVCL_Y664
DR   Wikidata; Q54972707
RX   PubMed=2096989;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   TMUU-08
AC   CVCL_W376
SY   Tokyo Medical University Urology-08
DR   Wikidata; Q54972708
RX   PubMed=19222609;
CC   Population: Japanese.
CC   Doubling time: ~52 hours (Note=At 10th passage) (PubMed=19222609).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4031; Bladder squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   TN-1
AC   CVCL_6738
SY   TN1
DR   CLO; CLO_0051418
DR   BioSample; SAMN03472008
DR   RCB; RCB2107
DR   TKG; TKG 0277
DR   Wikidata; Q54972709
RX   PubMed=2486611;
RX   PubMed=7768645;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=2486611).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): RCB=RCB2107; TKG=TKG 0277
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   TN-2
AC   CVCL_5602
SY   TN2
DR   CLO; CLO_0051415
DR   BioSample; SAMN03472085
DR   DepMap; ACH-002080
DR   RCB; RCB1896
DR   TKG; TKG 0278
DR   Wikidata; Q54972710
RX   PubMed=2486612;
RX   PubMed=7768645;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2486612).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): DepMap=ACH-002080; RCB=RCB1896; TKG=TKG 0278
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 10,11
ST   D18S51: 15,17
ST   D21S11: 29,33
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 11,16
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   TN-286
AC   CVCL_WF91
DR   IBRC; C10582
DR   Wikidata; Q98133483
CC   Population: Iranian; Turkamans.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TN-287
AC   CVCL_WF92
DR   IBRC; C10583
DR   Wikidata; Q98133484
CC   Population: Iranian; Turkamans.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TN-288
AC   CVCL_WF93
DR   IBRC; C10570
DR   Wikidata; Q98133486
CC   Population: Iranian; Turkamans.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TN-289
AC   CVCL_WF94
DR   IBRC; C10571
DR   Wikidata; Q98133487
CC   Population: Iranian; Turkamans.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TN-3
AC   CVCL_W517
SY   TN3
DR   Wikidata; Q54972711
RX   PubMed=2486613;
RX   PubMed=7768645;
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y2M
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   TN-345
AC   CVCL_WF95
DR   IBRC; C10828
DR   Wikidata; Q98133488
CC   Population: Iranian; Turkamans.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TN-346
AC   CVCL_WF96
DR   IBRC; C10846
DR   Wikidata; Q98133489
CC   Population: Iranian; Turkamans.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   TN-368
AC   CVCL_C412
SY   Tn-368; Tn 368; TN368; Tn368; Trichoplusia ni 368; Tni
DR   CLO; CLO_0009377
DR   CLDB; cl4534
DR   DSMZ; ACC-177
DR   DSMZCellDive; ACC-177
DR   ICLDB; tn-368
DR   Wikidata; Q54972712
RX   CelloPub=CLPUB00466;
RX   CelloPub=CLPUB00491;
RX   DOI=10.1007/BF02618167;
RX   DOI=10.1016/B978-0-12-429740-1.50032-1;
RX   DOI=10.1016/B978-0-12-429740-1.50033-3;
RX   DOI=10.1016/B978-0-12-709902-6.50017-0;
RX   DOI=10.1139/z85-337;
RX   DOI=10.2307/3576171;
RX   PubMed=669727;
RX   PubMed=1017845;
RX   PubMed=1104895;
RX   PubMed=1367489;
RX   PubMed=1369220;
RX   PubMed=1561320;
RX   PubMed=4471170;
RX   PubMed=8314732;
RX   PubMed=12623313;
RX   PubMed=15926859;
RX   PubMed=16057320;
RX   PubMed=16346059;
RX   PubMed=16593348;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Virology: Infected with alphanodavirus TnCLV (PubMed=29133148).
CC   Doubling time: 14.5 hours (PubMed=669727); ~24 hours (DSMZ=ACC-177).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   TN-368-10
AC   CVCL_Z078
SY   TN368-10; TN-368 clone 10
DR   ICLDB; tn-368-10
DR   Wikidata; Q54972713
RX   DOI=10.1016/B978-0-12-429740-1.50032-1;
RX   PubMed=357682;
RX   PubMed=1104895;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 14-17 hours (PubMed=1104895).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   TN-368-13
AC   CVCL_Z079
SY   TN368-13; TN-368 clone 13
DR   ICLDB; tn-368-13
DR   Wikidata; Q54972714
RX   DOI=10.1016/B978-0-12-429740-1.50032-1;
RX   PubMed=357682;
RX   PubMed=1104895;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 14-15 hours (PubMed=1104895).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   TN-368-3
AC   CVCL_C2R8
SY   TN-368 clone 3
DR   ICLDB; tn-368-3
DR   Wikidata; Q114313122
RX   DOI=10.1016/B978-0-12-429740-1.50032-1;
RX   PubMed=1104895;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 16 hours (PubMed=1104895).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   TN-368-5
AC   CVCL_C2R9
SY   TN-368 clone 5
DR   Wikidata; Q114313123
RX   DOI=10.1016/B978-0-12-429740-1.50032-1;
RX   PubMed=1104895;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 16-17 hours (PubMed=1104895).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   TN-368-8
AC   CVCL_C2RA
SY   TN-368 clone 8
DR   ICLDB; tn-368-8
DR   Wikidata; Q114313124
RX   DOI=10.1016/B978-0-12-429740-1.50032-1;
RX   PubMed=1104895;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 15-16 hours (PubMed=1104895).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   TN-368A
AC   CVCL_C413
SY   Tn-368A; TN-368 Attached
DR   ICLDB; tn-368a
DR   Wikidata; Q54972715
RX   DOI=10.1007/BF02618167;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   Tn-4h
AC   CVCL_Z431
SY   BTI-Tn-5B1-4h; Tn4h; 4h
DR   ICLDB; tn-4h
DR   Wikidata; Q54972716
RX   Patent=US6472175;
RX   PubMed=10933841;
RX   PubMed=11587569;
RX   PubMed=20574041;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-2355.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   TN-4H4-F11
AC   CVCL_C8I1
DR   Wikidata; Q123033631
RX   PubMed=23704981;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   Tn-4s
AC   CVCL_Z432
DR   ICLDB; tn-4s
DR   Wikidata; Q54972717
RX   PubMed=12573025;
RX   PubMed=12790633;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_Z431 ! Tn-4h
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   TN-5C5-F3
AC   CVCL_C8I2
DR   Wikidata; Q123033633
RX   PubMed=23704981;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TN-9H6-D10
AC   CVCL_C8I3
DR   Wikidata; Q123033634
RX   PubMed=23704981;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P60033; Human CD81.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TN-CL1
AC   CVCL_Z257
SY   TN-368 CL1; TN-368 clone 1
DR   ICLDB; tn-cl1
DR   Wikidata; Q54972719
RX   DOI=10.1016/0022-2011(89)90145-6;
RX   DOI=10.1016/0022-2011(91)90151-F;
RX   DOI=10.3923/jas.2007.4040.4043;
RX   PubMed=1522049;
RX   PubMed=4471170;
RX   PubMed=8799737;
RX   PubMed=10777062;
RX   PubMed=10852353;
RX   PubMed=15038778;
RX   PubMed=16409117;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   TN-I
AC   CVCL_E2WN
RX   DOI=10.1093/oxfordjournals.pcp.a075640;
CC   Group: Plant cell line.
CC   From: Ito, Masaki; Nagoya University; Nagoya; Japan.
CC   Characteristics: Highly chlorophyllous (DOI=10.1093/oxfordjournals.pcp.a075640).
CC   Derived from site: In situ; Pith; PO=PO_0006109.
CC   Breed/subspecies: Cultivar Samsun NN.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Tn-NVN
AC   CVCL_RT22
DR   ICLDB; tn-nvn
DR   Wikidata; Q54972720
RX   Patent=US11473055;
RX   PubMed=29133148;
RX   PubMed=32662870;
CC   Group: Insect cell line.
CC   Group: Patented cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Virology: Cured of TnCLV infection by ribavirin-treatment.
CC   Doubling time: 26.6 hours (PubMed=32662870).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C412 ! TN-368
SX   Female
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 12
//
ID   TN1.Lu
AC   CVCL_S393
DR   ATCC; CRL-6563
DR   Wikidata; Q54972721
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6563; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9361; ! Dasypus novemcinctus (Nine-banded armadillo)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   Tn5B-40
AC   CVCL_A8XU
DR   Wikidata; Q108821376
RX   DOI=10.1111/j.1744-7917.2004.tb00236.x;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 22 hours (DOI=10.1111/j.1744-7917.2004.tb00236.x).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   TN922
AC   CVCL_RM20
DR   Wikidata; Q54972722
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10226566;
CC   Population: Japanese.
CC   Doubling time: ~36 hours (PubMed=10226566).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TNB1
AC   CVCL_A443
SY   TNB-1
DR   CLO; CLO_0050265
DR   BioSample; SAMN03472325
DR   Cosmic; 920254
DR   RCB; RCB0481
DR   Wikidata; Q54972723
RX   PubMed=2335222;
RX   PubMed=2577250;
CC   Population: Japanese.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): RCB=RCB0481
ST   Amelogenin: X
ST   CSF1PO: 11,15
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D5S818: 13
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 18
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1771 ! TGW
SX   Male
AG   1Y11M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   TND-1
AC   CVCL_DP22
DR   Wikidata; Q54972725
RX   PubMed=3891604;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   TND-2
AC   CVCL_DP23
DR   Wikidata; Q54972726
RX   PubMed=3891604;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   TND-3
AC   CVCL_DP24
DR   Wikidata; Q54972727
RX   PubMed=3891604;
RX   PubMed=10074495;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:43; TAP1; Simple; c.778delG; Zygosity=Homozygous (PubMed=10074495).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171267; Bare lymphocyte syndrome type 1
DI   ORDO; Orphanet_34592; Immunodeficiency by defective expression of MHC class I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 10
//
ID   TND-4
AC   CVCL_DP25
DR   Wikidata; Q54972728
RX   PubMed=3891604;
RX   PubMed=10074495;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:43; TAP1; Simple; c.778delG; Zygosity=Heterozygous (from familial inference of TND-3).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   TNF Rec KO
AC   CVCL_C0MC
SY   TNF REC (Tnfrsf1a) KO; TNF Rec KO Macrophage Cell Line
DR   Kerafast; ENH185-FP
DR   Wikidata; Q112930479
CC   From: Young, Howard A.; National Cancer Institute, National Institutes of Health; Frederick; USA.
CC   Knockout cell: Method=KO mouse; MGI; MGI:1314884; Tnfrsf1a.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 5
//
ID   TNGB-64135
AC   CVCL_A9Y5
SY   64135
DR   TNGB; 64135
DR   Wikidata; Q102114996
CC   Discontinued: TNGB; 64135; true.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9Y4 ! TNGB-64137
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 5
//
ID   TNGB-64137
AC   CVCL_A9Y4
SY   64137
DR   TNGB; 64137
DR   Wikidata; Q102114997
CC   Discontinued: TNGB; 64137; true.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9Y5 ! TNGB-64135
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   TNGB-66257
AC   CVCL_A9ZD
SY   66257
DR   TNGB; 66257
DR   Wikidata; Q102114999
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TNGB-78816
AC   CVCL_A9ZG
SY   78816
DR   TNGB; 78816
DR   Wikidata; Q102115000
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   Tni PRO
AC   CVCL_RQ42
DR   ICLDB; tni-pro
DR   Wikidata; Q54972729
RX   PubMed=29133148;
WW   Provider; Expression Systems; 94-004F/94-004S/94-018F/94-018S; https://expressionsystems.com/wp-content/uploads/2023/09/Expression-Systems-Tni-Pro-Cells-Instructions-Rev-4.pdf
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Virology: Infected with alphanodavirus TnCLV (PubMed=29133148).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   Tni-FNL
AC   CVCL_RY32
DR   ICLDB; tni-fnl
DR   Kerafast; ENH127-FP
DR   Wikidata; Q54972730
RX   PubMed=27616621;
WW   Provider; NCI TTC; TAB-3964/E-146-2017-0; https://techtransfer.cancer.gov/available-technologies?abstract=TAB-3964
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Characteristics: Can grow efficiently at 21 or 27 Celsius in adherent or suspension conditions.
CC   Doubling time: 21 hours (Kerafast=ENH127-FP).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   Tnms42
AC   CVCL_RT23
DR   ICLDB; tnms42
DR   Wikidata; Q54972731
RX   PubMed=25231311;
RX   PubMed=29133148;
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7111; ! Trichoplusia ni (Cabbage looper)
HI   CVCL_C190 ! BTI-Tn-5B1-4
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   TNMY1
AC   CVCL_M836
DR   Wikidata; Q54972732
RX   PubMed=11564213;
CC   Population: Japanese.
CC   Doubling time: 62.7 hours (PubMed=11564213).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   TNO
AC   CVCL_YD97
DR   ABM; T8318
DR   Wikidata; Q98133491
RX   PubMed=31640712;
CC   Derived from site: In situ; Bone, radius; UBERON=UBERON_0001423.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   TNR-2
AC   CVCL_6739
DR   Wikidata; Q54972734
RX   PubMed=6971296;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TNR-9
AC   CVCL_6740
DR   Wikidata; Q54972746
RX   PubMed=6971296;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TNRMCi001-A
AC   CVCL_D0MZ
SY   iTAF32
DR   BioSamples; SAMEA114292483
DR   hPSCreg; TNRMCi001-A
DR   Wikidata; Q123033635
CC   From: Tomsk National Research Medical Center of the Russian Academy of Sciences; Tomsk; Russia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (hPSCreg=TNRMCi001-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   TO [Human B-cell IHW]
AC   CVCL_E854
SY   TO-PP
DR   dbMHC; 49045
DR   ECACC; 94022549
DR   IHW; IHW09218
DR   IPD-IMGT/HLA; 11482
DR   Wikidata; Q54972747
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*68:02,30:01; B*13:02:01,51:01:01; C*06:02,15:02 (IPD-IMGT/HLA=11482).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   TO [Salmo]
AC   CVCL_D140
DR   GEO; GSM1564238
DR   GEO; GSM1564239
DR   GEO; GSM1564240
DR   Wikidata; Q54972749
RX   PubMed=11383566;
RX   PubMed=19162334;
RX   PubMed=25765343;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8030; ! Salmo salar (Atlantic salmon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   TO 165.T
AC   CVCL_N528
DR   ATCC; CRL-7775
DR   Wikidata; Q54972750
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7775; true.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3805 ! TO 166.M
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TO 166.M
AC   CVCL_3805
DR   CLO; CLO_0009379
DR   ATCC; CRL-7776
DR   Wikidata; Q54972751
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7776; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N528 ! TO 165.T
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   TO 167.T
AC   CVCL_N530
DR   ATCC; CRL-7777
DR   Wikidata; Q54972752
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7777; true.
DI   NCIt; C2946; Chondrosarcoma
DI   ORDO; Orphanet_55880; Chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TO 173.T
AC   CVCL_N529
DR   ATCC; CRL-7778
DR   Wikidata; Q54972753
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7778; true.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TO 175.T
AC   CVCL_3806
SY   TO-175-T; TO175T
DR   CLO; CLO_0009380
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-7779
DR   BioSample; SAMN03471152
DR   BioSample; SAMN10988143
DR   cancercelllines; CVCL_3806
DR   Cell_Model_Passport; SIDM01759
DR   DepMap; ACH-000125
DR   GEO; GSM887708
DR   GEO; GSM888801
DR   IARC_TP53; 30181
DR   IGRhCellID; TO175T
DR   LiGeA; CCLE_159
DR   PharmacoDB; TO175_T_1602_2019
DR   Progenetix; CVCL_3806
DR   Wikidata; Q54972755
RX   DOI=10.1101/166199;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25355872;
RX   PubMed=26589293;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Problematic cell line: Misclassified. Originally thought to be a Hodgkin lymphoma cell line but using a variety of omics methods was shown to be a fibroblastic cell line (DOI=10.1101/166199; DepMap=ACH-000125).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian.
CC   HLA typing: A*01:01,32:01; B*08:01,44:02; C*05:01,07:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.27%; East Asian, North=0.13%; East Asian, South=0%; South Asian=0%; European, North=71.49%; European, South=28.11% (PubMed=30894373).
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-7779
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,14
ST   D16S539: 10,11
ST   D18S51: 11,14
ST   D19S433: 14,15
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 14,18
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 7,8
ST   TPOX: 10,12
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   TO 183.T
AC   CVCL_S257
DR   ATCC; CRL-7952
DR   Wikidata; Q54972757
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7952; true.
DI   NCIt; C3272; Neurofibroma
DI   ORDO; Orphanet_252183; Neurofibroma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TO 184.T
AC   CVCL_S258
DR   ATCC; CRL-7953
DR   Wikidata; Q54972758
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7953; true.
DI   NCIt; C3194; Liposarcoma
DI   ORDO; Orphanet_69078; Liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   TO 203.T
AC   CVCL_3610
SY   TO-203-T
DR   CLO; CLO_0009381
DR   ATCC; CRL-7780
DR   BioSample; SAMN03471153
DR   Cosmic; 687933
DR   Wikidata; Q54972759
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-7780; true.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): ATCC=CRL-7780
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   To Ser
AC   CVCL_U692
DR   ATCC; CRL-1111
DR   Wikidata; Q54972760
CC   Discontinued: ATCC; CRL-1111; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   To War
AC   CVCL_U794
DR   ATCC; CRL-1244
DR   Wikidata; Q54972761
CC   Discontinued: ATCC; CRL-1244; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C27576; Childhood dermatomyositis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   TO-2
AC   CVCL_R880
SY   Tilapia Ovary-2
DR   Wikidata; Q28471145
RX   CelloPub=CLPUB00022;
RX   DOI=10.3147/jsfp.18.13;
RX   PubMed=2592443;
RX   PubMed=3346335;
CC   Group: Fish cell line.
CC   Characteristics: Can grow between 15 to 34 Celsius, with an optimal growth temperature of 31 Celsius (PubMed=3346335).
CC   Doubling time: 12 hours (Note=In 20% FCS), 27 hours (Note=In 10% FCS), 30 hours (Note=In 5% FCS), 50 hours (Note=In 2% FCS) (DOI=10.3147/jsfp.18.13).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus (Hybrid tilapia)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 12
//
ID   TO-37c
AC   CVCL_R881
DR   Wikidata; Q54972763
RX   PubMed=2592443;
CC   Group: Fish cell line.
CC   Characteristics: Heat-resistant. Grows at 37 Celsius.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=304579; ! Oreochromis mossambicus x Oreochromis niloticus (Hybrid tilapia)
HI   CVCL_R880 ! TO-2
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   TO14
AC   CVCL_2734
SY   T014
DR   cancercelllines; CVCL_2734
DR   CancerTools; 151680
DR   Cell_Model_Passport; SIDM01420
DR   DepMap; ACH-001403
DR   ECACC; 10081203
DR   GEO; GSM726082
DR   Wikidata; Q54972764
DR   Ximbio; 151680
RX   PubMed=3167863;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 130 hours (PubMed=3167863).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277Phe (c.830G>T); ClinVar=VCV000458567; Zygosity=Unspecified (DepMap=ACH-001403).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 10081203; true.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): DepMap=ACH-001403
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 27,30
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2687 ! PEO14
OI   CVCL_2689 ! PEO23
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   TO4 Y56A
AC   CVCL_GT19
DR   ATCC; CRL-6580
DR   Wikidata; Q54972765
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6580; true.
DI   NCIt; C134526; Canine neoplasm
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 21-03-23; Version: 6
//
ID   TOB
AC   CVCL_YD92
DR   ABM; T8314
DR   Wikidata; Q98133492
RX   PubMed=31640712;
CC   Doubling time: 29.3 hours (PubMed=31640712).
CC   Derived from site: Metastatic; Bone, tibia; UBERON=UBERON_0000979.
CC   Breed/subspecies: Neapolitan Mastiff; VBO=VBO_0200930.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   TOB0004
AC   CVCL_E5AI
SY   TOB-00004
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0006
AC   CVCL_E5AJ
SY   TOB-00006
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0007
AC   CVCL_E5AK
SY   TOB-00007
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0009
AC   CVCL_E5AL
SY   TOB-00009
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0010
AC   CVCL_E5AM
SY   TOB-00010
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0014
AC   CVCL_E5AN
SY   TOB-00014
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0024
AC   CVCL_E5AP
SY   TOB-00024
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0040
AC   CVCL_E5AQ
SY   TOB-00040
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0046
AC   CVCL_E5AR
SY   TOB-00046
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0058
AC   CVCL_E5AS
SY   TOB-00058
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0064
AC   CVCL_E5AT
SY   TOB-00064; THBS0282; UOMELBi001-A
DR   hPSCreg; UOMELBi001-A
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0074
AC   CVCL_E5AU
SY   TOB-00074
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0105
AC   CVCL_E5AV
SY   TOB-00105
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0107
AC   CVCL_E5AW
SY   TOB-00107
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0121
AC   CVCL_E5AX
SY   TOB-00121
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0123
AC   CVCL_E5AY
SY   TOB-00123
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0167
AC   CVCL_E5AZ
SY   TOB-00167
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0168
AC   CVCL_E5B0
SY   TOB-00168
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0169
AC   CVCL_E5B1
SY   TOB-00169
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0173
AC   CVCL_E5B2
SY   TOB-00173
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0175
AC   CVCL_E5B3
SY   TOB-00175
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0176
AC   CVCL_E5B4
SY   TOB-00176
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0181
AC   CVCL_E5B5
SY   TOB-00181
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0182
AC   CVCL_E5B6
SY   TOB-00182
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0192
AC   CVCL_E5B7
SY   TOB-00192
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0193
AC   CVCL_E5B8
SY   TOB-00193
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0195
AC   CVCL_E5B9
SY   TOB-00195
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0197
AC   CVCL_E5BA
SY   TOB-00197
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0198
AC   CVCL_E5BB
SY   TOB-00198
DR   GEO; GSM7036163
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0199
AC   CVCL_E5BC
SY   TOB-00199
DR   GEO; GSM7036164
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0205
AC   CVCL_E5BD
SY   TOB-00205
DR   GEO; GSM7036165
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0206
AC   CVCL_E5BE
SY   TOB-00206
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0218
AC   CVCL_E5BF
SY   TOB-00218
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0220
AC   CVCL_E5BG
SY   TOB-00220
DR   GEO; GSM7036166
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
RX   PubMed=38433209;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0224
AC   CVCL_E5BH
SY   TOB-00224
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0231
AC   CVCL_E5BI
SY   TOB-00231
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0232
AC   CVCL_E5BJ
SY   TOB-00232
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0233
AC   CVCL_E5BK
SY   TOB-00233
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0234
AC   CVCL_E5BL
SY   TOB-00234
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0235
AC   CVCL_E5BM
SY   TOB-00235
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0236
AC   CVCL_E5BN
SY   TOB-00236
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0269
AC   CVCL_E5BP
SY   TOB-00269
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0371
AC   CVCL_E5BQ
SY   TOB-00371
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0375
AC   CVCL_E5BR
SY   TOB-00375
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0404
AC   CVCL_E5BS
SY   TOB-00404
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0405
AC   CVCL_E5BT
SY   TOB-00405
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0408
AC   CVCL_E5BU
SY   TOB-00408
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0409
AC   CVCL_E5BV
SY   TOB-00409
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0412
AC   CVCL_E5BW
SY   TOB-00412
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0421
AC   CVCL_E5BX
SY   TOB-00421
DR   GEO; GSM7036167
DR   GEO; GSM7043202
DR   GEO; GSM7043203
DR   GEO; GSM7043204
DR   GEO; GSM7043205
DR   GEO; GSM7043206
DR   GEO; GSM7043207
DR   GEO; GSM7043208
DR   GEO; GSM7043209
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0422
AC   CVCL_E5BY
SY   TOB-00422
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   96Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0431
AC   CVCL_E5BZ
SY   TOB-00431
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0435
AC   CVCL_E5C0
SY   TOB-00435
DR   GEO; GSM7036168
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0436
AC   CVCL_E5C1
SY   TOB-00436
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0461
AC   CVCL_E5C2
SY   TOB-00461
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0462
AC   CVCL_E5C3
SY   TOB-00462
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0474
AC   CVCL_E5C4
SY   TOB-00474
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TOB0479
AC   CVCL_E5C5
SY   TOB-00479
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0512
AC   CVCL_E5C6
SY   TOB-00512
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   93Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0513
AC   CVCL_E5C7
SY   TOB-00513
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0514
AC   CVCL_E5C8
SY   TOB-00514
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOB0515
AC   CVCL_E5C9
SY   TOB-00515
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35394; Primary open angle glaucoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOC-2
AC   CVCL_Y478
DR   Wikidata; Q54972766
RX   PubMed=7671230;
CC   From: Sato, Noriyuki; Sapporo Medical College; Sapporo; Japan.
CC   Population: Japanese.
CC   HLA typing: A*26,33; B*07,44; C*07 (PubMed=7671230).
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-09-24; Version: 8
//
ID   TOC-4 iPSC
AC   CVCL_GQ05
DR   Wikidata; Q54972767
RX   PubMed=27558612;
CC   From: D'Or Institute for Research and Education; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C88411; Obsessive compulsive disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 7
//
ID   TOC1
AC   CVCL_E3YV
SY   Tau oligomeric complex-1
DR   ABCD; ABCD_AF576
RX   Patent=US8697076;
RX   PubMed=21550980;
CC   Group: Serum/protein free medium cell line.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P10636; Human MAPT (Note=isoform Tau-F).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   TOCF
AC   CVCL_VG79
SY   Trachinotus Ovatus Caudal Fin
DR   Wikidata; Q54972768
RX   PubMed=29691845;
CC   Group: Fish cell line.
CC   Virology: Susceptible to infection by Singapore grouper iridovirus (SGIV) (PubMed=29691845).
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=173339; ! Trachinotus ovatus (Derbio)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   TOG
AC   CVCL_E7AT
SY   Takifugu Obscurus Gill
RX   PubMed=39181522;
CC   Group: Fish cell line.
CC   Characteristics: Optimal temperature for growth is 24 Celsius (PubMed=39181522).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=309541; ! Takifugu obscurus (Obscure pufferfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TOGB
AC   CVCL_AZ92
SY   Trachinotus Ovatus Golden Brain
DR   Wikidata; Q54972769
RX   PubMed=26822430;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=173339; ! Trachinotus ovatus (Derbio)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   TOHK
AC   CVCL_KB49
SY   Trachinotus Ovatus Head Kidney
DR   Wikidata; Q54972770
RX   PubMed=28271507;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=173339; ! Trachinotus ovatus (Derbio)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 7
//
ID   TOK [Dog]
AC   CVCL_YD93
DR   Wikidata; Q98133493
RX   PubMed=31640712;
CC   Doubling time: 32.07 hours (PubMed=31640712).
CC   Derived from site: In situ; Bone, proximal humerus; UBERON=UBERON_0004411.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   TOK [Trachinotus]
AC   CVCL_IQ76
SY   Trachinotus Ovatus Kidney
DR   Wikidata; Q54972771
RX   PubMed=27981423;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=173339; ! Trachinotus ovatus (Derbio)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   TOKUNAGA
AC   CVCL_E855
SY   TOK
DR   dbMHC; 49046
DR   ECACC; 85102916
DR   IHW; 9w 1202
DR   IHW; IHW09304
DR   IPD-IMGT/HLA; 11493
DR   Wikidata; Q54972773
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52; DPA1*02; DPB1*09:01; DQA1*01:03; DQB1*06:01; DRB1*15:02; DRB5*01:02; DRB6*02 (IPD-IMGT/HLA=11493).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   TOL
AC   CVCL_YD94
DR   ABM; T8315
DR   Wikidata; Q98133494
RX   PubMed=31640712;
CC   Doubling time: 35.7 hours (PubMed=31640712).
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Saint Bernard; VBO=VBO_0201160.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   Tol/F
AC   CVCL_W140
SY   Tol/FL; TOL/F; Tolstolob/Fin
DR   Wikidata; Q54972774
RX   PubMed=17497237;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=13095; ! Hypophthalmichthys molitrix (Silver carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 9
//
ID   Toledo
AC   CVCL_3611
SY   TOLEDO
DR   CLO; CLO_0009382
DR   EFO; EFO_0002383
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ATCC; CRL-2631
DR   BCRC; 60544
DR   BCRJ; 0235
DR   BioSample; SAMN03472953
DR   BioSample; SAMN10987633
DR   cancercelllines; CVCL_3611
DR   Cell_Model_Passport; SIDM01758
DR   ChEMBL-Cells; CHEMBL4295464
DR   ChEMBL-Targets; CHEMBL4296505
DR   Cosmic; 1541917
DR   Cosmic; 1670183
DR   Cosmic; 1945195
DR   Cosmic; 2022502
DR   Cosmic; 2276337
DR   DepMap; ACH-000285
DR   EGA; EGAS00001000610
DR   GDSC; 1331046
DR   GEO; GSM380151
DR   GEO; GSM552462
DR   GEO; GSM887709
DR   GEO; GSM888802
DR   GEO; GSM907526
DR   GEO; GSM1035336
DR   GEO; GSM3150257
DR   IARC_TP53; 28341
DR   IGRhCellID; Toledo
DR   LiGeA; CCLE_102
DR   LINCS_LDP; LCL-1124
DR   PharmacoDB; Toledo_1603_2019
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_3611
DR   PubChem_Cell_line; CVCL_3611
DR   Wikidata; Q54972777
RX   PubMed=10485273;
RX   PubMed=19278952;
RX   PubMed=19358282;
RX   PubMed=20215515;
RX   PubMed=20628145;
RX   PubMed=22460905;
RX   PubMed=23292937;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29666304;
RX   PubMed=30165192;
RX   PubMed=30285677;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~24-30 hours (ATCC=CRL-2631).
CC   HLA typing: A*24:02,30:02; B*18:01,41:01; C*12:03,17:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (DepMap=ACH-000285).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu198fs (c.592_596del5); Zygosity=Unspecified (DepMap=ACH-000285).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=7.85%; Native American=0%; East Asian, North=5.12%; East Asian, South=0%; South Asian=4.69%; European, North=17.53%; European, South=64.81% (PubMed=30894373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-2631; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 12
ST   D19S433: 15,15.2
ST   D21S11: 28,32.2
ST   D2S1338: 19,23
ST   D3S1358: 16,18
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 19,22
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   TOM
AC   CVCL_YD95
DR   ABM; T8316
DR   Wikidata; Q98133496
RX   PubMed=31640712;
CC   Doubling time: 34.85 hours (PubMed=31640712).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
CC   Breed/subspecies: Australian cattle dog; VBO=VBO_0200088.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 7
//
ID   TOM-1
AC   CVCL_1895
SY   TOM1
DR   BioSample; SAMN03473484
DR   Cosmic; 1012125
DR   Cosmic; 1026577
DR   Cosmic; 1524825
DR   Cosmic; 2491093
DR   Cosmic; 2649234
DR   DSMZ; ACC-578
DR   DSMZCellDive; ACC-578
DR   GEO; GSM236808
DR   GEO; GSM236844
DR   Wikidata; Q54972778
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1884023;
RX   PubMed=3103721;
RX   PubMed=3332852;
RX   PubMed=9067587;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Doubling time: ~60-70 hours (DSMZ=ACC-578).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=10071072; PubMed=10576511; PubMed=3103721).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-578
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 9,10
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 31,33.2
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 13,14
ST   FGA: 19,23
ST   Penta D: 10,12
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   TOM-2
AC   CVCL_5603
DR   CLO; CLO_0050880
DR   BioSample; SAMN03472155
DR   RCB; RCB1125
DR   Wikidata; Q54972781
RX   PubMed=9590502;
CC   Population: Japanese.
CC   Doubling time: 83 hours (PubMed=9590502).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): RCB=RCB1125
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10,14
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   TOMA 70
AC   CVCL_VQ06
SY   TOMA70
DR   Wikidata; Q98133498
RX   PubMed=10837406;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   TOMO
AC   CVCL_LM79
DR   Wikidata; Q54972782
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   TonB210.1
AC   CVCL_K246
SY   Baf3/TonB210.1
DR   Wikidata; Q54972783
RX   PubMed=9573031;
CC   Characteristics: IL3 dependent.
CC   Caution: The parent cell line was originally thought to originate from a BALB/c mouse but is in fact from a C3H mouse.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pro-B cell; CL=CL_0000826.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0161 ! Ba/F3
CA   Factor-dependent cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 9
//
ID   Tong/HCC
AC   CVCL_V640
SY   Tong; TONG; TONG/PHC; TONG PHC
DR   cancercelllines; CVCL_V640
DR   GEO; GSM2551595
DR   LIMORE; Tong
DR   Wikidata; Q54972784
RX   DOI=10.1007/978-4-431-68349-0_4;
RX   PubMed=2445644;
RX   PubMed=3023526;
RX   PubMed=8050184;
RX   PubMed=8224613;
RX   PubMed=31378681;
WW   Provider; BRICS; BRICS0056; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3871
CC   Part of: Liver Cancer Model Repository (LIMORE).
CC   Population: Caucasian; Italian.
CC   Doubling time: ~50 hours (PubMed=2445644); 26.71 hours (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; c.5125-1G>T; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:1058; BLM; Simple; p.Leu148Ter (c.443T>A); Zygosity=Unspecified (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31378681).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=31378681).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=31378681
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 14
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 8,10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 19
//
ID   Tor-1A5
AC   CVCL_C3BY
DR   Wikidata; Q114313125
RX   PubMed=3105603;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07692; Torpedo marmorata acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Tor-3E5
AC   CVCL_C3BZ
DR   Wikidata; Q114313126
RX   PubMed=3105603;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07692; Torpedo marmorata acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   Tor-ME8
AC   CVCL_C3C0
DR   Wikidata; Q114313128
RX   PubMed=3105603;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P07692; Torpedo marmorata acetylcholinesterase (Ache).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   TOS-1
AC   CVCL_A753
DR   Wikidata; Q54972785
RX   PubMed=8620516;
RX   PubMed=10775053;
RX   PubMed=11278988;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=10775053).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   TOS-2
AC   CVCL_A754
DR   Wikidata; Q54972786
RX   PubMed=8620516;
RX   PubMed=10775053;
CC   Population: Japanese.
CC   Doubling time: 37 hours (PubMed=10775053).
CC   Derived from site: Metastatic; Axilla, hypodermis; UBERON=UBERON_0009472+UBERON_0002072.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 14
//
ID   TOS-3
AC   CVCL_A755
DR   Wikidata; Q54972787
RX   PubMed=10775053;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=10775053).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A756 ! TOS-3LN
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   TOS-3LN
AC   CVCL_A756
DR   Wikidata; Q54972788
RX   PubMed=10775053;
CC   Population: Japanese.
CC   Doubling time: 33 hours (PubMed=10775053).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A755 ! TOS-3
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   TOS1
AC   CVCL_A0WK
SY   Telangiectatic OsteoSarcoma 1
DR   Wikidata; Q108821377
RX   PubMed=33503899;
CC   Doubling time: 125 hours (Direct_author_submission).
CC   Miscellaneous: Age/sex of donor, sampling site and doubling time from personal communication of Brandi, Maria Luisa.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C3902; Telangiectatic osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   TOS1-CSCs
AC   CVCL_A0WL
SY   Telangiectatic OsteoSarcoma 1-Cancer Stem Cells
DR   Wikidata; Q108821378
RX   PubMed=33503899;
CC   Group: Cancer stem cell line.
CC   Miscellaneous: Age/sex of donor and sampling site from personal communication of Brandi, Maria Luisa.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
DI   NCIt; C3902; Telangiectatic osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0WK ! TOS1
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   TOT
AC   CVCL_YD96
DR   ABM; T8317
DR   Wikidata; Q98133499
RX   PubMed=31640712;
CC   Doubling time: 33.78 hours (PubMed=31640712).
CC   Derived from site: In situ; Bone, proximal humerus; UBERON=UBERON_0004411.
CC   Breed/subspecies: Greyhound; VBO=VBO_0200638.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 6
//
ID   Tot2
AC   CVCL_0564
DR   MCCL; MCC:0000466
DR   Wikidata; Q54972789
RX   PubMed=10981959;
RX   PubMed=15947094;
CC   Characteristics: CSF2 dependent.
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:96395; Irf8.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TOTL-1
AC   CVCL_S612
SY   TOTL1; Transparent Ocular Tissue Laboratory-1
DR   Wikidata; Q54972790
RX   PubMed=2476248;
RX   PubMed=6351622;
CC   Population: Japanese.
CC   Doubling time: 160 hours (PubMed=2476248).
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y5M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   TOTL-86
AC   CVCL_ZF08
SY   Transparent Ocular Tissue Laboratory-86
DR   Wikidata; Q98133500
RX   PubMed=3295341;
RX   PubMed=8878182;
RX   PubMed=10460777;
RX   PubMed=19454181;
CC   Doubling time: 40 hours (PubMed=3295341).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
CC   Breed/subspecies: Albino.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 6
//
ID   TOU (TOU I-2)
AC   CVCL_2735
SY   TOU; TOU I-2
DR   CLO; CLO_0009383
DR   CLDB; cl4536
DR   ECACC; 93093001
DR   Wikidata; Q54972792
RX   PubMed=6438434;
WW   Info; IMGT; -; https://www.imgt.org/IMGTrepertoire/LocusGenes/locus/human/IGH/Hu_IGHcellines.html
CC   Population: Tunisian; Berber.
CC   Characteristics: Heterozygous for deletion of IGH G1-EP1-A1-GP-G2-G4 and of EP1-A1-GP.
CC   Sequence variation: Gene deletion; HGNC; HGNC:5478; IGHA1; Zygosity=Homozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5523; IGHEP1; Zygosity=Homozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5525; IGHG1; Zygosity=Heterozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5526; IGHG2; Zygosity=Heterozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5528; IGHG4; Zygosity=Heterozygous (PubMed=6438434).
CC   Sequence variation: Gene deletion; HGNC; HGNC:5529; IGHGP; Zygosity=Homozygous (PubMed=6438434).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   TOV-112D
AC   CVCL_3612
SY   TOV-112d; TOV112D; TOV-112; TOV112
DR   BTO; BTO_0005182
DR   CLO; CLO_0009384
DR   EFO; EFO_0005263
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3593
DR   ATCC; CRL-11731
DR   BCRC; 60408
DR   BioGRID_ORCS_Cell_line; 201
DR   BioSample; SAMN03471348
DR   BioSample; SAMN10988342
DR   cancercelllines; CVCL_3612
DR   CancerTools; 161766
DR   Cell_Model_Passport; SIDM01170
DR   ChEMBL-Cells; CHEMBL3707165
DR   ChEMBL-Targets; CHEMBL3707166
DR   Cosmic; 875292
DR   Cosmic; 1066219
DR   Cosmic; 1102818
DR   Cosmic; 1113278
DR   Cosmic; 1139220
DR   Cosmic; 1305335
DR   Cosmic; 1709264
DR   Cosmic; 2186587
DR   Cosmic-CLP; 1299070
DR   DepMap; ACH-000048
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 1299070
DR   GEO; GSE35972
DR   GEO; GSM274697
DR   GEO; GSM289383
DR   GEO; GSM289384
DR   GEO; GSM289387
DR   GEO; GSM289388
DR   GEO; GSM313690
DR   GEO; GSM659407
DR   GEO; GSM711721
DR   GEO; GSM784575
DR   GEO; GSM851944
DR   GEO; GSM887710
DR   GEO; GSM888803
DR   GEO; GSM1001425
DR   GEO; GSM1001426
DR   GEO; GSM1001489
DR   GEO; GSM1291152
DR   GEO; GSM1340594
DR   GEO; GSM1341134
DR   GEO; GSM1374964
DR   GEO; GSM1670546
DR   IARC_TP53; 20197
DR   LiGeA; CCLE_580
DR   LINCS_LDP; LCL-1920
DR   PharmacoDB; TOV112D_1604_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3612
DR   PubChem_Cell_line; CVCL_3612
DR   Wikidata; Q54972795
RX   Patent=US5710038;
RX   PubMed=10949993;
RX   PubMed=11641787;
RX   PubMed=16380993;
RX   PubMed=18507860;
RX   PubMed=19058220;
RX   PubMed=19288585;
RX   PubMed=20204287;
RX   PubMed=22328975;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=22931248;
RX   PubMed=24023729;
RX   PubMed=25230021;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27235858;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=33328126;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11371.
CC   Population: Caucasian.
CC   Doubling time: 0.8 day (PubMed=10949993); 1.0 +- 0.2 days (PubMed=18507860); 22 hours (PubMed=25984343); 1.49 days (PubMed=22931248); 29.13 hours (JWGray panel).
CC   HLA typing: A*03:01,03:01; B*14:01,14:01; C*08:02,08:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Ala (c.109T>G); ClinVar=VCV000376235; Zygosity=Homozygous (DepMap=ACH-000048).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Leu639fs (c.1915delC); Zygosity=Homozygous (PubMed=33328126; DepMap=ACH-000048).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=10949993; PubMed=18507860; PubMed=20204287; PubMed=22931248; PubMed=24023729; PubMed=25230021; PubMed=33328126; DepMap=ACH-000048).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.33%; East Asian, North=2.98%; East Asian, South=0%; South Asian=0.16%; European, North=53.45%; European, South=43.09% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-11731; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=CRL-3593; Cosmic-CLP=1299070; Direct_author_submission; PubMed=22710073; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 9,12 (ATCC=CRL-3593; Cosmic-CLP=1299070; Direct_author_submission; PubMed=22710073; PubMed=25877200; PubMed=30485824)
ST   D16S539: 11,12 (PubMed=25230021)
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 31
ST   D2S1338: 19,24
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 9,10
ST   D8S1179: 9,13
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   TOV-112DR
AC   CVCL_IQ56
SY   TOV112DR
DR   cancercelllines; CVCL_IQ56
DR   PRIDE; PXD003668
DR   Wikidata; Q54972796
RX   PubMed=27561551;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Ala (c.109T>G); ClinVar=VCV000376235; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11100; SMARCA4; Simple; p.Leu639fs (c.1915delC); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Omics: Proteomics.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3612 ! TOV-112D
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   TOV-1369
AC   CVCL_9T17
SY   TOV-1369 TR; TOV-1369TR; TOV1369; OVCA1369_TR
DR   cancercelllines; CVCL_9T17
DR   CancerTools; 161768
DR   GEO; GSM2475006
DR   Wikidata; Q54972797
RX   PubMed=22585861;
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 2.87 +- 0.03 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Cys (c.730G>T); ClinVar=VCV000376599; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D21S11: 30,31
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T12 ! OV-1369(R2)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 14
//
ID   TOV-1946
AC   CVCL_4062
SY   TOV1946
DR   cancercelllines; CVCL_4062
DR   CancerTools; 161770
DR   Cosmic; 1122314
DR   GEO; GSM2475007
DR   Wikidata; Q54972807
RX   PubMed=18507860;
RX   PubMed=22585861;
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 1.3 +- 0.4 days (PubMed=18507860); 2.2 +- 0.26 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=18507860; PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4375 ! OV-1946
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   TOV-21G
AC   CVCL_3613
SY   TOV-21g; TOV21G; TOV21
DR   BTO; BTO_0005183
DR   CLO; CLO_0009385
DR   EFO; EFO_0022427
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3577
DR   ATCC; CRL-11730
DR   BCRC; 60407
DR   BCRJ; 0236
DR   BioGRID_ORCS_Cell_line; 446
DR   BioSample; SAMN02800401
DR   BioSample; SAMN03471875
DR   BioSample; SAMN10988233
DR   cancercelllines; CVCL_3613
DR   CancerTools; 161764
DR   Cell_Model_Passport; SIDM01169
DR   ChEMBL-Cells; CHEMBL4630710
DR   ChEMBL-Targets; CHEMBL4630716
DR   Cosmic; 1066220
DR   Cosmic; 1102820
DR   Cosmic; 1139221
DR   Cosmic; 1223320
DR   Cosmic; 1305319
DR   Cosmic; 1312195
DR   Cosmic; 1328069
DR   Cosmic; 1434896
DR   Cosmic; 1449932
DR   Cosmic; 1707558
DR   Cosmic; 1708383
DR   Cosmic; 2074249
DR   Cosmic-CLP; 1240222
DR   DepMap; ACH-000885
DR   EGA; EGAS00001000978
DR   GDSC; 1240222
DR   GEO; GSM289385
DR   GEO; GSM289386
DR   GEO; GSM289416
DR   GEO; GSM289417
DR   GEO; GSM313692
DR   GEO; GSM416684
DR   GEO; GSM659408
DR   GEO; GSM784567
DR   GEO; GSM851945
DR   GEO; GSM887711
DR   GEO; GSM888804
DR   GEO; GSM1176285
DR   GEO; GSM1291153
DR   GEO; GSM1374965
DR   GEO; GSM1670547
DR   GEO; GSM2475008
DR   IARC_TP53; 21094
DR   LiGeA; CCLE_476
DR   LINCS_LDP; LCL-1530
DR   PharmacoDB; TOV21G_1605_2019
DR   PRIDE; PXD000901
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3613
DR   PubChem_Cell_line; CVCL_3613
DR   Wikidata; Q54972808
RX   Patent=US5710038;
RX   PubMed=10949993;
RX   PubMed=11641787;
RX   PubMed=19058220;
RX   PubMed=20081105;
RX   PubMed=20204287;
RX   PubMed=22460905;
RX   PubMed=22705003;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=24023729;
RX   PubMed=24224046;
RX   PubMed=25230021;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26388441;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28273451;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/ovarian-cancer-xenograft/tov-21g-xenograft-model/
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11370.
CC   Population: Caucasian.
CC   Doubling time: 1.5 days (PubMed=10949993); 27 hours (PubMed=25984343); 30.62 hours (JWGray panel).
CC   HLA typing: A*11:01,26:01; B*40:02,46:01; C*02:02,04:01 (PubMed=25960936).
CC   HLA typing: A*11:01,26:01; B*40:02,40:02; C*02:02,04:01; DQA1*04:01,04:01; DQB1*05:01,06:01; DRB1*01:01,11:01 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Heterozygous (PubMed=22705003; PubMed=24224046; PubMed=25230021; PubMed=28273451; Cosmic-CLP=1240222; DepMap=ACH-000885).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Tyr (c.3139C>T); ClinVar=VCV000039705; Zygosity=Heterozygous (PubMed=22705003; PubMed=24224046; PubMed=25230021; PubMed=28273451; Cosmic-CLP=1240222; DepMap=ACH-000885).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys267Argfs*9 (c.800delA) (p.Leu265fs, c.795delA); ClinVar=VCV000092828; Zygosity=Heterozygous (PubMed=25230021; Cosmic-CLP=1240222; DepMap=ACH-000885).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Phosphorylation; Quantitative.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=1.11%; East Asian, North=0.06%; East Asian, South=0%; South Asian=1.64%; European, North=59.77%; European, South=37.42% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-11730; true.
CC   Discontinued: BCRJ; 0236; probable.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=CRL-3577; Cosmic-CLP=1240222; Direct_author_submission; PubMed=22710073; PubMed=25230021; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 13,15
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 12 (PubMed=25230021; PubMed=25877200)
ST   D18S51: 12,16 (PubMed=22710073)
ST   D19S433: 14,16.2
ST   D21S11: 28,34.2
ST   D2S1338: 17
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13,16
ST   FGA: 20,23
ST   Penta D: 9
ST   Penta E: 17,18 (PubMed=25877200)
ST   Penta E: 17,19 (PubMed=25230021)
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17 (ATCC=CRL-3577; Cosmic-CLP=1240222; PubMed=22710073; PubMed=25230021; PubMed=25877200; PubMed=30485824)
ST   vWA: 17,18 (Direct_author_submission)
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 44
//
ID   TOV-2223
AC   CVCL_4063
SY   TOV-2223G; TOV2223G
DR   cancercelllines; CVCL_4063
DR   CancerTools; 161897
DR   Cosmic; 1122316
DR   GEO; GSM2475009
DR   Wikidata; Q54972809
RX   PubMed=18507860;
RX   PubMed=22585861;
RX   PubMed=28273451;
CC   Doubling time: 2.6 +- 0.7 days (PubMed=18507860).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.159G>A); ClinVar=VCV000420659; Zygosity=Unspecified (PubMed=18507860; PubMed=28273451).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission; PubMed=22585861
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,15
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 18,20
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 20,24
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   89Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TOV-2295(R)
AC   CVCL_9T18
SY   TOV2295(R); TOV-2295 (R)
DR   cancercelllines; CVCL_9T18
DR   CancerTools; 161775
DR   Wikidata; Q54972810
RX   PubMed=22931248;
CC   Doubling time: 2.49 +- 0.49 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=22931248).
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 14,15
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T13 ! OV-2295
OI   CVCL_9T14 ! OV-2295(R2)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   TOV-2414
AC   CVCL_A1SR
SY   TOV2414
DR   cancercelllines; CVCL_A1SR
DR   CancerTools; 161776
DR   Wikidata; Q105511234
RX   PubMed=32784519;
CC   Doubling time: 1.3 +- 0.2 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 13
ST   D21S11: 28,30
ST   D5S818: 9,11
ST   D7S820: 9,10
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   TOV-2835EP
AC   CVCL_A1SJ
SY   TOV2835EP
DR   cancercelllines; CVCL_A1SJ
DR   CancerTools; 161777
DR   Wikidata; Q105511237
RX   PubMed=32784519;
CC   Doubling time: 2.4 +- 0.3 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281Tyr (c.841G>T); ClinVar=VCV000376585; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D21S11: 28,30
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 12
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   TOV-2881EP
AC   CVCL_A1SK
SY   TOV2881EP
DR   cancercelllines; CVCL_A1SK
DR   CancerTools; 161901
DR   Wikidata; Q105511240
RX   PubMed=32784519;
CC   Doubling time: 6.1 +- 1.7 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:23112; FAT3; Simple; p.Gly90Ala (c.286G>C); Zygosity=Unspecified (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg156Pro (c.467G>C); ClinVar=VCV000634768; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 12
ST   D21S11: 32.2,33.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   TOV-2929D
AC   CVCL_A1SL
SY   TOV2929D
DR   CancerTools; 161778
DR   Wikidata; Q105511243
RX   PubMed=32784519;
CC   Doubling time: 6.0 +- 1.1 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Tyr (c.725G>A); ClinVar=VCV000012354; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 28,30
ST   D5S818: 11,12
ST   D7S820: 10,11,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   TOV-2978G
AC   CVCL_9U73
SY   TOV2978G
DR   cancercelllines; CVCL_9U73
DR   CancerTools; 161779
DR   Wikidata; Q54972811
RX   PubMed=26622941;
CC   Doubling time: 1.87 +- 0.11 days (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920-2A>G (IVS8-2A>G); ClinVar=VCV000043595; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 30,33.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1SM ! OV-2978
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   TOV-3041G
AC   CVCL_9T24
SY   TOV3041G
DR   CancerTools; 161780
DR   Wikidata; Q54972813
RX   PubMed=26622941;
CC   Doubling time: 1.33 +- 0.02 days (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 9,11
ST   D21S11: 29
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TOV-3121EP
AC   CVCL_A1SN
SY   TOV3121EP
DR   CancerTools; 161902
DR   Wikidata; Q105511246
RX   PubMed=32784519;
CC   Doubling time: 3.0 +- 0.5 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:19291; CSMD3; Simple; p.Asn563Ser (c.1688A>G); Zygosity=Unspecified (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Leufs*33 (c.641delA); Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12
ST   D21S11: 30,32.2
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   TOV-3133D
AC   CVCL_9T19
SY   TOV3133D
DR   cancercelllines; CVCL_9T19
DR   CancerTools; 161899
DR   Wikidata; Q54972814
RX   PubMed=22931248;
CC   Doubling time: 2.63 +- 0.11 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Unspecified (PubMed=22931248).
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 13
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T15 ! OV-3133(R)
OI   CVCL_9T16 ! OV-3133(R2)
OI   CVCL_4064 ! TOV-3133G
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 13
//
ID   TOV-3133G
AC   CVCL_4064
DR   cancercelllines; CVCL_4064
DR   CancerTools; 161781
DR   GEO; GSM2475010
DR   Wikidata; Q54972815
RX   PubMed=22585861;
RX   PubMed=22931248;
RX   PubMed=28273451;
CC   Doubling time: 2.70 +- 0.15 days (PubMed=22931248).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln192Ter (c.574C>T); ClinVar=VCV000406579; Zygosity=Unspecified (PubMed=22931248; PubMed=28273451).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=22585861; Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 17,25
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 19
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T15 ! OV-3133(R)
OI   CVCL_9T16 ! OV-3133(R2)
OI   CVCL_9T19 ! TOV-3133D
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   TOV-3291G
AC   CVCL_9T25
SY   TOV3291G
DR   cancercelllines; CVCL_9T25
DR   CancerTools; 161784
DR   Wikidata; Q54972816
RX   PubMed=26622941;
CC   Doubling time: 2.28 +- 0.19 days (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:24224; CDK12; Simple; c.3095+1G>A; dbSNP=rs2146575887; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=26622941).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Trp (c.745A>T); ClinVar=VCV000141881; Zygosity=Unspecified (PubMed=26622941).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1SP ! OV-3291
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   TOV-3392D
AC   CVCL_A1SS
SY   TOV3392D
DR   cancercelllines; CVCL_A1SS
DR   CancerTools; 161786
DR   Wikidata; Q105511248
RX   PubMed=32784519;
CC   Doubling time: 2.1 +- 0.4 days (PubMed=32784519).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (PubMed=32784519).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D21S11: 28,30
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   TOV-81D
AC   CVCL_A453
DR   CancerTools; 161895
DR   IARC_TP53; 21095
DR   Wikidata; Q54972819
RX   PubMed=10949993;
RX   PubMed=11641787;
CC   Doubling time: 4-6 days (PubMed=10949993).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: STR profile from personal communication of Mes-Masson, Anne-Marie.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D21S11: 28,29
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   Tp 242-C
AC   CVCL_M419
DR   Wikidata; Q54972820
RX   PubMed=6306758;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   Tp 362-C
AC   CVCL_M420
DR   Wikidata; Q54972821
RX   PubMed=6306758;
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   TP-023
AC   CVCL_E6B5
SY   TP-023(I)
DR   ABM; T0841
DR   GEO; GSM1639693
RX   PubMed=26032749;
RX   PubMed=26599327;
CC   Karyotypic information: 46,XY,der(9)t(1;9)(q42.3);q34.3 (PubMed=26032749).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6B6 ! TP-023(SI)
SX   Male
AG   10Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   TP-023(SI)
AC   CVCL_E6B6
RX   PubMed=26032749;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E6B5 ! TP-023
SX   Male
AG   10Y
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TP-037
AC   CVCL_E6B7
DR   ABM; T0842
DR   GEO; GSM1639697
RX   PubMed=26599327;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   TP-040
AC   CVCL_E6B8
RX   PubMed=26599327;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   TP-053(SI)
AC   CVCL_E6B9
RX   PubMed=26032749;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TP-076
AC   CVCL_E6BA
DR   GEO; GSM1639701
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
CC   Cell type: Dental pulp stem cell; CL=CL_4030035.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   TP-1 [Mouse hybridoma against human ALPL]
AC   CVCL_E8HW
SY   TP1
DR   ABCD; ABCD_AO839
RX   PubMed=3522438;
RX   PubMed=37291203;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05186; Human ALPL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TP-1 [Tur putotira]
AC   CVCL_S160
SY   Tor Putitora-1
DR   Wikidata; Q54972823
RX   CelloPub=CLPUB00463;
RX   DOI=10.1016/j.aquaculture.2005.09.021;
CC   Group: Fish cell line.
CC   Doubling time: 28 hours (DOI=10.1016/j.aquaculture.2005.09.021).
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=210638; ! Tor putitora (Putitor mahseer)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 11
//
ID   TP-3 [Mouse hybridoma against human ALPL]
AC   CVCL_E8HX
SY   TP3
DR   ABCD; ABCD_AO840
RX   PubMed=3522438;
RX   PubMed=37291203;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P05186; Human ALPL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TP-3 [Rabbit hybridoma fusion partner]
AC   CVCL_J968
DR   Wikidata; Q54972824
RX   Patent=US4859595;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8761.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   TP-D5
AC   CVCL_XE88
DR   CCRID; 4201PAT-CCTCC00430
DR   Wikidata; Q98133501
RX   Patent=CN103740651B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013184.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   Tp(Kilifi)
AC   CVCL_B6MU
DR   Wikidata; Q112041801
RX   PubMed=1979317;
CC   Characteristics: Infected by Theileria parva isolate Kilifi.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   TP1
AC   CVCL_A9RJ
DR   Wikidata; Q102115001
RX   Patent=US5587287;
RX   PubMed=7518481;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19821; Thermus aquaticus polA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   TP1-12.2
AC   CVCL_A9RK
DR   Wikidata; Q102115003
RX   Patent=US5985619;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19821; Thermus aquaticus polA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9RJ ! TP1
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   TP106
AC   CVCL_E2RZ
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TP108
AC   CVCL_E2S0
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TP115
AC   CVCL_E2S1
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TP17
AC   CVCL_A685
DR   BTO; BTO_0002959
DR   Wikidata; Q54972825
RX   PubMed=10892885;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   Tp242MG
AC   CVCL_M432
SY   Tp-242MG; TP 242 MG
DR   Wikidata; Q54972826
RX   Patent=US5525626;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   Tp265MG
AC   CVCL_A686
SY   TP265MG; Tp-265MG
DR   Cosmic; 849854
DR   Cosmic; 1610743
DR   Wikidata; Q54972827
RX   PubMed=6601641;
RX   PubMed=19435942;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   Tp276MG
AC   CVCL_A687
SY   TP276MG; Tp-276MG
DR   cancercelllines; CVCL_A687
DR   Cosmic; 849848
DR   Cosmic; 1610746
DR   Wikidata; Q54972828
RX   PubMed=2469512;
RX   PubMed=6601641;
RX   PubMed=10560660;
RX   PubMed=19435942;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.His93Tyr (c.277C>T); ClinVar=VCV000646993; Zygosity=Unspecified (PubMed=10560660).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   Tp301MG
AC   CVCL_UH35
SY   Tp-301MG
DR   Wikidata; Q98133502
RX   PubMed=2469512;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   TP31
AC   CVCL_W950
DR   Cosmic; 986622
DR   Wikidata; Q54972829
RX   PubMed=10892885;
RX   PubMed=21647268;
CC   Omics: Transcriptomics; Suppression subtractive hybridization (SSH).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 27-11-25; Version: 9
//
ID   Tp323MG
AC   CVCL_UH31
SY   Tp-323MG
DR   Wikidata; Q98133504
RX   PubMed=6601641;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   Tp336MG
AC   CVCL_A688
SY   TP336MG; Tp-336MG; TP 336 MG
DR   Cosmic; 851221
DR   Cosmic; 1610747
DR   Wikidata; Q54972831
RX   Patent=US5525626;
RX   PubMed=6601641;
RX   PubMed=10560660;
RX   PubMed=19435942;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr27Asn (c.79T>A); ClinVar=VCV002735432; Zygosity=Unspecified (PubMed=10560660).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 15
//
ID   Tp347MG
AC   CVCL_UH32
SY   Tp-347MG
DR   Wikidata; Q98133505
RX   PubMed=6601641;
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   Tp364MG
AC   CVCL_UH33
SY   Tp-364MG
DR   Wikidata; Q98133506
RX   PubMed=6601641;
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   Tp365MG
AC   CVCL_A689
SY   TP365MG; Tp-365MG
DR   Cosmic; 849855
DR   Cosmic; 1610744
DR   Wikidata; Q54972832
RX   PubMed=6601641;
RX   PubMed=19435942;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   Tp378MG
AC   CVCL_M433
SY   TP378MG; Tp-378MG
DR   Wikidata; Q54972833
RX   PubMed=2469512;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Tp385MG
AC   CVCL_UH34
SY   Tp-385MG
DR   Wikidata; Q98133507
RX   PubMed=6601641;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 21-03-23; Version: 4
//
ID   TP4
AC   CVCL_A9RH
DR   Wikidata; Q102115004
RX   Patent=US5587287;
RX   PubMed=7518481;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11126.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19821; Thermus aquaticus polA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   TP4-9.2
AC   CVCL_A9RL
DR   ATCC; HB-11807
DR   Wikidata; Q102115005
RX   Patent=US5985619;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11807.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19821; Thermus aquaticus polA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A9RH ! TP4
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   Tp410N
AC   CVCL_M434
SY   TP410N; TP 410 N; Tp-410
DR   Wikidata; Q54972834
RX   Patent=US5525626;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   Tp483MG
AC   CVCL_A690
SY   TP483MG; Tp-483MG
DR   cancercelllines; CVCL_A690
DR   Cosmic; 849846
DR   Cosmic; 1610745
DR   Wikidata; Q54972836
RX   PubMed=2469512;
RX   PubMed=10560660;
RX   PubMed=19435942;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly36Glu (c.107G>A); ClinVar=VCV000486972; Zygosity=Unspecified (PubMed=10560660).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.210-39A>G (IVS3-39A>G); ClinVar=VCV000255812; Zygosity=Unspecified (PubMed=10560660).
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   TP8
AC   CVCL_E2S2
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TP9
AC   CVCL_A9RI
DR   ATCC; HB-11127
DR   Wikidata; Q102115006
RX   Patent=US5587287;
RX   PubMed=7518481;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11127.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P19821; Thermus aquaticus polA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   TPA1-148
AC   CVCL_XA80
DR   Wikidata; Q98133508
RX   PubMed=1713912;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   TPA1-39
AC   CVCL_XA81
DR   Wikidata; Q98133510
RX   PubMed=1713912;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   TPA1-41
AC   CVCL_XA82
SY   TPA 1-41
DR   CCRID; 4201PAT-CCTCC00059
DR   JCRB; IFO50178
DR   Wikidata; Q98133512
RX   DOI=10.1038/nbt1189-1163;
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1713912;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2085.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Discontinued: JCRB; IFO50178; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   TPA1-70
AC   CVCL_XA83
SY   TPA 1-70
DR   CCRID; 4201PAT-CCTCC00060
DR   JCRB; IFO50179
DR   Wikidata; Q98133513
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1713912;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2086.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
CC   Discontinued: JCRB; IFO50179; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   TPA2-135
AC   CVCL_XA84
DR   Wikidata; Q98133515
RX   PubMed=1713912;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   TPA2-14
AC   CVCL_XA85
SY   TPA 2-14
DR   CCRID; 4201PAT-CCTCC00063
DR   JCRB; IFO50194
DR   Wikidata; Q98133517
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1713912;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2519.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
CC   Discontinued: JCRB; IFO50194; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   TPA2-6
AC   CVCL_XA86
DR   Wikidata; Q98133518
RX   PubMed=1713912;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P00750; Human PLAT.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 3
//
ID   TPA30-4
AC   CVCL_H690
DR   Wikidata; Q54972837
RX   PubMed=6274452;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts30).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   TPA30-6
AC   CVCL_H646
DR   Wikidata; Q54972838
RX   PubMed=206898;
RX   PubMed=6265484;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=ts30).
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2820 ! 3A(tPA-30-1)
OI   CVCL_H645 ! TPWT-2
SX   Female
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   TPB11 (DNAVEC)
AC   CVCL_RH57
SY   TPB11 [DNAVEC]; TPB11(DNAVEC)
DR   SKIP; SKIP000837
DR   Wikidata; Q54972840
RX   PubMed=26905201;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX90 ! PB(T-cell)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TPB27 (DNAVEC)
AC   CVCL_RH58
SY   TPB27 [DNAVEC]; TPB27(DNAVEC)
DR   SKIP; SKIP000838
DR   Wikidata; Q54972841
RX   PubMed=26905201;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX90 ! PB(T-cell)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TPB4 (DNAVEC)
AC   CVCL_RH59
SY   TPB4 [DNAVEC]; TPB4(DNAVEC); TiPS_TPB4
DR   GEO; GSM2038551
DR   SKIP; SKIP000835
DR   Wikidata; Q52059961
RX   PubMed=26905201;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX90 ! PB(T-cell)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   TPB8 (DNAVEC)
AC   CVCL_RH60
SY   TPB8 [DNAVEC]; TPB8(DNAVEC); TiPS_TPB8; TPB8
DR   GEO; GSM2038552
DR   SKIP; SKIP000836
DR   Wikidata; Q54972843
RX   PubMed=26905201;
RX   PubMed=27716287;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX90 ! PB(T-cell)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   TPC-1
AC   CVCL_6298
SY   TPC1
DR   BTO; BTO_0006508
DR   EFO; EFO_0022629
DR   BCRJ; 0397
DR   ChEMBL-Cells; CHEMBL3308064
DR   ChEMBL-Targets; CHEMBL613836
DR   CLS; 305054
DR   Cosmic; 686571
DR   Cosmic; 686572
DR   Cosmic; 686728
DR   Cosmic; 849969
DR   Cosmic; 931238
DR   Cosmic; 1021385
DR   Cosmic; 1084277
DR   Cosmic; 1132593
DR   Cosmic; 1152124
DR   Cosmic; 1237448
DR   Cosmic; 1239954
DR   Cosmic; 1280041
DR   Cosmic; 2036695
DR   Cosmic; 2054096
DR   Cosmic; 2319845
DR   Cosmic; 2613255
DR   IARC_TP53; 25009
DR   Millipore; SCC147
DR   PubChem_Cell_line; CVCL_6298
DR   TOKU-E; 4065
DR   Wikidata; Q54972844
RX   PubMed=2334411;
RX   PubMed=2516841;
RX   PubMed=2823470;
RX   PubMed=7491517;
RX   PubMed=11439348;
RX   PubMed=14522906;
RX   PubMed=15980887;
RX   PubMed=16778181;
RX   PubMed=17725429;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=19087340;
RX   PubMed=21868764;
RX   PubMed=22087789;
RX   PubMed=23162534;
RX   PubMed=23833040;
RX   PubMed=30737244;
RX   PubMed=36599897;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:18782; CCDC6 + HGNC; HGNC:9967; RET; Name(s)=CCDC6-RET, RET/PTC1 (PubMed=7491517; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala68fs (c.204_208delGGAGC); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Gln1089Ter (c.3265C>T); Zygosity=Heterozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Millipore=SCC147; PubMed=18713817; PubMed=21868764; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13,16
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 8,10
ST   D7S820: 11
ST   D8S1179: 11,17
ST   FGA: 20,21
ST   Penta D: 9,13
ST   Penta E: 18
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   TPC101
AC   CVCL_E2RP
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC104
AC   CVCL_E2RQ
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC108
AC   CVCL_E2RR
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC110
AC   CVCL_E2RS
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC117
AC   CVCL_E2RT
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC201
AC   CVCL_E2RU
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC206
AC   CVCL_E2RV
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC213
AC   CVCL_E2RW
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC413
AC   CVCL_E2RX
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPC417
AC   CVCL_E2RY
RX   PubMed=26090594;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P19429; Human TNNI3 (Note=Reacts with the N-terminal half of TNNI3 that is stable in human blood).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TPF-10-741
AC   CVCL_A1FD
DR   cancercelllines; CVCL_A1FD
DR   Cosmic; 2757122
DR   Wikidata; Q102115007
RX   PubMed=24732172;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=24732172).
CC   Derived from site: Metastatic; Cutaneous; UBERON=UBERON_0000014.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   TPH1
AC   CVCL_B6EP
DR   Wikidata; Q112041802
RX   PubMed=10814584;
CC   Transformant: NCBI_TaxID; 3052230; Hepatitis C virus.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   Tpit/E
AC   CVCL_U899
DR   CLO; CLO_0051605
DR   RCB; RCB1692
DR   Wikidata; Q54972845
RX   PubMed=11014214;
RX   PubMed=24881870;
CC   Doubling time: 28.6 hours (PubMed=24881870).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pituitary gland, adenohypophysis; UBERON=UBERON_0002196.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Conditionally immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   Tpit/F1
AC   CVCL_S513
DR   CLO; CLO_0050227
DR   RCB; RCB1691
DR   Wikidata; Q54972846
RX   PubMed=11014214;
RX   PubMed=15541569;
RX   PubMed=24881870;
CC   Doubling time: 31.6 hours (PubMed=24881870).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pituitary gland, adenohypophysis; UBERON=UBERON_0002196.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1M
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   TPK-1
AC   CVCL_DE01
SY   Transformed Porcine Kidney-1
DR   Wikidata; Q54972847
RX   PubMed=14120333;
RX   PubMed=14206435;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 11
//
ID   TpM(409)
AC   CVCL_6D37
SY   TpM(D409)
DR   Wikidata; Q54972849
RX   PubMed=1979317;
CC   Characteristics: Infected by Theileria parva isolate Muguga.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TpM(588)
AC   CVCL_B6MT
SY   T. parva (588)
DR   Wikidata; Q112041803
RX   DOI=10.1007/978-94-009-8346-5_51;
CC   Characteristics: Infected by Theileria parva isolate Muguga.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TpM(803)
AC   CVCL_F840
SY   TpM803; T.p. M 803; 803 TPM; T. parva (803)
DR   Wikidata; Q54972850
RX   DOI=10.1007/978-94-009-8346-5_51;
RX   PubMed=1899385;
RX   PubMed=1979317;
RX   PubMed=3133661;
CC   Characteristics: Infected by Theileria parva isolate Muguga.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   TPM2-187
AC   CVCL_6D25
DR   RCB; AES2228
DR   SKIP; SKIP002944
DR   Wikidata; Q54972851
CC   Knockout cell: Method=Gene trap; MGI; MGI:1350933; Bcap31.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   TPM5-123
AC   CVCL_6D34
DR   RCB; AES2486
DR   SKIP; SKIP002945
DR   Wikidata; Q54972852
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444748; Chd7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   TPM6-180
AC   CVCL_6D35
DR   RCB; AES2641
DR   SKIP; SKIP002946
DR   Wikidata; Q54972853
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142330; Ppm1n.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   TPM6-360
AC   CVCL_6D36
DR   RCB; AES2764
DR   SKIP; SKIP002947
DR   Wikidata; Q54972854
CC   Knockout cell: Method=Gene trap; MGI; MGI:1313312; Khdrbs3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6D29 ! v6.4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   TPMab-1
AC   CVCL_D3EF
DR   Wikidata; Q127384398
RX   PubMed=32214089;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT (Note=With phospho p.Thr249).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   TPMab-3
AC   CVCL_D3EG
DR   Wikidata; Q127384401
RX   PubMed=35094384;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O14746; Human TERT (Note=With phospho p.Thr249).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   TPP1 F/F (#35027-1)
AC   CVCL_UE15
SY   TPP1 F/F(#35027-1)
DR   ATCC; CRL-3320
DR   Wikidata; Q98133520
RX   PubMed=19995905;
CC   Characteristics: Embryonic fibroblasts that have loxP sites on either side of the first-eighth coding exon of mouse Tpp1. Tpp1 knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3320).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   TPP1-iPS 1A
AC   CVCL_VK66
DR   Wikidata; Q98133521
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK67 ! TPP1-iPS 1B
OI   CVCL_VK68 ! TPP1-iPS 1C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   TPP1-iPS 1B
AC   CVCL_VK67
DR   Wikidata; Q98133522
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK66 ! TPP1-iPS 1A
OI   CVCL_VK68 ! TPP1-iPS 1C
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   TPP1-iPS 1C
AC   CVCL_VK68
DR   Wikidata; Q98133523
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK66 ! TPP1-iPS 1A
OI   CVCL_VK67 ! TPP1-iPS 1B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   TPP1-iPS 2A
AC   CVCL_VK69
DR   Wikidata; Q98133526
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK70 ! TPP1-iPS 2B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   TPP1-iPS 2B
AC   CVCL_VK70
DR   Wikidata; Q98133527
RX   PubMed=24271013;
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=24271013).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Heterozygous (PubMed=24271013).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VK69 ! TPP1-iPS 2A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   TPS
AC   CVCL_4328
SY   Trout Pronephric Stroma
DR   CLO; CLO_0009390
DR   ECACC; 96112839
DR   Wikidata; Q54972856
RX   DOI=10.1006/fsim.1995.0042;
RX   DOI=10.1006/fsim.1997.0121;
RX   PubMed=28374170;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   TPS-2
AC   CVCL_M749
SY   Trout Pronephric Stroma-2
DR   Wikidata; Q54972863
RX   PubMed=22634253;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   TPWT-2
AC   CVCL_H645
DR   Wikidata; Q54972864
RX   PubMed=206898;
CC   Derived from site: In situ; Placenta; UBERON=UBERON_0001987.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2820 ! 3A(tPA-30-1)
OI   CVCL_H646 ! TPA30-6
SX   Female
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   TR 310
AC   CVCL_9239
DR   CLO; CLO_0009391
DR   ATCC; HB-219
DR   Wikidata; Q54972865
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   TR-1
AC   CVCL_A2JT
SY   TR1
DR   Wikidata; Q105511251
RX   PubMed=6544874;
RX   PubMed=7046561;
CC   Doubling time: 24 hours (PubMed=7046561).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   30D
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   TR-Ag-9-HPRT-
AC   CVCL_F740
DR   CLO; CLO_0009400
DR   CLDB; cl4537
DR   Wikidata; Q54972866
CC   Derived from site: In situ; Fetal trachea; UBERON=UBERON_0003126.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Undefined cell line type
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   TR-AST1
AC   CVCL_6B51
DR   Wikidata; Q54972867
RX   PubMed=11699636;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-AST2
AC   CVCL_6B52
DR   Wikidata; Q54972868
RX   PubMed=11699636;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-AST3
AC   CVCL_6B53
DR   Wikidata; Q54972869
RX   PubMed=11699636;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-AST4
AC   CVCL_6B54
DR   Wikidata; Q54972870
RX   PubMed=11699636;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-AST5
AC   CVCL_6B55
DR   Wikidata; Q54972871
RX   PubMed=11699636;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Astrocyte; CL=CL_0000127.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BBB1
AC   CVCL_5U70
SY   TR-BBB 1
DR   Wikidata; Q54972872
RX   Patent=US20020045254;
RX   PubMed=11328662;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Capillary endothelial cell; CL=CL_0002144.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U71 ! TR-BBB5
OI   CVCL_5U72 ! TR-BBB6
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BBB11
AC   CVCL_5U73
SY   TR-BBB 11
DR   Wikidata; Q54972873
RX   Patent=US20020045254;
RX   PubMed=11328662;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Capillary endothelial cell; CL=CL_0002144.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U74 ! TR-BBB13
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BBB13
AC   CVCL_5U74
SY   TR-BBB 13
DR   Wikidata; Q54972876
RX   Patent=US20020045254;
RX   PubMed=11328662;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Capillary endothelial cell; CL=CL_0002144.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U73 ! TR-BBB11
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BBB5
AC   CVCL_5U71
SY   TR-BBB 5
DR   Wikidata; Q54972877
RX   Patent=US20020045254;
RX   PubMed=11328662;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Capillary endothelial cell; CL=CL_0002144.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U70 ! TR-BBB1
OI   CVCL_5U72 ! TR-BBB6
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BBB6
AC   CVCL_5U72
SY   TR-BBB 6
DR   Wikidata; Q54972878
RX   Patent=US20020045254;
RX   PubMed=11328662;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, cerebrum; UBERON=UBERON_0001893.
CC   Cell type: Capillary endothelial cell; CL=CL_0002144.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U70 ! TR-BBB1
OI   CVCL_5U71 ! TR-BBB5
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BE
AC   CVCL_6C36
DR   Wikidata; Q54972879
RX   PubMed=16773315;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Inferior vena cava; UBERON=UBERON_0001072.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 EGFP transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BME clone 2
AC   CVCL_5U63
DR   Wikidata; Q54972880
RX   PubMed=11336358;
RX   PubMed=11520047;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U64 ! TR-BME clone 3
OI   CVCL_5U65 ! TR-BME clone 8
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BME clone 3
AC   CVCL_5U64
DR   Wikidata; Q54972881
RX   PubMed=11336358;
RX   PubMed=11520047;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U63 ! TR-BME clone 2
OI   CVCL_5U65 ! TR-BME clone 8
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-BME clone 8
AC   CVCL_5U65
DR   Wikidata; Q54972882
RX   PubMed=11336358;
RX   PubMed=11520047;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U63 ! TR-BME clone 2
OI   CVCL_5U64 ! TR-BME clone 3
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-CSFB1
AC   CVCL_F923
SY   TR-CSFB 1
DR   Wikidata; Q54972883
RX   Patent=US20020045254;
RX   PubMed=11336348;
RX   PubMed=11520047;
RX   PubMed=17233813;
RX   PubMed=18162136;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell of choroid plexus; CL=CL_0000706.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F924 ! TR-CSFB2
OI   CVCL_F925 ! TR-CSFB3
OI   CVCL_F926 ! TR-CSFB4
OI   CVCL_F927 ! TR-CSFB5
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-CSFB2
AC   CVCL_F924
SY   TR-CSFB 2
DR   Wikidata; Q54972884
RX   Patent=US20020045254;
RX   PubMed=11336348;
RX   PubMed=11520047;
RX   PubMed=17233813;
RX   PubMed=18162136;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell of choroid plexus; CL=CL_0000706.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F923 ! TR-CSFB1
OI   CVCL_F925 ! TR-CSFB3
OI   CVCL_F926 ! TR-CSFB4
OI   CVCL_F927 ! TR-CSFB5
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-CSFB3
AC   CVCL_F925
SY   TR-CSFB 3
DR   Wikidata; Q54972885
RX   Patent=US20020045254;
RX   PubMed=11336348;
RX   PubMed=11520047;
RX   PubMed=17233813;
RX   PubMed=18162136;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6508.
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell of choroid plexus; CL=CL_0000706.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F923 ! TR-CSFB1
OI   CVCL_F924 ! TR-CSFB2
OI   CVCL_F926 ! TR-CSFB4
OI   CVCL_F927 ! TR-CSFB5
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TR-CSFB4
AC   CVCL_F926
SY   TR-CSFB 4
DR   Wikidata; Q54972886
RX   Patent=US20020045254;
RX   PubMed=11336348;
RX   PubMed=11520047;
RX   PubMed=17233813;
RX   PubMed=18162136;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell of choroid plexus; CL=CL_0000706.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F923 ! TR-CSFB1
OI   CVCL_F924 ! TR-CSFB2
OI   CVCL_F925 ! TR-CSFB3
OI   CVCL_F927 ! TR-CSFB5
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-CSFB5
AC   CVCL_F927
SY   TR-CSFB 5
DR   Wikidata; Q54972888
RX   Patent=US20020045254;
RX   PubMed=11336348;
RX   PubMed=11520047;
RX   PubMed=17233813;
RX   PubMed=18162136;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell of choroid plexus; CL=CL_0000706.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_F923 ! TR-CSFB1
OI   CVCL_F924 ! TR-CSFB2
OI   CVCL_F925 ! TR-CSFB3
OI   CVCL_F926 ! TR-CSFB4
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-iBRB2
AC   CVCL_J379
DR   Wikidata; Q54972890
RX   Patent=US20020045254;
RX   PubMed=11161732;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-6507.
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_5U66 ! TR-iBRB4
OI   CVCL_5U67 ! TR-iBRB6
OI   CVCL_5U68 ! TR-iBRB8
OI   CVCL_5U69 ! TR-iBRB9
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TR-iBRB4
AC   CVCL_5U66
DR   Wikidata; Q54972891
RX   Patent=US20020045254;
RX   PubMed=11161732;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_J379 ! TR-iBRB2
OI   CVCL_5U67 ! TR-iBRB6
OI   CVCL_5U68 ! TR-iBRB8
OI   CVCL_5U69 ! TR-iBRB9
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-iBRB6
AC   CVCL_5U67
DR   Wikidata; Q54972892
RX   Patent=US20020045254;
RX   PubMed=11161732;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_J379 ! TR-iBRB2
OI   CVCL_5U66 ! TR-iBRB4
OI   CVCL_5U68 ! TR-iBRB8
OI   CVCL_5U69 ! TR-iBRB9
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-iBRB8
AC   CVCL_5U68
DR   Wikidata; Q54972893
RX   Patent=US20020045254;
RX   PubMed=11161732;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_J379 ! TR-iBRB2
OI   CVCL_5U66 ! TR-iBRB4
OI   CVCL_5U67 ! TR-iBRB6
OI   CVCL_5U69 ! TR-iBRB9
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-iBRB9
AC   CVCL_5U69
DR   Wikidata; Q54972894
RX   Patent=US20020045254;
RX   PubMed=11161732;
RX   PubMed=11520047;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_J379 ! TR-iBRB2
OI   CVCL_5U66 ! TR-iBRB4
OI   CVCL_5U67 ! TR-iBRB6
OI   CVCL_5U68 ! TR-iBRB8
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-IL2-NK-92
AC   CVCL_B3PC
DR   Wikidata; Q110433285
RX   PubMed=9573023;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 8
//
ID   TR-IL2-YT
AC   CVCL_B3PD
DR   Wikidata; Q110433286
RX   PubMed=9573023;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1JN ! YT clone 2C2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   TR-LCC-1
AC   CVCL_IU63
SY   LCC
DR   CCRID; 1101HUM-PUMC000483
DR   Wikidata; Q54972895
RX   PubMed=28104015;
CC   Population: Chinese.
CC   Doubling time: 201.2 hours (PubMed=28104015).
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): CCRID=1101HUM-PUMC000483; PubMed=28104015
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 20,23
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 14,18
ST   D7S820: 8
ST   D8S1179: 14,17
ST   FGA: 25
ST   Penta E: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9CG ! TR-LNN-1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 11
//
ID   TR-LE
AC   CVCL_6C37
DR   Wikidata; Q54972896
RX   PubMed=16773315;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Thoracic duct; UBERON=UBERON_0001631.
CC   Cell type: Endothelial cell of lymphatic vessel; CL=CL_0002138.
CC   Breed/subspecies: Wistar SV40-tsA58 EGFP transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-LNN-1
AC   CVCL_A9CG
SY   LNN
DR   CCRID; 1101HUM-PUMC000515
DR   Wikidata; Q108821379
CC   Population: Chinese.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): CCRID=1101HUM-PUMC000515
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 20,23
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 14,18
ST   D7S820: 8
ST   D8S1179: 14,17
ST   FGA: 25
ST   Penta E: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IU63 ! TR-LCC-1
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   TR-M
AC   CVCL_A2JU
DR   Wikidata; Q105511254
RX   PubMed=6544874;
RX   PubMed=7046561;
CC   Doubling time: 36 hours (PubMed=7046561).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Peritubular myoid cell; CL=CL_0002481.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A2JV ! TR-ST
SX   Male
AG   2Y
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   TR-MUL1
AC   CVCL_5U77
DR   Wikidata; Q54972897
RX   PubMed=12898700;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   TR-MUL2
AC   CVCL_5U78
DR   Wikidata; Q54972898
RX   PubMed=12898700;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   TR-MUL3
AC   CVCL_5U79
DR   Wikidata; Q54972899
RX   PubMed=12898700;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   TR-MUL4
AC   CVCL_5U80
DR   Wikidata; Q54972900
RX   PubMed=12898700;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   TR-MUL5
AC   CVCL_J380
DR   Wikidata; Q54972902
RX   PubMed=12898700;
RX   PubMed=17233813;
CC   Doubling time: 30.0 +- 0.6 hours (Note=At 33 Celsius), 46.3 +- 1.9 hours (Note=At 37 Celsius) (PubMed=12898700).
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 27-11-25; Version: 14
//
ID   TR-PCT1
AC   CVCL_6B56
DR   Wikidata; Q54972903
RX   PubMed=11998866;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Pericyte; CL=CL_0000669.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   16W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-rPCT1
AC   CVCL_J381
DR   Wikidata; Q54972904
RX   PubMed=12951435;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Pericyte; CL=CL_0000669.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-rPCT2
AC   CVCL_5U75
DR   Wikidata; Q54972905
RX   PubMed=12951435;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Pericyte; CL=CL_0000669.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-rPCT3
AC   CVCL_J382
DR   Wikidata; Q54972906
RX   PubMed=12951435;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Pericyte; CL=CL_0000669.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-rPCT4
AC   CVCL_J383
DR   Wikidata; Q54972907
RX   PubMed=12951435;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Pericyte; CL=CL_0000669.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TR-rPCT5
AC   CVCL_5U76
DR   Wikidata; Q54972917
RX   PubMed=12951435;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Eye, retina, capillary; UBERON=UBERON_0003501.
CC   Cell type: Pericyte; CL=CL_0000669.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-SIE1
AC   CVCL_6C38
DR   Wikidata; Q54972918
RX   PubMed=15499194;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-SIE2
AC   CVCL_6C39
DR   Wikidata; Q54972919
RX   PubMed=15499194;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Small intestine, ileum; UBERON=UBERON_0002116.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   4W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-ST
AC   CVCL_A2JV
DR   Wikidata; Q105511257
RX   PubMed=6544874;
RX   PubMed=7046561;
CC   Characteristics: Tumorigenic in BALB/c nu/nu mice.
CC   Doubling time: 10 hours (PubMed=7046561).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: Long-Evans; RS=RS_0000347.
DI   NCIt; C64058; Malignant Sertoli cell tumor of the rat testis
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_A2JU ! TR-M
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   TR-TBT 18d-1
AC   CVCL_6B14
DR   Wikidata; Q54972920
RX   PubMed=12384998;
RX   PubMed=17233813;
RX   PubMed=18329095;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Syncytiotrophoblast; UBERON=UBERON_0000371.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_6B15 ! TR-TBT 18d-2
OI   CVCL_6B16 ! TR-TBT 18d-3
OI   CVCL_6B17 ! TR-TBT 18d-4
SX   Sex unspecified
AG   18FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-TBT 18d-2
AC   CVCL_6B15
DR   Wikidata; Q54972921
RX   PubMed=12384998;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Syncytiotrophoblast; UBERON=UBERON_0000371.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_6B14 ! TR-TBT 18d-1
OI   CVCL_6B16 ! TR-TBT 18d-3
OI   CVCL_6B17 ! TR-TBT 18d-4
SX   Sex unspecified
AG   18FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-TBT 18d-3
AC   CVCL_6B16
DR   Wikidata; Q54972922
RX   PubMed=12384998;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Syncytiotrophoblast; UBERON=UBERON_0000371.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_6B14 ! TR-TBT 18d-1
OI   CVCL_6B15 ! TR-TBT 18d-2
OI   CVCL_6B17 ! TR-TBT 18d-4
SX   Sex unspecified
AG   18FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR-TBT 18d-4
AC   CVCL_6B17
DR   Wikidata; Q54972923
RX   PubMed=12384998;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Syncytiotrophoblast; UBERON=UBERON_0000371.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_6B14 ! TR-TBT 18d-1
OI   CVCL_6B15 ! TR-TBT 18d-2
OI   CVCL_6B16 ! TR-TBT 18d-3
SX   Sex unspecified
AG   18FD
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TR126
AC   CVCL_J955
SY   TR 126
DR   Wikidata; Q54972924
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2413234;
CC   Doubling time: 21 hours (PubMed=2413234).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   TR131
AC   CVCL_J954
SY   TR 131
DR   Wikidata; Q54972925
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2413234;
CC   Doubling time: 34 hours (PubMed=2413234).
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   TR138
AC   CVCL_J953
SY   TR 138; TR-138
DR   Wikidata; Q54972926
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2413234;
CC   Doubling time: 22 hours (PubMed=2413234).
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 11
//
ID   TR14
AC   CVCL_B474
SY   TR-14
DR   Cosmic; 1109113
DR   Cosmic; 1518080
DR   Cosmic; 1526657
DR   Cosmic; 2239466
DR   GEO; GSM692868
DR   IARC_TP53; 23836
DR   Wikidata; Q54972929
RX   PubMed=6144383;
RX   PubMed=6861117;
RX   PubMed=7838528;
RX   PubMed=9283597;
RX   PubMed=9516836;
RX   PubMed=20655465;
RX   PubMed=22213050;
RX   PubMed=39255063;
CC   Doubling time: 3 days (PubMed=6861117).
CC   Omics: Genomics; Extrachromosomal circular DNA (scEC); Single cell.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Miscellaneous: STR profile from personal communication of Henssen, Anton George & Roefzaad, Claudia.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11,12,13
ST   D13S317: 10,11
ST   D16S539: 10,11,12
ST   D18S51: 12,15,16
ST   D19S433: 12,13
ST   D21S11: 28,29,30,31,32
ST   D2S1338: 18,23
ST   D3S1358: 17
ST   D5S818: 11,12,13,14
ST   D7S820: 10,11,12
ST   D8S1179: 14,15,16,17
ST   FGA: 19,20,21,22
ST   TH01: 6,7
ST   TPOX: 9,11,12
ST   vWA: 14
DI   NCIt; C4827; Adrenal gland neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   TR146
AC   CVCL_2736
SY   Tr146; TR-146; TR 146
DR   BTO; BTO_0002718
DR   CancerTools; 151425
DR   Cosmic; 948039
DR   Cosmic; 2131857
DR   DepMap; ACH-001675
DR   ECACC; 10032305
DR   Wikidata; Q54972930
DR   Ximbio; 151425
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2413234;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 22 hours (PubMed=2413234).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Homozygous (DepMap=ACH-001675).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: ECACC; 10032305; true.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): DepMap=ACH-001675; ECACC=10032305; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,14
ST   D16S539: 13
ST   D18S51: 22
ST   D21S11: 30,33.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 10,12
ST   Penta E: 13,17
ST   TH01: 6,9 (DepMap=ACH-001675)
ST   TH01: 9 (ECACC=10032305; PubMed=21868764)
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   TR170
AC   CVCL_B475
SY   TR-170
DR   Wikidata; Q54972931
RX   PubMed=3804493;
CC   Doubling time: 31 +- 2 hours (PubMed=3804493).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   TR175
AC   CVCL_B476
SY   TR-175
DR   cancercelllines; CVCL_B476
DR   Cosmic; 991331
DR   Cosmic; 1524351
DR   GEO; GSM459651
DR   Progenetix; CVCL_B476
DR   Wikidata; Q54972932
RX   PubMed=3804493;
CC   Doubling time: 34 +- 1 hours (PubMed=3804493).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 11
//
ID   TR30-9
AC   CVCL_WY39
DR   Wikidata; Q98133528
RX   PubMed=16520097;
CC   Population: Lebanese.
CC   Characteristics: Wild type transfected POLH can be expressed upon addition of tetracycline.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ala35fs (c.104_116del); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9181; POLH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7395 ! XP30RO
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   TR33B
AC   CVCL_4329
DR   CLO; CLO_0009392
DR   CLDB; cl4538
DR   ECACC; 85040102
DR   Wikidata; Q54972933
RX   PubMed=1093176;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Spinal cord; UBERON=UBERON_0002240.
CC   Breed/subspecies: Wistar Furth; RS=RS_0000982.
DI   NCIt; C60461; Rat malignant oligodendroglioma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   TR5214-2
AC   CVCL_C9C5
DR   Wikidata; Q123033636
RX   PubMed=11070089;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TR6.1/52b
AC   CVCL_V133
DR   CLO; CLO_0009393
DR   CLDB; cl4539
DR   IHW; 11w 8133
DR   Wikidata; Q54972934
CC   Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   TR6Bc1
AC   CVCL_4330
SY   TR6B clone 1
DR   CLO; CLO_0009394
DR   CLDB; cl4540
DR   ECACC; 85042301
DR   Wikidata; Q54972935
RX   PubMed=1093176;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Peripheral nervous system, cranial nerve, trigeminal nerve; UBERON=UBERON_0001645.
CC   Cell type: Schwann cell; CL=CL_0002573.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C21997; Mouse schwannoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   TR9-7
AC   CVCL_IM77
SY   Tr9-7
DR   GEO; GSE7101
DR   Wikidata; Q54972936
RX   PubMed=7667317;
RX   PubMed=16966095;
CC   Characteristics: Expresses wild-type TP53 under the control of a tetracycline-regulated promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3476; Li-Fraumeni syndrome
DI   ORDO; Orphanet_524; Li-Fraumeni syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E212 ! MDAH041
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 11
//
ID   TRA-1-60
AC   CVCL_A1QS
SY   Tra-1-60; TRA-1-60 cl.A
DR   Wikidata; Q105511260
RX   PubMed=6396197;
RX   PubMed=21159783;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma along with that produced by TRA-1-81 (Cellosaurus=CVCL_A1QT) are widely used in human stem cell research as positive indicators of a true pluripotent human stem cell.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Type 1 lactosamine minimal epitope Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAc (Note=Recognizes human podocalyxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 5
//
ID   TRA-1-81
AC   CVCL_A1QT
SY   Tra-1-81; TRA-1-81 cl.26
DR   Wikidata; Q105511263
RX   PubMed=6396197;
RX   PubMed=21159783;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma along with that produced by TRA-1-60 (Cellosaurus=CVCL_A1QS) are widely used in human stem cell research as positive indicators of a true pluripotent human stem cell.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Type 1 lactosamine minimal epitope Galbeta1-3GlcNAcbeta1-3Galbeta1-4GlcNAc (Note=Recognizes human podocalyxin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 5
//
ID   TRA-147
AC   CVCL_1B65
DR   Wikidata; Q54972937
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1093/jmedent/18.2.140;
CC   Group: Insect cell line.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   TRA-171
AC   CVCL_Z235
SY   Tra-171; TRA171
DR   CLO; CLO_0009399
DR   CLDB; cl4543
DR   ATCC; CRL-1591
DR   ECACC; 90120514
DR   Wikidata; Q54972938
RX   DOI=10.1007/BF02619328;
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   PubMed=6126465;
RX   PubMed=6137452;
CC   Group: Insect cell line.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 9
//
ID   TRA-272
AC   CVCL_1B66
DR   Wikidata; Q54972939
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1093/jmedent/18.2.140;
CC   Group: Insect cell line.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   TRA-284
AC   CVCL_Z986
SY   Tra-284; TRA 284; TRA284
DR   Wikidata; Q54972941
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1093/jmedent/18.2.140;
RX   PubMed=2563994;
RX   PubMed=2861916;
RX   PubMed=6130104;
RX   PubMed=7636489;
CC   Group: Insect cell line.
CC   Virology: Infected by Toxorhynchites amboinensis densonucleosis virus (TaDNV) (PubMed=7636489).
CC   Misspelling: TRA-248; Note=Occasionally.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 10
//
ID   TRA-284-SF
AC   CVCL_Z987
SY   TRA-284-Serum Free
DR   Wikidata; Q54972942
RX   PubMed=2861916;
RX   PubMed=6130104;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
CC   Misspelling: TRA-28F-SF; PubMed=6130104; Note=In abstract.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
HI   CVCL_Z986 ! TRA-284
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   TRA-284-SFG
AC   CVCL_VN80
DR   Wikidata; Q98133529
RX   PubMed=3323582;
CC   Group: Insect cell line.
CC   Group: Serum/protein free medium cell line.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
HI   CVCL_Z987 ! TRA-284-SF
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   TRA-293
AC   CVCL_1B67
DR   Wikidata; Q54972943
RX   DOI=10.1016/B978-0-12-007903-2.50013-1;
RX   DOI=10.1093/jmedent/18.2.140;
CC   Group: Insect cell line.
OX   NCBI_TaxID=46208; ! Toxorhynchites amboinensis (Mosquito)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 7
//
ID   TRA-8
AC   CVCL_B3SG
DR   Wikidata; Q110433287
RX   PubMed=11479629;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; O14763; Human TNFRSF10B/CD262.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   TRACHT
AC   CVCL_E856
DR   dbMHC; 49047
DR   IHW; IHW09350
DR   IPD-IMGT/HLA; 11494
DR   Wikidata; Q54972944
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: DPB1*03:01,02:01; DQA1*01:01,01:02; DQB1*05:01,06:09; DRB1*01:01,13:02 (IPD-IMGT/HLA=11494).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   TRAMA
AC   CVCL_W398
DR   Wikidata; Q54972945
RX   CelloPub=CLPUB00019;
RX   PubMed=10936422;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 9
//
ID   TRAMP-C1
AC   CVCL_3614
DR   BTO; BTO_0005112
DR   CLO; CLO_0009401
DR   EFO; EFO_0022757
DR   ATCC; CRL-2730
DR   Wikidata; Q54972946
RX   PubMed=9269988;
RX   PubMed=25428506;
CC   Doubling time: 24.4 hours (PubMed=9269988).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3615 ! TRAMP-C2
OI   CVCL_3616 ! TRAMP-C3
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 16
//
ID   TRAMP-C1A
AC   CVCL_H593
SY   TRAMP.C1A; TRAMP C1A; C1A
DR   ChEMBL-Cells; CHEMBL3307772
DR   ChEMBL-Targets; CHEMBL614367
DR   PubChem_Cell_line; CVCL_H593
DR   Wikidata; Q54972947
RX   PubMed=11063747;
RX   PubMed=14559809;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3614 ! TRAMP-C1
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TRAMP-C1D
AC   CVCL_H594
SY   C1D
DR   Wikidata; Q54972948
RX   PubMed=11063747;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3614 ! TRAMP-C1
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   TRAMP-C2
AC   CVCL_3615
SY   TRAMP C2
DR   BTO; BTO_0005114
DR   CLO; CLO_0009402
DR   AddexBio; C0019006/5004
DR   ATCC; CRL-2731
DR   Wikidata; Q54972949
RX   PubMed=9269988;
CC   Doubling time: 25.4 hours (PubMed=9269988).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3614 ! TRAMP-C1
OI   CVCL_3616 ! TRAMP-C3
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   TRAMP-C2D
AC   CVCL_H596
SY   C2D; TR-C2D
DR   ChEMBL-Cells; CHEMBL3307920
DR   ChEMBL-Targets; CHEMBL614368
DR   PubChem_Cell_line; CVCL_H596
DR   Wikidata; Q54972950
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3615 ! TRAMP-C2
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TRAMP-C2G
AC   CVCL_H595
SY   C2G
DR   ChEMBL-Cells; CHEMBL3307817
DR   ChEMBL-Targets; CHEMBL613541
DR   PubChem_Cell_line; CVCL_H595
DR   Wikidata; Q54972951
RX   PubMed=11063747;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3615 ! TRAMP-C2
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TRAMP-C2H
AC   CVCL_H591
SY   C2H
DR   ChEMBL-Cells; CHEMBL3307609
DR   ChEMBL-Targets; CHEMBL614369
DR   PubChem_Cell_line; CVCL_H591
DR   Wikidata; Q54972953
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3615 ! TRAMP-C2
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   TRAMP-C2N
AC   CVCL_H592
SY   TRAMP.C2N; C2N
DR   Wikidata; Q54972954
RX   PubMed=14559809;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3615 ! TRAMP-C2
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   TRAMP-C3
AC   CVCL_3616
DR   BTO; BTO_0005113
DR   CLO; CLO_0009403
DR   ATCC; CRL-2732
DR   Wikidata; Q54972956
RX   PubMed=9269988;
CC   Doubling time: 37.3 hours (PubMed=9269988).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Breed/subspecies: C57BL/6-TgN(TRAMP)8247Ng.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_3614 ! TRAMP-C1
OI   CVCL_3615 ! TRAMP-C2
SX   Male
AG   32W
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   Tran/NS-1/1
AC   CVCL_D5FM
DR   Wikidata; Q127384402
RX   PubMed=2412946;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P50442; Rat Gatm.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   Tran/NS-1/3
AC   CVCL_D5FN
DR   Wikidata; Q127384403
RX   PubMed=2412946;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P50442; Rat Gatm.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   TRAR 60
AC   CVCL_VQ07
SY   TRAR60
DR   Wikidata; Q98133530
RX   PubMed=21863025;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   TrB12
AC   CVCL_B6SY
DR   Wikidata; Q112041804
RX   PubMed=2830209;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1.
CC   Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TrB50
AC   CVCL_B6V7
DR   Wikidata; Q112041805
RX   PubMed=2788637;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P04440; Human HLA-DPB1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TrBEp-1
AC   CVCL_UZ43
SY   TrBEp 1; TracheoBronchial Epithelial-1
DR   Wikidata; Q98133531
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Derived from site: In situ; Lung, bronchus, tracheobronchial epithelium; UBERON=UBERON_0008397.
CC   Cell type: Epithelial cell of tracheobronchial tree; CL=CL_0002202.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   TrBEp-1/bmi1/TERT
AC   CVCL_UZ44
DR   Wikidata; Q98133532
RX   PubMed=19489101;
WW   Provider; BWH dermatology; -; https://dermatology.bwh.harvard.edu/docs/Cell-Culture-Core-Cell-Lines.pdf
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung, bronchus, tracheobronchial epithelium; UBERON=UBERON_0008397.
CC   Cell type: Epithelial cell of tracheobronchial tree; CL=CL_0002202.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UZ43 ! TrBEp-1
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   TrC5
AC   CVCL_B6V8
DR   Wikidata; Q112041806
RX   PubMed=2464569;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3732 ! KR-12
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRD-1
AC   CVCL_6B63
DR   Wikidata; Q54972957
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-10
AC   CVCL_6B66
DR   Wikidata; Q54972958
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-12
AC   CVCL_6B67
DR   Wikidata; Q54972959
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-14
AC   CVCL_6B68
DR   Wikidata; Q54972960
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-15
AC   CVCL_6B69
DR   Wikidata; Q54972961
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-17
AC   CVCL_6B70
DR   Wikidata; Q54972969
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-19
AC   CVCL_6B71
DR   Wikidata; Q54972971
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-22
AC   CVCL_6B72
DR   Wikidata; Q54972972
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-24
AC   CVCL_6B73
DR   Wikidata; Q54972973
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-27
AC   CVCL_6B74
DR   Wikidata; Q54972974
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-29
AC   CVCL_6B75
DR   Wikidata; Q54972975
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-3
AC   CVCL_6B64
DR   Wikidata; Q54972976
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-33
AC   CVCL_6B76
DR   Wikidata; Q54972977
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-34
AC   CVCL_6B77
DR   Wikidata; Q54972978
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-35
AC   CVCL_6B78
DR   Wikidata; Q54972980
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-38
AC   CVCL_6B79
DR   Wikidata; Q54972981
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-4
AC   CVCL_6B65
DR   Wikidata; Q54972982
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-41
AC   CVCL_6B80
DR   Wikidata; Q54972984
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-42
AC   CVCL_6B81
DR   Wikidata; Q54972985
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-43
AC   CVCL_6B82
DR   Wikidata; Q54972986
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-44
AC   CVCL_6B83
DR   Wikidata; Q54972987
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-45
AC   CVCL_6B84
DR   Wikidata; Q54972988
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-49
AC   CVCL_6B85
DR   Wikidata; Q54972989
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-52
AC   CVCL_6B86
DR   Wikidata; Q54972990
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-58
AC   CVCL_6B87
DR   Wikidata; Q54972991
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-60
AC   CVCL_6B88
DR   Wikidata; Q54972992
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-61
AC   CVCL_6B89
DR   Wikidata; Q54972994
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-62
AC   CVCL_6B90
DR   Wikidata; Q54972995
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TRD-72
AC   CVCL_6B91
DR   Wikidata; Q54972996
RX   PubMed=21802454;
CC   Genetic integration: Method=Transgenic rat; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Dorsal root ganglion; UBERON=UBERON_0000044.
CC   Cell type: Neuron; CL=CL_0000540.
CC   Breed/subspecies: Wistar SV40-tsA58 transgenic.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   8-10W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   TrD3
AC   CVCL_B6SX
DR   Wikidata; Q112041807
RX   PubMed=1385373;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes HLA-Bw6 epitope).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRDSi001-A
AC   CVCL_VF05
SY   TRDS-Cardio-021
DR   BioSamples; SAMEA104620783
DR   hPSCreg; TRDSi001-A
DR   Wikidata; Q54972998
CC   From: Technion Research and Development Foundation; Haifa; Israel.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148368; Catecholaminergic polymorphic ventricular tachycardia type 2
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   TRDSi002-A
AC   CVCL_UL00
DR   BioSamples; SAMEA104620767
DR   hPSCreg; TRDSi002-A
DR   Wikidata; Q98133533
CC   From: Technion Research and Development Foundation; Haifa; Israel.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   TRDSi002-A-1
AC   CVCL_UL01
SY   TRDS-Cardio-ArcLight
DR   BioSamples; SAMEA104626297
DR   hPSCreg; TRDSi002-A-1
DR   Wikidata; Q98133534
CC   From: Technion Research and Development Foundation; Haifa; Israel.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UL00 ! TRDSi002-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   TRDSi003-A
AC   CVCL_VF06
SY   TRDS-Cardio-063
DR   BioSamples; SAMEA104620785
DR   hPSCreg; TRDSi003-A
DR   Wikidata; Q54972999
CC   From: Technion Research and Development Foundation; Haifa; Israel.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   TRDSi004-A
AC   CVCL_VF07
SY   TRDS-Cardio-012
DR   BioSamples; SAMEA104620787
DR   hPSCreg; TRDSi004-A
DR   Wikidata; Q54973001
CC   From: Technion Research and Development Foundation; Haifa; Israel.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   TrE11
AC   CVCL_B6V9
DR   Wikidata; Q112041808
RX   PubMed=2788637;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04440; Human HLA-DPB1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   Tree92
AC   CVCL_M659
SY   Tree 92; TREE-92
DR   JCRB; JCRB1781
DR   Wikidata; Q54973003
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8683996;
RX   PubMed=8704258;
RX   PubMed=8847894;
RX   PubMed=9454894;
RX   PubMed=12967475;
CC   Population: Japanese.
CC   Virology: EBV-negative.
CC   Doubling time: 35.4 hours (PubMed=8847894).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=9454894; PubMed=12967475).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: Indicated as originating from a 3 year old female patient in text of PubMed=8847894 and from a 9 month old in table 1 of same paper.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): JCRB=JCRB1781
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 10,13
ST   D5S818: 10,12
ST   D7S820: 13,14
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   Trex1-/- MEF
AC   CVCL_5A06
SY   MEF Trex1 KO; Trex1 KO cells; Trex1 KO
DR   CancerTools; 151558
DR   ECACC; 12021509
DR   Wikidata; Q54973004
DR   Ximbio; 151558
RX   PubMed=15254239;
RX   PubMed=18045533;
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1328317; Trex1.
CC   Discontinued: ECACC; 12021509; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/OlaHsd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 8
//
ID   TRF1 F/F
AC   CVCL_UE12
DR   ATCC; CRL-3316
DR   Wikidata; Q98133536
RX   PubMed=19596237;
CC   Characteristics: Embryonic fibroblasts that have loxP sites on both sides of the 1st coding exon of mouse Terf1 gene. Terf1 knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3316).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   TRF2 F/- Rosa26-CreERT2
AC   CVCL_UE13
DR   ATCC; CRL-3317
DR   Wikidata; Q98133538
CC   Characteristics: Useful in studies of telomere biology. Embryonic fibroblasts that have loxP sites on either side of the first and second coding exon of mouse Terf2. Also expresses CreERT2 from one Rosa26 locus. Terf2 knockout can be effected by transduction of Cre recombinase into the cell line (ATCC=CRL-3317).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: 129P2/Ola x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 8
//
ID   TRFK-1
AC   CVCL_D152
SY   TRFK 1
DR   Wikidata; Q54973006
RX   PubMed=2970507;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04401; Mouse Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   TRFK-2
AC   CVCL_D153
SY   TRFK 2
DR   Wikidata; Q54973007
RX   PubMed=2970507;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P04401; Mouse Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 8
//
ID   TRFK-4
AC   CVCL_D154
SY   TRFK 4; TRFK4
DR   BCRJ; 0237
DR   Wikidata; Q54973009
RX   PubMed=1387110;
RX   PubMed=2970507;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P04401; Mouse Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 8
//
ID   TRFK-5
AC   CVCL_D155
SY   TRFK 5; TRFK5
DR   BCRJ; 0238
DR   Wikidata; Q54973010
RX   PubMed=2970507;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04401; Mouse Il5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 9
//
ID   TrG6
AC   CVCL_B6VA
DR   Wikidata; Q112041809
RX   PubMed=2464569;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TrH6
AC   CVCL_B6VB
DR   Wikidata; Q112041810
RX   PubMed=2836964;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P79483; Human HLA-DRB3.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRI-C3H
AC   CVCL_5902
DR   CLS; 400359
DR   Wikidata; Q54973011
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C3H.
DI   NCIt; C21817; Trichoepithelioma type of basaloid follicular neoplasm of the mouse skin
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TRI102
AC   CVCL_JK08
SY   TRI-AML102
DR   cancercelllines; CVCL_JK08
DR   Wikidata; Q54973012
RX   PubMed=18570873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7368.
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Arg611Gln (c.1832G>A); ClinVar=VCV000012397; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C38153; Lung lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S879 ! 621-101
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 13
//
ID   TRI103
AC   CVCL_JK09
SY   TRI-AML103
DR   Wikidata; Q54973013
RX   PubMed=18570873;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-7369.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12363; TSC2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C38153; Lung lymphangioleiomyomatosis
DI   ORDO; Orphanet_538; Lymphangioleiomyomatosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JK08 ! TRI102
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   TRI13-iPS-C1
AC   CVCL_UG54
DR   Wikidata; Q98133539
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 12,16
ST   D21S11: 29
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 11,14
ST   FGA: 20.2,25
ST   Penta D: 9,13
ST   Penta E: 12,17
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X284 ! GM03330
SX   Male
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   TRI8-iPS-C12
AC   CVCL_UG55
DR   Wikidata; Q98133541
RX   PubMed=21949351;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 17,18
ST   D21S11: 25.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X269 ! GM02596
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TRI8-iPS-C8
AC   CVCL_A9E8
DR   Wikidata; Q102115008
RX   PubMed=21949351;
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X
ST   CSF1PO: 8,10
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 17,18
ST   D21S11: 25.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 11,12
ST   Penta E: 8,9
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C36396; Trisomy 8
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X269 ! GM02596
SX   Female
AG   10M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TrJ1
AC   CVCL_B6SZ
DR   Wikidata; Q112041811
RX   PubMed=8386401;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P01909; Human HLA-DQA1 (Note=Recognizes allele DQA1*05).
CC   Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1 (Note=Recognizes allele DQB1*02).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   TrJ3
AC   CVCL_B6SW
DR   Wikidata; Q112041812
RX   PubMed=1384167;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes alleles B*12=B*44/B*45).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TrJ5
AC   CVCL_B6SU
DR   Wikidata; Q112041813
RX   PubMed=7686545;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes alleles B*12=B*38/B*39).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   TrJ6
AC   CVCL_B6Y2
DR   Wikidata; Q112041814
RX   PubMed=7513681;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P01920; Human HLA-DQB1.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRK-1
AC   CVCL_T282
SY   Transformed Rabbit Kidney-1
DR   ATCC; CCL-143
DR   Wikidata; Q54973014
RX   PubMed=14120333;
RX   PubMed=14206435;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Discontinued: ATCC; CCL-143; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   2W
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   TRK-36
AC   CVCL_6F03
SY   TRK36; Transformed Rabbit Keratocytes-36
DR   Wikidata; Q54973015
RX   PubMed=8985637;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Keratocyte; CL=CL_0002363.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   TRK-43
AC   CVCL_4385
SY   TRK43; Transformed Rabbit Keratocytes-43
DR   BTO; BTO_0003224
DR   Wikidata; Q54973016
RX   PubMed=8985637;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Eye, cornea; UBERON=UBERON_0000964.
CC   Cell type: Keratocyte; CL=CL_0002363.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   TRK-73
AC   CVCL_D541
SY   Transformed Rabbit Kidney cells-73
DR   Wikidata; Q54973018
RX   PubMed=4124406;
RX   PubMed=4150020;
RX   PubMed=4150021;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   Trk27
AC   CVCL_B0XH
DR   Wikidata; Q108821380
RX   PubMed=17203998;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Trk49
AC   CVCL_B0XI
DR   Wikidata; Q108821381
RX   Patent=US7074903;
RX   Patent=US7611855;
RX   PubMed=17203998;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-8249.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Trk62
AC   CVCL_B0XJ
DR   Wikidata; Q108821382
RX   Patent=US7074903;
RX   Patent=US7611855;
RX   PubMed=17203998;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7890.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Trk73
AC   CVCL_B0XK
DR   Wikidata; Q108821383
RX   PubMed=17203998;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P13686; Human ACP5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   TRKE 1
AC   CVCL_E3K3
RX   PubMed=7427923;
CC   Doubling time: 24 hours (PubMed=7427923).
CC   Transformant: ChEBI; CHEBI_35807; N-nitrosodimethylamine (NDMA; Dimethylnitrosamine; DMN).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   2M
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   TRL 10
AC   CVCL_C7WT
SY   TRL10; Ten-day Rat Liver 10
DR   Wikidata; Q123033637
RX   PubMed=11177;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 12
AC   CVCL_C7WU
DR   Wikidata; Q123033638
RX   PubMed=11177;
CC   Donor information: Otained from pooling the livers of a number of rats (PubMed=11177).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   7D
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 12-13
AC   CVCL_C7X0
DR   Wikidata; Q123033639
RX   PubMed=11177;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7WU ! TRL 12
SX   Sex unspecified
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 12-15
AC   CVCL_C7X1
SY   TRL 1215
DR   Wikidata; Q123033640
RX   PubMed=11177;
RX   PubMed=6715008;
RX   PubMed=6825206;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7WU ! TRL 12
SX   Sex unspecified
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 12-21
AC   CVCL_C7X2
DR   Wikidata; Q123033641
RX   PubMed=11177;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7WU ! TRL 12
SX   Sex unspecified
AG   7D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 13-1
AC   CVCL_C7WV
SY   Ten-day Rat Liver 13-1
DR   Wikidata; Q123033643
RX   PubMed=11177;
CC   Donor information: Otained from pooling the livers of a number of rats (PubMed=11177).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   9D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 2
AC   CVCL_C7WW
SY   TRL2; Ten-day Rat Liver 2
DR   Wikidata; Q123033644
RX   PubMed=11177;
RX   PubMed=5124481;
CC   Doubling time: ~48 hours (Note=In 10% FCS) (PubMed=5124481).
CC   Donor information: Otained from pooling the livers of a number of rats (PubMed=5124481).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 4
AC   CVCL_C7WX
SY   Ten-day Rat Liver 4
DR   Wikidata; Q123033645
RX   PubMed=5124481;
CC   Doubling time: ~48 hours (Note=In 10% FCS) (PubMed=5124481).
CC   Donor information: Otained from pooling the livers of a number of rats (PubMed=5124481).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 6
AC   CVCL_C7WY
SY   Ten-day Rat Liver 6
DR   Wikidata; Q123033646
RX   PubMed=5124481;
CC   Doubling time: ~48 hours (Note=In 10% FCS) (PubMed=5124481).
CC   Donor information: Otained from pooling the livers of a number of rats (PubMed=5124481).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL 8
AC   CVCL_C7WZ
SY   TRL8; Ten-day Rat Liver 8
DR   Wikidata; Q123033647
RX   PubMed=11177;
RX   PubMed=5124481;
CC   Doubling time: ~48 hours (Note=In 10% FCS) (PubMed=5124481).
CC   Donor information: Otained from pooling the livers of a number of rats (PubMed=5124481).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   10D
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   TRL-01
AC   CVCL_W777
DR   Wikidata; Q54973026
RX   PubMed=16875930;
CC   Population: Japanese.
CC   Doubling time: 3-4 days (PubMed=16875930).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8252; Therapy-related acute myeloid leukemia
DI   ORDO; Orphanet_86846; Therapy related acute myeloid leukemia and myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 8
//
ID   TRLEC-03
AC   CVCL_F715
SY   Transformed Rat Lung Endothelial Cell line-03
DR   Wikidata; Q54973027
RX   PubMed=8034569;
CC   From: Institute of Cytosignal Research, Inc.; Tokyo; Japan.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   TRM-1
AC   CVCL_G709
DR   Wikidata; Q54973029
RX   PubMed=9040956;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   18FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   TRM-6
AC   CVCL_G708
DR   Wikidata; Q54973030
RX   PubMed=9193600;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   24FW
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   TRM-6/MSCV
AC   CVCL_E3FB
RX   PubMed=10847584;
CC   Characteristics: Control cell line for TRM-6/PDX-1 (Cellosaurus=CVCL_0562) (PubMed=10847584).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G708 ! TRM-6
SX   Sex unspecified
AG   24FW
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   TRM-6/PDX-1
AC   CVCL_0562
SY   T6/PDX
DR   MCCL; MCC:0000464
DR   Wikidata; Q54973031
RX   PubMed=10847584;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6107; PDX1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal pancreas; UBERON=UBERON_0003921.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G708 ! TRM-6
SX   Sex unspecified
AG   24FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   TrMab-29
AC   CVCL_B7JQ
DR   Wikidata; Q112930480
RX   PubMed=33490649;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   TrMab-6
AC   CVCL_B7JR
DR   Wikidata; Q112930481
RX   PubMed=33300065;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P09758; Human TACSTD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   TRMF
AC   CVCL_UC83
SY   Triploid Misgurnus Fin
DR   Wikidata; Q98133542
RX   Patent=CN103525749B;
RX   PubMed=25721100;
CC   Group: Fish cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2013110.
CC   Doubling time: 36.01 hours (Note=At 50th passage) (PubMed=25721100).
CC   Karyotypic information: Triploid karyotype.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75329; ! Misgurnus anguillicaudatus (Oriental weatherloach)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 05-10-23; Version: 11
//
ID   TRMP
AC   CVCL_XG04
DR   Wikidata; Q98133543
RX   PubMed=1314164;
RX   PubMed=1375321;
RX   PubMed=1688246;
RX   PubMed=2550144;
RX   PubMed=3233532;
RX   PubMed=7669722;
RX   PubMed=8069455;
RX   PubMed=8443409;
CC   Characteristics: Does not express PDGFRs (PubMed=2550144).
CC   Doubling time: 24 hours (PubMed=7669722).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   TRMP PDGFRB-p.Arg634
AC   CVCL_XG30
SY   TRMP PDGFR R635
DR   Wikidata; Q98133544
RX   PubMed=1314164;
RX   PubMed=2550144;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Lys634Arg).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Gly751
AC   CVCL_XG31
SY   TRMP PDGFR G751
DR   Wikidata; Q98133545
RX   PubMed=2550144;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr751Gly).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe1009
AC   CVCL_XG32
SY   TRMP PDGFR F1009; TRPM PDGFR F-1009; AT1009
DR   Wikidata; Q98133547
RX   PubMed=7691811;
RX   PubMed=8443409;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr1009Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe1009-p.Phe1021
AC   CVCL_XG33
SY   TRMP PDGFR F1009-F1021
DR   Wikidata; Q98133548
RX   PubMed=8443409;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr1009Phe and p.Tyr1021Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe1021
AC   CVCL_XG34
SY   TRMP PDGFR F1021
DR   Wikidata; Q98133549
RX   PubMed=8443409;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr1021Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe716
AC   CVCL_XG35
SY   TRMP PDGFR F716
DR   Wikidata; Q98133550
RX   PubMed=1314164;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr716Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe740
AC   CVCL_XG36
SY   TRMP PDGFR F740
DR   Wikidata; Q98133551
RX   PubMed=1314164;
RX   PubMed=1375321;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr740Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe740-p.Phe751
AC   CVCL_XG37
SY   TRMP PDGFR F740-F751
DR   Wikidata; Q98133553
RX   PubMed=1375321;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr740Phe and p.Tyr751Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe740-p.Phe751-p.Phe771
AC   CVCL_XG38
SY   TRMP PDGFR F740-F751-F771
DR   Wikidata; Q98133554
RX   PubMed=1375321;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr740Phe, p.Tyr751Phe and p.Tyr771Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe751
AC   CVCL_XG39
SY   TRMP PDGFR F751
DR   Wikidata; Q98133555
RX   PubMed=1314164;
RX   PubMed=1375321;
RX   PubMed=2550144;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr751Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe763
AC   CVCL_XG40
SY   TRMP PDGFR F763
DR   Wikidata; Q98133556
RX   PubMed=1314164;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr763Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe771
AC   CVCL_XG41
SY   TRMP PDGFR F771
DR   Wikidata; Q98133557
RX   PubMed=1314164;
RX   PubMed=1375321;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr771Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe775
AC   CVCL_XG42
SY   TRMP PDGFR F775
DR   Wikidata; Q98133558
RX   PubMed=1314164;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr775Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe778
AC   CVCL_XG43
SY   TRMP PDGFR F778
DR   Wikidata; Q98133559
RX   PubMed=1314164;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr778Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe857
AC   CVCL_XG44
SY   TRMP PDGFR F857
DR   Wikidata; Q98133560
RX   PubMed=1314164;
RX   PubMed=2550144;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr857Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe966
AC   CVCL_XG45
SY   TRMP PDGFR F966
DR   Wikidata; Q98133561
RX   PubMed=8443409;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr966Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-p.Phe970
AC   CVCL_XG46
SY   TRMP PDGFR F970
DR   Wikidata; Q98133562
RX   PubMed=8443409;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB (Note=With p.Tyr970Phe).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRMP PDGFRB-WT
AC   CVCL_XG47
SY   TRMP PDGFR WT; ATWT
DR   Wikidata; Q98133564
RX   PubMed=1314164;
RX   PubMed=1375321;
RX   PubMed=2550144;
RX   PubMed=7691811;
RX   PubMed=8443409;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_XG04 ! TRMP
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   TRNDi001-A
AC   CVCL_UL04
SY   HT307A
DR   hPSCreg; TRNDi001-A
DR   Wikidata; Q98133565
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi001-B
AC   CVCL_UL05
SY   HT307B
DR   hPSCreg; TRNDi001-B
DR   Wikidata; Q98133568
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi001-C
AC   CVCL_UL06
SY   HT307C
DR   hPSCreg; TRNDi001-C
DR   Wikidata; Q98133570
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi001-D
AC   CVCL_UL07
SY   HT307D; GM28227; GM28227*A
DR   Coriell; GM28227
DR   hPSCreg; TRNDi001-D
DR   Wikidata; Q98133571
RX   PubMed=32114296;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Homozygous (PubMed=32114296).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA78 ! GM18453
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   TRNDi002-A
AC   CVCL_UL08
SY   HT519A
DR   hPSCreg; TRNDi002-A
DR   Wikidata; Q98133572
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BX28 ! GM25344
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   TRNDi002-B
AC   CVCL_UL09
SY   HT519B
DR   hPSCreg; TRNDi002-B
DR   Wikidata; Q98133573
RX   PubMed=30612078;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (PubMed=30612078).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (PubMed=30612078).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BX28 ! GM25344
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   TRNDi002-C
AC   CVCL_UL10
SY   HT519C
DR   hPSCreg; TRNDi002-C
DR   Wikidata; Q98133574
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BX28 ! GM25344
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   TRNDi002-D
AC   CVCL_UL11
SY   HT519D
DR   hPSCreg; TRNDi002-D
DR   Wikidata; Q98133575
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1397; CACNA1S; Simple; p.Thr1354Ser (c.4060A>T); ClinVar=VCV000161208; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gln208Ter (c.622C>T); ClinVar=VCV000221578; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Gly310Gly (c.930C>T); ClinVar=VCV000221583; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BX28 ! GM25344
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   TRNDi003-A
AC   CVCL_UL12
SY   HT215A
DR   hPSCreg; TRNDi003-A
DR   Wikidata; Q98133577
RX   PubMed=30640061;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gln510Pro (c.1529A>C); ClinVar=VCV000013344; Zygosity=Heterozygous (PubMed=30640061).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL13 ! TRNDi003-B
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   TRNDi003-B
AC   CVCL_UL13
SY   HT215B
DR   hPSCreg; TRNDi003-B
DR   Wikidata; Q98133580
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gln510Pro (c.1529A>C); ClinVar=VCV000013344; Zygosity=Heterozygous (from autologous cell line TRNDi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL12 ! TRNDi003-A
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi004-A
AC   CVCL_UL14
SY   HT222A
DR   hPSCreg; TRNDi004-A
DR   Wikidata; Q98133581
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-B
AC   CVCL_UL15
SY   HT222B
DR   hPSCreg; TRNDi004-B
DR   Wikidata; Q98133582
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-C
AC   CVCL_UL16
SY   HT222C
DR   hPSCreg; TRNDi004-C
DR   Wikidata; Q98133583
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-D
AC   CVCL_UL17
SY   HT222D
DR   hPSCreg; TRNDi004-D
DR   Wikidata; Q98133584
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-E
AC   CVCL_UL18
SY   HT222E
DR   hPSCreg; TRNDi004-E
DR   Wikidata; Q98133585
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-F
AC   CVCL_UL19
SY   HT222F
DR   hPSCreg; TRNDi004-F
DR   Wikidata; Q98133586
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-G
AC   CVCL_UL20
SY   HT222G
DR   hPSCreg; TRNDi004-G
DR   Wikidata; Q98133587
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-H
AC   CVCL_UL21
SY   HT222H
DR   hPSCreg; TRNDi004-H
DR   Wikidata; Q98133588
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi004-I
AC   CVCL_UL22
SY   HT222I; GM28078; GM28078*C
DR   Coriell; GM28078
DR   hPSCreg; TRNDi004-I
DR   Wikidata; Q98133589
RX   PubMed=31009819;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (PubMed=31009819).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi004-J
AC   CVCL_UL23
SY   HT222J
DR   hPSCreg; TRNDi004-J
DR   Wikidata; Q98133591
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu43_Ala44del; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126866; Niemann-Pick disease, type B
DI   ORDO; Orphanet_77293; Niemann-Pick disease type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DA34 ! GM11097
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi005-A
AC   CVCL_UL24
SY   HT438A; GM28601; GM28601*C
DR   Coriell; GM28601
DR   hPSCreg; TRNDi005-A
DR   Wikidata; Q98133593
RX   PubMed=30797135;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4122; GALNS; Simple; p.Arg61Trp (c.181C>T); ClinVar=VCV000381663; Zygosity=Heterozygous (PubMed=30797135).
CC   Sequence variation: Mutation; HGNC; HGNC:4122; GALNS; Simple; p.Trp405_Thr406del (c.1207_1212TGGACC[1]) (c.1213_1218delTGGACC) (p.403_404WT[1]) (WT405del); ClinVar=VCV000566964; Zygosity=Heterozygous (PubMed=30797135).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84901; Mucopolysaccharidosis type IVA
DI   ORDO; Orphanet_309297; Mucopolysaccharidosis type 4A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9W81 ! GM01361
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 12
//
ID   TRNDi006-A
AC   CVCL_UL25
AS   CVCL_B5TN
SY   NCATS-CL7567; HT527A; GM29681; GM29681*B
DR   Coriell; GM29681
DR   hPSCreg; TRNDi006-A
DR   Wikidata; Q112129407
DR   Wikidata; Q98133594
RX   PubMed=30933722;
RX   PubMed=34411609;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Glu153Lys (c.457G>A); ClinVar=VCV001067431; Zygosity=Homozygous (PubMed=30933722).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0M01 ! GM01426
SX   Female
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 11
//
ID   TRNDi007-A
AC   CVCL_UL26
SY   HT521A
DR   hPSCreg; TRNDi007-A
DR   Wikidata; Q98133595
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K46 ! GM00248
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi007-B
AC   CVCL_UL27
SY   NCATS-CL9317; HT521B; GM28229; GM28229*B
DR   Coriell; GM28229
DR   hPSCreg; TRNDi007-B
DR   Wikidata; Q98133596
RX   PubMed=31026687;
RX   PubMed=33375166;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg854Ter (c.2560C>T); ClinVar=VCV000004034; Zygosity=Homozygous (PubMed=31026687).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1K46 ! GM00248
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 13
//
ID   TRNDi008-A
AC   CVCL_UL28
SY   NCATS-CL6485; HT525A
DR   hPSCreg; TRNDi008-A
DR   Wikidata; Q98133597
RX   PubMed=31071499;
RX   PubMed=34990619;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caribbean; Haitian.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.His70Profs*29 (c.208dupC) (c.208insC); ClinVar=VCV000195037; Zygosity=Hemizygous (PubMed=31071499).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N205 ! GM13203
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi008-B
AC   CVCL_B5V3
SY   NCATS-CL6486; HT525B; GM28230; GM28230*D
DR   Coriell; GM28230
DR   Wikidata; Q112041815
RX   PubMed=34990619;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caribbean; Haitian.
CC   Sequence variation: Mutation; HGNC; HGNC:5389; IDS; Simple; p.His70Profs*29 (c.208dupC) (c.208insC); ClinVar=VCV000195037; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61260; Hunter syndrome
DI   ORDO; Orphanet_580; Mucopolysaccharidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_N205 ! GM13203
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   TRNDi009-A
AC   CVCL_WU18
SY   HT220A
DR   hPSCreg; TRNDi009-A
DR   Wikidata; Q98133598
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7379 ! GM03252
SX   Female
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi009-B
AC   CVCL_WU19
SY   HT220B
DR   hPSCreg; TRNDi009-B
DR   Wikidata; Q98133600
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7379 ! GM03252
SX   Female
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   TRNDi009-C
AC   CVCL_WU20
SY   HT220C
DR   hPSCreg; TRNDi009-C
DR   Wikidata; Q98133601
RX   PubMed=31132580;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11120; SMPD1; Simple; p.Leu304Pro (c.911T>C) (L302P); ClinVar=VCV000002989; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126561; Niemann-Pick disease, type A
DI   ORDO; Orphanet_77292; Niemann-Pick disease type A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7379 ! GM03252
SX   Female
AG   21FW
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 8
//
ID   TRNDi010-A
AC   CVCL_XI86
SY   HT592A
DR   hPSCreg; TRNDi010-A
DR   Wikidata; Q98133602
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT93 ! GM26612
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi010-B
AC   CVCL_XI87
SY   HT592B
DR   hPSCreg; TRNDi010-B
DR   Wikidata; Q98133604
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT93 ! GM26612
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi010-C
AC   CVCL_XI88
SY   HT592C
DR   hPSCreg; TRNDi010-C
DR   Wikidata; Q98133605
RX   PubMed=31326749;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (PubMed=31326749).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT93 ! GM26612
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   TRNDi010-D
AC   CVCL_B5GI
SY   NCATS-CL6103; HT592D
DR   hPSCreg; TRNDi010-D
DR   Wikidata; Q110433289
RX   PubMed=34619643;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous (PubMed=34619643).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT93 ! GM26612
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   TRNDi010-D-1
AC   CVCL_B5GJ
SY   NGLY X401R M4; NCATS-CL6104; GM28560; GM28560*B
DR   Coriell; GM28560
DR   hPSCreg; TRNDi010-D-1
DR   Wikidata; Q110433290
RX   PubMed=34619643;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous (PubMed=34619643).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple_corrected; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34619643).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5GI ! TRNDi010-D
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi010-D-2
AC   CVCL_B5GK
SY   NGLY X401R I4; NCATS-CL6105; GM28561; GM28561*B
DR   Coriell; GM28561
DR   hPSCreg; TRNDi010-D-2
DR   Wikidata; Q110433291
RX   PubMed=34619643;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; English.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple_corrected; p.Arg401Ter (c.1201A>T); ClinVar=VCV000050962; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34619643).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5GI ! TRNDi010-D
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi011-A
AC   CVCL_B5U1
SY   HT58A
DR   hPSCreg; TRNDi011-A
DR   Wikidata; Q112041816
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U2 ! TRNDi011-B
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi011-B
AC   CVCL_B5U2
SY   HT58B
DR   hPSCreg; TRNDi011-B
DR   Wikidata; Q112041818
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U1 ! TRNDi011-A
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi012-A
AC   CVCL_A0LJ
SY   HT216A
DR   hPSCreg; TRNDi012-A
DR   Wikidata; Q108821384
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-B
AC   CVCL_A0LK
SY   NCATS-CL7989; HT216B; GM28385; GM28385*B
DR   Coriell; GM28385
DR   hPSCreg; TRNDi012-B
DR   Wikidata; Q108821385
RX   PubMed=34139597;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (PubMed=34139597).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   TRNDi012-C
AC   CVCL_A0LL
SY   HT216C
DR   hPSCreg; TRNDi012-C
DR   Wikidata; Q108821386
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-D
AC   CVCL_A0LM
SY   HT216D
DR   hPSCreg; TRNDi012-D
DR   Wikidata; Q108821387
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-E
AC   CVCL_A0LN
SY   HT216E
DR   hPSCreg; TRNDi012-E
DR   Wikidata; Q108821388
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-F
AC   CVCL_A0LP
SY   HT216F
DR   hPSCreg; TRNDi012-F
DR   Wikidata; Q108821389
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-G
AC   CVCL_A0LQ
SY   HT216G
DR   hPSCreg; TRNDi012-G
DR   Wikidata; Q108821390
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-H
AC   CVCL_A0LR
SY   HT216H
DR   hPSCreg; TRNDi012-H
DR   Wikidata; Q108821391
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi012-I
AC   CVCL_A0LS
SY   HT216I
DR   hPSCreg; TRNDi012-I
DR   Wikidata; Q108821393
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi013-A
AC   CVCL_B5U3
SY   HT218A
DR   hPSCreg; TRNDi013-A
DR   Wikidata; Q112041819
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U4 ! TRNDi013-B
OI   CVCL_B5U5 ! TRNDi013-C
OI   CVCL_B5U6 ! TRNDi013-D
OI   CVCL_B5U7 ! TRNDi013-E
OI   CVCL_B5U8 ! TRNDi013-F
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi013-B
AC   CVCL_B5U4
SY   HT218B
DR   hPSCreg; TRNDi013-B
DR   Wikidata; Q112041820
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U3 ! TRNDi013-A
OI   CVCL_B5U5 ! TRNDi013-C
OI   CVCL_B5U6 ! TRNDi013-D
OI   CVCL_B5U7 ! TRNDi013-E
OI   CVCL_B5U8 ! TRNDi013-F
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi013-C
AC   CVCL_B5U5
SY   HT218C
DR   hPSCreg; TRNDi013-C
DR   Wikidata; Q112041821
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U3 ! TRNDi013-A
OI   CVCL_B5U4 ! TRNDi013-B
OI   CVCL_B5U6 ! TRNDi013-D
OI   CVCL_B5U7 ! TRNDi013-E
OI   CVCL_B5U8 ! TRNDi013-F
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi013-D
AC   CVCL_B5U6
SY   HT218D
DR   hPSCreg; TRNDi013-D
DR   Wikidata; Q112041822
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U3 ! TRNDi013-A
OI   CVCL_B5U4 ! TRNDi013-B
OI   CVCL_B5U5 ! TRNDi013-C
OI   CVCL_B5U7 ! TRNDi013-E
OI   CVCL_B5U8 ! TRNDi013-F
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi013-E
AC   CVCL_B5U7
SY   HT218E
DR   hPSCreg; TRNDi013-E
DR   Wikidata; Q112041823
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U3 ! TRNDi013-A
OI   CVCL_B5U4 ! TRNDi013-B
OI   CVCL_B5U5 ! TRNDi013-C
OI   CVCL_B5U6 ! TRNDi013-D
OI   CVCL_B5U8 ! TRNDi013-F
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi013-F
AC   CVCL_B5U8
SY   HT218F
DR   hPSCreg; TRNDi013-F
DR   Wikidata; Q112041824
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U3 ! TRNDi013-A
OI   CVCL_B5U4 ! TRNDi013-B
OI   CVCL_B5U5 ! TRNDi013-C
OI   CVCL_B5U6 ! TRNDi013-D
OI   CVCL_B5U7 ! TRNDi013-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi014-A
AC   CVCL_B5U9
SY   HT219A
DR   hPSCreg; TRNDi014-A
DR   Wikidata; Q112041826
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UA ! TRNDi014-B
OI   CVCL_B5UB ! TRNDi014-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi014-B
AC   CVCL_B5UA
SY   HT219B
DR   hPSCreg; TRNDi014-B
DR   Wikidata; Q112041827
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U9 ! TRNDi014-A
OI   CVCL_B5UB ! TRNDi014-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi014-C
AC   CVCL_B5UB
SY   HT219C
DR   hPSCreg; TRNDi014-C
DR   Wikidata; Q112041828
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5U9 ! TRNDi014-A
OI   CVCL_B5UA ! TRNDi014-B
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi015-A
AC   CVCL_B5UC
SY   HT217A
DR   hPSCreg; TRNDi015-A
DR   Wikidata; Q112041829
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UD ! TRNDi015-B
OI   CVCL_B5UE ! TRNDi015-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi015-B
AC   CVCL_B5UD
SY   HT217B
DR   hPSCreg; TRNDi015-B
DR   Wikidata; Q112041830
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UC ! TRNDi015-A
OI   CVCL_B5UE ! TRNDi015-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi015-C
AC   CVCL_B5UE
SY   HT217C
DR   hPSCreg; TRNDi015-C
DR   Wikidata; Q112041831
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UC ! TRNDi015-A
OI   CVCL_B5UD ! TRNDi015-B
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi016-A
AC   CVCL_B5UF
SY   HT530A
DR   hPSCreg; TRNDi016-A
DR   Wikidata; Q112041832
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UG ! TRNDi016-B
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi016-B
AC   CVCL_B5UG
SY   HT530B
DR   hPSCreg; TRNDi016-B
DR   Wikidata; Q112041834
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UF ! TRNDi016-A
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi017-A
AC   CVCL_B5UH
SY   HT593A
DR   hPSCreg; TRNDi017-A
DR   Wikidata; Q112041835
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UI ! TRNDi017-B
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi017-B
AC   CVCL_B5UI
SY   HT593B
DR   hPSCreg; TRNDi017-B
DR   Wikidata; Q112041836
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UH ! TRNDi017-A
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi018-A
AC   CVCL_A8RE
SY   HT594A
DR   hPSCreg; TRNDi018-A
DR   Wikidata; Q108821394
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT85 ! GM26602
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   TRNDi018-B
AC   CVCL_A8RF
SY   HT594B
DR   hPSCreg; TRNDi018-B
DR   Wikidata; Q108821395
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT85 ! GM26602
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   TRNDi018-C
AC   CVCL_A8RG
SY   NCATS-CL9075; HT594C
DR   hPSCreg; TRNDi018-C
DR   Wikidata; Q108821396
RX   PubMed=34051448;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); ClinVar=VCV003769564; Zygosity=Heterozygous (PubMed=34051448).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (PubMed=34051448).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT85 ! GM26602
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   TRNDi018-D
AC   CVCL_A8RH
SY   HT594D
DR   hPSCreg; TRNDi018-D
DR   Wikidata; Q108821397
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Leu318Pro (c.953T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:17646; NGLY1; Simple; p.Arg390Pro (c.1169G>C); ClinVar=VCV000221580; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126746; Congenital disorder of deglycosylation
DI   ORDO; Orphanet_404454; Alacrimia-choreoathetosis-liver dysfunction syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RT85 ! GM26602
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   TRNDi019-A
AC   CVCL_B5UJ
SY   HT137A
DR   hPSCreg; TRNDi019-A
DR   Wikidata; Q112041837
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UK ! TRNDi019-B
OI   CVCL_B5UL ! TRNDi019-C
OI   CVCL_B5UM ! TRNDi019-D
OI   CVCL_B5UN ! TRNDi019-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi019-B
AC   CVCL_B5UK
SY   HT137B
DR   hPSCreg; TRNDi019-B
DR   Wikidata; Q112041838
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UJ ! TRNDi019-A
OI   CVCL_B5UL ! TRNDi019-C
OI   CVCL_B5UM ! TRNDi019-D
OI   CVCL_B5UN ! TRNDi019-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi019-C
AC   CVCL_B5UL
SY   HT137C
DR   hPSCreg; TRNDi019-C
DR   Wikidata; Q112041839
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UJ ! TRNDi019-A
OI   CVCL_B5UK ! TRNDi019-B
OI   CVCL_B5UM ! TRNDi019-D
OI   CVCL_B5UN ! TRNDi019-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi019-D
AC   CVCL_B5UM
SY   HT137D
DR   hPSCreg; TRNDi019-D
DR   Wikidata; Q112041841
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UJ ! TRNDi019-A
OI   CVCL_B5UK ! TRNDi019-B
OI   CVCL_B5UL ! TRNDi019-C
OI   CVCL_B5UN ! TRNDi019-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi019-E
AC   CVCL_B5UN
SY   HT137E
DR   hPSCreg; TRNDi019-E
DR   Wikidata; Q112041842
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UJ ! TRNDi019-A
OI   CVCL_B5UK ! TRNDi019-B
OI   CVCL_B5UL ! TRNDi019-C
OI   CVCL_B5UM ! TRNDi019-D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi020-A
AC   CVCL_B5UP
SY   HT150A
DR   hPSCreg; TRNDi020-A
DR   Wikidata; Q112041843
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UQ ! TRNDi020-B
OI   CVCL_B5UR ! TRNDi020-C
OI   CVCL_B5US ! TRNDi020-D
OI   CVCL_B5UT ! TRNDi020-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi020-B
AC   CVCL_B5UQ
SY   HT150B
DR   hPSCreg; TRNDi020-B
DR   Wikidata; Q112041844
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UP ! TRNDi020-A
OI   CVCL_B5UR ! TRNDi020-C
OI   CVCL_B5US ! TRNDi020-D
OI   CVCL_B5UT ! TRNDi020-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi020-C
AC   CVCL_B5UR
SY   HT150C
DR   hPSCreg; TRNDi020-C
DR   Wikidata; Q112041845
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UP ! TRNDi020-A
OI   CVCL_B5UQ ! TRNDi020-B
OI   CVCL_B5US ! TRNDi020-D
OI   CVCL_B5UT ! TRNDi020-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi020-D
AC   CVCL_B5US
SY   HT150D
DR   hPSCreg; TRNDi020-D
DR   Wikidata; Q112041846
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UP ! TRNDi020-A
OI   CVCL_B5UQ ! TRNDi020-B
OI   CVCL_B5UR ! TRNDi020-C
OI   CVCL_B5UT ! TRNDi020-E
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi020-E
AC   CVCL_B5UT
SY   HT150E
DR   hPSCreg; TRNDi020-E
DR   Wikidata; Q112041847
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UP ! TRNDi020-A
OI   CVCL_B5UQ ! TRNDi020-B
OI   CVCL_B5UR ! TRNDi020-C
OI   CVCL_B5US ! TRNDi020-D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi021-A
AC   CVCL_A1NG
SY   HT725A
DR   hPSCreg; TRNDi021-A
DR   Wikidata; Q102115011
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7348 ! GM02036
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TRNDi021-B
AC   CVCL_A1NH
SY   HT725B
DR   hPSCreg; TRNDi021-B
DR   Wikidata; Q102115013
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7348 ! GM02036
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TRNDi021-C
AC   CVCL_A1NI
SY   HT725C
DR   hPSCreg; TRNDi021-C
DR   Wikidata; Q102115014
RX   PubMed=33038742;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7348 ! GM02036
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TRNDi021-D
AC   CVCL_A1NJ
SY   HT725D
DR   hPSCreg; TRNDi021-D
DR   Wikidata; Q102115015
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7348 ! GM02036
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   TRNDi022-A
AC   CVCL_B5UU
SY   HT726A
DR   hPSCreg; TRNDi022-A
DR   Wikidata; Q112041848
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UV ! TRNDi022-B
OI   CVCL_B5UW ! TRNDi022-C
OI   CVCL_B5UX ! TRNDi022-D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi022-B
AC   CVCL_B5UV
SY   HT726B
DR   hPSCreg; TRNDi022-B
DR   Wikidata; Q112041850
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UU ! TRNDi022-A
OI   CVCL_B5UW ! TRNDi022-C
OI   CVCL_B5UX ! TRNDi022-D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi022-C
AC   CVCL_B5UW
SY   HT726C
DR   hPSCreg; TRNDi022-C
DR   Wikidata; Q112041851
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UU ! TRNDi022-A
OI   CVCL_B5UV ! TRNDi022-B
OI   CVCL_B5UX ! TRNDi022-D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi022-D
AC   CVCL_B5UX
SY   HT726D
DR   hPSCreg; TRNDi022-D
DR   Wikidata; Q112041853
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UU ! TRNDi022-A
OI   CVCL_B5UV ! TRNDi022-B
OI   CVCL_B5UW ! TRNDi022-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi023-A
AC   CVCL_A1NK
SY   HT727A
DR   hPSCreg; TRNDi023-A
DR   Wikidata; Q102115016
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   TRNDi023-B
AC   CVCL_A1NL
SY   HT727B
DR   hPSCreg; TRNDi023-B
DR   Wikidata; Q102115017
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   TRNDi023-C
AC   CVCL_A1NM
SY   HT727C
DR   hPSCreg; TRNDi023-C
DR   Wikidata; Q102115018
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   TRNDi023-D
AC   CVCL_A1NN
SY   HT727D
DR   hPSCreg; TRNDi023-D
DR   Wikidata; Q102115020
RX   PubMed=33038742;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   TRNDi024-A
AC   CVCL_A1NP
SY   HT728A
DR   hPSCreg; TRNDi024-A
DR   Wikidata; Q102115021
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7436 ! GM05756
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi024-B
AC   CVCL_A1NQ
SY   HT728B
DR   hPSCreg; TRNDi024-B
DR   Wikidata; Q102115023
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7436 ! GM05756
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi024-C
AC   CVCL_A1NR
SY   HT728C
DR   hPSCreg; TRNDi024-C
DR   Wikidata; Q102115024
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7436 ! GM05756
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi024-D
AC   CVCL_A1NS
SY   HT728D
DR   hPSCreg; TRNDi024-D
DR   Wikidata; Q102115025
RX   PubMed=33038742;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7436 ! GM05756
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi025-A
AC   CVCL_A1NT
SY   HT729A
DR   hPSCreg; TRNDi025-A
DR   Wikidata; Q102115026
RX   PubMed=33038742;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7481 ! GM08398
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi025-B
AC   CVCL_A1NU
SY   HT729B
DR   hPSCreg; TRNDi025-B
DR   Wikidata; Q102115027
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7481 ! GM08398
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi025-C
AC   CVCL_A1NV
SY   HT729C
DR   hPSCreg; TRNDi025-C
DR   Wikidata; Q102115028
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7481 ! GM08398
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi025-D
AC   CVCL_A1NW
SY   HT729D
DR   hPSCreg; TRNDi025-D
DR   Wikidata; Q102115029
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7481 ! GM08398
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   TRNDi026-A
AC   CVCL_B5UY
SY   HT265A
DR   hPSCreg; TRNDi026-A
DR   Wikidata; Q112041854
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UZ ! TRNDi026-B
OI   CVCL_B5V0 ! TRNDi026-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi026-B
AC   CVCL_B5UZ
SY   HT265B
DR   hPSCreg; TRNDi026-B
DR   Wikidata; Q112041855
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UY ! TRNDi026-A
OI   CVCL_B5V0 ! TRNDi026-C
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi026-C
AC   CVCL_B5V0
SY   HT265C
DR   hPSCreg; TRNDi026-C
DR   Wikidata; Q112041856
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5UY ! TRNDi026-A
OI   CVCL_B5UZ ! TRNDi026-B
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   TRNDi027-A
AC   CVCL_B5V1
SY   HT237A
DR   hPSCreg; TRNDi027-A
DR   Wikidata; Q112041857
RX   PubMed=29631617;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (PubMed=29631617).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (PubMed=29631617).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   TRNDi027-B
AC   CVCL_B5V2
SY   HT237B
DR   hPSCreg; TRNDi027-B
DR   Wikidata; Q112041858
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Pro237Ser (c.709C>T); ClinVar=VCV000021142; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7897; NPC1; Simple; p.Ile1061Thr (c.3182T>C); ClinVar=VCV000002967; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126864; Niemann-Pick disease, type C1
DI   ORDO; Orphanet_646; Niemann-Pick disease type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7374 ! GM03123
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   TRNDi028-A
AC   CVCL_B5TU
SY   HT268A
DR   hPSCreg; TRNDi028-A
DR   Wikidata; Q112041859
RX   PubMed=29631617;
RX   PubMed=30220252;
RX   PubMed=33375166;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   TRNDi028-B
AC   CVCL_B5TV
SY   HT268B
DR   hPSCreg; TRNDi028-B
DR   Wikidata; Q112041860
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   TRNDi028-C
AC   CVCL_B5TW
SY   HT268C
DR   hPSCreg; TRNDi028-C
DR   Wikidata; Q112041862
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Thr408Met (c.1223C>T) (T369M); ClinVar=VCV000093447; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7434 ! GM05659
SX   Male
AG   1Y2M
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   TRNDi029-A
AC   CVCL_A8NS
SY   NCATS-CL4870; HT822A; GM28558; GM28558*B
DR   Coriell; GM28558
DR   hPSCreg; TRNDi029-A
DR   Wikidata; Q108821398
RX   PubMed=34087995;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Arg465Arg (c.1395G>T) (chr20:g.10629709C>A); Zygosity=Heterozygous; Note=Splice site mutation (PubMed=34087995).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U944 ! GM05759
SX   Female
AG   3M
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   TRNDi030-A
AC   CVCL_A8PD
SY   NCATS-CL8549; HT143A
DR   hPSCreg; TRNDi030-A
DR   Wikidata; Q108821399
RX   PubMed=34088014;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:735; ASAH1; Simple; p.Tyr36Cys (c.107A>G) (p.Tyr52Cys, c.155A>G); ClinVar=VCV000000093; Zygosity=Homozygous (PubMed=34088014).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84710; Farber lipogranulomatosis
DI   ORDO; Orphanet_333; Farber disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8A69 ! GM20015
SX   Male
AG   0-2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   TRNDi031-A
AC   CVCL_A8PE
SY   NCATS-CL7739; HT824A; GM28559; GM28559*B
DR   Coriell; GM28559
DR   hPSCreg; TRNDi031-A
DR   Wikidata; Q108821400
RX   PubMed=34198154;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Cys312Ter (c.936T>A); ClinVar=VCV001358138; Zygosity=Heterozygous (PubMed=34198154).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U946 ! GM11091
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   TRNDi032-A
AC   CVCL_C9LN
SY   NCATS-CL4235; HT977A
DR   BioSamples; SAMEA112354454
DR   hPSCreg; TRNDi032-A
DR   Wikidata; Q123033648
RX   PubMed=37890331;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Cys682Leufs*7 (c.2044dupT); Zygosity=Heterozygous (PubMed=37890331).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   TRNDi033-A
AC   CVCL_C9LK
SY   NCATS-CL2462; HT1001-B; HT1001B
DR   BioSamples; SAMEA113570125
DR   hPSCreg; TRNDi033-A
DR   Wikidata; Q123033649
RX   PubMed=37393720;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2J36 ! AG14724
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TRNDi034-A
AC   CVCL_C9LL
SY   NCATS-CL2463; HT1002-A; HT1002A
DR   BioSamples; SAMEA113570127
DR   hPSCreg; TRNDi034-A
DR   Wikidata; Q123033650
RX   PubMed=37393720;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Latino or Hispanic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Q03 ! AG20473
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TRNDi035-A
AC   CVCL_C9LM
SY   NCATS-CL2464; HT1004-B; HT1004B
DR   BioSamples; SAMEA113570129
DR   hPSCreg; TRNDi035-A
DR   Wikidata; Q123033651
RX   PubMed=37393720;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7622 ! GM14681
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   TRNDi036-A
AC   CVCL_C9LP
SY   HT980A
DR   BioSamples; SAMEA114266353
DR   hPSCreg; TRNDi036-A
DR   Wikidata; Q123033652
RX   PubMed=38703666;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Asp692_Cys693insTer (c.2078_2079delGT) (p.Cys693Ter); ClinVar=VCV000843337; Zygosity=Heterozygous (PubMed=38703666).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   TRNDi037-A
AC   CVCL_D6R8
SY   NCATS-CL7833; HT976A
DR   BioSamples; SAMEA115457624
DR   hPSCreg; TRNDi037-A
RX   PubMed=39719802;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Val422Lysfs*6 (c.1264_1265del); Zygosity=Heterozygous (PubMed=39719802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=39719802
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 8,13
ST   D18S51: 17,19
ST   D21S11: 29,31
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 7,18
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   TRNDi038-A
AC   CVCL_D6R9
SY   NCATS-CL7834; HT978A
DR   BioSamples; SAMEA115412667
DR   hPSCreg; TRNDi038-A
RX   PubMed=39719802;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Gly353Ter (c.1057G>T); Zygosity=Heterozygous (PubMed=39719802).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=39719802
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13,16
ST   D21S11: 30.2,32.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 19,20
ST   Penta D: 8,12
ST   Penta E: 5,7
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C35139; Alagille syndrome
DI   ORDO; Orphanet_52; Alagille syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   TRNDi039-A
AC   CVCL_D6RA
DR   hPSCreg; TRNDi039-A
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6RB ! TRNDi039-B
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TRNDi039-B
AC   CVCL_D6RB
DR   hPSCreg; TRNDi039-B
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6RA ! TRNDi039-A
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TRNDi040-A
AC   CVCL_D6RC
DR   hPSCreg; TRNDi040-A
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6RD ! TRNDi040-B
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TRNDi040-B
AC   CVCL_D6RD
DR   hPSCreg; TRNDi040-B
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6RC ! TRNDi040-A
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   TRNDi042-A
AC   CVCL_B5TR
SY   NCATS-CL7570; NCATS-CL9554; HT528A; GM29682; GM29682*B
DR   BioSample; SAMEA115676041
DR   Coriell; GM29682
DR   Wikidata; Q112129410
RX   PubMed=34411609;
RX   PubMed=39579553;
CC   From: NIH-NCATS-TRND Branch; Rockville; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg626Ter (c.1876C>T); ClinVar=VCV000001561; Zygosity=Homozygous (PubMed=39579553).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0L90 ! GM00156
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 6
//
ID   Troja 1
AC   CVCL_D877
DR   Wikidata; Q54973032
RX   PubMed=10098769;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   Troja 2
AC   CVCL_D878
DR   Wikidata; Q54973033
RX   PubMed=10098769;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 8
//
ID   TROMA-1
AC   CVCL_A6QS
SY   TROMA 1; TROMA-I; Troma 1; TROphectodermal Monoclonal Antibody 1
DR   DSHB; TROMA-I
DR   Wikidata; Q107117121
RX   PubMed=6171607;
RX   PubMed=6933460;
RX   PubMed=9810706;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P11679; Mouse Krt8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   TROMA-2
AC   CVCL_A6RC
SY   TROMA 2; TROMA-II; TROphectodermal Monoclonal Antibody 2
DR   Wikidata; Q107117122
RX   PubMed=6171607;
RX   PubMed=6933460;
RX   PubMed=9810706;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P05784; Mouse Krt18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   TROMA-3
AC   CVCL_A6QT
SY   TROMA 3; TROMA-III; TROphectodermal Monoclonal Antibody 3
DR   DSHB; TROMA-III
DR   Wikidata; Q107117124
RX   PubMed=6933460;
RX   PubMed=9810706;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P19001; Mouse Krt19.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   TRP 7.4
AC   CVCL_C4ZC
DR   Wikidata; Q116050657
RX   PubMed=1816074;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P00895; Escherichia coli trpE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   TRP3
AC   CVCL_W908
DR   Wikidata; Q54973034
RX   PubMed=24853805;
CC   Sequence variation: Mutation; HGNC; HGNC:175; ACVRL1; Simple; p.Ile485Phe (c.1453A>T); Zygosity=Unspecified (PubMed=24853805).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
DI   NCIt; C35064; Hereditary hemorrhagic telangiectasia
DI   ORDO; Orphanet_774; Hereditary hemorrhagic telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Telomerase immortalized cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 11
//
ID   tRPE
AC   CVCL_DF64
DR   Wikidata; Q54973035
RX   PubMed=19413901;
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Calf
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   Trpl17
AC   CVCL_A4QV
SY   SUSMi005-A
DR   BioSamples; SAMEA12279542
DR   hPSCreg; SUSMi005-A
DR   SKIP; SKIP001068
DR   Wikidata; Q105511266
RX   PubMed=22110584;
RX   PubMed=35263701;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=22110584).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QU ! Trpl8
OI   CVCL_A4QW ! Trpl43
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   Trpl43
AC   CVCL_A4QW
DR   Wikidata; Q105511269
RX   PubMed=22110584;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=22110584).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QU ! Trpl8
OI   CVCL_A4QV ! Trpl17
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   Trpl8
AC   CVCL_A4QU
DR   Wikidata; Q105511272
RX   PubMed=22110584;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=22110584).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QV ! Trpl17
OI   CVCL_A4QW ! Trpl43
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   TRSC-1
AC   CVCL_D540
SY   Transformed Rabbit Spleen Cell line-1
DR   Wikidata; Q54973036
RX   PubMed=4150020;
RX   PubMed=4150021;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   TRSC-1-8
AC   CVCL_J952
DR   Wikidata; Q54973038
RX   PubMed=7021164;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
HI   CVCL_D540 ! TRSC-1
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   TRT-HU1
AC   CVCL_M720
DR   Wikidata; Q54973039
RX   PubMed=21136194;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 10
//
ID   TRT-HU2
AC   CVCL_9S98
DR   Wikidata; Q54973040
RX   PubMed=21136194;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   TruHD-Q21Q18F
AC   CVCL_A5VY
DR   Wikidata; Q107117125
RX   PubMed=30256717;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y898 ! ND30014
SX   Female
AG   52Y
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   TruHD-Q43Q17M
AC   CVCL_A5VZ
DR   Wikidata; Q107117126
RX   PubMed=30256717;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[43] (c.52CAG(43)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y899 ! ND30013
SX   Male
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   TruHD-Q50Q40F
AC   CVCL_A5WA
DR   Wikidata; Q107117127
RX   PubMed=30256717;
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[40] (c.52CAG(40)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717).
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[50] (c.52CAG(50)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Heterozygous (PubMed=30256717).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1I63 ! GM04857
SX   Female
AG   23Y
CA   Telomerase immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   TS
AC   CVCL_VH06
DR   Wikidata; Q54973041
RX   DOI=10.1093/oxfordjournals.jjco.a038751;
CC   Population: Japanese.
CC   Doubling time: ~47 hours (DOI=10.1093/oxfordjournals.jjco.a038751).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   TS 0111
AC   CVCL_E294
SY   TS0111; Pa29C; PL19
DR   Cosmic; 1473049
DR   Cosmic; 1509864
DR   Wikidata; Q54973042
RX   PubMed=16912165;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 11
//
ID   TS 0120
AC   CVCL_B7MK
SY   TS0120; PL20
DR   Wikidata; Q112930482
RX   PubMed=16912165;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   TS 0129
AC   CVCL_E295
SY   TS0129; Pa22C; Pa022C; PL21
DR   Cosmic; 1509874
DR   Wikidata; Q54973043
RX   PubMed=16912165;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 11
//
ID   TS 0226
AC   CVCL_E296
SY   TS0226; Pa112C; PL22
DR   Cosmic; 1473077
DR   Cosmic; 1509881
DR   Wikidata; Q54973044
RX   PubMed=16912165;
RX   PubMed=22753594;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 11
//
ID   TS 031
AC   CVCL_B7ML
SY   TS031; PL23
DR   Wikidata; Q112930483
RX   PubMed=16912165;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   TS 065
AC   CVCL_B7MM
SY   TS065; PL24
DR   Wikidata; Q112930484
RX   PubMed=16912165;
CC   From: Johns Hopkins University School of Medicine; Baltimore; USA.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   TS 10-7
AC   CVCL_V442
DR   ATCC; CRL-2835
DR   Wikidata; Q54973046
RX   PubMed=12734101;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-2835; true.
CC   Derived from site: In situ; Kidney, distal tubule; Note=From a cyst; UBERON=UBERON_0004135.
CC   Cell type: Epithelial cell of distal tubule; CL=CL_0002305.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V443 ! WT 10-7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   TS 106
AC   CVCL_F788
SY   TS106
DR   CLO; CLO_0009404
DR   ATCC; HB-12497
DR   Wikidata; Q54973048
RX   Patent=US5998151;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12497.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P04818; Human TYMS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   TS 111
AC   CVCL_F0V1
RX   PubMed=1170022;
CC   Characteristics: Temperature-sensitive; cytokinesis is blocked at 39 Celsius (PubMed=1170022).
CC   Doubling time: 24 hours (Note=At 34 Celsius) (PubMed=1170022).
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_RG46 ! GM7S
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   TS 9-7
AC   CVCL_V444
DR   ATCC; CRL-2831
DR   BioSample; SAMN03471800
DR   Wikidata; Q54973049
RX   PubMed=12734101;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-2831; true.
CC   Derived from site: In situ; Kidney, proximal tubule; Note=From a cyst; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): ATCC=CRL-2831
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_K231 ! WT 9-7
OI   CVCL_V445 ! WT 9-9
OI   CVCL_K230 ! WT 9-12
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 11
//
ID   TS ViPSC
AC   CVCL_JE74
DR   Wikidata; Q54973051
RX   PubMed=28412999;
CC   From: School of Regenerative Medicine, Manipal University; Bengaluru; India.
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
ST   Source(s): PubMed=28412999
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 8,11
ST   D18S51: 12,14
ST   D19S433: 12,14
ST   D21S11: 28
ST   D2S1338: 20,24
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   TS-2
AC   CVCL_A323
DR   Wikidata; Q54973052
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9494609;
RX   PubMed=15182431;
RX   PubMed=15744350;
RX   PubMed=32504922;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2683; DAZAP1 + HGNC; HGNC:6997; MEF2D; Name(s)=MEF2D-DAZAP1; Note=MEF2D exon 6 fused to DAZAP1 exon 7 and DAZAP1 exon 6 to MEF2D exon 7, both in frame (PubMed=15182431; PubMed=15744350; PubMed=32504922).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   TS-408
AC   CVCL_B5PW
DR   Wikidata; Q112041863
RX   PubMed=559490;
RX   PubMed=817596;
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TS-495
AC   CVCL_B5PX
DR   Wikidata; Q112041864
RX   PubMed=36611;
RX   PubMed=559490;
RX   PubMed=817596;
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ts-542
AC   CVCL_D6D8
DR   Wikidata; Q127384405
RX   PubMed=4856336;
CC   Characteristics: Does not grow at 39 Celsius. Before dying displays a peculiar web-like morphology and membrane projections (PubMed=4856336).
CC   Doubling time: 29 hours (Note=At 33 Celsius) (PubMed=4856336).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-546
AC   CVCL_D6D9
DR   Wikidata; Q127384406
RX   DOI=10.1016/0014-4827(76)90385-2;
RX   PubMed=4856409;
CC   Characteristics: Does not grow at 39 Celsius (PubMed=4856409).
CC   Doubling time: 25 hours (Note=At 33 Celsius) (PubMed=4856409).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-550C
AC   CVCL_D6DI
DR   Wikidata; Q127384407
RX   PubMed=6182621;
RX   PubMed=6499947;
CC   Characteristics: Does not grow at 39 Celsius (PubMed=6182621).
CC   Doubling time: 27 hours (Note=At 33 Celsius) (PubMed=6182621).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-559
AC   CVCL_D6DJ
DR   Wikidata; Q127384408
RX   PubMed=6499947;
CC   Characteristics: Does not grow at 39 Celsius (PubMed=6499947).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Misspelling: ts-669; PubMed=6499947; Note=In result section.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-655
AC   CVCL_D6DA
DR   Wikidata; Q127384409
RX   PubMed=986876;
CC   Characteristics: Does not grow at 39 Celsius (PubMed=986876).
CC   Doubling time: 30 hours (Note=At 33 Celsius) (PubMed=986876).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-687
AC   CVCL_D6DG
DR   Wikidata; Q127384410
RX   PubMed=631215;
CC   Characteristics: Does not grow at 39 Celsius. Defective in post-metaphase chromosome movement (PubMed=631215).
CC   Doubling time: 32 hours (Note=At 33 Celsius) (PubMed=631215).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-694
AC   CVCL_D6DK
SY   Ts-694
DR   Wikidata; Q127384412
RX   PubMed=6499947;
RX   PubMed=6569451;
CC   Characteristics: Does not grow at 39 Celsius (PubMed=6499947).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ts-745
AC   CVCL_D6DH
DR   Wikidata; Q127384413
RX   PubMed=6826652;
CC   Characteristics: Does not grow at 39 Celsius. Abnormal in centriole separation and chromosome movement (PubMed=6826652).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_D6D7 ! HM-1 [Hamster]
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   Ts-B
AC   CVCL_ZF50
DR   Wikidata; Q98133607
RX   PubMed=2160013;
CC   Group: Non-human primate cell line.
CC   Doubling time: ~4 days (PubMed=2160013).
CC   Transformant: NCBI_TaxID; 104240; Cynomolgus Epstein-Barr Virus TsB-B6.
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   Ts-B-6
AC   CVCL_ZF51
SY   Ts-B6; TsB6
DR   Wikidata; Q98133608
RX   PubMed=9227793;
RX   PubMed=10418823;
RX   PubMed=10971128;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 104240; Cynomolgus Epstein-Barr Virus TsB-B6.
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
HI   CVCL_ZF50 ! Ts-B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   Ts-B-9
AC   CVCL_ZF52
DR   Wikidata; Q98133609
RX   PubMed=1646886;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 104240; Cynomolgus Epstein-Barr Virus TsB-B6.
CC   Derived from site: In situ; Axillary lymph node; UBERON=UBERON_0001097.
OX   NCBI_TaxID=9541; ! Macaca fascicularis (Crab-eating macaque)
HI   CVCL_ZF50 ! Ts-B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   TS-CD4-38
AC   CVCL_XV56
DR   CCRID; 4201PAT-CCTCC00993
DR   Wikidata; Q98133610
RX   Patent=CN106995801B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016221.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; X2G4L1; Tupaia belangeri CD4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 7
//
ID   TS-ED
AC   CVCL_Y122
DR   ATCC; CRL-1406
DR   Wikidata; Q54973054
CC   Discontinued: ATCC; CRL-1406; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125699; Ehlers-Danlos syndrome, type IV
DI   ORDO; Orphanet_286; Vascular Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   TS-EH-1
AC   CVCL_A9HB
DR   CCRID; 5301MAM-KCB1007HZJ
DR   KCB; KCB 2010007HZJ
DR   Wikidata; Q108821402
CC   Derived from site: In situ; Fetal heart; UBERON=UBERON_0003084.
CC   Cell type: Fibroblast of heart; CL=CL_0002548.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
OI   CVCL_XC06 ! TS-EL-1
OI   CVCL_A9HC ! TS-ES-1
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   TS-EL-1
AC   CVCL_XC06
DR   CCRID; 5301MAM-KCB1007LZJ
DR   KCB; KCB 2010007LZJ
DR   KCB; KCB 2010134EL
DR   Wikidata; Q98133611
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
OI   CVCL_A9HB ! TS-EH-1
OI   CVCL_A9HC ! TS-ES-1
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   TS-ES-1
AC   CVCL_A9HC
DR   CCRID; 5301MAM-KCB1007SZJ
DR   KCB; KCB 2010007SZJ
DR   Wikidata; Q108821403
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
OI   CVCL_A9HB ! TS-EH-1
OI   CVCL_XC06 ! TS-EL-1
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   TS-IFNGamma-13
AC   CVCL_XV57
DR   CCRID; 4201PAT-CCTCC00994
DR   Wikidata; Q98133612
RX   Patent=CN107083370B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016222.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; S5WI25; Tupaia belangeri IFNG.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 7
//
ID   TS-K3
AC   CVCL_A9HE
SY   TSHK3
DR   CCRID; 5301MAM-KCB0305KZJ
DR   KCB; KCB 200305KZJ
DR   Wikidata; Q108821404
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
OI   CVCL_A9HF ! TS-L3
OI   CVCL_A9HG ! TS-R1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   TS-L3
AC   CVCL_A9HF
SY   TSHL3
DR   CCRID; 5301MAM-KCB0305LZJ
DR   KCB; KCB 200305LZJ
DR   Wikidata; Q108821405
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
OI   CVCL_A9HE ! TS-K3
OI   CVCL_A9HG ! TS-R1
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   TS-R1
AC   CVCL_A9HG
SY   TSHR1
DR   CCRID; 5301MAM-KCB0305RZJ
DR   KCB; KCB 200305RZJ
DR   Wikidata; Q108821406
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
OI   CVCL_A9HE ! TS-K3
OI   CVCL_A9HF ! TS-L3
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   TS-RM-1
AC   CVCL_W501
SY   TS-RM1
DR   Cosmic; 1718362
DR   Cosmic; 2356031
DR   Wikidata; Q54973055
RX   PubMed=7669751;
RX   PubMed=22142829;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Characteristics: Established from a transplanted tumor (TS-RM-1nu) in BALB/c nu/nu mice.
CC   Doubling time: 31 hours (PubMed=7669751).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 11
//
ID   TS-S4
AC   CVCL_A9HD
DR   CCRID; 5301MAM-KCB0306SZJ
DR   KCB; KCB 200306SZJ
DR   Wikidata; Q108821407
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   TS.10.1
AC   CVCL_6E16
SY   TS10.1; 10.1
DR   Wikidata; Q54973065
RX   PubMed=10706684;
RX   PubMed=26856701;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   TS.32.15
AC   CVCL_6E17
SY   TS32.15
DR   Wikidata; Q54973066
RX   PubMed=10706684;
RX   PubMed=18572245;
RX   PubMed=18824023;
RX   PubMed=31926174;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
OI   CVCL_6E20 ! TS.32.5
OI   CVCL_6E18 ! TS.32.17
OI   CVCL_6E19 ! TS.32.32
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   TS.32.17
AC   CVCL_6E18
SY   TS32.17
DR   Wikidata; Q54973067
RX   PubMed=10706684;
RX   PubMed=18824023;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
OI   CVCL_6E20 ! TS.32.5
OI   CVCL_6E17 ! TS.32.15
OI   CVCL_6E19 ! TS.32.32
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   TS.32.32
AC   CVCL_6E19
DR   Wikidata; Q54973068
RX   PubMed=10706684;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
OI   CVCL_6E20 ! TS.32.5
OI   CVCL_6E17 ! TS.32.15
OI   CVCL_6E18 ! TS.32.17
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   TS.32.5
AC   CVCL_6E20
DR   Wikidata; Q54973069
RX   PubMed=10706684;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
OI   CVCL_6E17 ! TS.32.15
OI   CVCL_6E18 ! TS.32.17
OI   CVCL_6E19 ! TS.32.32
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   TS.75.2
AC   CVCL_6E21
DR   Wikidata; Q54973070
RX   PubMed=10706684;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=7998; ! Ictalurus punctatus (Channel catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   TS/A
AC   CVCL_F736
SY   TSA
DR   BTO; BTO_0004282
DR   CLO; CLO_0009405
DR   CLDB; cl4545
DR   ChEMBL-Cells; CHEMBL3308478
DR   ChEMBL-Targets; CHEMBL615017
DR   Lonza; 103
DR   Millipore; SCC177
DR   PubChem_Cell_line; CVCL_F736
DR   Wikidata; Q50433109
RX   PubMed=3455746;
RX   PubMed=3875361;
RX   PubMed=6546207;
RX   PubMed=11263530;
RX   PubMed=15004469;
RX   PubMed=31783695;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/TS/A
WW   Provider; Metalab; -; https://web.archive.org/web/20170423051818/http://lollini.it/tsa.htm
CC   Characteristics: Metastatic. When injected subcutaneously into syngeneic BALB/c mice, give rise to local tumors rapidly disseminating to the lungs.
CC   Karyotypic information: Triploid karyotype (PubMed=15004469).
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (PubMed=11263530).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
ST   Source(s): Millipore=SCC177
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.1
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 15.2,16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 17
ST   Mouse STR 18-3: 18,19
ST   Mouse STR 19-2: 13,15
ST   Mouse STR X-1: 24,25
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   TS/A clone E1
AC   CVCL_L871
SY   E1
DR   CLO; CLO_0002857
DR   CLDB; cl1121
DR   Wikidata; Q54973058
RX   PubMed=3875361;
RX   PubMed=6543703;
CC   Characteristics: High metastatic potential.
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TS/A clone E2
AC   CVCL_L872
SY   E2
DR   CLO; CLO_0002860
DR   CLDB; cl1123
DR   Wikidata; Q54973059
RX   PubMed=3875361;
RX   PubMed=6543703;
CC   Characteristics: High metastatic potential.
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TS/A clone E3
AC   CVCL_L873
SY   E3
DR   CLO; CLO_0002861
DR   CLDB; cl1124
DR   Wikidata; Q54973060
RX   PubMed=3875361;
RX   PubMed=6543703;
CC   Characteristics: High metastatic potential.
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TS/A clone F1
AC   CVCL_L874
SY   F1
DR   CLO; CLO_0002960
DR   CLDB; cl1187
DR   Wikidata; Q54973061
RX   PubMed=3875361;
RX   PubMed=6543703;
CC   Characteristics: Low metastatic potential.
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TS/A clone F2
AC   CVCL_L875
SY   F2
DR   CLO; CLO_0002972
DR   CLDB; cl1192
DR   Wikidata; Q54973063
RX   PubMed=3875361;
RX   PubMed=6543703;
CC   Characteristics: Low metastatic potential.
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TS/A clone F5
AC   CVCL_L876
SY   F5
DR   CLO; CLO_0002983
DR   CLDB; cl1195
DR   Wikidata; Q54973064
RX   PubMed=3875361;
RX   PubMed=6543703;
CC   Characteristics: Low metastatic potential.
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   TS/A-pc
AC   CVCL_VQ63
SY   TSA-pc; TS/A p.c.; TS/A-parental cells
DR   Wikidata; Q98133613
RX   PubMed=7954438;
RX   PubMed=7989764;
RX   PubMed=31783695;
CC   Sequence variation: Mutation; MGI; MGI:98834; Trp53; Simple; p.Arg270His (c.809G>A); Zygosity=Unspecified (from parent cell line).
CC   Caution: Termed "pc" for "parental cells" not because it is supposed to be identical to TS/A but because it is the parent cell line for a number of transfectants.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cAnNCrlBR.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F736 ! TS/A
SX   Female
AG   1Y8M
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TS01
AC   CVCL_F0I2
RX   PubMed=1918041;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TS02
AC   CVCL_F0I3
RX   PubMed=1918041;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01222; Human TSHB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   TS1-iPS-C1
AC   CVCL_UG64
SY   TS1-iPS-C1P22
DR   GEO; GSM807102
DR   Wikidata; Q98133615
RX   PubMed=21949351;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG65 ! TS1-iPS-C2
OI   CVCL_UG66 ! TS1-iPS-C3
OI   CVCL_UG67 ! TS1-iPS-C5
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   TS1-iPS-C2
AC   CVCL_UG65
DR   Wikidata; Q98133616
RX   PubMed=21949351;
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 9
ST   D18S51: 14,24
ST   D21S11: 29,30
ST   D3S1358: 18
ST   D5S818: 10,13
ST   D7S820: 11,14
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG64 ! TS1-iPS-C1
OI   CVCL_UG66 ! TS1-iPS-C3
OI   CVCL_UG67 ! TS1-iPS-C5
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TS1-iPS-C3
AC   CVCL_UG66
SY   TS1-iPS-C3P24
DR   GEO; GSM807103
DR   Wikidata; Q98133618
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG64 ! TS1-iPS-C1
OI   CVCL_UG65 ! TS1-iPS-C2
OI   CVCL_UG67 ! TS1-iPS-C5
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   TS1-iPS-C5
AC   CVCL_UG67
SY   TS1-iPS-C5P20
DR   GEO; GSM807104
DR   Wikidata; Q98133619
RX   PubMed=21949351;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
ST   Source(s): PubMed=21949351
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 9
ST   D18S51: 14,24
ST   D21S11: 29,30
ST   D3S1358: 18
ST   D5S818: 10,13
ST   D7S820: 11,14
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   Penta D: 9,10
ST   Penta E: 11,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG64 ! TS1-iPS-C1
OI   CVCL_UG65 ! TS1-iPS-C2
OI   CVCL_UG66 ! TS1-iPS-C3
SX   Female
AG   20FW
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   TS1/18.1.2.11
AC   CVCL_F789
DR   CLO; CLO_0009406
DR   ATCC; HB-203
DR   Wikidata; Q54973071
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TS1/22.1.1.13
AC   CVCL_F790
DR   CLO; CLO_0009407
DR   ATCC; HB-202
DR   Wikidata; Q54973072
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TS10
AC   CVCL_E857
DR   IHW; 9w 1005
DR   Wikidata; Q54973073
CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.
CC   HLA typing: A*26; B*38 (IHW=9w 1005).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 16
//
ID   TS2-iPS-C11
AC   CVCL_UG58
DR   Wikidata; Q98133622
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X241 ! GM01176
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 02-05-24; Version: 7
//
ID   TS2-iPS-C7
AC   CVCL_UG59
DR   Wikidata; Q98133623
RX   PubMed=21949351;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X241 ! GM01176
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 02-05-24; Version: 7
//
ID   TS2/16.2.1
AC   CVCL_F791
DR   CLO; CLO_0009408
DR   ATCC; HB-243
DR   Wikidata; Q54973074
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05556; Human ITGB1/CD29.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   TS2/18.1.1
AC   CVCL_F792
DR   CLO; CLO_0009409
DR   ATCC; HB-195
DR   Wikidata; Q54973084
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TS2/4.1.1
AC   CVCL_F793
DR   CLO; CLO_0009410
DR   ATCC; HB-244
DR   Wikidata; Q54973085
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TS2/7.1.1
AC   CVCL_F794
DR   CLO; CLO_0009411
DR   ATCC; HB-245
DR   Wikidata; Q54973086
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P56199; Human ITGA1/CD49a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TS2/9.1.4.3
AC   CVCL_F795
SY   TS2/9.1.1.4.3
DR   CLO; CLO_0009412
DR   ATCC; HB-205
DR   Wikidata; Q54973088
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P19256; Human CD58.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TS3-iPS-C12
AC   CVCL_UG60
DR   Wikidata; Q98133624
RX   PubMed=21949351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X237 ! GM00857
SX   Female
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TS3-iPS-C7
AC   CVCL_UG61
DR   Wikidata; Q98133625
RX   PubMed=21949351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X237 ! GM00857
SX   Female
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   ts3b2
AC   CVCL_C568
SY   ts 3b-2
DR   Wikidata; Q54973092
RX   PubMed=6683997;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0386 ! L6E9
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   Ts4
AC   CVCL_A8EG
DR   Wikidata; Q107117128
RX   PubMed=18620756;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; Q9JMI7; Mouse Tex101.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   ts422E
AC   CVCL_LH71
SY   ts 422E; ts-422E; 422E
DR   Wikidata; Q54973093
RX   PubMed=291978;
RX   PubMed=528570;
RX   PubMed=4267115;
RX   PubMed=4515626;
CC   Characteristics: Temperature sensitive. Loses the ability to synthesize polyamines and 5.8s rRNA at the non-permissive temperature (39 Celsius).
CC   Doubling time: 16 hours (Note=At 33 Celsius) (PubMed=4515626).
CC   Transformant: ChEBI; CHEBI_60761; 5-fluoro-2'-deoxyuridine (FUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   ts485
AC   CVCL_C567
DR   Wikidata; Q54973094
RX   PubMed=3043175;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thigh, skeletal muscle; UBERON=UBERON_0004252.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C568 ! ts3b2
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   TS516
AC   CVCL_A5HY
DR   Wikidata; Q107117129
RX   PubMed=23558169;
CC   Doubling time: ~2 days (Direct_author_submission).
CC   Miscellaneous: Cell line has been lost (personal communication of Weis-Garcia, Frances M.B.).
CC   Miscellaneous: Doubling time from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   TS603
AC   CVCL_A5HW
DR   cancercelllines; CVCL_A5HW
DR   Wikidata; Q107117130
RX   PubMed=23558169;
RX   PubMed=33504762;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/ts603-human-brain-cancer-glioblastoma-cell-line
CC   Doubling time: ~7 days (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous (PubMed=23558169; PubMed=33504762).
CC   Miscellaneous: STR profile and doubling time from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 13,16
ST   D12S391: 20,22
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 14,16
ST   D19S433: 15.2
ST   D1S1656: 11,15
ST   D21S11: 29,32.2
ST   D22S1045: 16
ST   D2S1338: 17,25
ST   D2S441: 10,11.3
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 20,21
ST   Penta D: 8,14
ST   Penta E: 16
ST   TH01: 7,9.3
ST   TPOX: 9,10
ST   vWA: 16,18
DI   NCIt; C4326; Anaplastic oligodendroglioma
DI   ORDO; Orphanet_251630; Anaplastic oligodendroglioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   TS676
AC   CVCL_A5HX
DR   Wikidata; Q107117131
RX   PubMed=23558169;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/ts676-human-brain-cancer-glioblastoma-cell-line
CC   Doubling time: ~7 days (Direct_author_submission).
CC   Miscellaneous: STR profile and doubling time from MSKCC antibody and bioresource core facility.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 16
ST   D12S391: 18
ST   D13S317: 11,14
ST   D16S539: 10,12
ST   D18S51: 16,17
ST   D19S433: 14,16
ST   D1S1656: 14,16
ST   D21S11: 31,31.2
ST   D22S1045: 16
ST   D2S1338: 17,20
ST   D2S441: 10,11
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 8,12
ST   DYS391: 10
ST   FGA: 19,25
ST   Penta D: 7,15
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   TS9;22
AC   CVCL_A691
SY   TS9:22; TS9-22; TS 9:22
DR   cancercelllines; CVCL_A691
DR   CGH-DB; 9347-4
DR   Cosmic; 996326
DR   Cosmic; 998758
DR   Cosmic; 1012126
DR   Cosmic; 1037678
DR   Cosmic; 2089678
DR   Wikidata; Q54973096
RX   CelloPub=CLPUB00588;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7808006;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
RX   PubMed=16408098;
RX   PubMed=23955599;
RX   PubMed=26700326;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (CelloPub=CLPUB00588; PubMed=7808006; PubMed=10071072; PubMed=10576511).
CC   Sequence variation: Mutation; HGNC; HGNC:18318; ASXL1; Simple; p.Arg693Ter (c.2077C>T); ClinVar=VCV000620281; Zygosity=Homozygous (PubMed=26700326).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   tsA Cl2A
AC   CVCL_WW32
DR   Wikidata; Q98133626
RX   PubMed=6141846;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   tsa-N11
AC   CVCL_5V12
DR   Wikidata; Q54973097
RX   PubMed=201774;
RX   PubMed=214570;
CC   Transformant: NCBI_TaxID; 1891730; Murine polyomavirus (MPyV) (Note=Pytsa).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C691 ! FR3T3
SX   Sex unspecified
AG   15FD
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   tsA201
AC   CVCL_2737
SY   tsA-201
DR   BTO; BTO_0004232
DR   EFO; EFO_0022697
DR   ECACC; 96121229
DR   Wikidata; Q54973099
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-339.html
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=96121229
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,13
ST   D5S818: 8,9
ST   D7S820: 11
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   TSA8
AC   CVCL_A799
SY   TSA-8
DR   CLO; CLO_0050773
DR   RCB; RCB2852
DR   TKG; TKG 0370
DR   Wikidata; Q54973100
RX   PubMed=2835222;
RX   PubMed=6574510;
CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).
CC   Breed/subspecies: DBA/2.
DI   NCIt; C21895; Mouse erythroid leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   tsAF8
AC   CVCL_LH56
SY   ts AF8; AF8
DR   Wikidata; Q54973101
RX   PubMed=4267115;
RX   PubMed=4373487;
RX   PubMed=7191857;
RX   PubMed=11674999;
CC   Characteristics: Temperature sensitive. Arrests at the non-permissive temperature (40.6 Celsius) in the mid-G1 phase and is deficient in RNA polymerase II activity.
CC   Doubling time: ~18 hours (Note=At 33 Celsius) (PubMed=4373487).
CC   Sequence variation: Mutation; UniProtKB; A0A1U8BM24; Polr2a; Simple; p.Ala315Asp (c.944C>A); Zygosity=Heterozygous (PubMed=11674999).
CC   Transformant: ChEBI; CHEBI_60761; 5-fluoro-2'-deoxyuridine (FUdR).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   tsAM5D
AC   CVCL_6B20
DR   Wikidata; Q54973102
RX   PubMed=12753072;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: C57BL/6J SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   5-10M
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   tsAM5NE
AC   CVCL_F706
DR   Wikidata; Q54973103
RX   PubMed=21029049;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Adrenal gland, medulla; UBERON=UBERON_0001236.
CC   Cell type: Chromaffin cell; CL=CL_0000166.
CC   Breed/subspecies: C57BL/6J SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 11
//
ID   tsAUXB1
AC   CVCL_C8BU
DR   Wikidata; Q123033653
RX   PubMed=4472030;
CC   Characteristics: Auxotrophic for glycine, adenosine, and thymidine (GAT-) at 38.5 Celsius and prototrophic at 34 Celsius (PubMed=4472030).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D264 ! CHO-AUXB1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   TSB
AC   CVCL_B7QH
SY   Tilapia Spilurus Brain
DR   Wikidata; Q112930485
RX   DOI=10.1111/j.1095-8649.1987.tb05322.x;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 28 Celsius (DOI=10.1111/j.1095-8649.1987.tb05322.x).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=64544; ! Oreochromis spilurus (Sabaki tilapia)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   tsBN2
AC   CVCL_U467
DR   CLO; CLO_0051408
DR   RCB; RCB1264
DR   Wikidata; Q54973104
RX   PubMed=694723;
RX   PubMed=1851087;
RX   PubMed=2300055;
RX   PubMed=3785187;
CC   Characteristics: At the nonpermissive temperature (39.5 Celsius), the chromatin of tsBN2 cells is prematurely condensed, and the cells die (PubMed=694723).
CC   Sequence variation: Mutation; UniProtKB; P23800; Rcc1; Simple; p.Ser256Phe (c.767C>T); Zygosity=Homozygous (PubMed=2300055).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   tsBN2-N9
AC   CVCL_E3K4
RX   PubMed=3785187;
CC   Characteristics: Thymidine kinase-negative derivative of parent cell line (PubMed=3785187).
CC   Sequence variation: Mutation; UniProtKB; P23800; Rcc1; Simple; p.Ser256Phe (c.767C>T); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_U467 ! tsBN2
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   tsBN250
AC   CVCL_U468
SY   BN250
DR   CLO; CLO_0051405
DR   RCB; RCB1272
DR   Wikidata; Q54973106
RX   PubMed=6891837;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   tsBN269
AC   CVCL_U469
DR   CLO; CLO_0051406
DR   RCB; RCB1273
DR   Wikidata; Q54973108
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   tsBN462
AC   CVCL_U470
SY   BN462
DR   CLO; CLO_0051404
DR   RCB; RCB1268
DR   Wikidata; Q54973109
RX   PubMed=6891837;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 8
//
ID   tsBN51
AC   CVCL_U471
DR   CLO; CLO_0051410
DR   RCB; RCB1270
DR   Wikidata; Q54973110
RX   PubMed=694723;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   tsBN67
AC   CVCL_U472
DR   CLO; CLO_0051411
DR   RCB; RCB1271
DR   Wikidata; Q54973111
RX   PubMed=694723;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   tsBN7
AC   CVCL_U473
DR   CLO; CLO_0051409
DR   RCB; RCB1267
DR   TOKU-E; 3992
DR   Wikidata; Q54973112
RX   PubMed=694723;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   tsBN75
AC   CVCL_U474
DR   CLO; CLO_0051407
DR   RCB; RCB1269
DR   Wikidata; Q54973113
RX   PubMed=694723;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 9
//
ID   tsc2 ang1
AC   CVCL_6784
SY   tsc2ang1
DR   CLO; CLO_0009414
DR   ATCC; CRL-2620
DR   Wikidata; Q54973114
DI   NCIt; C21840; Sarcomas of the mouse skin and subcutis
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   TSCC-1
AC   CVCL_WD19
SY   Tongue Squamous Cell Carcinoma-1
DR   IBRC; C10555
DR   Wikidata; Q98133627
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   TSCC1
AC   CVCL_XE94
DR   CCRID; 4201PAT-CCTCC00436
DR   Wikidata; Q98133628
RX   PubMed=29770536;
CC   Group: Patented cell line.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   TSCCa
AC   CVCL_VL15
SY   TSCCA
DR   BTO; BTO_0006082
DR   CCTCC; GDC0184
DR   Wikidata; Q98133629
RX   PubMed=10779629;
RX   PubMed=12149736;
RX   PubMed=15929393;
RX   PubMed=26116706;
RX   PubMed=28107433;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706; PubMed=28107433). Originally thought to originate from a tongue squamous cell carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00579.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=26116706; PubMed=28107433
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D2S441: 10,11
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,13 (PubMed=28107433)
ST   Penta D: 8,15 (PubMed=26116706)
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   TsCD146
AC   CVCL_XB47
DR   Wikidata; Q98133630
RX   Patent=US11427648;
RX   PubMed=29348825;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-5246.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P43121; Human MCAM/CD146.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   TSCE5
AC   CVCL_WN50
DR   Wikidata; Q98133631
RX   PubMed=14673874;
RX   PubMed=20673130;
RX   PubMed=21161544;
CC   Group: Space-flown cell line (cellonaut).
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Anecdotal: Have been flown in space on the ISS in 2008-2009 to study the biological effects of space radiations, microgravity and the space environment on the expression of TP53-regulated genes (PubMed=20673130; PubMed=21161544).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0561 ! TK6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   TSCER2
AC   CVCL_WN51
DR   Wikidata; Q98133633
RX   PubMed=14673874;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=14673874).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Unexplicit; G>A at bp 23 of exon 5; Zygosity=Heterozygous (PubMed=14673874).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WN50 ! TSCE5
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   tsCLC-D
AC   CVCL_WK98
SY   temperature-sensitive Caprine Luteal Cell line-D
DR   Wikidata; Q98133634
RX   PubMed=19280881;
CC   Characteristics: At the permissive temperature (34 Celsius) these cells are spindle-shaped and grow rapidly. At the non-permissive temperature (40 Celsius) the cells exhibits a round shape and ceases to proliferate.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA209).
CC   Derived from site: In situ; Ovary, corpus luteum; UBERON=UBERON_0002512.
CC   Cell type: Luteal cell; CL=CL_0000175.
CC   Breed/subspecies: Taiwan native; VBO=VBO_0009453.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   1-3Y
CA   Conditionally immortalized cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 8
//
ID   TSD-01-hiPSC
AC   CVCL_A4NQ
DR   Wikidata; Q105511275
RX   PubMed=27879213;
CC   From: University of Alabama at Birmingham; Birmingham; USA.
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; p.Tyr427Ilefs*5 (c.1274_1277dupTATC) (c.1278insTATC); ClinVar=VCV000003889; Zygosity=Heterozygous (PubMed=27879213).
CC   Sequence variation: Mutation; HGNC; HGNC:4878; HEXA; Simple; c.1421+1G>C (IVS12+1G>C); ClinVar=VCV000003890; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=27879213).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U382 ! GM00502
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   TSd-1
AC   CVCL_XV58
DR   Wikidata; Q98133635
RX   PubMed=9560784;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Tupaia glis spermatogenic cells antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 3
//
ID   TSD-B4S
AC   CVCL_A7AK
DR   RCB; RCB5297
DR   Wikidata; Q107117132
RX   PubMed=24723111;
CC   Doubling time: 13.4 hours (Note=At 5th passage) (PubMed=24723111).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60468; Rat malignant teratoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A7AM ! TSD-P
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   TSD-F9R
AC   CVCL_A7AL
DR   RCB; RCB5298
DR   Wikidata; Q107117133
RX   PubMed=24723111;
CC   Doubling time: 15.7 hours (Note=At 5th passage) (PubMed=24723111).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60468; Rat malignant teratoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A7AM ! TSD-P
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   TSD-P
AC   CVCL_A7AM
DR   Wikidata; Q107117134
RX   PubMed=24723111;
CC   Doubling time: 12.1 hours (Note=At 25th passage) (PubMed=24723111).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60468; Rat malignant teratoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   2M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   tsDC
AC   CVCL_4331
SY   ts DC
DR   ECACC; 01081609
DR   Wikidata; Q54973115
RX   PubMed=8921940;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4W
CA   Conditionally immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   TSE
AC   CVCL_0563
DR   MCCL; MCC:0000465
DR   Wikidata; Q54973116
RX   PubMed=9288153;
CC   From: Powell, Simon N.; Department of Radiation Oncology, Massachusetts General Hospital; Boston; USA.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   TSE.06
AC   CVCL_UI44
DR   Wikidata; Q98133637
RX   PubMed=9288153;
CC   Characteristics: Adapted to glutamine deprivation.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0563 ! TSE
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   TSEC
AC   CVCL_LF84
SY   Transformed Sinusoidal Endothelial Cells
DR   GEO; GSE67651
DR   Wikidata; Q54973118
RX   PubMed=20644520;
RX   PubMed=27454769;
CC   Doubling time: ~10 hours (PubMed=20644520).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Endothelial cell of hepatic sinusoid; CL=CL_1000398.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 7
//
ID   tsET24
AC   CVCL_LJ52
SY   ts ET24; ET24
DR   Wikidata; Q54973119
RX   PubMed=9251028;
RX   PubMed=12944373;
RX   PubMed=15383328;
CC   Characteristics: Temperature sensitive. At the non-permissive temperature of 39.5 Celsius, this cell line is arrested in the G1-phase and survives for more than 3 days.
CC   Sequence variation: Mutation; UniProtKB; Q8K5D5; Ddx3x; Simple; p.Pro267Ser (c.799C>T); Zygosity=Unspecified (PubMed=12944373).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1915 ! BHK-21 clone 13
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 8
//
ID   TSF19
AC   CVCL_W807
SY   Texel Sheep Fibroblast 19
DR   Wikidata; Q54973120
RX   PubMed=19448741;
CC   Doubling time: 24.9 hours (PubMed=19448741).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Texel; VBO=VBO_0001641.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 9
//
ID   TSFAT-3
AC   CVCL_1N76
DR   Wikidata; Q54973121
RX   PubMed=1071084;
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N75 ! SFAT-3
SX   Male
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 21-03-23; Version: 3
//
ID   TSFAT-3.fl
AC   CVCL_F500
DR   CLO; CLO_0050782
DR   RCB; RCB0562
DR   Wikidata; Q54973122
RX   PubMed=1071084;
CC   Breed/subspecies: DDD.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1N76 ! TSFAT-3
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   TSG11
AC   CVCL_B477
SY   TSG-11
DR   Cosmic; 848378
DR   Wikidata; Q54973123
RX   CelloPub=CLPUB00145;
RX   PubMed=15767549;
CC   Part of: JFCR45 cancer cell line panel.
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: TGS-11; PubMed=15767549.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   TSG6
AC   CVCL_S861
SY   TSG-6
DR   Wikidata; Q54973124
RX   DOI=10.1016/B978-0-12-333530-2.50014-9;
RX   PubMed=8054813;
CC   Population: Japanese.
CC   Doubling time: ~44 hours (PubMed=8054813).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 12
//
ID   TSGH
AC   CVCL_E5JX
SY   Three Spot Gourami Heart
DR   NRFC; NRFC081
WW   Provider; NRFC; NRFC081; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC081.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=96903; ! Trichopodus trichopterus (Three spot gourami)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TSGH-8301
AC   CVCL_A342
SY   TSGH8301; TSGH 8301; Tri-Service General Hospital-8301
DR   BCRC; 60145
DR   cancercelllines; CVCL_A342
DR   Cosmic; 755397
DR   Wikidata; Q54973126
RX   PubMed=3352272;
RX   PubMed=29732388;
WW   Info; BCRC; -; https://www.bcrc.firdi.org.tw/attach/2019-05-28/a.pdf
CC   Problematic cell line: Contaminated. Shown to be a ME-180 derivative (BCRC=60145 and STR profile). Originally thought to originate from a 56 year old male patient with a grade 2 stage A papillary transitional cell carcinoma.
CC   Population: Caucasian.
CC   Doubling time: 26 hours (PubMed=3352272).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).
CC   Miscellaneous: STR profile from personal communication of Chow, Kin-Hoe.
CC   Discontinued: BCRC; 60145; true.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D21S11: 30,31
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1401 ! ME-180
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   TSGH-8302
AC   CVCL_N030
SY   TSGH8302; TSGH 8302; Tri-Service General Hospital-8302
DR   ChEMBL-Cells; CHEMBL3307472
DR   ChEMBL-Targets; CHEMBL615019
DR   PubChem_Cell_line; CVCL_N030
DR   Wikidata; Q54973127
RX   PubMed=1855216;
RX   PubMed=21607305;
DI   NCIt; C4029; Cervical adenocarcinoma
DI   ORDO; Orphanet_213772; Adenocarcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   TSGH-9201
AC   CVCL_5379
SY   TSGH9201; TSGH 9201; Tri-Service General Hospital-9201
DR   BCRC; 60146
DR   ChEMBL-Cells; CHEMBL3307708
DR   ChEMBL-Targets; CHEMBL614787
DR   PubChem_Cell_line; CVCL_5379
DR   Wikidata; Q54973128
RX   PubMed=7823569;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=TSGH9201
CC   Doubling time: 33-38 hours (PubMed=7823569).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): BCRC=60146
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TSHC
AC   CVCL_DE15
SY   Tongue Sole Heart Cell line
DR   Wikidata; Q54973129
RX   DOI=10.1111/are.12813;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 6
//
ID   TSHKC
AC   CVCL_R877
SY   Tong Sole Head Kidney Cell line
DR   Wikidata; Q54973131
RX   PubMed=22660891;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head kidney; UBERON=UBERON_0007132.
OX   NCBI_TaxID=244447; ! Cynoglossus semilaevis (Tongue sole)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   TSHR-R5T-34
AC   CVCL_F796
DR   CLO; CLO_0009416
DR   ATCC; CRL-2683
DR   Wikidata; Q54973132
RX   PubMed=1570295;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TSHR-R5T-44
AC   CVCL_F797
DR   CLO; CLO_0009417
DR   ATCC; CRL-2681
DR   Wikidata; Q54973133
RX   PubMed=1570295;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TSHR-T3-365
AC   CVCL_F798
SY   T3-356
DR   CLO; CLO_0009418
DR   ATCC; CRL-2684
DR   Wikidata; Q54973140
RX   PubMed=1570295;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TSHR-T5-51
AC   CVCL_F799
SY   T5-51
DR   CLO; CLO_0009419
DR   ATCC; CRL-2680
DR   Wikidata; Q54973141
RX   PubMed=1570295;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TSHR-T5U-317
AC   CVCL_F800
SY   T5-317
DR   CLO; CLO_0009420
DR   ATCC; CRL-2682
DR   Wikidata; Q54973142
RX   PubMed=1570295;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16473; Human TSHR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   TSHSUi001-A
AC   CVCL_C9LQ
DR   hPSCreg; TSHSUi001-A
DR   Wikidata; Q123033655
RX   PubMed=37392704;
CC   From: The Second Hospital of Shandong University; Jinan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; c.290+1G>A; ClinVar=VCV000428787; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=37392704).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3324; Peutz-Jeghers syndrome
DI   ORDO; Orphanet_2869; Peutz-Jeghers syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   TSHSUi002-A
AC   CVCL_C9LR
DR   hPSCreg; TSHSUi002-A
DR   Wikidata; Q123033656
CC   From: The Second Hospital of Shandong University; Jinan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   tsJT16
AC   CVCL_L709
SY   tsJT16(3Y1)
DR   JCRB; JCRB0153.2
DR   JCRB; NIHS0233.2
DR   Wikidata; Q54973143
RX   PubMed=6692850;
CC   Characteristics: Cell line grows at 34 Celsius but the growth is arrested at 40 Celsius (JCRB=JCRB0153.2).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0233.2; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   tsJT60
AC   CVCL_L710
SY   tsJT60(3Y1)
DR   JCRB; JCRB0153.3
DR   JCRB; NIHS0233.3
DR   Wikidata; Q54973144
RX   PubMed=6692850;
CC   Characteristics: Cell line grows at 34 Celsius but the growth is arrested at 40 Celsius (JCRB=JCRB0153.3).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0233.3; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   tsJT663
AC   CVCL_L711
SY   tsJT663(3Y1)
DR   JCRB; JCRB0153.1
DR   JCRB; NIHS0233.1
DR   Wikidata; Q54973146
RX   PubMed=8082723;
CC   Characteristics: Cell line grows at 34 Celsius but the growth is arrested at 40 Celsius (JCRB=JCRB0153.1).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Discontinued: JCRB; NIHS0233.1; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 14
//
ID   TSK-CHO1
AC   CVCL_B6KJ
DR   Wikidata; Q112041865
RX   PubMed=35098443;
CC   Population: Japanese.
CC   Doubling time: 47.8 hours (PubMed=35098443).
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
ST   Source(s): PubMed=35098443
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11,14
ST   D18S51: 14,17
ST   D21S11: 29
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,15
ST   FGA: 23,26
ST   Penta D: 9,14
ST   Penta E: 11,12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   TSL
AC   CVCL_A2JW
SY   Tilapia Stem Leydig
DR   Wikidata; Q105511278
RX   PubMed=33153523;
CC   Group: Fish cell line.
CC   Characteristics: Capable of 11- ketotestosterone (11-KT) production.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig stem cell; CL=CL_0009091.
OX   NCBI_TaxID=8128; ! Oreochromis niloticus (Nile tilapia)
SX   Male
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   TSM1
AC   CVCL_U157
SY   TSM
DR   BTO; BTO_0004762
DR   Wikidata; Q54973147
RX   PubMed=8793865;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P01110; Avian myelocytomatosis virus 29 v-Myc.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Transformant: v-Myc.
CC   Derived from site: In situ; Embryonic brain, neocortex; UBERON=UBERON_0006238+UBERON_0001950.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 12
//
ID   TSM15
AC   CVCL_LH53
DR   Wikidata; Q54973149
RX   PubMed=28063233;
CC   Population: Japanese.
CC   Characteristics: Exhibits a robust proliferation at the permissive temperature of 33 Celsius. One day after the temperature shift from 33 to 37 Celsius, the cell growth is arrested.
CC   Doubling time: ~4 days (PubMed=28063233).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Muscle, right biceps brachii; UBERON=UBERON_0001507.
CC   Cell type: Microvascular endothelial cell; CL=CL_2000008.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 10
//
ID   TSMK-1
AC   CVCL_DE04
SY   Transformed Swiss Mouse Kidney-1
DR   Wikidata; Q54973150
RX   PubMed=14120333;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   TSR6
AC   CVCL_WL33
SY   Tree Shrew Renal cell #6
DR   KCB; KCB 2018047YJ
DR   Wikidata; Q98133638
RX   PubMed=30637496;
CC   Doubling time: ~20 hours (Direct_author_submission).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Miscellaneous: Age/sex of donor and doubling time from personal communication of Gu, Tian-Le.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=246437; ! Tupaia chinensis (Chinese tree shrew)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   TSRI51i-HDF1003
AC   CVCL_UF48
SY   HDF51iPS1003
DR   Wikidata; Q98133640
RX   PubMed=26892726;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   TSRI51i-HDF11
AC   CVCL_UF49
SY   HDF51iPS11
DR   Wikidata; Q98133642
RX   PubMed=26892726;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   TSRI51i-HDF509
AC   CVCL_UF50
SY   HDF51i-509; HDF51i509; HDF51iPS509
DR   Wikidata; Q98133644
RX   PubMed=23514962;
RX   PubMed=26892726;
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   TSRI68i-HDF505
AC   CVCL_UF51
SY   HDF68i-505
DR   Wikidata; Q98133646
RX   PubMed=23514962;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   TSRIi-HEML503
AC   CVCL_UF52
SY   HMi-503
DR   Wikidata; Q98133647
RX   PubMed=23514962;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UF53 ! TSRIi-HEML506
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TSRIi-HEML506
AC   CVCL_UF53
SY   HMi-506
DR   Wikidata; Q98133649
RX   PubMed=23514962;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Melanocyte of skin; CL=CL_1000458.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UF52 ! TSRIi-HEML503
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   TSS
AC   CVCL_M750
SY   Trout Splenic Stroma
DR   Wikidata; Q54973151
RX   PubMed=22634253;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8022; ! Oncorhynchus mykiss (Rainbow trout)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   tST-14
AC   CVCL_GS38
SY   transformed Swine Testicle-clone 14
DR   Wikidata; Q54973152
RX   PubMed=2175590;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_GS40 ! tST-3
OI   CVCL_GS39 ! tST-18
SX   Male
AG   40D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   tST-18
AC   CVCL_GS39
SY   transformed Swine Testicle-clone 18
DR   Wikidata; Q54973154
RX   PubMed=2175590;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_GS40 ! tST-3
OI   CVCL_GS38 ! tST-14
SX   Male
AG   40D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   tST-3
AC   CVCL_GS40
SY   transformed Swine Testicle-clone 3
DR   Wikidata; Q54973155
RX   PubMed=2175590;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
OI   CVCL_GS38 ! tST-14
OI   CVCL_GS39 ! tST-18
SX   Male
AG   40D
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   TSt-4
AC   CVCL_B973
SY   Tst-4
DR   RCB; RCB2116
DR   Wikidata; Q54973156
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=1535830;
CC   Caution: Not from strain C57BL/6 as originally published but from strain BALB/c (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   15FD
CA   Somatic stem cell
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 13
//
ID   TSt-4/G
AC   CVCL_B974
DR   RCB; RCB2117
DR   Wikidata; Q54973157
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Characteristics: Control cell line for TSt-4/G-DLL1 (Cellosaurus=CVCL_B975).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Caution: Parent cell line is not from strain C57BL/6 as originally published but from strain BALB/c (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B973 ! TSt-4
SX   Sex unspecified
AG   15FD
CA   Somatic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   TSt-4/G-DLL1
AC   CVCL_B975
SY   TSt-4/DL1
DR   RCB; RCB2118
DR   Wikidata; Q54973158
RX   DOI=10.4051/ibc.2010.2.4.0014;
RX   PubMed=15728456;
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104659; Dll1.
CC   Caution: Parent cell line is not from strain C57BL/6 as originally published but from strain BALB/c (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B973 ! TSt-4
SX   Sex unspecified
AG   15FD
CA   Somatic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   TSt-4/N
AC   CVCL_B976
DR   RCB; RCB2119
DR   Wikidata; Q54973159
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7809; NGFR.
CC   Caution: Parent cell line is not from strain C57BL/6 as originally published but from strain BALB/c (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B973 ! TSt-4
SX   Sex unspecified
AG   15FD
CA   Somatic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   TSt-4/N-DLL1
AC   CVCL_B977
DR   RCB; RCB2120
DR   Wikidata; Q54973160
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7809; NGFR.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:104659; Dll1.
CC   Caution: Parent cell line is not from strain C57BL/6 as originally published but from strain BALB/c (DOI=10.4051/ibc.2010.2.4.0014).
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B976 ! TSt-4/N
SX   Sex unspecified
AG   15FD
CA   Somatic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   TSt-4/N-DLL4
AC   CVCL_VP74
DR   RCB; RCB4563
DR   Wikidata; Q98133651
RX   PubMed=20595615;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:7809; NGFR.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:1859388; Dll4.
CC   Caution: Parent cell line is not from strain C57BL/6 as originally published but from strain BALB/c.
CC   Derived from site: In situ; Embryonic thymus; UBERON=UBERON_0005562.
CC   Cell type: Stromal cell of thymus; CL=CL_4030001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B976 ! TSt-4/N
SX   Sex unspecified
AG   15FD
CA   Somatic stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   TSU
AC   CVCL_8763
DR   cancercelllines; CVCL_8763
DR   CGH-DB; 360-2
DR   ChEMBL-Cells; CHEMBL3308092
DR   ChEMBL-Targets; CHEMBL613973
DR   Cosmic; 850416
DR   Cosmic; 876397
DR   Cosmic; 930338
DR   Cosmic; 1046038
DR   Cosmic; 1123043
DR   IARC_TP53; 1107
DR   PubChem_Cell_line; CVCL_8763
DR   Wikidata; Q54973168
RX   PubMed=1570156;
RX   PubMed=8704650;
RX   PubMed=10069537;
RX   PubMed=12632084;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   TSU-1621MT
AC   CVCL_A455
SY   TSU-1621-MT; TSU1621MT
DR   Cosmic; 787482
DR   Cosmic; 975306
DR   Cosmic; 1106591
DR   Cosmic; 1281357
DR   Wikidata; Q54973169
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10354136;
CC   Population: Japanese.
CC   Characteristics: CSF3 dependent.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG (PubMed=10354136).
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   TSU-Pr1
AC   CVCL_4014
SY   Tsu-Pr1; TSU-PR1; TSUpr1; TSU
DR   BTO; BTO_0001065
DR   BioSample; SAMN03151952
DR   cancercelllines; CVCL_4014
DR   Cosmic; 704847
DR   Cosmic; 869158
DR   Cosmic; 921049
DR   Cosmic; 922552
DR   Cosmic; 923958
DR   Cosmic; 948073
DR   Cosmic; 1218867
DR   Cosmic; 2444243
DR   IARC_TP53; 753
DR   Wikidata; Q54973170
RX   CelloPub=CLPUB00698;
RX   PubMed=1873816;
RX   PubMed=3586177;
RX   PubMed=9018337;
RX   PubMed=9460501;
RX   PubMed=10972993;
RX   PubMed=11304728;
RX   PubMed=11522622;
RX   PubMed=12725112;
RX   PubMed=16271951;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=11304728; PubMed=11522622; PubMed=20143388; CelloPub=CLPUB00698). Originally thought to originate from a 73 year old male patient with a prostate carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00280.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (PubMed=11304728; PubMed=11522622).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (PubMed=11304728; PubMed=11522622).
CC   Misspelling: TSU-PRI; Note=Occasionally.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=11304728; PubMed=11522622
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 16,18
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   TSU-Pr1-B1
AC   CVCL_M904
DR   cancercelllines; CVCL_M904
DR   Wikidata; Q54973171
RX   PubMed=16086232;
CC   Problematic cell line: Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4014 ! TSU-Pr1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   TSU-Pr1-B2
AC   CVCL_M905
DR   cancercelllines; CVCL_M905
DR   Wikidata; Q54973172
RX   PubMed=16086232;
CC   Problematic cell line: Contaminated. Grand-parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M904 ! TSU-Pr1-B1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   tsU19-5
AC   CVCL_5H92
AS   CVCL_A9KP
SY   ts U195
DR   Wikidata; Q54973174
RX   Patent=US5270191;
RX   PubMed=1628212;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9729.
CC   Doubling time: 24-36 hours (PubMed=1628212).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsA58).
CC   Derived from site: In situ; Central nervous system, optic nerve; UBERON=UBERON_0000941.
CC   Cell type: Oligodendrocyte precursor cell; CL=CL_0002453.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3D
CA   Conditionally immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   TsuGK27
AC   CVCL_M134
SY   TSUGK27; TSUGK-27
DR   cancercelllines; CVCL_M134
DR   Wikidata; Q54973175
RX   PubMed=9365544;
CC   Problematic cell line: Contaminated. Parent cell line (TSU-Pr1) has been shown to be a T24 derivative.
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4014 ! TSU-Pr1
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   TSUS-1
AC   CVCL_W865
DR   Wikidata; Q54973176
RX   PubMed=6587762;
CC   Population: Japanese.
CC   Doubling time: 38 hours (Note=At 40th passage) (PubMed=6587762).
CC   Derived from site: Metastatic; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C7729; Squamous cell carcinoma of the penis
DI   ORDO; Orphanet_398058; Squamous cell carcinoma of the penis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 10
//
ID   TT
AC   CVCL_1774
SY   MTC-TT
DR   BTO; BTO_0003074
DR   CLO; CLO_0009421
DR   EFO; EFO_0002382
DR   CLDB; cl4547
DR   CLDB; cl4901
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1803
DR   BCRC; 60346
DR   BCRJ; 0259
DR   BioSample; SAMN03471250
DR   BioSample; SAMN10988442
DR   cancercelllines; CVCL_1774
DR   CCRID; 1101HUM-PUMC000268
DR   CCRID; 3101HUMTCHu78
DR   CCRID; 4201HUM-CCTCC00073
DR   CCTCC; GDC0073
DR   Cell_Model_Passport; SIDM00484
DR   ChEMBL-Cells; CHEMBL3308145
DR   ChEMBL-Targets; CHEMBL2366083
DR   CLS; 305027
DR   Cosmic; 796049
DR   Cosmic; 796731
DR   Cosmic; 930299
DR   Cosmic; 1005455
DR   Cosmic; 1094763
DR   Cosmic; 1175889
DR   Cosmic; 1239955
DR   Cosmic; 1608835
DR   Cosmic; 1612901
DR   Cosmic; 1699419
DR   Cosmic; 1876248
DR   Cosmic; 2036697
DR   Cosmic; 2050374
DR   Cosmic-CLP; 930299
DR   DepMap; ACH-001321
DR   ECACC; 92050721
DR   EGA; EGAS00001000978
DR   GDSC; 930299
DR   GEO; GSM887714
DR   GEO; GSM888807
DR   GEO; GSM1374966
DR   GEO; GSM1670548
DR   IARC_TP53; 27017
DR   IARC_TP53; 30182
DR   ICLC; HTL98004
DR   IGRhCellID; TT
DR   KCB; KCB 2013001YJ
DR   LiGeA; CCLE_452
DR   LINCS_LDP; LCL-1690
DR   Lonza; 1097
DR   PharmacoDB; TT_1606_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1774
DR   PubChem_Cell_line; CVCL_1774
DR   Wikidata; Q54973178
RX   CelloPub=CLPUB00116;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1516062;
RX   PubMed=2519210;
RX   PubMed=3467830;
RX   PubMed=7736432;
RX   PubMed=7864888;
RX   PubMed=9046062;
RX   PubMed=11751535;
RX   PubMed=19897677;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=22538498;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/normal-growth-and-morphology-of-atcc-crl-1803-the-tt-cells
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~83 hours (ATCC=CRL-1803).
CC   HLA typing: A*02:01,03:01; B*51:01,67:02; C*12:03,14:02; DQB1*05:01,06:07; DRB1*01:01,11:10 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Cys634Trp (c.1902C>G); ClinVar=VCV000013918; Zygosity=Heterozygous (PubMed=7736432; PubMed=30737244; Cosmic-CLP=930299; DepMap=ACH-001321).
CC   Sequence variation: Mutation; HGNC; HGNC:11602; TBX3; Simple; p.Trp197Ter (c.591G>A); Zygosity=Heterozygous (PubMed=30737244; Cosmic-CLP=930299; DepMap=ACH-001321).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.11%; Native American=0%; East Asian, North=2.03%; East Asian, South=0%; South Asian=6.11%; European, North=32.67%; European, South=57.09% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Cell type: Parafollicular cell; CL=CL_0000570.
ST   Source(s): ATCC=CRL-1803; CCRID; Cosmic-CLP=930299; ECACC=92050721; ICLC=HTL98004; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 29,32.2
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 15,16
ST   FGA: 21,25
ST   Penta D: 13
ST   Penta E: 7,13
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C46099; Hereditary thyroid gland medullary carcinoma
DI   NCIt; C123329; Multiple endocrine neoplasia type 2
DI   ORDO; Orphanet_99361; Familial medullary thyroid carcinoma
DI   ORDO; Orphanet_653; Multiple endocrine neoplasia type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   TT-D6
AC   CVCL_6B95
DR   CCRID; 3101MOUSCSP530
DR   Wikidata; Q54973179
RX   PubMed=12837285;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Achilles tendon; UBERON=UBERON_0003701.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   TT-E4
AC   CVCL_6B96
DR   Wikidata; Q54973180
RX   PubMed=12837285;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Achilles tendon; UBERON=UBERON_0003701.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   TT-G11
AC   CVCL_6B97
DR   Wikidata; Q54973181
RX   PubMed=12837285;
RX   PubMed=17233813;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Achilles tendon; UBERON=UBERON_0003701.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   8W
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 10
//
ID   TT-R
AC   CVCL_RX44
SY   TT-R.B
DR   CCLV; CCLV-RIE 1006
DR   Wikidata; Q54973182
RX   PubMed=24457147;
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
OX   NCBI_TaxID=9838; ! Camelus dromedarius (Dromedary)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TT0111
AC   CVCL_8Y78
DR   ECACC; 90062721
DR   Wikidata; Q54973183
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 90062721; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0112
AC   CVCL_8Y79
DR   ECACC; 90062722
DR   Wikidata; Q54973186
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 90062722; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0113
AC   CVCL_8Y80
DR   ECACC; 90062723
DR   Wikidata; Q54973187
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 90062723; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0114
AC   CVCL_8Y81
DR   ECACC; 90062724
DR   Wikidata; Q54973188
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 90062724; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0115
AC   CVCL_8Y82
DR   ECACC; 90062725
DR   Wikidata; Q54973189
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 90062725; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0122
AC   CVCL_8Y83
DR   ECACC; 90081619
DR   Wikidata; Q54973195
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 90081619; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0148
AC   CVCL_8Y84
DR   ECACC; 91012408
DR   Wikidata; Q54973196
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91012408; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0150
AC   CVCL_8Y85
DR   ECACC; 91012410
DR   Wikidata; Q54973197
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91012410; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0151
AC   CVCL_8Y86
DR   ECACC; 91012411
DR   Wikidata; Q54973198
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91012411; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0153
AC   CVCL_8Y87
DR   ECACC; 91012413
DR   Wikidata; Q54973199
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91012413; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0154
AC   CVCL_8Y88
DR   ECACC; 91012414
DR   Wikidata; Q54973201
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91012414; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0155
AC   CVCL_8Y89
DR   ECACC; 91012415
DR   Wikidata; Q54973202
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91012415; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0164
AC   CVCL_8Y90
DR   ECACC; 91020701
DR   Wikidata; Q54973203
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91020701; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0165
AC   CVCL_8Y91
DR   ECACC; 91020702
DR   Wikidata; Q54973204
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91020702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0201
AC   CVCL_8Y92
DR   ECACC; 91032620
DR   Wikidata; Q54973207
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91032620; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0202
AC   CVCL_8Y93
DR   ECACC; 91032621
DR   Wikidata; Q54973208
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91032621; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT0208
AC   CVCL_8Y94
DR   ECACC; 91042501
DR   Wikidata; Q54973209
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91042501; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0209
AC   CVCL_8Y95
DR   ECACC; 91042502
DR   Wikidata; Q54973210
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91042502; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0210
AC   CVCL_8Y96
DR   ECACC; 91042503
DR   Wikidata; Q54973211
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91042503; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0211
AC   CVCL_8Y97
DR   ECACC; 91042504
DR   Wikidata; Q54973212
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91042504; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0212
AC   CVCL_8Y98
DR   ECACC; 91042505
DR   Wikidata; Q54973213
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91042505; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0237
AC   CVCL_8Y99
DR   ECACC; 91062105
DR   Wikidata; Q54973214
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91062105; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TT0252
AC   CVCL_8Z00
DR   ECACC; 91080908
DR   Wikidata; Q54973215
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Was removed from the ECACC collection on demand of the person that established that cell line.
CC   Discontinued: ECACC; 91080908; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   TT1 [Human lung]
AC   CVCL_G005
SY   Transformed type 1
DR   Wikidata; Q54973216
RX   PubMed=18539954;
RX   PubMed=19199008;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Type 1 pneumocyte; CL=CL_0002062.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 12
//
ID   TT1 [Human ovarian carcinoma]
AC   CVCL_G001
DR   Cosmic; 1113280
DR   Wikidata; Q54973218
RX   PubMed=12429618;
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   TT1 [Human thyroid carcinoma]
AC   CVCL_B3S9
DR   Cosmic; 1021386
DR   Wikidata; Q110433292
RX   PubMed=15734994;
RX   PubMed=15980887;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   Tt1.Th
AC   CVCL_S389
SY   Tt1th
DR   ATCC; CRL-6553
DR   Wikidata; Q54973219
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6553; true.
OX   NCBI_TaxID=9801; ! Tapirus terrestris (Lowland tapir)
SX   Sex unspecified
AG   3Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 6
//
ID   TT10603
AC   CVCL_C1MK
DR   cancercelllines; CVCL_C1MK
DR   Wikidata; Q114313130
RX   PubMed=29100338;
CC   Population: Chinese.
CC   Doubling time: 67.6 +- 4.2 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=29100338).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT10630
AC   CVCL_C1ML
DR   cancercelllines; CVCL_C1ML
DR   Wikidata; Q114313131
RX   PubMed=29100338;
RX   PubMed=34732238;
CC   Population: Chinese.
CC   Doubling time: 43.1 +- 1.6 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Ser516Ter (c.1547C>G); Zygosity=Unspecified (PubMed=29100338).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8
ST   D16S539: 10,12
ST   D21S11: 31.2,33.2
ST   D5S818: 9,11
ST   D7S820: 8,13
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT10714
AC   CVCL_C1MM
DR   cancercelllines; CVCL_C1MM
DR   Wikidata; Q114313132
RX   PubMed=29100338;
RX   PubMed=32229503;
RX   PubMed=34732238;
CC   Population: Chinese.
CC   Doubling time: 37.1 +- 0.3 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338; PubMed=32229503; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Cys478Ter (c.1434C>A); ClinVar=VCV001802564; Zygosity=Unspecified (PubMed=29100338; PubMed=32229503; PubMed=34732238).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 8,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 28,30
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT10728
AC   CVCL_C1MN
DR   cancercelllines; CVCL_C1MN
DR   Wikidata; Q114313133
RX   PubMed=29100338;
RX   PubMed=32229503;
RX   PubMed=34732238;
CC   Population: Chinese.
CC   Doubling time: 46.8 +- 0.4 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338; PubMed=32229503; PubMed=34732238).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=29100338; PubMed=32229503; PubMed=34732238).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
ST   Source(s): PubMed=34732238
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 30
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT10902
AC   CVCL_C1MP
DR   cancercelllines; CVCL_C1MP
DR   Wikidata; Q114313134
RX   PubMed=29100338;
CC   Population: Chinese.
CC   Doubling time: 54.9 +- 0.1 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=29100338).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT11111
AC   CVCL_C1MQ
DR   cancercelllines; CVCL_C1MQ
DR   Wikidata; Q114313136
RX   PubMed=29100338;
CC   Population: Chinese.
CC   Doubling time: 49.0 +- 0.8 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT11118
AC   CVCL_C1MR
DR   cancercelllines; CVCL_C1MR
DR   Wikidata; Q114313137
RX   PubMed=29100338;
CC   Population: Chinese.
CC   Doubling time: 70.9 +- 4.7 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Unspecified (PubMed=29100338).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT11201
AC   CVCL_C1MS
DR   cancercelllines; CVCL_C1MS
DR   Wikidata; Q114313138
RX   PubMed=29100338;
CC   Population: Chinese.
CC   Doubling time: 49.5 +- 0.2 hours (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=29100338).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Unspecified (PubMed=29100338).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   TT1TKB
AC   CVCL_8764
SY   ShuFu
DR   CLO; CLO_0051401
DR   BioSample; SAMN03472173
DR   cancercelllines; CVCL_8764
DR   Cosmic; 2664055
DR   DepMap; ACH-002025
DR   FANTOM5_SSTAR; 10469-106I1
DR   RCB; RCB1185
DR   Wikidata; Q54973220
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys141Tyr (c.422G>A); ClinVar=VCV000140801; Zygosity=Unspecified (DepMap=ACH-002025).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): RCB=RCB1185
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9
ST   D5S818: 11,13
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TT2
AC   CVCL_C318
SY   TT2 ES; ES-TT2
DR   BTO; BTO_0004639
DR   EFO; EFO_0005485
DR   ENCODE; ENCBS317ENC
DR   ENCODE; ENCBS472MMU
DR   GEO; GSM450274
DR   GEO; GSM450284
DR   RCB; AES0014
DR   RCB; RCB2077
DR   SKIP; SKIP001624
DR   Wikidata; Q54973221
RX   PubMed=8250257;
RX   PubMed=9353641;
CC   Part of: ENCODE project mouse cell lines.
CC   Discontinued: RCB; RCB2077; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   TT2609-A02
AC   CVCL_A594
DR   DSMZ; ACC-859
DR   DSMZCellDive; ACC-859
DR   Wikidata; Q54973222
RX   PubMed=11716037;
CC   Population: Caucasian.
CC   Doubling time: 68 hours (PubMed=11716037); ~100 hours (DSMZ=ACC-859).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): DSMZ=ACC-859
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 19,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 12,14
ST   Penta E: 5
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A595 ! TT2609-B02
OI   CVCL_2218 ! TT2609-C02
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 16
//
ID   TT2609-B02
AC   CVCL_A595
DR   Wikidata; Q54973223
RX   PubMed=11716037;
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=11716037).
CC   Karyotypic information: Near diploid karyotype (PubMed=11716037).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A594 ! TT2609-A02
OI   CVCL_2218 ! TT2609-C02
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   TT2609-C02
AC   CVCL_2218
SY   TT2609-CO2; TT2609C02
DR   CLO; CLO_0037156
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03473513
DR   BioSample; SAMN10989561
DR   cancercelllines; CVCL_2218
DR   Cell_Model_Passport; SIDM00418
DR   Cosmic; 1995660
DR   Cosmic; 2054095
DR   Cosmic-CLP; 1240223
DR   DepMap; ACH-000716
DR   DSMZ; ACC-510
DR   DSMZCellDive; ACC-510
DR   EGA; EGAS00001000978
DR   GDSC; 1240223
DR   GEO; GSM887712
DR   GEO; GSM888805
DR   GEO; GSM1670550
DR   IARC_TP53; 28237
DR   LiGeA; CCLE_442
DR   LINCS_LDP; LCL-1681
DR   PharmacoDB; TT2609C02_1607_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2218
DR   Wikidata; Q54973225
RX   PubMed=11716037;
RX   PubMed=18713817;
RX   PubMed=22460905;
RX   PubMed=23833040;
RX   PubMed=25675381;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29066502;
RX   PubMed=30737244;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31443247;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 21 hours (PubMed=11716037); ~60-80 hours (DSMZ=ACC-510).
CC   HLA typing: A*03:01,24:02; B*15:01,51:01; C*02:02,03:03 (PubMed=26589293).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=11716037).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=23833040; PubMed=30737244; Cosmic-CLP=1240223; DepMap=ACH-000716).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Heterozygous; Note=In promoter (PubMed=23833040; PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile254Thr (c.761T>C); ClinVar=VCV001759844; Zygosity=Heterozygous (DepMap=ACH-000716).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (Cosmic-CLP=1240223; DepMap=ACH-000716).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.11%; Native American=0.39%; East Asian, North=2.11%; East Asian, South=0%; South Asian=1.31%; European, North=62.71%; European, South=33.37% (PubMed=30894373).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Cosmic-CLP=1240223; DSMZ=ACC-510; PubMed=18713817; PubMed=30737244
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 19,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 12,14
ST   Penta E: 5
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A594 ! TT2609-A02
OI   CVCL_A595 ! TT2609-B02
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   TTA-1
AC   CVCL_6297
SY   TTA1; TTA-I
DR   BTO; BTO_0004965
DR   cancercelllines; CVCL_6297
DR   CCRID; 3101HUMSCSP554
DR   CGH-DB; 46-1
DR   CLS; 305138
DR   Cosmic; 1152125
DR   Cosmic; 1239984
DR   Cosmic; 2054119
DR   RCB; RCB5467
DR   Wikidata; Q54973227
RX   Patent=US8029793;
RX   PubMed=8121182;
RX   PubMed=8176927;
RX   PubMed=9177455;
RX   PubMed=15613457;
RX   PubMed=16924234;
RX   PubMed=18713817;
RX   PubMed=23833040;
RX   PubMed=30737244;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7523.
CC   Population: Japanese.
CC   Doubling time: 28.8 hours (PubMed=8121182).
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Gly289fs (c.866delG); Zygosity=Homozygous (PubMed=30737244).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Leu (c.473G>T); ClinVar=VCV000528248; Zygosity=Homozygous (PubMed=30737244).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): PubMed=18713817; PubMed=30737244
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   TTA-2
AC   CVCL_9570
SY   TTA2; TTA-II
DR   CGH-DB; 47-1
DR   RCB; RCB5468
DR   Wikidata; Q54973228
RX   Patent=US8029793;
RX   PubMed=8121182;
RX   PubMed=9177455;
RX   PubMed=15613457;
RX   PubMed=16924234;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7527.
CC   Population: Japanese.
CC   Doubling time: 144.5 hours (PubMed=8121182).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   TTA-3
AC   CVCL_9571
SY   TTA3; TTA-III
DR   CGH-DB; 48-1
DR   RCB; RCB5469
DR   Wikidata; Q54973229
RX   PubMed=8121182;
RX   PubMed=9177455;
RX   PubMed=15613457;
RX   PubMed=16924234;
CC   Population: Japanese.
CC   Doubling time: 29.6 hours (PubMed=8121182).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   TTC-1240
AC   CVCL_8002
SY   TTC1240; TTC 1240
DR   BioSample; SAMN10989626
DR   Cell_Model_Passport; SIDM01459
DR   Cosmic; 801772
DR   Cosmic; 802055
DR   Cosmic; 2144783
DR   DepMap; ACH-001210
DR   GEO; GSM2409670
DR   GEO; GSM2409671
DR   GEO; GSM2409672
DR   GEO; GSM2409673
DR   GEO; GSM2409674
DR   GEO; GSM2409675
DR   GEO; GSM2409706
DR   GEO; GSM2495986
DR   GEO; GSM2495988
DR   GEO; GSM2787354
DR   Wikidata; Q54973230
RX   PubMed=10602515;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=14662021;
RX   PubMed=24418192;
RX   PubMed=28945250;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Glu216Ter (c.646G>T); Zygosity=Unspecified (PubMed=10602515; PubMed=11921280; PubMed=28945250).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: TTC1204; Cosmic=801772.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   TTC-1240 BAF47
AC   CVCL_QW57
SY   TTC1240 BAF47; TTC1240_BAF47
DR   GEO; GSM2409676
DR   GEO; GSM2409677
DR   GEO; GSM2409678
DR   GEO; GSM2409679
DR   GEO; GSM2409680
DR   GEO; GSM2409681
DR   GEO; GSM2409708
DR   GEO; GSM2495987
DR   GEO; GSM2495989
DR   GEO; GSM2787355
DR   Wikidata; Q54973231
RX   PubMed=28945250;
CC   Characteristics: Transfection of SMARCB1 rescues the phenotype of the parent cell line which has a deleterious mutation in that gene.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11103; SMARCB1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8002 ! TTC-1240
SX   Female
AG   9M
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   TTC-1318
AC   CVCL_AQ33
DR   Wikidata; Q54973232
RX   PubMed=19887553;
RX   PubMed=23665679;
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D19S433: 14,15
ST   D21S11: 32.2
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 20,24.2
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 4
//
ID   TTC-442
AC   CVCL_B255
SY   TTC442; TC-442; TU-442; A91
DR   Cell_Model_Passport; SIDM01458
DR   Cosmic; 802050
DR   DepMap; ACH-001750
DR   PRIDE; PXD039480
DR   Wikidata; Q54973233
RX   CelloPub=CLPUB00569;
RX   PubMed=7882340;
RX   PubMed=10602515;
RX   PubMed=19887553;
RX   PubMed=23665679;
RX   PubMed=23882450;
RX   PubMed=28196595;
RX   PubMed=36768928;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 15,24
ST   D19S433: 13,16.2
ST   D21S11: 29
ST   D2S1338: 20,21
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 10,13
ST   D8S1179: 11,14
ST   FGA: 27
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   TTC-445
AC   CVCL_8003
SY   TTC445
DR   Wikidata; Q54973234
RX   PubMed=10602515;
RX   PubMed=23665679;
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
DI   NCIt; C3359; Rhabdomyosarcoma
DI   ORDO; Orphanet_780; Rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 13
//
ID   TTC-466
AC   CVCL_A444
SY   TTC466; TCC466
DR   cancercelllines; CVCL_A444
DR   Cell_Model_Passport; SIDM01911
DR   Cosmic; 759889
DR   Cosmic; 1081765
DR   Cosmic; 2294590
DR   DepMap; ACH-001206
DR   GEO; GSM510014
DR   GEO; GSM1899424
DR   Progenetix; CVCL_A444
DR   Wikidata; Q54973236
RX   PubMed=8162068;
RX   PubMed=16631476;
RX   PubMed=21822310;
RX   PubMed=26428435;
RX   PubMed=26979953;
RX   PubMed=28196595;
RX   PubMed=29464090;
RX   PubMed=30879952;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG; Note=In frame (PubMed=8162068; PubMed=16631476).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (DepMap=ACH-001206).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Misspelling: TTC-446; PubMed=16631476.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D3S1358: 17,18
ST   D5S818: 10
ST   D7S820: 8,10
ST   FGA: 24,25
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M152 ! CHLA-25
SX   Female
AG   4-5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 26
//
ID   TTC-475
AC   CVCL_IW46
SY   TTC475
DR   Wikidata; Q54973237
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   TTC-487
AC   CVCL_B256
SY   TTC487; TC-487; TU-487; TU 487; CHLA 37
DR   Wikidata; Q54973239
RX   CelloPub=CLPUB00569;
RX   PubMed=7882340;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Left thigh; UBERON=UBERON_0000376.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   TTC-516
AC   CVCL_8004
SY   TTC516; TC-516; TU-516; A995
DR   Cosmic; 802051
DR   Wikidata; Q54973241
RX   CelloPub=CLPUB00569;
RX   PubMed=7882340;
RX   PubMed=10602515;
RX   PubMed=19887553;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D19S433: 14
ST   D21S11: 27,31.2
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 17,19
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   TTC-547
AC   CVCL_7152
SY   TTC547; TC-547; TU-547
DR   Cosmic; 1091072
DR   Cosmic; 2228247
DR   Wikidata; Q54973242
RX   CelloPub=CLPUB00569;
RX   PubMed=7882340;
RX   PubMed=23665679;
RX   PubMed=25010205;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=25010205).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=25010205).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pelvis; UBERON=UBERON_0002355.
ST   Source(s): PubMed=25010205
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 13,19
ST   D19S433: 12,13
ST   D21S11: 31,33.2
ST   D2S1338: 18,24
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   TTC-549
AC   CVCL_8005
SY   TTC 549; TTC549
DR   EFO; EFO_0005700
DR   BioSample; SAMN10989627
DR   Cell_Model_Passport; SIDM01457
DR   Cosmic; 801776
DR   Cosmic; 802052
DR   Cosmic; 1063888
DR   Cosmic; 2144784
DR   DepMap; ACH-001211
DR   ENCODE; ENCBS258AAA
DR   GEO; GSM3145597
DR   GEO; GSM3145740
DR   Wikidata; Q54973250
RX   PubMed=8818656;
RX   PubMed=9559292;
RX   PubMed=9920784;
RX   PubMed=10602515;
RX   PubMed=11557780;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=14662021;
RX   PubMed=16557275;
RX   PubMed=24418192;
RX   PubMed=31068700;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/MRTTTC549_Crawford_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=10602515; PubMed=11921280).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   TTC-633
AC   CVCL_B257
SY   TTC633
DR   Cosmic; 1081766
DR   Wikidata; Q54973251
RX   PubMed=8162068;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG; Note=In frame (PubMed=8162068).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   TTC-642
AC   CVCL_8006
SY   TTC 642; TTC642
DR   BioSample; SAMN10989628
DR   cancercelllines; CVCL_8006
DR   Cell_Model_Passport; SIDM01456
DR   Cosmic; 801774
DR   Cosmic; 802053
DR   Cosmic; 2144785
DR   DepMap; ACH-001212
DR   GEO; GSM3145598
DR   GEO; GSM3145741
DR   Wikidata; Q54973252
RX   PubMed=9559292;
RX   PubMed=9920784;
RX   PubMed=10602515;
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=14662021;
RX   PubMed=24418192;
RX   PubMed=31068700;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Triche, Timothy J.; Children's Hospital of Los Angeles; Los Angeles; USA.
CC   Karyotypic information: 45,XX,-22 (PubMed=9559292).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Arg40Ter (c.118C>T); ClinVar=VCV000410698; Zygosity=Unspecified (PubMed=10602515; PubMed=11921280; DepMap=ACH-001212).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
ST   Source(s): DepMap=ACH-001212
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D18S51: 17,20
ST   D21S11: 31.2
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   Penta D: 12,13
ST   Penta E: 9,17
ST   TH01: 9,9.3
ST   TPOX: 6,9
ST   vWA: 15,18
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   TTC-709
AC   CVCL_8007
SY   TTC 709; TTC709
DR   BioSample; SAMN10989625
DR   Cell_Model_Passport; SIDM01455
DR   Cosmic; 802054
DR   DepMap; ACH-000597
DR   GEO; GSM3145599
DR   GEO; GSM3145742
DR   PharmacoDB; TTC709_1608_2019
DR   Wikidata; Q54973253
RX   PubMed=10602515;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=10602515).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): DepMap=ACH-000597
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11
ST   D8S1179: 10,15
ST   FGA: 22,26
ST   Penta D: 10,17
ST   Penta E: 5,16
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   TTCF
AC   CVCL_Z506
SY   Tor Tor Caudal Fin
DR   NRFC; NRFC003
DR   Wikidata; Q54973254
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=22203177;
WW   Provider; NRFC; NRFC003; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC003.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=464755; ! Tor tor (Tor mahseer)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   TTD10PV
AC   CVCL_RU69
SY   TrichoThioDystrophy 10 PaVia
DR   CLO; CLO_0009422
DR   CLDB; cl4549
DR   Wikidata; Q54973257
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTD11PV
AC   CVCL_RU70
SY   TrichoThioDystrophy 11 PaVia
DR   CLO; CLO_0009423
DR   CLDB; cl4550
DR   Wikidata; Q54973258
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Unexplicit; Ex6del; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_33364; Trichothiodystrophy
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TTD12PV
AC   CVCL_ZT12
SY   TrichoThioDystrophy 12 PaVia
DR   Wikidata; Q98133652
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Cys259Tyr (c.776G>A); ClinVar=VCV000329522; Zygosity=Heterozygous (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TTD13PV
AC   CVCL_4Z80
SY   TrichoThioDystrophy 13 PaVia; TTD331BE; GM15908
DR   CLO; CLO_0018616
DR   Coriell; GM15908
DR   Wikidata; Q54848269
RX   PubMed=15220921;
RX   PubMed=18470933;
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV002136487; Zygosity=Homozygous (PubMed=15220921; PubMed=18470933).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z72 ! TTD13PV LCL
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   TTD13PV LCL
AC   CVCL_4Z72
SY   TrichoThioDystrophy 14 PaVia LCL; GM14576
DR   CLO; CLO_0031582
DR   Coriell; GM14576
DR   Wikidata; Q54847317
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV002136487; Zygosity=Homozygous (from autologous cell line TTD13PV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z80 ! TTD13PV
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   TTD14PV
AC   CVCL_4Z79
SY   TrichoThioDystrophy 14 PaVia; TTD332BE; GM15907
DR   CLO; CLO_0018617
DR   Coriell; GM15907
DR   Wikidata; Q54848268
RX   PubMed=15220921;
RX   PubMed=18470933;
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV002136487; Zygosity=Homozygous (PubMed=15220921; PubMed=18470933).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z73 ! TTD14PV LCL
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   TTD14PV LCL
AC   CVCL_4Z73
SY   TrichoThioDystrophy 14 PaVia LCL; GM14577
DR   CLO; CLO_0031583
DR   Coriell; GM14577
DR   Wikidata; Q54847318
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV002136487; Zygosity=Homozygous (from autologous cell line TTD14PV).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4Z79 ! TTD14PV
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   TTD15PV
AC   CVCL_ZT13
SY   TrichoThioDystrophy 15 PaVia
DR   Wikidata; Q98133653
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Cys259Tyr (c.776G>A); ClinVar=VCV000329522; Zygosity=Heterozygous (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3-4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TTD18PV
AC   CVCL_ZP49
SY   TrichoThioDystrophy 18 PaVia
DR   Wikidata; Q98133654
RX   PubMed=31374204;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11572; TARS1; Simple; p.Lys276Glu (c.826A>G); ClinVar=VCV000689398; Zygosity=Heterozygous (PubMed=31374204).
CC   Sequence variation: Mutation; HGNC; HGNC:11572; TARS1; Simple; p.Arg638Ter (c.1912C>T); ClinVar=VCV000689397; Zygosity=Heterozygous (PubMed=31374204).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173102; Trichothiodystrophy 7, nonphotosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   TTD1BEL
AC   CVCL_4Z77
SY   GM15753
DR   CLO; CLO_0027695
DR   Coriell; GM15753
DR   Wikidata; Q54848175
RX   PubMed=1372096;
RX   PubMed=7920640;
RX   PubMed=8571952;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=7920640; PubMed=8571952).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=7920640; PubMed=8571952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   TTD1BI
AC   CVCL_ZP57
SY   TrichoThioDystrophy 1 BIrmingham; P3
DR   Wikidata; Q98133655
RX   PubMed=2458832;
RX   PubMed=7920640;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Glu731Argfs*14 (c.2190delG) (730fs); Zygosity=Heterozygous (PubMed=7920640).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TTD1BR
AC   CVCL_W046
SY   TrichoThioDystrophy 1 BRighton
DR   Wikidata; Q54973259
RX   PubMed=1372096;
RX   PubMed=7671243;
RX   PubMed=8213812;
RX   PubMed=11416159;
RX   PubMed=15220921;
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Leu21Pro (c.62T>C); ClinVar=VCV000002104; Zygosity=Heterozygous (PubMed=15220921).
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Arg56Ter (c.166C>T); ClinVar=VCV000002103; Zygosity=Heterozygous (PubMed=15220921).
CC   Misspelling: TTD1BR3; PubMed=7671243.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13,21
ST   D21S11: 30,31
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   TH01: 9.3
ST   vWA: 17,18
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2555 ! TTD1BR LCL
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   TTD1BR LCL
AC   CVCL_2555
SY   TrichoThioDystrophy 1 BRighton LCL; LB199; 199
DR   ECACC; 98062321
DR   Wikidata; Q54902043
RX   PubMed=11416159;
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Leu21Pro (c.62T>C); ClinVar=VCV000002104; Zygosity=Heterozygous (from autologous cell line TTD1BR).
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Arg56Ter (c.166C>T); ClinVar=VCV000002103; Zygosity=Heterozygous (from autologous cell line TTD1BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 13,21
ST   D21S11: 30,31
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   TH01: 9.3
ST   vWA: 17,18
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W046 ! TTD1BR
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   TTD1BRSV
AC   CVCL_ZP45
SY   TTD1BR-sv
DR   Wikidata; Q98133656
RX   PubMed=15220921;
RX   PubMed=23637614;
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Leu21Pro (c.62T>C); ClinVar=VCV000002104; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Arg56Ter (c.166C>T); ClinVar=VCV000002103; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W046 ! TTD1BR
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   TTD1GL
AC   CVCL_ZU59
SY   TrichoThioDystrophy 1 GLascow; P1
DR   Wikidata; Q98133657
RX   PubMed=2458832;
RX   PubMed=6492094;
CC   Population: Caucasian; Scottish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   TTD1PV
AC   CVCL_RU71
SY   TrichoThioDystrophy 1 PaVia
DR   CLO; CLO_0009424
DR   CLDB; cl4551
DR   Wikidata; Q54973260
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTD1RO
AC   CVCL_V270
SY   TrichoThioDystrophy 1 ROtterdam; GM17424
DR   CLO; CLO_0012333
DR   Coriell; GM17424
DR   Wikidata; Q54848861
RX   PubMed=7802014;
RX   PubMed=8571952;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg658Cys (c.1972C>T); ClinVar=VCV000016785; Zygosity=Heterozygous (PubMed=8571952).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly713Arg (c.2137G>C); ClinVar=VCV000016786; Zygosity=Heterozygous (PubMed=8571952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_33364; Trichothiodystrophy
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   TTD1VI
AC   CVCL_XF98
SY   TTD 1VI; TrichoThioDystrophy 1 VIllejuif
DR   Wikidata; Q98133658
RX   PubMed=1281671;
RX   PubMed=7671243;
RX   PubMed=8055625;
RX   PubMed=8571952;
RX   PubMed=8824772;
RX   PubMed=15009740;
RX   PubMed=18470933;
RX   PubMed=18676829;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=8571952).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=8571952).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=8571952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   TTD1VI-LAS-KMT11
AC   CVCL_XG12
DR   Wikidata; Q98133659
RX   PubMed=7563073;
RX   PubMed=8968100;
RX   PubMed=9426065;
CC   Characteristics: Expression of the SV40 large T antigen is under the control of the metal ion-inducible mouse metallothionein-1 promoter (PubMed=7563073).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF99 ! TTD1VILas
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 15
//
ID   TTD1VI-LAS-KMT11-D10
AC   CVCL_XG13
SY   TTD + ERCC2
DR   Wikidata; Q98133662
RX   PubMed=8968100;
RX   PubMed=9426065;
CC   Characteristics: Transfection of wild type ERCC2 corrects the defects in the parent cell line.
CC   Characteristics: Expression of the SV40 large T antigen is under the control of the metal ion-inducible mouse metallothionein-1 promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3434; ERCC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG12 ! TTD1VI-LAS-KMT11
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 15
//
ID   TTD1VILas
AC   CVCL_XF99
SY   TTD1VI-LAS; SV40-TTD1VI
DR   Wikidata; Q98133663
RX   PubMed=7563073;
RX   PubMed=7671243;
RX   PubMed=8055625;
RX   PubMed=8824772;
RX   PubMed=18676829;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF98 ! TTD1VI
SX   Male
AG   9M
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 13
//
ID   TTD2BR
AC   CVCL_4Z76
SY   TrichoThioDystrophy 2 BRighton; GM15752
DR   CLO; CLO_0027694
DR   Coriell; GM15752
DR   Wikidata; Q54848174
RX   PubMed=7920640;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Val488_Met493del (c.1462_1479del18) (1540-1557del); Zygosity=Heterozygous (PubMed=7920640).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Glu731Argfs*14 (c.2190delG) (730fs); Zygosity=Heterozygous (PubMed=7920640).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   TTD2GL
AC   CVCL_4Z78
SY   TrichoThioDystrophy 2 GLascow; P2; GM15754
DR   CLO; CLO_0027696
DR   Coriell; GM15754
DR   Wikidata; Q54848176
RX   PubMed=2458832;
RX   PubMed=6492094;
RX   PubMed=7920640;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=7920640).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Unexplicit; IVS15+2dupT; Zygosity=Heterozygous (PubMed=7920640).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y6M
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   TTD2PV
AC   CVCL_RU72
SY   TrichoThioDystrophy 2 PaVia
DR   CLO; CLO_0009425
DR   CLDB; cl4552
DR   Wikidata; Q54973261
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTD2VI
AC   CVCL_XG00
SY   TTD 2VI; TrichoThioDystrophy 2 VIllejuif
DR   Wikidata; Q98133664
RX   PubMed=1281671;
RX   PubMed=7671243;
RX   PubMed=8055625;
RX   PubMed=8392442;
RX   PubMed=8824772;
RX   PubMed=9012405;
RX   PubMed=15009740;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   TTD2VILas
AC   CVCL_XG01
SY   TTD2VI-LAS
DR   Wikidata; Q98133665
RX   PubMed=7671243;
RX   PubMed=8055625;
RX   PubMed=8392442;
RX   PubMed=8824772;
RX   PubMed=9012405;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG00 ! TTD2VI
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 9
//
ID   TTD2VILasCl1
AC   CVCL_XG14
DR   Wikidata; Q98133667
RX   PubMed=8055625;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG01 ! TTD2VILas
SX   Female
AG   4Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 10-09-24; Version: 9
//
ID   TTD351BE
AC   CVCL_RG81
SY   TrichoThioDystrophy 351 BEthesda; JA1389
DR   Wikidata; Q54898501
RX   PubMed=18470933;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg378His (c.1133G>A); ClinVar=VCV001812770; Zygosity=Heterozygous (PubMed=18470933).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=18470933).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TTD355BE
AC   CVCL_RG82
SY   TrichoThioDystrophy 355 BEthesda; JA1410
DR   Wikidata; Q54898502
RX   PubMed=18470933;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Glu731Argfs*14 (c.2190delG) (730fs); Zygosity=Heterozygous; Note=Other allele is not expressed (PubMed=18470933).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TTD3PV
AC   CVCL_RU73
SY   TrichoThioDystrophy 3 PaVia
DR   CLO; CLO_0009426
DR   CLDB; cl4553
DR   Wikidata; Q54973262
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTD3VI
AC   CVCL_ZN54
SY   TrichoThioDystrophy 3 VIllejuif
DR   Wikidata; Q98133669
RX   PubMed=7671243;
RX   PubMed=8571952;
RX   PubMed=9012405;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=8571952).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg658His (c.1973G>A); ClinVar=VCV001499293; Zygosity=Heterozygous (PubMed=8571952).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=8571952).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   TTD3VILas
AC   CVCL_ZP24
DR   Wikidata; Q98133670
RX   PubMed=7671243;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg658His (c.1973G>A); ClinVar=VCV001499293; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZN54 ! TTD3VI
SX   Male
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 11
//
ID   TTD4BR
AC   CVCL_W052
SY   TrichoThioDystrophy 4 BRighton
DR   Wikidata; Q54973263
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2562 ! TTD4BR LCL
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   TTD4BR LCL
AC   CVCL_2562
SY   TrichoThioDystrophy 4 BRighton LCL; LB443; 443
DR   ECACC; 98062322
DR   Wikidata; Q54902069
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W052 ! TTD4BR
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   TTD4PV
AC   CVCL_RU74
SY   TrichoThioDystrophy 4 PaVia
DR   CLO; CLO_0009427
DR   CLDB; cl4554
DR   Wikidata; Q54973264
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Thr482del (c.1445_1447delCCA); Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TTD5PV
AC   CVCL_RU75
SY   TrichoThioDystrophy 5 PaVia
DR   CLO; CLO_0009428
DR   CLDB; cl4555
DR   Wikidata; Q54973265
RX   PubMed=16977596;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146899; Trichothiodystrophy 4, nonphotosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TTD4VI
AC   CVCL_ZP30
SY   TrichoThioDystrophy 4 VIllejuif
DR   Wikidata; Q98133671
RX   PubMed=9012405;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Thr119Pro (c.355A>C); ClinVar=VCV000016584; Zygosity=Homozygous (PubMed=9012405).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173103; Trichothiodystrophy 2, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   TTD4VILas
AC   CVCL_ZP31
DR   Wikidata; Q98133672
RX   PubMed=9012405;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Thr119Pro (c.355A>C); ClinVar=VCV000016584; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173103; Trichothiodystrophy 2, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP30 ! TTD4VI
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   TTD5VI
AC   CVCL_ZP25
SY   TrichoThioDystrophy 5 VIllejuif
DR   Wikidata; Q98133673
RX   PubMed=7671243;
RX   PubMed=31374204;
CC   Sequence variation: Mutation; HGNC; HGNC:11572; TARS1; Simple; p.Leu227Pro (c.680T>C); ClinVar=VCV000689399; Zygosity=Homozygous (PubMed=31374204).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173102; Trichothiodystrophy 7, nonphotosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   TTD6PV
AC   CVCL_RU76
SY   TrichoThioDystrophy 6 PaVia
DR   CLO; CLO_0009429
DR   CLDB; cl4556
DR   Wikidata; Q54973266
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Asp673Gly (c.2018A>G); Zygosity=Heterozygous; Note=Other allele is not expressed (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTD6VI
AC   CVCL_ZP26
SY   TrichoThioDystrophy 6 VIllejuif
DR   Wikidata; Q98133675
RX   PubMed=7671243;
RX   PubMed=9012405;
RX   PubMed=10332046;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Thr119Pro (c.355A>C); ClinVar=VCV000016584; Zygosity=Homozygous (PubMed=9012405).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173103; Trichothiodystrophy 2, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   TTD6VILas
AC   CVCL_ZP27
SY   TTD6VISV
DR   Wikidata; Q98133677
RX   PubMed=7671243;
RX   PubMed=9012405;
RX   PubMed=10332046;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Thr119Pro (c.355A>C); ClinVar=VCV000016584; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173103; Trichothiodystrophy 2, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP26 ! TTD6VI
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   TTD7PV
AC   CVCL_RU77
SY   TrichoThioDystrophy 7 PaVia
DR   CLO; CLO_0009430
DR   CLDB; cl4557
DR   Wikidata; Q54973267
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   TTD8PV
AC   CVCL_RU78
SY   TrichoThioDystrophy 8 PaVia
DR   CLO; CLO_0009431
DR   CLDB; cl4558
DR   Wikidata; Q54973269
RX   PubMed=7671243;
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTD8VI
AC   CVCL_ZP28
SY   TrichoThioDystrophy 8 VIllejuif
DR   Wikidata; Q98133678
RX   PubMed=7671243;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4924; Trichothiodystrophy
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   TTD99RO
AC   CVCL_ZP46
SY   TrichoThioDystrophy 99 ROtterdam
DR   Wikidata; Q98133679
RX   PubMed=15220921;
CC   Sequence variation: Mutation; HGNC; HGNC:21157; GTF2H5; Simple; p.Arg56Ter (c.166C>T); ClinVar=VCV000002103; Zygosity=Homozygous (PubMed=15220921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173099; Trichothiodystrophy 3, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   TTD9PV
AC   CVCL_RU79
SY   TrichoThioDystrophy 9 PaVia
DR   CLO; CLO_0009432
DR   CLDB; cl4559
DR   Wikidata; Q54973271
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   TTD9VI
AC   CVCL_ZP43
SY   TrichoThioDystrophy 9 VIllejuif
DR   Wikidata; Q98133680
RX   PubMed=7671243;
RX   PubMed=15009740;
RX   PubMed=18676829;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (PubMed=18676829).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   TTD9VILas
AC   CVCL_ZP44
DR   Wikidata; Q98133682
RX   PubMed=7671243;
RX   PubMed=18676829;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156433; Trichothiodystrophy 1, photosensitive
DI   ORDO; Orphanet_33364; Trichothiodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP43 ! TTD9VI
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   TTDH10PV
AC   CVCL_RU80
SY   TrichoThioDystrophy Heterozygote 10 PaVia
DR   CLO; CLO_0009433
DR   CLDB; cl4560
DR   Wikidata; Q54973272
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TTDH11PV
AC   CVCL_RU81
SY   TrichoThioDystrophy Heterozygote 11 PaVia
DR   CLO; CLO_0009434
DR   CLDB; cl4561
DR   Wikidata; Q54973273
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Unexplicit; Ex6del; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH12PV
AC   CVCL_RU82
SY   TrichoThioDystrophy Heterozygote 12 PaVia
DR   CLO; CLO_0009435
DR   CLDB; cl4562
DR   Wikidata; Q54973274
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH1PV
AC   CVCL_RU83
SY   TrichoThioDystrophy Heterozygote 1 PaVia
DR   CLO; CLO_0009436
DR   CLDB; cl4563
DR   Wikidata; Q54973275
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH2PV
AC   CVCL_RU84
SY   TrichoThioDystrophy Heterozygote 2 PaVia
DR   CLO; CLO_0009437
DR   CLDB; cl4564
DR   Wikidata; Q54973277
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH3PV
AC   CVCL_RU85
SY   TrichoThioDystrophy Heterozygote 3 PaVia
DR   CLO; CLO_0009438
DR   CLDB; cl4565
DR   Wikidata; Q54973279
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Asp673Gly (c.2018A>G); Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH4PV
AC   CVCL_RU86
SY   TrichoThioDystrophy Heterozygote 4 PaVia
DR   CLO; CLO_0009439
DR   CLDB; cl4566
DR   Wikidata; Q54973280
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TTDH5PV
AC   CVCL_RU87
SY   TrichoThioDystrophy Heterozygote 5 PaVia
DR   CLO; CLO_0009440
DR   CLDB; cl4567
DR   Wikidata; Q54973282
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=9758621).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH6PV
AC   CVCL_RU88
SY   TrichoThioDystrophy Heterozygote 6 PaVia
DR   CLO; CLO_0009441
DR   CLDB; cl4568
DR   Wikidata; Q54973283
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg722Trp (c.2164C>T); ClinVar=VCV000016792; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH7PV
AC   CVCL_RU89
SY   TrichoThioDystrophy Heterozygote 7 PaVia
DR   CLO; CLO_0009442
DR   CLDB; cl4569
DR   Wikidata; Q54973284
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH8PV
AC   CVCL_RU90
SY   TrichoThioDystrophy Heterozygote 8 PaVia
DR   CLO; CLO_0009443
DR   CLDB; cl4570
DR   Wikidata; Q54973285
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDH9PV
AC   CVCL_RU91
DR   CLO; CLO_0009444
DR   CLDB; cl4571
DR   Wikidata; Q54973286
RX   PubMed=9758621;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg112His (c.335G>A); ClinVar=VCV000016784; Zygosity=Heterozygous (PubMed=9758621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   TTDHM1BR
AC   CVCL_W045
SY   TTD HM 1BR; TrichoThioDystrophy Heterozygote Mother 1 BRighton
DR   Wikidata; Q54973255
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2554 ! TTDHM1BR LCL
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   TTDHM1BR LCL
AC   CVCL_2554
SY   TrichoThioDystrophy Heterozygote Mother 1 BRighton LCL; LB198; 198
DR   ECACC; 98062320
DR   Wikidata; Q54902042
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W045 ! TTDHM1BR
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   TTE1
AC   CVCL_D629
SY   TTE-1; TTE 1
DR   BTO; BTO_0005187
DR   Wikidata; Q54973287
RX   PubMed=11789682;
RX   PubMed=15541572;
RX   PubMed=17233813;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Growth is signicantly prevented at the nonpermissive temperature (39 Celsius) (PubMed=11789682).
CC   Doubling time: 24 hours (PubMed=11789682).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   TTE3
AC   CVCL_U448
AS   CVCL_9808
SY   TTE 3
DR   EFO; EFO_0002868
DR   Wikidata; Q54973226
RX   PubMed=11832784;
RX   PubMed=15541572;
RX   PubMed=17233813;
RX   PubMed=17543550;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Growth is signicantly prevented at the nonpermissive temperature (39 Celsius) (PubMed=11832784).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: TT3E; EFO=EFO_0002868.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Sertoli cell; CL=CL_0000216.
CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   2M
CA   Conditionally immortalized cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 17
//
ID   TTF-1 iPS
AC   CVCL_IT50
SY   Tail Tip Fibroblast-1 iPS
DR   PRIDE; PXD000589
DR   Wikidata; Q54973290
RX   PubMed=18371336;
RX   PubMed=25894527;
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Tail, tip; UBERON=UBERON_0010162.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   TTH-18
AC   CVCL_JC44
DR   Wikidata; Q54973292
RX   PubMed=9162096;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 8
//
ID   TTN-45
AC   CVCL_EJ25
SY   TTN45
DR   Cosmic; 2144786
DR   Wikidata; Q54973293
RX   PubMed=24418192;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 6
//
ID   TTNT-1
AC   CVCL_JX67
DR   Wikidata; Q54973294
RX   Patent=US7521234;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7498.
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Telomerase immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   TTNT-16
AC   CVCL_B6EN
SY   16
DR   Wikidata; Q112041866
RX   PubMed=17434229;
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the SV40 T gene thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   TTNT-16-3
AC   CVCL_B6EQ
SY   16-T3
DR   Wikidata; Q112041867
RX   PubMed=14693704;
RX   PubMed=17434229;
CC   Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the TERT gene.
CC   Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites and a plasmid pCAGMerCreMer/Puro that expresses Cre fused to 2 mutant estrogen-receptor ligand-binding domains (MerCreMer) under the control of the CAG promoter.
CC   Doubling time: ~48 hours (PubMed=17434229).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6EN ! TTNT-16
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   TTST0815
AC   CVCL_E5I2
RX   Patent=CN118726261A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202469.
ST   Source(s): Patent=CN118726261A
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 22
ST   D13S317: 8,10
ST   D16S539: 10,13
ST   D18S51: 12,22
ST   D19S433: 13.2,14.2
ST   D21S11: 29,33.2
ST   D2S1338: 16,21
ST   D2S441: 10,12
ST   D3S1358: 15,16
ST   D5S818: 12,14
ST   D6S1043: 18,19
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 23,24.2
ST   Penta D: 8,9
ST   Penta E: 12,21
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TtT/GF
AC   CVCL_S512
DR   CLO; CLO_0050271
DR   RCB; RCB1279
DR   Wikidata; Q54973295
RX   PubMed=1446645;
RX   PubMed=8404665;
RX   PubMed=15541569;
RX   PubMed=23881407;
RX   PubMed=24881870;
CC   Doubling time: 14.4 hours (PubMed=24881870).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Cell type: Folliculostellate cell; CL=CL_0000642.
CC   Breed/subspecies: C57BL/6N x C3H/2N.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_U804 ! TtT/M-87
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 10
//
ID   TtT/M-87
AC   CVCL_U804
SY   M-87
DR   CLO; CLO_0050272
DR   RCB; RCB0531
DR   Wikidata; Q54973297
RX   DOI=10.2220/biomedres.9.367;
RX   PubMed=8133800;
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6N x C3H/2N.
DI   NCIt; C24037; Mouse pituitary gland neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_S512 ! TtT/GF
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 6
//
ID   Tu 138
AC   CVCL_4910
SY   Tu-138; Tu138
DR   BioSample; SAMN03151956
DR   Wikidata; Q54973307
RX   PubMed=8033080;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764). Originally thought to originate from a gingivo-labial moderately differentiated squamous carcinoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00428.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   Tu 158LN
AC   CVCL_1T17
SY   Tu-158LN
DR   BioSample; SAMN03151957
DR   Wikidata; Q54973309
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00429.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_4910 ! Tu 138
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 10
//
ID   Tu 159
AC   CVCL_4911
SY   TU 159; Tu-159; Tu159; TU159
DR   BioSample; SAMN03151958
DR   Wikidata; Q54973310
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00430.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_4910 ! Tu 138
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Tu 167
AC   CVCL_4912
AS   CVCL_1Q87
SY   Tu-167; TU-167; Tu167; TU167; T167; T-167
DR   BioSample; SAMN03151992
DR   Cosmic; 1530763
DR   Cosmic; 1530765
DR   Cosmic; 2043887
DR   Wikidata; Q54973312
RX   PubMed=12907203;
RX   PubMed=16978912;
RX   PubMed=18234965;
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a UM-SCC-1 derivative (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00431.
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7707 ! UM-SCC-1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   Tu 167 c2
AC   CVCL_WI18
SY   Tu167-C2; Tu167c2
DR   Wikidata; Q98133683
RX   PubMed=16978912;
CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 30-01-24; Version: 7
//
ID   Tu 177
AC   CVCL_4913
SY   Tu-177; TU-177; Tu177
DR   PRIDE; PXD013072
DR   Wikidata; Q54973313
RX   PubMed=8033080;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Tu 182
AC   CVCL_4914
SY   Tu-182; Tu182
DR   BioSample; SAMN03151959
DR   Wikidata; Q54973314
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00432.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_4910 ! Tu 138
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4915 ! Tu 212
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   Tu 212
AC   CVCL_4915
SY   Tu-212; Tu212; TU212
DR   BioSample; SAMN03151960
DR   Wikidata; Q54973316
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00433.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_4910 ! Tu 138
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_1T18 ! Tu 212LN
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Tu 212LN
AC   CVCL_1T18
SY   Tu-212LN; 212LN
DR   BTO; BTO_0006085
DR   BioSample; SAMN03151961
DR   Wikidata; Q54973317
RX   PubMed=21868764;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. T404, T406, Tu 138, Tu 158LN, Tu 159, Tu 182, Tu 212 and Tu 212LN have been shown to be identical (PubMed=21868764).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00434.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 8,9
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 15,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1T20 ! T404
OI   CVCL_1T19 ! T406 [Human HNSCC]
OI   CVCL_4910 ! Tu 138
OI   CVCL_1T17 ! Tu 158LN
OI   CVCL_4911 ! Tu 159
OI   CVCL_4914 ! Tu 182
OI   CVCL_4915 ! Tu 212
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   Tu 686
AC   CVCL_4916
SY   Tu-686; Tu686
DR   Wikidata; Q54973318
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   Tu To
AC   CVCL_3328
DR   CLO; CLO_0009445
DR   ATCC; CRL-1298
DR   Wikidata; Q54973319
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3D
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   TU-1
AC   CVCL_M530
DR   cancercelllines; CVCL_M530
DR   Wikidata; Q54973321
RX   CelloPub=CLPUB00455;
RX   PubMed=9249875;
RX   PubMed=10936422;
RX   PubMed=11818668;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=9249875).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 16
//
ID   Tu-107
AC   CVCL_A5VJ
SY   Tu 107; Tu107; T107
DR   Wikidata; Q107117135
RX   PubMed=14655754;
RX   PubMed=17595512;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   Tu-113
AC   CVCL_4831
SY   Tu 113; Tu113; T113
DR   BTO; BTO_0004880
DR   Wikidata; Q54973298
RX   PubMed=14655754;
RX   PubMed=17595512;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   Tu-132
AC   CVCL_4909
SY   TU 132; Tu 132; Tu132; TU132; T132
DR   BTO; BTO_0004879
DR   Wikidata; Q54973306
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=19465936;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   Tu-140
AC   CVCL_W956
SY   Tu 140; Tu140; TU140; T140
DR   Wikidata; Q54973308
RX   PubMed=14655754;
RX   PubMed=17595512;
RX   PubMed=19465936;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 29-06-23; Version: 7
//
ID   Tu-159
AC   CVCL_A5VK
SY   Tu 159; Tu159; T159
DR   Wikidata; Q107117136
RX   PubMed=14655754;
RX   PubMed=17595512;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   TU-2
AC   CVCL_QX94
DR   cancercelllines; CVCL_QX94
DR   Wikidata; Q54973322
RX   CelloPub=CLPUB00455;
RX   PubMed=9249875;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=9249875).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   Tu-2449
AC   CVCL_D318
SY   TU2449
DR   Wikidata; Q54973324
RX   PubMed=9160879;
RX   PubMed=10493969;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00524; Rous sarcoma virus subgroup A (strain Schmidt-Ruppin) v-Src.
CC   Transformant: v-Src.
CC   Breed/subspecies: GFAP-v-src transgenic.
DI   NCIt; C21932; Mouse astrocytic tumours
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 6
//
ID   TU-3
AC   CVCL_QX95
DR   cancercelllines; CVCL_QX95
DR   Wikidata; Q54973323
RX   CelloPub=CLPUB00455;
RX   PubMed=9249875;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=9249875).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   Tu-323
AC   CVCL_A5VL
SY   TU323
DR   Wikidata; Q107117139
RX   PubMed=19465936;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   Tu-325
AC   CVCL_A5VM
SY   TU325
DR   Wikidata; Q107117141
RX   PubMed=19465936;
CC   Characteristics: Primary glioma cell culture.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   TU-ECS-1
AC   CVCL_IP26
DR   cancercelllines; CVCL_IP26
DR   Wikidata; Q54973325
RX   PubMed=27889902;
CC   Population: Japanese.
CC   Doubling time: 18.2 +- 2.1 hours (PubMed=27889902).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27889902).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala189Val (c.566C>T); ClinVar=VCV000012382; Zygosity=Unspecified (PubMed=27889902).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=27889902).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   TU-KATO-III
AC   CVCL_VL11
SY   TU-kato-III; TU-KatoIII; Tumorigenic-KATO-III
DR   BTO; BTO_0006122
DR   JCRB; JCRB1941
DR   Wikidata; Q98133684
RX   PubMed=17505008;
CC   Population: Japanese.
CC   Characteristics: Has a high tumorigenic potential. Established after seven tumor passages of KATO-III in nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1941
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C2993; Down syndrome
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0371 ! KATO III
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 12
//
ID   TU-MM-1
AC   CVCL_1G72
SY   Tottori University-Malignant Mesothelioma-1
DR   cancercelllines; CVCL_1G72
DR   Cosmic; 2758997
DR   Wikidata; Q54973327
RX   PubMed=26070481;
CC   Population: Japanese.
CC   Doubling time: 67.9 hours (PubMed=26070481).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26070481).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Val1822Asp (c.5465T>A) (V1804D); ClinVar=VCV000021030; Zygosity=Unspecified (PubMed=26070481).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=26070481).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 19
//
ID   TU-OC-1
AC   CVCL_L700
SY   TUOC1; Tottori University-Ovarian Clear cell-1
DR   cancercelllines; CVCL_L700
DR   Cosmic; 1889261
DR   Cosmic; 2482703
DR   Wikidata; Q54973329
RX   PubMed=23430509;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 38.4 +- 3.5 hours (PubMed=23430509).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=23430509).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   TU-OC-2
AC   CVCL_HE46
SY   Tottori University-Ovarian Clear cell-2
DR   Wikidata; Q54973330
RX   PubMed=26960408;
CC   Population: Japanese.
CC   Characteristics: Does not express ARID1A.
CC   Doubling time: 37.5 +- 3.3 hours (PubMed=26960408).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   TU-OM-1
AC   CVCL_W127
SY   TUOM-1; Tottori University-Ovarian Mucinous-1
DR   Cosmic; 2429305
DR   Wikidata; Q54973331
RX   PubMed=19154404;
CC   Population: Japanese.
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   TU-OS-3
AC   CVCL_K033
SY   TUOS-3; Tottori University-Ovarian Serous-3
DR   Cosmic; 2482711
DR   Wikidata; Q54973332
RX   PubMed=21610153;
CC   Population: Japanese.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 10
//
ID   TU-OS-4
AC   CVCL_K032
SY   TUOS-4; Tottori University-Ovarian Serous-4
DR   Cosmic; 2482712
DR   Wikidata; Q54973333
RX   PubMed=21610153;
RX   PubMed=23274876;
CC   Population: Japanese.
CC   Doubling time: 53.3 +- 8.1 hours (PubMed=23274876).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   TU101
AC   CVCL_B6U5
SY   TU 101; Tu 101
DR   Wikidata; Q112041868
RX   PubMed=6188732;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes alleles A*02/A*28).
CC   Caution: TU101 has a U umlaut and should thus be transcribed as TUE101, but the umlaut is most often ommitted in online resources.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 5
//
ID   TU110
AC   CVCL_B6U6
SY   TU 110; Tu 110
DR   Wikidata; Q112041869
RX   PubMed=6193088;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*13).
CC   Caution: TU110 has a U umlaut and should thus be transcribed as TUE110, but the umlaut is most often ommitted in online resources.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 5
//
ID   TU165
AC   CVCL_B6T0
SY   TUE165
DR   Wikidata; Q112041870
RX   PubMed=8449221;
RX   PubMed=9878435;
CC   Characteristics: Produces a mAb that acts in a T-cell receptor-like manner (PubMed=8449221).
CC   Characteristics: The produced mAb recognizes the nonapeptide LPPHDITPY from EBV EBNA6/EBNA3C when bound to HLAB*35:01 (PubMed=9878435).
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*35:01).
CC   Monoclonal antibody target: UniProtKB; P03204; Epstein-Barr virus (strain B95-8) nuclear antigen 6 (Note=Recognizes AA 98-106).
CC   Caution: TU165 has a U umlaut and should thus be transcribed as TUE165, but the umlaut is most often ommitted in online resources.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 27-11-25; Version: 5
//
ID   Tu167LN1
AC   CVCL_1Q85
SY   Tu167-LN1
DR   Wikidata; Q54973334
RX   PubMed=12907203;
CC   Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative.
CC   Population: Caucasian.
CC   Characteristics: Anoikis-resistant (PubMed=12907203).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4912 ! Tu 167
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 12
//
ID   TU223
AC   CVCL_C8BQ
DR   Wikidata; Q123033657
RX   PubMed=1326791;
CC   Population: Japanese.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P49961; Human ENTPD1/CD39.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from a pregnant woman (PubMed=1326791).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   TUAT-BME-11
AC   CVCL_Z083
SY   BME-11
DR   ICLDB; tuat-bme-11
DR   Wikidata; Q54973335
RX   DOI=10.1303/aez.29.604;
RX   DOI=10.1303/aez.32.227;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kuroko.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   TUAT-BME-15
AC   CVCL_Z084
SY   BME-15
DR   ICLDB; tuat-bme-15
DR   Wikidata; Q54973336
RX   DOI=10.1303/aez.29.604;
RX   DOI=10.1303/aez.32.227;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Kuroko.
OX   NCBI_TaxID=7091; ! Bombyx mori (Silk moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 27-11-25; Version: 9
//
ID   TUAT-SpLi-221
AC   CVCL_Z519
SY   TUAT-SpLi221; SpLi-221; SpLi221
DR   CLO; CLO_0050004
DR   ICLDB; tuat-spli-221
DR   NISES; SK0016
DR   RCB; RCB0406
DR   Wikidata; Q54973337
RX   DOI=10.1303/aez.30.75;
RX   PubMed=10358729;
CC   Group: Insect cell line.
CC   Discontinued: NGRC Genebank; Catalog number 275023.
CC   Discontinued: RCB; RCB0406; probable.
OX   NCBI_TaxID=69820; ! Spodoptera litura (Asian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   TUB-4D
AC   CVCL_GZ11
DR   cancercelllines; CVCL_GZ11
DR   Wikidata; Q54973338
RX   PubMed=2842332;
WW   Provider; ICOregon; 1626-B; https://web.archive.org/web/20230205100833/http://icoregon.technologypublisher.com/technology/18058
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 18
//
ID   TUBA1A-iPS-A#1
AC   CVCL_VG50
DR   SKIP; SKIP001341
DR   Wikidata; Q54973339
RX   PubMed=27431206;
CC   Sequence variation: Mutation; HGNC; HGNC:20766; TUBA1A; Simple; p.Asn329Ser (c.986A>G); ClinVar=VCV000160167; Zygosity=Heterozygous (PubMed=27431206).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Stromal cell; CL=CL_0000499.
DI   NCIt; C148461; Lissencephaly 3
DI   ORDO; Orphanet_171680; Lissencephaly due to TUBA1A mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG51 ! TUBA1A-iPS-A#3
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   TUBA1A-iPS-A#3
AC   CVCL_VG51
DR   SKIP; SKIP001344
DR   Wikidata; Q54973340
RX   PubMed=27431206;
CC   Sequence variation: Mutation; HGNC; HGNC:20766; TUBA1A; Simple; p.Asn329Ser (c.986A>G); ClinVar=VCV000160167; Zygosity=Heterozygous (PubMed=27431206).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Stromal cell; CL=CL_0000499.
DI   NCIt; C148461; Lissencephaly 3
DI   ORDO; Orphanet_171680; Lissencephaly due to TUBA1A mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG50 ! TUBA1A-iPS-A#1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   TUBA1A-iPS-B#1
AC   CVCL_VG52
DR   SKIP; SKIP001343
DR   Wikidata; Q54973341
RX   PubMed=27431206;
CC   Sequence variation: Mutation; HGNC; HGNC:20766; TUBA1A; Simple; p.Arg264Cys (c.790C>T); ClinVar=VCV000007070; Zygosity=Heterozygous (PubMed=27431206).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148461; Lissencephaly 3
DI   ORDO; Orphanet_171680; Lissencephaly due to TUBA1A mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG53 ! TUBA1A-iPS-B#2
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   TUBA1A-iPS-B#2
AC   CVCL_VG53
DR   SKIP; SKIP001345
DR   Wikidata; Q54973342
RX   PubMed=27431206;
CC   Sequence variation: Mutation; HGNC; HGNC:20766; TUBA1A; Simple; p.Arg264Cys (c.790C>T); ClinVar=VCV000007070; Zygosity=Heterozygous (PubMed=27431206).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148461; Lissencephaly 3
DI   ORDO; Orphanet_171680; Lissencephaly due to TUBA1A mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VG52 ! TUBA1A-iPS-B#1
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   TUBO [Human B-cell IHW]
AC   CVCL_E858
SY   Extract 509
DR   dbMHC; 49048
DR   ECACC; 88052045
DR   IHW; IHW09045
DR   IPD-IMGT/HLA; 11502
DR   Wikidata; Q54973344
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/356cx.pdf
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   HLA typing: A*02:16,03:01:01:01; B*51:01:01:01; C*07:04:01:01,15:02:01:01; DPA1*01:03:01:05,01:03:01:01; DPB1*02:01:02/02:01:19,04:02:01; DQA1*05:05:01; DQB1*03:01:01; DRA*01:01,01:02; DRB1*11:04:01,12:01:01/12:10; DRB3*02:02:01:02 (IPD-IMGT/HLA=11502).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   TUBO [Mouse mammary tumor]
AC   CVCL_2A33
SY   Turin-Bologna
DR   EFO; EFO_0006306
DR   Millipore; SCC222
DR   Wikidata; Q54973345
RX   PubMed=11046045;
RX   PubMed=25179116;
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB-neuT transgenic.
ST   Source(s): Millipore=SCC222
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 15,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 24.2,29
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 17
ST   Mouse STR 19-2: 14
ST   Mouse STR X-1: 25
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-04-25; Version: 8
//
ID   TUBO-P2J
AC   CVCL_2A34
DR   Wikidata; Q54973346
RX   Patent=KR101309902B1;
RX   PubMed=25179116;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00272.
CC   Characteristics: Metastatic phenotype. Established from metastatic lung nodules in mice implanted with the parent cell line (PubMed=25179116).
CC   Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu).
CC   Transformant: Activated Erbb2/neu.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB-neuT transgenic.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2A33 ! TUBO [Mouse mammary tumor]
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 8
//
ID   Tucker-HSA
AC   CVCL_0D01
SY   TUCKER; Tucker
DR   GEO; GSM377403
DR   Wikidata; Q54973347
RX   PubMed=19461996;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   TuD-1
AC   CVCL_5638
SY   TuD1
DR   JCRB; IFO50103
DR   Wikidata; Q54973348
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   TuD-1-1
AC   CVCL_M862
SY   TuD1-1
DR   Wikidata; Q54973350
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TuD-1-10
AC   CVCL_M871
SY   TuD1-10
DR   Wikidata; Q54973351
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TuD-1-2
AC   CVCL_M868
SY   TuD1-2
DR   Wikidata; Q54973352
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TuD-1-3
AC   CVCL_5639
SY   TuD1-3
DR   JCRB; IFO50152
DR   Wikidata; Q54973363
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   TuD-1-5
AC   CVCL_5640
SY   TuD1-5
DR   Wikidata; Q54973364
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   TuD-1-7
AC   CVCL_M869
SY   TuD1-7
DR   Wikidata; Q54973366
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TuD-1-9
AC   CVCL_M870
SY   TuD1-9
DR   Wikidata; Q54973367
RX   PubMed=2384449;
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: Epithelial cell of thymus; CL=CL_0002293.
CC   Breed/subspecies: ACI/NMna; RS=RS_0000030.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_5638 ! TuD-1
SX   Male
AG   8W
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 9
//
ID   TUHR10TKB
AC   CVCL_5952
SY   TUHR-10TKB; OgTs
DR   BTO; BTO_0003732
DR   CLO; CLO_0050896
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 354
DR   BioSample; SAMN03472180
DR   BioSample; SAMN10987736
DR   cancercelllines; CVCL_5952
DR   Cell_Model_Passport; SIDM01454
DR   DepMap; ACH-000459
DR   FANTOM5_SSTAR; 10471-106I3
DR   GEO; GSM887715
DR   GEO; GSM888808
DR   IARC_TP53; 30183
DR   LiGeA; CCLE_294
DR   PharmacoDB; TUHR10TKB_1610_2019
DR   Progenetix; CVCL_5952
DR   RCB; RCB1275
DR   Wikidata; Q54973368
RX   PubMed=9914789;
RX   PubMed=17284252;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*24:02 (PubMed=9914789).
CC   HLA typing: A*02:01,24:02; B*40:01,40:01; C*03:04,03:04 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=79.7%; East Asian, South=19.89%; South Asian=0.4%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1275
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 13
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   TUHR14TKB
AC   CVCL_5953
SY   TUHR-14TKB; 14T
DR   BTO; BTO_0003730
DR   CLO; CLO_0050897
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03472133
DR   BioSample; SAMN10987725
DR   cancercelllines; CVCL_5953
DR   Cell_Model_Passport; SIDM01433
DR   DepMap; ACH-000317
DR   GEO; GSM887716
DR   GEO; GSM888809
DR   IARC_TP53; 28394
DR   LiGeA; CCLE_858
DR   PharmacoDB; TUHR14TKB_1611_2019
DR   Progenetix; CVCL_5953
DR   RCB; RCB1383
DR   Wikidata; Q54973369
RX   PubMed=10929426;
RX   PubMed=14534724;
RX   PubMed=15604581;
RX   PubMed=17212712;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*24:02,24:02; B*39:01,40:02; C*03:04,03:04; DRB1*08:02,08:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.62%; Native American=0.46%; East Asian, North=87.1%; East Asian, South=7.82%; South Asian=0%; European, North=0%; European, South=4% (PubMed=30894373).
ST   Source(s): RCB=RCB1383
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   TUHR16TKB
AC   CVCL_5954
SY   TUHR-16TKB
DR   BTO; BTO_0003733
DR   Wikidata; Q54973371
RX   PubMed=17284252;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   TUHR25TKB
AC   CVCL_5955
SY   TUHR-25TKB
DR   BTO; BTO_0003735
DR   RCB; RCB1680
DR   Wikidata; Q54973372
RX   PubMed=17284252;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   TUHR3TKB
AC   CVCL_5956
SY   TUHR-3TKB
DR   CLO; CLO_0050895
DR   BioSample; SAMN03472175
DR   RCB; RCB1187
DR   Wikidata; Q54973373
RX   PubMed=9914789;
CC   Population: Japanese.
CC   HLA typing: A*02,24:02 (PubMed=9914789).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1187
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   TUHR4TKB
AC   CVCL_5957
SY   TUHR-4TKB; 4TUHR; 4T
DR   BTO; BTO_0003729
DR   CLO; CLO_0050898
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 353
DR   BioSample; SAMN03472178
DR   BioSample; SAMN10987695
DR   cancercelllines; CVCL_5957
DR   Cell_Model_Passport; SIDM01432
DR   DepMap; ACH-000495
DR   GEO; GSM887717
DR   GEO; GSM888810
DR   IARC_TP53; 30184
DR   LiGeA; CCLE_767
DR   PharmacoDB; TUHR4TKB_1612_2019
DR   Progenetix; CVCL_5957
DR   RCB; RCB1198
DR   Wikidata; Q54973374
RX   PubMed=9914789;
RX   PubMed=10929426;
RX   PubMed=14534724;
RX   PubMed=15604581;
RX   PubMed=22185343;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   HLA typing: A*02:06,02:06; B*15:18,15:18; C*07:04,07:04; DQA1*03:02,03:02; DQB1*03:02,03:02; DRB1*08:02,08:02 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.62%; Native American=0%; East Asian, North=85.09%; East Asian, South=5.8%; South Asian=0%; European, North=0%; European, South=5.48% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): RCB=RCB1198
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 10,12
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   TUMi001-A
AC   CVCL_VF08
SY   C25
DR   BioSamples; SAMEA104132875
DR   hPSCreg; TUMi001-A
DR   Wikidata; Q54973375
RX   PubMed=20660394;
CC   From: Technical University of Munich; Munich; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   TUR
AC   CVCL_1775
SY   TPA-U937-resistant
DR   CLO; CLO_0009447
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2367
DR   BioSample; SAMN03471833
DR   cancercelllines; CVCL_1775
DR   Cell_Model_Passport; SIDM01205
DR   ChEMBL-Cells; CHEMBL3308519
DR   ChEMBL-Targets; CHEMBL2366218
DR   Cosmic; 683549
DR   Cosmic; 909773
DR   Cosmic-CLP; 909773
DR   DepMap; ACH-002314
DR   EGA; EGAS00001000978
DR   GDSC; 909773
DR   GEO; GSM186464
DR   GEO; GSM1670551
DR   IARC_TP53; 27263
DR   LINCS_LDP; LCL-2063
DR   PharmacoDB; TUR_1613_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1775
DR   PubChem_Cell_line; CVCL_1775
DR   Wikidata; Q54973376
RX   PubMed=7720732;
RX   PubMed=8398907;
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-high) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (DepMap=ACH-002314).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (DepMap=ACH-002314).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (DepMap=ACH-002314).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (DepMap=ACH-002314).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.04%; East Asian, North=0.5%; East Asian, South=0%; South Asian=1.33%; European, North=75.18%; European, South=22.94% (PubMed=30894373).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2367; Cosmic-CLP=909773
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D21S11: 27,29
ST   D2S1338: 17,20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,22,24
ST   Penta D: 13
ST   Penta E: 13
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   TUR90010
AC   CVCL_VI18
DR   Wikidata; Q54973377
RX   PubMed=10606667;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1165Ter (c.3493C>T); ClinVar=VCV000005445; Zygosity=Homozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   TUR90050
AC   CVCL_VI19
DR   Wikidata; Q54973378
RX   PubMed=10606667;
CC   Population: Turkish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   TUR90060
AC   CVCL_VI20
DR   Wikidata; Q54973379
RX   PubMed=10606667;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Gln1165Ter (c.3493C>T); ClinVar=VCV000005445; Zygosity=Heterozygous (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   TUSMi001-A
AC   CVCL_LF70
DR   BioSamples; SAMEA104381570
DR   hPSCreg; TUSMi001-A
DR   SKIP; SKIP003217
DR   Wikidata; Q54973380
RX   PubMed=29035843;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29035843
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 13
ST   D12S391: 19,22
ST   D13S317: 8,10
ST   D16S539: 9
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 20,24
ST   D2S441: 10,13
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D6S1043: 14,18
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 23,25
ST   Penta D: 8,9
ST   Penta E: 11
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   TUSMi002-A
AC   CVCL_LF71
DR   BioSamples; SAMEA104387910
DR   hPSCreg; TUSMi002-A
DR   SKIP; SKIP003216
DR   Wikidata; Q54973382
RX   PubMed=29034892;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034892
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 14,16
ST   D12S391: 17,22
ST   D13S317: 8,11
ST   D16S539: 10,13
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 18,24
ST   D2S441: 10,11.3
ST   D3S1358: 17
ST   D5S818: 12
ST   D6S1043: 12,13
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 23,24
ST   Penta D: 9,10
ST   Penta E: 19,20
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   TUSMi003-A
AC   CVCL_VE35
DR   BioSamples; SAMEA104494350
DR   hPSCreg; TUSMi003-A
DR   SKIP; SKIP002967
DR   Wikidata; Q54973383
RX   PubMed=29328972;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29328972
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 12,13
ST   D12S391: 20,21
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 17,19
ST   D19S433: 12,13.2
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D2S441: 10,12
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D6S1043: 13,19
ST   D7S820: 8,9
ST   D8S1179: 10
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 10,15
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   TUSMi004-A
AC   CVCL_VR56
SY   XW
DR   BioSamples; SAMEA4675908
DR   hPSCreg; TUSMi004-A
DR   Wikidata; Q98133685
RX   PubMed=30223146;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C88411; Obsessive compulsive disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 4
//
ID   TUSMi005-A
AC   CVCL_UG24
DR   BioSamples; SAMEA4760481
DR   hPSCreg; TUSMi005-A
DR   Wikidata; Q98133686
RX   PubMed=30316949;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 4
//
ID   TUSMi006-A
AC   CVCL_VN40
SY   15M0014
DR   BioSamples; SAMEA4760629
DR   hPSCreg; TUSMi006-A
DR   Wikidata; Q98133687
RX   PubMed=30077089;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4586; GRIN2B; Simple; p.Arg712Lys (c.2135G>A); Zygosity=Unspecified (PubMed=30077089).
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple; p.Thr1483Ala (c.4447A>G); ClinVar=VCV000761546; Zygosity=Unspecified (PubMed=30077089).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30077089
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 17,18
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13,15.2
ST   D21S11: 30,32
ST   D2S1338: 20,23
ST   D2S441: 9.1,14
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 19,23
ST   Penta D: 8,12
ST   Penta E: 5,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   TUSMi007-A
AC   CVCL_UJ67
SY   15M005
DR   BioSamples; SAMEA5912466
DR   hPSCreg; TUSMi007-A
DR   Wikidata; Q98133689
RX   PubMed=30503970;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=30503970
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D10S1248: 14
ST   D12S391: 18,19
ST   D13S317: 8,12
ST   D16S539: 9
ST   D18S51: 15,16
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 23
ST   D2S441: 10,11
ST   D3S1358: 15,18
ST   D5S818: 9,10
ST   D6S1043: 19
ST   D7S820: 10,12
ST   D8S1179: 15,16
ST   FGA: 21,23
ST   Penta D: 11,12
ST   Penta E: 19,23
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 4
//
ID   TUSMi008-A
AC   CVCL_UM28
SY   15F0021
DR   BioSamples; SAMEA5912468
DR   hPSCreg; TUSMi008-A
DR   Wikidata; Q98133690
RX   PubMed=30831521;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8624; PAXIP1; Simple; p.Gln413_His414insGlnGln (c.1241_1242insGCAGCA); Zygosity=Heterozygous (PubMed=30831521).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   TUSMi009-A
AC   CVCL_A8NT
DR   hPSCreg; TUSMi009-A
DR   Wikidata; Q108821408
RX   PubMed=34587579;
CC   From: Tongji University School of Medicine; Wuhan; China.
CC   Population: Chinese; Han.
CC   Donor information: Established from a patient suffering from glioblastoma.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 6
//
ID   TUSMi010-A
AC   CVCL_A8NU
DR   hPSCreg; TUSMi010-A
DR   Wikidata; Q108821409
CC   From: Tongji University School of Medicine; Wuhan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   TuTruK
AC   CVCL_C8CM
DR   Wikidata; Q123033658
RX   PubMed=16290286;
CC   Group: Cetacean cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_C8CN ! TuTruL
SX   Sex unspecified
AG   Calf
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   TuTruL
AC   CVCL_C8CN
DR   Wikidata; Q123033659
RX   PubMed=16290286;
RX   PubMed=22619183;
CC   Group: Cetacean cell line.
CC   Doubling time: 41 +- 4 hours (PubMed=22619183).
CC   Derived from site: In situ; Lung, endothelium; UBERON=UBERON_0013479.
CC   Cell type: Endothelial cell of lung; CL=CL_1001567.
OX   NCBI_TaxID=9739; ! Tursiops truncatus (Atlantic bottle-nosed dolphin)
OI   CVCL_C8CM ! TuTruK
SX   Sex unspecified
AG   Calf
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   TUSMi011-A
AC   CVCL_C0CQ
DR   hPSCreg; TUSMi011-A
DR   Wikidata; Q112930486
CC   From: Tongji University School of Medicine; Wuhan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   TuWi
AC   CVCL_8275
SY   Tu Wi
DR   ATCC; CCL-31
DR   BioSample; SAMN03151763
DR   Wikidata; Q54973384
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=6451928;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from a Wilms tumor.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00028.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: ATCC; CCL-31; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   TV
AC   CVCL_VU90
DR   Wikidata; Q98133691
RX   DOI=10.2478/s11536-006-0007-x;
RX   PubMed=12067450;
RX   PubMed=15090264;
CC   Doubling time: ~48 hours (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Miscellaneous: Doubling time and HPV subtype from personal communication of Diaconu, Carmen Cristina.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 5
//
ID   TV-1
AC   CVCL_R817
SY   Turbot Vigo-1
DR   CCLV; CCLV-RIE 0855
DR   Wikidata; Q54973385
RX   CelloPub=CLPUB00121;
RX   CelloPub=CLPUB00601;
RX   CelloPub=CLPUB00602;
RX   DOI=10.1046/j.1365-2761.2002.00371.x;
RX   PubMed=8167908;
CC   Group: Fish cell line.
CC   Problematic cell line: Misidentified. Originally thought to originate from the caudal fin of the turbot Scophthalmus maximus, but has been found to be a cell line from an undefined fish species (CelloPub=CLPUB00602).
CC   Characteristics: Optimal growth temperature is 20 Celsius (DOI=10.1046/j.1365-2761.2002.00371.x; PubMed=8167908).
CC   Doubling time: 2 days (CelloPub=CLPUB00121).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=7898; ! Actinopterygii (Unidentified fish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 14
//
ID   TVBF-7
AC   CVCL_C4KR
SY   ACC115m
DR   Wikidata; Q116050658
RX   PubMed=33981288;
RX   PubMed=35563746;
RX   PubMed=35764904;
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln247Ter (c.739C>T); ClinVar=VCV000827018; Zygosity=Unspecified (PubMed=35563746).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=35563746
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D10S1248: 14
ST   D12S391: 18,20
ST   D13S317: 12
ST   D16S539: 8
ST   D18S51: 19
ST   D19S433: 13
ST   D1S1656: 16
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 19
ST   D2S441: 12
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 15
ST   FGA: 21
ST   Penta D: 9,12
ST   Penta E: 5
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C9325; Adrenal cortex carcinoma
DI   ORDO; Orphanet_1501; Adrenocortical carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   TVGH-iPSC-001-04
AC   CVCL_GT31
SY   TVGH-iPSC-01-04
DR   BCRC; SC81032
DR   BCRC; SC81118
DR   SKIP; SKIP005620
DR   SKIP; SKIP005722
DR   Wikidata; Q54973386
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 9
//
ID   TVGH-iPSC-002-07
AC   CVCL_GT32
SY   TVGH-iPSC-02-07
DR   BCRC; SC81033
DR   BCRC; SC81119
DR   SKIP; SKIP005621
DR   SKIP; SKIP005723
DR   Wikidata; Q54973387
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   TVGH-iPSC-003-12
AC   CVCL_QY11
DR   BCRC; SC81068
DR   SKIP; SKIP005664
DR   Wikidata; Q54973388
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-004-13
AC   CVCL_QY12
DR   BCRC; SC81069
DR   SKIP; SKIP005665
DR   Wikidata; Q54973389
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148316; Spinocerebellar ataxia type 36
DI   ORDO; Orphanet_276198; Spinocerebellar ataxia type 36
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-005-05
AC   CVCL_QY13
DR   BCRC; SC81070
DR   SKIP; SKIP005666
DR   Wikidata; Q54973390
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C148316; Spinocerebellar ataxia type 36
DI   ORDO; Orphanet_276198; Spinocerebellar ataxia type 36
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-006-06
AC   CVCL_RP85
DR   BCRC; SC81082
DR   SKIP; SKIP005678
DR   Wikidata; Q54973392
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-007-08
AC   CVCL_RP86
DR   BCRC; SC81083
DR   SKIP; SKIP005679
DR   Wikidata; Q54973394
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-010-09
AC   CVCL_RP84
SY   TVGHi001-A
DR   BCRC; SC81071
DR   hPSCreg; TVGHi001-A
DR   SKIP; SKIP003129
DR   SKIP; SKIP005667
DR   Wikidata; Q54973395
RX   PubMed=29427840;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7459; MT-ND4; Simple; p.Arg340His (m.11778G>A); ClinVar=VCV000009708; Zygosity=Unspecified (PubMed=29427840).
CC   Discontinued: hPSCreg; TVGHi001-A; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29427840
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 11,14
ST   D19S433: 14,14.2
ST   D21S11: 28,30.2
ST   D2S1338: 19,25
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 11,16
ST   FGA: 23,25
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C84808; Leber hereditary optic atrophy
DI   ORDO; Orphanet_104; Leber hereditary optic neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   TVGH-iPSC-012-04
AC   CVCL_QY14
SY   TVGHi002-A
DR   BCRC; SC81072
DR   hPSCreg; TVGHi002-A
DR   SKIP; SKIP005668
DR   Wikidata; Q54973396
RX   PubMed=29660606;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:12703; BEST1; Simple; p.Glu119Glnfs*3 (c.346_355dupGGCAAGGACG); Zygosity=Unspecified (PubMed=29660606).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C118788; Vitelliform macular dystrophy
DI   ORDO; Orphanet_1243; Best vitelliform macular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TVGH-iPSC-013-05
AC   CVCL_QY15
SY   TVGHi003-A
DR   BCRC; SC81073
DR   hPSCreg; TVGHi003-A
DR   SKIP; SKIP005669
DR   Wikidata; Q54973397
RX   PubMed=29674172;
RX   PubMed=30736915;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Trp163Ter (c.488G>A); ClinVar=VCV001687470; Zygosity=Hemizygous (PubMed=29674172).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   TVGH-iPSC-014-05
AC   CVCL_QY16
DR   BCRC; SC81074
DR   SKIP; SKIP005670
DR   Wikidata; Q54973398
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123330; Macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-015-16
AC   CVCL_RP87
DR   BCRC; SC81084
DR   SKIP; SKIP005680
DR   Wikidata; Q54973399
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-016-01
AC   CVCL_RP88
DR   BCRC; SC81085
DR   SKIP; SKIP005681
DR   Wikidata; Q54973400
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-017-08
AC   CVCL_VL34
DR   BCRC; SC81093
DR   SKIP; SKIP005698
DR   Wikidata; Q98133692
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129739; Monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-019-07
AC   CVCL_VL35
DR   BCRC; SC81094
DR   SKIP; SKIP005699
DR   Wikidata; Q98133693
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-020-10
AC   CVCL_QY17
DR   BCRC; SC81075
DR   SKIP; SKIP005671
DR   Wikidata; Q54973401
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-021-10
AC   CVCL_QY18
DR   BCRC; SC81076
DR   SKIP; SKIP005672
DR   Wikidata; Q54973402
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-022-04
AC   CVCL_RP89
DR   BCRC; SC81086
DR   SKIP; SKIP005682
DR   Wikidata; Q54973403
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-023-02
AC   CVCL_YN71
DR   BCRC; SC81097
DR   SKIP; SKIP005702
DR   Wikidata; Q98133694
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_282; Frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   TVGH-iPSC-024-42
AC   CVCL_UD70
DR   BCRC; SC81098
DR   SKIP; SKIP005703
DR   Wikidata; Q98133695
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   TVGH-iPSC-025-06
AC   CVCL_XD57
DR   BCRC; SC81120
DR   SKIP; SKIP005724
DR   Wikidata; Q98133696
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-026-11
AC   CVCL_XD58
DR   BCRC; SC81121
DR   SKIP; SKIP005725
DR   Wikidata; Q98133697
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Asian.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   TVGH-iPSC-SCA3-04
AC   CVCL_JL89
DR   Wikidata; Q54973405
RX   PubMed=28395798;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   TVGHi005-A
AC   CVCL_VN37
SY   TVGH-iPSC-MRF-Mlow; TVGH-iPSC-MRF-Ml
DR   hPSCreg; TVGHi005-A
DR   Wikidata; Q98133699
RX   PubMed=29960149;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7489; MT-TK; Simple; m.8344A>G; ClinVar=VCV000009579; Zygosity=Heteroplasmic; Note=1% (PubMed=29960149).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84889; Myoclonic epilepsy associated with ragged-red fibers
DI   ORDO; Orphanet_551; MERRF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VN38 ! TVGHi006-A
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   TVGHi006-A
AC   CVCL_VN38
SY   TVGH-iPSC-MRF-Mhigh; TVGH-iPSC-MRF-Mh
DR   hPSCreg; TVGHi006-A
DR   Wikidata; Q98133701
RX   PubMed=29960149;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7489; MT-TK; Simple; m.8344A>G; ClinVar=VCV000009579; Zygosity=Heteroplasmic; Note=76% (PubMed=29960149).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84889; Myoclonic epilepsy associated with ragged-red fibers
DI   ORDO; Orphanet_551; MERRF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VN37 ! TVGHi005-A
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   TVGHi007-A
AC   CVCL_YE47
SY   DE5205
DR   hPSCreg; TVGHi007-A
DR   SKIP; SKIP005794
DR   Wikidata; Q98133702
RX   PubMed=32388442;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Leu79Cysfs*3 (c.235delC); ClinVar=VCV000017014; Zygosity=Homozygous (PubMed=32388442).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   TVGHi008-A
AC   CVCL_C0F4
SY   TVGH-iPSC-CF-S308X
DR   hPSCreg; TVGHi008-A
DR   Wikidata; Q112930487
RX   PubMed=35091309;
CC   From: Taipei Veterans General Hospital; Taipei; Taiwan.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Ser308Ter (c.923C>A); Zygosity=Homozygous (PubMed=35091309).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   TVI
AC   CVCL_B7QJ
SY   Triton Vert Iris
DR   Wikidata; Q112930488
RX   PubMed=467859;
RX   PubMed=1010157;
RX   PubMed=7000607;
RX   PubMed=12058078;
CC   Group: Amphibian cell line.
CC   Doubling time: 84 hours (PubMed=1010157).
CC   Derived from site: In situ; Eye, iris, dorsal part; UBERON=UBERON_8480063.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8316; ! Notophthalmus viridescens (Eastern newt)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 5
//
ID   TVMBO
AC   CVCL_M220
DR   Wikidata; Q54973406
RX   PubMed=11121133;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   TW
AC   CVCL_F585
SY   Extract 253; Extract 455
DR   IPD-IMGT/HLA; 11856
DR   Wikidata; Q54973407
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/342cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,25:02; B*08:01,44:02; C*05:01,07:01; DQA1*03,05; DQB1*02:01,03:01; DRB1*03:01,04:01; DRB3*01:01; DRB4*01:AC (IPD-IMGT/HLA=11856).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   TW-EBV-LCL
AC   CVCL_J444
DR   CLO; CLO_0050984
DR   BioSample; SAMN03472141
DR   RCB; RCB1438
DR   Wikidata; Q54973408
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1438
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 10,14
ST   D7S820: 11,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   TW1
AC   CVCL_Y013
SY   hESC-TW1
DR   BCRC; hESC-TW1
DR   BCRC; SC81001
DR   BCRC; SC81143
DR   Wikidata; Q54973419
RX   PubMed=18765016;
CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Hsinchu City; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 30-01-24; Version: 7
//
ID   TW2
AC   CVCL_Y014
DR   Wikidata; Q54973420
RX   PubMed=18765016;
CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Hsinchu City; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   TW2.6
AC   CVCL_GZ05
DR   cancercelllines; CVCL_GZ05
DR   Wikidata; Q54973421
RX   PubMed=17070096;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 24 hours (PubMed=17070096).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=17070096).
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 10
//
ID   TW3
AC   CVCL_Y015
DR   BCRC; SC81003
DR   Wikidata; Q54973422
RX   PubMed=18765016;
CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Hsinchu City; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   TW4
AC   CVCL_Y016
DR   Wikidata; Q54973423
RX   PubMed=18765016;
CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Hsinchu City; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   TW5
AC   CVCL_Y017
DR   BCRC; SC81005
DR   Wikidata; Q54973424
RX   PubMed=18765016;
CC   From: Industrial Technology Research Institute (ITRI) and Lee Women's Hospital; Hsinchu City; Taiwan.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 6
//
ID   TWERC
AC   CVCL_7704
SY   Tumor-WERC
DR   CLO; CLO_0009448
DR   CLDB; cl4574
DR   Wikidata; Q54973425
RX   PubMed=4107530;
RX   PubMed=6250919;
CC   Transformant: NCBI_TaxID; 11888; Rous sarcoma virus (strain Prague C).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7881 ! WERC
SX   Sex unspecified
AG   16-18FD
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   Twin-DS
AC   CVCL_B4L1
SY   T1DS
DR   GEO; GSE123028
DR   GEO; GSE135500
DR   GEO; GSM1333659
DR   GEO; GSM1333661
DR   GEO; GSM1338307
DR   GEO; GSM1338308
DR   GEO; GSM1338311
DR   GEO; GSM1338313
DR   GEO; GSM1338315
DR   GEO; GSM1338317
DR   GEO; GSM1338341
DR   GEO; GSM1338343
DR   PRIDE; PXD004880
DR   Wikidata; Q110433293
RX   PubMed=24375627;
RX   PubMed=24740065;
RX   PubMed=28190458;
RX   PubMed=29089484;
RX   PubMed=30510006;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Doubling time: 48.4 hours (PubMed=29089484).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Donor information: Twin-DS and Twin-N (Cellosaurus=CVCL_B4L2) originate from monozygotic twins discordant for trisomy 21.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   Twin-DS-iPSC
AC   CVCL_W088
SY   T1DS iPS
DR   GEO; GSM1338321
DR   Wikidata; Q54973426
RX   PubMed=24375627;
RX   PubMed=24740065;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Twin-DS-iPSC and Twin-N-iPSC (Cellosaurus=CVCL_B4L3 and CVCL_W087) originate from monozygotic twins discordant for trisomy 21.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4L1 ! Twin-DS
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 16
//
ID   Twin-N
AC   CVCL_B4L2
SY   T2N
DR   GEO; GSE123028
DR   GEO; GSE135500
DR   GEO; GSM1333658
DR   GEO; GSM1333660
DR   GEO; GSM1338309
DR   GEO; GSM1338310
DR   GEO; GSM1338312
DR   GEO; GSM1338314
DR   GEO; GSM1338316
DR   GEO; GSM1338318
DR   GEO; GSM1338342
DR   GEO; GSM1338344
DR   PRIDE; PXD004880
DR   Wikidata; Q110433294
RX   PubMed=24375627;
RX   PubMed=24740065;
RX   PubMed=25557783;
RX   PubMed=28190458;
RX   PubMed=29089484;
RX   PubMed=30510006;
RX   PubMed=32739879;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Doubling time: 43.3 hours (PubMed=29089484).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Donor information: Twin-DS (Cellosaurus=CVCL_B4L1) and Twin-N originate from monozygotic twins discordant for trisomy 21.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 8
//
ID   Twin-N-iPSCs line#7
AC   CVCL_B4L3
SY   Twin-N-iPSC; T2N iPS; 46XX-iPSC; Twin-D21-iPSCs line #7; UNIGEi004-A
DR   GEO; GSM1338322
DR   hPSCreg; UNIGEi004-A
DR   Wikidata; Q110433295
RX   PubMed=24375627;
RX   PubMed=24740065;
RX   PubMed=32739879;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX (PubMed=32739879).
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Twin-DS-iPSC (Cellosaurus=CVCL_W088) and Twin-N-iPSC originate from monozygotic twins discordant for trisomy 21.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4L2 ! Twin-N
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 8
//
ID   Twin-N-iPSCs line#8
AC   CVCL_W087
SY   45X-iPSCs; UNIGEi002-A
DR   hPSCreg; UNIGEi002-A
DR   Wikidata; Q54973427
RX   PubMed=32739879;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Karyotypic information: 45,X (PubMed=32739879).
CC   Donor information: Twin-DS-iPSC (Cellosaurus=CVCL_W088) and Twin-N-iPSC originate from monozygotic twins discordant for trisomy 21.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4L2 ! Twin-N
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 13
//
ID   TWNT-1
AC   CVCL_J364
DR   JCRB; JCRB1582
DR   Wikidata; Q54973428
RX   Patent=US7521234;
RX   PubMed=12811248;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7843.
CC   Population: Japanese.
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the TERT gene thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
ST   Source(s): JCRB=JCRB1582
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3800; Epithelioid hemangioendothelioma
DI   ORDO; Orphanet_157791; Epithelioid hemangioendothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0390 ! LI90
SX   Female
AG   55Y
CA   Telomerase immortalized cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 21
//
ID   TWNT-4
AC   CVCL_W296
SY   TWNT4
DR   Wikidata; Q54973429
RX   PubMed=12953924;
CC   Population: Japanese.
CC   Characteristics: Because it has been transduced by a construct containing LoxP sites, transfection with the Cre recombinase eliminates the TERT gene thus reverting the cells to a non-immortal phenotype.
CC   Characteristics: Transduced with a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites.
CC   Genetic integration: Method=Transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
DI   NCIt; C3800; Epithelioid hemangioendothelioma
DI   ORDO; Orphanet_157791; Epithelioid hemangioendothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0390 ! LI90
SX   Female
AG   55Y
CA   Telomerase immortalized cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 15
//
ID   TX-7F
AC   CVCL_K256
DR   CLO; CLO_0050324
DR   RCB; RCB1856
DR   Wikidata; Q54973431
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: ChEBI; CHEBI_9506; Tetrodotoxin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 6
//
ID   TX-LY-172h
AC   CVCL_AQ50
DR   Wikidata; Q54973434
RX   PubMed=26080839;
RX   PubMed=28119491;
CC   From: Texas Cancer Cell Repository (TXCCR); Lubbock; USA.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   8Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 6
//
ID   TX-LY-245h
AC   CVCL_D5J4
DR   Wikidata; Q127384414
RX   PubMed=28119491;
CC   From: Texas Cancer Cell Repository (TXCCR); Lubbock; USA.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   92Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   TX100
AC   CVCL_E8GC
RX   PubMed=29648914;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P86176; Mouse Tigit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX103
AC   CVCL_E8GD
RX   PubMed=29648914;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P86176; Mouse Tigit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX104
AC   CVCL_E8GE
RX   PubMed=29648914;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P86176; Mouse Tigit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX105
AC   CVCL_E8GF
RX   PubMed=29648914;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P86176; Mouse Tigit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX107
AC   CVCL_E7PW
RX   PubMed=28498033;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TX108
AC   CVCL_E7PX
RX   PubMed=28498033;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TX42
AC   CVCL_E8GG
SY   TX-42
RX   PubMed=15752754;
RX   PubMed=23600509;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8K4F0; Mouse Cd226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX92
AC   CVCL_E8GH
RX   PubMed=23600509;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; Q8K4F0; Mouse Cd226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX99
AC   CVCL_E8GB
RX   PubMed=29648914;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P86176; Mouse Tigit.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 27-11-25; Version: 2
//
ID   TX3.833
AC   CVCL_U756
SY   TX3-833; 833
DR   ATCC; CRL-13013
DR   Wikidata; Q54973436
RX   Patent=US6255457;
RX   PubMed=11854497;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-542.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Rat 90 kDa protein expressed in lung caveolae.
CC   Discontinued: ATCC; CRL-13013; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   Tx3095
AC   CVCL_6853
SY   TX3095
DR   Wikidata; Q54973437
RX   PubMed=16061850;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   Tx3868
AC   CVCL_6854
SY   TX3868
DR   BTO; BTO_0002128
DR   Wikidata; Q54973438
RX   PubMed=8882887;
RX   PubMed=16061850;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   TX545
AC   CVCL_A1SH
DR   Wikidata; Q105511281
RX   PubMed=7859358;
RX   PubMed=11404339;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=7859358).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Thr163Lys (c.488_489CC>AG); Zygosity=Heterozygous (PubMed=7859358).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0561 ! TK6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   TX94
AC   CVCL_E7PT
RX   PubMed=28498033;
RX   PubMed=28636502;
CC   Characteristics: Produces a neutralizing antibody (TX94) that blocks the interaction between CD226 and CD155 (PubMed=28498033).
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TX95
AC   CVCL_E7PU
RX   PubMed=28498033;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TX96
AC   CVCL_E7PV
RX   PubMed=28498033;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q15762; Human CD226.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   TXM-1
AC   CVCL_5643
SY   TXM1
DR   Cosmic; 932705
DR   KCLB; 80028
DR   Wikidata; Q54973439
RX   PubMed=1826230;
RX   PubMed=2297053;
RX   PubMed=7648437;
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Discontinued: KCLB; 80028; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   TXM-13
AC   CVCL_5645
SY   TXM13
DR   BTO; BTO_0003728
DR   Cosmic; 932706
DR   KCLB; 80029
DR   Wikidata; Q54973440
RX   PubMed=1826230;
RX   PubMed=2297053;
RX   PubMed=7648437;
RX   PubMed=10987313;
RX   PubMed=16462895;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Characteristics: Pigmented.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=80029
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   FGA: 22.2,25
ST   TH01: 8
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TXM-18
AC   CVCL_5646
SY   TXM18
DR   BTO; BTO_0003983
DR   Cosmic; 932707
DR   Cosmic; 1238112
DR   KCLB; 80030
DR   Wikidata; Q54973441
RX   PubMed=1826230;
RX   PubMed=7648437;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): KCLB=80030
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D3S1358: 16,19
ST   D5S818: 13
ST   D7S820: 7,9
ST   FGA: 20
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   TXM-31-3
AC   CVCL_C8RZ
DR   Wikidata; Q123033660
RX   PubMed=2297053;
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8S0 ! TXM-31-4
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   TXM-31-4
AC   CVCL_C8S0
DR   Wikidata; Q123033661
RX   PubMed=2297053;
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C8RZ ! TXM-31-3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   TXM-34
AC   CVCL_5647
SY   TXM34
DR   Wikidata; Q54973442
RX   PubMed=1826230;
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   TXM-40
AC   CVCL_5648
SY   TXM40
DR   KCLB; 80031
DR   Wikidata; Q54973443
RX   PubMed=1826230;
RX   PubMed=2297053;
RX   PubMed=7648437;
WW   Provider; MD Anderson CCAC; -; https://www.mdanderson.org/content/dam/mdanderson/documents/core-facilities/Cytogenetics-and-Cell-Authentication-Core/Cell%20Line%20List%203-23-2022.pdf
CC   From: University of Texas M.D. Anderson Cancer Center; Houston; USA.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   TXNIP-null MEF
AC   CVCL_SA60
DR   Wikidata; Q54973444
RX   PubMed=21779470;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1889549; Txnip.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: B6;129-Txniptm1Rlee/J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   TY-1
AC   CVCL_DG42
SY   TY1
DR   cancercelllines; CVCL_DG42
DR   Cosmic; 1588565
DR   GEO; GSM634740
DR   GEO; GSM710425
DR   GEO; GSM710441
DR   Progenetix; CVCL_DG42
DR   Wikidata; Q54973445
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=10421407;
RX   PubMed=19521981;
RX   PubMed=21685375;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   Ty-82
AC   CVCL_3220
SY   TY-82; TY82; Ty82
DR   DepMap; ACH-001676
DR   EGA; EGAD00001003117
DR   FANTOM5_SSTAR; 10803-111A2
DR   GEO; GSM577206
DR   JCRB; JCRB1330
DR   JCRB; NIHS0541
DR   Wikidata; Q54973446
RX   PubMed=1730520;
RX   PubMed=21447744;
RX   PubMed=24736545;
RX   PubMed=28203693;
RX   PubMed=29348827;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Doubling time: ~30 hours (Note=Lot 02152010), ~53 hours (Note=Lot 09082016) (JCRB=JCRB1330).
CC   Sequence variation: Gene fusion; HGNC; HGNC:13575; BRD4 + HGNC; HGNC:29919; NUTM1; Name(s)=BRD4-NUTM1, BRD4-NUT; Note=BRD4 exon 14 fused to NUTM1 exon 2 (PubMed=24736545; PubMed=28203693; PubMed=29348827).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Discontinued: JCRB; NIHS0541; true.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB1330
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 9,11
ST   D7S820: 12,13
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C45716; NUT carcinoma
DI   NCIt; C35718; Thymic undifferentiated carcinoma
DI   ORDO; Orphanet_443167; NUT midline carcinoma
DI   ORDO; Orphanet_99868; Thymic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   TY-E
AC   CVCL_9V43
DR   Wikidata; Q54973448
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   TY-ES
AC   CVCL_S804
DR   Wikidata; Q54973449
RX   CelloPub=CLPUB00122;
CC   Doubling time: 40 hours (CelloPub=CLPUB00122).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   TY08
AC   CVCL_F712
DR   Wikidata; Q54973450
RX   DOI=10.1111/cen3.12001;
RX   PubMed=20458752;
CC   Population: Japanese.
CC   Characteristics: Exhibits a robust proliferation at the permissive temperature of 33 Celsius. Cell growth is arrested at 37 Celsius (PubMed=20458752).
CC   Characteristics: These cells do not grow beyond the 16th to 18th passages, even under the permissive temperature (DOI=10.1111/cen3.12001).
CC   Doubling time: ~3 days (PubMed=20458752).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, microvascular endothelium; UBERON=UBERON_0000955+UBERON_0008339.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   TY09
AC   CVCL_U943
DR   Wikidata; Q54973451
RX   DOI=10.1111/cen3.12001;
CC   Population: Japanese.
CC   Characteristics: Exhibits a robust proliferation at the permissive temperature of 33 Celsius. Cell growth is arrested at 37 Celsius.
CC   Doubling time: ~2 days (DOI=10.1111/cen3.12001).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, microvascular endothelium; UBERON=UBERON_0000955+UBERON_0008339.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F712 ! TY08
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   TY10
AC   CVCL_LH57
DR   Wikidata; Q54973452
RX   DOI=10.1111/cen3.12045;
RX   PubMed=28063233;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, microvascular endothelium; UBERON=UBERON_0000955+UBERON_0008339.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F712 ! TY08
SX   Sex unspecified
AG   Age unspecified
CA   Conditionally immortalized cell line
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 11
//
ID   TY25
AC   CVCL_CW90
DR   Wikidata; Q54973454
RX   PubMed=12421930;
RX   PubMed=14515261;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q9WUL5; Mouse Pdcd1lg2/Cd273.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 5
//
ID   TYAE-1
AC   CVCL_JY37
SY   TYAE-1c
DR   Wikidata; Q54973455
RX   DOI=10.1158/1538-7445.AM2013-2720;
CC   Population: Japanese.
DI   NCIt; C7027; Barrett adenocarcinoma
DI   ORDO; Orphanet_99976; Adenocarcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 6
//
ID   TYBDC-1
AC   CVCL_4W80
DR   JCRB; JCRB1501
DR   Wikidata; Q54973456
RX   CelloPub=CLPUB00766;
CC   Population: Japanese.
CC   Doubling time: 1.6-2.4 days (Note=Lot 12152016) (JCRB=JCRB1501).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1501
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C27813; Bile duct adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 9
//
ID   TYEK-1
AC   CVCL_LC37
DR   cancercelllines; CVCL_LC37
DR   JCRB; JCRB1668
DR   Wikidata; Q54973457
CC   Population: Japanese.
CC   Doubling time: 19.8 hours (JCRB=JCRB1668).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His214Arg (c.641A>G); ClinVar=VCV000376615; Zygosity=Unspecified (JCRB=JCRB1668).
CC   Derived from site: In situ; Pharynx; UBERON=UBERON_0006562.
ST   Source(s): JCRB=JCRB1668
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   TYEK-2
AC   CVCL_B3M7
DR   JCRB; JCRB1848
DR   Wikidata; Q110433296
CC   Population: Japanese.
CC   Doubling time: 21.9 hours (JCRB=JCRB1848).
CC   Derived from site: Metastatic; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1848
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   TYGBK-1
AC   CVCL_J034
DR   cancercelllines; CVCL_J034
DR   Cosmic; 2038290
DR   JCRB; JCRB1499
DR   Wikidata; Q54973458
RX   PubMed=22843894;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=22843894).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=22843894).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1499
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 11,14
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   TYGBK-8
AC   CVCL_4W81
DR   cancercelllines; CVCL_4W81
DR   JCRB; JCRB1590
DR   Wikidata; Q54973459
RX   CelloPub=CLPUB00766;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Unspecified (JCRB=JCRB1590).
CC   Derived from site: In situ; Gallbladder; UBERON=UBERON_0002110.
ST   Source(s): JCRB=JCRB1590
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   TYHPC-1
AC   CVCL_4W82
DR   JCRB; JCRB1520
DR   Wikidata; Q54973460
CC   Population: Japanese.
CC   Doubling time: 38.8 hours (JCRB=JCRB1520).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): JCRB=JCRB1520
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3087; Hemangiopericytoma
DI   ORDO; Orphanet_2126; Solitary fibrous tumour/hemangiopericytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   TYK-nu
AC   CVCL_1776
SY   TYK-NU; TYKnu; TYKNU
DR   CLO; CLO_0037104
DR   EFO; EFO_0006766
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1039
DR   BioSample; SAMN03471005
DR   BioSample; SAMN10988265
DR   cancercelllines; CVCL_1776
DR   Cell_Model_Passport; SIDM00321
DR   CGH-DB; 9359-4
DR   ChEMBL-Cells; CHEMBL3308805
DR   ChEMBL-Targets; CHEMBL1075601
DR   Cosmic; 909774
DR   Cosmic; 931359
DR   Cosmic; 948288
DR   Cosmic; 1077283
DR   Cosmic; 2582803
DR   Cosmic; 2674702
DR   Cosmic-CLP; 909774
DR   DepMap; ACH-000430
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909774
DR   GEO; GSM659409
DR   GEO; GSM711725
DR   GEO; GSM851946
DR   GEO; GSM887718
DR   GEO; GSM888811
DR   GEO; GSM1670552
DR   IARC_TP53; 27264
DR   JCRB; JCRB0234.0
DR   LiGeA; CCLE_471
DR   LINCS_LDP; LCL-1700
DR   PharmacoDB; TYKnu_1614_2019
DR   PRIDE; PXD003668
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1776
DR   PubChem_Cell_line; CVCL_1776
DR   Wikidata; Q54973461
RX   PubMed=2647872;
RX   PubMed=3658923;
RX   PubMed=3782955;
RX   PubMed=9290701;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22710073;
RX   PubMed=23839242;
RX   PubMed=25485619;
RX   PubMed=25846456;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27561551;
RX   PubMed=28196595;
RX   PubMed=30485824;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/t/cell-lines-detail-312.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Japanese.
CC   Doubling time: 43 hours (PubMed=2647872); 45 hours (PubMed=25984343).
CC   HLA typing: A*02:01,26:03; B*35:102,40:05; C*03:03,07:02; DRB1*13:07,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=25846456; Cosmic-CLP=909774; DepMap=ACH-000430).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=25846456; Cosmic-CLP=909774; DepMap=ACH-000430).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=25846456; Cosmic-CLP=909774; DepMap=ACH-000430).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.42%; Native American=0.15%; East Asian, North=83.85%; East Asian, South=15.58%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=909774; JCRB=JCRB0234.0; PubMed=22710073; PubMed=25877200; PubMed=30485824
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 14.2
ST   D21S11: 32.2
ST   D2S1338: 18,24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10,15
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 44
//
ID   TYK-nu.CP-r
AC   CVCL_3221
AS   CVCL_EQ58
SY   TYK-nu (R); TYKNU CPR; TYKnuCPr; TYK-nu-CisR; Tyk-nu-cisR; TYKnuCisR; TyknuCisR
DR   EFO; EFO_0006767
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_3221
DR   CGH-DB; 383-2
DR   CGH-DB; 9360-4
DR   EGA; EGAS00001000610
DR   GEO; GSM851947
DR   JCRB; JCRB0234.1
DR   PharmacoDB; TYKnu_CPr_1615_2019
DR   PRIDE; PXD003668
DR   Wikidata; Q54973462
RX   PubMed=2647872;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=22710073;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27561551;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=2647872).
CC   HLA typing: A*02:01,26:03; B*35:08,58:05; C*03:03,07:02; DRB1*13:07,15:01 (PubMed=26589293).
CC   Karyotypic information: Deletion of chromosome 7q (PubMed=2647872).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): JCRB=JCRB0234.1; PubMed=22710073
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 13
ST   D19S433: 14.2
ST   D21S11: 32.2
ST   D2S1338: 18,24
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 10,15
ST   FGA: 24
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,16
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1776 ! TYK-nu
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   Tyler1
AC   CVCL_WS64
SY   TYLER1
DR   Wikidata; Q98133703
RX   DOI=10.1158/1538-7445.AM2012-5258;
RX   PubMed=31175136;
CC   Sequence variation: Mutation; VGNC; VGNC:38093; ARID1A; Simple; p.Ala901fs (c.2700_2701insA); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:38297; ATRX; Simple; p.Cys1810Ter (c.5430T>A); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 239
ST   Dog FHC2054: 151
ST   Dog FHC2079: 271,275
ST   Dog PEZ1: 119
ST   Dog PEZ3: 134
ST   Dog PEZ5: 107,111
ST   Dog PEZ6: 175,183
ST   Dog PEZ8: 227,236
ST   Dog PEZ12: 263,281
ST   Dog PEZ20: 176,180
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_WS65 ! Tyler2
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   Tyler2
AC   CVCL_WS65
SY   TYLER2
DR   Wikidata; Q98133704
RX   DOI=10.1158/1538-7445.AM2012-5258;
RX   PubMed=31175136;
CC   Sequence variation: Mutation; VGNC; VGNC:38093; ARID1A; Simple; p.Ala901fs (c.2700_2701insA); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:38297; ATRX; Simple; p.Cys1810Ter (c.5430T>A); Zygosity=Homozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Breed/subspecies: Beagle; VBO=VBO_0200131.
ST   Source(s): PubMed=31175136
ST   Dog FHC2010: 239
ST   Dog FHC2054: 151
ST   Dog FHC2079: 271,275
ST   Dog PEZ1: 119
ST   Dog PEZ3: 134
ST   Dog PEZ5: 107,111
ST   Dog PEZ6: 175,183
ST   Dog PEZ8: 227,236
ST   Dog PEZ12: 263,281
ST   Dog PEZ20: 176,180
DI   NCIt; C128126; Canine transitional cell carcinoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_WS64 ! Tyler1
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 9
//
ID   TYLMS-1
AC   CVCL_4W83
DR   JCRB; JCRB1521
DR   Wikidata; Q54973465
CC   Population: Japanese.
CC   Doubling time: 38.8 hours (JCRB=JCRB1521).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
ST   Source(s): JCRB=JCRB1521
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C27904; Retroperitoneal leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 10
//
ID   TYPK-1
AC   CVCL_4V78
DR   JCRB; JCRB1500
DR   Wikidata; Q54973476
RX   CelloPub=CLPUB00766;
RX   PubMed=26124327;
CC   Population: Japanese.
CC   Doubling time: 22.1 hours (PubMed=26124327).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): JCRB=JCRB1500
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 9,12
ST   D5S818: 10
ST   D7S820: 8,14
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 12
//
ID   TYPK-2
AC   CVCL_4V79
DR   cancercelllines; CVCL_4V79
DR   JCRB; JCRB1708
DR   Wikidata; Q54973478
RX   PubMed=26124327;
CC   Population: Japanese.
CC   Doubling time: 40.4 hours (PubMed=26124327).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000012579; Zygosity=Unspecified (PubMed=26124327).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB1708
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 8,13
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 14,19
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   Tyr1
AC   CVCL_D3BH
DR   Wikidata; Q127384415
WW   Provider; CReM; 678; https://stemcellbank.bu.edu/Catalog/Item/Details/678
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000003807; Zygosity=Heterozygous (Boston University).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Gly47Asp (c.140G>A); ClinVar=VCV000003794; Zygosity=Heterozygous (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   TYR1-hiPSC1
AC   CVCL_C361
SY   TYR.1.H.iPSC.1; TYR1hiPSC1; T-hiPSC1; RIi005-A
DR   hPSCreg; RIi005-A
DR   RSCB; RSCB0067
DR   SKIP; SKIP002400
DR   SKIP; SKIP005840
DR   Wikidata; Q54973479
RX   PubMed=20821352;
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C362 ! TYR1-hiPSC2
OI   CVCL_C363 ! TYR1-hiPSC3
OI   CVCL_C364 ! TYR1-hiPSC4
OI   CVCL_C365 ! TYR1-hiPSC5
OI   CVCL_C366 ! TYR1-hiPSC6
OI   CVCL_C367 ! TYR1-hiPSC7
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   TYR1-hiPSC2
AC   CVCL_C362
SY   TYR.1.H.iPSC.2
DR   RSCB; RSCB0068
DR   Wikidata; Q54973480
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C361 ! TYR1-hiPSC1
OI   CVCL_C363 ! TYR1-hiPSC3
OI   CVCL_C364 ! TYR1-hiPSC4
OI   CVCL_C365 ! TYR1-hiPSC5
OI   CVCL_C366 ! TYR1-hiPSC6
OI   CVCL_C367 ! TYR1-hiPSC7
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   TYR1-hiPSC3
AC   CVCL_C363
SY   TYR.1.H.iPSC.3; T-hiPSC3
DR   RSCB; RSCB0069
DR   Wikidata; Q54973481
RX   PubMed=20821352;
RX   PubMed=22543856;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Omics: Proteomics; 2DE-MS.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C361 ! TYR1-hiPSC1
OI   CVCL_C362 ! TYR1-hiPSC2
OI   CVCL_C364 ! TYR1-hiPSC4
OI   CVCL_C365 ! TYR1-hiPSC5
OI   CVCL_C366 ! TYR1-hiPSC6
OI   CVCL_C367 ! TYR1-hiPSC7
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   TYR1-hiPSC4
AC   CVCL_C364
SY   TYR.1.H.iPSC.4
DR   RSCB; RSCB0070
DR   Wikidata; Q54973482
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C361 ! TYR1-hiPSC1
OI   CVCL_C362 ! TYR1-hiPSC2
OI   CVCL_C363 ! TYR1-hiPSC3
OI   CVCL_C365 ! TYR1-hiPSC5
OI   CVCL_C366 ! TYR1-hiPSC6
OI   CVCL_C367 ! TYR1-hiPSC7
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   TYR1-hiPSC5
AC   CVCL_C365
SY   TYR.1.H.iPSC.5
DR   RSCB; RSCB0071
DR   Wikidata; Q54973483
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C361 ! TYR1-hiPSC1
OI   CVCL_C362 ! TYR1-hiPSC2
OI   CVCL_C363 ! TYR1-hiPSC3
OI   CVCL_C364 ! TYR1-hiPSC4
OI   CVCL_C366 ! TYR1-hiPSC6
OI   CVCL_C367 ! TYR1-hiPSC7
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   TYR1-hiPSC6
AC   CVCL_C366
SY   TYR.1.H.iPSC.6
DR   RSCB; RSCB0072
DR   Wikidata; Q54973484
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C361 ! TYR1-hiPSC1
OI   CVCL_C362 ! TYR1-hiPSC2
OI   CVCL_C363 ! TYR1-hiPSC3
OI   CVCL_C364 ! TYR1-hiPSC4
OI   CVCL_C365 ! TYR1-hiPSC5
OI   CVCL_C367 ! TYR1-hiPSC7
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   TYR1-hiPSC7
AC   CVCL_C367
SY   TYR.1.H.iPSC.7
DR   RSCB; RSCB0073
DR   Wikidata; Q54973485
RX   PubMed=20821352;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:3579; FAH; Simple; p.Gln64His (c.192G>T); ClinVar=VCV000021054; Zygosity=Unspecified (PubMed=20821352).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98641; Tyrosinemia type I
DI   ORDO; Orphanet_882; Tyrosinemia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C361 ! TYR1-hiPSC1
OI   CVCL_C362 ! TYR1-hiPSC2
OI   CVCL_C363 ! TYR1-hiPSC3
OI   CVCL_C364 ! TYR1-hiPSC4
OI   CVCL_C365 ! TYR1-hiPSC5
OI   CVCL_C366 ! TYR1-hiPSC6
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   Tyr2
AC   CVCL_D3BI
DR   Wikidata; Q127384416
WW   Provider; CReM; 679; https://stemcellbank.bu.edu/Catalog/Item/Details/679
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Gly47Asp (c.140G>A); ClinVar=VCV000003794; Zygosity=Homozygous (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   Tyr3
AC   CVCL_D3BJ
DR   Wikidata; Q127384417
WW   Provider; CReM; 680; https://stemcellbank.bu.edu/Catalog/Item/Details/680
CC   From: Center for Regenerative Medicine; Boston; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Gly47Asp (c.140G>A); ClinVar=VCV000003794; Zygosity=Heterozygous (Boston University).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Thr373Lys (c.1118C>A); ClinVar=VCV000003774; Zygosity=Heterozygous (Boston University).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 4
//
ID   TYS
AC   CVCL_5G91
DR   EFO; EFO_0022575
DR   cancercelllines; CVCL_5G91
DR   IARC_TP53; 7583
DR   Wikidata; Q54973486
RX   DOI=10.1007/0-306-46872-7_9;
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=2429552;
RX   PubMed=7750082;
RX   PubMed=17390010;
CC   Population: Japanese.
CC   Doubling time: 44.4 hours (PubMed=2429552).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281His (c.841G>C); ClinVar=VCV000376588; Zygosity=Unspecified (PubMed=17390010).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   TYUC-1
AC   CVCL_4W84
DR   JCRB; JCRB1512
DR   Wikidata; Q54973487
RX   DOI=10.1158/1538-7445.AM2015-5126;
RX   PubMed=25667451;
RX   PubMed=29765522;
CC   Population: Japanese.
CC   Doubling time: ~30 hours (DOI=10.1158/1538-7445.AM2015-5126).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1512
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6762; Esophageal small cell carcinoma
DI   ORDO; Orphanet_506136; Neuroendocrine neoplasm of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   TYUC-1-Luc
AC   CVCL_JG96
DR   JCRB; JCRB1584
DR   Wikidata; Q54973488
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): JCRB=JCRB1584
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C6762; Esophageal small cell carcinoma
DI   ORDO; Orphanet_506136; Neuroendocrine neoplasm of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4W84 ! TYUC-1
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 12
//
ID   TYWHSTi001-A
AC   CVCL_YT47
DR   hPSCreg; TYWHSTi001-A
DR   Wikidata; Q98133705
CC   From: Tianyou Hospital, Wuhan University of Science and Technology; Wuhan; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   TYWHSTi002-A
AC   CVCL_YT48
DR   BioSamples; SAMEA6930346
DR   hPSCreg; TYWHSTi002-A
DR   Wikidata; Q98133706
RX   PubMed=32717573;
CC   From: Tianyou Hospital, Wuhan University of Science and Technology; Wuhan; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; c.919-2A>G (IVS7AS,A-G,-2); ClinVar=VCV000004840; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=32717573).
CC   Sequence variation: Mutation; HGNC; HGNC:8818; SLC26A4; Simple; c.1614+1G>A; ClinVar=VCV000043516; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=32717573).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121745; Pendred syndrome
DI   ORDO; Orphanet_705; Pendred syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   TZ-1
AC   CVCL_R882
DR   Cosmic; 2391883
DR   Wikidata; Q54973489
RX   PubMed=16826222;
CC   Population: Japanese.
CC   Doubling time: 36 hours (PubMed=16826222).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7171; Acute monoblastic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76-77Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   TZDR03
AC   CVCL_V386
DR   IPD-IMGT/HLA; 14467
DR   Wikidata; Q54973490
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:07,11:01; B*40:01,58:01; C*03:02,04:01; DQB1*02:01,04:01; DRB1*04:03,03:31 (IPD-IMGT/HLA=14467).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   TZM-bl
AC   CVCL_B478
SY   TZM; JC53-bl; JC53BL-13; JC.53bl-13; JC53-bl clone 13
DR   BTO; BTO_0005059
DR   BEI_Resources; ARP-8129
DR   ChEMBL-Cells; CHEMBL3307662
DR   ChEMBL-Targets; CHEMBL614612
DR   PubChem_Cell_line; CVCL_B478
DR   Wikidata; Q54973492
RX   PubMed=18842727;
RX   PubMed=19474095;
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: TZM-b1; Note=Occasionally.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   TZM-bl/FcalphaR
AC   CVCL_1F83
DR   Wikidata; Q54973493
RX   DOI=10.1186/1742-4690-6-S3-P152;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3608; FCAR.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3611; FCER1G.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B478 ! TZM-bl
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   TZM-bl/FcgammaRI
AC   CVCL_1E18
DR   BEI_Resources; ARP-11798
DR   Wikidata; Q54973494
RX   PubMed=19458010;
RX   PubMed=23408628;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3613; FCGR1A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B478 ! TZM-bl
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   TZM-bl/FcgammaRIIa
AC   CVCL_1E19
DR   BEI_Resources; ARP-11795
DR   Wikidata; Q54973495
RX   PubMed=19458010;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3616; FCGR2A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B478 ! TZM-bl
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   TZM-bl/FcgammaRIIb
AC   CVCL_1E20
DR   BEI_Resources; ARP-11797
DR   Wikidata; Q54973496
RX   PubMed=19458010;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3618; FCGR2B.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B478 ! TZM-bl
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   TZM-bl/FcgammaRIIIa
AC   CVCL_1E21
DR   BEI_Resources; ARP-11796
DR   Wikidata; Q54973497
RX   PubMed=19458010;
CC   Population: African American.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3619; FCGR3A.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B478 ! TZM-bl
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 14
//
ID   TZM-tfLC3B
AC   CVCL_0A24
DR   Wikidata; Q54973498
RX   PubMed=25241145;
CC   Population: African American.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:13352; MAP1LC3B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B478 ! TZM-bl
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   U-105MG
AC   CVCL_5903
SY   U-105 MG; U105MG; 105 MG; 105MG
DR   Wikidata; Q54973499
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=450131;
RX   PubMed=608846;
RX   PubMed=833871;
RX   PubMed=2454731;
RX   PubMed=3518877;
RX   PubMed=3675803;
RX   PubMed=4134536;
RX   PubMed=4313504;
RX   PubMed=4337530;
RX   PubMed=4369403;
RX   PubMed=6220172;
RX   PubMed=6260907;
RX   PubMed=7693337;
RX   PubMed=9220028;
RX   PubMed=22282976;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,26
ST   D3S1358: 17,18
ST   D5S818: 7,13
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 18,20
ST   Penta D: 8,12
ST   Penta E: 5,14
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   U-1073MG
AC   CVCL_GR52
SY   U1073MG; 1073 MG
DR   Wikidata; Q54973500
RX   PubMed=608846;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 13,15
ST   D18S51: 13,16
ST   D19S433: 13.2,14
ST   D21S11: 29
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 15
ST   FGA: 21,23
ST   Penta D: 9,13
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 6
//
ID   U-1176MG
AC   CVCL_GR53
SY   U1176MG
DR   Wikidata; Q54973501
RX   PubMed=27582061;
CC   Miscellaneous: Sex of donor from personal communication of Westermark, Bengt.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 12,15
ST   D19S433: 15
ST   D21S11: 28,30
ST   D2S1338: 19,25
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 21.2
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 6
//
ID   U-118MG
AC   CVCL_0633
SY   U-118 MG; U-118-MG; U118-MG; U118MG; U118; 118 MG; 118MG
DR   BTO; BTO_0004605
DR   CLO; CLO_0009451
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-7712
DR   ATCC; HTB-15
DR   BioGRID_ORCS_Cell_line; 445
DR   BioSample; SAMN03151974
DR   BioSample; SAMN03472723
DR   BioSample; SAMN10988042
DR   cancercelllines; CVCL_0633
DR   CCRID; 3101HUMTCHu216
DR   Cell_Model_Passport; SIDM01193
DR   ChEMBL-Cells; CHEMBL3308793
DR   ChEMBL-Targets; CHEMBL1075602
DR   CLS; 300362
DR   Cosmic; 687588
DR   Cosmic; 849852
DR   Cosmic; 849878
DR   Cosmic; 920817
DR   Cosmic; 1175822
DR   Cosmic; 1217672
DR   Cosmic; 1571919
DR   Cosmic; 1610738
DR   Cosmic; 2301554
DR   Cosmic; 2367553
DR   Cosmic; 2550362
DR   Cosmic; 2668299
DR   Cosmic; 2701084
DR   Cosmic-CLP; 687588
DR   DepMap; ACH-000040
DR   EGA; EGAS00001000978
DR   GDSC; 687588
DR   GEO; GSM101671
DR   GEO; GSM101672
DR   GEO; GSM888812
DR   GEO; GSM1374968
DR   GEO; GSM1374969
DR   GEO; GSM1670554
DR   IARC_TP53; 4195
DR   KCB; KCB 2013002YJ
DR   LiGeA; CCLE_075
DR   LINCS_LDP; LCL-1358
DR   PharmacoDB; U118MG_1616_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0633
DR   PubChem_Cell_line; CVCL_0633
DR   Wikidata; Q54973503
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=327080;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=2253244;
RX   PubMed=2454731;
RX   PubMed=3518877;
RX   PubMed=3675803;
RX   PubMed=4134536;
RX   PubMed=4312117;
RX   PubMed=4313504;
RX   PubMed=4337530;
RX   PubMed=4369403;
RX   PubMed=6220172;
RX   PubMed=6260907;
RX   PubMed=7017212;
RX   PubMed=7459858;
RX   PubMed=9220028;
RX   PubMed=10402232;
RX   PubMed=10416987;
RX   PubMed=10560660;
RX   PubMed=11414198;
RX   PubMed=16697959;
RX   PubMed=19365568;
RX   PubMed=19435942;
RX   PubMed=20143388;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=27397505;
RX   PubMed=27582061;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/u118/u118cells.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/u-118-mg-atcc-htb-15-u-138-mg-atcc-htb-16
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/cellsincultureindex
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=75
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/u118-brain-cancer-xenograft-model-altogen-labs/
CC   Problematic cell line: Contaminated. Shown to be a U-138MG derivative (PubMed=20143388).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00350.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=10560660; Cosmic-CLP=687588).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (PubMed=10416987; Cosmic-CLP=687588).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.71%; Native American=0%; East Asian, North=1.75%; East Asian, South=0%; South Asian=0%; European, North=96.54%; European, South=0% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-7712; true.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=HTB-15; CLS=300362; Cosmic-CLP=687588; PubMed=22570425; PubMed=27582061; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 13
ST   D12S391: 19,22
ST   D13S317: 9 (ATCC=HTB-15; Cosmic-CLP=687588; Technion Genomics Center)
ST   D13S317: 9,11 (CLS=300362; PubMed=22570425; PubMed=27582061)
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 11
ST   D21S11: 27,32.2
ST   D22S1045: 17
ST   D2S1338: 23,25
ST   D2S441: 11,15
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 14,15
ST   FGA: 18,23 (PubMed=27582061)
ST   FGA: 23 (ATCC=HTB-15; CLS=300362; PubMed=22570425; Technion Genomics Center)
ST   Penta D: 10,13 (ATCC=HTB-15; PubMed=22570425; PubMed=27582061; Technion Genomics Center)
ST   Penta D: 13 (CLS=300362)
ST   Penta E: 7 (ATCC=HTB-15; CLS=300362; PubMed=22570425; Technion Genomics Center)
ST   Penta E: 7,13 (PubMed=27582061)
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0020 ! U-138MG
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 48
//
ID   U-120MG
AC   CVCL_T446
SY   120MG
DR   Wikidata; Q54973505
RX   PubMed=4313504;
RX   PubMed=4337530;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   U-1231MG
AC   CVCL_5G55
SY   U-1231 MG; U1231MG
DR   Wikidata; Q54973507
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=27582061;
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 18,19
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 20,24
ST   Penta D: 9,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 7
//
ID   U-1240MG
AC   CVCL_5G54
SY   U-1240 MG; U1240MG
DR   Wikidata; Q54973509
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=27582061;
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 16
ST   D19S433: 13.2
ST   D21S11: 29,30.2
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,12
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 21-03-23; Version: 6
//
ID   U-1242MG
AC   CVCL_F841
SY   U-1242 MG; U1242MG
DR   Wikidata; Q54973510
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=27582061;
CC   Miscellaneous: Sex of donor from personal communication of Westermark, Bengt.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 17,18
ST   D3S1358: 17,19
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 19,22
ST   Penta D: 13,15
ST   Penta E: 17,19
ST   TH01: 9,10
ST   TPOX: 8,10
ST   vWA: 15
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 11
//
ID   U-1285
AC   CVCL_7153
SY   U1285; 1285
DR   BTO; BTO_0002389
DR   cancercelllines; CVCL_7153
DR   IARC_TP53; 18697
DR   Wikidata; Q54973511
RX   PubMed=2983887;
RX   PubMed=6285665;
RX   PubMed=12820372;
RX   PubMed=21508355;
CC   Doubling time: 80-84 hours (PubMed=6285665).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=12820372).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   U-1285dox
AC   CVCL_7154
SY   U-1285dox(900)
DR   BTO; BTO_0002391
DR   cancercelllines; CVCL_7154
DR   Wikidata; Q54973512
RX   PubMed=12766562;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.376-1G>A (p.Tyr126_Lys132del, c.376_396del21); ClinVar=VCV000481003; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7153 ! U-1285
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   U-138MG
AC   CVCL_0020
SY   U-138 MG; U-138-MG; U138-MG; U 138 MG; U138MG; U138; 138 MG; 138MG
DR   BTO; BTO_0002127
DR   CLO; CLO_0009452
DR   CLO; CLO_0009453
DR   CLDB; cl4577
DR   ArrayExpress; E-MTAB-38
DR   ATCC; HTB-16
DR   BCRJ; 0239
DR   BioGRID_ORCS_Cell_line; 1536
DR   BioSample; SAMN01821604
DR   BioSample; SAMN01821668
DR   BioSample; SAMN03472727
DR   BioSample; SAMN10987758
DR   cancercelllines; CVCL_0020
DR   Cell_Model_Passport; SIDM01192
DR   ChEMBL-Cells; CHEMBL4295387
DR   ChEMBL-Targets; CHEMBL4296506
DR   CLS; 300363
DR   Cosmic; 755288
DR   Cosmic; 850744
DR   Cosmic; 1571920
DR   Cosmic; 1610739
DR   Cosmic; 1746952
DR   Cosmic; 2060806
DR   Cosmic; 2301555
DR   Cosmic; 2302317
DR   Cosmic; 2580917
DR   Cosmic; 2701085
DR   DepMap; ACH-001214
DR   DSMZ; ACC-291
DR   DSMZCellDive; ACC-291
DR   GEO; GSM101673
DR   GEO; GSM101674
DR   GEO; GSM326234
DR   GEO; GSM887719
DR   GEO; GSM888813
DR   GEO; GSM7701433
DR   GEO; GSM7701434
DR   IGRhCellID; U138MG
DR   LINCS_LDP; LCL-1359
DR   Lonza; 104
DR   PharmacoDB; U138MG_1617_2019
DR   Progenetix; CVCL_0020
DR   PubChem_Cell_line; CVCL_0020
DR   Wikidata; Q54973513
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=2454731;
RX   PubMed=3518877;
RX   PubMed=3675803;
RX   PubMed=4134536;
RX   PubMed=4313504;
RX   PubMed=4337530;
RX   PubMed=4369403;
RX   PubMed=6220172;
RX   PubMed=6260907;
RX   PubMed=6582512;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=14961077;
RX   PubMed=16697959;
RX   PubMed=16957166;
RX   PubMed=17595512;
RX   PubMed=19365568;
RX   PubMed=19435942;
RX   PubMed=20215515;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=27582061;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=33385022;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/u-118-mg-atcc-htb-15-u-138-mg-atcc-htb-16
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Provider; NIBSC; 0028; http://www.nibsc.org/Default.aspx?pageid=597&id=0028&theme=default
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Doubling time: 47 hours (PubMed=9842975); ~70 hours (DSMZ=ACC-291).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (DepMap=ACH-001214).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (PubMed=10416987; DepMap=ACH-001214).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.64%; Native American=0%; East Asian, North=1.56%; East Asian, South=0%; South Asian=0%; European, North=96.13%; European, South=0.67% (PubMed=30894373).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=HTB-16; CLS=300363; DSMZ=ACC-291; PubMed=22570425; PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12 (PubMed=27582061)
ST   CSF1PO: 12 (ATCC=HTB-16; CLS=300363; DSMZ=ACC-291; PubMed=22570425)
ST   D13S317: 9,11
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 27,32.2
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 14,15
ST   FGA: 18,23
ST   Penta D: 9,13 (ATCC=HTB-16; CLS=300363; DSMZ=ACC-291; PubMed=22570425)
ST   Penta D: 10,13 (PubMed=27582061)
ST   Penta E: 7 (ATCC=HTB-16; CLS=300363; DSMZ=ACC-291; PubMed=22570425)
ST   Penta E: 7,13 (PubMed=27582061)
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 45
//
ID   U-1568
AC   CVCL_7155
SY   U1568
DR   BTO; BTO_0002390
DR   Wikidata; Q54973514
RX   PubMed=6285665;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   U-1690
AC   CVCL_D055
SY   U1690
DR   cancercelllines; CVCL_D055
DR   IARC_TP53; 18696
DR   Wikidata; Q54973515
RX   PubMed=2983887;
RX   PubMed=2990154;
RX   PubMed=12820372;
CC   Doubling time: 5-8 days (PubMed=2990154).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp259Val (c.776A>T); ClinVar=VCV000485034; Zygosity=Unspecified (PubMed=12820372).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   U-1752
AC   CVCL_0565
SY   U1752; 1752
DR   BTO; BTO_0005386
DR   MCCL; MCC:0000467
DR   cancercelllines; CVCL_0565
DR   Cosmic; 953988
DR   Cosmic; 1006541
DR   IARC_TP53; 18700
DR   Wikidata; Q54973517
RX   PubMed=2983887;
RX   PubMed=2990154;
RX   PubMed=6178358;
RX   PubMed=6272398;
RX   PubMed=9551745;
RX   PubMed=12820372;
RX   PubMed=21508355;
CC   Doubling time: 36 hours (PubMed=6178358).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala347Thr (c.1039G>A); ClinVar=VCV000662690; Zygosity=Unspecified (PubMed=12820372).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   U-1761
AC   CVCL_W848
SY   U1761
DR   Wikidata; Q54973518
RX   PubMed=2990154;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 7
//
ID   U-178MG
AC   CVCL_A758
SY   U-178-MG; U-178 MG; U178-MG; U 178 MG; U178MG; MG 178; U-178; 178 MG; 178MG; 178 MG(5)
DR   EFO; EFO_0022627
DR   BioGRID_ORCS_Cell_line; 692
DR   BioSample; SAMN10988405
DR   cancercelllines; CVCL_A758
DR   Cell_Model_Passport; SIDM01431
DR   Cosmic; 849851
DR   Cosmic; 849879
DR   Cosmic; 1610740
DR   Cosmic; 2516041
DR   DepMap; ACH-000208
DR   PharmacoDB; U178_1618_2019
DR   Progenetix; CVCL_A758
DR   Wikidata; Q54973519
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=77569;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=3518877;
RX   PubMed=4134536;
RX   PubMed=4139097;
RX   PubMed=4369403;
RX   PubMed=10416987;
RX   PubMed=10560660;
RX   PubMed=19435942;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=27582061;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=25984343).
CC   HLA typing: A*01,02; B*07,12 (PubMed=77569).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro248Thrfs*5 (c.741dupA) (c.741_742insA); ClinVar=VCV000142259; Zygosity=Homozygous (PubMed=10560660; DepMap=ACH-000208).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu271Lys (c.811G>A); ClinVar=VCV000406566; Zygosity=Heterozygous (DepMap=ACH-000208).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=2.94%; Native American=0%; East Asian, North=4.06%; East Asian, South=0%; South Asian=0%; European, North=69.5%; European, South=23.49% (PubMed=30894373).
ST   Source(s): PubMed=22570425; PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11 (PubMed=27582061)
ST   D13S317: 11 (PubMed=22570425)
ST   D16S539: 10,13
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 14,15
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8,10 (PubMed=27582061)
ST   D7S820: 10 (PubMed=22570425)
ST   D8S1179: 13,14
ST   FGA: 22,26
ST   Penta D: 7,12
ST   Penta E: 7,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   U-1796MG
AC   CVCL_5G61
SY   U-1796 MG; U1796MG
DR   Wikidata; Q54973520
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2454731;
RX   PubMed=27582061;
CC   Miscellaneous: Sex of donor from personal communication of Westermark, Bengt.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 14,15
ST   D21S11: 32.2,33.2
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   Penta D: 12,13
ST   Penta E: 11,14
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-09-24; Version: 7
//
ID   U-1810
AC   CVCL_D054
SY   U1810; 1810
DR   BTO; BTO_0003727
DR   IARC_TP53; 18699
DR   Wikidata; Q54973521
RX   PubMed=2983887;
RX   PubMed=2990154;
RX   PubMed=9551745;
RX   PubMed=12820372;
RX   PubMed=21508355;
CC   Doubling time: 1.5 days (PubMed=2990154).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val172Leufs*2 (c.514delG); Zygosity=Unspecified (PubMed=12820372).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   U-1906
AC   CVCL_D075
SY   U1906
DR   Wikidata; Q54973522
RX   PubMed=2983887;
RX   PubMed=2990154;
RX   PubMed=9551745;
CC   Doubling time: 3 days (PubMed=2990154).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   U-1906E
AC   CVCL_LM75
SY   U-1906 E; 1906E; U-1906 Early passage
DR   cancercelllines; CVCL_LM75
DR   IARC_TP53; 18698
DR   Wikidata; Q54973531
RX   PubMed=7655829;
RX   PubMed=12820372;
RX   PubMed=21508355;
CC   Doubling time: 56.0 +- 17.24 hours (PubMed=7655829).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Heterozygous (PubMed=12820372).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D075 ! U-1906
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   U-1906L
AC   CVCL_LM76
SY   U-1906 L; 1906L; U-1906 Late passage
DR   cancercelllines; CVCL_LM76
DR   IARC_TP53; 18698
DR   Wikidata; Q54973532
RX   PubMed=7655829;
RX   PubMed=12820372;
RX   PubMed=21508355;
CC   Doubling time: 55.0 +- 17.36 hours (PubMed=7655829).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Homozygous (PubMed=12820372).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D075 ! U-1906
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   U-1957
AC   CVCL_M493
DR   Wikidata; Q54973534
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=3580570;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: 48 hours (PubMed=3580570).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M494 ! U-1958
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   U-1958
AC   CVCL_M494
DR   Wikidata; Q54973535
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=3580570;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: 60 hours (PubMed=3580570).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M493 ! U-1957
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   U-1996
AC   CVCL_M495
DR   Wikidata; Q54973537
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=3580570;
RX   PubMed=10936422;
CC   Characteristics: Produces Ig kappa.
CC   Doubling time: 48 hours (PubMed=3580570).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   U-2 OS PINK1-GFP
AC   CVCL_F1H6
WW   Info; protocols.io; -; https://dx.doi.org/10.17504/protocols.io.dm6gpm38pgzp/v1
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 an PINK1-eGFP construct was integrated at the N-terminus of the endogenous PINK1 locus thus replacing it by PINK1-eGFP (protocols.io).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U-2 OS H2B-GFP+mCherry-TRF1
AC   CVCL_F0KK
RX   PubMed=38213617;
CC   Population: Caucasian.
CC   Characteristics: Transduced with both a pWZL-H2B-eGFP-HygR construct and a pLPC-mCherry-TRF1-Puro construct (PubMed=38213617).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11728; TERF1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U-2 OS-CRISPR-NUP96-Halo clone no.252
AC   CVCL_B7FI
DR   CLS; 300448
DR   Wikidata; Q112930489
RX   PubMed=31562488;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with a HaloTag (PubMed=31562488).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 8
//
ID   U-2 OS-CRISPR-NUP96-mEGFP clone no.195
AC   CVCL_B7FJ
DR   CLS; 300174
DR   Wikidata; Q112930490
RX   PubMed=31562488;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with mEGFP (PubMed=31562488).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
ID   U-2 OS-CRISPR-NUP96-mMaple clone no.16
AC   CVCL_B7FK
DR   CLS; 300461
DR   Wikidata; Q112930491
RX   PubMed=31562488;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with mMaple (PubMed=31562488).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; SXSQ9; mMaple (Note=Photoconvertible green fluorescent protein derived from cFP484).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   U-2 OS-CRISPR-NUP96-SNAP clone #33
AC   CVCL_B7FL
DR   CLS; 300444
DR   Wikidata; Q112930492
RX   PubMed=31562488;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A NUP96 has been endogenously tagged in both alleles at the C-terminus with a SNAP-tag (PubMed=31562488).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   U-2 OS-Luc
AC   CVCL_C8Y6
DR   Ubigene; YC-C030-Luc-P
DR   Wikidata; Q123033662
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   U-2 OS-Luc2
AC   CVCL_A4CF
DR   ATCC; HTB-96-LUC2
DR   Wikidata; Q105511285
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=HTB-96-LUC2).
CC   Doubling time: ~19 hours (ATCC=HTB-96-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): ATCC=HTB-96-LUC2
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   U-2 OS-ZFN-SNAP-Nup107 no.294
AC   CVCL_B7FM
DR   CLS; 300294
DR   Wikidata; Q112930493
RX   PubMed=29630062;
CC   Population: Caucasian.
CC   Characteristics: Using ZFN NUP107 has been endogenously tagged in both alleles at the N-terminus with a SNAP-tag (PubMed=29630062).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   U-2 OS/IDH1-R132C
AC   CVCL_D3DC
DR   Wikidata; Q127384418
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH1-R132G
AC   CVCL_D3DD
DR   Wikidata; Q127384419
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Gly).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH1-R132H
AC   CVCL_D3DE
DR   Wikidata; Q127384420
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH1-R132L
AC   CVCL_D3DF
DR   Wikidata; Q127384422
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Leu).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH1-R132S
AC   CVCL_D3DG
DR   Wikidata; Q127384423
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH1-WT
AC   CVCL_D3DH
DR   Wikidata; Q127384424
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH2-R172G
AC   CVCL_D3DI
DR   Wikidata; Q127384425
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Gly).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH2-R172K
AC   CVCL_D3DJ
DR   Wikidata; Q127384426
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Lys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH2-R172M
AC   CVCL_D3DK
DR   Wikidata; Q127384427
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Met).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH2-R172S
AC   CVCL_D3DL
DR   Wikidata; Q127384428
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Ser).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH2-R172W
AC   CVCL_D3DM
DR   Wikidata; Q127384429
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5383; IDH2 (Note=With p.Arg172Trp).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS/IDH2-WT
AC   CVCL_D3DN
DR   Wikidata; Q127384430
RX   PubMed=25753205;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5383; IDH2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   U-2 OS R1
AC   CVCL_T429
DR   Wikidata; Q54973538
RX   PubMed=17096323;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   U-2 OS R2
AC   CVCL_T430
SY   U-2OSR2
DR   Wikidata; Q54973539
RX   PubMed=17096323;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T429 ! U-2 OS R1
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   U-2 OS/Cas9-hyg
AC   CVCL_C9EZ
DR   GeneCopoeia; SL546
DR   Wikidata; Q123033663
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a EF1a-Cas9-HA-SV40-EGFP-IRES-HygR construct (GeneCopoeia=SL546).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   U-2020
AC   CVCL_D076
SY   U2020
DR   Wikidata; Q54973542
RX   PubMed=2983887;
RX   PubMed=2990154;
CC   Doubling time: 2 days (PubMed=2990154).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   U-2030
AC   CVCL_M581
DR   Wikidata; Q54973543
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=3583453;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA lambda.
CC   Doubling time: ~36 hours (PubMed=3583453).
CC   Miscellaneous: Cell line has been lost (PubMed=10936422).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M585 ! U-2031
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 15
//
ID   U-2030 TG
AC   CVCL_M582
DR   Wikidata; Q54973544
RX   PubMed=3583453;
CC   Characteristics: Produces IgA lambda.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M581 ! U-2030
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   U-2031
AC   CVCL_M585
DR   Wikidata; Q54973545
RX   PubMed=3583453;
CC   Doubling time: 24-48 hours (PubMed=3583453).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M581 ! U-2030
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   U-2050
AC   CVCL_D077
SY   U2050
DR   Wikidata; Q54973547
RX   PubMed=2990154;
CC   Doubling time: 3.5 days (PubMed=2990154).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   U-2149
AC   CVCL_W019
SY   U2149
DR   Wikidata; Q54973548
RX   PubMed=2556928;
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0043 ! U-2197
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   U-2197
AC   CVCL_0043
SY   U2197
DR   CLO; CLO_0009455
DR   BioSample; SAMN03473584
DR   Cosmic; 1933189
DR   DSMZ; ACC-406
DR   DSMZCellDive; ACC-406
DR   GEO; GSM7701450
DR   GEO; GSM7701451
DR   Wikidata; Q54973549
RX   PubMed=2556928;
RX   PubMed=16957166;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Doubling time: ~100-120 hours (DSMZ=ACC-406).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): DSMZ=ACC-406
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 31
ST   D2S1338: 16,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 11,13
ST   FGA: 19,21
ST   Penta D: 13
ST   Penta E: 10
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W019 ! U-2149
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   U-251MG
AC   CVCL_0021
SY   U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6)
DR   BTO; BTO_0002035
DR   CLO; CLO_0009456
DR   EFO; EFO_0006498
DR   CLDB; cl4583
DR   AddexBio; C0005029/5016
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 351
DR   BioSample; SAMN10988290
DR   cancercelllines; CVCL_0021
DR   CCRID; 1101HUM-PUMC000058
DR   CCRID; 3101HUMTCHu58
DR   CCRID; 4201HUM-CCTCC00093
DR   CCTCC; GDC0093
DR   Cell_Model_Passport; SIDM00111
DR   CGH-DB; 155-1
DR   ChEMBL-Cells; CHEMBL3307756
DR   ChEMBL-Targets; CHEMBL615022
DR   CLS; 300385
DR   Cosmic; 687451
DR   Cosmic; 848340
DR   Cosmic; 849850
DR   Cosmic; 850742
DR   Cosmic; 875896
DR   Cosmic; 897440
DR   Cosmic; 905983
DR   Cosmic; 920818
DR   Cosmic; 923899
DR   Cosmic; 970094
DR   Cosmic; 974243
DR   Cosmic; 1044250
DR   Cosmic; 1066235
DR   Cosmic; 1092644
DR   Cosmic; 1171225
DR   Cosmic; 1175823
DR   Cosmic; 1217673
DR   Cosmic; 1312345
DR   Cosmic; 1436038
DR   Cosmic; 1610741
DR   Cosmic; 1998487
DR   Cosmic; 2367502
DR   Cosmic; 2367554
DR   Cosmic; 2516042
DR   Cosmic; 2550363
DR   Cosmic; 2580916
DR   Cosmic-CLP; 905983
DR   DepMap; ACH-000232
DR   ECACC; 09063001
DR   EGA; EGAS00001000978
DR   GDSC; 905983
DR   GEO; GSE66597
DR   GEO; GSM2103
DR   GEO; GSM50180
DR   GEO; GSM50244
DR   GEO; GSM101675
DR   GEO; GSM101677
DR   GEO; GSM101678
DR   GEO; GSM101679
DR   GEO; GSM101680
DR   GEO; GSM101685
DR   GEO; GSM743440
DR   GEO; GSM750795
DR   GEO; GSM799328
DR   GEO; GSM799391
DR   GEO; GSM844718
DR   GEO; GSM844719
DR   GEO; GSM847166
DR   GEO; GSM887720
DR   GEO; GSM888814
DR   GEO; GSM1153398
DR   GEO; GSM1178662
DR   GEO; GSM1178663
DR   GEO; GSM1181247
DR   GEO; GSM1181342
DR   GEO; GSM1670555
DR   GEO; GSM2124691
DR   GEO; GSM7701412
DR   GEO; GSM7701413
DR   IARC_TP53; 2575
DR   ICLC; HTL99014
DR   JCRB; IFO50288
DR   KCB; KCB 200965YJ
DR   Kerafast; EDK001
DR   LiGeA; CCLE_040
DR   LINCS_LDP; LCL-1400
DR   Lonza; 105
DR   Lonza; 1007
DR   MetaboLights; MTBLS6212
DR   NCI-DTP; U-251
DR   PharmacoDB; U251MG_1629_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD003539
DR   PRIDE; PXD005940
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0021
DR   PubChem_Cell_line; CVCL_0021
DR   RCB; RCB0461
DR   SKY/M-FISH/CGH; 2825
DR   TOKU-E; 4005
DR   Ubigene; YC-D015
DR   Wikidata; Q54973550
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=77569;
RX   PubMed=450131;
RX   PubMed=608846;
RX   PubMed=833871;
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=3518877;
RX   PubMed=3675803;
RX   PubMed=4134536;
RX   PubMed=4369403;
RX   PubMed=6260907;
RX   PubMed=6582512;
RX   PubMed=7693337;
RX   PubMed=7763724;
RX   PubMed=8104691;
RX   PubMed=8878451;
RX   PubMed=9090379;
RX   PubMed=9220028;
RX   PubMed=9230885;
RX   PubMed=9331090;
RX   PubMed=9614553;
RX   PubMed=9842975;
RX   PubMed=10416987;
RX   PubMed=10551321;
RX   PubMed=10560660;
RX   PubMed=10700174;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=15748285;
RX   PubMed=15900046;
RX   PubMed=16232199;
RX   PubMed=16391870;
RX   PubMed=16697959;
RX   PubMed=16957166;
RX   PubMed=17088437;
RX   PubMed=17595512;
RX   PubMed=19372543;
RX   PubMed=19435942;
RX   PubMed=20215515;
RX   PubMed=20593219;
RX   PubMed=22068913;
RX   PubMed=22336246;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24810477;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27582061;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29716531;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=33385022;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/u251_snb-19.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=57
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-313.html
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/prostate-cancer-xenograft/lncap-xenograft-model/
WW   Provider; BRICS; BRICS0099; http://www.brics.ac.cn/cell/template/cell/cell_detail.html?id=3905
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: JFCR39 cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 23 hours (PubMed=9842975); 24 hours (PubMed=25984343); 23.8 hours (NCI-DTP=U-251).
CC   HLA typing: A*01,02; B*08,14 (PubMed=77569).
CC   HLA typing: A*02:01:01; B*18; C*05; DPB1*04:02; DQB1*02:01; DRB1*03:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,02:01; B*18:01,18:01; C*05:01,05:01 (PubMed=25960936).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (PubMed=9090379; PubMed=10551321; PubMed=10560660).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=8878451; PubMed=9331090; PubMed=9614553; PubMed=10416987; PubMed=14614447; PubMed=15900046).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.69%; Native American=0%; East Asian, North=2.21%; East Asian, South=0%; South Asian=0%; European, North=79.45%; European, South=17.65% (PubMed=30894373).
CC   Discontinued: RCB; RCB0461; true.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): AddexBio=C0005029/5016; CCRID; CLS=300385; Cosmic-CLP=905983; ECACC=09063001; JCRB=IFO50288; PubMed=19372543; PubMed=22570425; PubMed=24810477; PubMed=27582061
ST   Amelogenin: X (CCRID; PubMed=24810477_some_subclones)
ST   Amelogenin: X,Y (CLS=300385; Cosmic-CLP=905983; ECACC=09063001; JCRB=IFO50288; PubMed=22570425; PubMed=27582061)
ST   CSF1PO: 11,12 (AddexBio=C0005029/5016; CCRID; CLS=300385; Cosmic-CLP=905983; ECACC=09063001; JCRB=IFO50288; PubMed=22570425; PubMed=27582061)
ST   CSF1PO: 12,13 (PubMed=19372543)
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 29 (CCRID; PubMed=22570425; PubMed=24810477)
ST   D21S11: 29,30 (CLS=300385; PubMed=27582061)
ST   D2S1338: 22,24
ST   D3S1358: 16,17
ST   D5S818: 11 (PubMed=24810477)
ST   D5S818: 11,12 (CCRID; CLS=300385; Cosmic-CLP=905983; ECACC=09063001; JCRB=IFO50288; PubMed=22570425; PubMed=27582061)
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,25
ST   Penta D: 10,12 (CLS=300385; PubMed=27582061)
ST   Penta D: 12 (PubMed=22570425)
ST   Penta E: 7 (PubMed=22570425; PubMed=27582061)
ST   Penta E: 7,10 (CLS=300385)
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 50
//
ID   U-251MG (KO)
AC   CVCL_2809
SY   U-251 MG (KO)
DR   BioSample; SAMN03472772
DR   cancercelllines; CVCL_2809
DR   JCRB; IFO50285
DR   Wikidata; Q54973551
RX   PubMed=7763724;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): JCRB=IFO50285
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   U-251MG AgCl1
AC   CVCL_5G63
SY   U-251 MG AgCl1; U-251 MGAgCl1
DR   cancercelllines; CVCL_5G63
DR   Wikidata; Q54973553
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2454731;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   U-251MG IDH1 R132C
AC   CVCL_A5HP
SY   U251(R132C); U251R132C
DR   cancercelllines; CVCL_A5HP
DR   MetaboLights; MTBLS1973
DR   Wikidata; Q107117144
RX   PubMed=33504762;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   U-251MG IDH1 R132H
AC   CVCL_A5HQ
SY   U251(R132H); U251R132H
DR   cancercelllines; CVCL_A5HQ
DR   MetaboLights; MTBLS1973
DR   Wikidata; Q107117146
RX   PubMed=33504762;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1 (Note=With p.Arg132His).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   U-251MG IDH1 WT
AC   CVCL_A5HR
SY   U251(WT); U251WT
DR   cancercelllines; CVCL_A5HR
DR   MetaboLights; MTBLS1973
DR   Wikidata; Q107117148
RX   PubMed=33504762;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:5382; IDH1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   U-251MG PAX6-/- 2.10
AC   CVCL_A5TU
SY   PAX6 2.10 KO
DR   cancercelllines; CVCL_A5TU
DR   Wikidata; Q107117150
RX   PubMed=29716531;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   U-251MG PAX6-/- 2A.28
AC   CVCL_A5TV
SY   PAX6 2A.28 KO
DR   cancercelllines; CVCL_A5TV
DR   Wikidata; Q107117153
RX   PubMed=29716531;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   U-251MG PAX6-/- 2A.3
AC   CVCL_A5TW
SY   PAX6 2A.3 KO
DR   cancercelllines; CVCL_A5TW
DR   Wikidata; Q107117154
RX   PubMed=29716531;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8620; PAX6.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   U-251MG sp
AC   CVCL_5G56
SY   U-251 MG sp; U-251 MGsp; U-251SP
DR   BTO; BTO_0005865
DR   cancercelllines; CVCL_5G56
DR   Wikidata; Q54973555
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=3675803;
RX   PubMed=6260907;
CC   Population: Caucasian.
CC   Characteristics: Spindle cell variant obtained by differential trypsinization of parent cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 16
//
ID   U-251MG-GFP
AC   CVCL_C3I5
SY   U251-control
DR   cancercelllines; CVCL_C3I5
DR   GEO; GSM1517803
DR   GEO; GSM1517804
DR   GEO; GSM1517805
DR   Wikidata; Q114313139
RX   PubMed=25877876;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   U-251MG-Luc
AC   CVCL_J269
SY   U-251 MG-Luc
DR   cancercelllines; CVCL_J269
DR   JCRB; JCRB1386
DR   JCRB; NIHS0645
DR   Wikidata; Q54973556
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0645; true.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): JCRB=JCRB1386
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 23
//
ID   U-251MG-PARK2
AC   CVCL_C3I4
SY   U251-PARK2; U251-park2
DR   cancercelllines; CVCL_C3I4
DR   GEO; GSM1517806
DR   GEO; GSM1517807
DR   GEO; GSM1517808
DR   Wikidata; Q114313140
RX   PubMed=25877876;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   U-266/70
AC   CVCL_0015
SY   U-266-70; U266/70; U266-70
DR   cancercelllines; CVCL_0015
DR   GEO; GSM7701429
DR   GEO; GSM7701430
DR   Wikidata; Q54973557
RX   PubMed=16957166;
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   U-266/84
AC   CVCL_0016
SY   U266-84
DR   cancercelllines; CVCL_0016
DR   GEO; GSM7701400
DR   GEO; GSM7701401
DR   Wikidata; Q54973558
RX   PubMed=3133230;
RX   PubMed=16957166;
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   U-2904
AC   CVCL_X504
SY   U 2904; U2904
DR   Cell_Model_Passport; SIDM01417
DR   DepMap; ACH-001677
DR   DSMZ; ACC-768
DR   DSMZCellDive; ACC-768
DR   Wikidata; Q54973559
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7591289;
RX   PubMed=17926183;
RX   PubMed=26727417;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 24 hours (PubMed=7591289); ~25-35 hours (DSMZ=ACC-768).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, centroblastic-type.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001677; DSMZ=ACC-768
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 14,17.3 (DepMap=ACH-001677)
ST   D18S51: 14,18 (DSMZ=ACC-768)
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 11,16
ST   FGA: 19,24
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 17
//
ID   U-2932
AC   CVCL_1896
SY   U2932
DR   EFO; EFO_0006499
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-4527
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473452
DR   cancercelllines; CVCL_1896
DR   ChEMBL-Cells; CHEMBL4295421
DR   ChEMBL-Targets; CHEMBL4296507
DR   Cosmic; 1487546
DR   Cosmic; 1517654
DR   Cosmic; 1945196
DR   DSMZ; ACC-633
DR   DSMZCellDive; ACC-633
DR   EGA; EGAS00001000610
DR   GEO; GSM1035339
DR   GEO; GSM1059802
DR   GEO; GSM1374971
DR   PharmacoDB; U2932_1621_2019
DR   PRIDE; PXD000589
DR   Progenetix; CVCL_1896
DR   PubChem_Cell_line; CVCL_1896
DR   Ubigene; YC-C059
DR   Wikidata; Q54973560
RX   PubMed=12533045;
RX   PubMed=20054396;
RX   PubMed=23257783;
RX   PubMed=23292937;
RX   PubMed=23295736;
RX   PubMed=25485619;
RX   PubMed=25894527;
RX   PubMed=26589293;
RX   PubMed=27566572;
RX   PubMed=28196595;
RX   PubMed=29416618;
RX   PubMed=29533902;
RX   PubMed=29666304;
RX   PubMed=30165192;
RX   PubMed=31160637;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572).
CC   Doubling time: 48 hours (PubMed=12533045); ~50 hours (DSMZ=ACC-633).
CC   HLA typing: A*01:01,03:01; B*08:01,15:01; C*03:04,07:01 (PubMed=26589293).
CC   HLA typing: A*01:01:01,03:01:01; B*08:01:01,15:01:01; C*03:04:01,07:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,03:01:01; DQA1*03:01:01,05:01:01; DQB1*02:01:01,03:02:01; DRA*01:01:01,01:02:02; DRB1*03:01:01,04:01:01 (DSMZCellDive=ACC-633).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-633
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 28,29,30
ST   D2S1338: 22,23
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 13,14
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 14,17
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   U-2932-Luc
AC   CVCL_D7FP
DR   Ubigene; YC-C059-Luc-P
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1896 ! U-2932
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   U-2940
AC   CVCL_1897
SY   U2940
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473453
DR   cancercelllines; CVCL_1897
DR   ChEMBL-Cells; CHEMBL4523523
DR   ChEMBL-Targets; CHEMBL4523554
DR   Cosmic; 2437272
DR   Cosmic; 2479246
DR   DepMap; ACH-001678
DR   DSMZ; ACC-634
DR   DSMZCellDive; ACC-634
DR   GEO; GSM1374972
DR   GEO; GSM1897963
DR   Lonza; 1539
DR   Progenetix; CVCL_1897
DR   PubChem_Cell_line; CVCL_1897
DR   Wikidata; Q54973561
RX   PubMed=16106419;
RX   PubMed=27566572;
RX   PubMed=28196595;
RX   PubMed=29533902;
RX   PubMed=31160637;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Characteristics: Genetically heterogeneous, consists of 2 subclones (PubMed=27566572).
CC   Doubling time: ~50 hours (DSMZ=ACC-634).
CC   HLA typing: A*02:01:01,02:01:01; B*07:02:01,07:02:01; C*07:02:01,07:02:01; DPA1*02:06,02:06; DQA1*01:02:01,01:02:01; DQB1*06:02:01,06:02:01; DRA*01:02:03,01:02:03; DRB1*15:01:01,15:01:01 (DSMZCellDive=ACC-634).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Originally the patient was suffering from Hodgkin lymphoma.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-634
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 24,26
ST   Penta D: 14,15
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 17
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   U-2946
AC   CVCL_X503
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   DSMZ; ACC-795
DR   DSMZCellDive; ACC-795
DR   Wikidata; Q54973562
RX   PubMed=17926183;
RX   PubMed=27907212;
RX   PubMed=31160637;
CC   Part of: LL-100 blood cancer cell line panel.
CC   Doubling time: 48 hours (PubMed=27907212); ~20-30 hours (DSMZ=ACC-795).
CC   HLA typing: A*01:01:01,02:01:01; B*35:01:01,52:01:01; C*04:01:01,12:02:02; DPA1*01:03:01,01:03:01; DPB1*04:02:01,02:01:02; DQA1*01:03:01,01:01:01; DQB1*05:01:01,06:01:01; DRA*01:01:01,01:02:02; DRB1*01:01:01,15:02:01 (DSMZCellDive=ACC-795).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (PubMed=31160637).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-795
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 11,17
ST   D19S433: 12
ST   D21S11: 30
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 20,23
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 6,9.3
ST   TPOX: 9,12
ST   vWA: 17,18
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 19
//
ID   U-2973
AC   CVCL_1898
DR   BioSample; SAMN03473456
DR   ChEMBL-Cells; CHEMBL4523524
DR   ChEMBL-Targets; CHEMBL4523555
DR   DSMZ; ACC-642
DR   DSMZCellDive; ACC-642
DR   PubChem_Cell_line; CVCL_1898
DR   Wikidata; Q54973563
RX   PubMed=18510704;
RX   PubMed=23171647;
RX   PubMed=26727417;
CC   Doubling time: ~35 hours (DSMZ=ACC-642).
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (PubMed=18510704).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6690; IRAG2 + HGNC; HGNC:7553; MYC; Name(s)=MYC-IRAG2, MYC-LRMP (PubMed=23171647).
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-642
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 11,13
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 23,24
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 21,22
ST   Penta D: 12,13
ST   Penta E: 16
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C125904; High grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements
DI   ORDO; Orphanet_480541; High grade B-cell lymphoma with MYC and/or BCL2 and/or BCL6 rearrangement
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   U-2987-P3
AC   CVCL_S469
DR   Wikidata; Q54973564
RX   PubMed=19543319;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S468 ! U-2987MG
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   U-2987-P6
AC   CVCL_S470
DR   Wikidata; Q54973565
RX   PubMed=19543319;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S468 ! U-2987MG
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   U-2987MG
AC   CVCL_S468
DR   Wikidata; Q54973566
RX   PubMed=16547494;
RX   PubMed=19543319;
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   U-2OS-Cas9-4
AC   CVCL_C0ZD
DR   Wikidata; Q114313141
RX   PubMed=35445373;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Cas9-T2A-PuroR construct.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   U-2OSMR
AC   CVCL_A5VB
SY   U-2OS(MR)
DR   Wikidata; Q107117156
RX   PubMed=19638450;
RX   PubMed=25236161;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   U-2OSTR
AC   CVCL_A5VC
SY   U-2OS(TR)
DR   Wikidata; Q107117158
RX   PubMed=24866169;
RX   PubMed=25236161;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   U-33/c
AC   CVCL_B5VB
DR   GEO; GSM257412
DR   GEO; GSM257414
DR   GEO; GSM257415
DR   GEO; GSM257416
DR   GEO; GSM257417
DR   GEO; GSM257418
DR   GEO; GSM257419
DR   GEO; GSM257422
DR   GEO; GSM257423
DR   GEO; GSM257426
DR   GEO; GSM257427
DR   GEO; GSM257463
DR   Wikidata; Q112041871
RX   PubMed=10412038;
RX   PubMed=19115254;
CC   Characteristics: Control cell line for U-33/gamma-2 (Cellosaurus=CVCL_B5VC).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D625 ! UAMS-33
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   U-33/gamma-2
AC   CVCL_B5VC
SY   U-33/g2; Clone 28.6; Gamma2.28
DR   GEO; GSM257420
DR   GEO; GSM257421
DR   GEO; GSM257424
DR   GEO; GSM257425
DR   GEO; GSM257451
DR   GEO; GSM257452
DR   GEO; GSM257453
DR   GEO; GSM257454
DR   GEO; GSM257455
DR   GEO; GSM257456
DR   GEO; GSM257457
DR   GEO; GSM257458
DR   Wikidata; Q112041872
RX   PubMed=10412038;
RX   PubMed=19115254;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:97747; Pparg (Note=Isoform 2).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D625 ! UAMS-33
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   U-343MG
AC   CVCL_S471
SY   U-343 MG; U-343-MG; U343MG; U-343; U343; 343 MG; 343MG; 343 MG(9)
DR   BTO; BTO_0006221
DR   EFO; EFO_0022447
DR   Cell_Model_Passport; SIDM01495
DR   Cosmic; 849880
DR   Cosmic; 2367503
DR   Cosmic; 2491104
DR   Cosmic; 2516043
DR   Cosmic; 2701086
DR   Wikidata; Q54973568
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=77569;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=3518877;
RX   PubMed=3675803;
RX   PubMed=4134536;
RX   PubMed=4142792;
RX   PubMed=4359449;
RX   PubMed=4369403;
RX   PubMed=6260907;
RX   PubMed=10402232;
RX   PubMed=10416987;
RX   PubMed=11351043;
RX   PubMed=21061448;
RX   PubMed=21406405;
RX   PubMed=22570425;
RX   PubMed=25984343;
RX   PubMed=26496030;
RX   PubMed=27582061;
RX   PubMed=33385022;
CC   Population: Caucasian.
CC   Doubling time: 45 hours (PubMed=25984343).
CC   HLA typing: A*02,03; B*07,27 (PubMed=77569).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=22570425; PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D18S51: 21,23 (PubMed=27582061)
ST   D18S51: 23 (PubMed=22570425)
ST   D19S433: 13,14
ST   D21S11: 31,33.2
ST   D2S1338: 22,24
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17 (PubMed=22570425)
ST   vWA: 17,18 (PubMed=27582061)
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4773 ! U-343MGa
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 23
//
ID   U-343MGa
AC   CVCL_4773
SY   U-343 MG-A; U-343-MG-A; U343-MG-A; U-343 MGa; U343 MGa; U343MGa; U343
DR   BTO; BTO_0003218
DR   CLO; CLO_0009459
DR   CLDB; cl4586
DR   BioGRID_ORCS_Cell_line; 350
DR   BioSample; SAMN10988401
DR   Cell_Model_Passport; SIDM01421
DR   CLS; 300365
DR   DepMap; ACH-000036
DR   PharmacoDB; U343_1631_2019
DR   Wikidata; Q54973569
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=3497714;
RX   PubMed=10709103;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Genome ancestry: African=1.11%; Native American=0%; East Asian, North=4.21%; East Asian, South=0%; South Asian=0%; European, North=72.65%; European, South=22.03% (PubMed=30894373).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): CLS=300365
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D18S51: 23
ST   D21S11: 31,33.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S471 ! U-343MG
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   U-343MGa 31L
AC   CVCL_S472
SY   U-343 MGa 31L; U343MGa 31L
DR   Wikidata; Q54973570
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=3497714;
RX   PubMed=10709103;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4773 ! U-343MGa
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   U-343MGa Cl2
AC   CVCL_S474
SY   U-343 MGa Cl2; U-343 MGa Cl 2
DR   Wikidata; Q54973571
RX   PubMed=2998609;
RX   PubMed=3497714;
RX   PubMed=6296418;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4773 ! U-343MGa
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   U-343MGa Cl2:6
AC   CVCL_S473
SY   U-343 MGa Cl2:6; U-Cl2:6MG; U343MGGaCl26
DR   Wikidata; Q54973572
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=2998609;
RX   PubMed=3497714;
RX   PubMed=10709103;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S474 ! U-343MGa Cl2
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   U-343MGa Cl3
AC   CVCL_S475
SY   U-343 MGa Cl3; U-343 MGa Cl 3
DR   Wikidata; Q54973573
RX   PubMed=2998609;
RX   PubMed=6296418;
CC   Population: Caucasian.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4773 ! U-343MGa
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   U-348MG
AC   CVCL_A1QU
SY   348 MG
DR   Wikidata; Q105511289
RX   PubMed=4359449;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   U-372MG
AC   CVCL_5G60
SY   U-372 MG; U372MG; 372 MG
DR   Wikidata; Q54973574
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=608846;
RX   PubMed=2454731;
RX   PubMed=4359449;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 17,18
ST   D3S1358: 17,18
ST   D5S818: 9,11
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 12,14
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   U-373MG ATCC
AC   CVCL_2219
SY   U-373MG; U373 MG; U-373-MG; U-373 MG; U373-MG; U373MG; U373; 373 MG; 373MG
DR   BTO; BTO_0002126
DR   CLO; CLO_0009460
DR   CLO; CLO_0009461
DR   EFO; EFO_0001255
DR   CLDB; cl4587
DR   CLDB; cl4589
DR   CLDB; cl4964
DR   ATCC; HTB-17
DR   cancercelllines; CVCL_2219
DR   CCLV; CCLV-RIE 0675
DR   CGH-DB; 320-1
DR   ChEMBL-Cells; CHEMBL3307474
DR   ChEMBL-Cells; CHEMBL3886101
DR   ChEMBL-Targets; CHEMBL615024
DR   Cosmic; 687589
DR   Cosmic; 849849
DR   Cosmic; 850825
DR   Cosmic; 920819
DR   Cosmic; 970093
DR   Cosmic; 1066236
DR   Cosmic; 1171226
DR   Cosmic; 1175824
DR   Cosmic; 1217674
DR   Cosmic; 1294952
DR   Cosmic; 1610742
DR   Cosmic; 2367504
DR   Cosmic; 2491105
DR   Cosmic; 2701087
DR   ECACC; 89081403
DR   GEO; GSM101681
DR   GEO; GSM101682
DR   GEO; GSM827314
DR   GEO; GSM1638667
DR   IARC_TP53; 2576
DR   IZSLER; BS TCL 89
DR   JCRB; NIHS0295
DR   KCLB; 30017
DR   LINCS_LDP; LCL-1360
DR   Lonza; 334
DR   Lonza; 1006
DR   MetaboLights; MTBLS4708
DR   NCBI_Iran; C455
DR   PRIDE; PXD000430
DR   PRIDE; PXD031569
DR   Progenetix; CVCL_2219
DR   PubChem_Cell_line; CVCL_2219
DR   TOKU-E; 3660
DR   Wikidata; Q54973575
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=2253244;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6260907;
RX   PubMed=6582512;
RX   PubMed=8858520;
RX   PubMed=9220028;
RX   PubMed=9230885;
RX   PubMed=9842975;
RX   PubMed=10074188;
RX   PubMed=10402232;
RX   PubMed=10416987;
RX   PubMed=11351043;
RX   PubMed=11414198;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=16232199;
RX   PubMed=16697959;
RX   PubMed=17595512;
RX   PubMed=20215515;
RX   PubMed=20593219;
RX   PubMed=21406405;
RX   PubMed=22282976;
RX   PubMed=22570425;
RX   PubMed=26496030;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/u-373-mg-atcc-htb-17
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=76
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-510.html
WW   Provider; NIBSC; 0029; http://www.nibsc.org/Default.aspx?pageid=597&id=0029&theme=default
CC   Problematic cell line: Misidentified/contaminated. Shown to be a U-251MG derivative. This cell line is not the original astrocytoma cell line established in 1973 at the University of Uppsala. See U-373MG Uppsala (Cellosaurus=CVCL_2818) for the original U-373MG cell line.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00295.
CC   Population: Caucasian.
CC   Doubling time: 40 hours (PubMed=9842975).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=10416987; PubMed=14614447).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; HTB-17; true.
CC   Discontinued: ECACC; 89081403; true.
CC   Discontinued: JCRB; NIHS0295; true.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
ST   Source(s): ATCC=HTB-17; JCRB=NIHS0295; KCLB=30017; PubMed=22570425
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 12
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,25
ST   Penta D: 10,12
ST   Penta E: 7,10
ST   TH01: 9.3 (ATCC=HTB-17; KCLB=30017; PubMed=22570425)
ST   TH01: 9.3,11 (JCRB=NIHS0295)
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   U-373MG Uppsala
AC   CVCL_2818
SY   U-373 MG Uppsala; U-373 MG (Uppsala); U-373MG; U373 MG; U-373-MG; U-373 MG; U373-MG; U373MG; U373; 373 MG; 373MG
DR   BioSample; SAMN03471311
DR   ECACC; 08061901
DR   Wikidata; Q54973576
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=3675803;
RX   PubMed=4134536;
RX   PubMed=4359449;
RX   PubMed=4369403;
RX   PubMed=10560660;
RX   PubMed=19435942;
RX   PubMed=27582061;
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Ile135_Ala137delinsThr (c.404_409delTATGTG); Zygosity=Unspecified (PubMed=10560660).
CC   Caution: This is the original U-373MG cell line established in 1973 at the University of Uppsala. The cell line distributed by most cell collections is a different cell line.
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): ECACC=08061901; PubMed=27582061
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 14,22
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,12 (PubMed=27582061)
ST   D7S820: 8.2,12 (ECACC=08061901)
ST   D8S1179: 13,16
ST   FGA: 20
ST   Penta D: 9,13
ST   Penta E: 11,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   U-399MG
AC   CVCL_1E96
SY   U-399 MG; U399MG; 399 MG
DR   Wikidata; Q54973577
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2454731;
RX   PubMed=4359449;
RX   PubMed=4369403;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,18
ST   D5S818: 9,13
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 22,25
ST   Penta D: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   U-410MG
AC   CVCL_W020
SY   U-410 MG; U410MG; 410 MG
DR   Wikidata; Q54973579
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2253244;
RX   PubMed=2454731;
RX   PubMed=3675803;
RX   PubMed=4359449;
RX   PubMed=4369403;
RX   PubMed=6260907;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 13,18
ST   D19S433: 14,16.2
ST   D21S11: 28,31.2
ST   D2S1338: 18,20
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 20,22
ST   Penta D: 9
ST   Penta E: 7,11
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   U-47703 BL
AC   CVCL_IW55
DR   Wikidata; Q54973589
RX   PubMed=165156;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 02-05-24; Version: 6
//
ID   U-489MG
AC   CVCL_1E97
SY   U-489 MG; U489MG; 489 MG
DR   Wikidata; Q54973590
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2454731;
RX   PubMed=4359449;
RX   PubMed=4369403;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   U-495MG
AC   CVCL_1E98
SY   U-495 MG; 495 MG
DR   Wikidata; Q54973591
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   PubMed=3518877;
RX   PubMed=4359449;
RX   PubMed=4369403;
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   U-539MG
AC   CVCL_1E99
SY   U-539 MG; U539MG; 539 MG
DR   Wikidata; Q54973592
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2454731;
RX   PubMed=4369403;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 13,15
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 12,14
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 17,19
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 7
//
ID   U-563MG
AC   CVCL_A757
SY   U-563 MG; U563 MG; U-563-MG; U563MG; 563 MG
DR   Wikidata; Q54973594
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=1847665;
RX   PubMed=2454731;
RX   PubMed=10402232;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,21
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 21,25
ST   Penta D: 9,11
ST   Penta E: 10,16
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   U-692MG
AC   CVCL_1F00
SY   U-692 MG; 692 MG
DR   Wikidata; Q54973596
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   PubMed=4369403;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   U-698-M
AC   CVCL_0017
SY   U-698 M; U-698M; U698-M; U698M; U-698; U698
DR   CLO; CLO_0009462
DR   EFO; EFO_0006768
DR   CLDB; cl4591
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03471071
DR   cancercelllines; CVCL_0017
DR   Cell_Model_Passport; SIDM00424
DR   ChEMBL-Cells; CHEMBL3308280
DR   ChEMBL-Targets; CHEMBL2366098
DR   Cosmic; 909777
DR   Cosmic-CLP; 909777
DR   DepMap; ACH-001680
DR   DSMZ; ACC-4
DR   DSMZCellDive; ACC-4
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909777
DR   GEO; GSM1374973
DR   GEO; GSM1670558
DR   GEO; GSM7701383
DR   GEO; GSM7701384
DR   GEO; GSM7701408
DR   GEO; GSM7701409
DR   IARC_TP53; 27265
DR   LINCS_LDP; LCL-1008
DR   PharmacoDB; U698M_1622_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_0017
DR   Wikidata; Q54973597
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3518877;
RX   PubMed=3874327;
RX   PubMed=4136723;
RX   PubMed=4369887;
RX   PubMed=16957166;
RX   PubMed=20164919;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 60-65 hours (PubMed=4136723); ~48 hours (DSMZ=ACC-4).
CC   HLA typing: A*02:01,03:01; B*07:02,27:05; C*01:02,07:02; DQA1*01:02,03:02; DQB1*03:02,06:11; DRB1*04:01,15:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Arg1446Ter (c.4336C>T); Zygosity=Heterozygous (Cosmic-CLP=909777; DepMap=ACH-001680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (Cosmic-CLP=909777; DepMap=ACH-001680).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.7%; Native American=0%; East Asian, North=4.43%; East Asian, South=0%; South Asian=0%; European, North=69.32%; European, South=22.56% (PubMed=30894373).
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): Cosmic-CLP=909777; DepMap=ACH-001680; DSMZ=ACC-4; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 15,18
ST   D19S433: 13,16
ST   D21S11: 29,30
ST   D2S1338: 16,20
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 11,12
ST   Penta E: 11,12
ST   TH01: 6,10
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9360; Lymphoblastic lymphoma
DI   ORDO; Orphanet_547; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 41
//
ID   U-706MG
AC   CVCL_5G70
SY   U-706M; U706MG
DR   Wikidata; Q54973598
RX   PubMed=7319677;
RX   PubMed=27582061;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D21S11: 30,32.2
ST   D2S1338: 16,20
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 22,26
ST   Penta D: 9,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G71 ! U-706S
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   U-706S
AC   CVCL_5G71
SY   U-706 S
DR   Wikidata; Q54973599
RX   PubMed=2454731;
RX   PubMed=7319677;
CC   Characteristics: Grows in suspension (PubMed=7319677).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G70 ! U-706MG
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   U-715-M
AC   CVCL_4T89
SY   U-715 M; U-715M; U-715; U715
DR   Wikidata; Q54973600
RX   PubMed=4136723;
RX   PubMed=4369887;
CC   Doubling time: 125-130 hours (PubMed=4136723).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9360; Lymphoblastic lymphoma
DI   ORDO; Orphanet_547; Non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   U-87 MG-EGFP
AC   CVCL_C8WL
DR   Ubigene; YC-C028-EGFP-P
DR   Wikidata; Q123033664
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   U-87 MG-Luc
AC   CVCL_C8WM
DR   Ubigene; YC-C028-Luc-P
DR   Wikidata; Q123033665
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   U-87 MG-luc2
AC   CVCL_5J15
SY   U87MG-luc2
DR   cancercelllines; CVCL_5J15
DR   Revvity/PerkinElmer; 124577
DR   Wikidata; Q54973601
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Discontinued: Revvity/PerkinElmer; 124577; true.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   U-87 MG-Luc2
AC   CVCL_UR33
DR   ATCC; HTB-14-LUC2
DR   cancercelllines; CVCL_UR33
DR   Wikidata; Q98133707
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=HTB-14-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
ST   Source(s): ATCC=HTB-14-LUC2
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U-87MG ATCC
AC   CVCL_0022
SY   U-87MG; U-87 MG; U87 MG; U-87-MG; U87-MG; U87MG; U-87; U87; 87 MG; 87MG
DR   BTO; BTO_0002036
DR   CLO; CLO_0009463
DR   CLO; CLO_0009464
DR   EFO; EFO_0005237
DR   MCCL; MCC:0000469
DR   CLDB; cl4592
DR   CLDB; cl4594
DR   CLDB; cl4595
DR   CLDB; cl7166
DR   Abcam; ab278079
DR   AddexBio; C0005002/71
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-14
DR   BCRC; 60360
DR   BCRJ; 0241
DR   BEI_Resources; ARP-2188
DR   BioGRID_ORCS_Cell_line; 348
DR   BioSample; SAMN03472715
DR   BioSample; SAMN03473126
DR   BioSample; SAMN05292456
DR   BioSample; SAMN07710026
DR   BioSample; SAMN07710027
DR   BioSample; SAMN07710028
DR   BioSample; SAMN07710029
DR   BioSample; SAMN07710030
DR   BioSample; SAMN07710031
DR   BioSample; SAMN07710032
DR   BioSample; SAMN10988360
DR   cancercelllines; CVCL_0022
DR   CCRID; 1101HUM-PUMC000208
DR   CCRID; 3101HUMTCHu138
DR   CCTCC; GDC0157
DR   Cell_Model_Passport; SIDM01189
DR   CGH-DB; 157-1
DR   ChEMBL-Cells; CHEMBL3307575
DR   ChEMBL-Cells; CHEMBL3989361
DR   ChEMBL-Targets; CHEMBL614247
DR   CLS; 300367
DR   Cosmic; 687590
DR   Cosmic; 849853
DR   Cosmic; 850741
DR   Cosmic; 850822
DR   Cosmic; 920816
DR   Cosmic; 1036336
DR   Cosmic; 1064099
DR   Cosmic; 1066234
DR   Cosmic; 1171224
DR   Cosmic; 1175825
DR   Cosmic; 1198263
DR   Cosmic; 1217671
DR   Cosmic; 1219449
DR   Cosmic; 1237542
DR   Cosmic; 1294951
DR   Cosmic; 1610737
DR   Cosmic; 1746951
DR   Cosmic; 1945859
DR   Cosmic; 2302316
DR   Cosmic; 2367555
DR   Cosmic; 2491106
DR   Cosmic; 2516044
DR   Cosmic; 2550364
DR   Cosmic; 2568870
DR   Cosmic; 2580918
DR   Cosmic; 2701083
DR   Cosmic-CLP; 687590
DR   DepMap; ACH-000075
DR   ECACC; 89081402
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS424ENC
DR   GDSC; 687590
DR   GEO; GSM101676
DR   GEO; GSM101686
DR   GEO; GSM101687
DR   GEO; GSM101688
DR   GEO; GSM326243
DR   GEO; GSM481417
DR   GEO; GSM500897
DR   GEO; GSM887723
DR   GEO; GSM888817
DR   GEO; GSM923437
DR   GEO; GSM1374974
DR   GEO; GSM1638668
DR   GEO; GSM1670559
DR   GEO; GSM2113436
DR   GEO; GSM2113437
DR   GEO; GSM2113438
DR   GEO; GSM2113439
DR   GEO; GSM7701418
DR   GEO; GSM7701419
DR   IARC_TP53; 21096
DR   IBRC; C10982
DR   ICLC; HTL00013
DR   IZSLER; BS TCL 189
DR   KCB; KCB 2011101YJ
DR   KCLB; 30014
DR   LiGeA; CCLE_552
DR   LINCS_HMS; 50868
DR   LINCS_LDP; LCL-1364
DR   Lonza; 37
DR   Lonza; 808
DR   MetaboLights; MTBLS4708
DR   MetaboLights; MTBLS6212
DR   NCBI_Iran; C531
DR   PharmacoDB; U87MG_1623_2019
DR   PRIDE; PXD000589
DR   PRIDE; PXD000661
DR   PRIDE; PXD001565
DR   PRIDE; PXD003790
DR   Progenetix; CVCL_0022
DR   PubChem_Cell_line; CVCL_0022
DR   RCB; RCB0419
DR   TOKU-E; 3381
DR   Ubigene; YC-C028
DR   Wikidata; Q7863603
RX   PubMed=327080;
RX   PubMed=450131;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=7459858;
RX   PubMed=7763724;
RX   PubMed=8069455;
RX   PubMed=9090379;
RX   PubMed=9230885;
RX   PubMed=9842975;
RX   PubMed=10074188;
RX   PubMed=10402232;
RX   PubMed=10416987;
RX   PubMed=10560660;
RX   PubMed=11414198;
RX   PubMed=11416159;
RX   PubMed=11966317;
RX   PubMed=14614447;
RX   PubMed=14655754;
RX   PubMed=14961077;
RX   PubMed=16232199;
RX   PubMed=16697959;
RX   PubMed=17595512;
RX   PubMed=19365568;
RX   PubMed=19435942;
RX   PubMed=20126413;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=20587068;
RX   PubMed=20593219;
RX   PubMed=21406405;
RX   PubMed=22282976;
RX   PubMed=22460905;
RX   PubMed=22570425;
RX   PubMed=23325432;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26496030;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=27412690;
RX   PubMed=27582061;
RX   PubMed=27894925;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=33385022;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-htb-14-morphology-and-growth-conditions
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/U-87_Myers_protocol.pdf
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=58
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544489
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-314.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/U87
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/brain-cancer-xenograft/u87-xenograft-model/
CC   Problematic cell line: Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (Cellosaurus=CVCL_GP63) for the original U-87MG cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00535.
CC   Population: Caucasian.
CC   Doubling time: 39 hours (PubMed=9842975); 72 hours (PubMed=25984343); ~34 hours (PBCF).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01; DQA1*01:02,01:02; DQB1*06:02,06:02; DRB1*15:01,13:07 (PubMed=25960936).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,05:01 (PubMed=26589293).
CC   HLA typing: A*02:01:01; B*44:02; C*05:01:01 (PubMed=27412690).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; None_reported; -; Zygosity=- (PubMed=19435942).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (Cosmic-CLP=687590; DepMap=ACH-000075).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=9090379; Cosmic-CLP=687590; DepMap=ACH-000075).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=687590; DepMap=ACH-000075).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.69%; Native American=0%; East Asian, North=3.92%; East Asian, South=0%; South Asian=0%; European, North=72.18%; European, South=23.21% (PubMed=30894373).
CC   Discontinued: RCB; RCB0419; true.
ST   Source(s): AddexBio=C0005002/71; ATCC=HTB-14; CCRID; CLS=300367; Cosmic-CLP=687590; ECACC=89081402; KCLB=30014; PubMed=11416159; PubMed=22570425; PubMed=25877200; PubMed=27582061; Technion Genomics Center
ST   Amelogenin: X (AddexBio=C0005002/71; CCRID; CLS=300367; ECACC=89081402; PubMed=11416159; PubMed=22570425; PubMed=25877200; PubMed=27582061; Technion Genomics Center)
ST   Amelogenin: X,Y (ATCC=HTB-14; Cosmic-CLP=687590; KCLB=30014)
ST   CSF1PO: 10,11
ST   D10S1248: 14
ST   D12S391: 18,21
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13 (CLS=300367; PubMed=22570425)
ST   D18S51: 13,14 (ATCC=HTB-14; CCRID; PubMed=11416159; PubMed=25877200; Technion Genomics Center)
ST   D19S433: 15,15.2
ST   D1S1656: 15
ST   D21S11: 28,32.2
ST   D22S1045: 15,17
ST   D2S1338: 20,23
ST   D2S441: 10,11
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,11
ST   FGA: 18,24
ST   Penta D: 9,14
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 49
//
ID   U-87MG ATCC IDH1 p.R132H
AC   CVCL_UE09
SY   IDH1 mutant-U-87 Isogenic Cell Line
DR   ATCC; HTB-14IG
DR   cancercelllines; CVCL_UE09
DR   Wikidata; Q98133708
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Doubling time: ~25.6 hours (ATCC=HTB-14IG).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple_edited; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=HTB-14IG).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
ST   Source(s): ATCC=HTB-14IG
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   U-87MG ATCC IDH1 p.R132H-Luc2
AC   CVCL_UR35
SY   IDH1 Mutant U-87 Isogenic-Luc2
DR   ATCC; HTB-14IG-LUC2
DR   cancercelllines; CVCL_UR35
DR   Wikidata; Q98133709
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple_edited; p.Arg132His (c.395G>A); ClinVar=VCV000156444; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (ATCC=HTB-14IG-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
ST   Source(s): ATCC=HTB-14IG-LUC2
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UE09 ! U-87MG ATCC IDH1 p.R132H
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   U-87MG ATCC ECE1 KO
AC   CVCL_C6JA
DR   Wikidata; Q116050659
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3146; ECE1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Miscellaneous: Has been generated from a fee-for-service contract with Abcam. Cell line information from personal communication of Laflamme, Carl.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   U-87MG ATCC HTT KO
AC   CVCL_F0QD
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4851; HTT.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Park, Yang-Nim.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U-87MG EMC10 isoform HSS1
AC   CVCL_F1JR
SY   U87 pcDNA3.1-hHSS1
RX   PubMed=20680400;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Doubling time: 32.1 hours (PubMed=20680400).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27609; EMC10 (Note=Isoform HSS1).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U-87MG neo
AC   CVCL_F1JS
SY   U87 pcDNA3.1
RX   PubMed=20680400;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Characteristics: Control cell line for U-87MG EMC10 isoform HSS1 (Cellosaurus=CVCL_F1JR) (PubMed=20680400).
CC   Doubling time: 27.6 hours (PubMed=20680400).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U-87MG Uppsala
AC   CVCL_GP63
SY   U-87MG; U-87 MG; U87 MG; U-87-MG; U87-MG; U87MG; U-87; U87; 87 MG; 87MG
DR   Wikidata; Q28575999
RX   DOI=10.1007/0-306-46861-1_11;
RX   DOI=10.1007/978-1-4757-1647-4_7;
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=2454731;
RX   PubMed=4134536;
RX   PubMed=4313504;
RX   PubMed=4337530;
RX   PubMed=4369403;
RX   PubMed=27582061;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/U87
CC   Caution: This is the original U-87MG cell line established in 1968 at the University of Uppsala. The cell line distributed by most cell collections (including ATCC, CLS, ECACC, etc.) is a different cell line whose origin is not yet clear (PubMed=27582061). See U-87MG ATCC (Cellosaurus=CVCL_0022) for the cell line used by most research groups.
ST   Source(s): PubMed=27582061
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 11
ST   Penta E: 7,13
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 8
//
ID   U-87MG-parkin clone 19
AC   CVCL_C3IF
SY   U-87MG-PK19; U87-Parkin 19
DR   cancercelllines; CVCL_C3IF
DR   GEO; GSM729740
DR   GEO; GSM729743
DR   GEO; GSM729746
DR   Wikidata; Q114313142
RX   PubMed=22431710;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   U-87MG-parkin clone 25
AC   CVCL_C3IG
SY   U-87MG-PK25; U87-Parkin 25
DR   cancercelllines; CVCL_C3IG
DR   GEO; GSM729741
DR   GEO; GSM729744
DR   GEO; GSM729747
DR   Wikidata; Q114313143
RX   PubMed=22431710;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   U-87MG-parkin clone 7
AC   CVCL_C3IE
SY   U-87MG-PK7; U87-Parkin 7
DR   cancercelllines; CVCL_C3IE
DR   GEO; GSM729739
DR   GEO; GSM729742
DR   GEO; GSM729745
DR   Wikidata; Q114313144
RX   PubMed=22431710;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8607; PRKN (Note=With a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 8
//
ID   U-87MG/DDP
AC   CVCL_VL16
SY   U87MG/DDP
DR   BTO; BTO_0006083
DR   cancercelllines; CVCL_VL16
DR   Wikidata; Q98133710
RX   PubMed=24815474;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   U-937
AC   CVCL_0007
SY   U937; U 937
DR   BTO; BTO_0001412
DR   CLO; CLO_0009450
DR   CLO; CLO_0009465
DR   EFO; EFO_0001257
DR   MCCL; MCC:0000470
DR   CLDB; cl4597
DR   CLDB; cl4599
DR   CLDB; cl4600
DR   CLDB; cl4601
DR   CLDB; cl4602
DR   CLDB; cl4603
DR   CLDB; cl4604
DR   CLDB; cl4605
DR   CLDB; cl4606
DR   CLDB; cl4608
DR   AddexBio; C0003005/72
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ATCC; CRL-1593
DR   ATCC; CRL-1593.2
DR   BCRC; 60435
DR   BCRJ; 0242
DR   BioGRID_ORCS_Cell_line; 154
DR   BioSample; SAMN03472409
DR   BioSample; SAMN03473173
DR   BioSample; SAMN03473567
DR   BioSample; SAMN10988180
DR   cancercelllines; CVCL_0007
DR   CCRID; 1101HUM-PUMC000059
DR   CCRID; 3101HUMTCHu159
DR   CCRID; 4201HUM-CCTCC00080
DR   CCTCC; GDC0080
DR   Cell_Model_Passport; SIDM01195
DR   ChEMBL-Cells; CHEMBL3308006
DR   ChEMBL-Targets; CHEMBL612794
DR   CLS; 300368
DR   Cosmic; 787483
DR   Cosmic; 798666
DR   Cosmic; 821044
DR   Cosmic; 850382
DR   Cosmic; 852000
DR   Cosmic; 919123
DR   Cosmic; 922162
DR   Cosmic; 932770
DR   Cosmic; 947364
DR   Cosmic; 975307
DR   Cosmic; 991558
DR   Cosmic; 994178
DR   Cosmic; 999781
DR   Cosmic; 1012127
DR   Cosmic; 1019837
DR   Cosmic; 1067446
DR   Cosmic; 1070690
DR   Cosmic; 1078726
DR   Cosmic; 1082516
DR   Cosmic; 1086353
DR   Cosmic; 1089523
DR   Cosmic; 1107178
DR   Cosmic; 1127260
DR   Cosmic; 1150904
DR   Cosmic; 1176581
DR   Cosmic; 1181605
DR   Cosmic; 1191692
DR   Cosmic; 1465967
DR   Cosmic; 1523828
DR   Cosmic; 1524826
DR   Cosmic; 1582388
DR   Cosmic; 1601066
DR   Cosmic; 1604865
DR   Cosmic; 1995661
DR   Cosmic; 2301570
DR   Cosmic; 2361376
DR   Cosmic; 2750876
DR   DepMap; ACH-000406
DR   DSMZ; ACC-5
DR   DSMZCellDive; ACC-5
DR   ECACC; 85011440
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSE66854
DR   GEO; GSM2020
DR   GEO; GSM236809
DR   GEO; GSM236845
DR   GEO; GSM482491
DR   GEO; GSM743413
DR   GEO; GSM887724
DR   GEO; GSM888818
DR   GEO; GSM1028244
DR   GEO; GSM1028245
DR   GEO; GSM1374975
DR   GEO; GSM1670560
DR   GEO; GSM7701385
DR   GEO; GSM7701386
DR   GEO; GSM7701402
DR   GEO; GSM7701403
DR   IARC_TP53; 2199
DR   ICLC; HTL94002
DR   IPD-IMGT/HLA; 11507
DR   IZSLER; BS TCL 73
DR   JCRB; IFO50038
DR   JCRB; JCRB9021
DR   KCB; KCB 200676YJ
DR   KCLB; 21593.1
DR   LiGeA; CCLE_826
DR   LINCS_HMS; 50869
DR   LINCS_LDP; LCL-1125
DR   Lonza; 135
DR   MeSH; D020298
DR   NCBI_Iran; C130
DR   PharmacoDB; U937_1624_2019
DR   PRIDE; PXD001521
DR   PRIDE; PXD001522
DR   PRIDE; PXD001523
DR   Progenetix; CVCL_0007
DR   PubChem_Cell_line; CVCL_0007
DR   RCB; RCB1978
DR   TKG; TKG 0279
DR   TOKU-E; 3382
DR   Ubigene; YC-C021
DR   Wikidata; Q7863610
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/978-94-011-3550-4_20;
RX   DOI=10.1016/j.actaastro.2013.06.007;
RX   DOI=10.1159/000415060;
RX   PubMed=178611;
RX   PubMed=1083890;
RX   PubMed=1571549;
RX   PubMed=1913629;
RX   PubMed=2140233;
RX   PubMed=2243057;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=6091813;
RX   PubMed=6582512;
RX   PubMed=7759961;
RX   PubMed=8300570;
RX   PubMed=8547074;
RX   PubMed=8558913;
RX   PubMed=8558920;
RX   PubMed=8643484;
RX   PubMed=9371509;
RX   PubMed=9510473;
RX   PubMed=9685479;
RX   PubMed=9738977;
RX   PubMed=10352142;
RX   PubMed=10676951;
RX   PubMed=10739008;
RX   PubMed=10966170;
RX   PubMed=11226526;
RX   PubMed=11416159;
RX   PubMed=11701946;
RX   PubMed=12393283;
RX   PubMed=15637111;
RX   PubMed=15843827;
RX   PubMed=16311011;
RX   PubMed=16337770;
RX   PubMed=16408098;
RX   PubMed=16957166;
RX   PubMed=20801507;
RX   PubMed=21269460;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=29787063;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31978347;
RX   PubMed=33317567;
RX   PubMed=34707142;
RX   PubMed=36982453;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/growth-and-morphology-of-atcc-item-crl-1593-2
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=U937
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-315.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/U937_cells
WW   Provider; NIBSC; 0012; http://www.nibsc.org/Default.aspx?pageid=597&id=0012&theme=default
CC   Group: Space-flown cell line (cellonaut).
CC   Problematic cell line: Partially contaminated. Some ATCC stocks were cross-contaminated by K-562 initially (PubMed=7759961). The problem was corrected and subsequent stocks have been confirmed to carry only U-937.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00168.
CC   Population: Caucasian.
CC   Characteristics: Can be induced to differentiate into macrophages by several factors such as phorbol ester (PMA) and 12-O-tetradecanoyl-13-phorbol acetate (TPA).
CC   Doubling time: 95-100 hours (PubMed=178611); ~30-40 hours (DSMZ=ACC-5).
CC   HLA typing: DRB1*16:01 (IPD-IMGT/HLA=11507).
CC   HLA typing: A*03:01,03:01; B*18:01,51:01; C*01:02,07:01; DRB1*16:01,16:01 (PubMed=26589293).
CC   Karyotypic information: Has lost chromosome Y.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (PubMed=8643484; PubMed=25485619).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (PubMed=10966170; DepMap=ACH-000406).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (DepMap=ACH-000406).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=1571549; DepMap=ACH-000406).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (DepMap=ACH-000406).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; 2DE-MS.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.39%; East Asian, South=0%; South Asian=0%; European, North=71.54%; European, South=26.06% (PubMed=30894373).
CC   Anecdotal: Have been flown in space on shuttle flight STS-76 and on Shenzhou-8 to study growth and cytoskeletal changes in microgravity (PubMed=10352142; DOI=10.1016/j.actaastro.2013.06.007).
CC   Discontinued: ATCC; CRL-1593; true.
CC   Discontinued: RCB; RCB1978; true.
CC   Discontinued: TKG; TKG 0279; probable.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): AddexBio=C0003005/72; ATCC=CRL-1593.2; CCRID; CLS=300368; COG; DSMZ=ACC-5; ECACC=85011440; JCRB=IFO50038; JCRB=JCRB9021; KCLB=21593.1; PubMed=11416159; PubMed=15637111; PubMed=25877200; PubMed=34707142; RCB=RCB1978; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12 (DSMZ=ACC-5; PubMed=15637111)
ST   CSF1PO: 12 (AddexBio=C0003005/72; ATCC=CRL-1593.2; CCRID; CLS=300368; COG; ECACC=85011440; JCRB=IFO50038; JCRB=JCRB9021; KCLB=21593.1; PubMed=25877200; PubMed=34707142; RCB=RCB1978; Technion Genomics Center)
ST   D10S1248: 14
ST   D12S391: 17,18
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 14,16
ST   D1S1656: 17.3
ST   D21S11: 27 (DSMZ=ACC-5; PubMed=15637111)
ST   D21S11: 27,29 (ATCC=CRL-1593.2; CCRID; CLS=300368; COG; PubMed=25877200; PubMed=34707142; Technion Genomics Center)
ST   D22S1045: 17
ST   D2S1338: 17 (DSMZ=ACC-5)
ST   D2S1338: 17,20 (ATCC=CRL-1593.2; CCRID; CLS=300368; COG; PubMed=34707142; Technion Genomics Center)
ST   D2S441: 10
ST   D3S1358: 16 (ATCC=CRL-1593.2; CCRID; CLS=300368; COG; PubMed=25877200; PubMed=34707142; Technion Genomics Center)
ST   D3S1358: 16,17 (DSMZ=ACC-5)
ST   D5S818: 10,12 (PubMed=15637111)
ST   D5S818: 10,12,13 (DSMZ=ACC-5)
ST   D5S818: 12 (AddexBio=C0003005/72; ATCC=CRL-1593.2; CCRID; CLS=300368; COG; ECACC=85011440; JCRB=IFO50038; JCRB=JCRB9021; KCLB=21593.1; PubMed=25877200; PubMed=34707142; RCB=RCB1978; Technion Genomics Center)
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   Penta D: 12,13 (ATCC=CRL-1593.2; CLS=300368; COG; PubMed=25877200; Technion Genomics Center)
ST   Penta D: 13 (DSMZ=ACC-5; PubMed=15637111)
ST   Penta E: 13
ST   TH01: 6,9.3 (AddexBio=C0003005/72; ATCC=CRL-1593.2; CCRID; CLS=300368; COG; DSMZ=ACC-5; ECACC=85011440; JCRB=IFO50038; JCRB=JCRB9021; PubMed=11416159; PubMed=15637111; PubMed=25877200; PubMed=34707142; RCB=RCB1978; Technion Genomics Center)
ST   TH01: 9.3 (KCLB=21593.1)
ST   TPOX: 8,11
ST   vWA: 14,15 (AddexBio=C0003005/72; ATCC=CRL-1593.2; CCRID; CLS=300368; COG; DSMZ=ACC-5; ECACC=85011440; JCRB=IFO50038; JCRB=JCRB9021; PubMed=11416159; PubMed=15637111; PubMed=25877200; RCB=RCB1978; Technion Genomics Center)
ST   vWA: 15 (KCLB=21593.1; PubMed=34707142)
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 50
//
ID   U-937 cl1-14
AC   CVCL_2810
SY   U937 cl1-14
DR   cancercelllines; CVCL_2810
DR   JCRB; JCRB0116.1
DR   Wikidata; Q54973602
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0116.1
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   U-937 cl1-22
AC   CVCL_2811
SY   U937 cl1-22
DR   cancercelllines; CVCL_2811
DR   JCRB; JCRB0116.2
DR   Wikidata; Q54973604
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): JCRB=JCRB0116.2
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   U-937 DE-4
AC   CVCL_8765
DR   CLO; CLO_0050122
DR   BioSample; SAMN03472308
DR   cancercelllines; CVCL_8765
DR   FANTOM5_SSTAR; 10834-111D6
DR   RCB; RCB0435
DR   Wikidata; Q54973606
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB0435
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   U-937 GTB
AC   CVCL_U631
SY   U-937-GTB; U-937/GTB; U937/GTB; U937-GTB
DR   cancercelllines; CVCL_U631
DR   ChEMBL-Cells; CHEMBL3308007
DR   ChEMBL-Targets; CHEMBL612795
DR   PubChem_Cell_line; CVCL_U631
DR   Wikidata; Q54973607
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   U-937 INPP5D KO
AC   CVCL_C8E1
DR   Wikidata; Q123033666
CC   Population: Caucasian.
CC   Characteristics: Shows residual expression of INPP5D (Direct_author_submission).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6079; INPP5D.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   U-937 RERC
AC   CVCL_WV56
SY   U937/RERC; RERC
DR   cancercelllines; CVCL_WV56
DR   Wikidata; Q98133711
RX   PubMed=9371509;
CC   Population: Caucasian.
CC   Doubling time: ~22 hours (PubMed=9371509).
CC   Selected for resistance to: ChEBI; CHEBI_90225; Rubitecan (Orathecin; 9-nitrocamptothecin; 9NC).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Asp533Asn (c.1597G>A); Zygosity=Unspecified (PubMed=9371509).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   U-937-AG
AC   CVCL_X000
SY   U-937 AG
DR   cancercelllines; CVCL_X000
DR   Wikidata; Q54973608
RX   PubMed=6748730;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 15
//
ID   U-937-Luc
AC   CVCL_C8Y0
DR   Ubigene; YC-C021-Luc-P
DR   Wikidata; Q123033669
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   U-937/CR
AC   CVCL_WV55
SY   U937/CR
DR   cancercelllines; CVCL_WV55
DR   Wikidata; Q98133713
RX   PubMed=8300570;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_90225; Rubitecan (Orathecin; 9-nitrocamptothecin; 9NC).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11986; TOP1; Simple; p.Phe361Ser (c.1082T>C); Zygosity=Unspecified (PubMed=8300570).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   U-BLC1
AC   CVCL_2738
SY   UBLC1
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987727
DR   cancercelllines; CVCL_2738
DR   Cell_Model_Passport; SIDM01757
DR   Cosmic; 2050467
DR   Cosmic; 2212693
DR   DepMap; ACH-000741
DR   ECACC; 06013102
DR   IARC_TP53; 28257
DR   IARC_TP53; 28265
DR   LiGeA; CCLE_374
DR   PharmacoDB; UBLC1_1625_2019
DR   Wikidata; Q54973609
RX   PubMed=10074925;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=26589293;
RX   PubMed=29732388;
RX   PubMed=31068700;
RX   PubMed=31978347;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   HLA typing: A*01:01,01:01; B*07:02,13:02; C*02:02,06:02; DQB1*05:02,06:02; DRB1*15:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His296Tyr (c.886C>T); ClinVar=VCV000132973; Zygosity=Homozygous (DepMap=ACH-000741).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (DepMap=ACH-000741).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   U-CH1
AC   CVCL_4988
SY   UCH-1; UCH1
DR   EFO; EFO_0004389
DR   ATCC; CRL-3217
DR   cancercelllines; CVCL_4988
DR   Cosmic; 2663857
DR   DepMap; ACH-002335
DR   DSMZ; ACC-748
DR   DSMZCellDive; ACC-748
DR   ENCODE; ENCBS267AAA
DR   GDSC; 1503374
DR   GEO; GSM1673845
DR   GEO; GSM1673846
DR   PharmacoDB; UCH1_1626_2019
DR   PubChem_Cell_line; CVCL_4988
DR   Wikidata; Q54973610
RX   PubMed=11579460;
RX   PubMed=20461036;
RX   PubMed=21253487;
RX   PubMed=23325432;
RX   PubMed=26183925;
RX   PubMed=27102572;
RX   PubMed=28515451;
RX   PubMed=28606919;
RX   PubMed=28835717;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch1/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/UCH1_Crawford_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Doubling time: ~1 week (Note=But can be significantly longer after recovery from liquid nitrogen freezing) (DSMZ=ACC-748); 2 days (PubMed=26183925); 9 days (Chordoma Foundation).
CC   HLA typing: A*2 (Chordoma Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3217; DSMZ=ACC-748; PubMed=21253487; PubMed=26183925; PubMed=27102572; PubMed=28835717
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 15
ST   D12S391: 17,22
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 15
ST   D19S433: 14
ST   D1S1656: 16,16.3
ST   D21S11: 28,29
ST   D22S1045: 16
ST   D2S1338: 17,18
ST   D2S441: 12,14
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 10,15
ST   FGA: 20,21
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   U-CH1-N
AC   CVCL_4990
SY   U-CH1-NIRS
DR   Wikidata; Q54973611
RX   PubMed=21914223;
CC   Doubling time: ~3 days (PubMed=21914223).
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4988 ! U-CH1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   U-CH10
AC   CVCL_1D66
SY   UCH10
DR   cancercelllines; CVCL_1D66
DR   Cosmic; 2663860
DR   GEO; GSM1673855
DR   GEO; GSM1673856
DR   Wikidata; Q54973612
RX   PubMed=26183925;
RX   PubMed=27102572;
RX   PubMed=28515451;
CC   Doubling time: 14 days (PubMed=26183925).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): PubMed=26183925; PubMed=27102572
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,10 (PubMed=26183925)
ST   D7S820: 10 (PubMed=27102572)
ST   D8S1179: 8,13
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 18
ST   TH01: 8,9
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 16
//
ID   U-CH11
AC   CVCL_1D67
SY   UCH11
DR   ATCC; CRL-3302
DR   cancercelllines; CVCL_1D67
DR   GEO; GSM1673857
DR   GEO; GSM1673858
DR   Wikidata; Q54973613
RX   PubMed=26183925;
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch11/
CC   Population: Caucasian.
CC   Doubling time: 10 days (PubMed=26183925); 15 days (Chordoma Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-3302; true.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): PubMed=26183925
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D3S1358: 15
ST   D7S820: 9,10
ST   D8S1179: 13,16
ST   Penta D: 9,12
ST   Penta E: 7,14
ST   TH01: 6,9.3
ST   TPOX: 8
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR46 ! U-CH11R
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 17
//
ID   U-CH11R
AC   CVCL_VR46
SY   U-CH11-R
DR   ATCC; CRL-3399
DR   Wikidata; Q98133714
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch11r/
CC   Population: Caucasian.
CC   Doubling time: 35 days (Chordoma Foundation).
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3399
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D5S818: 11
ST   D7S820: 10
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1D67 ! U-CH11
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   U-CH12
AC   CVCL_IR27
SY   UCH12
DR   ATCC; CRL-3326
DR   cancercelllines; CVCL_IR27
DR   GEO; GSM1673859
DR   GEO; GSM1673860
DR   Wikidata; Q54973614
RX   PubMed=26183925;
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch12/
CC   Doubling time: 7 days (PubMed=26183925); 11-13 days (Chordoma Foundation).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3326; PubMed=26183925
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 19,19.3
ST   D13S317: 12,13
ST   D16S539: 15
ST   D18S51: 17,18
ST   D19S433: 12,15
ST   D1S1656: 13,16
ST   D21S11: 27,32.2
ST   D22S1045: 15
ST   D2S1338: 22,23
ST   D2S441: 11
ST   D3S1358: 14,19
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 14
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 12,15
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 15
//
ID   U-CH14
AC   CVCL_RA86
SY   UCH14
DR   cancercelllines; CVCL_RA86
DR   GEO; GSM2495964
DR   GEO; GSM2495965
DR   GEO; GSM2495966
DR   Wikidata; Q54973616
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch14/
CC   Doubling time: ~10 days (PubMed=28515451); 44 days (Chordoma Foundation).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=28515451).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
ST   Source(s): PubMed=28515451
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D3S1358: 17
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   Penta D: 14,15
ST   Penta E: 7,19
ST   TH01: 10
ST   TPOX: 8
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 13
//
ID   U-CH17M
AC   CVCL_VR43
DR   ATCC; CRL-3402
DR   GEO; GSM2585630
DR   GEO; GSM2585631
DR   GEO; GSM2585632
DR   Wikidata; Q98133715
RX   PubMed=29148152;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch17m/
CC   Doubling time: 3-10 days (PubMed=29148152); ~8-10 days (ATCC=CRL-3402); 6-8 days (Chordoma Foundation).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous or homozygous (PubMed=29148152).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Soft tissue; UBERON=UBERON_0034929.
ST   Source(s): ATCC=CRL-3402; PubMed=29148152
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 9,13 (PubMed=29148152)
ST   D16S539: 13 (ATCC=CRL-3402)
ST   D18S51: 12
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 9.2,12
ST   Penta D: 12,15
ST   Penta E: 11,14
ST   TH01: 7,9.3 (PubMed=29148152)
ST   TH01: 9.3 (ATCC=CRL-3402)
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR44 ! U-CH17P
OI   CVCL_B6R8 ! U-CH17PII
OI   CVCL_VR45 ! U-CH17S
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   U-CH17P
AC   CVCL_VR44
DR   GEO; GSM2585624
DR   GEO; GSM2585625
DR   GEO; GSM2585626
DR   Wikidata; Q98133716
RX   PubMed=29148152;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch17p/
CC   Doubling time: 6-12 days (PubMed=29148152); 34 days (Chordoma Foundation).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous or homozygous (PubMed=29148152).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): PubMed=29148152
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12
ST   D3S1358: 18
ST   D7S820: 9,12
ST   D8S1179: 9.2,12
ST   Penta D: 12
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 11
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR43 ! U-CH17M
OI   CVCL_B6R8 ! U-CH17PII
OI   CVCL_VR45 ! U-CH17S
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   U-CH17PII
AC   CVCL_B6R8
DR   Wikidata; Q112041873
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch17pii/
CC   Doubling time: 3-4 days (Chordoma Foundation).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous or homozygous (from autologous cell lines U-CH17M; U-CH17P; U-CH17S).
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): Chordoma Foundation
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 12
ST   D3S1358: 18
ST   D7S820: 9,12
ST   D8S1179: 9,12
ST   Penta D: 12
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 11
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR43 ! U-CH17M
OI   CVCL_VR44 ! U-CH17P
OI   CVCL_VR45 ! U-CH17S
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//
ID   U-CH17S
AC   CVCL_VR45
DR   ATCC; CRL-3401
DR   GEO; GSM2585627
DR   GEO; GSM2585628
DR   GEO; GSM2585629
DR   Wikidata; Q98133717
RX   PubMed=29148152;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch17s/
CC   Doubling time: 3-17 days (PubMed=29148152); 5-7 days (Chordoma Foundation); ~8-10 days (ATCC=CRL-3401).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous or homozygous (PubMed=29148152).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-3401; PubMed=29148152
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 9,13 (PubMed=29148152)
ST   D16S539: 13 (ATCC=CRL-3401)
ST   D18S51: 12,15
ST   D3S1358: 16,18
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 9.2,12
ST   Penta D: 12
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VR43 ! U-CH17M
OI   CVCL_VR44 ! U-CH17P
OI   CVCL_B6R8 ! U-CH17PII
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   U-CH18
AC   CVCL_A5IE
DR   Wikidata; Q107117160
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch18/
CC   Doubling time: ~7-8 days (Chordoma Foundation).
CC   Derived from site: In situ; Bone, chest; UBERON=UBERON_0003459.
ST   Source(s): Chordoma Foundation
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 10,12
ST   D18S51: 17
ST   D3S1358: 16
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   Penta D: 9,13
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 8,11
DI   NCIt; C177775; Thoracic chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   U-CH19
AC   CVCL_A5IF
DR   ATCC; CRL-3516
DR   Wikidata; Q107117164
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch19/
CC   Population: Caucasian.
CC   Doubling time: ~7 days (Chordoma Foundation).
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3516; Chordoma Foundation
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D3S1358: 14
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   Penta D: 13
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   U-CH2
AC   CVCL_4989
SY   UCH-2; UCH2
DR   ATCC; CRL-3218
DR   Cell_Model_Passport; SIDM01185
DR   Cosmic; 2663858
DR   Cosmic-CLP; 1503373
DR   DepMap; ACH-002204
DR   DSMZ; ACC-749
DR   DSMZCellDive; ACC-749
DR   GEO; GSM1670565
DR   GEO; GSM1673847
DR   GEO; GSM1673848
DR   PharmacoDB; UCH2_1627_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54973617
RX   PubMed=21253487;
RX   PubMed=26183925;
RX   PubMed=27102572;
RX   PubMed=27397505;
RX   PubMed=28515451;
RX   PubMed=28835717;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch2/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/UCH1_Crawford_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: ~1 week (Note=At 11th passage) (PubMed=21253487); 4 days (PubMed=26183925); ~5-7 days (DSMZ=ACC-749); 3 days (Chordoma Foundation).
CC   HLA typing: A*11:01; B*07; C*07:02; DQA1*02:01; DQB1*03; DRB4*01:03N (Chordoma Foundation).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Genome ancestry: African=0%; Native American=0.92%; East Asian, North=0%; East Asian, South=0.34%; South Asian=1.36%; European, North=67.93%; European, South=29.44% (PubMed=30894373).
ST   Source(s): ATCC=CRL-3218; Cosmic-CLP=1503373; DSMZ=ACC-749; PubMed=21253487; PubMed=26183925; PubMed=27102572; PubMed=28835717
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D10S1248: 13,16
ST   D12S391: 18,19
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,17.3 (DSMZ=ACC-749)
ST   D18S51: 12,18 (PubMed=26183925; PubMed=27102572; PubMed=28835717)
ST   D19S433: 15.2,17 (PubMed=26183925; PubMed=27102572)
ST   D19S433: 16,17 (DSMZ=ACC-749)
ST   D1S1656: 14.3,15
ST   D21S11: 29,30
ST   D22S1045: 15
ST   D2S1338: 24
ST   D2S441: 10,11.3
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 21,22.2
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 6 (Cosmic-CLP=1503373)
ST   TH01: 6,9.3 (PubMed=21253487)
ST   TH01: 9.3 (ATCC=CRL-3218; DSMZ=ACC-749; PubMed=26183925; PubMed=27102572)
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 31
//
ID   U-CH3
AC   CVCL_IR25
SY   UCH3
DR   cancercelllines; CVCL_IR25
DR   GEO; GSM1673849
DR   GEO; GSM1673850
DR   Wikidata; Q54973618
RX   PubMed=26183925;
RX   PubMed=28515451;
CC   Senescence: Seems not to grow above ~17 PDL and is therefore not going to be distributed (personal communication of Cogswell, Patty).
CC   Doubling time: 8 days (PubMed=26183925).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): PubMed=26183925
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D10S1248: 15
ST   D12S391: 17,18
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 17
ST   D19S433: 13,14
ST   D1S1656: 15,17
ST   D21S11: 30
ST   D22S1045: 11
ST   D2S1338: 18,22
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 16
ST   FGA: 26
ST   Penta D: 10
ST   Penta E: 7,14
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 14
//
ID   U-CH6
AC   CVCL_IR26
SY   UCH6
DR   cancercelllines; CVCL_IR26
DR   GEO; GSM1673851
DR   GEO; GSM1673852
DR   Wikidata; Q54973619
RX   PubMed=26183925;
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch6/
CC   Doubling time: 14 days (PubMed=26183925).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Unspecified (PubMed=28515451).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): PubMed=26183925
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D10S1248: 17
ST   D12S391: 18
ST   D13S317: 8
ST   D16S539: 12
ST   D18S51: 15
ST   D19S433: 13,16.2
ST   D1S1656: 17
ST   D21S11: 29
ST   D22S1045: 15
ST   D2S1338: 18,20
ST   D2S441: 11
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 19,21
ST   Penta D: 12
ST   Penta E: 13,20
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 14
//
ID   U-CH7
AC   CVCL_IR23
SY   UCH7
DR   ATCC; CRL-3404
DR   Cosmic; 2663859
DR   GEO; GSM1673853
DR   GEO; GSM1673854
DR   Wikidata; Q54973620
RX   PubMed=26183925;
RX   PubMed=27102572;
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-ch7/
CC   Doubling time: 7 days (PubMed=26183925); 8 days (Chordoma Foundation).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, sacrum; UBERON=UBERON_0003690.
ST   Source(s): ATCC=CRL-3404; PubMed=26183925; PubMed=27102572
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D10S1248: 13
ST   D12S391: 15,19
ST   D13S317: 10 (ATCC=CRL-3404; PubMed=27102572)
ST   D13S317: 10,12 (PubMed=26183925)
ST   D16S539: 10,12
ST   D18S51: 16
ST   D19S433: 13,14
ST   D1S1656: 17.3
ST   D21S11: 30,33.2
ST   D22S1045: 15
ST   D2S1338: 23
ST   D2S441: 10,14
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 12,15
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C129927; Sacral chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   U-CHCF359B
AC   CVCL_A5IH
DR   ATCC; CRL-3517
DR   Wikidata; Q107117166
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-chcf359b/
CC   Characteristics: Established from the CF359B patient-derived xenograft.
CC   Doubling time: 5-6 days (Chordoma Foundation).
CC   Derived from site: Metastatic; Brain, pineal gland; UBERON=UBERON_0001905.
ST   Source(s): ATCC=CRL-3517; Chordoma Foundation
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 16
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   Penta D: 9,10
ST   Penta E: 12
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <20Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   U-CHCF365
AC   CVCL_A5II
DR   ATCC; CRL-3518
DR   Wikidata; Q107117169
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/u-chcf365/
CC   Characteristics: Established from the CF365 patient-derived xenograft.
CC   Doubling time: ~4 days (Chordoma Foundation); ~4-5 days (ATCC=CRL-3518).
CC   Derived from site: Metastatic; Scalp; UBERON=UBERON_0000403.
ST   Source(s): ATCC=CRL-3518; Chordoma Foundation
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 12,14
ST   D18S51: 15,22
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   Penta D: 12
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   U-DCS
AC   CVCL_A2XZ
DR   Wikidata; Q105511292
RX   PubMed=33277516;
CC   Population: Caucasian.
CC   Doubling time: ~2 days (PubMed=33277516).
CC   HLA typing: A*11:01,24:02; B*15:01,35:01; C*03:03,04:01; DQB1*05:01,06:04; DRB1*01:01,13:02 (PubMed=33277516).
CC   Karyotypic information: More than tetraploid karyotype with approximately 130 chromosomes and multiple aberrations (PubMed=33277516).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=33277516
ST   Amelogenin: X,Y
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 12,13
ST   D21S11: 28,29
ST   D2S1338: 17,21
ST   D3S1358: 15
ST   D8S1179: 13,15
ST   FGA: 22
ST   SE33: 19,26.2
ST   TH01: 6,9
ST   vWA: 14,15
DI   NCIt; C9282; Interdigitating dendritic cell sarcoma
DI   ORDO; Orphanet_86900; Interdigitating dendritic cell sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A2YA ! LCL-U-DCS
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   U-HO1
AC   CVCL_2220
SY   U-H01; UHO1
DR   BioSample; SAMN03473507
DR   cancercelllines; CVCL_2220
DR   Cell_Model_Passport; SIDM01831
DR   Cosmic; 1289702
DR   Cosmic; 1432042
DR   DepMap; ACH-001685
DR   DSMZ; ACC-626
DR   DSMZCellDive; ACC-626
DR   GEO; GSM381299
DR   IGRhCellID; U-HO1
DR   Progenetix; CVCL_2220
DR   Wikidata; Q54973621
RX   CelloPub=CLPUB00457;
RX   PubMed=18253030;
RX   PubMed=18820924;
RX   PubMed=19380639;
RX   PubMed=21144060;
RX   PubMed=29533902;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~4 days (PubMed=18253030); ~100 hours (DSMZ=ACC-626).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11896; TNFAIP3; Zygosity=Heterozygous (PubMed=19380639).
CC   Sequence variation: Mutation; HGNC; HGNC:9642; PTPN1; Unexplicit; Ex2-8del; Zygosity=Unspecified (CelloPub=CLPUB00457).
CC   Sequence variation: Mutation; HGNC; HGNC:11896; TNFAIP3; Simple; p.Met43fs (c.127-134del) (del 193-200); Zygosity=Heterozygous (PubMed=19380639).
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Andreas Mader, the first author of the paper (PubMed=18253030) describing this cell line is the patient that donated the cell line. As it is not frequent to see a patient 'acknowledged' by being an author this fact should be emphasized.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DepMap=ACH-001685; DSMZ=ACC-626
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30,32.2
ST   D2S1338: 23,24
ST   D3S1358: 13,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13,16
ST   FGA: 21,24
ST   Penta D: 9,13
ST   Penta E: 5,18
ST   TH01: 7,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   U-HO1-PTPN1
AC   CVCL_UI40
DR   Cell_Model_Passport; SIDM01913
DR   Wikidata; Q98133718
RX   CelloPub=CLPUB00457;
RX   PubMed=21144060;
CC   Doubling time: ~14 days (PubMed=21144060).
CC   Sequence variation: Mutation; HGNC; HGNC:9642; PTPN1; Unexplicit; Ex2-8del; Zygosity=Unspecified (CelloPub=CLPUB00457).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9642; PTPN1.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2220 ! U-HO1
SX   Male
AG   23Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 10
//
ID   U-M
AC   CVCL_VG84
SY   UM
DR   cancercelllines; CVCL_VG84
DR   Wikidata; Q54973622
RX   DOI=10.1007/978-94-011-3550-4_20;
RX   PubMed=2243057;
CC   Population: Caucasian.
CC   Characteristics: Obtained by treatment of parent cell line with TPA in eRDF medium (DOI=10.1007/978-94-011-3550-4_20).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   U1/HIV-1
AC   CVCL_M769
SY   U1
DR   BEI_Resources; ARP-165
DR   cancercelllines; CVCL_M769
DR   ChEMBL-Cells; CHEMBL3307351
DR   ChEMBL-Targets; CHEMBL614246
DR   Lonza; 1169
DR   PubChem_Cell_line; CVCL_M769
DR   Wikidata; Q54973623
RX   PubMed=2449497;
RX   PubMed=3313729;
RX   PubMed=28086908;
CC   Population: Caucasian.
CC   Virology: Latently infected with HIV-1 isolate NY5. The two main sites of integrations are in chromosome 2 and chromosome X (PubMed=28086908).
CC   Doubling time: 36 hours (BEI_Resources=ARP-165).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 24
//
ID   U14
AC   CVCL_9U56
DR   CCRID; 1101MOU-PUMC000238
DR   CCRID; 1101MOU-PUMC000311
DR   Wikidata; Q54973624
RX   DOI=10.1007/s11805-008-0044-0;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Kunming.
DI   NCIt; C24068; Mouse cervical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_9U22 ! L10-90
OI   CVCL_9U43 ! P11-90
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 11
//
ID   U14-GFP
AC   CVCL_9U57
DR   CCRID; 1101MOU-PUMC000239
DR   CCRID; 4201MOU-CCTCC00316
DR   CCTCC; GDC0316
DR   Wikidata; Q54973625
RX   DOI=10.1007/s11805-008-0044-0;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: Kunming.
DI   NCIt; C24068; Mouse cervical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9U56 ! U14
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   U1I
AC   CVCL_IW88
DR   Wikidata; Q54973626
RX   PubMed=6773878;
CC   Doubling time: 27.2 hours (PubMed=6773878).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Melanocyte of choroid; CL=CL_4030000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Spontaneously immortalized cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   U2-OS Tet-On
AC   CVCL_V335
DR   Wikidata; Q54973628
WW   Provider; Takara Bio; 630919; https://www.takarabio.com/documents/Components%20List/631143-102318.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   U2-OS-Luc Tet-On
AC   CVCL_V336
SY   U-2 OS-Luc teT-on; U2OSLUC Tet ON
DR   CCRID; 1101HUM-PUMC000270
DR   Wikidata; Q54973629
WW   Provider; Takara Bio; 631123; https://www.takarabio.com/documents/Certificate%20of%20Analysis/631123/631123-100814.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16.
CC   Characteristics: The firefly luciferase reporter gene is under the control of a tetracycline-responsive promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): CCRID=1101HUM-PUMC000270
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 21
//
ID   U251-hrGFP
AC   CVCL_E9DU
SY   U251-GFP
RX   PubMed=32591581;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a CAG-hrGFP-PuroR construct was introduced in the AAVS1 safe harbor locus (PubMed=32591581).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 84CGO; rrGFP (Note=hrGFP; luorescent protein published in 2007, green fluorescent protein derived from R.reniformis).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U251-NF-kappaB-GFP-Luc-A1
AC   CVCL_C1CP
DR   cancercelllines; CVCL_C1CP
DR   Wikidata; Q114313145
RX   PubMed=28790798;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a construct containing a fused GFP-Luc protein expressed under the control of a promoter containing multiple copies of the NF-kappaB response element.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 9
//
ID   U251-TR3
AC   CVCL_1G29
SY   A172TR3; TR3
DR   BioSample; SAMN06481106
DR   cancercelllines; CVCL_1G29
DR   Cosmic; 1236361
DR   Wikidata; Q54973630
RX   DOI=10.1158/1078-0432.CCR-13-1821;
RX   PubMed=19584161;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought (PubMed=19584161) to be a A-172 (Cellosaurus=CVCL_0131) derivative but shown to be a U-251MG derivative (DOI=10.1158/1078-0432.CCR-13-1821).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00523.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_72564; Temozolomide (TMZ).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 24
//
ID   U251MG-Luc
AC   CVCL_C8XQ
DR   Ubigene; YC-D015-Luc-P
DR   Wikidata; Q123033670
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   U255
AC   CVCL_JA36
SY   255 Bm
DR   Wikidata; Q54973631
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=4097745;
RX   PubMed=4104421;
CC   Population: Caucasian.
CC   Doubling time: 30-48 hours (PubMed=4097745); 36-48 hours (PubMed=4104421).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0566 ! U266B1
OI   CVCL_W412 ! U268
SX   Male
AG   53Y
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 6
//
ID   U266-PSR
AC   CVCL_E5J9
SY   U266PSR
RX   DOI=10.1182/blood.V124.21.2084.2084;
CC   Population: Caucasian.
CC   Characteristics: Resistant to 15 nM of bortezomib (DOI=10.1182/blood.V124.21.2084.2084).
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U266/ADM
AC   CVCL_GZ72
DR   cancercelllines; CVCL_GZ72
DR   Wikidata; Q54973632
RX   PubMed=26045737;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 16
//
ID   U266/BR
AC   CVCL_VJ36
DR   cancercelllines; CVCL_VJ36
DR   Wikidata; Q98133719
RX   PubMed=25382610;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   U266/velR
AC   CVCL_T031
DR   cancercelllines; CVCL_T031
DR   Wikidata; Q54973633
RX   PubMed=24286313;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 19
//
ID   U266B1
AC   CVCL_0566
SY   U266-B1; U266 B1; U-266; U 266; U266; U266S; U266BL; U266 Bl; 266 Bl
DR   BTO; BTO_0001594
DR   CLO; CLO_0009457
DR   CLO; CLO_0009458
DR   EFO; EFO_0001254
DR   MCCL; MCC:0000471
DR   CLDB; cl4584
DR   CLDB; cl4609
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   ArrayExpress; E-TABM-937
DR   ATCC; TIB-196
DR   BCRC; 60437
DR   BCRJ; 0240
DR   BioSample; SAMN01821605
DR   BioSample; SAMN01821669
DR   BioSample; SAMN03472935
DR   BioSample; SAMN10987866
DR   cancercelllines; CVCL_0566
DR   CCRID; 1101HUM-PUMC000684
DR   CCRID; 4201HUM-CCTCC00325
DR   CCTCC; GDC0301
DR   CCTCC; GDC0325
DR   Cell_Model_Passport; SIDM00417
DR   CGH-DB; 37-1
DR   CGH-DB; 9155-4
DR   ChEMBL-Cells; CHEMBL3308535
DR   ChEMBL-Targets; CHEMBL2366315
DR   CLS; 300259
DR   Cosmic; 720795
DR   Cosmic; 742953
DR   Cosmic; 753615
DR   Cosmic; 759903
DR   Cosmic; 759912
DR   Cosmic; 760401
DR   Cosmic; 760647
DR   Cosmic; 886087
DR   Cosmic; 888019
DR   Cosmic; 991555
DR   Cosmic; 1424220
DR   Cosmic; 1483078
DR   Cosmic; 1762463
DR   Cosmic; 1889513
DR   Cosmic; 2081409
DR   Cosmic; 2159571
DR   Cosmic; 2367281
DR   Cosmic; 2391806
DR   Cosmic; 2809754
DR   Cosmic-CLP; 753615
DR   DepMap; ACH-000626
DR   DSMZ; ACC-9
DR   DSMZCellDive; ACC-9
DR   ECACC; 85051003
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 753615
DR   GEO; GSM143345
DR   GEO; GSM545498
DR   GEO; GSM545499
DR   GEO; GSM562821
DR   GEO; GSM827442
DR   GEO; GSM887721
DR   GEO; GSM888815
DR   GEO; GSM1374970
DR   GEO; GSM1670556
DR   IARC_TP53; 361
DR   IARC_TP53; 30185
DR   IBRC; C10148
DR   IGRhCellID; U266B1
DR   IZSLER; BS TCL 233
DR   KCB; KCB 2013024YJ
DR   LiGeA; CCLE_465
DR   LINCS_LDP; LCL-2050
DR   Lonza; 106
DR   Lonza; 807
DR   NCBI_Iran; C151
DR   PharmacoDB; U266B1_1630_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0566
DR   PubChem_Cell_line; CVCL_0566
DR   Wikidata; Q54973634
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1643757;
RX   PubMed=1720489;
RX   PubMed=2140233;
RX   PubMed=2537114;
RX   PubMed=2985879;
RX   PubMed=3159941;
RX   PubMed=3874327;
RX   PubMed=4097745;
RX   PubMed=4104421;
RX   PubMed=6350451;
RX   PubMed=8943038;
RX   PubMed=9685479;
RX   PubMed=10087940;
RX   PubMed=10557056;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=11154231;
RX   PubMed=11157491;
RX   PubMed=11429052;
RX   PubMed=14555701;
RX   PubMed=15215163;
RX   PubMed=16956823;
RX   PubMed=17171682;
RX   PubMed=17229644;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21173094;
RX   PubMed=22460905;
RX   PubMed=22806891;
RX   PubMed=23074853;
RX   PubMed=23992230;
RX   PubMed=25485619;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30545397;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=32123307;
RX   PubMed=35839778;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Group: Hybridoma fusion partner cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda.
CC   Doubling time: 108-144 hours (PubMed=4104421); ~55 hours (DSMZ=ACC-9).
CC   HLA typing: A*02:01,03; B*07,40; C*03:04,07 (Direct_author_submission).
CC   HLA typing: A*02:01,03:01; B*07:02,40:01; C*03:04,07:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01;03:01:01; B*07:02:01,40:01:02; C*03:04:01,07:02:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,02:01:02; DQA1*01:02:01,05:01:01; DQB1*02:01:01,06:02:01; DRA*01:02:02,01:02:03; DRB1*03:01:01,15:01:01 (DSMZCellDive=ACC-9).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (Cosmic-CLP=753615; DepMap=ACH-000626).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (Cosmic-CLP=753615; DepMap=ACH-000626).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (PubMed=1373872; PubMed=21173094; Cosmic-CLP=753615; DepMap=ACH-000626).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (PubMed=17692805).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=2.78%; East Asian, South=0.29%; South Asian=0.45%; European, North=80.76%; European, South=15.72% (PubMed=30894373).
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Discontinued: BCRJ; 0240; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
ST   Source(s): ATCC=TIB-196; CCRID; CLS=300259; Cosmic-CLP=753615; DSMZ=ACC-9; ECACC=85051003; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D10S1248: 14
ST   D12S391: 18
ST   D13S317: 12
ST   D16S539: 10
ST   D18S51: 12,14
ST   D19S433: 13,15
ST   D1S1656: 12,15
ST   D21S11: 28,29
ST   D22S1045: 15,16
ST   D2S1338: 20,23
ST   D2S441: 10,11
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D6S1043: 11,17
ST   D7S820: 11,12
ST   D8S1179: 13
ST   DYS391: 10
ST   FGA: 18
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 5,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JA36 ! U255
OI   CVCL_W412 ! U268
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   U266B1-Fluc-EmGFP
AC   CVCL_D5KP
DR   Imanis; CL176
DR   Wikidata; Q127384431
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-SFFV-Luc2-P2A-EmGFP vector encoding for luciferase linked via a P2A cleavage site to emerald GFP (EmGFP) and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL176).
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   U266B1-Fluc-Puro
AC   CVCL_D5KQ
DR   Imanis; CL173
DR   Wikidata; Q127384432
CC   Population: Caucasian.
CC   Characteristics: Reporter cell line, transduced with the LV-Fluc-P2A-Puro vector encoding for luciferase linked via a P2A cleavage peptide to the PuroR gene and under control of the spleen focus-forming virus (SFFV) promoter (Imanis=CL173).
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   U266R
AC   CVCL_C828
DR   cancercelllines; CVCL_C828
DR   Wikidata; Q54973647
RX   PubMed=8307198;
CC   Population: Caucasian.
CC   Characteristics: Produces IgE lambda (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Asn (c.1803A>T); ClinVar=VCV000376285; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Gly141Asp (c.422G>A); ClinVar=VCV001491786; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12033; TRAF3; Simple; p.Lys550Leufs*3 (c.1648_1649insT); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 20
//
ID   U268
AC   CVCL_W412
SY   U-268; 268 Bm
DR   Wikidata; Q54973649
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=4097745;
RX   PubMed=4104421;
RX   PubMed=10936422;
CC   Population: Caucasian.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JA36 ! U255
OI   CVCL_0566 ! U266B1
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   U28
AC   CVCL_J093
DR   ECACC; 93022518
DR   Wikidata; Q54973651
RX   PubMed=2177147;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   U2OS
AC   CVCL_0042
AS   CVCL_L856
SY   U-2 OS; U-2OS; U-2-OS; U2-OS; U20-S; U20S; 2T
DR   BTO; BTO_0001938
DR   CLO; CLO_0001272
DR   CLO; CLO_0009454
DR   EFO; EFO_0002869
DR   MCCL; MCC:0000468
DR   CLDB; cl53
DR   CLDB; cl4579
DR   CLDB; cl4580
DR   CLDB; cl4581
DR   CLDB; cl7217
DR   4DN; 4DNSR3V9ST6H
DR   Abcam; ab263976
DR   Abcam; ab279979
DR   ABM; T8293
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; HTB-96
DR   BCRC; 60187
DR   BCRJ; 0304
DR   BioGRID_ORCS_Cell_line; 265
DR   BioSample; SAMN03472549
DR   BioSample; SAMN03472766
DR   BioSample; SAMN10987914
DR   cancercelllines; CVCL_0042
DR   CCRID; 1101HUM-PUMC000028
DR   CCRID; 3101HUMSCSP5030
DR   CCRID; 3101HUMTCHu88
DR   CCRID; 4201HUM-CCTCC00626
DR   CCRID; 5301HUM-KCB09062YJ
DR   Cell_Model_Passport; SIDM01191
DR   ChEMBL-Cells; CHEMBL3307757
DR   ChEMBL-Targets; CHEMBL615023
DR   CLS; 300364
DR   Cosmic; 687934
DR   Cosmic; 755312
DR   Cosmic; 909776
DR   Cosmic; 931038
DR   Cosmic; 931909
DR   Cosmic; 1044081
DR   Cosmic; 1044268
DR   Cosmic; 1066238
DR   Cosmic; 1074397
DR   Cosmic; 1078392
DR   Cosmic; 1082493
DR   Cosmic; 1097758
DR   Cosmic; 1529905
DR   Cosmic; 1733128
DR   Cosmic; 2009542
DR   Cosmic; 2301583
DR   Cosmic; 2440477
DR   Cosmic; 2816207
DR   Cosmic-CLP; 909776
DR   DepMap; ACH-000364
DR   DSMZ; ACC-785
DR   DSMZCellDive; ACC-785
DR   ECACC; 92022711
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS200HLU
DR   ENCODE; ENCBS266AAA
DR   ENCODE; ENCBS953RZO
DR   GDSC; 909776
DR   GEO; GSE54820
DR   GEO; GSM170250
DR   GEO; GSM185160
DR   GEO; GSM185161
DR   GEO; GSM287989
DR   GEO; GSM287990
DR   GEO; GSM320831
DR   GEO; GSM827583
DR   GEO; GSM879223
DR   GEO; GSM887722
DR   GEO; GSM888816
DR   GEO; GSM1231597
DR   GEO; GSM1231598
DR   GEO; GSM1231599
DR   GEO; GSM1231600
DR   GEO; GSM1231601
DR   GEO; GSM1231602
DR   GEO; GSM1231603
DR   GEO; GSM1231604
DR   GEO; GSM1231605
DR   GEO; GSM1231606
DR   GEO; GSM1231607
DR   GEO; GSM1231608
DR   GEO; GSM1231609
DR   GEO; GSM1231610
DR   GEO; GSM1356565
DR   GEO; GSM1356566
DR   GEO; GSM1356567
DR   GEO; GSM1356568
DR   GEO; GSM1356569
DR   GEO; GSM1356570
DR   GEO; GSM1356571
DR   GEO; GSM1356572
DR   GEO; GSM1356573
DR   GEO; GSM1356574
DR   GEO; GSM1356575
DR   GEO; GSM1356576
DR   GEO; GSM1356577
DR   GEO; GSM1356578
DR   GEO; GSM1356579
DR   GEO; GSM1356580
DR   GEO; GSM1356581
DR   GEO; GSM1356582
DR   GEO; GSM1356583
DR   GEO; GSM1356584
DR   GEO; GSM1356585
DR   GEO; GSM1356586
DR   GEO; GSM1356587
DR   GEO; GSM1670557
DR   GEO; GSM1676324
DR   GEO; GSM1701657
DR   GEO; GSM7701414
DR   GEO; GSM7701415
DR   GEO; GSM7701442
DR   GEO; GSM7701443
DR   IARC_TP53; 27710
DR   ICLC; HTL11001
DR   KCB; KCB 200962YJ
DR   KCLB; 30096
DR   LiGeA; CCLE_160
DR   LINCS_LDP; LCL-1431
DR   Lonza; 676
DR   MetaboLights; MTBLS247
DR   MetaboLights; MTBLS292
DR   PharmacoDB; U2OS_1619_2019
DR   PRIDE; PRD000118
DR   PRIDE; PXD000157
DR   PRIDE; PXD000262
DR   PRIDE; PXD000589
DR   PRIDE; PXD000953
DR   PRIDE; PXD000954
DR   PRIDE; PXD001220
DR   PRIDE; PXD002073
DR   PRIDE; PXD002117
DR   PRIDE; PXD002395
DR   PRIDE; PXD003754
DR   PRIDE; PXD009668
DR   PRIDE; PXD017130
DR   PRIDE; PXD020622
DR   PRIDE; PXD024796
DR   PRIDE; PXD025890
DR   PRIDE; PXD028992
DR   PRIDE; PXD030166
DR   PRIDE; PXD030304
DR   PRIDE; PXD030644
DR   Progenetix; CVCL_0042
DR   PubChem_Cell_line; CVCL_0042
DR   TOKU-E; 3379
DR   Ubigene; YC-C030
DR   Wikidata; Q28473037
RX   PubMed=77569;
RX   PubMed=833871;
RX   PubMed=2233717;
RX   PubMed=2823272;
RX   PubMed=3518877;
RX   PubMed=6081590;
RX   PubMed=7017212;
RX   PubMed=8040301;
RX   PubMed=8275086;
RX   PubMed=8617485;
RX   PubMed=12645653;
RX   PubMed=15150091;
RX   PubMed=15736406;
RX   PubMed=16957166;
RX   PubMed=17354236;
RX   PubMed=17981215;
RX   PubMed=18359981;
RX   PubMed=19787792;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21519327;
RX   PubMed=22068332;
RX   PubMed=22278370;
RX   PubMed=22460905;
RX   PubMed=23144859;
RX   PubMed=23649806;
RX   PubMed=24136885;
RX   PubMed=24618588;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25894527;
RX   PubMed=25960936;
RX   PubMed=26351324;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28468878;
RX   PubMed=29853780;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/u2/u2cells.html
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=U2-OS
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/u-2-os/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/U2OS_Farnham_protocol.pdf
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/cellsincultureindex
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-92.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Virology: Reliable and efficient in vitro integration system for human herpesvirus 6A (HHV-6A) and 6B (HHV-6B) (PubMed=28468878).
CC   Doubling time: ~36 hours (PubMed=21519327); ~25-30 hours (DSMZ=ACC-785).
CC   HLA typing: A*01,02; B*12,w40; C*w02 (PubMed=77569).
CC   HLA typing: A*02:01,32:01; B*44:02,44:02; C*05:01,07:04; DQB1*03:04,05:03; DRB1*04:05,04:05 (PubMed=25960936).
CC   HLA typing: A*02:01,32:01; B*44:02,44:02; C*05:01,07:04; DQB1*03:02,05:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (PubMed=23649806; DepMap=ACH-000364).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Omics: Proteomics; Virome.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.75%; Native American=0%; East Asian, North=5.19%; East Asian, South=0%; South Asian=0%; European, North=60.98%; European, South=31.08% (PubMed=30894373).
CC   Misspelling: U-205; Note=Occasionally.
CC   Misspelling: U205; Note=Occasionally.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): ATCC=HTB-96; CLS=300364; CCRID; Cosmic-CLP=909776; DSMZ=ACC-785; ECACC=92022711; KCLB=30096; PubMed=19787792; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 12,13 (CLS=300364; DSMZ=ACC-785; Technion Genomics Center)
ST   CSF1PO: 13 (ATCC=HTB-96; CCRID; Cosmic-CLP=909776; ECACC=92022711; KCLB=30096; PubMed=25877200)
ST   D10S1248: 13,14
ST   D12S391: 19,20
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14 (CLS=300364; DSMZ=ACC-785; Technion Genomics Center)
ST   D18S51: 14 (ATCC=HTB-96; CCRID; PubMed=19787792; PubMed=25877200)
ST   D19S433: 15
ST   D1S1656: 16,17.3
ST   D21S11: 31
ST   D22S1045: 15,16
ST   D2S1338: 20,24
ST   D2S441: 10,14
ST   D3S1358: 16
ST   D5S818: 8,11 (CLS=300364; DSMZ=ACC-785; Technion Genomics Center)
ST   D5S818: 11 (ATCC=HTB-96; CCRID; Cosmic-CLP=909776; ECACC=92022711; KCLB=30096; PubMed=19787792; PubMed=25877200)
ST   D6S1043: 11
ST   D7S820: 11,12 (ATCC=HTB-96; CCRID; CLS=300364; Cosmic-CLP=909776; DSMZ=ACC-785; ECACC=92022711; KCLB=30096; Technion Genomics Center)
ST   D7S820: 12 (PubMed=25877200)
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13 (ATCC=HTB-96; PubMed=25877200; Technion Genomics Center)
ST   Penta E: 13 (DSMZ=ACC-785)
ST   SE33: 19
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 51
//
ID   U2OS ADCYAP1R1 cAMP-Nomad
AC   CVCL_YK25
SY   PAC1R cAMPNomad; PAC1R Nomad; cAMP Nomad PAC1R; cAMPNomad-PACAPR
DR   Innoprot; P70513
DR   Wikidata; Q98133720
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS ADRA1A DAG-Nomad
AC   CVCL_YK26
SY   DAG-NOMAD ADRA1A; DAGNomad-ADRA1A
DR   Innoprot; P70608
DR   Wikidata; Q98133721
CC   Population: Caucasian.
CC   Characteristics: In absence of DAG, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:277; ADRA1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS ADRA1A HiTSeeker
AC   CVCL_YK27
SY   HiTSeeker ADRA1A; ADRA1A/U2OS
DR   Innoprot; P30140
DR   Wikidata; Q98133723
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:277; ADRA1A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS ADRA1B DAG-Nomad
AC   CVCL_YK28
SY   DAG-NOMAD ADRA1B; DAGNomad-ADRA1B
DR   Innoprot; P70609
DR   Wikidata; Q98133724
CC   Population: Caucasian.
CC   Characteristics: In absence of DAG, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:278; ADRA1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS ADRA1B HiTSeeker
AC   CVCL_YK29
SY   HiTSeeker ADRA1B; ADRA1B/U2OS
DR   Innoprot; P30141
DR   Wikidata; Q98133726
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:278; ADRA1B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS ADRB2 cAMP-Nomad
AC   CVCL_YK30
SY   ADRB2 cAMP-Nomad; ADRB2 Nomad; cAMPNomad-ADRB2
DR   Innoprot; P70205
DR   Wikidata; Q98133727
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:286; ADRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS ATXN3 KO
AC   CVCL_A0SQ
DR   Wikidata; Q108821410
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7106; ATXN3.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   U2OS AVPR2 cAMP-Nomad
AC   CVCL_YK31
SY   AVPR2 cAMP-Nomad; AVPR2 Nomad; cAMPNomad-AVPR2
DR   Innoprot; P70517
DR   Wikidata; Q98133728
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:897; AVPR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS BDKRB2 HiTSeeker
AC   CVCL_YK32
SY   HiTSeeker BDKRB2 (U2OS)
DR   Innoprot; P30110
DR   Wikidata; Q98133729
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1030; BDKRB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS BFP-LMNB1 GFP-TUBA1B RFP-ACTB
AC   CVCL_C3C9
SY   U2OS BFP-LMNB1/GFP-TUBA1B/RFP-ACTB; U2OS LMNB1-TUBA1B-ACTB
DR   Sigma-Aldrich; CLL1218
DR   Wikidata; Q114313146
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the LMNB1 locus to insert a TagBFP construct at the N-terminus of the gene, at the TUB1A1B locus to insert a TagGFP2 construct at the N-terminus of the gene and at the ACTB locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1218).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C3CB ! U2OS BFP-LMNB1 RFP-ACTB
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 8
//
ID   U2OS BFP-LMNB1 RFP-ACTB
AC   CVCL_C3CB
DR   Sigma-Aldrich; CLL1038
DR   Wikidata; Q114313147
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the LMNB1 locus to insert a TagBFP construct at the N-terminus of the gene and at the ACTB locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1038).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   U2OS C9orf72-/-
AC   CVCL_A4HP
DR   Wikidata; Q105511297
RX   PubMed=31612854;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   U2OS Cas9
AC   CVCL_DX83
DR   Horizon_Discovery; HD+Cas9-012
DR   Wikidata; Q127384433
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-Cas9-WPRE (Horizon_Discovery=HD+Cas9-012).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS CASR Gq
AC   CVCL_KU66
DR   DiscoverX; 95-1014C3
DR   Wikidata; Q54973652
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1514; CASR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   U2OS CCKAR calcium-Nomad
AC   CVCL_YK33
SY   Ca++ Nomad CCK1/U2OS; CCK1 Nomad
DR   Innoprot; P70101
DR   Wikidata; Q98133730
CC   Population: Caucasian.
CC   Characteristics: In absence of calcium, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1570; CCKAR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS CCKAR DAG-Nomad
AC   CVCL_YK34
SY   DAG-NOMAD CCKAR; DAGNomad-CCKAR; CCKAR DAGNomad
DR   Innoprot; P70601
DR   Wikidata; Q98133731
CC   Population: Caucasian.
CC   Characteristics: In absence of DAG, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1570; CCKAR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS CCKAR HiTSeeker
AC   CVCL_YK35
SY   HiTSeeker CCK1; CCK1 (CCKAR)/U2OS
DR   Innoprot; P30178
DR   Wikidata; Q98133732
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1570; CCKAR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS CCKBR HiTSeeker
AC   CVCL_YK36
SY   HiTSeeker CCK2; CCK2 (CCKBR)/U2OS
DR   Innoprot; P30179
DR   Wikidata; Q98133733
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1571; CCKBR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS CHMP2B KO
AC   CVCL_B6JX
DR   Wikidata; Q112041874
RX   PubMed=37635943;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24537; CHMP2B.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   U2OS CHRM1 HiTSeeker
AC   CVCL_YK37
SY   HiTSeeker CHRM1 (U2OS); CHRM1/U2OS; M1 (CHRM1)/U2OS
DR   Innoprot; P30142
DR   Wikidata; Q98133735
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS CHRM3 HiTSeeker
AC   CVCL_YK68
SY   HiTSeeker CHRM3; CHRM3/U2OS; M3/U2OS
DR   Innoprot; P30144
DR   Wikidata; Q98133736
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1952; CHRM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS CHRM4 PKA-Nomad
AC   CVCL_YK38
SY   PKA-Nomad-CHRM4; PKANomad-CHRM4; M4 Nomad; CHRM4 PKANomad
DR   Innoprot; P70545
DR   Wikidata; Q98133738
CC   Population: Caucasian.
CC   Characteristics: Before PKA activation, the fluorescent biosensor is localized in the cellular membrane. After receptor activation, PKA is activated and this activated PKA leads to change in the structural folding of Nomad Biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1953; CHRM4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS CHRM5 calcium-Nomad
AC   CVCL_YK39
SY   Ca++ Nomad M5 (CHRM5)/U2OS; M5 Nomad
DR   Innoprot; P70103
DR   Wikidata; Q98133739
CC   Population: Caucasian.
CC   Characteristics: In absence of calcium, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS CHRM5 DAG-Nomad
AC   CVCL_YK40
SY   DAG-NOMAD Muscarinic 5; DAGNomad M5; DAGNOMAD M5
DR   Innoprot; P70603
DR   Wikidata; Q98133740
CC   Population: Caucasian.
CC   Characteristics: In absence of DAG, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS CHRM5 HiTSeeker
AC   CVCL_YK41
SY   HiTSeeker CHRM5; CHRM5/U2OS; M5 (CHRM5)/U2OS
DR   Innoprot; P30146
DR   Wikidata; Q98133742
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   U2OS CRHR2 cAMP-Nomad
AC   CVCL_YK42
SY   CRHR2 cAMP-Nomad; CRHR2 (CRF2) Nomad; cAMP Nomad CRF2; CRF2 Nomad
DR   Innoprot; P70207
DR   Wikidata; Q98133743
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2358; CRHR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS dCas9-VPR
AC   CVCL_DX84
DR   Horizon_Discovery; HD+dCas9-VPR-012
DR   Wikidata; Q127384434
CC   Population: Caucasian.
CC   Characteristics: Transduced with a lentiviral vector EF1a-Bsd-T2A-dCas9-VPR-WPRE, where VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA (Horizon_Discovery=HD+dCas9-VPR-012).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS DNM1 KO
AC   CVCL_A4NZ
DR   Wikidata; Q105511299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2972; DNM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS DR-GFP
AC   CVCL_B0A7
SY   U-2 OS DRGFP
DR   ATCC; CRL-3455
DR   Wikidata; Q108821411
CC   Population: Caucasian.
CC   Characteristics: Transfected with a DR-GFP reporter construct. The DR-GFP construct which contains a tandem repeat of two inactive genes coding for EGFP. After transfection with an expression vector coding for the I-SceI enzyme, recombination induced by the cleavage of the I-SceI site recreates a functional EGFP.
CC   Characteristics: Can be used to monitor homologous recombination efficiency using the DR-GFP reporter (ATCC=CRL-3455).
CC   Doubling time: ~18 hours (ATCC=CRL-3455).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): ATCC=CRL-3455
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS E2F7 KO
AC   CVCL_E5FF
DR   CancerTools; 156469
RX   PubMed=29590434;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23820; E2F7.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS EDNRA HiTSeeker
AC   CVCL_YK43
SY   HiTSeeker EDNRA; ETA (EDNRA)/U2OS
DR   Innoprot; P30151
DR   Wikidata; Q98133744
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3179; EDNRA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS EDNRB HiTSeeker
AC   CVCL_YK44
SY   HiTSeeker EDNRB; ETB (EDNRB)/U2OS
DR   Innoprot; P30152
DR   Wikidata; Q98133745
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3180; EDNRB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS EGFP-H2B
AC   CVCL_A7QQ
DR   Millipore; SCC293
DR   Wikidata; Q107117173
RX   PubMed=28415769;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): Millipore=SCC293
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D21S11: 31
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 10
//
ID   U2OS EZHIP KO
AC   CVCL_C8V6
SY   C67-KO U2OS
DR   Wikidata; Q123033671
RX   PubMed=33186520;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33738; EZHIP.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   U2OS FKHR-EGFP
AC   CVCL_KA03
SY   FKHR_U2OS
DR   Wikidata; Q54973653
WW   Provider; Thermo Fisher; R04-008-01; https://tools.thermofisher.com/content/sfs/manuals/D03266~.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with a fusion FOXO1-eGFP protein under the control of the CMV promoter (Thermo Fisher=R04-008-01).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3819; FOXO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Thermo Fisher/BioImage; Catalog number R04-008-01.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   U2OS FKHRL1-EGFP
AC   CVCL_KA04
SY   FKHRL1_U2OS
DR   Wikidata; Q54973654
WW   Provider; Thermo Fisher; R04-009-02; https://tools.thermofisher.com/content/sfs/manuals/D03267~.pdf
CC   Population: Caucasian.
CC   Characteristics: Transfected with a fusion FOXO3-eGFP protein under the control of the CMV promoter (Thermo Fisher=R04-009-02).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3821; FOXO3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Thermo Fisher/BioImage; Catalog number R04-009-02.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 12
//
ID   U2OS GFP-ACTB
AC   CVCL_RQ90
DR   Sigma-Aldrich; CLL1032
DR   Wikidata; Q54973655
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the N-terminus of the ACTB gene (Sigma-Aldrich=CLL1032).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   U2OS GFP-ACTB RFP-TUBA1B
AC   CVCL_C3CA
DR   Sigma-Aldrich; CLL1037
DR   Wikidata; Q114313148
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the ACTB locus to insert a TagGFP2 construct at the N-terminus of the gene and the TUBA1B locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1037).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   U2OS GFP-HMGA1
AC   CVCL_RQ91
DR   Sigma-Aldrich; CLL1036
DR   Wikidata; Q54973657
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the C-terminus of the HMGA1 gene (Sigma-Aldrich=CLL1036).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   U2OS GFP-LMNB1
AC   CVCL_RQ92
DR   Sigma-Aldrich; CLL1033
DR   Wikidata; Q54973658
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the N-terminus of the LMNB1 gene (Sigma-Aldrich=CLL1033).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   U2OS GFP-NUP98
AC   CVCL_RQ88
DR   Sigma-Aldrich; CLL1136
DR   Wikidata; Q54973659
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a 3XFLAG-TagGFP2 construct was integrated at the N-terminus of the NUP98 gene (Sigma-Aldrich=CLL1136).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   U2OS GFP-PEAK3
AC   CVCL_C0QT
DR   Wikidata; Q112930494
RX   PubMed=34944965;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pBABE-GFP-PEAK3 construct that contains a GFP-PEAK3 fusion (PubMed=34944965).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:24793; PEAK3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   U2OS GFP-TUBA1B
AC   CVCL_RQ93
DR   Sigma-Aldrich; CLL1031
DR   Wikidata; Q54973662
CC   Population: Caucasian.
CC   Characteristics: Using ZFN a TagGFP2 construct was integrated at the N-terminus of the TUBA1B gene (Sigma-Aldrich=CLL1031).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; GJETS; TagGFP2 (Note=Green fluorescent protein derived from Aequorea macrodactyla GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   U2OS GLP1R cAMP-Nomad
AC   CVCL_YK45
SY   GLP1R cAMP-Nomad; GLP1R Nomad; cAMPNomad-GLP1R
DR   Innoprot; P70503
DR   Wikidata; Q98133746
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4324; GLP1R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS GLP2R cAMP-Nomad
AC   CVCL_YK46
SY   GLP2R cAMP-Nomad; GLP2R Nomad; cAMPNomad-GLP2R
DR   Innoprot; P70514
DR   Wikidata; Q98133747
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4325; GLP2R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS GPR39 Gq
AC   CVCL_KU67
DR   DiscoverX; 95-1015C3
DR   Wikidata; Q54973663
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4496; GPR39.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   U2OS GRM1 Gq
AC   CVCL_KU68
DR   DiscoverX; 95-1021C3
DR   Wikidata; Q54973664
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4593; GRM1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   U2OS GRM5 Gq
AC   CVCL_KU69
DR   DiscoverX; 95-1020C3
DR   Wikidata; Q54973665
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4597; GRM5.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   U2OS GRPR calcium-Nomad
AC   CVCL_YK47
SY   Ca++ Nomad BB2 (GRPR)/U2OS; BB2 (GRPR) Nomad
DR   Innoprot; P70102
DR   Wikidata; Q98133749
CC   Population: Caucasian.
CC   Characteristics: In absence of calcium, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4609; GRPR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS GRPR HiTSeeker
AC   CVCL_YK48
SY   HiTSeeker GRPR; GRPR (BB2)/U2OS
DR   Innoprot; P30150
DR   Wikidata; Q98133750
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4609; GRPR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS His10-SUMO-2-K0-Q87R
AC   CVCL_RJ63
DR   PRIDE; PXD004927
DR   PRIDE; PXD005296
DR   Wikidata; Q54973666
RX   PubMed=25755297;
RX   PubMed=28112733;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a decahistidine (His10) tagged lysine-deficient (K0) and Q87R SUMO2 and GFP separated by an internal ribosome entry site (IRES).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11125; SUMO2 (Note=With p.Lys11Arg, p.Lys32Arg, p.Lys32Arg, p.Lys34Arg, p.Lys41Arg, p.Lys44Arg and p.Gln87Arg).
CC   Omics: Proteomics; PTM; Sumoylation.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   U2OS GSN KO
AC   CVCL_A4PA
DR   Wikidata; Q105511303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4620; GSN.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS HRH1 HiTSeeker
AC   CVCL_YK49
SY   HiTSeeker HRH1; HRH1/U2OS
DR   Innoprot; P30183
DR   Wikidata; Q98133751
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5182; HRH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS HTR2A HiTSeeker
AC   CVCL_YK50
SY   HiTSeeker HTR2A; HiTSeeker 5-HT2A; HTR2A (5-HT2A)/U2OS
DR   Innoprot; P30160
DR   Wikidata; Q98133752
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5293; HTR2A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS HTR2C HiTSeeker
AC   CVCL_YK51
SY   HiTSeeker HTR2C; HiTSeeker 5-HT2C; HTR2C (5-HT2C)/U2OS
DR   Innoprot; P30162
DR   Wikidata; Q98133753
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:5295; HTR2C.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS LHCGR cAMP-Nomad
AC   CVCL_YK52
SY   LHCGR Nomad; cAMPNomad-LHCGR
DR   Innoprot; P70502
DR   Wikidata; Q98133754
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6585; LHCGR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS LPAR3 HiTSeeker
AC   CVCL_YK53
SY   HiTSeeker LPA3; LPA3 (EDG7)/U2OS
DR   Innoprot; P30156
DR   Wikidata; Q98133755
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:14298; LPAR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS MC3R cAMP-Nomad
AC   CVCL_YK54
SY   cAMP Nomad MCR3; MCR3 Nomad
DR   Innoprot; P70204
DR   Wikidata; Q98133756
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6931; MC3R.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS mEGFP-LplA
AC   CVCL_E7RP
RX   PubMed=40069234;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a pCDH-mEGFP-LplA construct (PubMed=40069234).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P32099; Escherichia coli lipoate-protein ligase A (lplA).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS MPX-Nomad
AC   CVCL_YK69
SY   MPXNomad; MultiPleXed-Nomad U2OS
DR   Wikidata; Q98133757
RX   PubMed=29412765;
CC   Population: Caucasian.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS MPX-Nomad ETBR
AC   CVCL_YK70
SY   MPXNomad ETBR; MultiPleXed-Nomad ETBR U2OS
DR   Wikidata; Q98133758
RX   PubMed=29412765;
CC   Population: Caucasian.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3180; EDNRB.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YK69 ! U2OS MPX-Nomad
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS MPX-Nomad NK2R
AC   CVCL_YK71
SY   MPXNomad NK2R; MultiPleXed-Nomad NK2R U2OS
DR   Wikidata; Q98133759
RX   PubMed=29412765;
CC   Population: Caucasian.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11527; TACR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YK69 ! U2OS MPX-Nomad
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS NTN1 KO
AC   CVCL_E8G2
CC   From: Kahn, Richard A.; Emory University; Atlanta; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8029; NTN1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U2OS NTSR1 HiTSeeker
AC   CVCL_YK55
SY   HiTSeeker NTSR1; NTSR1 (NTR)/U2OS
DR   Innoprot; P30187
DR   Wikidata; Q98133760
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8039; NTSR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS OPTN KO
AC   CVCL_A6LN
DR   Wikidata; Q107117176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS OXGR1 Gq
AC   CVCL_KU70
DR   DiscoverX; 95-1017C3
DR   Wikidata; Q54973667
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4531; OXGR1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 10
//
ID   U2OS OXTR HiTSeeker
AC   CVCL_E3DT
SY   HiTSeeker OT Receptor
DR   Innoprot; P30425
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8529; OXTR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   U2OS PBRM1 KO 1
AC   CVCL_E5FH
SY   U2OS PBRM1 KO1; U2IS PBRM1 KO clone 1
DR   CancerTools; 161882
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:117; ACO1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS PBRM1 KO 2
AC   CVCL_E5FI
SY   U2OS PBRM1 KO2; U2IS PBRM1 KO clone 2
DR   CancerTools; 161883
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:117; ACO1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS PLEC KO
AC   CVCL_A4GM
DR   Wikidata; Q105511305
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9069; PLEC.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS PRDX1 KO
AC   CVCL_A4GN
DR   Wikidata; Q105511308
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9352; PRDX1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS PTGER1 HiTSeeker
AC   CVCL_YK56
SY   HiTSeeker PTGER1; PTGER1 (EP1)/U2OS
DR   Innoprot; P30402
DR   Wikidata; Q98133762
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9593; PTGER1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS PTGFR HiTSeeker
AC   CVCL_YK57
SY   HiTSeeker PTGFR; PTGFR/U2OS; FP (PTGFR)/U2OS
DR   Innoprot; P30408
DR   Wikidata; Q98133763
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9600; PTGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS RAD52 KO clone #1
AC   CVCL_B5DC
DR   Wikidata; Q110433298
RX   PubMed=30673617;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   U2OS RAD52 KO clone #2
AC   CVCL_B5DD
DR   Wikidata; Q110433300
RX   PubMed=30673617;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   U2OS RAD52 KO clone #3
AC   CVCL_B5DE
DR   Wikidata; Q110433302
RX   PubMed=30673617;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9824; RAD52.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   U2OS RFP-ACTB
AC   CVCL_RQ95
DR   Sigma-Aldrich; CLL1035
DR   Wikidata; Q54973669
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the ACTB locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1035).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   U2OS RFP-TUBA1B
AC   CVCL_RQ94
DR   Sigma-Aldrich; CLL1034
DR   Wikidata; Q54973670
CC   Population: Caucasian.
CC   Characteristics: Edited by ZFN at the TUBA1B locus to insert a TagRFP construct at the N-terminus of the gene (Sigma-Aldrich=CLL1034).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=ZFN; Gene=FPbase; S4HC8; TagRFP (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   U2OS SP1 CL1
AC   CVCL_D4XU
DR   Wikidata; Q127384435
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP1 CL2
AC   CVCL_D4XV
DR   Wikidata; Q127384436
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP1 CL3
AC   CVCL_D4XW
DR   Wikidata; Q127384437
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP2 CL1
AC   CVCL_D4XX
DR   Wikidata; Q127384438
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two constructs, one containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) and the other to the FKBP-rapamycin-binding (FRB) domain of mTOR linked to the N-terminal half of mouse BicD2 (BicD2N) and GFP (GFP-BicD2N-FRB) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1924145; Bicd2 (Note=With p.Arg401_Leu820del = Bicd2N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP2 CL2
AC   CVCL_D4XY
DR   Wikidata; Q127384439
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two constructs, one containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) and the other to the FKBP-rapamycin-binding (FRB) domain of mTOR linked to the N-terminal half of mouse BicD2 (BicD2N) and GFP (GFP-BicD2N-FRB) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1924145; Bicd2 (Note=With p.Arg401_Leu820del = Bicd2N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP2 CL3
AC   CVCL_D4XZ
DR   Wikidata; Q127384440
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two constructs, one containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) and the other to the FKBP-rapamycin-binding (FRB) domain of mTOR linked to the N-terminal half of mouse BicD2 (BicD2N) and GFP (GFP-BicD2N-FRB) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1924145; Bicd2 (Note=With p.Arg401_Leu820del = Bicd2N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP2 CL4
AC   CVCL_D4Y0
DR   Wikidata; Q127384441
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two constructs, one containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) and the other to the FKBP-rapamycin-binding (FRB) domain of mTOR linked to the N-terminal half of mouse BicD2 (BicD2N) and GFP (GFP-BicD2N-FRB) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1924145; Bicd2 (Note=With p.Arg401_Leu820del = Bicd2N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP2 CL5
AC   CVCL_D4Y1
DR   Wikidata; Q127384442
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two constructs, one containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) and the other to the FKBP-rapamycin-binding (FRB) domain of mTOR linked to the N-terminal half of mouse BicD2 (BicD2N) and GFP (GFP-BicD2N-FRB) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1924145; Bicd2 (Note=With p.Arg401_Leu820del = Bicd2N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SP2 CL6
AC   CVCL_D4Y2
DR   Wikidata; Q127384443
RX   PubMed=32436764;
CC   Population: Caucasian.
CC   Characteristics: Transfected with two constructs, one containing the PEX3 peroxisome targeting sequence (PTS) fused to RFP and FKBP (PTS-RFP-FKBP) and the other to the FKBP-rapamycin-binding (FRB) domain of mTOR linked to the N-terminal half of mouse BicD2 (BicD2N) and GFP (GFP-BicD2N-FRB) (PubMed=32436764).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3711; FKBP1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3942; MTOR (Note=With p.Met1_Arg2018del and p.Gln2114_Trp2549del = FRB).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:1924145; Bicd2 (Note=With p.Arg401_Leu820del = Bicd2N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   U2OS SQSTM1 KO
AC   CVCL_A6LP
DR   Wikidata; Q107117178
RX   PubMed=39006307;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   U2OS ST-PEAK3
AC   CVCL_C0QU
DR   PRIDE; PXD029417
DR   Wikidata; Q112930495
RX   PubMed=34944965;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pSBbi-PuroR-ST-PEAK3 that contains a N-terminally Strep-tagged PEAK3.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:24793; PEAK3 (Note=With a N-terminal Strep tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   U2OS TACR1 calcium-Nomad
AC   CVCL_YK58
SY   Ca++ Nomad TACR1 (NK1)/U2OS; NK1 (TACR1) Nomad; NK1 Nomad
DR   Innoprot; P70105
DR   Wikidata; Q98133764
CC   Population: Caucasian.
CC   Characteristics: In absence of calcium, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11526; TACR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS TACR2 HiTSeeker
AC   CVCL_YK59
SY   HiTSeeker TACR2; TACR2 (NK2)/U2OS
DR   Innoprot; P30148
DR   Wikidata; Q98133765
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11527; TACR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS TACR3 calcium-Nomad
AC   CVCL_YK60
SY   Ca++ Nomad TACR3 (NK3)/U2OS; NK3 (TACR3) Nomad; NK3 Nomad
DR   Innoprot; P70104
DR   Wikidata; Q98133766
CC   Population: Caucasian.
CC   Characteristics: In absence of calcium, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The green calcium-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboGFP fluorescent protein, a calmodulin-binding peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11528; TACR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS TACR3 HiTSeeker
AC   CVCL_YK61
SY   HiTSeeker TACR3; TACR3 (NK3)/U2OS
DR   Innoprot; P30149
DR   Wikidata; Q98133767
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11528; TACR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS TBK1 KO
AC   CVCL_A6LQ
DR   Wikidata; Q107117179
RX   PubMed=36415206;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   U2OS tGFP-ADCYAP1R1
AC   CVCL_B5WM
SY   ADCYAP1R1-tGFP_U2OS; PAC1-tGFP
DR   Innoprot; P30214
DR   Wikidata; Q112041875
CC   Population: Caucasian.
CC   Characteristics: Has been designed to assay potential agonists/antagonists against ADCYAP1R1, modulating its activation and the following redistribution process inside the cells (Innoprot=P30214).
CC   Characteristics: Transfected with ADCYAP1R1 N-terminally tagged with turboGFP.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:242; ADCYAP1R1.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 9
//
ID   U2OS tGFP-PFN1
AC   CVCL_YK62
SY   tGFP-Profilin 1 U2OS
DR   Innoprot; P30714
DR   Wikidata; Q98133768
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8881; PFN1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS TRH1 HiTSeeker
AC   CVCL_YK63
SY   HiTSeeker TRH1; TRH1/U2OS; TRH1 (TRHR)/U2OS
DR   Innoprot; P30423
DR   Wikidata; Q98133769
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12299; TRHR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   U2OS UTS2R HiTSeeker
AC   CVCL_YK64
SY   HiTSeeker UTS2R; UT (UTS2R)/U2OS
DR   Innoprot; P30424
DR   Wikidata; Q98133770
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4468; UTS2R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS VGF KO
AC   CVCL_B5CQ
DR   Wikidata; Q110433303
CC   From: Durcan, Thomas M.; Montreal Neurological Institute, McGill University; Montreal; Canada.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12684; VGF.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Cell line information from personal communication of Laflamme, Carl.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   U2OS VIPR1 cAMP-Nomad
AC   CVCL_YK65
SY   VIPR1 cAMPNomad; VIPR1 Nomad; cAMPNomad-VIPR1
DR   Innoprot; P70201
DR   Wikidata; Q98133771
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12694; VIPR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS VIPR2 cAMP-Nomad
AC   CVCL_YK66
SY   VIPR2 cAMPNomad; VIPR2 Nomad; cAMPNomad-VIPR2
DR   Innoprot; P70569
DR   Wikidata; Q98133774
CC   Population: Caucasian.
CC   Characteristics: In absence of cAMP, the fluorescent biosensor is localized in the cellular membrane. An increase in this second messenger concentration leads to change in the structural folding of Nomad biosensor that promotes its cellular relocation in the vesicular trafficking of the cells.
CC   Characteristics: The red cAMP-Nomad biosensor consists of a membrane localization peptide derived from interleukin-2 receptor alpha chain, a TurboFP650 fluorescent protein, a Ht31 peptide fused to a KDEL signal.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; JS838; TurboFP650 (Note=Far-red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12695; VIPR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18
AC   CVCL_VR75
SY   U2OS clone #18; U2OS reporter cell line #18
DR   DSMZ; ACC-832
DR   DSMZCellDive; ACC-832
DR   Wikidata; Q98133776
RX   PubMed=15590323;
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-832).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-832
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18-RAD51B-8
AC   CVCL_VR78
DR   DSMZ; ACC-833
DR   DSMZCellDive; ACC-833
DR   Wikidata; Q98133777
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~50 hours (DSMZ=ACC-833).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9822; RAD51B.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-833
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR75 ! U2OS#18
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18-RAD51B-8/B+
AC   CVCL_VR79
DR   DSMZ; ACC-838
DR   DSMZCellDive; ACC-838
DR   Wikidata; Q98133778
CC   Population: Caucasian.
CC   Characteristics: The parental RAD51B KO cell line is functionally reconstituted by retroviral transfection of RAD51B.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~25-30 hours (DSMZ=ACC-838).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9822; RAD51B.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9822; RAD51B.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-838
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR78 ! U2OS#18-RAD51B-8
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   U2OS#18-RAD51C-15
AC   CVCL_VR80
DR   DSMZ; ACC-834
DR   DSMZCellDive; ACC-834
DR   Wikidata; Q98133779
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-834).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9820; RAD51C.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-834
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR75 ! U2OS#18
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18-RAD51C-15/C+
AC   CVCL_VR81
DR   DSMZ; ACC-839
DR   DSMZCellDive; ACC-839
DR   Wikidata; Q98133780
CC   Population: Caucasian.
CC   Characteristics: The parental RAD51C KO cell line is functionally reconstituted by retroviral transfection of RAD51C.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~25-40 hours (DSMZ=ACC-839).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9820; RAD51C.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9820; RAD51C.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-839
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR80 ! U2OS#18-RAD51C-15
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   U2OS#18-RAD51D-4
AC   CVCL_VR82
DR   DSMZ; ACC-835
DR   DSMZCellDive; ACC-835
DR   Wikidata; Q98133781
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~4-6 days (DSMZ=ACC-835).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-835
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR75 ! U2OS#18
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18-RAD51D-4/D+
AC   CVCL_VR83
DR   DSMZ; ACC-840
DR   DSMZCellDive; ACC-840
DR   Wikidata; Q98133782
CC   Population: Caucasian.
CC   Characteristics: The parental RAD51D KO cell line is functionally reconstituted by retroviral transfection of RAD51D.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~20-50 hours (DSMZ=ACC-840).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9823; RAD51D.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9823; RAD51D.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-840
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR82 ! U2OS#18-RAD51D-4
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   U2OS#18-XRCC2-5E
AC   CVCL_VR84
DR   DSMZ; ACC-836
DR   DSMZCellDive; ACC-836
DR   Wikidata; Q98133783
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~4-6 days (DSMZ=ACC-836).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12829; XRCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-836
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR75 ! U2OS#18
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18-XRCC2-5E/X2+
AC   CVCL_VR85
DR   DSMZ; ACC-841
DR   DSMZCellDive; ACC-841
DR   Wikidata; Q98133784
CC   Population: Caucasian.
CC   Characteristics: The parental XRCC2 KO cell line is functionally reconstituted by retroviral transfection of XRCC2.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~24 hours (DSMZ=ACC-841).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12829; XRCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12829; XRCC2.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-841
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 8,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR84 ! U2OS#18-XRCC2-5E
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   U2OS#18-XRCC3-6A
AC   CVCL_VR86
DR   DSMZ; ACC-837
DR   DSMZCellDive; ACC-837
DR   Wikidata; Q98133785
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-837).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12830; XRCC3.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-837
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR75 ! U2OS#18
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 13
//
ID   U2OS#18-XRCC3-6A/X3+
AC   CVCL_YL50
DR   DSMZ; ACC-842
DR   DSMZCellDive; ACC-842
DR   Wikidata; Q98133786
CC   Population: Caucasian.
CC   Characteristics: The parental XRCC3 KO cell line is functionally reconstituted by retroviral transfection of XRCC3.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-842).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12830; XRCC3.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:12830; XRCC3.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
ST   Source(s): DSMZ=ACC-842
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15
ST   D21S11: 31,32
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,14,15
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 10,13
ST   TH01: 6,9.3
ST   TPOX: 11,12
ST   vWA: 14,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VR86 ! U2OS#18-XRCC3-6A
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 12
//
ID   U2OS#24
AC   CVCL_VR87
SY   U2OS clone #24; U2OS reporter cell line #24
DR   Wikidata; Q98133787
RX   PubMed=15590323;
CC   Population: Caucasian.
CC   Characteristics: Contains a 'nested intron' reporter construct HRsub that allows to study sister chromatid recombination (SCR) by positive selection of 'long tract' gene conversion events between sister chromatids.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   U2OS#6 rho-0
AC   CVCL_E0XV
DR   CancerTools; 162186
DR   Kerafast; ESA123
CC   Population: Caucasian.
CC   Characteristics: Cell line devoid of mitochondrial DNA (rho0).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   U2OS-AP3
AC   CVCL_E6ZT
RX   PubMed=28468878;
CC   Population: Caucasian.
CC   Virology: Contains chromosomally integrated human herpesvirus 6A (ciHHV-6A) (PubMed=28468878).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-AP3#19
AC   CVCL_E6ZU
SY   U2OS-AP3 clone 19
RX   PubMed=28468878;
CC   Population: Caucasian.
CC   Virology: The parent cell line which contains chromosomally integrated human herpesvirus 6A (ciHHV-6A) was surinfected with HHV-6B. The resulting cell line contains an average of 2.9 HHV-6A and 2.2 HHV-6B genomes/cell (PubMed=28468878).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6ZT ! U2OS-AP3
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-ATRkd
AC   CVCL_A5LZ
SY   U2OS/ATRkd; U2OS ATRkd
DR   BTO; BTO_0003696
DR   Wikidata; Q107117180
RX   PubMed=11481475;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:882; ATR (Note=With p.Asp2494Glu = ATRkd).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   U2OS-BioID2
AC   CVCL_C0QG
SY   U2OS-Myc-BioID2-13xLinker
DR   PRIDE; PXD025179
DR   Wikidata; Q112930496
RX   PubMed=35122331;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a Myc.BioID2.13xLinker construct. Control cell line for U2OS-PER2-BioID2 (Cellosaurus=CVCL_C0QF).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; O66837; Aquifex aeolicus biRA (Note=With p.Arg40Gly = BioID2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   U2OS-BP6
AC   CVCL_E6ZV
RX   PubMed=28468878;
CC   Population: Caucasian.
CC   Virology: Contains chromosomally integrated human herpesvirus 6B (ciHHV-6B) (PubMed=28468878).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-BP6#48
AC   CVCL_E6ZW
SY   U2OS-BP6 clone 48
RX   PubMed=28468878;
CC   Population: Caucasian.
CC   Virology: The parent cell line which contains chromosomally integrated human herpesvirus 6B (ciHHV-6B) was surinfected with HHV-6A. The resulting cell line contains an average of 0.6 HHV-6A and 0.6 HHV-6B genomes/cell (PubMed=28468878).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E6ZV ! U2OS-BP6
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-CRISPR-SNAPf-NUP133 no.80
AC   CVCL_E6B0
SY   U2OS-CRISPR-SNAPf-Nup133 #80; U2OS CRISPR SNAPf-NUP133 #80
DR   CLS; 300666
RX   PubMed=34191541;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A NUP1333 has been endogenously tagged in both alleles at the N-terminus with a SNAP-f tag (PubMed=34191541).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly183_Asn207del and 20 mutations = SNAP-f-tag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-CRISPR-SNAPf-RANBP2/NUP358 no.721
AC   CVCL_E6B1
SY   U2OS-CRISPR-SNAPf-Nup358/RanBP2 #721; U2OS CRISPR SNAPf-RANBP2/NUP358 #721
DR   CLS; 300663
RX   PubMed=34191541;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A RANBP2 has been endogenously tagged in both alleles at the N-terminus with a SNAP-f tag (PubMed=34191541).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly183_Asn207del and 20 mutations = SNAP-f-tag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-CRISPR-SNAPf-SEH1 no.238
AC   CVCL_E6B2
SY   U2OS-CRISPR-SNAPf-SEH1 #238; U2OS CRISPR SNAPf-SEH1 #238
DR   CLS; 300664
RX   PubMed=34191541;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A SEH1L has been endogenously tagged in both alleles at the N-terminus with a SNAP-f tag (PubMed=34191541).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly183_Asn207del and 20 mutations = SNAP-f-tag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-CRISPR-TPR-SNAPf no.2-F01
AC   CVCL_E6B3
SY   U2OS-CRISPR-TPR-SNAPf #2-F01; U2OS CRISPR TPR-SNAPf #2-F01
DR   CLS; 300667
RX   PubMed=34191541;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9D10A TPR has been endogenously tagged in both alleles at the C-terminus with a SNAP-f tag (PubMed=34191541).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly183_Asn207del and 20 mutations = SNAP-f-tag).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   U2OS-FGFR1
AC   CVCL_E6ZY
SY   U2OS FGFR1; U2OS-R1
RX   PubMed=18480409;
RX   PubMed=21779335;
WW   Provider; I2B; P-95; http://inven2biologics.com/shop/cell-lines/human/u2os-fgfr1-osteosarcoma-cell-line
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR1 15R
AC   CVCL_E7A0
SY   U2OS-R1 15R
RX   PubMed=18480409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1 (Note=With in the intracellular domain 15 Lys mutated to Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR1 25Ra
AC   CVCL_E7A1
SY   U2OS-R1 25Ra
RX   PubMed=18480409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1 (Note=With in the intracellular domain 25 Lys mutated to Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR1 25Rc
AC   CVCL_E7A2
SY   U2OS-R1 25Rc
RX   PubMed=18480409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1 (Note=With in the intracellular domain 15 Lys mutated to Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR1 29R
AC   CVCL_E7A3
SY   U2OS-R1 29R
RX   PubMed=18480409;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1 (Note=With in the intracellular domain 29 Lys mutated to Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR1-K514R
AC   CVCL_E7A6
WW   Provider; I2B; P-98; http://inven2biologics.com/shop/cell-lines/human/u2os-fgfr1-k514r-osteosarcoma-cell-line
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3688; FGFR1 (Note=With p.Lys514Arg).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR3
AC   CVCL_E7A5
SY   U2OS FGFR3; U2OS-R3
RX   PubMed=21779335;
WW   Provider; I2B; P-96; http://inven2biologics.com/shop/cell-lines/human/u2os-fgfr3-osteosarcoma-cell-line
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3690; FGFR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-FGFR4
AC   CVCL_E6ZZ
SY   U2OS-R4
RX   PubMed=18480409;
WW   Provider; I2B; P-97; http://inven2biologics.com/shop/cell-lines/human/u2os-fgfr4-osteosarcoma-cell-line
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3691; FGFR4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U2OS-GFP-HK2
AC   CVCL_C0Q8
DR   PRIDE; PXD028992
DR   Wikidata; Q112930498
RX   PubMed=35609998;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pCMV6-AC-HK2-GFP construct that contains HK2 c-terminally tagged with turbo-GFP.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4923; HK2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   U2OS-GFP-STAT1
AC   CVCL_D7E1
RX   Patent=US9683988;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11362; STAT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   U2OS-GFP-STAT1/CSF-1R
AC   CVCL_D7E2
RX   Patent=US9683988;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.4688.
CC   Population: Caucasian.
CC   Characteristics: Expresses both GFP-STAT1 and CSF1R (Patent=US9683988).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2433; CSF1R.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11362; STAT1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D7E1 ! U2OS-GFP-STAT1
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   U2OS-LacO-I-SceI-TetO
AC   CVCL_ZC51
DR   Kerafast; ENH105-FP
DR   Wikidata; Q98133788
RX   PubMed=25464843;
CC   Population: Caucasian.
CC   Characteristics: Cell line designed to probe the role of chromatin condensation in DNA damage response (DDR) using a lac-repressor/operator-tethering system (Kerafast=ENH105-FP).
CC   Characteristics: Contains 2 integrated copies of a construct that consist of a I-Scel endonuclease cut site (I-SceIcs) sandwiched between 256 copies of the lac operator (lacO) and 96 copies of the tet operator (tetO) (Kerafast=ENH105-FP).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   U2OS-PER2-BioID2
AC   CVCL_C0QF
SY   U2OS-PER2-13xLinker-BioID2-HA; U2OS-PER2-BioID
DR   PRIDE; PXD025179
DR   Wikidata; Q112930499
RX   PubMed=35122331;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a MCS-hPER2-13XLinker-BioID2-HA construct which express PER2 fused with the BioID2 protein so as to use proximity-dependent biotin labeling (PubMed=35122331).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:8846; PER2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; O66837; Aquifex aeolicus biRA (Note=With p.Arg40Gly = BioID2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 8
//
ID   U2OS-RFP-GAL3
AC   CVCL_F0QJ
RX   DOI=10.1101/2023.09.11.557213;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pmRFP-C1-Galectin-3 construct (DOI=10.1101/2023.09.11.557213).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 5YCFA; mRFP1 (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6563; LGALS3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U2OS-S1P1
AC   CVCL_RQ87
SY   S1P1-U2OS
DR   Wikidata; Q54973671
WW   Provider; Thermo Fisher; R04-039-01; https://assets.thermofisher.com/TFS-Assets/LSG/manuals/039-01.05_S1P1_RAP_LC06583404.pdf
CC   Population: Caucasian.
CC   Characteristics: Expresses S1PR1-EGFP under the control of the CMV promoter (Thermo Fisher=R04-039-01).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3165; S1PR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Thermo Fisher/BioImage; Catalog number R04-039-01.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 11
//
ID   U2OS-tetR
AC   CVCL_XZ88
DR   Wikidata; Q98133789
RX   PubMed=31674905;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   U2OS-tetR-PAmCherry1-KRAS G12D
AC   CVCL_XZ89
DR   Wikidata; Q98133790
RX   PubMed=31674905;
CC   Population: Caucasian.
CC   Characteristics: The PAmCherry1 fluorescent protein is fused to the N-terminal of KRAS with p.Gly12Asp (PubMed=31674905).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; OMODZ; PAmCherry1 (Note=Photoactivatable red fluorescent protein derived from mCherry).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6407; KRAS (Note=With p.Gly12Asp (c.35G>A)).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XZ88 ! U2OS-tetR
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   U2OS-TMEM192-3xHA
AC   CVCL_F0QI
SY   U2OS:TMEM192-3xHA
RX   DOI=10.1101/2023.09.11.557213;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pLJC5-Tmem192-3xHA construct (DOI=10.1101/2023.09.11.557213).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:26775; TMEM192 (Note=With a 3xHA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U2OS:GFP
AC   CVCL_F0QG
RX   PubMed=24446486;
CC   From: Screaton, Robert A.; Sunnybrook Research Institute; Toronto; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U2OS:GFP-parkin
AC   CVCL_F0QH
RX   PubMed=24446486;
CC   From: Screaton, Robert A.; Sunnybrook Research Institute; Toronto; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8607; PRKN.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   U2OSEBNALTD3
AC   CVCL_E3JH
RX   PubMed=23357356;
CC   Population: Caucasian.
CC   Biotechnology: Used in an expression system called QMCF Technology which allows transient mammalian expression system for recombinant protein production with high yields of up to 1g/L (Icosagen).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0DOJ5; Murine polyomavirus (strain A3) (MPyV) large T antigen.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 157703; Murine polyomavirus (strain A3) (MPyV).
CC   Miscellaneous: Information on transfected genes from personal communication of Mannik, Andres.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   U3-DT
AC   CVCL_B6R9
DR   JCRB; JCRB1136.01
DR   Wikidata; Q112041876
RX   PubMed=25978455;
CC   Population: Japanese and Korean.
CC   Senescence: Long term culture of parent cell line (maximum PDL is 252) (PubMed=25978455).
CC   Doubling time: 22 hours (PubMed=25978455).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1136.01
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3237 ! UE6E7T-3
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 11
//
ID   U3002MG
AC   CVCL_IR56
SY   U3002-MG; U3002
DR   cancercelllines; CVCL_IR56
DR   GEO; GSM1857567
DR   GEO; GSM1857783
DR   Progenetix; CVCL_IR56
DR   Wikidata; Q54973672
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3004MG
AC   CVCL_IR57
SY   U3004-MG; U3004
DR   cancercelllines; CVCL_IR57
DR   GEO; GSM1857568
DR   GEO; GSM1857784
DR   Progenetix; CVCL_IR57
DR   Wikidata; Q54973673
RX   PubMed=26629530;
RX   PubMed=27689322;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 16,19
ST   D19S433: 15.2,16.2
ST   D21S11: 29,31.2
ST   D2S1338: 19,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 20,23
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3005MG
AC   CVCL_IR58
SY   U3005-MG; U3005
DR   cancercelllines; CVCL_IR58
DR   GEO; GSM1857569
DR   GEO; GSM1857785
DR   Progenetix; CVCL_IR58
DR   Wikidata; Q54973674
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3008MG
AC   CVCL_IR59
SY   U3008-MG; U3008
DR   cancercelllines; CVCL_IR59
DR   GEO; GSM1857570
DR   GEO; GSM1857786
DR   Progenetix; CVCL_IR59
DR   Wikidata; Q54973676
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 15
ST   D21S11: 30,33.2
ST   D2S1338: 19,25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,15
ST   FGA: 21,25
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3009MG
AC   CVCL_IR60
SY   U3009-MG; U3009
DR   cancercelllines; CVCL_IR60
DR   GEO; GSM1857571
DR   GEO; GSM1857787
DR   Progenetix; CVCL_IR60
DR   Wikidata; Q54973677
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 19,22.2
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3013MG
AC   CVCL_IR61
SY   U3013-MG; U3013
DR   cancercelllines; CVCL_IR61
DR   ChEMBL-Cells; CHEMBL4483163
DR   GEO; GSM1857572
DR   GEO; GSM1857788
DR   Progenetix; CVCL_IR61
DR   PubChem_Cell_line; CVCL_IR61
DR   Wikidata; Q54973679
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 10
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 31.2,32.2
ST   D2S1338: 25,26
ST   D3S1358: 17,19
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 18,24
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   U3016MG
AC   CVCL_IR62
SY   U3016-MG; U3016
DR   cancercelllines; CVCL_IR62
DR   GEO; GSM1857573
DR   GEO; GSM1857789
DR   Progenetix; CVCL_IR62
DR   Wikidata; Q54973680
RX   PubMed=26629530;
RX   PubMed=27689322;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3017MG
AC   CVCL_IR63
SY   U3017-MG; U3017
DR   cancercelllines; CVCL_IR63
DR   GEO; GSM1857574
DR   GEO; GSM1857790
DR   GEO; GSM2368453
DR   GEO; GSM2368509
DR   Progenetix; CVCL_IR63
DR   Wikidata; Q54973681
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=27974212;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530; PubMed=27974212
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 14,18
ST   D19S433: 14,16.2
ST   D21S11: 29,31.2
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 20,26
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3019MG
AC   CVCL_IR64
SY   U3019-MG; U3019
DR   cancercelllines; CVCL_IR64
DR   GEO; GSM1857575
DR   GEO; GSM1857791
DR   Progenetix; CVCL_IR64
DR   Wikidata; Q54973682
RX   PubMed=26629530;
RX   PubMed=27689322;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 10
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 31.2,32.2
ST   D3S1358: 17,19
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 18,24
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3020MG
AC   CVCL_IR65
SY   U3020-MG; U3020
DR   cancercelllines; CVCL_IR65
DR   GEO; GSM1857576
DR   GEO; GSM1857792
DR   Progenetix; CVCL_IR65
DR   Wikidata; Q54973683
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 31.2
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   TH01: 6,7
ST   TPOX: 8,11
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3021MG
AC   CVCL_IR66
SY   U3021-MG; U3021
DR   cancercelllines; CVCL_IR66
DR   GEO; GSM1857577
DR   GEO; GSM1857793
DR   Progenetix; CVCL_IR66
DR   Wikidata; Q54973684
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21,25
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3024MG
AC   CVCL_IR67
SY   U3024-MG; U3024
DR   cancercelllines; CVCL_IR67
DR   GEO; GSM1857578
DR   GEO; GSM1857794
DR   Progenetix; CVCL_IR67
DR   Wikidata; Q54973685
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 14
ST   D16S539: 12,13
ST   D18S51: 15,17
ST   D19S433: 14,15
ST   D21S11: 32.2
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 19,23
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3027MG
AC   CVCL_IR68
SY   U3027-MG; U3027
DR   cancercelllines; CVCL_IR68
DR   GEO; GSM1857579
DR   GEO; GSM1857795
DR   Progenetix; CVCL_IR68
DR   Wikidata; Q54973686
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 21,24
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3028MG
AC   CVCL_IR69
SY   U3028-MG; U3028
DR   cancercelllines; CVCL_IR69
DR   GEO; GSM1857580
DR   GEO; GSM1857796
DR   Progenetix; CVCL_IR69
DR   Wikidata; Q54973688
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3029MG
AC   CVCL_IR70
SY   U3029-MG; U3029
DR   cancercelllines; CVCL_IR70
DR   GEO; GSM1857581
DR   GEO; GSM1857797
DR   Progenetix; CVCL_IR70
DR   Wikidata; Q54973689
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 12,14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3031MG
AC   CVCL_IR71
SY   U3031-MG; U3031
DR   cancercelllines; CVCL_IR71
DR   GEO; GSM1857582
DR   GEO; GSM1857798
DR   Progenetix; CVCL_IR71
DR   Wikidata; Q54973690
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 14.2
ST   D21S11: 30,33.2
ST   D2S1338: 18,19
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 22,24
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 18,20
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3033MG
AC   CVCL_IR72
SY   U3033-MG; U3033
DR   cancercelllines; CVCL_IR72
DR   GEO; GSM1857583
DR   GEO; GSM1857799
DR   Progenetix; CVCL_IR72
DR   Wikidata; Q54973691
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 17
ST   D19S433: 14
ST   D21S11: 29,32.2
ST   D2S1338: 16,24
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3034MG
AC   CVCL_IR73
SY   U3034-MG; U3034
DR   cancercelllines; CVCL_IR73
DR   GEO; GSM1857584
DR   GEO; GSM1857800
DR   Progenetix; CVCL_IR73
DR   Wikidata; Q54973692
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D18S51: 13,16
ST   D19S433: 13,13.2
ST   D21S11: 27,28
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 15,16
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3035MG
AC   CVCL_IR74
SY   U3035-MG; U3035
DR   cancercelllines; CVCL_IR74
DR   GEO; GSM1857585
DR   GEO; GSM1857801
DR   Progenetix; CVCL_IR74
DR   Wikidata; Q54973693
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,14
ST   D18S51: 14,18
ST   D19S433: 14,15
ST   D21S11: 28,30.2
ST   D2S1338: 17
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3037MG
AC   CVCL_IR75
SY   U3037-MG; U3037
DR   cancercelllines; CVCL_IR75
DR   GEO; GSM1857586
DR   GEO; GSM1857802
DR   Progenetix; CVCL_IR75
DR   Wikidata; Q54973694
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 12,16
ST   D19S433: 15
ST   D21S11: 30,31.2
ST   D2S1338: 25
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3039MG
AC   CVCL_IR76
SY   U3039-MG; U3039
DR   cancercelllines; CVCL_IR76
DR   GEO; GSM1857587
DR   GEO; GSM1857803
DR   Progenetix; CVCL_IR76
DR   Wikidata; Q54973695
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9,13
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 12,15
ST   D21S11: 29,33.2
ST   D2S1338: 17,20
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 11,14
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3042MG
AC   CVCL_IR77
SY   U3042-MG; U3042
DR   cancercelllines; CVCL_IR77
DR   GEO; GSM1857588
DR   GEO; GSM1857804
DR   Progenetix; CVCL_IR77
DR   Wikidata; Q54973703
RX   PubMed=26629530;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 12,13
ST   D18S51: 16,19
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 17,20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3046MG
AC   CVCL_IR78
SY   U3046-MG; U3046
DR   cancercelllines; CVCL_IR78
DR   GEO; GSM1857589
DR   GEO; GSM1857805
DR   Progenetix; CVCL_IR78
DR   Wikidata; Q54973704
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 20,22
ST   D3S1358: 14,18
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 23,25
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3047MG
AC   CVCL_IR79
SY   U3047-MG; U3047
DR   cancercelllines; CVCL_IR79
DR   GEO; GSM1857590
DR   GEO; GSM1857806
DR   Progenetix; CVCL_IR79
DR   Wikidata; Q54973705
RX   PubMed=25510230;
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 9
ST   D18S51: 14,20
ST   D19S433: 14,15.2
ST   D21S11: 28,31
ST   D2S1338: 23
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,23
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3048MG
AC   CVCL_IR80
SY   U3048-MG; U3048
DR   cancercelllines; CVCL_IR80
DR   GEO; GSM1857591
DR   GEO; GSM1857807
DR   Progenetix; CVCL_IR80
DR   Wikidata; Q54973708
RX   PubMed=26629530;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 13,18
ST   D19S433: 15,15.2
ST   D21S11: 30,31
ST   D2S1338: 23
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3051MG
AC   CVCL_IR81
SY   U3051-MG; U3051
DR   cancercelllines; CVCL_IR81
DR   GEO; GSM1857592
DR   GEO; GSM1857808
DR   Progenetix; CVCL_IR81
DR   Wikidata; Q54973709
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3053MG
AC   CVCL_IR82
SY   U3053-MG; U3053
DR   cancercelllines; CVCL_IR82
DR   GEO; GSM1857593
DR   GEO; GSM1857809
DR   Progenetix; CVCL_IR82
DR   Wikidata; Q54973710
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 14,18
ST   D19S433: 14,15
ST   D21S11: 28,31
ST   D2S1338: 16,24
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 10,12
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3054MG
AC   CVCL_IR83
SY   U3054-MG; U3054
DR   cancercelllines; CVCL_IR83
DR   GEO; GSM1857594
DR   GEO; GSM1857810
DR   Progenetix; CVCL_IR83
DR   Wikidata; Q54973711
RX   PubMed=26629530;
RX   PubMed=27689322;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 12
ST   D19S433: 14,14.2
ST   D21S11: 31,32.2
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13,17
ST   FGA: 21,23
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3056MG
AC   CVCL_IR84
SY   U3056-MG; U3056
DR   cancercelllines; CVCL_IR84
DR   GEO; GSM1857595
DR   GEO; GSM1857811
DR   Progenetix; CVCL_IR84
DR   Wikidata; Q54973713
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3060MG
AC   CVCL_IR85
SY   U3060-MG; U3060
DR   cancercelllines; CVCL_IR85
DR   GEO; GSM1857596
DR   GEO; GSM1857812
DR   Progenetix; CVCL_IR85
DR   Wikidata; Q54973714
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11,13
ST   D18S51: 17,18
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 10,14
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3062MG
AC   CVCL_IR86
SY   U3062-MG; U3062
DR   cancercelllines; CVCL_IR86
DR   GEO; GSM1857597
DR   GEO; GSM1857813
DR   Progenetix; CVCL_IR86
DR   Wikidata; Q54973715
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3065MG
AC   CVCL_IR87
SY   U3065-MG; U3065
DR   cancercelllines; CVCL_IR87
DR   GEO; GSM1857598
DR   GEO; GSM1857814
DR   GEO; GSM2368449
DR   GEO; GSM2368530
DR   GEO; GSM2368533
DR   GEO; GSM2369073
DR   Progenetix; CVCL_IR87
DR   Wikidata; Q54973716
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=27974212;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530; PubMed=27974212
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,10
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D19S433: 13
ST   D21S11: 28,30.2
ST   D2S1338: 19,21
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 14,15
ST   FGA: 21,25
ST   TH01: 9.3
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3067MG
AC   CVCL_IR88
SY   U3067-MG; U3067
DR   cancercelllines; CVCL_IR88
DR   Wikidata; Q54973717
RX   PubMed=26629530;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 14,17
ST   D19S433: 13,14
ST   D21S11: 27,29
ST   D2S1338: 17,18
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3068MG
AC   CVCL_IR89
SY   U3068-MG; U3068
DR   GEO; GSM1857599
DR   GEO; GSM1857815
DR   Progenetix; CVCL_IR89
DR   Wikidata; Q54973718
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   U3071MG
AC   CVCL_IR90
SY   U3071-MG; U3071
DR   cancercelllines; CVCL_IR90
DR   GEO; GSM1857600
DR   GEO; GSM1857816
DR   Progenetix; CVCL_IR90
DR   Wikidata; Q54973719
RX   PubMed=26629530;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 14,14.2
ST   D21S11: 30.2,31
ST   D2S1338: 20,23
ST   D3S1358: 16,18
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 19,23
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3073MG
AC   CVCL_IR91
SY   U3073-MG; U3073
DR   cancercelllines; CVCL_IR91
DR   GEO; GSM1857601
DR   GEO; GSM1857817
DR   Progenetix; CVCL_IR91
DR   Wikidata; Q54973720
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 13,15
ST   D21S11: 29,30.2
ST   D2S1338: 20,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,12
ST   FGA: 19,21
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3078MG
AC   CVCL_IR92
SY   U3078-MG; U3078
DR   cancercelllines; CVCL_IR92
DR   GEO; GSM1857602
DR   GEO; GSM1857818
DR   Progenetix; CVCL_IR92
DR   Wikidata; Q54973721
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 17,24
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23,25
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3082MG
AC   CVCL_IR93
SY   U3082-MG; U3082
DR   EFO; EFO_0022706
DR   cancercelllines; CVCL_IR93
DR   GEO; GSM1857603
DR   GEO; GSM1857819
DR   Progenetix; CVCL_IR93
DR   Wikidata; Q54973723
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 28,31.2
ST   D2S1338: 16,19
ST   D3S1358: 15,16
ST   D5S818: 9,12
ST   D7S820: 9,13
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   U3084MG
AC   CVCL_IR94
SY   U3084-MG; U3084
DR   cancercelllines; CVCL_IR94
DR   GEO; GSM1857604
DR   GEO; GSM1857820
DR   Progenetix; CVCL_IR94
DR   Wikidata; Q54973724
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D18S51: 12,18
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11,14
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IR96 ! U3086MG
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3085MG
AC   CVCL_IR95
SY   U3085-MG; U3085
DR   cancercelllines; CVCL_IR95
DR   GEO; GSM1857605
DR   GEO; GSM1857821
DR   Progenetix; CVCL_IR95
DR   Wikidata; Q54973725
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 12,14
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 21,24
ST   TH01: 6,9.3
ST   TPOX: 10,11
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3086MG
AC   CVCL_IR96
SY   U3086-MG; U3086
DR   cancercelllines; CVCL_IR96
DR   GEO; GSM1857606
DR   GEO; GSM1857822
DR   Progenetix; CVCL_IR96
DR   Wikidata; Q54973727
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,14
ST   D18S51: 12,18
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 17,20
ST   D3S1358: 15,17
ST   D5S818: 11,14
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IR94 ! U3084MG
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3088MG
AC   CVCL_IR97
SY   U3088-MG; U3088
DR   cancercelllines; CVCL_IR97
DR   GEO; GSM1857607
DR   GEO; GSM1857823
DR   Progenetix; CVCL_IR97
DR   Wikidata; Q54973728
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=26629530
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 17,18
ST   D19S433: 15,16.2
ST   D21S11: 27,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3093MG
AC   CVCL_A1FX
DR   Wikidata; Q102115030
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3101MG
AC   CVCL_IR98
SY   U3101-MG; U3101
DR   cancercelllines; CVCL_IR98
DR   GEO; GSM1857608
DR   GEO; GSM1857824
DR   Progenetix; CVCL_IR98
DR   Wikidata; Q54973729
RX   PubMed=26629530;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3102MG
AC   CVCL_A1FY
DR   Wikidata; Q102115031
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3104MG
AC   CVCL_A1FZ
DR   Wikidata; Q102115033
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3110MG
AC   CVCL_IR99
SY   U3110-MG; U3110
DR   cancercelllines; CVCL_IR99
DR   GEO; GSM1857609
DR   GEO; GSM1857825
DR   Progenetix; CVCL_IR99
DR   Wikidata; Q54973730
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3117MG
AC   CVCL_IS00
SY   U3117-MG; U3117
DR   cancercelllines; CVCL_IS00
DR   GEO; GSM1857610
DR   GEO; GSM1857826
DR   GEO; GSM2368450
DR   GEO; GSM2368607
DR   Progenetix; CVCL_IS00
DR   Wikidata; Q54973731
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=27974212;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27974212
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 16,18
ST   D5S818: 12,14
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IS01 ! U3118MG
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3118MG
AC   CVCL_IS01
SY   U3118-MG; U3118
DR   EFO; EFO_0022705
DR   cancercelllines; CVCL_IS01
DR   GEO; GSM1857611
DR   GEO; GSM1857827
DR   GEO; GSM2368451
DR   GEO; GSM2368566
DR   GEO; GSM2368567
DR   GEO; GSM2368568
DR   Progenetix; CVCL_IS01
DR   Wikidata; Q54973732
RX   PubMed=26629530;
RX   PubMed=27689322;
RX   PubMed=27974212;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27974212
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 12,14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 16,18
ST   D5S818: 12,14
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IS00 ! U3117MG
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   U3121MG
AC   CVCL_IS02
SY   U3121-MG; U3121
DR   cancercelllines; CVCL_IS02
DR   GEO; GSM1857612
DR   GEO; GSM1857828
DR   GEO; GSM2368454
DR   GEO; GSM2368585
DR   Progenetix; CVCL_IS02
DR   Wikidata; Q54973733
RX   PubMed=26629530;
RX   PubMed=27974212;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex2-5del; Zygosity=Unspecified (PubMed=27974212).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27974212
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 13,15.2
ST   D21S11: 28,30
ST   D2S1338: 16,17
ST   D3S1358: 14,15
ST   D5S818: 7,12
ST   D7S820: 10,13
ST   D8S1179: 13,14
ST   FGA: 19,24
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 10
//
ID   U3123MG
AC   CVCL_IS03
SY   U3123-MG; U3123
DR   cancercelllines; CVCL_IS03
DR   GEO; GSM1857613
DR   GEO; GSM1857829
DR   Progenetix; CVCL_IS03
DR   Wikidata; Q54973734
RX   PubMed=26629530;
RX   PubMed=28122246;
WW   Provider; HGCC; -; https://www.hgcc.se/
CC   Part of: Human Glioblastoma Cell Culture (HGCC) resource.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   U3129MG
AC   CVCL_IS04
SY   U3129-MG; U3129
DR   cancercelllines; CVCL_IS04
DR   GEO; GSM1857614
DR   Progenetix; CVCL_IS04
DR   Wikidata; Q54973735
RX   PubMed=27689322;
RX   PubMed=28122246;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   U3137MG
AC   CVCL_A1GA
DR   Wikidata; Q102115034
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3140MG
AC   CVCL_A1GB
DR   Wikidata; Q102115035
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3146MG
AC   CVCL_A1GC
DR   Wikidata; Q102115036
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3155MG
AC   CVCL_A1GD
DR   Wikidata; Q102115038
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3164MG
AC   CVCL_A1GE
DR   Wikidata; Q102115040
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3167MG
AC   CVCL_A1GF
DR   GEO; GSM2368452
DR   GEO; GSM2368634
DR   Wikidata; Q102115041
RX   PubMed=27974212;
RX   PubMed=28122246;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=27974212
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 13,14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 19,21
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   U3169MG
AC   CVCL_A1GG
DR   Wikidata; Q102115042
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3172MG
AC   CVCL_A1GH
DR   Wikidata; Q102115043
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3173MG
AC   CVCL_A1GI
DR   Wikidata; Q102115044
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3175MG
AC   CVCL_A1GJ
DR   Wikidata; Q102115045
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3180MG
AC   CVCL_A1GK
DR   Wikidata; Q102115046
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3189MG
AC   CVCL_A1GL
DR   Wikidata; Q102115047
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3198MG
AC   CVCL_A1GM
DR   Wikidata; Q102115048
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U3202MG
AC   CVCL_A1GN
DR   Wikidata; Q102115050
RX   PubMed=28122246;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   U373-CD4
AC   CVCL_E8AN
RX   PubMed=7690415;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2219 ! U-373MG ATCC
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U373-MAGI
AC   CVCL_1F84
SY   U373-CD4-LTR/beta-gal; U373-Multinuclear Activation of a Galactosidase Indicator
DR   BEI_Resources; ARP-3595
DR   ChEMBL-Cells; CHEMBL3886081
DR   PubChem_Cell_line; CVCL_1F84
DR   Wikidata; Q54973736
RX   PubMed=7690415;
RX   PubMed=9201229;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct pEQ447 containing the HIV-1 LTR fused to a lacZ reporter gene that contains a MPKKKRK N-terminal sequence directing it to the nucleus (PubMed=7690415).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AN ! U373-CD4
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 15
//
ID   U373-MAGI-CCR5
AC   CVCL_1F85
SY   U373-MAGI-CCR5E
DR   BEI_Resources; ARP-3597
DR   Wikidata; Q54973738
RX   PubMed=9201229;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct pEQ447 containing the HIV-1 LTR fused to a lacZ reporter gene that contains a MPKKKRK N-terminal sequence directing it to the nucleus (from parent cell line).
CC   Virology: Can be used to detect primary isolates of HIV-1, HIV-2 and SIV (PubMed=9201229).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1F84 ! U373-MAGI
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   U373-MAGI-CXCR4
AC   CVCL_1F86
SY   U373-MAGI-CXCR4CEM
DR   BEI_Resources; ARP-3596
DR   Wikidata; Q54973739
RX   PubMed=9201229;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a construct pEQ447 containing the HIV-1 LTR fused to a lacZ reporter gene that contains a MPKKKRK N-terminal sequence directing it to the nucleus (from parent cell line).
CC   Virology: Can be used to detect primary isolates of HIV-1, HIV-2 and SIV (PubMed=9201229).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1F84 ! U373-MAGI
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 13
//
ID   U38
AC   CVCL_M770
DR   BEI_Resources; ARP-1297
DR   cancercelllines; CVCL_M770
DR   Wikidata; Q54973740
RX   PubMed=3422113;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   U4.4
AC   CVCL_Z820
SY   u4.4
DR   Wikidata; Q54973741
RX   PubMed=3392770;
RX   PubMed=3951024;
WW   Info; VectorBase; -; https://vectorbase.org/vectorbase/app/record/dataset/DS_2c164a746d
WW   Provider; TCB; -; https://www.liverpool.ac.uk/research/facilities/tick-cell-biobank/
CC   Group: Insect cell line.
CC   Virology: Supports replication of Sindbis virus (PubMed=3392770; PubMed=3951024).
CC   Omics: Transcriptomics; RNAseq.
OX   NCBI_TaxID=7160; ! Aedes albopictus (Asian tiger mosquito)
HI   CVCL_Z223 ! ATC-15
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   U4F
AC   CVCL_LF81
SY   Urogenital sinus organ culture series 4, Fibroblast-like morphology
DR   Wikidata; Q54973742
RX   PubMed=1730568;
RX   PubMed=18462435;
CC   Derived from site: In situ; Urogenital sinus mesenchyme; UBERON=UBERON_0009845.
CC   Breed/subspecies: Harlan Sprague Dawley (Hsd:SD); RS=RS_0000698.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   18-19FD
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   U4F1
AC   CVCL_LF82
DR   Wikidata; Q54973743
RX   PubMed=1730568;
CC   Derived from site: In situ; Urogenital sinus mesenchyme; UBERON=UBERON_0009845.
CC   Breed/subspecies: Harlan Sprague Dawley (Hsd:SD); RS=RS_0000698.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_LF81 ! U4F
SX   Male
AG   18-19FD
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   U4SS
AC   CVCL_L857
SY   U-4 SS; 4T
DR   Wikidata; Q54973744
RX   PubMed=3518877;
RX   PubMed=6081590;
RX   PubMed=6220172;
DI   NCIt; C3829; Benign synovial neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   UG5LN
AC   CVCL_E7IT
WW   Provider; Inserm Transfert; RT00625; https://technology-offers.inserm-transfert.com/offer/ug5ln-cell-line/
CC   Population: Caucasian.
CC   Characteristics: Negative control cell line for measurement of nuclear receptor activity. Transfected with a (GAL4RE)5-betaGlobin-Luc-SV40-Neo construct where expression of the luciferase gene is driven by a pentamer of yeast activator GAL4-binding sites in front of beta-globin promoter (Inserm Transfert=RT00625).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   UG5LN GAL4-hMR
AC   CVCL_E7IU
WW   Provider; Inserm Transfert; RT00626; https://technology-offers.inserm-transfert.com/offer/ug5ln-gal4-hmr-cell-line/
CC   Population: Caucasian.
CC   Characteristics: Transfected with a (GAL4RE)5-betaGlobin-Luc-SV40-Neo construct where expression of the luciferase gene is driven by a pentamer of yeast activator GAL4-binding sites in front of beta-globin promoter and a pSG5-GAL4-hMR-puroR construct containing the GAL4 DNA-binding domain fused to the ligand-binding domain of human NR3C2/MR (Inserm Transfert=RT00626).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7979; NR3C2 (Note=Ligand-binding domain).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P04386; Yeast GAL4 (Note=With p.Ile148_Glu881del = DNA-binding domain).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7IT ! UG5LN
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   U87 MG-Red-FLuc
AC   CVCL_5J12
SY   Bioware Brite U87 MG-Red-FLuc; IVISbrite U87MG Red F-luc
DR   cancercelllines; CVCL_5J12
DR   Revvity/PerkinElmer; BW124577
DR   Wikidata; Q54973745
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Doubling time: 34 hours (Revvity/PerkinElmer=BW124577).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q1AG35; Luciola italica Italian firefly luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 16
//
ID   U87-CD4 clone 2
AC   CVCL_X702
SY   U87MG clone 2
DR   BEI_Resources; ARP-2187
DR   cancercelllines; CVCL_X702
DR   Wikidata; Q54973747
RX   PubMed=2293663;
RX   PubMed=8095307;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 15
//
ID   U87-MG/Cas9 AAVS1
AC   CVCL_C9F7
SY   U87-MG/Cas9-AAVS1
DR   GeneCopoeia; SL584
DR   Wikidata; Q123033672
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Characteristics: Stably expresses a CBh-3xFLAG-Cas9-NLS-bGHPolyA-EF1a-copGFP-T2A-HygR-SV40pa construct from the AAVS1 safe locus (GeneCopoeia=SL584).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 2BK6M; ppluGFP2 (copGFP, green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   U87-MG/Pt
AC   CVCL_4V16
DR   cancercelllines; CVCL_4V16
DR   Cosmic; 1198264
DR   Wikidata; Q54973748
RX   CelloPub=CLPUB00268;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   U87.CD4
AC   CVCL_X626
SY   U87/CD4; U87MG.CD4; U87 CD4+
DR   BEI_Resources; ARP-4031
DR   cancercelllines; CVCL_X626
DR   Wikidata; Q54973762
RX   PubMed=9311827;
WW   Provider; NIBSC; 0069c; http://www.nibsc.org/Default.aspx?pageid=597&id=0069&theme=default
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 18
//
ID   U87.CD4.CCR1
AC   CVCL_X627
SY   U87.CD4-CCR1; U87 CD4+CCR1+
DR   BEI_Resources; ARP-4032
DR   cancercelllines; CVCL_X627
DR   Wikidata; Q54973763
RX   PubMed=9311827;
WW   Provider; NIBSC; 0069; http://www.nibsc.org/Default.aspx?pageid=597&id=0069&theme=default
CC   Problematic cell line: Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1602; CCR1.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X626 ! U87.CD4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 17
//
ID   U87.CD4.CCR2
AC   CVCL_X628
SY   U87.CD4.CCR2b; U87.CD4-CCR2b; U87 CD4+CCR2+
DR   BEI_Resources; ARP-4033
DR   cancercelllines; CVCL_X628
DR   Wikidata; Q54973764
RX   PubMed=9311827;
WW   Provider; NIBSC; 0070; http://www.nibsc.org/Default.aspx?pageid=597&id=0070&theme=default
CC   Problematic cell line: Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1603; CCR2 (Note=Isoform B).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X626 ! U87.CD4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 18
//
ID   U87.CD4.CCR3
AC   CVCL_X629
SY   U87.CD4-CCR3; U87 CD4+CCR3+
DR   BEI_Resources; ARP-4034
DR   cancercelllines; CVCL_X629
DR   Wikidata; Q54973766
RX   PubMed=9311827;
WW   Provider; NIBSC; 0071; http://www.nibsc.org/Default.aspx?pageid=597&id=0071&theme=default
CC   Problematic cell line: Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1604; CCR3.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X626 ! U87.CD4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 17
//
ID   U87.CD4.CCR5
AC   CVCL_X630
SY   U87/CD4/CCR5; U87.CD4-CCR5; U87 CD4+CCR5+
DR   BEI_Resources; ARP-4035
DR   cancercelllines; CVCL_X630
DR   Wikidata; Q54973767
RX   PubMed=9311827;
RX   PubMed=15169555;
WW   Provider; NIBSC; 0072; http://www.nibsc.org/Default.aspx?pageid=597&id=0072&theme=default
CC   Problematic cell line: Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X626 ! U87.CD4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 18
//
ID   U87.CD4.CCR5.CXCR4
AC   CVCL_X631
DR   cancercelllines; CVCL_X631
DR   Wikidata; Q54973768
RX   PubMed=15169555;
CC   Problematic cell line: Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X626 ! U87.CD4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 16
//
ID   U87.CD4.CXCR4
AC   CVCL_X632
SY   U87.CD4-CXCR4; U87 CD4+CXCR4+
DR   BEI_Resources; ARP-4036
DR   cancercelllines; CVCL_X632
DR   Wikidata; Q54973769
RX   PubMed=9311827;
RX   PubMed=15169555;
WW   Provider; NIBSC; 0073; http://www.nibsc.org/Default.aspx?pageid=597&id=0073&theme=default
CC   Problematic cell line: Misidentified. Grand-parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:2561; CXCR4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X626 ! U87.CD4
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 14-08-25; Version: 17
//
ID   U87/DK
AC   CVCL_3428
SY   U87-DK; U87DK; U87 dead kinase; U87MG.deltaEGFR DK; U87MG.DK
DR   CLDB; cl7208
DR   cancercelllines; CVCL_3428
DR   ICLC; HTL08003
DR   Wikidata; Q54973750
RX   PubMed=8810340;
RX   PubMed=9006938;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del and p.Lys745Met = EGFRvIII and dead kinase).
ST   Source(s): ICLC=HTL08003
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 12
ST   D21S11: 28.2,32.2
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   U87/WT
AC   CVCL_3429
DR   CLDB; cl7209
DR   cancercelllines; CVCL_3429
DR   ICLC; HTL08004
DR   Wikidata; Q54973761
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
ST   Source(s): ICLC=HTL08004
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 28.2,32.2
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   U87DND
AC   CVCL_A5CL
DR   BTO; BTO_0006374
DR   cancercelllines; CVCL_A5CL
DR   Wikidata; Q107117181
RX   PubMed=27894925;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Characteristics: Exhibits a remarkably low competence at producing ceramide de novo (PubMed=27894925).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   U87MG-Fluc
AC   CVCL_E9YD
RX   PubMed=33241215;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a SV40-Fluc-mPGK-HygR construct (PubMed=33241215).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U87MG-Venus-Akaluc
AC   CVCL_E9YE
RX   PubMed=33241215;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a hPGK-Venus-Akaluc-WPRE-mPGK-Neo construct (PubMed=33241215).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=Photinus pyralis Akaluciferase (Akaluc) (Note=A luciferase-derived fluorescent protein).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U87MG-Venus-Fluc
AC   CVCL_E9YF
RX   PubMed=33241215;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a hPGK-Venus-Fluc-WPRE-mPGK-PuroR construct (PubMed=33241215).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U87MG.deltaEGFR
AC   CVCL_JY78
DR   cancercelllines; CVCL_JY78
DR   Wikidata; Q54973770
RX   PubMed=8810340;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del = EGFRvIII).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   U87MG.DY1
AC   CVCL_JY80
SY   U87/DY1
DR   cancercelllines; CVCL_JY80
DR   Wikidata; Q54973771
RX   PubMed=8810340;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del and p.Tyr1197Phe = EGFRvIII and 1 TyrP site dead).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   U87MG.DY2
AC   CVCL_JY81
SY   U87/DY2
DR   cancercelllines; CVCL_JY81
DR   Wikidata; Q54973772
RX   PubMed=8810340;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del, p.Tyr1092Phe and p.Tyr1197Phe = EGFRvIII and 2 TyrP site dead).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   U87MG.DY3
AC   CVCL_JY82
SY   U87/DY3
DR   cancercelllines; CVCL_JY82
DR   Wikidata; Q54973773
RX   PubMed=8810340;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del, p.Tyr1092Phe, p.Tyr1172Phe and p.Tyr1197Phe = EGFRvIII and 3 TyrP site dead).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   U87MG.DY4
AC   CVCL_JY83
SY   U87/DY4
DR   cancercelllines; CVCL_JY83
DR   Wikidata; Q54973774
RX   PubMed=8810340;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del, p.Tyr1016Phe, p.Tyr1092Phe, p.Tyr1110Phe and p.Tyr1172Phe = EGFRvIII and 4 TyrP site dead).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   U87MG.DY5
AC   CVCL_JY84
SY   U87/DY5
DR   cancercelllines; CVCL_JY84
DR   Wikidata; Q54973775
RX   PubMed=8810340;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3236; EGFR (Note=With p.Val30_Arg297del, p.Tyr1016Phe, p.Tyr1092Phe, p.Tyr1110Phe, p.Tyr1172Phe and p.Tyr1197Phe = EGFRvIII and 5 TyrP site dead).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   U87MG/ALDH1A3-KO.1
AC   CVCL_C6IK
DR   Wikidata; Q116050660
RX   PubMed=34934174;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:409; ALDH1A3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   U87MG/CPOX-KO
AC   CVCL_C6IL
DR   Wikidata; Q116050661
RX   PubMed=34934174;
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2321; CPOX.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   U937(CD59+)
AC   CVCL_8927
SY   CD59+ U937
DR   CLO; CLO_0009466
DR   CLDB; cl682
DR   cancercelllines; CVCL_8927
DR   ECACC; 95102435
DR   Wikidata; Q54973790
RX   PubMed=7518799;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: ECACC; 95102435; true.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   U937(CD59-)
AC   CVCL_8932
SY   CD59- U937
DR   cancercelllines; CVCL_8932
DR   Wikidata; Q54973789
RX   PubMed=7518799;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   U937(G)
AC   CVCL_E9WW
SY   U937G
RX   PubMed=11292320;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to cytotoxic action of TNF in the presence of cycloheximide (CHX) (PubMed=11292320).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U937(V)
AC   CVCL_E9WX
SY   U937V; U-937V; U937(M); U937M
RX   PubMed=11292320;
RX   PubMed=23605997;
RX   PubMed=36982453;
CC   Population: Caucasian.
CC   Characteristics: Sensitive to cytotoxic action of TNF in the presence and in the absence of cycloheximide (CHX) (PubMed=11292320).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   U937-ASPI3K
AC   CVCL_A5BW
DR   cancercelllines; CVCL_A5BW
DR   Wikidata; Q107117182
RX   PubMed=12578639;
RX   PubMed=12840909;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:795; ATM (Note=In antisense orientation).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 9
//
ID   U937-DC-SIGN
AC   CVCL_2Z95
DR   ATCC; CRL-3253
DR   cancercelllines; CVCL_2Z95
DR   Wikidata; Q54973776
RX   PubMed=17804661;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1641; CD209.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3253
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   U937/ara-C
AC   CVCL_4V23
DR   cancercelllines; CVCL_4V23
DR   Wikidata; Q54973777
RX   PubMed=21290089;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28680; Cytarabine (Arabinosylcytosine; Ara-C).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   U937/clone21
AC   CVCL_Y170
DR   cancercelllines; CVCL_Y170
DR   CGH-DB; 9116-4
DR   Wikidata; Q54973779
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   U937/clone36
AC   CVCL_Y171
DR   cancercelllines; CVCL_Y171
DR   CGH-DB; 9117-4
DR   Wikidata; Q54973780
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   U937/clone41
AC   CVCL_Y172
DR   cancercelllines; CVCL_Y172
DR   CGH-DB; 9118-4
DR   Wikidata; Q54973781
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   U937/clone49
AC   CVCL_Y173
DR   cancercelllines; CVCL_Y173
DR   CGH-DB; 9119-4
DR   Wikidata; Q54973783
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   U937/EVI1
AC   CVCL_A5ZK
DR   cancercelllines; CVCL_A5ZK
DR   Wikidata; Q107117183
RX   PubMed=21394097;
CC   Population: Caucasian.
CC   Characteristics: Transduced with a MECOM/EVI1-IRES-EGFP construct.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3498; MECOM.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   U937/HIV-2MS
AC   CVCL_X608
SY   U937 HIV-2 MS-Infected
DR   BEI_Resources; ARP-127
DR   cancercelllines; CVCL_X608
DR   Wikidata; Q54973784
CC   Population: Caucasian.
CC   Virology: Infected with HIV-2 isolate MS (BEI_Resources=ARP-127).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 17
//
ID   U937/UK110
AC   CVCL_Y174
SY   UK110
DR   cancercelllines; CVCL_Y174
DR   Wikidata; Q54973785
RX   PubMed=8845304;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 14
//
ID   U937/UK711
AC   CVCL_Y175
SY   UK711
DR   cancercelllines; CVCL_Y175
DR   CGH-DB; 9120-4
DR   Wikidata; Q54973787
RX   PubMed=7957669;
RX   PubMed=14973057;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 15
//
ID   UA-S2
AC   CVCL_E859
SY   BUA
DR   dbMHC; 49049
DR   ECACC; 94071430
DR   IHW; IHW09328
DR   IPD-IMGT/HLA; 11508
DR   Wikidata; Q54973791
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02,32; B*27,51; C*01; DPB1*04:01; DQA1*05:01; DQB1*03:01; DRB1*11:03,11:01; DRB3*02:02 (IPD-IMGT/HLA=11508).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   UAB-HEK293-PKD1 KO#1
AC   CVCL_E3XG
SY   UABHEK293-E15C04 PKD1 c4017_4018del/4017_4021del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-hek293-pkd1-ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-HEK293-PKD1 KO#2
AC   CVCL_E3XH
SY   UABHEK293-E11C09 PKD1 c2653_2668del/c2653_2668del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-hek293-pkd1-ko2/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-HEK293-PKD2 KO#1
AC   CVCL_E3XI
SY   UABHEK293-E3C1 PKD2 c835_836insT/c834_835del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-hek293-pkd2-ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-HEK293-PKD2 KO#2
AC   CVCL_E3XJ
SY   UABHEK293-E3C2 PKD2 c717_718del/c717_721del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-hek293-pkd2-ko2/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-HEK293-PKHD1 KO#1
AC   CVCL_E3XK
SY   UABHEK293-E3C06 PKHD1 c358_359insT/c347_359del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-hek293-pkhd1-ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9016; PKHD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-HEK293-PKHD1 KO#2
AC   CVCL_E3XL
SY   UABHEK293-E4C02 PKHD1 c358_359insT/c347_359del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-hek293-pkhd1-ko2/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9016; PKHD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-iPSC-IFT88 KO#1
AC   CVCL_E3XV
SY   UABiPGP1-E4C1 IFT88 c302_305del/c303_304;315_312del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-ift88-ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20606; IFT88.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD1 KO#1
AC   CVCL_E3XM
SY   UABiPGP1-E15C04 PKD1 c4019_4026del/4018^4019insC
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-ipsc-pkd1-ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): UAB-PKD
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 16,19
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 8,14
ST   Penta E: 17
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD1 KO het #2
AC   CVCL_E3XN
SY   UABiPGP1-E15C02 PKD1 c4017^4018>T/+
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-ipsc-pkd1-ko-het-2/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2 KO#1
AC   CVCL_E3XP
SY   UABiPGP1-E3C21 PKD2 c713_719>GA/c715_725>ATT
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-ipsc-pkd2-ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): UAB-PKD
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 16,19
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 8,14
ST   Penta E: 17
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2 KO#2
AC   CVCL_E3XS
SY   UABiPGP1-E9C6 PKD2 c1966_1968InsCT/c1960_1977del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-pkd2-ko-2/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2 L656W/null
AC   CVCL_E3XU
SY   UABiPGP1-E9C3 PKD2 c1967T>G/c1961_1963del
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-pkd2-l656w-null/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:9009; PKD2; Simple_edited; p.Leu656Trp (c.1967T>G); Zygosity=Heterozygous (UAB-PKD).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2-cKO NP/null #1
AC   CVCL_E3XX
SY   UABiPGP1-PKD2 conditional knockout non-permissive orientation over null (NP/null)
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-pkd2-cko-np-null-1-3/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Characteristics: This is a PKD2 conditional knockout non-permissive orientation over null (NP/null) cell line, equivalent to homozygous null, which can be converted to a heterozygous null with Cre (UAB-PKD).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2 (Note=Homozygous null that can be converted to heterozygous null with Cre or Flp recombinase).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2-cKO P/null #1
AC   CVCL_E3XY
SY   UABiPGP1-PKD2 conditional knockout permissive orientation over null (P/null)
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-pkd2-cko-p-null-1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Characteristics: This is a PKD2 conditional knockout permissive orientation over null (P/null) cell line, equivalent to heterozygous null, which can be converted to a homozygous null with Cre or Flp recombinase (UAB-PKD).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2 (Note=Heterozygous null that can be converted to homozygous null with Cre or Flp recombinase).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2-Halo#1
AC   CVCL_E3XT
SY   UABiPGP1-C6-PKD2 with C-term Halo tag
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-pkd2-halo1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9, a HaloTag was introduced at the C-terminus of one allele of PKD2. In the second allele a 10 residue sequence was introduced at the C-termimus (UAB-PKD).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKD2+IFT88 DKO#1
AC   CVCL_E3XR
SY   UABiPGP1-E3C21 PKD2 c713_719>GA/c715_725>ATT;E4C8 IFT88 C302_303del/304^305insT
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/new-uab-ipsc-pkd2ift88-dko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20606; IFT88.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E3XP ! UAB-iPSC-PKD2 KO#1
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-iPSC-PKHD1 KO#1
AC   CVCL_E3XQ
SY   UABiPGP1-E3C11 PKHD1 C93_111del/99^100insA
WW   Provider; PKD RRC; -; https://www.pkd-rrc.org/downloads/uab-ipsc-pkhd1ko1/
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9016; PKHD1.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): UAB-PKD
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 16,19
ST   D5S818: 9,11
ST   D7S820: 10,13
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 8,14
ST   Penta E: 17
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UAB-Pkd2 Ex15-HALO clone2
AC   CVCL_E3Y4
SY   PKD2 Ex15-HALO clone2
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Characteristics: In the donor mouse an HaloTag was inserted at the C-terminus (exon 15) of Pkd2 (UAB-PKD).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C57BL/6 Pkd2<em1bky>.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   UAB-Pkd2 Ex15-HALO/Pkd2 delta; CAGGcre; Sstr3GFP clone 15
AC   CVCL_E3Y6
SY   PKD2Ex15-HALO/PKD2 delta; CAGGcre; sstr3GFP clone15
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Characteristics: In the donor mouse an HaloTag was inserted at the C-terminus (exon 15) of one allele of Pkd2, the second allele of Pkd2 is floxed. Two transgene constructs expressing Sstr3:GFP and pCAGGCre-ER are also present (UAB-PKD).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1099818; Pkd2 (Note=1 of 2 alleles; floxed).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag; 1 of two alleles).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-Pkd2 Ex15-WT/Pkd2 delta; CAGGcre; Sstr3GFP clone 8
AC   CVCL_E3Y7
SY   PKD2Ex15-WT/PKD2 delta; CAGGcre; sstr3GFP clone8
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Characteristics: In the donor mouse one allele of Pkd2 is floxed. Two transgene constructs expressing Sstr3:GFP and pCAGGCre-ER are also present (UAB-PKD).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1099818; Pkd2 (Note=1 of 2 alleles; floxed).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transgenic mouse; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   UAB-Pkd2 WT clone3
AC   CVCL_E3Y5
SY   PKD2 WT clone3
CC   From: University of Alabama at Birmingham - Polycystic Kidney Disease center (UAB-PKD); Birmingham; USA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   1M
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 2
//
ID   UABCATe001-A
AC   CVCL_D6JC
SY   bc-1
DR   hPSCreg; UABCATe001-A
DR   Wikidata; Q127384444
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/bc-1%2520Solicitud.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bc-1%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D21S11: 30,31
ST   D5S818: 9,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe002-A
AC   CVCL_D6JD
SY   bc-4
DR   BioSamples; SAMEA114383987
DR   hPSCreg; UABCATe002-A
DR   Wikidata; Q127384445
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bc-4%2520Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D21S11: 30,31.2
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe002-B
AC   CVCL_D6JE
SY   bc-19
DR   hPSCreg; UABCATe002-B
DR   Wikidata; Q127384446
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-19.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo+-+bc-19+Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13,14
ST   D16S539: 13,14
ST   D21S11: 30,32.2
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe003-A
AC   CVCL_D6JF
SY   bc-6
DR   hPSCreg; UABCATe003-A
DR   Wikidata; Q127384447
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-6.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bc-6%2520Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12
ST   D21S11: 29,32.2
ST   D5S818: 12,13,15
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 9,10
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe004-A
AC   CVCL_D6JG
SY   bc-8
DR   hPSCreg; UABCATe004-A
DR   Wikidata; Q127384448
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bc-8%2520Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 13
ST   D21S11: 30,31
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe005-A
AC   CVCL_D6JH
SY   bc-17
DR   hPSCreg; UABCATe005-A
DR   Wikidata; Q127384449
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-17.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bc-17%2520Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Karyotypic information: 47,XY,+22 [17]; 46,XY [3] (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 11
ST   D21S11: 30,31.2
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe005-B
AC   CVCL_D6JI
SY   bc-20
DR   hPSCreg; UABCATe005-B
DR   Wikidata; Q127384451
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-20.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo+-+bc-20+Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,13
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe006-A
AC   CVCL_D6JJ
SY   bc-21
DR   hPSCreg; UABCATe006-A
DR   Wikidata; Q127384454
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bc-21.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo+-+bc-21+Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe007-A
AC   CVCL_D6JK
SY   bc-26
DR   hPSCreg; UABCATe007-A
DR   Wikidata; Q127384456
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/bc-26%2520Solicitud.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bc-26%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D21S11: 29,30
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,8
ST   TPOX: 9,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe008-A
AC   CVCL_D6JL
SY   bm-6.1
DR   hPSCreg; UABCATe008-A
DR   Wikidata; Q127384457
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bm-6.1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bm-6.1%2520Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Karyotypic information: 48,XY,+16,+20 (BNLC).
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 11
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe009-A
AC   CVCL_D6JM
SY   bm-23.3
DR   hPSCreg; UABCATe009-A
DR   Wikidata; Q127384458
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bm-23.3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bm-23.3%2520Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,10
ST   D16S539: 11
ST   D21S11: 30,32.2
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe010-A
AC   CVCL_D6JN
SY   bm-26.5
DR   hPSCreg; UABCATe010-A
DR   Wikidata; Q127384460
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/bm-26.5%2520Solicitud.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/bm-26.5%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D21S11: 30,31
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABCATe010-B
AC   CVCL_D6JP
SY   bm-31.5
DR   hPSCreg; UABCATe010-B
DR   Wikidata; Q127384461
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Caracteristicas+-+Documentaci%C3%B3n+bm-31.5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexo+-+bm-31.5+Solicitud.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universitat Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D21S11: 30,32.2
ST   D5S818: 12,13,15
ST   D7S820: 9,11
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UABi001-A
AC   CVCL_A8NY
SY   AG10039-iPSC-1
DR   hPSCreg; UABi001-A
DR   Wikidata; Q108821412
RX   PubMed=34392011;
CC   From: University of Alabama at Birmingham; Birmingham; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34392011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M16 ! AG10039
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UABi002-A
AC   CVCL_A8NZ
SY   AG08242-iPSC-1
DR   hPSCreg; UABi002-A
DR   Wikidata; Q108821413
RX   PubMed=34392011;
CC   From: University of Alabama at Birmingham; Birmingham; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Arg130Cys (c.388C>T); Zygosity=Homozygous; Note=ApoE3 allele (PubMed=34392011).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4K35 ! AG08242
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UACC-1012
AC   CVCL_M448
SY   UACC 1012; UACC1012; University of Arizona Cell Culture-1012
DR   Wikidata; Q54973792
RX   PubMed=10952317;
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   UACC-1022
AC   CVCL_4035
SY   UACC 1022; UACC1022; University of Arizona Cell Culture-1022
DR   Wikidata; Q54973793
RX   PubMed=9973934;
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UACC-1065
AC   CVCL_VP00
SY   UACC 1065; UACC1065; University of Arizona Cell Culture-1065
DR   Wikidata; Q98133792
RX   PubMed=9973934;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   UACC-1097
AC   CVCL_M449
SY   UACC 1097; UACC1097; University of Arizona Cell Culture-1097
DR   Wikidata; Q54973795
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Muscle; UBERON=UBERON_0001630.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   UACC-1118
AC   CVCL_DG48
SY   UACC 1118; UACC1118; University of Arizona Cell Culture-1118
DR   Wikidata; Q54973796
RX   PubMed=23039341;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 5
//
ID   UACC-1179
AC   CVCL_4036
SY   UACC 1179; UACC1179; University of Arizona Cell Culture-1179
DR   ATCC; CRL-3127
DR   Wikidata; Q54973797
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=7842014;
RX   PubMed=9778046;
RX   PubMed=15153330;
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive (ATCC=CRL-3127).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (ATCC=CRL-3127).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3127
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 20
ST   D19S433: 13.2,16.2
ST   D21S11: 31
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 27
ST   Penta D: 11
ST   Penta E: 13,17
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   UACC-1227
AC   CVCL_4037
SY   UACC 1227; UACC1227; University of Arizona Cell Culture-1227
DR   Wikidata; Q54973799
RX   PubMed=9973934;
RX   PubMed=10497214;
RX   PubMed=12115485;
RX   PubMed=19383853;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   UACC-1237
AC   CVCL_4038
SY   UACC 1237; UACC1237; University of Arizona Cell Culture-1237
DR   Wikidata; Q54973800
RX   PubMed=9973934;
RX   PubMed=12115485;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   UACC-1256
AC   CVCL_M450
SY   UACC1256
DR   Wikidata; Q54973801
RX   PubMed=10952317;
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   UACC-1273
AC   CVCL_G297
SY   UACC 1273; UACC1273; University of Arizona Cell Culture-1273
DR   Wikidata; Q54973802
RX   PubMed=10952317;
RX   PubMed=12086864;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   UACC-1273-4-3
AC   CVCL_A8JY
SY   UACC1273-4-3; 1273 4-3
DR   Wikidata; Q108821414
RX   PubMed=12086864;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12784; WNT5A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G297 ! UACC-1273
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   UACC-1273-4-7
AC   CVCL_A8JZ
SY   UACC1273-4-7; 1273 4-7
DR   Wikidata; Q108821415
RX   PubMed=12086864;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12784; WNT5A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G297 ! UACC-1273
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   UACC-1273EV
AC   CVCL_4039
SY   UACC1273-EV; UACC 1273EV; UACC1273EV; 1273 EV; UACC-1273 Empty Vector
DR   BTO; BTO_0005064
DR   Wikidata; Q54973803
RX   PubMed=12086864;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_G297 ! UACC-1273
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   UACC-1308
AC   CVCL_DG39
SY   UACC 1308; UACC1308; University of Arizona Cell Culture-1308
DR   BTO; BTO_0005895
DR   Wikidata; Q54973804
RX   PubMed=23039341;
RX   PubMed=24879157;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 6
//
ID   UACC-1460
AC   CVCL_VP01
SY   UACC 1460; UACC1460; University of Arizona Cell Culture-1460
DR   Wikidata; Q98133794
RX   PubMed=9973934;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   UACC-1529
AC   CVCL_M451
SY   UACC 1529; UACC1529; University of Arizona Cell Culture-1529
DR   Wikidata; Q54973805
RX   PubMed=10952317;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   UACC-1598
AC   CVCL_4040
SY   UACC 1598; UACC1598; University of Arizona Cell Culture-1598
DR   ATCC; CRL-3128
DR   BioSample; SAMN03471713
DR   Wikidata; Q54973806
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): ATCC=CRL-3128
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 11,12
ST   D18S51: 18
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 17,23
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 7,9
ST   D8S1179: 10,11
ST   FGA: 22
ST   Penta D: 13,14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   UACC-182
AC   CVCL_S728
SY   UACC 182; UACC182; University of Arizona Cell Culture-182
DR   Cosmic; 1020265
DR   Wikidata; Q54973808
RX   PubMed=10918183;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   UACC-1940
AC   CVCL_IN96
SY   UACC 1940; UACC1940; University of Arizona Cell Culture-1940
DR   BTO; BTO_0005896
DR   Cosmic; 1211150
DR   Wikidata; Q54973818
RX   PubMed=24879157;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   UACC-2087
AC   CVCL_4041
SY   UACC 2087; UACC2087; University of Arizona Cell Culture-2087
DR   ATCC; CRL-3180
DR   Wikidata; Q54973820
RX   PubMed=7842014;
RX   PubMed=9778046;
RX   PubMed=15153330;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val216Met (c.646G>A); ClinVar=VCV000182965; Zygosity=Unspecified (ATCC=CRL-3180).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3180
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 11
ST   D7S820: 10,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   UACC-2116
AC   CVCL_WS78
SY   UACC 2116; UACC2116; University of Arizona Cell Culture-2116
DR   Wikidata; Q98133795
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
CC   Characteristics: Established from a xenograft.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 4
//
ID   UACC-239
AC   CVCL_S729
SY   UACC 239 UACC239; University of Arizona Cell Culture-239
DR   Cosmic; 1020266
DR   Wikidata; Q54973821
RX   PubMed=10918183;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   UACC-2436
AC   CVCL_WS79
SY   UACC 2436; UACC2436; University of Arizona Cell Culture-2346
DR   Wikidata; Q98133796
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
CC   Derived from site: Metastatic; Bone, pubis; UBERON=UBERON_0001275.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 6
//
ID   UACC-245
AC   CVCL_WS80
SY   UACC 245; UACC245; University of Arizona Cell Culture-245
DR   Wikidata; Q98133797
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 6
//
ID   UACC-2534
AC   CVCL_M452
SY   UACC 2534; UACC2534; University of Arizona Cell Culture-2534
DR   BTO; BTO_0005897
DR   Cosmic; 1211155
DR   Wikidata; Q54973822
RX   PubMed=10952317;
RX   PubMed=23039341;
RX   PubMed=24879157;
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   UACC-2561
AC   CVCL_E116
SY   UACC 2561; UACC2561; University of Arizona Cell Culture-2561
DR   cancercelllines; CVCL_E116
DR   Cosmic; 730330
DR   Wikidata; Q54973823
RX   PubMed=8050085;
CC   Doubling time: 5 days (PubMed=8050085).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=8050085).
DI   NCIt; C45543; Lung carcinosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   UACC-2565
AC   CVCL_M453
SY   UACC 2565; UACC2565; University of Arizona Cell Culture-2565
DR   Wikidata; Q54973826
RX   PubMed=9973934;
RX   PubMed=19383853;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   UACC-257
AC   CVCL_1779
SY   UACC 257; UACC.257; UACC_257; UACC257; University of Arizona Cell Culture-257
DR   BTO; BTO_0004233
DR   CLO; CLO_0037135
DR   EFO; EFO_0005376
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 347
DR   BioSample; SAMN03473125
DR   BioSample; SAMN10988377
DR   cancercelllines; CVCL_1779
DR   Cell_Model_Passport; SIDM00108
DR   ChEMBL-Cells; CHEMBL3308008
DR   ChEMBL-Targets; CHEMBL612796
DR   Cosmic; 686478
DR   Cosmic; 688056
DR   Cosmic; 875890
DR   Cosmic; 905977
DR   Cosmic; 974070
DR   Cosmic; 974259
DR   Cosmic; 1054854
DR   Cosmic; 1092645
DR   Cosmic; 1175874
DR   Cosmic; 1303058
DR   Cosmic; 1305370
DR   Cosmic; 1507612
DR   Cosmic; 1998488
DR   Cosmic; 2233682
DR   Cosmic-CLP; 905977
DR   DepMap; ACH-000579
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 905977
DR   GEO; GSM2139
DR   GEO; GSM50207
DR   GEO; GSM50269
DR   GEO; GSM188228
DR   GEO; GSM188258
DR   GEO; GSM188317
DR   GEO; GSM743470
DR   GEO; GSM750818
DR   GEO; GSM799359
DR   GEO; GSM799422
DR   GEO; GSM844720
DR   GEO; GSM844721
DR   GEO; GSM847167
DR   GEO; GSM887725
DR   GEO; GSM888819
DR   GEO; GSM1153430
DR   GEO; GSM1181338
DR   GEO; GSM1181360
DR   GEO; GSM1670561
DR   GEO; GSM2124692
DR   IARC_TP53; 21098
DR   LiGeA; CCLE_557
DR   LINCS_LDP; LCL-1283
DR   NCI-DTP; UACC-257
DR   PharmacoDB; UACC257_1632_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1779
DR   PubChem_Cell_line; CVCL_1779
DR   SKY/M-FISH/CGH; 2826
DR   Wikidata; Q54973827
RX   PubMed=2041050;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=17308088;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23039341;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=24879157;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29492214;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=50
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Doubling time: >50 hours (PubMed=8631022); 38.5 hours (NCI-DTP=UACC-257).
CC   HLA typing: A*02:01:01; B*18,44; C*05,07; DPB1*04:01; DQB1*03:01:01,03:02; DRB1*04:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,02:01; B*37:09,44:02; C*05:01,07:04; DQA1*03:02,03:02; DQB1*03:02,03:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Unspecified (PubMed=29492214).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17088437; Cosmic-CLP=905977; DepMap=ACH-000579).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (Cosmic-CLP=905977; DepMap=ACH-000579).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.57%; East Asian, North=0.83%; East Asian, South=0%; South Asian=0%; European, North=65.94%; European, South=32.65% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=905977; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,13
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 12,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 9,12
ST   Penta E: 10
ST   TH01: 8
ST   TPOX: 9,12
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 47
//
ID   UACC-2648
AC   CVCL_W021
SY   UACC 2648; UACC2648; University of Arizona Cell Culture-2648
DR   ATCC; CRL-3121
DR   Wikidata; Q54973828
RX   PubMed=9778046;
CC   Population: Caucasian.
CC   Characteristics: ER-positive, PR-positive and ERBB2-negative (ATCC=CRL-3121).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3121
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 8
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,15
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 11
//
ID   UACC-265
AC   CVCL_WS81
SY   UACC 265; UACC265; University of Arizona Cell Culture-265
DR   Wikidata; Q98133798
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 6
//
ID   UACC-2715
AC   CVCL_ZE36
SY   UACC 2715; UACC2715; University of Arizona Cell Culture-2715
DR   ATCC; CRL-3190
DR   Wikidata; Q98133799
RX   PubMed=7842014;
CC   Discontinued: ATCC; CRL-3190; true.
ST   Source(s): ATCC=CRL-3190
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 10
ST   D7S820: 11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   UACC-2837
AC   CVCL_DG40
SY   UACC 2837; UACC2837; University of Arizona Cell Culture-2837
DR   Wikidata; Q54973829
RX   PubMed=23039341;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 5
//
ID   UACC-2972
AC   CVCL_1G28
SY   UACC 2972; UACC2972; University of Arizona Cell Culture-2972
DR   Wikidata; Q54973830
RX   PubMed=12115485;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 5
//
ID   UACC-2973
AC   CVCL_M454
SY   UACC 2973; UACC2973; University of Arizona Cell Culture-2973
DR   Wikidata; Q54973832
RX   PubMed=10952317;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   UACC-2996
AC   CVCL_W092
SY   UACC 2996; UACC2996; University of Arizona Cell Culture-2996
DR   ATCC; CRL-3123
DR   Wikidata; Q54973833
CC   Discontinued: ATCC; CRL-3123; true.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   UACC-3074
AC   CVCL_M455
SY   UACC 3074; UACC3074; University of Arizona Cell Culture-3074
DR   Wikidata; Q54973834
RX   PubMed=19383853;
RX   PubMed=23039341;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 8
//
ID   UACC-3093
AC   CVCL_A692
SY   UACC 3093; UACC3093; University of Arizona Cell Culture-3093
DR   Cosmic; 1211163
DR   Wikidata; Q54973835
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UACC-3133
AC   CVCL_B221
SY   UACC 3133; UACC3133; University of Arizona Cell Culture-3133
DR   ATCC; CRL-2988
DR   DepMap; ACH-001683
DR   Wikidata; Q54973837
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Characteristics: ER-positive, PR-negative and ERBB2-positive (ATCC=CRL-2988).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-2988
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 9,11
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 15
//
ID   UACC-3149
AC   CVCL_M456
SY   UACC 3149; UACC3149; University of Arizona Cell Culture-3149
DR   Wikidata; Q54973838
RX   PubMed=10952317;
DI   NCIt; C7700; Ovarian adenocarcinoma
DI   ORDO; Orphanet_213504; Adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   UACC-3199
AC   CVCL_4042
SY   UACC 3199; UACC3199; University of Arizona Cell Culture-3199
DR   ATCC; CRL-2983
DR   BioSample; SAMN03471703
DR   cancercelllines; CVCL_4042
DR   GEO; GSM481329
DR   GEO; GSM3145604
DR   GEO; GSM3145743
DR   PharmacoDB; UACC3199_1633_2019
DR   Progenetix; CVCL_4042
DR   Wikidata; Q54973840
RX   PubMed=9778046;
CC   Population: Caucasian.
CC   Characteristics: ER-negative, PR-negative and ERBB2-positive (ATCC=CRL-2983).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): ATCC=CRL-2983
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 20
ST   D19S433: 16
ST   D21S11: 30.2
ST   D2S1338: 23
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 11,13
ST   FGA: 23
ST   Penta D: 12
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 10,13
ST   vWA: 15,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   UACC-3247
AC   CVCL_W091
SY   UACC 3247; UACC3247; University of Arizona Cell Culture-3247
DR   ATCC; CRL-3124
DR   Wikidata; Q54973842
CC   Discontinued: ATCC; CRL-3124; true.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 7
//
ID   UACC-325
AC   CVCL_4043
SY   UACC 325; UACC325; University of Arizona Cell Culture-325
DR   Wikidata; Q54973843
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 8
//
ID   UACC-3291
AC   CVCL_IN97
SY   UACC 3291; UACC3291; University of Arizona Cell Culture-3291
DR   BTO; BTO_0005883
DR   Wikidata; Q54973845
RX   PubMed=24879157;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 5
//
ID   UACC-375
AC   CVCL_M457
SY   UACC 375; UACC375; University of Arizona Cell Culture-375
DR   ChEMBL-Cells; CHEMBL3307880
DR   ChEMBL-Targets; CHEMBL614127
DR   PubChem_Cell_line; CVCL_M457
DR   Wikidata; Q54973846
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 8
//
ID   UACC-383
AC   CVCL_4044
SY   UACC 383; UACC383; University of Arizona Cell Culture-383
DR   Wikidata; Q54973847
RX   PubMed=1371813;
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   UACC-456
AC   CVCL_4045
SY   UACC 456; UACC456; University of Arizona Cell Culture-456
DR   Wikidata; Q54973848
RX   PubMed=1371813;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   UACC-457
AC   CVCL_4046
SY   UACC 457; UACC457; University of Arizona Cell Culture-457
DR   Wikidata; Q54973849
RX   PubMed=9973934;
RX   PubMed=10952317;
RX   PubMed=19383853;
CC   Derived from site: Metastatic; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   UACC-462
AC   CVCL_4047
SY   UACC 462; UACC462; University of Arizona Cell Culture-462
DR   ATCC; CRL-2989
DR   Wikidata; Q54973851
RX   PubMed=3014534;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Peritoneum; UBERON=UBERON_0002358.
ST   Source(s): ATCC=CRL-2989
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 13
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 15
//
ID   UACC-502
AC   CVCL_M458
SY   UACC 502; UACC502; University of Arizona Cell Culture-502
DR   BTO; BTO_0005898
DR   Wikidata; Q54973852
RX   PubMed=9973934;
RX   PubMed=10952317;
RX   PubMed=12115485;
RX   PubMed=24879157;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   UACC-537
AC   CVCL_S730
SY   UACC 537; UACC537; University of Arizona Cell Culture-537
DR   Cosmic; 1020267
DR   Wikidata; Q54973853
RX   PubMed=10918183;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   UACC-558
AC   CVCL_DG41
SY   UACC 558; UACC558; University of Arizona Cell Culture-558
DR   Wikidata; Q54973854
RX   PubMed=23039341;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 5
//
ID   UACC-608
AC   CVCL_4048
SY   UACC 608; UACC608; University of Arizona Cell Culture-608
DR   Wikidata; Q54973857
RX   PubMed=1371813;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   UACC-612
AC   CVCL_VP02
SY   UACC 612; UACC612; University of Arizona Cell Culture-612
DR   Wikidata; Q98133800
RX   PubMed=9973934;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   UACC-62
AC   CVCL_1780
SY   UACC 62; UACC.62; UACC_62; UACC62; University of Arizona Cell Culture-62
DR   BTO; BTO_0004152
DR   EFO; EFO_0005377
DR   AddexBio; C0020003/414
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 346
DR   BioSample; SAMN03473228
DR   BioSample; SAMN10987794
DR   cancercelllines; CVCL_1780
DR   Cell_Model_Passport; SIDM00107
DR   ChEMBL-Cells; CHEMBL3307660
DR   ChEMBL-Targets; CHEMBL614610
DR   Cosmic; 686477
DR   Cosmic; 687447
DR   Cosmic; 875888
DR   Cosmic; 897469
DR   Cosmic; 905976
DR   Cosmic; 974067
DR   Cosmic; 974260
DR   Cosmic; 1044267
DR   Cosmic; 1092646
DR   Cosmic; 1132590
DR   Cosmic; 1175875
DR   Cosmic; 1303059
DR   Cosmic; 1305371
DR   Cosmic; 1312352
DR   Cosmic; 1537484
DR   Cosmic; 1888915
DR   Cosmic; 1998489
DR   Cosmic; 2791114
DR   Cosmic-CLP; 905976
DR   DepMap; ACH-000425
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 905976
DR   GEO; GSM2091
DR   GEO; GSM50208
DR   GEO; GSM50271
DR   GEO; GSM188229
DR   GEO; GSM188259
DR   GEO; GSM188318
DR   GEO; GSM743471
DR   GEO; GSM750828
DR   GEO; GSM799360
DR   GEO; GSM799423
DR   GEO; GSM844722
DR   GEO; GSM847168
DR   GEO; GSM887726
DR   GEO; GSM888820
DR   GEO; GSM1153431
DR   GEO; GSM1178679
DR   GEO; GSM1178680
DR   GEO; GSM1178681
DR   GEO; GSM1181275
DR   GEO; GSM1181277
DR   GEO; GSM1670562
DR   GEO; GSM2124693
DR   GEO; GSM3195611
DR   GEO; GSM3195612
DR   IARC_TP53; 21099
DR   LiGeA; CCLE_503
DR   NCI-DTP; UACC-62
DR   PharmacoDB; UACC62_1634_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1780
DR   PubChem_Cell_line; CVCL_1780
DR   SKY/M-FISH/CGH; 2827
DR   Wikidata; Q54973858
RX   DOI=10.1101/381806;
RX   PubMed=2041050;
RX   PubMed=8631022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=12068308;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=19727395;
RX   PubMed=20041153;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22460905;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=29492214;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=31978347;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=49
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 31 hours (PubMed=8631022); 31.3 hours (NCI-DTP=UACC-62).
CC   HLA typing: A*02,32; B*39,44; C*05,12; DPB1*04:01,14:01; DQB1*03:01:01,06:03; DRB1*12,13:01:01 (PubMed=15748285).
CC   HLA typing: A*02:01,32:03; B*39:01,44:02; C*05:01,12:03; DQA1*01:03,05:02; DQB1*03:09,06:11 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=12068308; PubMed=17088437; PubMed=29492214; Cosmic-CLP=905976; DepMap=ACH-000425).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro248Thrfs*5 (c.741dupA) (c.741_742insA); ClinVar=VCV000142259; Zygosity=Homozygous (PubMed=17088437; Cosmic-CLP=905976; DepMap=ACH-000425).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.45%; Native American=0%; East Asian, North=0.45%; East Asian, South=0%; South Asian=1.83%; European, North=67.39%; European, South=29.88% (PubMed=30894373).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Cosmic-CLP=905976; PubMed=19372543; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 15
ST   D19S433: 15
ST   D21S11: 28,31
ST   D2S1338: 18,20
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 23
ST   Penta D: 11,12
ST   Penta E: 5,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 47
//
ID   UACC-647
AC   CVCL_4049
SY   UACC 647; UACC647; University of Arizona Cell Culture-647
DR   BTO; BTO_0005063
DR   Cosmic; 1020270
DR   Wikidata; Q54973859
RX   PubMed=9973934;
RX   PubMed=10952317;
RX   PubMed=23039341;
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   UACC-732
AC   CVCL_4050
SY   UACC 732; UACC732; University of Arizona Cell Culture-732
DR   ATCC; CRL-3166
DR   Cosmic; 1348960
DR   Wikidata; Q54973860
RX   PubMed=7842014;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Characteristics: ER-negative, PR-positive and ERBB2-positive (ATCC=CRL-3166).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ATCC=CRL-3166
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,12
ST   D16S539: 9,10
ST   D5S818: 13,14
ST   D7S820: 12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UACC-793
AC   CVCL_S731
SY   UACC 793; UACC793; University of Arizona Cell Culture-793
DR   Cosmic; 1020268
DR   Wikidata; Q54973862
RX   PubMed=10918183;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   UACC-812
AC   CVCL_1781
SY   UACC 812; UACC812; University of Arizona Cell Culture-812
DR   BTO; BTO_0006220
DR   CLO; CLO_0009467
DR   EFO; EFO_0001258
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-1897
DR   BioSample; SAMN03471261
DR   BioSample; SAMN03471377
DR   BioSample; SAMN10988448
DR   cancercelllines; CVCL_1781
DR   CCRID; 1101HUM-PUMC000119
DR   Cell_Model_Passport; SIDM01187
DR   ChEMBL-Cells; CHEMBL3308475
DR   ChEMBL-Targets; CHEMBL1075604
DR   Cosmic; 687501
DR   Cosmic; 871158
DR   Cosmic; 894093
DR   Cosmic; 904396
DR   Cosmic; 910910
DR   Cosmic; 997926
DR   Cosmic; 1046963
DR   Cosmic; 1136361
DR   Cosmic; 1287902
DR   Cosmic; 1289419
DR   Cosmic; 1523774
DR   Cosmic; 1603227
DR   Cosmic; 2165014
DR   Cosmic-CLP; 910910
DR   DepMap; ACH-000568
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 910910
DR   GEO; GSM1717
DR   GEO; GSM73722
DR   GEO; GSM115104
DR   GEO; GSM217606
DR   GEO; GSM344359
DR   GEO; GSM344409
DR   GEO; GSM350516
DR   GEO; GSM421895
DR   GEO; GSM481327
DR   GEO; GSM783969
DR   GEO; GSM844723
DR   GEO; GSM847441
DR   GEO; GSM847508
DR   GEO; GSM887727
DR   GEO; GSM888821
DR   GEO; GSM984234
DR   GEO; GSM1008920
DR   GEO; GSM1053723
DR   GEO; GSM1172906
DR   GEO; GSM1173002
DR   GEO; GSM1215270
DR   GEO; GSM1670563
DR   GEO; GSM2258776
DR   GEO; GSM2258777
DR   GEO; GSM2258778
DR   GEO; GSM2258779
DR   GEO; GSM2258780
DR   GEO; GSM2258781
DR   GEO; GSM2258782
DR   GEO; GSM2258783
DR   GEO; GSM2258784
DR   GEO; GSM2258785
DR   GEO; GSM2258786
DR   GEO; GSM2258787
DR   GEO; GSM2258788
DR   GEO; GSM2258789
DR   GEO; GSM2258790
DR   GEO; GSM2258791
DR   GEO; GSM2258792
DR   GEO; GSM2258793
DR   GEO; GSM2258953
DR   GEO; GSM2258954
DR   GEO; GSM2258955
DR   IARC_TP53; 21097
DR   IGRhCellID; UACC812
DR   LiGeA; CCLE_335
DR   LINCS_HMS; 50556
DR   LINCS_LDP; LCL-1319
DR   PharmacoDB; UACC812_1635_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1781
DR   PubChem_Cell_line; CVCL_1781
DR   SLKBase; 3625
DR   Wikidata; Q54973863
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=1674877;
RX   PubMed=7842014;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11343771;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 100 hours (PubMed=1674877); 104.68 hours (JWGray panel).
CC   HLA typing: A*68:01,02:05; B*15:03,51:01; C*08:01,12:03; DQB1*02:01,04:01; DRB1*08:04,04:04 (PubMed=25960936).
CC   HLA typing: A*02:14,68:01; B*46:01,51:01; C*08:01,12:03 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ser1140Gly (c.3418A>G); ClinVar=VCV000041817; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Thr522Ile (c.1565C>T); ClinVar=VCV000216588; Zygosity=Heterozygous (PubMed=19593635).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=6.53%; Native American=50.48%; East Asian, North=6.42%; East Asian, South=0%; South Asian=1.78%; European, North=13.71%; European, South=21.07% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-1897; CCRID=1101HUM-PUMC000119; Cosmic-CLP=910910; PubMed=25877200; PubMed=28889351
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 8,11
ST   D18S51: 14,20
ST   D19S433: 15,15.2
ST   D21S11: 29,32.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9 (CCRID=1101HUM-PUMC000119; PubMed=25877200)
ST   D7S820: 9,12 (ATCC=CRL-1897; Cosmic-CLP=910910; PubMed=28889351)
ST   D8S1179: 12,15
ST   FGA: 25
ST   Penta D: 10,11
ST   Penta E: 14,18
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   UACC-827
AC   CVCL_4051
SY   UACC 827; UACC827; University of Arizona Cell Culture-827
DR   Wikidata; Q54973865
RX   PubMed=1371813;
RX   PubMed=9973934;
RX   PubMed=10952317;
RX   PubMed=12115485;
RX   PubMed=19383853;
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UACC-893
AC   CVCL_1782
SY   UACC 893; UACC893; University of Arizona Cell Culture-893
DR   BTO; BTO_0003443
DR   CLO; CLO_0009468
DR   EFO; EFO_0002385
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1902
DR   BioGRID_ORCS_Cell_line; 1040
DR   BioSample; SAMN03472115
DR   BioSample; SAMN10988479
DR   cancercelllines; CVCL_1782
DR   Cell_Model_Passport; SIDM01186
DR   ChEMBL-Cells; CHEMBL3308807
DR   ChEMBL-Targets; CHEMBL1075605
DR   Cosmic; 687502
DR   Cosmic; 871151
DR   Cosmic; 894092
DR   Cosmic; 897416
DR   Cosmic; 904397
DR   Cosmic; 909778
DR   Cosmic; 1017162
DR   Cosmic; 1018469
DR   Cosmic; 1044233
DR   Cosmic; 1046943
DR   Cosmic; 1047718
DR   Cosmic; 1136362
DR   Cosmic; 1287903
DR   Cosmic; 1289420
DR   Cosmic; 1523773
DR   Cosmic; 1603228
DR   Cosmic; 2165015
DR   Cosmic-CLP; 909778
DR   DepMap; ACH-000554
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909778
DR   GEO; GSM69197
DR   GEO; GSM73728
DR   GEO; GSM344384
DR   GEO; GSM344434
DR   GEO; GSM350529
DR   GEO; GSM421896
DR   GEO; GSM481326
DR   GEO; GSM783959
DR   GEO; GSM887728
DR   GEO; GSM888822
DR   GEO; GSM1053703
DR   GEO; GSM1172907
DR   GEO; GSM1173003
DR   GEO; GSM1215273
DR   GEO; GSM1238125
DR   GEO; GSM1670564
DR   IARC_TP53; 18369
DR   IGRhCellID; UACC893
DR   LiGeA; CCLE_058
DR   LINCS_HMS; 50557
DR   LINCS_LDP; LCL-1320
DR   PharmacoDB; UACC893_1636_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1782
DR   PubChem_Cell_line; CVCL_1782
DR   Wikidata; Q54973866
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=1674877;
RX   PubMed=7842014;
RX   PubMed=9778046;
RX   PubMed=10862037;
RX   PubMed=11343771;
RX   PubMed=15153330;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23601657;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 120 hours (PubMed=1674877); 248.53 hours (JWGray panel).
CC   HLA typing: B*46:01; C*16:01,06:02 (PubMed=25960936).
CC   HLA typing: A*01:01,29:02; B*07:17,15:50; C*16:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.His233Gln (c.699C>G); ClinVar=VCV000233773; Zygosity=Homozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (PubMed=19593635; ATCC=CRL-1902).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=16541312; ATCC=CRL-1902).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.96%; Native American=0%; East Asian, North=4.64%; East Asian, South=0%; South Asian=0%; European, North=57.9%; European, South=35.5% (PubMed=30894373).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): ATCC=CRL-1902; Cosmic-CLP=909778; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,13.1
ST   D21S11: 28,30.2
ST   D2S1338: 19,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 9,12
ST   Penta E: 13,17
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   UACC-903
AC   CVCL_4052
SY   UACC 903; UACC903; University of Arizona Cell Culture-903
DR   BTO; BTO_0005060
DR   EFO; EFO_0022581
DR   cancercelllines; CVCL_4052
DR   ChEMBL-Cells; CHEMBL3307961
DR   ChEMBL-Targets; CHEMBL612446
DR   Cosmic; 706103
DR   Cosmic; 888843
DR   Cosmic; 897489
DR   Cosmic; 905860
DR   Cosmic; 1020269
DR   Lonza; 39
DR   PubChem_Cell_line; CVCL_4052
DR   Wikidata; Q54973868
RX   PubMed=2068080;
RX   PubMed=2300817;
RX   PubMed=9598804;
RX   PubMed=9692547;
RX   PubMed=9823299;
RX   PubMed=9973934;
RX   PubMed=10766161;
RX   PubMed=10952317;
RX   PubMed=12115485;
RX   PubMed=15009714;
RX   PubMed=19383853;
RX   PubMed=23039341;
RX   PubMed=24879157;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Unspecified (PubMed=15009714).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr76Ter (c.228T>G); ClinVar=VCV000546013; Zygosity=Unspecified (PubMed=9692547; PubMed=10766161; PubMed=15009714).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Back; UBERON=UBERON_0001137.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   UACC-91
AC   CVCL_M447
SY   UACC 91; UACC91; UACC-091; UACC 091; UACC091; University of Arizona Cell Culture-91
DR   BTO; BTO_0005899
DR   Wikidata; Q54973869
RX   PubMed=2300817;
RX   PubMed=10952317;
RX   PubMed=23039341;
RX   PubMed=24879157;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 12
//
ID   UACC-929
AC   CVCL_M459
SY   UACC 929; UACC929; University of Arizona Cell Culture-929
DR   Wikidata; Q54973871
RX   PubMed=9973934;
RX   PubMed=19383853;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-09-24; Version: 9
//
ID   UACC-930
AC   CVCL_4053
SY   UACC 930; UACC930; University of Arizona Cell Culture-930
DR   Wikidata; Q54973873
RX   PubMed=10952317;
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UACC-SARC1
AC   CVCL_A7NG
SY   University of Arizona Cell Culture-SARComa 1
DR   ArrayExpress; E-MEXP-3419
DR   BioSamples; SAMEA1633151
DR   Wikidata; Q107117184
RX   PubMed=25644184;
CC   Characteristics: Obtained from a radiation-induced sarcoma.
CC   Doubling time: 28.3 hours (PubMed=25644184).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): PubMed=25644184
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 11,14
ST   D18S51: 12
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 25
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   TH01: 6,7
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 4
//
ID   UACC62-RMR
AC   CVCL_A1VN
SY   UACC62 RMR; UACC62 SKIN CJ1
DR   cancercelllines; CVCL_A1VN
DR   Cell_Model_Passport; SIDM01416
DR   DepMap; ACH-002004
DR   Wikidata; Q105511311
RX   PubMed=31882401;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Selected for resistance to: ChEBI; CHEBI_75998; Trametinib (Mekinist; GSK1120212).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (DepMap=ACH-002004).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro248Thrfs*5 (c.741dupA) (c.741_742insA); ClinVar=VCV000142259; Zygosity=Homozygous (DepMap=ACH-002004).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1780 ! UACC-62
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   UACC62R
AC   CVCL_WU69
DR   cancercelllines; CVCL_WU69
DR   GEO; GSM3195613
DR   GEO; GSM3195614
DR   Wikidata; Q98133801
RX   DOI=10.1101/381806;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Pro248Thrfs*5 (c.741dupA) (c.741_742insA); ClinVar=VCV000142259; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1780 ! UACC-62
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 8
//
ID   UALGi001-A
AC   CVCL_A7IV
SY   VITAL 16; VITAL16
DR   hPSCreg; UALGi001-A
DR   Wikidata; Q107117186
RX   PubMed=33799278;
CC   From: Universidade do Algarve; Faro; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UALGi002-A
AC   CVCL_A7IU
SY   VITAL 8; VITAL8
DR   hPSCreg; UALGi002-A
DR   Wikidata; Q107117187
RX   PubMed=34280889;
CC   From: Universidade do Algarve; Faro; Portugal.
CC   Population: Caucasian; Portuguese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UAMi001-A
AC   CVCL_QX83
SY   PCCA23-FiPS4F8
DR   BioSamples; SAMEA110403759
DR   hPSCreg; UAMi001-A
DR   Wikidata; Q54973881
RX   PubMed=28925364;
RX   PubMed=33503868;
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Gly477Glufs*9 (c.1430-?_1643+?del); Zygosity=Heterozygous (PubMed=28925364).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Cys616_Val633del (c.1899+4_1899+7delAGTA) (1824IVS+3del4) (IVS21+3del4); Zygosity=Heterozygous (PubMed=28925364).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UM92 ! UAMi001-B
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 16
//
ID   UAMi001-B
AC   CVCL_UM92
SY   PCCA23-FiPS4F6
DR   Wikidata; Q98133802
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Solicitud_deposito_IPS-PCCA23-Fi%2520PS4F6-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Gly477Glufs*9 (c.1430-?_1643+?del); Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Cys616_Val633del (c.1899+4_1899+7delAGTA) (1824IVS+3del4) (IVS21+3del4); Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_QX83 ! UAMi001-A
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   UAMi002-A
AC   CVCL_VF02
SY   MMAB35-FiPS4F4; MMAB35-FiS4F4
DR   hPSCreg; UAMi002-A
DR   Wikidata; Q54973883
RX   PubMed=29660608;
RX   PubMed=35569737;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_06_IPS_MMAB35-FiPS4F4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_06ANEXOS_A_LA_SOLICITUD_DE_DEPOSITO_DE_LA_LINEA_CELULAR_MMAB35-FiPS4F4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Ile96Thr (c.287T>C); ClinVar=VCV000218323; Zygosity=Heterozygous (PubMed=29660608).
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Ser174Cysfs*23 (c.584G>A); Zygosity=Heterozygous (PubMed=29660608).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   UAMi003-A
AC   CVCL_VF03
SY   MMAB44-FiPS4F11; MMAB44-FiS4F11
DR   hPSCreg; UAMi003-A
DR   Wikidata; Q54973885
RX   PubMed=29660608;
RX   PubMed=35569737;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/2017_06_06_IPS_MMAB44-FiPS4F11.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/2017_06_06ANEXOS_SOLICITUD_DEPOSITO_LINEA_CELULAR_MMAB44-FiPS4F11.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Ile96Thr (c.287T>C); ClinVar=VCV000218323; Zygosity=Heterozygous (PubMed=29660608).
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Ser174Cysfs*23 (c.584G>A); Zygosity=Heterozygous (PubMed=29660608).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 15
//
ID   UAMi004-A
AC   CVCL_WT14
SY   PCCB10-FiPS4F1
DR   hPSCreg; UAMi004-A
DR   Wikidata; Q98133803
RX   PubMed=31132581;
RX   PubMed=31365893;
RX   PubMed=33128956;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_PCCB10-FiPS4F-1-%2520genetically%2520corrected-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Homozygous (PubMed=31132581).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 10
//
ID   UAMi004-A-1
AC   CVCL_A1XD
SY   PCCB10-FiPS4F-1-genetically corrected; UAMi006-A
DR   hPSCreg; UAMi004-A-1
DR   Wikidata; Q105511313
RX   PubMed=33128956;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/ed1fe370-9476-de16-b79d-82e23075a747
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8654; PCCB; Simple_corrected; p.Gly407Argfs*14 (c.1218_1231delGGGCATCATCCGGCinsTAGAGCACAGGA) (c.1218_1231del14ins12); ClinVar=VCV000038875; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33128956).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WT14 ! UAMi004-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UAMi005-A
AC   CVCL_WT15
SY   GLDC27-FiPS4F-1; GLDC27-1
DR   BioSamples; SAMEA110403758
DR   hPSCreg; UAMi005-A
DR   Wikidata; Q98133804
RX   PubMed=31349202;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_Lineas_GLDC27-FiPS4F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Biologia Molecular Severo Ochoa, Universidad Autonoma de Madrid; Madrid; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4313; GLDC; Simple; p.Pro581Arg (c.1742C>G); ClinVar=VCV000216936; Zygosity=Heterozygous (PubMed=31349202).
CC   Sequence variation: Mutation; HGNC; HGNC:4313; GLDC; Simple; p.Arg790Trp (c.2368C>T); ClinVar=VCV000056075; Zygosity=Heterozygous (PubMed=31349202).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84937; Glycine encephalopathy
DI   ORDO; Orphanet_407; Glycine encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 13
//
ID   UAMS-32
AC   CVCL_D624
SY   UAMS32; University of Arkansas for Medical Sciences-32
DR   BTO; BTO_0005307
DR   Wikidata; Q54973886
RX   PubMed=10383440;
RX   PubMed=12364326;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   UAMS-32P
AC   CVCL_A8QR
DR   Wikidata; Q108821416
RX   PubMed=12364326;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9608; PTH1R.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D624 ! UAMS-32
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UAMS-33
AC   CVCL_D625
SY   U-33; University of Arkansas for Medical Sciences-33
DR   Wikidata; Q54973887
RX   PubMed=10412038;
RX   PubMed=19115254;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: SAMR1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   4-6M
CA   Spontaneously immortalized cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 9
//
ID   UAZTi009-A
AC   CVCL_C4P1
SY   MKAZ1
DR   BioSamples; SAMEA111453034
DR   hPSCreg; UAZTi009-A
DR   Wikidata; Q116050662
RX   PubMed=36257093;
CC   From: University of Arizona; Tucson; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:17944; EXOSC3; Simple; p.Asp132Ala (c.395A>C); ClinVar=VCV000031688; Zygosity=Heterozygous (PubMed=36257093).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   UAZTi010-A
AC   CVCL_C4P2
SY   MKAZ2
DR   hPSCreg; UAZTi010-A
DR   Wikidata; Q116050664
CC   From: University of Arizona; Tucson; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UAZTi011-A
AC   CVCL_C4P3
SY   MKAZ3
DR   BioSamples; SAMEA111453036
DR   hPSCreg; UAZTi011-A
DR   Wikidata; Q116050665
RX   PubMed=36257093;
CC   From: University of Arizona; Tucson; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:17944; EXOSC3; Simple; p.Asp132Ala (c.395A>C); ClinVar=VCV000031688; Zygosity=Homozygous (PubMed=36257093).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C190872; Pontocerebellar hypoplasia type 1B
DI   ORDO; Orphanet_2254; Pontocerebellar hypoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   UB/OC-1
AC   CVCL_9636
SY   University of Bristol/Organ of Corti-1; UB-OC1; UBOC-1; UBOC1
DR   EFO; EFO_0001259
DR   CancerTools; 153622
DR   GEO; GSE36
DR   Wikidata; Q54973888
DR   Ximbio; 153622
RX   PubMed=9753783;
RX   PubMed=12097346;
RX   PubMed=12382283;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   UB/OC-2
AC   CVCL_D790
SY   UB-OC2; University of Bristol/Organ of Corti-2
DR   CancerTools; 153623
DR   Wikidata; Q54973889
DR   Ximbio; 153623
RX   PubMed=9753783;
RX   PubMed=12382283;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, inner ear, cochlea, organ of Corti; UBERON=UBERON_0002227.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   UB/UE-1
AC   CVCL_D807
SY   UB-UE1; University of Bristol/Utricular Epithelium-1
DR   CancerTools; 153624
DR   Wikidata; Q54973890
DR   Ximbio; 153624
RX   PubMed=10531448;
RX   PubMed=12382283;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, utricular macula; UBERON=UBERON_0002214.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   2D
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   UBCi001-A
AC   CVCL_YC92
SY   GRN-R418X; R418X+/-
DR   hPSCreg; UBCi001-A
DR   Wikidata; Q98133805
RX   PubMed=31707213;
CC   From: University of British Columbia; Vancouver; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4601; GRN; Simple; p.Arg418Ter (c.1252C>T); ClinVar=VCV000098177; Zygosity=Heterozygous (PubMed=31707213).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UBCi002-A
AC   CVCL_C9IB
DR   BioSamples; SAMEA112937624
DR   hPSCreg; UBCi002-A
DR   Wikidata; Q123033673
RX   PubMed=37531724;
CC   From: University of British Columbia; Vancouver; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8514; CLDN11; Simple; p.Ter208Glnext*39 (c.622T>C); ClinVar=VCV001106668; Zygosity=Heterozygous (PubMed=37531724).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C201587; Hypomyelinating leukodystrophy-22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UBE6T-15
AC   CVCL_3222
SY   UBET-15
DR   CLO; CLO_0051558
DR   BioSample; SAMN03472472
DR   JCRB; JCRB1159
DR   JCRB; NIHS0456
DR   RCB; RCB2162
DR   SKIP; SKIP000724
DR   Wikidata; Q54973891
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0456; true.
CC   Discontinued: RCB; RCB2162; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1159; RCB=RCB2162
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   UBE6T-6
AC   CVCL_3223
SY   UBET-6
DR   CLO; CLO_0051552
DR   JCRB; JCRB1140
DR   JCRB; NIHS0450
DR   RCB; RCB2156
DR   SKIP; SKIP000714
DR   Wikidata; Q54973892
RX   PubMed=15923633;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0450; true.
CC   Discontinued: RCB; RCB2156; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1140; RCB=RCB2156
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   UBE6T-7
AC   CVCL_3224
SY   UBET-7
DR   CLO; CLO_0051553
DR   BioSample; SAMN03472463
DR   JCRB; JCRB1143
DR   JCRB; NIHS0451
DR   RCB; RCB2157
DR   SKIP; SKIP000715
DR   Wikidata; Q54973893
RX   PubMed=15293342;
RX   PubMed=15923633;
RX   PubMed=21155951;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0451; true.
CC   Discontinued: RCB; RCB2157; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1143; RCB=RCB2157
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   UBE6T-8
AC   CVCL_6F33
SY   UBET-8
DR   Wikidata; Q54973894
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 13
//
ID   UBi001-A
AC   CVCL_YM94
SY   WT1-iPS; WT-iPS
DR   BioSamples; SAMEA6298140
DR   hPSCreg; UBi001-A
DR   Wikidata; Q98133807
RX   PubMed=26411903;
RX   PubMed=31731183;
RX   PubMed=31825816;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+WT1-iPS+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/WT1-iPS%2520Anexo%2520I.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   UBi001-A-1
AC   CVCL_YM95
SY   HGSNAT1; HGSNAT-1
DR   BioSamples; SAMEA6286047
DR   hPSCreg; UBi001-A-1
DR   Wikidata; Q98133808
RX   PubMed=31731183;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+HGSNAT1+Solicitud+de+dep%C3%B3sito+v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/HGSNAT1%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple_edited; p.Asn94Glyfs*15 (c.279_294del) (p.Asn66Glyfs*15, c.195_210del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31731183).
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple_edited; p.Tyr98Hisfs*17 (c.291_292insCA) (p.Tyr70Hisfs*17, c.207_208insCA); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31731183).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YM94 ! UBi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   UBi001-A-2
AC   CVCL_YM96
SY   HGSNAT2; HSGNAT-2
DR   BioSamples; SAMEA6298141
DR   hPSCreg; UBi001-A-2
DR   Wikidata; Q98133809
RX   PubMed=31731183;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+HGSNAT2+Solicitud+de+dep%C3%B3sito+v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/HGSNAT2%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple_edited; p.Asn94Glyfs*15 (c.279_294del) (p.Asn66Glyfs*15, c.195_210del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31731183).
CC   Sequence variation: Mutation; HGNC; HGNC:26527; HGSNAT; Simple_edited; p.Tyr98Ter (c.293delinsGAATG) (p.Tyr70Ter, c.209delinsGAATG); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=31731183).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C84899; Mucopolysaccharidosis type IIIC
DI   ORDO; Orphanet_79271; Sanfilippo syndrome type C
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YM94 ! UBi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   UBi001-A-3
AC   CVCL_YN11
SY   NAGLU3; NAGLU-3
DR   hPSCreg; UBi001-A-3
DR   Wikidata; Q98133810
RX   PubMed=31825816;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+NAGLU3+Solicitud+de+dep%C3%B3sito-v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/NAGLU3%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple_edited; p.Phe288_Ile290del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31825816).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YM94 ! UBi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   UBi001-A-4
AC   CVCL_YN12
SY   NAGLU4; NAGLU-4
DR   hPSCreg; UBi001-A-4
DR   Wikidata; Q98133811
RX   PubMed=31825816;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+NAGLU4+Solicitud+de+dep%C3%B3sito+v3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/NAGLU4%2520Anexo.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple_edited; p.Phe288Ilefs*27; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=31825816).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 10,13
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YM94 ! UBi001-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   UBi002-A
AC   CVCL_A8PA
DR   BioSamples; SAMEA9000816
DR   hPSCreg; UBi002-A
DR   Wikidata; Q108821417
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 5
//
ID   UBi003-A
AC   CVCL_A8PB
DR   hPSCreg; UBi003-A
DR   Wikidata; Q108821418
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   UBi004-A
AC   CVCL_A8PC
DR   hPSCreg; UBi004-A
DR   Wikidata; Q108821419
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 4
//
ID   UBi005-A
AC   CVCL_C1WY
SY   BJ_iPSC_SV4F_9
DR   BioSamples; SAMEA110745367
DR   hPSCreg; UBi005-A
DR   Wikidata; Q114313149
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+BJiPSC_SV4F_9+Solicitud+de+dep%C3%B3sito.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/BJiPSC_SV4F_9%2520Anexo-v2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 7,8
ST   TPOX: 10,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   Ubigene 22Rv1 ATM KO
AC   CVCL_D7FW
SY   ATM Knockout cell line (22Rv1)
DR   Ubigene; YKO-H222
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 22Rv1 NQO1 KO
AC   CVCL_D7FX
SY   NQO1 Knockout cell line (22Rv1)
DR   Ubigene; YKO-H169
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2874; NQO1.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 22Rv1 PRDX5 KO
AC   CVCL_D7FY
SY   PRDX5 Knockout cell line (22Rv1)
DR   Ubigene; YKO-H206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9355; PRDX5.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 22Rv1 ZBTB33 KO
AC   CVCL_D7FZ
SY   ZBTB33 Knockout cell line (22Rv1)
DR   Ubigene; YKO-H691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16682; ZBTB33.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Leu597Arg (c.1790T>G); ClinVar=VCV000013968; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1252Ter (c.3754C>T); ClinVar=VCV000167228; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gln3158Ter (c.9472C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln546Arg (c.1637A>G); ClinVar=VCV000045466; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Arg (c.992A>G); ClinVar=VCV000421319; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1045 ! 22Rv1
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 266-6 Stx17 KO
AC   CVCL_D7G0
SY   Stx17 Knockout cell line (266-6)
DR   Ubigene; YKO-M229
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914977; Stx17.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Cell type: Pancreatic acinar cell; CL=CL_0002064.
DI   NCIt; C34036; Mouse pancreatic acinar neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3481 ! 266-6
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene 3D4/21 PLSCR3 KO
AC   CVCL_D7HV
SY   PLSCR3 Knockout cell line (3D4/21)
DR   Ubigene; YKO-R008
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:91574; PLSCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Lung, alveolus; UBERON=UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace; VBO=VBO_0001161.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_0F14 ! IPAM 3D4/21
SX   Sex unspecified
AG   12W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ar KO
AC   CVCL_D7HW
SY   Ar Knockout cell line (4T1)
DR   Ubigene; YKO-M138
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88064; Ar.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Arid1a KO
AC   CVCL_D7HX
SY   Arid1a Knockout cell line (4T1)
DR   Ubigene; YKO-M123
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1935147; Arid1a.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Arid2 KO
AC   CVCL_D7HY
SY   Arid2 Knockout cell line (4T1)
DR   Ubigene; YKO-M144
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924294; Arid2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Atg5 KO
AC   CVCL_D7HZ
SY   Atg5 Knockout cell line (4T1)
DR   Ubigene; YKO-M225
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1277186; Atg5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Atrx KO
AC   CVCL_D7I0
SY   Atrx Knockout cell line (4T1)
DR   Ubigene; YKO-M119
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103067; Atrx.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ccar1 KO
AC   CVCL_D7I1
SY   Ccar1 Knockout cell line (4T1)
DR   Ubigene; YKO-M184
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914750; Ccar1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Cgas KO
AC   CVCL_D7I2
SY   Cgas Knockout cell line (4T1)
DR   Ubigene; YKO-M170
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442261; Cgas.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ciita KO
AC   CVCL_D7I3
SY   Ciita Knockout cell line (4T1)
DR   Ubigene; YKO-M186
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108445; Ciita.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: Ubigene; YKO-M186; true.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ddr1 KO
AC   CVCL_D7I4
SY   Ddr1 Knockout cell line (4T1)
DR   Ubigene; YKO-M132
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99216; Ddr1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Drd1 KO
AC   CVCL_D7I5
SY   Drd1 Knockout cell line (4T1)
DR   Ubigene; YKO-M001
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99578; Drd1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Fat1 KO
AC   CVCL_D7I6
SY   Fat1 Knockout cell line (4T1)
DR   Ubigene; YKO-M117
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109168; Fat1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Grik1 KO
AC   CVCL_D7I7
SY   Grik1 Knockout cell line (4T1)
DR   Ubigene; YKO-M027
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95814; Grik1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ifi35 KO
AC   CVCL_D7I8
SY   Ifi35 Knockout cell line (4T1)
DR   Ubigene; YKO-M090
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917360; Ifi35.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Il17ra KO
AC   CVCL_D7I9
SY   Il17ra Knockout cell line (4T1)
DR   Ubigene; YKO-M137
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107399; Il17ra.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Kmt2c KO
AC   CVCL_D7IA
SY   Kmt2c Knockout cell line (4T1)
DR   Ubigene; YKO-M121
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2444959; Kmt2c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Kmt2d KO
AC   CVCL_D7IB
SY   Kmt2d Knockout cell line (4T1)
DR   Ubigene; YKO-M120
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2682319; Kmt2d.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene 4T1 Lamtor5 KO
AC   CVCL_D7IC
SY   Lamtor5 Knockout cell line (4T1)
DR   Ubigene; YKO-M070
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1915826; Lamtor5.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Lats2 KO
AC   CVCL_D7ID
SY   Lats2 Knockout cell line (4T1)
DR   Ubigene; YKO-MJ012
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1354386; Lats2.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Mctp1 KO
AC   CVCL_D7IE
SY   Mctp1 Knockout cell line (4T1)
DR   Ubigene; YKO-M017
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926021; Mctp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Nlgn4l KO
AC   CVCL_D7IF
SY   Nlgn4l Knockout cell line (4T1)
DR   Ubigene; YKO-M191
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3775191; Nlgn4l.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Pigr KO
AC   CVCL_D7IG
SY   Pigr Knockout cell line (4T1)
DR   Ubigene; YKO-M224
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103080; Pigr.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Rad51c KO
AC   CVCL_D7IH
SY   Rad51c Knockout cell line (4T1)
DR   Ubigene; YKO-M141
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2150020; Rad51c.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Rb1 KO
AC   CVCL_D7II
SY   Rb1 Knockout cell line (4T1)
DR   Ubigene; YKO-M118
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97874; Rb1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Smarca4 KO
AC   CVCL_D7IJ
SY   Smarca4 Knockout cell line (4T1)
DR   Ubigene; YKO-M122
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88192; Smarca4.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Spp1 KO
AC   CVCL_D7IK
SY   Spp1 Knockout cell line (4T1)
DR   Ubigene; YKO-M136
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98389; Spp1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Sting1 KO
AC   CVCL_D7IL
SY   Sting1 Knockout cell line (4T1)
DR   Ubigene; YKO-M135
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919762; Sting1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Tnfrsf1b KO
AC   CVCL_D7IM
SY   Tnfrsf1b Knockout cell line (4T1)
DR   Ubigene; YKO-M014
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1314883; Tnfrsf1b.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ttc14 KO
AC   CVCL_D7IN
SY   Ttc14 Knockout cell line (4T1)
DR   Ubigene; YKO-M028
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914370; Ttc14.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Ythdf1 KO
AC   CVCL_D7IP
SY   Ythdf1 Knockout cell line (4T1)
DR   Ubigene; YKO-M079
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917431; Ythdf1.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 4T1 Zbtb33 KO
AC   CVCL_D7IQ
SY   Zbtb33 Knockout cell line (4T1)
DR   Ubigene; YKO-M133
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1927290; Zbtb33.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/cfC3H.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0125 ! 4T1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene 5637 ATRX KO
AC   CVCL_D7IR
SY   ATRX Knockout cell line (5637)
DR   Ubigene; YKO-H518
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:886; ATRX.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 5637 FBXW7 KO
AC   CVCL_D7IS
SY   FBXW7 Knockout cell line (5637)
DR   Ubigene; YKO-H519
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 5637 RNF43 KO
AC   CVCL_D7IT
SY   RNF43 Knockout cell line (5637)
DR   Ubigene; YKO-H542
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18505; RNF43.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 5637 RXRA KO
AC   CVCL_D7IU
SY   RXRA Knockout cell line (5637)
DR   Ubigene; YKO-H536
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 5637 SPOP KO
AC   CVCL_D7IV
SY   SPOP Knockout cell line (5637)
DR   Ubigene; YKO-H520
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11254; SPOP.
CC   Sequence variation: Mutation; HGNC; HGNC:6871; MAPK1; Simple; p.Arg79Lys (c.236G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Tyr325Ter (c.975T>A); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0126 ! 5637
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O CD274 KO
AC   CVCL_D7IW
SY   CD274 Knockout cell line (786-O)
DR   Ubigene; YKO-HJ107
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O DUS3L KO
AC   CVCL_D7IX
SY   DUS3L Knockout cell line (786-O)
DR   Ubigene; YKO-H304
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26920; DUS3L.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O IGF2BP2 KO
AC   CVCL_D7IY
SY   IGF2BP2 Knockout cell line (786-O)
DR   Ubigene; YKO-H496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O LINC00944 KO
AC   CVCL_D7IZ
SY   LINC00944 Knockout cell line (786-O)
DR   Ubigene; YKO-HJ103
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:48640; LINC00944.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O PDCD1 KO
AC   CVCL_D7J0
SY   PDCD1 Knockout cell line (786-O)
DR   Ubigene; YKO-HJ104
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8760; PDCD1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O PDCD1LG2 KO
AC   CVCL_D7J1
SY   PDCD1LG2 Knockout cell line (786-O)
DR   Ubigene; YKO-HJ108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18731; PDCD1LG2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene 786-O ZNF83 KO
AC   CVCL_D7J2
SY   ZNF83 Knockout cell line (786-O)
DR   Ubigene; YKO-H1096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13158; ZNF83.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gln149Ter (c.445C>T); ClinVar=VCV000404164; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1051 ! 786-O
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-375 B2M KO
AC   CVCL_D7J3
SY   B2M Knockout cell line (A-375)
DR   Ubigene; YKO-HJ066
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-375 B3GNT2 KO
AC   CVCL_D7J4
SY   B3GNT2 Knockout cell line (A-375)
DR   Ubigene; YKO-H486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15629; B3GNT2.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-375 IGF2BP1 KO
AC   CVCL_D7J5
SY   IGF2BP1 Knockout cell line (A-375)
DR   Ubigene; YKO-H275
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28866; IGF2BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-375 MAGEA4 KO
AC   CVCL_D7J6
SY   MAGEA4 Knockout cell line (A-375)
DR   Ubigene; YKO-H274
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6802; MAGEA4.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-375 PRAME KO
AC   CVCL_D7J7
SY   PRAME Knockout cell line (A-375)
DR   Ubigene; YKO-H1073
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9336; PRAME.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-375 USP7 KO
AC   CVCL_D7J9
SY   USP7 Knockout cell line (A-375)
DR   Ubigene; YKO-H049
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu61Ter (c.181G>T) (p.Gly75Val, c.224G>T); ClinVar=VCV000376309; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu69Ter (c.205G>T) (p.Gly83Val, c.248G>T); ClinVar=VCV000376308; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3802; Amelanotic melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0132 ! A-375
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-431 TLR3 KO
AC   CVCL_D7JA
SY   TLR3 Knockout cell line (A-431)
DR   Ubigene; YKO-H072
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11849; TLR3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3236; EGFR + HGNC; HGNC:9237; PPARGC1A; Name(s)=EGFR-PPARGC1A (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0037 ! A-431
SX   Female
AG   85Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ABCA3 KO
AC   CVCL_D7JB
SY   ABCA3 Knockout cell line (A549)
DR   Ubigene; YKO-HS12961
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33; ABCA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ABL1 KO
AC   CVCL_D7JC
SY   ABL1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4676
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:76; ABL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ACLY KO
AC   CVCL_D7JD
SY   ACLY Knockout cell line (A549)
DR   Ubigene; YKO-H047
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:115; ACLY.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ACSS3 KO
AC   CVCL_D7JE
SY   ACSS3 Knockout cell line (A549)
DR   Ubigene; YKO-H297
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24723; ACSS3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ACTA2 KO
AC   CVCL_D7JF
SY   ACTA2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4869
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:130; ACTA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ACTL8 KO
AC   CVCL_D7JG
SY   ACTL8 Knockout cell line (A549)
DR   Ubigene; YKO-H1179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24018; ACTL8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ACVR1 KO
AC   CVCL_D7JH
SY   ACVR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:171; ACVR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ACVR2A KO
AC   CVCL_D7JI
SY   ACVR2A Knockout cell line (A549)
DR   Ubigene; YKO-HS11296
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADAM10 KO
AC   CVCL_D7JJ
SY   ADAM10 Knockout cell line (A549)
DR   Ubigene; YKO-H089
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:188; ADAM10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADAM17 KO
AC   CVCL_D7JK
SY   ADAM17 Knockout cell line (A549)
DR   Ubigene; YKO-HS163
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADAM9 KO
AC   CVCL_D7JL
SY   ADAM9 Knockout cell line (A549)
DR   Ubigene; YKO-XN40265
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADORA2A KO
AC   CVCL_D7JM
SY   ADORA2A Knockout cell line (A549)
DR   Ubigene; YKO-HS4687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADORA2B KO
AC   CVCL_D7JN
SY   ADORA2B Knockout cell line (A549)
DR   Ubigene; YKO-HS4688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:264; ADORA2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADPRS KO
AC   CVCL_D7JP
SY   ADPRS Knockout cell line (A549)
DR   Ubigene; YKO-XN85163
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21304; ADPRS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADRA1B KO
AC   CVCL_D7JQ
SY   ADRA1B Knockout cell line (A549)
DR   Ubigene; YKO-HS5031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:278; ADRA1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADRA1D KO
AC   CVCL_D7JR
SY   ADRA1D Knockout cell line (A549)
DR   Ubigene; YKO-HS5032
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:280; ADRA1D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ADRB2 KO
AC   CVCL_D7JS
SY   ADRB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4997
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AGR2 KO
AC   CVCL_D7JT
SY   AGR2 Knockout cell line (A549)
DR   Ubigene; YKO-XN96676
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:328; AGR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AGTR1 KO
AC   CVCL_D7JU
SY   AGTR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4870
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:336; AGTR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AHNAK2 KO
AC   CVCL_D7JV
SY   AHNAK2 Knockout cell line (A549)
DR   Ubigene; YKO-H593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20125; AHNAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AIFM2 KO
AC   CVCL_D7JW
SY   AIFM2 Knockout cell line (A549)
DR   Ubigene; YKO-HS09413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21411; AIFM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AKT1 KO
AC   CVCL_D7JX
SY   AKT1 Knockout cell line (A549)
DR   Ubigene; YKO-H348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AKT2 KO
AC   CVCL_D7JY
SY   AKT2 Knockout cell line (A549)
DR   Ubigene; YKO-HS198
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AKT3 KO
AC   CVCL_D7JZ
SY   AKT3 Knockout cell line (A549)
DR   Ubigene; YKO-HS199
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ALDH3A1 KO
AC   CVCL_D7K0
SY   ALDH3A1 Knockout cell line (A549)
DR   Ubigene; YKO-HS13250
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:405; ALDH3A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ANKRD30A KO
AC   CVCL_D7K1
SY   ANKRD30A Knockout cell line (A549)
DR   Ubigene; YKO-XN69861
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17234; ANKRD30A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ANLN KO
AC   CVCL_D7K2
SY   ANLN Knockout cell line (A549)
DR   Ubigene; YKO-H339
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14082; ANLN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ANP32A KO
AC   CVCL_D7K3
SY   ANP32A Knockout cell line (A549)
DR   Ubigene; YKO-H1032
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13233; ANP32A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AOX1 KO
AC   CVCL_D7K4
SY   AOX1 Knockout cell line (A549)
DR   Ubigene; YKO-HS200
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:553; AOX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 APBA2 KO
AC   CVCL_D7K5
SY   APBA2 Knockout cell line (A549)
DR   Ubigene; YKO-XN21025
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:579; APBA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 APC KO
AC   CVCL_D7K6
SY   APC Knockout cell line (A549)
DR   Ubigene; YKO-HS001
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 APEX1 KO
AC   CVCL_D7K7
SY   APEX1 Knockout cell line (A549)
DR   Ubigene; YKO-H787
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 APEX2 KO
AC   CVCL_D7K8
SY   APEX2 Knockout cell line (A549)
DR   Ubigene; YKO-H788
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17889; APEX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 APOD KO
AC   CVCL_D7K9
SY   APOD Knockout cell line (A549)
DR   Ubigene; YKO-XN21077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:612; APOD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARAF KO
AC   CVCL_D7KA
SY   ARAF Knockout cell line (A549)
DR   Ubigene; YKO-HS4961
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AREG KO
AC   CVCL_D7KB
SY   AREG Knockout cell line (A549)
DR   Ubigene; YKO-HS391
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:651; AREG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARID1A KO
AC   CVCL_D7KC
SY   ARID1A Knockout cell line (A549)
DR   Ubigene; YKO-H377
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARIH2 KO
AC   CVCL_D7KD
SY   ARIH2 Knockout cell line (A549)
DR   Ubigene; YKO-H996
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:690; ARIH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARPC2 KO
AC   CVCL_D7KE
SY   ARPC2 Knockout cell line (A549)
DR   Ubigene; YKO-H1029
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:705; ARPC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARPC4 KO
AC   CVCL_D7KF
SY   ARPC4 Knockout cell line (A549)
DR   Ubigene; YKO-H411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:707; ARPC4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARRB1 KO
AC   CVCL_D7KG
SY   ARRB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS392
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ARRB2 KO
AC   CVCL_D7KH
SY   ARRB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ART1 KO
AC   CVCL_D7KI
SY   ART1 Knockout cell line (A549)
DR   Ubigene; YKO-H291
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:723; ART1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ASGR1 KO
AC   CVCL_D7KJ
SY   ASGR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS10627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:742; ASGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ASH1L KO
AC   CVCL_D7KK
SY   ASH1L Knockout cell line (A549)
DR   Ubigene; YKO-XN80453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19088; ASH1L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ASL KO
AC   CVCL_D7KL
SY   ASL Knockout cell line (A549)
DR   Ubigene; YKO-XN21281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:746; ASL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATF2 KO
AC   CVCL_D7KM
SY   ATF2 Knockout cell line (A549)
DR   Ubigene; YKO-HS394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATF3 KO
AC   CVCL_D7KN
SY   ATF3 Knockout cell line (A549)
DR   Ubigene; YKO-H947
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATF4 KO
AC   CVCL_D7KP
SY   ATF4 Knockout cell line (A549)
DR   Ubigene; YKO-H959
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATG5 KO
AC   CVCL_D7KQ
SY   ATG5 Knockout cell line (A549)
DR   Ubigene; YKO-XN85675
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATM KO
AC   CVCL_D7KR
SY   ATM Knockout cell line (A549)
DR   Ubigene; YKO-H292
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATP2A2 KO
AC   CVCL_D7KS
SY   ATP2A2 Knockout cell line (A549)
DR   Ubigene; YKO-XN96678
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:812; ATP2A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ATP2A3 KO
AC   CVCL_D7KT
SY   ATP2A3 Knockout cell line (A549)
DR   Ubigene; YKO-HS5008
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:813; ATP2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 AXIN1 KO
AC   CVCL_D7KU
SY   AXIN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS003
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BAX KO
AC   CVCL_D7KV
SY   BAX Knockout cell line (A549)
DR   Ubigene; YKO-HS5221
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:959; BAX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BCL2A1 KO
AC   CVCL_D7KW
SY   BCL2A1 Knockout cell line (A549)
DR   Ubigene; YKO-HS309
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:991; BCL2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BCL2L13 KO
AC   CVCL_D7KX
SY   BCL2L13 Knockout cell line (A549)
DR   Ubigene; YKO-HS08834
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17164; BCL2L13.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BDKRB2 KO
AC   CVCL_D7KY
SY   BDKRB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5052
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1030; BDKRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BDNF KO
AC   CVCL_D7KZ
SY   BDNF Knockout cell line (A549)
DR   Ubigene; YKO-HS396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1033; BDNF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BIRC2 KO
AC   CVCL_D7L0
SY   BIRC2 Knockout cell line (A549)
DR   Ubigene; YKO-HS311
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:590; BIRC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BMP4 KO
AC   CVCL_D7L1
SY   BMP4 Knockout cell line (A549)
DR   Ubigene; YKO-HS109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1071; BMP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BMP6 KO
AC   CVCL_D7L2
SY   BMP6 Knockout cell line (A549)
DR   Ubigene; YKO-HS111
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1073; BMP6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BRAF KO
AC   CVCL_D7L3
SY   BRAF Knockout cell line (A549)
DR   Ubigene; YKO-HS397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 BTRC KO
AC   CVCL_D7L4
SY   BTRC Knockout cell line (A549)
DR   Ubigene; YKO-H751
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 C19orf18 KO
AC   CVCL_D7L5
SY   C19orf18 Knockout cell line (A549)
DR   Ubigene; YKO-H447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28642; C19orf18.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CA9 KO
AC   CVCL_D7L6
SY   CA9 Knockout cell line (A549)
DR   Ubigene; YKO-HS1548
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1383; CA9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNA1C KO
AC   CVCL_D7L7
SY   CACNA1C Knockout cell line (A549)
DR   Ubigene; YKO-XN96683
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1390; CACNA1C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNA1D KO
AC   CVCL_D7L8
SY   CACNA1D Knockout cell line (A549)
DR   Ubigene; YKO-HS401
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1391; CACNA1D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNA1G KO
AC   CVCL_D7L9
SY   CACNA1G Knockout cell line (A549)
DR   Ubigene; YKO-HS404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1394; CACNA1G.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNA1H KO
AC   CVCL_D7LA
SY   CACNA1H Knockout cell line (A549)
DR   Ubigene; YKO-HS405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1395; CACNA1H.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNA2D1 KO
AC   CVCL_D7LB
SY   CACNA2D1 Knockout cell line (A549)
DR   Ubigene; YKO-HS408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNB1 KO
AC   CVCL_D7LC
SY   CACNB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS13210
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1401; CACNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNB2 KO
AC   CVCL_D7LD
SY   CACNB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1402; CACNB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNG4 KO
AC   CVCL_D7LE
SY   CACNG4 Knockout cell line (A549)
DR   Ubigene; YKO-HS11729
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1408; CACNG4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNG6 KO
AC   CVCL_D7LF
SY   CACNG6 Knockout cell line (A549)
DR   Ubigene; YKO-XN86346
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13625; CACNG6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNG7 KO
AC   CVCL_D7LG
SY   CACNG7 Knockout cell line (A549)
DR   Ubigene; YKO-XN86348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13626; CACNG7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CACNG8 KO
AC   CVCL_D7LH
SY   CACNG8 Knockout cell line (A549)
DR   Ubigene; YKO-XN86350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13628; CACNG8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CAMK1 KO
AC   CVCL_D7LI
SY   CAMK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5098
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1459; CAMK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CAMK1D KO
AC   CVCL_D7LJ
SY   CAMK1D Knockout cell line (A549)
DR   Ubigene; YKO-HS5096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19341; CAMK1D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CAMK2D KO
AC   CVCL_D7LK
SY   CAMK2D Knockout cell line (A549)
DR   Ubigene; YKO-HS009
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CAMK2G KO
AC   CVCL_D7LL
SY   CAMK2G Knockout cell line (A549)
DR   Ubigene; YKO-HS010
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CAMKK2 KO
AC   CVCL_D7LM
SY   CAMKK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CAPRIN1 KO
AC   CVCL_D7LN
SY   CAPRIN1 Knockout cell line (A549)
DR   Ubigene; YKO-H981
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6743; CAPRIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CARD10 KO
AC   CVCL_D7LP
SY   CARD10 Knockout cell line (A549)
DR   Ubigene; YKO-HS314
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16422; CARD10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CARM1 KO
AC   CVCL_D7LQ
SY   CARM1 Knockout cell line (A549)
DR   Ubigene; YKO-H1197
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CASK KO
AC   CVCL_D7LR
SY   CASK Knockout cell line (A549)
DR   Ubigene; YKO-H1172
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1497; CASK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CASP3 KO
AC   CVCL_D7LS
SY   CASP3 Knockout cell line (A549)
DR   Ubigene; YKO-HS418
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CASP9 KO
AC   CVCL_D7LT
SY   CASP9 Knockout cell line (A549)
DR   Ubigene; YKO-H705
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CBL KO
AC   CVCL_D7LU
SY   CBL Knockout cell line (A549)
DR   Ubigene; YKO-H1031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1541; CBL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CCDC86 KO
AC   CVCL_D7LV
SY   CCDC86 Knockout cell line (A549)
DR   Ubigene; YKO-H515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28359; CCDC86.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CCN2 KO
AC   CVCL_D7LW
SY   CCN2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4798
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2500; CCN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CCND3 KO
AC   CVCL_D7LX
SY   CCND3 Knockout cell line (A549)
DR   Ubigene; YKO-HS011
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CCNE2 KO
AC   CVCL_D7LY
SY   CCNE2 Knockout cell line (A549)
DR   Ubigene; YKO-HS589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1590; CCNE2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD14 KO
AC   CVCL_D7LZ
SY   CD14 Knockout cell line (A549)
DR   Ubigene; YKO-HS322
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD163 KO
AC   CVCL_D7M0
SY   CD163 Knockout cell line (A549)
DR   Ubigene; YKO-XN96661
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1631; CD163.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD164 KO
AC   CVCL_D7M1
SY   CD164 Knockout cell line (A549)
DR   Ubigene; YKO-H693
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1632; CD164.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD276 KO
AC   CVCL_D7M2
SY   CD276 Knockout cell line (A549)
DR   Ubigene; YKO-XN86653
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD40 KO
AC   CVCL_D7M3
SY   CD40 Knockout cell line (A549)
DR   Ubigene; YKO-HS323
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11919; CD40.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD44 KO
AC   CVCL_D7M4
SY   CD44 Knockout cell line (A549)
DR   Ubigene; YKO-HS13066
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD46 KO
AC   CVCL_D7M5
SY   CD46 Knockout cell line (A549)
DR   Ubigene; YKO-HS1577
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6953; CD46.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD47 KO
AC   CVCL_D7M6
SY   CD47 Knockout cell line (A549)
DR   Ubigene; YKO-H602
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD63 KO
AC   CVCL_D7M7
SY   CD63 Knockout cell line (A549)
DR   Ubigene; YKO-HS12278
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD81 KO
AC   CVCL_D7M8
SY   CD81 Knockout cell line (A549)
DR   Ubigene; YKO-HS1871
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CD9 KO
AC   CVCL_D7M9
SY   CD9 Knockout cell line (A549)
DR   Ubigene; YKO-HS09540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CDC25B KO
AC   CVCL_D7MA
SY   CDC25B Knockout cell line (A549)
DR   Ubigene; YKO-HS419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1726; CDC25B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CDC42 KO
AC   CVCL_D7MB
SY   CDC42 Knockout cell line (A549)
DR   Ubigene; YKO-H345
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1736; CDC42.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CDKL2 KO
AC   CVCL_D7MC
SY   CDKL2 Knockout cell line (A549)
DR   Ubigene; YKO-XN40709
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1782; CDKL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CDKN1A KO
AC   CVCL_D7MD
SY   CDKN1A Knockout cell line (A549)
DR   Ubigene; YKO-HS201
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CDKN1B KO
AC   CVCL_D7ME
SY   CDKN1B Knockout cell line (A549)
DR   Ubigene; YKO-HS593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CDKN2D KO
AC   CVCL_D7MF
SY   CDKN2D Knockout cell line (A549)
DR   Ubigene; YKO-HS4970
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1790; CDKN2D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CHD8 KO
AC   CVCL_D7MG
SY   CHD8 Knockout cell line (A549)
DR   Ubigene; YKO-HS013
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CHRNA7 KO
AC   CVCL_D7MH
SY   CHRNA7 Knockout cell line (A549)
DR   Ubigene; YKO-HS1944
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1960; CHRNA7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CHUK KO
AC   CVCL_D7MI
SY   CHUK Knockout cell line (A549)
DR   Ubigene; YKO-HS326
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CIITA KO
AC   CVCL_D7MJ
SY   CIITA Knockout cell line (A549)
DR   Ubigene; YKO-H817
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7067; CIITA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H817; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 CIR1 KO
AC   CVCL_D7MK
SY   CIR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS165
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24217; CIR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CISD1 KO
AC   CVCL_D7ML
SY   CISD1 Knockout cell line (A549)
DR   Ubigene; YKO-H679
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30880; CISD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CKAP2 KO
AC   CVCL_D7MM
SY   CKAP2 Knockout cell line (A549)
DR   Ubigene; YKO-XN52701
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1990; CKAP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CLEC7A KO
AC   CVCL_D7MN
SY   CLEC7A Knockout cell line (A549)
DR   Ubigene; YKO-H290
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14558; CLEC7A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H290; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 CNTF KO
AC   CVCL_D7MP
SY   CNTF Knockout cell line (A549)
DR   Ubigene; YKO-HS203
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2169; CNTF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 COL6A1 KO
AC   CVCL_D7MQ
SY   COL6A1 Knockout cell line (A549)
DR   Ubigene; YKO-HS604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2211; COL6A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 COP1 KO
AC   CVCL_D7MR
SY   COP1 Knockout cell line (A549)
DR   Ubigene; YKO-H308
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17440; COP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 COQ8B KO
AC   CVCL_D7MS
SY   COQ8B Knockout cell line (A549)
DR   Ubigene; YKO-HS09607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19041; COQ8B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CRBN KO
AC   CVCL_D7MT
SY   CRBN Knockout cell line (A549)
DR   Ubigene; YKO-H232
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CREB1 KO
AC   CVCL_D7MU
SY   CREB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS610
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CREBBP KO
AC   CVCL_D7MV
SY   CREBBP Knockout cell line (A549)
DR   Ubigene; YKO-HS205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSF1 KO
AC   CVCL_D7MW
SY   CSF1 Knockout cell line (A549)
DR   Ubigene; YKO-HS422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSNK1D KO
AC   CVCL_D7MX
SY   CSNK1D Knockout cell line (A549)
DR   Ubigene; YKO-HS4790
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSNK1G1 KO
AC   CVCL_D7MY
SY   CSNK1G1 Knockout cell line (A549)
DR   Ubigene; YKO-HS730
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSNK1G2 KO
AC   CVCL_D7MZ
SY   CSNK1G2 Knockout cell line (A549)
DR   Ubigene; YKO-HS731
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2455; CSNK1G2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSNK1G3 KO
AC   CVCL_D7N0
SY   CSNK1G3 Knockout cell line (A549)
DR   Ubigene; YKO-HS732
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2456; CSNK1G3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSNK2A2 KO
AC   CVCL_D7N1
SY   CSNK2A2 Knockout cell line (A549)
DR   Ubigene; YKO-HS327
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2459; CSNK2A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CSNK2A3 KO
AC   CVCL_D7N2
SY   CSNK2A3 Knockout cell line (A549)
DR   Ubigene; YKO-XN87174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2458; CSNK2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CTBP2 KO
AC   CVCL_D7N3
SY   CTBP2 Knockout cell line (A549)
DR   Ubigene; YKO-HS016
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2495; CTBP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CTNNB1 KO
AC   CVCL_D7N4
SY   CTNNB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS017
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CTSL KO
AC   CVCL_D7N5
SY   CTSL Knockout cell line (A549)
DR   Ubigene; YKO-HS1605
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2537; CTSL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CTSS KO
AC   CVCL_D7N6
SY   CTSS Knockout cell line (A549)
DR   Ubigene; YKO-XN23561
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2545; CTSS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CXCL1 KO
AC   CVCL_D7N7
SY   CXCL1 Knockout cell line (A549)
DR   Ubigene; YKO-HS328
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4602; CXCL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CXCL8 KO
AC   CVCL_D7N8
SY   CXCL8 Knockout cell line (A549)
DR   Ubigene; YKO-HS332
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6025; CXCL8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CXCR4 KO
AC   CVCL_D7N9
SY   CXCR4 Knockout cell line (A549)
DR   Ubigene; YKO-XN96687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 CYLD KO
AC   CVCL_D7NA
SY   CYLD Knockout cell line (A549)
DR   Ubigene; YKO-HS333
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DAAM1 KO
AC   CVCL_D7NB
SY   DAAM1 Knockout cell line (A549)
DR   Ubigene; YKO-HS020
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18142; DAAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DAPK1 KO
AC   CVCL_D7NC
SY   DAPK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS14087
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2674; DAPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DAXX KO
AC   CVCL_D7ND
SY   DAXX Knockout cell line (A549)
DR   Ubigene; YKO-HS424
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DCAF11 KO
AC   CVCL_D7NE
SY   DCAF11 Knockout cell line (A549)
DR   Ubigene; YKO-H1086
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20258; DCAF11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DCAF16 KO
AC   CVCL_D7NF
SY   DCAF16 Knockout cell line (A549)
DR   Ubigene; YKO-XN87381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25987; DCAF16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DCDC2 KO
AC   CVCL_D7NG
SY   DCDC2 Knockout cell line (A549)
DR   Ubigene; YKO-XN72101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18141; DCDC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DDX39B KO
AC   CVCL_D7NH
SY   DDX39B Knockout cell line (A549)
DR   Ubigene; YKO-XN96665
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13917; DDX39B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKA KO
AC   CVCL_D7NI
SY   DGKA Knockout cell line (A549)
DR   Ubigene; YKO-HS5156
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKD KO
AC   CVCL_D7NJ
SY   DGKD Knockout cell line (A549)
DR   Ubigene; YKO-HS5154
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2851; DGKD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKE KO
AC   CVCL_D7NK
SY   DGKE Knockout cell line (A549)
DR   Ubigene; YKO-HS5157
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2852; DGKE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKG KO
AC   CVCL_D7NL
SY   DGKG Knockout cell line (A549)
DR   Ubigene; YKO-HS5160
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2853; DGKG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKH KO
AC   CVCL_D7NM
SY   DGKH Knockout cell line (A549)
DR   Ubigene; YKO-HS5159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2854; DGKH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKQ KO
AC   CVCL_D7NN
SY   DGKQ Knockout cell line (A549)
DR   Ubigene; YKO-HS5161
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2856; DGKQ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DGKZ KO
AC   CVCL_D7NP
SY   DGKZ Knockout cell line (A549)
DR   Ubigene; YKO-HS5153
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2857; DGKZ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DHODH KO
AC   CVCL_D7NQ
SY   DHODH Knockout cell line (A549)
DR   Ubigene; YKO-H139
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2867; DHODH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H139; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 DLG4 KO
AC   CVCL_D7NR
SY   DLG4 Knockout cell line (A549)
DR   Ubigene; YKO-HS4788
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2903; DLG4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DLL3 KO
AC   CVCL_D7NS
SY   DLL3 Knockout cell line (A549)
DR   Ubigene; YKO-HS167
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DNAH5 KO
AC   CVCL_D7NT
SY   DNAH5 Knockout cell line (A549)
DR   Ubigene; YKO-HS1728
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2950; DNAH5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DNASE1L1 KO
AC   CVCL_D7NU
SY   DNASE1L1 Knockout cell line (A549)
DR   Ubigene; YKO-XN24205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2957; DNASE1L1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DTX2 KO
AC   CVCL_D7NV
SY   DTX2 Knockout cell line (A549)
DR   Ubigene; YKO-HS170
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15973; DTX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DTX3 KO
AC   CVCL_D7NW
SY   DTX3 Knockout cell line (A549)
DR   Ubigene; YKO-HS171
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24457; DTX3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DTX3L KO
AC   CVCL_D7NX
SY   DTX3L Knockout cell line (A549)
DR   Ubigene; YKO-HS172
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DTX4 KO
AC   CVCL_D7NY
SY   DTX4 Knockout cell line (A549)
DR   Ubigene; YKO-HS173
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29151; DTX4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DUSP1 KO
AC   CVCL_D7NZ
SY   DUSP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS426
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3064; DUSP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DUSP10 KO
AC   CVCL_D7P0
SY   DUSP10 Knockout cell line (A549)
DR   Ubigene; YKO-HS427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3065; DUSP10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DUSP16 KO
AC   CVCL_D7P1
SY   DUSP16 Knockout cell line (A549)
DR   Ubigene; YKO-HS428
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17909; DUSP16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DUSP3 KO
AC   CVCL_D7P2
SY   DUSP3 Knockout cell line (A549)
DR   Ubigene; YKO-HS430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3069; DUSP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DUSP4 KO
AC   CVCL_D7P3
SY   DUSP4 Knockout cell line (A549)
DR   Ubigene; YKO-HS431
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DUSP5 KO
AC   CVCL_D7P4
SY   DUSP5 Knockout cell line (A549)
DR   Ubigene; YKO-HS432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3071; DUSP5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 DVL3 KO
AC   CVCL_D7P5
SY   DVL3 Knockout cell line (A549)
DR   Ubigene; YKO-HS026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EEF1A2 KO
AC   CVCL_D7P6
SY   EEF1A2 Knockout cell line (A549)
DR   Ubigene; YKO-XN24493
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3192; EEF1A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EGF KO
AC   CVCL_D7P7
SY   EGF Knockout cell line (A549)
DR   Ubigene; YKO-HS213
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3229; EGF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EGFR KO
AC   CVCL_D7P8
SY   EGFR Knockout cell line (A549)
DR   Ubigene; YKO-H1028
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EIF4E2 KO
AC   CVCL_D7P9
SY   EIF4E2 Knockout cell line (A549)
DR   Ubigene; YKO-HS621
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3293; EIF4E2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ELAVL1 KO
AC   CVCL_D7PA
SY   ELAVL1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5357
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3312; ELAVL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ELF3 KO
AC   CVCL_D7PB
SY   ELF3 Knockout cell line (A549)
DR   Ubigene; YKO-H726
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3318; ELF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ELK1 KO
AC   CVCL_D7PC
SY   ELK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3321; ELK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EP300 KO
AC   CVCL_D7PD
SY   EP300 Knockout cell line (A549)
DR   Ubigene; YKO-HS214
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EPHA2 KO
AC   CVCL_D7PE
SY   EPHA2 Knockout cell line (A549)
DR   Ubigene; YKO-HS442
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EPN1 KO
AC   CVCL_D7PF
SY   EPN1 Knockout cell line (A549)
DR   Ubigene; YKO-XN58853
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EPOR KO
AC   CVCL_D7PG
SY   EPOR Knockout cell line (A549)
DR   Ubigene; YKO-HS215
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3416; EPOR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ERBB2 KO
AC   CVCL_D7PH
SY   ERBB2 Knockout cell line (A549)
DR   Ubigene; YKO-H384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ERBB3 KO
AC   CVCL_D7PI
SY   ERBB3 Knockout cell line (A549)
DR   Ubigene; YKO-HS444
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ERC1 KO
AC   CVCL_D7PJ
SY   ERC1 Knockout cell line (A549)
DR   Ubigene; YKO-HS336
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17072; ERC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ERCC1 KO
AC   CVCL_D7PK
SY   ERCC1 Knockout cell line (A549)
DR   Ubigene; YKO-HS11228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3433; ERCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 EREG KO
AC   CVCL_D7PL
SY   EREG Knockout cell line (A549)
DR   Ubigene; YKO-HS446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3443; EREG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ERI1 KO
AC   CVCL_D7PM
SY   ERI1 Knockout cell line (A549)
DR   Ubigene; YKO-XN69453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23994; ERI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ERN1 KO
AC   CVCL_D7PN
SY   ERN1 Knockout cell line (A549)
DR   Ubigene; YKO-H818
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 F2R KO
AC   CVCL_D7PP
SY   F2R Knockout cell line (A549)
DR   Ubigene; YKO-HS622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FANCA KO
AC   CVCL_D7PQ
SY   FANCA Knockout cell line (A549)
DR   Ubigene; YKO-XN88376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FAT4 KO
AC   CVCL_D7PR
SY   FAT4 Knockout cell line (A549)
DR   Ubigene; YKO-XN96679
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23109; FAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FBXW7 KO
AC   CVCL_D7PS
SY   FBXW7 Knockout cell line (A549)
DR   Ubigene; YKO-XN88445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FEN1 KO
AC   CVCL_D7PT
SY   FEN1 Knockout cell line (A549)
DR   Ubigene; YKO-H789
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3650; FEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FFAR2 KO
AC   CVCL_D7PU
SY   FFAR2 Knockout cell line (A549)
DR   Ubigene; YKO-H606
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4501; FFAR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FGFR3 KO
AC   CVCL_D7PV
SY   FGFR3 Knockout cell line (A549)
DR   Ubigene; YKO-HS462
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3690; FGFR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FHL1 KO
AC   CVCL_D7PW
SY   FHL1 Knockout cell line (A549)
DR   Ubigene; YKO-HS216
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3702; FHL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FKBP5 KO
AC   CVCL_D7PX
SY   FKBP5 Knockout cell line (A549)
DR   Ubigene; YKO-XN25289
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3721; FKBP5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FLNB KO
AC   CVCL_D7PY
SY   FLNB Knockout cell line (A549)
DR   Ubigene; YKO-HS465
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3755; FLNB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FLNC KO
AC   CVCL_D7PZ
SY   FLNC Knockout cell line (A549)
DR   Ubigene; YKO-HS466
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3756; FLNC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FLT3LG KO
AC   CVCL_D7Q0
SY   FLT3LG Knockout cell line (A549)
DR   Ubigene; YKO-HS4578
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FLT4 KO
AC   CVCL_D7Q1
SY   FLT4 Knockout cell line (A549)
DR   Ubigene; YKO-HS469
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FN1 KO
AC   CVCL_D7Q2
SY   FN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FOS KO
AC   CVCL_D7Q3
SY   FOS Knockout cell line (A549)
DR   Ubigene; YKO-HS470
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FOSL1 KO
AC   CVCL_D7Q4
SY   FOSL1 Knockout cell line (A549)
DR   Ubigene; YKO-H1206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FOXM1 KO
AC   CVCL_D7Q5
SY   FOXM1 Knockout cell line (A549)
DR   Ubigene; YKO-H1050
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3818; FOXM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FRAT2 KO
AC   CVCL_D7Q6
SY   FRAT2 Knockout cell line (A549)
DR   Ubigene; YKO-HS030
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16048; FRAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZD1 KO
AC   CVCL_D7Q7
SY   FZD1 Knockout cell line (A549)
DR   Ubigene; YKO-HS031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4038; FZD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZD2 KO
AC   CVCL_D7Q8
SY   FZD2 Knockout cell line (A549)
DR   Ubigene; YKO-HS033
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZD3 KO
AC   CVCL_D7Q9
SY   FZD3 Knockout cell line (A549)
DR   Ubigene; YKO-HS034
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4041; FZD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZD4 KO
AC   CVCL_D7QA
SY   FZD4 Knockout cell line (A549)
DR   Ubigene; YKO-HS035
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4042; FZD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZD5 KO
AC   CVCL_D7QB
SY   FZD5 Knockout cell line (A549)
DR   Ubigene; YKO-HS036
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4043; FZD5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZD9 KO
AC   CVCL_D7QC
SY   FZD9 Knockout cell line (A549)
DR   Ubigene; YKO-HS040
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 FZR1 KO
AC   CVCL_D7QD
SY   FZR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS12246
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24824; FZR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 G6PC1 KO
AC   CVCL_D7QE
SY   G6PC1 Knockout cell line (A549)
DR   Ubigene; YKO-HS625
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4056; G6PC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GABBR1 KO
AC   CVCL_D7QF
SY   GABBR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5269
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GADD45A KO
AC   CVCL_D7QG
SY   GADD45A Knockout cell line (A549)
DR   Ubigene; YKO-HS337
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4095; GADD45A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GADD45B KO
AC   CVCL_D7QH
SY   GADD45B Knockout cell line (A549)
DR   Ubigene; YKO-HS338
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GAPDH KO
AC   CVCL_D7QI
SY   GAPDH Knockout cell line (A549)
DR   Ubigene; YKO-H498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4141; GAPDH.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H498; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 GBA2 KO
AC   CVCL_D7QJ
SY   GBA2 Knockout cell line (A549)
DR   Ubigene; YKO-XN82841
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18986; GBA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GCC2 KO
AC   CVCL_D7QK
SY   GCC2 Knockout cell line (A549)
DR   Ubigene; YKO-XN42101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23218; GCC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GFAP KO
AC   CVCL_D7QL
SY   GFAP Knockout cell line (A549)
DR   Ubigene; YKO-HS217
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4235; GFAP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GLB1 KO
AC   CVCL_D7QM
SY   GLB1 Knockout cell line (A549)
DR   Ubigene; YKO-XN26637
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4298; GLB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GLI1 KO
AC   CVCL_D7QN
SY   GLI1 Knockout cell line (A549)
DR   Ubigene; YKO-HS740
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4317; GLI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GNA12 KO
AC   CVCL_D7QP
SY   GNA12 Knockout cell line (A549)
DR   Ubigene; YKO-HS471
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4380; GNA12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GNB1 KO
AC   CVCL_D7QQ
SY   GNB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4396; GNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GNB2 KO
AC   CVCL_D7QR
SY   GNB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS628
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4398; GNB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GNB3 KO
AC   CVCL_D7QS
SY   GNB3 Knockout cell line (A549)
DR   Ubigene; YKO-HS629
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4400; GNB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GOLT1B KO
AC   CVCL_D7QT
SY   GOLT1B Knockout cell line (A549)
DR   Ubigene; YKO-HS08063
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20175; GOLT1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GPC1 KO
AC   CVCL_D7QU
SY   GPC1 Knockout cell line (A549)
DR   Ubigene; YKO-XN26865
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4449; GPC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GPR161 KO
AC   CVCL_D7QV
SY   GPR161 Knockout cell line (A549)
DR   Ubigene; YKO-HS743
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23694; GPR161.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GPR39 KO
AC   CVCL_D7QW
SY   GPR39 Knockout cell line (A549)
DR   Ubigene; YKO-H1047
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4496; GPR39.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GREM1 KO
AC   CVCL_D7QX
SY   GREM1 Knockout cell line (A549)
DR   Ubigene; YKO-HS124
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2001; GREM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GRIN2B KO
AC   CVCL_D7QY
SY   GRIN2B Knockout cell line (A549)
DR   Ubigene; YKO-HS4604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GRIN2D KO
AC   CVCL_D7QZ
SY   GRIN2D Knockout cell line (A549)
DR   Ubigene; YKO-HS5023
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4588; GRIN2D.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GRK2 KO
AC   CVCL_D7R0
SY   GRK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS744
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GRK3 KO
AC   CVCL_D7R1
SY   GRK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS745
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GSDMB KO
AC   CVCL_D7R2
SY   GSDMB Knockout cell line (A549)
DR   Ubigene; YKO-XN89038
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23690; GSDMB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 GSK3B KO
AC   CVCL_D7R3
SY   GSK3B Knockout cell line (A549)
DR   Ubigene; YKO-HS746
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HDAC1 KO
AC   CVCL_D7R4
SY   HDAC1 Knockout cell line (A549)
DR   Ubigene; YKO-HS174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HDAC2 KO
AC   CVCL_D7R5
SY   HDAC2 Knockout cell line (A549)
DR   Ubigene; YKO-HS175
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HDAC6 KO
AC   CVCL_D7R6
SY   HDAC6 Knockout cell line (A549)
DR   Ubigene; YKO-HS09751
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HES1 KO
AC   CVCL_D7R7
SY   HES1 Knockout cell line (A549)
DR   Ubigene; YKO-HS176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HEXA KO
AC   CVCL_D7R8
SY   HEXA Knockout cell line (A549)
DR   Ubigene; YKO-XN27589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4878; HEXA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HEXB KO
AC   CVCL_D7R9
SY   HEXB Knockout cell line (A549)
DR   Ubigene; YKO-XN96664
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4879; HEXB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HEY1 KO
AC   CVCL_D7RA
SY   HEY1 Knockout cell line (A549)
DR   Ubigene; YKO-HS177
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HEYL KO
AC   CVCL_D7RB
SY   HEYL Knockout cell line (A549)
DR   Ubigene; YKO-HS179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4882; HEYL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HIF1A KO
AC   CVCL_D7RC
SY   HIF1A Knockout cell line (A549)
DR   Ubigene; YKO-HS4903
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HNF4A KO
AC   CVCL_D7RD
SY   HNF4A Knockout cell line (A549)
DR   Ubigene; YKO-HS5356
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5024; HNF4A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HRAS KO
AC   CVCL_D7RE
SY   HRAS Knockout cell line (A549)
DR   Ubigene; YKO-HS220
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HRH1 KO
AC   CVCL_D7RF
SY   HRH1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5037
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5182; HRH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HRH2 KO
AC   CVCL_D7RG
SY   HRH2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5001
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5183; HRH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HSF4 KO
AC   CVCL_D7RH
SY   HSF4 Knockout cell line (A549)
DR   Ubigene; YKO-H946
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5227; HSF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HSP90AA1 KO
AC   CVCL_D7RI
SY   HSP90AA1 Knockout cell line (A549)
DR   Ubigene; YKO-HS637
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HSPA1L KO
AC   CVCL_D7RJ
SY   HSPA1L Knockout cell line (A549)
DR   Ubigene; YKO-HS474
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5234; HSPA1L.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HTR2B KO
AC   CVCL_D7RK
SY   HTR2B Knockout cell line (A549)
DR   Ubigene; YKO-HS5039
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5294; HTR2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 HTR4 KO
AC   CVCL_D7RL
SY   HTR4 Knockout cell line (A549)
DR   Ubigene; YKO-HJ074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5299; HTR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ICAM1 KO
AC   CVCL_D7RM
SY   ICAM1 Knockout cell line (A549)
DR   Ubigene; YKO-XN96686
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IDH1 KO
AC   CVCL_D7RN
SY   IDH1 Knockout cell line (A549)
DR   Ubigene; YKO-HS1618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IFNAR1 KO
AC   CVCL_D7RP
SY   IFNAR1 Knockout cell line (A549)
DR   Ubigene; YKO-H706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IFNE KO
AC   CVCL_D7RQ
SY   IFNE Knockout cell line (A549)
DR   Ubigene; YKO-HS228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18163; IFNE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IFNGR1 KO
AC   CVCL_D7RR
SY   IFNGR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS229
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IFNGR2 KO
AC   CVCL_D7RS
SY   IFNGR2 Knockout cell line (A549)
DR   Ubigene; YKO-HS230
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IGF1R KO
AC   CVCL_D7RT
SY   IGF1R Knockout cell line (A549)
DR   Ubigene; YKO-HS479
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IGF2BP1 KO
AC   CVCL_D7RU
SY   IGF2BP1 Knockout cell line (A549)
DR   Ubigene; YKO-HJ049
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28866; IGF2BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IGF2R KO
AC   CVCL_D7RV
SY   IGF2R Knockout cell line (A549)
DR   Ubigene; YKO-HS11013
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5467; IGF2R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IKBKB KO
AC   CVCL_D7RW
SY   IKBKB Knockout cell line (A549)
DR   Ubigene; YKO-HS340
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IKBKE KO
AC   CVCL_D7RX
SY   IKBKE Knockout cell line (A549)
DR   Ubigene; YKO-H670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IKBKG KO
AC   CVCL_D7RY
SY   IKBKG Knockout cell line (A549)
DR   Ubigene; YKO-HS341
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL11 KO
AC   CVCL_D7RZ
SY   IL11 Knockout cell line (A549)
DR   Ubigene; YKO-HS233
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5966; IL11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL12A KO
AC   CVCL_D7S0
SY   IL12A Knockout cell line (A549)
DR   Ubigene; YKO-HS234
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL13RA1 KO
AC   CVCL_D7S1
SY   IL13RA1 Knockout cell line (A549)
DR   Ubigene; YKO-HS238
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL15RA KO
AC   CVCL_D7S2
SY   IL15RA Knockout cell line (A549)
DR   Ubigene; YKO-HS240
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL1R1 KO
AC   CVCL_D7S3
SY   IL1R1 Knockout cell line (A549)
DR   Ubigene; YKO-HS343
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5993; IL1R1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL20RB KO
AC   CVCL_D7S4
SY   IL20RB Knockout cell line (A549)
DR   Ubigene; YKO-HS243
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6004; IL20RB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL27RA KO
AC   CVCL_D7S5
SY   IL27RA Knockout cell line (A549)
DR   Ubigene; YKO-HS249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17290; IL27RA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL4R KO
AC   CVCL_D7S6
SY   IL4R Knockout cell line (A549)
DR   Ubigene; YKO-HS253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL6 KO
AC   CVCL_D7S7
SY   IL6 Knockout cell line (A549)
DR   Ubigene; YKO-HS255
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6018; IL6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL6R KO
AC   CVCL_D7S8
SY   IL6R Knockout cell line (A549)
DR   Ubigene; YKO-HS256
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IL6ST KO
AC   CVCL_D7S9
SY   IL6ST Knockout cell line (A549)
DR   Ubigene; YKO-HS257
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 INHBE KO
AC   CVCL_D7SA
SY   INHBE Knockout cell line (A549)
DR   Ubigene; YKO-HS132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24029; INHBE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 INPP5K KO
AC   CVCL_D7SB
SY   INPP5K Knockout cell line (A549)
DR   Ubigene; YKO-XN96662
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33882; INPP5K.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 INSR KO
AC   CVCL_D7SC
SY   INSR Knockout cell line (A549)
DR   Ubigene; YKO-HS482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6091; INSR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IP6K1 KO
AC   CVCL_D7SD
SY   IP6K1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5144
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18360; IP6K1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IPPK KO
AC   CVCL_D7SE
SY   IPPK Knockout cell line (A549)
DR   Ubigene; YKO-HS5143
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14645; IPPK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IRAK1 KO
AC   CVCL_D7SF
SY   IRAK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS14822
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IRAK4 KO
AC   CVCL_D7SG
SY   IRAK4 Knockout cell line (A549)
DR   Ubigene; YKO-HS344
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IRF3 KO
AC   CVCL_D7SH
SY   IRF3 Knockout cell line (A549)
DR   Ubigene; YKO-H1046
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 IRF9 KO
AC   CVCL_D7SI
SY   IRF9 Knockout cell line (A549)
DR   Ubigene; YKO-HS261
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ISG15 KO
AC   CVCL_D7SJ
SY   ISG15 Knockout cell line (A549)
DR   Ubigene; YKO-H979
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITGA1 KO
AC   CVCL_D7SK
SY   ITGA1 Knockout cell line (A549)
DR   Ubigene; YKO-HS639
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6134; ITGA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITGA3 KO
AC   CVCL_D7SL
SY   ITGA3 Knockout cell line (A549)
DR   Ubigene; YKO-HS644
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6139; ITGA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITGA5 KO
AC   CVCL_D7SM
SY   ITGA5 Knockout cell line (A549)
DR   Ubigene; YKO-H471
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITGA7 KO
AC   CVCL_D7SN
SY   ITGA7 Knockout cell line (A549)
DR   Ubigene; YKO-HS648
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6143; ITGA7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITGAM KO
AC   CVCL_D7SP
SY   ITGAM Knockout cell line (A549)
DR   Ubigene; YKO-H258
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H258; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 ITGB4 KO
AC   CVCL_D7SQ
SY   ITGB4 Knockout cell line (A549)
DR   Ubigene; YKO-HS654
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6158; ITGB4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITGB6 KO
AC   CVCL_D7SR
SY   ITGB6 Knockout cell line (A549)
DR   Ubigene; YKO-HS656
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6161; ITGB6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITPK1 KO
AC   CVCL_D7SS
SY   ITPK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5142
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6177; ITPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITPKB KO
AC   CVCL_D7ST
SY   ITPKB Knockout cell line (A549)
DR   Ubigene; YKO-HS5103
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6179; ITPKB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITPR1 KO
AC   CVCL_D7SU
SY   ITPR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4822
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITPR2 KO
AC   CVCL_D7SV
SY   ITPR2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4823
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ITPR3 KO
AC   CVCL_D7SW
SY   ITPR3 Knockout cell line (A549)
DR   Ubigene; YKO-HS4824
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 JAG2 KO
AC   CVCL_D7SX
SY   JAG2 Knockout cell line (A549)
DR   Ubigene; YKO-HS181
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6189; JAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 JAK1 KO
AC   CVCL_D7SY
SY   JAK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS262
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 JAK2 KO
AC   CVCL_D7SZ
SY   JAK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS263
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 JMJD6 KO
AC   CVCL_D7T0
SY   JMJD6 Knockout cell line (A549)
DR   Ubigene; YKO-HS13172
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19355; JMJD6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KAT2B KO
AC   CVCL_D7T1
SY   KAT2B Knockout cell line (A549)
DR   Ubigene; YKO-HS182
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KCNH1 KO
AC   CVCL_D7T2
SY   KCNH1 Knockout cell line (A549)
DR   Ubigene; YKO-XN29245
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6250; KCNH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KCNJ8 KO
AC   CVCL_D7T3
SY   KCNJ8 Knockout cell line (A549)
DR   Ubigene; YKO-HS5347
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6269; KCNJ8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KCNMA1 KO
AC   CVCL_D7T4
SY   KCNMA1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5332
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6284; KCNMA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KDM1A KO
AC   CVCL_D7T5
SY   KDM1A Knockout cell line (A549)
DR   Ubigene; YKO-H263
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H263; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 KIF7 KO
AC   CVCL_D7T6
SY   KIF7 Knockout cell line (A549)
DR   Ubigene; YKO-HS748
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30497; KIF7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KITLG KO
AC   CVCL_D7T7
SY   KITLG Knockout cell line (A549)
DR   Ubigene; YKO-HS486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6343; KITLG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KRAS KO
AC   CVCL_D7T8
SY   KRAS Knockout cell line (A549)
DR   Ubigene; YKO-H476
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KSR1 KO
AC   CVCL_D7T9
SY   KSR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6465; KSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 KSR2 KO
AC   CVCL_D7TA
SY   KSR2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18610; KSR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LAMA2 KO
AC   CVCL_D7TB
SY   LAMA2 Knockout cell line (A549)
DR   Ubigene; YKO-HS659
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6482; LAMA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LAMB3 KO
AC   CVCL_D7TC
SY   LAMB3 Knockout cell line (A549)
DR   Ubigene; YKO-HS665
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6490; LAMB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LAMC1 KO
AC   CVCL_D7TD
SY   LAMC1 Knockout cell line (A549)
DR   Ubigene; YKO-HS667
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6492; LAMC1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LAMC3 KO
AC   CVCL_D7TE
SY   LAMC3 Knockout cell line (A549)
DR   Ubigene; YKO-HS669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6494; LAMC3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LATS1 KO
AC   CVCL_D7TF
SY   LATS1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4775
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LATS2 KO
AC   CVCL_D7TG
SY   LATS2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1918
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LEPR KO
AC   CVCL_D7TH
SY   LEPR Knockout cell line (A549)
DR   Ubigene; YKO-HS266
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6554; LEPR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LGALS3 KO
AC   CVCL_D7TI
SY   LGALS3 Knockout cell line (A549)
DR   Ubigene; YKO-H764
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H764; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 LGR4 KO
AC   CVCL_D7TJ
SY   LGR4 Knockout cell line (A549)
DR   Ubigene; YKO-XN90041
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LGSN KO
AC   CVCL_D7TK
SY   LGSN Knockout cell line (A549)
DR   Ubigene; YKO-XN96682
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21016; LGSN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LIF KO
AC   CVCL_D7TL
SY   LIF Knockout cell line (A549)
DR   Ubigene; YKO-HS267
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6596; LIF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LIFR KO
AC   CVCL_D7TM
SY   LIFR Knockout cell line (A549)
DR   Ubigene; YKO-HS268
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6597; LIFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LMAN1 KO
AC   CVCL_D7TN
SY   LMAN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS14869
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6631; LMAN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LMNA KO
AC   CVCL_D7TP
SY   LMNA Knockout cell line (A549)
DR   Ubigene; YKO-HS08332
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LPAR1 KO
AC   CVCL_D7TQ
SY   LPAR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3166; LPAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LPAR2 KO
AC   CVCL_D7TR
SY   LPAR2 Knockout cell line (A549)
DR   Ubigene; YKO-HS671
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3168; LPAR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LPAR5 KO
AC   CVCL_D7TS
SY   LPAR5 Knockout cell line (A549)
DR   Ubigene; YKO-HS4686
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13307; LPAR5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LPAR6 KO
AC   CVCL_D7TT
SY   LPAR6 Knockout cell line (A549)
DR   Ubigene; YKO-HS5189
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15520; LPAR6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LRRC28 KO
AC   CVCL_D7TU
SY   LRRC28 Knockout cell line (A549)
DR   Ubigene; YKO-XN50625
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28355; LRRC28.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LTBR KO
AC   CVCL_D7TV
SY   LTBR Knockout cell line (A549)
DR   Ubigene; YKO-HS348
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6718; LTBR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 LYN KO
AC   CVCL_D7TW
SY   LYN Knockout cell line (A549)
DR   Ubigene; YKO-HS349
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MACROH2A2 KO
AC   CVCL_D7TX
SY   MACROH2A2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1766
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14453; MACROH2A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAGI1 KO
AC   CVCL_D7TY
SY   MAGI1 Knockout cell line (A549)
DR   Ubigene; YKO-HS674
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:946; MAGI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAGI3 KO
AC   CVCL_D7TZ
SY   MAGI3 Knockout cell line (A549)
DR   Ubigene; YKO-HS4705
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29647; MAGI3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MALT1 KO
AC   CVCL_D7U0
SY   MALT1 Knockout cell line (A549)
DR   Ubigene; YKO-HS350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAML1 KO
AC   CVCL_D7U1
SY   MAML1 Knockout cell line (A549)
DR   Ubigene; YKO-HS183
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13632; MAML1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAML2 KO
AC   CVCL_D7U2
SY   MAML2 Knockout cell line (A549)
DR   Ubigene; YKO-HS184
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16259; MAML2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP2K1 KO
AC   CVCL_D7U3
SY   MAP2K1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4560
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP2K3 KO
AC   CVCL_D7U4
SY   MAP2K3 Knockout cell line (A549)
DR   Ubigene; YKO-HS489
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP2K5 KO
AC   CVCL_D7U5
SY   MAP2K5 Knockout cell line (A549)
DR   Ubigene; YKO-HS1945
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6845; MAP2K5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP2K6 KO
AC   CVCL_D7U6
SY   MAP2K6 Knockout cell line (A549)
DR   Ubigene; YKO-HS4754
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6846; MAP2K6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP2K7 KO
AC   CVCL_D7U7
SY   MAP2K7 Knockout cell line (A549)
DR   Ubigene; YKO-HS491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K12 KO
AC   CVCL_D7U8
SY   MAP3K12 Knockout cell line (A549)
DR   Ubigene; YKO-HS494
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K14 KO
AC   CVCL_D7U9
SY   MAP3K14 Knockout cell line (A549)
DR   Ubigene; YKO-HS351
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K2 KO
AC   CVCL_D7UA
SY   MAP3K2 Knockout cell line (A549)
DR   Ubigene; YKO-HS496
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K3 KO
AC   CVCL_D7UB
SY   MAP3K3 Knockout cell line (A549)
DR   Ubigene; YKO-HS498
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K6 KO
AC   CVCL_D7UC
SY   MAP3K6 Knockout cell line (A549)
DR   Ubigene; YKO-HS501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6858; MAP3K6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K7 KO
AC   CVCL_D7UD
SY   MAP3K7 Knockout cell line (A549)
DR   Ubigene; YKO-HS352
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP3K8 KO
AC   CVCL_D7UE
SY   MAP3K8 Knockout cell line (A549)
DR   Ubigene; YKO-HS502
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP4K2 KO
AC   CVCL_D7UF
SY   MAP4K2 Knockout cell line (A549)
DR   Ubigene; YKO-HS10131
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6864; MAP4K2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP4K3 KO
AC   CVCL_D7UG
SY   MAP4K3 Knockout cell line (A549)
DR   Ubigene; YKO-HS504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6865; MAP4K3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAP4K4 KO
AC   CVCL_D7UH
SY   MAP4K4 Knockout cell line (A549)
DR   Ubigene; YKO-HS505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK11 KO
AC   CVCL_D7UI
SY   MAPK11 Knockout cell line (A549)
DR   Ubigene; YKO-HS507
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6873; MAPK11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK12 KO
AC   CVCL_D7UJ
SY   MAPK12 Knockout cell line (A549)
DR   Ubigene; YKO-HS4755
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK14 KO
AC   CVCL_D7UK
SY   MAPK14 Knockout cell line (A549)
DR   Ubigene; YKO-HS509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK7 KO
AC   CVCL_D7UL
SY   MAPK7 Knockout cell line (A549)
DR   Ubigene; YKO-HS510
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK8 KO
AC   CVCL_D7UM
SY   MAPK8 Knockout cell line (A549)
DR   Ubigene; YKO-HS511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6881; MAPK8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK8IP1 KO
AC   CVCL_D7UN
SY   MAPK8IP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS512
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6882; MAPK8IP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK8IP3 KO
AC   CVCL_D7UP
SY   MAPK8IP3 Knockout cell line (A549)
DR   Ubigene; YKO-HS514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6884; MAPK8IP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPK9 KO
AC   CVCL_D7UQ
SY   MAPK9 Knockout cell line (A549)
DR   Ubigene; YKO-HS515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6886; MAPK9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPKAPK3 KO
AC   CVCL_D7UR
SY   MAPKAPK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS517
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6888; MAPKAPK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPKAPK5 KO
AC   CVCL_D7US
SY   MAPKAPK5 Knockout cell line (A549)
DR   Ubigene; YKO-HS518
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAPT KO
AC   CVCL_D7UT
SY   MAPT Knockout cell line (A549)
DR   Ubigene; YKO-HS519
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MAVS KO
AC   CVCL_D7UU
SY   MAVS Knockout cell line (A549)
DR   Ubigene; YKO-H1242
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MCL1 KO
AC   CVCL_D7UV
SY   MCL1 Knockout cell line (A549)
DR   Ubigene; YKO-HS269
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6943; MCL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MCOLN1 KO
AC   CVCL_D7UW
SY   MCOLN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MCOLN2 KO
AC   CVCL_D7UX
SY   MCOLN2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5078
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13357; MCOLN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MCOLN3 KO
AC   CVCL_D7UY
SY   MCOLN3 Knockout cell line (A549)
DR   Ubigene; YKO-HS5079
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13358; MCOLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MERTK KO
AC   CVCL_D7UZ
SY   MERTK Knockout cell line (A549)
DR   Ubigene; YKO-HS1611
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MET KO
AC   CVCL_D7V0
SY   MET Knockout cell line (A549)
DR   Ubigene; YKO-H1018
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MFNG KO
AC   CVCL_D7V1
SY   MFNG Knockout cell line (A549)
DR   Ubigene; YKO-HS185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7038; MFNG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MIDN KO
AC   CVCL_D7V2
SY   MIDN Knockout cell line (A549)
DR   Ubigene; YKO-H975
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16298; MIDN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MKNK1 KO
AC   CVCL_D7V3
SY   MKNK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4901
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MKNK2 KO
AC   CVCL_D7V4
SY   MKNK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4902
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MKRN3 KO
AC   CVCL_D7V5
SY   MKRN3 Knockout cell line (A549)
DR   Ubigene; YKO-XN38393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7114; MKRN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MLKL KO
AC   CVCL_D7V6
SY   MLKL Knockout cell line (A549)
DR   Ubigene; YKO-HS4876
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MMP7 KO
AC   CVCL_D7V7
SY   MMP7 Knockout cell line (A549)
DR   Ubigene; YKO-HS046
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7174; MMP7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MOB1A KO
AC   CVCL_D7V8
SY   MOB1A Knockout cell line (A549)
DR   Ubigene; YKO-HS4776
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16015; MOB1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MOB1B KO
AC   CVCL_D7V9
SY   MOB1B Knockout cell line (A549)
DR   Ubigene; YKO-HS4777
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29801; MOB1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MRAS KO
AC   CVCL_D7VA
SY   MRAS Knockout cell line (A549)
DR   Ubigene; YKO-HS523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7227; MRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MSH6 KO
AC   CVCL_D7VB
SY   MSH6 Knockout cell line (A549)
DR   Ubigene; YKO-XN27273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MST1R KO
AC   CVCL_D7VC
SY   MST1R Knockout cell line (A549)
DR   Ubigene; YKO-HS5067
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7381; MST1R.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MVP KO
AC   CVCL_D7VD
SY   MVP Knockout cell line (A549)
DR   Ubigene; YKO-HS08926
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7531; MVP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MYD88 KO
AC   CVCL_D7VE
SY   MYD88 Knockout cell line (A549)
DR   Ubigene; YKO-HS353
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MYLK KO
AC   CVCL_D7VF
SY   MYLK Knockout cell line (A549)
DR   Ubigene; YKO-HS4835
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7590; MYLK.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 MYO9B KO
AC   CVCL_D7VG
SY   MYO9B Knockout cell line (A549)
DR   Ubigene; YKO-HS1795
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7609; MYO9B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NADK2 KO
AC   CVCL_D7VH
SY   NADK2 Knockout cell line (A549)
DR   Ubigene; YKO-H1001
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26404; NADK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NAGLU KO
AC   CVCL_D7VI
SY   NAGLU Knockout cell line (A549)
DR   Ubigene; YKO-HS11138
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7632; NAGLU.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NCOR2 KO
AC   CVCL_D7VJ
SY   NCOR2 Knockout cell line (A549)
DR   Ubigene; YKO-HS186
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7673; NCOR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NCSTN KO
AC   CVCL_D7VK
SY   NCSTN Knockout cell line (A549)
DR   Ubigene; YKO-HS187
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NDRG1 KO
AC   CVCL_D7VL
SY   NDRG1 Knockout cell line (A549)
DR   Ubigene; YKO-HS08675
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7679; NDRG1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NEDD4 KO
AC   CVCL_D7VM
SY   NEDD4 Knockout cell line (A549)
DR   Ubigene; YKO-HS10556
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7727; NEDD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NEU1 KO
AC   CVCL_D7VN
SY   NEU1 Knockout cell line (A549)
DR   Ubigene; YKO-HS14074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7758; NEU1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NF1 KO
AC   CVCL_D7VP
SY   NF1 Knockout cell line (A549)
DR   Ubigene; YKO-HS524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NFE2L2 KO
AC   CVCL_D7VQ
SY   NFE2L2 Knockout cell line (A549)
DR   Ubigene; YKO-H174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NFKB1 KO
AC   CVCL_D7VR
SY   NFKB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS354
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NFKB2 KO
AC   CVCL_D7VS
SY   NFKB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS355
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NFKBIA KO
AC   CVCL_D7VT
SY   NFKBIA Knockout cell line (A549)
DR   Ubigene; YKO-HS356
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NGLY1 KO
AC   CVCL_D7VU
SY   NGLY1 Knockout cell line (A549)
DR   Ubigene; YKO-XN91087
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17646; NGLY1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NINJ1 KO
AC   CVCL_D7VV
SY   NINJ1 Knockout cell line (A549)
DR   Ubigene; YKO-H951
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7824; NINJ1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NME4 KO
AC   CVCL_D7VW
SY   NME4 Knockout cell line (A549)
DR   Ubigene; YKO-HS11053
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7852; NME4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NMRK1 KO
AC   CVCL_D7VX
SY   NMRK1 Knockout cell line (A549)
DR   Ubigene; YKO-XN91174
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26057; NMRK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NOTCH1 KO
AC   CVCL_D7VY
SY   NOTCH1 Knockout cell line (A549)
DR   Ubigene; YKO-HS188
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NOTCH2 KO
AC   CVCL_D7VZ
SY   NOTCH2 Knockout cell line (A549)
DR   Ubigene; YKO-HS189
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NOTCH3 KO
AC   CVCL_D7W0
SY   NOTCH3 Knockout cell line (A549)
DR   Ubigene; YKO-HS190
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NQO1 KO
AC   CVCL_D7W1
SY   NQO1 Knockout cell line (A549)
DR   Ubigene; YKO-XN91289
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2874; NQO1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NR1D1 KO
AC   CVCL_D7W2
SY   NR1D1 Knockout cell line (A549)
DR   Ubigene; YKO-H811
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7962; NR1D1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NR3C1 KO
AC   CVCL_D7W3
SY   NR3C1 Knockout cell line (A549)
DR   Ubigene; YKO-XN91304
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NR4A1 KO
AC   CVCL_D7W4
SY   NR4A1 Knockout cell line (A549)
DR   Ubigene; YKO-HS530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NRP1 KO
AC   CVCL_D7W5
SY   NRP1 Knockout cell line (A549)
DR   Ubigene; YKO-H264
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8004; NRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H264; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 NTRK3 KO
AC   CVCL_D7W6
SY   NTRK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS5066
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8033; NTRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NUMA1 KO
AC   CVCL_D7W7
SY   NUMA1 Knockout cell line (A549)
DR   Ubigene; YKO-H938
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8059; NUMA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NUMB KO
AC   CVCL_D7W8
SY   NUMB Knockout cell line (A549)
DR   Ubigene; YKO-HS192
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 NUMBL KO
AC   CVCL_D7W9
SY   NUMBL Knockout cell line (A549)
DR   Ubigene; YKO-HS193
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8061; NUMBL.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 OGT KO
AC   CVCL_D7WA
SY   OGT Knockout cell line (A549)
DR   Ubigene; YKO-H404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8127; OGT.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H404; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 OSMR KO
AC   CVCL_D7WB
SY   OSMR Knockout cell line (A549)
DR   Ubigene; YKO-HS273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8507; OSMR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 OXTR KO
AC   CVCL_D7WC
SY   OXTR Knockout cell line (A549)
DR   Ubigene; YKO-HS5043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8529; OXTR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 P2RX4 KO
AC   CVCL_D7WD
SY   P2RX4 Knockout cell line (A549)
DR   Ubigene; YKO-HS5019
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8535; P2RX4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 P2RX5 KO
AC   CVCL_D7WE
SY   P2RX5 Knockout cell line (A549)
DR   Ubigene; YKO-HS5020
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8536; P2RX5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PAK1 KO
AC   CVCL_D7WF
SY   PAK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS535
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PAK2 KO
AC   CVCL_D7WG
SY   PAK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS536
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PAK4 KO
AC   CVCL_D7WH
SY   PAK4 Knockout cell line (A549)
DR   Ubigene; YKO-HS4626
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PAPPA KO
AC   CVCL_D7WI
SY   PAPPA Knockout cell line (A549)
DR   Ubigene; YKO-XN32469
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8602; PAPPA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PARK7 KO
AC   CVCL_D7WJ
SY   PARK7 Knockout cell line (A549)
DR   Ubigene; YKO-H1014
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16369; PARK7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PARP1 KO
AC   CVCL_D7WK
SY   PARP1 Knockout cell line (A549)
DR   Ubigene; YKO-H954
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PARP2 KO
AC   CVCL_D7WL
SY   PARP2 Knockout cell line (A549)
DR   Ubigene; YKO-H435
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:272; PARP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PBLD KO
AC   CVCL_D7WM
SY   PBLD Knockout cell line (A549)
DR   Ubigene; YKO-XN91769
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23301; PBLD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PCM1 KO
AC   CVCL_D7WN
SY   PCM1 Knockout cell line (A549)
DR   Ubigene; YKO-H650
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8727; PCM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PDGFD KO
AC   CVCL_D7WP
SY   PDGFD Knockout cell line (A549)
DR   Ubigene; YKO-HS537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30620; PDGFD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PDIA4 KO
AC   CVCL_D7WQ
SY   PDIA4 Knockout cell line (A549)
DR   Ubigene; YKO-H682
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30167; PDIA4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PDK1 KO
AC   CVCL_D7WR
SY   PDK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4920
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8809; PDK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PFKFB2 KO
AC   CVCL_D7WS
SY   PFKFB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1862
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8873; PFKFB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PFKFB3 KO
AC   CVCL_D7WT
SY   PFKFB3 Knockout cell line (A549)
DR   Ubigene; YKO-HS4938
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PFKFB4 KO
AC   CVCL_D7WU
SY   PFKFB4 Knockout cell line (A549)
DR   Ubigene; YKO-HS5353
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8875; PFKFB4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PGF KO
AC   CVCL_D7WV
SY   PGF Knockout cell line (A549)
DR   Ubigene; YKO-HS538
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8893; PGF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PHKA1 KO
AC   CVCL_D7WW
SY   PHKA1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8925; PHKA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PHKA2 KO
AC   CVCL_D7WX
SY   PHKA2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5094
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8926; PHKA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PHKB KO
AC   CVCL_D7WY
SY   PHKB Knockout cell line (A549)
DR   Ubigene; YKO-HS5093
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8927; PHKB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PHKG2 KO
AC   CVCL_D7WZ
SY   PHKG2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5092
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8931; PHKG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PI4K2A KO
AC   CVCL_D7X0
SY   PI4K2A Knockout cell line (A549)
DR   Ubigene; YKO-HS5108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PI4K2B KO
AC   CVCL_D7X1
SY   PI4K2B Knockout cell line (A549)
DR   Ubigene; YKO-HS5109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PI4KB KO
AC   CVCL_D7X2
SY   PI4KB Knockout cell line (A549)
DR   Ubigene; YKO-HS5107
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIAS2 KO
AC   CVCL_D7X3
SY   PIAS2 Knockout cell line (A549)
DR   Ubigene; YKO-HS276
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17311; PIAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIAS3 KO
AC   CVCL_D7X4
SY   PIAS3 Knockout cell line (A549)
DR   Ubigene; YKO-HS277
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16861; PIAS3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIAS4 KO
AC   CVCL_D7X5
SY   PIAS4 Knockout cell line (A549)
DR   Ubigene; YKO-HS357
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17002; PIAS4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3AP1 KO
AC   CVCL_D7X6
SY   PIK3AP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS683
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30034; PIK3AP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3C2A KO
AC   CVCL_D7X7
SY   PIK3C2A Knockout cell line (A549)
DR   Ubigene; YKO-HS5138
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3C2B KO
AC   CVCL_D7X8
SY   PIK3C2B Knockout cell line (A549)
DR   Ubigene; YKO-HS5139
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8972; PIK3C2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3CB KO
AC   CVCL_D7X9
SY   PIK3CB Knockout cell line (A549)
DR   Ubigene; YKO-H351
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8976; PIK3CB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3CD KO
AC   CVCL_D7XA
SY   PIK3CD Knockout cell line (A549)
DR   Ubigene; YKO-HS280
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3R1 KO
AC   CVCL_D7XB
SY   PIK3R1 Knockout cell line (A549)
DR   Ubigene; YKO-HS281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3R2 KO
AC   CVCL_D7XC
SY   PIK3R2 Knockout cell line (A549)
DR   Ubigene; YKO-H1030
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIK3R3 KO
AC   CVCL_D7XD
SY   PIK3R3 Knockout cell line (A549)
DR   Ubigene; YKO-HS4562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8981; PIK3R3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIKFYVE KO
AC   CVCL_D7XE
SY   PIKFYVE Knockout cell line (A549)
DR   Ubigene; YKO-HS5123
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23785; PIKFYVE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIM1 KO
AC   CVCL_D7XF
SY   PIM1 Knockout cell line (A549)
DR   Ubigene; YKO-H260
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PINK1 KO
AC   CVCL_D7XG
SY   PINK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS13206
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIP4K2A KO
AC   CVCL_D7XH
SY   PIP4K2A Knockout cell line (A549)
DR   Ubigene; YKO-HS5133
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIP4K2B KO
AC   CVCL_D7XI
SY   PIP4K2B Knockout cell line (A549)
DR   Ubigene; YKO-HS5134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIP4K2C KO
AC   CVCL_D7XJ
SY   PIP4K2C Knockout cell line (A549)
DR   Ubigene; YKO-HS5132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIP5K1A KO
AC   CVCL_D7XK
SY   PIP5K1A Knockout cell line (A549)
DR   Ubigene; YKO-H1195
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PIP5K1C KO
AC   CVCL_D7XL
SY   PIP5K1C Knockout cell line (A549)
DR   Ubigene; YKO-HS5112
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PKM KO
AC   CVCL_D7XM
SY   PKM Knockout cell line (A549)
DR   Ubigene; YKO-H662
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9021; PKM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PKN1 KO
AC   CVCL_D7XN
SY   PKN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PKN2 KO
AC   CVCL_D7XP
SY   PKN2 Knockout cell line (A549)
DR   Ubigene; YKO-HS688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PKN3 KO
AC   CVCL_D7XQ
SY   PKN3 Knockout cell line (A549)
DR   Ubigene; YKO-HS689
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17999; PKN3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLA2G4A KO
AC   CVCL_D7XR
SY   PLA2G4A Knockout cell line (A549)
DR   Ubigene; YKO-H713
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLA2G4C KO
AC   CVCL_D7XS
SY   PLA2G4C Knockout cell line (A549)
DR   Ubigene; YKO-HS540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9037; PLA2G4C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLAU KO
AC   CVCL_D7XT
SY   PLAU Knockout cell line (A549)
DR   Ubigene; YKO-HS358
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLCG1 KO
AC   CVCL_D7XU
SY   PLCG1 Knockout cell line (A549)
DR   Ubigene; YKO-HS359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLCG2 KO
AC   CVCL_D7XV
SY   PLCG2 Knockout cell line (A549)
DR   Ubigene; YKO-HS360
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLK2 KO
AC   CVCL_D7XW
SY   PLK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4972
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLK3 KO
AC   CVCL_D7XX
SY   PLK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS4973
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2154; PLK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PLSCR1 KO
AC   CVCL_D7XY
SY   PLSCR1 Knockout cell line (A549)
DR   Ubigene; YKO-HJ048
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9092; PLSCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 POLD1 KO
AC   CVCL_D7XZ
SY   POLD1 Knockout cell line (A549)
DR   Ubigene; YKO-H791
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9175; POLD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 POLG KO
AC   CVCL_D7Y0
SY   POLG Knockout cell line (A549)
DR   Ubigene; YKO-HS14404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9179; POLG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PORCN KO
AC   CVCL_D7Y1
SY   PORCN Knockout cell line (A549)
DR   Ubigene; YKO-XN92218
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17652; PORCN.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPARA KO
AC   CVCL_D7Y2
SY   PPARA Knockout cell line (A549)
DR   Ubigene; YKO-HS5291
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPARG KO
AC   CVCL_D7Y3
SY   PPARG Knockout cell line (A549)
DR   Ubigene; YKO-HS1955
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPIP5K2 KO
AC   CVCL_D7Y4
SY   PPIP5K2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5148
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29035; PPIP5K2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPP2R2A KO
AC   CVCL_D7Y5
SY   PPP2R2A Knockout cell line (A549)
DR   Ubigene; YKO-HS690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9304; PPP2R2A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPP2R3A KO
AC   CVCL_D7Y6
SY   PPP2R3A Knockout cell line (A549)
DR   Ubigene; YKO-HS692
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9307; PPP2R3A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPP2R5A KO
AC   CVCL_D7Y7
SY   PPP2R5A Knockout cell line (A549)
DR   Ubigene; YKO-HS693
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9309; PPP2R5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PPP3CC KO
AC   CVCL_D7Y8
SY   PPP3CC Knockout cell line (A549)
DR   Ubigene; YKO-HS547
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9316; PPP3CC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKAA1 KO
AC   CVCL_D7Y9
SY   PRKAA1 Knockout cell line (A549)
DR   Ubigene; YKO-H895
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKAA2 KO
AC   CVCL_D7YA
SY   PRKAA2 Knockout cell line (A549)
DR   Ubigene; YKO-HS699
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKAB1 KO
AC   CVCL_D7YB
SY   PRKAB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4851
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKAB2 KO
AC   CVCL_D7YC
SY   PRKAB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4852
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9379; PRKAB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKACA KO
AC   CVCL_D7YD
SY   PRKACA Knockout cell line (A549)
DR   Ubigene; YKO-HS550
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKACB KO
AC   CVCL_D7YE
SY   PRKACB Knockout cell line (A549)
DR   Ubigene; YKO-HS4601
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKAG1 KO
AC   CVCL_D7YF
SY   PRKAG1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4853
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKAG2 KO
AC   CVCL_D7YG
SY   PRKAG2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4855
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9386; PRKAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKCE KO
AC   CVCL_D7YH
SY   PRKCE Knockout cell line (A549)
DR   Ubigene; YKO-HS4830
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKCG KO
AC   CVCL_D7YI
SY   PRKCG Knockout cell line (A549)
DR   Ubigene; YKO-HS552
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKCI KO
AC   CVCL_D7YJ
SY   PRKCI Knockout cell line (A549)
DR   Ubigene; YKO-HS4747
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKCQ KO
AC   CVCL_D7YK
SY   PRKCQ Knockout cell line (A549)
DR   Ubigene; YKO-HS362
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9410; PRKCQ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKCZ KO
AC   CVCL_D7YL
SY   PRKCZ Knockout cell line (A549)
DR   Ubigene; YKO-H755
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKD1 KO
AC   CVCL_D7YM
SY   PRKD1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4710
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKD2 KO
AC   CVCL_D7YN
SY   PRKD2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4712
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKD3 KO
AC   CVCL_D7YP
SY   PRKD3 Knockout cell line (A549)
DR   Ubigene; YKO-HS4711
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRKG2 KO
AC   CVCL_D7YQ
SY   PRKG2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5331
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9416; PRKG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PRNP KO
AC   CVCL_D7YR
SY   PRNP Knockout cell line (A549)
DR   Ubigene; YKO-H088
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9449; PRNP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PSEN1 KO
AC   CVCL_D7YS
SY   PSEN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS060
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PSEN2 KO
AC   CVCL_D7YT
SY   PSEN2 Knockout cell line (A549)
DR   Ubigene; YKO-HS194
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9509; PSEN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTAFR KO
AC   CVCL_D7YU
SY   PTAFR Knockout cell line (A549)
DR   Ubigene; YKO-HS5047
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9582; PTAFR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTGS2 KO
AC   CVCL_D7YV
SY   PTGS2 Knockout cell line (A549)
DR   Ubigene; YKO-H756
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9605; PTGS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTK2 KO
AC   CVCL_D7YW
SY   PTK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1818
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTK2B KO
AC   CVCL_D7YX
SY   PTK2B Knockout cell line (A549)
DR   Ubigene; YKO-HS5102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTPN13 KO
AC   CVCL_D7YY
SY   PTPN13 Knockout cell line (A549)
DR   Ubigene; YKO-HS11621
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9646; PTPN13.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTPN2 KO
AC   CVCL_D7YZ
SY   PTPN2 Knockout cell line (A549)
DR   Ubigene; YKO-HS285
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 PTPN6 KO
AC   CVCL_D7Z0
SY   PTPN6 Knockout cell line (A549)
DR   Ubigene; YKO-HS286
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 QKI KO
AC   CVCL_D7Z1
SY   QKI Knockout cell line (A549)
DR   Ubigene; YKO-XN41653
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21100; QKI.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RAB10 KO
AC   CVCL_D7Z2
SY   RAB10 Knockout cell line (A549)
DR   Ubigene; YKO-HS5375
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9759; RAB10.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RAB11A KO
AC   CVCL_D7Z3
SY   RAB11A Knockout cell line (A549)
DR   Ubigene; YKO-HS1810
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9760; RAB11A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RAB27A KO
AC   CVCL_D7Z4
SY   RAB27A Knockout cell line (A549)
DR   Ubigene; YKO-H491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RAF1 KO
AC   CVCL_D7Z5
SY   RAF1 Knockout cell line (A549)
DR   Ubigene; YKO-H760
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RASGRP1 KO
AC   CVCL_D7Z6
SY   RASGRP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9878; RASGRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RASSF4 KO
AC   CVCL_D7Z7
SY   RASSF4 Knockout cell line (A549)
DR   Ubigene; YKO-XN65693
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20793; RASSF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RB1 KO
AC   CVCL_D7Z8
SY   RB1 Knockout cell line (A549)
DR   Ubigene; YKO-H118
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RBL2 KO
AC   CVCL_D7Z9
SY   RBL2 Knockout cell line (A549)
DR   Ubigene; YKO-HS701
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9894; RBL2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RBPJ KO
AC   CVCL_D7ZA
SY   RBPJ Knockout cell line (A549)
DR   Ubigene; YKO-HS195
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5724; RBPJ.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RC3H2 KO
AC   CVCL_D7ZB
SY   RC3H2 Knockout cell line (A549)
DR   Ubigene; YKO-XN74953
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21461; RC3H2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RELA KO
AC   CVCL_D7ZC
SY   RELA Knockout cell line (A549)
DR   Ubigene; YKO-HS364
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RELB KO
AC   CVCL_D7ZD
SY   RELB Knockout cell line (A549)
DR   Ubigene; YKO-HS365
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9956; RELB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RIOK3 KO
AC   CVCL_D7ZE
SY   RIOK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS14192
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11451; RIOK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RIPK1 KO
AC   CVCL_D7ZF
SY   RIPK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS366
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RNF111 KO
AC   CVCL_D7ZG
SY   RNF111 Knockout cell line (A549)
DR   Ubigene; YKO-XN92894
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17384; RNF111.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RNF167 KO
AC   CVCL_D7ZH
SY   RNF167 Knockout cell line (A549)
DR   Ubigene; YKO-H1085
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24544; RNF167.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RNH1 KO
AC   CVCL_D7ZI
SY   RNH1 Knockout cell line (A549)
DR   Ubigene; YKO-XN34673
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10074; RNH1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ROCK1 KO
AC   CVCL_D7ZJ
SY   ROCK1 Knockout cell line (A549)
DR   Ubigene; YKO-H897
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ROCK2 KO
AC   CVCL_D7ZK
SY   ROCK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS062
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ROR1 KO
AC   CVCL_D7ZL
SY   ROR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS063
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RPS6KA3 KO
AC   CVCL_D7ZM
SY   RPS6KA3 Knockout cell line (A549)
DR   Ubigene; YKO-HS568
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RPS6KA6 KO
AC   CVCL_D7ZN
SY   RPS6KA6 Knockout cell line (A549)
DR   Ubigene; YKO-HS571
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10435; RPS6KA6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RRAS2 KO
AC   CVCL_D7ZP
SY   RRAS2 Knockout cell line (A549)
DR   Ubigene; YKO-HS572
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17271; RRAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RSPO2 KO
AC   CVCL_D7ZQ
SY   RSPO2 Knockout cell line (A549)
DR   Ubigene; YKO-XN96671
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28583; RSPO2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RSPO3 KO
AC   CVCL_D7ZR
SY   RSPO3 Knockout cell line (A549)
DR   Ubigene; YKO-HS065
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20866; RSPO3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RSRP1 KO
AC   CVCL_D7ZS
SY   RSRP1 Knockout cell line (A549)
DR   Ubigene; YKO-H1248
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25234; RSRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RTN4 KO
AC   CVCL_D7ZT
SY   RTN4 Knockout cell line (A549)
DR   Ubigene; YKO-XN80149
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14085; RTN4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RXRA KO
AC   CVCL_D7ZU
SY   RXRA Knockout cell line (A549)
DR   Ubigene; YKO-HS705
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 RYR1 KO
AC   CVCL_D7ZV
SY   RYR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4825
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10483; RYR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 S1PR3 KO
AC   CVCL_D7ZW
SY   S1PR3 Knockout cell line (A549)
DR   Ubigene; YKO-HS1825
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3167; S1PR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 S1PR5 KO
AC   CVCL_D7ZX
SY   S1PR5 Knockout cell line (A549)
DR   Ubigene; YKO-HS5233
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14299; S1PR5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SAMHD1 KO
AC   CVCL_D7ZY
SY   SAMHD1 Knockout cell line (A549)
DR   Ubigene; YKO-HS08219
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15925; SAMHD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SDHB KO
AC   CVCL_D7ZZ
SY   SDHB Knockout cell line (A549)
DR   Ubigene; YKO-H365
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10681; SDHB.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SEMA3C KO
AC   CVCL_D8A0
SY   SEMA3C Knockout cell line (A549)
DR   Ubigene; YKO-H1121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10725; SEMA3C.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SERPINE1 KO
AC   CVCL_D8A1
SY   SERPINE1 Knockout cell line (A549)
DR   Ubigene; YKO-H463
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SETD2 KO
AC   CVCL_D8A2
SY   SETD2 Knockout cell line (A549)
DR   Ubigene; YKO-XN96663
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SETDB1 KO
AC   CVCL_D8A3
SY   SETDB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS13218
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10761; SETDB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SGCA KO
AC   CVCL_D8A4
SY   SGCA Knockout cell line (A549)
DR   Ubigene; YKO-H809
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10805; SGCA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SGK1 KO
AC   CVCL_D8A5
SY   SGK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SGK2 KO
AC   CVCL_D8A6
SY   SGK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS707
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10811; SGK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SGMS2 KO
AC   CVCL_D8A7
SY   SGMS2 Knockout cell line (A549)
DR   Ubigene; YKO-H955
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28395; SGMS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SHKBP1 KO
AC   CVCL_D8A8
SY   SHKBP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS11642
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19214; SHKBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SIGMAR1 KO
AC   CVCL_D8A9
SY   SIGMAR1 Knockout cell line (A549)
DR   Ubigene; YKO-H216
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H216; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 SIRT2 KO
AC   CVCL_D8AA
SY   SIRT2 Knockout cell line (A549)
DR   Ubigene; YKO-H170
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H170; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 SIRT6 KO
AC   CVCL_D8AB
SY   SIRT6 Knockout cell line (A549)
DR   Ubigene; YKO-HS1752
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14934; SIRT6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SIRT7 KO
AC   CVCL_D8AC
SY   SIRT7 Knockout cell line (A549)
DR   Ubigene; YKO-H228
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SKP2 KO
AC   CVCL_D8AD
SY   SKP2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4531
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC25A4 KO
AC   CVCL_D8AE
SY   SLC25A4 Knockout cell line (A549)
DR   Ubigene; YKO-HS5084
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC2A1 KO
AC   CVCL_D8AF
SY   SLC2A1 Knockout cell line (A549)
DR   Ubigene; YKO-XN93409
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC38A9 KO
AC   CVCL_D8AG
SY   SLC38A9 Knockout cell line (A549)
DR   Ubigene; YKO-HS4495
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC39A6 KO
AC   CVCL_D8AH
SY   SLC39A6 Knockout cell line (A549)
DR   Ubigene; YKO-HS1569
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18607; SLC39A6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC39A8 KO
AC   CVCL_D8AI
SY   SLC39A8 Knockout cell line (A549)
DR   Ubigene; YKO-H036
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC3A2 KO
AC   CVCL_D8AJ
SY   SLC3A2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC7A11 KO
AC   CVCL_D8AK
SY   SLC7A11 Knockout cell line (A549)
DR   Ubigene; YKO-HS1921
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLC9A1 KO
AC   CVCL_D8AL
SY   SLC9A1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4831
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SLFN11 KO
AC   CVCL_D8AM
SY   SLFN11 Knockout cell line (A549)
DR   Ubigene; YKO-XN70185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26633; SLFN11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD1 KO
AC   CVCL_D8AN
SY   SMAD1 Knockout cell line (A549)
DR   Ubigene; YKO-HS148
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6767; SMAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD2 KO
AC   CVCL_D8AP
SY   SMAD2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1734
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD3 KO
AC   CVCL_D8AQ
SY   SMAD3 Knockout cell line (A549)
DR   Ubigene; YKO-HS149
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6769; SMAD3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD4 KO
AC   CVCL_D8AR
SY   SMAD4 Knockout cell line (A549)
DR   Ubigene; YKO-HS150
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD5 KO
AC   CVCL_D8AS
SY   SMAD5 Knockout cell line (A549)
DR   Ubigene; YKO-HS151
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD6 KO
AC   CVCL_D8AT
SY   SMAD6 Knockout cell line (A549)
DR   Ubigene; YKO-HS152
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6772; SMAD6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMAD7 KO
AC   CVCL_D8AU
SY   SMAD7 Knockout cell line (A549)
DR   Ubigene; YKO-HS153
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMARCA2 KO
AC   CVCL_D8AV
SY   SMARCA2 Knockout cell line (A549)
DR   Ubigene; YKO-H035
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11098; SMARCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMARCD2 KO
AC   CVCL_D8AW
SY   SMARCD2 Knockout cell line (A549)
DR   Ubigene; YKO-H034
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11107; SMARCD2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMDT1 KO
AC   CVCL_D8AX
SY   SMDT1 Knockout cell line (A549)
DR   Ubigene; YKO-HS13985
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25055; SMDT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMIM12 KO
AC   CVCL_D8AY
SY   SMIM12 Knockout cell line (A549)
DR   Ubigene; YKO-XN46205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25154; SMIM12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMO KO
AC   CVCL_D8AZ
SY   SMO Knockout cell line (A549)
DR   Ubigene; YKO-HS755
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMURF1 KO
AC   CVCL_D8B0
SY   SMURF1 Knockout cell line (A549)
DR   Ubigene; YKO-HS155
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SMURF2 KO
AC   CVCL_D8B1
SY   SMURF2 Knockout cell line (A549)
DR   Ubigene; YKO-HS156
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SNAI1 KO
AC   CVCL_D8B2
SY   SNAI1 Knockout cell line (A549)
DR   Ubigene; YKO-XN96694
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11128; SNAI1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOCS2 KO
AC   CVCL_D8B3
SY   SOCS2 Knockout cell line (A549)
DR   Ubigene; YKO-HS287
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19382; SOCS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOCS3 KO
AC   CVCL_D8B4
SY   SOCS3 Knockout cell line (A549)
DR   Ubigene; YKO-HS288
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOCS4 KO
AC   CVCL_D8B5
SY   SOCS4 Knockout cell line (A549)
DR   Ubigene; YKO-HS289
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOCS5 KO
AC   CVCL_D8B6
SY   SOCS5 Knockout cell line (A549)
DR   Ubigene; YKO-HS290
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16852; SOCS5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOCS6 KO
AC   CVCL_D8B7
SY   SOCS6 Knockout cell line (A549)
DR   Ubigene; YKO-HS291
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16833; SOCS6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOCS7 KO
AC   CVCL_D8B8
SY   SOCS7 Knockout cell line (A549)
DR   Ubigene; YKO-HS292
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29846; SOCS7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOS1 KO
AC   CVCL_D8B9
SY   SOS1 Knockout cell line (A549)
DR   Ubigene; YKO-HS293
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOS2 KO
AC   CVCL_D8BA
SY   SOS2 Knockout cell line (A549)
DR   Ubigene; YKO-HS294
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11188; SOS2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SP1 KO
AC   CVCL_D8BB
SY   SP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS157
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SPHK1 KO
AC   CVCL_D8BC
SY   SPHK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS1898
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SPHK2 KO
AC   CVCL_D8BD
SY   SPHK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS4815
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SRC KO
AC   CVCL_D8BE
SY   SRC Knockout cell line (A549)
DR   Ubigene; YKO-HS4737
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SRPX2 KO
AC   CVCL_D8BF
SY   SRPX2 Knockout cell line (A549)
DR   Ubigene; YKO-H146
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30668; SRPX2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAG2 KO
AC   CVCL_D8BG
SY   STAG2 Knockout cell line (A549)
DR   Ubigene; YKO-H448
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAM KO
AC   CVCL_D8BH
SY   STAM Knockout cell line (A549)
DR   Ubigene; YKO-HS295
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11357; STAM.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAM2 KO
AC   CVCL_D8BI
SY   STAM2 Knockout cell line (A549)
DR   Ubigene; YKO-HS296
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11358; STAM2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAT1 KO
AC   CVCL_D8BJ
SY   STAT1 Knockout cell line (A549)
DR   Ubigene; YKO-HS297
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAT2 KO
AC   CVCL_D8BK
SY   STAT2 Knockout cell line (A549)
DR   Ubigene; YKO-HS298
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAT4 KO
AC   CVCL_D8BL
SY   STAT4 Knockout cell line (A549)
DR   Ubigene; YKO-HS299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAT5A KO
AC   CVCL_D8BM
SY   STAT5A Knockout cell line (A549)
DR   Ubigene; YKO-HS300
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11366; STAT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAT5B KO
AC   CVCL_D8BN
SY   STAT5B Knockout cell line (A549)
DR   Ubigene; YKO-HS301
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STAT6 KO
AC   CVCL_D8BP
SY   STAT6 Knockout cell line (A549)
DR   Ubigene; YKO-HS302
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STING1 KO
AC   CVCL_D8BQ
SY   STING1 Knockout cell line (A549)
DR   Ubigene; YKO-H503
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STK11 KO
AC   CVCL_D8BR
SY   STK11 Knockout cell line (A549)
DR   Ubigene; YKO-HS709
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STK3 KO
AC   CVCL_D8BS
SY   STK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS574
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STK4 KO
AC   CVCL_D8BT
SY   STK4 Knockout cell line (A549)
DR   Ubigene; YKO-HS4622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 STRA6 KO
AC   CVCL_D8BU
SY   STRA6 Knockout cell line (A549)
DR   Ubigene; YKO-XN94138
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30650; STRA6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SYVN1 KO
AC   CVCL_D8BV
SY   SYVN1 Knockout cell line (A549)
DR   Ubigene; YKO-H740
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20738; SYVN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 SOX9 KO
AC   CVCL_D8BW
SY   SOX9 Knockout cell line (A549)
DR   Ubigene; YKO-H1035
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TAB1 KO
AC   CVCL_D8BX
SY   TAB1 Knockout cell line (A549)
DR   Ubigene; YKO-HS368
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TAB2 KO
AC   CVCL_D8BY
SY   TAB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TAB3 KO
AC   CVCL_D8BZ
SY   TAB3 Knockout cell line (A549)
DR   Ubigene; YKO-HS370
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30681; TAB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TAOK1 KO
AC   CVCL_D8C0
SY   TAOK1 Knockout cell line (A549)
DR   Ubigene; YKO-XN94301
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29259; TAOK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TAOK2 KO
AC   CVCL_D8C1
SY   TAOK2 Knockout cell line (A549)
DR   Ubigene; YKO-HS576
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16835; TAOK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TAOK3 KO
AC   CVCL_D8C2
SY   TAOK3 Knockout cell line (A549)
DR   Ubigene; YKO-HS577
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18133; TAOK3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TBK1 KO
AC   CVCL_D8C3
SY   TBK1 Knockout cell line (A549)
DR   Ubigene; YKO-HS4643
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TCF7L1 KO
AC   CVCL_D8C4
SY   TCF7L1 Knockout cell line (A549)
DR   Ubigene; YKO-HS077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11640; TCF7L1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TENT5A KO
AC   CVCL_D8C5
SY   TENT5A Knockout cell line (A549)
DR   Ubigene; YKO-H045
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18345; TENT5A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TF KO
AC   CVCL_D8C6
SY   TF Knockout cell line (A549)
DR   Ubigene; YKO-HS1584
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11740; TF.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TFG KO
AC   CVCL_D8C7
SY   TFG Knockout cell line (A549)
DR   Ubigene; YKO-HS1754
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11758; TFG.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TFRC KO
AC   CVCL_D8C8
SY   TFRC Knockout cell line (A549)
DR   Ubigene; YKO-HS4916
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11763; TFRC.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TGFA KO
AC   CVCL_D8C9
SY   TGFA Knockout cell line (A549)
DR   Ubigene; YKO-HS579
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11765; TGFA.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TGFB2 KO
AC   CVCL_D8CA
SY   TGFB2 Knockout cell line (A549)
DR   Ubigene; YKO-HS1592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11768; TGFB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TGFBR1 KO
AC   CVCL_D8CB
SY   TGFBR1 Knockout cell line (A549)
DR   Ubigene; YKO-HS581
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TGFBR2 KO
AC   CVCL_D8CC
SY   TGFBR2 Knockout cell line (A549)
DR   Ubigene; YKO-HS582
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TGIF1 KO
AC   CVCL_D8CD
SY   TGIF1 Knockout cell line (A549)
DR   Ubigene; YKO-HS159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11776; TGIF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 THAP12 KO
AC   CVCL_D8CE
SY   THAP12 Knockout cell line (A549)
DR   Ubigene; YKO-H835
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9440; THAP12.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 THBS1 KO
AC   CVCL_D8CF
SY   THBS1 Knockout cell line (A549)
DR   Ubigene; YKO-HS160
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11785; THBS1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TICAM1 KO
AC   CVCL_D8CG
SY   TICAM1 Knockout cell line (A549)
DR   Ubigene; YKO-HS371
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TIRAP KO
AC   CVCL_D8CH
SY   TIRAP Knockout cell line (A549)
DR   Ubigene; YKO-HS372
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17192; TIRAP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TLE1 KO
AC   CVCL_D8CI
SY   TLE1 Knockout cell line (A549)
DR   Ubigene; YKO-H664
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TLR2 KO
AC   CVCL_D8CJ
SY   TLR2 Knockout cell line (A549)
DR   Ubigene; YKO-H241
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TLR3 KO
AC   CVCL_D8CK
SY   TLR3 Knockout cell line (A549)
DR   Ubigene; YKO-H707
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11849; TLR3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TMEM161A KO
AC   CVCL_D8CL
SY   TMEM161A Knockout cell line (A549)
DR   Ubigene; YKO-XN94795
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26020; TMEM161A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TMEM171 KO
AC   CVCL_D8CM
SY   TMEM171 Knockout cell line (A549)
DR   Ubigene; YKO-H1033
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27031; TMEM171.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TMEM175 KO
AC   CVCL_D8CN
SY   TMEM175 Knockout cell line (A549)
DR   Ubigene; YKO-H1026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TNFAIP3 KO
AC   CVCL_D8CP
SY   TNFAIP3 Knockout cell line (A549)
DR   Ubigene; YKO-H783
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TNFRSF1A KO
AC   CVCL_D8CQ
SY   TNFRSF1A Knockout cell line (A549)
DR   Ubigene; YKO-HS376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TP53 KO
AC   CVCL_D8CR
SY   TP53 Knockout cell line (A549)
DR   Ubigene; YKO-H563
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TP53BP1 KO
AC   CVCL_D8CS
SY   TP53BP1 Knockout cell line (A549)
DR   Ubigene; YKO-HS14376
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TPCN1 KO
AC   CVCL_D8CT
SY   TPCN1 Knockout cell line (A549)
DR   Ubigene; YKO-HS5075
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18182; TPCN1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TPCN2 KO
AC   CVCL_D8CU
SY   TPCN2 Knockout cell line (A549)
DR   Ubigene; YKO-HS5076
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TPST1 KO
AC   CVCL_D8CV
SY   TPST1 Knockout cell line (A549)
DR   Ubigene; YKO-H140
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12020; TPST1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H140; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene A-549 TRADD KO
AC   CVCL_D8CW
SY   TRADD Knockout cell line (A549)
DR   Ubigene; YKO-HS380
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRAF1 KO
AC   CVCL_D8CX
SY   TRAF1 Knockout cell line (A549)
DR   Ubigene; YKO-HS381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRAF2 KO
AC   CVCL_D8CY
SY   TRAF2 Knockout cell line (A549)
DR   Ubigene; YKO-HS382
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12032; TRAF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRAF3 KO
AC   CVCL_D8CZ
SY   TRAF3 Knockout cell line (A549)
DR   Ubigene; YKO-HS383
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRAF5 KO
AC   CVCL_D8D0
SY   TRAF5 Knockout cell line (A549)
DR   Ubigene; YKO-HS384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRAF6 KO
AC   CVCL_D8D1
SY   TRAF6 Knockout cell line (A549)
DR   Ubigene; YKO-HS385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRDMT1 KO
AC   CVCL_D8D2
SY   TRDMT1 Knockout cell line (A549)
DR   Ubigene; YKO-XN24285
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2977; TRDMT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRIM25 KO
AC   CVCL_D8D3
SY   TRIM25 Knockout cell line (A549)
DR   Ubigene; YKO-H968
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRIM28 KO
AC   CVCL_D8D4
SY   TRIM28 Knockout cell line (A549)
DR   Ubigene; YKO-XN43337
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRPM6 KO
AC   CVCL_D8D5
SY   TRPM6 Knockout cell line (A549)
DR   Ubigene; YKO-H562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17995; TRPM6.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TRPM7 KO
AC   CVCL_D8D6
SY   TRPM7 Knockout cell line (A549)
DR   Ubigene; YKO-H712
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17994; TRPM7.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 TYK2 KO
AC   CVCL_D8D7
SY   TYK2 Knockout cell line (A549)
DR   Ubigene; YKO-H381
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ULK1 KO
AC   CVCL_D8D8
SY   ULK1 Knockout cell line (A549)
DR   Ubigene; YKO-H689
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ULK2 KO
AC   CVCL_D8D9
SY   ULK2 Knockout cell line (A549)
DR   Ubigene; YKO-H743
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 USP11 KO
AC   CVCL_D8DA
SY   USP11 Knockout cell line (A549)
DR   Ubigene; YKO-H1171
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12609; USP11.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 VAC14 KO
AC   CVCL_D8DB
SY   VAC14 Knockout cell line (A549)
DR   Ubigene; YKO-XN95567
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25507; VAC14.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 VDAC3 KO
AC   CVCL_D8DC
SY   VDAC3 Knockout cell line (A549)
DR   Ubigene; YKO-HS5083
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 VEGFD KO
AC   CVCL_D8DD
SY   VEGFD Knockout cell line (A549)
DR   Ubigene; YKO-HS585
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3708; VEGFD.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 VSIR KO
AC   CVCL_D8DE
SY   VSIR Knockout cell line (A549)
DR   Ubigene; YKO-KP153
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30085; VSIR.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 XIAP KO
AC   CVCL_D8DF
SY   XIAP Knockout cell line (A549)
DR   Ubigene; YKO-HS388
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 YTHDF1 KO
AC   CVCL_D8DG
SY   YTHDF1 Knockout cell line (A549)
DR   Ubigene; YKO-H972
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15867; YTHDF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ZDHHC5 KO
AC   CVCL_D8DH
SY   ZDHHC5 Knockout cell line (A549)
DR   Ubigene; YKO-H812
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18472; ZDHHC5.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ZFYVE16 KO
AC   CVCL_D8DI
SY   ZFYVE16 Knockout cell line (A549)
DR   Ubigene; YKO-HS161
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ZFYVE9 KO
AC   CVCL_D8DJ
SY   ZFYVE9 Knockout cell line (A549)
DR   Ubigene; YKO-HS162
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6775; ZFYVE9.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ZNRF2 KO
AC   CVCL_D8DK
SY   ZNRF2 Knockout cell line (A549)
DR   Ubigene; YKO-XN59165
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22316; ZNRF2.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549 ZNRF3 KO
AC   CVCL_D8DL
SY   ZNRF3 Knockout cell line (A549)
DR   Ubigene; YKO-HS101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18126; ZNRF3.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene A-549/DDP UCA1 KO
AC   CVCL_D8DM
SY   UCA1 Knockout cell line (A549/DDP)
DR   Ubigene; YKO-HJ080
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:37126; UCA1.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0W4 ! A549/DDP
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene AC16 RBM15 KO
AC   CVCL_D8DN
SY   RBM15 Knockout cell line (AC16)
DR   Ubigene; YKO-H823
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14959; RBM15.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, ventricle; UBERON=UBERON_0002082.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4U18 ! AC16 [Human hybrid cardiomyocyte]
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene ACHN IGF2BP3 KO
AC   CVCL_D8DP
SY   IGF2BP3 Knockout cell line (ACHN)
DR   Ubigene; YKO-H317
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg57Ter (c.169C>T); ClinVar=VCV000003285; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1067 ! ACHN
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene AGS ACSF3 KO
AC   CVCL_D8DQ
SY   ACSF3 Knockout cell line (AGS)
DR   Ubigene; YKO-H184
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27288; ACSF3.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene AGS GRIN2D KO
AC   CVCL_E2UZ
SY   GRIN2D Knockout cell line (AGS)
DR   Ubigene; YKO-HJ063
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4588; GRIN2D.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene AGS MLH1 KO
AC   CVCL_D8DR
SY   MLH1 Knockout cell line (AGS)
DR   Ubigene; YKO-H110
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7127; MLH1.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene AGS SOX9 KO
AC   CVCL_D8DS
SY   SOX9 Knockout cell line (AGS)
DR   Ubigene; YKO-H1134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11204; SOX9.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly34Glu (c.101G>A); ClinVar=VCV000017584; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu453Lys (c.1357G>A); ClinVar=VCV000376470; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Ala (c.1634A>C); ClinVar=VCV000013659; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Glu64del (c.192_194del); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0139 ! AGS
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene AML12 Atp7b KO
AC   CVCL_D8DT
SY   Atp7b Knockout cell line (AML12)
DR   Ubigene; YKO-M214
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103297; Atp7b.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene AML12 Cs KO
AC   CVCL_D8DU
SY   Cs Knockout cell line (AML12)
DR   Ubigene; YKO-M194
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88529; Cs.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene AML12 Faah KO
AC   CVCL_D8DV
SY   Faah Knockout cell line (AML12)
DR   Ubigene; YKO-M188
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109609; Faah.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene AML12 Fasn KO
AC   CVCL_D8DW
SY   Fasn Knockout cell line (AML12)
DR   Ubigene; YKO-M231
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95485; Fasn.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene AML12 Ldlr KO
AC   CVCL_D8DX
SY   Ldlr Knockout cell line (AML12)
DR   Ubigene; YKO-M198
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96765; Ldlr.
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:11765; TGFA.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: CD-1 MT42 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0140 ! AML12
SX   Male
AG   5M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ARPE-19 ABCA1 KO
AC   CVCL_D8DY
SY   ABCA1 Knockout cell line (ARPE-19)
DR   Ubigene; YKO-H173
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ARPE-19 LYPLA2 KO
AC   CVCL_D8DZ
SY   LYPLA2 Knockout cell line (ARPE-19)
DR   Ubigene; YKO-H409
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6738; LYPLA2.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ARPE-19 TMEM214 KO
AC   CVCL_D8E0
SY   TMEM214 Knockout cell line (ARPE-19)
DR   Ubigene; YKO-H616
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25983; TMEM214.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ARPE-19 ZNF644 KO
AC   CVCL_D8E1
SY   ZNF644 Knockout cell line (ARPE-19)
DR   Ubigene; YKO-H552
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29222; ZNF644.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0145 ! ARPE-19
SX   Male
AG   19Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene B16-F10 Acad10 KO
AC   CVCL_D8E2
SY   Acad10 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M059
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919235; Acad10.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Art1 KO
AC   CVCL_D8E3
SY   Art1 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M082
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107511; Art1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Cstf2 KO
AC   CVCL_D8E4
SY   Cstf2 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M089
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1343054; Cstf2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Cyp11a1 KO
AC   CVCL_D8E5
SY   Cyp11a1 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M071
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88582; Cyp11a1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Egfr KO
AC   CVCL_D8E6
SY   Egfr Knockout cell line (B16-F10)
DR   Ubigene; YKO-M212
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95294; Egfr.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 F3 KO
AC   CVCL_D8E7
SY   F3 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M052
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88381; F3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Fas KO
AC   CVCL_D8E8
SY   Fas Knockout cell line (B16-F10)
DR   Ubigene; YKO-M157
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95484; Fas.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Glp1r KO
AC   CVCL_D8E9
SY   Glp1r Knockout cell line (B16-F10)
DR   Ubigene; YKO-M074
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99571; Glp1r.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Klf12 KO
AC   CVCL_D8EA
SY   Klf12 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M057
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1333796; Klf12.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Msh2 KO
AC   CVCL_D8EB
SY   Msh2 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M208
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:101816; Msh2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Notch3 KO
AC   CVCL_D8EC
SY   Notch3 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M218
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99460; Notch3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Spp1 KO
AC   CVCL_D8ED
SY   Spp1 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M187
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98389; Spp1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Tgfb3 KO
AC   CVCL_D8EE
SY   Tgfb3 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M026
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98727; Tgfb3.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Ttc14 KO
AC   CVCL_D8EF
SY   Ttc14 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M053
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914370; Ttc14.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Vtcn1 KO
AC   CVCL_D8EG
SY   Vtcn1 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M097
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3039619; Vtcn1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene B16-F10 Ythdf1 KO
AC   CVCL_D8EH
SY   Ythdf1 Knockout cell line (B16-F10)
DR   Ubigene; YKO-M043
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917431; Ythdf1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene BEAS-2B CLEC7A KO
AC   CVCL_D8EI
SY   CLEC7A Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H323
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14558; CLEC7A.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: Ubigene; YKO-H323; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Ubigene BEAS-2B ITGAM KO
AC   CVCL_D8EJ
SY   ITGAM Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H287
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6149; ITGAM.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: Ubigene; YKO-H287; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Ubigene BEAS-2B NCOA4 KO
AC   CVCL_D8EK
SY   NCOA4 Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H202
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7671; NCOA4.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BEAS-2B PIEZO1 KO
AC   CVCL_D8EL
SY   PIEZO1 Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H054
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28993; PIEZO1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BEAS-2B SOCS1 KO
AC   CVCL_D8EM
SY   SOCS1 Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H399
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19383; SOCS1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BEAS-2B SOCS3 KO
AC   CVCL_D8EN
SY   SOCS3 Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H397
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BEAS-2B SOCS4 KO
AC   CVCL_D8EP
SY   SOCS4 Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H398
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BEAS-2B SQSTM1 KO
AC   CVCL_D8EQ
SY   SQSTM1 Knockout cell line (BEAS-2B)
DR   Ubigene; YKO-H152
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0168 ! BEAS-2B
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BEL-7402 KLF14 KO
AC   CVCL_D8ER
SY   KLF14 Knockout cell line (BEL-7402)
DR   Ubigene; YKO-HJ046
CC   Problematic cell line: Contaminated. Parent cell line (BEL-7402) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23025; KLF14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5492 ! BEL-7402
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene BeWo ERVFRD-1 KO
AC   CVCL_D8ES
SY   ERVFRD-1 Knockout cell line (BeWo)
DR   Ubigene; YKO-H208
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33823; ERVFRD-1.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene BeWo TRPV6 KO
AC   CVCL_D8ET
SY   TRPV6 Knockout cell line (BeWo)
DR   Ubigene; YKO-H124
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14006; TRPV6.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006238.
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0044 ! BeWo
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene BHK-21 Amfr KO
AC   CVCL_D8EU
SY   Amfr Knockout cell line (BHK-21)
DR   Ubigene; YKO-R070
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A3Q0D116; Amfr.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1914 ! BHK-21
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BHK-21 Arl8b KO
AC   CVCL_D8EV
SY   Arl8b Knockout cell line (BHK-21)
DR   Ubigene; YKO-R069
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A1U7Q8M2; Arl8b.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_1914 ! BHK-21
SX   Male
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BV-2 Ifngr1 KO
AC   CVCL_D8EW
SY   Ifngr1 Knockout cell line (BV2)
DR   Ubigene; YKO-M183
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107655; Ifngr1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BV-2 Lpl KO
AC   CVCL_D8EX
SY   Lpl Knockout cell line (BV2)
DR   Ubigene; YKO-M201
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96820; Lpl.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BV-2 Plin2 KO
AC   CVCL_D8EY
SY   Plin2 Knockout cell line (BV2)
DR   Ubigene; YKO-M172
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:87920; Plin2.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BV-2 Syk KO
AC   CVCL_D8EZ
SY   Syk Knockout cell line (BV2)
DR   Ubigene; YKO-M202
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99515; Syk.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BV-2 Usp7 KO
AC   CVCL_D8F0
SY   Usp7 Knockout cell line (BV2)
DR   Ubigene; YKO-M155
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2182061; Usp7.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Cell type: Microglial cell; CL=CL_0000129.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0182 ! BV-2
SX   Female
AG   1W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene BxPC-3 GPC1 KO
AC   CVCL_D8F1
SY   GPC1 Knockout cell line (BxPC-3)
DR   Ubigene; YKO-H983
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4449; GPC1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:6770; SMAD4; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val487_Pro492delinsAla (c.1460_1474delGTGTAGGTGCTGTCA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; None_reported; -; Zygosity=- (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0186 ! BxPC-3
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene C2C12 Lmod2 KO
AC   CVCL_D8F2
SY   Lmod2 Knockout cell line (C2C12)
DR   Ubigene; YKO-M195
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2135672; Lmod2.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Micu1 KO
AC   CVCL_D8F3
SY   Micu1 Knockout cell line (C2C12)
DR   Ubigene; YKO-M232
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2384909; Micu1.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Pdk4 KO
AC   CVCL_D8F4
SY   Pdk4 Knockout cell line (C2C12)
DR   Ubigene; YKO-M134
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1351481; Pdk4.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Recql5 KO
AC   CVCL_D8F5
SY   Recql5 Knockout cell line (C2C12)
DR   Ubigene; YKO-M104
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2156841; Recql5.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Shmt2 KO
AC   CVCL_D8F6
SY   Shmt2 Knockout cell line (C2C12)
DR   Ubigene; YKO-M158
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1277989; Shmt2.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Slc38a9 KO
AC   CVCL_D8F7
SY   Slc38a9 Knockout cell line (C2C12)
DR   Ubigene; YKO-MJ010
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1918839; Slc38a9.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Trib1 KO
AC   CVCL_D8F8
SY   Trib1 Knockout cell line (C2C12)
DR   Ubigene; YKO-M179
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2443397; Trib1.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Vav3 KO
AC   CVCL_D8F9
SY   Vav3 Knockout cell line (C2C12)
DR   Ubigene; YKO-M088
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1888518; Vav3.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C2C12 Zbtb5 KO
AC   CVCL_D8FA
SY   Zbtb5 Knockout cell line (C2C12)
DR   Ubigene; YKO-M037
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924601; Zbtb5.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0188 ! C2C12
SX   Female
AG   2M
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene C4-2B MRPL40 KO
AC   CVCL_D8FB
SY   MRPL40 Knockout cell line (C4-2B)
DR   Ubigene; YKO-H1106
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14491; MRPL40.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4784 ! LNCaP C4-2B
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Caco-2 PPIF KO
AC   CVCL_D8FC
SY   PPIF Knockout cell line (Caco-2)
DR   Ubigene; YKO-H342
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9259; PPIF.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Caco-2 SLC39A8 KO
AC   CVCL_D8FD
SY   SLC39A8 Knockout cell line (Caco-2)
DR   Ubigene; YKO-H312
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Caco-2 TAF15 KO
AC   CVCL_D8FE
SY   TAF15 Knockout cell line (Caco-2)
DR   Ubigene; YKO-H1060
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11547; TAF15.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Caco-2 TRPV1 KO
AC   CVCL_D8FF
SY   TRPV1 Knockout cell line (Caco-2)
DR   Ubigene; YKO-HJ018
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12716; TRPV1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1367Ter (c.4099C>T); ClinVar=VCV000376060; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Gly245Ala (c.734G>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp351His (c.1051G>C); ClinVar=VCV000375998; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0025 ! Caco-2
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Calu-1 ICAM1 KO
AC   CVCL_D8FG
SY   ICAM1 Knockout cell line (Calu-1)
DR   Ubigene; YKO-HJ095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0608 ! Calu-1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CHO-K1 Adipor1 KO
AC   CVCL_D8FH
SY   Adipor1 Knockout cell line (CHO-K1)
DR   Ubigene; YKO-R023
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C2N276; Adipor1.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene CHO-K1 Adipor2 KO
AC   CVCL_D8FI
SY   Adipor2 Knockout cell line (CHO-K1)
DR   Ubigene; YKO-R022
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3H867; Adipor2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene CHO-K1 Ago2 KO
AC   CVCL_D8FJ
SY   Ago2 Knockout cell line (CHO-K1)
DR   Ubigene; YKO-R007
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A8C2M349; Ago2.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene CHO-K1 Fut8 KO
AC   CVCL_D8FK
SY   Fut8 Knockout cell line (CHO-K1)
DR   Ubigene; YKO-R044
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; G3HCE4; Fut8.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene CHO-K1 Glul(GS) KO
AC   CVCL_D8FL
SY   Glul(GS) Knockout cell line (CHO-K1)
DR   Ubigene; YKO-R014
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; P04773; Glul.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene CNE-1 SETD2 KO
AC   CVCL_D8FM
SY   SETD2 Knockout cell line (CNE1)
DR   Ubigene; YKO-H044
CC   Problematic cell line: Contaminated. The parent cell line (CNE-1) seems to be a hybrid of HeLa and of cell line of unknown origin.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6888 ! CNE-1
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene COS-1 ANO6 KO
AC   CVCL_D8FN
SY   ANO6 Knockout cell line (COS-1)
DR   Ubigene; YKO-R068
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9R355; ANO6; Note=From C.sabeus because C.aethiops entry not available in UniProtKB.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene COS-1 MFSD8 KO
AC   CVCL_D8FP
SY   MFSD8 Knockout cell line (COS-1)
DR   Ubigene; YKO-R054
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S0R2; MFSD8; Note=From C.sabeus because C.aethiops entry not available in UniProtKB.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene COS-1 TMEM184B KO
AC   CVCL_D8FQ
SY   TMEM184B Knockout cell line (COS-1)
DR   Ubigene; YKO-R065
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9R312; TMEM184B; Note=From C.sabeus because C.aethiops entry not available in UniProtKB.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV6-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9534; ! Chlorocebus aethiops (Green monkey)
HI   CVCL_0223 ! COS-1
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene CT26.WT Ddr1 KO
AC   CVCL_D8FR
SY   Ddr1 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M216
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99216; Ddr1.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Ecm1 KO
AC   CVCL_D8FS
SY   Ecm1 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M165
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103060; Ecm1.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Il1r1 KO
AC   CVCL_D8FT
SY   Il1r1 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M205
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96545; Il1r1.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Lrpprc KO
AC   CVCL_D8FU
SY   Lrpprc Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M103
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919666; Lrpprc.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Stat3 KO
AC   CVCL_D8FV
SY   Stat3 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M032
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103038; Stat3.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Tead1 KO
AC   CVCL_D8FW
SY   Tead1 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M024
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:101876; Tead1.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Tead4 KO
AC   CVCL_D8FX
SY   Tead4 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M025
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:106907; Tead4.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Tnfrsf1b KO
AC   CVCL_D8FY
SY   Tnfrsf1b Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M013
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1314883; Tnfrsf1b.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene CT26.WT Zc3h3 KO
AC   CVCL_D8FZ
SY   Zc3h3 Knockout cell line (CT26.WT)
DR   Ubigene; YKO-M185
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2663721; Zc3h3.
CC   Sequence variation: Gene deletion; MGI; MGI:104738; Cdkn2a; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; MGI; MGI:96680; Kras; Simple; p.Gly12Asp (c.35G>A); Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_82373; N-nitroso-N-methylurethane (NNMU).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7256 ! CT26.WT
SX   Female
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene EO771 Ccl5 KO
AC   CVCL_D8G0
SY   Ccl5 Knockout cell line (EO771)
DR   Ubigene; YKO-M221
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98262; Ccl5.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene EO771 Epha2 KO
AC   CVCL_D8G1
SY   Epha2 Knockout cell line (EO771)
DR   Ubigene; YKO-M200
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95278; Epha2.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene EO771 Fabp4 KO
AC   CVCL_D8G2
SY   Fabp4 Knockout cell line (EO771)
DR   Ubigene; YKO-M143
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88038; Fabp4.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene EO771 Pik3ca KO
AC   CVCL_D8G3
SY   Pik3ca Knockout cell line (EO771)
DR   Ubigene; YKO-M091
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1206581; Pik3ca.
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_GR23 ! EO771
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene H1 ELAVL4 KO
AC   CVCL_D8G4
SY   ELAVL4 Knockout cell line (H1)
DR   Ubigene; YKO-H989
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3315; ELAVL4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H1 PKD1 KO
AC   CVCL_D8G5
SY   PKD1 Knockout cell line (H1)
DR   Ubigene; YKO-H321
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Discontinued: Ubigene; YKO-H321; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene H1 PKD2 KO
AC   CVCL_D8G6
SY   PKD2 Knockout cell line (H1)
DR   Ubigene; YKO-H319
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9009; PKD2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H1 RMND5B KO
AC   CVCL_D8G7
SY   RMND5B Knockout cell line (H1)
DR   Ubigene; YKO-H007
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26181; RMND5B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H1 SIGLEC7 KO
AC   CVCL_D8G8
SY   SIGLEC7 Knockout cell line (H1)
DR   Ubigene; YKO-H359
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10876; SIGLEC7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H22 Hc KO
AC   CVCL_D8G9
SY   Hc Knockout cell line (H22)
DR   Ubigene; YKO-M047
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96031; Hc.
CC   Transformant: ChEBI; CHEBI_82285; Ortho-aminoazotoluene (OAAT).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C3HA.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_H613 ! H22
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene H9 CDYL KO
AC   CVCL_D8GA
SY   CDYL Knockout cell line (H9)
DR   Ubigene; YKO-H282
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1811; CDYL.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H9 FGF12 KO
AC   CVCL_D8GB
SY   FGF12 Knockout cell line (H9)
DR   Ubigene; YKO-H554
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3668; FGF12.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H9 FGF14 KO
AC   CVCL_D8GC
SY   FGF14 Knockout cell line (H9)
DR   Ubigene; YKO-H1005
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3671; FGF14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H9 MIR503HG KO
AC   CVCL_D8GD
SY   MIR503HG Knockout cell line (H9)
DR   Ubigene; YKO-H889
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28258; MIR503HG.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H9 SIRT2 KO
AC   CVCL_D8GE
SY   SIRT2 Knockout cell line (H9)
DR   Ubigene; YKO-H1123
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10886; SIRT2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene H9c2(2-1) Ankrd23 KO
AC   CVCL_D8GF
SY   Ankrd23 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R001
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1310398; Ankrd23.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Dsp KO
AC   CVCL_D8GG
SY   Dsp Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R035
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1305794; Dsp.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Fgfr1 KO
AC   CVCL_D8GH
SY   Fgfr1 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R020
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 620713; Fgfr1.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Glp1r KO
AC   CVCL_D8GI
SY   Glp1r Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R010
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 2703; Glp1r.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Hif1an KO
AC   CVCL_D8GJ
SY   Hif1an Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R052
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1308281; Hif1an.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Otub1 KO
AC   CVCL_D8GK
SY   Otub1 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R059
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1311329; Otub1.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Piezo2 KO
AC   CVCL_D8GL
SY   Piezo2 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R031
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1582973; Piezo2.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Scaf1 KO
AC   CVCL_D8GM
SY   Scaf1 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R019
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 708405; Scaf1.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Senp1 KO
AC   CVCL_D8GN
SY   Senp1 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R048
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1310275; Senp1.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Tmem175 KO
AC   CVCL_D8GP
SY   Tmem175 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R061
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1309712; Tmem175.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene H9c2(2-1) Tpm1 KO
AC   CVCL_D8GQ
SY   Tpm1 Knockout cell line (H9c2(2-1))
DR   Ubigene; YKO-R047
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 3898; Tpm1.
CC   Derived from site: In situ; Embryonic heart, cardiac muscle; UBERON=UBERON_0003084+UBERON_0001133.
CC   Breed/subspecies: BDIX; RS=RS_0000091.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0286 ! H9c2(2-1)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene HaCaT GJB2 KO
AC   CVCL_D9WZ
SY   GJB2 Knockout cell line (HaCaT)
DR   Ubigene; YKO-HJ050
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4284; GJB2.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.843_844CC>TT); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Back, skin, epidermis; UBERON=UBERON_0001068+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0038 ! HaCaT
SX   Male
AG   62Y
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HBZY-1 Fbxo28 KO
AC   CVCL_D8GS
SY   Fbxo28 Knockout cell line (HBZY-1)
DR   Ubigene; YKO-RJ012
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1304584; Fbxo28.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7213 ! HBZY-1
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene HBZY-1 Kat2a KO
AC   CVCL_D8GT
SY   Kat2a Knockout cell line (HBZY-1)
DR   Ubigene; YKO-RJ016
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1307242; Kat2a.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7213 ! HBZY-1
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene HBZY-1 Sox9 KO
AC   CVCL_D8GU
SY   Sox9 Knockout cell line (HBZY-1)
DR   Ubigene; YKO-RJ015
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 620474; Sox9.
CC   Derived from site: In situ; Kidney, glomerulus; UBERON=UBERON_0000074.
CC   Cell type: Mesangial cell; CL=CL_0000650.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_7213 ! HBZY-1
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene HCA-7 RNF43 KO
AC   CVCL_D8GV
SY   RNF43 Knockout cell line (HCA-7)
DR   Ubigene; YKO-HJ114
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18505; RNF43.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu582fs*20 (c.1742_1743insA); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg479Ter (c.1435C>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro301Glnfs*44 (c.898delC); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0289 ! HCA7
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCC1806 ADPRS KO
AC   CVCL_D8GW
SY   ADPRS Knockout cell line (HCC1806)
DR   Ubigene; YKO-H1057
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21304; ADPRS.
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr256Lysfs*90 (c.766_767insAA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C40359; Breast acantholytic squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1258 ! HCC1806
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene hCMEC/D3 JAM2 KO
AC   CVCL_D8GX
SY   JAM2 Knockout cell line (HCMEC/D3)
DR   Ubigene; YKO-H1098
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14686; JAM2.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, temporal lobe, blood microvessel; UBERON=UBERON_0001871+UBERON_8410081.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U985 ! hCMEC/D3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene hCMEC/D3 JAM3 KO
AC   CVCL_D8GY
SY   JAM3 Knockout cell line (HCMEC/D3)
DR   Ubigene; YKO-H1012
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15532; JAM3.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brain, temporal lobe, blood microvessel; UBERON=UBERON_0001871+UBERON_8410081.
CC   Cell type: Endothelial cell; CL=CL_0000115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U985 ! hCMEC/D3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HCT 116 ABCB1 KO
AC   CVCL_D8GZ
SY   ABCB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS13596
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ABCG2 KO
AC   CVCL_D8H0
SY   ABCG2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS10958
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:74; ABCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ABL2 KO
AC   CVCL_D8H1
SY   ABL2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ACVR1B KO
AC   CVCL_D8H2
SY   ACVR1B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2351
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:172; ACVR1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ADAM12 KO
AC   CVCL_D8H3
SY   ADAM12 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H612
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:190; ADAM12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ADAM17 KO
AC   CVCL_D8H4
SY   ADAM17 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ADAR KO
AC   CVCL_D8H5
SY   ADAR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS09687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ADORA1 KO
AC   CVCL_D8H6
SY   ADORA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6993
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:262; ADORA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ADORA2A KO
AC   CVCL_D8H7
SY   ADORA2A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6455
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 AKT1 KO
AC   CVCL_D8H8
SY   AKT1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 AKT2 KO
AC   CVCL_D8H9
SY   AKT2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ALDH1B1 KO
AC   CVCL_D8HA
SY   ALDH1B1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H966
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:407; ALDH1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ALDH2 KO
AC   CVCL_D8HB
SY   ALDH2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN85267
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:404; ALDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 APC KO
AC   CVCL_D8HC
SY   APC Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 APC2 KO
AC   CVCL_D8HD
SY   APC2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2250
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24036; APC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 APOBEC3B KO
AC   CVCL_D8HE
SY   APOBEC3B Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN41947
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17352; APOBEC3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ARAF KO
AC   CVCL_D8HF
SY   ARAF Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6729
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 AREG KO
AC   CVCL_D8HG
SY   AREG Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2639
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:651; AREG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ARRB1 KO
AC   CVCL_D8HH
SY   ARRB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2640
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ARRB2 KO
AC   CVCL_D8HI
SY   ARRB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2641
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ASS1 KO
AC   CVCL_D8HJ
SY   ASS1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H964
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ATF2 KO
AC   CVCL_D8HK
SY   ATF2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2642
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ATF3 KO
AC   CVCL_D8HL
SY   ATF3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS14629
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:785; ATF3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ATF4 KO
AC   CVCL_D8HM
SY   ATF4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2643
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ATF6B KO
AC   CVCL_D8HN
SY   ATF6B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2834
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2349; ATF6B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ATG5 KO
AC   CVCL_D8HP
SY   ATG5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1129
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ATM KO
AC   CVCL_D8HQ
SY   ATM Knockout cell line (HCT 116)
DR   Ubigene; YKO-H600
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 AXIN1 KO
AC   CVCL_D8HR
SY   AXIN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2251
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 AXIN2 KO
AC   CVCL_D8HS
SY   AXIN2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:904; AXIN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 AXL KO
AC   CVCL_D8HT
SY   AXL Knockout cell line (HCT 116)
DR   Ubigene; YKO-H748
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 B3GNT2 KO
AC   CVCL_D8HU
SY   B3GNT2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1009
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15629; B3GNT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 BCL2 KO
AC   CVCL_D8HV
SY   BCL2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2556
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 BDNF KO
AC   CVCL_D8HW
SY   BDNF Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2644
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1033; BDNF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 BRAF KO
AC   CVCL_D8HX
SY   BRAF Knockout cell line (HCT 116)
DR   Ubigene; YKO-H526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 BRCA2 KO
AC   CVCL_D8HY
SY   BRCA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H668
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 BTRC KO
AC   CVCL_D8HZ
SY   BTRC Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 C5AR1 KO
AC   CVCL_D8I0
SY   C5AR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3143
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1338; C5AR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNA1A KO
AC   CVCL_D8I1
SY   CACNA1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2646
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1388; CACNA1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNA1B KO
AC   CVCL_D8I2
SY   CACNA1B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2647
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1389; CACNA1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNA1G KO
AC   CVCL_D8I3
SY   CACNA1G Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2652
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1394; CACNA1G.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNA1H KO
AC   CVCL_D8I4
SY   CACNA1H Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2653
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1395; CACNA1H.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNA2D2 KO
AC   CVCL_D8I5
SY   CACNA2D2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2657
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1400; CACNA2D2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNB2 KO
AC   CVCL_D8I6
SY   CACNB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2659
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1402; CACNB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNB3 KO
AC   CVCL_D8I7
SY   CACNB3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2660
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CACNB4 KO
AC   CVCL_D8I8
SY   CACNB4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2661
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1404; CACNB4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CAMK1 KO
AC   CVCL_D8I9
SY   CAMK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6866
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1459; CAMK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CAMK1D KO
AC   CVCL_D8IA
SY   CAMK1D Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6864
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19341; CAMK1D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CAMK2D KO
AC   CVCL_D8IB
SY   CAMK2D Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2257
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CAMK2G KO
AC   CVCL_D8IC
SY   CAMK2G Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2258
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CAMK4 KO
AC   CVCL_D8ID
SY   CAMK4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6631
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1464; CAMK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CAMKK2 KO
AC   CVCL_D8IE
SY   CAMKK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7116
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CARD10 KO
AC   CVCL_D8IF
SY   CARD10 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2562
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16422; CARD10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CARM1 KO
AC   CVCL_D8IG
SY   CARM1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1023
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23393; CARM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CASP3 KO
AC   CVCL_D8IH
SY   CASP3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2666
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CASP9 KO
AC   CVCL_D8II
SY   CASP9 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2836
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CCAR1 KO
AC   CVCL_D8IJ
SY   CCAR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1007
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24236; CCAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CCDC25 KO
AC   CVCL_D8IK
SY   CCDC25 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H880
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25591; CCDC25.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CCND3 KO
AC   CVCL_D8IL
SY   CCND3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2259
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CD274 KO
AC   CVCL_D8IM
SY   CD274 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN86651
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17635; CD274.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CD40 KO
AC   CVCL_D8IN
SY   CD40 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2571
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11919; CD40.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CD47 KO
AC   CVCL_D8IP
SY   CD47 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1196
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CDC25B KO
AC   CVCL_D8IQ
SY   CDC25B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2667
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1726; CDC25B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CDK2 KO
AC   CVCL_D8IR
SY   CDK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6730
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1771; CDK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CDK6 KO
AC   CVCL_D8IS
SY   CDK6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2840
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CDKN1A KO
AC   CVCL_D8IT
SY   CDKN1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2449
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CDKN2D KO
AC   CVCL_D8IU
SY   CDKN2D Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6738
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1790; CDKN2D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CFLAR KO
AC   CVCL_D8IV
SY   CFLAR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2573
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1876; CFLAR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CHD1L KO
AC   CVCL_D8IW
SY   CHD1L Knockout cell line (HCT 116)
DR   Ubigene; YKO-H598
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1916; CHD1L.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CHD8 KO
AC   CVCL_D8IX
SY   CHD8 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2261
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CHEK2 KO
AC   CVCL_D8IY
SY   CHEK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN45719
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16627; CHEK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CHRNA7 KO
AC   CVCL_D8IZ
SY   CHRNA7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H594
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1960; CHRNA7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CHUK KO
AC   CVCL_D8J0
SY   CHUK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2574
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CIR1 KO
AC   CVCL_D8J1
SY   CIR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2413
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24217; CIR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CISH KO
AC   CVCL_D8J2
SY   CISH Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2450
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1984; CISH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CKAP4 KO
AC   CVCL_D8J3
SY   CKAP4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H484
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16991; CKAP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CNGA1 KO
AC   CVCL_D8J4
SY   CNGA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7051
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2148; CNGA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CNTF KO
AC   CVCL_D8J5
SY   CNTF Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2451
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2169; CNTF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 COL12A1 KO
AC   CVCL_D8J6
SY   COL12A1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2188; COL12A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 COL4A6 KO
AC   CVCL_D8J7
SY   COL4A6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2851
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2208; COL4A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CREB3L4 KO
AC   CVCL_D8J8
SY   CREB3L4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2862
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18854; CREB3L4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CREBBP KO
AC   CVCL_D8J9
SY   CREBBP Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CRK KO
AC   CVCL_D8JA
SY   CRK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2668
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2362; CRK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CRKL KO
AC   CVCL_D8JB
SY   CRKL Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2363; CRKL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CRTC2 KO
AC   CVCL_D8JC
SY   CRTC2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2864
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27301; CRTC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSF1 KO
AC   CVCL_D8JD
SY   CSF1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSNK1D KO
AC   CVCL_D8JE
SY   CSNK1D Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6558
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSNK1G1 KO
AC   CVCL_D8JF
SY   CSNK1G1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2978
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSNK1G2 KO
AC   CVCL_D8JG
SY   CSNK1G2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2979
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2455; CSNK1G2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSNK1G3 KO
AC   CVCL_D8JH
SY   CSNK1G3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2980
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2456; CSNK1G3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSNK2A2 KO
AC   CVCL_D8JI
SY   CSNK2A2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2575
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2459; CSNK2A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CSNK2A3 KO
AC   CVCL_D8JJ
SY   CSNK2A3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN87176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2458; CSNK2A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CTNNB1 KO
AC   CVCL_D8JK
SY   CTNNB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H851
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CTSC KO
AC   CVCL_D8JL
SY   CTSC Knockout cell line (HCT 116)
DR   Ubigene; YKO-H942
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2528; CTSC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CUL3 KO
AC   CVCL_D8JM
SY   CUL3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H761
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2553; CUL3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CUL4A KO
AC   CVCL_D8JN
SY   CUL4A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS12810
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2554; CUL4A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CXCL1 KO
AC   CVCL_D8JP
SY   CXCL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2576
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4602; CXCL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CXCL8 KO
AC   CVCL_D8JQ
SY   CXCL8 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2580
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6025; CXCL8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CXCR1 KO
AC   CVCL_D8JR
SY   CXCR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1126
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6026; CXCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CYLD KO
AC   CVCL_D8JS
SY   CYLD Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2581
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CYP27B1 KO
AC   CVCL_D8JT
SY   CYP27B1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS14300
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2606; CYP27B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 CYP51A1 KO
AC   CVCL_D8JU
SY   CYP51A1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96692
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2649; CYP51A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DAXX KO
AC   CVCL_D8JV
SY   DAXX Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2672
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DDIT4 KO
AC   CVCL_D8JW
SY   DDIT4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2865
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DEPDC1 KO
AC   CVCL_D8JX
SY   DEPDC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1011
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22949; DEPDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DGKA KO
AC   CVCL_D8JY
SY   DGKA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6924
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DGKD KO
AC   CVCL_D8JZ
SY   DGKD Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6922
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2851; DGKD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DGKE KO
AC   CVCL_D8K0
SY   DGKE Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6925
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2852; DGKE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DGKH KO
AC   CVCL_D8K1
SY   DGKH Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6927
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2854; DGKH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DGKZ KO
AC   CVCL_D8K2
SY   DGKZ Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6921
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2857; DGKZ.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DHODH KO
AC   CVCL_D8K3
SY   DHODH Knockout cell line (HCT 116)
DR   Ubigene; YKO-H132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2867; DHODH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H132; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HCT 116 DICER1 KO
AC   CVCL_D8K4
SY   DICER1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1250
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17098; DICER1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DLL1 KO
AC   CVCL_D8K5
SY   DLL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2414
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2908; DLL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DNAH5 KO
AC   CVCL_D8K6
SY   DNAH5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3115
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2950; DNAH5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DNMT3B KO
AC   CVCL_D8K7
SY   DNMT3B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS09358
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2979; DNMT3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DPP4 KO
AC   CVCL_D8K8
SY   DPP4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3007
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3009; DPP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DSTYK KO
AC   CVCL_D8K9
SY   DSTYK Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN50811
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29043; DSTYK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DTX2 KO
AC   CVCL_D8KA
SY   DTX2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2418
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15973; DTX2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DTX3L KO
AC   CVCL_D8KB
SY   DTX3L Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2420
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DTX4 KO
AC   CVCL_D8KC
SY   DTX4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2421
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29151; DTX4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP1 KO
AC   CVCL_D8KD
SY   DUSP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2674
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3064; DUSP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP10 KO
AC   CVCL_D8KE
SY   DUSP10 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2675
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3065; DUSP10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP16 KO
AC   CVCL_D8KF
SY   DUSP16 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2676
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17909; DUSP16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP2 KO
AC   CVCL_D8KG
SY   DUSP2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2677
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3068; DUSP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP3 KO
AC   CVCL_D8KH
SY   DUSP3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2678
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3069; DUSP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP4 KO
AC   CVCL_D8KI
SY   DUSP4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2679
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 DUSP6 KO
AC   CVCL_D8KJ
SY   DUSP6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2681
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3072; DUSP6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 E2F4 KO
AC   CVCL_D8KK
SY   E2F4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2366
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3118; E2F4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ECM1 KO
AC   CVCL_D8KL
SY   ECM1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H613
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3153; ECM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EDA KO
AC   CVCL_D8KM
SY   EDA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2582
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3157; EDA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EDNRA KO
AC   CVCL_D8KN
SY   EDNRA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6801
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3179; EDNRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EFNA2 KO
AC   CVCL_D8KP
SY   EFNA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2686
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3222; EFNA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EGFR KO
AC   CVCL_D8KQ
SY   EGFR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6350
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EIF4B KO
AC   CVCL_D8KR
SY   EIF4B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2866
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3285; EIF4B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ELK4 KO
AC   CVCL_D8KS
SY   ELK4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2689
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3326; ELK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ENTPD1 KO
AC   CVCL_D8KT
SY   ENTPD1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-KP149
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EP300 KO
AC   CVCL_D8KU
SY   EP300 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2462
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EPCAM KO
AC   CVCL_D8KV
SY   EPCAM Knockout cell line (HCT 116)
DR   Ubigene; YKO-H752
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11529; EPCAM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EPHA2 KO
AC   CVCL_D8KW
SY   EPHA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EPN1 KO
AC   CVCL_D8KX
SY   EPN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN58855
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 EPOR KO
AC   CVCL_D8KY
SY   EPOR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2463
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3416; EPOR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ERBB2 KO
AC   CVCL_D8KZ
SY   ERBB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ERBB3 KO
AC   CVCL_D8L0
SY   ERBB3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2692
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ERC1 KO
AC   CVCL_D8L1
SY   ERC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2584
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17072; ERC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 F2R KO
AC   CVCL_D8L2
SY   F2R Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2870
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FANCA KO
AC   CVCL_D8L3
SY   FANCA Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN88378
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3582; FANCA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FANCI KO
AC   CVCL_D8L4
SY   FANCI Knockout cell line (HCT 116)
DR   Ubigene; YKO-H599
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25568; FANCI.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FANCM KO
AC   CVCL_D8L5
SY   FANCM Knockout cell line (HCT 116)
DR   Ubigene; YKO-H736
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23168; FANCM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FBXW7 KO
AC   CVCL_D8L6
SY   FBXW7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FGF19 KO
AC   CVCL_D8L7
SY   FGF19 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2699
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3675; FGF19.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FGF2 KO
AC   CVCL_D8L8
SY   FGF2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2700
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3676; FGF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FGF8 KO
AC   CVCL_D8L9
SY   FGF8 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3686; FGF8.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FGF9 KO
AC   CVCL_D8LA
SY   FGF9 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2707
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3687; FGF9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FGFR1 KO
AC   CVCL_D8LB
SY   FGFR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2708
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FGFR2 KO
AC   CVCL_D8LC
SY   FGFR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2709
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FHAD1 KO
AC   CVCL_D8LD
SY   FHAD1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN46691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29408; FHAD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FHL1 KO
AC   CVCL_D8LE
SY   FHL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2464
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3702; FHL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FHL3 KO
AC   CVCL_D8LF
SY   FHL3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3704; FHL3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FLCN KO
AC   CVCL_D8LG
SY   FLCN Knockout cell line (HCT 116)
DR   Ubigene; YKO-H179
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27310; FLCN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FLNA KO
AC   CVCL_D8LH
SY   FLNA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2712
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3754; FLNA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FLT3LG KO
AC   CVCL_D8LI
SY   FLT3LG Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6346
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FOLR1 KO
AC   CVCL_D8LJ
SY   FOLR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3031
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FOSL1 KO
AC   CVCL_D8LK
SY   FOSL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2276
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FRAT2 KO
AC   CVCL_D8LL
SY   FRAT2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2278
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16048; FRAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FZD2 KO
AC   CVCL_D8LM
SY   FZD2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 FZD3 KO
AC   CVCL_D8LN
SY   FZD3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2282
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4041; FZD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 G6PC3 KO
AC   CVCL_D8LP
SY   G6PC3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2874
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24861; G6PC3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GAA KO
AC   CVCL_D8LQ
SY   GAA Knockout cell line (HCT 116)
DR   Ubigene; YKO-H882
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GABBR1 KO
AC   CVCL_D8LR
SY   GABBR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7037
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GADD45A KO
AC   CVCL_D8LS
SY   GADD45A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2585
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4095; GADD45A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GADD45B KO
AC   CVCL_D8LT
SY   GADD45B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2586
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GAL KO
AC   CVCL_D8LU
SY   GAL Knockout cell line (HCT 116)
DR   Ubigene; YKO-H385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4114; GAL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GIPR KO
AC   CVCL_D8LV
SY   GIPR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7022
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4271; GIPR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GLA KO
AC   CVCL_D8LW
SY   GLA Knockout cell line (HCT 116)
DR   Ubigene; YKO-H445
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GLI1 KO
AC   CVCL_D8LX
SY   GLI1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2988
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4317; GLI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GNB5 KO
AC   CVCL_D8LY
SY   GNB5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2879
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4401; GNB5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GPC3 KO
AC   CVCL_D8LZ
SY   GPC3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4451; GPC3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GPNMB KO
AC   CVCL_D8M0
SY   GPNMB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS09530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GPR161 KO
AC   CVCL_D8M1
SY   GPR161 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2991
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23694; GPR161.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GRIN1 KO
AC   CVCL_D8M2
SY   GRIN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6370
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4584; GRIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GRIN2B KO
AC   CVCL_D8M3
SY   GRIN2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6372
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4586; GRIN2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GRIN2D KO
AC   CVCL_D8M4
SY   GRIN2D Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6791
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4588; GRIN2D.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GRK2 KO
AC   CVCL_D8M5
SY   GRK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2992
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GRK3 KO
AC   CVCL_D8M6
SY   GRK3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2993
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GSK3B KO
AC   CVCL_D8M7
SY   GSK3B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2994
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 GSKIP KO
AC   CVCL_D8M8
SY   GSKIP Knockout cell line (HCT 116)
DR   Ubigene; YKO-H085
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20343; GSKIP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HCN4 KO
AC   CVCL_D8M9
SY   HCN4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7050
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16882; HCN4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HDAC1 KO
AC   CVCL_D8MA
SY   HDAC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2422
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HDAC2 KO
AC   CVCL_D8MB
SY   HDAC2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2423
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HES1 KO
AC   CVCL_D8MC
SY   HES1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2424
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HEYL KO
AC   CVCL_D8MD
SY   HEYL Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4882; HEYL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HK2 KO
AC   CVCL_D8ME
SY   HK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H881
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4923; HK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HLA-A KO
AC   CVCL_D8MF
SY   HLA-A Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN89249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4931; HLA-A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HMGA2 KO
AC   CVCL_D8MG
SY   HMGA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3114
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5009; HMGA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HNF1B KO
AC   CVCL_D8MH
SY   HNF1B Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN36627
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11630; HNF1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HNF4A KO
AC   CVCL_D8MI
SY   HNF4A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7124
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5024; HNF4A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HPF1 KO
AC   CVCL_D8MJ
SY   HPF1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN89309
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26051; HPF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HRAS KO
AC   CVCL_D8MK
SY   HRAS Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2468
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HRH1 KO
AC   CVCL_D8ML
SY   HRH1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6805
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5182; HRH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HSPB1 KO
AC   CVCL_D8MM
SY   HSPB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H875
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HTR7 KO
AC   CVCL_D8MN
SY   HTR7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5302; HTR7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 HYCC1 KO
AC   CVCL_D8MP
SY   HYCC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN89361
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24587; HYCC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ID1 KO
AC   CVCL_D8MQ
SY   ID1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2374
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IFIT1 KO
AC   CVCL_D8MR
SY   IFIT1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H801
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5407; IFIT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IFNAR1 KO
AC   CVCL_D8MS
SY   IFNAR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2473
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IFNE KO
AC   CVCL_D8MT
SY   IFNE Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2476
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18163; IFNE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IFNGR1 KO
AC   CVCL_D8MU
SY   IFNGR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2477
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IFNGR2 KO
AC   CVCL_D8MV
SY   IFNGR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2478
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IGF1R KO
AC   CVCL_D8MW
SY   IGF1R Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2727
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IGF2BP3 KO
AC   CVCL_D8MX
SY   IGF2BP3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H725
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IKBKB KO
AC   CVCL_D8MY
SY   IKBKB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2588
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IKBKG KO
AC   CVCL_D8MZ
SY   IKBKG Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2589
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL10RA KO
AC   CVCL_D8N0
SY   IL10RA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2480
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5964; IL10RA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL12A KO
AC   CVCL_D8N1
SY   IL12A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL13RA1 KO
AC   CVCL_D8N2
SY   IL13RA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2486
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL15RA KO
AC   CVCL_D8N3
SY   IL15RA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2488
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL1R1 KO
AC   CVCL_D8N4
SY   IL1R1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2591
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5993; IL1R1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL20RB KO
AC   CVCL_D8N5
SY   IL20RB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2491
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6004; IL20RB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL27RA KO
AC   CVCL_D8N6
SY   IL27RA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2497
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17290; IL27RA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL4R KO
AC   CVCL_D8N7
SY   IL4R Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2501
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL6R KO
AC   CVCL_D8N8
SY   IL6R Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2504
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IL6ST KO
AC   CVCL_D8N9
SY   IL6ST Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2505
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IP6K2 KO
AC   CVCL_D8NA
SY   IP6K2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6913
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17313; IP6K2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IPMK KO
AC   CVCL_D8NB
SY   IPMK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6908
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20739; IPMK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IRAK4 KO
AC   CVCL_D8NC
SY   IRAK4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IRF3 KO
AC   CVCL_D8ND
SY   IRF3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3150
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6118; IRF3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 IRF9 KO
AC   CVCL_D8NE
SY   IRF9 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2509
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITGA10 KO
AC   CVCL_D8NF
SY   ITGA10 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2888
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6135; ITGA10.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITGA2 KO
AC   CVCL_D8NG
SY   ITGA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2890
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6137; ITGA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITGA2B KO
AC   CVCL_D8NH
SY   ITGA2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2891
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6138; ITGA2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITGAV KO
AC   CVCL_D8NI
SY   ITGAV Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2899
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6150; ITGAV.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITPK1 KO
AC   CVCL_D8NJ
SY   ITPK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6910
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6177; ITPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITPKB KO
AC   CVCL_D8NK
SY   ITPKB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6871
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6179; ITPKB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITPR1 KO
AC   CVCL_D8NL
SY   ITPR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6590
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITPR2 KO
AC   CVCL_D8NM
SY   ITPR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6591
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ITPR3 KO
AC   CVCL_D8NN
SY   ITPR3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 JAG2 KO
AC   CVCL_D8NP
SY   JAG2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2429
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6189; JAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 JAK1 KO
AC   CVCL_D8NQ
SY   JAK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2510
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 JAK2 KO
AC   CVCL_D8NR
SY   JAK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 JAK3 KO
AC   CVCL_D8NS
SY   JAK3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2512
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KAT2B KO
AC   CVCL_D8NT
SY   KAT2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2430
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KDM1A KO
AC   CVCL_D8NU
SY   KDM1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96684
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KLHL12 KO
AC   CVCL_D8NV
SY   KLHL12 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN84447
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19360; KLHL12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KLRK1 KO
AC   CVCL_D8NW
SY   KLRK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3041
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18788; KLRK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KRAS KO
AC   CVCL_D8NX
SY   KRAS Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3108
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KSR1 KO
AC   CVCL_D8NY
SY   KSR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6465; KSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 KSR2 KO
AC   CVCL_D8NZ
SY   KSR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18610; KSR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LAMB2 KO
AC   CVCL_D8P0
SY   LAMB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2912
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6487; LAMB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LAMC1 KO
AC   CVCL_D8P1
SY   LAMC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H446
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6492; LAMC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LAMC2 KO
AC   CVCL_D8P2
SY   LAMC2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2916
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6493; LAMC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LATS1 KO
AC   CVCL_D8P3
SY   LATS1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6543
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LATS2 KO
AC   CVCL_D8P4
SY   LATS2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3305
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LDLR KO
AC   CVCL_D8P5
SY   LDLR Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN90015
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LEPR KO
AC   CVCL_D8P6
SY   LEPR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6554; LEPR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LGR4 KO
AC   CVCL_D8P7
SY   LGR4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN90043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LIF KO
AC   CVCL_D8P8
SY   LIF Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6596; LIF.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LIFR KO
AC   CVCL_D8P9
SY   LIFR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2516
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6597; LIFR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LIMA1 KO
AC   CVCL_D8PA
SY   LIMA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96691
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24636; LIMA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LPAR1 KO
AC   CVCL_D8PB
SY   LPAR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2918
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3166; LPAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LPAR2 KO
AC   CVCL_D8PC
SY   LPAR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2919
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3168; LPAR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LPAR3 KO
AC   CVCL_D8PD
SY   LPAR3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2920
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14298; LPAR3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LPAR5 KO
AC   CVCL_D8PE
SY   LPAR5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6454
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13307; LPAR5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LRP1 KO
AC   CVCL_D8PF
SY   LRP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H656
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6692; LRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LRRC59 KO
AC   CVCL_D8PG
SY   LRRC59 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H483
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28817; LRRC59.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LSR KO
AC   CVCL_D8PH
SY   LSR Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN72359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29572; LSR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LTBR KO
AC   CVCL_D8PI
SY   LTBR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2596
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6718; LTBR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LTN1 KO
AC   CVCL_D8PJ
SY   LTN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN90248
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13082; LTN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 LYN KO
AC   CVCL_D8PK
SY   LYN Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2597
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAEA KO
AC   CVCL_D8PL
SY   MAEA Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN43711
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13731; MAEA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAGI1 KO
AC   CVCL_D8PM
SY   MAGI1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2922
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:946; MAGI1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAGI3 KO
AC   CVCL_D8PN
SY   MAGI3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6473
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29647; MAGI3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MALT1 KO
AC   CVCL_D8PP
SY   MALT1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-KP127
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAML1 KO
AC   CVCL_D8PQ
SY   MAML1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2431
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13632; MAML1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAML2 KO
AC   CVCL_D8PR
SY   MAML2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2432
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16259; MAML2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP2K1 KO
AC   CVCL_D8PS
SY   MAP2K1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6328
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP2K2 KO
AC   CVCL_D8PT
SY   MAP2K2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2736
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP2K3 KO
AC   CVCL_D8PU
SY   MAP2K3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2737
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP2K4 KO
AC   CVCL_D8PV
SY   MAP2K4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2738
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6844; MAP2K4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP2K5 KO
AC   CVCL_D8PW
SY   MAP2K5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3332
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6845; MAP2K5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K1 KO
AC   CVCL_D8PX
SY   MAP3K1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2740
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K11 KO
AC   CVCL_D8PY
SY   MAP3K11 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2741
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K13 KO
AC   CVCL_D8PZ
SY   MAP3K13 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2743
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6852; MAP3K13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K14 KO
AC   CVCL_D8Q0
SY   MAP3K14 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2599
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K3 KO
AC   CVCL_D8Q1
SY   MAP3K3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2746
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6855; MAP3K3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K4 KO
AC   CVCL_D8Q2
SY   MAP3K4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2747
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K5 KO
AC   CVCL_D8Q3
SY   MAP3K5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2748
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6857; MAP3K5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAP3K7 KO
AC   CVCL_D8Q4
SY   MAP3K7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2600
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPK12 KO
AC   CVCL_D8Q5
SY   MAPK12 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPK13 KO
AC   CVCL_D8Q6
SY   MAPK13 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2756
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6875; MAPK13.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPK3 KO
AC   CVCL_D8Q7
SY   MAPK3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2384
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6877; MAPK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPK7 KO
AC   CVCL_D8Q8
SY   MAPK7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2758
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPK8IP2 KO
AC   CVCL_D8Q9
SY   MAPK8IP2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2761
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6883; MAPK8IP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPKAPK2 KO
AC   CVCL_D8QA
SY   MAPKAPK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2764
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPKAPK3 KO
AC   CVCL_D8QB
SY   MAPKAPK3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2765
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6888; MAPKAPK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPKAPK5 KO
AC   CVCL_D8QC
SY   MAPKAPK5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2766
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MAPT KO
AC   CVCL_D8QD
SY   MAPT Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1058
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MCL1 KO
AC   CVCL_D8QE
SY   MCL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1132
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6943; MCL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MCOLN1 KO
AC   CVCL_D8QF
SY   MCOLN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6845
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MCOLN2 KO
AC   CVCL_D8QG
SY   MCOLN2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6846
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13357; MCOLN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MCOLN3 KO
AC   CVCL_D8QH
SY   MCOLN3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6847
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13358; MCOLN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MDM2 KO
AC   CVCL_D8QI
SY   MDM2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2924
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6973; MDM2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MET KO
AC   CVCL_D8QJ
SY   MET Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2770
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MFNG KO
AC   CVCL_D8QK
SY   MFNG Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2433
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7038; MFNG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MICU2 KO
AC   CVCL_D8QL
SY   MICU2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H060
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31830; MICU2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MKNK1 KO
AC   CVCL_D8QM
SY   MKNK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6669
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MKNK2 KO
AC   CVCL_D8QN
SY   MKNK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6670
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MLKL KO
AC   CVCL_D8QP
SY   MLKL Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6644
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MMP14 KO
AC   CVCL_D8QQ
SY   MMP14 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H940
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7160; MMP14.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MOB1A KO
AC   CVCL_D8QR
SY   MOB1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6544
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16015; MOB1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MOB1B KO
AC   CVCL_D8QS
SY   MOB1B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6545
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29801; MOB1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MSH6 KO
AC   CVCL_D8QT
SY   MSH6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN27275
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MSLN KO
AC   CVCL_D8QU
SY   MSLN Knockout cell line (HCT 116)
DR   Ubigene; YKO-H932
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7371; MSLN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MTAP KO
AC   CVCL_D8QV
SY   MTAP Knockout cell line (HCT 116)
DR   Ubigene; YKO-H144
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7413; MTAP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MTX2 KO
AC   CVCL_D8QW
SY   MTX2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H843
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7506; MTX2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MYD88 KO
AC   CVCL_D8QX
SY   MYD88 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1183
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MYLK KO
AC   CVCL_D8QY
SY   MYLK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6603
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7590; MYLK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 MYLK2 KO
AC   CVCL_D8QZ
SY   MYLK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16243; MYLK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NABP1 KO
AC   CVCL_D8R0
SY   NABP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN90900
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26232; NABP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NBL1 KO
AC   CVCL_D8R1
SY   NBL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2385
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7650; NBL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NCOR2 KO
AC   CVCL_D8R2
SY   NCOR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2434
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7673; NCOR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NCSTN KO
AC   CVCL_D8R3
SY   NCSTN Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2435
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NDFIP2 KO
AC   CVCL_D8R4
SY   NDFIP2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H943
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18537; NDFIP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NEFL KO
AC   CVCL_D8R5
SY   NEFL Knockout cell line (HCT 116)
DR   Ubigene; YKO-H090
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7739; NEFL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NEK7 KO
AC   CVCL_D8R6
SY   NEK7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H888
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13386; NEK7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NEO1 KO
AC   CVCL_D8R7
SY   NEO1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2386
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7754; NEO1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NFKB1 KO
AC   CVCL_D8R8
SY   NFKB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2602
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NFKB2 KO
AC   CVCL_D8R9
SY   NFKB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2603
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NFKBIA KO
AC   CVCL_D8RA
SY   NFKBIA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NGFR KO
AC   CVCL_D8RB
SY   NGFR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2776
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7809; NGFR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NKD1 KO
AC   CVCL_D8RC
SY   NKD1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2298
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17045; NKD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NKD2 KO
AC   CVCL_D8RD
SY   NKD2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17046; NKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NLK KO
AC   CVCL_D8RE
SY   NLK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2777
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29858; NLK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NME7 KO
AC   CVCL_D8RF
SY   NME7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN58847
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20461; NME7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NMNAT1 KO
AC   CVCL_D8RG
SY   NMNAT1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96675
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17877; NMNAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NMRK1 KO
AC   CVCL_D8RH
SY   NMRK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN91176
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26057; NMRK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NOS3 KO
AC   CVCL_D8RI
SY   NOS3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2927
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7876; NOS3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NOTCH1 KO
AC   CVCL_D8RJ
SY   NOTCH1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2436
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NOTCH2 KO
AC   CVCL_D8RK
SY   NOTCH2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2437
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NOTCH3 KO
AC   CVCL_D8RL
SY   NOTCH3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2438
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NQO2 KO
AC   CVCL_D8RM
SY   NQO2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS09039
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7856; NQO2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NR1D1 KO
AC   CVCL_D8RN
SY   NR1D1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS09450
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7962; NR1D1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NR4A1 KO
AC   CVCL_D8RP
SY   NR4A1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2778
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NTSR1 KO
AC   CVCL_D8RQ
SY   NTSR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6810
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8039; NTSR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NUMB KO
AC   CVCL_D8RR
SY   NUMB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2440
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 NUMBL KO
AC   CVCL_D8RS
SY   NUMBL Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2441
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8061; NUMBL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 OLA1 KO
AC   CVCL_D8RT
SY   OLA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HJ082
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28833; OLA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 OSMR KO
AC   CVCL_D8RU
SY   OSMR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2521
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8507; OSMR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 OXTR KO
AC   CVCL_D8RV
SY   OXTR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6811
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8529; OXTR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 P2RX4 KO
AC   CVCL_D8RW
SY   P2RX4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6787
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8535; P2RX4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 P2RX5 KO
AC   CVCL_D8RX
SY   P2RX5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6788
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8536; P2RX5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 P2RY1 KO
AC   CVCL_D8RY
SY   P2RY1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6452
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8539; P2RY1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PADI2 KO
AC   CVCL_D8RZ
SY   PADI2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H352
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18341; PADI2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PAK4 KO
AC   CVCL_D8S0
SY   PAK4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6394
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PAK6 KO
AC   CVCL_D8S1
SY   PAK6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16061; PAK6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PARP1 KO
AC   CVCL_D8S2
SY   PARP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H383
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PCSK4 KO
AC   CVCL_D8S3
SY   PCSK4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H162
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8746; PCSK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PDK1 KO
AC   CVCL_D8S4
SY   PDK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8809; PDK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PFKFB2 KO
AC   CVCL_D8S5
SY   PFKFB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8873; PFKFB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PFKFB3 KO
AC   CVCL_D8S6
SY   PFKFB3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6706
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PFKFB4 KO
AC   CVCL_D8S7
SY   PFKFB4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8875; PFKFB4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PHKA1 KO
AC   CVCL_D8S8
SY   PHKA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6863
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8925; PHKA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PHKA2 KO
AC   CVCL_D8S9
SY   PHKA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6862
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8926; PHKA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PHKB KO
AC   CVCL_D8SA
SY   PHKB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6861
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8927; PHKB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PHKG1 KO
AC   CVCL_D8SB
SY   PHKG1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6859
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8930; PHKG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PHKG2 KO
AC   CVCL_D8SC
SY   PHKG2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6860
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8931; PHKG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PI4K2A KO
AC   CVCL_D8SD
SY   PI4K2A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6876
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PI4K2B KO
AC   CVCL_D8SE
SY   PI4K2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6877
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PI4KB KO
AC   CVCL_D8SF
SY   PI4KB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6875
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIAS1 KO
AC   CVCL_D8SG
SY   PIAS1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2523
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2752; PIAS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIAS2 KO
AC   CVCL_D8SH
SY   PIAS2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2524
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17311; PIAS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIAS3 KO
AC   CVCL_D8SI
SY   PIAS3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2525
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16861; PIAS3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIAS4 KO
AC   CVCL_D8SJ
SY   PIAS4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2605
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17002; PIAS4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PICK1 KO
AC   CVCL_D8SK
SY   PICK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H388
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9394; PICK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3AP1 KO
AC   CVCL_D8SL
SY   PIK3AP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2931
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30034; PIK3AP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3C2A KO
AC   CVCL_D8SM
SY   PIK3C2A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6906
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3C2B KO
AC   CVCL_D8SN
SY   PIK3C2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6907
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8972; PIK3C2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3CA KO
AC   CVCL_D8SP
SY   PIK3CA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2526
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3CB KO
AC   CVCL_D8SQ
SY   PIK3CB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2527
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8976; PIK3CB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3CD KO
AC   CVCL_D8SR
SY   PIK3CD Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2528
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3R1 KO
AC   CVCL_D8SS
SY   PIK3R1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3R2 KO
AC   CVCL_D8ST
SY   PIK3R2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2530
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3R3 KO
AC   CVCL_D8SU
SY   PIK3R3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6330
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8981; PIK3R3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIK3R5 KO
AC   CVCL_D8SV
SY   PIK3R5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2933
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30035; PIK3R5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIKFYVE KO
AC   CVCL_D8SW
SY   PIKFYVE Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6891
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23785; PIKFYVE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIM1 KO
AC   CVCL_D8SX
SY   PIM1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN92026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIP4K2A KO
AC   CVCL_D8SY
SY   PIP4K2A Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96689
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIP4K2B KO
AC   CVCL_D8SZ
SY   PIP4K2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6902
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIP4K2C KO
AC   CVCL_D8T0
SY   PIP4K2C Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6900
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIP5K1A KO
AC   CVCL_D8T1
SY   PIP5K1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6881
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PIP5K1C KO
AC   CVCL_D8T2
SY   PIP5K1C Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6880
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PITX2 KO
AC   CVCL_D8T3
SY   PITX2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2388
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9005; PITX2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PKN1 KO
AC   CVCL_D8T4
SY   PKN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2935
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PKN2 KO
AC   CVCL_D8T5
SY   PKN2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2936
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PKN3 KO
AC   CVCL_D8T6
SY   PKN3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2937
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17999; PKN3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLAU KO
AC   CVCL_D8T7
SY   PLAU Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2606
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLCB1 KO
AC   CVCL_D8T8
SY   PLCB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2300
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15917; PLCB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLCB2 KO
AC   CVCL_D8T9
SY   PLCB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2301
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9055; PLCB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLCG1 KO
AC   CVCL_D8TA
SY   PLCG1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLCG2 KO
AC   CVCL_D8TB
SY   PLCG2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2608
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLEKHH1 KO
AC   CVCL_D8TC
SY   PLEKHH1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN92112
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17733; PLEKHH1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLK2 KO
AC   CVCL_D8TD
SY   PLK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6740
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PLK3 KO
AC   CVCL_D8TE
SY   PLK3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6741
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2154; PLK3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PNLDC1 KO
AC   CVCL_D8TF
SY   PNLDC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H211
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21185; PNLDC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 POFUT2 KO
AC   CVCL_D8TG
SY   POFUT2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN49011
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14683; POFUT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 POMGNT1 KO
AC   CVCL_D8TH
SY   POMGNT1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H957
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19139; POMGNT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PPARA KO
AC   CVCL_D8TI
SY   PPARA Knockout cell line (HCT 116)
DR   Ubigene; YKO-H592
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PPARG KO
AC   CVCL_D8TJ
SY   PPARG Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3342
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PPIP5K2 KO
AC   CVCL_D8TK
SY   PPIP5K2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6916
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29035; PPIP5K2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PPP2R1B KO
AC   CVCL_D8TL
SY   PPP2R1B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2390
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9303; PPP2R1B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PPP2R5E KO
AC   CVCL_D8TM
SY   PPP2R5E Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2945
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9313; PPP2R5E.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRAME KO
AC   CVCL_D8TN
SY   PRAME Knockout cell line (HCT 116)
DR   Ubigene; YKO-H723
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9336; PRAME.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRICKLE3 KO
AC   CVCL_D8TP
SY   PRICKLE3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2306
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6645; PRICKLE3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKAA1 KO
AC   CVCL_D8TQ
SY   PRKAA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2946
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKAA2 KO
AC   CVCL_D8TR
SY   PRKAA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2947
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKAB1 KO
AC   CVCL_D8TS
SY   PRKAB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKAB2 KO
AC   CVCL_D8TT
SY   PRKAB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9379; PRKAB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKACB KO
AC   CVCL_D8TU
SY   PRKACB Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKAG1 KO
AC   CVCL_D8TV
SY   PRKAG1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6621
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKAG2 KO
AC   CVCL_D8TW
SY   PRKAG2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9386; PRKAG2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKCE KO
AC   CVCL_D8TX
SY   PRKCE Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6598
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKCG KO
AC   CVCL_D8TY
SY   PRKCG Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2800
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9402; PRKCG.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKCI KO
AC   CVCL_D8TZ
SY   PRKCI Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6515
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKCZ KO
AC   CVCL_D8U0
SY   PRKCZ Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKD2 KO
AC   CVCL_D8U1
SY   PRKD2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6480
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PRKD3 KO
AC   CVCL_D8U2
SY   PRKD3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6479
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PROM1 KO
AC   CVCL_D8U3
SY   PROM1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS12397
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9454; PROM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PSEN2 KO
AC   CVCL_D8U4
SY   PSEN2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2442
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9509; PSEN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTAFR KO
AC   CVCL_D8U5
SY   PTAFR Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6815
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9582; PTAFR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTEN KO
AC   CVCL_D8U6
SY   PTEN Knockout cell line (HCT 116)
DR   Ubigene; YKO-H243
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTGER2 KO
AC   CVCL_D8U7
SY   PTGER2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7014
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9594; PTGER2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTK2 KO
AC   CVCL_D8U8
SY   PTK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3205
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTK2B KO
AC   CVCL_D8U9
SY   PTK2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6870
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTPN2 KO
AC   CVCL_D8UA
SY   PTPN2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 PTPN6 KO
AC   CVCL_D8UB
SY   PTPN6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2534
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RAF1 KO
AC   CVCL_D8UC
SY   RAF1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6327
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RAP1A KO
AC   CVCL_D8UD
SY   RAP1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-H091
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9855; RAP1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RASGRP2 KO
AC   CVCL_D8UE
SY   RASGRP2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2811
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9879; RASGRP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RASSF4 KO
AC   CVCL_D8UF
SY   RASSF4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN65695
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20793; RASSF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RBL1 KO
AC   CVCL_D8UG
SY   RBL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2391
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9893; RBL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RBPJ KO
AC   CVCL_D8UH
SY   RBPJ Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5724; RBPJ.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RELA KO
AC   CVCL_D8UI
SY   RELA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2612
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RET KO
AC   CVCL_D8UJ
SY   RET Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6836
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9967; RET.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 REV1 KO
AC   CVCL_D8UK
SY   REV1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H566
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14060; REV1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RHBDF1 KO
AC   CVCL_D8UL
SY   RHBDF1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN82651
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20561; RHBDF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RIPK1 KO
AC   CVCL_D8UM
SY   RIPK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2614
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RNF123 KO
AC   CVCL_D8UN
SY   RNF123 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H465
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ROCK1 KO
AC   CVCL_D8UP
SY   ROCK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2393
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ROCK2 KO
AC   CVCL_D8UQ
SY   ROCK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2310
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10252; ROCK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RPS6KA1 KO
AC   CVCL_D8UR
SY   RPS6KA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2814
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RPS6KA2 KO
AC   CVCL_D8US
SY   RPS6KA2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2815
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10431; RPS6KA2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RPS6KA4 KO
AC   CVCL_D8UT
SY   RPS6KA4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2817
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RPS6KA5 KO
AC   CVCL_D8UU
SY   RPS6KA5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2818
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RUNX2 KO
AC   CVCL_D8UV
SY   RUNX2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H151
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10472; RUNX2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RXRA KO
AC   CVCL_D8UW
SY   RXRA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2953
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RYK KO
AC   CVCL_D8UX
SY   RYK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2315
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10481; RYK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 RYR1 KO
AC   CVCL_D8UY
SY   RYR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6593
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10483; RYR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SCAPER KO
AC   CVCL_D8UZ
SY   SCAPER Knockout cell line (HCT 116)
DR   Ubigene; YKO-H191
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13081; SCAPER.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SEC61B KO
AC   CVCL_D8V0
SY   SEC61B Knockout cell line (HCT 116)
DR   Ubigene; YKO-H482
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16993; SEC61B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SF3A3 KO
AC   CVCL_D8V1
SY   SF3A3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96688
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10767; SF3A3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SGK1 KO
AC   CVCL_D8V2
SY   SGK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2954
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SGK2 KO
AC   CVCL_D8V3
SY   SGK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2955
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10811; SGK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SIGMAR1 KO
AC   CVCL_D8V4
SY   SIGMAR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H794
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SKAP1 KO
AC   CVCL_D8V5
SY   SKAP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H113
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15605; SKAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SKP2 KO
AC   CVCL_D8V6
SY   SKP2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6299
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC25A15 KO
AC   CVCL_D8V7
SY   SLC25A15 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN43359
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10985; SLC25A15.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC25A5 KO
AC   CVCL_D8V8
SY   SLC25A5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6853
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC25A6 KO
AC   CVCL_D8V9
SY   SLC25A6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6854
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10992; SLC25A6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC2A1 KO
AC   CVCL_D8VA
SY   SLC2A1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6687
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC2A4 KO
AC   CVCL_D8VB
SY   SLC2A4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6716
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11009; SLC2A4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC35C1 KO
AC   CVCL_D8VC
SY   SLC35C1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN93529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC38A9 KO
AC   CVCL_D8VD
SY   SLC38A9 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H604
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC3A2 KO
AC   CVCL_D8VE
SY   SLC3A2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3080
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC7A5 KO
AC   CVCL_D8VF
SY   SLC7A5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS12630
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC8B1 KO
AC   CVCL_D8VG
SY   SLC8B1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H059
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26175; SLC8B1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SLC9A1 KO
AC   CVCL_D8VH
SY   SLC9A1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H976
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMAD4 KO
AC   CVCL_D8VI
SY   SMAD4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H822
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMAD5 KO
AC   CVCL_D8VJ
SY   SMAD5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2399
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMAD6 KO
AC   CVCL_D8VK
SY   SMAD6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6772; SMAD6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMAD7 KO
AC   CVCL_D8VL
SY   SMAD7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2401
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMAD9 KO
AC   CVCL_D8VM
SY   SMAD9 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2402
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6774; SMAD9.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMARCA1 KO
AC   CVCL_D8VN
SY   SMARCA1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN35943
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11097; SMARCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMO KO
AC   CVCL_D8VP
SY   SMO Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3003
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMURF1 KO
AC   CVCL_D8VQ
SY   SMURF1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2403
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SMURF2 KO
AC   CVCL_D8VR
SY   SMURF2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2404
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SNCA KO
AC   CVCL_D8VS
SY   SNCA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3145
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SNX5 KO
AC   CVCL_D8VT
SY   SNX5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H734
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14969; SNX5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOCS2 KO
AC   CVCL_D8VU
SY   SOCS2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2535
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19382; SOCS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOCS3 KO
AC   CVCL_D8VV
SY   SOCS3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2536
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOCS4 KO
AC   CVCL_D8VW
SY   SOCS4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOCS5 KO
AC   CVCL_D8VX
SY   SOCS5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2538
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16852; SOCS5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOCS6 KO
AC   CVCL_D8VY
SY   SOCS6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2539
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16833; SOCS6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOCS7 KO
AC   CVCL_D8VZ
SY   SOCS7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29846; SOCS7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOS1 KO
AC   CVCL_D8W0
SY   SOS1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2541
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SOS2 KO
AC   CVCL_D8W1
SY   SOS2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2542
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11188; SOS2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SP1 KO
AC   CVCL_D8W2
SY   SP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SPHK1 KO
AC   CVCL_D8W3
SY   SPHK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3285
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SPHK2 KO
AC   CVCL_D8W4
SY   SPHK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6583
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SPOCD1 KO
AC   CVCL_D8W5
SY   SPOCD1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H677
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26338; SPOCD1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SQOR KO
AC   CVCL_D8W6
SY   SQOR Knockout cell line (HCT 116)
DR   Ubigene; YKO-H459
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20390; SQOR.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SQSTM1 KO
AC   CVCL_D8W7
SY   SQSTM1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H900
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SRC KO
AC   CVCL_D8W8
SY   SRC Knockout cell line (HCT 116)
DR   Ubigene; YKO-H074
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SSTR5 KO
AC   CVCL_D8W9
SY   SSTR5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS7042
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11334; SSTR5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ST6GAL1 KO
AC   CVCL_D8WA
SY   ST6GAL1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS12357
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10860; ST6GAL1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAM KO
AC   CVCL_D8WB
SY   STAM Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1252
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11357; STAM.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAM2 KO
AC   CVCL_D8WC
SY   STAM2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2544
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11358; STAM2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAT1 KO
AC   CVCL_D8WD
SY   STAT1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2545
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAT2 KO
AC   CVCL_D8WE
SY   STAT2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2546
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAT3 KO
AC   CVCL_D8WF
SY   STAT3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6666
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAT4 KO
AC   CVCL_D8WG
SY   STAT4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2547
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAT5B KO
AC   CVCL_D8WH
SY   STAT5B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2549
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STAT6 KO
AC   CVCL_D8WI
SY   STAT6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2550
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STING1 KO
AC   CVCL_D8WJ
SY   STING1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H941
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27962; STING1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STK11 KO
AC   CVCL_D8WK
SY   STK11 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H956
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STK4 KO
AC   CVCL_D8WL
SY   STK4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6390
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 STMN1 KO
AC   CVCL_D8WM
SY   STMN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2823
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6510; STMN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SUCLG1 KO
AC   CVCL_D8WN
SY   SUCLG1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H626
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11449; SUCLG1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SUCNR1 KO
AC   CVCL_D8WP
SY   SUCNR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H666
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4542; SUCNR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 SYK KO
AC   CVCL_D8WQ
SY   SYK Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2615
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TAB1 KO
AC   CVCL_D8WR
SY   TAB1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2616
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TAB2 KO
AC   CVCL_D8WS
SY   TAB2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2617
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TACSTD2 KO
AC   CVCL_D8WT
SY   TACSTD2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS3059
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11530; TACSTD2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TAOK1 KO
AC   CVCL_D8WU
SY   TAOK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN94303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29259; TAOK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TBK1 KO
AC   CVCL_D8WV
SY   TBK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6411
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TBXA2R KO
AC   CVCL_D8WW
SY   TBXA2R Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6824
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11608; TBXA2R.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TCF7 KO
AC   CVCL_D8WX
SY   TCF7 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2324
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11639; TCF7.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TERT KO
AC   CVCL_D8WY
SY   TERT Knockout cell line (HCT 116)
DR   Ubigene; YKO-H724
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11730; TERT.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TFDP1 KO
AC   CVCL_D8WZ
SY   TFDP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2406
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TGFBR1 KO
AC   CVCL_D8X0
SY   TGFBR1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2829
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TGFBR2 KO
AC   CVCL_D8X1
SY   TGFBR2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2830
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TGIF1 KO
AC   CVCL_D8X2
SY   TGIF1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2407
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11776; TGIF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 THBS1 KO
AC   CVCL_D8X3
SY   THBS1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2408
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11785; THBS1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TICAM1 KO
AC   CVCL_D8X4
SY   TICAM1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2619
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TIRAP KO
AC   CVCL_D8X5
SY   TIRAP Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2620
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17192; TIRAP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TLE2 KO
AC   CVCL_D8X6
SY   TLE2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2328
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11838; TLE2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TLR4 KO
AC   CVCL_D8X7
SY   TLR4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H607
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TMEM175 KO
AC   CVCL_D8X8
SY   TMEM175 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H934
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TNFAIP3 KO
AC   CVCL_D8X9
SY   TNFAIP3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2622
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TNFRSF10B KO
AC   CVCL_D8XA
SY   TNFRSF10B Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN40371
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11905; TNFRSF10B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TNFRSF13C KO
AC   CVCL_D8XB
SY   TNFRSF13C Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2623
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17755; TNFRSF13C.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TNFRSF1A KO
AC   CVCL_D8XC
SY   TNFRSF1A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2624
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TNFSF18 KO
AC   CVCL_D8XD
SY   TNFSF18 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H672
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11932; TNFSF18.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TNKS KO
AC   CVCL_D8XE
SY   TNKS Knockout cell line (HCT 116)
DR   Ubigene; YKO-KP148
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11941; TNKS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TP53 KO
AC   CVCL_D8XF
SY   TP53 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H175
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TP53BP1 KO
AC   CVCL_D8XG
SY   TP53BP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS14378
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11999; TP53BP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TPCN1 KO
AC   CVCL_D8XH
SY   TPCN1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6843
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18182; TPCN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TPCN2 KO
AC   CVCL_D8XI
SY   TPCN2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6844
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRADD KO
AC   CVCL_D8XJ
SY   TRADD Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2628
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRAF2 KO
AC   CVCL_D8XK
SY   TRAF2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2630
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12032; TRAF2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRAF3 KO
AC   CVCL_D8XL
SY   TRAF3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2631
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRAF4 KO
AC   CVCL_D8XM
SY   TRAF4 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1075
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12034; TRAF4.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRAF5 KO
AC   CVCL_D8XN
SY   TRAF5 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2632
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRAF6 KO
AC   CVCL_D8XP
SY   TRAF6 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2633
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRIM15 KO
AC   CVCL_D8XQ
SY   TRIM15 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H309
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16284; TRIM15.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRIM25 KO
AC   CVCL_D8XR
SY   TRIM25 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2634
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TRIM28 KO
AC   CVCL_D8XS
SY   TRIM28 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1189
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16384; TRIM28.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TSC1 KO
AC   CVCL_D8XT
SY   TSC1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H453
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TSC2 KO
AC   CVCL_D8XU
SY   TSC2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H452
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TST KO
AC   CVCL_D8XV
SY   TST Knockout cell line (HCT 116)
DR   Ubigene; YKO-H094
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12388; TST.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 TYK2 KO
AC   CVCL_D8XW
SY   TYK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN95287
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 UGDH KO
AC   CVCL_D8XX
SY   UGDH Knockout cell line (HCT 116)
DR   Ubigene; YKO-H1042
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12525; UGDH.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ULK1 KO
AC   CVCL_D8XY
SY   ULK1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H690
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ULK2 KO
AC   CVCL_D8XZ
SY   ULK2 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H744
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 USP25 KO
AC   CVCL_D8Y0
SY   USP25 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H163
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12624; USP25.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 USP28 KO
AC   CVCL_D8Y1
SY   USP28 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H134
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12625; USP28.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 VDAC3 KO
AC   CVCL_D8Y2
SY   VDAC3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6851
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 VEGFA KO
AC   CVCL_D8Y3
SY   VEGFA Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2831
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 VHL KO
AC   CVCL_D8Y4
SY   VHL Knockout cell line (HCT 116)
DR   Ubigene; YKO-H414
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12687; VHL.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 VPS4B KO
AC   CVCL_D8Y5
SY   VPS4B Knockout cell line (HCT 116)
DR   Ubigene; YKO-H673
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10895; VPS4B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 WNT16 KO
AC   CVCL_D8Y6
SY   WNT16 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2337
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16267; WNT16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 WNT2B KO
AC   CVCL_D8Y7
SY   WNT2B Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2338
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12781; WNT2B.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 WNT3 KO
AC   CVCL_D8Y8
SY   WNT3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2339
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12782; WNT3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 WNT3A KO
AC   CVCL_D8Y9
SY   WNT3A Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2340
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15983; WNT3A.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 XIAP KO
AC   CVCL_D8YA
SY   XIAP Knockout cell line (HCT 116)
DR   Ubigene; YKO-H753
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 YAP1 KO
AC   CVCL_D8YB
SY   YAP1 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS6529
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16262; YAP1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 YWHAE KO
AC   CVCL_D8YC
SY   YWHAE Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2972
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12851; YWHAE.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ZFYVE16 KO
AC   CVCL_D8YD
SY   ZFYVE16 Knockout cell line (HCT 116)
DR   Ubigene; YKO-HS2409
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ZMAT3 KO
AC   CVCL_D8YE
SY   ZMAT3 Knockout cell line (HCT 116)
DR   Ubigene; YKO-H768
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29983; ZMAT3.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HCT 116 ZNF398 KO
AC   CVCL_D8YF
SY   ZNF398 Knockout cell line (HCT 116)
DR   Ubigene; YKO-XN96131
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18373; ZNF398.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ile2675Aspfs*6 (c.8021dupA) (c.8021_8022insA); ClinVar=VCV000267050; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg24Serfs*20 (c.68dupG) (c.68_69insG) (p.G23fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Met1470Cysfs*22 (c.4408delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Leu450Ter (c.1349delT) (p.Leu450fs) (c.1344delT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0291 ! HCT 116
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HEK293 AAK1 KO
AC   CVCL_D8YG
SY   AAK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ041
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19679; AAK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ABCB1 KO
AC   CVCL_D8YH
SY   ABCB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13595
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:40; ABCB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ABCD1 KO
AC   CVCL_D8YI
SY   ABCD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN20778
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ACADSB KO
AC   CVCL_D8YJ
SY   ACADSB Knockout cell line (HEK293)
DR   Ubigene; YKO-XN20446
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:91; ACADSB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ACAT1 KO
AC   CVCL_D8YK
SY   ACAT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08819
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:93; ACAT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ACVR1C KO
AC   CVCL_D8YL
SY   ACVR1C Knockout cell line (HEK293)
DR   Ubigene; YKO-HS861
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18123; ACVR1C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ACVR2A KO
AC   CVCL_D8YM
SY   ACVR2A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11297
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:173; ACVR2A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ACVR2B KO
AC   CVCL_D8YN
SY   ACVR2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS862
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:174; ACVR2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ADAM17 KO
AC   CVCL_D8YP
SY   ADAM17 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS920
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ADAM9 KO
AC   CVCL_D8YQ
SY   ADAM9 Knockout cell line (HEK293)
DR   Ubigene; YKO-H667
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:216; ADAM9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ADAR KO
AC   CVCL_D8YR
SY   ADAR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS09686
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:225; ADAR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ADCY1 KO
AC   CVCL_D8YS
SY   ADCY1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5574
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:232; ADCY1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ADORA2A KO
AC   CVCL_D8YT
SY   ADORA2A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5571
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:263; ADORA2A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ADORA2B KO
AC   CVCL_D8YU
SY   ADORA2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5572
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:264; ADORA2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AGO2 KO
AC   CVCL_D8YV
SY   AGO2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13752
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AGO3 KO
AC   CVCL_D8YW
SY   AGO3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12052
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18421; AGO3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AHR KO
AC   CVCL_D8YX
SY   AHR Knockout cell line (HEK293)
DR   Ubigene; YKO-H796
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AKT1 KO
AC   CVCL_D8YY
SY   AKT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS954
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AKT2 KO
AC   CVCL_D8YZ
SY   AKT2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS955
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AKT3 KO
AC   CVCL_D8Z0
SY   AKT3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS956
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:393; AKT3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ALDH18A1 KO
AC   CVCL_D8Z1
SY   ALDH18A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H944
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9722; ALDH18A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ALKBH5 KO
AC   CVCL_D8Z2
SY   ALKBH5 Knockout cell line (HEK293)
DR   Ubigene; YKO-H378
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25996; ALKBH5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H378; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AMHR2 KO
AC   CVCL_D8Z3
SY   AMHR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS863
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:465; AMHR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AMPH KO
AC   CVCL_D8Z4
SY   AMPH Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13342
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:471; AMPH.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ANO6 KO
AC   CVCL_D8Z5
SY   ANO6 Knockout cell line (HEK293)
DR   Ubigene; YKO-H608
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ANXA6 KO
AC   CVCL_D8Z6
SY   ANXA6 Knockout cell line (HEK293)
DR   Ubigene; YKO-H739
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:544; ANXA6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AP1B1 KO
AC   CVCL_D8Z7
SY   AP1B1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN85445
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:554; AP1B1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 APC KO
AC   CVCL_D8Z8
SY   APC Knockout cell line (HEK293)
DR   Ubigene; YKO-HS758
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 APEX1 KO
AC   CVCL_D8Z9
SY   APEX1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS09463
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:587; APEX1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 APOD KO
AC   CVCL_D8ZA
SY   APOD Knockout cell line (HEK293)
DR   Ubigene; YKO-H973
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:612; APOD.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 APOE KO
AC   CVCL_D8ZB
SY   APOE Knockout cell line (HEK293)
DR   Ubigene; YKO-H245
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 APP KO
AC   CVCL_D8ZC
SY   APP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13522
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ARAF KO
AC   CVCL_D8ZD
SY   ARAF Knockout cell line (HEK293)
DR   Ubigene; YKO-H558
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H558; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ARHGEF2 KO
AC   CVCL_D8ZE
SY   ARHGEF2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11383
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:682; ARHGEF2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ARID1B KO
AC   CVCL_D8ZF
SY   ARID1B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11233
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18040; ARID1B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ARRB1 KO
AC   CVCL_D8ZG
SY   ARRB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1149
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ARRB2 KO
AC   CVCL_D8ZH
SY   ARRB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1150
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ASAP3 KO
AC   CVCL_D8ZI
SY   ASAP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN85631
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14987; ASAP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATE1 KO
AC   CVCL_D8ZJ
SY   ATE1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN45506
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:782; ATE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATF2 KO
AC   CVCL_D8ZK
SY   ATF2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1151
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATF4 KO
AC   CVCL_D8ZL
SY   ATF4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1152
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATG5 KO
AC   CVCL_D8ZM
SY   ATG5 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN85676
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATG7 KO
AC   CVCL_D8ZN
SY   ATG7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13728
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATM KO
AC   CVCL_D8ZP
SY   ATM Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1063
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATP23 KO
AC   CVCL_D8ZQ
SY   ATP23 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1082
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29452; ATP23.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATP5F1B KO
AC   CVCL_D8ZR
SY   ATP5F1B Knockout cell line (HEK293)
DR   Ubigene; YKO-XN85695
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:830; ATP5F1B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATP7A KO
AC   CVCL_D8ZS
SY   ATP7A Knockout cell line (HEK293)
DR   Ubigene; YKO-XN21474
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:869; ATP7A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ATXN2 KO
AC   CVCL_D8ZT
SY   ATXN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS14467
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10555; ATXN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AXIN1 KO
AC   CVCL_D8ZU
SY   AXIN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS760
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 AXIN2 KO
AC   CVCL_D8ZV
SY   AXIN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS761
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:904; AXIN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 B2M KO
AC   CVCL_D8ZW
SY   B2M Knockout cell line (HEK293)
DR   Ubigene; YKO-XN85793
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:914; B2M.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BACE1 KO
AC   CVCL_D8ZX
SY   BACE1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1713
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:933; BACE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BACH1 KO
AC   CVCL_D8ZY
SY   BACH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11519
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:935; BACH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BAG3 KO
AC   CVCL_D8ZZ
SY   BAG3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H927
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:939; BAG3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BAMBI KO
AC   CVCL_D9A0
SY   BAMBI Knockout cell line (HEK293)
DR   Ubigene; YKO-HS864
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30251; BAMBI.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BCL2 KO
AC   CVCL_D9A1
SY   BCL2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1065
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BCL9L KO
AC   CVCL_D9A2
SY   BCL9L Knockout cell line (HEK293)
DR   Ubigene; YKO-XN82302
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23688; BCL9L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BDH1 KO
AC   CVCL_D9A3
SY   BDH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H625
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1027; BDH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BMP2 KO
AC   CVCL_D9A4
SY   BMP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS865
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1069; BMP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BMP7 KO
AC   CVCL_D9A5
SY   BMP7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS869
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1074; BMP7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BMPR1A KO
AC   CVCL_D9A6
SY   BMPR1A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS870
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1076; BMPR1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BMPR1B KO
AC   CVCL_D9A7
SY   BMPR1B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS871
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1077; BMPR1B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BMPR2 KO
AC   CVCL_D9A8
SY   BMPR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS872
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BRAF KO
AC   CVCL_D9A9
SY   BRAF Knockout cell line (HEK293)
DR   Ubigene; YKO-H559
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H559; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BRIP1 KO
AC   CVCL_D9AA
SY   BRIP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08651
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20473; BRIP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BSG KO
AC   CVCL_D9AB
SY   BSG Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1647
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1116; BSG.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BST2 KO
AC   CVCL_D9AC
SY   BST2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2001
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1119; BST2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 BTRC KO
AC   CVCL_D9AD
SY   BTRC Knockout cell line (HEK293)
DR   Ubigene; YKO-HS762
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 C1GALT1 KO
AC   CVCL_D9AE
SY   C1GALT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12111
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24337; C1GALT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 C1QBP KO
AC   CVCL_D9AF
SY   C1QBP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08438
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1243; C1QBP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 C2orf69 KO
AC   CVCL_D9AG
SY   C2orf69 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN38890
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26799; C2orf69.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNA1C KO
AC   CVCL_D9AH
SY   CACNA1C Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1157
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1390; CACNA1C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNA1H KO
AC   CVCL_D9AI
SY   CACNA1H Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1162
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1395; CACNA1H.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNA2D1 KO
AC   CVCL_D9AJ
SY   CACNA2D1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1165
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNA2D2 KO
AC   CVCL_D9AK
SY   CACNA2D2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1166
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1400; CACNA2D2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNA2D3 KO
AC   CVCL_D9AL
SY   CACNA2D3 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN86344
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15460; CACNA2D3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNB1 KO
AC   CVCL_D9AM
SY   CACNB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13211
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1401; CACNB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNB2 KO
AC   CVCL_D9AN
SY   CACNB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1168
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1402; CACNB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNB3 KO
AC   CVCL_D9AP
SY   CACNB3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1169
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNB4 KO
AC   CVCL_D9AQ
SY   CACNB4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1170
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1404; CACNB4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CACNG8 KO
AC   CVCL_D9AR
SY   CACNG8 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN86351
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13628; CACNG8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAMK1 KO
AC   CVCL_D9AS
SY   CAMK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5982
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1459; CAMK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAMK1D KO
AC   CVCL_D9AT
SY   CAMK1D Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5980
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19341; CAMK1D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAMK2B KO
AC   CVCL_D9AU
SY   CAMK2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS765
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1461; CAMK2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAMK2D KO
AC   CVCL_D9AV
SY   CAMK2D Knockout cell line (HEK293)
DR   Ubigene; YKO-HS766
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAMK2G KO
AC   CVCL_D9AW
SY   CAMK2G Knockout cell line (HEK293)
DR   Ubigene; YKO-HS767
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAMK4 KO
AC   CVCL_D9AX
SY   CAMK4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5747
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1464; CAMK4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAPN1 KO
AC   CVCL_D9AY
SY   CAPN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13247
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1476; CAPN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAPN2 KO
AC   CVCL_D9AZ
SY   CAPN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN22106
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1479; CAPN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CARD10 KO
AC   CVCL_D9B0
SY   CARD10 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1071
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16422; CARD10.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CARD11 KO
AC   CVCL_D9B1
SY   CARD11 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1072
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16393; CARD11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CASP3 KO
AC   CVCL_D9B2
SY   CASP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1175
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CASP9 KO
AC   CVCL_D9B3
SY   CASP9 Knockout cell line (HEK293)
DR   Ubigene; YKO-H372
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CAV1 KO
AC   CVCL_D9B4
SY   CAV1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H904
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CBLB KO
AC   CVCL_D9B5
SY   CBLB Knockout cell line (HEK293)
DR   Ubigene; YKO-H779
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1542; CBLB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCAR1 KO
AC   CVCL_D9B6
SY   CCAR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS09182
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24236; CCAR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCDC150 KO
AC   CVCL_D9B7
SY   CCDC150 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN86551
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26834; CCDC150.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCHCR1 KO
AC   CVCL_D9B8
SY   CCHCR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H971
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13930; CCHCR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCKBR KO
AC   CVCL_D9B9
SY   CCKBR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5943
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1571; CCKBR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCN2 KO
AC   CVCL_D9BA
SY   CCN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5682
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2500; CCN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCND1 KO
AC   CVCL_D9BB
SY   CCND1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H680
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCND2 KO
AC   CVCL_D9BC
SY   CCND2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1485
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1583; CCND2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CCND3 KO
AC   CVCL_D9BD
SY   CCND3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS768
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD14 KO
AC   CVCL_D9BE
SY   CD14 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1079
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1628; CD14.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD163 KO
AC   CVCL_D9BF
SY   CD163 Knockout cell line (HEK293)
DR   Ubigene; YKO-H223
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1631; CD163.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD164 KO
AC   CVCL_D9BG
SY   CD164 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN40310
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1632; CD164.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD55 KO
AC   CVCL_D9BH
SY   CD55 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12558
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2665; CD55.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD63 KO
AC   CVCL_D9BI
SY   CD63 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12279
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD81 KO
AC   CVCL_D9BJ
SY   CD81 Knockout cell line (HEK293)
DR   Ubigene; YKO-H883
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1701; CD81.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CD86 KO
AC   CVCL_D9BK
SY   CD86 Knockout cell line (HEK293)
DR   Ubigene; YKO-H240
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1705; CD86.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDC25B KO
AC   CVCL_D9BL
SY   CDC25B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1176
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1726; CDC25B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDH1 KO
AC   CVCL_D9BM
SY   CDH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5588
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1748; CDH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDK2 KO
AC   CVCL_D9BN
SY   CDK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5846
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1771; CDK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDK6 KO
AC   CVCL_D9BP
SY   CDK6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1349
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDKL5 KO
AC   CVCL_D9BQ
SY   CDKL5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08267
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11411; CDKL5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDKN1A KO
AC   CVCL_D9BR
SY   CDKN1A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS958
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDKN2B KO
AC   CVCL_D9BS
SY   CDKN2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5853
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1788; CDKN2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CDKN2D KO
AC   CVCL_D9BT
SY   CDKN2D Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5854
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1790; CDKN2D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CEACAM1 KO
AC   CVCL_D9BU
SY   CEACAM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ040
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1814; CEACAM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CEPT1 KO
AC   CVCL_D9BV
SY   CEPT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN43926
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24289; CEPT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CFLAR KO
AC   CVCL_D9BW
SY   CFLAR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1082
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1876; CFLAR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CHD8 KO
AC   CVCL_D9BX
SY   CHD8 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS770
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CHRM3 KO
AC   CVCL_D9BY
SY   CHRM3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5878
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1952; CHRM3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CHRNA7 KO
AC   CVCL_D9BZ
SY   CHRNA7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2206
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1960; CHRNA7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CHUK KO
AC   CVCL_D9C0
SY   CHUK Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1083
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CIR1 KO
AC   CVCL_D9C1
SY   CIR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS922
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24217; CIR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CISH KO
AC   CVCL_D9C2
SY   CISH Knockout cell line (HEK293)
DR   Ubigene; YKO-HS959
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1984; CISH.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CLK1 KO
AC   CVCL_D9C3
SY   CLK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ042
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2068; CLK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CLPB KO
AC   CVCL_D9C4
SY   CLPB Knockout cell line (HEK293)
DR   Ubigene; YKO-H775
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30664; CLPB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CNTF KO
AC   CVCL_D9C5
SY   CNTF Knockout cell line (HEK293)
DR   Ubigene; YKO-HS960
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2169; CNTF.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CNTFR KO
AC   CVCL_D9C6
SY   CNTFR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS961
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2170; CNTFR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 COL2A1 KO
AC   CVCL_D9C7
SY   COL2A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1354
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2200; COL2A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 COL4A2 KO
AC   CVCL_D9C8
SY   COL4A2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1356
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2203; COL4A2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 COL4A5 KO
AC   CVCL_D9C9
SY   COL4A5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1359
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CREB1 KO
AC   CVCL_D9CA
SY   CREB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1127
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CREBBP KO
AC   CVCL_D9CB
SY   CREBBP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS962
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CRK KO
AC   CVCL_D9CC
SY   CRK Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1177
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2362; CRK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CRKL KO
AC   CVCL_D9CD
SY   CRKL Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1178
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2363; CRKL.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSF1 KO
AC   CVCL_D9CE
SY   CSF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1179
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSNK1D KO
AC   CVCL_D9CF
SY   CSNK1D Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5674
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSNK1G1 KO
AC   CVCL_D9CG
SY   CSNK1G1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1487
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSNK1G2 KO
AC   CVCL_D9CH
SY   CSNK1G2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1488
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2455; CSNK1G2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSNK1G3 KO
AC   CVCL_D9CI
SY   CSNK1G3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1489
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2456; CSNK1G3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSNK2A2 KO
AC   CVCL_D9CJ
SY   CSNK2A2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1084
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2459; CSNK2A2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CSPG5 KO
AC   CVCL_D9CK
SY   CSPG5 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN44470
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2467; CSPG5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CTNNA1 KO
AC   CVCL_D9CL
SY   CTNNA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H915
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2509; CTNNA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CTNNB1 KO
AC   CVCL_D9CM
SY   CTNNB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H671
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CTNND2 KO
AC   CVCL_D9CN
SY   CTNND2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS775
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2516; CTNND2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CTNS KO
AC   CVCL_D9CP
SY   CTNS Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12017
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2518; CTNS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CUL3 KO
AC   CVCL_D9CQ
SY   CUL3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1490
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2553; CUL3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CXCR2 KO
AC   CVCL_D9CR
SY   CXCR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ081
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6027; CXCR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CXCR4 KO
AC   CVCL_D9CS
SY   CXCR4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5944
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CXXC1 KO
AC   CVCL_D9CT
SY   CXXC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN59538
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24343; CXXC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CYBB KO
AC   CVCL_D9CU
SY   CYBB Knockout cell line (HEK293)
DR   Ubigene; YKO-H462
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2578; CYBB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CYLD KO
AC   CVCL_D9CV
SY   CYLD Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1090
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 CYP2E1 KO
AC   CVCL_D9CW
SY   CYP2E1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2023
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2631; CYP2E1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DAAM2 KO
AC   CVCL_D9CX
SY   DAAM2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS778
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18143; DAAM2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DAXX KO
AC   CVCL_D9CY
SY   DAXX Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1181
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DCAF11 KO
AC   CVCL_D9CZ
SY   DCAF11 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1087
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20258; DCAF11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DCAF16 KO
AC   CVCL_D9D0
SY   DCAF16 Knockout cell line (HEK293)
DR   Ubigene; YKO-H721
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25987; DCAF16.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DCLK1 KO
AC   CVCL_D9D1
SY   DCLK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN41126
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2700; DCLK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DDX21 KO
AC   CVCL_D9D2
SY   DDX21 Knockout cell line (HEK293)
DR   Ubigene; YKO-H353
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2744; DDX21.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DECR1 KO
AC   CVCL_D9D3
SY   DECR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2021
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2753; DECR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DENND3 KO
AC   CVCL_D9D4
SY   DENND3 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN48062
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29134; DENND3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DEPDC1 KO
AC   CVCL_D9D5
SY   DEPDC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN87511
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22949; DEPDC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DEPDC5 KO
AC   CVCL_D9D6
SY   DEPDC5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5412
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18423; DEPDC5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGKA KO
AC   CVCL_D9D7
SY   DGKA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6040
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGKD KO
AC   CVCL_D9D8
SY   DGKD Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6038
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2851; DGKD.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGKE KO
AC   CVCL_D9D9
SY   DGKE Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6041
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2852; DGKE.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGKH KO
AC   CVCL_D9DA
SY   DGKH Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6043
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2854; DGKH.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGKQ KO
AC   CVCL_D9DB
SY   DGKQ Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6045
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2856; DGKQ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGKZ KO
AC   CVCL_D9DC
SY   DGKZ Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6037
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2857; DGKZ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DGUOK KO
AC   CVCL_D9DD
SY   DGUOK Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08680
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2858; DGUOK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DHX58 KO
AC   CVCL_D9DE
SY   DHX58 Knockout cell line (HEK293)
DR   Ubigene; YKO-H532
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DISC1 KO
AC   CVCL_D9DF
SY   DISC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN54314
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2888; DISC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DLL3 KO
AC   CVCL_D9DG
SY   DLL3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS924
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DLL4 KO
AC   CVCL_D9DH
SY   DLL4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS925
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2910; DLL4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DNAJC7 KO
AC   CVCL_D9DI
SY   DNAJC7 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN37386
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12392; DNAJC7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DNASE1 KO
AC   CVCL_D9DJ
SY   DNASE1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN24234
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2956; DNASE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DNM2 KO
AC   CVCL_D9DK
SY   DNM2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H389
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2974; DNM2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DPH1 KO
AC   CVCL_D9DL
SY   DPH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H746
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3003; DPH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DTX2 KO
AC   CVCL_D9DM
SY   DTX2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS927
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15973; DTX2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DTX3 KO
AC   CVCL_D9DN
SY   DTX3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS928
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24457; DTX3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DTX3L KO
AC   CVCL_D9DP
SY   DTX3L Knockout cell line (HEK293)
DR   Ubigene; YKO-HS929
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DUSP1 KO
AC   CVCL_D9DQ
SY   DUSP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1183
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3064; DUSP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DUSP10 KO
AC   CVCL_D9DR
SY   DUSP10 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1184
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3065; DUSP10.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DUSP16 KO
AC   CVCL_D9DS
SY   DUSP16 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1185
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17909; DUSP16.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DUSP3 KO
AC   CVCL_D9DT
SY   DUSP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1187
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3069; DUSP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DUSP4 KO
AC   CVCL_D9DU
SY   DUSP4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1188
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 DVL2 KO
AC   CVCL_D9DV
SY   DVL2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS782
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3086; DVL2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 E2F5 KO
AC   CVCL_D9DW
SY   E2F5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS876
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3119; E2F5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EDA KO
AC   CVCL_D9DX
SY   EDA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1091
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3157; EDA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EDNRA KO
AC   CVCL_D9DY
SY   EDNRA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5917
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3179; EDNRA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EEF1D KO
AC   CVCL_D9DZ
SY   EEF1D Knockout cell line (HEK293)
DR   Ubigene; YKO-XN24586
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3211; EEF1D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EGFR KO
AC   CVCL_D9E0
SY   EGFR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5466
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EGLN1 KO
AC   CVCL_D9E1
SY   EGLN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H986
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1232; EGLN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EGLN2 KO
AC   CVCL_D9E2
SY   EGLN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1052
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14660; EGLN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EGLN3 KO
AC   CVCL_D9E3
SY   EGLN3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H885
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14661; EGLN3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EHMT2 KO
AC   CVCL_D9E4
SY   EHMT2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12688
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14129; EHMT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EIF2A KO
AC   CVCL_D9E5
SY   EIF2A Knockout cell line (HEK293)
DR   Ubigene; YKO-XN65698
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3254; EIF2A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EIF2AK2 KO
AC   CVCL_D9E6
SY   EIF2AK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08520
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EIF2AK3 KO
AC   CVCL_D9E7
SY   EIF2AK3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08195
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ELF3 KO
AC   CVCL_D9E8
SY   ELF3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H767
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3318; ELF3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ENDOV KO
AC   CVCL_D9E9
SY   ENDOV Knockout cell line (HEK293)
DR   Ubigene; YKO-XN87911
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26640; ENDOV.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ENPP1 KO
AC   CVCL_D9EA
SY   ENPP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN32718
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3356; ENPP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EP300 KO
AC   CVCL_D9EB
SY   EP300 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS971
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EPHA2 KO
AC   CVCL_D9EC
SY   EPHA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1199
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EPN1 KO
AC   CVCL_D9ED
SY   EPN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN58854
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 EPOR KO
AC   CVCL_D9EE
SY   EPOR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS972
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3416; EPOR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ERBB2 KO
AC   CVCL_D9EF
SY   ERBB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H709
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H709; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ERBB3 KO
AC   CVCL_D9EG
SY   ERBB3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1201
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3431; ERBB3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ERBB4 KO
AC   CVCL_D9EH
SY   ERBB4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1202
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ERC1 KO
AC   CVCL_D9EI
SY   ERC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1093
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17072; ERC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ERI1 KO
AC   CVCL_D9EJ
SY   ERI1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN69454
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23994; ERI1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ERN1 KO
AC   CVCL_D9EK
SY   ERN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H896
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ESRRA KO
AC   CVCL_D9EL
SY   ESRRA Knockout cell line (HEK293)
DR   Ubigene; YKO-XN24934
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3471; ESRRA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 F2R KO
AC   CVCL_D9EM
SY   F2R Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1379
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FAN1 KO
AC   CVCL_D9EN
SY   FAN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN48126
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29170; FAN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FAS KO
AC   CVCL_D9EP
SY   FAS Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1204
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11920; FAS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FBN1 KO
AC   CVCL_D9EQ
SY   FBN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS877
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3603; FBN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FBXW7 KO
AC   CVCL_D9ER
SY   FBXW7 Knockout cell line (HEK293)
DR   Ubigene; YKO-H702
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FGF13 KO
AC   CVCL_D9ES
SY   FGF13 Knockout cell line (HEK293)
DR   Ubigene; YKO-H967
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3670; FGF13.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FGF5 KO
AC   CVCL_D9ET
SY   FGF5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1213
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3683; FGF5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FGFR1 KO
AC   CVCL_D9EU
SY   FGFR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1217
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FGFR2 KO
AC   CVCL_D9EV
SY   FGFR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1218
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3689; FGFR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FHL1 KO
AC   CVCL_D9EW
SY   FHL1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS973
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3702; FHL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FIBP KO
AC   CVCL_D9EX
SY   FIBP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08734
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3705; FIBP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FLT1 KO
AC   CVCL_D9EY
SY   FLT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1224
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3763; FLT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FLT3LG KO
AC   CVCL_D9EZ
SY   FLT3LG Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5462
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FLT4 KO
AC   CVCL_D9F0
SY   FLT4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1226
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3767; FLT4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FOSL1 KO
AC   CVCL_D9F1
SY   FOSL1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS785
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FRAT1 KO
AC   CVCL_D9F2
SY   FRAT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS786
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3944; FRAT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FRAT2 KO
AC   CVCL_D9F3
SY   FRAT2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS787
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16048; FRAT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FTO KO
AC   CVCL_D9F4
SY   FTO Knockout cell line (HEK293)
DR   Ubigene; YKO-H379
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H379; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FYN KO
AC   CVCL_D9F5
SY   FYN Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6054
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FZD2 KO
AC   CVCL_D9F6
SY   FZD2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS790
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FZD3 KO
AC   CVCL_D9F7
SY   FZD3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS791
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4041; FZD3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 FZD9 KO
AC   CVCL_D9F8
SY   FZD9 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS797
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4047; FZD9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GAA KO
AC   CVCL_D9F9
SY   GAA Knockout cell line (HEK293)
DR   Ubigene; YKO-XN26298
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GABBR1 KO
AC   CVCL_D9FA
SY   GABBR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6153
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GADD45A KO
AC   CVCL_D9FB
SY   GADD45A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1094
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4095; GADD45A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GADD45B KO
AC   CVCL_D9FC
SY   GADD45B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1095
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GADD45G KO
AC   CVCL_D9FD
SY   GADD45G Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1096
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4097; GADD45G.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GALT KO
AC   CVCL_D9FE
SY   GALT Knockout cell line (HEK293)
DR   Ubigene; YKO-H651
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4135; GALT.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GFAP KO
AC   CVCL_D9FF
SY   GFAP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS974
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4235; GFAP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GGCX KO
AC   CVCL_D9FG
SY   GGCX Knockout cell line (HEK293)
DR   Ubigene; YKO-H948
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4247; GGCX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GHR KO
AC   CVCL_D9FH
SY   GHR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS976
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4263; GHR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GLMP KO
AC   CVCL_D9FI
SY   GLMP Knockout cell line (HEK293)
DR   Ubigene; YKO-XN46086
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29436; GLMP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GNA12 KO
AC   CVCL_D9FJ
SY   GNA12 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1228
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4380; GNA12.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GNA13 KO
AC   CVCL_D9FK
SY   GNA13 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5746
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4381; GNA13.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GNAQ KO
AC   CVCL_D9FL
SY   GNAQ Knockout cell line (HEK293)
DR   Ubigene; YKO-H456
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4390; GNAQ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GNB4 KO
AC   CVCL_D9FM
SY   GNB4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1387
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20731; GNB4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GNE KO
AC   CVCL_D9FN
SY   GNE Knockout cell line (HEK293)
DR   Ubigene; YKO-XN43002
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23657; GNE.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GNPTAB KO
AC   CVCL_D9FP
SY   GNPTAB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08345
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29670; GNPTAB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GORASP2 KO
AC   CVCL_D9FQ
SY   GORASP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H585
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17500; GORASP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GPR155 KO
AC   CVCL_D9FR
SY   GPR155 Knockout cell line (HEK293)
DR   Ubigene; YKO-H919
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22951; GPR155.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GPR161 KO
AC   CVCL_D9FS
SY   GPR161 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1500
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23694; GPR161.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GPR75 KO
AC   CVCL_D9FT
SY   GPR75 Knockout cell line (HEK293)
DR   Ubigene; YKO-H708
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4526; GPR75.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GRIN3B KO
AC   CVCL_D9FU
SY   GRIN3B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6182
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16768; GRIN3B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GRK2 KO
AC   CVCL_D9FV
SY   GRK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H597
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GRK3 KO
AC   CVCL_D9FW
SY   GRK3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1502
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:290; GRK3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GRM2 KO
AC   CVCL_D9FX
SY   GRM2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ038
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4594; GRM2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GRM8 KO
AC   CVCL_D9FY
SY   GRM8 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6071
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4600; GRM8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GSK3A KO
AC   CVCL_D9FZ
SY   GSK3A Knockout cell line (HEK293)
DR   Ubigene; YKO-H841
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4616; GSK3A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GSK3B KO
AC   CVCL_D9G0
SY   GSK3B Knockout cell line (HEK293)
DR   Ubigene; YKO-H911
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 GSTP1 KO
AC   CVCL_D9G1
SY   GSTP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2154
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4638; GSTP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HCK KO
AC   CVCL_D9G2
SY   HCK Knockout cell line (HEK293)
DR   Ubigene; YKO-H899
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4840; HCK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HDAC1 KO
AC   CVCL_D9G3
SY   HDAC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS931
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HDAC2 KO
AC   CVCL_D9G4
SY   HDAC2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS932
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HES1 KO
AC   CVCL_D9G5
SY   HES1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS933
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HEY1 KO
AC   CVCL_D9G6
SY   HEY1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS934
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HEY2 KO
AC   CVCL_D9G7
SY   HEY2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS935
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4881; HEY2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HEYL KO
AC   CVCL_D9G8
SY   HEYL Knockout cell line (HEK293)
DR   Ubigene; YKO-HS936
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4882; HEYL.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HIF1AN KO
AC   CVCL_D9G9
SY   HIF1AN Knockout cell line (HEK293)
DR   Ubigene; YKO-H987
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17113; HIF1AN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HK2 KO
AC   CVCL_D9GA
SY   HK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5807
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4923; HK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HOXA1 KO
AC   CVCL_D9GB
SY   HOXA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN27930
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5099; HOXA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HRAS KO
AC   CVCL_D9GC
SY   HRAS Knockout cell line (HEK293)
DR   Ubigene; YKO-H711
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H711; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HSP90AA1 KO
AC   CVCL_D9GD
SY   HSP90AA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H450
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5253; HSP90AA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HSP90AB1 KO
AC   CVCL_D9GE
SY   HSP90AB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H451
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5258; HSP90AB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HSP90B1 KO
AC   CVCL_D9GF
SY   HSP90B1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H449
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12028; HSP90B1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HSPA4 KO
AC   CVCL_D9GG
SY   HSPA4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2029
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5237; HSPA4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HSPG2 KO
AC   CVCL_D9GH
SY   HSPG2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11932
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5273; HSPG2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 HTRA2 KO
AC   CVCL_D9GI
SY   HTRA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1078
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14348; HTRA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ICAM1 KO
AC   CVCL_D9GJ
SY   ICAM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H023
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5344; ICAM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ID2 KO
AC   CVCL_D9GK
SY   ID2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS884
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5361; ID2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ID3 KO
AC   CVCL_D9GL
SY   ID3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS885
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5362; ID3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IFIH1 KO
AC   CVCL_D9GM
SY   IFIH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS14310
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IFNAR1 KO
AC   CVCL_D9GN
SY   IFNAR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS982
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IFNGR1 KO
AC   CVCL_D9GP
SY   IFNGR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS986
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IFNGR2 KO
AC   CVCL_D9GQ
SY   IFNGR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS987
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IGF1R KO
AC   CVCL_D9GR
SY   IGF1R Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1236
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IGF2BP2 KO
AC   CVCL_D9GS
SY   IGF2BP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H005
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IGF2BP3 KO
AC   CVCL_D9GT
SY   IGF2BP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H013
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28868; IGF2BP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IGSF3 KO
AC   CVCL_D9GU
SY   IGSF3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12971
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5950; IGSF3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IKBKB KO
AC   CVCL_D9GV
SY   IKBKB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1097
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IKBKE KO
AC   CVCL_D9GW
SY   IKBKE Knockout cell line (HEK293)
DR   Ubigene; YKO-H678
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14552; IKBKE.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IKBKG KO
AC   CVCL_D9GX
SY   IKBKG Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1098
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL11 KO
AC   CVCL_D9GY
SY   IL11 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS990
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5966; IL11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL12A KO
AC   CVCL_D9GZ
SY   IL12A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS991
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5969; IL12A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL13RA1 KO
AC   CVCL_D9H0
SY   IL13RA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS995
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL15RA KO
AC   CVCL_D9H1
SY   IL15RA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS997
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL18R1 KO
AC   CVCL_D9H2
SY   IL18R1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H675
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5988; IL18R1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL27RA KO
AC   CVCL_D9H3
SY   IL27RA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1006
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17290; IL27RA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL4R KO
AC   CVCL_D9H4
SY   IL4R Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1010
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL6R KO
AC   CVCL_D9H5
SY   IL6R Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1013
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL6ST KO
AC   CVCL_D9H6
SY   IL6ST Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1014
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IL7R KO
AC   CVCL_D9H7
SY   IL7R Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1016
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IMMP1L KO
AC   CVCL_D9H8
SY   IMMP1L Knockout cell line (HEK293)
DR   Ubigene; YKO-H1083
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26317; IMMP1L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IMMP2L KO
AC   CVCL_D9H9
SY   IMMP2L Knockout cell line (HEK293)
DR   Ubigene; YKO-H1084
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14598; IMMP2L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 INVS KO
AC   CVCL_D9HA
SY   INVS Knockout cell line (HEK293)
DR   Ubigene; YKO-H754
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17870; INVS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IP6K1 KO
AC   CVCL_D9HB
SY   IP6K1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6028
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18360; IP6K1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IPPK KO
AC   CVCL_D9HC
SY   IPPK Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6027
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14645; IPPK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IRAK1 KO
AC   CVCL_D9HD
SY   IRAK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS14823
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6112; IRAK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 IRAK4 KO
AC   CVCL_D9HE
SY   IRAK4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1101
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITGA4 KO
AC   CVCL_D9HF
SY   ITGA4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1402
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6140; ITGA4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITGA8 KO
AC   CVCL_D9HG
SY   ITGA8 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1406
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6144; ITGA8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITGB2 KO
AC   CVCL_D9HH
SY   ITGB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5637
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6155; ITGB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITGB8 KO
AC   CVCL_D9HI
SY   ITGB8 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1415
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6163; ITGB8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITPK1 KO
AC   CVCL_D9HJ
SY   ITPK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6026
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6177; ITPK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITPKB KO
AC   CVCL_D9HK
SY   ITPKB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5987
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6179; ITPKB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITPR1 KO
AC   CVCL_D9HL
SY   ITPR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5706
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITPR2 KO
AC   CVCL_D9HM
SY   ITPR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5707
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ITPR3 KO
AC   CVCL_D9HN
SY   ITPR3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5708
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 JAG1 KO
AC   CVCL_D9HP
SY   JAG1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS937
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 JAG2 KO
AC   CVCL_D9HQ
SY   JAG2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS938
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6189; JAG2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 JAK1 KO
AC   CVCL_D9HR
SY   JAK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1016
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 JAK2 KO
AC   CVCL_D9HS
SY   JAK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1020
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 JUN KO
AC   CVCL_D9HT
SY   JUN Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1240
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KAT2B KO
AC   CVCL_D9HU
SY   KAT2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS939
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KCNMA1 KO
AC   CVCL_D9HV
SY   KCNMA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ037
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6284; KCNMA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KCTD5 KO
AC   CVCL_D9HW
SY   KCTD5 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN74718
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21423; KCTD5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KEAP1 KO
AC   CVCL_D9HX
SY   KEAP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13549
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KIAA0319L KO
AC   CVCL_D9HY
SY   KIAA0319L Knockout cell line (HEK293)
DR   Ubigene; YKO-H819
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30071; KIAA0319L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KIF24 KO
AC   CVCL_D9HZ
SY   KIF24 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN89780
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19916; KIF24.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KIT KO
AC   CVCL_D9I0
SY   KIT Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1242
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6342; KIT.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KLF4 KO
AC   CVCL_D9I1
SY   KLF4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10141
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6348; KLF4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KLHL20 KO
AC   CVCL_D9I2
SY   KLHL20 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1013
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25056; KLHL20.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KRAS KO
AC   CVCL_D9I3
SY   KRAS Knockout cell line (HEK293)
DR   Ubigene; YKO-H710
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H710; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 KSR1 KO
AC   CVCL_D9I4
SY   KSR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5553
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6465; KSR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LACTB KO
AC   CVCL_D9I5
SY   LACTB Knockout cell line (HEK293)
DR   Ubigene; YKO-H717
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16468; LACTB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LACTB2 KO
AC   CVCL_D9I6
SY   LACTB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1079
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18512; LACTB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LAMA3 KO
AC   CVCL_D9I7
SY   LAMA3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1417
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6483; LAMA3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LAMA4 KO
AC   CVCL_D9I8
SY   LAMA4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1418
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6484; LAMA4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LAMA5 KO
AC   CVCL_D9I9
SY   LAMA5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1419
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6485; LAMA5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LAMB1 KO
AC   CVCL_D9IA
SY   LAMB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1420
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6486; LAMB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LAMP1 KO
AC   CVCL_D9IB
SY   LAMP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1232
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6499; LAMP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LAMP2 KO
AC   CVCL_D9IC
SY   LAMP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H969
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LARP4 KO
AC   CVCL_D9ID
SY   LARP4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H056
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24320; LARP4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LATS1 KO
AC   CVCL_D9IE
SY   LATS1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5659
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LATS2 KO
AC   CVCL_D9IF
SY   LATS2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2180
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LDHA KO
AC   CVCL_D9IG
SY   LDHA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5825
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LEF1 KO
AC   CVCL_D9IH
SY   LEF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS799
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6551; LEF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LEPR KO
AC   CVCL_D9II
SY   LEPR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1023
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6554; LEPR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LGR4 KO
AC   CVCL_D9IJ
SY   LGR4 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN90042
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LGR5 KO
AC   CVCL_D9IK
SY   LGR5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS800
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4504; LGR5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LIF KO
AC   CVCL_D9IL
SY   LIF Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1024
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6596; LIF.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LIFR KO
AC   CVCL_D9IM
SY   LIFR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1025
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6597; LIFR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LPAR1 KO
AC   CVCL_D9IN
SY   LPAR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1427
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3166; LPAR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LPAR2 KO
AC   CVCL_D9IP
SY   LPAR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1428
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3168; LPAR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LPAR3 KO
AC   CVCL_D9IQ
SY   LPAR3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1429
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14298; LPAR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LPAR6 KO
AC   CVCL_D9IR
SY   LPAR6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6073
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15520; LPAR6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LRP1 KO
AC   CVCL_D9IS
SY   LRP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H655
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6692; LRP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LRP5 KO
AC   CVCL_D9IT
SY   LRP5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS801
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LRP6 KO
AC   CVCL_D9IU
SY   LRP6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS802
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6698; LRP6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LRRC8A KO
AC   CVCL_D9IV
SY   LRRC8A Knockout cell line (HEK293)
DR   Ubigene; YKO-H887
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19027; LRRC8A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LTBP1 KO
AC   CVCL_D9IW
SY   LTBP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS891
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6714; LTBP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 LYN KO
AC   CVCL_D9IX
SY   LYN Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1106
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAGI1 KO
AC   CVCL_D9IY
SY   MAGI1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1431
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:946; MAGI1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAGI2 KO
AC   CVCL_D9IZ
SY   MAGI2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1432
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18957; MAGI2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAGI3 KO
AC   CVCL_D9J0
SY   MAGI3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5589
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29647; MAGI3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MALT1 KO
AC   CVCL_D9J1
SY   MALT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1107
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAML2 KO
AC   CVCL_D9J2
SY   MAML2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS941
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16259; MAML2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP2K1 KO
AC   CVCL_D9J3
SY   MAP2K1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5444
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP2K3 KO
AC   CVCL_D9J4
SY   MAP2K3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1246
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP2K5 KO
AC   CVCL_D9J5
SY   MAP2K5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2207
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6845; MAP2K5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP2K6 KO
AC   CVCL_D9J6
SY   MAP2K6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5638
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6846; MAP2K6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP2K7 KO
AC   CVCL_D9J7
SY   MAP2K7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1248
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K1 KO
AC   CVCL_D9J8
SY   MAP3K1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1249
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K11 KO
AC   CVCL_D9J9
SY   MAP3K11 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1250
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6850; MAP3K11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K12 KO
AC   CVCL_D9JA
SY   MAP3K12 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1251
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6851; MAP3K12.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K13 KO
AC   CVCL_D9JB
SY   MAP3K13 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1252
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6852; MAP3K13.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K14 KO
AC   CVCL_D9JC
SY   MAP3K14 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1108
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K20 KO
AC   CVCL_D9JD
SY   MAP3K20 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1254
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17797; MAP3K20.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K4 KO
AC   CVCL_D9JE
SY   MAP3K4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1256
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6856; MAP3K4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K6 KO
AC   CVCL_D9JF
SY   MAP3K6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1258
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6858; MAP3K6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP3K7 KO
AC   CVCL_D9JG
SY   MAP3K7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1109
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP4K2 KO
AC   CVCL_D9JH
SY   MAP4K2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10132
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6864; MAP4K2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAP4K4 KO
AC   CVCL_D9JI
SY   MAP4K4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H458
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK1 KO
AC   CVCL_D9JJ
SY   MAPK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS892
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK10 KO
AC   CVCL_D9JK
SY   MAPK10 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1263
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6872; MAPK10.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK11 KO
AC   CVCL_D9JL
SY   MAPK11 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1264
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6873; MAPK11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK12 KO
AC   CVCL_D9JM
SY   MAPK12 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5639
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK13 KO
AC   CVCL_D9JN
SY   MAPK13 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1265
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6875; MAPK13.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK14 KO
AC   CVCL_D9JP
SY   MAPK14 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1266
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK8 KO
AC   CVCL_D9JQ
SY   MAPK8 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1268
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6881; MAPK8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK8IP1 KO
AC   CVCL_D9JR
SY   MAPK8IP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1269
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6882; MAPK8IP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK8IP2 KO
AC   CVCL_D9JS
SY   MAPK8IP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1270
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6883; MAPK8IP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPK8IP3 KO
AC   CVCL_D9JT
SY   MAPK8IP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1271
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6884; MAPK8IP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPKAPK3 KO
AC   CVCL_D9JU
SY   MAPKAPK3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1274
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6888; MAPKAPK3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPKAPK5 KO
AC   CVCL_D9JV
SY   MAPKAPK5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1275
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAPT KO
AC   CVCL_D9JW
SY   MAPT Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1276
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6893; MAPT.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MAVS KO
AC   CVCL_D9JX
SY   MAVS Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13667
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MCCC1 KO
AC   CVCL_D9JY
SY   MCCC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN90427
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6936; MCCC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MCL1 KO
AC   CVCL_D9JZ
SY   MCL1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1026
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6943; MCL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MCOLN1 KO
AC   CVCL_D9K0
SY   MCOLN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5961
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MCOLN2 KO
AC   CVCL_D9K1
SY   MCOLN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5962
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13357; MCOLN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MCOLN3 KO
AC   CVCL_D9K2
SY   MCOLN3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5963
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13358; MCOLN3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MDM2 KO
AC   CVCL_D9K3
SY   MDM2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1433
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6973; MDM2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MED23 KO
AC   CVCL_D9K4
SY   MED23 Knockout cell line (HEK293)
DR   Ubigene; YKO-H316
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2372; MED23.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MET KO
AC   CVCL_D9K5
SY   MET Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1279
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MFAP4 KO
AC   CVCL_D9K6
SY   MFAP4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H627
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7035; MFAP4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MFN1 KO
AC   CVCL_D9K7
SY   MFN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1071
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18262; MFN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MFNG KO
AC   CVCL_D9K8
SY   MFNG Knockout cell line (HEK293)
DR   Ubigene; YKO-HS942
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7038; MFNG.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MFSD1 KO
AC   CVCL_D9K9
SY   MFSD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN84478
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25874; MFSD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MICAL1 KO
AC   CVCL_D9KA
SY   MICAL1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN81022
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20619; MICAL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MINDY1 KO
AC   CVCL_D9KB
SY   MINDY1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS13125
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25648; MINDY1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MKNK1 KO
AC   CVCL_D9KC
SY   MKNK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5785
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MKNK2 KO
AC   CVCL_D9KD
SY   MKNK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5786
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MKRN1 KO
AC   CVCL_D9KE
SY   MKRN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN49754
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7112; MKRN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MLXIP KO
AC   CVCL_D9KF
SY   MLXIP Knockout cell line (HEK293)
DR   Ubigene; YKO-XN48010
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17055; MLXIP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MME KO
AC   CVCL_D9KG
SY   MME Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1714
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7154; MME.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MMP11 KO
AC   CVCL_D9KH
SY   MMP11 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08163
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7157; MMP11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MMP3 KO
AC   CVCL_D9KI
SY   MMP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H750
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7173; MMP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MMP9 KO
AC   CVCL_D9KJ
SY   MMP9 Knockout cell line (HEK293)
DR   Ubigene; YKO-H749
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7176; MMP9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MOB1A KO
AC   CVCL_D9KK
SY   MOB1A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5660
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16015; MOB1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MOB1B KO
AC   CVCL_D9KL
SY   MOB1B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5661
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29801; MOB1B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MPHOSPH6 KO
AC   CVCL_D9KM
SY   MPHOSPH6 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN96669
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7214; MPHOSPH6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MPHOSPH8 KO
AC   CVCL_D9KN
SY   MPHOSPH8 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN90684
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29810; MPHOSPH8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MSH6 KO
AC   CVCL_D9KP
SY   MSH6 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN27274
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MTHFD1 KO
AC   CVCL_D9KQ
SY   MTHFD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H658
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7432; MTHFD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MTO1 KO
AC   CVCL_D9KR
SY   MTO1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN50930
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19261; MTO1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MTX3 KO
AC   CVCL_D9KS
SY   MTX3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H395
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24812; MTX3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MYC KO
AC   CVCL_D9KT
SY   MYC Knockout cell line (HEK293)
DR   Ubigene; YKO-H244
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7553; MYC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MYD88 KO
AC   CVCL_D9KU
SY   MYD88 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1110
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MYLK KO
AC   CVCL_D9KV
SY   MYLK Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5719
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7590; MYLK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 MYO19 KO
AC   CVCL_D9KW
SY   MYO19 Knockout cell line (HEK293)
DR   Ubigene; YKO-H808
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26234; MYO19.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NAGLU KO
AC   CVCL_D9KX
SY   NAGLU Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11139
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7632; NAGLU.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NBR1 KO
AC   CVCL_D9KY
SY   NBR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11372
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6746; NBR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NCAM1 KO
AC   CVCL_D9KZ
SY   NCAM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1645
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7656; NCAM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NCOR2 KO
AC   CVCL_D9L0
SY   NCOR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS943
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7673; NCOR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NCSTN KO
AC   CVCL_D9L1
SY   NCSTN Knockout cell line (HEK293)
DR   Ubigene; YKO-HS944
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NDUFAF6 KO
AC   CVCL_D9L2
SY   NDUFAF6 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN60806
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28625; NDUFAF6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NDUFB7 KO
AC   CVCL_D9L3
SY   NDUFB7 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN31714
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7702; NDUFB7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NDUFS2 KO
AC   CVCL_D9L4
SY   NDUFS2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN31778
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7708; NDUFS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NDUFS8 KO
AC   CVCL_D9L5
SY   NDUFS8 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN31750
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7715; NDUFS8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NF1 KO
AC   CVCL_D9L6
SY   NF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H466
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NFE2L2 KO
AC   CVCL_D9L7
SY   NFE2L2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN91079
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NFKB1 KO
AC   CVCL_D9L8
SY   NFKB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1111
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NFKB2 KO
AC   CVCL_D9L9
SY   NFKB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1112
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NFKBIA KO
AC   CVCL_D9LA
SY   NFKBIA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1113
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NKD1 KO
AC   CVCL_D9LB
SY   NKD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS807
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17045; NKD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NLN KO
AC   CVCL_D9LC
SY   NLN Knockout cell line (HEK293)
DR   Ubigene; YKO-H1080
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16058; NLN.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NMT1 KO
AC   CVCL_D9LD
SY   NMT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN32014
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7857; NMT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOTCH1 KO
AC   CVCL_D9LE
SY   NOTCH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS945
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOTCH2 KO
AC   CVCL_D9LF
SY   NOTCH2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS946
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOTCH3 KO
AC   CVCL_D9LG
SY   NOTCH3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS947
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOVA1 KO
AC   CVCL_D9LH
SY   NOVA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H284
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7886; NOVA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOVA2 KO
AC   CVCL_D9LI
SY   NOVA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H354
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7887; NOVA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOX1 KO
AC   CVCL_D9LJ
SY   NOX1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN53962
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7889; NOX1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOX4 KO
AC   CVCL_D9LK
SY   NOX4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H461
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7891; NOX4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NOX5 KO
AC   CVCL_D9LL
SY   NOX5 Knockout cell line (HEK293)
DR   Ubigene; YKO-H460
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14874; NOX5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NR4A1 KO
AC   CVCL_D9LM
SY   NR4A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1287
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NRAS KO
AC   CVCL_D9LN
SY   NRAS Knockout cell line (HEK293)
DR   Ubigene; YKO-H773
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7989; NRAS.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H773; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NRP2 KO
AC   CVCL_D9LP
SY   NRP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN40426
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8005; NRP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NSUN2 KO
AC   CVCL_D9LQ
SY   NSUN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H962
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NUMA1 KO
AC   CVCL_D9LR
SY   NUMA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H939
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8059; NUMA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NUMB KO
AC   CVCL_D9LS
SY   NUMB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS949
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 NUMBL KO
AC   CVCL_D9LT
SY   NUMBL Knockout cell line (HEK293)
DR   Ubigene; YKO-HS950
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8061; NUMBL.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 OFD1 KO
AC   CVCL_D9LU
SY   OFD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H980
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2567; OFD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 OMA1 KO
AC   CVCL_D9LV
SY   OMA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1107
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29661; OMA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ORAI1 KO
AC   CVCL_D9LW
SY   ORAI1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5897
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25896; ORAI1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 OSMR KO
AC   CVCL_D9LX
SY   OSMR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1030
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8507; OSMR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 OXCT1 KO
AC   CVCL_D9LY
SY   OXCT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H694
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8527; OXCT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 OXTR KO
AC   CVCL_D9LZ
SY   OXTR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5927
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8529; OXTR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 P2RX2 KO
AC   CVCL_D9M0
SY   P2RX2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5901
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15459; P2RX2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 P2RX4 KO
AC   CVCL_D9M1
SY   P2RX4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5903
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8535; P2RX4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 P2RX5 KO
AC   CVCL_D9M2
SY   P2RX5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5904
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8536; P2RX5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 P2RY1 KO
AC   CVCL_D9M3
SY   P2RY1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5568
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8539; P2RY1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PACC1 KO
AC   CVCL_D9M4
SY   PACC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H052
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25593; PACC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PACSIN2 KO
AC   CVCL_D9M5
SY   PACSIN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08637
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8571; PACSIN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PAK1 KO
AC   CVCL_D9M6
SY   PAK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1292
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8590; PAK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PAK2 KO
AC   CVCL_D9M7
SY   PAK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1293
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8591; PAK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PAK4 KO
AC   CVCL_D9M8
SY   PAK4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5510
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PAK6 KO
AC   CVCL_D9M9
SY   PAK6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ110
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16061; PAK6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PARL KO
AC   CVCL_D9MA
SY   PARL Knockout cell line (HEK293)
DR   Ubigene; YKO-H1077
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18253; PARL.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PARP1 KO
AC   CVCL_D9MB
SY   PARP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2159
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PASK KO
AC   CVCL_D9MC
SY   PASK Knockout cell line (HEK293)
DR   Ubigene; YKO-XN48730
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17270; PASK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PC KO
AC   CVCL_D9MD
SY   PC Knockout cell line (HEK293)
DR   Ubigene; YKO-H531
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8636; PC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PDCD10 KO
AC   CVCL_D9ME
SY   PDCD10 Knockout cell line (HEK293)
DR   Ubigene; YKO-H945
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8761; PDCD10.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PDCD5 KO
AC   CVCL_D9MF
SY   PDCD5 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN40998
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8764; PDCD5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PDGFRA KO
AC   CVCL_D9MG
SY   PDGFRA Knockout cell line (HEK293)
DR   Ubigene; YKO-XN91844
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8803; PDGFRA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PDHA1 KO
AC   CVCL_D9MH
SY   PDHA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN96685
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8806; PDHA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PDK1 KO
AC   CVCL_D9MI
SY   PDK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5804
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8809; PDK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PDK4 KO
AC   CVCL_D9MJ
SY   PDK4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2091
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8812; PDK4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PFKFB1 KO
AC   CVCL_D9MK
SY   PFKFB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6236
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8872; PFKFB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PFKFB2 KO
AC   CVCL_D9ML
SY   PFKFB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2124
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8873; PFKFB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PFKFB3 KO
AC   CVCL_D9MM
SY   PFKFB3 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN91905
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PFKFB4 KO
AC   CVCL_D9MN
SY   PFKFB4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6237
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8875; PFKFB4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PHF20 KO
AC   CVCL_D9MP
SY   PHF20 Knockout cell line (HEK293)
DR   Ubigene; YKO-H950
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16098; PHF20.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PHKA1 KO
AC   CVCL_D9MQ
SY   PHKA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5979
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8925; PHKA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PHKA2 KO
AC   CVCL_D9MR
SY   PHKA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5978
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8926; PHKA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PHKB KO
AC   CVCL_D9MS
SY   PHKB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5977
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8927; PHKB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PHKG1 KO
AC   CVCL_D9MT
SY   PHKG1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5975
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8930; PHKG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PHKG2 KO
AC   CVCL_D9MU
SY   PHKG2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5976
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8931; PHKG2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PI4K2A KO
AC   CVCL_D9MV
SY   PI4K2A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5992
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PI4K2B KO
AC   CVCL_D9MW
SY   PI4K2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5993
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PI4KB KO
AC   CVCL_D9MX
SY   PI4KB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5991
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIAS1 KO
AC   CVCL_D9MY
SY   PIAS1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1032
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2752; PIAS1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIAS2 KO
AC   CVCL_D9MZ
SY   PIAS2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1033
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17311; PIAS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIAS3 KO
AC   CVCL_D9N0
SY   PIAS3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1034
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16861; PIAS3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIAS4 KO
AC   CVCL_D9N1
SY   PIAS4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1114
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17002; PIAS4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PICALM KO
AC   CVCL_D9N2
SY   PICALM Knockout cell line (HEK293)
DR   Ubigene; YKO-XN91970
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15514; PICALM.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIGO KO
AC   CVCL_D9N3
SY   PIGO Knockout cell line (HEK293)
DR   Ubigene; YKO-H534
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23215; PIGO.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3AP1 KO
AC   CVCL_D9N4
SY   PIK3AP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1440
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30034; PIK3AP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3C2A KO
AC   CVCL_D9N5
SY   PIK3C2A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6022
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3C2B KO
AC   CVCL_D9N6
SY   PIK3C2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6023
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8972; PIK3C2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3CA KO
AC   CVCL_D9N7
SY   PIK3CA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1035
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8975; PIK3CA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3CB KO
AC   CVCL_D9N8
SY   PIK3CB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1036
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8976; PIK3CB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3R1 KO
AC   CVCL_D9N9
SY   PIK3R1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1038
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3R2 KO
AC   CVCL_D9NA
SY   PIK3R2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1039
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIK3R3 KO
AC   CVCL_D9NB
SY   PIK3R3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5446
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8981; PIK3R3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIKFYVE KO
AC   CVCL_D9NC
SY   PIKFYVE Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6007
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23785; PIKFYVE.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIM1 KO
AC   CVCL_D9ND
SY   PIM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92025
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PINK1 KO
AC   CVCL_D9NE
SY   PINK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1041
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14581; PINK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIP4K2A KO
AC   CVCL_D9NF
SY   PIP4K2A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6017
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIP4K2B KO
AC   CVCL_D9NG
SY   PIP4K2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6018
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIP4K2C KO
AC   CVCL_D9NH
SY   PIP4K2C Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6016
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIP5K1A KO
AC   CVCL_D9NI
SY   PIP5K1A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5997
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIP5K1B KO
AC   CVCL_D9NJ
SY   PIP5K1B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5998
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8995; PIP5K1B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PIP5K1C KO
AC   CVCL_D9NK
SY   PIP5K1C Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5996
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PJA2 KO
AC   CVCL_D9NL
SY   PJA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1112
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17481; PJA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PKD1 KO
AC   CVCL_D9NM
SY   PKD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92045
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PKN1 KO
AC   CVCL_D9NN
SY   PKN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1444
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PKN2 KO
AC   CVCL_D9NP
SY   PKN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1445
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PKN3 KO
AC   CVCL_D9NQ
SY   PKN3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1446
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17999; PKN3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PLA2G4A KO
AC   CVCL_D9NR
SY   PLA2G4A Knockout cell line (HEK293)
DR   Ubigene; YKO-H1015
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PLCG1 KO
AC   CVCL_D9NS
SY   PLCG1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1116
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PLCG2 KO
AC   CVCL_D9NT
SY   PLCG2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1117
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9066; PLCG2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PLK2 KO
AC   CVCL_D9NU
SY   PLK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5856
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PLK3 KO
AC   CVCL_D9NV
SY   PLK3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5857
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2154; PLK3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PNPO KO
AC   CVCL_D9NW
SY   PNPO Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10656
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30260; PNPO.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 POLB KO
AC   CVCL_D9NX
SY   POLB Knockout cell line (HEK293)
DR   Ubigene; YKO-XN33274
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9174; POLB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 POLQ KO
AC   CVCL_D9NY
SY   POLQ Knockout cell line (HEK293)
DR   Ubigene; YKO-XN44574
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9186; POLQ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 POT1 KO
AC   CVCL_D9NZ
SY   POT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H715
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17284; POT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPA2 KO
AC   CVCL_D9P0
SY   PPA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN54014
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28883; PPA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPARA KO
AC   CVCL_D9P1
SY   PPARA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6175
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPARD KO
AC   CVCL_D9P2
SY   PPARD Knockout cell line (HEK293)
DR   Ubigene; YKO-HS813
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9235; PPARD.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPARG KO
AC   CVCL_D9P3
SY   PPARG Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2217
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPIP5K2 KO
AC   CVCL_D9P4
SY   PPIP5K2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6032
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29035; PPIP5K2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPP2R5B KO
AC   CVCL_D9P5
SY   PPP2R5B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1451
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9310; PPP2R5B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPP2R5C KO
AC   CVCL_D9P6
SY   PPP2R5C Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1452
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9311; PPP2R5C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPP2R5D KO
AC   CVCL_D9P7
SY   PPP2R5D Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1453
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9312; PPP2R5D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPP3CA KO
AC   CVCL_D9P8
SY   PPP3CA Knockout cell line (HEK293)
DR   Ubigene; YKO-H999
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9314; PPP3CA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPP3CB KO
AC   CVCL_D9P9
SY   PPP3CB Knockout cell line (HEK293)
DR   Ubigene; YKO-H1000
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9315; PPP3CB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PPP5C KO
AC   CVCL_D9PA
SY   PPP5C Knockout cell line (HEK293)
DR   Ubigene; YKO-H737
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9322; PPP5C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRICKLE1 KO
AC   CVCL_D9PB
SY   PRICKLE1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS814
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKAA1 KO
AC   CVCL_D9PC
SY   PRKAA1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H961
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKAA2 KO
AC   CVCL_D9PD
SY   PRKAA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1456
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKAB1 KO
AC   CVCL_D9PE
SY   PRKAB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5735
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKAB2 KO
AC   CVCL_D9PF
SY   PRKAB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5736
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9379; PRKAB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKACA KO
AC   CVCL_D9PG
SY   PRKACA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1307
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9380; PRKACA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKACB KO
AC   CVCL_D9PH
SY   PRKACB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5485
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKAG1 KO
AC   CVCL_D9PI
SY   PRKAG1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5737
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKAG2 KO
AC   CVCL_D9PJ
SY   PRKAG2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5739
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9386; PRKAG2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKCA KO
AC   CVCL_D9PK
SY   PRKCA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS816
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9393; PRKCA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKCB KO
AC   CVCL_D9PL
SY   PRKCB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1118
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9395; PRKCB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKCE KO
AC   CVCL_D9PM
SY   PRKCE Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5714
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKCI KO
AC   CVCL_D9PN
SY   PRKCI Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5631
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKCQ KO
AC   CVCL_D9PP
SY   PRKCQ Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1119
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9410; PRKCQ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKCZ KO
AC   CVCL_D9PQ
SY   PRKCZ Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5630
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKD1 KO
AC   CVCL_D9PR
SY   PRKD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5594
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9407; PRKD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKD2 KO
AC   CVCL_D9PS
SY   PRKD2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5596
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKD3 KO
AC   CVCL_D9PT
SY   PRKD3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5595
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKDC KO
AC   CVCL_D9PU
SY   PRKDC Knockout cell line (HEK293)
DR   Ubigene; YKO-H609
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9413; PRKDC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PRKG1 KO
AC   CVCL_D9PV
SY   PRKG1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6214
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9414; PRKG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PSAP KO
AC   CVCL_D9PW
SY   PSAP Knockout cell line (HEK293)
DR   Ubigene; YKO-H772
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9498; PSAP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PSEN1 KO
AC   CVCL_D9PX
SY   PSEN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS817
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9508; PSEN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PSEN2 KO
AC   CVCL_D9PY
SY   PSEN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS951
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9509; PSEN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTCH2 KO
AC   CVCL_D9PZ
SY   PTCH2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1510
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9586; PTCH2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTGER2 KO
AC   CVCL_D9Q0
SY   PTGER2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6130
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9594; PTGER2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTK2 KO
AC   CVCL_D9Q1
SY   PTK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2080
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTK2B KO
AC   CVCL_D9Q2
SY   PTK2B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5986
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTPN1 KO
AC   CVCL_D9Q3
SY   PTPN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS09440
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9642; PTPN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTPN2 KO
AC   CVCL_D9Q4
SY   PTPN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1042
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PTPN6 KO
AC   CVCL_D9Q5
SY   PTPN6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1043
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PVR KO
AC   CVCL_D9Q6
SY   PVR Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10419
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9705; PVR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 PYCR3 KO
AC   CVCL_D9Q7
SY   PYCR3 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92516
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25846; PYCR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RAD54L KO
AC   CVCL_D9Q8
SY   RAD54L Knockout cell line (HEK293)
DR   Ubigene; YKO-H747
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9826; RAD54L.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RAF1 KO
AC   CVCL_D9Q9
SY   RAF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H560
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H560; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RASA2 KO
AC   CVCL_D9QA
SY   RASA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1316
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9872; RASA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RASGRP1 KO
AC   CVCL_D9QB
SY   RASGRP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H376
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9878; RASGRP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RBM15B KO
AC   CVCL_D9QC
SY   RBM15B Knockout cell line (HEK293)
DR   Ubigene; YKO-XN58766
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24303; RBM15B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RBPJ KO
AC   CVCL_D9QD
SY   RBPJ Knockout cell line (HEK293)
DR   Ubigene; YKO-HS952
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5724; RBPJ.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RELA KO
AC   CVCL_D9QE
SY   RELA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1121
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RGMB KO
AC   CVCL_D9QF
SY   RGMB Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92779
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26896; RGMB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RHOT1 KO
AC   CVCL_D9QG
SY   RHOT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92802
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21168; RHOT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RICTOR KO
AC   CVCL_D9QH
SY   RICTOR Knockout cell line (HEK293)
DR   Ubigene; YKO-H611
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28611; RICTOR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RIGI KO
AC   CVCL_D9QI
SY   RIGI Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92830
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RIPK1 KO
AC   CVCL_D9QJ
SY   RIPK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1123
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RIPK2 KO
AC   CVCL_D9QK
SY   RIPK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN40314
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10020; RIPK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RIPK3 KO
AC   CVCL_D9QL
SY   RIPK3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H918
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10021; RIPK3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RMC1 KO
AC   CVCL_D9QM
SY   RMC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN92864
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24326; RMC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RNASEH1 KO
AC   CVCL_D9QN
SY   RNASEH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN75706
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18466; RNASEH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RNF123 KO
AC   CVCL_D9QP
SY   RNF123 Knockout cell line (HEK293)
DR   Ubigene; YKO-H157
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21148; RNF123.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RNF125 KO
AC   CVCL_D9QQ
SY   RNF125 Knockout cell line (HEK293)
DR   Ubigene; YKO-H057
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21150; RNF125.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RNF135 KO
AC   CVCL_D9QR
SY   RNF135 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN66318
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21158; RNF135.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RNF149 KO
AC   CVCL_D9QS
SY   RNF149 Knockout cell line (HEK293)
DR   Ubigene; YKO-H977
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23137; RNF149.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RNF181 KO
AC   CVCL_D9QT
SY   RNF181 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1051
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28037; RNF181.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ROR2 KO
AC   CVCL_D9QU
SY   ROR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS821
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RORA KO
AC   CVCL_D9QV
SY   RORA Knockout cell line (HEK293)
DR   Ubigene; YKO-H878
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10258; RORA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RPS6KA2 KO
AC   CVCL_D9QW
SY   RPS6KA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1324
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10431; RPS6KA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RPS6KA4 KO
AC   CVCL_D9QX
SY   RPS6KA4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1326
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10433; RPS6KA4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RPS6KA5 KO
AC   CVCL_D9QY
SY   RPS6KA5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1327
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10434; RPS6KA5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RPS6KA6 KO
AC   CVCL_D9QZ
SY   RPS6KA6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1328
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10435; RPS6KA6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RPS6KB1 KO
AC   CVCL_D9R0
SY   RPS6KB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS903
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10436; RPS6KB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RPS6KB2 KO
AC   CVCL_D9R1
SY   RPS6KB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS904
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10437; RPS6KB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RTCB KO
AC   CVCL_D9R2
SY   RTCB Knockout cell line (HEK293)
DR   Ubigene; YKO-XN72166
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26935; RTCB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RTN4 KO
AC   CVCL_D9R3
SY   RTN4 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN80150
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14085; RTN4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RXRA KO
AC   CVCL_D9R4
SY   RXRA Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1462
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 RYR2 KO
AC   CVCL_D9R5
SY   RYR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5710
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10484; RYR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 S1PR1 KO
AC   CVCL_D9R6
SY   S1PR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2086
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 S1PR2 KO
AC   CVCL_D9R7
SY   S1PR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6116
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3169; S1PR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 S1PR3 KO
AC   CVCL_D9R8
SY   S1PR3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2087
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3167; S1PR3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 S1PR5 KO
AC   CVCL_D9R9
SY   S1PR5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS6117
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14299; S1PR5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SAMHD1 KO
AC   CVCL_D9RA
SY   SAMHD1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1036
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15925; SAMHD1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SCARF1 KO
AC   CVCL_D9RB
SY   SCARF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H849
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16820; SCARF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SDC1 KO
AC   CVCL_D9RC
SY   SDC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1641
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10658; SDC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SEC24C KO
AC   CVCL_D9RD
SY   SEC24C Knockout cell line (HEK293)
DR   Ubigene; YKO-H960
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10705; SEC24C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SELENOI KO
AC   CVCL_D9RE
SY   SELENOI Knockout cell line (HEK293)
DR   Ubigene; YKO-XN68074
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29361; SELENOI.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SENP2 KO
AC   CVCL_D9RF
SY   SENP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS825
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23116; SENP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SERPINE1 KO
AC   CVCL_D9RG
SY   SERPINE1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2011
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SERPINF1 KO
AC   CVCL_D9RH
SY   SERPINF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS826
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8824; SERPINF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SGK1 KO
AC   CVCL_D9RI
SY   SGK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1463
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SH3BP4 KO
AC   CVCL_D9RJ
SY   SH3BP4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ039
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10826; SH3BP4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SHMT2 KO
AC   CVCL_D9RK
SY   SHMT2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2122
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SIGMAR1 KO
AC   CVCL_D9RL
SY   SIGMAR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H958
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8157; SIGMAR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SIRT1 KO
AC   CVCL_D9RM
SY   SIRT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2232
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14929; SIRT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SKP2 KO
AC   CVCL_D9RN
SY   SKP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5415
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC15A4 KO
AC   CVCL_D9RP
SY   SLC15A4 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN48866
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC1A5 KO
AC   CVCL_D9RQ
SY   SLC1A5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ019
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10943; SLC1A5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC25A13 KO
AC   CVCL_D9RR
SY   SLC25A13 Knockout cell line (HEK293)
DR   Ubigene; YKO-H742
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10983; SLC25A13.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC25A4 KO
AC   CVCL_D9RS
SY   SLC25A4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5968
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10990; SLC25A4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC25A42 KO
AC   CVCL_D9RT
SY   SLC25A42 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10610
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28380; SLC25A42.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC25A5 KO
AC   CVCL_D9RU
SY   SLC25A5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5969
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC29A1 KO
AC   CVCL_D9RV
SY   SLC29A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1135
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11003; SLC29A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC29A2 KO
AC   CVCL_D9RW
SY   SLC29A2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1136
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11004; SLC29A2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC2A1 KO
AC   CVCL_D9RX
SY   SLC2A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H765
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC30A9 KO
AC   CVCL_D9RY
SY   SLC30A9 Knockout cell line (HEK293)
DR   Ubigene; YKO-H827
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1329; SLC30A9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC33A1 KO
AC   CVCL_D9RZ
SY   SLC33A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN41074
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:95; SLC33A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC38A9 KO
AC   CVCL_D9S0
SY   SLC38A9 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5379
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC3A2 KO
AC   CVCL_D9S1
SY   SLC3A2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1693
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC6A6 KO
AC   CVCL_D9S2
SY   SLC6A6 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN35806
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11052; SLC6A6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC6A8 KO
AC   CVCL_D9S3
SY   SLC6A8 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN35822
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11055; SLC6A8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC7A5 KO
AC   CVCL_D9S4
SY   SLC7A5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12629
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC8A1 KO
AC   CVCL_D9S5
SY   SLC8A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5716
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11068; SLC8A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC9A1 KO
AC   CVCL_D9S6
SY   SLC9A1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5715
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SLC9B2 KO
AC   CVCL_D9S7
SY   SLC9B2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H043
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25143; SLC9B2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMAD4 KO
AC   CVCL_D9S8
SY   SMAD4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS907
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMAD5 KO
AC   CVCL_D9S9
SY   SMAD5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS908
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMAD6 KO
AC   CVCL_D9SA
SY   SMAD6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS909
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6772; SMAD6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMAD7 KO
AC   CVCL_D9SB
SY   SMAD7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS910
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMAD9 KO
AC   CVCL_D9SC
SY   SMAD9 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS911
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6774; SMAD9.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMO KO
AC   CVCL_D9SD
SY   SMO Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1512
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMURF1 KO
AC   CVCL_D9SE
SY   SMURF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS912
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SMURF2 KO
AC   CVCL_D9SF
SY   SMURF2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS913
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SND1 KO
AC   CVCL_D9SG
SY   SND1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN53978
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30646; SND1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOCS2 KO
AC   CVCL_D9SH
SY   SOCS2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1044
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19382; SOCS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOCS3 KO
AC   CVCL_D9SI
SY   SOCS3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1045
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOCS4 KO
AC   CVCL_D9SJ
SY   SOCS4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1046
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOCS5 KO
AC   CVCL_D9SK
SY   SOCS5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1047
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16852; SOCS5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOCS6 KO
AC   CVCL_D9SL
SY   SOCS6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1048
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16833; SOCS6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOCS7 KO
AC   CVCL_D9SM
SY   SOCS7 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1049
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29846; SOCS7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SORD KO
AC   CVCL_D9SN
SY   SORD Knockout cell line (HEK293)
DR   Ubigene; YKO-XN36074
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11184; SORD.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SORT1 KO
AC   CVCL_D9SP
SY   SORT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1130
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11186; SORT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOS1 KO
AC   CVCL_D9SQ
SY   SOS1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1050
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOS2 KO
AC   CVCL_D9SR
SY   SOS2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1051
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11188; SOS2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SOX2 KO
AC   CVCL_D9SS
SY   SOX2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1021
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11195; SOX2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Ubigene; YKO-H1021; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SP1 KO
AC   CVCL_D9ST
SY   SP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H741
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SPAST KO
AC   CVCL_D9SU
SY   SPAST Knockout cell line (HEK293)
DR   Ubigene; YKO-XN36138
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11233; SPAST.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SPHK1 KO
AC   CVCL_D9SV
SY   SPHK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2160
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SPHK2 KO
AC   CVCL_D9SW
SY   SPHK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5699
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SPPL3 KO
AC   CVCL_D9SX
SY   SPPL3 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN49946
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30424; SPPL3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SQSTM1 KO
AC   CVCL_D9SZ
SY   SQSTM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H433
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SRC KO
AC   CVCL_D9T0
SY   SRC Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5621
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SREBF2 KO
AC   CVCL_D9T1
SY   SREBF2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H745
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11290; SREBF2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ST3GAL1 KO
AC   CVCL_D9T2
SY   ST3GAL1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN35694
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10862; ST3GAL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAG2 KO
AC   CVCL_D9T3
SY   STAG2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12736
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11355; STAG2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAM KO
AC   CVCL_D9T4
SY   STAM Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1052
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11357; STAM.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAM2 KO
AC   CVCL_D9T5
SY   STAM2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1053
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11358; STAM2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAT1 KO
AC   CVCL_D9T6
SY   STAT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H386
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAT2 KO
AC   CVCL_D9T7
SY   STAT2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1055
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAT3 KO
AC   CVCL_D9T8
SY   STAT3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5782
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAT4 KO
AC   CVCL_D9T9
SY   STAT4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1056
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11365; STAT4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAT5B KO
AC   CVCL_D9TA
SY   STAT5B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1058
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STAT6 KO
AC   CVCL_D9TB
SY   STAT6 Knockout cell line (HEK293)
DR   Ubigene; YKO-H681
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STK11 KO
AC   CVCL_D9TC
SY   STK11 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1466
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STK3 KO
AC   CVCL_D9TD
SY   STK3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1331
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11406; STK3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STK4 KO
AC   CVCL_D9TE
SY   STK4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5506
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STT3A KO
AC   CVCL_D9TF
SY   STT3A Knockout cell line (HEK293)
DR   Ubigene; YKO-H894
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6172; STT3A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STUB1 KO
AC   CVCL_D9TG
SY   STUB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H719
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11427; STUB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STYX KO
AC   CVCL_D9TH
SY   STYX Knockout cell line (HEK293)
DR   Ubigene; YKO-H683
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11447; STYX.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STYXL1 KO
AC   CVCL_D9TI
SY   STYXL1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H685
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18165; STYXL1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 STYXL2 KO
AC   CVCL_D9TJ
SY   STYXL2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H687
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25034; STYXL2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SUCLA2 KO
AC   CVCL_D9TK
SY   SUCLA2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H628
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11448; SUCLA2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SUCLG1 KO
AC   CVCL_D9TL
SY   SUCLG1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H872
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11449; SUCLG1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SUFU KO
AC   CVCL_D9TM
SY   SUFU Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1514
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16466; SUFU.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SURF1 KO
AC   CVCL_D9TN
SY   SURF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN83738
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11474; SURF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SYK KO
AC   CVCL_D9TP
SY   SYK Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1124
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11491; SYK.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SYT7 KO
AC   CVCL_D9TQ
SY   SYT7 Knockout cell line (HEK293)
DR   Ubigene; YKO-H963
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11514; SYT7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 SYVN1 KO
AC   CVCL_D9TR
SY   SYVN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2176
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20738; SYVN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TAB1 KO
AC   CVCL_D9TS
SY   TAB1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1125
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TAB2 KO
AC   CVCL_D9TT
SY   TAB2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1126
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TAB3 KO
AC   CVCL_D9TU
SY   TAB3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1127
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30681; TAB3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TAOK1 KO
AC   CVCL_D9TV
SY   TAOK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN94302
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29259; TAOK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TAPT1 KO
AC   CVCL_D9TW
SY   TAPT1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H798
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26887; TAPT1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TASOR KO
AC   CVCL_D9TX
SY   TASOR Knockout cell line (HEK293)
DR   Ubigene; YKO-XN48998
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30314; TASOR.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TBK1 KO
AC   CVCL_D9TY
SY   TBK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H457
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TBL1XR1 KO
AC   CVCL_D9TZ
SY   TBL1XR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS831
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29529; TBL1XR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TBXA2R KO
AC   CVCL_D9U0
SY   TBXA2R Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5940
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11608; TBXA2R.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TCF4 KO
AC   CVCL_D9U1
SY   TCF4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS09137
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11634; TCF4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TCF7L2 KO
AC   CVCL_D9U2
SY   TCF7L2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS835
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11641; TCF7L2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TFDP1 KO
AC   CVCL_D9U3
SY   TFDP1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS915
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TFRC KO
AC   CVCL_D9U4
SY   TFRC Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5800
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11763; TFRC.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TGFBR1 KO
AC   CVCL_D9U5
SY   TGFBR1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1338
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TGFBR2 KO
AC   CVCL_D9U6
SY   TGFBR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1339
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TGIF1 KO
AC   CVCL_D9U7
SY   TGIF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS916
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11776; TGIF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 THRB KO
AC   CVCL_D9U8
SY   THRB Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10377
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11799; THRB.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TICAM1 KO
AC   CVCL_D9U9
SY   TICAM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1128
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TIRAP KO
AC   CVCL_D9UA
SY   TIRAP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1129
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17192; TIRAP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TLE1 KO
AC   CVCL_D9UB
SY   TLE1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H738
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11837; TLE1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TLE4 KO
AC   CVCL_D9UC
SY   TLE4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS839
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11840; TLE4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TLR2 KO
AC   CVCL_D9UD
SY   TLR2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H820
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TMEM175 KO
AC   CVCL_D9UE
SY   TMEM175 Knockout cell line (HEK293)
DR   Ubigene; YKO-H933
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TMEM187 KO
AC   CVCL_D9UF
SY   TMEM187 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ032
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13705; TMEM187.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TMEM250 KO
AC   CVCL_D9UG
SY   TMEM250 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS12889
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31009; TMEM250.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TMEM97 KO
AC   CVCL_D9UH
SY   TMEM97 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN54662
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28106; TMEM97.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TNFAIP3 KO
AC   CVCL_D9UI
SY   TNFAIP3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1131
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TNFRSF10D KO
AC   CVCL_D9UJ
SY   TNFRSF10D Knockout cell line (HEK293)
DR   Ubigene; YKO-H848
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11907; TNFRSF10D.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TNFRSF13C KO
AC   CVCL_D9UK
SY   TNFRSF13C Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1132
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17755; TNFRSF13C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TNFRSF1A KO
AC   CVCL_D9UL
SY   TNFRSF1A Knockout cell line (HEK293)
DR   Ubigene; YKO-H375
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TOLLIP KO
AC   CVCL_D9UM
SY   TOLLIP Knockout cell line (HEK293)
DR   Ubigene; YKO-XN74790
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16476; TOLLIP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TP53 KO
AC   CVCL_D9UN
SY   TP53 Knockout cell line (HEK293)
DR   Ubigene; YKO-H177
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TPCN1 KO
AC   CVCL_D9UP
SY   TPCN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5959
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18182; TPCN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TPCN2 KO
AC   CVCL_D9UQ
SY   TPCN2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5960
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TPH1 KO
AC   CVCL_D9UR
SY   TPH1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1128
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12008; TPH1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRADD KO
AC   CVCL_D9US
SY   TRADD Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1137
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRAF2 KO
AC   CVCL_D9UT
SY   TRAF2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1139
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12032; TRAF2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRAF3 KO
AC   CVCL_D9UU
SY   TRAF3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1140
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRAF5 KO
AC   CVCL_D9UV
SY   TRAF5 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1141
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRAF6 KO
AC   CVCL_D9UW
SY   TRAF6 Knockout cell line (HEK293)
DR   Ubigene; YKO-HJ093
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRIM21 KO
AC   CVCL_D9UX
SY   TRIM21 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2120
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRIM25 KO
AC   CVCL_D9UY
SY   TRIM25 Knockout cell line (HEK293)
DR   Ubigene; YKO-H758
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRIM4 KO
AC   CVCL_D9UZ
SY   TRIM4 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN68734
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16275; TRIM4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRPM3 KO
AC   CVCL_D9V0
SY   TRPM3 Knockout cell line (HEK293)
DR   Ubigene; YKO-H107
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17992; TRPM3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TRPM4 KO
AC   CVCL_D9V1
SY   TRPM4 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2156
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17993; TRPM4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TSC1 KO
AC   CVCL_D9V2
SY   TSC1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1476
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12362; TSC1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TSC2 KO
AC   CVCL_D9V3
SY   TSC2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1477
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TSLP KO
AC   CVCL_D9V4
SY   TSLP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1061
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30743; TSLP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TSPYL2 KO
AC   CVCL_D9V5
SY   TSPYL2 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN80550
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24358; TSPYL2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TTC7B KO
AC   CVCL_D9V6
SY   TTC7B Knockout cell line (HEK293)
DR   Ubigene; YKO-XN68566
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19858; TTC7B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TYK2 KO
AC   CVCL_D9V7
SY   TYK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H242
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 TYRO3 KO
AC   CVCL_D9V8
SY   TYRO3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1718
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12446; TYRO3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 UBE2J1 KO
AC   CVCL_D9V9
SY   UBE2J1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS08774
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17598; UBE2J1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 UBE3A KO
AC   CVCL_D9VA
SY   UBE3A Knockout cell line (HEK293)
DR   Ubigene; YKO-H923
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12496; UBE3A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 UBQLN1 KO
AC   CVCL_D9VB
SY   UBQLN1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H431
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 UBQLN4 KO
AC   CVCL_D9VC
SY   UBQLN4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H432
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1237; UBQLN4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 UBR4 KO
AC   CVCL_D9VD
SY   UBR4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H676
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30313; UBR4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 UFM1 KO
AC   CVCL_D9VE
SY   UFM1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H591
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20597; UFM1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ULK1 KO
AC   CVCL_D9VF
SY   ULK1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5425
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ULK2 KO
AC   CVCL_D9VG
SY   ULK2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5426
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 USP10 KO
AC   CVCL_D9VH
SY   USP10 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1034
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12608; USP10.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 USP2 KO
AC   CVCL_D9VI
SY   USP2 Knockout cell line (HEK293)
DR   Ubigene; YKO-H902
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12618; USP2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 USP21 KO
AC   CVCL_D9VJ
SY   USP21 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS11688
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12620; USP21.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 USP7 KO
AC   CVCL_D9VK
SY   USP7 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1100
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 VDAC3 KO
AC   CVCL_D9VL
SY   VDAC3 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS5967
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 VEGFA KO
AC   CVCL_D9VM
SY   VEGFA Knockout cell line (HEK293)
DR   Ubigene; YKO-H852
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12680; VEGFA.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 VPS26C KO
AC   CVCL_D9VN
SY   VPS26C Knockout cell line (HEK293)
DR   Ubigene; YKO-H800
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3044; VPS26C.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 VPS35 KO
AC   CVCL_D9VP
SY   VPS35 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1231
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13487; VPS35.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 WDR24 KO
AC   CVCL_D9VQ
SY   WDR24 Knockout cell line (HEK293)
DR   Ubigene; YKO-H810
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20852; WDR24.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 WIF1 KO
AC   CVCL_D9VR
SY   WIF1 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS842
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18081; WIF1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 WNT10B KO
AC   CVCL_D9VS
SY   WNT10B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS845
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12775; WNT10B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 WNT3A KO
AC   CVCL_D9VT
SY   WNT3A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS849
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15983; WNT3A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 WNT5A KO
AC   CVCL_D9VU
SY   WNT5A Knockout cell line (HEK293)
DR   Ubigene; YKO-HS851
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12784; WNT5A.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 WNT7B KO
AC   CVCL_D9VV
SY   WNT7B Knockout cell line (HEK293)
DR   Ubigene; YKO-HS854
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12787; WNT7B.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 XIAP KO
AC   CVCL_D9VW
SY   XIAP Knockout cell line (HEK293)
DR   Ubigene; YKO-HS1145
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 YME1L1 KO
AC   CVCL_D9VX
SY   YME1L1 Knockout cell line (HEK293)
DR   Ubigene; YKO-H1081
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12843; YME1L1.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ZC3H4 KO
AC   CVCL_D9VY
SY   ZC3H4 Knockout cell line (HEK293)
DR   Ubigene; YKO-H225
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17808; ZC3H4.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ZCCHC8 KO
AC   CVCL_D9VZ
SY   ZCCHC8 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN96668
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25265; ZCCHC8.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ZFP36 KO
AC   CVCL_D9W0
SY   ZFP36 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS2094
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12862; ZFP36.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ZFYVE16 KO
AC   CVCL_D9W1
SY   ZFYVE16 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS918
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ZNF263 KO
AC   CVCL_D9W2
SY   ZNF263 Knockout cell line (HEK293)
DR   Ubigene; YKO-XN43266
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13056; ZNF263.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293 ZNRD2 KO
AC   CVCL_D9W3
SY   ZNRD2 Knockout cell line (HEK293)
DR   Ubigene; YKO-HS10982
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11328; ZNRD2.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T ACTN1 KO
AC   CVCL_D7G1
SY   ACTN1 Knockout cell line (293T)
DR   Ubigene; YKO-H430
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:163; ACTN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T AIFM3 KO
AC   CVCL_D7G2
SY   AIFM3 Knockout cell line (293T)
DR   Ubigene; YKO-H1076
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26398; AIFM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T ANKH KO
AC   CVCL_D7G3
SY   ANKH Knockout cell line (293T)
DR   Ubigene; YKO-H846
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15492; ANKH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T ANO6 KO
AC   CVCL_D7G4
SY   ANO6 Knockout cell line (293T)
DR   Ubigene; YKO-H930
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25240; ANO6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T ATM KO
AC   CVCL_D7G5
SY   ATM Knockout cell line (293T)
DR   Ubigene; YKO-H1054
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T BATF2 KO
AC   CVCL_D7G6
SY   BATF2 Knockout cell line (293T)
DR   Ubigene; YKO-H103
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25163; BATF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T CEPT1 KO
AC   CVCL_D7G7
SY   CEPT1 Knockout cell line (293T)
DR   Ubigene; YKO-H733
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24289; CEPT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T CRBN KO
AC   CVCL_D7G8
SY   CRBN Knockout cell line (293T)
DR   Ubigene; YKO-H116
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T DHX58 KO
AC   CVCL_D7G9
SY   DHX58 Knockout cell line (293T)
DR   Ubigene; YKO-H805
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29517; DHX58.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T DKK1 KO
AC   CVCL_D7GA
SY   DKK1 Knockout cell line (293T)
DR   Ubigene; YKO-H071
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2891; DKK1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T EMC8 KO
AC   CVCL_D7GB
SY   EMC8 Knockout cell line (293T)
DR   Ubigene; YKO-H806
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7864; EMC8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T EMC9 KO
AC   CVCL_D7GC
SY   EMC9 Knockout cell line (293T)
DR   Ubigene; YKO-H1122
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20273; EMC9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T ERAP1 KO
AC   CVCL_D7GD
SY   ERAP1 Knockout cell line (293T)
DR   Ubigene; YKO-H063
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18173; ERAP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T F2RL1 KO
AC   CVCL_D7GE
SY   F2RL1 Knockout cell line (293T)
DR   Ubigene; YKO-H561
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3538; F2RL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T FMR1 KO
AC   CVCL_D7GF
SY   FMR1 Knockout cell line (293T)
DR   Ubigene; YKO-H530
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T FUT8 KO
AC   CVCL_D7GG
SY   FUT8 Knockout cell line (293T)
DR   Ubigene; YKO-H490
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4019; FUT8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T GAL KO
AC   CVCL_D7GH
SY   GAL Knockout cell line (293T)
DR   Ubigene; YKO-H361
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4114; GAL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T GBA1 KO
AC   CVCL_D7GI
SY   GBA1 Knockout cell line (293T)
DR   Ubigene; YKO-H061
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4177; GBA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T GLA KO
AC   CVCL_D7GJ
SY   GLA Knockout cell line (293T)
DR   Ubigene; YKO-H474
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T GPR50 KO
AC   CVCL_D7GK
SY   GPR50 Knockout cell line (293T)
DR   Ubigene; YKO-H161
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4506; GPR50.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T IFIH1 KO
AC   CVCL_D7GL
SY   IFIH1 Knockout cell line (293T)
DR   Ubigene; YKO-H825
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18873; IFIH1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T IKBKG KO
AC   CVCL_D7GM
SY   IKBKG Knockout cell line (293T)
DR   Ubigene; YKO-H502
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T JUN KO
AC   CVCL_D7GN
SY   JUN Knockout cell line (293T)
DR   Ubigene; YKO-H374
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T KIAA0319L KO
AC   CVCL_D7GP
SY   KIAA0319L Knockout cell line (293T)
DR   Ubigene; YKO-H863
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30071; KIAA0319L.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T KLHDC2 KO
AC   CVCL_D7GQ
SY   KLHDC2 Knockout cell line (293T)
DR   Ubigene; YKO-H652
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20231; KLHDC2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T KREMEN1 KO
AC   CVCL_D7GR
SY   KREMEN1 Knockout cell line (293T)
DR   Ubigene; YKO-H192
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17550; KREMEN1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T LDLR KO
AC   CVCL_D7GS
SY   LDLR Knockout cell line (293T)
DR   Ubigene; YKO-HJ105
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T LDLRAD3 KO
AC   CVCL_D7GT
SY   LDLRAD3 Knockout cell line (293T)
DR   Ubigene; YKO-H136
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27046; LDLRAD3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T LRP6 KO
AC   CVCL_D7GU
SY   LRP6 Knockout cell line (293T)
DR   Ubigene; YKO-H070
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6698; LRP6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T M6PR KO
AC   CVCL_D7GV
SY   M6PR Knockout cell line (293T)
DR   Ubigene; YKO-H478
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6752; M6PR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T MAOA KO
AC   CVCL_D7GW
SY   MAOA Knockout cell line (293T)
DR   Ubigene; YKO-H541
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6833; MAOA.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T MAVS KO
AC   CVCL_D7GX
SY   MAVS Knockout cell line (293T)
DR   Ubigene; YKO-H840
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29233; MAVS.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T METTL1 KO
AC   CVCL_D7GY
SY   METTL1 Knockout cell line (293T)
DR   Ubigene; YKO-H527
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7030; METTL1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T MFSD8 KO
AC   CVCL_D7GZ
SY   MFSD8 Knockout cell line (293T)
DR   Ubigene; YKO-H197
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T MIR183 KO
AC   CVCL_D7H0
SY   MIR183 Knockout cell line (293T)
DR   Ubigene; YKO-H420
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31554; MIR183.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T NONO KO
AC   CVCL_D7H1
SY   NONO Knockout cell line (293T)
DR   Ubigene; YKO-H360
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7871; NONO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Ubigene; YKO-H360; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T NPC1 KO
AC   CVCL_D7H2
SY   NPC1 Knockout cell line (293T)
DR   Ubigene; YKO-H663
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T NR1H2 KO
AC   CVCL_D7H3
SY   NR1H2 Knockout cell line (293T)
DR   Ubigene; YKO-H016
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7965; NR1H2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T NR1H3 KO
AC   CVCL_D7H4
SY   NR1H3 Knockout cell line (293T)
DR   Ubigene; YKO-H015
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7966; NR1H3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T OPTN KO
AC   CVCL_D7H5
SY   OPTN Knockout cell line (293T)
DR   Ubigene; YKO-H434
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17142; OPTN.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T PACC1 KO
AC   CVCL_D7H6
SY   PACC1 Knockout cell line (293T)
DR   Ubigene; YKO-H1017
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25593; PACC1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T PIEZO1 KO
AC   CVCL_D7H7
SY   PIEZO1 Knockout cell line (293T)
DR   Ubigene; YKO-HJ085
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28993; PIEZO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T PIK3R1 KO
AC   CVCL_D7H8
SY   PIK3R1 Knockout cell line (293T)
DR   Ubigene; YKO-H137
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T PKD1 KO
AC   CVCL_D7H9
SY   PKD1 Knockout cell line (293T)
DR   Ubigene; YKO-H886
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T RAPGEF2 KO
AC   CVCL_D7HA
SY   RAPGEF2 Knockout cell line (293T)
DR   Ubigene; YKO-H370
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16854; RAPGEF2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T RBFOX2 KO
AC   CVCL_D7HB
SY   RBFOX2 Knockout cell line (293T)
DR   Ubigene; YKO-H1111
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9906; RBFOX2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T RNASEL KO
AC   CVCL_D7HC
SY   RNASEL Knockout cell line (293T)
DR   Ubigene; YKO-H153
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10050; RNASEL.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T RORC KO
AC   CVCL_D7HD
SY   RORC Knockout cell line (293T)
DR   Ubigene; YKO-H931
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10260; RORC.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SBF1 KO
AC   CVCL_D7HE
SY   SBF1 Knockout cell line (293T)
DR   Ubigene; YKO-H130
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10542; SBF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SCARF1 KO
AC   CVCL_D7HF
SY   SCARF1 Knockout cell line (293T)
DR   Ubigene; YKO-H757
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16820; SCARF1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SERBP1 KO
AC   CVCL_D7HG
SY   SERBP1 Knockout cell line (293T)
DR   Ubigene; YKO-H988
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17860; SERBP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SETD2 KO
AC   CVCL_D7HH
SY   SETD2 Knockout cell line (293T)
DR   Ubigene; YKO-H735
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SIDT1 KO
AC   CVCL_D7HI
SY   SIDT1 Knockout cell line (293T)
DR   Ubigene; YKO-H929
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25967; SIDT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SLC38A9 KO
AC   CVCL_D7HJ
SY   SLC38A9 Knockout cell line (293T)
DR   Ubigene; YKO-H529
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T SMG6 KO
AC   CVCL_D7HK
SY   SMG6 Knockout cell line (293T)
DR   Ubigene; YKO-H164
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17809; SMG6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T STAT3 KO
AC   CVCL_D7HL
SY   STAT3 Knockout cell line (293T)
DR   Ubigene; YKO-H970
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T TAP2 KO
AC   CVCL_D7HM
SY   TAP2 Knockout cell line (293T)
DR   Ubigene; YKO-H406
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:44; TAP2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T TMCO1 KO
AC   CVCL_D7HN
SY   TMCO1 Knockout cell line (293T)
DR   Ubigene; YKO-H807
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18188; TMCO1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T TMEM87A KO
AC   CVCL_D7HP
SY   TMEM87A Knockout cell line (293T)
DR   Ubigene; YKO-H653
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24522; TMEM87A.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T UBR1 KO
AC   CVCL_D7HQ
SY   UBR1 Knockout cell line (293T)
DR   Ubigene; YKO-H557
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16808; UBR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T UBR2 KO
AC   CVCL_D7HR
SY   UBR2 Knockout cell line (293T)
DR   Ubigene; YKO-H556
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21289; UBR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T WSB1 KO
AC   CVCL_D7HS
SY   WSB1 Knockout cell line (293T)
DR   Ubigene; YKO-H704
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19221; WSB1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T XPO5 KO
AC   CVCL_D7HT
SY   XPO5 Knockout cell line (293T)
DR   Ubigene; YKO-H302
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17675; XPO5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEK293T ZDHHC13 KO
AC   CVCL_D7HU
SY   ZDHHC13 Knockout cell line (293T)
DR   Ubigene; YKO-H804
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18413; ZDHHC13.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA).
CC   Discontinued: Ubigene; YKO-H804; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0063 ! HEK293T
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HEL BCL2L1 KO
AC   CVCL_D9W4
SY   BCL2L1 Knockout cell line (HEL)
DR   Ubigene; YKO-KP178
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:992; BCL2L1.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met133Lys (c.398T>A); ClinVar=VCV002430159; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
DI   NCIt; C7152; Erythroleukemia
DI   ORDO; Orphanet_318; Acute erythroid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0001 ! HEL
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HeLa A4GALT KO
AC   CVCL_D9X0
SY   A4GALT Knockout cell line (HeLa)
DR   Ubigene; YKO-H1008
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18149; A4GALT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ABCA4 KO
AC   CVCL_D9X1
SY   ABCA4 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP030
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34; ABCA4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ABCD1 KO
AC   CVCL_D9X2
SY   ABCD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN20780
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ABCD3 KO
AC   CVCL_D9X3
SY   ABCD3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1020
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:67; ABCD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ABL2 KO
AC   CVCL_D9X4
SY   ABL2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7329
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:77; ABL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ACACA KO
AC   CVCL_D9X5
SY   ACACA Knockout cell line (HeLa)
DR   Ubigene; YKO-H119
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:84; ACACA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ADAM17 KO
AC   CVCL_D9X6
SY   ADAM17 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3534
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:195; ADAM17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ADD1 KO
AC   CVCL_D9X7
SY   ADD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H974
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:243; ADD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ADRA1B KO
AC   CVCL_D9X8
SY   ADRA1B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7683
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:278; ADRA1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ADRA2A KO
AC   CVCL_D9X9
SY   ADRA2A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7972
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:281; ADRA2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ADRB2 KO
AC   CVCL_D9XA
SY   ADRB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7649
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:286; ADRB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ADRM1 KO
AC   CVCL_D9XB
SY   ADRM1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H265
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15759; ADRM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AGGF1 KO
AC   CVCL_D9XC
SY   AGGF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H949
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24684; AGGF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AGO2 KO
AC   CVCL_D9XD
SY   AGO2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS13754
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3263; AGO2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AHCYL1 KO
AC   CVCL_D9XE
SY   AHCYL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN44684
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:344; AHCYL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AHCYL2 KO
AC   CVCL_D9XF
SY   AHCYL2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN49276
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22204; AHCYL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AHR KO
AC   CVCL_D9XG
SY   AHR Knockout cell line (HeLa)
DR   Ubigene; YKO-HJ014
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AKT1 KO
AC   CVCL_D9XH
SY   AKT1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP096
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:391; AKT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AKT2 KO
AC   CVCL_D9XI
SY   AKT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP097
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:392; AKT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AOX1 KO
AC   CVCL_D9XJ
SY   AOX1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3571
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:553; AOX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AP1AR KO
AC   CVCL_D9XK
SY   AP1AR Knockout cell line (HeLa)
DR   Ubigene; YKO-XN85443
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28808; AP1AR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa APC KO
AC   CVCL_D9XL
SY   APC Knockout cell line (HeLa)
DR   Ubigene; YKO-KP040
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:583; APC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa APC2 KO
AC   CVCL_D9XM
SY   APC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP101
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24036; APC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa APEX2 KO
AC   CVCL_D9XN
SY   APEX2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN54552
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17889; APEX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa APP KO
AC   CVCL_D9XP
SY   APP Knockout cell line (HeLa)
DR   Ubigene; YKO-HS13524
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AQP11 KO
AC   CVCL_D9XQ
SY   AQP11 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN85488
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19940; AQP11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ARAF KO
AC   CVCL_D9XR
SY   ARAF Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7613
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:646; ARAF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AREG KO
AC   CVCL_D9XS
SY   AREG Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3762
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:651; AREG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ARID2 KO
AC   CVCL_D9XT
SY   ARID2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H489
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18037; ARID2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ARRB1 KO
AC   CVCL_D9XU
SY   ARRB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP059
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:711; ARRB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ARRB2 KO
AC   CVCL_D9XV
SY   ARRB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP060
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:712; ARRB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ASCC1 KO
AC   CVCL_D9XW
SY   ASCC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS09684
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24268; ASCC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ASCC2 KO
AC   CVCL_D9XX
SY   ASCC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H587
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24103; ASCC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ASCC3 KO
AC   CVCL_D9XY
SY   ASCC3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H588
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18697; ASCC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATF2 KO
AC   CVCL_D9XZ
SY   ATF2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3765
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:784; ATF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATF4 KO
AC   CVCL_D9Y0
SY   ATF4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3766
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:786; ATF4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATF6 KO
AC   CVCL_D9Y1
SY   ATF6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H732
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:791; ATF6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATF6B KO
AC   CVCL_D9Y2
SY   ATF6B Knockout cell line (HeLa)
DR   Ubigene; YKO-KP109
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2349; ATF6B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATG13 KO
AC   CVCL_D9Y3
SY   ATG13 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN42404
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29091; ATG13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATG5 KO
AC   CVCL_D9Y4
SY   ATG5 Knockout cell line (HeLa)
DR   Ubigene; YKO-H468
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATG7 KO
AC   CVCL_D9Y5
SY   ATG7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H669
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16935; ATG7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATM KO
AC   CVCL_D9Y6
SY   ATM Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3677
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:795; ATM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATP13A2 KO
AC   CVCL_D9Y7
SY   ATP13A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H573
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30213; ATP13A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATP5F1A KO
AC   CVCL_D9Y8
SY   ATP5F1A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS14108
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:823; ATP5F1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ATP5F1D KO
AC   CVCL_D9Y9
SY   ATP5F1D Knockout cell line (HeLa)
DR   Ubigene; YKO-H893
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:837; ATP5F1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AXIN1 KO
AC   CVCL_D9YA
SY   AXIN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP102
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:903; AXIN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AXIN2 KO
AC   CVCL_D9YB
SY   AXIN2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP103
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:904; AXIN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa AXL KO
AC   CVCL_D9YC
SY   AXL Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4141
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:905; AXL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa B3GNT2 KO
AC   CVCL_D9YD
SY   B3GNT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS11831
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15629; B3GNT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BACE1 KO
AC   CVCL_D9YE
SY   BACE1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4223
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:933; BACE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BAG3 KO
AC   CVCL_D9YF
SY   BAG3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H928
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:939; BAG3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BAHD1 KO
AC   CVCL_D9YG
SY   BAHD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H193
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29153; BAHD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BCHE KO
AC   CVCL_D9YH
SY   BCHE Knockout cell line (HeLa)
DR   Ubigene; YKO-H166
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:983; BCHE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BCL2 KO
AC   CVCL_D9YI
SY   BCL2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3679
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:990; BCL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BDKRB2 KO
AC   CVCL_D9YJ
SY   BDKRB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7704
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1030; BDKRB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BDNF KO
AC   CVCL_D9YK
SY   BDNF Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3767
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1033; BDNF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BICD2 KO
AC   CVCL_D9YL
SY   BICD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN49076
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17208; BICD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BIRC2 KO
AC   CVCL_D9YM
SY   BIRC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3682
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:590; BIRC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BMPR2 KO
AC   CVCL_D9YN
SY   BMPR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP052
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1078; BMPR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BNIP3L KO
AC   CVCL_D9YP
SY   BNIP3L Knockout cell line (HeLa)
DR   Ubigene; YKO-H259
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1085; BNIP3L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BORCS5 KO
AC   CVCL_D9YQ
SY   BORCS5 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN47464
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17950; BORCS5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BRAF KO
AC   CVCL_D9YR
SY   BRAF Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3768
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1097; BRAF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BRAT1 KO
AC   CVCL_D9YS
SY   BRAT1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H769
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21701; BRAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BRCA1 KO
AC   CVCL_D9YT
SY   BRCA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP049
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1100; BRCA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BRD9 KO
AC   CVCL_D9YU
SY   BRD9 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP152
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25818; BRD9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa BTRC KO
AC   CVCL_D9YV
SY   BTRC Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3376
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1144; BTRC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa C15orf61 KO
AC   CVCL_D9YW
SY   C15orf61 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN68632
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34453; C15orf61.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa C1QBP KO
AC   CVCL_D9YX
SY   C1QBP Knockout cell line (HeLa)
DR   Ubigene; YKO-H603
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1243; C1QBP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa C9orf72 KO
AC   CVCL_D9YY
SY   C9orf72 Knockout cell line (HeLa)
DR   Ubigene; YKO-H624
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28337; C9orf72.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CACNA1G KO
AC   CVCL_D9YZ
SY   CACNA1G Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3775
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1394; CACNA1G.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CACNA2D1 KO
AC   CVCL_D9Z0
SY   CACNA2D1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3779
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1399; CACNA2D1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CACNA2D3 KO
AC   CVCL_D9Z1
SY   CACNA2D3 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN86345
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15460; CACNA2D3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CACNB2 KO
AC   CVCL_D9Z2
SY   CACNB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3782
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1402; CACNB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CACNB3 KO
AC   CVCL_D9Z3
SY   CACNB3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3783
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1403; CACNB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CACNB4 KO
AC   CVCL_D9Z4
SY   CACNB4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3784
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1404; CACNB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAD KO
AC   CVCL_D9Z5
SY   CAD Knockout cell line (HeLa)
DR   Ubigene; YKO-H075
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1424; CAD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAMK1 KO
AC   CVCL_D9Z6
SY   CAMK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7750
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1459; CAMK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAMK1D KO
AC   CVCL_D9Z7
SY   CAMK1D Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7748
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19341; CAMK1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAMK2D KO
AC   CVCL_D9Z8
SY   CAMK2D Knockout cell line (HeLa)
DR   Ubigene; YKO-KP104
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1462; CAMK2D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAMK2G KO
AC   CVCL_D9Z9
SY   CAMK2G Knockout cell line (HeLa)
DR   Ubigene; YKO-KP105
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1463; CAMK2G.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAMK4 KO
AC   CVCL_D9ZA
SY   CAMK4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7515
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1464; CAMK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CAMKK2 KO
AC   CVCL_D9ZB
SY   CAMKK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS8000
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1470; CAMKK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CARD10 KO
AC   CVCL_D9ZC
SY   CARD10 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3685
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16422; CARD10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CARD11 KO
AC   CVCL_D9ZD
SY   CARD11 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3686
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16393; CARD11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CASP3 KO
AC   CVCL_D9ZE
SY   CASP3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3789
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1504; CASP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CASP6 KO
AC   CVCL_D9ZF
SY   CASP6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HJ120
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1507; CASP6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CASP8 KO
AC   CVCL_D9ZG
SY   CASP8 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1038
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1509; CASP8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CASP8AP2 KO
AC   CVCL_D9ZH
SY   CASP8AP2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN86413
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1510; CASP8AP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CASP9 KO
AC   CVCL_D9ZI
SY   CASP9 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP110
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1511; CASP9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CCDC115 KO
AC   CVCL_D9ZJ
SY   CCDC115 Knockout cell line (HeLa)
DR   Ubigene; YKO-H586
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28178; CCDC115.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CCND1 KO
AC   CVCL_D9ZK
SY   CCND1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4098
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1582; CCND1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CCND3 KO
AC   CVCL_D9ZL
SY   CCND3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3382
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1585; CCND3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CD44 KO
AC   CVCL_D9ZM
SY   CD44 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1006
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1681; CD44.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CD47 KO
AC   CVCL_D9ZN
SY   CD47 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS08299
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1682; CD47.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CD55 KO
AC   CVCL_D9ZP
SY   CD55 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS12560
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2665; CD55.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CD63 KO
AC   CVCL_D9ZQ
SY   CD63 Knockout cell line (HeLa)
DR   Ubigene; YKO-H575
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1692; CD63.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CD74 KO
AC   CVCL_D9ZR
SY   CD74 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4192
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1697; CD74.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDC25B KO
AC   CVCL_D9ZS
SY   CDC25B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3790
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1726; CDC25B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDC37 KO
AC   CVCL_D9ZT
SY   CDC37 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP111
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1735; CDC37.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDK2 KO
AC   CVCL_D9ZU
SY   CDK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7614
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1771; CDK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDK6 KO
AC   CVCL_D9ZV
SY   CDK6 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP113
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1777; CDK6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDK9 KO
AC   CVCL_D9ZW
SY   CDK9 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP067
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1780; CDK9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDKN1A KO
AC   CVCL_D9ZX
SY   CDKN1A Knockout cell line (HeLa)
DR   Ubigene; YKO-KP034
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1784; CDKN1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDKN1B KO
AC   CVCL_D9ZY
SY   CDKN1B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3964
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1785; CDKN1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDKN2B KO
AC   CVCL_D9ZZ
SY   CDKN2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7621
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1788; CDKN2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CDKN2D KO
AC   CVCL_E0A0
SY   CDKN2D Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7622
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1790; CDKN2D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CETN2 KO
AC   CVCL_E0A1
SY   CETN2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN22580
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1867; CETN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CFLAR KO
AC   CVCL_E0A2
SY   CFLAR Knockout cell line (HeLa)
DR   Ubigene; YKO-H371
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1876; CFLAR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CGAS KO
AC   CVCL_E0A3
SY   CGAS Knockout cell line (HeLa)
DR   Ubigene; YKO-H584
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21367; CGAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CHCHD3 KO
AC   CVCL_E0A4
SY   CHCHD3 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN86869
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21906; CHCHD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CHD8 KO
AC   CVCL_E0A5
SY   CHD8 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP106
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20153; CHD8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CHUK KO
AC   CVCL_E0A6
SY   CHUK Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3697
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1974; CHUK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CIR1 KO
AC   CVCL_E0A7
SY   CIR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3536
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24217; CIR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CISH KO
AC   CVCL_E0A8
SY   CISH Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3573
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1984; CISH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CLCN5 KO
AC   CVCL_E0A9
SY   CLCN5 Knockout cell line (HeLa)
DR   Ubigene; YKO-H630
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2023; CLCN5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CLCN6 KO
AC   CVCL_E0AA
SY   CLCN6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H543
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2024; CLCN6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CLCN7 KO
AC   CVCL_E0AB
SY   CLCN7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H544
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2025; CLCN7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CLN3 KO
AC   CVCL_E0AC
SY   CLN3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H576
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2074; CLN3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CLN8 KO
AC   CVCL_E0AD
SY   CLN8 Knockout cell line (HeLa)
DR   Ubigene; YKO-H620
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2079; CLN8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CLTB KO
AC   CVCL_E0AE
SY   CLTB Knockout cell line (HeLa)
DR   Ubigene; YKO-XN22888
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2091; CLTB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CNOT2 KO
AC   CVCL_E0AF
SY   CNOT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H041
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7878; CNOT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CNR1 KO
AC   CVCL_E0AG
SY   CNR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7366
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2159; CNR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CNTF KO
AC   CVCL_E0AH
SY   CNTF Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3574
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2169; CNTF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL1A1 KO
AC   CVCL_E0AI
SY   COL1A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3967
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2197; COL1A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL4A1 KO
AC   CVCL_E0AJ
SY   COL4A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3969
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2202; COL4A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL4A2 KO
AC   CVCL_E0AK
SY   COL4A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP114
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2203; COL4A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL4A3 KO
AC   CVCL_E0AL
SY   COL4A3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3971
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2204; COL4A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL4A4 KO
AC   CVCL_E0AM
SY   COL4A4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3972
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2206; COL4A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL4A5 KO
AC   CVCL_E0AN
SY   COL4A5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3973
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL4A6 KO
AC   CVCL_E0AP
SY   COL4A6 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP116
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2208; COL4A6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COL6A3 KO
AC   CVCL_E0AQ
SY   COL6A3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3976
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2213; COL6A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COP1 KO
AC   CVCL_E0AR
SY   COP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4445
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17440; COP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa COQ6 KO
AC   CVCL_E0AS
SY   COQ6 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN70908
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20233; COQ6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CRBN KO
AC   CVCL_E0AT
SY   CRBN Knockout cell line (HeLa)
DR   Ubigene; YKO-XN87136
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CREB1 KO
AC   CVCL_E0AU
SY   CREB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP117
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2345; CREB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CREB3L1 KO
AC   CVCL_E0AV
SY   CREB3L1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3982
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18856; CREB3L1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CREB3L2 KO
AC   CVCL_E0AW
SY   CREB3L2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3983
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23720; CREB3L2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CREB5 KO
AC   CVCL_E0AX
SY   CREB5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3986
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16844; CREB5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CREBBP KO
AC   CVCL_E0AY
SY   CREBBP Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3576
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2348; CREBBP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CRK KO
AC   CVCL_E0AZ
SY   CRK Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3791
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2362; CRK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CRKL KO
AC   CVCL_E0B0
SY   CRKL Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3792
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2363; CRKL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CRTC2 KO
AC   CVCL_E0B1
SY   CRTC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP118
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27301; CRTC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSF1 KO
AC   CVCL_E0B2
SY   CSF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3793
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2432; CSF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK1A1 KO
AC   CVCL_E0B3
SY   CSNK1A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP107
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2451; CSNK1A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK1D KO
AC   CVCL_E0B4
SY   CSNK1D Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7442
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2452; CSNK1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK1G1 KO
AC   CVCL_E0B5
SY   CSNK1G1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4101
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2454; CSNK1G1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK1G2 KO
AC   CVCL_E0B6
SY   CSNK1G2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4102
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2455; CSNK1G2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK1G3 KO
AC   CVCL_E0B7
SY   CSNK1G3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4103
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2456; CSNK1G3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK2A2 KO
AC   CVCL_E0B8
SY   CSNK2A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3698
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2459; CSNK2A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CSNK2A3 KO
AC   CVCL_E0B9
SY   CSNK2A3 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN87177
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2458; CSNK2A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CTNNB1 KO
AC   CVCL_E0BA
SY   CTNNB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP056
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2514; CTNNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CTSB KO
AC   CVCL_E0BB
SY   CTSB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4220
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2527; CTSB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CXCL1 KO
AC   CVCL_E0BC
SY   CXCL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3699
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4602; CXCL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CXCL8 KO
AC   CVCL_E0BD
SY   CXCL8 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3703
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6025; CXCL8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CXCR4 KO
AC   CVCL_E0BE
SY   CXCR4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7712
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CXXC4 KO
AC   CVCL_E0BF
SY   CXXC4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3390
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24593; CXXC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa CYLD KO
AC   CVCL_E0BG
SY   CYLD Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3704
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2584; CYLD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DAXX KO
AC   CVCL_E0BH
SY   DAXX Knockout cell line (HeLa)
DR   Ubigene; YKO-H1039
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2681; DAXX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DCN KO
AC   CVCL_E0BI
SY   DCN Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3488
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2705; DCN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DDIT4 KO
AC   CVCL_E0BJ
SY   DDIT4 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP119
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24944; DDIT4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DDR1 KO
AC   CVCL_E0BK
SY   DDR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP093
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2730; DDR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DDX39B KO
AC   CVCL_E0BL
SY   DDX39B Knockout cell line (HeLa)
DR   Ubigene; YKO-KP068
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13917; DDX39B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DGKA KO
AC   CVCL_E0BM
SY   DGKA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7808
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2849; DGKA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DGKD KO
AC   CVCL_E0BN
SY   DGKD Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7806
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2851; DGKD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DGKE KO
AC   CVCL_E0BP
SY   DGKE Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7809
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2852; DGKE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DGKZ KO
AC   CVCL_E0BQ
SY   DGKZ Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7805
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2857; DGKZ.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DICER1 KO
AC   CVCL_E0BR
SY   DICER1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS14100
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17098; DICER1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DKK1 KO
AC   CVCL_E0BS
SY   DKK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3393
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2891; DKK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DLL3 KO
AC   CVCL_E0BT
SY   DLL3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3538
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2909; DLL3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DNMT3A KO
AC   CVCL_E0BU
SY   DNMT3A Knockout cell line (HeLa)
DR   Ubigene; YKO-KP029
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2978; DNMT3A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DTX2 KO
AC   CVCL_E0BV
SY   DTX2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3541
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15973; DTX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DTX3 KO
AC   CVCL_E0BW
SY   DTX3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3542
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24457; DTX3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DTX3L KO
AC   CVCL_E0BX
SY   DTX3L Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3543
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30323; DTX3L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DTX4 KO
AC   CVCL_E0BY
SY   DTX4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3544
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29151; DTX4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUS3L KO
AC   CVCL_E0BZ
SY   DUS3L Knockout cell line (HeLa)
DR   Ubigene; YKO-H267
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26920; DUS3L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP1 KO
AC   CVCL_E0C0
SY   DUSP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3797
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3064; DUSP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP10 KO
AC   CVCL_E0C1
SY   DUSP10 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3798
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3065; DUSP10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP16 KO
AC   CVCL_E0C2
SY   DUSP16 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3799
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17909; DUSP16.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP2 KO
AC   CVCL_E0C3
SY   DUSP2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3800
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3068; DUSP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP3 KO
AC   CVCL_E0C4
SY   DUSP3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3801
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3069; DUSP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP4 KO
AC   CVCL_E0C5
SY   DUSP4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3802
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3070; DUSP4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DUSP6 KO
AC   CVCL_E0C6
SY   DUSP6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3804
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3072; DUSP6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DVL1 KO
AC   CVCL_E0C7
SY   DVL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H219
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3084; DVL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DVL2 KO
AC   CVCL_E0C8
SY   DVL2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H135
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3086; DVL2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DVL3 KO
AC   CVCL_E0C9
SY   DVL3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H313
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa DYRK1A KO
AC   CVCL_E0CA
SY   DYRK1A Knockout cell line (HeLa)
DR   Ubigene; YKO-H601
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3091; DYRK1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EEF2K KO
AC   CVCL_E0CB
SY   EEF2K Knockout cell line (HeLa)
DR   Ubigene; YKO-HS8012
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24615; EEF2K.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EFNA1 KO
AC   CVCL_E0CC
SY   EFNA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3808
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3221; EFNA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EFNA5 KO
AC   CVCL_E0CD
SY   EFNA5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3810
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3225; EFNA5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EGFR KO
AC   CVCL_E0CE
SY   EGFR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7234
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EHD1 KO
AC   CVCL_E0CF
SY   EHD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN45104
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3242; EHD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EIF2A KO
AC   CVCL_E0CG
SY   EIF2A Knockout cell line (HeLa)
DR   Ubigene; YKO-H590
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3254; EIF2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EIF2AK2 KO
AC   CVCL_E0CH
SY   EIF2AK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP089
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9437; EIF2AK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EIF2AK3 KO
AC   CVCL_E0CI
SY   EIF2AK3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H730
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3255; EIF2AK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EIF4B KO
AC   CVCL_E0CJ
SY   EIF4B Knockout cell line (HeLa)
DR   Ubigene; YKO-H1010
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3285; EIF4B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ELF3 KO
AC   CVCL_E0CK
SY   ELF3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H727
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3318; ELF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ENTPD1 KO
AC   CVCL_E0CL
SY   ENTPD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4215
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3363; ENTPD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EP300 KO
AC   CVCL_E0CM
SY   EP300 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP080
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3373; EP300.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EPHA2 KO
AC   CVCL_E0CN
SY   EPHA2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP026
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3386; EPHA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EPN1 KO
AC   CVCL_E0CP
SY   EPN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1022
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21604; EPN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EPOR KO
AC   CVCL_E0CQ
SY   EPOR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3586
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3416; EPOR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ERBB2 KO
AC   CVCL_E0CR
SY   ERBB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP050
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3430; ERBB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ERBB4 KO
AC   CVCL_E0CS
SY   ERBB4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3816
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3432; ERBB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ERC1 KO
AC   CVCL_E0CT
SY   ERC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3707
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17072; ERC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ERCC1 KO
AC   CVCL_E0CU
SY   ERCC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS11231
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3433; ERCC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ERCC6L KO
AC   CVCL_E0CV
SY   ERCC6L Knockout cell line (HeLa)
DR   Ubigene; YKO-H720
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20794; ERCC6L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ERN1 KO
AC   CVCL_E0CW
SY   ERN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H731
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3449; ERN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa EVA1A KO
AC   CVCL_E0CX
SY   EVA1A Knockout cell line (HeLa)
DR   Ubigene; YKO-H641
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25816; EVA1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa F2R KO
AC   CVCL_E0CY
SY   F2R Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3993
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FASN KO
AC   CVCL_E0CZ
SY   FASN Knockout cell line (HeLa)
DR   Ubigene; YKO-H081
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3594; FASN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FGF23 KO
AC   CVCL_E0D0
SY   FGF23 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP036
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3680; FGF23.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FGFR1 KO
AC   CVCL_E0D1
SY   FGFR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3831
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FGFR4 KO
AC   CVCL_E0D2
SY   FGFR4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3834
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3691; FGFR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FHL1 KO
AC   CVCL_E0D3
SY   FHL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HJ001
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3702; FHL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FLNA KO
AC   CVCL_E0D4
SY   FLNA Knockout cell line (HeLa)
DR   Ubigene; YKO-KP054
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3754; FLNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FLT3LG KO
AC   CVCL_E0D5
SY   FLT3LG Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7230
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3766; FLT3LG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FMOD KO
AC   CVCL_E0D6
SY   FMOD Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3492
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3774; FMOD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FOLR1 KO
AC   CVCL_E0D7
SY   FOLR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP041
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3791; FOLR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FOSL1 KO
AC   CVCL_E0D8
SY   FOSL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3399
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13718; FOSL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FOXO3 KO
AC   CVCL_E0D9
SY   FOXO3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3995
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3821; FOXO3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FRAT1 KO
AC   CVCL_E0DA
SY   FRAT1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3400
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3944; FRAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FRAT2 KO
AC   CVCL_E0DB
SY   FRAT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3401
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16048; FRAT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FSCN1 KO
AC   CVCL_E0DC
SY   FSCN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H816
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11148; FSCN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FST KO
AC   CVCL_E0DD
SY   FST Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3493
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3971; FST.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FURIN KO
AC   CVCL_E0DE
SY   FURIN Knockout cell line (HeLa)
DR   Ubigene; YKO-H025
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8568; FURIN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FYN KO
AC   CVCL_E0DF
SY   FYN Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7822
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4037; FYN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FZD2 KO
AC   CVCL_E0DG
SY   FZD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3404
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4040; FZD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FZD6 KO
AC   CVCL_E0DH
SY   FZD6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3408
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4044; FZD6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FZD7 KO
AC   CVCL_E0DI
SY   FZD7 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3409
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4045; FZD7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa FZD8 KO
AC   CVCL_E0DJ
SY   FZD8 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3410
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4046; FZD8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GAA KO
AC   CVCL_E0DK
SY   GAA Knockout cell line (HeLa)
DR   Ubigene; YKO-XN26300
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4065; GAA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GABBR1 KO
AC   CVCL_E0DL
SY   GABBR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7921
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4070; GABBR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GADD45A KO
AC   CVCL_E0DM
SY   GADD45A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3708
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4095; GADD45A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GADD45B KO
AC   CVCL_E0DN
SY   GADD45B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3709
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4096; GADD45B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GAK KO
AC   CVCL_E0DP
SY   GAK Knockout cell line (HeLa)
DR   Ubigene; YKO-XN26264
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4113; GAK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GALNT13 KO
AC   CVCL_E0DQ
SY   GALNT13 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP091
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23242; GALNT13.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GGA3 KO
AC   CVCL_E0DR
SY   GGA3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H213
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17079; GGA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GLI2 KO
AC   CVCL_E0DS
SY   GLI2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4112
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4318; GLI2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GLI3 KO
AC   CVCL_E0DT
SY   GLI3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4113
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4319; GLI3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GLMP KO
AC   CVCL_E0DU
SY   GLMP Knockout cell line (HeLa)
DR   Ubigene; YKO-H574
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29436; GLMP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GNAS KO
AC   CVCL_E0DV
SY   GNAS Knockout cell line (HeLa)
DR   Ubigene; YKO-H212
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4392; GNAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GNB1 KO
AC   CVCL_E0DW
SY   GNB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP120
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4396; GNB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GNB2 KO
AC   CVCL_E0DX
SY   GNB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP121
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4398; GNB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GNB3 KO
AC   CVCL_E0DY
SY   GNB3 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP122
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4400; GNB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GNB4 KO
AC   CVCL_E0DZ
SY   GNB4 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP123
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20731; GNB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GOLGA4 KO
AC   CVCL_E0E0
SY   GOLGA4 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN26856
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4427; GOLGA4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GPR137B KO
AC   CVCL_E0E1
SY   GPR137B Knockout cell line (HeLa)
DR   Ubigene; YKO-H648
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11862; GPR137B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GPR161 KO
AC   CVCL_E0E2
SY   GPR161 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4114
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23694; GPR161.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GRK2 KO
AC   CVCL_E0E3
SY   GRK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4115
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:289; GRK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GSK3B KO
AC   CVCL_E0E4
SY   GSK3B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4117
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4617; GSK3B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa GYS1 KO
AC   CVCL_E0E5
SY   GYS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4006
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4706; GYS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HDAC1 KO
AC   CVCL_E0E6
SY   HDAC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3545
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4852; HDAC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HDAC2 KO
AC   CVCL_E0E7
SY   HDAC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3546
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4853; HDAC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HES1 KO
AC   CVCL_E0E8
SY   HES1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3547
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5192; HES1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HEY1 KO
AC   CVCL_E0E9
SY   HEY1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3548
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4880; HEY1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HLCS KO
AC   CVCL_E0EA
SY   HLCS Knockout cell line (HeLa)
DR   Ubigene; YKO-H080
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4976; HLCS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HMGB1 KO
AC   CVCL_E0EB
SY   HMGB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H790
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4983; HMGB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HNRNPLL KO
AC   CVCL_E0EC
SY   HNRNPLL Knockout cell line (HeLa)
DR   Ubigene; YKO-HS10402
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25127; HNRNPLL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HRAS KO
AC   CVCL_E0ED
SY   HRAS Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3591
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5173; HRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HRH1 KO
AC   CVCL_E0EE
SY   HRH1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7689
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5182; HRH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HSP90B1 KO
AC   CVCL_E0EF
SY   HSP90B1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4009
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12028; HSP90B1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HSPA2 KO
AC   CVCL_E0EG
SY   HSPA2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3846
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5235; HSPA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HSPA8 KO
AC   CVCL_E0EH
SY   HSPA8 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP047
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5241; HSPA8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HSPB1 KO
AC   CVCL_E0EI
SY   HSPB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3849
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5246; HSPB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa HUWE1 KO
AC   CVCL_E0EJ
SY   HUWE1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H147
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30892; HUWE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IFNA1 KO
AC   CVCL_E0EK
SY   IFNA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3592
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5417; IFNA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IFNAR1 KO
AC   CVCL_E0EL
SY   IFNAR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1219
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5432; IFNAR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IFNE KO
AC   CVCL_E0EM
SY   IFNE Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3599
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18163; IFNE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IFNGR1 KO
AC   CVCL_E0EN
SY   IFNGR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3600
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5439; IFNGR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IFNGR2 KO
AC   CVCL_E0EP
SY   IFNGR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3601
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5440; IFNGR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IGF1 KO
AC   CVCL_E0EQ
SY   IGF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4194
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5464; IGF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IGF1R KO
AC   CVCL_E0ER
SY   IGF1R Knockout cell line (HeLa)
DR   Ubigene; YKO-KP065
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5465; IGF1R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IKBKB KO
AC   CVCL_E0ES
SY   IKBKB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3711
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5960; IKBKB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IKBKG KO
AC   CVCL_E0ET
SY   IKBKG Knockout cell line (HeLa)
DR   Ubigene; YKO-H1208
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5961; IKBKG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL10RB KO
AC   CVCL_E0EU
SY   IL10RB Knockout cell line (HeLa)
DR   Ubigene; YKO-H010
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5965; IL10RB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL11 KO
AC   CVCL_E0EV
SY   IL11 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3604
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5966; IL11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL13RA1 KO
AC   CVCL_E0EW
SY   IL13RA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H009
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5974; IL13RA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL15RA KO
AC   CVCL_E0EX
SY   IL15RA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3611
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5978; IL15RA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL1A KO
AC   CVCL_E0EY
SY   IL1A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3851
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5991; IL1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL1B KO
AC   CVCL_E0EZ
SY   IL1B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3713
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5992; IL1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL1R1 KO
AC   CVCL_E0F0
SY   IL1R1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3714
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5993; IL1R1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL20RB KO
AC   CVCL_E0F1
SY   IL20RB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3614
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6004; IL20RB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL27RA KO
AC   CVCL_E0F2
SY   IL27RA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3620
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17290; IL27RA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL4R KO
AC   CVCL_E0F3
SY   IL4R Knockout cell line (HeLa)
DR   Ubigene; YKO-H008
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6015; IL4R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL6 KO
AC   CVCL_E0F4
SY   IL6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3626
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6018; IL6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL6R KO
AC   CVCL_E0F5
SY   IL6R Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3627
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6019; IL6R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL6ST KO
AC   CVCL_E0F6
SY   IL6ST Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3628
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IL7R KO
AC   CVCL_E0F7
SY   IL7R Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3630
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6024; IL7R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa INVS KO
AC   CVCL_E0F8
SY   INVS Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3412
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17870; INVS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IP6K2 KO
AC   CVCL_E0F9
SY   IP6K2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7797
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17313; IP6K2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IRAK3 KO
AC   CVCL_E0FA
SY   IRAK3 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN45760
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17020; IRAK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IRAK4 KO
AC   CVCL_E0FB
SY   IRAK4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3715
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17967; IRAK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa IRF9 KO
AC   CVCL_E0FC
SY   IRF9 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3632
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6131; IRF9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ISG15 KO
AC   CVCL_E0FD
SY   ISG15 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS10829
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITCH KO
AC   CVCL_E0FE
SY   ITCH Knockout cell line (HeLa)
DR   Ubigene; YKO-H615
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13890; ITCH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGA11 KO
AC   CVCL_E0FF
SY   ITGA11 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4012
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6136; ITGA11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGA3 KO
AC   CVCL_E0FG
SY   ITGA3 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP051
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6139; ITGA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGA5 KO
AC   CVCL_E0FH
SY   ITGA5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4017
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6141; ITGA5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGA6 KO
AC   CVCL_E0FI
SY   ITGA6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4018
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6142; ITGA6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGB1 KO
AC   CVCL_E0FJ
SY   ITGB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4023
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6153; ITGB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGB3 KO
AC   CVCL_E0FK
SY   ITGB3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4024
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6156; ITGB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITGB5 KO
AC   CVCL_E0FL
SY   ITGB5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4026
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6160; ITGB5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITM2C KO
AC   CVCL_E0FM
SY   ITM2C Knockout cell line (HeLa)
DR   Ubigene; YKO-H568
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6175; ITM2C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITPK1 KO
AC   CVCL_E0FN
SY   ITPK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7794
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6177; ITPK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITPKB KO
AC   CVCL_E0FP
SY   ITPKB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7755
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6179; ITPKB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITPR1 KO
AC   CVCL_E0FQ
SY   ITPR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7474
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6180; ITPR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITPR2 KO
AC   CVCL_E0FR
SY   ITPR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7475
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6181; ITPR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ITPR3 KO
AC   CVCL_E0FS
SY   ITPR3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7476
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6182; ITPR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa JAG1 KO
AC   CVCL_E0FT
SY   JAG1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3551
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa JAG2 KO
AC   CVCL_E0FU
SY   JAG2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3552
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6189; JAG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa JAK1 KO
AC   CVCL_E0FV
SY   JAK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1088
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6190; JAK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa JAK2 KO
AC   CVCL_E0FW
SY   JAK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1110
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6192; JAK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa JUN KO
AC   CVCL_E0FX
SY   JUN Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3854
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6204; JUN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KAT2B KO
AC   CVCL_E0FY
SY   KAT2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3553
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8638; KAT2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KAT5 KO
AC   CVCL_E0FZ
SY   KAT5 Knockout cell line (HeLa)
DR   Ubigene; YKO-H475
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5275; KAT5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KCNMA1 KO
AC   CVCL_E0G0
SY   KCNMA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H571
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6284; KCNMA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KDM1A KO
AC   CVCL_E0G1
SY   KDM1A Knockout cell line (HeLa)
DR   Ubigene; YKO-XN89696
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29079; KDM1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KEAP1 KO
AC   CVCL_E0G2
SY   KEAP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H965
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23177; KEAP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KIFC1 KO
AC   CVCL_E0G4
SY   KIFC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS12039
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6389; KIFC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KLF7 KO
AC   CVCL_E0G5
SY   KLF7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H131
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6350; KLF7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KMT2D KO
AC   CVCL_E0G6
SY   KMT2D Knockout cell line (HeLa)
DR   Ubigene; YKO-H473
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KRAS KO
AC   CVCL_E0G7
SY   KRAS Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4231
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa KSR1 KO
AC   CVCL_E0G8
SY   KSR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7321
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6465; KSR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LAPTM4A KO
AC   CVCL_E0G9
SY   LAPTM4A Knockout cell line (HeLa)
DR   Ubigene; YKO-H579
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6924; LAPTM4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LAPTM4B KO
AC   CVCL_E0GA
SY   LAPTM4B Knockout cell line (HeLa)
DR   Ubigene; YKO-H569
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13646; LAPTM4B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LAPTM5 KO
AC   CVCL_E0GB
SY   LAPTM5 Knockout cell line (HeLa)
DR   Ubigene; YKO-H580
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29612; LAPTM5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LATS1 KO
AC   CVCL_E0GC
SY   LATS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7427
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6514; LATS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LATS2 KO
AC   CVCL_E0GD
SY   LATS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4428
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6515; LATS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LDLR KO
AC   CVCL_E0GE
SY   LDLR Knockout cell line (HeLa)
DR   Ubigene; YKO-H1027
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LEPR KO
AC   CVCL_E0GF
SY   LEPR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3637
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6554; LEPR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LGR4 KO
AC   CVCL_E0GG
SY   LGR4 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN90044
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13299; LGR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LGR6 KO
AC   CVCL_E0GH
SY   LGR6 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN90046
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19719; LGR6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LIF KO
AC   CVCL_E0GI
SY   LIF Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3638
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6596; LIF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LIFR KO
AC   CVCL_E0GJ
SY   LIFR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3639
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6597; LIFR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LMBRD1 KO
AC   CVCL_E0GK
SY   LMBRD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H581
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23038; LMBRD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LMNA KO
AC   CVCL_E0GL
SY   LMNA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS08335
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6636; LMNA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LPAR2 KO
AC   CVCL_E0GM
SY   LPAR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4042
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3168; LPAR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LPAR5 KO
AC   CVCL_E0GN
SY   LPAR5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7338
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13307; LPAR5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LRATD2 KO
AC   CVCL_E0GP
SY   LRATD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN90138
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24166; LRATD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LRP5 KO
AC   CVCL_E0GQ
SY   LRP5 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP062
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6697; LRP5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LTBR KO
AC   CVCL_E0GR
SY   LTBR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3719
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6718; LTBR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LTN1 KO
AC   CVCL_E0GS
SY   LTN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HJ004
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13082; LTN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa LYN KO
AC   CVCL_E0GT
SY   LYN Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3720
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6735; LYN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa M6PR KO
AC   CVCL_E0GU
SY   M6PR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS08051
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6752; M6PR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAGI1 KO
AC   CVCL_E0GV
SY   MAGI1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4045
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:946; MAGI1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAGI3 KO
AC   CVCL_E0GW
SY   MAGI3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7357
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29647; MAGI3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MALT1 KO
AC   CVCL_E0GX
SY   MALT1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3721
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6819; MALT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAML1 KO
AC   CVCL_E0GY
SY   MAML1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3554
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13632; MAML1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAML2 KO
AC   CVCL_E0GZ
SY   MAML2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3555
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16259; MAML2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP1LC3B2 KO
AC   CVCL_E0H0
SY   MAP1LC3B2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H815
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:34390; MAP1LC3B2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP2K1 KO
AC   CVCL_E0H1
SY   MAP2K1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7212
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6840; MAP2K1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP2K2 KO
AC   CVCL_E0H2
SY   MAP2K2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3859
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6842; MAP2K2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP2K3 KO
AC   CVCL_E0H3
SY   MAP2K3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3860
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6843; MAP2K3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP2K5 KO
AC   CVCL_E0H4
SY   MAP2K5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4455
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6845; MAP2K5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP2K6 KO
AC   CVCL_E0H5
SY   MAP2K6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7406
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6846; MAP2K6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K1 KO
AC   CVCL_E0H6
SY   MAP3K1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H454
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6848; MAP3K1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K14 KO
AC   CVCL_E0H7
SY   MAP3K14 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3722
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6853; MAP3K14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K2 KO
AC   CVCL_E0H8
SY   MAP3K2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3867
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6854; MAP3K2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K20 KO
AC   CVCL_E0H9
SY   MAP3K20 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3868
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17797; MAP3K20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K5 KO
AC   CVCL_E0HA
SY   MAP3K5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3871
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6857; MAP3K5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K7 KO
AC   CVCL_E0HB
SY   MAP3K7 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3723
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6859; MAP3K7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP3K8 KO
AC   CVCL_E0HC
SY   MAP3K8 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3873
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6860; MAP3K8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP4K3 KO
AC   CVCL_E0HD
SY   MAP4K3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3875
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6865; MAP4K3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAP4K4 KO
AC   CVCL_E0HE
SY   MAP4K4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3876
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6866; MAP4K4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPK1 KO
AC   CVCL_E0HF
SY   MAPK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3506
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6871; MAPK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPK12 KO
AC   CVCL_E0HG
SY   MAPK12 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7407
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6874; MAPK12.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPK14 KO
AC   CVCL_E0HH
SY   MAPK14 Knockout cell line (HeLa)
DR   Ubigene; YKO-H148
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6876; MAPK14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPK7 KO
AC   CVCL_E0HI
SY   MAPK7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H178
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6880; MAPK7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPK9 KO
AC   CVCL_E0HJ
SY   MAPK9 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3886
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6886; MAPK9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPKAPK2 KO
AC   CVCL_E0HK
SY   MAPKAPK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3887
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6887; MAPKAPK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPKAPK3 KO
AC   CVCL_E0HL
SY   MAPKAPK3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3888
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6888; MAPKAPK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MAPKAPK5 KO
AC   CVCL_E0HM
SY   MAPKAPK5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3889
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6889; MAPKAPK5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MCF2L KO
AC   CVCL_E0HN
SY   MCF2L Knockout cell line (HeLa)
DR   Ubigene; YKO-H464
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14576; MCF2L.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MCL1 KO
AC   CVCL_E0HP
SY   MCL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1133
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6943; MCL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MCOLN1 KO
AC   CVCL_E0HQ
SY   MCOLN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1003
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MCOLN3 KO
AC   CVCL_E0HR
SY   MCOLN3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7731
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13358; MCOLN3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MCU KO
AC   CVCL_E0HS
SY   MCU Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7732
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23526; MCU.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MDM2 KO
AC   CVCL_E0HT
SY   MDM2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4047
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6973; MDM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MECOM KO
AC   CVCL_E0HU
SY   MECOM Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3891
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3498; MECOM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MECP2 KO
AC   CVCL_E0HV
SY   MECP2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS13077
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6990; MECP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MEF2C KO
AC   CVCL_E0HW
SY   MEF2C Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3892
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6996; MEF2C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MET KO
AC   CVCL_E0HX
SY   MET Knockout cell line (HeLa)
DR   Ubigene; YKO-KP033
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7029; MET.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MFSD6 KO
AC   CVCL_E0HY
SY   MFSD6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H546
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24711; MFSD6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MFSD8 KO
AC   CVCL_E0HZ
SY   MFSD8 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN90546
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28486; MFSD8.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MGMT KO
AC   CVCL_E0I0
SY   MGMT Knockout cell line (HeLa)
DR   Ubigene; YKO-H814
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7059; MGMT.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MICU1 KO
AC   CVCL_E0I1
SY   MICU1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H892
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1530; MICU1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MIX23 KO
AC   CVCL_E0I2
SY   MIX23 Knockout cell line (HeLa)
DR   Ubigene; YKO-H876
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31136; MIX23.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MKI67 KO
AC   CVCL_E0I3
SY   MKI67 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN96673
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7107; MKI67.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MKNK1 KO
AC   CVCL_E0I4
SY   MKNK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7553
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7110; MKNK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MKNK2 KO
AC   CVCL_E0I5
SY   MKNK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7554
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7111; MKNK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MLKL KO
AC   CVCL_E0I6
SY   MLKL Knockout cell line (HeLa)
DR   Ubigene; YKO-H821
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26617; MLKL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MMP1 KO
AC   CVCL_E0I7
SY   MMP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4216
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7155; MMP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MMP2 KO
AC   CVCL_E0I8
SY   MMP2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4217
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7166; MMP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MOB1A KO
AC   CVCL_E0I9
SY   MOB1A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7428
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16015; MOB1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MOB1B KO
AC   CVCL_E0IA
SY   MOB1B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7429
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29801; MOB1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MORC2 KO
AC   CVCL_E0IB
SY   MORC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H332
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23573; MORC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MPHOSPH6 KO
AC   CVCL_E0IC
SY   MPHOSPH6 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP070
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7214; MPHOSPH6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MRE11 KO
AC   CVCL_E0ID
SY   MRE11 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS14261
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7230; MRE11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MSH6 KO
AC   CVCL_E0IE
SY   MSH6 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN27276
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7329; MSH6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MTM1 KO
AC   CVCL_E0IF
SY   MTM1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7776
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7448; MTM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MTX2 KO
AC   CVCL_E0IG
SY   MTX2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H828
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7506; MTX2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MUC16 KO
AC   CVCL_E0IH
SY   MUC16 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4161
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15582; MUC16.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MUC5AC KO
AC   CVCL_E0II
SY   MUC5AC Knockout cell line (HeLa)
DR   Ubigene; YKO-XN96672
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7515; MUC5AC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MUTYH KO
AC   CVCL_E0IJ
SY   MUTYH Knockout cell line (HeLa)
DR   Ubigene; YKO-H813
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7527; MUTYH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MYB KO
AC   CVCL_E0IK
SY   MYB Knockout cell line (HeLa)
DR   Ubigene; YKO-KP032
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MYD88 KO
AC   CVCL_E0IL
SY   MYD88 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3724
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7562; MYD88.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MYLK KO
AC   CVCL_E0IM
SY   MYLK Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7487
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7590; MYLK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MYLK2 KO
AC   CVCL_E0IN
SY   MYLK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7488
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16243; MYLK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MYLK3 KO
AC   CVCL_E0IP
SY   MYLK3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7489
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29826; MYLK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa MYO19 KO
AC   CVCL_E0IQ
SY   MYO19 Knockout cell line (HeLa)
DR   Ubigene; YKO-H891
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26234; MYO19.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NAA20 KO
AC   CVCL_E0IR
SY   NAA20 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1124
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15908; NAA20.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NCOR1 KO
AC   CVCL_E0IS
SY   NCOR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H802
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7672; NCOR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NCOR2 KO
AC   CVCL_E0IT
SY   NCOR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3557
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7673; NCOR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NCSTN KO
AC   CVCL_E0IU
SY   NCSTN Knockout cell line (HeLa)
DR   Ubigene; YKO-KP055
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17091; NCSTN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NECTIN4 KO
AC   CVCL_E0IV
SY   NECTIN4 Knockout cell line (HeLa)
DR   Ubigene; YKO-H937
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19688; NECTIN4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NEK7 KO
AC   CVCL_E0IW
SY   NEK7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H916
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13386; NEK7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFATC1 KO
AC   CVCL_E0IX
SY   NFATC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3896
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7775; NFATC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFATC2 KO
AC   CVCL_E0IY
SY   NFATC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3419
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7776; NFATC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFATC3 KO
AC   CVCL_E0IZ
SY   NFATC3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3897
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7777; NFATC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFATC4 KO
AC   CVCL_E0J0
SY   NFATC4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3420
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7778; NFATC4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFKB1 KO
AC   CVCL_E0J1
SY   NFKB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3725
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFKB2 KO
AC   CVCL_E0J2
SY   NFKB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3726
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7795; NFKB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NFKBIA KO
AC   CVCL_E0J3
SY   NFKBIA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3727
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7797; NFKBIA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NINJ1 KO
AC   CVCL_E0J4
SY   NINJ1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H271
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7824; NINJ1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NLK KO
AC   CVCL_E0J5
SY   NLK Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3900
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29858; NLK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NLRX1 KO
AC   CVCL_E0J6
SY   NLRX1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN91158
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29890; NLRX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NOD1 KO
AC   CVCL_E0J7
SY   NOD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4380
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16390; NOD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NOTCH1 KO
AC   CVCL_E0J8
SY   NOTCH1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP038
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7881; NOTCH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NOTCH2 KO
AC   CVCL_E0J9
SY   NOTCH2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3560
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7882; NOTCH2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NOTCH3 KO
AC   CVCL_E0JA
SY   NOTCH3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3561
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NPC1 KO
AC   CVCL_E0JB
SY   NPC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN91204
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7897; NPC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NPR3 KO
AC   CVCL_E0JC
SY   NPR3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HJ115
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7945; NPR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NR4A1 KO
AC   CVCL_E0JD
SY   NR4A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3901
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7980; NR4A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NUMB KO
AC   CVCL_E0JE
SY   NUMB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3563
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8060; NUMB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa NUMBL KO
AC   CVCL_E0JF
SY   NUMBL Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3564
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8061; NUMBL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa OAS1 KO
AC   CVCL_E0JG
SY   OAS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP087
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8086; OAS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa OLA1 KO
AC   CVCL_E0JH
SY   OLA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H387
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28833; OLA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa OSGIN1 KO
AC   CVCL_E0JI
SY   OSGIN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN58956
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30093; OSGIN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa OSMR KO
AC   CVCL_E0JJ
SY   OSMR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3644
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8507; OSMR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa OXTR KO
AC   CVCL_E0JK
SY   OXTR Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7695
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8529; OXTR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa P2RX1 KO
AC   CVCL_E0JL
SY   P2RX1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7668
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8533; P2RX1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa P2RX4 KO
AC   CVCL_E0JM
SY   P2RX4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7671
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8535; P2RX4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa P2RX5 KO
AC   CVCL_E0JN
SY   P2RX5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7672
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8536; P2RX5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PAK4 KO
AC   CVCL_E0JP
SY   PAK4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7278
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16059; PAK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PAK6 KO
AC   CVCL_E0JQ
SY   PAK6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7280
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16061; PAK6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PBRM1 KO
AC   CVCL_E0JR
SY   PBRM1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H488
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30064; PBRM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PCCA KO
AC   CVCL_E0JS
SY   PCCA Knockout cell line (HeLa)
DR   Ubigene; YKO-H120
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8653; PCCA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PDGFRB KO
AC   CVCL_E0JT
SY   PDGFRB Knockout cell line (HeLa)
DR   Ubigene; YKO-KP064
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8804; PDGFRB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PDHA1 KO
AC   CVCL_E0JU
SY   PDHA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP075
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8806; PDHA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PDIA4 KO
AC   CVCL_E0JV
SY   PDIA4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4247
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30167; PDIA4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PDK1 KO
AC   CVCL_E0JW
SY   PDK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7572
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8809; PDK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PEX3 KO
AC   CVCL_E0JX
SY   PEX3 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN39712
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8858; PEX3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PFKFB2 KO
AC   CVCL_E0JY
SY   PFKFB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4372
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8873; PFKFB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PFKFB3 KO
AC   CVCL_E0JZ
SY   PFKFB3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H076
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PFKFB4 KO
AC   CVCL_E0K0
SY   PFKFB4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS8005
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8875; PFKFB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PFKM KO
AC   CVCL_E0K1
SY   PFKM Knockout cell line (HeLa)
DR   Ubigene; YKO-H952
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8877; PFKM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PGLS KO
AC   CVCL_E0K2
SY   PGLS Knockout cell line (HeLa)
DR   Ubigene; YKO-XN50880
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8903; PGLS.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PHGDH KO
AC   CVCL_E0K3
SY   PHGDH Knockout cell line (HeLa)
DR   Ubigene; YKO-H905
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8923; PHGDH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PHKA1 KO
AC   CVCL_E0K4
SY   PHKA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7747
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8925; PHKA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PHKA2 KO
AC   CVCL_E0K5
SY   PHKA2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7746
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8926; PHKA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PHKB KO
AC   CVCL_E0K6
SY   PHKB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7745
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8927; PHKB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PHKG2 KO
AC   CVCL_E0K7
SY   PHKG2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7744
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8931; PHKG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PI4K2A KO
AC   CVCL_E0K8
SY   PI4K2A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7760
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30031; PI4K2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PI4K2B KO
AC   CVCL_E0K9
SY   PI4K2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7761
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18215; PI4K2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PI4KB KO
AC   CVCL_E0KA
SY   PI4KB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7759
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8984; PI4KB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIAS1 KO
AC   CVCL_E0KB
SY   PIAS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3646
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2752; PIAS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIAS2 KO
AC   CVCL_E0KC
SY   PIAS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3647
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17311; PIAS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIAS3 KO
AC   CVCL_E0KD
SY   PIAS3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3648
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16861; PIAS3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIAS4 KO
AC   CVCL_E0KE
SY   PIAS4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3728
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17002; PIAS4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PICK1 KO
AC   CVCL_E0KF
SY   PICK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H183
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9394; PICK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIGA KO
AC   CVCL_E0KG
SY   PIGA Knockout cell line (HeLa)
DR   Ubigene; YKO-XN91997
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8957; PIGA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIGK KO
AC   CVCL_E0KH
SY   PIGK Knockout cell line (HeLa)
DR   Ubigene; YKO-H039
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8965; PIGK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3C2A KO
AC   CVCL_E0KI
SY   PIK3C2A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7790
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8971; PIK3C2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3C2B KO
AC   CVCL_E0KJ
SY   PIK3C2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7791
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8972; PIK3C2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3CB KO
AC   CVCL_E0KK
SY   PIK3CB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3650
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8976; PIK3CB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3CD KO
AC   CVCL_E0KL
SY   PIK3CD Knockout cell line (HeLa)
DR   Ubigene; YKO-KP099
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8977; PIK3CD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3R1 KO
AC   CVCL_E0KM
SY   PIK3R1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3652
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8979; PIK3R1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3R2 KO
AC   CVCL_E0KN
SY   PIK3R2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP100
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8980; PIK3R2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIK3R3 KO
AC   CVCL_E0KP
SY   PIK3R3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7214
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8981; PIK3R3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIKFYVE KO
AC   CVCL_E0KQ
SY   PIKFYVE Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7775
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23785; PIKFYVE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIM1 KO
AC   CVCL_E0KR
SY   PIM1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN92027
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIP4K2A KO
AC   CVCL_E0KS
SY   PIP4K2A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7785
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8997; PIP4K2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIP4K2B KO
AC   CVCL_E0KT
SY   PIP4K2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7786
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8998; PIP4K2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIP4K2C KO
AC   CVCL_E0KU
SY   PIP4K2C Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7784
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23786; PIP4K2C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIP5K1A KO
AC   CVCL_E0KV
SY   PIP5K1A Knockout cell line (HeLa)
DR   Ubigene; YKO-H1194
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8994; PIP5K1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIP5K1B KO
AC   CVCL_E0KW
SY   PIP5K1B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7766
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8995; PIP5K1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PIP5K1C KO
AC   CVCL_E0KX
SY   PIP5K1C Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7764
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8996; PIP5K1C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PKD1 KO
AC   CVCL_E0KY
SY   PKD1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1040
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9008; PKD1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Discontinued: Ubigene; YKO-H1040; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 4
//
ID   Ubigene HeLa PKM KO
AC   CVCL_E0KZ
SY   PKM Knockout cell line (HeLa)
DR   Ubigene; YKO-H033
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9021; PKM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PKN1 KO
AC   CVCL_E0L0
SY   PKN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4058
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9405; PKN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PKN2 KO
AC   CVCL_E0L1
SY   PKN2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4059
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9406; PKN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PKN3 KO
AC   CVCL_E0L2
SY   PKN3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4060
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17999; PKN3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLA2G4A KO
AC   CVCL_E0L3
SY   PLA2G4A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3910
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9035; PLA2G4A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLAU KO
AC   CVCL_E0L4
SY   PLAU Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3729
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9052; PLAU.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLCB2 KO
AC   CVCL_E0L5
SY   PLCB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3424
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9055; PLCB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLCB3 KO
AC   CVCL_E0L6
SY   PLCB3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3425
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9056; PLCB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLCB4 KO
AC   CVCL_E0L7
SY   PLCB4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3426
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9059; PLCB4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLCG1 KO
AC   CVCL_E0L8
SY   PLCG1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3730
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9065; PLCG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLK2 KO
AC   CVCL_E0L9
SY   PLK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7624
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19699; PLK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLK3 KO
AC   CVCL_E0LA
SY   PLK3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7625
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2154; PLK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PLSCR3 KO
AC   CVCL_E0LB
SY   PLSCR3 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN92149
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16495; PLSCR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PML KO
AC   CVCL_E0LC
SY   PML Knockout cell line (HeLa)
DR   Ubigene; YKO-H143
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9113; PML.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPARA KO
AC   CVCL_E0LD
SY   PPARA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7943
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9232; PPARA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPARG KO
AC   CVCL_E0LE
SY   PPARG Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4465
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9236; PPARG.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPIP5K2 KO
AC   CVCL_E0LF
SY   PPIP5K2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7800
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29035; PPIP5K2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPM1D KO
AC   CVCL_E0LG
SY   PPM1D Knockout cell line (HeLa)
DR   Ubigene; YKO-HS13004
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9277; PPM1D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPP2R2A KO
AC   CVCL_E0LH
SY   PPP2R2A Knockout cell line (HeLa)
DR   Ubigene; YKO-KP061
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9304; PPP2R2A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPP2R2B KO
AC   CVCL_E0LI
SY   PPP2R2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4062
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9305; PPP2R2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPP3CA KO
AC   CVCL_E0LJ
SY   PPP3CA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3916
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9314; PPP3CA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPP3CB KO
AC   CVCL_E0LK
SY   PPP3CB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3917
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9315; PPP3CB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PPP3R1 KO
AC   CVCL_E0LL
SY   PPP3R1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3919
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9317; PPP3R1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRICKLE1 KO
AC   CVCL_E0LM
SY   PRICKLE1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP037
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17019; PRICKLE1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKAA1 KO
AC   CVCL_E0LN
SY   PRKAA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP053
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9376; PRKAA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKAA2 KO
AC   CVCL_E0LP
SY   PRKAA2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4070
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9377; PRKAA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKAB1 KO
AC   CVCL_E0LQ
SY   PRKAB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7503
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9378; PRKAB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKAB2 KO
AC   CVCL_E0LR
SY   PRKAB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7504
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9379; PRKAB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKACB KO
AC   CVCL_E0LS
SY   PRKACB Knockout cell line (HeLa)
DR   Ubigene; YKO-H1199
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9381; PRKACB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKAG1 KO
AC   CVCL_E0LT
SY   PRKAG1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7505
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9385; PRKAG1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKAG2 KO
AC   CVCL_E0LU
SY   PRKAG2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7507
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9386; PRKAG2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKCB KO
AC   CVCL_E0LV
SY   PRKCB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3732
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9395; PRKCB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKCE KO
AC   CVCL_E0LW
SY   PRKCE Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7482
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9401; PRKCE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKCI KO
AC   CVCL_E0LX
SY   PRKCI Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7399
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9404; PRKCI.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKCZ KO
AC   CVCL_E0LY
SY   PRKCZ Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7398
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9412; PRKCZ.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKD2 KO
AC   CVCL_E0LZ
SY   PRKD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7364
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17293; PRKD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRKD3 KO
AC   CVCL_E0M0
SY   PRKD3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7363
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9408; PRKD3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PRPF40B KO
AC   CVCL_E0M1
SY   PRPF40B Knockout cell line (HeLa)
DR   Ubigene; YKO-H262
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25031; PRPF40B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PSEN2 KO
AC   CVCL_E0M2
SY   PSEN2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3565
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9509; PSEN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTBP1 KO
AC   CVCL_E0M3
SY   PTBP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS08555
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9583; PTBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTCH1 KO
AC   CVCL_E0M4
SY   PTCH1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4123
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9585; PTCH1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTDSS1 KO
AC   CVCL_E0M5
SY   PTDSS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H906
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9587; PTDSS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTGS2 KO
AC   CVCL_E0M6
SY   PTGS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3734
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9605; PTGS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTK2 KO
AC   CVCL_E0M7
SY   PTK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4328
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9611; PTK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTK2B KO
AC   CVCL_E0M8
SY   PTK2B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7754
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9612; PTK2B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTK7 KO
AC   CVCL_E0M9
SY   PTK7 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP043
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9618; PTK7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTPN2 KO
AC   CVCL_E0MA
SY   PTPN2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3656
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9650; PTPN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PTPN6 KO
AC   CVCL_E0MB
SY   PTPN6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3657
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9658; PTPN6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PUS1 KO
AC   CVCL_E0MC
SY   PUS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP083
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15508; PUS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa PUS7 KO
AC   CVCL_E0MD
SY   PUS7 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP085
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26033; PUS7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa QKI KO
AC   CVCL_E0ME
SY   QKI Knockout cell line (HeLa)
DR   Ubigene; YKO-H978
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21100; QKI.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RAB27A KO
AC   CVCL_E0MF
SY   RAB27A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS14486
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9766; RAB27A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RABL6 KO
AC   CVCL_E0MG
SY   RABL6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H058
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24703; RABL6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RAC2 KO
AC   CVCL_E0MH
SY   RAC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3927
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9802; RAC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RAF1 KO
AC   CVCL_E0MI
SY   RAF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7211
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9829; RAF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RASGRP3 KO
AC   CVCL_E0MJ
SY   RASGRP3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3935
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14545; RASGRP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RB1 KO
AC   CVCL_E0MK
SY   RB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1025
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RB1CC1 KO
AC   CVCL_E0ML
SY   RB1CC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H605
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15574; RB1CC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RBPJ KO
AC   CVCL_E0MM
SY   RBPJ Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3566
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5724; RBPJ.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RELA KO
AC   CVCL_E0MN
SY   RELA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3735
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9955; RELA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RELB KO
AC   CVCL_E0MP
SY   RELB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3736
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9956; RELB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RHOT2 KO
AC   CVCL_E0MQ
SY   RHOT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS12469
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21169; RHOT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RIGI KO
AC   CVCL_E0MR
SY   RIGI Knockout cell line (HeLa)
DR   Ubigene; YKO-XN92832
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19102; RIGI.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RIPK1 KO
AC   CVCL_E0MS
SY   RIPK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP078
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RMC1 KO
AC   CVCL_E0MT
SY   RMC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H276
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24326; RMC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RNF167 KO
AC   CVCL_E0MU
SY   RNF167 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS11428
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24544; RNF167.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RNF43 KO
AC   CVCL_E0MV
SY   RNF43 Knockout cell line (HeLa)
DR   Ubigene; YKO-H487
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18505; RNF43.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ROCK1 KO
AC   CVCL_E0MW
SY   ROCK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3516
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10251; ROCK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ROR1 KO
AC   CVCL_E0MX
SY   ROR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP044
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10256; ROR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ROR2 KO
AC   CVCL_E0MY
SY   ROR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP045
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10257; ROR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RPS6KA1 KO
AC   CVCL_E0MZ
SY   RPS6KA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3937
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10430; RPS6KA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RPS6KA2 KO
AC   CVCL_E0N0
SY   RPS6KA2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3938
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10431; RPS6KA2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RPS6KA3 KO
AC   CVCL_E0N1
SY   RPS6KA3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3939
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10432; RPS6KA3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RUVBL1 KO
AC   CVCL_E0N2
SY   RUVBL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP063
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10474; RUVBL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RXRA KO
AC   CVCL_E0N3
SY   RXRA Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4076
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10477; RXRA.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa RYR3 KO
AC   CVCL_E0N4
SY   RYR3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7479
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10485; RYR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa S1PR1 KO
AC   CVCL_E0N5
SY   S1PR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4334
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3165; S1PR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa S1PR3 KO
AC   CVCL_E0N6
SY   S1PR3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4335
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3167; S1PR3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SCARB2 KO
AC   CVCL_E0N7
SY   SCARB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H570
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1665; SCARB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SDHB KO
AC   CVCL_E0N8
SY   SDHB Knockout cell line (HeLa)
DR   Ubigene; YKO-H079
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10681; SDHB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SEC24C KO
AC   CVCL_E0N9
SY   SEC24C Knockout cell line (HeLa)
DR   Ubigene; YKO-HJ122
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10705; SEC24C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SELENOO KO
AC   CVCL_E0NA
SY   SELENOO Knockout cell line (HeLa)
DR   Ubigene; YKO-H029
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30395; SELENOO.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SETD2 KO
AC   CVCL_E0NB
SY   SETD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN93292
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18420; SETD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SETX KO
AC   CVCL_E0NC
SY   SETX Knockout cell line (HeLa)
DR   Ubigene; YKO-XN48492
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:445; SETX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SGPL1 KO
AC   CVCL_E0ND
SY   SGPL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7883
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10817; SGPL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SHFL KO
AC   CVCL_E0NE
SY   SHFL Knockout cell line (HeLa)
DR   Ubigene; YKO-H716
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25649; SHFL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SIDT2 KO
AC   CVCL_E0NF
SY   SIDT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H582
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24272; SIDT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SKP2 KO
AC   CVCL_E0NG
SY   SKP2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H912
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10901; SKP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC12A4 KO
AC   CVCL_E0NH
SY   SLC12A4 Knockout cell line (HeLa)
DR   Ubigene; YKO-H633
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10913; SLC12A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC12A9 KO
AC   CVCL_E0NI
SY   SLC12A9 Knockout cell line (HeLa)
DR   Ubigene; YKO-H634
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17435; SLC12A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC15A1 KO
AC   CVCL_E0NJ
SY   SLC15A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H635
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10920; SLC15A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC15A3 KO
AC   CVCL_E0NK
SY   SLC15A3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1074
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18068; SLC15A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC15A4 KO
AC   CVCL_E0NL
SY   SLC15A4 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1105
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23090; SLC15A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC17A5 KO
AC   CVCL_E0NM
SY   SLC17A5 Knockout cell line (HeLa)
DR   Ubigene; YKO-H545
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10933; SLC17A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC17A9 KO
AC   CVCL_E0NN
SY   SLC17A9 Knockout cell line (HeLa)
DR   Ubigene; YKO-H549
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16192; SLC17A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC23A2 KO
AC   CVCL_E0NP
SY   SLC23A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP090
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10973; SLC23A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC25A6 KO
AC   CVCL_E0NQ
SY   SLC25A6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7738
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10992; SLC25A6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC29A3 KO
AC   CVCL_E0NR
SY   SLC29A3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H547
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23096; SLC29A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC2A1 KO
AC   CVCL_E0NS
SY   SLC2A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H762
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11005; SLC2A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC2A6 KO
AC   CVCL_E0NT
SY   SLC2A6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H636
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11011; SLC2A6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC2A9 KO
AC   CVCL_E0NU
SY   SLC2A9 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN80960
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13446; SLC2A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC31A2 KO
AC   CVCL_E0NV
SY   SLC31A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1045
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11017; SLC31A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC37A3 KO
AC   CVCL_E0NW
SY   SLC37A3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H583
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20651; SLC37A3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC38A7 KO
AC   CVCL_E0NX
SY   SLC38A7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H548
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25582; SLC38A7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC38A9 KO
AC   CVCL_E0NY
SY   SLC38A9 Knockout cell line (HeLa)
DR   Ubigene; YKO-H553
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26907; SLC38A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC3A2 KO
AC   CVCL_E0NZ
SY   SLC3A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H781
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11026; SLC3A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC49A4 KO
AC   CVCL_E0P0
SY   SLC49A4 Knockout cell line (HeLa)
DR   Ubigene; YKO-H577
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16628; SLC49A4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC7A11 KO
AC   CVCL_E0P1
SY   SLC7A11 Knockout cell line (HeLa)
DR   Ubigene; YKO-H729
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC7A14 KO
AC   CVCL_E0P2
SY   SLC7A14 Knockout cell line (HeLa)
DR   Ubigene; YKO-H550
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29326; SLC7A14.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC7A2 KO
AC   CVCL_E0P3
SY   SLC7A2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H637
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11060; SLC7A2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC7A5 KO
AC   CVCL_E0P4
SY   SLC7A5 Knockout cell line (HeLa)
DR   Ubigene; YKO-H759
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11063; SLC7A5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC9A1 KO
AC   CVCL_E0P5
SY   SLC9A1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7483
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11071; SLC9A1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC9A6 KO
AC   CVCL_E0P6
SY   SLC9A6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H631
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11079; SLC9A6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC9A9 KO
AC   CVCL_E0P7
SY   SLC9A9 Knockout cell line (HeLa)
DR   Ubigene; YKO-H632
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20653; SLC9A9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SLC9B2 KO
AC   CVCL_E0P8
SY   SLC9B2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H042
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25143; SLC9B2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMAD2 KO
AC   CVCL_E0P9
SY   SMAD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP074
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6768; SMAD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMAD4 KO
AC   CVCL_E0PA
SY   SMAD4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3521
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMAD5 KO
AC   CVCL_E0PB
SY   SMAD5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3522
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6771; SMAD5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMAD6 KO
AC   CVCL_E0PC
SY   SMAD6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3523
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6772; SMAD6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMAD7 KO
AC   CVCL_E0PD
SY   SMAD7 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3524
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6773; SMAD7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMAD9 KO
AC   CVCL_E0PE
SY   SMAD9 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3525
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6774; SMAD9.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMARCA4 KO
AC   CVCL_E0PF
SY   SMARCA4 Knockout cell line (HeLa)
DR   Ubigene; YKO-H501
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMURF1 KO
AC   CVCL_E0PG
SY   SMURF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3526
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16807; SMURF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SMURF2 KO
AC   CVCL_E0PH
SY   SMURF2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3527
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16809; SMURF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOCS2 KO
AC   CVCL_E0PI
SY   SOCS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3658
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19382; SOCS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOCS3 KO
AC   CVCL_E0PJ
SY   SOCS3 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP079
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19391; SOCS3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOCS4 KO
AC   CVCL_E0PK
SY   SOCS4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3660
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19392; SOCS4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOCS5 KO
AC   CVCL_E0PL
SY   SOCS5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3661
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16852; SOCS5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOCS6 KO
AC   CVCL_E0PM
SY   SOCS6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3662
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16833; SOCS6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOCS7 KO
AC   CVCL_E0PN
SY   SOCS7 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3663
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29846; SOCS7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOS1 KO
AC   CVCL_E0PP
SY   SOS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3664
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11187; SOS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOS2 KO
AC   CVCL_E0PQ
SY   SOS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3665
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11188; SOS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SOX17 KO
AC   CVCL_E0PR
SY   SOX17 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3444
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18122; SOX17.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SP1 KO
AC   CVCL_E0PS
SY   SP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3528
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11205; SP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SPHK1 KO
AC   CVCL_E0PT
SY   SPHK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4408
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11240; SPHK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SPHK2 KO
AC   CVCL_E0PU
SY   SPHK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7467
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18859; SPHK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SPNS1 KO
AC   CVCL_E0PV
SY   SPNS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H578
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30621; SPNS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SPP1 KO
AC   CVCL_E0PW
SY   SPP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4079
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11255; SPP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SQSTM1 KO
AC   CVCL_E0PX
SY   SQSTM1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1044
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SRC KO
AC   CVCL_E0PY
SY   SRC Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7389
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11283; SRC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa SSTR1 KO
AC   CVCL_E0PZ
SY   SSTR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7924
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11330; SSTR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAM KO
AC   CVCL_E0Q0
SY   STAM Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3666
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11357; STAM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAM2 KO
AC   CVCL_E0Q1
SY   STAM2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3667
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11358; STAM2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAT1 KO
AC   CVCL_E0Q2
SY   STAT1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3668
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11362; STAT1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAT2 KO
AC   CVCL_E0Q3
SY   STAT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3669
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11363; STAT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAT3 KO
AC   CVCL_E0Q4
SY   STAT3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H142
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11364; STAT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAT5A KO
AC   CVCL_E0Q5
SY   STAT5A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3671
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11366; STAT5A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAT5B KO
AC   CVCL_E0Q6
SY   STAT5B Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3672
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11367; STAT5B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STAT6 KO
AC   CVCL_E0Q7
SY   STAT6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3673
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11368; STAT6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STEAP3 KO
AC   CVCL_E0Q8
SY   STEAP3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1037
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24592; STEAP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STIMATE KO
AC   CVCL_E0Q9
SY   STIMATE Knockout cell line (HeLa)
DR   Ubigene; YKO-H643
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30526; STIMATE.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STK11 KO
AC   CVCL_E0QA
SY   STK11 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4080
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11389; STK11.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STK4 KO
AC   CVCL_E0QB
SY   STK4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7274
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11408; STK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STYX KO
AC   CVCL_E0QC
SY   STYX Knockout cell line (HeLa)
DR   Ubigene; YKO-H684
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11447; STYX.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa STYXL1 KO
AC   CVCL_E0QD
SY   STYXL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H686
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18165; STYXL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TAB1 KO
AC   CVCL_E0QE
SY   TAB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3739
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18157; TAB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TAB2 KO
AC   CVCL_E0QF
SY   TAB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3740
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TAOK1 KO
AC   CVCL_E0QG
SY   TAOK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN94304
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29259; TAOK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TAOK2 KO
AC   CVCL_E0QH
SY   TAOK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3947
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16835; TAOK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TAOK3 KO
AC   CVCL_E0QI
SY   TAOK3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3948
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18133; TAOK3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TARS2 KO
AC   CVCL_E0QJ
SY   TARS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP073
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30740; TARS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TBK1 KO
AC   CVCL_E0QK
SY   TBK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H953
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11584; TBK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TBXA2R KO
AC   CVCL_E0QL
SY   TBXA2R Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7708
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11608; TBXA2R.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TEK KO
AC   CVCL_E0QM
SY   TEK Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3949
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11724; TEK.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TET2 KO
AC   CVCL_E0QN
SY   TET2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4324
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TET3 KO
AC   CVCL_E0QP
SY   TET3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H277
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28313; TET3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TFB2M KO
AC   CVCL_E0QQ
SY   TFB2M Knockout cell line (HeLa)
DR   Ubigene; YKO-XN81692
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18559; TFB2M.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TFDP1 KO
AC   CVCL_E0QR
SY   TFDP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3529
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11749; TFDP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TFE3 KO
AC   CVCL_E0QS
SY   TFE3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1210
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11752; TFE3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TGFB1I1 KO
AC   CVCL_E0QT
SY   TGFB1I1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN36908
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11767; TGFB1I1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TGFB3 KO
AC   CVCL_E0QU
SY   TGFB3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3951
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11769; TGFB3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TGFBR1 KO
AC   CVCL_E0QV
SY   TGFBR1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3952
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11772; TGFBR1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TGFBR2 KO
AC   CVCL_E0QW
SY   TGFBR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3953
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11773; TGFBR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TGIF1 KO
AC   CVCL_E0QX
SY   TGIF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3530
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11776; TGIF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa THBS1 KO
AC   CVCL_E0QY
SY   THBS1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3531
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11785; THBS1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa THBS3 KO
AC   CVCL_E0QZ
SY   THBS3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4084
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11787; THBS3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TICAM1 KO
AC   CVCL_E0R0
SY   TICAM1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3742
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18348; TICAM1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TIRAP KO
AC   CVCL_E0R1
SY   TIRAP Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3743
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17192; TIRAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TLE3 KO
AC   CVCL_E0R2
SY   TLE3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3452
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11839; TLE3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TLR4 KO
AC   CVCL_E0R3
SY   TLR4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7551
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TM9SF1 KO
AC   CVCL_E0R4
SY   TM9SF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H638
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11864; TM9SF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM106B KO
AC   CVCL_E0R5
SY   TMEM106B Knockout cell line (HeLa)
DR   Ubigene; YKO-H639
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22407; TMEM106B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM127 KO
AC   CVCL_E0R6
SY   TMEM127 Knockout cell line (HeLa)
DR   Ubigene; YKO-H640
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26038; TMEM127.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM161A KO
AC   CVCL_E0R7
SY   TMEM161A Knockout cell line (HeLa)
DR   Ubigene; YKO-H1068
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26020; TMEM161A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM161B KO
AC   CVCL_E0R8
SY   TMEM161B Knockout cell line (HeLa)
DR   Ubigene; YKO-H1069
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28483; TMEM161B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM163 KO
AC   CVCL_E0R9
SY   TMEM163 Knockout cell line (HeLa)
DR   Ubigene; YKO-H645
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25380; TMEM163.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM165 KO
AC   CVCL_E0RA
SY   TMEM165 Knockout cell line (HeLa)
DR   Ubigene; YKO-H572
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30760; TMEM165.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM175 KO
AC   CVCL_E0RB
SY   TMEM175 Knockout cell line (HeLa)
DR   Ubigene; YKO-H935
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM176A KO
AC   CVCL_E0RC
SY   TMEM176A Knockout cell line (HeLa)
DR   Ubigene; YKO-H644
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24930; TMEM176A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM243 KO
AC   CVCL_E0RD
SY   TMEM243 Knockout cell line (HeLa)
DR   Ubigene; YKO-H661
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21707; TMEM243.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM245 KO
AC   CVCL_E0RE
SY   TMEM245 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1024
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1363; TMEM245.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM268 KO
AC   CVCL_E0RF
SY   TMEM268 Knockout cell line (HeLa)
DR   Ubigene; YKO-H629
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24513; TMEM268.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM43 KO
AC   CVCL_E0RG
SY   TMEM43 Knockout cell line (HeLa)
DR   Ubigene; YKO-H647
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28472; TMEM43.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM50B KO
AC   CVCL_E0RH
SY   TMEM50B Knockout cell line (HeLa)
DR   Ubigene; YKO-H646
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1280; TMEM50B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMEM63B KO
AC   CVCL_E0RI
SY   TMEM63B Knockout cell line (HeLa)
DR   Ubigene; YKO-H642
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17735; TMEM63B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TMPRSS2 KO
AC   CVCL_E0RJ
SY   TMPRSS2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H022
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11876; TMPRSS2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNC KO
AC   CVCL_E0RK
SY   TNC Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4087
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5318; TNC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNF KO
AC   CVCL_E0RL
SY   TNF Knockout cell line (HeLa)
DR   Ubigene; YKO-H903
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11892; TNF.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNFAIP3 KO
AC   CVCL_E0RM
SY   TNFAIP3 Knockout cell line (HeLa)
DR   Ubigene; YKO-H528
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNFRSF1A KO
AC   CVCL_E0RN
SY   TNFRSF1A Knockout cell line (HeLa)
DR   Ubigene; YKO-H1053
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11916; TNFRSF1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNFRSF1B KO
AC   CVCL_E0RP
SY   TNFRSF1B Knockout cell line (HeLa)
DR   Ubigene; YKO-H990
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11917; TNFRSF1B.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNFSF10 KO
AC   CVCL_E0RQ
SY   TNFSF10 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4197
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11925; TNFSF10.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNNT2 KO
AC   CVCL_E0RR
SY   TNNT2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4253
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11949; TNNT2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TNXB KO
AC   CVCL_E0RS
SY   TNXB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4089
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11976; TNXB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TP53 KO
AC   CVCL_E0RT
SY   TP53 Knockout cell line (HeLa)
DR   Ubigene; YKO-H176
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11998; TP53.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TPCN1 KO
AC   CVCL_E0RU
SY   TPCN1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7727
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18182; TPCN1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TPCN2 KO
AC   CVCL_E0RV
SY   TPCN2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7728
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TPP1 KO
AC   CVCL_E0RW
SY   TPP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN22852
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2073; TPP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TPRA1 KO
AC   CVCL_E0RX
SY   TPRA1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H649
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30413; TPRA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRADD KO
AC   CVCL_E0RY
SY   TRADD Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3751
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12030; TRADD.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAF1 KO
AC   CVCL_E0RZ
SY   TRAF1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP046
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12031; TRAF1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAF2 KO
AC   CVCL_E0S0
SY   TRAF2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3753
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12032; TRAF2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAF3 KO
AC   CVCL_E0S1
SY   TRAF3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3754
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12033; TRAF3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAF5 KO
AC   CVCL_E0S2
SY   TRAF5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3755
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12035; TRAF5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAF6 KO
AC   CVCL_E0S3
SY   TRAF6 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3756
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12036; TRAF6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAK1 KO
AC   CVCL_E0S4
SY   TRAK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1115
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29947; TRAK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRAK2 KO
AC   CVCL_E0S5
SY   TRAK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1116
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13206; TRAK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRIM21 KO
AC   CVCL_E0S6
SY   TRIM21 Knockout cell line (HeLa)
DR   Ubigene; YKO-H926
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11312; TRIM21.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRIM25 KO
AC   CVCL_E0S7
SY   TRIM25 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP058
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12932; TRIM25.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRIM4 KO
AC   CVCL_E0S8
SY   TRIM4 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN68736
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16275; TRIM4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRIP4 KO
AC   CVCL_E0S9
SY   TRIP4 Knockout cell line (HeLa)
DR   Ubigene; YKO-H589
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12310; TRIP4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRPM6 KO
AC   CVCL_E0SA
SY   TRPM6 Knockout cell line (HeLa)
DR   Ubigene; YKO-H564
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17995; TRPM6.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRPM7 KO
AC   CVCL_E0SB
SY   TRPM7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1066
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17994; TRPM7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TRUB1 KO
AC   CVCL_E0SC
SY   TRUB1 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP084
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16060; TRUB1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TSC2 KO
AC   CVCL_E0SD
SY   TSC2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4091
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TSPO KO
AC   CVCL_E0SE
SY   TSPO Knockout cell line (HeLa)
DR   Ubigene; YKO-H455
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1158; TSPO.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TTL KO
AC   CVCL_E0SF
SY   TTL Knockout cell line (HeLa)
DR   Ubigene; YKO-XN73384
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21586; TTL.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TXNIP KO
AC   CVCL_E0SG
SY   TXNIP Knockout cell line (HeLa)
DR   Ubigene; YKO-HS13953
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16952; TXNIP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa TYK2 KO
AC   CVCL_E0SH
SY   TYK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN95288
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12440; TYK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa UBE3C KO
AC   CVCL_E0SI
SY   UBE3C Knockout cell line (HeLa)
DR   Ubigene; YKO-H149
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16803; UBE3C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ULK1 KO
AC   CVCL_E0SJ
SY   ULK1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7193
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ULK2 KO
AC   CVCL_E0SK
SY   ULK2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7194
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa USP2 KO
AC   CVCL_E0SL
SY   USP2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H614
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12618; USP2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa USP53 KO
AC   CVCL_E0SM
SY   USP53 Knockout cell line (HeLa)
DR   Ubigene; YKO-KP092
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29255; USP53.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa USP7 KO
AC   CVCL_E0SN
SY   USP7 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1019
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12630; USP7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VANGL1 KO
AC   CVCL_E0SP
SY   VANGL1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3455
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15512; VANGL1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VBP1 KO
AC   CVCL_E0SQ
SY   VBP1 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4317
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12662; VBP1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VDAC1 KO
AC   CVCL_E0SR
SY   VDAC1 Knockout cell line (HeLa)
DR   Ubigene; YKO-H688
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12669; VDAC1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VDAC3 KO
AC   CVCL_E0SS
SY   VDAC3 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7735
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12674; VDAC3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VDR KO
AC   CVCL_E0ST
SY   VDR Knockout cell line (HeLa)
DR   Ubigene; YKO-H357
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VEGFB KO
AC   CVCL_E0SU
SY   VEGFB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4208
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12681; VEGFB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VEGFC KO
AC   CVCL_E0SV
SY   VEGFC Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3955
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12682; VEGFC.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VIM KO
AC   CVCL_E0SW
SY   VIM Knockout cell line (HeLa)
DR   Ubigene; YKO-KP066
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12692; VIM.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VIPR2 KO
AC   CVCL_E0SX
SY   VIPR2 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS7900
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12695; VIPR2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VLDLR KO
AC   CVCL_E0SY
SY   VLDLR Knockout cell line (HeLa)
DR   Ubigene; YKO-XN83428
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12698; VLDLR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VPS13A KO
AC   CVCL_E0SZ
SY   VPS13A Knockout cell line (HeLa)
DR   Ubigene; YKO-XN48876
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1908; VPS13A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VPS37A KO
AC   CVCL_E0T0
SY   VPS37A Knockout cell line (HeLa)
DR   Ubigene; YKO-KP072
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24928; VPS37A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa VTN KO
AC   CVCL_E0T1
SY   VTN Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4092
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12724; VTN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa WNT4 KO
AC   CVCL_E0T2
SY   WNT4 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3464
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12783; WNT4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa WNT9A KO
AC   CVCL_E0T3
SY   WNT9A Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3470
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12778; WNT9A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa WRN KO
AC   CVCL_E0T4
SY   WRN Knockout cell line (HeLa)
DR   Ubigene; YKO-HS11267
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12791; WRN.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa XDH KO
AC   CVCL_E0T5
SY   XDH Knockout cell line (HeLa)
DR   Ubigene; YKO-H665
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12805; XDH.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa XIAP KO
AC   CVCL_E0T6
SY   XIAP Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3759
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:592; XIAP.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa YWHAB KO
AC   CVCL_E0T7
SY   YWHAB Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4094
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12849; YWHAB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa YWHAQ KO
AC   CVCL_E0T8
SY   YWHAQ Knockout cell line (HeLa)
DR   Ubigene; YKO-HS4096
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12854; YWHAQ.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ZDHHC5 KO
AC   CVCL_E0T9
SY   ZDHHC5 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS14575
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18472; ZDHHC5.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ZEB2 KO
AC   CVCL_E0TA
SY   ZEB2 Knockout cell line (HeLa)
DR   Ubigene; YKO-XN42544
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14881; ZEB2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ZFYVE16 KO
AC   CVCL_E0TB
SY   ZFYVE16 Knockout cell line (HeLa)
DR   Ubigene; YKO-HS3532
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20756; ZFYVE16.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ZNF432 KO
AC   CVCL_E0TC
SY   ZNF432 Knockout cell line (HeLa)
DR   Ubigene; YKO-H064
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20810; ZNF432.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLa ZNRD2 KO
AC   CVCL_E0TD
SY   ZNRD2 Knockout cell line (HeLa)
DR   Ubigene; YKO-H1215
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11328; ZNRD2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLaS3 SIRT3 KO
AC   CVCL_E0TE
SY   SIRT3 Knockout cell line (HeLaS3)
DR   Ubigene; YKO-HJ099
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene HeLaS3 SIRT7 KO
AC   CVCL_E0TF
SY   SIRT7 Knockout cell line (HeLaS3)
DR   Ubigene; YKO-HJ100
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0058 ! HeLa S3
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene Hep 3B2.1-7 LZTR1 KO
AC   CVCL_D9W5
SY   LZTR1 Knockout cell line (Hep 3B2.1-7)
DR   Ubigene; YKO-H844
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6742; LZTR1.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep 3B2.1-7 NR1H4 KO
AC   CVCL_D9W6
SY   NR1H4 Knockout cell line (Hep 3B2.1-7)
DR   Ubigene; YKO-H066
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7967; NR1H4.
CC   Sequence variation: Mutation; HGNC; HGNC:903; AXIN1; Simple; p.Arg146Ter (c.436C>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Ser576Ter (c.1727C>G); Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7955; Childhood hepatocellular carcinoma
DI   ORDO; Orphanet_33402; Pediatric hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0326 ! Hep 3B2.1-7
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 ACOX1 KO
AC   CVCL_E0TG
SY   ACOX1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H362
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:119; ACOX1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 ACSL1 KO
AC   CVCL_E0TH
SY   ACSL1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H048
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3569; ACSL1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 ACVR1 KO
AC   CVCL_E0TI
SY   ACVR1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H1102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:171; ACVR1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 AKR1B10 KO
AC   CVCL_E0TJ
SY   AKR1B10 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H018
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:382; AKR1B10.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 ALDH2 KO
AC   CVCL_E0TK
SY   ALDH2 Knockout cell line (Hep G2)
DR   Ubigene; YKO-HJ086
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:404; ALDH2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 ANGPTL8 KO
AC   CVCL_E0TL
SY   ANGPTL8 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H256
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24933; ANGPTL8.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 AP1B1 KO
AC   CVCL_E0TM
SY   AP1B1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H186
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:554; AP1B1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 AP1S1 KO
AC   CVCL_E0TN
SY   AP1S1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H185
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:559; AP1S1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 APOA2 KO
AC   CVCL_E0TP
SY   APOA2 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H492
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:601; APOA2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H492; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 ATP7B KO
AC   CVCL_E0TQ
SY   ATP7B Knockout cell line (Hep G2)
DR   Ubigene; YKO-H237
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:870; ATP7B.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 BCAT1 KO
AC   CVCL_E0TR
SY   BCAT1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H419
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 BCHE KO
AC   CVCL_E0TS
SY   BCHE Knockout cell line (Hep G2)
DR   Ubigene; YKO-H405
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:983; BCHE.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 CCDC80 KO
AC   CVCL_E0TT
SY   CCDC80 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H270
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30649; CCDC80.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 CDCA5 KO
AC   CVCL_E0TU
SY   CDCA5 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H126
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14626; CDCA5.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 CPT1A KO
AC   CVCL_E0TV
SY   CPT1A Knockout cell line (Hep G2)
DR   Ubigene; YKO-H293
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2328; CPT1A.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 CRBN KO
AC   CVCL_E0TW
SY   CRBN Knockout cell line (Hep G2)
DR   Ubigene; YKO-H824
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30185; CRBN.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 CYP51A1 KO
AC   CVCL_E0TX
SY   CYP51A1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H234
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2649; CYP51A1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 DGKQ KO
AC   CVCL_E0TY
SY   DGKQ Knockout cell line (Hep G2)
DR   Ubigene; YKO-H002
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2856; DGKQ.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 DUS1L KO
AC   CVCL_E0TZ
SY   DUS1L Knockout cell line (Hep G2)
DR   Ubigene; YKO-H286
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30086; DUS1L.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 DUS2 KO
AC   CVCL_E0U0
SY   DUS2 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H278
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26014; DUS2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 DUS3L KO
AC   CVCL_E0U1
SY   DUS3L Knockout cell line (Hep G2)
DR   Ubigene; YKO-H281
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26920; DUS3L.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 DUS4L KO
AC   CVCL_E0U2
SY   DUS4L Knockout cell line (Hep G2)
DR   Ubigene; YKO-H279
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21517; DUS4L.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 F2R KO
AC   CVCL_E0U3
SY   F2R Knockout cell line (Hep G2)
DR   Ubigene; YKO-H273
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3537; F2R.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 F2RL3 KO
AC   CVCL_E0U4
SY   F2RL3 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H855
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3540; F2RL3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H855; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 FAH KO
AC   CVCL_E0U5
SY   FAH Knockout cell line (Hep G2)
DR   Ubigene; YKO-H231
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3579; FAH.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 FAM216A KO
AC   CVCL_E0U6
SY   FAM216A Knockout cell line (Hep G2)
DR   Ubigene; YKO-H266
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30180; FAM216A.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 FBXO3 KO
AC   CVCL_E0U7
SY   FBXO3 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H335
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13582; FBXO3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 FGA KO
AC   CVCL_E0U8
SY   FGA Knockout cell line (Hep G2)
DR   Ubigene; YKO-H425
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3661; FGA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H425; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 FN1 KO
AC   CVCL_E0U9
SY   FN1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-KP126
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3778; FN1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 G6PC3 KO
AC   CVCL_E0UA
SY   G6PC3 Knockout cell line (Hep G2)
DR   Ubigene; YKO-KP125
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24861; G6PC3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 GLUL KO
AC   CVCL_E0UB
SY   GLUL Knockout cell line (Hep G2)
DR   Ubigene; YKO-H253
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4341; GLUL.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 HIF1A KO
AC   CVCL_E0UC
SY   HIF1A Knockout cell line (Hep G2)
DR   Ubigene; YKO-H898
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 HLA-C KO
AC   CVCL_E0UD
SY   HLA-C Knockout cell line (Hep G2)
DR   Ubigene; YKO-H511
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4933; HLA-C.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 KAT7 KO
AC   CVCL_E0UE
SY   KAT7 Knockout cell line (Hep G2)
DR   Ubigene; YKO-HJ026
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17016; KAT7.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 KCNJ12 KO
AC   CVCL_E0UF
SY   KCNJ12 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H426
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6258; KCNJ12.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H426; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 KL KO
AC   CVCL_E0UG
SY   KL Knockout cell line (Hep G2)
DR   Ubigene; YKO-H517
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6344; KL.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 LDLR KO
AC   CVCL_E0UH
SY   LDLR Knockout cell line (Hep G2)
DR   Ubigene; YKO-H1091
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6547; LDLR.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 MAT2A KO
AC   CVCL_E0UI
SY   MAT2A Knockout cell line (Hep G2)
DR   Ubigene; YKO-H239
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6904; MAT2A.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 MMACHC KO
AC   CVCL_E0UJ
SY   MMACHC Knockout cell line (Hep G2)
DR   Ubigene; YKO-H836
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24525; MMACHC.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 MTRR KO
AC   CVCL_E0UK
SY   MTRR Knockout cell line (Hep G2)
DR   Ubigene; YKO-H826
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7473; MTRR.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 NCOA3 KO
AC   CVCL_E0UL
SY   NCOA3 Knockout cell line (Hep G2)
DR   Ubigene; YKO-HJ055
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7670; NCOA3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 NFE2L2 KO
AC   CVCL_E0UM
SY   NFE2L2 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H294
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 NSUN2 KO
AC   CVCL_E0UN
SY   NSUN2 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H522
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25994; NSUN2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 NUP133 KO
AC   CVCL_E0UP
SY   NUP133 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H785
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18016; NUP133.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H785; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 OTULIN KO
AC   CVCL_E0UQ
SY   OTULIN Knockout cell line (Hep G2)
DR   Ubigene; YKO-H784
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25118; OTULIN.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 PCCA KO
AC   CVCL_E0UR
SY   PCCA Knockout cell line (Hep G2)
DR   Ubigene; YKO-H514
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8653; PCCA.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 PCK1 KO
AC   CVCL_E0US
SY   PCK1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H099
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8724; PCK1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 PPP1R12B KO
AC   CVCL_E0UT
SY   PPP1R12B Knockout cell line (Hep G2)
DR   Ubigene; YKO-H427
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7619; PPP1R12B.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H427; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 PPT1 KO
AC   CVCL_E0UU
SY   PPT1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H423
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9325; PPT1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SCUBE3 KO
AC   CVCL_E0UV
SY   SCUBE3 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H921
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13655; SCUBE3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SEL1L KO
AC   CVCL_E0UW
SY   SEL1L Knockout cell line (Hep G2)
DR   Ubigene; YKO-H1056
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10717; SEL1L.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SGMS1 KO
AC   CVCL_E0UX
SY   SGMS1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H310
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29799; SGMS1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H310; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 SGMS2 KO
AC   CVCL_E0UY
SY   SGMS2 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H218
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28395; SGMS2.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H218; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hep G2 SIRT4 KO
AC   CVCL_E0UZ
SY   SIRT4 Knockout cell line (Hep G2)
DR   Ubigene; YKO-HJ111
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14932; SIRT4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SIX1 KO
AC   CVCL_E0V0
SY   SIX1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-HJ027
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10887; SIX1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SLC35C1 KO
AC   CVCL_E0V1
SY   SLC35C1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H871
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20197; SLC35C1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SMARCA4 KO
AC   CVCL_E0V2
SY   SMARCA4 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H040
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11100; SMARCA4.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SMPD1 KO
AC   CVCL_E0V3
SY   SMPD1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H019
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11120; SMPD1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SNORD17 KO
AC   CVCL_E0V4
SY   SNORD17 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H003
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32713; SNORD17.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 SQSTM1 KO
AC   CVCL_E0V5
SY   SQSTM1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H901
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 TNFAIP3 KO
AC   CVCL_E0V6
SY   TNFAIP3 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H782
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11896; TNFAIP3.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 TREM1 KO
AC   CVCL_E0V7
SY   TREM1 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H837
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17760; TREM1.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hep G2 ZNF133 KO
AC   CVCL_E0V8
SY   ZNF133 Knockout cell line (Hep G2)
DR   Ubigene; YKO-H105
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12917; ZNF133.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Hepa 1-6 Bcl9 KO
AC   CVCL_E0V9
SY   Bcl9 Knockout cell line (Hepa 1-6)
DR   Ubigene; YKO-M087
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924828; Bcl9.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hepa 1-6 C3 KO
AC   CVCL_E0VA
SY   C3 Knockout cell line (Hepa 1-6)
DR   Ubigene; YKO-M044
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88227; C3.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hepa 1-6 Clec10a KO
AC   CVCL_E0VB
SY   Clec10a Knockout cell line (Hepa 1-6)
DR   Ubigene; YKO-M092
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96975; Clec10a.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hepa 1-6 Hif1a KO
AC   CVCL_E0VC
SY   Hif1a Knockout cell line (Hepa 1-6)
DR   Ubigene; YKO-M100
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:106918; Hif1a.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Hepa 1-6 Mettl4 KO
AC   CVCL_E0VD
SY   Mettl4 Knockout cell line (Hepa 1-6)
DR   Ubigene; YKO-M066
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924031; Mettl4.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0327 ! Hepa 1-6
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HGC-27 FGFR1 KO
AC   CVCL_D9W7
SY   FGFR1 Knockout cell line (HGC-27)
DR   Ubigene; YKO-H209
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3688; FGFR1.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HGC-27 PIN1 KO
AC   CVCL_D9W8
SY   PIN1 Knockout cell line (HGC-27)
DR   Ubigene; YKO-H864
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8988; PIN1.
CC   Sequence variation: Mutation; HGNC; HGNC:882; ATR; Simple; p.Gly2316fs*9 (c.6947delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro153Alafs*28 (c.455dupC) (c.455_456insC) (p.P152fs) (c.459_460insC); ClinVar=VCV000182958; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H864; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4911; Gastric carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1279 ! HGC-27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HK-2 ALDOB KO
AC   CVCL_D9W9
SY   ALDOB Knockout cell line (HK2)
DR   Ubigene; YKO-H1118
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:417; ALDOB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0302 ! HK-2 [Human kidney]
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HL-1 Sirt5 KO
AC   CVCL_D9WA
SY   Sirt5 Knockout cell line (HL-1)
DR   Ubigene; YKO-M018
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1915596; Sirt5.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Heart, left atrium; UBERON=UBERON_0002079.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
CC   Breed/subspecies: C3HeB/FeJ transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0303 ! HL-1
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HMC3 CLEC3B KO
AC   CVCL_D9WB
SY   CLEC3B Knockout cell line (HMC3)
DR   Ubigene; YKO-H1120
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11891; CLEC3B.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Cell type: Microglial cell; CL=CL_0000129.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_II76 ! HMC3
SX   Sex unspecified
AG   8-10FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HSC-3 IGF2BP2 KO
AC   CVCL_D9WC
SY   IGF2BP2 Knockout cell line (HSC3)
DR   Ubigene; YKO-H100
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28867; IGF2BP2.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Gly (c.1634A>G); ClinVar=VCV000013656; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs (c.912_913insTAAG); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1288 ! HSC-3
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-1080 AIFM2 KO
AC   CVCL_D9WD
SY   AIFM2 Knockout cell line (HT-1080)
DR   Ubigene; YKO-H363
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21411; AIFM2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-1080 RIPK1 KO
AC   CVCL_D9WE
SY   RIPK1 Knockout cell line (HT-1080)
DR   Ubigene; YKO-HJ060
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Arg132Cys (c.394C>T); ClinVar=VCV000375891; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, pelvis, acetabulum; UBERON=UBERON_0001269.
DI   NCIt; C3043; Fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0317 ! HT-1080
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 ESRP2 KO
AC   CVCL_D9WF
SY   ESRP2 Knockout cell line (HT-29)
DR   Ubigene; YKO-H187
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26152; ESRP2.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 ETHE1 KO
AC   CVCL_D9WG
SY   ETHE1 Knockout cell line (HT-29)
DR   Ubigene; YKO-H1125
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23287; ETHE1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 FKBP10 KO
AC   CVCL_D9WH
SY   FKBP10 Knockout cell line (HT-29)
DR   Ubigene; YKO-H210
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18169; FKBP10.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 HDGF KO
AC   CVCL_D9WI
SY   HDGF Knockout cell line (HT-29)
DR   Ubigene; YKO-H479
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4856; HDGF.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 PIEZO1 KO
AC   CVCL_D9WJ
SY   PIEZO1 Knockout cell line (HT-29)
DR   Ubigene; YKO-H073
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28993; PIEZO1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 SELENBP1 KO
AC   CVCL_D9WK
SY   SELENBP1 Knockout cell line (HT-29)
DR   Ubigene; YKO-H998
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10719; SELENBP1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 SIRT3 KO
AC   CVCL_D9WL
SY   SIRT3 Knockout cell line (HT-29)
DR   Ubigene; YKO-H196
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT-29 SQSTM1 KO
AC   CVCL_D9WM
SY   SQSTM1 Knockout cell line (HT-29)
DR   Ubigene; YKO-H917
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11280; SQSTM1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene HT22 Atg5 KO
AC   CVCL_D9WN
SY   Atg5 Knockout cell line (HT22)
DR   Ubigene; YKO-M197
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1277186; Atg5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene HT22 Atp7b KO
AC   CVCL_D9WP
SY   Atp7b Knockout cell line (HT22)
DR   Ubigene; YKO-M139
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103297; Atp7b.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene HT22 Cbs KO
AC   CVCL_D9WQ
SY   Cbs Knockout cell line (HT22)
DR   Ubigene; YKO-M159
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88285; Cbs.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene HT22 Dgcr8 KO
AC   CVCL_D9WR
SY   Dgcr8 Knockout cell line (HT22)
DR   Ubigene; YKO-M196
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2151114; Dgcr8.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene HT22 Lox KO
AC   CVCL_D9WS
SY   Lox Knockout cell line (HT22)
DR   Ubigene; YKO-M005
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96817; Lox.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene HT22 Prlr KO
AC   CVCL_D9WT
SY   Prlr Knockout cell line (HT22)
DR   Ubigene; YKO-M116
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97763; Prlr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Cell type: Neuron; CL=CL_0000540.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0321 ! HT22
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene HTR-8/SVneo EPO KO
AC   CVCL_D9WU
SY   EPO Knockout cell line (HTR-8/SVneo)
DR   Ubigene; YKO-H306
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3415; EPO.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HTR-8/SVneo GSDMB KO
AC   CVCL_D9WV
SY   GSDMB Knockout cell line (HTR-8/SVneo)
DR   Ubigene; YKO-H233
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23690; GSDMB.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HTR-8/SVneo GSDMD KO
AC   CVCL_D9WW
SY   GSDMD Knockout cell line (HTR-8/SVneo)
DR   Ubigene; YKO-H257
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HTR-8/SVneo SMAD4 KO
AC   CVCL_D9WX
SY   SMAD4 Knockout cell line (HTR-8/SVneo)
DR   Ubigene; YKO-H087
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6770; SMAD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene HTR-8/SVneo TREM1 KO
AC   CVCL_D9WY
SY   TREM1 Knockout cell line (HTR-8/SVneo)
DR   Ubigene; YKO-H301
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17760; TREM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Trophoblast; UBERON=UBERON_0000088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7162 ! HTR-8/SVneo
SX   Sex unspecified
AG   6-12FW
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 ALDH5A1 KO
AC   CVCL_E0VE
SY   ALDH5A1 Knockout cell line (HuH-7)
DR   Ubigene; YKO-H829
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:408; ALDH5A1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 ATG5 KO
AC   CVCL_E0VF
SY   ATG5 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H046
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H046; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 BCAT1 KO
AC   CVCL_E0VG
SY   BCAT1 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H418
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:976; BCAT1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 DCP1A KO
AC   CVCL_E0VH
SY   DCP1A Knockout cell line (Huh-7)
DR   Ubigene; YKO-H495
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18714; DCP1A.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H495; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 DCP1B KO
AC   CVCL_E0VI
SY   DCP1B Knockout cell line (Huh-7)
DR   Ubigene; YKO-H867
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24451; DCP1B.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H867; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 DKKL1 KO
AC   CVCL_E0VJ
SY   DKKL1 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H006
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16528; DKKL1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 EIF4ENIF1 KO
AC   CVCL_E0VK
SY   EIF4ENIF1 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H494
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16687; EIF4ENIF1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H494; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 FAM216A KO
AC   CVCL_E0VL
SY   FAM216A Knockout cell line (Huh-7)
DR   Ubigene; YKO-H523
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30180; FAM216A.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 FBXO28 KO
AC   CVCL_E0VM
SY   FBXO28 Knockout cell line (Huh-7)
DR   Ubigene; YKO-KP180
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29046; FBXO28.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 GSDME KO
AC   CVCL_E0VN
SY   GSDME Knockout cell line (Huh-7)
DR   Ubigene; YKO-H227
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2810; GSDME.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H227; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 HMGB2 KO
AC   CVCL_E0VP
SY   HMGB2 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H255
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5000; HMGB2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 LDHA KO
AC   CVCL_E0VQ
SY   LDHA Knockout cell line (Huh-7)
DR   Ubigene; YKO-H524
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H524; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 LDHB KO
AC   CVCL_E0VR
SY   LDHB Knockout cell line (Huh-7)
DR   Ubigene; YKO-H525
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6541; LDHB.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H525; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 LEAP2 KO
AC   CVCL_E0VS
SY   LEAP2 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H150
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29571; LEAP2.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 NOTCH3 KO
AC   CVCL_E0VT
SY   NOTCH3 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H415
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7883; NOTCH3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 NR1H4 KO
AC   CVCL_E0VU
SY   NR1H4 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H660
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7967; NR1H4.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 NUP133 KO
AC   CVCL_E0VV
SY   NUP133 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H982
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18016; NUP133.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H982; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene Huh-7 PFKFB3 KO
AC   CVCL_E0VW
SY   PFKFB3 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H030
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8874; PFKFB3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 PNPLA3 KO
AC   CVCL_E0VX
SY   PNPLA3 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H322
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18590; PNPLA3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 SCUBE3 KO
AC   CVCL_E0VY
SY   SCUBE3 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H922
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13655; SCUBE3.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Huh-7 TREM1 KO
AC   CVCL_E0VZ
SY   TREM1 Knockout cell line (Huh-7)
DR   Ubigene; YKO-H838
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17760; TREM1.
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:20932; POLD3; Simple; p.Lys109Arg (c.326A>G) (p.Lys70Arg, c.209A>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0336 ! Huh-7
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ID8 Arid1a KO
AC   CVCL_E0W3
SY   Arid1a Knockout cell line (ID8)
DR   Ubigene; YKO-M145
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1935147; Arid1a.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Atrx KO
AC   CVCL_E0W4
SY   Atrx Knockout cell line (ID8)
DR   Ubigene; YKO-M149
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103067; Atrx.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Fat1 KO
AC   CVCL_E0W5
SY   Fat1 Knockout cell line (ID8)
DR   Ubigene; YKO-M151
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109168; Fat1.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Hk2 KO
AC   CVCL_E0W6
SY   Hk2 Knockout cell line (ID8)
DR   Ubigene; YKO-R071
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1315197; Hk2.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Kmt2c KO
AC   CVCL_E0W7
SY   Kmt2c Knockout cell line (ID8)
DR   Ubigene; YKO-M147
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2444959; Kmt2c.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Kmt2d KO
AC   CVCL_E0W8
SY   Kmt2d Knockout cell line (ID8)
DR   Ubigene; YKO-M148
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2682319; Kmt2d.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Rb1 KO
AC   CVCL_E0W9
SY   Rb1 Knockout cell line (ID8)
DR   Ubigene; YKO-M150
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97874; Rb1.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene ID8 Smarca4 KO
AC   CVCL_E0WA
SY   Smarca4 Knockout cell line (ID8)
DR   Ubigene; YKO-M146
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88192; Smarca4.
CC   Derived from site: In situ; Ovary, surface epithelium; UBERON=UBERON_0001304.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_IU14 ! ID8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene IPEC-J2 ANPEP KO
AC   CVCL_E0WB
SY   ANPEP Knockout cell line (IPEC-J2)
DR   Ubigene; YKO-RJ011
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:85362; ANPEP.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene IPEC-J2 GDPD2 KO
AC   CVCL_E0WC
SY   GDPD2 Knockout cell line (IPEC-J2)
DR   Ubigene; YKO-RJ014
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:88407; GDPD2.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene IPEC-J2 KLF4 KO
AC   CVCL_E0WD
SY   KLF4 Knockout cell line (IPEC-J2)
DR   Ubigene; YKO-RJ013
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:98062; KLF4.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene IPEC-J2 YTHDF2 KO
AC   CVCL_E0WE
SY   YTHDF2 Knockout cell line (IPEC-J2)
DR   Ubigene; YKO-R064
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:95043; YTHDF2.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
CC   Cell type: Enterocyte; CL=CL_0000584.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2246 ! IPEC-J2
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene JIMT-1 LGALS3 KO
AC   CVCL_E0WF
SY   LGALS3 Knockout cell line (JIMT-1)
DR   Ubigene; YKO-H121
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6563; LGALS3.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4017; Breast ductal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2077 ! JIMT-1
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 CARD8 KO
AC   CVCL_E0WG
SY   CARD8 Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H771
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17057; CARD8.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 CXCR4 KO
AC   CVCL_E0WJ
SY   CXCR4 Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H533
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 DGKZ KO
AC   CVCL_E0WH
SY   DGKZ Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H203
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2857; DGKZ.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 JAK3 KO
AC   CVCL_E0WK
SY   JAK3 Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H763
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6193; JAK3.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 LRBA KO
AC   CVCL_E0WI
SY   LRBA Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H396
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1742; LRBA.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 PRG2 KO
AC   CVCL_E0WL
SY   PRG2 Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H618
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9362; PRG2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Jurkat, Clone E6-1 TPCN2 KO
AC   CVCL_E0WM
SY   TPCN2 Knockout cell line (Jurkat, Clone E6-1)
DR   Ubigene; YKO-H069
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11491; SYK; Simple; p.Met34Hisfs*3 (c.98_99insG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0367 ! Jurkat E6.1
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene K-562 PIGA KO
AC   CVCL_E0WN
SY   PIGA Knockout cell line (K-562)
DR   Ubigene; YKO-H109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8957; PIGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene K-562 RAPSN KO
AC   CVCL_E0WP
SY   RAPSN Knockout cell line (K-562)
DR   Ubigene; YKO-HJ102
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9863; RAPSN.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene K-562 RBKS KO
AC   CVCL_E0WQ
SY   RBKS Knockout cell line (K-562)
DR   Ubigene; YKO-H303
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30325; RBKS.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene K-562 SET KO
AC   CVCL_E0WR
SY   SET Knockout cell line (K-562)
DR   Ubigene; YKO-HJ101
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10760; SET.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene K-562 SLC39A8 KO
AC   CVCL_E0WS
SY   SLC39A8 Knockout cell line (K-562)
DR   Ubigene; YKO-H077
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene K-562 TMEM187 KO
AC   CVCL_E0WT
SY   TMEM187 Knockout cell line (K-562)
DR   Ubigene; YKO-HJ021
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13705; TMEM187.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-150 MCM10 KO
AC   CVCL_E0WU
SY   MCM10 Knockout cell line (KYSE-150)
DR   Ubigene; YKO-HJ090
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18043; MCM10.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-150 SLC25A5 KO
AC   CVCL_E0WV
SY   SLC25A5 Knockout cell line (KYSE-150)
DR   Ubigene; YKO-H138
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10991; SLC25A5.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H138; true.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1348 ! KYSE-150
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene KYSE-30 CCHCR1 KO
AC   CVCL_E0WW
SY   CCHCR1 Knockout cell line (KYSE-30)
DR   Ubigene; YKO-HJ023
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13930; CCHCR1.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-30 CYP26B1 KO
AC   CVCL_E0WX
SY   CYP26B1 Knockout cell line (KYSE-30)
DR   Ubigene; YKO-HJ033
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20581; CYP26B1.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-30 DDAH2 KO
AC   CVCL_E0WY
SY   DDAH2 Knockout cell line (KYSE-30)
DR   Ubigene; YKO-HJ024
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2716; DDAH2.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-30 FASN KO
AC   CVCL_E0WZ
SY   FASN Knockout cell line (KYSE-30)
DR   Ubigene; YKO-HJ034
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3594; FASN.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-30 MCM10 KO
AC   CVCL_E0X0
SY   MCM10 Knockout cell line (KYSE-30)
DR   Ubigene; YKO-HJ089
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18043; MCM10.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-30 TNXB KO
AC   CVCL_E0X1
SY   TNXB Knockout cell line (KYSE-30)
DR   Ubigene; YKO-HJ025
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11976; TNXB.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene KYSE-30 ZNF750 KO
AC   CVCL_E0X2
SY   ZNF750 Knockout cell line (KYSE-30)
DR   Ubigene; YKO-H028
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25843; ZNF750.
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu120Ter (c.358G>T); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000376033; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-22del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>G (IVS6-2A>G); ClinVar=VCV000458555; Zygosity=Unspecified; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1351 ! KYSE-30
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene L-02 ACSL4 KO
AC   CVCL_E0X3
SY   ACSL4 Knockout cell line (L-02)
DR   Ubigene; YKO-H104
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3571; ACSL4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene L-02 EIF2AK4 KO
AC   CVCL_E0X4
SY   EIF2AK4 Knockout cell line (L-02)
DR   Ubigene; YKO-H845
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19687; EIF2AK4.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene L-02 HIF1A KO
AC   CVCL_E0X5
SY   HIF1A Knockout cell line (L-02)
DR   Ubigene; YKO-H877
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4910; HIF1A.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene L-02 OLA1 KO
AC   CVCL_E0X6
SY   OLA1 Knockout cell line (L-02)
DR   Ubigene; YKO-H869
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28833; OLA1.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene L-02 TFEB KO
AC   CVCL_E0X7
SY   TFEB Knockout cell line (L-02)
DR   Ubigene; YKO-H032
CC   Problematic cell line: Contaminated. Parent cell line (L-02) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11753; TFEB.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6926 ! L-02
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene LbetaT2 Foxk2 KO
AC   CVCL_E0X8
SY   Foxk2 Knockout cell line (Lbetat2)
DR   Ubigene; YKO-M015
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916087; Foxk2.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pituitary gland; UBERON=UBERON_0000007.
CC   Breed/subspecies: C57BL/6 x BALB/c transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0398 ! LbetaT2
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene LLC Keap1 KO
AC   CVCL_E0X9
SY   Keap1 Knockout cell line (LLC)
DR   Ubigene; YKO-M050
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1858732; Keap1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene LLC Nadk2 KO
AC   CVCL_E0XA
SY   Nadk2 Knockout cell line (LLC)
DR   Ubigene; YKO-M215
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1915896; Nadk2.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4358 ! LL/2 (LLC1)
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene LLC-MK2 APOE KO
AC   CVCL_E0XB
SY   APOE Knockout cell line (LLC-MK2)
DR   Ubigene; YKO-RJ001
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:108468; APOE.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
HI   CVCL_3009 ! LLC-MK2
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LMH MYH9 KO
AC   CVCL_E0XC
SY   MYH9 Knockout cell line (LMH)
DR   Ubigene; YKO-R046
CC   Group: Bird cell line.
CC   Knockout cell: Method=CRISPR/Cas9; CGNC; 49820; MYH9.
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: White Leghorn L-M.
DI   NCIt; C134558; Chicken hepatoma
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
HI   CVCL_2580 ! LMH
SX   Male
AG   1Y4M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LN-229 PICALM KO
AC   CVCL_E0XD
SY   PICALM Knockout cell line (LN-229)
DR   Ubigene; YKO-HJ084
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15514; PICALM.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LN-229 RSRP1 KO
AC   CVCL_E0XE
SY   RSRP1 Knockout cell line (LN-229)
DR   Ubigene; YKO-HJ072
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25234; RSRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:6597; LIFR; Simple; p.Pro1060Ala (c.3178C>G); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9811; RAD21; Simple; p.Gln132Ter (c.394C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro98Leu (c.293C>T); ClinVar=VCV000528236; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain, right frontal parieto-occipital cortex.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0393 ! LN-229
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LNCAP Clone FGC BRCA2 KO
AC   CVCL_E0XF
SY   BRCA2 Knockout cell line (LNCAP Clone FGC)
DR   Ubigene; YKO-H1090
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1101; BRCA2.
CC   Sequence variation: Mutation; HGNC; HGNC:644; AR; Simple; p.Thr878Ala (c.2632A>G); ClinVar=VCV000009831; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7010; MEN1; Simple; p.Tyr318Ter (c.954T>G) (p.Tyr313Ter, c.939T>A); ClinVar=VCV000439894; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; p.Arg639Ter (c.1915C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys6Argfs*4 (c.17_18delAA); ClinVar=VCV000231649; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1379 ! LNCaP clone FGC
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LoVo ATF1 KO
AC   CVCL_E0XG
SY   ATF1 Knockout cell line (LoVo)
DR   Ubigene; YKO-HJ045
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:783; ATF1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LoVo OLA1 KO
AC   CVCL_E0XH
SY   OLA1 Knockout cell line (LoVo)
DR   Ubigene; YKO-HJ083
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28833; OLA1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg1114Ter (c.3340C>T); ClinVar=VCV000236589; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Met1431fs*42 (c.4289delC) (p.T1430fs); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg2816Gln (c.8447G>A); ClinVar=VCV000419681; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Leu15Phefs*41 (c.43_44delCT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6768; SMAD2; Simple; p.Ala292Val (c.875C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Left supraclavicular lymph node; UBERON=UBERON_8480056.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0399 ! LoVo
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene LS174T HMGB1 KO
AC   CVCL_E0XI
SY   HMGB1 Knockout cell line (LS 174T)
DR   Ubigene; YKO-H913
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4983; HMGB1.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1384 ! LS174T
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MC-38 Alkbh1 KO
AC   CVCL_E0XJ
SY   Alkbh1 Knockout cell line (MC38)
DR   Ubigene; YKO-M110
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2384034; Alkbh1.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Arid1a KO
AC   CVCL_E0XK
SY   Arid1a Knockout cell line (MC38)
DR   Ubigene; YKO-M131
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1935147; Arid1a.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Arid2 KO
AC   CVCL_E0XL
SY   Arid2 Knockout cell line (MC38)
DR   Ubigene; YKO-M142
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924294; Arid2.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Atrx KO
AC   CVCL_E0XM
SY   Atrx Knockout cell line (MC38)
DR   Ubigene; YKO-M128
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103067; Atrx.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 B2m KO
AC   CVCL_E0XN
SY   B2m Knockout cell line (MC38)
DR   Ubigene; YKO-R034
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Cd274 KO
AC   CVCL_E0XP
SY   Cd274 Knockout cell line (MC38)
DR   Ubigene; YKO-M099
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1926446; Cd274.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Cd276 KO
AC   CVCL_E0XQ
SY   Cd276 Knockout cell line (MC38)
DR   Ubigene; YKO-M098
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2183926; Cd276.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Cd38 KO
AC   CVCL_E0XR
SY   Cd38 Knockout cell line (MC38)
DR   Ubigene; YKO-M207
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107474; Cd38.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Cd47 KO
AC   CVCL_E0XS
SY   Cd47 Knockout cell line (MC38)
DR   Ubigene; YKO-M095
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96617; Cd47.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Epha2 KO
AC   CVCL_E0XT
SY   Epha2 Knockout cell line (MC38)
DR   Ubigene; YKO-M199
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95278; Epha2.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Erbb2 KO
AC   CVCL_E0XU
SY   Erbb2 Knockout cell line (MC38)
DR   Ubigene; YKO-M094
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95410; Erbb2.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Fat1 KO
AC   CVCL_E0XW
SY   Fat1 Knockout cell line (MC38)
DR   Ubigene; YKO-M126
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:109168; Fat1.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Il1r1 KO
AC   CVCL_E0XX
SY   Il1r1 Knockout cell line (MC38)
DR   Ubigene; YKO-M226
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96545; Il1r1.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Kmt2c KO
AC   CVCL_E0XY
SY   Kmt2c Knockout cell line (MC38)
DR   Ubigene; YKO-M130
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2444959; Kmt2c.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Kmt2d KO
AC   CVCL_E0XZ
SY   Kmt2d Knockout cell line (MC38)
DR   Ubigene; YKO-M129
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2682319; Kmt2d.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Lrpprc KO
AC   CVCL_E0Y0
SY   Lrpprc Knockout cell line (MC38)
DR   Ubigene; YKO-M077
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919666; Lrpprc.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Mif KO
AC   CVCL_E0Y1
SY   Mif Knockout cell line (MC38)
DR   Ubigene; YKO-M105
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96982; Mif.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Rb1 KO
AC   CVCL_E0Y2
SY   Rb1 Knockout cell line (MC38)
DR   Ubigene; YKO-M127
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97874; Rb1.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Siglec15 KO
AC   CVCL_E0Y3
SY   Siglec15 Knockout cell line (MC38)
DR   Ubigene; YKO-M093
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3646642; Siglec15.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Tnfrsf10b KO
AC   CVCL_E0Y4
SY   Tnfrsf10b Knockout cell line (MC38)
DR   Ubigene; YKO-M069
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1341090; Tnfrsf10b.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Tnfrsf14 KO
AC   CVCL_E0Y5
SY   Tnfrsf14(HVEM) Knockout cell line (MC38)
DR   Ubigene; YKO-HP003
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2675303; Tnfrsf14.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Tnfrsf17 KO
AC   CVCL_E0Y6
SY   Tnfrsf17(BCMA) Knockout cell line (MC38)
DR   Ubigene; YKO-HP007
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1343050; Tnfrsf17.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Tnfrsf1b KO
AC   CVCL_E0Y7
SY   Tnfrsf1b Knockout cell line (MC38)
DR   Ubigene; YKO-M012
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1314883; Tnfrsf1b.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC-38 Ythdf1 KO
AC   CVCL_E0Y8
SY   Ythdf1 Knockout cell line (MC38)
DR   Ubigene; YKO-M078
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917431; Ythdf1.
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C120044; Mouse colon adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B288 ! MC-38
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 27-11-25; Version: 2
//
ID   Ubigene MC3T3-E1 Subclone 14 Clk4 KO
AC   CVCL_E0Y9
SY   Clk4 Knockout cell line (MC3T3-E1)
DR   Ubigene; YKO-M004
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1098551; Clk4.
CC   Discontinued: Ubigene; YKO-M004; true.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5437 ! MC3T3-E1 Subclone 14
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene MC3T3-E1 Subclone 14 Egfr KO
AC   CVCL_E0YA
SY   Egfr Knockout cell line (MC3T3-E1)
DR   Ubigene; YKO-M008
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95294; Egfr.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5437 ! MC3T3-E1 Subclone 14
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene MC3T3-E1 Subclone 14 Notum KO
AC   CVCL_E0YB
SY   Notum Knockout cell line (MC3T3-E1)
DR   Ubigene; YKO-M019
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1924833; Notum.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5437 ! MC3T3-E1 Subclone 14
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene MC3T3-E1 Subclone 14 Npnt KO
AC   CVCL_E0YC
SY   Npnt Knockout cell line (MC3T3-E1)
DR   Ubigene; YKO-M002
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2148811; Npnt.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5437 ! MC3T3-E1 Subclone 14
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene MC3T3-E1 Subclone 14 Tsc1 KO
AC   CVCL_E0YD
SY   Tsc1 Knockout cell line (MC3T3-E1 Subclone 14)
DR   Ubigene; YKO-M060
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929183; Tsc1.
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5437 ! MC3T3-E1 Subclone 14
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene MCF-7 CAV1 KO
AC   CVCL_E0YE
SY   CAV1 Knockout cell line (MCF7)
DR   Ubigene; YKO-H254
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1527; CAV1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MCF-7 NCOA3 KO
AC   CVCL_E0YF
SY   NCOA3 Knockout cell line (MCF7)
DR   Ubigene; YKO-H159
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7670; NCOA3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MCF-7 OVOL2 KO
AC   CVCL_E0YG
SY   OVOL2 Knockout cell line (MCF7)
DR   Ubigene; YKO-HJ094
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15804; OVOL2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MCF-7 RABL6 KO
AC   CVCL_E0YH
SY   RABL6 Knockout cell line (MCF7)
DR   Ubigene; YKO-H1117
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24703; RABL6.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 DRD2 KO
AC   CVCL_E0YI
SY   DRD2 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H190
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3023; DRD2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 FABP5 KO
AC   CVCL_E0YJ
SY   FABP5 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H509
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3560; FABP5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 IL4I1 KO
AC   CVCL_E0YK
SY   IL4I1 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H410
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19094; IL4I1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 LAMTOR5 KO
AC   CVCL_E0YL
SY   LAMTOR5 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H367
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17955; LAMTOR5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 NLGN4X KO
AC   CVCL_E0YM
SY   NLGN4X Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H098
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14287; NLGN4X.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 PKM KO
AC   CVCL_E0YN
SY   PKM Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H014
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9021; PKM.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 RIPK1 KO
AC   CVCL_E0YP
SY   RIPK1 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-HJ061
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 RNF114 KO
AC   CVCL_E0YQ
SY   RNF114 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H699
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13094; RNF114.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 SHMT2 KO
AC   CVCL_E0YR
SY   SHMT2 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-H866
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDA-MB-231 ZNF217 KO
AC   CVCL_E0YS
SY   ZNF217 Knockout cell line (MDA-MB-231)
DR   Ubigene; YKO-HJ047
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13009; ZNF217.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK ANP32A KO
AC   CVCL_E0YT
SY   ANP32A Knockout cell line (MDCK)
DR   Ubigene; YKO-R002
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112752; ANP32A.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK CADM1 KO
AC   CVCL_E0YU
SY   CADM1 Knockout cell line (MDCK)
DR   Ubigene; YKO-R072
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:38655; CADM1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK GSR KO
AC   CVCL_E0YV
SY   GSR Knockout cell line (MDCK)
DR   Ubigene; YKO-R011
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:110510; GSR.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK JAM2 KO
AC   CVCL_E0YW
SY   JAM2 Knockout cell line (MDCK)
DR   Ubigene; YKO-R062
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:53029; JAM2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK JAM3 KO
AC   CVCL_E0YX
SY   JAM3 Knockout cell line (MDCK)
DR   Ubigene; YKO-R067
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:53419; JAM3.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK L1CAM KO
AC   CVCL_E0YY
SY   L1CAM Knockout cell line (MDCK)
DR   Ubigene; YKO-R073
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:42556; L1CAM.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK MAS1 KO
AC   CVCL_E0YZ
SY   MAS1 Knockout cell line (MDCK)
DR   Ubigene; YKO-R041
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111563; MAS1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK NPHP1 KO
AC   CVCL_E0Z0
SY   NPHP1 Knockout cell line (MDCK)
DR   Ubigene; YKO-R012
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:43918; NPHP1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK STAT1 KO
AC   CVCL_E0Z1
SY   STAT1 Knockout cell line (MDCK)
DR   Ubigene; YKO-R015
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112730; STAT1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MDCK TGM2 KO
AC   CVCL_E0Z2
SY   TGM2 Knockout cell line (MDCK)
DR   Ubigene; YKO-R006
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:47316; TGM2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MG-63 CD276 KO
AC   CVCL_E0Z3
SY   CD276 Knockout cell line (MG-63)
DR   Ubigene; YKO-HJ009
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19137; CD276.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MG-63 DCX KO
AC   CVCL_E0Z4
SY   DCX Knockout cell line (MG-63)
DR   Ubigene; YKO-H884
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2714; DCX.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, left femur; UBERON=UBERON_0000981.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0426 ! MG-63
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MGC-803 DSC2 KO
AC   CVCL_E0Z6
SY   DSC2 Knockout cell line (MGC80-3)
DR   Ubigene; YKO-H037
CC   Problematic cell line: Contaminated. Parent cell line (MGC-803) seems to be a derivative of HeLa and probably of a gastric cancer cell.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3036; DSC2.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Proteomics; Subcellular; Secretome; 2DE-MS.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5334 ! MGC-803
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   Ubigene MLO-Y4 Tnfsf11 KO
AC   CVCL_E0Z7
SY   Tnfsf11 Knockout cell line (MLO-Y4)
DR   Ubigene; YKO-M055
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1100089; Tnfsf11.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, long bone; UBERON=UBERON_0002495.
CC   Cell type: Osteocyte; CL=CL_0000137.
CC   Breed/subspecies: (C57BL/6J x BALB/cJ) F2 Bgla promoter T-Ag transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_M098 ! MLO-Y4
SX   Sex unspecified
AG   14D
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene MODE-K Gpx4 KO
AC   CVCL_E0Z8
SY   Gpx4 Knockout cell line (MODE-K)
DR   Ubigene; YKO-M156
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104767; Gpx4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4FG ! MODE-K
SX   Female
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene MODE-K Hsp90ab1 KO
AC   CVCL_E0Z9
SY   Hsp90ab1 Knockout cell line (MODE-K)
DR   Ubigene; YKO-M210
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96247; Hsp90ab1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
CC   Cell type: Epithelial cell of intestine; CL=CL_0002563.
CC   Breed/subspecies: C3H/HeJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B4FG ! MODE-K
SX   Female
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene MPC-5 Tollip KO
AC   CVCL_E0ZA
SY   Tollip Knockout cell line (MPC-5)
DR   Ubigene; YKO-M112
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1891808; Tollip.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Podocyte; CL=CL_0000653.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AS87 ! MPC-5
SX   Sex unspecified
AG   10W
CA   Conditionally immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene MS751 KMT2D KO
AC   CVCL_E0ZB
SY   KMT2D Knockout cell line (MS751)
DR   Ubigene; YKO-H766
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7133; KMT2D.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCBI_TaxID; 10593; Human papillomavirus type 45 (HPV45).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4996 ! MS751
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene MSTO-211H LDHA KO
AC   CVCL_E0ZC
SY   LDHA Knockout cell line (MSTO-211H)
DR   Ubigene; YKO-H910
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6514; LATS1 + HGNC; HGNC:9508; PSEN1; Name(s)=LATS1-PSEN1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6515; LATS2; Simple; p.Met785_Leu798del14 (c.2355_2396del42); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1430 ! MSTO-211H
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene N2A Aldh2 KO
AC   CVCL_E0ZD
SY   Aldh2 Knockout cell line (N2A)
DR   Ubigene; YKO-MJ009
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99600; Aldh2.
CC   Derived from site: In situ; Peripheral nervous system; UBERON=UBERON_0000010.
CC   Cell type: Neural crest derived neuroblast; CL=CL_0002676.
CC   Breed/subspecies: A/J.
DI   NCIt; C21993; Mouse neuroblastoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0470 ! Neuro-2a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene NB4 TLN1 KO
AC   CVCL_E0ZE
SY   TLN1 Knockout cell line (NB4)
DR   Ubigene; YKO-H400
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11845; TLN1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala18Asp (c.53C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0005 ! NB4
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 ARID1A KO
AC   CVCL_E0ZF
SY   ARID1A Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H416
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11110; ARID1A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 ATG5 KO
AC   CVCL_E0ZG
SY   ATG5 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H238
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:589; ATG5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 ATG9A KO
AC   CVCL_E0ZH
SY   ATG9A Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H062
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:22408; ATG9A.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 CCDC86 KO
AC   CVCL_E0ZI
SY   CCDC86 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H516
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28359; CCDC86.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 IL6ST KO
AC   CVCL_E0ZJ
SY   IL6ST Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H249
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6021; IL6ST.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 KREMEN1 KO
AC   CVCL_E0ZK
SY   KREMEN1 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H011
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17550; KREMEN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 LIFR KO
AC   CVCL_E0ZL
SY   LIFR Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H318
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6597; LIFR.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 PIM1 KO
AC   CVCL_E0ZM
SY   PIM1 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H369
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8986; PIM1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 SCARB2 KO
AC   CVCL_E0ZN
SY   SCARB2 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H012
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1665; SCARB2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 SGMS2 KO
AC   CVCL_E0ZP
SY   SGMS2 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H865
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28395; SGMS2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 SLC9A3 KO
AC   CVCL_E0ZQ
SY   SLC9A3 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H344
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11073; SLC9A3.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1299 ZDHHC5 KO
AC   CVCL_E0ZR
SY   ZDHHC5 Knockout cell line (NCI-H1299)
DR   Ubigene; YKO-H795
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18472; ZDHHC5.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0060 ! NCI-H1299
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H1975 BAD KO
AC   CVCL_E0ZS
SY   BAD Knockout cell line (NCI-H1975)
DR   Ubigene; YKO-H1099
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:936; BAD.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gly118Asp (c.353G>A); ClinVar=VCV000156446; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1511 ! NCI-H1975
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NCI-H292 EPCAM KO
AC   CVCL_E0ZT
SY   EPCAM Knockout cell line (NCI-H292)
DR   Ubigene; YKO-H780
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11529; EPCAM.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Pro496Thrfs*8 (c.1484_1485insA); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C45544; Lung mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0455 ! NCI-H292
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NIH/3T3 Bdnf KO
AC   CVCL_E0ZU
SY   Bdnf Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M068
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88145; Bdnf.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Dnm3os KO
AC   CVCL_E0ZV
SY   Dnm3os Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M029
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3052332; Dnm3os.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Fabp4 KO
AC   CVCL_E0ZW
SY   Fabp4 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M154
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88038; Fabp4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Mecp2 KO
AC   CVCL_E0ZX
SY   Mecp2 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-MJ014
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99918; Mecp2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Pdk4 KO
AC   CVCL_E0ZY
SY   Pdk4 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M106
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1351481; Pdk4.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Ppp2r1b KO
AC   CVCL_E0ZZ
SY   Ppp2r1b Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-MJ013
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1920949; Ppp2r1b.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Prmt2 KO
AC   CVCL_E1A0
SY   Prmt2 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M192
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1316652; Prmt2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Rock1 KO
AC   CVCL_E1A1
SY   Rock1 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-MJ005
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107927; Rock1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Tfap2a KO
AC   CVCL_E1A2
SY   Tfap2a Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-MJ011
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104671; Tfap2a.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Tns1 KO
AC   CVCL_E1A3
SY   Tns1 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M171
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104552; Tns1.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Tsc2 KO
AC   CVCL_E1A4
SY   Tsc2 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M006
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:102548; Tsc2.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIH/3T3 Usp20 KO
AC   CVCL_E1A5
SY   Usp20 Knockout cell line (NIH/3T3)
DR   Ubigene; YKO-M054
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1921520; Usp20.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene NIT-1 Esr1 KO
AC   CVCL_E1A6
SY   Esr1 Knockout cell line (NIT-1)
DR   Ubigene; YKO-M063
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1352467; Esr1.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NOD/Lt-Tg(RIPTag)1Lt transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3561 ! NIT-1
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene NIT-1 Fto KO
AC   CVCL_E1A7
SY   Fto Knockout cell line (NIT-1)
DR   Ubigene; YKO-M213
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1347093; Fto.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NOD/Lt-Tg(RIPTag)1Lt transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3561 ! NIT-1
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene NIT-1 Ythdc2 KO
AC   CVCL_E1A8
SY   Ythdc2 Knockout cell line (NIT-1)
DR   Ubigene; YKO-M203
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2448561; Ythdc2.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Pancreas, islets of Langerhans; UBERON=UBERON_0000006.
CC   Cell type: Pancreatic beta cell; CL=CL_0000169.
CC   Breed/subspecies: NOD/Lt-Tg(RIPTag)1Lt transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3561 ! NIT-1
SX   Female
AG   10W
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene NK-92 FCER1G KO
AC   CVCL_E1A9
SY   FCER1G Knockout cell line (NK-92)
DR   Ubigene; YKO-H1109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3611; FCER1G.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2142 ! NK-92
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene NRK-52E Slc39a7 KO
AC   CVCL_E1AA
SY   Slc39a7 Knockout cell line (NRK-52E)
DR   Ubigene; YKO-R063
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1593280; Slc39a7.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Osborne-Mendel; RS=RS_0000629.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0468 ! NRK-52E
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene NSC-34 Sigmar1 KO
AC   CVCL_E1AB
SY   Sigmar1 Knockout cell line (NSC34)
DR   Ubigene; YKO-M168
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1195268; Sigmar1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D356 ! NSC-34
CA   Hybrid cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene OVCAR-3 CDR1 KO
AC   CVCL_E1AC
SY   CDR1 Knockout cell line (OVCAR-3)
DR   Ubigene; YKO-H123
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1798; CDR1.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene OVCAR-3 CDR2 KO
AC   CVCL_E1AD
SY   CDR2 Knockout cell line (OVCAR-3)
DR   Ubigene; YKO-H095
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1799; CDR2.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene OVCAR-3 CDR2L KO
AC   CVCL_E1AE
SY   CDR2L Knockout cell line (OVCAR-3)
DR   Ubigene; YKO-H096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29999; CDR2L.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene OVCAR-3 DVL3 KO
AC   CVCL_E1AF
SY   DVL3 Knockout cell line (OVCAR-3)
DR   Ubigene; YKO-H500
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3087; DVL3.
CC   Sequence variation: Mutation; HGNC; HGNC:8979; PIK3R1; Simple; c.1746-2A>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0465 ! OVCAR-3
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Panc02 Bhlhe40 KO
AC   CVCL_E1AG
SY   Bhlhe40 Knockout cell line (Pan-02)
DR   Ubigene; YKO-M217
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1097714; Bhlhe40.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene Panc02 Cd44 KO
AC   CVCL_E1AH
SY   Cd44 Knockout cell line (Pan-02)
DR   Ubigene; YKO-M022
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88338; Cd44.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D627 ! Panc02
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PANC-1 ACLY KO
AC   CVCL_E1AI
SY   ACLY Knockout cell line (PANC-1)
DR   Ubigene; YKO-H555
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:115; ACLY.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PANC-1 CAV2 KO
AC   CVCL_E1AJ
SY   CAV2 Knockout cell line (PANC-1)
DR   Ubigene; YKO-HJ043
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1528; CAV2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PANC-1 PTEN KO
AC   CVCL_E1AK
SY   PTEN Knockout cell line (PANC-1)
DR   Ubigene; YKO-HJ117
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9588; PTEN.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0480 ! PANC-1
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PC-3 DLX1 KO
AC   CVCL_E1AN
SY   DLX1 Knockout cell line (PC-3)
DR   Ubigene; YKO-HJ109
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2914; DLX1.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PC-3 SNORD48 KO
AC   CVCL_E1AP
SY   SNORD48 Knockout cell line (PC-3)
DR   Ubigene; YKO-H112
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10188; SNORD48.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PC12 Gga3 KO
AC   CVCL_E1AL
SY   Gga3 Knockout cell line (PC-12)
DR   Ubigene; YKO-R056
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 1309553; Gga3.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene PC12 Slc38a2 KO
AC   CVCL_E1AM
SY   Slc38a2 Knockout cell line (PC-12)
DR   Ubigene; YKO-R055
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 69420; Slc38a2.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: NEDH; RS=RS_0000603.
DI   NCIt; C121568; Rat adrenal gland pheochromocytoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0481 ! PC12
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene PK-15 ATG5 KO
AC   CVCL_E1AQ
SY   ATG5 Knockout cell line (PK-15)
DR   Ubigene; YKO-R025
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:103029; ATG5.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PK-15 EEF1B2 KO
AC   CVCL_E1AR
SY   EEF1B2 Knockout cell line (PK-15)
DR   Ubigene; YKO-R053
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112739; EEF1B2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PK-15 PGAM5 KO
AC   CVCL_E1AS
SY   PGAM5 Knockout cell line (PK-15)
DR   Ubigene; YKO-R027
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:111126; PGAM5.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PK-15 RIPK3 KO
AC   CVCL_E1AT
SY   RIPK3 Knockout cell line (PK-15)
DR   Ubigene; YKO-R051
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:92320; RIPK3.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PK-15 SHMT1 KO
AC   CVCL_E1AU
SY   SHMT1 Knockout cell line (PK-15)
DR   Ubigene; YKO-R028
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:92855; SHMT1.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PK-15 SHMT2 KO
AC   CVCL_E1AV
SY   SHMT2 Knockout cell line (PK-15)
DR   Ubigene; YKO-R026
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:92856; SHMT2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene PK-15 VAMP2 KO
AC   CVCL_E1AW
SY   VAMP2 Knockout cell line (PK-15)
DR   Ubigene; YKO-R060
CC   Knockout cell: Method=CRISPR/Cas9; VGNC; VGNC:112740; VAMP2.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: Hampshire; VBO=VBO_0001146.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_2160 ! PK-15
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene RAW 264.7 AA467197 KO
AC   CVCL_E1AX
SY   AA467197 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M048
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3034182; AA467197.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Ahr KO
AC   CVCL_E1AY
SY   Ahr Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M166
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:105043; Ahr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 C3ar1 KO
AC   CVCL_E1AZ
SY   C3ar1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M209
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1097680; C3ar1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: Ubigene; YKO-M209; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene RAW 264.7 Ccdc115 KO
AC   CVCL_E1B0
SY   Ccdc115 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M175
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1916918; Ccdc115.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Cd180 KO
AC   CVCL_E1B1
SY   Cd180 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M041
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1194924; Cd180.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Cdkn1b KO
AC   CVCL_E1B2
SY   Cdkn1b Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M023
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104565; Cdkn1b.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Cgas KO
AC   CVCL_E1B3
SY   Cgas Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M233
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2442261; Cgas.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Chrna7 KO
AC   CVCL_E1B4
SY   Chrna7 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M182
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99779; Chrna7.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Coro1a KO
AC   CVCL_E1B5
SY   Coro1a Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M113
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1345961; Coro1a.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Csf3 KO
AC   CVCL_E1B6
SY   Csf3 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M061
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1339751; Csf3.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Dancr KO
AC   CVCL_E1B7
SY   Dancr Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M003
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1917286; Dancr.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Fabp5 KO
AC   CVCL_E1B8
SY   Fabp5 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M124
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:101790; Fabp5.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Fcer1g KO
AC   CVCL_E1B9
SY   Fcer1g Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M011
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95496; Fcer1g.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Fgfr3 KO
AC   CVCL_E1BA
SY   Fgfr3 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M020
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:95524; Fgfr3.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: Ubigene; YKO-M020; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene RAW 264.7 Gpx4 KO
AC   CVCL_E1BB
SY   Gpx4 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M109
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:104767; Gpx4.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Hif1a KO
AC   CVCL_E1BC
SY   Hif1a Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M042
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:106918; Hif1a.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Hmgb1 KO
AC   CVCL_E1BD
SY   Hmgb1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M031
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:96113; Hmgb1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Hsd11b1 KO
AC   CVCL_E1BE
SY   Hsd11b1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M223
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:103562; Hsd11b1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Ift140 KO
AC   CVCL_E1BF
SY   Ift140 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M064
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2146906; Ift140.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Lgals8 KO
AC   CVCL_E1BG
SY   Lgals8 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M085
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1928481; Lgals8.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Lgr4 KO
AC   CVCL_E1BH
SY   Lgr4 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M065
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1891468; Lgr4.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Mirlet7f-1 KO
AC   CVCL_E1BI
SY   Mirlet7f-1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M067
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:2676798; Mirlet7f-1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Myd88 KO
AC   CVCL_E1BJ
SY   Myd88 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M010
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108005; Myd88.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Myl12a KO
AC   CVCL_E1BK
SY   Myl12a Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M058
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914518; Myl12a.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Ncf1 KO
AC   CVCL_E1BL
SY   Ncf1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M114
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97283; Ncf1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Nfe2l2 KO
AC   CVCL_E1BM
SY   Nfe2l2 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M030
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:108420; Nfe2l2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Pik3r1 KO
AC   CVCL_E1BN
SY   Pik3r1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M125
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97583; Pik3r1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Ppt1 KO
AC   CVCL_E1BP
SY   Ppt1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M230
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1298204; Ppt1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Ptpn11 KO
AC   CVCL_E1BQ
SY   Ptpn11 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M163
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:99511; Ptpn11.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Rheb KO
AC   CVCL_E1BR
SY   Rheb Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M036
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:97912; Rheb.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 S100a8 KO
AC   CVCL_E1BS
SY   S100a8 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M072
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88244; S100a8.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Sat1 KO
AC   CVCL_E1BT
SY   Sat1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M211
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:98233; Sat1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Sdha KO
AC   CVCL_E1BU
SY   Sdha Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M101
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1914195; Sdha.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: Ubigene; YKO-M101; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene RAW 264.7 Siglec15 KO
AC   CVCL_E1BV
SY   Siglec15 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M009
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:3646642; Siglec15.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Sqstm1 KO
AC   CVCL_E1BW
SY   Sqstm1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M062
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:107931; Sqstm1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Tbk1 KO
AC   CVCL_E1BX
SY   Tbk1 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M140
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1929658; Tbk1.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Tsc2 KO
AC   CVCL_E1BY
SY   Tsc2 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M086
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:102548; Tsc2.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene RAW 264.7 Zdhhc13 KO
AC   CVCL_E1BZ
SY   Zdhhc13 Knockout cell line (RAW 264.7)
DR   Ubigene; YKO-M083
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1919227; Zdhhc13.
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Discontinued: Ubigene; YKO-M083; true.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Macrophage; CL=CL_0000235.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0493 ! RAW 264.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene RKO KRAS KO
AC   CVCL_E1C0
SY   KRAS Knockout cell line (RKO)
DR   Ubigene; YKO-H251
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6407; KRAS.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene RKO KREMEN1 KO
AC   CVCL_E1C1
SY   KREMEN1 Knockout cell line (RKO)
DR   Ubigene; YKO-H004
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17550; KREMEN1.
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Leu452Pro (c.1355T>C); ClinVar=VCV000930524; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0504 ! RKO
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene RM-1 Zbtb33 KO
AC   CVCL_E1C2
SY   Zbtb33 Knockout cell line (RM-1)
DR   Ubigene; YKO-M115
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1927290; Zbtb33.
CC   Transformant: Recombinant retrovirus Zipras/myc9 (v-Ha-Ras and v-Myc).
CC   Derived from site: In situ; Embryonic prostate; UBERON=UBERON_0003820.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21732; Carcinoma of the mouse prostate gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B459 ! RM-1 [Mouse prostate carcinoma]
SX   Male
AG   17FD
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene SCC7 Msh2 KO
AC   CVCL_E1C3
SY   Msh2 Knockout cell line (SCC7)
DR   Ubigene; YKO-M007
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:101816; Msh2.
CC   Derived from site: In situ; Abdominal wall; UBERON=UBERON_0003697.
CC   Breed/subspecies: C3H.
DI   NCIt; C21609; Mouse squamous cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_V412 ! SCC7
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene SH-SY5Y BTBD9 KO
AC   CVCL_E1C4
SY   BTBD9 Knockout cell line (SH-SY5Y)
DR   Ubigene; YKO-H248
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21228; BTBD9.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SH-SY5Y LIPA KO
AC   CVCL_E1C5
SY   LIPA Knockout cell line (SH-SY5Y)
DR   Ubigene; YKO-H261
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6617; LIPA.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SH-SY5Y TMEM175 KO
AC   CVCL_E1C6
SY   TMEM175 Knockout cell line (SH-SY5Y)
DR   Ubigene; YKO-H907
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SK-BR-3 SENP7 KO
AC   CVCL_E1C7
SY   SENP7 Knockout cell line (SK-BR-3)
DR   Ubigene; YKO-HJ064
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30402; SENP7.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SK-LMS-1 ARL4C KO
AC   CVCL_E1C8
SY   ARL4C Knockout cell line (SK-LMS-1)
DR   Ubigene; YKO-HJ070
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:698; ARL4C.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Lys (c.710T>A); ClinVar=VCV000376636; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C40318; Vulvar leiomyosarcoma
DI   ORDO; Orphanet_64720; Leiomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0628 ! SK-LMS-1
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SK-MES-1 SNORA59B KO
AC   CVCL_E1C9
SY   SNORA59B Knockout cell line (SK-MES-1)
DR   Ubigene; YKO-H165
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32658; SNORA59B.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu298Ter (c.892G>T); ClinVar=VCV000093323; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0630 ! SK-MES-1
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SK-N-SH CAPNS1 KO
AC   CVCL_E1CA
SY   CAPNS1 Knockout cell line (SK-N-SH)
DR   Ubigene; YKO-HJ065
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1481; CAPNS1.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0531 ! SK-N-SH
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SK-OV-3 RIPK1 KO
AC   CVCL_E1CB
SY   RIPK1 Knockout cell line (SK-OV-3)
DR   Ubigene; YKO-HJ062
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10019; RIPK1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Leufs*9 (c.4666delA); ClinVar=VCV000156477; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Leu (c.1514G>T); ClinVar=VCV000376424; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser90Profs*33 (c.267delC); ClinVar=VCV000156515; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0532 ! SK-OV-3
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SNU-398 LZTR1 KO
AC   CVCL_E1CC
SY   LZTR1 Knockout cell line (SNU-398)
DR   Ubigene; YKO-H1002
CC   Population: Korean.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6742; LZTR1.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser37Cys (c.110C>G); ClinVar=VCV000017579; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser215Ile (c.644G>T); ClinVar=VCV000376660; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0077 ! SNU-398
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SRA01/04 CYP51A1 KO
AC   CVCL_E1CD
SY   CYP51A1 Knockout cell line (SRA01/04)
DR   Ubigene; YKO-H799
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2649; CYP51A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Eye, ocular lens, epithelium; UBERON=UBERON_0001803.
CC   Cell type: Epithelial cell of ocular lens; CL=CL_0002224.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7157 ! SRA01/04
SX   Male
AG   5M
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene SU-DHL-4 SGK1 KO
AC   CVCL_E1CE
SY   SGK1 Knockout cell line (SU-DHL-4)
DR   Ubigene; YKO-H188
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10810; SGK1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5477; IGH; Name(s)=IGH-BCL2 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr646Ser (c.1937A>C) (Y641S); ClinVar=VCV000376218; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr666Asn (c.1996T>A) (Y661N); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peritoneal effusion; UBERON=UBERON_0001268.
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0539 ! SU-DHL-4
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SW480 FBXW7 KO
AC   CVCL_E1CF
SY   FBXW7 Knockout cell line (SW480)
DR   Ubigene; YKO-H499
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16712; FBXW7.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SW480 HUNK KO
AC   CVCL_E1CG
SY   HUNK Knockout cell line (SW480)
DR   Ubigene; YKO-HJ096
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13326; HUNK.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0546 ! SW480
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SW620 DNAJB1 KO
AC   CVCL_E1CH
SY   DNAJB1 Knockout cell line (SW620)
DR   Ubigene; YKO-HJ124
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5270; DNAJB1.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Gln1338Ter (c.4012C>T); ClinVar=VCV000000801; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro309Ser (c.925C>T); ClinVar=VCV000458575; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0547 ! SW620
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene SW780 NECTIN4 KO
AC   CVCL_E1CI
SY   NECTIN4 Knockout cell line (SW780)
DR   Ubigene; YKO-H909
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:19688; NECTIN4.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1728 ! SW780
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene T98G MCOLN1 KO
AC   CVCL_E1CJ
SY   MCOLN1 Knockout cell line (T98G)
DR   Ubigene; YKO-H792
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13356; MCOLN1.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-20del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu42Arg (c.125T>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0556 ! T98G
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene T98G TPCN2 KO
AC   CVCL_E1CK
SY   TPCN2 Knockout cell line (T98G)
DR   Ubigene; YKO-H793
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20820; TPCN2.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16051; PARD3; Unexplicit; Ex3-20del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu42Arg (c.125T>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>T); ClinVar=VCV000634770; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0556 ! T98G
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene TCCSUP NR3C1 KO
AC   CVCL_E1CL
SY   NR3C1 Knockout cell line (TCCSUP)
DR   Ubigene; YKO-HJ069
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7978; NR3C1.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1738 ! TCCSUP
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 ACOD1 KO
AC   CVCL_E1CM
SY   ACOD1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H839
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:33904; ACOD1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 ADA2 KO
AC   CVCL_E1CN
SY   ADA2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H084
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1839; ADA2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 AHR KO
AC   CVCL_E1CP
SY   AHR Knockout cell line (THP-1)
DR   Ubigene; YKO-H692
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:348; AHR.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 C15orf48 KO
AC   CVCL_E1CQ
SY   C15orf48 Knockout cell line (THP-1)
DR   Ubigene; YKO-H155
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29898; C15orf48.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 CARD8 KO
AC   CVCL_E1CR
SY   CARD8 Knockout cell line (THP-1)
DR   Ubigene; YKO-H858
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17057; CARD8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 CES1 KO
AC   CVCL_E1CS
SY   CES1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H229
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1863; CES1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 CLEC10A KO
AC   CVCL_E1CT
SY   CLEC10A Knockout cell line (THP-1)
DR   Ubigene; YKO-H774
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16916; CLEC10A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 CLEC4A KO
AC   CVCL_E1CU
SY   CLEC4A Knockout cell line (THP-1)
DR   Ubigene; YKO-H521
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13257; CLEC4A.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 EGR1 KO
AC   CVCL_E1CV
SY   EGR1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H127
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3238; EGR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 GLP1R KO
AC   CVCL_E1CW
SY   GLP1R Knockout cell line (THP-1)
DR   Ubigene; YKO-H128
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4324; GLP1R.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 GPNMB KO
AC   CVCL_E1CX
SY   GPNMB Knockout cell line (THP-1)
DR   Ubigene; YKO-H623
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4462; GPNMB.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 GSDMD KO
AC   CVCL_E1CY
SY   GSDMD Knockout cell line (THP-1)
DR   Ubigene; YKO-H172
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25697; GSDMD.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 HERC5 KO
AC   CVCL_E1CZ
SY   HERC5 Knockout cell line (THP-1)
DR   Ubigene; YKO-H1055
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24368; HERC5.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 IFI35 KO
AC   CVCL_E1D0
SY   IFI35 Knockout cell line (THP-1)
DR   Ubigene; YKO-H220
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5399; IFI35.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 ISG15 KO
AC   CVCL_E1D1
SY   ISG15 Knockout cell line (THP-1)
DR   Ubigene; YKO-H722
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4053; ISG15.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 MCU KO
AC   CVCL_E1D2
SY   MCU Knockout cell line (THP-1)
DR   Ubigene; YKO-H1063
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23526; MCU.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 MILR1 KO
AC   CVCL_E1D3
SY   MILR1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H621
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:27570; MILR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 NFE2L2 KO
AC   CVCL_E1D4
SY   NFE2L2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H083
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 NLRP3 KO
AC   CVCL_E1D5
SY   NLRP3 Knockout cell line (THP-1)
DR   Ubigene; YKO-H145
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16400; NLRP3.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 NMI KO
AC   CVCL_E1D6
SY   NMI Knockout cell line (THP-1)
DR   Ubigene; YKO-H997
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7854; NMI.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 PIGA KO
AC   CVCL_E1D7
SY   PIGA Knockout cell line (THP-1)
DR   Ubigene; YKO-H914
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8957; PIGA.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 PTPN11 KO
AC   CVCL_E1D8
SY   PTPN11 Knockout cell line (THP-1)
DR   Ubigene; YKO-H504
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9644; PTPN11.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 RNASE1 KO
AC   CVCL_E1D9
SY   RNASE1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H068
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10044; RNASE1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 SIGLEC9 KO
AC   CVCL_E1DA
SY   SIGLEC9 Knockout cell line (THP-1)
DR   Ubigene; YKO-H1064
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10878; SIGLEC9.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 SLAMF7 KO
AC   CVCL_E1DB
SY   SLAMF7 Knockout cell line (THP-1)
DR   Ubigene; YKO-H324
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21394; SLAMF7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 SLC37A4 KO
AC   CVCL_E1DC
SY   SLC37A4 Knockout cell line (THP-1)
DR   Ubigene; YKO-H873
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4061; SLC37A4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 SLC39A8 KO
AC   CVCL_E1DD
SY   SLC39A8 Knockout cell line (THP-1)
DR   Ubigene; YKO-H320
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20862; SLC39A8.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 SLC6A6 KO
AC   CVCL_E1DE
SY   SLC6A6 Knockout cell line (THP-1)
DR   Ubigene; YKO-H778
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11052; SLC6A6.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 TCN2 KO
AC   CVCL_E1DF
SY   TCN2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H156
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11653; TCN2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 TET2 KO
AC   CVCL_E1DG
SY   TET2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H230
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25941; TET2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 TLR1 KO
AC   CVCL_E1DH
SY   TLR1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H125
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11847; TLR1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 TLR2 KO
AC   CVCL_E1DI
SY   TLR2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H101
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 TLR4 KO
AC   CVCL_E1DJ
SY   TLR4 Knockout cell line (THP-1)
DR   Ubigene; YKO-H289
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 TREM2 KO
AC   CVCL_E1DK
SY   TREM2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H189
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17761; TREM2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 UBA7 KO
AC   CVCL_E1DL
SY   UBA7 Knockout cell line (THP-1)
DR   Ubigene; YKO-H1004
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12471; UBA7.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 USP22 KO
AC   CVCL_E1DM
SY   USP22 Knockout cell line (THP-1)
DR   Ubigene; YKO-H021
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12621; USP22.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 VAMP2 KO
AC   CVCL_E1DN
SY   VAMP2 Knockout cell line (THP-1)
DR   Ubigene; YKO-H1108
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12643; VAMP2.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene THP-1 ZEB1 KO
AC   CVCL_E1DP
SY   ZEB1 Knockout cell line (THP-1)
DR   Ubigene; YKO-H695
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11642; ZEB1.
CC   Sequence variation: Gene fusion; HGNC; HGNC:2457; CSNK2A1 + HGNC; HGNC:13917; DDX39B; Name(s)=CSNK2A1-DDX39B (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg174fs*3 (c.520_545del26); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0006 ! THP-1
SX   Male
AG   1Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene TM3 Gstk1 KO
AC   CVCL_E1DQ
SY   Gstk1 Knockout cell line (TM3)
DR   Ubigene; YKO-M045
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:1923513; Gstk1.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4326 ! TM3 [Mouse testis]
SX   Male
AG   11-13D
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene U-251 MG HMOX1 KO
AC   CVCL_E1E1
SY   HMOX1 Knockout cell line (U-251 MG)
DR   Ubigene; YKO-H994
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5013; HMOX1.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-251 MG IRGM KO
AC   CVCL_E1E2
SY   IRGM Knockout cell line (U-251 MG)
DR   Ubigene; YKO-H338
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29597; IRGM.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-251 MG NFE2L2 KO
AC   CVCL_E1E3
SY   NFE2L2 Knockout cell line (U-251 MG)
DR   Ubigene; YKO-H924
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-251 MG PTPRF KO
AC   CVCL_E1E4
SY   PTPRF Knockout cell line (U-251 MG)
DR   Ubigene; YKO-H194
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9670; PTPRF.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-251 MG SLC7A11 KO
AC   CVCL_E1E5
SY   SLC7A11 Knockout cell line (U-251 MG)
DR   Ubigene; YKO-H925
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-251 MG TANGO6 KO
AC   CVCL_E1E6
SY   TANGO6 Knockout cell line (U-251 MG)
DR   Ubigene; YKO-HJ097
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25749; TANGO6.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Glu242Valfs*15 (c.723_724dupTG); ClinVar=VCV000536553; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, parietal lobe; UBERON=UBERON_0001872.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0021 ! U-251MG
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-2932 BTK KO
AC   CVCL_E1E7
SY   BTK Knockout cell line (U-2932)
DR   Ubigene; YKO-H067
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1133; BTK.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1896 ! U-2932
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-2932 ENPP2 KO
AC   CVCL_E1E8
SY   ENPP2 Knockout cell line (U-2932)
DR   Ubigene; YKO-H055
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3357; ENPP2.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1896 ! U-2932
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG ABCA1 KO
AC   CVCL_E1E9
SY   ABCA1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H247
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:29; ABCA1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG CARD8-AS1 KO
AC   CVCL_E1EA
SY   CARD8-AS1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H700
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:51408; CARD8-AS1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG CD9 KO
AC   CVCL_E1EB
SY   CD9 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H786
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1709; CD9.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG DUS4L KO
AC   CVCL_E1EC
SY   DUS4L Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H305
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21517; DUS4L.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG DYNC2H1 KO
AC   CVCL_E1ED
SY   DYNC2H1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-HJ036
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2962; DYNC2H1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG EREG KO
AC   CVCL_E1EE
SY   EREG Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H092
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3443; EREG.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG FAP KO
AC   CVCL_E1EF
SY   FAP Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H314
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3590; FAP.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG HMOX1 KO
AC   CVCL_E1EG
SY   HMOX1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H993
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5013; HMOX1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG IDH1 KO
AC   CVCL_E1EH
SY   IDH1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H1101
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5382; IDH1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Discontinued: Ubigene; YKO-H1101; true.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene U-87 MG NF1 KO
AC   CVCL_E1EI
SY   NF1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H833
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7765; NF1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG NFE2L2 KO
AC   CVCL_E1EJ
SY   NFE2L2 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H992
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7782; NFE2L2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG NFKB1 KO
AC   CVCL_E1EK
SY   NFKB1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H770
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7794; NFKB1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG RSRP1 KO
AC   CVCL_E1EL
SY   RSRP1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-HJ071
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:25234; RSRP1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG SAMD9L KO
AC   CVCL_E1EM
SY   SAMD9L Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H180
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1349; SAMD9L.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG SERPINE1 KO
AC   CVCL_E1EN
SY   SERPINE1 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H285
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8583; SERPINE1.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG SIRT3 KO
AC   CVCL_E1EP
SY   SIRT3 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H252
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14931; SIRT3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG SIRT7 KO
AC   CVCL_E1EQ
SY   SIRT7 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H226
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14935; SIRT7.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG SLC7A11 KO
AC   CVCL_E1ER
SY   SLC7A11 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H995
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11059; SLC7A11.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG TRIB3 KO
AC   CVCL_E1ES
SY   TRIB3 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H510
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16228; TRIB3.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U-87 MG TSC2 KO
AC   CVCL_E1ET
SY   TSC2 Knockout cell line (U-87 MG)
DR   Ubigene; YKO-H205
CC   Problematic cell line: Misidentified. Parent cell line (U-87MG ATCC) is not the original glioblastoma cell line established in 1968 at the University of Uppsala.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Phe1247Ilefs*18 (c.3739_3742delTTTG) (3737_3740delTGTT); ClinVar=VCV000420078; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.209+1G>T; ClinVar=VCV000229705; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0022 ! U-87MG ATCC
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS CLCN7 KO
AC   CVCL_E1DR
SY   CLCN7 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H856
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2025; CLCN7.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS CXCR4 KO
AC   CVCL_E1DS
SY   CXCR4 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H443
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2561; CXCR4.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS LAMP2 KO
AC   CVCL_E1DT
SY   LAMP2 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H1119
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6501; LAMP2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS PBK KO
AC   CVCL_E1DU
SY   PBK Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H537
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18282; PBK.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS TMEM175 KO
AC   CVCL_E1DV
SY   TMEM175 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H714
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28709; TMEM175.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS UBQLN1 KO
AC   CVCL_E1DW
SY   UBQLN1 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H539
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12508; UBQLN1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS UBQLN4 KO
AC   CVCL_E1DX
SY   UBQLN4 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H540
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1237; UBQLN4.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS ULK1 KO
AC   CVCL_E1DY
SY   ULK1 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H830
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12558; ULK1.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS ULK2 KO
AC   CVCL_E1DZ
SY   ULK2 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H831
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13480; ULK2.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene U2OS ZNF432 KO
AC   CVCL_E1E0
SY   ZNF432 Knockout cell line (U-2 OS)
DR   Ubigene; YKO-H065
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20810; ZNF432.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene UMR-106 Enpp1 KO
AC   CVCL_E1EU
SY   Enpp1 Knockout cell line (UMR-106)
DR   Ubigene; YKO-R040
CC   Knockout cell: Method=CRISPR/Cas9; RGD; 628825; Enpp1.
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3617 ! UMR-106
AG   Adult
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   Ubigene Vero ATG16L1 KO
AC   CVCL_E1EV
SY   ATG16L1 Knockout cell line (Vero)
DR   Ubigene; YKO-R058
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9R217; ATG16L1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Vero ATG5 KO
AC   CVCL_E1EZ
SY   ATG5 Knockout cell line (Vero)
DR   Ubigene; YKO-R003
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RQI0; ATG5.
CC   Discontinued: Ubigene; YKO-R003; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene Vero NECTIN1 KO
AC   CVCL_E1EW
SY   NECTIN1 Knockout cell line (Vero)
DR   Ubigene; YKO-R017
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S3W9; NECTIN1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Vero STAT3 KO
AC   CVCL_E1EX
SY   STAT3 Knockout cell line (Vero)
DR   Ubigene; YKO-R045
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1T9; STAT3.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Vero STING1 KO
AC   CVCL_E1F5
SY   STING1 Knockout cell line (Vero)
DR   Ubigene; YKO-R024
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RKP9; STING1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Vero TNFRSF14 KO
AC   CVCL_E1EY
SY   TNFRSF14 Knockout cell line (Vero)
DR   Ubigene; YKO-R016
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S8V2; TNFRSF14.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Vero E6 ATG7 KO
AC   CVCL_E1F0
SY   ATG7 Knockout cell line (Vero E6)
DR   Ubigene; YKO-R009
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RBZ0; ATG7.
CC   Discontinued: Ubigene; YKO-R009; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene Vero E6 GSDME KO
AC   CVCL_E1F1
SY   GSDME Knockout cell line (Vero E6)
DR   Ubigene; YKO-R005
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RNS0; GSDME.
CC   Discontinued: Ubigene; YKO-R005; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene Vero E6 PIK3C3 KO
AC   CVCL_E1F2
SY   PIK3C3 Knockout cell line (Vero E6)
DR   Ubigene; YKO-R021
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RZC3; PIK3C3.
CC   Discontinued: Ubigene; YKO-R021; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   Ubigene Vero E6 STAT1 KO
AC   CVCL_E1F4
SY   STAT1 Knockout cell line (Vero E6)
DR   Ubigene; YKO-R013
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RIE1; STAT1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Vero E6 ZDHHC20 KO
AC   CVCL_E1F6
SY   ZDHHC20 Knockout cell line (Vero E6)
DR   Ubigene; YKO-R018
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RZN5; ZDHHC20.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   Ubigene Y-79 SFXN5 KO
AC   CVCL_E1F7
SY   SFXN5 Knockout cell line (Y79)
DR   Ubigene; YKO-H1097
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16073; SFXN5.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Discontinued: Ubigene; YKO-H1097; true.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   Ubigene ZR-75-1 CEBPA KO
AC   CVCL_E1F8
SY   CEBPA Knockout cell line (ZR75-1)
DR   Ubigene; YKO-HJ056
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1833; CEBPA.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ZR-75-1 CEBPB KO
AC   CVCL_E1F9
SY   CEBPB Knockout cell line (ZR75-1)
DR   Ubigene; YKO-HJ058
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1834; CEBPB.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ZR-75-1 LDHA KO
AC   CVCL_E1FA
SY   LDHA Knockout cell line (ZR75-1)
DR   Ubigene; YKO-HJ112
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6535; LDHA.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ZR-75-1 RNF20 KO
AC   CVCL_E1FB
SY   RNF20 Knockout cell line (ZR75-1)
DR   Ubigene; YKO-HJ057
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10062; RNF20.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ZR-75-1 SATB1 KO
AC   CVCL_E1FC
SY   SATB1 Knockout cell line (ZR75-1)
DR   Ubigene; YKO-HJ059
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10541; SATB1.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   Ubigene ZR-75-1 SLC25A38 KO
AC   CVCL_E1FD
SY   SLC25A38 Knockout cell line (ZR75-1)
DR   Ubigene; YKO-HJ113
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:26054; SLC25A38.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   UBM12218693
AC   CVCL_F586
SY   TER291; TER-291; Ter 291; TER371; TER-371; Ter 371; TER451; TER-451; Ter 451
DR   IPD-IMGT/HLA; 11509
DR   Wikidata; Q54973895
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/356cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03,26; B*27,57; DPB1*04:01:01,04:01:01; DQA1*01:02,02:01; DQB1*03:03:02,06:02:01; DRB1*07:01:01,15:07:01; DRB4*01:03:01:02N; DRB5*01:01:01 (IPD-IMGT/HLA=11509).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   UBM13129406
AC   CVCL_F587
SY   29036; TER450; TER-450; Ter 450; TER455; TER-455; Ter 455; Extract 185; Extract 352
DR   IPD-IMGT/HLA; 11510
DR   Wikidata; Q54973897
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/354cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/358cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,24:02; B*50:02,55:01; C*03:03,06:02; DQA1*01,03; DQB1*04:02,05:03; DRB1*04:06,14:01; DRB3*02; DRB4*01 (IPD-IMGT/HLA=11510).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   UBT-10
AC   CVCL_6F38
DR   Wikidata; Q54973898
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   UBT-14
AC   CVCL_B971
SY   UBT-15
DR   Wikidata; Q54973899
RX   PubMed=15923633;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   UBT-5
AC   CVCL_B972
DR   Wikidata; Q54973900
RX   PubMed=15293342;
RX   PubMed=15923633;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1066; BMI1.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Telomerase immortalized cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   UBTi001-A
AC   CVCL_C1XH
SY   PEB-AL#6
DR   BioSamples; SAMEA14180087
DR   hPSCreg; UBTi001-A
DR   Wikidata; Q114313150
RX   PubMed=36103773;
CC   From: Department for Blood Group Serology and Transfusion Medicine, Medical University of Graz; Graz; Austria.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UC 729-6
AC   CVCL_D039
SY   UC729-6; UC729.6
DR   Wikidata; Q54973901
RX   DOI=10.1007/BF01404489;
RX   Patent=US4451570;
RX   PubMed=6350451;
RX   PubMed=6604917;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-447.html
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8061.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   UC C0406-iPS C4
AC   CVCL_YE60
DR   Wikidata; Q98133812
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 12,13
ST   D18S51: 19,20
ST   D21S11: 33.2,35.2
ST   D3S1358: 16,17
ST   D5S818: 12,15
ST   D7S820: 10,13
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 17,23
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC CGK0828-iPS C2
AC   CVCL_YE61
DR   Wikidata; Q98133813
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 10
ST   D18S51: 20
ST   D21S11: 30.2
ST   D3S1358: 14
ST   D5S818: 11,16
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 21,24
ST   Penta D: 9
ST   Penta E: 17
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC GM1020-iPS C1
AC   CVCL_YE62
DR   Wikidata; Q98133814
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9,12
ST   D16S539: 10,12
ST   D18S51: 12,21
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 12,13
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC LBJ0828-iPS C1
AC   CVCL_YE63
DR   Wikidata; Q98133815
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 15,22
ST   D21S11: 28.2,29.2
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 12
ST   D8S1179: 11,14
ST   FGA: 19,23
ST   Penta D: 10
ST   Penta E: 10,12
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC LXY0828-iPS C1
AC   CVCL_YE64
DR   Wikidata; Q98133816
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 29.2,30.2
ST   D3S1358: 14,16
ST   D5S818: 13,14
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21,24
ST   Penta D: 9,10
ST   Penta E: 11,15
ST   TH01: 9,10
ST   TPOX: 8,9
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC LY0815-iPS C1
AC   CVCL_YE65
DR   Wikidata; Q98133818
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 14,17
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 11,15
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC NS0816-iPS C3
AC   CVCL_YE66
DR   Wikidata; Q98133819
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13.2,20
ST   D21S11: 30.2,32
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 11
ST   FGA: 21,23
ST   Penta D: 9
ST   Penta E: 15,20
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC WXM0816-iPS C2
AC   CVCL_YE68
DR   Wikidata; Q98133821
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D18S51: 13,20
ST   D21S11: 29,29.2
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 9,14
ST   Penta E: 5,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC XB0722-iPS C2
AC   CVCL_YE69
DR   Wikidata; Q98133822
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 10,11
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 11,13
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 7
ST   Penta E: 23
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC XJY0903-iPS C1
AC   CVCL_YE70
DR   Wikidata; Q98133823
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D21S11: 30,31.2
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 15,17
ST   FGA: 21,24.2
ST   Penta D: 9
ST   Penta E: 15
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC ZGZ0816-iPS C1
AC   CVCL_YE71
DR   Wikidata; Q98133824
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 13,14
ST   D21S11: 30,32.2
ST   D3S1358: 14,16
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 18,20
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC ZQ0907-iPS C1
AC   CVCL_YE72
DR   Wikidata; Q98133825
RX   PubMed=21636641;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=21636641
ST   Amelogenin: X,Y
ST   CSF1PO: 10,15
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D18S51: 14,15
ST   D21S11: 28.2,30.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 9,11
ST   Penta E: 12,17
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 5
//
ID   UC-11MG
AC   CVCL_M421
SY   UC-11 MG; UC11MG
DR   Wikidata; Q54973903
RX   PubMed=2566365;
RX   PubMed=3007688;
CC   Doubling time: 41.0 +- 6.4 hours (PubMed=3007688).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   UC-11MG SC-A3
AC   CVCL_C8E2
DR   Wikidata; Q123033675
RX   PubMed=10402232;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M421 ! UC-11MG
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   UC-302MG
AC   CVCL_M422
DR   Wikidata; Q54973904
RX   PubMed=3007688;
CC   Doubling time: 43.7 +- 6.6 hours (PubMed=3007688).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 8
//
ID   UC10-4F10-11
AC   CVCL_8977
DR   CLO; CLO_0009469
DR   ATCC; HB-304
DR   CCTCC; GDC0281
DR   Wikidata; Q54973905
RX   PubMed=7882171;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P09793; Mouse Ctla4/Cd152.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   UC11
AC   CVCL_M872
SY   UC 11
DR   Wikidata; Q54973906
RX   Patent=US5292667;
RX   PubMed=2455670;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9756.
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 7
//
ID   UC1B
AC   CVCL_6462
DR   CLO; CLO_0009470
DR   ATCC; CRL-6465
DR   ATCC; CRL-6465_FL
DR   Wikidata; Q54973907
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6465; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0184 ! BALB/3T3 clone A31
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UC1BC1
AC   CVCL_6463
DR   CLO; CLO_0009471
DR   ATCC; CRL-6460
DR   Wikidata; Q54973908
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6460; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6462 ! UC1B
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UC1BC2
AC   CVCL_6464
DR   CLO; CLO_0009472
DR   ATCC; CRL-6461
DR   Wikidata; Q54973909
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6461; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6462 ! UC1B
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UC1BC3
AC   CVCL_6465
DR   CLO; CLO_0009473
DR   ATCC; CRL-6462
DR   Wikidata; Q54973910
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6462; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6462 ! UC1B
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UC1BC4
AC   CVCL_6466
DR   CLO; CLO_0009474
DR   ATCC; CRL-6463
DR   Wikidata; Q54973911
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6463; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6462 ! UC1B
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UC1BC5
AC   CVCL_6467
DR   CLO; CLO_0009475
DR   ATCC; CRL-6464
DR   Wikidata; Q54973913
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6464; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6462 ! UC1B
SX   Sex unspecified
AG   14-17FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UC3-10A6
AC   CVCL_8978
DR   CLO; CLO_0009476
DR   ATCC; CRL-1988
DR   Wikidata; Q54973914
RX   PubMed=7882171;
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 7
//
ID   UC7
AC   CVCL_F801
SY   UC 7
DR   CLO; CLO_0009477
DR   ATCC; HB-9753
DR   Wikidata; Q54973915
RX   Patent=US5292667;
RX   PubMed=2455670;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9753.
CC   Monoclonal antibody isotype: IgG2a.
CC   Discontinued: ATCC; HB-9753; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 8
//
ID   UC7-13D5
AC   CVCL_8979
DR   CLO; CLO_0009478
DR   ATCC; CRL-1989
DR   Wikidata; Q54973916
CC   Monoclonal antibody isotype: IgG.
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 6
//
ID   UC701
AC   CVCL_3225
DR   JCRB; JCRB1218
DR   JCRB; NIHS0549
DR   Wikidata; Q54973917
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0549; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
ST   Source(s): JCRB=JCRB1218
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,10
ST   D16S539: 10,11
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   UC702
AC   CVCL_3226
DR   BioSample; SAMN03472445
DR   JCRB; JCRB1220
DR   JCRB; NIHS0550
DR   Wikidata; Q54973918
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0550; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
ST   Source(s): JCRB=JCRB1220
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   UC704
AC   CVCL_3227
DR   BioSample; SAMN03472447
DR   JCRB; JCRB1224
DR   JCRB; NIHS0551
DR   Wikidata; Q54973919
CC   Population: Japanese.
CC   Discontinued: JCRB; NIHS0551; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
ST   Source(s): JCRB=JCRB1224
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 8,13
ST   D7S820: 8,11
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   UC705
AC   CVCL_8315
DR   JCRB; JCRB1227
DR   Wikidata; Q54973921
CC   Population: Japanese.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   UC706
AC   CVCL_T842
DR   SKIP; SKIP000169
DR   Wikidata; Q54973923
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1M
CA   Somatic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   UC8-1B9
AC   CVCL_8980
SY   UC81B9
DR   CLO; CLO_0009479
DR   ATCC; CRL-1968
DR   Wikidata; Q54973924
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: ChEBI; CHEBI_53018; 2,4-dinitrophenyl group (DNP).
OX   NCBI_TaxID=3122392; ! Nothocricetulus migratorius (Gray dwarf hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   UCA
AC   CVCL_1M77
SY   GM08604
DR   CLO; CLO_0010608
DR   BioSample; SAMN00798104
DR   Coriell; GM08604
DR   Wikidata; Q55068367
RX   CelloPub=CLPUB00447;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*09; B*35 (Coriell=GM08604).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 12
//
ID   UCB-Od-1
AC   CVCL_WL86
SY   University of California, Berkeley-Ochlerotatus dorsalis-1
DR   Wikidata; Q98133826
RX   CelloPub=CLPUB00496;
RX   PubMed=27445;
CC   Group: Insect cell line.
CC   Doubling time: ~46 hours (Note=At 12th passage), 22 hours (Note=At 95th passage) (PubMed=27445).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
OX   NCBI_TaxID=663928; ! Ochlerotatus dorsalis (Summer saltmarsh mosquito)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   UCB-Od-1 C-21
AC   CVCL_WL87
SY   C-23
DR   Wikidata; Q98133827
RX   PubMed=27445;
CC   Group: Insect cell line.
OX   NCBI_TaxID=663928; ! Ochlerotatus dorsalis (Summer saltmarsh mosquito)
HI   CVCL_WL86 ! UCB-Od-1
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   UCB-Od-1 C-23
AC   CVCL_WL88
SY   C-23
DR   Wikidata; Q98133828
RX   PubMed=27445;
CC   Group: Insect cell line.
OX   NCBI_TaxID=663928; ! Ochlerotatus dorsalis (Summer saltmarsh mosquito)
HI   CVCL_WL86 ! UCB-Od-1
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   UCB0018
AC   CVCL_B4UL
DR   EGA; EGAS00001003485
DR   GEO; GSM431748
DR   Wikidata; Q110433304
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PC ! UCF0018
OI   CVCL_B4UM ! UCT0018
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0019
AC   CVCL_B4UN
DR   EGA; EGAS00001003485
DR   GEO; GSM431749
DR   Wikidata; Q110433305
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PD ! UCF0019
OI   CVCL_B4UP ! UCT0019
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0024
AC   CVCL_B4UQ
DR   GEO; GSM431750
DR   Wikidata; Q110433306
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PG ! UCF0024
OI   CVCL_B4UR ! UCT0024
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0025
AC   CVCL_B4US
DR   GEO; GSM431751
DR   Wikidata; Q110433308
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PH ! UCF0025
OI   CVCL_B4UT ! UCT0025
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0034
AC   CVCL_B4UU
DR   EGA; EGAS00001003485
DR   GEO; GSM431752
DR   Wikidata; Q110433309
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PM ! UCF0034
OI   CVCL_B4UV ! UCT0034
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0041
AC   CVCL_B4UW
DR   GEO; GSM431753
DR   Wikidata; Q110433310
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UX ! UCF0041
OI   CVCL_B4UY ! UCT0041
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0042
AC   CVCL_B4UZ
DR   EGA; EGAS00001003485
DR   GEO; GSM431754
DR   Wikidata; Q110433312
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PQ ! UCF0042
OI   CVCL_B4V0 ! UCT0042
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0045
AC   CVCL_B4V1
DR   GEO; GSM431755
DR   Wikidata; Q110433313
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V2 ! UCF0045
OI   CVCL_B4V3 ! UCT0045
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0048
AC   CVCL_B4V4
DR   GEO; GSM431756
DR   Wikidata; Q110433314
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PT ! UCF0048
OI   CVCL_B4V5 ! UCT0048
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0049
AC   CVCL_B4V6
DR   GEO; GSM431757
DR   Wikidata; Q110433315
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PU ! UCF0049
OI   CVCL_B4V7 ! UCT0049
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0050
AC   CVCL_B4V8
DR   EGA; EGAS00001003485
DR   GEO; GSM431758
DR   Wikidata; Q110433316
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V9 ! UCF0050
OI   CVCL_B4VA ! UCT0050
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0051
AC   CVCL_B4VB
DR   EGA; EGAS00001003485
DR   GEO; GSM431759
DR   Wikidata; Q110433318
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4PV ! UCF0051
OI   CVCL_B4VC ! UCT0051
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0055
AC   CVCL_B4VD
DR   GEO; GSM431760
DR   Wikidata; Q110433320
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VE ! UCF0055
OI   CVCL_B4VF ! UCT0055
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0060
AC   CVCL_B4VG
DR   EGA; EGAS00001003485
DR   GEO; GSM431761
DR   Wikidata; Q110433321
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Q0 ! UCF0060
OI   CVCL_B4VH ! UCT0060
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0062
AC   CVCL_B4VI
DR   EGA; EGAS00001003485
DR   GEO; GSM431762
DR   Wikidata; Q110433322
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Q1 ! UCF0062
OI   CVCL_B4VJ ! UCT0062
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0070
AC   CVCL_B4VK
DR   GEO; GSM431763
DR   Wikidata; Q110433323
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Q3 ! UCF0070
OI   CVCL_B4VL ! UCT0070
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0078
AC   CVCL_B4VM
DR   GEO; GSM431764
DR   Wikidata; Q110433324
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Q5 ! UCF0078
OI   CVCL_B4VN ! UCT0078
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0079
AC   CVCL_B4VP
DR   GEO; GSM431765
DR   Wikidata; Q110433325
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Q6 ! UCF0079
OI   CVCL_B4VQ ! UCT0079
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0081
AC   CVCL_B4VR
DR   GEO; GSM431766
DR   Wikidata; Q110433326
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VS ! UCF0081
OI   CVCL_B4VT ! UCT0081
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0083
AC   CVCL_B4VU
DR   GEO; GSM431767
DR   Wikidata; Q110433327
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Q8 ! UCF0083
OI   CVCL_B4VV ! UCT0083
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0086
AC   CVCL_B4VW
DR   EGA; EGAS00001003485
DR   GEO; GSM431768
DR   Wikidata; Q110433329
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QA ! UCF0086
OI   CVCL_B4VX ! UCT0086
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0087
AC   CVCL_B4VY
DR   EGA; EGAS00001003485
DR   GEO; GSM431769
DR   Wikidata; Q110433330
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QB ! UCF0087
OI   CVCL_B4VZ ! UCT0087
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0088
AC   CVCL_B4W0
DR   EGA; EGAS00001003485
DR   GEO; GSM431770
DR   Wikidata; Q110433331
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QC ! UCF0088
OI   CVCL_B4W1 ! UCT0088
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0093
AC   CVCL_B4W2
DR   GEO; GSM431771
DR   Wikidata; Q110433333
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QG ! UCF0093
OI   CVCL_B4W3 ! UCT0093
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0094
AC   CVCL_B4W4
DR   GEO; GSM431772
DR   Wikidata; Q110433334
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W5 ! UCF0094
OI   CVCL_B4W6 ! UCT0094
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0095
AC   CVCL_B4W7
DR   GEO; GSM431773
DR   Wikidata; Q110433335
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QH ! UCF0095
OI   CVCL_B4W8 ! UCT0095
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0097
AC   CVCL_B4W9
DR   GEO; GSM431774
DR   Wikidata; Q110433336
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QI ! UCF0097
OI   CVCL_B4WA ! UCT0097
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0100
AC   CVCL_B4WB
DR   EGA; EGAS00001003485
DR   GEO; GSM431861
DR   Wikidata; Q110433337
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QL ! UCF0100
OI   CVCL_B4WC ! UCT0100
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0103
AC   CVCL_B4WD
DR   EGA; EGAS00001003485
DR   GEO; GSM431776
DR   Wikidata; Q110433339
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QP ! UCF0103
OI   CVCL_B4WE ! UCT0103
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0105
AC   CVCL_B4WF
DR   EGA; EGAS00001003485
DR   GEO; GSM431777
DR   Wikidata; Q110433340
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QQ ! UCF0105
OI   CVCL_B4WG ! UCT0105
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0108
AC   CVCL_B4WH
DR   EGA; EGAS00001003485
DR   GEO; GSM431778
DR   Wikidata; Q110433341
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QS ! UCF0108
OI   CVCL_B4WI ! UCT0108
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0110
AC   CVCL_B4WJ
DR   GEO; GSM431779
DR   Wikidata; Q110433342
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QT ! UCF0110
OI   CVCL_B4WK ! UCT0110
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0112
AC   CVCL_B4WL
DR   GEO; GSM431780
DR   Wikidata; Q110433343
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QU ! UCF0112
OI   CVCL_B4WM ! UCT0112
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0113
AC   CVCL_B4WN
DR   EGA; EGAS00001003485
DR   GEO; GSM431781
DR   Wikidata; Q110433344
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QV ! UCF0113
OI   CVCL_B4WP ! UCT0113
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0114
AC   CVCL_B4WQ
DR   GEO; GSM431782
DR   Wikidata; Q110433347
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QW ! UCF0114
OI   CVCL_B4WR ! UCT0114
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0115
AC   CVCL_B4WS
DR   GEO; GSM431783
DR   Wikidata; Q110433350
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QX ! UCF0115
OI   CVCL_B4WT ! UCT0115
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0116
AC   CVCL_B4WU
DR   GEO; GSM431784
DR   Wikidata; Q110433351
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QY ! UCF0116
OI   CVCL_B4WV ! UCT0116
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0117
AC   CVCL_B4WW
DR   EGA; EGAS00001003485
DR   GEO; GSM431786
DR   Wikidata; Q110433352
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4QZ ! UCF0117
OI   CVCL_B4WX ! UCT0117
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0119
AC   CVCL_B4WY
DR   GEO; GSM431787
DR   Wikidata; Q110433353
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R0 ! UCF0119
OI   CVCL_B4WZ ! UCT0119
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0121
AC   CVCL_B4X0
DR   GEO; GSM431788
DR   Wikidata; Q110433354
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R2 ! UCF0121
OI   CVCL_B4X1 ! UCT0121
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0122
AC   CVCL_B4X2
DR   EGA; EGAS00001003485
DR   GEO; GSM431789
DR   Wikidata; Q110433356
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R3 ! UCF0122
OI   CVCL_B4X3 ! UCT0122
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0124
AC   CVCL_B4X4
DR   EGA; EGAS00001003485
DR   GEO; GSM431790
DR   Wikidata; Q110433358
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R5 ! UCF0124
OI   CVCL_B4X5 ! UCT0124
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0125
AC   CVCL_B4X6
DR   EGA; EGAS00001003485
DR   GEO; GSM431791
DR   Wikidata; Q110433359
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R6 ! UCF0125
OI   CVCL_B4X7 ! UCT0125
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0128
AC   CVCL_B4X8
DR   GEO; GSM431792
DR   Wikidata; Q110433361
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R7 ! UCF0128
OI   CVCL_B4X9 ! UCT0128
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0130
AC   CVCL_B4XA
DR   GEO; GSM431793
DR   Wikidata; Q110433364
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4R9 ! UCF0130
OI   CVCL_B4XB ! UCT0130
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0137
AC   CVCL_B4XC
DR   EGA; EGAS00001003485
DR   GEO; GSM431794
DR   Wikidata; Q110433365
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RE ! UCF0137
OI   CVCL_B4XD ! UCT0137
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0139
AC   CVCL_B4XE
DR   EGA; EGAS00001003485
DR   GEO; GSM431795
DR   Wikidata; Q110433366
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RG ! UCF0139
OI   CVCL_B4XF ! UCT0139
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0140
AC   CVCL_B4XG
DR   GEO; GSM431796
DR   Wikidata; Q110433367
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RH ! UCF0140
OI   CVCL_B4XH ! UCT0140
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0141
AC   CVCL_B4XI
DR   EGA; EGAS00001003485
DR   GEO; GSM431797
DR   Wikidata; Q110433369
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RI ! UCF0141
OI   CVCL_B4XJ ! UCT0141
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0144
AC   CVCL_B4XK
DR   EGA; EGAS00001003485
DR   GEO; GSM431798
DR   Wikidata; Q110433370
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RK ! UCF0144
OI   CVCL_B4XL ! UCT0144
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0152
AC   CVCL_B4XM
DR   EGA; EGAS00001003485
DR   GEO; GSM431799
DR   Wikidata; Q110433371
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RP ! UCF0152
OI   CVCL_B4XN ! UCT0152
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0155
AC   CVCL_B4XP
DR   GEO; GSM431800
DR   Wikidata; Q110433372
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RR ! UCF0155
OI   CVCL_B4XQ ! UCT0155
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0161
AC   CVCL_B5B4
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433375
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RT ! UCF0161
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0164
AC   CVCL_B4XR
DR   EGA; EGAS00001003485
DR   GEO; GSM431801
DR   Wikidata; Q110433376
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RU ! UCF0164
OI   CVCL_B4XS ! UCT0164
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0167
AC   CVCL_B4XT
DR   EGA; EGAS00001003485
DR   GEO; GSM431802
DR   Wikidata; Q110433377
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RW ! UCF0167
OI   CVCL_B4XU ! UCT0167
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0169
AC   CVCL_B4XV
DR   EGA; EGAS00001003485
DR   GEO; GSM431803
DR   Wikidata; Q110433378
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4RY ! UCF0169
OI   CVCL_B4XW ! UCT0169
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0172
AC   CVCL_B4XX
DR   GEO; GSM431804
DR   Wikidata; Q110433379
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XY ! UCF0172
OI   CVCL_B4XZ ! UCT0172
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0176
AC   CVCL_B4Y0
DR   GEO; GSM431805
DR   Wikidata; Q110433380
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S1 ! UCF0176
OI   CVCL_B4Y1 ! UCT0176
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0177
AC   CVCL_B4Y2
DR   EGA; EGAS00001003485
DR   GEO; GSM431806
DR   Wikidata; Q110433381
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S2 ! UCF0177
OI   CVCL_B4Y3 ! UCT0177
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0180
AC   CVCL_B4Y4
DR   GEO; GSM431807
DR   Wikidata; Q110433382
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S3 ! UCF0180
OI   CVCL_B4Y5 ! UCT0180
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0181
AC   CVCL_B4Y6
DR   EGA; EGAS00001003485
DR   GEO; GSM431808
DR   Wikidata; Q110433384
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S4 ! UCF0181
OI   CVCL_B4Y7 ! UCT0181
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0183
AC   CVCL_B4Y8
DR   EGA; EGAS00001003485
DR   GEO; GSM431809
DR   Wikidata; Q110433385
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S5 ! UCF0183
OI   CVCL_B4Y9 ! UCT0183
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0187
AC   CVCL_B4YA
DR   GEO; GSM431810
DR   Wikidata; Q110433386
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S7 ! UCF0187
OI   CVCL_B4YB ! UCT0187
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0188
AC   CVCL_B4YC
DR   EGA; EGAS00001003485
DR   GEO; GSM431811
DR   Wikidata; Q110433387
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4S8 ! UCF0188
OI   CVCL_B4YD ! UCT0188
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0217
AC   CVCL_B4YE
DR   GEO; GSM431812
DR   Wikidata; Q110433388
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SN ! UCF0217
OI   CVCL_B4YF ! UCT0217
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0218
AC   CVCL_B4YG
DR   GEO; GSM431813
DR   Wikidata; Q110433389
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SP ! UCF0218
OI   CVCL_B4YH ! UCT0218
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0223
AC   CVCL_B4YI
DR   EGA; EGAS00001003485
DR   GEO; GSM431814
DR   Wikidata; Q110433390
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SS ! UCF0223
OI   CVCL_B4YJ ! UCT0223
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0225
AC   CVCL_B4YK
DR   EGA; EGAS00001003485
DR   GEO; GSM431815
DR   Wikidata; Q110433391
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ST ! UCF0225
OI   CVCL_B4YL ! UCT0225
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0226
AC   CVCL_B4YM
DR   EGA; EGAS00001003485
DR   GEO; GSM431816
DR   Wikidata; Q110433392
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SU ! UCF0226
OI   CVCL_B4YN ! UCT0226
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0227
AC   CVCL_B4YP
DR   EGA; EGAS00001003485
DR   GEO; GSM431817
DR   Wikidata; Q110433394
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SV ! UCF0227
OI   CVCL_B4YQ ! UCT0227
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0228
AC   CVCL_B4YR
DR   GEO; GSM431818
DR   Wikidata; Q110433395
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SW ! UCF0228
OI   CVCL_B4YS ! UCT0228
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0234
AC   CVCL_B4YT
DR   GEO; GSM431819
DR   Wikidata; Q110433396
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4SZ ! UCF0234
OI   CVCL_B4YU ! UCT0234
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0243
AC   CVCL_B4YV
DR   GEO; GSM431820
DR   Wikidata; Q110433397
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4T4 ! UCF0243
OI   CVCL_B4YW ! UCT0243
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0251
AC   CVCL_B4YX
DR   EGA; EGAS00001003485
DR   GEO; GSM431821
DR   Wikidata; Q110433398
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TB ! UCF0251
OI   CVCL_B4YY ! UCT0251
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0253
AC   CVCL_B4YZ
DR   GEO; GSM431822
DR   Wikidata; Q110433399
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TD ! UCF0253
OI   CVCL_B4Z0 ! UCT0253
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0255
AC   CVCL_B4Z1
DR   EGA; EGAS00001003485
DR   GEO; GSM431823
DR   Wikidata; Q110433400
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TF ! UCF0255
OI   CVCL_B4Z2 ! UCT0255
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0270
AC   CVCL_B4Z3
DR   GEO; GSM431824
DR   Wikidata; Q110433401
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TM ! UCF0270
OI   CVCL_B4Z4 ! UCT0270
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0271
AC   CVCL_B4Z5
DR   GEO; GSM431825
DR   Wikidata; Q110433403
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TN ! UCF0271
OI   CVCL_B4Z6 ! UCT0271
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0276
AC   CVCL_B4Z7
DR   GEO; GSM431826
DR   Wikidata; Q110433405
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TS ! UCF0276
OI   CVCL_B4Z8 ! UCT0276
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0277
AC   CVCL_B4Z9
DR   GEO; GSM431827
DR   Wikidata; Q110433406
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TT ! UCF0277
OI   CVCL_B4ZA ! UCT0277
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0282
AC   CVCL_B4ZB
DR   EGA; EGAS00001003485
DR   GEO; GSM431828
DR   Wikidata; Q110433408
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TW ! UCF0282
OI   CVCL_B4ZC ! UCT0282
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0284
AC   CVCL_B4ZD
DR   GEO; GSM431829
DR   Wikidata; Q110433409
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4TY ! UCF0284
OI   CVCL_B4ZE ! UCT0284
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0285
AC   CVCL_B4ZF
DR   EGA; EGAS00001003485
DR   GEO; GSM431830
DR   Wikidata; Q110433410
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UB ! UCF0285
OI   CVCL_B4ZG ! UCT0285
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0295
AC   CVCL_B4ZH
DR   GEO; GSM431831
DR   Wikidata; Q110433412
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4U5 ! UCF0295
OI   CVCL_B4ZI ! UCT0295
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB0304
AC   CVCL_B4ZJ
DR   EGA; EGAS00001003485
DR   GEO; GSM431832
DR   Wikidata; Q110433413
RX   PubMed=19644074;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4U9 ! UCF0304
OI   CVCL_B4ZK ! UCT0304
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB0313
AC   CVCL_B4ZL
DR   GEO; GSM431833
DR   Wikidata; Q110433414
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZM ! UCF0313
OI   CVCL_B4ZN ! UCT0313
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1000
AC   CVCL_B5B5
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433415
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1001
AC   CVCL_B4L6
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433416
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1002
AC   CVCL_B5B6
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433417
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1004
AC   CVCL_B5B7
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433419
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1006
AC   CVCL_B5B8
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433421
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1007
AC   CVCL_B5B9
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433422
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1008
AC   CVCL_B5BA
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433423
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1011
AC   CVCL_B4L7
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433424
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1012
AC   CVCL_B4L8
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433425
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1013
AC   CVCL_B5BB
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433426
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1014
AC   CVCL_B4L5
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   GEO; GSE123028
DR   Wikidata; Q110433427
RX   PubMed=29116076;
RX   PubMed=30510006;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4L4 ! UCF1014
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1015
AC   CVCL_B5BC
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433428
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1016
AC   CVCL_B4L9
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433430
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1021
AC   CVCL_B5BD
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433432
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1022
AC   CVCL_B5BE
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433433
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1023
AC   CVCL_B4LA
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433434
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1025
AC   CVCL_B4LB
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433435
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1026
AC   CVCL_B5BF
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433436
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1027
AC   CVCL_B4LC
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433437
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1028
AC   CVCL_B5BG
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433438
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1029
AC   CVCL_B4LD
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433440
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1030
AC   CVCL_B5BN
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433441
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1037
AC   CVCL_B5BH
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433442
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1040
AC   CVCL_B5BI
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433444
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1045
AC   CVCL_B5BJ
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433445
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1046
AC   CVCL_B4LE
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433446
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1047
AC   CVCL_B5BK
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433447
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1048
AC   CVCL_B4LF
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433448
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1052
AC   CVCL_B4LG
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433450
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1053
AC   CVCL_B4LH
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433451
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1055
AC   CVCL_B5BL
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433452
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1056
AC   CVCL_B4LI
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433453
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1057
AC   CVCL_B5BM
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433454
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1058
AC   CVCL_B4LJ
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433456
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1059
AC   CVCL_B5BP
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433457
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1061
AC   CVCL_B4LK
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433458
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1063
AC   CVCL_B5BQ
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433460
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1064
AC   CVCL_B4LL
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433461
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1067
AC   CVCL_B4LM
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433462
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1068
AC   CVCL_B5BR
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433463
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1069
AC   CVCL_B4LN
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433464
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1070
AC   CVCL_B4LP
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433465
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1071
AC   CVCL_B4LQ
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433466
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1072
AC   CVCL_B4LR
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433467
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1073
AC   CVCL_B4LS
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433469
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1074
AC   CVCL_B4LT
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433470
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1075
AC   CVCL_B4LU
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433471
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1076
AC   CVCL_B4LV
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433472
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1077
AC   CVCL_B4LW
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433473
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1078
AC   CVCL_B5BS
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433474
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1079
AC   CVCL_B4LX
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433475
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1080
AC   CVCL_B4LY
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433476
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1083
AC   CVCL_B4LZ
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433478
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1084
AC   CVCL_B5BT
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433479
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1085
AC   CVCL_B5BU
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433480
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1086
AC   CVCL_B4M0
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433481
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1087
AC   CVCL_B4M1
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433482
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1088
AC   CVCL_B5BV
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433483
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1089
AC   CVCL_B4M2
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433485
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1090
AC   CVCL_B5BW
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433486
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1091
AC   CVCL_B4M3
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433488
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1092
AC   CVCL_B4M4
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433489
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1093
AC   CVCL_B5BX
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433490
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1094
AC   CVCL_B4M5
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433491
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1096
AC   CVCL_B4M6
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433492
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1098
AC   CVCL_B4M7
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433493
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1099
AC   CVCL_B4M8
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433494
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1100
AC   CVCL_B4M9
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433496
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1101
AC   CVCL_B4MA
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433498
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1102
AC   CVCL_B4MB
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433499
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1103
AC   CVCL_B4MC
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433500
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1104
AC   CVCL_B5BY
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433501
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1105
AC   CVCL_B4MD
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433502
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1106
AC   CVCL_B5C1
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433503
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1107
AC   CVCL_B4ME
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433504
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1108
AC   CVCL_B4MF
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433505
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1109
AC   CVCL_B5C2
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433507
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1112
AC   CVCL_B4MG
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433508
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1113
AC   CVCL_B4MH
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433509
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1115
AC   CVCL_B5C3
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433511
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1116
AC   CVCL_B5C4
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433512
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1117
AC   CVCL_B4MI
DR   ArrayExpress; E-MTAB-5835
DR   Wikidata; Q110433513
RX   PubMed=29116076;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; CAGE-seq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1119
AC   CVCL_B4MJ
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433514
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1120
AC   CVCL_B4MK
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433515
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1123
AC   CVCL_B5C5
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433517
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1124
AC   CVCL_B5C6
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433519
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1125
AC   CVCL_B5C7
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433520
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1126
AC   CVCL_B5C8
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433521
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1128
AC   CVCL_B5C9
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433522
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1129
AC   CVCL_B4ML
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433523
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1130
AC   CVCL_B4MM
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433525
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1131
AC   CVCL_B4MN
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433526
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1135
AC   CVCL_B5CA
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433528
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1136
AC   CVCL_B4MP
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433529
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1137
AC   CVCL_B5CC
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433531
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1138
AC   CVCL_B5CB
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433532
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1139
AC   CVCL_B4MQ
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433533
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1140
AC   CVCL_B5CD
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433534
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1143
AC   CVCL_B5CE
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433535
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1146
AC   CVCL_B5CF
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433536
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1148
AC   CVCL_B4MR
DR   ArrayExpress; E-MTAB-5835
DR   Wikidata; Q110433538
RX   PubMed=29116076;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; CAGE-seq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1196
AC   CVCL_B4MS
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433541
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1197
AC   CVCL_B5CG
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433542
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1198
AC   CVCL_B5CH
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433543
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1199
AC   CVCL_B4MT
DR   ArrayExpress; E-MTAB-5835
DR   Wikidata; Q110433544
RX   PubMed=29116076;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; CAGE-seq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCB1200
AC   CVCL_B4MU
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433545
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1201
AC   CVCL_B5CI
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433546
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1203
AC   CVCL_B4MV
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433548
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1204
AC   CVCL_B5CJ
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433549
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1205
AC   CVCL_B5CK
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433551
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1206
AC   CVCL_B4MW
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433552
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1207
AC   CVCL_B4MX
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433553
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1208
AC   CVCL_B4MY
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433554
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1210
AC   CVCL_B4MZ
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433555
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1211
AC   CVCL_B5CL
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433556
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1212
AC   CVCL_B4N0
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433557
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1214
AC   CVCL_B5CM
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433559
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1215
AC   CVCL_B5CN
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433560
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1216
AC   CVCL_B4N1
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433561
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1217
AC   CVCL_B5CP
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433562
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB1218
AC   CVCL_B4N2
DR   ArrayExpress; E-MTAB-5835
DR   EGA; EGAS00001003485
DR   Wikidata; Q110433563
RX   PubMed=29116076;
RX   PubMed=31048460;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; CAGE-seq.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   UCB302MSCs
AC   CVCL_3228
SY   UCB302
DR   BioSample; SAMN03472509
DR   JCRB; JCRB1106
DR   JCRB; NIHS0410
DR   SKIP; SKIP000284
DR   Wikidata; Q54989570
RX   PubMed=21155951;
CC   Discontinued: JCRB; NIHS0410; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): JCRB=JCRB1106
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 12,14
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   UCB408E6E7-31
AC   CVCL_3229
DR   BioSample; SAMN03472450
DR   JCRB; JCRB1108
DR   JCRB; NIHS0412
DR   SKIP; SKIP000286
DR   Wikidata; Q54989571
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0412; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): JCRB=JCRB1108
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3231 ! UCB408E6E7TERT-33
OI   CVCL_3230 ! UCB408E7-32
OI   CVCL_4W85 ! UCB408E7TERT-34
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 17
//
ID   UCB408E6E7TERT-33
AC   CVCL_3231
DR   CLO; CLO_0050434
DR   JCRB; JCRB1110
DR   JCRB; NIHS0414
DR   RCB; RCB2080
DR   SKIP; SKIP000288
DR   Wikidata; Q54989572
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0414; true.
CC   Discontinued: RCB; RCB2080; probable.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): JCRB=JCRB1110; RCB=RCB2080
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3229 ! UCB408E6E7-31
OI   CVCL_3230 ! UCB408E7-32
OI   CVCL_4W85 ! UCB408E7TERT-34
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   UCB408E7-32
AC   CVCL_3230
DR   JCRB; JCRB1109
DR   JCRB; NIHS0413
DR   SKIP; SKIP000287
DR   Wikidata; Q54989573
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0413; true.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): JCRB=JCRB1109
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3229 ! UCB408E6E7-31
OI   CVCL_3231 ! UCB408E6E7TERT-33
OI   CVCL_4W85 ! UCB408E7TERT-34
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   UCB408E7TERT-34
AC   CVCL_4W85
SY   UCB408E7-TERT34
DR   JCRB; JCRB1546
DR   Wikidata; Q54989574
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): JCRB=JCRB1546
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3229 ! UCB408E6E7-31
OI   CVCL_3231 ! UCB408E6E7TERT-33
OI   CVCL_3230 ! UCB408E7-32
SX   Male
AG   <1D
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   UCBiPS7
AC   CVCL_0H61
DR   SKIP; SKIP000585
DR   Wikidata; Q54989576
RX   PubMed=23326500;
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   UCBTERT-21
AC   CVCL_3232
SY   UCB-TERT-21
DR   CLO; CLO_0050433
DR   BioSample; SAMN01821720
DR   JCRB; JCRB1107
DR   JCRB; NIHS0411
DR   RCB; RCB2079
DR   SKIP; SKIP000285
DR   Wikidata; Q54989578
RX   PubMed=15647378;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Discontinued: JCRB; NIHS0411; true.
CC   Discontinued: RCB; RCB2079; probable.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Mesenchymal stem cell of umbilical cord; CL=CL_0002569.
ST   Source(s): JCRB=JCRB1107; RCB=RCB2079
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 12,14
ST   D7S820: 10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   UCCA-21
AC   CVCL_W502
DR   JCRB; JCRB1963
DR   Wikidata; Q54989580
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 63.6 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): JCRB=JCRB1963
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W503 ! UCCA-22
OI   CVCL_W504 ! UCCA-23
OI   CVCL_W505 ! UCCA-24
OI   CVCL_W506 ! UCCA-25
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   UCCA-22
AC   CVCL_W503
DR   Wikidata; Q54989581
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 43.8 hours (PubMed=15016319).
CC   Microsatellite instability: Stable (MSS) (PubMed=15016319).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W502 ! UCCA-21
OI   CVCL_W504 ! UCCA-23
OI   CVCL_W505 ! UCCA-24
OI   CVCL_W506 ! UCCA-25
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   UCCA-23
AC   CVCL_W504
DR   Wikidata; Q54989582
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 44.4 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W502 ! UCCA-21
OI   CVCL_W503 ! UCCA-22
OI   CVCL_W505 ! UCCA-24
OI   CVCL_W506 ! UCCA-25
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   UCCA-24
AC   CVCL_W505
DR   JCRB; JCRB1986
DR   Wikidata; Q54989584
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 37.3 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): JCRB=JCRB1986
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W502 ! UCCA-21
OI   CVCL_W503 ! UCCA-22
OI   CVCL_W504 ! UCCA-23
OI   CVCL_W506 ! UCCA-25
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   UCCA-25
AC   CVCL_W506
DR   JCRB; JCRB1997
DR   Wikidata; Q54989585
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Doubling time: 40.5 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): JCRB=JCRB1997
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 10
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W502 ! UCCA-21
OI   CVCL_W503 ! UCCA-22
OI   CVCL_W504 ! UCCA-23
OI   CVCL_W505 ! UCCA-24
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   UCCA-3
AC   CVCL_W507
DR   cancercelllines; CVCL_W507
DR   Wikidata; Q54989586
RX   PubMed=15016319;
CC   Population: Japanese.
CC   Characteristics: Established from an implant of the original tumor in SCID mice (PubMed=15016319).
CC   Doubling time: 56.9 hours (PubMed=15016319).
CC   Microsatellite instability: Instable (MSI-low) (PubMed=15016319).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=15016319).
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   UCD-Dm-mei-218-1
AC   CVCL_Z920
SY   mei-218-1; mei-218
DR   FlyBase_Cell_line; FBtc9000035
DR   Wikidata; Q54989587
RX   DOI=10.1007/BF02618446;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=826452;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   UCD-Dm-mei-41-1
AC   CVCL_Z921
SY   mei-41-1
DR   FlyBase_Cell_line; FBtc9000039
DR   Wikidata; Q54989588
RX   DOI=10.1007/BF02618446;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   UCD-Dm-mei-9-1
AC   CVCL_Z922
SY   mei-9-1; mei-9a-1
DR   FlyBase_Cell_line; FBtc9000040
DR   Wikidata; Q54989590
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=826452;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UCD-Dm-mei-9-2
AC   CVCL_Z923
SY   UCD Dm mei-9-2; mei-9-2; mei-9a-2; Mei9a
DR   ECACC; 90070553
DR   FlyBase_Cell_line; FBtc9000036
DR   Wikidata; Q54989592
RX   DOI=10.1007/BF02618446;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=826452;
RX   PubMed=3141801;
CC   Group: Insect cell line.
CC   Caution: It is uncertain whether ECACC Mei9a is UCD-Dm-mei-9-2 or UCD-Dm-mei-9-1. We believe it is the first one based on its use by many investigators.
CC   Discontinued: ECACC; 90070553; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 10
//
ID   UCD-Dm-mus103-1
AC   CVCL_Z924
SY   mus103-1
DR   FlyBase_Cell_line; FBtc9000037
DR   Wikidata; Q54989593
RX   DOI=10.1007/BF02618446;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   UCD-Dm-mus104-1
AC   CVCL_Z925
SY   mus104-1
DR   FlyBase_Cell_line; FBtc9000038
DR   Wikidata; Q54989594
RX   DOI=10.1007/BF02618446;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UCD-Dm-w-1
AC   CVCL_Z873
SY   w-1
DR   FlyBase_Cell_line; FBtc9000034
DR   Wikidata; Q54989595
RX   DOI=10.1007/BF02618446;
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=826452;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 9
//
ID   UCD-Mel-N
AC   CVCL_WS21
SY   UCD Mel N
DR   Wikidata; Q98133829
RX   PubMed=10811875;
RX   PubMed=11719430;
RX   PubMed=14583455;
RX   PubMed=15313901;
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 4
//
ID   UCD-Mel-N(Ski+)
AC   CVCL_WS22
SY   UCD(SKI+)
DR   Wikidata; Q98133830
RX   PubMed=10811875;
RX   PubMed=14583455;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10896; SKI.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS21 ! UCD-Mel-N
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 7
//
ID   UCD-Mel-N(Ski+/Fhl2+)
AC   CVCL_WS23
SY   UCD(SKI+/FHL2+)
DR   Wikidata; Q98133831
RX   PubMed=14583455;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:10896; SKI.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3703; FHL2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS22 ! UCD-Mel-N(Ski+)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 10
//
ID   UCD-Mel-N-GFP
AC   CVCL_WS24
SY   UCD-GFP
DR   Wikidata; Q98133833
RX   PubMed=15313901;
RX   PubMed=21673604;
CC   Characteristics: Stably transduced with a pLZR-IRES-EGFP construct (PubMed=15313901).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS21 ! UCD-Mel-N
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 5
//
ID   UCD-Mel-N-PEDF
AC   CVCL_WS25
SY   UCD-PEDF
DR   Wikidata; Q98133834
RX   PubMed=15313901;
RX   PubMed=21673604;
CC   Characteristics: Stably transduced with a pLZR-PEDF-IRES-EGFP construct (PubMed=15313901).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8824; SERPINF1.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WS21 ! UCD-Mel-N
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 7
//
ID   UCD/AB 6.01
AC   CVCL_F802
SY   UCD/AB6.01
DR   CLO; CLO_0009480
DR   ATCC; HB-8693
DR   Wikidata; Q54989596
RX   Patent=US4775620;
RX   PubMed=2430694;
RX   PubMed=6426784;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8693.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05787; Human KRT8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   UCD/AB 6.11
AC   CVCL_F803
DR   CLO; CLO_0009481
DR   Wikidata; Q54989600
RX   Patent=US4775620;
RX   PubMed=2430694;
RX   PubMed=2451420;
RX   PubMed=6426784;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8458.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   UCD/PR 10.11
AC   CVCL_F804
SY   UCD/PR10.11
DR   CLO; CLO_0009482
DR   ATCC; HB-8694
DR   Wikidata; Q54989601
RX   Patent=US4775620;
RX   PubMed=2430694;
RX   PubMed=2451420;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8694.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05783; Human KRT18.
CC   Monoclonal antibody target: UniProtKB; P05787; Human KRT8.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   UCD115
AC   CVCL_ZV45
DR   Wikidata; Q98133835
RX   PubMed=32576280;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 65.4 hours, 67.7 hours (Note=With 17-beta-estradiol) (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys305fs*47 (c.892_911dupGAGCTGCCCCCAGGGAGCAC); Zygosity=Unspecified (PubMed=32576280).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   UCD12
AC   CVCL_ZV42
DR   cancercelllines; CVCL_ZV42
DR   Wikidata; Q98133836
RX   PubMed=32576280;
CC   Characteristics: Established from a patient-derived xenograft.
CC   Characteristics: ER-positive, PR-negative and ERBB2-negative.
CC   Doubling time: 110.1 hours, 94.6 hours (Note=With 17-beta-estradiol) (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Ala1648Glufs*22 (c.4943delC); ClinVar=VCV001458405; Zygosity=Unspecified (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Leu (c.3140A>T); ClinVar=VCV000013653; Zygosity=Unspecified (PubMed=32576280).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   UCD178
AC   CVCL_ZV46
DR   Wikidata; Q98133837
RX   PubMed=32576280;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 54.1 hours, 55.8 hours (Note=With 17-beta-estradiol) (PubMed=32576280).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7881; NOTCH1 + HGNC; HGNC:29006; SEC16A; Name(s)=SEC16A-NOTCH1 (PubMed=32576280).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   UCD4
AC   CVCL_ZV41
DR   cancercelllines; CVCL_ZV41
DR   Wikidata; Q98133838
RX   PubMed=32576280;
CC   Characteristics: Established from a patient-derived xenograft.
CC   Characteristics: ER/PR-positive and ERBB2-negative.
CC   Doubling time: 95.9 hours, 89.3 hours (Note=With 17-beta-estradiol) (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:1101; BRCA2; Simple; p.Lys585Asnfs*3 (c.1755_1759delGAAAA); ClinVar=VCV000037754; Zygosity=Unspecified (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:3467; ESR1; Simple; p.Asp538Gly (c.1613A>G); ClinVar=VCV003764845; Zygosity=Unspecified (PubMed=32576280).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   UCD46
AC   CVCL_ZV43
DR   Wikidata; Q98133839
RX   PubMed=32576280;
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Characteristics: Established from a patient-derived xenograft.
CC   Doubling time: 81.5 hours, 89.4 hours (Note=With 17-beta-estradiol) (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser94Ter (c.281C>G); Zygosity=Unspecified (PubMed=32576280).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   UCD65
AC   CVCL_ZV44
DR   cancercelllines; CVCL_ZV44
DR   Wikidata; Q98133840
RX   PubMed=32576280;
CC   Characteristics: Established from a patient-derived xenograft.
CC   Characteristics: ER/PR-positive and ERBB2-negative.
CC   Doubling time: 132.8 hours, 109.3 hours (Note=With 17-beta-estradiol) (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu792fs*2 (c.2372dupT); Zygosity=Unspecified (PubMed=32576280).
CC   Sequence variation: Mutation; HGNC; HGNC:7882; NOTCH2; Simple; p.Leu2135Glufs*2 (c.6403_6404delCT); ClinVar=VCV000946387; Zygosity=Unspecified (PubMed=32576280).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   UCF0010
AC   CVCL_B4P9
DR   EGA; EGAS00000000056
DR   GEO; GSM606652
DR   Wikidata; Q110433564
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0011
AC   CVCL_B4PA
DR   EGA; EGAS00000000056
DR   GEO; GSM606710
DR   Wikidata; Q110433565
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0012
AC   CVCL_B4PB
DR   EGA; EGAS00000000056
DR   GEO; GSM606711
DR   Wikidata; Q110433567
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0018
AC   CVCL_B4PC
DR   EGA; EGAS00000000056
DR   GEO; GSM431663
DR   GEO; GSM606712
DR   Wikidata; Q110433568
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UL ! UCB0018
OI   CVCL_B4UM ! UCT0018
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0019
AC   CVCL_B4PD
DR   EGA; EGAS00000000056
DR   GEO; GSM431664
DR   GEO; GSM606713
DR   Wikidata; Q110433571
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UN ! UCB0019
OI   CVCL_B4UP ! UCT0019
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0022
AC   CVCL_B4PE
DR   EGA; EGAS00000000056
DR   GEO; GSM606714
DR   Wikidata; Q110433572
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0023
AC   CVCL_B4PF
DR   EGA; EGAS00000000056
DR   GEO; GSM606715
DR   Wikidata; Q110433573
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0024
AC   CVCL_B4PG
DR   EGA; EGAS00000000056
DR   GEO; GSM431665
DR   GEO; GSM606716
DR   Wikidata; Q110433575
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UQ ! UCB0024
OI   CVCL_B4UR ! UCT0024
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0025
AC   CVCL_B4PH
DR   EGA; EGAS00000000056
DR   GEO; GSM431666
DR   GEO; GSM606732
DR   Wikidata; Q110433576
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4US ! UCB0025
OI   CVCL_B4UT ! UCT0025
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0026
AC   CVCL_B4PI
DR   EGA; EGAS00000000056
DR   GEO; GSM606717
DR   Wikidata; Q110433577
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0028
AC   CVCL_B4PJ
DR   EGA; EGAS00000000056
DR   GEO; GSM606718
DR   Wikidata; Q110433578
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0029
AC   CVCL_B4PK
DR   EGA; EGAS00000000056
DR   GEO; GSM606719
DR   Wikidata; Q110433579
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0033
AC   CVCL_B4PL
DR   EGA; EGAS00000000056
DR   GEO; GSM606720
DR   Wikidata; Q110433582
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0034
AC   CVCL_B4PM
DR   EGA; EGAS00000000056
DR   GEO; GSM431667
DR   GEO; GSM606733
DR   Wikidata; Q110433583
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UU ! UCB0034
OI   CVCL_B4UV ! UCT0034
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0039
AC   CVCL_B4PN
DR   EGA; EGAS00000000056
DR   GEO; GSM606741
DR   Wikidata; Q110433584
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0040
AC   CVCL_B4PP
DR   EGA; EGAS00000000056
DR   GEO; GSM606734
DR   Wikidata; Q110433587
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0041
AC   CVCL_B4UX
DR   GEO; GSM431668
DR   Wikidata; Q110433588
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UW ! UCB0041
OI   CVCL_B4UY ! UCT0041
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0042
AC   CVCL_B4PQ
DR   EGA; EGAS00000000056
DR   GEO; GSM431669
DR   GEO; GSM606735
DR   Wikidata; Q110433589
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UZ ! UCB0042
OI   CVCL_B4V0 ! UCT0042
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0043
AC   CVCL_B4PR
DR   EGA; EGAS00000000056
DR   GEO; GSM606736
DR   Wikidata; Q110433591
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0045
AC   CVCL_B4V2
DR   GEO; GSM431670
DR   Wikidata; Q110433592
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V1 ! UCB0045
OI   CVCL_B4V3 ! UCT0045
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0047
AC   CVCL_B4PS
DR   EGA; EGAS00000000056
DR   GEO; GSM606737
DR   Wikidata; Q110433594
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0048
AC   CVCL_B4PT
DR   EGA; EGAS00000000056
DR   GEO; GSM431671
DR   GEO; GSM606738
DR   Wikidata; Q110433595
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V4 ! UCB0048
OI   CVCL_B4V5 ! UCT0048
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0049
AC   CVCL_B4PU
DR   EGA; EGAS00000000056
DR   GEO; GSM431672
DR   GEO; GSM606739
DR   Wikidata; Q110433596
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V6 ! UCB0049
OI   CVCL_B4V7 ! UCT0049
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0050
AC   CVCL_B4V9
DR   GEO; GSM431673
DR   Wikidata; Q110433597
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V8 ! UCB0050
OI   CVCL_B4VA ! UCT0050
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0051
AC   CVCL_B4PV
DR   EGA; EGAS00000000056
DR   GEO; GSM431674
DR   GEO; GSM606740
DR   Wikidata; Q110433598
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VB ! UCB0051
OI   CVCL_B4VC ! UCT0051
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0052
AC   CVCL_B4PW
DR   EGA; EGAS00000000056
DR   GEO; GSM606742
DR   Wikidata; Q110433600
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0055
AC   CVCL_B4VE
DR   GEO; GSM431675
DR   Wikidata; Q110433601
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VD ! UCB0055
OI   CVCL_B4VF ! UCT0055
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0056
AC   CVCL_B4PX
DR   EGA; EGAS00000000056
DR   GEO; GSM606743
DR   Wikidata; Q110433603
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0057
AC   CVCL_B4PY
DR   EGA; EGAS00000000056
DR   GEO; GSM606744
DR   Wikidata; Q110433604
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0058
AC   CVCL_B4PZ
DR   EGA; EGAS00000000056
DR   GEO; GSM606793
DR   Wikidata; Q110433605
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0060
AC   CVCL_B4Q0
DR   EGA; EGAS00000000056
DR   GEO; GSM431676
DR   GEO; GSM606745
DR   Wikidata; Q110433606
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VG ! UCB0060
OI   CVCL_B4VH ! UCT0060
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0062
AC   CVCL_B4Q1
DR   EGA; EGAS00000000056
DR   GEO; GSM431677
DR   GEO; GSM606746
DR   Wikidata; Q110433607
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VI ! UCB0062
OI   CVCL_B4VJ ! UCT0062
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0068
AC   CVCL_B4Q2
DR   EGA; EGAS00000000056
DR   GEO; GSM606747
DR   Wikidata; Q110433608
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0070
AC   CVCL_B4Q3
DR   EGA; EGAS00000000056
DR   GEO; GSM431678
DR   GEO; GSM606748
DR   Wikidata; Q110433609
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VK ! UCB0070
OI   CVCL_B4VL ! UCT0070
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0075
AC   CVCL_B4Q4
DR   EGA; EGAS00000000056
DR   GEO; GSM606828
DR   Wikidata; Q110433610
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0078
AC   CVCL_B4Q5
DR   EGA; EGAS00000000056
DR   GEO; GSM431679
DR   GEO; GSM606763
DR   Wikidata; Q110433612
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VM ! UCB0078
OI   CVCL_B4VN ! UCT0078
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0079
AC   CVCL_B4Q6
DR   EGA; EGAS00000000056
DR   GEO; GSM431680
DR   GEO; GSM606829
DR   Wikidata; Q110433614
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VP ! UCB0079
OI   CVCL_B4VQ ! UCT0079
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0081
AC   CVCL_B4VS
DR   GEO; GSM431681
DR   Wikidata; Q110433615
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VR ! UCB0081
OI   CVCL_B4VT ! UCT0081
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0082
AC   CVCL_B4Q7
DR   EGA; EGAS00000000056
DR   GEO; GSM606819
DR   Wikidata; Q110433616
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0083
AC   CVCL_B4Q8
DR   EGA; EGAS00000000056
DR   GEO; GSM431682
DR   GEO; GSM606820
DR   Wikidata; Q110433617
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VU ! UCB0083
OI   CVCL_B4VV ! UCT0083
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0084
AC   CVCL_B4Q9
DR   EGA; EGAS00000000056
DR   GEO; GSM606821
DR   Wikidata; Q110433618
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0086
AC   CVCL_B4QA
DR   EGA; EGAS00000000056
DR   GEO; GSM431683
DR   GEO; GSM606822
DR   Wikidata; Q110433619
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VW ! UCB0086
OI   CVCL_B4VX ! UCT0086
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0087
AC   CVCL_B4QB
DR   EGA; EGAS00000000056
DR   GEO; GSM431684
DR   GEO; GSM606823
DR   Wikidata; Q110433620
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VY ! UCB0087
OI   CVCL_B4VZ ! UCT0087
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0088
AC   CVCL_B4QC
DR   EGA; EGAS00000000056
DR   GEO; GSM431685
DR   GEO; GSM606824
DR   Wikidata; Q110433622
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W0 ! UCB0088
OI   CVCL_B4W1 ! UCT0088
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0089
AC   CVCL_B4QD
DR   EGA; EGAS00000000056
DR   GEO; GSM606799
DR   Wikidata; Q110433623
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0090
AC   CVCL_B4QE
DR   EGA; EGAS00000000056
DR   GEO; GSM606784
DR   Wikidata; Q110433624
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0092
AC   CVCL_B4QF
DR   EGA; EGAS00000000056
DR   GEO; GSM606773
DR   Wikidata; Q110433626
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0093
AC   CVCL_B4QG
DR   EGA; EGAS00000000056
DR   GEO; GSM431686
DR   GEO; GSM606785
DR   Wikidata; Q110433627
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W2 ! UCB0093
OI   CVCL_B4W3 ! UCT0093
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0094
AC   CVCL_B4W5
DR   GEO; GSM431687
DR   Wikidata; Q110433628
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W4 ! UCB0094
OI   CVCL_B4W6 ! UCT0094
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0095
AC   CVCL_B4QH
DR   EGA; EGAS00000000056
DR   GEO; GSM431688
DR   GEO; GSM606786
DR   Wikidata; Q110433630
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W7 ! UCB0095
OI   CVCL_B4W8 ! UCT0095
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0097
AC   CVCL_B4QI
DR   EGA; EGAS00000000056
DR   GEO; GSM431689
DR   GEO; GSM606774
DR   Wikidata; Q110433631
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W9 ! UCB0097
OI   CVCL_B4WA ! UCT0097
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0098
AC   CVCL_B4QJ
DR   EGA; EGAS00000000056
DR   GEO; GSM606651
DR   Wikidata; Q110433633
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0099
AC   CVCL_B4QK
DR   EGA; EGAS00000000056
DR   GEO; GSM606775
DR   Wikidata; Q110433634
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0100
AC   CVCL_B4QL
DR   EGA; EGAS00000000056
DR   GEO; GSM431690
DR   GEO; GSM606776
DR   Wikidata; Q110433635
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WB ! UCB0100
OI   CVCL_B4WC ! UCT0100
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0101
AC   CVCL_B4QM
DR   EGA; EGAS00000000056
DR   GEO; GSM606698
DR   Wikidata; Q110433637
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0102
AC   CVCL_B4QN
DR   EGA; EGAS00000000056
DR   GEO; GSM606699
DR   Wikidata; Q110433638
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0103
AC   CVCL_B4QP
DR   EGA; EGAS00000000056
DR   GEO; GSM431691
DR   GEO; GSM606777
DR   Wikidata; Q110433639
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WD ! UCB0103
OI   CVCL_B4WE ! UCT0103
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0105
AC   CVCL_B4QQ
DR   EGA; EGAS00000000056
DR   GEO; GSM431692
DR   GEO; GSM606787
DR   Wikidata; Q110433640
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WF ! UCB0105
OI   CVCL_B4WG ! UCT0105
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0106
AC   CVCL_B4QR
DR   EGA; EGAS00000000056
DR   GEO; GSM606788
DR   Wikidata; Q110433641
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0108
AC   CVCL_B4QS
DR   EGA; EGAS00000000056
DR   GEO; GSM431693
DR   GEO; GSM606789
DR   Wikidata; Q110433643
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WH ! UCB0108
OI   CVCL_B4WI ! UCT0108
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0110
AC   CVCL_B4QT
DR   EGA; EGAS00000000056
DR   GEO; GSM431694
DR   GEO; GSM606790
DR   Wikidata; Q110433644
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WJ ! UCB0110
OI   CVCL_B4WK ! UCT0110
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0112
AC   CVCL_B4QU
DR   EGA; EGAS00000000056
DR   GEO; GSM431695
DR   GEO; GSM606791
DR   Wikidata; Q110433645
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WL ! UCB0112
OI   CVCL_B4WM ! UCT0112
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0113
AC   CVCL_B4QV
DR   EGA; EGAS00000000056
DR   GEO; GSM431696
DR   GEO; GSM606700
DR   Wikidata; Q110433646
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WN ! UCB0113
OI   CVCL_B4WP ! UCT0113
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0114
AC   CVCL_B4QW
DR   EGA; EGAS00000000056
DR   GEO; GSM431697
DR   GEO; GSM606751
DR   Wikidata; Q110433647
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WQ ! UCB0114
OI   CVCL_B4WR ! UCT0114
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0115
AC   CVCL_B4QX
DR   EGA; EGAS00000000056
DR   GEO; GSM431698
DR   GEO; GSM606757
DR   Wikidata; Q110433648
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WS ! UCB0115
OI   CVCL_B4WT ! UCT0115
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0116
AC   CVCL_B4QY
DR   EGA; EGAS00000000056
DR   GEO; GSM431699
DR   GEO; GSM606701
DR   Wikidata; Q110433649
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WU ! UCB0116
OI   CVCL_B4WV ! UCT0116
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0117
AC   CVCL_B4QZ
DR   EGA; EGAS00000000056
DR   GEO; GSM431700
DR   GEO; GSM606702
DR   Wikidata; Q110433651
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WW ! UCB0117
OI   CVCL_B4WX ! UCT0117
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0119
AC   CVCL_B4R0
DR   EGA; EGAS00000000056
DR   GEO; GSM431701
DR   GEO; GSM606764
DR   Wikidata; Q110433652
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WY ! UCB0119
OI   CVCL_B4WZ ! UCT0119
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0120
AC   CVCL_B4R1
DR   EGA; EGAS00000000056
DR   GEO; GSM606758
DR   Wikidata; Q110433654
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0121
AC   CVCL_B4R2
DR   EGA; EGAS00000000056
DR   GEO; GSM431702
DR   GEO; GSM606759
DR   Wikidata; Q110433655
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X0 ! UCB0121
OI   CVCL_B4X1 ! UCT0121
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0122
AC   CVCL_B4R3
DR   EGA; EGAS00000000056
DR   GEO; GSM431703
DR   GEO; GSM606760
DR   Wikidata; Q110433656
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X2 ! UCB0122
OI   CVCL_B4X3 ! UCT0122
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0123
AC   CVCL_B4R4
DR   EGA; EGAS00000000056
DR   GEO; GSM606721
DR   Wikidata; Q110433657
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0124
AC   CVCL_B4R5
DR   EGA; EGAS00000000056
DR   GEO; GSM431704
DR   GEO; GSM606761
DR   Wikidata; Q110433658
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X4 ! UCB0124
OI   CVCL_B4X5 ! UCT0124
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0125
AC   CVCL_B4R6
DR   EGA; EGAS00000000056
DR   GEO; GSM431705
DR   GEO; GSM606762
DR   Wikidata; Q110433659
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X6 ! UCB0125
OI   CVCL_B4X7 ! UCT0125
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0128
AC   CVCL_B4R7
DR   EGA; EGAS00000000056
DR   GEO; GSM431706
DR   GEO; GSM606722
DR   Wikidata; Q110433660
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X8 ! UCB0128
OI   CVCL_B4X9 ! UCT0128
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0129
AC   CVCL_B4R8
DR   EGA; EGAS00000000056
DR   GEO; GSM606792
DR   Wikidata; Q110433662
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0130
AC   CVCL_B4R9
DR   EGA; EGAS00000000056
DR   GEO; GSM431707
DR   GEO; GSM606753
DR   Wikidata; Q110433663
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XA ! UCB0130
OI   CVCL_B4XB ! UCT0130
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0131
AC   CVCL_B4RA
DR   EGA; EGAS00000000056
DR   GEO; GSM606794
DR   Wikidata; Q110433664
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0132
AC   CVCL_B4RB
DR   EGA; EGAS00000000056
DR   GEO; GSM606795
DR   Wikidata; Q110433665
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0133
AC   CVCL_B4RC
DR   EGA; EGAS00000000056
DR   GEO; GSM606756
DR   Wikidata; Q110433666
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0134
AC   CVCL_B4RD
DR   EGA; EGAS00000000056
DR   GEO; GSM606752
DR   Wikidata; Q110433667
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0137
AC   CVCL_B4RE
DR   EGA; EGAS00000000056
DR   GEO; GSM431708
DR   GEO; GSM606754
DR   Wikidata; Q110433669
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XC ! UCB0137
OI   CVCL_B4XD ! UCT0137
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0138
AC   CVCL_B4RF
DR   EGA; EGAS00000000056
DR   GEO; GSM606755
DR   Wikidata; Q110433670
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0139
AC   CVCL_B4RG
DR   EGA; EGAS00000000056
DR   GEO; GSM431709
DR   GEO; GSM606655
DR   Wikidata; Q110433671
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XE ! UCB0139
OI   CVCL_B4XF ! UCT0139
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0140
AC   CVCL_B4RH
DR   EGA; EGAS00000000056
DR   GEO; GSM431710
DR   GEO; GSM606656
DR   Wikidata; Q110433673
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XG ! UCB0140
OI   CVCL_B4XH ! UCT0140
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0141
AC   CVCL_B4RI
DR   EGA; EGAS00000000056
DR   GEO; GSM431711
DR   GEO; GSM606657
DR   Wikidata; Q110433674
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XI ! UCB0141
OI   CVCL_B4XJ ! UCT0141
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0142
AC   CVCL_B4RJ
DR   EGA; EGAS00000000056
DR   GEO; GSM606658
DR   Wikidata; Q110433675
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0144
AC   CVCL_B4RK
DR   EGA; EGAS00000000056
DR   GEO; GSM431712
DR   GEO; GSM606659
DR   Wikidata; Q110433677
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XK ! UCB0144
OI   CVCL_B4XL ! UCT0144
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0146
AC   CVCL_B4RL
DR   EGA; EGAS00000000056
DR   GEO; GSM606660
DR   Wikidata; Q110433678
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0149
AC   CVCL_B4RM
DR   EGA; EGAS00000000056
DR   GEO; GSM606661
DR   Wikidata; Q110433679
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0150
AC   CVCL_B4RN
DR   EGA; EGAS00000000056
DR   GEO; GSM606800
DR   Wikidata; Q110433682
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0152
AC   CVCL_B4RP
DR   EGA; EGAS00000000056
DR   GEO; GSM431713
DR   GEO; GSM606662
DR   Wikidata; Q110433685
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XM ! UCB0152
OI   CVCL_B4XN ! UCT0152
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0154
AC   CVCL_B4RQ
DR   EGA; EGAS00000000056
DR   GEO; GSM606723
DR   Wikidata; Q110433688
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0155
AC   CVCL_B4RR
DR   EGA; EGAS00000000056
DR   GEO; GSM431714
DR   GEO; GSM606663
DR   Wikidata; Q110433690
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XP ! UCB0155
OI   CVCL_B4XQ ! UCT0155
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0159
AC   CVCL_B4RS
DR   EGA; EGAS00000000056
DR   GEO; GSM606664
DR   Wikidata; Q110433692
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0161
AC   CVCL_B4RT
DR   EGA; EGAS00000000056
DR   GEO; GSM606665
DR   Wikidata; Q110433693
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B5B4 ! UCB0161
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0164
AC   CVCL_B4RU
DR   EGA; EGAS00000000056
DR   GEO; GSM431715
DR   GEO; GSM606703
DR   Wikidata; Q110433694
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XR ! UCB0164
OI   CVCL_B4XS ! UCT0164
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0165
AC   CVCL_B4RV
DR   EGA; EGAS00000000056
DR   GEO; GSM606724
DR   Wikidata; Q110433695
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0167
AC   CVCL_B4RW
DR   EGA; EGAS00000000056
DR   GEO; GSM431716
DR   GEO; GSM606666
DR   Wikidata; Q110433696
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XT ! UCB0167
OI   CVCL_B4XU ! UCT0167
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0168
AC   CVCL_B4RX
DR   EGA; EGAS00000000056
DR   GEO; GSM606765
DR   Wikidata; Q110433697
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0169
AC   CVCL_B4RY
DR   EGA; EGAS00000000056
DR   GEO; GSM431717
DR   GEO; GSM606667
DR   Wikidata; Q110433699
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XV ! UCB0169
OI   CVCL_B4XW ! UCT0169
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0171
AC   CVCL_B4RZ
DR   EGA; EGAS00000000056
DR   GEO; GSM606668
DR   Wikidata; Q110433700
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0172
AC   CVCL_B4XY
DR   GEO; GSM431718
DR   Wikidata; Q110433701
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XX ! UCB0172
OI   CVCL_B4XZ ! UCT0172
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0174
AC   CVCL_B4S0
DR   EGA; EGAS00000000056
DR   GEO; GSM606669
DR   Wikidata; Q110433703
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0176
AC   CVCL_B4S1
DR   EGA; EGAS00000000056
DR   GEO; GSM431719
DR   GEO; GSM606670
DR   Wikidata; Q110433705
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y0 ! UCB0176
OI   CVCL_B4Y1 ! UCT0176
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0177
AC   CVCL_B4S2
DR   EGA; EGAS00000000056
DR   GEO; GSM431720
DR   GEO; GSM606671
DR   Wikidata; Q110433706
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y2 ! UCB0177
OI   CVCL_B4Y3 ! UCT0177
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0180
AC   CVCL_B4S3
DR   EGA; EGAS00000000056
DR   GEO; GSM431721
DR   GEO; GSM606672
DR   Wikidata; Q110433707
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y4 ! UCB0180
OI   CVCL_B4Y5 ! UCT0180
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0181
AC   CVCL_B4S4
DR   EGA; EGAS00000000056
DR   GEO; GSM431722
DR   GEO; GSM606673
DR   Wikidata; Q110433708
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y6 ! UCB0181
OI   CVCL_B4Y7 ! UCT0181
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0183
AC   CVCL_B4S5
DR   EGA; EGAS00000000056
DR   GEO; GSM431723
DR   GEO; GSM606674
DR   Wikidata; Q110433710
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y8 ! UCB0183
OI   CVCL_B4Y9 ! UCT0183
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0184
AC   CVCL_B4UD
DR   EGA; EGAS00000000056
DR   GEO; GSM606807
DR   Wikidata; Q110433712
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0185
AC   CVCL_B4S6
DR   EGA; EGAS00000000056
DR   GEO; GSM606675
DR   Wikidata; Q110433713
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0187
AC   CVCL_B4S7
DR   EGA; EGAS00000000056
DR   GEO; GSM431724
DR   GEO; GSM606676
DR   Wikidata; Q110433714
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YA ! UCB0187
OI   CVCL_B4YB ! UCT0187
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0188
AC   CVCL_B4S8
DR   EGA; EGAS00000000056
DR   GEO; GSM431725
DR   GEO; GSM606808
DR   Wikidata; Q110433715
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YC ! UCB0188
OI   CVCL_B4YD ! UCT0188
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0189
AC   CVCL_B4S9
DR   EGA; EGAS00000000056
DR   GEO; GSM606796
DR   Wikidata; Q110433716
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0190
AC   CVCL_B4SA
DR   EGA; EGAS00000000056
DR   GEO; GSM606809
DR   Wikidata; Q110433717
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0193
AC   CVCL_B4SB
DR   EGA; EGAS00000000056
DR   GEO; GSM606810
DR   Wikidata; Q110433718
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0194
AC   CVCL_B4SC
DR   EGA; EGAS00000000056
DR   GEO; GSM606811
DR   Wikidata; Q110433720
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0195
AC   CVCL_B4SD
DR   EGA; EGAS00000000056
DR   GEO; GSM606812
DR   Wikidata; Q110433722
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0198
AC   CVCL_B4SE
DR   EGA; EGAS00000000056
DR   GEO; GSM606650
DR   Wikidata; Q110433723
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0201
AC   CVCL_B4SF
DR   EGA; EGAS00000000056
DR   GEO; GSM606766
DR   Wikidata; Q110433724
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0202
AC   CVCL_B4SG
DR   EGA; EGAS00000000056
DR   GEO; GSM606813
DR   Wikidata; Q110433725
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0204
AC   CVCL_B4SH
DR   EGA; EGAS00000000056
DR   GEO; GSM606814
DR   Wikidata; Q110433726
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0205
AC   CVCL_B4SI
DR   EGA; EGAS00000000056
DR   GEO; GSM606767
DR   Wikidata; Q110433727
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0210
AC   CVCL_B4SJ
DR   EGA; EGAS00000000056
DR   GEO; GSM606825
DR   Wikidata; Q110433728
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0211
AC   CVCL_B4SK
DR   EGA; EGAS00000000056
DR   GEO; GSM606815
DR   Wikidata; Q110433730
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0212
AC   CVCL_B4SL
DR   EGA; EGAS00000000056
DR   GEO; GSM606801
DR   Wikidata; Q110433733
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0216
AC   CVCL_B4SM
DR   EGA; EGAS00000000056
DR   GEO; GSM606816
DR   Wikidata; Q110433734
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0217
AC   CVCL_B4SN
DR   EGA; EGAS00000000056
DR   GEO; GSM431726
DR   GEO; GSM606817
DR   Wikidata; Q110433736
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YE ! UCB0217
OI   CVCL_B4YF ! UCT0217
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0218
AC   CVCL_B4SP
DR   EGA; EGAS00000000056
DR   GEO; GSM431727
DR   GEO; GSM606749
DR   Wikidata; Q110433737
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YG ! UCB0218
OI   CVCL_B4YH ! UCT0218
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0221
AC   CVCL_B4SQ
DR   EGA; EGAS00000000056
DR   GEO; GSM606818
DR   Wikidata; Q110433738
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0222
AC   CVCL_B4SR
DR   EGA; EGAS00000000056
DR   GEO; GSM606725
DR   Wikidata; Q110433739
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0223
AC   CVCL_B4SS
DR   EGA; EGAS00000000056
DR   GEO; GSM431728
DR   GEO; GSM606677
DR   Wikidata; Q110433741
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YI ! UCB0223
OI   CVCL_B4YJ ! UCT0223
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0225
AC   CVCL_B4ST
DR   EGA; EGAS00000000056
DR   GEO; GSM431729
DR   GEO; GSM606726
DR   Wikidata; Q110433742
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YK ! UCB0225
OI   CVCL_B4YL ! UCT0225
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0226
AC   CVCL_B4SU
DR   EGA; EGAS00000000056
DR   GEO; GSM431730
DR   GEO; GSM606727
DR   Wikidata; Q110433743
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YM ! UCB0226
OI   CVCL_B4YN ! UCT0226
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0227
AC   CVCL_B4SV
DR   EGA; EGAS00000000056
DR   GEO; GSM431731
DR   GEO; GSM606678
DR   Wikidata; Q110433745
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YP ! UCB0227
OI   CVCL_B4YQ ! UCT0227
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0228
AC   CVCL_B4SW
DR   EGA; EGAS00000000056
DR   GEO; GSM431732
DR   GEO; GSM606728
DR   Wikidata; Q110433746
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YR ! UCB0228
OI   CVCL_B4YS ! UCT0228
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0230
AC   CVCL_B4SX
DR   EGA; EGAS00000000056
DR   GEO; GSM606729
DR   Wikidata; Q110433747
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0231
AC   CVCL_B4SY
DR   EGA; EGAS00000000056
DR   GEO; GSM606679
DR   Wikidata; Q110433748
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0234
AC   CVCL_B4SZ
DR   EGA; EGAS00000000056
DR   GEO; GSM431733
DR   GEO; GSM606680
DR   Wikidata; Q110433750
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YT ! UCB0234
OI   CVCL_B4YU ! UCT0234
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0235
AC   CVCL_B4T0
DR   EGA; EGAS00000000056
DR   GEO; GSM606653
DR   Wikidata; Q110433751
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0236
AC   CVCL_B4T1
DR   EGA; EGAS00000000056
DR   GEO; GSM606768
DR   Wikidata; Q110433752
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0239
AC   CVCL_B4T2
DR   EGA; EGAS00000000056
DR   GEO; GSM606681
DR   Wikidata; Q110433754
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0242
AC   CVCL_B4T3
DR   EGA; EGAS00000000056
DR   GEO; GSM606682
DR   Wikidata; Q110433755
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0243
AC   CVCL_B4T4
DR   EGA; EGAS00000000056
DR   GEO; GSM431734
DR   GEO; GSM606704
DR   Wikidata; Q110433757
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YV ! UCB0243
OI   CVCL_B4YW ! UCT0243
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0244
AC   CVCL_B4T5
DR   EGA; EGAS00000000056
DR   GEO; GSM606705
DR   Wikidata; Q110433758
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0245
AC   CVCL_B4T6
DR   EGA; EGAS00000000056
DR   GEO; GSM606769
DR   Wikidata; Q110433760
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0246
AC   CVCL_B4T7
DR   EGA; EGAS00000000056
DR   GEO; GSM606706
DR   Wikidata; Q110433761
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0247
AC   CVCL_B4T8
DR   EGA; EGAS00000000056
DR   GEO; GSM606778
DR   Wikidata; Q110433762
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0249
AC   CVCL_B4T9
DR   EGA; EGAS00000000056
DR   GEO; GSM606707
DR   Wikidata; Q110433763
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0250
AC   CVCL_B4TA
DR   EGA; EGAS00000000056
DR   GEO; GSM606797
DR   Wikidata; Q110433765
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0251
AC   CVCL_B4TB
DR   EGA; EGAS00000000056
DR   GEO; GSM431735
DR   GEO; GSM606683
DR   Wikidata; Q110433766
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YX ! UCB0251
OI   CVCL_B4YY ! UCT0251
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0252
AC   CVCL_B4TC
DR   EGA; EGAS00000000056
DR   GEO; GSM606779
DR   Wikidata; Q110433768
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0253
AC   CVCL_B4TD
DR   EGA; EGAS00000000056
DR   GEO; GSM431736
DR   GEO; GSM606708
DR   Wikidata; Q110433769
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YZ ! UCB0253
OI   CVCL_B4Z0 ! UCT0253
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0254
AC   CVCL_B4TE
DR   EGA; EGAS00000000056
DR   GEO; GSM606730
DR   Wikidata; Q110433772
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0255
AC   CVCL_B4TF
DR   EGA; EGAS00000000056
DR   GEO; GSM431737
DR   GEO; GSM606709
DR   Wikidata; Q110433773
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z1 ! UCB0255
OI   CVCL_B4Z2 ! UCT0255
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0257
AC   CVCL_B4TG
DR   EGA; EGAS00000000056
DR   GEO; GSM606687
DR   Wikidata; Q110433774
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0258
AC   CVCL_B4TH
DR   EGA; EGAS00000000056
DR   GEO; GSM606750
DR   Wikidata; Q110433775
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0262
AC   CVCL_B4TI
DR   EGA; EGAS00000000056
DR   GEO; GSM606802
DR   Wikidata; Q110433777
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0266
AC   CVCL_B4TJ
DR   EGA; EGAS00000000056
DR   GEO; GSM606770
DR   Wikidata; Q110433779
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0267
AC   CVCL_B4TK
DR   EGA; EGAS00000000056
DR   GEO; GSM606688
DR   Wikidata; Q110433780
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0268
AC   CVCL_B4TL
DR   EGA; EGAS00000000056
DR   GEO; GSM606771
DR   Wikidata; Q110433781
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0270
AC   CVCL_B4TM
DR   EGA; EGAS00000000056
DR   GEO; GSM431738
DR   GEO; GSM606780
DR   Wikidata; Q110433783
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z3 ! UCB0270
OI   CVCL_B4Z4 ! UCT0270
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0271
AC   CVCL_B4TN
DR   EGA; EGAS00000000056
DR   GEO; GSM431739
DR   GEO; GSM606684
DR   Wikidata; Q110433784
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z5 ! UCB0271
OI   CVCL_B4Z6 ! UCT0271
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0272
AC   CVCL_B4TP
DR   EGA; EGAS00000000056
DR   GEO; GSM606827
DR   Wikidata; Q110433786
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0273
AC   CVCL_B4TQ
DR   EGA; EGAS00000000056
DR   GEO; GSM606689
DR   Wikidata; Q110433787
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0274
AC   CVCL_B4TR
DR   EGA; EGAS00000000056
DR   GEO; GSM606826
DR   Wikidata; Q110433788
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0275
AC   CVCL_B4UC
DR   EGA; EGAS00000000056
DR   GEO; GSM606803
DR   Wikidata; Q110433790
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0276
AC   CVCL_B4TS
DR   EGA; EGAS00000000056
DR   GEO; GSM431740
DR   GEO; GSM606804
DR   Wikidata; Q110433791
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z7 ! UCB0276
OI   CVCL_B4Z8 ! UCT0276
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0277
AC   CVCL_B4TT
DR   EGA; EGAS00000000056
DR   GEO; GSM431741
DR   GEO; GSM606654
DR   Wikidata; Q110433793
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z9 ! UCB0277
OI   CVCL_B4ZA ! UCT0277
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0278
AC   CVCL_B4TU
DR   EGA; EGAS00000000056
DR   GEO; GSM606781
DR   Wikidata; Q110433794
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0279
AC   CVCL_B4TV
DR   EGA; EGAS00000000056
DR   GEO; GSM606731
DR   Wikidata; Q110433795
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0282
AC   CVCL_B4TW
DR   EGA; EGAS00000000056
DR   GEO; GSM431742
DR   GEO; GSM606782
DR   Wikidata; Q110433797
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZB ! UCB0282
OI   CVCL_B4ZC ! UCT0282
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0283
AC   CVCL_B4TX
DR   EGA; EGAS00000000056
DR   GEO; GSM606783
DR   Wikidata; Q110433798
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0284
AC   CVCL_B4TY
DR   EGA; EGAS00000000056
DR   GEO; GSM431743
DR   GEO; GSM606805
DR   Wikidata; Q110433799
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZD ! UCB0284
OI   CVCL_B4ZE ! UCT0284
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0285
AC   CVCL_B4UB
DR   EGA; EGAS00000000056
DR   GEO; GSM431744
DR   GEO; GSM606798
DR   Wikidata; Q110433801
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZF ! UCB0285
OI   CVCL_B4ZG ! UCT0285
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0288
AC   CVCL_B4TZ
DR   EGA; EGAS00000000056
DR   GEO; GSM606690
DR   Wikidata; Q110433802
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0289
AC   CVCL_B4U0
DR   EGA; EGAS00000000056
DR   GEO; GSM606691
DR   Wikidata; Q110433803
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0290
AC   CVCL_B4U1
DR   EGA; EGAS00000000056
DR   GEO; GSM606692
DR   Wikidata; Q110433804
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0292
AC   CVCL_B4U2
DR   EGA; EGAS00000000056
DR   GEO; GSM606685
DR   Wikidata; Q110433805
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0293
AC   CVCL_B4U3
DR   EGA; EGAS00000000056
DR   GEO; GSM606772
DR   Wikidata; Q110433806
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0294
AC   CVCL_B4U4
DR   EGA; EGAS00000000056
DR   GEO; GSM606806
DR   Wikidata; Q110433807
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0295
AC   CVCL_B4U5
DR   EGA; EGAS00000000056
DR   GEO; GSM431745
DR   GEO; GSM606693
DR   Wikidata; Q110433808
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZH ! UCB0295
OI   CVCL_B4ZI ! UCT0295
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0298
AC   CVCL_B4U6
DR   EGA; EGAS00000000056
DR   GEO; GSM606694
DR   Wikidata; Q110433811
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0300
AC   CVCL_B4U7
DR   EGA; EGAS00000000056
DR   GEO; GSM606695
DR   Wikidata; Q110433812
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0303
AC   CVCL_B4U8
DR   EGA; EGAS00000000056
DR   GEO; GSM606686
DR   Wikidata; Q110433813
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0304
AC   CVCL_B4U9
DR   EGA; EGAS00000000056
DR   GEO; GSM431746
DR   GEO; GSM606696
DR   Wikidata; Q110433814
RX   PubMed=19644074;
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZJ ! UCB0304
OI   CVCL_B4ZK ! UCT0304
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0305
AC   CVCL_B4UA
DR   EGA; EGAS00000000056
DR   GEO; GSM606697
DR   Wikidata; Q110433815
RX   PubMed=21147911;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF0313
AC   CVCL_B4ZM
DR   GEO; GSM431747
DR   Wikidata; Q110433816
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZL ! UCB0313
OI   CVCL_B4ZN ! UCT0313
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCF1014
AC   CVCL_B4L4
DR   GEO; GSE123028
DR   Wikidata; Q110433817
RX   PubMed=25557783;
RX   PubMed=28190458;
RX   PubMed=30510006;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4L5 ! UCB1014
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCDK9B1
AC   CVCL_GY10
DR   cancercelllines; CVCL_GY10
DR   Wikidata; Q54989602
RX   DOI=10.1016/j.leukres.2012.09.007;
RX   PubMed=22136758;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a female Bullmastiff with a lymphoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00540.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Samples were supplied to ICLAC for STR profiling by Kent M. (UCSD) and tested by Hall E. (Genetica DNA Laboratories).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ICLAC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20,21,22
ST   D21S11: 31.2,32.2,33.2,34.2
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14,15
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 21
//
ID   UCDK9B2
AC   CVCL_GY11
DR   cancercelllines; CVCL_GY11
DR   Wikidata; Q54989604
RX   DOI=10.1016/j.leukres.2012.09.007;
RX   PubMed=22136758;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a male German Shorthaired Pointer with a lymphoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00541.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Samples were supplied to ICLAC for STR profiling by Kent M. (UCSD) and tested by Hall E. (Genetica DNA Laboratories).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ICLAC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,21,22
ST   D21S11: 31.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 21
//
ID   UCDK9B3
AC   CVCL_GY12
DR   cancercelllines; CVCL_GY12
DR   Wikidata; Q54989605
RX   DOI=10.1016/j.leukres.2012.09.007;
RX   PubMed=22136758;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male Labrador Retriever.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00542.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Samples were supplied to ICLAC for STR profiling by Kent M. (UCSD) and tested by Hall E. (Genetica DNA Laboratories).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ICLAC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20,21
ST   D21S11: 31.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 21
//
ID   UCDK9B4
AC   CVCL_GY13
DR   cancercelllines; CVCL_GY13
DR   Wikidata; Q54989606
RX   DOI=10.1016/j.leukres.2012.09.007;
RX   PubMed=22136758;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male Basset Hound.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00543.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Samples were supplied to ICLAC for STR profiling by Kent M. (UCSD) and tested by Hall E. (Genetica DNA Laboratories).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ICLAC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,19,20,21
ST   D21S11: 31.2,33.2,34.2
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 12,13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 21
//
ID   UCDK9B5
AC   CVCL_GY14
DR   cancercelllines; CVCL_GY14
DR   Wikidata; Q54989607
RX   DOI=10.1016/j.leukres.2012.09.007;
RX   PubMed=22136758;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (DOI=10.1016/j.leukres.2012.09.007, ICLAC). Originally thought to be of dog origin and to originate from a lymphoma from a male Greyhound.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00544.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (from parent cell line).
CC   Miscellaneous: Samples were supplied to ICLAC for STR profiling by Kent M. (UCSD) and tested by Hall E. (Genetica DNA Laboratories).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): ICLAC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13,20,21
ST   D21S11: 31.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D7S820: 8,12
ST   D8S1179: 12,13,14
ST   FGA: 20,21
ST   Penta D: 11,13
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0065 ! Jurkat
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 21
//
ID   UCDK9M1
AC   CVCL_0C77
DR   Wikidata; Q54989609
RX   PubMed=21722969;
RX   PubMed=22901430;
RX   PubMed=30188000;
CC   Miscellaneous: Breed and age/sex of donor from personal communication of Kent, Michael S.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Miniature Poodle; VBO=VBO_0201051.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   17Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 14
//
ID   UCDK9M2
AC   CVCL_0C78
DR   Wikidata; Q54989610
RX   PubMed=21722969;
RX   PubMed=22901430;
CC   Miscellaneous: Breed and age/sex of donor from personal communication of Kent, Michael S.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Irish Terrier; VBO=VBO_0200704.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   UCDK9M3
AC   CVCL_0C79
DR   Wikidata; Q54989611
RX   PubMed=21722969;
RX   PubMed=22901430;
RX   PubMed=30188000;
CC   Miscellaneous: Breed and age/sex of donor from personal communication of Kent, Michael S.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: Chow x English Springer Spaniel; VBO=VBO_0200361+VBO_0200497.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   UCDK9M4
AC   CVCL_0C80
DR   Wikidata; Q54989612
RX   PubMed=21722969;
RX   PubMed=22901430;
RX   PubMed=30188000;
CC   Miscellaneous: Breed and age/sex of donor from personal communication of Kent, Michael S.
CC   Derived from site: In situ; Oral cavity; UBERON=UBERON_0000167.
CC   Breed/subspecies: German Shorthaired Pointer; VBO=VBO_0200583.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 12
//
ID   UCDK9M5
AC   CVCL_0C81
DR   Wikidata; Q54989614
RX   PubMed=21722969;
RX   PubMed=22901430;
RX   PubMed=30188000;
CC   Miscellaneous: Breed and age/sex of donor from personal communication of Kent, Michael S.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
DI   NCIt; C185639; Canine oral melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 14
//
ID   UCH D4
AC   CVCL_C4PX
SY   UCHD4
DR   Wikidata; Q116050668
RX   PubMed=2580779;
RX   PubMed=6089730;
RX   PubMed=6130380;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q02161; Human RHD.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UCH-CBLR-48A
AC   CVCL_E5HA
SY   CBLR, RX48A; CB-iPS-lenti
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mononuclear cell of umbilical cord; CL=CL_2000085.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HB ! UCH-CBY4-48B
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-CBY4-48B
AC   CVCL_E5HB
SY   CBY4; RX48B; CB-iPS-epi
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mononuclear cell of umbilical cord; CL=CL_2000085.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5HA ! UCH-CBLR-48A
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-12
AC   CVCL_E5HD
SY   BJRV; RX12
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-13
AC   CVCL_E5HE
SY   BJLV; RX13
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-47
AC   CVCL_E5HF
SY   RX47I-RIP1; RiP1; RX47
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-49A
AC   CVCL_E5HJ
SY   HFY4; RX49A; hFib_epi
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-63
AC   CVCL_E5HG
SY   BJSV; RX63
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-121
AC   CVCL_E5HH
SY   BJY4 FF; BJY4 Feeder Free; RX121
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-2
AC   CVCL_E5GT
SY   HDFa-TK2; TK2
DR   GEO; GSM658938
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Karyotypic information: 46,XX,t(6;16)(q15;q13),t(13;14)(q14.1;q24.3) (at 31th passage) (PubMed=21654665).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-3
AC   CVCL_E5GU
SY   HDFa-TK3; TK3
DR   GEO; GSM658974
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-4
AC   CVCL_E5GV
SY   HDFa-TK4; TK4
DR   GEO; GSM658979
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-5
AC   CVCL_E5GW
SY   HDFa-TK5; TK5
DR   GEO; GSM658978
DR   GEO; GSM658981
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-6
AC   CVCL_E5GX
SY   HDFa-TK6; TK6
DR   GEO; GSM658975
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-7
AC   CVCL_E5GY
SY   HDFa-TK7; TK7
DR   GEO; GSM658980
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TK-8
AC   CVCL_E5GZ
SY   HDFa-TK8; TK8
DR   GEO; GSM658941
DR   GEO; GSM659044
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-TZ-1
AC   CVCL_E5G8
SY   IMR90-TZ1; TZ-1
DR   GEO; GSM658943
DR   GEO; GSM659048
RX   PubMed=21654665;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YTC-1
AC   CVCL_E5H0
SY   HDFa-YTC1; YTC1
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YTC-5
AC   CVCL_E5H1
SY   HDFa-YTC5; YTC5
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YTC-6
AC   CVCL_E5H2
SY   HDFa-YTC6; YTC6
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YTC-7
AC   CVCL_E5H3
SY   HDFa-YTC7; YTC7
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YTC-8
AC   CVCL_E5H4
SY   HDFa-YTC8; YTC8
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YK-16
AC   CVCL_E5H5
SY   HDFa-YK16; YK16
DR   GEO; GSM658977
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YK-22
AC   CVCL_E5H6
SY   HDFa-YK22; YK22
DR   GEO; GSM658936
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Karyotypic information: 46,XX,inv(8)(q24.1;q13),t(18;20)(q21.3;q11.2) (PubMed=21654665).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YK-26
AC   CVCL_E5H7
SY   HDFa-YK26; YK26
DR   GEO; GSM658937
DR   GEO; GSM659045
DR   GEO; GSM659051
RX   PubMed=21654665;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H8 ! UCH-HF-YK-27
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YK-27
AC   CVCL_E5H8
SY   HDFa-YK27; YK27
RX   PubMed=21654665;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H9 ! UCH-HF-YK-37
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YK-37
AC   CVCL_E5H9
SY   HDFa-YK37; YK37
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E5GT ! UCH-HF-TK-2
OI   CVCL_E5GU ! UCH-HF-TK-3
OI   CVCL_E5GV ! UCH-HF-TK-4
OI   CVCL_E5GW ! UCH-HF-TK-5
OI   CVCL_E5GX ! UCH-HF-TK-6
OI   CVCL_E5GY ! UCH-HF-TK-7
OI   CVCL_E5GZ ! UCH-HF-TK-8
OI   CVCL_E5H0 ! UCH-HF-YTC-1
OI   CVCL_E5H1 ! UCH-HF-YTC-5
OI   CVCL_E5H2 ! UCH-HF-YTC-6
OI   CVCL_E5H3 ! UCH-HF-YTC-7
OI   CVCL_E5H4 ! UCH-HF-YTC-8
OI   CVCL_E5H5 ! UCH-HF-YK-16
OI   CVCL_E5H6 ! UCH-HF-YK-22
OI   CVCL_E5H7 ! UCH-HF-YK-26
OI   CVCL_E5H8 ! UCH-HF-YK-27
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-HF-YZ-1
AC   CVCL_E5G9
SY   IMR90-YZ1; YZ-1
DR   GEO; GSM658951
RX   PubMed=21654665;
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-ICF-TK-1
AC   CVCL_E5GP
SY   ICF-TK1; TK1
DR   GEO; GSM658970
DR   GEO; GSM659046
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Glu806_Arg807insSerThrPro (c.2397-11G>A) (IVS22AS,G>A,-11) (744ins3); ClinVar=VCV000006741; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C156430; Immunodeficiency-centromeric instability-facial anomalies syndrome 1
DI   ORDO; Orphanet_2268; ICF syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E130 ! GM08747
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-ICF-TK-10
AC   CVCL_E5GS
SY   ICF-TK10; TK10
DR   GEO; GSM659047
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Glu806_Arg807insSerThrPro (c.2397-11G>A) (IVS22AS,G>A,-11) (744ins3); ClinVar=VCV000006741; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C156430; Immunodeficiency-centromeric instability-facial anomalies syndrome 1
DI   ORDO; Orphanet_2268; ICF syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E130 ! GM08747
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-ICF-TK-4
AC   CVCL_E5GQ
SY   ICF-TK4; TK4
DR   GEO; GSM658934
DR   GEO; GSM658935
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Glu806_Arg807insSerThrPro (c.2397-11G>A) (IVS22AS,G>A,-11) (744ins3); ClinVar=VCV000006741; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C156430; Immunodeficiency-centromeric instability-facial anomalies syndrome 1
DI   ORDO; Orphanet_2268; ICF syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E130 ! GM08747
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-ICF-TK-7
AC   CVCL_E5GR
SY   ICF-TK7; TK7
DR   GEO; GSM658972
DR   GEO; GSM659102
RX   PubMed=21654665;
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Ala603Thr (c.1807G>A); ClinVar=VCV000006740; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2979; DNMT3B; Simple; p.Glu806_Arg807insSerThrPro (c.2397-11G>A) (IVS22AS,G>A,-11) (744ins3); ClinVar=VCV000006741; Zygosity=Heterozygous; Note=De novo mutation (from parent cell line).
CC   Omics: Variations; Array-based CGH.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C156430; Immunodeficiency-centromeric instability-facial anomalies syndrome 1
DI   ORDO; Orphanet_2268; ICF syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E130 ! GM08747
SX   Female
AG   1Y5M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-PB-48E
AC   CVCL_E5HI
SY   PB-BD1-Y4; PB-iPS-BD1; RX48E
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH-PBY4-48D
AC   CVCL_E5HC
SY   PBY4; RX48D; PB-iPS
WW   Provider; UConn Health; -; https://health.uconn.edu/stem-cell-core/uconn-stem-cell-core-hipscs/
CC   From: University of Connecticut Health Center; Farmington; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Mononuclear cell; CL=CL_0000842.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCH1
AC   CVCL_4991
DR   Cosmic; 1529013
DR   Wikidata; Q54989615
RX   PubMed=17454636;
CC   Population: Japanese.
CC   Doubling time: 60 hours (PubMed=17454636).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UCHCC1
AC   CVCL_9W59
DR   Wikidata; Q54989616
RX   Patent=US8337829;
RX   PubMed=2418922;
CC   Doubling time: ~20 hours (PubMed=2418922).
CC   Transformant: Unknown product of UCHT1 (Cellosaurus=CVCL_9W35) conditioned media.
CC   Derived from site: In situ; Brain, cerebellum; UBERON=UBERON_0002037.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   6M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   UCHT1
AC   CVCL_9W35
DR   Wikidata; Q54989617
RX   Patent=US8337829;
RX   PubMed=954652;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2535.
CC   Doubling time: ~24 hours (PubMed=954652).
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
DI   NCIt; C60369; Rat C-cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 9
//
ID   UCI 101
AC   CVCL_5380
SY   UCI-101; UCI101; University of California, Irvine 101
DR   BTO; BTO_0002630
DR   CLO; CLO_0037206
DR   Wikidata; Q54989618
RX   PubMed=8428692;
RX   PubMed=9554442;
RX   PubMed=11314036;
RX   PubMed=12080474;
RX   PubMed=15677628;
CC   Doubling time: 24 hours (PubMed=8428692).
CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   UCI 107
AC   CVCL_5381
SY   UCI-107; UCI107; University of California, Irvine 107
DR   BTO; BTO_0004036
DR   CLO; CLO_0037205
DR   cancercelllines; CVCL_5381
DR   Cosmic; 1113281
DR   GEO; GSM459738
DR   Progenetix; CVCL_5381
DR   Wikidata; Q54989620
RX   PubMed=7672698;
RX   PubMed=9554442;
RX   PubMed=11314036;
RX   PubMed=12080474;
RX   PubMed=15677628;
CC   Doubling time: 24-36 hours (PubMed=7672698).
CC   Microsatellite instability: Instable (MSI) (PubMed=15677628).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   UCI-VULV-1
AC   CVCL_S961
SY   University of California, Irvine-VULVar-1
DR   Wikidata; Q54989622
RX   PubMed=7729733;
CC   Population: Caucasian.
CC   Doubling time: 60 hours (PubMed=7729733).
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   UCLA # 1
AC   CVCL_M586
SY   UCLA#1
DR   Wikidata; Q54989623
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=9639523;
RX   PubMed=10936422;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
ID   UCLA 1
AC   CVCL_9951
SY   UCLA1
DR   GEO; GSM1395311
DR   NIHhESC; NIHhESC-10-0058
DR   SKIP; SKIP001356
DR   Wikidata; Q54989635
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0058.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCLA 1-iSTAG
AC   CVCL_F1H9
CC   Characteristics: Using CRISPR/Cas9 a P2A-tdTomato construct was inserted at the C-terminal end of SOX17 as well as either a P2A-eGFP or a P2A-H2B-eGFP construct at the C-terminal end of each TFAP2C allele (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Miscellaneous: Cell line information from personal communication of Hwang, Young Sun.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9951 ! UCLA 1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UCLA 1-STAG
AC   CVCL_F1HA
CC   Characteristics: Using CRISPR/Cas9 a P2A-tdTomato construct was inserted at the C-terminal end of SOX17 as well as a P2A-eGFP construct at the C-terminal end of TFAP2C (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Miscellaneous: Cell line information from personal communication of Hwang, Young Sun.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9951 ! UCLA 1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UCLA 10
AC   CVCL_9952
DR   NIHhESC; NIHhESC-12-0146
DR   Wikidata; Q54989637
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0146.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   UCLA 11
AC   CVCL_C941
DR   NIHhESC; NIHhESC-12-0185
DR   Wikidata; Q54989638
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0185.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   UCLA 12
AC   CVCL_C942
DR   NIHhESC; NIHhESC-12-0186
DR   Wikidata; Q54989639
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0186.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   UCLA 13
AC   CVCL_W013
DR   NIHhESC; NIHhESC-14-0293
DR   Wikidata; Q54989640
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0293.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   UCLA 14
AC   CVCL_W014
DR   NIHhESC; NIHhESC-14-0294
DR   Wikidata; Q54989641
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0294.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   UCLA 144
AC   CVCL_JD26
SY   Extract 476
DR   IPD-IMGT/HLA; 11511
DR   Wikidata; Q54989643
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/347cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*01:03,69:01; B*51:01,73:01; C*15,16:02; DQA1*01:02,05:01; DQB1*03:01,05:02; DRB1*11:01,15:01; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=11511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   UCLA 15
AC   CVCL_W015
DR   NIHhESC; NIHhESC-14-0295
DR   Wikidata; Q54989644
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0295.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   UCLA 16
AC   CVCL_W016
DR   NIHhESC; NIHhESC-14-0296
DR   Wikidata; Q54989645
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0296.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   UCLA 17
AC   CVCL_W017
DR   NIHhESC; NIHhESC-14-0297
DR   Wikidata; Q54989646
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0297.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   UCLA 18
AC   CVCL_W018
DR   NIHhESC; NIHhESC-14-0298
DR   Wikidata; Q54989647
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0298.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 11
//
ID   UCLA 19n
AC   CVCL_IS73
SY   UCLA19n
DR   NIHhESC; NIHhESC-17-0385
DR   Wikidata; Q54989648
RX   PubMed=26853856;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0385.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   UCLA 2
AC   CVCL_9953
SY   UCLA2
DR   GEO; GSM1395312
DR   NIHhESC; NIHhESC-10-0059
DR   Wikidata; Q54989649
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0059.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCLA 2-AGDT
AC   CVCL_F1HB
CC   Characteristics: Using CRISPR/Cas9 a P2A-eGFP construct was inserted at the C-terminal end of TFAP2C as well as a P2A-tdTomato construct at the C-terminal end of DND1 (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Miscellaneous: Cell line information from personal communication of Hwang, Young Sun.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9953 ! UCLA 2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UCLA 2-AGZT
AC   CVCL_F1HC
CC   Characteristics: Using CRISPR/Cas9 a P2A-eGFP construct was inserted at the C-terminal end of TFAP2C as well as a P2A-tdTomato construct at the C-terminal end of DAZL (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Miscellaneous: Cell line information from personal communication of Hwang, Young Sun.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9953 ! UCLA 2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UCLA 2-STAG
AC   CVCL_F1HD
CC   Characteristics: Using CRISPR/Cas9 a P2A-tdTomato construct was inserted at the C-terminal end of SOX17 as well as a P2A-eGFP construct at the C-terminal end of TFAP2C.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Miscellaneous: Cell line information from personal communication of Hwang, Young Sun.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9953 ! UCLA 2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UCLA 20n
AC   CVCL_IS74
SY   UCLA20n
DR   NIHhESC; NIHhESC-17-0386
DR   Wikidata; Q54989650
RX   PubMed=26853856;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0386.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   UCLA 21
AC   CVCL_UF54
DR   NIHhESC; NIHhESC-19-0405
DR   Wikidata; Q98133841
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0405.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCLA 22
AC   CVCL_UF55
DR   NIHhESC; NIHhESC-19-0406
DR   Wikidata; Q98133842
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0406.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCLA 23
AC   CVCL_UF56
DR   NIHhESC; NIHhESC-19-0407
DR   Wikidata; Q98133843
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0407.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCLA 3
AC   CVCL_9954
SY   UCLA3
DR   GEO; GSM1395313
DR   NIHhESC; NIHhESC-10-0060
DR   Wikidata; Q54989651
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0060.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCLA 4
AC   CVCL_9955
SY   UCLA4
DR   GEO; GSM1395314
DR   NIHhESC; NIHhESC-11-0087
DR   Wikidata; Q54989652
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0087.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCLA 5
AC   CVCL_9956
SY   UCLA5
DR   GEO; GSM1395315
DR   NIHhESC; NIHhESC-11-0088
DR   Wikidata; Q54989653
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0088.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCLA 6
AC   CVCL_9957
SY   UCLA6
DR   GEO; GSM1395316
DR   NIHhESC; NIHhESC-11-0089
DR   Wikidata; Q54989654
RX   PubMed=22058289;
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0089.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCLA 7
AC   CVCL_9958
DR   NIHhESC; NIHhESC-12-0143
DR   Wikidata; Q54989655
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0143.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCLA 8
AC   CVCL_9959
DR   NIHhESC; NIHhESC-12-0144
DR   Wikidata; Q54989657
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0144.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   UCLA 9
AC   CVCL_9960
DR   NIHhESC; NIHhESC-12-0145
DR   Wikidata; Q54989659
RX   PubMed=28445466;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0145.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   UCLA-P3
AC   CVCL_N513
AS   CVCL_7211
SY   UCLA P3; UCLA P-3; UCLA-SO-P3; UCP-3; UCP3
DR   BTO; BTO_0004841
DR   ChEMBL-Cells; CHEMBL3307243
DR   ChEMBL-Targets; CHEMBL612797
DR   PubChem_Cell_line; CVCL_N513
DR   Wikidata; Q54989661
RX   PubMed=2469722;
RX   PubMed=3596831;
RX   PubMed=6362852;
RX   PubMed=6785528;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5VD ! UCLA-PL3
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 13
//
ID   UCLA-PL3
AC   CVCL_A5VD
SY   PL3; PL-3
DR   Wikidata; Q107117188
RX   PubMed=2469722;
RX   PubMed=6362852;
RX   PubMed=6785528;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_N513 ! UCLA-P3
SX   Male
AG   53Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UCLAi001-A
AC   CVCL_WT92
SY   MZT04-D; MZT04D
DR   hPSCreg; UCLAi001-A
DR   Wikidata; Q98133844
RX   PubMed=31622877;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi004-A (Cellosaurus=CVCL_A5HJ), UCLAi004-B (Cellosaurus=CVCL_A5HK) and UCLAi004-C (Cellosaurus=CVCL_A5HL).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT93 ! UCLAi001-B
OI   CVCL_WT94 ! UCLAi001-C
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   UCLAi001-B
AC   CVCL_WT93
SY   MZT04-J; MZT04J
DR   BioSamples; SAMEA5573406
DR   hPSCreg; UCLAi001-B
DR   Wikidata; Q98133845
RX   PubMed=31622877;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi004-A (Cellosaurus=CVCL_A5HJ), UCLAi004-B (Cellosaurus=CVCL_A5HK) and UCLAi004-C (Cellosaurus=CVCL_A5HL).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT92 ! UCLAi001-A
OI   CVCL_WT94 ! UCLAi001-C
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   UCLAi001-C
AC   CVCL_WT94
SY   MZT04-C; MZT04C
DR   hPSCreg; UCLAi001-C
DR   Wikidata; Q98133846
RX   PubMed=31622877;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi004-A (Cellosaurus=CVCL_A5HJ), UCLAi004-B (Cellosaurus=CVCL_A5HK) and UCLAi004-C (Cellosaurus=CVCL_A5HL).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT92 ! UCLAi001-A
OI   CVCL_WT93 ! UCLAi001-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 8
//
ID   UCLAi002-A
AC   CVCL_A5HD
SY   MZT01-E; MZT01E
DR   hPSCreg; UCLAi002-A
DR   Wikidata; Q107117189
RX   PubMed=33548810;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HE ! UCLAi002-B
OI   CVCL_A5HF ! UCLAi002-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi002-B
AC   CVCL_A5HE
SY   MZT01-F; MZT01F
DR   hPSCreg; UCLAi002-B
DR   Wikidata; Q107117190
RX   PubMed=33548810;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HD ! UCLAi002-A
OI   CVCL_A5HF ! UCLAi002-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi002-C
AC   CVCL_A5HF
SY   MZT01-N; MZT01N
DR   hPSCreg; UCLAi002-C
DR   Wikidata; Q107117191
RX   PubMed=33548810;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi003-A (Cellosaurus=CVCL_A5HG), UCLAi003-B (Cellosaurus=CVCL_A5HH) and UCLAi003-C (Cellosaurus=CVCL_A5HI).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HD ! UCLAi002-A
OI   CVCL_A5HE ! UCLAi002-B
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi003-A
AC   CVCL_A5HG
SY   MZT02-D; MZT02D
DR   hPSCreg; UCLAi003-A
DR   Wikidata; Q107117192
RX   PubMed=33548810;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HH ! UCLAi003-B
OI   CVCL_A5HI ! UCLAi003-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi003-B
AC   CVCL_A5HH
SY   MZT02-G; MZT02G
DR   hPSCreg; UCLAi003-B
DR   Wikidata; Q107117193
RX   PubMed=33548810;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HG ! UCLAi003-A
OI   CVCL_A5HI ! UCLAi003-C
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi003-C
AC   CVCL_A5HI
SY   MZT02-H; MZT02H
DR   hPSCreg; UCLAi003-C
DR   Wikidata; Q107117194
RX   PubMed=33548810;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Donor information: Established from monozygotic twin of UCLAi002-A (Cellosaurus=CVCL_A5HD), UCLAi002-B (Cellosaurus=CVCL_A5HE) and UCLAi002-C (Cellosaurus=CVCL_A5HF).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HG ! UCLAi003-A
OI   CVCL_A5HH ! UCLAi003-B
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi004-A
AC   CVCL_A5HJ
SY   MZT06-B; MZT06B
DR   hPSCreg; UCLAi004-A
DR   Wikidata; Q107117195
RX   PubMed=34216981;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34216981
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 32.2
ST   D3S1358: 12
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HK ! UCLAi004-B
OI   CVCL_A5HL ! UCLAi004-C
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi004-B
AC   CVCL_A5HK
SY   MZT06-C; MZT06C
DR   hPSCreg; UCLAi004-B
DR   Wikidata; Q107117196
RX   PubMed=34216981;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34216981
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 32.2
ST   D3S1358: 12
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HJ ! UCLAi004-A
OI   CVCL_A5HL ! UCLAi004-C
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi004-C
AC   CVCL_A5HL
SY   MZT06-D; MZT06D
DR   hPSCreg; UCLAi004-C
DR   Wikidata; Q107117197
RX   PubMed=34216981;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCLAi001-A (Cellosaurus=CVCL_WT92), UCLAi001-B (Cellosaurus=CVCL_WT93) and UCLAi001-C (Cellosaurus=CVCL_WT94).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34216981
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 32.2
ST   D3S1358: 12
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,23
ST   Penta D: 9,12
ST   Penta E: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C131427; Congenital ovarian failure
DI   ORDO; Orphanet_485382; Genetic non-acquired premature ovarian failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5HJ ! UCLAi004-A
OI   CVCL_A5HK ! UCLAi004-B
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UCLAi005-A
AC   CVCL_A0KD
SY   MZT05-D
DR   hPSCreg; UCLAi005-A
DR   Wikidata; Q108821420
RX   PubMed=34130154;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34130154
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8
ST   D8S1179: 15
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 13,14
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0KE ! UCLAi005-B
OI   CVCL_A0KF ! UCLAi005-C
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UCLAi005-B
AC   CVCL_A0KE
SY   MZT05-F
DR   hPSCreg; UCLAi005-B
DR   Wikidata; Q108821421
RX   PubMed=34130154;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34130154
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8
ST   D8S1179: 15
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 13,14
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0KD ! UCLAi005-A
OI   CVCL_A0KF ! UCLAi005-C
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UCLAi005-C
AC   CVCL_A0KF
SY   MZT05-L
DR   hPSCreg; UCLAi005-C
DR   Wikidata; Q108821422
RX   PubMed=34130154;
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34130154
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,10
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 9,11
ST   D7S820: 8
ST   D8S1179: 15
ST   FGA: 20,23
ST   Penta D: 9,11
ST   Penta E: 13,14
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0KD ! UCLAi005-A
OI   CVCL_A0KE ! UCLAi005-B
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UCLAi089-A
AC   CVCL_WT91
SY   riPSC89
DR   Wikidata; Q98133847
RX   PubMed=27879222;
CC   Group: Non-human primate cell line.
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   47FD
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 5
//
ID   UCLAi090-A
AC   CVCL_KR62
SY   riPSC90
DR   Wikidata; Q54989662
RX   PubMed=28677539;
CC   Group: Non-human primate cell line.
CC   From: University of California, Los Angeles; Los Angeles; USA.
CC   Derived from site: In situ; Trunk, skin; UBERON=UBERON_0001085.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9544; ! Macaca mulatta (Rhesus macaque)
SX   Male
AG   47FD
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   UCLC11
AC   CVCL_S741
SY   UCLC-11
DR   Cosmic; 844588
DR   Cosmic; 877399
DR   Cosmic; 1152494
DR   Wikidata; Q54989664
DI   NCIt; C2926; Lung non-small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   UCLi001-A
AC   CVCL_9S54
SY   HHItC9S-V19
DR   BioSamples; SAMEA3174455
DR   EBiSC; UCLi001-A
DR   ECACC; 66540028
DR   hPSCreg; UCLi001-A
DR   SKIP; SKIP002627
DR   Wikidata; Q54989666
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (EBiSC=UCLi001-A).
CC   Discontinued: ECACC; 66540028; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   UCLi002-A
AC   CVCL_9S55
SY   HHItC9D-V34; DN19
DR   BioSamples; SAMEA3174461
DR   EBiSC; UCLi002-A
DR   ECACC; 66540029
DR   hPSCreg; UCLi002-A
DR   Wikidata; Q54989667
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (EBiSC=UCLi002-A).
CC   Discontinued: ECACC; 66540029; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 15
//
ID   UCLi003-A
AC   CVCL_9S56
SY   TSM(Exon10+16)V97
DR   BioSamples; SAMEA3174519
DR   EBiSC; UCLi003-A
DR   ECACC; 66540027
DR   hPSCreg; UCLi003-A
DR   SKIP; SKIP002676
DR   Wikidata; Q54989668
RX   PubMed=26136155;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Unspecified (EBiSC=UCLi003-A).
CC   Discontinued: ECACC; 66540027; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9Q6 ! UCLi003-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   UCLi003-B
AC   CVCL_A9Q6
SY   TSM(10+16)V98
DR   hPSCreg; UCLi003-B
DR   Wikidata; Q102115051
RX   PubMed=26136155;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6893; MAPT; Simple; c.1920+16C>T (c.2091+16C>T) (c.1866+16C>T) (c.915+16C>T) (c.828+16C>T) (IVS10+16C>T); ClinVar=VCV000098222; Zygosity=Unspecified (from autologous cell line UCLi003-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_275864; Behavioral variant of frontotemporal dementia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S56 ! UCLi003-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   UCLi004-A
AC   CVCL_II89
SY   RCi173; RCFB60c6
DR   BioSamples; SAMEA3964268
DR   EBiSC; UCLi004-A
DR   ECACC; 66540123
DR   hPSCreg; UCLi004-A
DR   SKIP; SKIP002667
DR   Wikidata; Q54989670
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (hPSCreg=UCLi004-A).
CC   Discontinued: ECACC; 66540123; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EE26 ! UCLi004-B
OI   CVCL_II90 ! UCLi004-C
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   UCLi004-B
AC   CVCL_EE26
SY   RCi177; RCFB60c7
DR   BioSamples; SAMEA4084285
DR   EBiSC; UCLi004-B
DR   ECACC; 66540154
DR   hPSCreg; UCLi004-B
DR   SKIP; SKIP002668
DR   Wikidata; Q54989671
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (hPSCreg=UCLi004-B).
CC   Discontinued: ECACC; 66540154; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_II89 ! UCLi004-A
OI   CVCL_II90 ! UCLi004-C
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 15
//
ID   UCLi004-C
AC   CVCL_II90
SY   RCi172; RCFB60c2
DR   BioSamples; SAMEA4085372
DR   EBiSC; UCLi004-C
DR   ECACC; 66540165
DR   hPSCreg; UCLi004-C
DR   SKIP; SKIP002672
DR   Wikidata; Q54989672
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (hPSCreg=UCLi004-C).
CC   Discontinued: ECACC; 66540165; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_II89 ! UCLi004-A
OI   CVCL_EE26 ! UCLi004-B
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 14
//
ID   UCLi005-A
AC   CVCL_9S57
SY   LGMD2D #4; LGMD2D Pt. 4; LGMD2D Pt.4
DR   BioSamples; SAMEA4091959
DR   EBiSC; UCLi005-A
DR   ECACC; 66541068
DR   hPSCreg; UCLi005-A
DR   SKIP; SKIP002568
DR   Wikidata; Q54989673
RX   PubMed=22745439;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:10805; SGCA; Simple; p.Arg77Cys (c.229C>T); ClinVar=VCV000009437; Zygosity=Homozygous (PubMed=22745439).
CC   Discontinued: ECACC; 66541068; true.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
CC   Cell type: Myoblast; CL=CL_0000056.
DI   NCIt; C142081; Limb-girdle muscular dystrophy type 2D
DI   ORDO; Orphanet_62; Autosomal recessive limb-girdle muscular dystrophy type 2D
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   UCLi006-A
AC   CVCL_VF11
SY   LCMD-L302P-UCL01C2
DR   BioSamples; SAMEA104130970
DR   EBiSC; UCLi006-A
DR   ECACC; 66540593
DR   hPSCreg; UCLi006-A
DR   Wikidata; Q54989674
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Leu302Pro (c.905T>C); ClinVar=VCV000066953; Zygosity=Heterozygous (hPSCreg=UCLi006-A).
CC   Discontinued: ECACC; 66540593; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148369; Muscular dystrophy congenital, LMNA-related
DI   ORDO; Orphanet_157973; Congenital muscular dystrophy due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UCLi007-A
AC   CVCL_VF12
SY   STM2012CTRL03(401)
DR   BioSamples; SAMEA104619826
DR   hPSCreg; UCLi007-A
DR   Wikidata; Q54989675
CC   From: University College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 4
//
ID   UCLi008-A
AC   CVCL_A9Q7
DR   hPSCreg; UCLi008-A
DR   Wikidata; Q102115052
CC   From: University College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 4
//
ID   UCLi009-A
AC   CVCL_VF13
SY   R155C 1; CB1D; MUT 1
DR   BioSamples; SAMEA4675625
DR   hPSCreg; UCLi009-A
DR   Wikidata; Q54989678
RX   PubMed=28360103;
RX   PubMed=28564594;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (PubMed=28360103).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF14 ! UCLi009-B
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   UCLi009-B
AC   CVCL_VF14
SY   R155C 2; CB1E; MUT 2
DR   BioSamples; SAMEA4675627
DR   hPSCreg; UCLi009-B
DR   Wikidata; Q54989679
RX   PubMed=28360103;
RX   PubMed=28564594;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg155Cys (c.463C>T); ClinVar=VCV000008469; Zygosity=Heterozygous (PubMed=28360103).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF13 ! UCLi009-A
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   UCLi010-A
AC   CVCL_VF15
SY   R191Q 1; GL1A; MUT 3
DR   BioSamples; SAMEA4675628
DR   hPSCreg; UCLi010-A
DR   Wikidata; Q54989680
RX   PubMed=28360103;
RX   PubMed=28564594;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Heterozygous (PubMed=28360103).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF16 ! UCLi010-B
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   UCLi010-B
AC   CVCL_VF16
SY   R191Q 2; GL1B; MUT 4
DR   BioSamples; SAMEA4675630
DR   hPSCreg; UCLi010-B
DR   Wikidata; Q54989681
RX   PubMed=28360103;
RX   PubMed=28564594;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Arg191Gln (c.572G>A); ClinVar=VCV000008473; Zygosity=Heterozygous (PubMed=28360103).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168754; Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF15 ! UCLi010-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 14
//
ID   UCLi011-A
AC   CVCL_WT95
SY   DMD iPSCs ex.68
DR   BioSamples; SAMEA5574032
DR   hPSCreg; UCLi011-A
DR   Wikidata; Q98133848
RX   PubMed=32087527;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Trp3284Ter (c.9851G>A); ClinVar=VCV001322632; Zygosity=Hemizygous (PubMed=32087527).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   UCLi012-A
AC   CVCL_WT96
SY   DMD iPSCs ex.70
DR   BioSamples; SAMEA5574041
DR   hPSCreg; UCLi012-A
DR   Wikidata; Q98133849
RX   PubMed=32087527;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Arg3381Ter (c.10141C>T); ClinVar=VCV000011273; Zygosity=Hemizygous (PubMed=32087527).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   UCLi013-A
AC   CVCL_ZA79
SY   PAX6 p.N124K; PAX6 p.Asn124Lys
DR   BioSamples; SAMEA9370377
DR   hPSCreg; UCLi013-A
DR   Wikidata; Q98133850
RX   PubMed=33524672;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8620; PAX6; Simple; p.Asn124Lys (c.372C>A); Zygosity=Heterozygous (PubMed=33524672).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_98557; Syndromic aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   UCLi014-A
AC   CVCL_A0KB
AS   CVCL_A4DN
SY   RDH12 AD
DR   hPSCreg; UCLi014-A
DR   Wikidata; Q105511316
RX   PubMed=34216980;
CC   From: University College London; London; United Kingdom.
CC   Population: Kurdistani and Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Phe254Leufs*24 (c.759delC); ClinVar=VCV000812389; Zygosity=Heterozygous (PubMed=34216980).
CC   Misspelling: UCLAi014-A; Note=In Cellosaurus release 39.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34216980
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8,9
ST   D18S51: 13
ST   D21S11: 28,30.2
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 10,12
ST   FGA: 19,23
ST   Penta D: 12,14
ST   Penta E: 13,18
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 16,18
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UCLi015-A
AC   CVCL_A0KC
AS   CVCL_A4DP
SY   RDH12 AR
DR   hPSCreg; UCLi015-A
DR   Wikidata; Q105511320
RX   PubMed=34216980;
CC   From: University College London; London; United Kingdom.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:19977; RDH12; Simple; p.Asn207Asp (c.619A>G); ClinVar=VCV000805924; Zygosity=Homozygous (PubMed=34216980).
CC   Misspelling: UCLAi015-A; Note=In Cellosaurus release 39.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34216980
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D21S11: 28,31.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 21,27
ST   Penta D: 9,11
ST   Penta E: 7,11
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C129075; Leber congenital amaurosis
DI   ORDO; Orphanet_65; Leber congenital amaurosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UCLi016-A
AC   CVCL_A4DK
SY   WT1
DR   BioSamples; SAMEA9370375
DR   hPSCreg; UCLi016-A
DR   Wikidata; Q105511324
RX   PubMed=33370878;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 30-01-24; Version: 8
//
ID   UCLi017-A
AC   CVCL_A4DL
SY   WT2
DR   hPSCreg; UCLi017-A
DR   Wikidata; Q105511326
RX   PubMed=33370878;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 7
//
ID   UCLi018-A
AC   CVCL_A4DM
DR   hPSCreg; UCLi018-A
DR   Wikidata; Q105511329
CC   From: University College London; London; United Kingdom.
CC   Discontinued: hPSCreg; UCLi018-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   UCLi019-A
AC   CVCL_B5G0
DR   BioSamples; SAMEA11349193
DR   hPSCreg; UCLi019-A
DR   Wikidata; Q110433818
CC   From: University College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   UCLi020-A
AC   CVCL_B5FZ
DR   hPSCreg; UCLi020-A
DR   Wikidata; Q110433820
CC   From: University College London; London; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   UCLi021-A
AC   CVCL_C6T1
SY   CLN5c.335G>A;619T>C; 484Pb
DR   BioSamples; SAMEA111341775
DR   hPSCreg; UCLi021-A
DR   Wikidata; Q117704909
RX   PubMed=38141358;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:2076; CLN5; Simple; p.Arg63His (c.188G>A) (p.Arg112His, c.335G>A); ClinVar=VCV000002567; Zygosity=Heterozygous (PubMed=38141358).
CC   Sequence variation: Mutation; HGNC; HGNC:2076; CLN5; Simple; p.Trp158Arg (c.472T>C) (p.Trp207Arg, c.619T>C); ClinVar=VCV001302670; Zygosity=Heterozygous (PubMed=38141358).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192090; Neuronal ceroid lipofuscinosis type 5
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   UCLi022-A
AC   CVCL_C6T2
SY   CLN5c.1072-1073delTT; 546Pa
DR   BioSamples; SAMEA111342314
DR   hPSCreg; UCLi022-A
DR   Wikidata; Q117704910
RX   PubMed=38141358;
CC   From: University College London; London; United Kingdom.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:2076; CLN5; Simple; p.Leu309Alafs*4 (c.925_926delTT) (p.Leu358Alafs*4, c.1072_1073delTT); ClinVar=VCV000056527; Zygosity=Homozygous (PubMed=38141358).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C192090; Neuronal ceroid lipofuscinosis type 5
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   UCLi023-A
AC   CVCL_D0N0
SY   UCLIoO-041-A; LORD-S163R-01
DR   hPSCreg; UCLi023-A
DR   Wikidata; Q123033676
RX   PubMed=37207468;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14344; C1QTNF5; Simple; p.Ser163Arg (c.489C>G); ClinVar=VCV000002126; Zygosity=Heterozygous (PubMed=37207468).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=37207468
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D10S1248: 12,15
ST   D12S391: 15,18
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 18,19
ST   D19S433: 14
ST   D1S1656: 12,16
ST   D21S11: 29,30
ST   D22S1045: 11,15
ST   D2S1338: 17,25
ST   D2S441: 11,14
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   DYS391: 9
ST   DYS570: 20
ST   DYS576: 16
ST   FGA: 19,20
ST   Penta D: 11,12
ST   Penta E: 12,14
ST   SE33: 18.3,20
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C202070; Late-onset retinal degeneration
DI   ORDO; Orphanet_67042; Late-onset retinal degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UCLi024-A
AC   CVCL_D0N1
SY   SIMD277; GOS111B
DR   BioSamples; SAMEA114335215
DR   hPSCreg; UCLi024-A
DR   Wikidata; Q123033677
RX   PubMed=38422816;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:746; ASL; Simple; p.Arg146Gln (c.437G>A); ClinVar=VCV000203627; Zygosity=Homozygous (PubMed=38422816).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84569; Argininosuccinic aciduria
DI   ORDO; Orphanet_23; Argininosuccinic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UCLi025-A
AC   CVCL_D6NT
SY   ABHD12 c.193C>T
DR   hPSCreg; UCLi025-A
WW   Info; Mendeley Data; 10.17632/knr3ctxj8d.1; https://data.mendeley.com/datasets/knr3ctxj8d/1
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:15868; ABHD12; Simple; p.Arg65Ter (c.193C>T); ClinVar=VCV000438130; Zygosity=Homozygous (hPSCreg=UCLi025-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206116; Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract
DI   ORDO; Orphanet_171848; Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   UCLi026-A
AC   CVCL_E6MB
SY   UCL-NG-ADCY5-001
DR   BioSamples; SAMEA116293327
DR   hPSCreg; UCLi026-A
RX   PubMed=39919432;
CC   From: University College London; London; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:236; ADCY5; Simple; p.Arg418Gln (c.1253G>A); ClinVar=VCV000218354; Zygosity=Heterozygous (PubMed=39919432).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C215052; Dyskinesia with orofacial involvement, autosomal dominant
DI   ORDO; Orphanet_324588; Familial dyskinesia and facial myokymia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UCL-CTRL001
AC   CVCL_B7T4
SY   CTRL001
DR   Wikidata; Q112930500
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Doubling time: 48 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   UCL-CTRL002
AC   CVCL_B7T5
SY   CTRL002
DR   Wikidata; Q112930501
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Doubling time: 48 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   UCL-CTRL003
AC   CVCL_B7T6
SY   CTRL003
DR   Wikidata; Q112930502
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Doubling time: 48 hours (Direct_author_submission).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   UCL-E001K
AC   CVCL_B7T9
SY   E001K
DR   Wikidata; Q112930503
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Doubling time: 72 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Glu365Lys (c.1093G>A) (E326K); ClinVar=VCV000199044; Zygosity=Heterozygous (PubMed=36130205).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 9
//
ID   UCL-N001S
AC   CVCL_B7TA
SY   N001S
DR   Wikidata; Q112930504
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Doubling time: 48 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=36130205).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 8
//
ID   UCL-N002S
AC   CVCL_B7TB
SY   N002S
DR   Wikidata; Q112930505
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Doubling time: 96 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (PubMed=36130205).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 8
//
ID   UCL-YCTRL001
AC   CVCL_B7T8
SY   YCTRL001
DR   Wikidata; Q112930506
RX   PubMed=36130205;
CC   From: University College London; London; United Kingdom.
CC   Population: Caucasian.
CC   Doubling time: ~2 days (Direct_author_submission).
CC   Miscellaneous: Doubling time information from personal communication of Koletsi, Sofia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   UCO-Mel-2
AC   CVCL_C264
SY   UCO-Mel2; University of COrdoba-Melanoma-2
DR   ESTDAB; ESTDAB-188
DR   Wikidata; Q54989683
RX   PubMed=16485126;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 8
//
ID   UCONN-L2
AC   CVCL_A693
SY   UCONN-2
DR   Cosmic; 1086005
DR   Cosmic; 1086368
DR   Cosmic; 1152616
DR   Wikidata; Q54989684
RX   PubMed=7824924;
RX   PubMed=8558920;
RX   PubMed=9121481;
RX   PubMed=15356658;
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:7910; NPM1; Name(s)=NPM1-ALK (PubMed=7824924; PubMed=9121481).
DI   NCIt; C37193; Anaplastic large cell lymphoma, ALK-positive
DI   ORDO; Orphanet_300895; ALK-positive anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   UCP1:mCherry H1 hES
AC   CVCL_VJ25
DR   Wikidata; Q98133852
RX   PubMed=29777802;
CC   Characteristics: Using CRISPR-Cas9 a IRES-PuroR-P2A-mCherry construct was integrated at the C-terminus of UCP1 (PubMed=29777802).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   UCR-SE-1
AC   CVCL_Z311
SY   UCR-Se-1; UCR-Se1
DR   ICLDB; ucr-se-1
DR   Wikidata; Q54989685
RX   DOI=10.1016/0022-2011(86)90124-2;
RX   PubMed=1367489;
CC   Group: Insect cell line.
CC   Doubling time: 56 hours (DOI=10.1016/0022-2011(86)90124-2).
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   UCR-SE-1a
AC   CVCL_Z312
SY   UCR-SE-1A; UCR-SE1a; SE-UCR-1A
DR   ICLDB; ucr-se-1a
DR   Wikidata; Q54989697
RX   DOI=10.1016/0022-1910(94)90067-1;
RX   PubMed=1367489;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
HI   CVCL_Z311 ! UCR-SE-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   UCR-SE-1B
AC   CVCL_C2TF
DR   ICLDB; ucr-se-1b
DR   Wikidata; Q114313151
CC   Group: Insect cell line.
CC   From: Harrison, Robert L.; USDA, ARS, Invasive Insect Biocontrol and Behavior Laboratory; Beltsville; USA.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
HI   CVCL_Z311 ! UCR-SE-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 4
//
ID   UCR-SE-1C
AC   CVCL_Z313
SY   SE-1C
DR   ICLDB; ucr-se-1c
DR   Wikidata; Q54989698
RX   DOI=10.3923/jas.2007.4040.4043;
RX   PubMed=8799737;
CC   Group: Insect cell line.
OX   NCBI_TaxID=7107; ! Spodoptera exigua (Beet armyworm)
HI   CVCL_Z311 ! UCR-SE-1
SX   Sex unspecified
AG   Neonate larva
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   UCR4
AC   CVCL_C9BT
SY   Union hospital Cervical cancer Radioresistant 4
DR   Wikidata; Q123033678
RX   PubMed=36867313;
CC   Population: Chinese.
CC   Doubling time: 1.249 days (PubMed=36867313).
CC   Transformant: NCBI_TaxID; 10598; Human papillomavirus type 58 (HPV58).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=36867313
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 15,18
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 14,15
ST   D1S1656: 15,17
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D6S1043: 11,14
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22,26
ST   Penta D: 9,12
ST   Penta E: 14
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   UCR7
AC   CVCL_C9BU
SY   Union hospital Cervical cancer Radioresistant 7
DR   Wikidata; Q123033679
RX   PubMed=36867313;
CC   Population: Chinese.
CC   Doubling time: 1.319 days (PubMed=36867313).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=36867313
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 22
ST   D13S317: 8,13
ST   D16S539: 9
ST   D18S51: 16
ST   D19S433: 13
ST   D1S1656: 11,16
ST   D21S11: 30,31.2
ST   D2S1338: 17,19
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D6S1043: 13,14
ST   D7S820: 8,12
ST   D8S1179: 10,13
ST   FGA: 19,24
ST   Penta D: 10,11
ST   Penta E: 20,21
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UCR8
AC   CVCL_C9BV
SY   Union hospital Cervical cancer Radioresistant 8
DR   Wikidata; Q123033680
RX   PubMed=36867313;
CC   Population: Chinese.
CC   Doubling time: 1.567 days (PubMed=36867313).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=36867313
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13
ST   D1S1656: 16,17
ST   D21S11: 31
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 7,12
ST   D6S1043: 14
ST   D7S820: 8
ST   D8S1179: 10
ST   FGA: 24,26
ST   Penta D: 10,13
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UCRU-BL-12
AC   CVCL_M874
SY   BL-12; Urological Cancer Research Unit-BLadder-12
DR   Cosmic; 735764
DR   Wikidata; Q54989699
RX   PubMed=2418959;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 8
//
ID   UCRU-BL-13
AC   CVCL_M873
SY   UCRU-BL-13 CL; UCRU BL 13/0; UCRU-BL-13/0 CL; BL-13; BL13; Urological Cancer Research Unit-BLadder-13
DR   Cosmic; 735765
DR   Cosmic; 928827
DR   Cosmic; 1927310
DR   Wikidata; Q54989700
RX   PubMed=2418959;
RX   PubMed=2685375;
RX   PubMed=2759734;
RX   PubMed=8873383;
RX   PubMed=9246190;
RX   PubMed=23401075;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
ID   UCRU-BL-17
AC   CVCL_M007
SY   UCRU-BL-17-CL; UCRU-BL-17CL; UCRU BL 17CL; UCRU-BL 17; BL-17; BL17; Urological Cancer Research Unit-BLadder-17
DR   cancercelllines; CVCL_M007
DR   Cosmic; 735768
DR   Cosmic; 928828
DR   Cosmic; 1927311
DR   IARC_TP53; 9355
DR   Wikidata; Q54989701
RX   Patent=US5622836;
RX   PubMed=2328200;
RX   PubMed=2418959;
RX   PubMed=2685375;
RX   PubMed=3335421;
RX   PubMed=8635192;
RX   PubMed=8873383;
RX   PubMed=9246190;
RX   PubMed=23401075;
CC   Characteristics: Established from a xenograft (PubMed=2328200).
CC   Doubling time: 2.7 days (PubMed=2328200).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Unspecified (PubMed=9246190).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 13
//
ID   UCRU-BL-23
AC   CVCL_M008
SY   UCRU-BL-23/3; BL-23; BL23; UCRU-BL-17/23alpha; Urological Cancer Research Unit-BLadder-23
DR   Cosmic; 735773
DR   Wikidata; Q54989702
RX   Patent=US5622836;
RX   PubMed=2685375;
RX   PubMed=8635192;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M007 ! UCRU-BL-17
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   UCRU-BL-28
AC   CVCL_4904
SY   UCRU-BL 28; BL-28; BL28; Urological Cancer Research Unit-BLadder-28
DR   Cosmic; 735774
DR   Cosmic; 928829
DR   Cosmic; 1927312
DR   Wikidata; Q54989704
RX   PubMed=8345582;
RX   PubMed=8873383;
RX   PubMed=9246190;
RX   PubMed=23401075;
CC   Misspelling: BL-128; Cosmic=1927312.
CC   Misspelling: BL128; PubMed=23401075.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   UCRU-Pr-2
AC   CVCL_4905
SY   UCRU-PR-2; Urological Cancer Research Unit-Prostate-2
DR   Wikidata; Q54989705
RX   PubMed=2825148;
RX   PubMed=2833415;
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C6766; Prostate small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UCS
AC   CVCL_1G59
SY   Ussuri Catfish Skin
DR   Wikidata; Q29886988
RX   PubMed=24794839;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=1828414; ! Tachysurus ussuriensis (Ussuri catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 9
//
ID   UCS-2
AC   CVCL_W508
DR   Wikidata; Q54989706
RX   PubMed=12237927;
CC   Derived from site: In situ; Thigh; UBERON=UBERON_0000376.
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 6
//
ID   UCS-4
AC   CVCL_W509
DR   Wikidata; Q54989707
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   UCS-5
AC   CVCL_W510
DR   Wikidata; Q54989709
RX   PubMed=12237927;
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C9118; Sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   UCS14
AC   CVCL_C9BW
SY   Union hospital Cervical cancer radioSensitive 14
DR   Wikidata; Q123033681
RX   PubMed=36867313;
CC   Population: Chinese.
CC   Doubling time: 32 hours (PubMed=36867313).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=36867313
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 20,26
ST   D13S317: 11,13
ST   D16S539: 9
ST   D18S51: 16,17
ST   D19S433: 14.2
ST   D1S1656: 11,13
ST   D21S11: 31.2
ST   D2S1338: 23
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D6S1043: 12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 8,10
ST   Penta E: 10,12
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   UCS19
AC   CVCL_C9BX
SY   Union hospital Cervical cancer radioSensitive 19
DR   Wikidata; Q123033682
RX   PubMed=36867313;
CC   Population: Chinese.
CC   Doubling time: 1.495 days (PubMed=36867313).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=36867313
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20,23
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 15,16
ST   D19S433: 13.2,14
ST   D1S1656: 16,17
ST   D21S11: 31
ST   D2S1338: 21,24
ST   D3S1358: 16
ST   D5S818: 9,13
ST   D6S1043: 10,13
ST   D7S820: 9.1,10
ST   D8S1179: 12,14
ST   FGA: 20,26
ST   Penta D: 9,16
ST   Penta E: 15,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   UCSC.PG128.CHO.S.F4
AC   CVCL_A0AU
DR   BEI_Resources; ARP-13590
DR   Wikidata; Q108821425
CC   Characteristics: Expresses the PGT128 neutralizing monoclonal antibody against the HIV-1 gp120, specifically to the V3 glycan (BEI_Resources=ARP-13590).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7183 ! CHO-S
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   UCSCi001-A
AC   CVCL_A8ZZ
SY   SII-1802; SII-1802 cl. R
DR   BioSamples; SAMEA9197919
DR   hPSCreg; UCSCi001-A
DR   Wikidata; Q108821426
RX   PubMed=34303285;
CC   From: Universita Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli; Rome; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Arg518Ile (c.1553G>T); Zygosity=Heterozygous (PubMed=34303285).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   UCSCi002-A
AC   CVCL_C0JS
SY   LIF-1989
DR   BioSamples; SAMEA10774218
DR   hPSCreg; UCSCi002-A
DR   Wikidata; Q112930507
RX   PubMed=35667216;
CC   From: Universita Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli; Rome; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple; p.Ser332Asn (c.995G>A); ClinVar=VCV001448395; Zygosity=Heterozygous (PubMed=35667216).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   UCSD-242L
AC   CVCL_M009
SY   UCSD-242l; UCSD 242L; UCSD242L
DR   EFO; EFO_0006769
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03473115
DR   Cosmic; 1303060
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   NCI-DTP; UCSD 242L
DR   PharmacoDB; UCSD242l_1637_2019
DR   Wikidata; Q54989710
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
CC   HLA typing: A*02:02,32:01; B*40:02,40:02; C*02:02,03:04; DQA1*01:03,03:02; DQB1*03:02,06:11; DRB1*04:04,13:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,10
ST   D16S539: 9,12,13
ST   D18S51: 14,16
ST   D21S11: 28,31.2
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 10,12
ST   FGA: 20,21,23
ST   Penta D: 10,12
ST   Penta E: 8,10
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 16
//
ID   UCSD-354L
AC   CVCL_M010
SY   UCSD 354L
DR   Cosmic; 1303061
DR   NCI-DTP; UCSD 354K
DR   Wikidata; Q54989711
CC   Misspelling: UCSD 354K; NCI-DTP=UCSD 354K.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 8
//
ID   UCSD-AML1
AC   CVCL_1853
SY   UCSD/AML1; UCSD/AML-1; UCSD/AML 1
DR   BioSample; SAMN03473441
DR   Cosmic; 787484
DR   Cosmic; 975308
DR   Cosmic; 1281358
DR   Cosmic; 2306242
DR   Cosmic; 2378089
DR   Cosmic; 2733529
DR   DSMZ; ACC-691
DR   DSMZCellDive; ACC-691
DR   Wikidata; Q54989712
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1698479;
RX   PubMed=9195772;
RX   PubMed=15229617;
CC   Characteristics: CSF1 or CSF2 or IL6 dependent.
CC   Doubling time: 48-72 hours (PubMed=1698479); ~50-60 hours (DSMZ=ACC-691).
CC   Misspelling: UCSC-AML1; Cosmic=1281358.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-691
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 8,12
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,20
ST   D3S1358: 14,18
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 11
ST   FGA: 20,22
ST   Penta D: 11
ST   Penta E: 9,17
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C82426; Acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2) GATA2, MECOM
DI   ORDO; Orphanet_402020; Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 23
//
ID   UCSD-NDC3.1
AC   CVCL_UB88
SY   UCSD-ADRC#14096
DR   Wikidata; Q98133853
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-NDC4.43
AC   CVCL_UB89
SY   UCSD-ADRC#40
DR   Wikidata; Q98133854
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-NDC5.20
AC   CVCL_UB90
SY   UCSD-ADRC#8078
DR   Wikidata; Q98133855
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-SAD3.7
AC   CVCL_UB91
SY   UCSD-ADRC#2991
DR   Wikidata; Q98133856
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   89Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-SAD4.43
AC   CVCL_UB92
SY   UCSD-ADRC#3121
DR   Wikidata; Q98133857
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-SAD5.17
AC   CVCL_UB93
SY   UCSD-ADRC#3158
DR   Wikidata; Q98133858
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-SAD6.9
AC   CVCL_UB94
SY   UCSD-ADRC#8097
DR   Wikidata; Q98133859
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD-SAD7D
AC   CVCL_UB95
SY   UCSD-ADRC#2800
DR   Wikidata; Q98133860
RX   PubMed=25772071;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   UCSD001i-5-1
AC   CVCL_EM44
SY   iPSCORE_5_1; NextGen_5_1
DR   SKIP; SKIP003480
DR   WiCell; ucsd001i-5-1
DR   Wikidata; Q54989713
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD002i-16-1
AC   CVCL_EM45
SY   iPSCORE_16_1; NextGen_16_1
DR   SKIP; SKIP003388
DR   WiCell; ucsd002i-16-1
DR   Wikidata; Q54989714
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD003i-16-2
AC   CVCL_EM46
SY   iPSCORE_16_2; NextGen_16_2
DR   SKIP; SKIP003389
DR   WiCell; ucsd003i-16-2
DR   Wikidata; Q54989715
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84735; Glycogen storage disease type IIb
DI   ORDO; Orphanet_34587; Glycogen storage disease due to LAMP-2 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD004i-42-1
AC   CVCL_EM47
SY   iPSCORE_42_1; NextGen_42_1
DR   SKIP; SKIP003472
DR   WiCell; ucsd004i-42-1
DR   Wikidata; Q54989716
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD005i-43-1
AC   CVCL_EM48
SY   iPSCORE_43_1; NextGen_43_1
DR   SKIP; SKIP003473
DR   WiCell; ucsd005i-43-1
DR   Wikidata; Q54989717
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD006i-21-1
AC   CVCL_EM49
SY   iPSCORE_21_1; NextGen_21_1
DR   SKIP; SKIP003414
DR   WiCell; ucsd006i-21-1
DR   Wikidata; Q54989719
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD007i-21-2
AC   CVCL_EM50
SY   iPSCORE_21_2; NextGen_21_2
DR   SKIP; SKIP003415
DR   WiCell; ucsd007i-21-2
DR   Wikidata; Q54989720
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD008i-44-1
AC   CVCL_EM51
SY   iPSCORE_44_1; NextGen_44_1
DR   SKIP; SKIP003474
DR   WiCell; ucsd008i-44-1
DR   Wikidata; Q54989721
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD009i-5-2
AC   CVCL_EM52
SY   iPSCORE_5_2; NextGen_5_2
DR   SKIP; SKIP003481
DR   WiCell; ucsd009i-5-2
DR   Wikidata; Q54989722
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD010i-5-3
AC   CVCL_EM53
SY   iPSCORE_5_3; NextGen_5_3
DR   SKIP; SKIP003482
DR   WiCell; ucsd010i-5-3
DR   Wikidata; Q54989723
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD011i-5-4
AC   CVCL_EM54
SY   iPSCORE_5_4; NextGen_5_4
DR   SKIP; SKIP003483
DR   WiCell; ucsd011i-5-4
DR   Wikidata; Q54989724
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD012i-5-5
AC   CVCL_EM55
SY   iPSCORE_5_5; NextGen_5_5
DR   SKIP; SKIP003484
DR   WiCell; ucsd012i-5-5
DR   Wikidata; Q54989725
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD013i-16-3
AC   CVCL_EM56
SY   iPSCORE_16_3; NextGen_16_3
DR   SKIP; SKIP003390
DR   WiCell; ucsd013i-16-3
DR   Wikidata; Q54989726
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84735; Glycogen storage disease type IIb
DI   ORDO; Orphanet_34587; Glycogen storage disease due to LAMP-2 deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 12
//
ID   UCSD014i-21-3
AC   CVCL_EM57
SY   iPSCORE_21_3; NextGen_21_3
DR   SKIP; SKIP003416
DR   WiCell; ucsd014i-21-3
DR   Wikidata; Q54989727
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD015i-3-3
AC   CVCL_EM58
SY   iPSCORE_3_3; NextGen_3_3
DR   SKIP; SKIP003436
DR   WiCell; ucsd015i-3-3
DR   Wikidata; Q54989728
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian, Japanese and Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD016i-3-4
AC   CVCL_EM59
SY   iPSCORE_3_4; NextGen_3_4
DR   SKIP; SKIP003437
DR   WiCell; ucsd016i-3-4
DR   Wikidata; Q54989729
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD017i-3-5
AC   CVCL_EM60
SY   iPSCORE_3_5; NextGen_3_5
DR   SKIP; SKIP003438
DR   WiCell; ucsd017i-3-5
DR   Wikidata; Q54989730
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD018i-3-6
AC   CVCL_EM61
SY   iPSCORE_3_6; NextGen_3_6
DR   SKIP; SKIP003439
DR   WiCell; ucsd018i-3-6
DR   Wikidata; Q54989732
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD019i-3-7
AC   CVCL_EM62
SY   iPSCORE_3_7; NextGen_3_7
DR   SKIP; SKIP003440
DR   WiCell; ucsd019i-3-7
DR   Wikidata; Q54989733
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD020i-3-8
AC   CVCL_EM63
SY   iPSCORE_3_8; NextGen_3_8
DR   SKIP; SKIP003441
DR   WiCell; ucsd020i-3-8
DR   Wikidata; Q54989734
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD021i-3-9
AC   CVCL_EM64
SY   iPSCORE_3_9; NextGen_3_9
DR   SKIP; SKIP003442
DR   WiCell; ucsd021i-3-9
DR   Wikidata; Q54989735
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD022i-8-3
AC   CVCL_EM65
SY   iPSCORE_8_3; NextGen_8_3
DR   SKIP; SKIP003527
DR   WiCell; ucsd022i-8-3
DR   Wikidata; Q54989736
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD023i-8-4
AC   CVCL_EM66
SY   iPSCORE_8_4; NextGen_8_4
DR   SKIP; SKIP003528
DR   WiCell; ucsd023i-8-4
DR   Wikidata; Q54989738
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD024i-13-3
AC   CVCL_EM67
SY   iPSCORE_13_3; NextGen_13_3
DR   SKIP; SKIP003380
DR   WiCell; ucsd024i-13-3
DR   Wikidata; Q54989740
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD025i-13-4
AC   CVCL_EM68
SY   iPSCORE_13_4; NextGen_13_4
DR   SKIP; SKIP003381
DR   WiCell; ucsd025i-13-4
DR   Wikidata; Q54989741
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD026i-9-1
AC   CVCL_EM69
SY   iPSCORE_9_1; NextGen_9_1
DR   SKIP; SKIP003539
DR   WiCell; ucsd026i-9-1
DR   Wikidata; Q54989742
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD027i-9-2
AC   CVCL_EM70
SY   iPSCORE_9_2; NextGen_9_2
DR   SKIP; SKIP003540
DR   WiCell; ucsd027i-9-2
DR   Wikidata; Q54989744
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD028i-9-3
AC   CVCL_EM71
SY   iPSCORE_9_3; NextGen_9_3
DR   SKIP; SKIP003541
DR   WiCell; ucsd028i-9-3
DR   Wikidata; Q54989745
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD029i-9-4
AC   CVCL_EM72
SY   iPSCORE_9_4; NextGen_9_4
DR   SKIP; SKIP003542
DR   WiCell; ucsd029i-9-4
DR   Wikidata; Q54989747
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD030i-23-2
AC   CVCL_EM73
SY   iPSCORE_23_2; NextGen_23_2
DR   SKIP; SKIP003421
DR   WiCell; ucsd030i-23-2
DR   Wikidata; Q54989748
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD031i-45-1
AC   CVCL_EM74
SY   iPSCORE_45_1; NextGen_45_1
DR   SKIP; SKIP003475
DR   WiCell; ucsd031i-45-1
DR   Wikidata; Q54989749
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD032i-41-1
AC   CVCL_EM75
SY   iPSCORE_41_1; NextGen_41_1
DR   SKIP; SKIP003470
DR   WiCell; ucsd032i-41-1
DR   Wikidata; Q54989750
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD033i-41-2
AC   CVCL_EM76
SY   iPSCORE_41_2; NextGen_41_2
DR   SKIP; SKIP003471
DR   WiCell; ucsd033i-41-2
DR   Wikidata; Q54989751
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD034i-4-3
AC   CVCL_EM77
SY   iPSCORE_4_3; NextGen_4_3
DR   SKIP; SKIP003465
DR   WiCell; ucsd034i-4-3
DR   Wikidata; Q54989752
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD035i-4-4
AC   CVCL_EM78
SY   iPSCORE_4_4; NextGen_4_4
DR   SKIP; SKIP003466
DR   WiCell; ucsd035i-4-4
DR   Wikidata; Q54989753
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD036i-4-5
AC   CVCL_EM79
SY   iPSCORE_4_5; NextGen_4_5
DR   SKIP; SKIP003467
DR   WiCell; ucsd036i-4-5
DR   Wikidata; Q54989754
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD037i-26-2
AC   CVCL_EM80
SY   iPSCORE_26_2; NextGen_26_2
DR   SKIP; SKIP003427
DR   WiCell; ucsd037i-26-2
DR   Wikidata; Q54989755
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD038i-24-2
AC   CVCL_EM81
SY   iPSCORE_24_2; NextGen_24_2
DR   SKIP; SKIP003423
DR   WiCell; ucsd038i-24-2
DR   Wikidata; Q54989756
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD039i-14-3
AC   CVCL_EM82
SY   iPSCORE_14_3; NextGen_14_3
DR   SKIP; SKIP003384
DR   WiCell; ucsd039i-14-3
DR   Wikidata; Q54989757
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD040i-33-1
AC   CVCL_EM83
SY   iPSCORE_33_1; NextGen_33_1
DR   SKIP; SKIP003449
DR   WiCell; ucsd040i-33-1
DR   Wikidata; Q54989758
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD041i-33-2
AC   CVCL_EM84
SY   iPSCORE_33_2; NextGen_33_2
DR   SKIP; SKIP003450
DR   WiCell; ucsd041i-33-2
DR   Wikidata; Q54989759
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD042i-46-1
AC   CVCL_EM85
SY   iPSCORE_46_1; NextGen_46_1
DR   SKIP; SKIP003476
DR   WiCell; ucsd042i-46-1
DR   Wikidata; Q54989760
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50802; Ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD043i-47-1
AC   CVCL_EM86
SY   iPSCORE_47_1; NextGen_47_1
DR   SKIP; SKIP003477
DR   WiCell; ucsd043i-47-1
DR   Wikidata; Q54989761
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD044i-48-1
AC   CVCL_EM87
SY   iPSCORE_48_1; NextGen_48_1
DR   SKIP; SKIP003478
DR   WiCell; ucsd044i-48-1
DR   Wikidata; Q54989762
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34786; Long QT syndrome
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD045i-49-1
AC   CVCL_EM88
SY   iPSCORE_49_1; NextGen_49_1
DR   SKIP; SKIP003479
DR   WiCell; ucsd045i-49-1
DR   Wikidata; Q54989763
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD046i-50-1
AC   CVCL_EM89
SY   iPSCORE_50_1; NextGen_50_1
DR   SKIP; SKIP003485
DR   WiCell; ucsd046i-50-1
DR   Wikidata; Q54989764
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD047i-51-1
AC   CVCL_EM90
SY   iPSCORE_51_1; NextGen_51_1
DR   SKIP; SKIP003486
DR   WiCell; ucsd047i-51-1
DR   Wikidata; Q54989765
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD048i-52-1
AC   CVCL_EM91
SY   iPSCORE_52_1; NextGen_52_1
DR   SKIP; SKIP003487
DR   WiCell; ucsd048i-52-1
DR   Wikidata; Q54989766
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26732; Coronary artery disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD049i-53-1
AC   CVCL_EM92
SY   iPSCORE_53_1; NextGen_53_1
DR   SKIP; SKIP003488
DR   WiCell; ucsd049i-53-1
DR   Wikidata; Q54989767
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD050i-54-1
AC   CVCL_EM93
SY   iPSCORE_54_1; NextGen_54_1
DR   SKIP; SKIP003489
DR   WiCell; ucsd050i-54-1
DR   Wikidata; Q54989768
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD051i-55-1
AC   CVCL_EM94
SY   iPSCORE_55_1; NextGen_55_1
DR   SKIP; SKIP003490
DR   WiCell; ucsd051i-55-1
DR   Wikidata; Q54989771
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD052i-56-1
AC   CVCL_EM95
SY   iPSCORE_56_1; NextGen_56_1
DR   SKIP; SKIP003491
DR   WiCell; ucsd052i-56-1
DR   Wikidata; Q54989772
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD053i-57-1
AC   CVCL_EM96
SY   iPSCORE_57_1; NextGen_57_1
DR   SKIP; SKIP003492
DR   WiCell; ucsd053i-57-1
DR   Wikidata; Q54989773
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD054i-58-1
AC   CVCL_EM97
SY   iPSCORE_58_1; NextGen_58_1
DR   SKIP; SKIP003493
DR   WiCell; ucsd054i-58-1
DR   Wikidata; Q54989775
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD055i-59-1
AC   CVCL_EM98
SY   iPSCORE_59_1; NextGen_59_1
DR   SKIP; SKIP003494
DR   WiCell; ucsd055i-59-1
DR   Wikidata; Q54989776
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD056i-60-1
AC   CVCL_EM99
SY   iPSCORE_60_1; NextGen_60_1
DR   SKIP; SKIP003500
DR   WiCell; ucsd056i-60-1
DR   Wikidata; Q54989777
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   NCIt; C50802; Ventricular tachycardia
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD057i-61-1
AC   CVCL_EN00
SY   iPSCORE_61_1; NextGen_61_1
DR   SKIP; SKIP003501
DR   WiCell; ucsd057i-61-1
DR   Wikidata; Q54989778
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD058i-62-1
AC   CVCL_EN01
SY   iPSCORE_62_1; NextGen_62_1
DR   SKIP; SKIP003502
DR   WiCell; ucsd058i-62-1
DR   Wikidata; Q54989779
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50802; Ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD059i-63-1
AC   CVCL_EN02
SY   iPSCORE_63_1; NextGen_63_1
DR   SKIP; SKIP003503
DR   WiCell; ucsd059i-63-1
DR   Wikidata; Q54989780
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD060i-64-1
AC   CVCL_EN03
SY   iPSCORE_64_1; NextGen_64_1
DR   SKIP; SKIP003504
DR   WiCell; ucsd060i-64-1
DR   Wikidata; Q54989781
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C54936; Premature ventricular contraction, CTCAE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD061i-65-1
AC   CVCL_EN04
SY   iPSCORE_65_1; NextGen_65_1
DR   SKIP; SKIP003505
DR   WiCell; ucsd061i-65-1
DR   Wikidata; Q54989782
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3080; Congestive heart failure
DI   NCIt; C84673; Dilated cardiomyopathy
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD062i-66-1
AC   CVCL_EN05
SY   iPSCORE_66_1; NextGen_66_1
DR   SKIP; SKIP003506
DR   WiCell; ucsd062i-66-1
DR   Wikidata; Q54989783
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34786; Long QT syndrome
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD063i-20-1
AC   CVCL_EN06
SY   iPSCORE_20_1; NextGen_20_1
DR   SKIP; SKIP003411
DR   WiCell; ucsd063i-20-1
DR   Wikidata; Q54989785
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD064i-20-2
AC   CVCL_EN07
SY   iPSCORE_20_2; NextGen_20_2
DR   SKIP; SKIP003412
DR   WiCell; ucsd064i-20-2
DR   Wikidata; Q54989786
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD065i-20-3
AC   CVCL_EN08
SY   iPSCORE_20_3; NextGen_20_3
DR   SKIP; SKIP003413
DR   WiCell; ucsd065i-20-3
DR   Wikidata; Q54989787
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD066i-67-1
AC   CVCL_EN09
SY   iPSCORE_67_1; NextGen_67_1
DR   SKIP; SKIP003507
DR   WiCell; ucsd066i-67-1
DR   Wikidata; Q54989788
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD067i-19-1
AC   CVCL_EN10
SY   iPSCORE_19_1; NextGen_19_1
DR   SKIP; SKIP003397
DR   WiCell; ucsd067i-19-1
DR   Wikidata; Q54989793
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD068i-19-2
AC   CVCL_EN11
SY   iPSCORE_19_2; NextGen_19_2
DR   SKIP; SKIP003398
DR   WiCell; ucsd068i-19-2
DR   Wikidata; Q54989794
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD069i-19-3
AC   CVCL_EN12
SY   iPSCORE_19_3; NextGen_19_3
DR   SKIP; SKIP003399
DR   WiCell; ucsd069i-19-3
DR   Wikidata; Q54989795
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD070i-1-1
AC   CVCL_EN13
SY   iPSCORE_1_1; NextGen_1_1
DR   SKIP; SKIP003331
DR   WiCell; ucsd070i-1-1
DR   Wikidata; Q54989796
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic and Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD071i-1-2
AC   CVCL_EN14
SY   iPSCORE_1_2; NextGen_1_2
DR   SKIP; SKIP003337
DR   WiCell; ucsd071i-1-2
DR   Wikidata; Q54989797
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD072i-1-3
AC   CVCL_EN15
SY   iPSCORE_1_3; NextGen_1_3
DR   SKIP; SKIP003338
DR   WiCell; ucsd072i-1-3
DR   Wikidata; Q54989798
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD073i-1-4
AC   CVCL_EN16
SY   iPSCORE_1_4; NextGen_1_4
DR   SKIP; SKIP003339
DR   WiCell; ucsd073i-1-4
DR   Wikidata; Q54989799
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD074i-1-5
AC   CVCL_EN17
SY   iPSCORE_1_5; NextGen_1_5
DR   SKIP; SKIP003340
DR   WiCell; ucsd074i-1-5
DR   Wikidata; Q54989800
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD075i-1-6
AC   CVCL_EN18
SY   iPSCORE_1_6; NextGen_1_6
DR   SKIP; SKIP003341
DR   WiCell; ucsd075i-1-6
DR   Wikidata; Q54989801
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD076i-1-7
AC   CVCL_EN19
SY   iPSCORE_1_7; NextGen_1_7
DR   SKIP; SKIP003342
DR   WiCell; ucsd076i-1-7
DR   Wikidata; Q54989802
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD077i-1-8
AC   CVCL_EN20
SY   iPSCORE_1_8; NextGen_1_8
DR   SKIP; SKIP003343
DR   WiCell; ucsd077i-1-8
DR   Wikidata; Q54989803
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD078i-1-9
AC   CVCL_EN21
SY   iPSCORE_1_9; NextGen_1_9
DR   SKIP; SKIP003344
DR   WiCell; ucsd078i-1-9
DR   Wikidata; Q54989804
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD079i-1-12
AC   CVCL_EN22
SY   iPSCORE_1_12; NextGen_1_12
DR   SKIP; SKIP003334
DR   WiCell; ucsd079i-1-12
DR   Wikidata; Q54989805
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: African and Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD080i-1-13
AC   CVCL_EN23
SY   iPSCORE_1_13; NextGen_1_13
DR   SKIP; SKIP003335
DR   WiCell; ucsd080i-1-13
DR   Wikidata; Q54989806
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD081i-1-14
AC   CVCL_EN24
SY   iPSCORE_1_14; NextGen_1_14
DR   SKIP; SKIP003336
DR   WiCell; ucsd081i-1-14
DR   Wikidata; Q54989807
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD082i-40-1
AC   CVCL_EN25
SY   iPSCORE_40_1; NextGen_40_1
DR   SKIP; SKIP003468
DR   WiCell; ucsd082i-40-1
DR   Wikidata; Q54989808
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD083i-40-2
AC   CVCL_EN26
SY   iPSCORE_40_2; NextGen_40_2
DR   SKIP; SKIP003469
DR   WiCell; ucsd083i-40-2
DR   Wikidata; Q54989809
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD084i-6-1
AC   CVCL_EN27
SY   iPSCORE_6_1; NextGen_6_1
DR   SKIP; SKIP003495
DR   WiCell; ucsd084i-6-1
DR   Wikidata; Q54989811
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD085i-6-2
AC   CVCL_EN28
SY   iPSCORE_6_2; NextGen_6_2
DR   SKIP; SKIP003496
DR   WiCell; ucsd085i-6-2
DR   Wikidata; Q54989812
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD086i-6-3
AC   CVCL_EN29
SY   iPSCORE_6_3; NextGen_6_3
DR   SKIP; SKIP003497
DR   WiCell; ucsd086i-6-3
DR   Wikidata; Q54989813
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD087i-6-4
AC   CVCL_EN30
SY   iPSCORE_6_4; NextGen_6_4
DR   SKIP; SKIP003498
DR   WiCell; ucsd087i-6-4
DR   Wikidata; Q54989814
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD088i-6-5
AC   CVCL_EN31
SY   iPSCORE_6_5; NextGen_6_5
DR   SKIP; SKIP003499
DR   WiCell; ucsd088i-6-5
DR   Wikidata; Q54989815
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD089i-15-1
AC   CVCL_EN32
SY   iPSCORE_15_1; NextGen_15_1
DR   SKIP; SKIP003385
DR   WiCell; ucsd089i-15-1
DR   Wikidata; Q54989816
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD090i-15-2
AC   CVCL_EN33
SY   iPSCORE_15_2; NextGen_15_2
DR   SKIP; SKIP003386
DR   WiCell; ucsd090i-15-2
DR   Wikidata; Q54989817
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD091i-15-3
AC   CVCL_EN34
SY   iPSCORE_15_3; NextGen_15_3
DR   SKIP; SKIP003387
DR   WiCell; ucsd091i-15-3
DR   Wikidata; Q54989818
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD092i-1-10
AC   CVCL_EN35
SY   iPSCORE_1_10; NextGen_1_10
DR   SKIP; SKIP003332
DR   WiCell; ucsd092i-1-10
DR   Wikidata; Q54989819
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD093i-1-11
AC   CVCL_EN36
SY   iPSCORE_1_11; NextGen_1_11
DR   SKIP; SKIP003333
DR   WiCell; ucsd093i-1-11
DR   Wikidata; Q54989820
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD094i-25-1
AC   CVCL_EN37
SY   iPSCORE_25_1; NextGen_25_1
DR   SKIP; SKIP003424
DR   WiCell; ucsd094i-25-1
DR   Wikidata; Q54989821
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Iraqi.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD095i-25-2
AC   CVCL_EN38
SY   iPSCORE_25_2; NextGen_25_2
DR   SKIP; SKIP003425
DR   WiCell; ucsd095i-25-2
DR   Wikidata; Q54989822
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD096i-34-1
AC   CVCL_EN39
SY   iPSCORE_34_1; NextGen_34_1
DR   SKIP; SKIP003451
DR   WiCell; ucsd096i-34-1
DR   Wikidata; Q54989823
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD097i-34-2
AC   CVCL_EN40
SY   iPSCORE_34_2; NextGen_34_2
DR   SKIP; SKIP003452
DR   WiCell; ucsd097i-34-2
DR   Wikidata; Q54989824
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian, Mexican and Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD098i-35-1
AC   CVCL_EN41
SY   iPSCORE_35_1; NextGen_35_1
DR   SKIP; SKIP003453
DR   WiCell; ucsd098i-35-1
DR   Wikidata; Q54989825
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD099i-35-2
AC   CVCL_EN42
SY   iPSCORE_35_2; NextGen_35_2
DR   SKIP; SKIP003454
DR   WiCell; ucsd099i-35-2
DR   Wikidata; Q54989826
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD100i-36-1
AC   CVCL_EN43
SY   iPSCORE_36_1; NextGen_36_1
DR   SKIP; SKIP003455
DR   WiCell; ucsd100i-36-1
DR   Wikidata; Q54989827
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD101i-36-2
AC   CVCL_EN44
SY   iPSCORE_36_2; NextGen_36_2
DR   SKIP; SKIP003456
DR   WiCell; ucsd101i-36-2
DR   Wikidata; Q54989828
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD102i-2-1
AC   CVCL_EN45
SY   iPSCORE_2_1; NextGen_2_1
DR   SKIP; SKIP003400
DR   WiCell; ucsd102i-2-1
DR   Wikidata; Q54989829
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34786; Long QT syndrome
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD103i-2-2
AC   CVCL_EN46
SY   iPSCORE_2_2; NextGen_2_2
DR   SKIP; SKIP003403
DR   WiCell; ucsd103i-2-2
DR   Wikidata; Q54989830
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian and Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD104i-2-3
AC   CVCL_EN47
SY   iPSCORE_2_3; NextGen_2_3
DR   SKIP; SKIP003404
DR   WiCell; ucsd104i-2-3
DR   Wikidata; Q54989831
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian and Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD105i-2-4
AC   CVCL_EN48
SY   iPSCORE_2_4; NextGen_2_4
DR   SKIP; SKIP003405
DR   WiCell; ucsd105i-2-4
DR   Wikidata; Q54989832
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian and Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD106i-2-5
AC   CVCL_EN49
SY   iPSCORE_2_5; NextGen_2_5
DR   SKIP; SKIP003406
DR   WiCell; ucsd106i-2-5
DR   Wikidata; Q54989833
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian and Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD107i-2-6
AC   CVCL_EN50
SY   iPSCORE_2_6; NextGen_2_6
DR   SKIP; SKIP003407
DR   WiCell; ucsd107i-2-6
DR   Wikidata; Q54989844
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD108i-2-7
AC   CVCL_EN51
SY   iPSCORE_2_7; NextGen_2_7
DR   SKIP; SKIP003408
DR   WiCell; ucsd108i-2-7
DR   Wikidata; Q54989845
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD109i-2-8
AC   CVCL_EN52
SY   iPSCORE_2_8; NextGen_2_8
DR   SKIP; SKIP003409
DR   WiCell; ucsd109i-2-8
DR   Wikidata; Q54989846
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD110i-2-9
AC   CVCL_EN53
SY   iPSCORE_2_9; NextGen_2_9
DR   SKIP; SKIP003410
DR   WiCell; ucsd110i-2-9
DR   Wikidata; Q54989847
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD111i-2-10
AC   CVCL_EN54
SY   iPSCORE_2_10; NextGen_2_10
DR   SKIP; SKIP003401
DR   WiCell; ucsd111i-2-10
DR   Wikidata; Q54989848
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian and Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD112i-2-11
AC   CVCL_EN55
SY   iPSCORE_2_11; NextGen_2_11
DR   SKIP; SKIP003402
DR   WiCell; ucsd112i-2-11
DR   Wikidata; Q54989850
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD113i-68-1
AC   CVCL_EN56
SY   iPSCORE_68_1; NextGen_68_1
DR   SKIP; SKIP003508
DR   WiCell; ucsd113i-68-1
DR   Wikidata; Q54989851
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD114i-69-1
AC   CVCL_EN57
SY   iPSCORE_69_1; NextGen_69_1
DR   SKIP; SKIP003509
DR   WiCell; ucsd114i-69-1
DR   Wikidata; Q54989852
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD115i-70-1
AC   CVCL_EN58
SY   iPSCORE_70_1; NextGen_70_1
DR   SKIP; SKIP003515
DR   WiCell; ucsd115i-70-1
DR   Wikidata; Q54989853
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD116i-71-1
AC   CVCL_EN59
SY   iPSCORE_71_1; NextGen_71_1
DR   SKIP; SKIP003516
DR   WiCell; ucsd116i-71-1
DR   Wikidata; Q54989855
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD117i-72-1
AC   CVCL_EN60
SY   iPSCORE_72_1; NextGen_72_1
DR   SKIP; SKIP003517
DR   WiCell; ucsd117i-72-1
DR   Wikidata; Q54989856
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD118i-38-1
AC   CVCL_EN61
SY   iPSCORE_38_1; NextGen_38_1
DR   SKIP; SKIP003459
DR   WiCell; ucsd118i-38-1
DR   Wikidata; Q54989857
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD119i-38-2
AC   CVCL_EN62
SY   iPSCORE_38_2; NextGen_38_2
DR   SKIP; SKIP003460
DR   WiCell; ucsd119i-38-2
DR   Wikidata; Q54989858
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD120i-39-1
AC   CVCL_EN63
SY   iPSCORE_39_1; NextGen_39_1
DR   SKIP; SKIP003461
DR   WiCell; ucsd120i-39-1
DR   Wikidata; Q54989859
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD121i-39-2
AC   CVCL_EN64
SY   iPSCORE_39_2; NextGen_39_2
DR   SKIP; SKIP003462
DR   WiCell; ucsd121i-39-2
DR   Wikidata; Q54989860
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Hispanic.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD122i-73-1
AC   CVCL_EN65
SY   iPSCORE_73_1; NextGen_73_1
DR   SKIP; SKIP003518
DR   WiCell; ucsd122i-73-1
DR   Wikidata; Q54989861
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD123i-74-1
AC   CVCL_EN66
SY   iPSCORE_74_1; NextGen_74_1
DR   SKIP; SKIP003519
DR   WiCell; ucsd123i-74-1
DR   Wikidata; Q54989862
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD124i-7-1
AC   CVCL_EN67
SY   iPSCORE_7_1; NextGen_7_1
DR   SKIP; SKIP003510
DR   WiCell; ucsd124i-7-1
DR   Wikidata; Q54989863
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD125i-7-2
AC   CVCL_EN68
SY   iPSCORE_7_2; NextGen_7_2
DR   SKIP; SKIP003511
DR   WiCell; ucsd125i-7-2
DR   Wikidata; Q54989864
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD126i-7-3
AC   CVCL_EN69
SY   iPSCORE_7_3; NextGen_7_3
DR   SKIP; SKIP003512
DR   WiCell; ucsd126i-7-3
DR   Wikidata; Q54989865
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD127i-7-4
AC   CVCL_EN70
SY   iPSCORE_7_4; NextGen_7_4
DR   SKIP; SKIP003513
DR   WiCell; ucsd127i-7-4
DR   Wikidata; Q54989866
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD128i-7-5
AC   CVCL_EN71
SY   iPSCORE_7_5; NextGen_7_5
DR   SKIP; SKIP003514
DR   WiCell; ucsd128i-7-5
DR   Wikidata; Q54989868
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD129i-75-1
AC   CVCL_EN72
SY   iPSCORE_75_1; NextGen_75_1
DR   SKIP; SKIP003520
DR   WiCell; ucsd129i-75-1
DR   Wikidata; Q54989869
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Iranian; Persian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD130i-76-1
AC   CVCL_EN73
SY   iPSCORE_76_1; NextGen_76_1
DR   SKIP; SKIP003521
DR   WiCell; ucsd130i-76-1
DR   Wikidata; Q54989870
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD131i-77-1
AC   CVCL_EN74
SY   iPSCORE_77_1; NextGen_77_1
DR   SKIP; SKIP003522
DR   WiCell; ucsd131i-77-1
DR   Wikidata; Q54989871
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD132i-78-1
AC   CVCL_EN75
SY   iPSCORE_78_1; NextGen_78_1
DR   SKIP; SKIP003523
DR   WiCell; ucsd132i-78-1
DR   Wikidata; Q54989872
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD133i-79-1
AC   CVCL_EN76
SY   iPSCORE_79_1; NextGen_79_1
DR   SKIP; SKIP003524
DR   WiCell; ucsd133i-79-1
DR   Wikidata; Q54989873
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD134i-80-1
AC   CVCL_EN77
SY   iPSCORE_80_1; NextGen_80_1
DR   SKIP; SKIP003529
DR   WiCell; ucsd134i-80-1
DR   Wikidata; Q54989874
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD135i-81-1
AC   CVCL_EN78
SY   iPSCORE_81_1; NextGen_81_1
DR   SKIP; SKIP003530
DR   WiCell; ucsd135i-81-1
DR   Wikidata; Q54989876
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian and Native American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD136i-82-1
AC   CVCL_EN79
SY   iPSCORE_82_1; NextGen_82_1
DR   SKIP; SKIP003531
DR   WiCell; ucsd136i-82-1
DR   Wikidata; Q54989877
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD137i-83-1
AC   CVCL_EN80
SY   iPSCORE_83_1; NextGen_83_1
DR   SKIP; SKIP003532
DR   WiCell; ucsd137i-83-1
DR   Wikidata; Q54989878
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD138i-84-1
AC   CVCL_EN81
SY   iPSCORE_84_1; NextGen_84_1
DR   SKIP; SKIP003533
DR   WiCell; ucsd138i-84-1
DR   Wikidata; Q54989879
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD139i-85-1
AC   CVCL_EN82
SY   iPSCORE_85_1; NextGen_85_1
DR   SKIP; SKIP003534
DR   WiCell; ucsd139i-85-1
DR   Wikidata; Q54989880
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD140i-37-1
AC   CVCL_EN83
SY   iPSCORE_37_1; NextGen_37_1
DR   SKIP; SKIP003457
DR   WiCell; ucsd140i-37-1
DR   Wikidata; Q54989882
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD141i-37-2
AC   CVCL_EN84
SY   iPSCORE_37_2; NextGen_37_2
DR   SKIP; SKIP003458
DR   WiCell; ucsd141i-37-2
DR   Wikidata; Q54989883
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD142i-86-1
AC   CVCL_EN85
SY   iPSCORE_86_1; NextGen_86_1
DR   SKIP; SKIP003535
DR   WiCell; ucsd142i-86-1
DR   Wikidata; Q54989885
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD143i-87-1
AC   CVCL_EN86
SY   iPSCORE_87_1; NextGen_87_1
DR   SKIP; SKIP003536
DR   WiCell; ucsd143i-87-1
DR   Wikidata; Q54989886
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD144i-88-1
AC   CVCL_EN87
SY   iPSCORE_88_1; NextGen_88_1
DR   SKIP; SKIP003537
DR   WiCell; ucsd144i-88-1
DR   Wikidata; Q54989887
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD145i-89-1
AC   CVCL_EN88
SY   iPSCORE_89_1; NextGen_89_1
DR   SKIP; SKIP003538
DR   WiCell; ucsd145i-89-1
DR   Wikidata; Q54989888
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: African and Korean.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD146i-10-1
AC   CVCL_EN89
SY   iPSCORE_10_1; NextGen_10_1
DR   SKIP; SKIP003345
DR   WiCell; ucsd146i-10-1
DR   Wikidata; Q54989889
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD147i-10-2
AC   CVCL_EN90
SY   iPSCORE_10_2; NextGen_10_2
DR   SKIP; SKIP003346
DR   WiCell; ucsd147i-10-2
DR   Wikidata; Q54989904
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD148i-10-3
AC   CVCL_EN91
SY   iPSCORE_10_3; NextGen_10_3
DR   SKIP; SKIP003347
DR   WiCell; ucsd148i-10-3
DR   Wikidata; Q54989905
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian and Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD149i-10-4
AC   CVCL_EN92
SY   iPSCORE_10_4; NextGen_10_4
DR   SKIP; SKIP003348
DR   WiCell; ucsd149i-10-4
DR   Wikidata; Q54989906
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD150i-11-1
AC   CVCL_EN93
SY   iPSCORE_11_1; NextGen_11_1
DR   SKIP; SKIP003359
DR   WiCell; ucsd150i-11-1
DR   Wikidata; Q54989907
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD151i-11-2
AC   CVCL_EN94
SY   iPSCORE_11_2; NextGen_11_2
DR   SKIP; SKIP003360
DR   WiCell; ucsd151i-11-2
DR   Wikidata; Q54989908
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD152i-11-3
AC   CVCL_EN95
SY   iPSCORE_11_3; NextGen_11_3
DR   SKIP; SKIP003361
DR   WiCell; ucsd152i-11-3
DR   Wikidata; Q54989909
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD153i-11-4
AC   CVCL_EN96
SY   iPSCORE_11_4; NextGen_11_4
DR   SKIP; SKIP003362
DR   WiCell; ucsd153i-11-4
DR   Wikidata; Q54989910
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD154i-90-1
AC   CVCL_EN97
SY   iPSCORE_90_1; NextGen_90_1
DR   SKIP; SKIP003543
DR   WiCell; ucsd154i-90-1
DR   Wikidata; Q54989912
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD155i-12-1
AC   CVCL_EN98
SY   iPSCORE_12_1; NextGen_12_1
DR   SKIP; SKIP003373
DR   WiCell; ucsd155i-12-1
DR   Wikidata; Q54989913
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD156i-12-2
AC   CVCL_EN99
SY   iPSCORE_12_2; NextGen_12_2
DR   SKIP; SKIP003374
DR   WiCell; ucsd156i-12-2
DR   Wikidata; Q54989914
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Pacific.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD157i-12-3
AC   CVCL_EP00
SY   iPSCORE_12_3; NextGen_12_3
DR   SKIP; SKIP003375
DR   WiCell; ucsd157i-12-3
DR   Wikidata; Q54989915
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD158i-12-4
AC   CVCL_EP01
SY   iPSCORE_12_4; NextGen_12_4
DR   SKIP; SKIP003376
DR   WiCell; ucsd158i-12-4
DR   Wikidata; Q54989917
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD159i-91-1
AC   CVCL_EP02
SY   iPSCORE_91_1; NextGen_91_1
DR   SKIP; SKIP003544
DR   WiCell; ucsd159i-91-1
DR   Wikidata; Q54989919
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD160i-92-1
AC   CVCL_EP03
SY   iPSCORE_92_1; NextGen_92_1
DR   SKIP; SKIP003545
DR   WiCell; ucsd160i-92-1
DR   Wikidata; Q54989920
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD161i-93-1
AC   CVCL_EP04
SY   iPSCORE_93_1; NextGen_93_1
DR   SKIP; SKIP003546
DR   WiCell; ucsd161i-93-1
DR   Wikidata; Q54989921
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD162i-94-1
AC   CVCL_EP05
SY   iPSCORE_94_1; NextGen_94_1
DR   SKIP; SKIP003547
DR   WiCell; ucsd162i-94-1
DR   Wikidata; Q54989922
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD163i-95-1
AC   CVCL_EP06
SY   iPSCORE_95_1; NextGen_95_1
DR   SKIP; SKIP003548
DR   WiCell; ucsd163i-95-1
DR   Wikidata; Q54989923
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD164i-96-1
AC   CVCL_EP07
SY   iPSCORE_96_1; NextGen_96_1
DR   SKIP; SKIP003549
DR   WiCell; ucsd164i-96-1
DR   Wikidata; Q54989924
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD165i-97-1
AC   CVCL_EP08
SY   iPSCORE_97_1; NextGen_97_1
DR   SKIP; SKIP003550
DR   WiCell; ucsd165i-97-1
DR   Wikidata; Q54989925
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD166i-98-1
AC   CVCL_EP09
SY   iPSCORE_98_1; NextGen_98_1
DR   SKIP; SKIP003551
DR   WiCell; ucsd166i-98-1
DR   Wikidata; Q54989926
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD167i-99-1
AC   CVCL_EP10
SY   iPSCORE_99_1; NextGen_99_1
DR   SKIP; SKIP003552
DR   WiCell; ucsd167i-99-1
DR   Wikidata; Q54989927
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD168i-22-1
AC   CVCL_EP11
SY   iPSCORE_22_1; NextGen_22_1
DR   SKIP; SKIP003417
DR   WiCell; ucsd168i-22-1
DR   Wikidata; Q54989928
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian and Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD169i-22-2
AC   CVCL_EP12
SY   iPSCORE_22_2; NextGen_22_2
DR   SKIP; SKIP003418
DR   WiCell; ucsd169i-22-2
DR   Wikidata; Q54989929
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian and Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD170i-22-3
AC   CVCL_EP13
SY   iPSCORE_22_3; NextGen_22_3
DR   SKIP; SKIP003419
DR   WiCell; ucsd170i-22-3
DR   Wikidata; Q54989930
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD171i-100-1
AC   CVCL_EP14
SY   iPSCORE_100_1; NextGen_100_1
DR   SKIP; SKIP003349
DR   WiCell; ucsd171i-100-1
DR   Wikidata; Q54989931
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD172i-101-1
AC   CVCL_EP15
SY   iPSCORE_101_1; NextGen_101_1
DR   SKIP; SKIP003350
DR   WiCell; ucsd172i-101-1
DR   Wikidata; Q54989932
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD173i-18-1
AC   CVCL_EP16
SY   iPSCORE_18_1; NextGen_18_1
DR   SKIP; SKIP003394
DR   WiCell; ucsd173i-18-1
DR   Wikidata; Q54989933
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD174i-18-2
AC   CVCL_EP17
SY   iPSCORE_18_2; NextGen_18_2
DR   SKIP; SKIP003395
DR   WiCell; ucsd174i-18-2
DR   Wikidata; Q54989934
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD175i-18-3
AC   CVCL_EP18
SY   iPSCORE_18_3; NextGen_18_3
DR   SKIP; SKIP003396
DR   WiCell; ucsd175i-18-3
DR   Wikidata; Q54989935
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD176i-17-1
AC   CVCL_EP19
SY   iPSCORE_17_1; NextGen_17_1
DR   SKIP; SKIP003391
DR   WiCell; ucsd176i-17-1
DR   Wikidata; Q54989936
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD177i-17-2
AC   CVCL_EP20
SY   iPSCORE_17_2; NextGen_17_2
DR   SKIP; SKIP003392
DR   WiCell; ucsd177i-17-2
DR   Wikidata; Q54989937
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD178i-17-3
AC   CVCL_EP21
SY   iPSCORE_17_3; NextGen_17_3
DR   SKIP; SKIP003393
DR   WiCell; ucsd178i-17-3
DR   Wikidata; Q54989938
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian and Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 13
//
ID   UCSD179i-27-1
AC   CVCL_EP22
SY   iPSCORE_27_1; NextGen_27_1
DR   SKIP; SKIP003428
DR   WiCell; ucsd179i-27-1
DR   Wikidata; Q54989940
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD180i-27-2
AC   CVCL_EP23
SY   iPSCORE_27_2; NextGen_27_2
DR   SKIP; SKIP003429
DR   WiCell; ucsd180i-27-2
DR   Wikidata; Q54989941
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD181i-3-1
AC   CVCL_EP24
SY   iPSCORE_3_1; NextGen_3_1
DR   SKIP; SKIP003434
DR   WiCell; ucsd181i-3-1
DR   Wikidata; Q54989942
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD182i-3-2 (Cellosaurus=CVCL_EP25).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD182i-3-2
AC   CVCL_EP25
SY   iPSCORE_3_2; NextGen_3_2; UCSDi001-A
DR   hPSCreg; UCSDi001-A
DR   SKIP; SKIP003435
DR   WiCell; ucsd182i-3-2
DR   Wikidata; Q54989943
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD181i-3-1 (Cellosaurus=CVCL_EP24).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 16
//
ID   UCSD183i-102-1
AC   CVCL_EP26
SY   iPSCORE_102_1; NextGen_102_1
DR   SKIP; SKIP003351
DR   WiCell; ucsd183i-102-1
DR   Wikidata; Q54989944
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD184i-8-1
AC   CVCL_EP27
SY   iPSCORE_8_1; NextGen_8_1
DR   SKIP; SKIP003525
DR   WiCell; ucsd184i-8-1
DR   Wikidata; Q54989945
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD185i-8-2 (Cellosaurus=CVCL_EP28).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD185i-8-2
AC   CVCL_EP28
SY   iPSCORE_8_2; NextGen_8_2
DR   SKIP; SKIP003526
DR   WiCell; ucsd185i-8-2
DR   Wikidata; Q54989946
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD184i-8-1 (Cellosaurus=CVCL_EP27).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD186i-103-1
AC   CVCL_EP29
SY   iPSCORE_103_1; NextGen_103_1
DR   SKIP; SKIP003352
DR   WiCell; ucsd186i-103-1
DR   Wikidata; Q54989947
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD187i-104-1
AC   CVCL_EP30
SY   iPSCORE_104_1; NextGen_104_1
DR   SKIP; SKIP003353
DR   WiCell; ucsd187i-104-1
DR   Wikidata; Q54989966
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD188i-105-1
AC   CVCL_EP31
SY   iPSCORE_105_1; NextGen_105_1
DR   SKIP; SKIP003354
DR   WiCell; ucsd188i-105-1
DR   Wikidata; Q54989967
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD189i-28-1
AC   CVCL_EP32
SY   iPSCORE_28_1; NextGen_28_1
DR   SKIP; SKIP003430
DR   WiCell; ucsd189i-28-1
DR   Wikidata; Q54989968
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD190i-28-2 (Cellosaurus=CVCL_EP33).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD190i-28-2
AC   CVCL_EP33
SY   iPSCORE_28_2; NextGen_28_2
DR   SKIP; SKIP003431
DR   WiCell; ucsd190i-28-2
DR   Wikidata; Q54989969
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD189i-28-1 (Cellosaurus=CVCL_EP32).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD191i-13-1
AC   CVCL_EP34
SY   iPSCORE_13_1; NextGen_13_1
DR   SKIP; SKIP003378
DR   WiCell; ucsd191i-13-1
DR   Wikidata; Q54989970
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD192i-13-2 (Cellosaurus=CVCL_EP35).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD192i-13-2
AC   CVCL_EP35
SY   iPSCORE_13_2; NextGen_13_2
DR   SKIP; SKIP003379
DR   WiCell; ucsd192i-13-2
DR   Wikidata; Q54989971
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD191i-13-1 (Cellosaurus=CVCL_EP34).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD193i-106-1
AC   CVCL_EP36
SY   iPSCORE_106_1; NextGen_106_1
DR   SKIP; SKIP003355
DR   WiCell; ucsd193i-106-1
DR   Wikidata; Q54989972
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD194i-29-1
AC   CVCL_EP37
SY   iPSCORE_29_1; NextGen_29_1
DR   SKIP; SKIP003432
DR   WiCell; ucsd194i-29-1
DR   Wikidata; Q54989974
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD195i-29-2 (Cellosaurus=CVCL_EP38).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD195i-29-2
AC   CVCL_EP38
SY   iPSCORE_29_2; NextGen_29_2
DR   SKIP; SKIP003433
DR   WiCell; ucsd195i-29-2
DR   Wikidata; Q54989975
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD194i-29-1 (Cellosaurus=CVCL_EP37).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD196i-30-1
AC   CVCL_EP39
SY   iPSCORE_30_1; NextGen_30_1
DR   SKIP; SKIP003443
DR   WiCell; ucsd196i-30-1
DR   Wikidata; Q54989976
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD197i-30-2 (Cellosaurus=CVCL_EP40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD197i-30-2
AC   CVCL_EP40
SY   iPSCORE_30_2; NextGen_30_2
DR   SKIP; SKIP003444
DR   WiCell; ucsd197i-30-2
DR   Wikidata; Q54989977
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD196i-30-1 (Cellosaurus=CVCL_EP39).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD198i-23-1
AC   CVCL_EP41
SY   iPSCORE_23_1; NextGen_23_1
DR   SKIP; SKIP003420
DR   WiCell; ucsd198i-23-1
DR   Wikidata; Q54989978
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD199i-107-1
AC   CVCL_EP42
SY   iPSCORE_107_1; NextGen_107_1
DR   SKIP; SKIP003356
DR   WiCell; ucsd199i-107-1
DR   Wikidata; Q54989979
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD200i-4-1
AC   CVCL_EP43
SY   iPSCORE_4_1; NextGen_4_1
DR   SKIP; SKIP003463
DR   WiCell; ucsd200i-4-1
DR   Wikidata; Q54989980
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Donor information: Established from monozygotic twin of UCSD201i-4-2 (Cellosaurus=CVCL_EP44).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD201i-4-2
AC   CVCL_EP44
SY   iPSCORE_4_2; NextGen_4_2
DR   SKIP; SKIP003464
DR   WiCell; ucsd201i-4-2
DR   Wikidata; Q54989982
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Southeast Asian; Filipino.
CC   Donor information: Established from monozygotic twin of UCSD200i-4-1 (Cellosaurus=CVCL_EP43).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD202i-108-1
AC   CVCL_EP45
SY   iPSCORE_108_1; NextGen_108_1
DR   SKIP; SKIP003357
DR   WiCell; ucsd202i-108-1
DR   Wikidata; Q54989983
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD203i-109-1
AC   CVCL_EP46
SY   iPSCORE_109_1; NextGen_109_1
DR   SKIP; SKIP003358
DR   WiCell; ucsd203i-109-1
DR   Wikidata; Q54989984
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD204i-26-1
AC   CVCL_EP47
SY   iPSCORE_26_1; NextGen_26_1
DR   SKIP; SKIP003426
DR   WiCell; ucsd204i-26-1
DR   Wikidata; Q54989985
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD205i-110-1
AC   CVCL_EP48
SY   iPSCORE_110_1; NextGen_110_1
DR   SKIP; SKIP003363
DR   WiCell; ucsd205i-110-1
DR   Wikidata; Q54989986
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD206i-31-1
AC   CVCL_EP49
SY   iPSCORE_31_1; NextGen_31_1
DR   SKIP; SKIP003445
DR   WiCell; ucsd206i-31-1
DR   Wikidata; Q54989987
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD207i-31-2 (Cellosaurus=CVCL_EP50).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD207i-31-2
AC   CVCL_EP50
SY   iPSCORE_31_2; NextGen_31_2
DR   SKIP; SKIP003446
DR   WiCell; ucsd207i-31-2
DR   Wikidata; Q54989988
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from monozygotic twin of UCSD206i-31-1 (Cellosaurus=CVCL_EP49).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD208i-111-1
AC   CVCL_EP51
SY   iPSCORE_111_1; NextGen_111_1
DR   SKIP; SKIP003364
DR   WiCell; ucsd208i-111-1
DR   Wikidata; Q54989990
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD209i-24-1
AC   CVCL_EP52
SY   iPSCORE_24_1; NextGen_24_1
DR   SKIP; SKIP003422
DR   WiCell; ucsd209i-24-1
DR   Wikidata; Q54989991
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD210i-112-1
AC   CVCL_EP53
SY   iPSCORE_112_1; NextGen_112_1
DR   SKIP; SKIP003365
DR   WiCell; ucsd210i-112-1
DR   Wikidata; Q54989993
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD211i-32-1
AC   CVCL_EP54
SY   iPSCORE_32_1; NextGen_32_1
DR   SKIP; SKIP003447
DR   WiCell; ucsd211i-32-1
DR   Wikidata; Q54989994
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from dizygotic twin of UCSD212i-32-2 (Cellosaurus=CVCL_EP55).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD212i-32-2
AC   CVCL_EP55
SY   iPSCORE_32_2; NextGen_32_2
DR   SKIP; SKIP003448
DR   WiCell; ucsd212i-32-2
DR   Wikidata; Q54989995
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from dizygotic twin of UCSD211i-32-1 (Cellosaurus=CVCL_EP54).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD213i-14-1
AC   CVCL_EP56
SY   iPSCORE_14_1; NextGen_14_1
DR   SKIP; SKIP003382
DR   WiCell; ucsd213i-14-1
DR   Wikidata; Q54989996
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from dizygotic twin of UCSD214i-14-2 (Cellosaurus=CVCL_EP57).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD214i-14-2
AC   CVCL_EP57
SY   iPSCORE_14_2; NextGen_14_2
DR   SKIP; SKIP003383
DR   WiCell; ucsd214i-14-2
DR   Wikidata; Q54989997
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Donor information: Established from dizygotic twin of UCSD213i-14-1 (Cellosaurus=CVCL_EP56).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 15
//
ID   UCSD215i-113-1
AC   CVCL_EP58
SY   iPSCORE_113_1; NextGen_113_1
DR   SKIP; SKIP003366
DR   WiCell; ucsd215i-113-1
DR   Wikidata; Q54989998
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD216i-114-1
AC   CVCL_EP59
SY   iPSCORE_114_1; NextGen_114_1
DR   SKIP; SKIP003367
DR   WiCell; ucsd216i-114-1
DR   Wikidata; Q54989999
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD217i-115-1
AC   CVCL_EP60
SY   iPSCORE_115_1; NextGen_115_1
DR   SKIP; SKIP003368
DR   WiCell; ucsd217i-115-1
DR   Wikidata; Q54990001
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD218i-116-1
AC   CVCL_EP61
SY   iPSCORE_116_1; NextGen_116_1
DR   SKIP; SKIP003369
DR   WiCell; ucsd218i-116-1
DR   Wikidata; Q54990003
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD219i-117-1
AC   CVCL_EP62
SY   iPSCORE_117_1; NextGen_117_1
DR   SKIP; SKIP003370
DR   WiCell; ucsd219i-117-1
DR   Wikidata; Q54990004
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD220i-118-1
AC   CVCL_EP63
SY   iPSCORE_118_1; NextGen_118_1
DR   SKIP; SKIP003371
DR   WiCell; ucsd220i-118-1
DR   Wikidata; Q54990005
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD221i-119-1
AC   CVCL_EP64
SY   iPSCORE_119_1; NextGen_119_1
DR   SKIP; SKIP003372
DR   WiCell; ucsd221i-119-1
DR   Wikidata; Q54990006
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD222i-120-1
AC   CVCL_EP65
SY   iPSCORE_120_1; NextGen_120_1
DR   SKIP; SKIP003377
DR   WiCell; ucsd222i-120-1
DR   Wikidata; Q54990007
RX   PubMed=28410642;
CC   Part of: iPSC Collection for Omic Research (iPSCORE).
CC   Part of: Next Generation Genetic Association studies (Next Gen) program cell lines.
CC   From: Frazer, Kelly A.; University of California, San Diego; San Diego; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-09-24; Version: 14
//
ID   UCSD223i-NDC1-1
AC   CVCL_EJ84
SY   NDC1.1; UCSD-ADRC#27-1
DR   SKIP; SKIP005429
DR   WiCell; ucsd223i-ndc1-1
DR   Wikidata; Q54990008
RX   PubMed=22278060;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ85 ! UCSD224i-NDC1-2
OI   CVCL_EJ86 ! UCSD225i-NDC1-3
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD224i-NDC1-2
AC   CVCL_EJ85
SY   NDC1.2; UCSD-ADRC#27-2
DR   SKIP; SKIP005430
DR   WiCell; ucsd224i-ndc1-2
DR   Wikidata; Q54990009
RX   PubMed=22278060;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ84 ! UCSD223i-NDC1-1
OI   CVCL_EJ86 ! UCSD225i-NDC1-3
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD225i-NDC1-3
AC   CVCL_EJ86
SY   NDC1.3; UCSD-ADRC#27-3
DR   SKIP; SKIP005431
DR   WiCell; ucsd225i-ndc1-3
DR   Wikidata; Q54990010
RX   PubMed=22278060;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ84 ! UCSD223i-NDC1-1
OI   CVCL_EJ85 ! UCSD224i-NDC1-2
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD226i-NDC2-1
AC   CVCL_EJ87
SY   NDC2.1; UCSD-ADRC#8011-1
DR   SKIP; SKIP005434
DR   WiCell; ucsd226i-ndc2-1
DR   Wikidata; Q54990011
RX   PubMed=22278060;
RX   PubMed=30686764;
CC   Discontinued: WiCell; ucsd226i-ndc2-1; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ88 ! UCSD227i-NDC2-2
OI   CVCL_EJ89 ! UCSD228i-NDC2-3
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD227i-NDC2-2
AC   CVCL_EJ88
SY   NDC2.2; UCSD-ADRC#8011-2
DR   SKIP; SKIP005433
DR   WiCell; ucsd227i-ndc2-2
DR   Wikidata; Q54990032
RX   PubMed=22278060;
CC   Discontinued: WiCell; ucsd227i-ndc2-2; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ87 ! UCSD226i-NDC2-1
OI   CVCL_EJ89 ! UCSD228i-NDC2-3
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD228i-NDC2-3
AC   CVCL_EJ89
SY   NDC2.3; UCSD-ADRC#8011-3
DR   SKIP; SKIP005432
DR   WiCell; ucsd228i-ndc2-3
DR   Wikidata; Q54990034
RX   PubMed=22278060;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ87 ! UCSD226i-NDC2-1
OI   CVCL_EJ88 ! UCSD227i-NDC2-2
SX   Male
AG   86Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD229i-SAD1-1
AC   CVCL_EJ90
SY   sAD1.1; SAD1.1; UCSD-ADRC#8149-1
DR   SKIP; SKIP005435
DR   WiCell; ucsd229i-sad1-1
DR   Wikidata; Q54990035
RX   PubMed=22278060;
RX   PubMed=30686764;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ91 ! UCSD230i-SAD1-2
OI   CVCL_EJ92 ! UCSD231i-SAD1-3
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD230i-SAD1-2
AC   CVCL_EJ91
SY   sAD1.2; SAD1.2; UCSD-ADRC#8149-2
DR   SKIP; SKIP005437
DR   WiCell; ucsd230i-sad1-2
DR   Wikidata; Q54990036
RX   PubMed=22278060;
CC   Discontinued: WiCell; ucsd230i-sad1-2; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ90 ! UCSD229i-SAD1-1
OI   CVCL_EJ92 ! UCSD231i-SAD1-3
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD231i-SAD1-3
AC   CVCL_EJ92
SY   sAD1.3; SAD1.3; UCSD-ADRC#8149-3
DR   SKIP; SKIP005436
DR   WiCell; ucsd231i-sad1-3
DR   Wikidata; Q54990037
RX   PubMed=22278060;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ90 ! UCSD229i-SAD1-1
OI   CVCL_EJ91 ! UCSD230i-SAD1-2
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD232i-SAD2-1
AC   CVCL_EJ93
SY   sAD2.1; SAD2.1; UCSD-ADRC#3093-1
DR   SKIP; SKIP005439
DR   WiCell; ucsd232i-sad2-1
DR   Wikidata; Q54990038
RX   PubMed=22278060;
RX   PubMed=30686764;
CC   Population: Caucasian.
CC   Discontinued: WiCell; ucsd232i-sad2-1; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1N91 ! UCSD233i-SAD2-2
OI   CVCL_EJ94 ! UCSD234i-SAD2-3
OI   CVCL_EJ95 ! UCSD235i-SAD2-4
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD233i-SAD2-2
AC   CVCL_1N91
SY   sAD2.2; SAD2.2; UCSD-ADRC#3093-2; GM24666; GM24666*A
DR   Coriell; GM24666
DR   SKIP; SKIP000733
DR   SKIP; SKIP005438
DR   WiCell; ucsd233i-sad2-2
DR   Wikidata; Q54990039
RX   PubMed=22278060;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ93 ! UCSD232i-SAD2-1
OI   CVCL_EJ94 ! UCSD234i-SAD2-3
OI   CVCL_EJ95 ! UCSD235i-SAD2-4
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 14
//
ID   UCSD234i-SAD2-3
AC   CVCL_EJ94
SY   sAD2.3; SAD2.3; UCSD-ADRC#3093-3
DR   SKIP; SKIP005441
DR   WiCell; ucsd234i-sad2-3
DR   Wikidata; Q54990040
RX   PubMed=22278060;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ93 ! UCSD232i-SAD2-1
OI   CVCL_1N91 ! UCSD233i-SAD2-2
OI   CVCL_EJ95 ! UCSD235i-SAD2-4
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD235i-SAD2-4
AC   CVCL_EJ95
SY   sAD2.4; SAD2.4; UCSD-ADRC#3093-4
DR   SKIP; SKIP005440
DR   WiCell; ucsd235i-sad2-4
DR   Wikidata; Q54990041
RX   PubMed=22278060;
CC   Population: Caucasian.
CC   Discontinued: WiCell; ucsd235i-sad2-4; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ93 ! UCSD232i-SAD2-1
OI   CVCL_1N91 ! UCSD233i-SAD2-2
OI   CVCL_EJ94 ! UCSD234i-SAD2-3
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   UCSD236i-APP1-1
AC   CVCL_EJ96
SY   APPDp1.1; APP1.1
DR   SKIP; SKIP005442
DR   WiCell; ucsd236i-app1-1
DR   Wikidata; Q54990042
RX   PubMed=22278060;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ97 ! UCSD237i-APP1-2
OI   CVCL_EJ98 ! UCSD238i-APP1-3
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   UCSD237i-APP1-2
AC   CVCL_EJ97
SY   APPDp1.2; Appdp1.2; APPdp1.2
DR   SKIP; SKIP005444
DR   WiCell; ucsd237i-app1-2
DR   Wikidata; Q54990043
RX   PubMed=22278060;
RX   PubMed=30686764;
CC   Discontinued: WiCell; ucsd237i-app1-2; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ96 ! UCSD236i-APP1-1
OI   CVCL_EJ98 ! UCSD238i-APP1-3
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   UCSD237i-APP1-2 APPnull
AC   CVCL_UI23
SY   APPDp1.2 APPnull; APP 1KO; APPnull in APPdp1.2 background
DR   Wikidata; Q98133861
RX   PubMed=30686764;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:620; APP.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EJ97 ! UCSD237i-APP1-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 8
//
ID   UCSD238i-APP1-3
AC   CVCL_EJ98
SY   APPDp1.3; Appdp1.3
DR   SKIP; SKIP005443
DR   WiCell; ucsd238i-app1-3
DR   Wikidata; Q54990045
RX   PubMed=22278060;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ96 ! UCSD236i-APP1-1
OI   CVCL_EJ97 ! UCSD237i-APP1-2
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 13
//
ID   UCSD239i-APP2-1
AC   CVCL_EJ99
SY   APPDp2.1; Appdp2.1; APPdp2.1
DR   SKIP; SKIP005445
DR   WiCell; ucsd239i-app2-1
DR   Wikidata; Q54990046
RX   PubMed=22278060;
RX   PubMed=30686764;
CC   Population: Caucasian; Finnish.
CC   Discontinued: WiCell; ucsd239i-app2-1; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EK00 ! UCSD240i-APP2-2
OI   CVCL_1N92 ! UCSD241i-APP2-3
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 14
//
ID   UCSD240i-APP2-2
AC   CVCL_EK00
SY   APPDp2.2; Appdp2.2
DR   SKIP; SKIP005447
DR   WiCell; ucsd240i-app2-2
DR   Wikidata; Q54990047
RX   PubMed=22278060;
CC   Population: Caucasian; Finnish.
CC   Discontinued: WiCell; ucsd240i-app2-2; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ99 ! UCSD239i-APP2-1
OI   CVCL_1N92 ! UCSD241i-APP2-3
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 14
//
ID   UCSD241i-APP2-3
AC   CVCL_1N92
SY   APPDp2.3; Appdp2.3; APP2.3; GM24675; GM24675*A
DR   Coriell; GM24675
DR   SKIP; SKIP000734
DR   SKIP; SKIP005446
DR   WiCell; ucsd241i-app2-3
DR   Wikidata; Q54990048
RX   PubMed=22278060;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ99 ! UCSD239i-APP2-1
OI   CVCL_EK00 ! UCSD240i-APP2-2
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   UCSF-OT-1109
AC   CVCL_JE76
SY   University of California, San Francisco-Oral Tongue-1109
DR   ATCC; CRL-3442
DR   Wikidata; Q54990049
RX   PubMed=28559012;
CC   Population: Caucasian.
CC   Doubling time: ~4-5 days (ATCC=CRL-3442).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=28559012).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-3442; PubMed=28559012
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   UCSF1
AC   CVCL_A019
SY   UCSF-1; UCSFe004-A
DR   hPSCreg; UCSFe004-A
DR   SKIP; SKIP002074
DR   Wikidata; Q54990050
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UCSF2
AC   CVCL_A020
SY   UCSF-2; UCSFe005-A
DR   hPSCreg; UCSFe005-A
DR   SKIP; SKIP002075
DR   Wikidata; Q54990051
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UCSF3
AC   CVCL_A021
SY   UCSF-3
DR   Wikidata; Q54990053
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   UCSF4
AC   CVCL_A022
SY   UCSF-4
DR   EFO; EFO_0007116
DR   ENCODE; ENCBS274MNP
DR   ENCODE; ENCBS281XEU
DR   ENCODE; ENCBS296VOU
DR   ENCODE; ENCBS311CPE
DR   ENCODE; ENCBS488VWE
DR   ENCODE; ENCBS496TQG
DR   ENCODE; ENCBS497PCQ
DR   ENCODE; ENCBS838AWQ
DR   GEO; GSM941748
DR   GEO; GSM941749
DR   GEO; GSM941750
DR   GEO; GSM941751
DR   GEO; GSM941752
DR   GEO; GSM941753
DR   GEO; GSM958175
DR   GEO; GSM958179
DR   GEO; GSM1127063
DR   GEO; GSM1127070
DR   GEO; GSM1127080
DR   GEO; GSM1127081
DR   GEO; GSM1127084
DR   GEO; GSM1127090
DR   GEO; GSM1127109
DR   GEO; GSM1127112
DR   GEO; GSM1127122
DR   GEO; GSM1127123
DR   GEO; GSM1582485
DR   NIHhESC; NIHhESC-10-0044
DR   Wikidata; Q54990054
RX   PubMed=28445466;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0044.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   UCSFB-1
AC   CVCL_A023
SY   UCSFB1
DR   Wikidata; Q54990055
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A025 ! UCSFB-2
OI   CVCL_A026 ! UCSFB-3
OI   CVCL_A027 ! UCSFB-4
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-10
AC   CVCL_A024
SY   UCSFB10
DR   Wikidata; Q54990056
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-2
AC   CVCL_A025
SY   UCSFB2
DR   Wikidata; Q54990057
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A023 ! UCSFB-1
OI   CVCL_A026 ! UCSFB-3
OI   CVCL_A027 ! UCSFB-4
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-3
AC   CVCL_A026
SY   UCSFB3
DR   Wikidata; Q54990058
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A023 ! UCSFB-1
OI   CVCL_A025 ! UCSFB-2
OI   CVCL_A027 ! UCSFB-4
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-4
AC   CVCL_A027
SY   UCSFB4
DR   Wikidata; Q54990059
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A023 ! UCSFB-1
OI   CVCL_A025 ! UCSFB-2
OI   CVCL_A026 ! UCSFB-3
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-5
AC   CVCL_A028
SY   UCSFB5
DR   Wikidata; Q54990060
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A029 ! UCSFB-6
OI   CVCL_A030 ! UCSFB-7
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-6
AC   CVCL_A029
SY   UCSFB6
DR   Wikidata; Q54990061
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A028 ! UCSFB-5
OI   CVCL_A030 ! UCSFB-7
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-7
AC   CVCL_A030
SY   UCSFB7
DR   Wikidata; Q54990062
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A028 ! UCSFB-5
OI   CVCL_A029 ! UCSFB-6
SX   Male
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UCSFB-8
AC   CVCL_A031
SY   UCSFB8
DR   Wikidata; Q54990063
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCSFB-9
AC   CVCL_A032
SY   UCSFB9
DR   Wikidata; Q54990064
RX   PubMed=26483210;
CC   From: University of California, San Francisco; San Francisco; USA.
CC   Donor information: Embryos giving rise to UCSFB-1 to UCSFB-10 are all siblings.
CC   Derived from site: In situ; Morula; UBERON=UBERON_0000085.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Morula stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UCSFi001-A-49
AC   CVCL_A8PL
SY   DYT1-HET-1C8; YH653-MUT-1C8-HET; ULLi002-A-49
DR   BioSamples; SAMEA8868384
DR   hPSCreg; UCSFi001-A-49
DR   Wikidata; Q108821427
RX   PubMed=34536661;
CC   From: University of Louisiana at Lafayette; Lafayette; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34536661).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34536661
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UCSFi001-A-50
AC   CVCL_A8PM
SY   DYT1-HET-H6; YH653-MUT-H6-HET; ULLi002-A-50
DR   BioSamples; SAMEA8868385
DR   hPSCreg; UCSFi001-A-50
DR   Wikidata; Q108821428
CC   From: University of Louisiana at Lafayette; Lafayette; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UCSFi001-A-50).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UCSFi001-A-51
AC   CVCL_A8PN
SY   DYT1-HOMO-2F2; YH653-MUT-2F2-HOMO; ULLi002-A-51
DR   BioSamples; SAMEA8868386
DR   hPSCreg; UCSFi001-A-51
DR   Wikidata; Q108821429
RX   PubMed=34536661;
CC   From: University of Louisiana at Lafayette; Lafayette; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3098; TOR1A; Simple_edited; p.Glu303del (c.907_909delGAG); ClinVar=VCV000005180; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34536661).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=34536661
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UCSFi001-A-52
AC   CVCL_A8PP
SY   ISO-WT-1A2; YH653-WT-1A2; ULLi002-A-52
DR   BioSamples; SAMEA8868387
DR   hPSCreg; UCSFi001-A-52
DR   Wikidata; Q108821430
CC   From: University of Louisiana at Lafayette; Lafayette; USA.
CC   Population: Japanese.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UCSFi001-A-53
AC   CVCL_A8PQ
SY   ISO-WT-1F6; YH653-WT-1F6
DR   BioSamples; SAMEA8868388
DR   hPSCreg; UCSFi001-A-53
DR   Wikidata; Q108821431
CC   From: University of Louisiana at Lafayette; Lafayette; USA.
CC   Population: Japanese.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UCSFi001-A-58
AC   CVCL_B3XM
SY   JAG1KO_IIA5
DR   hPSCreg; UCSFi001-A-58
DR   Wikidata; Q110433822
RX   PubMed=34736037;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   UCSFi001-A-59
AC   CVCL_B3XN
SY   JAG1KO_IIIB4
DR   hPSCreg; UCSFi001-A-59
DR   Wikidata; Q110433823
RX   PubMed=34736037;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6188; JAG1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   UCSFi001-A-60
AC   CVCL_C0IV
SY   CACNA1A+/- clone 1
DR   hPSCreg; UCSFi001-A-60
DR   Wikidata; Q112930508
RX   PubMed=35286975;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1388; CACNA1A (Note=1 of 2 alleles).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   UCSFi001-A-61
AC   CVCL_C0IW
SY   CACNA1A-/- clone 1
DR   hPSCreg; UCSFi001-A-61
DR   Wikidata; Q112930509
RX   PubMed=35286975;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1388; CACNA1A.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UCSFi001-A-62
AC   CVCL_C0IX
SY   CACNA1A-/- clone 2
DR   hPSCreg; UCSFi001-A-62
DR   Wikidata; Q112930510
RX   PubMed=35286975;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1388; CACNA1A.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UCSFi001-A-64
AC   CVCL_C1XK
SY   iPSC-RBM20 P633L; P633L RBM20 iPSCs
DR   BioSamples; SAMEA12395727
DR   hPSCreg; UCSFi001-A-64
DR   Wikidata; Q114313152
RX   PubMed=32905764;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:27424; RBM20; Simple_edited; p.Pro633Leu (c.1898C>T); ClinVar=VCV000572099; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32905764).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174435; Dilated cardiomyopathy-1DD
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UCSFi001-A-65
AC   CVCL_C1XL
SY   iPSC-RBM20 R634Q
DR   BioSamples; SAMEA12399777
DR   hPSCreg; UCSFi001-A-65
DR   Wikidata; Q114313153
RX   PubMed=32905764;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:27424; RBM20; Simple_edited; p.Arg634Gln (c.1901G>A); ClinVar=VCV000000269; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32905764).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174435; Dilated cardiomyopathy-1DD
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UCSFi001-A-68
AC   CVCL_D0NH
SY   IPS21-00087 NPHP1-/-; RMCGENi004-A-68
DR   hPSCreg; UCSFi001-A-68
DR   Wikidata; Q123033683
CC   From: Radboudumc Stem Cell Technology Center; Nijmegen; Netherlands.
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7905; NPHP1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UCSFi001-A-72
AC   CVCL_D0NI
SY   FUS-R521G HET 2B10; LSUHSi004-A-72
DR   BioSamples; SAMEA5843920
DR   hPSCreg; UCSFi001-A-72
DR   Wikidata; Q123033684
RX   PubMed=36965406;
CC   From: LSU Health Sciences Center in Shreveport; Shreveport; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36965406).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36965406
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   UCSFi001-A-73
AC   CVCL_D0NJ
SY   FUS-R521G HOM 1D9; LSUHSi004-A-73
DR   BioSamples; SAMEA112670806
DR   hPSCreg; UCSFi001-A-73
DR   Wikidata; Q123033685
RX   PubMed=36965406;
CC   From: LSU Health Sciences Center in Shreveport; Shreveport; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Arg521Gly (c.1561C>G); ClinVar=VCV000016222; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36965406).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36965406
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   UCSFi001-A-74
AC   CVCL_D0NK
SY   FUS-P525L HET 2D1; LSUHSi004-A-74
DR   BioSamples; SAMEA112670807
DR   hPSCreg; UCSFi001-A-74
DR   Wikidata; Q123033686
RX   PubMed=37116345;
CC   From: LSU Health Sciences Center in Shreveport; Shreveport; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Pro525Leu (c.1574C>T); ClinVar=VCV000280110; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37116345).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=37116345
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   UCSFi001-A-75
AC   CVCL_D0NL
SY   FUS-P525L HOM 2D2; LSUHSi004-A-75
DR   BioSamples; SAMEA112670813
DR   hPSCreg; UCSFi001-A-75
DR   Wikidata; Q123033687
RX   PubMed=37116345;
CC   From: LSU Health Sciences Center in Shreveport; Shreveport; USA.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Pro525Leu (c.1574C>T); ClinVar=VCV000280110; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37116345).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=37116345
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,10
ST   D18S51: 12,21
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 10,12
ST   D8S1179: 11,13
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,15
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   UCSFi001-A-78
AC   CVCL_E4G4
SY   WTC11-KL-GFP; CMCi014-A-78
DR   BioSamples; SAMEA115128015
DR   hPSCreg; UCSFi001-A-78
RX   PubMed=39111000;
CC   From: The Catholic University of Korea; Seoul; South Korea.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR-Cas9 a P2A-GFP-IRES-HygR construct was integrated at the 3'UTR region of KLOTHO (PubMed=39111000).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UCSFi001-A-79
AC   CVCL_E6IL
SY   MSE2336A; WTC11-AAVS1-GCaMP6-C1; ISMMSi059-A-79
DR   BioSamples; SAMEA115658882
DR   hPSCreg; UCSFi001-A-79
RX   PubMed=38896969;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 a IRES-Neo-UCOE-CAGp-GCamP6s construct was introduced in the AAVS1 safe harbor locus (PubMed=38896969).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; -; GCaMP6s (Note=Green fluorescent calcium sensor).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   UCSFi002-A
AC   CVCL_E8WP
DR   BioSamples; SAMEA116084039
DR   hPSCreg; UCSFi002-A
RX   PubMed=39662461;
CC   From: Icahn School of Medicine at Mount Sinai; New York; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous (PubMed=39662461).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UCSFi002-A-1
AC   CVCL_E8WQ
SY   UKBi024-A-1
DR   BioSamples; SAMEA116132044
DR   hPSCreg; UCSFi002-A-1
RX   PubMed=39662461;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_corrected; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39662461).
CC   Omics: Variations; SNP array analysis.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8WP ! UCSFi002-A
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UCT-Br 1
AC   CVCL_B1D6
SY   UCT-BR-1; UCT Br-1; UCT Br 1; University of Cape Town-Breast carcinoma cell line 1
DR   Wikidata; Q123033688
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00745;
RX   CelloPub=CLPUB00746;
CC   Doubling time: ~60 hours (CelloPub=CLPUB00745).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UCT-Ca 2
AC   CVCL_A0LD
SY   UCT-CA-2; UCT-Ca-2; University of Cape Town-Carcinoma cell line 2
DR   Wikidata; Q123033689
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00745;
CC   Doubling time: 24 hours (CelloPub=CLPUB00745).
CC   Donor information: Established from a secondary carcinoma in bone where the primary site is unknown.
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
DI   NCIt; C3262; Neoplasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UCT-Gli 1
AC   CVCL_A8SN
SY   UCT Gli-1; University of Cape Town-Glioblastoma cell line 1
DR   Wikidata; Q123033691
RX   CelloPub=CLPUB00744;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UCT-Mel 1
AC   CVCL_T304
SY   UCT Mel-1; University of Cape Town-Melanoma cell line 1
DR   Wikidata; Q54990066
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=3091056;
RX   PubMed=6814752;
CC   Population: Caucasian.
CC   Characteristics: Pigmented.
CC   Doubling time: 41 hours (Note=In RPMI 1640 + 10% FBS), 42 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Right inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   UCT-Mel 2
AC   CVCL_T305
SY   UCT Mel-2; University of Cape Town-Melanoma cell line 2
DR   Wikidata; Q54990067
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=3091056;
RX   PubMed=6814752;
CC   Population: Caucasian.
CC   Characteristics: Pigmented.
CC   Doubling time: 50 hours (Note=In RPMI 1640 + 10% FBS), 70 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   UCT-Mel 3
AC   CVCL_T306
SY   UCT Mel-3; University of Cape Town-Melanoma cell line 3
DR   Wikidata; Q54990068
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=3091056;
RX   PubMed=3335422;
CC   Population: Caucasian.
CC   Doubling time: 50 hours (Note=In RPMI 1640 + 10% FBS), 50 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   UCT-Mel 4a
AC   CVCL_T307
SY   UCT Mel-4a; UCT-Mel 4; UCT Mel-4; University of Cape Town-Melanoma cell line 4a
DR   Wikidata; Q54990069
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=3091056;
CC   Population: Caucasian.
CC   Doubling time: 52 hours (Note=In RPMI 1640 + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9C6 ! UCT-Mel 4b
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 12
//
ID   UCT-Mel 4b
AC   CVCL_C9C6
SY   UCT Mel-4b; University of Cape Town-Melanoma cell line 4b
DR   Wikidata; Q123033692
RX   CelloPub=CLPUB00744;
CC   Population: Caucasian.
CC   Doubling time: 54 hours (Note=In RPMI 1640 + 10% FBS), 83 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744).
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_T307 ! UCT-Mel 4a
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UCT-Mel 5
AC   CVCL_T308
SY   UCT Mel-5; University of Cape Town-Melanoma cell line 5
DR   Wikidata; Q54990070
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=3091056;
CC   Population: Caucasian.
CC   Doubling time: 58 hours (Note=In RPMI 1640 + 10% FBS), 58 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   UCT-Mel 6
AC   CVCL_T309
SY   UCT Mel-6; University of Cape Town-Melanoma cell line 6
DR   Wikidata; Q54990071
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=3091056;
CC   Population: Caucasian.
CC   Doubling time: 33 hours (Note=In RPMI 1640 + 10% FBS), 74 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   UCT-Mel 7
AC   CVCL_T310
SY   UCT Mel-7; UCT-Mel-7; University of Cape Town-Melanoma cell line 7
DR   Wikidata; Q54990072
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00747;
RX   PubMed=1562456;
RX   PubMed=3091056;
CC   Population: African.
CC   Doubling time: 95 hours (Note=In RPMI 1640 + 10% FBS), 119 hours (Note=In DMEM + 10% FBS) (CelloPub=CLPUB00744; PubMed=3091056).
CC   Derived from site: Metastatic; Left femoral lymph node; UBERON=UBERON_0009006.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 14
//
ID   UCT-Sq 1
AC   CVCL_A0LE
SY   UCT-SQ-1; UCT-Sq-1; University of Cape Town-SQuamous carcinoma cell line 1
DR   Wikidata; Q123033693
RX   CelloPub=CLPUB00744;
RX   CelloPub=CLPUB00745;
CC   Donor information: Established from a metastasis of a carcinoma of the lip.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   UCT0018
AC   CVCL_B4UM
DR   GEO; GSM431834
DR   Wikidata; Q110433824
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UL ! UCB0018
OI   CVCL_B4PC ! UCF0018
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0019
AC   CVCL_B4UP
DR   GEO; GSM431835
DR   Wikidata; Q110433825
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UN ! UCB0019
OI   CVCL_B4PD ! UCF0019
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0024
AC   CVCL_B4UR
DR   GEO; GSM431836
DR   Wikidata; Q110433826
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UQ ! UCB0024
OI   CVCL_B4PG ! UCF0024
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0025
AC   CVCL_B4UT
DR   GEO; GSM431837
DR   Wikidata; Q110433827
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4US ! UCB0025
OI   CVCL_B4PH ! UCF0025
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0034
AC   CVCL_B4UV
DR   GEO; GSM431838
DR   Wikidata; Q110433829
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UU ! UCB0034
OI   CVCL_B4PM ! UCF0034
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0041
AC   CVCL_B4UY
DR   GEO; GSM431839
DR   Wikidata; Q110433830
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UW ! UCB0041
OI   CVCL_B4UX ! UCF0041
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0042
AC   CVCL_B4V0
DR   GEO; GSM431840
DR   Wikidata; Q110433832
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4UZ ! UCB0042
OI   CVCL_B4PQ ! UCF0042
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0045
AC   CVCL_B4V3
DR   GEO; GSM431841
DR   Wikidata; Q110433833
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V1 ! UCB0045
OI   CVCL_B4V2 ! UCF0045
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0048
AC   CVCL_B4V5
DR   GEO; GSM431842
DR   Wikidata; Q110433834
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V4 ! UCB0048
OI   CVCL_B4PT ! UCF0048
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0049
AC   CVCL_B4V7
DR   GEO; GSM431843
DR   Wikidata; Q110433835
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V6 ! UCB0049
OI   CVCL_B4PU ! UCF0049
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0050
AC   CVCL_B4VA
DR   GEO; GSM431844
DR   Wikidata; Q110433836
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4V8 ! UCB0050
OI   CVCL_B4V9 ! UCF0050
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0051
AC   CVCL_B4VC
DR   GEO; GSM431845
DR   Wikidata; Q110433837
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VB ! UCB0051
OI   CVCL_B4PV ! UCF0051
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0055
AC   CVCL_B4VF
DR   GEO; GSM431846
DR   Wikidata; Q110433838
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VD ! UCB0055
OI   CVCL_B4VE ! UCF0055
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0060
AC   CVCL_B4VH
DR   GEO; GSM431847
DR   Wikidata; Q110433839
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VG ! UCB0060
OI   CVCL_B4Q0 ! UCF0060
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0062
AC   CVCL_B4VJ
DR   GEO; GSM431848
DR   Wikidata; Q110433841
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VI ! UCB0062
OI   CVCL_B4Q1 ! UCF0062
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0070
AC   CVCL_B4VL
DR   GEO; GSM431849
DR   Wikidata; Q110433842
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VK ! UCB0070
OI   CVCL_B4Q3 ! UCF0070
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0078
AC   CVCL_B4VN
DR   GEO; GSM431850
DR   Wikidata; Q110433843
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VM ! UCB0078
OI   CVCL_B4Q5 ! UCF0078
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0079
AC   CVCL_B4VQ
DR   GEO; GSM431851
DR   Wikidata; Q110433844
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VP ! UCB0079
OI   CVCL_B4Q6 ! UCF0079
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0081
AC   CVCL_B4VT
DR   GEO; GSM431852
DR   Wikidata; Q110433846
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VR ! UCB0081
OI   CVCL_B4VS ! UCF0081
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0083
AC   CVCL_B4VV
DR   GEO; GSM431853
DR   Wikidata; Q110433847
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VU ! UCB0083
OI   CVCL_B4Q8 ! UCF0083
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0086
AC   CVCL_B4VX
DR   GEO; GSM431854
DR   Wikidata; Q110433848
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VW ! UCB0086
OI   CVCL_B4QA ! UCF0086
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0087
AC   CVCL_B4VZ
DR   GEO; GSM431855
DR   Wikidata; Q110433849
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4VY ! UCB0087
OI   CVCL_B4QB ! UCF0087
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0088
AC   CVCL_B4W1
DR   GEO; GSM431856
DR   Wikidata; Q110433850
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W0 ! UCB0088
OI   CVCL_B4QC ! UCF0088
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0093
AC   CVCL_B4W3
DR   GEO; GSM431857
DR   Wikidata; Q110433852
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W2 ! UCB0093
OI   CVCL_B4QG ! UCF0093
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0094
AC   CVCL_B4W6
DR   GEO; GSM431858
DR   Wikidata; Q110433853
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W4 ! UCB0094
OI   CVCL_B4W5 ! UCF0094
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0095
AC   CVCL_B4W8
DR   GEO; GSM431859
DR   Wikidata; Q110433855
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W7 ! UCB0095
OI   CVCL_B4QH ! UCF0095
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0097
AC   CVCL_B4WA
DR   GEO; GSM431860
DR   Wikidata; Q110433857
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4W9 ! UCB0097
OI   CVCL_B4QI ! UCF0097
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0100
AC   CVCL_B4WC
DR   GEO; GSM431775
DR   Wikidata; Q110433858
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WB ! UCB0100
OI   CVCL_B4QL ! UCF0100
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0103
AC   CVCL_B4WE
DR   GEO; GSM431862
DR   Wikidata; Q110433859
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WD ! UCB0103
OI   CVCL_B4QP ! UCF0103
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0105
AC   CVCL_B4WG
DR   GEO; GSM431863
DR   Wikidata; Q110433860
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WF ! UCB0105
OI   CVCL_B4QQ ! UCF0105
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0108
AC   CVCL_B4WI
DR   GEO; GSM431864
DR   Wikidata; Q110433861
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WH ! UCB0108
OI   CVCL_B4QS ! UCF0108
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0110
AC   CVCL_B4WK
DR   GEO; GSM431865
DR   Wikidata; Q110433863
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WJ ! UCB0110
OI   CVCL_B4QT ! UCF0110
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0112
AC   CVCL_B4WM
DR   GEO; GSM431866
DR   Wikidata; Q110433864
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WL ! UCB0112
OI   CVCL_B4QU ! UCF0112
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0113
AC   CVCL_B4WP
DR   GEO; GSM431867
DR   Wikidata; Q110433865
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WN ! UCB0113
OI   CVCL_B4QV ! UCF0113
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0114
AC   CVCL_B4WR
DR   GEO; GSM431868
DR   Wikidata; Q110433866
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WQ ! UCB0114
OI   CVCL_B4QW ! UCF0114
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0115
AC   CVCL_B4WT
DR   GEO; GSM431869
DR   Wikidata; Q110433867
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WS ! UCB0115
OI   CVCL_B4QX ! UCF0115
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0116
AC   CVCL_B4WV
DR   GEO; GSM431870
DR   Wikidata; Q110433868
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WU ! UCB0116
OI   CVCL_B4QY ! UCF0116
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0117
AC   CVCL_B4WX
DR   GEO; GSM431871
DR   Wikidata; Q110433870
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WW ! UCB0117
OI   CVCL_B4QZ ! UCF0117
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0119
AC   CVCL_B4WZ
DR   GEO; GSM431872
DR   Wikidata; Q110433871
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4WY ! UCB0119
OI   CVCL_B4R0 ! UCF0119
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0121
AC   CVCL_B4X1
DR   GEO; GSM431873
DR   Wikidata; Q110433873
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X0 ! UCB0121
OI   CVCL_B4R2 ! UCF0121
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0122
AC   CVCL_B4X3
DR   GEO; GSM431874
DR   Wikidata; Q110433874
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X2 ! UCB0122
OI   CVCL_B4R3 ! UCF0122
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0124
AC   CVCL_B4X5
DR   GEO; GSM431875
DR   Wikidata; Q110433875
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X4 ! UCB0124
OI   CVCL_B4R5 ! UCF0124
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0125
AC   CVCL_B4X7
DR   GEO; GSM431876
DR   Wikidata; Q110433876
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X6 ! UCB0125
OI   CVCL_B4R6 ! UCF0125
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0128
AC   CVCL_B4X9
DR   GEO; GSM431877
DR   Wikidata; Q110433877
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4X8 ! UCB0128
OI   CVCL_B4R7 ! UCF0128
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0130
AC   CVCL_B4XB
DR   GEO; GSM431878
DR   Wikidata; Q110433878
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XA ! UCB0130
OI   CVCL_B4R9 ! UCF0130
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0137
AC   CVCL_B4XD
DR   GEO; GSM431879
DR   Wikidata; Q110433879
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XC ! UCB0137
OI   CVCL_B4RE ! UCF0137
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0139
AC   CVCL_B4XF
DR   GEO; GSM431880
DR   Wikidata; Q110433880
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XE ! UCB0139
OI   CVCL_B4RG ! UCF0139
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0140
AC   CVCL_B4XH
DR   GEO; GSM431881
DR   Wikidata; Q110433882
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XG ! UCB0140
OI   CVCL_B4RH ! UCF0140
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0141
AC   CVCL_B4XJ
DR   GEO; GSM431882
DR   Wikidata; Q110433884
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XI ! UCB0141
OI   CVCL_B4RI ! UCF0141
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0144
AC   CVCL_B4XL
DR   GEO; GSM431883
DR   Wikidata; Q110433885
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XK ! UCB0144
OI   CVCL_B4RK ! UCF0144
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0152
AC   CVCL_B4XN
DR   GEO; GSM431884
DR   Wikidata; Q110433887
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XM ! UCB0152
OI   CVCL_B4RP ! UCF0152
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0155
AC   CVCL_B4XQ
DR   GEO; GSM431885
DR   Wikidata; Q110433888
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XP ! UCB0155
OI   CVCL_B4RR ! UCF0155
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0164
AC   CVCL_B4XS
DR   GEO; GSM431886
DR   Wikidata; Q110433889
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XR ! UCB0164
OI   CVCL_B4RU ! UCF0164
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0167
AC   CVCL_B4XU
DR   GEO; GSM431887
DR   Wikidata; Q110433890
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XT ! UCB0167
OI   CVCL_B4RW ! UCF0167
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0169
AC   CVCL_B4XW
DR   GEO; GSM431888
DR   Wikidata; Q110433891
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XV ! UCB0169
OI   CVCL_B4RY ! UCF0169
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0172
AC   CVCL_B4XZ
DR   GEO; GSM431889
DR   Wikidata; Q110433893
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4XX ! UCB0172
OI   CVCL_B4XY ! UCF0172
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0176
AC   CVCL_B4Y1
DR   GEO; GSM431890
DR   Wikidata; Q110433894
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y0 ! UCB0176
OI   CVCL_B4S1 ! UCF0176
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0177
AC   CVCL_B4Y3
DR   GEO; GSM431891
DR   Wikidata; Q110433897
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y2 ! UCB0177
OI   CVCL_B4S2 ! UCF0177
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0180
AC   CVCL_B4Y5
DR   GEO; GSM431892
DR   Wikidata; Q110433899
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y4 ! UCB0180
OI   CVCL_B4S3 ! UCF0180
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0181
AC   CVCL_B4Y7
DR   GEO; GSM431893
DR   Wikidata; Q110433900
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y6 ! UCB0181
OI   CVCL_B4S4 ! UCF0181
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0183
AC   CVCL_B4Y9
DR   GEO; GSM431894
DR   Wikidata; Q110433901
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Y8 ! UCB0183
OI   CVCL_B4S5 ! UCF0183
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0187
AC   CVCL_B4YB
DR   GEO; GSM431895
DR   Wikidata; Q110433902
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YA ! UCB0187
OI   CVCL_B4S7 ! UCF0187
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0188
AC   CVCL_B4YD
DR   GEO; GSM431896
DR   Wikidata; Q110433903
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YC ! UCB0188
OI   CVCL_B4S8 ! UCF0188
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0217
AC   CVCL_B4YF
DR   GEO; GSM431897
DR   Wikidata; Q110433905
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YE ! UCB0217
OI   CVCL_B4SN ! UCF0217
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0218
AC   CVCL_B4YH
DR   GEO; GSM431898
DR   Wikidata; Q110433907
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YG ! UCB0218
OI   CVCL_B4SP ! UCF0218
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0223
AC   CVCL_B4YJ
DR   GEO; GSM431899
DR   Wikidata; Q110433909
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YI ! UCB0223
OI   CVCL_B4SS ! UCF0223
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0225
AC   CVCL_B4YL
DR   GEO; GSM431900
DR   Wikidata; Q110433910
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YK ! UCB0225
OI   CVCL_B4ST ! UCF0225
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0226
AC   CVCL_B4YN
DR   GEO; GSM431901
DR   Wikidata; Q110433911
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YM ! UCB0226
OI   CVCL_B4SU ! UCF0226
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0227
AC   CVCL_B4YQ
DR   GEO; GSM431902
DR   Wikidata; Q110433912
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YP ! UCB0227
OI   CVCL_B4SV ! UCF0227
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0228
AC   CVCL_B4YS
DR   GEO; GSM431903
DR   Wikidata; Q110433913
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YR ! UCB0228
OI   CVCL_B4SW ! UCF0228
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0234
AC   CVCL_B4YU
DR   GEO; GSM431904
DR   Wikidata; Q110433914
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YT ! UCB0234
OI   CVCL_B4SZ ! UCF0234
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0243
AC   CVCL_B4YW
DR   GEO; GSM431905
DR   Wikidata; Q110433916
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YV ! UCB0243
OI   CVCL_B4T4 ! UCF0243
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0251
AC   CVCL_B4YY
DR   GEO; GSM431906
DR   Wikidata; Q110433917
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YX ! UCB0251
OI   CVCL_B4TB ! UCF0251
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0253
AC   CVCL_B4Z0
DR   GEO; GSM431907
DR   Wikidata; Q110433918
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4YZ ! UCB0253
OI   CVCL_B4TD ! UCF0253
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0255
AC   CVCL_B4Z2
DR   GEO; GSM431908
DR   Wikidata; Q110433919
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z1 ! UCB0255
OI   CVCL_B4TF ! UCF0255
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0270
AC   CVCL_B4Z4
DR   GEO; GSM431909
DR   Wikidata; Q110433920
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z3 ! UCB0270
OI   CVCL_B4TM ! UCF0270
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0271
AC   CVCL_B4Z6
DR   GEO; GSM431910
DR   Wikidata; Q110433921
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z5 ! UCB0271
OI   CVCL_B4TN ! UCF0271
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0276
AC   CVCL_B4Z8
DR   GEO; GSM431911
DR   Wikidata; Q110433922
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z7 ! UCB0276
OI   CVCL_B4TS ! UCF0276
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0277
AC   CVCL_B4ZA
DR   GEO; GSM431912
DR   Wikidata; Q110433923
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4Z9 ! UCB0277
OI   CVCL_B4TT ! UCF0277
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0282
AC   CVCL_B4ZC
DR   GEO; GSM431913
DR   Wikidata; Q110433924
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZB ! UCB0282
OI   CVCL_B4TW ! UCF0282
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0284
AC   CVCL_B4ZE
DR   GEO; GSM431914
DR   Wikidata; Q110433928
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZD ! UCB0284
OI   CVCL_B4TY ! UCF0284
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0285
AC   CVCL_B4ZG
DR   GEO; GSM431915
DR   Wikidata; Q110433929
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZF ! UCB0285
OI   CVCL_B4UB ! UCF0285
SX   Male
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0295
AC   CVCL_B4ZI
DR   GEO; GSM431916
DR   Wikidata; Q110433930
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZH ! UCB0295
OI   CVCL_B4U5 ! UCF0295
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0304
AC   CVCL_B4ZK
DR   GEO; GSM431917
DR   Wikidata; Q110433931
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZJ ! UCB0304
OI   CVCL_B4U9 ! UCF0304
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCT0313
AC   CVCL_B4ZN
DR   GEO; GSM431918
DR   Wikidata; Q110433932
RX   PubMed=19644074;
CC   Part of: GenCord collection.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4ZL ! UCB0313
OI   CVCL_B4ZM ! UCF0313
SX   Female
AG   <1D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   UCVA-1
AC   CVCL_1G10
SY   UCVA
DR   Wikidata; Q54990073
RX   PubMed=6092175;
RX   PubMed=6401685;
CC   Population: Japanese.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 8
//
ID   UCW 10
AC   CVCL_0F82
DR   Wikidata; Q54990074
RX   PubMed=6965094;
RX   PubMed=7193212;
RX   PubMed=7444715;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0F81 ! CHO-tsH1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 11
//
ID   UCW 113
AC   CVCL_5T99
DR   Wikidata; Q54990075
RX   PubMed=6965094;
RX   PubMed=7193212;
RX   PubMed=7444715;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   UCW 124
AC   CVCL_5U00
DR   Wikidata; Q54990097
RX   PubMed=6965094;
RX   PubMed=7444715;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5T99 ! UCW 113
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   UCW 181
AC   CVCL_5U01
DR   Wikidata; Q54990098
RX   PubMed=6965094;
RX   PubMed=7444715;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5U00 ! UCW 124
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   UCW 206
AC   CVCL_0F85
SY   UCW206; Asn-5; lys 65a; CHO lys 65a
DR   Wikidata; Q54990099
RX   PubMed=618867;
RX   PubMed=6836455;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0213 ! CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 8
//
ID   UCW 282
AC   CVCL_5U02
SY   UCW-282
DR   Wikidata; Q54990101
RX   PubMed=6965094;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_L858 ! B14-150
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   UCW 296
AC   CVCL_5U03
DR   Wikidata; Q54990103
RX   PubMed=6965094;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_L858 ! B14-150
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   UCW 56
AC   CVCL_0F83
SY   UCW56
DR   Wikidata; Q54990104
RX   PubMed=7193212;
RX   PubMed=9732752;
CC   Selected for resistance to: ChEBI; CHEBI_4781; Emetine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0F82 ! UCW 10
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   UD-PTC
AC   CVCL_W337
DR   Wikidata; Q54990105
RX   PubMed=24567186;
CC   Population: Japanese.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   UD-SCC-1
AC   CVCL_E324
SY   UD-SCC 1; UD-SCC1; UDSCC1; University of Dusseldorf-Squamous Cell Carcinoma-1
DR   Cosmic; 932281
DR   Wikidata; Q54990106
RX   PubMed=10628319;
RX   PubMed=15495191;
RX   PubMed=16331601;
RX   PubMed=18487078;
RX   PubMed=26045983;
CC   Doubling time: 32.5 hours (PubMed=10628319).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu26Profs*10 (c.75delA); Zygosity=Unspecified (PubMed=10628319; PubMed=18487078).
CC   Derived from site: In situ; Pharynx, oropharynx; UBERON=UBERON_0001729.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   UD-SCC-2
AC   CVCL_E325
SY   UD-SCC 2; UD-SCC2; UDSCC-2; UDSCC2; University of Dusseldorf-Squamous Cell Carcinoma-2
DR   cancercelllines; CVCL_E325
DR   Cell_Model_Passport; SIDM00025
DR   Cosmic; 932282
DR   Cosmic; 2296311
DR   Cosmic-CLP; 1299073
DR   DepMap; ACH-002391
DR   GDSC; 1299073
DR   GEO; GSM3631261
DR   PharmacoDB; UDSCC2_1638_2019
DR   Progenetix; CVCL_E325
DR   Wikidata; Q54990107
RX   PubMed=10628319;
RX   PubMed=15495191;
RX   PubMed=16331601;
RX   PubMed=18487078;
RX   PubMed=20215515;
RX   PubMed=24201445;
RX   PubMed=25275298;
RX   PubMed=28236344;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=31541927;
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/24336/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   Virology: Contains from 14 to 23 copies of the HPV16 genome (PubMed=24201445).
CC   Doubling time: 42 hours (PubMed=10628319); 4.1 days (PubMed=29156801).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg5154Gln (c.15461G>A); ClinVar=VCV000286834; Zygosity=Homozygous (PubMed=31541927).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.2%; Native American=0%; East Asian, North=4%; East Asian, South=0%; South Asian=0%; European, North=57.49%; European, South=35.31% (PubMed=30894373).
ST   Source(s): PubMed=25275298; PubMed=29156801
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D21S11: 30,31.2
ST   D3S1358: 14,16
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 20,27
ST   Penta D: 9,13
ST   Penta E: 10
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   UD-SCC-3
AC   CVCL_E326
SY   UD-SCC 3; UD-SCC3; University of Dusseldorf-Squamous Cell Carcinoma-3
DR   Cosmic; 932283
DR   Wikidata; Q54990108
RX   PubMed=10628319;
RX   PubMed=15495191;
RX   PubMed=16331601;
RX   PubMed=18487078;
CC   Doubling time: 31 hours (PubMed=10628319; PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Ter (c.670G>T); Zygosity=Unspecified (PubMed=10628319).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
ID   UD-SCC-4
AC   CVCL_E327
SY   UD-SCC 4; UD-SCC4; University of Dusseldorf-Squamous Cell Carcinoma-4
DR   Cosmic; 932284
DR   Wikidata; Q54990109
RX   PubMed=10628319;
RX   PubMed=15495191;
RX   PubMed=16331601;
RX   PubMed=18487078;
CC   Doubling time: 36 hours (PubMed=10628319).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.449del13; Zygosity=Unspecified (PubMed=10628319; PubMed=18487078).
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 12
//
ID   UD-SCC-5
AC   CVCL_L548
SY   UD-SCC 5; UD-SCC5; University of Dusseldorf-Squamous Cell Carcinoma-5
DR   cancercelllines; CVCL_L548
DR   Cosmic; 932285
DR   Wikidata; Q54990110
RX   PubMed=15495191;
RX   PubMed=18487078;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=18487078).
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   UD-SCC-6
AC   CVCL_M120
SY   UD-SCC 6; UD-SCC6; University of Dusseldorf-Squamous Cell Carcinoma-6
DR   cancercelllines; CVCL_M120
DR   Wikidata; Q54990111
RX   PubMed=16331601;
RX   PubMed=18487078;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=18487078).
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   UD-SCC-7A
AC   CVCL_M118
SY   UD-SCC 7A; UD-SCC7A; UD-SCC7a; University of Dusseldorf-Squamous Cell Carcinoma-7A
DR   cancercelllines; CVCL_M118
DR   Wikidata; Q54990112
RX   PubMed=16331601;
RX   PubMed=18487078;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=18487078).
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M119 ! UD-SCC-7B
OI   CVCL_YD75 ! UD-SCC-7C
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   UD-SCC-7B
AC   CVCL_M119
SY   UD-SCC 7B; UD-SCC7B; University of Dusseldorf-Squamous Cell Carcinoma-7B
DR   cancercelllines; CVCL_M119
DR   Cosmic; 932286
DR   Wikidata; Q54990113
RX   PubMed=15495191;
RX   PubMed=18487078;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=18487078).
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M118 ! UD-SCC-7A
OI   CVCL_YD75 ! UD-SCC-7C
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 11
//
ID   UD-SCC-7C
AC   CVCL_YD75
SY   UD-SCC 7C; University of Dusseldorf-Squamous Cell Carcinoma-7C
DR   cancercelllines; CVCL_YD75
DR   Wikidata; Q98133862
RX   PubMed=18487078;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Leu (c.743G>T); ClinVar=VCV000230253; Zygosity=Unspecified (PubMed=18487078).
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M118 ! UD-SCC-7A
OI   CVCL_M119 ! UD-SCC-7B
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UD-SCC-8
AC   CVCL_YD74
SY   UD-SCC 8; University of Dusseldorf-Squamous Cell Carcinoma-8
DR   cancercelllines; CVCL_YD74
DR   Wikidata; Q98133864
RX   PubMed=16331601;
RX   PubMed=18487078;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Unspecified (PubMed=18487078).
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UD3.E5
AC   CVCL_F0L1
RX   PubMed=3866115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UE1
AC   CVCL_C4KH
DR   Wikidata; Q116050672
RX   PubMed=9358279;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UE2
AC   CVCL_C4KI
DR   Wikidata; Q116050673
RX   PubMed=9358279;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UE6E7-16
AC   CVCL_3233
SY   UEE-16
DR   CLO; CLO_0051559
DR   JCRB; JCRB1160
DR   JCRB; NIHS0457
DR   RCB; RCB2163
DR   SKIP; SKIP000725
DR   Wikidata; Q54990114
RX   PubMed=15923633;
RX   PubMed=38639832;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0457; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1160; RCB=RCB2163
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 18
//
ID   UE6E7T-1
AC   CVCL_8306
SY   UEET-1; Th-1; ThMSC1
DR   JCRB; JCRB1131
DR   JCRB; NIHS0446
DR   SKIP; SKIP000710
DR   Wikidata; Q54990116
RX   PubMed=15293342;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0446; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1131
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   UE6E7T-11
AC   CVCL_3234
AS   CVCL_4070
SY   UEET-11
DR   CLO; CLO_0051555
DR   JCRB; JCRB1149
DR   JCRB; NIHS0453
DR   RCB; RCB2159
DR   SKIP; SKIP000717
DR   Wikidata; Q54990117
RX   PubMed=15293342;
RX   PubMed=15923633;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0453; true.
CC   Discontinued: RCB; RCB2159; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1149; RCB=RCB2159
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   UE6E7T-12
AC   CVCL_3235
AS   CVCL_4071
SY   UEET-12
DR   CLO; CLO_0051557
DR   JCRB; JCRB1151
DR   JCRB; NIHS0454
DR   RCB; RCB2160
DR   SKIP; SKIP000718
DR   Wikidata; Q54990119
RX   PubMed=15923633;
RX   PubMed=21155951;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0454; true.
CC   Discontinued: RCB; RCB2160; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1151; RCB=RCB2160
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 24
//
ID   UE6E7T-2
AC   CVCL_3236
SY   UEET-2; Th-2
DR   CLO; CLO_0051550
DR   cancercelllines; CVCL_3236
DR   GEO; GSM827241
DR   JCRB; JCRB1133
DR   JCRB; NIHS0447
DR   Progenetix; CVCL_3236
DR   RCB; RCB2153
DR   SKIP; SKIP000711
DR   Wikidata; Q54990122
RX   PubMed=20215515;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; NIHS0447; true.
CC   Discontinued: RCB; RCB2153; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1133; RCB=RCB2153
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11 (JCRB=JCRB1133)
ST   TPOX: 11 (RCB=RCB2153)
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   UE6E7T-3
AC   CVCL_3237
SY   UEET-3; Th-3; ThMSC3
DR   CLO; CLO_0051551
DR   ArrayExpress; E-MTAB-3610
DR   Cell_Model_Passport; SIDM00024
DR   JCRB; JCRB1136
DR   JCRB; NIHS0448
DR   PharmacoDB; UE6E7T3_1639_2019
DR   RCB; RCB2154
DR   SKIP; SKIP000712
DR   Wikidata; Q54990123
RX   PubMed=25978455;
CC   Population: Japanese and Korean.
CC   Doubling time: 40 hours (PubMed=25978455).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: JCRB; NIHS0448; true.
CC   Discontinued: RCB; RCB2154; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1136; RCB=RCB2154
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   UE6E7TC-4
AC   CVCL_8307
SY   UEETC-4; TdHC1
DR   BioSample; SAMN03472383
DR   JCRB; JCRB1137
DR   JCRB; NIHS0449
DR   SKIP; SKIP000713
DR   Wikidata; Q54990124
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0449; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1137
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 22
//
ID   UE7T-13
AC   CVCL_3238
SY   UET-13
DR   CLO; CLO_0051556
DR   JCRB; JCRB1154
DR   JCRB; NIHS0455
DR   RCB; RCB2161
DR   SKIP; SKIP000719
DR   Wikidata; Q54990125
RX   PubMed=15293342;
RX   PubMed=15923633;
RX   PubMed=21155951;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0455; true.
CC   Discontinued: RCB; RCB2161; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1154; RCB=RCB2161
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   UE7T-9
AC   CVCL_3239
SY   UET-9
DR   CLO; CLO_0051554
DR   JCRB; JCRB1147
DR   JCRB; NIHS0452
DR   RCB; RCB2158
DR   SKIP; SKIP000716
DR   Wikidata; Q54990127
RX   PubMed=15923633;
CC   Population: Japanese and Korean.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Discontinued: JCRB; NIHS0452; true.
CC   Discontinued: RCB; RCB2158; probable.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
ST   Source(s): JCRB=JCRB1147; RCB=RCB2158
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6F32 ! H4-1 [Human bone marrow]
SX   Female
AG   91Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   UE8
AC   CVCL_5T89
DR   Wikidata; Q54990128
RX   DOI=10.2108/zsj.15.277;
RX   PubMed=9358279;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   UE9
AC   CVCL_C4KJ
DR   Wikidata; Q116050674
RX   PubMed=9358279;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UEC-4
AC   CVCL_D808
SY   Utricular Epithelial Cell line-4
DR   Wikidata; Q54990129
RX   PubMed=9557974;
RX   PubMed=12382283;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Ear, utricular macula; UBERON=UBERON_0002214.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   3-4D
CA   Conditionally immortalized cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   UEFi001-A
AC   CVCL_VK75
SY   MADGIC 4A
DR   hPSCreg; UEFi001-A
DR   Wikidata; Q98133866
RX   PubMed=29807259;
CC   From: University of Eastern Finland; Kuopio; Finland.
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Ala673Thr (c.2017G>A); ClinVar=VCV000037145; Zygosity=Heterozygous (PubMed=29807259).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   UEFi002-A
AC   CVCL_VN60
SY   LL008 1.4
DR   hPSCreg; UEFi002-A
DR   Wikidata; Q98133867
RX   PubMed=30099334;
CC   From: University of Eastern Finland; Kuopio; Finland.
CC   Population: Caucasian; Scandinavian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Lys670_Met671delinsAsnLeu (c.2010_2011inv) (c.2010_2011delGAinsTC); ClinVar=VCV000018093; Zygosity=Heterozygous (PubMed=30099334).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   UEFi003-A
AC   CVCL_A9QA
SY   MADGIC 12B
DR   hPSCreg; UEFi003-A
DR   Wikidata; Q102115053
RX   PubMed=32911327;
CC   From: University of Eastern Finland; Kuopio; Finland.
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Ala673Thr (c.2017G>A); ClinVar=VCV000037145; Zygosity=Heterozygous (PubMed=32911327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UEFi004-A
AC   CVCL_D0N4
SY   EPM1-49
DR   BioSamples; SAMEA114492943
DR   hPSCreg; UEFi004-A
DR   Wikidata; Q123033694
RX   PubMed=37951142;
CC   From: University of Eastern Finland; Kuopio; Finland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Homozygous (PubMed=37951142).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179710; Myoclonic epilepsy of Unverricht and Lundborg
DI   ORDO; Orphanet_308; Unverricht-Lundborg disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UF-1
AC   CVCL_0567
DR   MCCL; MCC:0000472
DR   cancercelllines; CVCL_0567
DR   Cosmic; 787485
DR   Cosmic; 975309
DR   Cosmic; 1281359
DR   Wikidata; Q54990130
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8781440;
RX   PubMed=11438209;
RX   PubMed=15234573;
RX   PubMed=36982453;
CC   Population: Japanese.
CC   Characteristics: Resistant to all-trans retinoic acid (ATRA).
CC   Doubling time: 72 hours (PubMed=8781440); 96 hours (PubMed=15234573).
CC   Sequence variation: Gene fusion; HGNC; HGNC:9113; PML + HGNC; HGNC:9864; RARA; Name(s)=PML-RARA (PubMed=8781440).
CC   Sequence variation: Mutation; HGNC; HGNC:9864; RARA; Simple; p.Arg276Trp (c.826C>T); ClinVar=VCV000191350; Zygosity=Unspecified; Note=Equivalent to p.Arg611Trp in the PML-RARA fusion protein (PubMed=11438209).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3182; Acute promyelocytic leukemia with PML-RARA
DI   ORDO; Orphanet_520; Acute promyelocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   UFCVM Alligator missippiensis mass
AC   CVCL_D5CF
DR   Wikidata; Q127384462
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8496; ! Alligator mississippiensis (American alligator)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Alligator sinensis heart
AC   CVCL_D5CI
DR   Wikidata; Q127384463
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=38654; ! Alligator sinensis (Chinese alligator)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Alligator sinensis lung
AC   CVCL_D5CJ
DR   Wikidata; Q127384464
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=38654; ! Alligator sinensis (Chinese alligator)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Alligator sinensis spleen
AC   CVCL_D5CK
DR   Wikidata; Q127384466
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=38654; ! Alligator sinensis (Chinese alligator)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Anolis equestris kidney
AC   CVCL_D5BZ
DR   Wikidata; Q127384468
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=75253; ! Anolis equestris (Knight anole)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Anolis sagrei kidney
AC   CVCL_D5BX
DR   Wikidata; Q127384469
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=38937; ! Anolis sagrei (Bahaman brown anole)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Anolis sagrei lung
AC   CVCL_D5BY
DR   Wikidata; Q127384470
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=38937; ! Anolis sagrei (Bahaman brown anole)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Apalone ferox lung
AC   CVCL_D5CD
DR   Wikidata; Q127384471
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=100213; ! Apalone ferox (Florida softshell turtle)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Boa imperator heart
AC   CVCL_D5BA
DR   Wikidata; Q127384473
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=401042; ! Boa imperator (Central American boa constrictor)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Boa imperator kidney
AC   CVCL_D5BB
DR   Wikidata; Q127384475
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=401042; ! Boa imperator (Central American boa constrictor)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Boa imperator lung
AC   CVCL_D5BC
DR   Wikidata; Q127384476
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=401042; ! Boa imperator (Central American boa constrictor)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Boa imperator spleen
AC   CVCL_D5BD
DR   Wikidata; Q127384479
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=401042; ! Boa imperator (Central American boa constrictor)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Boa imperator thymus
AC   CVCL_D5BE
DR   Wikidata; Q127384481
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
OX   NCBI_TaxID=401042; ! Boa imperator (Central American boa constrictor)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Bogertophis subocularis kidney
AC   CVCL_D5BW
DR   Wikidata; Q127384482
RX   PubMed=37374873;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=94906; ! Bogertophis subocularis (Trans-pecos rat snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   UFCVM Caiman latirostrus heart
AC   CVCL_D5CG
DR   Wikidata; Q127384485
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=190476; ! Caiman latirostris (Broad-snouted caiman)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Caiman latirostrus pancreas
AC   CVCL_D5CH
DR   Wikidata; Q127384486
RX   PubMed=37374873;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
OX   NCBI_TaxID=190476; ! Caiman latirostris (Broad-snouted caiman)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   UFCVM Chelonoidis niger heart
AC   CVCL_D5C3
DR   Wikidata; Q127384487
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=66189; ! Chelonoidis niger (Galapagos giant tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Chelonoidis niger liver
AC   CVCL_D5C4
DR   Wikidata; Q127384489
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=66189; ! Chelonoidis niger (Galapagos giant tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Chelonoidis niger lung
AC   CVCL_D5C5
DR   Wikidata; Q127384492
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=66189; ! Chelonoidis niger (Galapagos giant tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Chelonoidis niger spleen
AC   CVCL_D5C6
DR   Wikidata; Q127384495
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=66189; ! Chelonoidis niger (Galapagos giant tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Crocodylus porosus heart
AC   CVCL_D5CL
DR   Wikidata; Q127384498
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8502; ! Crocodylus porosus (Saltwater crocodile)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Crocodylus porosus lung
AC   CVCL_D5CM
DR   Wikidata; Q127384500
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=8502; ! Crocodylus porosus (Saltwater crocodile)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Crocodylus porosus skeletal muscle
AC   CVCL_D5CN
DR   Wikidata; Q127384502
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skeletal muscle; UBERON=UBERON_0001134.
OX   NCBI_TaxID=8502; ! Crocodylus porosus (Saltwater crocodile)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Crotalus durissus heart
AC   CVCL_D5BU
DR   Wikidata; Q127384504
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=184542; ! Crotalus durissus cumanensis (South American rattlesnake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Crotalus durissus spleen
AC   CVCL_D5BV
DR   Wikidata; Q127384506
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=184542; ! Crotalus durissus cumanensis (South American rattlesnake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Drymarchon corais lung
AC   CVCL_D5BR
DR   Wikidata; Q127384507
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=186583; ! Drymarchon corais (Indigo snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Drymarchon corais spleen
AC   CVCL_D5BS
DR   Wikidata; Q127384509
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=186583; ! Drymarchon corais (Indigo snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Eublepharis macularius chromatophoroma
AC   CVCL_D5C0
DR   Wikidata; Q127384511
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Dermal chromatophore; CL=CL_4040006.
OX   NCBI_TaxID=481883; ! Eublepharis macularius (Leopard gecko)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Eublepharis macularius lung
AC   CVCL_D5C1
DR   Wikidata; Q127384513
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=481883; ! Eublepharis macularius (Leopard gecko)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Eublepharis macularius spleen
AC   CVCL_D5C2
DR   Wikidata; Q127384515
RX   PubMed=37374873;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=481883; ! Eublepharis macularius (Leopard gecko)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   UFCVM Geochelone elegans spleen
AC   CVCL_D5CA
DR   Wikidata; Q127384517
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=180179; ! Geochelone elegans (Indian star tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Gopherus polyphemus heart
AC   CVCL_D5C7
DR   Wikidata; Q127384520
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=38773; ! Gopherus polyphemus (Gopher tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   UFCVM Gopherus polyphemus kidney
AC   CVCL_D5C8
DR   Wikidata; Q127384522
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=38773; ! Gopherus polyphemus (Gopher tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 4
//
ID   UFCVM Gopherus polyphemus spleen
AC   CVCL_D5C9
DR   Wikidata; Q127384525
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=38773; ! Gopherus polyphemus (Gopher tortoise)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Malaclemys terrapin kidney
AC   CVCL_D5CB
DR   Wikidata; Q127384527
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8485; ! Malaclemys terrapin (Diamondback terrapin)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Malaclemys terrapin lung
AC   CVCL_D5CC
DR   Wikidata; Q127384529
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=8485; ! Malaclemys terrapin (Diamondback terrapin)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Morelia spilota heart
AC   CVCL_D5BG
DR   Wikidata; Q127384532
RX   PubMed=37374873;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=51896; ! Morelia spilota (Carpet python)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   UFCVM Morelia spilota kidney
AC   CVCL_D5BH
DR   Wikidata; Q127384534
RX   PubMed=37374873;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=51896; ! Morelia spilota (Carpet python)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   UFCVM Morelia spilota lung
AC   CVCL_D5BI
DR   Wikidata; Q127384536
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=51896; ! Morelia spilota (Carpet python)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Morelia spilota spilota heart
AC   CVCL_D5BJ
SY   DPHt
DR   Wikidata; Q127384538
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=1716564; ! Morelia spilota spilota (Diamond python)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Opheodrys vernalis kidney
AC   CVCL_D5BP
DR   Wikidata; Q127384540
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=469619; ! Opheodrys vernalis (Smooth green snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Opheodrys vernalis lung
AC   CVCL_D5BQ
DR   Wikidata; Q127384542
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=469619; ! Opheodrys vernalis (Smooth green snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Pantherophis guttatus heart
AC   CVCL_D5BK
DR   Wikidata; Q127384544
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=94885; ! Pantherophis guttatus (Corn snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Pantherophis guttatus kidney
AC   CVCL_D5BL
DR   Wikidata; Q127384547
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=94885; ! Pantherophis guttatus (Corn snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Pantherophis guttatus lung
AC   CVCL_D5BM
DR   Wikidata; Q127384549
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=94885; ! Pantherophis guttatus (Corn snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Pantherophis guttatus mass
AC   CVCL_D5BN
SY   CoSnMs
DR   Wikidata; Q127384551
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
OX   NCBI_TaxID=94885; ! Pantherophis guttatus (Corn snake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Python bivittatus heart
AC   CVCL_D5BF
DR   Wikidata; Q127384554
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=176946; ! Python bivittatus (Burmese python)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Simalia amethistina spleen
AC   CVCL_D5B9
DR   Wikidata; Q127384556
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=51895; ! Simalia amethistina (Amethystine python)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Sistrurus miliarius kidney
AC   CVCL_D5BT
DR   Wikidata; Q127384557
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8758; ! Sistrurus miliarius (Pigmy rattlesnake)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFCVM Trachemys scripta scripta heart
AC   CVCL_D5CE
DR   Wikidata; Q127384559
RX   PubMed=37374873;
WW   Provider; UF CDPM; -; https://cdpm.vetmed.ufl.edu/services/zoological-medicine-overview/zoological-medicine-diagnostics-and-treatment/reptile-tissue-culture-cell-lines/
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=365635; ! Trachemys scripta scripta (Yellow-bellied slider)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UFERSA-PC1
AC   CVCL_B6YZ
SY   PC1
DR   Wikidata; Q112041877
RX   PubMed=35049356;
CC   Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9696; ! Puma concolor (Mountain lion)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   UFERSA-PC2
AC   CVCL_B6Z0
SY   PC2
DR   Wikidata; Q112041878
RX   PubMed=35049356;
CC   Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9696; ! Puma concolor (Mountain lion)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   UFERSA-PC3
AC   CVCL_B6Z1
SY   PC3
DR   Wikidata; Q112041879
RX   PubMed=35049356;
CC   Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9696; ! Puma concolor (Mountain lion)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   UFERSA-PC4
AC   CVCL_B6Z2
SY   PC4
DR   Wikidata; Q112041880
RX   PubMed=35049356;
CC   Miscellaneous: Age/sex of donor and cell line name from personal communication of Pereira, Alexsandra Fernandes.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9696; ! Puma concolor (Mountain lion)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   UFERSA-SBA-1
AC   CVCL_E3XW
RX   PubMed=38424379;
CC   Doubling time: 15.2 +- 2.0 hours (Note=At 4th passage), 14.3 +- 0.9 hours (Note=At 7th passage), 21.5 +- 2.7 hours (Note=At 10th passage) (PubMed=38424379).
CC   Miscellaneous: Cell line name from personal communication of Fernandes, Denilsa Pires.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=143300; ! Euphractus sexcinctus (Six-banded armadillo)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   UFERSA-SBA-2
AC   CVCL_E4KE
RX   PubMed=38424379;
CC   Miscellaneous: Cell line name from personal communication of Fernandes, Denilsa Pires.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=143300; ! Euphractus sexcinctus (Six-banded armadillo)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UFERSA-SBA-3
AC   CVCL_E4KF
RX   PubMed=38424379;
CC   Miscellaneous: Cell line name from personal communication of Fernandes, Denilsa Pires.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=143300; ! Euphractus sexcinctus (Six-banded armadillo)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UFERSA-SBA-4
AC   CVCL_E4KG
RX   PubMed=38424379;
CC   Miscellaneous: Cell line name from personal communication of Fernandes, Denilsa Pires.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=143300; ! Euphractus sexcinctus (Six-banded armadillo)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UFERSA-SBA-5
AC   CVCL_E4KH
RX   PubMed=38424379;
CC   Miscellaneous: Cell line name from personal communication of Fernandes, Denilsa Pires.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=143300; ! Euphractus sexcinctus (Six-banded armadillo)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UFH-001
AC   CVCL_VC35
DR   GEO; GSM2862789
DR   GEO; GSM2862790
DR   GEO; GSM2862791
DR   Millipore; SCC210
DR   Wikidata; Q54990133
RX   PubMed=29561695;
CC   Characteristics: Expresses CA9 (PubMed=29561695).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367.
ST   Source(s): Millipore=SCC210; PubMed=29561695
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 11,12
ST   D18S51: 18,19
ST   D21S11: 28,30
ST   D3S1358: 14,18
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 22,24
ST   Penta D: 10,12
ST   Penta E: 13,14
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 15,16,17 (PubMed=29561695)
ST   vWA: 15,17 (Millipore=SCC210)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0598 ! MCF-10A
SX   Female
AG   36Y
CA   Spontaneously immortalized cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 13
//
ID   UFL-AG-286
AC   CVCL_Z440
SY   UFL-Ag-286; UFL-AG286; UFL-Ag286
DR   ICLDB; ufl-ag286
DR   Wikidata; Q54990135
RX   DOI=10.1007/BF02623546;
RX   DOI=10.1016/0022-2011(88)90058-4;
RX   PubMed=1367489;
RX   PubMed=12623313;
RX   PubMed=15926859;
RX   PubMed=19002870;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Anticarsia gemmatalis nuclear polyhedrosis virus (AgNPV), Autographa californica nuclear polyhedrosis virus (AcMNPV) and Spodoptera frugiperda nuclear polyhedrosis virus (SfNPV). There is limited replication of SfNPV DNA in this cell line (DOI=10.1016/0022-2011(88)90058-4).
CC   Doubling time: 5.9 days (Note=When seeded at 2x10^5 cells ml), 6.7 days (Note=When seeded at 3X10^5 cells/ml) (DOI=10.1007/BF02623546).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=129554; ! Anticarsia gemmatalis (Velvetbean caterpillar moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 9
//
ID   UFRJi001-A
AC   CVCL_VF17
SY   Pac6cl3; Pac6 cl3
DR   BioSamples; SAMEA4675330
DR   hPSCreg; UFRJi001-A
DR   Wikidata; Q54990136
RX   PubMed=30099333;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:6240; KCNE1; Simple; p.Ser38Gly (c.112A>G); ClinVar=VCV000132651; Zygosity=Heterozygous (PubMed=30099333).
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.1394-2A>G; ClinVar=VCV001500718; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=30099333).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84793; Jervell and Lange Nielsen syndrome
DI   ORDO; Orphanet_90647; Jervell and Lange-Nielsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UFRJi002-A
AC   CVCL_VF18
SY   Pac8 cl7
DR   BioSamples; SAMEA4675331
DR   hPSCreg; UFRJi002-A
DR   Wikidata; Q54990137
RX   PubMed=30099333;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:6240; KCNE1; Simple; p.Ser38Gly (c.112A>G); ClinVar=VCV000132651; Zygosity=Heterozygous (PubMed=30099333).
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.1394-2A>G; ClinVar=VCV001500718; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=30099333).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UFRJi003-A
AC   CVCL_VF19
SY   Pac24 cl1
DR   hPSCreg; UFRJi003-A
DR   Wikidata; Q54990138
RX   PubMed=30099333;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6240; KCNE1; Simple; p.Ser38Gly (c.112A>G); ClinVar=VCV000132651; Zygosity=Heterozygous (PubMed=30099333).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   UFRJi004-A
AC   CVCL_VF20
SY   Pac25 cl4.1
DR   hPSCreg; UFRJi004-A
DR   Wikidata; Q54990139
RX   PubMed=30099333;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 5
//
ID   UFRJi005-A
AC   CVCL_WN08
SY   fALS
DR   hPSCreg; UFRJi005-A
DR   Wikidata; Q98133868
RX   PubMed=31077962;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:10555; ATXN2; Repeat_expansion; p.Gln166[36] (p.Gln166(>=33)); ClinVar=VCV000065668; Zygosity=Heterozygous (PubMed=31077962).
CC   Sequence variation: Mutation; HGNC; HGNC:12649; VAPB; Simple; p.Pro56Ser (c.166C>T); ClinVar=VCV000004806; Zygosity=Heterozygous (PubMed=31077962).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168751; Amyotrophic lateral sclerosis 8
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   UFRJi006-A
AC   CVCL_WN09
SY   sALS
DR   hPSCreg; UFRJi006-A
DR   Wikidata; Q98133869
RX   PubMed=31077962;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UFRJi007-A
AC   CVCL_WN10
SY   UFRJi007A
DR   hPSCreg; UFRJi007-A
DR   Wikidata; Q98133870
RX   PubMed=31301488;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; c.521_523+3delGAGGTG; ClinVar=VCV000540281; Zygosity=Unspecified (PubMed=31301488).
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Phe21Cys (c.62T>G) (F20C); ClinVar=VCV001459352; Zygosity=Unspecified (PubMed=31301488).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 10
//
ID   UFRJi008-A
AC   CVCL_WN11
SY   CTRL1
DR   hPSCreg; UFRJi008-A
DR   Wikidata; Q98133871
RX   PubMed=31077962;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UFRJi009-A
AC   CVCL_WN12
SY   CTRL2
DR   hPSCreg; UFRJi009-A
DR   Wikidata; Q98133872
RX   PubMed=31077962;
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UFRJi010-A
AC   CVCL_ZA80
DR   hPSCreg; UFRJi010-A
DR   Wikidata; Q98133873
CC   From: Universidade Federal do Rio de Janeiro; Rio de Janeiro; Brazil.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   UG-GlyPy-Hem-1
AC   CVCL_B7HA
DR   Wikidata; Q112930511
RX   PubMed=35075604;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution, the species Latin name and the tissue.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=1242752; ! Glyphodes pyloalis (Lesser mulberry snout moth)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   UG07-1C6
AC   CVCL_VV36
SY   UG07.1C6
DR   Wikidata; Q98133874
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:106651; Ly6e.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: Ly-6E.1/LacZ (BL1b) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Stromal cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   UG15-1B7
AC   CVCL_VV37
SY   UG15.1B7
DR   Wikidata; Q98133875
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:106651; Ly6e.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: Ly-6E.1/LacZ (BL1b) transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   11FD
CA   Stromal cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   UG26-1B4
AC   CVCL_VV38
SY   UG26.1B4
DR   Wikidata; Q98133877
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV39 ! UG26-1B6
OI   CVCL_VV40 ! UG26-2D3
OI   CVCL_VV41 ! UG26-3D4
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   UG26-1B6
AC   CVCL_VV39
SY   UG26.1B6
DR   GEO; GSE68834
DR   Wikidata; Q98133878
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV38 ! UG26-1B4
OI   CVCL_VV40 ! UG26-2D3
OI   CVCL_VV41 ! UG26-3D4
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 9
//
ID   UG26-2D3
AC   CVCL_VV40
SY   UG26.2D3
DR   Wikidata; Q98133879
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV38 ! UG26-1B4
OI   CVCL_VV39 ! UG26-1B6
OI   CVCL_VV41 ! UG26-3D4
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   UG26-3D4
AC   CVCL_VV41
SY   UG26.3D4
DR   Wikidata; Q98133881
RX   PubMed=11830464;
RX   PubMed=11973351;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic aorta-gonad-mesonephros; UBERON=UBERON_0003105.
CC   Breed/subspecies: (CBA/Ca x C57BL/10) beta-actin-tsA58 transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_VV38 ! UG26-1B4
OI   CVCL_VV39 ! UG26-1B6
OI   CVCL_VV40 ! UG26-2D3
SX   Sex unspecified
AG   11FD
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 8
//
ID   UG3
AC   CVCL_5382
SY   UG-3
DR   Cosmic; 787486
DR   Cosmic; 975310
DR   Cosmic; 1281360
DR   Wikidata; Q54990140
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9616150;
RX   PubMed=14671638;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=UG3
CC   Population: Japanese.
CC   Characteristics: IL3 dependent.
CC   Doubling time: 60-70 hours (PubMed=9616150).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=14671638).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   UGA-CiE1
AC   CVCL_AV43
SY   CiE1
DR   Wikidata; Q54990142
RX   PubMed=20381615;
CC   Group: Insect cell line.
CC   Doubling time: 66.3 +- 5.5 hours (Note=At 44th passage), 62.5 +- 4.3 hours (Note=At 64th passage) (PubMed=20381615).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=689277; ! Chrysodeixis includens (Soybean looper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   UGENTi001-A
AC   CVCL_C6T5
SY   UGENT-MFS003
DR   BioSamples; SAMEA111501119
DR   hPSCreg; UGENTi001-A
DR   Wikidata; Q117704911
RX   PubMed=36724552;
CC   From: Ghent University; Ghent; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Ile2585Thr (c.7754T>C); ClinVar=VCV000163462; Zygosity=Heterozygous (PubMed=36724552).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 5
//
ID   UGENTi001-A-1
AC   CVCL_D0ML
SY   UGENT-MFS003-CRISPR
DR   BioSamples; SAMEA112285422
DR   hPSCreg; UGENTi001-A-1
DR   Wikidata; Q123033695
RX   PubMed=36724552;
CC   From: Ghent University; Ghent; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple_corrected; p.Ile2585Thr (c.7754T>C); ClinVar=VCV000163462; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36724552).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C6T5 ! UGENTi001-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UGENTi002-A
AC   CVCL_D0MM
DR   BioSamples; SAMEA113939453
DR   hPSCreg; UGENTi002-A
DR   Wikidata; Q123033696
RX   PubMed=39217685;
CC   From: Ghent University; Ghent; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple; p.Gln273Ter (c.817C>T); Zygosity=Heterozygous (PubMed=39217685).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UGENTi002-A-1
AC   CVCL_D0MN
DR   BioSamples; SAMEA113958745
DR   hPSCreg; UGENTi002-A-1
DR   Wikidata; Q123033697
RX   PubMed=39217685;
CC   From: Ghent University; Ghent; Belgium.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3052; DSP; Simple_corrected; p.Gln273Ter (c.817C>T); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39217685).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0MM ! UGENTi002-A
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UGOTSAi001-A
AC   CVCL_A0MB
SY   A2B
DR   hPSCreg; UGOTSAi001-A
DR   Wikidata; Q108821432
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UGOTSAi002-B
AC   CVCL_C1X4
SY   N1-001iC2
DR   BioSamples; SAMEA110472362
DR   hPSCreg; UGOTSAi002-B
DR   Wikidata; Q114313154
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   UGOTSAi003-A
AC   CVCL_C1X5
SY   N1-002iC3A
DR   BioSamples; SAMEA110474129
DR   hPSCreg; UGOTSAi003-A
DR   Wikidata; Q114313155
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1X6 ! UGOTSAi003-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   UGOTSAi003-B
AC   CVCL_C1X6
SY   N1-002iC4
DR   BioSamples; SAMEA110584232
DR   hPSCreg; UGOTSAi003-B
DR   Wikidata; Q114313156
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1X5 ! UGOTSAi003-A
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   UGOTSAi004-A
AC   CVCL_C1X7
SY   N1-003iC3
DR   BioSamples; SAMEA110585827
DR   hPSCreg; UGOTSAi004-A
DR   Wikidata; Q114313157
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1X8 ! UGOTSAi004-B
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   UGOTSAi004-B
AC   CVCL_C1X8
SY   N1-003iC4
DR   BioSamples; SAMEA112259049
DR   hPSCreg; UGOTSAi004-B
DR   Wikidata; Q114313158
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1X7 ! UGOTSAi004-A
SX   Female
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   UGOTSAi005-A
AC   CVCL_C1X9
SY   N1-004iC2
DR   BioSamples; SAMEA110585932
DR   hPSCreg; UGOTSAi005-A
DR   Wikidata; Q114313159
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XA ! UGOTSAi005-B
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 4
//
ID   UGOTSAi005-B
AC   CVCL_C1XA
SY   N1-004iC6
DR   BioSamples; SAMEA110586254
DR   hPSCreg; UGOTSAi005-B
DR   Wikidata; Q114313160
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1X9 ! UGOTSAi005-A
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 4
//
ID   UGOTSAi006-A
AC   CVCL_C1XB
SY   N1-005iC1
DR   BioSamples; SAMEA110104322
DR   hPSCreg; UGOTSAi006-A
DR   Wikidata; Q114313161
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   UGOTSAi007-A
AC   CVCL_E8WT
SY   SBP_cntrl_1
DR   BioSamples; SAMEA115955748
DR   hPSCreg; UGOTSAi007-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi008-A
AC   CVCL_E8WU
SY   SBP_cntrl_2
DR   hPSCreg; UGOTSAi008-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi009-A
AC   CVCL_E8WV
SY   SBP_cntrl_3
DR   hPSCreg; UGOTSAi009-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi010-A
AC   CVCL_E8WW
SY   SBP_cntrl_4
DR   hPSCreg; UGOTSAi010-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi011-A
AC   CVCL_E8WX
SY   SBP_cntrl_5
DR   hPSCreg; UGOTSAi011-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi012-A
AC   CVCL_E8WY
SY   SBP_cntrl_6
DR   hPSCreg; UGOTSAi012-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi013-A
AC   CVCL_E8WZ
SY   SBP_cntrl_7
DR   hPSCreg; UGOTSAi013-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi014-A
AC   CVCL_E8X0
SY   SBP_cntrl_8
DR   hPSCreg; UGOTSAi014-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi015-A
AC   CVCL_E8X1
SY   SBP_cntrl_9
DR   hPSCreg; UGOTSAi015-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi016-A
AC   CVCL_E8X2
SY   SBP_cntrl_10
DR   hPSCreg; UGOTSAi016-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi017-A
AC   CVCL_E8X3
SY   SBP_cntrl_11
DR   hPSCreg; UGOTSAi017-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi018-A
AC   CVCL_E8X4
SY   SBP_BD_1
DR   hPSCreg; UGOTSAi018-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi019-A
AC   CVCL_E8X5
SY   SBP_BD_2
DR   hPSCreg; UGOTSAi019-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi020-A
AC   CVCL_E8X6
SY   SBP_BD_3
DR   hPSCreg; UGOTSAi020-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi021-A
AC   CVCL_E8X7
SY   SBP_BD_4
DR   hPSCreg; UGOTSAi021-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi022-A
AC   CVCL_E8X8
SY   SBP_BD_5
DR   hPSCreg; UGOTSAi022-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi023-A
AC   CVCL_E8X9
SY   SBP_BD_6
DR   hPSCreg; UGOTSAi023-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGOTSAi024-A
AC   CVCL_E8XA
SY   SBP_BD_7
DR   hPSCreg; UGOTSAi024-A
CC   From: The Sahlgrenska Academy, University of Gothenburg; Gothenburg; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UGSM-2
AC   CVCL_LF83
SY   UroGenital Sinus Mesenchyme cell line-2
DR   ABM; T0653
DR   Wikidata; Q54990143
RX   PubMed=16752376;
RX   PubMed=18462435;
CC   Doubling time: 13 hours (PubMed=16752376).
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Derived from site: In situ; Urogenital sinus mesenchyme; UBERON=UBERON_0009845.
CC   Breed/subspecies: Ink4a/Arf-/- transgenic.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   16FD
CA   Spontaneously immortalized cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   UH607902
AC   CVCL_A9G2
DR   Wikidata; Q102115054
RX   PubMed=7822435;
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   UHG-NP
AC   CVCL_A436
SY   UHGNP
DR   Cosmic; 1109109
DR   Cosmic; 1518081
DR   Cosmic; 1526658
DR   Cosmic; 1543777
DR   GEO; GSM692876
DR   Wikidata; Q54990144
RX   PubMed=7838528;
RX   PubMed=9283597;
RX   PubMed=9516836;
RX   PubMed=11319804;
RX   PubMed=20655465;
RX   PubMed=22213050;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   UHG-RaC '93
AC   CVCL_5U49
DR   Wikidata; Q54990145
RX   PubMed=7586205;
CC   Doubling time: 25 hours (PubMed=7586205).
CC   Transformant: ChEBI; CHEBI_16907; 4-nitroquinoline N-oxide (4NQO).
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60511; Rat squamous cell carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 7
//
ID   UHi004-A
AC   CVCL_UL29
SY   HEL157.1
DR   BioSamples; SAMEA5236893
DR   hPSCreg; UHi004-A
DR   Wikidata; Q98133882
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL30 ! UHi004-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   UHi004-B
AC   CVCL_UL30
SY   HEL157.3
DR   BioSamples; SAMEA5237141
DR   hPSCreg; UHi004-B
DR   Wikidata; Q98133883
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL29 ! UHi004-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   UHi005-A
AC   CVCL_UL31
SY   HEL158.1
DR   BioSamples; SAMEA5237368
DR   hPSCreg; UHi005-A
DR   Wikidata; Q98133884
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL32 ! UHi005-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   UHi005-B
AC   CVCL_UL32
SY   HEL158.2
DR   BioSamples; SAMEA5237522
DR   hPSCreg; UHi005-B
DR   Wikidata; Q98133885
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UL31 ! UHi005-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   UHi006-A
AC   CVCL_9T96
SY   HEL24.3; Hel24.3
DR   BioSamples; SAMEA5239483
DR   hPSCreg; UHi006-A
DR   Wikidata; Q54882510
RX   PubMed=23341440;
RX   PubMed=26093941;
RX   PubMed=28402852;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=26093941
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 11
//
ID   UHi006-A-1
AC   CVCL_LJ89
SY   HEL24.3-SOX2-NTdT; HEL24.3-SOX2-NTdT-C9-H5; UHi001-A
DR   BioSamples; SAMEA104134270
DR   hPSCreg; UHi006-A-1
DR   Wikidata; Q54990146
RX   PubMed=28952927;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian.
CC   Characteristics: Expresses bright nuclear located tDTomato upon SOX2 activation. Heterozygous knockin by CRISPR/Cas9 of a T2A-NLS-tdTomato-F2A-Pac cassette at the C-terminus of the SOX2 gene by CRISPR/Cas9.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T96 ! UHi006-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   UHi006-A-2
AC   CVCL_LJ88
SY   HEL24.3-OCT4-nEmGFP; HEL24.3-OCT4-nEmGFP-A-G3; UHi001-B
DR   BioSamples; SAMEA104277230
DR   hPSCreg; UHi006-A-2
DR   Wikidata; Q54990148
RX   PubMed=28925359;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Population: Caucasian.
CC   Characteristics: Expresses bright nuclear located EmGFP upon POU5F1 activation. Heterozygous knockin by CRISPR/Cas9 of a T2A-NLS-EmGFP-P2A-Pac cassette at the C-terminus of the POU5F1/OCT4 gene by CRISPR/Cas9.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; GLAD6; Emerald (Note=EmGFP, green fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
ST   Source(s): PubMed=28925359
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9T96 ! UHi006-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 13
//
ID   UHi007-A
AC   CVCL_9T97
SY   HEL47.2
DR   BioSamples; SAMEA5248245
DR   hPSCreg; UHi007-A
DR   Wikidata; Q54882511
RX   PubMed=26096151;
RX   PubMed=28402852;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JE79 ! UHi007-B
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   UHi007-B
AC   CVCL_JE79
SY   HEL11.4; HEL 11.4
DR   hPSCreg; UHi007-B
DR   Wikidata; Q54882509
RX   PubMed=23106381;
RX   PubMed=24098444;
RX   PubMed=27411166;
RX   PubMed=29339535;
RX   PubMed=30503263;
RX   PubMed=35677646;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T97 ! UHi007-A
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 11
//
ID   UHi020-A
AC   CVCL_D0N5
SY   HEL62.4
DR   hPSCreg; UHi020-A
DR   Wikidata; Q123033698
RX   PubMed=35677646;
CC   From: University of Helsinki; Helsinki; Finland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UHi021-A
AC   CVCL_D0N6
SY   HEL61.1
DR   hPSCreg; UHi021-A
DR   Wikidata; Q123033699
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0N7 ! UHi021-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UHi021-B
AC   CVCL_D0N7
SY   HEL61.2
DR   hPSCreg; UHi021-B
DR   Wikidata; Q123033700
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0N6 ! UHi021-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UHi022-A
AC   CVCL_D0N8
SY   HEL82.6
DR   hPSCreg; UHi022-A
DR   Wikidata; Q123033701
CC   From: University of Helsinki; Helsinki; Finland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UHKBR-01
AC   CVCL_JY21
DR   Wikidata; Q54990153
RX   PubMed=12726884;
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 8
//
ID   UHKT-1
AC   CVCL_RI32
SY   Ustav Hematologie a Krevni Transfuze-1
DR   Wikidata; Q54990154
RX   PubMed=6315324;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UHKT-2
AC   CVCL_RI33
SY   Ustav Hematologie a Krevni Transfuze-2
DR   Wikidata; Q54990155
RX   PubMed=6270579;
RX   PubMed=6315324;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UHKT-3
AC   CVCL_RI34
SY   Ustav Hematologie a Krevni Transfuze-3
DR   Wikidata; Q54990156
RX   PubMed=6315324;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UHKT-4
AC   CVCL_RI35
SY   Ustav Hematologie a Krevni Transfuze-4
DR   Wikidata; Q54990157
RX   PubMed=6270579;
RX   PubMed=6315324;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UHKT-40
AC   CVCL_RI30
SY   Ustav Hematologie a Krevni Transfuze-40
DR   Wikidata; Q54990158
RX   PubMed=11734303;
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3183; T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   UHKT-42
AC   CVCL_K243
SY   Ustav Hematologie a Krevni Transfuze-42
DR   Wikidata; Q54990159
RX   PubMed=7517692;
RX   PubMed=11734303;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   UHKT-5
AC   CVCL_RI36
SY   Ustav Hematologie a Krevni Transfuze-5
DR   Wikidata; Q54990161
RX   PubMed=6270579;
RX   PubMed=6315324;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7962; Adult acute myelomonocytic leukemia
DI   ORDO; Orphanet_517; Acute myelomonocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 6
//
ID   UHKT-6
AC   CVCL_RI37
SY   Ustav Hematologie a Krevni Transfuze-6
DR   Wikidata; Q54990163
RX   PubMed=6315324;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UHKT-7
AC   CVCL_RI39
SY   Ustav Hematologie a Krevni Transfuze-7
DR   Wikidata; Q54990164
RX   PubMed=6270579;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UHKT-893
AC   CVCL_M522
SY   Ustav Hematologie a Krevni Transfuze-893
DR   Wikidata; Q54990165
RX   PubMed=23290585;
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: IL6 dependent.
CC   Doubling time: 3.4-3.8 days (PubMed=23290585).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   UHKT-893a
AC   CVCL_HX22
SY   Ustav Hematologie a Krevni Transfuze-893a
DR   Wikidata; Q54990167
RX   PubMed=23290585;
CC   Characteristics: Produces IgG kappa.
CC   Characteristics: In contrast to the parent cell line it is no longer IL6 dependent.
CC   Doubling time: 4.2-5.4 days (PubMed=23290585).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M522 ! UHKT-893
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   UHKT-944
AC   CVCL_1K05
SY   Ustav Hematologie a Krevni Transfuze-944
DR   ABM; T8094
DR   Wikidata; Q54990168
RX   PubMed=25600340;
CC   Characteristics: Produces IgA1 kappa (PubMed=25600340).
CC   Characteristics: IL6 dependent (PubMed=25600340).
CC   Doubling time: 65-77 hours (PubMed=25600340).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 14-08-25; Version: 11
//
ID   UHOMe001-A
AC   CVCL_C391
SY   HD90; HD90/FE07-142-L1; HD90/D18/FE07-142-L1; HD90/D18E7; D18
DR   hPSCreg; UHOMe001-A
DR   SKIP; SKIP002299
DR   Wikidata; Q54990169
RX   DOI=10.1016/S1472-6483(10)62372-3;
RX   PubMed=19128516;
WW   Info; Agence de la biomedecine; -; https://www.agence-biomedecine.fr/IMG/pdf/chu_montpellier_hd90.pdf
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Registration: French Agence de la Biomedecine; FE07-142-L1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   UHOMi001-A
AC   CVCL_VF21
SY   iPCD02.30; PCD02.30
DR   BioSamples; SAMEA8477514
DR   EBiSC; UHOMi001-A
DR   ECACC; 66770019
DR   hPSCreg; UHOMi001-A
DR   Wikidata; Q54990170
RX   CelloPub=CLPUB00426;
RX   DOI=10.1101/2020.11.29.400358;
RX   PubMed=30296669;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Sequence variation: Mutation; HGNC; HGNC:26090; CCDC40; Simple; c.1116_1117delCT; Zygosity=Heterozygous (PubMed=30296669).
CC   Sequence variation: Mutation; HGNC; HGNC:26090; CCDC40; Simple; c.3180+1G>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=30296669).
CC   Discontinued: ECACC; 66770019; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C155999; Primary ciliary dyskinesia 15
DI   ORDO; Orphanet_244; Primary ciliary dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   UHOMi002-A
AC   CVCL_A1NX
SY   Hy03; HY03
DR   hPSCreg; UHOMi002-A
DR   Wikidata; Q102115055
RX   DOI=10.1101/2020.11.29.400358;
RX   PubMed=33099111;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   UHOMi003-A
AC   CVCL_A5ZX
SY   iCOPD2
DR   hPSCreg; UHOMi003-A
DR   Wikidata; Q107117199
RX   DOI=10.1101/2020.11.29.400358;
RX   PubMed=34624616;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3199; Chronic obstructive pulmonary disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UHOMi004-A
AC   CVCL_A5ZY
SY   iCOPD8
DR   BioSamples; SAMEA8477516
DR   hPSCreg; UHOMi004-A
DR   Wikidata; Q107117200
RX   DOI=10.1101/2020.11.29.400358;
RX   PubMed=34624616;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3199; Chronic obstructive pulmonary disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UHOMi005-A
AC   CVCL_A5ZZ
SY   iCOPD9
DR   hPSCreg; UHOMi005-A
DR   Wikidata; Q107117201
RX   DOI=10.1101/2020.11.29.400358;
RX   PubMed=34624616;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3199; Chronic obstructive pulmonary disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UHOMi006-A
AC   CVCL_A6AB
SY   iCOPD6
DR   hPSCreg; UHOMi006-A
DR   Wikidata; Q107117202
RX   PubMed=34624616;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3199; Chronic obstructive pulmonary disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   UHOMi007-A
AC   CVCL_A6AA
SY   SMOK1
DR   BioSamples; SAMEA110587396
DR   hPSCreg; UHOMi007-A
DR   Wikidata; Q107117203
RX   PubMed=38723411;
CC   From: University Hospital of Montpellier; Montpellier; France.
CC   Population: Caucasian.
CC   Donor information: Established from a healthy heavy smoker (>50 pack years) (PubMed=38723411).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 6
//
ID   UHOMi008-A
AC   CVCL_D0NM
SY   ABPA
DR   hPSCreg; UHOMi008-A
DR   Wikidata; Q123033702
CC   From: University Hospital of Montpellier; Montpellier; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UHOMi009-A
AC   CVCL_D0NN
SY   T2 SA-1
DR   hPSCreg; UHOMi009-A
DR   Wikidata; Q123033703
CC   From: University Hospital of Montpellier; Montpellier; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UHOMi010-A
AC   CVCL_D0NP
SY   T2 SA-2
DR   hPSCreg; UHOMi010-A
DR   Wikidata; Q123033705
CC   From: University Hospital of Montpellier; Montpellier; France.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UIA-MM1
AC   CVCL_A694
SY   UIA-MM 1; Universitaire Instelling Antwerpen-Malignant Mesothelioma 1
DR   Cosmic; 1016277
DR   Wikidata; Q54990171
RX   PubMed=9072005;
RX   PubMed=10193387;
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   UIA-MM2
AC   CVCL_A695
SY   UIA-MM 2; UIAMM2; Universitaire Instelling Antwerpen-Malignant Mesothelioma 2
DR   Cosmic; 1016278
DR   Wikidata; Q54990174
RX   PubMed=9072005;
RX   PubMed=10193387;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   UIA-MM3
AC   CVCL_A696
SY   UIA-MM 3; Universitaire Instelling Antwerpen-Malignant Mesothelioma 3
DR   Cosmic; 1016279
DR   Wikidata; Q54990175
RX   PubMed=9072005;
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   UIA-MM4
AC   CVCL_M479
SY   UIA-MM 4; Universitaire Instelling Antwerpen-Malignant Mesothelioma 4
DR   Wikidata; Q54990176
RX   PubMed=9072005;
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   UIA-MM5
AC   CVCL_A697
SY   UIA-MM 5; Universitaire Instelling Antwerpen-Malignant Mesothelioma 5
DR   Wikidata; Q54990177
RX   PubMed=10193387;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   UIA-MM6
AC   CVCL_M480
SY   UIA-MM 6; Universitaire Instelling Antwerpen-Malignant Mesothelioma 6
DR   Wikidata; Q54990178
RX   PubMed=9072005;
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   UIA-MM7
AC   CVCL_A698
SY   UIA-MM 7; UIAMM7; Universitaire Instelling Antwerpen-Malignant Mesothelioma 7
DR   Wikidata; Q54990180
RX   PubMed=10193387;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   UIA-MM8
AC   CVCL_A699
SY   UIA-MM 8; Universitaire Instelling Antwerpen-Malignant Mesothelioma 8
DR   Wikidata; Q54990181
RX   PubMed=9503661;
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   UIC2
AC   CVCL_B0FB
DR   ATCC; HB-11027
DR   Wikidata; Q108821433
RX   Patent=US5773280;
RX   Patent=US7598340;
RX   PubMed=1352877;
RX   PubMed=9205000;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11027.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UIC2/A
AC   CVCL_B0FC
DR   Wikidata; Q108821434
RX   Patent=US5773280;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-11287.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08183; Human ABCB1/CD243.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B0FB ! UIC2
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UIi001-A
AC   CVCL_B5RX
SY   SCZ019-A; SCZ019
DR   hPSCreg; UIi001-A
DR   Wikidata; Q112041881
RX   PubMed=34953327;
CC   From: University of Iowa; Iowa City; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C120408; Chromosome 16p11.2 deletion syndrome
DI   NCIt; C3362; Schizophrenia
DI   ORDO; Orphanet_261197; Proximal 16p11.2 microdeletion syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   UIOi001-A
AC   CVCL_YC60
SY   AG27; hiPSC line AG05836B clone #27
DR   BioSamples; SAMEA5928374
DR   hPSCreg; UIOi001-A
DR   Wikidata; Q98133887
RX   PubMed=27532814;
CC   From: University of Oslo; Oslo; Norway.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2B58 ! AG05836
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UIOi002-A
AC   CVCL_C1X2
DR   BioSamples; SAMEA14018866
DR   hPSCreg; UIOi002-A
DR   Wikidata; Q114313162
CC   From: University of Oslo; Oslo; Norway.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4L66 ! AG09173
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UIOi006-A
AC   CVCL_C1X3
DR   BioSamples; SAMEA14018868
DR   hPSCreg; UIOi006-A
DR   Wikidata; Q114313163
CC   From: University of Oslo; Oslo; Norway.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4M37 ! AG10788
SX   Female
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UiPS-1
AC   CVCL_UG42
DR   Wikidata; Q98133888
RX   PubMed=30308486;
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr2476Asp (c.7426T>G); Zygosity=Heterozygous (PubMed=30308486).
CC   Caution: The mutation indicated in PubMed=30308486 (c.7448T>G; p.L2483R) is incorrect and does not correspond to the sequence trace in Figure 2, we have therefore corrected it.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG43 ! UiPS-2
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   UiPS-2
AC   CVCL_UG43
DR   Wikidata; Q98133891
RX   PubMed=30308486;
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Tyr2476Asp (c.7426T>G); Zygosity=Heterozygous (PubMed=30308486).
CC   Caution: The mutation indicated in the paper (c.7448T>G; p.L2483R) is incorrect and does not correspond to the sequence trace in Figure 2, we have therefore corrected it.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG42 ! UiPS-1
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   UiPSC-001
AC   CVCL_RH85
SY   UC-001
DR   SKIP; SKIP001299
DR   Wikidata; Q54990182
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-002
AC   CVCL_RH86
SY   UC-002
DR   Wikidata; Q54990184
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C26721; Hemophilia B
DI   ORDO; Orphanet_98879; Hemophilia B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-003
AC   CVCL_RH87
SY   UC-003
DR   Wikidata; Q54990185
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-004
AC   CVCL_RH88
SY   UC-004
DR   Wikidata; Q54990187
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-005
AC   CVCL_RH89
SY   UC-005; UC-5; UC5
DR   SKIP; SKIP001065
DR   SKIP; SKIP001300
DR   Wikidata; Q54990188
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-006
AC   CVCL_RH90
SY   UC-006
DR   Wikidata; Q54990189
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-007
AC   CVCL_RH91
SY   UC-007
DR   Wikidata; Q54990190
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-008
AC   CVCL_RH92
SY   UC-008
DR   SKIP; SKIP001301
DR   Wikidata; Q54990191
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-009
AC   CVCL_RH93
SY   UC-009
DR   Wikidata; Q54990192
RX   PubMed=23940595;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Phe42Leufs*19 (c.126_129delCTTT) (c.125_128delTCTT) (CD 41/42); ClinVar=VCV000015417; Zygosity=Heterozygous (PubMed=23940595).
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-197C>T (IVS2-654C>T); ClinVar=VCV000015458; Zygosity=Heterozygous (PubMed=23940595).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   UiPSC-010
AC   CVCL_RH94
SY   UC-010
DR   Wikidata; Q54990193
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-011
AC   CVCL_RH95
SY   UC-011
DR   SKIP; SKIP001302
DR   Wikidata; Q54990194
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-012
AC   CVCL_RH96
SY   UC-012
DR   SKIP; SKIP001303
DR   Wikidata; Q54990195
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-013
AC   CVCL_RH97
SY   UC-013
DR   Wikidata; Q54990197
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-014
AC   CVCL_RH98
SY   UC-014
DR   Wikidata; Q54990198
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C75467; Charcot-Marie-Tooth disease
DI   ORDO; Orphanet_166; Charcot-Marie-Tooth disease/Hereditary motor and sensory neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-015
AC   CVCL_RH99
SY   UC-015
DR   SKIP; SKIP001304
DR   Wikidata; Q54990199
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-016
AC   CVCL_RK70
SY   UC-016
DR   Wikidata; Q54990201
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-017
AC   CVCL_RI00
SY   UC-017
DR   Wikidata; Q54990202
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-018
AC   CVCL_RI01
SY   UC-018
DR   Wikidata; Q54990207
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-019
AC   CVCL_RI02
SY   UC-019
DR   Wikidata; Q54990208
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-020
AC   CVCL_RI03
SY   UC-020
DR   Wikidata; Q54990209
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-021
AC   CVCL_RI04
SY   UC-021
DR   Wikidata; Q54990210
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-022
AC   CVCL_RI05
SY   UC-022
DR   Wikidata; Q54990211
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-023
AC   CVCL_RI06
SY   UC-023
DR   Wikidata; Q54990212
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-024
AC   CVCL_RI07
SY   UC-024
DR   Wikidata; Q54990213
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-025
AC   CVCL_RI08
SY   UC-025
DR   Wikidata; Q54990216
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-026
AC   CVCL_RI09
SY   UC-026
DR   Wikidata; Q54990217
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-027
AC   CVCL_RI10
SY   UC-027
DR   Wikidata; Q54990218
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-028
AC   CVCL_RI11
SY   UC-028
DR   Wikidata; Q54990220
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-029
AC   CVCL_RI12
SY   UC-029
DR   Wikidata; Q54990221
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-030
AC   CVCL_RI13
SY   UC-030
DR   Wikidata; Q54990223
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-031
AC   CVCL_RI14
SY   UC-031
DR   Wikidata; Q54990224
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-032
AC   CVCL_RI15
SY   UC-032
DR   Wikidata; Q54990225
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-033
AC   CVCL_RI16
SY   UC-033
DR   Wikidata; Q54990226
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-034
AC   CVCL_RI17
SY   UC-034
DR   Wikidata; Q54990227
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-035
AC   CVCL_RI18
SY   UC-035
DR   Wikidata; Q54990228
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-036
AC   CVCL_RI19
SY   UC-036
DR   Wikidata; Q54990229
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   UiPSC-037
AC   CVCL_RI20
SY   UC-037
DR   Wikidata; Q54990230
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-038
AC   CVCL_RI21
SY   UC-038
DR   Wikidata; Q54990231
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-039
AC   CVCL_RI22
SY   UC-039
DR   Wikidata; Q54990232
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   UiPSC-040
AC   CVCL_RI23
SY   UC-040
DR   Wikidata; Q54990233
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 8
//
ID   UiPSC-041
AC   CVCL_RI24
SY   UC-041
DR   SKIP; SKIP001305
DR   Wikidata; Q54990234
RX   PubMed=23940595;
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; c.316-197C>T (IVS2-654C>T); ClinVar=VCV000015458; Zygosity=Heterozygous (PubMed=23940595).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UiPSC-042
AC   CVCL_RI25
SY   UC-042
DR   Wikidata; Q54990235
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-043
AC   CVCL_RI26
SY   UC-043
DR   Wikidata; Q54990236
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-044
AC   CVCL_RI27
SY   UC-044
DR   Wikidata; Q54990237
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   UiPSC-045
AC   CVCL_RI28
SY   UC-045
DR   Wikidata; Q54990238
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UiPSC-046
AC   CVCL_RI29
SY   UC-046
DR   Wikidata; Q54990239
RX   PubMed=23940595;
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 6
//
ID   UISO-BCA-1
AC   CVCL_D249
SY   UISO BCA 1; UISOBCA1; University of Illinois Surgical Oncology-Breast CArcinoma-1
DR   Wikidata; Q54990240
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=1377894;
CC   Doubling time: 31.2 +- 9.6 hours (PubMed=1377894).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 15
//
ID   UISO-BCA-2
AC   CVCL_D250
SY   UISO BCA 2; University of Illinois Surgical Oncology-Breast CArcinoma-2
DR   Wikidata; Q54990241
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=1377894;
CC   Doubling time: 56.0 +- 5.0 hours (PubMed=1377894).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   UISO-BCA-3
AC   CVCL_D251
SY   UISO BCA 3; University of Illinois Surgical Oncology-Breast CArcinoma-3
DR   Wikidata; Q54990242
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 9
//
ID   UISO-BCA-4
AC   CVCL_D252
SY   UISO BCA 4; University of Illinois Surgical Oncology-Breast CArcinoma-4
DR   Wikidata; Q54990243
RX   DOI=10.1016/0165-4608(96)85256-3;
RX   PubMed=10601550;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   UISO-CMN-1
AC   CVCL_ZL44
SY   CMN-1; University of Illinois Surgical Oncology-Congenital Melanocytic Naevus-1
DR   Wikidata; Q98133893
RX   PubMed=11828255;
RX   PubMed=12894234;
CC   Derived from site: In situ; Skin, dermis, nevus; UBERON=UBERON_1000010.
DI   NCIt; C3944; Congenital melanocytic nevus
DI   ORDO; Orphanet_626; Large congenital melanocytic nevus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9M
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UISO-GCT-1
AC   CVCL_XF38
SY   University of Illinois Surgical Oncology-Giant Cell Tumor-1
DR   Wikidata; Q98133896
RX   PubMed=8095436;
CC   Doubling time: 76.8 hours (Note=At 5th passage) (PubMed=8095436).
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
DI   NCIt; C4304; Malignancy in giant cell tumor of bone
DI   ORDO; Orphanet_363976; Giant cell tumor of bone
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   UISO-H-MEL-2-IL-2
AC   CVCL_XF40
DR   Wikidata; Q98133898
RX   PubMed=9322873;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6001; IL2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF39 ! UISO-MEL-2
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 27-11-25; Version: 9
//
ID   UISO-MCC-1
AC   CVCL_E996
SY   UISO-MCC 1; UISO-MCC1; UISO-mcc1; UISO; University of Illinois Surgical Oncology-Merkel Cell Carcinoma-1
DR   Cosmic; 1693074
DR   Cosmic; 1699814
DR   GDSC; 1299074
DR   PharmacoDB; UISOMCC1_1640_2019
DR   Wikidata; Q54990245
RX   PubMed=8227544;
RX   PubMed=10732753;
RX   PubMed=12209990;
RX   PubMed=20444890;
RX   PubMed=22363598;
RX   PubMed=23563200;
CC   Doubling time: 64.8 hours (PubMed=8227544); 1.5 days (PubMed=20444890).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   UISO-MEL-1
AC   CVCL_XF80
SY   University of Illinois Surgical Oncology-MELanoma-1
DR   Wikidata; Q98133901
RX   PubMed=3191486;
RX   PubMed=8012659;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Submandibular lymph node; UBERON=UBERON_0002520.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   UISO-MEL-11
AC   CVCL_ZL36
SY   MEL-11; University of Illinois Surgical Oncology-MELanoma-11
DR   cancercelllines; CVCL_ZL36
DR   IARC_TP53; 23796
DR   Wikidata; Q98133903
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=12894234;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Thr (c.584T>C); ClinVar=VCV000216077; Zygosity=Unspecified (PubMed=12894234).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   UISO-MEL-16
AC   CVCL_ZL37
SY   MEL-16; University of Illinois Surgical Oncology-MELanoma-16
DR   IARC_TP53; 23797
DR   Wikidata; Q98133905
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=12894234;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   UISO-MEL-2
AC   CVCL_XF39
SY   UISO-Mel-2; UISO-H-MEL-2; MEL-2; University of Illinois Surgical Oncology-MELanoma-2
DR   IARC_TP53; 23790
DR   Wikidata; Q98133908
RX   PubMed=3191486;
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=9322873;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   UISO-MEL-23
AC   CVCL_ZL38
SY   UISO-Mel-23; MEL-23; University of Illinois Surgical Oncology-MELanoma-23
DR   IARC_TP53; 23798
DR   Wikidata; Q98133911
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=12894234;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-12G>T; Zygosity=Unspecified (PubMed=7872667).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   UISO-MEL-29
AC   CVCL_ZL43
SY   UISO-Mel-29; University of Illinois Surgical Oncology-MELanoma-29
DR   Wikidata; Q98133913
RX   PubMed=12894234;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   UISO-MEL-3
AC   CVCL_ZL39
SY   MEL-3; University of Illinois Surgical Oncology-MELanoma-3
DR   IARC_TP53; 23791
DR   Wikidata; Q98133915
RX   PubMed=7872667;
RX   PubMed=8012659;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   UISO-MEL-4
AC   CVCL_XF81
SY   MEL-4; University of Illinois Surgical Oncology-MELanoma-4
DR   IARC_TP53; 23792
DR   Wikidata; Q98133917
RX   PubMed=3191486;
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=9184169;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   UISO-MEL-4WP
AC   CVCL_ZL45
DR   Wikidata; Q98133920
RX   PubMed=9184169;
CC   Population: Caucasian.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11998; TP53.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF81 ! UISO-MEL-4
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   UISO-MEL-6
AC   CVCL_ZL40
SY   UISO-Mel-6; MEL-6; University of Illinois Surgical Oncology-MELanoma-6
DR   IARC_TP53; 23793
DR   Wikidata; Q98133922
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=9184169;
RX   PubMed=12894234;
CC   Characteristics: Metastatic to lung and liver in nude mice.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   UISO-MEL-7
AC   CVCL_ZL41
SY   MEL-7; University of Illinois Surgical Oncology-MELanoma-7
DR   IARC_TP53; 23794
DR   Wikidata; Q98133924
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=9184169;
RX   PubMed=12894234;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   UISO-MEL-8
AC   CVCL_ZL42
SY   MEL-8; University of Illinois Surgical Oncology-MELanoma-8
DR   IARC_TP53; 23795
DR   Wikidata; Q98133928
RX   PubMed=7872667;
RX   PubMed=8012659;
RX   PubMed=9184169;
RX   PubMed=12894234;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 4
//
ID   UISO-RS-3
AC   CVCL_Y581
SY   University of Illinois Surgical Oncology-RhadbomyoSarcoma-3
DR   Wikidata; Q54990246
RX   PubMed=2243060;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Doubling time: 1.5-2 days (Note=Depending on growth conditions) (PubMed=2243060).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UISO-SSCM-433
AC   CVCL_F0XI
SY   University of Illinois Surgical Oncology-Sinclair Swine Cutaneous Melanoma-433
RX   PubMed=1638485;
CC   Doubling time: 51.6 hours (Note=At 19th passage), 98.5 hours (Note=At 29th passage) (PubMed=1638485).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Sinclair Miniature pig.
DI   NCIt; C222359; Sinclair swine cutaneous melanoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   26W
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UISO-SSCM-438
AC   CVCL_F0XJ
SY   University of Illinois Surgical Oncology-Sinclair Swine Cutaneous Melanoma-438
RX   PubMed=1638485;
CC   Doubling time: 65.6 hours (Note=At 23th passage), 98.4 hours (Note=At 29th passage) (PubMed=1638485).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Sinclair Miniature pig.
DI   NCIt; C222359; Sinclair swine cutaneous melanoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   8W
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UISO-SSCM-5052
AC   CVCL_F0XK
SY   University of Illinois Surgical Oncology-Sinclair Swine Cutaneous Melanoma-5052
RX   PubMed=1638485;
CC   Doubling time: 106.4 hours (Note=At 11th passage), 76.8 hours (Note=At 29th passage) (PubMed=1638485).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Sinclair Miniature pig.
DI   NCIt; C222359; Sinclair swine cutaneous melanoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   8W
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UISO-SSCM-8093
AC   CVCL_F0XL
SY   University of Illinois Surgical Oncology-Sinclair Swine Cutaneous Melanoma-8093
RX   PubMed=1638485;
CC   Doubling time: 102.0 hours (Note=At 10th passage), 98.5 hours (Note=At 29th passage) (PubMed=1638485).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Sinclair Miniature pig.
DI   NCIt; C222359; Sinclair swine cutaneous melanoma
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Female
AG   15FW
CA   Cancer cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UIV-SL-373
AC   CVCL_AV44
DR   ICLDB; uiv-sl-373
DR   Wikidata; Q54990247
RX   DOI=10.1007/BF02618358;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   UIV-SL-573
AC   CVCL_AV45
DR   ICLDB; uiv-sl-573
DR   Wikidata; Q54990248
RX   DOI=10.1007/BF02618358;
CC   Group: Insect cell line.
CC   Doubling time: ~30 hours (DOI=10.1007/BF02618358).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   UIV-SL-673
AC   CVCL_AV46
DR   ICLDB; uiv-sl-673
DR   Wikidata; Q54990249
RX   DOI=10.1007/BF02618358;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7109; ! Spodoptera littoralis (Egyptian cotton leafworm)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   UJ13A
AC   CVCL_F0QL
RX   PubMed=2558078;
RX   PubMed=6852977;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13591; Human NCAM1/CD56.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UJ181.4
AC   CVCL_KS81
DR   Wikidata; Q54990250
RX   PubMed=2550359;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P32004; Human L1CAM/CD171.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   UJSi001-A
AC   CVCL_WN55
SY   WXZ-C3
DR   BioSamples; SAMEA5573422
DR   hPSCreg; UJSi001-A
DR   Wikidata; Q98133931
RX   PubMed=31102833;
CC   From: Jiangsu University; Jiangsu; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   UJSi002-A
AC   CVCL_B7MD
SY   ZRH-1
DR   BioSamples; SAMEA13061466
DR   hPSCreg; UJSi002-A
DR   Wikidata; Q112930512
RX   PubMed=35367693;
CC   From: Jiangsu University; Jiangsu; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   UJSi003-A
AC   CVCL_E8XB
SY   CZG
DR   BioSamples; SAMEA115628504
DR   hPSCreg; UJSi003-A
RX   PubMed=39154415;
CC   From: Jiangsu University; Jiangsu; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C140267; Hereditary spastic paraplegia
DI   ORDO; Orphanet_685; Hereditary spastic paraplegia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UJSi004-A
AC   CVCL_E8XC
SY   WSD
DR   BioSamples; SAMEA115658984
DR   hPSCreg; UJSi004-A
RX   PubMed=39423675;
CC   From: Jiangsu University; Jiangsu; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UJSi005-A
AC   CVCL_E8XD
DR   BioSamples; SAMEA118017496
DR   hPSCreg; UJSi005-A
CC   From: Jiangsu University; Jiangsu; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UK Pan-1
AC   CVCL_UW41
DR   cancercelllines; CVCL_UW41
DR   IARC_TP53; 17901
DR   Wikidata; Q98133936
RX   DOI=10.4172/2324-9293.1000104;
RX   PubMed=10813711;
CC   Doubling time: <24 hours (PubMed=10813711).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (PubMed=10813711).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (PubMed=10813711).
DI   NCIt; C9120; Pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   UK1
AC   CVCL_A5TT
DR   Wikidata; Q107117204
RX   PubMed=17944752;
RX   PubMed=20426848;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   UK1-3
AC   CVCL_XA87
SY   UK 1-3
DR   CCRID; 4201PAT-CCTCC00057
DR   JCRB; IFO50176
DR   Wikidata; Q98133940
RX   Patent=US5496549;
RX   Patent=US5506135;
RX   PubMed=1796414;
RX   PubMed=2107601;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2083.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Discontinued: JCRB; IFO50176; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   UK1-6
AC   CVCL_XA88
SY   UK 1-6
DR   CCRID; 4201PAT-CCTCC00065
DR   JCRB; IFO50208
DR   Wikidata; Q98133944
RX   Patent=US5496549;
RX   Patent=US5506135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2548.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Discontinued: JCRB; IFO50208; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   UK1-87
AC   CVCL_XA89
SY   UK 1-87
DR   CCRID; 4201PAT-CCTCC00058
DR   JCRB; IFO50177
DR   Wikidata; Q98133948
RX   Patent=US5496549;
RX   Patent=US5506135;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2084.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Discontinued: JCRB; IFO50177; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   UKAi001-A
AC   CVCL_A5GM
SY   iPS1; hsc3_hiPS_11
DR   BioSamples; SAMEA8133084
DR   hPSCreg; UKAi001-A
DR   Wikidata; Q107117205
RX   PubMed=28090699;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-A).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5GN ! UKAi001-B
OI   CVCL_A5GP ! UKAi001-C
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi001-A-1
AC   CVCL_A5GQ
SY   IRF8-/- iPS1; hsc3_hiPS_11_4; UKAi001-D
DR   BioSamples; SAMEA8152169
DR   hPSCreg; UKAi001-A-1
DR   Wikidata; Q107117206
RX   PubMed=28090699;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-A-1).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5GM ! UKAi001-A
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi001-B
AC   CVCL_A5GN
SY   iPS2; hsc3_hiPS_29
DR   BioSamples; SAMEA8133085
DR   hPSCreg; UKAi001-B
DR   Wikidata; Q107117207
RX   PubMed=28090699;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-B).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5GM ! UKAi001-A
OI   CVCL_A5GP ! UKAi001-C
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi001-B-1
AC   CVCL_A5GR
SY   IRF8-/- iPS2; hsc3_hiPS_29_23; UKAi001-E
DR   BioSamples; SAMEA8152171
DR   hPSCreg; UKAi001-B-1
DR   Wikidata; Q107117208
RX   PubMed=28090699;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-B-1).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5GN ! UKAi001-B
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi001-C
AC   CVCL_A5GP
SY   iPS3; hsc3_hiPS_40
DR   BioSamples; SAMEA8152162
DR   hPSCreg; UKAi001-C
DR   Wikidata; Q107117209
RX   PubMed=28090699;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-C).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5GM ! UKAi001-A
OI   CVCL_A5GN ! UKAi001-B
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi001-C-1
AC   CVCL_A5GS
SY   IRF8-/- iPS3; hsc3_hiPS_40_16_6; UKAi001-F
DR   BioSamples; SAMEA8152172
DR   hPSCreg; UKAi001-C-1
DR   Wikidata; Q107117210
RX   PubMed=28090699;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5358; IRF8.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Heterozygous (hPSCreg=UKAi001-C-1).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5GP ! UKAi001-C
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi002-A
AC   CVCL_A7GU
SY   PBMNC2_hiPS_007; PV1 JAK2
DR   BioSamples; SAMEA8377052
DR   hPSCreg; UKAi002-A
DR   Wikidata; Q107117211
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a JAK2 p.Val617Phe mutation, but this cell line does not contain this mutation.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7GV ! UKAi002-B
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UKAi002-A-1
AC   CVCL_A7GW
SY   PV1 JAK2:CXCL4 KO; JAK2:CXCL4KO
DR   BioSamples; SAMEA8686796
DR   hPSCreg; UKAi002-A-1
DR   Wikidata; Q107117213
RX   PubMed=34391098;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a JAK2 p.Val617Phe mutation, but this cell line does not contain this mutation.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8861; PF4.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34391098
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,14
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12,15
ST   FGA: 20,24
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7GU ! UKAi002-A
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi002-B
AC   CVCL_A7GV
SY   PBMNC2_hiPS_009; PV1 JAK2 V617F het
DR   BioSamples; SAMEA8549164
DR   hPSCreg; UKAi002-B
DR   Wikidata; Q107117214
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (hPSCreg=UKAi002-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7GU ! UKAi002-A
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi002-B-1
AC   CVCL_A7GX
SY   PV1 JAK2 V617F het:CXCL4 KO; JAK2 V617Fhet:CXCL4KO
DR   BioSamples; SAMEA8686795
DR   hPSCreg; UKAi002-B-1
DR   Wikidata; Q107117215
RX   PubMed=34391098;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8861; PF4.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (PubMed=34391098).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34391098
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,14
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 29,30.2
ST   D2S1338: 17,25
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,9
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 15,16
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7GV ! UKAi002-B
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi003-A
AC   CVCL_A7GY
SY   hsc4_hiPS_021; PV2 JAK2 V617F hom
DR   BioSamples; SAMEA8394205
DR   hPSCreg; UKAi003-A
DR   Wikidata; Q107117216
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (hPSCreg=UKAi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi003-A-1
AC   CVCL_A7GZ
SY   PV2 JAK2 V617F het
DR   BioSamples; SAMEA8686793
DR   hPSCreg; UKAi003-A-1
DR   Wikidata; Q107117218
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous (hPSCreg=UKAi003-A-1).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_corrected; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UKAi003-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7GY ! UKAi003-A
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi003-A-2
AC   CVCL_A7HA
SY   PV2 JAK2
DR   BioSamples; SAMEA8686794
DR   hPSCreg; UKAi003-A-2
DR   Wikidata; Q107117219
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple_corrected; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=UKAi003-A-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3336; Polycythemia vera
DI   ORDO; Orphanet_729; Polycythemia vera
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A7GY ! UKAi003-A
SX   Male
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi004-A
AC   CVCL_A5IU
SY   P4_wt4; Patient 1 control 1
DR   BioSamples; SAMEA8172007
DR   hPSCreg; UKAi004-A
DR   Wikidata; Q107117221
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IV ! UKAi004-B
OI   CVCL_A5IW ! UKAi004-C
OI   CVCL_A5IX ! UKAi004-D
OI   CVCL_A5IY ! UKAi004-E
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi004-B
AC   CVCL_A5IV
SY   P4_wt8; Patient 1 control 2
DR   BioSamples; SAMEA8231213
DR   hPSCreg; UKAi004-B
DR   Wikidata; Q107117222
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Cys973Alafs*34 (c.2917delT); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IU ! UKAi004-A
OI   CVCL_A5IW ! UKAi004-C
OI   CVCL_A5IX ! UKAi004-D
OI   CVCL_A5IY ! UKAi004-E
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi004-C
AC   CVCL_A5IW
SY   P4_mut13; Patient 1 KIT D816V 1
DR   BioSamples; SAMEA8231214
DR   hPSCreg; UKAi004-C
DR   Wikidata; Q107117223
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IU ! UKAi004-A
OI   CVCL_A5IV ! UKAi004-B
OI   CVCL_A5IX ! UKAi004-D
OI   CVCL_A5IY ! UKAi004-E
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi004-D
AC   CVCL_A5IX
SY   P4_mut28; Patient 1 KIT D816V 2
DR   BioSamples; SAMEA8231215
DR   hPSCreg; UKAi004-D
DR   Wikidata; Q107117224
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IU ! UKAi004-A
OI   CVCL_A5IV ! UKAi004-B
OI   CVCL_A5IW ! UKAi004-C
OI   CVCL_A5IY ! UKAi004-E
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi004-E
AC   CVCL_A5IY
SY   P4_mut30; Patient 1 KIT D816V 3
DR   BioSamples; SAMEA8231216
DR   hPSCreg; UKAi004-E
DR   Wikidata; Q107117225
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Ser972Leu (c.2915C>T); ClinVar=VCV000133443; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:7780; NFE2; Simple; p.Glu261Alafs*3 (c.782_785delAGAG); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A.G); ClinVar=VCV000135287; Zygosity=Homozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Heterozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IU ! UKAi004-A
OI   CVCL_A5IV ! UKAi004-B
OI   CVCL_A5IW ! UKAi004-C
OI   CVCL_A5IX ! UKAi004-D
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi005-A
AC   CVCL_A5MX
SY   IEM 1
DR   hPSCreg; UKAi005-A
DR   Wikidata; Q107117226
RX   PubMed=30720580;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=30720580).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   UKAi006-A
AC   CVCL_A5MY
SY   IEM 2
DR   BioSamples; SAMEA8268469
DR   hPSCreg; UKAi006-A
DR   Wikidata; Q107117227
RX   PubMed=30720580;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10597; SCN9A; Simple; p.Ile859Thr (c.2576T>C) (p.Ile848Thr, c.2543T>C); ClinVar=VCV000006350; Zygosity=Heterozygous (PubMed=30720580).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34593; Erythromelalgia
DI   ORDO; Orphanet_90026; Primary erythromelalgia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   UKAi007-A
AC   CVCL_A5MZ
SY   P13_wt5; Patient 2 control 1
DR   BioSamples; SAMEA8268471
DR   hPSCreg; UKAi007-A
DR   Wikidata; Q107117229
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:10471; RUNX1; Simple; p.Val101Alafs*31 (c.302_318del); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Arg1465Ter (c.4393C>T); ClinVar=VCV001899776; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NA ! UKAi007-B
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi007-B
AC   CVCL_A5NA
SY   P13_mut1; Patient 2 KIT D816V 1
DR   BioSamples; SAMEA8268472
DR   hPSCreg; UKAi007-B
DR   Wikidata; Q107117230
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:76; ABL1; Simple; p.Gly725Ser (c.2173G>A) (p.Gly706Ser, c.2116G>A); ClinVar=VCV000133445; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:5382; IDH1; Simple; p.Val178Ile (c.532G>A); ClinVar=VCV000134520; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:10471; RUNX1; Simple; p.Met133Ile (c.399G>A); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:10783; SRSF2; Simple; p.Pro95_Arg102del (c.284_307del); dbSNP=rs766200080; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Arg1261Cys (c.3781C>T); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ser1292Arg (c.3876C>G); Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5MZ ! UKAi007-A
SX   Male
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi008-A
AC   CVCL_A5NB
SY   P15_wt37; Patient 3 control 1
DR   BioSamples; SAMEA8268473
DR   hPSCreg; UKAi008-A
DR   Wikidata; Q107117231
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NC ! UKAi008-B
OI   CVCL_A5ND ! UKAi008-C
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi008-B
AC   CVCL_A5NC
SY   P15_wt108; Patient 3 control 2
DR   BioSamples; SAMEA8268474
DR   hPSCreg; UKAi008-B
DR   Wikidata; Q107117232
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Characteristics: Established from a patient that has a KIT p.Asp816Val mutation, but this cell line does not contain this mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NB ! UKAi008-A
OI   CVCL_A5ND ! UKAi008-C
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi008-C
AC   CVCL_A5ND
SY   P15_mut131; Patient 3 KIT D816V 1
DR   BioSamples; SAMEA8268475
DR   hPSCreg; UKAi008-C
DR   Wikidata; Q107117234
RX   PubMed=33512435;
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asp816Val (c.2447A>T); ClinVar=VCV000013852; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Ser478Pro (c.1432T>C); ClinVar=VCV000041794; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Leu34Phe (c.100C>T); ClinVar=VCV000135308; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Val218Met (c.652G>A); ClinVar=VCV000135321; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.Ile1762Val (c.5284A>G); ClinVar=VCV000135287; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:25941; TET2; Simple; p.His1778Arg (c.5333A>G); ClinVar=VCV000135289; Zygosity=Heterozygous (PubMed=33512435).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro72Arg (c.215C>G); ClinVar=VCV000012351; Zygosity=Homozygous (PubMed=33512435).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9235; Systemic mastocytosis
DI   ORDO; Orphanet_2467; Systemic mastocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5NB ! UKAi008-A
OI   CVCL_A5NC ! UKAi008-B
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UKAi009-A
AC   CVCL_C6T6
SY   BM 102-2
DR   BioSamples; SAMEA111343657
DR   hPSCreg; UKAi009-A
DR   Wikidata; Q117704912
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKAi010-A
AC   CVCL_C6T7
SY   BM 104-12
DR   BioSamples; SAMEA111374631
DR   hPSCreg; UKAi010-A
DR   Wikidata; Q117704913
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKAi011-A
AC   CVCL_C6T8
SY   BM 106-3
DR   BioSamples; SAMEA111379120
DR   hPSCreg; UKAi011-A
DR   Wikidata; Q117704914
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKAi012-A
AC   CVCL_C6T9
SY   TF11-C2.3
DR   hPSCreg; UKAi012-A
DR   Wikidata; Q117704915
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKAi013-A
AC   CVCL_D0NQ
SY   PV3026WT
DR   BioSamples; SAMEA113565947
DR   hPSCreg; UKAi013-A
DR   Wikidata; Q123033707
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
OI   CVCL_D0NR ! UKAi013-B
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKAi013-B
AC   CVCL_D0NR
SY   PV3006HT
DR   hPSCreg; UKAi013-B
DR   Wikidata; Q123033708
CC   From: Universitatsklinikum Aachen; Aachen; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
OI   CVCL_D0NQ ! UKAi013-A
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKBi005-A
AC   CVCL_1E85
SY   iLB-C-31f-r1; iLB-C-31f-R1; LB-31-1
DR   BioSamples; SAMEA4584351
DR   EBiSC; UKBi005-A
DR   ECACC; 66540008
DR   hPSCreg; UKBi005-A
DR   SKIP; SKIP002508
DR   Wikidata; Q54990251
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Discontinued: ECACC; 66540008; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 12
//
ID   UKBi006-A
AC   CVCL_1E86
SY   iLB-C-35m-R1; LB-35-1
DR   BioSamples; SAMEA2590936
DR   EBiSC; UKBi006-A
DR   ECACC; 66540004
DR   hPSCreg; UKBi006-A
DR   SKIP; SKIP002509
DR   Wikidata; Q54990265
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian; German.
CC   Discontinued: ECACC; 66540004; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 12
//
ID   UKBi010-A
AC   CVCL_IU29
SY   iLB-DS-95f-r8
DR   BioSamples; SAMEA104008300
DR   EBiSC; UKBi010-A
DR   ECACC; 66540572
DR   hPSCreg; UKBi010-A
DR   SKIP; SKIP002908
DR   Wikidata; Q54990266
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Ile110Valfs*10 (c.323_326dupTGTA); Zygosity=Unspecified (EBiSC=UKBi010-A).
CC   Discontinued: EBiSC; UKBi010-A; true.
CC   Discontinued: ECACC; 66540572; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-9Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 16
//
ID   UKBi011-A
AC   CVCL_LE34
SY   iLB-AD-169bm-S24
DR   BioSamples; SAMEA104132640
DR   EBiSC; UKBi011-A
DR   ECACC; 66540594
DR   hPSCreg; UKBi011-A
DR   Wikidata; Q54990267
RX   PubMed=29753274;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=29753274).
CC   Discontinued: ECACC; 66540594; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   UKBi011-A-1
AC   CVCL_RM82
SY   APOE-KO; iLB-AD + ApoE KO
DR   BioSamples; SAMEA104243174
DR   EBiSC; UKBi011-A-1
DR   ECACC; 66540617
DR   hPSCreg; UKBi011-A-1
DR   Wikidata; Q54990269
RX   PubMed=33556820;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:613; APOE.
CC   Discontinued: ECACC; 66540617; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LE34 ! UKBi011-A
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   UKBi011-A-2
AC   CVCL_VN45
SY   APOE-2/2; ApoE 2/2
DR   BioSamples; SAMEA104243175
DR   EBiSC; UKBi011-A-2
DR   ECACC; 66540618
DR   hPSCreg; UKBi011-A-2
DR   Wikidata; Q98133951
RX   PubMed=33556820;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_corrected; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33556820).
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_edited; p.Arg176Cys (c.526C>T); ClinVar=VCV000017848; Zygosity=Homozygous; Note=By CRISPR/Cas9. ApoE2 allele (PubMed=33556820).
CC   Discontinued: ECACC; 66540618; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RX83 ! UKBi011-A-3
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 11
//
ID   UKBi011-A-3
AC   CVCL_RX83
SY   APOE-3/3; ApoE 3/3
DR   BioSamples; SAMEA104243176
DR   EBiSC; UKBi011-A-3
DR   ECACC; 66540619
DR   hPSCreg; UKBi011-A-3
DR   Wikidata; Q54990270
RX   PubMed=33556820;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_corrected; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33556820).
CC   Discontinued: ECACC; 66540619; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LE34 ! UKBi011-A
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   UKBi011-A-4
AC   CVCL_RM83
SY   APOE-3/4; ApoE 3/4
DR   BioSamples; SAMEA104243177
DR   EBiSC; UKBi011-A-4
DR   ECACC; 66540620
DR   hPSCreg; UKBi011-A-4
DR   Wikidata; Q54990271
RX   PubMed=33556820;
CC   From: Bioneer A/S; Horsholm; Denmark.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous (PubMed=33556820).
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_corrected; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33556820).
CC   Discontinued: EBiSC; UKBi011-A-4; true.
CC   Discontinued: ECACC; 66540620; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LE34 ! UKBi011-A
SX   Male
AG   80Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   UKBi012-A
AC   CVCL_LE35
SY   ILB-C-108bm-S3
DR   BioSamples; SAMEA104382074
DR   hPSCreg; UKBi012-A
DR   Wikidata; Q54990273
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 7
//
ID   UKBi013-A
AC   CVCL_LE36
SY   ILB-C-133bm-S4
DR   BioSamples; SAMEA104382150
DR   hPSCreg; UKBi013-A
DR   Wikidata; Q54990274
RX   PubMed=35392923;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 8
//
ID   UKBi014-A
AC   CVCL_YT14
SY   A-257s2; LB257-s2
DR   BioSamples; SAMEA5782238
DR   hPSCreg; UKBi014-A
DR   Wikidata; Q98133955
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C126742; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 2
DI   ORDO; Orphanet_899; Walker-Warburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   UKBi015-A
AC   CVCL_A9Q8
SY   iLB-C16bm-s6; iLB-C16bm s6
DR   BioSamples; SAMEA7249008
DR   hPSCreg; UKBi015-A
DR   Wikidata; Q102115056
RX   PubMed=35392923;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XE ! UKBi015-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 6
//
ID   UKBi015-A-6
AC   CVCL_E8WL
SY   iLB-C16bm-s6 edit BAG3 E2
DR   BioSamples; SAMEA115753180
DR   hPSCreg; UKBi015-A-6
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_edited; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UKBi015-A-6).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q8 ! UKBi015-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi015-A-7
AC   CVCL_E8WM
SY   iLB-C16bm-s6 edit BAG3 E10
DR   BioSamples; SAMEA115753181
DR   hPSCreg; UKBi015-A-7
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_edited; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UKBi015-A-7).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q8 ! UKBi015-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi015-A-8
AC   CVCL_E8WN
SY   iLB-C16bm-s6 non-edit BAG3 E5
DR   BioSamples; SAMEA115753257
DR   hPSCreg; UKBi015-A-8
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Characteristics: Control cell line for UKBi015-A-6 (Cellosaurus=CVCL_E8WL) and UKBi015-A-7 (Cellosaurus=CVCL_E8WM). underwent the same experimental procedure without actual genetic modification of the BAG3 gene (hPSCreg=UKBi015-A-8).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9Q8 ! UKBi015-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi015-B
AC   CVCL_C1XE
SY   iLB-C16bm-2; iLB-C16bm-s16
DR   BioSamples; SAMEA112136914
DR   hPSCreg; UKBi015-B
DR   Wikidata; Q114313164
RX   PubMed=35392923;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9Q8 ! UKBi015-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 5
//
ID   UKBi016-A
AC   CVCL_A9Q9
SY   iLB-C107bm-s9
DR   BioSamples; SAMEA7655479
DR   hPSCreg; UKBi016-A
DR   Wikidata; Q102115057
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   UKBi017-A
AC   CVCL_A1XE
SY   iLB-C14m-s11; C14
DR   BioSamples; SAMEA7629287
DR   hPSCreg; UKBi017-A
DR   Wikidata; Q105511332
RX   PubMed=37137886;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 6
//
ID   UKBi018-A
AC   CVCL_C1XD
SY   iLB-C-106bf-s8
DR   BioSamples; SAMEA12364165
DR   hPSCreg; UKBi018-A
DR   Wikidata; Q114313165
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 05-10-23; Version: 4
//
ID   UKBi019-A
AC   CVCL_D0MP
SY   iLB-C89bf-s7
DR   BioSamples; SAMEA112682503
DR   hPSCreg; UKBi019-A
DR   Wikidata; Q123033709
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   UKBi020-A
AC   CVCL_E8WF
SY   iLB-C-105bm-s4
DR   BioSamples; SAMEA115633943
DR   hPSCreg; UKBi020-A
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi021-A
AC   CVCL_E8WG
SY   iLB-C-109bm-s6
DR   BioSamples; SAMEA115633944
DR   hPSCreg; UKBi021-A
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi022-A
AC   CVCL_E8WH
SY   iLB-BAG3-301bm-s2; DE20RENUKBD102753 / R06C02
DR   BioSamples; SAMEA116110572
DR   hPSCreg; UKBi022-A
RX   PubMed=39662463;
RX   PubMed=40252588;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous (PubMed=40252588).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi022-A-1
AC   CVCL_E8WI
SY   iLB-BAG3-301bm-s2 BAG3 edit
DR   BioSamples; SAMEA116131058
DR   hPSCreg; UKBi022-A-1
RX   PubMed=39662463;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_corrected; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39662463).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8WH ! UKBi022-A
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi023-A
AC   CVCL_E8WJ
SY   iLB-BAG3-P209L-313bm-s9; DE02RENUKBD102786
DR   BioSamples; SAMEA116113088
DR   hPSCreg; UKBi023-A
RX   PubMed=39662463;
RX   PubMed=40252588;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous (PubMed=40252588).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKBi023-A-1
AC   CVCL_E8WK
SY   iLB-BAG3-P209L-313bm-s9 BAG3 edit
DR   BioSamples; SAMEA116132043
DR   hPSCreg; UKBi023-A-1
RX   PubMed=39662463;
CC   From: Institut fur Rekonstruktive Neurobiologie, University Clinic of Bonn; Bonn; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:939; BAG3; Simple_corrected; p.Pro209Leu (c.626C>T); ClinVar=VCV000005981; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39662463).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217088; Myofibrillar myopathy 6
DI   ORDO; Orphanet_199340; Muscular dystrophy, Selcen type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8WJ ! UKBi023-A
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UKE-1
AC   CVCL_0104
SY   UKE1; GM23245
DR   BTO; BTO_0004765
DR   EFO; EFO_0006307
DR   ArrayExpress; E-MTAB-2706
DR   cancercelllines; CVCL_0104
DR   Coriell; GM23245
DR   Cosmic; 1012055
DR   Cosmic; 1281361
DR   Cosmic; 1519161
DR   Cosmic; 1633514
DR   Cosmic; 2306996
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM1374976
DR   PharmacoDB; UKE1_1641_2019
DR   Wikidata; Q54990275
RX   PubMed=10640966;
RX   PubMed=16408098;
RX   PubMed=22829968;
RX   PubMed=25485619;
RX   PubMed=26589293;
CC   HLA typing: A*02:01,03:01; B*07:02,35:03; C*04:01,07:02; DQA1*01:02,04:01; DQB1*04:01,06:02; DRB1*08:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (PubMed=16408098).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Patient had a essential thrombocythemia transformed into acute leukemia.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3407; Essential thrombocythemia
DI   ORDO; Orphanet_3318; Essential thrombocythemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   UKE-1/TGR
AC   CVCL_4Z62
DR   cancercelllines; CVCL_4Z62
DR   Wikidata; Q54990276
RX   PubMed=21976548;
CC   Selected for resistance to: ChEBI; CHEBI_90304; TG101209 (N-(tert-butyl)-3-((5-methyl-2-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Val617Phe (c.1849G>T); ClinVar=VCV000014662; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3407; Essential thrombocythemia
DI   ORDO; Orphanet_3318; Essential thrombocythemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0104 ! UKE-1
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   UKEAC-99
AC   CVCL_EJ02
SY   Universitats Klinikum Eppendorf Ampullary Cancer-1999
DR   Wikidata; Q54990277
RX   PubMed=12680226;
RX   PubMed=26951071;
CC   Doubling time: 27 hours (PubMed=12680226).
CC   Miscellaneous: Cell line has been discarded (PubMed=26951071).
CC   Derived from site: In situ; Pancreas, ampulla of Vater; UBERON=UBERON_0004913.
DI   NCIt; C6650; Ampulla of Vater adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   UKEi001-A
AC   CVCL_A8PR
SY   ERC001sv1162; ERC001
DR   BioSamples; SAMEA6235102
DR   hPSCreg; UKEi001-A
DR   Wikidata; Q108821435
RX   PubMed=32697997;
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PS ! UKEi001-B
OI   CVCL_C9HG ! UKEi001-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   UKEi001-A-1
AC   CVCL_C9HF
SY   CRYABhom
DR   BioSamples; SAMEA112647719
DR   hPSCreg; UKEi001-A-1
DR   Wikidata; Q123033710
RX   PubMed=37633027;
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2389; CRYAB; Simple_edited; p.Arg120Gly (c.358A>G); ClinVar=VCV000016953; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37633027).
CC   Sequence variation: Mutation; HGNC; HGNC:2389; CRYAB; Simple_edited; p.Arg120Arg (c.360G>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37633027).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206516; Myofibrillar myopathy 2
DI   ORDO; Orphanet_399058; Alpha-B crystallin-related late-onset myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8PR ! UKEi001-A
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UKEi001-B
AC   CVCL_A8PS
SY   ERC001sv1352
DR   hPSCreg; UKEi001-B
DR   Wikidata; Q108821436
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PR ! UKEi001-A
OI   CVCL_C9HG ! UKEi001-C
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   UKEi001-C
AC   CVCL_C9HG
SY   ERC001sv1355
DR   BioSamples; SAMEA112286109
DR   hPSCreg; UKEi001-C
DR   Wikidata; Q123033711
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PR ! UKEi001-A
OI   CVCL_A8PS ! UKEi001-B
SX   Female
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKEi002-A
AC   CVCL_C9HH
SY   ERC017sv2575
DR   BioSamples; SAMEA112286195
DR   hPSCreg; UKEi002-A
DR   Wikidata; Q123033712
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9HI ! UKEi002-B
OI   CVCL_C9HJ ! UKEi002-C
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKEi002-B
AC   CVCL_C9HI
SY   ERC017sv2576
DR   BioSamples; SAMEA112294707
DR   hPSCreg; UKEi002-B
DR   Wikidata; Q123033713
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9HH ! UKEi002-A
OI   CVCL_C9HJ ! UKEi002-C
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKEi002-C
AC   CVCL_C9HJ
SY   ERC017sv2596
DR   BioSamples; SAMEA112294708
DR   hPSCreg; UKEi002-C
DR   Wikidata; Q123033714
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9HH ! UKEi002-A
OI   CVCL_C9HI ! UKEi002-B
SX   Female
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKEi003-A
AC   CVCL_A8PT
SY   ERC018sv1583
DR   BioSamples; SAMEA112322125
DR   hPSCreg; UKEi003-A
DR   Wikidata; Q108821437
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PU ! UKEi003-B
OI   CVCL_A8PV ! UKEi003-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   UKEi003-B
AC   CVCL_A8PU
SY   ERC018sv1590
DR   BioSamples; SAMEA112295062
DR   hPSCreg; UKEi003-B
DR   Wikidata; Q108821438
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PT ! UKEi003-A
OI   CVCL_A8PV ! UKEi003-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   UKEi003-C
AC   CVCL_A8PV
SY   ERC018sv1634
DR   BioSamples; SAMEA6248848
DR   hPSCreg; UKEi003-C
DR   Wikidata; Q108821439
RX   PubMed=32697997;
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PT ! UKEi003-A
OI   CVCL_A8PU ! UKEi003-B
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 6
//
ID   UKEi004-A
AC   CVCL_C9HK
SY   ERC004sv4369
DR   hPSCreg; UKEi004-A
DR   Wikidata; Q123033716
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UKEi070-A
AC   CVCL_A0YS
SY   Het
DR   BioSamples; SAMEA8944455
DR   hPSCreg; UKEi070-A
DR   Wikidata; Q108821440
RX   PubMed=34375846;
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=34375846).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UKEi070-A-1
AC   CVCL_A0YT
SY   Iso Co; Rep 28
DR   BioSamples; SAMEA8944457
DR   hPSCreg; UKEi070-A-1
DR   Wikidata; Q108821441
RX   PubMed=34375846;
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_corrected; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Causes aberrant splicing (PubMed=34375846).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0YS ! UKEi070-A
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UKEi070-A-2
AC   CVCL_A0YU
SY   cpHet; Mut 103
DR   BioSamples; SAMEA8944461
DR   hPSCreg; UKEi070-A-2
DR   Wikidata; Q108821442
RX   PubMed=34375846;
CC   From: University Medical Center Hamburg-Eppendorf; Hamburg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Asp770Asn (c.2308G>A) (p.Asp770Serfs*98); ClinVar=VCV000036604; Zygosity=Heterozygous; Note=Causes aberrant splicing (PubMed=34375846).
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple_edited; p.Arg943Ter (c.2827C>T); ClinVar=VCV000037039; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34375846).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A0YS ! UKEi070-A
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UKERe006-C
AC   CVCL_A9YT
SY   84e5 S9
DR   BioSamples; SAMEA6655204
DR   hPSCreg; UKERe006-C
DR   Wikidata; Q102115059
RX   PubMed=32682288;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   UKERe006-D
AC   CVCL_A9YU
SY   922e6 S8
DR   BioSamples; SAMEA6655205
DR   hPSCreg; UKERe006-D
DR   Wikidata; Q102115060
RX   PubMed=32682288;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B194 ! HUES 6
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   UKERe008-A-1
AC   CVCL_C7FI
DR   BioSamples; SAMEA111502280
DR   hPSCreg; UKERe008-A-1
DR   Wikidata; Q117704916
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKERe008-A-2
AC   CVCL_C7FJ
DR   BioSamples; SAMEA111502281
DR   hPSCreg; UKERe008-A-2
DR   Wikidata; Q117704917
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKERe008-A-3
AC   CVCL_C7FK
DR   BioSamples; SAMEA111502282
DR   hPSCreg; UKERe008-A-3
DR   Wikidata; Q117704918
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKERe008-A-4
AC   CVCL_C7FL
DR   BioSamples; SAMEA111502283
DR   hPSCreg; UKERe008-A-4
DR   Wikidata; Q117704919
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36610307).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKERe008-A-5
AC   CVCL_C7FM
DR   BioSamples; SAMEA111502284
DR   hPSCreg; UKERe008-A-5
DR   Wikidata; Q117704920
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36610307).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKERe008-A-6
AC   CVCL_C7FN
DR   BioSamples; SAMEA111502285
DR   hPSCreg; UKERe008-A-6
DR   Wikidata; Q117704921
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=36610307).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKERe008-A-7
AC   CVCL_C7FP
DR   BioSamples; SAMEA111502286
DR   hPSCreg; UKERe008-A-7
DR   Wikidata; Q117704922
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36610307).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKERe008-A-8
AC   CVCL_C7FQ
DR   BioSamples; SAMEA111502519
DR   hPSCreg; UKERe008-A-8
DR   Wikidata; Q117704923
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36610307).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKERe008-A-9
AC   CVCL_C7FR
DR   BioSamples; SAMEA111502521
DR   hPSCreg; UKERe008-A-9
DR   Wikidata; Q117704924
RX   PubMed=36610307;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=36610307).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKERi001-A
AC   CVCL_IT77
SY   UKERiG3G-R1-047
DR   BioSamples; SAMEA104010735
DR   hPSCreg; UKERi001-A
DR   SKIP; SKIP002909
DR   Wikidata; Q54990279
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   UKERi002-A
AC   CVCL_VF22
SY   UKERiM89-R1-006
DR   BioSamples; SAMEA104010907
DR   hPSCreg; UKERi002-A
DR   Wikidata; Q54990281
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1K0 ! UKERi002-B
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   UKERi002-B
AC   CVCL_C1K0
SY   UKERiM89-R1-005
DR   Wikidata; Q114313166
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF22 ! UKERi002-A
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UKERi003-A
AC   CVCL_VF23
SY   UKERiPX7-R1-001
DR   BioSamples; SAMEA104010909
DR   hPSCreg; UKERi003-A
DR   Wikidata; Q54990282
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1K1 ! UKERi003-B
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   UKERi003-B
AC   CVCL_C1K1
SY   UKERiPX7-R1-002
DR   Wikidata; Q114313168
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF23 ! UKERi003-A
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UKERi004-A
AC   CVCL_IT78
SY   UKERi88H-R1-001
DR   BioSamples; SAMEA104010911
DR   hPSCreg; UKERi004-A
DR   SKIP; SKIP002910
DR   Wikidata; Q54990283
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1K2 ! UKERi004-B
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   UKERi004-B
AC   CVCL_C1K2
SY   UKERi88H-R1-002
DR   Wikidata; Q114313169
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT78 ! UKERi004-A
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UKERi005-A
AC   CVCL_IT79
SY   UKERiO3H-R1-001
DR   BioSamples; SAMEA104010913
DR   hPSCreg; UKERi005-A
DR   SKIP; SKIP002911
DR   Wikidata; Q54990284
RX   PubMed=30503201;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   UKERi006-A
AC   CVCL_IT80
SY   UKERi82A-R1-002
DR   BioSamples; SAMEA104011169
DR   hPSCreg; UKERi006-A
DR   SKIP; SKIP002912
DR   Wikidata; Q54990286
RX   CelloPub=CLPUB00713;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN18 ! UKERi006-B
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 8
//
ID   UKERi006-B
AC   CVCL_YN18
SY   UKERi82A-R1-001; UKERi82A-S1-017
DR   BioSamples; SAMEA13024975
DR   hPSCreg; UKERi006-B
DR   Wikidata; Q98133960
RX   CelloPub=CLPUB00713;
RX   PubMed=30503201;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT80 ! UKERi006-A
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   UKERi009-A
AC   CVCL_C1JQ
SY   UKERi33Q-R2-006
DR   BioSamples; SAMEA13024890
DR   hPSCreg; UKERi009-A
DR   Wikidata; Q114313170
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UKERi010-A
AC   CVCL_C1JR
SY   UKERi7MN-S1-010
DR   BioSamples; SAMEA110284858
DR   hPSCreg; UKERi010-A
DR   Wikidata; Q114313171
RX   PubMed=36283273;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UKERi010-A-1
AC   CVCL_C1JS
SY   UKERi7MN-010-1
DR   BioSamples; SAMEA110290094
DR   hPSCreg; UKERi010-A-1
DR   Wikidata; Q114313172
RX   PubMed=36283273;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA.
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1JR ! UKERi010-A
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UKERi010-A-2
AC   CVCL_C1JT
SY   UKERi7MN-010-2
DR   BioSamples; SAMEA110290101
DR   hPSCreg; UKERi010-A-2
DR   Wikidata; Q114313173
RX   PubMed=36283273;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11138; SNCA (Note=1 of 2 alleles).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C1JR ! UKERi010-A
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   UKERi313-R1
AC   CVCL_YN19
DR   Wikidata; Q98133964
RX   PubMed=30503201;
CC   From: Universitatsklinikum Erlangen (UKER); Erlangen; Germany.
CC   Population: Caucasian; Norwegian.
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg923His (c.2768G>A); ClinVar=VCV000936757; Zygosity=Unspecified (PubMed=30503201).
CC   Sequence variation: Mutation; HGNC; HGNC:10583; SCN11A; Simple; p.Asn1169Ser (c.3506A>G); ClinVar=VCV000474720; Zygosity=Unspecified (PubMed=30503201).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125389; Small fiber neuropathy
DI   ORDO; Orphanet_306577; Sodium channelopathy-related small fiber neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-1
AC   CVCL_XA30
DR   Wikidata; Q98133968
RX   CelloPub=CLPUB00123;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   UKF-NB-2
AC   CVCL_9902
SY   UKF-NB2
DR   Wikidata; Q54990287
RX   CelloPub=CLPUB00123;
RX   PubMed=8949988;
RX   PubMed=9201287;
RX   PubMed=9443419;
RX   PubMed=12532417;
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=22170099;
RX   PubMed=24466371;
RX   PubMed=25749379;
CC   Doubling time: 22.5-25.6 hours (PubMed=9443419); 25 hours (PubMed=12532417).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UKF-NB-2AD169
AC   CVCL_9903
DR   Wikidata; Q54990288
RX   PubMed=9443419;
CC   Virology: Persistently infected with human cytomegalovirus (HCMV) strain AD169.
CC   Doubling time: 28.2-31.5 hours (PubMed=9443419).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 13
//
ID   UKF-NB-2rCARBO2000
AC   CVCL_RT20
DR   Wikidata; Q54990289
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rCDDP1000
AC   CVCL_9908
SY   UKF-NB-2 CDDP
DR   Wikidata; Q54990291
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UKF-NB-2rDACARB4
AC   CVCL_RT02
DR   Wikidata; Q54990292
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-2rDOCE10
AC   CVCL_RR83
SY   UKF-NB-2rDoce10
DR   Wikidata; Q54990293
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rDOX100
AC   CVCL_9909
SY   UKF-NB-2 DOXO
DR   Wikidata; Q54990294
RX   PubMed=12532417;
RX   PubMed=16151587;
RX   PubMed=17505515;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 21 hours (PubMed=12532417).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UKF-NB-2rDOX20
AC   CVCL_RS01
DR   Wikidata; Q54990295
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rETO40
AC   CVCL_RT03
DR   Wikidata; Q54990297
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rETO400
AC   CVCL_RT04
DR   Wikidata; Q54990298
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rIRINO400
AC   CVCL_RT05
DR   Wikidata; Q54990299
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rMEL600
AC   CVCL_RR84
DR   Wikidata; Q54990300
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rNutlin10muM
AC   CVCL_RS02
DR   Wikidata; Q54990301
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rOXALI600
AC   CVCL_RR85
DR   Wikidata; Q54990303
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rPCL20
AC   CVCL_RT06
DR   Wikidata; Q54990304
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rTOPO10
AC   CVCL_RR86
DR   Wikidata; Q54990305
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rVCR10
AC   CVCL_9910
SY   UKF-NB-2 VCR
DR   Wikidata; Q54990306
RX   PubMed=12532417;
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=22170099;
RX   PubMed=25749379;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 27 hours (PubMed=12532417).
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   UKF-NB-2rVCR20
AC   CVCL_RS00
DR   Wikidata; Q54990307
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rVINB10
AC   CVCL_RR87
DR   Wikidata; Q54990309
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-2rVINOR10
AC   CVCL_RR88
DR   Wikidata; Q54990310
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9902 ! UKF-NB-2
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-3
AC   CVCL_9904
SY   UKF-NB3
DR   IARC_TP53; 26506
DR   Wikidata; Q54990311
RX   CelloPub=CLPUB00123;
RX   PubMed=8949988;
RX   PubMed=9201287;
RX   PubMed=16142320;
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=19147553;
RX   PubMed=22170099;
RX   PubMed=22476102;
RX   PubMed=24466371;
RX   PubMed=25749379;
RX   PubMed=27517323;
RX   PubMed=27735941;
RX   PubMed=31581737;
CC   Doubling time: 22 +- 1.9 hours (PubMed=16142320); 26.6 +- 8.2 hours (PubMed=27517323).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 16,21
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 9,10
ST   FGA: 19,25
ST   Penta D: 8,15
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 27-11-25; Version: 15
//
ID   UKF-NB-3rBORTE20
AC   CVCL_RT07
DR   Wikidata; Q54990312
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_52717; Bortezomib (Velcade).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rCABAZI2
AC   CVCL_RT08
DR   Wikidata; Q54990313
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63584; Cabazitaxel.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rCARBO2000
AC   CVCL_RR89
DR   Wikidata; Q54990332
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rCDDP1000
AC   CVCL_M478
SY   UKF-NB-3 CDDP
DR   Wikidata; Q54990334
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=22170099;
RX   PubMed=24466371;
RX   PubMed=27517323;
RX   PubMed=27735941;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 16,21
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 9,10
ST   FGA: 19,25
ST   Penta D: 8,15
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   UKF-NB-3rDACARB8
AC   CVCL_RQ61
SY   UKF-NB-3rDAC8
DR   Wikidata; Q54990335
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   UKF-NB-3rDOCE10
AC   CVCL_RS03
DR   Wikidata; Q54990336
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rDOCE20
AC   CVCL_RR90
DR   Wikidata; Q54990337
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rDOX100
AC   CVCL_9906
AS   CVCL_9911
SY   UKF-NB-3 DOXO
DR   Wikidata; Q54990338
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   UKF-NB-3rDOX20
AC   CVCL_RS04
DR   Wikidata; Q54990339
RX   PubMed=16142320;
RX   PubMed=19147553;
RX   PubMed=22170099;
RX   PubMed=27517323;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 18 +- 1.9 hours (PubMed=16142320).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rETO100
AC   CVCL_RR91
DR   Wikidata; Q54990340
RX   PubMed=24466371;
RX   PubMed=27517323;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rETO200
AC   CVCL_RT09
DR   Wikidata; Q54990341
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rGEMCI10
AC   CVCL_RQ62
DR   Wikidata; Q54990342
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rGEMCI20
AC   CVCL_RT10
DR   Wikidata; Q54990343
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rIRINO800
AC   CVCL_RQ63
DR   Wikidata; Q54990345
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rMEL2000
AC   CVCL_RS06
DR   Wikidata; Q54990347
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rMEL400
AC   CVCL_RQ64
DR   Wikidata; Q54990349
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rNutlin10muM
AC   CVCL_RS05
DR   cancercelllines; CVCL_RS05
DR   Wikidata; Q54990350
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=22170099).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   UKF-NB-3rOXALI2000
AC   CVCL_RQ65
DR   Wikidata; Q54990351
RX   PubMed=22170099;
RX   PubMed=24466371;
RX   PubMed=31581737;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31581737
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 16,18
ST   D19S433: 14
ST   D21S11: 29,33.2
ST   D2S1338: 16,21
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 9,10
ST   FGA: 19,25
ST   Penta D: 8,15
ST   Penta E: 12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rOXALI4000
AC   CVCL_RT11
DR   Wikidata; Q54990352
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rPCL20
AC   CVCL_RQ66
DR   Wikidata; Q54990353
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rRITA10muM
AC   CVCL_RS21
DR   Wikidata; Q54990354
RX   PubMed=22476102;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_94980; [5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol (RITA).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rSNS-032_300nM
AC   CVCL_RS19
SY   UKF-NB-3rSNS-032(300nM)
DR   Wikidata; Q54990355
RX   PubMed=27517323;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 32.9 +- 12.8 hours (PubMed=27517323).
CC   Selected for resistance to: ChEBI; CHEBI_91399; N-[5-[(5-tert-butyl-2-oxazolyl)methylthio]-2-thiazolyl]-4-piperidinecarboxamide (SNS-032; BMS-387032).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 10
//
ID   UKF-NB-3rTOPO15
AC   CVCL_RQ67
DR   Wikidata; Q54990356
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rTOPO20
AC   CVCL_RT12
DR   Wikidata; Q54990358
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rVCR10
AC   CVCL_9905
AS   CVCL_9912
SY   UKF-NB-3 VCR; UKF-NB-3rVCR
DR   cancercelllines; CVCL_9905
DR   IARC_TP53; 26507
DR   Wikidata; Q54990359
RX   PubMed=16142320;
RX   PubMed=16151587;
RX   PubMed=17505515;
RX   PubMed=19147553;
RX   PubMed=22170099;
RX   PubMed=24466371;
RX   PubMed=25749379;
RX   PubMed=27517323;
RX   PubMed=27735941;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Doubling time: 19 +- 2.1 hours (PubMed=16142320).
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Phe (c.404G>T); ClinVar=VCV000376559; Zygosity=Heterozygous (PubMed=16142320; PubMed=19147553; PubMed=22170099).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   UKF-NB-3rVCR20
AC   CVCL_RS08
DR   Wikidata; Q54990361
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rVINB10
AC   CVCL_RR82
SY   UKF-NB-3rVBL10
DR   Wikidata; Q54990362
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rVINOR20
AC   CVCL_RQ68
DR   Wikidata; Q54990363
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-3rYM155_20nM
AC   CVCL_RT24
SY   UKF-NB-3rYM155(20nM)
DR   Wikidata; Q54990364
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_139608; Sepantronium bromide (YM155).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-4
AC   CVCL_9907
SY   UKF-NB4
DR   cancercelllines; CVCL_9907
DR   Wikidata; Q54990365
RX   PubMed=8543403;
RX   PubMed=16151587;
RX   PubMed=19147553;
RX   PubMed=24466371;
CC   Doubling time: 19.5-20.3 hours (PubMed=8543403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=19147553).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   UKF-NB-4AD169
AC   CVCL_RS20
DR   cancercelllines; CVCL_RS20
DR   Wikidata; Q54990366
RX   PubMed=8543403;
CC   Virology: Persistently infected with human cytomegalovirus (HCMV) strain AD169.
CC   Doubling time: 24.5-26.6 hours (PubMed=8543403).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9907 ! UKF-NB-4
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UKF-NB-4rCDDP1000
AC   CVCL_9913
SY   UKF-NB-4 CDDP
DR   cancercelllines; CVCL_9913
DR   Wikidata; Q54990367
RX   PubMed=16151587;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9907 ! UKF-NB-4
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   UKF-NB-4rDOX350
AC   CVCL_9914
SY   UKF-NB-4 DOXO
DR   cancercelllines; CVCL_9914
DR   Wikidata; Q54990368
RX   PubMed=16151587;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9907 ! UKF-NB-4
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   UKF-NB-4rVCR50
AC   CVCL_9915
SY   UKF-NB-4 VCR
DR   cancercelllines; CVCL_9915
DR   Wikidata; Q54990370
RX   PubMed=16151587;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9907 ! UKF-NB-4
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   UKF-NB-6
AC   CVCL_M474
DR   Wikidata; Q54990372
RX   PubMed=17505515;
RX   PubMed=22170099;
RX   PubMed=24466371;
RX   PubMed=27735941;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   UKF-NB-6rCARBO2000
AC   CVCL_RR93
DR   Wikidata; Q54990373
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31355; Carboplatin (CBP; Paraplatin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rCDDP1000
AC   CVCL_M475
SY   UKF-NB-6 CDDP
DR   Wikidata; Q54990374
RX   PubMed=17505515;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   UKF-NB-6rCDDP2000
AC   CVCL_RS09
DR   Wikidata; Q54990375
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rDACARB8
AC   CVCL_RS10
SY   UKF-NB-6rDAC8
DR   Wikidata; Q54990376
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4305; Dacarbazine (DTIC; (5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide)).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UKF-NB-6rDOCE10
AC   CVCL_RS11
DR   Wikidata; Q54990377
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rDOX20
AC   CVCL_M476
SY   UKF-NB-6 DOX
DR   Wikidata; Q54990378
RX   PubMed=17505515;
RX   PubMed=27735941;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   UKF-NB-6rDOX60
AC   CVCL_RS12
DR   Wikidata; Q54990379
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rETO200
AC   CVCL_RR94
DR   Wikidata; Q54990391
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rGEMCI10
AC   CVCL_RS13
DR   Wikidata; Q54990392
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rIRINO1000
AC   CVCL_RT25
DR   Wikidata; Q54990393
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rMEL1000
AC   CVCL_RR95
DR   Wikidata; Q54990394
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rMEL2000
AC   CVCL_RS14
DR   Wikidata; Q54990395
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rNutlin10muM
AC   CVCL_RS15
DR   cancercelllines; CVCL_RS15
DR   Wikidata; Q54990396
RX   PubMed=22170099;
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Unspecified (PubMed=22170099).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Unspecified (PubMed=22170099).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   UKF-NB-6rOXALI4000
AC   CVCL_RR96
DR   Wikidata; Q54990397
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rPCL20
AC   CVCL_RR97
DR   Wikidata; Q54990398
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rTOPO20
AC   CVCL_RR98
DR   Wikidata; Q54990399
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_63632; Topotecan.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rVCR10
AC   CVCL_M477
SY   UKF-NB-6 VCR
DR   Wikidata; Q54990402
RX   PubMed=17505515;
RX   PubMed=24466371;
RX   PubMed=27735941;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   UKF-NB-6rVINB10
AC   CVCL_RS16
SY   UKF-NB-6rVBL10
DR   Wikidata; Q54990401
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rVINOR40
AC   CVCL_RR99
DR   Wikidata; Q54990403
RX   PubMed=24466371;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_480999; Vinorelbine (Navelbine; NVB).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-NB-6rYM155_20nM
AC   CVCL_RT26
SY   UKF-NB-6rYM155(20nM)
DR   Wikidata; Q54990404
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_139608; Sepantronium bromide (YM155).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M474 ! UKF-NB-6
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1
AC   CVCL_4Z17
DR   Wikidata; Q54990406
RX   PubMed=19147553;
RX   PubMed=22170099;
RX   PubMed=23665679;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   UKF-Rhb-1rCDDP1000
AC   CVCL_RQ48
DR   Wikidata; Q54990407
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rDOCE10
AC   CVCL_RQ49
DR   Wikidata; Q54990408
RX   PubMed=22170099;
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   UKF-Rhb-1rDOCE20
AC   CVCL_RT27
DR   Wikidata; Q54990409
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rDOX10
AC   CVCL_RQ56
DR   Wikidata; Q54990411
RX   PubMed=22170099;
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   UKF-Rhb-1rDOX20
AC   CVCL_RT28
DR   Wikidata; Q54990412
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rGEMCI10
AC   CVCL_RQ57
DR   Wikidata; Q54990413
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rIRINO200
AC   CVCL_RQ58
DR   Wikidata; Q54990415
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_80630; Irinotecan (Camptothecin-11; CPT-11).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rMEL400
AC   CVCL_RQ59
DR   Wikidata; Q54990416
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28876; Melphalan (L-phenylalanine mustard; LPAM; Alkeran).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rNutlin10muM
AC   CVCL_RS17
DR   Wikidata; Q54990417
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_46742; Nutlin-3.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rOXALI1000
AC   CVCL_RQ60
DR   Wikidata; Q54990418
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_31941; Oxaliplatin (Elotaxin; L-OHP).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UKF-Rhb-1rVCR10
AC   CVCL_4Z18
DR   Wikidata; Q54990419
RX   PubMed=19147553;
RX   PubMed=22170099;
WW   Provider; RCCL; -; https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys291Ter (c.871A>T); Zygosity=Unspecified (PubMed=19147553).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3749; Alveolar rhabdomyosarcoma
DI   ORDO; Orphanet_99756; Alveolar rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Z17 ! UKF-Rhb-1
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   UKHGi001-A
AC   CVCL_A1QE
SY   M-PKE (c)
DR   BioSamples; SAMEA7390805
DR   hPSCreg; UKHGi001-A
DR   Wikidata; Q102115061
RX   PubMed=33002717;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1QF ! UKHGi001-B
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   UKHGi001-B
AC   CVCL_A1QF
SY   M-PKE (e)
DR   BioSamples; SAMEA7390803
DR   hPSCreg; UKHGi001-B
DR   Wikidata; Q102115062
RX   PubMed=33002717;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1QE ! UKHGi001-A
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   UKHGi002-A
AC   CVCL_A1QG
SY   F-PKE (2)
DR   BioSamples; SAMEA7390806
DR   hPSCreg; UKHGi002-A
DR   Wikidata; Q102115064
RX   PubMed=33002717;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1QH ! UKHGi002-B
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   UKHGi002-B
AC   CVCL_A1QH
SY   F-PKE (3)
DR   BioSamples; SAMEA7390808
DR   hPSCreg; UKHGi002-B
DR   Wikidata; Q102115066
RX   PubMed=33002717;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1QG ! UKHGi002-A
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 6
//
ID   UKHGi003-A
AC   CVCL_A1QI
SY   PKE (C)
DR   BioSamples; SAMEA7390810
DR   hPSCreg; UKHGi003-A
DR   Wikidata; Q102115067
RX   PubMed=33002717;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:14295; SHANK2; Unexplicit; 120 kb deletion; Zygosity=Unspecified; Note=De novo mutation (PubMed=33002717).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1QJ ! UKHGi003-B
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   UKHGi003-B
AC   CVCL_A1QJ
SY   PKE (D)
DR   BioSamples; SAMEA7390811
DR   hPSCreg; UKHGi003-B
DR   Wikidata; Q102115070
RX   PubMed=33002717;
CC   From: Institute of Human Genetics, University Hospital Heidelberg; Heidelberg; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:14295; SHANK2; Unexplicit; 120 kb deletion; Zygosity=Unspecified; Note=De novo mutation (PubMed=33002717).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1QI ! UKHGi003-A
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   UKJi001-A
AC   CVCL_E7UQ
SY   PKP2-hiPSC
DR   BioSamples; SAMEA115717852
DR   hPSCreg; UKJi001-A
RX   PubMed=39332132;
CC   From: Klinik fur Innere Medizin I (KIM I), Universitatsklinikum Jena (UKJ); Jena; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Gln62Ter (c.184C>T); Zygosity=Heterozygous (PubMed=39332132).
CC   Donor information: At sampling donor was not affected with ARVC.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UKJi003-A
AC   CVCL_E7UR
SY   hiPSC-FD
DR   BioSamples; SAMEA115728248
DR   hPSCreg; UKJi003-A
RX   PubMed=39701018;
CC   From: Klinik fur Innere Medizin I (KIM I), Universitatsklinikum Jena (UKJ); Jena; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; c.1000-10G>A (IVS6-10G>A); ClinVar=VCV000222110; Zygosity=Hemizygous (PubMed=39701018).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UKJi004-A
AC   CVCL_E7US
SY   hiPSC-WT
DR   BioSamples; SAMEA115719755
DR   hPSCreg; UKJi004-A
RX   PubMed=39701018;
CC   From: Klinik fur Innere Medizin I (KIM I), Universitatsklinikum Jena (UKJ); Jena; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UKJi005-A
AC   CVCL_E7UT
SY   hiPSC-FS.2
DR   BioSamples; SAMEA115715116
DR   hPSCreg; UKJi005-A
CC   From: Klinik fur Innere Medizin I (KIM I), Universitatsklinikum Jena (UKJ); Jena; Germany.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UKJi006-A
AC   CVCL_E7UU
SY   PKP2-hiPSC-ARVC
DR   BioSamples; SAMEA115718865
DR   hPSCreg; UKJi006-A
RX   PubMed=39332132;
CC   From: Klinik fur Innere Medizin I (KIM I), Universitatsklinikum Jena (UKJ); Jena; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Gln62Ter (c.184C>T); Zygosity=Heterozygous (PubMed=39332132).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173471; Familial arrhythmogenic right ventricular dysplasia 9
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UKKi006-A
AC   CVCL_9S59
SY   NP0053-5; M4C4; iP-MSC D4 cB; D4-CB; D4-cB; iP-MSC donor 4 clone B
DR   BioSamples; SAMEA2825851
DR   EBiSC; UKKi006-A
DR   ECACC; 66540018
DR   hPSCreg; UKKi006-A
DR   SKIP; SKIP002458
DR   Wikidata; Q54990421
RX   PubMed=23032973;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Discontinued: ECACC; 66540018; true.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Mesenchymal stem cell of bone marrow; CL=CL_0002540.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9PJ ! iP-MSC D4 cA
OI   CVCL_A9PK ! iP-MSC D4 cC
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   UKKi007-A
AC   CVCL_2Z94
SY   NP0014-6; NP0014; iPs CPVT1; CPVT-iPSC-c6
DR   BioSamples; SAMEA2629464
DR   EBiSC; UKKi007-A
DR   ECACC; 66540001
DR   hPSCreg; UKKi007-A
DR   SKIP; SKIP001411
DR   SKIP; SKIP002459
DR   Wikidata; Q54990422
DR   Ximbio; 153331
RX   PubMed=22178870;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Phe2483Ile (c.7447T>A); Zygosity=Heterozygous (PubMed=22178870).
CC   Discontinued: ECACC; 66540001; true.
CC   Discontinued: Ximbio; 153331; probable.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S36 ! UKKi007-B
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 16
//
ID   UKKi007-B
AC   CVCL_9S36
SY   NP0014-5; CPVT-iPSC-c5
DR   BioSamples; SAMEA2698638
DR   EBiSC; UKKi007-B
DR   ECACC; 66540013
DR   hPSCreg; UKKi007-B
DR   SKIP; SKIP001410
DR   SKIP; SKIP002465
DR   Wikidata; Q54990423
RX   PubMed=22178870;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Phe2483Ile (c.7447T>A); Zygosity=Heterozygous (PubMed=22178870).
CC   Discontinued: ECACC; 66540013; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2Z94 ! UKKi007-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   UKKi008-A
AC   CVCL_9S60
SY   NP0016-3; V240M-LQTS-3
DR   BioSamples; SAMEA4583697
DR   EBiSC; UKKi008-A
DR   ECACC; 66540015
DR   hPSCreg; UKKi008-A
DR   SKIP; SKIP002460
DR   Wikidata; Q54990425
RX   PubMed=24349418;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Val240Met (c.718G>A); ClinVar=VCV000068039; Zygosity=Heterozygous (PubMed=24349418).
CC   Discontinued: ECACC; 66540015; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   UKKi009-A
AC   CVCL_9S61
SY   NP0011-8
DR   BioSamples; SAMEA4583816
DR   EBiSC; UKKi009-A
DR   ECACC; 66540002
DR   ECACC; 66540031
DR   hPSCreg; UKKi009-A
DR   SKIP; SKIP002461
DR   Wikidata; Q54990426
RX   PubMed=27345990;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Leu1012Profs*55 (c.3035_3045delTCCCTCGATGC); Zygosity=Heterozygous (PubMed=27345990).
CC   Discontinued: ECACC; 66540002; true.
CC   Discontinued: ECACC; 66540031; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S62 ! UKKi009-B
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 17
//
ID   UKKi009-B
AC   CVCL_9S62
SY   NP0011-19
DR   BioSamples; SAMEA2825897
DR   EBiSC; UKKi009-B
DR   ECACC; 66540032
DR   hPSCreg; UKKi009-B
DR   SKIP; SKIP002462
DR   Wikidata; Q54990427
RX   PubMed=27345990;
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Leu1012Profs*55 (c.3035_3045delTCCCTCGATGC); Zygosity=Heterozygous (PubMed=27345990).
CC   Discontinued: ECACC; 66540032; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9S61 ! UKKi009-A
SX   Female
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 16
//
ID   UKKi011-A
AC   CVCL_9S63
SY   NP0040-8
DR   BioSamples; SAMEA2774610
DR   EBiSC; UKKi011-A
DR   ECACC; 66540010
DR   hPSCreg; UKKi011-A
DR   SKIP; SKIP002463
DR   Wikidata; Q54990428
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540010; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35-39Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 12
//
ID   UKKi012-A
AC   CVCL_9S64
SY   NP0041-17; NP0041
DR   BioSamples; SAMEA2825964
DR   EBiSC; UKKi012-A
DR   ECACC; 66540019
DR   hPSCreg; UKKi012-A
DR   SKIP; SKIP002464
DR   Wikidata; Q54990429
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540019; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 30-01-24; Version: 12
//
ID   UKKi014-A
AC   CVCL_A9PL
SY   NP0125
DR   hPSCreg; UKKi014-A
DR   Wikidata; Q102115071
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   UKKi016-A
AC   CVCL_VF33
SY   NP0078-10
DR   BioSamples; SAMEA104615854
DR   EBiSC; UKKi016-A
DR   ECACC; 66540886
DR   hPSCreg; UKKi016-A
DR   Wikidata; Q54990430
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg366Trp (c.1096C>T); ClinVar=VCV000052955; Zygosity=Heterozygous (EBiSC=UKKi016-A).
CC   Discontinued: ECACC; 66540886; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF34 ! UKKi016-B
OI   CVCL_VF35 ! UKKi016-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   UKKi016-B
AC   CVCL_VF34
SY   NP0078-12
DR   BioSamples; SAMEA104615855
DR   EBiSC; UKKi016-B
DR   ECACC; 66540887
DR   hPSCreg; UKKi016-B
DR   Wikidata; Q54990432
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg366Trp (c.1096C>T); ClinVar=VCV000052955; Zygosity=Heterozygous (EBiSC=UKKi016-B).
CC   Discontinued: ECACC; 66540887; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF33 ! UKKi016-A
OI   CVCL_VF35 ! UKKi016-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   UKKi016-C
AC   CVCL_VF35
SY   NP0078-13
DR   BioSamples; SAMEA104615853
DR   EBiSC; UKKi016-C
DR   ECACC; 66540888
DR   hPSCreg; UKKi016-C
DR   Wikidata; Q54990433
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Arg366Trp (c.1096C>T); ClinVar=VCV000052955; Zygosity=Heterozygous (EBiSC=UKKi016-C).
CC   Discontinued: ECACC; 66540888; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF33 ! UKKi016-A
OI   CVCL_VF34 ! UKKi016-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   UKKi017-A
AC   CVCL_LD22
SY   NP0075-8D
DR   BioSamples; SAMEA17619418
DR   EBiSC; UKKi017-A
DR   ECACC; 66540475
DR   hPSCreg; UKKi017-A
DR   Wikidata; Q54990435
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540475; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD23 ! UKKi017-B
OI   CVCL_LD24 ! UKKi017-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi017-B
AC   CVCL_LD23
SY   NP0075-10K
DR   BioSamples; SAMEA17620918
DR   EBiSC; UKKi017-B
DR   ECACC; 66540476
DR   hPSCreg; UKKi017-B
DR   Wikidata; Q54990436
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540476; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD22 ! UKKi017-A
OI   CVCL_LD24 ! UKKi017-C
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi017-C
AC   CVCL_LD24
SY   NP0075-11B
DR   BioSamples; SAMEA17621668
DR   EBiSC; UKKi017-C
DR   ECACC; 66540477
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi017-C
DR   Wikidata; Q54990437
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540477; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD22 ! UKKi017-A
OI   CVCL_LD23 ! UKKi017-B
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UKKi018-A
AC   CVCL_LD25
SY   NP0080-2B
DR   BioSamples; SAMEA17622418
DR   EBiSC; UKKi018-A
DR   ECACC; 66540478
DR   hPSCreg; UKKi018-A
DR   Wikidata; Q54990438
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Glu58Gly (c.173A>G); ClinVar=VCV000067257; Zygosity=Heterozygous (EBiSC=UKKi018-A).
CC   Discontinued: ECACC; 66540478; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD26 ! UKKi018-B
OI   CVCL_LD27 ! UKKi018-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi018-B
AC   CVCL_LD26
SY   NP0080-6A
DR   BioSamples; SAMEA17623918
DR   EBiSC; UKKi018-B
DR   ECACC; 66540479
DR   hPSCreg; UKKi018-B
DR   Wikidata; Q54990466
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Glu58Gly (c.173A>G); ClinVar=VCV000067257; Zygosity=Heterozygous (EBiSC=UKKi018-B).
CC   Discontinued: ECACC; 66540479; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD25 ! UKKi018-A
OI   CVCL_LD27 ! UKKi018-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi018-C
AC   CVCL_LD27
SY   NP0080-8B
DR   BioSamples; SAMEA103988380
DR   EBiSC; UKKi018-C
DR   ECACC; 66540569
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi018-C
DR   Wikidata; Q54990468
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Glu58Gly (c.173A>G); ClinVar=VCV000067257; Zygosity=Heterozygous (EBiSC=UKKi018-C).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540569; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD25 ! UKKi018-A
OI   CVCL_LD26 ! UKKi018-B
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   UKKi019-A
AC   CVCL_LD28
SY   NP0081-1A
DR   BioSamples; SAMEA17624668
DR   EBiSC; UKKi019-A
DR   ECACC; 66540480
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi019-A
DR   Wikidata; Q54990469
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Tyr427Cys (c.1280A>G); ClinVar=VCV000067179; Zygosity=Heterozygous (EBiSC=UKKi019-A).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540480; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD29 ! UKKi019-B
OI   CVCL_LD30 ! UKKi019-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   UKKi019-B
AC   CVCL_LD29
SY   NP0081-11
DR   BioSamples; SAMEA17626168
DR   EBiSC; UKKi019-B
DR   ECACC; 66540481
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi019-B
DR   Wikidata; Q54990470
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Tyr427Cys (c.1280A>G); ClinVar=VCV000067179; Zygosity=Heterozygous (EBiSC=UKKi019-B).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540481; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD28 ! UKKi019-A
OI   CVCL_LD30 ! UKKi019-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   UKKi019-C
AC   CVCL_LD30
SY   NP0081-12C
DR   BioSamples; SAMEA17626918
DR   EBiSC; UKKi019-C
DR   ECACC; 66540482
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi019-C
DR   Wikidata; Q54990471
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Tyr427Cys (c.1280A>G); ClinVar=VCV000067179; Zygosity=Heterozygous (EBiSC=UKKi019-C).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540482; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD28 ! UKKi019-A
OI   CVCL_LD29 ! UKKi019-B
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   UKKi020-A
AC   CVCL_LD18
SY   NP0100-4
DR   BioSamples; SAMEA17627668
DR   EBiSC; UKKi020-A
DR   ECACC; 66540483
DR   hPSCreg; UKKi020-A
DR   Wikidata; Q54990472
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540483; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD19 ! UKKi020-B
OI   CVCL_LD20 ! UKKi020-C
OI   CVCL_LD21 ! UKKi020-D
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi020-B
AC   CVCL_LD19
SY   NP0100-8
DR   BioSamples; SAMEA103988343
DR   EBiSC; UKKi020-B
DR   ECACC; 66540562
DR   hPSCreg; UKKi020-B
DR   Wikidata; Q54990473
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540562; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD18 ! UKKi020-A
OI   CVCL_LD20 ! UKKi020-C
OI   CVCL_LD21 ! UKKi020-D
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi020-C
AC   CVCL_LD20
SY   NP0100-10E
DR   BioSamples; SAMEA103988344
DR   EBiSC; UKKi020-C
DR   ECACC; 66540563
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi020-C
DR   Wikidata; Q54990474
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540563; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD18 ! UKKi020-A
OI   CVCL_LD19 ! UKKi020-B
OI   CVCL_LD21 ! UKKi020-D
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   UKKi020-D
AC   CVCL_LD21
SY   NP0100-11
DR   BioSamples; SAMEA103988345
DR   EBiSC; UKKi020-D
DR   ECACC; 66540564
DR   hPSCreg; UKKi020-D
DR   Wikidata; Q54990476
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540564; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD18 ! UKKi020-A
OI   CVCL_LD19 ! UKKi020-B
OI   CVCL_LD20 ! UKKi020-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 10
//
ID   UKKi021-A
AC   CVCL_LD31
SY   NP0105-2
DR   BioSamples; SAMEA103885570
DR   EBiSC; UKKi021-A
DR   ECACC; 66540547
DR   hPSCreg; UKKi021-A
DR   Wikidata; Q54990477
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Indian.
CC   Discontinued: ECACC; 66540547; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD32 ! UKKi021-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi021-B
AC   CVCL_LD32
SY   NP0105-19
DR   BioSamples; SAMEA103988346
DR   EBiSC; UKKi021-B
DR   ECACC; 66540565
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi021-B
DR   Wikidata; Q54990479
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Indian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540565; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD31 ! UKKi021-A
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UKKi022-A
AC   CVCL_LD33
SY   NP0106-34
DR   BioSamples; SAMEA17629168
DR   EBiSC; UKKi022-A
DR   ECACC; 66540484
DR   hPSCreg; UKKi022-A
DR   Wikidata; Q54990480
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Indian.
CC   Discontinued: ECACC; 66540484; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD34 ! UKKi022-B
OI   CVCL_LD35 ! UKKi022-C
OI   CVCL_LD36 ! UKKi022-D
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi022-B
AC   CVCL_LD34
DR   BioSamples; SAMEA103988348
DR   hPSCreg; UKKi022-B
DR   Wikidata; Q54990481
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Indian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD33 ! UKKi022-A
OI   CVCL_LD35 ! UKKi022-C
OI   CVCL_LD36 ! UKKi022-D
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   UKKi022-C
AC   CVCL_LD35
SY   NP0106-10A
DR   BioSamples; SAMEA103988349
DR   EBiSC; UKKi022-C
DR   ECACC; 66540568
DR   EGA; EGAS00001002755
DR   hPSCreg; UKKi022-C
DR   Wikidata; Q54990482
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Indian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: ECACC; 66540568; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD33 ! UKKi022-A
OI   CVCL_LD34 ! UKKi022-B
OI   CVCL_LD36 ! UKKi022-D
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UKKi022-D
AC   CVCL_LD36
SY   NP0106-5
DR   BioSamples; SAMEA104012541
DR   EBiSC; UKKi022-D
DR   ECACC; 66540579
DR   hPSCreg; UKKi022-D
DR   Wikidata; Q54990483
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Indian.
CC   Discontinued: ECACC; 66540579; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD33 ! UKKi022-A
OI   CVCL_LD34 ! UKKi022-B
OI   CVCL_LD35 ! UKKi022-C
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi023-A
AC   CVCL_LD37
SY   NP0126-1
DR   BioSamples; SAMEA17630668
DR   EBiSC; UKKi023-A
DR   ECACC; 66540485
DR   hPSCreg; UKKi023-A
DR   Wikidata; Q54990484
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Arg531Trp (c.1591C>T); ClinVar=VCV000067218; Zygosity=Heterozygous (EBiSC=UKKi023-A).
CC   Discontinued: ECACC; 66540485; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD38 ! UKKi023-B
OI   CVCL_LD39 ! UKKi023-C
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi023-B
AC   CVCL_LD38
SY   NP0126-5
DR   BioSamples; SAMEA17632168
DR   EBiSC; UKKi023-B
DR   ECACC; 66540486
DR   hPSCreg; UKKi023-B
DR   Wikidata; Q54990485
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Arg531Trp (c.1591C>T); ClinVar=VCV000067218; Zygosity=Heterozygous (EBiSC=UKKi023-B).
CC   Discontinued: ECACC; 66540486; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD37 ! UKKi023-A
OI   CVCL_LD39 ! UKKi023-C
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi023-C
AC   CVCL_LD39
SY   NP0126-6
DR   BioSamples; SAMEA17632918
DR   EBiSC; UKKi023-C
DR   ECACC; 66540487
DR   hPSCreg; UKKi023-C
DR   Wikidata; Q54990486
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Arg531Trp (c.1591C>T); ClinVar=VCV000067218; Zygosity=Heterozygous (EBiSC=UKKi023-C).
CC   Discontinued: ECACC; 66540487; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD37 ! UKKi023-A
OI   CVCL_LD38 ! UKKi023-B
SX   Male
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi024-A
AC   CVCL_LD84
SY   NP0133-5
DR   BioSamples; SAMEA17633668
DR   EBiSC; UKKi024-A
DR   ECACC; 66540488
DR   hPSCreg; UKKi024-A
DR   Wikidata; Q54990487
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540488; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD85 ! UKKi024-B
OI   CVCL_LD86 ! UKKi024-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi024-B
AC   CVCL_LD85
SY   NP0133-1
DR   BioSamples; SAMEA17635168
DR   EBiSC; UKKi024-B
DR   ECACC; 66540489
DR   hPSCreg; UKKi024-B
DR   Wikidata; Q54990488
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540489; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD84 ! UKKi024-A
OI   CVCL_LD86 ! UKKi024-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi024-C
AC   CVCL_LD86
SY   NP0133-4
DR   BioSamples; SAMEA17635918
DR   EBiSC; UKKi024-C
DR   ECACC; 66540490
DR   hPSCreg; UKKi024-C
DR   Wikidata; Q54990489
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540490; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD84 ! UKKi024-A
OI   CVCL_LD85 ! UKKi024-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi025-A
AC   CVCL_LD42
SY   NP0135-1
DR   BioSamples; SAMEA17636668
DR   EBiSC; UKKi025-A
DR   ECACC; 66540491
DR   hPSCreg; UKKi025-A
DR   Wikidata; Q54990490
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg719Gly (c.2156G>A); Zygosity=Heterozygous (EBiSC=UKKi025-A).
CC   Discontinued: ECACC; 66540491; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD43 ! UKKi025-B
OI   CVCL_LD44 ! UKKi025-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi025-B
AC   CVCL_LD43
SY   NP0135-2
DR   BioSamples; SAMEA17638168
DR   EBiSC; UKKi025-B
DR   ECACC; 66540492
DR   hPSCreg; UKKi025-B
DR   Wikidata; Q54990491
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg719Gly (c.2156G>A); Zygosity=Heterozygous (EBiSC=UKKi025-B).
CC   Discontinued: ECACC; 66540492; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD42 ! UKKi025-A
OI   CVCL_LD44 ! UKKi025-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi025-C
AC   CVCL_LD44
SY   NP0135-7
DR   BioSamples; SAMEA17638918
DR   EBiSC; UKKi025-C
DR   ECACC; 66540493
DR   hPSCreg; UKKi025-C
DR   Wikidata; Q54990493
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg719Gly (c.2156G>A); Zygosity=Heterozygous (EBiSC=UKKi025-C).
CC   Discontinued: ECACC; 66540493; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD42 ! UKKi025-A
OI   CVCL_LD43 ! UKKi025-B
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 13
//
ID   UKKi026-A
AC   CVCL_LD45
SY   NP0114-1A
DR   BioSamples; SAMEA104132930
DR   EBiSC; UKKi026-A
DR   ECACC; 66540621
DR   hPSCreg; UKKi026-A
DR   Wikidata; Q54990494
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Chinese.
CC   Discontinued: ECACC; 66540621; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD46 ! UKKi026-B
OI   CVCL_LD47 ! UKKi026-C
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   UKKi026-B
AC   CVCL_LD46
SY   NP0114-2C
DR   BioSamples; SAMEA104132932
DR   EBiSC; UKKi026-B
DR   ECACC; 66540595
DR   hPSCreg; UKKi026-B
DR   Wikidata; Q54990495
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Chinese.
CC   Discontinued: ECACC; 66540595; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD45 ! UKKi026-A
OI   CVCL_LD47 ! UKKi026-C
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi026-C
AC   CVCL_LD47
SY   NP0114-5E
DR   BioSamples; SAMEA104132933
DR   EBiSC; UKKi026-C
DR   ECACC; 66540596
DR   hPSCreg; UKKi026-C
DR   Wikidata; Q54990496
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Chinese.
CC   Discontinued: ECACC; 66540596; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD45 ! UKKi026-A
OI   CVCL_LD46 ! UKKi026-B
SX   Male
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   UKKi027-A
AC   CVCL_LD48
SY   NP0101-A; NP0101-3D
DR   BioSamples; SAMEA104381170
DR   EBiSC; UKKi027-A
DR   ECACC; 66540622
DR   hPSCreg; UKKi027-A
DR   Wikidata; Q54990497
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: African.
CC   Discontinued: ECACC; 66540622; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD49 ! UKKi027-B
OI   CVCL_LD50 ! UKKi027-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   UKKi027-B
AC   CVCL_LD49
SY   NP0101-B; NP0101-4C
DR   BioSamples; SAMEA104381172
DR   EBiSC; UKKi027-B
DR   ECACC; 66540623
DR   hPSCreg; UKKi027-B
DR   Wikidata; Q54990499
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: African.
CC   Discontinued: ECACC; 66540623; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD48 ! UKKi027-A
OI   CVCL_LD50 ! UKKi027-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi027-C
AC   CVCL_LD50
SY   NP0101-C; NP0101-10H
DR   BioSamples; SAMEA104381173
DR   EBiSC; UKKi027-C
DR   ECACC; 66540624
DR   hPSCreg; UKKi027-C
DR   Wikidata; Q54990501
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: African.
CC   Discontinued: ECACC; 66540624; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD48 ! UKKi027-A
OI   CVCL_LD49 ! UKKi027-B
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   UKKi028-A
AC   CVCL_LD51
SY   NP0115-A; NP0115-4
DR   BioSamples; SAMEA104381174
DR   EBiSC; UKKi028-A
DR   ECACC; 66540625
DR   hPSCreg; UKKi028-A
DR   Wikidata; Q54990502
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Chinese.
CC   Discontinued: ECACC; 66540625; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD52 ! UKKi028-B
OI   CVCL_LD53 ! UKKi028-C
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   UKKi028-B
AC   CVCL_LD52
SY   NP0115-B
DR   BioSamples; SAMEA104381176
DR   EBiSC; UKKi028-B
DR   ECACC; 66540626
DR   hPSCreg; UKKi028-B
DR   Wikidata; Q54990503
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Chinese.
CC   Discontinued: ECACC; 66540626; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD51 ! UKKi028-A
OI   CVCL_LD53 ! UKKi028-C
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 8
//
ID   UKKi028-C
AC   CVCL_LD53
SY   NP0115-C
DR   BioSamples; SAMEA104381177
DR   EBiSC; UKKi028-C
DR   ECACC; 66540627
DR   hPSCreg; UKKi028-C
DR   Wikidata; Q54990504
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Population: Chinese.
CC   Discontinued: ECACC; 66540627; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LD51 ! UKKi028-A
OI   CVCL_LD52 ! UKKi028-B
SX   Female
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 30-01-24; Version: 9
//
ID   UKKi029-A
AC   CVCL_RM68
SY   NP0077-6D
DR   BioSamples; SAMEA104494405
DR   EBiSC; UKKi029-A
DR   ECACC; 66540872
DR   hPSCreg; UKKi029-A
DR   Wikidata; Q54990505
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Asp564His (c.1690G>T); Zygosity=Heterozygous (EBiSC=UKKi029-A).
CC   Discontinued: ECACC; 66540872; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM69 ! UKKi029-B
OI   CVCL_RM70 ! UKKi029-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi029-B
AC   CVCL_RM69
SY   NP0077-16E
DR   BioSamples; SAMEA104494407
DR   EBiSC; UKKi029-B
DR   ECACC; 66540873
DR   hPSCreg; UKKi029-B
DR   Wikidata; Q54990506
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Asp564His (c.1690G>T); Zygosity=Heterozygous (EBiSC=UKKi029-B).
CC   Discontinued: ECACC; 66540873; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM68 ! UKKi029-A
OI   CVCL_RM70 ! UKKi029-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi029-C
AC   CVCL_RM70
SY   NP0077-18C
DR   BioSamples; SAMEA104494408
DR   EBiSC; UKKi029-C
DR   ECACC; 66540874
DR   hPSCreg; UKKi029-C
DR   Wikidata; Q54990507
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Asp564His (c.1690G>T); Zygosity=Heterozygous (EBiSC=UKKi029-C).
CC   Discontinued: ECACC; 66540874; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM68 ! UKKi029-A
OI   CVCL_RM69 ! UKKi029-B
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi030-A
AC   CVCL_RM71
SY   NP0134-6D
DR   BioSamples; SAMEA104494409
DR   EBiSC; UKKi030-A
DR   ECACC; 66540875
DR   hPSCreg; UKKi030-A
DR   Wikidata; Q54990508
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Gln646Argfs*5 (c.1936delC); ClinVar=VCV000179829; Zygosity=Heterozygous (EBiSC=UKKi030-A).
CC   Discontinued: ECACC; 66540875; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM72 ! UKKi030-B
OI   CVCL_RM73 ! UKKi030-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi030-B
AC   CVCL_RM72
SY   NP0134-18A
DR   BioSamples; SAMEA104494411
DR   EBiSC; UKKi030-B
DR   ECACC; 66540876
DR   hPSCreg; UKKi030-B
DR   Wikidata; Q54990509
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Gln646Argfs*5 (c.1936delC); ClinVar=VCV000179829; Zygosity=Heterozygous (EBiSC=UKKi030-B).
CC   Discontinued: ECACC; 66540876; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM71 ! UKKi030-A
OI   CVCL_RM73 ! UKKi030-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi030-C
AC   CVCL_RM73
SY   NP0134-26B
DR   BioSamples; SAMEA104494412
DR   EBiSC; UKKi030-C
DR   ECACC; 66540877
DR   hPSCreg; UKKi030-C
DR   Wikidata; Q54990510
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Gln646Argfs*5 (c.1936delC); ClinVar=VCV000179829; Zygosity=Heterozygous (EBiSC=UKKi030-C).
CC   Discontinued: ECACC; 66540877; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM71 ! UKKi030-A
OI   CVCL_RM72 ! UKKi030-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi031-A
AC   CVCL_RM74
SY   NP0138-8B
DR   BioSamples; SAMEA104494413
DR   EBiSC; UKKi031-A
DR   ECACC; 66540878
DR   hPSCreg; UKKi031-A
DR   Wikidata; Q54990511
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Arg94Leu (c.281G>T); ClinVar=VCV000043629; Zygosity=Heterozygous (EBiSC=UKKi031-A).
CC   Discontinued: ECACC; 66540878; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142892; Familial hypertrophic cardiomyopathy type 2
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM75 ! UKKi031-B
OI   CVCL_RM76 ! UKKi031-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi031-B
AC   CVCL_RM75
SY   NP0138-19E
DR   BioSamples; SAMEA104494415
DR   EBiSC; UKKi031-B
DR   ECACC; 66540879
DR   hPSCreg; UKKi031-B
DR   Wikidata; Q54990528
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Arg94Leu (c.281G>T); ClinVar=VCV000043629; Zygosity=Heterozygous (EBiSC=UKKi031-B).
CC   Discontinued: ECACC; 66540879; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142892; Familial hypertrophic cardiomyopathy type 2
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM74 ! UKKi031-A
OI   CVCL_RM76 ! UKKi031-C
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi031-C
AC   CVCL_RM76
SY   NP0138-31B
DR   BioSamples; SAMEA104494416
DR   EBiSC; UKKi031-C
DR   ECACC; 66540880
DR   hPSCreg; UKKi031-C
DR   Wikidata; Q54990529
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Arg94Leu (c.281G>T); ClinVar=VCV000043629; Zygosity=Heterozygous (EBiSC=UKKi031-C).
CC   Discontinued: ECACC; 66540880; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142892; Familial hypertrophic cardiomyopathy type 2
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM74 ! UKKi031-A
OI   CVCL_RM75 ! UKKi031-B
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi032-A
AC   CVCL_RM77
SY   NP0141-12C
DR   BioSamples; SAMEA104494417
DR   EBiSC; UKKi032-A
DR   ECACC; 66540881
DR   hPSCreg; UKKi032-A
DR   Wikidata; Q54990530
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540881; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM78 ! UKKi032-B
OI   CVCL_RM79 ! UKKi032-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 7
//
ID   UKKi032-B
AC   CVCL_RM78
SY   NP0141-17A
DR   BioSamples; SAMEA104494419
DR   EBiSC; UKKi032-B
DR   ECACC; 66540882
DR   hPSCreg; UKKi032-B
DR   Wikidata; Q54990531
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540882; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM77 ! UKKi032-A
OI   CVCL_RM79 ! UKKi032-C
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 7
//
ID   UKKi032-C
AC   CVCL_RM79
SY   NP0141-31B
DR   BioSamples; SAMEA104494420
DR   EBiSC; UKKi032-C
DR   ECACC; 66540883
DR   hPSCreg; UKKi032-C
DR   Wikidata; Q54990533
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540883; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RM77 ! UKKi032-A
OI   CVCL_RM78 ! UKKi032-B
SX   Female
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 30-01-24; Version: 7
//
ID   UKKi033-A
AC   CVCL_VF36
SY   NP0070-A
DR   BioSamples; SAMEA104615850
DR   EBiSC; UKKi033-A
DR   ECACC; 66540889
DR   hPSCreg; UKKi033-A
DR   Wikidata; Q54990534
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: EBiSC; UKKi033-A; true.
CC   Discontinued: ECACC; 66540889; true.
CC   Discontinued: hPSCreg; UKKi033-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF37 ! UKKi033-B
OI   CVCL_VF38 ! UKKi033-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   UKKi033-B
AC   CVCL_VF37
SY   NP0070-B
DR   BioSamples; SAMEA104615851
DR   EBiSC; UKKi033-B
DR   ECACC; 66540890
DR   hPSCreg; UKKi033-B
DR   Wikidata; Q54990535
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: EBiSC; UKKi033-B; true.
CC   Discontinued: ECACC; 66540890; true.
CC   Discontinued: hPSCreg; UKKi033-B; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF36 ! UKKi033-A
OI   CVCL_VF38 ! UKKi033-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   UKKi033-C
AC   CVCL_VF38
SY   NP0070-C
DR   BioSamples; SAMEA104615852
DR   EBiSC; UKKi033-C
DR   ECACC; 66540891
DR   hPSCreg; UKKi033-C
DR   Wikidata; Q54990536
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: EBiSC; UKKi033-C; true.
CC   Discontinued: ECACC; 66540891; true.
CC   Discontinued: hPSCreg; UKKi033-C; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF36 ! UKKi033-A
OI   CVCL_VF37 ! UKKi033-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   UKKi034-A
AC   CVCL_VF39
SY   NP0079-A; NP0079-7B
DR   BioSamples; SAMEA104615856
DR   EBiSC; UKKi034-A
DR   ECACC; 66540892
DR   hPSCreg; UKKi034-A
DR   Wikidata; Q54990537
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser277Leu (c.830C>T) (p.Ser150Leu, c.449C>T); ClinVar=VCV000053116; Zygosity=Heterozygous (EBiSC=UKKi034-A).
CC   Discontinued: ECACC; 66540892; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF40 ! UKKi034-B
OI   CVCL_VF41 ! UKKi034-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi034-B
AC   CVCL_VF40
SY   NP0079-B; NP0079-15B
DR   BioSamples; SAMEA104615857
DR   EBiSC; UKKi034-B
DR   ECACC; 66540893
DR   hPSCreg; UKKi034-B
DR   Wikidata; Q54990538
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser277Leu (c.830C>T) (p.Ser150Leu, c.449C>T); ClinVar=VCV000053116; Zygosity=Heterozygous (EBiSC=UKKi034-B).
CC   Discontinued: ECACC; 66540893; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF39 ! UKKi034-A
OI   CVCL_VF41 ! UKKi034-C
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi034-C
AC   CVCL_VF41
SY   NP0079-C; NP0079-16H
DR   BioSamples; SAMEA104615858
DR   EBiSC; UKKi034-C
DR   ECACC; 66540894
DR   hPSCreg; UKKi034-C
DR   Wikidata; Q54990540
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ser277Leu (c.830C>T) (p.Ser150Leu, c.449C>T); ClinVar=VCV000053116; Zygosity=Heterozygous (EBiSC=UKKi034-C).
CC   Discontinued: ECACC; 66540894; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF39 ! UKKi034-A
OI   CVCL_VF40 ! UKKi034-B
SX   Female
AG   25-29Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi035-A
AC   CVCL_VF42
SY   NP0139-A; NP0139-3E
DR   BioSamples; SAMEA104615859
DR   EBiSC; UKKi035-A
DR   ECACC; 66540895
DR   hPSCreg; UKKi035-A
DR   Wikidata; Q54990541
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg943Ter (c.2827C>T); ClinVar=VCV000037039; Zygosity=Heterozygous (hPSCreg=UKKi035-A).
CC   Discontinued: ECACC; 66540895; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF43 ! UKKi035-B
OI   CVCL_VF44 ! UKKi035-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi035-B
AC   CVCL_VF43
SY   NP0139-B; NP0139-6C
DR   BioSamples; SAMEA104615860
DR   EBiSC; UKKi035-B
DR   ECACC; 66540896
DR   hPSCreg; UKKi035-B
DR   Wikidata; Q54990542
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg943Ter (c.2827C>T); ClinVar=VCV000037039; Zygosity=Heterozygous (hPSCreg=UKKi035-B).
CC   Discontinued: ECACC; 66540896; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF42 ! UKKi035-A
OI   CVCL_VF44 ! UKKi035-C
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi035-C
AC   CVCL_VF44
SY   NP0139-C; NP0139-24D
DR   BioSamples; SAMEA104615861
DR   EBiSC; UKKi035-C
DR   ECACC; 66540897
DR   hPSCreg; UKKi035-C
DR   Wikidata; Q54990544
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg943Ter (c.2827C>T); ClinVar=VCV000037039; Zygosity=Heterozygous (hPSCreg=UKKi035-C).
CC   Discontinued: ECACC; 66540897; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF42 ! UKKi035-A
OI   CVCL_VF43 ! UKKi035-B
SX   Male
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 12
//
ID   UKKi036-A
AC   CVCL_VF45
SY   NP0143-A; NP0143-5
DR   BioSamples; SAMEA104615862
DR   EBiSC; UKKi036-A
DR   ECACC; 66540898
DR   hPSCreg; UKKi036-A
DR   Wikidata; Q54990545
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540898; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF46 ! UKKi036-B
OI   CVCL_VF47 ! UKKi036-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   UKKi036-B
AC   CVCL_VF46
SY   NP0143-B; NP0143-15
DR   BioSamples; SAMEA104615863
DR   EBiSC; UKKi036-B
DR   ECACC; 66540899
DR   hPSCreg; UKKi036-B
DR   Wikidata; Q54990546
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540899; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF45 ! UKKi036-A
OI   CVCL_VF47 ! UKKi036-C
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   UKKi036-C
AC   CVCL_VF47
SY   NP0143-C; NP0143-18
DR   BioSamples; SAMEA104615864
DR   EBiSC; UKKi036-C
DR   ECACC; 66540900
DR   hPSCreg; UKKi036-C
DR   Wikidata; Q54990548
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540900; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF45 ! UKKi036-A
OI   CVCL_VF46 ! UKKi036-B
SX   Female
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   UKKi037-A
AC   CVCL_VF48
SY   NP0144-A; NP0144-32
DR   BioSamples; SAMEA104615865
DR   EBiSC; UKKi037-A
DR   ECACC; 66540901
DR   hPSCreg; UKKi037-A
DR   Wikidata; Q54990549
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF49 ! UKKi037-B
OI   CVCL_VF50 ! UKKi037-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   UKKi037-B
AC   CVCL_VF49
SY   NP0144-B; NP0144-33
DR   BioSamples; SAMEA104615866
DR   EBiSC; UKKi037-B
DR   ECACC; 66540902
DR   hPSCreg; UKKi037-B
DR   Wikidata; Q54990551
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540902; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF48 ! UKKi037-A
OI   CVCL_VF50 ! UKKi037-C
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   UKKi037-C
AC   CVCL_VF50
SY   NP0144-C; NP0144-41
DR   BioSamples; SAMEA104615867
DR   EBiSC; UKKi037-C
DR   ECACC; 66540903
DR   hPSCreg; UKKi037-C
DR   Wikidata; Q54990552
CC   From: Institute for Neurophysiology, Medical Faculty, University of Cologne; Cologne; Germany.
CC   Discontinued: ECACC; 66540903; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF48 ! UKKi037-A
OI   CVCL_VF49 ! UKKi037-B
SX   Male
AG   30-34Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 8
//
ID   UKMi001-A
AC   CVCL_YT49
SY   CRLF1-iPSC-C1
DR   hPSCreg; UKMi001-A
DR   Wikidata; Q98133972
RX   PubMed=32492556;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:2364; CRLF1; Simple; p.Pro238Argfs*6 (c.708_709delinsT); ClinVar=VCV000005712; Zygosity=Homozygous (PubMed=32492556).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173147; Crisponi/cold-induced sweating syndrome-1
DI   ORDO; Orphanet_1545; Crisponi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT50 ! UKMi001-B
OI   CVCL_YT51 ! UKMi001-C
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   UKMi001-B
AC   CVCL_YT50
SY   CRLF1-iPSC-C4
DR   hPSCreg; UKMi001-B
DR   Wikidata; Q98133977
RX   PubMed=32492556;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:2364; CRLF1; Simple; p.Pro238Argfs*6 (c.708_709delinsT); ClinVar=VCV000005712; Zygosity=Homozygous (PubMed=32492556).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173147; Crisponi/cold-induced sweating syndrome-1
DI   ORDO; Orphanet_1545; Crisponi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT49 ! UKMi001-A
OI   CVCL_YT51 ! UKMi001-C
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   UKMi001-C
AC   CVCL_YT51
SY   CRLF1-iPSC-C6
DR   hPSCreg; UKMi001-C
DR   Wikidata; Q98133980
RX   PubMed=32492556;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:2364; CRLF1; Simple; p.Pro238Argfs*6 (c.708_709delinsT); ClinVar=VCV000005712; Zygosity=Homozygous (PubMed=32492556).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173147; Crisponi/cold-induced sweating syndrome-1
DI   ORDO; Orphanet_1545; Crisponi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT49 ! UKMi001-A
OI   CVCL_YT50 ! UKMi001-B
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   UKMi002-A
AC   CVCL_ZL84
SY   CLCF1-iPSC-C2
DR   hPSCreg; UKMi002-A
DR   Wikidata; Q98133985
RX   PubMed=32512309;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17412; CLCF1; Simple; p.Tyr107Ter (c.321C>G); ClinVar=VCV000002930; Zygosity=Homozygous (PubMed=32512309).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173148; Crisponi/cold-induced sweating syndrome-2
DI   ORDO; Orphanet_1545; Crisponi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL85 ! UKMi002-B
OI   CVCL_ZL86 ! UKMi002-C
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UKMi002-B
AC   CVCL_ZL85
SY   CLCF1-iPSC-C4
DR   Wikidata; Q98133988
RX   PubMed=32512309;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17412; CLCF1; Simple; p.Tyr107Ter (c.321C>G); ClinVar=VCV000002930; Zygosity=Homozygous (PubMed=32512309).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173148; Crisponi/cold-induced sweating syndrome-2
DI   ORDO; Orphanet_1545; Crisponi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL84 ! UKMi002-A
OI   CVCL_ZL86 ! UKMi002-C
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UKMi002-C
AC   CVCL_ZL86
SY   CLCF1-iPSC-C19
DR   Wikidata; Q98133992
RX   PubMed=32512309;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:17412; CLCF1; Simple; p.Tyr107Ter (c.321C>G); ClinVar=VCV000002930; Zygosity=Homozygous (PubMed=32512309).
CC   Derived from site: In situ; Nose; UBERON=UBERON_0000004.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173148; Crisponi/cold-induced sweating syndrome-2
DI   ORDO; Orphanet_1545; Crisponi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL84 ! UKMi002-A
OI   CVCL_ZL85 ! UKMi002-B
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UKMi003-A
AC   CVCL_D1G9
DR   BioSamples; SAMEA114426146
DR   hPSCreg; UKMi003-A
DR   Wikidata; Q127384562
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C26923; Sinus bradycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   UKMi004-A
AC   CVCL_D1GA
DR   BioSamples; SAMEA114518810
DR   hPSCreg; UKMi004-A
DR   Wikidata; Q127384565
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   UKMi005-A
AC   CVCL_D0N9
SY   KCNJ5 K8
DR   BioSamples; SAMEA114385442
DR   hPSCreg; UKMi005-A
DR   Wikidata; Q123033717
RX   PubMed=37890333;
RX   PubMed=37894977;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6266; KCNJ5; Simple; p.Trp101Cys (c.303G>C); Zygosity=Heterozygous (PubMed=37890333).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62243; Sinus node dysfunction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UKMi006-A
AC   CVCL_D1GB
DR   hPSCreg; UKMi006-A
DR   Wikidata; Q127384567
RX   PubMed=37894977;
CC   From: Muenster University Children's Hospital; Muenster; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6266; KCNJ5; Simple_corrected; p.Trp101Cys (c.303G>C); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37894977).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C62243; Sinus node dysfunction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0N9 ! UKMi005-A
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   UKMi007-A
AC   CVCL_D3FA
DR   BioSamples; SAMEA114482894
DR   hPSCreg; UKMi007-A
DR   Wikidata; Q127384569
CC   From: Muenster University Children's Hospital; Muenster; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   UKMi008-A
AC   CVCL_D3FB
DR   hPSCreg; UKMi008-A
DR   Wikidata; Q127384572
CC   From: Muenster University Children's Hospital; Muenster; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   UKNEQAS_ED04/02
AC   CVCL_JD59
SY   Extract 393
DR   Wikidata; Q54990553
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/327cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   UKNEQAS_H&I_411/2003
AC   CVCL_JD69
SY   UKNEQAS_H; 41869; Extract 421
DR   IPD-IMGT/HLA; 13254
DR   Wikidata; Q54990554
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/334cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:01,23:12; B*27:05,44:02; C*01:AFB,05:AG; DPA1*01:03,07; DPB1*04:01,04:02; DQA1*01:01,03; DQB1*05:01,03:01; DRB1*01:01,04:01; DRB4*01:03 (IPD-IMGT/HLA=13254).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   UKRV-Mel-01
AC   CVCL_N789
SY   UKRV-Mel-1
DR   Cosmic; 1846688
DR   Cosmic; 2686499
DR   Wikidata; Q54990555
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 9
//
ID   UKRV-Mel-02
AC   CVCL_A700
SY   UKRV-Mel-2; UKRV-MEL-2
DR   BTO; BTO_0005335
DR   cancercelllines; CVCL_A700
DR   Cosmic; 1846689
DR   Cosmic; 2163821
DR   Cosmic; 2686500
DR   ECACC; 13012436
DR   ESTDAB; ESTDAB-109
DR   Wikidata; Q54990556
RX   PubMed=7646526;
RX   PubMed=8688321;
RX   PubMed=15592718;
RX   PubMed=17311103;
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   HLA typing: A*01:01,25:01; B*08:01,18:01; C*07:01:01,12:04:02; DPB1*02:01:02,15:01; DQB1*06:02,02:01; DRB1*15:01,07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.237_238CC>TT) (c.237_238delinsTT) (p.Pro94Leu, c.280_281CC>TT); Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=13012436; ESTDAB=ESTDAB-109
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   FGA: 20
ST   TH01: 6,9.3
ST   TPOX: 10
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 24
//
ID   UKRV-Mel-03
AC   CVCL_A701
SY   UKRV-Mel-3
DR   cancercelllines; CVCL_A701
DR   Cosmic; 1846690
DR   Cosmic; 2163858
DR   Cosmic; 2686501
DR   ECACC; 13012499
DR   ESTDAB; ESTDAB-176
DR   Wikidata; Q54990557
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012499; ESTDAB=ESTDAB-176
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   FGA: 22
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   UKRV-Mel-04
AC   CVCL_A702
SY   UKRV-Mel-4; UKRV-MEL-4
DR   BTO; BTO_0005334
DR   Cosmic; 906467
DR   Cosmic; 2686503
DR   Wikidata; Q54990558
RX   PubMed=7646526;
RX   PubMed=8688321;
RX   PubMed=15760917;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 11
//
ID   UKRV-Mel-05
AC   CVCL_A703
SY   UKRV-Mel-5
DR   Cosmic; 906468
DR   Cosmic; 1846692
DR   Cosmic; 2686504
DR   ESTDAB; ESTDAB-145
DR   Wikidata; Q54990560
RX   PubMed=15760917;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-145
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D3S1358: 16,17
ST   D5S818: 9
ST   D7S820: 10
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   UKRV-Mel-06a
AC   CVCL_A704
SY   UKRV-Mel-6a; UKRV-Mel-6
DR   BTO; BTO_0005347
DR   ESTDAB; ESTDAB-111
DR   Wikidata; Q54990561
RX   PubMed=7646526;
RX   PubMed=10594685;
RX   PubMed=15592718;
CC   HLA typing: A*02:01,01:01; B*15:01:01:01,40:01; C*03:04,03:03; DPB1*04:01,03:01; DQB1*06:04,03:02; DRB1*04:01,13:02 (PubMed=15592718).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-111
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 12,13
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A705 ! UKRV-Mel-06b
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UKRV-Mel-06b
AC   CVCL_A705
SY   UKRV-Mel-6b
DR   cancercelllines; CVCL_A705
DR   Cosmic; 1846693
DR   Cosmic; 2686505
DR   ECACC; 13012538
DR   ESTDAB; ESTDAB-222
DR   Wikidata; Q54990562
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ECACC=13012538; ESTDAB=ESTDAB-222
ST   Amelogenin: X
ST   CSF1PO: 7,11 (ESTDAB=ESTDAB-222)
ST   CSF1PO: 11 (ECACC=13012538)
ST   D13S317: 11
ST   D16S539: 9,11
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 12,13
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A704 ! UKRV-Mel-06a
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   UKRV-Mel-07
AC   CVCL_A706
SY   UKRV-Mel-7; UKRV MEL7
DR   cancercelllines; CVCL_A706
DR   Cosmic; 972285
DR   Cosmic; 1846694
DR   Cosmic; 2686507
DR   Wikidata; Q54990563
RX   PubMed=7646526;
RX   PubMed=10594685;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UKRV-Mel-10
AC   CVCL_A707
SY   UKRV-MEL-10
DR   Wikidata; Q54990564
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   UKRV-Mel-11
AC   CVCL_A708
DR   Cosmic; 906469
DR   Cosmic; 2686508
DR   Wikidata; Q54990565
RX   PubMed=15760917;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 11
//
ID   UKRV-Mel-12
AC   CVCL_A709
DR   cancercelllines; CVCL_A709
DR   Cosmic; 1846696
DR   Cosmic; 2686509
DR   Wikidata; Q54990566
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UKRV-Mel-12a
AC   CVCL_C659
DR   cancercelllines; CVCL_C659
DR   Cosmic; 1846697
DR   Cosmic; 2686510
DR   ESTDAB; ESTDAB-223
DR   Wikidata; Q54990568
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-223
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   FGA: 22,25
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C660 ! UKRV-Mel-12b
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   UKRV-Mel-12b
AC   CVCL_C660
DR   cancercelllines; CVCL_C660
DR   Cosmic; 1846698
DR   Cosmic; 2686511
DR   ESTDAB; ESTDAB-224
DR   Wikidata; Q54990569
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.228_229CC>TT (-124/-125CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-224
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 8,11
ST   FGA: 22,25
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C659 ! UKRV-Mel-12a
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   UKRV-Mel-13
AC   CVCL_C408
DR   cancercelllines; CVCL_C408
DR   Cosmic; 2163859
DR   Cosmic; 2686512
DR   ESTDAB; ESTDAB-179
DR   Wikidata; Q54990570
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Leu97Pro (c.290T>C); ClinVar=VCV000962431; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.662_672+40del; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-179
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D3S1358: 17
ST   D5S818: 13,14
ST   D7S820: 8
ST   FGA: 23.2,24
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   UKRV-Mel-14a
AC   CVCL_A710
DR   cancercelllines; CVCL_A710
DR   Cosmic; 2163822
DR   ESTDAB; ESTDAB-110
DR   Wikidata; Q54990571
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Ala148Thr (c.442G>A); ClinVar=VCV000041580; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu326fs (c.976insGA); Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-110
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   FGA: 25
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A711 ! UKRV-Mel-14b
OI   CVCL_C409 ! UKRV-Mel-14c
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UKRV-Mel-14b
AC   CVCL_A711
DR   cancercelllines; CVCL_A711
DR   Cosmic; 1846700
DR   Cosmic; 2686513
DR   ECACC; 13012529
DR   ESTDAB; ESTDAB-225
DR   Wikidata; Q54990572
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012529; ESTDAB=ESTDAB-225
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 11
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   FGA: 25
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A710 ! UKRV-Mel-14a
OI   CVCL_C409 ! UKRV-Mel-14c
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   UKRV-Mel-14c
AC   CVCL_C409
DR   cancercelllines; CVCL_C409
DR   Cosmic; 1846701
DR   Cosmic; 2686514
DR   ESTDAB; ESTDAB-226
DR   Wikidata; Q54990574
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-226
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   FGA: 25
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A710 ! UKRV-Mel-14a
OI   CVCL_A711 ! UKRV-Mel-14b
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   UKRV-Mel-15
AC   CVCL_A712
SY   UKRV-MEL-15
DR   cancercelllines; CVCL_A712
DR   Cosmic; 1846702
DR   Cosmic; 2686515
DR   Wikidata; Q54990575
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-149C>T (c.253C>T) (C253T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   UKRV-Mel-15a
AC   CVCL_A713
SY   UKRV-Mel-15A
DR   cancercelllines; CVCL_A713
DR   Cosmic; 2163819
DR   ESTDAB; ESTDAB-107
DR   Wikidata; Q54990594
RX   PubMed=10594685;
RX   PubMed=15592718;
RX   PubMed=23851445;
CC   HLA typing: A*02:01,11:01; B*15:01:01:01,56:01; C*01:02,03:03; DPB1*04:01; DQB1*06:02,05:01; DRB1*01:01,15:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-107
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,12
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C397 ! UKRV-Mel-15b
OI   CVCL_C398 ! UKRV-Mel-15c
OI   CVCL_A714 ! UKRV-Mel-15d
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 17
//
ID   UKRV-Mel-15b
AC   CVCL_C397
DR   cancercelllines; CVCL_C397
DR   Cosmic; 1846703
DR   Cosmic; 2686516
DR   ESTDAB; ESTDAB-227
DR   Wikidata; Q54990596
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-149C>T (c.253C>T) (C253T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-227
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,12
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A713 ! UKRV-Mel-15a
OI   CVCL_C398 ! UKRV-Mel-15c
OI   CVCL_A714 ! UKRV-Mel-15d
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 16
//
ID   UKRV-Mel-15c
AC   CVCL_C398
DR   ESTDAB; ESTDAB-228
DR   Wikidata; Q54990597
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A713 ! UKRV-Mel-15a
OI   CVCL_C397 ! UKRV-Mel-15b
OI   CVCL_A714 ! UKRV-Mel-15d
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 6
//
ID   UKRV-Mel-15d
AC   CVCL_A714
DR   cancercelllines; CVCL_A714
DR   Cosmic; 906463
DR   Cosmic; 1846704
DR   Cosmic; 2686517
DR   ESTDAB; ESTDAB-229
DR   Wikidata; Q54990598
RX   PubMed=15760917;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-149C>T (c.253C>T) (C253T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-229
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 8,12
ST   FGA: 21,22
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A713 ! UKRV-Mel-15a
OI   CVCL_C397 ! UKRV-Mel-15b
OI   CVCL_C398 ! UKRV-Mel-15c
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   UKRV-Mel-16
AC   CVCL_A715
SY   UKRV-Mel-16a
DR   cancercelllines; CVCL_A715
DR   Cosmic; 2686518
DR   ESTDAB; ESTDAB-180
DR   Wikidata; Q54990599
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-180
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D3S1358: 16
ST   D5S818: 9,12
ST   D7S820: 8
ST   FGA: 26
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   UKRV-Mel-17
AC   CVCL_A716
DR   cancercelllines; CVCL_A716
DR   Cosmic; 2163837
DR   Cosmic; 2686519
DR   ECACC; 13012514
DR   ESTDAB; ESTDAB-147
DR   Wikidata; Q54990600
RX   PubMed=10594685;
RX   PubMed=15592718;
RX   PubMed=17311103;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   HLA typing: A*01:01,03:01; B*15:01:01:01,57:01:01; C*06:02,03:04; DPB1*04:01; DQB1*03:02,02:01; DRB1*04:01,03:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503; PubMed=23851445).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012514; ESTDAB=ESTDAB-147
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 10,13
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   FGA: 21,24
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 23
//
ID   UKRV-Mel-18a
AC   CVCL_A717
SY   UKRV-Mel-18A
DR   ESTDAB; ESTDAB-106
DR   Wikidata; Q54990602
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A718 ! UKRV-Mel-18b
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   UKRV-Mel-18b
AC   CVCL_A718
SY   UKRV-Mel-18B
DR   ESTDAB; ESTDAB-230
DR   Wikidata; Q54990603
ST   Source(s): ESTDAB=ESTDAB-230
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,11
ST   FGA: 19,22
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A717 ! UKRV-Mel-18a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 9
//
ID   UKRV-Mel-19
AC   CVCL_A719
DR   cancercelllines; CVCL_A719
DR   Wikidata; Q54990604
RX   PubMed=17311103;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   UKRV-Mel-19a
AC   CVCL_A720
DR   cancercelllines; CVCL_A720
DR   Cosmic; 906464
DR   Cosmic; 1846707
DR   Cosmic; 2686520
DR   Wikidata; Q54990605
RX   PubMed=10594685;
RX   PubMed=15760917;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-149C>T (c.253C>T) (C253T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C399 ! UKRV-Mel-19b
OI   CVCL_C400 ! UKRV-Mel-19c
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   UKRV-Mel-19b
AC   CVCL_C399
DR   cancercelllines; CVCL_C399
DR   Cosmic; 1846708
DR   Cosmic; 2686521
DR   ECACC; 13012536
DR   ESTDAB; ESTDAB-231
DR   Wikidata; Q54990606
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=13012536; ESTDAB=ESTDAB-231
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11
ST   D3S1358: 14,20
ST   D5S818: 11
ST   D7S820: 11,12
ST   FGA: 22,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A720 ! UKRV-Mel-19a
OI   CVCL_C400 ! UKRV-Mel-19c
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   UKRV-Mel-19c
AC   CVCL_C400
DR   cancercelllines; CVCL_C400
DR   Cosmic; 2686522
DR   ESTDAB; ESTDAB-232
DR   Wikidata; Q54990607
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-232
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D3S1358: 14,20
ST   D5S818: 11
ST   D7S820: 11,12
ST   FGA: 22,23
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A720 ! UKRV-Mel-19a
OI   CVCL_C399 ! UKRV-Mel-19b
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 12
//
ID   UKRV-Mel-20a
AC   CVCL_A721
DR   cancercelllines; CVCL_A721
DR   Cosmic; 1846710
DR   Cosmic; 2686523
DR   Wikidata; Q54990608
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C402 ! UKRV-Mel-20c
OI   CVCL_C403 ! UKRV-Mel-20e
OI   CVCL_C404 ! UKRV-Mel-20f
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UKRV-Mel-20b
AC   CVCL_C401
DR   ESTDAB; ESTDAB-233
DR   Wikidata; Q54990609
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C402 ! UKRV-Mel-20c
OI   CVCL_C403 ! UKRV-Mel-20e
OI   CVCL_C404 ! UKRV-Mel-20f
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 7
//
ID   UKRV-Mel-20c
AC   CVCL_C402
DR   cancercelllines; CVCL_C402
DR   Cosmic; 1846711
DR   Cosmic; 2686524
DR   ESTDAB; ESTDAB-234
DR   Wikidata; Q54990611
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-234
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 12
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C403 ! UKRV-Mel-20e
OI   CVCL_C404 ! UKRV-Mel-20f
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 15
//
ID   UKRV-Mel-20e
AC   CVCL_C403
DR   cancercelllines; CVCL_C403
DR   Cosmic; 1846712
DR   Cosmic; 2686525
DR   ESTDAB; ESTDAB-235
DR   Wikidata; Q54990612
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-235
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C402 ! UKRV-Mel-20c
OI   CVCL_C404 ! UKRV-Mel-20f
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   UKRV-Mel-20f
AC   CVCL_C404
DR   cancercelllines; CVCL_C404
DR   Cosmic; 1846713
DR   Cosmic; 2686526
DR   ESTDAB; ESTDAB-236
DR   Wikidata; Q54990613
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-236
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D3S1358: 17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C402 ! UKRV-Mel-20c
OI   CVCL_C403 ! UKRV-Mel-20e
OI   CVCL_C405 ! UKRV-Mel-20h
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   UKRV-Mel-20h
AC   CVCL_C405
DR   ESTDAB; ESTDAB-237
DR   Wikidata; Q54990615
ST   Source(s): ESTDAB=ESTDAB-237
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D3S1358: 16,17
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,25
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A721 ! UKRV-Mel-20a
OI   CVCL_C401 ! UKRV-Mel-20b
OI   CVCL_C402 ! UKRV-Mel-20c
OI   CVCL_C403 ! UKRV-Mel-20e
OI   CVCL_C404 ! UKRV-Mel-20f
SX   Male
AG   27Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 02-05-24; Version: 9
//
ID   UKRV-Mel-21a
AC   CVCL_A722
DR   BTO; BTO_0005348
DR   cancercelllines; CVCL_A722
DR   Cosmic; 1846715
DR   Cosmic; 2686528
DR   ESTDAB; ESTDAB-063
DR   Wikidata; Q54990616
RX   PubMed=10594685;
RX   PubMed=15592718;
RX   PubMed=23348503;
CC   HLA typing: A*02:01,23:01; B*44:02,44:03:01; C*04:01:01,05:01; DPB1*04:01; DQB1*03:01:01,02:01; DRB1*11:01,07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-063
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13,14
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 10,11
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   UKRV-Mel-22
AC   CVCL_A723
SY   UKRV-Mel22; UKRV MEL22
DR   cancercelllines; CVCL_A723
DR   Cosmic; 972281
DR   Cosmic; 1846716
DR   Cosmic; 2686529
DR   Wikidata; Q54990617
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 13
//
ID   UKRV-Mel-22a
AC   CVCL_C661
DR   cancercelllines; CVCL_C661
DR   Cosmic; 1846717
DR   Cosmic; 2163860
DR   Cosmic; 2686530
DR   ESTDAB; ESTDAB-182
DR   Wikidata; Q54990618
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-182
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C662 ! UKRV-Mel-22b
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   UKRV-Mel-22b
AC   CVCL_C662
SY   UKRVMEL22b
DR   cancercelllines; CVCL_C662
DR   Cosmic; 1846718
DR   Cosmic; 2686531
DR   ESTDAB; ESTDAB-183
DR   Wikidata; Q54990619
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Heterozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-183
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: Not_detected
ST   FGA: 24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C661 ! UKRV-Mel-22a
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   UKRV-Mel-23
AC   CVCL_A724
DR   Wikidata; Q54990620
RX   PubMed=10594685;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   UKRV-Mel-24
AC   CVCL_A725
DR   cancercelllines; CVCL_A725
DR   Cosmic; 2686532
DR   ESTDAB; ESTDAB-099
DR   Wikidata; Q54990621
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UKRV-Mel-25
AC   CVCL_C406
DR   cancercelllines; CVCL_C406
DR   Cosmic; 1846720
DR   Cosmic; 2163861
DR   Cosmic; 2686533
DR   ESTDAB; ESTDAB-184
DR   Wikidata; Q54990623
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-184
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   FGA: 22
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 18
//
ID   UKRV-Mel-27
AC   CVCL_A726
DR   BTO; BTO_0005349
DR   cancercelllines; CVCL_A726
DR   Cosmic; 1846721
DR   Cosmic; 2686534
DR   ESTDAB; ESTDAB-238
DR   Wikidata; Q54990624
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-238
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 10,12
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,13
ST   FGA: 22,23.2
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   UKRV-Mel-29
AC   CVCL_A727
DR   cancercelllines; CVCL_A727
DR   Cosmic; 1846722
DR   Cosmic; 2686535
DR   Wikidata; Q54990626
RX   PubMed=10594685;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UKRV-Mel-30
AC   CVCL_C407
DR   cancercelllines; CVCL_C407
DR   Cosmic; 1846723
DR   Cosmic; 2163836
DR   Cosmic; 2686536
DR   ESTDAB; ESTDAB-146
DR   Wikidata; Q54990627
RX   PubMed=19340423;
RX   PubMed=23348503;
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.242_243CC>TT (-138/-139CC>TT); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
ST   Source(s): ESTDAB=ESTDAB-146
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D3S1358: 14
ST   D5S818: 12,14
ST   D7S820: 10,12
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   UKRV-Mel-31
AC   CVCL_A728
DR   BTO; BTO_0005350
DR   cancercelllines; CVCL_A728
DR   Cosmic; 1846724
DR   Cosmic; 2686537
DR   ESTDAB; ESTDAB-101
DR   Wikidata; Q54990628
RX   PubMed=15592718;
RX   PubMed=17311103;
RX   PubMed=23348503;
CC   HLA typing: A*03:01,ND; B*44:03:01,27:05:02; DPB1*04:01,17:01; DQB1*03:01:01,02:01; DRB1*11:01,07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17311103; PubMed=23348503).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-101
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10,11
ST   FGA: 24
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 22
//
ID   UKRV-Mel-32
AC   CVCL_VK54
SY   UKRVMEL32
DR   Cosmic; 2686538
DR   Wikidata; Q98133996
RX   PubMed=23348503;
RX   PubMed=26909863;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=26909863).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7413; MTAP + HGNC; HGNC:34341; CDKN2B-AS1; Name(s)=MTAP-ANRIL (PubMed=26909863).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   UKRV-Mel-37
AC   CVCL_A729
DR   Cosmic; 1846726
DR   Cosmic; 2686539
DR   Wikidata; Q54990629
RX   PubMed=23348503;
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=23348503).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   UKRV-Mel-38
AC   CVCL_A730
DR   cancercelllines; CVCL_A730
DR   Cosmic; 2163823
DR   ESTDAB; ESTDAB-112
DR   Wikidata; Q54990630
RX   PubMed=15592718;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   HLA typing: A*01:01,32:01; B*08:01,44:02; C*05:01,07:01:01; DPB1*02:01:02,04:01; DQB1*03:01:01,03:03:02; DRB1*04:01:01,15:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-112
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   FGA: 23
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   UKTS8049
AC   CVCL_K960
DR   ECACC; 91032120
DR   Wikidata; Q54990631
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8660
AC   CVCL_K961
DR   ECACC; 91032121
DR   Wikidata; Q54990632
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032121; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS8670
AC   CVCL_K962
DR   ECACC; 91031441
DR   Wikidata; Q54990635
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8695
AC   CVCL_K963
DR   ECACC; 91021102
DR   Wikidata; Q54990636
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8713
AC   CVCL_K964
DR   ECACC; 91031446
DR   Wikidata; Q54990637
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS8727
AC   CVCL_K965
DR   ECACC; 91021107
DR   Wikidata; Q54990638
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS8740
AC   CVCL_K966
DR   ECACC; 91031437
DR   Wikidata; Q54990639
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8754
AC   CVCL_K967
DR   ECACC; 91070908
DR   Wikidata; Q54990640
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8768
AC   CVCL_K968
DR   ECACC; 91031439
DR   Wikidata; Q54990642
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8770
AC   CVCL_K969
DR   ECACC; 91070910
DR   Wikidata; Q54990653
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS8791
AC   CVCL_K970
DR   ECACC; 91032122
DR   Wikidata; Q54990655
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8792
AC   CVCL_K971
DR   ECACC; 91032123
DR   Wikidata; Q54990656
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8796
AC   CVCL_K972
DR   ECACC; 91032124
DR   Wikidata; Q54990657
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8797
AC   CVCL_K973
DR   ECACC; 91032125
DR   Wikidata; Q54990658
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8802
AC   CVCL_K974
DR   ECACC; 91032126
DR   Wikidata; Q54990659
RX   PubMed=27995740;
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:3620; FCGR3B; Zygosity=Homozygous (PubMed=27995740).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 15
//
ID   UKTS8825
AC   CVCL_K975
DR   ECACC; 91030444
DR   Wikidata; Q54990660
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS8837
AC   CVCL_K976
DR   ECACC; 91021101
DR   Wikidata; Q54990661
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8840
AC   CVCL_K977
DR   ECACC; 91031438
DR   Wikidata; Q54990662
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS8878
AC   CVCL_K978
DR   ECACC; 91032127
DR   Wikidata; Q54990663
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS8964
AC   CVCL_K979
DR   ECACC; 91070916
DR   Wikidata; Q54990664
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070916; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS8966
AC   CVCL_K980
DR   ECACC; 91021106
DR   Wikidata; Q54990665
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8989
AC   CVCL_K981
DR   ECACC; 91031443
DR   Wikidata; Q54990666
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS8992
AC   CVCL_K982
DR   ECACC; 91030401
DR   Wikidata; Q54990667
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9002
AC   CVCL_K983
DR   ECACC; 91031447
DR   Wikidata; Q54990668
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9003
AC   CVCL_K984
DR   ECACC; 91031436
DR   Wikidata; Q54990671
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9019
AC   CVCL_K985
DR   ECACC; 91032128
DR   Wikidata; Q54990672
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9020
AC   CVCL_K986
DR   ECACC; 91070903
DR   Wikidata; Q54990673
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9025
AC   CVCL_K987
DR   ECACC; 91021104
DR   Wikidata; Q54990676
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9034
AC   CVCL_K988
DR   ECACC; 91070905
DR   Wikidata; Q54990677
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS9046
AC   CVCL_K989
DR   ECACC; 91030402
DR   Wikidata; Q54990678
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9050
AC   CVCL_K990
DR   ECACC; 91030403
DR   Wikidata; Q54990680
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS9051
AC   CVCL_K991
DR   ECACC; 91032129
DR   Wikidata; Q54990681
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9074
AC   CVCL_K992
DR   ECACC; 91021103
DR   Wikidata; Q54990682
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9082
AC   CVCL_K993
DR   ECACC; 91031445
DR   Wikidata; Q54990683
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS9087
AC   CVCL_K994
DR   ECACC; 91070901
DR   Wikidata; Q54990684
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070901; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS9109
AC   CVCL_K995
DR   ECACC; 91032130
DR   Wikidata; Q54990685
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9110
AC   CVCL_K996
DR   ECACC; 91032131
DR   Wikidata; Q54990686
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9114
AC   CVCL_K997
DR   ECACC; 91031442
DR   Wikidata; Q54990687
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9115
AC   CVCL_K998
DR   ECACC; 91032132
DR   Wikidata; Q54990688
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS9142
AC   CVCL_K999
DR   ECACC; 91070909
DR   Wikidata; Q54990689
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9160
AC   CVCL_L000
DR   ECACC; 91032133
DR   Wikidata; Q54990690
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032133; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS9161
AC   CVCL_L001
DR   ECACC; 91032134
DR   Wikidata; Q54990691
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91032134; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS9175
AC   CVCL_L002
DR   ECACC; 91021105
DR   Wikidata; Q54990692
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9201
AC   CVCL_L003
DR   ECACC; 91070902
DR   Wikidata; Q54990693
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9204
AC   CVCL_L004
DR   ECACC; 91070906
DR   Wikidata; Q54990694
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 91070906; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 13
//
ID   UKTS9213
AC   CVCL_L005
DR   ECACC; 91070904
DR   Wikidata; Q54990696
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   UKTS9225
AC   CVCL_L006
SY   UKTS9225?
DR   ECACC; 91032135
DR   Wikidata; Q54990697
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9242
AC   CVCL_L007
DR   ECACC; 91031440
DR   Wikidata; Q54990699
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKTS9260
AC   CVCL_L008
DR   ECACC; 91070907
DR   Wikidata; Q54990700
CC   Part of: ECACC randomly selected UK Caucasian blood donors cell line selection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   UKWi001-A
AC   CVCL_RJ97
SY   SLC2A3-D2-iPSC
DR   hPSCreg; UKWi001-A
DR   SKIP; SKIP003161
DR   Wikidata; Q54990716
RX   PubMed=29477591;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Unspecified (PubMed=29477591).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   UKWi002-A
AC   CVCL_C7F9
SY   awr925 CL28
DR   hPSCreg; UKWi002-A
DR   Wikidata; Q117704925
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 8,9
ST   D18S51: 12,14
ST   D21S11: 28,29
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 10,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKWi002-A-1
AC   CVCL_C7FA
SY   awr925 CLM+
DR   hPSCreg; UKWi002-A-1
DR   Wikidata; Q117704926
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 8,9
ST   D18S51: 12,14
ST   D21S11: 28,29
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,25
ST   Penta D: 12,13
ST   Penta E: 10,15
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7F9 ! UKWi002-A
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKWi003-A
AC   CVCL_C7FB
SY   jem839 CL5
DR   hPSCreg; UKWi003-A
DR   Wikidata; Q117704927
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20974; ADGRL3; Simple; c.2913C>G; dbSNP=rs1397547; Zygosity=Heterozygous (PubMed=36640473).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 17,18
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 7
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 10,12
ST   Penta E: 14,18
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKWi003-A-1
AC   CVCL_C7FC
SY   jem839 CL7
DR   hPSCreg; UKWi003-A-1
DR   Wikidata; Q117704928
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20974; ADGRL3; Simple; c.2913C>G; dbSNP=rs1397547; Zygosity=Heterozygous (PubMed=36640473).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 10,12
ST   D18S51: 17,18
ST   D21S11: 28
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 7
ST   D8S1179: 12,13
ST   FGA: 23,24
ST   Penta D: 10,12
ST   Penta E: 14,18
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7FB ! UKWi003-A
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKWi004-A
AC   CVCL_C7FD
SY   wya376 CL4
DR   hPSCreg; UKWi004-A
DR   Wikidata; Q117704929
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20974; ADGRL3; Simple; c.2913C>G; dbSNP=rs1397547; Zygosity=Heterozygous (PubMed=36640473).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 30.2,32.2
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   Penta D: 9,14
ST   Penta E: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKWi004-A-1
AC   CVCL_C7FE
SY   wya376 CL6; nuc752 CL6
DR   hPSCreg; UKWi004-A-1
DR   Wikidata; Q117704930
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:20974; ADGRL3; Simple; c.2913C>G; dbSNP=rs1397547; Zygosity=Heterozygous (PubMed=36640473).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 16,18
ST   D21S11: 30.2,32.2
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 10,13
ST   FGA: 21,23
ST   Penta D: 9,14
ST   Penta E: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7FD ! UKWi004-A
SX   Male
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UKWi005-A
AC   CVCL_C7FF
SY   rnk730 CL20
DR   hPSCreg; UKWi005-A
DR   Wikidata; Q117704931
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 31.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 13,14
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 15,17
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKWi005-A-1
AC   CVCL_C7FG
SY   rnk730 CLM+
DR   hPSCreg; UKWi005-A-1
DR   Wikidata; Q117704932
RX   PubMed=36640473;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=36640473
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 31.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 22
ST   Penta D: 13,14
ST   Penta E: 7,13
ST   TH01: 6,9.3
ST   TPOX: 9,10
ST   vWA: 15,17
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7FF ! UKWi005-A
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UKWMPi001-A
AC   CVCL_A4YH
DR   BioSamples; SAMEA112661752
DR   hPSCreg; UKWMPi001-A
DR   Wikidata; Q107117235
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YI ! UKWMPi001-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 4
//
ID   UKWMPi001-B
AC   CVCL_A4YI
DR   hPSCreg; UKWMPi001-B
DR   Wikidata; Q107117236
RX   PubMed=33560471;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YH ! UKWMPi001-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 4
//
ID   UKWMPi002-A
AC   CVCL_A4YC
DR   hPSCreg; UKWMPi002-A
DR   Wikidata; Q107117237
RX   PubMed=33486346;
RX   PubMed=36746102;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YF ! UKWMPi002-B
OI   CVCL_A4YG ! UKWMPi002-C
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 6
//
ID   UKWMPi002-A-1
AC   CVCL_A4YD
SY   CDH13+/- iPSC
DR   hPSCreg; UKWMPi002-A-1
DR   Wikidata; Q107117238
RX   PubMed=33486346;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1753; CDH13 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4YC ! UKWMPi002-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   UKWMPi002-A-2
AC   CVCL_A4YE
SY   CDH13-/- iPSC
DR   hPSCreg; UKWMPi002-A-2
DR   Wikidata; Q107117239
RX   PubMed=33486346;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1753; CDH13.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4YC ! UKWMPi002-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   UKWMPi002-A-3
AC   CVCL_D0NA
SY   ST3GAL3-/- iPSC
DR   hPSCreg; UKWMPi002-A-3
DR   Wikidata; Q123033718
RX   PubMed=36746102;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10866; ST3GAL3.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4YC ! UKWMPi002-A
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UKWMPi002-B
AC   CVCL_A4YF
DR   hPSCreg; UKWMPi002-B
DR   Wikidata; Q107117241
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YC ! UKWMPi002-A
OI   CVCL_A4YG ! UKWMPi002-C
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UKWMPi002-C
AC   CVCL_A4YG
DR   hPSCreg; UKWMPi002-C
DR   Wikidata; Q107117243
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4YC ! UKWMPi002-A
OI   CVCL_A4YF ! UKWMPi002-B
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UKWMPi007-A
AC   CVCL_B0P9
SY   bCJ9cl1
DR   hPSCreg; UKWMPi007-A
DR   Wikidata; Q108821443
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PA ! UKWMPi007-B
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi007-B
AC   CVCL_B0PA
SY   bCJ9cl3
DR   hPSCreg; UKWMPi007-B
DR   Wikidata; Q108821444
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0P9 ! UKWMPi007-A
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi008-A
AC   CVCL_B0PB
SY   bCJ10cl2
DR   hPSCreg; UKWMPi008-A
DR   Wikidata; Q108821445
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PC ! UKWMPi008-B
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi008-B
AC   CVCL_B0PC
SY   bCJ10cl6
DR   hPSCreg; UKWMPi008-B
DR   Wikidata; Q108821446
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11007; SLC2A3; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PB ! UKWMPi008-A
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi011-A
AC   CVCL_B0PD
SY   bCJ13cl3
DR   hPSCreg; UKWMPi011-A
DR   Wikidata; Q108821447
RX   PubMed=34492570;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PE ! UKWMPi011-B
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi011-B
AC   CVCL_B0PE
SY   bCJ13cl5
DR   hPSCreg; UKWMPi011-B
DR   Wikidata; Q108821448
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PD ! UKWMPi011-A
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi012-A
AC   CVCL_B0PF
SY   bCJ14cl1
DR   hPSCreg; UKWMPi012-A
DR   Wikidata; Q108821449
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PG ! UKWMPi012-B
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWMPi012-B
AC   CVCL_B0PG
SY   bCJ14cl2
DR   hPSCreg; UKWMPi012-B
DR   Wikidata; Q108821450
RX   PubMed=34492570;
CC   From: Division of Molecular Psychiatry, Center of Mental Health, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11007; SLC2A3; Duplication; Zygosity=Heterozygous (PubMed=34492570).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C97160; Attention deficit hyperactivity disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B0PF ! UKWMPi012-A
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UKWNLi001-A
AC   CVCL_VN62
SY   FD-W236C-iPSC
DR   hPSCreg; UKWNLi001-A
DR   Wikidata; Q98134000
RX   PubMed=30130681;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Trp236Cys (c.708G>C); Zygosity=Heterozygous (PubMed=30130681).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   UKWNLi002-A
AC   CVCL_UG27
SY   HSAN5-T203M-iPSC
DR   hPSCreg; UKWNLi002-A
DR   Wikidata; Q98134002
RX   PubMed=30384131;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7808; NGF; Simple; p.Thr203Met (c.608C>T); Zygosity=Heterozygous (PubMed=30384131).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156360; Neuropathy, hereditary sensory and autonomic, type V
DI   ORDO; Orphanet_64752; Hereditary sensory and autonomic neuropathy type 5
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   UKWNLi003-A
AC   CVCL_VR98
SY   SCN10A-A-T365N-iPSC
DR   hPSCreg; UKWNLi003-A
DR   Wikidata; Q98134005
RX   PubMed=30731422;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Thr365Asn (c.1094C>A); dbSNP=rs754960592; Zygosity=Heterozygous (PubMed=30731422).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125389; Small fiber neuropathy
DI   ORDO; Orphanet_306577; Sodium channelopathy-related small fiber neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   UKWNLi004-A
AC   CVCL_VR99
SY   SCN10A-B-T365N-iPSC
DR   hPSCreg; UKWNLi004-A
DR   Wikidata; Q98134008
RX   PubMed=30731422;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Thr365Asn (c.1094C>A); dbSNP=rs754960592; Zygosity=Heterozygous (PubMed=30731422).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125389; Small fiber neuropathy
DI   ORDO; Orphanet_306577; Sodium channelopathy-related small fiber neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   UKWNLi005-A
AC   CVCL_B5II
SY   GLA-S126G-iPSC; MB1/5 iPSC
DR   hPSCreg; UKWNLi005-A
DR   Wikidata; Q110433933
RX   PubMed=35325818;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Ser126Gly (c.376A>G); ClinVar=VCV000163547; Zygosity=Hemizygous (PubMed=35325818).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   UKWNLi006-A
AC   CVCL_C0H3
SY   GLA-D170N-iPSC; FD1089/20
DR   BioSamples; SAMEA110695543
DR   hPSCreg; UKWNLi006-A
DR   Wikidata; Q112930513
RX   PubMed=36640471;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Asp170Asn (c.508G>A); Zygosity=Hemizygous (PubMed=36640471).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6TA ! UKWNLi006-B
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   UKWNLi006-B
AC   CVCL_C6TA
SY   FD1089/21
DR   BioSamples; SAMEA112262710
DR   hPSCreg; UKWNLi006-B
DR   Wikidata; Q117704933
RX   PubMed=36640471;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Asp170Asn (c.508G>A); Zygosity=Hemizygous (PubMed=36640471).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0H3 ! UKWNLi006-A
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   UKWNLi007-A
AC   CVCL_C0H4
SY   FD1210/1
DR   BioSamples; SAMEA112262705
DR   hPSCreg; UKWNLi007-A
DR   Wikidata; Q112930514
RX   PubMed=36640471;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Cys172Tyr (c.515G>A); ClinVar=VCV001323002; Zygosity=Hemizygous (PubMed=36640471).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C6TB ! UKWNLi007-B
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   UKWNLi007-B
AC   CVCL_C6TB
SY   FD1210/2
DR   BioSamples; SAMEA112262708
DR   hPSCreg; UKWNLi007-B
DR   Wikidata; Q117704934
RX   PubMed=36640471;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Cys172Tyr (c.515G>A); ClinVar=VCV001323002; Zygosity=Hemizygous (PubMed=36640471).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0H4 ! UKWNLi007-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   UKWNLi008-A
AC   CVCL_D0NB
SY   SFN 1097_2
DR   BioSamples; SAMEA112765274
DR   hPSCreg; UKWNLi008-A
DR   Wikidata; Q123033719
RX   PubMed=37079968;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:497; TRPA1; Simple; p.His560Asp (c.1678C>G); Zygosity=Heterozygous (PubMed=37079968).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125389; Small fiber neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0NC ! UKWNLi008-B
OI   CVCL_D0ND ! UKWNLi008-C
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UKWNLi008-B
AC   CVCL_D0NC
SY   SFN 1097_3
DR   BioSamples; SAMEA112359777
DR   hPSCreg; UKWNLi008-B
DR   Wikidata; Q123033720
RX   PubMed=37079968;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:497; TRPA1; Simple; p.His560Asp (c.1678C>G); Zygosity=Heterozygous (PubMed=37079968).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125389; Small fiber neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0NB ! UKWNLi008-A
OI   CVCL_D0ND ! UKWNLi008-C
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UKWNLi008-C
AC   CVCL_D0ND
SY   SFN 1097_5
DR   BioSamples; SAMEA112359778
DR   hPSCreg; UKWNLi008-C
DR   Wikidata; Q123033721
RX   PubMed=37079968;
CC   From: Department of Neurology, University of Wurzburg; Wurzburg; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:497; TRPA1; Simple; p.His560Asp (c.1678C>G); Zygosity=Heterozygous (PubMed=37079968).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125389; Small fiber neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0NB ! UKWNLi008-A
OI   CVCL_D0NC ! UKWNLi008-B
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UL-1 [Dog leukemia]
AC   CVCL_L421
DR   GEO; GSM2282270
DR   Wikidata; Q54990717
RX   PubMed=23196801;
RX   PubMed=27639374;
CC   Doubling time: 20.9 hours (PubMed=23196801).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Caution: Was originally classified as originating from a T-cell lymphoma, but is reclassified as a T-cell acute lymphoblastic leukemia based on characteristic cytogenomic properties (PubMed=27639374).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: Labrador Retriever x Unspecified breed; VBO=VBO_0200800+VBO_0400024.
DI   NCIt; C128120; Canine leukemia
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 15
//
ID   UL-1 [Human peritoneal carcinoma]
AC   CVCL_C3SC
DR   Wikidata; Q116050695
RX   PubMed=18589210;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   UL-101/68
AC   CVCL_B6U7
DR   Wikidata; Q112041883
RX   PubMed=3497470;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes allele A*03).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   UL-2
AC   CVCL_C3SD
DR   Wikidata; Q116050697
RX   PubMed=18589210;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   UL-39/10
AC   CVCL_B6U8
DR   Wikidata; Q112041884
RX   PubMed=3497470;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*13).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   UL-39/24
AC   CVCL_B6U9
DR   Wikidata; Q112041885
RX   PubMed=3497470;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P04439; Human HLA-A (Note=Recognizes alleles A*02/A*69).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 30-01-24; Version: 4
//
ID   UL-3A
AC   CVCL_C3S9
DR   Wikidata; Q116050698
RX   PubMed=9412727;
CC   Doubling time: 36 hours (PubMed=9412727).
CC   Donor information: Established during surgical debulking.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3SA ! UL-3B
OI   CVCL_C3SB ! UL-3C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   UL-3B
AC   CVCL_C3SA
DR   Wikidata; Q116050699
RX   PubMed=9412727;
CC   Doubling time: 30 hours (PubMed=9412727).
CC   Donor information: Established during chemotherapy.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3S9 ! UL-3A
OI   CVCL_C3SB ! UL-3C
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   UL-3C
AC   CVCL_C3SB
DR   Wikidata; Q116050700
RX   PubMed=9412727;
RX   PubMed=15161029;
CC   Doubling time: 20 hours (PubMed=9412727).
CC   Donor information: Established after clinical progression of the disease.
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C3S9 ! UL-3A
OI   CVCL_C3SA ! UL-3B
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   UL-4F11
AC   CVCL_B6V5
DR   Wikidata; Q112041886
RX   PubMed=8560449;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*27).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   UL-5
AC   CVCL_C3SE
DR   Wikidata; Q116050701
RX   PubMed=15161029;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   UL-52
AC   CVCL_B6UA
DR   Wikidata; Q112041887
RX   PubMed=2476377;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01903; Human HLA-DRA.
CC   Monoclonal antibody target: UniProtKB; P79483; Human HLA-DRB3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_Z070 ! PAI-0
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   UL-6
AC   CVCL_C3SF
DR   Wikidata; Q116050702
RX   PubMed=15161029;
RX   PubMed=18589210;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   UL-7
AC   CVCL_C3SG
DR   Wikidata; Q116050703
RX   PubMed=15161029;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   UL-8
AC   CVCL_C3SH
DR   Wikidata; Q116050704
RX   PubMed=15161029;
CC   Miscellaneous: This cell line was originally classified as originating from an ovarian serous surface papillary adenocarcinoma and has been reclassified as a peritoneal serous papillary adenocarcinoma The reason being that serous surface papillary adenocarcinoma is no longer considered an ovarian primary tumor. The assumption is that all cases have peritoneal primaries.
DI   NCIt; C7695; Primary peritoneal serous papillary adenocarcinoma
DI   ORDO; Orphanet_168829; Primary peritoneal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   UL-B
AC   CVCL_C3SI
DR   Wikidata; Q116050705
RX   Patent=US20120277326;
RX   PubMed=18589210;
CC   Population: Caucasian.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   Ul-F
AC   CVCL_6F96
SY   ULF; Umbra limi Fin
DR   Wikidata; Q54990718
RX   PubMed=6541753;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75935; ! Umbra limi (Central mudminnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   UL-F6
AC   CVCL_B6V6
DR   Wikidata; Q112041889
RX   PubMed=8560449;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes allele B*27).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 4
//
ID   Ul-H
AC   CVCL_6F97
SY   ULH; Umbra limi Heart
DR   Wikidata; Q54990720
RX   PubMed=6541753;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=75935; ! Umbra limi (Central mudminnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   UL-O
AC   CVCL_C3SJ
DR   Wikidata; Q116050706
RX   Patent=US20120277326;
RX   PubMed=18589210;
CC   Population: Caucasian.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C36100; BRCA1 syndrome
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   UL/F10
AC   CVCL_B6SS
SY   Ul/F10
DR   Wikidata; Q112041890
RX   PubMed=7515376;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P26663; Hepatitis C virus genotype 1b (isolate BK) genome polyprotein (Note=AA 1-150 = Core protein p21).
CC   Misspelling: U1/F10; Note=Occasionally.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   UL/F11
AC   CVCL_B6ST
SY   Ul/F11
DR   Wikidata; Q112041891
RX   PubMed=7515376;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: UniProtKB; P26663; Hepatitis C virus genotype 1b (isolate BK) genome polyprotein (Note=AA 1-150 = Core protein p21).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 10-09-24; Version: 5
//
ID   UL/F14
AC   CVCL_B6SV
DR   Wikidata; Q112041892
RX   PubMed=7526486;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01889; Human HLA-B (Note=Recognizes alleles B*12=B*44/B*45).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2538 ! K6H6/B5
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ULA
AC   CVCL_1854
SY   Uppsala Lymphoma Ascites-fluid
DR   BioSample; SAMN03473508
DR   ChEMBL-Cells; CHEMBL4523525
DR   ChEMBL-Targets; CHEMBL4523556
DR   DSMZ; ACC-627
DR   DSMZCellDive; ACC-627
DR   GEO; GSM1374977
DR   PubChem_Cell_line; CVCL_1854
DR   Wikidata; Q54990721
RX   PubMed=17487752;
RX   PubMed=26727417;
CC   Doubling time: ~40-60 hours (DSMZ=ACC-627).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-627
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14,16
ST   D21S11: 30,31
ST   D2S1338: 23,25
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 19,21
ST   Penta D: 9,12
ST   Penta E: 7
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   ULBe001-A
AC   CVCL_9005
SY   ERA-1; ERA1
DR   hPSCreg; ULBe001-A
DR   SKIP; SKIP001883
DR   Wikidata; Q54990722
RX   PubMed=19549452;
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   ULBe002-A
AC   CVCL_9006
SY   ERA-2; ERA2
DR   hPSCreg; ULBe002-A
DR   SKIP; SKIP001884
DR   Wikidata; Q54990723
RX   PubMed=19549452;
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   ULBe003-A
AC   CVCL_9007
SY   ERA-3; ERA3
DR   hPSCreg; ULBe003-A
DR   SKIP; SKIP001885
DR   Wikidata; Q54990724
RX   PubMed=19549452;
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   ULBe004-A
AC   CVCL_9008
SY   ERAMUC-1; ERAMUC1
DR   hPSCreg; ULBe004-A
DR   SKIP; SKIP001886
DR   Wikidata; Q54990725
RX   PubMed=19549452;
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19549452).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; c.3718-2477C>T (3849+10KB,C>T); ClinVar=VCV000007166; Zygosity=Heterozygous (PubMed=19549452).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   ULBe005-A
AC   CVCL_9009
SY   ERAMUC-2; ERAMUC2
DR   hPSCreg; ULBe005-A
DR   SKIP; SKIP001887
DR   Wikidata; Q54990726
RX   PubMed=19549452;
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Heterozygous (PubMed=19549452).
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Glu585Ter (c.1753G>T); ClinVar=VCV000053374; Zygosity=Heterozygous (PubMed=19549452).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   ULBi001-A
AC   CVCL_UL39
SY   ULBi.001.BJ.6
DR   BioSamples; SAMEA5309511
DR   hPSCreg; ULBi001-A
DR   Wikidata; Q98134012
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Discontinued: hPSCreg; ULBi001-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   ULBi004-A
AC   CVCL_B5H0
SY   AH
DR   BioSamples; SAMEA9468449
DR   hPSCreg; ULBi004-A
DR   Wikidata; Q110433934
CC   From: Universite Libre de Bruxelles; Brussels; Belgium.
CC   Population: Caucasian.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Cell type: Fibroblast of muscle; CL=CL_1001609.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   ULEIi001-A
AC   CVCL_IT81
DR   BioSamples; SAMEA7410418
DR   hPSCreg; ULEIi001-A
DR   SKIP; SKIP002893
DR   Wikidata; Q54990727
RX   PubMed=27789413;
CC   From: Leipzig University Center for Biotechnology and Biomedicine; Leipzig; Germany.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   ULEIi002-A
AC   CVCL_UM23
DR   hPSCreg; ULEIi002-A
DR   Wikidata; Q98134016
CC   From: Leipzig University Center for Biotechnology and Biomedicine; Leipzig; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   ULEIi003-A
AC   CVCL_UM24
DR   hPSCreg; ULEIi003-A
DR   Wikidata; Q98134019
CC   From: Leipzig University Center for Biotechnology and Biomedicine; Leipzig; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   ULF-23
AC   CVCL_5641
SY   Umbra Limi Fin-23
DR   CLO; CLO_0050006
DR   RCB; RCB0568
DR   Wikidata; Q54990729
RX   CelloPub=CLPUB00124;
CC   Group: Fish cell line.
CC   Doubling time: 72 hours (CelloPub=CLPUB00124).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75935; ! Umbra limi (Central mudminnow)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   ULF-23HU
AC   CVCL_5642
DR   Wikidata; Q54990730
RX   DOI=10.1007/BF02624131;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=75935; ! Umbra limi (Central mudminnow)
HI   CVCL_5641 ! ULF-23
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   ULK1 KO MEF (SIM)
AC   CVCL_5A52
SY   ULK1-/-ULK2+/+
DR   CancerTools; 151715
DR   ECACC; 14050806
DR   Wikidata; Q54990731
DR   Ximbio; 151715
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC   Discontinued: ECACC; 14050806; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   ULK1 KO MEF (SV40)
AC   CVCL_5A53
DR   CancerTools; 152609
DR   ECACC; 14050807
DR   Wikidata; Q54990732
DR   Ximbio; 152609
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 14050807; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   ULK1+ULK2 DKO MEF (SIM)
AC   CVCL_5A56
SY   MEF Ulk1 -/- Ulk2 -/- (DKO) (SIM)
DR   CancerTools; 151774
DR   ECACC; 14050803
DR   Wikidata; Q54990735
DR   Ximbio; 151774
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
CC   Discontinued: ECACC; 14050803; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   ULK1+ULK2 DKO MEF (SV40)
AC   CVCL_5A57
SY   MEF Ulk1 -/- Ulk2 -/- (DKO) (SV40)
DR   CancerTools; 152608
DR   ECACC; 14050802
DR   Wikidata; Q54990736
DR   Ximbio; 152608
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1270126; Ulk1.
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 14050802; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   ULK1/2 WT MEF (SIM)
AC   CVCL_5A50
DR   CancerTools; 151714
DR   ECACC; 14050808
DR   Wikidata; Q54990733
DR   Ximbio; 151714
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Discontinued: ECACC; 14050808; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   ULK1/2 WT MEF (SV40)
AC   CVCL_5A51
DR   CancerTools; 152607
DR   ECACC; 14050804
DR   Wikidata; Q54990734
DR   Ximbio; 152607
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 14050804; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   ULK2 KO MEF (SIM)
AC   CVCL_5A54
SY   ULK1+/+ULK2-/-
DR   CancerTools; 151776
DR   ECACC; 14050810
DR   Wikidata; Q54990737
DR   Ximbio; 151776
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
CC   Discontinued: ECACC; 14050810; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   ULK2 KO MEF (SV40)
AC   CVCL_5A55
DR   CancerTools; 152610
DR   ECACC; 14050805
DR   Wikidata; Q54990739
DR   Ximbio; 152610
RX   PubMed=23291478;
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/ulk/
CC   Knockout cell: Method=Gene-targeted KO mouse; MGI; MGI:1352758; Ulk2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 14050805; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 14
//
ID   ULT-1
AC   CVCL_L784
DR   Wikidata; Q54990741
RX   PubMed=22273270;
CC   Population: Japanese.
CC   Senescence: Ultra long-lived cell line with a life span of 166 PDL (PubMed=22273270).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0560 ! TIG-1
SX   Female
AG   20FW
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 17
//
ID   ULTR
AC   CVCL_8138
DR   Wikidata; Q54990742
RX   PubMed=1311088;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Cell type: Uterine smooth muscle cell; CL=CL_0002601.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   ULTR-hT
AC   CVCL_8139
SY   ULTRhT
DR   Wikidata; Q54990743
RX   PubMed=19767538;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Cell type: Uterine smooth muscle cell; CL=CL_0002601.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8138 ! ULTR
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   ULUNDi001-A
AC   CVCL_VA37
SY   CSC-40F; CSC-40
DR   hPSCreg; ULUNDi001-A
DR   SKIP; SKIP002981
DR   Wikidata; Q54990744
RX   PubMed=29331938;
CC   From: University of Lund; Lund; Sweden.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Gln456Ter (c.1366C>T); ClinVar=VCV000002415; Zygosity=Homozygous (PubMed=29331938).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29331938
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 11,12
ST   D21S11: 31.2,32.2
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 16
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ULUNDi002-A
AC   CVCL_RV26
SY   CSC-41C; CSC-41
DR   hPSCreg; ULUNDi002-A
DR   Wikidata; Q54990745
RX   PubMed=29414418;
CC   From: University of Lund; Lund; Sweden.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=29414418).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29414418
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,9
ST   D16S539: 8,11
ST   D21S11: 32.2
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   ULUNDi004-A
AC   CVCL_VA38
SY   CSC-42L; CSC-42
DR   hPSCreg; ULUNDi004-A
DR   SKIP; SKIP002978
DR   Wikidata; Q54990746
RX   PubMed=29334629;
CC   From: University of Lund; Lund; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29334629
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 28,33.2
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 8
//
ID   ULUNDi005-A
AC   CVCL_RV27
SY   CSC-43J; CSC-43
DR   hPSCreg; ULUNDi005-A
DR   SKIP; SKIP002979
DR   Wikidata; Q54990747
RX   PubMed=29334630;
CC   From: University of Lund; Lund; Sweden.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29334630
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D21S11: 28,33.2
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   ULUNDi006-A
AC   CVCL_RV28
SY   CSC-44I; CSC-44
DR   hPSCreg; ULUNDi006-A
DR   SKIP; SKIP002948
DR   Wikidata; Q54990748
RX   PubMed=29353703;
CC   From: University of Lund; Lund; Sweden.
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Arg275Trp (c.823C>T); ClinVar=VCV000007050; Zygosity=Heterozygous (PubMed=29353703).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6del; Zygosity=Heterozygous (PubMed=29353703).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29353703
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 30,31
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   ULUNDi007-A
AC   CVCL_UL02
SY   CSC-46L; CSC-46
DR   hPSCreg; ULUNDi007-A
DR   Wikidata; Q98134022
RX   PubMed=30640063;
CC   From: University of Lund; Lund; Sweden.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Arg301Cys (c.901C>T) (R252C); ClinVar=VCV001303549; Zygosity=Heterozygous (PubMed=30640063).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   ULUNDi008-A
AC   CVCL_YC61
SY   CSC-32B; CSC-32
DR   hPSCreg; ULUNDi008-A
DR   Wikidata; Q98134025
RX   PubMed=31954327;
CC   From: University of Lund; Lund; Sweden.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous (PubMed=31954327).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UM
AC   CVCL_WL56
SY   Uveal Melanocytes
DR   Wikidata; Q98134027
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000209). It was the sole source of information for this entry.
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
CC   Cell type: Melanocyte of choroid; CL=CL_4030000.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 9,11,12
ST   D18S51: 13,15,16
ST   D19S433: 13,16.2
ST   D21S11: 28,30,31.2
ST   D2S1338: 17,19,22
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 10,11,12
ST   D8S1179: 10,12,14
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 9,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   UM-1 [Human LCL]
AC   CVCL_VJ00
SY   UM 1; University of Michigan lymphoid line no.1; University of Michigan long-term lymphocyte line 1
DR   Wikidata; Q98134029
RX   CelloPub=CLPUB00749;
RX   PubMed=869901;
RX   PubMed=4323795;
RX   PubMed=5452899;
CC   Population: Korean.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Donor information: Established from the author own blood (CelloPub=CLPUB00749).
CC   Miscellaneous: Source of immortalizing EBV is cell line PGLC-33H (Cellosaurus=CVCL_HA64).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   UM-1 [Human plasma cell myeloma]
AC   CVCL_W392
DR   Wikidata; Q54990749
RX   PubMed=10087940;
RX   PubMed=10936422;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   UM-1-6TGr
AC   CVCL_VJ01
SY   UM 1-6TG
DR   Wikidata; Q98134031
RX   PubMed=869901;
RX   PubMed=4368696;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VJ00 ! UM-1 [Human LCL]
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   UM-10
AC   CVCL_A7SV
SY   UM 10; University of Michigan lymphoid line no.10
DR   Wikidata; Q107117244
RX   CelloPub=CLPUB00749;
RX   PubMed=4354564;
RX   PubMed=5452899;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus=CVCL_A7SR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7SW ! UM-11
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   UM-11
AC   CVCL_A7SW
SY   UM 11; University of Michigan lymphoid line no.11
DR   Wikidata; Q107117245
RX   CelloPub=CLPUB00749;
RX   PubMed=4354564;
RX   PubMed=5452899;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus=CVCL_A7SR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C61255; Lesch-Nyhan syndrome
DI   ORDO; Orphanet_510; Lesch-Nyhan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7SV ! UM-10
SX   Male
AG   2Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   UM-12
AC   CVCL_C9GK
SY   UM 12; University of Michigan lymphoid line no.12
DR   Wikidata; Q123033722
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-4 (Cellosaurus=CVCL_C9GE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GL ! UM-13
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-13
AC   CVCL_C9GL
SY   UM 13; University of Michigan lymphoid line no.13
DR   Wikidata; Q123033723
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-4 (Cellosaurus=CVCL_C9GE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GK ! UM-12
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-14
AC   CVCL_C9GM
SY   UM 14; University of Michigan lymphoid line no.14
DR   Wikidata; Q123033724
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-6 (Cellosaurus= CVCL_C9GG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GF ! UM-5
OI   CVCL_C9GN ! UM-15
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-15
AC   CVCL_C9GN
SY   UM 15; University of Michigan lymphoid line no.15
DR   Wikidata; Q123033725
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-6 (Cellosaurus= CVCL_C9GG).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GF ! UM-5
OI   CVCL_C9GM ! UM-14
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-16
AC   CVCL_C9GP
SY   UM 16; University of Michigan lymphoid line no.16
DR   Wikidata; Q123033726
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-3 (Cellosaurus= CVCL_A7SR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-17
AC   CVCL_C9GQ
SY   UM 17; University of Michigan lymphoid line no.17
DR   Wikidata; Q123033727
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line PGLC-33H (Cellosaurus=CVCL_HA64).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-2 [Human LCL]
AC   CVCL_C9GD
SY   UM 2; University of Michigan lymphoid line no.2
DR   Wikidata; Q123033728
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line PGLC-33H (Cellosaurus=CVCL_HA64).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-2 [Human plasma cell myeloma]
AC   CVCL_W393
DR   Wikidata; Q54990750
RX   PubMed=10087940;
RX   PubMed=10936422;
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   UM-21-5
AC   CVCL_VJ02
SY   UM-21 clone 5
DR   Wikidata; Q98134033
RX   PubMed=869901;
RX   PubMed=1180883;
RX   PubMed=4323795;
RX   PubMed=4368696;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J103 ! GM00235
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   UM-21-6
AC   CVCL_VJ03
SY   UM-21 clone 6
DR   Wikidata; Q98134036
RX   PubMed=869901;
RX   PubMed=1180883;
RX   PubMed=4323795;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C150601; Citrullinemia type I
DI   ORDO; Orphanet_247525; Citrullinemia type I
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J103 ! GM00235
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 05-10-23; Version: 6
//
ID   UM-26
AC   CVCL_C9GR
SY   UM 26; University of Michigan lymphoid line no.26
DR   Wikidata; Q123033729
RX   PubMed=4323795;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GS ! UM-27
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-27
AC   CVCL_C9GS
SY   UM 27; University of Michigan lymphoid line no.27
DR   Wikidata; Q123033730
RX   PubMed=4323795;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GR ! UM-26
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-3 [Human LCL]
AC   CVCL_A7SR
SY   UM 3; University of Michigan lymphoid line no.3
DR   Wikidata; Q107117246
RX   CelloPub=CLPUB00749;
RX   PubMed=5452899;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-1 (Cellosaurus=CVCL_VJ00).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   UM-3 [Human plasma cell myeloma]
AC   CVCL_W394
SY   UM3
DR   Wikidata; Q54990753
RX   PubMed=10087940;
RX   PubMed=10936422;
RX   PubMed=15257707;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   UM-39
AC   CVCL_A7SU
SY   UM 39; University of Michigan lymphoid line no.39
DR   Wikidata; Q107117248
RX   PubMed=869901;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UM-4
AC   CVCL_C9GE
SY   UM 4; University of Michigan lymphoid line no.4
DR   Wikidata; Q123033731
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-1 (Cellosaurus=CVCL_VJ00).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C84392; Intellectual developmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 3
//
ID   UM-43
AC   CVCL_VJ04
SY   UM 43; University of Michigan lymphoid line no.43; University of Michigan long-term lymphocyte line 43
DR   Wikidata; Q98134038
RX   PubMed=216485;
RX   PubMed=869901;
RX   PubMed=1180883;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-5
AC   CVCL_C9GF
SY   UM 5; University of Michigan lymphoid line no.5
DR   Wikidata; Q123033732
RX   CelloPub=CLPUB00749;
RX   PubMed=4323795;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line PGLC-33H (Cellosaurus=CVCL_HA64).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GM ! UM-14
OI   CVCL_C9GN ! UM-15
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-55
AC   CVCL_A7SS
SY   UM 55; University of Michigan lymphoid line no.55
DR   Wikidata; Q107117249
RX   PubMed=869901;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UM-56
AC   CVCL_A7ST
SY   UM 56; U.M.-56; University of Michigan lymphoid line no.56
DR   Wikidata; Q107117250
RX   PubMed=62390;
RX   PubMed=869901;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UM-6 [Human LCL]
AC   CVCL_C9GG
SY   UM 6; University of Michigan lymphoid line no.6
DR   Wikidata; Q123033734
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-2 (Cellosaurus=CVCL_C9GD).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GH ! UM-7
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-6 [Human plasma cell myeloma]
AC   CVCL_W395
DR   Wikidata; Q54990754
RX   PubMed=10087940;
RX   PubMed=10936422;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 11
//
ID   UM-61
AC   CVCL_VJ05
SY   UM 61; U.M.-61; University of Michigan lymphoid line no.61; University of Michigan long-term lymphocyte line 61
DR   Wikidata; Q98134040
RX   PubMed=62390;
RX   PubMed=216485;
RX   PubMed=869901;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-7
AC   CVCL_C9GH
SY   UM 7; University of Michigan lymphoid line no.6
DR   Wikidata; Q123033735
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-1 (Cellosaurus=CVCL_VJ00).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C9GG ! UM-6 [Human LCL]
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-8
AC   CVCL_C9GI
SY   UM 8; University of Michigan lymphoid line no.8
DR   Wikidata; Q123033736
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-1 (Cellosaurus=CVCL_VJ00).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-9
AC   CVCL_C9GJ
SY   UM 9; University of Michigan lymphoid line no.9
DR   Wikidata; Q123033737
RX   CelloPub=CLPUB00749;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Miscellaneous: Source of immortalizing EBV is cell line UM-2 (Cellosaurus=CVCL_C9GD).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UM-A9
AC   CVCL_WN42
SY   A9
DR   Wikidata; Q98134042
RX   PubMed=6417595;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P16144; Human ITGB4/CD104.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   UM-AVE1
AC   CVCL_Z825
DR   Wikidata; Q54990755
RX   PubMed=1367156;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7163; ! Aedes vexans (Inland floodwater mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UM-BGE-1
AC   CVCL_Z332
SY   BGE-1
DR   Wikidata; Q54990756
RX   DOI=10.1016/B978-0-12-470270-7.50008-2;
RX   PubMed=192663;
RX   PubMed=16690920;
CC   Group: Insect cell line.
CC   Doubling time: 4.8 days (PubMed=192663).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6973; ! Blattella germanica (German cockroach)
SX   Sex unspecified
AG   Embryo 5D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UM-BGE-2
AC   CVCL_Z333
SY   UMN-BGE-2; UMBGE-2; BGE-2
DR   Wikidata; Q54990757
RX   DOI=10.1016/B978-0-12-470270-7.50008-2;
RX   PubMed=192663;
RX   PubMed=16593348;
RX   PubMed=16690920;
CC   Group: Insect cell line.
CC   Virology: Susceptible to infection by Blattella germanica densovirus (BgDNV) (PubMed=16690920).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6973; ! Blattella germanica (German cockroach)
SX   Sex unspecified
AG   Embryo 7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UM-BGE-4
AC   CVCL_Z334
SY   UMBGE-4
DR   Wikidata; Q54990758
RX   DOI=10.1016/B978-0-12-470270-7.50008-2;
RX   PubMed=192663;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6973; ! Blattella germanica (German cockroach)
SX   Sex unspecified
AG   Embryo 5-7D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   UM-BGE-5 alpha
AC   CVCL_Z335
DR   Wikidata; Q54990759
RX   DOI=10.1016/B978-0-12-470270-7.50008-2;
RX   PubMed=192663;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6973; ! Blattella germanica (German cockroach)
OI   CVCL_Z336 ! UM-BGE-5 beta
SX   Sex unspecified
AG   Embryo 10D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   UM-BGE-5 beta
AC   CVCL_Z336
SY   UMN-BGE-5beta
DR   Wikidata; Q54990760
RX   DOI=10.1016/B978-0-12-470270-7.50008-2;
RX   PubMed=192663;
RX   PubMed=16593348;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=6973; ! Blattella germanica (German cockroach)
OI   CVCL_Z335 ! UM-BGE-5 alpha
SX   Sex unspecified
AG   Embryo 10D
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   UM-CCS-1
AC   CVCL_0J37
SY   UM-CCS1
DR   Wikidata; Q54990761
RX   PubMed=12237889;
CC   Characteristics: Established through serial subcutaneous transplantation of intact tumour tissue in nude mice (PubMed=12237889).
CC   Sequence variation: Gene fusion; HGNC; HGNC:783; ATF1 + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ATF1, EWS-ATF; Note=Type 2: EWSR1 exon 5 fused to ATF1 exon 5 (PubMed=12237889).
CC   Derived from site: In situ; Thigh, quadriceps skeletal muscle; UBERON=UBERON_0004498.
DI   NCIt; C3745; Clear cell sarcoma of soft tissue
DI   ORDO; Orphanet_3394; Soft tissue sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 6
//
ID   UM-Chor1
AC   CVCL_1D68
SY   UM-CHOR-1; UMCHOR1; University of Michigan-Chordoma-1
DR   ABM; T8149
DR   ATCC; CRL-3270
DR   Cell_Model_Passport; SIDM01415
DR   Cosmic; 2663863
DR   DepMap; ACH-001957
DR   GEO; GSM2495967
DR   GEO; GSM2495968
DR   GEO; GSM2495969
DR   Wikidata; Q54990767
RX   PubMed=27102572;
RX   PubMed=28430034;
RX   PubMed=28515451;
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/um-chor1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~5 days (PubMed=28430034); 5 days (Chordoma Foundation).
CC   HLA typing: A*02,03 (Chordoma Foundation).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
ST   Source(s): ATCC=CRL-3270; PubMed=27102572
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14,16
ST   D21S11: 27,31
ST   D2S1338: 18,20
ST   D3S1358: 18
ST   D5S818: 9,13
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   Penta D: 8,9
ST   Penta E: 7
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 20
//
ID   UM-Chor2
AC   CVCL_5T81
SY   UM-CHOR-2; University of Michigan-Chordoma-2
DR   Wikidata; Q54990768
WW   Info; -; -; https://ahns.jnabstracts.com/2014/Detail.aspx?ID=57728
CC   Derived from site: In situ; Bone, spine; UBERON=UBERON_0001130.
DI   NCIt; C5156; Spinal chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   UM-Chor5
AC   CVCL_UZ98
SY   University of Michigan-Chordoma-5
DR   ATCC; CRL-3428
DR   Wikidata; Q98134043
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/um-chor5/
CC   Population: Caucasian.
CC   Doubling time: 96 hours (Chordoma Foundation).
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
ST   Source(s): ATCC=CRL-3428
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,16
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5IC ! UM-Chor5C
OI   CVCL_A5ID ! UM-Chor5D
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   UM-Chor5C
AC   CVCL_A5IC
SY   University of Michigan-Chordoma-5C
DR   ATCC; CRL-3512
DR   Wikidata; Q107117251
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/um-chor5c/
CC   Population: Caucasian.
CC   Doubling time: 3.794 days (Chordoma Foundation).
CC   Derived from site: Metastatic; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UZ98 ! UM-Chor5
OI   CVCL_A5ID ! UM-Chor5D
SX   Male
AG   16-20Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   UM-Chor5D
AC   CVCL_A5ID
SY   University of Michigan-Chordoma-5D
DR   ATCC; CRL-3513
DR   Wikidata; Q107117252
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/um-chor5d/
CC   Population: Caucasian.
CC   Doubling time: 4.632 days (Chordoma Foundation).
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UZ98 ! UM-Chor5
OI   CVCL_A5IC ! UM-Chor5C
SX   Male
AG   16-20Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UM-Chor6
AC   CVCL_A5IG
SY   University of Michigan-Chordoma-6
DR   Wikidata; Q107117254
WW   Info; Chordoma Foundation; -; https://www.chordomafoundation.org/researchers/disease-models/um-chor6/
CC   Doubling time: ~21 days (Chordoma Foundation).
CC   Derived from site: In situ; Bone, cranium, clivus; UBERON=UBERON_0004108.
DI   NCIt; C5412; Clivus chordoma
DI   ORDO; Orphanet_178; Chordoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UM-E7
AC   CVCL_WN41
SY   E7
DR   Wikidata; Q98134045
RX   PubMed=1958593;
RX   PubMed=6417595;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human cell surface antigen on many cell types.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   UM-EC-1
AC   CVCL_5972
SY   University of Michigan-Endometrial Carcinoma-1
DR   IARC_TP53; 21684
DR   Wikidata; Q54990769
RX   PubMed=1541432;
RX   PubMed=3349465;
RX   PubMed=7798295;
RX   PubMed=8123477;
RX   PubMed=9887230;
RX   PubMed=17178626;
CC   Doubling time: 24 hours (PubMed=1541432).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   UM-EC-2
AC   CVCL_X001
SY   University of Michigan-Endometrial Carcinoma-2
DR   IARC_TP53; 21685
DR   Wikidata; Q54990770
RX   PubMed=1541432;
RX   PubMed=2344964;
RX   PubMed=7798295;
RX   PubMed=8123477;
RX   PubMed=9887230;
CC   Doubling time: 36 hours (PubMed=1541432).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 14
//
ID   UM-EC-3
AC   CVCL_X002
SY   University of Michigan-Endometrial carcinoma-3
DR   IARC_TP53; 21686
DR   Wikidata; Q54990771
RX   CelloPub=CLPUB00591;
RX   PubMed=1541432;
RX   PubMed=7798295;
RX   PubMed=8123477;
RX   PubMed=9887230;
RX   PubMed=10367939;
CC   Doubling time: 45 hours (PubMed=1541432).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   UM-FSC-1
AC   CVCL_W199
SY   UM-FS-1; University of Michigan-FibroSarComa-1
DR   Wikidata; Q54990772
RX   PubMed=3855324;
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
DI   NCIt; C6604; Bone fibrosarcoma
DI   ORDO; Orphanet_2030; Fibrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   UM-G10
AC   CVCL_WN43
SY   G10
DR   Wikidata; Q98134047
RX   PubMed=2416979;
RX   PubMed=6417595;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_42088; Alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc (Human blood group H type 2 trisaccharide).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 4
//
ID   UM-GCC-1
AC   CVCL_HX25
SY   University of Michigan-Glassy cell Cervix Carcinoma-1
DR   IARC_TP53; 21694
DR   Wikidata; Q54990774
RX   PubMed=1958593;
RX   PubMed=7751322;
RX   PubMed=9887230;
RX   PubMed=28236344;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
DI   NCIt; C40212; Cervical adenosquamous carcinoma, glassy cell variant
DI   ORDO; Orphanet_213833; Glassy cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   UM-HACC-14
AC   CVCL_E7RZ
SY   University of Michigan-Human Adenoid Cystic Carcinoma-14
RX   PubMed=38971694;
CC   Population: Indian.
CC   Doubling time: 24 hours (PubMed=38971694).
CC   Derived from site: Metastatic; Eye lid; UBERON=UBERON_0001711.
ST   Source(s): PubMed=38971694
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 19,20
ST   Penta D: 11,12
ST   Penta E: 7,14
ST   TH01: 9.3
ST   TPOX: 12,13
ST   vWA: 17,18
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UM-HACC-2A
AC   CVCL_C4UW
SY   University of Michigan-Human Adenoid Cystic Carcinoma-2A
DR   ABM; T8326
DR   Wikidata; Q116050707
RX   PubMed=30527239;
RX   PubMed=38971694;
CC   Population: Caucasian.
CC   Doubling time: 3.47 days (Note=At 0-4th passages), 2.21 days (Note=At 96-100th passages) (PubMed=30527239).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7545; MYB + HGNC; HGNC:7785; NFIB; Name(s)=MYB-NFIB; Note=MYB exon 5/6 fused to NFIB exon 9 (PubMed=30527239).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
ST   Source(s): PubMed=30527239
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 18
ST   D21S11: 30,31.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 9,12
ST   Penta E: 7,12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 14,18
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   UM-HACC-6
AC   CVCL_E7S0
SY   University of Michigan-Human Adenoid Cystic Carcinoma-14
RX   PubMed=38971694;
CC   Population: Caucasian.
CC   Doubling time: 54 hours (PubMed=38971694).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
ST   Source(s): PubMed=38971694
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11
ST   D18S51: 14,19
ST   D21S11: 32,33.2
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 13
ST   Penta E: 13,16
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UM-HMC-1
AC   CVCL_Y473
SY   University of Michigan-Human Mucoepidermoid Carcinoma-1
DR   ABM; T8173
DR   Wikidata; Q54990775
RX   PubMed=24035723;
CC   Population: African American.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=24035723).
CC   Derived from site: In situ; Salivary gland, anterior buccal gland; UBERON=UBERON_0010242.
DI   NCIt; C5908; Salivary gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 10
//
ID   UM-HMC-2
AC   CVCL_Y474
SY   University of Michigan-Human Mucoepidermoid Carcinoma-2
DR   Wikidata; Q54990776
RX   PubMed=24035723;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=24035723).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 19-12-24; Version: 9
//
ID   UM-HMC-3A
AC   CVCL_Y471
SY   University of Michigan-Human Mucoepidermoid Carcinoma-3A
DR   ABM; T8160
DR   Wikidata; Q54990777
RX   PubMed=24035723;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=24035723).
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
ST   Source(s): PubMed=24035723
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 16,25
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 8
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y472 ! UM-HMC-3B
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 10
//
ID   UM-HMC-3B
AC   CVCL_Y472
SY   University of Michigan-Human Mucoepidermoid Carcinoma-3B
DR   ABM; T8161
DR   Wikidata; Q54990778
RX   PubMed=24035723;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2 (PubMed=24035723).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=24035723
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D21S11: 29,32.2
ST   D2S1338: 16,25
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 20,21
ST   TH01: 8,9
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y471 ! UM-HMC-3A
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 12
//
ID   UM-HPA-1
AC   CVCL_Y475
SY   University of Michigan-Human Pleomorphic Adenoma-1
DR   Wikidata; Q54990780
RX   PubMed=24035723;
CC   Population: Caucasian.
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 7
//
ID   UM-LAd-1
AC   CVCL_WN45
SY   University of Michigan-Lung Adenocarcinoma-1
DR   Wikidata; Q98134050
RX   PubMed=2416979;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   UM-Ly(ebv)-17
AC   CVCL_5G90
SY   UM-Lyebv-17
DR   Wikidata; Q54990781
RX   PubMed=2790823;
RX   PubMed=6417595;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7724 ! UM-SCC-17A
OI   CVCL_7725 ! UM-SCC-17B
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   UM-MCC13
AC   CVCL_VL97
SY   MCC13
DR   GEO; GSM973032
DR   Wikidata; Q98134052
RX   PubMed=23223137;
RX   PubMed=24614157;
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Leg; UBERON=UBERON_0000978.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   UM-MCC19
AC   CVCL_UL66
SY   MCC19
DR   GEO; GSM973033
DR   Wikidata; Q98134054
RX   PubMed=23223137;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 5
//
ID   UM-MCC21
AC   CVCL_UL67
SY   MCC21
DR   GEO; GSM973034
DR   Wikidata; Q98134056
RX   PubMed=23223137;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 5
//
ID   UM-MCC29
AC   CVCL_VM00
DR   Wikidata; Q98134058
RX   PubMed=24614157;
CC   Doubling time: 27 hours (PubMed=24614157).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-MCC31
AC   CVCL_VM01
DR   Wikidata; Q98134060
RX   PubMed=24614157;
CC   Doubling time: 32 hours (PubMed=24614157).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-MCC32
AC   CVCL_VM02
DR   Wikidata; Q98134062
RX   PubMed=24614157;
CC   Doubling time: 35 hours (PubMed=24614157).
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   UM-MCC34
AC   CVCL_VM04
DR   Wikidata; Q98134063
RX   PubMed=24614157;
CC   Doubling time: 28 hours (PubMed=24614157).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   88Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-MCC35
AC   CVCL_VM03
DR   Wikidata; Q98134065
RX   PubMed=24614157;
CC   Doubling time: 29 hours (PubMed=24614157).
CC   Derived from site: Metastatic; Mastoid lymph node; UBERON=UBERON_0016392.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   UM-MCC40
AC   CVCL_VM05
DR   Wikidata; Q98134069
RX   PubMed=24614157;
CC   Doubling time: 33 hours (PubMed=24614157).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-MCC565
AC   CVCL_VM06
SY   MCC565
DR   GEO; GSM973035
DR   Wikidata; Q98134072
RX   PubMed=23223137;
RX   PubMed=24614157;
CC   Characteristics: Established from a mouse tumor xenograft in NOD/SCID/IL2RgammaNULL mice.
CC   Doubling time: 36 hours (PubMed=24614157).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 5
//
ID   UM-MCC623
AC   CVCL_VL98
DR   Wikidata; Q98134074
RX   PubMed=24614157;
CC   Characteristics: Established from a mouse tumor xenograft in NOD/SCID/IL2RgammaNULL mice.
CC   Doubling time: 34 hours (PubMed=24614157).
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL99 ! UM-MCC624
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   UM-MCC624
AC   CVCL_VL99
DR   Wikidata; Q98134076
RX   PubMed=24614157;
CC   Characteristics: Established from a mouse tumor xenograft in NOD/SCID/IL2RgammaNULL mice.
CC   Doubling time: 32 hours (PubMed=24614157).
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VL98 ! UM-MCC623
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   UM-MCC9
AC   CVCL_VL96
DR   Wikidata; Q98134078
RX   PubMed=24614157;
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   UM-PAd-1
AC   CVCL_WN44
SY   University of Michigan-Pancreatic Adenocarcinoma-1
DR   Wikidata; Q98134079
RX   PubMed=2416979;
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   UM-RC-11
AC   CVCL_B226
SY   UMRC-11; UMRC11; University of Michigan-Renal Carcinoma-11
DR   Cosmic; 972915
DR   Wikidata; Q54990782
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.407_408ins?; Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   UM-RC-2
AC   CVCL_2739
SY   UMRC-2; UMRC2; University of Michigan-Renal Carcinoma-2
DR   cancercelllines; CVCL_2739
DR   CancerTools; 160446
DR   Cell_Model_Passport; SIDM01830
DR   Cosmic; 972910
DR   DepMap; ACH-001224
DR   ECACC; 08090511
DR   GEO; GSM374476
DR   PharmacoDB; UMRC2_1645_2019
DR   Progenetix; CVCL_2739
DR   Wikidata; Q54990783
DR   Ximbio; 160446
RX   PubMed=4038766;
RX   PubMed=7915601;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (PubMed=4038766).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Arg82Pro (c.245G>C); ClinVar=VCV000193118; Zygosity=Unspecified (PubMed=7915601).
CC   Genome ancestry: African=5.05%; Native American=0.53%; East Asian, North=4.92%; East Asian, South=0%; South Asian=0%; European, North=55.48%; European, South=34.02% (PubMed=30894373).
CC   Discontinued: ECACC; 08090511; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UM-RC-3
AC   CVCL_2740
SY   UMRC-3; UMRC3; University of Michigan-Renal Carcinoma-3
DR   cancercelllines; CVCL_2740
DR   CancerTools; 160447
DR   Cosmic; 972911
DR   DepMap; ACH-001687
DR   ECACC; 08090512
DR   PRIDE; PXD003105
DR   Wikidata; Q54990784
DR   Ximbio; 160447
RX   PubMed=4038766;
RX   PubMed=7915601;
RX   PubMed=26972028;
RX   PubMed=27141528;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~29 hours (PubMed=4038766).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu89His (c.266T>A); ClinVar=VCV000376047; Zygosity=Unspecified (PubMed=7915601).
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Discontinued: ECACC; 08090512; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): DepMap=ACH-001687; ECACC=08090512
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 13,15
ST   D21S11: 30.2
ST   D3S1358: 18
ST   D5S818: 9,12
ST   D7S820: 9
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 13
ST   Penta E: 11,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   UM-RC-5
AC   CVCL_B227
SY   UMRC-5; UMRC5; University of Michigan-Renal Carcinoma-5
DR   Cosmic; 972872
DR   Cosmic; 972912
DR   Wikidata; Q54990785
RX   PubMed=4038766;
RX   PubMed=7915601;
RX   PubMed=8493574;
CC   Doubling time: ~43 hours (PubMed=4038766).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Tyr175Serfs*27 (c.524delA); Zygosity=Unspecified (PubMed=7915601; PubMed=8493574).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UM-RC-6
AC   CVCL_2741
SY   UMRC-6; UMRC6; University of Michigan-Renal Carcinoma-6
DR   BioSample; SAMN03470958
DR   cancercelllines; CVCL_2741
DR   CancerTools; 160448
DR   Cell_Model_Passport; SIDM01829
DR   Cosmic; 972873
DR   Cosmic; 972913
DR   Cosmic; 1779196
DR   DepMap; ACH-001225
DR   ECACC; 08090513
DR   GEO; GSM374477
DR   PharmacoDB; UMRC6_1646_2019
DR   Progenetix; CVCL_2741
DR   Wikidata; Q54990787
DR   Ximbio; 160448
RX   PubMed=4038766;
RX   PubMed=7915601;
RX   PubMed=8493574;
RX   PubMed=25877200;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-317.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: African American.
CC   Doubling time: ~43 hours (PubMed=4038766).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Val170Argfs*29 (c.502_511del10); Zygosity=Unspecified (PubMed=8493574).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser168Argfs*3 (c.504_511del); Zygosity=Unspecified (PubMed=7915601).
CC   Genome ancestry: African=81.78%; Native American=0.05%; East Asian, North=2.02%; East Asian, South=0%; South Asian=0%; European, North=4.24%; European, South=11.91% (PubMed=30894373).
CC   Discontinued: ECACC; 08090513; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ECACC=08090513; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 8,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 18
ST   D19S433: 14,18.2
ST   D21S11: 28
ST   D2S1338: 19,22
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 7
ST   Penta E: 8
ST   TH01: 6
ST   TPOX: 10
ST   vWA: 18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM-RC-7
AC   CVCL_2742
SY   UMRC-7; UMRC7; University of Michigan-Renal Carcinoma-7
DR   BioSample; SAMN03470957
DR   CancerTools; 160449
DR   Cosmic; 972914
DR   DepMap; ACH-001688
DR   ECACC; 08090514
DR   Wikidata; Q54990788
DR   Ximbio; 160449
RX   PubMed=4038766;
RX   PubMed=7915601;
RX   PubMed=25877200;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~53 hours (PubMed=4038766).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Pro61Alafs*61 (c.180_208del); Zygosity=Unspecified (PubMed=7915601).
CC   Discontinued: ECACC; 08090514; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): DepMap=ACH-001688; ECACC=08090514; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 11
ST   D18S51: 13,14,19 (PubMed=25877200)
ST   D18S51: 14,19 (DepMap=ACH-001688)
ST   D19S433: 14,15,16.2
ST   D21S11: 31.2,33.2
ST   D2S1338: 17,25
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9,12
ST   Penta E: 7,9
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   UM-SCC-1
AC   CVCL_7707
SY   UMSCC-1; UM-SCC1; UMSCC1; UM-SCC-01; SCC-1; SCC1; University of Michigan-Squamous Cell Carcinoma-1
DR   BTO; BTO_0003138
DR   cancercelllines; CVCL_7707
DR   ChEMBL-Cells; CHEMBL3707167
DR   ChEMBL-Targets; CHEMBL3707168
DR   Cosmic; 1483455
DR   Cosmic; 1530751
DR   Cosmic; 2131858
DR   GEO; GSM3631262
DR   IARC_TP53; 21100
DR   Millipore; SCC070
DR   Progenetix; CVCL_7707
DR   PubChem_Cell_line; CVCL_7707
DR   Wikidata; Q54990789
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=30527230;
RX   PubMed=36912284;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8725545; PubMed=8782485; PubMed=12884349; PubMed=18006756).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Miscellaneous: The STR profile undergoes a loss of the Amelogenin Y, D8S1179 13 and FGA 22 alleles at passages >=150 (PubMed=19760794).
CC   Caution: Indicated as originating from a 60 year old patient in PubMed=3855324 and from a 72 year old in PubMed=1851275 and PubMed=18006756.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): Millipore=SCC070; PubMed=19760794; PubMed=21868764; PubMed=36912284
ST   Amelogenin: X (PubMed=21868764; PubMed=36912284)
ST   Amelogenin: X,Y (Millipore=SCC070; PubMed=19760794)
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 18
ST   D19S433: 12
ST   D21S11: 27
ST   D2S1338: 20,22
ST   D3S1358: 18
ST   D5S818: 10,13
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 18,22 (PubMed=19760794)
ST   FGA: 22 (Millipore=SCC070)
ST   Penta D: 9
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   UM-SCC-100
AC   CVCL_7708
SY   UMSCC-100; UMSCC100; University of Michigan-Squamous Cell Carcinoma-100
DR   Wikidata; Q54990790
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   UM-SCC-101A
AC   CVCL_7709
SY   UMSCC-101A; UMSCC101A; University of Michigan-Squamous Cell Carcinoma-101A
DR   Wikidata; Q54990791
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7710 ! UM-SCC-101B
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UM-SCC-101B
AC   CVCL_7710
SY   UMSCC-101B; UMSCC101B; University of Michigan-Squamous Cell Carcinoma-101B
DR   Wikidata; Q54990793
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7709 ! UM-SCC-101A
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   UM-SCC-103
AC   CVCL_7711
SY   UMSCC-103; UMSCC103; University of Michigan-Squamous Cell Carcinoma-103
DR   cancercelllines; CVCL_7711
DR   GEO; GSM3631289
DR   Progenetix; CVCL_7711
DR   Wikidata; Q54990796
RX   PubMed=30527230;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UM-SCC-104
AC   CVCL_7712
SY   UMSCC-104; UMSCC104; University of Michigan-Squamous Cell Carcinoma-104
DR   cancercelllines; CVCL_7712
DR   GEO; GSM3631290
DR   Millipore; SCC072
DR   Progenetix; CVCL_7712
DR   Wikidata; Q54990797
RX   PubMed=22162267;
RX   PubMed=24201445;
RX   PubMed=26045983;
RX   PubMed=28236344;
RX   PubMed=29156801;
RX   PubMed=31541927;
RX   PubMed=32574978;
CC   Doubling time: 48 hours (PubMed=22162267); 2.6 days (PubMed=29156801).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Ile1829Val (c.5485A>G); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Ala12Val (c.35C>T); ClinVar=VCV001494610; Zygosity=Homozygous (PubMed=31541927).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
ST   Source(s): Millipore=SCC072; PubMed=22162267; PubMed=29156801
ST   Amelogenin: X (Millipore=SCC072)
ST   Amelogenin: X,Y (PubMed=22162267; PubMed=29156801)
ST   CSF1PO: 10 (Millipore=SCC072; PubMed=22162267)
ST   CSF1PO: 10,12 (PubMed=29156801)
ST   D13S317: 8 (Millipore=SCC072)
ST   D13S317: 8,9 (PubMed=22162267; PubMed=29156801)
ST   D16S539: 9 (Millipore=SCC072; PubMed=22162267)
ST   D16S539: 9,13 (PubMed=29156801)
ST   D18S51: 13,14
ST   D19S433: 14,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 9,13
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UM-SCC-105
AC   CVCL_0C69
SY   UMSCC-105; University of Michigan-Squamous Cell Carcinoma-105
DR   cancercelllines; CVCL_0C69
DR   GEO; GSM3631291
DR   Millipore; SCC189
DR   Progenetix; CVCL_0C69
DR   Wikidata; Q54990798
RX   PubMed=25677579;
RX   PubMed=28236344;
RX   PubMed=31090975;
RX   PubMed=32574978;
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=25677579
ST   Amelogenin: X,Y
ST   D13S317: 11,12
ST   D18S51: 12,16
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 12,15
ST   FGA: 18,21
ST   vWA: 15,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 13
//
ID   UM-SCC-106
AC   CVCL_0C70
SY   University of Michigan-Squamous Cell Carcinoma-106
DR   ABM; T8056
DR   Wikidata; Q54990799
RX   PubMed=25677579;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=25677579
ST   Amelogenin: X
ST   D13S317: 10,11
ST   D18S51: 12
ST   D21S11: 30,31
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 14
ST   FGA: 20,21
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   UM-SCC-108
AC   CVCL_0C71
SY   University of Michigan-Squamous Cell Carcinoma-108
DR   ABM; T8057
DR   cancercelllines; CVCL_0C71
DR   GEO; GSM3631292
DR   Progenetix; CVCL_0C71
DR   Wikidata; Q54990800
RX   PubMed=25677579;
RX   PubMed=30527230;
CC   Population: Asian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue, lateral border; UBERON=UBERON_0011877.
ST   Source(s): PubMed=25677579
ST   Amelogenin: X
ST   D13S317: 9,11
ST   D18S51: 15
ST   D21S11: 29,30.2
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   UM-SCC-109
AC   CVCL_0C72
SY   University of Michigan-Squamous Cell Carcinoma-109
DR   ABM; T8058
DR   Wikidata; Q54990801
RX   PubMed=25677579;
CC   Derived from site: In situ; Oral cavity, tongue, base; UBERON=UBERON_0010033.
ST   Source(s): PubMed=25677579
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 12
ST   D21S11: 30,32.2
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 8,13
ST   FGA: 22
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   UM-SCC-10A
AC   CVCL_7713
SY   UM-SCC 10A; UMSCC-10A; UMSCC 10A; UMSCC10A; University of Michigan-Squamous Cell Carcinoma-10A
DR   cancercelllines; CVCL_7713
DR   Cosmic; 948025
DR   Cosmic; 2131859
DR   GEO; GSM3631264
DR   IARC_TP53; 1682
DR   Progenetix; CVCL_7713
DR   Wikidata; Q54990802
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=8552396;
RX   PubMed=8679156;
RX   PubMed=9815580;
RX   PubMed=15287027;
RX   PubMed=16331601;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20947470;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=31090975;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Unspecified (PubMed=1394225; PubMed=15287027; PubMed=18487078).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx, vocal fold; UBERON=UBERON_0003706.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 22,26
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7714 ! UM-SCC-10B
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM-SCC-10B
AC   CVCL_7714
SY   UM-SCC 10B; UMSCC-10B; UMSCC 10B; UMSCC10B; UM-SCC10B; University of Michigan-Squamous Cell Carcinoma-10B
DR   cancercelllines; CVCL_7714
DR   Cosmic; 932287
DR   Cosmic; 948026
DR   Cosmic; 2439751
DR   Cosmic; 2602594
DR   GEO; GSM3631265
DR   IARC_TP53; 18875
DR   Progenetix; CVCL_7714
DR   Wikidata; Q54990803
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=3855324;
RX   PubMed=8552396;
RX   PubMed=8679156;
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=15495191;
RX   PubMed=16020667;
RX   PubMed=16331601;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20947470;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=31090975;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Cys (c.733G>T); ClinVar=VCV000012349; Zygosity=Heterozygous (PubMed=1394225; PubMed=12884349; PubMed=15287027; PubMed=16020667; PubMed=18487078).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Submental lymph node; UBERON=UBERON_0016397.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7713 ! UM-SCC-10A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   UM-SCC-10BPT
AC   CVCL_A5TP
SY   10BPT; 10B PT
DR   Wikidata; Q107117255
RX   PubMed=16020667;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667).
CC   Derived from site: Metastatic; Submental lymph node; UBERON=UBERON_0016397.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7714 ! UM-SCC-10B
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UM-SCC-110
AC   CVCL_0C73
SY   University of Michigan-Squamous Cell Carcinoma-110
DR   ABM; T8059
DR   cancercelllines; CVCL_0C73
DR   GEO; GSM3631293
DR   Progenetix; CVCL_0C73
DR   Wikidata; Q54990805
RX   PubMed=25677579;
RX   PubMed=30527230;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue, anterior part; UBERON=UBERON_0010032.
ST   Source(s): PubMed=25677579
ST   Amelogenin: X,Y
ST   D13S317: 13
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 9
ST   D7S820: 9,11
ST   D8S1179: 8,9
ST   FGA: 21
ST   vWA: 17,20
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   UM-SCC-111
AC   CVCL_0C74
SY   University of Michigan-Squamous Cell Carcinoma-111
DR   Wikidata; Q54990806
RX   PubMed=25677579;
CC   Derived from site: In situ; Oral cavity, tongue, lateral border; UBERON=UBERON_0011877.
ST   Source(s): PubMed=25677579
ST   Amelogenin: X
ST   D13S317: 8,14
ST   D18S51: 13,19
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 11,14
ST   FGA: 20,24
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   UM-SCC-118
AC   CVCL_A1FW
SY   UMSCC-118; University of Michigan-Squamous Cell Carcinoma-118
DR   GEO; GSM3631294
DR   Wikidata; Q102115073
CC   Omics: Variations; CNV analysis.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 4
//
ID   UM-SCC-11A
AC   CVCL_7715
SY   UMSCC-11A; UMSCC11A; University of Michigan-Squamous Cell Carcinoma-11A
DR   cancercelllines; CVCL_7715
DR   Cosmic; 948027
DR   Cosmic; 2131860
DR   GEO; GSM3631266
DR   IARC_TP53; 25907
DR   Progenetix; CVCL_7715
DR   Wikidata; Q54990807
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=3855324;
RX   PubMed=15287027;
RX   PubMed=16785414;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=29156801;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18006756).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 7
ST   D13S317: 14
ST   D16S539: 12,14
ST   D18S51: 16
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 12,15
ST   FGA: 19,24
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 16,17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7716 ! UM-SCC-11B
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UM-SCC-11B
AC   CVCL_7716
SY   UM-SCC-11b; UM-SCC 11B; UMSCC-11B; UMSCC11B; UM-SCC11B; SCC11B; University of Michigan-Squamous Cell Carcinoma-11B; 11B
DR   BTO; BTO_0005995
DR   cancercelllines; CVCL_7716
DR   Cosmic; 932288
DR   Cosmic; 948028
DR   Cosmic; 1130354
DR   Cosmic; 1317414
DR   Cosmic; 1351517
DR   Cosmic; 2131861
DR   Cosmic; 2296306
DR   Cosmic; 2602597
DR   IARC_TP53; 18876
DR   Wikidata; Q54990808
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=3855324;
RX   PubMed=8679156;
RX   PubMed=9139877;
RX   PubMed=10956384;
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=15495191;
RX   PubMed=16785414;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20947470;
RX   PubMed=21868764;
RX   PubMed=23613873;
RX   PubMed=25275298;
RX   PubMed=26045983;
RX   PubMed=26122845;
RX   PubMed=29156801;
RX   PubMed=31541927;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Doubling time: 31 +- 3 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Gly2569Ser (c.7705G>A); ClinVar=VCV000134697; Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Leu4069Phe (c.12205C>T); ClinVar=VCV001412971; Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Arg912Trp (c.2734C>T); ClinVar=VCV000134921; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Ser (c.725G>C); ClinVar=VCV000647334; Zygosity=Homozygous (PubMed=12884349; PubMed=15287027; PubMed=18006756; PubMed=18487078; PubMed=23613873; PubMed=25275298; PubMed=31541927).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=19760794; PubMed=21868764; PubMed=25275298
ST   Amelogenin: X
ST   CSF1PO: 7
ST   D13S317: 14
ST   D16S539: 12,14
ST   D18S51: 16
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 19
ST   Penta D: 2.2
ST   Penta E: 8,13
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7715 ! UM-SCC-11A
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   UM-SCC-12
AC   CVCL_7717
SY   UMSCC-12; UMSCC12; University of Michigan-Squamous Cell Carcinoma-12
DR   BTO; BTO_0003139
DR   cancercelllines; CVCL_7717
DR   GEO; GSM3631267
DR   IARC_TP53; 18877
DR   Progenetix; CVCL_7717
DR   Wikidata; Q54990809
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3855324;
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=22265717;
RX   PubMed=28196595;
RX   PubMed=31090975;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Unspecified (PubMed=12884349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 13
ST   D18S51: 12,16
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 23,25
ST   vWA: 16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   UM-SCC-12-Luc-YFP
AC   CVCL_E6YS
SY   UMSCC12Luc
RX   PubMed=22265717;
CC   Characteristics: Transfected with a luciferase-YFP fusion protein whose expression is under the control of a CMV promoter (PubMed=22265717).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7717 ! UM-SCC-12
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   UM-SCC-13
AC   CVCL_7718
SY   UMSCC-13; UMSCC13; University of Michigan-Squamous Cell Carcinoma-13
DR   cancercelllines; CVCL_7718
DR   IARC_TP53; 18878
DR   Wikidata; Q54990810
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr163Cys (c.488A>G); ClinVar=VCV000127814; Zygosity=Unspecified (PubMed=12884349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 14,16
ST   D21S11: 27,28
ST   D3S1358: 16,18
ST   D5S818: 13
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 19,24
ST   vWA: 17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   UM-SCC-14A
AC   CVCL_7719
SY   UM-SCC 14A; UMSCC-14A; UMSCC14A; University of Michigan-Squamous Cell Carcinoma-14A
DR   BTO; BTO_0003140
DR   cancercelllines; CVCL_7719
DR   ChEMBL-Cells; CHEMBL3707162
DR   ChEMBL-Targets; CHEMBL3707164
DR   Cosmic; 948029
DR   Cosmic; 1483458
DR   GEO; GSM3631268
DR   IARC_TP53; 11062
DR   IARC_TP53; 18879
DR   Progenetix; CVCL_7719
DR   PubChem_Cell_line; CVCL_7719
DR   Wikidata; Q54990811
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3855324;
RX   PubMed=8679156;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=9041179;
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20947470;
RX   PubMed=21868764;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=29156801;
RX   PubMed=30527230;
RX   PubMed=31541927;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18487078; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1324Thr (c.3971G>C); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277_Glu286del (c.829_858del30); Zygosity=Heterozygous (PubMed=8725545; PubMed=8782485; PubMed=12884349; PubMed=15287027; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (PubMed=8725545; PubMed=8782485; PubMed=12884349; PubMed=15287027; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   D8S1179: 8,13
ST   FGA: 20,21
ST   TH01: 6,8
ST   vWA: 14,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7720 ! UM-SCC-14B
OI   CVCL_7721 ! UM-SCC-14C
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM-SCC-14B
AC   CVCL_7720
SY   UM-SCC 14B; UMSCC-14B; UMSCC14B; University of Michigan-Squamous Cell Carcinoma-14B
DR   BTO; BTO_0002710
DR   cancercelllines; CVCL_7720
DR   Cosmic; 948030
DR   Cosmic; 2513912
DR   Cosmic; 2602595
DR   Wikidata; Q54990812
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3335022;
RX   PubMed=8679156;
RX   PubMed=9041179;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20947470;
RX   PubMed=21868764;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=31541927;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1324Thr (c.3971G>C); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Phe977Tyr (c.2930T>A); Zygosity=Unspecified (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277_Glu286del (c.829_858del30); Zygosity=Heterozygous (PubMed=15287027; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (PubMed=15287027; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,14
ST   D7S820: 9,10 (PubMed=19760794)
ST   D7S820: 9,10,11 (PubMed=21868764)
ST   D8S1179: 8,13
ST   FGA: 20,21
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7719 ! UM-SCC-14A
OI   CVCL_7721 ! UM-SCC-14C
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UM-SCC-14C
AC   CVCL_7721
SY   UM-SCC 14C; UMSCC-14C; UMSCC14C; UM-SCC14C; University of Michigan-Squamous Cell Carcinoma-14C; 14C
DR   cancercelllines; CVCL_7721
DR   CLS; 300370
DR   Cosmic; 932289
DR   Wikidata; Q54990813
RX   PubMed=3335022;
RX   PubMed=8679156;
RX   PubMed=9041179;
RX   PubMed=9139877;
RX   PubMed=10956384;
RX   PubMed=15287027;
RX   PubMed=15495191;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20947470;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=31541927;
CC   Population: Caucasian.
CC   Doubling time: 27 +- 4 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg1324Thr (c.3971G>C); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys277_Glu286del (c.829_858del30); Zygosity=Heterozygous (PubMed=15287027; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Ser (c.840A>T); ClinVar=VCV000988616; Zygosity=Heterozygous (PubMed=15287027; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Discontinued: CLS; 300370; true.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): CLS=300370; PubMed=19760794
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,14
ST   D7S820: 9,10
ST   D8S1179: 8,13
ST   FGA: 20,21
ST   Penta D: 12,16
ST   Penta E: 7
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7719 ! UM-SCC-14A
OI   CVCL_7720 ! UM-SCC-14B
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   UM-SCC-15
AC   CVCL_7722
SY   UMSCC-15; UMSCC15; University of Michigan-Squamous Cell Carcinoma-15
DR   Wikidata; Q54990824
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3855324;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 14
ST   D21S11: 31,31.2
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 13,14
ST   FGA: 23
ST   vWA: 17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   UM-SCC-16
AC   CVCL_7723
SY   UMSCC-16; UMSCC 16; UMSCC16; University of Michigan-Squamous Cell Carcinoma-16
DR   Wikidata; Q54990825
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=8552396;
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 8,10
ST   D18S51: 15
ST   D21S11: 28,29.2
ST   D3S1358: 14
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 21,24
ST   vWA: 15,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   UM-SCC-17A
AC   CVCL_7724
SY   UM-SCC 17A; UMSCC-17A; UMSCC17A; UM-SCC17A; SCC17A; University of Michigan-Squamous Cell Carcinoma-17A
DR   BTO; BTO_0004022
DR   Cosmic; 932290
DR   Cosmic; 948031
DR   Cosmic; 1130355
DR   Millipore; SCC074
DR   Wikidata; Q54990826
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=2790823;
RX   PubMed=3855324;
RX   PubMed=6417595;
RX   PubMed=8679156;
RX   PubMed=15287027;
RX   PubMed=15495191;
RX   PubMed=16331601;
RX   PubMed=16785414;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=32574978;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): Millipore=SCC074; PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 17,22
ST   D21S11: 28
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 13
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 10
ST   Penta E: 5,19
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G90 ! UM-Ly(ebv)-17
OI   CVCL_7725 ! UM-SCC-17B
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   UM-SCC-17As
AC   CVCL_9T71
SY   UM-SCC-17as; SCC17as; University of Michigan-Squamous Cell Carcinoma-As
DR   Cosmic; 1130356
DR   Wikidata; Q54990827
RX   PubMed=1958593;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7724 ! UM-SCC-17A
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   UM-SCC-17B
AC   CVCL_7725
SY   UMSCC-17B; UMSCC17B; University of Michigan-Squamous Cell Carcinoma-17B
DR   BTO; BTO_0002711
DR   cancercelllines; CVCL_7725
DR   Cosmic; 948032
DR   Cosmic; 2296307
DR   Cosmic; 2602596
DR   GEO; GSM3631269
DR   IARC_TP53; 21101
DR   Millipore; SCC075
DR   Progenetix; CVCL_7725
DR   Wikidata; Q54990828
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=2790823;
RX   PubMed=3855324;
RX   PubMed=6417595;
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=16331601;
RX   PubMed=16785414;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=25275298;
RX   PubMed=26754630;
RX   PubMed=29156801;
RX   PubMed=31090975;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=18487078).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Millipore=SCC075; PubMed=19760794; PubMed=21868764; PubMed=25275298
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 22
ST   D21S11: 28
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 13
ST   D8S1179: 12,13
ST   FGA: 20,22
ST   Penta D: 10
ST   Penta E: 5,19
ST   TH01: 6,8
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5G90 ! UM-Ly(ebv)-17
OI   CVCL_7724 ! UM-SCC-17A
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   UM-SCC-18
AC   CVCL_7726
SY   UMSCC-18; UMSCC18; University of Michigan-Squamous Cell Carcinoma-18
DR   Wikidata; Q54990830
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3855324;
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 9,12
ST   D18S51: 14
ST   D21S11: 29,30
ST   D3S1358: 13,14
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 14,15
ST   FGA: 19,20
ST   vWA: 15,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   UM-SCC-19
AC   CVCL_7727
SY   UMSCC-19; UMSCC 19; UMSCC19; UMC19; UMC-19; umc-19; University of Michigan-Squamous Cell Carcinoma-19
DR   cancercelllines; CVCL_7727
DR   Cosmic; 844589
DR   Cosmic; 877398
DR   Cosmic; 1152493
DR   Cosmic; 2043900
DR   Cosmic; 2439755
DR   GEO; GSM3631270
DR   Progenetix; CVCL_7727
DR   Wikidata; Q54990831
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=8552396;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 10,16
ST   D21S11: 28,30
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 10,12
ST   FGA: 24
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   UM-SCC-2
AC   CVCL_7728
SY   UMSCC-2; UMSCC2; University of Michigan-Squamous Cell Carcinoma-2
DR   BTO; BTO_0003315
DR   Cosmic; 2043890
DR   Cosmic; 2296304
DR   Wikidata; Q54990832
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=25275298;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11,13
ST   D18S51: 18
ST   D21S11: 30,33.2
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 19
ST   vWA: 16
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UM-SCC-20
AC   CVCL_7729
SY   UMSCC-20; UMSCC20; University of Michigan-Squamous Cell Carcinoma-20
DR   IARC_TP53; 18880
DR   Wikidata; Q54990834
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro71_Pro72del (c.211_216del6); Zygosity=Unspecified (PubMed=12884349).
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 8,10
ST   D18S51: 13,15
ST   D21S11: 28,30.2
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,15
ST   FGA: 18,22.2
ST   vWA: 16,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   UM-SCC-21A
AC   CVCL_7730
SY   UMSCC-21A; UMSCC21A; University of Michigan-Squamous Cell Carcinoma-21A
DR   BTO; BTO_0002713
DR   Wikidata; Q54990835
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=3335022;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 8,9
ST   D18S51: 14
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   vWA: 16,18
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L143 ! UM-SCC-21B
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   UM-SCC-21B
AC   CVCL_L143
SY   UMSCC-21B; UMSCC21B; University of Michigan-Squamous Cell Carcinoma-21B
DR   Wikidata; Q54990836
RX   PubMed=1958593;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7730 ! UM-SCC-21A
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   UM-SCC-22A
AC   CVCL_7731
SY   UMSCC-22A; UMSCC22A; SCC22A; UMC-22a; UMC22a; UM-22A; University of Michigan-Squamous Cell Carcinoma-22A
DR   BTO; BTO_0002714
DR   cancercelllines; CVCL_7731
DR   Cosmic; 948033
DR   Cosmic; 1130357
DR   Cosmic; 2439752
DR   Cosmic; 2513913
DR   IARC_TP53; 25908
DR   Millipore; SCC076
DR   Wikidata; Q54990837
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1958593;
RX   PubMed=9139877;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=31541927;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 31 +- 4 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu341Gln (c.1021G>C); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Leu1935Val (c.5803C>G); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Glu1679Ter (c.5035G>T); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Heterozygous (PubMed=18006756; PubMed=23613873; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=18006756; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: In STR vWA allele 15 which is present at passage 16 is missing at passage 138 (PubMed=19760794).
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
ST   Source(s): Millipore=SCC076; PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 18
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 12,18
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18 (Millipore=SCC076)
ST   vWA: 18 (PubMed=19760794; PubMed=21868764)
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7732 ! UM-SCC-22B
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   UM-SCC-22B
AC   CVCL_7732
SY   UM-SCC 22B; UMSCC-22B; UMSCC22B; UM-SCC22B; SCC22B; UMC-22b; UMC22b; UMC22B; UM-22B; University of Michigan-Squamous Cell Carcinoma-22B; 22B
DR   cancercelllines; CVCL_7732
DR   ChEMBL-Cells; CHEMBL3307244
DR   ChEMBL-Targets; CHEMBL612798
DR   Cosmic; 932291
DR   Cosmic; 948034
DR   Cosmic; 1130358
DR   Cosmic; 1483459
DR   Cosmic; 2131862
DR   Cosmic; 2513914
DR   Cosmic; 2602598
DR   IARC_TP53; 21637
DR   IARC_TP53; 25909
DR   Millipore; SCC077
DR   PubChem_Cell_line; CVCL_7732
DR   Wikidata; Q54990838
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1958593;
RX   PubMed=3335022;
RX   PubMed=8679156;
RX   PubMed=9139877;
RX   PubMed=10956384;
RX   PubMed=15287027;
RX   PubMed=15495191;
RX   PubMed=16203773;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=18487078;
RX   PubMed=19760794;
RX   PubMed=20145189;
RX   PubMed=20947470;
RX   PubMed=21868764;
RX   PubMed=23613873;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=29873307;
RX   PubMed=31541927;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Problematic cell line: Partially contaminated. At least one lab used a stock contaminated by T24 (Cellosaurus=CVCL_0554) (PubMed=29873307).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 34 +- 2 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Glu1679Ter (c.5035G>T); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=15287027; PubMed=16203773; PubMed=18006756; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.993+1G>T (IVS9+1G>T); ClinVar=VCV000634766; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=15287027; PubMed=16203773; PubMed=18006756; PubMed=18487078; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Millipore=SCC077; PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 18
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 11,13
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 12,18
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7731 ! UM-SCC-22A
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   UM-SCC-23
AC   CVCL_7733
SY   UMSCC-23; UMSCC 23; UMSCC23; University of Michigan-Squamous Cell Carcinoma-23
DR   cancercelllines; CVCL_7733
DR   ChEMBL-Cells; CHEMBL4483166
DR   ChEMBL-Targets; CHEMBL4483274
DR   GEO; GSM3631271
DR   IARC_TP53; 1685
DR   IARC_TP53; 18881
DR   Progenetix; CVCL_7733
DR   PubChem_Cell_line; CVCL_7733
DR   Wikidata; Q54990839
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1394225;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=8552396;
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Heterozygous (PubMed=1394225; PubMed=12884349).
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 8
ST   D18S51: 10
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,13
ST   D8S1179: 10,15
ST   FGA: 20
ST   vWA: 17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UM-SCC-24
AC   CVCL_7734
SY   UMSCC-24; UMSCC24; University of Michigan-Squamous Cell Carcinoma-24
DR   Wikidata; Q54990840
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Derived from site: In situ; Larynx, vocal fold; UBERON=UBERON_0003706.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11,12
ST   D18S51: 15
ST   D21S11: 32.2
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 18,25
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   UM-SCC-25
AC   CVCL_7735
SY   UMSCC-25; UMSCC25; SCC25; UMC-25; UMC25; University of Michigan-Squamous Cell Carcinoma-25
DR   cancercelllines; CVCL_7735
DR   Cosmic; 1130359
DR   Cosmic; 2131863
DR   GEO; GSM960575
DR   GEO; GSM960577
DR   GEO; GSM960579
DR   GEO; GSM960581
DR   GEO; GSM960583
DR   GEO; GSM960586
DR   GEO; GSM960588
DR   GEO; GSM3631272
DR   IARC_TP53; 21102
DR   Progenetix; CVCL_7735
DR   Wikidata; Q54990841
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=31090975;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,15
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 19
ST   D21S11: 27
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   UM-SCC-26
AC   CVCL_7736
SY   UMSCC-26; UMSCC26; University of Michigan-Squamous Cell Carcinoma-26
DR   Wikidata; Q54990842
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11
ST   D18S51: 14
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 7,12
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   vWA: 16,17
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-27
AC   CVCL_7737
SY   UMSCC-27; UMSCC27; University of Michigan-Squamous Cell Carcinoma-27
DR   Cosmic; 1483460
DR   IARC_TP53; 21638
DR   Wikidata; Q54990843
RX   PubMed=16035614;
RX   PubMed=16203773;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=16203773).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 8
ST   D18S51: 14,16
ST   D21S11: 29,32.2
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 19
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   UM-SCC-28
AC   CVCL_7738
SY   UMSCC-28; UMSCC28; University of Michigan-Squamous Cell Carcinoma-28
DR   cancercelllines; CVCL_7738
DR   GEO; GSM3631273
DR   Progenetix; CVCL_7738
DR   Wikidata; Q54990845
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx, vocal fold; UBERON=UBERON_0003706.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 14
ST   D21S11: 30,32.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 23,25
ST   vWA: 18,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UM-SCC-29
AC   CVCL_7739
SY   UMSCC-29; UMSCC29; University of Michigan-Squamous Cell Carcinoma-29
DR   cancercelllines; CVCL_7739
DR   GEO; GSM3631274
DR   Progenetix; CVCL_7739
DR   Wikidata; Q54990846
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 8,11
ST   D18S51: 15
ST   D21S11: 28
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 15
ST   FGA: 23,25
ST   vWA: 18,19
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UM-SCC-3
AC   CVCL_7740
SY   UMSCC-3; UMSCC3; SCC3; University of Michigan-Squamous Cell Carcinoma-3
DR   cancercelllines; CVCL_7740
DR   Cosmic; 1130350
DR   Cosmic; 1483456
DR   IARC_TP53; 21636
DR   Wikidata; Q54990847
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=16035614;
RX   PubMed=16203773;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=29156801;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=16203773).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 12,15
ST   D21S11: 31.2
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   D8S1179: 14
ST   FGA: 20,27
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C34447; Head and neck squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   UM-SCC-30
AC   CVCL_7741
SY   UMSCC-30; UMSCC30; University of Michigan-Squamous Cell Carcinoma-30
DR   Cosmic; 2513915
DR   Wikidata; Q54990848
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 13
ST   D18S51: 14
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   vWA: 16,17
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   UM-SCC-31
AC   CVCL_7742
SY   UMSCC-31; UMSCC31; UMC-31; UMC31; University of Michigan-Squamous Cell Carcinoma-31
DR   Wikidata; Q54990850
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 10,12
ST   D18S51: 13,18
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 14
ST   FGA: 24
ST   vWA: 17,18
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   UM-SCC-32
AC   CVCL_7743
SY   UMSCC-32; UMSCC32; University of Michigan-Squamous Cell Carcinoma-32
DR   Wikidata; Q54990851
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=17312569;
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UM-SCC-33
AC   CVCL_7744
SY   UMSCC-33; UMSCC33; University of Michigan-Squamous Cell Carcinoma-33
DR   Wikidata; Q54990852
RX   PubMed=1851275;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=29156801;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 18
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 12
ST   FGA: 19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UM-SCC-34
AC   CVCL_7745
SY   UMSCC-34; UMSCC34; University of Michigan-Squamous Cell Carcinoma-34
DR   Wikidata; Q54990853
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 12,13
ST   D18S51: 13
ST   D21S11: 30,31
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 9,14
ST   FGA: 23
ST   vWA: 15,18
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UM-SCC-35
AC   CVCL_7746
SY   UMSCC-35; UMSCC35; University of Michigan-Squamous Cell Carcinoma-35
DR   cancercelllines; CVCL_7746
DR   Wikidata; Q54990855
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=9139877;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=26122845;
RX   PubMed=31541927;
CC   Doubling time: 38 +- 2 hours (PubMed=9139877).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Val584Met (c.1750G>A); ClinVar=VCV001303523; Zygosity=Unspecified (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Pro2559Leu (c.7676C>T); Zygosity=Unspecified (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Unspecified (PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11
ST   D18S51: 15
ST   D21S11: 36
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 11,15,16
ST   FGA: 18.2,26
ST   vWA: 15,18
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   UM-SCC-36
AC   CVCL_7747
SY   UMSCC-36; UMSCC36; UMC-36; UMC36; University of Michigan-Squamous Cell Carcinoma-36
DR   cancercelllines; CVCL_7747
DR   IARC_TP53; 18882
DR   Wikidata; Q54990856
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Pro (c.473G>C); ClinVar=VCV000246118; Zygosity=Unspecified (PubMed=12884349).
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11,12
ST   D18S51: 20
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   UM-SCC-37
AC   CVCL_7748
SY   UMSCC-37; UMSCC37; University of Michigan-Squamous Cell Carcinoma-37
DR   Wikidata; Q54990857
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 10
ST   D18S51: 14,17
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 20,22
ST   vWA: 18,19
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-38
AC   CVCL_7749
SY   UMSCC-38; UMSCC38; University of Michigan-Squamous Cell Carcinoma-38
DR   BTO; BTO_0002715
DR   cancercelllines; CVCL_7749
DR   Cosmic; 948035
DR   Cosmic; 2513916
DR   Cosmic; 2602599
DR   IARC_TP53; 25910
DR   Wikidata; Q54990858
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=8033114;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
RX   PubMed=23613873;
RX   PubMed=28196595;
RX   PubMed=31541927;
RX   PubMed=32574978;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Met3586Thr (c.10757T>C); ClinVar=VCV000785111; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Homozygous (PubMed=18006756; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Oral cavity, tonsil, tonsillar fossa; UBERON=UBERON_0035228.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 10,11
ST   D18S51: 19
ST   D21S11: 27,29
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 14,15
ST   FGA: 28
ST   vWA: 17,18
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UM-SCC-39
AC   CVCL_7750
SY   UMSCC-39; UMSCC39; University of Michigan-Squamous Cell Carcinoma-39
DR   Wikidata; Q54990859
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 13
ST   D18S51: 16,17
ST   D21S11: 32.2
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 24
ST   vWA: 17,18
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-4
AC   CVCL_7751
SY   UMSCC-4; UMSCC4; SCC4; University of Michigan-Squamous Cell Carcinoma-4
DR   cancercelllines; CVCL_7751
DR   Cosmic; 1130351
DR   Cosmic; 1483457
DR   Cosmic; 2131864
DR   Cosmic; 2296305
DR   IARC_TP53; 23608
DR   Wikidata; Q54990861
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=16203773;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=25275298;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Unspecified (PubMed=25275298).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (PubMed=16203773).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=19760794; PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 16
ST   D21S11: 28
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 26
ST   TH01: 7
ST   TPOX: 9,10
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   UM-SCC-40
AC   CVCL_7752
SY   UMSCC-40; UMSCC40; University of Michigan-Squamous Cell Carcinoma-40
DR   Wikidata; Q54990863
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 10
ST   D18S51: 12
ST   D21S11: 28,30
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21,22
ST   vWA: 14,16
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-41
AC   CVCL_7753
SY   UMSCC-41; UMSCC41; University of Michigan-Squamous Cell Carcinoma-41
DR   cancercelllines; CVCL_7753
DR   GEO; GSM3631275
DR   Progenetix; CVCL_7753
DR   Wikidata; Q54990864
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 18
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 14
ST   FGA: 25
ST   vWA: 18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UM-SCC-42
AC   CVCL_7754
SY   UMSCC-42; UMSCC42; University of Michigan-Squamous Cell Carcinoma-42
DR   Wikidata; Q54990865
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 13
ST   D18S51: 12
ST   D21S11: 29,30
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,14
ST   FGA: 19,20
ST   vWA: 18
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-43
AC   CVCL_7755
SY   UMSCC-43; UMSCC43; University of Michigan-Squamous Cell Carcinoma-43
DR   cancercelllines; CVCL_7755
DR   GEO; GSM3631276
DR   Progenetix; CVCL_7755
DR   Wikidata; Q54990866
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11,13
ST   D18S51: 14,16
ST   D21S11: 32.2
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   vWA: 14,15
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UM-SCC-44
AC   CVCL_7756
SY   UMSCC-44; UMSCC44; University of Michigan-Squamous Cell Carcinoma-44
DR   Wikidata; Q54990867
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 12,13
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 13
ST   FGA: 24
ST   vWA: 16,17
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-45
AC   CVCL_7757
SY   UMSCC-45; UMSCC45; University of Michigan-Squamous Cell Carcinoma-45
DR   Wikidata; Q54990868
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 10
ST   D18S51: 19
ST   D21S11: 28,30
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 11,14
ST   FGA: 21
ST   vWA: 14,16
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-46
AC   CVCL_7758
SY   UMSCC-46; UMSCC46; University of Michigan-Squamous Cell Carcinoma-46
DR   cancercelllines; CVCL_7758
DR   GEO; GSM3631277
DR   IARC_TP53; 18883
DR   Progenetix; CVCL_7758
DR   Wikidata; Q54990869
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ala (c.832C>G); ClinVar=VCV000376645; Zygosity=Unspecified (PubMed=12884349; PubMed=18006756).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 10
ST   D18S51: 19
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 12,14
ST   D8S1179: 13,15
ST   FGA: 21
ST   vWA: 14,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   UM-SCC-47
AC   CVCL_7759
SY   UMSCC-47; UMSCC47; UM-SCC47; UM:SCC047; UMSCC047; University of Michigan-Squamous Cell Carcinoma-47
DR   cancercelllines; CVCL_7759
DR   Cosmic; 1122677
DR   Cosmic; 2131865
DR   Cosmic; 2296309
DR   GEO; GSM937830
DR   GEO; GSM937831
DR   GEO; GSM3631278
DR   IARC_TP53; 21103
DR   Millipore; SCC071
DR   Progenetix; CVCL_7759
DR   Wikidata; Q54990870
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=17848307;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=23419152;
RX   PubMed=24201445;
RX   PubMed=25275298;
RX   PubMed=26045983;
RX   PubMed=28196595;
RX   PubMed=28236344;
RX   PubMed=29156801;
RX   PubMed=31541927;
RX   PubMed=32574978;
RX   PubMed=33802339;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/24336/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Virology: Contains from 21 to 47 copies of the HPV16 genome (PubMed=24201445).
CC   Doubling time: 2.2 days (PubMed=29156801).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly192Ter (c.574G>T); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Misspelling: UPCI:SCC47; GEO=GSM937830; GEO=GSM937831.
CC   Derived from site: In situ; Oral cavity, tongue, lateral border; UBERON=UBERON_0011877.
ST   Source(s): Millipore=SCC071; PubMed=19760794; PubMed=21868764; PubMed=25275298; PubMed=29156801; PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 8,13
ST   D18S51: 18
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 25
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 23,25
ST   Penta D: 9,10
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 10,11
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM-SCC-48
AC   CVCL_7760
SY   UMSCC-48; UMSCC48; University of Michigan-Squamous Cell Carcinoma-48
DR   Wikidata; Q54990879
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 15
ST   D21S11: 29,31.2
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 18,21
ST   vWA: 17
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-49
AC   CVCL_7761
SY   UMSCC-49; UMSCC49; University of Michigan-Squamous Cell Carcinoma-49
DR   cancercelllines; CVCL_7761
DR   GEO; GSM3631279
DR   Progenetix; CVCL_7761
DR   Wikidata; Q54990880
RX   PubMed=1851275;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
CC   Population: African American.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue, lateral border; UBERON=UBERON_0011877.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12,13
ST   D18S51: 15
ST   D21S11: 27
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12
ST   FGA: 23,26
ST   vWA: 16,20
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UM-SCC-5
AC   CVCL_7762
SY   UMSCC-5; UM-SCC5; UMSCC5; University of Michigan-Squamous Cell Carcinoma-5
DR   BTO; BTO_0004023
DR   cancercelllines; CVCL_7762
DR   IARC_TP53; 18874
DR   Wikidata; Q54990881
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=12884349;
RX   PubMed=14720192;
RX   PubMed=16020667;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Heterozygous (PubMed=12884349).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 8,11
ST   D18S51: 12,16
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9
ST   D8S1179: 11,13
ST   FGA: 25
ST   vWA: 18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   UM-SCC-5PT
AC   CVCL_A5TN
SY   UM-5PT; 5PT; 5 PT
DR   Wikidata; Q107117256
RX   PubMed=14720192;
RX   PubMed=16020667;
RX   PubMed=17944752;
RX   PubMed=20426848;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16020667).
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7762 ! UM-SCC-5
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UM-SCC-50
AC   CVCL_7763
SY   UMSCC-50; UMSCC50; University of Michigan-Squamous Cell Carcinoma-50
DR   Wikidata; Q54990882
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 17
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   UM-SCC-51
AC   CVCL_7764
SY   UMSCC-51; UMSCC51; University of Michigan-Squamous Cell Carcinoma-51
DR   Wikidata; Q54990883
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 14
ST   D21S11: 29
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 13
ST   D8S1179: 9,12
ST   FGA: 20,21
ST   vWA: 14,15
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   UM-SCC-52
AC   CVCL_7765
SY   UMSCC-52; UMSCC52; University of Michigan-Squamous Cell Carcinoma-52
DR   Wikidata; Q54990884
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 13
ST   D18S51: 12
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 13,16,17
ST   FGA: 19
ST   vWA: 16,18,19
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-53
AC   CVCL_7766
SY   UMSCC-53; UMSCC53; University of Michigan-Squamous Cell Carcinoma-53
DR   Wikidata; Q54990885
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 8
ST   D18S51: 14,21
ST   D21S11: 27,30
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 12,15
ST   FGA: 24
ST   vWA: 17
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UM-SCC-54
AC   CVCL_7767
SY   UMSCC-54; UMSCC54; UMC-54; UMC54; University of Michigan-Squamous Cell Carcinoma-54
DR   IARC_TP53; 21104
DR   Wikidata; Q54990886
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 10,11
ST   D18S51: 14,15
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 12,14
ST   FGA: 24,25
ST   vWA: 14,17
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   UM-SCC-55
AC   CVCL_7768
SY   UMSCC-55; UMSCC55; University of Michigan-Squamous Cell Carcinoma-55
DR   cancercelllines; CVCL_7768
DR   GEO; GSM3631280
DR   Progenetix; CVCL_7768
DR   Wikidata; Q54990887
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 8,13
ST   D18S51: 16
ST   D21S11: 30,31
ST   D3S1358: 17
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   vWA: 17
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UM-SCC-56
AC   CVCL_7769
SY   UMSCC-56; UMSCC56; University of Michigan-Squamous Cell Carcinoma-56
DR   Wikidata; Q54990889
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UM-SCC-57
AC   CVCL_7770
SY   UMSCC-57; UMSCC57; University of Michigan-Squamous Cell Carcinoma-57
DR   cancercelllines; CVCL_7770
DR   GEO; GSM3631281
DR   IARC_TP53; 18884
DR   Progenetix; CVCL_7770
DR   Wikidata; Q54990890
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Unspecified (PubMed=12884349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 9,12
ST   D18S51: 17,18
ST   D21S11: 29
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 23,24
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   UM-SCC-58
AC   CVCL_7771
SY   UMSCC-58; UMSCC58; University of Michigan-Squamous Cell Carcinoma-58
DR   Wikidata; Q54990891
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 9,13
ST   D18S51: 13
ST   D21S11: 30,32.2
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   vWA: 15,16,17
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-59
AC   CVCL_7772
SY   UMSCC-59; UMSCC59; University of Michigan-Squamous Cell Carcinoma-59
DR   cancercelllines; CVCL_7772
DR   GEO; GSM3631282
DR   Progenetix; CVCL_7772
DR   Wikidata; Q54990892
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue, lateral border; UBERON=UBERON_0011877.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 10
ST   D18S51: 12
ST   D21S11: 28,29
ST   D3S1358: 14
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   vWA: 15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UM-SCC-6
AC   CVCL_7773
SY   UMSCC-6; UMSCC6; SCC-6; University of Michigan-Squamous Cell Carcinoma-6
DR   Cosmic; 1530755
DR   IARC_TP53; 21105
DR   Millipore; SCC073
DR   Wikidata; Q54990893
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=3855324;
RX   PubMed=12884349;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
RX   PubMed=21868764;
RX   PubMed=23613873;
RX   PubMed=26045983;
RX   PubMed=28196595;
RX   PubMed=29156801;
RX   PubMed=31541927;
RX   PubMed=33802339;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349; PubMed=18006756; PubMed=23613873).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Caution: Indicated as originating from a 32 year old patient in PubMed=3855324 and from a 37 year old in PubMed=18006756 and PubMed=33802339.
ST   Source(s): Millipore=SCC073; PubMed=19760794; PubMed=21868764; PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 11,19
ST   D19S433: 11,14
ST   D21S11: 28 (PubMed=19760794)
ST   D21S11: 28,35.1 (Millipore=SCC073; PubMed=33802339)
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 8,17
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   UM-SCC-60
AC   CVCL_7774
SY   UMSCC-60; UMSCC60; University of Michigan-Squamous Cell Carcinoma-60
DR   Wikidata; Q54990894
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 14
ST   D18S51: 12
ST   D21S11: 32
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 11
ST   FGA: 19,26
ST   vWA: 14,15
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   UM-SCC-62
AC   CVCL_L129
SY   UMSCC-62; UMSCC62; University of Michigan-Squamous Cell Carcinoma-62
DR   Wikidata; Q54990895
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-63
AC   CVCL_L130
SY   UMSCC-63; UMSCC 63; UMSCC63; University of Michigan-Squamous Cell Carcinoma-63
DR   cancercelllines; CVCL_L130
DR   Wikidata; Q54990896
RX   PubMed=1394225;
RX   PubMed=1851275;
RX   PubMed=8552396;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Phe (c.725G>T); ClinVar=VCV000376578; Zygosity=Unspecified (PubMed=1394225).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: NCBI_TaxID; 10585; Human papillomavirus type 31 (HPV31).
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 10
//
ID   UM-SCC-64
AC   CVCL_A1RA
SY   UMSCC-64; UMSCC64; University of Michigan-Squamous Cell Carcinoma-64
DR   Wikidata; Q105511335
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   UM-SCC-65
AC   CVCL_L131
SY   UMSCC-65; UMSCC65; University of Michigan-Squamous Cell Carcinoma-65
DR   Wikidata; Q54990897
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   UM-SCC-66
AC   CVCL_L132
SY   UMSCC-66; UMSCC66; University of Michigan-Squamous Cell Carcinoma-66
DR   Wikidata; Q54990898
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   UM-SCC-67
AC   CVCL_L133
SY   UMSCC-67; UMSCC67; University of Michigan-Squamous Cell Carcinoma-67
DR   Wikidata; Q54990899
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 6
//
ID   UM-SCC-68A
AC   CVCL_L134
SY   UM-SCC-68; UMSCC-68A; UMSCC68A; University of Michigan-Squamous Cell Carcinoma-68A
DR   cancercelllines; CVCL_L134
DR   IARC_TP53; 18885
DR   Wikidata; Q54990900
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=12884349; PubMed=15287027).
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L135 ! UM-SCC-68B
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   UM-SCC-68B
AC   CVCL_L135
SY   UMSCC-68B; UMSCC68B; University of Michigan-Squamous Cell Carcinoma-68B
DR   Wikidata; Q54990903
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L134 ! UM-SCC-68A
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   UM-SCC-69
AC   CVCL_7775
SY   UMSCC-69; UMSCC69; University of Michigan-Squamous Cell Carcinoma-69
DR   cancercelllines; CVCL_7775
DR   GEO; GSM3631283
DR   Progenetix; CVCL_7775
DR   Wikidata; Q54990905
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 15,16
ST   D21S11: 30,32.2
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 10,14
ST   FGA: 20,24
ST   vWA: 16,17
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UM-SCC-7
AC   CVCL_7776
SY   UMSCC-7; UMSCC7; University of Michigan-Squamous Cell Carcinoma-7
DR   Wikidata; Q54990906
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 10
ST   D18S51: 14,15
ST   D21S11: 33.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 20,22
ST   vWA: 16
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UM-SCC-70
AC   CVCL_7777
SY   UMSCC-70; UMSCC70; University of Michigan-Squamous Cell Carcinoma-70
DR   Wikidata; Q54990907
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11
ST   D18S51: 18
ST   D21S11: 30
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 20
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-71
AC   CVCL_L136
SY   UMSCC-71; UMSCC71; University of Michigan-Squamous Cell Carcinoma-71
DR   Wikidata; Q54990908
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-72
AC   CVCL_L137
SY   UMSCC-72; UMSCC72; University of Michigan-Squamous Cell Carcinoma-72
DR   IARC_TP53; 21106
DR   Wikidata; Q54990909
RX   PubMed=12884349;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 9
//
ID   UM-SCC-73A
AC   CVCL_9T70
SY   University of Michigan-Squamous Cell Carcinoma-73A
DR   Wikidata; Q54990910
RX   PubMed=15287027;
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7778 ! UM-SCC-73B
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 7
//
ID   UM-SCC-73B
AC   CVCL_7778
SY   UMSCC-73B; UMSCC73B; University of Michigan-Squamous Cell Carcinoma-73B
DR   Wikidata; Q54990911
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11
ST   D18S51: 12,14
ST   D21S11: 30
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,9
ST   D8S1179: 13,15
ST   FGA: 21
ST   vWA: 16,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9T70 ! UM-SCC-73A
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 16
//
ID   UM-SCC-74A
AC   CVCL_7779
SY   UMSCC-74A; UMSCC74A; University of Michigan-Squamous Cell Carcinoma-74A
DR   IARC_TP53; 21107
DR   Wikidata; Q54990912
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 17
ST   D21S11: 30,34.2
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7780 ! UM-SCC-74B
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   UM-SCC-74B
AC   CVCL_7780
SY   UMSCC-74B; UMSCC74B; University of Michigan-Squamous Cell Carcinoma-74B
DR   IARC_TP53; 21108
DR   Wikidata; Q54990913
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=19760794;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 17
ST   D21S11: 30,34.2
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7779 ! UM-SCC-74A
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   UM-SCC-75
AC   CVCL_L138
SY   UMSCC-75; UMSCC75; University of Michigan-Squamous Cell Carcinoma-75
DR   Wikidata; Q54990914
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-76
AC   CVCL_L139
SY   UMSCC-76; UMSCC76; University of Michigan-Squamous Cell Carcinoma-76
DR   Wikidata; Q54990915
RX   PubMed=17312569;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Glu248Lys (c.742C>T); Zygosity=Unspecified (PubMed=31090975).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 12
//
ID   UM-SCC-77
AC   CVCL_L140
SY   UMSCC-77; UMSCC77; University of Michigan-Squamous Cell Carcinoma-77
DR   Wikidata; Q54990916
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-78A
AC   CVCL_L141
SY   UMSCC-78A; UMSCC78A; University of Michigan-Squamous Cell Carcinoma-78A
DR   Wikidata; Q54990918
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L142 ! UM-SCC-78B
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-78B
AC   CVCL_L142
SY   UMSCC-78B; UMSCC78B; University of Michigan-Squamous Cell Carcinoma-78B
DR   Wikidata; Q54990919
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L141 ! UM-SCC-78A
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-79
AC   CVCL_L299
SY   UMSCC-79; UMSCC79; University of Michigan-Squamous Cell Carcinoma-79
DR   Wikidata; Q54990920
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-8
AC   CVCL_7781
SY   UMSCC-8; UMSCC8; SCC8; University of Michigan-Squamous Cell Carcinoma-8
DR   cancercelllines; CVCL_7781
DR   Cosmic; 1130352
DR   Cosmic; 2043898
DR   GEO; GSM3631263
DR   Progenetix; CVCL_7781
DR   Wikidata; Q54990921
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=1958593;
RX   PubMed=3855324;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=28196595;
RX   PubMed=30527230;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12
ST   D18S51: 13,15
ST   D21S11: 29,31.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   vWA: 16
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   UM-SCC-80
AC   CVCL_7782
SY   UMSCC-80; UMSCC80; University of Michigan-Squamous Cell Carcinoma-80
DR   Wikidata; Q54990922
RX   PubMed=17312569;
RX   PubMed=19760794;
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 11
ST   D18S51: 24
ST   D21S11: 31.2
ST   D3S1358: 17
ST   D5S818: 9
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 22
ST   vWA: 14,17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-81A
AC   CVCL_7783
SY   UMSCC-81A; UMSCC81A; University of Michigan-Squamous Cell Carcinoma-81A
DR   cancercelllines; CVCL_7783
DR   GEO; GSM3631284
DR   IARC_TP53; 21109
DR   Progenetix; CVCL_7783
DR   Wikidata; Q54990923
RX   PubMed=9041179;
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=16785414;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=28196595;
RX   PubMed=31090975;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=12884349).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 9
ST   D18S51: 14,19
ST   D21S11: 33.2
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10
ST   FGA: 22
ST   vWA: 17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7784 ! UM-SCC-81B
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   UM-SCC-81B
AC   CVCL_7784
SY   UMSCC-81B; UMSCC81B; University of Michigan-Squamous Cell Carcinoma-81B
DR   cancercelllines; CVCL_7784
DR   GEO; GSM3631285
DR   IARC_TP53; 18886
DR   Progenetix; CVCL_7784
DR   Wikidata; Q54990931
RX   PubMed=9041179;
RX   PubMed=12884349;
RX   PubMed=15287027;
RX   PubMed=16785414;
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=31090975;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified (PubMed=12884349; PubMed=15287027).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tonsil, tonsillar pillar; UBERON=UBERON_0036274.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X,Y
ST   D13S317: 9,11
ST   D18S51: 14
ST   D21S11: 29
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 20,22
ST   vWA: 17
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7783 ! UM-SCC-81A
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   UM-SCC-82A
AC   CVCL_L127
SY   UMSCC-82A; UMSCC82A; University of Michigan-Squamous Cell Carcinoma-82A
DR   Wikidata; Q54990932
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L128 ! UM-SCC-82B
SX   Female
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-82B
AC   CVCL_L128
SY   UMSCC-82B; UMSCC82B; University of Michigan-Squamous Cell Carcinoma-82B
DR   Wikidata; Q54990933
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L127 ! UM-SCC-82A
SX   Female
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 5
//
ID   UM-SCC-83A
AC   CVCL_7785
SY   UMSCC-83A; UMSCC83A; University of Michigan-Squamous Cell Carcinoma-83A
DR   Wikidata; Q54990934
RX   PubMed=9041179;
RX   PubMed=15287027;
RX   PubMed=17312569;
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7786 ! UM-SCC-83B
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   UM-SCC-83B
AC   CVCL_7786
SY   UMSCC-83B; UMSCC83B; University of Michigan-Squamous Cell Carcinoma-83B
DR   Wikidata; Q54990935
RX   PubMed=9041179;
RX   PubMed=15287027;
RX   PubMed=17312569;
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7785 ! UM-SCC-83A
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 12
//
ID   UM-SCC-84
AC   CVCL_7787
SY   UMSCC-84; UMSCC84; University of Michigan-Squamous Cell Carcinoma-84
DR   Wikidata; Q54990936
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   UM-SCC-85
AC   CVCL_7788
SY   UMSCC-85; UMSCC85; University of Michigan-Squamous Cell Carcinoma-85
DR   cancercelllines; CVCL_7788
DR   GEO; GSM3631286
DR   Progenetix; CVCL_7788
DR   Wikidata; Q54990937
RX   PubMed=17312569;
RX   PubMed=21868764;
RX   PubMed=29156801;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C8192; Nasal cavity squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UM-SCC-86
AC   CVCL_7789
SY   UMSCC-86; UMSCC86; University of Michigan-Squamous Cell Carcinoma-86
DR   Wikidata; Q54990940
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UM-SCC-87
AC   CVCL_7790
SY   UMSCC-87; UMSCC87; University of Michigan-Squamous Cell Carcinoma-87
DR   Wikidata; Q54990941
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UM-SCC-88
AC   CVCL_7791
SY   UMSCC-88; UMSCC88; University of Michigan-Squamous Cell Carcinoma-88
DR   Wikidata; Q54990942
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   UM-SCC-89
AC   CVCL_7792
SY   UMSCC-89; UMSCC89; University of Michigan-Squamous Cell Carcinoma-89
DR   Wikidata; Q54990944
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UM-SCC-9
AC   CVCL_7793
SY   UMSCC-9; UMSCC9; UM-SCC9; SCC9; University of Michigan-Squamous Cell Carcinoma-9
DR   Cosmic; 1130353
DR   Cosmic; 1317413
DR   IARC_TP53; 25906
DR   Wikidata; Q54990945
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1851275;
RX   PubMed=3855324;
RX   PubMed=17312569;
RX   PubMed=18006756;
RX   PubMed=19760794;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18006756).
CC   Caution: Indicated as originating from a 74 year old patient in PubMed=3855324 and from a 72 year old in PubMed=18006756.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 11,14
ST   D18S51: 13,15
ST   D21S11: 30,31.2
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 8,11
ST   D8S1179: 9,13
ST   FGA: 22
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   UM-SCC-90
AC   CVCL_7794
SY   UMSCC-90; UMSCC90; University of Michigan-Squamous Cell Carcinoma-90
DR   Wikidata; Q54990946
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-91
AC   CVCL_7795
SY   UMSCC-91; UMSCC91; University of Michigan-Squamous Cell Carcinoma-91
DR   Wikidata; Q54990947
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-92
AC   CVCL_7796
SY   UMSCC-92; UMSCC92; University of Michigan-Squamous Cell Carcinoma-92
DR   cancercelllines; CVCL_7796
DR   GEO; GSM3631287
DR   Progenetix; CVCL_7796
DR   Wikidata; Q54990948
RX   PubMed=17312569;
RX   PubMed=19760794;
RX   PubMed=30527230;
RX   PubMed=37844343;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=19760794
ST   Amelogenin: X
ST   D13S317: 12,14
ST   D18S51: 14,15
ST   D21S11: 29,31
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 19,21
ST   vWA: 17,20
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UM-SCC-92 EGFR KO
AC   CVCL_D2PH
SY   UM-SCC-92 EGFR K/O
DR   Wikidata; Q127384574
RX   PubMed=37844343;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3236; EGFR (Note=3 of 3 alleles).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7796 ! UM-SCC-92
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   UM-SCC-93
AC   CVCL_7797
SY   UMSCC-93; UMSCC93; University of Michigan-Squamous Cell Carcinoma-93
DR   Wikidata; Q54990949
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-94
AC   CVCL_7798
SY   UMSCC-94; UMSCC94; University of Michigan-Squamous Cell Carcinoma-94
DR   Wikidata; Q54990950
RX   PubMed=9041179;
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   UM-SCC-95
AC   CVCL_7799
SY   UMSCC-95; UMSCC95; University of Michigan-Squamous Cell Carcinoma-95
DR   Wikidata; Q54990951
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UM-SCC-96
AC   CVCL_7800
SY   UMSCC-96; UMSCC96; University of Michigan-Squamous Cell Carcinoma-96
DR   Wikidata; Q54990952
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UM-SCC-97
AC   CVCL_7801
SY   UMSCC-97; UMSCC97; University of Michigan-Squamous Cell Carcinoma-97
DR   cancercelllines; CVCL_7801
DR   GEO; GSM3631288
DR   Progenetix; CVCL_7801
DR   Wikidata; Q54990954
RX   PubMed=17312569;
RX   PubMed=30527230;
CC   Population: Caucasian.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   UM-SCC-98
AC   CVCL_7802
SY   UMSCC-98; UMSCC9; University of Michigan-Squamous Cell Carcinoma-98
DR   Wikidata; Q54990955
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UM-SCC-99
AC   CVCL_7803
SY   UMSCC-99; UMSCC99; University of Michigan-Squamous Cell Carcinoma-9
DR   Wikidata; Q54990956
RX   PubMed=17312569;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   UM-SCP-1
AC   CVCL_4906
SY   UMSCP-1; UMSCP1; University of Michigan-Squamous Cell carcinoma of the Prostate-1
DR   Wikidata; Q54990957
RX   CelloPub=CLPUB00698;
RX   PubMed=3335022;
RX   PubMed=6378378;
RX   PubMed=14518029;
CC   Population: Caucasian.
CC   Doubling time: ~36 hours (PubMed=6378378).
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
ST   Source(s): PubMed=14518029
ST   Amelogenin: X,Y
ST   D13S317: 10,14
ST   D18S51: 16,17
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 23,24
ST   vWA: 16,17
DI   NCIt; C5536; Prostate squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   UM-SCV-1A
AC   CVCL_0568
SY   UMSCV-1A; UMSCV1A; University of Michigan-Squamous cell Carcinoma of the Vulva-1A
DR   MCCL; MCC:0000473
DR   IARC_TP53; 21680
DR   Wikidata; Q54990958
RX   CelloPub=CLPUB00591;
RX   PubMed=1777413;
RX   PubMed=1958593;
RX   PubMed=2335395;
RX   PubMed=2758419;
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=8646696;
RX   PubMed=9887230;
RX   PubMed=15047230;
RX   PubMed=31654625;
CC   Doubling time: 32 hours (PubMed=15047230); 30.12 +- 0.43 hours (PubMed=31654625).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=7503188; PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5973 ! UM-SCV-1B
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   UM-SCV-1B
AC   CVCL_5973
SY   UMSCV-1B; University of Michigan-Squamous cell Carcinoma of the Vulva-1B
DR   IARC_TP53; 21681
DR   Wikidata; Q54990960
RX   PubMed=1777413;
RX   PubMed=1958593;
RX   PubMed=2335395;
RX   PubMed=2758419;
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=8646696;
RX   PubMed=9887230;
RX   PubMed=15047230;
CC   Doubling time: 34 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=7503188; PubMed=9887230).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0568 ! UM-SCV-1A
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   UM-SCV-2
AC   CVCL_5974
SY   UMSCV-2; University of Michigan-Squamous cell Carcinoma of the Vulva-2
DR   cancercelllines; CVCL_5974
DR   IARC_TP53; 6926
DR   Wikidata; Q54990961
RX   PubMed=1777413;
RX   PubMed=1958593;
RX   PubMed=2758419;
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=8646696;
RX   PubMed=9887230;
RX   PubMed=15047230;
RX   PubMed=17178626;
CC   Doubling time: 58 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Ter (c.511G>T); ClinVar=VCV000634771; Zygosity=Unspecified (PubMed=7503188; PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   UM-SCV-3
AC   CVCL_5975
SY   UMSCV-3; University of Michigan-Squamous cell Carcinoma of the Vulva-3
DR   cancercelllines; CVCL_5975
DR   IARC_TP53; 6927
DR   Wikidata; Q54990962
RX   PubMed=1777413;
RX   PubMed=1958593;
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=9887230;
RX   PubMed=15047230;
CC   Doubling time: 76 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=7503188; PubMed=9887230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser314Ser (c.942C>T); dbSNP=rs765930028; Zygosity=Unspecified (PubMed=7503188; PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   UM-SCV-4
AC   CVCL_5976
SY   UMSCV-4; UMSCV4; University of Michigan-Squamous cell Carcinoma of the Vulva-4
DR   cancercelllines; CVCL_5976
DR   IARC_TP53; 6929
DR   Wikidata; Q54990963
RX   PubMed=1777413;
RX   PubMed=1958593;
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=8646696;
RX   PubMed=9887230;
RX   PubMed=15047230;
RX   PubMed=31654625;
CC   Doubling time: 56 hours (PubMed=15047230); 54.7 +- 5.27 hours (PubMed=31654625).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (PubMed=7503188; PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   UM-SCV-5
AC   CVCL_HX24
SY   UMSCV-5; University of Michigan-Squamous cell Carcinoma of the Vulva-5
DR   cancercelllines; CVCL_HX24
DR   IARC_TP53; 6930
DR   Wikidata; Q54990965
RX   PubMed=1777413;
RX   PubMed=7503188;
RX   PubMed=7599042;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Ile (c.464C>T); ClinVar=VCV001005876; Zygosity=Unspecified (PubMed=7503188).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   UM-SCV-6
AC   CVCL_0569
SY   UMSCV-6; University of Michigan-Squamous cell Carcinoma of the Vulva-6
DR   MCCL; MCC:0000474
DR   IARC_TP53; 21682
DR   Wikidata; Q54990966
RX   CelloPub=CLPUB00591;
RX   PubMed=1777413;
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=9887230;
RX   PubMed=15047230;
CC   Virology: Contains an integrated HPV16 genome.
CC   Doubling time: 53 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=7503188; PubMed=9887230).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   UM-SCV-7
AC   CVCL_5977
SY   UMSCV-7; University of Michigan-Squamous cell Carcinoma of the Vulva-7
DR   cancercelllines; CVCL_5977
DR   IARC_TP53; 6931
DR   Wikidata; Q54990967
RX   PubMed=7503188;
RX   PubMed=7599042;
RX   PubMed=9887230;
RX   PubMed=15047230;
RX   PubMed=17178626;
CC   Doubling time: 37 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified (PubMed=7503188; PubMed=9887230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=7503188; PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UM-SCVa-1
AC   CVCL_HX28
SY   UM-SCVA-1; University of Michigan-Squamous cell Carcinoma of the Vagina-1
DR   cancercelllines; CVCL_HX28
DR   IARC_TP53; 10158
DR   Wikidata; Q54990968
RX   PubMed=1958593;
RX   PubMed=7599042;
RX   PubMed=9887230;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9887230).
CC   Derived from site: In situ; Vagina; UBERON=UBERON_0000996.
DI   NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   UM-U-95
AC   CVCL_RY60
DR   Wikidata; Q54990969
RX   PubMed=21305041;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye, choroid; UBERON=UBERON_0001776.
CC   Cell type: Melanocyte of choroid; CL=CL_4030000.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 7
//
ID   UM-UC-1
AC   CVCL_2743
SY   UMUC1; University of Michigan-Urothelial Carcinoma-1
DR   BTO; BTO_0006457
DR   EFO; EFO_0006770
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03473231
DR   BioSample; SAMN10988038
DR   cancercelllines; CVCL_2743
DR   CancerTools; 160436
DR   Cell_Model_Passport; SIDM01409
DR   Cosmic; 1927293
DR   Cosmic; 1938699
DR   Cosmic; 2700981
DR   DepMap; ACH-000834
DR   ECACC; 06080301
DR   EGA; EGAS00001000610
DR   GEO; GSM136249
DR   GEO; GSM888823
DR   GEO; GSM1574557
DR   LiGeA; CCLE_460
DR   PharmacoDB; UMUC1_1642_2019
DR   Progenetix; CVCL_2743
DR   Wikidata; Q54990970
RX   PubMed=3761468;
RX   PubMed=6471236;
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=27270441;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: African American.
CC   Doubling time: 26 hours (PubMed=3761468).
CC   HLA typing: A*30:02,36:01; B*35:01,53:01; C*04:01,16:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1102; BRD1; Simple; p.Gln340Ter (c.1018C>T); Zygosity=Heterozygous (PubMed=27270441).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=85.83%; Native American=0%; East Asian, North=2.25%; East Asian, South=0%; South Asian=0%; European, North=2.87%; European, South=9.04% (PubMed=30894373).
CC   Discontinued: ECACC; 06080301; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ECACC=06080301; PubMed=25877200; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,11
ST   D18S51: 15
ST   D21S11: 28,29
ST   D3S1358: 17,18
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   Penta D: 2.2
ST   Penta E: 7,17
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   UM-UC-10
AC   CVCL_2744
SY   UMUC10; University of Michigan-Urothelial Carcinoma-10
DR   BTO; BTO_0004992
DR   cancercelllines; CVCL_2744
DR   CancerTools; 160440
DR   Cell_Model_Passport; SIDM01408
DR   Cosmic; 1082651
DR   Cosmic; 1927297
DR   Cosmic; 1938705
DR   Cosmic; 2037962
DR   Cosmic; 2700987
DR   DepMap; ACH-001412
DR   ECACC; 08090506
DR   GEO; GSM1567857
DR   Wikidata; Q54990972
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (DepMap=ACH-001412).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090506; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001412
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,14
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 13
ST   D21S11: 30.2,33.2
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 13
ST   FGA: 25
ST   Penta D: 12
ST   Penta E: 12,17
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM-UC-11
AC   CVCL_2745
SY   UM-UC11; UMUC11; UC-11; University of Michigan-Urothelial Carcinoma-11
DR   CancerTools; 160441
DR   Cell_Model_Passport; SIDM01407
DR   Cosmic; 846279
DR   Cosmic; 1927298
DR   Cosmic; 1938706
DR   Cosmic; 2037963
DR   DepMap; ACH-001413
DR   ECACC; 08090507
DR   GEO; GSM1567858
DR   GEO; GSM1574591
DR   Wikidata; Q54990973
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090507; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001413; ECACC=08090507
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,14
ST   D16S539: 11
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   Penta D: 11,13
ST   Penta E: 7,10
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 14,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   UM-UC-12
AC   CVCL_S992
SY   UMUC12; University of Michigan-Urothelial Carcinoma-12
DR   Cosmic; 1938707
DR   Cosmic; 2700988
DR   GEO; GSM1567859
DR   GEO; GSM1574592
DR   Wikidata; Q54990975
RX   PubMed=25997541;
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 13
//
ID   UM-UC-13
AC   CVCL_2746
SY   UMUC13; UC-13; University of Michigan-Urothelial Carcinoma-13
DR   CancerTools; 160442
DR   Cell_Model_Passport; SIDM01406
DR   Cosmic; 846280
DR   Cosmic; 1082652
DR   Cosmic; 1938708
DR   Cosmic; 2037964
DR   Cosmic; 2700989
DR   DepMap; ACH-001407
DR   ECACC; 08090508
DR   GEO; GSM1574560
DR   Wikidata; Q54990976
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090508; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): DepMap=ACH-001407; ECACC=08090508; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 11 (DepMap=ACH-001407; ECACC=08090508)
ST   D16S539: 11,12 (PubMed=27270441)
ST   D18S51: 14
ST   D21S11: 27,30
ST   D3S1358: 16
ST   D5S818: 9,13
ST   D7S820: 8 (PubMed=27270441)
ST   D7S820: 8,9 (DepMap=ACH-001407; ECACC=08090508)
ST   D8S1179: 8
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 7,16
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM-UC-14
AC   CVCL_2747
SY   UMUC-14; UM-UC14; UMUC14; University of Michigan-Urothelial Carcinoma-14
DR   BTO; BTO_0004991
DR   cancercelllines; CVCL_2747
DR   CancerTools; 160443
DR   Cell_Model_Passport; SIDM01405
DR   Cosmic; 1082653
DR   Cosmic; 1302360
DR   Cosmic; 1938709
DR   Cosmic; 2037965
DR   Cosmic; 2050469
DR   Cosmic; 2057447
DR   Cosmic; 2212695
DR   Cosmic; 2444231
DR   Cosmic; 2700990
DR   DepMap; ACH-001408
DR   ECACC; 08090509
DR   GEO; GSM136259
DR   GEO; GSM1574586
DR   GEO; GSM1574587
DR   Wikidata; Q54990977
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Unspecified (DepMap=ACH-001408).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090509; true.
CC   Derived from site: In situ; Kidney, renal pelvis; UBERON=UBERON_0001224.
ST   Source(s): DepMap=ACH-001408; ECACC=08090509
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 12,15
ST   D21S11: 30.2,31.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,15
ST   FGA: 24,25
ST   Penta D: 9,14
ST   Penta E: 12,18
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C6142; Renal pelvis carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   UM-UC-15
AC   CVCL_R742
SY   UMUC15; University of Michigan-Urothelial Carcinoma-15
DR   Cosmic; 1927299
DR   Cosmic; 1938710
DR   Cosmic; 2037966
DR   Cosmic; 2700991
DR   GEO; GSM1567860
DR   Wikidata; Q54990978
RX   PubMed=18812553;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 16
//
ID   UM-UC-16
AC   CVCL_2748
SY   UMUC16; University of Michigan-Urothelial Carcinoma-16
DR   Cell_Model_Passport; SIDM01404
DR   Cosmic; 1082654
DR   Cosmic; 1938711
DR   DepMap; ACH-001409
DR   ECACC; 08090510
DR   Wikidata; Q54990984
RX   PubMed=16469639;
RX   PubMed=19375735;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: ECACC; 08090510; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001409; ECACC=08090510
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,18
ST   D21S11: 30,32
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 22,24.2
ST   Penta D: 11,12
ST   Penta E: 13,17
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   UM-UC-17
AC   CVCL_R743
SY   UMUC17; University of Michigan-Urothelial Carcinoma-17
DR   Cosmic; 1927300
DR   Cosmic; 1938481
DR   Cosmic; 1938712
DR   Cosmic; 2700992
DR   GEO; GSM1567861
DR   GEO; GSM1574541
DR   GEO; GSM1574590
DR   Wikidata; Q54990985
RX   PubMed=18812553;
RX   PubMed=23401075;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   UM-UC-18
AC   CVCL_R744
SY   UMUC18; University of Michigan-Urothelial Carcinoma-18
DR   Cosmic; 2037967
DR   Cosmic; 2700993
DR   GEO; GSM1567862
DR   GEO; GSM1574561
DR   Wikidata; Q54990986
RX   PubMed=18812553;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 14
//
ID   UM-UC-2
AC   CVCL_8155
SY   UM-UC2; UMUC2; UC-2; University of Michigan-Urothelial Carcinoma-2
DR   BTO; BTO_0006290
DR   BioSample; SAMN03151953
DR   cancercelllines; CVCL_8155
DR   Cosmic; 846277
DR   Cosmic; 1302357
DR   Cosmic; 2037968
DR   GEO; GSM136237
DR   Wikidata; Q54990987
RX   PubMed=3761468;
RX   PubMed=6471236;
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=20143388;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=26621286;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=19375735; PubMed=20143388). Originally thought to originate from a 61 year old male patient with a ureter transitional cell carcinoma.
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00281.
CC   Population: Caucasian; Swedish.
CC   Doubling time: 22 hours (PubMed=3761468).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   UM-UC-3
AC   CVCL_1783
SY   UMUC-3; UM-UC3; UMUC3; UC-3; University of Michigan-Urothelial Carcinoma-3
DR   BTO; BTO_0003723
DR   CLO; CLO_0009487
DR   EFO; EFO_0006771
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1749
DR   BioGRID_ORCS_Cell_line; 444
DR   BioSample; SAMN03471418
DR   BioSample; SAMN03473229
DR   BioSample; SAMN10987601
DR   cancercelllines; CVCL_1783
DR   CancerTools; 160434
DR   CCRID; 3101HUMTCHu217
DR   Cell_Model_Passport; SIDM01182
DR   ChEMBL-Cells; CHEMBL3307245
DR   ChEMBL-Targets; CHEMBL612799
DR   CLS; 305074
DR   Cosmic; 715827
DR   Cosmic; 724838
DR   Cosmic; 760478
DR   Cosmic; 845568
DR   Cosmic; 846273
DR   Cosmic; 928818
DR   Cosmic; 943744
DR   Cosmic; 1046684
DR   Cosmic; 1082647
DR   Cosmic; 1285132
DR   Cosmic; 1285995
DR   Cosmic; 1302358
DR   Cosmic; 1927294
DR   Cosmic; 1938480
DR   Cosmic; 1938700
DR   Cosmic; 2050468
DR   Cosmic; 2057446
DR   Cosmic; 2212694
DR   Cosmic; 2444238
DR   Cosmic; 2700982
DR   Cosmic-CLP; 724838
DR   DepMap; ACH-000522
DR   ECACC; 96020936
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 724838
DR   GEO; GSM136234
DR   GEO; GSM887729
DR   GEO; GSM888824
DR   GEO; GSM1374978
DR   GEO; GSM1574568
DR   GEO; GSM1670567
DR   IARC_TP53; 377
DR   IGRhCellID; UMUC3
DR   KCB; KCB 2014053YJ
DR   LiGeA; CCLE_492
DR   LINCS_LDP; LCL-1721
DR   PharmacoDB; UMUC3_1643_2019
DR   PRIDE; PXD003105
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1783
DR   PubChem_Cell_line; CVCL_1783
DR   Wikidata; Q54990989
RX   PubMed=3761468;
RX   PubMed=7787250;
RX   PubMed=8873383;
RX   PubMed=9850064;
RX   PubMed=11921286;
RX   PubMed=12068308;
RX   PubMed=12127398;
RX   PubMed=15846775;
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23401075;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25997541;
RX   PubMed=26589293;
RX   PubMed=26972028;
RX   PubMed=27141528;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=3761468).
CC   HLA typing: A*02:01,33:01; B*07:02,14:02; C*07:02,07:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9850064).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (ATCC=CRL-1749).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (Cosmic-CLP=724838; DepMap=ACH-000522).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (PubMed=12068308; Cosmic-CLP=724838; DepMap=ACH-000522).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (PubMed=20215515).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Homozygous (PubMed=7787250; PubMed=9850064; Cosmic-CLP=724838; DepMap=ACH-000522).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; PTM; GPI-anchored proteins.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.66%; Native American=0%; East Asian, North=3.71%; East Asian, South=0%; South Asian=0%; European, North=55.69%; European, South=36.94% (PubMed=30894373).
CC   Discontinued: ECACC; 96020936; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): ATCC=CRL-1749; Cosmic-CLP=724838; ECACC=96020936; PubMed=25877200; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 10 (ECACC=96020936; PubMed=25877200; PubMed=27270441)
ST   CSF1PO: 10,11 (ATCC=CRL-1749; Cosmic-CLP=724838)
ST   D13S317: 8
ST   D16S539: 8,9
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 23
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 8,9 (ATCC=CRL-1749; Cosmic-CLP=724838; ECACC=96020936; PubMed=25877200)
ST   D7S820: 9 (PubMed=27270441)
ST   D8S1179: 13
ST   FGA: 20,21
ST   Penta D: 13
ST   Penta E: 12
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   UM-UC-3 LLWO1
AC   CVCL_A5WS
SY   LLWO1
DR   cancercelllines; CVCL_A5WS
DR   Wikidata; Q107117257
RX   PubMed=12914669;
CC   Population: Caucasian.
CC   Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter. The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1783 ! UM-UC-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   UM-UC-3 LLWO2F
AC   CVCL_A5WT
SY   LLWO2F
DR   cancercelllines; CVCL_A5WT
DR   Wikidata; Q107117258
RX   PubMed=12914669;
CC   Population: Caucasian.
CC   Characteristics: Expresses PPP1CA induced by doxycycline. Transfected with the plasmid 6-HA-PP1alpha-pTEP4m plasmid that express a 6His-HA tagged PP1C1 undert the control of a Teto/CMV promoter.
CC   Characteristics: Transfected with the plasmid pUHD172-1neo which contains a rtTA under the control of the CMV promoter. The reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=12914669).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9281; PPP1CA (Note=With a N-terminal His6-HA tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5WS ! UM-UC-3 LLWO1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 11
//
ID   UM-UC-3-GFP
AC   CVCL_1R40
DR   BioSample; SAMN03152036
DR   Wikidata; Q54990990
RX   PubMed=19375735;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified/contaminated. Shown not to be derived from UM-UC-3, its origin is unknown (PubMed=19375735; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00282.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   UM-UC-3-Luc
AC   CVCL_VL56
DR   cancercelllines; CVCL_VL56
DR   Wikidata; Q98134081
RX   PubMed=21482678;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1783 ! UM-UC-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   UM-UC-3-LuL-1
AC   CVCL_VL57
SY   LuL-1; Luciferase Lung metastasis-1
DR   cancercelllines; CVCL_VL57
DR   Wikidata; Q98134083
RX   PubMed=21482678;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Characteristics: Produced after passage of UM-UC-3-Luc into nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VL56 ! UM-UC-3-Luc
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   UM-UC-3-LuL-2
AC   CVCL_VL58
SY   LuL-2; Luciferase Lung metastasis-2
DR   cancercelllines; CVCL_VL58
DR   Wikidata; Q98134085
RX   PubMed=21482678;
RX   PubMed=29732388;
CC   Population: Caucasian.
CC   Characteristics: Produced after passage of UM-UC-3-LuL-1 into nude mice.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Gln2800fs*6 (c.8400delG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:14446; PARD3B; Unexplicit; Ex9-18del; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Cys (c.338T>G); ClinVar=VCV000634690; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VL57 ! UM-UC-3-LuL-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   UM-UC-4
AC   CVCL_2749
SY   UMUC4; University of Michigan-Urothelial Carcinoma-4
DR   BioGRID_ORCS_Cell_line; 1827
DR   CancerTools; 160435
DR   Cell_Model_Passport; SIDM01910
DR   Cosmic; 1938701
DR   DepMap; ACH-001410
DR   ECACC; 08090501
DR   GEO; GSM1574566
DR   GEO; GSM1574569
DR   Wikidata; Q54990991
RX   PubMed=3761468;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Doubling time: 32 hours (PubMed=3761468).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Arg (c.389T>G); Zygosity=Unspecified (DepMap=ACH-001410).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090501; true.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): DepMap=ACH-001410; ECACC=08090501
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 13
ST   D18S51: 16
ST   D21S11: 29
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 9,13
ST   D8S1179: 14
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 12,13
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UM-UC-5
AC   CVCL_2750
SY   UMUC5; University of Michigan-Urothelial Carcinoma-5
DR   BTO; BTO_0004993
DR   cancercelllines; CVCL_2750
DR   CancerTools; 160437
DR   Cell_Model_Passport; SIDM01909
DR   Cosmic; 1082648
DR   Cosmic; 1938702
DR   Cosmic; 2037969
DR   Cosmic; 2700983
DR   DepMap; ACH-001411
DR   ECACC; 08090502
DR   GEO; GSM1567863
DR   GEO; GSM1574558
DR   Wikidata; Q54990992
RX   PubMed=3761468;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Doubling time: 19 hours (PubMed=3761468).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp53Ter (c.159G>A); ClinVar=VCV000420659; Zygosity=Unspecified (DepMap=ACH-001411).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001411; ECACC=08090502
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 13,16
ST   D21S11: 32.2
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 15,17
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   UM-UC-6
AC   CVCL_2751
SY   UM-UC6; UMUC6; UC-6; University of Michigan-Urothelial Carcinoma-6
DR   cancercelllines; CVCL_2751
DR   CancerTools; 161805
DR   Cell_Model_Passport; SIDM01403
DR   Cosmic; 846278
DR   Cosmic; 1082649
DR   Cosmic; 1302359
DR   Cosmic; 1927295
DR   Cosmic; 1938703
DR   Cosmic; 2700984
DR   DepMap; ACH-001414
DR   ECACC; 08090503
DR   GEO; GSM136244
DR   GEO; GSM1567864
DR   GEO; GSM1574559
DR   Wikidata; Q54990993
RX   PubMed=3761468;
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=23401075;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Doubling time: 38 hours (PubMed=3761468).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu198Ter (c.592G>T); ClinVar=VCV000634704; Zygosity=Homozygous (PubMed=27270441).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090503; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001414; ECACC=08090503; PubMed=27270441
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13,14
ST   D16S539: 9,13
ST   D18S51: 14
ST   D21S11: 31.2
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 10,11
ST   FGA: 21,24
ST   Penta D: 10
ST   Penta E: 12,13
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   UM-UC-7
AC   CVCL_2752
SY   UMUC7; University of Michigan-Urothelial Carcinoma-7
DR   cancercelllines; CVCL_2752
DR   CancerTools; 160438
DR   Cell_Model_Passport; SIDM01402
DR   Cosmic; 1927296
DR   Cosmic; 1938704
DR   Cosmic; 2037970
DR   Cosmic; 2700985
DR   DepMap; ACH-001415
DR   ECACC; 08090504
DR   GEO; GSM1567865
DR   GEO; GSM1574564
DR   Wikidata; Q54990994
RX   PubMed=3761468;
RX   PubMed=18812553;
RX   PubMed=23401075;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=29732388;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Doubling time: 41 hours (PubMed=3761468).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Ter (c.637C>T); ClinVar=VCV000043590; Zygosity=Unspecified (DepMap=ACH-001415).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 08090504; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001415; ECACC=08090504
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12 (DepMap=ACH-001415)
ST   D13S317: 12 (ECACC=08090504)
ST   D16S539: 10,11
ST   D18S51: 13
ST   D21S11: 31,32
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 20,22
ST   Penta D: 12,13
ST   Penta E: 7
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 29
//
ID   UM-UC-8
AC   CVCL_RT31
SY   University of Michigan-Urothelial Carcinoma-8
DR   Wikidata; Q54990995
RX   PubMed=3761468;
CC   Doubling time: 53 hours (PubMed=3761468).
CC   Miscellaneous: Cell line has been discarded (PubMed=3761468).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   UM-UC-9
AC   CVCL_2753
SY   UMUC9; UC-9; University of Michigan-Urothelial Carcinoma-9
DR   BTO; BTO_0004990
DR   cancercelllines; CVCL_2753
DR   CancerTools; 160439
DR   Cell_Model_Passport; SIDM01401
DR   Cosmic; 846274
DR   Cosmic; 1082650
DR   Cosmic; 2037971
DR   Cosmic; 2700986
DR   DepMap; ACH-001416
DR   ECACC; 08090505
DR   GEO; GSM136260
DR   GEO; GSM1574565
DR   Wikidata; Q54990997
RX   PubMed=16469639;
RX   PubMed=18812553;
RX   PubMed=19375735;
RX   PubMed=24018021;
RX   PubMed=25997541;
RX   PubMed=27270441;
RX   PubMed=28196595;
RX   PubMed=29732388;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ile2888Thr (c.8663T>C); ClinVar=VCV000245842; Zygosity=Heterozygous (PubMed=27270441).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu348fs (c.1044delG); Zygosity=Unspecified (PubMed=27270441).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Caution: PubMed=27270441 reports a STR profile (CSF1PO: 10; D13S317: 11; D16S539: 9,11; D5S818: 13; D7S820: 8,10; TH01: 7; TPOX: 8; vWA: 17,19) which is completely different from that of DepMap and ECACC.
CC   Discontinued: ECACC; 08090505; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): DepMap=ACH-001416; ECACC=08090505
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D21S11: 29
ST   D3S1358: 14,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 12,14 (DepMap=ACH-001416)
ST   D8S1179: 14 (ECACC=08090505)
ST   FGA: 22,25,26
ST   Penta D: 10
ST   Penta E: 7,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   UM1
AC   CVCL_VH00
DR   Wikidata; Q54990998
RX   PubMed=10729767;
CC   Population: Japanese.
CC   Characteristics: Highly metastatic. Has loose cell-cell adhesion and exhibits high motility. High invasive activity on a collagen gel matrix.
CC   Doubling time: 18.85 hours (PubMed=10729767).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH01 ! UM2
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   UM10
AC   CVCL_C4KL
DR   Wikidata; Q116050708
RX   PubMed=9358279;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UM103-1 PGD
AC   CVCL_HF75
SY   UM103-1-PGD
DR   NIHhESC; NIHhESC-17-0383
DR   Wikidata; Q54990999
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0383.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   UM11-1 PGD
AC   CVCL_B837
SY   UM11-1-PGD; UM11-1PGD
DR   NIHhESC; NIHhESC-12-0153
DR   Wikidata; Q54991001
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0153.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   UM112-1 PGD
AC   CVCL_X369
SY   UM112-1-PGD
DR   NIHhESC; NIHhESC-14-0285
DR   Wikidata; Q54991002
WW   Info; -; -; https://eu.freep.com/story/news/local/2015/01/18/embryo-donation-disease-cure/21921281/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0285.
CC   Donor information: Embryo is sibling to that giving rise to UM112-2 PGD (Cellosaurus=CVCL_Z077).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   UM112-2 PGD
AC   CVCL_Z077
SY   UM112-2-PGD
DR   NIHhESC; NIHhESC-15-0307
DR   Wikidata; Q54991003
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0307.
CC   Donor information: Embryo is sibling to that giving rise to UM112-1 PGD (Cellosaurus=CVCL_X369).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 14
//
ID   UM114-10
AC   CVCL_X368
DR   NIHhESC; NIHhESC-14-0290
DR   Wikidata; Q54991004
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0290.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   UM121-7
AC   CVCL_X367
DR   NIHhESC; NIHhESC-14-0291
DR   Wikidata; Q54991005
RX   PubMed=28445466;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0291.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   UM126-2
AC   CVCL_5H74
DR   NIHhESC; NIHhESC-16-0356
DR   Wikidata; Q54991006
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0356.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   UM127-1
AC   CVCL_XD48
DR   NIHhESC; NIHhESC-19-0410
DR   Wikidata; Q98134087
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0410.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   UM134-1 PGD
AC   CVCL_X365
SY   UM134-1-PGD; UM134-1; SCA3-hESC; UMICHe001-A
DR   BioSamples; SAMEA110401634
DR   hPSCreg; UMICHe001-A
DR   NIHhESC; NIHhESC-14-0286
DR   Wikidata; Q54991007
RX   PubMed=31374463;
RX   PubMed=35952620;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0286.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[70]; Zygosity=Heterozygous; Note=The other allele has 13 repeats (PubMed=31374463; PubMed=35952620).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   UM139-2 PGD
AC   CVCL_X366
SY   UM139-2-PGD; UM 139-2; UM139-2
DR   GEO; GSM3053266
DR   GEO; GSM3053267
DR   NIHhESC; NIHhESC-14-0292
DR   Wikidata; Q54991008
RX   PubMed=30158855;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0292.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 12
//
ID   UM14-1
AC   CVCL_B914
DR   NIHhESC; NIHhESC-12-0162
DR   Wikidata; Q54991009
RX   PubMed=28445466;
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0162.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UM14-2
AC   CVCL_B915
DR   NIHhESC; NIHhESC-12-0163
DR   Wikidata; Q54991010
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0163.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   UM14-3
AC   CVCL_5H73
DR   NIHhESC; NIHhESC-16-0355
DR   Wikidata; Q54991011
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0355.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 11
//
ID   UM141-6 PGD
AC   CVCL_5H72
SY   UM141-6-PGD
DR   NIHhESC; NIHhESC-16-0360
DR   Wikidata; Q54991012
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0360.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   UM15-4 PGD
AC   CVCL_B838
SY   UM15-4-PGD
DR   NIHhESC; NIHhESC-12-0161
DR   Wikidata; Q54991013
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0161.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C119676; D-bifunctional protein deficiency
DI   ORDO; Orphanet_300; Bifunctional enzyme deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UM150-1 PGD
AC   CVCL_HF76
SY   UM150-1-PGD
DR   NIHhESC; NIHhESC-17-0384
DR   Wikidata; Q54991015
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0384.
CC   Donor information: Embryo is sibling to those giving rise to UM150-3 PGD (Cellosaurus=CVCL_IS75) and UM150-4 PGD (Cellosaurus=CVCL_QY88).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   UM150-3 PGD
AC   CVCL_IS75
SY   UM150-3-PGD
DR   NIHhESC; NIHhESC-17-0387
DR   Wikidata; Q54991017
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0387.
CC   Donor information: Embryo is sibling to those giving rise to UM150-1 PGD (Cellosaurus=CVCL_HF76) and UM150-4 PGD (Cellosaurus=CVCL_QY88).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   UM150-4 PGD
AC   CVCL_QY88
SY   UM150-4-PGD
DR   NIHhESC; NIHhESC-18-0391
DR   Wikidata; Q54991018
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0391.
CC   Donor information: Embryo is sibling to those giving rise to UM150-1 PGD (Cellosaurus=CVCL_HF76) and UM150-3 PGD (Cellosaurus=CVCL_IS75).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C129870; Nemaline myopathy 3
DI   ORDO; Orphanet_171436; Typical nemaline myopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   UM152-1 PGS
AC   CVCL_QY89
SY   UM152-1-PGS
DR   NIHhESC; NIHhESC-18-0392
DR   Wikidata; Q54991019
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0392.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   UM153-1 PGD
AC   CVCL_IS76
SY   UM153-1-PGD
DR   NIHhESC; NIHhESC-17-0388
DR   Wikidata; Q54991020
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0388.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 11
//
ID   UM159-1 PGD
AC   CVCL_QY90
SY   UM159-1-PGD
DR   NIHhESC; NIHhESC-18-0393
DR   Wikidata; Q54991021
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0393.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   UM160-3
AC   CVCL_QY91
DR   NIHhESC; NIHhESC-18-0395
DR   Wikidata; Q54991022
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0395.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UM161-1 PGD
AC   CVCL_QY92
SY   UM161-1-PGD
DR   NIHhESC; NIHhESC-18-0394
DR   Wikidata; Q54991023
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-18-0394.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61269; Niemann-Pick disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   UM17-1 PGD
AC   CVCL_B913
SY   UM17-1-PGD
DR   NIHhESC; NIHhESC-12-0160
DR   Wikidata; Q54991024
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0160.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   UM178-1
AC   CVCL_WW06
DR   NIHhESC; NIHhESC-19-0403
DR   Wikidata; Q98134089
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0403.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   UM181-1 PDG
AC   CVCL_WW13
DR   NIHhESC; NIHhESC-19-0408
DR   Wikidata; Q98134091
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0408.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C27644; Deafness
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   UM197-1 PGD
AC   CVCL_UF57
DR   NIHhESC; NIHhESC-19-0399
DR   Wikidata; Q98134095
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0399.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85233; Spinal and bulbar muscular atrophy, X-linked 1
DI   ORDO; Orphanet_481; Kennedy disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 8
//
ID   UM2
AC   CVCL_VH01
DR   Wikidata; Q54991025
RX   PubMed=10729767;
CC   Population: Japanese.
CC   Characteristics: Low metastatic potential. Shows a firm cell-cell attachment and exhibits low motility. Negligible invasive activity on a collagen gel matrix.
CC   Doubling time: 19.18 hours (PubMed=10729767).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VH00 ! UM1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   UM202-1 PGS
AC   CVCL_UF58
DR   NIHhESC; NIHhESC-19-0400
DR   Wikidata; Q98134097
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0400.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 7
//
ID   UM204-1 PGD
AC   CVCL_WW03
DR   NIHhESC; NIHhESC-19-0401
DR   Wikidata; Q98134099
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0401.
CC   Donor information: Embryo is sibling to those giving rise to UM204-4 PGD (Cellosaurus=CVCL_C3F2) and UM204-7 PGD (Cellosaurus=CVCL_C3F3).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C74984; Stickler syndrome
DI   ORDO; Orphanet_828; Stickler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 8
//
ID   UM204-4 PGD
AC   CVCL_C3F2
DR   NIHhESC; NIHhESC-22-0488
DR   Wikidata; Q114313175
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0488.
CC   Donor information: Embryo is sibling to that giving rise to UM204-1 PGD (Cellosaurus=CVCL_WW03) and UM204-7 PGD (Cellosaurus=CVCL_C3F3).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C74984; Stickler syndrome
DI   ORDO; Orphanet_828; Stickler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM204-7 PGD
AC   CVCL_C3F3
DR   NIHhESC; NIHhESC-22-0489
DR   Wikidata; Q114313176
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0489.
CC   Donor information: Embryo is sibling to those giving rise to UM204-1 PGD (Cellosaurus=CVCL_WW03) and UM204-4 PGD (Cellosaurus=CVCL_C3F2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C74984; Stickler syndrome
DI   ORDO; Orphanet_828; Stickler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM205-1
AC   CVCL_WW04
DR   NIHhESC; NIHhESC-19-0404
DR   Wikidata; Q98134101
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0404.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   UM206-2 PGD
AC   CVCL_C3F9
DR   NIHhESC; NIHhESC-22-0491
DR   Wikidata; Q114313177
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0491.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C189921; Spastic paraplegia 31
DI   ORDO; Orphanet_101011; Autosomal dominant spastic paraplegia type 31
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM207-3 PGD
AC   CVCL_WW05
DR   NIHhESC; NIHhESC-19-0402
DR   Wikidata; Q98134103
WW   Info; -; -; https://eu.detroitnews.com/story/news/local/michigan/2019/09/13/couple-gives-embryos-university-michigan-fight-against-rare-disease/2266391001/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0402.
CC   Donor information: Embryo is sibling to that giving rise to UM207-4 PGD (Cellosaurus=CVCL_XD47).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   UM207-4 PGD
AC   CVCL_XD47
DR   NIHhESC; NIHhESC-19-0409
DR   Wikidata; Q98134105
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-19-0409.
CC   Donor information: Embryo is sibling to that giving rise to UM207-1 PGD (Cellosaurus=CVCL_WW05).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 9
//
ID   UM217-1 PGD
AC   CVCL_A2HS
DR   NIHhESC; NIHhESC-21-0485
DR   Wikidata; Q105511338
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-21-0485.
CC   Donor information: Embryo is sibling to that giving rise to UM217-2 PGD (Cellosaurus=CVCL_C3F4).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UM217-2 PGD
AC   CVCL_C3F4
DR   NIHhESC; NIHhESC-22-0490
DR   Wikidata; Q114313178
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0490.
CC   Donor information: Embryo is sibling to that giving rise to UM217-1 PGD (Cellosaurus=CVCL_A2HS).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM22-2
AC   CVCL_E087
DR   NIHhESC; NIHhESC-13-0209
DR   Wikidata; Q54991027
RX   PubMed=28445466;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0209.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   UM229-1 PGS
AC   CVCL_C3F1
DR   NIHhESC; NIHhESC-22-0496
DR   Wikidata; Q114313179
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0496.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C43224; Trisomy 21
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM245-2 PGD
AC   CVCL_C3F5
DR   NIHhESC; NIHhESC-22-0492
DR   Wikidata; Q114313180
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0492.
CC   Donor information: Embryo is sibling to that giving rise to UM245-3 PGD (Cellosaurus=CVCL_C3F6).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM245-3 PGD
AC   CVCL_C3F6
DR   NIHhESC; NIHhESC-22-0493
DR   Wikidata; Q114313181
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0493.
CC   Donor information: Embryo is sibling to that giving rise to UM245-2 PGD (Cellosaurus=CVCL_C3F5).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84787; Incontinentia pigmenti
DI   ORDO; Orphanet_464; Incontinentia pigmenti
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM25-2
AC   CVCL_Z076
SY   UM25-2 PGD
DR   NIHhESC; NIHhESC-15-0305
DR   Wikidata; Q54991028
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0305.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   UM263-1
AC   CVCL_D4CC
DR   NIHhESC; NIHhESC-23-0502
DR   Wikidata; Q127384576
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-23-0502.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   UM274-1 PGD
AC   CVCL_C3F7
DR   NIHhESC; NIHhESC-22-0494
DR   Wikidata; Q114313182
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0494.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM281-1 PGD
AC   CVCL_A8DM
DR   NIHhESC; NIHhESC-21-0486
DR   Wikidata; Q107117259
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-21-0486.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UM29-2 PGD
AC   CVCL_B916
SY   UM29-2-PGD
DR   NIHhESC; NIHhESC-12-0164
DR   Wikidata; Q54991029
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0164.
CC   Donor information: Embryo is sibling to that giving rise to UM29-3 PGD (Cellosaurus=CVCL_B917).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   UM29-3 PGD
AC   CVCL_B917
SY   UM29-3-PGD
DR   NIHhESC; NIHhESC-12-0165
DR   Wikidata; Q54991038
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0165.
CC   Donor information: Embryo is sibling to that giving rise to UM29-2 PGD (Cellosaurus=CVCL_B916).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   UM3
AC   CVCL_C4KK
DR   Wikidata; Q116050717
RX   PubMed=9358279;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Derived from site: In situ; Embryonic uterus; UBERON=UBERON_0005795.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6 x CBA Trp53-/-.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   17FD
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UM300-1 PGD
AC   CVCL_C3FA
DR   NIHhESC; NIHhESC-22-0497
DR   Wikidata; Q114313183
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0497.
CC   Donor information: Embryo is sibling to that giving rise to UM300-2 PGD (Cellosaurus=CVCL_C3FB).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UM300-2 PGD
AC   CVCL_C3FB
DR   NIHhESC; NIHhESC-22-0498
DR   Wikidata; Q114313184
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0498.
CC   Donor information: Embryo is sibling to that giving rise to UM300-1 PGD (Cellosaurus=CVCL_C3FA).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UM302-1 PGD
AC   CVCL_C3F8
DR   NIHhESC; NIHhESC-22-0495
DR   Wikidata; Q114313185
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0495.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85071; Smith-Lemli-Opitz syndrome
DI   ORDO; Orphanet_818; Smith-Lemli-Opitz syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UM305-1 PGS
AC   CVCL_D4CD
DR   NIHhESC; NIHhESC-23-0501
DR   Wikidata; Q127384578
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-23-0501.
CC   Karyotypic information: 45,X (NIHhESC=NIHhESC-23-0501).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26900; Turner syndrome
DI   ORDO; Orphanet_881; Turner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   UM314-1 PGD
AC   CVCL_C6NR
DR   NIHhESC; NIHhESC-22-0500
DR   Wikidata; Q117704936
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0500.
CC   Donor information: Embryo is sibling to that giving rise to UM314-2 PGD (Cellosaurus=CVCL_C6NS).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UM314-2 PGD
AC   CVCL_C6NS
DR   NIHhESC; NIHhESC-22-0499
DR   Wikidata; Q117704937
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-22-0499.
CC   Donor information: Embryo is sibling to that giving rise to UM314-1 PGD (Cellosaurus=CVCL_C6NR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UM33-4
AC   CVCL_R781
DR   NIHhESC; NIHhESC-14-0279
DR   Wikidata; Q54991040
RX   PubMed=28445466;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0279.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   UM38-2 PGD
AC   CVCL_B839
SY   UM38-2-PGD; UM38-2PGD
DR   NIHhESC; NIHhESC-12-0155
DR   Wikidata; Q54991041
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0155.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Unexplicit; Not described; Zygosity=Unspecified (NIHhESC=NIHhESC-12-0155).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   UM4-10
AC   CVCL_WW07
DR   Wikidata; Q98134106
CC   From: University of Michigan; Ann Arbor; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 5
//
ID   UM4-11
AC   CVCL_5H75
DR   NIHhESC; NIHhESC-16-0353
DR   Wikidata; Q54991042
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0353.
CC   Donor information: Embryo is sibling to those giving rise to UM4-6 (Cellosaurus=CVCL_B840), UM4-9 (Cellosaurus=CVCL_5H77), UM4-12 (Cellosaurus=CVCL_5H76) and UM4-13 (Cellosaurus=CVCL_WW08).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   UM4-12
AC   CVCL_5H76
DR   NIHhESC; NIHhESC-16-0354
DR   Wikidata; Q54991043
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0354.
CC   Donor information: Embryo is sibling to those giving rise to UM4-6 (Cellosaurus=CVCL_B840), UM4-9 (Cellosaurus=CVCL_5H77), UM4-11 (Cellosaurus=CVCL_5H75) and UM4-13 (Cellosaurus=CVCL_WW08).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   UM4-13
AC   CVCL_WW08
DR   Wikidata; Q98134109
CC   From: University of Michigan; Ann Arbor; USA.
CC   Donor information: Embryo is sibling to those giving rise to UM4-6 (Cellosaurus=CVCL_B840), UM4-9 (Cellosaurus=CVCL_5H77), UM4-11 (Cellosaurus=CVCL_5H75) and UM4-12 (Cellosaurus=CVCL_5H76).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
ID   UM4-6
AC   CVCL_B840
DR   GEO; GSM3053264
DR   GEO; GSM3053265
DR   NIHhESC; NIHhESC-12-0147
DR   Wikidata; Q54991044
RX   PubMed=28445466;
RX   PubMed=30158855;
RX   PubMed=31374463;
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0147.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Donor information: Embryo is sibling to those giving rise to UM4-9 (Cellosaurus=CVCL_5H77), UM4-11 (Cellosaurus=CVCL_5H75), UM4-12 (Cellosaurus=CVCL_5H76) and UM4-13 (Cellosaurus=CVCL_WW08).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   UM4-9
AC   CVCL_5H77
DR   NIHhESC; NIHhESC-16-0352
DR   Wikidata; Q54991045
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0352.
CC   Donor information: Embryo is sibling to those giving rise to UM4-6 (Cellosaurus=CVCL_B840), UM4-11 (Cellosaurus=CVCL_5H75), UM4-12 (Cellosaurus=CVCL_5H76) and UM4-13 (Cellosaurus=CVCL_WW08).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   UM57-1 PGD
AC   CVCL_E088
SY   UM57-1-PGD
DR   NIHhESC; NIHhESC-13-0208
DR   Wikidata; Q54991046
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0208.
CC   Donor information: Embryo is sibling to that giving rise to UM57-3 PGD (Cellosaurus=CVCL_HF77).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3226; Multiple endocrine neoplasia type 2A
DI   ORDO; Orphanet_247698; Multiple endocrine neoplasia type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   UM57-3 PGD
AC   CVCL_HF77
SY   UM57-3-PGD
DR   NIHhESC; NIHhESC-17-0380
DR   Wikidata; Q54991047
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0380.
CC   Donor information: Embryo is sibling to that giving rise to UM57-2 PGD (Cellosaurus=CVCL_E088).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C3226; Multiple endocrine neoplasia type 2A
DI   ORDO; Orphanet_247698; Multiple endocrine neoplasia type 2A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   UM59-2 PGD
AC   CVCL_N808
SY   UM59-2-PGD
DR   NIHhESC; NIHhESC-14-0275
DR   Wikidata; Q54991048
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0275.
CC   Donor information: Embryo is sibling to that giving rise to UM59-4 PGD (Cellosaurus=CVCL_5H78).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   UM59-4 PGD
AC   CVCL_5H78
SY   UM59-4-PGD
DR   NIHhESC; NIHhESC-16-0357
DR   Wikidata; Q54991049
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0357.
CC   Donor information: Embryo is sibling to that giving rise to UM59-2 PGD (Cellosaurus=CVCL_N808).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   UM63-1
AC   CVCL_R782
DR   NIHhESC; NIHhESC-14-0277
DR   Wikidata; Q54991050
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0277.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   UM66-3 PGD
AC   CVCL_HF78
SY   UM66-3-PGD
DR   NIHhESC; NIHhESC-17-0381
DR   Wikidata; Q54991051
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0381.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84563; Aniridia
DI   ORDO; Orphanet_250923; Isolated aniridia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   UM76-1 PGS
AC   CVCL_X362
SY   UM76-1-PGS
DR   NIHhESC; NIHhESC-14-0289
DR   Wikidata; Q54991052
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0289.
CC   Karyotypic information: 45,XX,der(13;14)(q10;q10) (NIHhESC=NIHhESC-14-0289).
CC   Donor information: Embryo is sibling to that giving rise to UM76-2 (Cellosaurus=CVCL_5H68).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   UM76-2
AC   CVCL_5H68
DR   NIHhESC; NIHhESC-16-0361
DR   Wikidata; Q54991053
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0361.
CC   Donor information: Embryo is sibling to that giving rise to UM76-1 PGD (Cellosaurus=CVCL_X362).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   UM77-2
AC   CVCL_R783
DR   NIHhESC; NIHhESC-14-0278
DR   Wikidata; Q54991054
RX   PubMed=28445466;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0278.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   UM78-2
AC   CVCL_X363
DR   NIHhESC; NIHhESC-14-0288
DR   Wikidata; Q54991055
RX   PubMed=28445466;
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0288.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 13
//
ID   UM89-1 PGD
AC   CVCL_N809
SY   UM89-1-PGD
DR   NIHhESC; NIHhESC-14-0276
DR   Wikidata; Q54991056
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0276.
CC   Donor information: Embryo is sibling to those giving rise to UM89-2 PGD (Cellosaurus=CVCL_5H69), UM89-3 PGD (Cellosaurus=CVCL_5H70), UM89-4 PGD (Cellosaurus=CVCL_5H71) and UM89-5 PGD (Cellosaurus=CVCL_HF79).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 15
//
ID   UM89-2
AC   CVCL_5H69
DR   NIHhESC; NIHhESC-16-0362
DR   Wikidata; Q54991058
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0362.
CC   Donor information: Embryo is sibling to those giving rise to UM89-1 PGD (Cellosaurus=CVCL_N809), UM89-3 PGD (Cellosaurus=CVCL_5H70), UM89-4 PGD (Cellosaurus=CVCL_5H71) and UM89-5 PGD (Cellosaurus=CVCL_HF79).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 12
//
ID   UM89-3 PGD
AC   CVCL_5H70
SY   UM89-3-PGD
DR   NIHhESC; NIHhESC-16-0358
DR   Wikidata; Q54991059
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0358.
CC   Donor information: Embryo is sibling to those giving rise to UM89-1 PGD (Cellosaurus=CVCL_N809), UM89-2 PGD (Cellosaurus=CVCL_5H69), UM89-4 PGD (Cellosaurus=CVCL_5H71) and UM89-5 PGD (Cellosaurus=CVCL_HF79).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   UM89-4 PGD
AC   CVCL_5H71
SY   UM89-4-PGD
DR   NIHhESC; NIHhESC-16-0359
DR   Wikidata; Q54991061
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0359.
CC   Donor information: Embryo is sibling to those giving rise to UM89-1 PGD (Cellosaurus=CVCL_N809), UM89-2 PGD (Cellosaurus=CVCL_5H69), UM89-3 PGD (Cellosaurus=CVCL_5H70) and UM89-5 PGD (Cellosaurus=CVCL_HF79).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   UM89-5 PGD
AC   CVCL_HF79
SY   UM89-5-PGD
DR   NIHhESC; NIHhESC-17-0382
DR   Wikidata; Q54991063
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-17-0382.
CC   Donor information: Embryo is sibling to those giving rise to UM89-1 PGD (Cellosaurus=CVCL_N809), UM89-2 PGD (Cellosaurus=CVCL_5H69), UM89-3 PGD (Cellosaurus=CVCL_5H70) and UM89-4 PGD (Cellosaurus=CVCL_5H71).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   UM9-1 PGD
AC   CVCL_B841
SY   UM9-1-PGD; UM9-1PGD
DR   NIHhESC; NIHhESC-12-0154
DR   Wikidata; Q54991064
WW   Info; U-M; -; https://record.umich.edu/articles/a3647-new-stem-cell/
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0154.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26721; Hemophilia B
DI   ORDO; Orphanet_98879; Hemophilia B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   UM90-12 PGS
AC   CVCL_X364
SY   UM90-12-PGS
DR   NIHhESC; NIHhESC-14-0287
DR   Wikidata; Q54991065
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0287.
CC   Donor information: Embryo is sibling to that giving rise to UM90-14 PGD (Cellosaurus=CVCL_Z075).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C37866; Trisomy 16
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 14
//
ID   UM90-14 PGD
AC   CVCL_Z075
SY   UM90-14-PGD
DR   NIHhESC; NIHhESC-15-0306
DR   Wikidata; Q54991066
WW   Provider; MStem Cell; -; https://www.mstemcell.org/purchase-stem-cell-lines/
CC   From: University of Michigan; Ann Arbor; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-15-0306.
CC   Donor information: Embryo is sibling to that giving rise to UM90-12 PGD (Cellosaurus=CVCL_X364).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 11
//
ID   UMANe002-A-1
AC   CVCL_D6JQ
DR   BioSamples; SAMEA114210484
DR   hPSCreg; UMANe002-A-1
DR   Wikidata; Q127384580
RX   PubMed=38100908;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: Produces a robust fluorescent signal in cardiac cells and have wide utility particularly for research on developmental biology and disease modelling (PubMed=38100908).
CC   Characteristics: Using CRISPR/Cas9 a eGFP-T2A construct was integrated at the 5'end of one allele of NKX2-5 (PubMed=38100908).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L201 ! Man-13
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UMANe002-A-2
AC   CVCL_D6JR
DR   BioSamples; SAMEA114295974
DR   hPSCreg; UMANe002-A-2
DR   Wikidata; Q127384582
RX   PubMed=38100908;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: Produces a robust fluorescent signal in cardiac cells and have wide utility particularly for research on developmental biology and disease modelling (PubMed=38100908).
CC   Characteristics: Using CRISPR/Cas9 a T2A-eGFP construct was integrated at the 3'end of one allele of NKX2-5 (PubMed=38100908).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L201 ! Man-13
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UMANe002-A-3
AC   CVCL_E3RR
SY   BIRe003-A-3
DR   BioSamples; SAMEA114526381
DR   hPSCreg; UMANe002-A-3
RX   PubMed=38460234;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Population: Caucasian.
CC   Characteristics: Produces a robust fluorescent signal in cardiac cells and have wide utility particularly for research on developmental biology and disease modelling (from parent cell line).
CC   Characteristics: Using CRISPR/Cas9 a T2A-dTomato construct was integrated at the 3'end of both alleles of HAND1 (PubMed=38460234).
CC   Characteristics: Using CRISPR/Cas9 a T2A-eGFP construct was integrated at the 3'end of one allele of NKX2-5 (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D6JR ! UMANe002-A-2
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UMANe002-A-4
AC   CVCL_E3RS
SY   IBM13-19; UMANCe003-A-4
DR   BioSamples; SAMEA115495030
DR   hPSCreg; UMANe002-A-4
RX   PubMed=38788724;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11630; HNF1B (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L201 ! Man-13
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UMANe002-A-5
AC   CVCL_E3RT
SY   IBM13-08; UMANCe003-A-5
DR   BioSamples; SAMEA115495029
DR   hPSCreg; UMANe002-A-5
RX   PubMed=38788724;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for UMANe002-A-4 (Cellosaurus=CVCL_E3RS) (PubMed=38788724).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L201 ! Man-13
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UMB-1897
AC   CVCL_C2AQ
DR   Wikidata; Q114313187
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   From: NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,13
ST   D16S539: 13
ST   D5S818: 12
ST   D7S820: 11
ST   TH01: 8,9.3
ST   TPOX: 11,12
ST   vWA: 16,20
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMB-4648
AC   CVCL_C2AR
DR   Wikidata; Q114313188
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   From: NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMB-4994
AC   CVCL_C2AS
DR   Wikidata; Q114313189
RX   PubMed=26247043;
RX   PubMed=28284873;
CC   From: NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland; Baltimore; USA.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11117; SMN1; Zygosity=Homozygous (PubMed=28284873).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=28284873
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,13
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 11,13
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMB-SCC-745
AC   CVCL_A093
SY   University of Marburg-Squamous Cell Carcinoma-745
DR   cancercelllines; CVCL_A093
DR   Cosmic; 1483461
DR   IARC_TP53; 23609
DR   Wikidata; Q54991067
RX   PubMed=16035614;
RX   PubMed=16203773;
RX   PubMed=19414362;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu349Ter (c.1045G>T); ClinVar=VCV000634695; Zygosity=Unspecified (PubMed=16203773).
CC   Caution: Indicated as originating from tonsil in PubMed=16035614 and from orapharynx in PubMed=16203773 and PubMed=19414362.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UMB-SCC-864
AC   CVCL_A094
SY   University of Marburg-Squamous Cell Carcinoma-864
DR   Cosmic; 1483462
DR   IARC_TP53; 23610
DR   Wikidata; Q54991068
RX   PubMed=16035614;
RX   PubMed=16203773;
RX   PubMed=19414362;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe270Leufs*72 (c.810delT); ClinVar=VCV000634749; Zygosity=Unspecified (PubMed=16203773).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   UMB-SCC-969
AC   CVCL_A095
SY   University of Marburg-Squamous Cell Carcinoma-969
DR   cancercelllines; CVCL_A095
DR   Cosmic; 1483463
DR   IARC_TP53; 21639
DR   Wikidata; Q54991069
RX   PubMed=16035614;
RX   PubMed=16203773;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr205His (c.613T>C); ClinVar=VCV000376685; Zygosity=Unspecified (PubMed=16203773).
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UMB1949
AC   CVCL_C471
SY   UMBSVtel
DR   ATCC; CRL-4004
DR   BioSample; SAMN03471715
DR   Wikidata; Q54991071
RX   PubMed=17592550;
CC   Sequence variation: Mutation; HGNC; HGNC:12363; TSC2; Simple; p.Val1362Leufs*50 (c.4083_4087delAGTCG); ClinVar=VCV000049741; Zygosity=Unspecified (PubMed=17592550).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-4004
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 17,19
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 23
ST   Penta D: 10,13
ST   Penta E: 5,7
ST   TH01: 6,8
ST   TPOX: 12
ST   vWA: 18
DI   NCIt; C3888; Kidney angiomyolipoma
DI   NCIt; C75331; Tuberous sclerosis 2
DI   ORDO; Orphanet_805; Tuberous sclerosis complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   UMC-11
AC   CVCL_1784
SY   UMC11; NCI-UMC-11
DR   CLO; CLO_0009483
DR   EFO; EFO_0002386
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-5975
DR   BioSample; SAMN03473023
DR   cancercelllines; CVCL_1784
DR   Cell_Model_Passport; SIDM01183
DR   ChEMBL-Cells; CHEMBL3308343
DR   ChEMBL-Targets; CHEMBL1075606
DR   Cosmic; 687835
DR   Cosmic; 909779
DR   Cosmic; 1879414
DR   Cosmic; 1995662
DR   Cosmic; 2433549
DR   Cosmic-CLP; 909779
DR   DepMap; ACH-001417
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 909779
DR   GEO; GSM784236
DR   GEO; GSM827360
DR   GEO; GSM1670566
DR   IARC_TP53; 27266
DR   LINCS_LDP; LCL-1154
DR   PharmacoDB; UMC11_1644_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1784
DR   PubChem_Cell_line; CVCL_1784
DR   Wikidata; Q54991072
RX   PubMed=1311061;
RX   PubMed=1563005;
RX   PubMed=8806092;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26087898;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   HLA typing: A*03:02,29:02; B*35:08,51:09; C*04:01,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Leu536fs*14 (c.1606_1612delCTAGACG); Zygosity=Heterozygous (Cosmic-CLP=909779; DepMap=ACH-001417).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp228fs*19 (c.681delT) (p.S227fs); Zygosity=Homozygous (Cosmic-CLP=909779; DepMap=ACH-001417).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.55%; Native American=0%; East Asian, North=1.07%; East Asian, South=0.34%; South Asian=2.02%; European, North=69.48%; European, South=26.54% (PubMed=30894373).
CC   Misspelling: UNC-11; PubMed=1563005.
ST   Source(s): ATCC=CRL-5975; Cosmic-CLP=909779; DepMap=ACH-001417; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2
ST   D2S1338: 18,21
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 20,24
ST   Penta D: 13
ST   Penta E: 18,19
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 14,15
DI   NCIt; C4038; Lung carcinoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   UMC-DgE
AC   CVCL_Z423
SY   DgE
DR   Wikidata; Q54991074
RX   PubMed=10950000;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=61289; ! Diatraea grandiosella (Southwestern corn borer)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   UMC-iPS-C1
AC   CVCL_UG71
SY   UMC-iPSC-C1; UMC-C1
DR   Wikidata; Q98134111
RX   PubMed=20139068;
RX   PubMed=21949351;
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG72 ! UMC-iPS-C6
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   UMC-iPS-C6
AC   CVCL_UG72
SY   UMC-iPSC-C6; UMC-C6
DR   Wikidata; Q98134113
RX   PubMed=20139068;
RX   PubMed=21949351;
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UG71 ! UMC-iPS-C1
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   UMC-OnE
AC   CVCL_Z424
SY   OnE
DR   Wikidata; Q54991075
RX   PubMed=10950000;
CC   Group: Insect cell line.
CC   Doubling time: 56 hours (Note=At 17th passage), 36 hours (Note=At 79th passage) (PubMed=10950000).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=29057; ! Ostrinia nubilalis (European corn borer)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   UMCGi001-A
AC   CVCL_ZA86
SY   PPCM RC1 c1
DR   BioSamples; SAMEA6878079
DR   hPSCreg; UMCGi001-A
DR   Wikidata; Q98134114
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA87 ! UMCGi001-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 4
//
ID   UMCGi001-B
AC   CVCL_ZA87
SY   PPCM RC1 c2
DR   BioSamples; SAMEA6878083
DR   hPSCreg; UMCGi001-B
DR   Wikidata; Q98134117
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA86 ! UMCGi001-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 4
//
ID   UMCGi002-A
AC   CVCL_ZA88
SY   CTP1-C1
DR   BioSamples; SAMEA6878114
DR   hPSCreg; UMCGi002-A
DR   Wikidata; Q98134119
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA89 ! UMCGi002-B
OI   CVCL_ZA90 ! UMCGi002-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi002-B
AC   CVCL_ZA89
SY   CTP1-C2
DR   BioSamples; SAMEA6878106
DR   hPSCreg; UMCGi002-B
DR   Wikidata; Q98134121
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA88 ! UMCGi002-A
OI   CVCL_ZA90 ! UMCGi002-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi002-C
AC   CVCL_ZA90
SY   CTP1-C3
DR   BioSamples; SAMEA6878108
DR   hPSCreg; UMCGi002-C
DR   Wikidata; Q98134124
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA88 ! UMCGi002-A
OI   CVCL_ZA89 ! UMCGi002-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi003-A
AC   CVCL_ZA91
SY   PPCM RP1 c1
DR   BioSamples; SAMEA6878089
DR   hPSCreg; UMCGi003-A
DR   Wikidata; Q98134126
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C171602; Peripartum cardiomyopathy
DI   ORDO; Orphanet_563; Peripartum cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA92 ! UMCGi003-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi003-B
AC   CVCL_ZA92
SY   PPCM RP1 c3
DR   BioSamples; SAMEA6878090
DR   hPSCreg; UMCGi003-B
DR   Wikidata; Q98134128
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C171602; Peripartum cardiomyopathy
DI   ORDO; Orphanet_563; Peripartum cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA91 ! UMCGi003-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi004-A
AC   CVCL_ZA93
SY   PPCM RC2 c1
DR   BioSamples; SAMEA6878091
DR   hPSCreg; UMCGi004-A
DR   Wikidata; Q98134130
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA94 ! UMCGi004-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi004-B
AC   CVCL_ZA94
SY   PPCM RC2 c2
DR   BioSamples; SAMEA6878094
DR   hPSCreg; UMCGi004-B
DR   Wikidata; Q98134132
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA93 ! UMCGi004-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi005-A
AC   CVCL_ZA95
SY   PPCM RP2 c2
DR   BioSamples; SAMEA6878095
DR   hPSCreg; UMCGi005-A
DR   Wikidata; Q98134134
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C171602; Peripartum cardiomyopathy
DI   ORDO; Orphanet_563; Peripartum cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA96 ! UMCGi005-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi005-B
AC   CVCL_ZA96
SY   PPCM RP2 c9
DR   BioSamples; SAMEA6878098
DR   hPSCreg; UMCGi005-B
DR   Wikidata; Q98134136
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C171602; Peripartum cardiomyopathy
DI   ORDO; Orphanet_563; Peripartum cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA95 ! UMCGi005-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi006-A
AC   CVCL_ZA97
SY   DRP1-C2
DR   BioSamples; SAMEA6878104
DR   hPSCreg; UMCGi006-A
DR   Wikidata; Q98134138
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA98 ! UMCGi006-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi006-B
AC   CVCL_ZA98
SY   DRP1-C3
DR   BioSamples; SAMEA6878110
DR   hPSCreg; UMCGi006-B
DR   Wikidata; Q98134141
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA97 ! UMCGi006-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi007-A
AC   CVCL_ZA99
SY   DRP2-C2
DR   BioSamples; SAMEA6878117
DR   hPSCreg; UMCGi007-A
DR   Wikidata; Q98134143
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB00 ! UMCGi007-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi007-B
AC   CVCL_ZB00
SY   DRP2-C4
DR   BioSamples; SAMEA6878121
DR   hPSCreg; UMCGi007-B
DR   Wikidata; Q98134144
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZA99 ! UMCGi007-A
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMCGi008-A
AC   CVCL_ZB01
SY   DRP3-C5
DR   BioSamples; SAMEA6878123
DR   hPSCreg; UMCGi008-A
DR   Wikidata; Q98134146
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5BX ! UMCGi008-B
OI   CVCL_A5BY ! UMCGi008-C
OI   CVCL_A5BZ ! UMCGi008-D
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   UMCGi008-B
AC   CVCL_A5BX
SY   DRP3-C7
DR   BioSamples; SAMEA8112837
DR   hPSCreg; UMCGi008-B
DR   Wikidata; Q107117260
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB01 ! UMCGi008-A
OI   CVCL_A5BY ! UMCGi008-C
OI   CVCL_A5BZ ! UMCGi008-D
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UMCGi008-C
AC   CVCL_A5BY
SY   DRP3-C10
DR   BioSamples; SAMEA8112838
DR   hPSCreg; UMCGi008-C
DR   Wikidata; Q107117261
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB01 ! UMCGi008-A
OI   CVCL_A5BX ! UMCGi008-B
OI   CVCL_A5BZ ! UMCGi008-D
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UMCGi008-D
AC   CVCL_A5BZ
SY   DRP3-C11
DR   BioSamples; SAMEA8112839
DR   hPSCreg; UMCGi008-D
DR   Wikidata; Q107117262
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB01 ! UMCGi008-A
OI   CVCL_A5BX ! UMCGi008-B
OI   CVCL_A5BY ! UMCGi008-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UMCGi009-A
AC   CVCL_ZX65
SY   PLN2-C2
DR   BioSamples; SAMEA7071386
DR   hPSCreg; UMCGi009-A
DR   Wikidata; Q102115074
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple; p.Arg14del (c.37_39AGA[1]) (c.40_42delAGA) (R14del); ClinVar=VCV000044580; Zygosity=Heterozygous (hPSCreg=UMCGi009-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   UMCGi010-A
AC   CVCL_A8PW
DR   BioSamples; SAMEA8519700
DR   hPSCreg; UMCGi010-A
DR   Wikidata; Q108821451
CC   From: University Medical Center Groningen; Groningen; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UMCGi011-A
AC   CVCL_C1WZ
SY   CTP2
DR   BioSamples; SAMEA13603590
DR   hPSCreg; UMCGi011-A
DR   Wikidata; Q114313192
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C50577; Heart failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1X0 ! UMCGi011-B
OI   CVCL_C1X1 ! UMCGi011-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UMCGi011-B
AC   CVCL_C1X0
SY   CTP2-C5
DR   BioSamples; SAMEA13604353
DR   hPSCreg; UMCGi011-B
DR   Wikidata; Q114313193
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C50577; Heart failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1WZ ! UMCGi011-A
OI   CVCL_C1X1 ! UMCGi011-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UMCGi011-C
AC   CVCL_C1X1
SY   CTP2-C4
DR   BioSamples; SAMEA13928821
DR   hPSCreg; UMCGi011-C
DR   Wikidata; Q114313194
CC   From: University Medical Center Groningen; Groningen; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C50577; Heart failure
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1WZ ! UMCGi011-A
OI   CVCL_C1X0 ! UMCGi011-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UMCL01-101
AC   CVCL_C9FN
DR   GEO; GSE18826
DR   Wikidata; Q123033738
RX   PubMed=17324269;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7213; AIDS-related diffuse large cell lymphoma
DI   ORDO; Orphanet_443291; HIV-associated cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   UMCUi001-A
AC   CVCL_D6JS
SY   CRYAB-A527G-11C1
DR   BioSamples; SAMEA114292120
DR   hPSCreg; UMCUi001-A
DR   Wikidata; Q127384584
CC   From: Department of Heart and Lungs, University Medical Center Utrecht; Utrecht; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2389; CRYAB; Simple; p.Ter176Ter (c.527G>A); Zygosity=Heterozygous (hPSCreg=UMCUi001-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206099; Dilated cardiomyopathy-1II
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UMCUi002-A
AC   CVCL_D6JT
SY   CRYAB-A527G-12C6
DR   BioSamples; SAMEA114569690
DR   hPSCreg; UMCUi002-A
DR   Wikidata; Q127384587
CC   From: Department of Heart and Lungs, University Medical Center Utrecht; Utrecht; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2389; CRYAB; Simple; p.Ter176Ter (c.527G>A); Zygosity=Heterozygous (hPSCreg=UMCUi002-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206099; Dilated cardiomyopathy-1II
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UMCUi003-A
AC   CVCL_D6JU
SY   CRYAB-A527G-91C10
DR   BioSamples; SAMEA114569715
DR   hPSCreg; UMCUi003-A
DR   Wikidata; Q127384590
CC   From: Department of Heart and Lungs, University Medical Center Utrecht; Utrecht; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2389; CRYAB; Simple; p.Ter176Ter (c.527G>A); Zygosity=Heterozygous (hPSCreg=UMCUi003-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206099; Dilated cardiomyopathy-1II
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UMCUi004-A
AC   CVCL_D6JV
SY   CRYAB-A527G-92C25
DR   BioSamples; SAMEA114569721
DR   hPSCreg; UMCUi004-A
DR   Wikidata; Q127384592
CC   From: Department of Heart and Lungs, University Medical Center Utrecht; Utrecht; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   UMG1
AC   CVCL_A0IL
DR   Wikidata; Q108821452
RX   Patent=US20210155706;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 16001.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A0IK ! UN1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UMGACBi001-A
AC   CVCL_D0NS
SY   iPSC 1.3.3 DUSC-CKD
DR   BioSamples; SAMEA114401594
DR   hPSCreg; UMGACBi001-A
DR   Wikidata; Q123033739
RX   PubMed=38323759;
CC   From: Institute of Anatomy and Cell Biology, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=38323759
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 17,18
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 11,19
ST   D19S433: 11,14
ST   D1S1656: 12,16.1
ST   D21S11: 28,29
ST   D2S1338: 22,23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D6S1043: 12,17
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 7,14
ST   TH01: 6,8
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C84417; Diabetic nephropathy
DI   NCIt; C80078; Chronic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UMGi001-A
AC   CVCL_A4IV
SY   iWT.D2.1
DR   hPSCreg; UMGi001-A
DR   Wikidata; Q105511342
RX   PubMed=22798560;
RX   PubMed=29925689;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=1
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi002-A
AC   CVCL_A4IW
DR   hPSCreg; UMGi002-A
DR   Wikidata; Q105511344
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=2
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi003-A
AC   CVCL_A4IX
DR   hPSCreg; UMGi003-A
DR   Wikidata; Q105511347
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=3
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi004-A
AC   CVCL_A4IY
DR   hPSCreg; UMGi004-A
DR   Wikidata; Q105511353
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=4
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi005-A
AC   CVCL_A4IZ
SY   iBM76.3
DR   hPSCreg; UMGi005-A
DR   Wikidata; Q105511356
RX   PubMed=22798560;
RX   PubMed=29925689;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=5
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi006-A
AC   CVCL_A4JA
DR   hPSCreg; UMGi006-A
DR   Wikidata; Q105511359
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=6
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi007-A
AC   CVCL_A4JB
SY   D1-iPSC4; Kera4-iPS4
DR   hPSCreg; UMGi007-A
DR   Wikidata; Q105511362
RX   PubMed=22798560;
RX   PubMed=25950680;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=7
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi008-A
AC   CVCL_A4JC
DR   hPSCreg; UMGi008-A
DR   Wikidata; Q105511365
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=8
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi009-A
AC   CVCL_A4JD
SY   D2-iPSC1; Kera2-iPS1
DR   hPSCreg; UMGi009-A
DR   Wikidata; Q105511368
RX   PubMed=22798560;
RX   PubMed=25950680;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=9
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi010-A
AC   CVCL_A4JE
DR   hPSCreg; UMGi010-A
DR   Wikidata; Q105511371
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=10
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi011-A
AC   CVCL_A4JF
SY   D3-iPSC3
DR   hPSCreg; UMGi011-A
DR   Wikidata; Q105511375
RX   PubMed=25950680;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=11
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi012-A
AC   CVCL_A4JG
DR   hPSCreg; UMGi012-A
DR   Wikidata; Q105511379
RX   PubMed=22798560;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=12
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi013-A
AC   CVCL_A4JU
DR   hPSCreg; UMGi013-A
DR   Wikidata; Q105511381
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=13
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi014-A
AC   CVCL_A4JH
SY   isWT1.Bld2
DR   hPSCreg; UMGi014-A
DR   Wikidata; Q105511384
RX   PubMed=29925689;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=14
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JI ! UMGi014-B.1
OI   CVCL_A4JJ ! UMGi014-B.3
OI   CVCL_A4JK ! UMGi014-B.6
OI   CVCL_A4ZE ! UMGi014-C
OI   CVCL_A4ZF ! UMGi014-D
OI   CVCL_A4TT ! UMGi014-E
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi014-B.1
AC   CVCL_A4JI
SY   GOEi014-B.1; ipWT1.1
DR   hPSCreg; UMGi014-B
DR   SKIP; SKIP003208
DR   Wikidata; Q105511387
RX   PubMed=29566126;
RX   PubMed=29574456;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=15
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi014-B) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JH ! UMGi014-A
OI   CVCL_A4JJ ! UMGi014-B.3
OI   CVCL_A4JK ! UMGi014-B.6
OI   CVCL_A4ZE ! UMGi014-C
OI   CVCL_A4ZF ! UMGi014-D
OI   CVCL_A4TT ! UMGi014-E
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi014-B.3
AC   CVCL_A4JJ
SY   GOEi014-B.3; ipWT1.3
DR   hPSCreg; UMGi014-B
DR   SKIP; SKIP003209
DR   Wikidata; Q105511390
RX   PubMed=29566126;
RX   PubMed=29574456;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=15
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi014-B) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JH ! UMGi014-A
OI   CVCL_A4JI ! UMGi014-B.1
OI   CVCL_A4JK ! UMGi014-B.6
OI   CVCL_A4ZE ! UMGi014-C
OI   CVCL_A4ZF ! UMGi014-D
OI   CVCL_A4TT ! UMGi014-E
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi014-B.6
AC   CVCL_A4JK
SY   GOEi014-B.6; ipWT1.6
DR   hPSCreg; UMGi014-B
DR   SKIP; SKIP003210
DR   Wikidata; Q105511392
RX   PubMed=29566126;
RX   PubMed=29574456;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=15
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi014-B) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JH ! UMGi014-A
OI   CVCL_A4JI ! UMGi014-B.1
OI   CVCL_A4JJ ! UMGi014-B.3
OI   CVCL_A4ZE ! UMGi014-C
OI   CVCL_A4ZF ! UMGi014-D
OI   CVCL_A4TT ! UMGi014-E
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi014-C
AC   CVCL_A4ZE
SY   UMGi014-C clone 14; isWT1.14
DR   hPSCreg; UMGi014-C
DR   Wikidata; Q107117263
RX   PubMed=37121193;
RX   PubMed=37141804;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=16
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JH ! UMGi014-A
OI   CVCL_A4JI ! UMGi014-B.1
OI   CVCL_A4JJ ! UMGi014-B.3
OI   CVCL_A4JK ! UMGi014-B.6
OI   CVCL_A4ZF ! UMGi014-D
OI   CVCL_A4TT ! UMGi014-E
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi014-C-17
AC   CVCL_D0QM
SY   isWT1-MRAS-G23V.G2; UMGi014-C-17 clone G2
DR   hPSCreg; UMGi014-C-17
DR   Wikidata; Q123033740
RX   PubMed=37141804;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7227; MRAS; Simple_edited; p.Gly23Val (c.68G>T); ClinVar=VCV000635781; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37141804).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4ZE ! UMGi014-C
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UMGi014-C-2
AC   CVCL_D0QN
SY   isWT1-KRAS-G12V.64; UMGi014-C-2 clone 64
DR   hPSCreg; UMGi014-C-2
DR   Wikidata; Q123033741
RX   PubMed=37121193;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple_edited; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37121193).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4ZE ! UMGi014-C
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UMGi014-D
AC   CVCL_A4ZF
DR   hPSCreg; UMGi014-D
DR   Wikidata; Q107117264
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=17
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JH ! UMGi014-A
OI   CVCL_A4JI ! UMGi014-B.1
OI   CVCL_A4JJ ! UMGi014-B.3
OI   CVCL_A4JK ! UMGi014-B.6
OI   CVCL_A4ZE ! UMGi014-C
OI   CVCL_A4TT ! UMGi014-E
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi014-E
AC   CVCL_A4TT
DR   hPSCreg; UMGi014-E
DR   Wikidata; Q107117266
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=407
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JH ! UMGi014-A
OI   CVCL_A4JI ! UMGi014-B.1
OI   CVCL_A4JJ ! UMGi014-B.3
OI   CVCL_A4JK ! UMGi014-B.6
OI   CVCL_A4ZE ! UMGi014-C
OI   CVCL_A4ZF ! UMGi014-D
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi015-A
AC   CVCL_A4JV
DR   hPSCreg; UMGi015-A
DR   Wikidata; Q105511395
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=18
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi016-A
AC   CVCL_A4JW
DR   hPSCreg; UMGi016-A
DR   Wikidata; Q105511398
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=19
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi017-A
AC   CVCL_A4JX
DR   hPSCreg; UMGi017-A
DR   Wikidata; Q105511402
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=20
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi018-A
AC   CVCL_A4JY
DR   hPSCreg; UMGi018-A
DR   Wikidata; Q105511405
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=21
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi019-A
AC   CVCL_A4JZ
DR   hPSCreg; UMGi019-A
DR   Wikidata; Q105511407
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=22
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi020-A
AC   CVCL_A4KA
DR   hPSCreg; UMGi020-A
DR   Wikidata; Q105511409
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=23
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KB ! UMGi020-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi020-B
AC   CVCL_A4KB
DR   hPSCreg; UMGi020-B
DR   Wikidata; Q105511412
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=24
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KA ! UMGi020-A
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi021-A
AC   CVCL_A4KC
DR   hPSCreg; UMGi021-A
DR   Wikidata; Q105511416
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=25
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi022-A
AC   CVCL_A4KD
DR   hPSCreg; UMGi022-A
DR   Wikidata; Q105511419
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=26
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi023-A
AC   CVCL_A4KE
DR   hPSCreg; UMGi023-A
DR   Wikidata; Q105511422
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=27
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi024-A
AC   CVCL_A4KF
DR   hPSCreg; UMGi024-A
DR   Wikidata; Q105511428
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=30
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi025-A
AC   CVCL_A4KG
DR   hPSCreg; UMGi025-A
DR   Wikidata; Q105511431
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=31
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi026-A
AC   CVCL_A4KH
DR   hPSCreg; UMGi026-A
DR   Wikidata; Q105511434
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=32
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi027-A
AC   CVCL_A4KI
DR   hPSCreg; UMGi027-A
DR   Wikidata; Q105511437
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=34
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi028-A
AC   CVCL_A4KJ
DR   hPSCreg; UMGi028-A
DR   Wikidata; Q105511441
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=35
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi029-A
AC   CVCL_A4KK
DR   hPSCreg; UMGi029-A
DR   Wikidata; Q105511443
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=41
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KL ! UMGi029-B
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi029-B
AC   CVCL_A4KL
DR   hPSCreg; UMGi029-B
DR   Wikidata; Q105511446
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=42
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KK ! UMGi029-A
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi030-A
AC   CVCL_A4KM
DR   hPSCreg; UMGi030-A
DR   Wikidata; Q105511449
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=44
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi031-A
AC   CVCL_A4KN
DR   hPSCreg; UMGi031-A
DR   Wikidata; Q105511453
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=45
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi032-A
AC   CVCL_A4KP
DR   hPSCreg; UMGi032-A
DR   Wikidata; Q105511455
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=46
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi033-A
AC   CVCL_A4KQ
DR   hPSCreg; UMGi033-A
DR   Wikidata; Q105511458
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=47
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi034-A
AC   CVCL_A4KR
DR   hPSCreg; UMGi034-A
DR   Wikidata; Q105511462
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=48
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi035-A
AC   CVCL_A4KS
DR   hPSCreg; UMGi035-A
DR   Wikidata; Q105511465
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=49
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi036-A
AC   CVCL_A4KT
DR   hPSCreg; UMGi036-A
DR   Wikidata; Q105511468
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=51
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi037-A
AC   CVCL_A4KU
DR   hPSCreg; UMGi037-A
DR   Wikidata; Q105511470
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=52
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi038-A
AC   CVCL_A4KV
DR   hPSCreg; UMGi038-A
DR   Wikidata; Q105511474
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=53
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi039-A
AC   CVCL_A4KW
DR   hPSCreg; UMGi039-A
DR   Wikidata; Q105511477
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=56
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi040-A
AC   CVCL_A4KX
DR   hPSCreg; UMGi040-A
DR   Wikidata; Q105511481
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=57
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi041-A
AC   CVCL_A4KY
DR   hPSCreg; UMGi041-A
DR   Wikidata; Q105511483
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=58
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Ala2254Val (c.6761C>T); Zygosity=Heterozygous (from autologous cell lines UMGi041-B.2; UMGi041-B.3).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KZ ! UMGi041-B.2
OI   CVCL_A5QG ! UMGi041-B.3
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   UMGi041-B.2
AC   CVCL_A4KZ
SY   UMGi041-B clone 2; isCPVTA2254V1-2
DR   hPSCreg; UMGi041-B
DR   Wikidata; Q105511485
RX   PubMed=33640691;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=59
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Ala2254Val (c.6761C>T); Zygosity=Heterozygous (PubMed=33640691).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KY ! UMGi041-A
OI   CVCL_A5QG ! UMGi041-B.3
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi041-B.3
AC   CVCL_A5QG
SY   UMGi041-B clone 3; isCPVTA2254V1-3
DR   hPSCreg; UMGi041-B
DR   Wikidata; Q107117267
RX   PubMed=33640691;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=59
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Ala2254Val (c.6761C>T); Zygosity=Heterozygous (PubMed=33640691).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4KY ! UMGi041-A
OI   CVCL_A4KZ ! UMGi041-B.2
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi042-A
AC   CVCL_A4LA
DR   hPSCreg; UMGi042-A
DR   Wikidata; Q105511488
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=60
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4LB ! UMGi042-B
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi042-B
AC   CVCL_A4LB
DR   hPSCreg; UMGi042-B
DR   Wikidata; Q105511491
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=61
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4LA ! UMGi042-A
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi043-A
AC   CVCL_A4LC
DR   hPSCreg; UMGi043-A
DR   Wikidata; Q105511495
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=62
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4LD ! UMGi043-B
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi043-B
AC   CVCL_A4LD
DR   hPSCreg; UMGi043-B
DR   Wikidata; Q105511498
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=63
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4LC ! UMGi043-A
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi044-A
AC   CVCL_A4LE
DR   hPSCreg; UMGi044-A
DR   Wikidata; Q105511502
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=64
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi045-A
AC   CVCL_A4LF
DR   hPSCreg; UMGi045-A
DR   Wikidata; Q105511505
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=65
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi046-A
AC   CVCL_A4JL
SY   iBrs1
DR   hPSCreg; UMGi046-A
DR   Wikidata; Q105511508
RX   PubMed=27485484;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=66
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi047-A
AC   CVCL_A4JM
SY   iBrs2
DR   hPSCreg; UMGi047-A
DR   Wikidata; Q105511511
RX   PubMed=27485484;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=67
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi048-A
AC   CVCL_A4LG
SY   iBrs3
DR   hPSCreg; UMGi048-A
DR   Wikidata; Q105511514
RX   PubMed=27485484;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=68
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi049-A
AC   CVCL_A4LI
DR   hPSCreg; UMGi049-A
DR   Wikidata; Q105511517
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=69
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi050-A
AC   CVCL_A4LJ
DR   hPSCreg; UMGi050-A
DR   Wikidata; Q105511521
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=70
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi051-A
AC   CVCL_A4LK
DR   hPSCreg; UMGi051-A
DR   Wikidata; Q105511524
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=72
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi052-A
AC   CVCL_A4LL
DR   hPSCreg; UMGi052-A
DR   Wikidata; Q105511528
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=75
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi053-A
AC   CVCL_A4LM
DR   hPSCreg; UMGi053-A
DR   Wikidata; Q105511533
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=76
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi054-A.3
AC   CVCL_A1YS
SY   TAZ10-3
DR   hPSCreg; UMGi054-A
DR   Wikidata; Q105511537
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=77
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Gly197Val (c.590G>T); Zygosity=Hemizygous (PubMed=23792436).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi054-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YT ! UMGi054-A.4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi054-A.4
AC   CVCL_A1YT
SY   TAZ10-4
DR   hPSCreg; UMGi054-A
DR   Wikidata; Q105511540
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=77
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Gly197Val (c.590G>T); Zygosity=Hemizygous (PubMed=23792436).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi054-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YS ! UMGi054-A.3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi055-A.3
AC   CVCL_A1YU
SY   TAZ13-3
DR   hPSCreg; UMGi055-A
DR   Wikidata; Q105511545
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=78
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; c.110-1G>C; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=23792436).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi055-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YV ! UMGi055-A.4
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi055-A.4
AC   CVCL_A1YV
SY   TAZ13-4
DR   hPSCreg; UMGi055-A
DR   Wikidata; Q105511548
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=78
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi055-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YU ! UMGi055-A.3
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi056-A.1
AC   CVCL_A1YW
SY   TAZ15-1
DR   hPSCreg; UMGi056-A
DR   Wikidata; Q105511551
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=79
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Arg57Leu (c.170G>T); Zygosity=Hemizygous (PubMed=23792436).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi056-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YX ! UMGi056-A.5
OI   CVCL_A1YY ! UMGi056-A.8
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi056-A.5
AC   CVCL_A1YX
SY   TAZ15-5
DR   hPSCreg; UMGi056-A
DR   Wikidata; Q105511555
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=79
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Arg57Leu (c.170G>T); Zygosity=Hemizygous (PubMed=23792436).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi056-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YW ! UMGi056-A.1
OI   CVCL_A1YY ! UMGi056-A.8
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi056-A.8
AC   CVCL_A1YY
SY   TAZ15-8
DR   hPSCreg; UMGi056-A
DR   Wikidata; Q105511559
RX   PubMed=23792436;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=79
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Arg57Leu (c.170G>T); Zygosity=Hemizygous (PubMed=23792436).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi056-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1YW ! UMGi056-A.1
OI   CVCL_A1YX ! UMGi056-A.5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi057-A
AC   CVCL_A4LN
DR   hPSCreg; UMGi057-A
DR   Wikidata; Q105511563
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=80
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi058-A
AC   CVCL_A4LP
DR   hPSCreg; UMGi058-A
DR   Wikidata; Q105511566
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=81
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi059-A
AC   CVCL_A4LQ
DR   hPSCreg; UMGi059-A
DR   Wikidata; Q105511571
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=82
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi060-A
AC   CVCL_A4LR
DR   hPSCreg; UMGi060-A
DR   Wikidata; Q105511573
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=83
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84910; Muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi061-A
AC   CVCL_A4LS
DR   hPSCreg; UMGi061-A
DR   Wikidata; Q105511576
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=84
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84910; Muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi062-A
AC   CVCL_A4RK
DR   hPSCreg; UMGi062-A
DR   Wikidata; Q105511578
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=85
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi063-A
AC   CVCL_A4LT
DR   hPSCreg; UMGi063-A
DR   Wikidata; Q105511581
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=86
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84559; Long QT syndrome 7
DI   ORDO; Orphanet_37553; Andersen-Tawil syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi064-A
AC   CVCL_A4LU
DR   hPSCreg; UMGi064-A
DR   Wikidata; Q105511587
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=87
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi065-A
AC   CVCL_A4LV
DR   hPSCreg; UMGi065-A
DR   Wikidata; Q105511589
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=88
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34830; Cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi066-A
AC   CVCL_A4LW
DR   hPSCreg; UMGi066-A
DR   Wikidata; Q105511592
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=89
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi067-A
AC   CVCL_A4LX
DR   hPSCreg; UMGi067-A
DR   Wikidata; Q105511596
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=90
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99236; Neonatal lupus erythematosus
DI   ORDO; Orphanet_398124; Neonatal lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi068-A
AC   CVCL_A4RL
DR   hPSCreg; UMGi068-A
DR   Wikidata; Q105511600
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=91
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4RM ! UMGi068-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi068-B
AC   CVCL_A4RM
DR   hPSCreg; UMGi068-B
DR   Wikidata; Q105511605
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=92
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4RL ! UMGi068-A
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi069-A
AC   CVCL_A4RN
DR   hPSCreg; UMGi069-A
DR   Wikidata; Q105511606
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=93
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4RP ! UMGi069-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi069-B
AC   CVCL_A4RP
DR   hPSCreg; UMGi069-B
DR   Wikidata; Q105511607
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=94
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Hair; UBERON=UBERON_0001037.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4RN ! UMGi069-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi070-A
AC   CVCL_A4SL
DR   hPSCreg; UMGi070-A
DR   Wikidata; Q107117268
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=95
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi071-A
AC   CVCL_A4SM
DR   hPSCreg; UMGi071-A
DR   Wikidata; Q107117269
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=97
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi072-A
AC   CVCL_A4SN
DR   hPSCreg; UMGi072-A
DR   Wikidata; Q107117271
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=99
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi073-A
AC   CVCL_A4SP
DR   hPSCreg; UMGi073-A
DR   Wikidata; Q107117272
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=100
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi074-A
AC   CVCL_A4SQ
DR   hPSCreg; UMGi074-A
DR   Wikidata; Q107117273
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=101
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi075-A
AC   CVCL_A4SR
DR   hPSCreg; UMGi075-A
DR   Wikidata; Q107117274
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=102
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi076-A
AC   CVCL_A4SS
DR   hPSCreg; UMGi076-A
DR   Wikidata; Q107117275
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=103
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi077-A
AC   CVCL_A4ST
DR   hPSCreg; UMGi077-A
DR   Wikidata; Q107117276
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=104
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi078-A
AC   CVCL_A4SU
DR   hPSCreg; UMGi078-A
DR   Wikidata; Q107117277
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=105
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi079-A
AC   CVCL_A4SV
DR   hPSCreg; UMGi079-A
DR   Wikidata; Q107117279
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=106
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi080-A
AC   CVCL_A4SW
DR   hPSCreg; UMGi080-A
DR   Wikidata; Q107117280
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=107
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi081-A
AC   CVCL_A4SX
DR   hPSCreg; UMGi081-A
DR   Wikidata; Q107117281
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=108
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi082-A
AC   CVCL_A4SY
DR   hPSCreg; UMGi082-A
DR   Wikidata; Q107117282
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=109
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi083-A
AC   CVCL_A4SZ
DR   hPSCreg; UMGi083-A
DR   Wikidata; Q107117283
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=110
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi084-A
AC   CVCL_A4TA
DR   hPSCreg; UMGi084-A
DR   Wikidata; Q107117284
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=111
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi085-A
AC   CVCL_A4TB
DR   hPSCreg; UMGi085-A
DR   Wikidata; Q107117285
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=112
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi086-A
AC   CVCL_A4TC
DR   hPSCreg; UMGi086-A
DR   Wikidata; Q107117286
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=113
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi090-A
AC   CVCL_A4TQ
DR   hPSCreg; UMGi090-A
DR   Wikidata; Q107117287
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=118
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi091-A
AC   CVCL_A4TR
DR   hPSCreg; UMGi091-A
DR   Wikidata; Q107117288
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=119
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3243; Multiple sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi092-A
AC   CVCL_A4ZG
DR   hPSCreg; UMGi092-A
DR   Wikidata; Q107117289
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=124
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176016; Febrile seizures, familial, 3A
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi093-A
AC   CVCL_A4VA
DR   hPSCreg; UMGi093-A
DR   Wikidata; Q107117290
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=125
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi094-A
AC   CVCL_A4VB
DR   hPSCreg; UMGi094-A
DR   Wikidata; Q107117291
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=126
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi099-A
AC   CVCL_A4ZH
DR   hPSCreg; UMGi099-A
DR   Wikidata; Q107117292
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=133
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84549; Alstrom syndrome
DI   ORDO; Orphanet_64; Alstrom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4ZI ! UMGi099-B
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi099-B
AC   CVCL_A4ZI
DR   hPSCreg; UMGi099-B
DR   Wikidata; Q107117294
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=134
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84549; Alstrom syndrome
DI   ORDO; Orphanet_64; Alstrom syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4ZH ! UMGi099-A
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi101-A
AC   CVCL_A4ZA
DR   hPSCreg; UMGi101-A
DR   Wikidata; Q107117295
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=177
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi102-A
AC   CVCL_A4UX
DR   hPSCreg; UMGi102-A
DR   Wikidata; Q107117296
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=137
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi103-A
AC   CVCL_A4UY
DR   hPSCreg; UMGi103-A
DR   Wikidata; Q107117297
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=138
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi104-A
AC   CVCL_A4UZ
DR   hPSCreg; UMGi104-A
DR   Wikidata; Q107117298
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=139
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi105-A
AC   CVCL_A4UP
SY   isAu1-3
DR   hPSCreg; UMGi105-A
DR   Wikidata; Q107117299
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=141
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi106-A
AC   CVCL_A4UQ
DR   hPSCreg; UMGi106-A
DR   Wikidata; Q107117300
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=143
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UR ! UMGi106-B
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi106-B
AC   CVCL_A4UR
SY   isAu3-2
DR   hPSCreg; UMGi106-B
DR   Wikidata; Q107117301
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=144
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UQ ! UMGi106-A
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi107-A
AC   CVCL_A4US
DR   hPSCreg; UMGi107-A
DR   Wikidata; Q107117303
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=146
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UT ! UMGi107-B
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi107-B
AC   CVCL_A4UT
DR   hPSCreg; UMGi107-B
DR   Wikidata; Q107117304
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=147
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4US ! UMGi107-A
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi108-A
AC   CVCL_A4UU
DR   hPSCreg; UMGi108-A
DR   Wikidata; Q107117305
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=148
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UV ! UMGi108-B
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi108-B
AC   CVCL_A4UV
DR   hPSCreg; UMGi108-B
DR   Wikidata; Q107117306
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=149
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UU ! UMGi108-A
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi109-A
AC   CVCL_A4UW
DR   hPSCreg; UMGi109-A
DR   Wikidata; Q107117307
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=151
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C88412; Autism spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi120-A.15
AC   CVCL_A4JQ
SY   GOEi091-A.15; isSQTSa1.15
DR   hPSCreg; UMGi120-A
DR   SKIP; SKIP003213
DR   Wikidata; Q105511611
RX   PubMed=29574456;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=163
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Asn588Lys (c.1764C>G); ClinVar=VCV000014436; Zygosity=Heterozygous (PubMed=29574456).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi120-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C71060; Short QT syndrome
DI   ORDO; Orphanet_51083; Familial short QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JN ! UMGi120-A.7
OI   CVCL_A4JP ! UMGi120-A.8
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi120-A.7
AC   CVCL_A4JN
SY   GOEi091-A.7; isSQTSa1.7
DR   hPSCreg; UMGi120-A
DR   SKIP; SKIP003211
DR   Wikidata; Q105511613
RX   PubMed=29574456;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=163
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Asn588Lys (c.1764C>G); ClinVar=VCV000014436; Zygosity=Heterozygous (PubMed=29574456).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi120-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C71060; Short QT syndrome
DI   ORDO; Orphanet_51083; Familial short QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JP ! UMGi120-A.8
OI   CVCL_A4JQ ! UMGi120-A.15
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi120-A.8
AC   CVCL_A4JP
SY   GOEi091-A.8; isSQTSa1.8
DR   hPSCreg; UMGi120-A
DR   SKIP; SKIP003212
DR   Wikidata; Q105511615
RX   PubMed=29574456;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=163
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Asn588Lys (c.1764C>G); ClinVar=VCV000014436; Zygosity=Heterozygous (PubMed=29574456).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi120-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C71060; Short QT syndrome
DI   ORDO; Orphanet_51083; Familial short QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JN ! UMGi120-A.7
OI   CVCL_A4JQ ! UMGi120-A.15
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi121-A.2
AC   CVCL_A4JR
SY   GOEi092-A.2; isARVCb1.2
DR   hPSCreg; UMGi121-A
DR   SKIP; SKIP003195
DR   Wikidata; Q105511617
RX   PubMed=29566126;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=164
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:3049; DSG2; Simple; p.Gly638Arg (c.1912G>A); ClinVar=VCV000161224; Zygosity=Heterozygous (PubMed=29566126).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi121-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177248; Familial arrhythmogenic right ventricular dysplasia 10
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JS ! UMGi121-A.3
OI   CVCL_A4JT ! UMGi121-A.4
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi121-A.3
AC   CVCL_A4JS
SY   GOEi092-A.3; isARVCb1.3
DR   hPSCreg; UMGi121-A
DR   SKIP; SKIP003196
DR   Wikidata; Q105511620
RX   PubMed=29566126;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=164
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:3049; DSG2; Simple; p.Gly638Arg (c.1912G>A); ClinVar=VCV000161224; Zygosity=Heterozygous (PubMed=29566126).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi121-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177248; Familial arrhythmogenic right ventricular dysplasia 10
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JR ! UMGi121-A.2
OI   CVCL_A4JT ! UMGi121-A.4
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi121-A.4
AC   CVCL_A4JT
SY   GOEi092-A.4; isARVCb1.4
DR   hPSCreg; UMGi121-A
DR   SKIP; SKIP003197
DR   Wikidata; Q105511623
RX   PubMed=29566126;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=164
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:3049; DSG2; Simple; p.Gly638Arg (c.1912G>A); ClinVar=VCV000161224; Zygosity=Heterozygous (PubMed=29566126).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi121-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177248; Familial arrhythmogenic right ventricular dysplasia 10
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4JR ! UMGi121-A.2
OI   CVCL_A4JS ! UMGi121-A.3
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi126-A.12
AC   CVCL_A4UE
SY   GOEi098-A.12; isBrSd1.12
DR   hPSCreg; UMGi126-A
DR   Wikidata; Q107117308
RX   PubMed=31106349;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=171
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349).
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UD ! UMGi126-A.9
OI   CVCL_A4UF ! UMGi126-A.13
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi126-A.13
AC   CVCL_A4UF
SY   GOEi098-A.23; isBrSd1.23
DR   hPSCreg; UMGi126-A
DR   Wikidata; Q107117309
RX   PubMed=31106349;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=171
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349).
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UD ! UMGi126-A.9
OI   CVCL_A4UE ! UMGi126-A.12
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi126-A.9
AC   CVCL_A4UD
SY   GOEi098-A.9; isBrSd1.9
DR   hPSCreg; UMGi126-A
DR   Wikidata; Q107117310
RX   PubMed=31106349;
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=171
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1250Gln (c.3749G>A); ClinVar=VCV000221068; Zygosity=Heterozygous (PubMed=31106349).
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Arg1268Gln (c.3803G>A); ClinVar=VCV000240673; Zygosity=Heterozygous (PubMed=31106349).
CC   Caution: The University Medical Center Goettingen is not following the guidelines of hPSCreg regarding the naming of their cell lines: they are assigning a single name (here UMGi126-A) for a series of distinct clones.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4UE ! UMGi126-A.12
OI   CVCL_A4UF ! UMGi126-A.13
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UMGi127-A
AC   CVCL_A4UG
DR   hPSCreg; UMGi127-A
DR   Wikidata; Q107117311
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=172
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi128-A
AC   CVCL_A4UH
DR   hPSCreg; UMGi128-A
DR   Wikidata; Q107117312
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=173
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142891; Brugada syndrome
DI   ORDO; Orphanet_130; Brugada syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi130-A
AC   CVCL_A4TU
DR   hPSCreg; UMGi130-A
DR   Wikidata; Q107117313
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=29
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi132-A
AC   CVCL_A4ZB
DR   hPSCreg; UMGi132-A
DR   Wikidata; Q107117315
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=178
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi140-A
AC   CVCL_A4ZC
DR   hPSCreg; UMGi140-A
DR   Wikidata; Q107117316
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=342
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi141-A
AC   CVCL_A4ZD
DR   hPSCreg; UMGi141-A
DR   Wikidata; Q107117317
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=343
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84617; Cardiofaciocutaneous syndrome
DI   ORDO; Orphanet_1340; Cardiofaciocutaneous syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi144-A
AC   CVCL_A9YQ
SY   DCM-R634W
DR   hPSCreg; UMGi144-A
DR   Wikidata; Q102115075
RX   PubMed=32674065;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27424; RBM20; Simple; p.Arg634Trp (c.1900C>T); ClinVar=VCV000411653; Zygosity=Heterozygous (PubMed=32674065).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174435; Dilated cardiomyopathy-1DD
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   UMGi144-A-1
AC   CVCL_A9YR
SY   rescueDCM-iPSC; rescue-DCM
DR   hPSCreg; UMGi144-A-1
DR   Wikidata; Q102115076
RX   PubMed=32674065;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27424; RBM20; Simple_corrected; p.Arg634Trp (c.1900C>T); ClinVar=VCV000411653; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32674065).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174435; Dilated cardiomyopathy-1DD
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9YQ ! UMGi144-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UMGi145-A
AC   CVCL_ZE71
SY   TTS-10; 10-TTS
DR   hPSCreg; UMGi145-A
DR   Wikidata; Q98134149
RX   PubMed=32302918;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32302918
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D18S51: 14,17
ST   D19S433: 14,15
ST   D21S11: 31,32.2
ST   D2S1338: 24,25
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C85181; Takotsubo cardiomyopathy
DI   ORDO; Orphanet_66529; Tako-Tsubo cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMGi146-A
AC   CVCL_ZE72
SY   TTS-11; 11-TTS
DR   hPSCreg; UMGi146-A
DR   Wikidata; Q98134151
RX   PubMed=32302918;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=32302918
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12,13
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 31,31.2
ST   D2S1338: 17,21
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C85181; Takotsubo cardiomyopathy
DI   ORDO; Orphanet_66529; Tako-Tsubo cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UMGi148-A
AC   CVCL_A4TF
DR   hPSCreg; UMGi148-A
DR   Wikidata; Q107117318
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=395
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi150-A
AC   CVCL_A4YZ
DR   hPSCreg; UMGi150-A
DR   Wikidata; Q107117319
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=380
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi153-A
AC   CVCL_A4YY
DR   hPSCreg; UMGi153-A
DR   Wikidata; Q107117320
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=397
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98894; Hypoplastic left heart syndrome
DI   ORDO; Orphanet_2248; Hypoplastic left heart syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UMGi154-A
AC   CVCL_A4TE
DR   hPSCreg; UMGi154-A
DR   Wikidata; Q107117321
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=398
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi155-A
AC   CVCL_A4TD
DR   hPSCreg; UMGi155-A
DR   Wikidata; Q107117322
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=408
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi156-A
AC   CVCL_A5GJ
DR   hPSCreg; UMGi156-A
DR   Wikidata; Q107117323
WW   Provider; UMCG; -; https://sfb1002.med.uni-goettingen.de/production/cellmodel/cell-line/view?tab=internal&line=474
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176016; Febrile seizures, familial, 3A
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UMGi157-A
AC   CVCL_A5QP
SY   AIC2.3; AIC-iPSC 2.3
DR   hPSCreg; UMGi157-A
DR   Wikidata; Q107117324
RX   PubMed=33631417;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178417; Arrhythmia-induced cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UMGi158-A
AC   CVCL_C0GM
DR   hPSCreg; UMGi158-A
DR   Wikidata; Q112930515
RX   PubMed=35092938;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   UMGi158-A-1.1
AC   CVCL_C0GN
SY   Nav1.8_KO_K62.1; K62.1
DR   hPSCreg; UMGi158-A-1
DR   Wikidata; Q112930517
RX   PubMed=35092938;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10582; SCN10A.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0GM ! UMGi158-A
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UMGi158-A-1.2
AC   CVCL_C0GP
SY   Nav1.8_KO_K62.4; K62.4
DR   hPSCreg; UMGi158-A-1
DR   Wikidata; Q112930518
RX   PubMed=35092938;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10582; SCN10A.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0GM ! UMGi158-A
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UMGi158-B
AC   CVCL_E4JF
SY   CasQ2-CTRL; CASQ2-Ctrl1.1-K50
DR   hPSCreg; UMGi158-B
RX   PubMed=39378715;
CC   From: University Medical Center Goettingen; Goettingen; Germany.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1513; CASQ2; Simple_edited; p.Phe189Leu (c.567C>G); ClinVar=VCV000162814; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39378715).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148368; Catecholaminergic polymorphic ventricular tachycardia type 2
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0GM ! UMGi158-A
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UMGi255-A
AC   CVCL_D6MD
SY   resDCM-634L-clone5
DR   BioSamples; SAMEA114347212
DR   hPSCreg; UMGi255-A
DR   Wikidata; Q127384594
RX   PubMed=38141360;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:27424; RBM20; Simple_corrected; p.Arg634Trp (c.1900C>T); ClinVar=VCV000411653; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:27424; RBM20; Simple_edited; p.Arg634Leu (c.1901G>T); ClinVar=VCV000689585; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38141360).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174435; Dilated cardiomyopathy-1DD
DI   NCIt; C99544; Left ventricular non-compaction syndrome
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
DI   ORDO; Orphanet_54260; Left ventricular noncompaction
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9YR ! UMGi144-A-1
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UMGWi001-B
AC   CVCL_A1XF
SY   Z1-K3v3; Z1 K3v3
DR   BioSamples; SAMEA7222557
DR   hPSCreg; UMGWi001-B
DR   Wikidata; Q105511626
RX   PubMed=33099107;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:16974; SRCAP; Simple; p.Arg2444Ter (c.7330C>T); ClinVar=VCV000030908; Zygosity=Heterozygous (PubMed=33099107).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
CC   Cell type: Fibroblast of gingiva; CL=CL_0002552.
DI   NCIt; C175241; Floating-Harbor syndrome
DI   ORDO; Orphanet_2044; Floating-Harbor syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   UMGWi004-A
AC   CVCL_D6RN
SY   BNH1_iPSC_WT_8
DR   BioSamples; SAMEA115116691
DR   hPSCreg; UMGWi004-A
RX   PubMed=38555715;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6RP ! UMGWi004-B
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   UMGWi004-B
AC   CVCL_D6RP
SY   BNH1_iPSC_WT_48
DR   BioSamples; SAMEA115119309
DR   hPSCreg; UMGWi004-B
RX   PubMed=38555715;
CC   From: Department of Functional Genomics - Human Molecular Genetics, University Medicine Greifswald; Greifswald; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6RN ! UMGWi004-A
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   UMi027-A
AC   CVCL_YT52
DR   hPSCreg; UMi027-A
DR   Wikidata; Q98134153
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   UMi028-A
AC   CVCL_A1MH
SY   ASE9203
DR   hPSCreg; UMi028-A
DR   Wikidata; Q102115077
RX   PubMed=33038743;
RX   PubMed=37677864;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33038743
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 18,19
ST   D21S11: 30.2,32.2
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 10,14
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 30-01-24; Version: 6
//
ID   UMi028-A-1
AC   CVCL_A1MI
SY   C1661_C5; C1661 clone C5
DR   hPSCreg; UMi028-A-1
DR   Wikidata; Q102115078
RX   PubMed=33038743;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15459; P2RX2; Simple_edited; p.Val60Leu (c.178G>T); ClinVar=VCV000155762; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=33038743).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=33038743
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 18,19
ST   D21S11: 30.2,32.2
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 12,15
ST   FGA: 23
ST   Penta D: 12,13
ST   Penta E: 10,14
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C175700; Deafness, autosomal dominant 41
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1MH ! UMi028-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UMi028-A-2
AC   CVCL_A5QS
SY   TTC3 clone 50
DR   hPSCreg; UMi028-A-2
DR   Wikidata; Q107117326
RX   PubMed=33626494;
RX   PubMed=37677864;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12393; TTC3; Simple_edited; p.Ser1038Cys (c.3113C>G); dbSNP=rs377155188; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33626494).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1MH ! UMi028-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   UMi029-A
AC   CVCL_A1XG
SY   UMNSDF215-001 clone 1
DR   hPSCreg; UMi029-A
DR   Wikidata; Q105511629
RX   PubMed=34052664;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11122; SMPX; Simple; p.Gly45Valfs*36 (c.133-1G>A); ClinVar=VCV000417903; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=34052664).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34052664
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 12,18
ST   D21S11: 29,31
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 7,11
ST   D8S1179: 10,13
ST   FGA: 19,24
ST   Penta D: 11,12
ST   Penta E: 5,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15
DI   NCIt; C180844; X-linked deafness-4
DI   ORDO; Orphanet_90625; X-linked non-syndromic sensorineural deafness type DFN
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   UMi030-A
AC   CVCL_A5GK
SY   UMNSDF253-100
DR   hPSCreg; UMi030-A
DR   Wikidata; Q107117327
RX   PubMed=34883447;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4284; GJB2; Simple; p.Val37Ile (c.109G>A); ClinVar=VCV000017023; Zygosity=Homozygous (PubMed=34883447).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129022; Deafness, autosomal recessive 1A
DI   ORDO; Orphanet_90636; Autosomal recessive non-syndromic sensorineural deafness type DFNB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   UMi031-A-2
AC   CVCL_A0ZU
SY   PGP-1 clone L5; HVRDi004-B-2
DR   hPSCreg; UMi031-A-2
DR   Wikidata; Q108821454
RX   PubMed=34352618;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple_edited; p.Leu64Pro (c.191T>C); ClinVar=VCV001006297; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=34352618).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3274; Neurofibromatosis type 2
DI   ORDO; Orphanet_637; Neurofibromatosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F182 ! GM23338
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UMi032-A
AC   CVCL_B0IX
DR   hPSCreg; UMi032-A
DR   Wikidata; Q108821455
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UMi033-A
AC   CVCL_B0IY
DR   hPSCreg; UMi033-A
DR   Wikidata; Q112041893
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   UMi034-A
AC   CVCL_B5F0
DR   hPSCreg; UMi034-A
DR   Wikidata; Q110433936
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UMi035-A
AC   CVCL_B5F1
DR   BioSamples; SAMEA112444977
DR   hPSCreg; UMi035-A
DR   Wikidata; Q110433938
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Leu483Pro (c.1448T>C) (L444P); ClinVar=VCV000004288; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0R34 ! GM07968
SX   Male
AG   19FW
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   UMi036-A
AC   CVCL_C0Z1
DR   BioSamples; SAMEA112445420
DR   hPSCreg; UMi036-A
DR   Wikidata; Q114313195
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61268; Gaucher disease
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_355; Gaucher disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EY99 ! ND34263
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   UMi037-A
AC   CVCL_C0Z2
DR   hPSCreg; UMi037-A
DR   Wikidata; Q114313197
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   UMi038-A
AC   CVCL_C0YV
SY   AD380187
DR   BioSamples; SAMEA14096004
DR   hPSCreg; UMi038-A
DR   Wikidata; Q114313198
RX   PubMed=35671596;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple; p.Cys1431Trpfs*2 (c.4293delC); Zygosity=Heterozygous (PubMed=35671596).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0YX ! UMi038-B
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMi038-A-1
AC   CVCL_C0YZ
DR   BioSamples; SAMEA14341487
DR   hPSCreg; UMi038-A-1
DR   Wikidata; Q114313199
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_corrected; p.Cys1431Trpfs*2 (c.4293delC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UMi038-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0YV ! UMi038-A
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMi038-B
AC   CVCL_C0YX
DR   BioSamples; SAMEA14096096
DR   hPSCreg; UMi038-B
DR   Wikidata; Q114313200
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple; p.Cys1431Trpfs*2 (c.4293delC); Zygosity=Heterozygous (from autologous cell line UMi038-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0YV ! UMi038-A
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMi039-A
AC   CVCL_C0YW
SY   AD380261
DR   BioSamples; SAMEA14096007
DR   hPSCreg; UMi039-A
DR   Wikidata; Q114313201
RX   PubMed=35671596;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple; p.Cys1431Trpfs*2 (c.4293delC); Zygosity=Heterozygous (PubMed=35671596).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0YY ! UMi039-B
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMi039-A-1
AC   CVCL_C0Z0
DR   BioSamples; SAMEA110371900
DR   hPSCreg; UMi039-A-1
DR   Wikidata; Q114313202
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple_corrected; p.Cys1431Trpfs*2 (c.4293delC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=UMi039-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0YW ! UMi039-A
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMi039-B
AC   CVCL_C0YY
DR   hPSCreg; UMi039-B
DR   Wikidata; Q114313203
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11185; SORL1; Simple; p.Cys1431Trpfs*2 (c.4293delC); Zygosity=Heterozygous (from autologous cell line UMi039-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C0YW ! UMi039-A
SX   Female
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UMi040-A
AC   CVCL_B7CI
SY   SB162-284 cl.1
DR   BioSamples; SAMEA13260017
DR   hPSCreg; UMi040-A
DR   Wikidata; Q112930519
RX   PubMed=35364395;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:28472; TMEM43; Simple; p.Arg372Ter (c.1114C>T); ClinVar=VCV000403555; Zygosity=Heterozygous (PubMed=35364395).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C116364; Auditory neuropathy spectrum disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UMi041-A
AC   CVCL_D0NV
SY   410730
DR   BioSamples; SAMEA112348301
DR   hPSCreg; UMi041-A
DR   Wikidata; Q123033743
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UMi042-A
AC   CVCL_D0NT
DR   BioSamples; SAMEA112484913
DR   hPSCreg; UMi042-A
DR   Wikidata; Q123033744
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (hPSCreg=UMi042-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UMi042-A-1
AC   CVCL_D0NU
SY   408737 CB9
DR   BioSamples; SAMEA112485561
DR   hPSCreg; UMi042-A-1
DR   Wikidata; Q123033745
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple_corrected; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=By CRISPR/Cas9. The ApoE4 allele was edited back to an ApoE3 allele (hPSCreg=UMi042-A-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0NT ! UMi042-A
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   UMi043-A
AC   CVCL_D0NW
SY   AD 381852 clone #1
DR   hPSCreg; UMi043-A
DR   Wikidata; Q123033746
RX   PubMed=38422817;
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:37; ABCA7; Simple; p.Arg578Alafs (c.1732_1775del); ClinVar=VCV000785599; Zygosity=Heterozygous (PubMed=38422817).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C206083; Alzheimer disease 9, late-onset
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   90Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UMi044-A
AC   CVCL_D0NX
SY   JG1113.4
DR   BioSamples; SAMEA115158260
DR   hPSCreg; UMi044-A
DR   Wikidata; Q123033747
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   UMi045-A
AC   CVCL_D0NY
SY   MI1159.1
DR   hPSCreg; UMi045-A
DR   Wikidata; Q123033748
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   UMi046-A
AC   CVCL_D0NZ
SY   SAF1407.3
DR   BioSamples; SAMEA115462195
DR   hPSCreg; UMi046-A
DR   Wikidata; Q123033749
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   UMi047-A
AC   CVCL_D6NQ
SY   sord1 DM
DR   BioSamples; SAMEA115145676
DR   hPSCreg; UMi047-A
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian; German/Swedish.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206095; Autosomal recessive distal hereditary motor neuronopathy 8
DI   ORDO; Orphanet_140468; Autosomal recessive distal hereditary motor neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   UMi048-A
AC   CVCL_D6NR
SY   sord1 GB
DR   BioSamples; SAMEA115158158
DR   hPSCreg; UMi048-A
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Jewish; Ashkenazi.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206095; Autosomal recessive distal hereditary motor neuronopathy 8
DI   ORDO; Orphanet_140468; Autosomal recessive distal hereditary motor neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   UMi049-A
AC   CVCL_D6NS
SY   IIsord1 RV
DR   BioSamples; SAMEA115158159
DR   hPSCreg; UMi049-A
CC   From: Miller School of Medicine, University of Miami; Miami; USA.
CC   Population: Caucasian; Irish/Italian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206095; Autosomal recessive distal hereditary motor neuronopathy 8
DI   ORDO; Orphanet_140468; Autosomal recessive distal hereditary motor neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   UMILi001-A
AC   CVCL_YC65
SY   KAB07
DR   BioSamples; SAMEA6049736
DR   hPSCreg; UMILi001-A
DR   Wikidata; Q98134155
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg2635Ter (c.7903C>T); ClinVar=VCV000196692; Zygosity=Unspecified (hPSCreg=UMILi001-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UMILi002-A
AC   CVCL_YC66
SY   KAB01
DR   BioSamples; SAMEA6049740
DR   hPSCreg; UMILi002-A
DR   Wikidata; Q98134156
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Cys197Alafs*11 (c.588del); Zygosity=Unspecified (hPSCreg=UMILi002-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UMILi003-A
AC   CVCL_YC67
SY   KAB03
DR   BioSamples; SAMEA6049744
DR   hPSCreg; UMILi003-A
DR   Wikidata; Q98134159
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Pro235Glnfs*26 (c.702delG); ClinVar=VCV000547399; Zygosity=Unspecified (hPSCreg=UMILi003-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UMILi004-A
AC   CVCL_YC68
SY   KAB04
DR   BioSamples; SAMEA6049748
DR   hPSCreg; UMILi004-A
DR   Wikidata; Q98134160
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg2635Ter (c.7903C>T); ClinVar=VCV000196692; Zygosity=Unspecified (hPSCreg=UMILi004-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UMILi005-A
AC   CVCL_YC69
SY   KAB05
DR   BioSamples; SAMEA6032590
DR   hPSCreg; UMILi005-A
DR   Wikidata; Q98134162
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Arg3321Ter (c.9961C>T); ClinVar=VCV000183371; Zygosity=Unspecified (hPSCreg=UMILi005-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C124837; Kabuki syndrome
DI   ORDO; Orphanet_2322; Kabuki syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UMILi006-A
AC   CVCL_YC70
SY   CTL05
DR   BioSamples; SAMEA6049751
DR   hPSCreg; UMILi006-A
DR   Wikidata; Q98134164
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   UMILi007-A
AC   CVCL_YC71
SY   CTL06
DR   BioSamples; SAMEA6049754
DR   hPSCreg; UMILi007-A
DR   Wikidata; Q98134167
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   UMILi008-A
AC   CVCL_YC72
SY   CTL07
DR   BioSamples; SAMEA6047966
DR   hPSCreg; UMILi008-A
DR   Wikidata; Q98134169
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   UMILi009-A
AC   CVCL_A8PF
SY   GAD02
DR   BioSamples; SAMEA6049774
DR   hPSCreg; UMILi009-A
DR   Wikidata; Q108821457
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:12856; YY1; Simple; p.Asp129Ilefs*127 (c.385delG); ClinVar=VCV000817604; Zygosity=Unspecified (hPSCreg=UMILi009-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C165531; Gabriele-de Vries syndrome
DI   ORDO; Orphanet_506358; Gabriele-de Vries syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   UMILi010-A
AC   CVCL_YC73
SY   GAD01
DR   BioSamples; SAMEA6049762
DR   hPSCreg; UMILi010-A
DR   Wikidata; Q98134171
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:12856; YY1; Simple; p.Lys179Ter (c.535A>T); ClinVar=VCV000430621; Zygosity=Unspecified (hPSCreg=UMILi010-A).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165531; Gabriele-de Vries syndrome
DI   ORDO; Orphanet_506358; Gabriele-de Vries syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UMILi011-A
AC   CVCL_YC74
SY   CTL10
DR   BioSamples; SAMEA6049756
DR   hPSCreg; UMILi011-A
DR   Wikidata; Q98134173
CC   From: University of Milan; Milan; Italy.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 4
//
ID   UMILi012-A
AC   CVCL_YC75
SY   WVS02
DR   BioSamples; SAMEA6049768
DR   hPSCreg; UMILi012-A
DR   Wikidata; Q98134176
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Val626Met (c.1876G>A) (V621M); ClinVar=VCV000158579; Zygosity=Heterozygous (hPSCreg=UMILi012-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125599; Weaver syndrome
DI   ORDO; Orphanet_3447; Weaver syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   UMILi013-A
AC   CVCL_YC76
SY   WVS01
DR   BioSamples; SAMEA6049770
DR   hPSCreg; UMILi013-A
DR   Wikidata; Q98134178
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Pro132Ser (c.394C>T); ClinVar=VCV000030200; Zygosity=Heterozygous (hPSCreg=UMILi013-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125599; Weaver syndrome
DI   ORDO; Orphanet_3447; Weaver syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UMILi014-A
AC   CVCL_YC77
SY   WVS04
DR   BioSamples; SAMEA6049766
DR   hPSCreg; UMILi014-A
DR   Wikidata; Q98134180
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:3188; EED; Simple; p.His258Tyr (c.772C>T); ClinVar=VCV000430644; Zygosity=Heterozygous (hPSCreg=UMILi014-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125599; Weaver syndrome
DI   ORDO; Orphanet_3447; Weaver syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UMILi015-A
AC   CVCL_YC78
SY   WVS03
DR   BioSamples; SAMEA6049772
DR   hPSCreg; UMILi015-A
DR   Wikidata; Q98134182
CC   From: University of Milan; Milan; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Ala738Thr (c.2212G>A) (A733T); ClinVar=VCV001307224; Zygosity=Heterozygous (hPSCreg=UMILi015-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125599; Weaver syndrome
DI   ORDO; Orphanet_3447; Weaver syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   UMILi016-A
AC   CVCL_YC79
SY   DUP01
DR   BioSamples; SAMEA6049758
DR   hPSCreg; UMILi016-A
DR   Wikidata; Q98134184
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi017-A
AC   CVCL_YC80
SY   DUP02
DR   BioSamples; SAMEA6049746
DR   hPSCreg; UMILi017-A
DR   Wikidata; Q98134186
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi018-A
AC   CVCL_YC81
SY   DUP03
DR   BioSamples; SAMEA6049750
DR   hPSCreg; UMILi018-A
DR   Wikidata; Q98134188
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi019-A
AC   CVCL_YC82
SY   DUP04
DR   BioSamples; SAMEA6049760
DR   hPSCreg; UMILi019-A
DR   Wikidata; Q98134190
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi020-A
AC   CVCL_YC83
SY   WBS04
DR   BioSamples; SAMEA6049732
DR   hPSCreg; UMILi020-A
DR   Wikidata; Q98134192
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi021-A
AC   CVCL_YC84
SY   WBS03
DR   BioSamples; SAMEA6049734
DR   hPSCreg; UMILi021-A
DR   Wikidata; Q98134194
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi022-A
AC   CVCL_YC85
SY   WBS01
DR   BioSamples; SAMEA6049738
DR   hPSCreg; UMILi022-A
DR   Wikidata; Q98134195
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi023-A
AC   CVCL_YC86
SY   WBS02
DR   BioSamples; SAMEA6049742
DR   hPSCreg; UMILi023-A
DR   Wikidata; Q98134197
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   UMILi024-A
AC   CVCL_YC87
SY   CTL04
DR   BioSamples; SAMEA6045950
DR   hPSCreg; UMILi024-A
DR   Wikidata; Q98134200
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   UMILi025-A
AC   CVCL_YC88
SY   CTL09
DR   BioSamples; SAMEA6049764
DR   hPSCreg; UMILi025-A
DR   Wikidata; Q98134202
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   UMILi026-A
AC   CVCL_YC89
SY   CTL01
DR   BioSamples; SAMEA6049730
DR   hPSCreg; UMILi026-A
DR   Wikidata; Q98134204
CC   From: University of Milan; Milan; Italy.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   UMILi027-A
AC   CVCL_C0ID
DR   BioSamples; SAMEA13565884
DR   hPSCreg; UMILi027-A
DR   Wikidata; Q112930520
RX   PubMed=35421844;
CC   From: University of Milan; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Simple; p.Ala260(5_9) (c.765_779dup); ClinVar=VCV000006008; Zygosity=Heterozygous (PubMed=35421844).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   UMILi028-A
AC   CVCL_C0IE
DR   BioSamples; SAMEA13565938
DR   hPSCreg; UMILi028-A
DR   Wikidata; Q112930521
RX   PubMed=35421844;
CC   From: University of Milan; Milan; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9143; PHOX2B; Simple; p.Ala260(5_9) (c.765_779dup); ClinVar=VCV000006008; Zygosity=Heterozygous (PubMed=35421844).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98889; Congenital central hypoventilation
DI   ORDO; Orphanet_661; Ondine syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   UMJF-2
AC   CVCL_M548
DR   Wikidata; Q54991076
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=1649357;
RX   PubMed=10936422;
CC   Problematic cell line: Misclassified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=10936422).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   UMK-1 [Human bladder carcinoma]
AC   CVCL_WL40
DR   Wikidata; Q98134206
RX   PubMed=7610502;
RX   PubMed=8348978;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=7610502).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   UMK-1 [Human gastric carcinoma]
AC   CVCL_WL42
DR   Wikidata; Q98134208
RX   CelloPub=CLPUB00504;
CC   Population: Japanese.
CC   Doubling time: 28 hours (CelloPub=CLPUB00504).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMK-2
AC   CVCL_WL41
DR   Wikidata; Q98134210
RX   PubMed=10027404;
CC   Population: Japanese.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   UML-49
AC   CVCL_D646
DR   BTO; BTO_0005284
DR   Wikidata; Q54991078
RX   PubMed=20413351;
CC   Miscellaneous: Only mentioned as a lymphoblastoid cell line in PubMed=20413351.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   UMMT-ARK-1
AC   CVCL_IW26
DR   Wikidata; Q54991080
RX   PubMed=22498937;
CC   Population: African American.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   UMMT-ARK-2
AC   CVCL_IW27
DR   Wikidata; Q54991082
RX   PubMed=22498937;
CC   Population: Caucasian.
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   UMN-MDH-1
AC   CVCL_AV47
DR   ICLDB; umn-mdh-1
DR   Wikidata; Q54991084
RX   DOI=10.1111/j.1550-7408.1983.tb05338.x;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=40071; ! Malacosoma disstria (Forest tent caterpillar)
SX   Sex unspecified
AG   Fifth instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   UMN-PIE-1181
AC   CVCL_Z394
DR   ICLDB; umn-pie-1181
DR   Wikidata; Q54991086
RX   DOI=10.1016/0022-2011(85)90147-8;
RX   PubMed=1561320;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=58824; ! Plodia interpunctella (Indianmeal moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   UMNi001-A
AC   CVCL_A4EW
SY   iPSC LUCAS1; lenti-8.4.1; PCBC16hsi2011111501; SC12-023
DR   BioSamples; SAMEA7996631
DR   hPSCreg; UMNi001-A
DR   Wikidata; Q105511631
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Minnesota; Minneapolis; USA.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0H60 ! UMNi001-B
OI   CVCL_B5R9 ! UMNi001-C
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   UMNi001-B
AC   CVCL_0H60
SY   PCBC16iPS; UMN PCBC16iPS; Sendai-9-1; PCBC16hsi2011111503; SC12-025
DR   SKIP; SKIP000584
DR   Wikidata; Q54938609
RX   PubMed=23326500;
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4EW ! UMNi001-A
OI   CVCL_B5R9 ! UMNi001-C
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 7
//
ID   UMNi001-C
AC   CVCL_B5R9
SY   retro-20.1; PCBC16hsi2011111502; SC12-024
DR   Wikidata; Q112041894
RX   PubMed=27293150;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4EW ! UMNi001-A
OI   CVCL_0H60 ! UMNi001-B
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 5
//
ID   UMNSAH/DF-1
AC   CVCL_0570
SY   UMNSAH-DF-1; UMNSAH-DF 1; UMNSAH-DF1; UMNSAH/DF1; UMNSAH/DF#1; DF-1; DF1; Douglas Foster-1
DR   BTO; BTO_0005956
DR   CLO; CLO_0009484
DR   MCCL; MCC:0000475
DR   ATCC; CRL-3586
DR   ATCC; CRL-12203
DR   BCRJ; 0307
DR   CCLV; CCLV-RIE 1029
DR   CCRID; 1101BIR-PUMC000417
DR   CLS; 305016
DR   GEO; GSE29257
DR   IZSLER; BS CL 197
DR   KCB; KCB 2012111YJ
DR   Wikidata; Q54991087
RX   CelloPub=CLPUB00401;
RX   Patent=US6207415;
RX   Patent=US20200179507;
RX   PubMed=9721238;
RX   PubMed=9721239;
RX   PubMed=11420679;
RX   PubMed=11513975;
RX   PubMed=16313905;
RX   PubMed=18638503;
RX   PubMed=19941903;
RX   PubMed=22111699;
RX   PubMed=32005267;
RX   PubMed=33743496;
RX   PubMed=34737324;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/cef/cefcells.html
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-546.html
WW   Provider; UMN; 95149; https://web.archive.org/web/20141118003019/http://license.umn.edu/technologies/95149_retrovirus-free-cell-line-for-vaccine-development
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-12203.
CC   Virology: Low susceptibility to infection by aquatic bird bornavirus 1 (ABBV-1) strain UoG-CG (PubMed=32005267).
CC   Doubling time: 13.22 hours (Note=In DMEM/F-12 medium), 33.64 hours (Note=In MEM medium), 15.30 hours (Note=In RPMI 1640 medium), 21.39 hours (Note=In DMEM medium) (CelloPub=CLPUB00401).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ATCC; CRL-12203; true.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   UMR-104
AC   CVCL_S478
SY   UMR 104
DR   Wikidata; Q54991089
RX   PubMed=6575864;
CC   Characteristics: Established from a transplantable tumor.
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S479 ! UMR-105
OI   CVCL_3617 ! UMR-106
OI   CVCL_3618 ! UMR-108
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   UMR-105
AC   CVCL_S479
SY   UMR 105
DR   Wikidata; Q54991128
RX   PubMed=6575864;
CC   Characteristics: Established from a transplantable tumor.
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S478 ! UMR-104
OI   CVCL_3617 ! UMR-106
OI   CVCL_3618 ! UMR-108
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   UMR-106
AC   CVCL_3617
SY   UMR 106; UMR106
DR   BTO; BTO_0002576
DR   CLO; CLO_0009485
DR   EFO; EFO_0022806
DR   CLDB; cl4610
DR   ATCC; CRL-1661
DR   BCRC; 60270
DR   BCRJ; 0243
DR   CCRID; 3101RATTCR11
DR   CLS; 305197
DR   ECACC; 90111314
DR   IZSLER; BS TCL 106
DR   NCBI_Iran; C586
DR   Ubigene; YC-A015
DR   Wikidata; Q54991129
RX   PubMed=6575864;
RX   PubMed=7988420;
CC   Characteristics: Established from a transplantable tumor.
CC   Characteristics: Responsive to PTH, prostaglandins and bone-resorbing steroids.
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S478 ! UMR-104
OI   CVCL_S479 ! UMR-105
OI   CVCL_3618 ! UMR-108
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   UMR-106-01
AC   CVCL_D580
SY   UMR 106-01; UMR106-01; UMR 106-1
DR   BTO; BTO_0005173
DR   Lonza; 1311
DR   Wikidata; Q54991130
RX   PubMed=2318894;
RX   PubMed=3922597;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-316.html
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3617 ! UMR-106
AG   Adult
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   UMR-106-06
AC   CVCL_S477
SY   UMR 106-06; UMR106-06
DR   ChEMBL-Cells; CHEMBL3307259
DR   ChEMBL-Targets; CHEMBL613502
DR   PubChem_Cell_line; CVCL_S477
DR   Wikidata; Q54991132
RX   PubMed=1659122;
RX   PubMed=3922597;
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3617 ! UMR-106
AG   Adult
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 14
//
ID   UMR-108
AC   CVCL_3618
SY   UMR 108; UMR108
DR   BTO; BTO_0002577
DR   CLO; CLO_0009486
DR   CLDB; cl4611
DR   ATCC; CRL-1663
DR   ChEMBL-Cells; CHEMBL4483173
DR   ChEMBL-Targets; CHEMBL4483273
DR   ECACC; 91060527
DR   IZSLER; BS TCL 107
DR   PubChem_Cell_line; CVCL_3618
DR   Wikidata; Q54991133
RX   PubMed=6575864;
RX   PubMed=10457266;
CC   Characteristics: Established from a transplantable tumor.
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_S478 ! UMR-104
OI   CVCL_S479 ! UMR-105
OI   CVCL_3617 ! UMR-106
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UMR-201
AC   CVCL_F683
SY   UMR 201; UMR201
DR   Wikidata; Q54991134
RX   PubMed=1659122;
RX   PubMed=3213604;
CC   Doubling time: ~24 hours (PubMed=3213604).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   1D
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   UMR-201-10A
AC   CVCL_IR40
SY   10A
DR   Wikidata; Q54991135
RX   PubMed=1659122;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F683 ! UMR-201
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   UMR-201-10B
AC   CVCL_IR41
SY   UMR 201-10B; 10B
DR   Wikidata; Q54991136
RX   PubMed=1659122;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_F683 ! UMR-201
SX   Sex unspecified
AG   1D
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   UMRCC1
AC   CVCL_WN20
SY   University of Malaya Renal Carcinoma Cell line 1
DR   Wikidata; Q98134212
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Doubling time: 6-7 days (Direct_author_submission).
CC   Miscellaneous: Doubling time from personal communication of Yap, Ning Yi.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   UMRCC10
AC   CVCL_WN29
SY   University of Malaya Renal Carcinoma Cell line 10
DR   Wikidata; Q98134214
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC2
AC   CVCL_WN21
SY   University of Malaya Renal Carcinoma Cell line 2
DR   Wikidata; Q98134216
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Doubling time: 2-3 days (Direct_author_submission).
CC   Miscellaneous: Doubling time from personal communication of Yap, Ning Yi.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   UMRCC3
AC   CVCL_WN22
SY   University of Malaya Renal Carcinoma Cell line 3
DR   Wikidata; Q98134218
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC4
AC   CVCL_WN23
SY   University of Malaya Renal Carcinoma Cell line 4
DR   Wikidata; Q98134220
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC5
AC   CVCL_WN24
SY   University of Malaya Renal Carcinoma Cell line 5
DR   Wikidata; Q98134223
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC6
AC   CVCL_WN25
SY   University of Malaya Renal Carcinoma Cell line 6
DR   Wikidata; Q98134225
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC7
AC   CVCL_WN26
SY   University of Malaya Renal Carcinoma Cell line 7
DR   Wikidata; Q98134227
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC8
AC   CVCL_WN27
SY   University of Malaya Renal Carcinoma Cell line 8
DR   Wikidata; Q98134229
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMRCC9
AC   CVCL_WN28
SY   University of Malaya Renal Carcinoma Cell line 9
DR   Wikidata; Q98134231
RX   PubMed=31062478;
CC   Population: Malaysian.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   UMT2
AC   CVCL_R739
SY   Uveal Melanoma Tubingen 2
DR   cancercelllines; CVCL_R739
DR   Cosmic; 1879475
DR   Wikidata; Q54991137
RX   PubMed=23456173;
RX   PubMed=27505446;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 3-4 days (PubMed=23456173).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=23456173).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   UMT26
AC   CVCL_R740
SY   Uveal Melanoma Tubingen 26
DR   cancercelllines; CVCL_R740
DR   Cosmic; 1879477
DR   Wikidata; Q54991138
RX   PubMed=23456173;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 3-4 months (PubMed=23456173).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=23456173).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   UMT33
AC   CVCL_R741
SY   Uveal Melanoma Tubingen 33
DR   cancercelllines; CVCL_R741
DR   Cosmic; 1879479
DR   Wikidata; Q54991139
RX   PubMed=23456173;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 33 days (PubMed=23456173).
CC   Karyotypic information: Monosomy of chromosome 3 (PubMed=23456173).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=23456173).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   UMT42
AC   CVCL_C7RM
SY   Uveal Melanoma Tubingen 42
DR   Wikidata; Q117704938
RX   PubMed=27505446;
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 29-06-23; Version: 2
//
ID   UN-KC-6141
AC   CVCL_1U11
DR   Wikidata; Q54991141
RX   PubMed=24278292;
CC   Doubling time: 70 hours (PubMed=24278292).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   UN-KPC-960
AC   CVCL_1U12
DR   Wikidata; Q54991143
RX   PubMed=24278292;
CC   Doubling time: 60 hours (PubMed=24278292).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+),LSL-Trp53(R175H/+).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   UN-KPC-961
AC   CVCL_1U13
DR   Wikidata; Q54991144
RX   PubMed=24278292;
CC   Doubling time: 33 hours (PubMed=24278292).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:96680; Kras (Note=With p.Gly12Asp).
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: B6.FVB-Tg(Pdx1-cre)6Tuv/J,LSL-Kras(G12D/+),LSL-Trp53(R175H/+).
DI   NCIt; C34041; Mouse pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 27-11-25; Version: 7
//
ID   UN1
AC   CVCL_A0IK
DR   Wikidata; Q108821458
RX   PubMed=7817381;
RX   PubMed=21372249;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P16150; Human SPN/CD43.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   UN7RGB
AC   CVCL_T332
DR   CLO; CLO_0050700
DR   BioSample; SAMN03472186
DR   RCB; GMC0010
DR   RCB; RCB0873
DR   Wikidata; Q54991146
CC   Population: Japanese.
CC   Senescence: Senesces at >60 PDL (RCB=GMC0010).
CC   Donor information: Was originally thought to be from a Werner syndrome patient but this is no longer thought to be the case.
CC   Discontinued: RCB; RCB0873; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=GMC0010
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 14,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 12
//
ID   UN8RGB
AC   CVCL_T333
DR   CLO; CLO_0050695
DR   BioSample; SAMN03472159
DR   RCB; GMC0011
DR   RCB; RCB1141
DR   Wikidata; Q54991147
CC   Population: Japanese.
CC   Senescence: Senesces at >50 PDL (RCB=GMC0011).
CC   Donor information: Was originally thought to be from a Werner syndrome patient but this is no longer thought to be the case.
CC   Discontinued: RCB; RCB1141; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=GMC0011
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 12
//
ID   UNAMi001-A
AC   CVCL_C5YM
SY   IFC-UNAM iPD01-S
DR   BioSamples; SAMEA111547618
DR   hPSCreg; UNAMi001-A
DR   Wikidata; Q116050737
RX   PubMed=36427474;
CC   From: Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico; Mexico city; Mexico.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
ID   UNAMi002-A
AC   CVCL_D6P6
SY   IFC-UNAM iPD02-S
DR   BioSamples; SAMEA114597867
DR   hPSCreg; UNAMi002-A
RX   PubMed=38359473;
CC   From: Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico; Mexico city; Mexico.
CC   Population: Mexican.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 2
//
ID   UNAMi003-A
AC   CVCL_D6P7
SY   IFC-UNAM iPD03-PINK1
DR   BioSamples; SAMEA114630726
DR   hPSCreg; UNAMi003-A
RX   PubMed=38359473;
CC   From: Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico; Mexico city; Mexico.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple; p.Ala443Alafs*39 (c.1423delC); Zygosity=Homozygous (PubMed=38359473).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   UNC 65.56.18.11
AC   CVCL_E9E6
WW   Info; NeuroMab; -; https://neuromab.ucdavis.edu/datasheet/UNC65561811.pdf
CC   Part of: UC Davis/NIH NeuroMab Facility hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q9UI46; Human DNAI1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   UNC-10
AC   CVCL_L890
SY   UNC10
DR   Cosmic; 1122676
DR   Wikidata; Q54991148
RX   PubMed=14732763;
RX   PubMed=17848307;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   UNC-7
AC   CVCL_L891
SY   UNC7
DR   Cosmic; 1122675
DR   Cosmic; 1530766
DR   Wikidata; Q54991149
RX   PubMed=14732763;
RX   PubMed=17848307;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 10
//
ID   UNC4
AC   CVCL_UD41
DR   Wikidata; Q98134234
RX   DOI=10.1007/0-306-46872-7_9;
RX   PubMed=8398066;
CC   Population: Caucasian.
CC   Doubling time: 25 hours (PubMed=8398066).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
DI   NCIt; C5976; Minor salivary gland carcinoma ex pleomorphic adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   UNCCF1T
AC   CVCL_ZC88
DR   Kerafast; ENC014
DR   Wikidata; Q98134236
RX   PubMed=18978040;
WW   Provider; UNC OTC; 23-0093; https://unc.flintbox.com/technologies/f6e42a74-2851-4bf7-9e18-ad63f53454de
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=18978040).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Discontinued: Kerafast; ENC014; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=18978040
ST   Amelogenin: X,Y
ST   CSF1PO: 11,14
ST   D13S317: 8,13
ST   D16S539: 10,12
ST   D5S818: 9,11
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,12
ST   vWA: 18
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   UNCCF2T
AC   CVCL_ZC89
DR   Kerafast; ENC015
DR   Wikidata; Q98134237
RX   PubMed=18978040;
WW   Provider; UNC OTC; 23-0093; https://unc.flintbox.com/technologies/f6e42a74-2851-4bf7-9e18-ad63f53454de
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=18978040).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Discontinued: Kerafast; ENC015; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=18978040
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 13,14
ST   D7S820: 9,10
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   UNCCF3T
AC   CVCL_ZC90
DR   ABM; T0738
DR   Kerafast; ENC016
DR   Wikidata; Q98134239
RX   PubMed=18978040;
WW   Provider; UNC OTC; 23-0093; https://unc.flintbox.com/technologies/f6e42a74-2851-4bf7-9e18-ad63f53454de
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=18978040).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Discontinued: Kerafast; ENC016; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=18978040
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 8,10
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   UNCi001-A
AC   CVCL_A1NF
SY   UNC001-A; 15CA
DR   hPSCreg; UNCi001-A
DR   Wikidata; Q102115079
RX   PubMed=33038744;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Erythroblast; CL=CL_0000765.
ST   Source(s): PubMed=33038744
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 19,23
ST   D21S11: 30,32.2
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11,13
ST   D8S1179: 11,13
ST   FGA: 25,26
ST   Penta D: 9,12
ST   Penta E: 13,19
ST   TH01: 7
ST   TPOX: 9,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 7
//
ID   UNCi002-A
AC   CVCL_A5GI
SY   HPC26; UNCCi002-A
DR   hPSCreg; UNCi002-A
DR   Wikidata; Q107117328
RX   PubMed=34130156;
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UNCi003-A
AC   CVCL_B5F2
SY   Tess #1; Tess_001_02_FC
DR   hPSCreg; UNCi003-A
DR   Wikidata; Q110433939
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCi004-A
AC   CVCL_B5F3
SY   Tess #2; Tess_001_01_FA
DR   hPSCreg; UNCi004-A
DR   Wikidata; Q110433940
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCi005-A
AC   CVCL_B5F4
SY   Tess #3; Tess_001_04_MA
DR   hPSCreg; UNCi005-A
DR   Wikidata; Q110433941
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCi006-A
AC   CVCL_B5F5
SY   Tess #4; Tess_007_03_MC
DR   hPSCreg; UNCi006-A
DR   Wikidata; Q110433942
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCi007-A
AC   CVCL_B5F6
SY   Tess #5; Tess_007_01_FA
DR   hPSCreg; UNCi007-A
DR   Wikidata; Q110433943
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCi008-A
AC   CVCL_B5F7
SY   Tess #6; Tess_006_02_FX
DR   hPSCreg; UNCi008-A
DR   Wikidata; Q110433945
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCi009-A
AC   CVCL_B5F8
SY   Tess #7; Tess_006_01_FA
DR   hPSCreg; UNCi009-A
DR   Wikidata; Q110433947
CC   From: University of North Carolina at Chapel Hill; Chapel Hill; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   UNCN1T
AC   CVCL_ZC91
DR   Kerafast; ENC011
DR   Wikidata; Q98134241
RX   PubMed=18978040;
WW   Provider; UNC OTC; 23-0109; https://unc.flintbox.com/technologies/f6e42a74-2851-4bf7-9e18-ad63f53454de
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Discontinued: Kerafast; ENC011; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=18978040
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 11
ST   D16S539: 10,11
ST   D5S818: 12
ST   D7S820: 8,10
ST   TH01: 8,9
ST   TPOX: 8,10
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   UNCN2T
AC   CVCL_ZC92
DR   Kerafast; ENC012
DR   Wikidata; Q98134243
RX   PubMed=18978040;
WW   Provider; UNC OTC; 23-0109; https://unc.flintbox.com/technologies/f6e42a74-2851-4bf7-9e18-ad63f53454de
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Discontinued: Kerafast; ENC012; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=18978040
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   UNCN3T
AC   CVCL_ZC93
DR   Kerafast; ENC013
DR   Wikidata; Q98134247
RX   PubMed=18978040;
WW   Provider; UNC OTC; 23-0109; https://unc.flintbox.com/technologies/f6e42a74-2851-4bf7-9e18-ad63f53454de
CC   Population: Caucasian.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=MGI; MGI:88174; Bmi1.
CC   Discontinued: Kerafast; ENC013; true.
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
ST   Source(s): PubMed=18978040
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9.3,10
ST   TPOX: 8,9
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   UNESP-CM1
AC   CVCL_A6ER
DR   Wikidata; Q107117329
RX   PubMed=33195606;
CC   Doubling time: 6.31 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A6EY ! UNESP-MM1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-CM11
AC   CVCL_A6EV
DR   Wikidata; Q107117330
RX   PubMed=33195606;
CC   Doubling time: 7.45 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-CM4
AC   CVCL_A6ES
DR   Wikidata; Q107117332
RX   PubMed=33195606;
CC   Doubling time: 5.1 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-CM5
AC   CVCL_A6ET
DR   Wikidata; Q107117333
RX   PubMed=33195606;
CC   Doubling time: 7.5 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-CM60
AC   CVCL_A6EW
DR   Wikidata; Q107117334
RX   PubMed=33195606;
CC   Doubling time: 11.79 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A6FA ! UNESP-MM4
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-CM61
AC   CVCL_A6EX
DR   Wikidata; Q107117335
RX   PubMed=33195606;
CC   Doubling time: 13.06 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A6EZ ! UNESP-MM3
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-CM9
AC   CVCL_A6EU
DR   Wikidata; Q107117336
RX   PubMed=33195606;
CC   Doubling time: 8.95 hours (PubMed=33195606).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Mixed breed; VBO=VBO_0200902.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-MM1
AC   CVCL_A6EY
DR   Wikidata; Q107117337
RX   PubMed=33195606;
CC   Doubling time: 25.41 hours (PubMed=33195606).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
CC   Breed/subspecies: Poodle; VBO=VBO_0201048.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A6ER ! UNESP-CM1
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-MM3
AC   CVCL_A6EZ
DR   Wikidata; Q107117338
RX   PubMed=33195606;
CC   Doubling time: 34.17 hours (PubMed=33195606).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A6EX ! UNESP-CM61
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNESP-MM4
AC   CVCL_A6FA
DR   Wikidata; Q107117339
RX   PubMed=33195606;
CC   Doubling time: 10.28 hours (PubMed=33195606).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Breed/subspecies: Dachshund; VBO=VBO_0200406.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
OI   CVCL_A6EW ! UNESP-CM60
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   UNEWe001-A
AC   CVCL_A002
SY   NCL1; NCL-1; NCL01; hES-NCL-1; HES-NCL-1; hES-NCL1
DR   hPSCreg; UNEWe001-A
DR   SKIP; SKIP002542
DR   Wikidata; Q54908221
RX   PubMed=17572666;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/ncl-1.aspx
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-05-013, Steering comm. appl. SCSC04-01.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UNEWe002-A
AC   CVCL_A003
SY   NCL2; NCL-2; NCL02; hES-NCL-2; hES-NCL2
DR   hPSCreg; UNEWe002-A
DR   SKIP; SKIP002543
DR   Wikidata; Q54908227
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/ncl-2.aspx
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-014, Steering comm. appl. SCSC06-46(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UNEWe003-A
AC   CVCL_A004
SY   NCL3; NCL-3; NCL03; hES-NCL-3; hES-NCL3
DR   BioSamples; SAMEA104628035
DR   hPSCreg; UNEWe003-A
DR   SKIP; SKIP002544
DR   Wikidata; Q54908228
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/ncl-3.aspx
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-015, Steering comm. appl. SCSC06-46(2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   UNEWe004-A
AC   CVCL_A005
SY   NCL4; NCL-4; NCL04; hES-NCL-4; hES-NCL4
DR   hPSCreg; UNEWe004-A
DR   SKIP; SKIP002545
DR   Wikidata; Q54908229
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/ncl-4.aspx
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-016, Steering comm. appl. SCSC06-46(3).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UNEWe005-A
AC   CVCL_A006
SY   NCL5; NCL-5; NCL05; hES-NCL-5; hES-NCL5
DR   hPSCreg; UNEWe005-A
DR   SKIP; SKIP002546
DR   Wikidata; Q54908230
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines/laboratory_grade/ncl-5.aspx
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-017, Steering comm. appl. SCSC06-46(4).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   UNEWe006-A
AC   CVCL_A007
SY   NCL6; NCL-6; hES-NCL-6; hES-NCL6
DR   hPSCreg; UNEWe006-A
DR   SKIP; SKIP002547
DR   Wikidata; Q54908234
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-018, Steering comm. appl. SCSC06-46(5).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   UNEWe007-A
AC   CVCL_A008
SY   NCL7; NCL-7; hES-NCL-7; hES-NCL7
DR   hPSCreg; UNEWe007-A
DR   SKIP; SKIP002548
DR   Wikidata; Q54908235
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-019, Steering comm. appl. SCSC06-47(1).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   UNEWe008-A
AC   CVCL_A009
SY   NCL8; NCL-8; hES-NCL-8; hES-NCL8
DR   hPSCreg; UNEWe008-A
DR   SKIP; SKIP002549
DR   Wikidata; Q54908236
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-020, Steering comm. appl. SCSC06-47(2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   UNEWe009-A
AC   CVCL_A010
SY   NCL9; NCL-9; hES-NCL-9; hES-NCL9
DR   hPSCreg; UNEWe009-A
DR   SKIP; SKIP002550
DR   Wikidata; Q54908237
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: UK Stem Cell Bank (UKSCB); R-07-021, Steering comm. appl. SCSC06-47(3).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   UNEWi001-A
AC   CVCL_9S37
SY   PRPF31 iPSC; UNEW001Ai
DR   BioSamples; SAMEA2629641
DR   EBiSC; UNEWi001-A
DR   ECACC; 66540039
DR   hPSCreg; UNEWi001-A
DR   SKIP; SKIP002468
DR   Wikidata; Q54991151
RX   DOI=10.1101/232397;
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; c.522_527del6+IVS6+1_+10del10; Zygosity=Heterozygous (DOI=10.1101/232397).
CC   Discontinued: ECACC; 66540039; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   UNEWi002-A
AC   CVCL_9S38
SY   PRPF31 AW; UNEW002Ai
DR   BioSamples; SAMEA2629491
DR   EBiSC; UNEWi002-A
DR   ECACC; 66540040
DR   hPSCreg; UNEWi002-A
DR   SKIP; SKIP002469
DR   Wikidata; Q54991152
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; c.522_527del6+IVS6+1_+10del10; Zygosity=Heterozygous (EBiSC=UNEWi002-A).
CC   Discontinued: ECACC; 66540040; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-54Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 14
//
ID   UNEWi003-A
AC   CVCL_IU01
SY   PRPF31 HD
DR   hPSCreg; UNEWi003-A
DR   SKIP; SKIP002470
DR   Wikidata; Q54991153
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 9
//
ID   UNEWi004-A
AC   CVCL_9S39
SY   PRPF31 SH
DR   BioSamples; SAMEA3275846
DR   EBiSC; UNEWi004-A
DR   ECACC; 66540017
DR   hPSCreg; UNEWi004-A
DR   SKIP; SKIP002471
DR   Wikidata; Q54991154
RX   DOI=10.1101/232397;
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Arg372Glnfs*99 (c.1115_1125del11); ClinVar=VCV000004358; Zygosity=Heterozygous (DOI=10.1101/232397).
CC   Discontinued: ECACC; 66540017; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   UNEWi005-A
AC   CVCL_9S40
SY   PRPF31 RH
DR   BioSamples; SAMEA3275904
DR   EBiSC; UNEWi005-A
DR   ECACC; 66540020
DR   hPSCreg; UNEWi005-A
DR   SKIP; SKIP002472
DR   Wikidata; Q54991155
RX   DOI=10.1101/232397;
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Arg372Glnfs*99 (c.1115_1125del11); ClinVar=VCV000004358; Zygosity=Heterozygous (DOI=10.1101/232397).
CC   Discontinued: ECACC; 66540020; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 15
//
ID   UNEWi006-A
AC   CVCL_UM25
DR   hPSCreg; UNEWi006-A
DR   Wikidata; Q98134249
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   UNEWi007-A
AC   CVCL_YR28
DR   hPSCreg; UNEWi007-A
DR   Wikidata; Q98134251
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   UNEWi008-A
AC   CVCL_YR29
DR   hPSCreg; UNEWi008-A
DR   Wikidata; Q98134252
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   UNEWi009-A
AC   CVCL_YR30
DR   hPSCreg; UNEWi009-A
DR   Wikidata; Q98134254
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   UNEWi010-A
AC   CVCL_YR31
DR   hPSCreg; UNEWi010-A
DR   Wikidata; Q98134257
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 4
//
ID   UNEWi011-A
AC   CVCL_VF32
SY   UNEW011Ai
DR   BioSamples; SAMEA2629624
DR   EBiSC; UNEWi011-A
DR   ECACC; 66540041
DR   hPSCreg; UNEWi011-A
DR   Wikidata; Q54991156
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Miscellaneous: Cell line has been lost (EBiSC=UNEWi011-A).
CC   Discontinued: EBiSC; UNEWi011-A; true.
CC   Discontinued: ECACC; 66540041; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C162695; Severe combined immunodeficiency due to NHEJ1 deficiency
DI   ORDO; Orphanet_169079; Cernunnos-XLF deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1-4Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 30-01-24; Version: 10
//
ID   UNEWi017-A
AC   CVCL_II93
DR   BioSamples; SAMEA3142096
DR   EBiSC; UNEWi017-A
DR   ECACC; 66540057
DR   hPSCreg; UNEWi017-A
DR   SKIP; SKIP002565
DR   Wikidata; Q54991157
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540057; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_182040; Aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-19Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   UNEWi018-A
AC   CVCL_II94
DR   BioSamples; SAMEA3142165
DR   EBiSC; UNEWi018-A
DR   ECACC; 66540012
DR   hPSCreg; UNEWi018-A
DR   SKIP; SKIP002566
DR   Wikidata; Q54991159
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540012; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2870; Aplastic anemia
DI   ORDO; Orphanet_182040; Aplastic anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10-14Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 11
//
ID   UNEWi019-A
AC   CVCL_II95
DR   BioSamples; SAMEA3275958
DR   EBiSC; UNEWi019-A
DR   ECACC; 66540021
DR   hPSCreg; UNEWi019-A
DR   SKIP; SKIP002567
DR   Wikidata; Q54991160
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Population: Caucasian.
CC   Discontinued: ECACC; 66540021; true.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C2869; Anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20-24Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 30-01-24; Version: 10
//
ID   UNEWi020-A
AC   CVCL_UM26
DR   hPSCreg; UNEWi020-A
DR   Wikidata; Q98134259
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   UNEWi021-A
AC   CVCL_IT82
SY   F018 13.2
DR   BioSamples; SAMEA4092799
DR   EBiSC; UNEWi021-A
DR   ECACC; 66540174
DR   hPSCreg; UNEWi021-A
DR   SKIP; SKIP002678
DR   Wikidata; Q54991161
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Discontinued: ECACC; 66540174; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT83 ! UNEWi021-B
OI   CVCL_IT84 ! UNEWi021-C
SX   Female
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 10
//
ID   UNEWi021-B
AC   CVCL_IT83
SY   F018 15.8
DR   BioSamples; SAMEA4092819
DR   EBiSC; UNEWi021-B
DR   ECACC; 66540175
DR   hPSCreg; UNEWi021-B
DR   SKIP; SKIP002680
DR   Wikidata; Q54991162
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Discontinued: ECACC; 66540175; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT82 ! UNEWi021-A
OI   CVCL_IT84 ! UNEWi021-C
SX   Female
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 10
//
ID   UNEWi021-C
AC   CVCL_IT84
SY   F018 17/8-1
DR   BioSamples; SAMEA4092855
DR   EBiSC; UNEWi021-C
DR   ECACC; 66540176
DR   hPSCreg; UNEWi021-C
DR   SKIP; SKIP002681
DR   Wikidata; Q54991163
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Discontinued: ECACC; 66540176; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT82 ! UNEWi021-A
OI   CVCL_IT83 ! UNEWi021-B
SX   Female
AG   80-84Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 10
//
ID   UNEWi022-A
AC   CVCL_IT85
SY   F181 5.8
DR   BioSamples; SAMEA4092883
DR   EBiSC; UNEWi022-A
DR   ECACC; 66540177
DR   hPSCreg; UNEWi022-A
DR   SKIP; SKIP002679
DR   Wikidata; Q54991164
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204C>T); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi022-A).
CC   Discontinued: ECACC; 66540177; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT86 ! UNEWi022-B
OI   CVCL_IT87 ! UNEWi022-C
SX   Male
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi022-B
AC   CVCL_IT86
SY   F181 18.2
DR   BioSamples; SAMEA4092901
DR   EBiSC; UNEWi022-B
DR   ECACC; 66540178
DR   hPSCreg; UNEWi022-B
DR   SKIP; SKIP002683
DR   Wikidata; Q54991165
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204C>T); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi022-B).
CC   Discontinued: ECACC; 66540178; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT85 ! UNEWi022-A
OI   CVCL_IT87 ! UNEWi022-C
SX   Male
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi022-C
AC   CVCL_IT87
SY   F181 25.7
DR   BioSamples; SAMEA4092914
DR   EBiSC; UNEWi022-C
DR   ECACC; 66540179
DR   hPSCreg; UNEWi022-C
DR   SKIP; SKIP002684
DR   Wikidata; Q54991166
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi022-C).
CC   Discontinued: ECACC; 66540179; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT85 ! UNEWi022-A
OI   CVCL_IT86 ! UNEWi022-B
SX   Male
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi023-A
AC   CVCL_IT88
SY   F343 clone 2
DR   BioSamples; SAMEA4567585
DR   EBiSC; UNEWi023-A
DR   ECACC; 66540441
DR   hPSCreg; UNEWi023-A
DR   SKIP; SKIP002788
DR   Wikidata; Q54991167
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Discontinued: ECACC; 66540441; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT89 ! UNEWi023-B
OI   CVCL_IT90 ! UNEWi023-C
SX   Female
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 11
//
ID   UNEWi023-B
AC   CVCL_IT89
SY   F343 clone 3
DR   BioSamples; SAMEA4567587
DR   EBiSC; UNEWi023-B
DR   ECACC; 66540442
DR   hPSCreg; UNEWi023-B
DR   SKIP; SKIP002792
DR   Wikidata; Q54991168
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Discontinued: ECACC; 66540442; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT88 ! UNEWi023-A
OI   CVCL_IT90 ! UNEWi023-C
SX   Female
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 11
//
ID   UNEWi023-C
AC   CVCL_IT90
SY   F343 clone 4
DR   BioSamples; SAMEA4567588
DR   EBiSC; UNEWi023-C
DR   ECACC; 66540443
DR   hPSCreg; UNEWi023-C
DR   SKIP; SKIP002793
DR   Wikidata; Q54991169
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Discontinued: ECACC; 66540443; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84391; Age-related macular degeneration
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT88 ! UNEWi023-A
OI   CVCL_IT89 ! UNEWi023-B
SX   Female
AG   85-89Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 30-01-24; Version: 11
//
ID   UNEWi024-A
AC   CVCL_IT91
SY   F180-1
DR   BioSamples; SAMEA4446992
DR   EBiSC; UNEWi024-A
DR   ECACC; 66540323
DR   hPSCreg; UNEWi024-A
DR   SKIP; SKIP002789
DR   Wikidata; Q54991171
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi024-A).
CC   Discontinued: ECACC; 66540323; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT92 ! UNEWi024-B
OI   CVCL_IT93 ! UNEWi024-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 14
//
ID   UNEWi024-B
AC   CVCL_IT92
SY   F180-2
DR   BioSamples; SAMEA4447006
DR   EBiSC; UNEWi024-B
DR   ECACC; 66540324
DR   hPSCreg; UNEWi024-B
DR   SKIP; SKIP002794
DR   Wikidata; Q54991172
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi024-B).
CC   Discontinued: ECACC; 66540324; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT91 ! UNEWi024-A
OI   CVCL_IT93 ! UNEWi024-C
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi024-C
AC   CVCL_IT93
SY   F180-3
DR   BioSamples; SAMEA4447024
DR   EBiSC; UNEWi024-C
DR   ECACC; 66540325
DR   hPSCreg; UNEWi024-C
DR   SKIP; SKIP002795
DR   Wikidata; Q54991173
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi024-C).
CC   Discontinued: ECACC; 66540325; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT91 ! UNEWi024-A
OI   CVCL_IT92 ! UNEWi024-B
SX   Male
AG   75-79Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi025-A
AC   CVCL_IT94
SY   F324 5.8
DR   BioSamples; SAMEA4447907
DR   EBiSC; UNEWi025-A
DR   ECACC; 66540328
DR   hPSCreg; UNEWi025-A
DR   SKIP; SKIP002790
DR   Wikidata; Q54991174
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi025-A).
CC   Discontinued: ECACC; 66540328; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT95 ! UNEWi025-B
OI   CVCL_IT96 ! UNEWi025-C
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi025-B
AC   CVCL_IT95
SY   F324 12.8
DR   BioSamples; SAMEA4447908
DR   EBiSC; UNEWi025-B
DR   ECACC; 66540329
DR   hPSCreg; UNEWi025-B
DR   SKIP; SKIP002796
DR   Wikidata; Q54991223
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi025-B).
CC   Discontinued: ECACC; 66540329; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT94 ! UNEWi025-A
OI   CVCL_IT96 ! UNEWi025-C
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi025-C
AC   CVCL_IT96
SY   F324 19.7
DR   BioSamples; SAMEA4447909
DR   EBiSC; UNEWi025-C
DR   ECACC; 66540330
DR   hPSCreg; UNEWi025-C
DR   SKIP; SKIP002797
DR   Wikidata; Q54991225
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204T>C); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi025-C).
CC   Discontinued: ECACC; 66540330; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IT94 ! UNEWi025-A
OI   CVCL_IT95 ! UNEWi025-B
SX   Female
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi026-A
AC   CVCL_IT97
SY   SF116 clone 1
DR   BioSamples; SAMEA4567589
DR   EBiSC; UNEWi026-A
DR   ECACC; 66540444
DR   hPSCreg; UNEWi026-A
DR   SKIP; SKIP002791
DR   Wikidata; Q54991226
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204C>T); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi026-A).
CC   Discontinued: ECACC; 66540444; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD80 ! STBCi110-A
OI   CVCL_IT98 ! UNEWi026-B
OI   CVCL_IT99 ! UNEWi026-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi026-B
AC   CVCL_IT98
SY   SF116 clone 2
DR   BioSamples; SAMEA4567590
DR   EBiSC; UNEWi026-B
DR   ECACC; 66540445
DR   hPSCreg; UNEWi026-B
DR   SKIP; SKIP002798
DR   Wikidata; Q54991227
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204C>T); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi026-B).
CC   Discontinued: ECACC; 66540445; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD80 ! STBCi110-A
OI   CVCL_IT97 ! UNEWi026-A
OI   CVCL_IT99 ! UNEWi026-C
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi026-C
AC   CVCL_IT99
SY   SF116 clone K
DR   BioSamples; SAMEA4567591
DR   EBiSC; UNEWi026-C
DR   ECACC; 66540446
DR   hPSCreg; UNEWi026-C
DR   SKIP; SKIP002799
DR   Wikidata; Q54991229
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4883; CFH; Simple; p.Tyr402His (c.1204C>T); ClinVar=VCV000294490; Zygosity=Homozygous (EBiSC=UNEWi026-C).
CC   Discontinued: ECACC; 66540446; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C174215; Age-related macular degeneration-4
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RD80 ! STBCi110-A
OI   CVCL_IT97 ! UNEWi026-A
OI   CVCL_IT98 ! UNEWi026-B
SX   Male
AG   60-64Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi027-A
AC   CVCL_IU00
SY   F116
DR   BioSamples; SAMEA4458542
DR   EBiSC; UNEWi027-A
DR   ECACC; 66540406
DR   hPSCreg; UNEWi027-A
DR   SKIP; SKIP002880
DR   Wikidata; Q54991232
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:15446; PRPF31; Simple; p.Arg372Glnfs*99 (c.1115_1125del11); ClinVar=VCV000004358; Zygosity=Heterozygous (EBiSC=UNEWi027-A).
CC   Discontinued: ECACC; 66540406; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   UNEWi028-A
AC   CVCL_UM27
DR   hPSCreg; UNEWi028-A
DR   Wikidata; Q98134261
CC   From: University of Newcastle; Newcastle; United Kingdom.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   UNIBSi001-A
AC   CVCL_QX79
SY   M016
DR   hPSCreg; UNIBSi001-A
DR   Wikidata; Q54991234
RX   PubMed=29034891;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6224; KCNA5; Simple; p.Asp322His (c.964G>C); ClinVar=VCV000469603; Zygosity=Heterozygous (PubMed=29034891).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=29034891
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D10S1248: 14,15
ST   D12S391: 22,23
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D1S1656: 12,16
ST   D21S11: 26,31.2
ST   D22S1045: 15
ST   D2S1338: 17,20
ST   D2S441: 11,14
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 7,12
ST   D8S1179: 13
ST   FGA: 21,22
ST   SE33: 28.2,32.2
ST   TH01: 9
ST   TPOX: 9,12
ST   vWA: 17
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi002-A
AC   CVCL_UM22
DR   hPSCreg; UNIBSi002-A
DR   Wikidata; Q98134264
CC   From: University of Brescia; Brescia; Italy.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   UNIBSi003-A
AC   CVCL_QX80
SY   MI37
DR   hPSCreg; UNIBSi003-A
DR   Wikidata; Q54991236
RX   PubMed=29034898;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9005; PITX2; Simple; p.Met200Val (c.598A>G) (p.Met207Val, c.619A>G); ClinVar=VCV000559593; Zygosity=Heterozygous (PubMed=29034898).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi004-A
AC   CVCL_UL40
SY   BF17-1
DR   hPSCreg; UNIBSi004-A
DR   Wikidata; Q98134266
RX   PubMed=30711802;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34518; Cri du chat syndrome
DI   ORDO; Orphanet_281; Monosomy 5p
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   UNIBSi005-A
AC   CVCL_WT75
SY   iPSC-AG-Crohn-C1; C1
DR   hPSCreg; UNIBSi005-A
DR   Wikidata; Q98134267
RX   PubMed=31536868;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT76 ! UNIBSi005-B
OI   CVCL_WT77 ! UNIBSi005-C
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   UNIBSi005-B
AC   CVCL_WT76
SY   iPSC-AG-Crohn-C5; C5
DR   hPSCreg; UNIBSi005-B
DR   Wikidata; Q98134269
RX   PubMed=31536868;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT75 ! UNIBSi005-A
OI   CVCL_WT77 ! UNIBSi005-C
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   UNIBSi005-C
AC   CVCL_WT77
SY   iPSC-AG-Crohn-C20; C20
DR   hPSCreg; UNIBSi005-C
DR   Wikidata; Q98134273
RX   PubMed=31536868;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2965; Crohn disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WT75 ! UNIBSi005-A
OI   CVCL_WT76 ! UNIBSi005-B
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 29-06-23; Version: 6
//
ID   UNIBSi006-A
AC   CVCL_YB45
SY   AGS1_MM_C12
DR   hPSCreg; UNIBSi006-A
DR   Wikidata; Q98134275
RX   PubMed=31644995;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Ser88fs*22 (c.260insAG); Zygosity=Heterozygous (PubMed=31644995).
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Arg97His (c.290G>A); ClinVar=VCV000225498; Zygosity=Heterozygous (PubMed=31644995).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB46 ! UNIBSi006-B
OI   CVCL_YB47 ! UNIBSi006-C
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi006-B
AC   CVCL_YB46
SY   AGS1_MM_C13
DR   hPSCreg; UNIBSi006-B
DR   Wikidata; Q98134277
RX   PubMed=31644995;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Ser88fs*22 (c.260insAG); Zygosity=Heterozygous (PubMed=31644995).
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Arg97His (c.290G>A); ClinVar=VCV000225498; Zygosity=Heterozygous (PubMed=31644995).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB45 ! UNIBSi006-A
OI   CVCL_YB47 ! UNIBSi006-C
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi006-C
AC   CVCL_YB47
SY   AGS1_MM_C14
DR   hPSCreg; UNIBSi006-C
DR   Wikidata; Q98134280
RX   PubMed=31644995;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Ser88fs*22 (c.260insAG); Zygosity=Heterozygous (PubMed=31644995).
CC   Sequence variation: Mutation; HGNC; HGNC:12269; TREX1; Simple; p.Arg97His (c.290G>A); ClinVar=VCV000225498; Zygosity=Heterozygous (PubMed=31644995).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165501; Aicardi-Goutieres syndrome 1
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB45 ! UNIBSi006-A
OI   CVCL_YB46 ! UNIBSi006-B
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi007-A
AC   CVCL_YB48
SY   AGS2_MV_C3
DR   hPSCreg; UNIBSi007-A
DR   Wikidata; Q98134282
RX   PubMed=31678772;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25671; RNASEH2B; Simple; p.Ala177Thr (c.529G>A); ClinVar=VCV000001262; Zygosity=Homozygous (PubMed=31678772).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165673; Aicardi-Goutieres syndrome 2
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB49 ! UNIBSi007-B
OI   CVCL_YB50 ! UNIBSi007-C
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UNIBSi007-B
AC   CVCL_YB49
SY   AGS2_MV_C4
DR   hPSCreg; UNIBSi007-B
DR   Wikidata; Q98134284
RX   PubMed=31678772;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25671; RNASEH2B; Simple; p.Ala177Thr (c.529G>A); ClinVar=VCV000001262; Zygosity=Homozygous (PubMed=31678772).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165673; Aicardi-Goutieres syndrome 2
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB48 ! UNIBSi007-A
OI   CVCL_YB50 ! UNIBSi007-C
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi007-C
AC   CVCL_YB50
SY   AGS2_MV_C6
DR   hPSCreg; UNIBSi007-C
DR   Wikidata; Q98134286
RX   PubMed=31678772;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25671; RNASEH2B; Simple; p.Ala177Thr (c.529G>A); ClinVar=VCV000001262; Zygosity=Homozygous (PubMed=31678772).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165673; Aicardi-Goutieres syndrome 2
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB48 ! UNIBSi007-A
OI   CVCL_YB49 ! UNIBSi007-B
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi008-A
AC   CVCL_YB51
SY   AT-MC-C1
DR   hPSCreg; UNIBSi008-A
DR   Wikidata; Q98134288
RX   PubMed=31669783;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; chr11:g.108105741_108115748del (Ex5-7del); Zygosity=Heterozygous (PubMed=31669783).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB52 ! UNIBSi008-B
OI   CVCL_YB53 ! UNIBSi008-C
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UNIBSi008-B
AC   CVCL_YB52
SY   AT-MC-C2
DR   hPSCreg; UNIBSi008-B
DR   Wikidata; Q98134290
RX   PubMed=31669783;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; chr11:g.108105741_108115748del (Ex5-7del); Zygosity=Heterozygous (PubMed=31669783).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB51 ! UNIBSi008-A
OI   CVCL_YB53 ! UNIBSi008-C
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UNIBSi008-C
AC   CVCL_YB53
SY   AT-MC-C12
DR   hPSCreg; UNIBSi008-C
DR   Wikidata; Q98134292
RX   PubMed=31669783;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; chr11:g.108105741_108115748del (Ex5-7del); Zygosity=Heterozygous (PubMed=31669783).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB51 ! UNIBSi008-A
OI   CVCL_YB52 ! UNIBSi008-B
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   UNIBSi009-A
AC   CVCL_YB54
SY   AGS7-GS-C3.A
DR   hPSCreg; UNIBSi009-A
DR   Wikidata; Q98134294
RX   PubMed=31698194;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18873; IFIH1; Simple; p.Arg824Lys (c.2471G>A); ClinVar=VCV000812536; Zygosity=Heterozygous (PubMed=31698194).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168585; Aicardi-Goutieres syndrome 7
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB55 ! UNIBSi009-B
OI   CVCL_YB56 ! UNIBSi009-C
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi009-B
AC   CVCL_YB55
SY   AGS7-GS-C6.4
DR   hPSCreg; UNIBSi009-B
DR   Wikidata; Q98134296
RX   PubMed=31698194;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18873; IFIH1; Simple; p.Arg824Lys (c.2471G>A); ClinVar=VCV000812536; Zygosity=Heterozygous (PubMed=31698194).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168585; Aicardi-Goutieres syndrome 7
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB54 ! UNIBSi009-A
OI   CVCL_YB56 ! UNIBSi009-C
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi009-C
AC   CVCL_YB56
SY   AGS7-GS-C7.4
DR   hPSCreg; UNIBSi009-C
DR   Wikidata; Q98134300
RX   PubMed=31698194;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:18873; IFIH1; Simple; p.Arg824Lys (c.2471G>A); ClinVar=VCV000812536; Zygosity=Heterozygous (PubMed=31698194).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168585; Aicardi-Goutieres syndrome 7
DI   ORDO; Orphanet_51; Aicardi-Goutieres syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB54 ! UNIBSi009-A
OI   CVCL_YB55 ! UNIBSi009-B
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   UNIBSi010-A
AC   CVCL_YB57
SY   iPSC-TCIRG1-C1
DR   hPSCreg; UNIBSi010-A
DR   Wikidata; Q98134302
RX   PubMed=31794943;
CC   From: University of Brescia; Brescia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; p.Tyr512Ter (c.1536C>A); ClinVar=VCV002679138; Zygosity=Heterozygous (PubMed=31794943).
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; c.2236+1G>A; ClinVar=VCV000558226; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=31794943).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C167215; Autosomal recessive osteopetrosis 1
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB58 ! UNIBSi010-B
OI   CVCL_YB59 ! UNIBSi010-C
SX   Male
AG   4-5M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   UNIBSi010-B
AC   CVCL_YB58
SY   iPSC-TCIRG1-C2
DR   hPSCreg; UNIBSi010-B
DR   Wikidata; Q98134304
RX   PubMed=31794943;
CC   From: University of Brescia; Brescia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; p.Tyr512Ter (c.1536C>A); ClinVar=VCV002679138; Zygosity=Heterozygous (PubMed=31794943).
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; c.2236+1G>A; ClinVar=VCV000558226; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=31794943).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C167215; Autosomal recessive osteopetrosis 1
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB57 ! UNIBSi010-A
OI   CVCL_YB59 ! UNIBSi010-C
SX   Male
AG   4-5M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   UNIBSi010-C
AC   CVCL_YB59
SY   iPSC-TCIRG1-C3
DR   hPSCreg; UNIBSi010-C
DR   Wikidata; Q98134306
RX   PubMed=31794943;
CC   From: University of Brescia; Brescia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; p.Tyr512Ter (c.1536C>A); ClinVar=VCV002679138; Zygosity=Heterozygous (PubMed=31794943).
CC   Sequence variation: Mutation; HGNC; HGNC:11647; TCIRG1; Simple; c.2236+1G>A; ClinVar=VCV000558226; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=31794943).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C167215; Autosomal recessive osteopetrosis 1
DI   ORDO; Orphanet_667; Autosomal recessive malignant osteopetrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YB57 ! UNIBSi010-A
OI   CVCL_YB58 ! UNIBSi010-B
SX   Male
AG   4-5M
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   UNIBSi011-A
AC   CVCL_A1PV
SY   JS_MA_C3
DR   hPSCreg; UNIBSi011-A
DR   Wikidata; Q102115081
RX   PubMed=33010677;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Ser1290Pro (c.3868T>C); Zygosity=Heterozygous (PubMed=33010677).
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Arg2493Ter (c.7477C>A); ClinVar=VCV000031223; Zygosity=Heterozygous (PubMed=33010677).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175702; Joubert syndrome 17
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PW ! UNIBSi011-B
OI   CVCL_A1PX ! UNIBSi011-C
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UNIBSi011-B
AC   CVCL_A1PW
SY   JS_MA_C5
DR   hPSCreg; UNIBSi011-B
DR   Wikidata; Q102115082
RX   PubMed=33010677;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Ser1290Pro (c.3868T>C); Zygosity=Heterozygous (PubMed=33010677).
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Arg2493Ter (c.7477C>A); ClinVar=VCV000031223; Zygosity=Heterozygous (PubMed=33010677).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175702; Joubert syndrome 17
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PV ! UNIBSi011-A
OI   CVCL_A1PX ! UNIBSi011-C
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UNIBSi011-C
AC   CVCL_A1PX
SY   JS_MA_C10
DR   hPSCreg; UNIBSi011-C
DR   Wikidata; Q102115084
RX   PubMed=33010677;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Ser1290Pro (c.3868T>C); Zygosity=Heterozygous (PubMed=33010677).
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Arg2493Ter (c.7477C>A); ClinVar=VCV000031223; Zygosity=Heterozygous (PubMed=33010677).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175702; Joubert syndrome 17
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1PV ! UNIBSi011-A
OI   CVCL_A1PW ! UNIBSi011-B
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UNIBSi012-A
AC   CVCL_A2XS
SY   P1MD40
DR   hPSCreg; UNIBSi012-A
DR   Wikidata; Q105511634
RX   PubMed=33291010;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   UNIBSi013-A
AC   CVCL_A2XT
SY   P2MD06
DR   hPSCreg; UNIBSi013-A
DR   Wikidata; Q105511636
RX   PubMed=33291010;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   UNIBSi014-A
AC   CVCL_A5GZ
SY   C1MD14
DR   hPSCreg; UNIBSi014-A
DR   Wikidata; Q107117340
RX   PubMed=33548809;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UNIBSi015-A
AC   CVCL_A0KP
SY   JS_GC_C3
DR   hPSCreg; UNIBSi015-A
DR   Wikidata; Q108821459
CC   From: University of Brescia; Brescia; Italy.
DI   NCIt; C74996; Joubert syndrome
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 4
//
ID   UNIBSi016-A
AC   CVCL_A0KQ
SY   JS_CG_C6
DR   hPSCreg; UNIBSi016-A
DR   Wikidata; Q108821460
RX   PubMed=34182252;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252).
CC   Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C181002; Joubert syndrome 9
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0KR ! UNIBSi016-B
OI   CVCL_A0KS ! UNIBSi016-C
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UNIBSi016-B
AC   CVCL_A0KR
SY   JS_CG_C7
DR   hPSCreg; UNIBSi016-B
DR   Wikidata; Q108821461
RX   PubMed=34182252;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252).
CC   Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C181002; Joubert syndrome 9
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0KQ ! UNIBSi016-A
OI   CVCL_A0KS ! UNIBSi016-C
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UNIBSi016-C
AC   CVCL_A0KS
SY   JS_CG_C17
DR   hPSCreg; UNIBSi016-C
DR   Wikidata; Q108821463
RX   PubMed=34182252;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Glu1000Val (c.2999A>T); ClinVar=VCV000217604; Zygosity=Heterozygous (PubMed=34182252).
CC   Sequence variation: Mutation; HGNC; HGNC:29253; CC2D2A; Simple; p.Gly1213Alafs*7 (c.3638delG); ClinVar=VCV002040349; Zygosity=Heterozygous (PubMed=34182252).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C181002; Joubert syndrome 9
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0KQ ! UNIBSi016-A
OI   CVCL_A0KR ! UNIBSi016-B
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UNIBSi017-A
AC   CVCL_B7EZ
SY   EDS1331-iPSC; EDS1331
DR   BioSamples; SAMEA14099154
DR   hPSCreg; UNIBSi017-A
DR   Wikidata; Q112930522
RX   PubMed=35700636;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Karyotypic information: 45,XX,rob(13;14)(q10;q10) (PubMed=35700636).
CC   Sequence variation: Mutation; HGNC; HGNC:6859; MAP3K7; Simple; p.Asn245_Gly246insValVal (c.737-7A>G) (IVS7AS,A-G,-7); ClinVar=VCV000974910; Zygosity=Heterozygous (PubMed=35700636).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C188216; Cardiospondylocarpofacial syndrome
DI   ORDO; Orphanet_3238; Cardiospondylocarpofacial syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UNIBSi018-A
AC   CVCL_D6MS
SY   P1NS_26
DR   BioSamples; SAMEA114862746
DR   hPSCreg; UNIBSi018-A
DR   Wikidata; Q127384596
RX   PubMed=38160629;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Tyr63Cys (c.188A>G); ClinVar=VCV000013333; Zygosity=Heterozygous (PubMed=38160629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MT ! UNIBSi018-B
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UNIBSi018-B
AC   CVCL_D6MT
SY   P1NS_37
DR   BioSamples; SAMEA114863443
DR   hPSCreg; UNIBSi018-B
DR   Wikidata; Q127384598
RX   PubMed=38160629;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Tyr63Cys (c.188A>G); ClinVar=VCV000013333; Zygosity=Heterozygous (PubMed=38160629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6MS ! UNIBSi018-A
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UNIBSi019-A
AC   CVCL_D6M5
SY   P2NS_203
DR   BioSamples; SAMEA114863466
DR   hPSCreg; UNIBSi019-A
DR   Wikidata; Q127384600
RX   PubMed=38160629;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Tyr63Cys (c.188A>G); ClinVar=VCV000013333; Zygosity=Heterozygous (PubMed=38160629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M6 ! UNIBSi019-B
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UNIBSi019-B
AC   CVCL_D6M6
SY   P2NS_222
DR   BioSamples; SAMEA114863484
DR   hPSCreg; UNIBSi019-B
DR   Wikidata; Q127384603
RX   PubMed=38160629;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Tyr63Cys (c.188A>G); ClinVar=VCV000013333; Zygosity=Heterozygous (PubMed=38160629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M5 ! UNIBSi019-A
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UNIBSi020-A
AC   CVCL_D6M7
SY   P3NS_306
DR   BioSamples; SAMEA114870879
DR   hPSCreg; UNIBSi020-A
DR   Wikidata; Q127384605
RX   PubMed=38160629;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Tyr63Cys (c.188A>G); ClinVar=VCV000013333; Zygosity=Heterozygous (PubMed=38160629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M8 ! UNIBSi020-B
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UNIBSi020-B
AC   CVCL_D6M8
SY   P3NS_315
DR   BioSamples; SAMEA114877017
DR   hPSCreg; UNIBSi020-B
DR   Wikidata; Q127384608
RX   PubMed=38160629;
CC   From: University of Brescia; Brescia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Tyr63Cys (c.188A>G); ClinVar=VCV000013333; Zygosity=Heterozygous (PubMed=38160629).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34854; Noonan syndrome
DI   ORDO; Orphanet_648; Noonan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D6M7 ! UNIBSi020-A
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   UNIFEi001-A
AC   CVCL_E6MA
SY   iPSca1N1; MARPiPSCA1N1; UniFei001-A
DR   BioSamples; SAMEA116085258
DR   hPSCreg; UNIFEi001-A
RX   PubMed=39892158;
CC   From: University of Ferrara; Ferrara; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10548; ATXN1; Repeat_expansion; CAG[60]; Zygosity=Heterozygous (PubMed=39892158).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129982; Spinocerebellar ataxia type 1
DI   ORDO; Orphanet_98755; Spinocerebellar ataxia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UNIGEi001-A
AC   CVCL_YC62
SY   MPS1-H.2y.S4; MPS1.2y.S4
DR   hPSCreg; UNIGEi001-A
DR   Wikidata; Q98134309
RX   PubMed=31678774;
RX   PubMed=33287330;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.His358_Thr364del (c.1073_1093del); ClinVar=VCV000557260; Zygosity=Heterozygous (PubMed=31678774).
CC   Sequence variation: Mutation; HGNC; HGNC:5391; IDUA; Simple; p.Trp402Ter (c.1205G>A); ClinVar=VCV000011908; Zygosity=Heterozygous (PubMed=31678774).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61261; Hurler syndrome
DI   ORDO; Orphanet_93473; Hurler syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   UNIGEi003-A
AC   CVCL_ZX57
SY   F1MS
DR   hPSCreg; UNIGEi003-A
DR   Wikidata; Q102115085
RX   PubMed=32805538;
CC   From: University of Geneva; Geneva; Switzerland.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 6
//
ID   UNIMGi001-A
AC   CVCL_A1XH
SY   SCN1A_mut-1; SCN1Amut-1; SCN1A_Severe
DR   hPSCreg; UNIMGi001-A
DR   Wikidata; Q105511638
RX   PubMed=33370868;
CC   From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Met145Thr (c.434T>C); ClinVar=VCV000012896; Zygosity=Heterozygous (PubMed=33370868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176016; Febrile seizures, familial, 3A
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   UNIMGi002-A
AC   CVCL_A1XI
SY   SCN1A_mut-2; SCN1Amut-2; SCN1A_Mild
DR   hPSCreg; UNIMGi002-A
DR   Wikidata; Q105511641
RX   PubMed=33370868;
CC   From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Met145Thr (c.434T>C); ClinVar=VCV000012896; Zygosity=Heterozygous (PubMed=33370868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C176016; Febrile seizures, familial, 3A
DI   ORDO; Orphanet_36387; Generalized epilepsy with febrile seizures-plus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   UNIMGi003-A
AC   CVCL_A7KZ
SY   ULD1
DR   hPSCreg; UNIMGi003-A
DR   Wikidata; Q107117341
RX   PubMed=33865103;
CC   From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Unspecified (PubMed=33865103).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179710; Myoclonic epilepsy of Unverricht and Lundborg
DI   ORDO; Orphanet_308; Unverricht-Lundborg disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UNIMGi004-A
AC   CVCL_A7LA
SY   ULD2
DR   hPSCreg; UNIMGi004-A
DR   Wikidata; Q107117342
RX   PubMed=33865103;
CC   From: Universita degli Studi Magna Graecia di Catanzaro; Catanzaro; Italy.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:2482; CSTB; Repeat_expansion; c.-210CCCCGCCCCGCG[(2_3)]; ClinVar=VCV000008398; Zygosity=Unspecified (PubMed=33865103).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C179710; Myoclonic epilepsy of Unverricht and Lundborg
DI   ORDO; Orphanet_308; Unverricht-Lundborg disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   UNINAi001-A
AC   CVCL_A6XR
SY   Q3HOMOFS1
DR   hPSCreg; UNINAi001-A
DR   Wikidata; Q107117343
RX   PubMed=33799276;
CC   From: University of Naples Federico II; Napoli; Italy.
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:6297; KCNQ3; Simple; p.Phe534Ilefs*15 (c.1599dupT); ClinVar=VCV000205978; Zygosity=Homozygous (PubMed=33799276).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84392; Intellectual developmental disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6XS ! UNINAi001-B
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 7
//
ID   UNINAi001-B
AC   CVCL_A6XS
DR   hPSCreg; UNINAi001-B
DR   Wikidata; Q107117344
CC   From: University of Naples Federico II; Napoli; Italy.
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:6297; KCNQ3; Simple; p.Phe534Ilefs*15 (c.1599dupT); ClinVar=VCV000205978; Zygosity=Homozygous (from autologous cell line UNINAi001-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84392; Intellectual developmental disorder
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A6XR ! UNINAi001-A
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   UNINAi002-A
AC   CVCL_A6XT
SY   Q3CONTR
DR   hPSCreg; UNINAi002-A
DR   Wikidata; Q107117345
RX   PubMed=33799276;
CC   From: University of Naples Federico II; Napoli; Italy.
CC   Population: Moroccan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UNIPDi001-A
AC   CVCL_VF24
SY   UNIPDi001-A-hiPSC; KeNu-C
DR   hPSCreg; UNIPDi001-A
DR   SKIP; SKIP003158
DR   Wikidata; Q54991237
RX   PubMed=29547871;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial stem cell; CL=CL_0000036.
ST   Source(s): PubMed=29547871
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,12
ST   D18S51: 15,18
ST   D19S433: 13,16
ST   D21S11: 29,30.2
ST   D2S1338: 16,17
ST   D3S1358: 14,15
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 14,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   UNIPDi002-A
AC   CVCL_RJ95
SY   304D-hiPSC
DR   hPSCreg; UNIPDi002-A
DR   SKIP; SKIP003157
DR   Wikidata; Q54991238
RX   PubMed=29486400;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15979; TP63; Simple; p.Arg343Gln (c.1028G>A) (R304Q); ClinVar=VCV000006534; Zygosity=Heterozygous (PubMed=29486400).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial stem cell; CL=CL_0000036.
ST   Source(s): PubMed=29486400
ST   CSF1PO: 8,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 13,16
ST   D19S433: 15,16.2
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 23,25
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 14,16
DI   NCIt; C148261; Ectrodactyly-ectodermal dysplasia-cleft syndrome
DI   ORDO; Orphanet_1071; Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UNIPDi003-A
AC   CVCL_RJ96
SY   EEC-A-hiPSCs
DR   hPSCreg; UNIPDi003-A
DR   SKIP; SKIP003159
DR   Wikidata; Q54991239
RX   PubMed=29477592;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:15979; TP63; Simple; p.Arg318His (c.953G>A) (R279H); ClinVar=VCV000006533; Zygosity=Heterozygous (PubMed=29477592).
CC   Derived from site: In situ; Oral cavity, oral mucosa; UBERON=UBERON_0003729.
CC   Cell type: Epithelial stem cell; CL=CL_0000036.
ST   Source(s): PubMed=29477592
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 19,20
ST   D19S433: 13,15.2
ST   D21S11: 29,30
ST   D2S1338: 16,18
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 20,22
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C148261; Ectrodactyly-ectodermal dysplasia-cleft syndrome
DI   ORDO; Orphanet_1071; Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   UNIPDi004-A
AC   CVCL_YR26
DR   BioSamples; SAMEA7059976
DR   hPSCreg; UNIPDi004-A
DR   Wikidata; Q98134310
RX   PubMed=30598530;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   UNIPDi004-B
AC   CVCL_YR27
SY   HPD04
DR   BioSample; SAMN08384435
DR   GEO; GSM2988904
DR   hPSCreg; UNIPDi004-B
DR   Wikidata; Q98134312
RX   PubMed=30598530;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 7
//
ID   UNIPDi005-A
AC   CVCL_YS96
SY   HPD08
DR   BioSamples; SAMEA6456097
DR   GEO; GSM2988908
DR   hPSCreg; UNIPDi005-A
DR   Wikidata; Q98134314
RX   PubMed=30598530;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 7
//
ID   UNIPDi006-A
AC   CVCL_A5CD
SY   DSG2_Q558*
DR   BioSamples; SAMEA117634706
DR   hPSCreg; UNIPDi006-A
DR   Wikidata; Q107117347
RX   PubMed=40106965;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3049; DSG2; Simple; p.Gln558Ter (c.1672C>T); ClinVar=VCV001075931; Zygosity=Heterozygous (PubMed=40106965).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C177248; Familial arrhythmogenic right ventricular dysplasia 10
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 4
//
ID   UNIPDi007-A
AC   CVCL_A5CE
SY   Ep11
DR   hPSCreg; UNIPDi007-A
DR   Wikidata; Q107117348
RX   PubMed=34831478;
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 4
//
ID   UNIPDi008-A
AC   CVCL_E7VR
SY   FXS-GM05131
DR   BioSamples; SAMEA116332829
DR   hPSCreg; UNIPDi008-A
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AX78 ! GM05131
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UNIPDi008-B
AC   CVCL_E7VS
SY   FXS-GM05131 primed
DR   BioSamples; SAMEA116333411
DR   hPSCreg; UNIPDi008-B
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AX78 ! GM05131
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UNIPDi009-A
AC   CVCL_E7VT
DR   BioSamples; SAMEA116341198
DR   hPSCreg; UNIPDi009-A
CC   From: University of Padova; Padova; Italy.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AX83 ! GM05848
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UNIPVi001-A
AC   CVCL_C6TC
SY   COR248; NG2409
DR   BioSamples; SAMEA110683809
DR   hPSCreg; UNIPVi001-A
DR   Wikidata; Q117704940
RX   PubMed=36521382;
CC   From: Units of Biology and Genetics, University of Pavia; Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21575; AHI1; Simple; p.Gln263Profs*8 (c.787dupC); Zygosity=Homozygous (PubMed=36521382).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148259; Joubert syndrome 3
DI   ORDO; Orphanet_220493; Joubert syndrome with ocular defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   UNIPVi002-A
AC   CVCL_D0NF
SY   HDF108
DR   BioSamples; SAMEA115067775
DR   hPSCreg; UNIPVi002-A
DR   Wikidata; Q123033750
RX   PubMed=38354648;
CC   From: Units of Biology and Genetics, University of Pavia; Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UNIPVi003-A
AC   CVCL_D0NG
SY   HDF109
DR   BioSamples; SAMEA115067777
DR   hPSCreg; UNIPVi003-A
DR   Wikidata; Q123033751
RX   PubMed=38354648;
CC   From: Units of Biology and Genetics, University of Pavia; Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UNIPVi004-A
AC   CVCL_D0NE
SY   COR316; NG3157
DR   BioSamples; SAMEA113552511
DR   hPSCreg; UNIPVi004-A
DR   Wikidata; Q123033752
RX   PubMed=38100914;
CC   From: Units of Biology and Genetics, University of Pavia; Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Gly48Glu (c.143G>A); ClinVar=VCV001447842; Zygosity=Heterozygous (PubMed=38100914).
CC   Sequence variation: Mutation; HGNC; HGNC:25801; CPLANE1; Simple; p.Leu595Ter (c.1784T>G); ClinVar=VCV000217580; Zygosity=Heterozygous (PubMed=38100914).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C175702; Joubert syndrome 17
DI   ORDO; Orphanet_475; Joubert syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UNIVAX 70
AC   CVCL_B0LR
SY   UNIVAX 70/138; R70
DR   Wikidata; Q108821464
RX   Patent=US5626844;
RX   PubMed=7860097;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12054.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02879; Ricinus communis ricin (Note=AA 36-302 = A chain).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   UNIZARi001-A
AC   CVCL_B5RL
SY   FiPSTK2-2
DR   BioSamples; SAMEA10984146
DR   hPSCreg; UNIZARi001-A
DR   Wikidata; Q112041895
RX   PubMed=34973561;
CC   From: University of Zaragoza; Zaragoza; Spain.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:11831; TK2; Simple; p.Arg130Trp (c.388C>T); ClinVar=VCV000038988; Zygosity=Heterozygous (PubMed=34973561).
CC   Sequence variation: Mutation; HGNC; HGNC:11831; TK2; Simple; p.Lys202del (c.604_606delAAG); ClinVar=VCV000038995; Zygosity=Heterozygous (PubMed=34973561).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C185236; Mitochondrial DNA depletion syndrome 2 (myopathic type)
DI   ORDO; Orphanet_254875; Mitochondrial DNA depletion syndrome, myopathic form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   UO-31
AC   CVCL_1911
AS   CVCL_1777
SY   UO.31; UO_31; UO31; U031
DR   BTO; BTO_0004234
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN10989590
DR   cancercelllines; CVCL_1911
DR   Cell_Model_Passport; SIDM00112
DR   ChEMBL-Cells; CHEMBL3307612
DR   ChEMBL-Targets; CHEMBL614388
DR   Cosmic; 687945
DR   Cosmic; 875869
DR   Cosmic; 897465
DR   Cosmic; 905981
DR   Cosmic; 974304
DR   Cosmic; 1044263
DR   Cosmic; 1092643
DR   Cosmic; 1175853
DR   Cosmic; 1305379
DR   Cosmic; 1998486
DR   Cosmic-CLP; 905981
DR   DepMap; ACH-000428
DR   DepMap; ACH-002203
DR   EGA; EGAS00001000978
DR   GDSC; 905981
DR   GEO; GSM2104
DR   GEO; GSM50232
DR   GEO; GSM50296
DR   GEO; GSM743487
DR   GEO; GSM750841
DR   GEO; GSM799378
DR   GEO; GSM799441
DR   GEO; GSM844724
DR   GEO; GSM847169
DR   GEO; GSM1153451
DR   GEO; GSM1181309
DR   GEO; GSM1181327
DR   GEO; GSM1670553
DR   GEO; GSM2124694
DR   IARC_TP53; 21110
DR   LiGeA; CCLE_021
DR   NCI-DTP; UO-31
DR   PharmacoDB; UO31_1647_2019
DR   PRIDE; PXD003539
DR   PRIDE; PXD005942
DR   PRIDE; PXD005946
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1911
DR   PubChem_Cell_line; CVCL_1911
DR   SKY/M-FISH/CGH; 2808
DR   Wikidata; Q54991243
RX   PubMed=2041050;
RX   PubMed=3335022;
RX   PubMed=9331090;
RX   PubMed=10700174;
RX   PubMed=15748285;
RX   PubMed=17088437;
RX   PubMed=19372543;
RX   PubMed=20164919;
RX   PubMed=22068913;
RX   PubMed=22347499;
RX   PubMed=22384151;
RX   PubMed=22628656;
RX   PubMed=23856246;
RX   PubMed=23933261;
RX   PubMed=24279929;
RX   PubMed=24670534;
RX   PubMed=27377824;
RX   PubMed=27397505;
RX   PubMed=27807467;
RX   PubMed=28196595;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31733513;
RX   PubMed=35839778;
RX   PubMed=38861359;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; NCI DTP; NCI-60; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=35
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: NCI-60 cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 41.7 hours (NCI-DTP=UO-31).
CC   HLA typing: A*01:01:01,03:01:01; B*07,14; C*07,08; DPB1*04:02,05:01; DQB1*06:02,06:09; DRB1*13:02:01,15:01:01 (PubMed=15748285).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; Fluorescent probe library screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; lncRNA profiling; RT-qPCR platform.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.96%; Native American=0%; East Asian, North=3.55%; East Asian, South=0%; South Asian=0%; European, North=65.67%; European, South=28.82% (PubMed=30894373).
CC   Discontinued: DepMap; ACH-002203; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Cosmic-CLP=905981; PubMed=19372543
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 13,16.2
ST   D21S11: 32.2
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 21,25
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,20
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 42
//
ID   UoC-B1
AC   CVCL_A296
SY   UOC-B1; UOCB1; UoCB1
DR   ChEMBL-Cells; CHEMBL4513110
DR   ChEMBL-Targets; CHEMBL4513133
DR   Cosmic; 1524827
DR   GEO; GSM236810
DR   GEO; GSM236846
DR   GEO; GSM3145575
DR   GEO; GSM3145744
DR   IARC_TP53; 28429
DR   PubChem_Cell_line; CVCL_A296
DR   Wikidata; Q54991245
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7849311;
RX   PubMed=7888679;
RX   PubMed=8164688;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=9108419;
RX   PubMed=9823951;
RX   PubMed=20147975;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:4977; HLF + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-HLF, E2A-HLF (PubMed=8164688).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Cys477_Arg478insGlyLeuGly (c.1431_1432insGGTCTGGGC); Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C199241; B acute lymphoblastic leukemia with TCF3-HLF rearrangement
DI   ORDO; Orphanet_641375; B-lymphoblastic leukemia/lymphoma with t(17;19)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 22
//
ID   UoC-B10
AC   CVCL_A301
SY   UOC-B10; UOCB10
DR   Wikidata; Q54991247
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8069867;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UoC-B11
AC   CVCL_A299
SY   UOC-B11; UOCB11
DR   Wikidata; Q54991249
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8704231;
RX   PubMed=9108419;
RX   PubMed=9823951;
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   UoC-B12
AC   CVCL_A300
SY   UOC-B12; UOCB12
DR   Wikidata; Q54991252
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8704231;
CC   Doubling time: 10-14 days (PubMed=8704231).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=8704231).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UoC-B2
AC   CVCL_A302
SY   UOC-B2; UOCB2
DR   Wikidata; Q54991254
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7687517;
RX   PubMed=8704231;
CC   Doubling time: 50 hours (PubMed=7687517).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UoC-B3
AC   CVCL_A298
SY   UOC-B3; UOCB3
DR   Wikidata; Q54991256
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7888679;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Population: African American.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A303 ! UoC-B5
SX   Female
AG   14Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   UoC-B4
AC   CVCL_A297
SY   UOC-B4; UOCB4; UoCB4
DR   Wikidata; Q54991257
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7630190;
RX   PubMed=7849311;
RX   PubMed=7888679;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=9108419;
RX   PubMed=9823951;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=8704231).
CC   Derived from site: In situ; Cerebrospinal fluid; UBERON=UBERON_0001359.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A304 ! UoC-B6
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   UoC-B5
AC   CVCL_A303
SY   UOC-B5; UOCB5
DR   Wikidata; Q54991259
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: African American.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A298 ! UoC-B3
SX   Female
AG   14Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   UoC-B6
AC   CVCL_A304
SY   UOC-B6; UOCB6
DR   Wikidata; Q54991260
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (PubMed=8704231).
CC   Miscellaneous: STR profile from personal communication of Ryan, Russell James Hubbard.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11,13
ST   D18S51: 19
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 11,13
ST   FGA: 20,21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A297 ! UoC-B4
SX   Female
AG   3Y6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   UoC-B7
AC   CVCL_A305
SY   UOC-B7; UOCB7
DR   Wikidata; Q54991261
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: Caucasian.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y8M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   UoC-B8
AC   CVCL_A306
SY   UOC-B8; UOCB8
DR   Wikidata; Q54991263
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
CC   Population: African American.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y2M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   UoC-B9
AC   CVCL_A307
SY   UOC-B9; UOCB9
DR   Cosmic; 2491079
DR   Wikidata; Q54991264
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8231254;
RX   PubMed=8704231;
RX   PubMed=9067587;
CC   Population: African American.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y3M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   UoC-M1
AC   CVCL_A480
SY   UOC-M1; UOCM1
DR   cancercelllines; CVCL_A480
DR   Cosmic; 975311
DR   DSMZ; ACC-775
DR   DSMZCellDive; ACC-775
DR   GEO; GSM1040774
DR   Progenetix; CVCL_A480
DR   Wikidata; Q54991265
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9665199;
RX   PubMed=14671638;
RX   PubMed=36982453;
CC   Doubling time: ~50-60 hours (DSMZ=ACC-775).
CC   Misspelling: UCM1; GEO=GSM1040774.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-775
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 17,19
ST   D19S433: 11
ST   D21S11: 28
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 20,22
ST   Penta D: 11,12
ST   Penta E: 5,7
ST   TH01: 7
ST   TPOX: 9
ST   vWA: 15,16
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   UOCi001-A
AC   CVCL_C1QJ
SY   CIM001.4
DR   BioSamples; SAMEA110148252
DR   hPSCreg; UOCi001-A
DR   Wikidata; Q114313204
RX   PubMed=35917601;
CC   From: University of Calgary; Calgary; Canada.
CC   Population: Southeast Asian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UOCi002-A
AC   CVCL_C1QK
SY   CIM008.6
DR   BioSamples; SAMEA110148730
DR   hPSCreg; UOCi002-A
DR   Wikidata; Q114313205
RX   PubMed=35917601;
CC   From: University of Calgary; Calgary; Canada.
CC   Population: Southeast Asian.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   UOCi003-A
AC   CVCL_D0P0
SY   GPiPSC 31-1
DR   BioSamples; SAMEA114284527
DR   hPSCreg; UOCi003-A
DR   Wikidata; Q123033753
RX   PubMed=38364506;
CC   From: University of Calgary; Calgary; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2550; CELF2; Simple; p.Arg506His (c.1517G>A) (p.Arg493His, c.1478G>A) (c.1554G>A); ClinVar=VCV001334733; Zygosity=Heterozygous; Note=De novo mutation (PubMed=38364506).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206520; Developmental and epileptic encephalopathy 97
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UOCi003-A-1
AC   CVCL_D0P5
SY   A18 GPiPSC 31-1
DR   BioSamples; SAMEA114285740
DR   hPSCreg; UOCi003-A-1
DR   Wikidata; Q123033754
RX   PubMed=38364506;
CC   From: University of Calgary; Calgary; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2550; CELF2; Simple_corrected; p.Arg506His (c.1517G>A) (p.Arg493His, c.1478G>A) (c.1554G>A); ClinVar=VCV001334733; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38364506).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206520; Developmental and epileptic encephalopathy 97
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0P0 ! UOCi003-A
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UOCi004-A
AC   CVCL_E7VU
DR   hPSCreg; UOCi004-A
CC   From: University of Calgary; Calgary; Canada.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C125598; Spondylocostal dysostosis
DI   ORDO; Orphanet_2311; Autosomal recessive spondylocostal dysostosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UOCi005-A
AC   CVCL_E7VV
DR   hPSCreg; UOCi005-A
CC   From: University of Calgary; Calgary; Canada.
CC   Population: Mexican; native South American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84560; Anencephaly
DI   ORDO; Orphanet_1048; Isolated anencephaly/exencephaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LN94 ! GM25255
SX   Male
AG   18FW
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UOFS-CT-1
AC   CVCL_Z828
SY   University of the Orange Free State-Culex Theileri-1
DR   Wikidata; Q54991266
RX   PubMed=2280394;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=561267; ! Culex theileri (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   UOHi002-A
AC   CVCL_C1XV
SY   UOH002iShank3; UOH002iSHANK3
DR   BioSamples; SAMEA110547451
DR   hPSCreg; UOHi002-A
DR   Wikidata; Q114313206
RX   DOI=10.1101/2022.04.13.486968;
RX   PubMed=36044808;
CC   From: University of Haifa; Haifa; Israel.
CC   Population: Caucasian.
CC   Miscellaneous: We have kept in this entry the reference of the preprint (DOI=10.1101/2022.04.13.486968) because it contains the STR profile which is no longer available in the published paper (PubMed=36044808).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): DOI=10.1101/2022.04.13.486968
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13,15.2
ST   D21S11: 28,29
ST   D2S1338: 19,20
ST   D3S1358: 16,18
ST   D5S818: 9,10
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 26,27
ST   TH01: 9.3,10
ST   TPOX: 9,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   UOHi003-A
AC   CVCL_C1XU
SY   UOH001iShank3; UOH001iSHANK3; UOHi001-A
DR   BioSamples; SAMEA111396693
DR   hPSCreg; UOHi003-A
DR   Wikidata; Q114313208
RX   DOI=10.1101/2022.04.13.486968;
RX   PubMed=36044808;
CC   From: University of Haifa; Haifa; Israel.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14294; SHANK3; Simple; p.Ala1227Glyfs*69 (c.3679dupG) (c.3679insG); ClinVar=VCV000208759; Zygosity=Heterozygous (PubMed=36044808).
CC   Miscellaneous: We have kept in this entry the reference of the preprint (DOI=10.1101/2022.04.13.486968) because it contains the STR profile which is no longer available in the published paper (PubMed=36044808).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): DOI=10.1101/2022.04.13.486968
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 12
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 15,18
ST   D5S818: 9,11
ST   D7S820: 10
ST   D8S1179: 15
ST   FGA: 20,26
ST   TH01: 7,10
ST   TPOX: 9,11
ST   vWA: 16,18
DI   NCIt; C157124; Phelan-McDermid syndrome
DI   ORDO; Orphanet_48652; Monosomy 22q13.3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 7
//
ID   UOK101
AC   CVCL_B076
SY   UOK-101; UOK 101
DR   BioGRID_ORCS_Cell_line; 691
DR   BioSample; SAMN10988421
DR   Cell_Model_Passport; SIDM01400
DR   Cosmic; 972889
DR   DepMap; ACH-000262
DR   PharmacoDB; UOK101_1648_2019
DR   Progenetix; CVCL_B076
DR   Wikidata; Q54991268
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=25984343;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 28 hours (PubMed=25984343).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.341-3_341-2del; Zygosity=Unspecified (PubMed=7915601).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; shRNA library screening.
CC   Genome ancestry: African=1.6%; Native American=0%; East Asian, North=2.72%; East Asian, South=0%; South Asian=1.25%; European, North=60.33%; European, South=34.1% (PubMed=30894373).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   UOK102
AC   CVCL_B080
SY   UOK-102; UOK 102
DR   Cosmic; 972890
DR   Wikidata; Q54991269
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Pro138Arg (c.413C>G); Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UOK103
AC   CVCL_B081
SY   UOK-103; UOK 103
DR   Wikidata; Q54991271
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK104
AC   CVCL_B082
SY   UOK-104; UOK 104
DR   Wikidata; Q54991272
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK105
AC   CVCL_B083
SY   UOK-105; UOK 105
DR   Wikidata; Q54991273
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=27993170;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK106
AC   CVCL_B084
SY   UOK-106; UOK 106
DR   Wikidata; Q54991274
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK107
AC   CVCL_B085
SY   UOK-107; UOK 107; UOK 50
DR   IARC_TP53; 720
DR   Wikidata; Q54991277
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg249Serfs*95 (c.747delG); Zygosity=Unspecified (PubMed=8319216).
CC   Misspelling: Re-107; IARC_TP53=720; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UOK108
AC   CVCL_B086
SY   UOK-108; UOK 108
DR   Wikidata; Q54991278
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=27993170;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK109
AC   CVCL_B087
SY   UOK-109; UOK 109
DR   Cosmic; 1241981
DR   Wikidata; Q54991280
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=9393982;
CC   Sequence variation: Gene fusion; HGNC; HGNC:7871; NONO + HGNC; HGNC:11752; TFE3; Name(s)=NONO-TFE3 (PubMed=9393982).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B088 ! UOK109LN
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UOK109LN
AC   CVCL_B088
SY   UOK-109LN; UOK 109LN
DR   Wikidata; Q54991281
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B087 ! UOK109
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   UOK110
AC   CVCL_B089
SY   UOK-110; UOK 110
DR   cancercelllines; CVCL_B089
DR   Cosmic; 972891
DR   IARC_TP53; 721
DR   Wikidata; Q54991282
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Gly (c.518T>G); ClinVar=VCV000376016; Zygosity=Unspecified (PubMed=8319216).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly114Ser (c.340G>A); ClinVar=VCV000583094; Zygosity=Unspecified (PubMed=7915601).
CC   Misspelling: Re-110; IARC_TP53=721; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK111
AC   CVCL_B090
SY   UOK-111; UOK 111; UOK 39
DR   cancercelllines; CVCL_B090
DR   Cosmic; 972892
DR   IARC_TP53; 722
DR   SKY/M-FISH/CGH; 1526
DR   Wikidata; Q54991285
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=12759923;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Gly (c.518T>G); ClinVar=VCV000376016; Zygosity=Unspecified (PubMed=8319216).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Trp117Arg (c.349T>A); Zygosity=Unspecified (PubMed=7915601).
CC   Misspelling: Re-111; IARC_TP53=722; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK112
AC   CVCL_B091
SY   UOK-112; UOK 112
DR   Wikidata; Q54991287
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=9393982;
RX   PubMed=27993170;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK113
AC   CVCL_B092
SY   UOK-113; UOK 113
DR   Wikidata; Q54991289
RX   PubMed=1345811;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UOK114
AC   CVCL_B093
SY   UOK-114; UOK 114
DR   Wikidata; Q54991314
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK115
AC   CVCL_B094
SY   UOK-115; UOK 115
DR   cancercelllines; CVCL_B094
DR   Cosmic; 845932
DR   Cosmic; 972893
DR   SKY/M-FISH/CGH; 1484
DR   Wikidata; Q54991318
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=10723130;
RX   PubMed=12759923;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.309delT); ClinVar=VCV000223180; Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UOK116
AC   CVCL_B095
SY   UOK-116; UOK 116
DR   Wikidata; Q54991320
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK117
AC   CVCL_B096
SY   UOK-117; UOK 117
DR   cancercelllines; CVCL_B096
DR   Cosmic; 972894
DR   SKY/M-FISH/CGH; 1485
DR   Wikidata; Q54991322
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=9255309;
RX   PubMed=12759923;
RX   PubMed=27993170;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu158Pro (c.473T>C); ClinVar=VCV000182980; Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK117-5
AC   CVCL_IS29
DR   cancercelllines; CVCL_IS29
DR   Cosmic; 845927
DR   Wikidata; Q54991325
RX   PubMed=10723130;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu158Pro (c.473T>C); ClinVar=VCV000182980; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B096 ! UOK117
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   UOK117C4
AC   CVCL_RN44
DR   Wikidata; Q54991326
RX   PubMed=21907923;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B096 ! UOK117
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   UOK118
AC   CVCL_B097
SY   UOK-118; UOK 118
DR   Cosmic; 972871
DR   Cosmic; 972895
DR   Wikidata; Q54991328
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=8493574;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Tyr175Thrfs*27 (c.523delT); Zygosity=Unspecified (PubMed=7915601; PubMed=8493574).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UOK119
AC   CVCL_B098
SY   UOK-119; UOK 119
DR   Wikidata; Q54991331
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=27993170;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK120
AC   CVCL_B099
SY   UOK-120; UOK 120
DR   Cosmic; 1330966
DR   Wikidata; Q54991334
RX   PubMed=1345811;
RX   PubMed=7587394;
RX   PubMed=8319216;
RX   PubMed=8872474;
RX   PubMed=9255309;
RX   PubMed=27993170;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8872474).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UOK121
AC   CVCL_B100
SY   UOK-121; UOK 121; UoK121
DR   cancercelllines; CVCL_B100
DR   IARC_TP53; 723
DR   SKY/M-FISH/CGH; 1480
DR   Wikidata; Q54991335
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=12759923;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Unspecified (PubMed=8319216).
CC   Misspelling: Re-121; IARC_TP53=723; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B101 ! UOK121LN
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UOK121LN
AC   CVCL_B101
SY   UOK-121LN; UOK 121LN
DR   cancercelllines; CVCL_B101
DR   Wikidata; Q54991337
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Tyr (c.824G>A); ClinVar=VCV000215997; Zygosity=Unspecified (PubMed=8319216).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B100 ! UOK121
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   UOK122
AC   CVCL_B102
SY   UOK-122; UOK 122
DR   cancercelllines; CVCL_B102
DR   IARC_TP53; 724
DR   SKY/M-FISH/CGH; 1475
DR   Wikidata; Q54991339
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=12759923;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Unspecified (PubMed=8319216).
CC   Misspelling: Re-122; IARC_TP53=724; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B103 ! UOK122LN
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK122LN
AC   CVCL_B103
SY   UOK-122LN; UOK 122LN
DR   cancercelllines; CVCL_B103
DR   Wikidata; Q54991340
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Unspecified (PubMed=8319216).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B102 ! UOK122
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   UOK123
AC   CVCL_B104
SY   UOK-123; UOK 123
DR   cancercelllines; CVCL_B104
DR   Cosmic; 845926
DR   Cosmic; 972896
DR   IARC_TP53; 725
DR   Wikidata; Q54991342
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=10723130;
RX   PubMed=27993170;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.946del1; Zygosity=Unspecified (PubMed=8319216).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ile151Ser (c.452T>G); ClinVar=VCV000223215; Zygosity=Unspecified (PubMed=7915601).
CC   Misspelling: Re-123; IARC_TP53=725; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UOK124
AC   CVCL_B105
SY   UOK-124; UOK 124
DR   cancercelllines; CVCL_B105
DR   Cosmic; 1330967
DR   Cosmic; 2702366
DR   IARC_TP53; 726
DR   Wikidata; Q54991345
RX   PubMed=1345811;
RX   PubMed=7587394;
RX   PubMed=8319216;
RX   PubMed=8872474;
RX   PubMed=9255309;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8872474).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=8319216).
CC   Misspelling: Re-124; IARC_TP53=726; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B106 ! UOK124LN
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   UOK124LN
AC   CVCL_B106
SY   UOK-124LN; UOK 124LN
DR   Wikidata; Q54991347
RX   PubMed=1345811;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B105 ! UOK124
SX   Female
AG   21Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   UOK125
AC   CVCL_B107
SY   UOK-125; UOK 125
DR   Cosmic; 845931
DR   Wikidata; Q54991349
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK126
AC   CVCL_B108
SY   UOK-126; UOK 126
DR   Wikidata; Q54991350
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK127
AC   CVCL_B109
SY   UOK-127; UOK 127
DR   Wikidata; Q54991352
RX   PubMed=1345811;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=27993170;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK128
AC   CVCL_B110
SY   UOK-128; UOK 128
DR   Wikidata; Q54991354
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK129
AC   CVCL_B111
SY   UOK-129; UOK 129
DR   Wikidata; Q54991355
RX   PubMed=1345811;
RX   PubMed=8319216;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK130
AC   CVCL_B112
SY   UOK-130; UOK 130
DR   Cosmic; 972897
DR   Cosmic; 981000
DR   SKY/M-FISH/CGH; 1527
DR   Wikidata; Q54991357
RX   PubMed=1345811;
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=12759923;
RX   PubMed=17509556;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu153Pro (c.458T>C); Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   UOK131
AC   CVCL_B113
SY   UOK-131; UOK 131
DR   Wikidata; Q54991358
RX   PubMed=1345811;
RX   PubMed=9255309;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK132
AC   CVCL_B114
SY   UOK-132; UOK 132
DR   Wikidata; Q54991360
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=9393982;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UOK133
AC   CVCL_B115
SY   UOK-133; UOK 133
DR   Wikidata; Q54991362
RX   PubMed=9255309;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UOK134
AC   CVCL_B116
SY   UOK-134; UOK 134
DR   Wikidata; Q54991363
RX   PubMed=9255309;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UOK135
AC   CVCL_B117
SY   UOK-135; UOK 135
DR   cancercelllines; CVCL_B117
DR   Cosmic; 972898
DR   Wikidata; Q54991365
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asn90Ile (c.269A>T); ClinVar=VCV000223172; Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   UOK136COL
AC   CVCL_IS28
SY   UOK-136COL; UOK 136COL
DR   Wikidata; Q54991367
RX   PubMed=9255309;
CC   Derived from site: Metastatic; Colon; UBERON=UBERON_0001155.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 6
//
ID   UOK139
AC   CVCL_B118
SY   UOK-139; UOK 139
DR   Cosmic; 972899
DR   Wikidata; Q54991370
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Thr157Leufs*2 (c.469delA); Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UOK140
AC   CVCL_B119
SY   UOK-140; UOK 140
DR   cancercelllines; CVCL_B119
DR   Cosmic; 972900
DR   Cosmic; 981002
DR   Wikidata; Q54991371
RX   PubMed=7915601;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asp126Gly (c.377A>G); ClinVar=VCV000456585; Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK141
AC   CVCL_B120
SY   UOK-141; UOK 141
DR   Cosmic; 972901
DR   Wikidata; Q54991373
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gly104Alafs*55 (c.311delG); Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   UOK142
AC   CVCL_B121
SY   UOK-142; UOK 142
DR   Cosmic; 972902
DR   Wikidata; Q54991375
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Asp121_Ala122del (c.362_367del); Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   UOK143
AC   CVCL_B225
SY   UOK-143; UOK 143; UoK143
DR   SKY/M-FISH/CGH; 1473
DR   Wikidata; Q54991376
RX   PubMed=9255309;
RX   PubMed=12759923;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UOK145
AC   CVCL_B122
SY   UOK-145; UOK 145
DR   Cosmic; 1241980
DR   Wikidata; Q54991377
RX   PubMed=9393982;
RX   PubMed=23628822;
CC   Sequence variation: Gene fusion; HGNC; HGNC:10774; SFPQ + HGNC; HGNC:11752; TFE3; Name(s)=SFPQ-TFE3, PSF-TFE3 (PubMed=9393982).
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UOK146
AC   CVCL_B123
SY   UOK-146; UOK 146
DR   Cosmic; 1330968
DR   Wikidata; Q54991378
RX   PubMed=8872474;
RX   PubMed=9255309;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8872474).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C6975; Papillary renal cell carcinoma
DI   ORDO; Orphanet_319298; Papillary renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK147
AC   CVCL_B124
SY   UOK-147; UOK 147
DR   Cosmic; 845924
DR   Wikidata; Q54991379
RX   PubMed=9255309;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UOK150
AC   CVCL_B125
SY   UOK-150; UOK 150
DR   Cosmic; 972903
DR   Wikidata; Q54991380
RX   PubMed=7915601;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Tyr98Asn (c.292T>A); Zygosity=Unspecified (PubMed=7915601).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   UOK151
AC   CVCL_B126
SY   UOK-151; UOK 151
DR   cancercelllines; CVCL_B126
DR   Cosmic; 972875
DR   Cosmic; 972904
DR   Wikidata; Q54991381
RX   PubMed=7915601;
RX   PubMed=8493574;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser183Ter (c.548C>A); ClinVar=VCV000002215; Zygosity=Unspecified (PubMed=7915601; PubMed=8493574).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UOK152
AC   CVCL_B252
SY   UOK-152; UOK 152
DR   Wikidata; Q54991383
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   UOK154
AC   CVCL_B127
SY   UOK-154; UOK 154
DR   cancercelllines; CVCL_B127
DR   Cosmic; 972905
DR   IARC_TP53; 727
DR   SKY/M-FISH/CGH; 1524
DR   Wikidata; Q54991384
RX   PubMed=7915601;
RX   PubMed=8319216;
RX   PubMed=9255309;
RX   PubMed=12759923;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8319216).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gln203Argfs*16 (c.607del); Zygosity=Unspecified (PubMed=7915601).
CC   Misspelling: Re-154; IARC_TP53=727; Note=Not really a misspelling but an assignment of a name based on first author of publication because assignment of correct cell line name was not done correctly.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IS27 ! UOK154LN
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UOK154LN
AC   CVCL_IS27
SY   UOK-154LN; UOK 154LN
DR   cancercelllines; CVCL_IS27
DR   Wikidata; Q54991405
RX   PubMed=8319216;
RX   PubMed=9255309;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=8319216).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B127 ! UOK154
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   UOK156
AC   CVCL_A1UC
SY   UOK-156; UOK 156
DR   Wikidata; Q105511643
RX   PubMed=8319216;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   UOK157
AC   CVCL_A1UD
SY   UOK-157; UOK 157
DR   Wikidata; Q105511645
RX   PubMed=8319216;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 4
//
ID   UOK161
AC   CVCL_B128
SY   UOK-161; UOK 161
DR   cancercelllines; CVCL_B128
DR   Cosmic; 972906
DR   Wikidata; Q54991407
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Gln164Ter (c.490C>T); ClinVar=VCV000223228; Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   UOK162
AC   CVCL_B129
SY   UOK-162; UOK 162
DR   Cosmic; 972907
DR   Cosmic; 981004
DR   Wikidata; Q54991408
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu140Profs*19 (c.419del); Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   UOK163
AC   CVCL_B130
SY   UOK-163; UOK 163
DR   Cosmic; 972908
DR   Wikidata; Q54991409
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Trp117Ter (c.351G>A); Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   UOK164
AC   CVCL_B131
SY   UOK-164; UOK 164
DR   cancercelllines; CVCL_B131
DR   Cosmic; 972909
DR   Wikidata; Q54991410
RX   PubMed=7915601;
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Leu (c.194C>T); ClinVar=VCV000182975; Zygosity=Unspecified (PubMed=7915601).
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   UOK171
AC   CVCL_B223
SY   UOK-171; UOK 171
DR   SKY/M-FISH/CGH; 1525
DR   Wikidata; Q54991411
RX   PubMed=12759923;
WW   Provider; NIH OTT; E-033-2010/0; https://web.archive.org/web/20150920015218/http://www.ott.nih.gov/technology/e-033-2010
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 12
//
ID   UOK181
AC   CVCL_B224
SY   UOK-181; UOK 181
DR   SKY/M-FISH/CGH; 1483
DR   Wikidata; Q54991413
RX   PubMed=12759923;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UOK257
AC   CVCL_S717
SY   UOK-257; UOK 257
DR   cancercelllines; CVCL_S717
DR   PRIDE; PXD030237
DR   SKY/M-FISH/CGH; 5607
DR   Wikidata; Q54991414
RX   PubMed=17028174;
RX   PubMed=18206534;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-605.html
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.His429Profs*27 (c.1285dupC) (1733insC); ClinVar=VCV000003363; Zygosity=Hemizygous (PubMed=18206534).
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C28244; Birt-Hogg-Dube syndrome
DI   ORDO; Orphanet_122; Birt-Hogg-Dube syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
ID   UOK257-2
AC   CVCL_1D69
DR   cancercelllines; CVCL_1D69
DR   Wikidata; Q54991415
RX   PubMed=17028174;
CC   Characteristics: Transduction of wild type FLCN corrects the defects of this gene in the cell line (PubMed=17028174).
CC   Sequence variation: Mutation; HGNC; HGNC:27310; FLCN; Simple; p.His429Profs*27 (c.1285dupC) (1733insC); ClinVar=VCV000003363; Zygosity=Hemizygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:27310; FLCN.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C28244; Birt-Hogg-Dube syndrome
DI   ORDO; Orphanet_122; Birt-Hogg-Dube syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S717 ! UOK257
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   UOK262
AC   CVCL_1D72
SY   UOK-262; UOK 262
DR   BTO; BTO_0005727
DR   Wikidata; Q54991416
RX   PubMed=19963135;
RX   PubMed=21907923;
RX   PubMed=22867999;
RX   PubMed=27993170;
RX   PubMed=33402335;
WW   Provider; NIH OTT; E-216-2008/0-28; https://web.archive.org/web/20150922090236/http://www.ott.nih.gov/erma/uok-262-hereditary-leiomyomatosis-and-renal-cell-carcinoma-hlrcc-cell-line
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:3700; FH; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=19963135; PubMed=33402335).
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.Gln439Pro (c.1316A>C); ClinVar=VCV003230435; Zygosity=Heterozygous (PubMed=19963135; PubMed=33402335).
CC   Derived from site: Metastatic; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell carcinoma
DI   ORDO; Orphanet_523; Hereditary leiomyomatosis and renal cell cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   UOK262-WT
AC   CVCL_RN43
SY   262FH+
DR   Wikidata; Q54991418
RX   PubMed=21907923;
RX   PubMed=22867999;
CC   Population: Caucasian.
CC   Characteristics: Has a normal FH activity thanks to the transfection of the wild-type FH gene (PubMed=21907923).
CC   Sequence variation: Gene deletion; HGNC; HGNC:3700; FH; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.Gln439Pro (c.1316A>C); ClinVar=VCV003230435; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3700; FH.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell carcinoma
DI   ORDO; Orphanet_523; Hereditary leiomyomatosis and renal cell cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1D72 ! UOK262
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   UOK268
AC   CVCL_1D73
SY   UOK 268
DR   cancercelllines; CVCL_1D73
DR   Wikidata; Q54991421
RX   PubMed=21907923;
RX   PubMed=22867999;
RX   PubMed=27993170;
RX   PubMed=33402335;
WW   Provider; NIH OTT; E-254-2010/0-79; https://web.archive.org/web/20150923173311/http://www.ott.nih.gov/erma/one-1-vial-uok-268-hereditary-leiomyomatosis-and-renal-cell-carcinoma-hlrcc-human-cell-line
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.His235Asp (c.703C>G); ClinVar=VCV000393569; Zygosity=Homozygous (PubMed=22867999; PubMed=33402335).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell carcinoma
DI   ORDO; Orphanet_523; Hereditary leiomyomatosis and renal cell cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   UOK271
AC   CVCL_E7RC
RX   PubMed=33402335;
CC   Doubling time: 48-72 hours (Direct_author_submission).
CC   Sequence variation: Gene deletion; HGNC; HGNC:3700; FH; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=33402335).
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.Leu244Arg (c.731T>G); ClinVar=VCV000393571; Zygosity=Heterozygous (PubMed=33402335).
CC   Miscellaneous: Doubling time and STR profile from personal communication of Yang, You-Feng.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14,15
ST   D21S11: 28,31.2
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 18,22
ST   Penta D: 9,11
ST   Penta E: 12,15
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell carcinoma
DI   ORDO; Orphanet_523; Hereditary leiomyomatosis and renal cell cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UOK276
AC   CVCL_LC28
DR   cancercelllines; CVCL_LC28
DR   Wikidata; Q54991422
RX   PubMed=28736828;
CC   Doubling time: ~24 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Tyr (c.577C>T); ClinVar=VCV000230256; Zygosity=Homozygous (PubMed=28736828).
CC   Sequence variation: Mutation; HGNC; HGNC:20456; TRAF7; Simple; p.Pro22_Thr25del; Zygosity=Homozygous; Note=Heterozygous mutation in germline of patient (PubMed=28736828).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Miscellaneous: Doubling time from personal communication of Yang, You-Feng.
CC   Derived from site: Metastatic; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=28736828
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 10,12
ST   FGA: 20
ST   Penta D: 10
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4146; Chromophobe renal cell carcinoma
DI   ORDO; Orphanet_319303; Chromophobe renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 12
//
ID   UOK348
AC   CVCL_E7RD
RX   PubMed=33402335;
CC   Doubling time: 48-72 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.Phe191Leufs*11 (c.573delT); Zygosity=Heterozygous (PubMed=33402335).
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.Lys371Ter (c.1111A>T); Zygosity=Heterozygous (PubMed=33402335).
CC   Miscellaneous: Age/sex of donor, doubling time, sampling site and STR profile from personal communication of Yang, You-Feng.
CC   Derived from site: Metastatic; Pelvis; UBERON=UBERON_0002355.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15,18
ST   D21S11: 29,31.2
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 14,15
ST   FGA: 18,22
ST   Penta D: 10,13
ST   Penta E: 10,14
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell carcinoma
DI   ORDO; Orphanet_523; Hereditary leiomyomatosis and renal cell cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UOK350
AC   CVCL_E7RE
RX   PubMed=33402335;
CC   Doubling time: 48-72 hours (Direct_author_submission).
CC   Sequence variation: Gene deletion; HGNC; HGNC:3700; FH; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=33402335).
CC   Sequence variation: Mutation; HGNC; HGNC:3700; FH; Simple; p.Val322Gly (c.965T>G); ClinVar=VCV000214417; Zygosity=Heterozygous (PubMed=33402335).
CC   Miscellaneous: Doubling time and STR profile from personal communication of Yang, You-Feng.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 7,13
ST   D16S539: 9,13
ST   D18S51: 17,19
ST   D21S11: 32.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 9,12
ST   Penta E: 10
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C51302; Hereditary leiomyomatosis and renal cell carcinoma
DI   ORDO; Orphanet_523; Hereditary leiomyomatosis and renal cell cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UOK353
AC   CVCL_B3PQ
DR   cancercelllines; CVCL_B3PQ
DR   Wikidata; Q110433949
RX   PubMed=32259323;
CC   Population: African American.
CC   Doubling time: ~72 hours (PubMed=32259323).
CC   Karyotypic information: 43,XX,-4,-9,-15,t(19;22)(p13.1;q11.2) (PubMed=32259323).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Heterozygous (PubMed=32259323).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   UOK360
AC   CVCL_B3PR
DR   Wikidata; Q110433950
RX   PubMed=32259323;
CC   Population: African American.
CC   Doubling time: ~24 hours (PubMed=32259323).
CC   Karyotypic information: Hypertriploid karyotype (PubMed=32259323).
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Ser258Valfs*23 (c.771insA); Zygosity=Homozygous (PubMed=32259323).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C7572; Kidney medullary carcinoma
DI   ORDO; Orphanet_319319; Renal medullary carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   UOK85
AC   CVCL_A5PY
SY   UOK-85
DR   Wikidata; Q107117349
RX   PubMed=2294252;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UOKCR
AC   CVCL_4Z16
SY   UOK(CR)
DR   Wikidata; Q54991423
RX   PubMed=17509556;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Leu153Pro (c.458T>C); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B112 ! UOK130
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 9
//
ID   UOMELBi002-A
AC   CVCL_A8YZ
SY   F16574c3_A_A1_G8; F16574c3_AAG8
DR   BioSamples; SAMEA110403319
DR   hPSCreg; UOMELBi002-A
DR   Wikidata; Q108821465
RX   PubMed=34088002;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple_corrected; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34088002).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8YY ! F16574
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   UOMELBi004-A
AC   CVCL_E5E4
SY   F114030c3AA3
DR   hPSCreg; UOMELBi004-A
RX   PubMed=39079290;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple_corrected; p.His163Arg (c.488A>G); ClinVar=VCV000018124; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=39079290).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8YT ! F11430
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UOMi001-A
AC   CVCL_ZA81
SY   LCS-hiPSC-PT5
DR   BioSamples; SAMEA6877855
DR   hPSCreg; UOMi001-A
DR   Wikidata; Q98134316
RX   PubMed=32777769;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Ala173Val (c.518C>T); ClinVar=VCV000377257; Zygosity=Heterozygous (PubMed=32777769).
CC   Sequence variation: Mutation; HGNC; HGNC:3151; ECHS1; Simple; p.Lys284Profs*31 (c.849_852delAAAG); ClinVar=VCV001357281; Zygosity=Heterozygous (PubMed=32777769).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32777769
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D21S11: 28,31.2
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C174218; Mitochondrial short-chain enoyl-CoA hydratase-1 deficiency
DI   ORDO; Orphanet_255241; Leigh syndrome with leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 8
//
ID   UOMi002-A
AC   CVCL_ZA82
SY   LCS-hiPSC-PT2; C1 iPSC
DR   hPSCreg; UOMi002-A
DR   Wikidata; Q98134318
RX   PubMed=32871395;
RX   PubMed=33807701;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Population: Caucasian; Mennonite.
CC   Sequence variation: Mutation; HGNC; HGNC:7716; NDUFV1; Simple; p.Tyr177Leufs*1 (c.529dupT); Zygosity=Heterozygous (PubMed=32871395).
CC   Sequence variation: Mutation; HGNC; HGNC:7716; NDUFV1; Simple; p.Glu214Lys (c.640G>A); ClinVar=VCV000014059; Zygosity=Heterozygous (PubMed=32871395).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84814; Leigh disease
DI   ORDO; Orphanet_506; Leigh syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2-3Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UOMi003-A
AC   CVCL_ZA83
SY   LCS-hiPSC-PT3
DR   hPSCreg; UOMi003-A
DR   Wikidata; Q98134322
RX   PubMed=32777772;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Characteristics: This cell line does not harbor the sequence variation MT-TL1 m.3243A>G found in some mitochondria of the patient (PubMed=32777772).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=32777772
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D21S11: 27,29
ST   D5S818: 12,14
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C84885; MELAS syndrome
DI   ORDO; Orphanet_550; MELAS
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   UOMi004-A
AC   CVCL_ZA84
SY   LCS-hiPSC-PT7
DR   hPSCreg; UOMi004-A
DR   Wikidata; Q98134324
CC   From: University of Manitoba; Winnipeg; Canada.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   UOMi005-A
AC   CVCL_A7IM
SY   ALKCS-hiPSC-PT4; KSS2 iPSC
DR   BioSamples; SAMEA8268537
DR   hPSCreg; UOMi005-A
DR   Wikidata; Q107117350
RX   PubMed=33756177;
RX   PubMed=33807701;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Characteristics: While the patient has a 7.3 kb deletion in her mitochondrial DNA, this cell line does not show this deletion (PubMed=33756177; PubMed=33807701).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33756177
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D21S11: 31,31.2
ST   D5S818: 11
ST   D7S820: 9,13
ST   TH01: 8,10
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   UOMi006-A
AC   CVCL_A7IN
SY   AKLCS-hiPSC-PT6; KSS1 iPSC
DR   hPSCreg; UOMi006-A
DR   Wikidata; Q107117352
RX   PubMed=33807701;
RX   PubMed=33901817;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Characteristics: While the patient has a 5 kb deletion in her mitochondrial DNA, this cell line does not show this deletion (PubMed=33807701; PubMed=33901817).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84798; Kearns-Sayre syndrome
DI   ORDO; Orphanet_480; Kearns-Sayre syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   UOMi007-A
AC   CVCL_C0ZH
SY   ACS-hiPSC-HPP1
DR   hPSCreg; UOMi007-A
DR   Wikidata; Q114313209
RX   PubMed=35700635;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Glu191Lys (c.571G>A) (E174K); ClinVar=VCV000013670; Zygosity=Heterozygous (PubMed=35700635).
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Gly334Asp (c.1001G>A) (G317D, 1177A); ClinVar=VCV000013672; Zygosity=Heterozygous (PubMed=35700635).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UOMi008-A
AC   CVCL_C0ZI
SY   ACS-hiPSC-HPP2
DR   BioSamples; SAMEA110191722
DR   hPSCreg; UOMi008-A
DR   Wikidata; Q114313210
RX   PubMed=35964540;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Glu191Lys (c.571G>A) (E174K); ClinVar=VCV000013670; Zygosity=Heterozygous (PubMed=35964540).
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Gly334Asp (c.1001G>A) (G317D, 1177A); ClinVar=VCV000013672; Zygosity=Heterozygous (PubMed=35964540).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   UOMi009-A
AC   CVCL_C3MJ
SY   ACS-hiPSC-HPP3
DR   BioSamples; SAMEA110654725
DR   hPSCreg; UOMi009-A
DR   Wikidata; Q116050744
RX   PubMed=36152425;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Glu191Lys (c.571G>A) (E174K); ClinVar=VCV000013670; Zygosity=Heterozygous (PubMed=36152425).
CC   Sequence variation: Mutation; HGNC; HGNC:438; ALPL; Simple; p.Gly334Asp (c.1001G>A) (G317D, 1177A); ClinVar=VCV000013672; Zygosity=Heterozygous (PubMed=36152425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   UOMi010-A
AC   CVCL_E5E5
SY   ANCS-hiPSC-HPP5
DR   BioSamples; SAMEA115296777
DR   hPSCreg; UOMi010-A
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UOMi011-A
AC   CVCL_E5E6
SY   ANCS-hiPSC-HPP6
DR   BioSamples; SAMEA115296779
DR   hPSCreg; UOMi011-A
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C26798; Hypophosphatasia
DI   ORDO; Orphanet_436; Hypophosphatasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UOMi012-A
AC   CVCL_E5E7
SY   NAAS-hiPSC-Fontan1
DR   BioSamples; SAMEA115296781
DR   hPSCreg; UOMi012-A
RX   PubMed=39089181;
CC   From: University of Manitoba; Winnipeg; Canada.
CC   Donor information: Established from a patient that who went through the surgical procedure for Fontan circulation at the age of 13 (PubMed=39089181).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C95834; Congenital heart disease
DI   ORDO; Orphanet_156532; Rare syndrome with cardiac malformations
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   UOWi001-A
AC   CVCL_VF27
SY   RB 9-8; iPSC RB 9-8; RB9-8; HC3
DR   hPSCreg; UOWi001-A
DR   Wikidata; Q54991424
RX   PubMed=30278375;
RX   PubMed=32887382;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=30278375
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 12,13
ST   D21S11: 30.2,31
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 10
ST   Penta E: 12,13
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 7
//
ID   UOWi002-A
AC   CVCL_VF28
SY   6846.2; iPSC 6846.2; HC2
DR   BioSamples; SAMEA4760844
DR   hPSCreg; UOWi002-A
DR   Wikidata; Q54991426
RX   PubMed=30138848;
RX   PubMed=32887382;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_H799 ! AG06846
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 8
//
ID   UOWi003-A
AC   CVCL_VF29
SY   6848.2; iPSC 6848.2; FAD1
DR   hPSCreg; UOWi003-A
DR   Wikidata; Q54991427
RX   PubMed=30138848;
RX   PubMed=32887382;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.Ala246Glu (c.737C>A); ClinVar=VCV000018125; Zygosity=Heterozygous (PubMed=30138848).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D534 ! AG06848
SX   Female
AG   55Y6M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   UOWi004-A
AC   CVCL_VF30
SY   CCNF Control; CCNF1
DR   hPSCreg; UOWi004-A
DR   Wikidata; Q54991429
CC   From: University of Wollongong; Wollongong; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   UOWi005-A
AC   CVCL_VF31
SY   CCNF; CCNF2; iPSC MB2-1
DR   hPSCreg; UOWi005-A
DR   Wikidata; Q54991430
RX   PubMed=31445393;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:1591; CCNF; Simple; p.Ser621Gly (c.1861A>G); ClinVar=VCV000992591; Zygosity=Unspecified (PubMed=31445393).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=31445393
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 17,19
ST   D19S433: 14
ST   D21S11: 28,32.2
ST   D2S1338: 23
ST   D3S1358: 14,16
ST   D5S818: 11,13
ST   D7S820: 8,13
ST   D8S1179: 13,15
ST   FGA: 19,20
ST   Penta D: 11,13
ST   Penta E: 7,10
ST   TH01: 6,8
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   UOWi006-A
AC   CVCL_VP84
SY   RB7-11; SAD1
DR   hPSCreg; UOWi006-A
DR   Wikidata; Q98134328
RX   PubMed=32887382;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=32887382).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   UOWi007-A
AC   CVCL_VP85
SY   UOWi007; MQ54-2
DR   hPSCreg; UOWi007-A
DR   Wikidata; Q98134329
RX   PubMed=32006803;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Glu101Gly (c.302A>G) (E100G); ClinVar=VCV000014761; Zygosity=Heterozygous (PubMed=32006803).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   UOWi008-A
AC   CVCL_VP86
SY   RBC-10; C-10; ALS/FTD1
DR   hPSCreg; UOWi008-A
DR   Wikidata; Q98134331
RX   PubMed=32887382;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=32887382).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 7
//
ID   UOWi009-A
AC   CVCL_WT98
SY   MC_6-3
DR   hPSCreg; UOWi009-A
DR   Wikidata; Q98134332
CC   From: University of Wollongong; Wollongong; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 21-03-23; Version: 3
//
ID   UOWi010-A
AC   CVCL_B5GZ
SY   MB3-10
DR   hPSCreg; UOWi010-A
DR   Wikidata; Q110433951
CC   From: University of Wollongong; Wollongong; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   UOXFi001-A
AC   CVCL_EE27
SY   MK071-1; iPS.MK071.1; GBA-PD 1#1; GBA-PD 1 iPSc clone 1
DR   BioSamples; SAMEA4453897
DR   EBiSC; UOXFi001-A
DR   ECACC; 66540384
DR   GEO; GSM1291200
DR   GEO; GSM1291206
DR   hPSCreg; UOXFi001-A
DR   SKIP; SKIP002855
DR   Wikidata; Q54991432
RX   PubMed=26905200;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=26905200).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 66540384; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z6 ! MK071
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi001-B
AC   CVCL_EE28
SY   MK071-3; iPS.MK071.3; GBA-PD 1#2; GBA-PD 1 iPSc clone 3
DR   BioSamples; SAMEA4453900
DR   EBiSC; UOXFi001-B
DR   ECACC; 66540385
DR   GEO; GSM1291201
DR   GEO; GSM1291207
DR   hPSCreg; UOXFi001-B
DR   Wikidata; Q54991433
RX   PubMed=26905200;
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=26905200).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 66540385; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z6 ! MK071
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi001-C
AC   CVCL_EE29
SY   MK071-5; iPS.MK071.5
DR   BioSamples; SAMEA4453901
DR   EBiSC; UOXFi001-C
DR   ECACC; 66540386
DR   hPSCreg; UOXFi001-C
DR   SKIP; SKIP002856
DR   Wikidata; Q54991434
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (EBiSC=UOXFi001-C).
CC   Discontinued: EBiSC; UOXFi001-C; true.
CC   Discontinued: ECACC; 66540386; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z6 ! MK071
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi001-D
AC   CVCL_EE30
SY   MK071-6; iPS.MK071.6
DR   BioSamples; SAMEA4454476
DR   EBiSC; UOXFi001-D
DR   ECACC; 66540387
DR   hPSCreg; UOXFi001-D
DR   SKIP; SKIP002857
DR   Wikidata; Q54991435
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (EBiSC=UOXFi001-D).
CC   Discontinued: EBiSC; UOXFi001-D; true.
CC   Discontinued: ECACC; 66540387; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z6 ! MK071
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi002-A
AC   CVCL_IJ04
SY   MK082-26
DR   BioSamples; SAMEA4458672
DR   EBiSC; UOXFi002-A
DR   ECACC; 66540388
DR   hPSCreg; UOXFi002-A
DR   Wikidata; Q54991436
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=30503143).
CC   Discontinued: EBiSC; UOXFi002-A; true.
CC   Discontinued: ECACC; 66540388; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y8 ! MK082
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi002-B
AC   CVCL_IJ05
SY   MK082-30
DR   BioSamples; SAMEA4458549
DR   EBiSC; UOXFi002-B
DR   ECACC; 66540389
DR   hPSCreg; UOXFi002-B
DR   Wikidata; Q54991437
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (EBiSC=UOXFi002-B).
CC   Discontinued: ECACC; 66540389; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y8 ! MK082
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi002-C
AC   CVCL_IJ06
SY   MK082-31
DR   BioSamples; SAMEA7615168
DR   EBiSC; UOXFi002-C
DR   ECACC; 66540390
DR   GEO; GSM2634092
DR   GEO; GSM2644509
DR   hPSCreg; UOXFi002-C
DR   Wikidata; Q54991438
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (EBiSC=UOXFi002-C).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: EBiSC; UOXFi002-C; true.
CC   Discontinued: ECACC; 66540390; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y8 ! MK082
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 17
//
ID   UOXFi003-A
AC   CVCL_EE31
SY   MK088-1; GBA-PD 2#1; GBA-PD 2 iPSc clone 1
DR   BioSamples; SAMEA4454477
DR   EBiSC; UOXFi003-A
DR   ECACC; 66540391
DR   GEO; GSM1291202
DR   GEO; GSM1291209
DR   hPSCreg; UOXFi003-A
DR   Wikidata; Q54991439
RX   PubMed=26905200;
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (PubMed=26905200).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 66540391; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y9 ! MK088
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 18
//
ID   UOXFi003-B
AC   CVCL_WG64
SY   MK088-8
DR   hPSCreg; UOXFi003-B
DR   Wikidata; Q98134335
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y9 ! MK088
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 13
//
ID   UOXFi003-C
AC   CVCL_EE32
SY   MK088-7
DR   BioSamples; SAMEA4454479
DR   EBiSC; UOXFi003-C
DR   ECACC; 66540392
DR   GEO; GSM2634093
DR   GEO; GSM2644507
DR   hPSCreg; UOXFi003-C
DR   Wikidata; Q54991442
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple; p.Asn409Ser (c.1226A>G) (N370S); ClinVar=VCV000004290; Zygosity=Heterozygous (EBiSC=UOXFi003-C).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: EBiSC; UOXFi003-C; true.
CC   Discontinued: ECACC; 66540392; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y9 ! MK088
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 18
//
ID   UOXFi004-A
AC   CVCL_IJ07
SY   iPS-OX1-18; OX1-18; iPSc clone 18 from OX1 fibroblasts
DR   BioSamples; SAMEA7615918
DR   EBiSC; UOXFi004-A
DR   ECACC; 66540393
DR   GEO; GSM1105117
DR   GEO; GSM1105121
DR   hPSCreg; UOXFi004-A
DR   Wikidata; Q54991443
RX   PubMed=23951090;
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: EBiSC; UOXFi004-A; true.
CC   Discontinued: ECACC; 66540393; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y7 ! OX1
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   UOXFi004-B
AC   CVCL_IJ08
SY   iPS-OX1-19; OX1-19; iPSc clone 19 from OX1 fibroblasts; Ctrl 2#1
DR   BioSamples; SAMEA4454111
DR   EBiSC; UOXFi004-B
DR   ECACC; 66540394
DR   GEO; GSM1105118
DR   GEO; GSM1105122
DR   hPSCreg; UOXFi004-B
DR   Wikidata; Q54991444
RX   PubMed=23951090;
RX   PubMed=26905200;
RX   PubMed=28096185;
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: EBiSC; UOXFi004-B; true.
CC   Discontinued: ECACC; 66540394; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y7 ! OX1
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   UOXFi004-C
AC   CVCL_A9A4
SY   iPS-OX1-23; OX1-23; iPSc clone 23 from OX1 fibroblasts
DR   GEO; GSM1105119
DR   GEO; GSM1105123
DR   Wikidata; Q102115087
RX   PubMed=23951090;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y7 ! OX1
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
ID   UOXFi005-A
AC   CVCL_EE33
SY   JR053-1
DR   BioSamples; SAMEA4453899
DR   EBiSC; UOXFi005-A
DR   ECACC; 66540395
DR   GEO; GSM2634090
DR   GEO; GSM2644503
DR   hPSCreg; UOXFi005-A
DR   Wikidata; Q54991445
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540395; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z1 ! JR053
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   UOXFi005-B
AC   CVCL_EE34
SY   JR053-6
DR   BioSamples; SAMEA4454480
DR   EBiSC; UOXFi005-B
DR   ECACC; 66540396
DR   GEO; GSM2634091
DR   GEO; GSM2644504
DR   hPSCreg; UOXFi005-B
DR   Wikidata; Q54991446
RX   PubMed=30503143;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540396; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z1 ! JR053
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
ID   UOXFi005-C
AC   CVCL_EE35
SY   JR053-7
DR   BioSamples; SAMEA4454481
DR   EBiSC; UOXFi005-C
DR   ECACC; 66540397
DR   hPSCreg; UOXFi005-C
DR   Wikidata; Q54991448
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Discontinued: EBiSC; UOXFi005-C; true.
CC   Discontinued: ECACC; 66540397; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z1 ! JR053
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 11
//
ID   UOXFi006-A
AC   CVCL_IJ09
SY   OX2-28; OX2 clone 28
DR   BioSamples; SAMEA4458551
DR   EBiSC; UOXFi006-A
DR   ECACC; 66540398
DR   GEO; GSM2634089
DR   GEO; GSM2644518
DR   hPSCreg; UOXFi006-A
DR   Wikidata; Q54991449
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540398; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z0 ! OX2
SX   Male
AG   40-44Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   UOXFi007-A
AC   CVCL_LE37
SY   MK002-4; iPS-MK002-4
DR   BioSamples; SAMEA103988274
DR   EBiSC; UOXFi007-A
DR   ECACC; 66540556
DR   EGA; EGAS00001002755
DR   GEO; GSM2055810
DR   GEO; GSM2055815
DR   hPSCreg; UOXFi007-A
DR   Wikidata; Q54991451
RX   PubMed=28096185;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=28096185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540556; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y3 ! MK002
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   UOXFi007-B
AC   CVCL_LE38
SY   MK002-6
DR   BioSamples; SAMEA103887562
DR   EBiSC; UOXFi007-B
DR   ECACC; 66540549
DR   hPSCreg; UOXFi007-B
DR   Wikidata; Q54991455
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (EBiSC=UOXFi007-B).
CC   Omics: Genomics; Whole genome sequencing.
CC   Discontinued: EBiSC; UOXFi007-B; true.
CC   Discontinued: ECACC; 66540549; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y3 ! MK002
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 15
//
ID   UOXFi007-C
AC   CVCL_LE39
SY   MK002-7
DR   BioSamples; SAMEA103988271
DR   EBiSC; UOXFi007-C
DR   ECACC; 66540557
DR   hPSCreg; UOXFi007-C
DR   Wikidata; Q54991456
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (EBiSC=UOXFi007-C).
CC   Discontinued: EBiSC; UOXFi007-C; true.
CC   Discontinued: ECACC; 66540557; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y3 ! MK002
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   UOXFi008-A
AC   CVCL_LE40
SY   MK144-1
DR   BioSamples; SAMEA103887559
DR   EBiSC; UOXFi008-A
DR   ECACC; 66540550
DR   hPSCreg; UOXFi008-A
DR   Wikidata; Q54991458
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (EBiSC=UOXFi008-A).
CC   Discontinued: EBiSC; UOXFi008-A; true.
CC   Discontinued: ECACC; 66540550; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y4 ! MK144
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   UOXFi008-B
AC   CVCL_LE41
SY   MK144-7; iPS-MK144-7
DR   BioSamples; SAMEA103887561
DR   EBiSC; UOXFi008-B
DR   ECACC; 66540551
DR   EGA; EGAS00001002755
DR   GEO; GSM2055808
DR   GEO; GSM2055814
DR   hPSCreg; UOXFi008-B
DR   Wikidata; Q54991460
RX   PubMed=28096185;
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (PubMed=28096185).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540551; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y4 ! MK144
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 16
//
ID   UOXFi008-C
AC   CVCL_LE42
SY   MK144-10
DR   BioSamples; SAMEA103887557
DR   EBiSC; UOXFi008-C
DR   ECACC; 66540552
DR   hPSCreg; UOXFi008-C
DR   Wikidata; Q54991462
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous (EBiSC=UOXFi008-C).
CC   Discontinued: EBiSC; UOXFi008-C; true.
CC   Discontinued: ECACC; 66540552; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y4 ! MK144
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 14
//
ID   UOXFi009-A
AC   CVCL_LE43
SY   MK024-3; iPS MK024-3; IDI-PD 1 iPSc clone 3
DR   BioSamples; SAMEA103887539
DR   EBiSC; UOXFi009-A
DR   ECACC; 66540548
DR   GEO; GSM1291211
DR   hPSCreg; UOXFi009-A
DR   Wikidata; Q54991531
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: EBiSC; UOXFi009-A; true.
CC   Discontinued: ECACC; 66540548; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z5 ! MK024
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UOXFi009-B
AC   CVCL_LE44
SY   MK024-4
DR   BioSamples; SAMEA103988273
DR   EBiSC; UOXFi009-B
DR   ECACC; 66540558
DR   hPSCreg; UOXFi009-B
DR   Wikidata; Q54991533
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Discontinued: EBiSC; UOXFi009-B; true.
CC   Discontinued: ECACC; 66540558; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z5 ! MK024
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UOXFi009-C
AC   CVCL_LE45
SY   MK024-9
DR   BioSamples; SAMEA103988272
DR   EBiSC; UOXFi009-C
DR   ECACC; 66540559
DR   hPSCreg; UOXFi009-C
DR   Wikidata; Q54991535
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Discontinued: EBiSC; UOXFi009-C; true.
CC   Discontinued: ECACC; 66540559; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Z5 ! MK024
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UOXFi010-A
AC   CVCL_LE46
SY   JR023-1
DR   BioSamples; SAMEA103988270
DR   EBiSC; UOXFi010-A
DR   ECACC; 66540560
DR   hPSCreg; UOXFi010-A
DR   Wikidata; Q54991537
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Discontinued: EBiSC; UOXFi010-A; true.
CC   Discontinued: ECACC; 66540560; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9A3 ! JR023
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UOXFi010-B
AC   CVCL_LE47
SY   JR023-2; iPS JR023-2; IDI-PD 2 iPSc clone 3
DR   BioSamples; SAMEA103887564
DR   EBiSC; UOXFi010-B
DR   ECACC; 66540553
DR   GEO; GSM1291213
DR   hPSCreg; UOXFi010-B
DR   Wikidata; Q54991539
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: EBiSC; UOXFi010-B; true.
CC   Discontinued: ECACC; 66540553; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9A3 ! JR023
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UOXFi010-C
AC   CVCL_LE48
SY   JR023-5
DR   BioSamples; SAMEA103887560
DR   EBiSC; UOXFi010-C
DR   ECACC; 66540554
DR   hPSCreg; UOXFi010-C
DR   Wikidata; Q54991541
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Discontinued: EBiSC; UOXFi010-C; true.
CC   Discontinued: ECACC; 66540554; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9A3 ! JR023
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UOXFi010-D
AC   CVCL_LE49
SY   JR023-7
DR   BioSamples; SAMEA103887555
DR   EBiSC; UOXFi010-D
DR   ECACC; 66540555
DR   hPSCreg; UOXFi010-D
DR   Wikidata; Q54991543
CC   From: University of Oxford; Oxford; United Kingdom.
CC   Discontinued: EBiSC; UOXFi010-D; true.
CC   Discontinued: ECACC; 66540555; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9A3 ! JR023
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 11
//
ID   UP-007
AC   CVCL_AP56
DR   Wikidata; Q54991544
RX   PubMed=25550537;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   UP-019
AC   CVCL_AP57
DR   Wikidata; Q54991547
RX   PubMed=24335698;
RX   PubMed=25550537;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=24335698
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 9.3
ST   TPOX: 12
ST   vWA: 17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   UP-029
AC   CVCL_AU95
DR   Wikidata; Q54991549
RX   PubMed=24335698;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=24335698
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 10,11
ST   D21S11: 28,30
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   UP-032
AC   CVCL_AP58
DR   Wikidata; Q54991552
RX   PubMed=24335698;
RX   PubMed=25550537;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
ST   Source(s): PubMed=24335698
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 30,31
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 6
//
ID   UP-ALL13
AC   CVCL_UD75
SY   University of Padua-T-cell Acute Lymphoblastic Leukemia 13
DR   cancercelllines; CVCL_UD75
DR   Wikidata; Q98134337
RX   PubMed=30304769;
CC   Doubling time: 60-72 hours (PubMed=30304769).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=30304769).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=30304769).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Heterozygous (PubMed=30304769).
CC   Sequence variation: Mutation; HGNC; HGNC:2978; DNMT3A; Simple; p.Arg882His (c.2645G>A); ClinVar=VCV000375881; Zygosity=Heterozygous (PubMed=30304769).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
ST   Source(s): PubMed=30304769
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D21S11: 29,30
ST   D3S1358: 14
ST   D5S818: 12,13
ST   D7S820: 9,13
ST   D8S1179: 14,15
ST   FGA: 23,24
ST   Penta D: 9,14
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   UP3-175
AC   CVCL_XA94
DR   JCRB; IFO50224
DR   Wikidata; Q98134339
RX   Patent=US5496549;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2845.
CC   Characteristics: This is a tetradoma, a fusion of two hybridomas.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
CC   Discontinued: JCRB; IFO50224; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA93 ! 2T60
HI   CVCL_XA88 ! UK1-6
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   UP4-33
AC   CVCL_XA95
DR   JCRB; IFO50251
DR   Wikidata; Q98134341
RX   Patent=US5496549;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-3018.
CC   Characteristics: This is a tetradoma, a fusion of two hybridomas.
CC   Monoclonal antibody target: UniProtKB; P00749; Human PLAU.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
CC   Discontinued: JCRB; IFO50251; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XA93 ! 2T60
HI   CVCL_XA87 ! UK1-3
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 4
//
ID   UPAB
AC   CVCL_1R54
SY   University of Portsmouth AB
DR   Wikidata; Q54991554
RX   CelloPub=CLPUB00261;
RX   PubMed=20951163;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   UPAM
AC   CVCL_1T12
SY   University of Portsmouth AM
DR   Wikidata; Q54991555
RX   PubMed=20951163;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   UPCI-SCC-002
AC   CVCL_C024
SY   UPCI:SCC002; SCC002
DR   Wikidata; Q54991557
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-003
AC   CVCL_C025
SY   UPCI:SCC003; UPCISCC003; SCC003
DR   DSMZ; ACC-863
DR   DSMZCellDive; ACC-863
DR   GEO; GSM937836
DR   GEO; GSM937837
DR   Wikidata; Q54991560
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=23419152;
RX   PubMed=24142626;
RX   PubMed=24403267;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~45 hours (DSMZ=ACC-863).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): DSMZ=ACC-863
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 8,14
ST   D8S1179: 8
ST   FGA: 25
ST   Penta D: 11,13
ST   Penta E: 12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   UPCI-SCC-013
AC   CVCL_C026
SY   UPCI:SCC013; SCC013
DR   Wikidata; Q54991562
RX   PubMed=17112776;
CC   Population: Caucasian.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   UPCI-SCC-016
AC   CVCL_C027
SY   UPCI:SCC016; UPCISCC016; SCC016
DR   Cell_Model_Passport; SIDM01827
DR   DSMZ; ACC-884
DR   DSMZCellDive; ACC-884
DR   IARC_TP53; 18350
DR   Wikidata; Q54991564
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-884).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=12872257).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DSMZ=ACC-884
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 13,15
ST   D21S11: 29,31
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23,25
ST   Penta D: 9,11
ST   Penta E: 10,13
ST   TH01: 9.3,10
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2221 ! UPCI-SCC-026
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   UPCI-SCC-026
AC   CVCL_2221
SY   UPCI:SCC026; UPCISCC026; SCC026
DR   BioSample; SAMN03473471
DR   Cell_Model_Passport; SIDM01828
DR   DepMap; ACH-001690
DR   DSMZ; ACC-658
DR   DSMZCellDive; ACC-658
DR   Wikidata; Q54991567
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-658).
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): DepMap=ACH-001690; DSMZ=ACC-658
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 15
ST   D21S11: 31
ST   D2S1338: 20,24
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 23,25
ST   Penta D: 11
ST   Penta E: 10,13
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,18
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C027 ! UPCI-SCC-016
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 20
//
ID   UPCI-SCC-029A
AC   CVCL_1855
SY   UPCI-SCC-29A; UPCI:SCC029A; UPCISCC029A; UPCI-SCC-029B; UPCI:SCC029B; UPCI:SCC029; SCC029
DR   BioSample; SAMN03473472
DR   cancercelllines; CVCL_1855
DR   DepMap; ACH-001691
DR   DSMZ; ACC-659
DR   DSMZCellDive; ACC-659
DR   IARC_TP53; 18351
DR   Wikidata; Q54991569
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-659).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Thr (c.839G>C); ClinVar=VCV000012368; Zygosity=Heterozygous (PubMed=12872257; DepMap=ACH-001691).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): DSMZ=ACC-659
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14,18.2
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,25
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 8,9
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 13
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   UPCI-SCC-030
AC   CVCL_C028
SY   UPCI:SCC030; SCC030
DR   Wikidata; Q54991570
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UPCI-SCC-032
AC   CVCL_C029
SY   UPCI:SCC032; SCC032
DR   DSMZ; ACC-864
DR   DSMZCellDive; ACC-864
DR   IARC_TP53; 18352
DR   Wikidata; Q54991572
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-864).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu289fs (c.867_868del2); Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
ST   Source(s): DSMZ=ACC-864
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 12,13
ST   D21S11: 29,31
ST   D2S1338: 24
ST   D3S1358: 15
ST   D5S818: 13
ST   D7S820: 11,14
ST   D8S1179: 13
ST   FGA: 22,22.2
ST   Penta D: 11,12
ST   Penta E: 12,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UPCI-SCC-036
AC   CVCL_C030
SY   UPCI:SCC036; SCC036
DR   cancercelllines; CVCL_C030
DR   DSMZ; ACC-865
DR   DSMZCellDive; ACC-865
DR   GEO; GSM937838
DR   GEO; GSM937839
DR   IARC_TP53; 18353
DR   Wikidata; Q54991573
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=23419152;
RX   PubMed=24403267;
CC   Population: Caucasian.
CC   Virology: The tumor is positive to HPV (PubMed=17112776), but the cell line is HPV negative (PubMed=23419152; PubMed=24403267).
CC   Doubling time: ~48 hours (DSMZ=ACC-865).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile195Phe (c.583A>T); ClinVar=VCV000376617; Zygosity=Unspecified (PubMed=12872257).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): DSMZ=ACC-865
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 22,25
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C050 ! UPCI-SCC-104
OI   CVCL_C056 ! UPCI-SCC-142
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   UPCI-SCC-040
AC   CVCL_2222
SY   UPCI:SCC040; UPCISCC040; SCC040
DR   BioSample; SAMN03473474
DR   ChEMBL-Cells; CHEMBL4482982
DR   ChEMBL-Targets; CHEMBL4483277
DR   DepMap; ACH-001692
DR   DSMZ; ACC-660
DR   DSMZCellDive; ACC-660
DR   PubChem_Cell_line; CVCL_2222
DR   Wikidata; Q54991575
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~70-80 hours (DSMZ=ACC-660).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DepMap=ACH-001692; DSMZ=ACC-660
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 10
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 14 (DSMZ=ACC-660)
ST   D8S1179: 14,16 (DepMap=ACH-001692)
ST   FGA: 20,21
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 17 (DSMZ=ACC-660)
ST   vWA: 17,18 (DepMap=ACH-001692)
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 19
//
ID   UPCI-SCC-044
AC   CVCL_C031
SY   UPCI:SCC044; SCC044
DR   Wikidata; Q54991577
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-045
AC   CVCL_C032
SY   UPCI:SCC045; SCC045
DR   Wikidata; Q54991580
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UPCI-SCC-051
AC   CVCL_C033
SY   UPCI:SCC051; SCC051
DR   Wikidata; Q54991582
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UPCI-SCC-052
AC   CVCL_C034
SY   UPCI:SCC052; SCC052
DR   Wikidata; Q54991584
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UPCI-SCC-053
AC   CVCL_C035
SY   UPCI:SCC053; SCC053
DR   Wikidata; Q54991586
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UPCI-SCC-056
AC   CVCL_C036
SY   UPCI:SCC056; SCC056
DR   Wikidata; Q54991588
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-062
AC   CVCL_C037
SY   UPCI:SCC062; SCC062
DR   Wikidata; Q54991591
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-065
AC   CVCL_C038
SY   UPCI:SCC065; SCC065
DR   Wikidata; Q54991593
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-066
AC   CVCL_C039
SY   UPCI:SCC066; SCC066
DR   Wikidata; Q54991596
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   UPCI-SCC-068
AC   CVCL_C040
SY   UPCI:SCC068; SCC068
DR   Wikidata; Q54991597
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-070
AC   CVCL_C041
SY   UPCI:SCC070; SCC070
DR   cancercelllines; CVCL_C041
DR   IARC_TP53; 18354
DR   Wikidata; Q54991599
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=12872257).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UPCI-SCC-072
AC   CVCL_2223
SY   UPCI:SCC072; SCC072
DR   BioSample; SAMN03473421
DR   cancercelllines; CVCL_2223
DR   DepMap; ACH-001693
DR   DSMZ; ACC-667
DR   DSMZCellDive; ACC-667
DR   IARC_TP53; 18355
DR   Wikidata; Q54991601
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~120 hours (DSMZ=ACC-667).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): DSMZ=ACC-667
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 13
ST   D21S11: 17,24
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 14
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   Penta D: 13
ST   Penta E: 5,7
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   UPCI-SCC-074
AC   CVCL_2224
SY   UPCI:SCC074; UPCISCC074; SCC074
DR   BioSample; SAMN03473478
DR   cancercelllines; CVCL_2224
DR   DepMap; ACH-001694
DR   DSMZ; ACC-664
DR   DSMZCellDive; ACC-664
DR   Wikidata; Q54991604
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Indian.
CC   Doubling time: ~60 hours (DSMZ=ACC-664).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys132Asn (c.396G>T); ClinVar=VCV000634773; Zygosity=Heterozygous (DepMap=ACH-001694).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Heterozygous (DepMap=ACH-001694).
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): DepMap=ACH-001694; DSMZ=ACC-664
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,11
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,15
ST   D21S11: 30.2,31.2
ST   D2S1338: 20
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 10,15
ST   FGA: 20,24
ST   Penta D: 6,8
ST   Penta E: 7,13
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UPCI-SCC-075
AC   CVCL_C042
SY   UPCI:SCC075; SCC075
DR   Wikidata; Q54991606
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-077
AC   CVCL_C043
SY   UPCI:SCC077; SCC077
DR   DSMZ; ACC-866
DR   DSMZCellDive; ACC-866
DR   IARC_TP53; 18356
DR   Wikidata; Q54991608
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Doubling time: ~60-70 hours (DSMZ=ACC-866).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln317Hisfs*28 (c.951del); Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ=ACC-866
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 12,14
ST   D21S11: 27,29
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 9
ST   D7S820: 8
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 13
ST   Penta E: 7,13
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UPCI-SCC-078
AC   CVCL_C044
SY   UPCI:SCC078; SCC078
DR   cancercelllines; CVCL_C044
DR   DSMZ; ACC-867
DR   DSMZCellDive; ACC-867
DR   Wikidata; Q54991610
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-867).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg158Gly (c.472C>G); ClinVar=VCV000856171; Zygosity=Unspecified (DSMZ=ACC-867).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ=ACC-867
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 12,13
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 18
ST   D5S818: 8,11
ST   D7S820: 9,11
ST   D8S1179: 14,15
ST   FGA: 19
ST   Penta D: 10
ST   Penta E: 7,10
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   UPCI-SCC-080
AC   CVCL_C045
SY   UPCI:SCC080; SCC080
DR   Wikidata; Q54991613
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UPCI-SCC-081
AC   CVCL_C046
SY   UPCI:SCC081; SCC081
DR   DSMZ; ACC-868
DR   DSMZCellDive; ACC-868
DR   Wikidata; Q54991652
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Population: Caucasian.
CC   Doubling time: ~48 hours (DSMZ=ACC-868).
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): DSMZ=ACC-868
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 12
ST   FGA: 20,23
ST   Penta D: 9,12
ST   Penta E: 12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   87Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   UPCI-SCC-084
AC   CVCL_C047
SY   UPCI:SCC084; SCC084
DR   Cosmic; 1969497
DR   DSMZ; ACC-878
DR   DSMZCellDive; ACC-878
DR   IARC_TP53; 18357
DR   Wikidata; Q54991654
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
RX   PubMed=27045798;
CC   Population: Caucasian.
CC   Doubling time: ~22 hours (DSMZ=ACC-878).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220fs*27 (c.655delC) (p.P219Lfs); Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
ST   Source(s): DSMZ=ACC-878
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 28
ST   D2S1338: 17
ST   D3S1358: 16
ST   D5S818: 13
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 20
ST   Penta D: 9
ST   Penta E: 11,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   UPCI-SCC-089
AC   CVCL_C048
SY   UPCI:SCC089; SCC089
DR   Wikidata; Q54991656
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24403267;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UPCI-SCC-090
AC   CVCL_1899
SY   UPCI-SCC-90; UPCI:SCC090; UPCI:SCC90; UPCI-SCC090; UPCISCC090; SCC090; SCC90
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-3239
DR   BioGRID_ORCS_Cell_line; 1007
DR   BioSample; SAMN03473425
DR   Cell_Model_Passport; SIDM00399
DR   Cosmic; 1122679
DR   Cosmic; 1530750
DR   Cosmic; 2296310
DR   Cosmic-CLP; 1299052
DR   DepMap; ACH-001227
DR   DSMZ; ACC-670
DR   DSMZCellDive; ACC-670
DR   EGA; EGAS00001000978
DR   GDSC; 1299052
DR   GEO; GSM937832
DR   GEO; GSM937833
DR   PharmacoDB; SCC90_1357_2019
DR   PRIDE; PXD030304
DR   Wikidata; Q54991658
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=17848307;
RX   PubMed=20215515;
RX   PubMed=23419152;
RX   PubMed=24201445;
RX   PubMed=24403267;
RX   PubMed=25275298;
RX   PubMed=27397505;
RX   PubMed=28236344;
RX   PubMed=29156801;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=33802339;
RX   PubMed=35839778;
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/24336/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Population: Caucasian.
CC   Virology: Contains from 100 to 500 copies of the HPV16 genome (PubMed=24201445).
CC   Doubling time: 2.8 days (PubMed=29156801); ~120-150 hours (DSMZ=ACC-670).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=3.18%; East Asian, South=0%; South Asian=0%; European, North=67.02%; European, South=29.79% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-3239; Cosmic-CLP=1299052; DepMap=ACH-001227; DSMZ=ACC-670; PubMed=25275298; PubMed=29156801; PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,17 (DSMZ=ACC-670)
ST   D18S51: 14,18 (DepMap=ACH-001227; PubMed=25275298; PubMed=33802339)
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 22
ST   D3S1358: 14
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 20
ST   Penta D: 11
ST   Penta E: 11,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C058 ! UPCI-SCC-152
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 33
//
ID   UPCI-SCC-099
AC   CVCL_2225
SY   UPCI:SCC099; SCC099
DR   BioSample; SAMN03473479
DR   cancercelllines; CVCL_2225
DR   DSMZ; ACC-665
DR   DSMZCellDive; ACC-665
DR   IARC_TP53; 18358
DR   Wikidata; Q54991660
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Doubling time: ~50 hours (DSMZ=ACC-665).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro177Arg (c.530C>G); ClinVar=VCV000458547; Zygosity=Unspecified (PubMed=12872257).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: While the tumor has been shown to be HPV16 positive (PubMed=17112776), the cell line seems to be HPV16 negative (DSMZ=ACC-665).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ=ACC-665
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 14,16
ST   D21S11: 28
ST   D2S1338: 18
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7,9,10
ST   D8S1179: 13
ST   FGA: 23,23.2
ST   Penta D: 9
ST   Penta E: 7,8
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,18,19
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UPCI-SCC-103
AC   CVCL_C049
SY   UPCI:SCC103; SCC103
DR   DSMZ; ACC-879
DR   DSMZCellDive; ACC-879
DR   IARC_TP53; 18359
DR   Wikidata; Q54991662
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Doubling time: ~25-30 hours (DSMZ=ACC-879).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=12872257).
CC   Misspelling: UPMC-SCC103; Note=Occasionally.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DSMZ=ACC-879
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 21,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 21,24
ST   Penta D: 11,12
ST   Penta E: 13,14
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   UPCI-SCC-104
AC   CVCL_C050
SY   UPCI:SCC104; SCC104
DR   Wikidata; Q54991664
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C030 ! UPCI-SCC-036
OI   CVCL_C056 ! UPCI-SCC-142
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UPCI-SCC-105
AC   CVCL_C051
SY   UPCI:SCC105; SCC105
DR   IARC_TP53; 18360
DR   Wikidata; Q54991667
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Pro (c.463A>C); Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   UPCI-SCC-111
AC   CVCL_2226
SY   UPCI:SCC111; SCC111; SCC-111
DR   BioSample; SAMN03473480
DR   cancercelllines; CVCL_2226
DR   Cosmic; 927220
DR   Cosmic; 932154
DR   DepMap; ACH-001696
DR   DSMZ; ACC-666
DR   DSMZCellDive; ACC-666
DR   IARC_TP53; 18361
DR   Wikidata; Q54991668
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~40 hours (DSMZ=ACC-666).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Tyr (c.535C>T); ClinVar=VCV000127815; Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ=ACC-666
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 16.2
ST   D19S433: 14
ST   D21S11: 29,30,31
ST   D2S1338: 19,26
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 20
ST   Penta D: 11,14
ST   Penta E: 13
ST   TH01: 8,10
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   UPCI-SCC-114
AC   CVCL_2227
SY   UPCI:SCC114; SCC114
DR   BioSample; SAMN03473476
DR   cancercelllines; CVCL_2227
DR   DSMZ; ACC-662
DR   DSMZCellDive; ACC-662
DR   IARC_TP53; 18362
DR   Wikidata; Q54991670
RX   PubMed=12872257;
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (DSMZ=ACC-662).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ=ACC-662
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D19S433: 14
ST   D21S11: 27,30
ST   D2S1338: 17
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 13
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 16,20
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UPCI-SCC-116
AC   CVCL_2228
SY   UPCI:SCC116; UPCISCC116; SCC116
DR   BioSample; SAMN03473477
DR   cancercelllines; CVCL_2228
DR   DepMap; ACH-001698
DR   DSMZ; ACC-663
DR   DSMZCellDive; ACC-663
DR   IARC_TP53; 18363
DR   Wikidata; Q54991671
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~80 hours (DSMZ=ACC-663).
CC   Sequence variation: Mutation; HGNC; HGNC:667; RHOA; Simple; p.Gly17Val (c.50G>T); Zygosity=Unspecified (DepMap=ACH-001698).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=12872257; DepMap=ACH-001698).
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): DepMap=ACH-001698; DSMZ=ACC-663
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 12,14
ST   D21S11: 30
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   Penta D: 11
ST   Penta E: 7,10
ST   TH01: 9.3 (DepMap=ACH-001698)
ST   TH01: 10 (DSMZ=ACC-663)
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 23
//
ID   UPCI-SCC-121
AC   CVCL_C052
SY   UPCI:SCC121; SCC121
DR   Wikidata; Q54991673
RX   PubMed=17112776;
CC   Population: African American.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   UPCI-SCC-122
AC   CVCL_C053
SY   UPCI:SCC122; SCC122
DR   IARC_TP53; 18364
DR   Wikidata; Q54991674
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 12
//
ID   UPCI-SCC-125
AC   CVCL_C054
SY   UPCI:SCC125; UPCISCC125; SCC125
DR   cancercelllines; CVCL_C054
DR   DSMZ; ACC-885
DR   DSMZCellDive; ACC-885
DR   IARC_TP53; 18365
DR   Wikidata; Q54991675
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=17681875;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-885).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (PubMed=12872257).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
ST   Source(s): DSMZ=ACC-885
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 10,13
ST   Penta E: 7,18
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   UPCI-SCC-131
AC   CVCL_2229
SY   UPCI:SCC131; UPCISCC131; SCC131
DR   EFO; EFO_0022650
DR   BioSample; SAMN03473422
DR   DepMap; ACH-001699
DR   DSMZ; ACC-668
DR   DSMZCellDive; ACC-668
DR   Wikidata; Q54991676
RX   PubMed=17112776;
RX   PubMed=24142626;
RX   PubMed=27045798;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~50-60 hours (DSMZ=ACC-668).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DepMap=ACH-001699; DSMZ=ACC-668
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 13
ST   D18S51: 17,19
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 19,23
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 10
ST   TH01: 7,9
ST   TPOX: 8,11 (DepMap=ACH-001699)
ST   TPOX: 11 (DSMZ=ACC-668)
ST   vWA: 15,17
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 22
//
ID   UPCI-SCC-136
AC   CVCL_C055
SY   UPCI:SCC136; SCC136
DR   IARC_TP53; 18366
DR   Wikidata; Q54991678
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu224Ter (c.670G>T); Zygosity=Unspecified (PubMed=12872257).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 10
//
ID   UPCI-SCC-142
AC   CVCL_C056
SY   UPCI:SCC142; SCC142
DR   Wikidata; Q54991680
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Population: Caucasian.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C030 ! UPCI-SCC-036
OI   CVCL_C050 ! UPCI-SCC-104
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   UPCI-SCC-143
AC   CVCL_C057
SY   UPCI:SCC143; SCC143
DR   DSMZ; ACC-886
DR   DSMZCellDive; ACC-886
DR   Wikidata; Q54991682
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-886).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ=ACC-886
ST   Amelogenin: X
ST   CSF1PO: 13,15
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 29,31
ST   D2S1338: 18,25
ST   D3S1358: 18,19
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   Penta D: 14
ST   Penta E: 7,12
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 02-05-24; Version: 13
//
ID   UPCI-SCC-152
AC   CVCL_C058
SY   UPCI:SCC152; UPCISCC152; SCC152
DR   ATCC; CRL-3240
DR   Cell_Model_Passport; SIDM00398
DR   DepMap; ACH-001228
DR   Wikidata; Q54991684
RX   PubMed=17112776;
RX   PubMed=24403267;
RX   PubMed=26045983;
RX   PubMed=28236344;
RX   PubMed=29156801;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 2 days (PubMed=29156801).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Pharynx, hypopharynx; UBERON=UBERON_0001051.
ST   Source(s): ATCC=CRL-3240; PubMed=29156801
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1899 ! UPCI-SCC-090
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   UPCI-SCC-153
AC   CVCL_C059
SY   UPCI:SCC153; UPCISCC153; SCC153
DR   Wikidata; Q54991685
RX   PubMed=17112776;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   UPCI-SCC-154
AC   CVCL_2230
SY   UPCI:SCC154; UPCISCC154; SCC154
DR   ATCC; CRL-3241
DR   BioSample; SAMN03473423
DR   DepMap; ACH-001229
DR   DSMZ; ACC-669
DR   DSMZCellDive; ACC-669
DR   IZSLER; BS TCL 245
DR   Wikidata; Q54991687
RX   PubMed=17112776;
RX   PubMed=24403267;
RX   PubMed=28196595;
RX   PubMed=28236344;
RX   PubMed=28476783;
RX   PubMed=29156801;
RX   PubMed=33802339;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 3.8 days (PubMed=29156801); ~50-60 hours (DSMZ=ACC-669).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): ATCC=CRL-3241; DepMap=ACH-001229; DSMZ=ACC-669; PubMed=29156801; PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 15.2,16 (PubMed=33802339)
ST   D19S433: 16 (DSMZ=ACC-669)
ST   D21S11: 28,29
ST   D2S1338: 25
ST   D3S1358: 15,16 (DSMZ=ACC-669)
ST   D3S1358: 16 (DepMap=ACH-001229; PubMed=33802339)
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12
ST   FGA: 20,24
ST   Penta D: 11,13
ST   Penta E: 5,14
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UPCI-SCC-172
AC   CVCL_2231
SY   UPCI:SCC172; SCC172
DR   BioSample; SAMN03473475
DR   DSMZ; ACC-661
DR   DSMZCellDive; ACC-661
DR   IARC_TP53; 18367
DR   Wikidata; Q54991688
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Doubling time: ~50 hours (DSMZ=ACC-661).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Pro (c.463A>C); Zygosity=Unspecified (PubMed=12872257).
ST   Source(s): DSMZ=ACC-661
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 11
ST   D19S433: 13,15
ST   D21S11: 29,33.2
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 11,13
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   UPCI-SCC-182
AC   CVCL_C060
SY   UPCI:SCC182; SCC-182; SCC182
DR   cancercelllines; CVCL_C060
DR   DSMZ; ACC-887
DR   DSMZCellDive; ACC-887
DR   IARC_TP53; 18368
DR   Wikidata; Q54991689
RX   PubMed=12872257;
RX   PubMed=17112776;
RX   PubMed=24142626;
CC   Population: Caucasian.
CC   Doubling time: ~60-80 hours, ~100 hours (Note=After recovery from liquid nitrogen freezing) (DSMZ=ACC-887).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu294Ter (c.880G>T); ClinVar=VCV000379471; Zygosity=Unspecified (PubMed=12872257).
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
ST   Source(s): DSMZ=ACC-887
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13,19
ST   D19S433: 14,15
ST   D21S11: 31
ST   D2S1338: 24,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 13,14
ST   FGA: 21,28
ST   Penta D: 13
ST   Penta E: 15,17
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   UPCI-SCC-192
AC   CVCL_C061
SY   UPCI:SCC192; SCC192
DR   DSMZCellDive; ACC-888
DR   Wikidata; Q54991691
RX   PubMed=17112776;
CC   Population: Caucasian.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): DSMZ
ST   Amelogenin: X
ST   CSF1PO: 12,14
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 25
ST   Penta D: 13
ST   Penta E: 7,12
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 13
//
ID   UPCI-SCC-200
AC   CVCL_2232
SY   UPCI:SCC200; SCC200
DR   BioSample; SAMN03473427
DR   DepMap; ACH-001701
DR   DSMZ; ACC-672
DR   DSMZCellDive; ACC-672
DR   Wikidata; Q54991694
RX   PubMed=17112776;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~60-80 hours (DSMZ=ACC-672).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Caution: While the tumor has been shown to be HPV16 positive (PubMed=17112776), the cell line seems to be HPV16 negative (DSMZ=ACC-672).
ST   Source(s): DepMap=ACH-001701; DSMZ=ACC-672
ST   Amelogenin: X (DSMZ=ACC-672)
ST   Amelogenin: X,Y (DepMap=ACH-001701)
ST   CSF1PO: 11,14
ST   D13S317: 13,14
ST   D16S539: 10,12
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 30,32.2
ST   D2S1338: 19,23
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,7
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   UPES/C
AC   CVCL_1R55
DR   BioSample; SAMN03152029
DR   Wikidata; Q54991696
RX   PubMed=20951163;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from mouse (PubMed=20951163).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00388.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 11
//
ID   UPHHJA
AC   CVCL_1R56
DR   BioSample; SAMN03152030
DR   Wikidata; Q54991697
RX   PubMed=20951163;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be of human origin but found to be from rat (PubMed=20951163).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00389.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   UPITTi001-A
AC   CVCL_C0ES
DR   hPSCreg; UPITTi001-A
DR   Wikidata; Q112930523
CC   From: University of Pittsburgh; Pittsburgh; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   UPITTi002-A
AC   CVCL_C0ET
SY   NHLBI BhiPSC-CVD 75N9202D00019
DR   hPSCreg; UPITTi002-A
DR   Wikidata; Q112930524
RX   PubMed=34583280;
CC   From: University of Pittsburgh; Pittsburgh; USA.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   UPITTi002-A-1
AC   CVCL_C0EU
SY   PLN-R9C
DR   hPSCreg; UPITTi002-A-1
DR   Wikidata; Q112930525
RX   PubMed=34583280;
CC   From: University of Pittsburgh; Pittsburgh; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:9080; PLN; Simple_edited; p.Arg9Cys (c.25C>T); ClinVar=VCV000013636; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34583280).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173625; Dilated cardiomyopathy-1P
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0ET ! UPITTi002-A
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UPITTi003-A
AC   CVCL_C0EV
DR   hPSCreg; UPITTi003-A
DR   Wikidata; Q112930526
CC   From: University of Pittsburgh; Pittsburgh; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   UPITTi004-A
AC   CVCL_D0P6
SY   CN090 C5A5J2
DR   BioSamples; SAMEA114066390
DR   hPSCreg; UPITTi004-A
DR   Wikidata; Q123033755
RX   PubMed=38000347;
CC   From: University of Pittsburgh; Pittsburgh; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=38000347).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=38000347
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 16,19
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13,17
ST   FGA: 26,28
ST   Penta D: 5,11
ST   Penta E: 5,7
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0P7 ! UPITTi004-B
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UPITTi004-B
AC   CVCL_D0P7
SY   CN090 C1B5B5
DR   BioSamples; SAMEA114066531
DR   hPSCreg; UPITTi004-B
DR   Wikidata; Q123033756
RX   PubMed=38000347;
CC   From: University of Pittsburgh; Pittsburgh; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Homozygous (PubMed=38000347).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=38000347
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 16,19
ST   D21S11: 28,29
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 13,17
ST   FGA: 26,28
ST   Penta D: 5,11
ST   Penta E: 5,7
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0P6 ! UPITTi004-A
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   UPJM
AC   CVCL_1T13
SY   University of Portsmouth JM
DR   Wikidata; Q54991699
RX   CelloPub=CLPUB00261;
RX   PubMed=20951163;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   UPMC
AC   CVCL_1S99
SY   University of Portsmouth MC
DR   Wikidata; Q54991700
RX   CelloPub=CLPUB00261;
RX   PubMed=20951163;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 6
//
ID   UPMD-1
AC   CVCL_C297
SY   UPMD1; Uveal Primary Melanoma with Disomy-3 1
DR   cancercelllines; CVCL_C297
DR   Cosmic; 1628403
DR   DepMap; ACH-002926
DR   Wikidata; Q54991702
RX   PubMed=19212147;
RX   PubMed=22236444;
RX   PubMed=23849826;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: 100 hours (PubMed=19212147).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=22236444).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=22236444
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,13
ST   D16S539: 12
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 11,12
ST   vWA: 14,15
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   UPMD-2
AC   CVCL_C298
SY   UPMD2; Uveal Primary Melanoma with Disomy-3 2
DR   cancercelllines; CVCL_C298
DR   Cosmic; 1628404
DR   Wikidata; Q54991704
RX   PubMed=19212147;
RX   PubMed=22236444;
RX   PubMed=23849826;
CC   Doubling time: 150 hours (PubMed=19212147).
CC   Sequence variation: Mutation; HGNC; HGNC:4379; GNA11; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000376002; Zygosity=Unspecified (PubMed=22236444).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=22236444
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8
ST   FGA: 24,25
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   UPMM-1
AC   CVCL_C299
SY   UPMM1; Uveal Primary Melanoma with Monosomy-3 1
DR   cancercelllines; CVCL_C299
DR   Cosmic; 1628399
DR   Kerafast; EDE001
DR   Wikidata; Q54991706
RX   PubMed=16750193;
RX   PubMed=19212147;
RX   PubMed=22236444;
RX   PubMed=23849826;
CC   Doubling time: 100-150 hours (PubMed=19212147).
CC   Karyotypic information: Monosomy of chromosome 3 (PubMed=16750193).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Arg183Gln (c.548G>A); ClinVar=VCV000050853; Zygosity=Unspecified (PubMed=22236444).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=22236444
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 13
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 8
ST   FGA: 21
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   UPMM-2
AC   CVCL_C294
SY   UPMM2; Uveal Primary Melanoma with Monosomy-3 2
DR   cancercelllines; CVCL_C294
DR   Cosmic; 1628400
DR   Kerafast; EDE002
DR   Wikidata; Q54991707
RX   PubMed=16750193;
RX   PubMed=19212147;
RX   PubMed=22236444;
RX   PubMed=23849826;
CC   Doubling time: 150 hours (PubMed=19212147).
CC   Karyotypic information: Monosomy of chromosome 3 (PubMed=16750193).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Leu (c.626A>T); ClinVar=VCV000375955; Zygosity=Unspecified (PubMed=22236444).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=22236444
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,12
ST   D16S539: 12
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D7S820: 9
ST   FGA: 21.2,24
ST   TH01: 9,9.3
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   UPMM-3
AC   CVCL_C295
SY   UPMM3; Uveal Primary Melanoma with Monosomy-3 3
DR   CLDB; cl7223
DR   cancercelllines; CVCL_C295
DR   Cosmic; 1628401
DR   ICLC; HTL13001
DR   Wikidata; Q54991709
RX   PubMed=19212147;
RX   PubMed=22236444;
RX   PubMed=23849826;
CC   Doubling time: 100 hours (PubMed=19212147).
CC   Karyotypic information: Monosomy of chromosome 3 (PubMed=19212147).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Unspecified (PubMed=22236444).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): ICLC=HTL13001; PubMed=22236444
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 28,31.2
ST   D5S818: 10,11
ST   D7S820: 8,11
ST   FGA: 19
ST   TH01: 7,9.3
ST   TPOX: 9,10
ST   vWA: 16,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   UPMM-4
AC   CVCL_C296
SY   UPMM4; Uveal Primary Melanoma with Monosomy-3 4
DR   Cosmic; 1628407
DR   Wikidata; Q54991711
RX   PubMed=19212147;
RX   PubMed=22236444;
CC   Doubling time: 300 hours (PubMed=19212147).
CC   Karyotypic information: Monosomy of chromosome 3 (PubMed=19212147).
CC   Derived from site: In situ; Eye, uvea; UBERON=UBERON_0001768.
ST   Source(s): PubMed=22236444
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 12
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: Not_detected
ST   FGA: Not_detected
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPN1
AC   CVCL_A795
SY   UPN-1
DR   cancercelllines; CVCL_A795
DR   Cosmic; 1047109
DR   Cosmic; 2296996
DR   GEO; GSM119542
DR   GEO; GSM155075
DR   GEO; GSM155076
DR   GEO; GSM155077
DR   GEO; GSM629500
DR   GEO; GSM629501
DR   GEO; GSM2322623
DR   IARC_TP53; 25020
DR   Progenetix; CVCL_A795
DR   Wikidata; Q54991714
RX   PubMed=12742154;
RX   PubMed=12970738;
RX   PubMed=16960149;
RX   PubMed=17332242;
RX   PubMed=21746927;
RX   PubMed=25688540;
CC   HLA typing: A*24,32; B*07,18; C*07,07 (PubMed=25688540).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (PubMed=17332242).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu286Lys (c.856G>A); ClinVar=VCV000183752; Zygosity=Homozygous (PubMed=16960149; PubMed=17332242).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   UPN2
AC   CVCL_A796
SY   UPN-2
DR   cancercelllines; CVCL_A796
DR   Cosmic; 2296997
DR   GEO; GSM119504
DR   Progenetix; CVCL_A796
DR   Wikidata; Q54991716
RX   PubMed=12742154;
RX   PubMed=12970738;
RX   PubMed=16960149;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=16960149).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   UPN251
AC   CVCL_DG78
SY   UPN-251
DR   cancercelllines; CVCL_DG78
DR   GEO; GSM185162
DR   GEO; GSM185163
DR   GEO; GSM743489
DR   Progenetix; CVCL_DG78
DR   Wikidata; Q54991718
RX   PubMed=23415752;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: 24.29 hours (JWGray panel).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   UPPL1541
AC   CVCL_C0CT
DR   ABM; T8245
DR   Wikidata; Q112930527
RX   PubMed=29784854;
CC   Characteristics: Displays a similar expression profiles to luminal-like molecular subtype bladder cancers in humans (ABM=T8245).
CC   Doubling time: 24-36 hours (ABM=T8245).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6 Upk3a-CreERT2, Trp53L/L, PtenL/L, Rosa26LSL-Luc transgenic.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   UPPL1591
AC   CVCL_E5UL
DR   ABM; T8071
CC   From: Kim, William Y.; University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Characteristics: Displays a similar expression profiles to luminal-like molecular subtype bladder cancers in humans (ABM=T8071).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6 Upk3a-CreERT2, Trp53L/L, PtenL/L, Rosa26LSL-Luc transgenic.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UPPL1595
AC   CVCL_E5UM
DR   ABM; T8072
CC   From: Kim, William Y.; University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Characteristics: Displays a similar expression profiles to luminal-like molecular subtype bladder cancers in humans (ABM=T8072).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6 Upk3a-CreERT2, Trp53L/L, PtenL/L, Rosa26LSL-Luc transgenic.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UPPL1694
AC   CVCL_E5UN
DR   ABM; T8073
CC   From: Kim, William Y.; University of North Carolina at Chapel Hill; Chapel Hill; USA.
CC   Characteristics: Displays a similar expression profiles to luminal-like molecular subtype bladder cancers in humans (ABM=T8073).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
CC   Cell type: Urothelial cell; CL=CL_0000731.
CC   Breed/subspecies: C57BL/6 Upk3a-CreERT2, Trp53L/L, PtenL/L, Rosa26LSL-Luc transgenic.
DI   NCIt; C25823; Mouse bladder transitional cell carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UPS-1
AC   CVCL_T762
DR   RCB; RCB4451
DR   Wikidata; Q54991719
RX   PubMed=7876305;
RX   PubMed=26420878;
CC   Characteristics: Defective in the uptake of fluorescent phosphatidylserine analogs by the nonendocytic pathway (PubMed=7876305).
CC   Sequence variation: Mutation; UniProtKB; A0A061HXB8; Atp11c; Simple; p.Trp836Ter (c.2508G>A) (W664X); Zygosity=Homozygous (PubMed=26420878).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 10
//
ID   UPSFRi001-A
AC   CVCL_C345
SY   PB03; PB3; UPS-FRi004-A
DR   hPSCreg; UPSFRi001-A
DR   SKIP; SKIP002386
DR   Wikidata; Q54991721
RX   PubMed=22425713;
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPSFRi002-A
AC   CVCL_C346
SY   PB04; PB4; UPS-FRi005-A
DR   hPSCreg; UPSFRi002-A
DR   SKIP; SKIP002387
DR   Wikidata; Q54991762
RX   PubMed=22425713;
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 16
//
ID   UPSFRi004-A
AC   CVCL_C347
SY   PB05; PB5; UPS-FRi007-A
DR   hPSCreg; UPSFRi004-A
DR   SKIP; SKIP002389
DR   Wikidata; Q54991764
RX   PubMed=22425713;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 16
//
ID   UPSFRi004-A-1
AC   CVCL_C348
SY   PB05-1; PB05.1; UPS-FRi006-A; UPSFRi003-A
DR   hPSCreg; UPSFRi004-A-1
DR   SKIP; SKIP002388
DR   Wikidata; Q54991766
RX   PubMed=22425713;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C347 ! UPSFRi004-A
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   UPSFRi005-A
AC   CVCL_C349
SY   PB06; PB6; UPS-FRi008-A
DR   hPSCreg; UPSFRi005-A
DR   SKIP; SKIP002390
DR   Wikidata; Q54991770
RX   PubMed=22425713;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Karyotypic information: 47,XY,+21 (hPSCreg=UPSFRi005-A).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
ID   UPSFRi005-A-1
AC   CVCL_C350
SY   PB06-1; UPS-FRi008-A-1
DR   hPSCreg; UPSFRi005-A-1
DR   SKIP; SKIP002391
DR   Wikidata; Q54991772
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C349 ! UPSFRi005-A
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPSFRi006-A
AC   CVCL_C351
SY   PB07; PB7; UPS-FRi009-A
DR   hPSCreg; UPSFRi006-A
DR   SKIP; SKIP002392
DR   Wikidata; Q54991773
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPSFRi007-A
AC   CVCL_C352
SY   PB08; PB8; UPS-FRi010-A
DR   hPSCreg; UPSFRi007-A
DR   SKIP; SKIP002393
DR   Wikidata; Q54991775
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPSFRi008-A
AC   CVCL_C353
SY   PB09; PB9; UPS-FRi011-A
DR   hPSCreg; UPSFRi008-A
DR   SKIP; SKIP002394
DR   Wikidata; Q54991777
RX   PubMed=22425713;
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPSFRi009-A
AC   CVCL_C354
SY   PB10; UPS-FRi012-A
DR   hPSCreg; UPSFRi009-A
DR   SKIP; SKIP002395
DR   Wikidata; Q54991779
RX   PubMed=22425713;
RX   PubMed=22514597;
RX   PubMed=26938212;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 14
//
ID   UPSFRi010-A
AC   CVCL_QX68
SY   PB50
DR   hPSCreg; UPSFRi010-A
DR   Wikidata; Q54991782
RX   PubMed=28925363;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:9967; RET; Simple; p.Met918Thr (c.2753T>C); ClinVar=VCV000013919; Zygosity=Unspecified (PubMed=28925363).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3227; Multiple endocrine neoplasia type 2B
DI   ORDO; Orphanet_247709; Multiple endocrine neoplasia type 2B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 10
//
ID   UPSFRi011-A
AC   CVCL_QX70
SY   PB38
DR   hPSCreg; UPSFRi011-A
DR   Wikidata; Q54991785
RX   PubMed=29034880;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Unexplicit; Ex17del; Zygosity=Heterozygous (PubMed=29034880).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 11
//
ID   UPSFRi012-A
AC   CVCL_QX69
SY   PB52
DR   hPSCreg; UPSFRi012-A
DR   SKIP; SKIP003206
DR   Wikidata; Q54991787
RX   PubMed=28925365;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:6257; KCNJ11; Simple; p.Glu227Lys (c.679G>A); ClinVar=VCV000158682; Zygosity=Heterozygous (PubMed=28925365).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114769; Maturity-onset diabetes of the young
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
ID   UPSFRi013-A
AC   CVCL_VF25
SY   PB51; HNF1A(S142F)mutated iPSC
DR   hPSCreg; UPSFRi013-A
DR   SKIP; SKIP003204
DR   Wikidata; Q54991790
RX   PubMed=29597128;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Sequence variation: Mutation; HGNC; HGNC:11621; HNF1A; Simple; p.Ser142Phe (c.425C>T); ClinVar=VCV001327620; Zygosity=Heterozygous (PubMed=29597128).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129742; Hepatocyte nuclear factor 1-alpha-associated monogenic diabetes
DI   ORDO; Orphanet_552; MODY
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   UQACi001-A
AC   CVCL_YC63
SY   iPSC-EBS21
DR   BioSamples; SAMEA6114044
DR   hPSCreg; UQACi001-A
DR   Wikidata; Q98134343
RX   PubMed=32179493;
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:6416; KRT14; Simple; p.Arg125Ser (c.373C>A); ClinVar=VCV001338973; Zygosity=Heterozygous (PubMed=32179493).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 10
//
ID   UQACi002-A
AC   CVCL_C0GA
SY   iPSC-EBS1
DR   BioSamples; SAMEA10289463
DR   hPSCreg; UQACi002-A
DR   Wikidata; Q112930528
RX   PubMed=35334406;
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6416; KRT14; Simple; p.Ile377Thr (c.1130T>C); ClinVar=VCV000066303; Zygosity=Heterozygous (PubMed=35334406).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UQACi003-A
AC   CVCL_C0G7
SY   iPSC-EBS2
DR   BioSamples; SAMEA10379660
DR   hPSCreg; UQACi003-A
DR   Wikidata; Q112930529
RX   PubMed=35247839;
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Leu150Pro (c.449T>C); ClinVar=VCV000066241; Zygosity=Heterozygous (PubMed=35247839).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UQACi004-A
AC   CVCL_C0G8
SY   iPSC-EBS9
DR   BioSamples; SAMEA10379661
DR   hPSCreg; UQACi004-A
DR   Wikidata; Q112930530
RX   PubMed=35247839;
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Met327Thr (c.980T>C); ClinVar=VCV000014641; Zygosity=Heterozygous (PubMed=35247839).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UQACi005-A
AC   CVCL_C0GB
SY   iPSC-EBS10
DR   BioSamples; SAMEA10379662
DR   hPSCreg; UQACi005-A
DR   Wikidata; Q112930531
RX   PubMed=35334406;
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6416; KRT14; Simple; p.Ile412Phe (c.1234A>T); ClinVar=VCV000066317; Zygosity=Heterozygous (PubMed=35334406).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UQACi006-A
AC   CVCL_C0G9
SY   iPSC-EBS26
DR   BioSamples; SAMEA10379663
DR   hPSCreg; UQACi006-A
DR   Wikidata; Q112930532
RX   PubMed=35247839;
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6442; KRT5; Simple; p.Leu203Pro (c.608T>C); Zygosity=Heterozygous (PubMed=35247839).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UQACi007-A
AC   CVCL_C0GC
SY   iPSC-EBS29
DR   BioSamples; SAMEA10379664
DR   hPSCreg; UQACi007-A
DR   Wikidata; Q112930533
CC   From: Universite du Quebec a Chicoutimi; Chicoutimi; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6416; KRT14; Simple; p.Ile377Thr (c.1130T>C); ClinVar=VCV000066303; Zygosity=Heterozygous (hPSCreg=UQACi007-A).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84692; Epidermolysis bullosa simplex
DI   ORDO; Orphanet_79396; Epidermolysis bullosa simplex, generalized severe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   UQCRFS1 KO clone 8.5
AC   CVCL_ZC32
DR   Kerafast; EMI020
DR   Wikidata; Q98134345
RX   PubMed=22106410;
CC   Knockout cell: Method=Floxing/Cre recombination; MGI; MGI:1913944; Uqcrfs1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: 129X1/SvJ x C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   UQi001-A
AC   CVCL_D0P8
SY   C11-WT
DR   BioSamples; SAMEA113429808
DR   hPSCreg; UQi001-A
DR   Wikidata; Q123033757
RX   PubMed=37315423;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UQi001-A-1
AC   CVCL_D0P9
SY   C11-TDP43-A382T
DR   BioSamples; SAMEA113429835
DR   hPSCreg; UQi001-A-1
DR   Wikidata; Q123033758
RX   PubMed=37315423;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11571; TARDBP; Simple_edited; p.Ala382Thr (c.1144G>A); ClinVar=VCV000021474; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37315423).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
DI   NCIt; C168752; Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D0P8 ! UQi001-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 5
//
ID   UQi002-A
AC   CVCL_D0PA
SY   C3
DR   BioSamples; SAMEA113933048
DR   hPSCreg; UQi002-A
DR   Wikidata; Q123033759
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   UQi003-A
AC   CVCL_D6JW
SY   C7
DR   BioSamples; SAMEA114591113
DR   hPSCreg; UQi003-A
DR   Wikidata; Q127384610
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UQi004-A
AC   CVCL_D6JX
SY   C12
DR   BioSamples; SAMEA114591115
DR   hPSCreg; UQi004-A
DR   Wikidata; Q127384612
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UQi005-A
AC   CVCL_D6JY
SY   C13
DR   BioSamples; SAMEA114591117
DR   hPSCreg; UQi005-A
DR   Wikidata; Q127384615
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UQi006-A
AC   CVCL_D6JZ
SY   M2
DR   BioSamples; SAMEA114591119
DR   hPSCreg; UQi006-A
DR   Wikidata; Q127384617
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UQi007-A
AC   CVCL_D6K0
SY   M4
DR   BioSamples; SAMEA114591121
DR   hPSCreg; UQi007-A
DR   Wikidata; Q127384619
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   NCIt; C84719; Frontotemporal dementia
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UQi008-A
AC   CVCL_D6K1
SY   M8
DR   BioSamples; SAMEA114591123
DR   hPSCreg; UQi008-A
DR   Wikidata; Q127384622
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:28337; C9orf72; Repeat_expansion; c.-45+163GGGGCC[>24] (GGGGCC repeat expansion); ClinVar=VCV000031151; Zygosity=Unspecified (PubMed=38796984).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168756; Frontotemporal dementia and/or amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   UQi009-A
AC   CVCL_D6K2
SY   M15
DR   BioSamples; SAMEA114591125
DR   hPSCreg; UQi009-A
DR   Wikidata; Q127384624
RX   PubMed=38796984;
CC   From: Australian Institute for Bioengineering and Nanotechnology, University of Queensland; Brisbane; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp77Tyr (c.229G>T) (D76Y); ClinVar=VCV000805494; Zygosity=Heterozygous (PubMed=38796984).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   Urd-A
AC   CVCL_1N54
SY   CHO Urd-A
DR   Wikidata; Q54991792
RX   PubMed=21463;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   Urd-B
AC   CVCL_1N55
SY   A204
DR   Wikidata; Q54991795
RX   PubMed=220270;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   Urd-C
AC   CVCL_1N56
SY   URD-C; CHO Urd-C
DR   Wikidata; Q54991796
RX   PubMed=7368045;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 7
//
ID   URi001-A
AC   CVCL_C4RJ
SY   OPG-A01-6
DR   BioSamples; SAMEA110743878
DR   hPSCreg; URi001-A
DR   Wikidata; Q116050745
RX   PubMed=36166871;
CC   From: University of the Ryukyus; Okinawa; Japan.
CC   Population: Ryukyuan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C2982; Depression
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80-89Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   URi002-A
AC   CVCL_C4RK
SY   OPG-A08-13
DR   BioSamples; SAMEA110746352
DR   hPSCreg; URi002-A
DR   Wikidata; Q116050746
RX   PubMed=36166871;
CC   From: University of the Ryukyus; Okinawa; Japan.
CC   Population: Ryukyuan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50-59Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   URi004-A
AC   CVCL_C4RL
SY   OPG-A09-8
DR   BioSamples; SAMEA110746354
DR   hPSCreg; URi004-A
DR   Wikidata; Q116050747
RX   PubMed=36166871;
CC   From: University of the Ryukyus; Okinawa; Japan.
CC   Population: Ryukyuan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   URi005-A
AC   CVCL_C4RM
SY   OPG-A10-1
DR   BioSamples; SAMEA110746356
DR   hPSCreg; URi005-A
DR   Wikidata; Q116050748
RX   PubMed=36166871;
CC   From: University of the Ryukyus; Okinawa; Japan.
CC   Population: Ryukyuan.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30-39Y
CA   Induced pluripotent stem cell
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   UROtsa
AC   CVCL_0571
DR   BTO; BTO_0005004
DR   MCCL; MCC:0000476
DR   Cosmic; 867840
DR   ENCODE; ENCBS268AAA
DR   ENCODE; ENCBS269AAA
DR   GEO; GSM659708
DR   GEO; GSM659709
DR   GEO; GSM659710
DR   Wikidata; Q28872803
RX   PubMed=8788275;
RX   PubMed=11564615;
RX   PubMed=19921857;
RX   PubMed=20186695;
RX   PubMed=23691160;
RX   PubMed=26783756;
RX   PubMed=30550540;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/Urothelia_Crawford_protocol.pdf
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/u/cell-lines-detail-540.html
CC   Problematic cell line: Partially contaminated. Some stocks of UROTsa are contaminated with T24 (PubMed=23691160). However it must be noted that the stocks from the laboratory distributing/curating this cell line are not contaminated; therefore the contamination event has probably occurred through secondary sources after UROtsa was given to other investigators (PubMed=26783756).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00484.
CC   Doubling time: 29.7 hours (PubMed=8788275); 33.2 +- 0.8 hours (PubMed=19921857; PubMed=20186695).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
ST   Source(s): PubMed=23691160; PubMed=26783756
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 16
ST   D21S11: 27,29
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 20
ST   Penta D: 11,12
ST   Penta E: 11,17
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UROtsa As#1
AC   CVCL_LM59
SY   UT As #1
DR   Wikidata; Q54991805
RX   PubMed=20186695;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 26.4 +- 1.1 hours (PubMed=20186695).
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 9
//
ID   UROtsa As#2
AC   CVCL_LM60
SY   UT As #2
DR   Wikidata; Q54991808
RX   PubMed=20186695;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 14.1 +- 0.9 hours (PubMed=20186695).
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 9
//
ID   UROtsa As#3
AC   CVCL_LM61
SY   UT As #3
DR   Wikidata; Q54991811
RX   PubMed=20186695;
RX   PubMed=26783756;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 33.3 +- 1.4 hours (PubMed=20186695).
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 9
//
ID   UROtsa As#3-SPARC
AC   CVCL_LM67
SY   As#3-SPARC
DR   Wikidata; Q54991814
RX   PubMed=26783756;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11219; SPARC.
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LM61 ! UROtsa As#3
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   UROtsa As#4
AC   CVCL_LM62
SY   UT As #4
DR   Wikidata; Q54991818
RX   PubMed=20186695;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 21.0 +- 0.9 hours (PubMed=20186695).
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 9
//
ID   UROtsa As#5
AC   CVCL_LM63
SY   UT As #5
DR   Wikidata; Q54991820
RX   PubMed=20186695;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 16.4 +- 0.7 hours (PubMed=20186695).
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 9
//
ID   UROtsa As#6
AC   CVCL_LM64
SY   UT As #6
DR   Wikidata; Q54991822
RX   PubMed=20186695;
RX   PubMed=26783756;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 21.6 +- 1.6 hours (PubMed=20186695).
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 27-11-25; Version: 9
//
ID   UROtsa As#6-SPARC
AC   CVCL_LM68
SY   As#6-SPARC
DR   Wikidata; Q54991824
RX   PubMed=26783756;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11219; SPARC.
CC   Transformant: ChEBI; CHEBI_29678; Sodium arsenite.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LM64 ! UROtsa As#6
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   UROtsa Cd#1
AC   CVCL_IX03
SY   UTCd#1; UROtsa_Cd_1
DR   Wikidata; Q54991826
RX   PubMed=19921857;
RX   PubMed=26783756;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 27.8 +- 0.6 hours (PubMed=19921857).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 9
//
ID   UROtsa Cd#1-SPARC
AC   CVCL_LM65
SY   Cd#1-SPARC
DR   Wikidata; Q54991828
RX   PubMed=26783756;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11219; SPARC.
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IX03 ! UROtsa Cd#1
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   UROtsa Cd#2
AC   CVCL_IX04
SY   UTCd#2; UROtsa_Cd_2
DR   GEO; GSM659711
DR   Wikidata; Q54991831
RX   PubMed=19921857;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 18.8 +- 1.5 hours (PubMed=19921857).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   UROtsa Cd#3
AC   CVCL_IX05
SY   UTCd#3; UROtsa_Cd_3
DR   GEO; GSM659712
DR   Wikidata; Q54991834
RX   PubMed=19921857;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 16.4 +- 1.8 hours (PubMed=19921857).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   UROtsa Cd#4
AC   CVCL_IX06
SY   UTCd#4; UROtsa_Cd_4
DR   GEO; GSM659713
DR   Wikidata; Q54991836
RX   PubMed=19921857;
RX   PubMed=26783756;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 20.7 +- 1.1 hours (PubMed=19921857).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   UROtsa Cd#4-SPARC
AC   CVCL_LM66
SY   Cd#4-SPARC
DR   Wikidata; Q54991838
RX   PubMed=26783756;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11219; SPARC.
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_IX06 ! UROtsa Cd#4
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 9
//
ID   UROtsa Cd#5
AC   CVCL_IX07
SY   UTCd#5; UROtsa_Cd_5
DR   GEO; GSM659714
DR   Wikidata; Q54991840
RX   PubMed=19921857;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 18.2 +- 0.8 hours (PubMed=19921857).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   UROtsa Cd#6
AC   CVCL_IX08
SY   UTCd#6; UROtsa_Cd_6
DR   GEO; GSM659715
DR   Wikidata; Q54991842
RX   PubMed=19921857;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 16.9 +- 1.0 hours (PubMed=19921857).
CC   Transformant: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   UROtsa Cd#7
AC   CVCL_IX09
SY   UTCd#7; UROtsa_Cd_7
DR   GEO; GSM659716
DR   Wikidata; Q54991844
RX   PubMed=19921857;
RX   PubMed=30550540;
CC   Characteristics: Tumorigenic derivative of UROtsa. Subcutaneous injection of this cell line in nude mice produces tumors.
CC   Doubling time: 27.1 +- 1.3 hours (PubMed=19921857).
CC   Selected for resistance to: ChEBI; CHEBI_48775; Cadmium(2+).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   UROtsa N6AMT1
AC   CVCL_F1K8
RX   PubMed=21193388;
CC   Characteristics: Transduced with a HEMK2(N6AMT1)-IRES-ZsGreen construct (PubMed=21193388).
CC   Genetic integration: Method=Transduction; Gene=FPbase; W8LAG; ZsGreen (Note=FP506, green fluorescent protein derived from Zoanthus sp).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:16021; HEMK2.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Urinary bladder, urothelium; UBERON=UBERON_0004645.
CC   Cell type: Urothelial cell; CL=CL_0000731.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0571 ! UROtsa
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   UROtsa/F35
AC   CVCL_M721
DR   cancercelllines; CVCL_M721
DR   Wikidata; Q54991845
RX   PubMed=16102566;
RX   PubMed=23691160;
CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=23691160).
CC   Population: Caucasian; Swedish.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012600; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Ter (c.378C>G); ClinVar=VCV000578988; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0554 ! T24
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   URVIN
AC   CVCL_WZ46
DR   Wikidata; Q98134347
RX   PubMed=23936203;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 6
//
ID   US/VOT-E36
AC   CVCL_VC36
SY   VOT-E36; University of Sheffield/Ventral OTocyst-Epithelial 36
DR   CancerTools; 153625
DR   Wikidata; Q54991846
DR   Ximbio; 153625
RX   PubMed=15499550;
RX   PubMed=17331193;
CC   Characteristics: Suitable for studies on inner ear development, gene expression and function of inner ear-specific genes, in vitro screening for gene activation and promoter analysis, ototoxicity and in vitro analysis of inherited deafness mutations and of ion channels, receptors and signalling pathways in vitro.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Conditionally immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 12
//
ID   US/VOT-N33
AC   CVCL_VC37
SY   VOT-N33; University of Sheffield/Ventral OTocyst-Neuroblast 33
DR   CancerTools; 153626
DR   Wikidata; Q54991849
DR   Ximbio; 153626
RX   PubMed=15499550;
CC   Characteristics: Neuroblast cell line suitable for studies on: inner ear development; gene expression and function of inner ear-specific genes; in vitro screening for gene activation and promoter analysis; ototoxicity; and in vitro analysis of inherited deafness mutations and of ion channels, receptors and signalling pathways in vitro.
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Embryonic ear, inner ear, otocyst; UBERON=UBERON_0003051.
CC   Cell type: Neuroblast; CL=CL_0000031.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Conditionally immortalized cell line
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 12
//
ID   US8-93
AC   CVCL_WU93
DR   cancercelllines; CVCL_WU93
DR   IARC_TP53; 14966
DR   Wikidata; Q98134349
RX   PubMed=10737722;
RX   PubMed=15375518;
RX   PubMed=21528241;
CC   Doubling time: 21 +- 3.8 hours (PubMed=21528241).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Heterozygous (PubMed=21528241).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   US8-93A
AC   CVCL_WV03
DR   cancercelllines; CVCL_WV03
DR   Wikidata; Q98134351
RX   PubMed=21528241;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Heterozygous (PubMed=21528241).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU93 ! US8-93
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   US8-93B
AC   CVCL_WU95
DR   cancercelllines; CVCL_WU95
DR   Wikidata; Q98134353
RX   PubMed=21528241;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Heterozygous (PubMed=21528241).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU93 ! US8-93
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   US8-93C
AC   CVCL_WU96
DR   cancercelllines; CVCL_WU96
DR   Wikidata; Q98134356
RX   PubMed=21528241;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp91Ter (c.272G>A); ClinVar=VCV000233650; Zygosity=Heterozygous (PubMed=21528241).
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_WU93 ! US8-93
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 7
//
ID   USASK/DSIL-LHRH-A1
AC   CVCL_F805
SY   USASK/DSIL-GnRH
DR   CLO; CLO_0009488
DR   ATCC; HB-9094
DR   Wikidata; Q54991851
RX   Patent=US4676981;
RX   PubMed=3884802;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9094.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01148; Human GNRH1 (Note=AA 24-33 = Gonadoliberin-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 7
//
ID   USC-DHL-1
AC   CVCL_DH84
DR   GEO; GSM380152
DR   Wikidata; Q54991853
RX   PubMed=19278952;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   USC-HN1
AC   CVCL_D656
SY   USC-HNI
DR   ATCC; CRL-3026
DR   Wikidata; Q38122528
RX   PubMed=20175927;
CC   Doubling time: 18 hours (PubMed=20175927).
CC   Discontinued: ATCC; CRL-3026; true.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 11
//
ID   USC-HN1-GFP
AC   CVCL_LG26
DR   GEO; GSM1027069
DR   GEO; GSM1027070
DR   GEO; GSM1027071
DR   GEO; GSM1027072
DR   Wikidata; Q54991862
RX   PubMed=24018643;
CC   Characteristics: Transfected with an H2B-GFP fusion protein.
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4761; H2BC11.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: USC-HN3-GFP; PubMed=24018643.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D656 ! USC-HN1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 7
//
ID   USC-HN1-GFP-G1
AC   CVCL_LG27
DR   GEO; GSM1027073
DR   GEO; GSM1027074
DR   GEO; GSM1027075
DR   GEO; GSM1027076
DR   Wikidata; Q54991864
RX   PubMed=24018643;
CC   Characteristics: Transfected with an H2B-GFP fusion protein.
CC   Characteristics: Metastatic. Parent cell line was injected into the tongues of SCID/nude mice. The metastatic cells were collected at lymph nodes, separated and cultured (PubMed=24018643).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4761; H2BC11.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: USC-HN3-GFP-G1; PubMed=24018643.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LG26 ! USC-HN1-GFP
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 7
//
ID   USC-HN1-GFP-G2
AC   CVCL_LG28
DR   GEO; GSM1027077
DR   GEO; GSM1027078
DR   GEO; GSM1027079
DR   GEO; GSM1027080
DR   Wikidata; Q54991904
RX   PubMed=24018643;
CC   Characteristics: Transfected with an H2B-GFP fusion protein.
CC   Characteristics: Metastatic. Parent cell line was injected into the tongues of SCID/nude mice. The metastatic cells were collected at lymph nodes, separated and cultured (PubMed=24018643).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4761; H2BC11.
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: USC-HN3-GFP-G2; PubMed=24018643.
CC   Derived from site: In situ; Oral cavity, alveolar ridge; UBERON=UBERON_0004103.
DI   NCIt; C170774; Alveolar ridge squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_LG27 ! USC-HN1-GFP-G1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   USC-HN2
AC   CVCL_W327
DR   Wikidata; Q54991905
RX   PubMed=21719345;
CC   Doubling time: 22 hours (PubMed=21719345).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a patient with a 50-pack-year history of tobacco smoking and occasional alcohol consumption and a past medical history of recurrent left sided oral cancer (PubMed=21719345).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 10
//
ID   USCBi001-A
AC   CVCL_VF51
SY   NIBSC_i008; NIBSC8
DR   BioSamples; SAMEA12616336
DR   hPSCreg; USCBi001-A
DR   Wikidata; Q54991906
RX   PubMed=36744062;
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/apply_for_cell_lines.aspx
WW   Provider; NIBSC; -; https://nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_line_catalogue/research_grade_stem_cell_lines.aspx
CC   From: National Institute for Biological Standards and Control - UK Stem Cell Bank; South Mimms Potters Bar; United Kingdom.
CC   Population: Caucasian.
CC   Karyotypic information: 46,XX,t(14;22)(q24;q11.2) (hPSCreg=USCBi001-A).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=36744062
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 12,19
ST   D19S433: 13.2,14
ST   D21S11: 29,30.2
ST   D2S1338: 23
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2629 ! MRC-9
SX   Female
AG   15FW
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 10
//
ID   USCi001-A
AC   CVCL_UL45
SY   iCHARGE2; CHD7Q1701X; G08; 22C
DR   BioSamples; SAMEA5573421
DR   hPSCreg; USCi001-A
DR   Wikidata; Q98134359
CC   From: University of Southern California, Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Gln1701Ter (c.5101C>T); ClinVar=VCV002444122; Zygosity=Unspecified (hPSCreg=USCi001-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   USCi002-A
AC   CVCL_UL46
SY   iCHARGE1; CHD7R1036X; 21C
DR   hPSCreg; USCi002-A
DR   Wikidata; Q98134361
CC   From: University of Southern California, Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:20626; CHD7; Simple; p.Arg1036Ter (c.3106C>T); ClinVar=VCV000488373; Zygosity=Unspecified (hPSCreg=USCi002-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75100; CHARGE syndrome
DI   ORDO; Orphanet_138; CHARGE syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   USCi003-A
AC   CVCL_UL41
SY   iBFLS1; 25B
DR   hPSCreg; USCi003-A
DR   Wikidata; Q98134363
CC   From: University of Southern California, Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18145; PHF6; Simple; p.Cys45Tyr (c.134G>A); ClinVar=VCV000011066; Zygosity=Unspecified (hPSCreg=USCi003-A).
DI   NCIt; C157122; Intellectual developmental disorder, X-linked syndromic, Borjeson-Forssman-Lehmann type
DI   ORDO; Orphanet_127; Borjeson-Forssman-Lehmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 9
//
ID   USCi004-A
AC   CVCL_UL42
SY   iBFLS2; 26B
DR   hPSCreg; USCi004-A
DR   Wikidata; Q98134365
CC   From: University of Southern California, Los Angeles; Los Angeles; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18145; PHF6; Simple; p.Cys45Tyr (c.134G>A); ClinVar=VCV000011066; Zygosity=Unspecified (hPSCreg=USCi004-A).
DI   NCIt; C157122; Intellectual developmental disorder, X-linked syndromic, Borjeson-Forssman-Lehmann type
DI   ORDO; Orphanet_127; Borjeson-Forssman-Lehmann syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 27-11-25; Version: 9
//
ID   USCi005-A
AC   CVCL_UL43
SY   iFF-1; normal iPSC-1
DR   hPSCreg; USCi005-A
DR   Wikidata; Q98134367
CC   From: University of Southern California, Los Angeles; Los Angeles; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 4
//
ID   USCi006-A
AC   CVCL_UL44
SY   iMF-2; normal iPSC-2
DR   hPSCreg; USCi006-A
DR   Wikidata; Q98134369
CC   From: University of Southern California, Los Angeles; Los Angeles; USA.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   USCLS-1
AC   CVCL_KR66
SY   University of Southern California Lung Squamous-1
DR   Wikidata; Q54991909
RX   PubMed=2654003;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 8
//
ID   USEM
AC   CVCL_JJ70
SY   Ujumqin Sheep Ear Marginal tissue
DR   Wikidata; Q54991910
RX   PubMed=20383581;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: ~72 hours (PubMed=20383581).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Ujumqin; VBO=VBO_0015769.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Female
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 7
//
ID   USF-MC1
AC   CVCL_E7Y5
SY   University of South Florida-Mast Cell line 1
RX   DOI=10.1016/j.jaci.2008.12.750;
RX   Patent=US9096829;
WW   Info; IdeaConnection; -; https://www.ideaconnection.com/patents/14886-Human-Mast-Cell-Line-and-Uses-Thereof.html
CC   Group: Patented cell line.
CC   Doubling time: 1-2 weeks (Patent=US9096829).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
CC   Cell type: Mast cell; CL=CL_0000097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   USFi001-A
AC   CVCL_A6XD
SY   1CN1.5
DR   BioSamples; SAMEA8192624
DR   hPSCreg; USFi001-A
DR   Wikidata; Q107117353
RX   PubMed=34034220;
CC   From: University of South Florida; Tampa; USA.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[781]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=34034220).
CC   Sequence variation: Mutation; HGNC; HGNC:3951; FXN; Repeat_expansion; IVS1 GAA[1092]; ClinVar=VCV000561195; Zygosity=Heterozygous (PubMed=34034220).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   USFi002-A
AC   CVCL_A6XE
SY   0AS1
DR   BioSamples; SAMEA8445429
DR   hPSCreg; USFi002-A
DR   Wikidata; Q107117354
RX   PubMed=34088019;
CC   From: University of South Florida; Tampa; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Asp2116Argfs*37 (c.6345_6352delTGACAAGC); ClinVar=VCV000959711; Zygosity=Heterozygous (PubMed=34088019).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179295; Familial hypertrophic cardiomyopathy type 26
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   USFi003-A
AC   CVCL_A6XF
SY   1AB1
DR   BioSamples; SAMEA8660436
DR   hPSCreg; USFi003-A
DR   Wikidata; Q107117355
RX   PubMed=34029931;
CC   From: University of South Florida; Tampa; USA.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Arg541Cys (c.1621C>T); ClinVar=VCV000048046; Zygosity=Heterozygous (PubMed=34029931).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84673; Dilated cardiomyopathy
DI   ORDO; Orphanet_217604; Dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   USFi004-A
AC   CVCL_A6XG
SY   3IV6
DR   BioSamples; SAMEA8717120
DR   hPSCreg; USFi004-A
DR   Wikidata; Q107117356
RX   PubMed=34034221;
CC   From: University of South Florida; Tampa; USA.
CC   Population: Caribbean; Haitian and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; p.Asp600Valfs*56 (c.1799delA); ClinVar=VCV000202020; Zygosity=Heterozygous (PubMed=34034221).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   USH1-hiPSC1
AC   CVCL_C368
SY   USH-hiPSC1; USH.1.H.iPSC.1
DR   RSCB; RSCB0100
DR   Wikidata; Q54991913
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C374 ! USH1-hiPSC7
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USH1-hiPSC2
AC   CVCL_C369
SY   USH-hiPSC2; USH.1.H.iPSC.2
DR   RSCB; RSCB0101
DR   Wikidata; Q54991914
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C374 ! USH1-hiPSC7
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USH1-hiPSC3
AC   CVCL_C370
SY   USH-hiPSC3; USH.1.H.iPSC.3
DR   RSCB; RSCB0102
DR   Wikidata; Q54991915
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C374 ! USH1-hiPSC7
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USH1-hiPSC4
AC   CVCL_C371
SY   USH-hiPSC4; USH.1.H.iPSC.4
DR   RSCB; RSCB0103
DR   Wikidata; Q54991916
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C374 ! USH1-hiPSC7
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USH1-hiPSC5
AC   CVCL_C372
SY   USH-hiPSC5; USH.1.H.iPSC.5
DR   RSCB; RSCB0104
DR   Wikidata; Q54991917
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C374 ! USH1-hiPSC7
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USH1-hiPSC6
AC   CVCL_C373
SY   USH-hiPSC6; USH.1.H.iPSC.6; RIi011-A
DR   hPSCreg; RIi011-A
DR   RSCB; RSCB0105
DR   SKIP; SKIP002406
DR   SKIP; SKIP005846
DR   Wikidata; Q54991920
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C374 ! USH1-hiPSC7
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
ID   USH1-hiPSC7
AC   CVCL_C374
SY   USH-hiPSC7; USH.1.H.iPSC.7
DR   RSCB; RSCB0106
DR   Wikidata; Q54991921
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C375 ! USH1-hiPSC8
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USH1-hiPSC8
AC   CVCL_C375
SY   USH-hiPSC8; USH.1.H.iPSC.8
DR   RSCB; RSCB0107
DR   Wikidata; Q54991923
RX   PubMed=22145677;
CC   From: Royan Institute; Theran; Iran.
CC   Population: Iranian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85217; Usher syndrome
DI   ORDO; Orphanet_886; Usher syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C368 ! USH1-hiPSC1
OI   CVCL_C369 ! USH1-hiPSC2
OI   CVCL_C370 ! USH1-hiPSC3
OI   CVCL_C371 ! USH1-hiPSC4
OI   CVCL_C372 ! USH1-hiPSC5
OI   CVCL_C373 ! USH1-hiPSC6
OI   CVCL_C374 ! USH1-hiPSC7
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
ID   USM-BC-1
AC   CVCL_VP41
SY   Universiti Sains Malaysia-Bladder Cancer-1
DR   Wikidata; Q98134370
RX   CelloPub=CLPUB00438;
CC   Population: Malaysian.
CC   Doubling time: 44.8 hours (CelloPub=CLPUB00438).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): CelloPub=CLPUB00438
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 10,11
ST   D18S51: 17,18
ST   D19S433: 15.2,16
ST   D21S11: 31,31.2
ST   D2S1338: 19,26
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   TH01: 9.3,10
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   USP-1
AC   CVCL_Z290
SY   A32
DR   Wikidata; Q54991924
RX   PubMed=12011937;
RX   PubMed=25761219;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   USP-13-Med
AC   CVCL_4U90
SY   USP-13-MED
DR   Wikidata; Q54991925
RX   PubMed=26358937;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 24.5 hours (PubMed=26358937).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26358937).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 10
//
ID   USP-2
AC   CVCL_Z291
SY   A414
DR   Wikidata; Q54991927
RX   PubMed=12011937;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   USP-3
AC   CVCL_Z292
SY   B310
DR   Wikidata; Q54991930
RX   PubMed=12011937;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   USP-4
AC   CVCL_Z293
SY   B410
DR   Wikidata; Q54991933
RX   PubMed=12011937;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   USP-91
AC   CVCL_H634
DR   Wikidata; Q54991936
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8400235;
RX   PubMed=15356658;
CC   Doubling time: 26 hours (PubMed=8400235).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3720; Anaplastic large cell lymphoma
DI   ORDO; Orphanet_98841; Anaplastic large cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   USPC-ARK-1
AC   CVCL_IV72
SY   USPC ARK-1; USPC-ARK1; USC ARK-1; ARK-1
DR   cancercelllines; CVCL_IV72
DR   Wikidata; Q54991940
RX   PubMed=19920829;
RX   PubMed=21246534;
RX   PubMed=23891627;
RX   PubMed=26325104;
RX   PubMed=26625219;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=23891627; PubMed=26325104).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   USPC-ARK-10
AC   CVCL_IV81
SY   USPC-ARK10
DR   Wikidata; Q54991943
RX   PubMed=23891627;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-11
AC   CVCL_IV82
SY   USPC-ARK11; ARK11
DR   Cosmic; 2640560
DR   Wikidata; Q54991945
RX   PubMed=23891627;
RX   PubMed=25268372;
RX   PubMed=27894751;
CC   Population: African American.
CC   Doubling time: 23.1 hours (PubMed=25268372).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
ID   USPC-ARK-12
AC   CVCL_IV83
SY   USPC-ARK12
DR   Wikidata; Q54991948
RX   PubMed=23891627;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-13
AC   CVCL_IV84
SY   USPC-ARK13
DR   Wikidata; Q54991951
RX   PubMed=23891627;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-14
AC   CVCL_IV85
SY   USPC-ARK14
DR   Wikidata; Q54991954
RX   PubMed=23891627;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-15
AC   CVCL_IV86
SY   USPC-ARK15
DR   Wikidata; Q54991956
RX   PubMed=23891627;
CC   Population: Caucasian.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 4
//
ID   USPC-ARK-16
AC   CVCL_IV87
SY   USPC-ARK16
DR   Wikidata; Q54991957
RX   PubMed=23891627;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-17
AC   CVCL_IV88
SY   USPC-ARK17
DR   Wikidata; Q54991958
RX   PubMed=23891627;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-18
AC   CVCL_IV89
SY   USPC-ARK18
DR   Wikidata; Q54991959
RX   PubMed=23891627;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-19
AC   CVCL_IV90
SY   USPC-ARK19; ARK19
DR   Wikidata; Q54991960
RX   PubMed=23891627;
RX   PubMed=25268372;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-2
AC   CVCL_IV73
SY   USPC ARK-2; USPC-ARK2; USC ARK-2; ARK-2; ARK2
DR   Cosmic; 2640558
DR   Wikidata; Q54991963
RX   PubMed=19920829;
RX   PubMed=21246534;
RX   PubMed=23891627;
RX   PubMed=25268372;
RX   PubMed=26325104;
RX   PubMed=26625219;
RX   PubMed=27894751;
CC   Population: African American.
CC   Doubling time: 18.2 hours (PubMed=25268372).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 6
//
ID   USPC-ARK-20
AC   CVCL_IV91
SY   USPC-ARK20; USC ARK-20; ARK-20; ARK20
DR   cancercelllines; CVCL_IV91
DR   Wikidata; Q54991965
RX   PubMed=23891627;
RX   PubMed=25268372;
RX   PubMed=26325104;
RX   PubMed=26625219;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=23891627; PubMed=26325104).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 11
//
ID   USPC-ARK-21
AC   CVCL_IV92
SY   USPC-ARK21; USC ARK-21; ARK-21; ARK21
DR   Wikidata; Q54991967
RX   PubMed=23891627;
RX   PubMed=25268372;
RX   PubMed=26325104;
RX   PubMed=26625219;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-22
AC   CVCL_IV93
SY   USPC-ARK22; ARK22
DR   Wikidata; Q54991970
RX   PubMed=23891627;
RX   PubMed=25268372;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-3
AC   CVCL_IV74
SY   USPC ARK-3; USPC-ARK3; ARK3
DR   Wikidata; Q54991972
RX   PubMed=19920829;
RX   PubMed=21246534;
RX   PubMed=23891627;
RX   PubMed=25268372;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-4
AC   CVCL_IV75
SY   USPC ARK-4; USPC-ARK4
DR   Wikidata; Q54991974
RX   PubMed=19920829;
RX   PubMed=21246534;
RX   PubMed=23891627;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-5
AC   CVCL_IV76
SY   USPC ARK-5; USPC-ARK5
DR   Wikidata; Q54991976
RX   PubMed=19920829;
RX   PubMed=21246534;
RX   PubMed=23891627;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-6
AC   CVCL_IV77
SY   USPC ARK-6; USPC-ARK6; ARK6
DR   cancercelllines; CVCL_IV77
DR   Cosmic; 2640556
DR   Wikidata; Q54991978
RX   PubMed=19920829;
RX   PubMed=21246534;
RX   PubMed=23891627;
RX   PubMed=27894751;
CC   Population: Caucasian.
CC   Microsatellite instability: Instable (MSI-high) (Note=After >50 passages) (PubMed=27894751).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.His67Asn (c.199C>A); ClinVar=VCV000473501; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Ala1967Val (c.5900C>T); ClinVar=VCV000246263; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Asp368Tyr; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Ala832Thr; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Cys1642Tyr; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Gly2076Val; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Leu2207Ile; Zygosity=Unspecified (PubMed=27894751; Direct_author_submission).
CC   Miscellaneous: Correct age of donor (not 62 year old as indicated in PubMed=19920829) and sequence variation in POLE from personal communication of Santin, Alessandro D.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 14
//
ID   USPC-ARK-7
AC   CVCL_IV78
SY   USPC-ARK7; ARK7
DR   Cosmic; 2640559
DR   Wikidata; Q54991980
RX   PubMed=23891627;
RX   PubMed=25268372;
RX   PubMed=27894751;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-8
AC   CVCL_IV79
SY   USPC-ARK8
DR   Wikidata; Q54991982
RX   PubMed=23891627;
CC   Population: Caucasian.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPC-ARK-9
AC   CVCL_IV80
SY   USPC-ARK9
DR   Wikidata; Q54992030
RX   PubMed=23891627;
CC   Population: African American.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 5
//
ID   USPi001-A
AC   CVCL_C6TD
SY   iPS_LGH_AHDC1_P1
DR   BioSamples; SAMEA111496317
DR   hPSCreg; USPi001-A
DR   Wikidata; Q117704947
RX   PubMed=37054903;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:25230; AHDC1; Simple; p.Gln332Ter (c.994C>T); ClinVar=VCV000800800; Zygosity=Heterozygous; Note=De novo mutation (PubMed=37054903).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192092; Xia-Gibbs syndrome
DI   ORDO; Orphanet_412069; AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   USPi002-A
AC   CVCL_C6TE
SY   iPS_LGH_AHDC1_P2
DR   BioSamples; SAMEA111502785
DR   hPSCreg; USPi002-A
DR   Wikidata; Q117704948
RX   PubMed=37054903;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:25230; AHDC1; Simple; p.Lys552Argfs*33 (c.1653del); ClinVar=VCV002583159; Zygosity=Heterozygous; Note=De novo mutation (PubMed=37054903).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192092; Xia-Gibbs syndrome
DI   ORDO; Orphanet_412069; AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 27-11-25; Version: 4
//
ID   USPi003-A
AC   CVCL_C6TF
SY   iPS_LGH_AHDC1_P3
DR   BioSamples; SAMEA111506901
DR   hPSCreg; USPi003-A
DR   Wikidata; Q117704949
RX   PubMed=37054903;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Sequence variation: Mutation; HGNC; HGNC:25230; AHDC1; Simple; p.Lys494Serfs*22 (c.1481_1482delTT); ClinVar=VCV001320043; Zygosity=Heterozygous; Note=De novo mutation (PubMed=37054903).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192092; Xia-Gibbs syndrome
DI   ORDO; Orphanet_412069; AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   USPi004-A
AC   CVCL_C9HN
SY   DFNA58-ipsc-con1-cl4
DR   BioSamples; SAMEA112657207
DR   hPSCreg; USPi004-A
DR   Wikidata; Q123033760
RX   PubMed=37595341;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   USPi005-A
AC   CVCL_C9HP
SY   DFNA58-ipsc-con2-cl1
DR   BioSamples; SAMEA112657210
DR   hPSCreg; USPi005-A
DR   Wikidata; Q123033761
RX   PubMed=37595341;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Population: Caucasian.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 3
//
ID   USPi006-A
AC   CVCL_C9HQ
SY   DFNA58-ipsc-dup1-cl2
DR   BioSamples; SAMEA112657231
DR   hPSCreg; USPi006-A
DR   Wikidata; Q123033762
RX   PubMed=37595341;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34029; DFNA58; Unexplicit; 2p14-13.3(chr2:g.68475209_68676657)x3; ClinVar=VCV001184810; Zygosity=Heterozygous (PubMed=37595341).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201585; Deafness, autosomal dominant 58
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   USPi007-A
AC   CVCL_C9HR
SY   DFNA58-ipsc-dup2-cl5
DR   BioSamples; SAMEA112657232
DR   hPSCreg; USPi007-A
DR   Wikidata; Q123033763
RX   PubMed=37595341;
CC   From: Laboratory of Human Genetics, Institute of Biosciences; Sao Paulo; Brazil.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:34029; DFNA58; Unexplicit; 2p14-13.3(chr2:g.68475209_68676657)x3; ClinVar=VCV001184810; Zygosity=Heterozygous (PubMed=37595341).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201585; Deafness, autosomal dominant 58
DI   ORDO; Orphanet_90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   USTCi001-A
AC   CVCL_ZE23
SY   Epi-hiPSC
DR   hPSCreg; USTCi001-A
DR   SKIP; SKIP005741
DR   Wikidata; Q98134372
RX   PubMed=32335389;
CC   From: School of Life Sciences, University of Science and Technology of China; Hefei; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Gln1923Arg (c.5768A>G); ClinVar=VCV003067164; Zygosity=Heterozygous (PubMed=32335389).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   USTCi001-A-1
AC   CVCL_ZU60
DR   hPSCreg; USTCi001-A-1
DR   SKIP; SKIP005779
DR   Wikidata; Q98134374
RX   PubMed=32544858;
CC   From: School of Life Sciences, University of Science and Technology of China; Hefei; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple_corrected; p.Gln1923Arg (c.5768A>G); ClinVar=VCV003067164; Zygosity=Heterozygous; Note=By TALEN (PubMed=32544858).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE23 ! USTCi001-A
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   USTCi001-A-2
AC   CVCL_A1QQ
SY   Epi-tdTomato-hiPSC
DR   hPSCreg; USTCi001-A-2
DR   Wikidata; Q102115089
RX   PubMed=32977294;
CC   From: School of Life Sciences, University of Science and Technology of China; Hefei; China.
CC   Population: Asian.
CC   Characteristics: Using CRISPR/Cas9 a tdTomato gene was introduced into the first exon of the GAD67 gene (PubMed=32977294).
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Gln1923Arg (c.5768A>G); ClinVar=VCV003067164; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZE23 ! USTCi001-A
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 10
//
ID   USTCi002-A
AC   CVCL_A4DS
DR   hPSCreg; USTCi002-A
DR   Wikidata; Q105511648
RX   PubMed=33189042;
CC   From: School of Life Sciences, University of Science and Technology of China; Hefei; China.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple_edited; p.Gln1923Arg (c.5768A>G); ClinVar=VCV003067164; Zygosity=Heterozygous; Note=By TALEN (PubMed=33189042).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4DT ! Nor-iPSC
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 8
//
ID   USZ20-EMC1
AC   CVCL_C6MX
SY   UniversitatsSpital Zurich 2020-Extraskeletal Myxoid Chondrosarcoma 1
DR   Wikidata; Q116050751
RX   PubMed=36316541;
CC   Characteristics: Maintained as a sarco-sphere (PubMed=36316541).
CC   Doubling time: 5.09 days (PubMed=36316541).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:7982; NR4A3; Name(s)=EWSR1-NR4A3; Note=EWSR1 exon 13 fused to NR4A3 exon 2 (PubMed=36316541).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Leg; UBERON=UBERON_0000978.
ST   Source(s): PubMed=36316541
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D18S51: 15
ST   D21S11: 30
ST   D3S1358: 15,17
ST   D5S818: 9,13
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 13,15
ST   Penta E: 5,10
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C27502; Extraskeletal myxoid chondrosarcoma
DI   ORDO; Orphanet_209916; Extraskeletal myxoid chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   USZ20-ESOS1
AC   CVCL_D4AB
SY   UniversitatsSpital Zurich 2020-ExtraSkeletal OsteoSarcoma 1
DR   Wikidata; Q127384626
RX   PubMed=37951844;
CC   Characteristics: Maintained as a sarco-sphere (PubMed=37951844).
CC   Doubling time: 5.8 days (PubMed=37951844).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3299; EIF5 + HGNC; HGNC:12629; USP6; Name(s)=EIF5-USP6 (PubMed=37951844).
CC   Derived from site: Metastatic; Skin, dermis; UBERON=UBERON_0002067.
ST   Source(s): PubMed=37951844
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12
ST   D21S11: 27,30
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 12,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8810; Extraskeletal osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   USZ22-EMC2
AC   CVCL_C6MY
SY   UniversitatsSpital Zurich 2022-Extraskeletal Myxoid Chondrosarcoma 2
DR   Wikidata; Q116050752
RX   PubMed=36316541;
CC   Characteristics: Maintained as a sarco-sphere (PubMed=36316541).
CC   Doubling time: 6.05 days (PubMed=36316541).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7982; NR4A3 + HGNC; HGNC:11547; TAF15; Name(s)=TAF15-NR4A3; Note=TAF15 exon 6 fused to NR4A3 exon 2 (PubMed=36316541).
CC   Sequence variation: Mutation; HGNC; HGNC:11114; KDM5C; Simple; c.1584-2A>T; Zygosity=Hemizygous; Note=Splice acceptor mutation (PubMed=36316541).
CC   Sequence variation: Mutation; HGNC; HGNC:13726; KMT2C; Simple; p.Glu1689fs*28 (c.5065delG); Zygosity=Unspecified (PubMed=36316541).
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Left thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=36316541
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 10,12
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 22
ST   Penta D: 12,13
ST   Penta E: 12,13
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C27502; Extraskeletal myxoid chondrosarcoma
DI   ORDO; Orphanet_209916; Extraskeletal myxoid chondrosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 6
//
ID   UT-1
AC   CVCL_4332
SY   UT1
DR   CLO; CLO_0009489
DR   CLDB; cl4612
DR   ECACC; 87100701
DR   Wikidata; Q54992033
RX   PubMed=6951166;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 9
//
ID   UT-2
AC   CVCL_DC04
SY   UT2
DR   Wikidata; Q54992035
RX   PubMed=6643457;
RX   PubMed=9305924;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   UT-7
AC   CVCL_2233
SY   UT7
DR   BTO; BTO_0000960
DR   CLO; CLO_0009490
DR   EFO; EFO_0022372
DR   CLDB; cl5398
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03472875
DR   BioSample; SAMN10988426
DR   cancercelllines; CVCL_2233
DR   CCRID; 1101HUM-PUMC000120
DR   Cell_Model_Passport; SIDM01908
DR   ChEMBL-Cells; CHEMBL3307293
DR   ChEMBL-Targets; CHEMBL614057
DR   Cosmic; 787487
DR   Cosmic; 919130
DR   Cosmic; 975312
DR   Cosmic; 1012128
DR   Cosmic; 1281362
DR   Cosmic; 1465951
DR   Cosmic; 2089659
DR   DepMap; ACH-001230
DR   DSMZ; ACC-137
DR   DSMZCellDive; ACC-137
DR   GEO; GSM743411
DR   GEO; GSM887730
DR   GEO; GSM888825
DR   GEO; GSM1374979
DR   IARC_TP53; 2200
DR   Lonza; 41
DR   PharmacoDB; UT7_1649_2019
DR   Progenetix; CVCL_2233
DR   PubChem_Cell_line; CVCL_2233
DR   Wikidata; Q54992037
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1571549;
RX   PubMed=1824823;
RX   PubMed=2217443;
RX   PubMed=7647001;
RX   PubMed=9096695;
RX   PubMed=9195772;
RX   PubMed=9510473;
RX   PubMed=10739008;
RX   PubMed=11021758;
RX   PubMed=11226526;
RX   PubMed=16408098;
RX   PubMed=22460905;
RX   PubMed=23955599;
RX   PubMed=25877200;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Characteristics: CSF2 dependent.
CC   Doubling time: ~36-48 hours (PubMed=1824823); ~70 hours (DSMZ=ACC-137).
CC   HLA typing: A*02:01:01,11:01:01; B*55:02:01,55:02:01; C*01:02:01,01:02:01; DPA1*01:03:01,02:02:02; DPB1*03:01:01,03:01:01; DRA*01:01:01,01:02:02; DRB1*08:02:01,08:02:01 (DSMZCellDive=ACC-137).
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783_919del137; Zygosity=Unspecified (PubMed=1571549).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.07%; Native American=0%; East Asian, North=82.57%; East Asian, South=12%; South Asian=0%; European, North=0%; European, South=3.36% (PubMed=30894373).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): CCRID=1101HUM-PUMC000120; DSMZ=ACC-137; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 14,17
ST   D19S433: 14,14.2 (CCRID=1101HUM-PUMC000120)
ST   D19S433: 14,15 (DSMZ=ACC-137)
ST   D21S11: 31.2
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 8
ST   D8S1179: 11,15
ST   FGA: 23
ST   Penta D: 9,11
ST   Penta E: 16,17
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 14,18 (DSMZ=ACC-137; PubMed=25877200)
ST   vWA: 14,18,19 (CCRID=1101HUM-PUMC000120)
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   UT-7/Epo
AC   CVCL_5202
SY   UT-7/EPO; UT-7-EPO; UT7-Epo
DR   Cell_Model_Passport; SIDM01925
DR   Lonza; 169
DR   Wikidata; Q54992038
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8329702;
RX   PubMed=36982453;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fEpo
CC   Population: Japanese.
CC   Characteristics: EPO dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2233 ! UT-7
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 17
//
ID   UT-7/GM
AC   CVCL_5203
SY   UT-7-GM; UT7-GM
DR   Cell_Model_Passport; SIDM01926
DR   Lonza; 170
DR   Wikidata; Q54992039
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9166841;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fGM
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783_919del137; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2233 ! UT-7
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   UT-7/TPO
AC   CVCL_5204
SY   UT-7-TPO; UT7-TPO
DR   Cell_Model_Passport; SIDM01931
DR   Lonza; 171
DR   Wikidata; Q54992040
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8639823;
RX   PubMed=32180119;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=UT-7%2fTPO
CC   Population: Japanese.
CC   Characteristics: TPO dependent.
CC   Doubling time: 24 hours (PubMed=8639823).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.783_919del137; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7965; Adult acute megakaryoblastic leukemia
DI   ORDO; Orphanet_518; Acute megakaryoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5203 ! UT-7/GM
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 21
//
ID   UT-EC-1
AC   CVCL_X003
SY   University of Turku-Endometrial Carcinoma-1
DR   IARC_TP53; 21687
DR   Wikidata; Q54992042
RX   PubMed=1541432;
RX   PubMed=7798295;
RX   PubMed=9887230;
CC   Doubling time: 72 hours (PubMed=1541432).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C27838; Endometrial serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   UT-EC-2A
AC   CVCL_X004
SY   University of Turku-Endometrial Carcinoma-2A
DR   IARC_TP53; 21688
DR   Wikidata; Q54992043
RX   PubMed=7798295;
RX   PubMed=7821848;
RX   PubMed=8123477;
RX   PubMed=9887230;
CC   Doubling time: 40 hours (Note=At 17th passage) (PubMed=7821848).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X005 ! UT-EC-2B
OI   CVCL_WM05 ! UT-EC-2C
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 11
//
ID   UT-EC-2B
AC   CVCL_X005
SY   University of Turku-Endometrial Carcinoma-2B
DR   IARC_TP53; 21689
DR   Wikidata; Q54992045
RX   PubMed=7798295;
RX   PubMed=7821848;
RX   PubMed=8123477;
RX   PubMed=9887230;
RX   PubMed=17178626;
CC   Doubling time: 30 hours (Note=At 14th passage) (PubMed=7821848).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: Metastatic; Supraclavicular lymph node; UBERON=UBERON_0035279.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X004 ! UT-EC-2A
OI   CVCL_WM05 ! UT-EC-2C
SX   Female
AG   45-46Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   UT-EC-2C
AC   CVCL_WM05
SY   University of Turku-Endometrial Carcinoma-2C
DR   IARC_TP53; 21690
DR   Wikidata; Q98134376
RX   PubMed=9887230;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: Metastatic; Abdominal cavity; UBERON=UBERON_0003684.
DI   NCIt; C114656; Endometrial adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X004 ! UT-EC-2A
OI   CVCL_X005 ! UT-EC-2B
SX   Female
AG   45-46Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 7
//
ID   UT-EC-3
AC   CVCL_X006
SY   University of Turku-Endometrial Carcinoma-3
DR   IARC_TP53; 21691
DR   Wikidata; Q54992046
RX   PubMed=7798295;
RX   PubMed=8123477;
RX   PubMed=9887230;
RX   PubMed=17178626;
CC   Doubling time: 28 hours (PubMed=8123477).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 10
//
ID   UT-MUC-1
AC   CVCL_A438
SY   University of Turku-MUcoepidermoid Carcinoma-1
DR   Cosmic; 1520948
DR   Wikidata; Q54992047
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=1571132;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=16444749;
CC   Doubling time: 52 hours (Note=At 9th passage) (PubMed=1571132).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8725545; PubMed=8782485).
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   UT-MUC-2
AC   CVCL_A439
SY   University of Turku-MUcoepidermoid Carcinoma-2
DR   Cosmic; 1520949
DR   Wikidata; Q54992048
RX   PubMed=16444749;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   UT-OC-1
AC   CVCL_A1QV
SY   UT-OV-1
DR   Wikidata; Q105511650
RX   PubMed=9888470;
RX   PubMed=32487607;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C5243; Ovarian mucinous adenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   UT-OC-2
AC   CVCL_A1QW
SY   UT-OV-2
DR   Wikidata; Q105511652
RX   CelloPub=CLPUB00591;
RX   PubMed=9888470;
RX   PubMed=32487607;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   UT-OC-3
AC   CVCL_A1QX
DR   Wikidata; Q105511653
RX   CelloPub=CLPUB00591;
RX   PubMed=9888470;
RX   PubMed=10754482;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   UT-OC-4
AC   CVCL_A1QY
SY   UT-OV-4
DR   Wikidata; Q105511654
RX   PubMed=9888470;
RX   PubMed=32487607;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   UT-OC-5
AC   CVCL_A1QZ
DR   Wikidata; Q105511657
RX   CelloPub=CLPUB00591;
RX   PubMed=9888470;
RX   PubMed=10367939;
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 5
//
ID   UT-SCC-10
AC   CVCL_7804
SY   University of Turku-Squamous Cell Carcinoma-10
DR   GEO; GSM2883357
DR   GEO; GSM2888820
DR   IARC_TP53; 11066
DR   Wikidata; Q54992050
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=11799138;
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln144Ter (c.430C>T); ClinVar=VCV000634688; Zygosity=Heterozygous (PubMed=8725545; PubMed=8782485; PubMed=11799138; PubMed=29970484).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=8725545; PubMed=8782485; PubMed=11799138).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-105
AC   CVCL_A5VF
SY   UT-SCC105; University of Turku-Squamous Cell Carcinoma-105
DR   Wikidata; Q107117357
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-106A
AC   CVCL_JA23
SY   University of Turku-Squamous Cell Carcinoma-106A
DR   GEO; GSM2883392
DR   GEO; GSM2888855
DR   Wikidata; Q54992051
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=26694163;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   UT-SCC-106B
AC   CVCL_JA24
SY   University of Turku-Squamous Cell Carcinoma-106B
DR   Wikidata; Q54992052
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=26694163;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   UT-SCC-107
AC   CVCL_JA25
SY   University of Turku-Squamous Cell Carcinoma-107
DR   cancercelllines; CVCL_JA25
DR   GEO; GSM2883393
DR   GEO; GSM2888856
DR   Wikidata; Q54992054
RX   PubMed=26694163;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   UT-SCC-108
AC   CVCL_JA26
SY   University of Turku-Squamous Cell Carcinoma-108
DR   Wikidata; Q54992055
RX   PubMed=26694163;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-11
AC   CVCL_7805
SY   UTSCC11; University of Turku-Squamous Cell Carcinoma-11
DR   GEO; GSM2883358
DR   GEO; GSM2888821
DR   Wikidata; Q54992056
RX   PubMed=9187133;
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=26694163;
RX   PubMed=29970484;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly187_Arg196del (c.560_589del); Zygosity=Unspecified (PubMed=33802339).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, glottis; UBERON=UBERON_0002486.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 15,17
ST   D19S433: 13,14
ST   D21S11: 28
ST   D2S1338: 19,20
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 22,23
ST   TH01: 6,9
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   UT-SCC-110A
AC   CVCL_A7EB
SY   University of Turku-Squamous Cell Carcinoma-110B
DR   cancercelllines; CVCL_A7EB
DR   GEO; GSM2883394
DR   GEO; GSM2888857
DR   Wikidata; Q107117358
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 11,12
ST   D18S51: 13,16,17
ST   D19S433: 14,16
ST   D21S11: 31,31.2
ST   D2S1338: 20
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D7S820: 9,12
ST   D8S1179: 11,14
ST   FGA: 20
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A091 ! UT-SCC-110B
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   UT-SCC-110B
AC   CVCL_A091
SY   University of Turku-Squamous Cell Carcinoma-110B
DR   Cosmic; 1140779
DR   Cosmic; 1219863
DR   Wikidata; Q54992057
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 16,17
ST   D19S433: 14,16
ST   D21S11: 30,31.2
ST   D2S1338: 20,26
ST   D3S1358: 14,17
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 11,14
ST   FGA: 20,21
ST   TH01: 8
ST   TPOX: 8,10,11
ST   vWA: 16,17
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EB ! UT-SCC-110A
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 8
//
ID   UT-SCC-111
AC   CVCL_A5VE
SY   UT-SCC111; University of Turku-Squamous Cell Carcinoma-111
DR   Wikidata; Q107117359
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-112
AC   CVCL_A7ES
SY   University of Turku-Squamous Cell Carcinoma-112
DR   GEO; GSM2883395
DR   GEO; GSM2888858
DR   Wikidata; Q107117361
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   94Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-114
AC   CVCL_A7ET
SY   University of Turku-Squamous Cell Carcinoma-114
DR   GEO; GSM2883396
DR   GEO; GSM2888859
DR   Wikidata; Q107117362
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, lower lip; UBERON=UBERON_0001835.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-115
AC   CVCL_A5VG
SY   UT-SCC115; University of Turku-Squamous Cell Carcinoma-115
DR   Wikidata; Q107117363
RX   PubMed=22427941;
RX   PubMed=28322200;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-116
AC   CVCL_JA27
SY   University of Turku-Squamous Cell Carcinoma-116
DR   Wikidata; Q54992058
RX   PubMed=26694163;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-118
AC   CVCL_7806
SY   UT-SCC118; University of Turku-Squamous Cell Carcinoma-118
DR   BTO; BTO_0004873
DR   Wikidata; Q54992060
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Derived from site: In situ; Face, skin; UBERON=UBERON_1000021.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   UT-SCC-122
AC   CVCL_A7EU
SY   University of Turku-Squamous Cell Carcinoma-122
DR   GEO; GSM2883397
DR   GEO; GSM2888860
DR   Wikidata; Q107117364
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-126A
AC   CVCL_A7EC
SY   University of Turku-Squamous Cell Carcinoma-126A
DR   cancercelllines; CVCL_A7EC
DR   GEO; GSM2883398
DR   GEO; GSM2888861
DR   Wikidata; Q107117366
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Phe (c.388C>T); ClinVar=VCV000216466; Zygosity=Heterozygous (PubMed=29970484).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu171Lys (c.511G>A); ClinVar=VCV000141566; Zygosity=Heterozygous (PubMed=29970484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, lower lip; UBERON=UBERON_0001835.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 22
ST   TH01: 8,9
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   UT-SCC-12A
AC   CVCL_7807
SY   UT-SCC12A; University of Turku-Squamous Cell Carcinoma-12A
DR   cancercelllines; CVCL_7807
DR   Cosmic; 1140772
DR   Cosmic; 1219856
DR   Cosmic; 1351518
DR   IARC_TP53; 11068
DR   Wikidata; Q54992062
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=17312569;
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=8782485).
CC   Derived from site: In situ; Nose, skin; UBERON=UBERON_0015476.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7808 ! UT-SCC-12B
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   UT-SCC-12B
AC   CVCL_7808
SY   University of Turku-Squamous Cell Carcinoma-12b
DR   cancercelllines; CVCL_7808
DR   Cosmic; 1140773
DR   Cosmic; 1219857
DR   Wikidata; Q54992063
RX   PubMed=8782485;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Unspecified (PubMed=8782485).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7807 ! UT-SCC-12A
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   UT-SCC-13
AC   CVCL_7809
SY   University of Turku-Squamous Cell Carcinoma-13
DR   Wikidata; Q54992065
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-14
AC   CVCL_7810
SY   UT-SCC 14; UTSCC14; University of Turku-Squamous Cell Carcinoma-14
DR   BTO; BTO_0004440
DR   GEO; GSM1716435
DR   GEO; GSM1716436
DR   GEO; GSM1716437
DR   GEO; GSM1716438
DR   GEO; GSM2883359
DR   GEO; GSM2888822
DR   Wikidata; Q54992068
RX   PubMed=11799138;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=20429727;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Met53Val (c.157A>G) (p.Asp67Gly, c.200A>G); ClinVar=VCV001467708; Zygosity=Homozygous (PubMed=18487078; PubMed=29970484).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>C (IVS8+1G>C); ClinVar=VCV000428905; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-15
AC   CVCL_7811
SY   UT-SCC 15; UTSCC15; University of Turku-Squamous Cell Carcinoma-15
DR   BTO; BTO_0004441
DR   cancercelllines; CVCL_7811
DR   GEO; GSM901099
DR   GEO; GSM1716439
DR   GEO; GSM1716440
DR   GEO; GSM1716441
DR   GEO; GSM1716442
DR   Progenetix; CVCL_7811
DR   Wikidata; Q54992070
RX   PubMed=8725545;
RX   PubMed=11799138;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=20429727;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-1G>T; ClinVar=VCV003148249; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X
ST   CSF1PO: 12,15
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D19S433: 15,15.2
ST   D21S11: 28
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 25
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UT-SCC-16A
AC   CVCL_7812
SY   University of Turku-Squamous Cell Carcinoma-16A
DR   Cosmic; 1140774
DR   Cosmic; 1219858
DR   GEO; GSM2883360
DR   GEO; GSM2888823
DR   IARC_TP53; 11064
DR   Wikidata; Q54992071
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=11799138;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (PubMed=8725545; PubMed=8782485; PubMed=11799138; PubMed=15287027; PubMed=29970484).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Asn (c.695T>A); ClinVar=VCV000850008; Zygosity=Heterozygous (PubMed=8725545; PubMed=8782485; PubMed=11799138; PubMed=15287027; PubMed=29970484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Caution: UT-SCC-16A and UT-SCC-16B are supposed to originate from the same patient but have totally different STR profiles.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D19S433: 13,16
ST   D21S11: 30.2
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 9,13
ST   FGA: 20
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 17,18,19,20
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7813 ! UT-SCC-16B
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UT-SCC-16B
AC   CVCL_7813
SY   University of Turku-Squamous Cell Carcinoma-16B
DR   Cosmic; 1140775
DR   Cosmic; 1219859
DR   Wikidata; Q54992072
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Unspecified (PubMed=8725545; PubMed=8782485; PubMed=15287027).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Asn (c.695T>A); ClinVar=VCV000850008; Zygosity=Unspecified (PubMed=8725545; PubMed=8782485; PubMed=15287027).
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: UT-SCC-16A and UT-SCC-16B are supposed to originate from the same patient but have totally different STR profiles.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 14,15.2
ST   D21S11: 31,32.2
ST   D2S1338: 27
ST   D3S1358: 14,17
ST   D5S818: 12,14
ST   D7S820: 9,11
ST   D8S1179: 12,13
ST   FGA: 21,22
ST   TH01: 7.9
ST   TPOX: 9
ST   vWA: 18,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7812 ! UT-SCC-16A
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   UT-SCC-17
AC   CVCL_7814
SY   University of Turku-Squamous Cell Carcinoma-17
DR   cancercelllines; CVCL_7814
DR   GEO; GSM901097
DR   Progenetix; CVCL_7814
DR   Wikidata; Q54992075
RX   PubMed=17312569;
RX   PubMed=26694163;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   UT-SCC-18
AC   CVCL_7815
SY   University of Turku-Squamous Cell Carcinoma-18
DR   Wikidata; Q54992076
RX   PubMed=17312569;
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-19A
AC   CVCL_7816
SY   UTSCC19A; University of Turku-Squamous Cell Carcinoma-19A
DR   cancercelllines; CVCL_7816
DR   GEO; GSM2883361
DR   GEO; GSM2888824
DR   IARC_TP53; 11061
DR   Wikidata; Q54992077
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8782485;
RX   PubMed=15287027;
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=26694163;
RX   PubMed=29970484;
RX   PubMed=30135316;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=8782485; PubMed=15287027; PubMed=33802339).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, glottis; UBERON=UBERON_0002486.
ST   Source(s): PubMed=30135316; PubMed=33802339
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12,13
ST   D16S539: 12,13
ST   D18S51: 16
ST   D19S433: 13.2,18.2
ST   D21S11: 30,32.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 24
ST   TH01: 6
ST   TPOX: 8,10
ST   vWA: 14,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7817 ! UT-SCC-19B
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UT-SCC-19B
AC   CVCL_7817
SY   UTSCC19B; University of Turku-Squamous Cell Carcinoma-19B
DR   cancercelllines; CVCL_7817
DR   Wikidata; Q54992078
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8782485;
RX   PubMed=15287027;
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=26694163;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=8782485; PubMed=15287027).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, glottis; UBERON=UBERON_0002486.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 18.2
ST   D21S11: 32.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7816 ! UT-SCC-19A
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UT-SCC-1A
AC   CVCL_7818
SY   University of Turku-Squamous Cell Carcinoma-1A
DR   cancercelllines; CVCL_7818
DR   IARC_TP53; 11059
DR   Wikidata; Q54992080
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=17312569;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=8725545; PubMed=8782485).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 15
ST   D21S11: 29,31
ST   D2S1338: 25
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 10,11
ST   FGA: 22,24
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7819 ! UT-SCC-1B
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-1B
AC   CVCL_7819
SY   University of Turku-Squamous Cell Carcinoma-1B
DR   cancercelllines; CVCL_7819
DR   GEO; GSM901092
DR   Wikidata; Q54992081
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=17312569;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=8725545; PubMed=8782485).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 9,10
ST   D16S539: 11
ST   D18S51: 16
ST   D19S433: 15
ST   D21S11: 29,31
ST   D2S1338: 25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 10,11
ST   FGA: 22,24
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 15,17
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7818 ! UT-SCC-1A
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-2
AC   CVCL_7820
SY   University of Turku-Squamous Cell Carcinoma-2
DR   BTO; BTO_0003721
DR   cancercelllines; CVCL_7820
DR   GEO; GSM901093
DR   GEO; GSM2883354
DR   GEO; GSM2888817
DR   IARC_TP53; 11063
DR   Progenetix; CVCL_7820
DR   Wikidata; Q54992082
RX   DOI=10.1016/B978-0-12-333530-2.50007-1;
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys275Phe (c.824G>T); ClinVar=VCV000376582; Zygosity=Homozygous (PubMed=8725545; PubMed=8782485; PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UT-SCC-20A
AC   CVCL_7821
SY   University of Turku-Squamous Cell Carcinoma-20A
DR   cancercelllines; CVCL_7821
DR   IARC_TP53; 5104
DR   Wikidata; Q54992083
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8725545; PubMed=15287027).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7822 ! UT-SCC-20B
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   UT-SCC-20B
AC   CVCL_7822
SY   University of Turku-Squamous Cell Carcinoma-20B
DR   cancercelllines; CVCL_7822
DR   Wikidata; Q54992085
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=8725545; PubMed=15287027).
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7821 ! UT-SCC-20A
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   UT-SCC-21
AC   CVCL_7823
SY   University of Turku-Squamous Cell Carcinoma-21
DR   GEO; GSM2883362
DR   GEO; GSM2888825
DR   Wikidata; Q54992086
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-22
AC   CVCL_7824
SY   UT-SCC 22; University of Turku-Squamous Cell Carcinoma-22
DR   cancercelllines; CVCL_7824
DR   Wikidata; Q54992087
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=26694163;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys238Phe (c.713G>T); ClinVar=VCV000376574; Zygosity=Unspecified (PubMed=18487078).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-23
AC   CVCL_7825
SY   UT-SCC 23; UT-SCC23; University of Turku-Squamous Cell Carcinoma-23
DR   cancercelllines; CVCL_7825
DR   Cosmic; 932292
DR   Cosmic; 932293
DR   GEO; GSM901098
DR   Progenetix; CVCL_7825
DR   Wikidata; Q54992101
RX   PubMed=15495191;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=26694163;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15495191; PubMed=18487078).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UT-SCC-24A
AC   CVCL_7826
SY   UT-SCC 24A; University of Turku-Squamous Cell Carcinoma-24A
DR   BTO; BTO_0003722
DR   Cosmic; 1140778
DR   Cosmic; 1219862
DR   Cosmic; 1483464
DR   GEO; GSM2883363
DR   GEO; GSM2888826
DR   Wikidata; Q54992103
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=16203773;
RX   PubMed=16331601;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=29970484;
RX   PubMed=30135316;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=16203773; PubMed=29970484; PubMed=33802339).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=30135316; PubMed=33802339
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12,14
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 12,14.2
ST   D21S11: 29,30
ST   D2S1338: 19,20 (PubMed=30135316)
ST   D2S1338: 20 (PubMed=33802339)
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 8,11 (PubMed=30135316)
ST   D7S820: 11 (PubMed=33802339)
ST   D8S1179: 13,15
ST   FGA: 19,22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7827 ! UT-SCC-24B
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   UT-SCC-24B
AC   CVCL_7827
SY   UT-SCC-24b; UT-SCC 24B; University of Turku-Squamous Cell Carcinoma-24B
DR   IARC_TP53; 17655
DR   Wikidata; Q54992104
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8725545;
RX   PubMed=11799138;
RX   PubMed=16331601;
RX   PubMed=17312569;
RX   PubMed=18487078;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.673-2A>T (IVS6-2A>T); ClinVar=VCV000635388; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=11799138).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7826 ! UT-SCC-24A
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   UT-SCC-25
AC   CVCL_7828
SY   University of Turku-Squamous Cell Carcinoma-25
DR   cancercelllines; CVCL_7828
DR   GEO; GSM901095
DR   Progenetix; CVCL_7828
DR   Wikidata; Q54992105
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 12
//
ID   UT-SCC-26A
AC   CVCL_7829
SY   University of Turku-Squamous Cell Carcinoma-26A
DR   Cosmic; 1483465
DR   IARC_TP53; 23611
DR   Wikidata; Q54992106
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=16035614;
RX   PubMed=16203773;
RX   PubMed=17312569;
RX   PubMed=19414362;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Ter (c.708C>A); Zygosity=Unspecified (PubMed=16203773).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7830 ! UT-SCC-26B
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   UT-SCC-26B
AC   CVCL_7830
SY   University of Turku-Squamous Cell Carcinoma-26B
DR   Wikidata; Q54992107
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=17312569;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7829 ! UT-SCC-26A
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   UT-SCC-27
AC   CVCL_7831
SY   University of Turku-Squamous Cell Carcinoma-27
DR   GEO; GSM2883364
DR   GEO; GSM2888827
DR   Wikidata; Q54992108
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-28
AC   CVCL_7832
SY   University of Turku-Squamous Cell Carcinoma-28
DR   GEO; GSM2883365
DR   GEO; GSM2888828
DR   Wikidata; Q54992109
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-29
AC   CVCL_7833
SY   UTSCC29; University of Turku-Squamous Cell Carcinoma-29
DR   cancercelllines; CVCL_7833
DR   GEO; GSM901096
DR   GEO; GSM2883366
DR   GEO; GSM2888829
DR   Progenetix; CVCL_7833
DR   Wikidata; Q54992110
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=26694163;
RX   PubMed=29970484;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln104Ter (c.310C>T); ClinVar=VCV000566924; Zygosity=Homozygous (PubMed=29970484; PubMed=33802339).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, glottis; UBERON=UBERON_0002486.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 31
ST   D2S1338: 17,20
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-30
AC   CVCL_7834
SY   University of Turku-Squamous Cell Carcinoma-30
DR   GEO; GSM2883367
DR   GEO; GSM2888830
DR   IARC_TP53; 5105
DR   Wikidata; Q54992113
RX   PubMed=8725545;
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Pro (c.845G>C); ClinVar=VCV000376659; Zygosity=Homozygous (PubMed=8725545; PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   UT-SCC-31
AC   CVCL_7835
SY   University of Turku-Squamous Cell Carcinoma-31
DR   Wikidata; Q54992114
RX   PubMed=17312569;
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-32
AC   CVCL_7836
SY   University of Turku-Squamous Cell Carcinoma-32
DR   Wikidata; Q54992115
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-33
AC   CVCL_7837
SY   UT-SCC 33; University of Turku-Squamous Cell Carcinoma-33
DR   cancercelllines; CVCL_7837
DR   IARC_TP53; 17656
DR   Wikidata; Q54992116
RX   PubMed=11799138;
RX   PubMed=15495191;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=26045983;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=11799138; PubMed=18487078).
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   UT-SCC-34
AC   CVCL_7838
SY   UT-SCC 34; UTSCC34; University of Turku-Squamous Cell Carcinoma-34
DR   Wikidata; Q54992117
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=26694163;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   UT-SCC-35
AC   CVCL_7839
SY   University of Turku-Squamous Cell Carcinoma-35
DR   Wikidata; Q54992120
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-36
AC   CVCL_7840
SY   University of Turku-Squamous Cell Carcinoma-36
DR   cancercelllines; CVCL_7840
DR   GEO; GSM2883368
DR   GEO; GSM2888831
DR   Wikidata; Q54992121
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly244Ser (c.730G>A); ClinVar=VCV000376600; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   UT-SCC-37
AC   CVCL_7841
SY   University of Turku-Squamous Cell Carcinoma-37
DR   GEO; GSM2883369
DR   GEO; GSM2888832
DR   Wikidata; Q54992122
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val73Argfs (c.216_217insCCCC); Zygosity=Heterozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   UT-SCC-38
AC   CVCL_7842
SY   UTSCC38; University of Turku-Squamous Cell Carcinoma-38
DR   cancercelllines; CVCL_7842
DR   GEO; GSM2883370
DR   GEO; GSM2888833
DR   Wikidata; Q54992123
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=26694163;
RX   PubMed=29970484;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>T; ClinVar=VCV000422058; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=33802339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.375+5G>A; ClinVar=VCV000481015; Zygosity=Unspecified (PubMed=33802339).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, glottis; UBERON=UBERON_0002486.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 12,14
ST   D18S51: 15,22
ST   D19S433: 13,15
ST   D21S11: 32.2
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18,20
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-39
AC   CVCL_7843
SY   University of Turku-Squamous Cell Carcinoma-39
DR   Wikidata; Q54992124
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-4
AC   CVCL_7844
SY   University of Turku-Squamous Cell Carcinoma-4
DR   IARC_TP53; 11060
DR   Wikidata; Q54992125
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=17312569;
RX   PubMed=26694163;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248_Pro250del (c.742_750del9); Zygosity=Unspecified (PubMed=8782485).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   UT-SCC-40
AC   CVCL_7845
SY   University of Turku-Squamous Cell Carcinoma-40
DR   GEO; GSM2883371
DR   GEO; GSM2888834
DR   Wikidata; Q54992126
RX   PubMed=17312569;
RX   PubMed=29970484;
RX   PubMed=33802339;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 12
ST   D21S11: 29,31.2
ST   D2S1338: 17,25
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 12,14
ST   FGA: 22
ST   TH01: 7,9
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-41
AC   CVCL_7846
SY   University of Turku-Squamous Cell Carcinoma-41
DR   Wikidata; Q54992127
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-42A
AC   CVCL_7847
SY   UTSCC42A; University of Turku-Squamous Cell Carcinoma-42A
DR   cancercelllines; CVCL_7847
DR   GEO; GSM2883372
DR   GEO; GSM2888835
DR   Wikidata; Q54992130
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln331Ter (c.991C>T); ClinVar=VCV000922893; Zygosity=Homozygous (PubMed=15287027; PubMed=29970484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14,15.2
ST   D21S11: 28,30
ST   D2S1338: 17,26
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 7,10
ST   D8S1179: 11,13
ST   FGA: 23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7848 ! UT-SCC-42B
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UT-SCC-42B
AC   CVCL_7848
SY   University of Turku-Squamous Cell Carcinoma-42B
DR   Wikidata; Q54992131
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D18S51: 15
ST   D19S433: 14,15.2
ST   D21S11: 28,30
ST   D2S1338: 17,26
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 7,10
ST   D8S1179: 11,13
ST   FGA: 22.2,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7847 ! UT-SCC-42A
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   UT-SCC-43A
AC   CVCL_7849
SY   UT-SCC-43; University of Turku-Squamous Cell Carcinoma-43A
DR   GEO; GSM2883373
DR   GEO; GSM2888836
DR   Wikidata; Q54992132
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7850 ! UT-SCC-43B
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   UT-SCC-43B
AC   CVCL_7850
SY   University of Turku-Squamous Cell Carcinoma-43B
DR   cancercelllines; CVCL_7850
DR   Wikidata; Q54992133
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Unspecified (PubMed=15287027).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7849 ! UT-SCC-43A
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   UT-SCC-44
AC   CVCL_7851
SY   University of Turku-Squamous Cell Carcinoma-44
DR   GEO; GSM2883374
DR   GEO; GSM2888837
DR   Wikidata; Q54992134
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-45
AC   CVCL_7852
SY   UTSCC45; University of Turku-Squamous Cell Carcinoma-45
DR   cancercelllines; CVCL_7852
DR   Wikidata; Q54992135
RX   PubMed=17312569;
RX   PubMed=29156801;
RX   PubMed=31541927;
RX   PubMed=33802339;
CC   Doubling time: 1.3 days (PubMed=29156801).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Gly72Arg (c.214G>A); ClinVar=VCV002164792; Zygosity=Homozygous (PubMed=31541927).
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=29156801; PubMed=33802339
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 9,13
ST   D18S51: 15
ST   D19S433: 14,15
ST   D21S11: 31.2
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13,18
ST   FGA: 21,23
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 18,20
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-46A
AC   CVCL_7853
SY   University of Turku-Squamous Cell Carcinoma-46A
DR   Wikidata; Q54992136
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,14
ST   D16S539: 11
ST   D18S51: 13,15
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 22,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17,18
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7854 ! UT-SCC-46B
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   UT-SCC-46B
AC   CVCL_7854
SY   University of Turku-Squamous Cell Carcinoma-46B
DR   Wikidata; Q54992138
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7853 ! UT-SCC-46A
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UT-SCC-47
AC   CVCL_7855
SY   University of Turku-Squamous Cell Carcinoma-47
DR   cancercelllines; CVCL_7855
DR   GEO; GSM901101
DR   GEO; GSM2883375
DR   GEO; GSM2888838
DR   Progenetix; CVCL_7855
DR   Wikidata; Q54992140
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Gly (c.653T>G); ClinVar=VCV000528249; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-48
AC   CVCL_7856
SY   University of Turku-Squamous Cell Carcinoma-48
DR   Wikidata; Q54992141
RX   PubMed=17312569;
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5942; Parotid gland squamous cell carcinoma
DI   ORDO; Orphanet_500481; Squamous cell carcinoma of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   UT-SCC-49
AC   CVCL_7857
SY   UTSCC49; University of Turku-Squamous Cell Carcinoma-49
DR   cancercelllines; CVCL_7857
DR   GEO; GSM2883376
DR   GEO; GSM2888839
DR   Wikidata; Q54992142
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-5
AC   CVCL_7858
SY   UTSCC5; University of Turku-Squamous Cell Carcinoma-5
DR   BTO; BTO_0004442
DR   GEO; GSM1716431
DR   GEO; GSM1716432
DR   GEO; GSM1716433
DR   GEO; GSM1716434
DR   IARC_TP53; 11069
DR   Wikidata; Q54992143
RX   PubMed=8725545;
RX   PubMed=8782485;
RX   PubMed=11799138;
RX   PubMed=17312569;
RX   PubMed=20429727;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gly111Leufs*28 (c.331_352del); Zygosity=Unspecified (PubMed=33802339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151His (c.452C>A); ClinVar=VCV000376639; Zygosity=Unspecified (PubMed=8725545; PubMed=8782485; PubMed=11799138; PubMed=33802339).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 18
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 17,22
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 15,16
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   UT-SCC-50
AC   CVCL_7859
SY   UT-SCC 50; University of Turku-Squamous Cell Carcinoma-50
DR   Wikidata; Q54992146
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=26694163;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.920del73; Zygosity=Unspecified (PubMed=18487078).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   UT-SCC-51
AC   CVCL_7860
SY   University of Turku-Squamous Cell Carcinoma-51
DR   Wikidata; Q54992148
RX   PubMed=17312569;
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-52
AC   CVCL_7861
SY   University of Turku-Squamous Cell Carcinoma-52
DR   Wikidata; Q54992151
RX   PubMed=17312569;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UT-SCC-53
AC   CVCL_7862
SY   University of Turku-Squamous Cell Carcinoma-53
DR   GEO; GSM2883377
DR   GEO; GSM2888840
DR   Wikidata; Q54992152
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Nose, nasal cavity, maxillary sinus; UBERON=UBERON_0001764.
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 13
//
ID   UT-SCC-54A
AC   CVCL_7863
SY   University of Turku-Squamous Cell Carcinoma-54A
DR   cancercelllines; CVCL_7863
DR   GEO; GSM2883378
DR   GEO; GSM2888841
DR   Wikidata; Q54992153
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=15287027).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Caution: UT-SCC-54A, UT-SCC-54B and UT-SCC-54C are supposed to originate from the same patient but the STR profile of UT-SCC-54C is totally different from that of the two other cell lines.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14,16
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 26
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7864 ! UT-SCC-54B
OI   CVCL_A7DW ! UT-SCC-54C
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-54B
AC   CVCL_7864
SY   University of Turku-Squamous Cell Carcinoma-54B
DR   cancercelllines; CVCL_7864
DR   Wikidata; Q54992154
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=15287027).
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: UT-SCC-54A, UT-SCC-54B and UT-SCC-54C are supposed to originate from the same patient but the STR profile of UT-SCC-54C is totally different from that of the two other cell lines.
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 14
ST   D21S11: 31,32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 10,14
ST   FGA: 21,26
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7863 ! UT-SCC-54A
OI   CVCL_A7DW ! UT-SCC-54C
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-54C
AC   CVCL_A7DW
SY   University of Turku-Squamous Cell Carcinoma-54C
DR   Wikidata; Q107117367
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: UT-SCC-54A, UT-SCC-54B and UT-SCC-54C are supposed to originate from the same patient but the STR profile of UT-SCC-54C is totally different from that of the two other cell lines.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 7,11
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D18S51: 16,17
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 16
ST   D3S1358: 12,19
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 18,23
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,22
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7863 ! UT-SCC-54A
OI   CVCL_7864 ! UT-SCC-54B
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-55
AC   CVCL_7865
SY   University of Turku-Squamous Cell Carcinoma-55
DR   GEO; GSM2883379
DR   GEO; GSM2888842
DR   Wikidata; Q54992178
RX   PubMed=17312569;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-57
AC   CVCL_JA28
SY   University of Turku-Squamous Cell Carcinoma-57
DR   Wikidata; Q54992181
RX   PubMed=26694163;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-59A
AC   CVCL_A5VI
SY   UT-SCC59A; University of Turku-Squamous Cell Carcinoma-59A
DR   Wikidata; Q107117368
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Derived from site: Metastatic; Temple, skin; UBERON=UBERON_8480028.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EG ! UT-SCC-59B
OI   CVCL_A7EF ! UT-SCC-59C
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-59B
AC   CVCL_A7EG
SY   University of Turku-Squamous Cell Carcinoma-59B
DR   Wikidata; Q107117369
RX   DOI=10.1158/1538-7445.AM2020-507;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5VI ! UT-SCC-59A
OI   CVCL_A7EF ! UT-SCC-59C
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-59C
AC   CVCL_A7EF
SY   University of Turku-Squamous Cell Carcinoma-59C
DR   Wikidata; Q107117370
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 9,11,12
ST   D16S539: 11,12,13
ST   D18S51: 16,18
ST   D19S433: 14,15
ST   D21S11: 30,30.2,31,32.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17,18
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 10,11,14
ST   FGA: 21,23,26
ST   TH01: 7,8,9.3
ST   TPOX: 8,9,11
ST   vWA: 14,17,18
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5VI ! UT-SCC-59A
OI   CVCL_A7EG ! UT-SCC-59B
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-60A
AC   CVCL_A089
SY   UT-SCC 60 A; University of Turku-Squamous Cell Carcinoma-60A
DR   cancercelllines; CVCL_A089
DR   Cosmic; 1140776
DR   Cosmic; 1219860
DR   GEO; GSM2883380
DR   GEO; GSM2888843
DR   Wikidata; Q54992182
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg342Ter (c.1024C>T); ClinVar=VCV000182970; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 12,16
ST   D19S433: 13,16
ST   D21S11: 30.2
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 9,13
ST   FGA: 20,21
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A090 ! UT-SCC-60B
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 13
//
ID   UT-SCC-60B
AC   CVCL_A090
SY   UT-SCC 60 B; University of Turku-Squamous Cell Carcinoma-60B
DR   Cosmic; 1140777
DR   Cosmic; 1219861
DR   Wikidata; Q54992184
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=15287027;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A089 ! UT-SCC-60A
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   UT-SCC-63A
AC   CVCL_A7ED
SY   University of Turku-Squamous Cell Carcinoma-63A
DR   Wikidata; Q107117371
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13
ST   D18S51: 15
ST   D19S433: 12,15
ST   D21S11: 31,31.2
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 7
ST   D8S1179: 13,14
ST   FGA: 24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EH ! UT-SCC-63B
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-63B
AC   CVCL_A7EH
SY   University of Turku-Squamous Cell Carcinoma-63B
DR   Wikidata; Q107117372
RX   DOI=10.1158/1538-7445.AM2020-507;
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7ED ! UT-SCC-63A
SX   Male
AG   >52Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-65
AC   CVCL_A7EK
SY   University of Turku-Squamous Cell Carcinoma-65
DR   GEO; GSM2883381
DR   GEO; GSM2888844
DR   Wikidata; Q107117373
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, soft palate; UBERON=UBERON_0001733.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-67
AC   CVCL_A7EJ
SY   University of Turku-Squamous Cell Carcinoma-67
DR   GEO; GSM2883382
DR   GEO; GSM2888845
DR   Wikidata; Q107117375
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.560-2A>G; ClinVar=VCV003148158; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-6A
AC   CVCL_7866
SY   University of Turku-Squamous Cell Carcinoma-6A
DR   cancercelllines; CVCL_7866
DR   GEO; GSM2883355
DR   GEO; GSM2888818
DR   Wikidata; Q54992187
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8782485;
RX   PubMed=15287027;
RX   PubMed=17312569;
RX   PubMed=26694163;
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg110Cys (c.328C>T); ClinVar=VCV000142206; Zygosity=Heterozygous (PubMed=29970484).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile232Asn (c.695T>A); ClinVar=VCV000850008; Zygosity=Heterozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7867 ! UT-SCC-6B
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UT-SCC-6B
AC   CVCL_7867
SY   University of Turku-Squamous Cell Carcinoma-6B
DR   Wikidata; Q54992188
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=8782485;
RX   PubMed=15287027;
RX   PubMed=17312569;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=8782485).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7866 ! UT-SCC-6A
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   UT-SCC-7
AC   CVCL_7868
SY   UT-SCC7; University of Turku-Squamous Cell Carcinoma-7
DR   cancercelllines; CVCL_7868
DR   IARC_TP53; 11067
DR   Wikidata; Q54992189
RX   PubMed=8782485;
RX   PubMed=9187133;
RX   PubMed=17312569;
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (PubMed=8782485).
CC   Derived from site: Metastatic; Temple, skin; UBERON=UBERON_8480028.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   UT-SCC-72
AC   CVCL_A7EL
SY   University of Turku-Squamous Cell Carcinoma-72
DR   GEO; GSM2883383
DR   GEO; GSM2888846
DR   Wikidata; Q107117376
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-73
AC   CVCL_A7EM
SY   University of Turku-Squamous Cell Carcinoma-73
DR   GEO; GSM2883384
DR   GEO; GSM2888847
DR   Wikidata; Q107117377
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-74A
AC   CVCL_A7DX
SY   University of Turku-Squamous Cell Carcinoma-74A
DR   GEO; GSM2883385
DR   GEO; GSM2888848
DR   Wikidata; Q107117378
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 15,16
ST   D21S11: 27
ST   D2S1338: 18,19
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,12
ST   FGA: 27
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7DY ! UT-SCC-74B
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-74B
AC   CVCL_A7DY
SY   University of Turku-Squamous Cell Carcinoma-74B
DR   Wikidata; Q107117380
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 12
ST   D18S51: 16
ST   D19S433: 12,13,15
ST   D21S11: 27
ST   D2S1338: 18,19
ST   D3S1358: 12,16,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,11,12
ST   FGA: 24
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7DX ! UT-SCC-74A
SX   Male
AG   >31Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-75
AC   CVCL_A092
SY   UTSCC75; University of Turku-Squamous Cell Carcinoma-75
DR   GEO; GSM2883386
DR   GEO; GSM2888849
DR   Wikidata; Q54992190
RX   PubMed=16715129;
RX   PubMed=26694163;
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   UT-SCC-76A
AC   CVCL_A7DZ
SY   University of Turku-Squamous Cell Carcinoma-76A
DR   GEO; GSM2883387
DR   GEO; GSM2888850
DR   Wikidata; Q107117381
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=29970484;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Caution: UT-SCC-76A and UT-SCC-76B are supposed to originate from the same patient but have totally different STR profiles.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 15
ST   D19S433: 15,16
ST   D21S11: 33.2
ST   D2S1338: 20,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EA ! UT-SCC-76B
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-76B
AC   CVCL_A7EA
SY   University of Turku-Squamous Cell Carcinoma-76B
DR   Wikidata; Q107117383
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Caution: UT-SCC-76A and UT-SCC-76B are supposed to originate from the same patient but have totally different STR profiles.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=30135316
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 19
ST   D19S433: 13
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 10,13
ST   FGA: 24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7DZ ! UT-SCC-76A
SX   Male
AG   >52Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-79A
AC   CVCL_A7EE
SY   University of Turku-Squamous Cell Carcinoma-79A
DR   Wikidata; Q107117384
RX   DOI=10.1158/1538-7445.AM2020-507;
RX   PubMed=30135316;
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Parotid lymph node; UBERON=UBERON_0015857.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EI ! UT-SCC-79B
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-79B
AC   CVCL_A7EI
SY   University of Turku-Squamous Cell Carcinoma-79B
DR   Wikidata; Q107117385
RX   DOI=10.1158/1538-7445.AM2020-507;
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7EE ! UT-SCC-79A
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-8
AC   CVCL_7869
SY   UTSCC8; University of Turku-Squamous Cell Carcinoma-8
DR   cancercelllines; CVCL_7869
DR   GEO; GSM2883356
DR   GEO; GSM2888819
DR   IARC_TP53; 11065
DR   Wikidata; Q54992191
RX   PubMed=8782485;
RX   PubMed=16715129;
RX   PubMed=17312569;
RX   PubMed=29970484;
RX   PubMed=33802339;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Phe (c.763A>T); ClinVar=VCV000376621; Zygosity=Unspecified (PubMed=8782485; PubMed=33802339).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Larynx, supraglottis; UBERON=UBERON_0036263.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,14
ST   D16S539: 12
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30,31.2
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   UT-SCC-81
AC   CVCL_A7EN
SY   University of Turku-Squamous Cell Carcinoma-81
DR   GEO; GSM2883388
DR   GEO; GSM2888851
DR   Wikidata; Q107117386
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCC-87
AC   CVCL_A7EP
SY   University of Turku-Squamous Cell Carcinoma-87
DR   GEO; GSM2883389
DR   GEO; GSM2888852
DR   Wikidata; Q107117387
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ile255Phe (c.763A>T); ClinVar=VCV000376621; Zygosity=Homozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-9
AC   CVCL_7870
SY   UT-SCC 9; University of Turku-Squamous Cell Carcinoma-9
DR   BTO; BTO_0003720
DR   Wikidata; Q54992193
RX   PubMed=8782485;
RX   PubMed=17312569;
RX   PubMed=18487078;
RX   PubMed=26694163;
RX   PubMed=33802339;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (PubMed=8782485; PubMed=33802339).
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Larynx, glottis; UBERON=UBERON_0002486.
ST   Source(s): PubMed=33802339
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 18,20
ST   D19S433: 15
ST   D21S11: 29,31.2
ST   D2S1338: 25
ST   D3S1358: 15
ST   D5S818: 13,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   UT-SCC-91
AC   CVCL_A5VH
SY   UT-SCC91; University of Turku-Squamous Cell Carcinoma-91
DR   Wikidata; Q107117388
RX   PubMed=22427941;
RX   PubMed=27305645;
RX   PubMed=28322200;
CC   Derived from site: In situ; Nose, skin; UBERON=UBERON_0015476.
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   UT-SCC-95
AC   CVCL_A7EQ
SY   University of Turku-Squamous Cell Carcinoma-95
DR   GEO; GSM2883390
DR   GEO; GSM2888853
DR   Wikidata; Q107117389
RX   PubMed=29970484;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val143Gly (c.428T>G); ClinVar=VCV000486556; Zygosity=Heterozygous (PubMed=29970484).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   UT-SCC-99
AC   CVCL_A7ER
SY   University of Turku-Squamous Cell Carcinoma-99
DR   GEO; GSM2883391
DR   GEO; GSM2888854
DR   Wikidata; Q107117390
RX   PubMed=29970484;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 5
//
ID   UT-SCV-1
AC   CVCL_6468
SY   University of Turku-Squamous cell Carcinoma of the Vulva-1
DR   cancercelllines; CVCL_6468
DR   IARC_TP53; 10156
DR   Wikidata; Q54992194
RX   PubMed=9887230;
RX   PubMed=15047230;
CC   Doubling time: 38 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=9887230).
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   UT-SCV-2
AC   CVCL_6469
SY   University of Turku-Squamous cell Carcinoma of the Vulva-2
DR   IARC_TP53; 21683
DR   Wikidata; Q54992195
RX   PubMed=9887230;
RX   PubMed=15047230;
CC   Doubling time: 56 hours (PubMed=15047230).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   UT-SCV-3
AC   CVCL_6470
SY   University of Turku-Squamous cell Carcinoma of the Vulva-3
DR   Wikidata; Q54992197
RX   PubMed=15047230;
CC   Doubling time: 13 hours (PubMed=15047230).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   UT14
AC   CVCL_VJ96
DR   CCRID; 1101HUM-PUMC000598
DR   Cosmic; 2653720
DR   GEO; GSM2375328
DR   GEO; GSM2375329
DR   GEO; GSM2375330
DR   GEO; GSM2386067
DR   GEO; GSM2386072
DR   GEO; GSM2386073
DR   Wikidata; Q98134379
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000598; PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 23,26
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   UT16
AC   CVCL_VJ97
DR   CCRID; 1101HUM-PUMC000599
DR   Cosmic; 2653721
DR   GEO; GSM2375331
DR   GEO; GSM2386068
DR   Wikidata; Q98134381
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000599; PubMed=28256713
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 16,21
ST   D19S433: 14.2,15
ST   D21S11: 28,29
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 10,12
ST   D6S1043: 12
ST   D7S820: 8,12
ST   D8S1179: 12,14
ST   FGA: 24.2,25
ST   Penta E: 15
ST   TH01: 7,9
ST   TPOX: 8,14
ST   vWA: 18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   UT33a
AC   CVCL_VJ98
DR   CCRID; 1101HUM-PUMC000600
DR   Cosmic; 2653726
DR   GEO; GSM2375332
DR   GEO; GSM2386069
DR   Wikidata; Q98134383
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000600; PubMed=28256713
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19,21
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 18
ST   D5S818: 11,12
ST   D6S1043: 13
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 20,24
ST   Penta E: 14,15
ST   TH01: 7,10
ST   TPOX: 12
ST   vWA: 14,18
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   UT44
AC   CVCL_VJ99
DR   CCRID; 1101HUM-PUMC000601
DR   Cosmic; 2653722
DR   Wikidata; Q98134385
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000601; PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,24
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 12,13
ST   D19S433: 14.2,15
ST   D21S11: 31,33.2
ST   D2S1338: 23,25
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 11,14
ST   D7S820: 11,12
ST   D8S1179: 16
ST   FGA: 24
ST   Penta E: 18,22
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 8
//
ID   UT48
AC   CVCL_VK00
DR   CCRID; 1101HUM-PUMC000602
DR   Cosmic; 2653723
DR   GEO; GSM2375333
DR   GEO; GSM2386070
DR   Wikidata; Q98134387
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000602; PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 19
ST   D13S317: 11,13
ST   D16S539: 10,12
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 31.2
ST   D2S1338: 20,23
ST   D3S1358: 17
ST   D5S818: 9,12
ST   D6S1043: 19,20
ST   D7S820: 9,11
ST   D8S1179: 10,11
ST   FGA: 23,24
ST   Penta E: 15,19
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 16
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   UT56
AC   CVCL_VK01
DR   Cosmic; 2653724
DR   GEO; GSM2375334
DR   GEO; GSM2386071
DR   Wikidata; Q98134389
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 19,22
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 15,16
ST   D19S433: 14,14.2
ST   D21S11: 29,30
ST   D2S1338: 24,26
ST   D3S1358: 18
ST   D5S818: 13
ST   D6S1043: 14
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta E: 15,18
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 8
//
ID   UT62a
AC   CVCL_VK02
DR   Cosmic; 2653725
DR   Wikidata; Q98134392
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 19
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 14,18
ST   D19S433: 13,14.2
ST   D21S11: 28.2,30
ST   D2S1338: 22,23
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D6S1043: 12,21
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta E: 17,19
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 6
//
ID   UTA-SF2-2
AC   CVCL_AS03
DR   JCRB; JCRB1493
DR   JCRB; NIHS0693
DR   SKIP; SKIP000693
DR   Wikidata; Q54992198
RX   PubMed=21124894;
CC   Doubling time: 28.2 +- 4.9 hours (PubMed=21124894).
CC   Discontinued: JCRB; NIHS0693; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1493
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 9
//
ID   UTA-SF3-2
AC   CVCL_AS04
DR   JCRB; NIHS0695
DR   Wikidata; Q54992199
RX   PubMed=21124894;
CC   Discontinued: JCRB; NIHS0695; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   UTA.00102.LQT1
AC   CVCL_A8PG
SY   TAUi006-A
DR   BioSamples; SAMEA8549174
DR   hPSCreg; TAUi006-A
DR   Wikidata; Q108821466
RX   PubMed=28785673;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.1129-2A>G (IVS7-2A>G); dbSNP=rs768022350; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=28785673).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PH ! UTA.00118.LQT1
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UTA.00106.hFF
AC   CVCL_RN24
SY   UTA.00106
DR   Wikidata; Q54992200
RX   PubMed=22315618;
RX   PubMed=23119085;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   UTA.00112.hFF
AC   CVCL_RN16
SY   UTA.00112; WTa
DR   Wikidata; Q54992201
RX   PubMed=22052944;
RX   PubMed=22315618;
RX   PubMed=22962621;
RX   PubMed=23119085;
RX   PubMed=23341440;
RX   PubMed=27026928;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   UTA.00118.LQT1
AC   CVCL_A8PH
SY   TAUi006-B
DR   BioSamples; SAMEA8549176
DR   hPSCreg; TAUi006-B
DR   Wikidata; Q108821467
RX   PubMed=28785673;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; c.1129-2A>G (IVS7-2A>G); dbSNP=rs768022350; Zygosity=Unspecified; Note=Splice acceptor mutation (PubMed=28785673).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PG ! UTA.00102.LQT1
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   UTA.00208.LQT1
AC   CVCL_RN17
SY   TAUi007-A
DR   BioSamples; SAMEA8549177
DR   hPSCreg; TAUi007-A
DR   Wikidata; Q54992202
RX   PubMed=27026928;
RX   PubMed=28785673;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly589Asp (c.1766G>A) (p.Gly462Asp, c.1385G>A); ClinVar=VCV000003140; Zygosity=Unspecified (PubMed=27026928; PubMed=28785673).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN18 ! UTA.00211.LQT1
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UTA.00211.LQT1
AC   CVCL_RN18
SY   TAUi007-B
DR   BioSamples; SAMEA8549178
DR   hPSCreg; TAUi007-B
DR   Wikidata; Q54992203
RX   PubMed=27026928;
RX   PubMed=28785673;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly589Asp (c.1766G>A) (p.Gly462Asp, c.1385G>A); ClinVar=VCV000003140; Zygosity=Unspecified (PubMed=27026928; PubMed=28785673).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN17 ! UTA.00208.LQT1
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UTA.00303.LQT1
AC   CVCL_RN19
DR   Wikidata; Q54992204
RX   PubMed=27026928;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly589Asp (c.1766G>A) (p.Gly462Asp, c.1385G>A); ClinVar=VCV000003140; Zygosity=Unspecified (PubMed=27026928).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN20 ! UTA.00313.LQT1
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UTA.00313.LQT1
AC   CVCL_RN20
DR   Wikidata; Q54992205
RX   PubMed=27026928;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly589Asp (c.1766G>A) (p.Gly462Asp, c.1385G>A); ClinVar=VCV000003140; Zygosity=Unspecified (PubMed=27026928).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN19 ! UTA.00303.LQT1
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UTA.00514.LQT2
AC   CVCL_RN21
DR   Wikidata; Q54992206
RX   PubMed=22052944;
RX   PubMed=27026928;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Arg176Trp (c.526C>T); ClinVar=VCV000067509; Zygosity=Unspecified (PubMed=22052944; PubMed=27026928).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN22 ! UTA.00525.LQT2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   UTA.00525.LQT2
AC   CVCL_RN22
DR   Wikidata; Q54992207
RX   PubMed=22052944;
RX   PubMed=23119085;
RX   PubMed=27026928;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Arg176Trp (c.526C>T); ClinVar=VCV000067509; Zygosity=Unspecified (PubMed=22052944; PubMed=27026928).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN21 ! UTA.00514.LQT2
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   UTA.01006.WT
AC   CVCL_RN23
SY   WTb
DR   Wikidata; Q54992208
RX   PubMed=22052944;
RX   PubMed=23341440;
RX   PubMed=27026928;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   UTA.04602.WT
AC   CVCL_RN25
SY   TAUi002-A
DR   BioSamples; SAMEA6880676
DR   hPSCreg; TAUi002-A
DR   SKIP; SKIP001418
DR   Wikidata; Q54992209
RX   PubMed=22052944;
RX   PubMed=22962621;
RX   PubMed=23119085;
RX   PubMed=24708714;
RX   PubMed=28785673;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8PI ! UTA.04607.WT
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   UTA.04607.WT
AC   CVCL_A8PI
DR   Wikidata; Q108821468
RX   PubMed=24708714;
RX   PubMed=28785673;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN25 ! UTA.04602.WT
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UTA.05203.CPVT
AC   CVCL_RN14
DR   SKIP; SKIP001416
DR   Wikidata; Q54992210
RX   PubMed=22962621;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Pro2328Ser (c.6982C>T); ClinVar=VCV000012960; Zygosity=Unspecified (PubMed=22962621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN15 ! UTA.05208.CPVT
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UTA.05208.CPVT
AC   CVCL_RN15
SY   TAUi004-A
DR   BioSamples; SAMEA6880680
DR   hPSCreg; TAUi004-A
DR   SKIP; SKIP001417
DR   Wikidata; Q54992211
RX   PubMed=22962621;
CC   From: Institute of Biomedical Technology, University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Pro2328Ser (c.6982C>T); ClinVar=VCV000012960; Zygosity=Unspecified (PubMed=22962621).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN14 ! UTA.05203.CPVT
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   UTA.11505.WTsb
AC   CVCL_ZX61
SY   TAUi003-A
DR   BioSamples; SAMEA6880678
DR   hPSCreg; TAUi003-A
DR   Wikidata; Q102115090
CC   From: University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 4
//
ID   UTA.14511.CPVT
AC   CVCL_ZX62
SY   TAUi005-A
DR   BioSamples; SAMEA6880681
DR   hPSCreg; TAUi005-A
DR   Wikidata; Q102115092
CC   From: University of Tampere; Tampere; Finland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Pro2328Ser (c.6982C>T); ClinVar=VCV000012960; Zygosity=Unspecified (hPSCreg=TAUi005-A).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   UTA1
AC   CVCL_AS02
DR   Wikidata; Q54992213
RX   PubMed=21124894;
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 6
//
ID   UTA21.15
AC   CVCL_XF82
DR   Wikidata; Q98134393
RX   PubMed=9484832;
RX   PubMed=10913154;
CC   Population: Caucasian.
CC   Characteristics: Expresses very little CDKN1A when cultured in the presence of tetracycline, whereas CDKN1A expression is dramatically induced upon removal of tetracycline from the culture medium.
CC   Characteristics: Transfected with an expression plasmid containing CKN1A (p21waf1) under control of a minimal CMV promoter fused to tetracycline operator sequences.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1784; CDKN1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF79 ! UTA6
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   UTA21.9
AC   CVCL_XF83
DR   Wikidata; Q98134396
RX   PubMed=9484832;
CC   Population: Caucasian.
CC   Characteristics: Expresses very little CDKN1A when cultured in the presence of tetracycline, whereas CDKN1A expression is dramatically induced upon removal of tetracycline from the culture medium.
CC   Characteristics: Transfected with an expression plasmid containing CKN1A (p21waf1) under control of a minimal CMV promoter fused to tetracycline operator sequences.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1784; CDKN1A.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XF79 ! UTA6
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 10
//
ID   UTA6
AC   CVCL_XF79
SY   UTA 6
DR   Wikidata; Q98134398
RX   PubMed=7588596;
RX   PubMed=9484832;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   UTARi001-A
AC   CVCL_C1XI
SY   NHDF-iPSC SeV
DR   BioSamples; SAMEA13610177
DR   hPSCreg; UTARi001-A
DR   Wikidata; Q114313211
RX   PubMed=30580364;
CC   From: Universiti Tunku Abdul Rahman; Kajang; Malaysia.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   UtE-iPS-1
AC   CVCL_E031
SY   Center; UtE-iPS-A01
DR   SKIP; SKIP000350
DR   Wikidata; Q54992214
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   UtE-iPS-10
AC   CVCL_E032
SY   Flanker; UtE-iPS-B03
DR   SKIP; SKIP000386
DR   Wikidata; Q54992215
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   UtE-iPS-11
AC   CVCL_E033
SY   SplitEnd; UtE-iPS-B05; UtEiPS-11
DR   GEO; GSM520698
DR   GEO; GSM520699
DR   GEO; GSM520700
DR   GEO; GSM520701
DR   GEO; GSM520702
DR   GEO; GSM520703
DR   GEO; GSM608006
DR   GEO; GSM608007
DR   GEO; GSM608008
DR   GEO; GSM608009
DR   GEO; GSM608026
DR   GEO; GSM608027
DR   SKIP; SKIP000357
DR   Wikidata; Q54992216
RX   PubMed=21637780;
RX   PubMed=23631808;
RX   PubMed=26477663;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Glycomics; Glycosphingolipids.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,23
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   UtE-iPS-2
AC   CVCL_E034
SY   Guard; UtE-iPS-A02
DR   SKIP; SKIP000383
DR   Wikidata; Q54992218
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   UtE-iPS-3
AC   CVCL_E035
SY   Tackle; UtE-iPS-A03
DR   SKIP; SKIP000384
DR   Wikidata; Q54992219
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   UtE-iPS-4
AC   CVCL_E036
SY   TightEnd; UtE-iPS-A04
DR   GEO; GSM520695
DR   GEO; GSM520696
DR   GEO; GSM520697
DR   GEO; GSM520709
DR   GEO; GSM520710
DR   GEO; GSM520712
DR   GEO; GSM608002
DR   GEO; GSM608003
DR   SKIP; SKIP000349
DR   Wikidata; Q54992220
RX   PubMed=21637780;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,23
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   UtE-iPS-5
AC   CVCL_E037
SY   FullBack; UtE-iPS-A05
DR   SKIP; SKIP000385
DR   Wikidata; Q54992221
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 10
//
ID   UtE-iPS-6
AC   CVCL_E038
SY   TailBack; UtE-iPS-A06
DR   GEO; GSM608004
DR   SKIP; SKIP000356
DR   Wikidata; Q54992222
RX   PubMed=21637780;
RX   PubMed=23631808;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,23
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 13
//
ID   UtE-iPS-7
AC   CVCL_E039
SY   QuaterBack; UtE-iPS-A07; UtEiPS-07
DR   GEO; GSM608005
DR   SKIP; SKIP000358
DR   Wikidata; Q54992223
RX   PubMed=21637780;
RX   PubMed=26477663;
WW   Provider; NRICHD; -; https://web.archive.org/web/20211129215433/http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Glycomics; Glycosphingolipids.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,23
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D693 ! UtE1104
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 12
//
ID   UtE1104
AC   CVCL_D693
SY   UtE, specimen number 1104; Uterus Endometrial 1104
DR   GEO; GSM520692
DR   GEO; GSM520693
DR   GEO; GSM520694
DR   GEO; GSM608001
DR   GEO; GSM1906543
DR   JCRB; JCRB1573
DR   Wikidata; Q54992224
RX   PubMed=21155951;
RX   PubMed=21637780;
RX   PubMed=23631808;
RX   PubMed=26477663;
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Glycomics; Glycosphingolipids.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): JCRB=JCRB1573; PubMed=21637780
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 31.2,32.2
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 13,16
ST   FGA: 19,23
ST   Penta D: 9,10
ST   Penta E: 5
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   UTE3
AC   CVCL_VK03
DR   Cosmic; 2640557
DR   Wikidata; Q98134399
RX   PubMed=27894751;
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 4
//
ID   UTE4
AC   CVCL_VK04
DR   Cosmic; 2640555
DR   Wikidata; Q98134401
RX   PubMed=27894751;
CC   Microsatellite instability: Stable (MSS) (PubMed=27894751).
CC   Sequence variation: Mutation; HGNC; HGNC:9177; POLE; Simple; p.Ala957Val; Zygosity=Unspecified (PubMed=27894751).
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   UTHs
AC   CVCL_7871
DR   CLO; CLO_0009491
DR   CLDB; cl4613
DR   Wikidata; Q54992225
CC   Population: Caucasian; Swedish.
CC   Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HHV-1).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   UtLM-hTERT
AC   CVCL_9Z19
SY   ht-UtLM; Uterine LeioMyoma-hTERT immortalized
DR   Wikidata; Q54992226
RX   PubMed=12065682;
RX   PubMed=35032343;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
DI   NCIt; C3434; Uterine corpus leiomyoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2T99 ! GM10964
SX   Female
AG   39Y
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   UTMB-460
AC   CVCL_8276
SY   University of Texas Medical Branch-460
DR   BioSample; SAMN03151622
DR   cancercelllines; CVCL_8276
DR   Wikidata; Q54992238
RX   PubMed=3022081;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Was originally thought to originate from the bone marrow of a 33 year old healthy woman who was seropositive for a EBV infection.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00283.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   UTMC-2
AC   CVCL_4802
SY   UTMC2; University of Tennessee Medical Center-2
DR   EFO; EFO_0022513
DR   Cosmic; 720762
DR   Cosmic; 759911
DR   Cosmic; 760393
DR   Cosmic; 2081410
DR   Cosmic; 2302412
DR   Cosmic; 2367294
DR   Cosmic; 2391804
DR   Wikidata; Q54992240
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7528862;
RX   PubMed=8943038;
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=32123307;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=UTMC-2
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   Characteristics: Produces IgA kappa.
CC   Doubling time: 48 hours (PubMed=7528862).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   UTO-EW1
AC   CVCL_W452
DR   Wikidata; Q54992241
RX   PubMed=9573488;
CC   Population: Japanese.
CC   Doubling time: 49 hours (PubMed=9573488).
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
DI   NCIt; C3716; Primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   UTOS-1
AC   CVCL_H195
SY   University of Toyama OSteosarcoma-1
DR   Wikidata; Q54992243
RX   PubMed=19239720;
CC   Population: Japanese.
CC   Doubling time: 40 hours (PubMed=19239720).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Bone, left humerus; UBERON=UBERON_0000976.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   UTP-2
AC   CVCL_5383
DR   BTO; BTO_0004948
DR   Cosmic; 996289
DR   Cosmic; 998697
DR   Cosmic; 1037707
DR   Wikidata; Q54992244
RX   PubMed=10233379;
RX   PubMed=14504097;
CC   Population: Japanese.
CC   Caution: It is possible that UTP2 and UTP-L2 (Cellosaurus=CVCL_WZ69) are the same cell line.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   UTP-5
AC   CVCL_W267
DR   Cosmic; 721711
DR   Wikidata; Q54992246
RX   PubMed=10071127;
CC   Population: Japanese.
CC   Caution: It is possible that UTP5 and UTP-L5 (Cellosaurus=CVCL_5388) are the same cell line.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   UTP-6
AC   CVCL_W268
DR   Cosmic; 721712
DR   Wikidata; Q54992247
RX   PubMed=10071127;
CC   Population: Japanese.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 8
//
ID   UTP-DSAL-1
AC   CVCL_0C63
DR   Cosmic; 2089671
DR   Wikidata; Q54992248
RX   PubMed=23955599;
CC   Population: Japanese.
DI   NCIt; C2993; Down syndrome
DI   NCIt; C43223; Myeloid leukemia associated with Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
DI   ORDO; Orphanet_99887; Acute megakaryoblastic leukemia in Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 7
//
ID   UTP-ES1
AC   CVCL_DH85
SY   UTP-ES-1
DR   cancercelllines; CVCL_DH85
DR   GEO; GSM393043
DR   Progenetix; CVCL_DH85
DR   Wikidata; Q54992249
RX   PubMed=18082704;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   UTP-L10
AC   CVCL_5385
DR   BTO; BTO_0004947
DR   Cosmic; 996288
DR   Wikidata; Q54992250
RX   PubMed=14504097;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   UTP-L12
AC   CVCL_A7NN
DR   Wikidata; Q107117392
RX   PubMed=8187069;
RX   PubMed=9242552;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG; Note=In frame (PubMed=8187069).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   UTP-L2
AC   CVCL_WZ69
SY   UTPL2
DR   Wikidata; Q98134403
RX   CelloPub=CLPUB00111;
RX   PubMed=7647001;
RX   PubMed=8139288;
RX   PubMed=10739008;
RX   PubMed=11226526;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=7647001; PubMed=8139288).
CC   Caution: It is possible that UTP2 (Cellosaurus=CVCL_5383) and UTP-L2 are the same cell line.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   UTP-L20
AC   CVCL_5386
DR   Cosmic; 998693
DR   Cosmic; 1037709
DR   Wikidata; Q54992251
RX   PubMed=10233379;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   UTP-L3
AC   CVCL_5387
DR   Cosmic; 998739
DR   Wikidata; Q54992252
RX   PubMed=10233379;
CC   Population: Japanese.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UTP-L5
AC   CVCL_5388
DR   BTO; BTO_0004946
DR   Cosmic; 996286
DR   Cosmic; 998691
DR   Cosmic; 1037708
DR   Wikidata; Q54992253
RX   PubMed=10233379;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=14504097;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Caution: It is possible that UTP5 (Cellosaurus=CVCL_W267) and UTP-L5 are the same cell line.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   UTP-L51
AC   CVCL_5389
DR   Cosmic; 998690
DR   Wikidata; Q54992254
RX   PubMed=10233379;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UTP-M1
AC   CVCL_5390
DR   Cosmic; 998742
DR   Wikidata; Q54992256
RX   PubMed=10233379;
CC   Population: Japanese.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   UTP-M2
AC   CVCL_5391
DR   Cosmic; 998741
DR   Wikidata; Q54992257
RX   PubMed=10233379;
CC   Population: Japanese.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 10
//
ID   UTP-N-1
AC   CVCL_DF75
DR   cancercelllines; CVCL_DF75
DR   Cosmic; 1153802
DR   GEO; GSM333824
DR   GEO; GSM333826
DR   Progenetix; CVCL_DF75
DR   Wikidata; Q54992259
RX   PubMed=18923524;
CC   Population: Japanese.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 7
//
ID   utr-1
AC   CVCL_U033
DR   ECACC; 10080904
DR   Wikidata; Q54992260
RX   PubMed=2158104;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P20333; Human TNFRSF1B/CD120b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   utr-4a
AC   CVCL_U034
DR   ECACC; 10080901
DR   Wikidata; Q54992261
RX   PubMed=2158104;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20333; Human TNFRSF1B/CD120b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   UTree-O2
AC   CVCL_W195
DR   Wikidata; Q54992262
RX   PubMed=16809887;
CC   Population: Japanese.
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 7
//
ID   UtSMC-hTERT
AC   CVCL_9Z20
SY   Uterine Smooth Muscle Cell-hTERT immortalized
DR   Wikidata; Q54992263
RX   PubMed=12065682;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Uterus, myometrium; UBERON=UBERON_0001296.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 8
//
ID   UTSW-ACC112
AC   CVCL_Y492
SY   ACC112; ACC-112
DR   EFO; EFO_0007070
DR   ENCODE; ENCBS726UUU
DR   ENCODE; ENCBS827JIC
DR   Wikidata; Q54992264
RX   DOI=10.4103/2468-5585.200513;
RX   PubMed=10328235;
CC   Doubling time: 30 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 14
//
ID   UTSW-ACC52
AC   CVCL_Y489
SY   ACC52
DR   Wikidata; Q54992266
RX   PubMed=10328235;
CC   Doubling time: 32 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, minor salivary gland; UBERON=UBERON_0001830.
DI   NCIt; C8026; Salivary gland adenoid cystic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   UTSW-CaPA79
AC   CVCL_Y490
SY   CaPA79
DR   Wikidata; Q54992267
RX   PubMed=10328235;
CC   Doubling time: 35 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40410; Salivary gland carcinoma ex pleomorphic adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   UTSW-EMC23
AC   CVCL_Y491
DR   Wikidata; Q54992268
RX   PubMed=10328235;
CC   Doubling time: 26 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Misspelling: UTSW-EMC52; PubMed=10328235; Note=In table I.
CC   Derived from site: In situ; Salivary gland, submandibular gland; UBERON=UBERON_0001736.
DI   NCIt; C35701; Salivary gland epithelial-myoepithelial carcinoma
DI   ORDO; Orphanet_276145; Malignant epithelial tumor of salivary glands
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 14
//
ID   UTSW-MEC49
AC   CVCL_Y488
SY   MEC49
DR   Wikidata; Q54992269
RX   PubMed=10328235;
CC   Doubling time: 46 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C5908; Salivary gland mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 12
//
ID   UTSW-PA116
AC   CVCL_Y485
DR   Wikidata; Q54992270
RX   PubMed=10328235;
CC   Doubling time: 41 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   UTSW-PA125
AC   CVCL_Y486
DR   Wikidata; Q54992271
RX   PubMed=10328235;
CC   Doubling time: 34 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   UTSW-PA37
AC   CVCL_Y487
DR   Wikidata; Q54992272
RX   PubMed=10328235;
CC   Doubling time: 24 hours (PubMed=10328235).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Salivary gland, parotid gland; UBERON=UBERON_0001831.
DI   NCIt; C40409; Salivary gland pleomorphic adenoma
DI   ORDO; Orphanet_454821; Pleomorphic salivary gland adenoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 13
//
ID   UTUi001-A
AC   CVCL_D0PB
SY   TUR1
DR   BioSamples; SAMEA112302760
DR   hPSCreg; UTUi001-A
DR   Wikidata; Q123033764
RX   PubMed=38176368;
CC   From: University of Turku; Turku; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UTUi001-B
AC   CVCL_D0PC
SY   TUR2
DR   BioSamples; SAMEA112319796
DR   hPSCreg; UTUi001-B
DR   Wikidata; Q123033765
RX   PubMed=38176368;
CC   From: University of Turku; Turku; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UTUi001-C
AC   CVCL_D0PD
SY   TUR3
DR   BioSamples; SAMEA112319797
DR   hPSCreg; UTUi001-C
DR   Wikidata; Q123033766
RX   PubMed=38176368;
CC   From: University of Turku; Turku; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3653 ! BJ [Human fibroblast]
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   UTUi002-A
AC   CVCL_E7VW
SY   TUR-STAB1-B1
DR   BioSamples; SAMEA115975667
DR   hPSCreg; UTUi002-A
CC   From: University of Turku; Turku; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UTUi003-A
AC   CVCL_E7VX
SY   TUR-B1
DR   BioSamples; SAMEA115988250
DR   hPSCreg; UTUi003-A
CC   From: University of Turku; Turku; Finland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   UUIGPi001-A
AC   CVCL_WT78
SY   VHL2-10
DR   hPSCreg; UUIGPi001-A
DR   Wikidata; Q98134405
RX   PubMed=31176917;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Trp (c.194C>G); ClinVar=VCV000043597; Zygosity=Heterozygous (PubMed=31176917).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   UUIGPi002-A
AC   CVCL_WT79
SY   VHL3-9
DR   hPSCreg; UUIGPi002-A
DR   Wikidata; Q98134407
RX   PubMed=31176917;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Ser65Leu (c.194C>T); ClinVar=VCV000182975; Zygosity=Heterozygous (PubMed=31176917).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   UUIGPi003-A
AC   CVCL_WT80
SY   VHL4-10
DR   hPSCreg; UUIGPi003-A
DR   Wikidata; Q98134409
RX   PubMed=31176917;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; p.Phe76del (c.227_229delTCT); Zygosity=Heterozygous (PubMed=31176917).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3105; Von Hippel-Lindau syndrome
DI   ORDO; Orphanet_892; Von Hippel-Lindau disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   UUIGPi004-A
AC   CVCL_WT81
SY   UUIGPi004A; UUIGPi04; MW2; MWS26B
DR   hPSCreg; UUIGPi004-A
DR   Wikidata; Q98134412
RX   PubMed=31376723;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14881; ZEB2; Simple; p.Arg343Ter (c.1027C>T); ClinVar=VCV000189281; Zygosity=Heterozygous (PubMed=31376723).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74999; Mowat-Wilson syndrome
DI   ORDO; Orphanet_261552; Mowat-Wilson syndrome due to a ZEB2 point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   UUIGPi005-A
AC   CVCL_WT82
SY   UUIGPi005A; UUIGPi005; MW1; MWS27(7)
DR   hPSCreg; UUIGPi005-A
DR   Wikidata; Q98134414
RX   PubMed=31376723;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:14881; ZEB2; Simple; p.Arg343Ter (c.1027C>T); ClinVar=VCV000189281; Zygosity=Heterozygous (PubMed=31376723).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C74999; Mowat-Wilson syndrome
DI   ORDO; Orphanet_261552; Mowat-Wilson syndrome due to a ZEB2 point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   UUIGPi006-A
AC   CVCL_WT83
SY   UUIGPi006A; DD1C; DRS1C
DR   hPSCreg; UUIGPi006-A
DR   Wikidata; Q98134417
RX   PubMed=31400703;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Pro1837fs (c.5502_5509dupGCTTGAAC); Zygosity=Heterozygous (PubMed=31400703).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 13
//
ID   UUIGPi007-A
AC   CVCL_WT84
SY   UUIGPi007A; DD4A; DRS4A
DR   hPSCreg; UUIGPi007-A
DR   Wikidata; Q98134419
RX   PubMed=31400703;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Ala989Phe (c.2965G>C); Zygosity=Heterozygous (PubMed=31400703).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   UUIGPi008-A
AC   CVCL_WT85
SY   UUIGPi008A; DD5A; DRS5A
DR   hPSCreg; UUIGPi008-A
DR   Wikidata; Q98134420
RX   PubMed=31400703;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:10585; SCN1A; Simple; p.Thr217Arg (c.651C>G); Zygosity=Heterozygous (PubMed=31400703).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 12
//
ID   UUIGPi009-A
AC   CVCL_YR36
SY   Ctl1B
DR   hPSCreg; UUIGPi009-A
DR   Wikidata; Q98134422
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   UUIGPi010-A
AC   CVCL_YR37
SY   Ctl8F
DR   hPSCreg; UUIGPi010-A
DR   Wikidata; Q98134424
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   UUIGPi011-A
AC   CVCL_YR38
SY   Ctl2B
DR   hPSCreg; UUIGPi011-A
DR   Wikidata; Q98134426
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   UUIGPi013-A
AC   CVCL_A1XJ
SY   DS1.1
DR   hPSCreg; UUIGPi013-A
DR   Wikidata; Q105511659
RX   PubMed=33220594;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   UUIGPi014-A
AC   CVCL_A1XK
SY   DS3.1
DR   hPSCreg; UUIGPi014-A
DR   Wikidata; Q105511662
RX   PubMed=33220594;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   UUIGPi015-A
AC   CVCL_B5GU
SY   DD3A
DR   hPSCreg; UUIGPi015-A
DR   Wikidata; Q110433952
RX   PubMed=35203050;
CC   From: Department of Immunology, Genetics and Pathology, Uppsala University; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:10585; SCN1A; Zygosity=Heterozygous; Note=2,9 Mbp deletion that spans 10 genes (PubMed=35203050).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C147071; Developmental and epileptic encephalopathy 6A
DI   ORDO; Orphanet_33069; Dravet syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   UUMCBi001-A
AC   CVCL_A4XB
SY   JLB1c10
DR   hPSCreg; UUMCBi001-A
DR   Wikidata; Q107117395
RX   PubMed=33340796;
CC   From: Department of Medical Cell Biology, Biomedical Centre; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UUMCBi002-A
AC   CVCL_A4XC
SY   JLB2c2
DR   hPSCreg; UUMCBi002-A
DR   Wikidata; Q107117396
RX   PubMed=33340796;
CC   From: Department of Medical Cell Biology, Biomedical Centre; Uppsala; Sweden.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   UV female 1A
AC   CVCL_4E30
DR   CLO; CLO_0050766
DR   RCB; RCB1993
DR   Wikidata; Q54992273
RX   PubMed=8205558;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 6
//
ID   UV female 2
AC   CVCL_U951
DR   CLO; CLO_0050223
DR   RCB; RCB1994
DR   Wikidata; Q54992275
RX   PubMed=8205558;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6 x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 7
//
ID   UV male 1d
AC   CVCL_4E31
DR   CLO; CLO_0050765
DR   RCB; RCB1992
DR   Wikidata; Q54992276
RX   PubMed=8205558;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 6
//
ID   UV-2237-IP3
AC   CVCL_0J66
SY   UV-2237 ip-3; UV2237-IP3
DR   Wikidata; Q54992277
RX   PubMed=2529426;
RX   PubMed=6935459;
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_B479 ! UV-2237M
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   UV-2237M
AC   CVCL_B479
SY   UV-2237m; UV2237M; UV2237m; UV2237 M; UV-2237
DR   KCLB; 80032
DR   Wikidata; Q54992278
RX   PubMed=679204;
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0J66 ! UV-2237-IP3
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   UV-2237M-ADMR
AC   CVCL_D696
SY   UV-2237-ADMR
DR   Wikidata; Q54992279
RX   PubMed=6616446;
RX   PubMed=6831444;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Breed/subspecies: C3H/HeN.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_B479 ! UV-2237M
SX   Female
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 7
//
ID   UV-P3U1-B8
AC   CVCL_U860
DR   CLO; CLO_0050397
DR   RCB; RCB1157
DR   Wikidata; Q54992280
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_81145; Thymine dimer.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 5
//
ID   UV.B6-1.1
AC   CVCL_4E33
DR   CLO; CLO_0050754
DR   RCB; RCB1997
DR   Wikidata; Q54992281
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.B6-2.1A
AC   CVCL_4E34
DR   CLO; CLO_0050755
DR   RCB; RCB1998
DR   Wikidata; Q54992282
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.B6-4.1
AC   CVCL_4E35
DR   CLO; CLO_0050756
DR   RCB; RCB1999
DR   Wikidata; Q54992283
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.B6-5.1
AC   CVCL_4E36
DR   CLO; CLO_0050757
DR   RCB; RCB2000
DR   Wikidata; Q54992284
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-1.1
AC   CVCL_4E37
DR   CLO; CLO_0050730
DR   RCB; RCB1995
DR   Wikidata; Q54992303
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-12.1
AC   CVCL_4E38
DR   CLO; CLO_0050735
DR   RCB; RCB2030
DR   Wikidata; Q54992304
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-13.1
AC   CVCL_4E39
DR   CLO; CLO_0050736
DR   RCB; RCB2031
DR   Wikidata; Q54992305
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-14.2
AC   CVCL_4E40
DR   CLO; CLO_0050737
DR   RCB; RCB2032
DR   Wikidata; Q54992306
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-15.1
AC   CVCL_4E41
DR   CLO; CLO_0050738
DR   RCB; RCB2033
DR   Wikidata; Q54992307
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-16.1
AC   CVCL_4E42
DR   CLO; CLO_0050739
DR   RCB; RCB2034
DR   Wikidata; Q54992308
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-17.1
AC   CVCL_4E43
DR   CLO; CLO_0050740
DR   RCB; RCB2035
DR   Wikidata; Q54992309
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-18.1
AC   CVCL_4E44
DR   CLO; CLO_0050741
DR   RCB; RCB2036
DR   Wikidata; Q54992310
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-19.1A
AC   CVCL_4E45
DR   CLO; CLO_0050742
DR   RCB; RCB2057
DR   Wikidata; Q54992312
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-2.1D
AC   CVCL_4E46
DR   CLO; CLO_0050731
DR   RCB; RCB1996
DR   Wikidata; Q54992314
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-20.1
AC   CVCL_4E47
DR   CLO; CLO_0050743
DR   RCB; RCB2058
DR   Wikidata; Q54992315
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-21.1
AC   CVCL_4E48
DR   CLO; CLO_0050744
DR   RCB; RCB2059
DR   Wikidata; Q54992316
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-23.1
AC   CVCL_4E49
DR   CLO; CLO_0050745
DR   RCB; RCB2060
DR   Wikidata; Q54992317
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-3.3
AC   CVCL_4E50
DR   CLO; CLO_0050747
DR   RCB; RCB2024
DR   Wikidata; Q54992318
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-5.4G
AC   CVCL_4E51
DR   CLO; CLO_0050748
DR   RCB; RCB2025
DR   Wikidata; Q54992319
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-6.1E
AC   CVCL_4E52
DR   CLO; CLO_0050732
DR   RCB; RCB2026
DR   Wikidata; Q54992320
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-7.1
AC   CVCL_4E53
DR   CLO; CLO_0050733
DR   RCB; RCB2027
DR   Wikidata; Q54992321
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-8.1
AC   CVCL_4E54
DR   CLO; CLO_0050734
DR   RCB; RCB2028
DR   Wikidata; Q54992322
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.BAL-8.1C
AC   CVCL_JE80
DR   CLO; CLO_0050746
DR   RCB; RCB2029
DR   Wikidata; Q54992323
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4E54 ! UV.BAL-8.1
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   UV.C3B6-1.1
AC   CVCL_4E55
DR   CLO; CLO_0050728
DR   RCB; RCB2061
DR   Wikidata; Q54992324
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.C3B6-1.1C
AC   CVCL_JE81
DR   CLO; CLO_0050729
DR   RCB; RCB2062
DR   Wikidata; Q54992327
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4E55 ! UV.C3B6-1.1
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   UV.C3H-3.3
AC   CVCL_4E56
DR   CLO; CLO_0050751
DR   RCB; RCB2053
DR   Wikidata; Q54992328
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.C3H-8.2
AC   CVCL_4E57
DR   CLO; CLO_0050750
DR   RCB; RCB2056
DR   Wikidata; Q54992329
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C3H/HeN.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.CB6-2.1F
AC   CVCL_4E58
SY   2.1F
DR   CLO; CLO_0050720
DR   RCB; RCB2065
DR   Wikidata; Q54992330
RX   PubMed=8205558;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.CB6-3.4B
AC   CVCL_8B28
DR   CLO; CLO_0050719
DR   RCB; RCB2066
DR   Wikidata; Q54992331
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   UV.CB6-4.1D
AC   CVCL_8B29
DR   CLO; CLO_0050721
DR   RCB; RCB2067
DR   Wikidata; Q54992332
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   UV.CB6-4.1F
AC   CVCL_8B30
DR   CLO; CLO_0050722
DR   RCB; RCB2068
DR   Wikidata; Q54992333
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   UV.CB6-5.2B
AC   CVCL_4E59
SY   5.2B
DR   CLO; CLO_0050725
DR   RCB; RCB2071
DR   Wikidata; Q54992334
RX   PubMed=8205558;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.CB6-6.1B
AC   CVCL_4E60
SY   6.1B
DR   CLO; CLO_0050724
DR   RCB; RCB2073
DR   Wikidata; Q54992335
RX   PubMed=8205558;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6 x BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV.CC3-11.1
AC   CVCL_4E61
DR   CLO; CLO_0050727
DR   RCB; RCB2074
DR   Wikidata; Q54992336
RX   DOI=10.4051/ibc.2010.2.4.0014;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: BALB/c x C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Transformed cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   UV135
AC   CVCL_4595
SY   CHO UV-135; UV-135; GM10908
DR   CLO; CLO_0009492
DR   CLO; CLO_0023394
DR   ATCC; CRL-1867
DR   Coriell; GM10908
DR   Wikidata; Q54992337
RX   CelloPub=CLPUB00447;
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=8765433;
RX   PubMed=9804340;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 16
//
ID   UV152
AC   CVCL_1N44
DR   Wikidata; Q54992339
RX   PubMed=2687628;
RX   PubMed=3919945;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UV20
AC   CVCL_4596
SY   UV-20
DR   CLO; CLO_0009493
DR   ATCC; CRL-1862
DR   Wikidata; Q54992340
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=6943579;
RX   PubMed=7404270;
RX   PubMed=8765433;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 13
//
ID   UV24
AC   CVCL_4597
SY   UV-24; UV 24; 60-21
DR   CLO; CLO_0009494
DR   ATCC; CRL-1866
DR   BCRC; 60175
DR   Wikidata; Q54992341
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=6943579;
RX   PubMed=8765433;
RX   PubMed=16143348;
CC   Sequence variation: Mutation; UniProtKB; A0MQ57; Ercc3; Simple; p.Ser382Pro (c.1144T>C); Zygosity=Unspecified (PubMed=16143348).
CC   Sequence variation: Mutation; UniProtKB; A0MQ57; Ercc3; Simple; p.Gln739Ter (c.2215C>T); Zygosity=Unspecified (PubMed=16143348).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 17
//
ID   UV4
AC   CVCL_S480
SY   UV-4; AA8 / UV4
DR   ChEMBL-Cells; CHEMBL3307475
DR   ChEMBL-Targets; CHEMBL612800
DR   PubChem_Cell_line; CVCL_S480
DR   Wikidata; Q54992342
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=8765433;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 30-01-24; Version: 13
//
ID   UV40
AC   CVCL_1N50
SY   361-114-33
DR   Wikidata; Q54992343
RX   PubMed=8765162;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UV41
AC   CVCL_4598
SY   UV-41; 361-112-10b
DR   CLO; CLO_0009495
DR   ATCC; CRL-1860
DR   Wikidata; Q54992345
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=6943579;
RX   PubMed=8765433;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 13
//
ID   UV46
AC   CVCL_1N45
DR   Wikidata; Q54992346
RX   PubMed=3919945;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UV47
AC   CVCL_1N46
DR   Wikidata; Q54992347
RX   PubMed=3919945;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UV5
AC   CVCL_4599
SY   UV-5; UV 5
DR   CLO; CLO_0009496
DR   ATCC; CRL-1865
DR   BCRC; 60174
DR   Wikidata; Q54992348
RX   PubMed=2687628;
RX   PubMed=3919945;
RX   PubMed=6943579;
RX   PubMed=7404270;
RX   PubMed=8765433;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 14
//
ID   UV57
AC   CVCL_1N47
DR   Wikidata; Q54992358
RX   PubMed=3919945;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UV61
AC   CVCL_1N42
DR   Wikidata; Q54992359
RX   PubMed=2687628;
RX   PubMed=8765433;
RX   PubMed=9806502;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UV78
AC   CVCL_1N48
DR   Wikidata; Q54992360
RX   PubMed=3919945;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 10
//
ID   UVE-10
AC   CVCL_4600
DR   CLO; CLO_0009497
DR   ATCC; CRL-6515
DR   Wikidata; Q54992363
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 10533; Adenovirus 1.
CC   Discontinued: ATCC; CRL-6515; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UVL-1
AC   CVCL_DE20
SY   UVL1
DR   Wikidata; Q54992364
RX   PubMed=3129654;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DE19 ! CHO-AT3-2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   UVL-10
AC   CVCL_DE21
SY   UVL10
DR   Wikidata; Q54992365
RX   PubMed=3129654;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_77751; 8-azaadenine.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_DE19 ! CHO-AT3-2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   UVs1KO
AC   CVCL_ZP07
DR   Wikidata; Q98134428
RX   PubMed=7264357;
RX   PubMed=8763445;
RX   PubMed=15486090;
RX   PubMed=21143350;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg77Ter (c.229C>T) (C308T); ClinVar=VCV000001708; Zygosity=Homozygous (PubMed=15486090).
CC   Misspelling: US81KO; PubMed=7264357; Note=In abstract.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173106; UV-sensitive syndrome 1
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UVs1KOSV
AC   CVCL_ZP08
DR   GEO; GSM3048738
DR   GEO; GSM3048739
DR   GEO; GSM3048740
DR   GEO; GSM3048741
DR   Wikidata; Q98134430
RX   PubMed=15486090;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg77Ter (c.229C>T) (C308T); ClinVar=VCV000001708; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173106; UV-sensitive syndrome 1
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP07 ! UVs1KO
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   UVsH-F
AC   CVCL_ZP05
DR   Wikidata; Q98134432
RX   PubMed=7264357;
RX   PubMed=15486090;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg77Ter (c.229C>T) (C308T); ClinVar=VCV000001708; Zygosity=Heterozygous (PubMed=15486090).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UVsH-M
AC   CVCL_ZP06
DR   Wikidata; Q98134434
RX   PubMed=7264357;
RX   PubMed=15486090;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3438; ERCC6; Simple; p.Arg77Ter (c.229C>T) (C308T); ClinVar=VCV000001708; Zygosity=Heterozygous (PubMed=15486090).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UVSS1VI
AC   CVCL_ZP12
SY   UV-Sensitive Syndrome 1 VIllejuif
DR   Wikidata; Q98134436
RX   PubMed=19329487;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3439; ERCC8; Simple; p.Trp361Cys (c.1083G>T); ClinVar=VCV000068752; Zygosity=Homozygous (PubMed=19329487).
CC   Derived from site: In situ; Buttock, skin; UBERON=UBERON_8480014.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173110; UV-sensitive syndrome 2
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UVSS24TA
AC   CVCL_ZP13
DR   Wikidata; Q98134438
RX   PubMed=22466610;
CC   Population: Israeli.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Ile31Phefs*9 (c.87delG); ClinVar=VCV000031570; Zygosity=Homozygous (PubMed=22466610).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173107; UV-sensitive syndrome 3
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   UVU1
AC   CVCL_1N43
SY   UVU1-CHO
DR   Wikidata; Q54992366
RX   PubMed=2687628;
RX   PubMed=9258434;
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_S480 ! UV4
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 30-01-24; Version: 9
//
ID   UW-1
AC   CVCL_8008
DR   GEO; GSM276760
DR   Wikidata; Q54992367
RX   PubMed=9154388;
RX   PubMed=15714118;
RX   PubMed=17487557;
CC   From: Albert, Daniel M.; University of Wisconsin; Madison; USA.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Eye; UBERON=UBERON_0000970.
CC   Cell type: Melanocyte; CL=CL_0000148.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   UW-DS
AC   CVCL_B7LS
DR   Wikidata; Q112930534
RX   PubMed=6967232;
CC   HLA typing: A*01,29; B*12,37 (PubMed=6967232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   UW-NLA-D1
AC   CVCL_ZR41
DR   Wikidata; Q98134441
RX   PubMed=30199234;
CC   Miscellaneous: Cell line name from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   UW-NLA-D2
AC   CVCL_ZR42
DR   Wikidata; Q98134444
CC   Miscellaneous: Cell line information from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   UW-NLA-D3
AC   CVCL_ZR43
DR   Wikidata; Q98134446
CC   Miscellaneous: Cell line information from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   UW-NLA-D4
AC   CVCL_ZR44
DR   Wikidata; Q98134448
CC   Miscellaneous: Cell line information from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   UW-NLA-D5
AC   CVCL_ZR45
DR   Wikidata; Q98134450
CC   Miscellaneous: Cell line information from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Intestine; UBERON=UBERON_0000160.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   UW-NLA-HC3
AC   CVCL_ZL23
DR   Wikidata; Q98134452
RX   PubMed=31692334;
CC   Miscellaneous: Cell line name from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 6
//
ID   UW-NLA-HSI1
AC   CVCL_ZR40
DR   Wikidata; Q98134454
RX   PubMed=29094594;
CC   Miscellaneous: Cell line name from personal communication of Hinman, Samuel S.
CC   Derived from site: In situ; Small intestine, jejunum; UBERON=UBERON_0002115.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Somatic stem cell
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 5
//
ID   UW14
AC   CVCL_8582
SY   HBT 14; HBT14
DR   Wikidata; Q54992368
RX   PubMed=7767897;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UW15
AC   CVCL_8583
DR   Wikidata; Q54992370
RX   PubMed=19706761;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UW18
AC   CVCL_A3BC
SY   HBT 18; HBT18
DR   Wikidata; Q105511664
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7767897;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   UW19
AC   CVCL_8584
DR   Wikidata; Q54992371
RX   PubMed=19706761;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UW228
AC   CVCL_8585
SY   UW 228; HBT 228; HBT228
DR   cancercelllines; CVCL_8585
DR   Cell_Model_Passport; SIDM01399
DR   DepMap; ACH-001232
DR   GEO; GSM919366
DR   IARC_TP53; 26932
DR   Progenetix; CVCL_8585
DR   Wikidata; Q54992372
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=10667577;
RX   PubMed=11023825;
RX   PubMed=18505928;
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=24297863;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Unspecified (PubMed=18505928; DepMap=ACH-001232).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DH81 ! UW402
OI   CVCL_DH82 ! UW426
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   UW228-1
AC   CVCL_4460
DR   BTO; BTO_0004330
DR   cancercelllines; CVCL_4460
DR   Wikidata; Q54992373
RX   PubMed=1292757;
RX   PubMed=8674085;
RX   PubMed=8866661;
RX   PubMed=15814657;
CC   Doubling time: 25.2 +- 2.1 hours (PubMed=8866661).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8585 ! UW228
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UW228-2
AC   CVCL_0572
DR   BTO; BTO_0004331
DR   MCCL; MCC:0000477
DR   cancercelllines; CVCL_0572
DR   Wikidata; Q54992374
RX   PubMed=1292757;
RX   PubMed=8674085;
RX   PubMed=8866661;
RX   PubMed=15814657;
CC   Doubling time: 33.4 +- 0.1 hours (PubMed=8866661).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8585 ! UW228
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UW228-3
AC   CVCL_0573
DR   BTO; BTO_0004332
DR   MCCL; MCC:0000478
DR   cancercelllines; CVCL_0573
DR   Wikidata; Q54992375
RX   PubMed=8674085;
RX   PubMed=8866661;
RX   PubMed=15814657;
CC   Doubling time: 29.0 +- 2.0 hours (PubMed=8866661).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Thr155Asn (c.464C>A); ClinVar=VCV000406564; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Brain, posterior fossa; UBERON=UBERON_0008788.
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8585 ! UW228
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   UW28
AC   CVCL_8586
SY   HBT 28; HBT28
DR   IARC_TP53; 26927
DR   Wikidata; Q54992376
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7767897;
RX   PubMed=18505928;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18505928).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   UW281
AC   CVCL_8587
DR   IARC_TP53; 26928
DR   Wikidata; Q54992377
RX   PubMed=18505928;
RX   PubMed=19706761;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18505928).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   UW35
AC   CVCL_8588
SY   HBT 35; HBT35
DR   Wikidata; Q54992378
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7767897;
RX   PubMed=19706761;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   UW402
AC   CVCL_DH81
SY   Uw-402; UW 402
DR   cancercelllines; CVCL_DH81
DR   GEO; GSM482331
DR   Progenetix; CVCL_DH81
DR   Wikidata; Q54992379
RX   PubMed=20847082;
RX   PubMed=22723427;
RX   PubMed=23325114;
RX   PubMed=27498314;
RX   PubMed=27812533;
RX   PubMed=31346954;
CC   Doubling time: 32 +- 0.5 hours (PubMed=31346954).
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8585 ! UW228
OI   CVCL_DH82 ! UW426
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 05-10-23; Version: 9
//
ID   UW426
AC   CVCL_DH82
SY   Uw-426
DR   Wikidata; Q54992380
RX   PubMed=20847082;
RX   PubMed=21177782;
RX   PubMed=22723427;
RX   PubMed=27498314;
RX   PubMed=27812533;
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8585 ! UW228
OI   CVCL_DH81 ! UW402
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 6
//
ID   UW443
AC   CVCL_M135
SY   UW 443
DR   Wikidata; Q54992381
RX   PubMed=8674085;
RX   PubMed=8866661;
RX   PubMed=27498314;
RX   PubMed=27812533;
CC   Doubling time: 48.1 +- 1.6 hours (PubMed=8866661).
CC   Karyotypic information: Tetraploid karyotype (PubMed=8866661).
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 9
//
ID   UW467
AC   CVCL_DG13
DR   Wikidata; Q54992383
RX   PubMed=15814657;
RX   PubMed=33385022;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   UW473
AC   CVCL_DG14
SY   Uw-473; UW 473
DR   Wikidata; Q54992384
RX   PubMed=15814657;
RX   PubMed=20847082;
RX   PubMed=22723427;
RX   PubMed=23325114;
RX   PubMed=27498314;
RX   PubMed=27812533;
RX   PubMed=31346954;
CC   Doubling time: 25 +- 0.7 hours (PubMed=31346954).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C129442; Medulloblastoma, SHH-activated, TP53-mutant
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   UW479
AC   CVCL_DG15
SY   UW-479
DR   BTO; BTO_0005888
DR   cancercelllines; CVCL_DG15
DR   GEO; GSM2197892
DR   GEO; GSM2197893
DR   GEO; GSM2197894
DR   GEO; GSM2197895
DR   GEO; GSM2197896
DR   GEO; GSM2197897
DR   Progenetix; CVCL_DG15
DR   Wikidata; Q54992385
RX   PubMed=15814657;
RX   PubMed=19365568;
CC   Doubling time: 28 hours (PubMed=19365568).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C9477; Anaplastic astrocytoma
DI   ORDO; Orphanet_251589; Anaplastic astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 12
//
ID   UW5
AC   CVCL_8589
DR   Wikidata; Q54992386
RX   PubMed=19706761;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   UW77iSMA-e.x
AC   CVCL_W563
SY   77iSMA
DR   SKIP; SKIP000318
DR   Wikidata; Q54992387
RX   PubMed=22723941;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Eye, ocular lens; UBERON=UBERON_0000965.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W562 ! GM09677
SX   Male
AG   1Y11M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   UW78
AC   CVCL_8590
DR   IARC_TP53; 26929
DR   Wikidata; Q54992388
RX   PubMed=18505928;
RX   PubMed=19706761;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=18505928).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   UW83iCTR-i.8
AC   CVCL_W565
SY   83iCTR
DR   Wikidata; Q54992389
RX   PubMed=22723941;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[33] (c.52CAG(33)) (c.52CAG[(27_35)]); ClinVar=VCV000031915; Zygosity=Heterozygous (from parent cell line).
CC   Donor information: At sampling donor was not affected with Huntington disease but at significant risk for disease.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W557 ! GM02183
SX   Female
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   UWB1.289
AC   CVCL_B079
SY   UWB1-289; UWB1289
DR   BTO; BTO_0006253
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2945
DR   BioGRID_ORCS_Cell_line; 1041
DR   BioSample; SAMN03471702
DR   cancercelllines; CVCL_B079
DR   Cell_Model_Passport; SIDM00815
DR   Cosmic-CLP; 1480374
DR   DepMap; ACH-001418
DR   EGA; EGAS00001000978
DR   GDSC; 1480374
DR   GEO; GSM711714
DR   GEO; GSM1291155
DR   GEO; GSM1670568
DR   Lonza; 1665
DR   PharmacoDB; UWB1_289_1650_2019
DR   PRIDE; PXD006939
DR   PRIDE; PXD030304
DR   Wikidata; Q54992390
RX   PubMed=17259345;
RX   PubMed=25230021;
RX   PubMed=27397505;
RX   PubMed=29242379;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 15.3 hours (PubMed=17259345); ~53 hours (ATCC=CRL-2945).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1100; BRCA1; Zygosity=Heterozygous (PubMed=17259345).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Asp825Glufs*21 (c.2475delC); ClinVar=VCV000037472; Zygosity=Heterozygous (PubMed=17259345).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; HLA class I peptidome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0.18%; Native American=0%; East Asian, North=0.95%; East Asian, South=0%; South Asian=1.35%; European, North=70.57%; European, South=26.96% (PubMed=30894373).
ST   Source(s): ATCC=CRL-2945; Cosmic-CLP=1480374; DepMap=ACH-001418; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 14,15
ST   D21S11: 28,31
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 7,10
ST   D8S1179: 11,12 (DepMap=ACH-001418)
ST   D8S1179: 12 (ATCC=CRL-2945; PubMed=25230021)
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 8
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,19
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   UWB1.289+BRCA1
AC   CVCL_B078
DR   BTO; BTO_0006254
DR   ATCC; CRL-2946
DR   GEO; GSM1291154
DR   Wikidata; Q54992391
RX   PubMed=17259345;
RX   PubMed=25230021;
CC   Part of: OCCP ovarian cancer cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Due to the high expression of the transfected wild-type BRCA1 gene, this cell line is partially rescued in term of its response to DNA damage.
CC   Doubling time: 20.0 hours (PubMed=17259345); ~36 hours (ATCC=CRL-2946).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1100; BRCA1; Zygosity=Heterozygous (PubMed=17259345).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Asp825Glufs*21 (c.2475delC); ClinVar=VCV000037472; Zygosity=Heterozygous (PubMed=17259345).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1100; BRCA1 (Note=With a HA tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): ATCC=CRL-2946; PubMed=25230021
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12
ST   D18S51: 19
ST   D19S433: 14,15
ST   D21S11: 28,31
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 13
ST   D7S820: 7,10
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 8
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 16,19
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B079 ! UWB1.289
SX   Female
AG   56Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 20
//
ID   UWG01CTC
AC   CVCL_YN85
SY   University of Wollongong Gastric cancer 01 Circulating Tumor Cells
DR   Wikidata; Q98134456
RX   PubMed=31953491;
CC   Doubling time: 55 hours (Direct_author_submission).
CC   Miscellaneous: Age of donor and doubling time from personal communication of Brungs, Daniel.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31953491
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 10,11
ST   D18S51: 17
ST   D19S433: 14,15
ST   D21S11: 32.2
ST   D2S1338: 19
ST   D3S1358: 15,16,18
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 9
ST   Penta E: 12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C126323; Gastroesophageal junction large cell neuroendocrine carcinoma
DI   ORDO; Orphanet_506136; Neuroendocrine neoplasm of esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 7
//
ID   UWG02ASC
AC   CVCL_YN86
SY   University of Wollongong Gastric cancer 02 ASCites
DR   Wikidata; Q98134458
RX   PubMed=31953491;
CC   Miscellaneous: Age of donor from personal communication of Brungs, Daniel.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=31953491
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 9,14
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN87 ! UWG02CTC
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-09-24; Version: 6
//
ID   UWG02CTC
AC   CVCL_YN87
SY   University of Wollongong Gastric cancer 02 Circulating Tumor Cells
DR   cancercelllines; CVCL_YN87
DR   Wikidata; Q98134460
RX   PubMed=31953491;
CC   Doubling time: 18 hours (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:2348; CREBBP; Simple; p.Arg1446Cys (c.4336C>T); ClinVar=VCV000095047; Zygosity=Heterozygous (PubMed=31953491).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser33Phe (c.98C>T); ClinVar=VCV000017583; Zygosity=Heterozygous (PubMed=31953491).
CC   Sequence variation: Mutation; HGNC; HGNC:4392; GNAS; Simple; p.Arg201His (c.602G>A); ClinVar=VCV000015934; Zygosity=Heterozygous (PubMed=31953491).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Thr992Ile (c.2975C>T) (p.Thr1010Ile, c.3029C>T); ClinVar=VCV000041624; Zygosity=Heterozygous (PubMed=31953491).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu418Lys (c.1252G>A); ClinVar=VCV000045464; Zygosity=Heterozygous (PubMed=31953491).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Gln (c.1624G>C); ClinVar=VCV000376244; Zygosity=Heterozygous (PubMed=31953491).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Asp537His (c.1609G>C); Zygosity=Homozygous (PubMed=31953491).
CC   Miscellaneous: Age of donor, doubling time and zygosity of sequence variations from personal communication of Brungs, Daniel.
CC   Derived from site: Metastatic; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31953491
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 9,14
ST   Penta E: 7
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YN86 ! UWG02ASC
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 10
//
ID   UWKOS1
AC   CVCL_X350
DR   Wikidata; Q54992392
RX   PubMed=23489774;
CC   Derived from site: In situ; Bone, proximal humerus; UBERON=UBERON_0004411.
CC   Breed/subspecies: Rottweiler; VBO=VBO_0201143.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   UWKOS2
AC   CVCL_X351
DR   Wikidata; Q54992393
RX   PubMed=23489774;
CC   Derived from site: In situ; Bone, proximal humerus; UBERON=UBERON_0004411.
CC   Breed/subspecies: Irish Terrier; VBO=VBO_0200704.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   UWKOS3
AC   CVCL_X352
DR   Wikidata; Q54992394
RX   PubMed=23489774;
CC   Derived from site: In situ; Bone, proximal tibia; UBERON=UBERON_0008772.
CC   Breed/subspecies: Mastiff; VBO=VBO_0200867.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   10Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   UWKOS6
AC   CVCL_X353
DR   Wikidata; Q54992395
RX   PubMed=23489774;
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Labrador Retriever; VBO=VBO_0200800.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   UWKOS7
AC   CVCL_X354
DR   Wikidata; Q54992397
RX   PubMed=23489774;
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: German Shepherd; VBO=VBO_0200577.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   9Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   UWKOS8
AC   CVCL_X355
DR   Wikidata; Q54992398
RX   PubMed=23489774;
CC   Derived from site: In situ; Bone, distal radius; UBERON=UBERON_0004407.
CC   Breed/subspecies: Border Collie; VBO=VBO_0200193.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   9Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 10
//
ID   UWO17
AC   CVCL_B7ME
SY   University of Western Ontario 17
DR   Wikidata; Q112930535
RX   PubMed=35317874;
CC   Doubling time: 40 +- 4 hours (PubMed=35317874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=35317874
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D21S11: 29,32.2
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 7,8
ST   TPOX: 10
ST   vWA: 17,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   UWO23
AC   CVCL_B7MF
SY   University of Western Ontario 23
DR   ABM; T8289
DR   CLS; 300258
DR   Wikidata; Q112930536
RX   PubMed=35317874;
CC   Doubling time: 50 +- 6 hours (PubMed=35317874).
CC   Transformant: NCBI_TaxID; 10586; Human papillomavirus type 33 (HPV33).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=35317874
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,10
ST   D16S539: 12
ST   D21S11: 28,30
ST   D5S818: 11
ST   D7S820: 9,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   UWO31
AC   CVCL_B7MG
SY   University of Western Ontario 31
DR   Wikidata; Q112930537
RX   PubMed=35317874;
CC   Doubling time: 62 +- 6 hours (PubMed=35317874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): PubMed=35317874
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 12
ST   D21S11: 28,31.2
ST   D5S818: 11,12
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 14,15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   UWO37
AC   CVCL_B7MH
SY   University of Western Ontario 37
DR   ABM; T8290
DR   CLS; 300257
DR   Wikidata; Q112930538
RX   PubMed=35317874;
CC   Doubling time: 41 +- 4 hours (PubMed=35317874).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
ST   Source(s): PubMed=35317874
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 27,34.2
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 8,10
ST   vWA: 16,17
DI   NCIt; C8183; Tonsillar squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 5
//
ID   UWOV1
AC   CVCL_9809
SY   University of Witwatersrand OVarian 1
DR   Wikidata; Q54992399
RX   PubMed=2351639;
CC   Doubling time: 34.0 +- 15.6 hours (Note=In 2.5% FBS), 36.8 +- 6.5 hours (Note=In 5% FBS), 36.5 +- 9.1 hours (Note=In 10% FBS) (PubMed=2351639).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UWOV2
AC   CVCL_9810
SY   University of Witwatersrand OVarian 2
DR   Wikidata; Q54992402
RX   PubMed=2351639;
CC   Doubling time: 38.8 +- 4.8 hours (Note=In 2.5% FBS), 28.0 +- 1.4 hours (Note=In 5% FBS), 45.6 +- 14.4 hours (Note=In 10% FBS) (PubMed=2351639).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UWOV2 Sf
AC   CVCL_9811
SY   UWOV2 (Sf); University of Witwatersrand OVarian 2 Serum free
DR   Wikidata; Q54992404
RX   PubMed=2351639;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 74 +- 10 hours (PubMed=2351639).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5228; Ovarian cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9810 ! UWOV2
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   UWRBTi001-A
AC   CVCL_A0YZ
SY   C1M35 1.9
DR   hPSCreg; UWRBTi001-A
DR   Wikidata; Q108821469
RX   PubMed=34419748;
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZA ! UWRBTi001-B
OI   CVCL_A0ZB ! UWRBTi001-C
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UWRBTi001-B
AC   CVCL_A0ZA
SY   C1M35 L21
DR   hPSCreg; UWRBTi001-B
DR   Wikidata; Q108821470
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0YZ ! UWRBTi001-A
OI   CVCL_A0ZB ! UWRBTi001-C
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UWRBTi001-C
AC   CVCL_A0ZB
SY   C1M35 L26
DR   hPSCreg; UWRBTi001-C
DR   Wikidata; Q108821471
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0YZ ! UWRBTi001-A
OI   CVCL_A0ZA ! UWRBTi001-B
SX   Male
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UWRBTi002-A
AC   CVCL_A0ZC
SY   C1M46 1.2
DR   hPSCreg; UWRBTi002-A
DR   Wikidata; Q108821472
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZD ! UWRBTi002-B
OI   CVCL_A0ZE ! UWRBTi002-C
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UWRBTi002-B
AC   CVCL_A0ZD
SY   C1M46 1.4
DR   hPSCreg; UWRBTi002-B
DR   Wikidata; Q108821473
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZC ! UWRBTi002-A
OI   CVCL_A0ZE ! UWRBTi002-C
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UWRBTi002-C
AC   CVCL_A0ZE
SY   C1M46 1.10
DR   hPSCreg; UWRBTi002-C
DR   Wikidata; Q108821474
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZC ! UWRBTi002-A
OI   CVCL_A0ZD ! UWRBTi002-B
SX   Male
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   UWRBTi003-A
AC   CVCL_A0ZF
SY   E1M40 1.4
DR   hPSCreg; UWRBTi003-A
DR   Wikidata; Q108821475
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (from autologous cell lines UWRBTi003-B; UWRBTi003-C).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZG ! UWRBTi003-B
OI   CVCL_A0ZH ! UWRBTi003-C
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   UWRBTi003-B
AC   CVCL_A0ZG
SY   E1M40 1.7
DR   hPSCreg; UWRBTi003-B
DR   Wikidata; Q108821476
RX   PubMed=34419748;
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZF ! UWRBTi003-A
OI   CVCL_A0ZH ! UWRBTi003-C
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UWRBTi003-C
AC   CVCL_A0ZH
SY   E1M40 1.9
DR   hPSCreg; UWRBTi003-C
DR   Wikidata; Q108821477
RX   PubMed=34419748;
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZF ! UWRBTi003-A
OI   CVCL_A0ZG ! UWRBTi003-B
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UWRBTi004-A
AC   CVCL_A0ZI
SY   E1M51 1.4
DR   hPSCreg; UWRBTi004-A
DR   Wikidata; Q108821478
RX   PubMed=34419748;
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZJ ! UWRBTi004-B
OI   CVCL_A0ZK ! UWRBTi004-C
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UWRBTi004-B
AC   CVCL_A0ZJ
SY   E1M51 1.8
DR   hPSCreg; UWRBTi004-B
DR   Wikidata; Q108821479
RX   PubMed=34419748;
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (PubMed=34419748).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZI ! UWRBTi004-A
OI   CVCL_A0ZK ! UWRBTi004-C
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   UWRBTi004-C
AC   CVCL_A0ZK
SY   E1M51 1.11
DR   hPSCreg; UWRBTi004-C
DR   Wikidata; Q108821480
CC   From: Faculty of Biotechnology, University of Wroclaw; Wroclaw; Poland.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3331; EMD; Simple; p.Ser52Alafs*13 (c.153delC); ClinVar=VCV001074960; Zygosity=Hemizygous (from autologous cell lines UWRBTi004-A; UWRBTi004-B).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168730; Emery-Dreifuss muscular dystrophy 1, X-linked
DI   ORDO; Orphanet_98863; X-linked Emery-Dreifuss muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A0ZI ! UWRBTi004-A
OI   CVCL_A0ZJ ! UWRBTi004-B
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 8
//
ID   Uyghur-UCSCCL
AC   CVCL_IM36
SY   Uyghur Uterine Cervical Squamous Carcinoma Cell Line
DR   Wikidata; Q54992405
RX   PubMed=22800521;
CC   Population: Chinese/Asian ethnic group: Uyghur.
CC   Doubling time: 51.9 hours (PubMed=22800521).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180839; Cervical squamous cell carcinoma, not otherwise specified
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 10
//
ID   V-1181N1
AC   CVCL_T435
DR   cancercelllines; CVCL_T435
DR   Wikidata; Q54992444
RX   PubMed=4354152;
RX   PubMed=4370460;
CC   Problematic cell line: Contaminated. Grand-parent cell line (U-118MG) has been shown to be a U-138MG derivative.
CC   Population: Caucasian.
CC   Virology: Infected with maedi visna virus (MVV).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.1026+1G>T (IVS8+1G>T); ClinVar=VCV000635377; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C60781; Astrocytoma
DI   ORDO; Orphanet_94; Astrocytoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D317 ! 1181N1
SX   Male
AG   47Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 17
//
ID   V-3
AC   CVCL_K039
SY   CHO-V3; CHO V3; V3
DR   CLO; CLO_0050428
DR   RCB; RCB2329
DR   Wikidata; Q54992446
RX   PubMed=2573661;
RX   PubMed=7724535;
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4386 ! CHO-AA8
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 11
//
ID   V-ABI2
AC   CVCL_B3SQ
DR   Wikidata; Q110433954
RX   PubMed=6186670;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Chicken type V collagen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   V-B11
AC   CVCL_V246
SY   GM16137
DR   CLO; CLO_0018899
DR   Coriell; GM16137
DR   Wikidata; Q54992448
RX   PubMed=3412364;
RX   PubMed=3587254;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   V-C4
AC   CVCL_T044
SY   GM16138
DR   CLO; CLO_0018897
DR   Coriell; GM16138
DR   Wikidata; Q54992451
RX   PubMed=2466555;
RX   PubMed=3587254;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   V-C8
AC   CVCL_X405
SY   VC8
DR   Wikidata; Q54992453
RX   PubMed=3587254;
RX   PubMed=7565860;
RX   PubMed=11756561;
RX   PubMed=16643964;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 19-12-24; Version: 13
//
ID   V-DH2
AC   CVCL_B3SR
DR   Wikidata; Q110433956
RX   PubMed=6186670;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Chicken type V collagen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   V-E5
AC   CVCL_T045
SY   GM16139
DR   CLO; CLO_0018896
DR   CLO; CLO_0051578
DR   Coriell; GM16139
DR   RCB; RCB2335
DR   Wikidata; Q54992454
RX   PubMed=2466555;
RX   PubMed=3587254;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   V-G8
AC   CVCL_T046
SY   GM16140
DR   CLO; CLO_0018895
DR   CLO; CLO_0051579
DR   Coriell; GM16140
DR   RCB; RCB2336
DR   Wikidata; Q54992456
RX   PubMed=2466555;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   V-H1
AC   CVCL_V247
SY   GM16141
DR   CLO; CLO_0018894
DR   Coriell; GM16141
DR   Wikidata; Q54992458
RX   PubMed=3587254;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   V-H4
AC   CVCL_V248
SY   GM16142
DR   CLO; CLO_0018893
DR   Coriell; GM16142
DR   Wikidata; Q54992460
RX   PubMed=3587254;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   V-MG-33
AC   CVCL_A8RP
DR   Wikidata; Q108821481
RX   PubMed=8934553;
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   V-MG-35/CE
AC   CVCL_A8RM
DR   cancercelllines; CVCL_A8RM
DR   IARC_TP53; 8288
DR   Wikidata; Q108821482
RX   PubMed=8934553;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8934553).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8RN ! V-MG-35/FTC
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   V-MG-35/FTC
AC   CVCL_A8RN
DR   cancercelllines; CVCL_A8RN
DR   Wikidata; Q108821483
RX   PubMed=8934553;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Unspecified (PubMed=8934553).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8RM ! V-MG-35/CE
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   V-MG-6/STT
AC   CVCL_A8RQ
DR   IARC_TP53; 8294
DR   Wikidata; Q108821484
RX   PubMed=8934553;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218Ala (c.653T>C); Zygosity=Unspecified (PubMed=8934553).
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 4
//
ID   V/1Ki
AC   CVCL_B6ZL
DR   Wikidata; Q112041897
RX   PubMed=32184255;
RX   PubMed=32252443;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
OI   CVCL_B6ZM ! V/1Liv
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   V/1Ki-Delta
AC   CVCL_B6ZT
DR   Wikidata; Q112041898
RX   PubMed=32184255;
CC   Group: Reptilian cell line.
CC   Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
HI   CVCL_B6ZL ! V/1Ki
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   V/1Liv
AC   CVCL_B6ZM
DR   Wikidata; Q112041899
RX   PubMed=32184255;
RX   PubMed=32252443;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
OI   CVCL_B6ZL ! V/1Ki
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   V/1Liv-Delta
AC   CVCL_B6ZW
DR   Wikidata; Q112041900
RX   PubMed=32184255;
CC   Group: Reptilian cell line.
CC   Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatic stellate cell; CL=CL_0000632.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
HI   CVCL_B6ZM ! V/1Liv
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   V/2Hz
AC   CVCL_B6ZN
DR   Wikidata; Q112041901
RX   PubMed=32184255;
RX   PubMed=32252443;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   V/2Hz-Delta
AC   CVCL_B6ZU
DR   Wikidata; Q112041902
RX   PubMed=32184255;
CC   Group: Reptilian cell line.
CC   Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
HI   CVCL_B6ZN ! V/2Hz
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   V/4Br
AC   CVCL_B6ZP
DR   Wikidata; Q112041903
RX   PubMed=28794044;
RX   PubMed=32252443;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
OI   CVCL_B6ZQ ! V/4Lu
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   V/4Lu
AC   CVCL_B6ZQ
DR   Wikidata; Q112041905
RX   PubMed=28794044;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
OI   CVCL_B6ZP ! V/4Br
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   V/5Lu
AC   CVCL_B6ZR
DR   Wikidata; Q112041907
RX   PubMed=32184255;
RX   PubMed=32252443;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Lung, smooth muscle; UBERON=UBERON_0004225.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   V/5Lu-Delta
AC   CVCL_B6ZV
DR   Wikidata; Q112041908
RX   PubMed=32184255;
CC   Group: Reptilian cell line.
CC   Virology: Persistently infected by Swiss snake colony virus 1 (SwSCV-1).
CC   Derived from site: In situ; Lung, smooth muscle; UBERON=UBERON_0004225.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
OX   NCBI_TaxID=8574; ! Boa constrictor (Boa)
HI   CVCL_B6ZR ! V/5Lu
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
ID   V.E.C.
AC   CVCL_E860
DR   dbMHC; 49050
DR   ECACC; 94050309
DR   IHW; IHW09314
DR   IPD-IMGT/HLA; 11521
DR   Wikidata; Q54992461
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Belgian.
CC   HLA typing: DPA1*01:03:01; DPB1*04:01,46:01; DQA1*01:02,03; DQB1*06:09,03:02; DRB1*13:02,04:01; DRB3*03:01; DRB4*01:01 (IPD-IMGT/HLA=11521).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   V038 AGM BLCL
AC   CVCL_SA51
SY   V038
DR   Wikidata; Q54992463
RX   PubMed=22264516;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 106332; Papiine herpesvirus 1 (Herpesvirus papio).
CC   Discontinued: NHPRR; Catalog number 141.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 6
//
ID   V1
AC   CVCL_KB84
DR   Wikidata; Q54992465
RX   Patent=US4935344;
RX   PubMed=3857626;
RX   PubMed=6946460;
CC   Monoclonal antibody isotype: IgG1.
CC   Caution: Indicated in Patent=US4935344 to have been deposited at ATCC under the catalog number HB-8424. But HB-8424 is another patent deposition (Cellosaurus=CVCL_N310).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   V12S-3Y1-2
AC   CVCL_K114
DR   RCB; RCB0381
DR   Wikidata; Q54992467
RX   PubMed=2920374;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A 12S isoform).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   V13S-3Y1-4
AC   CVCL_K115
DR   RCB; RCB0384
DR   Wikidata; Q54992469
RX   PubMed=2920374;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A 13S isoform).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   V14-203
AC   CVCL_C4ED
DR   ABCD; ABCD_AE810
DR   Wikidata; Q116050754
RX   PubMed=2122240;
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   V14-306
AC   CVCL_C4EE
DR   Wikidata; Q116050755
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   V14-343
AC   CVCL_C4EF
DR   Wikidata; Q116050756
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   V14-54-20
AC   CVCL_C4EG
DR   Wikidata; Q116050758
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgA, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   v17.2
AC   CVCL_6D26
SY   V17.2
DR   Wikidata; Q54992471
RX   PubMed=9054943;
RX   PubMed=9501308;
RX   PubMed=11331774;
RX   PubMed=11441181;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/cTa x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   v18.6
AC   CVCL_6D27
SY   v 18.6; V18.6
DR   Wikidata; Q54992472
RX   PubMed=10655052;
RX   PubMed=11331774;
RX   PubMed=11441181;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   V1C12A1
AC   CVCL_XG89
DR   Wikidata; Q98134462
RX   Patent=CN101955531B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200850.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04558; Porcine reproductive and respiratory syndrome virus (strain Lelystad) nucleoprotein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   V2387
AC   CVCL_IP02
DR   Wikidata; Q54992475
RX   PubMed=22249266;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   v26.2
AC   CVCL_6D28
SY   V26.2
DR   Wikidata; Q54992477
RX   PubMed=11331774;
RX   PubMed=11441181;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   v30.30
AC   CVCL_6D30
SY   V30.30
DR   Wikidata; Q54992483
RX   PubMed=11331774;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   v39.7
AC   CVCL_6D31
SY   V39.7
DR   Wikidata; Q54992485
RX   PubMed=11331774;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   V45-180-56
AC   CVCL_C4EH
DR   Wikidata; Q116050759
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   V45-187-15
AC   CVCL_C4EI
DR   Wikidata; Q116050760
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   V45-271-10
AC   CVCL_C4EJ
DR   ABCD; ABCD_AE813
DR   Wikidata; Q116050761
RX   PubMed=2122240;
RX   PubMed=2447493;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_4031; Cyclosporin A (CsA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   V58A4
AC   CVCL_C4R3
DR   Wikidata; Q116050762
RX   PubMed=8013625;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P07996; Human THBS1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   v6.4
AC   CVCL_6D29
SY   V6.4
DR   Wikidata; Q54992487
RX   PubMed=9501308;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   v6.5
AC   CVCL_C865
SY   v 6.5; V6.5
DR   EFO; EFO_0006308
DR   GEO; GSM344757
DR   GEO; GSM344758
DR   GEO; GSM1385513
DR   Wikidata; Q54992491
RX   PubMed=10655052;
RX   PubMed=11331774;
RX   PubMed=11441181;
RX   PubMed=15464582;
WW   Provider; Novus; NBP1-41162; https://www.novusbio.com/products/v65-mouse-embryonic-stem-cells_nbp1-41162
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Novus; Catalog number NBP1-41162.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 13
//
ID   v6.5 1110007L15Rik-K1
AC   CVCL_E5W7
SY   1110007L15Rik-K1; K18C02
DR   JCRB; AyuK18C02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914854; Get4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 5830457O10Rik-K1
AC   CVCL_RZ88
SY   5830457O10Rik-K1; K6C07
DR   JCRB; AyuK6C07
DR   Wikidata; Q54992494
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443370; Chtf8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 5930416I19Rik-K1
AC   CVCL_E5W8
SY   5930416I19Rik-K1; K19B07
DR   JCRB; AyuK19B07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915315; Rhno1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 AU019823-K1
AC   CVCL_E5W9
SY   AU019823-K1; K9E04
DR   JCRB; AyuK9E04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2143205; Nkapd1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ahsa1-K1
AC   CVCL_E5WA
SY   Ahsa1-K1; K11C02
DR   JCRB; AyuK11C02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2387603; Ahsa1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Anks3-K1
AC   CVCL_E5WB
SY   Anks3-K1; K12F03
DR   JCRB; AyuK12F03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919865; Anks3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Anp32e-K1
AC   CVCL_E5WC
SY   Anp32e-K1; K15A08
DR   JCRB; AyuK15A08
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913721; Anp32e.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Armet-K1
AC   CVCL_E5WD
SY   Armet-K1; K6E04
DR   JCRB; AyuK6E04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1922090; Manf.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Atad1-K1
AC   CVCL_E5WE
SY   Atad1-K1; K12H05
DR   JCRB; AyuK12H05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915229; Atad1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Atf1-K1
AC   CVCL_E5WF
SY   Atf1-K1; K11B06
DR   JCRB; AyuK11B06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1298366; Atf1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Avpi1-K1
AC   CVCL_E5WG
SY   Avpi1-K1; K7B02
DR   JCRB; AyuK7B02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1916784; Avpi1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Axin1-K1
AC   CVCL_E5WH
SY   Axin1-K1; K7C09
DR   JCRB; AyuK7C09
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1096327; Axin1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 BC024479-K1
AC   CVCL_E5WI
SY   BC024479-K1; K13G06
DR   JCRB; AyuK13G06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384579; Msantd2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 BC057627-K1
AC   CVCL_E5WJ
SY   BC057627-K1; K19G11
DR   JCRB; AyuK19G11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2682314; Zc3h4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Bat2d-K1
AC   CVCL_E5WK
SY   Bat2d-K1; K6F07
DR   JCRB; AyuK6F07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913754; Prrc2c.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Birc6-K1
AC   CVCL_E5WL
SY   Birc6-K1; K18D01
DR   JCRB; AyuK18D01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1276108; Birc6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Capza2-K1
AC   CVCL_E5WM
SY   Capza2-K1; K15G06
DR   JCRB; AyuK15G06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106222; Capza2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cbx1-K1
AC   CVCL_E5WN
SY   Cbx1-K1; K6H07
DR   JCRB; AyuK6H07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:105369; Cbx1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cbx3-K1
AC   CVCL_E5WP
SY   Cbx3-K1; K10H04
DR   JCRB; AyuK10H04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108515; Cbx3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cbx5-K1
AC   CVCL_E5WQ
SY   Cbx5-K1; K13E11
DR   JCRB; AyuK13E11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:109372; Cbx5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ccdc58-K1
AC   CVCL_E5WR
SY   Ccdc58-K1; K12D06
DR   JCRB; AyuK12D06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146423; Mix23.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ccdc77-K1
AC   CVCL_E5WS
SY   Ccdc77-K1; K8D05
DR   JCRB; AyuK8D05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914450; Ccdc77.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cdc42se1-K1
AC   CVCL_E5WT
SY   Cdc42se1-K1; K10A10
DR   JCRB; AyuK10A10
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889510; Cdc42se1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cdca7-K1
AC   CVCL_E5WU
SY   Cdca7-K1; K14G01
DR   JCRB; AyuK14G01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914203; Cdca7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cfdp1-K1
AC   CVCL_E5W5
SY   Cfdp1-K1; K7D01
DR   JCRB; AyuK7D01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1344403; Cfdp1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cnbp-K1
AC   CVCL_E5WV
SY   Cnbp-K1; K7H06
DR   JCRB; AyuK7H06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88431; Cnbp.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cnot10-K1
AC   CVCL_E5WW
SY   Cnot10-K1; K8C06
DR   JCRB; AyuK8C06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1926143; Cnot10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Csnk2a1-K1
AC   CVCL_E5WX
SY   Csnk2a1-K1; K11E04
DR   JCRB; AyuK11E04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:88543; Csnk2a1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ctdspl2-K1
AC   CVCL_E5WY
SY   Ctdspl2-K1; K12C11
DR   JCRB; AyuK12C11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1196405; Ctdspl2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Cxxc5-K1
AC   CVCL_E5WZ
SY   Cxxc5-K1; K7A07
DR   JCRB; AyuK7A07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1914643; Cxxc5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ddx11-K1
AC   CVCL_E5X0
SY   Ddx11-K1; K9F06
DR   JCRB; AyuK9F06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443590; Ddx11.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Deaf1-K1
AC   CVCL_E5X1
SY   Deaf1-K1; K15F02
DR   JCRB; AyuK15F02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1858496; Deaf1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Dgcr8-K1
AC   CVCL_E5X2
SY   Dgcr8-K1; K16C06
DR   JCRB; AyuK16C06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2151114; Dgcr8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Eapp-K1
AC   CVCL_RZ89
SY   Eapp-K1; K5F06
DR   JCRB; AyuK5F06
DR   Wikidata; Q54992496
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913516; Eapp.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Eif4b-K1
AC   CVCL_E5X3
SY   Eif4b-K1; K6G02
DR   JCRB; AyuK6G02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95304; Eif4b.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Eno1-K1
AC   CVCL_E5X4
SY   Eno1-K1; K8D01
DR   JCRB; AyuK8D01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95393; Eno1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Epb4.1l5-K1
AC   CVCL_E5X5
SY   Epb4.1l5-K1; K7A06
DR   JCRB; AyuK7A06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103006; Epb41l5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Epn2-K1
AC   CVCL_E5X6
SY   Epn2-K1; K18B12
DR   JCRB; AyuK18B12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1333766; Epn2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Fam49b-K1
AC   CVCL_E5X7
SY   Fam49b-K1; K19D05
DR   JCRB; AyuK19D05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1923520; Cyrib.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Fmnl2-K1
AC   CVCL_E5W1
SY   Fmnl2-K1; K16A10
DR   JCRB; AyuK16A10
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918659; Fmnl2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Fryl-K1
AC   CVCL_E5X8
SY   Fryl-K1; K12C03
DR   JCRB; AyuK12C03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919563; Fryl.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Fubp3-K1
AC   CVCL_E5X9
SY   Fubp3-K1; K14C04
DR   JCRB; AyuK14C04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2443699; Fubp3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 G3bp2-K1
AC   CVCL_E5XA
SY   G3bp2-K1; K6B03
DR   JCRB; AyuK6B03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442040; G3bp2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Gatad2a-K1
AC   CVCL_E5XB
SY   Gatad2a-K1; K10C08
DR   JCRB; AyuK10C08
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384585; Gatad2a.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Gm561-K1
AC   CVCL_E5XC
SY   Gm561-K1; K8C12
DR   JCRB; AyuK8C12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685407; Smim26.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Gnb2-K1
AC   CVCL_E5XD
SY   Gnb2-K1; K16C10
DR   JCRB; AyuK16C10
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:95784; Gnb2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Gpatch4-K1
AC   CVCL_E5XE
SY   Gpatch4-K1; K6F01
DR   JCRB; AyuK6F01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913864; Gpatch4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Gtf2h1-K1
AC   CVCL_RZ90
SY   Gtf2h1-K1; K17G03
DR   JCRB; AyuK17G03
DR   Wikidata; Q54992499
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277216; Gtf2h1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Hspbap1-K1
AC   CVCL_E5XF
SY   Hspbap1-K1; K17C03
DR   JCRB; AyuK17C03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913917; Hspbap1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ibtk-K1
AC   CVCL_E5XG
SY   Ibtk-K1; K18E01
DR   JCRB; AyuK18E01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918677; Ibtk.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Igsf9b-K1
AC   CVCL_E5XH
SY   Igsf9b-K1; K12C12
DR   JCRB; AyuK12C12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685354; Igsf9b.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ilf2-K1
AC   CVCL_E5XI
SY   Ilf2-K1; K8B01
DR   JCRB; AyuK8B01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915031; Ilf2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Jagn1-K1
AC   CVCL_E5XJ
SY   Jagn1-K1; K6C01
DR   JCRB; AyuK6C01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915017; Jagn1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Jrk-K1
AC   CVCL_E5XK
SY   Jrk-K1; K13C12
DR   JCRB; AyuK13C12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106214; Jrk.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Kntc1-K1
AC   CVCL_E5XL
SY   Kntc1-K1; K14E01
DR   JCRB; AyuK14E01
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2673709; Kntc1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Kpna4-K1
AC   CVCL_E5XM
SY   Kpna4-K1; K15G02
DR   JCRB; AyuK15G02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100848; Kpna4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Leo1-K1
AC   CVCL_E5XN
SY   Leo1-K1; K15E07
DR   JCRB; AyuK15E07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685031; Leo1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Lnx2-K1
AC   CVCL_E5XP
SY   Lnx2-K1; K17A12
DR   JCRB; AyuK17A12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2155959; Lnx2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Lrch4-K1
AC   CVCL_E5XQ
SY   Lrch4-K1; K16E07
DR   JCRB; AyuK16E07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1917193; Lrch4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Map2k1-K1
AC   CVCL_E5XR
SY   Map2k1-K1; K10C05
DR   JCRB; AyuK10C05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346866; Map2k1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Mapk1ip1l-K1
AC   CVCL_RZ91
SY   Mapk1ip1l-K1; K10H01
DR   JCRB; AyuK10H01
DR   Wikidata; Q54992502
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444022; Mapk1ip1l.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Mipol1-K1
AC   CVCL_RZ92
SY   Mipol1-K1; K12A12
DR   JCRB; AyuK12A12
DR   Wikidata; Q54992505
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920740; Mipol1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Mllt6-K1
AC   CVCL_E5XS
SY   Mllt6-K1; K14E11
DR   JCRB; AyuK14E11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1935145; Mllt6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Myh9-K1
AC   CVCL_E5XT
SY   Myh9-K1; K17E10
DR   JCRB; AyuK17E10
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:107717; Myh9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Nedd4-K1
AC   CVCL_E5XU
SY   Nedd4-K1; K8G11
DR   JCRB; AyuK8G11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:97297; Nedd4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Nmnat2-K1
AC   CVCL_E5XV
SY   Nmnat2-K1; K16H07
DR   JCRB; AyuK16H07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444155; Nmnat2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Nmt1-K1
AC   CVCL_E5XW
SY   Nmt1-K1; K8A06
DR   JCRB; AyuK8A06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:102579; Nmt1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Nmt2-K1
AC   CVCL_E5XX
SY   Nmt2-K1; K19F03
DR   JCRB; AyuK19F03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1202298; Nmt2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Nosip-K1
AC   CVCL_E5XY
SY   Nosip-K1; K8G02
DR   JCRB; AyuK8G02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913644; Nosip.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Nr5a2-K1
AC   CVCL_E5W4
SY   Nr5a2-K1; 14G12
DR   JCRB; AyuK14G12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1346834; Nr5a2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Pcbp2-K1
AC   CVCL_E5XZ
SY   Pcbp2-K1; K17H08
DR   JCRB; AyuK17H08
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:108202; Pcbp2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Phf20-K1
AC   CVCL_E5Y0
SY   Phf20-K1; K13F05
DR   JCRB; AyuK13F05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2444148; Phf20.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Pml-K1
AC   CVCL_E5Y1
SY   Pml-K1; K9F02
DR   JCRB; AyuK9F02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:104662; Pml.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ppp2r2d-K1
AC   CVCL_E5Y2
SY   Ppp2r2d-K1; K10D10
DR   JCRB; AyuK10D10
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1289252; Ppp2r2d.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Psmc3ip-K1
AC   CVCL_E5Y3
SY   Psmc3ip-K1; K15H03
DR   JCRB; AyuK15H03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098610; Psmc3ip.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Pspc1-K1
AC   CVCL_RZ93
SY   Pspc1-K1; K14E08
DR   JCRB; AyuK14E08
DR   Wikidata; Q54992508
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913895; Pspc1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Ptpn11-K1
AC   CVCL_E5W6
SY   Ptpn11-K1; K17E05
DR   JCRB; AyuK17E05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:99511; Ptpn11.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Rad51ap1-K1
AC   CVCL_E5Y4
SY   Rad51ap1-K1; K12E09
DR   JCRB; AyuK12E09
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1098224; Rad51ap1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ranbp1-K1
AC   CVCL_E5Y5
SY   Ranbp1-K1; K6A05
DR   JCRB; AyuK6A05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:96269; Ranbp1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Rap1b-K1
AC   CVCL_E5W2
SY   Rap1b-K1; K13A11
DR   JCRB; AyuK13A11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:894315; Rap1b.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Rbm5-K1
AC   CVCL_E5Y6
SY   Rbm5-K1; K7G08
DR   JCRB; AyuK7G08
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1933204; Rbm5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Rbpms-K1
AC   CVCL_RZ94
SY   Rbpms-K1; K16E08
DR   JCRB; AyuK16E08
DR   Wikidata; Q54992510
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1334446; Rbpms.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Rnf44-K1
AC   CVCL_E5Y7
SY   Rnf44-K1; K6F11
DR   JCRB; AyuK6F11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2145310; Rnf44.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Rsrc2-K1
AC   CVCL_E5Y8
SY   Rsrc2-K1; K7G11
DR   JCRB; AyuK7G11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1913489; Rsrc2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Saps3-K1
AC   CVCL_E5Y9
SY   Saps3-K1; K12A07
DR   JCRB; AyuK12A07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1921807; Ppp6r3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Setd5-K1
AC   CVCL_E5YA
SY   Setd5-K1; K18B08
DR   JCRB; AyuK18B08
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920145; Setd5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Slc39a14-K1
AC   CVCL_RZ95
SY   Slc39a14-K1; K8F07
DR   JCRB; AyuK8F07
DR   Wikidata; Q54992514
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2384851; Slc39a14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Smg5-K1
AC   CVCL_E5YB
SY   Smg5-K1; K6D12
DR   JCRB; AyuK6D12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2447364; Smg5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Srpk1-K1
AC   CVCL_E5YC
SY   Srpk1-K1; K20B09
DR   JCRB; AyuK20B09
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:106908; Srpk1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Tada2l-K1
AC   CVCL_E5YD
SY   Tada2l-K1; K17B02
DR   JCRB; AyuK17B02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2144471; Tada2a.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Tarbp2-K1
AC   CVCL_E5YE
SY   Tarbp2-K1; K13F02
DR   JCRB; AyuK13F02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:103027; Tarbp2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Tbrg4-K1
AC   CVCL_E5YF
SY   Tbrg4-K1; K6B09
DR   JCRB; AyuK6B09
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1100868; Tbrg4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Tex19-K1
AC   CVCL_E5YG
SY   Tex19-K1; K19F08
DR   JCRB; AyuK19F08
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1920929; Tex19.1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Thrap3-K1
AC   CVCL_E5YH
SY   Thrap3-K1; K12E12
DR   JCRB; AyuK12E12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442637; Thrap3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Thumpd3-K1
AC   CVCL_E5YI
SY   Thumpd3-K1; K18E04
DR   JCRB; AyuK18E04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1277973; Thumpd3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Tjp2-K1
AC   CVCL_E5YJ
SY   Tjp2-K1; K20B04
DR   JCRB; AyuK20B04
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1341872; Tjp2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Trerf1-K1
AC   CVCL_RZ96
SY   Trerf1-K1; K14A05
DR   JCRB; AyuK14A05
DR   Wikidata; Q54992517
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2442086; Trerf1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 5
//
ID   v6.5 Trim6-K1
AC   CVCL_E5YK
SY   Trim6-K1; K17A06
DR   JCRB; AyuK17A06
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2137352; Trim6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Trim71-K1
AC   CVCL_E5YL
SY   Trim71-K1; K16C12
DR   JCRB; AyuK16C12
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2685973; Trim71.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Trip10-K1
AC   CVCL_E5YM
SY   Trip10-K1; K12E07
DR   JCRB; AyuK12E07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2146901; Trip10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ube2c-K1
AC   CVCL_E5YN
SY   Ube2c-K1; K8E11
DR   JCRB; AyuK8E11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1915862; Ube2c.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Ubr5-K1
AC   CVCL_E5W3
SY   Ubr5-K1; K10D02
DR   JCRB; AyuK10D02
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1918040; Ubr5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Wdr4-K1
AC   CVCL_E5YP
SY   Wdr4-K1; K11E11
DR   JCRB; AyuK11E11
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1889002; Wdr4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Zfp206-K1
AC   CVCL_E5YQ
SY   Zfp206-K1; K13G03
DR   JCRB; AyuK13G03
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3040700; Zscan10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Zfp280b-K1
AC   CVCL_E5W0
SY   Zfp280b-K1; K7G10
DR   JCRB; AyuK7G10
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1927865; Zfp280b.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Zfp518-K1
AC   CVCL_E5YR
SY   Zfp518-K1; K18B07
DR   JCRB; AyuK18B07
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:1919922; Zfp518a.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Zfp532-K1
AC   CVCL_E5YS
SY   Zfp532-K1; K9B05
DR   JCRB; AyuK9B05
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:3036282; Zfp532.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   v6.5 Zfp568-K1
AC   CVCL_E5YT
SY   Zfp568-K1; K11D09
DR   JCRB; AyuK11D09
RX   PubMed=22020066;
CC   Knockout cell: Method=Gene trap; MGI; MGI:2142347; Zfp568.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   V79
AC   CVCL_2234
SY   V-79; V 79; Strain V; V79-1; GM00215; GM-215; GM00215A; GM16136; UCW 100
DR   BTO; BTO_0001425
DR   CLO; CLO_0009500
DR   CLO; CLO_0018898
DR   CLO; CLO_0025501
DR   CLO; CLO_0051573
DR   EFO; EFO_0022813
DR   CLDB; cl4625
DR   CLDB; cl4626
DR   CLDB; cl4627
DR   CLDB; cl4628
DR   CLDB; cl4952
DR   CCRID; 3101HAMGNHa6
DR   CCRID; 5301HAM-KCB93015YJ
DR   ChEMBL-Cells; CHEMBL3307528
DR   ChEMBL-Targets; CHEMBL614074
DR   CLS; 305012
DR   Coriell; GM00215
DR   Coriell; GM16136
DR   DSMZ; ACC-335
DR   DSMZCellDive; ACC-335
DR   ECACC; 86041102
DR   ICLC; AL99002
DR   KCB; KCB 93015YJ
DR   Lonza; 731
DR   PubChem_Cell_line; CVCL_2234
DR   RCB; RCB0008
DR   Wikidata; Q54992521
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=688393;
RX   PubMed=3030579;
RX   PubMed=3558490;
RX   PubMed=8320183;
RX   PubMed=13576097;
RX   PubMed=13726391;
RX   PubMed=13901497;
CC   Characteristics: Widely used to study DNA damage induced by X-ray, UV radiation and oxidizing agents.
CC   Doubling time: ~16-20 hours (DSMZ=ACC-335).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from child cell line V79-4).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from child cell line V79-4).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 34
//
ID   V79 A3
AC   CVCL_5A61
SY   V-79 A3; V-79 A-3; V79, clone A3; A-3; A3
DR   Wikidata; Q54992524
RX   PubMed=220255;
RX   PubMed=954094;
RX   PubMed=1170021;
RX   PubMed=4345996;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   V79 clone S
AC   CVCL_7230
DR   CLO; CLO_0009501
DR   CLDB; cl4629
DR   Wikidata; Q54992527
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   V79 Dtxr-1
AC   CVCL_U412
SY   Dtxr-1
DR   Wikidata; Q54992530
RX   PubMed=117016;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   V79 Dtxr-2
AC   CVCL_U413
SY   Dtxr-2
DR   Wikidata; Q54992532
RX   PubMed=117016;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   V79 Dtxr-3
AC   CVCL_U414
SY   Dtxr-3
DR   Wikidata; Q54992534
RX   PubMed=117016;
CC   Selected for resistance to: UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   V79 FomR 1
AC   CVCL_F0EC
SY   FomR 1; VF1
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 10
AC   CVCL_F0ED
SY   FomR 10; VF10
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 11
AC   CVCL_F0EE
SY   FomR 11; VF11
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 12
AC   CVCL_F0EF
SY   FomR 12; VF12
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 13
AC   CVCL_F0EG
SY   FomR 13; VF13
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 15
AC   CVCL_F0EH
SY   FomR 15; VF15
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 18
AC   CVCL_F0EI
SY   FomR 18; VF18
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Simple; p.Leu188Phe; Zygosity=Unspecified (PubMed=21586167).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 19
AC   CVCL_F0EJ
SY   FomR 19; VF19
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Simple; p.Leu188Phe; Zygosity=Unspecified (PubMed=21586167).
CC   Sequence variation: Mutation; UniProtKB; P55262; Adk; Simple; p.Phe221Leu; Zygosity=Unspecified (PubMed=21586167).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 2
AC   CVCL_F0EK
SY   FomR 2; VF2
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 20
AC   CVCL_F0EL
SY   FomR 20; VF20
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 23
AC   CVCL_F0EM
SY   FomR 23; VF23
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 24
AC   CVCL_F0EN
SY   FomR 24; VF24
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 26
AC   CVCL_F0EP
SY   FomR 26; VF26
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 3
AC   CVCL_F0EQ
SY   FomR 3; VF3
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 4
AC   CVCL_F0ER
SY   FomR 4; VF4
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 5
AC   CVCL_F0ES
SY   FomR 5; VF5
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 6
AC   CVCL_F0ET
SY   FomR 6; VF6
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 7
AC   CVCL_F0EU
SY   FomR 7; VF7
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 8
AC   CVCL_F0EV
SY   FomR 8; VF8
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 FomR 9
AC   CVCL_F0EW
SY   FomR 9; VF9
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_42452; Formycin A.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 HPRT~
AC   CVCL_8556
SY   T2-14
DR   JCRB; JCRB0707
DR   Wikidata; Q54992536
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   V79 HRC
AC   CVCL_7231
DR   CLO; CLO_0009502
DR   CLDB; cl4630
DR   Wikidata; Q54992537
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   V79 SP5
AC   CVCL_RW41
SY   V79 Sp5; V79/SP5; SP5; Sp5; SP5/V79
DR   Wikidata; Q54992579
RX   PubMed=1576714;
RX   PubMed=2471930;
RX   PubMed=7955071;
RX   PubMed=8914605;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; P00494; Hprt1; Unexplicit; Ex2dup; Zygosity=Unspecified (PubMed=1576714).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   V79 SPD8
AC   CVCL_RW42
SY   V79/SPD8; V79(SPD8); SPD8; SPD8/V79
DR   Wikidata; Q54992582
RX   PubMed=8914605;
RX   PubMed=9642052;
RX   PubMed=10373364;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; P00494; Hprt1; Unexplicit; Ex7dup; Zygosity=Unspecified (PubMed=8914605).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   V79 TubR 2
AC   CVCL_F0EX
SY   TubR 2; VT2
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 TubR 3
AC   CVCL_F0EY
SY   TubR 3; VT3
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 TubR 4
AC   CVCL_F0EZ
SY   TubR 4; VT4
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79 TubR 5
AC   CVCL_F0F0
SY   TubR 5; VT5
RX   PubMed=21586167;
CC   Selected for resistance to: ChEBI; CHEBI_48267; Tubercidin (7-deazaadenosine).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79-122D1
AC   CVCL_UK06
DR   Wikidata; Q98134464
RX   PubMed=5249812;
RX   PubMed=5392645;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   V79-379A
AC   CVCL_J371
SY   V79 379A; V79.379A; V79-379-A; V-79-379A; V-79-379 A
DR   JCRB; IFO50082
DR   Wikidata; Q54992584
RX   PubMed=475817;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 11
//
ID   V79-4
AC   CVCL_2796
SY   V-79-4; V 79-4
DR   BTO; BTO_0003719
DR   CLO; CLO_0009504
DR   CLO; CLO_0051576
DR   CLDB; cl4632
DR   ATCC; CCL-93
DR   BCRC; 60183
DR   BCRJ; 0244
DR   ChEMBL-Cells; CHEMBL3307246
DR   ChEMBL-Targets; CHEMBL612801
DR   CLS; 603371
DR   ECACC; 93010723
DR   JCRB; JCRB0603
DR   PubChem_Cell_line; CVCL_2796
DR   RCB; RCB2332
DR   Wikidata; Q54992586
RX   PubMed=301865;
RX   PubMed=5392645;
RX   PubMed=9023109;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Widely used to study DNA damage induced by X-ray, UV radiation and oxidizing agents.
CC   Doubling time: 12-14 hours (ECACC=93010723).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (PubMed=9023109).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (PubMed=9023109).
CC   Discontinued: CLS; 603371; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_UK06 ! V79-122D1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   V79-6TG
AC   CVCL_3241
DR   JCRB; JCRB0219
DR   Wikidata; Q54992588
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   V79-8
AC   CVCL_M079
DR   Wikidata; Q54992590
RX   PubMed=658159;
RX   PubMed=6035652;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   V79-8HG-
AC   CVCL_M080
DR   Wikidata; Q54992592
RX   PubMed=658159;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_M079 ! V79-8
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   V79-B310H
AC   CVCL_A2PN
SY   B310H
DR   Wikidata; Q105511667
RX   PubMed=2854561;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   V79-E
AC   CVCL_C8AE
SY   V 79-E
DR   Wikidata; Q123033767
RX   PubMed=446595;
RX   PubMed=6170606;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
ID   V79-ETO1
AC   CVCL_5A65
SY   ETO1
DR   Wikidata; Q54992594
RX   PubMed=10606818;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2796 ! V79-4
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   V79-ETO2
AC   CVCL_5A66
SY   ETO2
DR   Wikidata; Q54992595
RX   PubMed=10606818;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2796 ! V79-4
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   V79-ETO3
AC   CVCL_5A67
SY   ETO3
DR   Wikidata; Q54992597
RX   PubMed=10606818;
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2796 ! V79-4
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   V79-G7
AC   CVCL_DQ79
SY   G7
DR   Wikidata; Q54992599
RX   PubMed=196202;
RX   PubMed=1027147;
RX   PubMed=6265473;
RX   PubMed=9217999;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 9
//
ID   V79-GalK1
AC   CVCL_2797
SY   GalK1; GalK 1; DR2R1610; DR2R 1610; R1610; R 1610
DR   CLO; CLO_0008690
DR   ATCC; CRL-1657
DR   CCRID; 3101HAMGNHa5
DR   CLS; 305011
DR   Wikidata; Q54992601
RX   PubMed=1269916;
RX   PubMed=6513922;
CC   Selected for resistance to: ChEBI; CHEBI_27411; 2-deoxy-D-galactose.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   V79-HG04
AC   CVCL_4333
DR   CLO; CLO_0009505
DR   CLDB; cl4633
DR   ECACC; 87020406
DR   Wikidata; Q54992607
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   V79-hSULT1A1
AC   CVCL_A2GW
SY   V79-hP-PST; V79/P-PST
DR   Wikidata; Q105511677
RX   PubMed=7695643;
RX   PubMed=10657971;
RX   PubMed=31112310;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11453; SULT1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   V79-hSULT1A3
AC   CVCL_A2GX
SY   V79-hM-PST; V79/M-PST
DR   Wikidata; Q105511679
RX   PubMed=7695643;
RX   PubMed=10657971;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11455; SULT1A3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   V79-hSULT2A1
AC   CVCL_A2GV
SY   V79-h-HST; V79/HST-hfa
DR   Wikidata; Q105511682
RX   PubMed=7589785;
RX   PubMed=10657971;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11458; SULT2A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   V79-HydR-4
AC   CVCL_D5AV
SY   HydR-4
DR   Wikidata; Q127384628
RX   PubMed=6308422;
CC   Selected for resistance to: ChEBI; CHEBI_44423; Hydroxyurea.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   V79/380
AC   CVCL_HM61
SY   V79, clone 380; 380
DR   Wikidata; Q54992609
RX   PubMed=291939;
RX   PubMed=6251472;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   V79/380-6
AC   CVCL_HM62
DR   Wikidata; Q54992612
RX   PubMed=6251472;
RX   PubMed=6510024;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HM61 ! V79/380
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   V79/B7
AC   CVCL_7232
SY   V79,B7
DR   CLO; CLO_0009503
DR   CLDB; cl4631
DR   Wikidata; Q54992614
RX   PubMed=2896299;
RX   PubMed=7679200;
CC   Characteristics: Thymidine kinase-deficient.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   V79/E36
AC   CVCL_5A58
SY   E36; E-36; E36,HGPRT-
DR   KCB; KCB 87014YJ
DR   Wikidata; Q54992615
RX   PubMed=3049611;
RX   PubMed=4345996;
RX   PubMed=6752155;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Misspelling: CHO-E36; Note=Incorrect as not a CHO derivative but a V79 derivative.
CC   Misspelling: CHO E36; Note=Incorrect as not a CHO derivative but a V79 derivative.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A61 ! V79 A3
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   V79/E36-ts20
AC   CVCL_0215
SY   E36-ts20; E36ts20; TS20; ts20; ts 20
DR   MCCL; MCC:0000104
DR   Wikidata; Q54992616
RX   PubMed=3049611;
RX   PubMed=6752155;
CC   Characteristics: Has a thermolabile ubiquitin-like modifier-activating enzyme 1 (Uba1) (PubMed=3049611).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Misspelling: CHO-TS20; Note=Incorrect as not a CHO derivative but a V79 derivative.
CC   Misspelling: CHO-ts20; Note=Incorrect as not a CHO derivative but a V79 derivative.
CC   Misspelling: CHO ts20; Note=Incorrect as not a CHO derivative but a V79 derivative.
CC   Misspelling: CHOTS20; Note=Incorrect as not a CHO derivative but a V79 derivative.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_5A58 ! V79/E36
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   V79/M12G
AC   CVCL_S250
SY   M12G
DR   Wikidata; Q54992617
RX   PubMed=1900371;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A2PN ! V79-B310H
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   V79/UC
AC   CVCL_S170
DR   Wikidata; Q54992621
RX   PubMed=1900371;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_S250 ! V79/M12G
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   V79B
AC   CVCL_6296
SY   V79b; V79 Brighton; GM16143
DR   CLO; CLO_0018892
DR   CLO; CLO_0051577
DR   Coriell; GM16143
DR   RCB; RCB2337
DR   Wikidata; Q54992623
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   V79MZ
AC   CVCL_4V36
SY   V79-MZ; V79-Mz; V79 Mainz; V79d MZ
DR   Wikidata; Q54992625
RX   PubMed=1446722;
RX   PubMed=7588408;
RX   PubMed=8236270;
RX   PubMed=8293790;
RX   PubMed=8596476;
RX   PubMed=9625737;
RX   PubMed=10474822;
RX   PubMed=10657971;
RX   PubMed=18616954;
RX   PubMed=31112310;
RX   PubMed=33035519;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_2234 ! V79
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 05-10-23; Version: 11
//
ID   V79MZf1A1
AC   CVCL_F0FT
SY   V79MZf1A1 (scup)
RX   DOI=10.1016/S0141-1136(00)00153-7;
RX   DOI=10.1080/10406639908020586;
RX   PubMed=10335445;
RX   PubMed=12947487;
WW   Info; EPA; -; https://cfpub.epa.gov/ncer_abstracts/INDEX.cfm/fuseaction/display.abstractDetail/abstract_id/480/report/F
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q92116; Stenotomus chrysops cyp1a1.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh1A1
AC   CVCL_4V37
SY   V79-hCYP1A1; V79MZ-h1A1
DR   Wikidata; Q54992631
RX   DOI=10.1080/10406639908020586;
RX   PubMed=8293790;
RX   PubMed=9625737;
RX   PubMed=10335445;
RX   PubMed=12584184;
RX   PubMed=12947487;
RX   PubMed=19330882;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   V79MZh1A1/hGSTP1-23
AC   CVCL_F0F8
RX   PubMed=19330882;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4638; GSTP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V37 ! V79MZh1A1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh1A1/hGSTP1-25
AC   CVCL_F0F9
RX   PubMed=19330882;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2595; CYP1A1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4638; GSTP1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V37 ! V79MZh1A1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh1A2
AC   CVCL_4V39
SY   V79MZ-h1A2; V79-hCYP1A2; V79-CYP1A2; XEMhIA2-MZ#1; XEMh1A2-MZ*1; XEMhIA2-MZ
DR   Wikidata; Q54992632
RX   DOI=10.1080/10406639908020586;
RX   PubMed=1446722;
RX   PubMed=8293790;
RX   PubMed=10335445;
RX   PubMed=12584184;
RX   PubMed=31112310;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   V79MZh1A2/hNAT1
AC   CVCL_A2GZ
SY   V79-hCYP1A2-hNAT1; V79-CYP1A2-NAT1
DR   Wikidata; Q105511669
RX   PubMed=14729582;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7645; NAT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V39 ! V79MZh1A2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   V79MZh1A2/hNAT2
AC   CVCL_A2HA
SY   V79-hCYP1A2-hNAT2; V79-CYP1A2-NAT2
DR   Wikidata; Q105511671
RX   PubMed=14729582;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7646; NAT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V39 ! V79MZh1A2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   V79MZh1A2/hSULT1A1
AC   CVCL_A2GY
SY   V79-hCYP1A2-hSULT1A1; V79-CYP1A2-SULT1A1
DR   Wikidata; Q105511673
RX   PubMed=14729582;
RX   PubMed=31112310;
RX   PubMed=33035519;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11453; SULT1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V39 ! V79MZh1A2
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   V79MZh1B1
AC   CVCL_B5WP
SY   V79MZ-h1B1; V79 cell clone #6
DR   Wikidata; Q112041909
RX   DOI=10.1080/10406639908020586;
RX   PubMed=9625737;
RX   PubMed=10335445;
RX   PubMed=12584184;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2597; CYP1B1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 7
//
ID   V79MZh11B1
AC   CVCL_4709
SY   V79 MZh 11 B1
DR   BTO; BTO_0003278
DR   Wikidata; Q54992626
RX   PubMed=7588408;
RX   PubMed=12530636;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2591; CYP11B1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   V79MZh11B2
AC   CVCL_4710
SY   V79 MZh 11 B2
DR   BTO; BTO_0003279
DR   Wikidata; Q54992628
RX   PubMed=7588408;
RX   PubMed=12530636;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2592; CYP11B2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   V79MZh2A6
AC   CVCL_F0FX
RX   DOI=10.1080/10406639908020586;
RX   PubMed=10335445;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2610; CYP2A6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*1
AC   CVCL_F0FI
RX   Patent=US20050130116;
RX   PubMed=12947487;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2446.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*1-H
AC   CVCL_F0FN
RX   Patent=US20050130116;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*10
AC   CVCL_F0FL
RX   Patent=US20050130116;
RX   PubMed=12947487;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2449.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Pro34Ser (c.100C>T) and p.Arg296Cys (c.886C>T). Allele CYP2D6*10).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*10-H
AC   CVCL_F0FP
RX   Patent=US20050130116;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Pro34Ser (c.100C>T) and p.Arg296Cys (c.886C>T). Allele CYP2D6*10).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*17
AC   CVCL_F0FM
RX   Patent=US20050130116;
RX   PubMed=12947487;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2450.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Thr107Ile (c.320C>T) and p.Arg296Cys (c.886C>T). Allele CYP2D6*17).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*17-H
AC   CVCL_F0FQ
RX   Patent=US20050130116;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Thr107Ile (c.320C>T) and p.Arg296Cys (c.886C>T). Allele CYP2D6*17).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*2
AC   CVCL_F0FJ
RX   Patent=US20050130116;
RX   PubMed=12947487;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2447.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Arg296Cys (c.886C>T). Allele CYP2D6*2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*2-H
AC   CVCL_F0FR
RX   Patent=US20050130116;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Arg296Cys (c.886C>T). Allele CYP2D6*2).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*9
AC   CVCL_F0FK
SY   V79MZh2D6*9#C6
RX   Patent=US20050130116;
RX   PubMed=12947487;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2448.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Lys281del (c.841_843delAAG). Allele CYP2D6*9).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2D6*9-H
AC   CVCL_F0FS
RX   Patent=US20050130116;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2625; CYP2D6 (Note=With p.Lys281del (c.841_843delAAG). Allele CYP2D6*9).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh2E1
AC   CVCL_A2GU
SY   V79-hCYP2E1; V79h2E1
DR   Wikidata; Q105511675
RX   DOI=10.1016/0926-6917(95)00008-9;
RX   DOI=10.1080/10406639908020586;
RX   PubMed=10335445;
RX   PubMed=12947487;
RX   PubMed=16221041;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   V79MZh2E1/hSULT1A1
AC   CVCL_5A60
SY   V79-hCYP2E1-hSULT1A1
DR   Wikidata; Q54992604
RX   PubMed=15668106;
RX   PubMed=18616954;
RX   PubMed=19484729;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2631; CYP2E1.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11453; SULT1A1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_A2GU ! V79MZh2E1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 13
//
ID   V79MZh3A4(LNC)
AC   CVCL_F0FD
RX   PubMed=8806738;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh3A4
AC   CVCL_F0FE
SY   V79MZh3A4(SV)
RX   DOI=10.1080/10406639908020586;
RX   PubMed=8806738;
RX   PubMed=10335445;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh3A4/hOR-1
AC   CVCL_F0FC
SY   V79MZh3A4hOR-1; V79MZh3A4-hOR; V79MZ-h3A4-CYPhOR
RX   PubMed=8806738;
RX   PubMed=12947487;
RX   PubMed=20654528;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZh3A4/hOR-2
AC   CVCL_F0FF
SY   V79MZh3A4hOR-2
RX   PubMed=8806738;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2637; CYP3A4.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZhOR
AC   CVCL_F0FG
SY   V79MZ-CYPhOR
RX   PubMed=8806738;
RX   PubMed=12947487;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:9208; POR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZm1A1
AC   CVCL_F0FB
SY   V79MZ-m1A1
RX   PubMed=12584184;
RX   PubMed=12947487;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88588; Cyp1a1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZm1B1
AC   CVCL_F0FU
RX   PubMed=12584184;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88590; Cyp1b1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZm2E1
AC   CVCL_F0FV
SY   V79m2E1; V79m2E1 clone #16
RX   PubMed=16221041;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88607; Cyp2e1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZmockneo
AC   CVCL_F0FH
SY   V79MZmockneo130
RX   Patent=US20050130116;
RX   PubMed=12947487;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZr1A1
AC   CVCL_GR62
SY   V79-rCYP1A1; V79-XEM2; XEM2
DR   Wikidata; Q54994668
RX   DOI=10.1080/10406639908020586;
RX   PubMed=1441600;
RX   PubMed=1692605;
RX   PubMed=1800893;
RX   PubMed=7565906;
RX   PubMed=8236270;
RX   PubMed=10335445;
RX   PubMed=10474822;
RX   PubMed=12947487;
RX   PubMed=19330882;
CC   Karyotypic information: 22,X,-5,+5q (PubMed=10474822).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2458; Cyp1a1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   V79MZr1A1/hGSTP1-33
AC   CVCL_F0FA
RX   PubMed=19330882;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4638; GSTP1.
CC   Genetic integration: Method=Transfection; Gene=RGD; 2458; Cyp1a1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_GR62 ! V79MZr1A1
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79MZr1A2
AC   CVCL_GR63
SY   V79-rCYP1A2; XEMd-MZ; XEMd.MZ; XEMdMZ
DR   Wikidata; Q54994669
RX   DOI=10.1080/10406639908020586;
RX   PubMed=1441600;
RX   PubMed=1793487;
RX   PubMed=1800893;
RX   PubMed=7565906;
RX   PubMed=8236270;
RX   PubMed=10335445;
RX   PubMed=10474822;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2459; Cyp1a2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   V79MZr2B1
AC   CVCL_GR60
SY   V79-rCYP2B1; V79/SD1; SD1; SD-1
DR   TOKU-E; 4043
DR   Wikidata; Q54992618
RX   DOI=10.1080/10406639908020586;
RX   PubMed=1441600;
RX   PubMed=1800893;
RX   PubMed=3137560;
RX   PubMed=7565906;
RX   PubMed=8596476;
RX   PubMed=10335445;
RX   PubMed=10474822;
CC   Karyotypic information: 21,X,-7,-8der,+mar (PubMed=10474822).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2466; Cyp2b1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 12
//
ID   V79MZr2E1
AC   CVCL_F0FW
SY   V79r2e1
RX   DOI=10.1080/10406639908020586;
RX   PubMed=10335445;
RX   PubMed=16221041;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=RGD; 2475; Cyp2e1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   V79NH
AC   CVCL_4V38
SY   V79-NH
DR   Wikidata; Q54992635
RX   PubMed=1446722;
RX   PubMed=8293790;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_J371 ! V79-379A
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 9
//
ID   V79NHh1A2
AC   CVCL_4V40
SY   V79NH-h1A2; XEMhIA2-NH#1; XEMhIA2NH
DR   Wikidata; Q54992637
RX   PubMed=1446722;
RX   PubMed=8293790;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2596; CYP1A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V38 ! V79NH
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   v8.1
AC   CVCL_6D32
SY   V8.1
DR   Wikidata; Q54992638
RX   PubMed=11331774;
RX   PubMed=11441181;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S4/SvJae x FVB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   V81C6-R1B6
AC   CVCL_A2IA
SY   B3
DR   Wikidata; Q105511684
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   V82A6-R1C4
AC   CVCL_A2IB
SY   V82A6.1G4; B24; MB24; SCRF 72.0
DR   ATCC; HB-8742
DR   Wikidata; Q105511685
RX   Patent=US4828986;
RX   PubMed=3524903;
RX   PubMed=7174693;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8742.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 5
//
ID   V82B1-R2D4
AC   CVCL_A2IF
SY   B14
DR   Wikidata; Q105511687
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   V82B2-R1F6
AC   CVCL_A2IC
SY   B19
DR   Wikidata; Q105511691
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   V82G12-R1G1
AC   CVCL_A2IE
SY   B2
DR   Wikidata; Q105511693
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   V82G3-R1D6
AC   CVCL_A2ID
SY   B1
DR   Wikidata; Q105511696
RX   PubMed=7174693;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P04114; Human APOB.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   V9-7A
AC   CVCL_C658
SY   NED5; NED 5
DR   Wikidata; Q54992640
RX   PubMed=18371431;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   VA-ES-BJ
AC   CVCL_1785
SY   VAESBJ; Valhalla-Epithelioid Sarcoma-BJ
DR   CLO; CLO_0009509
DR   CLDB; cl4635
DR   CLDB; cl4636
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2138
DR   BioSample; SAMN03472555
DR   Cell_Model_Passport; SIDM01179
DR   ChEMBL-Cells; CHEMBL3308888
DR   ChEMBL-Targets; CHEMBL2366259
DR   Cosmic; 688121
DR   Cosmic-CLP; 688121
DR   DepMap; ACH-001702
DR   DSMZ; ACC-328
DR   DSMZCellDive; ACC-328
DR   ECACC; 94092303
DR   EGA; EGAS00001000978
DR   GDSC; 688121
DR   GEO; GSM1632462
DR   GEO; GSM1632463
DR   GEO; GSM1632464
DR   GEO; GSM1632465
DR   GEO; GSM1670569
DR   GEO; GSM1676344
DR   GEO; GSM1701675
DR   GEO; GSM2409694
DR   GEO; GSM2409695
DR   GEO; GSM2409696
DR   GEO; GSM2409697
DR   GEO; GSM2409698
DR   GEO; GSM2409699
DR   GEO; GSM2787358
DR   IARC_TP53; 21268
DR   ICLC; HTL97024
DR   LINCS_LDP; LCL-1945
DR   PharmacoDB; VAESBJ_1651_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1785
DR   Wikidata; Q54992642
RX   PubMed=11668190;
RX   PubMed=20164919;
RX   PubMed=21357725;
RX   PubMed=21552805;
RX   PubMed=26351324;
RX   PubMed=26365879;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=28945250;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 36-39 hours (PubMed=21552805); ~32 hours (PubMed=21357725); ~60-90 hours (DSMZ=ACC-328).
CC   Karyotypic information: Near triploid karyotype. Trisomy of chromosomes 2, 5, 8, 10, 12, 13, 16, 17, 18 and 19, tetrasomy of chromosomes 6, 20 and 21 and pentasomy of chromosome 7 (PubMed=21552805).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Homozygous (Cosmic-CLP=688121; DepMap=ACH-001702).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.49%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=3.35%; European, North=67.75%; European, South=28.41% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-2138; Cosmic-CLP=688121; DepMap=ACH-001702; DSMZ=ACC-328; ECACC=94092303; ICLC=HTL97024
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,13
ST   D19S433: 14
ST   D21S11: 27,28
ST   D2S1338: 16,17
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 11 (DSMZ=ACC-328)
ST   D8S1179: 11,15 (ATCC=CRL-2138; DepMap=ACH-001702)
ST   FGA: 22
ST   Penta D: 7,10,13 (DepMap=ACH-001702)
ST   Penta D: 10,13 (ATCC=CRL-2138; DSMZ=ACC-328)
ST   Penta E: 13
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,19
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   VA-ES-BJ BAF47
AC   CVCL_QW58
SY   VA-ES-BJ_BAF47; VAESBJ_BAF47
DR   GEO; GSM2409700
DR   GEO; GSM2409701
DR   GEO; GSM2409702
DR   GEO; GSM2409703
DR   GEO; GSM2409704
DR   GEO; GSM2409705
DR   GEO; GSM2787359
DR   Wikidata; Q54992644
RX   PubMed=28945250;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Ser87Ter (c.260C>A); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11103; SMARCB1.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1785 ! VA-ES-BJ
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   VA-N-BR
AC   CVCL_9880
SY   Valhalla-Neuroblastoma-BR
DR   Wikidata; Q54992646
RX   DOI=10.1007/0-306-46872-7_2;
RX   DOI=10.1016/B978-0-12-333530-2.50006-X;
RX   PubMed=1580564;
CC   Population: Caucasian.
CC   Doubling time: 36 +- 6 hours (PubMed=1580564).
CC   Derived from site: In situ; Abdomen; UBERON=UBERON_0000916.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   VA10
AC   CVCL_B7MR
DR   Wikidata; Q112930540
RX   PubMed=17876679;
RX   PubMed=23135824;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Lung, bronchus, epithelium; UBERON=UBERON_0002031.
CC   Cell type: Epithelial cell of bronchus; CL=CL_0002328.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   VA13-TS4
AC   CVCL_U971
DR   BTO; BTO_0003065
DR   Wikidata; Q54992647
RX   PubMed=14701864;
CC   Population: Caucasian; Swedish.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:220; ADAMTS4.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2759 ! WI-38 VA13 subline 2RA
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   VAB5
AC   CVCL_S600
DR   Wikidata; Q54992649
RX   Patent=US6660276;
RX   PubMed=7681084;
CC   HLA typing: A*02,25; B*60,62; C*03 (PubMed=7681084).
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   VACC1430
AC   CVCL_VK06
DR   cancercelllines; CVCL_VK06
DR   Cosmic; 2667979
DR   Wikidata; Q98134467
RX   PubMed=12615714;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (PubMed=12615714).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 6
//
ID   VACO 1
AC   CVCL_5392
SY   VACO1
DR   Wikidata; Q54992651
RX   PubMed=6498841;
CC   Doubling time: 65 hours (PubMed=6498841).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   VACO 10MS
AC   CVCL_5393
SY   VACO10MS; Vaco10MS; V10MS; VACO-10M; VACO10M; V10M; VACO 10; VACO10
DR   cancercelllines; CVCL_5393
DR   ColonAtlas; VACO10
DR   Cosmic; 948824
DR   Cosmic; 986022
DR   Cosmic; 1223152
DR   Cosmic; 1312319
DR   Cosmic; 2302023
DR   Cosmic; 2760086
DR   GEO; GSM784050
DR   GEO; GSM1346859
DR   GEO; GSM1374980
DR   IARC_TP53; 21745
DR   Progenetix; CVCL_5393
DR   Wikidata; Q54992654
RX   PubMed=6498841;
RX   PubMed=7761852;
RX   PubMed=8755562;
RX   PubMed=16418264;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Doubling time: 36 hours (PubMed=6498841).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Omentum; UBERON=UBERON_0003688.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5394 ! VACO 10P
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   VACO 10P
AC   CVCL_5394
SY   VACO10P
DR   Wikidata; Q54992656
RX   PubMed=6498841;
CC   Doubling time: 45 hours (PubMed=6498841).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5393 ! VACO 10MS
SX   Female
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   VACO 143
AC   CVCL_9U74
SY   VACO143; VaCo143; V143
DR   Wikidata; Q54992693
RX   PubMed=9515795;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 5
//
ID   VACO 206
AC   CVCL_5395
SY   VACO206; Vaco206; V206
DR   Wikidata; Q54992695
RX   PubMed=3567899;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=11314036;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   VACO 235
AC   CVCL_5175
SY   VACO235; VACO-235; V235
DR   ColonAtlas; VACO235
DR   Cosmic; 736333
DR   Cosmic; 956085
DR   IARC_TP53; 23619
DR   Wikidata; Q54992697
RX   PubMed=2253215;
RX   PubMed=3567899;
RX   PubMed=8132740;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=2253215).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   VACO 241
AC   CVCL_5396
SY   VACO241; Vaco241; V241
DR   Wikidata; Q54992699
RX   PubMed=3567899;
RX   PubMed=8385345;
RX   PubMed=11314036;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   VACO 264
AC   CVCL_8629
SY   Vaco 264; VACO264; V264
DR   Wikidata; Q54992702
RX   PubMed=7761852;
RX   PubMed=8385345;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   VACO 3
AC   CVCL_5397
SY   VACO3
DR   Wikidata; Q54992703
RX   PubMed=6498841;
CC   Doubling time: 39 hours (PubMed=6498841).
CC   Derived from site: Metastatic; Mesenteric lymph node; UBERON=UBERON_0002509.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   VACO 310
AC   CVCL_5398
SY   VACO310; V310
DR   Wikidata; Q54992706
RX   PubMed=3567899;
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   VACO 330
AC   CVCL_5399
SY   VACO330; VACO-330; V330
DR   cancercelllines; CVCL_5399
DR   IARC_TP53; 217
DR   Wikidata; Q54992707
RX   PubMed=2253215;
RX   PubMed=3567899;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Unspecified (PubMed=2253215).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   VACO 364
AC   CVCL_8630
SY   VACO364; Vaco364; V364
DR   Wikidata; Q54992709
RX   PubMed=11314036;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   VACO 389
AC   CVCL_IZ98
SY   V389
DR   Wikidata; Q54992711
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 3
//
ID   VACO 394
AC   CVCL_8631
SY   Vaco 394; VACO394; Vaco394; V394
DR   cancercelllines; CVCL_8631
DR   GEO; GSM784026
DR   Progenetix; CVCL_8631
DR   Wikidata; Q54992714
RX   PubMed=8385345;
RX   PubMed=11314036;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   VACO 400
AC   CVCL_5400
SY   Vaco 400; VACO-400; Vaco-400; VACO400; Vaco400; V400
DR   BTO; BTO_0004764
DR   cancercelllines; CVCL_5400
DR   Cosmic; 1312318
DR   Cosmic; 2647362
DR   GEO; GSM784046
DR   IARC_TP53; 21757
DR   Progenetix; CVCL_5400
DR   Wikidata; Q54992719
RX   PubMed=9927040;
RX   PubMed=15162061;
RX   PubMed=16418264;
RX   PubMed=18167186;
RX   PubMed=20606684;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/VACO400.html
CC   Microsatellite instability: Stable (MSS) (PubMed=9927040).
CC   Sequence variation: Mutation; HGNC; HGNC:1148; BUB1; Unexplicit; IVS4+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=15162061).
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Thr45Thr (c.135G>A); ClinVar=VCV000186358; Zygosity=Heterozygous (PubMed=18167186).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys52Thr (c.155A>C); Zygosity=Heterozygous (PubMed=9927040).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Tyr470Asp (c.1408T>G); ClinVar=VCV000217016; Zygosity=Heterozygous (PubMed=9927040).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.74+2T>C; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=16418264).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   VACO 410
AC   CVCL_8632
SY   Vaco 410; VACO410; VaCo410; Vaco410; V410
DR   cancercelllines; CVCL_8632
DR   Cosmic; 2647364
DR   GEO; GSM784047
DR   Progenetix; CVCL_8632
DR   Wikidata; Q54992722
RX   PubMed=7824277;
RX   PubMed=8385345;
RX   PubMed=9927040;
RX   PubMed=11314036;
CC   Microsatellite instability: Stable (MSS) (PubMed=9927040).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Arg528His (c.1583G>A); ClinVar=VCV000012511; Zygosity=Homozygous (PubMed=9927040).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   VACO 411
AC   CVCL_5176
SY   Vaco 411; VACO-411; VACO411; V411
DR   ColonAtlas; VACO411
DR   Cosmic; 736334
DR   GEO; GSM1448221
DR   IARC_TP53; 23620
DR   Wikidata; Q54992726
RX   PubMed=7761852;
RX   PubMed=8132740;
RX   PubMed=12595761;
RX   PubMed=25926053;
CC   Characteristics: Established from a late passage nude mouse xenograft of the parent cell line (PubMed=8132740).
CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D21S11: 29,32.2
ST   D5S818: 13
ST   D7S820: 9,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5175 ! VACO 235
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   VACO 425
AC   CVCL_8633
SY   VACO425; Vaco 425; Vaco425; V425
DR   cancercelllines; CVCL_8633
DR   Wikidata; Q54992729
RX   PubMed=8385345;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:30881; ALG13; Simple; p.Glu729Ter (c.2185G>T); Zygosity=Unspecified (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   VACO 429
AC   CVCL_5401
SY   Vaco 429; VACO-429; Vaco-429; VACO429; V429
DR   cancercelllines; CVCL_5401
DR   Cosmic; 1312320
DR   GEO; GSM784051
DR   IARC_TP53; 21753
DR   Progenetix; CVCL_5401
DR   Wikidata; Q54992732
RX   PubMed=7816807;
RX   PubMed=8385345;
RX   PubMed=15162061;
RX   PubMed=16418264;
RX   PubMed=20606684;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/VACO429.html
CC   Sequence variation: Mutation; HGNC; HGNC:1148; BUB1; Simple; p.Ser492Tyr (c.1542C>A); ClinVar=VCV000007083; Zygosity=Unspecified (PubMed=15162061).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Heterozygous (PubMed=16418264).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   VACO 432
AC   CVCL_5402
SY   Vaco 432; VACO432; VaCo432; Vaco432; V432
DR   cancercelllines; CVCL_5402
DR   GEO; GSM1448124
DR   Wikidata; Q54992735
RX   PubMed=7761852;
RX   PubMed=7816807;
RX   PubMed=7824277;
RX   PubMed=8755562;
RX   PubMed=9515795;
RX   PubMed=11314036;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25926053).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D21S11: 28,33.2
ST   D5S818: 9,10,15,16
ST   D7S820: 11,13
ST   TH01: 8,9.3
ST   TPOX: 7,8
ST   vWA: 14,19
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   VACO 432 MAP2K1 (-/-)
AC   CVCL_A4IM
SY   MAP2K1 (-/-) VACO 432
DR   cancercelllines; CVCL_A4IM
DR   Horizon_Discovery; HD+R07-001
DR   Wikidata; Q105511698
CC   Knockout cell: Method=Not specified; HGNC; HGNC:6840; MAP2K1.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5402 ! VACO 432
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   VACO 432 MAP2K2 (-/-)
AC   CVCL_A4IN
SY   MAP2K2 (-/-) VACO 432
DR   cancercelllines; CVCL_A4IN
DR   Horizon_Discovery; HD+R07-002
DR   Wikidata; Q105511700
CC   Knockout cell: Method=Not specified; HGNC; HGNC:6842; MAP2K2.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5402 ! VACO 432
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   VACO 432 PIK3CA (H1047R/+)
AC   CVCL_LD57
SY   PIK3CA (H1047R/+) VACO 432
DR   cancercelllines; CVCL_LD57
DR   Horizon_Discovery; HD+107-003
DR   Wikidata; Q54992738
CC   Characteristics: Heterozygous knockin of a PIK3CA kinase domain activating mutation.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple_edited; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Heterozygous; Note=By method not specified (Horizon_Discovery=HD+107-003).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5402 ! VACO 432
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   VACO 441
AC   CVCL_5403
SY   VACO441; VaCo441; Vaco441; Vaco 441; V441
DR   Wikidata; Q54992741
RX   PubMed=7816807;
RX   PubMed=8385345;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   VACO 444
AC   CVCL_8634
SY   Vaco 444; VACO444; V444
DR   cancercelllines; CVCL_8634
DR   Cosmic; 1090614
DR   Cosmic; 2667969
DR   Cosmic; 2727475
DR   Wikidata; Q54992744
RX   PubMed=7704014;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=8755562;
RX   PubMed=9515795;
RX   PubMed=12615714;
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Asp96fs*54 (c.278delA); Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   VACO 451
AC   CVCL_8635
SY   Vaco 451; VACO451; Vaco451; V451
DR   cancercelllines; CVCL_8635
DR   Wikidata; Q54992746
RX   PubMed=8385345;
RX   PubMed=11314036;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:10867; ST6GALNAC2; Simple; p.Arg115Trp (c.343C>T); Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   VACO 456
AC   CVCL_5404
SY   Vaco 456; VACO456; VaCo456; V456
DR   cancercelllines; CVCL_5404
DR   GEO; GSM784052
DR   Progenetix; CVCL_5404
DR   Wikidata; Q54992748
RX   PubMed=7816807;
RX   PubMed=8385345;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 13
//
ID   VACO 457
AC   CVCL_9T31
SY   Vaco 457; Vaco-457; VACO457; Vaco457; V457
DR   cancercelllines; CVCL_9T31
DR   Cosmic; 2646667
DR   Cosmic; 2667982
DR   Cosmic; 2727476
DR   GEO; GSM1448081
DR   IARC_TP53; 9389
DR   Wikidata; Q54992751
RX   PubMed=7704014;
RX   PubMed=7761852;
RX   PubMed=7824277;
RX   PubMed=8755562;
RX   PubMed=9515795;
RX   PubMed=9715273;
RX   PubMed=11314036;
RX   PubMed=12615714;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly154Ser (c.460G>A); ClinVar=VCV000133284; Zygosity=Heterozygous (PubMed=9715273).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 29,32
ST   D5S818: 11,16
ST   D7S820: 12,13
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 18
//
ID   VACO 459
AC   CVCL_8636
SY   Vaco 459; VACO459; V459
DR   Wikidata; Q54992753
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   VACO 478
AC   CVCL_8637
SY   Vaco 478; VACO478; Vaco478; V478
DR   cancercelllines; CVCL_8637
DR   Wikidata; Q54992755
RX   PubMed=8385345;
RX   PubMed=11314036;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   VACO 481
AC   CVCL_8638
SY   Vaco 481; VACO481; Vaco481; V481
DR   EFO; EFO_0022534
DR   cancercelllines; CVCL_8638
DR   ColonAtlas; VACO481
DR   Cosmic; 1090615
DR   Cosmic; 1131690
DR   Cosmic; 2646665
DR   Cosmic; 2650773
DR   Cosmic; 2667970
DR   Cosmic; 2727477
DR   GEO; GSM1448110
DR   Wikidata; Q54992758
RX   PubMed=7704014;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=8755562;
RX   PubMed=9515795;
RX   PubMed=9715273;
RX   PubMed=11314036;
RX   PubMed=12615714;
RX   PubMed=17363507;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Asp96fs*4 (c.278_279insA); Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Ala535fs*30 (c.1597_1598TG[4]) (c.1602_1603insTG); ClinVar=VCV000012501; Zygosity=Heterozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9715273).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 7,12
ST   D13S317: 11,13
ST   D16S539: 11,15
ST   D21S11: 31
ST   D5S818: 8,11
ST   D7S820: 8
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 17,18,21
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   VACO 486
AC   CVCL_8639
SY   Vaco 486; VACO486; V486
DR   Wikidata; Q54992760
RX   PubMed=8385345;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   VACO 489
AC   CVCL_8640
SY   Vaco 489; VACO489; V489
DR   cancercelllines; CVCL_8640
DR   IARC_TP53; 9386
DR   Wikidata; Q54992761
RX   PubMed=7824277;
RX   PubMed=8385345;
RX   PubMed=9715273;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Trp (c.405C>G); ClinVar=VCV000376561; Zygosity=Homozygous (PubMed=9715273).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   VACO 4A
AC   CVCL_5405
SY   Vaco 4A; VACO4A; Vaco4A
DR   cancercelllines; CVCL_5405
DR   ColonAtlas; VACO4A
DR   Cosmic; 948843
DR   Cosmic; 985654
DR   Cosmic; 995404
DR   Cosmic; 1043833
DR   Cosmic; 1312321
DR   Cosmic; 2760085
DR   Cosmic; 2800593
DR   GEO; GSM1374981
DR   IARC_TP53; 21758
DR   PRIDE; PXD005354
DR   PRIDE; PXD005355
DR   Wikidata; Q54992765
RX   PubMed=6498841;
RX   PubMed=8464898;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=16418264;
RX   PubMed=18258742;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=29101300;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/VACO4A.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Doubling time: 30 hours (PubMed=6498841).
CC   HLA typing: A*01,03 (PubMed=8464898).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1355fs*18 (c.4062_4066delTTCTT); Zygosity=Unspecified (from autologous cell line VACO 4S).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (from autologous cell line VACO 4S).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Trp524Cys (c.1572G>T); ClinVar=VCV002147050; Zygosity=Unspecified (from autologous cell line VACO 4S).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239fs*1 (c.715_717AAC>T); Zygosity=Unspecified (PubMed=16418264).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5406 ! VACO 4S
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   VACO 4S
AC   CVCL_5406
SY   VACO-4S; VACO4S; Vaco4S
DR   cancercelllines; CVCL_5406
DR   ColonAtlas; VACO4S
DR   Cosmic; 948849
DR   Cosmic; 986023
DR   Cosmic; 1043834
DR   Cosmic; 2302024
DR   Cosmic; 2760188
DR   GEO; GSM1346860
DR   GEO; GSM1374982
DR   Wikidata; Q54992767
RX   PubMed=6498841;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=24755471;
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Doubling time: 30 hours (PubMed=6498841).
CC   Microsatellite instability: Stable (MSS) (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Ser1355fs*18 (c.4062_4066delTTCTT); Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Trp524Cys (c.1572G>T); ClinVar=VCV002147050; Zygosity=Unspecified (PubMed=24755471).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn239fs*1 (c.715_717AAC>T); Zygosity=Unspecified (PubMed=24755471).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5405 ! VACO 4A
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   VACO 5
AC   CVCL_5407
SY   Vaco 5; Vaco-5; VACO5; Vaco5; V5
DR   cancercelllines; CVCL_5407
DR   ColonAtlas; VACO5
DR   Cosmic; 948859
DR   Cosmic; 995385
DR   Cosmic; 1043835
DR   Cosmic; 1090612
DR   Cosmic; 1223153
DR   Cosmic; 1312322
DR   Cosmic; 1479608
DR   Cosmic; 2667980
DR   Cosmic; 2760097
DR   Cosmic; 2800573
DR   GEO; GSM1374983
DR   GEO; GSM1448121
DR   IARC_TP53; 9390
DR   Wikidata; Q54992770
RX   PubMed=6498841;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=8464898;
RX   PubMed=8755562;
RX   PubMed=9515795;
RX   PubMed=9715273;
RX   PubMed=10737795;
RX   PubMed=11226274;
RX   PubMed=11314036;
RX   PubMed=12615714;
RX   PubMed=16418264;
RX   PubMed=20570890;
RX   PubMed=20606684;
RX   PubMed=23272949;
RX   PubMed=25926053;
RX   PubMed=25944804;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/ColonCellLineDescriptions/VACO5.html
CC   Part of: AstraZeneca Colorectal cell line (AZCL) panel.
CC   Doubling time: 29 hours (PubMed=6498841); 28.85 hours (PubMed=25944804).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=20570890; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.His1047Arg (c.3140A>G); ClinVar=VCV000013652; Zygosity=Unspecified (PubMed=20570890; PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (PubMed=9715273; PubMed=16418264).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,13.1
ST   D13S317: 9,13
ST   D16S539: 9,13
ST   D21S11: 24.2,29
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 9.3
ST   TPOX: 9,11
ST   vWA: 14,18
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5409 ! VACO 5A
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   VACO 503
AC   CVCL_8641
SY   Vaco 503; VACO503; V503
DR   cancercelllines; CVCL_8641
DR   GEO; GSM784048
DR   Progenetix; CVCL_8641
DR   Wikidata; Q54992772
RX   PubMed=8385345;
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 11
//
ID   VACO 531
AC   CVCL_DG24
SY   V531
DR   cancercelllines; CVCL_DG24
DR   GEO; GSM784053
DR   Progenetix; CVCL_DG24
DR   Wikidata; Q54992773
RX   PubMed=8755562;
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 9
//
ID   VACO 576
AC   CVCL_5408
SY   VACO576; Vaco576; V576
DR   cancercelllines; CVCL_5408
DR   GEO; GSM784049
DR   IARC_TP53; 9387
DR   Progenetix; CVCL_5408
DR   Wikidata; Q54992775
RX   PubMed=7816807;
RX   PubMed=7824277;
RX   PubMed=9715273;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=9715273).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   VACO 5A
AC   CVCL_5409
SY   VACO5A
DR   Wikidata; Q54992777
RX   PubMed=6498841;
CC   Doubling time: 42 hours (PubMed=6498841).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5407 ! VACO 5
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   VACO 6
AC   CVCL_5410
SY   Vaco 6; VACO6; Vaco6; V6
DR   cancercelllines; CVCL_5410
DR   Cosmic; 1090613
DR   Cosmic; 2667981
DR   GEO; GSM1448220
DR   Wikidata; Q54992779
RX   PubMed=6498841;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=8755562;
RX   PubMed=9515795;
RX   PubMed=9715273;
RX   PubMed=11314036;
RX   PubMed=12615714;
RX   PubMed=25926053;
CC   Doubling time: 26 hours (PubMed=6498841).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:173; ACVR2A; Simple; p.Lys437Argfs*5 (c.1310delA); dbSNP=rs764719749; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Lys128Serfs*35 (c.383delA); ClinVar=VCV000477546; Zygosity=Homozygous (PubMed=12615714).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9715273).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 10,12,13
ST   D21S11: 29,31.2
ST   D5S818: 11
ST   D7S820: 7,10
ST   TH01: 9,9.3
ST   TPOX: 8,10
ST   vWA: 18,20,22
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   VACO 670
AC   CVCL_9T32
SY   Vaco 670; VACO670; Vaco670; V670
DR   cancercelllines; CVCL_9T32
DR   IARC_TP53; 9391
DR   Wikidata; Q54992781
RX   PubMed=7761852;
RX   PubMed=9715273;
RX   PubMed=11314036;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Homozygous (PubMed=9715273).
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   VACO 703
AC   CVCL_9T33
SY   Vaco 703; VACO703; Vaco703; V703
DR   cancercelllines; CVCL_9T33
DR   GEO; GSM1448108
DR   IARC_TP53; 9388
DR   Wikidata; Q54992783
RX   PubMed=7761852;
RX   PubMed=9715273;
RX   PubMed=11314036;
RX   PubMed=25926053;
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly374Valfs*48 (c.1121delG) (Lys373fs); ClinVar=VCV000237940; Zygosity=Heterozygous (PubMed=9715273).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,12
ST   D16S539: 9
ST   D21S11: 29.2,31
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 7,10
ST   vWA: 18,21
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 12
//
ID   VACO 784
AC   CVCL_8642
SY   VACO784; V784
DR   Wikidata; Q54992784
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   VACO 786
AC   CVCL_8643
SY   VACO786; V786
DR   Wikidata; Q54992786
DI   NCIt; C4910; Colon carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   VACO 8
AC   CVCL_5411
SY   Vaco 8; VACO8; Vaco8; V8
DR   cancercelllines; CVCL_5411
DR   IARC_TP53; 9384
DR   Wikidata; Q54992812
RX   PubMed=6498841;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=8755562;
RX   PubMed=9715273;
RX   PubMed=11314036;
CC   Doubling time: 46 hours (PubMed=6498841).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leu (c.569C>T); ClinVar=VCV000418517; Zygosity=Hemizygous (PubMed=9715273).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   VACO 8-2
AC   CVCL_VK10
SY   Vaco 8-2; VACO8-2; Vaco8-2
DR   cancercelllines; CVCL_VK10
DR   Cosmic; 2647360
DR   Wikidata; Q98134469
RX   PubMed=9927040;
CC   Microsatellite instability: Stable (MSS) (PubMed=9927040).
CC   Sequence variation: Mutation; HGNC; HGNC:11773; TGFBR2; Simple; p.Asp522Asn (c.1564G>A); ClinVar=VCV000213936; Zygosity=Homozygous (PubMed=9927040).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro190Leu (c.569C>T); ClinVar=VCV000418517; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Cecum; UBERON=UBERON_0001153.
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5411 ! VACO 8
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   VACO 847
AC   CVCL_IZ99
SY   V847
DR   Wikidata; Q54992813
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-09-24; Version: 5
//
ID   VACO 865
AC   CVCL_JA00
SY   V865
DR   cancercelllines; CVCL_JA00
DR   Wikidata; Q54992814
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   VACO 866
AC   CVCL_8644
SY   VACO866; V866
DR   BTO; BTO_0004763
DR   cancercelllines; CVCL_8644
DR   Wikidata; Q54992815
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Ala146Thr (c.436G>A); ClinVar=VCV000197243; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 12
//
ID   VACO 868
AC   CVCL_JA01
SY   V868
DR   Wikidata; Q54992816
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 871
AC   CVCL_JA02
SY   V871
DR   cancercelllines; CVCL_JA02
DR   Wikidata; Q54992818
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000045115; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   VACO 872
AC   CVCL_JA03
SY   V872
DR   cancercelllines; CVCL_JA03
DR   Wikidata; Q54992819
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   VACO 874
AC   CVCL_JA04
SY   V874
DR   cancercelllines; CVCL_JA04
DR   Wikidata; Q54992820
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   VACO 893
AC   CVCL_JA05
SY   V893
DR   Wikidata; Q54992821
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 896
AC   CVCL_JA06
SY   V896
DR   Wikidata; Q54992822
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 900
AC   CVCL_JA07
SY   V900
DR   Wikidata; Q54992824
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 907
AC   CVCL_JA08
SY   V907
DR   cancercelllines; CVCL_JA08
DR   Wikidata; Q54992825
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   VACO 909
AC   CVCL_JA09
SY   V909
DR   Wikidata; Q54992826
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 911
AC   CVCL_JA10
SY   V911
DR   Wikidata; Q54992827
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 915
AC   CVCL_JA11
SY   V915
DR   cancercelllines; CVCL_JA11
DR   Wikidata; Q54992828
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:15629; B3GNT2; Simple; p.Pro186Thr (c.556C>A); Zygosity=Unspecified (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Unspecified (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:10867; ST6GALNAC2; Simple; p.Asp43His (c.127G>C); Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 8
//
ID   VACO 920
AC   CVCL_JA12
SY   V920
DR   Wikidata; Q54992829
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:15629; B3GNT2; Simple; p.Asp247His (c.739G>C); Zygosity=Unspecified; Note=Loss of activity (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 7
//
ID   VACO 922
AC   CVCL_JA13
SY   V922
DR   Wikidata; Q54992830
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 936
AC   CVCL_JA14
SY   V936
DR   Wikidata; Q54992831
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 940
AC   CVCL_JA15
SY   V940
DR   Wikidata; Q54992832
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 3
//
ID   VACO 947
AC   CVCL_JA16
SY   V947
DR   Wikidata; Q54992833
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 4
//
ID   VACO 954
AC   CVCL_JA17
SY   V954
DR   Wikidata; Q54992834
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 21-03-23; Version: 3
//
ID   VACO 957
AC   CVCL_JA18
SY   V957
DR   Wikidata; Q54992835
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:925; B4GALT2; Simple; p.Ala146Val (c.437C>T); Zygosity=Unspecified; Note=Loss of activity (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 7
//
ID   VACO 964
AC   CVCL_JA19
SY   V964
DR   cancercelllines; CVCL_JA19
DR   Wikidata; Q54992836
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:15629; B3GNT2; Simple; p.Arg6Ter (c.16C>T); Zygosity=Unspecified; Note=N-terminally truncated and mislocalized (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27004849).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   VACO 968
AC   CVCL_JA20
SY   V968
DR   cancercelllines; CVCL_JA20
DR   Wikidata; Q54992837
RX   PubMed=27004849;
CC   Microsatellite instability: Stable (MSS) (PubMed=27004849).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=27004849).
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 7
//
ID   VACO 9M
AC   CVCL_5412
SY   Vaco 9M; VACO9M; Vaco9M; V9M
DR   cancercelllines; CVCL_5412
DR   GEO; GSM784025
DR   Progenetix; CVCL_5412
DR   Wikidata; Q54992839
RX   PubMed=6498841;
RX   PubMed=7761852;
RX   PubMed=8385345;
RX   PubMed=8755562;
CC   Doubling time: 80 hours (PubMed=6498841).
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5413 ! VACO 9P
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
ID   VACO 9P
AC   CVCL_5413
AS   CVCL_A437
SY   Vaco 9P; VACO9P; V9P
DR   cancercelllines; CVCL_5413
DR   ColonAtlas; V9P
DR   Cosmic; 711267
DR   Cosmic; 887233
DR   Cosmic; 1132562
DR   Cosmic; 1479634
DR   GEO; GSM2550021
DR   IARC_TP53; 6485
DR   Wikidata; Q54992840
RX   PubMed=3349466;
RX   PubMed=6498841;
RX   PubMed=9000147;
RX   PubMed=9000572;
RX   PubMed=11526487;
RX   PubMed=20570890;
RX   PubMed=24042735;
RX   PubMed=28683746;
CC   Doubling time: 110 hours (PubMed=6498841).
CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Asp (c.734G>A); ClinVar=VCV000012355; Zygosity=Homozygous (PubMed=9000147; PubMed=24042735; PubMed=28683746).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained from personal communication of Lind, Guro Elisabeth.
CC   Derived from site: In situ; Rectum; UBERON=UBERON_0001052.
ST   Source(s): PubMed=24042735
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 17,20
ST   D3S1358: 13,15
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 23,25
ST   TH01: 6,9.3
ST   TPOX: 8,12
ST   vWA: 19
DI   NCIt; C9383; Rectal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5412 ! VACO 9M
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   VAH-01
AC   CVCL_VZ51
DR   IBRC; C10702
DR   Wikidata; Q98134471
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   VAH-02
AC   CVCL_VZ52
DR   IBRC; C11191
DR   Wikidata; Q98134474
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3448; Wiskott-Aldrich syndrome
DI   ORDO; Orphanet_906; Wiskott-Aldrich syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   VAL
AC   CVCL_1819
DR   CLO; CLO_0037067
DR   EFO; EFO_0022344
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473489
DR   cancercelllines; CVCL_1819
DR   Cell_Model_Passport; SIDM00416
DR   Cosmic; 1086346
DR   Cosmic; 1517631
DR   Cosmic; 1541908
DR   Cosmic; 2276320
DR   Cosmic; 2297002
DR   Cosmic; 2590022
DR   Cosmic-CLP; 1331048
DR   DepMap; ACH-001703
DR   DSMZ; ACC-586
DR   DSMZCellDive; ACC-586
DR   EGA; EGAS00001000978
DR   GDSC; 1331048
DR   GEO; GSM115973
DR   GEO; GSM201349
DR   GEO; GSM1035309
DR   GEO; GSM1670570
DR   LINCS_LDP; LCL-1915
DR   Lonza; 1237
DR   PharmacoDB; VAL_1652_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1819
DR   Wikidata; Q54992842
RX   PubMed=8220427;
RX   PubMed=8558920;
RX   PubMed=16960149;
RX   PubMed=19358282;
RX   PubMed=20454443;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: ~50-70 hours (DSMZ=ACC-586).
CC   HLA typing: A*02:01:01,68:01:01; B*15:01:01,15:01:01; C*03:03:01,03:03:01; DPA1*02:02:02,02:01:02; DPB1*19:01,19:01; DQA1*01:03:01,01:03:01; DQB1*06:03:01,06:03:01; DRA*01:01:01,01:01:01; DRB1*13:01:01,13:01:01 (DSMZCellDive=ACC-586).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0%; East Asian, South=0.47%; South Asian=2.83%; European, North=64.59%; European, South=32.11% (PubMed=30894373).
CC   Miscellaneous: Originally assigned to be from a B-cell acute lymphoblastic leukemia.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Cosmic-CLP=1331048; DepMap=ACH-001703; DSMZ=ACC-586
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,14
ST   D16S539: 9,13
ST   D18S51: 14,16,17 (DSMZ=ACC-586)
ST   D18S51: 16,17 (DepMap=ACH-001703)
ST   D19S433: 13,14
ST   D21S11: 27,30
ST   D2S1338: 20,23
ST   D3S1358: 17,19
ST   D5S818: 11
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 22,24
ST   Penta D: 9
ST   Penta E: 7
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   VAL-1
AC   CVCL_9969
DR   Wikidata; Q54992843
RX   PubMed=15652923;
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   VAL-10B
AC   CVCL_9961
SY   ESe020-A
DR   hPSCreg; ESe020-A
DR   SKIP; SKIP002301
DR   Wikidata; Q54992844
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_VAL_10B.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_VAL_10B.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   HLA typing: A*29:02,30:02; B*44:03,58:01; C*07:18,16:01:01; DPB1*01:01,04:01; DQA1*01:01,01:02; DQB1*05:01,06:02; DRB1*01:02,15:01; DRB5*01:01:01 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   VAL-11B
AC   CVCL_V174
DR   Wikidata; Q54992846
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_VAL_11B.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_VAL_11B.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   HLA typing: A*01:01,02:01; B*15:01,37:01; C*03:03,06:02; DPB1*04:01,05:02; DQA1*03:01,05:05; DQB1*03:02,03:01; DRB1*04:01,11:04 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 12
//
ID   VAL-2
AC   CVCL_9970
DR   Wikidata; Q54992847
RX   PubMed=15652923;
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
ID   VAL-3
AC   CVCL_9962
SY   VAL3; ESe011-A
DR   GEO; GSM569195
DR   GEO; GSM569196
DR   hPSCreg; ESe011-A
DR   SKIP; SKIP001821
DR   Wikidata; Q54992848
RX   PubMed=17169214;
RX   PubMed=20186513;
RX   PubMed=20736931;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/VAL3.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anexo_val_3.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Registration: Swiss research registry; BAG-hES-IMP-0021.
CC   HLA typing: A*02:01; B*07:02,38:01; C*07:02,12:03; DPB1*04:01,17:01; DQA1*01:03,06:03; DRB1*13:01; DRB3*01:01,02:02 (PubMed=17169214).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   VAL-4
AC   CVCL_9963
SY   ESe012-A
DR   hPSCreg; ESe012-A
DR   SKIP; SKIP001822
DR   Wikidata; Q54992849
RX   PubMed=17169214;
RX   PubMed=20186513;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/VAL4.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anexo_val_4.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Registration: Swiss research registry; BAG-hES-IMP-0022.
CC   HLA typing: A*02:01,24:02; B*18:01,44:03; C*04:01,07:01; DPB1*02:01,04:01; DQA1*05:05; DQB1*03:01; DRB1*11:01,11:04; DRB3*02:02 (PubMed=17169214).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   VAL-5
AC   CVCL_9964
SY   VAL5; ESe013-A
DR   hPSCreg; ESe013-A
DR   SKIP; SKIP001823
DR   Wikidata; Q54992850
RX   PubMed=17169214;
RX   PubMed=20186513;
RX   PubMed=20736931;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/VAL5.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/anexo_val_5.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Registration: Swiss research registry; BAG-hES-IMP-0023.
CC   HLA typing: A*01:01,24:02; B*08:01,44:03; C*02:02,07:01; DPB1*02:01,04:01; DQA1*05:01,03:01:01; DQB1*02:01,03:02; DRB1*03:01,04:02; DRB3*01:01; DRB4*01:03 (PubMed=17169214).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   VAL-6M
AC   CVCL_9965
SY   ESe017-A
DR   hPSCreg; ESe017-A
DR   SKIP; SKIP001976
DR   Wikidata; Q54992852
RX   PubMed=20186513;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_VAL_6M_febrero_2008.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   HLA typing: A*02,24; B*14,52; C*02,15; DRB1*01,16 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   VAL-7
AC   CVCL_9966
SY   ESe018-A
DR   hPSCreg; ESe018-A
DR   SKIP; SKIP001977
DR   Wikidata; Q54992853
RX   PubMed=20186513;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_VAL_7_febrero_2008.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   HLA typing: A*24,25; B*18,40; C*02,12; DRB1*04,11 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   VAL-8
AC   CVCL_9967
SY   ESe021-A
DR   hPSCreg; ESe021-A
DR   SKIP; SKIP002302
DR   Wikidata; Q54992854
RX   PubMed=20186513;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_Deposito_VAL8.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos__VAL8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   HLA typing: A*02:01,31; B*07,40; C*03,07; DPB1*02:02,04:01; DQA1*01,03; DQB1*05:01,03:02; DRB1*01:03,04:04 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   VAL-9
AC   CVCL_9968
SY   Val 9; Val9; ESe019-A
DR   hPSCreg; ESe019-A
DR   SKIP; SKIP002300
DR   Wikidata; Q54992855
RX   PubMed=20186513;
RX   PubMed=26385115;
RX   PubMed=29026098;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Solicitud_Deposito_VAL_9.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos__VAL_9.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC10-45.
CC   HLA typing: A*02,11; B*07,51; C*02,07; DQA1*01,05; DQB1*03,06; DRB1*11,15 (PubMed=29026098).
CC   HLA typing: A*02:01,11:01; B*07:02,51:01; C*02:02,07:02; DPB1*04:01,06:02; DQA1*01:02,05:05; DQB1*03:01,06:02; DRB1*11:01,15:01 (BNLC).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   VAL-9-GFP
AC   CVCL_V165
SY   VAL-9 GFP
DR   Wikidata; Q54992856
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879042/Documento_Deposito_VAL-9-GFP.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/879055/Anexos_VAL-9-GFP.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Valencian Node of the Spanish Stem Cell Bank; Valencia; Spain.
CC   HLA typing: A*02:01,11:01; B*07:02,51:01; C*02:02,07:02; DPB1*04:01,05:01; DQA1*01:02,05:05; DQB1*03:01,06:02; DRB1*11:01,15:01; DRB3*02:02 (BNLC).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9968 ! VAL-9
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 13
//
ID   ValiScreen human CCR1
AC   CVCL_RQ08
SY   ValiScreen chemokine CCR1 receptor; CCR1/CHO
DR   Revvity/PerkinElmer; ES-132-C
DR   Wikidata; Q54992857
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1602; CCR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CCR2b
AC   CVCL_RQ09
SY   ValiScreen human chemokine CCR2b receptor
DR   Revvity/PerkinElmer; ES-133-C
DR   Wikidata; Q54992909
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1603; CCR2 (Note=Isoform B).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Revvity/PerkinElmer; ES-133-C; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CHRM1
AC   CVCL_RQ16
SY   ValiScreen human muscarinic acetylcholine receptor M1
DR   Revvity/PerkinElmer; ES-210-C
DR   Wikidata; Q54992911
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1950; CHRM1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CHRM2
AC   CVCL_RQ17
SY   ValiScreen human muscarinic acetylcholine receptor M2
DR   Revvity/PerkinElmer; ES-211-C
DR   Wikidata; Q54992914
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1951; CHRM2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 10
//
ID   ValiScreen human CHRM3
AC   CVCL_RQ18
SY   ValiScreen human muscarinic acetylcholine receptor M3
DR   Revvity/PerkinElmer; ES-212-C
DR   Wikidata; Q54992916
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1952; CHRM3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CHRM4
AC   CVCL_RQ19
SY   ValiScreen human muscarinic acetylcholine receptor M4
DR   Revvity/PerkinElmer; ES-213-C
DR   Wikidata; Q54992918
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1953; CHRM4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CHRM5
AC   CVCL_RQ20
SY   ValiScreen human muscarinic acetylcholine receptor M5
DR   Revvity/PerkinElmer; ES-214-C
DR   Wikidata; Q54992920
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1954; CHRM5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CRTH2
AC   CVCL_LC58
SY   ValiScreen human prostanoid receptor DP2; CHO-CRTH2; hCRTH2-CHO
DR   Revvity/PerkinElmer; ES-561-C
DR   Wikidata; Q54992922
RX   PubMed=21916510;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4502; PTGDR2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 12
//
ID   ValiScreen human CX3CR1
AC   CVCL_RP99
SY   ValiScreen human chemokine CX3CR1 receptor; CHO-hCX3CR1
DR   Revvity/PerkinElmer; ES-137-C
DR   Wikidata; Q54992925
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2558; CX3CR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human CXCR3
AC   CVCL_RQ07
SY   ValiScreen human chemokine CXCR3 receptor isoform A
DR   Revvity/PerkinElmer; ES-142-C
DR   Wikidata; Q54992927
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4540; CXCR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Discontinued: Revvity/PerkinElmer; ES-142-C; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 27-11-25; Version: 11
//
ID   ValiScreen human KCNA3
AC   CVCL_5I79
SY   ValiScreen human Kv1.3
DR   Revvity/PerkinElmer; AX-010-C
DR   Wikidata; Q54992930
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:6221; KCNA3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 11
//
ID   ValiScreen human SLC6A2
AC   CVCL_F1X3
SY   ValiScreen human Norepinephrine Transporter
DR   Revvity/PerkinElmer; RBHNETM-K
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11048; SLC6A2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: Cocker Spaniel; VBO=VBO_0200372.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
HI   CVCL_0422 ! MDCK
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ValiScreen human SLC6A3
AC   CVCL_F1X4
SY   ValiScreen human Dopamine Transporter
DR   Revvity/PerkinElmer; RBHDATM-K
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11049; SLC6A3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ValiScreen human SLC6A4
AC   CVCL_F1X5
SY   ValiScreen human Serotonin Transporter
DR   Revvity/PerkinElmer; RBHSTM-K
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11050; SLC6A4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   ValiScreen human TRPC3
AC   CVCL_5I80
SY   ValiScreen human TRP-3; HEK-293 / TRPC3
DR   Revvity/PerkinElmer; AX-011-C
DR   Wikidata; Q54992932
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12335; TRPC3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Discontinued: Revvity/PerkinElmer; AX-011-C; true.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   ValiScreen human TRPC6
AC   CVCL_5I81
SY   ValiScreen human TRP-6; HEK-293 / TRPC6
DR   Revvity/PerkinElmer; AX-012-C
DR   Wikidata; Q54992935
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:12338; TRPC6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 10
//
ID   VAMPIRO 3T3
AC   CVCL_YJ64
SY   VAMPIRO-3T3/NIH; FP602-3T3
DR   Innoprot; P20305
DR   Wikidata; Q98134476
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Swiss albino.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0120 ! 3T3-Swiss albino
SX   Male
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   VAMPIRO B16-F10
AC   CVCL_YJ65
SY   VAMPIRO-B16-F10; Turbo FP602-B16-F10; turboFP602-B16F10
DR   Innoprot; P20321
DR   Wikidata; Q98134478
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0159 ! B16-F10
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   VAMPIRO CHO-K1
AC   CVCL_YJ66
SY   VAMPIRO-CHO-K1; Turbo FP602-CHOK1; FP602-CHOK1
DR   Innoprot; P20302
DR   Wikidata; Q98134479
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   VAMPIRO HEK293
AC   CVCL_YJ67
SY   VAMPIRO-HEK293; Turbo FP602-HEK293; FP602-HEK293
DR   Innoprot; P20308
DR   Wikidata; Q98134482
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   VAMPIRO MDA-MB-231
AC   CVCL_YJ68
SY   VAMPIRO-MDA-MB-231; Turbo FP602 MDA-MB-231; turboFP602-MDA-MB-231
DR   cancercelllines; CVCL_YJ68
DR   Innoprot; P20317
DR   Wikidata; Q98134484
CC   Group: Triple negative breast cancer (TNBC) cell line.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly464Val (c.1391G>T); ClinVar=VCV000040364; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012580; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg280Lys (c.839G>A); ClinVar=VCV000376657; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0062 ! MDA-MB-231
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 15
//
ID   VAMPIRO PC-3
AC   CVCL_YJ69
SY   VAMPIRO-PC-3; turboFP602-PC3
DR   cancercelllines; CVCL_YJ69
DR   Innoprot; P20315
DR   Wikidata; Q98134486
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Lys139Argfs*31 (c.414delC) (413delC); ClinVar=VCV000133281; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: Metastatic; Bone; UBERON=UBERON_0002481.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0035 ! PC-3
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   VAMPIRO SH-SY5Y
AC   CVCL_YJ70
SY   VAMPIRO-SH-SY5Y; FP602-SH-SY5Y
DR   cancercelllines; CVCL_YJ70
DR   Innoprot; P20303
DR   Wikidata; Q98134489
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0019 ! SH-SY5Y
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 14
//
ID   VAMPIRO SK-BR-3
AC   CVCL_YJ71
SY   VAMPIRO-SK-BR-3; Turbo FP602 SK-BR-3; turboFP602-SK-BR-3
DR   cancercelllines; CVCL_YJ71
DR   Innoprot; P20329
DR   Wikidata; Q98134491
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0033 ! SK-BR-3
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   VAMPIRO U2OS
AC   CVCL_YJ72
SY   VAMPIRO-U-2 OS; turboFP602-U2OS
DR   Innoprot; P20316
DR   Wikidata; Q98134493
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4QJ63; TurboFP602 (Note=Basic red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 13
//
ID   VAMT-1
AC   CVCL_A731
SY   VAMT 1; VAMT1; VAMT
DR   BioSamples; SAMEA100992
DR   cancercelllines; CVCL_A731
DR   Cosmic; 733834
DR   Cosmic; 1522779
DR   Cosmic; 1541209
DR   GEO; GSM726285
DR   IARC_TP53; 23638
DR   Progenetix; CVCL_A731
DR   Wikidata; Q54992937
RX   CelloPub=CLPUB00125;
RX   PubMed=1568228;
RX   PubMed=21642991;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=21642991).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=1568228).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   VAn2H
AC   CVCL_6E14
SY   VAN2H; Vertebra Acipenser naccarii 2H
DR   Wikidata; Q54992939
RX   DOI=10.1111/j.1439-0426.2010.01408.x;
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone, vertebra; UBERON=UBERON_0002412.
OX   NCBI_TaxID=42330; ! Acipenser naccarii (Adriatic sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   VAO1
AC   CVCL_S601
DR   Wikidata; Q54992941
RX   Patent=US6660276;
RX   PubMed=7681084;
CC   HLA typing: A*02 (PubMed=7681084).
DI   NCIt; C4908; Ovarian carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   VAPACLi001-A
AC   CVCL_F0RN
DR   BioSamples; SAMEA115955487
DR   hPSCreg; VAPACLi001-A
RX   PubMed=39729862;
CC   From: Veterans Affairs Palo Alto Health Care System; Palo Alto; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34515; Coronary vasospasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   VAPACLi002-A
AC   CVCL_F0RP
DR   BioSamples; SAMEA115955489
DR   hPSCreg; VAPACLi002-A
RX   PubMed=39729862;
CC   From: Veterans Affairs Palo Alto Health Care System; Palo Alto; USA.
CC   Population: African American.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34515; Coronary vasospasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   VAPACLi003-A
AC   CVCL_F0RQ
DR   BioSamples; SAMEA115955491
DR   hPSCreg; VAPACLi003-A
RX   PubMed=39729862;
CC   From: Veterans Affairs Palo Alto Health Care System; Palo Alto; USA.
CC   Population: Latino or Hispanic.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34515; Coronary vasospasm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   VAT-39
AC   CVCL_0U25
DR   Wikidata; Q54992943
RX   PubMed=24481592;
CC   Population: Japanese.
CC   Doubling time: 34 hours (Note=At 50th passage) (PubMed=24481592).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=24481592
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D21S11: 30
ST   D5S818: 12
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C95966; Ampulla of Vater hepatoid adenocarcinoma
DI   ORDO; Orphanet_300557; Carcinoma of the ampulla of Vater
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-09-24; Version: 11
//
ID   VAVY
AC   CVCL_E861
SY   Vavy
DR   dbMHC; 49051
DR   ECACC; 88052023
DR   IHW; IHW09023
DR   IPD-IMGT/HLA; 11522
DR   Wikidata; Q54992945
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=7615790;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; French.
CC   HLA typing: A*01:01:01:01; B*08:01:01:01; C*07:01:01:01; DPA1*02:01; DPB1*01:01:01; DQA1*05:01:01; DQB1*02:01:01; DRA*01:02; DRB1*03:01:01; DRB3*01:01 (IPD-IMGT/HLA=11522).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   VBD234
AC   CVCL_E862
SY   VBD 234
DR   dbMHC; 49052
DR   ECACC; 94082260
DR   IHW; IHW09160
DR   IPD-IMGT/HLA; 11703
DR   Wikidata; Q54992949
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*01; B*07,08; C*07; DPB1*04:01,04:02; DQA1*01:01,05:01; DQB1*05:01,02:01; DRB1*01:01,03:01; DRB3*01:01 (IPD-IMGT/HLA=11703).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   VBT2
AC   CVCL_S587
DR   Wikidata; Q54992951
RX   Patent=US6660276;
RX   PubMed=7513255;
CC   Doubling time: 1.5 days (PubMed=7513255).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S588 ! VBT2-EBV
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   VBT2-EBV
AC   CVCL_S588
DR   Wikidata; Q54992953
RX   PubMed=7513255;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S587 ! VBT2
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   VC1.1
AC   CVCL_C2X3
DR   Wikidata; Q114313212
RX   PubMed=1723642;
RX   PubMed=3553447;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_60322; Beta-D-GlcA3S-(1->3)-beta-D-Gal-(1->4)-D-GlcNAc (HNK-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   VC1.Ov
AC   CVCL_S371
DR   ATCC; CRL-6266
DR   Wikidata; Q54992954
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6266; true.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9626; ! Vulpes chama (Cape fox)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   VC312R
AC   CVCL_1R57
DR   BioSample; SAMN03152031
DR   Wikidata; Q54992956
RX   PubMed=16309171;
RX   PubMed=20951163;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to originate from a human 2 year old male patient with medullablastoma but found to be from rat (PubMed=20951163).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00390.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   VC5
AC   CVCL_M545
DR   Wikidata; Q54992959
RX   PubMed=10936422;
CC   Characteristics: Produces IgG lambda.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   VC5.1
AC   CVCL_C2X4
DR   Wikidata; Q114313213
RX   PubMed=3553447;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Cat antigen on visual cortex ganglion cell axons.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 4
//
ID   VCAF2B
AC   CVCL_A9BH
DR   Wikidata; Q108821485
RX   PubMed=31659294;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   VCAF8
AC   CVCL_A9BI
DR   Wikidata; Q108821486
RX   PubMed=31659294;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   VCaP
AC   CVCL_2235
SY   VCAP; Vcap; Vertebral Cancer of the Prostate
DR   BTO; BTO_0003215
DR   CLO; CLO_0037117
DR   EFO; EFO_0007752
DR   AddexBio; C0019001/73
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2876
DR   BioSample; SAMN03473238
DR   BioSample; SAMN05292448
DR   BioSample; SAMN10988209
DR   cancercelllines; CVCL_2235
DR   CCRID; 3101HUMSCSP5034
DR   CCRID; 3101HUMTCHu220
DR   Cell_Model_Passport; SIDM01077
DR   ChEMBL-Cells; CHEMBL4295435
DR   ChEMBL-Targets; CHEMBL4296508
DR   CLS; 300631
DR   Cosmic; 1028646
DR   Cosmic; 1028698
DR   Cosmic; 1043330
DR   Cosmic; 1071482
DR   Cosmic; 1689710
DR   Cosmic; 1995663
DR   Cosmic; 2580131
DR   Cosmic-CLP; 1299075
DR   DepMap; ACH-000115
DR   ECACC; 06020201
DR   EGA; EGAS00001000978
DR   ENCODE; ENCBS316RCQ
DR   ENCODE; ENCBS626UQL
DR   GDSC; 1299075
DR   GEO; GSM525805
DR   GEO; GSM648824
DR   GEO; GSM887731
DR   GEO; GSM888826
DR   GEO; GSM1374984
DR   GEO; GSM1440913
DR   GEO; GSM1440914
DR   GEO; GSM1633311
DR   GEO; GSM1633312
DR   GEO; GSM1633313
DR   GEO; GSM1670571
DR   GEO; GSM2069530
DR   GEO; GSM2069531
DR   GEO; GSM2069532
DR   GEO; GSM2069533
DR   GEO; GSM2069534
DR   GEO; GSM2069535
DR   GEO; GSM2069536
DR   GEO; GSM2069537
DR   GEO; GSM3145594
DR   GEO; GSM3145745
DR   GEO; GSM3407124
DR   GEO; GSM3407125
DR   GEO; GSM3407126
DR   GEO; GSM3407127
DR   GEO; GSM3407128
DR   GEO; GSM3407129
DR   GEO; GSM5402196
DR   IARC_TP53; 18891
DR   IZSLER; BS TCL 234
DR   LiGeA; CCLE_269
DR   LINCS_LDP; LCL-1147
DR   PharmacoDB; VCaP_1653_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2235
DR   PubChem_Cell_line; CVCL_2235
DR   Wikidata; Q29511246
RX   CelloPub=CLPUB00698;
RX   PubMed=11317522;
RX   PubMed=14518029;
RX   PubMed=14518030;
RX   PubMed=21698104;
RX   PubMed=22460905;
RX   PubMed=23447416;
RX   PubMed=23615946;
RX   PubMed=23671654;
RX   PubMed=25877200;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=28145883;
RX   PubMed=29194687;
RX   PubMed=30244336;
RX   PubMed=30305041;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=31978347;
RX   PubMed=34402095;
RX   PubMed=35839778;
RX   PubMed=38892296;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/atcc-crl-2876-growth-and-morphology
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/vcap/
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544522
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/VCaP
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Caucasian.
CC   Characteristics: Established from a xenograft produced by implantation of tumor cells in a SCID mouse.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (PubMed=21698104).
CC   Doubling time: 220 hours (PubMed=25984343); ~53 hours (ATCC=CRL-2876); ~51 hours (PBCF); 126.45 hours (JWGray panel).
CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (PubMed=23447416; PubMed=23615946).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (PubMed=23615946).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (PubMed=14518029; PubMed=23615946; Cosmic-CLP=1299075; DepMap=ACH-000115).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.05%; East Asian, North=1.4%; East Asian, South=0%; South Asian=0.98%; European, North=69.8%; European, South=27.77% (PubMed=30894373).
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
ST   Source(s): AddexBio=C0019001/73; ATCC=CRL-2876; CCRID; CLS=300631; Cosmic-CLP=1299075; ECACC=06020201; IZSLER=BS TCL 234; PubMed=14518029; PubMed=25877200; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D10S1248: 13,14
ST   D12S391: 21,23
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13
ST   D1S1656: 13,17.3
ST   D21S11: 31
ST   D22S1045: 16,17
ST   D2S1338: 17,25
ST   D2S441: 11,14
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D6S1043: 11
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   DYS391: 11
ST   FGA: 21,26 (ATCC=CRL-2876; PubMed=25877200; Technion Genomics Center)
ST   FGA: 26 (CLS=300631)
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2025 ! DuCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 46
//
ID   VCaP AR-V7/pHag
AC   CVCL_A1BP
SY   VCaPAR-V7/pHag
DR   cancercelllines; CVCL_A1BP
DR   Wikidata; Q102115093
RX   PubMed=25008967;
CC   Population: Caucasian.
CC   Characteristics: Inducibly expresses AR variant 7 (ARv7).
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:644; AR (Note=Isoform ARv7).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2235 ! VCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 12
//
ID   VCaP-CR
AC   CVCL_A0BX
DR   cancercelllines; CVCL_A0BX
DR   GEO; GSM5402197
DR   Wikidata; Q108821488
RX   PubMed=34402095;
RX   PubMed=38892296;
CC   Population: Caucasian.
CC   Characteristics: Derived after a passage of the parent cell line in castrated nude mice.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Doubling time: ~60 hours (PubMed=34402095).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2235 ! VCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 9
//
ID   VCaP-EnzR
AC   CVCL_RA58
DR   cancercelllines; CVCL_RA58
DR   GEO; GSM2069538
DR   GEO; GSM2069539
DR   GEO; GSM2069540
DR   GEO; GSM2069541
DR   Millipore; SCC421
DR   Wikidata; Q54992965
RX   PubMed=27036029;
CC   Population: Caucasian.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_68534; Enzalutamide (Xtandi; MDV-3100).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
ST   Source(s): Millipore=SCC421
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 21,26
ST   Penta D: 9
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2235 ! VCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 18
//
ID   VCaP-R
AC   CVCL_C0QQ
DR   cancercelllines; CVCL_C0QQ
DR   Wikidata; Q112930541
RX   PubMed=30244336;
CC   Population: Caucasian.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2235 ! VCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   VCaP-SL
AC   CVCL_WZ27
SY   Stem-Like VCaP; VCaP-Stem Like
DR   cancercelllines; CVCL_WZ27
DR   GEO; GSM1633314
DR   GEO; GSM1633315
DR   GEO; GSM1633316
DR   Wikidata; Q98134496
RX   PubMed=28145883;
CC   Population: Caucasian.
CC   Characteristics: Reprogrammed to, maintained and propagated as cancer stem-like cells (CSCs) by growth in androgen-free neural/neural crest (N/NC) stem medium.
CC   Virology: Contains an integrated xenotropic MuLV-related virus (XMRV) Bxv-1 (from parent cell line).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:11876; TMPRSS2; Name(s)=TMPRSS2-ERG (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7127; MLH1; Simple; p.Ile219Val (c.655A>G); ClinVar=VCV000036557; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Bone, vertebra; UBERON=UBERON_0002412.
DI   NCIt; C4863; Prostate carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2235 ! VCaP
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 14
//
ID   VCC1
AC   CVCL_YD88
SY   Vulva Cancer Cells 1
DR   Wikidata; Q98134498
RX   PubMed=31654625;
CC   Doubling time: 18.90 +- 0.53 hours (PubMed=31654625).
CC   Derived from site: In situ; Vulva; UBERON=UBERON_0000997.
ST   Source(s): PubMed=31654625
ST   Amelogenin: X
ST   D13S317: 9
ST   D18S51: 13
ST   D21S11: 27
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 9
ST   D8S1179: 14
ST   vWA: 18
DI   NCIt; C4052; Vulvar squamous cell carcinoma
DI   NCIt; C27723; Vulvar lichen sclerosus
DI   ORDO; Orphanet_494448; Vulvar squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   VCCRIi001-A
AC   CVCL_YC64
DR   hPSCreg; VCCRIi001-A
DR   Wikidata; Q98134501
RX   PubMed=31707208;
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
CC   Sequence variation: Mutation; HGNC; HGNC:20990; PHACTR1; Simple; c.251-149640A>G (chr6:g.12903725A>G); ClinVar=VCV001289844; Zygosity=Heterozygous (PubMed=31707208).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 27-11-25; Version: 9
//
ID   VCCRIi002-A
AC   CVCL_D0PE
SY   SCAD-069; 069
DR   BioSamples; SAMEA114465051
DR   hPSCreg; VCCRIi002-A
DR   Wikidata; Q123033768
RX   PubMed=37939621;
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   VCCRIi003-A
AC   CVCL_D0PF
SY   SCAD-096; 096
DR   BioSamples; SAMEA114465052
DR   hPSCreg; VCCRIi003-A
DR   Wikidata; Q123033770
RX   PubMed=37939621;
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   VCCRIi004-A
AC   CVCL_E7VY
SY   03028
DR   BioSamples; SAMEA114644356
DR   hPSCreg; VCCRIi004-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi005-A
AC   CVCL_E7VZ
SY   03517
DR   hPSCreg; VCCRIi005-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi006-A
AC   CVCL_E7W0
SY   03132
DR   hPSCreg; VCCRIi006-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi007-A
AC   CVCL_E7W1
SY   01835
DR   hPSCreg; VCCRIi007-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi008-A
AC   CVCL_E7W2
SY   02051
DR   hPSCreg; VCCRIi008-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi009-A
AC   CVCL_E7W3
SY   02083
DR   hPSCreg; VCCRIi009-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi010-A
AC   CVCL_E7W4
SY   04915
DR   hPSCreg; VCCRIi010-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi011-A
AC   CVCL_E7W5
SY   02879
DR   hPSCreg; VCCRIi011-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi012-A
AC   CVCL_E7W6
SY   02101
DR   hPSCreg; VCCRIi012-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi013-A
AC   CVCL_E7W7
SY   03774
DR   hPSCreg; VCCRIi013-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi014-A
AC   CVCL_E7W8
SY   03022
DR   hPSCreg; VCCRIi014-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi015-A
AC   CVCL_E7W9
SY   402C
DR   hPSCreg; VCCRIi015-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi016-A
AC   CVCL_E7WA
SY   6017
DR   hPSCreg; VCCRIi016-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi017-A
AC   CVCL_E7WB
SY   SCAD-065; 065
DR   hPSCreg; VCCRIi017-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi018-A
AC   CVCL_E7WC
SY   SCAD-136; 136
DR   hPSCreg; VCCRIi018-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi019-A
AC   CVCL_E7WD
SY   SCAD-105; 105
DR   hPSCreg; VCCRIi019-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi020-A
AC   CVCL_E7WE
SY   SCAD-544; 544
DR   hPSCreg; VCCRIi020-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi021-A
AC   CVCL_E7WF
SY   SCAD-166; 166
DR   hPSCreg; VCCRIi021-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi022-A
AC   CVCL_E7WG
SY   SCAD-180; 180
DR   hPSCreg; VCCRIi022-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi023-A
AC   CVCL_E7WH
SY   SCAD-179; 179
DR   hPSCreg; VCCRIi023-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi024-A
AC   CVCL_E7WI
SY   326
DR   hPSCreg; VCCRIi024-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi025-A
AC   CVCL_E7WJ
SY   SCAD-337; 337
DR   hPSCreg; VCCRIi025-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi026-A
AC   CVCL_E7WK
SY   SCAD-338; 338
DR   hPSCreg; VCCRIi026-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi027-A
AC   CVCL_E7WL
SY   SCAD-248; 248
DR   hPSCreg; VCCRIi027-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi028-A
AC   CVCL_E7WM
SY   272
DR   hPSCreg; VCCRIi028-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi029-A
AC   CVCL_E7WN
SY   SCAD-318; 318
DR   hPSCreg; VCCRIi029-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi030-A
AC   CVCL_E7WP
SY   SCAD-244; 244
DR   hPSCreg; VCCRIi030-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
DI   NCIt; C165532; Spontaneous coronary artery dissection
DI   ORDO; Orphanet_458718; Idiopathic spontaneous coronary artery dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi031-A
AC   CVCL_E7WQ
SY   HLH-04374
DR   hPSCreg; VCCRIi031-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi032-A
AC   CVCL_E7WR
SY   HLH-04373
DR   hPSCreg; VCCRIi032-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi033-A
AC   CVCL_E7WS
SY   HLH-3092; SII
DR   hPSCreg; VCCRIi033-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi034-A
AC   CVCL_E7WT
SY   HLH-4372
DR   hPSCreg; VCCRIi034-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi035-A
AC   CVCL_E7WU
SY   4372 - SI
DR   hPSCreg; VCCRIi035-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi036-A
AC   CVCL_E7WV
DR   hPSCreg; VCCRIi036-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi037-A
AC   CVCL_E7WW
SY   ADC41
DR   BioSamples; SAMEA117078827
DR   hPSCreg; VCCRIi037-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi038-A
AC   CVCL_E7WX
DR   hPSCreg; VCCRIi038-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi039-A
AC   CVCL_E7WY
SY   ADC40
DR   hPSCreg; VCCRIi039-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCCRIi040-A
AC   CVCL_E7WZ
SY   AG91
DR   hPSCreg; VCCRIi040-A
CC   From: Victor Chang Cardiac Research Institute; Sidney; Australia.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VCEFi
AC   CVCL_B6MQ
SY   Vector-derived CEF immortal
DR   Wikidata; Q112041910
RX   PubMed=11237869;
RX   PubMed=11420679;
RX   PubMed=11513975;
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0 (ELL-0).
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   vCor.4U
AC   CVCL_B3PH
SY   vCor4U
DR   Wikidata; Q110433958
RX   DOI=10.1016/j.vascn.2018.01.543;
WW   Info; -; -; https://metrionbiosciences.com/vcor-4u-ventricular-enriched-cardiomyocytes-pharmacological-characterization-utilizing-manual-patch-clamp/
CC   From: Ncardia B.V. (formerly Axiogenesis); Leiden; Netherlands.
CC   Cell type: Cardiomyocyte; CL=CL_0002495.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   VCP-#1
AC   CVCL_T897
SY   HPS0351
DR   RCB; HPS0351
DR   SKIP; SKIP000225
DR   Wikidata; Q54992967
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T894 ! GM22394
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   VCP-#2
AC   CVCL_T898
SY   HPS0352
DR   RCB; HPS0352
DR   SKIP; SKIP000226
DR   Wikidata; Q54992969
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T894 ! GM22394
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 13
//
ID   VCP-#4
AC   CVCL_T899
SY   HPS0353
DR   RCB; HPS0353
DR   SKIP; SKIP000227
DR   Wikidata; Q54992971
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12666; VCP; Simple; p.Leu198Trp (c.593T>G); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Thigh, skin; UBERON=UBERON_0004262.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122663; Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 1
DI   ORDO; Orphanet_329478; Adult-onset distal myopathy due to VCP mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T894 ! GM22394
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 12
//
ID   VD-10
AC   CVCL_F806
SY   VD10
DR   CLO; CLO_0009520
DR   ATCC; HB-68
DR   Wikidata; Q54992973
RX   PubMed=6280195;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Electrophorus electricus saxitoxin-binding component of electroplex.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VD60
AC   CVCL_RW60
DR   Wikidata; Q54992975
RX   PubMed=2833603;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q69091; Human herpesvirus 1 (strain 17) glycoprotein D (gD).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 7
//
ID   vdR2-4
AC   CVCL_JG31
DR   JCRB; JCRB1658
DR   Wikidata; Q54992977
WW   Info; EGTC; -; https://web.archive.org/web/20201202094525/http://egtc.jp/action/access/cellline_detail?cellline=vdR2-4+
CC   Characteristics: Both alleles of Blm locus were modified for tetracycline-dependent gene regulation. A 4-hydroxytamoxifen-regulatable Cre recombinase, ERT2-Cre-ERT2 was knocked into the Rosa26 locus for constitutive expression.
CC   Genetic integration: Method=Homologous recombination; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6J x 129S4/SvJae.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C865 ! v6.5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   VDS
AC   CVCL_E7E8
RX   PubMed=3018084;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VDS-0
AC   CVCL_E7E3
SY   VDS-O; VDSO; VDSO/parental; VDSO/P
RX   PubMed=3018084;
RX   PubMed=9563901;
RX   PubMed=9973220;
CC   Characteristics: Seems to be composed of immature B cells. Does not secretes Ig nor contains intracellular Ig (PubMed=3018084).
CC   Doubling time: 28 hours (PubMed=9563901).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7E8 ! VDS
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VDSO/CMV-8
AC   CVCL_E7E4
RX   PubMed=9563901;
CC   Characteristics: Control cell line for VDSO/E6-18 (Cellosaurus=CVCL_E7E5) and VDSO/E6-19 (Cellosaurus=CVCL_E7EA) (PubMed=9563901).
CC   Doubling time: 28 hours (PubMed=9563901).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7E3 ! VDS-0
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   VDSO/CMV-9
AC   CVCL_E7E9
CC   Characteristics: Control cell line for VDSO/E6-18 (Cellosaurus=CVCL_E7E5) and VDSO/E6-19 (Cellosaurus=CVCL_E7EA).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7E3 ! VDS-0
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   VDSO/E6-18
AC   CVCL_E7E5
RX   PubMed=9563901;
CC   Doubling time: 27 hours (PubMed=9563901).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7E3 ! VDS-0
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   VDSO/E6-19
AC   CVCL_E7EA
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E7E3 ! VDS-0
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   VE-CL-01
AC   CVCL_Z454
SY   VE-Clp1; Super Sf9-1; superSf9-1
DR   Wikidata; Q54992979
RX   Patent=US7842493;
RX   PubMed=19453763;
WW   Provider; OET; -; https://www.oetltd.com/product-page/supersf9-1-cells
WW   Provider; ParaTechs; -; https://paratechs.com/pages/ve-bevs-cell-line-resource-page
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 37.6 hours (OET).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   VE-CL-02
AC   CVCL_Z455
SY   VE-CL2; Super Sf9-2; superSf9-2
DR   Wikidata; Q54992981
RX   Patent=US7842493;
RX   PubMed=19453763;
WW   Provider; OET; -; https://www.oetltd.com/product-page/supersf9-2-cells
WW   Provider; ParaTechs; -; https://paratechs.com/pages/ve-bevs-cell-line-resource-page
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 29.7 hours (OET).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   VE-CL-03
AC   CVCL_Z456
SY   VE-CL03; Super Sf9-3; superSf9-3
DR   Wikidata; Q54992982
RX   Patent=US7842493;
WW   Provider; OET; -; https://www.oetltd.com/product-page/supersf9-3-cells
WW   Provider; ParaTechs; -; https://paratechs.com/pages/ve-bevs-cell-line-resource-page
CC   Group: Insect cell line.
CC   Group: Recombinant protein production insect cell line.
CC   Doubling time: 43.6 hours (OET).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q56IA8; Campoletis sonorensis ichnovirus P-vankyrin-1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7108; ! Spodoptera frugiperda (Fall armyworm)
HI   CVCL_0549 ! Sf9
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   VE45
AC   CVCL_ZS72
SY   VE 45
DR   Wikidata; Q98134504
RX   PubMed=3136916;
RX   PubMed=6422469;
RX   PubMed=17409408;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   Vebr-10
AC   CVCL_F0XE
RX   PubMed=8754132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0SV ! CHL V-79 RJK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Vebr-2
AC   CVCL_F0SW
RX   PubMed=8754132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0SV ! CHL V-79 RJK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Vebr-20
AC   CVCL_F0SX
RX   PubMed=8754132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0SV ! CHL V-79 RJK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Vebr-25
AC   CVCL_F0XF
RX   PubMed=8754132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0SV ! CHL V-79 RJK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Vebr-30
AC   CVCL_F0XG
RX   PubMed=8754132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0SV ! CHL V-79 RJK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Vebr-5
AC   CVCL_F0SY
SY   RJKEB
RX   DOI=10.1134/S1990519X15050028;
RX   DOI=10.1134/S1990519X21010041;
RX   PubMed=8754132;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Selected for resistance to: ChEBI; CHEBI_4883; Ethidium bromide.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_F0SV ! CHL V-79 RJK
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   VEGF-D 293 clone 11
AC   CVCL_W713
DR   IZSLER; BS CL 202
DR   Wikidata; Q54992986
RX   PubMed=11175849;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3708; VEGFD.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6974 ! HEK293-EBNA
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 16
//
ID   VEGF120 fibrosarcoma
AC   CVCL_HG18
DR   CancerTools; 153239
DR   ECACC; 17100509
DR   Wikidata; Q54992988
DR   Ximbio; 153239
RX   PubMed=18381437;
CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF120.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100509; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   VEGF120 fibrosarcoma Luc2/mStrawberry
AC   CVCL_HG19
DR   CancerTools; 152853
DR   ECACC; 17100526
DR   Wikidata; Q54992990
DR   Ximbio; 152853
CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF120.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TN3DM; mStrawberry (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100526; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG18 ! VEGF120 fibrosarcoma
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   VEGF164 fibrosarcoma
AC   CVCL_HG20
DR   CancerTools; 153240
DR   ECACC; 17100510
DR   Wikidata; Q54992992
DR   Ximbio; 153240
RX   PubMed=18381437;
CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF164.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100510; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   VEGF164 fibrosarcoma Luc2/mStrawberry
AC   CVCL_HG21
DR   CancerTools; 152854
DR   ECACC; 17100527
DR   Wikidata; Q54992994
DR   Ximbio; 152854
CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF164.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TN3DM; mStrawberry (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100527; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG20 ! VEGF164 fibrosarcoma
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   VEGF188 fibrosarcoma
AC   CVCL_HG22
DR   CancerTools; 153241
DR   ECACC; 17100508
DR   Wikidata; Q54992995
DR   Ximbio; 153241
RX   PubMed=18381437;
CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF188.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100508; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   VEGF188 fibrosarcoma Luc2/mStrawberry
AC   CVCL_HG23
DR   CancerTools; 152855
DR   ECACC; 17100528
DR   Wikidata; Q54993034
DR   Ximbio; 152855
CC   Characteristics: Derived from a transgenic mouse strain expressing only a single isoform of Vegfa, VEGF188.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TN3DM; mStrawberry (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100528; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG22 ! VEGF188 fibrosarcoma
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   VEGFWT fibrosarcoma
AC   CVCL_HG24
DR   CancerTools; 153238
DR   ECACC; 17100507
DR   Wikidata; Q54993035
DR   Ximbio; 153238
RX   PubMed=18381437;
CC   Characteristics: Control cell line for the Vegfa isoform-specific cell lines.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100507; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 8
//
ID   VEGFWT fibrosarcoma Luc2/mStrawberry
AC   CVCL_HG25
DR   CancerTools; 152852
DR   ECACC; 17100518
DR   Wikidata; Q54993038
DR   Ximbio; 152852
RX   PubMed=18381437;
CC   Characteristics: Control cell line for the Vegfa isoform-specific cell lines.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; TN3DM; mStrawberry (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Discontinued: ECACC; 17100518; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_HG24 ! VEGFWT fibrosarcoma
SX   Sex unspecified
AG   13-14FD
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 9
//
ID   Veggie-CHO
AC   CVCL_B6FH
DR   Wikidata; Q112041911
RX   PubMed=19003404;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 22.5 hours (PubMed=19003404).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_1977 ! CHO-DXB11
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   Veggie-CHO:FLT-3L
AC   CVCL_B6FI
DR   Wikidata; Q112041912
RX   PubMed=19003404;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 21.2 +- 2.9 hours (PubMed=19003404).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3766; FLT3LG.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:94890; Dhfr.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_B6FH ! Veggie-CHO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   VEN
AC   CVCL_E863
DR   dbMHC; 49053
DR   ECACC; 94022550
DR   IHW; IHW09238
DR   IPD-IMGT/HLA; 11525
DR   Wikidata; Q54993039
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03:01:01:01,31:01:02:01; B*55:01:01,18:01:01:01; C*05:01:01:01,03:03:01:01; DPA1*01:03:01:02; DPB1*104:01,04:01:01; DQA1*01:01:01:02,05:01:01:01; DQB1*02:01:01,05:01:01; DRB1*01:01:01,03:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=11525).
CC   HLA typing: A*03:01:01:01,31:01:02:01; B*18:01:01:01,55:01:01; C*05:01:01:01,03:03:01:01; DPA1*01:03:01:02; DPB1*04:01:01:01(350:01),104:01(124:01); DQA1*05:01:01:01,01:01:01; DQB1*02:01:01,05:01:01:03; DRB1*03:01:01,01:01:01; DRB3*02:02:01:01 (PubMed=30844424).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   vEPT
AC   CVCL_4626
DR   CLO; CLO_0009523
DR   ATCC; CRL-2087
DR   Wikidata; Q54993040
RX   PubMed=1280703;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   VerA 3
AC   CVCL_F1XL
RX   PubMed=25184275;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_18227; Sterigmatocystin (ST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   VerA 4
AC   CVCL_F1XM
RX   PubMed=25184275;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_18227; Sterigmatocystin (ST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   VerA 5
AC   CVCL_F1XN
RX   PubMed=25184275;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_18227; Sterigmatocystin (ST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   Vero
AC   CVCL_0059
SY   VERO; VeroCCL81; Vero 81; Vero-81; Verda reno
DR   BTO; BTO_0001444
DR   CLO; CLO_0009524
DR   CLO; CLO_0050515
DR   EFO; EFO_0022734
DR   MCCL; MCC:0000480
DR   CLDB; cl4643
DR   CLDB; cl4644
DR   CLDB; cl4645
DR   CLDB; cl4648
DR   CLDB; cl4649
DR   CLDB; cl4650
DR   CLDB; cl4651
DR   CLDB; cl5170
DR   AddexBio; P0014002/4920
DR   ATCC; CCL-81
DR   ATCC; CCL-81.4
DR   ATCC; CRL-6318
DR   BCRC; 60013
DR   BCRJ; 0245
DR   CCLV; CCLV-RIE 0015
DR   CCLV; CCLV-RIE 0078
DR   CCRID; 1101MON-PUMC000060
DR   CCRID; 1102MON-NIFDC00001
DR   CCRID; 3101MONGNO10
DR   CCRID; 3101MONSCSP520
DR   CCRID; 4201MON-CCTCC00029
DR   CCRID; 5301MON-KCB92017YJ
DR   CCTCC; GDC0029
DR   ChEMBL-Cells; CHEMBL3307520
DR   ChEMBL-Targets; CHEMBL391
DR   CLS; 605372
DR   ECACC; 08011101
DR   ECACC; 84113001
DR   FCS-free; 165-11-307-1-16-6
DR   FCS-free; 29-11-249-1-3-3
DR   FCS-free; 29-11-31-2-4-4
DR   FCS-free; 29-11-338-1-16-3
DR   FCS-free; 29-11-420-1-16-12
DR   FCS-free; 29-11-433-1-16-12
DR   FCS-free; 29-11-47-1-8-9
DR   FCS-free; 29-11-566-1-17-2
DR   FCS-free; 29-11-587-1-18-2
DR   IBRC; C10001
DR   ICLC; ATL95005
DR   IZSLER; BS CL 86
DR   JCRB; IFO50471
DR   JCRB; JCRB0111
DR   JCRB; JCRB9013
DR   KCB; KCB 92017YJ
DR   KCLB; 10081
DR   Lonza; 173
DR   MeSH; D014709
DR   MetaboLights; MTBLS2840
DR   NCBI_Iran; C101
DR   PubChem_Cell_line; CVCL_0059
DR   RCB; RCB0001
DR   TKG; TKG 0280
DR   TOKU-E; 3415
DR   Ubigene; YC-A001
DR   Wikidata; Q3066564
RX   CelloPub=CLPUB00126;
RX   CelloPub=CLPUB00328;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.12665/J63.Morgan;
RX   PubMed=2260226;
RX   PubMed=4043530;
RX   PubMed=6027511;
RX   PubMed=6298990;
RX   PubMed=10403033;
RX   PubMed=10494966;
RX   PubMed=12667817;
RX   PubMed=15731278;
RX   PubMed=16494729;
RX   PubMed=19003288;
RX   PubMed=19016439;
RX   PubMed=19768803;
RX   PubMed=19941903;
RX   PubMed=22059503;
RX   PubMed=24975811;
RX   PubMed=25267831;
RX   PubMed=25903999;
RX   PubMed=28386771;
RX   PubMed=32376603;
RX   PubMed=32511316;
RX   PubMed=33389257;
WW   Info; -; -; https://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/vero/verocells.html
WW   Info; -; -; https://www.niid.go.jp/niid/ja/chlamydia-pneumonia-m/818-biochem/5752-vero.html
WW   Info; -; -; https://www.vax-before-travel.com/vaccines/covaxin-covid-19-vaccine
WW   Info; ECACC; -; https://www.culturecollections.org.uk/products/cell-cultures/ecacc-cell-line-profiles/vero/
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/image-gallery/confocal/epithelialindex
WW   Info; Evident; -; https://evidentscientific.com/en/microscope-resource/knowledge-hub/techniques/fluorescence/gallery/cells/agmindex
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/v/cell-lines-detail-60.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Vero_cell
WW   Provider; Vircell; -; https://www.vircell.com/en/products/vero-cell-line
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Biotechnology: Used for the production of the Japanese encephalitis virus (JEV) vaccine (Trade name: IXIARO/JESPECT).
CC   Biotechnology: Used for the production of the inactivated poliovirus vaccine (Trade name: Imovax Polio).
CC   Biotechnology: Used for the production of the Purified Vero-cell Rabies Vaccine (PVRV) (Trade name: VERORAB).
CC   Biotechnology: Used for the production of the Chromatographically Purified Rabies Vaccine (CPRV).
CC   Biotechnology: Used for the production of the live oral rotavirus vaccine (Trade Name: Rotarix).
CC   Biotechnology: Used for the production of the live smallpox (vaccinia) vaccine (Trade name: ACAM2000).
CC   Biotechnology: Used for the production of the tetravalent dengue vaccine (Trade Name: Dengvaxia).
CC   Biotechnology: Used for the production of the Bharat Biotech SARS-CoV-2 (COVID-19) vaccine (Trade name: Covaxin; also known as BBV152) (DrugBank=DB15847). The cell line is used to produces a inactivated SARS-CoV-2 virus strain.
CC   Biotechnology: Used for the production of the Sinovax SARS-CoV-2 (COVID-19) vaccine (Trade name: CoronaVac; also known as PiCoVacc) (DrugBank=DB15806). The cell line is used to produces the inactivated SARS-CoV-2 virus strain CN02 (PubMed=32376603).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV). Produces a lytic infection (PubMed=15731278; PubMed=16494729).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19). But Vero C1008 (often known as Vero E6) (Cellosaurus=CVCL_0574) seems to be more appropriate for amplification and quantification (PubMed=32511316; PubMed=33389257).
CC   Doubling time: 16 hours (Note=In medium with serum), 26 hours (Note=In serum-free medium) (PubMed=19003288).
CC   Omics: Genomics; Whole genome sequencing.
CC   Anecdotal: Verda reno means green kidney in Esperanto and Vero means truth also in Esperanto.
CC   Discontinued: ATCC; CRL-6318; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   Vero 2.2
AC   CVCL_A5BG
SY   Vero 2-2; VERO 2-2; 2-2
DR   BTO; BTO_0006289
DR   Wikidata; Q107117397
RX   PubMed=2846867;
RX   PubMed=9371577;
RX   PubMed=10074128;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; Q9J0X9; Human herpesvirus 1 (strain KOS) ICP27 (UL54).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   Vero 303
AC   CVCL_L035
DR   Wikidata; Q54993041
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 12
//
ID   Vero 317
AC   CVCL_3863
SY   Vero-317; Vero317
DR   CLO; CLO_0009525
DR   CLO; CLO_0050513
DR   CLDB; cl4652
DR   ECACC; 89070502
DR   RCB; RCB0272
DR   Wikidata; Q54993042
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Discontinued: ECACC; 89070502; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_L035 ! Vero 303
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 16
//
ID   Vero 76
AC   CVCL_0603
SY   VERO 76; Vero-76; VERO-76; VERO76; Vero76; Vero from pool #76
DR   BTO; BTO_0004754
DR   CLO; CLO_0009526
DR   CLDB; cl4653
DR   CLDB; cl4654
DR   CLDB; cl4655
DR   ATCC; CRL-1587
DR   BCRC; 60477
DR   CCLV; CCLV-RIE 0228
DR   CCRID; 1102MON-NIFDC00007
DR   ChEMBL-Cells; CHEMBL3885981
DR   ChEMBL-Targets; CHEMBL4296509
DR   ECACC; 85020205
DR   IZSLER; BS CL 101
DR   JCRB; IFO50410
DR   JCRB; JCRB9007
DR   KCLB; 21587
DR   PubChem_Cell_line; CVCL_0603
DR   Wikidata; Q54993043
RX   CelloPub=CLPUB00328;
RX   PubMed=19016439;
RX   PubMed=19941903;
RX   PubMed=22059503;
RX   PubMed=24973239;
RX   PubMed=34737324;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Vero_cell
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   Vero C1008
AC   CVCL_0574
SY   VERO C1008; VeroC1008; VEROC1008; VERO C 1008; VERO C1008 (E6); Vero 76 clone E6; Vero 76 clone E-6; Vero E-6; Vero E6; VERO E6; Vero-E6; VeroE6
DR   BTO; BTO_0004755
DR   CLO; CLO_0009527
DR   MCCL; MCC:0000479
DR   CLDB; cl4656
DR   CLDB; cl4657
DR   ATCC; CRL-1586
DR   BCRC; 60476
DR   BCRJ; 0407
DR   BioGRID_ORCS_Cell_line; 1349
DR   CCRID; 1101MON-PUMC000388
DR   CCRID; 1102MON-NIFDC00097
DR   CCRID; 3101MONGNO17
DR   CCRID; 4201MON-CCTCC00146
DR   CCTCC; GDC0146
DR   ChEMBL-Cells; CHEMBL4295411
DR   ChEMBL-Targets; CHEMBL4303840
DR   CLS; 305008
DR   ECACC; 85020206
DR   GEO; GSM758827
DR   GEO; GSM758828
DR   GEO; GSM758829
DR   GEO; GSM758830
DR   GEO; GSM758831
DR   GEO; GSM758832
DR   GEO; GSM758833
DR   GEO; GSM758834
DR   GEO; GSM758835
DR   GEO; GSM758836
DR   GEO; GSM758837
DR   GEO; GSM758838
DR   GEO; GSM758839
DR   GEO; GSM758840
DR   GEO; GSM758841
DR   GEO; GSM758842
DR   GEO; GSM758843
DR   GEO; GSM758844
DR   IZSLER; BS CL 87
DR   PRIDE; PXD018594
DR   PRIDE; PXD018760
DR   PRIDE; PXD019645
DR   PRIDE; PXD023538
DR   PubChem_Cell_line; CVCL_0574
DR   Ubigene; YC-A003
DR   Wikidata; Q54993044
RX   CelloPub=CLPUB00328;
RX   PubMed=15731278;
RX   PubMed=16494729;
RX   PubMed=19016439;
RX   PubMed=32020029;
RX   PubMed=32511316;
RX   PubMed=33389257;
RX   PubMed=34339474;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Vero_cell
WW   Provider; Vircell; -; https://www.vircell.com/en/products/vero-e6-cell-line
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Virology: Susceptible to infection by many viruses. Supports the growth of slowly replicating viruses (ATCC=CRL-1586).
CC   Virology: Susceptible to infection by SARS coronavirus (SARS-CoV). Produces a lytic infection (PubMed=15731278; PubMed=16494729).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=32020029; PubMed=32511316; PubMed=33389257; PubMed=34339474).
CC   Doubling time: 22 hours (ATCC=CRL-1586).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0603 ! Vero 76
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   Vero PVR1 KO
AC   CVCL_B3LR
SY   Vero delta PVR1; Vero delta PVR1-1
DR   JCRB; JCRB1831
DR   Wikidata; Q110433959
RX   PubMed=33762624;
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1N4; PVR1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   Vero PVR1/2 DKO
AC   CVCL_B3LS
SY   Vero delta PVR1/2; Vero delta PVR1/2-1
DR   JCRB; JCRB1840
DR   Wikidata; Q110433961
RX   PubMed=33762624;
CC   Group: Non-human primate cell line.
CC   Virology: Not susceptible to infection by poliovirus.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1N4; PVR1.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1L1; PVR2.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_B3LR ! Vero PVR1 KO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 6
//
ID   Vero PVR1/2 DKO hSLAM+
AC   CVCL_C7UT
SY   Vero deltaPVR1/2 hSLAM+ c1
DR   JCRB; JCRB1901
DR   Wikidata; Q123033771
RX   PubMed=36564197;
CC   Group: Non-human primate cell line.
CC   Virology: Not susceptible to infection by poliovirus. Useful for the isolation of measles virus (MeV) and rubella virus (RuV) as both viruses replicate efficiently in this cell line (PubMed=36564197).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1N4; PVR1.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1L1; PVR2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10903; SLAMF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_B3LS ! Vero PVR1/2 DKO
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 14-08-25; Version: 6
//
ID   Vero PVR2 KO
AC   CVCL_B3LT
SY   Vero delta PVR2; Vero delta PVR2-1
DR   JCRB; JCRB1834
DR   Wikidata; Q110433963
RX   PubMed=33762624;
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9S1L1; PVR2.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 05-10-23; Version: 5
//
ID   Vero E6-high ACE2
AC   CVCL_A7UJ
DR   BEI_Resources; NR-53726
DR   Wikidata; Q107117398
CC   Group: Non-human primate cell line.
CC   Characteristics: Obtained by sorting Vero E6 cells for cells expressing high levels of endogenous ACE2.
CC   Characteristics: Application in SARS-CoV-2 research.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 5
//
ID   Vero E6-S
AC   CVCL_XD71
DR   CCRID; 4201PAT-CCTCC01085
DR   Wikidata; Q98134505
RX   Patent=CN107267443B;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017101.
CC   Characteristics: Adapted to suspension growth.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 9
//
ID   Vero E6-TMPRSS2-T2A-ACE2
AC   CVCL_C7NK
DR   BEI_Resources; NR-54970
DR   Wikidata; Q117704960
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Transfected with a PuroR-P2A-TMPRSS2-T2A-ACE2 plasmid under the control of a CAG promoter (BEI_Resources=NR-54970).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:13557; ACE2.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 7
//
ID   Vero E6/NPC1-KO cl.19
AC   CVCL_YZ66
SY   Vero E6/NPC1-KO cl. 19
DR   Wikidata; Q98134508
RX   PubMed=30010949;
RX   PubMed=31940478;
CC   Group: Non-human primate cell line.
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RYM1; NPC1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 5
//
ID   Vero F6
AC   CVCL_L036
SY   F6; F6B2
DR   Wikidata; Q54993046
RX   PubMed=1309250;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Vero_cell
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08356; Human herpesvirus 1 (strain HFEM) (HHV-1) glycoprotein H (gH).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 15
//
ID   Vero M
AC   CVCL_EJ70
SY   Vero-M; VERO-M; Vero-MARU; Vero Maru; VM
DR   Wikidata; Q54993047
CC   Group: Non-human primate cell line.
CC   From: Middle America Research Unit (MARU); Corozal; Panama.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 05-10-23; Version: 9
//
ID   Vero Mx-Luc
AC   CVCL_RX68
DR   Wikidata; Q54993049
RX   PubMed=8960100;
CC   Group: Non-human primate cell line.
CC   Characteristics: Can be used as a reporter cell line to study interferon pathways.
CC   Characteristics: The expression of the luciferase reporter gene is under control of the mouse Mx1 gene promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   Vero Mx13
AC   CVCL_RX03
SY   VeroMx13
DR   Wikidata; Q54993050
RX   PubMed=1366960;
CC   Group: Non-human primate cell line.
CC   Characteristics: Can be used as a reporter cell line to study interferon pathways.
CC   Characteristics: The expression of the growth hormone gene is under control of the mouse Mx1 gene promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4261; GH1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   Vero MxA clone VA8
AC   CVCL_D5HC
SY   VA8
DR   Wikidata; Q127384631
RX   PubMed=7745744;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7532; MX1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vero MxA clone VA9
AC   CVCL_D5HD
SY   VA9
DR   Wikidata; Q127384633
RX   PubMed=7745744;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7532; MX1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vero MxB clone VB33
AC   CVCL_D5HE
SY   VB33
DR   Wikidata; Q127384635
RX   PubMed=7745744;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7533; MX2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vero MxB clone VB72
AC   CVCL_D5HF
SY   VB72
DR   Wikidata; Q127384637
RX   PubMed=7745744;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7533; MX2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vero RCB 10-87
AC   CVCL_JF53
SY   Vero (WHO); Vero(WHO); Vero-WHO; WHO Vero RCB 10-87; WHO Vero 10-87; 10-87 Vero
DR   BioSample; SAMN15458746
DR   ECACC; 88020401
DR   Wikidata; Q54993052
RX   DOI=10.12665/J63.Morgan;
RX   PubMed=10494966;
RX   PubMed=19016439;
RX   PubMed=34417462;
RX   PubMed=37680537;
WW   Provider; WHO; -; https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/norms-and-standards/who-reference-cell-banks
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: A World Health Organisation (WHO) working cell bank of 1000 ampoules deposited at ECACC, derived from an original American Type Culture Collection (ATCC) ampoule. Available free of charge to organisations producing vaccines following receipt of approval to supply from WHO (ECACC=88020401).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   Vero-B4
AC   CVCL_1912
SY   VERO-B4; Vero B4; VeroB4
DR   CLO; CLO_0009528
DR   CLDB; cl4659
DR   CCLV; CCLV-RIE 0929
DR   CCLV; CCLV-RIE 1146
DR   DSMZ; ACC-33
DR   DSMZCellDive; ACC-33
DR   Wikidata; Q54993054
RX   PubMed=25531820;
RX   PubMed=34339474;
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Virology: Susceptible to infection by Middle East respiratory syndrome-related coronavirus (MERS-CoV) (PubMed=25531820).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=34339474).
CC   Doubling time: ~25 hours (DSMZ=ACC-33).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 20
//
ID   Vero-CD4/CCR5
AC   CVCL_ZX02
SY   VeroCD4/CCR5; VERO-hCD4/CCR5 clone 4F11
DR   Wikidata; Q102115094
RX   Patent=US10894080;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1678; CD4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 9
//
ID   Vero-CDM
AC   CVCL_B7DX
DR   CLS; 605372-CDM
DR   Wikidata; Q112930542
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to the serum free, chemically-defined culture medium SciN4Vero (CLS=605372-CDM).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   Vero-EGFP-SBV-N
AC   CVCL_B6C5
DR   Wikidata; Q112041913
RX   PubMed=28083834;
CC   Group: Non-human primate cell line.
CC   Characteristics: Transfected with a fusion eGFP-SBV-N protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; H2AM13; Schmallenberg virus (SBV) nucleoprotein (N).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   Vero-furin
AC   CVCL_C7NL
DR   BEI_Resources; NR-55312
DR   Wikidata; Q117704961
RX   PubMed=27420797;
CC   Group: Non-human primate cell line.
CC   Virology: Useful for the production of viruses with more effective furin cleavage (BEI_Resources=NR-55312).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8568; FURIN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 7
//
ID   Vero-Hektor
AC   CVCL_4334
SY   Vero Hektor
DR   ECACC; 03092503
DR   Wikidata; Q54993056
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to growth in the chemically defined protein- and peptide-free Hektor media from Cell Culture Technologies.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   Vero-Luc
AC   CVCL_C8WZ
DR   Ubigene; YC-A001-Luc-P
DR   Wikidata; Q123033772
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   Vero-Luc2p
AC   CVCL_A7UI
DR   BEI_Resources; NR-10385
DR   Wikidata; Q107117399
RX   PubMed=20585113;
CC   Group: Non-human primate cell line.
CC   Biotechnology: Used in a quantitative and sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis (PubMed=20585113).
CC   Characteristics: Stably expresses luciferase Luc2p which is tagged with a PEST sequence which promotes rapid turnover. Therefore, luciferase activity reflects the current level of protein synthesis (PubMed=20585113).
CC   Characteristics: Transduced with a Luc2P-IRES-eGFP construct.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   Vero-pA104R
AC   CVCL_ZW93
DR   Wikidata; Q102115095
RX   PubMed=31323824;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P68742; African swine fever virus (strain Badajoz 1971 Vero-adapted) pA104R.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 8
//
ID   Vero-SCARB2
AC   CVCL_A5IB
SY   VeroS
DR   Wikidata; Q107117400
RX   PubMed=23919614;
CC   Group: Non-human primate cell line.
CC   Virology: Highly susceptible to infection by enterovirus type 71 (EV71) and coxsackievirus A group type 16 (CA16) (PubMed=23919614).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:1665; SCARB2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   Vero-SF-ACF
AC   CVCL_1K11
SY   Vero-Serum Free-Animal Component Free
DR   ATCC; CCL-81.5
DR   Wikidata; Q54993058
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to serum-free and animal component-free medium.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 11
//
ID   Vero-SF-adapted
AC   CVCL_AS92
SY   VERO-SF
DR   CLS; 605372-SF
DR   Wikidata; Q54993059
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Discontinued: CLS; 605372-SF; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 10
//
ID   Vero-SV2neo clone VN5
AC   CVCL_GA12
SY   Vn5; Vero/G418
DR   Wikidata; Q54993060
RX   Patent=US7655406;
RX   PubMed=7745744;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2659.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   Vero-TB
AC   CVCL_A2ST
SY   VERO-TB
DR   CCRID; 4201PAT-CCTCC01613
DR   Wikidata; Q105511703
RX   Patent=CN111826339A;
CC   Group: Non-human primate cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202054.
CC   Virology: Highly susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 05-10-23; Version: 8
//
ID   Vero.DogSLAMtag
AC   CVCL_A8GK
DR   JCRB; JCRB1904
DR   Wikidata; Q107117401
RX   PubMed=12941904;
RX   PubMed=18689645;
CC   Group: Non-human primate cell line.
CC   Virology: Highly susceptible to infection by canine distemper virus (CDV) (PubMed=12941904).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=VGNC; VGNC:46206; Dog SLAMF1 (Note=With a N-terminal HA tag).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   Vero.STAT1 KO
AC   CVCL_YZ45
SY   Vero.STAT1-KO
DR   ATCC; CCL-81-VHG
DR   Wikidata; Q98134511
RX   CelloPub=CLPUB00659;
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Virology: Excellent cell model for virus propagation and viral vaccine production. It exhibits significant increased viral titer and enhanced virus production capability when compared to its parental cell line (ATCC=CCL-81-VHG).
CC   Doubling time: ~28 hours (ATCC=CCL-81-VHG).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RIE1; STAT1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 02-07-20; Last updated: 05-10-23; Version: 8
//
ID   Vero/HER2
AC   CVCL_E8FR
SY   VERO/HER2 clone B1
DR   ABM; T3189
RX   PubMed=26121156;
CC   Group: Non-human primate cell line.
CC   Doubling time: 19-29 hours (ABM=T3189).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Vero/HER2/HER3
AC   CVCL_E8FS
SY   VERO/HER2/HER3
DR   ABM; T3191
RX   PubMed=26121156;
CC   Group: Non-human primate cell line.
CC   Doubling time: 19-29 hours (ABM=T3191).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3430; ERBB2.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3431; ERBB3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_E8FR ! Vero/HER2
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Vero/HER3
AC   CVCL_E8FT
SY   VERO/HER3 clone C4
DR   ABM; T3190
RX   PubMed=26121156;
CC   Group: Non-human primate cell line.
CC   Doubling time: 19-29 hours (ABM=T3190).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3431; ERBB3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Vero/hSLAM
AC   CVCL_L037
DR   ECACC; 04091501
DR   JCRB; JCRB1809
DR   Wikidata; Q54993061
RX   PubMed=33389257;
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Virology: Can be used to isolate measles virus from human clinical samples (ECACC=04091501).
CC   Virology: Susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:10903; SLAMF1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 18
//
ID   VERO/IgR
AC   CVCL_WC99
DR   CCTCC; GDC0404
DR   Wikidata; Q98134513
CC   Group: Non-human primate cell line.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000150). It was the sole source of information for this entry.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 8
//
ID   Vero/PPRV H
AC   CVCL_GA11
DR   Wikidata; Q54993062
RX   PubMed=17050742;
CC   Group: Non-human primate cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q6Q498; Peste-des-petits-ruminants virus (PPRV) hemagglutinin (H).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 10
//
ID   Vero/SF
AC   CVCL_1K13
SY   VERO/SF
DR   ATCC; CCL-81.1
DR   Wikidata; Q54993063
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Discontinued: ATCC; CCL-81.1; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 05-10-23; Version: 9
//
ID   Vero/TMPRSS2
AC   CVCL_YQ48
DR   JCRB; JCRB1818
DR   Wikidata; Q98134516
RX   PubMed=18562527;
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   VeroE6-Pgp-KO
AC   CVCL_C4RQ
DR   Wikidata; Q116050765
RX   PubMed=36208677;
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Virology: Can be used for in vitro virus infection system for SARS-CoV-2 and possibly other viruses to test antiviral therapies without a need to control the ABCB1/Pgp efflux transporter activity (PubMed=36208677).
CC   Knockout cell: Method=CRISPR/Cas9; UniProtKB; A0A0D9RIY5; ABCB1.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 05-10-23; Version: 4
//
ID   VeroE6/TMPRSS2
AC   CVCL_YQ49
DR   JCRB; JCRB1819
DR   Wikidata; Q91354600
RX   PubMed=31013314;
RX   PubMed=32165541;
WW   Provider; NIBSC; 100978; https://www.nibsc.org/products/brm_product_catalogue/detail_page.aspx?catid=100978
CC   Group: Non-human primate cell line.
CC   Group: SARS-CoV-2 research cell line.
CC   Virology: Highly susceptible to infection by Middle East respiratory syndrome-related coronavirus (MERS-CoV), SARS coronavirus (SARS-CoV) and SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=32165541).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11876; TMPRSS2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0574 ! Vero C1008
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 12
//
ID   Veronica-HSA
AC   CVCL_0D02
SY   Veronica
DR   Wikidata; Q54993064
RX   PubMed=19461996;
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: Golden Retriever; VBO=VBO_0200610.
DI   NCIt; C122783; Canine hemangiosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-09-24; Version: 9
//
ID   VeroS
AC   CVCL_ZW77
DR   Wikidata; Q102115096
RX   PubMed=31201054;
CC   Group: Non-human primate cell line.
CC   Group: Vaccine production cell line.
CC   Characteristics: Adapted to suspension growth.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 29-10-20; Last updated: 05-10-23; Version: 5
//
ID   Verots S3
AC   CVCL_T368
DR   CLO; CLO_0050511
DR   RCB; RCB0707
DR   Wikidata; Q54993066
RX   PubMed=1368119;
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_3863 ! Vero 317
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 16
//
ID   Verots S3(SF)
AC   CVCL_T369
DR   CLO; CLO_0050512
DR   RCB; RCB0706
DR   Wikidata; Q54993068
CC   Group: Non-human primate cell line.
CC   Group: Serum/protein free medium cell line.
CC   Group: Vaccine production cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_T368 ! Verots S3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 15
//
ID   Vester
AC   CVCL_G707
DR   BTO; BTO_0003757
DR   Wikidata; Q54993069
RX   PubMed=16177958;
CC   Miscellaneous: Only mentioned as a mesothelioma cell line in PubMed=16177958.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   vFOP1-1
AC   CVCL_W549
DR   SKIP; SKIP000345
DR   Wikidata; Q54993071
RX   PubMed=24321451;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   vFOP1-4
AC   CVCL_W550
DR   SKIP; SKIP000341
DR   Wikidata; Q54993073
RX   PubMed=24321451;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W541 ! GM00513
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   vFOP2-1
AC   CVCL_W551
DR   SKIP; SKIP000336
DR   Wikidata; Q54993075
RX   PubMed=24321451;
CC   Population: African American.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W542 ! GM00783
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   vFOP2-2
AC   CVCL_W552
DR   SKIP; SKIP000335
DR   Wikidata; Q54993077
RX   PubMed=24321451;
CC   Population: African American.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W542 ! GM00783
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   vFOP4-1
AC   CVCL_W553
SY   CiRA00041; HPS0376
DR   RCB; HPS0376
DR   SKIP; SKIP000339
DR   SKIP; SKIP000635
DR   Wikidata; Q54993078
RX   PubMed=24321451;
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   Miscellaneous: Assignment of vFOP4-1 to CiRA00041 from personal communication of CiRA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W554 ! vFOP4-3
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 12
//
ID   vFOP4-3
AC   CVCL_W554
SY   CiRA00042; HPS0377
DR   RCB; HPS0377
DR   SKIP; SKIP000338
DR   SKIP; SKIP003026
DR   Wikidata; Q54993080
RX   PubMed=24321451;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W553 ! vFOP4-1
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   vFOP5-22
AC   CVCL_W555
SY   CiRA00043; HPS0378
DR   RCB; HPS0378
DR   SKIP; SKIP000340
DR   Wikidata; Q54993082
RX   PubMed=24321451;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3040; Fibrodysplasia ossificans progressiva
DI   ORDO; Orphanet_337; Fibrodysplasia ossificans progressiva
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   VG
AC   CVCL_X927
DR   Wikidata; Q54993084
RX   PubMed=7535998;
CC   Group: Non-human primate cell line.
CC   Doubling time: ~30 hours (PubMed=7535998).
CC   Transformant: NCBI_TaxID; 33747; Simian T-lymphotropic virus 1 (STLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9556; ! Papio cynocephalus (Yellow baboon)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 8
//
ID   VG-1
AC   CVCL_0106
SY   VG1
DR   cancercelllines; CVCL_0106
DR   Cosmic; 1588566
DR   GEO; GSM634741
DR   GEO; GSM710426
DR   GEO; GSM710442
DR   GEO; GSM3150258
DR   IARC_TP53; 23658
DR   PRIDE; PXD012087
DR   Progenetix; CVCL_0106
DR   Wikidata; Q16258509
RX   PubMed=10925292;
RX   PubMed=15613351;
RX   PubMed=17121789;
RX   PubMed=21685375;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/VG-1_(cell_line)
CC   Population: Caribbean; Haitian.
CC   Transformant: NCBI_TaxID; 37296; Human herpesvirus 8 (HHV-8/KSHV).
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: Established from a cardiac transplant patient (PubMed=10925292).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C6915; Primary effusion lymphoma
DI   ORDO; Orphanet_48686; Primary effusion lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M579 ! B301
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   VGE
AC   CVCL_W084
DR   BioSamples; SAMEA100981
DR   cancercelllines; CVCL_W084
DR   Cosmic; 1522765
DR   GEO; GSM726286
DR   Progenetix; CVCL_W084
DR   Wikidata; Q54993092
RX   PubMed=21642991;
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Phe118Leufs*69 (c.354delC); Zygosity=Heterozygous (PubMed=21642991).
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 14
//
ID   VGH-EPY
AC   CVCL_Y107
DR   BCRC; 60374
DR   Wikidata; Q54993094
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Brain, ventricle; UBERON=UBERON_0004086.
ST   Source(s): BCRC=60374
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3017; Ependymoma
DI   ORDO; Orphanet_251636; Ependymoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 02-05-24; Version: 9
//
ID   VGH-MED
AC   CVCL_Y106
SY   VGH-Med
DR   BCRC; 60375
DR   GEO; GSM1938722
DR   Wikidata; Q54993096
CC   Discontinued: BCRC; 60375; probable.
DI   NCIt; C3222; Medulloblastoma
DI   ORDO; Orphanet_616; Medulloblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 21-03-23; Version: 5
//
ID   VH-64
AC   CVCL_9672
SY   VH 64; VH64
DR   EFO; EFO_0002870
DR   cancercelllines; CVCL_9672
DR   GEO; GSM510015
DR   IARC_TP53; 23653
DR   Progenetix; CVCL_9672
DR   Wikidata; Q54993098
RX   PubMed=1320624;
RX   PubMed=8335680;
RX   PubMed=8378080;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21822310;
RX   PubMed=26428435;
RX   PubMed=30879952;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=15150091).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): PubMed=19787792; PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 13,14
ST   D19S433: 12,15
ST   D21S11: 30.2,31
ST   D2S1338: 19,24
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 14
ST   FGA: 22,23 (PubMed=30879952)
ST   FGA: 23 (PubMed=19787792)
ST   SE33: 16,23
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 25
//
ID   VH-Renal
AC   CVCL_X539
DR   Cosmic; 849369
DR   Wikidata; Q54993100
RX   PubMed=11146448;
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 21-03-23; Version: 4
//
ID   VH10
AC   CVCL_RW72
SY   VH-10
DR   Wikidata; Q54993103
RX   PubMed=1541259;
RX   PubMed=2175267;
RX   PubMed=3011251;
RX   PubMed=6096694;
RX   PubMed=6096706;
RX   PubMed=7957119;
RX   PubMed=38162630;
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   VH10-SV
AC   CVCL_E9V2
SY   VH-10 SV; VH10/SV; VH1O SV40
RX   PubMed=2175267;
RX   PubMed=3011251;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RW72 ! VH10
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VH12
AC   CVCL_RW73
SY   VH-12
DR   Wikidata; Q54993150
RX   PubMed=2175267;
RX   PubMed=6096694;
RX   PubMed=6096706;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 7
//
ID   VH2
AC   CVCL_4369
SY   VH 2; VH-2; Viper Heart-2
DR   CLO; CLO_0009531
DR   CLO; CLO_0009532
DR   CLDB; cl4662
DR   ATCC; CCL-140
DR   ECACC; 90102539
DR   IZSLER; BS CL 187
DR   Wikidata; Q54993152
RX   PubMed=4350126;
RX   PubMed=4358139;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=8707; ! Daboia russelii (Russel's viper)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   VHB-1
AC   CVCL_M381
DR   Wikidata; Q54993154
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=2824520;
CC   Doubling time: 37 hours (Note=At 25th passage), 31 hours (Note=At 87th passage) (PubMed=2824520).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   vHFF1-iPS4
AC   CVCL_DQ55
SY   vHFF1_iPS_iPS4
DR   Wikidata; Q54993156
RX   PubMed=27345787;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3285 ! HFF-1
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   VHIRi001-A
AC   CVCL_E7T6
SY   C1(RP25)_UiPSC_mR5F_7
DR   BioSamples; SAMEA117479140
DR   hPSCreg; VHIRi001-A
RX   PubMed=39742628;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+C1%28RP25%29+Documento_Deposito_Lineas_iPSC.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+ANEXO+C1%28RP25%29_UiPSC_mR5F_7.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Vall d'Hebron Institut de Recerca (VHIR); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Gly2945Glu (c.8834G>A); ClinVar=VCV00083606; Zygosity=Heterozygous (PubMed=39742628).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=39742628
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 9,15
ST   D21S11: 26,28
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VHIRi002-A
AC   CVCL_E7T7
SY   C2(RP25)_UiPSC_mR5F_1
DR   BioSamples; SAMEA117479146
DR   hPSCreg; VHIRi002-A
RX   PubMed=39742628;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+C2%28RP25%29+Documento_Deposito_Lineas_iPSC.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+ANEXO+C2%28RP25%29_UiPSC_mR5F_1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Vall d'Hebron Institut de Recerca (VHIR); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Gly2945Glu (c.8834G>A); ClinVar=VCV00083606; Zygosity=Heterozygous (PubMed=39742628).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=39742628
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D21S11: 26,32.2
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VHIRi003-A
AC   CVCL_E7T8
SY   RP25_UiPSC_mR5F_8
DR   BioSamples; SAMEA117479213
DR   hPSCreg; VHIRi003-A
RX   PubMed=39742628;
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Caracteristicas+-+RP25+Documento_Deposito_Lineas_iPSC.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo+-+ANEXO+RP25_UiPSC_mR5F_8.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Vall d'Hebron Institut de Recerca (VHIR); Barcelona; Spain.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:21555; EYS; Simple; p.Gly2945Glu (c.8834G>A); ClinVar=VCV00083606; Zygosity=Homozygous (PubMed=39742628).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=39742628
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 9,14
ST   D21S11: 26,30
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   VI-2A5-A4
AC   CVCL_U040
SY   B-4; B4
DR   Wikidata; Q54993158
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania panamensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   VI-4D10-D12
AC   CVCL_U039
SY   B-3; B3
DR   Wikidata; Q54993160
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania brazilensis.
CC   Monoclonal antibody target: Leishmania panamensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   Vi-856
AC   CVCL_A440
SY   Vi856; VI856
DR   Cosmic; 1167986
DR   Wikidata; Q54993162
RX   PubMed=18165268;
CC   From: Majdic, Otto; Institute for Immunology; Vienna; Austria.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 8
//
ID   VI-MC
AC   CVCL_WH43
SY   Visceral Mastocytoma-Mast Cells
DR   Wikidata; Q98134518
RX   PubMed=11490155;
RX   PubMed=30268330;
CC   Doubling time: 27.5 +- 2.3 hours (PubMed=11490155).
CC   Derived from site: In situ; Viscera; UBERON=UBERON_0002075.
CC   Cell type: Mast cell; CL=CL_0000097.
CC   Breed/subspecies: Maltese; VBO=VBO_0200856.
DI   NCIt; C129077; Canine mastocytoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   VIDO R1
AC   CVCL_RT36
SY   VIDOR1; Veterinary Infectious Disease Organization Retina-1
DR   Wikidata; Q54993165
RX   PubMed=10580052;
RX   PubMed=26103808;
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 8
//
ID   VIDO R2
AC   CVCL_RT37
SY   VIDO-R2; VIDOR2; Veterinary Infectious Disease Organization Retina-2
DR   Wikidata; Q54993167
RX   Patent=US6458586;
RX   PubMed=10516020;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-156.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E1A/E1B).
CC   Derived from site: In situ; Fetal eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Fetus
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 9
//
ID   VII-II-5G3-F3
AC   CVCL_U041
SY   VII-5G3-F3; B-11; B11
DR   Wikidata; Q54993170
RX   PubMed=3826486;
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania panamensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   VII/2Liv
AC   CVCL_B7AF
DR   Wikidata; Q112041914
RX   PubMed=28794044;
RX   PubMed=32252443;
CC   Group: Reptilian cell line.
CC   Derived from site: In situ; Fetal liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=129333; ! Morelia viridis (Green tree python)
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   VIII-6G10
AC   CVCL_F807
DR   CLO; CLO_0009533
DR   ATCC; HB-10519
DR   Wikidata; Q54993174
RX   Patent=US5206345;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10519.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P19320; Human VCAM1/CD106.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   VIIIC3.78
AC   CVCL_B0D1
SY   VIII C3.78; CIII.78
DR   ATCC; HB-10878
DR   Wikidata; Q108821489
RX   Patent=US6344552;
RX   PubMed=2237407;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-10878.
CC   Registration: International Depositary Authority, In Vitro International Inc., USA; IVI-10256.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: UniProtKB; C6C2D6; Borreliella burgdorferi (strain N40) outer surface protein A (ospA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 27-11-25; Version: 5
//
ID   Vin Dor
AC   CVCL_U681
DR   ATCC; CRL-1097
DR   Wikidata; Q54993176
CC   Discontinued: ATCC; CRL-1097; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   VIP-VIIIC8
AC   CVCL_2236
DR   CLO; CLO_0009534
DR   DSMZ; ACC-479
DR   DSMZCellDive; ACC-479
DR   Wikidata; Q54993178
CC   Doubling time: ~40-50 hours (DSMZ=ACC-479).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06729; Human CD2.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   VIP1
AC   CVCL_B7K9
DR   Wikidata; Q112930543
RX   PubMed=20197681;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:7067; CIITA; Simple; p.Glu381Ter (c.1141G>T) (G1256T); ClinVar=VCV000009541; Zygosity=Homozygous (PubMed=20197681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   VIP2
AC   CVCL_B7KA
DR   Wikidata; Q112930544
RX   PubMed=20197681;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=20197681).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   VIPA
AC   CVCL_5177
DR   BTO; BTO_0003111
DR   SKY/M-FISH/CGH; 2649
DR   Wikidata; Q54993181
RX   PubMed=12659655;
CC   Population: Mexican.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   VIPI
AC   CVCL_A1YR
DR   Wikidata; Q105511706
RX   PubMed=24443327;
CC   Group: Cancer stem cell line.
CC   Doubling time: 18 hours (PubMed=24443327).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   VJ-300
AC   CVCL_X217
SY   KB/VJ300
DR   ChEMBL-Cells; CHEMBL4513114
DR   ChEMBL-Targets; CHEMBL4513128
DR   PubChem_Cell_line; CVCL_X217
DR   Wikidata; Q54993183
RX   PubMed=2568984;
RX   PubMed=2906349;
CC   Problematic cell line: Contaminated. Parent cell line (KB) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_28445; Vincristine (VCR).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0372 ! KB
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 17
//
ID   VK [Human B-cell IHW]
AC   CVCL_JC31
SY   TER353; TER-353; Ter 353; TER464; TER-464; Ter 464
DR   IPD-IMGT/HLA; 11527
DR   Wikidata; Q54993185
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/362cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DPB1*04:01,17:01; DQA1*02:01,03:03; DQB1*02:02,03:01; DRB1*04:14,07:01; DRB4*01:01,01:03 (IPD-IMGT/HLA=11527).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   VK [Human embryonal rhabdomyosarcoma]
AC   CVCL_Y578
SY   Urumov-1
DR   Wikidata; Q54993188
RX   PubMed=1322234;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Doubling time: 38 hours (PubMed=1322234).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 8
//
ID   Vk12598.VITRO
AC   CVCL_D5FT
DR   GEO; GSM8066997
DR   GEO; GSM8077880
DR   GEO; GSM8077896
DR   Wikidata; Q127384639
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x Aicdatm1Hon+/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   87W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk12653.VITRO
AC   CVCL_D5FU
DR   GEO; GSM8066998
DR   GEO; GSM8077897
DR   Wikidata; Q127384641
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x Aicdatm1Hon+/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   116W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk14750.VITRO
AC   CVCL_D5FV
DR   GEO; GSM8067001
DR   GEO; GSM8077884
DR   GEO; GSM8077898
DR   GEO; GSM8077947
DR   Wikidata; Q127384643
RX   PubMed=37546905;
CC   Characteristics: Produces IgG3 kappa (PubMed=37546905).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYC,MYC11.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   98W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   VK2/E6E7
AC   CVCL_6471
SY   Vk2/E6E7; VK-2/E6E7; VK2 (E6/E7); VK2
DR   BTO; BTO_0005683
DR   CLO; CLO_0009535
DR   ATCC; CRL-2616
DR   BioSample; SAMN03471675
DR   Wikidata; Q54993191
RX   PubMed=9314589;
CC   Doubling time: ~24 hours (ATCC=CRL-2616).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Vagina, mucosa; UBERON=UBERON_0004983.
CC   Cell type: Epithelial cell; CL=CL_0000066.
ST   Source(s): ATCC=CRL-2616
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 9
ST   D18S51: 17,19
ST   D19S433: 11,12
ST   D21S11: 29,31.2
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 19,25
ST   Penta D: 9,12
ST   Penta E: 7,8
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   VK219
AC   CVCL_WL55
SY   VK.219; Vero-rKSHV.219
DR   Wikidata; Q98134520
RX   PubMed=15246263;
CC   Group: Non-human primate cell line.
CC   Characteristics: rKSHV.219 includes a RFP-GFP-PuroR construct that contains RFP under the control of the lytic PAN RNA promoter, GFP under the control of human EF1a promoter and PuroR expressed by the RSV promoter.
CC   Virology: Infected with a recombinant human herpesvirus 8 (HHV-8/KSHV) rKSHV.219.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   Vk31080.VITRO
AC   CVCL_D5FW
DR   GEO; GSM8067013
DR   GEO; GSM8077901
DR   Wikidata; Q127384645
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Genetic integration: Method=Transgenic mouse; Gene=MGI; MGI:1352467; Esr1 (Note=Ligand binding domain; with p.Gly525Arg. Fused to Cre = CreERT2).
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P06956; Escherichia phage P1 cre (Note=Fused to ligand domain of mouse Esr1 = CreERT2).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL11 x R26-CreERT2.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   74W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk31159.VITRO
AC   CVCL_D5FX
DR   GEO; GSM8067015
DR   GEO; GSM8077902
DR   Wikidata; Q127384646
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYC,MYC11.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   119W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk32245.VITRO
AC   CVCL_D5FY
DR   GEO; GSM8067020
DR   GEO; GSM8067021
DR   GEO; GSM8077893
DR   GEO; GSM8077894
DR   GEO; GSM8077971
DR   GEO; GSM8077972
DR   Wikidata; Q127384648
RX   PubMed=37546905;
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL10.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   94W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk33059.VITRO
AC   CVCL_D5FZ
DR   GEO; GSM8067029
DR   Wikidata; Q127384649
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2c kappa (PubMed=37546905).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x Nsd2tm1Plbe-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   85W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk34286.VITRO
AC   CVCL_D5G0
DR   GEO; GSM8067040
DR   GEO; GSM8077915
DR   Wikidata; Q127384651
RX   PubMed=37546905;
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL11 x TRE-Omomyc x Actin-rtTA.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   66W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk35707.VITRO
AC   CVCL_D5G1
DR   GEO; GSM8067054
DR   GEO; GSM8077917
DR   Wikidata; Q127384653
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   65W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk36485.VITRO
AC   CVCL_E7EN
CC   Characteristics: Produces IgG1 kappa (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Bergsagel, Peter Leif.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   49W
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   Vk37296.VITRO
AC   CVCL_D5G2
DR   GEO; GSM8067065
DR   GEO; GSM8067066
DR   GEO; GSM8067067
DR   GEO; GSM8067068
DR   GEO; GSM8077924
DR   GEO; GSM8077925
DR   Wikidata; Q127384655
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   70W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk37553.VITRO
AC   CVCL_D5G3
DR   GEO; GSM8067070
DR   GEO; GSM8077926
DR   Wikidata; Q127384656
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x CRBN123 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   81W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk37783.VITRO
AC   CVCL_D5G4
DR   GEO; GSM8067071
DR   GEO; GSM8077928
DR   GEO; GSM8077929
DR   Wikidata; Q127384657
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYC,MYC11 x TRE-Omomyc x Actin-rtTA.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   83W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38150.VITRO
AC   CVCL_D5G5
DR   GEO; GSM8067072
DR   GEO; GSM8077930
DR   Wikidata; Q127384658
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   84W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38290.VITRO
AC   CVCL_D5G6
DR   GEO; GSM8067074
DR   GEO; GSM8067075
DR   GEO; GSM8077931
DR   Wikidata; Q127384659
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   61W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38291.VITRO
AC   CVCL_D5G7
DR   GEO; GSM8067077
DR   GEO; GSM8077932
DR   Wikidata; Q127384661
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   94W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38525.VITRO
AC   CVCL_D5G8
DR   GEO; GSM8067079
DR   GEO; GSM8077933
DR   Wikidata; Q127384663
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   68W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38862.VITRO
AC   CVCL_D5G9
DR   GEO; GSM8067081
DR   GEO; GSM8077934
DR   Wikidata; Q127384665
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   86W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38951.VITRO
AC   CVCL_D5GA
DR   GEO; GSM8067084
DR   Wikidata; Q127384667
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   81W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk38975.VITRO
AC   CVCL_D5GB
DR   GEO; GSM8067086
DR   GEO; GSM8067087
DR   GEO; GSM8067088
DR   GEO; GSM8077935
DR   Wikidata; Q127384669
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: A transplantable tumor also exists that originate from the same mouse.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   80W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk39227.VITRO
AC   CVCL_D5GC
DR   GEO; GSM8067089
DR   GEO; GSM8077936
DR   Wikidata; Q127384671
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   74W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk39337.VITRO
AC   CVCL_D5GD
DR   GEO; GSM8067091
DR   GEO; GSM8077937
DR   Wikidata; Q127384672
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   91W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk39687.VITRO
AC   CVCL_D5GE
DR   GEO; GSM8067092
DR   GEO; GSM8067093
DR   Wikidata; Q127384673
RX   PubMed=37546905;
CC   Characteristics: Produces IgG2b kappa (PubMed=37546905).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   90W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk39885.VITRO
AC   CVCL_D5GF
DR   GEO; GSM8067094
DR   GEO; GSM8067095
DR   GEO; GSM8077938
DR   Wikidata; Q127384674
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*MYCDLoxP,MDL4 x CRBN343 x Crbntm1.2Jjh-/-.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   62W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk40173.VITRO
AC   CVCL_D5GG
DR   GEO; GSM8067096
DR   Wikidata; Q127384675
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   73W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   Vk40264.VITRO
AC   CVCL_D5GH
DR   GEO; GSM8067097
DR   Wikidata; Q127384677
RX   PubMed=37546905;
CC   Characteristics: Produces IgA kappa (PubMed=37546905).
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C57BL/6 Vk*E28MYC,MYC24.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   89W
CA   Cancer cell line
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   VL-001
AC   CVCL_C3MC
DR   Wikidata; Q116050766
RX   Patent=WO2022178441A1;
CC   Group: Patented cell line.
CC   Doubling time: 19.1-23.7 hours (Patent=WO2022178441A1).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9913; ! Bos taurus (Bovine)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   VL-68
AC   CVCL_B480
DR   Cosmic; 1429647
DR   Wikidata; Q54993193
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   VL3-3L2
AC   CVCL_XF86
DR   Wikidata; Q98134522
RX   PubMed=7730608;
CC   Transformant: NCBI_TaxID; 11787; Radiation murine leukemia virus.
CC   Breed/subspecies: C57BL/6Ka.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XF85 ! BL/VL3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 4
//
ID   VL3-3M2
AC   CVCL_XF87
SY   VL3.3M2
DR   GEO; GSM3184378
DR   GEO; GSM3184379
DR   GEO; GSM3184380
DR   Wikidata; Q98134524
RX   PubMed=7730608;
RX   PubMed=30428344;
CC   Transformant: NCBI_TaxID; 11787; Radiation murine leukemia virus.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K9me2.
CC   Breed/subspecies: C57BL/6Ka.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_XF85 ! BL/VL3
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 5
//
ID   VL51
AC   CVCL_3169
SY   SLVL; VL-51
DR   CLO; CLO_0050869
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472064
DR   cancercelllines; CVCL_3169
DR   Cell_Model_Passport; SIDM00374
DR   Cosmic-CLP; 1331032
DR   DepMap; ACH-002062
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10424-106D1
DR   GDSC; 1331032
DR   GEO; GSM827255
DR   GEO; GSM866167
DR   GEO; GSM1035345
DR   GEO; GSM1035346
DR   GEO; GSM1670458
DR   JCRB; JCRB0159
DR   JCRB; NIHS0247
DR   LINCS_LDP; LCL-1952
DR   PharmacoDB; SLVL_1427_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_3169
DR   RCB; RCB1702
DR   Wikidata; Q54993196
RX   PubMed=8551798;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 70-80 hours (PubMed=8551798); ~28 hours (Note=Lot 11252016) (JCRB=JCRB0159).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.61%; Native American=0.13%; East Asian, North=76.13%; East Asian, South=22.43%; South Asian=0.59%; European, North=0%; European, South=0.1% (PubMed=30894373).
CC   Discontinued: JCRB; NIHS0247; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Cosmic-CLP=1331032; JCRB=JCRB0159; RCB=RCB1702
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,10
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4663; Splenic marginal zone lymphoma
DI   ORDO; Orphanet_86854; Splenic marginal zone lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   VLL1
AC   CVCL_UE05
SY   VLL 1
DR   Wikidata; Q98134526
RX   PubMed=3013426;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Adult
CA   Transformed cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 4
//
ID   VLM
AC   CVCL_2237
SY   SV40-VLM
DR   CLO; CLO_0009539
DR   DSMZ; ACC-429
DR   DSMZCellDive; ACC-429
DR   Wikidata; Q54993198
RX   PubMed=4348218;
CC   Doubling time: ~25 hours (DSMZ=ACC-429).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   VLN1F9
AC   CVCL_Z072
DR   ATCC; HB-8635
DR   Wikidata; Q54993200
RX   Patent=US4761377;
RX   PubMed=3621203;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8635.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   VLN1H12
AC   CVCL_D3UD
DR   Wikidata; Q127384679
RX   PubMed=3721525;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human 68 kDa antigen on cell surface of A-431.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   VLN2D3
AC   CVCL_D3UE
DR   Wikidata; Q127384680
RX   Patent=US4761377;
RX   PubMed=3621203;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   VLN3F10
AC   CVCL_Z073
DR   ATCC; HB-8632
DR   Wikidata; Q54993202
RX   Patent=US4761377;
RX   PubMed=3621203;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8632.
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   VLN3G2
AC   CVCL_8009
DR   CLO; CLO_0009540
DR   ATCC; HB-8636
DR   BioSample; SAMN03471084
DR   Wikidata; Q54993204
RX   Patent=US4761377;
RX   PubMed=3621203;
RX   PubMed=3721525;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8636.
CC   Monoclonal antibody isotype: IgG1, kappa (PubMed=3621203); IgG4 (ATCC=HB-8636).
CC   Monoclonal antibody target: Human 68 kDa antigen on cell surface of A-431.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): ATCC=HB-8636
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,12,13
ST   D5S818: 11,12,13
ST   D7S820: 9,10,11,14
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   VLN5C7
AC   CVCL_Z074
DR   ATCC; HB-8634
DR   Wikidata; Q54993205
RX   Patent=US4761377;
RX   PubMed=3621203;
RX   PubMed=3721525;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8634.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 68 kDa antigen on cell surface of A-431.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 10-04-15; Last updated: 30-01-24; Version: 6
//
ID   VLN6H2
AC   CVCL_8010
DR   CLO; CLO_0009541
DR   ATCC; HB-8633
DR   Wikidata; Q54993207
RX   Patent=US4761377;
RX   PubMed=3621203;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8633.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 68 kDa antigen on cell surface of A-431.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
ID   VM-2
AC   CVCL_F808
DR   CLO; CLO_0009542
DR   ATCC; HB-8530
DR   Wikidata; Q54993209
RX   Patent=US4886745;
RX   PubMed=3840497;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8530.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P26006; Human ITGA3/CD49c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   VM-CUB-1
AC   CVCL_1786
SY   VM-CUB1; VMCUB-1; VMCUB1; VMCub1; VM Cub 1; VM-CUB-I
DR   CLO; CLO_0009545
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 443
DR   BioSample; SAMN03473580
DR   BioSample; SAMN10988492
DR   cancercelllines; CVCL_1786
DR   Cell_Model_Passport; SIDM00414
DR   ChEMBL-Cells; CHEMBL3308476
DR   ChEMBL-Targets; CHEMBL1075607
DR   Cosmic; 909780
DR   Cosmic; 925825
DR   Cosmic; 1016889
DR   Cosmic; 1046677
DR   Cosmic; 1285133
DR   Cosmic; 1285992
DR   Cosmic; 2037972
DR   Cosmic; 2050470
DR   Cosmic; 2057461
DR   Cosmic; 2212696
DR   Cosmic; 2444228
DR   Cosmic-CLP; 909780
DR   DepMap; ACH-000545
DR   DSMZ; ACC-400
DR   DSMZCellDive; ACC-400
DR   EGA; EGAS00001000978
DR   GDSC; 909780
DR   GEO; GSM136261
DR   GEO; GSM827147
DR   GEO; GSM887732
DR   GEO; GSM888827
DR   GEO; GSM1374985
DR   GEO; GSM1574550
DR   GEO; GSM1670572
DR   LiGeA; CCLE_744
DR   LINCS_LDP; LCL-1722
DR   PharmacoDB; VMCUB1_1654_2019
DR   Progenetix; CVCL_1786
DR   PubChem_Cell_line; CVCL_1786
DR   Wikidata; Q54993211
RX   PubMed=571047;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=11416159;
RX   PubMed=16885334;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=24018021;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=27397505;
RX   PubMed=29732388;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Population: Caucasian.
CC   Doubling time: ~30-45 hours (DSMZ=ACC-400).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680; PubMed=31068700).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=27270441).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.21%; Native American=0%; East Asian, North=3.22%; East Asian, South=0%; South Asian=0%; European, North=60.31%; European, South=35.26% (PubMed=30894373).
CC   Misspelling: VM-CB-1; Cosmic=1285992.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): Cosmic-CLP=909780; DSMZ=ACC-400; PubMed=11416159; PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 11 (DSMZ=ACC-400; PubMed=27270441)
ST   CSF1PO: 11,12 (Cosmic-CLP=909780)
ST   D13S317: 10 (DSMZ=ACC-400; PubMed=27270441)
ST   D13S317: 10,12 (Cosmic-CLP=909780)
ST   D16S539: 9,11,12 (Cosmic-CLP=909780)
ST   D16S539: 11,12 (DSMZ=ACC-400; PubMed=27270441)
ST   D18S51: 16,19,20 (PubMed=11416159)
ST   D18S51: 19 (DSMZ=ACC-400)
ST   D19S433: 14,15
ST   D21S11: 30 (DSMZ=ACC-400)
ST   D21S11: 31 (PubMed=11416159)
ST   D2S1338: 26
ST   D3S1358: 15,16
ST   D5S818: 10,11 (Cosmic-CLP=909780)
ST   D5S818: 11 (DSMZ=ACC-400; PubMed=27270441)
ST   D7S820: 8,11
ST   D8S1179: 11 (DSMZ=ACC-400)
ST   D8S1179: 12,13 (PubMed=11416159)
ST   FGA: 22,24 (PubMed=11416159)
ST   FGA: 24 (DSMZ=ACC-400)
ST   Penta D: 13
ST   Penta E: 7
ST   TH01: 6,9 (Cosmic-CLP=909780)
ST   TH01: 9 (DSMZ=ACC-400; PubMed=27270441)
ST   TH01: 9.3 (PubMed=11416159)
ST   TPOX: 8
ST   vWA: 16 (PubMed=11416159)
ST   vWA: 18,19 (Cosmic-CLP=909780; DSMZ=ACC-400; PubMed=27270441)
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   VM-CUB-2
AC   CVCL_9829
SY   VM-CUB2; VMCUB-2; VMCUB2; VMCub2; VM Cub 2; VM-CUB-II; VMCUBII
DR   Cosmic; 715728
DR   Cosmic; 760477
DR   Cosmic; 845569
DR   Cosmic; 1046678
DR   Cosmic; 1285134
DR   Cosmic; 1285993
DR   Cosmic; 2050471
DR   Cosmic; 2057462
DR   Cosmic; 2444233
DR   Cosmic; 2686119
DR   Cosmic; 2702367
DR   GEO; GSM136262
DR   GEO; GSM1574583
DR   Wikidata; Q54993213
RX   PubMed=327080;
RX   PubMed=571047;
RX   PubMed=3518877;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=6582512;
RX   PubMed=11921286;
RX   PubMed=15846775;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=29732388;
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Obturator lymph node; UBERON=UBERON_0035171.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   VM-CUB-3
AC   CVCL_9830
SY   VM-CUB3; VMCUB-3; VMCUB3; VMCub3; VM Cub 3; VM-CUB-III; VMCUBIII; CUB III; CUBIII
DR   ATCC; HTB-6
DR   BioSample; SAMN03152040
DR   cancercelllines; CVCL_9830
DR   Cosmic; 925826
DR   Cosmic; 1016888
DR   Cosmic; 1046679
DR   Cosmic; 1285135
DR   Cosmic; 1285994
DR   Cosmic; 1938425
DR   Cosmic; 2050472
DR   Cosmic; 2057463
DR   Cosmic; 2212697
DR   Cosmic; 2444225
DR   GEO; GSM136263
DR   GEO; GSM1574580
DR   IARC_TP53; 6611
DR   Wikidata; Q54993215
RX   PubMed=571047;
RX   PubMed=3518877;
RX   PubMed=3708594;
RX   PubMed=6220172;
RX   PubMed=6244232;
RX   PubMed=7459858;
RX   PubMed=15846775;
RX   PubMed=16885334;
RX   PubMed=20143388;
RX   PubMed=24035680;
RX   PubMed=24367658;
RX   PubMed=25997541;
RX   PubMed=26621286;
RX   PubMed=27270441;
RX   PubMed=29732388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Info; Synapse; Bladder Cancer exome; https://www.synapse.org/Synapse:syn4970200
CC   Problematic cell line: Partially contaminated. Some stocks are contaminated by VM-CUB-1 (PubMed=3708594; PubMed=20143388). Although PubMed=26621286 shows it to be different from VM-CUB-1.
CC   Part of: BLA-40 bladder carcinoma cell line panel.
CC   Part of: UBC-40 urothelial bladder cancer cell line index.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00102.
CC   Doubling time: 26 hours (PubMed=3708594).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (PubMed=24035680).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Leu (c.833C>T); ClinVar=VCV000232497; Zygosity=Homozygous (PubMed=27270441).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ATCC; HTB-6; true.
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
ST   Source(s): PubMed=27270441
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,9
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 33
//
ID   VM-M2/Fluc
AC   CVCL_0P41
SY   VM-M2
DR   Kerafast; EBC001
DR   Wikidata; Q54993217
RX   PubMed=18398829;
CC   Doubling time: 2 days (Kerafast=EBC001).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Kerafast; EBC001; true.
CC   Breed/subspecies: VM/Dk.
DI   NCIt; C24006; Mouse neural cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 12
//
ID   VM-M3/Fluc
AC   CVCL_0P42
SY   VM-M3
DR   ABM; T8016
DR   Kerafast; EBC002
DR   Wikidata; Q54993219
RX   PubMed=18398829;
CC   Doubling time: 2 days (Kerafast=EBC002).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Kerafast; EBC002; true.
CC   Breed/subspecies: VM/Dk.
DI   NCIt; C24006; Mouse neural cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   VM-NM1/Fluc
AC   CVCL_0P43
SY   VM-NM1
DR   ABM; T8018
DR   Kerafast; EBC003
DR   Wikidata; Q54993221
RX   PubMed=18398829;
CC   Doubling time: 2-5 days (Kerafast=EBC003).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Discontinued: Kerafast; EBC003; true.
CC   Breed/subspecies: VM/Dk.
DI   NCIt; C24006; Mouse neural cell neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 13
//
ID   VM7Luc4E2
AC   CVCL_6571
SY   BG1Luc4E2; BG-1Luc4E2; BG1Luc4E(2); BG1-ER
DR   Wikidata; Q54796232
RX   DOI=10.1787/9789264185395-en;
RX   PubMed=10900408;
RX   PubMed=26139245;
WW   Info; EURL ECVAM-TSAR; TM2016-09; https://tsar.jrc.ec.europa.eu/test-method/tm2016-09
WW   Provider; Alion; -; https://web.archive.org/web/20120303122316/http://www.alionscience.com/Services/Energy-and-Environmental-Sciences/Environmental-Science/Bioassay-Solutions/Endocrine-Disruptor-Testing
CC   Problematic cell line: Contaminated. Shown to be a MCF-7 derivative (EURL ECVAM-TSAR=TM2016-09). Originally thought to be a BG1 (Cellosaurus=CVCL_6570) derivative.
CC   Population: Caucasian.
CC   Biotechnology: Cell line developed for VM7Luc ER TA (VM7Luc Estrogen Receptor TransActivation) bioassay which was formerly known as BG1Luc ER TA (BG1Luc Estrogen Receptor TransActivation).
CC   Biotechnology: Used in the Organisation for Economic Co-operation and Development (OECD) detection of estrogenic/antiestrogenic chemicals test method 457 (DOI=10.1787/9789264185395-en).
CC   Characteristics: Emits measurable light in response to estrogen and estrogen-like substances. Used for identifying estrogen receptor agonists and antagonists.
CC   Characteristics: Acts through the activation of a luciferase reporter gene under the control of estrogen response elements (EREs) upstream of the mouse mammary tumor viral (MMTV) promoter.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 26
//
ID   VMCs
AC   CVCL_A7NY
DR   Wikidata; Q107117402
RX   PubMed=8228520;
CC   Doubling time: ~15 hours (PubMed=8228520).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Bone, calvaria; UBERON=UBERON_0004339.
CC   Cell type: Osteoblast; CL=CL_0000062.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
AG   5D
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   VMM1
AC   CVCL_A732
DR   ATCC; CRL-3225
DR   GEO; GSM1572805
DR   GEO; GSM1572806
DR   GEO; GSM1572807
DR   GEO; GSM1572808
DR   GEO; GSM1572809
DR   GEO; GSM1572810
DR   Wikidata; Q54993224
RX   PubMed=7681084;
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=20856146;
RX   PubMed=21654344;
CC   Population: Caucasian.
CC   HLA typing: A*03,26; B*51 (PubMed=10752474).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): ATCC=CRL-3225
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 9,11
ST   D16S539: 10
ST   D5S818: 9
ST   D7S820: 9,12
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 17
//
ID   VMM1040
AC   CVCL_A733
DR   Wikidata; Q54993226
RX   PubMed=20856146;
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   VMM105
AC   CVCL_ZV81
DR   Wikidata; Q98134527
RX   PubMed=14871852;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM12
AC   CVCL_A734
DR   cancercelllines; CVCL_A734
DR   Cosmic; 890887
DR   GEO; GSM1672073
DR   GEO; GSM1672085
DR   GEO; GSM1672092
DR   GEO; GSM1672110
DR   GEO; GSM1672120
DR   GEO; GSM1672134
DR   Wikidata; Q54993228
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=15378283;
RX   PubMed=20856146;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   HLA typing: A*01,03; B*07,14 (PubMed=10752474).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F863 ! VMM12-EBV
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   VMM12-EBV
AC   CVCL_F863
DR   Wikidata; Q54993230
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A734 ! VMM12
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   VMM13
AC   CVCL_ZV79
DR   Wikidata; Q98134531
RX   PubMed=10752474;
CC   HLA typing: A*01,02; B*53 (PubMed=10752474).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM14
AC   CVCL_A735
DR   Wikidata; Q54993231
RX   PubMed=20856146;
RX   PubMed=21654344;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   VMM15
AC   CVCL_A736
DR   ATCC; CRL-3227
DR   cancercelllines; CVCL_A736
DR   GEO; GSM1672070
DR   GEO; GSM1672077
DR   GEO; GSM1672090
DR   GEO; GSM1672106
DR   GEO; GSM1672122
DR   GEO; GSM1672127
DR   Wikidata; Q54993234
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=20856146;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   Population: Caucasian.
CC   HLA typing: A*01,25; B*08,18 (PubMed=10752474).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3227
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 9,15
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   VMM150
AC   CVCL_S583
DR   Wikidata; Q54993236
RX   PubMed=14871852;
RX   PubMed=15378283;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   VMM17
AC   CVCL_S581
DR   ATCC; CRL-3228
DR   cancercelllines; CVCL_S581
DR   GEO; GSM1672065
DR   GEO; GSM1672082
DR   GEO; GSM1672095
DR   GEO; GSM1672105
DR   GEO; GSM1672118
DR   GEO; GSM1672132
DR   Wikidata; Q54993263
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   Population: Caucasian.
CC   HLA typing: A*0201,33; B*45,55/66 (PubMed=10752474).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3228
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 16
//
ID   VMM18
AC   CVCL_A737
SY   VMM-18
DR   ATCC; CRL-3229
DR   cancercelllines; CVCL_A737
DR   GEO; GSM1671995
DR   GEO; GSM1672013
DR   GEO; GSM1672046
DR   GEO; GSM1672074
DR   GEO; GSM1672084
DR   GEO; GSM1672096
DR   GEO; GSM1672103
DR   GEO; GSM1672116
DR   GEO; GSM1672124
DR   Wikidata; Q54993264
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=15378283;
RX   PubMed=20856146;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   Population: Caucasian.
CC   HLA typing: A*03,31/33; B*60 (PubMed=10752474).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3229
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 9
ST   TH01: 6,9.3
ST   TPOX: 8,10
ST   vWA: 15,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F862 ! VMM18-EBV
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   VMM18-EBV
AC   CVCL_F862
DR   Wikidata; Q54993265
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A737 ! VMM18
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 9
//
ID   VMM19
AC   CVCL_A738
DR   Wikidata; Q54993266
RX   PubMed=14871852;
RX   PubMed=15378283;
RX   PubMed=20856146;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   VMM273
AC   CVCL_ZV82
DR   Wikidata; Q98134532
RX   PubMed=14871852;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM330
AC   CVCL_ZV83
DR   Wikidata; Q98134534
RX   PubMed=14871852;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM34
AC   CVCL_ZV84
DR   Wikidata; Q98134536
RX   PubMed=14871852;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM39
AC   CVCL_A739
DR   BTO; BTO_0005447
DR   ATCC; CRL-3230
DR   ChEMBL-Cells; CHEMBL4483141
DR   ChEMBL-Targets; CHEMBL4483275
DR   Cosmic; 890888
DR   Cosmic; 1054848
DR   Cosmic; 1507601
DR   Cosmic; 2233683
DR   GEO; GSM1572823
DR   GEO; GSM1572824
DR   GEO; GSM1572825
DR   GEO; GSM1572826
DR   GEO; GSM1572827
DR   GEO; GSM1572828
DR   GEO; GSM1671975
DR   GEO; GSM1672000
DR   GEO; GSM1672042
DR   GEO; GSM1672069
DR   GEO; GSM1672087
DR   GEO; GSM1672091
DR   GEO; GSM1672111
DR   GEO; GSM1672121
DR   GEO; GSM1672128
DR   PubChem_Cell_line; CVCL_A739
DR   Wikidata; Q54993268
RX   PubMed=14871852;
RX   PubMed=17308088;
RX   PubMed=20856146;
RX   PubMed=21654344;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3230
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 7,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   VMM425
AC   CVCL_4D07
DR   ATCC; CRL-3231
DR   Wikidata; Q54993269
RX   PubMed=21654344;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Pelvis, hypodermis; UBERON=UBERON_0002355+UBERON_0002072.
ST   Source(s): ATCC=CRL-3231
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8,9.3
ST   TPOX: 8,12
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 8
//
ID   VMM5A
AC   CVCL_A740
SY   VMM-5A; VMM5
DR   ATCC; CRL-3226
DR   cancercelllines; CVCL_A740
DR   Cosmic; 890886
DR   GEO; GSM1672036
DR   GEO; GSM1672041
DR   GEO; GSM1672053
DR   GEO; GSM1672068
DR   GEO; GSM1672080
DR   GEO; GSM1672099
DR   GEO; GSM1672107
DR   GEO; GSM1672112
DR   GEO; GSM1672125
DR   Wikidata; Q54993271
RX   PubMed=7681084;
RX   PubMed=10752474;
RX   PubMed=14871852;
RX   PubMed=15905528;
RX   PubMed=20856146;
RX   PubMed=21654344;
RX   PubMed=26405815;
RX   PubMed=26673621;
CC   Population: Caucasian.
CC   HLA typing: A*02:01; B*39 (PubMed=10752474).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26405815).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173His (c.518G>A); ClinVar=VCV000376032; Zygosity=Unspecified (ATCC=CRL-3226).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ATCC=CRL-3226
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12
ST   D5S818: 9
ST   D7S820: 9,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S584 ! VMM5B
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   VMM5B
AC   CVCL_S584
SY   VMM-5B
DR   Wikidata; Q54993272
RX   PubMed=15905528;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A740 ! VMM5A
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 8
//
ID   VMM6
AC   CVCL_ZV80
DR   Wikidata; Q98134538
RX   PubMed=10752474;
CC   HLA typing: A*0201,33; B*14,44 (PubMed=10752474).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM609
AC   CVCL_4D08
DR   Wikidata; Q54993273
RX   PubMed=21654344;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 10-09-24; Version: 7
//
ID   VMM64
AC   CVCL_ZV85
DR   Wikidata; Q98134540
RX   PubMed=14871852;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   VMM86
AC   CVCL_S582
DR   Wikidata; Q54993274
RX   PubMed=14871852;
RX   PubMed=15378283;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 7
//
ID   VMM917
AC   CVCL_4D09
DR   ATCC; CRL-3232
DR   Wikidata; Q54993275
RX   PubMed=21654344;
CC   Population: Caucasian.
CC   Derived from site: Metastatic; Right posterior thigh adjacent to buttocks, hypodermis; UBERON=UBERON_0036014+UBERON_0002072.
ST   Source(s): ATCC=CRL-3232
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,10
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 02-05-24; Version: 9
//
ID   VMR-0
AC   CVCL_F849
SY   VMR-O
DR   Wikidata; Q54993276
RX   CelloPub=CLPUB00133;
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   VMR-100-Liv
AC   CVCL_F850
SY   VMR-Liv; VMR-liv; VMRLiv
DR   Wikidata; Q54993278
RX   CelloPub=CLPUB00133;
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F849 ! VMR-0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   VMR-100-Ov
AC   CVCL_F851
SY   VMR-Ov
DR   Wikidata; Q54993280
RX   CelloPub=CLPUB00133;
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F849 ! VMR-0
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 6
//
ID   VMRC-LCD
AC   CVCL_1787
SY   VMRCLCD; LCD; Virginia Mason Research Center-Lung Cancer D
DR   EFO; EFO_0006773
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1042
DR   BioSample; SAMN03471805
DR   BioSample; SAMN10988043
DR   cancercelllines; CVCL_1787
DR   Cell_Model_Passport; SIDM00320
DR   CGH-DB; 210-1
DR   CGH-DB; 9168-4
DR   Cosmic; 713869
DR   Cosmic; 801581
DR   Cosmic; 876140
DR   Cosmic; 889100
DR   Cosmic; 917975
DR   Cosmic; 929163
DR   Cosmic; 932928
DR   Cosmic; 1066174
DR   Cosmic; 1089220
DR   Cosmic; 1154600
DR   Cosmic; 1239900
DR   Cosmic; 1571730
DR   Cosmic; 2668322
DR   Cosmic-CLP; 713869
DR   DepMap; ACH-001233
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 713869
DR   GEO; GSM274669
DR   GEO; GSM784287
DR   GEO; GSM827592
DR   GEO; GSM1670573
DR   IARC_TP53; 11874
DR   JCRB; JCRB0814
DR   PharmacoDB; VMRCLCD_1655_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1787
DR   Wikidata; Q54993281
RX   PubMed=4005855;
RX   PubMed=9290701;
RX   PubMed=10536175;
RX   PubMed=11005564;
RX   PubMed=11416159;
RX   PubMed=12569360;
RX   PubMed=12794755;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=19472407;
RX   PubMed=20215515;
RX   PubMed=20557307;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
CC   Population: Caucasian.
CC   Doubling time: ~51 hours (Note=Lot 01182010) (JCRB=JCRB0814).
CC   HLA typing: A*02:01,02:01; B*07:02,44:02; C*05:01,07:02; DQB1*06:02,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Homozygous (PubMed=10536175; PubMed=12794755; PubMed=20557307; Cosmic-CLP=713869; DepMap=ACH-001233).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.98%; Native American=0%; East Asian, North=3.69%; East Asian, South=0%; South Asian=0%; European, North=56.21%; European, South=39.12% (PubMed=30894373).
CC   Misspelling: RERF-LCD; PubMed=11005564.
CC   Misspelling: VMR-LCD; Cosmic=889100.
CC   Misspelling: VRMC-LCD; Cosmic=1571730.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): Cosmic-CLP=713869; JCRB=JCRB0814; PubMed=11416159; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 15,16
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   VMRC-LCF
AC   CVCL_S848
SY   Virginia Mason Research Center-Lung Cancer F
DR   Wikidata; Q54993282
RX   PubMed=4005855;
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 6
//
ID   VMRC-LCP
AC   CVCL_1788
SY   VMRCLCP; Patton; Virginia Mason Research Center-Lung Cancer P
DR   CLO; CLO_0037045
DR   BioSample; SAMN03470791
DR   BioSample; SAMN10987738
DR   cancercelllines; CVCL_1788
DR   Cell_Model_Passport; SIDM01904
DR   CGH-DB; 193-1
DR   CGH-DB; 9177-4
DR   ChEMBL-Cells; CHEMBL3308808
DR   ChEMBL-Targets; CHEMBL1075608
DR   Cosmic; 889101
DR   Cosmic; 930300
DR   Cosmic; 1066175
DR   DepMap; ACH-001234
DR   GEO; GSM827200
DR   GEO; GSM1374986
DR   IARC_TP53; 28370
DR   JCRB; JCRB0103
DR   LINCS_LDP; LCL-1594
DR   PharmacoDB; VMRCLCP_1656_2019
DR   Progenetix; CVCL_1788
DR   PubChem_Cell_line; CVCL_1788
DR   Wikidata; Q54993283
RX   PubMed=4005855;
RX   PubMed=9290701;
RX   PubMed=14581340;
RX   PubMed=15185009;
RX   PubMed=15746151;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=24002593;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
CC   Population: Caucasian.
CC   Doubling time: 93 hours (Note=Lot 082994), ~79 hours (Note=Lot 11132014) (JCRB=JCRB0103).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val157Phe (c.469G>T); ClinVar=VCV000012353; Zygosity=Homozygous (DepMap=ACH-001234).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.95%; Native American=0%; East Asian, North=1.52%; East Asian, South=0%; South Asian=0.62%; European, North=62.75%; European, South=34.15% (PubMed=30894373).
CC   Misspelling: VMR-LCP; Cosmic=889101.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
ST   Source(s): JCRB=JCRB0103
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D16S539: 12
ST   D5S818: 13
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   VMRC-LCR
AC   CVCL_RQ27
SY   Virginia Mason Research Center-Lung Cancer R
DR   Wikidata; Q54993284
RX   PubMed=4005855;
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-09-24; Version: 4
//
ID   VMRC-MELG
AC   CVCL_1789
SY   VMRCMELG; Leggee; Virginia Mason Research Center-Melanoma G
DR   CLO; CLO_0037136
DR   ArrayExpress; E-MTAB-783
DR   BioSample; SAMN03471062
DR   cancercelllines; CVCL_1789
DR   Cell_Model_Passport; SIDM00319
DR   ChEMBL-Cells; CHEMBL3308809
DR   ChEMBL-Targets; CHEMBL1075609
DR   Cosmic; 930301
DR   Cosmic-CLP; 930301
DR   DepMap; ACH-001704
DR   GDSC; 930301
DR   IARC_TP53; 27587
DR   JCRB; JCRB0074
DR   LINCS_LDP; LCL-1258
DR   PharmacoDB; VMRCMELG_1657_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1789
DR   Wikidata; Q54993286
RX   PubMed=20164919;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
CC   Population: Caucasian.
CC   Doubling time: 60-80 hours (Note=Lot 06232008) (JCRB=JCRB0074).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Cosmic-CLP=930301; DepMap=ACH-001704).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; c.151-1G>A; ClinVar=VCV000635365; Zygosity=Homozygous; Note=Splice acceptor mutation (Cosmic-CLP=930301; DepMap=ACH-001704).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=4.63%; Native American=0%; East Asian, North=0.15%; East Asian, South=2.24%; South Asian=0.66%; European, North=63.56%; European, South=28.76% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=930301; DepMap=ACH-001704; JCRB=JCRB0074
ST   Amelogenin: X (Cosmic-CLP=930301; DepMap=ACH-001704)
ST   Amelogenin: X,Y (JCRB=JCRB0074)
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 12
ST   D18S51: 15,18
ST   D21S11: 27,32.2
ST   D3S1358: 14,16
ST   D5S818: 10,13
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 19,23
ST   Penta D: 10,12
ST   Penta E: 5
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   VMRC-RCW
AC   CVCL_1790
SY   VMRCRCW; Thomas Wirts; Virginia Mason Research Center-Renal Cancer W
DR   BTO; BTO_0003714
DR   CLO; CLO_0050893
DR   EFO; EFO_0022457
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN03470901
DR   BioSample; SAMN03472513
DR   BioSample; SAMN10987862
DR   cancercelllines; CVCL_1790
DR   Cell_Model_Passport; SIDM00318
DR   Cosmic; 756014
DR   Cosmic; 849370
DR   Cosmic-CLP; 1240224
DR   DepMap; ACH-000484
DR   GDSC; 1240224
DR   GEO; GSM827232
DR   GEO; GSM887733
DR   GEO; GSM888828
DR   JCRB; JCRB0813
DR   LiGeA; CCLE_018
DR   LINCS_LDP; LCL-1759
DR   PharmacoDB; VMRCRCW_1658_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1790
DR   RCB; RCB1963
DR   TKG; TKG 0447
DR   Wikidata; Q54993288
RX   PubMed=9290701;
RX   PubMed=10929426;
RX   PubMed=11146448;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
CC   Population: Caucasian.
CC   Doubling time: ~60 hours (Note=Lot 102398), ~27 hours (Note=Lot 10052009), ~35 hours (Note=Lot 11082016) (JCRB=JCRB0813).
CC   HLA typing: A*02:01,33:03; B*07:02,18:01; C*04:01,07:06; DQA1*01:02,04:01; DQB1*02:02,02:02; DRB1*11:08,15:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.21%; Native American=0.43%; East Asian, North=1.64%; East Asian, South=0%; South Asian=1.16%; European, North=69.86%; European, South=24.69% (PubMed=30894373).
ST   Source(s): Cosmic-CLP=1240224; JCRB=JCRB0813; PubMed=25877200; RCB=RCB1963; TKG=TKG 0447
ST   Amelogenin: X,Y (JCRB=JCRB0813; RCB=RCB1963; TKG=TKG 0447)
ST   Amelogenin: Y (Cosmic-CLP=1240224; PubMed=25877200)
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D16S539: 11,15
ST   D18S51: 15,16
ST   D19S433: 13
ST   D21S11: 32.2,33.2
ST   D2S1338: 21,22
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 12
ST   FGA: 21,22
ST   Penta D: 9,11
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 32
//
ID   VMRC-RCZ
AC   CVCL_1791
AS   CVCL_X543
SY   VMRCRCZ; Virginia Mason Research Center-Renal Cancer Z
DR   BTO; BTO_0003715
DR   CLO; CLO_0009984
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472519
DR   BioSample; SAMN10988252
DR   cancercelllines; CVCL_1791
DR   Cell_Model_Passport; SIDM00317
DR   ChEMBL-Cells; CHEMBL3308810
DR   ChEMBL-Targets; CHEMBL1075610
DR   Cosmic; 849371
DR   Cosmic; 909781
DR   Cosmic-CLP; 909781
DR   DepMap; ACH-000171
DR   EGA; EGAS00001000978
DR   GDSC; 909781
DR   GEO; GSM827243
DR   GEO; GSM887734
DR   GEO; GSM888829
DR   GEO; GSM1670574
DR   IARC_TP53; 21269
DR   JCRB; JCRB0827
DR   LiGeA; CCLE_234
DR   LINCS_LDP; LCL-1760
DR   PharmacoDB; VMRCRCZ_1659_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1791
DR   PubChem_Cell_line; CVCL_1791
DR   Wikidata; Q54993289
RX   PubMed=7591954;
RX   PubMed=9290701;
RX   PubMed=11146448;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28489074;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   From: Bean, Michael A.; Virginia Mason Research Center; Seattle; USA.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,24:02; B*07:02,38:01; C*07:02,12:03; DQA1*02:01,05:02; DQB1*03:04,03:04; DRB1*11:77,13:10' (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp48Valfs*74 (c.143_146del4); Zygosity=Heterozygous (Cosmic-CLP=909781; DepMap=ACH-000171).
CC   Sequence variation: Mutation; HGNC; HGNC:12687; VHL; Simple; c.463+2T>C; ClinVar=VCV000569414; Zygosity=Heterozygous; Note=Splice donor mutation (Cosmic-CLP=909781; DepMap=ACH-000171).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.43%; Native American=0%; East Asian, North=2.06%; East Asian, South=0%; South Asian=1.38%; European, North=61.8%; European, South=34.32% (PubMed=30894373).
CC   Misspelling: VMRC-PCZ; Cosmic=849371; PubMed=11146448.
ST   Source(s): Cosmic-CLP=909781; JCRB=JCRB0827
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   Vn-324
AC   CVCL_VN84
DR   JCRB; JCRB1742
DR   Wikidata; Q98134542
RX   PubMed=6264127;
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
DI   NCIt; C134988; Hamster neoplasm
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 5
//
ID   Vn19
AC   CVCL_8538
SY   Vn1919
DR   JCRB; JCRB1361
DR   Wikidata; Q54993290
RX   PubMed=21073635;
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Vn19-15
AC   CVCL_8539
DR   Wikidata; Q54993291
RX   PubMed=21073635;
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8538 ! Vn19
SX   Sex unspecified
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Vn19-21
AC   CVCL_8540
DR   Wikidata; Q54993292
RX   PubMed=21073635;
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8538 ! Vn19
SX   Sex unspecified
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Vn19-4
AC   CVCL_8541
SY   Vn1919 cl4
DR   JCRB; JCRB1365
DR   Wikidata; Q54993294
RX   PubMed=21073635;
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8538 ! Vn19
SX   Sex unspecified
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   Vn19-49
AC   CVCL_8542
SY   Vn1919 cl49
DR   JCRB; JCRB1367
DR   Wikidata; Q54993295
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8538 ! Vn19
SX   Sex unspecified
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   Vn19-59
AC   CVCL_8543
SY   Vn1919 cl59
DR   JCRB; JCRB1368
DR   Wikidata; Q54993296
CC   Transformant: NCBI_TaxID; 1891762; BK polyomavirus (BKPyV).
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21951; Mouse ependymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8538 ! Vn19
SX   Sex unspecified
AG   1Y3M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   vNBS8-iPS-c1
AC   CVCL_9U58
DR   Wikidata; Q54993297
RX   PubMed=26987925;
CC   From: Max Planck Institute for Molecular Genetics; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (PubMed=26987925).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U59 ! vNBS8-iPS-c2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   vNBS8-iPS-c2
AC   CVCL_9U59
DR   Wikidata; Q54993298
RX   PubMed=26987925;
CC   From: Max Planck Institute for Molecular Genetics; Berlin; Germany.
CC   Sequence variation: Mutation; HGNC; HGNC:7652; NBN; Simple; p.Lys219Asnfs*16 (c.657_661delACAAA) (657del5); ClinVar=VCV000006940; Zygosity=Heterozygous (PubMed=26987925).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9U58 ! vNBS8-iPS-c1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   VOA1056
AC   CVCL_V536
SY   VOA1056_CL; VOA-1056; VOA 1056
DR   cancercelllines; CVCL_V536
DR   Wikidata; Q54993299
RX   DOI=10.14288/1.0319145;
RX   PubMed=24023729;
RX   PubMed=27822414;
RX   PubMed=28545687;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Phe384Leu (c.1150T>C) (F386L); ClinVar=VCV000134404; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Val722Ile (c.2164G>A); ClinVar=VCV000134573; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=27822414).
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 30,32.2
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 18,19
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ42 ! VOA3993
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   VOA1066
AC   CVCL_A1SF
DR   cancercelllines; CVCL_A1SF
DR   Millipore; SCC489
DR   Wikidata; Q105511708
RX   PubMed=33052929;
CC   Doubling time: ~35 hours (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Asp1503fs (c.4509_4510insATGACCT); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:11110; ARID1A; Simple; p.Gly2087Ter (c.6259G>T); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Trp1109Ter (c.3327G>A); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:18040; ARID1B; Simple; p.Ile1778fs (c.5334dupA); Zygosity=Unspecified (PubMed=33052929).
CC   Sequence variation: Mutation; HGNC; HGNC:17098; DICER1; Simple; p.Asp1810Tyr (c.5428G>T); ClinVar=VCV000933084; Zygosity=Heterozygous (PubMed=33052929).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Millipore=SCC489; PubMed=33052929
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 29,31.2
ST   D3S1358: 14,15
ST   D5S818: 11,15
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 23,24
ST   Penta D: 12
ST   Penta E: 7,10
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 16
DI   NCIt; C40156; Endometrial undifferentiated carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 10
//
ID   VOA1072
AC   CVCL_V537
SY   VOA1072_CL
DR   cancercelllines; CVCL_V537
DR   Wikidata; Q54993301
RX   PubMed=24023729;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (PubMed=24023729).
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 8
//
ID   VOA1312
AC   CVCL_V538
SY   VOA1312_CL; VOA-1312; VOA 1312
DR   cancercelllines; CVCL_V538
DR   Wikidata; Q54993302
RX   DOI=10.14288/1.0319145;
RX   PubMed=24023729;
RX   PubMed=27822414;
RX   PubMed=28545687;
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (PubMed=27822414).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D21S11: 29
ST   D5S818: 12
ST   D7S820: 8,11
ST   TH01: 7,9
ST   TPOX: 10,11
ST   vWA: 17,19
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   VOA1400
AC   CVCL_V539
SY   VOA1400_CL
DR   cancercelllines; CVCL_V539
DR   Wikidata; Q54993303
RX   PubMed=24023729;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu198Ter (c.592G>T); ClinVar=VCV000634704; Zygosity=Heterozygous (PubMed=24023729).
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 8
//
ID   VOA1416
AC   CVCL_V540
SY   VOA1416_CL
DR   Wikidata; Q54993304
RX   PubMed=24023729;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 5
//
ID   VOA3448
AC   CVCL_VQ40
SY   VOA-3448
DR   cancercelllines; CVCL_VQ40
DR   Wikidata; Q98134544
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ile391Met (c.1173A>G); ClinVar=VCV000135038; Zygosity=Heterozygous (PubMed=27822414).
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 9,10
ST   D16S539: 10,13
ST   D21S11: 28,29
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ41 ! VOA3723
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   VOA3723
AC   CVCL_VQ41
SY   VOA-3723
DR   cancercelllines; CVCL_VQ41
DR   Wikidata; Q98134547
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
CC   Sequence variation: Mutation; HGNC; HGNC:6307; KDR; Simple; p.Gln472His (c.1416A>T); ClinVar=VCV000134603; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ile391Met (c.1173A>G); ClinVar=VCV000135038; Zygosity=Heterozygous (PubMed=27822414).
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 9,10
ST   D16S539: 10,13
ST   D21S11: 28,29
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ40 ! VOA3448
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   VOA3993
AC   CVCL_VQ42
SY   VOA-3993
DR   cancercelllines; CVCL_VQ42
DR   Wikidata; Q98134549
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
CC   Sequence variation: Mutation; HGNC; HGNC:3690; FGFR3; Simple; p.Phe384Leu (c.1150T>C) (F386L); ClinVar=VCV000134404; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:6193; JAK3; Simple; p.Val722Ile (c.2164G>A); ClinVar=VCV000134573; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=27822414).
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D21S11: 30,32.2
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 18
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V536 ! VOA1056
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 7
//
ID   VOA4627
AC   CVCL_VQ38
SY   VOA-4627
DR   cancercelllines; CVCL_VQ38
DR   Wikidata; Q98134551
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
RX   PubMed=28545687;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Met541Leu (c.1621A>C); ClinVar=VCV000041599; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ile391Met (c.1173A>G); ClinVar=VCV000135038; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Heterozygous (PubMed=27822414).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 8,10
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 9,12
ST   vWA: 15,17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ43 ! VOA4698
OI   CVCL_VQ51 ! VOA4881
OI   CVCL_VQ39 ! VOA5646
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   VOA4698
AC   CVCL_VQ43
SY   VOA-4698
DR   cancercelllines; CVCL_VQ43
DR   Wikidata; Q98134554
RX   DOI=10.14288/1.0319145;
RX   PubMed=27822414;
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Met541Leu (c.1621A>C); ClinVar=VCV000041599; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Ile391Met (c.1173A>G); ClinVar=VCV000135038; Zygosity=Heterozygous (PubMed=27822414).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr234Cys (c.701A>G); ClinVar=VCV000127820; Zygosity=Heterozygous (PubMed=27822414).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=27822414
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 8,10
ST   D21S11: 30
ST   D5S818: 13
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 12
ST   vWA: 15,17
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ38 ! VOA4627
OI   CVCL_VQ51 ! VOA4881
OI   CVCL_VQ39 ! VOA5646
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 8
//
ID   VOA4881
AC   CVCL_VQ51
SY   VOA-4881
DR   Wikidata; Q98134555
RX   DOI=10.14288/1.0319145;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ38 ! VOA4627
OI   CVCL_VQ43 ! VOA4698
OI   CVCL_VQ39 ! VOA5646
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 29-06-23; Version: 4
//
ID   VOA5646
AC   CVCL_VQ39
SY   VOA-5646; VOA 5646
DR   Wikidata; Q98134557
RX   PubMed=28545687;
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VQ38 ! VOA4627
OI   CVCL_VQ43 ! VOA4698
OI   CVCL_VQ51 ! VOA4881
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   VOA6406
AC   CVCL_VQ52
SY   VOA-6406
DR   Wikidata; Q98134560
RX   DOI=10.14288/1.0319145;
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   VOA6800
AC   CVCL_VQ53
SY   VOA-6800
DR   Wikidata; Q98134562
RX   DOI=10.14288/1.0319145;
DI   NCIt; C105556; Low grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 4
//
ID   Vogel
AC   CVCL_L422
DR   GEO; GSM1974800
DR   Wikidata; Q54993305
RX   PubMed=21908323;
RX   PubMed=22916246;
RX   PubMed=27197945;
RX   PubMed=31175136;
CC   Part of: FACC canine tumor cell line panel.
CC   Doubling time: 35.9 hours (PubMed=22916246).
CC   Sequence variation: Mutation; VGNC; VGNC:38514; BRAF; Simple; p.Val588Glu (c.1763T>A); Zygosity=Heterozygous (PubMed=27197945; PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:43120; MED12; Simple; p.Leu1349fs (c.4041_4044dupTATT); Zygosity=Heterozygous (PubMed=31175136).
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Val162Leu (c.484G>T); Zygosity=Heterozygous (PubMed=31175136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=27197945; PubMed=31175136
ST   Dog FHC2010: 235,239
ST   Dog FHC2054: 156,172
ST   Dog FHC2079: 271,275
ST   Dog PEZ1: 115,119
ST   Dog PEZ3: 115,131
ST   Dog PEZ5: 103
ST   Dog PEZ6: 176,183
ST   Dog PEZ8: 228,232
ST   Dog PEZ12: 274
ST   Dog PEZ20: 176
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 17
//
ID   VOLIN
AC   CVCL_WZ47
DR   cancercelllines; CVCL_WZ47
DR   Wikidata; Q98134565
RX   PubMed=23936203;
RX   PubMed=27311012;
CC   Characteristics: Produces IgG lambda.
CC   Doubling time: ~5 days (PubMed=27311012).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu130Val (c.388C>G); ClinVar=VCV000458543; Zygosity=Homozygous (PubMed=27311012).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 11
//
ID   VOO
AC   CVCL_E864
DR   dbMHC; 49054
DR   ECACC; 94022551
DR   IHW; IHW09241
DR   IPD-IMGT/HLA; 11528
DR   Wikidata; Q54993306
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01:01,03:01:01:01; B*08:01:03,56:01; C*01:02:01,07:01:01; DPA1*01:03; DPB1*02:01:02,04:01:01; DQA1*01:01:01,05:01:01; DQB1*02:01:01,05:01:01; DRB1*01:01:01,03:01:01 (IPD-IMGT/HLA=11528).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   VP-6
AC   CVCL_YQ09
SY   VP6
DR   Wikidata; Q98134567
RX   CelloPub=CLPUB00604;
RX   PubMed=24013424;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Omics: Transcriptomics; RNAseq.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 8
//
ID   VP185
AC   CVCL_D130
DR   cancercelllines; CVCL_D130
DR   GEO; GSM115103
DR   GEO; GSM217607
DR   Progenetix; CVCL_D130
DR   Wikidata; Q54993307
RX   PubMed=8877005;
RX   PubMed=15677628;
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 10
//
ID   VP207
AC   CVCL_W115
SY   VP 207
DR   Wikidata; Q54993308
RX   PubMed=8877005;
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   VP223
AC   CVCL_W116
DR   Wikidata; Q54993311
RX   PubMed=8877005;
CC   Miscellaneous: Cell line has been lost.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   VP229
AC   CVCL_2754
SY   VP 229; BrCL18
DR   BioSample; SAMN03472874
DR   cancercelllines; CVCL_2754
DR   Cell_Model_Passport; SIDM01826
DR   Cosmic; 1523834
DR   DepMap; ACH-001419
DR   ECACC; 05092804
DR   EGA; EGAS00001002554
DR   GEO; GSM115113
DR   GEO; GSM217608
DR   GEO; GSM219888
DR   Progenetix; CVCL_2754
DR   Wikidata; Q54993312
RX   PubMed=8877005;
RX   PubMed=10700188;
RX   PubMed=11044355;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=25877200;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/VP229.html
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Sequence variation: Mutation; HGNC; HGNC:3373; EP300; Simple; p.Asn1700Thrfs*9 (c.5099delA); Zygosity=Hemizygous (PubMed=10700188).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=10700188; DepMap=ACH-001419).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
ST   Source(s): DepMap=ACH-001419; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 18
ST   Penta D: 10
ST   Penta E: 13,17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2755 ! VP267
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   VP267
AC   CVCL_2755
SY   VP 267
DR   BioSample; SAMN03472912
DR   cancercelllines; CVCL_2755
DR   Cell_Model_Passport; SIDM01825
DR   ECACC; 05092805
DR   EGA; EGAS00001002554
DR   GEO; GSM115114
DR   GEO; GSM217609
DR   Progenetix; CVCL_2755
DR   Wikidata; Q54993322
RX   PubMed=8877005;
RX   PubMed=11044355;
RX   PubMed=15677628;
RX   PubMed=25877200;
RX   PubMed=29045385;
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/VP267.html
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=29045385).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): ECACC=05092805; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D18S51: 16
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 25
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,13
ST   FGA: 18
ST   Penta D: 10
ST   Penta E: 13,17
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2754 ! VP229
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   VP298
AC   CVCL_W117
DR   Wikidata; Q54993323
RX   PubMed=8877005;
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   VP303
AC   CVCL_2756
DR   BioSample; SAMN03472873
DR   cancercelllines; CVCL_2756
DR   ECACC; 05092806
DR   GEO; GSM217610
DR   Progenetix; CVCL_2756
DR   Wikidata; Q54993324
RX   PubMed=8877005;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=25877200;
ST   Source(s): PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 25
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 11
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 14
//
ID   VP317
AC   CVCL_W118
DR   Wikidata; Q54993325
RX   PubMed=8877005;
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   VP331
AC   CVCL_W119
DR   Wikidata; Q54993326
RX   PubMed=8877005;
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   VP342
AC   CVCL_W120
DR   Wikidata; Q54993327
RX   PubMed=8877005;
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 6
//
ID   VP348
AC   CVCL_W180
DR   Wikidata; Q54993328
RX   PubMed=8877005;
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 5
//
ID   VPC-6
AC   CVCL_IP77
DR   Wikidata; Q54993329
RX   DOI=10.1182/blood.V112.11.2732.2732;
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 14-08-25; Version: 6
//
ID   VPM 1
AC   CVCL_KA81
DR   Wikidata; Q54993330
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 14
AC   CVCL_KA82
DR   Wikidata; Q54993331
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 15
AC   CVCL_KA83
DR   Wikidata; Q54993333
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 16
AC   CVCL_KA84
DR   Wikidata; Q54993334
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 17
AC   CVCL_KA85
DR   Wikidata; Q54993335
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 18
AC   CVCL_G164
SY   VPM18
DR   ECACC; 93113025
DR   Wikidata; Q54993336
RX   PubMed=1692651;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5Q2E5; Sheep PTPRC/CD45 (Note=Also reacts with bovine).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   VPM 19
AC   CVCL_G165
SY   VPM19
DR   ECACC; 93113026
DR   Wikidata; Q54993337
RX   PubMed=1692651;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Sheep MHC class I heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 29
AC   CVCL_KA89
SY   VPM29
DR   Wikidata; Q54993338
RX   PubMed=1692651;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; W5Q3P2; Sheep CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 3
AC   CVCL_KA86
DR   Wikidata; Q54993339
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 30
AC   CVCL_KR64
SY   VPM30
DR   Wikidata; Q54993341
RX   PubMed=2021068;
RX   PubMed=8310643;
RX   PubMed=9581800;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Bovine antigen on B-cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 36
AC   CVCL_G166
DR   ECACC; 93113027
DR   Wikidata; Q54993342
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1, kappa.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 37
AC   CVCL_G167
DR   ECACC; 93113028
DR   Wikidata; Q54993343
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 38
AC   CVCL_G168
DR   ECACC; 93113029
DR   Wikidata; Q54993344
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 39
AC   CVCL_KA87
DR   Wikidata; Q54993345
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 4
AC   CVCL_KA88
DR   Wikidata; Q54993346
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   VPM 40
AC   CVCL_G169
DR   ECACC; 93113030
DR   Wikidata; Q54993347
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 41
AC   CVCL_G170
DR   ECACC; 93113031
DR   Wikidata; Q54993348
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 43
AC   CVCL_G171
DR   ECACC; 93113032
DR   Wikidata; Q54993349
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 44
AC   CVCL_G172
DR   ECACC; 93113033
DR   Wikidata; Q54993350
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 45
AC   CVCL_G173
DR   ECACC; 93113034
DR   Wikidata; Q54993352
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 46
AC   CVCL_G174
DR   ECACC; 93113035
DR   Wikidata; Q54993354
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 47
AC   CVCL_G175
DR   ECACC; 93113036
DR   Wikidata; Q54993355
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 48
AC   CVCL_G176
DR   ECACC; 93113037
DR   Wikidata; Q54993356
RX   PubMed=2354860;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Sheep MHC class II alpha chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 5
AC   CVCL_G177
DR   ECACC; 93113022
DR   Wikidata; Q54993357
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 54
AC   CVCL_G178
DR   ECACC; 93113038
DR   Wikidata; Q54993358
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 6
AC   CVCL_G179
DR   ECACC; 93113023
DR   Wikidata; Q54993359
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Sheep IgG heavy chain.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VPM 8
AC   CVCL_G180
DR   ECACC; 93113024
DR   Wikidata; Q54993361
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Sheep Ig light chains.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3940 ! NS0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   VR-ALL
AC   CVCL_WR52
DR   cancercelllines; CVCL_WR52
DR   Wikidata; Q98134569
RX   PubMed=29719609;
CC   Doubling time: ~56 hours (PubMed=29719609).
CC   Sequence variation: Mutation; HGNC; HGNC:3386; EPHA2; Simple; p.Arg876His (c.2627G>A); ClinVar=VCV000259391; Zygosity=Heterozygous (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:6188; JAG1; Simple; p.Pro871Arg (c.2612C>G); ClinVar=VCV000042475; Zygosity=Unspecified (PubMed=29719609).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Lys1821Asn; Zygosity=Heterozygous (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7883; NOTCH3; Simple; p.Val1952Met (c.5854G>A); ClinVar=VCV000256146; Zygosity=Heterozygous (Direct_author_submission).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: STR profile and sequence variation from personal communication of Takam Kamga, Paul.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 14,16
ST   D12S391: 18,19
ST   D13S317: 12,13
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D19S433: 14
ST   D1S1656: 17.3
ST   D21S11: 28,30
ST   D22S1045: 15,16
ST   D2S1338: 17,19
ST   D2S441: 11,12
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 13
ST   DYS391: 11
ST   FGA: 21,24
ST   Penta D: 12,13
ST   Penta E: 10
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C9143; Adult B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Cancer cell line
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 11
//
ID   VR09
AC   CVCL_N794
DR   Cosmic; 1840004
DR   Wikidata; Q37816038
RX   PubMed=23285191;
CC   Population: Caucasian.
CC   Doubling time: ~84 hours (PubMed=23285191).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   VRC-4
AC   CVCL_UD92
SY   VRC 4
DR   Wikidata; Q98134571
RX   PubMed=4792746;
CC   Caution: This is said to be a spontaneously immortalized amnion-derived cell line. At the time this cell line was established other amnion-derived cell lines were thought to exist (AV3, FL, WISH), but all these cell lines were later shown to be HeLa contaminated. As there is no publication reporting the use and characterisation of VRC-4 except the original one, it is impossible to establish the real origin of this cell line.
CC   Derived from site: In situ; Amnion; UBERON=UBERON_0000305.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   VRFi001-A
AC   CVCL_VE82
SY   VRF-RBiPSC01
DR   BioSamples; SAMEA14155240
DR   hPSCreg; VRFi001-A
DR   SKIP; SKIP003205
DR   Wikidata; Q54993363
RX   PubMed=29579639;
CC   From: Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision Research Foundation; Chennai; India.
CC   Population: Indian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Heterozygous (PubMed=29579639).
CC   Derived from site: In situ; Eye, orbital adipose tissue; UBERON=UBERON_0006671.
CC   Cell type: Mesenchymal stem cell of orbital adipose tissue; CL=CL_4040004.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 13
//
ID   VRISGi001-A
AC   CVCL_A7JA
SY   UCB01-hiPS-CL2
DR   hPSCreg; VRISGi001-A
DR   Wikidata; Q107117404
RX   PubMed=33878709;
CC   From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam.
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   VRISGi002-A
AC   CVCL_B7CH
SY   ERY01-hiPS-CL2
DR   BioSamples; SAMEA13368531
DR   hPSCreg; VRISGi002-A
DR   Wikidata; Q112930545
RX   PubMed=35679757;
CC   From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam.
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   VRISGi004-A
AC   CVCL_D0PG
SY   ERY02-hiPSC-CL
DR   BioSamples; SAMEA113597710
DR   hPSCreg; VRISGi004-A
DR   Wikidata; Q123033773
RX   PubMed=38341988;
CC   From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam.
CC   Population: Southeast Asian; Vietnamese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-09-24; Version: 3
//
ID   VRISGi005-A
AC   CVCL_D0PH
DR   BioSamples; SAMEA113597711
DR   hPSCreg; VRISGi005-A
DR   Wikidata; Q123033774
CC   From: Vinmec Research Insitute of Stem Cell and Gene Technology; Hanoi; Vietnam.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   VSa13
AC   CVCL_S952
SY   Vertebra Sparus aurata 13
DR   Wikidata; Q54993364
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
RX   PubMed=14762709;
RX   PubMed=15820747;
RX   PubMed=17899405;
RX   PubMed=19002990;
RX   PubMed=21668972;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, vertebra; UBERON=UBERON_0002412.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   VSa16
AC   CVCL_S953
SY   Vertebra Sparus aurata 16
DR   Wikidata; Q54993365
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
RX   PubMed=14762709;
RX   PubMed=15820747;
RX   PubMed=19002990;
RX   PubMed=21668972;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone, vertebra; UBERON=UBERON_0002412.
OX   NCBI_TaxID=8175; ! Sparus aurata (Gilthead sea bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 11
//
ID   VSMUi001-D
AC   CVCL_QX76
SY   PR39
DR   SKIP; SKIP003168
DR   Wikidata; Q54993366
RX   PubMed=29034889;
CC   From: Faculty of Veterinary Science, Mahidol University; Bangkok; Thailand.
CC   Derived from site: In situ; Fetus; UBERON=UBERON_0000323.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Landrace x Large White x Duroc (LWD); VBO=VBO_0001161+VBO_0001163+VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   28FD
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-09-24; Version: 8
//
ID   VSW
AC   CVCL_4370
DR   CLO; CLO_0009549
DR   ATCC; CCL-129
DR   Wikidata; Q54993368
RX   PubMed=4350126;
RX   PubMed=4358139;
RX   PubMed=5165585;
CC   Group: Reptilian cell line.
CC   Virology: Infected by a C-type retrovirus.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=8707; ! Daboia russelii (Russel's viper)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   VT-E
AC   CVCL_0C28
DR   Wikidata; Q54993373
RX   PubMed=7736387;
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   vT{2}
AC   CVCL_4010
DR   CLO; CLO_0009550
DR   ATCC; CRL-2712
DR   Wikidata; Q54993375
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:700; ARNT.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: C57L/J.
DI   NCIt; C38756; Hepatocellular carcinoma of the mouse
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_9085 ! c4 (B13NBii1)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   VTIS39243
AC   CVCL_6G71
DR   IPD-IMGT/HLA; 12637
DR   Wikidata; Q54993376
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*07:02:01,40:38; DRB1*04:04,15:01:01 (IPD-IMGT/HLA=12637).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   VTIS43878
AC   CVCL_6G72
DR   IPD-IMGT/HLA; 12642
DR   Wikidata; Q54993377
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*32:01,68:BG; B*35:19,40:01:01/40:01:02; C*03,08; DRB1*04 (IPD-IMGT/HLA=12642).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   VTIS45561
AC   CVCL_6G73
DR   IPD-IMGT/HLA; 12638
DR   Wikidata; Q54993378
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: B*07:02:01,56:07 (IPD-IMGT/HLA=12638).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   VTIS46155
AC   CVCL_6G74
DR   IPD-IMGT/HLA; 12643
DR   Wikidata; Q54993379
RX   PubMed=11782282;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*31:01; B*15:07,39:03; C*01:02,07:02; DRB1*04 (IPD-IMGT/HLA=12643).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 9
//
ID   VTTC2
AC   CVCL_VZ65
SY   Vaginalis Tunica Testis Cat 2
DR   IBRC; C11089
DR   Wikidata; Q98134573
CC   Derived from site: In situ; Testis, tunica vaginalis; UBERON=UBERON_0006650.
CC   Breed/subspecies: Persian; VBO=VBO_0100188.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
OI   CVCL_VZ63 ! ATTC2
OI   CVCL_VY52 ! EPTC2
OI   CVCL_VZ64 ! SMTC2
SX   Male
AG   6Y6M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   VU-SCC-040
AC   CVCL_JL62
SY   VU-SCC-40; 92VU040; 92VU040T
DR   IARC_TP53; 21673
DR   Wikidata; Q54993380
RX   PubMed=8824719;
RX   PubMed=9139877;
RX   PubMed=15735012;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=31541927;
CC   Doubling time: 27 +- 3 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:20250; AJUBA; Simple; p.Ser263fs (c.788_789delCT); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:1509; CASP8; Simple; p.Glu17Lys (c.49G>A); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asn390Lys (c.1170C>A); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Leu989Val (c.2965C>G); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15735012; PubMed=23613873).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 10
//
ID   VU-SCC-041
AC   CVCL_XX14
SY   VU-SCC-41; 92VU041
DR   IARC_TP53; 21674
DR   Wikidata; Q98134575
RX   PubMed=15735012;
RX   PubMed=26122845;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15735012).
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   VU-SCC-078
AC   CVCL_XX15
SY   VU-SCC-78; 92VU078
DR   IARC_TP53; 21676
DR   Wikidata; Q98134578
RX   PubMed=15735012;
RX   PubMed=26122845;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Thr (c.481G>A); ClinVar=VCV000161518; Zygosity=Unspecified (PubMed=15735012).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 7
//
ID   VU-SCC-080
AC   CVCL_XX16
SY   VU-SCC-80
DR   IARC_TP53; 21677
DR   Wikidata; Q98134581
RX   PubMed=15735012;
RX   PubMed=26122845;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Unexplicit; Del300bp; Zygosity=Unspecified (PubMed=15735012).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 6
//
ID   VU-SCC-094
AC   CVCL_XX17
SY   VU-SCC-94; 93VU094
DR   Wikidata; Q98134583
RX   PubMed=15735012;
RX   PubMed=23613873;
RX   PubMed=26122845;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.919+1G>A (IVS8+1G>A); ClinVar=VCV000633606; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=15735012; PubMed=23613873).
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   VU-SCC-096
AC   CVCL_JL63
SY   93VU096Ta; 93VU096aT
DR   cancercelllines; CVCL_JL63
DR   Wikidata; Q54993381
RX   PubMed=8824719;
RX   PubMed=9139877;
RX   PubMed=23613873;
RX   PubMed=31541927;
CC   Doubling time: 41 +- 3 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Leu (c.578A>T); ClinVar=VCV000185822; Zygosity=Unspecified (PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: In situ; Oral cavity, retromolar trigone; UBERON=UBERON_0012376.
DI   NCIt; C8172; Retromolar trigone squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   VU-SCC-1131
AC   CVCL_XX18
SY   VU1131; VU-1131; VU-1131-T2.8
DR   cancercelllines; CVCL_XX18
DR   IARC_TP53; 21670
DR   Wikidata; Q98134585
RX   PubMed=15735012;
RX   PubMed=23613873;
RX   PubMed=25609062;
RX   PubMed=26122845;
RX   PubMed=31541927;
RX   PubMed=36912284;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:3584; FANCC; Simple; p.Asp23Ilefs*23 (c.67delG) (322delG); ClinVar=VCV000012049; Zygosity=Unspecified (PubMed=15735012).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; c.1252-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Leu (c.818G>T); ClinVar=VCV000376655; Zygosity=Homozygous (PubMed=15735012; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
ST   Source(s): PubMed=36912284
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C125704; Fanconi anemia, complementation group C
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_84; Fanconi anemia
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   VU-SCC-120
AC   CVCL_JL64
SY   93VU120T; 93VU120; 120T
DR   IARC_TP53; 21679
DR   Wikidata; Q54993382
RX   PubMed=8824719;
RX   PubMed=9139877;
RX   PubMed=15735012;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=31541927;
CC   Doubling time: 34 +- 3 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu415Ter (c.1243G>T); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Arg234His (c.701G>A); ClinVar=VCV000134959; Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ala161Phe (c.481_482GC>TT); Zygosity=Heterozygous (PubMed=23613873; PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Heterozygous (PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Caution: TP53 mutation indicated to be at p.Ala159Phe (c.475_476GC>TT) in PubMed=15735012.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 13
//
ID   VU-SCC-1365
AC   CVCL_XX19
SY   VU1365; VU-1365
DR   cancercelllines; CVCL_XX19
DR   IARC_TP53; 21671
DR   Wikidata; Q98134588
RX   PubMed=15735012;
RX   PubMed=23613873;
RX   PubMed=25609062;
RX   PubMed=26122845;
RX   PubMed=31541927;
RX   PubMed=36912284;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:1509; CASP8; Simple; p.Arg432Ter (c.1294C>T); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Glu838Lys (c.2512G>A); Zygosity=Heterozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous (PubMed=15735012; PubMed=23613873; PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
ST   Source(s): PubMed=36912284
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 8
ST   D7S820: 8
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 11
//
ID   VU-SCC-147
AC   CVCL_L895
SY   93-VU-147T; 93VU-147T; 93VU147T; 147T
DR   cancercelllines; CVCL_L895
DR   Cosmic; 1122678
DR   Cosmic; 1530733
DR   Cosmic; 2296308
DR   GEO; GSM937834
DR   GEO; GSM937835
DR   Wikidata; Q54993383
RX   PubMed=7585617;
RX   PubMed=8824719;
RX   PubMed=17848307;
RX   PubMed=23419152;
RX   PubMed=23613873;
RX   PubMed=25275298;
RX   PubMed=26045983;
RX   PubMed=26122845;
RX   PubMed=28236344;
RX   PubMed=29156801;
RX   PubMed=31541927;
RX   PubMed=33802339;
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/24336/
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Doubling time: 2.2 days (PubMed=29156801).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Asp108Tyr (c.322G>T); Zygosity=Unspecified (PubMed=31541927; PubMed=33802339).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu257Arg (c.770T>G); ClinVar=VCV000142134; Zygosity=Unspecified (PubMed=23613873; PubMed=25275298; PubMed=31541927; PubMed=33802339).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Misspelling: 93YU47; Cosmic=1530733.
CC   Derived from site: In situ; Oral cavity, floor of mouth; UBERON=UBERON_0003679.
ST   Source(s): PubMed=25275298; PubMed=29156801; PubMed=33802339
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 14,15
ST   D21S11: 30,31 (PubMed=25275298)
ST   D21S11: 31 (PubMed=33802339)
ST   D2S1338: 20,24
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22
ST   Penta D: 12,13.4
ST   Penta E: 11,12
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   VU-SCC-1604
AC   CVCL_XX20
SY   VU1604
DR   Wikidata; Q98134590
RX   PubMed=26122845;
RX   PubMed=31541927;
RX   PubMed=36912284;
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg21Lys (c.62G>A); ClinVar=VCV000371974; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Asp84Asn (c.250G>A) (p.Arg98Gln, c.293G>A); ClinVar=VCV000229806; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:3595; FAT1; Simple; p.Gln1455Ter (c.4363C>T); Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:7133; KMT2D; Simple; p.Pro1131Leu (c.3392C>T); ClinVar=VCV000134672; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val218del (c.646_648GTG[2]) (c.652_654delGTG); ClinVar=VCV000634761; Zygosity=Homozygous (PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
ST   Source(s): PubMed=36912284
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C164677; Fanconi anemia, complementation group L
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_84; Fanconi anemia
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   VU-SCC-9917
AC   CVCL_XX24
DR   cancercelllines; CVCL_XX24
DR   Wikidata; Q98134592
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=26423134;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=23613873).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   VU-SCC-OE
AC   CVCL_XX21
DR   cancercelllines; CVCL_XX21
DR   Wikidata; Q98134594
RX   PubMed=9139877;
RX   PubMed=23613873;
RX   PubMed=26122845;
RX   PubMed=31541927;
CC   Characteristics: Established from a xenograft.
CC   Doubling time: 48 +- 3 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Glu542Lys (c.1624G>A); ClinVar=VCV000031944; Zygosity=Unspecified (PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 12
//
ID   VU-SCC-RO
AC   CVCL_XX22
DR   Wikidata; Q98134596
RX   PubMed=9139877;
RX   PubMed=31541927;
CC   Characteristics: Established from a xenograft.
CC   Doubling time: 43 +- 4 hours (PubMed=9139877).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=31541927).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 8
//
ID   VU1149+SV40+DDX11
AC   CVCL_XX29
SY   DDX11+
DR   Wikidata; Q98134598
RX   PubMed=26423134;
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:2736; DDX11.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C164675; Warsaw breakage syndrome
DI   ORDO; Orphanet_280558; Warsaw breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XX30 ! VU1149+SV40+pcDNA
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   VU1149+SV40+pcDNA
AC   CVCL_XX30
SY   DDX11-
DR   Wikidata; Q98134601
RX   PubMed=26423134;
CC   Characteristics: Control cell line for VU1149+SV40+DDX11 (Cellosaurus=CVCL_XX29) (PubMed=26423134).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C164675; Warsaw breakage syndrome
DI   ORDO; Orphanet_280558; Warsaw breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XX29 ! VU1149+SV40+DDX11
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   VU1199-F
AC   CVCL_XX25
SY   VU1199
DR   Wikidata; Q98134603
RX   PubMed=19738907;
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Arg293Serfs*7 (c.877_878AG[1]) (c.877_878delAG); ClinVar=VCV000021251; Zygosity=Homozygous (PubMed=19738907).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126326; Roberts syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   VU1199-F SV40
AC   CVCL_XX26
SY   VU1199 + SV40; ESCO2-
DR   Wikidata; Q98134605
RX   PubMed=19738907;
RX   PubMed=26423134;
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Arg293Serfs*7 (c.877_878AG[1]) (c.877_878delAG); ClinVar=VCV000021251; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126326; Roberts syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX25 ! VU1199-F
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   VU1199-F SV40+GFP-ESCO2
AC   CVCL_XX27
DR   Wikidata; Q98134607
RX   PubMed=19738907;
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Arg293Serfs*7 (c.877_878AG[1]) (c.877_878delAG); ClinVar=VCV000021251; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27230; ESCO2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126326; Roberts syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX26 ! VU1199-F SV40
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 12
//
ID   VU1199-F SV40+V5-ESCO2
AC   CVCL_XX28
SY   VU1199+SV40+V5-ESCO2; ESCO2+
DR   Wikidata; Q98134609
RX   PubMed=19738907;
RX   PubMed=26423134;
CC   Sequence variation: Mutation; HGNC; HGNC:27230; ESCO2; Simple; p.Arg293Serfs*7 (c.877_878AG[1]) (c.877_878delAG); ClinVar=VCV000021251; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:27230; ESCO2 (Note=With a N-terminal V5 tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C126326; Roberts syndrome
DI   ORDO; Orphanet_3103; Roberts syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XX26 ! VU1199-F SV40
SX   Male
AG   2M
CA   Transformed cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   VUB01
AC   CVCL_9838
SY   VUB-01-WT; VUBe001-A
DR   hPSCreg; VUBe001-A
DR   SKIP; SKIP001824
DR   Wikidata; Q54993384
RX   PubMed=16284066;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-24.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   VUB02
AC   CVCL_9839
SY   VUBe002-A
DR   hPSCreg; VUBe002-A
DR   SKIP; SKIP001825
DR   Wikidata; Q54993385
RX   PubMed=16284066;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   VUB03_DM1
AC   CVCL_9840
SY   VUBe003-A
DR   hPSCreg; VUBe003-A
DR   SKIP; SKIP001826
DR   Wikidata; Q54993386
RX   PubMed=16284066;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   VUB04_CF
AC   CVCL_9841
SY   VUBe004-A
DR   hPSCreg; VUBe004-A
DR   SKIP; SKIP001827
DR   Wikidata; Q54993388
RX   PubMed=16284066;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=16284066).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   VUB05_HD
AC   CVCL_9842
SY   VUB-05-HD; VUBe005-A
DR   hPSCreg; VUBe005-A
DR   SKIP; SKIP001828
DR   Wikidata; Q54993389
RX   PubMed=16284066;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-24.
CC   Sequence variation: Mutation; HGNC; HGNC:4851; HTT; Repeat_expansion; p.Gln18[44] (c.52CAG(44)) (c.52CAG[(40_?)]); ClinVar=VCV000000409; Zygosity=Unspecified (PubMed=16284066).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   ORDO; Orphanet_399; Huntington disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   VUB06
AC   CVCL_9843
SY   VUBe006-A
DR   hPSCreg; VUBe006-A
DR   SKIP; SKIP001829
DR   Wikidata; Q54993391
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   VUB07
AC   CVCL_9844
SY   VUBe007-A
DR   hPSCreg; VUBe007-A
DR   SKIP; SKIP001830
DR   Wikidata; Q54993392
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   VUB08_MFS
AC   CVCL_9845
SY   VUBe008-A
DR   hPSCreg; VUBe008-A
DR   SKIP; SKIP001831
DR   Wikidata; Q54993393
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   VUB09_FSHD
AC   CVCL_9846
SY   VUBe009-A
DR   hPSCreg; VUBe009-A
DR   SKIP; SKIP001832
DR   Wikidata; Q54993395
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172704; Facioscapulohumeral muscular dystrophy 1
DI   ORDO; Orphanet_269; Facioscapulohumeral dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   VUB10_SCA7
AC   CVCL_9847
SY   VUBe010-A
DR   hPSCreg; VUBe010-A
DR   SKIP; SKIP001833
DR   Wikidata; Q54993396
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:10560; ATXN7; Repeat_expansion; CAG[37] (g.53130CAG[(38_130)]); ClinVar=VCV000562100; Zygosity=Unspecified (PubMed=20224973).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C126562; Spinocerebellar ataxia type 7
DI   ORDO; Orphanet_94147; Spinocerebellar ataxia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   VUB11_FXS
AC   CVCL_9848
SY   VUBe011-A
DR   hPSCreg; VUBe011-A
DR   SKIP; SKIP001834
DR   Wikidata; Q54993397
RX   PubMed=20224973;
RX   PubMed=27690107;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[2000-2010]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   VUB13_FXS
AC   CVCL_9849
SY   VUBe013-A
DR   hPSCreg; VUBe013-A
DR   SKIP; SKIP001835
DR   Wikidata; Q54993398
RX   PubMed=20224973;
RX   PubMed=27690107;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[2000]; ClinVar=VCV000009972; Zygosity=Unspecified (PubMed=27690107).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 20
//
ID   VUB14
AC   CVCL_9850
SY   VUBe014-A
DR   hPSCreg; VUBe014-A
DR   SKIP; SKIP002352
DR   Wikidata; Q54993400
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   VUB15
AC   CVCL_9851
SY   VUBe015-A
DR   hPSCreg; VUBe015-A
DR   Wikidata; Q54993402
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   VUB16
AC   CVCL_9852
SY   VUBe016-A
DR   hPSCreg; VUBe016-A
DR   Wikidata; Q54993403
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   VUB17
AC   CVCL_9853
SY   VUBe017-A
DR   hPSCreg; VUBe017-A
DR   Wikidata; Q54993404
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   VUB19_DM1
AC   CVCL_9854
SY   VUBe019-A
DR   hPSCreg; VUBe019-A
DR   SKIP; SKIP002028
DR   Wikidata; Q54993405
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~250] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=20224973).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 19
//
ID   VUB20_CMT1A
AC   CVCL_9855
SY   VUBe020-A
DR   hPSCreg; VUBe020-A
DR   SKIP; SKIP002029
DR   Wikidata; Q54993406
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   VUB21_HEMA
AC   CVCL_9856
SY   VUBe021-A
DR   hPSCreg; VUBe021-A
DR   Wikidata; Q54993408
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 10
//
ID   VUB22_CF
AC   CVCL_9857
SY   VUBe022-A
DR   hPSCreg; VUBe022-A
DR   SKIP; SKIP002030
DR   Wikidata; Q54993409
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1884; CFTR; Simple; p.Phe508del (c.1521_1523delCTT); ClinVar=VCV000007105; Zygosity=Homozygous (PubMed=20224973).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   VUB23_OI
AC   CVCL_9858
SY   VUBe023-A
DR   hPSCreg; VUBe023-A
DR   SKIP; SKIP002031
DR   Wikidata; Q54993410
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 16
//
ID   VUB24_DM1
AC   CVCL_9859
SY   VUBe024-A
DR   hPSCreg; VUBe024-A
DR   SKIP; SKIP002033
DR   Wikidata; Q54993412
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[~1800] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Unspecified (PubMed=20224973).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   VUB25_CMT1A
AC   CVCL_C1TH
SY   VUBe025-A
DR   hPSCreg; VUBe025-A
DR   Wikidata; Q114313214
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75468; Charcot-Marie-Tooth disease type 1A
DI   ORDO; Orphanet_101081; Charcot-Marie-Tooth disease type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   VUB26
AC   CVCL_9860
SY   VUB26_QUATRO; VUBe026-A
DR   hPSCreg; VUBe026-A
DR   SKIP; SKIP002035
DR   Wikidata; Q54993413
RX   PubMed=19633307;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   VUB27
AC   CVCL_9861
SY   VUB27_PATRU; VUBe027-A
DR   hPSCreg; VUBe027-A
DR   SKIP; SKIP002333
DR   Wikidata; Q54993414
RX   PubMed=19633307;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   VUB28_HD_MFS
AC   CVCL_9862
SY   VUBe028-A
DR   hPSCreg; VUBe028-A
DR   SKIP; SKIP002034
DR   Wikidata; Q54993415
RX   PubMed=20224973;
CC   From: Vrije Universiteit Brussel; Brussels; Belgium.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_399; Huntington disease
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 15
//
ID   VUi001-A
AC   CVCL_ZB02
SY   SCZ 14.3; hvs479
DR   BioSamples; SAMEA7762110
DR   hPSCreg; VUi001-A
DR   Wikidata; Q98134611
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   VUi002-A
AC   CVCL_ZB03
SY   SCZ 18.10; hvs483
DR   BioSamples; SAMEA6878071
DR   hPSCreg; VUi002-A
DR   Wikidata; Q98134613
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi003-A
AC   CVCL_ZB04
SY   SCZ 13.2; hvs478
DR   BioSamples; SAMEA115574344
DR   hPSCreg; VUi003-A
DR   Wikidata; Q98134616
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi004-A
AC   CVCL_ZB05
SY   SCZ 19.2; hvs-484; hvs484
DR   hPSCreg; VUi004-A
DR   Wikidata; Q98134618
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi005-A
AC   CVCL_ZB06
SY   787.3
DR   BioSamples; SAMEA7762134
DR   hPSCreg; VUi005-A
DR   Wikidata; Q98134620
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   VUi006-A
AC   CVCL_ZB07
SY   SCZ 21.5
DR   BioSamples; SAMEA7762130
DR   hPSCreg; VUi006-A
DR   Wikidata; Q98134622
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi007-A
AC   CVCL_ZB08
SY   786.1
DR   BioSamples; SAMEA7762118
DR   hPSCreg; VUi007-A
DR   Wikidata; Q98134625
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi008-A
AC   CVCL_ZB09
SY   SCZ 6.2
DR   BioSamples; SAMEA7762120
DR   hPSCreg; VUi008-A
DR   Wikidata; Q98134627
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi009-A
AC   CVCL_ZB10
SY   SCZ 10.1
DR   BioSamples; SAMEA7762126
DR   hPSCreg; VUi009-A
DR   Wikidata; Q98134630
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi010-A
AC   CVCL_ZB11
SY   SCZ 1.1
DR   BioSamples; SAMEA7762129
DR   hPSCreg; VUi010-A
DR   Wikidata; Q98134632
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi011-A
AC   CVCL_ZB12
SY   SCZ 3.5
DR   BioSamples; SAMEA7762116
DR   hPSCreg; VUi011-A
DR   Wikidata; Q98134634
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi012-A
AC   CVCL_ZB13
SY   SCZ 7.2
DR   BioSamples; SAMEA114469022
DR   hPSCreg; VUi012-A
DR   Wikidata; Q98134636
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 30-01-24; Version: 5
//
ID   VUi013-A
AC   CVCL_ZB14
SY   804.3
DR   BioSamples; SAMEA7762132
DR   hPSCreg; VUi013-A
DR   Wikidata; Q98134637
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   VUi014-A
AC   CVCL_ZB15
SY   SCZ 11.8; hvs476
DR   hPSCreg; VUi014-A
DR   Wikidata; Q98134641
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi015-A
AC   CVCL_ZB16
SY   SCZ 12.1; hvs-477; hvs477
DR   BioSamples; SAMEA115544589
DR   hPSCreg; VUi015-A
DR   Wikidata; Q98134643
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi016-A
AC   CVCL_ZB17
SY   789.A1; hvs341
DR   BioSamples; SAMEA117428546
DR   hPSCreg; VUi016-A
DR   Wikidata; Q98134645
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   VUi017-A
AC   CVCL_ZB18
SY   SCZ 4.3
DR   BioSamples; SAMEA7762115
DR   hPSCreg; VUi017-A
DR   Wikidata; Q98134649
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 7
//
ID   VUi018-A
AC   CVCL_ZB19
SY   SCZ 5.1; hvs487
DR   BioSamples; SAMEA118005452
DR   hPSCreg; VUi018-A
DR   Wikidata; Q98134651
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi019-A
AC   CVCL_ZB20
SY   SCZ 15.2; hvs480
DR   BioSamples; SAMEA118004882
DR   hPSCreg; VUi019-A
DR   Wikidata; Q98134653
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi020-A
AC   CVCL_ZB21
SY   SCZ 20.1; hvs485
DR   BioSamples; SAMEA118004886
DR   hPSCreg; VUi020-A
DR   Wikidata; Q98134655
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi021-A
AC   CVCL_ZB22
SY   793.3; hvs473
DR   BioSamples; SAMEA118004891
DR   hPSCreg; VUi021-A
DR   Wikidata; Q98134657
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 4
//
ID   VUi022-A
AC   CVCL_ZB23
SY   771.2
DR   BioSamples; SAMEA7762124
DR   hPSCreg; VUi022-A
DR   Wikidata; Q98134659
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Discontinued: hPSCreg; VUi022-A; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   VUi023-A
AC   CVCL_ZB24
SY   801.A1; hvs474
DR   BioSamples; SAMEA7762122
DR   hPSCreg; VUi023-A
DR   Wikidata; Q98134660
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 7
//
ID   VUi024-A
AC   CVCL_ZB25
SY   SCZ 9.4
DR   BioSamples; SAMEA7762113
DR   hPSCreg; VUi024-A
DR   Wikidata; Q98134662
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   VUi025-A
AC   CVCL_A8NL
SY   hvs93
DR   BioSamples; SAMEA8268548
DR   hPSCreg; VUi025-A
DR   Wikidata; Q108821490
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Tyr596Ter (c.1788C>A); ClinVar=VCV001184064; Zygosity=Heterozygous (hPSCreg=VUi025-A).
CC   Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Leu727Ser (c.2180T>C); ClinVar=VCV001184068; Zygosity=Heterozygous (hPSCreg=VUi025-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C180850; Hypomyelinating leukodystrophy-8
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   VUi026-A
AC   CVCL_A8NM
SY   hvs97
DR   BioSamples; SAMEA8268549
DR   hPSCreg; VUi026-A
DR   Wikidata; Q108821491
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Val523Glu (c.1568T>A); ClinVar=VCV000031166; Zygosity=Heterozygous (hPSCreg=VUi026-A).
CC   Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; c.2084-6A>G; ClinVar=VCV000419962; Zygosity=Heterozygous (hPSCreg=VUi026-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C180850; Hypomyelinating leukodystrophy-8
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   VUi027-A
AC   CVCL_A8NN
SY   hvs201
DR   BioSamples; SAMEA8268550
DR   hPSCreg; VUi027-A
DR   Wikidata; Q108821492
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Asp57Asn (c.169G>A); ClinVar=VCV001184032; Zygosity=Heterozygous (hPSCreg=VUi027-A).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Ile700Phe (c.2098A>T); ClinVar=VCV001184041; Zygosity=Heterozygous (hPSCreg=VUi027-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C210817; Hypomyelinating leukodystrophy-7
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   VUi028-A
AC   CVCL_A8NP
SY   hvs369
DR   BioSamples; SAMEA8268551
DR   hPSCreg; VUi028-A
DR   Wikidata; Q108821493
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; c.303+1G>A; ClinVar=VCV001184092; Zygosity=Heterozygous; Note=Splice donor mutation (hPSCreg=VUi028-A).
CC   Sequence variation: Mutation; HGNC; HGNC:30348; POLR3B; Simple; p.Val523Glu (c.1568T>A); ClinVar=VCV000031166; Zygosity=Heterozygous (hPSCreg=VUi028-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C180850; Hypomyelinating leukodystrophy-8
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   VUi029-A
AC   CVCL_A8NQ
SY   hvs449a
DR   BioSamples; SAMEA8268552
DR   hPSCreg; VUi029-A
DR   Wikidata; Q108821494
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; c.1771-6C>G; ClinVar=VCV000976718; Zygosity=Heterozygous (hPSCreg=VUi029-A).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; p.Arg1069Trp (c.3205C>T); ClinVar=VCV001184053; Zygosity=Heterozygous (hPSCreg=VUi029-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C210817; Hypomyelinating leukodystrophy-7
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   VUi030-A
AC   CVCL_A8NR
SY   hvs450a
DR   BioSamples; SAMEA8268553
DR   hPSCreg; VUi030-A
DR   Wikidata; Q108821495
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; c.1048+5G>T; ClinVar=VCV000549560; Zygosity=Heterozygous (hPSCreg=VUi030-A).
CC   Sequence variation: Mutation; HGNC; HGNC:30074; POLR3A; Simple; c.1771-7C>G; ClinVar=VCV000449556; Zygosity=Heterozygous (hPSCreg=VUi030-A).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C210817; Hypomyelinating leukodystrophy-7
DI   ORDO; Orphanet_289494; 4H leukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   VUi031-A
AC   CVCL_A8ST
SY   hvs488
DR   BioSamples; SAMEA9071315
DR   hPSCreg; VUi031-A
DR   Wikidata; Q108821496
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   VUi032-A
AC   CVCL_A8SU
SY   hvs421
DR   BioSamples; SAMEA9071318
DR   hPSCreg; VUi032-A
DR   Wikidata; Q108821497
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW42 ! GM23973
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   VUi033-A
AC   CVCL_A8SV
SY   hvs445a
DR   BioSamples; SAMEA9097649
DR   hPSCreg; VUi033-A
DR   Wikidata; Q108821498
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7348 ! GM02036
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   VUi034-A
AC   CVCL_D0PL
SY   SCZ 8.1; hvs-304; hvs304
DR   hPSCreg; VUi034-A
DR   Wikidata; Q123033776
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi035-A
AC   CVCL_D0PM
SY   SCZ 802.2A; hvs-471; hvs471
DR   BioSamples; SAMEA118007460
DR   hPSCreg; VUi035-A
DR   Wikidata; Q123033777
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi036-A
AC   CVCL_D0PN
SY   hvs420
DR   BioSamples; SAMEA112957061
DR   hPSCreg; VUi036-A
DR   Wikidata; Q123033778
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW33 ! GM23964
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   VUi037-A
AC   CVCL_D0PP
SY   hvs421
DR   hPSCreg; VUi037-A
DR   Wikidata; Q123033779
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_BW42 ! GM23973
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   VUi038-A
AC   CVCL_D0PQ
SY   hvs444a
DR   BioSamples; SAMEA117481936
DR   hPSCreg; VUi038-A
DR   Wikidata; Q123033780
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7329 ! GM01651
SX   Female
AG   13Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi039-A
AC   CVCL_D0PR
SY   hvs446a
DR   BioSamples; SAMEA117483283
DR   hPSCreg; VUi039-A
DR   Wikidata; Q123033781
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Population: African American.
CC   Derived from site: In situ; Umbilical area, skin; UBERON=UBERON_8480053.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7419 ! GM05381
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi040-A
AC   CVCL_D0PS
SY   GB3g
DR   BioSamples; SAMEA113314776
DR   hPSCreg; VUi040-A
DR   Wikidata; Q123033782
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   VUi041-A
AC   CVCL_D0PT
SY   GB4d
DR   BioSamples; SAMEA113319678
DR   hPSCreg; VUi041-A
DR   Wikidata; Q123033783
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   VUi042-A
AC   CVCL_D0PU
SY   GB2a
DR   hPSCreg; VUi042-A
DR   Wikidata; Q123033784
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   VUi043-A
AC   CVCL_D0PV
SY   hvs492a
DR   hPSCreg; VUi043-A
DR   Wikidata; Q123033785
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8YM ! VUi043-B
OI   CVCL_E8YN ! VUi043-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi043-B
AC   CVCL_E8YM
SY   hvs492b
DR   hPSCreg; VUi043-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0PV ! VUi043-A
OI   CVCL_E8YN ! VUi043-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi043-C
AC   CVCL_E8YN
SY   hvs492c
DR   hPSCreg; VUi043-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_D0PV ! VUi043-A
OI   CVCL_E8YM ! VUi043-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi044-A
AC   CVCL_D0PW
SY   hvs493a
DR   BioSamples; SAMEA113575031
DR   hPSCreg; VUi044-A
DR   Wikidata; Q123033786
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi045-A
AC   CVCL_D0PX
SY   04D0020; hvs459a
DR   BioSamples; SAMEA113575050
DR   hPSCreg; VUi045-A
DR   Wikidata; Q123033787
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi046-A
AC   CVCL_D0PY
SY   06D1640; hvs460a
DR   BioSamples; SAMEA113575052
DR   hPSCreg; VUi046-A
DR   Wikidata; Q123033788
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   VUi047-A
AC   CVCL_E8YP
SY   785.10; hvs337
DR   BioSamples; SAMEA118004894
DR   hPSCreg; VUi047-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi048-A
AC   CVCL_E8YQ
SY   788.A1; hvs469
DR   BioSamples; SAMEA118005093
DR   hPSCreg; VUi048-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi049-A
AC   CVCL_E8YR
SY   790.3; hvs470
DR   BioSamples; SAMEA118005641
DR   hPSCreg; VUi049-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi052-A
AC   CVCL_E8YS
SY   17.6; hvs482
DR   BioSamples; SAMEA118005650
DR   hPSCreg; VUi052-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi053-A
AC   CVCL_E8YT
SY   2.5; hvs317
DR   BioSamples; SAMEA118005665
DR   hPSCreg; VUi053-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi056-A
AC   CVCL_E8YU
SY   PEX1-023; hvs520a
DR   BioSamples; SAMEA117056113
DR   hPSCreg; VUi056-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi058-A
AC   CVCL_E8YV
SY   PEX1-024; hvs521a
DR   BioSamples; SAMEA117056114
DR   hPSCreg; VUi058-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi059-A
AC   CVCL_E8YW
SY   PEX1-025; hvs522a
DR   BioSamples; SAMEA117056115
DR   hPSCreg; VUi059-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi060-A
AC   CVCL_E8YX
SY   PEX1-026; hvs523a
DR   BioSamples; SAMEA117056116
DR   hPSCreg; VUi060-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi061-A
AC   CVCL_E8YY
SY   PEX1-003; hvs524a
DR   BioSamples; SAMEA117056117
DR   hPSCreg; VUi061-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C155748; Peroxisome biogenesis disorder 1A
DI   ORDO; Orphanet_79189; Peroxisome biogenesis disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi062-A
AC   CVCL_E8YJ
SY   hvs512b
DR   BioSamples; SAMEA115292494
DR   hPSCreg; VUi062-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8YK ! VUi062-B
OI   CVCL_E8YL ! VUi062-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi062-B
AC   CVCL_E8YK
SY   hvs512c
DR   BioSamples; SAMEA115875390
DR   hPSCreg; VUi062-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8YJ ! VUi062-A
OI   CVCL_E8YL ! VUi062-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi062-C
AC   CVCL_E8YL
SY   hvs512d
DR   BioSamples; SAMEA115876365
DR   hPSCreg; VUi062-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8YJ ! VUi062-A
OI   CVCL_E8YK ! VUi062-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi063-A
AC   CVCL_E8YZ
SY   hvs513a
DR   BioSamples; SAMEA115292496
DR   hPSCreg; VUi063-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3010; DPP6; Simple; c.1-340C>T; Zygosity=Unspecified (hPSCreg=VUi063-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8Z0 ! VUi063-B
OI   CVCL_E8Z1 ! VUi063-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi063-B
AC   CVCL_E8Z0
SY   hvs513b
DR   BioSamples; SAMEA115882144
DR   hPSCreg; VUi063-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3010; DPP6; Simple; c.1-340C>T; Zygosity=Unspecified (hPSCreg=VUi063-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8YZ ! VUi063-A
OI   CVCL_E8Z1 ! VUi063-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi063-C
AC   CVCL_E8Z1
SY   hvs513c
DR   BioSamples; SAMEA115882212
DR   hPSCreg; VUi063-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3010; DPP6; Simple; c.1-340C>T; Zygosity=Unspecified (hPSCreg=VUi063-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8YZ ! VUi063-A
OI   CVCL_E8Z0 ! VUi063-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi064-A
AC   CVCL_E8Z6
SY   hvs514a
DR   BioSamples; SAMEA115292504
DR   hPSCreg; VUi064-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3010; DPP6; Simple; c.1-340C>T; Zygosity=Unspecified (hPSCreg=VUi064-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8Z7 ! VUi064-B
OI   CVCL_E8Z8 ! VUi064-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi064-B
AC   CVCL_E8Z7
SY   hvs514b
DR   BioSamples; SAMEA115882213
DR   hPSCreg; VUi064-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3010; DPP6; Simple; c.1-340C>T; Zygosity=Unspecified (hPSCreg=VUi064-B).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8Z6 ! VUi064-A
OI   CVCL_E8Z8 ! VUi064-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi064-C
AC   CVCL_E8Z8
SY   hvs514c
DR   BioSamples; SAMEA115882214
DR   hPSCreg; VUi064-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Sequence variation: Mutation; HGNC; HGNC:3010; DPP6; Simple; c.1-340C>T; Zygosity=Unspecified (hPSCreg=VUi064-C).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C217089; Paroxysmal familial ventricular fibrillation-2
DI   ORDO; Orphanet_228140; Idiopathic ventricular fibrillation, non Brugada type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8Z6 ! VUi064-A
OI   CVCL_E8Z7 ! VUi064-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi067-A
AC   CVCL_E8ZC
SY   328.A; hvs462a
DR   BioSamples; SAMEA118007470
DR   hPSCreg; VUi067-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZD ! VUi067-B
OI   CVCL_E8ZE ! VUi067-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi067-B
AC   CVCL_E8ZD
SY   328.B; hvs462b
DR   hPSCreg; VUi067-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZC ! VUi067-A
OI   CVCL_E8ZE ! VUi067-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi067-C
AC   CVCL_E8ZE
SY   328.C; hvs462c
DR   hPSCreg; VUi067-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZC ! VUi067-A
OI   CVCL_E8ZD ! VUi067-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi068-A
AC   CVCL_E8ZF
SY   238.A; hvs463a
DR   BioSamples; SAMEA118007480
DR   hPSCreg; VUi068-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZG ! VUi068-B
OI   CVCL_E8ZH ! VUi068-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi068-B
AC   CVCL_E8ZG
SY   238.B; hvs463b
DR   hPSCreg; VUi068-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZF ! VUi068-A
OI   CVCL_E8ZH ! VUi068-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi068-C
AC   CVCL_E8ZH
SY   238.C; hvs463c
DR   hPSCreg; VUi068-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZF ! VUi068-A
OI   CVCL_E8ZG ! VUi068-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi069-A
AC   CVCL_E8ZI
SY   237.A; hvs464a
DR   hPSCreg; VUi069-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZJ ! VUi069-B
OI   CVCL_E8ZK ! VUi069-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi069-B
AC   CVCL_E8ZJ
SY   237.B; hvs464b
DR   BioSamples; SAMEA118007482
DR   hPSCreg; VUi069-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZI ! VUi069-A
OI   CVCL_E8ZK ! VUi069-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi069-C
AC   CVCL_E8ZK
SY   237.C; hvs464c
DR   hPSCreg; VUi069-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZI ! VUi069-A
OI   CVCL_E8ZJ ! VUi069-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi070-A
AC   CVCL_E8ZL
SY   298.A; hvs465a
DR   hPSCreg; VUi070-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZM ! VUi070-B
OI   CVCL_E8ZN ! VUi070-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi070-B
AC   CVCL_E8ZM
SY   298.B; hvs465b
DR   BioSamples; SAMEA118007466
DR   hPSCreg; VUi070-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZL ! VUi070-A
OI   CVCL_E8ZN ! VUi070-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi070-C
AC   CVCL_E8ZN
SY   298.C; hvs465c
DR   hPSCreg; VUi070-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZL ! VUi070-A
OI   CVCL_E8ZM ! VUi070-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi071-A
AC   CVCL_E8ZP
SY   307.A; hvs466a
DR   hPSCreg; VUi071-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZQ ! VUi071-B
OI   CVCL_E8ZR ! VUi071-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi071-B
AC   CVCL_E8ZQ
SY   307.B; hvs466b
DR   BioSamples; SAMEA118007467
DR   hPSCreg; VUi071-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZP ! VUi071-A
OI   CVCL_E8ZR ! VUi071-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi071-C
AC   CVCL_E8ZR
SY   307.C; hvs466c
DR   hPSCreg; VUi071-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZP ! VUi071-A
OI   CVCL_E8ZQ ! VUi071-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi072-A
AC   CVCL_E8ZS
SY   297.A; hvs467a
DR   BioSamples; SAMEA118007468
DR   hPSCreg; VUi072-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZT ! VUi072-B
OI   CVCL_E8ZU ! VUi072-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi072-B
AC   CVCL_E8ZT
SY   297.B; hvs467b
DR   hPSCreg; VUi072-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZS ! VUi072-A
OI   CVCL_E8ZU ! VUi072-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi072-C
AC   CVCL_E8ZU
SY   297.C; hvs467c
DR   hPSCreg; VUi072-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZS ! VUi072-A
OI   CVCL_E8ZT ! VUi072-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi073-A
AC   CVCL_E8ZV
SY   157.A; hvs468a
DR   BioSamples; SAMEA118007469
DR   hPSCreg; VUi073-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZW ! VUi073-B
OI   CVCL_E8ZX ! VUi073-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi073-B
AC   CVCL_E8ZW
SY   157.B; hvs468b
DR   hPSCreg; VUi073-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZV ! VUi073-A
OI   CVCL_E8ZX ! VUi073-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi073-C
AC   CVCL_E8ZX
SY   157.C; hvs468c
DR   hPSCreg; VUi073-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZV ! VUi073-A
OI   CVCL_E8ZW ! VUi073-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi074-A
AC   CVCL_E8ZY
SY   113.A; hvs497a
DR   BioSamples; SAMEA116132652
DR   hPSCreg; VUi074-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZZ ! VUi074-B
OI   CVCL_E9A0 ! VUi074-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi074-B
AC   CVCL_E8ZZ
SY   113.B; hvs497b
DR   BioSamples; SAMEA116132744
DR   hPSCreg; VUi074-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZY ! VUi074-A
OI   CVCL_E9A0 ! VUi074-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi074-C
AC   CVCL_E9A0
SY   113.C; hvs497c
DR   BioSamples; SAMEA116132745
DR   hPSCreg; VUi074-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZY ! VUi074-A
OI   CVCL_E8ZZ ! VUi074-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi075-A
AC   CVCL_E9A1
SY   105.A; hvs498a
DR   BioSamples; SAMEA116132746
DR   hPSCreg; VUi075-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A2 ! VUi075-B
OI   CVCL_E9A3 ! VUi075-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi075-B
AC   CVCL_E9A2
SY   105.B; hvs498b
DR   BioSamples; SAMEA116132749
DR   hPSCreg; VUi075-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A1 ! VUi075-A
OI   CVCL_E9A3 ! VUi075-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi075-C
AC   CVCL_E9A3
SY   105.C; hvs498c
DR   BioSamples; SAMEA116132751
DR   hPSCreg; VUi075-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A1 ! VUi075-A
OI   CVCL_E9A2 ! VUi075-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi076-A
AC   CVCL_E9A4
SY   509.A; hvs499a
DR   BioSamples; SAMEA116132753
DR   hPSCreg; VUi076-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A5 ! VUi076-B
OI   CVCL_E9A6 ! VUi076-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi076-B
AC   CVCL_E9A5
SY   509.B; hvs499b
DR   BioSamples; SAMEA116132832
DR   hPSCreg; VUi076-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A4 ! VUi076-A
OI   CVCL_E9A6 ! VUi076-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi076-C
AC   CVCL_E9A6
SY   509.C; hvs499c
DR   BioSamples; SAMEA116132833
DR   hPSCreg; VUi076-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A4 ! VUi076-A
OI   CVCL_E9A5 ! VUi076-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi077-A
AC   CVCL_E9A7
SY   315.A; hvs500a
DR   BioSamples; SAMEA116132835
DR   hPSCreg; VUi077-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A8 ! VUi077-B
OI   CVCL_E9A9 ! VUi077-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi077-B
AC   CVCL_E9A8
SY   315.B; hvs500b
DR   BioSamples; SAMEA116132867
DR   hPSCreg; VUi077-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A7 ! VUi077-A
OI   CVCL_E9A9 ! VUi077-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi077-C
AC   CVCL_E9A9
SY   315.C; hvs500c
DR   BioSamples; SAMEA116133055
DR   hPSCreg; VUi077-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9A7 ! VUi077-A
OI   CVCL_E9A8 ! VUi077-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi078-A
AC   CVCL_E9AA
SY   152.A; hvs501a
DR   BioSamples; SAMEA116133056
DR   hPSCreg; VUi078-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AB ! VUi078-B
OI   CVCL_E9AC ! VUi078-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi078-B
AC   CVCL_E9AB
SY   152.B; hvs501b
DR   BioSamples; SAMEA116133059
DR   hPSCreg; VUi078-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AA ! VUi078-A
OI   CVCL_E9AC ! VUi078-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi078-C
AC   CVCL_E9AC
SY   152.C; hvs501c
DR   BioSamples; SAMEA116133061
DR   hPSCreg; VUi078-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AA ! VUi078-A
OI   CVCL_E9AB ! VUi078-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi079-A
AC   CVCL_E9AD
SY   470.A; hvs502a
DR   BioSamples; SAMEA116133062
DR   hPSCreg; VUi079-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AE ! VUi079-B
OI   CVCL_E9AF ! VUi079-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi079-B
AC   CVCL_E9AE
SY   470.B; hvs502b
DR   BioSamples; SAMEA116133064
DR   hPSCreg; VUi079-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AD ! VUi079-A
OI   CVCL_E9AF ! VUi079-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi079-C
AC   CVCL_E9AF
SY   470.C; hvs502c
DR   BioSamples; SAMEA116133065
DR   hPSCreg; VUi079-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AD ! VUi079-A
OI   CVCL_E9AE ! VUi079-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi080-A
AC   CVCL_E9AG
SY   293.A; hvs503a
DR   BioSamples; SAMEA116133067
DR   hPSCreg; VUi080-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AH ! VUi080-B
OI   CVCL_E9AI ! VUi080-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi080-B
AC   CVCL_E9AH
SY   293.B; hvs503b
DR   BioSamples; SAMEA116133069
DR   hPSCreg; VUi080-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AG ! VUi080-A
OI   CVCL_E9AI ! VUi080-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi080-C
AC   CVCL_E9AI
SY   293.C; hvs503c
DR   BioSamples; SAMEA116133070
DR   hPSCreg; VUi080-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AG ! VUi080-A
OI   CVCL_E9AH ! VUi080-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi081-A
AC   CVCL_E9AJ
SY   379.A; hvs504a
DR   BioSamples; SAMEA116133071
DR   hPSCreg; VUi081-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AK ! VUi081-B
OI   CVCL_E9AL ! VUi081-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi081-B
AC   CVCL_E9AK
SY   379.B; hvs504b
DR   BioSamples; SAMEA116133073
DR   hPSCreg; VUi081-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AJ ! VUi081-A
OI   CVCL_E9AL ! VUi081-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi081-C
AC   CVCL_E9AL
SY   379.C; hvs504c
DR   BioSamples; SAMEA116133076
DR   hPSCreg; VUi081-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AJ ! VUi081-A
OI   CVCL_E9AK ! VUi081-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi082-A
AC   CVCL_E9AM
SY   311.A; hvs505a
DR   BioSamples; SAMEA116133193
DR   hPSCreg; VUi082-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AN ! VUi082-B
OI   CVCL_E9AP ! VUi082-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi082-B
AC   CVCL_E9AN
SY   311.B; hvs505b
DR   BioSamples; SAMEA116133195
DR   hPSCreg; VUi082-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AM ! VUi082-A
OI   CVCL_E9AP ! VUi082-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi082-C
AC   CVCL_E9AP
SY   311.C; hvs505c
DR   BioSamples; SAMEA116133196
DR   hPSCreg; VUi082-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AM ! VUi082-A
OI   CVCL_E9AN ! VUi082-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi083-A
AC   CVCL_E9AQ
SY   339.A; hvs506a
DR   BioSamples; SAMEA116133197
DR   hPSCreg; VUi083-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AR ! VUi083-B
OI   CVCL_E9AS ! VUi083-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi083-B
AC   CVCL_E9AR
SY   339.B; hvs506b
DR   BioSamples; SAMEA116133200
DR   hPSCreg; VUi083-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AQ ! VUi083-A
OI   CVCL_E9AS ! VUi083-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi083-C
AC   CVCL_E9AS
SY   339.C; hvs506c
DR   BioSamples; SAMEA116133201
DR   hPSCreg; VUi083-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AQ ! VUi083-A
OI   CVCL_E9AR ! VUi083-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi084-A
AC   CVCL_E9AT
SY   78.A; hvs507a
DR   BioSamples; SAMEA116133202
DR   hPSCreg; VUi084-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AU ! VUi084-B
OI   CVCL_E9AV ! VUi084-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi084-B
AC   CVCL_E9AU
SY   78.B; hvs507b
DR   BioSamples; SAMEA116133254
DR   hPSCreg; VUi084-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AT ! VUi084-A
OI   CVCL_E9AV ! VUi084-C
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi084-C
AC   CVCL_E9AV
SY   78.C; hvs507c
DR   BioSamples; SAMEA116133256
DR   hPSCreg; VUi084-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AT ! VUi084-A
OI   CVCL_E9AU ! VUi084-B
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi085-A
AC   CVCL_E9AW
SY   175.A; hvs508a
DR   BioSamples; SAMEA116133258
DR   hPSCreg; VUi085-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AX ! VUi085-B
OI   CVCL_E9AY ! VUi085-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi085-B
AC   CVCL_E9AX
SY   175.B; hvs508b
DR   BioSamples; SAMEA116133260
DR   hPSCreg; VUi085-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AW ! VUi085-A
OI   CVCL_E9AY ! VUi085-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi085-C
AC   CVCL_E9AY
SY   175.C; hvs508c
DR   BioSamples; SAMEA116133261
DR   hPSCreg; VUi085-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AW ! VUi085-A
OI   CVCL_E9AX ! VUi085-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi086-A
AC   CVCL_E9AZ
SY   217.A; hvs509a
DR   BioSamples; SAMEA116133263
DR   hPSCreg; VUi086-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9B0 ! VUi086-B
OI   CVCL_E9B1 ! VUi086-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi086-B
AC   CVCL_E9B0
SY   217.B; hvs509b
DR   BioSamples; SAMEA116133265
DR   hPSCreg; VUi086-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AZ ! VUi086-A
OI   CVCL_E9B1 ! VUi086-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi086-C
AC   CVCL_E9B1
SY   217.C; hvs509c
DR   BioSamples; SAMEA116133266
DR   hPSCreg; VUi086-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9AZ ! VUi086-A
OI   CVCL_E9B0 ! VUi086-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi087-A
AC   CVCL_E9B2
SY   305.A; hvs510a
DR   BioSamples; SAMEA116133267
DR   hPSCreg; VUi087-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9B3 ! VUi087-B
OI   CVCL_E9B4 ! VUi087-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi087-B
AC   CVCL_E9B3
SY   305.B; hvs510b
DR   BioSamples; SAMEA116133270
DR   hPSCreg; VUi087-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9B2 ! VUi087-A
OI   CVCL_E9B4 ! VUi087-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi087-C
AC   CVCL_E9B4
SY   305.C; hvs510c
DR   BioSamples; SAMEA116133271
DR   hPSCreg; VUi087-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9B2 ! VUi087-A
OI   CVCL_E9B3 ! VUi087-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi089-A
AC   CVCL_E8Z5
SY   16.1; hvs-481; hvs481
DR   BioSamples; SAMEA118007462
DR   hPSCreg; VUi089-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi090-A
AC   CVCL_E8Z9
SY   hvs533a
DR   BioSamples; SAMEA116074829
DR   hPSCreg; VUi090-A
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8ZA ! VUi090-B
OI   CVCL_E8ZB ! VUi090-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi090-B
AC   CVCL_E8ZA
SY   hvs533b
DR   BioSamples; SAMEA116074835
DR   hPSCreg; VUi090-B
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8Z9 ! VUi090-A
OI   CVCL_E8ZB ! VUi090-C
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUi090-C
AC   CVCL_E8ZB
SY   hvs533c
DR   BioSamples; SAMEA116074836
DR   hPSCreg; VUi090-C
CC   From: Vrije Universiteit Amsterdam; Amsterdam; Netherlands.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E8Z9 ! VUi090-A
OI   CVCL_E8ZA ! VUi090-B
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   VUMC-DIPG-A
AC   CVCL_IT43
SY   VU-DIPG-A; VU-DIPG.A; DIPG-A
DR   cancercelllines; CVCL_IT43
DR   Wikidata; Q54993418
RX   PubMed=23637844;
RX   PubMed=25939062;
CC   Sequence variation: Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=25939062).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 13
//
ID   VUMC-DIPG-B
AC   CVCL_IT44
SY   VU-DIPG-B; VU-DIPG.B; DIPG-B
DR   Wikidata; Q54993419
RX   PubMed=23637844;
RX   PubMed=25939062;
CC   Sequence variation: Mutation; HGNC; HGNC:4776; H3C2; Simple; p.Lys28Met (c.83A>T) (H3.1K27M); Zygosity=Unspecified (PubMed=25939062).
CC   Derived from site: In situ; Brainstem, pons; UBERON=UBERON_0000988.
DI   NCIt; C94764; Diffuse intrinsic pontine glioma
DI   ORDO; Orphanet_497188; Diffuse intrinsic pontine glioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 10
//
ID   VUMC-RB-26
AC   CVCL_ZF03
DR   GEO; GSM2043883
DR   GEO; GSM2043884
DR   GEO; GSM2043885
DR   Wikidata; Q98134664
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 4
//
ID   VUP-1
AC   CVCL_J307
SY   VUP 1; VUP
DR   Wikidata; Q54993421
RX   CelloPub=CLPUB00127;
RX   PubMed=885282;
RX   PubMed=885283;
RX   PubMed=6819484;
RX   PubMed=7542669;
RX   PubMed=12098005;
CC   Doubling time: 38.7 hours (PubMed=6819484).
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   VUP-1 V+B2
AC   CVCL_VP04
SY   V+B2
DR   Wikidata; Q98134666
DR   Ximbio; 153371
RX   PubMed=7542669;
CC   Characteristics: Expresses ITGAV/ITGB1 at high level and does not express ITGAV/ITGB3.
CC   Discontinued: Ximbio; 153371; probable.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J307 ! VUP-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 6
//
ID   VUP-1 V+D9H
AC   CVCL_VP05
SY   V+D9H
DR   Wikidata; Q98134668
DR   Ximbio; 153372
RX   PubMed=7542669;
CC   Characteristics: Expresses ITGAV/ITGB1 at high level and does not express ITGAV/ITGB3.
CC   Discontinued: Ximbio; 153372; probable.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J307 ! VUP-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 6
//
ID   VUP-1 V-C10
AC   CVCL_VP03
SY   V-C10
DR   Wikidata; Q98134671
DR   Ximbio; 153373
RX   PubMed=7542669;
CC   Characteristics: Expresses ITGAV/ITGB1 at low level and does not express ITGAV/ITGB3.
CC   Discontinued: Ximbio; 153373; probable.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J307 ! VUP-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 6
//
ID   VUP-1 V-D9
AC   CVCL_VN99
SY   V-D9
DR   Wikidata; Q98134673
DR   Ximbio; 153374
RX   PubMed=7542669;
CC   Characteristics: Expresses ITGAV/ITGB1 at low level and does not express ITGAV/ITGB4.
CC   Discontinued: Ximbio; 153374; probable.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J307 ! VUP-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 6
//
ID   VUP15
AC   CVCL_J305
DR   Wikidata; Q54993422
RX   Patent=WO2006091868A2;
RX   PubMed=10205165;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6156; ITGB3.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J307 ! VUP-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   VUP20
AC   CVCL_J306
DR   Wikidata; Q54993423
RX   Patent=WO2006091868A2;
CC   Selected for resistance to: ChEBI; CHEBI_17939; Puromycin.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_J307 ! VUP-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 11
//
ID   VUZUZLi001-A
AC   CVCL_UG25
SY   hVH-1; hVH1
DR   hPSCreg; VUZUZLi001-A
DR   Wikidata; Q98134674
RX   PubMed=30321832;
CC   From: Institut fur Virologie und Zellbiologie; Lubeck; Germany.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   VV-1H831
AC   CVCL_EG63
SY   1H831
DR   JCRB; JCRB1632
DR   Wikidata; Q54993433
RX   PubMed=3008418;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08714; Vaccinia virus hemagglutinin OPG185 (A56R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 6
//
ID   VV-B2D10
AC   CVCL_JF85
SY   B2D10
DR   JCRB; JCRB1634
DR   Wikidata; Q54993434
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08714; Vaccinia virus hemagglutinin OPG185 (A56R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   VV-B6F4
AC   CVCL_JF90
SY   B6F4
DR   JCRB; JCRB1651
DR   Wikidata; Q54993435
RX   PubMed=2450423;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08714; Vaccinia virus hemagglutinin OPG185 (A56R).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 6
//
ID   VvmAb1m1n7
AC   CVCL_B6Z9
DR   Wikidata; Q112041915
RX   Patent=CN108251379B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016146.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Vibrio vulnificus membrane protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   vWTa
AC   CVCL_0G81
DR   SKIP; SKIP000533
DR   Wikidata; Q54993436
RX   PubMed=24321451;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   vWTb
AC   CVCL_0G82
SY   WTB
DR   SKIP; SKIP000534
DR   SKIP; SKIP001333
DR   Wikidata; Q54993437
RX   PubMed=24321451;
RX   PubMed=26740656;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   Vx2
AC   CVCL_3864
SY   VX2; Vx-2; VX-2
DR   CLO; CLO_0009553
DR   CLDB; cl4673
DR   ATCC; CRL-6503
DR   BCRJ; 0297
DR   CCRID; 1101RAB-PUMC000320
DR   CCTCC; GDC0165
DR   CLS; 609374
DR   ECACC; 90030912
DR   NCI-DTP; VX-2
DR   TKG; TKG 0332
DR   Wikidata; Q54993438
RX   PubMed=6126038;
RX   PubMed=6500159;
RX   PubMed=14955572;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Characteristics: Established from the VX2 (V2) transplantable tumor which was initiated in 1938.
CC   Doubling time: ~2-2.5 days (PubMed=6126038).
CC   Transformant: NCBI_TaxID; 10271; Rabbit fibroma virus (SFV).
CC   Discontinued: ATCC; CRL-6503; true.
CC   Discontinued: CLS; 609374; true.
DI   NCIt; C134989; Rabbit neoplasm
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 19
//
ID   Vx7
AC   CVCL_3470
SY   VX7; Vx-7; VX-7
DR   CLO; CLO_0009554
DR   ATCC; CRL-6504
DR   BCRJ; 0246
DR   Wikidata; Q54993439
RX   PubMed=6286852;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 10271; Rabbit fibroma virus (SFV).
CC   Discontinued: ATCC; CRL-6504; true.
CC   Breed/subspecies: New Zealand white; VBO=VBO_0001267.
DI   NCIt; C133740; Rabbit fibroma
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
OI   CVCL_S376 ! Oc2T(VX7)
OI   CVCL_T725 ! Oc4T/cc
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 8
//
ID   VXG3
AC   CVCL_J128
DR   cancercelllines; CVCL_J128
DR   Wikidata; Q54993440
RX   Patent=US5976860;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11865.
CC   Population: Caucasian.
CC   Characteristics: Infected with Ehrlichia.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   W-18 VA 2
AC   CVCL_LG29
SY   W-18 VA2; W18 Va2; W-18VA 2; W-18 Va-2; W-18/VA-2; W-18VA2; W18VA2
DR   Wikidata; Q54993442
RX   PubMed=174085;
RX   PubMed=1260760;
RX   PubMed=4304841;
RX   PubMed=13972152;
RX   PubMed=14051836;
RX   PubMed=14288316;
RX   PubMed=14288318;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   W-20-17
AC   CVCL_6529
SY   W-20 clone 17; W20-17
DR   CLO; CLO_0009556
DR   ATCC; CRL-2623
DR   BioSample; SAMN11397648
DR   Wikidata; Q54993443
RX   PubMed=1311236;
RX   PubMed=31220119;
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: W++.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,17
ST   Mouse STR 1-2: 13,20
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3,23.3
ST   Mouse STR 5-5: 12,17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12,17
ST   Mouse STR 7-1: 26.2,29
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 16,17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 15,16
ST   Mouse STR 18-3: 16,18
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 27
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   W-2K-11
AC   CVCL_6E69
DR   Wikidata; Q54993445
RX   PubMed=195084;
RX   PubMed=6262522;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
CC   Breed/subspecies: C3H/He.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6E66 ! C3H2K-C4
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 8
//
ID   W-3Y-23
AC   CVCL_6E71
DR   Wikidata; Q54993447
RX   PubMed=195084;
RX   PubMed=6262522;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=777).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E147 ! 3Y1-B clone 1-6
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   W-98
AC   CVCL_DG19
DR   GEO; GSM114602
DR   Wikidata; Q54993448
RX   PubMed=16966431;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   W-ES
AC   CVCL_W528
DR   cancercelllines; CVCL_W528
DR   Cosmic; 1085908
DR   Cosmic; 1381110
DR   IARC_TP53; 1275
DR   Wikidata; Q54993449
RX   PubMed=2486606;
RX   PubMed=2731119;
RX   PubMed=8221663;
RX   PubMed=9738976;
RX   PubMed=12054564;
CC   Population: Japanese.
CC   Doubling time: 35 hours (PubMed=2486606).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:3508; EWSR1; Name(s)=EWSR1-ERG, EWS-ERG (PubMed=9738976).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Phe (c.527G>T); ClinVar=VCV000376569; Zygosity=Unspecified (PubMed=8221663).
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   W-V
AC   CVCL_E079
SY   WV1
DR   CLO; CLO_0050644
DR   BioSample; SAMN03472349
DR   RCB; RCB0252
DR   Wikidata; Q54993450
RX   CelloPub=CLPUB00712;
RX   PubMed=2762303;
RX   PubMed=2878433;
RX   PubMed=9230208;
RX   PubMed=19935656;
RX   PubMed=22989712;
CC   Characteristics: Cell line positive for alternative lengthening of telomeres (ALT+) (CelloPub=CLPUB00712; PubMed=19935656).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys924fs*973 (c.2773delG); Zygosity=Unspecified (PubMed=9230208).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0252
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   W. C.
AC   CVCL_C8NW
DR   Wikidata; Q123033789
RX   PubMed=1374683;
CC   Doubling time: 45.4 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   W. S.
AC   CVCL_C8NX
DR   Wikidata; Q123033790
RX   PubMed=1374683;
CC   Doubling time: 45.4 hours (PubMed=1374683).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   W.Hb12
AC   CVCL_C7PV
SY   Hb12
DR   Wikidata; Q117704964
RX   PubMed=8022822;
RX   PubMed=9371519;
RX   PubMed=12203227;
RX   PubMed=15702245;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   W.Hb13
AC   CVCL_C7PW
DR   Wikidata; Q117704965
RX   PubMed=8022822;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:990; BCL2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   W001C
AC   CVCL_E2WR
DR   BTO; BTO_0005256
RX   PubMed=8972597;
RX   PubMed=16593974;
RX   PubMed=16661882;
RX   PubMed=16664958;
CC   Group: Plant cell line.
CC   From: Street, Herbert E.; Botanical Laboratories, University of Leicester; Leicester; United Kingdom.
CC   Characteristics: Model system to study plant embryogenesis (PubMed=16593974; PubMed=16661882; PubMed=16664958).
OX   NCBI_TaxID=4039; ! Daucus carota (Wild carrot)
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   W0-2
AC   CVCL_F1EB
SY   W02; mW02
DR   ABCD; ABCD_AA445
RX   PubMed=8798471;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05067; Human APP (Note=Binds to APP40, APP42 and APP43 AA 5-8; Abeta(5-8)).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   W1
AC   CVCL_0C64
DR   Cosmic; 2089679
DR   Wikidata; Q54993451
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7769852;
RX   PubMed=8182949;
RX   PubMed=23955599;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7320; Childhood chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   W10
AC   CVCL_RU25
SY   PureStem W10 progenitor; ACTC196
DR   Wikidata; Q54993452
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-196; https://web.archive.org/web/20141202111907/http://www.esibio.com/purestemr-w10-progenitor/
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Senescence: Can undergo >40 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   W10-1A
AC   CVCL_C706
DR   Wikidata; Q54993453
RX   PubMed=19222349;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   W112 6G-2
AC   CVCL_A0ES
SY   W112
DR   Wikidata; Q108821499
RX   Patent=US6171799;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9927.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human T-cell receptor variable beta-5.3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   W12 [Human keratinocyte]
AC   CVCL_T290
DR   Wikidata; Q54993456
RX   PubMed=2467886;
RX   PubMed=7707525;
RX   PubMed=16505361;
CC   Virology: At early passages contains about 100 HPV16 episomes per cell (PubMed=7707525).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (PubMed=2467886).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 10-09-24; Version: 16
//
ID   W12 [Mouse ESC]
AC   CVCL_Y631
DR   Wikidata; Q54993457
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   W12 clone 20822
AC   CVCL_D6N8
RX   PubMed=7707525;
CC   Virology: Contains 3 integrated HPV16 genomes per cell (PubMed=7707525).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T290 ! W12 [Human keratinocyte]
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   W12 clone 20850
AC   CVCL_D6N9
RX   PubMed=7707525;
CC   Virology: Contains about 1000 HPV16 episomes per cell (PubMed=7707525).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T290 ! W12 [Human keratinocyte]
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   W12 clone 20861
AC   CVCL_D6NA
RX   PubMed=7707525;
CC   Virology: Contains about 30 integrated HPV16 genomes per cell (PubMed=7707525).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T290 ! W12 [Human keratinocyte]
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   W12 clone 20862
AC   CVCL_D6NB
RX   PubMed=7707525;
CC   Virology: Contains about 60 integrated HPV16 genomes per cell (PubMed=7707525).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T290 ! W12 [Human keratinocyte]
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   W12 clone 20863
AC   CVCL_D6N7
SY   W12E
RX   PubMed=7707525;
RX   PubMed=29021401;
CC   Virology: Contains about 1000 HPV16 episomes per cell (PubMed=7707525).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Donor information: Established from a patient suffering from a low-grade squamous intraepithelial lesion (LG-SIL) (from parent cell line).
CC   Derived from site: In situ; Skin, epidermis; UBERON=UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T290 ! W12 [Human keratinocyte]
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   W13-1C
AC   CVCL_C707
DR   Wikidata; Q54993458
RX   PubMed=19222349;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   W14-1A
AC   CVCL_C708
DR   Wikidata; Q54993459
RX   PubMed=19222349;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   W162
AC   CVCL_3807
DR   CLO; CLO_0009555
DR   ATCC; CRL-2783
DR   ATCC; JHU-66
DR   Wikidata; Q54993461
RX   PubMed=6310575;
CC   Group: Non-human primate cell line.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5 (Note=E4).
CC   Discontinued: ATCC; CRL-2783; true.
CC   Discontinued: ATCC; JHU-66; true.
CC   Derived from site: In situ; Kidney, epithelium; UBERON=UBERON_0004819.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=60711; ! Chlorocebus sabaeus (Green monkey)
HI   CVCL_0059 ! Vero
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 15
//
ID   W1799
AC   CVCL_VL05
DR   Wikidata; Q98134676
RX   PubMed=9590181;
RX   PubMed=12446774;
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 10
//
ID   W1799-hTERT
AC   CVCL_VL06
DR   Wikidata; Q98134678
RX   PubMed=12446774;
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C4692; Nijmegen breakage syndrome
DI   ORDO; Orphanet_647; Nijmegen breakage syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VL05 ! W1799
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 13
//
ID   W2 [Mouse ESC]
AC   CVCL_Y632
DR   Wikidata; Q54993462
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   W2 [Mouse hybridoma against bovine S100A8/S100A9]
AC   CVCL_C6II
DR   Wikidata; Q116050768
RX   PubMed=8505358;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P28782; Bovine S100A8.
CC   Monoclonal antibody target: UniProtKB; P28783; Bovine S100A9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   W20C6
AC   CVCL_Z823
DR   DGRC; 159
DR   FlyBase_Cell_line; FBtc0000159
DR   Wikidata; Q54993463
RX   PubMed=1905427;
CC   Group: Insect cell line.
CC   Doubling time: 102 hours (DGRC=159).
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   W3
AC   CVCL_Y633
DR   Wikidata; Q54993464
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   W3.5
AC   CVCL_A7WJ
DR   BEI_Resources; MRA-669
DR   Wikidata; Q107117405
RX   PubMed=2652137;
RX   PubMed=3539609;
CC   Group: Malaria research cell line.
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Plasmodium berghei erythrocytic-stage exoantigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 4
//
ID   W3/13
AC   CVCL_G185
DR   ECACC; 84112001
DR   Wikidata; Q54993465
RX   PubMed=88272;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P13838; Rat Spn.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   W3/15
AC   CVCL_G186
SY   W3/15 HLK
DR   ECACC; 88051305
DR   Wikidata; Q54993466
RX   PubMed=88272;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   W3/25
AC   CVCL_G187
SY   W3/25 HL
DR   ECACC; 84112002
DR   Wikidata; Q54993467
RX   PubMed=88272;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P05540; Rat Cd4.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   W3C4E11
AC   CVCL_IQ37
DR   Wikidata; Q54993468
RX   Patent=US7659116;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2668.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; O60353; Human FZD6.
CC   Monoclonal antibody target: UniProtKB; O00144; Human FZD9/CD349.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   W3D2B10
AC   CVCL_IQ38
DR   Wikidata; Q54993469
RX   Patent=US7659116;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2669.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; O75084; Human FZD7.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 03-03-17; Last updated: 21-03-23; Version: 5
//
ID   W3UF
AC   CVCL_X940
SY   W3uF
DR   CGH-DB; 333-2
DR   CGH-DB; 9355-4
DR   Wikidata; Q54993470
RX   PubMed=10457904;
RX   PubMed=11330945;
RX   PubMed=12417041;
RX   PubMed=17671176;
CC   Population: Japanese.
CC   Doubling time: 22-24 hours (PubMed=10457904).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A620 ! HUOCA-II
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 9
//
ID   W4 [Mouse ESC]
AC   CVCL_Y634
SY   W4/129S6
DR   Wikidata; Q54993471
RX   PubMed=11084865;
RX   PubMed=25277546;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 8
//
ID   W4 [Mouse lymphoma]
AC   CVCL_H588
DR   ChEMBL-Cells; CHEMBL3308050
DR   ChEMBL-Targets; CHEMBL613708
DR   PubChem_Cell_line; CVCL_H588
DR   Wikidata; Q54993472
RX   PubMed=7689176;
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:95484; Fas.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4338 ! WR19L
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 10
//
ID   W4F.5B
AC   CVCL_F809
DR   CLO; CLO_0009557
DR   ATCC; HB-9282
DR   Wikidata; Q54993473
RX   Patent=US4845026;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9282.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   W5
AC   CVCL_Y635
DR   Wikidata; Q54993475
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129S9/SvEvH.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   W6/1
AC   CVCL_U056
SY   W6/1 HLK
DR   ECACC; 13082201
DR   Wikidata; Q54993478
RX   PubMed=88272;
RX   PubMed=667938;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human antigen on group A erythrocytes.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 7
//
ID   W6/32
AC   CVCL_7872
SY   HB95
DR   CLO; CLO_0009558
DR   ATCC; HB-95
DR   CCRID; 1101MOU-PUMC000389
DR   CCRID; 4201MOU-CCTCC00123
DR   CCTCC; GDC0123
DR   ECACC; 84112003
DR   IZSLER; BS Hy 32
DR   PRIDE; PXD000394
DR   Wikidata; Q54993479
RX   PubMed=88272;
RX   PubMed=667938;
RX   PubMed=25576301;
CC   Monoclonal antibody isotype: IgG2a.
CC   Omics: Proteomics; HLA class I peptidome.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   W6/32HK
AC   CVCL_G134
DR   ECACC; 86012801
DR   Wikidata; Q54993481
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7872 ! W6/32
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   W6/32HL
AC   CVCL_G135
DR   ECACC; 85102222
DR   NCBI_Iran; H127
DR   Wikidata; Q54993493
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_7872 ! W6/32
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   W7C5
AC   CVCL_B0N4
DR   Wikidata; Q108821500
RX   PubMed=11458505;
RX   PubMed=12799300;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q6YHK3; Human CD109.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   W8-8A
AC   CVCL_C705
DR   Wikidata; Q54993494
RX   PubMed=19222349;
CC   From: StemLifeLine, Inc.; San Carlos; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   W8B2
AC   CVCL_B0N6
DR   Wikidata; Q108821501
RX   Patent=US9052316;
RX   PubMed=12604402;
RX   PubMed=19066333;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2567.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05186; Human ALPL.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   W9.5
AC   CVCL_WS26
DR   FCS-free; 259-2-537-2-3-3
DR   Wikidata; Q98134680
RX   PubMed=8050371;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/w/cell-lines-detail-151.html
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129/Sv.C3-+c+p.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-07-19; Last updated: 10-04-25; Version: 6
//
ID   Wa Fen
AC   CVCL_3279
DR   CLO; CLO_0009559
DR   ATCC; CRL-1271
DR   Wikidata; Q54993495
CC   Discontinued: ATCC; CRL-1271; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   WA-1
AC   CVCL_JL42
SY   WA1
DR   Wikidata; Q54993497
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   WA-2
AC   CVCL_JL43
SY   WA2
DR   Wikidata; Q54993498
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   Wa-2
AC   CVCL_M847
SY   Wa2
DR   Cosmic; 802253
DR   Wikidata; Q54993500
RX   PubMed=2180563;
RX   PubMed=9671307;
RX   PubMed=10397258;
CC   Doubling time: 53 hours (Note=At 50th passage) (PubMed=2180563).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=9671307).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C6586; Extrarenal rhabdoid tumor
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   WA-3
AC   CVCL_JL44
SY   WA3
DR   Wikidata; Q54993501
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   WA-4
AC   CVCL_JL45
SY   WA4
DR   Wikidata; Q54993502
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   WA-C3CD5+
AC   CVCL_Y438
SY   WaC3 CD5+; WaC3CD5+; WaC3CD5; WAC3CD5+; WAC3-CD5; WAC-CD5+; Wa C3,CD5+; Waco3-CD5
DR   ArrayExpress; E-MTAB-4527
DR   DSMZ; ACC-769
DR   DSMZCellDive; ACC-769
DR   NCBI_Iran; C547
DR   Wikidata; Q54993504
RX   PubMed=8127151;
RX   PubMed=19358282;
RX   PubMed=23297799;
CC   Doubling time: ~40-50 hours (DSMZ=ACC-769).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-769; NCBI_Iran=C547
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 8,11 (NCBI_Iran=C547)
ST   D16S539: 9,12 (DSMZ=ACC-769)
ST   D18S51: 11,18 (NCBI_Iran=C547)
ST   D18S51: 12,20.2 (DSMZ=ACC-769)
ST   D19S433: 13,14
ST   D21S11: 29,30 (NCBI_Iran=C547)
ST   D21S11: 30,31 (DSMZ=ACC-769)
ST   D2S1338: 20,25
ST   D3S1358: 15,16 (NCBI_Iran=C547)
ST   D3S1358: 16,17 (DSMZ=ACC-769)
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 19,20 (NCBI_Iran=C547)
ST   FGA: 20,21 (DSMZ=ACC-769)
ST   Penta D: 11,12
ST   Penta E: 15,21
ST   TH01: 8,9 (NCBI_Iran=C547)
ST   TH01: 8,9.3 (DSMZ=ACC-769)
ST   TPOX: 7,11 (NCBI_Iran=C547)
ST   TPOX: 8,11 (DSMZ=ACC-769)
ST   vWA: 18
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y549 ! WA-OSEL
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 16
//
ID   WA-hT
AC   CVCL_8766
SY   KAR-0104
DR   CLO; CLO_0050041
DR   BioSample; SAMN03471949
DR   FANTOM5_SSTAR; 10562-108A4
DR   RCB; RCB2279
DR   Wikidata; Q54993505
RX   PubMed=16142338;
RX   PubMed=22576795;
RX   PubMed=38639832;
CC   Population: Japanese.
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): RCB=RCB2279
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 9,10
ST   vWA: 17
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   WA-mFib
AC   CVCL_U894
DR   CLO; CLO_0050749
DR   RCB; RCB1925
DR   Wikidata; Q54993507
RX   PubMed=16142338;
RX   PubMed=26421875;
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: BALB/c(nu/nu).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WA-OSEL
AC   CVCL_Y549
SY   WA-osel; Wa osel; WAOSEL4
DR   ArrayExpress; E-MTAB-4527
DR   DepMap; ACH-001707
DR   DSMZ; ACC-767
DR   DSMZCellDive; ACC-767
DR   Wikidata; Q54993509
RX   PubMed=8127151;
RX   PubMed=23297799;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Doubling time: ~40 hours (DSMZ=ACC-767).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-767
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9
ST   D16S539: 9,12
ST   D18S51: 12,19.2
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 20,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 20,21
ST   Penta D: 11,12
ST   Penta E: 15,20
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C3163; Chronic lymphocytic leukemia
DI   ORDO; Orphanet_67038; B-cell chronic lymphocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_Y438 ! WA-C3CD5+
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 15
//
ID   WA01
AC   CVCL_9771
SY   WA 01; WA-01; WA1; H1; H1-hESC; ESC H1; GE01; WAe001-A; WICELLe001-A; WA01-PCBC; PCBC02hse2011100705; SC11-014
DR   BTO; BTO_0006060
DR   CLO; CLO_0037281
DR   EFO; EFO_0003042
DR   4DN; 4DNSRHNAF6M6
DR   4DN; 4DNSRV3SKQ8M
DR   BioSample; SAMN03471895
DR   BioSamples; SAMEA7768168
DR   CCRID; 3101HUMSCSP301
DR   CCRID; 3101HUMSCSP306
DR   ENCODE; ENCBS001VRA
DR   ENCODE; ENCBS011NFB
DR   ENCODE; ENCBS019EUF
DR   ENCODE; ENCBS040WGM
DR   ENCODE; ENCBS051SJH
DR   ENCODE; ENCBS055BDT
DR   ENCODE; ENCBS055DBZ
DR   ENCODE; ENCBS060CKC
DR   ENCODE; ENCBS060MZO
DR   ENCODE; ENCBS081AUS
DR   ENCODE; ENCBS083WOY
DR   ENCODE; ENCBS086PQW
DR   ENCODE; ENCBS103ZIA
DR   ENCODE; ENCBS111ENC
DR   ENCODE; ENCBS131GSD
DR   ENCODE; ENCBS153GON
DR   ENCODE; ENCBS182IPV
DR   ENCODE; ENCBS215WGD
DR   ENCODE; ENCBS244HDB
DR   ENCODE; ENCBS253TYD
DR   ENCODE; ENCBS262EHC
DR   ENCODE; ENCBS270AGK
DR   ENCODE; ENCBS282MUP
DR   ENCODE; ENCBS284CPV
DR   ENCODE; ENCBS285QSX
DR   ENCODE; ENCBS299BNQ
DR   ENCODE; ENCBS299NOL
DR   ENCODE; ENCBS307HNW
DR   ENCODE; ENCBS309DZE
DR   ENCODE; ENCBS345JIP
DR   ENCODE; ENCBS364BFI
DR   ENCODE; ENCBS368BPP
DR   ENCODE; ENCBS371MFZ
DR   ENCODE; ENCBS380OBH
DR   ENCODE; ENCBS409PYK
DR   ENCODE; ENCBS428NIG
DR   ENCODE; ENCBS440MTS
DR   ENCODE; ENCBS479XUT
DR   ENCODE; ENCBS484NGW
DR   ENCODE; ENCBS497CZZ
DR   ENCODE; ENCBS513BIK
DR   ENCODE; ENCBS534NMZ
DR   ENCODE; ENCBS540UTP
DR   ENCODE; ENCBS559QNR
DR   ENCODE; ENCBS568FYY
DR   ENCODE; ENCBS570AYT
DR   ENCODE; ENCBS582QGL
DR   ENCODE; ENCBS614LXI
DR   ENCODE; ENCBS626BQK
DR   ENCODE; ENCBS649THQ
DR   ENCODE; ENCBS661AAA
DR   ENCODE; ENCBS665AAA
DR   ENCODE; ENCBS668AAA
DR   ENCODE; ENCBS670AAA
DR   ENCODE; ENCBS704NOS
DR   ENCODE; ENCBS706WYC
DR   ENCODE; ENCBS708BLT
DR   ENCODE; ENCBS711AAA
DR   ENCODE; ENCBS716AAA
DR   ENCODE; ENCBS716FMR
DR   ENCODE; ENCBS717WTB
DR   ENCODE; ENCBS718AAA
DR   ENCODE; ENCBS720AAA
DR   ENCODE; ENCBS731AAA
DR   ENCODE; ENCBS732AAA
DR   ENCODE; ENCBS733AAA
DR   ENCODE; ENCBS734AAA
DR   ENCODE; ENCBS739PSV
DR   ENCODE; ENCBS740OND
DR   ENCODE; ENCBS780AAA
DR   ENCODE; ENCBS780WAB
DR   ENCODE; ENCBS797AAA
DR   ENCODE; ENCBS802AAA
DR   ENCODE; ENCBS803AAA
DR   ENCODE; ENCBS819TBN
DR   ENCODE; ENCBS820AAA
DR   ENCODE; ENCBS847AAA
DR   ENCODE; ENCBS849HZG
DR   ENCODE; ENCBS854AAA
DR   ENCODE; ENCBS855AAA
DR   ENCODE; ENCBS874KZJ
DR   ENCODE; ENCBS899KQD
DR   ENCODE; ENCBS899NYB
DR   ENCODE; ENCBS929BKG
DR   ENCODE; ENCBS945MCY
DR   ENCODE; ENCBS951DDF
DR   ENCODE; ENCBS952IPA
DR   ENCODE; ENCBS977TKX
DR   ENCODE; ENCBS982HXP
DR   ENCODE; ENCBS984IPH
DR   GEO; GSM288339
DR   GEO; GSM347921
DR   GEO; GSM383873
DR   GEO; GSM383874
DR   GEO; GSM384095
DR   GEO; GSM384096
DR   GEO; GSM409307
DR   GEO; GSM409308
DR   GEO; GSM409312
DR   GEO; GSM410807
DR   GEO; GSM410808
DR   GEO; GSM428286
DR   GEO; GSM428289
DR   GEO; GSM428291
DR   GEO; GSM428295
DR   GEO; GSM428296
DR   GEO; GSM429321
DR   GEO; GSM429322
DR   GEO; GSM429323
DR   GEO; GSM432392
DR   GEO; GSM432685
DR   GEO; GSM432686
DR   GEO; GSM433167
DR   GEO; GSM433170
DR   GEO; GSM433171
DR   GEO; GSM433174
DR   GEO; GSM433176
DR   GEO; GSM433177
DR   GEO; GSM433179
DR   GEO; GSM434762
DR   GEO; GSM434776
DR   GEO; GSM434785
DR   GEO; GSM438361
DR   GEO; GSM438362
DR   GEO; GSM450236
DR   GEO; GSM450239
DR   GEO; GSM450266
DR   GEO; GSM450268
DR   GEO; GSM450270
DR   GEO; GSM466732
DR   GEO; GSM466734
DR   GEO; GSM466737
DR   GEO; GSM466739
DR   GEO; GSM469971
DR   GEO; GSM484408
DR   GEO; GSM537679
DR   GEO; GSM537680
DR   GEO; GSM537681
DR   GEO; GSM537682
DR   GEO; GSM537683
DR   GEO; GSM537684
DR   GEO; GSM537685
DR   GEO; GSM543005
DR   GEO; GSM569199
DR   GEO; GSM569200
DR   GEO; GSM579898
DR   GEO; GSM579899
DR   GEO; GSM602251
DR   GEO; GSM602252
DR   GEO; GSM602253
DR   GEO; GSM637775
DR   GEO; GSM733657
DR   GEO; GSM733670
DR   GEO; GSM733672
DR   GEO; GSM733687
DR   GEO; GSM733718
DR   GEO; GSM733725
DR   GEO; GSM733748
DR   GEO; GSM733773
DR   GEO; GSM733782
DR   GEO; GSM736582
DR   GEO; GSM803345
DR   GEO; GSM803365
DR   GEO; GSM803366
DR   GEO; GSM803377
DR   GEO; GSM803382
DR   GEO; GSM803396
DR   GEO; GSM803405
DR   GEO; GSM803419
DR   GEO; GSM803424
DR   GEO; GSM803425
DR   GEO; GSM803426
DR   GEO; GSM803427
DR   GEO; GSM803428
DR   GEO; GSM803430
DR   GEO; GSM803437
DR   GEO; GSM803438
DR   GEO; GSM803450
DR   GEO; GSM803466
DR   GEO; GSM803476
DR   GEO; GSM803484
DR   GEO; GSM803501
DR   GEO; GSM803506
DR   GEO; GSM803512
DR   GEO; GSM803513
DR   GEO; GSM803529
DR   GEO; GSM803542
DR   GEO; GSM816632
DR   GEO; GSM822274
DR   GEO; GSM822297
DR   GEO; GSM822300
DR   GEO; GSM856729
DR   GEO; GSM862728
DR   GEO; GSM935289
DR   GEO; GSM935292
DR   GEO; GSM935293
DR   GEO; GSM935295
DR   GEO; GSM935296
DR   GEO; GSM935297
DR   GEO; GSM935303
DR   GEO; GSM935308
DR   GEO; GSM935348
DR   GEO; GSM935352
DR   GEO; GSM935379
DR   GEO; GSM935380
DR   GEO; GSM935382
DR   GEO; GSM935434
DR   GEO; GSM935463
DR   GEO; GSM935509
DR   GEO; GSM935514
DR   GEO; GSM935517
DR   GEO; GSM935580
DR   GEO; GSM935581
DR   GEO; GSM935614
DR   GEO; GSM1003444
DR   GEO; GSM1003446
DR   GEO; GSM1003451
DR   GEO; GSM1003457
DR   GEO; GSM1003472
DR   GEO; GSM1003473
DR   GEO; GSM1003479
DR   GEO; GSM1003509
DR   GEO; GSM1003513
DR   GEO; GSM1003524
DR   GEO; GSM1003547
DR   GEO; GSM1003571
DR   GEO; GSM1003572
DR   GEO; GSM1003573
DR   GEO; GSM1003579
DR   GEO; GSM1003584
DR   GEO; GSM1003585
DR   GEO; GSM1003619
DR   GEO; GSM1010742
DR   GEO; GSM1010743
DR   GEO; GSM1010776
DR   GEO; GSM1010845
DR   GEO; GSM1010896
DR   GEO; GSM1010898
DR   GEO; GSM1010899
DR   GEO; GSM1040242
DR   GEO; GSM1040312
DR   GEO; GSM1084833
DR   GEO; GSM1084941
DR   GEO; GSM1084942
DR   GEO; GSM1153529
DR   GEO; GSM1489248
DR   GEO; GSM1489459
DR   GEO; GSM1582545
DR   GEO; GSM1658376
DR   hPSCreg; WAe001-A
DR   IGRhCellID; H1%20p61
DR   NIHhESC; NIHhESC-10-0043
DR   PRIDE; PXD003903
DR   SKIP; SKIP001933
DR   WiCell; wa01
DR   WiCell; wa01-cgmp-material
DR   WiCell; wa01-matched-research-bank
DR   WiCell; wa01-pcbc
DR   Wikidata; Q54993510
RX   PubMed=9804556;
RX   PubMed=14745950;
RX   PubMed=16388305;
RX   PubMed=16919167;
RX   PubMed=17287758;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=18713948;
RX   PubMed=20428235;
RX   PubMed=20641038;
RX   PubMed=20736931;
RX   PubMed=21295703;
RX   PubMed=21714037;
RX   PubMed=21983960;
RX   PubMed=22514597;
RX   PubMed=22802639;
RX   PubMed=23117585;
RX   PubMed=23325432;
RX   PubMed=24259714;
RX   PubMed=24374290;
RX   PubMed=27476965;
RX   PubMed=28445466;
RX   PubMed=29034888;
RX   PubMed=29034901;
RX   PubMed=30388422;
WW   Info; -; -; https://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/affy/12
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/12
CC   Part of: ENCODE project common cell types; tier 1.
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0043.
CC   Registration: Swiss research registry; BAG-hES-IMP-0001.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.
CC   HLA typing: A*02:03; B*08,35; C*04,07; DQB1*02,05; DRB1*01,03; DRB3*01 (PubMed=16919167).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; PubMed=24374290; PubMed=29034888; PubMed=29034901; WiCell=wa01
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 40
//
ID   WA01 TH-TdTomato
AC   CVCL_C8FP
SY   TH-TdTomato WA01 Reporter line; WA01-TH-WT
DR   Wikidata; Q123033791
RX   PubMed=31902706;
CC   Characteristics: Fluorescent (tdTomato) reporter cell line for TH expression. Using CRISPR/Cas9 a P2A-tdTomato construct was introduced in the C-terminal end of TH (PubMed=31902706).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 3
//
ID   WA07
AC   CVCL_9772
SY   WA 07; WA-07; WA7; H7; H7 GE07; H7-hESC; ES-WA7; WAe002-A; WICELLe002-A; WAe007-A; WA07-PCBC; PCBC02hse2014030501; SC14-066
DR   BTO; BTO_0006061
DR   EFO; EFO_0005904
DR   BioSample; SAMN03471896
DR   ENCODE; ENCBS017AOD
DR   ENCODE; ENCBS052WSJ
DR   ENCODE; ENCBS058YII
DR   ENCODE; ENCBS068KXI
DR   ENCODE; ENCBS291AAA
DR   ENCODE; ENCBS292AAA
DR   ENCODE; ENCBS293AAA
DR   ENCODE; ENCBS297CQV
DR   ENCODE; ENCBS311AAZ
DR   ENCODE; ENCBS336AYE
DR   ENCODE; ENCBS465FZV
DR   ENCODE; ENCBS559YVY
DR   ENCODE; ENCBS611ORI
DR   ENCODE; ENCBS624XJG
DR   ENCODE; ENCBS721YNV
DR   ENCODE; ENCBS851RDN
DR   ENCODE; ENCBS884CKU
DR   ENCODE; ENCBS920PVU
DR   ENCODE; ENCBS962QAF
DR   GEO; GSM347922
DR   GEO; GSM383877
DR   GEO; GSM384099
DR   GEO; GSM499755
DR   GEO; GSM499756
DR   GEO; GSM500935
DR   GEO; GSM510581
DR   GEO; GSM537623
DR   GEO; GSM537639
DR   GEO; GSM537640
DR   GEO; GSM537641
DR   GEO; GSM537657
DR   GEO; GSM580005
DR   GEO; GSM621347
DR   GEO; GSM621353
DR   GEO; GSM637776
DR   GEO; GSM669896
DR   GEO; GSM669926
DR   GEO; GSM736610
DR   GEO; GSM736638
DR   GEO; GSM856730
DR   GEO; GSM862732
DR   GEO; GSM945183
DR   GEO; GSM945184
DR   GEO; GSM945185
DR   GEO; GSM945186
DR   GEO; GSM981283
DR   GEO; GSM1008596
DR   GEO; GSM1022649
DR   GEO; GSM1022656
DR   GEO; GSM1022660
DR   GEO; GSM1022670
DR   GEO; GSM1084991
DR   GEO; GSM1085014
DR   GEO; GSM1215275
DR   GEO; GSM1215276
DR   GEO; GSM1589801
DR   GEO; GSM1589813
DR   GEO; GSM1589933
DR   GEO; GSM1589945
DR   hPSCreg; WAe007-A
DR   IGRhCellID; H7%20p91
DR   NIHhESC; NIHhESC-10-0061
DR   SKIP; SKIP001934
DR   WiCell; wa07
DR   WiCell; wa07-pcbc
DR   Wikidata; Q54993513
RX   PubMed=9804556;
RX   PubMed=14745950;
RX   PubMed=15345125;
RX   PubMed=16388305;
RX   PubMed=16919167;
RX   PubMed=17287758;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=21295703;
RX   PubMed=21983960;
RX   PubMed=22315618;
RX   PubMed=23117585;
RX   PubMed=23341440;
RX   PubMed=27293150;
RX   PubMed=27688775;
RX   PubMed=28445466;
RX   PubMed=30388422;
WW   Info; -; -; https://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/H7-hESC_StamAndCrawford_protocol.pdf
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/3
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0061.
CC   Registration: Swiss research registry; BAG-hES-IMP-0034.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-18.
CC   HLA typing: A*02:25; B*18,35; C*04,12; DQB1*02,03; DRB1*07,11; DRB3*02 (PubMed=16919167).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
CC   Donor information: Embryo is sibling to those giving rise to WA13 (Cellosaurus=CVCL_9774) and WA14 (Cellosaurus=CVCL_9775).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; WiCell=wa07
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 37
//
ID   WA09
AC   CVCL_9773
SY   WA 09; WA-09; WA9; H9; H9.hESCs; H9 ESC; H9 hES; H9ES; GE09; WAe003-A; WICELLe003-A; WAe009-A; WA09-PCBC; PCBC02hse2014030502; SC14-067; UKERe008-A
DR   BTO; BTO_0006062
DR   CLO; CLO_0037313
DR   4DN; 4DNSR9WBB58Z
DR   BioGRID_ORCS_Cell_line; 1321
DR   BioSample; SAMN03471903
DR   BioSamples; SAMEA7769668
DR   CCRID; 3101HUMSCSP302
DR   CCRID; 3101HUMSCSP307
DR   ENCODE; ENCBS013BRF
DR   ENCODE; ENCBS061KRP
DR   ENCODE; ENCBS113LZP
DR   ENCODE; ENCBS140HIH
DR   ENCODE; ENCBS156LDX
DR   ENCODE; ENCBS220TZB
DR   ENCODE; ENCBS277KDR
DR   ENCODE; ENCBS298AAA
DR   ENCODE; ENCBS299AAA
DR   ENCODE; ENCBS300AAA
DR   ENCODE; ENCBS315DEY
DR   ENCODE; ENCBS375GFI
DR   ENCODE; ENCBS377MXB
DR   ENCODE; ENCBS399JWQ
DR   ENCODE; ENCBS410BMR
DR   ENCODE; ENCBS417MAQ
DR   ENCODE; ENCBS477SFO
DR   ENCODE; ENCBS485PGF
DR   ENCODE; ENCBS532LWE
DR   ENCODE; ENCBS616QKE
DR   ENCODE; ENCBS656LSW
DR   ENCODE; ENCBS692FVF
DR   ENCODE; ENCBS703ZDS
DR   ENCODE; ENCBS741LLD
DR   ENCODE; ENCBS757OPX
DR   ENCODE; ENCBS769EPD
DR   ENCODE; ENCBS808UWK
DR   ENCODE; ENCBS853WXF
DR   ENCODE; ENCBS883RFB
DR   ENCODE; ENCBS996IWU
DR   GEO; GSM239975
DR   GEO; GSM288333
DR   GEO; GSM288335
DR   GEO; GSM288397
DR   GEO; GSM347923
DR   GEO; GSM383878
DR   GEO; GSM383879
DR   GEO; GSM384100
DR   GEO; GSM500936
DR   GEO; GSM569191
DR   GEO; GSM569192
DR   GEO; GSM579901
DR   GEO; GSM579902
DR   GEO; GSM603054
DR   GEO; GSM603055
DR   GEO; GSM605307
DR   GEO; GSM605310
DR   GEO; GSM605314
DR   GEO; GSM605316
DR   GEO; GSM605324
DR   GEO; GSM616127
DR   GEO; GSM616128
DR   GEO; GSM616129
DR   GEO; GSM627785
DR   GEO; GSM637777
DR   GEO; GSM665037
DR   GEO; GSM667608
DR   GEO; GSM667609
DR   GEO; GSM667610
DR   GEO; GSM667611
DR   GEO; GSM667612
DR   GEO; GSM667613
DR   GEO; GSM667616
DR   GEO; GSM667619
DR   GEO; GSM667620
DR   GEO; GSM667621
DR   GEO; GSM667622
DR   GEO; GSM667623
DR   GEO; GSM667625
DR   GEO; GSM667626
DR   GEO; GSM667628
DR   GEO; GSM667629
DR   GEO; GSM667630
DR   GEO; GSM667631
DR   GEO; GSM667632
DR   GEO; GSM667633
DR   GEO; GSM667634
DR   GEO; GSM667635
DR   GEO; GSM667636
DR   GEO; GSM667637
DR   GEO; GSM667638
DR   GEO; GSM667639
DR   GEO; GSM667640
DR   GEO; GSM667643
DR   GEO; GSM669899
DR   GEO; GSM669901
DR   GEO; GSM670053
DR   GEO; GSM674603
DR   GEO; GSM706044
DR   GEO; GSM706059
DR   GEO; GSM706060
DR   GEO; GSM706061
DR   GEO; GSM706062
DR   GEO; GSM706063
DR   GEO; GSM706064
DR   GEO; GSM706066
DR   GEO; GSM706071
DR   GEO; GSM706076
DR   GEO; GSM755488
DR   GEO; GSM755491
DR   GEO; GSM816629
DR   GEO; GSM856731
DR   GEO; GSM860961
DR   GEO; GSM860962
DR   GEO; GSM860963
DR   GEO; GSM862733
DR   GEO; GSM927236
DR   GEO; GSM997555
DR   GEO; GSM997556
DR   GEO; GSM997557
DR   GEO; GSM1040243
DR   GEO; GSM1040313
DR   GEO; GSM1084832
DR   GEO; GSM1084835
DR   GEO; GSM1084943
DR   GEO; GSM1084944
DR   GEO; GSM1084992
DR   GEO; GSM1085015
DR   GEO; GSM1215278
DR   GEO; GSM1215279
DR   GEO; GSM1227088
DR   GEO; GSM1489249
DR   GEO; GSM1489460
DR   GEO; GSM1589800
DR   GEO; GSM1589812
DR   GEO; GSM1589932
DR   GEO; GSM1589944
DR   GEO; GSM1658377
DR   hPSCreg; WAe009-A
DR   IGRhCellID; H9%20p25-2
DR   IGRhCellID; H9%20p34
DR   LINCS_LDP; ES-1001
DR   NIHhESC; NIHhESC-10-0062
DR   PRIDE; PXD003903
DR   PRIDE; PXD006271
DR   SKIP; SKIP001452
DR   SKIP; SKIP001935
DR   TOKU-E; 4223
DR   WiCell; wa09
DR   WiCell; wa09-cgmp-material
DR   WiCell; wa09-matched-research
DR   WiCell; wa09-pcbc
DR   Wikidata; Q27555433
RX   PubMed=9804556;
RX   PubMed=14745950;
RX   PubMed=16388305;
RX   PubMed=16919167;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=20641038;
RX   PubMed=20736931;
RX   PubMed=21295703;
RX   PubMed=21936705;
RX   PubMed=21983960;
RX   PubMed=22514597;
RX   PubMed=22802639;
RX   PubMed=23117585;
RX   PubMed=24259714;
RX   PubMed=27293150;
RX   PubMed=27476965;
RX   PubMed=27688775;
RX   PubMed=28435121;
RX   PubMed=28445466;
RX   PubMed=28664172;
RX   PubMed=29246576;
RX   PubMed=29861859;
RX   PubMed=30388422;
RX   PubMed=35805069;
WW   Info; -; -; https://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/BG02ES_and_H9ES_Myers_protocols.pdf
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/13
WW   Info; StRAP; -; https://strap.nci.nih.gov/celline_detail.php?sample_id=88
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: ENCODE project common cell types; tier 3.
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0062.
CC   Registration: Swiss research registry; BAG-hES-IMP-0016.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-06.
CC   HLA typing: A*02:03; B*35,44; C*04,07; DQB1*05,06; DRB1*15,16:01; DRB5*01 (PubMed=16919167).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Ser (c.451C>T); ClinVar=VCV000012370; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Trp (c.799C>T); ClinVar=VCV000141764; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; ChIP-seq; H2AK5ac.
CC   Omics: Genomics; ChIP-seq; H2BK12ac.
CC   Omics: Genomics; ChIP-seq; H2BK15ac.
CC   Omics: Genomics; ChIP-seq; H2BK5ac.
CC   Omics: Genomics; ChIP-seq; H3K18ac.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K23me2.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4ac.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me2.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K56ac.
CC   Omics: Genomics; ChIP-seq; H3K79me1.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K20me1.
CC   Omics: Genomics; ChIP-seq; H4K5ac.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; ChIP-seq; H4K91ac.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Proteomics; Subcellular; Mitochondrion.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=16919167; PubMed=29246576; WiCell=wa09
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 41
//
ID   WA09 BIN3 OE
AC   CVCL_E6BE
SY   H9-BIN3OE
CC   Characteristics: Dox-inducible expression of BIN3. Using CRISPR/Cas9 a T2A-PuroR-BIN3-TRE3G-CAG-rtTA construct was introduced in the AAVS1 safe harbor locus (Direct_author_submission).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:1054; BIN3 (Note with a C-terminal 3xFLAG tag).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Cell line information from personal communication of Mathivanan, Sakthikumar.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   WA09 CRX+/tdTomato
AC   CVCL_B5ZJ
SY   CRX+/tdTomato
DR   Wikidata; Q112041916
RX   PubMed=29230913;
CC   Characteristics: Using BAC homologous recombination a single allele of CRX was replaced with a tdTomato reporter gene (PubMed=29230913).
CC   Knockout cell: Method=BAC homologous recombination; HGNC; HGNC:2383; CRX (Note=1 of 2 alleles).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   WA09 MIXL1-2A-eGFP
AC   CVCL_GQ06
SY   MIXL1-2A-eGFP
DR   Wikidata; Q54993515
RX   PubMed=27558609;
CC   Characteristics: TALEN-engineered line where the stop codon of MIXL1 was replaced with a 2A-eGFP cassette, thus, creating a MIXL1-2A-eGFP allele.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27558609
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   WA1
AC   CVCL_B6FA
DR   Wikidata; Q112041919
RX   PubMed=10762059;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059).
CC   Doubling time: 42.2 hours (Note=At 15th passage), 30.8 hours (Note=At 50th passage) (PubMed=10762059).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   WA13
AC   CVCL_9774
SY   WA 13; H13; H13C; GE13; WAe004-A; WICELLe004-A; WAe013-A
DR   BioSample; SAMN03471898
DR   GEO; GSM288396
DR   GEO; GSM347924
DR   GEO; GSM383875
DR   GEO; GSM384097
DR   GEO; GSM755489
DR   GEO; GSM755492
DR   GEO; GSM856732
DR   GEO; GSM862738
DR   hPSCreg; WAe013-A
DR   NIHhESC; NIHhESC-10-0063
DR   SKIP; SKIP001936
DR   WiCell; wa13
DR   Wikidata; Q54993516
RX   PubMed=9804556;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=20736931;
RX   PubMed=21936705;
RX   PubMed=23117585;
RX   PubMed=28445466;
RX   PubMed=30388422;
WW   Info; -; -; https://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/4
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0063.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
CC   Donor information: Embryo is sibling to those giving rise to WA07 (Cellosaurus=CVCL_9772) and WA14 (Cellosaurus=CVCL_9775).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa13
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   WA14
AC   CVCL_9775
SY   WA 14; H14; GE14; WAe005-A; WICELLe005-A; WAe014-A
DR   BioSample; SAMN03471899
DR   GEO; GSM151738
DR   GEO; GSM151740
DR   GEO; GSM347925
DR   GEO; GSM383876
DR   GEO; GSM384098
DR   GEO; GSM856733
DR   GEO; GSM862739
DR   hPSCreg; WAe014-A
DR   NIHhESC; NIHhESC-10-0064
DR   SKIP; SKIP001937
DR   WiCell; wa14
DR   WiCell; wa14-cgmp-material
DR   WiCell; wa14-matched-research
DR   Wikidata; Q54993517
RX   PubMed=9804556;
RX   PubMed=14745950;
RX   PubMed=16388305;
RX   PubMed=17287758;
RX   PubMed=17570852;
RX   PubMed=17572666;
RX   PubMed=21983960;
RX   PubMed=23117585;
RX   PubMed=28445466;
RX   PubMed=30388422;
WW   Info; -; -; https://news.wisc.edu/nih-reapproves-wicells-h9-and-three-other-wisconsin-stem-cell-lines-for-federally-funded-research/
WW   Info; StemCellDB; -; https://stemcelldb.nih.gov/cellLineDetails/Agilent/29
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0064.
CC   Registration: Swiss research registry; BAG-hES-IMP-0033.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC06-18/SCSC11-18.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: WA01, WA07, WA09, WA13 and WA14 were the first human embryonic stem cells to be established.
CC   Donor information: Embryo is sibling to those giving rise to WA07 (Cellosaurus=CVCL_9772) and WA13 (Cellosaurus=CVCL_9774).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa14
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 12,14
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 13,20
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 30
//
ID   WA14 GLA KO clone 01-56
AC   CVCL_C3LV
DR   Wikidata; Q116050769
RX   PubMed=36092250;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   WA14 GLA KO clone 334-04
AC   CVCL_C3LW
DR   Wikidata; Q116050770
RX   PubMed=36092250;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4296; GLA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   WA15
AC   CVCL_9776
SY   WISCe001-A
DR   hPSCreg; WISCe001-A
DR   NIHhESC; NIHhESC-11-0096
DR   SKIP; SKIP002032
DR   WiCell; wa15
DR   Wikidata; Q54993518
RX   PubMed=16388305;
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0096.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa15
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,12
ST   D16S539: 11,12
ST   D5S818: 9,13
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   WA16
AC   CVCL_9777
SY   WISCe002-A
DR   hPSCreg; WISCe002-A
DR   NIHhESC; NIHhESC-11-0097
DR   SKIP; SKIP002036
DR   WiCell; wa16
DR   Wikidata; Q54993519
RX   PubMed=16388305;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0097.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa16
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C34752; Klinefelter syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 20
//
ID   WA17
AC   CVCL_9778
DR   NIHhESC; NIHhESC-11-0098
DR   WiCell; wa17
DR   Wikidata; Q54993520
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0098.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa17
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   WA18
AC   CVCL_9779
DR   NIHhESC; NIHhESC-11-0099
DR   WiCell; wa18
DR   Wikidata; Q54993523
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0099.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa18
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 15,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   WA19
AC   CVCL_9780
DR   NIHhESC; NIHhESC-11-0100
DR   WiCell; wa19
DR   Wikidata; Q54993525
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0100.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa19
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 12
ST   D16S539: 13
ST   D5S818: 11
ST   D7S820: 9,10
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   WA20
AC   CVCL_9781
DR   NIHhESC; NIHhESC-11-0101
DR   WiCell; wa20
DR   Wikidata; Q54993526
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0101.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa20
ST   Amelogenin: X
ST   CSF1PO: 11,14
ST   D13S317: 13,14
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   WA21
AC   CVCL_9782
DR   NIHhESC; NIHhESC-11-0102
DR   WiCell; wa21
DR   Wikidata; Q54993527
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0102.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa21
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 8,9
ST   TPOX: 8,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   WA22
AC   CVCL_9783
SY   WAe022-A
DR   hPSCreg; WAe022-A
DR   NIHhESC; NIHhESC-11-0103
DR   SKIP; SKIP002582
DR   WiCell; wa22
DR   Wikidata; Q54993528
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0103.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa22
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,14
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   WA23
AC   CVCL_9784
SY   WAe023-A
DR   hPSCreg; WAe023-A
DR   NIHhESC; NIHhESC-11-0104
DR   WiCell; wa23
DR   Wikidata; Q54993529
RX   PubMed=28445466;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0104.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa23
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   WA24
AC   CVCL_9785
SY   WA24-PCBC; PCBC02hse2011100706; SC11-015; WAe024-A
DR   hPSCreg; WAe024-A
DR   NIHhESC; NIHhESC-11-0105
DR   WiCell; wa24
DR   WiCell; wa24-pcbc
DR   Wikidata; Q54993530
RX   PubMed=27293150;
RX   PubMed=28445466;
CC   Part of: NHBLI Progenitor Cell Biology Consortium (PCBC) collection.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0105.
CC   Registration: Swiss research registry; BAG-hES-IMP-0069.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa24
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 22
//
ID   WA25
AC   CVCL_E080
SY   WA-25; WAe025-A
DR   hPSCreg; WAe025-A
DR   NIHhESC; NIHhESC-12-0196
DR   WiCell; wa25
DR   Wikidata; Q54993532
RX   PubMed=28445466;
WW   Info; WiCell; -; https://www.wicell.org/media/Ads/2013.ISSCR.DerivationFinal.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0196.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa25
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 8,14
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   WA26
AC   CVCL_E081
SY   WAe026-A
DR   hPSCreg; WAe026-A
DR   NIHhESC; NIHhESC-12-0197
DR   WiCell; wa26
DR   Wikidata; Q54993533
RX   PubMed=28445466;
WW   Info; WiCell; -; https://www.wicell.org/media/Ads/2013.ISSCR.DerivationFinal.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0197.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly245Ser (c.733G>A); ClinVar=VCV000012365; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa26
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,14
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 7,10
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   WA27
AC   CVCL_E082
SY   WAe027-A
DR   hPSCreg; WAe027-A
DR   NIHhESC; NIHhESC-12-0198
DR   WiCell; wa27
DR   Wikidata; Q54993534
RX   PubMed=28445466;
WW   Info; WiCell; -; https://www.wicell.org/media/Ads/2013.ISSCR.DerivationFinal.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0198.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): WiCell=wa27
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 10
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   WA29
AC   CVCL_LJ40
SY   4F-iPS; WAe029-A
DR   hPSCreg; WAe029-A
DR   Wikidata; Q54993535
RX   PubMed=21249204;
RX   PubMed=23483397;
RX   PubMed=29179815;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 8
//
ID   WAB0001
AC   CVCL_E5CA
SY   WAB-00001
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0004
AC   CVCL_E5CB
SY   WAB-00004
DR   GEO; GSM7036169
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   WAB0005
AC   CVCL_E5CC
SY   WAB-00005
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0013
AC   CVCL_E5CD
SY   WAB-00013
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0014
AC   CVCL_E5CE
SY   WAB-00014
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0025
AC   CVCL_E5CF
SY   WAB-00025
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0033
AC   CVCL_E5CG
SY   WAB-00033
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0034
AC   CVCL_E5CH
SY   WAB-00034
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0038
AC   CVCL_E5CI
SY   WAB-00038
DR   GEO; GSM7036170
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   WAB0043
AC   CVCL_E5CJ
SY   WAB-00043
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0058
AC   CVCL_E5CK
SY   WAB-00058
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0059
AC   CVCL_E5CL
SY   WAB-00059
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0069
AC   CVCL_E5CM
SY   WAB-00069
RX   PubMed=30267684;
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   WAB0089
AC   CVCL_E5CN
SY   WAB-00089
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0093
AC   CVCL_E5CP
SY   WAB-00093
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0103
AC   CVCL_E5CQ
SY   WAB-00103
DR   GEO; GSM7036171
DR   GEO; GSM7043210
DR   GEO; GSM7043211
DR   GEO; GSM7043212
RX   PubMed=36778138;
RX   PubMed=37296104;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   WAB0104
AC   CVCL_E5CR
SY   WAB-00104
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0112
AC   CVCL_E5CS
SY   WAB-00112
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0113
AC   CVCL_E5CT
SY   WAB-00113
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0131
AC   CVCL_E5CU
SY   WAB-00131
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0132
AC   CVCL_E5CV
SY   WAB-00132
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0134
AC   CVCL_E5CW
SY   WAB-00134
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0135
AC   CVCL_E5CX
SY   WAB-00135
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0137
AC   CVCL_E5CY
SY   WAB-00137
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0148
AC   CVCL_E5CZ
SY   WAB-00148
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0157
AC   CVCL_E5D0
SY   WAB-00157
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0161
AC   CVCL_E5D1
SY   WAB-00161
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0162
AC   CVCL_E5D2
SY   WAB-00162
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0164
AC   CVCL_E5D3
SY   WAB-00164
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0187
AC   CVCL_E5D4
SY   WAB-00187
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0207
AC   CVCL_E5D5
SY   WAB-00207
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0214
AC   CVCL_E5D6
SY   WAB-00214
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0215
AC   CVCL_E5D7
SY   WAB-00215
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0216
AC   CVCL_E5D8
SY   WAB-00216
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0220
AC   CVCL_E5D9
SY   WAB-00220
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0221
AC   CVCL_E5DA
SY   WAB-00221
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   87Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0222
AC   CVCL_E5DB
SY   WAB-00222
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0227
AC   CVCL_E5DC
SY   WAB-00227
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0228
AC   CVCL_E5DD
SY   WAB-00228
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   74Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0237
AC   CVCL_E5DE
SY   WAB-00237
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0263
AC   CVCL_E5DF
SY   WAB-00263
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0329
AC   CVCL_E5DG
SY   WAB-00329
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0380
AC   CVCL_E5DH
SY   WAB-00380
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0397
AC   CVCL_E5DI
SY   WAB-00397
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0418
AC   CVCL_E5DJ
SY   WAB-00418
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0429
AC   CVCL_E5DK
SY   WAB-00429
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0445
AC   CVCL_E5DL
SY   WAB-00445
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0448
AC   CVCL_E5DM
SY   WAB-00448
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0450
AC   CVCL_E5DN
SY   WAB-00450
RX   PubMed=30267684;
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Omics: Transcriptomics; RNAseq; Single cell.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   WAB0452
AC   CVCL_E5DP
SY   WAB-00452
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0453
AC   CVCL_E5DQ
SY   WAB-00453
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0458
AC   CVCL_E5DR
SY   WAB-00458
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0463
AC   CVCL_E5DS
SY   WAB-00463
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0492
AC   CVCL_E5DT
SY   WAB-00492
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0501
AC   CVCL_E5DU
SY   WAB-00501
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0520
AC   CVCL_E5DV
SY   WAB-00520
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0546
AC   CVCL_E5DW
SY   WAB-00546
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0573
AC   CVCL_E5DX
SY   WAB-00573
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAB0598
AC   CVCL_E5DY
SY   WAB-00598
RX   PubMed=36778138;
CC   From: University of Melbourne; Melbourne; Australia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAC2
AC   CVCL_0575
SY   WAC-2; WAC 2
DR   MCCL; MCC:0000481
DR   cancercelllines; CVCL_0575
DR   Wikidata; Q54993536
RX   PubMed=2364393;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Phe1174Leu (c.3522C>A); ClinVar=VCV000217852; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0522 ! SH-EP007
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   WAe001-A-10
AC   CVCL_VE15
SY   H1_RB1ex3_G3; G3
DR   BioSamples; SAMEA5912509
DR   hPSCreg; WAe001-A-10
DR   Wikidata; Q54993537
RX   PubMed=29246572;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu125Valfs*9 (c.374_380del); Zygosity=Heterozygous (PubMed=29246572).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29246572
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 9
//
ID   WAe001-A-11
AC   CVCL_VE16
SY   H1_RB1ex3_G4; G4
DR   BioSamples; SAMEA5912510
DR   hPSCreg; WAe001-A-11
DR   Wikidata; Q54993538
RX   PubMed=29246572;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu125Valfs*9 (c.374_380del); Zygosity=Homozygous (PubMed=29246572).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29246572
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 10
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   WAe001-A-12
AC   CVCL_LI07
SY   H1KCNJ11KO-A9
DR   hPSCreg; WAe001-A-12
DR   Wikidata; Q54993539
RX   PubMed=29034901;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6257; KCNJ11.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29034901
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-13
AC   CVCL_RL77
SY   H1ASS1KO-A10
DR   hPSCreg; WAe001-A-13
DR   Wikidata; Q54993540
RX   PubMed=29247816;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:758; ASS1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29247816
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-14
AC   CVCL_VE33
SY   GDE-C11; GIBHe007-A-14
DR   hPSCreg; WAe001-A-14
DR   Wikidata; Q54993541
RX   PubMed=29310060;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:321; AGL (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29310060
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   WAe001-A-15
AC   CVCL_VF26
SY   H1-MIR122-Tet-On; PB-TRE-MIR122; GIBHe007-A-15
DR   hPSCreg; WAe001-A-15
DR   Wikidata; Q54993542
RX   PubMed=29627726;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Characteristics: Upon doxycycline-induction expresses miR-122. Developed to study the role of miR-122 in embryonic development, organogenesis, steatosis and tumorigenesis.
CC   Characteristics: Transfected with a PB-TRE-miR-122-EF1a-rtTA-2A-puroR-2A-EGFP construct.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:31501; MIR122.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29627726
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 13
//
ID   WAe001-A-16
AC   CVCL_RL89
SY   H1-SMO-KO; GIBHe007-A-16
DR   hPSCreg; WAe001-A-16
DR   Wikidata; Q54993544
RX   PubMed=29278761;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11119; SMO.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29278761
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-17
AC   CVCL_VN44
SY   H1-p53(R248W/R248W); 1P6; CDMLe004-A-17
DR   hPSCreg; WAe001-A-17
DR   Wikidata; Q98134682
RX   PubMed=29730572;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple_edited; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous; Note=By TALEN (PubMed=29730572).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   WAe001-A-18
AC   CVCL_RV18
SY   H1-p53(R282W/R282W); 1R5; CDMLe003-A; CDMLe004-A-18
DR   hPSCreg; WAe001-A-18
DR   Wikidata; Q54993545
RX   PubMed=29414603;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple_edited; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Homozygous; Note=By TALEN (PubMed=29414603).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WAe001-A-19
AC   CVCL_VF82
SY   H1-RB1(E16)-/+; CDMLe001-A; CDMLe004-A-19
DR   hPSCreg; WAe001-A-19
DR   SKIP; SKIP003207
DR   Wikidata; Q54993552
RX   PubMed=29414415;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29414415
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   WAe001-A-1A
AC   CVCL_C9KZ
SY   H1.2-13/H1.4-69; KAUSTe002-A-1A
DR   BioSamples; SAMEA112250767
DR   hPSCreg; WAe001-A-1A
DR   Wikidata; Q123033792
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JW ! WAe001-A-87
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1B
AC   CVCL_C9L0
SY   H1.2-124/H1.4-84; KAUSTe002-A-1B
DR   BioSamples; SAMEA112250768
DR   hPSCreg; WAe001-A-1B
DR   Wikidata; Q123033794
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JX ! WAe001-A-88
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1C
AC   CVCL_C9L1
SY   H1.2-13/H1.5-23; KAUSTe002-A-1C
DR   BioSamples; SAMEA112250769
DR   hPSCreg; WAe001-A-1C
DR   Wikidata; Q123033795
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JW ! WAe001-A-87
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1D
AC   CVCL_C9L2
SY   H1.2-124/H1.5-70; KAUSTe002-A-1D
DR   BioSamples; SAMEA112250770
DR   hPSCreg; WAe001-A-1D
DR   Wikidata; Q123033796
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JX ! WAe001-A-88
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1E
AC   CVCL_C9L3
SY   H1.3-64/H1.1-37; KAUSTe002-A-1E
DR   BioSamples; SAMEA112250771
DR   hPSCreg; WAe001-A-1E
DR   Wikidata; Q123033797
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JY ! WAe001-A-89
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1F
AC   CVCL_C9L4
SY   H1.3-191/H1.1-9; KAUSTe002-A-1F
DR   BioSamples; SAMEA112250775
DR   hPSCreg; WAe001-A-1F
DR   Wikidata; Q123033798
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JZ ! WAe001-A-90
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1G
AC   CVCL_C9L5
SY   H1.3-64/H1.4-15; KAUSTe002-A-1G
DR   BioSamples; SAMEA112250947
DR   hPSCreg; WAe001-A-1G
DR   Wikidata; Q123033799
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JY ! WAe001-A-89
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1H
AC   CVCL_C9L6
SY   H1.3-191/H1.4-11; KAUSTe002-A-1H
DR   BioSamples; SAMEA112250948
DR   hPSCreg; WAe001-A-1H
DR   Wikidata; Q123033800
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JZ ! WAe001-A-90
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1I
AC   CVCL_C9L7
SY   H1.3-64/H1.5-38; KAUSTe002-A-1I
DR   BioSamples; SAMEA112250949
DR   hPSCreg; WAe001-A-1I
DR   Wikidata; Q123033801
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JY ! WAe001-A-89
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1J
AC   CVCL_C9L8
SY   H1.3-191/H1.5-2; KAUSTe002-A-1J
DR   BioSamples; SAMEA112251004
DR   hPSCreg; WAe001-A-1J
DR   Wikidata; Q123033802
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JZ ! WAe001-A-90
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1K
AC   CVCL_C9L9
SY   H1.4-126/H1.5-73; KAUSTe002-A-1K
DR   BioSamples; SAMEA112251005
DR   hPSCreg; WAe001-A-1K
DR   Wikidata; Q123033803
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9K0 ! WAe001-A-91
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1L
AC   CVCL_C9LA
SY   H1.4-143/H1.5-36; KAUSTe002-A-1L
DR   BioSamples; SAMEA112251006
DR   hPSCreg; WAe001-A-1L
DR   Wikidata; Q123033804
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9K1 ! WAe001-A-92
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1N
AC   CVCL_C9LB
SY   H1-FIS1-KO; WA01-FIS1-KO; GIBHe007-A-1N
DR   BioSamples; SAMEA112614557
DR   hPSCreg; WAe001-A-1N
DR   Wikidata; Q123033805
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:21689; FIS1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1O
AC   CVCL_C9LC
SY   H1-MYB-KO; WA01-MYB-KO; GIBHe007-A-1O
DR   BioSamples; SAMEA112614558
DR   hPSCreg; WAe001-A-1O
DR   Wikidata; Q123033806
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7545; MYB.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1S
AC   CVCL_C9JQ
SY   hESC-MB-/-#1; MB-/-#1; KAIMRCe002-A-1S
DR   BioSamples; SAMEA112769105
DR   hPSCreg; WAe001-A-1S
DR   Wikidata; Q123033807
RX   PubMed=37406498;
CC   From: King Abdullah International Medical Research Center; Jeddah; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6915; MB.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-1X
AC   CVCL_C9LD
SY   H1 MYH11-NLuc-tdTomato
DR   hPSCreg; WAe001-A-1X
DR   Wikidata; Q123033809
RX   PubMed=31080110;
CC   Characteristics: Using CRISPR/Cas9 a Nanoluc-T2A-tdTomato-neo construct was integrated at the N-terminus of MYH11 (PubMed=31080110).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 5
//
ID   WAe001-A-2
AC   CVCL_VE93
SY   H1-HBB11-GFP; ISMMSe002-B
DR   hPSCreg; WAe001-A-2
DR   Wikidata; Q54993553
RX   PubMed=32413789;
CC   Characteristics: Using TALEN a 2A-GFP-PGKp-PuroR construct was integrated at the C-terminus of HBB (PubMed=32413789).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   WAe001-A-20
AC   CVCL_UD91
SY   H1-GLI3-KO; GIBHe007-A-20
DR   hPSCreg; WAe001-A-20
DR   Wikidata; Q98134684
RX   PubMed=30278376;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4319; GLI3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=30278376
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-21
AC   CVCL_UM34
SY   H1-DKK1-KO; GIBHe007-A-21
DR   hPSCreg; WAe001-A-21
DR   Wikidata; Q98134686
RX   PubMed=33461039;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2891; DKK1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-22
AC   CVCL_UL61
SY   H1-EDA-KO1; GZHMUe002-A-22
DR   hPSCreg; WAe001-A-22
DR   Wikidata; Q98134687
RX   PubMed=30605838;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3157; EDA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-23
AC   CVCL_UM35
SY   H1-FOS-Knockout-25; H1-FOS-/- 25(del8/del1); GZHMUe002-A-23
DR   hPSCreg; WAe001-A-23
DR   Wikidata; Q98134689
RX   PubMed=31229900;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-24
AC   CVCL_UM36
SY   H1-FOS-Knockout-37; H1-FOS-/- 37(del2/del5); GZHMUe002-A-24
DR   hPSCreg; WAe001-A-24
DR   Wikidata; Q98134692
RX   PubMed=31229900;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3796; FOS.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-25
AC   CVCL_XD76
SY   H1_MECP2_KO1; KO1; MAPe002-A-25
DR   hPSCreg; WAe001-A-25
DR   Wikidata; Q98134694
RX   PubMed=31450191;
CC   From: Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple_edited; p.Pro230fs; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=31450191).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   WAe001-A-26
AC   CVCL_XD77
SY   H1_MECP2_M2; M2; MAPe002-A-26
DR   hPSCreg; WAe001-A-26
DR   Wikidata; Q98134697
RX   PubMed=31450191;
CC   From: Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple_edited; p.Thr160_Lys233del; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=31450191).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   WAe001-A-27
AC   CVCL_XD78
SY   H1_MECP2_KO3; KO3; MAPe002-A-27
DR   hPSCreg; WAe001-A-27
DR   Wikidata; Q98134699
RX   PubMed=31450191;
CC   From: Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple_edited; p.Pro230fs; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=31450191).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   WAe001-A-28
AC   CVCL_XD79
SY   H1_MECP2_KO4; KO4; MAPe002-A-28
DR   hPSCreg; WAe001-A-28
DR   Wikidata; Q98134701
RX   PubMed=31450191;
CC   From: Translational Laboratory in Genetic Medicine, Agency for Science, Technology and Research; Singapore; Singapore.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple_edited; p.Gln110fs; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=31450191).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   WAe001-A-29
AC   CVCL_YC93
SY   H1_mCh-ATOX1 (KI); UHMCe002-A-29
DR   BioSamples; SAMEA6260533
DR   hPSCreg; WAe001-A-29
DR   Wikidata; Q98134703
RX   PubMed=31704540;
CC   From: Department of Chemistry, University of Houston; Houston; USA.
CC   Characteristics: Using CRISPR/Cas9 mCherry was integrated in front of the start codon of ATOX1 in one allele (PubMed=31704540).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 10-09-24; Version: 6
//
ID   WAe001-A-2B
AC   CVCL_C9LE
SY   H1-NSD2-/-; CTUe002-A-2B
DR   BioSamples; SAMEA114306601
DR   hPSCreg; WAe001-A-2B
DR   Wikidata; Q123033810
RX   PubMed=37992565;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12766; NSD2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   WAe001-A-2C
AC   CVCL_D6S8
SY   SST-P2A-mCherry; GLe002-A-2C
DR   BioSamples; SAMEA114608438
DR   hPSCreg; WAe001-A-2C
RX   PubMed=38547668;
CC   From: Guangzhou Laboratory; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a P2A-mCherry-3xNLS-loxP-PGKp-PuroR-LoxP construct was integrated at the C-terminus of one allele of SST (PubMed=38547668).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   WAe001-A-2E
AC   CVCL_E7AS
SY   H1-ASCL1-mCherry; GZLe014-A-2E
DR   BioSamples; SAMEA115345313
DR   hPSCreg; WAe001-A-2E
RX   PubMed=39059080;
CC   From: Guangzhou Laboratory; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a P2A-mCherry-LoxP-PGK-Puro-LoxP construct was inserted at the C-terminus of both alleles of ASCL1 (PubMed=39059080).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   WAe001-A-2F
AC   CVCL_D6SS
SY   HNMUe002-A-2F
DR   BioSamples; SAMEA115343060
DR   hPSCreg; WAe001-A-2F
RX   PubMed=38733811;
CC   From: Hainan Medical University; Haikou; China.
CC   Characteristics: Using CRISPR/Cas9 the chromosome Y AZFa region was deleted (PubMed=38733811).
CC   Sequence variation: Gene deletion; HGNC; HGNC:2699; DDX3Y; Zygosity=Hemizygous (PubMed=38733811).
CC   Sequence variation: Gene deletion; HGNC; HGNC:11882; TMSB4Y; Zygosity=Hemizygous (PubMed=38733811).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12633; USP9Y; Zygosity=Hemizygous (PubMed=38733811).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12638; UTY; Zygosity=Hemizygous (PubMed=38733811).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe001-A-3
AC   CVCL_QY38
SY   H1-MSX1-DKO1
DR   hPSCreg; WAe001-A-3
DR   Wikidata; Q54993554
RX   PubMed=29034883;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-30
AC   CVCL_A5QW
SY   UHMCe002-A-30
DR   hPSCreg; WAe001-A-30
DR   Wikidata; Q107117406
CC   From: University of Houston; Houston; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WAe001-A-31
AC   CVCL_XC42
SY   H1_RB1ex1_D6; D6; UDEe011-A-31
DR   BioSamples; SAMEA6877446
DR   hPSCreg; WAe001-A-31
DR   Wikidata; Q98134704
RX   PubMed=31404748;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-32
AC   CVCL_XC43
SY   H1_RB1ex1_E9; E9; UDEe011-A-32
DR   BioSamples; SAMEA6877447
DR   hPSCreg; WAe001-A-32
DR   Wikidata; Q98134706
RX   PubMed=31404748;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   WAe001-A-33
AC   CVCL_YN08
SY   H1-ERF-Knockout-1#; JLUe002-A-33
DR   BioSamples; SAMEA8093236
DR   hPSCreg; WAe001-A-33
DR   SKIP; SKIP005588
DR   Wikidata; Q98134708
RX   PubMed=31743839;
CC   From: Jilin University; Changchun; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3444; ERF.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   WAe001-A-34
AC   CVCL_YN09
SY   H1-ERF-Knockout-2#; JLUe002-A-34
DR   hPSCreg; WAe001-A-34
DR   SKIP; SKIP005589
DR   Wikidata; Q98134710
RX   PubMed=31743839;
CC   From: Jilin University; Changchun; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3444; ERF.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-35
AC   CVCL_A1YB
SY   H1-RGS18-/-; ZSSYLNe002-A-35
DR   BioSamples; SAMEA7059967
DR   hPSCreg; WAe001-A-35
DR   Wikidata; Q105511710
RX   PubMed=33157388;
CC   From: Sun Yat-sen University Third Affiliated Hospital; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14261; RGS18.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WAe001-A-4
AC   CVCL_QY75
SY   H1-MEN1-CRISPR-2; GIBHe002-A
DR   hPSCreg; WAe001-A-4
DR   Wikidata; Q54993555
RX   PubMed=29034888;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29034888
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-40
AC   CVCL_ZB34
SY   WISCe011-A-40
DR   hPSCreg; WAe001-A-40
DR   Wikidata; Q98134711
CC   From: University of Wisconsin; Madison; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   WAe001-A-41
AC   CVCL_ZB31
SY   H1-RNF2-KO-1#; H1-RNF2-Knockout-1#; NFYYe002-A-41
DR   BioSamples; SAMEA6878078
DR   hPSCreg; WAe001-A-41
DR   Wikidata; Q98134714
RX   PubMed=32610219;
CC   From: Nanfang Hospital, Southern Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-42
AC   CVCL_ZB32
SY   H1-RNF2-KO-2#; H1-RNF2-Knockout-2#; NFYYe002-A-42
DR   BioSamples; SAMEA7059968
DR   hPSCreg; WAe001-A-42
DR   Wikidata; Q98134716
RX   PubMed=32610219;
CC   From: Nanfang Hospital, Southern Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10061; RNF2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-43
AC   CVCL_ZB33
SY   GIBHe007-A-43
DR   hPSCreg; WAe001-A-43
DR   Wikidata; Q98134718
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   WAe001-A-44
AC   CVCL_ZE37
SY   H1 RUNX1-/- C4; GIBHe007-A-44; GIBHe008-A
DR   hPSCreg; WAe001-A-44
DR   Wikidata; Q98134720
RX   PubMed=32371361;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:10471; RUNX1.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   WAe001-A-45
AC   CVCL_ZZ84
SY   H1 MYB-/-14; GIBHe007-A-45
DR   hPSCreg; WAe001-A-45
DR   Wikidata; Q102115098
RX   PubMed=32526676;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:7545; MYB.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-46
AC   CVCL_ZZ85
SY   H1 MYB-/-20; GIBHe007-A-46
DR   hPSCreg; WAe001-A-46
DR   Wikidata; Q102115099
RX   PubMed=32526676;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:7545; MYB.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-47
AC   CVCL_A4TX
SY   H1-hVGLL4-Tet-On; WMUe002-A-47
DR   hPSCreg; WAe001-A-47
DR   Wikidata; Q107117407
RX   PubMed=33385792;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Characteristics: Dox-inducible expression of VGLL4. The cell has been transfected with a PB-TRE6P-VGLL4-P2A-EGFP-3xFLAG-PA-EF1a-5'LTR-rtTA-T2A-puroR construct (PubMed=33385792).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:28966; VGLL4.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 10
//
ID   WAe001-A-49
AC   CVCL_A4EH
SY   SCRe002-A-49
DR   hPSCreg; WAe001-A-49
DR   Wikidata; Q105511713
RX   PubMed=33157390;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a EF1A-PuroR-polyA construct was integrated in both alleles of MEIS1 exon 2 (PubMed=33157390).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7000; MEIS1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   WAe001-A-5
AC   CVCL_QY76
SY   H1-MEN1-CRISPR-9; GIBHe003-A
DR   BioSamples; SAMEA104134890
DR   hPSCreg; WAe001-A-5
DR   Wikidata; Q54993556
RX   PubMed=29034888;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7010; MEN1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29034888
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-50
AC   CVCL_C0CC
SY   H1-FMR1-KO; WISCe011-A-50
DR   hPSCreg; WAe001-A-50
DR   WiCell; h1-fmr1-ko
DR   Wikidata; Q112930546
RX   PubMed=32179589;
CC   Registration: Swiss research registry; BAG-hES-IMP-0073.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   WAe001-A-51
AC   CVCL_C0CD
SY   H1-FMR1-FLAG; WISCe011-A-51
DR   hPSCreg; WAe001-A-51
DR   WiCell; h1-fmr1-flag
DR   Wikidata; Q112930547
RX   PubMed=32179589;
CC   Registration: Swiss research registry; BAG-hES-IMP-0074.
CC   Characteristics: Using CRISPR/Cas9 3 FLAG tags were introduced at the C-terminus of both alleles of FMR1 (PubMed=32179589).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   WAe001-A-52
AC   CVCL_A4DQ
SY   H1-MCPH1-/-7; SMBCe002-A-52
DR   BioSamples; SAMEA7709329
DR   hPSCreg; WAe001-A-52
DR   Wikidata; Q105511716
RX   PubMed=33370873;
CC   From: Shandong Medical Biotechnological Center; Jinan; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6954; MCPH1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WAe001-A-53
AC   CVCL_A1MX
SY   H1-ANP32A-/-; NFYYe002-A-53
DR   BioSamples; SAMEA7542501
DR   hPSCreg; WAe001-A-53
DR   Wikidata; Q102115100
RX   PubMed=33607472;
CC   From: Nanfang Hospital, Southern Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:13233; ANP32A.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-54
AC   CVCL_A5QT
SY   MKK7 KO1; UMANe005-A-54
DR   hPSCreg; WAe001-A-54
DR   Wikidata; Q107117408
RX   PubMed=33611044;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-55
AC   CVCL_A5QU
SY   MKK7 KO4-7; UMANe005-A-55
DR   hPSCreg; WAe001-A-55
DR   Wikidata; Q107117409
RX   PubMed=33611044;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6847; MAP2K7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-56
AC   CVCL_A5QV
SY   H1_SOD1-SNAP; UHMCe002-A-56
DR   BioSamples; SAMEA7710161
DR   hPSCreg; WAe001-A-56
DR   Wikidata; Q107117410
RX   PubMed=34118566;
CC   From: University of Houston; Houston; USA.
CC   Characteristics: Using CRISPR/Cas9 a SNAP-tag was in-frame inserted at the C-terminus of the SOD1 coding region following a 3 amino-acid linker (PubMed=34118566).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:7059; MGMT (Note=With p.Gly180_Asn207del and 19 mutations = SNAP-tag).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   WAe001-A-57
AC   CVCL_A4TY
SY   H1-EFNB2-mCherry; H1-EFNB2-2A-mCherry+/-; ICSSUe009-A-57
DR   BioSamples; SAMEA7807659
DR   hPSCreg; WAe001-A-57
DR   Wikidata; Q107117411
RX   PubMed=33611045;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a 2A-mCherry cassette was integrated in front of the stop codon of EFNB2 in one allele (PubMed=33611045).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 10-09-24; Version: 5
//
ID   WAe001-A-58
AC   CVCL_A7IJ
SY   H1-SARS-CoV-2-N-Teton; GIBHe007-A-58
DR   hPSCreg; WAe001-A-58
DR   Wikidata; Q107117412
RX   PubMed=33771478;
CC   Group: SARS-CoV-2 research cell line.
CC   Characteristics: Transduced with a pB-TRE-[SARS-CoV-2-N]-EF1a-rtTA-2A-puroR-2A-EGFP construct. In the presence of doxycycline rtTA undergo conformational change, binds to the TRE and activates SARS-CoV-2 N protein expression (PubMed=33771478).
CC   Genetic integration: Method=Transduction; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P0DTC9; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleoprotein (N).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 9
//
ID   WAe001-A-59
AC   CVCL_A2YB
SY   WA01-GADD45A-Knockout; GIBHe007-A-59; GIBHe011-A
DR   hPSCreg; WAe001-A-59
DR   Wikidata; Q105511718
RX   PubMed=33232900;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4095; GADD45A.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-6
AC   CVCL_LK60
SY   H1-ASGR1-KO
DR   hPSCreg; WAe001-A-6
DR   Wikidata; Q54993557
RX   PubMed=28952928;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:742; ASGR1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-60
AC   CVCL_A7II
SY   H1-ALX1-KO-7#; GIBHe007-A-60
DR   hPSCreg; WAe001-A-60
DR   Wikidata; Q107117414
RX   PubMed=33799274;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1494; ALX1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-63
AC   CVCL_A7IH
SY   WA01-PARP1-/-; GIBHe007-A-63
DR   hPSCreg; WAe001-A-63
DR   Wikidata; Q107117415
RX   PubMed=33740642;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:270; PARP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe001-A-64
AC   CVCL_A8RB
SY   H1-TLR2-KO; GIBHe007-A-64
DR   hPSCreg; WAe001-A-64
DR   Wikidata; Q108821502
RX   PubMed=34058685;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11848; TLR2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-65
AC   CVCL_A7IK
SY   NFYYe002-A-65
DR   BioSamples; SAMEA8268467
DR   hPSCreg; WAe001-A-65
DR   Wikidata; Q107117416
CC   From: Nanfang Hospital, Southern Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:160; ACTL6B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C179296; Developmental and epileptic encephalopathy 76
DI   ORDO; Orphanet_1934; Early infantile epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe001-A-66
AC   CVCL_B0WC
SY   H1-AAVS1-EF1a-Akaluc-KI; AkalucHES; GIBHe007-A-66
DR   hPSCreg; WAe001-A-66
DR   Wikidata; Q108821503
RX   PubMed=34509917;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a construct containing the Akaluc gene under the control of a EF1a promoter was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Photinus pyralis Akaluciferase (Akaluc) (Note=A luciferase-derived fluorescent protein).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 9
//
ID   WAe001-A-67
AC   CVCL_A8RC
SY   H1-hTEAD1-Tet-On; WMUe002-A-67
DR   hPSCreg; WAe001-A-67
DR   Wikidata; Q108821504
RX   PubMed=34058684;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Characteristics: Transduced with a TRE6P-TEAD1-P2A-EGFP construct. Overexpression of TEAD1 is induced by doxycyclin.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11714; TEAD1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   WAe001-A-68
AC   CVCL_A8RD
SY   H1-hTEAD4-Tet-On; WMUe002-A-68
DR   hPSCreg; WAe001-A-68
DR   Wikidata; Q108821505
RX   PubMed=34058684;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Characteristics: Transduced with a TRE6P-TEAD4-P2A-EGFP construct. Overexpression of TEAD4 is induced by doxycyclin.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11717; TEAD4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   WAe001-A-7
AC   CVCL_QY77
SY   H1-MIR122-CRISPR-2; GIBHe004-A
DR   hPSCreg; WAe001-A-7
DR   Wikidata; Q54993558
RX   PubMed=29034887;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31501; MIR122.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29034887
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-72
AC   CVCL_A7NX
SY   H1-FTO-Knockout-13; FAHZUe004-A; FAHZUe005-A-72
DR   BioSamples; SAMEA8811934
DR   hPSCreg; WAe001-A-72
DR   Wikidata; Q107117417
RX   PubMed=34087991;
CC   From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24678; FTO.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe001-A-73
AC   CVCL_A0VU
SY   H1-GATAD2B-KO-79#; GIBHe007-A-73
DR   BioSamples; SAMEA9486177
DR   hPSCreg; WAe001-A-73
DR   Wikidata; Q108821506
RX   PubMed=34749018;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30778; GATAD2B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-74
AC   CVCL_A0VV
SY   H1-GATAD2B-KO-81#; GIBHe007-A-74
DR   BioSamples; SAMEA9486178
DR   hPSCreg; WAe001-A-74
DR   Wikidata; Q108821507
RX   PubMed=34749018;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30778; GATAD2B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-76
AC   CVCL_B5QP
SY   H1-RNF1-/-; GIBHe007-A-76
DR   BioSamples; SAMEA12038602
DR   hPSCreg; WAe001-A-76
DR   Wikidata; Q112041920
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10018; RING1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   WAe001-A-77
AC   CVCL_C0CB
SY   H1 RYBP-FLAG-HA KI; GIBHe007-A-77
DR   BioSamples; SAMEA12946815
DR   hPSCreg; WAe001-A-77
DR   Wikidata; Q112930548
RX   PubMed=35537243;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a FLAG-HA tag followed by a PGKp-PuroR cassette were introduced at the C-terminus of both alleles of RYBP (PubMed=35537243).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   WAe001-A-78
AC   CVCL_C0CA
SY   H1.X-10; H1.X-10 SKO; H1X10; KAUSTe002-A-78
DR   BioSamples; SAMEA14213405
DR   hPSCreg; WAe001-A-78
DR   Wikidata; Q112930549
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-79
AC   CVCL_C0C9
SY   H1_CTR1-mEos4b; UHMCe002-A-79
DR   BioSamples; SAMEA14370583
DR   hPSCreg; WAe001-A-79
DR   Wikidata; Q112930550
RX   PubMed=35728441;
CC   From: University of Houston; Houston; USA.
CC   Characteristics: Using CRISPR/Cas9 mEos4b followed by a FLAG tag was inserted 4 amino acids before the HCH domain of the cytoplasmic tail of CTR1 (PubMed=35728441).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; V2GB1; mEos4b (Note=Photoconvertible red fluorescent protein derived from EosFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   WAe001-A-8
AC   CVCL_QY78
SY   H1-MIR122-CRISPR-9; GIBHe005-A
DR   hPSCreg; WAe001-A-8
DR   Wikidata; Q54993559
RX   PubMed=29034887;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31501; MIR122.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29034887
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   WAe001-A-80
AC   CVCL_A4WB
SY   H1.CD43/CD144DR; H1 VEC-tdTomato/CD43-eGFP dual reporter; WISCe011-A-80
DR   hPSCreg; WAe001-A-80
DR   Wikidata; Q107115213
RX   PubMed=27879215;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0081.
CC   Characteristics: Using ZFN a 2A-PuroR-CD43_promoter-eGFP was introduced in the AAVS1 safe harbor locus and CDH5(CD144) promoter-tdTomato-Zeo construct was transposed using a piggyBac transposon vector (PubMed=27879215).
CC   Genetic integration: Method=PiggyBac transposition; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=PiggyBac transposition; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=ZFN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27879215
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D21S11: 28,32.2
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   WAe001-A-81
AC   CVCL_C4RP
SY   WA01-CD16A-/-; WA01-CD16A-knockout; SYSUSHe002-A-81
DR   BioSamples; SAMEA110743880
DR   hPSCreg; WAe001-A-81
DR   Wikidata; Q116050772
RX   PubMed=36219983;
CC   From: Sun Yat-sen University Seventh Affiliated Hospital; Shenzhen; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3619; FCGR3A.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   WAe001-A-82
AC   CVCL_C9JR
SY   H1.X-59; H1X59; KAUSTe002-A-82
DR   BioSamples; SAMEA110702388
DR   hPSCreg; WAe001-A-82
DR   Wikidata; Q123033811
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-83
AC   CVCL_C9JS
SY   H1.0-29; H1.029; KAUSTe002-A-83
DR   BioSamples; SAMEA111264273
DR   hPSCreg; WAe001-A-83
DR   Wikidata; Q123033812
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-84
AC   CVCL_C9JT
SY   H1.1-17; H1.117; KAUSTe002-A-84
DR   BioSamples; SAMEA111265303
DR   hPSCreg; WAe001-A-84
DR   Wikidata; Q123033813
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-85
AC   CVCL_C9JU
SY   H1.0-102; H1.0102; KAUSTe002-A-85
DR   BioSamples; SAMEA111265304
DR   hPSCreg; WAe001-A-85
DR   Wikidata; Q123033814
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-86
AC   CVCL_C9JV
SY   H1.1-39; H1.139; KAUSTe002-A-86
DR   BioSamples; SAMEA111344725
DR   hPSCreg; WAe001-A-86
DR   Wikidata; Q123033815
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-87
AC   CVCL_C9JW
SY   H1.2-13; H1.213; KAUSTe002-A-87
DR   BioSamples; SAMEA111346165
DR   hPSCreg; WAe001-A-87
DR   Wikidata; Q123033816
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-88
AC   CVCL_C9JX
SY   H1.2-124; H1.2124; KAUSTe002-A-88
DR   BioSamples; SAMEA111346166
DR   hPSCreg; WAe001-A-88
DR   Wikidata; Q123033817
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-89
AC   CVCL_C9JY
SY   H1.3-64; H1.364; KAUSTe002-A-89
DR   BioSamples; SAMEA111347416
DR   hPSCreg; WAe001-A-89
DR   Wikidata; Q123033818
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-9
AC   CVCL_QY79
SY   H1-MIR122-CRISPR-24
DR   hPSCreg; WAe001-A-9
DR   Wikidata; Q54993560
RX   PubMed=29034887;
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:31501; MIR122.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29034887
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 20
ST   D13S317: 8,11
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 13,15
ST   D21S11: 28,32.2
ST   D2S1338: 18,19
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D6S1043: 12,14
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 20,24
ST   Penta D: 10,13
ST   Penta E: 10,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
ID   WAe001-A-90
AC   CVCL_C9JZ
SY   H1.3-191; H1.3191; KAUSTe002-A-90
DR   BioSamples; SAMEA111347417
DR   hPSCreg; WAe001-A-90
DR   Wikidata; Q123033820
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-91
AC   CVCL_C9K0
SY   H1.4-126; H1.4126; KAUSTe002-A-91
DR   BioSamples; SAMEA111365974
DR   hPSCreg; WAe001-A-91
DR   Wikidata; Q123033821
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-92
AC   CVCL_C9K1
SY   H1.4-143; H1.4143; KAUSTe002-A-92
DR   BioSamples; SAMEA111365975
DR   hPSCreg; WAe001-A-92
DR   Wikidata; Q123033822
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-93
AC   CVCL_C9K2
SY   H1.5-23; H1.523; KAUSTe002-A-93
DR   BioSamples; SAMEA111365976
DR   hPSCreg; WAe001-A-93
DR   Wikidata; Q123033823
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-94
AC   CVCL_C9K3
SY   H1.5-28; H1.528; KAUSTe002-A-94
DR   BioSamples; SAMEA111365977
DR   hPSCreg; WAe001-A-94
DR   Wikidata; Q123033824
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-95
AC   CVCL_C6TG
SY   CTU-hES-1; CTUe002-A-95
DR   BioSamples; SAMEA111450569
DR   hPSCreg; WAe001-A-95
DR   Wikidata; Q117704971
CC   From: Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16950; STAMBP.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192098; Microcephaly-capillary malformation syndrome
DI   ORDO; Orphanet_294016; Microcephaly-capillary malformation syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-96
AC   CVCL_C9K4
SY   H1.X-10/H1.0-31; H1X10/H1.031; KAUSTe002-A-96
DR   BioSamples; SAMEA111453859
DR   hPSCreg; WAe001-A-96
DR   Wikidata; Q123033825
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CA ! WAe001-A-78
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-97
AC   CVCL_C9K5
SY   H1.X-59/H1.0-19; H1X59/H1019; KAUSTe002-A-97
DR   BioSamples; SAMEA111454151
DR   hPSCreg; WAe001-A-97
DR   Wikidata; Q123033826
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JR ! WAe001-A-82
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-98
AC   CVCL_C9K6
SY   H1.X-10/H1.1-1; H1X10/H1.11; KAUSTe002-A-98
DR   BioSamples; SAMEA111454153
DR   hPSCreg; WAe001-A-98
DR   Wikidata; Q123033827
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CA ! WAe001-A-78
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-99
AC   CVCL_C9K7
SY   H1.X-59/H1.1-13; H1X59/H1.113; KAUSTe002-A-99
DR   BioSamples; SAMEA111454154
DR   hPSCreg; WAe001-A-99
DR   Wikidata; Q123033828
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JR ! WAe001-A-82
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-A
AC   CVCL_C9K8
SY   H1.X-10/H1.2-20; KAUSTe002-A-A
DR   BioSamples; SAMEA112192699
DR   hPSCreg; WAe001-A-A
DR   Wikidata; Q123033829
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CA ! WAe001-A-78
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-B
AC   CVCL_C9K9
SY   H1.X-59/H1.2-6; KAUSTe002-A-B
DR   BioSamples; SAMEA112192882
DR   hPSCreg; WAe001-A-B
DR   Wikidata; Q123033830
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JR ! WAe001-A-82
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-C
AC   CVCL_C9KA
SY   H1.X-10/H1.3-62; KAUSTe002-A-C
DR   BioSamples; SAMEA112195203
DR   hPSCreg; WAe001-A-C
DR   Wikidata; Q123033831
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CA ! WAe001-A-78
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-D
AC   CVCL_C9KB
SY   H1.X-59/H1.3-68; KAUSTe002-A-D
DR   BioSamples; SAMEA112195213
DR   hPSCreg; WAe001-A-D
DR   Wikidata; Q123033832
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JR ! WAe001-A-82
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-E
AC   CVCL_C9KC
SY   H1.X-10/H1.4-4; KAUSTe002-A-E
DR   BioSamples; SAMEA112195214
DR   hPSCreg; WAe001-A-E
DR   Wikidata; Q123033833
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CA ! WAe001-A-78
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-F
AC   CVCL_C9KD
SY   H1.X-59/H1.4-5; KAUSTe002-A-F
DR   BioSamples; SAMEA112195736
DR   hPSCreg; WAe001-A-F
DR   Wikidata; Q123033834
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JR ! WAe001-A-82
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-G
AC   CVCL_C9KE
SY   H1.X-10/H1.5-1; KAUSTe002-A-G
DR   BioSamples; SAMEA112205460
DR   hPSCreg; WAe001-A-G
DR   Wikidata; Q123033835
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C0CA ! WAe001-A-78
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-H
AC   CVCL_C9KF
SY   H1.X-59/H1.5-33; KAUSTe002-A-H
DR   BioSamples; SAMEA112205461
DR   hPSCreg; WAe001-A-H
DR   Wikidata; Q123033836
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4722; H1-10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JR ! WAe001-A-82
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-I
AC   CVCL_C9KG
SY   H1.0-29/H1.1-13; KAUSTe002-A-I
DR   BioSamples; SAMEA112206179
DR   hPSCreg; WAe001-A-I
DR   Wikidata; Q123033837
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JS ! WAe001-A-83
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-J
AC   CVCL_C9KH
SY   H1.0-102/H1.1-34; KAUSTe002-A-J
DR   BioSamples; SAMEA112206180
DR   hPSCreg; WAe001-A-J
DR   Wikidata; Q123033839
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JU ! WAe001-A-85
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-K
AC   CVCL_C9KI
SY   H1.0-29/H1.2-31; KAUSTe002-A-K
DR   BioSamples; SAMEA112206181
DR   hPSCreg; WAe001-A-K
DR   Wikidata; Q123033840
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JS ! WAe001-A-83
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-L
AC   CVCL_C9KJ
SY   H1.0-102/H1.2-6; KAUSTe002-A-L
DR   BioSamples; SAMEA112226453
DR   hPSCreg; WAe001-A-L
DR   Wikidata; Q123033841
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JU ! WAe001-A-85
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-M
AC   CVCL_C9KK
SY   H1.0-29/H1.3-22; KAUSTe002-A-M
DR   BioSamples; SAMEA112229066
DR   hPSCreg; WAe001-A-M
DR   Wikidata; Q123033842
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JS ! WAe001-A-83
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-N
AC   CVCL_C9KL
SY   H1.0-102/H1.3-90; KAUSTe002-A-N
DR   BioSamples; SAMEA112234840
DR   hPSCreg; WAe001-A-N
DR   Wikidata; Q123033843
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JU ! WAe001-A-85
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-O
AC   CVCL_C9KM
SY   H1.0-29/H1.4-14; KAUSTe002-A-O
DR   BioSamples; SAMEA112234862
DR   hPSCreg; WAe001-A-O
DR   Wikidata; Q123033844
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JS ! WAe001-A-83
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-P
AC   CVCL_C9KN
SY   H1.0-102/H1.4-19; KAUSTe002-A-P
DR   BioSamples; SAMEA112234863
DR   hPSCreg; WAe001-A-P
DR   Wikidata; Q123033845
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JU ! WAe001-A-85
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-Q
AC   CVCL_C9KP
SY   H1.0-29/H1.5-6; KAUSTe002-A-Q
DR   BioSamples; SAMEA112240602
DR   hPSCreg; WAe001-A-Q
DR   Wikidata; Q123033846
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JS ! WAe001-A-83
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-R
AC   CVCL_C9KQ
SY   H1.0-102/H1.5-44; KAUSTe002-A-R
DR   BioSamples; SAMEA112240603
DR   hPSCreg; WAe001-A-R
DR   Wikidata; Q123033848
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4714; H1-0.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JU ! WAe001-A-85
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-S
AC   CVCL_C9KR
SY   H1.1-17/H1.2-11; KAUSTe002-A-S
DR   BioSamples; SAMEA112244816
DR   hPSCreg; WAe001-A-S
DR   Wikidata; Q123033849
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JT ! WAe001-A-84
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-T
AC   CVCL_C9KS
SY   H1.1-39/H1.2-9; KAUSTe002-A-T
DR   BioSamples; SAMEA112245872
DR   hPSCreg; WAe001-A-T
DR   Wikidata; Q123033850
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JV ! WAe001-A-86
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-U
AC   CVCL_C9KT
SY   H1.1-17/H1.4-18; KAUSTe002-A-U
DR   BioSamples; SAMEA112245939
DR   hPSCreg; WAe001-A-U
DR   Wikidata; Q123033851
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JT ! WAe001-A-84
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-V
AC   CVCL_C9KU
SY   H1.1-39/H1.4-17; KAUSTe002-A-V
DR   BioSamples; SAMEA112245949
DR   hPSCreg; WAe001-A-V
DR   Wikidata; Q123033852
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4718; H1-4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JV ! WAe001-A-86
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-W
AC   CVCL_C9KV
SY   H1.1-17/H1.5-14; KAUSTe002-A-W
DR   BioSamples; SAMEA112245950
DR   hPSCreg; WAe001-A-W
DR   Wikidata; Q123033853
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JT ! WAe001-A-84
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-X
AC   CVCL_C9KW
SY   H1.1-39/H1.5-26; KAUSTe002-A-X
DR   BioSamples; SAMEA112245963
DR   hPSCreg; WAe001-A-X
DR   Wikidata; Q123033854
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4715; H1-1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4719; H1-5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JV ! WAe001-A-86
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-Y
AC   CVCL_C9KX
SY   H1.2-13/H1.3-35; KAUSTe002-A-Y
DR   BioSamples; SAMEA112245964
DR   hPSCreg; WAe001-A-Y
DR   Wikidata; Q123033855
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JW ! WAe001-A-87
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe001-A-Z
AC   CVCL_C9KY
SY   H1.2-124/H1.3-23; KAUSTe002-A-Z
DR   BioSamples; SAMEA112246050
DR   hPSCreg; WAe001-A-Z
DR   Wikidata; Q123033856
CC   From: King Abdullah University of Science and Technology; Thuwal; Saudi Arabia.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4716; H1-2.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4717; H1-3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C9JX ! WAe001-A-88
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe007-A-1
AC   CVCL_A8WK
SY   H7-GATA4-T280M; H7-GATA4T280M; ICSSUe008-A-1
DR   BioSamples; SAMEA7807658
DR   hPSCreg; WAe007-A-1
DR   Wikidata; Q108821508
RX   PubMed=34088018;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4173; GATA4; Simple_edited; p.Thr280Met (c.839C>T); ClinVar=VCV000030108; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=34088018).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   WAe007-A-2
AC   CVCL_C4MS
SY   H7-BMP10del; ICSSUe008-A-2
DR   hPSCreg; WAe007-A-2
DR   Wikidata; Q116050773
RX   PubMed=36257094;
CC   From: Institute for Cardiovascular Science of Soochow University; Suzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:20869; BMP10.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   WAe007-A-3
AC   CVCL_D0PI
SY   DNAJC19 KO; NCCDFWe013-A-3
DR   BioSamples; SAMEA114299692
DR   hPSCreg; WAe007-A-3
DR   Wikidata; Q123033857
RX   PubMed=38696852;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:30528; DNAJC19.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C173146; 3-methylglutaconic aciduria type 5
DI   ORDO; Orphanet_66634; Dilated cardiomyopathy with ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9772 ! WA07
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   WAe009-A-1
AC   CVCL_C811
SY   H9.1; WA09.1; WAe003-A-1; WICELLe003-A-1
DR   BioSamples; SAMEA13600231
DR   hPSCreg; WAe009-A-1
DR   SKIP; SKIP001548
DR   SKIP; SKIP001998
DR   Wikidata; Q54993561
RX   PubMed=11071754;
CC   From: University of Wisconsin; Madison; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 13
//
ID   WAe009-A-10
AC   CVCL_C100
SY   EBNA1+H9; H9-EBNA; CSUe002-A; CSUe010-A-10
DR   BioSamples; SAMEA104620317
DR   hPSCreg; WAe009-A-10
DR   SKIP; SKIP002067
DR   Wikidata; Q54993563
RX   PubMed=15645084;
CC   From: Central South University; Changsha; China.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   WAe009-A-11
AC   CVCL_UM37
SY   H9-p53(WT/R249S); A94-42; CDMLe010-A-11
DR   hPSCreg; WAe009-A-11
DR   Wikidata; Q98134722
RX   PubMed=30640060;
CC   From: Cancer Disease Modeling Laboratory, University of Texas Health Center at Houston; Houston; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple_edited; p.Arg249Ser (c.747G>T); ClinVar=VCV000012352; Zygosity=Heterozygous; Note=By TALEN (PubMed=30640060).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   WAe009-A-12
AC   CVCL_UG28
SY   H9_RB1ex3_C7; C7; UDEe010-A-12
DR   BioSamples; SAMEA5912511
DR   hPSCreg; WAe009-A-12
DR   Wikidata; Q98134724
RX   PubMed=30312872;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu125Valfs*9 (c.374_380del); Zygosity=Homozygous (PubMed=30312872).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-13
AC   CVCL_UG29
SY   H9_RB1ex3_G12LS; G12LS; UDEe010-A-13
DR   BioSamples; SAMEA5912512
DR   hPSCreg; WAe009-A-13
DR   Wikidata; Q98134726
RX   PubMed=30312872;
CC   From: Universitat Duisburg-Essen; Duisburg; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Glu125Valfs*9 (c.374_380del); Zygosity=Heterozygous (PubMed=30312872).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-14
AC   CVCL_UM38
SY   H9-ATP2A2-/-; FAHGMUe010-A-14
DR   BioSamples; SAMEA5573702
DR   hPSCreg; WAe009-A-14
DR   Wikidata; Q98134728
CC   From: The First Affiliated Hospital of Guangxi Medical University; Guangxi; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:812; ATP2A2.
CC   Discontinued: hPSCreg; WAe009-A-14; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-16
AC   CVCL_WW89
SY   H9-FMR1-/-(C93); INSTEMe010-A-16
DR   hPSCreg; WAe009-A-16
DR   SKIP; SKIP005538
DR   Wikidata; Q98134731
RX   PubMed=31280136;
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-17
AC   CVCL_ZB39
SY   aMHC-mCherry-BSDr H9; PSUe010-A-17
DR   hPSCreg; WAe009-A-17
DR   Wikidata; Q98134733
CC   From: Pennsylvania State University; State College; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 8
//
ID   WAe009-A-18
AC   CVCL_ZC37
SY   H9TLR7HET; KSCBe010-A-18
DR   hPSCreg; WAe009-A-18
DR   SKIP; SKIP005733
DR   Wikidata; Q98134735
RX   PubMed=32268246;
CC   From: National Institute of Health, Korea-National Stem Cell Bank (KSCB); Cheongwon-gun; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15631; TLR7 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=32268246
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 12.3,13
ST   D21S11: 30
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-19
AC   CVCL_WJ41
SY   VIBCBDe010-A-19
DR   BioSamples; SAMEA5712215
DR   hPSCreg; WAe009-A-19
DR   Wikidata; Q98134738
CC   From: VIB - KU Leuven Center for Brain and Disease Research; Leuven; Belgium.
CC   Characteristics: Using homologous recombination a doxycycline inducible dCAS9 along with GFP and rtTA driven by CAGS promoter was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 7
//
ID   WAe009-A-1A
AC   CVCL_D6K3
SY   SMUDHe010-A-1A
DR   BioSamples; SAMEA114492926
DR   hPSCreg; WAe009-A-1A
DR   Wikidata; Q127384681
RX   PubMed=38507883;
CC   From: Southern Medical University; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a Brainbow-2.1 R cassette that includes nuclear GFP (nGFP), EYFP, RFP (red) and membrane-bound mCerulean was introduced in the AAVS1 safe harbor locus. Stochastic recombination using incompatible lox sites can produce by inversions and excisions four different mixtures of fluorescent proteins (PubMed=38507883).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; J2JWA; mCerulean (Note=Bright cyan fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   WAe009-A-1B
AC   CVCL_D6K4
SY   SMUDHe010-A-1B
DR   BioSamples; SAMEA115474880
DR   hPSCreg; WAe009-A-1B
DR   Wikidata; Q127384682
RX   PubMed=38103335;
CC   From: Southern Medical University; Guangzhou; China.
CC   Characteristics: Using CRISPR/Cas9 a loxP-stop-loxP-DTA (LSL-DTA) construct was introduced in the AAVS1 safe harbor locus (PubMed=38103335).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00588; Corynephage beta diphtheria toxin.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   WAe009-A-1C
AC   CVCL_D1GC
SY   ZZUSAe010-A-1C
DR   BioSamples; SAMEA114466775
DR   hPSCreg; WAe009-A-1C
DR   Wikidata; Q127384683
RX   PubMed=38428348;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple_edited; c.7285+2T>C; Zygosity=Homozygous; Note=By CRISPR/Cas9. Splice donor mutation (PubMed=38428348).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-1D
AC   CVCL_D1GD
SY   CCUHe010-A-1D
DR   BioSamples; SAMEA114467815
DR   hPSCreg; WAe009-A-1D
DR   Wikidata; Q127384684
RX   PubMed=38653148;
CC   From: Cancer Center, Union Hospital, Huazhong University of Science and Technology; Wuhan; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple_edited; c.1032+2T>C; ClinVar=VCV000939724; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice donor mutation (PubMed=38653148).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-1E
AC   CVCL_D6SC
SY   TBX20-KO; AZHe010-A-1E
DR   BioSamples; SAMEA114469216
DR   hPSCreg; WAe009-A-1E
RX   PubMed=38479330;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11598; TBX20.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1F
AC   CVCL_D6SA
SY   TSC2-/- H9; ANZHe010-A-1F
DR   BioSamples; SAMEA114469194
DR   hPSCreg; WAe009-A-1F
RX   PubMed=38574666;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12363; TSC2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1G
AC   CVCL_D6PC
SY   ISL1-KO; SWMUe010-A-1G
DR   BioSamples; SAMEA114498216
DR   hPSCreg; WAe009-A-1G
RX   PubMed=38452706;
CC   From: Southwest Medical University; Luzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6132; ISL1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1H
AC   CVCL_D6SD
SY   MYL3-KO; AZHe010-A-1H
DR   BioSamples; SAMEA114539640
DR   hPSCreg; WAe009-A-1H
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7584; MYL3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1S
AC   CVCL_D6SE
SY   KUe017-A-1S
DR   BioSamples; SAMEA115346752
DR   hPSCreg; WAe009-A-1S
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32751; SNORD90.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1T
AC   CVCL_D6SF
SY   KUe017-A-1T
DR   BioSamples; SAMEA115346754
DR   hPSCreg; WAe009-A-1T
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32763; SNORD100.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1U
AC   CVCL_D6SG
SY   KUe017-A-1U
DR   BioSamples; SAMEA115346755
DR   hPSCreg; WAe009-A-1U
CC   From: University of Copenhagen; Copenhagen; Denmark.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:32732; SNORD71.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1Y
AC   CVCL_D6SB
SY   TRPV2-KO
DR   hPSCreg; WAe009-A-1Y
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:18082; TRPV2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-1Z
AC   CVCL_D6SH
SY   ZJULLe010-A-1Z
DR   BioSamples; SAMEA115532276
DR   hPSCreg; WAe009-A-1Z
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:16920; CIB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WAe009-A-2
AC   CVCL_C812
SY   H9.2; WA09.2; WAe003-A-2; WICELLe003-A-2
DR   hPSCreg; WAe009-A-2
DR   SKIP; SKIP001549
DR   SKIP; SKIP001999
DR   Wikidata; Q54993564
RX   PubMed=11071754;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0014.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 12
//
ID   WAe009-A-20
AC   CVCL_WJ42
SY   VIBCBDe010-A-20
DR   BioSamples; SAMEA5728497
DR   hPSCreg; WAe009-A-20
DR   Wikidata; Q98134740
CC   From: VIB - KU Leuven Center for Brain and Disease Research; Leuven; Belgium.
CC   Characteristics: Using homologous recombination a doxycycline inducible dCAS9-VPR (VPR is a tripartite activation system made of a fusion of VP64, p65(relA), and RTA) along with GFP and rtTA driven by CAGS promoter was introduced in the AAVS1 safe harbor locus.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Homologous recombination; Gene=MGI; MGI:103290; Rela (Note=With p.Met1_Leu368del).
CC   Genetic integration: Method=Homologous recombination; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 9
//
ID   WAe009-A-21
AC   CVCL_YJ22
SY   H9-HDAC6-KO-3; CSUDOOe010-A-21
DR   hPSCreg; WAe009-A-21
DR   SKIP; SKIP005645
DR   Wikidata; Q98134743
RX   PubMed=31775087;
CC   From: Department of Obstetrics, Central South University; Changsha; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14064; HDAC6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-22
AC   CVCL_ZB40
SY   INSTEMe010-A-22
DR   hPSCreg; WAe009-A-22
DR   Wikidata; Q98134745
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   WAe009-A-23
AC   CVCL_WZ23
SY   PITX3-mCherry hESC; WAe009-A-PITX3; YONSEIe010-A-23
DR   hPSCreg; WAe009-A-23
DR   SKIP; SKIP005556
DR   Wikidata; Q98134746
RX   PubMed=31352199;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Characteristics: Using CRISPR/Cas9 a T2A-mCherry-P2A-PGKp-Neo-P2A construct was integrated in front of the stop codon of PITX3.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 7
//
ID   WAe009-A-24
AC   CVCL_YN82
SY   MIPSe010-A-24
DR   BioSamples; SAMEA6324522
DR   hPSCreg; WAe009-A-24
DR   Wikidata; Q98134748
CC   From: Monash University; Melbourne; Australia.
CC   Characteristics: Using CRISPR/Cas9 a IRES-tdTomato-T2A-NanoLuc-pA-FRT-neo-FRT was integrated in front of the stop codon of CX3CR1.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 9
//
ID   WAe009-A-25
AC   CVCL_ZB41
SY   ZSSYLNe010-A-25
DR   BioSamples; SAMEA7274738
DR   hPSCreg; WAe009-A-25
DR   Wikidata; Q98134750
CC   From: Sun Yat-sen University Third Affiliated Hospital; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   WAe009-A-26
AC   CVCL_A1YF
SY   ZSSYLNe010-A-26
DR   hPSCreg; WAe009-A-26
DR   Wikidata; Q105511719
CC   From: Sun Yat-sen University Third Affiliated Hospital; Guangzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WAe009-A-28
AC   CVCL_ZB42
SY   INSTEMe010-A-28
DR   BioSamples; SAMEA6703338
DR   hPSCreg; WAe009-A-28
DR   Wikidata; Q98134753
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24650; EHMT1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-29
AC   CVCL_ZB43
SY   H9-CAG-ChR2-EYFP; H9-AAVS-Puro-CAG-ChR2-eYFP #11CB3; WISCe010-A-29
DR   hPSCreg; WAe009-A-29
DR   WiCell; h9-cag-chr2-eyfp
DR   Wikidata; Q98134755
RX   PubMed=31981924;
CC   From: University of Wisconsin; Madison; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0102.
CC   Characteristics: Using CRISPR/Cas9 a PuroR-CAG-ChR2(H134R)-eYFP construct was introduced in the AAVS1 safe harbor locus (PubMed=31981924).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; 8DNLG; YFP (Note=EYFP, yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q8RUT8; Chlamydomonas reinhardtii channelrhodopsin-2 (cop4) (Note=With p.His134Arg).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   WAe009-A-2A
AC   CVCL_E4DC
SY   H9-ID1/ID3 KO-#1; BTHBIOe010-A-2A
DR   BioSamples; SAMEA115547984
DR   hPSCreg; WAe009-A-2A
RX   PubMed=39342788;
CC   From: Beijing Institute of Ophthalmology, Beijing Tongren Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5362; ID3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=39342788
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 15,19
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 12.3,13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D6S1043: 12,19
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAe009-A-2B
AC   CVCL_E4DD
SY   H9-ID1/ID3 KO-#2; BTHBIOe010-A-2B
DR   BioSamples; SAMEA115547969
DR   hPSCreg; WAe009-A-2B
RX   PubMed=39342788;
CC   From: Beijing Institute of Ophthalmology, Beijing Tongren Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5360; ID1.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:5362; ID3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=39342788
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 15,19
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 12.3,13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D6S1043: 12,19
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 9,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   WAe009-A-30
AC   CVCL_ZB44
SY   H9_RB1ex1del_RC9; UDEe010-A-30
DR   BioSamples; SAMEA6877448
DR   hPSCreg; WAe009-A-30
DR   Wikidata; Q98134757
RX   PubMed=32268247;
CC   From: University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-31
AC   CVCL_ZB45
SY   H9_RB1ex1del_8B3; UDEe010-A-31
DR   BioSamples; SAMEA6877449
DR   hPSCreg; WAe009-A-31
DR   Wikidata; Q98134760
RX   PubMed=32268247;
CC   From: University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-32
AC   CVCL_ZB46
SY   H9_RB1ex1del_9H10; UDEe010-A-32
DR   BioSamples; SAMEA6877450
DR   hPSCreg; WAe009-A-32
DR   Wikidata; Q98134763
RX   PubMed=32268247;
CC   From: University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-33
AC   CVCL_ZB47
SY   H9_RB1ex1del_8C2; UDEe010-A-33
DR   BioSamples; SAMEA6877451
DR   hPSCreg; WAe009-A-33
DR   Wikidata; Q98134765
RX   PubMed=32268247;
CC   From: University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-34
AC   CVCL_ZB48
SY   H9_RB1ex1del_8F2; UDEe010-A-34
DR   BioSamples; SAMEA6877452
DR   hPSCreg; WAe009-A-34
DR   Wikidata; Q98134768
RX   PubMed=32268247;
CC   From: University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-35
AC   CVCL_ZB49
SY   H9_RB1exdel_9H6; UDEe010-A-35
DR   BioSamples; SAMEA6877453
DR   hPSCreg; WAe009-A-35
DR   Wikidata; Q98134770
RX   PubMed=32268247;
CC   From: University Hospital Essen, University of Duisburg-Essen; Essen; Germany.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-36
AC   CVCL_ZX63
SY   JPH2-KO; ANZHENe010-A-36
DR   BioSamples; SAMEA7258631
DR   hPSCreg; WAe009-A-36
DR   Wikidata; Q102115101
RX   PubMed=32777767;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:14202; JPH2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172093; Familial hypertrophic cardiomyopathy type 17
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-37
AC   CVCL_A1PJ
SY   H9-GSX2-tTA:GFP; UMILe010-A-37
DR   BioSamples; SAMEA7201185
DR   hPSCreg; WAe009-A-37
DR   Wikidata; Q102115102
RX   PubMed=33039807;
CC   From: University of Milan; Milan; Italy.
CC   Characteristics: Using CRISPR/Cas9 a tTA-turbo GFP construct was integrated in front of the stop codon of GSX2 (PubMed=33039807).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 10-09-24; Version: 6
//
ID   WAe009-A-38
AC   CVCL_A4DV
SY   C31; ZOCe010-A-38
DR   BioSamples; SAMEA14095994
DR   hPSCreg; WAe009-A-38
DR   Wikidata; Q105511723
RX   PubMed=33128952;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2343; CRB1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-39
AC   CVCL_A7IL
SY   M62; ZOCe010-A-39
DR   BioSamples; SAMEA14095995
DR   hPSCreg; WAe009-A-39
DR   Wikidata; Q107117418
RX   PubMed=33812335;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7027; MERTK.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-4
AC   CVCL_VE22
SY   H9-EGFP
DR   hPSCreg; WAe009-A-4
DR   Wikidata; Q54993566
RX   PubMed=29246576;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29246576
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-09-24; Version: 5
//
ID   WAe009-A-40
AC   CVCL_WM07
SY   H9 CBFA2T3-GLIS2; H9-CBFA2T3-GLIS2; H9 ETO2-GLIS2; GENYOe001-B; GENYOe010-A-40
DR   BioSamples; SAMEA7124963
DR   hPSCreg; WAe009-A-40
DR   Wikidata; Q93937305
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1537; CBFA2T3 (Note=CBFA2T3-GLIS2 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29450; GLIS2 (Note=CBFA2T3-GLIS2 fusion).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-41
AC   CVCL_A1YG
SY   ZZUSAHe010-A-41
DR   hPSCreg; WAe009-A-41
DR   Wikidata; Q105511725
RX   PubMed=33176267;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2472; CSRP3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-42
AC   CVCL_A4DW
SY   H9-FOXH1-/--3#; NFYYe010-A-42
DR   BioSamples; SAMEA7274721
DR   hPSCreg; WAe009-A-42
DR   Wikidata; Q105511727
RX   PubMed=33348200;
CC   From: Nanfang Hospital, Southern Medical University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3814; FOXH1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-43
AC   CVCL_A9XX
SY   FAHGMUe010-A-43
DR   BioSamples; SAMEA8072992
DR   hPSCreg; WAe009-A-43
DR   Wikidata; Q102115103
RX   PubMed=32911324;
CC   From: The First Affiliated Hospital of Guangxi Medical University; Guangxi; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple_edited; p.Tyr475Cys (c.1424A>G); ClinVar=VCV000067199; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32911324).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-45
AC   CVCL_A1MY
SY   TBX5-KO; GOAHe010-A-45
DR   BioSamples; SAMEA8072991
DR   hPSCreg; WAe009-A-45
DR   Wikidata; Q102115104
RX   PubMed=33497883;
CC   From: Gynaecology and Obstetrics, Anzhen Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11604; TBX5.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): hPSCreg=WAe009-A-45
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
DI   NCIt; C125592; Holt-Oram syndrome
DI   ORDO; Orphanet_392; Holt-Oram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-46
AC   CVCL_A4UC
SY   LCSPHe001-A-46
DR   hPSCreg; WAe009-A-46
DR   Wikidata; Q107117419
RX   PubMed=33360099;
CC   From: The Second People's Hospital of Liaocheng; Liaocheng; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7576; MYH6.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C176899; Familial hypertrophic cardiomyopathy type 14
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-47
AC   CVCL_A4UB
SY   COX6A2-KO; PUHTe010-A-47
DR   BioSamples; SAMEA7679543
DR   hPSCreg; WAe009-A-47
DR   Wikidata; Q107117420
RX   PubMed=33418201;
CC   From: Peking University Third Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2279; COX6A2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-48
AC   CVCL_A4TZ
SY   SPHe010-A-48
DR   BioSamples; SAMEA8093237
DR   hPSCreg; WAe009-A-48
DR   Wikidata; Q107117421
RX   PubMed=33517120;
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Glu1784Lys (c.5350G>A) (p.Glu1783Lys, c.5347G>A); ClinVar=VCV000009377; Zygosity=Heterozygous; Note=By method not specified (PubMed=33517120).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-49
AC   CVCL_A7HB
SY   TPP1 c.509-1G > C, clone #23; EMe-TPint5GC23: H9 TPP1 INT5 SA#23; BROWNe010-A-49
DR   hPSCreg; WAe009-A-49
DR   Wikidata; Q107117424
RX   PubMed=33845243;
CC   From: Brown University; Providence; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-5
AC   CVCL_DQ84
SY   H9 shSCR; H9 NEO; H9 neo
DR   hPSCreg; WAe009-A-5
DR   Wikidata; Q54993568
RX   PubMed=27346199;
RX   PubMed=28412998;
RX   PubMed=29246573;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346199
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 8
//
ID   WAe009-A-50
AC   CVCL_A5EP
SY   H9SNTA1KO; CMUe010-A-50
DR   hPSCreg; WAe009-A-50
DR   Wikidata; Q107117425
RX   PubMed=33524674;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11167; SNTA1.
CC   Caution: There is another H9SNTA1KO cell line established in China (Cellosaurus=CVCL_C5TU).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192202; Long QT syndrome 12
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-51
AC   CVCL_A7HC
SY   TPP1 c.509-1G > C, clone #42; EMe-TPint5GC42; H9 TPP1 INT5 SA#42; BROWNe010-A-51
DR   hPSCreg; WAe009-A-51
DR   Wikidata; Q107117426
RX   PubMed=33845243;
CC   From: Brown University; Providence; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-52
AC   CVCL_A7HD
SY   EMe-TPint5GCA5; WA09 TPP1 INT5 SA Het A5; BROWNe010-A-52
DR   hPSCreg; WAe009-A-52
DR   Wikidata; Q107117427
CC   From: Brown University; Providence; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=WAe009-A-52).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-53
AC   CVCL_A7HE
SY   EMe-TPint5GCC1; WA09 TPP1 INT5 SA Hom C1; BROWNe010-A-53
DR   hPSCreg; WAe009-A-53
DR   Wikidata; Q107117428
CC   From: Brown University; Providence; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; c.509-1G>C (IVS5-1G>C); ClinVar=VCV000002644; Zygosity=Homozygous; Note=By CRISPR/Cas9 (hPSCreg=WAe009-A-53).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-54
AC   CVCL_A7HF
SY   TPP1 c.622C>T;630C>T (p.(Arg208*;Asn210Asn)), clone #12; EMe-TPR208X12; H9 TPP1 C>T#12; BROWNe010-A-54
DR   hPSCreg; WAe009-A-54
DR   Wikidata; Q107117429
RX   PubMed=33845243;
CC   From: Brown University; Providence; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Asn210Asn (c.630C>T); ClinVar=VCV003678568; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   WAe009-A-55
AC   CVCL_A7HG
SY   TPP1 c.622C>T;630C>T (p.(Arg208*;Asn210Asn)), clone #25; EMe-TPR208X25; H9 TPP1 C>T#25; BROWNe010-A-55
DR   hPSCreg; WAe009-A-55
DR   Wikidata; Q107117430
RX   PubMed=33845243;
CC   From: Brown University; Providence; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Arg208Ter (c.622C>T); ClinVar=VCV000002643; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243).
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple_edited; p.Asn210Asn (c.630C>T); ClinVar=VCV003678568; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=33845243).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   WAe009-A-56
AC   CVCL_A5EQ
SY   LRP2-KO hESCs; FDCHDPe010-A-56
DR   BioSamples; SAMEA8050680
DR   hPSCreg; WAe009-A-56
DR   Wikidata; Q107117431
RX   PubMed=33878707;
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6694; LRP2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-58
AC   CVCL_A7NC
SY   COL4A5 heterozygote; DZMHe010-A-58
DR   BioSamples; SAMEA8811933
DR   hPSCreg; WAe009-A-58
DR   Wikidata; Q107117432
RX   PubMed=34419749;
CC   From: Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2207; COL4A5 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-59
AC   CVCL_A7RX
SY   dHAND KO; ANZHENe010-A-59
DR   BioSamples; SAMEA8868394
DR   hPSCreg; WAe009-A-59
DR   Wikidata; Q107117433
RX   PubMed=34332328;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4808; HAND2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-6
AC   CVCL_DQ83
SY   H9 shDLL4; H9 DLL4
DR   hPSCreg; WAe009-A-6
DR   Wikidata; Q54993569
RX   PubMed=27346199;
RX   PubMed=29246573;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:2910; DLL4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=27346199
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-60
AC   CVCL_A8DI
SY   H9 iNK5A; GENYOe010-A-60
DR   BioSamples; SAMEA8944454
DR   hPSCreg; WAe009-A-60
DR   Wikidata; Q107117435
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:9886; KDM5A (Note=NUP98-KDM5 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:8068; NUP98 (Note=NUP98-KDM5 fusion).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   WAe009-A-61
AC   CVCL_A7RW
SY   TPM1-/- H9; ANZHENe010-A-61
DR   BioSamples; SAMEA8868393
DR   hPSCreg; WAe009-A-61
DR   Wikidata; Q107117436
RX   PubMed=34352617;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12010; TPM1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C182076; Familial hypertrophic cardiomyopathy type 3
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-62
AC   CVCL_A7RV
SY   KCNQ1-KO; ANZHENe010-A-62
DR   BioSamples; SAMEA8868435
DR   hPSCreg; WAe009-A-62
DR   Wikidata; Q107117437
RX   PubMed=34343827;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6294; KCNQ1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-67
AC   CVCL_B3RP
SY   SHMT2-KO; IHSTMe010-A-67
DR   hPSCreg; WAe009-A-67
DR   Wikidata; Q110433964
RX   PubMed=34688993;
CC   From: Institute of Health Service and Transfusion Medicine; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10852; SHMT2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-69
AC   CVCL_B0FR
SY   MYH7-KO; ANZHENe010-A-69
DR   BioSamples; SAMEA9787090
DR   hPSCreg; WAe009-A-69
DR   Wikidata; Q108821509
RX   PubMed=34678661;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7577; MYH7.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-7
AC   CVCL_VE23
SY   H9-HOXA9; H9-mHOXA9; H9-HoxA9-EGFP; H9-HOXA9-EGFP
DR   BioSamples; SAMEA7124960
DR   hPSCreg; WAe009-A-7
DR   Wikidata; Q54993570
RX   PubMed=29246576;
CC   From: Centre for Genomics and Oncological Research (GENYO); Granada; Spain.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:96180; Hoxa9.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=29246576
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 30
ST   D2S1338: 18,24
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 10-04-25; Version: 9
//
ID   WAe009-A-70
AC   CVCL_B3PX
SY   ZZUSAHe010-A-70
DR   hPSCreg; WAe009-A-70
DR   Wikidata; Q110433966
RX   PubMed=34634758;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3756; FLNC.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-71
AC   CVCL_B0JR
SY   H9-SOX10+/-; SYSUe010-A-71
DR   BioSamples; SAMEA9828964
DR   hPSCreg; WAe009-A-71
DR   Wikidata; Q108821510
RX   PubMed=34678662;
CC   From: Sun Yat-sen University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11190; SOX10 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C124842; Waardenburg syndrome type 4
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-72
AC   CVCL_B3SB
SY   COL1A2 -/-; COL1A2 KO; ANZHENe010-A-72
DR   BioSamples; SAMEA10199952
DR   hPSCreg; WAe009-A-72
DR   Wikidata; Q110433967
RX   PubMed=34999419;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2198; COL1A2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-73
AC   CVCL_B3S6
SY   S100A1-KO; CMUe010-A-73
DR   BioSamples; SAMEA10379659
DR   hPSCreg; WAe009-A-73
DR   Wikidata; Q110433969
RX   PubMed=34953326;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10486; S100A1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-74
AC   CVCL_B3S7
SY   KCNH2Y616C/+; SPHe010-A-74
DR   BioSamples; SAMEA10772827
DR   hPSCreg; WAe009-A-74
DR   Wikidata; Q110433970
RX   PubMed=35247842;
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple_edited; p.Tyr616Cys (c.1847A>G); ClinVar=VCV000067295; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35247842).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-75
AC   CVCL_B3SA
SY   SPHe010-A-75
DR   hPSCreg; WAe009-A-75
DR   Wikidata; Q110433972
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 5
//
ID   WAe009-A-76
AC   CVCL_B5QI
SY   IMPe010-A-76
DR   BioSamples; SAMEA10839123
DR   hPSCreg; WAe009-A-76
DR   Wikidata; Q112041921
CC   From: Research Institute of Molecular Pathology; Vienna; Austria.
CC   Characteristics: Using TALEN a construct containing CAGGS:loxP-STOP-loxp_mCherryNLS-T2A-PuroR was introduced in the AAVS1 safe harbor locus (hPSCreg=WAe009-A-76).
CC   Characteristics: Using CRISPR/Cas9 a construct containing T2A-H2B-Venus-p2A-CreERT was introduced at the C-terminus of BEST1 (hPSCreg=WAe009-A-76).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; YUJWJ; Venus (Note=Bright yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 6
//
ID   WAe009-A-78
AC   CVCL_B5QJ
SY   TBX18-KO; NCCDFWe010-A-78
DR   BioSamples; SAMEA11978601
DR   hPSCreg; WAe009-A-78
DR   Wikidata; Q112041922
RX   PubMed=35533514;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11595; TBX18.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-79
AC   CVCL_B5QK
SY   KCNQ1L114P/+; ANZHENe010-A-79
DR   BioSamples; SAMEA10987223
DR   hPSCreg; WAe009-A-79
DR   Wikidata; Q112041923
RX   PubMed=37244124;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple_edited; p.Leu114Pro (c.341T>C); ClinVar=VCV000053036; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=37244124).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-8
AC   CVCL_VE36
SY   FHL2#4; NTUe010-A-8
DR   hPSCreg; WAe009-A-8
DR   Wikidata; Q54993571
RX   PubMed=29291512;
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3703; FHL2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-80
AC   CVCL_B5QL
SY   H9GPD1LKO; QMUe010-A-80
DR   hPSCreg; WAe009-A-80
DR   Wikidata; Q112041924
CC   From: Qiqihar Medical University; Qiqihar; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:28956; GPD1L.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-81
AC   CVCL_B5QM
SY   H9-MSX1-/-; SYSUSCe010-A-81
DR   BioSamples; SAMEA12095259
DR   hPSCreg; WAe009-A-81
DR   Wikidata; Q112041925
RX   PubMed=35247841;
CC   From: Center for Stem Cell Biology and Tissue Engineering, Sun Yat-sen University; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7391; MSX1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-82
AC   CVCL_B5QN
SY   SMUDHe010-A-82
DR   BioSamples; SAMEA12121387
DR   hPSCreg; WAe009-A-82
DR   Wikidata; Q112041926
RX   PubMed=35714449;
CC   From: Southern Medical University; Guangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:8507; OSMR; Simple_edited; p.Gly513Asp (c.1538G>A); ClinVar=VCV000802119; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=35714449).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C189282; Familial primary localized cutaneous amyloidosis-1
DI   ORDO; Orphanet_353220; Familial primary localized cutaneous amyloidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-83
AC   CVCL_C0GL
SY   H9-FUS-Q290x; ZZUe010-A-83
DR   hPSCreg; WAe009-A-83
DR   Wikidata; Q112930551
RX   PubMed=35247836;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple_edited; p.Gln290Ter (c.868C>T); ClinVar=VCV000037070; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35247836).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 7
//
ID   WAe009-A-84
AC   CVCL_C9JC
SY   TBX20-KO; GICDe010-A-84
DR   BioSamples; SAMEA114594496
DR   hPSCreg; WAe009-A-84
DR   Wikidata; Q123033858
RX   PubMed=36963213;
CC   From: Guangxi Institute of Cardiovascular Diseases; Nanning; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11598; TBX20.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   WAe009-A-86
AC   CVCL_C0JE
SY   SPHe010-A-86
DR   BioSamples; SAMEA13372015
DR   hPSCreg; WAe009-A-86
DR   Wikidata; Q112930552
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple_edited; p.Arg541Cys (c.1621 C>T); ClinVar=VCV000937094; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=WAe009-A-86).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-88
AC   CVCL_C0JD
SY   KCNH2M574V/+; SPHe010-A-88
DR   BioSamples; SAMEA14307683
DR   hPSCreg; WAe009-A-88
DR   Wikidata; Q112930553
RX   PubMed=35526388;
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple_edited; p.Met574Val (c.1720 A>G); ClinVar=VCV000067252; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=35526388).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-89
AC   CVCL_C1JM
SY   ANZHENe010-A-89
DR   BioSamples; SAMEA14029747
DR   hPSCreg; WAe009-A-89
DR   Wikidata; Q114313215
RX   PubMed=36716678;
CC   From: Anzhen Hospital, Capital Medical University; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11822; TIMP3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-9
AC   CVCL_VE37
SY   FHL2#6; NTUe010-A-9
DR   BioSamples; SAMEA8944196
DR   hPSCreg; WAe009-A-9
DR   Wikidata; Q54993572
RX   PubMed=29291512;
CC   From: National Taiwan University; Taipei; Taiwan.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3703; FHL2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-91
AC   CVCL_C1JN
SY   TAZ-KO H9; NCCDFWe010-A-91
DR   BioSamples; SAMEA110341202
DR   hPSCreg; WAe009-A-91
DR   Wikidata; Q114313217
RX   PubMed=36219982;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11577; TAFAZZIN.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-92
AC   CVCL_C4RV
SY   Tet-on-ETV2 H9; NCCDFWe010-A-92
DR   BioSamples; SAMEA110358604
DR   hPSCreg; WAe009-A-92
DR   Wikidata; Q116050776
RX   PubMed=36463633;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Characteristics: Expresses ETV2 induced by doxycyclin. Transduced with a Tre-hETV2-PGKp-PuroR-rtTA-T2A-EF1a construct that contains the reverse tetracycline-controlled transactivator (rtTA), a fusion between a mutated version of E.coli TetR and the activating domain of HSV-1 VP16 (PubMed=36463633).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3491; ETV2.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   WAe009-A-93
AC   CVCL_C6U6
SY   NIS-EGFP-Fluc H9; NCCDFWe010-A-93
DR   BioSamples; SAMEA110401623
DR   hPSCreg; WAe009-A-93
DR   Wikidata; Q117704974
RX   PubMed=36403548;
CC   From: National Center for Cardiovascular Diseases and Fuwai Hospital; Beijing; China.
CC   Characteristics: Transduced with a SLC5A5/NIS-P2A-eGFP-EF1a-Luc-T2A-PuroR construct (PubMed=36403548).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11040; SLC5A5.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   WAe009-A-94
AC   CVCL_C4P7
SY   S100B-KO; LZUSSe010-A-94
DR   hPSCreg; WAe009-A-94
DR   Wikidata; Q116050777
RX   PubMed=36182708;
CC   From: Lanzhou University School of Stomatology; Lanzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:10500; S100B.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 4
//
ID   WAe009-A-95
AC   CVCL_C3LH
SY   hTRF1-KO #3; KRIBBe010-A-95
DR   BioSamples; SAMEA110666770
DR   hPSCreg; WAe009-A-95
DR   Wikidata; Q114313218
RX   PubMed=36805322;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11728; TERF1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-96
AC   CVCL_C3LI
SY   hTRF1-KO #6; KRIBBe010-A-96
DR   BioSamples; SAMEA110691899
DR   hPSCreg; WAe009-A-96
DR   Wikidata; Q114313219
RX   PubMed=36805322;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11728; TERF1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-97
AC   CVCL_C3LJ
SY   hTRF1-KO #9; KRIBBe010-A-97
DR   BioSamples; SAMEA110691900
DR   hPSCreg; WAe009-A-97
DR   Wikidata; Q114313220
RX   PubMed=36805322;
CC   From: Korea Research Institute of Bioscience and Biotechnology; Daejeon; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11728; TERF1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 6
//
ID   WAe009-A-98
AC   CVCL_C9GZ
SY   CtBP1 991C>T; FAUe010-A-98
DR   BioSamples; SAMEA111264470
DR   hPSCreg; WAe009-A-98
DR   Wikidata; Q123033859
CC   Sequence variation: Mutation; HGNC; HGNC:2494; CTBP1; Simple_edited; p.Arg331Trp (c.991C>T); ClinVar=VCV000225758; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (hPSCreg=WAe009-A-98).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C192635; Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-99
AC   CVCL_C6TU
SY   dCas9-p300 H9 21; dCas9-p300 H9 clone 21; KITe010-A-99
DR   BioSamples; SAMEA111365973
DR   hPSCreg; WAe009-A-99
DR   Wikidata; Q117704976
RX   PubMed=36493708;
CC   From: Korea Institute of Toxicology; Daejeon; South Korea.
CC   Characteristics: Transduced with a dCas9-p300-P2A-PuroR construct where the dCas9 is fused to the catalytic HAT core domain of p300 (PubMed=36493708).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3373; EP300 (Note=With p.Met1_Lys1047del and p.Arg1665_His2414del = catalytic domain).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala = dCas9).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 7
//
ID   WAe009-A-A
AC   CVCL_C9J9
SY   ZZUNEUe010-A-A
DR   BioSamples; SAMEA111416148
DR   hPSCreg; WAe009-A-A
DR   Wikidata; Q123033860
RX   PubMed=36796252;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17961; TRPM8.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   WAe009-A-B
AC   CVCL_C9H0
SY   WAE009-A-B; ZZCHe010-A-B
DR   BioSamples; SAMEA111450648
DR   hPSCreg; WAe009-A-B
DR   Wikidata; Q123033861
RX   PubMed=36965407;
CC   From: Zhengzhou Central Hospital Affiliated; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9281; PPP1CA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-C
AC   CVCL_C9JA
SY   PPP2CA KO; ZZUSAe010-A-C
DR   BioSamples; SAMEA111451439
DR   hPSCreg; WAe009-A-C
DR   Wikidata; Q123033862
RX   PubMed=36724553;
CC   From: The Second Affiliated Hospital, University of Zhengzhou; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9299; PPP2CA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-D
AC   CVCL_D6KQ
SY   H9-TMEM119-EGFP; AUSOMe010-A-D
DR   hPSCreg; WAe009-A-D
DR   Wikidata; Q127384685
RX   PubMed=38029556;
CC   From: Ajou University School of Medicine; Suwon-si; South Korea.
CC   Characteristics: Using CRISPR/Cas9 TMEM119 has been endogenously tagged in both alleles at the C-terminus with T2A-EGFP (PubMed=38029556).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   WAe009-A-G
AC   CVCL_WN07
SY   V-H9 hESC; INSTEMe001-A; INSTEMe010-A-G
DR   BioSamples; SAMEA5397443
DR   BioSamples; SAMEA112681014
DR   hPSCreg; WAe009-A-G
DR   Wikidata; Q94318201
RX   PubMed=31075691;
CC   From: Institute for Stem Cell Biology and Regenerative Medicine; Bangalore; India.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 7
//
ID   WAe009-A-H
AC   CVCL_C7FS
SY   H9-NKX2.5GFP/TBX5Td-T2A-18; SKLRMe004-A
DR   hPSCreg; WAe009-A-H
DR   Wikidata; Q117704873
RX   PubMed=36608451;
CC   From: State Key Laboratory of Reproductive Medicine, Nanjing Medical University; Nanjing; China.
CC   Characteristics: Using CRISPR/Cas9 two constructs T2A-EGFP-PGKp-PuroR and T2A-Tdtomato-EF1a-Neo were respectively inserted at the C-terminus of NKX2.5 and TBX5 (PubMed=36608451).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; PGG5S; tdTomato (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 6
//
ID   WAe009-A-J
AC   CVCL_C3RE
SY   P4HA2-KO hESCs; FDCHDPe012-A
DR   BioSamples; SAMEA110669198
DR   hPSCreg; WAe009-A-J
DR   Wikidata; Q116049009
RX   PubMed=36206672;
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8547; P4HA2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-L
AC   CVCL_C0CX
SY   FDCHDPe009-B; LRPAP1-KO hESCs
DR   BioSamples; SAMEA9333559
DR   hPSCreg; WAe009-A-L
DR   Wikidata; Q112929558
RX   PubMed=34469777;
CC   From: Eye & ENT Hospital, Shanghai Medical School, Fudan University; Shanghai; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6701; LRPAP1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   WAe009-A-N
AC   CVCL_C9JB
SY   HPCHe010-A-N
DR   BioSamples; SAMEA112945612
DR   hPSCreg; WAe009-A-N
DR   Wikidata; Q123033863
RX   PubMed=37931537;
CC   From: Henan Provincial Chest Hospital; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11850; TLR4.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   WAe009-A-O
AC   CVCL_VP31
SY   H9 CRX-GFP; H9-CRX-GFP; H9 hESC EGFP-Cone-Rod homeobox Cell Line; CRX-GFP WAe009; UNEWe010-A-O
DR   BioSamples; SAMEA112970166
DR   CancerTools; 153313
DR   hPSCreg; WAe009-A-O
DR   Wikidata; Q93937313
DR   Ximbio; 153313
CC   From: University of Newcastle; Newcastle; United Kingdom.
CC   Registration: Swiss research registry; BAG-hES-IMP-0066.
CC   Characteristics: Using ZFN CRX has been endogenously tagged in both alleles at the 3'UTR with EGFP.
CC   Genetic integration: Method=ZFN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 10
//
ID   WAe009-A-P
AC   CVCL_C9J7
SY   ZZUSAHe010-A-P
DR   BioSamples; SAMEA113425361
DR   hPSCreg; WAe009-A-P
DR   Wikidata; Q123033864
RX   PubMed=37429070;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3754; FLNA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-Q
AC   CVCL_C9J8
SY   CCRIe010-A-Q
DR   BioSamples; SAMEA113610264
DR   hPSCreg; WAe009-A-Q
DR   Wikidata; Q123033865
CC   From: St. Anna Kinderkrebsforschung GmbH; Vienna; Austria.
CC   Characteristics: Using TALEN, a EWSR1/FLI1 construct was introduced in the AAVS1 safe harbor locus (hPSCreg=WAe009-A-Q).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:3508; EWSR1 (Note=EWSR1-FLI1 fusion).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:3749; FLI1 (Note=EWSR1-FLI1 fusion).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   WAe009-A-R
AC   CVCL_B5ZI
SY   WA09 NRL+/eGFP; H9-NRL-GP
DR   BioSamples; SAMEA113967375
DR   hPSCreg; WAe009-A-R
DR   Wikidata; Q112041918
RX   PubMed=29402929;
CC   Characteristics: Valuable tool for studying human rod development and disease and testing therapeutic strategies for retinitis pigmentosa (PubMed=29402929).
CC   Characteristics: Using CRISPR/Cas9 a single allele of NRL was replaced with an eGFP reporter gene (PubMed=29402929).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:8002; NRL (Note=1 of 2 alleles).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 8
//
ID   WAe009-A-U
AC   CVCL_C9GY
SY   TRPV1-KO; ZJULLe010-A-U
DR   BioSamples; SAMEA114036218
DR   hPSCreg; WAe009-A-U
DR   Wikidata; Q123033866
RX   PubMed=37708613;
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12716; TRPV1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAe009-A-V
AC   CVCL_E7BH
SY   H9-TH-EGFP; AUSOMe010-A-V
DR   hPSCreg; WAe009-A-V
RX   PubMed=39577309;
CC   From: Ajou University School of Medicine; Suwon-si; South Korea.
CC   Characteristics: Using CRISPR/Cas9 TH has been endogenously tagged in both alleles at the C-terminus with T2A-EGFP (PubMed=39577309).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WAe009-A-W
AC   CVCL_D6K5
SY   H9 NGN2 B6; UOWe010-A-W
DR   BioSamples; SAMEA114312888
DR   hPSCreg; WAe009-A-W
DR   Wikidata; Q127384686
RX   PubMed=38244534;
CC   From: University of Wollongong; Wollongong; Australia.
CC   Characteristics: Using CRISPR/Cas9 a stably integrated doxycycline-inducible NEUROG2/NGN2 construct (LoxP-EF1A-Bsd-mApple-LoxP-CAG-rtTA3G-NEUROG2-TRe3G was introduced in the CLYBL locus (PubMed=38244534).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; T5UGO; mApple (Note=Bright red fluorescent protein derived from drFP583 (DsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 5
//
ID   WAe009-A-Z
AC   CVCL_D6K6
SY   ZZUNEUe010-A-Z
DR   BioSamples; SAMEA114514495
DR   hPSCreg; WAe009-A-Z
DR   Wikidata; Q127384687
RX   PubMed=38118206;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17075; TAB2.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 4
//
ID   WAe013-A-1
AC   CVCL_C0CE
SY   H13-FMR1-KO; WISCe014-A-1
DR   hPSCreg; WAe013-A-1
DR   Wikidata; Q112930554
RX   PubMed=32179589;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:3775; FMR1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9774 ! WA13
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WAe013-A-2
AC   CVCL_C0CF
SY   H13-FMR1-FLAG; WISCe014-A-2
DR   hPSCreg; WAe013-A-2
DR   Wikidata; Q112930555
RX   PubMed=32179589;
CC   Characteristics: Using CRISPR/Cas9 3 FLAG tags were introduced at the C-terminus of both alleles of FMR1 (PubMed=32179589).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9774 ! WA13
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 23-06-22; Last updated: 05-10-23; Version: 5
//
ID   WAe014-A-1
AC   CVCL_A5QX
SY   W14A5_1-9-7; KUCFRe015-A-1
DR   hPSCreg; WAe014-A-1
DR   Wikidata; Q107117439
RX   PubMed=33611043;
CC   From: Korea University Cell Function Regulation Lab; Seoul; South Korea.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:61; ABCD1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9775 ! WA14
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   WAe025-A-1
AC   CVCL_D0PJ
SY   WA25-CHD4c.3008A/A (C3); ULIEGEe026-A-1
DR   hPSCreg; WAe025-A-1
DR   Wikidata; Q123033868
RX   PubMed=37445725;
CC   From: University of Lieges; Lieges; Belgium.
CC   Sequence variation: Mutation; HGNC; HGNC:1919; CHD4; Simple_edited; p.Gly1003Asp (c.3008G>A); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37445725).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C201595; Sifrim-Hitz-Weiss syndrome
DI   ORDO; Orphanet_653712; CHD4-related neurodevelopmental disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E080 ! WA25
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WAF
AC   CVCL_1H00
SY   Wallago Attu Fin
DR   NRFC; NRFC005
DR   Wikidata; Q54993573
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   PubMed=24381102;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC005.
CC   Miscellaneous: Cell line is available for distribution but not authenticated (NRFC=NRFC005).
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=36718; ! Wallago attu (Helicopter catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 15
//
ID   wAflu1
AC   CVCL_B7AU
DR   Wikidata; Q112041927
RX   PubMed=34584163;
CC   Group: Insect cell line.
CC   Characteristics: Infected by Wolbachia strain wFlu (PubMed=34584163).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=658031; ! Aedes fluviatilis (Mosquito)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   wAflu1.tet
AC   CVCL_B7AV
DR   Wikidata; Q112041928
RX   PubMed=34584163;
CC   Group: Insect cell line.
CC   Characteristics: Cured of Wolbachia strain wFlu infection by tetracycline (PubMed=34584163).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=658031; ! Aedes fluviatilis (Mosquito)
HI   CVCL_B7AU ! wAflu1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   WAG
AC   CVCL_1H01
SY   Wallago Attu Gill
DR   NRFC; NRFC048
DR   Wikidata; Q54993574
RX   DOI=10.1007/s40009-015-0365-5;
WW   Provider; NRFC; NRFC048; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC048.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=36718; ! Wallago attu (Helicopter catfish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 13
//
ID   WaGa
AC   CVCL_E998
SY   WAGA
DR   Cosmic; 1699819
DR   Cosmic; 2273918
DR   PRIDE; PXD008181
DR   Wikidata; Q54993575
RX   PubMed=20444890;
RX   PubMed=22363598;
RX   PubMed=23563200;
RX   PubMed=27121059;
RX   PubMed=30873613;
RX   PubMed=31889939;
CC   Doubling time: 4 days (PubMed=20444890); 2-3 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Proteomics; Quantitative.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 11,12
ST   D18S51: 10,13
ST   D21S11: 28,30
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 19
ST   Penta D: 12
ST   Penta E: 5,10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   WAI,DL
AC   CVCL_E865
SY   WAI, DL
DR   dbMHC; 49055
DR   IHW; IHW09204
DR   IPD-IMGT/HLA; 11745
DR   Wikidata; Q54993576
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,03:01; B*07,21; DPB1*04:02,06:01; DQA1*05:01,03; DQB1*03:02,02:01; DRB1*03:01,04; DRB3*01:01; DRB4*01:01 (IPD-IMGT/HLA=11745).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Waji
AC   CVCL_W202
SY   WAJI
DR   Wikidata; Q54993577
RX   PubMed=3164747;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WAL,FD
AC   CVCL_E866
SY   WAL, FD
DR   dbMHC; 49056
DR   ECACC; 94082228
DR   IHW; IHW09129
DR   IPD-IMGT/HLA; 11672
DR   Wikidata; Q54993578
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*03; B*07; C*07; DPB1*04:01; DQA1*01:02; DQB1*06:02; DRB1*15:01; DRB5*01:01 (IPD-IMGT/HLA=11672).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   Walker-256-TC
AC   CVCL_4984
SY   Walker256-TC
DR   CLO; CLO_0051604
DR   RCB; RCB2909
DR   TKG; TKG 0565
DR   Wikidata; Q54993579
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3537 ! LLC-WRC 256
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   Wall
AC   CVCL_A0XA
DR   Wikidata; Q108821511
RX   PubMed=22704137;
RX   PubMed=31816142;
RX   PubMed=34079834;
CC   Sequence variation: Mutation; VGNC; VGNC:47719; TP53; Simple; p.Glu273Lys (c.818C>T); Zygosity=Unspecified (PubMed=34079834).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Sampling site and breed from personal communication of Gola, Cecilia.
CC   Derived from site: In situ; Bone, rib; UBERON=UBERON_0002228.
CC   Breed/subspecies: Giant Schnauzer; VBO=VBO_0200604.
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   1-2Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 7
//
ID   Walvax-2
AC   CVCL_5J50
SY   WALVAX-2; WALVAX 2; Walvax 2; WALVAX2; Walvax2
DR   CCRID; 4201PAT-CCTCC00374
DR   Wikidata; Q54993580
RX   Patent=CN102911910A;
RX   Patent=CN103525770B;
RX   PubMed=25803132;
RX   PubMed=26116706;
CC   Group: Patented cell line.
CC   Group: Vaccine production cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201055.
CC   Senescence: Maintains excellent capabilities for growth and proliferation until PDL 50 (maximum PDL is 58).
CC   Doubling time: 39-41 hours (Note=At 28th passage), 40-42 hours (Note=At 38th passage), 57-62 hours (Note=At 48th passage) (PubMed=25803132).
CC   Anecdotal: Is causing an outrage in some pro-lifer circles because it is a cell line originating from an aborted (for medical reasons) 3-month old female fetus.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): PubMed=25803132; PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 19,22
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 15,18
ST   D19S433: 13.2,14.2
ST   D21S11: 29,30
ST   D2S1338: 20,25
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D6S1043: 14,19
ST   D7S820: 8,12
ST   D8S1179: 13,15
ST   FGA: 21,24
ST   Penta D: 10,11
ST   Penta E: 5,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3FM
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 18
//
ID   WAM
AC   CVCL_1H02
SY   Wallago Attu Muscle
DR   NRFC; NRFC047
DR   Wikidata; Q54993582
RX   CelloPub=CLPUB00463;
RX   DOI=10.1007/s40009-015-0365-5;
RX   DOI=10.17795/gct-25568;
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC047.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=36718; ! Wallago attu (Helicopter catfish)
SX   Sex unspecified
AG   Fingerling
CA   Spontaneously immortalized cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   Wan-BL
AC   CVCL_M654
SY   WAN-BL; WAN BL; Wan.BL; WAN; Wan
DR   Wikidata; Q54993583
RX   PubMed=1356511;
RX   PubMed=2824665;
RX   PubMed=2898508;
RX   PubMed=2943927;
RX   PubMed=2985508;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, mandible; UBERON=UBERON_0001684.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU66 ! Wan-LCL
SX   Male
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 14
//
ID   Wan-LCL
AC   CVCL_ZU66
SY   Wan.LCL
DR   Wikidata; Q98134772
RX   PubMed=1356511;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M654 ! Wan-BL
SX   Male
AG   3Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   WAPS 12.2
AC   CVCL_F810
SY   WAPS12.2; 12.2
DR   CLO; CLO_0009560
DR   ATCC; HB-299
DR   Wikidata; Q54993584
RX   PubMed=7523509;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 6
//
ID   WART
AC   CVCL_8011
SY   Wart
DR   Wikidata; Q54993585
RX   PubMed=1902574;
RX   PubMed=9551745;
RX   PubMed=9615717;
CC   Doubling time: ~15 hours (PubMed=9615717).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   WASMC
AC   CVCL_9500
DR   CLO; CLO_0009561
DR   CLDB; cl4677
DR   Wikidata; Q54993586
CC   Derived from site: In situ; Aorta; UBERON=UBERON_0000947.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus (Rabbit)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 8
//
ID   WATANABE
AC   CVCL_E867
SY   WATANABI
DR   dbMHC; 49057
DR   ECACC; 94082225
DR   IHW; IHW09126
DR   IPD-IMGT/HLA; 11669
DR   Wikidata; Q54993587
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*02:01:01,02:07; B*46:01; C*01; DPB1*05:01; DQA1*01:03; DQB1*06:01; DRB1*08:03:02 (IPD-IMGT/HLA=11669).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   Watanabe
AC   CVCL_W437
DR   Wikidata; Q54993588
RX   PubMed=8721091;
CC   Population: Japanese.
CC   Doubling time: 60 hours (Note=At 10th passage) (PubMed=8721091).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WAZ-1
AC   CVCL_C4S4
DR   Wikidata; Q116050781
RX   PubMed=232056;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   WAZ-2T
AC   CVCL_5G88
SY   WAZ-2t; WAZ2T
DR   Wikidata; Q54993589
RX   PubMed=7306960;
RX   PubMed=7371012;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 4
//
ID   WAZ-2T +SA
AC   CVCL_XC33
SY   +SA
DR   Wikidata; Q98134774
RX   PubMed=2606877;
RX   PubMed=7371012;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5G88 ! WAZ-2T
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   WAZ-2T -SA
AC   CVCL_XC32
SY   -SA
DR   Wikidata; Q98134776
RX   PubMed=2606877;
RX   PubMed=7371012;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5G88 ! WAZ-2T
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 14-08-25; Version: 4
//
ID   WB-5-11
AC   CVCL_DN33
DR   Wikidata; Q54993596
RX   PubMed=2862991;
RX   PubMed=2862992;
RX   PubMed=3970142;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9806 ! WB-F344
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   WB-F344
AC   CVCL_9806
SY   WB F344; WBF344
DR   BTO; BTO_0004318
DR   EFO; EFO_0002871
DR   CLS; 305201
DR   JCRB; JCRB0193
DR   Millipore; SCC253
DR   Wikidata; Q54993590
RX   PubMed=6468534;
RX   PubMed=9745712;
RX   PubMed=9846981;
RX   PubMed=20140209;
CC   Group: Space-flown cell line (cellonaut).
CC   Characteristics: Well-established and versatile model for studies of liver cell renewal, differentiation, and origination of hepatic cancers. Expresses markers of liver progenitor cells, including EpCAM, Thy1, and Afp (Millipore=SCC253).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: CLS; 305201; true.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   WB-S1
AC   CVCL_A9JM
DR   CCRID; 5301BOV-KCB10218ZJ
DR   KCB; KCB 2010218ZJ
DR   Wikidata; Q108821512
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=365610; ! Bubalus bubalis x Bubalus carabanensis (Hybrid buffalo)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   WB-S2
AC   CVCL_A9JN
DR   CCRID; 5301BOV-KCB10220ZJ
DR   KCB; KCB 2010220ZJ
DR   Wikidata; Q108821513
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   WB-S3
AC   CVCL_A9JP
DR   CCRID; 5301BOV-KCB10224ZJ
DR   KCB; KCB 2010224ZJ
DR   Wikidata; Q108821514
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=3119969; ! Bubalus carabanensis (Swamp type water buffalo)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 6
//
ID   WB-S4
AC   CVCL_A9JQ
DR   CCRID; 5301BOV-KCB10225ZJ
DR   KCB; KCB 2010225ZJ
DR   Wikidata; Q108821515
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=89462; ! Bubalus bubalis (Domestic water buffalo)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   WB-S5
AC   CVCL_A9JR
DR   CCRID; 5301BOV-KCB10233ZJ
DR   KCB; KCB 2010233ZJ
DR   Wikidata; Q108821516
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=365610; ! Bubalus bubalis x Bubalus carabanensis (Hybrid buffalo)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   WB2054
AC   CVCL_4335
SY   WB-2054
DR   Wikidata; Q54993592
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Breed/subspecies: Wistar Furth x Brown Norway; RS=RS_0000982+RS_0000113.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   WB2054M
AC   CVCL_4336
DR   CLO; CLO_0009562
DR   CLDB; cl4678
DR   ECACC; 91011802
DR   Wikidata; Q54993594
RX   PubMed=2910247;
CC   Transformant: ChEBI; CHEBI_73755; 1,2-dimethylhydrazine (DMH).
CC   Breed/subspecies: Wistar Furth x Brown Norway; RS=RS_0000982+RS_0000113.
DI   NCIt; C63866; Adenocarcinoma of the rat colon
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4335 ! WB2054
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   WB311
AC   CVCL_X199
SY   WB-311
DR   BTO; BTO_0004319
DR   Wikidata; Q54993595
RX   PubMed=2774059;
RX   PubMed=20140209;
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_9806 ! WB-F344
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 15
//
ID   WB6
AC   CVCL_B6FB
DR   Wikidata; Q112041930
RX   PubMed=10762059;
CC   Characteristics: Proliferates at the permissive temperature (33 Celsius). Rapid decrease in cell proliferation at the restrictive temperature (39 Celsius) (PubMed=10762059).
CC   Doubling time: 28.7 hours (Note=At 15th passage), 23.5 hours (Note=At 50th passage) (PubMed=10762059).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Adult
CA   Conditionally immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 9
//
ID   WB6a
AC   CVCL_Y636
DR   Wikidata; Q54993597
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   WB6b
AC   CVCL_Y637
DR   Wikidata; Q54993603
RX   PubMed=11084865;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   WB6d
AC   CVCL_Y638
DR   Wikidata; Q54993604
RX   PubMed=11084865;
RX   PubMed=17828574;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: C57BL/6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   WBC264-9C
AC   CVCL_8981
SY   WBC264-9
DR   CLO; CLO_0009563
DR   ATCC; HB-8902
DR   Wikidata; Q54993606
RX   Patent=US4970162;
RX   PubMed=3741419;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8902.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_1P00 ! RAW264-TG3
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   WBD001088
AC   CVCL_E868
DR   dbMHC; 49058
DR   ECACC; 94082253
DR   IHW; IHW09153
DR   IPD-IMGT/HLA; 11696
DR   Wikidata; Q54993607
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*01,02; B*27,37; C*02,06; DPB1*04:01,04:02; DQA1*01:04,01:02; DQB1*05:01,05:02; DRB1*16:01,10:01; DRB5*02 (IPD-IMGT/HLA=11696).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WBD001816
AC   CVCL_E869
DR   dbMHC; 49059
DR   ECACC; 94082254
DR   IHW; IHW09154
DR   IPD-IMGT/HLA; 11697
DR   Wikidata; Q54993608
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*01; B*17; DPB1*01:01,04:01; DQA1*02:01; DQB1*03:03:02; DRB1*07; DRB4*01:01 (IPD-IMGT/HLA=11697).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WBE
AC   CVCL_5604
SY   White Bass Embryo
DR   CLO; CLO_0009564
DR   ATCC; CRL-2773
DR   Wikidata; Q54993609
RX   PubMed=12892524;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=46259; ! Morone chrysops (White bass)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   WBS-A
AC   CVCL_0G88
DR   SKIP; SKIP000557
DR   Wikidata; Q54993610
RX   PubMed=23283491;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G89 ! WBS-B
OI   CVCL_0G90 ! WBS-C
OI   CVCL_0G91 ! WBS-I
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WBS-B
AC   CVCL_0G89
DR   SKIP; SKIP000558
DR   Wikidata; Q54993611
RX   PubMed=23283491;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G88 ! WBS-A
OI   CVCL_0G90 ! WBS-C
OI   CVCL_0G91 ! WBS-I
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WBS-C
AC   CVCL_0G90
DR   SKIP; SKIP000559
DR   Wikidata; Q54993613
RX   PubMed=23283491;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G88 ! WBS-A
OI   CVCL_0G89 ! WBS-B
OI   CVCL_0G91 ! WBS-I
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WBS-I
AC   CVCL_0G91
DR   SKIP; SKIP000560
DR   Wikidata; Q54993614
RX   PubMed=23283491;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0G88 ! WBS-A
OI   CVCL_0G89 ! WBS-B
OI   CVCL_0G90 ! WBS-C
SX   Male
AG   11M
CA   Induced pluripotent stem cell
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WC-1
AC   CVCL_4555
SY   WC 1; Walleye Cell line-1
DR   CLO; CLO_0009565
DR   CLDB; cl4679
DR   IZSLER; BS TCL 65
DR   Wikidata; Q54993615
RX   DOI=10.1139/f80-139;
CC   Group: Fish cell line.
DI   NCIt; C135002; Walleye dermal sarcoma
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   WC-24-02-DS-A
AC   CVCL_C1XM
SY   WISCi018-A
DR   hPSCreg; WISCi018-A
DR   WiCell; wc-24-02-ds-a
DR   Wikidata; Q114313223
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a trisomy 21, but this cell line does not contain the karyotypic abnormality.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XN ! WC-24-02-DS-B
OI   CVCL_C1XP ! WC-24-02-DS-C
OI   CVCL_C1XQ ! WC-24-02-DS-M
OI   CVCL_C1XR ! WC-24-02-DS-O
OI   CVCL_C1XS ! WC-24-02-DS-P
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   WC-24-02-DS-B
AC   CVCL_C1XN
SY   WC24-B; WISCi018-B
DR   hPSCreg; WISCi018-B
DR   WiCell; wc-24-02-ds-b
DR   Wikidata; Q114313226
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a trisomy 21, but this cell line does not contain the karyotypic abnormality.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XM ! WC-24-02-DS-A
OI   CVCL_C1XP ! WC-24-02-DS-C
OI   CVCL_C1XQ ! WC-24-02-DS-M
OI   CVCL_C1XR ! WC-24-02-DS-O
OI   CVCL_C1XS ! WC-24-02-DS-P
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   WC-24-02-DS-C
AC   CVCL_C1XP
SY   WISCi018-C
DR   hPSCreg; WISCi018-C
DR   WiCell; wc-24-02-ds-c
DR   Wikidata; Q114313229
CC   Population: Caucasian.
CC   Characteristics: Established from a patient that is mosaic for a trisomy 21, but this cell line does not contain the karyotypic abnormality.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XM ! WC-24-02-DS-A
OI   CVCL_C1XN ! WC-24-02-DS-B
OI   CVCL_C1XQ ! WC-24-02-DS-M
OI   CVCL_C1XR ! WC-24-02-DS-O
OI   CVCL_C1XS ! WC-24-02-DS-P
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   WC-24-02-DS-M
AC   CVCL_C1XQ
SY   WC24-M; WISCi018-D
DR   hPSCreg; WISCi018-D
DR   WiCell; wc-24-02-ds-m
DR   Wikidata; Q114313231
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XM ! WC-24-02-DS-A
OI   CVCL_C1XN ! WC-24-02-DS-B
OI   CVCL_C1XP ! WC-24-02-DS-C
OI   CVCL_C1XR ! WC-24-02-DS-O
OI   CVCL_C1XS ! WC-24-02-DS-P
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   WC-24-02-DS-O
AC   CVCL_C1XR
SY   WISCi018-E
DR   hPSCreg; WISCi018-E
DR   WiCell; wc-24-02-ds-o
DR   Wikidata; Q114313234
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XM ! WC-24-02-DS-A
OI   CVCL_C1XN ! WC-24-02-DS-B
OI   CVCL_C1XP ! WC-24-02-DS-C
OI   CVCL_C1XQ ! WC-24-02-DS-M
OI   CVCL_C1XS ! WC-24-02-DS-P
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   WC-24-02-DS-P
AC   CVCL_C1XS
SY   WISCi018-F
DR   hPSCreg; WISCi018-F
DR   WiCell; wc-24-02-ds-p
DR   Wikidata; Q114313237
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1XM ! WC-24-02-DS-A
OI   CVCL_C1XN ! WC-24-02-DS-B
OI   CVCL_C1XP ! WC-24-02-DS-C
OI   CVCL_C1XQ ! WC-24-02-DS-M
OI   CVCL_C1XR ! WC-24-02-DS-O
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   WC005i-FX11-7
AC   CVCL_EJ76
SY   FX11-7
DR   WiCell; wc005i-fx11-7
DR   Wikidata; Q54993616
RX   PubMed=24654675;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>435]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=24654675).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ77 ! WC006i-FX11-9U
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   WC006i-FX11-9U
AC   CVCL_EJ77
SY   FX11-9U
DR   WiCell; wc006i-fx11-9u
DR   Wikidata; Q54993617
RX   PubMed=24654675;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[114]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=24654675).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_EJ76 ! WC005i-FX11-7
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   WC007i-FX13-2
AC   CVCL_EJ78
SY   FX13-2
DR   WiCell; wc007i-fx13-2
DR   Wikidata; Q54993618
RX   PubMed=24654675;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>435]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=24654675).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   WC008i-C603-4
AC   CVCL_YZ41
SY   C603-4
DR   WiCell; wc008i-c603-4
DR   Wikidata; Q98134779
RX   PubMed=24654675;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   WC009i-FX08-01
AC   CVCL_EJ79
SY   FX08-1
DR   WiCell; wc009i-fx08-01
DR   Wikidata; Q54993619
RX   PubMed=24654675;
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>435]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=24654675).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 13
//
ID   WC010i-CMT2A-1.1
AC   CVCL_UB79
DR   WiCell; wc010i-cmt2a-1-1
DR   Wikidata; Q98134781
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Unexplicit; Not described; Zygosity=Unspecified (WiCell=wc010i-cmt2a-1.1).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB80 ! WC011i-CMT2A-1.2
OI   CVCL_UB81 ! WC012i-CMT2A-1.3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   WC011i-CMT2A-1.2
AC   CVCL_UB80
DR   WiCell; wc011i-cmt2a-1-2
DR   Wikidata; Q98134782
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Unexplicit; Not described; Zygosity=Unspecified (WiCell=wc011i-cmt2a-1.2).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB79 ! WC010i-CMT2A-1.1
OI   CVCL_UB81 ! WC012i-CMT2A-1.3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   WC012i-CMT2A-1.3
AC   CVCL_UB81
DR   WiCell; wc012i-cmt2a-1-3
DR   Wikidata; Q98134785
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Unexplicit; Not described; Zygosity=Unspecified (WiCell=wc012i-cmt2a-1.3).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB79 ! WC010i-CMT2A-1.1
OI   CVCL_UB80 ! WC011i-CMT2A-1.2
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 11
//
ID   WC013i-CMT2A-2.1
AC   CVCL_UB82
DR   WiCell; wc013i-cmt2a-2-1
DR   Wikidata; Q98134788
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB83 ! WC014i-CMT2A-2.2
OI   CVCL_UB84 ! WC015i-CMT2A-2.3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   WC014i-CMT2A-2.2
AC   CVCL_UB83
DR   WiCell; wc014i-cmt2a-2-2
DR   Wikidata; Q98134789
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB82 ! WC013i-CMT2A-2.1
OI   CVCL_UB84 ! WC015i-CMT2A-2.3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   WC015i-CMT2A-2.3
AC   CVCL_UB84
DR   WiCell; wc015i-cmt2a-2-3
DR   Wikidata; Q98134791
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB82 ! WC013i-CMT2A-2.1
OI   CVCL_UB83 ! WC014i-CMT2A-2.2
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 7
//
ID   WC016i-CMT2A-3.1
AC   CVCL_UB85
DR   WiCell; wc016i-cmt2a-3-1
DR   Wikidata; Q98134793
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB86 ! WC017i-CMT2A-3.2
OI   CVCL_UB87 ! WC018i-CMT2A-3.3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   WC017i-CMT2A-3.2
AC   CVCL_UB86
DR   WiCell; wc017i-cmt2a-3-2
DR   Wikidata; Q98134795
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB85 ! WC016i-CMT2A-3.1
OI   CVCL_UB87 ! WC018i-CMT2A-3.3
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   WC018i-CMT2A-3.3
AC   CVCL_UB87
DR   WiCell; wc018i-cmt2a-3-3
DR   Wikidata; Q98134797
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_UB85 ! WC016i-CMT2A-3.1
OI   CVCL_UB86 ! WC017i-CMT2A-3.2
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 6
//
ID   WC019i-SMA-GM13
AC   CVCL_UB64
SY   SMA-1
DR   WiCell; wc019i-sma-gm13
DR   Wikidata; Q98134799
RX   PubMed=26190808;
CC   Problematic cell line: Misclassified. Parent cell line originally thought to be a SMA type 1 (SMA1) cell line but shown to be from a SMA type 2 (SMA2).
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Triplication; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (PubMed=26190808).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156310; Spinal muscular atrophy type 2
DI   ORDO; Orphanet_83418; Proximal spinal muscular atrophy type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F172 ! GM03813
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   WC020i-SMA-GM14
AC   CVCL_UB65
SY   Contl-2
DR   WiCell; wc020i-sma-gm14
DR   Wikidata; Q98134802
RX   PubMed=26190808;
CC   Population: Caucasian.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11118; SMN2; Extensive; Zygosity=Unspecified; Note=5 copies (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (PubMed=26190808).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F173 ! GM03814
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   WC021i-SMA-GM15
AC   CVCL_UB66
SY   Contl-3
DR   WiCell; wc021i-sma-gm15
DR   Wikidata; Q98134805
RX   PubMed=26190808;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Heterozygous (PubMed=26190808).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F174 ! GM03815
SX   Male
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   WC022i-SMA-GM77
AC   CVCL_UB67
SY   SMA-2
DR   WiCell; wc022i-sma-gm77
DR   Wikidata; Q98134807
RX   PubMed=26190808;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (PubMed=26190808).
CC   Derived from site: In situ; Eye, ocular lens; UBERON=UBERON_0000965.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W562 ! GM09677
SX   Male
AG   1Y11M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   WC023i-SMA-GM232
AC   CVCL_UB68
SY   SMA-3
DR   WiCell; wc023i-sma-gm232
DR   Wikidata; Q98134809
RX   PubMed=26190808;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11117; SMN1; Unexplicit; Ex7-8del; Zygosity=Homozygous (PubMed=26190808).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98670; Werdnig-Hoffmann disease
DI   ORDO; Orphanet_83330; Proximal spinal muscular atrophy type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y965 ! GM00232
SX   Male
AG   7M
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   WC024i-FXS-Nluc1
AC   CVCL_UA51
SY   FX-iPSC-Nluc1
DR   WiCell; wc024i-fxs-nluc1
DR   Wikidata; Q98134811
RX   PubMed=27422057;
CC   Characteristics: CRISPR/Cas9-mediated knock-in of a P2A-NanoLuc construct at the C-terminal end of FMR1.
CC   Characteristics: Reporter cell line to detect FMR1 gene reactivation in human neural cells and can be a valuable resource to identify novel compounds for FMR1 gene reactivation studies (WiCell=wc024i-fxs-nluc1).
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[>435]; ClinVar=VCV000009972; Zygosity=Hemizygous (PubMed=27422057).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=Oplophorus gracilirostris NanoLuc (Note=19 kDa ATP-independent bright luminescent protein derived from O.gracilirostris luciferase).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EJ78 ! WC007i-FX13-2
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 14
//
ID   WC034i-SOD1-D90A
AC   CVCL_UA49
SY   WiCell; wc034i-sod1-d90a
DR   Wikidata; Q98134813
RX   PubMed=24704493;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Heterozygous (PubMed=24704493).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=24704493
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   D8S1179: 10,15
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T849 ! ND29149
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 9
//
ID   WC035i-SOD1-D90D
AC   CVCL_UA50
SY   WiCell; wc035i-sod1-d90d
DR   Wikidata; Q98134815
RX   PubMed=24704493;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11179; SOD1; Simple_corrected; p.Asp91Ala (c.272A>C) (D90A); ClinVar=VCV000014766; Zygosity=Heterozygous; Note=By TALEN (PubMed=24704493).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=24704493
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D5S818: 9,11
ST   D7S820: 8,9
ST   D8S1179: 10,15
ST   FGA: 21,22
ST   Penta D: 9,12
ST   Penta E: 10,11
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C168749; Amyotrophic lateral sclerosis 1
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UA49 ! WC034i-SOD1-D90A
SX   Female
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   WCB-1
AC   CVCL_F0J4
SY   WCB; Whole cell body-1
DR   ECACC; 19072511
RX   PubMed=1478963;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Trypanosoma brucei brucei cytoskeletal antigen WCB210.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WCF
AC   CVCL_WL57
SY   Wuchang bream Caudal Fin
DR   CCTCC; GDC0087
DR   Wikidata; Q98134816
CC   Group: Fish cell line.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3142C0001000000106). It was the sole source of information for this entry.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=75352; ! Megalobrama amblycephala (Chinese blunt snout bream)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 05-10-23; Version: 8
//
ID   WCH-17
AC   CVCL_3471
SY   WCH17
DR   CLO; CLO_0009566
DR   ATCC; CRL-2082
DR   CCRID; 1102MAM-NIFDC00095
DR   NCBI_Iran; C573
DR   Wikidata; Q54993620
RX   PubMed=2839596;
RX   PubMed=20698576;
CC   From: Fernie, Bruce F.; Georgetown University; Rockville; USA.
CC   Transformant: NCBI_TaxID; 35269; Woodchuck hepatitis virus.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C124251; Woodchuck hepatocellular carcinoma
OX   NCBI_TaxID=9995; ! Marmota monax (Woodchuck)
SX   Sex unspecified
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   WCHi001-A
AC   CVCL_C0CL
DR   BioSamples; SAMEA14449548
DR   hPSCreg; WCHi001-A
DR   Wikidata; Q112930556
RX   PubMed=35182860;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Donor information: Established from dizygotic twin of WCHi003-A (Cellosaurus=CVCL_C0CM).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 02-05-24; Version: 5
//
ID   WCHi002-A
AC   CVCL_C0NL
DR   BioSamples; SAMEA110218992
DR   hPSCreg; WCHi002-A
DR   Wikidata; Q112930558
RX   PubMed=35924034;
RX   PubMed=36535090;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6482; LAMA2; Simple; p.Gly2948Ser (c.8842G>A); ClinVar=VCV000432055; Zygosity=Heterozygous (PubMed=35924034; PubMed=36535090).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WCHi003-A
AC   CVCL_C0CM
AS   CVCL_C0IP
SY   WCHi001-B
DR   BioSamples; SAMEA14449555
DR   hPSCreg; WCHi001-B
DR   hPSCreg; WCHi003-A
DR   Wikidata; Q112930557
RX   PubMed=35182860;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Donor information: Established from dizygotic twin of WCHi001-A (Cellosaurus=CVCL_C0CL).
CC   Discontinued: hPSCreg; WCHi001-B; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 10-09-24; Version: 6
//
ID   WCHi004-A
AC   CVCL_C0IQ
DR   BioSamples; SAMEA14449566
DR   hPSCreg; WCHi004-A
DR   Wikidata; Q112930560
RX   PubMed=35700633;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   WCHi005-A
AC   CVCL_C0IR
DR   BioSamples; SAMEA14449581
DR   hPSCreg; WCHi005-A
DR   Wikidata; Q112930561
RX   PubMed=35700633;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34423; Bipolar disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   WCHi006-A
AC   CVCL_C0IN
DR   BioSamples; SAMEA14449515
DR   hPSCreg; WCHi006-A
DR   Wikidata; Q112930562
RX   PubMed=35700633;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   WCHPSYi001-A
AC   CVCL_E8VT
DR   BioSamples; SAMEA117562485
DR   hPSCreg; WCHPSYi001-A
CC   From: Psychiatry Laboratory, West China Hospital, Sichuan University; Chengdu; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WCHPSYi002-A
AC   CVCL_E8VS
DR   BioSamples; SAMEA117562486
DR   hPSCreg; WCHPSYi002-A
RX   PubMed=40280000;
CC   From: Psychiatry Laboratory, West China Hospital, Sichuan University; Chengdu; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WCHSCUi001-A
AC   CVCL_C1XJ
SY   WCHSCU-iPS-PD-CHCHD2-001
DR   hPSCreg; WCHSCUi001-A
DR   Wikidata; Q114313239
RX   PubMed=35944313;
CC   From: West China Hospital, Sichuan university; Chengdu; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:21645; CHCHD2; Simple; p.Pro53Alafs*38 (c.156_157insGCAG) (c.153_156dup); ClinVar=VCV003673940; Zygosity=Heterozygous (PubMed=35944313).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C205643; Parkinson disease 22, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 27-11-25; Version: 7
//
ID   WCMC-1
AC   CVCL_V488
SY   WMC 1; WMC1
DR   Wikidata; Q54993622
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WCMC-10
AC   CVCL_V493
SY   WCMC 10; WMC 10
DR   NIHhESC; NIHhESC-16-0367
DR   Wikidata; Q54993623
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0367.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 14
//
ID   WCMC-11
AC   CVCL_V494
SY   WCMC 11; WMC 11
DR   NIHhESC; NIHhESC-16-0366
DR   Wikidata; Q54993624
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0366.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 18
//
ID   WCMC-12
AC   CVCL_V495
SY   WMC 12
DR   Wikidata; Q54993625
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-13
AC   CVCL_V496
SY   WCMC 13; WMC 13
DR   NIHhESC; NIHhESC-16-0365
DR   Wikidata; Q54993626
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0365.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   WCMC-14
AC   CVCL_V497
SY   WMC 14
DR   Wikidata; Q54993628
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-15
AC   CVCL_V498
SY   WMC 15
DR   Wikidata; Q54993629
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C82342; Huntington's disease
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_399; Huntington disease
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-16
AC   CVCL_V499
SY   WMC 16
DR   Wikidata; Q54993630
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-17
AC   CVCL_V500
SY   WMC 17
DR   Wikidata; Q54993631
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C2975; Cystic fibrosis
DI   ORDO; Orphanet_586; Cystic fibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-18
AC   CVCL_V501
SY   WMC 18
DR   Wikidata; Q54993632
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-19
AC   CVCL_V502
SY   WMC 19
DR   Wikidata; Q54993633
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-2
AC   CVCL_B922
SY   WMC 2; WMC-2; WMC2
DR   Wikidata; Q54993635
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC14-14.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
ID   WCMC-20
AC   CVCL_V503
SY   WMC 20
DR   Wikidata; Q54993636
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-21
AC   CVCL_V504
SY   WMC 21
DR   Wikidata; Q54993638
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-22
AC   CVCL_V505
SY   WMC 22
DR   Wikidata; Q54993639
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-23
AC   CVCL_V506
SY   WCMC 23; WMC 23
DR   NIHhESC; NIHhESC-16-0364
DR   Wikidata; Q54993640
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0364.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   WCMC-24
AC   CVCL_V507
SY   WMC 24
DR   Wikidata; Q54993641
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-25
AC   CVCL_V508
SY   WMC 25
DR   Wikidata; Q54993642
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-26
AC   CVCL_V509
SY   WMC 26
DR   Wikidata; Q54993643
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-27
AC   CVCL_V510
SY   WMC 27
DR   Wikidata; Q54993644
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-28
AC   CVCL_V511
SY   WMC 28
DR   Wikidata; Q54993645
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-29
AC   CVCL_V512
SY   WMC 29
DR   Wikidata; Q54993646
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-3
AC   CVCL_V489
SY   WMC 3; WMC3
DR   Wikidata; Q54993648
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WCMC-30
AC   CVCL_V513
SY   WMC 30
DR   Wikidata; Q54993661
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C118780; Autosomal dominant torsion dystonia 1
DI   ORDO; Orphanet_256; Early-onset generalized limb-onset dystonia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-31
AC   CVCL_V514
SY   WMC 31
DR   Wikidata; Q54993662
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-32
AC   CVCL_V515
SY   WMC 32
DR   Wikidata; Q54993663
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-33
AC   CVCL_V516
SY   WMC 33
DR   Wikidata; Q54993664
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-34
AC   CVCL_V517
SY   WMC 34
DR   Wikidata; Q54993665
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-35
AC   CVCL_V518
SY   WMC 35
DR   Wikidata; Q54993667
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-36
AC   CVCL_V519
SY   WMC 36
DR   Wikidata; Q54993668
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C37865; Trisomy 17
DI   NCIt; C36626; Trisomy 18
DI   ORDO; Orphanet_3380; Trisomy 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   WCMC-37
AC   CVCL_B919
SY   WCMC 37; WCMC37; WMC 37
DR   NIHhESC; NIHhESC-13-0211
DR   Wikidata; Q54993669
RX   PubMed=24289922;
RX   PubMed=27690107;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-13-0211.
CC   Sequence variation: Mutation; HGNC; HGNC:3775; FMR1; Repeat_expansion; CGG[142-450]; Zygosity=Hemizygous (PubMed=24289922).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 21
//
ID   WCMC-38
AC   CVCL_V520
SY   WMC 38
DR   Wikidata; Q54993671
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C114765; Trisomy 22
DI   ORDO; Orphanet_98131; Total autosomal trisomy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   WCMC-39
AC   CVCL_V521
SY   WCMC 39; WMC 39
DR   NIHhESC; NIHhESC-16-0363
DR   Wikidata; Q54993672
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0363.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   WCMC-4
AC   CVCL_V490
SY   WMC 4; WMC4
DR   Wikidata; Q54993673
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V491 ! WCMC-5
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WCMC-40
AC   CVCL_V522
SY   WMC 40
DR   Wikidata; Q54993674
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C34345; Achondroplasia
DI   ORDO; Orphanet_15; Achondroplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-41
AC   CVCL_V523
SY   WMC 41
DR   Wikidata; Q54993675
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C61268; Gaucher disease
DI   ORDO; Orphanet_355; Gaucher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-42
AC   CVCL_V524
SY   WMC 42
DR   Wikidata; Q54993676
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36529; Trisomy 13
DI   ORDO; Orphanet_3378; Trisomy 13
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   WCMC-43
AC   CVCL_V525
SY   WMC 43
DR   Wikidata; Q54993677
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WCMC-5
AC   CVCL_V491
SY   WMC 5; WMC5
DR   Wikidata; Q54993678
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V490 ! WCMC-4
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WCMC-6
AC   CVCL_V492
SY   WCMC 6; WMC 6; WMC6
DR   Wikidata; Q54993679
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V419 ! WCMC-7
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   WCMC-7
AC   CVCL_V419
SY   WCMC 7; WMC 7; WMC7
DR   Wikidata; Q54993680
RX   CelloPub=CLPUB00245;
CC   From: Weill Cornell Medical College; New York; USA.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V492 ! WCMC-6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   WCMC-8
AC   CVCL_B920
SY   WCMC 8; WMC 8; WMC8
DR   NIHhESC; NIHhESC-16-0369
DR   Wikidata; Q54993681
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0369.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   WCMC-9
AC   CVCL_B921
SY   WCMC 9; WMC 9; WMC9
DR   NIHhESC; NIHhESC-16-0368
DR   Wikidata; Q54993682
CC   From: Weill Cornell Medical College; New York; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-16-0368.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C36101; BRCA2 syndrome
DI   ORDO; Orphanet_145; Hereditary breast and ovarian cancer syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   WCQH-9801
AC   CVCL_X186
DR   Wikidata; Q54993683
RX   PubMed=21310132;
CC   Population: Chinese.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 7
//
ID   WCRC-25
AC   CVCL_B7HJ
SY   WCRC0025-76M
DR   ABM; T8074
DR   Wikidata; Q112930563
RX   CelloPub=CLPUB00696;
RX   DOI=10.1158/1538-7445.SABCS17-P5-06-03;
RX   DOI=10.1158/1538-7445.SABCS21-P5-12-03;
CC   Population: Caucasian.
CC   Characteristics: ER-positive, PR-negative and ERBB2-negative.
CC   Doubling time: ~5 days (CelloPub=CLPUB00696).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1748; CDH1; Zygosity=Heterozygous (CelloPub=CLPUB00696).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Gln706Ter (c.2116C>T); Zygosity=Heterozygous (CelloPub=CLPUB00696).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   77Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   WD PaCa
AC   CVCL_8435
SY   WDPaCa; Well-Differentiated Pancreatic adenoCarcinoma; WD
DR   Wikidata; Q54993685
RX   PubMed=3971476;
RX   PubMed=6435863;
RX   PubMed=6805945;
RX   PubMed=8863680;
CC   Doubling time: ~24 hours (PubMed=3971476).
CC   Transformant: ChEBI; CHEBI_134609; Nitrosobis(2-oxopropyl)amine.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C133090; Hamster pancreatic ductal adenocarcinoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   WD0082
AC   CVCL_RT59
DR   Wikidata; Q54993687
RX   PubMed=21693658;
RX   PubMed=22328974;
DI   NCIt; C6505; Atypical lipomatous tumor/well differentiated liposarcoma
DI   ORDO; Orphanet_99971; Well-differentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   WD39
AC   CVCL_Y528
DR   SKIP; SKIP000514
DR   Wikidata; Q54993689
RX   PubMed=23039195;
RX   PubMed=24389010;
RX   PubMed=24936452;
RX   PubMed=26056228;
RX   PubMed=28052261;
RX   PubMed=29179815;
RX   PubMed=30127392;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 8
//
ID   WDC-1
AC   CVCL_R803
DR   Wikidata; Q54993691
RX   PubMed=10721940;
CC   Population: Japanese.
CC   Doubling time: 50 hours (PubMed=10721940).
CC   Derived from site: In situ; Small intestine, duodenum; UBERON=UBERON_0002114.
DI   NCIt; C7889; Duodenal adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   81Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   WDS3
AC   CVCL_A741
DR   Cosmic; 1006171
DR   Wikidata; Q54993692
RX   PubMed=10201537;
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 6
//
ID   WDT2
AC   CVCL_LJ41
SY   3F-iPS
DR   SKIP; SKIP001122
DR   Wikidata; Q54993693
RX   PubMed=21249204;
RX   PubMed=23483397;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
ID   WDV
AC   CVCL_E870
AS   CVCL_F296
SY   WVB; GM06816; GM17002
DR   CLO; CLO_0018043
DR   CLO; CLO_0036533
DR   Coriell; GM06816
DR   Coriell; GM17002
DR   dbMHC; 49060
DR   ECACC; 88052062
DR   IHW; IHW09062
DR   IPD-IMGT/HLA; 11555
DR   Wikidata; Q54993694
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6417008;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Part of: Human variation panel.
CC   Population: Caucasian; Dutch.
CC   HLA typing: A*02:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01; DPB1*02:01:02/02:01:19,04:01:01; DQA1*01:03; DQB1*06:03:01; DRA*01:02; DRB1*13:01:01; DRB3*01:01 (IPD-IMGT/HLA=11555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Misspelling: WVD; Coriell=GM06816.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   WE
AC   CVCL_5M23
DR   Wikidata; Q54993695
RX   PubMed=4735239;
DI   NCIt; C133089; Hamster melanoma
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
OI   CVCL_5M20 ! KF
OI   CVCL_5M21 ! MB
OI   CVCL_5M22 ! TD
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 5
//
ID   WE-68
AC   CVCL_9717
SY   WE 68; WE68
DR   EFO; EFO_0002872
DR   cancercelllines; CVCL_9717
DR   GEO; GSM510016
DR   IARC_TP53; 23651
DR   Progenetix; CVCL_9717
DR   Wikidata; Q54993696
RX   PubMed=1320624;
RX   PubMed=8335680;
RX   PubMed=8378080;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21822310;
RX   PubMed=26428435;
RX   PubMed=30879952;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Hemizygous (PubMed=19787792).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=15150091).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone, fibula; UBERON=UBERON_0001446.
ST   Source(s): PubMed=19787792; PubMed=30879952
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11,12 (PubMed=19787792)
ST   D16S539: 12 (PubMed=30879952)
ST   D18S51: 11,18
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 19,20
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,15
ST   FGA: 19,23
ST   SE33: 19
ST   TH01: 6,8
ST   TPOX: 8,10
ST   vWA: 16,18
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9718 ! WE-M1-68
OI   CVCL_9719 ! WE-M2-68
SX   Female
AG   19Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   WE-afin8e
AC   CVCL_AZ93
SY   Wall Eye-anal fin 8e
DR   Wikidata; Q54993697
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Anal fin; UBERON=UBERON_4000163.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-brain3
AC   CVCL_AZ94
SY   Wall Eye-brain 3
DR   Wikidata; Q54993698
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-brain5
AC   CVCL_AZ95
SY   Wall Eye-brain 5
DR   Wikidata; Q54993699
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
RX   PubMed=26251287;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-cfin11e
AC   CVCL_AZ96
SY   Wall Eye-caudal fin 11e; WECF11e; Wall Eye Caudal Fine 11e
DR   Wikidata; Q54993700
RX   CelloPub=CLPUB00324;
RX   PubMed=23891577;
RX   PubMed=25424833;
RX   PubMed=25643858;
RX   PubMed=26251287;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-cfin11f
AC   CVCL_AZ97
SY   Wall Eye-caudal fin 11f
DR   Wikidata; Q54993701
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
RX   PubMed=25589167;
RX   PubMed=25643858;
RX   PubMed=26251287;
RX   PubMed=31512261;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   WE-heart1
AC   CVCL_AZ98
SY   Wall Eye-heart 1
DR   Wikidata; Q54993703
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-heart6
AC   CVCL_AZ99
SY   Wall Eye-heart 6
DR   Wikidata; Q54993704
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-liver3
AC   CVCL_BA00
SY   Wall Eye-liver 3
DR   Wikidata; Q54993705
RX   CelloPub=CLPUB00324;
RX   PubMed=26251287;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 7
//
ID   WE-M1-68
AC   CVCL_9718
DR   Wikidata; Q54993706
RX   PubMed=1320624;
CC   Derived from site: Metastatic; Chest wall; UBERON=UBERON_0016435.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9717 ! WE-68
OI   CVCL_9719 ! WE-M2-68
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   WE-M2-68
AC   CVCL_9719
SY   WEM2 68
DR   IARC_TP53; 23652
DR   Wikidata; Q54993707
RX   PubMed=1320624;
RX   PubMed=8378080;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_9717 ! WE-68
OI   CVCL_9718 ! WE-M1-68
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 13
//
ID   WE-skin11f
AC   CVCL_BA01
SY   Wall Eye-skin 11f
DR   Wikidata; Q54993727
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
RX   PubMed=26251287;
RX   PubMed=31512261;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Characteristics: Grows at temperatures from 4 to 26 Celsius but proliferated only at the higher temperatures (PubMed=31512261).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   WE-spleen6
AC   CVCL_BA02
SY   WEspleen6; Wall Eye-spleen 6; WE-spleen
DR   Wikidata; Q54993728
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
RX   PubMed=25701636;
RX   PubMed=26251287;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   WE17/10
AC   CVCL_X625
SY   We17/10
DR   BEI_Resources; ARP-462
DR   Wikidata; Q54993729
RX   CelloPub=CLPUB00150;
RX   PubMed=2144349;
CC   Characteristics: IL2 dependent.
CC   Doubling time: 24 hours (CelloPub=CLPUB00150).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3466; T-cell non-Hodgkin lymphoma
DI   ORDO; Orphanet_171918; T-cell non-Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Factor-dependent cell line
DT   Created: 05-09-14; Last updated: 10-09-24; Version: 10
//
ID   WEBA
AC   CVCL_BA03
SY   Wall Eye Bulbus Arteriosus
DR   Wikidata; Q54993731
RX   CelloPub=CLPUB00324;
RX   PubMed=25424833;
RX   PubMed=25461487;
RX   PubMed=26251287;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart, bulbus arteriosus; UBERON=UBERON_0004152.
CC   Cell type: Vascular endothelial cell; CL=CL_0002139.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 27-11-25; Version: 9
//
ID   WEG-1
AC   CVCL_8012
DR   Wikidata; Q54993732
RX   PubMed=8536610;
WW   Info; -; -; https://web.archive.org/web/20141104152240/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/weg1.htm
WW   Info; ResearchGate; -; https://www.researchgate.net/post/Does_anyone_know_of_an_established_mouse_uterine_epithelial_cell_line_in_existence
CC   Characteristics: Retains the epithelial morphology of the parent uterine epithelial cells (UEC).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: CF-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 13
//
ID   WEGLI-11
AC   CVCL_7873
SY   WEGLI 11; WEGLI11; Wegli 11
DR   Wikidata; Q54993733
RX   PubMed=7684623;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   WEGLI-13
AC   CVCL_7874
SY   WEGLI 13; WEGLI13
DR   Wikidata; Q54993734
RX   PubMed=7684623;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   WEGLI-16
AC   CVCL_7875
SY   WEGLI 16; WEGLI16
DR   Wikidata; Q54993735
RX   PubMed=7684623;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   WEGLI-18
AC   CVCL_7876
SY   WEGLI 18; WEGLI18
DR   BTO; BTO_0001927
DR   Wikidata; Q54993736
RX   PubMed=7684623;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   WEGLI-20
AC   CVCL_7877
SY   WEGLI 20; WEGLI20
DR   Wikidata; Q54993737
RX   PubMed=7684623;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   WEGLI-22
AC   CVCL_7878
SY   WEGLI 22; WEGLI22
DR   Wikidata; Q54993739
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   WEGLI-3
AC   CVCL_7879
SY   WEGLI 3; WEGLI3
DR   Wikidata; Q54993741
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   WEGLI-9
AC   CVCL_7880
SY   WEGLI 9; WEGLI9
DR   Wikidata; Q54993742
RX   PubMed=7684623;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   WEHI 1.14
AC   CVCL_JY73
DR   Wikidata; Q54993743
RX   PubMed=11238627;
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J47 ! WEHI-164 clone 13
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   WEHI-105.7
AC   CVCL_F528
SY   WEHI 105.7
DR   Wikidata; Q54993744
RX   PubMed=4630643;
CC   Doubling time: ~18 hours (PubMed=4630643).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: NZB.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 6
//
ID   WEHI-13VAR
AC   CVCL_3619
SY   WEHI-13var; WEHI 13 Var
DR   CLO; CLO_0009572
DR   ATCC; CRL-2148
DR   BioSample; SAMN11397643
DR   CCRID; 1102MOU-NIFDC00029
DR   Wikidata; Q54993746
RX   PubMed=7590904;
RX   PubMed=31220119;
CC   Biotechnology: Used for a sensitive bioessay to detect and measure TNF-alpha in the presence of Actinomycin D.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 17,18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 15.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 17,18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0J47 ! WEHI-164 clone 13
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   WEHI-164
AC   CVCL_2251
SY   WEHI 164; WEHI164; WEHI 164 TC
DR   CLO; CLO_0009567
DR   CLO; CLO_0009573
DR   CLDB; cl4680
DR   CLDB; cl4681
DR   CLDB; cl4683
DR   ATCC; CRL-1751
DR   BCRJ; 0247
DR   BioSample; SAMN11397634
DR   CCRID; 4201MOU-CCTCC00092
DR   CCTCC; GDC0092
DR   ChEMBL-Cells; CHEMBL3308344
DR   ChEMBL-Targets; CHEMBL614227
DR   CLS; 400438
DR   ECACC; 87022501
DR   ICLC; ATL96004
DR   IZSLER; BS TCL 195
DR   KCLB; 21751
DR   NCBI_Iran; C200
DR   PubChem_Cell_line; CVCL_2251
DR   Wikidata; Q54993747
RX   PubMed=4543620;
RX   PubMed=9753870;
RX   PubMed=31220119;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-164
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,19
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 13
ST   Mouse STR 11-2: 18
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 15.2
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   WEHI-164 clone 13
AC   CVCL_0J47
SY   WEHI 164 clone 13; WEHI 164(13)
DR   Wikidata; Q54993748
RX   PubMed=3782828;
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2251 ! WEHI-164
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 6
//
ID   WEHI-164R
AC   CVCL_4561
SY   WEHI 164R; WEHI164R
DR   CLO; CLO_0050182
DR   RCB; RCB2904
DR   TKG; TKG 0281
DR   Wikidata; Q54993750
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2251 ! WEHI-164
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   WEHI-164S
AC   CVCL_2238
SY   WEHI 164S; WEHI164S
DR   CLO; CLO_0009574
DR   CLO; CLO_0050183
DR   CLDB; cl4682
DR   DSMZ; ACC-25
DR   DSMZCellDive; ACC-25
DR   RCB; RCB2905
DR   TKG; TKG 0282
DR   Wikidata; Q54993752
CC   Doubling time: ~30-50 hours (DSMZ=ACC-25).
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Breed/subspecies: BALB/c.
ST   Source(s): DSMZ=ACC-25
ST   Mouse STR 4-2: 21.3,22.3
ST   Mouse STR 5-5: 13,14
ST   Mouse STR 6-4: 17,18
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 16
ST   Mouse STR 15-3: 21.3,22.3
ST   Mouse STR 18-3: 17,18
ST   Mouse STR X-1: 26
DI   NCIt; C24017; Mouse fibrosarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2251 ! WEHI-164
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   WEHI-22.1
AC   CVCL_2248
SY   WEHI 22.1
DR   CLO; CLO_0009568
DR   ATCC; TIB-54
DR   Wikidata; Q54993753
RX   PubMed=4630643;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~12 hours (PubMed=4630643).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   WEHI-231
AC   CVCL_0577
SY   WEHI 231; WEHI231
DR   BTO; BTO_0001093
DR   CLO; CLO_0009575
DR   MCCL; MCC:0000483
DR   CLDB; cl4687
DR   ATCC; CRL-1702
DR   ECACC; 85022107
DR   Lonza; 756
DR   PRIDE; PRD000029
DR   TOKU-E; 3440
DR   Wikidata; Q54993754
RX   PubMed=3495708;
RX   PubMed=6170720;
RX   PubMed=6969756;
RX   PubMed=7561089;
RX   PubMed=14729942;
RX   PubMed=25277546;
CC   Omics: Proteomics; PTM; Phosphorylation.
CC   Omics: Variations; SNP array analysis.
CC   Breed/subspecies: BALB/c x NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   WEHI-231-bcl-xL clone 18
AC   CVCL_C4M0
SY   WEHI-231-Clone 18; WEHI-231 Clone 18
DR   Wikidata; Q116050789
RX   PubMed=7561089;
CC   Doubling time: 13.3 +- 2.2 hours (PubMed=7561089).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88139; Bcl2l1 (Note=Isoform Bcl-xL; with a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: BALB/c x NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0577 ! WEHI-231
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   WEHI-231-bcl-xL clone 3
AC   CVCL_C4M1
SY   WEHI-231-Clone 3; WEHI-231 Clone 3
DR   Wikidata; Q116050791
RX   PubMed=7561089;
CC   Doubling time: 14.6 +- 1.2 hours (PubMed=7561089).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88139; Bcl2l1 (Note=Isoform Bcl-xL; with a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: BALB/c x NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0577 ! WEHI-231
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   WEHI-231-bcl-xL clone 69
AC   CVCL_C4M2
SY   WEHI-231-Clone 69; WEHI-231 Clone 69
DR   Wikidata; Q116050792
RX   PubMed=7561089;
CC   Doubling time: 13.4 +- 2.1 hours (PubMed=7561089).
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:88139; Bcl2l1 (Note=Isoform Bcl-xL with a N-terminal FLAG tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: BALB/c x NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0577 ! WEHI-231
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   WEHI-231-Neo
AC   CVCL_C4LZ
SY   WEHI-231-NEO
DR   Wikidata; Q116050793
RX   PubMed=7561089;
CC   Characteristics: Control cell line for the WEHI-231-Bcl-xL cell lines.
CC   Doubling time: 15.1 +- 0.7 hours (PubMed=7561089).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Breed/subspecies: BALB/c x NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0577 ! WEHI-231
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 5
//
ID   WEHI-265.1
AC   CVCL_3620
SY   WEHI 265.1; WEHI265.1; WEHI:265
DR   CLO; CLO_0009576
DR   ATCC; TIB-204
DR   ChEMBL-Cells; CHEMBL3307249
DR   ChEMBL-Targets; CHEMBL612805
DR   PubChem_Cell_line; CVCL_3620
DR   Wikidata; Q54993755
RX   PubMed=6170720;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   WEHI-274.1
AC   CVCL_3621
SY   Wehi-274.1; WEHI 274.1; WEHI:274
DR   CLO; CLO_0009577
DR   CLDB; cl4688
DR   ATCC; CRL-1679
DR   ECACC; 91061231
DR   Wikidata; Q54993758
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21894; Mouse monocytic leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   WEHI-279
AC   CVCL_3278
DR   CLO; CLO_0009578
DR   CLDB; cl4689
DR   ATCC; CRL-1704
DR   ECACC; 94110901
DR   Lonza; 1131
DR   Wikidata; Q54993759
CC   Breed/subspecies: NZC.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 6
//
ID   WEHI-3
AC   CVCL_3622
SY   Wehi-3; WEHI 3; WEHI3
DR   BTO; BTO_0000295
DR   CLO; CLO_0009579
DR   CLO; CLO_0051420
DR   CLDB; cl4691
DR   ATCC; TIB-68
DR   BCRC; 60176
DR   BioSample; SAMN11397664
DR   CCRID; 1101MOU-PUMC000029
DR   CLS; 400381
DR   JCRB; JCRB9093
DR   KCB; KCB 2012094YJ
DR   RCB; RCB0035
DR   Wikidata; Q54993760
RX   PubMed=3005406;
RX   PubMed=3792703;
RX   PubMed=3967303;
RX   PubMed=4543620;
RX   PubMed=5259325;
RX   PubMed=6170720;
RX   PubMed=6687612;
RX   PubMed=25277546;
RX   PubMed=31220119;
WW   Info; -; -; https://web.archive.org/web/20201109215324/www.infarktforschung.de/macrophages_cell_lines.html
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 18 hours (Note=In 2% FCS) (PubMed=3005406); 17.2-22.7 hours (PubMed=3967303).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: WEIHI3; Note=Occasionally.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 15,16,18
ST   Mouse STR 1-2: 17
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14,15
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,19,20,21
ST   Mouse STR 6-7: 12,13,14
ST   Mouse STR 7-1: 25.2,26.2,27.2
ST   Mouse STR 8-1: 13,14
ST   Mouse STR 11-2: 18,19
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 13-1: 15.2,16.2
ST   Mouse STR 15-3: 22.3,23.3,25.5
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 26,27
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 28
//
ID   WEHI-3B
AC   CVCL_2239
SY   WEHI-3b; Wehi-3B; WEHI 3B; WEHI3B; W3(H); WEHI-3 subline B
DR   BTO; BTO_0005282
DR   CLO; CLO_0009569
DR   CLO; CLO_0009580
DR   CLO; CLO_0050196
DR   CLDB; cl4684
DR   CLDB; cl4685
DR   CLDB; cl4686
DR   CLDB; cl4937
DR   BCRJ; 0248
DR   ChEMBL-Cells; CHEMBL3307352
DR   ChEMBL-Targets; CHEMBL614249
DR   CLS; 400376
DR   DSMZ; ACC-26
DR   DSMZCellDive; ACC-26
DR   ECACC; 86013003
DR   IBRC; C10075
DR   ICLC; ATL99003
DR   JCRB; IFO50296
DR   Lonza; 1430
DR   PubChem_Cell_line; CVCL_2239
DR   RCB; RCB2853
DR   TKG; TKG 0584
DR   Wikidata; Q54993761
RX   DOI=10.1016/0165-4608(80)90043-6;
RX   PubMed=3792703;
RX   PubMed=5259325;
RX   PubMed=8343448;
RX   PubMed=17635523;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=WEHI-3B
CC   Characteristics: Constitutively produces interleukin-3 (IL3).
CC   Doubling time: 20 hours (PubMed=8343448); ~20-30 hours (DSMZ=ACC-26).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
ST   Source(s): DSMZ=ACC-26
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 14
ST   Mouse STR 6-4: 18,19,20
ST   Mouse STR 6-7: 12
ST   Mouse STR 12-1: 16,17
ST   Mouse STR 15-3: 22.3,23.3,25.3
ST   Mouse STR 18-3: 18
ST   Mouse STR X-1: 25,26
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3622 ! WEHI-3
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   WEHI-3B D+
AC   CVCL_4357
SY   WEHI-3B(D+); WEHI-3BD; WEHI 3BD
DR   CLO; CLO_0009570
DR   CLO; CLO_0009581
DR   CLDB; cl4693
DR   CLDB; cl4694
DR   ECACC; 92110401
DR   Wikidata; Q54993762
RX   CelloPub=CLPUB00272;
RX   PubMed=2824536;
RX   PubMed=8642845;
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2239 ! WEHI-3B
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
ID   WEHI-3B D+ F17
AC   CVCL_C7PP
SY   F17
DR   Wikidata; Q117704982
RX   PubMed=8642845;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   WEHI-3B D+ P1
AC   CVCL_C7PQ
SY   P1
DR   Wikidata; Q117704983
RX   PubMed=8642845;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   WEHI-3B*
AC   CVCL_WB18
DR   IBRC; C10084
DR   Wikidata; Q98134818
CC   Characteristics: Adapted to growth in DMEM medium.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2239 ! WEHI-3B
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   WEHI-3B-Y1
AC   CVCL_WW74
DR   Wikidata; Q98134821
RX   PubMed=8343448;
CC   Group: Serum/protein free medium cell line.
CC   Doubling time: 24 hours (PubMed=8343448).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2239 ! WEHI-3B
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 4
//
ID   WEHI-3B/CPX
AC   CVCL_3430
SY   WEHI-3B/CPXRES
DR   CLO; CLO_0009582
DR   CLDB; cl4938
DR   ICLC; ATL99004
DR   Wikidata; Q54993763
RX   CelloPub=CLPUB00272;
RX   PubMed=17635523;
CC   Selected for resistance to: ChEBI; CHEBI_100241; Ciprofloxacin (CIP).
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   WEHI-3B/CTRES
AC   CVCL_4Y52
SY   WEHI-3B/CT/REV
DR   Wikidata; Q54993765
RX   PubMed=12083375;
RX   PubMed=16541129;
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   WEHI-3B/NOVO
AC   CVCL_9260
DR   Wikidata; Q54993766
RX   PubMed=1316227;
CC   Selected for resistance to: ChEBI; CHEBI_28368; Novobiocin.
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 9
//
ID   WEHI-3B/S
AC   CVCL_9261
DR   Wikidata; Q54993767
RX   PubMed=1316227;
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4357 ! WEHI-3B D+
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 7
//
ID   WEHI-5
AC   CVCL_0J46
SY   WEHI 5
DR   Wikidata; Q54993768
RX   PubMed=3495708;
RX   PubMed=6170720;
CC   Cell type: B-cell; CL=CL_0000236.
CC   Breed/subspecies: BALB/c x NZB.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 4
//
ID   WEHI-7
AC   CVCL_F526
SY   WEHI 7; WEHI7
DR   Wikidata; Q54993769
RX   PubMed=2019585;
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 6
//
ID   WEHI-7.1
AC   CVCL_0576
SY   W7; WEHI 7.1; WEHI7.1; Wehi 7.1
DR   CLO; CLO_0009571
DR   MCCL; MCC:0000482
DR   ATCC; TIB-53
DR   Wikidata; Q54993770
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F526 ! WEHI-7
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 9
//
ID   WEHI-7.2
AC   CVCL_3950
SY   WEHI 7.2; WEHI7.2
DR   BTO; BTO_0003181
DR   Lonza; 1003
DR   Wikidata; Q54993771
RX   PubMed=8022822;
RX   PubMed=9371519;
RX   PubMed=11289160;
RX   PubMed=11526450;
RX   PubMed=12203227;
RX   PubMed=15702245;
RX   PubMed=17180014;
CC   Characteristics: Treatment with dexamethasone, a synthetic glucocorticoid, causes the cells to undergo apoptosis (PubMed=17180014).
CC   Doubling time: 13.78 +- 0.38 hours (PubMed=11526450).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F526 ! WEHI-7
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   WEHI-7.2 100R
AC   CVCL_C7PX
SY   100R
DR   Wikidata; Q117704984
RX   PubMed=11526450;
CC   Doubling time: 14.20 +- 0.49 hours (PubMed=11526450).
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   WEHI-7.2 200R
AC   CVCL_C7PY
SY   200R
DR   Wikidata; Q117704985
RX   PubMed=11526450;
RX   PubMed=12203227;
RX   PubMed=15702245;
CC   Doubling time: 14.63 +- 0.31 hours (PubMed=11526450).
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   WEHI-7.2 50R
AC   CVCL_C7PZ
SY   50R
DR   Wikidata; Q117704986
RX   PubMed=11526450;
CC   Doubling time: 14.62 +- 0.76 hours (PubMed=11526450).
CC   Selected for resistance to: ChEBI; CHEBI_16240; Hydrogen peroxide.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   WEHI-7.2 CAT2
AC   CVCL_C7PR
SY   CAT2
DR   Wikidata; Q117704987
RX   PubMed=11289160;
RX   PubMed=12203227;
RX   PubMed=15702245;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2279; Cat.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   WEHI-7.2 CAT38
AC   CVCL_C7PS
SY   CAT38
DR   Wikidata; Q117704988
RX   PubMed=11289160;
RX   PubMed=12203227;
RX   PubMed=15702245;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2279; Cat.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 4
//
ID   WEHI-7.2 Trx5
AC   CVCL_C7PT
SY   Trx5
DR   Wikidata; Q117704989
RX   PubMed=9371519;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12435; TXN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   WEHI-7.2 Trx6
AC   CVCL_C7PU
SY   Trx6
DR   Wikidata; Q117704990
RX   PubMed=9371519;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12435; TXN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3950 ! WEHI-7.2
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 14-08-25; Version: 5
//
ID   WEHI-7TG
AC   CVCL_F527
SY   WEHI7TG
DR   Wikidata; Q54993773
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: NCIt; C17262; X-Ray.
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C198577; Mouse thymoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_F526 ! WEHI-7
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 7
//
ID   Well5
AC   CVCL_YK72
DR   Wikidata; Q98134822
RX   PubMed=31807554;
CC   Population: Chinese.
CC   Characteristics: Established from a xenograft produced in NOD/SCID mice. Will develop spontaneous pulmonary metastases when orthotopically implanted.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   WERC
AC   CVCL_7881
DR   Wikidata; Q54993774
RX   PubMed=4107530;
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   16-18FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 10
//
ID   WERI-Rb-1
AC   CVCL_1792
AS   CVCL_2757
SY   WERI-RB-1; WERI-Rb 1; WERI-Rb1; WERI-RB1; WERI Rb-1; WERIRb1; WERI; Wills Eye Research Institute-Retinoblastoma-1
DR   CLO; CLO_0009583
DR   CLO; CLO_0009584
DR   CLO; CLO_0051563
DR   EFO; EFO_0005715
DR   CLDB; cl4695
DR   AddexBio; C0029002/4899
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ATCC; HTB-169
DR   BioSample; SAMN03472730
DR   cancercelllines; CVCL_1792
DR   CCRID; 3101HUMTCHu213
DR   Cell_Model_Passport; SIDM01414
DR   CLS; 300632
DR   Cosmic; 688119
DR   Cosmic; 909782
DR   DepMap; ACH-001421
DR   DSMZ; ACC-90
DR   DSMZCellDive; ACC-90
DR   ECACC; 06070602
DR   ENCODE; ENCBS087YAE
DR   ENCODE; ENCBS270AAA
DR   ENCODE; ENCBS282DQM
DR   ENCODE; ENCBS283KOW
DR   ENCODE; ENCBS283WND
DR   ENCODE; ENCBS679NMZ
DR   GEO; GSM749679
DR   GEO; GSM749766
DR   GEO; GSM749768
DR   GEO; GSM824870
DR   GEO; GSM945263
DR   GEO; GSM945318
DR   GEO; GSM1486290
DR   GEO; GSM2043881
DR   IGRhCellID; WERIRb1
DR   IZSLER; BS TCL 231
DR   JCRB; JCRB3028
DR   JCRB; KURB2683
DR   Lonza; 1147
DR   PRIDE; PXD030924
DR   Progenetix; CVCL_1792
DR   RCB; RCB2146
DR   TKG; TKG 0601
DR   Wikidata; Q54993776
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=679190;
RX   PubMed=844036;
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=6351622;
RX   PubMed=7499444;
RX   PubMed=7689221;
RX   PubMed=19686387;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=23498719;
RX   PubMed=25326674;
RX   PubMed=27115612;
RX   PubMed=28713896;
RX   PubMed=29192327;
RX   PubMed=30584916;
RX   PubMed=31781967;
RX   PubMed=32123578;
RX   PubMed=35409416;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/WERI-Rb-1_Stam_protocol.pdf
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian.
CC   Doubling time: 96 hours (PubMed=844036); 50 hours (PubMed=25326674); 84 hours (PubMed=31781967); ~49 hours (DSMZ=ACC-90).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9884; RB1; Zygosity=Homozygous (PubMed=25326674).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: JCRB; KURB2683; probable.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
ST   Source(s): ATCC=HTB-169; DepMap=ACH-001421; DSMZ=ACC-90; JCRB=JCRB3028; RCB=RCB2146; TKG=TKG 0601
ST   Amelogenin: X
ST   CSF1PO: 10 (TKG=TKG 0601)
ST   CSF1PO: 10,12,13 (ATCC=HTB-169; DepMap=ACH-001421; DSMZ=ACC-90; RCB=RCB2146)
ST   CSF1PO: 11,12 (JCRB=JCRB3028)
ST   D13S317: 14
ST   D16S539: 13
ST   D18S51: 13,19
ST   D19S433: 14,15
ST   D21S11: 29
ST   D2S1338: 12,15
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,12,13 (JCRB=JCRB3028)
ST   D7S820: 10,13 (ATCC=HTB-169; DepMap=ACH-001421; DSMZ=ACC-90; RCB=RCB2146; TKG=TKG 0601)
ST   D8S1179: 12,15
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,11
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   WERI-Rb-1 CDDP-R
AC   CVCL_B7IE
SY   WERI-Rb1 cisplatin-resistant; WERI-Rb1 CisPt
DR   Wikidata; Q112930564
RX   PubMed=29192327;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1792 ! WERI-Rb-1
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WERI-Rb-1 Eto-R
AC   CVCL_B7ID
SY   WERI-Rb1 etoposide-resistant; WERI-Rb1 Etop; WERI-ETOR
DR   PRIDE; PXD030924
DR   Wikidata; Q112930565
RX   PubMed=29192327;
RX   PubMed=35409416;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1792 ! WERI-Rb-1
SX   Female
AG   1Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
ID   WERI-Rb-24
AC   CVCL_S609
SY   WERI-Rb24; WERI-24; W-24; W24; Wills Eye Research Institute-Retinoblastoma-24
DR   cancercelllines; CVCL_S609
DR   Cosmic; 808516
DR   Wikidata; Q54993777
RX   PubMed=2391623;
RX   PubMed=2594029;
CC   Doubling time: 1.6 days (PubMed=2391623).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Simple; p.Arg358Ter (c.1072C>T); ClinVar=VCV000013076; Zygosity=Unspecified (PubMed=2594029).
DI   NCIt; C42596; Sporadic retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 15
//
ID   WERI-Rb-27
AC   CVCL_S610
SY   WERI-Rb27; WERI-RB27; W-27; Wills Eye Research Institute-Retinoblastoma-27
DR   Wikidata; Q54993784
RX   PubMed=1679230;
RX   PubMed=2391623;
CC   Problematic cell line: Contaminated. Shown to be a Y-79 derivative (PubMed=1679230). Originally thought to originate from a 2 year old boy with a bilateral retinoblastoma.
CC   Population: Caucasian.
CC   Doubling time: 1.9 days (PubMed=2391623).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 16
//
ID   Werner
AC   CVCL_JH28
DR   JCRB; JCRB3041
DR   JCRB; KURB2881
DR   Wikidata; Q54993785
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB2881; probable.
ST   Source(s): JCRB=JCRB3041
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,12
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 7
//
ID   WErpe
AC   CVCL_BA04
SY   Wall Eye retinal pigment epithelium
DR   Wikidata; Q54993786
RX   PubMed=26251287;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 05-10-23; Version: 8
//
ID   WES
AC   CVCL_4337
SY   Ad12-SV40 WES
DR   CLO; CLO_0009585
DR   CLDB; cl4696
DR   ATCC; CRL-1609
DR   ECACC; 91011612
DR   KCB; KCB 93006YJ
DR   Wikidata; Q54993789
RX   PubMed=1335029;
RX   PubMed=6264437;
CC   Group: Non-human primate cell line.
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-1609; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=9598; ! Pan troglodytes (Chimpanzee)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   WeWak1
AC   CVCL_E871
SY   Wewak1; WEWAK1; Wewak-1
DR   Cosmic; 2804851
DR   dbMHC; 49061
DR   ECACC; 94022553
DR   IHW; IHW09219
DR   IPD-IMGT/HLA; 11558
DR   Wikidata; Q54993790
RX   PubMed=8108117;
RX   PubMed=9583678;
RX   PubMed=25787276;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Papuan.
CC   Virology: Contains a complete EBV genome (strain WeWak1) which has been sequenced (PubMed=25787276).
CC   HLA typing: A*11:01,24:02; B*27:04:01,15:06; C*04:01,12:02; DPB1*01:01:01,03:01 (IPD-IMGT/HLA=11558).
CC   Sequence variation: Mutation; HGNC; HGNC:7553; MYC; Simple; p.Pro72Thr (c.214C>A); Zygosity=Unspecified (PubMed=8108117).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Could be identical to QIMR-WW1-LCL (Cellosaurus=CVCL_W930).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   WF-1
AC   CVCL_R857
SY   Wakasaki Fin-1
DR   Wikidata; Q54993791
RX   CelloPub=CLPUB00103;
RX   DOI=10.1577/1548-8667(1993)005<0137:EACOSC>2.3.CO;2;
RX   DOI=10.3147/jsfp.28.27;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=240830; ! Hypomesus olidus (Pond smelt)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 11
//
ID   WF-2
AC   CVCL_WY67
SY   Wakasaki Fin-2
DR   Wikidata; Q98134824
RX   CelloPub=CLPUB00103;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=240830; ! Hypomesus olidus (Pond smelt)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 6
//
ID   WF2
AC   CVCL_4556
SY   WF 2; WF-2; Walleye Fry-2
DR   CLO; CLO_0009586
DR   CLDB; cl4697
DR   IZSLER; BS CL 88
DR   Wikidata; Q54993792
RX   DOI=10.1111/j.1749-7345.2005.tb00402.x;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole fry; UBERON=UBERON_0002548.
OX   NCBI_TaxID=283036; ! Sander vitreus (Walleye)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 11
//
ID   WF215-200
AC   CVCL_V387
DR   IPD-IMGT/HLA; 14463
DR   Wikidata; Q54993793
RX   PubMed=16948657;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DQA1*01:02,01:02; DQB1*05:02,06:04:03; DRB1*13:02,16:01 (IPD-IMGT/HLA=14463).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 10
//
ID   WFL3C6.1
AC   CVCL_9240
SY   3C6
DR   CLO; CLO_0009587
DR   ATCC; HB-8157
DR   Wikidata; Q54993794
RX   Patent=US4517289;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8157.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   WFL4F12.3
AC   CVCL_9241
SY   4F12
DR   CLO; CLO_0009588
DR   ATCC; HB-8156
DR   Wikidata; Q54993795
RX   Patent=US4517289;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8156.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   WFS1 FiPS 04-Ep6F-10
AC   CVCL_E7TK
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_WFS1+FiPS+04-Ep6F-+10+%281%29.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_WFS1+FiPS+04-Ep6F-10+%281%29.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Ser430Ter (c.1289C>A); ClinVar=VCV002043736; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Val491_Pro492insLeuIleThrVal (c.1463_1474dupTCATCACCGTGC); Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12,15
ST   D21S11: 31,32.2
ST   D2S1338: 23,25
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 11,12
ST   FGA: 22,22.2
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TJ ! WFS1 FiPS 04-Ep6F-3
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WFS1 FiPS 04-Ep6F-3
AC   CVCL_E7TJ
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_WFS1+FiPS+04-Ep6F-3+%282%29.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_WFS1+FiPS+04-Ep6F-3+%282%29.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Ser430Ter (c.1289C>A); ClinVar=VCV002043736; Zygosity=Heterozygous (BNLC).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Val491_Pro492insLeuIleThrVal (c.1463_1474dupTCATCACCGTGC); Zygosity=Heterozygous (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12,15
ST   D21S11: 31,32.2
ST   D2S1338: 23,25
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 9
ST   D8S1179: 11,12
ST   FGA: 22,22.2
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TK ! WFS1 FiPS 04-Ep6F-10
SX   Female
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WFS1 FiPS 34-Ep6F-13
AC   CVCL_E7TM
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_WFS1+FiPS+34-Ep6F-13.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_WFS1+FiPS+34-Ep6F-13.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Val491_Pro492insLeuIleThrVal (c.1463_1474dupTCATCACCGTGC); Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 32.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,12
ST   FGA: 22.2,23
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TL ! WFS1 FiPS 34-Ep6F-3
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WFS1 FiPS 34-Ep6F-3
AC   CVCL_E7TL
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/0/Anexo_dep%C3%B3sito_WFS1+FiPS34-Ep6F-3+%281%29.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/Documento_Deposito_WFS1+FiPS+34-Ep6F-3+%281%29.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Universidad Autonoma de Barcelona; Barcelona; Spain.
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Val491_Pro492insLeuIleThrVal (c.1463_1474dupTCATCACCGTGC); Zygosity=Unspecified (BNLC).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 32.2
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 10,12
ST   FGA: 22.2,23
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,18
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E7TM ! WFS1 FiPS 34-Ep6F-13
SX   Female
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WFS2_1
AC   CVCL_A5DN
DR   Wikidata; Q107117440
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   WFS2_1#10
AC   CVCL_A4FJ
SY   HIPS WFS2_1#10
DR   Wikidata; Q105511735
RX   PubMed=29239282;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DN ! WFS2_1
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   WFS2_1#11
AC   CVCL_A4FK
SY   HIPS WFS2_1#11
DR   Wikidata; Q105511738
RX   PubMed=29239282;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DN ! WFS2_1
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   WFS2_1#2
AC   CVCL_A4FH
SY   HIPS WFS2_1#2
DR   SKIP; SKIP003061
DR   Wikidata; Q105511730
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DN ! WFS2_1
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   WFS2_1#24
AC   CVCL_A4FL
SY   HIPS WFS2_1#24
DR   SKIP; SKIP003093
DR   Wikidata; Q105511740
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DN ! WFS2_1
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   WFS2_1#3
AC   CVCL_A4FI
SY   HIPS WFS2_1#3
DR   SKIP; SKIP003092
DR   Wikidata; Q105511732
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DN ! WFS2_1
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   WFS2_2
AC   CVCL_A5DM
DR   Wikidata; Q107117442
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   WFS2_3
AC   CVCL_A5DL
DR   Wikidata; Q107117443
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   WFS2_3#1
AC   CVCL_A4FM
SY   HIPS WFS2_3#1
DR   SKIP; SKIP003120
DR   Wikidata; Q105511743
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DL ! WFS2_3
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   WFS2_3#6
AC   CVCL_A4FN
SY   HIPS WFS2_3#6
DR   SKIP; SKIP003121
DR   Wikidata; Q105511746
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-stem-cells-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A5DL ! WFS2_3
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   WFS2_4
AC   CVCL_A5DK
DR   Wikidata; Q107117444
RX   PubMed=29239282;
WW   Provider; BioKryo; -; https://biokryo.airliquide.com/sites/biokryo/files/2022-07/human-fibroblasts-catalogue-isenet.pdf
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:24212; CISD2; Simple; c.103+1G>A; ClinVar=VCV000638297; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=29239282).
CC   Derived from site: In situ; Arm, skin, dermis; UBERON=UBERON_0002427+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   Wg-1A
AC   CVCL_0F72
SY   WG-1A; Wg1A; Wg1a; CH-WG-1A
DR   Wikidata; Q54993796
RX   PubMed=762193;
RX   PubMed=4359531;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_3472 ! Don
SX   Male
AG   8M
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   WG-59
AC   CVCL_FA28
DR   Wikidata; Q54993797
RX   PubMed=27110824;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Aorta, tunica media; UBERON=UBERON_0003618.
CC   Cell type: Vascular associated smooth muscle cell; CL=CL_0000359.
ST   Source(s): PubMed=27110824
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 12,13
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C128803; Bicuspid aortic valve
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   WG-S1
AC   CVCL_XZ97
SY   WGS1; KCB 90015
DR   CCRID; 5301OVI-KCB90015ZJ
DR   KCB; KCB 90015ZJ
DR   Wikidata; Q94337380
RX   PubMed=15973503;
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9923; ! Capra hircus aegagrus (Wild goat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 7
//
ID   WG0026
AC   CVCL_B3VL
SY   WG26; GK09
DR   Wikidata; Q110433973
RX   PubMed=8103405;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:93; ACAT1; Simple; c.1163+2T>C (IVS11,T-C,+2); ClinVar=VCV000002837; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=8103405).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98841; Alpha-methylacetoacetic aciduria
DI   ORDO; Orphanet_134; Beta-ketothiolase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0067
AC   CVCL_B3U2
SY   WG67
DR   Wikidata; Q110433975
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99003; Osteogenesis imperfecta type I
DI   ORDO; Orphanet_216796; Osteogenesis imperfecta type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0098
AC   CVCL_B3WC
SY   WG98
DR   Wikidata; Q110433977
RX   PubMed=908752;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85052; Sandhoff disease
DI   ORDO; Orphanet_796; Sandhoff disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0100
AC   CVCL_RG77
DR   Wikidata; Q54993798
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0102
AC   CVCL_RG72
DR   Wikidata; Q54993799
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y8M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0103
AC   CVCL_B3WB
SY   WG103
DR   Wikidata; Q110433978
RX   PubMed=3375249;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0107
AC   CVCL_B3WA
SY   WG107
DR   Wikidata; Q110433980
RX   PubMed=3375249;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85184; Tay-Sachs disease
DI   ORDO; Orphanet_845; Tay-Sachs disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0109
AC   CVCL_B3W7
SY   WG 0109
DR   Wikidata; Q110433981
RX   PubMed=17056595;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125595; Mucolipidosis type IIIA
DI   ORDO; Orphanet_423461; Mucolipidosis type III alpha/beta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0119
AC   CVCL_RG73
DR   Wikidata; Q54993800
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0124
AC   CVCL_B3U3
SY   WG124
DR   Wikidata; Q110433983
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0126
AC   CVCL_RH06
SY   WG-126
DR   Wikidata; Q54993801
RX   PubMed=7070882;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG0131
AC   CVCL_RH02
DR   Wikidata; Q54993803
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG0132
AC   CVCL_RG84
DR   Wikidata; Q54993805
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0138
AC   CVCL_B3VK
SY   WG138; GK08
DR   Wikidata; Q110433984
RX   PubMed=8103405;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:93; ACAT1; Simple; p.Met1Lys (c.2T>A); ClinVar=VCV000002838; Zygosity=Homozygous (PubMed=8103405).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98841; Alpha-methylacetoacetic aciduria
DI   ORDO; Orphanet_134; Beta-ketothiolase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0139
AC   CVCL_UD62
SY   WG 139; WG139
DR   Wikidata; Q98134827
RX   PubMed=3880753;
RX   PubMed=6280044;
RX   PubMed=6315439;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84728; Giant axonal neuropathy
DI   ORDO; Orphanet_643; Giant axonal neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   WG0140
AC   CVCL_B3W9
SY   WG 0140
DR   Wikidata; Q110433985
RX   PubMed=17056595;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0153
AC   CVCL_B3U4
SY   WG153
DR   Wikidata; Q110433987
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0160
AC   CVCL_RG85
DR   Wikidata; Q54993807
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0167
AC   CVCL_RG86
DR   Wikidata; Q54993808
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0173
AC   CVCL_UT36
SY   WG 173; WG-173; WG173
DR   Wikidata; Q98134829
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   WG0220
AC   CVCL_B3U5
SY   WG220
DR   Wikidata; Q110433988
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0223
AC   CVCL_RG87
DR   Wikidata; Q54993809
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0229
AC   CVCL_B3W8
SY   WG 0229
DR   Wikidata; Q110433990
RX   PubMed=17056595;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C61270; I-cell disease
DI   ORDO; Orphanet_576; Mucolipidosis type II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0240
AC   CVCL_B3U6
SY   WG240
DR   Wikidata; Q110433991
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98576; Osteogenesis imperfecta type IV
DI   ORDO; Orphanet_216820; Osteogenesis imperfecta type 4
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0241
AC   CVCL_B3U7
SY   WG241
DR   Wikidata; Q110433992
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99001; Osteogenesis imperfecta type II
DI   ORDO; Orphanet_216804; Osteogenesis imperfecta type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0280
AC   CVCL_UH88
SY   W.G. 280; WG 280
DR   Wikidata; Q98134831
RX   CelloPub=CLPUB00454;
RX   PubMed=6093571;
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0285
AC   CVCL_UT37
SY   WG 285; WG-285; WG285
DR   Wikidata; Q98134833
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   WG0290
AC   CVCL_B4KY
SY   WG 290
DR   Wikidata; Q110433993
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0291
AC   CVCL_B4L0
SY   WG 291
DR   Wikidata; Q110433994
RX   PubMed=2567118;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0305
AC   CVCL_B3W0
SY   WG305
DR   Wikidata; Q110433996
RX   PubMed=9295267;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Cys365Tyr (c.1094G>A); ClinVar=VCV000002642; Zygosity=Homozygous (PubMed=9295267).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG0308
AC   CVCL_B3W1
SY   WG308
DR   Wikidata; Q110433997
RX   PubMed=9295267;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:2073; TPP1; Simple; p.Cys365Arg (c.1093T>C); ClinVar=VCV000002641; Zygosity=Heterozygous (PubMed=9295267).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85864; Neuronal ceroid lipofuscinosis type 2
DI   ORDO; Orphanet_168486; Congenital neuronal ceroid lipofuscinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG0321
AC   CVCL_UD63
SY   WG 321; WG321
DR   Wikidata; Q98134835
RX   PubMed=3880753;
RX   PubMed=6273766;
RX   PubMed=6280044;
RX   PubMed=6315439;
RX   PubMed=17331252;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:4137; GAN; Unexplicit; Ex10-11del; Zygosity=Unspecified (PubMed=17331252).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84728; Giant axonal neuropathy
DI   ORDO; Orphanet_643; Giant axonal neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-6Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 10
//
ID   WG0329
AC   CVCL_RG92
SY   WG 329
DR   Wikidata; Q54993810
RX   PubMed=872438;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG0330
AC   CVCL_RG88
DR   Wikidata; Q54993811
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0347
AC   CVCL_RH03
SY   WG 347
DR   Wikidata; Q54993812
RX   CelloPub=CLPUB00661;
RX   PubMed=872438;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3M2W
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG0348
AC   CVCL_UH89
SY   W.G. 348; WG 348
DR   Wikidata; Q98134839
RX   CelloPub=CLPUB00454;
RX   PubMed=6093571;
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Misspelling: MG 348; PubMed=6773986.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4-5Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0354
AC   CVCL_B3VN
SY   WG 354; 354
DR   Wikidata; Q110433999
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; c.780+1G>A (c.792+1G>A); ClinVar=VCV002733824; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 6
//
ID   WG0355
AC   CVCL_B3VP
SY   WG 355; 355
DR   Wikidata; Q110434000
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; c.780+1G>A (c.792+1G>A); ClinVar=VCV002733824; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 6
//
ID   WG0356
AC   CVCL_B3VY
SY   WG 356; 356
DR   Wikidata; Q110434001
RX   Patent=US6528259;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg325Cys (c.973C>T); ClinVar=VCV000975600; Zygosity=Homozygous (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0358
AC   CVCL_UH96
SY   WG 358
DR   Wikidata; Q98134841
RX   PubMed=6574472;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0370
AC   CVCL_B3WD
SY   WG 370
DR   Wikidata; Q110434002
RX   PubMed=6766954;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84739; GM1 gangliosidosis
DI   ORDO; Orphanet_354; GM1 gangliosidosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0386
AC   CVCL_RG89
SY   WG386
DR   Wikidata; Q54993813
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0421
AC   CVCL_B3VM
SY   WG 0421
DR   Wikidata; Q110434003
RX   DOI=10.26502/acbr.50170022;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Tyr140Cys (c.419A>G); ClinVar=VCV000371634; Zygosity=Heterozygous (DOI=10.26502/acbr.50170022).
CC   Sequence variation: Mutation; HGNC; HGNC:7632; NAGLU; Simple; p.Arg297Ter (c.889C>T); ClinVar=VCV000001562; Zygosity=Heterozygous (DOI=10.26502/acbr.50170022).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84898; Mucopolysaccharidosis type IIIB
DI   ORDO; Orphanet_79270; Sanfilippo syndrome type B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG0433
AC   CVCL_UH90
SY   W.G. 433; WG 433
DR   Wikidata; Q98134843
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0448
AC   CVCL_UH91
SY   W.G. 448; WG 448
DR   Wikidata; Q98134846
RX   CelloPub=CLPUB00454;
RX   PubMed=6093571;
RX   PubMed=6574472;
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0449
AC   CVCL_B3U8
SY   WG449
DR   Wikidata; Q110434004
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Abdomen, skin; UBERON=UBERON_0001416.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99002; Osteogenesis imperfecta type III
DI   ORDO; Orphanet_216812; Osteogenesis imperfecta type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0458
AC   CVCL_B3VQ
SY   WG 458; 458
DR   Wikidata; Q110434006
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg52Gln (c.155G>A); ClinVar=VCV000570071; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg335Cys (c.1003C>T); ClinVar=VCV002054912; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0482
AC   CVCL_UT38
SY   WG 482; WG-482; WG482
DR   Wikidata; Q98134847
RX   PubMed=1652892;
RX   PubMed=2112341;
RX   PubMed=6401921;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 8
//
ID   WG0497
AC   CVCL_B4C9
DR   Wikidata; Q110434007
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+2T>A; ClinVar=VCV000203856; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0502
AC   CVCL_UH92
SY   W.G. 502; WG 502
DR   Wikidata; Q98134849
RX   CelloPub=CLPUB00454;
RX   PubMed=6773986;
RX   PubMed=6782112;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-6Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0516
AC   CVCL_B3U9
SY   WG516
DR   Wikidata; Q110434008
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99002; Osteogenesis imperfecta type III
DI   ORDO; Orphanet_216812; Osteogenesis imperfecta type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0544
AC   CVCL_YP60
SY   WG544
DR   Wikidata; Q98134852
RX   PubMed=9054950;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C125596; Neuraminidase deficiency
DI   ORDO; Orphanet_87876; Sialidosis type 2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   WG0548
AC   CVCL_B4KZ
SY   WG 548
DR   Wikidata; Q110434009
RX   PubMed=1346349;
RX   PubMed=1680289;
RX   PubMed=2567118;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0555
AC   CVCL_RG90
DR   Wikidata; Q54993814
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0571
AC   CVCL_RG91
DR   Wikidata; Q54993815
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0575
AC   CVCL_LK47
DR   Wikidata; Q54993816
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C128802; Acrodermatitis enteropathica
DI   ORDO; Orphanet_37; Acrodermatitis enteropathica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   WG0576
AC   CVCL_LK48
DR   Wikidata; Q54993817
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C128802; Acrodermatitis enteropathica
DI   ORDO; Orphanet_37; Acrodermatitis enteropathica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   WG0577
AC   CVCL_LK49
DR   Wikidata; Q54993818
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C128802; Acrodermatitis enteropathica
DI   ORDO; Orphanet_37; Acrodermatitis enteropathica
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 9
//
ID   WG0614
AC   CVCL_B3UA
SY   WG 614; WG614
DR   Wikidata; Q110434010
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99002; Osteogenesis imperfecta type III
DI   ORDO; Orphanet_216812; Osteogenesis imperfecta type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0670
AC   CVCL_B3VR
SY   WG 670; 670
DR   Wikidata; Q110434011
RX   PubMed=1627352;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Gly149Val (c.446_447delinsTT) (458_459GC>TT); ClinVar=VCV000848483; Zygosity=Homozygous (PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0674
AC   CVCL_B3TU
SY   WG 674; WG674
DR   Wikidata; Q110434012
RX   CelloPub=CLPUB00661;
RX   PubMed=6221880;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Shoulder, skin; UBERON=UBERON_0001483.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG0676
AC   CVCL_RG78
SY   WG-676
DR   Wikidata; Q54993819
RX   PubMed=7070882;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG0679
AC   CVCL_QZ40
DR   Wikidata; Q54993821
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0680
AC   CVCL_QZ41
DR   Wikidata; Q54993822
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84718; Friedreich ataxia
DI   ORDO; Orphanet_95; Friedreich ataxia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0699
AC   CVCL_UH68
SY   WG 699
DR   Wikidata; Q98134854
RX   CelloPub=CLPUB00452;
RX   PubMed=3937470;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156424; Hereditary folate malabsorption
DI   ORDO; Orphanet_90045; Hereditary folate malabsorption
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0707
AC   CVCL_RH21
SY   WG-707
DR   Wikidata; Q54993823
RX   PubMed=7070882;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129932; Nephropathic cystinosis
DI   ORDO; Orphanet_411629; Nephropathic infantile cystinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y6M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0729
AC   CVCL_UI06
SY   WG 729; WG729
DR   Wikidata; Q98134856
RX   CelloPub=CLPUB00454;
RX   PubMed=6088703;
RX   PubMed=6093571;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13-14Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   WG0730
AC   CVCL_UI05
SY   WG 730
DR   Wikidata; Q98134858
RX   CelloPub=CLPUB00454;
RX   PubMed=6093571;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15-16Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0735
AC   CVCL_B3VS
SY   WG 735; 735
DR   Wikidata; Q110434013
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African and Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Thr227Met (c.680C>T); ClinVar=VCV000800827; Zygosity=Homozygous (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG0738
AC   CVCL_UH69
SY   WG 738
DR   Wikidata; Q98134860
RX   CelloPub=CLPUB00452;
RX   PubMed=3937470;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0788
AC   CVCL_QZ18
SY   WG 788; WG788
DR   Wikidata; Q54993824
RX   CelloPub=CLPUB00452;
RX   PubMed=1627355;
RX   PubMed=9235907;
RX   PubMed=9501215;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Val56Met (c.166G>A); ClinVar=VCV001176807; Zygosity=Heterozygous (PubMed=9501215; PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; c.1675del4; ClinVar=VCV000007027; Zygosity=Heterozygous (PubMed=9501215; PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   WG0791
AC   CVCL_UD64
SY   WG 791; WG791
DR   Wikidata; Q98134863
RX   PubMed=3880753;
RX   PubMed=6280044;
RX   PubMed=6315439;
RX   PubMed=17331252;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4137; GAN; Simple; c.282+3A>C (Ex2del); ClinVar=VCV000637094; Zygosity=Heterozygous (PubMed=17331252).
CC   Sequence variation: Mutation; HGNC; HGNC:4137; GAN; Simple; p.Ile182Asn (c.545T>A); ClinVar=VCV000637093; Zygosity=Heterozygous (PubMed=17331252).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84728; Giant axonal neuropathy
DI   ORDO; Orphanet_643; Giant axonal neuropathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   WG0799
AC   CVCL_UH70
SY   WG 799
DR   Wikidata; Q98134865
RX   CelloPub=CLPUB00452;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0839
AC   CVCL_UH97
SY   WG 839; WG839
DR   Wikidata; Q98134866
RX   PubMed=6088703;
RX   PubMed=6574472;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 8
//
ID   WG0840
AC   CVCL_UH98
SY   WG 840
DR   Wikidata; Q98134868
RX   CelloPub=CLPUB00454;
RX   PubMed=6574472;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5-6Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0909
AC   CVCL_UB69
SY   WG 0909; WG909
DR   Wikidata; Q98134870
RX   PubMed=11013137;
RX   PubMed=17056595;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11013137).
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Heterozygous (PubMed=11013137).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84896; Mucolipidosis type IV
DI   ORDO; Orphanet_578; Mucolipidosis type IV
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   WG0915
AC   CVCL_0E55
SY   WG915
DR   Wikidata; Q54993825
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WG0918
AC   CVCL_UH71
SY   WG 918
DR   Wikidata; Q98134872
RX   CelloPub=CLPUB00452;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG0919
AC   CVCL_0E56
SY   WG919
DR   Wikidata; Q54993826
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WG0955
AC   CVCL_QZ16
SY   WG955
DR   Wikidata; Q54993827
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG0987
AC   CVCL_UA00
SY   WG 0987; WG987
DR   Wikidata; Q98134874
RX   PubMed=11013137;
RX   PubMed=17056595;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.511del6434 (Ex1-7del) (delta6432); Zygosity=Heterozygous (PubMed=11013137).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   WG0988
AC   CVCL_UA01
SY   WG988
DR   Wikidata; Q98134877
RX   PubMed=11013137;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:13356; MCOLN1; Simple; c.406-2A>G (IVS3AS-2A>G); ClinVar=VCV000005131; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=11013137).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   WG1032
AC   CVCL_RG74
DR   Wikidata; Q54993828
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1033
AC   CVCL_RG75
DR   Wikidata; Q54993829
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1070
AC   CVCL_B3WE
DR   Wikidata; Q110434015
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1077
AC   CVCL_0E57
SY   WG 1077
DR   Wikidata; Q54993848
RX   CelloPub=CLPUB00409;
RX   CelloPub=CLPUB00453;
RX   PubMed=1437403;
RX   PubMed=2705457;
RX   PubMed=8900231;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Simple; p.Arg184Gln (c.551G>A); ClinVar=VCV000000211; Zygosity=Heterozygous (PubMed=8900231).
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Simple; p.Gly278Asp (c.833G>A); ClinVar=VCV000000212; Zygosity=Heterozygous (PubMed=8900231).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   WG1078
AC   CVCL_UH74
SY   WG 1078
DR   Wikidata; Q98134879
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   WG1079
AC   CVCL_UH75
SY   WG 1079
DR   Wikidata; Q98134881
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   WG1082
AC   CVCL_UH76
SY   WG 1082
DR   Wikidata; Q98134883
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Simple; p.Glu453del (c.1356_1358GGA[1]) (c.1359_1361delGGA); ClinVar=VCV000000214; Zygosity=Heterozygous (PubMed=8198124).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   WG1083
AC   CVCL_UH77
SY   WG 1083
DR   Wikidata; Q98134885
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG1084
AC   CVCL_RA62
SY   WG 1084; 1084
DR   GEO; GSM651138
DR   GEO; GSM651139
DR   GEO; GSM1266935
DR   GEO; GSM1267024
DR   Wikidata; Q54993849
RX   Patent=US6528259;
RX   PubMed=7726158;
RX   PubMed=8940272;
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Thr227Met (c.680C>T); ClinVar=VCV000800827; Zygosity=Homozygous (PubMed=7726158; PubMed=8940272).
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 10
//
ID   WG1087
AC   CVCL_B4GU
DR   Wikidata; Q110434016
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4GV ! WG1173
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1099
AC   CVCL_UT39
SY   WG 1099
DR   Wikidata; Q98134887
RX   PubMed=1652892;
RX   PubMed=2112341;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG1101
AC   CVCL_XY53
DR   Wikidata; Q98134888
RX   PubMed=8845835;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple; p.Ala2067Glnfs*10 (c.6199_6347del149); Zygosity=Heterozygous (PubMed=8845835).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   WG1102
AC   CVCL_UT40
SY   WG 1102
DR   Wikidata; Q98134890
RX   PubMed=1652892;
RX   PubMed=2112341;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG1127
AC   CVCL_B3WF
DR   Wikidata; Q110434017
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1129
AC   CVCL_B3WG
DR   Wikidata; Q110434018
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1130
AC   CVCL_0F56
SY   WG 1130
DR   Wikidata; Q54993850
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Homozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <5M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 13
//
ID   WG1135
AC   CVCL_B3WH
DR   Wikidata; Q110434019
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1146
AC   CVCL_QZ19
DR   Wikidata; Q54993852
RX   PubMed=1627355;
RX   PubMed=9235907;
RX   PubMed=9501215;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Val56Met (c.166G>A); ClinVar=VCV001176807; Zygosity=Heterozygous (PubMed=9501215; PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; c.1675del4; ClinVar=VCV000007027; Zygosity=Heterozygous (PubMed=9501215; PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1173
AC   CVCL_B4GV
DR   Wikidata; Q110434020
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4GU ! WG1087
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1176
AC   CVCL_B3X5
DR   Wikidata; Q110434021
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1186
AC   CVCL_B4CV
DR   Wikidata; Q110434022
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg511Ter (c.1531C>T); ClinVar=VCV000556124; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His678Arg (c.2033A>G); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1191
AC   CVCL_B4ES
DR   Wikidata; Q110434024
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG1194
AC   CVCL_UH78
SY   WG 1194
DR   Wikidata; Q98134892
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Simple; p.Gly448Arg (c.1342G>A); ClinVar=VCV000000213; Zygosity=Homozygous (PubMed=8198124).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   WG1205
AC   CVCL_QZ20
DR   Wikidata; Q54993853
RX   PubMed=1627355;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1220
AC   CVCL_B4EM
DR   Wikidata; Q110434025
RX   PubMed=18385497;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Arg250Ter (c.748C>T); ClinVar=VCV000000767; Zygosity=Homozygous (PubMed=18385497).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1223
AC   CVCL_QZ21
DR   Wikidata; Q54993854
RX   PubMed=1627355;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1226
AC   CVCL_RA83
DR   GEO; GSM651128
DR   GEO; GSM651129
DR   GEO; GSM1266932
DR   GEO; GSM1267021
DR   Wikidata; Q54993855
RX   PubMed=21418647;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   WG1264
AC   CVCL_0E58
DR   Wikidata; Q54993856
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WG1265
AC   CVCL_0E59
DR   Wikidata; Q54993857
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WG1269
AC   CVCL_0E60
DR   Wikidata; Q54993858
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WG1270
AC   CVCL_0E61
DR   Wikidata; Q54993859
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WG1271
AC   CVCL_0E62
DR   Wikidata; Q54993860
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WG1273
AC   CVCL_0E63
DR   Wikidata; Q54993861
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C121563; Lysinuric protein intolerance
DI   ORDO; Orphanet_470; Lysinuric protein intolerance
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WG1282
AC   CVCL_RA84
DR   GEO; GSM651124
DR   GEO; GSM651125
DR   GEO; GSM1257689
DR   GEO; GSM1266930
DR   GEO; GSM1267019
DR   GEO; GSM1288449
DR   Wikidata; Q54993862
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1283
AC   CVCL_RA85
DR   GEO; GSM651126
DR   GEO; GSM651127
DR   GEO; GSM1257690
DR   GEO; GSM1266931
DR   GEO; GSM1267020
DR   GEO; GSM1288450
DR   Wikidata; Q54993863
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1288
AC   CVCL_0E65
DR   Wikidata; Q54993864
RX   PubMed=3478720;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84664; Cystinuria
DI   ORDO; Orphanet_214; Cystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y6M
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   WG1296
AC   CVCL_QZ22
DR   Wikidata; Q54993866
RX   PubMed=1627355;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; c.903+469T>C; ClinVar=VCV000662553; Zygosity=Heterozygous (PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Val488_Lys519del (c.1557-4_1557+3del7) (c.1554del7); Zygosity=Heterozygous (PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1298
AC   CVCL_UH79
SY   WG 1298
DR   Wikidata; Q98134894
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Unexplicit; Ex5del (IVS4-1G>C); Zygosity=Heterozygous (PubMed=8198124).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   WG1302
AC   CVCL_QY99
DR   Wikidata; Q54993867
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C138171; Hyperphenylalaninemia, BH4-deficient A
DI   ORDO; Orphanet_13; 6-pyruvoyl-tetrahydropterin synthase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1308
AC   CVCL_QZ23
DR   Wikidata; Q54993868
RX   PubMed=1627355;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1309
AC   CVCL_RG09
DR   GEO; GSM1257711
DR   GEO; GSM1266927
DR   GEO; GSM1267017
DR   GEO; GSM1288451
DR   Wikidata; Q54993869
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WG1310
AC   CVCL_RG10
DR   GEO; GSM1257712
DR   GEO; GSM1266928
DR   GEO; GSM1267018
DR   GEO; GSM1288452
DR   Wikidata; Q54993870
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WG1311
AC   CVCL_RG11
DR   GEO; GSM1266929
DR   Wikidata; Q54993871
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1320
AC   CVCL_RG83
DR   Wikidata; Q54993872
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98910; Cytochrome-c oxidase deficiency
DI   ORDO; Orphanet_254905; Isolated cytochrome C oxidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5D
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1343
AC   CVCL_UH80
SY   WG 1343
DR   Wikidata; Q98134896
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Simple; p.Gly448Arg (c.1342G>A); ClinVar=VCV000000213; Zygosity=Heterozygous (PubMed=8198124).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   WG1350
AC   CVCL_B4GX
DR   Wikidata; Q110434026
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: El Salvadoran.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1352
AC   CVCL_QZ24
DR   Wikidata; Q54993873
RX   PubMed=1627355;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y6M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1371
AC   CVCL_UH93
DR   Wikidata; Q98134898
RX   PubMed=16098205;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84598; Biotinidase deficiency
DI   ORDO; Orphanet_79241; Biotinidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG1384
AC   CVCL_QZ25
DR   Wikidata; Q54993874
RX   PubMed=1627355;
RX   PubMed=9235907;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Val54del (c.160_162delGTT); Zygosity=Heterozygous (PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Ala129Thr (c.385G>A); Zygosity=Heterozygous (PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <5Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1386
AC   CVCL_QZ26
DR   Wikidata; Q54993875
RX   PubMed=1627355;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1391
AC   CVCL_B3WI
DR   Wikidata; Q110434027
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1396
AC   CVCL_B3VT
SY   WG 1396; 1396
DR   Wikidata; Q110434028
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg52Gln (c.155G>A); ClinVar=VCV000570071; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg357Cys (c.1069C>T); ClinVar=VCV001452549; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG1401
AC   CVCL_QZ27
DR   Wikidata; Q54993876
RX   PubMed=1627355;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Leu6_Leu7del (c.16del6); Zygosity=Heterozygous (PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Leu333Val (c.997C>G); ClinVar=VCV000354359; Zygosity=Heterozygous (PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1404
AC   CVCL_B3WJ
DR   Wikidata; Q110434029
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1408
AC   CVCL_QZ28
DR   Wikidata; Q54993877
RX   PubMed=1627355;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1422
AC   CVCL_B3X9
DR   Wikidata; Q110434030
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1431
AC   CVCL_B3ZJ
DR   Wikidata; Q110434031
RX   PubMed=9554742;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly312Val (c.935G>T); ClinVar=VCV000218988; Zygosity=Homozygous (PubMed=9554742; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1437
AC   CVCL_B4EN
DR   Wikidata; Q110434033
RX   PubMed=2339678;
RX   PubMed=18385497;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caribbean; Haitian.
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Arg54Ter (c.160C>T); ClinVar=VCV000000765; Zygosity=Heterozygous (PubMed=18385497).
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Leu103_Ser108dup (c.307_324dup); ClinVar=VCV000000766; Zygosity=Heterozygous (PubMed=18385497).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1481
AC   CVCL_B3WK
DR   Wikidata; Q110434035
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1496
AC   CVCL_B3WL
DR   Wikidata; Q110434036
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1505
AC   CVCL_QZ29
DR   Wikidata; Q54993878
RX   PubMed=1627355;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; p.Pro1173Leu (c.3518C>T); ClinVar=VCV000014278; Zygosity=Heterozygous (PubMed=9235907).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1510
AC   CVCL_B3ZK
DR   Wikidata; Q110434037
RX   PubMed=9554742;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu346del (c.1036_1038delCTT); Zygosity=Homozygous (PubMed=9554742; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1511
AC   CVCL_QZ14
SY   WG 1511; Yale 589
DR   Wikidata; Q54993880
RX   PubMed=7909321;
RX   PubMed=9285782;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His678Arg (c.2033A>G); Zygosity=Homozygous (PubMed=7909321; PubMed=9285782).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1512
AC   CVCL_B4BW
DR   Wikidata; Q110434038
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1513
AC   CVCL_RG12
DR   GEO; GSM1257715
DR   GEO; GSM1266921
DR   GEO; GSM1267013
DR   GEO; GSM1288453
DR   Wikidata; Q54993881
RX   CelloPub=CLPUB00668;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   WG1514
AC   CVCL_RG13
DR   GEO; GSM1257716
DR   GEO; GSM1266922
DR   GEO; GSM1267014
DR   GEO; GSM1288454
DR   Wikidata; Q54993882
RX   CelloPub=CLPUB00668;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   WG1516
AC   CVCL_RG93
DR   Wikidata; Q54993883
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1517
AC   CVCL_B3ZT
DR   Wikidata; Q110434039
RX   PubMed=9554742;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Heterozygous (PubMed=9554742; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1518
AC   CVCL_RG98
DR   Wikidata; Q54993884
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1528
AC   CVCL_UH84
SY   WG 1528
DR   Wikidata; Q98134900
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   WG1529
AC   CVCL_UH81
SY   WG 1529
DR   Wikidata; Q98134902
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   WG1530
AC   CVCL_UH82
SY   WG 1530
DR   Wikidata; Q98134905
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   WG1531
AC   CVCL_UH83
SY   WG 1531
DR   Wikidata; Q98134907
RX   CelloPub=CLPUB00453;
RX   PubMed=2705457;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   WG1534
AC   CVCL_5I47
SY   PWSdel1; PWS-1
DR   Wikidata; Q54993885
RX   PubMed=20876107;
RX   PubMed=24816254;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   WG1539
AC   CVCL_B3X8
DR   Wikidata; Q110434040
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1554
AC   CVCL_RA63
SY   WG 1554; 1554
DR   Wikidata; Q54993886
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=7920641;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Native North American; Hopi.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg183Ter (c.547C>T); ClinVar=VCV000003518; Zygosity=Homozygous (PubMed=7920641; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1562
AC   CVCL_B4A3
DR   Wikidata; Q110434041
RX   PubMed=9452100;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African; Ghanaian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=9452100; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1575
AC   CVCL_QZ30
DR   Wikidata; Q54993887
RX   PubMed=1627355;
RX   PubMed=9235907;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Cys405Arg (c.1213T>C); Zygosity=Heterozygous (PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1586
AC   CVCL_QZ06
SY   WG 1586
DR   Wikidata; Q54993888
RX   PubMed=7909321;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1588
AC   CVCL_QZ07
SY   WG 1588
DR   Wikidata; Q54993889
RX   PubMed=7909321;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <5M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1599
AC   CVCL_QZ08
SY   WG 1599; Yale 378
DR   Wikidata; Q54993890
RX   PubMed=7909321;
RX   PubMed=9285782;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Gly (c.322C>G); ClinVar=VCV001499832; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=7909321; PubMed=9285782; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   WG1600
AC   CVCL_B4D4
SY   Yale 394
DR   Wikidata; Q110434043
RX   PubMed=9285782;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr231Asn (c.691T>A); ClinVar=VCV000218992; Zygosity=Heterozygous (PubMed=9285782; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Miscellaneous: Second MMUT mutation was not detected.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1601
AC   CVCL_B4AZ
DR   Wikidata; Q110434044
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser594Argfs*11 (c.1778_1782delAAAGT); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1605
AC   CVCL_B4B5
DR   Wikidata; Q110434045
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro649Leufs*23 (c.1946delC); ClinVar=VCV000556782; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1606
AC   CVCL_B3YM
DR   Wikidata; Q110434046
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly203Arg (c.607G>A); ClinVar=VCV000218987; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1607
AC   CVCL_QZ09
SY   WG 1607
DR   Wikidata; Q54993898
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Heterozygous (PubMed=7909321; PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala377Glu (c.1130C>A); ClinVar=VCV000001879; Zygosity=Heterozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   WG1608
AC   CVCL_B4BB
DR   Wikidata; Q110434048
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His350Tyr (c.1048C>T); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1609
AC   CVCL_QZ10
SY   WG 1609
DR   Wikidata; Q54993899
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly630Glu (c.1889G>A); ClinVar=VCV000426995; Zygosity=Homozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1610
AC   CVCL_QZ15
SY   WG 1610
DR   Wikidata; Q54993900
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1611
AC   CVCL_QZ11
SY   WG 1611
DR   Wikidata; Q54993901
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1612
AC   CVCL_B3ZW
DR   Wikidata; Q110434049
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1613
AC   CVCL_QZ12
SY   WG 1613
DR   Wikidata; Q54993902
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1618
AC   CVCL_QZ13
SY   WG 1618
DR   Wikidata; Q54993904
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His265Tyr (c.791C>T); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly426Arg (c.1276G>A); ClinVar=VCV000993879; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   WG1625
AC   CVCL_0E64
SY   WG 1625
DR   Wikidata; Q54993905
RX   CelloPub=CLPUB00409;
RX   PubMed=1437403;
RX   PubMed=8198124;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:8840; PEPD; Unexplicit; IVS6-2A>G (Ex7del); Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=8198124).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85029; Prolidase deficiency
DI   ORDO; Orphanet_742; Prolidase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   WG1627
AC   CVCL_RA64
SY   WG 1627; 1627
DR   Wikidata; Q54993906
RX   Patent=US6528259;
RX   PubMed=7726158;
RX   PubMed=7920641;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Native North American; Choctaw.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg183Ter (c.547C>T); ClinVar=VCV000003518; Zygosity=Homozygous (PubMed=7920641; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1631
AC   CVCL_5I46
SY   ASdel2
DR   Wikidata; Q54993908
RX   PubMed=20876107;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   WG1635
AC   CVCL_RG14
DR   GEO; GSM1266923
DR   Wikidata; Q54993909
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y5M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   WG1641
AC   CVCL_B3UK
DR   Wikidata; Q110434050
RX   CelloPub=CLPUB00662;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Gln234Ter (c.700C>T); ClinVar=VCV000203820; Zygosity=Homozygous (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1654
AC   CVCL_B3VU
SY   WG 1654; 1654
DR   Wikidata; Q110434051
RX   PubMed=1627352;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG1655
AC   CVCL_QZ31
DR   Wikidata; Q54993910
RX   PubMed=1627355;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1656
AC   CVCL_RG06
DR   GEO; GSM651134
DR   GEO; GSM651135
DR   GEO; GSM1266920
DR   GEO; GSM1267012
DR   Wikidata; Q54993911
RX   PubMed=21418647;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142806; Transcobalamin II deficiency
DI   ORDO; Orphanet_859; Transcobalamin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   WG1657
AC   CVCL_RG07
DR   GEO; GSM651130
DR   GEO; GSM651131
DR   GEO; GSM1257687
DR   GEO; GSM1266918
DR   GEO; GSM1267010
DR   GEO; GSM1288455
DR   Wikidata; Q54993912
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1658
AC   CVCL_RG08
DR   GEO; GSM651132
DR   GEO; GSM651133
DR   GEO; GSM1257688
DR   GEO; GSM1266919
DR   GEO; GSM1267011
DR   GEO; GSM1288456
DR   Wikidata; Q54993913
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1663
AC   CVCL_QZ32
DR   Wikidata; Q54993914
RX   PubMed=1627355;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Misspelling: WB1663; PubMed=1627355.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1670
AC   CVCL_QZ33
DR   Wikidata; Q54993915
RX   PubMed=1627355;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1671
AC   CVCL_QZ34
DR   Wikidata; Q54993916
RX   CelloPub=CLPUB00662;
RX   PubMed=1627355;
RX   PubMed=8968737;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; c.340-166A>G; ClinVar=VCV000014281; Zygosity=Heterozygous (CelloPub=CLPUB00662).
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; p.Leu705Glnfs*4 (c.2114_2115delTC) (c.2112_2113delTC); ClinVar=VCV000014282; Zygosity=Heterozygous (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1681
AC   CVCL_0D81
SY   WG 1681
DR   Wikidata; Q54993918
RX   PubMed=7909321;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=7909321; PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly703Arg (c.2107G>C); ClinVar=VCV000001885; Zygosity=Heterozygous (PubMed=7909321; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 14
//
ID   WG1692
AC   CVCL_B3WQ
DR   Wikidata; Q110434052
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1693
AC   CVCL_B4B8
DR   Wikidata; Q110434054
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1705
AC   CVCL_B3XD
DR   Wikidata; Q110434056
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Leu116Pro (c.347T>C); ClinVar=VCV000001422; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1713
AC   CVCL_B3Y1
DR   Wikidata; Q110434057
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG1719
AC   CVCL_B3XC
DR   Wikidata; Q110434059
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Jewish.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; c.792_818del27; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1720
AC   CVCL_RG15
DR   GEO; GSM1266917
DR   Wikidata; Q54993919
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y6M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 9
//
ID   WG1721
AC   CVCL_RG16
DR   GEO; GSM1257717
DR   GEO; GSM1266915
DR   GEO; GSM1267008
DR   GEO; GSM1288457
DR   Wikidata; Q54993921
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1722
AC   CVCL_RG17
DR   GEO; GSM1257718
DR   GEO; GSM1266916
DR   GEO; GSM1267009
DR   GEO; GSM1288458
DR   Wikidata; Q54993922
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1727
AC   CVCL_B3ZX
DR   Wikidata; Q110434060
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Canadian Dariusleut Hutterite.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1738
AC   CVCL_B3ZU
DR   Wikidata; Q110434061
RX   PubMed=9554742;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Irish/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=9554742; PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val633Gly (c.1898T>G); ClinVar=VCV000449393; Zygosity=Heterozygous (PubMed=9554742; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG1742
AC   CVCL_RH00
DR   Wikidata; Q54993923
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1743
AC   CVCL_RH01
DR   Wikidata; Q54993924
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1761
AC   CVCL_RG94
DR   Wikidata; Q54993925
RX   CelloPub=CLPUB00662;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18871; MMAA; Simple; p.Arg145Ter (c.433C>T); ClinVar=VCV000003160; Zygosity=Homozygous (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y3M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   WG1767
AC   CVCL_B3VV
SY   WG 1767; 1767
DR   Wikidata; Q110434062
RX   PubMed=1627352;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Leu323Pro (c.968T>C); ClinVar=VCV000003529; Zygosity=Heterozygous (PubMed=8940272).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg377Cys (c.1129C>T); ClinVar=VCV000003528; Zygosity=Heterozygous (PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1772
AC   CVCL_B3VW
SY   WG 1772; 1772
DR   Wikidata; Q110434064
RX   PubMed=1627352;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg51Pro (c.152G>C); ClinVar=VCV003769560; Zygosity=Heterozygous (PubMed=8940272).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; c.237-1G>T (c.249-1G>T); ClinVar=VCV002733826; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 6
//
ID   WG1776
AC   CVCL_RG95
DR   Wikidata; Q54993926
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1779
AC   CVCL_RA65
SY   WG 1779; 1779
DR   Wikidata; Q54993927
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=7920641;
RX   PubMed=8940272;
RX   PubMed=10679944;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg157Gln (c.470G>A); ClinVar=VCV000003519; Zygosity=Heterozygous (PubMed=7726158; PubMed=8940272; PubMed=10679944).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg567Ter (c.1699C>T); ClinVar=VCV000660609; Zygosity=Heterozygous (PubMed=10679944).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   WG1784
AC   CVCL_B4C1
DR   Wikidata; Q110434066
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr566Arg (c.1697C>G); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1794
AC   CVCL_RA66
DR   Wikidata; Q54993928
RX   PubMed=10679944;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Lys584Ter (c.1750A>T); ClinVar=VCV001066378; Zygosity=Homozygous (PubMed=10679944).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29D
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG1796
AC   CVCL_RG96
DR   Wikidata; Q54993929
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1797
AC   CVCL_B3ZN
DR   Wikidata; Q110434067
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn388His (c.1162A>C); ClinVar=VCV001804011; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1798
AC   CVCL_RG97
DR   Wikidata; Q54993930
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1800
AC   CVCL_B4A4
DR   Wikidata; Q110434068
RX   PubMed=9452100;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=9452100; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1801
AC   CVCL_UI01
DR   Wikidata; Q98134909
RX   PubMed=19447654;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg73Ter (c.217C>T); ClinVar=VCV000203825; Zygosity=Homozygous (PubMed=19447654).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   WG1807
AC   CVCL_RA67
SY   WG 1807; 1807
DR   Wikidata; Q54993932
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Pro251Leu (c.752C>T); Zygosity=Homozygous (PubMed=7726158; PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   WG1826
AC   CVCL_B5P9
SY   1826
DR   Wikidata; Q112041931
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   WG1827
AC   CVCL_B4D2
DR   Wikidata; Q110434069
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Cys (c.643G>T); ClinVar=VCV000418341; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1834
AC   CVCL_RA68
SY   WG 1834; 1834
DR   Wikidata; Q54993933
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=7920641;
RX   PubMed=8940272;
RX   PubMed=10679944;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg157Gln (c.470G>A); ClinVar=VCV000003519; Zygosity=Heterozygous (PubMed=7920641; PubMed=8940272; PubMed=10679944).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg567Ter (c.1699C>T); ClinVar=VCV000660609; Zygosity=Heterozygous (PubMed=7920641; PubMed=10679944).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   WG1836
AC   CVCL_QZ42
DR   Wikidata; Q54993934
RX   PubMed=9501215;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Leu576del (c.1726_1728delTTG); ClinVar=VCV000007028; Zygosity=Heterozygous (PubMed=9501215).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG1863
AC   CVCL_RA69
SY   WG 1863; 1863
DR   Wikidata; Q54993935
RX   Patent=US6528259;
RX   PubMed=1627352;
RX   PubMed=7726158;
RX   PubMed=7920641;
RX   PubMed=8940272;
RX   PubMed=10679944;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg157Gln (c.470G>A); ClinVar=VCV000003519; Zygosity=Heterozygous (PubMed=7920641; PubMed=8940272; PubMed=10679944).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Pro572Leu (c.1715C>T); ClinVar=VCV002202701; Zygosity=Heterozygous (PubMed=7920641; PubMed=10679944).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   WG1864
AC   CVCL_B4C0
DR   Wikidata; Q110434070
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His386Asn (c.1156C>A); ClinVar=VCV000558672; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser389del (c.1166_1168delCTT); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1871
AC   CVCL_B5PC
SY   1871
DR   Wikidata; Q112041932
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg157Gln (c.470G>A); ClinVar=VCV000003519; Zygosity=Heterozygous (PubMed=8940272).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 5
//
ID   WG1872
AC   CVCL_B5PD
SY   1872
DR   Wikidata; Q112041933
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg567Ter (c.1699C>T); ClinVar=VCV000660609; Zygosity=Heterozygous (from familial inference of WG1779; WG1871).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   WG1886
AC   CVCL_B3VX
SY   WG 1886
DR   Wikidata; Q110434071
RX   PubMed=1627352;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Japanese.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG1892
AC   CVCL_QZ35
DR   Wikidata; Q54993936
RX   PubMed=8968737;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; p.Ile881del (c.2640_2642delAAT); ClinVar=VCV000014279; Zygosity=Heterozygous (PubMed=9235907).
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; p.Pro1173Leu (c.3518C>T); ClinVar=VCV000014278; Zygosity=Heterozygous (PubMed=9235907).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 12
//
ID   WG1903
AC   CVCL_B4GW
DR   Wikidata; Q110434072
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1908
AC   CVCL_B4GS
DR   Wikidata; Q110434073
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Native North American; Dakelh.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1919
AC   CVCL_B3ZV
DR   Wikidata; Q110434074
RX   PubMed=9554742;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu685dup (c.2053_2055dupCTC) (684insL); Zygosity=Homozygous (PubMed=9554742; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1925
AC   CVCL_RA70
DR   Wikidata; Q54993937
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG1926
AC   CVCL_RG18
DR   GEO; GSM1266902
DR   Wikidata; Q54993938
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1943
AC   CVCL_RG99
DR   Wikidata; Q54993939
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG1951
AC   CVCL_B5PA
SY   1951
DR   Wikidata; Q112041934
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   WG1958
AC   CVCL_B3WM
DR   Wikidata; Q110434077
RX   CelloPub=CLPUB00668;
RX   PubMed=9554742;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu685Arg (c.2054T>G); ClinVar=VCV000218995; Zygosity=Homozygous (PubMed=9554742; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1959
AC   CVCL_B4GY
DR   Wikidata; Q110434078
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Lys281fs*4 (c.842_845delAGAG); Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG1976
AC   CVCL_RG19
DR   GEO; GSM1266926
DR   Wikidata; Q54993940
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2D
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1977
AC   CVCL_RG20
DR   GEO; GSM1257713
DR   GEO; GSM1266925
DR   GEO; GSM1267016
DR   GEO; GSM1288459
DR   Wikidata; Q54993941
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1978
AC   CVCL_RG21
DR   GEO; GSM1257714
DR   GEO; GSM1266924
DR   GEO; GSM1267015
DR   GEO; GSM1288460
DR   Wikidata; Q54993942
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1983
AC   CVCL_RG22
DR   GEO; GSM1257730
DR   GEO; GSM1266901
DR   GEO; GSM1266998
DR   GEO; GSM1288461
DR   Wikidata; Q54993953
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   >20Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1984
AC   CVCL_RG23
DR   GEO; GSM1257729
DR   GEO; GSM1266900
DR   GEO; GSM1266997
DR   GEO; GSM1288462
DR   Wikidata; Q54993954
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   >20Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG1999
AC   CVCL_B3ZQ
DR   Wikidata; Q110434079
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2006
AC   CVCL_RA71
SY   2006
DR   Wikidata; Q54993955
RX   PubMed=8940272;
RX   PubMed=10679944;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Gly387Asp (c.1160G>A); ClinVar=VCV002202702; Zygosity=Heterozygous (PubMed=10679944).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Glu586Lys (c.1756G>A); Zygosity=Heterozygous (PubMed=10679944).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG2025
AC   CVCL_B4ET
DR   Wikidata; Q110434080
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG2041
AC   CVCL_B4AH
DR   Wikidata; Q110434081
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu443Phefs*5 (c.1328dupT); ClinVar=VCV000934454; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2046
AC   CVCL_B3ZE
DR   Wikidata; Q110434082
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Cys (c.643G>T); ClinVar=VCV000418341; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2064
AC   CVCL_RG24
DR   GEO; GSM1266899
DR   GEO; GSM1266996
DR   Wikidata; Q54993956
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2065
AC   CVCL_RG25
DR   GEO; GSM1266898
DR   GEO; GSM1266995
DR   GEO; GSM1288463
DR   Wikidata; Q54993959
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2066
AC   CVCL_RG26
DR   GEO; GSM1266897
DR   GEO; GSM1266994
DR   GEO; GSM1288464
DR   Wikidata; Q54993960
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2073
AC   CVCL_B5PB
SY   2073
DR   Wikidata; Q112041935
RX   PubMed=8940272;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   WG2076
AC   CVCL_B3XA
DR   Wikidata; Q110434083
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2077
AC   CVCL_B4BS
DR   Wikidata; Q110434084
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr429Ter (c.1287C>G); ClinVar=VCV000554278; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2083
AC   CVCL_B4CC
DR   Wikidata; Q110434086
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Dutch.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1677-1G>A; ClinVar=VCV000550012; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2113
AC   CVCL_B3WN
DR   Wikidata; Q110434087
RX   CelloPub=CLPUB00668;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Native North American; Cherokee.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2120
AC   CVCL_RG27
DR   GEO; GSM1257709
DR   GEO; GSM1266936
DR   GEO; GSM1267025
DR   GEO; GSM1288465
DR   Wikidata; Q54993961
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2121
AC   CVCL_RG28
DR   GEO; GSM1257710
DR   GEO; GSM1266937
DR   GEO; GSM1267026
DR   GEO; GSM1288466
DR   Wikidata; Q54993962
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2122
AC   CVCL_RG29
DR   GEO; GSM1266938
DR   Wikidata; Q54993963
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2147
AC   CVCL_B3UH
DR   Wikidata; Q110434088
RX   CelloPub=CLPUB00662;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Val188_Ala192dup (c.563_577dupTGTGCCGCCGGGCCG); ClinVar=VCV000203822; Zygosity=Homozygous (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2153
AC   CVCL_B4BV
DR   Wikidata; Q110434089
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2174
AC   CVCL_B4BR
DR   Wikidata; Q110434090
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln383Pro (c.1148A>C); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2176
AC   CVCL_UI02
DR   Wikidata; Q98134911
RX   PubMed=19447654;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; c.1-234A>G; Zygosity=Heterozygous (PubMed=19447654).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp203Ter (c.609G>A); ClinVar=VCV000030800; Zygosity=Heterozygous (PubMed=19447654).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   WG2181
AC   CVCL_B3UE
DR   Wikidata; Q110434092
RX   CelloPub=CLPUB00662;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2184
AC   CVCL_RA72
DR   Wikidata; Q54993965
RX   PubMed=10679944;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala116Thr (c.346G>A); ClinVar=VCV001333614; Zygosity=Heterozygous (PubMed=10679944).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Tyr374Ter (c.1122C>G); Zygosity=Heterozygous (PubMed=10679944).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84524; 5' 10' methylenetetrahydrofolate reductase deficiency
DI   ORDO; Orphanet_395; Homocystinuria due to methylene tetrahydrofolate reductase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   16Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   WG2187
AC   CVCL_B4AK
DR   Wikidata; Q110434093
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln514Argfs*24 (c.1541delA); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2190
AC   CVCL_B4D3
DR   Wikidata; Q110434094
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2193
AC   CVCL_RG30
DR   GEO; GSM1257707
DR   GEO; GSM1266939
DR   GEO; GSM1267027
DR   GEO; GSM1288467
DR   Wikidata; Q54993966
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2194
AC   CVCL_RG31
DR   GEO; GSM1257708
DR   GEO; GSM1266940
DR   GEO; GSM1267028
DR   GEO; GSM1288468
DR   Wikidata; Q54993967
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2195
AC   CVCL_RG32
DR   GEO; GSM1266941
DR   Wikidata; Q54993968
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WG2202
AC   CVCL_B4BX
DR   Wikidata; Q110434096
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Metfs*3 (c.656delA); ClinVar=VCV001073471; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2209
AC   CVCL_B4CW
DR   Wikidata; Q110434097
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe174Ser (c.521T>C); ClinVar=VCV000218986; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe573Ser (c.1718T>C); ClinVar=VCV000284235; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2215
AC   CVCL_UH94
DR   Wikidata; Q98134913
RX   PubMed=16098205;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98842; Holocarboxylase synthetase deficiency
DI   ORDO; Orphanet_79242; Holocarboxylase synthetase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 7
//
ID   WG2219
AC   CVCL_B4CD
DR   Wikidata; Q110434098
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Danish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1957-2A>G; ClinVar=VCV000555787; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ile697Valfs*4 (c.2089_2101del); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2247
AC   CVCL_B4B6
DR   Wikidata; Q110434099
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly203Arg (c.607G>A); ClinVar=VCV000218987; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2249
AC   CVCL_RG76
DR   Wikidata; Q54993969
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C118434; Albright's hereditary osteodystrophy
DI   ORDO; Orphanet_665; Albright hereditary osteodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y6M
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 8
//
ID   WG2269
AC   CVCL_B4CJ
DR   Wikidata; Q110434100
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu451Ter (c.1351G>T); ClinVar=VCV000557114; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Miscellaneous: Second MMUT mutation was not detected.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2271
AC   CVCL_B4C2
DR   Wikidata; Q110434101
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly145Ser (c.433G>A); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2274
AC   CVCL_RG33
DR   GEO; GSM1266896
DR   Wikidata; Q54993970
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2275
AC   CVCL_RG34
DR   GEO; GSM1257727
DR   GEO; GSM1266894
DR   GEO; GSM1266992
DR   GEO; GSM1288469
DR   Wikidata; Q54993971
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2276
AC   CVCL_RG35
DR   GEO; GSM1257728
DR   GEO; GSM1266895
DR   GEO; GSM1266993
DR   GEO; GSM1288470
DR   Wikidata; Q54993974
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2279
AC   CVCL_B3X2
DR   Wikidata; Q110434102
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2290
AC   CVCL_QZ36
DR   Wikidata; Q54993975
RX   PubMed=8968737;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7468; MTR; Simple; p.His920Asp (c.2758C>G); ClinVar=VCV000014280; Zygosity=Unspecified (PubMed=8968737; PubMed=9235907).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   WG2292
AC   CVCL_QZ37
DR   Wikidata; Q54993976
RX   PubMed=8968737;
RX   PubMed=9235907;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   WG2310
AC   CVCL_B4AA
DR   Wikidata; Q110434103
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala732Trpfs*6 (c.2194_2197delGCCGinsTGGAA); ClinVar=VCV000222942; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2312
AC   CVCL_B4A5
DR   Wikidata; Q110434104
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2316
AC   CVCL_B3YN
DR   Wikidata; Q110434107
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2317
AC   CVCL_QZ39
DR   Wikidata; Q54993978
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Arg114Ter (c.340C>T); ClinVar=VCV000666994; Zygosity=Heterozygous (PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; c.903+469T>C; ClinVar=VCV000662553; Zygosity=Heterozygous (PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG2319
AC   CVCL_B4D5
DR   Wikidata; Q110434108
RX   CelloPub=CLPUB00669;
RX   PubMed=16281286;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Irish/Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:11449; SUCLG1; Simple; p.Glu145Lys (c.433G>A); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:11449; SUCLG1; Simple; p.Asn171His (c.511A>C); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183531; Mitochondrial DNA depletion syndrome-9
DI   ORDO; Orphanet_17; Fatal infantile lactic acidosis with methylmalonic aciduria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3W
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2322
AC   CVCL_B3Y2
DR   Wikidata; Q110434109
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG2324
AC   CVCL_B3YP
DR   Wikidata; Q110434110
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2325
AC   CVCL_B4AB
DR   Wikidata; Q110434111
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2328
AC   CVCL_B3WP
DR   Wikidata; Q110434112
RX   CelloPub=CLPUB00668;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr316Cys (c.947A>G); ClinVar=VCV000640484; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly426Ter (c.1276G>T); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2339
AC   CVCL_B3WR
DR   Wikidata; Q110434113
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2341
AC   CVCL_B4CG
DR   Wikidata; Q110434114
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Cys560Tyr (c.1679G>A); ClinVar=VCV000554451; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.2125-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2348
AC   CVCL_B4AC
DR   Wikidata; Q110434116
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2366
AC   CVCL_QZ38
DR   Wikidata; Q54993979
RX   PubMed=9235907;
RX   PubMed=10484769;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Gly487Arg (c.1459G>A); ClinVar=VCV000007030; Zygosity=Heterozygous (PubMed=10484769).
CC   Sequence variation: Mutation; HGNC; HGNC:7473; MTRR; Simple; p.Gly554Arg (c.1660G>A); Zygosity=Heterozygous (PubMed=10484769).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   WG2368
AC   CVCL_B3YQ
DR   Wikidata; Q110434117
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7-8M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2377
AC   CVCL_B3ZL
DR   Wikidata; Q110434119
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2389
AC   CVCL_B3YR
DR   Wikidata; Q110434120
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6-7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2405
AC   CVCL_B4AM
DR   Wikidata; Q110434122
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2408
AC   CVCL_B3UF
DR   Wikidata; Q110434123
RX   CelloPub=CLPUB00662;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2413
AC   CVCL_RG36
DR   GEO; GSM1266944
DR   Wikidata; Q54993980
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2414
AC   CVCL_RG37
DR   GEO; GSM1257675
DR   GEO; GSM1266942
DR   GEO; GSM1267029
DR   GEO; GSM1288471
DR   Wikidata; Q54993982
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2415
AC   CVCL_RG38
DR   GEO; GSM1257676
DR   GEO; GSM1266943
DR   GEO; GSM1267030
DR   GEO; GSM1288472
DR   Wikidata; Q54993983
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2416
AC   CVCL_B4AL
DR   Wikidata; Q110434124
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Portuguese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu518Pro (c.1553T>C); ClinVar=VCV000218994; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2419
AC   CVCL_B3ZF
DR   Wikidata; Q110434125
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Ser (c.643G>A); ClinVar=VCV000001888; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2429
AC   CVCL_B4CR
DR   Wikidata; Q110434127
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala631Glnfs*17 (c.1891delG); ClinVar=VCV000242511; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2432
AC   CVCL_B4GT
DR   Wikidata; Q110434128
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2433
AC   CVCL_B4BT
DR   Wikidata; Q110434129
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2435
AC   CVCL_B4BY
DR   Wikidata; Q110434130
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.His386Arg (c.1157A>G); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2436
AC   CVCL_B3YS
DR   Wikidata; Q110434131
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4268; CBLIF; Simple; p.Lys145del (c.432GAA[1]) (c.435_437delGAA); ClinVar=VCV000208192; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG2451
AC   CVCL_B4CI
DR   Wikidata; Q110434133
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Miscellaneous: Second MMUT mutation was not detected.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG2452
AC   CVCL_B3X3
DR   Wikidata; Q110434134
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2454
AC   CVCL_B4C4
DR   Wikidata; Q110434136
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln383His (c.1149G>T); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2456
AC   CVCL_B4CQ
DR   Wikidata; Q110434137
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr316Cys (c.947A>G); ClinVar=VCV000640484; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2460
AC   CVCL_B3WS
DR   Wikidata; Q110434138
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2468
AC   CVCL_B4D8
DR   Wikidata; Q110434139
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Dutch/German.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG2469
AC   CVCL_B4AD
DR   Wikidata; Q110434140
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2471
AC   CVCL_B3Y0
DR   Wikidata; Q110434141
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg153Ter (c.457C>T); ClinVar=VCV000550539; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2474
AC   CVCL_B4BN
DR   Wikidata; Q110434142
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2503
AC   CVCL_B3ZG
DR   Wikidata; Q110434143
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Ser (c.643G>A); ClinVar=VCV000001888; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2515
AC   CVCL_B4AY
DR   Wikidata; Q110434145
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2516
AC   CVCL_B3ZI
DR   Wikidata; Q110434147
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser306Phe (c.917C>T); ClinVar=VCV000553978; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2541
AC   CVCL_B3ZH
DR   Wikidata; Q110434148
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2545
AC   CVCL_B4D6
DR   Wikidata; Q110434149
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Miscellaneous: Cell line no longer available.
CC   Miscellaneous: No MMUT mutations were detected.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG2547
AC   CVCL_B4CT
DR   Wikidata; Q110434150
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1083+2T>A; ClinVar=VCV000495775; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu443Phefs*5 (c.1328dupT); ClinVar=VCV000934454; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2562
AC   CVCL_B3ZR
DR   Wikidata; Q110434153
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2564
AC   CVCL_B3Y3
DR   Wikidata; Q110434154
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG2575
AC   CVCL_B3YT
DR   Wikidata; Q110434155
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2597
AC   CVCL_B4B9
DR   Wikidata; Q110434156
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala197Glu (c.591C>A); ClinVar=VCV002734895; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly637Arg (c.1909G>A); ClinVar=VCV001486406; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 7
//
ID   WG2599
AC   CVCL_B3WT
DR   Wikidata; Q110434158
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2600
AC   CVCL_B4CX
DR   Wikidata; Q110434159
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr370Pro (c.1108A>C); ClinVar=VCV000203847; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe573Ser (c.1718T>C); ClinVar=VCV000284235; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2603
AC   CVCL_B4B4
DR   Wikidata; Q110434161
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly161Ter (c.481G>T); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg694Trp (c.2080C>T); ClinVar=VCV000218996; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2606
AC   CVCL_B4CU
DR   Wikidata; Q110434162
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe174Ser (c.521T>C); ClinVar=VCV000218986; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2608
AC   CVCL_B4AF
DR   Wikidata; Q110434163
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg581Ter (c.1741C>T); ClinVar=VCV000554675; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2622
AC   CVCL_B4AG
DR   Wikidata; Q110434164
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2625
AC   CVCL_B3YU
DR   Wikidata; Q110434165
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Ser3329Leu (c.9986C>T); ClinVar=VCV000532212; Zygosity=Heterozygous (PubMed=31462756).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Simple; p.Glu584Ter (c.1749_1750delGGinsTT); Zygosity=Heterozygous (PubMed=31462756).
CC   Sequence variation: Mutation; HGNC; HGNC:8653; PCCA; Unexplicit; Ex21 intragenic 9-kb duplication; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Donor information: Established from a patient which had elevated level of methylmalonic acid thus was originally diagnosed as suffering from methylmalonic acidemia.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85030; Propionic acidemia
DI   ORDO; Orphanet_35; Propionic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   WG2628
AC   CVCL_B4A6
DR   Wikidata; Q110434166
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2634
AC   CVCL_B4C6
DR   Wikidata; Q110434168
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2636
AC   CVCL_B3XI
DR   Wikidata; Q110434169
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Asn110Aspfs*13 (c.328_331delAACC); ClinVar=VCV000203835; Zygosity=Homozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2638
AC   CVCL_B4BE
DR   Wikidata; Q110434170
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val227Asnfs*16 (c.671_678dupAATTTATG); ClinVar=VCV000554641; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2644
AC   CVCL_B4BL
DR   Wikidata; Q110434171
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2646
AC   CVCL_B4CK
DR   Wikidata; Q110434172
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic and Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2658
AC   CVCL_B4CH
DR   Wikidata; Q110434173
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln18Ter (c.52C>T); ClinVar=VCV000001877; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Miscellaneous: Second MMUT mutation was not detected.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2659
AC   CVCL_B4AT
DR   Wikidata; Q110434174
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2662
AC   CVCL_B3UG
DR   Wikidata; Q110434175
RX   CelloPub=CLPUB00662;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Pacific.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Lys48Phefs*2 (c.141_142insTTTT); Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2664
AC   CVCL_B3UL
DR   Wikidata; Q110434176
RX   CelloPub=CLPUB00662;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:18871; MMAA; Simple; p.Arg145Ter (c.433C>T); ClinVar=VCV000003160; Zygosity=Heterozygous (CelloPub=CLPUB00662).
CC   Sequence variation: Mutation; HGNC; HGNC:18871; MMAA; Simple; p.Thr198Serfs*6 (c.593_596delCTGA) (c.592_595del); ClinVar=VCV000203815; Zygosity=Heterozygous (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2670
AC   CVCL_B4CM
DR   Wikidata; Q110434178
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met186Val (c.556A>G); ClinVar=VCV000551460; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2672
AC   CVCL_B4AI
DR   Wikidata; Q110434179
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly284Ter (c.850G>T); ClinVar=VCV000553762; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2676
AC   CVCL_B4B7
DR   Wikidata; Q110434181
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr429Ter (c.1287C>G); ClinVar=VCV000554278; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2679
AC   CVCL_B4CN
DR   Wikidata; Q110434182
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2680
AC   CVCL_B4A1
DR   Wikidata; Q110434183
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2683
AC   CVCL_B4C3
DR   Wikidata; Q110434184
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly355Ilefs*8 (c.1062delTinsCATCCAGA); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2686
AC   CVCL_B3YV
DR   Wikidata; Q110434185
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2691
AC   CVCL_B4B1
DR   Wikidata; Q110434187
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser135Ter (c.404C>A); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2700
AC   CVCL_B4DK
DR   Wikidata; Q110434189
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met186Val (c.556A>G); ClinVar=VCV000551460; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2701
AC   CVCL_B3YW
DR   Wikidata; Q110434190
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Arg445Trp (c.1333C>T); ClinVar=VCV000973456; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG2711
AC   CVCL_B3XE
DR   Wikidata; Q110434191
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr130Cys (c.389A>G); ClinVar=VCV000297484; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2716
AC   CVCL_B3YX
DR   Wikidata; Q110434192
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2717
AC   CVCL_B4B0
DR   Wikidata; Q110434193
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2718
AC   CVCL_B3YY
DR   Wikidata; Q110434194
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2719
AC   CVCL_B4BZ
DR   Wikidata; Q110434195
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser594Argfs*11 (c.1778_1782delAAAGT); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2722
AC   CVCL_B3X6
DR   Wikidata; Q110434197
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2727
AC   CVCL_B3YZ
DR   Wikidata; Q110434198
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2731
AC   CVCL_B3Z0
DR   Wikidata; Q110434199
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:27288; ACSF3; Simple; p.Pro285Leu (c.854C>T); ClinVar=VCV000381877; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG2740
AC   CVCL_B3Z1
DR   Wikidata; Q110434200
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6-7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2786
AC   CVCL_B4BU
DR   Wikidata; Q110434201
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369Cys (c.1105C>T); ClinVar=VCV000218989; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2798
AC   CVCL_B4BF
DR   Wikidata; Q110434203
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val227Asnfs*16 (c.671_678dupAATTTATG); ClinVar=VCV000554641; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg616Cys (c.1846C>T); ClinVar=VCV000551499; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2808
AC   CVCL_B3YL
DR   Wikidata; Q110434204
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2821
AC   CVCL_B4AJ
DR   Wikidata; Q110434206
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly87Glu (c.260G>A); ClinVar=VCV000558311; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg467Ter (c.1399C>T); ClinVar=VCV000495778; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2823
AC   CVCL_B3Z2
DR   Wikidata; Q110434207
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG2837
AC   CVCL_B3Z3
DR   Wikidata; Q110434208
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:27288; ACSF3; Simple; p.Arg558Trp (c.1672C>T); ClinVar=VCV000031134; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG2838
AC   CVCL_B4AR
DR   Wikidata; Q110434209
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly284Ter (c.850G>T); ClinVar=VCV000553762; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2839
AC   CVCL_B4A2
DR   Wikidata; Q110434210
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly642Arg (c.1924G>C); ClinVar=VCV000551102; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2842
AC   CVCL_B3YK
DR   Wikidata; Q110434211
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2843
AC   CVCL_RA73
DR   GEO; GSM651136
DR   GEO; GSM651137
DR   GEO; GSM1257691
DR   GEO; GSM1266933
DR   GEO; GSM1267022
DR   GEO; GSM1288473
DR   Wikidata; Q54993984
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2844
AC   CVCL_RA74
DR   GEO; GSM651154
DR   GEO; GSM651155
DR   GEO; GSM1257692
DR   GEO; GSM1266934
DR   GEO; GSM1267023
DR   GEO; GSM1288474
DR   Wikidata; Q54993985
RX   PubMed=21418647;
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG2860
AC   CVCL_B3Y6
DR   Wikidata; Q110434212
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro95Arg (c.284C>G); ClinVar=VCV000218985; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2863
AC   CVCL_B3XJ
DR   Wikidata; Q110434213
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Asn110Aspfs*13 (c.328_331delAACC); ClinVar=VCV000203835; Zygosity=Homozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Ile190Tyrfs*13 (c.567dupT); ClinVar=VCV000556708; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2871
AC   CVCL_B4BQ
DR   Wikidata; Q110434214
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly158Glufs*22 (c.459delT); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu347Arg (c.1040T>G); ClinVar=VCV000807633; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2872
AC   CVCL_B4BG
DR   Wikidata; Q110434217
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg511Ter (c.1531C>T); ClinVar=VCV000556124; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2873
AC   CVCL_B4AN
DR   Wikidata; Q110434218
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2883
AC   CVCL_B4CB
DR   Wikidata; Q110434219
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+2T>A; ClinVar=VCV000203856; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg581Ter (c.1741C>T); ClinVar=VCV000554675; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2896
AC   CVCL_B4A7
DR   Wikidata; Q110434220
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African; Nigerian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2910
AC   CVCL_B4CL
DR   Wikidata; Q110434221
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp105Arg (c.313T>C); ClinVar=VCV000001878; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2924
AC   CVCL_B4AU
DR   Wikidata; Q110434222
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu281Ser (c.842T>C); ClinVar=VCV000203858; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2951
AC   CVCL_B4EU
DR   Wikidata; Q110434223
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG2958
AC   CVCL_B4CP
DR   Wikidata; Q110434224
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn189Lys (c.567T>G); ClinVar=VCV000618734; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr230Ile (c.689C>T); ClinVar=VCV001512244; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG2973
AC   CVCL_B4BA
DR   Wikidata; Q110434226
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly215Ser (c.643G>A); ClinVar=VCV000001888; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu346del (c.1036_1038delCTT); Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG2983
AC   CVCL_B4CS
DR   Wikidata; Q110434227
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3014
AC   CVCL_B3WU
DR   Wikidata; Q110434228
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3017
AC   CVCL_B4CE
DR   Wikidata; Q110434230
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ile412del (c.1230CAT[1]) (c.1233_1235delCAT); ClinVar=VCV000978689; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1957-2A>G; ClinVar=VCV000555787; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3020
AC   CVCL_B4BC
DR   Wikidata; Q110434231
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; English/French.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn720Serfs*17 (c.2159_2160delAT); ClinVar=VCV001459265; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3023
AC   CVCL_B3Z7
DR   Wikidata; Q110434232
RX   CelloPub=CLPUB00669;
RX   PubMed=16281286;
RX   PubMed=27233228;
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Arab; Saudi Arabian and Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:4839; HCFC1; Simple; p.Pro1492Leu (c.4475C>T); ClinVar=VCV002432377; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228; PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Misspelling: WG3123; PubMed=31462756; Note=In table 1.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG3026
AC   CVCL_B3ZS
DR   Wikidata; Q110434233
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3027
AC   CVCL_B4C5
DR   Wikidata; Q110434234
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly544Ter (c.1630_1631delGGinsTA); ClinVar=VCV000203860; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3031
AC   CVCL_B4C8
DR   Wikidata; Q110434236
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu434Hisfs*3 (c.1301_1302delTC); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro615Arg (c.1844C>G); ClinVar=VCV000550276; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3036
AC   CVCL_B4D0
DR   Wikidata; Q110434237
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+1G>A; ClinVar=VCV000633322; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG3040
AC   CVCL_B4BH
DR   Wikidata; Q110434238
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Southeast Asian; Vietnamese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu688Ter (c.2062G>T); ClinVar=VCV002136402; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3044
AC   CVCL_B4BI
DR   Wikidata; Q110434239
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu224Ter (c.670G>T); ClinVar=VCV000552718; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3050
AC   CVCL_B4B2
DR   Wikidata; Q110434240
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg629Lysfs*12 (c.1885dupA); ClinVar=VCV000568904; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3051
AC   CVCL_B4B3
DR   Wikidata; Q110434242
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.385+3insTAAGGGT; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3056
AC   CVCL_B3ZM
DR   Wikidata; Q110434243
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Greek.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3059
AC   CVCL_B3ZY
DR   Wikidata; Q110434244
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly544Ter (c.1630_1631delGGinsTA); ClinVar=VCV000203860; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3065
AC   CVCL_B4CA
DR   Wikidata; Q110434246
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu443Phefs*5 (c.1328dupT); ClinVar=VCV000934454; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1956+1G>A; ClinVar=VCV002734886; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 6
//
ID   WG3067
AC   CVCL_B4D1
DR   Wikidata; Q110434247
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3068
AC   CVCL_B4A8
DR   Wikidata; Q110434248
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3070
AC   CVCL_B4A9
DR   Wikidata; Q110434250
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3071
AC   CVCL_B4BD
DR   Wikidata; Q110434251
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val227Asnfs*16 (c.671_678dupAATTTATG); ClinVar=VCV000554641; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn341Lysfs*20 (c.1022dupA); ClinVar=VCV000553958; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3072
AC   CVCL_B3WV
DR   Wikidata; Q110434252
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3086
AC   CVCL_B3Z4
DR   Wikidata; Q110434253
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Ser865Asn (c.2594G>A); ClinVar=VCV000265086; Zygosity=Heterozygous (PubMed=31462756).
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Asn2157Asp (c.6469A>G); ClinVar=VCV000695565; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG3092
AC   CVCL_B3Z5
DR   Wikidata; Q110434254
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9-10M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG3099
AC   CVCL_B3Z6
DR   Wikidata; Q110434256
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG3112
AC   CVCL_B4BJ
DR   Wikidata; Q110434257
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser262Asn (c.785G>A); ClinVar=VCV001499715; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3118
AC   CVCL_B3ZZ
DR   Wikidata; Q110434258
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg616Cys (c.1846C>T); ClinVar=VCV000551499; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3122
AC   CVCL_B3ZP
DR   Wikidata; Q110434259
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Brazilian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val399Glufs*24 (c.1196_1197delTG); ClinVar=VCV000578141; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3126
AC   CVCL_B4D7
DR   Wikidata; Q110434260
RX   CelloPub=CLPUB00669;
RX   PubMed=16281286;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11450; SUCLG2; Simple; p.Arg91Ser (c.273A>T); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Miscellaneous: No MMUT mutations were detected.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   4M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3127
AC   CVCL_B4AE
DR   Wikidata; Q110434262
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Arg (c.280G>A); ClinVar=VCV000167312; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3129
AC   CVCL_B3XW
DR   Wikidata; Q110434263
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg153Ter (c.457C>T); ClinVar=VCV000550539; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Ter (c.481C>T); ClinVar=VCV000095703; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Glu170Cysfs*36 (c.507_519del13); ClinVar=VCV000556017; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3130
AC   CVCL_B3WW
DR   Wikidata; Q110434264
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3140
AC   CVCL_B4AQ
DR   Wikidata; Q110434266
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Thr370Pro (c.1108A>C); ClinVar=VCV000203847; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3158
AC   CVCL_B4AV
DR   Wikidata; Q110434267
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln589Ter (c.1765C>T); ClinVar=VCV000845401; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3162
AC   CVCL_B3Z8
DR   Wikidata; Q110434268
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG3163
AC   CVCL_B3VZ
DR   Wikidata; Q110434269
RX   CelloPub=CLPUB00662;
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Homozygous (CelloPub=CLPUB00662; PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3170
AC   CVCL_B4BM
DR   Wikidata; Q110434270
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly630Glu (c.1889G>A); ClinVar=VCV000426995; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3174
AC   CVCL_B3Y4
DR   Wikidata; Q110434271
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3183
AC   CVCL_B3X7
DR   Wikidata; Q110434272
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg132Ter (c.394C>T); ClinVar=VCV000001423; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3185
AC   CVCL_B4EV
DR   Wikidata; Q110434273
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3189
AC   CVCL_RG39
DR   GEO; GSM1266947
DR   Wikidata; Q54993986
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG3191
AC   CVCL_B4BP
DR   Wikidata; Q110434275
RX   PubMed=16281286;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asp244Leufs*39 (c.729_730insTT); ClinVar=VCV000552079; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu305Ser (c.914T>C); ClinVar=VCV000556865; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3192
AC   CVCL_B4AW
DR   Wikidata; Q110434276
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3199
AC   CVCL_B3Y5
DR   Wikidata; Q110434277
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3200
AC   CVCL_B4AX
DR   Wikidata; Q110434278
RX   PubMed=16281286;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3205
AC   CVCL_B4AS
DR   Wikidata; Q110434279
RX   PubMed=16281286;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3207
AC   CVCL_B4A0
DR   Wikidata; Q110434280
RX   PubMed=16281286;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Homozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3210
AC   CVCL_B4BK
DR   Wikidata; Q110434281
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly203Arg (c.607G>A); ClinVar=VCV000218987; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3211
AC   CVCL_B4AP
DR   Wikidata; Q110434283
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly94Val (c.281G>T); ClinVar=VCV000657887; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg152Ter (c.454C>T); ClinVar=VCV000426467; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3218
AC   CVCL_B4C7
DR   Wikidata; Q110434285
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Greek Cypriot.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly291Glu (c.870G>A); Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg511Ter (c.1531C>T); ClinVar=VCV000556124; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG3221
AC   CVCL_B3Z9
DR   Wikidata; Q110434286
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG3224
AC   CVCL_B4EW
DR   Wikidata; Q110434287
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3233
AC   CVCL_B4CF
DR   Wikidata; Q110434288
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1677-1G>A; ClinVar=VCV000550012; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3246
AC   CVCL_B4CY
DR   Wikidata; Q110434289
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Phe573Ser (c.1718T>C); ClinVar=VCV000284235; Zygosity=Heterozygous (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly623Arg (c.1867G>A); ClinVar=VCV000001884; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3265
AC   CVCL_B4GR
DR   Wikidata; Q110434290
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Thr172Argfs*10 (c.515_516delAC); ClinVar=VCV000000517; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3280
AC   CVCL_B4EP
DR   Wikidata; Q110434291
RX   CelloPub=CLPUB00671;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Leu21Ilefs*2 (c.60_61insAT); ClinVar=VCV000219001; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19058814).
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Cys153Metfs*10 (c.455dupC); ClinVar=VCV000219002; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19058814).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3281
AC   CVCL_B3WY
DR   Wikidata; Q110434293
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3287
AC   CVCL_B4EX
DR   Wikidata; Q110434294
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3293
AC   CVCL_B3UI
DR   Wikidata; Q110434295
RX   CelloPub=CLPUB00662;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; c.197-1G>T; ClinVar=VCV000219008; Zygosity=Homozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3298
AC   CVCL_B4EY
DR   Wikidata; Q110434296
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3308
AC   CVCL_B3XK
DR   Wikidata; Q110434298
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Asn110Aspfs*13 (c.328_331delAACC); ClinVar=VCV000203835; Zygosity=Homozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3310
AC   CVCL_B4E1
DR   Wikidata; Q110434299
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu394Phefs*30 (c.1181dupT); ClinVar=VCV000222930; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln659Ter (c.1975C>T); ClinVar=VCV000222939; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3322
AC   CVCL_B4EZ
DR   Wikidata; Q110434300
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3325
AC   CVCL_B4E5
DR   Wikidata; Q110434301
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg93His (c.278G>A); ClinVar=VCV000001880; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   10Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3329
AC   CVCL_B4DV
DR   Wikidata; Q110434302
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu494Ter (c.1481T>A); ClinVar=VCV000551275; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2Y4M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3332
AC   CVCL_B3UJ
DR   Wikidata; Q110434304
RX   CelloPub=CLPUB00662;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; c.291-1G>A; ClinVar=VCV000219004; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00662).
CC   Sequence variation: Mutation; HGNC; HGNC:19331; MMAB; Simple; p.Gln234Ter (c.700C>T); ClinVar=VCV000203820; Zygosity=Heterozygous (CelloPub=CLPUB00662).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142172; Methylmalonic aciduria, cblB type
DI   ORDO; Orphanet_79311; Vitamin B12-responsive methylmalonic acidemia type cblB
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3336
AC   CVCL_B4E6
DR   Wikidata; Q110434305
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   9M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3337
AC   CVCL_B4DG
DR   Wikidata; Q110434306
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   12D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3354
AC   CVCL_UI03
DR   Wikidata; Q98134916
RX   PubMed=19447654;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Ser146Argfs*35 (c.435_436delAT); ClinVar=VCV001455466; Zygosity=Homozygous (PubMed=19447654).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   WG3357
AC   CVCL_B3ZA
DR   Wikidata; Q110434307
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:4839; HCFC1; Simple; p.Thr1481Met (c.4442C>T); ClinVar=VCV000382802; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y5M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG3361
AC   CVCL_B4E7
DR   Wikidata; Q110434308
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3-4W
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3365
AC   CVCL_B3UM
DR   Wikidata; Q110434309
RX   CelloPub=CLPUB00662;
RX   CelloPub=CLPUB00670;
RX   CelloPub=CLPUB00671;
RX   PubMed=19136951;
RX   PubMed=21303734;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; c.916-1G>T; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00671; PubMed=21303734).
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3366
AC   CVCL_B3X4
DR   Wikidata; Q110434311
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Homozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3369
AC   CVCL_B4CZ
DR   Wikidata; Q110434312
RX   PubMed=16281286;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+2T>A; ClinVar=VCV000203856; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=16281286).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met700Lys (c.2099T>A); ClinVar=VCV000218997; Zygosity=Heterozygous (PubMed=16281286).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3374
AC   CVCL_B4DR
DR   Wikidata; Q110434314
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu414Lysfs*17 (c.1240delG); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3377
AC   CVCL_B4F0
DR   Wikidata; Q110434315
RX   CelloPub=CLPUB00670;
RX   CelloPub=CLPUB00671;
RX   PubMed=19058814;
RX   PubMed=19136951;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Thr238Ter (c.712_713delAC) (T237X); Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=19136951).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3387
AC   CVCL_B3XB
DR   Wikidata; Q110434316
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Met1Val (c.1A>G); ClinVar=VCV000381577; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3397
AC   CVCL_B4EK
DR   Wikidata; Q110434317
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caribbean; Barbadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2Y7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3412
AC   CVCL_B4F1
DR   Wikidata; Q110434318
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C99081; Arakawa syndrome II
DI   ORDO; Orphanet_2170; Methylcobalamin deficiency type cblG
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3423
AC   CVCL_B3XG
DR   Wikidata; Q110434320
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp203Ter (c.608G>A); ClinVar=VCV000095706; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3426
AC   CVCL_B4EB
DR   Wikidata; Q110434321
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; German/Polish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   9Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3427
AC   CVCL_B4DB
DR   Wikidata; Q110434322
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Leu10Phefs*39 (c.29dupT); ClinVar=VCV000553287; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val553Glyfs*17 (c.1658delT); ClinVar=VCV001069591; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   19Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3439
AC   CVCL_B4EC
DR   Wikidata; Q110434324
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3447
AC   CVCL_B4EL
DR   Wikidata; Q110434326
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg727Ter (c.2179C>T); ClinVar=VCV000218998; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   8M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3458
AC   CVCL_B3XX
DR   Wikidata; Q110434327
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Homozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3465
AC   CVCL_RG40
DR   GEO; GSM1257677
DR   GEO; GSM1266945
DR   GEO; GSM1267031
DR   GEO; GSM1288475
DR   Wikidata; Q54993987
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG3466
AC   CVCL_RG41
DR   GEO; GSM1257678
DR   GEO; GSM1266946
DR   GEO; GSM1267032
DR   GEO; GSM1288476
DR   Wikidata; Q54993988
RX   PubMed=24555846;
RX   PubMed=25326100;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   WG3468
AC   CVCL_B4D9
DR   Wikidata; Q110434329
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met1Val (c.1A>G); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly717Val (c.2150G>T); ClinVar=VCV000001881; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3470
AC   CVCL_B4F2
DR   Wikidata; Q110434330
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142171; Methylmalonic aciduria, cblA type
DI   ORDO; Orphanet_79310; Vitamin B12-responsive methylmalonic acidemia type cblA
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3473
AC   CVCL_B4DE
DR   Wikidata; Q110434331
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Trp43Ter (c.129G>A); ClinVar=VCV000222908; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr100Cys (c.299A>G); ClinVar=VCV000218991; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3480
AC   CVCL_B3WX
DR   Wikidata; Q110434332
RX   CelloPub=CLPUB00668;
RX   PubMed=19058814;
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3482
AC   CVCL_B4ED
DR   Wikidata; Q110434334
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Middle Eastern.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg474Ter (c.1420C>T); ClinVar=VCV000554873; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3495
AC   CVCL_B4DL
DR   Wikidata; Q110434336
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; English/Irish.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   21Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3496
AC   CVCL_B3XH
DR   Wikidata; Q110434337
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr205Ter (c.615C>G); ClinVar=VCV000281007; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3499
AC   CVCL_B4DQ
DR   Wikidata; Q110434338
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African or African American.
CC   Sequence variation: Mutation; HGNC; HGNC:16732; MCEE; Simple; p.Arg143His (c.428G>A); ClinVar=VCV000336936; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu211del (c.631_633delGAG); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3512
AC   CVCL_B4DC
DR   Wikidata; Q110434340
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: African or African American.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108His (c.323G>A); ClinVar=VCV000100707; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:11653; TCN2; Simple; p.Leu30Arg (c.89T>G); ClinVar=VCV000529781; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3514
AC   CVCL_B3WZ
DR   Wikidata; Q110434341
RX   CelloPub=CLPUB00668;
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Italian and Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (CelloPub=CLPUB00668; PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3520
AC   CVCL_B4DT
DR   Wikidata; Q110434342
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg369His (c.1106G>A); ClinVar=VCV000203846; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3529
AC   CVCL_B4DI
DR   Wikidata; Q110434343
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and Southeast Asian; Filipino.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3539
AC   CVCL_B3XL
DR   Wikidata; Q110434344
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Gly147Asp (c.440G>A); ClinVar=VCV000203829; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp157Valfs*24 (c.468_469delCT); Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3547
AC   CVCL_B4EG
DR   Wikidata; Q110434346
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg581Ter (c.1741C>T); ClinVar=VCV000554675; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   20Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3556
AC   CVCL_B4DS
DR   Wikidata; Q110434347
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3560
AC   CVCL_B4F3
DR   Wikidata; Q110434348
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3561
AC   CVCL_B3XY
DR   Wikidata; Q110434350
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp157Ter (c.471G>A); ClinVar=VCV000553844; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Tyr222Ter (c.666C>A); ClinVar=VCV000496436; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3564
AC   CVCL_B4EJ
DR   Wikidata; Q110434351
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro654_Arg655insTer (c.1962_1963delTC) (p.Pro654Profs*2); ClinVar=VCV000552144; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3572
AC   CVCL_B4DA
DR   Wikidata; Q110434353
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Gly220Arg (c.658G>A); ClinVar=VCV000136684; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met1Thr (c.2T>C); ClinVar=VCV000222903; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly544Ter (c.1630_1631delGGinsTA); ClinVar=VCV000203860; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3580
AC   CVCL_B3XZ
DR   Wikidata; Q110434354
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese; Taiwan.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Trp203Ter (c.609G>A); ClinVar=VCV000030800; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Lys220del (c.658_660delAAG); ClinVar=VCV000095707; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3583
AC   CVCL_B4EQ
DR   Wikidata; Q110434355
RX   CelloPub=CLPUB00671;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Ser228Ter (c.683C>G); ClinVar=VCV002507317; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19058814).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4F7 ! WG3646
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 6
//
ID   WG3589
AC   CVCL_B4F4
DR   Wikidata; Q110434357
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3599
AC   CVCL_B4EI
DR   Wikidata; Q110434358
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala631Glnfs*17 (c.1891delG); ClinVar=VCV000242511; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3602
AC   CVCL_B4DY
DR   Wikidata; Q110434359
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly312Val (c.935G>T); ClinVar=VCV000218988; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly637Arg (c.1909G>A); ClinVar=VCV001486406; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   25Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3630
AC   CVCL_B4GI
DR   Wikidata; Q110434360
RX   CelloPub=CLPUB00670;
RX   PubMed=23141461;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Asn141Lys (c.423C>G); ClinVar=VCV001343599; Zygosity=Homozygous (PubMed=23141461).
CC   Sequence variation: Mutation; HGNC; HGNC:7436; MTHFR; Simple; p.Ala222Val (c.665C>T) (C677T); ClinVar=VCV000003520; Zygosity=Homozygous (PubMed=23141461).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183526; Methylmalonic aciduria and homocystinuria, cblJ type
DI   ORDO; Orphanet_369955; Methylmalonic acidemia with homocystinuria, type cblJ
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 7
//
ID   WG3637
AC   CVCL_B4DX
DR   Wikidata; Q110434361
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Met266Tyrfs*7 (c.795_796insT); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg403Ter (c.1207C>T); ClinVar=VCV000167310; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3646
AC   CVCL_B4F7
DR   Wikidata; Q110434362
RX   CelloPub=CLPUB00670;
RX   PubMed=22832074;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Ser228Ter (c.683C>G); ClinVar=VCV002507317; Zygosity=Homozygous (from autologous cell line WG3583).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4EQ ! WG3583
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 7
//
ID   WG3650
AC   CVCL_B4DD
DR   Wikidata; Q110434363
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg31Ter (c.91C>T); ClinVar=VCV000092688; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Glu117Ter (c.349G>T); ClinVar=VCV000001882; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y9M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3654
AC   CVCL_B4DF
DR   Wikidata; Q110434364
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.146_147ins279; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asp125_Asn126insGlu (c.372_374dupGGA) (p.K124_D125insE); ClinVar=VCV000203861; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   10D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3664
AC   CVCL_B4EE
DR   Wikidata; Q110434365
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Lys520Asn (c.1560G>C); Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3665
AC   CVCL_B3X0
DR   Wikidata; Q110434367
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg111Ter (c.331C>T); ClinVar=VCV000001424; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3669
AC   CVCL_B4E0
DR   Wikidata; Q110434368
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Afghan.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser354Trpfs*20 (c.1061delCinsGGA); Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ser357Metfs*5 (c.1065_1068dupATGG); ClinVar=VCV000280817; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3W
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3676
AC   CVCL_B3XF
DR   Wikidata; Q110434369
RX   PubMed=19370762;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (PubMed=19370762).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg189Valfs*21 (c.565delC); ClinVar=VCV000553238; Zygosity=Heterozygous (PubMed=19370762).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3679
AC   CVCL_B4DJ
DR   Wikidata; Q110434370
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian and Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn189Ile (c.566A>T); ClinVar=VCV000222915; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Asn219Tyr (c.655A>T); ClinVar=VCV000001886; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3686
AC   CVCL_B3X1
DR   Wikidata; Q110434372
RX   CelloPub=CLPUB00668;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg91Lysfs*14 (c.271dupA); ClinVar=VCV000001421; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Arg161Gln (c.482G>A); ClinVar=VCV000001425; Zygosity=Heterozygous (CelloPub=CLPUB00668).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3705
AC   CVCL_B4EF
DR   Wikidata; Q110434374
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese/Asian ethnic group; Hmong.
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Gly1167Val (c.3500G>T); ClinVar=VCV001444711; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:2548; CUBN; Simple; p.Ile2071Val (c.6211A>G); ClinVar=VCV001478369; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala555Thr (c.1663G>A); ClinVar=VCV000203850; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y7M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3707
AC   CVCL_B4E2
DR   Wikidata; Q110434375
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gly427Asp (c.1280G>A); ClinVar=VCV000218990; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Unexplicit; Ex13 del; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:11653; TCN2; Simple; p.Arg170Gln (c.509G>A); ClinVar=VCV000341197; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3721
AC   CVCL_B4E9
DR   Wikidata; Q110434376
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val136Phe (c.406G>T); ClinVar=VCV001071892; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3728
AC   CVCL_B4F5
DR   Wikidata; Q110434377
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3732
AC   CVCL_B4F6
DR   Wikidata; Q110434378
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142173; Homocystinuria-megaloblastic anemia, cblE complementation type
DI   ORDO; Orphanet_2169; Methylcobalamin deficiency type cblE
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3733
AC   CVCL_B3Y7
DR   Wikidata; Q110434379
RX   PubMed=20524213;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Glu88del (c.256GAG[2]) (c.262_264delGAG); ClinVar=VCV000203643; Zygosity=Homozygous (PubMed=20524213).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183527; Methylmalonic acidemia, TcblR type
DI   ORDO; Orphanet_280183; Methylmalonic aciduria due to transcobalamin receptor defect
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3742
AC   CVCL_B4E8
DR   Wikidata; Q110434380
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3745
AC   CVCL_B4ER
DR   Wikidata; Q110434381
RX   CelloPub=CLPUB00671;
RX   PubMed=19058814;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Mexican.
CC   Sequence variation: Mutation; HGNC; HGNC:25221; MMADHC; Simple; p.Asp246Gly (c.737A>G); ClinVar=VCV000839892; Zygosity=Homozygous (CelloPub=CLPUB00671; PubMed=19058814).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183524; Methylmalonic aciduria and homocystinuria, cblD type
DI   ORDO; Orphanet_79283; Methylmalonic acidemia with homocystinuria, type cblD
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3760
AC   CVCL_B4DZ
DR   Wikidata; Q110434382
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala324Thr (c.970G>A); ClinVar=VCV000550893; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg616Cys (c.1846C>T); ClinVar=VCV000551499; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Caution: MMUT c.1846C>T mutation indicated incorrectly as being causative of p.Pro649Leu in CelloPub=CLPUB00669 and PubMed=27233228 (personal communication of Rosenblatt, David S.).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   7Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3784
AC   CVCL_B4E4
DR   Wikidata; Q110434384
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro86Leu (c.257C>T); ClinVar=VCV000553773; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3794
AC   CVCL_B4E3
DR   Wikidata; Q110434385
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Val19Glyfs*39 (c.55dupG); ClinVar=VCV000222906; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   6W
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3820
AC   CVCL_B4EH
DR   Wikidata; Q110434386
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Arab.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln624Arg (c.1871A>G); ClinVar=VCV001459267; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   13Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG3838
AC   CVCL_B4K5
SY   WG-3838
DR   Wikidata; Q110434387
RX   PubMed=29302025;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Japanese and Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:24525; MMACHC; Simple; p.Gln27Arg (c.80A>G); ClinVar=VCV000552467; Zygosity=Heterozygous (PubMed=29302025).
CC   Sequence variation: Mutation; HGNC; HGNC:9352; PRDX1; Simple; c.515-2A>T; ClinVar=VCV000495210; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=29302025).
CC   Miscellaneous: Cell line no longer available.
CC   Caution: The mutation indicated in PubMed=29302025 for MMACHC (c.81G>A) is incorrect. The correct mutation is c.80G>A (personal communication of Rosenblatt, David S.).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1-2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   WG3863
AC   CVCL_B4DH
DR   Wikidata; Q110434388
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Hispanic.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg108Cys (c.322C>T); ClinVar=VCV000001887; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Gln218His (c.654A>C); ClinVar=VCV000551243; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   46D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3869
AC   CVCL_B4DN
DR   Wikidata; Q110434389
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.754-2A>G; ClinVar=VCV000552691; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3W
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3897
AC   CVCL_B4GL
DR   Wikidata; Q110434390
RX   CelloPub=CLPUB00670;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG3965
AC   CVCL_B4DU
DR   Wikidata; Q110434391
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Tyr429Ter (c.1287C>G); ClinVar=VCV000554278; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   2M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG3972
AC   CVCL_B4DP
DR   Wikidata; Q110434392
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; Portuguese and Mexican and Southeast Asian; Lao/Thai.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Pro194Leu (c.581C>T); ClinVar=VCV001073632; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   5D
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG4008
AC   CVCL_B4GZ
DR   Wikidata; Q110434393
RX   CelloPub=CLPUB00671;
RX   PubMed=21303734;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671).
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; c.1339-1G>T; ClinVar=VCV001323238; Zygosity=Heterozygous; Note=Splice acceptor mutation (CelloPub=CLPUB00671; PubMed=21303734).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   WG4027
AC   CVCL_B4EA
DR   Wikidata; Q110434394
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Gln (c.683G>A); ClinVar=VCV002136408; Zygosity=Homozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   1Y6M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG4042
AC   CVCL_B4H0
DR   Wikidata; Q110434396
RX   CelloPub=CLPUB00671;
RX   PubMed=21303734;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Ala24_Lys82del (c.70-4298_246+2311del6785); Zygosity=Heterozygous (CelloPub=CLPUB00671; PubMed=21303734).
CC   Sequence variation: Mutation; HGNC; HGNC:23038; LMBRD1; Simple; p.Asn353Ilefs*18 (c.1056delG) (L352fsX18); ClinVar=VCV000225048; Zygosity=Heterozygous (CelloPub=CLPUB00671).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183525; Methylmalonic aciduria and homocystinuria, cblF type
DI   ORDO; Orphanet_79284; Methylmalonic acidemia with homocystinuria type cblF
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG4053
AC   CVCL_B4GM
DR   Wikidata; Q110434397
RX   CelloPub=CLPUB00670;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG4055
AC   CVCL_B4DM
DR   Wikidata; Q110434398
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Aboriginal Australian and Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Ala191Glu (c.572C>A); ClinVar=VCV000203854; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000203855; Zygosity=Heterozygous (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG4066
AC   CVCL_B4GJ
DR   Wikidata; Q110434399
RX   CelloPub=CLPUB00670;
RX   PubMed=22922874;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Tyr319Cys (c.956A>G); ClinVar=VCV000037319; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Glu583Leufs*9 (c.1746_1747insCT); ClinVar=VCV000037320; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Sequence variation: Mutation; HGNC; HGNC:6694; LRP2; Simple; p.Arg1311His (c.3932G>A); ClinVar=VCV000893877; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Sequence variation: Mutation; HGNC; HGNC:6694; LRP2; Simple; p.Arg3646His (c.10937G>A); ClinVar=VCV000074222; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Sequence variation: Mutation; HGNC; HGNC:24759; TPRG1; Simple; p.Tyr61Ter (c.183_192del); Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Sequence variation: Mutation; HGNC; HGNC:24759; TPRG1; Simple; p.Ser141Ile (c.422G>T); Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183526; Methylmalonic aciduria and homocystinuria, cblJ type
DI   ORDO; Orphanet_369955; Methylmalonic acidemia with homocystinuria, type cblJ
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG4095
AC   CVCL_B4GH
DR   Wikidata; Q110434400
RX   CelloPub=CLPUB00670;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG4131
AC   CVCL_B3ZB
DR   Wikidata; Q110434401
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Glu88del (c.256GAG[2]) (c.262_264delGAG); ClinVar=VCV000203643; Zygosity=Heterozygous (PubMed=31462756).
CC   Sequence variation: Mutation; HGNC; HGNC:16692; CD320; Simple; p.Gly220Arg (c.658G>A); ClinVar=VCV000136684; Zygosity=Heterozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WG4140
AC   CVCL_B4GK
DR   Wikidata; Q110434402
RX   CelloPub=CLPUB00670;
RX   PubMed=22922874;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; c.542+1G>T; ClinVar=VCV000280107; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00670; PubMed=22922874).
CC   Sequence variation: Mutation; HGNC; HGNC:68; ABCD4; Simple; p.Gly486Cys (c.1456G>T); ClinVar=VCV000037322; Zygosity=Heterozygous (CelloPub=CLPUB00670; PubMed=22922874).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183526; Methylmalonic aciduria and homocystinuria, cblJ type
DI   ORDO; Orphanet_369955; Methylmalonic acidemia with homocystinuria, type cblJ
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   WG4142
AC   CVCL_B3ZC
DR   Wikidata; Q110434403
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 5
//
ID   WG4152
AC   CVCL_B4K6
SY   WG-4152
DR   Wikidata; Q110434404
RX   PubMed=29302025;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142174; Methylmalonic aciduria and homocystinuria, cblC type
DI   ORDO; Orphanet_79282; Methylmalonic acidemia with homocystinuria, type cblC
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   WG4169
AC   CVCL_B4DW
DR   Wikidata; Q110434405
RX   CelloPub=CLPUB00669;
RX   PubMed=27233228;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Population: Caucasian; French Canadian.
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.753+3A>G; ClinVar=VCV003061795; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00669; PubMed=27233228).
CC   Sequence variation: Mutation; HGNC; HGNC:7526; MMUT; Simple; c.1332+1delG; ClinVar=VCV000554656; Zygosity=Heterozygous; Note=Splice donor mutation (CelloPub=CLPUB00669; PubMed=27233228).
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C148366; Methylmalonic aciduria due to methylmalonyl-CoA mutase deficiency
DI   ORDO; Orphanet_27; Vitamin B12-unresponsive methylmalonic acidemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   3M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 7
//
ID   WG4190
AC   CVCL_B3ZD
DR   Wikidata; Q110434407
RX   PubMed=31462756;
CC   From: Montreal Children's Hospital cell repository; Montreal; Canada.
CC   Sequence variation: Mutation; HGNC; HGNC:11529; EPCAM; Simple; p.Gln167Profs*21 (c.499dupC); ClinVar=VCV000012774; Zygosity=Homozygous (PubMed=31462756).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Miscellaneous: Cell line no longer available.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C183530; Diarrhea 5, with tufting enteropathy, congenital
DI   NCIt; C98986; Methylmalonic acidemia
DI   ORDO; Orphanet_92050; Congenital tufting enteropathy
DI   ORDO; Orphanet_293355; Methylmalonic acidemia without homocystinuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   WGA
AC   CVCL_0578
DR   MCCL; MCC:0000484
DR   cancercelllines; CVCL_0578
DR   Wikidata; Q54993989
RX   PubMed=15572372;
CC   Population: Caucasian.
CC   Characteristics: Derived from the parent cell line by metabolic selection using the ability to grow on fructose as the selection system.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-124C>T (c.228C>T) (C228T); Zygosity=Unspecified; Note=In promoter (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3728; Hepatoblastoma
DI   ORDO; Orphanet_449; Hepatoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0027 ! Hep-G2
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   WGA-1
AC   CVCL_E4A3
RX   PubMed=1381405;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P16109; Human SELP/CD62P.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   Wgd5
AC   CVCL_3808
DR   CLO; CLO_0009589
DR   CLDB; cl4698
DR   ATCC; CRL-1817
DR   ECACC; 95082908
DR   Wikidata; Q54993992
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Discontinued: ECACC; 95082908; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3433 ! WOP
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 14
//
ID   WH
AC   CVCL_0C39
DR   Cosmic; 2057464
DR   Cosmic; 2444235
DR   Wikidata; Q54993993
RX   PubMed=2296606;
RX   PubMed=7508897;
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C39851; Bladder urothelial carcinoma
DI   ORDO; Orphanet_209989; Non-papillary transitional cell carcinoma of the bladder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   Wh-Ir
AC   CVCL_S392
DR   ATCC; CRL-6562
DR   Wikidata; Q54993995
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6562; true.
OX   NCBI_TaxID=9770; ! Balaenoptera physalus (Fin whale)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   WH12/6
AC   CVCL_WH58
DR   Wikidata; Q98134918
RX   PubMed=9847331;
RX   PubMed=11739671;
CC   From: Bannasch, Peter; Deutsches Krebsforschungszentrum; Heidelberg; Germany.
CC   Transformant: NCBI_TaxID; 35269; Woodchuck hepatitis virus.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C124251; Woodchuck hepatocellular carcinoma
OX   NCBI_TaxID=9995; ! Marmota monax (Woodchuck)
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 6
//
ID   WH19-4
AC   CVCL_H783
DR   Wikidata; Q54993996
RX   PubMed=1316607;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=U19tsa).
CC   Derived from site: In situ; Brain, hippocampus; UBERON=UBERON_0002421.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
AG   18FD
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   WH22
AC   CVCL_C3UH
DR   Wikidata; Q116050794
RX   PubMed=7553244;
RX   PubMed=8556554;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P49273; Dermatophagoides pteronyssinus allergen Der p 7 (DERP7) (Note=Also reacts with D.farinae Der f 7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   WH257GE10
AC   CVCL_4Z95
DR   Wikidata; Q54993997
RX   PubMed=3905560;
CC   Characteristics: Derived from a serially transplanted tumor maintained in nude mice.
CC   Doubling time: ~40 hours (Note=At 110th passage) (PubMed=3905560).
CC   Transformant: NCBI_TaxID; 35269; Woodchuck hepatitis virus.
DI   NCIt; C124251; Woodchuck hepatocellular carcinoma
OX   NCBI_TaxID=9995; ! Marmota monax (Woodchuck)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 5
//
ID   Wh3
AC   CVCL_C0HV
DR   Wikidata; Q112930566
RX   PubMed=11877067;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   Wh43
AC   CVCL_C0HW
DR   Wikidata; Q112930567
RX   PubMed=11877067;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   WH44KA
AC   CVCL_4Z96
DR   Wikidata; Q54993998
RX   DOI=10.2957/kanzo.29.272;
RX   PubMed=2453497;
CC   Doubling time: ~36 hours (PubMed=2453497).
CC   Transformant: NCBI_TaxID; 35269; Woodchuck hepatitis virus.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C124251; Woodchuck hepatocellular carcinoma
OX   NCBI_TaxID=9995; ! Marmota monax (Woodchuck)
SX   Sex unspecified
AG   3-4Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 7
//
ID   Wh8
AC   CVCL_C0HX
DR   Wikidata; Q112930568
RX   PubMed=11877067;
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C125702; Fanconi anemia, complementation group A
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   WH9
AC   CVCL_C3UI
DR   ABCD; ABCD_AD582
DR   Wikidata; Q116050795
RX   PubMed=7553244;
RX   PubMed=8556554;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P49273; Dermatophagoides pteronyssinus allergen Der p 7 (DERP7) (Note=Also reacts with D.farinae Der f 7).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   WH94
AC   CVCL_RN49
DR   Wikidata; Q54993999
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690048;
CC   Population: Japanese.
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 6
//
ID   WHCO1
AC   CVCL_D7EJ
SY   WHCO-1
RX   CelloPub=CLPUB00772;
RX   PubMed=16643659;
RX   PubMed=16895604;
RX   PubMed=21734802;
CC   Sequence variation: Gene deletion; HGNC; HGNC:3701; FHIT; Zygosity=Homozygous (PubMed=16895604).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WHCO2
AC   CVCL_D7FU
SY   WHCO-2
RX   CelloPub=CLPUB00772;
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   WHCO3
AC   CVCL_D7EK
SY   WHCO-3
RX   CelloPub=CLPUB00772;
RX   PubMed=16643659;
RX   PubMed=16895604;
RX   PubMed=21734802;
CC   Characteristics: Derived from a nu/nu mouse tumor resulting from the xenotransplantation of the original tumor (CelloPub=CLPUB00772).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   WHCO5
AC   CVCL_D7EL
RX   PubMed=16643659;
RX   PubMed=16895604;
RX   PubMed=21734802;
CC   Sequence variation: Mutation; HGNC; HGNC:3701; FHIT; Unexplicit; Ex4-5del; Zygosity=Homozygous (PubMed=16895604).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WHCO6
AC   CVCL_D7EM
DR   EFO; EFO_0022557
RX   PubMed=16643659;
RX   PubMed=16895604;
RX   PubMed=21734802;
CC   Sequence variation: Gene deletion; HGNC; HGNC:3701; FHIT; Zygosity=Homozygous (PubMed=16895604).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   whiov-P24C-MoAb
AC   CVCL_XX95
DR   CCRID; 4201PAT-CCTCC00245
DR   Wikidata; Q98134919
RX   Patent=CN101671655B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200818.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: HIV-1 capsid protein p24.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   WHIRC01
AC   CVCL_LB55
SY   Women's Health Integrated Research Center 01
DR   cancercelllines; CVCL_LB55
DR   Wikidata; Q54994000
RX   PubMed=28251557;
CC   Characteristics: Derived from a patient-derived mouse xenograft.
CC   Doubling time: ~30 hours (PubMed=28251557).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gly (c.742C>G); ClinVar=VCV000376652; Zygosity=Unspecified (PubMed=28251557).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=28251557
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C105555; High grade ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   WHN2
AC   CVCL_0G08
SY   WHN-2
DR   Wikidata; Q54994001
RX   PubMed=8390425;
RX   PubMed=9738977;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Doubling time: ~3 days (PubMed=8390425).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WHO NP192
AC   CVCL_E872
SY   WHONP192
DR   dbMHC; 49062
DR   ECACC; 94082240
DR   IHW; IHW09140
DR   IPD-IMGT/HLA; 11683
DR   Wikidata; Q54994003
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02:07,11:01:01; B*46:01; C*01; DPB1*02:01:02,05:01; DQA1*03,03:02; DQB1*03:03:02,04:01; DRB1*04:05:01,09:01:02; DRB4*01:03:01:01 (IPD-IMGT/HLA=11683).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 30-01-24; Version: 17
//
ID   WHO NP199
AC   CVCL_E873
SY   WHONP199
DR   dbMHC; 49063
DR   ECACC; 94082233
DR   IHW; IHW09134
DR   IPD-IMGT/HLA; 11677
DR   Wikidata; Q54994016
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02,30; B*13,46; C*06:02; DPB1*05:01; DQA1*02:01,03:02; DQB1*02:01,03:03; DRB1*07,09; DRB4*01:01 (IPD-IMGT/HLA=11677).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WHO NP439
AC   CVCL_E874
SY   WHONP439
DR   dbMHC; 49064
DR   ECACC; 94082239
DR   IHW; IHW09139
DR   IPD-IMGT/HLA; 11682
DR   Wikidata; Q54994017
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Asian.
CC   HLA typing: A*02,24; B*46; C*01; DPB1*05:01; DQA1*03:02; DQB1*03:03:02; DRB1*09:01; DRB4*01:01 (IPD-IMGT/HLA=11682).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   WI-1 [Human fetal lung]
AC   CVCL_JE97
SY   WI1; Wistar Institute-1; WIHL; Wistar Institute Human Lung
DR   Wikidata; Q54994019
RX   CelloPub=CLPUB00391;
RX   PubMed=13905658;
RX   PubMed=13905660;
RX   PubMed=14315085;
CC   Anecdotal: First cell line derived by Leonard Hayflick from fetal cells.
CC   Anecdotal: The cell lines WI-1 to WI-25 derived by Leonard Hayflick were lost in 1961 when an electrical freezer failed at the Wistar Insitute (CelloPub=CLPUB00391).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 27-11-25; Version: 8
//
ID   WI-1 [Mouse hybridoma against human 42 kDa antigen]
AC   CVCL_D5EI
SY   WIMM-A80-1B
DR   Wikidata; Q127384688
RX   PubMed=6759147;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown 42 kDa antigen on cell line HL-60.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-04-25; Version: 3
//
ID   WI-1003
AC   CVCL_4557
SY   WI 1003; Wistar Institute-1003
DR   CLO; CLO_0009590
DR   CLO; CLO_0009592
DR   CLDB; cl4699
DR   CLDB; cl4700
DR   ATCC; CCL-154
DR   IZSLER; BS CL 108
DR   Wikidata; Q54994021
RX   PubMed=7065527;
RX   PubMed=14315085;
CC   Senescence: Senesces at 8-10 PDL (ATCC=CCL-154).
CC   Discontinued: ATCC; CCL-154; true.
CC   Discontinued: IZSLER; BS CL 108; probable.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   WI-2 [Dog ESC]
AC   CVCL_JL46
SY   WI2
DR   Wikidata; Q54994023
RX   PubMed=19038794;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 6
//
ID   WI-2 [Mouse hybridoma against human 43 kDa antigen]
AC   CVCL_D5DD
DR   Wikidata; Q127384689
RX   PubMed=6520969;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human unknown 43 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   WI-25
AC   CVCL_V827
SY   WI 25; WI25; Wistar Institute-25
DR   Wikidata; Q54994024
RX   CelloPub=CLPUB00391;
RX   PubMed=13905658;
RX   PubMed=13905660;
RX   PubMed=14315085;
CC   Anecdotal: The cell lines WI-1 to WI-25 derived by Leonard Hayflick were lost in 1961 when an electrical freezer failed at the Wistar Insitute (CelloPub=CLPUB00391).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Fetus
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 8
//
ID   WI-26
AC   CVCL_V826
SY   WI 26; WI26; Wistar Institute-26
DR   BTO; BTO_0003482
DR   ATCC; CCL-95
DR   BioSample; SAMN03471292
DR   Wikidata; Q54994025
RX   CelloPub=CLPUB00391;
RX   PubMed=699332;
RX   PubMed=6256643;
RX   PubMed=7065527;
RX   PubMed=14064953;
RX   PubMed=14315085;
CC   Group: Space-flown cell line (cellonaut).
CC   Population: Caucasian; Swedish.
CC   Senescence: Senesces at 36 PDL and are distributed at 27 PDL (ATCC=CCL-95).
CC   Discontinued: ATCC; CCL-95; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-95
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3FM
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   WI-26 VA4
AC   CVCL_2758
SY   WI 26 VA4; WI 26 VA 4; WI-26VA4; WI26 VA4; WI26VA4; VA-4
DR   CLO; CLO_0009593
DR   CLDB; cl4701
DR   CLDB; cl4702
DR   ATCC; CCL-95.1
DR   cancercelllines; CVCL_2758
DR   ECACC; 89101301
DR   GEO; GSM827466
DR   IZSLER; BS CL 89
DR   JCRB; JCRB9042
DR   KCLB; 10095.1
DR   Progenetix; CVCL_2758
DR   Wikidata; Q54994026
RX   PubMed=699332;
RX   PubMed=6256643;
RX   PubMed=7065527;
RX   PubMed=14288316;
RX   PubMed=20215515;
CC   Population: Caucasian; Swedish.
CC   Doubling time: ~42 hours (Note=Lot 02102015) (JCRB=JCRB9042).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-95.1; JCRB=JCRB9042; KCLB=10095.1
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 9,11
ST   D18S51: 17
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 14
ST   FGA: 25
ST   Penta D: 10,12
ST   Penta E: 10,12
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 17,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V826 ! WI-26
SX   Male
AG   3FM
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   WI-38
AC   CVCL_0579
SY   Wi-38; WI 38; WI38; Wistar Institute-38; AG06814E; AG06814G; AG06814H; AG06814-J; AG06814J; AG06814-M; AG06814-N
DR   BTO; BTO_0000458
DR   CLO; CLO_0009591
DR   CLO; CLO_0009594
DR   CLO; CLO_0035526
DR   CLO; CLO_0035534
DR   EFO; EFO_0001260
DR   MCCL; MCC:0000485
DR   CLDB; cl4703
DR   CLDB; cl4704
DR   CLDB; cl4705
DR   AddexBio; T0016037/5007
DR   ArrayExpress; E-MTAB-38
DR   ATCC; CCL-75
DR   ATCC; CRL-7728
DR   BioSample; SAMN01821606
DR   BioSample; SAMN01821721
DR   BioSample; SAMN03471285
DR   cancercelllines; CVCL_0579
DR   CCRID; 1101HUM-PUMC000210
DR   CCRID; 1102HUM-NIFDC00067
DR   CCRID; 3101HUMGNHu42
DR   CCRID; 3101HUMSCSP521
DR   CCRID; 4201HUM-CCTCC00016
DR   CCTCC; GDC0016
DR   ChEMBL-Cells; CHEMBL3307476
DR   ChEMBL-Cells; CHEMBL3307614
DR   ChEMBL-Targets; CHEMBL612806
DR   ChEMBL-Targets; CHEMBL614391
DR   CLS; 300428
DR   Coriell; AG06814-J
DR   Coriell; AG06814-M
DR   Coriell; AG06814-N
DR   ECACC; 90020107
DR   GEO; GSE12450
DR   GEO; GSE33710
DR   GEO; GSM827323
DR   GEO; GSM1022634
DR   GEO; GSM1022637
DR   GEO; GSM1022647
DR   GEO; GSM1022655
DR   GEO; GSM1887928
DR   GEO; GSM1887984
DR   IGRhCellID; WI38
DR   IZSLER; BS CL 90
DR   JCRB; IFO50075
DR   JCRB; JCRB9017
DR   KCB; KCB 200556YJ
DR   KCLB; 10075
DR   Lonza; 495
DR   Progenetix; CVCL_0579
DR   PubChem_Cell_line; CVCL_0579
DR   RCB; RCB0702
DR   RCB; RCB0704
DR   TKG; TKG 0360
DR   Wikidata; Q7950532
RX   CelloPub=CLPUB00391;
RX   CelloPub=CLPUB00597;
RX   DOI=10.1007/BF02618370;
RX   DOI=10.1016/B978-0-12-007903-2.50014-3;
RX   DOI=10.1038/498407a;
RX   DOI=10.1038/498422a;
RX   DOI=10.11418/jtca1981.16.3_147;
RX   PubMed=211143;
RX   PubMed=352912;
RX   PubMed=535915;
RX   PubMed=656543;
RX   PubMed=699332;
RX   PubMed=1031681;
RX   PubMed=1249414;
RX   PubMed=1756776;
RX   PubMed=3016668;
RX   PubMed=4203458;
RX   PubMed=4329447;
RX   PubMed=4695793;
RX   PubMed=4817727;
RX   PubMed=5347639;
RX   PubMed=5668122;
RX   PubMed=5801069;
RX   PubMed=5834207;
RX   PubMed=5956336;
RX   PubMed=6256643;
RX   PubMed=6409440;
RX   PubMed=6538202;
RX   PubMed=6887978;
RX   PubMed=7065527;
RX   PubMed=7972006;
RX   PubMed=14064953;
RX   PubMed=14218592;
RX   PubMed=14315085;
RX   PubMed=17395773;
RX   PubMed=17792436;
RX   PubMed=19896956;
RX   PubMed=20215515;
RX   PubMed=22984048;
RX   PubMed=25063771;
RX   PubMed=25903999;
RX   PubMed=29546209;
WW   Info; -; -; https://web.archive.org/web/20160502013052/http://www.bioedge.org/bioethics/bioethics_article/10637
WW   Info; -; -; https://web.archive.org/web/20170206220904/http://www.ascb.org/activation-energy/the-story-of-wi-38-the-other-famous-cell-line/
WW   Info; -; -; https://web.archive.org/web/20200208221629/https://www.aginginterventionfoundation.org/BookReview2.pdf
WW   Info; Slate; -; https://www.slate.com/articles/technology/future_tense/2017/03/the_woman_whose_aborted_fetus_helped_create_the_rubella_vaccine.html
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/WI-38
CC   Group: Space-flown cell line (cellonaut).
CC   Group: Vaccine production cell line.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Population: Caucasian; Swedish.
CC   Biotechnology: Used for the production of RA27/3 - the first rubella virus vaccine.
CC   Biotechnology: Used for the production of live oral adenovirus type 4 and type 7 vaccine used by the US military. Produced first by Wyeth Laboratories from 1971 to 1999 and from 2011 onward by Barr Pharmaceuticals.
CC   Biotechnology: Was used in the early 1970's for the production of the Human Diploid Cell Vaccine (HDCV) vaccine against rabies by Institut Merieux.
CC   Characteristics: Used in many context such as senescence and aging studies.
CC   Senescence: Life expectancy of 50 +- 10 population doublings. Senesces at 38 PDL (PubMed=17395773).
CC   Doubling time: ~24 hours (ATCC=CCL-75; ECACC=90020107).
CC   Omics: Genomics; ChIP-seq; CTCF.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Leonard Hayflick when numbering diploid cell strains 'jumped' directly from WI-27 (which failed) to WI-38 (CelloPub=CLPUB00391).
CC   Anecdotal: Have been flown in space on Skylab-3 to study growth in microgravity (PubMed=352912).
CC   Discontinued: ATCC; CRL-7728; true.
CC   Discontinued: JCRB; JCRB9017; true.
CC   Discontinued: KCLB; 10075; probable.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): AddexBio=T0016037/5007; ATCC=CCL-75; CCRID; ECACC=90020107; JCRB=IFO50075; JCRB=JCRB9017; RCB=RCB0702; RCB=RCB0704; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13,15
ST   D12S391: 21,23
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 13,16.2
ST   D1S1656: 11,18.3
ST   D21S11: 30,30.2
ST   D22S1045: 11,17
ST   D2S1338: 19,25
ST   D2S441: 11
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 13,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 46
//
ID   WI-38 (HSV-2)Tr
AC   CVCL_YU09
SY   WI-38(HSV-2)Tr
DR   CLO; CLO_0009595
DR   CLDB; cl4709
DR   Wikidata; Q98134921
RX   CelloPub=CLPUB00555;
CC   Population: Caucasian; Swedish.
CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HHV-2).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
//
ID   WI-38 CT-1
AC   CVCL_L281
SY   CT-1
DR   Wikidata; Q54994029
RX   PubMed=7418975;
CC   Population: Caucasian; Swedish.
CC   Doubling time: ~24 hours (PubMed=7418975).
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   WI-38 Tr
AC   CVCL_5605
SY   WI-38Tr; WI-38 KTr
DR   CLO; CLO_0009596
DR   CLDB; cl4710
DR   Wikidata; Q54994030
RX   CelloPub=CLPUB00555;
CC   Population: Caucasian; Swedish.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   WI-38 VA13 subline 2RA
AC   CVCL_2759
SY   WI 38 VA13 subline 2RA; WI 38 VA-13 subline 2RA; WI 38VA13 subline 2RA; WI-38 VA13 sub 2 RA; WI38-VA13 subline 2RA; WI38 VA13/2RA; WI38VA13/2RA; VA13 2RA; WI-38 VA13; WI 38 VA 13; WI38-VA13; WI38/VA13; WI38VA13; VA-13; VA13; VA13A; AG07217; AG7217
DR   BTO; BTO_0003066
DR   CLO; CLO_0009597
DR   CLO; CLO_0009598
DR   CLO; CLO_0009599
DR   CLO; CLO_0035575
DR   CLO; CLO_0050044
DR   CLDB; cl4711
DR   CLDB; cl4712
DR   CLDB; cl4713
DR   CLDB; cl4714
DR   ATCC; CCL-75.1
DR   BCRC; 60504
DR   BioSample; SAMN03471286
DR   cancercelllines; CVCL_2759
DR   CCRID; 1101HUM-PUMC000390
DR   CCRID; 4201HUM-CCTCC00122
DR   CCTCC; GDC0122
DR   ChEMBL-Cells; CHEMBL3308010
DR   ChEMBL-Targets; CHEMBL612807
DR   CLS; 300421
DR   Coriell; AG07217
DR   ECACC; 85062512
DR   GEO; GSM784286
DR   GEO; GSM3048734
DR   GEO; GSM3048735
DR   GEO; GSM3048736
DR   GEO; GSM3048737
DR   IZSLER; BS CL 91
DR   JCRB; JCRB9057
DR   KCLB; 10075.1
DR   Progenetix; CVCL_2759
DR   PubChem_Cell_line; CVCL_2759
DR   RCB; RCB0251
DR   TOKU-E; 3451
DR   Wikidata; Q54994032
RX   CelloPub=CLPUB00597;
RX   DOI=10.2307/1308677;
RX   PubMed=656543;
RX   PubMed=699332;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=3002148;
RX   PubMed=3016668;
RX   PubMed=3413074;
RX   PubMed=4290661;
RX   PubMed=6256643;
RX   PubMed=6538202;
RX   PubMed=7065527;
RX   PubMed=9175740;
RX   PubMed=24116068;
CC   Population: Caucasian; Swedish.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): ATCC=CCL-75.1; CCRID; CLS=300421; JCRB=JCRB9057; KCLB=10075.1; PubMed=24116068; RCB=RCB0251
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D19S433: 13,16.2
ST   D21S11: 30,30.2
ST   D2S1338: 19,25
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 13,14
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 39
//
ID   WI-38-30
AC   CVCL_2812
SY   WI 38-30; WI-38 PDL 30
DR   JCRB; JCRB0517
DR   Wikidata; Q54994033
CC   Population: Caucasian; Swedish.
CC   Discontinued: JCRB; JCRB0517; true.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   WI-38-40
AC   CVCL_2813
SY   WI 38-40; WI-38 PDL 40
DR   JCRB; JCRB0518
DR   Wikidata; Q54994035
CC   Population: Caucasian; Swedish.
CC   Doubling time: ~2 days (Note=Lot 04102007), 36-42 hours (Note=Lot 11022015) (JCRB=JCRB0518).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
ST   Source(s): JCRB=JCRB0518
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 16,18
ST   D21S11: 30,30.2
ST   D3S1358: 16,17
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 13
ST   Penta E: 13,14
ST   TH01: 8,9.3
ST   TPOX: 8
ST   vWA: 19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   WI-38/hTERT/GFP-RAF-ER
AC   CVCL_N806
DR   ENCODE; ENCBS070MZP
DR   ENCODE; ENCBS157XHV
DR   ENCODE; ENCBS601ENJ
DR   ENCODE; ENCBS606ENC
DR   ENCODE; ENCBS607ENC
DR   ENCODE; ENCBS608ENC
DR   ENCODE; ENCBS715PYA
DR   ENCODE; ENCBS787LHJ
DR   GEO; GSM651580
DR   GEO; GSM651581
DR   GEO; GSM651582
DR   GEO; GSM651583
DR   GEO; GSM945215
DR   GEO; GSM945223
DR   GEO; GSM945245
DR   GEO; GSM945265
DR   Wikidata; Q54994036
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/human/WI38_Stam_protocol.pdf
CC   Part of: ENCODE project common cell types; tier 3.
CC   Population: Caucasian; Swedish.
CC   Characteristics: Transduced with a construct that is composed of EGFP at the N-terminus, the catalytic domain of RAF1 (with p.Tyr340Asp and p.Tyr341Asp) in the middle and the hormone-binding domain of ESR1 at the C-terminus. Protein kinase activity is activated by estrogen or analogs such as 4-hydroxy-tamoxifen.
CC   Senescence: Cells can be senesced after exposure for 72 hours with 4-hydroxy-tamoxifen.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:3467; ESR1 (Note=Hormone-binding domain).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9829; RAF1 (Note=Catalytic domain with p.Tyr340Asp and p.Tyr341Asp).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Telomerase immortalized cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 19
//
ID   WI-L2-729HF2
AC   CVCL_6741
SY   WI-L2-729-HF2; WI-L2-729 HF2; 729-HF2; UC729-HF2; UC729HF2; HF2
DR   CLO; CLO_0009603
DR   ATCC; CRL-8062
DR   Wikidata; Q54994037
RX   DOI=10.1038/nbt1185-971;
RX   Patent=US4594325;
RX   PubMed=3101287;
RX   PubMed=3365703;
RX   PubMed=6350451;
RX   PubMed=6699402;
WW   Info; -; -; https://digitalcommons.law.uw.edu/wlr/vol61/iss4/12
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8062.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Anecdotal: Because this cell line was deposited at ATCC on April 2, 1981 and the patent describing it was filled one week earlier (March, 26), the patent was first rejected. This decision was later reversed in a ruling that changed the deposition rules (DOI=10.1038/nbt1185-971).
CC   Misspelling: W1-L2-729-HF2; PubMed=3101287.
CC   Discontinued: ATCC; CRL-8062; true.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
ST   Source(s): ATCC=CRL-8062
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 20
//
ID   WI-MN-1
AC   CVCL_F811
DR   CLO; CLO_0009607
DR   ATCC; HB-8672
DR   Wikidata; Q54994038
RX   Patent=US5654408;
RX   PubMed=6196109;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8672.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human melanoma cell surface antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   WI38-E6-E7
AC   CVCL_F0KC
RX   PubMed=24413054;
CC   Population: Caucasian; Swedish.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WI38-hTERT
AC   CVCL_F0KD
RX   PubMed=24413054;
CC   Population: Caucasian; Swedish.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Telomerase immortalized cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WI38-hTERT-E6-E7
AC   CVCL_F0KE
RX   PubMed=24413054;
CC   Population: Caucasian; Swedish.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03126; Human papillomavirus type 16 protein E6.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03129; Human papillomavirus type 16 protein E7.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0579 ! WI-38
SX   Female
AG   16FW
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WIBR1
AC   CVCL_9765
SY   WIBR 1; WIBRe003-A
DR   BioSamples; SAMEA185109
DR   GEO; GSM523596
DR   GEO; GSM523597
DR   GEO; GSM529408
DR   GEO; GSM529411
DR   GEO; GSM529414
DR   GEO; GSM529417
DR   hPSCreg; WIBRe003-A
DR   NIHhESC; NIHhESC-10-0074
DR   SKIP; SKIP002899
DR   Wikidata; Q54994039
RX   PubMed=20471072;
RX   PubMed=28445466;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0074.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   WIBR2
AC   CVCL_9766
SY   WIBR 2; WIBRe002-A
DR   BioSamples; SAMEA2660497
DR   GEO; GSM523598
DR   GEO; GSM523599
DR   GEO; GSM529409
DR   GEO; GSM529412
DR   GEO; GSM529415
DR   GEO; GSM529418
DR   hPSCreg; WIBRe002-A
DR   NIHhESC; NIHhESC-10-0075
DR   SKIP; SKIP002898
DR   Wikidata; Q54994040
RX   PubMed=20471072;
RX   PubMed=25090446;
RX   PubMed=28445466;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0075.
CC   Registration: Swiss research registry; BAG-hES-IMP-0094.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-58.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   WIBR3
AC   CVCL_9767
SY   WIBR 3; WIBR38; WIBRe001-A
DR   BioSample; SAMN00010935
DR   GEO; GSM523600
DR   GEO; GSM523601
DR   GEO; GSM529410
DR   GEO; GSM529413
DR   GEO; GSM529416
DR   GEO; GSM529419
DR   GEO; GSM1272761
DR   GEO; GSM1272762
DR   GEO; GSM1272763
DR   GEO; GSM1272764
DR   GEO; GSM1272765
DR   GEO; GSM1272766
DR   GEO; GSM1272767
DR   GEO; GSM1272768
DR   GEO; GSM1272769
DR   GEO; GSM1272770
DR   GEO; GSM1272771
DR   GEO; GSM1272772
DR   GEO; GSM1564930
DR   GEO; GSM1564931
DR   GEO; GSM1564932
DR   hPSCreg; WIBRe001-A
DR   NIHhESC; NIHhESC-10-0079
DR   SKIP; SKIP002896
DR   Wikidata; Q54994042
RX   PubMed=20471072;
RX   PubMed=24172903;
RX   PubMed=24936472;
RX   PubMed=25090446;
RX   PubMed=28445466;
RX   PubMed=38405931;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0079.
CC   Registration: Swiss research registry; BAG-hES-IMP-0051.
CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC11-58.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His193Arg (c.578A>G); ClinVar=VCV000184979; Zygosity=Unspecified; Note=Somatic mutation acquired during proliferation (PubMed=28445466).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 23
//
ID   WIBR3_ATP13A2_FS_Homo_6_2
AC   CVCL_F0Y3
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.Thr368Argfs*29 (c.1102_1103insGA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Busquets Figueras, Oriol.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203534; Parkinson disease 9
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   WIBR3_DJ1_X1-5DEL_2073
AC   CVCL_C7UU
DR   Wikidata; Q123033869
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line not distributed because it failed quality controls (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBR3_FBXO7_FS_B6-1
AC   CVCL_C7VA
DR   Wikidata; Q123033870
CC   Sequence variation: Mutation; HGNC; HGNC:13586; FBXO7; Simple_edited; p.Arg498Glufs (c.1491delC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line not distributed because it failed quality controls (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBR3_FBXO7_R498X_G7-1
AC   CVCL_C7VC
DR   Wikidata; Q123033871
CC   Sequence variation: Mutation; HGNC; HGNC:13586; FBXO7; Simple_edited; p.Arg498Ter (c.1492C>T); ClinVar=VCV000004809; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line not distributed because it failed quality controls (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBR3_GBA1_IVS2_D6B
AC   CVCL_C7VE
DR   Wikidata; Q123033872
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Homozygous; Note=By CRISPR/Cas9. Splice donor mutation that causes skipping of exon 2 (Direct_author_submission).
CC   Miscellaneous: Cell line not distributed because it failed quality controls (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBR3_LRRK2_G2019S_315_Homo
AC   CVCL_C7VK
DR   Wikidata; Q123033873
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line not distributed because it failed quality controls (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   WIBR3_PLA2G6_D331Y_A4_C2
AC   CVCL_E2W4
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple_edited; p.Asp331Tyr (c.991G>T); ClinVar=VCV000030371; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WIBR3_PLA2G6_D331Y_A9_A4
AC   CVCL_E2W5
CC   Sequence variation: Mutation; HGNC; HGNC:9039; PLA2G6; Simple_edited; p.Asp331Tyr (c.991G>T); ClinVar=VCV000030371; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C201519; Parkinson disease 14, autosomal recessive
DI   ORDO; Orphanet_199351; Adult-onset dystonia-parkinsonism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WIBR4
AC   CVCL_9768
SY   WIBR 4
DR   NIHhESC; NIHhESC-10-0080
DR   Wikidata; Q54994046
RX   PubMed=20471072;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0080.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 14
//
ID   WIBR5
AC   CVCL_9769
SY   WIBR 5
DR   NIHhESC; NIHhESC-10-0081
DR   Wikidata; Q54994047
RX   PubMed=20471072;
RX   PubMed=28445466;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0081.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   WIBR6
AC   CVCL_9770
SY   WIBR 6
DR   NIHhESC; NIHhESC-10-0082
DR   Wikidata; Q54994048
RX   PubMed=20471072;
RX   PubMed=28445466;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0082.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   WIBRe001-A-1
AC   CVCL_IU04
SY   WIBR3 Oct4-deltaPE-GFP; WIBR3 dPE Oct4-GFP
DR   BioSamples; SAMEA103887532
DR   hPSCreg; WIBRe001-A-1
DR   SKIP; SKIP002900
DR   Wikidata; Q54994044
RX   PubMed=25090446;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0053.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   WIBRe001-A-10
AC   CVCL_C7V9
SY   WIBR3_FBXO7_FS_A3-1; CALe002-A-10
DR   BioSamples; SAMEA114332350
DR   hPSCreg; WIBRe001-A-10
DR   Wikidata; Q123033877
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:13586; FBXO7; Simple_edited; p.Arg498Glufs (c.1491delC); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-11
AC   CVCL_C7VL
SY   WIBR3_PINK1_Q129X_C4-1; CALe002-A-11
DR   BioSamples; SAMEA114332351
DR   hPSCreg; WIBRe001-A-11
DR   Wikidata; Q123033878
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Gln129Ter (c.385C>T); ClinVar=VCV002627454; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-12
AC   CVCL_C7VM
SY   WIBR3_PINK1_Q129X_E2-2; CALe002-A-12
DR   BioSamples; SAMEA114332364
DR   hPSCreg; WIBRe001-A-12
DR   Wikidata; Q123033879
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Gln129Ter (c.385C>T); ClinVar=VCV002627454; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-13
AC   CVCL_C7VN
SY   WIBR3_PINK1_Q129X_E7-1; CALe002-A-13
DR   BioSamples; SAMEA114332365
DR   hPSCreg; WIBRe001-A-13
DR   Wikidata; Q123033880
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:14581; PINK1; Simple_edited; p.Gln129Ter (c.385C>T); ClinVar=VCV002627454; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C184990; Parkinson disease 6, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-14
AC   CVCL_C7UY
SY   WIBR3_DNAJC6_c.801-2A>G+FS/c.801-2A>G+FS_A12-2; CALe002-A-14
DR   BioSamples; SAMEA114332374
DR   hPSCreg; WIBRe001-A-14
DR   Wikidata; Q123033881
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; c.801-2A>G (IVS6AS,A-G,-2); ClinVar=VCV000088854; Zygosity=Homozygous; Note=By CRISPR/Cas9. Splice acceptor mutation (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; c.823_824insC; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line not distributed because it failed quality controls (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198608; Parkinson disease 19A, juvenile-onset
DI   NCIt; C198609; Parkinson disease 19B, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-15
AC   CVCL_C7UZ
SY   WIBR3_DNAJC6_c.801-2A>G+FS/FS_G12-2; WIBR3_DNAJC6_c.801-2A>G+FS/c.801-2A>G_G12-2; CALe002-A-15
DR   BioSamples; SAMEA114410564
DR   hPSCreg; WIBRe001-A-15
DR   Wikidata; Q123033882
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; c.801-2A>G (IVS6AS,A-G,-2); ClinVar=VCV000088854; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice acceptor mutation (PubMed=38405931).
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; p.Met272Serfs (c.815_836del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; c.823_826del; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198608; Parkinson disease 19A, juvenile-onset
DI   NCIt; C198609; Parkinson disease 19B, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-16
AC   CVCL_C7V0
SY   WIBR3_DNAJC6_FS/FS_H10-1; CALe002-A-16
DR   BioSamples; SAMEA114410563
DR   hPSCreg; WIBRe001-A-16
DR   Wikidata; Q123033884
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; p.Met272Tyrfs (c.813_822del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Sequence variation: Mutation; HGNC; HGNC:15469; DNAJC6; Simple_edited; p.Leu275Argfs (c.824_828del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198608; Parkinson disease 19A, juvenile-onset
DI   NCIt; C198609; Parkinson disease 19B, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-17
AC   CVCL_C7VF
SY   WIBR3_GBA1_IVS2_G2E; CALe002-A-17
DR   BioSamples; SAMEA114410562
DR   hPSCreg; WIBRe001-A-17
DR   Wikidata; Q123033885
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Homozygous; Note=By CRISPR/Cas9. Splice donor mutation that causes skipping of exon 2 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-18
AC   CVCL_C7VD
SY   WIBR3_GBA1_IVS2_E10B; CALe002-A-18
DR   hPSCreg; WIBRe001-A-18
DR   Wikidata; Q123033886
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Homozygous; Note=By CRISPR/Cas9. Splice donor mutation that causes skipping of exon 2 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-19
AC   CVCL_C7VW
SY   WIBR3_SNCA_A53T_1; AECMe002-A-19
DR   BioSamples; SAMEA114404505
DR   hPSCreg; WIBRe001-A-19
DR   Wikidata; Q123033887
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-2
AC   CVCL_IU05
SY   WIBR3 Oct4-2A-GFP
DR   BioSamples; SAMEA103887531
DR   hPSCreg; WIBRe001-A-2
DR   SKIP; SKIP002901
DR   Wikidata; Q54994043
RX   PubMed=25090446;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: Swiss research registry; BAG-hES-IMP-0052.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-09-24; Version: 9
//
ID   WIBRe001-A-20
AC   CVCL_C7VX
SY   WIBR3_SNCA_A53T_2; AECMe002-A-20
DR   BioSamples; SAMEA114404504
DR   hPSCreg; WIBRe001-A-20
DR   Wikidata; Q123033888
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-21
AC   CVCL_C7VY
SY   WIBR3_SNCA_A53T_4; AECMe002-A-21
DR   BioSamples; SAMEA114404503
DR   hPSCreg; WIBRe001-A-21
DR   Wikidata; Q123033889
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala53Thr (c.157G>A); ClinVar=VCV000014007; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-22
AC   CVCL_C7VG
SY   WIBR3_LRRK2_G2019S_5_Het; AECMe002-A-22
DR   BioSamples; SAMEA114404502
DR   hPSCreg; WIBRe001-A-22
DR   Wikidata; Q123033890
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-23
AC   CVCL_C7VH
SY   WIBR3_LRRK2_G2019S_6_Het; AECMe002-A-23
DR   BioSamples; SAMEA114404501
DR   hPSCreg; WIBRe001-A-23
DR   Wikidata; Q123033891
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-24
AC   CVCL_C7VI
SY   WIBR3_LRRK2_G2019S_216_Het; AECMe002-A-24
DR   BioSamples; SAMEA114404500
DR   hPSCreg; WIBRe001-A-24
DR   Wikidata; Q123033892
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By TALEN (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-25
AC   CVCL_C7VJ
SY   WIBR3_LRRK2_G2019S_65_Homo; AECMe002-A-25
DR   BioSamples; SAMEA114404499
DR   hPSCreg; WIBRe001-A-25
DR   Wikidata; Q123033893
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Homozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-26
AC   CVCL_C7UV
SY   WIBR3_DJ1_X1-5DEL_2860; AECMe002-A-26
DR   BioSamples; SAMEA114404245
DR   hPSCreg; WIBRe001-A-26
DR   Wikidata; Q123033894
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-27
AC   CVCL_C7UW
SY   WIBR3_DJ1_X1-5DEL_2872; AECMe002-A-27
DR   BioSamples; SAMEA114404246
DR   hPSCreg; WIBRe001-A-27
DR   Wikidata; Q123033895
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-28
AC   CVCL_C7UX
SY   WIBR3_DJ1_X1-5DEL_2876; AECMe002-A-28
DR   BioSamples; SAMEA114334954
DR   hPSCreg; WIBRe001-A-28
DR   Wikidata; Q123033896
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIBRe001-A-29
AC   CVCL_C8BD
SY   WIBR3-S1
DR   BioSamples; SAMEA114409962
DR   hPSCreg; WIBRe001-A-29
DR   Wikidata; Q123033897
RX   PubMed=38405931;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Characteristics: Subclone of WIBR3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-30
AC   CVCL_C8BE
SY   WIBR3-S2
DR   BioSamples; SAMEA114409963
DR   hPSCreg; WIBRe001-A-30
DR   Wikidata; Q123033898
RX   PubMed=38405931;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Characteristics: Subclone of WIBR3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-31
AC   CVCL_C8BF
SY   WIBR3-S3
DR   BioSamples; SAMEA114409964
DR   hPSCreg; WIBRe001-A-31
DR   Wikidata; Q123033900
RX   PubMed=38405931;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Characteristics: Subclone of WIBR3.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-32
AC   CVCL_C7V1
SY   WIBR3_EWT_S1; AECMe002-A-32
DR   BioSamples; SAMEA114403789
DR   hPSCreg; WIBRe001-A-32
DR   Wikidata; Q123033901
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-33
AC   CVCL_C7V2
SY   WIBR3_EWT_S2; AECMe002-A-33
DR   BioSamples; SAMEA114403788
DR   hPSCreg; WIBRe001-A-33
DR   Wikidata; Q123033903
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-34
AC   CVCL_C7V3
SY   WIBR3_EWT_S3; AECMe002-A-34
DR   BioSamples; SAMEA114403787
DR   hPSCreg; WIBRe001-A-34
DR   Wikidata; Q123033904
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-35
AC   CVCL_C7V4
SY   WIBR3_EWT_S4; AECMe002-A-35
DR   hPSCreg; WIBRe001-A-35
DR   Wikidata; Q123033905
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-36
AC   CVCL_C7V5
SY   WIBR3_EWT_S5; AECMe002-A-36
DR   BioSamples; SAMEA114403786
DR   hPSCreg; WIBRe001-A-36
DR   Wikidata; Q123033906
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-37
AC   CVCL_C7V6
SY   WIBR3_EWT_S6; AECMe002-A-37
DR   BioSamples; SAMEA114403785
DR   hPSCreg; WIBRe001-A-37
DR   Wikidata; Q123033907
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-38
AC   CVCL_C7V7
SY   WIBR3_EWT_S7; AECMe002-A-38
DR   BioSamples; SAMEA114403784
DR   hPSCreg; WIBRe001-A-38
DR   Wikidata; Q123033908
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-39
AC   CVCL_C7V8
SY   WIBR3_EWT_S8; AECMe002-A-39
DR   BioSamples; SAMEA114403699
DR   hPSCreg; WIBRe001-A-39
DR   Wikidata; Q123033909
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Characteristics: Control cell line for the various Parkinson-causing mutation edited WIBR3 derived cell lines. This cell has been generated to evaluate the potential side effects of being exposed to editing stressors and chemical reagents, removing confounding variables from observed effects in edited cell lines.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-09-24; Version: 5
//
ID   WIBRe001-A-4
AC   CVCL_C7VP
SY   WIBR3_PRKN_X3DEL_B1-3; CALe002-A-4
DR   BioSamples; SAMEA114295604
DR   hPSCreg; WIBRe001-A-4
DR   Wikidata; Q123033910
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit_edited; Ex3del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-40
AC   CVCL_D3YC
SY   WIBR3_LRRK2_G2019S_2093_Het; AECMe002-A-40
DR   BioSamples; SAMEA115332520
DR   hPSCreg; WIBRe001-A-40
DR   Wikidata; Q127384701
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:18618; LRRK2; Simple_edited; p.Gly2019Ser (c.6055G>A); ClinVar=VCV000001940; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198605; Parkinson disease 8, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-41
AC   CVCL_C7VV
SY   WIBR3_SNCA_A30P_Homo_C8-2; WIBR3_SNCA_A30P_C8-2; AECMe002-A-41
DR   BioSamples; SAMEA115873258
DR   hPSCreg; WIBRe001-A-41
DR   Wikidata; Q123033875
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Homozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   WIBRe001-A-42
AC   CVCL_C7VU
SY   WIBR3_SNCA_A30P_F12-1; WIBR3_SNCA A30P_F12-1; AECMe002-A-42
DR   BioSamples; SAMEA115873259
DR   hPSCreg; WIBRe001-A-42
DR   Wikidata; Q123033876
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 5
//
ID   WIBRe001-A-43
AC   CVCL_D3YP
SY   WIBR3_GBA1_IVS2_Het_10C2F; AECMe002-A-43
DR   BioSamples; SAMEA115873267
DR   hPSCreg; WIBRe001-A-43
DR   Wikidata; Q127384695
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Ser38Ilefs*9 (c.110_111insC); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   WIBRe001-A-44
AC   CVCL_D3YQ
SY   WIBR3_GBA1_IVS2_Het_10D11A; AECMe002-A-44
DR   BioSamples; SAMEA115873268
DR   hPSCreg; WIBRe001-A-44
DR   Wikidata; Q127384696
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Leu31Argfs*8 (c.90_112del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   WIBRe001-A-45
AC   CVCL_D3YN
SY   WIBR3_GBA1_IVS2_Het_3C4B; AECMe002-A-45
DR   BioSamples; SAMEA115873269
DR   hPSCreg; WIBRe001-A-45
DR   Wikidata; Q127384700
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice donor mutation that causes skipping of exon 2 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   WIBRe001-A-46
AC   CVCL_D3YM
SY   WIBR3_GBA1_IVS2_Het_3C3I; AECMe002-A-46
DR   BioSamples; SAMEA115873270
DR   hPSCreg; WIBRe001-A-46
DR   Wikidata; Q127384698
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:4177; GBA1; Simple_edited; p.Gly39Aspfs*3 (c.115+1G>A) (IVS2+1G>A) (IVS2DS,G-A,+1); ClinVar=VCV000093445; Zygosity=Heterozygous; Note=By CRISPR/Cas9. Splice donor mutation that causes skipping of exon 2 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C26845; Parkinson disease
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   WIBRe001-A-47
AC   CVCL_D3YE
SY   WIBR3_SYNJ1_R258Q/FS_E4-1; AECMe002-A-47
DR   BioSamples; SAMEA115873271
DR   hPSCreg; WIBRe001-A-47
DR   Wikidata; Q127384704
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11503; SYNJ1; Simple_edited; p.Val218Cysfs*6 (c.651_652insT) (p.Val257Cysfs*6, c.768_769insT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Sequence variation: Mutation; HGNC; HGNC:11503; SYNJ1; Simple_edited; p.Arg219Gln (c.656G>A) (p.Arg258Gln, c.773G>A); ClinVar=VCV000088844; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203535; Parkinson disease 20, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 5
//
ID   WIBRe001-A-48
AC   CVCL_D3YD
SY   WIBR3_SYNJ1_R258Q_Homo_A5-1; AECMe002-A-48
DR   BioSamples; SAMEA115873272
DR   hPSCreg; WIBRe001-A-48
DR   Wikidata; Q127384703
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:11503; SYNJ1; Simple_edited; p.Arg219Gln (c.656G>A) (p.Arg258Gln, c.773G>A); ClinVar=VCV000088844; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203535; Parkinson disease 20, early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-49
AC   CVCL_D3Y9
SY   WIBR3_ATP13A2_FS_Homo_12_6; AECMe002-A-49
DR   BioSamples; SAMEA115873273
DR   hPSCreg; WIBRe001-A-49
DR   Wikidata; Q127384692
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.His369Thrfs*27 (c.1104del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203534; Parkinson disease 9
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-5
AC   CVCL_C7VQ
SY   WIBR3_PRKN_X3DEL_F2-5; CALe002-A-5
DR   BioSamples; SAMEA114332305
DR   hPSCreg; WIBRe001-A-5
DR   Wikidata; Q123033911
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit_edited; Ex3del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-50
AC   CVCL_D3Y8
SY   WIBR3_ATP13A2_FS_Homo_12_2; AECMe002-A-50
DR   BioSamples; SAMEA115873274
DR   hPSCreg; WIBRe001-A-50
DR   Wikidata; Q127384691
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.His369Thrfs*55 (c.1104_1105insA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203534; Parkinson disease 9
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-51
AC   CVCL_D3YB
SY   WIBR3_ATP13A2_FS_Homo_6_1; AECMe002-A-51
DR   BioSamples; SAMEA115873275
DR   hPSCreg; WIBRe001-A-51
DR   Wikidata; Q127384694
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.Thr368Argfs*29 (c.1102_1103insGA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203534; Parkinson disease 9
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-52
AC   CVCL_D3Y7
SY   WIBR3_ATP13A2_FS_5_6; AECMe002-A-52
DR   BioSamples; SAMEA115873276
DR   hPSCreg; WIBRe001-A-52
DR   Wikidata; Q127384690
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.Thr368Argfs*29 (c.1102_1103insGA); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.His369Profs*54 (c.1106_1107del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203534; Parkinson disease 9
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-53
AC   CVCL_D3YA
SY   WIBR3_ATP13A2_FS_Homo_2_5; AECMe002-A-53
DR   BioSamples; SAMEA115873277
DR   hPSCreg; WIBRe001-A-53
DR   Wikidata; Q127384693
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:30213; ATP13A2; Simple_edited; p.His369Thrfs*55 (c.1104_1105insA); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203534; Parkinson disease 9
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-54
AC   CVCL_D3YL
SY   WIBR3_VPS13C_FS_Homo_E10-2; AECMe002-A-54
DR   BioSamples; SAMEA115873278
DR   hPSCreg; WIBRe001-A-54
DR   Wikidata; Q127384707
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; p.Trp393Cysfs*6 (c.1179del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-55
AC   CVCL_D3YK
SY   WIBR3_VPS13C_W395C_Homo_C11-3; AECMe002-A-55
DR   BioSamples; SAMEA115873279
DR   hPSCreg; WIBRe001-A-55
DR   Wikidata; Q127384711
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; p.Trp395Cys (c.1185G>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-56
AC   CVCL_D3YJ
SY   WIBR3_VPS13C_W395C_Homo_C6-2; AECMe002-A-56
DR   BioSamples; SAMEA115873280
DR   hPSCreg; WIBRe001-A-56
DR   Wikidata; Q127384713
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; p.Trp395Cys (c.1185G>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-57
AC   CVCL_D3YI
SY   WIBR3_VPS13C_W395C_Homo_C3-1; AECMe002-A-57
DR   BioSamples; SAMEA115873281
DR   hPSCreg; WIBRe001-A-57
DR   Wikidata; Q127384712
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; p.Trp395Cys (c.1185G>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-58
AC   CVCL_D3YH
SY   WIBR3_VPS13C_FS_Homo_H3-1; AECMe002-A-58
DR   BioSamples; SAMEA115873282
DR   hPSCreg; WIBRe001-A-58
DR   Wikidata; Q127384710
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; c.1349_1354del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-59
AC   CVCL_D3YG
SY   WIBR3_VPS13C_A444P_Het_E12-1; AECMe002-A-59
DR   BioSamples; SAMEA115873283
DR   hPSCreg; WIBRe001-A-59
DR   Wikidata; Q127384705
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; p.Ala444Pro (c.1330G>C); ClinVar=VCV002645405; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-6
AC   CVCL_C7VR
SY   WIBR3_PRKN_X3DEL_H2-2; CALe002-A-6
DR   BioSamples; SAMEA114332306
DR   hPSCreg; WIBRe001-A-6
DR   Wikidata; Q123033912
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit_edited; Ex3del; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-60
AC   CVCL_D3YF
SY   WIBR3_VPS13C_A444P_Homo_C8-2; AECMe002-A-60
DR   BioSamples; SAMEA115873284
DR   hPSCreg; WIBRe001-A-60
DR   Wikidata; Q127384706
RX   PubMed=38405931;
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:23594; VPS13C; Simple_edited; p.Ala444Pro (c.1330G>C); ClinVar=VCV002645405; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C203536; Parkinson disease 23, autosomal recessive, early onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 4
//
ID   WIBRe001-A-61
AC   CVCL_E2VZ
SY   WIBR3_DJ1_X1-5DEL_Het_2036; AECMe002-A-61
DR   BioSamples; SAMEA117548984
DR   hPSCreg; WIBRe001-A-61
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   WIBRe001-A-62
AC   CVCL_E2W0
SY   WIBR3_DJ1_X1-5DEL_Het_2038; AECMe002-A-62
DR   BioSamples; SAMEA117548985
DR   hPSCreg; WIBRe001-A-62
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   WIBRe001-A-63
AC   CVCL_E2W1
SY   WIBR3_DJ1_X1-5DEL_Het_2046; AECMe002-A-63
DR   BioSamples; SAMEA117548986
DR   hPSCreg; WIBRe001-A-63
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   WIBRe001-A-64
AC   CVCL_E2W2
SY   WIBR3_DJ1_X1-5DEL_Het_2051; AECMe002-A-64
DR   BioSamples; SAMEA117548987
DR   hPSCreg; WIBRe001-A-64
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   WIBRe001-A-65
AC   CVCL_E2W3
SY   WIBR3_DJ1_X1-5DEL_Het_2067; AECMe002-A-65
DR   BioSamples; SAMEA117548988
DR   hPSCreg; WIBRe001-A-65
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-09-24; Last updated: 10-04-25; Version: 3
//
ID   WIBRe001-A-66
AC   CVCL_E5GG
SY   WIBR3_DJ1_X1-5DEL_6235
DR   hPSCreg; WIBRe001-A-66
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WIBRe001-A-67
AC   CVCL_E5GH
SY   WIBR3_DJ1_X1-5DEL_6348
DR   hPSCreg; WIBRe001-A-67
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WIBRe001-A-68
AC   CVCL_E5GI
SY   WIBR3_DJ1_X1-5DEL_6390
DR   hPSCreg; WIBRe001-A-68
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WIBRe001-A-69
AC   CVCL_E5GJ
SY   WIBR3_DJ1_X1-5DEL_6407
DR   hPSCreg; WIBRe001-A-69
CC   From: Albert Einstein College of Medicine; New York; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:16369; PARK7; Simple_edited; c.-4245_322+1941del (Ex1-5del); Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198606; Parkinson disease 7, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   WIBRe001-A-7
AC   CVCL_C7VS
SY   WIBR3_SNCA_A30P_A2-3; CALe002-A-7
DR   BioSamples; SAMEA114332307
DR   hPSCreg; WIBRe001-A-7
DR   Wikidata; Q123033913
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-8
AC   CVCL_C7VT
SY   WIBR3_SNCA_A30P_E1-3; CALe002-A-8
DR   BioSamples; SAMEA114332308
DR   hPSCreg; WIBRe001-A-8
DR   Wikidata; Q123033914
RX   PubMed=38405931;
CC   Sequence variation: Mutation; HGNC; HGNC:11138; SNCA; Simple_edited; p.Ala30Pro (c.88G>C); ClinVar=VCV000014008; Zygosity=Heterozygous; Note=By prime editing (PubMed=38405931).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198602; Parkinson disease 1, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 6
//
ID   WIBRe001-A-9
AC   CVCL_C7VB
SY   WIBR3_FBXO7_R498X_A7-1; CALe002-A-9
DR   BioSamples; SAMEA114332349
DR   hPSCreg; WIBRe001-A-9
DR   Wikidata; Q123033915
CC   Sequence variation: Mutation; HGNC; HGNC:13586; FBXO7; Simple_edited; p.Arg498Ter (c.1492C>T); ClinVar=VCV000004809; Zygosity=Homozygous; Note=By CRISPR/Cas9 (Direct_author_submission).
CC   Miscellaneous: Cell line information from personal communication of Booth, Ezgi O.
CC   Discontinued: hPSCreg; WIBRe001-A-9; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
DI   NCIt; C198607; Parkinson disease 15, autosomal recessive early-onset
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9767 ! WIBR3
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 7
//
ID   WIC04i-127-33
AC   CVCL_EJ72
SY   iPS-R306C-WT
DR   WiCell; wic04i-127-33
DR   Wikidata; Q54994049
RX   PubMed=21074045;
RX   PubMed=21966470;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F181 ! GM11270
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   WIC05i-127-325
AC   CVCL_EJ73
SY   iPS-R306C-MT
DR   WiCell; wic05i-127-325
DR   Wikidata; Q54994051
RX   PubMed=21074045;
RX   PubMed=21966470;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Arg306Cys (c.916C>T) (p.Arg318Cys, c.952C>T); ClinVar=VCV000011824; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F181 ! GM11270
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   WIC06i-07982-2
AC   CVCL_EJ74
SY   iPS-V247X-WT
DR   WiCell; wic06i-07982-2
DR   Wikidata; Q54994052
RX   PubMed=21966470;
CC   Population: Caucasian; Austrian.
CC   Characteristics: Due to X chromosome inactivation does not express the mutated allele.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 11
//
ID   WIC07i-07982-4
AC   CVCL_EJ75
SY   iPS-V247X-MT
DR   WiCell; wic07i-07982-4
DR   Wikidata; Q54994054
RX   PubMed=21966470;
CC   Population: Caucasian; Austrian.
CC   Sequence variation: Mutation; HGNC; HGNC:6990; MECP2; Simple; p.Val247Terfs (c.739delG) (p.Met246_Val247insTer) (p.Met258_Val259insTer, c.775delG); ClinVar=VCV000143674; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75488; Rett syndrome
DI   ORDO; Orphanet_778; Rett syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V341 ! GM07982
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 19-12-24; Version: 12
//
ID   WiDr
AC   CVCL_2760
SY   WiDR; WIDR; WiDr/S; WiDr-TC; WiDrTC; LED-WiDr; Led-WiDr
DR   BTO; BTO_0001483
DR   CLO; CLO_0009600
DR   EFO; EFO_0002389
DR   CLDB; cl4715
DR   CLDB; cl4988
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-2706
DR   ATCC; CCL-218
DR   BCRC; 60157
DR   BioSample; SAMN03151797
DR   cancercelllines; CVCL_2760
DR   Cell_Model_Passport; SIDM00152
DR   ChEMBL-Cells; CHEMBL3307674
DR   ChEMBL-Targets; CHEMBL614647
DR   CLS; 300377
DR   ColonAtlas; WIDR
DR   Cosmic; 738928
DR   Cosmic; 887216
DR   Cosmic; 897740
DR   Cosmic; 905002
DR   Cosmic; 1066213
DR   Cosmic; 1122336
DR   Cosmic; 1132695
DR   Cosmic; 1184091
DR   Cosmic; 1187326
DR   Cosmic; 1218881
DR   Cosmic; 1466826
DR   Cosmic; 1479615
DR   Cosmic; 1609498
DR   Cosmic; 1676736
DR   Cosmic; 2651871
DR   Cosmic; 2664048
DR   Cosmic; 2668255
DR   Cosmic; 2760078
DR   ECACC; 85111501
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   FCS-free; 180-2-342-3-16-3
DR   GEO; GSM784020
DR   GEO; GSM827327
DR   GEO; GSM1006242
DR   GEO; GSM1006243
DR   GEO; GSM1006244
DR   GEO; GSM1374987
DR   GEO; GSM1374988
DR   GEO; GSM1448091
DR   GEO; GSM2550022
DR   IARC_TP53; 21
DR   ICLC; HTL00003
DR   IGRhCellID; WIDR
DR   JCRB; IFO50043
DR   JCRB; JCRB0224
DR   KCLB; 10218
DR   LINCS_HMS; 50049
DR   LINCS_LDP; LCL-1169
DR   MetaboLights; MTBLS227
DR   NCI-DTP; WIDR
DR   PharmacoDB; WIDR_1660_2019
DR   Progenetix; CVCL_2760
DR   PubChem_Cell_line; CVCL_2760
DR   RCB; RCB1908
DR   TKG; TKG 0513
DR   TKG; TKG 0516
DR   Wikidata; Q54994056
RX   CelloPub=CLPUB00271;
RX   PubMed=90012;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=1389533;
RX   PubMed=1657424;
RX   PubMed=3335022;
RX   PubMed=3472642;
RX   PubMed=3518877;
RX   PubMed=4203458;
RX   PubMed=7118132;
RX   PubMed=7874267;
RX   PubMed=8464898;
RX   PubMed=9290701;
RX   PubMed=9488600;
RX   PubMed=10674020;
RX   PubMed=10956384;
RX   PubMed=11414198;
RX   PubMed=16854228;
RX   PubMed=20143388;
RX   PubMed=20215515;
RX   PubMed=20570890;
RX   PubMed=23932154;
RX   PubMed=24042735;
RX   PubMed=25485619;
RX   PubMed=25926053;
RX   PubMed=25944804;
RX   PubMed=26537799;
RX   PubMed=26589293;
RX   PubMed=28683746;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/colon-cancer-xenograft/widr-xenograft-model/
CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=3472642; PubMed=20143388). Originally thought to originate from a 78 year old female patient with a primary adenocarcinoma of the rectosigmoid colon.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00103.
CC   Population: Caucasian.
CC   Doubling time: 15 hours (PubMed=90012); 18 hours (PubMed=9488600); 45.68 hours (PubMed=25944804).
CC   HLA typing: A*01:01,24:03; B*35:01,44:03; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (PubMed=10674020; PubMed=24042735; PubMed=25926053; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20570890; PubMed=24042735; PubMed=28683746).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (PubMed=24042735).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=24042735; PubMed=28683746).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: RCB; RCB1908; true.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
ST   Source(s): ATCC=CCL-218; CLS=300377; ECACC=85111501; JCRB=IFO50043; JCRB=JCRB0224; KCLB=10218; PubMed=25926053
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11 (CLS=300377; JCRB=JCRB0224)
ST   D13S317: 11,12 (ATCC=CCL-218; ECACC=85111501; JCRB=IFO50043; KCLB=10218; PubMed=25926053)
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,23
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10 (CLS=300377)
ST   D8S1179: 10,16 (ATCC=CCL-218)
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 14,16
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0320 ! HT-29
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   WiDr/R
AC   CVCL_2N03
DR   cancercelllines; CVCL_2N03
DR   Wikidata; Q54994057
RX   CelloPub=CLPUB00271;
RX   PubMed=2894893;
CC   Problematic cell line: Contaminated. Parent cell line (WiDr) had been shown to be a HT-29 derivative.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_50729; Mitoxantrone.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Glu853Ter (c.2557G>T); ClinVar=VCV001071632; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Thr1556Asnfs*3 (c.4666dupA) (c.4666_4667insA); ClinVar=VCV000428112; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Pro449Thr (c.1345C>A); ClinVar=VCV001333250; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6770; SMAD4; Simple; p.Gln311Ter (c.931C>T); ClinVar=VCV000230663; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2760 ! WiDr
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 19
//
ID   Wien 133
AC   CVCL_6958
SY   WIEN 133; Wien-133; Wien133; WIEN133; W133
DR   cancercelllines; CVCL_6958
DR   Cosmic; 2297026
DR   GEO; GSM115810
DR   Progenetix; CVCL_6958
DR   Wikidata; Q54994058
RX   PubMed=3496952;
RX   PubMed=7849311;
RX   PubMed=16960149;
CC   Virology: EBV-negative.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   Wien 135
AC   CVCL_UM18
SY   WIEN 135; Wien line 135
DR   Wikidata; Q98134923
RX   DOI=10.1007/978-1-4613-2823-0_29;
RX   PubMed=3496952;
CC   Virology: EBV-negative.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 02-05-24; Version: 6
//
ID   Wien 330
AC   CVCL_E9Y6
RX   PubMed=6932956;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9160; Childhood acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E9Y5 ! Karpas-330
SX   Male
AG   7-8Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WIF-B
AC   CVCL_A050
SY   WI-38/Fao hybrid-B
DR   BTO; BTO_0005889
DR   Wikidata; Q54994059
RX   PubMed=7506266;
RX   PubMed=8056838;
RX   PubMed=9462660;
RX   PubMed=9657109;
CC   Doubling time: 2.5 days (PubMed=8056838).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A051 ! WIF12-1
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 8
//
ID   WIF-B9
AC   CVCL_A5BJ
SY   WI-38/Fao hybrid-B9
DR   BTO; BTO_0006309
DR   Wikidata; Q107117446
RX   PubMed=9462660;
RX   PubMed=9657109;
RX   PubMed=12606785;
RX   PubMed=17276572;
CC   Doubling time: 2.6 +- 0.1 days (PubMed=17276572).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A050 ! WIF-B
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   WIF-B9/R
AC   CVCL_A5BK
SY   WI-38/Fao hybrid-B9/R
DR   BTO; BTO_0006310
DR   Wikidata; Q107117447
RX   PubMed=12606785;
RX   PubMed=17276572;
CC   Doubling time: 2.9 +- 0.3 days (PubMed=17276572).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A5BJ ! WIF-B9
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   WIF-B9/Rev
AC   CVCL_A5BL
SY   WI-38/Fao hybrid-B9/Revertant
DR   Wikidata; Q107117448
RX   PubMed=17276572;
CC   Characteristics: Established by culturing the parent cell line without cisplatin in the medium for 2 months.
CC   Doubling time: 2.7 +- 0.1 days (PubMed=17276572).
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A5BK ! WIF-B9/R
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   WIF12
AC   CVCL_A5BN
SY   WIF 12; WI-38/Fao hybrid 12
DR   Wikidata; Q107117451
RX   PubMed=1955480;
RX   PubMed=8056838;
RX   PubMed=9462660;
RX   PubMed=9657109;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_0269 ! Fao
HI   CVCL_0579 ! WI-38
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   WIF12-1
AC   CVCL_A051
SY   WIF 12-1; WI-38/Fao hybrid 12-1
DR   Wikidata; Q54994060
RX   PubMed=1955480;
RX   PubMed=8056838;
RX   PubMed=9462660;
RX   PubMed=9657109;
CC   Doubling time: 2.5 days (PubMed=8056838).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A5BN ! WIF12
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   WIF12-1 TGdelta
AC   CVCL_A5BM
SY   WIF 12-1 TGdelta; WI-38/Fao hybrid 12-1 TioGuanine delta
DR   Wikidata; Q107117452
RX   PubMed=9462660;
RX   PubMed=9657109;
CC   Karyotypic information: Has lost the human chromosome X.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A051 ! WIF12-1
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 4
//
ID   WIF12-6
AC   CVCL_A5BP
SY   WIF 12-6; WI-38/Fao hybrid 12-6
DR   Wikidata; Q107117453
RX   PubMed=9462660;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_A5BN ! WIF12
CA   Hybrid cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   WIL,M
AC   CVCL_E875
SY   WIL, M
DR   dbMHC; 49065
DR   ECACC; 94082213
DR   IHW; IHW09114
DR   IPD-IMGT/HLA; 11659
DR   Wikidata; Q54994061
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*29:02:01,02:02; B*15:03,41:01; C*02:02; DPB1*04:01,13:01; DQA1*05:01,03:01; DQB1*03:01,03:02; DRB1*04:03,11:01; DRB3*02:02; DRB4*01:01 (IPD-IMGT/HLA=11659).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WIL1
AC   CVCL_6747
SY   WIL-1; WI-L1
DR   Wikidata; Q54994062
RX   PubMed=4323138;
RX   PubMed=5673231;
CC   Population: Caucasian.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3246; Mycosis fungoides
DI   ORDO; Orphanet_2584; Classic mycosis fungoides
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   WIL2
AC   CVCL_6544
SY   WIL-2; Wil.2; WI-L2; Wi-L2
DR   BTO; BTO_0001523
DR   ChEMBL-Cells; CHEMBL3308011
DR   ChEMBL-Targets; CHEMBL612809
DR   CLS; 302011
DR   PubChem_Cell_line; CVCL_6544
DR   Wikidata; Q54994064
RX   PubMed=174085;
RX   PubMed=197600;
RX   PubMed=893394;
RX   PubMed=1260760;
RX   PubMed=4102022;
RX   PubMed=4323138;
RX   PubMed=4527800;
RX   PubMed=5087481;
RX   PubMed=5673231;
RX   PubMed=6600440;
RX   PubMed=8316623;
CC   Population: Caucasian.
CC   HLA typing: A*01:01:01,02:01:01; B*53:38:02,57:01:01; C*06:02:01,14:02:01; DPB1*13:01:01G,16:01:01; DQA1*02:01:01; DQB1*02:02:01G,03:03:02; DRB1*07:01:01 (CLS=302011).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from child cell lines TK6; WIL2 NS).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Misspelling: W1-L2; Note=Occasionally.
CC   Misspelling: WI-L; Note=Occasionally.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302011
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11,16
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   FGA: 22,24
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   WIL2 AGr9 clone 3-1
AC   CVCL_A6HT
SY   AGr9 clone 3-1; AGR9 cl 3 sc 1
DR   Wikidata; Q107117454
RX   PubMed=893394;
RX   PubMed=4527800;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WIL2 AGr9 clone 35-1
AC   CVCL_A6HQ
SY   AGr9 clone 35-1; AGR9 cl 35 sc 1; AGR 35sc1
DR   Wikidata; Q107117455
RX   PubMed=893394;
RX   PubMed=4527800;
RX   PubMed=6286839;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WIL2 H35.1.1
AC   CVCL_A6HU
SY   H35.1.1; WI-L2 AGR 35sc 1.1
DR   Wikidata; Q107117456
RX   PubMed=6286839;
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6HQ ! WIL2 AGr9 clone 35-1
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WIL2 MTI-TG
AC   CVCL_A6HS
SY   MTI-TG
DR   Wikidata; Q107117458
RX   PubMed=197600;
RX   PubMed=893394;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside).
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A6HR ! WIL2 MTIr-107
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WIL2 MTIr-107
AC   CVCL_A6HR
SY   MTIr-107; MTIr mutant 107
DR   Wikidata; Q107117459
RX   PubMed=197600;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_44081; 6-methylthioinosine (6-methylmercaptopurine riboside).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WIL2 NS
AC   CVCL_2761
SY   WIL2-NS; WIL-2NS; WIL-2-NS; WI-L2-NS; WI-L2 NS; WIL2NS; WIL2 Non-Secreting
DR   BTO; BTO_0001524
DR   CLO; CLO_0009601
DR   CLO; CLO_0009604
DR   CLDB; cl4717
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-8155
DR   BioSample; SAMN03471196
DR   BioSample; SAMN03472416
DR   cancercelllines; CVCL_2761
DR   Cell_Model_Passport; SIDM01102
DR   ChEMBL-Cells; CHEMBL3308012
DR   ChEMBL-Targets; CHEMBL612810
DR   Cosmic-CLP; 1331049
DR   DepMap; ACH-002316
DR   ECACC; 90112121
DR   EGA; EGAS00001000978
DR   FANTOM5_SSTAR; 10808-111A7
DR   GDSC; 1331049
DR   GEO; GSM827461
DR   GEO; GSM1670575
DR   GEO; GSM4288411
DR   IARC_TP53; 4041
DR   IPD-IMGT/HLA; 11561
DR   JCRB; JCRB9063
DR   PharmacoDB; WIL2NS_1661_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_2761
DR   PubChem_Cell_line; CVCL_2761
DR   RCB; RCB2285
DR   TKG; TKG 0374
DR   Wikidata; Q54994065
RX   Patent=US4806476;
RX   PubMed=1677771;
RX   PubMed=7798274;
RX   PubMed=20215515;
RX   PubMed=27397505;
RX   PubMed=29892436;
RX   PubMed=30894373;
RX   PubMed=33198927;
RX   PubMed=35839778;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8155.
CC   Population: Caucasian.
CC   Characteristics: Does not secrete immunoglobulins.
CC   HLA typing: DPA1*02:02:02 (IPD-IMGT/HLA=11561).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (PubMed=33198927).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (PubMed=7798274; PubMed=33198927).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.61%; East Asian, North=0%; East Asian, South=0%; South Asian=1.47%; European, North=69.86%; European, South=28.06% (PubMed=30894373).
CC   Discontinued: RCB; RCB2285; true.
CC   Discontinued: TKG; TKG 0374; probable.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8155; Cosmic-CLP=1331049; ECACC=90112121; JCRB=JCRB9063; RCB=RCB2285
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11,15
ST   D19S433: 14,16
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,12
ST   D8S1179: 10,13
ST   F13A01: 6,7
ST   F13B: 10
ST   FESFPS: 11,12
ST   FGA: 22,24
ST   LPL: 9,10
ST   Penta D: 11,12
ST   Penta E: 5,7
ST   TH01: 8,9.3 (ATCC=CRL-8155; Cosmic-CLP=1331049; ECACC=90112121; RCB=RCB2285)
ST   TH01: 8,10 (JCRB=JCRB9063)
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   WIL2 S
AC   CVCL_3809
SY   WIL2-S; WIL2/S; WIL2S; WIL2 Secreting
DR   BTO; BTO_0001525
DR   CLO; CLO_0009605
DR   AddexBio; C0003018/4890
DR   ATCC; CRL-8885
DR   CCRID; 1102HUM-NIFDC00032
DR   Cell_Model_Passport; SIDM01075
DR   Lonza; 966
DR   Wikidata; Q54994066
RX   Patent=US4806476;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8885.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): AddexBio=C0003018/4890; ATCC=CRL-8885
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 11
ST   D19S433: 15,16
ST   D21S11: 29
ST   D2S1338: 17,25
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 10,13
ST   F13A01: 6,7
ST   F13B: 10
ST   FESFPS: 11,12
ST   FGA: 22,24
ST   LPL: 9,10
ST   Penta D: 11,12
ST   Penta E: 5,7
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   WIL2-A3
AC   CVCL_A7TT
SY   Wil2-A3; WIL2.A3; WIL2 clone A3; WIL2 clone 3A
DR   Wikidata; Q107117460
RX   PubMed=4587229;
RX   PubMed=5087481;
RX   PubMed=7060222;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WIL2-S-Luc2
AC   CVCL_B7AE
DR   ATCC; CRL-8885-LUC2
DR   Wikidata; Q123033916
CC   Population: Caucasian.
CC   Characteristics: Stably expresses firefly luciferase under the control of the human EF1a promoter (ATCC=CRL-8885-LUC2).
CC   Doubling time: 15.5 hours (ATCC=CRL-8885-LUC2).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): ATCC=CRL-8885-LUC2
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,20
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3809 ! WIL2 S
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 7
//
ID   WIL2.NS.6TG
AC   CVCL_2762
SY   Wil2.NS.6TG
DR   CLO; CLO_0009602
DR   CLDB; cl4718
DR   ECACC; 93031001
DR   NCBI_Iran; C148
DR   Wikidata; Q54994067
CC   Group: Hybridoma fusion partner cell line.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2761 ! WIL2 NS
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   WIL2:RD1694
AC   CVCL_Y425
DR   Wikidata; Q54994069
RX   PubMed=7537518;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_5847; ICI D1694 (Tomudex; ZD1694).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6544 ! WIL2
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 07-11-14; Last updated: 10-04-25; Version: 13
//
ID   WILCL
AC   CVCL_2763
DR   CLO; CLO_0009606
DR   CLDB; cl4719
DR   ECACC; 89120565
DR   GEO; GSM827325
DR   Wikidata; Q54994079
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_E340 ! LUDLU-23
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 12
//
ID   WILF 7C11
AC   CVCL_9Q57
SY   WILF-7C11; WILF7C11
DR   Wikidata; Q54994080
RX   PubMed=2542153;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0F71 ! MB63
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   WILF 7C9
AC   CVCL_9Q58
SY   WILF7C9
DR   ATCC; CRL-2790
DR   Wikidata; Q54994081
RX   PubMed=2542153;
CC   Discontinued: ATCC; CRL-2790; true.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0F71 ! MB63
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 4
//
ID   Wilkister
AC   CVCL_ZU76
SY   NK23; NK-23; NK 23
DR   Wikidata; Q98134926
RX   PubMed=4178827;
RX   PubMed=4878906;
RX   PubMed=5021706;
RX   PubMed=11515428;
CC   Population: African; Kenyan.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 02-05-24; Version: 6
//
ID   WILL-1
AC   CVCL_1900
SY   WILL1
DR   BioSample; SAMN03473464
DR   DSMZ; ACC-651
DR   DSMZCellDive; ACC-651
DR   GEO; GSM1374989
DR   Wikidata; Q54994082
RX   PubMed=18972186;
CC   Population: Japanese.
CC   Doubling time: ~30-50 hours, 50-70 hours (Note=After recovery from liquid nitrogen freezing) (DSMZ=ACC-651).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-651
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 14,22
ST   D19S433: 13,14
ST   D21S11: 28,32.2
ST   D2S1338: 19
ST   D3S1358: 15,16
ST   D5S818: 10
ST   D7S820: 11,12
ST   D8S1179: 14
ST   FGA: 22
ST   Penta D: 9,13
ST   Penta E: 12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   WILL-2
AC   CVCL_1901
SY   WILL2
DR   BioSample; SAMN03473465
DR   DSMZ; ACC-652
DR   DSMZCellDive; ACC-652
DR   GEO; GSM1374990
DR   Wikidata; Q54994083
RX   PubMed=19330555;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Doubling time: ~36-48 hours (DSMZ=ACC-652).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-652
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 14,17
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 15,18
ST   D5S818: 9,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 19,21
ST   Penta D: 11
ST   Penta E: 5,14
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Wilms1-2l
AC   CVCL_A5SC
SY   Wilms1
DR   CLS; 300411
DR   Wikidata; Q107117461
RX   PubMed=17551084;
RX   PubMed=20106868;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Phe (c.134C>T); ClinVar=VCV000017588; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=20106868; PubMed=33379206).
CC   Donor information: Established from the left kidney of the recurrence (2nd tumor) of the patient.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 11,14
ST   D18S51: 15,18
ST   D21S11: 30,31
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 9,14
ST   D8S1179: 12,14
ST   FGA: 22,25
ST   Penta D: 13
ST   Penta E: 5,14
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5SD ! Wilms1-2r
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   Wilms1-2r
AC   CVCL_A5SD
DR   Wikidata; Q107117463
RX   PubMed=17551084;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Cys (c.134C>G); ClinVar=VCV000376242; Zygosity=Heterozygous (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Ser50Ter (c.149C>A); Zygosity=Homozygous (PubMed=33379206).
CC   Donor information: Established from the right kidney of the recurrence (2nd tumor) of the patient.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5SC ! Wilms1-2l
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   Wilms10M
AC   CVCL_A5SK
DR   CLS; 300418
DR   Wikidata; Q107117464
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 22,24
ST   Penta D: 10,13
ST   Penta E: 7,10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5SL ! Wilms10T
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   Wilms10T
AC   CVCL_A5SL
SY   Wilms10
DR   CLS; 300417
DR   GEO; GSM1831635
DR   GEO; GSM1831636
DR   Wikidata; Q107117465
RX   PubMed=27213811;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Homozygous; Note=Nested within a heterozygous 11p13 deletion (PubMed=27213811; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=27213811; PubMed=33379206).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300417; PubMed=33379206
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12 (CLS=300417)
ST   D13S317: 12,13 (PubMed=33379206)
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D21S11: 29,30
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 22,24
ST   Penta D: 10,13
ST   Penta E: 7,10
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A5SK ! Wilms10M
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   Wilms11
AC   CVCL_A5SM
DR   CLS; 300420
DR   Wikidata; Q107117466
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Homozygous; Note=Somatic (PubMed=33379206).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14,21
ST   D21S11: 29,30
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13
ST   FGA: 23,26
ST   Penta D: 11
ST   Penta E: 5,7
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y10M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   Wilms2
AC   CVCL_A5SE
DR   CLS; 300413
DR   Wikidata; Q107117468
RX   PubMed=20106868;
RX   PubMed=24619359;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Tyr (c.134C>A); ClinVar=VCV000375895; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg362Ter (c.1084C>T) (p.Arg435Ter, c.1303C>T); ClinVar=VCV000003497; Zygosity=Homozygous (PubMed=20106868; PubMed=24619359; PubMed=33379206).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300413; PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 11 (PubMed=33379206)
ST   CSF1PO: 11,12 (CLS=300413)
ST   D13S317: 9,11
ST   D16S539: 9
ST   D18S51: 12,17
ST   D21S11: 29,32.2
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 21
ST   Penta D: 10,12
ST   Penta E: 11,15
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   Wilms3
AC   CVCL_A5SF
DR   CLS; 300414
DR   Wikidata; Q107117469
RX   PubMed=20106868;
RX   PubMed=24619359;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=20106868; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Val432Serfs*87 (c.1293_1294insA); Zygosity=Homozygous; Note=Somatic (PubMed=20106868; PubMed=24619359; PubMed=33379206).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300414; PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 13,17
ST   D21S11: 29,31
ST   D3S1358: 15,16
ST   D5S818: 9
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 22,24
ST   Penta D: 9,13
ST   Penta E: 7,10
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11-12M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   Wilms4
AC   CVCL_A5SG
DR   Wikidata; Q107117471
RX   PubMed=20106868;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:12796; WT1; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.His438Profs*7 (c.1311_1312insC); Zygosity=Heterozygous (PubMed=20106868; PubMed=33379206).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 16,17
ST   D21S11: 27,31.2
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13
ST   FGA: 20
ST   Penta D: 10,12
ST   Penta E: 11,15
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3718; WAGR syndrome
DI   ORDO; Orphanet_893; WAGR syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   Wilms5
AC   CVCL_A5SH
DR   Wikidata; Q107117472
RX   PubMed=20106868;
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; None_reported; -; Zygosity=- (PubMed=20106868; PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg433Profs*84 (c.1296_1299delGC); Zygosity=Homozygous; Note=Somatic (PubMed=20106868; PubMed=33379206).
CC   Donor information: The patient has a germline WT1 p.Arg390Ter (c.1168C>T) mutation that was lost in the tumor.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 12,16
ST   D21S11: 28,29
ST   D3S1358: 15,16
ST   D5S818: 10,13
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,22
ST   Penta D: 11,13
ST   Penta E: 7,15
ST   TH01: 8
ST   TPOX: 9,10
ST   vWA: 17,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   Wilms6
AC   CVCL_A5SI
DR   CLS; 300415
DR   Wikidata; Q107117473
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45del (c.133_135delTCT); ClinVar=VCV000017576; Zygosity=Homozygous (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300415; PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 9,11
ST   D18S51: 12,16
ST   D21S11: 28,30
ST   D3S1358: 15,16
ST   D5S818: 8,9
ST   D7S820: 8,11
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 11
ST   Penta E: 8,13
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y3M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 7
//
ID   Wilms8
AC   CVCL_A5SJ
DR   CLS; 300416
DR   Wikidata; Q107117474
RX   PubMed=33379206;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45Ala (c.133T>G); ClinVar=VCV000376241; Zygosity=Heterozygous (PubMed=33379206).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg390Ter (c.1168C>T) (p.Arg463Ter, c.1387C>T); ClinVar=VCV000003494; Zygosity=Homozygous (PubMed=33379206).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300416; PubMed=33379206
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 13
ST   D18S51: 12
ST   D21S11: 29,33.2
ST   D3S1358: 16,17,18 (CLS=300416)
ST   D3S1358: 16,18 (PubMed=33379206)
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 8,13
ST   FGA: 20,21
ST   Penta D: 10,12
ST   Penta E: 12,17
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   WILTU-1
AC   CVCL_B481
SY   Wiltu-1; WIL-TU-1; WILTU1
DR   ATCC; HTB-50
DR   Wikidata; Q54994084
RX   PubMed=571047;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=6244232;
CC   Population: Caucasian.
CC   Discontinued: ATCC; HTB-50; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WIMRi001-A
AC   CVCL_D6RJ
SY   PKU_LCL_11195
DR   BioSamples; SAMEA115160099
DR   hPSCreg; WIMRi001-A
RX   PubMed=38552357;
CC   From: Westmead Institute for Medical Research; Sydney; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Ser196_Leu197insTer (p.Leu197Terfs) (c.590_612del23); ClinVar=VCV000102745; Zygosity=Heterozygous (PubMed=38552357).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.912+1G>A (IVS8+1G>A); ClinVar=VCV000092752; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38552357).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9R90 ! GM11195
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WIMRi002-A
AC   CVCL_D6RK
SY   PKU_LCL_01565
DR   BioSamples; SAMEA115160101
DR   hPSCreg; WIMRi002-A
RX   PubMed=38552357;
CC   From: Westmead Institute for Medical Research; Sydney; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2501; CTH; Simple; p.Thr67Ile (c.200C>T); ClinVar=VCV000002939; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg252Gln (c.755G>A); ClinVar=VCV000102824; Zygosity=Heterozygous (PubMed=38552357).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.1315+1G>A (IVS12+1G>A); ClinVar=VCV000000576; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=38552357).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C129070; Cystathioninuria
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_212; Cystathioninuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9R62 ! GM01565
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WIMRi003-A
AC   CVCL_D6RL
SY   PKU_FIB_00937; GM00937 C12
DR   BioSamples; SAMEA115160137
DR   hPSCreg; WIMRi003-A
RX   PubMed=38555716;
CC   From: Westmead Institute for Medical Research; Sydney; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Phe39Leu (c.117C>G); ClinVar=VCV000000605; Zygosity=Heterozygous (PubMed=38555716).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; c.1066-11G>A (IVS10-11G>A); ClinVar=VCV000000607; Zygosity=Heterozygous (PubMed=38555716).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W147 ! GM00937
SX   Male
AG   1Y7M
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WIMRi004-A
AC   CVCL_D6RM
SY   PKU_FIB_02406; GM02406 C15
DR   BioSamples; SAMEA115160192
DR   hPSCreg; WIMRi004-A
RX   PubMed=38555716;
CC   From: Westmead Institute for Medical Research; Sydney; Australia.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Phe299Cys (c.896T>G); ClinVar=VCV000000613; Zygosity=Heterozygous (PubMed=38555716).
CC   Sequence variation: Mutation; HGNC; HGNC:8582; PAH; Simple; p.Arg408Trp (c.1222C>T); ClinVar=VCV000000577; Zygosity=Heterozygous (PubMed=38555716).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C81315; Phenylketonuria
DI   ORDO; Orphanet_716; Phenylketonuria
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_W148 ! GM02406
SX   Male
AG   2M
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WIN
AC   CVCL_E876
DR   dbMHC; 49066
DR   ECACC; 94092814
DR   IHW; IHW09095
DR   IPD-IMGT/HLA; 11565
DR   Wikidata; Q54994085
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; German.
CC   HLA typing: A*01:01:01:01; B*57:01:01; C*06:02:01:01; DPA1*01:03,02:01:02; DPB1*04:01:01,13:01:01/107:01; DQA1*02:01; DQB1*02:02:01,03:03:02; DRA*01:01; DRB1*07:01:01; DRB4*01:01 (IPD-IMGT/HLA=11565).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   Win Mec
AC   CVCL_3277
DR   CLO; CLO_0009608
DR   ATCC; CRL-1172
DR   Wikidata; Q54994086
RX   PubMed=225015;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   WIN-1
AC   CVCL_Y311
SY   WIN1; Whitehead Institute Naive-1; WIBRe004-A
DR   BioSamples; SAMEA103887533
DR   hPSCreg; WIBRe004-A
DR   NIHhESC; NIHhESC-14-0299
DR   Wikidata; Q54994087
RX   PubMed=25090446;
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0299.
CC   Registration: Swiss research registry; BAG-hES-IMP-0050.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   WIN-2
AC   CVCL_Y312
SY   WIN2; Whitehead Institute Naive-2
DR   NIHhESC; NIHhESC-14-0300
DR   Wikidata; Q54994088
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0300.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   WIN-3
AC   CVCL_Y313
SY   WIN3; Whitehead Institute Naive-3
DR   NIHhESC; NIHhESC-14-0301
DR   Wikidata; Q54994089
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0301.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   WIN-4
AC   CVCL_Y314
SY   WIN4; Whitehead Institute Naive-4
DR   NIHhESC; NIHhESC-14-0302
DR   Wikidata; Q54994090
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0302.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   WIN-5
AC   CVCL_Y315
SY   WIN5; Whitehead Institute Naive-5
DR   NIHhESC; NIHhESC-14-0303
DR   Wikidata; Q54994091
CC   From: Whitehead Institute for Biomedical Research; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-14-0303.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 07-11-14; Last updated: 29-06-23; Version: 10
//
ID   WIRL-3B
AC   CVCL_C7X3
SY   WIstar Rat Liver-3B
DR   Wikidata; Q123033917
RX   PubMed=3431441;
RX   PubMed=4147851;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_C7X4 ! WIRL-3C
SX   Male
AG   4W
CA   Finite cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   WIRL-3B/SV
AC   CVCL_C7X5
SY   WIstar Rat Liver-3B/SV40
DR   Wikidata; Q123033919
RX   PubMed=206565;
RX   PubMed=4147851;
CC   Doubling time: 12-14.5 hours (Note=At 29th passage) (PubMed=4147851).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7X3 ! WIRL-3B
SX   Male
AG   4W
CA   Transformed cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   WIRL-3BS
AC   CVCL_C7X6
SY   WIstar Rat Liver-3B Suspension
DR   Wikidata; Q123033920
RX   PubMed=206565;
RX   PubMed=4147851;
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_C7X3 ! WIRL-3B
SX   Male
AG   4W
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 4
//
ID   WIRL-3C
AC   CVCL_C7X4
SY   WIstar Rat Liver-3C
DR   Wikidata; Q123033922
RX   PubMed=206565;
RX   PubMed=3431441;
RX   PubMed=4147851;
RX   PubMed=6939365;
RX   PubMed=7440648;
CC   Senescence: After passage 55, the cells either die or form a continuous cell line which morphologically is more transformed and proliferates rapidly (PubMed=206565).
CC   Doubling time: 19-22 hours (PubMed=4147851); 12 hours (PubMed=7440648).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_C7X3 ! WIRL-3B
SX   Male
AG   4W
CA   Spontaneously immortalized cell line
DT   Created: 29-06-23; Last updated: 10-04-25; Version: 5
//
ID   WIS2-NANOS3-mCherry
AC   CVCL_A4QX
DR   SKIP; SKIP001197
DR   Wikidata; Q105511748
RX   PubMed=25543152;
CC   From: Weizmann Institute of Science; Rehovot; Israel.
CC   Population: Jewish.
CC   Characteristics: Using TALEN a P2A-mCherry construct was integrated at the C-terminus of NANOS3 (PubMed=25543152).
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD15 ! WISe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-01-21; Last updated: 10-09-24; Version: 5
//
ID   WISC011i-inGFPpuro
AC   CVCL_VS02
SY   DF19-9-7TinGFPpuro; WAi001-A-1; WISCi011-A-1
DR   hPSCreg; WAi001-A-1
DR   WiCell; wisc011i-ingfppuro
DR   Wikidata; Q98134928
RX   PubMed=26670276;
CC   From: University of Wisconsin; Madison; USA.
CC   Characteristics: The expression of the Clover GFP gene is under the control of the human EF1a promoter.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_K055 ! iPS-DF19-9-7T
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 14
//
ID   WISC012i-SCA
AC   CVCL_VS03
DR   WiCell; wisc012i-sca
DR   Wikidata; Q98134930
CC   From: University of Wisconsin; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4827; HBB; Simple; p.Glu7Val (c.20A>T) (E6V); ClinVar=VCV000015333; Zygosity=Unspecified (WiCell=wisc012i-sca).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34383; Sickle cell disease
DI   ORDO; Orphanet_232; Sickle cell anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_HL77 ! GM20920
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   WISC013i-SCID
AC   CVCL_VS04
DR   WiCell; wisc013i-scid
DR   Wikidata; Q98134933
CC   From: University of Wisconsin; Madison; USA.
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; c.33+1G>C (IVS1DS,G-C,+1); ClinVar=VCV000001976; Zygosity=Heterozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:186; ADA; Simple; p.Arg101Gln (c.302G>A); ClinVar=VCV000001956; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3962; Adenosine deaminase deficiency
DI   ORDO; Orphanet_277; Severe combined immunodeficiency due to adenosine deaminase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_GS54 ! GM01715
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 10
//
ID   WISC014i-SC1
AC   CVCL_VS05
SY   GFP-CCR5mut-hiPSC-Comb2-SC1
DR   Wikidata; Q98134936
RX   PubMed=26670276;
CC   From: University of Wisconsin; Madison; USA.
CC   Characteristics: The expression of the Clover GFP gene is under the control of the human EF1a promoter.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1606; CCR5.
CC   Genetic integration: Method=Transfection; Gene=FPbase; 4Z641; Clover (Note=Basic green/yellow fluorescent protein derived from GFP).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VS02 ! WISC011i-inGFPpuro
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   WISCi004-A-1
AC   CVCL_JW67
SY   YZ1 DISC1 wt 1.4; YZ1 WT 1.4; HVRDi003-A-2
DR   hPSCreg; WISCi004-A-1
DR   WiCell; wisci004-a-1
DR   Wikidata; Q54994092
RX   PubMed=26299970;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW74 ! YZ1
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 9
//
ID   WISCi004-A-2
AC   CVCL_JW68
SY   YZ1 DISC1 wt V2.11; YZ1 WT v2.11; HVRDi003-A-3
DR   hPSCreg; WISCi004-A-2
DR   WiCell; wisci004-a-2
DR   Wikidata; Q54994093
RX   PubMed=26299970;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW74 ! YZ1
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 9
//
ID   WISCi004-A-3
AC   CVCL_JW69
SY   YZ1 DISC1 ex8wm 1.10; HVRDi003-A-1
DR   hPSCreg; WISCi004-A-3
DR   WiCell; wisci004-a-3
DR   Wikidata; Q54994094
RX   PubMed=26299970;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2888; DISC1 (Note=Exon 8 disruption).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW74 ! YZ1
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   WISCi004-A-4
AC   CVCL_JW70
SY   YZ1 DISC1 ex8wm v2.27; HVRDi003-A
DR   hPSCreg; WISCi004-A-4
DR   WiCell; wisci004-a-4
DR   Wikidata; Q54994095
RX   PubMed=26299970;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Knockout cell: Method=TALEN; HGNC; HGNC:2888; DISC1 (Note=Exon 8 disruption).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_JW74 ! YZ1
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 11
//
ID   WISCi005-A
AC   CVCL_EJ81
SY   UWWC1-DS1; DS1
DR   BioSamples; SAMEA104242072
DR   hPSCreg; WISCi005-A
DR   WiCell; uwwc1-ds1
DR   Wikidata; Q54994097
RX   PubMed=23716668;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L780 ! AG05397
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   WISCi005-B
AC   CVCL_EJ83
SY   UWWC1-DS4; DS4
DR   BioSamples; SAMEA104388691
DR   hPSCreg; WISCi005-B
DR   WiCell; uwwc1-ds4
DR   Wikidata; Q54994098
RX   PubMed=23716668;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=23716668
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L780 ! AG05397
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 12
//
ID   WISCi005-C
AC   CVCL_EJ82
SY   UWWC1-DS2U; DS2U
DR   BioSamples; SAMEA104388690
DR   hPSCreg; WISCi005-C
DR   WiCell; uwwc1-ds2u
DR   Wikidata; Q54994099
RX   PubMed=23716668;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Karyotypic information: Lost the third copy of chromosome 21.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=23716668
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 10,12
ST   D7S820: 10,12
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L780 ! AG05397
SX   Male
AG   1Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 13
//
ID   WISCi006-A
AC   CVCL_EJ80
SY   UWWC1-2DS3; 2DS3
DR   BioSamples; SAMEA104381150
DR   hPSCreg; WISCi006-A
DR   WiCell; uwwc1-2ds3
DR   Wikidata; Q54994101
RX   PubMed=23716668;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: African American.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L976 ! GM02504
SX   Male
AG   1M
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 11
//
ID   WISCi007-A
AC   CVCL_VF52
SY   WC026i-5807-3
DR   BioSamples; SAMEA104627977
DR   hPSCreg; WISCi007-A
DR   WiCell; wc026i-5807-3
DR   Wikidata; Q54994102
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc026i-5807-3
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 14,15
ST   D21S11: 32.2
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 9,13
ST   Penta E: 11,17
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF53 ! WISCi007-B
OI   CVCL_VF54 ! WISCi007-C
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi007-B
AC   CVCL_VF53
SY   WC027i-5807-5
DR   BioSamples; SAMEA994659
DR   hPSCreg; WISCi007-B
DR   WiCell; wc027i-5807-5
DR   Wikidata; Q54994103
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc027i-5807-5
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 14,15
ST   D21S11: 32.2
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 9,13
ST   Penta E: 11,17
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF52 ! WISCi007-A
OI   CVCL_VF54 ! WISCi007-C
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi007-C
AC   CVCL_VF54
SY   WC028i-5807-6
DR   BioSamples; SAMEA1080613
DR   hPSCreg; WISCi007-C
DR   WiCell; wc028i-5807-6
DR   Wikidata; Q54994104
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc028i-5807-6
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 13
ST   D18S51: 14,15
ST   D21S11: 32.2
ST   D3S1358: 17,18
ST   D5S818: 12,13
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   Penta D: 9,13
ST   Penta E: 11,17
ST   TH01: 7,8
ST   TPOX: 8,12
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF52 ! WISCi007-A
OI   CVCL_VF53 ! WISCi007-B
SX   Female
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi008-A
AC   CVCL_VF55
SY   WC029i-5907-1
DR   BioSamples; SAMEA1080614
DR   hPSCreg; WISCi008-A
DR   WiCell; wc029i-5907-1
DR   Wikidata; Q54994105
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: African.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc029i-5907-1
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 25,26
ST   Penta D: 10,13
ST   Penta E: 7,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF56 ! WISCi008-B
OI   CVCL_VF57 ! WISCi008-C
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi008-B
AC   CVCL_VF56
SY   WC030i-5907-2
DR   BioSamples; SAMEA1080615
DR   hPSCreg; WISCi008-B
DR   WiCell; wc030i-5907-2
DR   Wikidata; Q54994106
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: African.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc030i-5907-2
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 25,26
ST   Penta D: 10,13
ST   Penta E: 7,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF55 ! WISCi008-A
OI   CVCL_VF57 ! WISCi008-C
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi008-C
AC   CVCL_VF57
SY   WC031i-5907-6
DR   BioSamples; SAMEA1080616
DR   hPSCreg; WISCi008-C
DR   WiCell; wc031i-5907-6
DR   Wikidata; Q54994107
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: African.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc031i-5907-6
ST   Amelogenin: X,Y
ST   CSF1PO: 7,11
ST   D13S317: 12,14
ST   D16S539: 12,13
ST   D18S51: 15,16
ST   D21S11: 28,30
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 9,10
ST   D8S1179: 14,16
ST   FGA: 25,26
ST   Penta D: 10,13
ST   Penta E: 7,16
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF55 ! WISCi008-A
OI   CVCL_VF56 ! WISCi008-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi009-A
AC   CVCL_VF58
SY   WC032i-6007-1
DR   BioSamples; SAMEA1080617
DR   hPSCreg; WISCi009-A
DR   WiCell; wc032i-6007-1
DR   Wikidata; Q54994108
RX   PubMed=30605841;
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): WiCell=wc032i-6007-1
ST   Amelogenin: X,Y
ST   CSF1PO: 9,10
ST   D13S317: 9,12
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 21.2,22
ST   Penta D: 9,12
ST   Penta E: 5,17
ST   TH01: 9,9.3
ST   TPOX: 8,9
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF59 ! WISCi009-B
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 9
//
ID   WISCi009-B
AC   CVCL_VF59
SY   WC033i-6007-2
DR   BioSamples; SAMEA1080618
DR   hPSCreg; WISCi009-B
DR   Wikidata; Q54994109
CC   From: University of Wisconsin; Madison; USA.
CC   Population: Asian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF58 ! WISCi009-A
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   WISCi010-A
AC   CVCL_VF60
SY   BDH-024-1
DR   hPSCreg; WISCi010-A
DR   Wikidata; Q54994110
CC   From: University of Wisconsin; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF61 ! WISCi010-B
OI   CVCL_VF62 ! WISCi010-C
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   WISCi010-B
AC   CVCL_VF61
SY   BDH-024-2
DR   hPSCreg; WISCi010-B
DR   Wikidata; Q54994112
CC   From: University of Wisconsin; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF60 ! WISCi010-A
OI   CVCL_VF62 ! WISCi010-C
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   WISCi010-C
AC   CVCL_VF62
SY   BDH-024-3
DR   hPSCreg; WISCi010-C
DR   Wikidata; Q54994113
CC   From: University of Wisconsin; Madison; USA.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_VF60 ! WISCi010-A
OI   CVCL_VF61 ! WISCi010-B
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 3
//
ID   WISCi015-A
AC   CVCL_ZB35
SY   WC-01-01-AL-AM-GFAP-R88C
DR   hPSCreg; WISCi015-A
DR   Wikidata; Q98134938
RX   PubMed=30355500;
CC   From: University of Wisconsin; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg88Cys (c.262C>T); ClinVar=VCV000016172; Zygosity=Heterozygous (PubMed=30355500).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   WISCi015-A-1
AC   CVCL_ZB36
SY   WC-01-01-AL-AM-GFAP-R88R
DR   hPSCreg; WISCi015-A-1
DR   Wikidata; Q98134940
RX   PubMed=30355500;
CC   From: University of Wisconsin; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple_corrected; p.Arg88Cys (c.262C>T); ClinVar=VCV000016172; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30355500).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZB35 ! WISCi015-A
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   WISCi016-A
AC   CVCL_ZB37
SY   WC-14-01-AL-AM-GFAP-R416W
DR   hPSCreg; WISCi016-A
DR   Wikidata; Q98134942
RX   PubMed=30355500;
CC   From: University of Wisconsin; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple; p.Arg416Trp (c.1246C>T); ClinVar=VCV000016169; Zygosity=Heterozygous (PubMed=30355500).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   WISCi016-A-1
AC   CVCL_ZB38
SY   WC-14-01-AL-AM-GFAP-R416R
DR   hPSCreg; WISCi016-A-1
DR   Wikidata; Q98134944
RX   PubMed=30355500;
CC   From: University of Wisconsin; Madison; USA.
CC   Sequence variation: Mutation; HGNC; HGNC:4235; GFAP; Simple_corrected; p.Arg416Trp (c.1246C>T); ClinVar=VCV000016169; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=30355500).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84545; Alexander disease
DI   ORDO; Orphanet_58; Alexander disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZB37 ! WISCi016-A
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   WISe001-A
AC   CVCL_XD15
SY   WIS2
DR   BioSamples; SAMEA6014092
DR   GEO; GSM1466237
DR   GEO; GSM1466238
DR   GEO; GSM1574593
DR   GEO; GSM1574594
DR   GEO; GSM1574595
DR   GEO; GSM1574596
DR   hPSCreg; WISe001-A
DR   Wikidata; Q98134947
RX   PubMed=25543152;
CC   From: Weizmann Institute of Science; Rehovot; Israel.
CC   Population: Jewish.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 6
//
ID   WISe001-A-1
AC   CVCL_XD16
SY   CAMe003-A-1
DR   BioSamples; SAMEA6032109
DR   hPSCreg; WISe001-A-1
DR   Wikidata; Q98134950
CC   From: University of Cambridge; Cambridge; United Kingdom.
CC   Population: Jewish.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XD15 ! WISe001-A
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   WISH
AC   CVCL_1909
SY   Wish; WISH (HeLa derivative); Wistar Institute, Susan Hayflick
DR   BTO; BTO_0000069
DR   CLO; CLO_0009609
DR   CLDB; cl4720
DR   CLDB; cl4721
DR   CLDB; cl4723
DR   CLDB; cl4724
DR   ATCC; CCL-25
DR   ATCC; CRL-7727
DR   BioSample; SAMN03151764
DR   CCRID; 1101HUM-PUMC000088
DR   CCRID; 3101HUMGNHu38
DR   ChEMBL-Cells; CHEMBL3308013
DR   ChEMBL-Targets; CHEMBL612811
DR   ECACC; 88102403
DR   IZSLER; BS CL 92
DR   JCRB; IFO50004
DR   KCLB; 10025
DR   PubChem_Cell_line; CVCL_1909
DR   Wikidata; Q54994114
RX   CelloPub=CLPUB00262;
RX   DOI=10.1007/978-1-4757-1647-4_13;
RX   DOI=10.1007/BF02618370;
RX   PubMed=566722;
RX   PubMed=1246601;
RX   PubMed=4864103;
RX   PubMed=5641128;
RX   PubMed=5668122;
RX   PubMed=6451928;
RX   PubMed=13712490;
RX   PubMed=14185313;
RX   PubMed=20143388;
RX   PubMed=22549076;
RX   PubMed=23925245;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=WISH
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=6451928; PubMed=20143388). Originally thought to originate from cells of the amniotic sac of Susan Hayflick, the daughter of Leonard Hayflick.
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00013.
CC   Population: African American.
CC   Virology: Used for differentiation of virulent and non virulent strains of measles virus (ECACC=88102403; IZSLER=BS CL 92).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Omics: Genomics; Whole genome sequencing; Low read coverage.
CC   Discontinued: ATCC; CRL-7727; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CCL-25; CCRID=1101HUM-PUMC000088; ECACC=88102403; JCRB=IFO50004; KCLB=10025
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 13.3 (ATCC=CCL-25; CCRID=1101HUM-PUMC000088; JCRB=IFO50004; KCLB=10025)
ST   D13S317: 14 (ECACC=88102403)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12 (ATCC=CCL-25; CCRID=1101HUM-PUMC000088; JCRB=IFO50004; KCLB=10025)
ST   D7S820: 12 (ECACC=88102403)
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 34
//
ID   WISH-Mx2/EGFP
AC   CVCL_A8RR
SY   WISH-Mx2/eGFP; WISH-Mx/eGFP; L1G3
DR   Wikidata; Q108821517
RX   PubMed=22549076;
RX   PubMed=27346232;
RX   PubMed=31699391;
CC   Problematic cell line: Contaminated. Parent cell line (WISH) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=22549076).
CC   Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=22549076).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1909 ! WISH
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 8
//
ID   WISH-PC2
AC   CVCL_4907
SY   Weizmann Institute Sheba Hospital-Prostate Cancer 2
DR   Wikidata; Q54994115
RX   PubMed=11118033;
RX   PubMed=15643173;
CC   Population: Caucasian.
CC   Miscellaneous: This is not a cell line but a xenograft.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
DI   NCIt; C6766; Prostate small cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   WISi005-A
AC   CVCL_IU02
SY   BF1
DR   BioSamples; SAMEA103992707
DR   hPSCreg; WISi005-A
DR   SKIP; SKIP002897
DR   Wikidata; Q54994116
CC   From: Weizmann Institute of Science; Rehovot; Israel.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   WISi006-A
AC   CVCL_IU03
SY   FX1 iPSC
DR   BioSamples; SAMEA103992705
DR   hPSCreg; WISi006-A
DR   SKIP; SKIP002906
DR   Wikidata; Q54994117
CC   From: Weizmann Institute of Science; Rehovot; Israel.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84717; Fragile X syndrome
DI   ORDO; Orphanet_908; Fragile X syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AX78 ! GM05131
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   WiT49
AC   CVCL_0583
SY   WiT 49
DR   MCCL; MCC:0000489
DR   cancercelllines; CVCL_0583
DR   Cosmic; 1196557
DR   IARC_TP53; 18935
DR   Wikidata; Q54994118
RX   PubMed=8623926;
RX   PubMed=14506735;
RX   PubMed=19824073;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/w/cell-lines-detail-622.html
CC   Characteristics: Established from a first-generation nude mouse subcutaneous xenograft.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=14506735).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Wittier
AC   CVCL_M734
DR   Wikidata; Q54994119
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 7
//
ID   WIV-BS-02
AC   CVCL_Z703
DR   Wikidata; Q54994120
RX   DOI=10.13242/j.cnki.bingduxuebao.000368;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=1049282; ! Biston suppressaria (Tea looper moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   WIV-BS-481
AC   CVCL_Z701
DR   Wikidata; Q54994121
CC   Group: Insect cell line.
CC   Derived from site: In situ; Hemolymph; UBERON=UBERON_0001011.
CC   Cell type: Hemocyte; CL=CL_0000387.
OX   NCBI_TaxID=1049282; ! Biston suppressaria (Tea looper moth)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   WIV-BS-484
AC   CVCL_Z702
SY   BS-484; Bs-484
DR   Wikidata; Q54994129
RX   CelloPub=CLPUB00201;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=1049282; ! Biston suppressaria (Tea looper moth)
SX   Female
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   WIZ02e-H9CAGhM4Di
AC   CVCL_E9C4
DR   WiCell; wiz02e-h9caghm4di
RX   PubMed=27133795;
CC   Registration: Swiss research registry; BAG-hES-IMP-0104.
CC   Characteristics: Expresses hM4Di, a modified form of human CHRM4 that can no longer bind the native ligand, acetylcholine, but is activated by the inert clozapine metabolite clozapine-N-oxide (CNO), engaging the Gi signaling pathway (PubMed=27133795).
CC   Characteristics: Using CRISPR/Cas9 a T2A-PuroR-CAG-hM4Di-mCherry construct was introduced in the AAVS1 safe harbor locus (PubMed=27133795).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:1953; CHRM4 (Note=With p.Tyr113Cys and p.Ala203Gly = hM4Di).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WIZ03e-H9CAGhM3Dq
AC   CVCL_E9C5
DR   WiCell; wiz03e-h9caghm3dq
RX   PubMed=27133795;
CC   Registration: Swiss research registry; BAG-hES-IMP-0105.
CC   Characteristics: Expresses hM3Dq, a modified form of human CHRM3 that can no longer bind the native ligand, acetylcholine, but is activated by the inert clozapine metabolite clozapine-N-oxide (CNO), engaging the Gq signaling pathway (PubMed=27133795).
CC   Characteristics: Using CRISPR/Cas9 a T2A-PuroR-CAG-hM3Dq-mCherry construct was introduced in the AAVS1 safe harbor locus (PubMed=27133795).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=HGNC; HGNC:1952; CHRM3 (Note=With p.Tyr149Cys and p.Ala239Gly = hM3Dq).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WIZ04e-H9CAGmChry
AC   CVCL_E9C6
DR   WiCell; wiz04e-h9cagmchry
RX   PubMed=27133795;
CC   Registration: Swiss research registry; BAG-hES-IMP-0106.
CC   Characteristics: Control cell line for the WIZ02e-H9CAGhM4Di (Cellosaurus=CVCL_E9C4) and WIZ03e-H9CAGhM3Dq (Cellosaurus=CVCL_E9C5) cell lines.
CC   Characteristics: Using CRISPR/Cas9 a T2A-PuroR-CAG-mCherry construct was introduced in the AAVS1 safe harbor locus (PubMed=27133795).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WJ-MSC/TERT273
AC   CVCL_B5SZ
DR   Evercyte; CHT-059-0273
DR   Wikidata; Q112041936
RX   DOI=10.1101/2024.12.05.626964;
CC   Doubling time: 40-44 hours (Evercyte=CHT-059-0273).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Miscellaneous: STR profile and sex of donor from personal communication of Evercyte.
CC   Derived from site: In situ; Umbilical cord, Wharton's jelly; UBERON=UBERON_0003422.
CC   Cell type: Mesenchymal stem cell of Wharton's jelly; CL=CL_0002568.
ST   Source(s): Evercyte=CHT-059-0273
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,11
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 8,9
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   WJ1
AC   CVCL_W352
DR   Wikidata; Q54994130
RX   PubMed=17703357;
CC   Population: Chinese.
CC   Doubling time: ~60 hours (PubMed=17703357).
CC   Derived from site: In situ; Brain, right temporo-parietal junction; UBERON=UBERON_0023852.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 9
//
ID   WJR076
AC   CVCL_E877
SY   WJR 076
DR   dbMHC; 49067
DR   ECACC; 88052012
DR   IHW; IHW09012
DR   IPD-IMGT/HLA; 11567
DR   Wikidata; Q54994132
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian.
CC   HLA typing: A*02:01:01:01; B*57:01:01; C*07:01:01:01; DPB1*02:01:02/02:01:19; DQA1*01:02:02; DQB1*05:02:01; DRB1*16:02:01 (IPD-IMGT/HLA=11567).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   WK-1
AC   CVCL_GR57
DR   Wikidata; Q54994133
WW   Provider; UMN; z04191; https://web.archive.org/web/20170713122603/http://license.umn.edu/technologies/z04191_avian-cell-lines-a-rapidly-growing-immortal-chicken-embryo-fibroblast-cell-line-wk-1
CC   Group: Bird cell line.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   Embryo
CA   Undefined cell line type
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 9
//
ID   WK2
AC   CVCL_HF83
DR   Wikidata; Q54994135
RX   PubMed=24627082;
CC   Population: Japanese.
CC   Doubling time: 32 hours (PubMed=24627082).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
DI   NCIt; C8171; Lower gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF84 ! WK3F
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   WK3F
AC   CVCL_HF84
DR   Wikidata; Q54994136
RX   PubMed=24627082;
CC   Population: Japanese.
CC   Doubling time: 24 hours (PubMed=24627082).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C8171; Lower gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HF83 ! WK2
SX   Male
AG   58-59Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
ID   WK8013
AC   CVCL_E9UY
SY   WK 8013
RX   PubMed=6096706;
RX   PubMed=6437965;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C62505; Fanconi anemia
DI   ORDO; Orphanet_84; Fanconi anemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WK93
AC   CVCL_RN60
DR   Wikidata; Q54994137
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8690048;
CC   Population: Japanese.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   WKD
AC   CVCL_2764
SY   Wong-Kilbourne Derivative; Wong-Kilbourne; ChWK
DR   CLO; CLO_0009610
DR   CLDB; cl4725
DR   BioSample; SAMN03151765
DR   BioSample; SAMN03151766
DR   ECACC; 93120839
DR   Wikidata; Q54994138
RX   PubMed=1246601;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00030.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   WKPT-0293 Cl.2
AC   CVCL_R947
DR   Wikidata; Q54994139
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R948 ! WKPT-0293 Cl.3
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   WKPT-0293 Cl.3
AC   CVCL_R948
DR   Wikidata; Q54994140
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R947 ! WKPT-0293 Cl.2
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   WKPT-1292 Cl.10
AC   CVCL_R949
DR   Wikidata; Q54994141
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R951 ! WKPT-1292 Cl.3
OI   CVCL_R952 ! WKPT-1292 Cl.4
OI   CVCL_R953 ! WKPT-1292 Cl.8
OI   CVCL_R950 ! WKPT-1292 Cl.16
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   WKPT-1292 Cl.16
AC   CVCL_R950
DR   Wikidata; Q54994142
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R951 ! WKPT-1292 Cl.3
OI   CVCL_R952 ! WKPT-1292 Cl.4
OI   CVCL_R953 ! WKPT-1292 Cl.8
OI   CVCL_R949 ! WKPT-1292 Cl.10
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   WKPT-1292 Cl.3
AC   CVCL_R951
DR   Wikidata; Q54994143
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R952 ! WKPT-1292 Cl.4
OI   CVCL_R953 ! WKPT-1292 Cl.8
OI   CVCL_R949 ! WKPT-1292 Cl.10
OI   CVCL_R950 ! WKPT-1292 Cl.16
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   WKPT-1292 Cl.4
AC   CVCL_R952
DR   Wikidata; Q54994145
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R951 ! WKPT-1292 Cl.3
OI   CVCL_R953 ! WKPT-1292 Cl.8
OI   CVCL_R949 ! WKPT-1292 Cl.10
OI   CVCL_R950 ! WKPT-1292 Cl.16
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   WKPT-1292 Cl.8
AC   CVCL_R953
DR   Wikidata; Q54994147
RX   PubMed=8807581;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney, proximal tubule; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
CC   Breed/subspecies: Wistar Kyoto; RS=RS_0000742.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_R951 ! WKPT-1292 Cl.3
OI   CVCL_R952 ! WKPT-1292 Cl.4
OI   CVCL_R949 ! WKPT-1292 Cl.10
OI   CVCL_R950 ! WKPT-1292 Cl.16
SX   Male
AG   4-8W
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 13
//
ID   WL-3C2
AC   CVCL_XY07
SY   3C2
DR   CCRID; 4201PAT-CCTCC00283
DR   Wikidata; Q98134952
RX   Patent=CN101570742A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200916.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P20591; Human MX1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 6
//
ID   WL-E
AC   CVCL_0C29
DR   Cosmic; 2239084
DR   Wikidata; Q54994148
RX   PubMed=1311980;
RX   PubMed=7736387;
RX   PubMed=9559344;
RX   PubMed=9815546;
RX   PubMed=10037197;
CC   Doubling time: 48 hours (PubMed=1311980).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   WLC-3
AC   CVCL_5A04
SY   Woodchuck Liver Cells-3
DR   Wikidata; Q54994149
RX   PubMed=2888713;
CC   Doubling time: ~38 hours (PubMed=2888713).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9995; ! Marmota monax (Woodchuck)
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 10
//
ID   WLM-20
AC   CVCL_ZL60
DR   Cosmic; 801778
DR   Wikidata; Q98134954
RX   PubMed=11921280;
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Homozygous (PubMed=11921280).
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   WLNA6
AC   CVCL_H618
DR   Wikidata; Q54994150
RX   PubMed=6604917;
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   WLS-1
AC   CVCL_VZ76
SY   WiLSon disease-1
DR   IBRC; C10418
DR   Wikidata; Q98134958
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   WM 1043
AC   CVCL_4602
DR   CLO; CLO_0009611
DR   ATCC; CRL-6466
DR   Wikidata; Q54994151
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6466; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 7
//
ID   WM-9001
AC   CVCL_B5DJ
DR   Wikidata; Q110434408
RX   PubMed=11229590;
RX   PubMed=11330178;
CC   Group: Fish cell line.
CC   Characteristics: Optimal growth at 30 to 37 Celsius (PubMed=11229590).
CC   Doubling time: 19.71 +- 3.74 hours (PubMed=11229590; PubMed=11330178).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=42529; ! Piaractus brachypomus (Pirapitinga)
SX   Sex unspecified
AG   Blastocyst stage
CA   Spontaneously immortalized cell line
DT   Created: 16-12-21; Last updated: 27-11-25; Version: 4
//
ID   WM-L2
AC   CVCL_XB58
SY   WML2
DR   CCRID; 5301MOU-KCB85024ZJ
DR   KCB; KCB 85024ZJ
DR   Wikidata; Q98134966
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   WM1 [Human Waldenstrom macroglobulinemia]
AC   CVCL_M088
DR   Wikidata; Q54994152
RX   PubMed=6288575;
RX   PubMed=22950966;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   WM1 [Mouse hybridoma against human C3]
AC   CVCL_J776
DR   ECACC; 92021211
DR   NCBI_Iran; H126
DR   Wikidata; Q54994153
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; P01024; Human C3.
CC   Discontinued: ECACC; 92021211; true.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 9
//
ID   WM1-LCL-PI 13
AC   CVCL_9V71
DR   NCBI_Iran; C215
DR   Wikidata; Q54994154
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Lymphocyte; CL=CL_0000542.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 9
//
ID   WM1026
AC   CVCL_AP84
DR   cancercelllines; CVCL_AP84
DR   Rockland; WM1026-01-0001
DR   Wikidata; Q54994155
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 8,11
ST   D13S317: 9,11
ST   D16S539: 9,13
ST   D18S51: 13,16
ST   D19S433: 14
ST   D21S11: 28,31
ST   D2S1338: 18,25
ST   D3S1358: 16,17
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 21,22
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   WM115
AC   CVCL_0040
SY   WM-115; WM 115; WM115F; WM115-mel; WM115mel; WC00079
DR   BTO; BTO_0003075
DR   CLO; CLO_0009613
DR   EFO; EFO_0002390
DR   CLDB; cl4727
DR   CLDB; cl4728
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1675
DR   BioGRID_ORCS_Cell_line; 345
DR   BioSample; SAMN10987773
DR   cancercelllines; CVCL_0040
DR   Cell_Model_Passport; SIDM01000
DR   CGH-DB; 9323-4
DR   ChEMBL-Cells; CHEMBL3308813
DR   ChEMBL-Targets; CHEMBL1075611
DR   Coriell; WC00079
DR   Cosmic; 886835
DR   Cosmic; 888868
DR   Cosmic; 897480
DR   Cosmic; 905236
DR   Cosmic; 909784
DR   Cosmic; 932717
DR   Cosmic; 972277
DR   Cosmic; 1155268
DR   Cosmic; 1155547
DR   Cosmic; 1238102
DR   Cosmic; 1238104
DR   Cosmic-CLP; 909784
DR   DepMap; ACH-000304
DR   ECACC; 91061232
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ESTDAB; ESTDAB-066
DR   GDSC; 909784
DR   GEO; GSM109022
DR   GEO; GSM827472
DR   GEO; GSM887735
DR   GEO; GSM888830
DR   GEO; GSM1670576
DR   GEO; GSM7701424
DR   GEO; GSM7701435
DR   IARC_TP53; 21271
DR   IARC_TP53; 24992
DR   IGRhCellID; WM115
DR   IZSLER; BS TCL 74
DR   LiGeA; CCLE_370
DR   LINCS_HMS; 50567
DR   LINCS_LDP; LCL-1260
DR   Lonza; 584
DR   PharmacoDB; WM115_1662_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0040
DR   PubChem_Cell_line; CVCL_0040
DR   Rockland; WM115-01-0001
DR   Wikidata; Q54994157
RX   PubMed=2253310;
RX   PubMed=3020539;
RX   PubMed=3856042;
RX   PubMed=4053039;
RX   PubMed=11121133;
RX   PubMed=15009714;
RX   PubMed=15467732;
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=16957166;
RX   PubMed=18632627;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=21424129;
RX   PubMed=22460905;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; HPA; -; https://www.proteinatlas.org/learn/cellines
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Human Protein Atlas, Cell Atlas panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,29:02; B*13:02,44:03:01; C*06:02,16:01; DPB1*02:01:02,02:01:02; DQB1*02:01,02:01; DRB1*07:01,07:01 (PubMed=15592718).
CC   HLA typing: A*02:01,29:02; B*13:02,44:03; C*06:02,16:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (PubMed=15009714; PubMed=15467732; Wistar).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Large antibody panel staining analysis.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.17%; East Asian, North=0%; East Asian, South=0%; South Asian=0.85%; European, North=67.47%; European, South=31.51% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO: 11,12->12, D18S51: 17->17,21 and D8S1179: 8,13->13,15.
CC   Misspelling: WH115mel; CGH-DB=9323-4.
CC   Discontinued: ATCC; CRL-1675; true.
CC   Discontinued: Coriell; WC00079; probable.
CC   Discontinued: ECACC; 91061232; true.
CC   Derived from site: Metastatic; Right anterior leg, skin; UBERON=UBERON_0001511.
ST   Source(s): ATCC=CRL-1675; Cosmic-CLP=909784; ESTDAB=ESTDAB-066; Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 17,21
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 49
//
ID   WM115-MOCK
AC   CVCL_C3N6
DR   Wikidata; Q116050796
RX   PubMed=24613454;
RX   PubMed=25310905;
CC   Population: Caucasian.
CC   Characteristics: Control cell line for WM115-RAGE (Cellosaurus=CVCL_C3N7). Transfected with an empty pcDNA3 vector.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right anterior leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0040 ! WM115
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   WM115-RAGE
AC   CVCL_C3N7
DR   ABM; T6013
DR   Wikidata; Q116050797
RX   PubMed=24613454;
RX   PubMed=25310905;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:320; AGER.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Right anterior leg, skin; UBERON=UBERON_0001511.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0040 ! WM115
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 6
//
ID   WM1158
AC   CVCL_6785
SY   WM-1158; WM 1158; WC00046
DR   cancercelllines; CVCL_6785
DR   Coriell; WC00046
DR   Cosmic; 686407
DR   Cosmic; 888849
DR   Cosmic; 897486
DR   Cosmic; 928686
DR   Cosmic; 1155287
DR   Cosmic; 1507610
DR   Cosmic; 2233684
DR   GEO; GSM185164
DR   GEO; GSM185165
DR   IARC_TP53; 24996
DR   PharmacoDB; WM1158_1667_2019
DR   Progenetix; CVCL_6785
DR   Rockland; WM1158-01-0001
DR   Wikidata; Q54994159
RX   PubMed=11123321;
RX   PubMed=15009714;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15009714; Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00046; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 12,14
ST   D18S51: 12,13
ST   D19S433: 13,15
ST   D21S11: 31.2,33
ST   D2S1338: 22,25
ST   D3S1358: 17,18
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 10,15
ST   FGA: 21
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   WM1193C
AC   CVCL_C265
SY   WM-1193C; WM 1193C
DR   cancercelllines; CVCL_C265
DR   GEO; GSM185166
DR   GEO; GSM185167
DR   Progenetix; CVCL_C265
DR   Wikidata; Q54994160
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 14
//
ID   WM122
AC   CVCL_DG74
SY   WM 122
DR   cancercelllines; CVCL_DG74
DR   GEO; GSM186467
DR   GEO; GSM186468
DR   GEO; GSM188230
DR   GEO; GSM188260
DR   GEO; GSM188319
DR   Progenetix; CVCL_DG74
DR   Wikidata; Q54994162
RX   PubMed=2068080;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Misspelling: MW122; PubMed=2068080; Note=In material and methods.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 11
//
ID   WM1232
AC   CVCL_6786
SY   WM-1232; WM 1232; WC00084
DR   cancercelllines; CVCL_6786
DR   Coriell; WC00084
DR   Cosmic; 2233685
DR   GEO; GSM185168
DR   GEO; GSM185169
DR   Progenetix; CVCL_6786
DR   Rockland; WM1232-01-0001
DR   Wikidata; Q54994163
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00084; probable.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 20,25
ST   D3S1358: 18
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 7,9.3
ST   TPOX: 11,12
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   WM1321
AC   CVCL_W887
SY   WM-1321
DR   Cosmic; 1155566
DR   GEO; GSM109023
DR   Wikidata; Q54994164
RX   PubMed=16827748;
RX   PubMed=18632627;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 9
//
ID   WM1341B
AC   CVCL_A396
SY   WM-1341B; WM 1341B; WM1341; WM 1341
DR   cancercelllines; CVCL_A396
DR   Cosmic; 1303062
DR   Wikidata; Q54994165
RX   PubMed=2068080;
RX   PubMed=7646526;
RX   PubMed=8160777;
RX   PubMed=8688321;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (from autologous cell line WM1341D).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6787 ! WM1341D
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   WM1341B-P1N1
AC   CVCL_C8VJ
SY   1341-P1-N1
DR   Wikidata; Q123033923
RX   PubMed=8160777;
CC   Characteristics: Established after 1 passage of WM1341B co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A396 ! WM1341B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WM1341B-P1N2
AC   CVCL_C8VK
SY   1341-P1-N2
DR   Wikidata; Q123033925
RX   PubMed=8160777;
CC   Characteristics: Established after 1 passage of WM1341B co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A396 ! WM1341B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WM1341B-P1N3
AC   CVCL_C8VL
SY   1341-P1-N3
DR   Wikidata; Q123033926
RX   PubMed=8160777;
CC   Characteristics: Established after 1 passage of WM1341B co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A396 ! WM1341B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WM1341D
AC   CVCL_6787
SY   WM1341-D; WM-1341D; WM 1341D; WC00096
DR   cancercelllines; CVCL_6787
DR   Coriell; WC00096
DR   Cosmic; 1477407
DR   Rockland; WM1341D-01-0001
DR   Wikidata; Q54994166
RX   PubMed=2253310;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00096; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 14,15
ST   D19S433: 12,14
ST   D21S11: 31.2,32.2
ST   D2S1338: 16,18
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 9,11
ST   D8S1179: 12,14
ST   FGA: 19,22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A396 ! WM1341B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   WM1346
AC   CVCL_W886
SY   WM-1346; WM 1346; WC00121
DR   cancercelllines; CVCL_W886
DR   Coriell; WC00121
DR   Cosmic; 1155538
DR   GEO; GSM109024
DR   GEO; GSM185170
DR   GEO; GSM185171
DR   GEO; GSM185172
DR   GEO; GSM185173
DR   Progenetix; CVCL_W886
DR   Wikidata; Q54994167
RX   PubMed=16827748;
RX   PubMed=18632627;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00121; probable.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 13
//
ID   WM1361A
AC   CVCL_6788
SY   WM-1361A; WM 1361A; WC00075; EST69
DR   BioGRID_ORCS_Cell_line; 1751
DR   cancercelllines; CVCL_6788
DR   Coriell; WC00075
DR   Cosmic; 686402
DR   Cosmic; 1047649
DR   Cosmic; 1155284
DR   Cosmic; 1155540
DR   Cosmic; 1303063
DR   Cosmic; 1507599
DR   Cosmic; 1669263
DR   Cosmic; 2163799
DR   Cosmic; 2233686
DR   ESTDAB; ESTDAB-069
DR   GEO; GSM109025
DR   GEO; GSM156022
DR   GEO; GSM185174
DR   GEO; GSM185175
DR   GEO; GSM185176
DR   GEO; GSM185177
DR   GEO; GSM952593
DR   IARC_TP53; 26076
DR   Progenetix; CVCL_6788
DR   Rockland; WM1361A-01-0001
DR   Wikidata; Q54994168
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=16827748;
RX   PubMed=17260012;
RX   PubMed=18632627;
RX   PubMed=19340423;
RX   PubMed=23851445;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (PubMed=17260012; PubMed=23851445; Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: Coriell; WC00075; probable.
ST   Source(s): ESTDAB=ESTDAB-069; Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13,14
ST   D21S11: 30,31.2
ST   D2S1338: 25
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 22,25
ST   TH01: 7 (Wistar)
ST   TH01: 7,8 (ESTDAB=ESTDAB-069)
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6993 ! WM1361B
OI   CVCL_6994 ! WM1361C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   WM1361B
AC   CVCL_6993
SY   WM-1361B; WM 1361B
DR   cancercelllines; CVCL_6993
DR   Cosmic; 686403
DR   Cosmic; 1155555
DR   GEO; GSM109026
DR   Wikidata; Q54994170
RX   PubMed=2253310;
RX   PubMed=16827748;
RX   PubMed=18632627;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell line WM1361A).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=16827748).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (from autologous cell line WM1361A).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6788 ! WM1361A
OI   CVCL_6994 ! WM1361C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   WM1361C
AC   CVCL_6994
SY   WM-1361C; WM 1361C
DR   cancercelllines; CVCL_6994
DR   Cosmic; 686404
DR   Wikidata; Q54994171
RX   PubMed=2253310;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell line WM1361A).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (from autologous cell line WM1361A).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6788 ! WM1361A
OI   CVCL_6993 ! WM1361B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   WM1366
AC   CVCL_6789
SY   WM-1366; WM 1366; WC00078; EST70
DR   cancercelllines; CVCL_6789
DR   Coriell; WC00078
DR   Cosmic; 1047650
DR   Cosmic; 1155539
DR   Cosmic; 1665010
DR   Cosmic; 2163800
DR   ESTDAB; ESTDAB-070
DR   GEO; GSM109027
DR   GEO; GSM185178
DR   GEO; GSM185179
DR   GEO; GSM185180
DR   GEO; GSM185181
DR   GEO; GSM188064
DR   GEO; GSM188116
DR   GEO; GSM188189
DR   GEO; GSM188204
DR   GEO; GSM188217
DR   GEO; GSM188231
DR   GEO; GSM188261
DR   GEO; GSM188280
DR   GEO; GSM188289
DR   GEO; GSM188320
DR   GEO; GSM952594
DR   GEO; GSM1507941
DR   IARC_TP53; 26077
DR   Progenetix; CVCL_6789
DR   Rockland; WM1366-01-0001
DR   SKY/M-FISH/CGH; 4947
DR   Wikidata; Q54994172
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=17260012;
RX   PubMed=18632627;
RX   PubMed=19340423;
RX   PubMed=23851445;
RX   PubMed=25502142;
RX   PubMed=25645078;
RX   PubMed=25728708;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*32:01,32:01; B*41:01,41:01; C*17:01,17:01; DPB1*03:01,03:01; DQB1*02:01,02:01; DRB1*03:01:02,03:01:02 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Pro48Leu (c.143C>T); Zygosity=Unspecified (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; PubMed=25645078; PubMed=25728708; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu285Lys (c.853G>A); ClinVar=VCV000420133; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO: 11,12->12, D5S818: 12,13->13 and D7S820: 11,12->12.
CC   Misspelling: Wn1366; Cosmic=1665010.
CC   Discontinued: Coriell; WC00078; probable.
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
ST   Source(s): ESTDAB=ESTDAB-070; Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 12,13
ST   D18S51: 12,16
ST   D19S433: 14,15
ST   D21S11: 28,30
ST   D2S1338: 20,22
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   WM1382
AC   CVCL_6790
SY   WM-1382; WM 1382; WC00055
DR   cancercelllines; CVCL_6790
DR   Coriell; WC00055
DR   Cosmic; 1155542
DR   Cosmic; 1669264
DR   GEO; GSM109028
DR   Wikidata; Q54994173
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=24576830;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Unspecified (PubMed=24576830).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00055; probable.
CC   Derived from site: Metastatic; Axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 21
//
ID   WM139
AC   CVCL_C266
SY   WM-139; WM 139; EST71
DR   cancercelllines; CVCL_C266
DR   Cosmic; 1047651
DR   Cosmic; 2163801
DR   ESTDAB; ESTDAB-071
DR   GEO; GSM156024
DR   IARC_TP53; 26078
DR   Progenetix; CVCL_C266
DR   Wikidata; Q54994174
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*32:01,32:01; B*14:01,14:01; C*08:02,08:02; DPB1*02:01:02,02:01:02; DQB1*02:01,02:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Val82fs (c.243_244ins19) (p.Arg96fs, c.286_287ins19); Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
ST   Source(s): ESTDAB=ESTDAB-071
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D3S1358: 14,17
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   FGA: 20,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 24
//
ID   WM1552C
AC   CVCL_6472
SY   WM-1552C; WM 1552C; WM-1552; WM1552; EST73
DR   CLO; CLO_0009614
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2808
DR   BioSample; SAMN03471792
DR   cancercelllines; CVCL_6472
DR   Cell_Model_Passport; SIDM00976
DR   Cosmic; 886833
DR   Cosmic; 1047652
DR   Cosmic; 1303064
DR   Cosmic; 1995664
DR   Cosmic; 2159426
DR   Cosmic; 2163802
DR   Cosmic-CLP; 1299078
DR   DepMap; ACH-002205
DR   EGA; EGAS00001000978
DR   ESTDAB; ESTDAB-073
DR   GDSC; 1299078
DR   GEO; GSM156020
DR   GEO; GSM186469
DR   GEO; GSM186470
DR   GEO; GSM555134
DR   GEO; GSM555186
DR   GEO; GSM952582
DR   GEO; GSM1670577
DR   IARC_TP53; 26079
DR   LINCS_HMS; 50568
DR   LINCS_LDP; LCL-1261
DR   PharmacoDB; WM1552C_1668_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_6472
DR   Rockland; WM1552C-01-0001
DR   Wikidata; Q54994175
RX   PubMed=11123321;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=21343389;
RX   PubMed=23851445;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*03:01,02:01; B*13:02,07:02; C*07:02,06:02; DPB1*04:01,04:02; DQB1*06:02,02:01; DRB1*15:01,ND (PubMed=15592718).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; Cosmic-CLP=1299078; DepMap=ACH-002205; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; c.634+5G>T; ClinVar=VCV001338631; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; Cosmic-CLP=1299078; DepMap=ACH-002205).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.24%; East Asian, North=0%; East Asian, South=1.1%; South Asian=2.39%; European, North=72.29%; European, South=23.98% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D13S317: 12->11,12.
CC   Discontinued: ATCC; CRL-2808; true.
CC   Derived from site: In situ; Hypodermis; UBERON=UBERON_0002072.
ST   Source(s): ATCC=CRL-2808; Cosmic-CLP=1299078; ESTDAB=ESTDAB-073; Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12 (Wistar)
ST   D13S317: 12 (Cosmic-CLP=1299078; ESTDAB=ESTDAB-073)
ST   D13S317: 12,14 (ATCC=CRL-2808)
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 24,25
ST   D3S1358: 14
ST   D5S818: 12
ST   D7S820: 10,11,12 (ATCC=CRL-2808)
ST   D7S820: 10,12 (Cosmic-CLP=1299078; ESTDAB=ESTDAB-073; Wistar)
ST   D8S1179: 11,12
ST   FGA: 22
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 40
//
ID   WM1575
AC   CVCL_L027
SY   WM-1575; WM 1575
DR   Wikidata; Q54994176
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 7
//
ID   WM1617
AC   CVCL_6791
SY   WM-1617; WM 1617; WC00076
DR   cancercelllines; CVCL_6791
DR   Coriell; WC00076
DR   Cosmic; 686409
DR   GEO; GSM109029
DR   GEO; GSM952583
DR   Progenetix; CVCL_6791
DR   Wikidata; Q54994186
RX   PubMed=2253310;
RX   PubMed=16827748;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell line WM278).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00076; probable.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6473 ! WM278
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   WM164
AC   CVCL_7928
SY   WM-164; WM 164
DR   cancercelllines; CVCL_7928
DR   Cell_Model_Passport; SIDM00802
DR   ChEMBL-Cells; CHEMBL4630601
DR   ChEMBL-Targets; CHEMBL4630701
DR   Cosmic; 888857
DR   Cosmic; 897481
DR   Cosmic; 928684
DR   Cosmic; 1155550
DR   Cosmic; 1187586
DR   Cosmic; 1303065
DR   GEO; GSM109030
DR   GEO; GSM186471
DR   GEO; GSM186472
DR   GEO; GSM952584
DR   PRIDE; PXD004343
DR   Progenetix; CVCL_7928
DR   PubChem_Cell_line; CVCL_7928
DR   Rockland; WM164-01-0001
DR   Wikidata; Q54994187
RX   PubMed=2156614;
RX   PubMed=2253310;
RX   PubMed=2918552;
RX   PubMed=8342600;
RX   PubMed=15009714;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=18790768;
RX   PubMed=30380804;
RX   PubMed=34206371;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Doubling time: 48 hours (PubMed=2253310).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=15009714; PubMed=18632627; Wistar).
CC   Omics: Proteomics.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO: 11,12->12, D18S51: 12,21->10,12,13, D2S1338: 19->18,19, D5S818: 11,12->12, FGA: 20->21,25 and vWA: 14,15->14,18.
CC   Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 10,12,13
ST   D19S433: 13
ST   D21S11: 28,31.2
ST   D2S1338: 18,19
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   TH01: 9
ST   TPOX: 8,10
ST   vWA: 14,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_DG51 ! Mel1617
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   WM164 VDR KO
AC   CVCL_B6Q1
SY   VDR KO WM164
DR   cancercelllines; CVCL_B6Q1
DR   Wikidata; Q112041937
RX   PubMed=34206371;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:12679; VDR.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7928 ! WM164
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   WM164-Bch4
AC   CVCL_B6Q0
SY   WM164-Boyden chamber 4
DR   cancercelllines; CVCL_B6Q0
DR   Wikidata; Q112041939
RX   PubMed=2156614;
CC   Population: Caucasian.
CC   Characteristics: Highly invasive variant obtained from WM164 cells by four serial passages of these cells in the Boyden chamber assay (PubMed=2156614).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Arm, skin; UBERON=UBERON_0002427.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7928 ! WM164
SX   Male
AG   22Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   WM165-1
AC   CVCL_L033
SY   WM-165-1; WM 165-1
DR   cancercelllines; CVCL_L033
DR   Cell_Model_Passport; SIDM00977
DR   Rockland; WM165-1-01-0001
DR   Wikidata; Q54994189
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 15,17
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 22
//
ID   WM165-2
AC   CVCL_RN55
SY   WM-165-2; WM 165-2
DR   cancercelllines; CVCL_RN55
DR   Wikidata; Q54994190
RX   PubMed=2253310;
RX   PubMed=3856042;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   WM1650
AC   CVCL_D555
SY   WM-1650; WM 1650; WM 1650V
DR   ATCC; CRL-2810
DR   Wikidata; Q54994191
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=8342600;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Discontinued: ATCC; CRL-2810; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 12
//
ID   WM1716
AC   CVCL_AP82
DR   cancercelllines; CVCL_AP82
DR   Rockland; WM1716-01-0001
DR   Wikidata; Q54994192
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 13,13.2
ST   D21S11: 31,32
ST   D2S1338: 19,24
ST   D3S1358: 16
ST   D5S818: 10
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 13
//
ID   WM1727A
AC   CVCL_A339
SY   WM-1727A; WM 1727A
DR   cancercelllines; CVCL_A339
DR   Cosmic; 1155559
DR   Cosmic; 1303066
DR   GEO; GSM109031
DR   GEO; GSM186473
DR   GEO; GSM186474
DR   Progenetix; CVCL_A339
DR   Rockland; WM1727A-01-0001
DR   Wikidata; Q54994193
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D18S51: 14
ST   D19S433: 14
ST   D21S11: 28,33.2
ST   D2S1338: 20,23
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 13,14
ST   FGA: 22
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   WM1789
AC   CVCL_6792
SY   WM-1789; WM 1789; WC00080
DR   cancercelllines; CVCL_6792
DR   Coriell; WC00080
DR   Cosmic; 686395
DR   Cosmic; 1477416
DR   GEO; GSM186475
DR   GEO; GSM186476
DR   Progenetix; CVCL_6792
DR   Rockland; WM1789-01-0001
DR   Wikidata; Q54994194
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Ser363Phe (c.1088C>T); Zygosity=Unspecified (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Glu (c.1801A>G); ClinVar=VCV000013966; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00080; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 9,13
ST   D7S820: 8,9
ST   D8S1179: 10,15
ST   FGA: 19,22
ST   TH01: 7
ST   TPOX: 10,11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   WM1791A
AC   CVCL_C267
SY   WM-1791A; WM 1791A; WM 1791-A; EST74
DR   cancercelllines; CVCL_C267
DR   Cosmic; 1047653
DR   ESTDAB; ESTDAB-074
DR   GEO; GSM156013
DR   IARC_TP53; 26080
DR   Progenetix; CVCL_C267
DR   Wikidata; Q54994195
RX   PubMed=2253310;
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=23851445;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*02:01; B*07:02,44:02; C*07:02,05:01; DPB1*06:01,19:01; DQB1*06:02,03:01:01; DRB1*15:01,ND (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; PubMed=23851445).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-074
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   FGA: 19,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6793 ! WM1791C
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   WM1791C
AC   CVCL_6793
SY   WM-1791C; WM 1791C; WM 1791-C; WC00086
DR   EFO; EFO_0022370
DR   cancercelllines; CVCL_6793
DR   Coriell; WC00086
DR   GEO; GSM952585
DR   Progenetix; CVCL_6793
DR   Rockland; WM1791C-01-0001
DR   Wikidata; Q54994196
RX   PubMed=2253310;
RX   PubMed=10952317;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Unspecified (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Thr50Ile (c.149_150delinsTT); Zygosity=Unspecified (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Glu62Lys (c.184G>A); Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00086; probable.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 17
ST   D19S433: 12,16.2
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 19,22
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C267 ! WM1791A
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   WM1799
AC   CVCL_A341
SY   WM-1799; WM 1799
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 690
DR   BioSample; SAMN10987990
DR   cancercelllines; CVCL_A341
DR   Cell_Model_Passport; SIDM01398
DR   Cosmic; 888851
DR   Cosmic; 1155560
DR   Cosmic; 1303067
DR   DepMap; ACH-000661
DR   GEO; GSM109032
DR   GEO; GSM186477
DR   GEO; GSM186478
DR   GEO; GSM887736
DR   GEO; GSM888831
DR   IARC_TP53; 30187
DR   LiGeA; CCLE_808
DR   PharmacoDB; WM1799_1669_2019
DR   Progenetix; CVCL_A341
DR   Rockland; WM1799-01-0001
DR   Wikidata; Q54994197
RX   PubMed=15009714;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*26:01,26:01; B*38:01,44:02; C*12:03,12:03; DQA1*01:02,03:02; DQB1*03:02,06:11; DRB1*04:02,15:01 (PubMed=26589293).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=15009714; DepMap=ACH-000661; Wistar).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.37%; Native American=0%; East Asian, North=4.29%; East Asian, South=0%; South Asian=2.08%; European, North=47.56%; European, South=45.7% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X->X,Y.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D18S51: 13,16
ST   D19S433: 16,16.2
ST   D21S11: 30
ST   D2S1338: 18
ST   D3S1358: 14,15
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 12,14
ST   FGA: 19,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 33
//
ID   WM1819
AC   CVCL_0B65
SY   WM-1819
DR   cancercelllines; CVCL_0B65
DR   Cosmic; 1303068
DR   GEO; GSM109033
DR   Rockland; WM1819-01-0001
DR   Wikidata; Q54994198
RX   PubMed=16827748;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: FGA: 23->20,23.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,14
ST   D16S539: 11,14
ST   D18S51: 12,16
ST   D19S433: 15
ST   D21S11: 29
ST   D2S1338: 17,18
ST   D3S1358: 14,15
ST   D5S818: 11,13
ST   D7S820: 10
ST   D8S1179: 11,12
ST   FGA: 20,23
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   WM1852
AC   CVCL_0L86
SY   WM-1852
DR   cancercelllines; CVCL_0L86
DR   Rockland; WM1852-01-0001
DR   Wikidata; Q54994199
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 11
ST   D18S51: 13
ST   D19S433: 14,15
ST   D21S11: 28,33.2
ST   D2S1338: 17,25
ST   D3S1358: 16,17
ST   D5S818: 12
ST   D7S820: 9,13
ST   D8S1179: 12,15
ST   FGA: 21,23
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   WM1862
AC   CVCL_C268
SY   WM-1862; WM 1862; EST75
DR   cancercelllines; CVCL_C268
DR   Cosmic; 972270
DR   Cosmic; 1047654
DR   Cosmic; 2163803
DR   ESTDAB; ESTDAB-075
DR   GEO; GSM156010
DR   IARC_TP53; 26081
DR   Progenetix; CVCL_C268
DR   Rockland; WM1862-01-0001
DR   Wikidata; Q54994200
RX   PubMed=15592718;
RX   PubMed=17260012;
RX   PubMed=23851445;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   HLA typing: A*32:01,68:01:02; B*14:01; C*08:01; DPB1*04:02,02:01:02; DQB1*02:01; DRB1*07:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012; Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=17260012; PubMed=23851445; Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ESTDAB=ESTDAB-075; Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13
ST   D18S51: 12,17
ST   D19S433: 13,14
ST   D21S11: 28,29
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 11,14
ST   D7S820: 10
ST   D8S1179: 13,14
ST   FGA: 20,21
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 27
//
ID   WM1922
AC   CVCL_6794
SY   WM-1922; WM 1922; WC00093
DR   Coriell; WC00093
DR   Wikidata; Q54994201
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Discontinued: Coriell; WC00093; probable.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
ID   WM1942
AC   CVCL_DI27
SY   WM-1942; WM 1942
DR   cancercelllines; CVCL_DI27
DR   GEO; GSM482482
DR   Progenetix; CVCL_DI27
DR   Wikidata; Q54994202
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   WM1960
AC   CVCL_AP76
DR   cancercelllines; CVCL_AP76
DR   Rockland; WM1960-01-0001
DR   Wikidata; Q54994203
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 8
ST   D18S51: 19
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,16
ST   FGA: 22,24
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP77 ! WM2013
OI   CVCL_6796 ! WM3060
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   WM1963
AC   CVCL_0B66
DR   cancercelllines; CVCL_0B66
DR   GEO; GSM952603
DR   Progenetix; CVCL_0B66
DR   Rockland; WM1963-01-0001
DR   Wikidata; Q54994205
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn581Ser (c.1742A>G); ClinVar=VCV000177776; Zygosity=Heterozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Ala146Thr (c.436G>A); Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D13S317: 9,11->9,14.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,14
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 18,24
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   D8S1179: 12,13
ST   FGA: 22,23
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   WM1985
AC   CVCL_0B67
DR   cancercelllines; CVCL_0B67
DR   GEO; GSM185182
DR   GEO; GSM185183
DR   Progenetix; CVCL_0B67
DR   Rockland; WM1985-01-0001
DR   Wikidata; Q54994206
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 11,15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 18,23
ST   D3S1358: 15,17
ST   D5S818: 9,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 22,23
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   WM2013
AC   CVCL_AP77
DR   cancercelllines; CVCL_AP77
DR   GEO; GSM952595
DR   Progenetix; CVCL_AP77
DR   Rockland; WM2013-01-0001
DR   Wikidata; Q54994207
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 19
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,16
ST   FGA: 22,24
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP76 ! WM1960
OI   CVCL_6796 ! WM3060
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   WM2032
AC   CVCL_0B68
DR   cancercelllines; CVCL_0B68
DR   GEO; GSM952596
DR   Progenetix; CVCL_0B68
DR   Rockland; WM2032-01-0001
DR   Wikidata; Q54994208
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 8,11
ST   D18S51: 25
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 20,21
ST   TH01: 10
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP86 ! WM3000
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 18
//
ID   WM2044
AC   CVCL_0B69
DR   cancercelllines; CVCL_0B69
DR   Rockland; WM2044-01-0001
DR   Wikidata; Q54994209
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 20
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 18
ST   D3S1358: 16,17
ST   D5S818: 11
ST   D7S820: 9
ST   D8S1179: 13
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   WM2067
AC   CVCL_0L85
DR   Wikidata; Q54994210
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   WM209
AC   CVCL_C269
SY   WM-209; WM 209
DR   cancercelllines; CVCL_C269
DR   GEO; GSM952604
DR   Progenetix; CVCL_C269
DR   Rockland; WM209-01-0001
DR   Rockland; WM209-01-0005
DR   Rockland; WM209-01-0010
DR   Wikidata; Q54994211
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000219097; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO: 11,12->12, D13S317: 11,12->12, D5S818: 10,11->11 and D7S820: 10,11->11.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 11,18
ST   D19S433: 12,15
ST   D21S11: 28,31
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 21
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 17,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 24
//
ID   WM2090
AC   CVCL_0B70
DR   cancercelllines; CVCL_0B70
DR   Rockland; WM2090-01-0001
DR   Wikidata; Q54994212
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11
ST   D18S51: 12,16
ST   D19S433: 13,14
ST   D21S11: 30,31
ST   D2S1338: 24,25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 12,13
ST   FGA: 23
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   WM218
AC   CVCL_L029
SY   WM-218; WM 218
DR   Wikidata; Q54994213
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 14-08-25; Version: 7
//
ID   WM239A
AC   CVCL_6795
SY   WM-239A; WM-239-A; WM 239-A; WM 239A; WM-239; WM239; WM 239; WC00044
DR   BTO; BTO_0003474
DR   cancercelllines; CVCL_6795
DR   Cell_Model_Passport; SIDM00978
DR   Coriell; WC00044
DR   Cosmic; 888850
DR   Cosmic; 928690
DR   Cosmic; 972260
DR   Cosmic; 1155288
DR   Cosmic; 1155564
DR   Cosmic; 1303069
DR   Cosmic; 1477413
DR   GDSC; 1240225
DR   GEO; GSM109034
DR   GEO; GSM188232
DR   GEO; GSM188262
DR   GEO; GSM188321
DR   IARC_TP53; 24993
DR   PharmacoDB; WM239A_1670_2019
DR   Progenetix; CVCL_6795
DR   Rockland; WM239A-01-0001
DR   Wikidata; Q54994215
RX   PubMed=2253310;
RX   PubMed=3020539;
RX   PubMed=3856042;
RX   PubMed=4053039;
RX   PubMed=15009714;
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (PubMed=15009714; Wistar).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00044; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D21S11: 28,29
ST   D5S818: 12,13
ST   D7S820: 7,8
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   WM239A HmR
AC   CVCL_VS31
SY   WM-239A HmR
DR   cancercelllines; CVCL_VS31
DR   Wikidata; Q98134959
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6795 ! WM239A
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   WM239B
AC   CVCL_RN56
SY   WM-239B; WM 239B
DR   cancercelllines; CVCL_RN56
DR   Wikidata; Q54994216
RX   PubMed=2253310;
RX   PubMed=3856042;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 13
//
ID   WM245
AC   CVCL_J513
SY   WM-245; WM 245
DR   Wikidata; Q54994217
RX   PubMed=4053039;
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   WM262
AC   CVCL_AP85
DR   cancercelllines; CVCL_AP85
DR   Rockland; WM262-01-0001
DR   Wikidata; Q54994218
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 20,25->20.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 9,11
ST   D18S51: 20
ST   D19S433: 12.2,13
ST   D21S11: 28,29,32.2
ST   D2S1338: 23,24
ST   D3S1358: 17
ST   D5S818: 13
ST   D7S820: 8,11
ST   D8S1179: 15,16
ST   FGA: 20
ST   TH01: 6,9
ST   TPOX: 9,12
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 15
//
ID   WM266-1
AC   CVCL_RN57
SY   WM-266-1; WM 266-1
DR   cancercelllines; CVCL_RN57
DR   Wikidata; Q54994219
RX   PubMed=2253310;
RX   PubMed=3856042;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   WM266-2
AC   CVCL_RN58
SY   WM-266-2; WM 266-2
DR   cancercelllines; CVCL_RN58
DR   Wikidata; Q54994220
RX   PubMed=2253310;
RX   PubMed=3856042;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN59 ! WM266-3
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   WM266-3
AC   CVCL_RN59
SY   WM-266-3; WM 266-3
DR   cancercelllines; CVCL_RN59
DR   Wikidata; Q54994221
RX   PubMed=2253310;
RX   PubMed=3856042;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (from autologous cell lines WM165-1; WM239A; WM266-4).
CC   Derived from site: Metastatic; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_2765 ! WM266-4
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 14
//
ID   WM266-4
AC   CVCL_2765
SY   WM-266-4; WM 266-4; WM-2664; WM2664; WM 2664; WM266; WM-266-mel; WM266mel; WC00097
DR   BTO; BTO_0001595
DR   CLO; CLO_0009612
DR   CLO; CLO_0009615
DR   EFO; EFO_0006774
DR   CLDB; cl4726
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-1676
DR   BioGRID_ORCS_Cell_line; 344
DR   BioSample; SAMN05292442
DR   BioSample; SAMN10988367
DR   cancercelllines; CVCL_2765
DR   Cell_Model_Passport; SIDM00979
DR   CGH-DB; 9312-4
DR   ChEMBL-Cells; CHEMBL4295431
DR   ChEMBL-Targets; CHEMBL4296510
DR   Coriell; WC00097
DR   Cosmic; 687444
DR   Cosmic; 905225
DR   Cosmic; 932718
DR   Cosmic; 972276
DR   Cosmic; 1022277
DR   Cosmic; 1054856
DR   Cosmic; 1155273
DR   Cosmic; 1238103
DR   Cosmic; 1295343
DR   Cosmic; 1303070
DR   Cosmic; 1458970
DR   Cosmic; 1459638
DR   Cosmic; 1477409
DR   Cosmic; 1507624
DR   Cosmic; 1949557
DR   Cosmic; 2163804
DR   Cosmic; 2233687
DR   Cosmic; 2651885
DR   DepMap; ACH-001239
DR   ECACC; 91061233
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   ESTDAB; ESTDAB-076
DR   GEO; GSE17551
DR   GEO; GSM827418
DR   GEO; GSM887737
DR   GEO; GSM888832
DR   GEO; GSM1138792
DR   GEO; GSM1670578
DR   IARC_TP53; 30188
DR   KCLB; 21676
DR   LiGeA; CCLE_891
DR   LINCS_LDP; LCL-1259
DR   Lonza; 1375
DR   PharmacoDB; WM2664_1663_2019
DR   Progenetix; CVCL_2765
DR   PubChem_Cell_line; CVCL_2765
DR   Rockland; WM266-4-01-0001
DR   Wikidata; Q54994222
RX   PubMed=2253310;
RX   PubMed=3020539;
RX   PubMed=3856042;
RX   PubMed=4053039;
RX   PubMed=11121133;
RX   PubMed=12068308;
RX   PubMed=15467732;
RX   PubMed=15592718;
RX   PubMed=17308088;
RX   PubMed=19799798;
RX   PubMed=20215515;
RX   PubMed=21424129;
RX   PubMed=22460905;
RX   PubMed=23851445;
RX   PubMed=25485619;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=28158294;
RX   PubMed=28196595;
RX   PubMed=29492214;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544557
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Doubling time: ~30 hours (PBCF).
CC   HLA typing: A*02:01,29:02; B*13:02,44:03:01; C*06:02,16:01; DPB1*02:01:02,02:01:02; DQB1*02:01,02:01; DRB1*07:01,07:01 (PubMed=15592718).
CC   HLA typing: A*02:01,29:01; B*13:02,44:02; C*06:02,06:02; DQB1*06:04,06:04; DRB1*07:01,14:103 (PubMed=25960936).
CC   HLA typing: A*02:01,29:02; B*13:02,44:03; C*06:02,16:01 (PubMed=26589293).
CC   Karyotypic information: Hypertriploid karyotype.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Asp (c.1799_1800delTGinsAT); ClinVar=VCV000375939; Zygosity=Heterozygous (PubMed=12068308; PubMed=19799798; PubMed=23851445; PubMed=29492214; ATCC=CRL-1676; DepMap=ACH-001239; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:11730; TERT; Simple; c.1-146C>T (c.250C>T) (C250T); Zygosity=Unspecified; Note=In promoter (PubMed=31068700).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.04%; Native American=0%; East Asian, North=0%; East Asian, South=0.62%; South Asian=0.32%; European, North=66.56%; European, South=32.46% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-1676; true.
CC   Discontinued: Coriell; WC00097; probable.
CC   Discontinued: ECACC; 91061233; true.
CC   Derived from site: Metastatic; Right thigh, skin; UBERON=UBERON_0004262.
ST   Source(s): ATCC=CRL-1676; ESTDAB=ESTDAB-076; KCLB=21676; Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 11,12
ST   D18S51: 21
ST   D19S433: 13
ST   D21S11: 29
ST   D2S1338: 19
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 8
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0040 ! WM115
OI   CVCL_L033 ! WM165-1
OI   CVCL_RN55 ! WM165-2
OI   CVCL_6795 ! WM239A
OI   CVCL_RN56 ! WM239B
OI   CVCL_RN57 ! WM266-1
OI   CVCL_RN58 ! WM266-2
OI   CVCL_RN59 ! WM266-3
SX   Female
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 48
//
ID   WM278
AC   CVCL_6473
SY   WM-278; WM 278; WC00054
DR   BTO; BTO_0005480
DR   CLO; CLO_0009616
DR   EFO; EFO_0022559
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2809
DR   BioSample; SAMN03471796
DR   cancercelllines; CVCL_6473
DR   Cell_Model_Passport; SIDM00975
DR   Coriell; WC00054
DR   Cosmic; 686401
DR   Cosmic; 972271
DR   Cosmic; 1155544
DR   Cosmic; 1995665
DR   Cosmic; 2159427
DR   Cosmic; 2163805
DR   Cosmic-CLP; 1240226
DR   DepMap; ACH-002206
DR   EGA; EGAS00001000978
DR   ESTDAB; ESTDAB-077
DR   GDSC; 1240226
DR   GEO; GSM109035
DR   GEO; GSM186479
DR   GEO; GSM186480
DR   GEO; GSM555133
DR   GEO; GSM555172
DR   GEO; GSM1670579
DR   LINCS_LDP; LCL-1262
DR   PharmacoDB; WM278_1671_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_6473
DR   Rockland; WM278-01-0001
DR   Wikidata; Q54994223
RX   PubMed=2253310;
RX   PubMed=4053039;
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=21343389;
RX   PubMed=23851445;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*02:01,26:01; B*13:02,38:01; C*06:02,12:03; DPB1*02:01:02,01:01:02; DQB1*06:03,02:01; DRB1*13:01,07:01 (PubMed=15592718).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=23851445; Cosmic-CLP=1240226; DepMap=ACH-002206; Wistar).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.85%; Native American=0%; East Asian, North=0.99%; East Asian, South=2.12%; South Asian=1.13%; European, North=64.04%; European, South=30.87% (PubMed=30894373).
CC   Discontinued: ATCC; CRL-2809; true.
CC   Discontinued: Coriell; WC00054; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2809; Cosmic-CLP=1240226; ESTDAB=ESTDAB-077; Wistar
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 12,15
ST   D19S433: 15,16
ST   D21S11: 27,30
ST   D2S1338: 19,25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 19,22
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6791 ! WM1617
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 41
//
ID   WM28
AC   CVCL_L034
SY   WM-28; WM 28
DR   Wikidata; Q54994224
RX   PubMed=4053039;
RX   PubMed=6159966;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   WM3000
AC   CVCL_AP86
DR   cancercelllines; CVCL_AP86
DR   GEO; GSM185184
DR   Progenetix; CVCL_AP86
DR   Rockland; WM3000-01-0001
DR   Wikidata; Q54994225
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,12
ST   D16S539: 8,11
ST   D18S51: 14,16
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 17,23
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 12
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0B68 ! WM2032
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   WM3004
AC   CVCL_DG75
SY   WM 3004
DR   cancercelllines; CVCL_DG75
DR   GEO; GSM185185
DR   GEO; GSM185186
DR   Progenetix; CVCL_DG75
DR   Wikidata; Q54994226
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   WM3060
AC   CVCL_6796
SY   WM-3060; WM 3060; WC00126
DR   cancercelllines; CVCL_6796
DR   Coriell; WC00126
DR   Cosmic; 2159440
DR   Cosmic; 2230118
DR   GEO; GSM186481
DR   GEO; GSM186482
DR   Progenetix; CVCL_6796
DR   Rockland; WM3060-01-0001
DR   Wikidata; Q54994227
RX   PubMed=25056119;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=25056119; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9801; RAC1; Simple; p.Pro29Ser (c.85C>T); ClinVar=VCV000376362; Zygosity=Heterozygous (PubMed=25056119).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: VM3060; Cosmic=2230118.
CC   Discontinued: Coriell; WC00126; probable.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 19
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 18,21
ST   D3S1358: 14,18
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,16
ST   FGA: 22
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP76 ! WM1960
OI   CVCL_AP77 ! WM2013
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 26
//
ID   WM3061
AC   CVCL_AP87
DR   cancercelllines; CVCL_AP87
DR   Rockland; WM3061-01-0001
DR   Wikidata; Q54994228
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   WM3066
AC   CVCL_C270
SY   WM-3066; WM 3066
DR   cancercelllines; CVCL_C270
DR   GEO; GSM185187
DR   GEO; GSM185188
DR   GEO; GSM952597
DR   Progenetix; CVCL_C270
DR   Wikidata; Q54994234
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 14
//
ID   WM3077
AC   CVCL_DG76
SY   WM 3077
DR   cancercelllines; CVCL_DG76
DR   GEO; GSM185189
DR   GEO; GSM186483
DR   Progenetix; CVCL_DG76
DR   Wikidata; Q54994235
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 14-08-25; Version: 7
//
ID   WM3130
AC   CVCL_C271
SY   WM-3130; WM 3130
DR   Wikidata; Q54994236
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 10
//
ID   WM3152
AC   CVCL_A340
SY   WM-3152; WM 3152
DR   Cosmic; 1477414
DR   Wikidata; Q54994237
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 11
//
ID   WM3208V
AC   CVCL_L028
SY   WM-3208V; WM 3208V; WM3208; WM 3208
DR   cancercelllines; CVCL_L028
DR   GEO; GSM185190
DR   GEO; GSM185191
DR   GEO; GSM185192
DR   GEO; GSM185193
DR   Progenetix; CVCL_L028
DR   Wikidata; Q54994238
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   91Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 05-10-23; Version: 10
//
ID   WM3211
AC   CVCL_6797
SY   WM-3211; WM 3211; WC00045; EST79
DR   cancercelllines; CVCL_6797
DR   Coriell; WC00045
DR   Cosmic; 972286
DR   Cosmic; 1047655
DR   Cosmic; 1155289
DR   Cosmic; 1155541
DR   Cosmic; 1284919
DR   Cosmic; 1303071
DR   Cosmic; 2144978
DR   Cosmic; 2159443
DR   Cosmic; 2163806
DR   DepMap; ACH-002508
DR   ESTDAB; ESTDAB-079
DR   GEO; GSM109036
DR   GEO; GSM156008
DR   GEO; GSM185194
DR   GEO; GSM185195
DR   GEO; GSM188070
DR   GEO; GSM188122
DR   GEO; GSM188195
DR   GEO; GSM188210
DR   GEO; GSM188216
DR   GEO; GSM188233
DR   GEO; GSM188263
DR   GEO; GSM188286
DR   GEO; GSM188295
DR   GEO; GSM188322
DR   IARC_TP53; 26082
DR   Progenetix; CVCL_6797
DR   Rockland; WM3211-01-0001
DR   Wikidata; Q54994241
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=17260012;
RX   PubMed=18632627;
RX   PubMed=22578220;
RX   PubMed=23851445;
RX   PubMed=24576830;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*03:01,24:02; B*07:02; C*07:02; DPB1*04:01; DQB1*06:02,03:01:01; DRB1*04:01:01,15:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Gln50Ter (c.148C>T); ClinVar=VCV000220711; Zygosity=Unspecified (PubMed=23851445).
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Leu576Pro (c.1727T>C); ClinVar=VCV000375919; Zygosity=Unspecified (PubMed=23851445; PubMed=24576830; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys242Gly (c.724T>G); ClinVar=VCV000376581; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Discontinued: Coriell; WC00045; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): ESTDAB=ESTDAB-079; Wistar
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 12
ST   D18S51: 12
ST   D19S433: 13,14
ST   D21S11: 29,31.2
ST   D2S1338: 20,24
ST   D3S1358: 15,16
ST   D5S818: 11
ST   D7S820: 10,12
ST   D8S1179: 10,11
ST   FGA: 20
ST   TH01: 6,9.3
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 35
//
ID   WM3214
AC   CVCL_0L87
DR   Wikidata; Q54994242
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   WM3246
AC   CVCL_AP88
DR   cancercelllines; CVCL_AP88
DR   GEO; GSM952605
DR   Progenetix; CVCL_AP88
DR   Rockland; WM3246-01-0001
DR   Wikidata; Q54994243
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys80_Arg84del (c.238_252del); Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Adrenal gland; UBERON=UBERON_0002369.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 13,14
ST   D16S539: 11,14
ST   D18S51: 13,22
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 20,22
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 20,23
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   WM3248
AC   CVCL_6798
SY   WM-3248; WM 3248; WC00081
DR   cancercelllines; CVCL_6798
DR   Coriell; WC00081
DR   Cosmic; 1155546
DR   Cosmic; 1303073
DR   GEO; GSM109037
DR   GEO; GSM185196
DR   GEO; GSM185197
DR   GEO; GSM188066
DR   GEO; GSM188118
DR   GEO; GSM188191
DR   GEO; GSM188206
DR   GEO; GSM188215
DR   GEO; GSM188234
DR   GEO; GSM188264
DR   GEO; GSM188282
DR   GEO; GSM188291
DR   GEO; GSM188323
DR   Progenetix; CVCL_6798
DR   Rockland; WM3248-01-0001
DR   Wikidata; Q54994244
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Lys144Ter (c.430A>T); ClinVar=VCV000379501; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Misspelling: WM-3428; Cosmic=1303073.
CC   Discontinued: Coriell; WC00081; probable.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   WM3258
AC   CVCL_0L88
DR   Wikidata; Q54994245
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 5
//
ID   WM3268
AC   CVCL_L031
SY   WM-3268; WM 3268; WM3268V; WM-3268V; WM 3268V; WM3268A
DR   cancercelllines; CVCL_L031
DR   Cosmic; 1155561
DR   Cosmic; 1303072
DR   GEO; GSM109038
DR   GEO; GSM185198
DR   GEO; GSM185199
DR   Progenetix; CVCL_L031
DR   Rockland; WM3268-01-0001
DR   Wikidata; Q54994246
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,13
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 12,13
ST   D21S11: 29,32.2
ST   D2S1338: 17,18
ST   D3S1358: 13,16
ST   D5S818: 9,10
ST   D7S820: 9,12
ST   D8S1179: 13,14
ST   FGA: 22,23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 20
//
ID   WM3282
AC   CVCL_0B71
SY   WM 3282
DR   cancercelllines; CVCL_0B71
DR   Rockland; WM3282-01-0001
DR   Wikidata; Q54994247
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,14
ST   D16S539: 11,13
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 25
ST   D3S1358: 15
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 25,26
ST   TH01: 7,9.3
ST   TPOX: 9,11
ST   vWA: 20
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   WM3301
AC   CVCL_AP89
DR   cancercelllines; CVCL_AP89
DR   Rockland; WM3301-01-0001
DR   Wikidata; Q54994248
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10
ST   D16S539: 11,12
ST   D18S51: 12,16
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17
ST   D3S1358: 16,18
ST   D5S818: 9,13
ST   D7S820: 12,13
ST   D8S1179: 13,16
ST   FGA: 21
ST   TH01: 8,9
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   WM3311
AC   CVCL_0B72
SY   WM-3311; WM 3311
DR   cancercelllines; CVCL_0B72
DR   GEO; GSM952606
DR   Progenetix; CVCL_0B72
DR   Rockland; WM3311-01-0001
DR   Wikidata; Q54994249
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 11,17
ST   D19S433: 12,14
ST   D21S11: 31
ST   D2S1338: 19,23
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 23,25
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   WM3314
AC   CVCL_VI99
DR   GEO; GSM2094910
DR   GEO; GSM2094911
DR   Wikidata; Q98134960
RX   PubMed=21109473;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 4
//
ID   WM3406
AC   CVCL_AP90
DR   cancercelllines; CVCL_AP90
DR   Rockland; WM3406-01-0001
DR   Wikidata; Q54994250
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12,14
ST   D16S539: 11,13
ST   D18S51: 16
ST   D19S433: 13,16
ST   D21S11: 30.2
ST   D2S1338: 19,26
ST   D3S1358: 16
ST   D5S818: 10,11
ST   D7S820: 13
ST   D8S1179: 14,15
ST   FGA: 25
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   WM3438
AC   CVCL_C272
SY   WM-3438; WM 3438
DR   cancercelllines; CVCL_C272
DR   GEO; GSM952607
DR   Progenetix; CVCL_C272
DR   Rockland; WM3438-01-0001
DR   Wikidata; Q54994252
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 8
ST   D16S539: 12,14
ST   D18S51: 12,14
ST   D19S433: 14,14.2
ST   D21S11: 32.2
ST   D2S1338: 17,19
ST   D3S1358: 14
ST   D5S818: 13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 21
//
ID   WM3451
AC   CVCL_C273
SY   WM-3451; WM 3451
DR   cancercelllines; CVCL_C273
DR   Cosmic; 1303074
DR   GEO; GSM109039
DR   GEO; GSM482483
DR   GEO; GSM952598
DR   Progenetix; CVCL_C273
DR   Wikidata; Q54994253
RX   PubMed=16827748;
WW   Info; Wistar; -; https://web.archive.org/web/20141129125241/http://www.wistar.org:80/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D19S433: 12,12.2->13,14 and D3S1358: 12,16->16,17.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 20,26
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP91 ! WM3456
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   WM3456
AC   CVCL_AP91
DR   cancercelllines; CVCL_AP91
DR   Rockland; WM3456-01-0001
DR   Wikidata; Q54994254
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: vWA: 18->17,18.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D18S51: 12,13
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 20,26
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 8,10
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C273 ! WM3451
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 15
//
ID   WM3482
AC   CVCL_AP92
DR   cancercelllines; CVCL_AP92
DR   Rockland; WM3482-01-0001
DR   Wikidata; Q54994255
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 15
ST   D21S11: 27
ST   D2S1338: 25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 9,13
ST   FGA: 21,22
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   WM35
AC   CVCL_0580
SY   WM-35; WM 35; WC00060
DR   BTO; BTO_0003475
DR   CLO; CLO_0009617
DR   EFO; EFO_0022558
DR   MCCL; MCC:0000486
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2807
DR   BioSample; SAMN03471793
DR   cancercelllines; CVCL_0580
DR   Cell_Model_Passport; SIDM00974
DR   Coriell; WC00060
DR   Cosmic; 686396
DR   Cosmic; 886834
DR   Cosmic; 1155548
DR   Cosmic; 1187584
DR   Cosmic; 1247866
DR   Cosmic; 1303075
DR   Cosmic; 1507600
DR   Cosmic; 1995666
DR   Cosmic; 2159431
DR   Cosmic-CLP; 1299080
DR   DepMap; ACH-002207
DR   EGA; EGAS00001000978
DR   GDSC; 1299080
DR   GEO; GSM109040
DR   GEO; GSM186484
DR   GEO; GSM186485
DR   GEO; GSM188068
DR   GEO; GSM188120
DR   GEO; GSM188193
DR   GEO; GSM188208
DR   GEO; GSM188213
DR   GEO; GSM188284
DR   GEO; GSM188293
DR   GEO; GSM555119
DR   GEO; GSM555188
DR   GEO; GSM952586
DR   GEO; GSM1670580
DR   LINCS_LDP; LCL-1263
DR   Lonza; 583
DR   PharmacoDB; WM35_1672_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0580
DR   Wikidata; Q54994256
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=8160777;
RX   PubMed=11123321;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=18790768;
RX   PubMed=23039341;
RX   PubMed=27087056;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; Wistar; -; https://web.archive.org/web/20141129125241/http://www.wistar.org:80/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=18632627; Cosmic-CLP=1299080; DepMap=ACH-002207; Wistar).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=0.26%; East Asian, South=0.38%; South Asian=0.25%; European, North=72.7%; European, South=26.42% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 20->14,15 and FGA: 19->19,24.
CC   Discontinued: ATCC; CRL-2807; true.
CC   Discontinued: Coriell; WC00060; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2807; Cosmic-CLP=1299080; PubMed=27087056; Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11
ST   D16S539: 12,13
ST   D18S51: 14,15
ST   D19S433: 15,16
ST   D21S11: 29,32.2
ST   D2S1338: 18,25
ST   D3S1358: 16,18
ST   D5S818: 11,12
ST   D7S820: 10,13
ST   D8S1179: 11,13
ST   FGA: 19,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 37
//
ID   WM35-P1N1
AC   CVCL_A806
SY   35-P1-N1
DR   cancercelllines; CVCL_A806
DR   Wikidata; Q54994257
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 1 passage of WM35 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0580 ! WM35
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   WM35-P1N2
AC   CVCL_A807
SY   35-P1-N2
DR   cancercelllines; CVCL_A807
DR   Wikidata; Q54994258
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 1 passage of WM35 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0580 ! WM35
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   WM35-P1N3
AC   CVCL_A808
SY   35-P1-N3
DR   Wikidata; Q54994259
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 1 passage of WM35 co-injected with Matrigel into nude mice.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0580 ! WM35
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 9
//
ID   WM35-P2N1
AC   CVCL_A809
SY   35-P2-N1
DR   cancercelllines; CVCL_A809
DR   Wikidata; Q54994261
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 2 passages of WM35 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0580 ! WM35
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   WM35-P2N2
AC   CVCL_A810
SY   35-P2-N2
DR   cancercelllines; CVCL_A810
DR   Wikidata; Q54994262
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 2 passages of WM35 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0580 ! WM35
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   WM35-P2N3
AC   CVCL_A811
SY   35-P2-N3
DR   cancercelllines; CVCL_A811
DR   Wikidata; Q54994263
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 2 passages of WM35 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0580 ! WM35
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   WM3506
AC   CVCL_AP93
DR   cancercelllines; CVCL_AP93
DR   Rockland; WM3506-01-0001
DR   Wikidata; Q54994264
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D13S317: 8->8,12.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 14,18
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 19,23
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 24,25
ST   TH01: 8
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 14-08-25; Version: 15
//
ID   WM3533
AC   CVCL_0B73
DR   cancercelllines; CVCL_0B73
DR   Rockland; WM3533-01-0001
DR   Wikidata; Q54994266
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 9,12
ST   D18S51: 13,16
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 25,26
ST   D3S1358: 15,17
ST   D5S818: 10,12
ST   D7S820: 9,12
ST   D8S1179: 10,15
ST   FGA: 22,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 17
//
ID   WM3540
AC   CVCL_AP94
DR   cancercelllines; CVCL_AP94
DR   Rockland; WM3540-01-0001
DR   Wikidata; Q54994267
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Asp97His (c.289G>C); ClinVar=VCV000408340; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 9
ST   D13S317: 9
ST   D16S539: 12
ST   D19S433: 12,13
ST   D21S11: 27,32
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11,12
ST   D8S1179: 9,13
ST   FGA: 20,24
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   WM3618F
AC   CVCL_0B74
SY   WM3618
DR   cancercelllines; CVCL_0B74
DR   Rockland; WM3618F-01-0001
DR   Wikidata; Q54994268
RX   PubMed=32430489;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Unspecified (PubMed=32430489).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 10,15
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0B81 ! WM3772F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   WM3619
AC   CVCL_0B75
DR   cancercelllines; CVCL_0B75
DR   Rockland; WM3619-01-0001
DR   Wikidata; Q54994269
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: FGA: 23->21,23.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 12
ST   D18S51: 12,15
ST   D19S433: 13
ST   D21S11: 28,32.2
ST   D2S1338: 20,21
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,10
ST   D8S1179: 9,14
ST   FGA: 21,23
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   WM3622
AC   CVCL_AP95
DR   cancercelllines; CVCL_AP95
DR   GEO; GSM952599
DR   Progenetix; CVCL_AP95
DR   Rockland; WM3622-01-0001
DR   Wikidata; Q54994270
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Phe337Ser (c.1010T>C); ClinVar=VCV001728487; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 11
ST   D18S51: 10,19
ST   D19S433: 14
ST   D21S11: 28,33.2
ST   D2S1338: 17,25
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 7,8
ST   D8S1179: 12,14
ST   FGA: 21
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   WM3623
AC   CVCL_C274
SY   WM-3623; WM 3623
DR   cancercelllines; CVCL_C274
DR   Rockland; WM3623-01-0001
DR   Wikidata; Q54994272
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 12,13
ST   D16S539: 11
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   WM3629
AC   CVCL_C275
SY   WM-3629; WM 3629; WC00117; WC00117A
DR   cancercelllines; CVCL_C275
DR   Coriell; WC00117
DR   Cosmic; 1812179
DR   Rockland; WM3629-01-0001
DR   Wikidata; Q54994273
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp594Gly (c.1781A>G); ClinVar=VCV000013972; Zygosity=Heterozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Homozygous (Wistar).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00117; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 11,12
ST   D19S433: 13,15
ST   D21S11: 31,32
ST   D2S1338: 32
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D7S820: 10
ST   D8S1179: 8,13
ST   FGA: 22
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 18,20
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   WM3630
AC   CVCL_0B76
DR   cancercelllines; CVCL_0B76
DR   Rockland; WM3630-01-0001
DR   Wikidata; Q54994274
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D13S317: 9,13->13, D18S51: 14->14,17, D19S433: 13,14->13 and D8S1179: 13->12,13.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 9,11
ST   D18S51: 14,17
ST   D19S433: 13
ST   D21S11: 28,31.2
ST   D2S1338: 24,25
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 19
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 17
//
ID   WM3670
AC   CVCL_6799
SY   WM-3670; WM 3670; WC00119; WC00119A
DR   cancercelllines; CVCL_6799
DR   Coriell; WC00119
DR   Cosmic; 1812180
DR   Cosmic; 2159436
DR   Rockland; WM3670-01-0001
DR   Wikidata; Q54994275
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Gly469Glu (c.1406G>A) (p.Gly509Glu, c.1526G>A); ClinVar=VCV000013974; Zygosity=Unspecified (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000039648; Zygosity=Unspecified (Wistar).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X,Y->X and CSF1PO: 11,12->12.
CC   Discontinued: Coriell; WC00119; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14,19
ST   D19S433: 14,17
ST   D21S11: 30
ST   D2S1338: 17,25
ST   D3S1358: 16,18
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 13
ST   FGA: 18,19
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   WM3681
AC   CVCL_C276
SY   WM-3681; WM 3681
DR   Rockland; WM3681-01-0001
DR   Wikidata; Q54994276
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 11
ST   D18S51: 13,19
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 19,25
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 13
ST   FGA: 24,25
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   WM3682
AC   CVCL_AP78
DR   cancercelllines; CVCL_AP78
DR   GEO; GSM2094908
DR   GEO; GSM2094909
DR   Rockland; WM3682-01-0001
DR   Wikidata; Q54994277
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 13,14
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0B77 ! WM3702
OI   CVCL_AP79 ! WM3758
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 16
//
ID   WM3702
AC   CVCL_0B77
DR   cancercelllines; CVCL_0B77
DR   Cosmic; 2159432
DR   GEO; GSM952600
DR   Progenetix; CVCL_0B77
DR   Rockland; WM3702-01-0001
DR   Wikidata; Q54994278
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D16S539: 13,14->14 and D5S818: 12,13->13.
CC   Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 14
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP78 ! WM3682
OI   CVCL_AP79 ! WM3758
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 20
//
ID   WM3704
AC   CVCL_0B78
DR   cancercelllines; CVCL_0B78
DR   Rockland; WM3704-01-0001
DR   Wikidata; Q54994279
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24His (c.71G>A); ClinVar=VCV000016929; Zygosity=Unspecified (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg130Glnfs*4 (c.389delG); ClinVar=VCV000192224; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: CSF1PO: 12,14->12, D13S317: 13->12, D18S51: 21->13, D7S820: 10->10,12 and FGA: 22->22,25.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D16S539: 13
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 31.2
ST   D2S1338: 16,19
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 10,12
ST   D8S1179: 13,15
ST   FGA: 22,25
ST   TH01: 7,9.3
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 19
//
ID   WM373
AC   CVCL_C277
SY   WM-373; WM 373
DR   cancercelllines; CVCL_C277
DR   Cosmic; 928687
DR   Rockland; WM373-01-0001
DR   Wikidata; Q54994291
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Back, skin; UBERON=UBERON_0001068.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 12,14
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 8
ST   D8S1179: 13
ST   FGA: 20
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7156 ! WM75
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 23
//
ID   WM3734
AC   CVCL_6800
SY   WM-3734; WM 3734; WC00090
DR   cancercelllines; CVCL_6800
DR   Coriell; WC00090
DR   Rockland; WM3734-01-0001
DR   Wikidata; Q54994292
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00090; probable.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 13
ST   D21S11: 30
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   WM3743
AC   CVCL_0B79
DR   Rockland; WM3743-01-0001
DR   Wikidata; Q54994293
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg15Ter (c.43A>T); ClinVar=VCV001422662; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 8,11
ST   D18S51: 16,18
ST   D19S433: 13,14
ST   D21S11: 31,31.2
ST   D2S1338: 19,21
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 8,12
ST   FGA: 21,26
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 15
//
ID   WM3749
AC   CVCL_AP80
DR   cancercelllines; CVCL_AP80
DR   Rockland; WM3749-01-0001
DR   Wikidata; Q54994294
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 14
ST   D16S539: 12
ST   D18S51: 16,17
ST   D19S433: 14,15
ST   D21S11: 30.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   D8S1179: 13,14
ST   FGA: 20,24
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 15
//
ID   WM3755
AC   CVCL_0B80
DR   cancercelllines; CVCL_0B80
DR   Rockland; WM3755-01-0001
DR   Wikidata; Q54994295
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 15->15,19, D3S1358: 16,17->16,17,18 and FGA: 23->20,23.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D19S433: 13,16
ST   D21S11: 29
ST   D2S1338: 17,20
ST   D3S1358: 16,17,18
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 16
//
ID   WM3758
AC   CVCL_AP79
DR   cancercelllines; CVCL_AP79
DR   Rockland; WM3758-01-0001
DR   Wikidata; Q54994296
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 14
ST   D18S51: 14,15
ST   D19S433: 14,15
ST   D21S11: 28,29
ST   D2S1338: 17,23
ST   D3S1358: 14,17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 11,12
ST   FGA: 22
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AP78 ! WM3682
OI   CVCL_0B77 ! WM3702
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 14
//
ID   WM3772F
AC   CVCL_0B81
SY   WM3772
DR   DepMap; ACH-002687
DR   Rockland; WM3772F-01-0001
DR   Wikidata; Q54994297
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:4390; GNAQ; Simple; p.Gln209Pro (c.626A>C); ClinVar=VCV000375957; Zygosity=Heterozygous (DepMap=ACH-002687).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 13
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D21S11: 28,31
ST   D2S1338: 20,25
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 10,13
ST   D8S1179: 10,15
ST   FGA: 20
ST   TH01: 9.3
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_0B74 ! WM3618F
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   WM3792
AC   CVCL_0B82
DR   cancercelllines; CVCL_0B82
DR   Rockland; WM3792-01-0001
DR   Wikidata; Q54994298
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601del (c.1801_1803delAAA); ClinVar=VCV000376287; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 11
ST   D18S51: 10,14
ST   D19S433: 14,15
ST   D21S11: 30,31.2
ST   D2S1338: 17,20
ST   D3S1358: 18
ST   D5S818: 13
ST   D7S820: 11,12
ST   D8S1179: 9,15
ST   FGA: 19,20
ST   TH01: 8
ST   TPOX: 8,10
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 16
//
ID   WM3854
AC   CVCL_6801
SY   WM-3854; WM 3854; WC00125
DR   cancercelllines; CVCL_6801
DR   Coriell; WC00125
DR   Cosmic; 2159435
DR   Rockland; WM3854-01-0001
DR   Wikidata; Q54994299
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00125; probable.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 9,12
ST   D16S539: 12
ST   D18S51: 12,15
ST   D19S433: 13,15
ST   D21S11: 29,33.2
ST   D2S1338: 17,25
ST   D3S1358: 14,17
ST   D5S818: 12,13
ST   D7S820: 11,13
ST   D8S1179: 11,16
ST   FGA: 20,24
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   WM3862
AC   CVCL_0B83
DR   Cosmic; 2159429
DR   Wikidata; Q54994300
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 7
//
ID   WM39
AC   CVCL_2240
SY   WM-39; WM 39; WC00077
DR   CLO; CLO_0009618
DR   ATCC; CRL-2811
DR   BioSample; SAMN03471795
DR   cancercelllines; CVCL_2240
DR   Coriell; WC00077
DR   Cosmic; 686399
DR   Cosmic; 1155549
DR   Cosmic; 1187580
DR   Cosmic; 2159437
DR   Cosmic; 2163807
DR   ESTDAB; ESTDAB-080
DR   GEO; GSM109041
DR   GEO; GSM186486
DR   GEO; GSM186487
DR   GEO; GSM186488
DR   GEO; GSM555136
DR   GEO; GSM555171
DR   Progenetix; CVCL_2240
DR   Rockland; WM39-01-0001
DR   Wikidata; Q54994301
RX   PubMed=2253310;
RX   PubMed=4053039;
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=18790768;
RX   PubMed=21343389;
RX   PubMed=23851445;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*02:01,02:05; B*07:02,15:03; C*07:02,15:05; DPB1*04:02,02:01:02; DQB1*05:01,02:01; DRB1*01:01,07:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Homozygous (PubMed=16827748; PubMed=18632627; PubMed=23851445; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (PubMed=23851445; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ser45ins4aa (c.134ins12bp); Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X->X,Y.
CC   Discontinued: ATCC; CRL-2811; true.
CC   Discontinued: Coriell; WC00077; probable.
ST   Source(s): ATCC=CRL-2811; ESTDAB=ESTDAB-080; Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 12,16
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 17,19
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 14
ST   D8S1179: 13,15
ST   FGA: 20,22
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 30
//
ID   WM3912
AC   CVCL_C278
SY   WM-3912; WM 3912
DR   Rockland; WM3912-01-0001
DR   Wikidata; Q54994302
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asn581Tyr (c.1741A>T); Zygosity=Unspecified (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Leu213Phe; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X,Y->X.
CC   Derived from site: Metastatic; Neck; UBERON=UBERON_0000974.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 13,19
ST   D19S433: 12
ST   D21S11: 29,31
ST   D2S1338: 17,19
ST   D3S1358: 14,16
ST   D5S818: 11
ST   D7S820: 7,8
ST   D8S1179: 13,14
ST   FGA: 21
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 19
//
ID   WM3918
AC   CVCL_C279
SY   WM-3918; WM 3918
DR   cancercelllines; CVCL_C279
DR   GEO; GSM952608
DR   Progenetix; CVCL_C279
DR   Rockland; WM3918-01-0001
DR   Wikidata; Q54994303
RX   PubMed=24576830;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 13->9,13 and FGA: 21,24->20,21,24.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 10,13
ST   D18S51: 9,13
ST   D19S433: 14,16
ST   D21S11: 28,30
ST   D2S1338: 19,24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 12
ST   D8S1179: 13,16
ST   FGA: 20,21,24
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 22
//
ID   WM3928
AC   CVCL_6802
SY   WM-3928; WM 3928; WM3928F; WC00115
DR   cancercelllines; CVCL_6802
DR   Coriell; WC00115
DR   GEO; GSM952609
DR   Progenetix; CVCL_6802
DR   Rockland; WM3928-01-0001
DR   Wikidata; Q54994304
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Tyr177Ter (c.531T>G); ClinVar=VCV000235334; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00115; probable.
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,9
ST   D16S539: 10
ST   D18S51: 14,19
ST   D19S433: 12,17
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 14,15
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 21
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   WM4002
AC   CVCL_L032
SY   WM-4002; WM 4002; WM4002F; WM-4002F; WM 4002F
DR   cancercelllines; CVCL_L032
DR   Rockland; WM4002-01-0001
DR   Wikidata; Q54994305
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 15,17
ST   D19S433: 14,14.2
ST   D21S11: 28,30
ST   D2S1338: 17,20
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D7S820: 9
ST   D8S1179: 11,13
ST   FGA: 20,23
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 18
//
ID   WM4235
AC   CVCL_A1UG
DR   cancercelllines; CVCL_A1UG
DR   DepMap; ACH-002509
DR   Wikidata; Q105511750
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (DepMap=ACH-002509).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 9
//
ID   WM46
AC   CVCL_6803
SY   WM-46; WM 46; WC00069
DR   cancercelllines; CVCL_6803
DR   Coriell; WC00069
DR   Cosmic; 1155269
DR   Cosmic; 1155552
DR   Cosmic; 1187582
DR   Cosmic; 1303076
DR   GEO; GSM186489
DR   GEO; GSM186490
DR   IARC_TP53; 24991
DR   Progenetix; CVCL_6803
DR   Rockland; WM46-01-0001
DR   Wikidata; Q54994306
RX   PubMed=4053039;
RX   PubMed=18632627;
RX   PubMed=18790768;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Highly pigmented.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=18632627; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Cys (c.70C>T); ClinVar=VCV000016928; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D13S317: 11,13->14, D8S1179: 13,14->14 and FGA: 22,23,28->23.
CC   Discontinued: Coriell; WC00069; probable.
CC   Derived from site: Metastatic; Abdomen, skin; UBERON=UBERON_0001416.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 14
ST   D16S539: 11,14
ST   D18S51: 19,20
ST   D19S433: 13,14
ST   D21S11: 29,30
ST   D2S1338: 17,18
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 23
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   WM47
AC   CVCL_C280
SY   WM-47; WM 47
DR   cancercelllines; CVCL_C280
DR   GEO; GSM186491
DR   GEO; GSM186492
DR   Progenetix; CVCL_C280
DR   Rockland; 51398
DR   Wikidata; Q54994307
RX   PubMed=6159966;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Rockland; 51398; true.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 10,12
ST   D16S539: 8,12
ST   D21S11: 28,29
ST   D5S818: 11
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   WM51
AC   CVCL_6995
SY   WM-51; WM 51; WC00122
DR   cancercelllines; CVCL_6995
DR   Coriell; WC00122
DR   Cosmic; 1155276
DR   Cosmic; 1155562
DR   Cosmic; 1303077
DR   GEO; GSM109042
DR   GEO; GSM186493
DR   GEO; GSM186494
DR   Progenetix; CVCL_6995
DR   Rockland; WM51-01-0001
DR   Wikidata; Q54994308
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00122; probable.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 9,14
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 19
ST   D19S433: 15,16
ST   D21S11: 30
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 22,23,24
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 16,18,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 24
//
ID   WM740V
AC   CVCL_L030
SY   WM-740V; WM 740V; WML-740V
DR   cancercelllines; CVCL_L030
DR   Wikidata; Q54994309
RX   PubMed=2253310;
RX   PubMed=3856042;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C283 ! WM858
OI   CVCL_C284 ! WM873-1
OI   CVCL_C285 ! WM873-2
OI   CVCL_C286 ! WM873-3
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   WM747
AC   CVCL_RN51
SY   WM-747; WM 747
DR   Wikidata; Q54994310
RX   PubMed=2253310;
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   WM75
AC   CVCL_7156
SY   WM-75; WM 75; WM75C
DR   BTO; BTO_0003711
DR   cancercelllines; CVCL_7156
DR   Cosmic; 686400
DR   Cosmic; 972272
DR   Cosmic; 1155551
DR   Cosmic; 2163809
DR   ESTDAB; ESTDAB-082
DR   GEO; GSM185200
DR   GEO; GSM185201
DR   GEO; GSM186495
DR   GEO; GSM186496
DR   Progenetix; CVCL_7156
DR   Rockland; WM75-01-0001
DR   Wikidata; Q54994311
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
RX   PubMed=15592718;
RX   PubMed=18632627;
RX   PubMed=23851445;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Characteristics: Pigmented.
CC   HLA typing: A*02:01,29:02; B*44:03:01; C*16:01; DPB1*04:01,03:01:01; DQB1*03:02,02:01; DRB1*04:05:01,01:01:01 (PubMed=15592718).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=23851445; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Lys (c.261_262GG>AA) (p.Gly102Lys, c.304_305GG>AA); Zygosity=Unspecified (PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
ST   Source(s): ESTDAB=ESTDAB-082; Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 12,13
ST   D21S11: 28,29
ST   D3S1358: 14
ST   D5S818: 11
ST   D7S820: 8,9
ST   FGA: 19,20
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C277 ! WM373
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 25
//
ID   WM793
AC   CVCL_8787
AS   CVCL_5414
SY   WM-793; WM 793; WML 793; WM793B; WM-793B; WM 793B; WM793b; WC00062
DR   BTO; BTO_0004612
DR   CLO; CLO_0009619
DR   EFO; EFO_0002873
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ATCC; CRL-2806
DR   BioGRID_ORCS_Cell_line; 343
DR   BioSample; SAMN03471791
DR   BioSample; SAMN10987987
DR   cancercelllines; CVCL_8787
DR   Cell_Model_Passport; SIDM00973
DR   ChEMBL-Cells; CHEMBL4630605
DR   ChEMBL-Targets; CHEMBL4630705
DR   Coriell; WC00062
DR   Cosmic; 686397
DR   Cosmic; 886836
DR   Cosmic; 928693
DR   Cosmic; 972274
DR   Cosmic; 1155266
DR   Cosmic; 1155545
DR   Cosmic; 1155567
DR   Cosmic; 1238114
DR   Cosmic; 1303078
DR   Cosmic; 2159433
DR   Cosmic; 2163810
DR   Cosmic-CLP; 1299081
DR   DepMap; ACH-000827
DR   EGA; EGAS00001000978
DR   ESTDAB; ESTDAB-083
DR   GDSC; 1299081
DR   GEO; GSM109043
DR   GEO; GSM185202
DR   GEO; GSM185203
DR   GEO; GSM185204
DR   GEO; GSM185205
DR   GEO; GSM188235
DR   GEO; GSM188265
DR   GEO; GSM188324
DR   GEO; GSM887738
DR   GEO; GSM888833
DR   GEO; GSM952587
DR   GEO; GSM1670581
DR   IARC_TP53; 24995
DR   LiGeA; CCLE_074
DR   LINCS_LDP; LCL-1264
DR   PharmacoDB; WM793_1664_2019
DR   PRIDE; PXD004343
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_8787
DR   PubChem_Cell_line; CVCL_8787
DR   Wikidata; Q54994312
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=4053039;
RX   PubMed=8160777;
RX   PubMed=8342600;
RX   PubMed=11123321;
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=22460905;
RX   PubMed=23851445;
RX   PubMed=24576830;
RX   PubMed=26589293;
RX   PubMed=27087056;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
RX   PubMed=35839778;
WW   Info; Wistar; -; https://web.archive.org/web/20141129125241/http://www.wistar.org:80/lab/meenhard-herlyn-dvm-dsc/page/melanoma-cell-lines-0
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,29:01; B*35:01,57:01; C*04:01:01,06:02; DPB1*04:01,04:01; DQB1*03:01:01,03:01:01; DRB1*11:03:01,11:03:01 (PubMed=15592718).
CC   HLA typing: A*01:01,29:01; B*35:02,57:01; C*04:01,06:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; PubMed=23851445; PubMed=24576830; Cosmic-CLP=1299081; DepMap=ACH-000827; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (PubMed=23851445; Cosmic-CLP=1299081; DepMap=ACH-000827; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (PubMed=23851445; Cosmic-CLP=1299081; DepMap=ACH-000827).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.43%; Native American=0.27%; East Asian, North=4.02%; East Asian, South=1.29%; South Asian=5.85%; European, North=24.77%; European, South=61.38% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 11,14->14,15.
CC   Discontinued: ATCC; CRL-2806; true.
CC   Discontinued: Coriell; WC00062; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): ATCC=CRL-2806; Cosmic-CLP=1299081; ESTDAB=ESTDAB-083; PubMed=27087056; Technion Genomics Center; Wistar
ST   Amelogenin: X (Wistar)
ST   Amelogenin: X,Y (ATCC=CRL-2806; Cosmic-CLP=1299081; ESTDAB=ESTDAB-083; PubMed=27087056; Technion Genomics Center)
ST   CSF1PO: 11
ST   D10S1248: 16
ST   D12S391: 18,24
ST   D13S317: 8,14
ST   D16S539: 12
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D1S1656: 12,17
ST   D21S11: 28,29
ST   D22S1045: 15,16
ST   D2S1338: 17,24
ST   D2S441: 11
ST   D3S1358: 14,16
ST   D5S818: 10,12
ST   D7S820: 10 (ESTDAB=ESTDAB-083)
ST   D7S820: 10,12 (ATCC=CRL-2806; Cosmic-CLP=1299081; PubMed=27087056; Technion Genomics Center; Wistar)
ST   D8S1179: 12,14
ST   DYS391: 10
ST   FGA: 20,21
ST   Penta D: 13
ST   Penta E: 5,12
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 43
//
ID   WM793-P1N1
AC   CVCL_A800
SY   793-P1-N1
DR   EFO; EFO_0002874
DR   cancercelllines; CVCL_A800
DR   Wikidata; Q54994313
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 1 passage of WM793 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WM793-P1N2
AC   CVCL_A801
SY   793-P1-N2
DR   cancercelllines; CVCL_A801
DR   Wikidata; Q54994314
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 1 passage of WM793 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WM793-P1N3
AC   CVCL_A802
SY   793-P1-N3
DR   cancercelllines; CVCL_A802
DR   Wikidata; Q54994315
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 1 passage of WM793 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WM793-P2N1
AC   CVCL_A803
SY   793-P2-N1
DR   EFO; EFO_0002875
DR   cancercelllines; CVCL_A803
DR   Wikidata; Q54994316
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 2 passages of WM793 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WM793-P2N2
AC   CVCL_A804
SY   793-P2-N2
DR   cancercelllines; CVCL_A804
DR   Wikidata; Q54994317
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 2 passages of WM793 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WM793-P2N3
AC   CVCL_A805
SY   793-P2-N3
DR   cancercelllines; CVCL_A805
DR   Wikidata; Q54994318
RX   PubMed=8160777;
CC   Population: Caucasian.
CC   Characteristics: Established after 2 passages of WM793 co-injected with Matrigel into nude mice.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Lys22Gln (c.64A>C); ClinVar=VCV000485487; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Trp274Ter (c.821G>A); ClinVar=VCV001762511; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8787 ! WM793
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
ID   WM8
AC   CVCL_C281
SY   WM-8; WM 8
DR   cancercelllines; CVCL_C281
DR   Cosmic; 928683
DR   Cosmic; 1155543
DR   GEO; GSM185206
DR   GEO; GSM185207
DR   GEO; GSM952610
DR   IARC_TP53; 24989
DR   Progenetix; CVCL_C281
DR   Rockland; WM8-01-0001
DR   Wikidata; Q54994319
RX   PubMed=286328;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:6342; KIT; Simple; p.Asn822Lys (c.2466T>A) (N818K); ClinVar=VCV000375931; Zygosity=Unspecified (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D19S433: 12.2,15->15, D8S1179: 11,12,14->12,14 and FGA: 22->22,27.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9
ST   D18S51: 19,20
ST   D19S433: 15
ST   D21S11: 30
ST   D2S1338: 17,23
ST   D3S1358: 15,16
ST   D5S818: 12,13
ST   D7S820: 9,13
ST   D8S1179: 12,14
ST   FGA: 22,27
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 23
//
ID   WM806
AC   CVCL_RN40
SY   WM-806; WM 806
DR   Wikidata; Q54994320
RX   PubMed=4053039;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   WM811M
AC   CVCL_RN52
SY   WM-811M; WM 811M
DR   Wikidata; Q54994321
RX   PubMed=2253310;
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN53 ! WM811P
OI   CVCL_RN54 ! WM862
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   WM811P
AC   CVCL_RN53
SY   WM-811P; WM 811P
DR   Wikidata; Q54994322
RX   PubMed=2253310;
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN52 ! WM811M
OI   CVCL_RN54 ! WM862
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   WM852
AC   CVCL_6804
SY   WM-852; WM 852; WML 852; WC00065; EST84
DR   EFO; EFO_0022366
DR   cancercelllines; CVCL_6804
DR   Coriell; WC00065
DR   Cosmic; 886832
DR   Cosmic; 972282
DR   Cosmic; 1047657
DR   Cosmic; 1155275
DR   Cosmic; 1303079
DR   Cosmic; 2163811
DR   Cosmic; 2479249
DR   ESTDAB; ESTDAB-084
DR   GEO; GSM109044
DR   GEO; GSM156017
DR   GEO; GSM952601
DR   IARC_TP53; 1193
DR   IARC_TP53; 26084
DR   Progenetix; CVCL_6804
DR   Rockland; WM852-01-0001
DR   Wikidata; Q54994323
RX   PubMed=4053039;
RX   PubMed=8342600;
RX   PubMed=15592718;
RX   PubMed=16827748;
RX   PubMed=17260012;
RX   PubMed=19340423;
RX   PubMed=23851445;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*03:01,02:01; B*15:01:01:01,07:02; C*03:04,07:02; DPB1*04:01; DQB1*06:02,03:02; DRB1*04:01,15:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=17260012).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; None_reported; -; Zygosity=- (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Ser241Phe (c.722C>T); ClinVar=VCV000012359; Zygosity=Unspecified (PubMed=17260012; PubMed=23851445).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D18S51: 18->16, D5S818: 12,13->13, D8S1179: 12,13->13 and FGA: 21->21,26.
CC   Misspelling: VM852; Cosmic=2479249.
CC   Discontinued: Coriell; WC00065; probable.
CC   Derived from site: Metastatic; Abdomen, skin; UBERON=UBERON_0001416.
ST   Source(s): ESTDAB=ESTDAB-084; Wistar
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 30
ST   D2S1338: 16,17
ST   D3S1358: 15,18
ST   D5S818: 13
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 21,26
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14,15 (Wistar)
ST   vWA: 15,17 (ESTDAB=ESTDAB-084)
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 36
//
ID   WM853-2
AC   CVCL_C282
SY   WM-853-2; WM 853-2; WML 853-2
DR   cancercelllines; CVCL_C282
DR   Rockland; WM853-2-01-0001
DR   Wikidata; Q54994324
RX   PubMed=2253310;
RX   PubMed=4053039;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D8S1179: 11->11,14 and FGA: 22->20,22.
CC   Derived from site: In situ; Back, skin; UBERON=UBERON_0001068.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 14,15
ST   D21S11: 29,30
ST   D2S1338: 17,24
ST   D3S1358: 16,17
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   D8S1179: 11,14
ST   FGA: 20,22
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 14-08-25; Version: 21
//
ID   WM858
AC   CVCL_C283
SY   WM-858; WM 858; Wm858; WML-858
DR   cancercelllines; CVCL_C283
DR   Cosmic; 1155558
DR   GEO; GSM109045
DR   GEO; GSM186497
DR   GEO; GSM186498
DR   GEO; GSM952588
DR   Progenetix; CVCL_C283
DR   Rockland; WM858-01-0001
DR   Wikidata; Q54994326
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 22,23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L030 ! WM740V
OI   CVCL_C284 ! WM873-1
OI   CVCL_C285 ! WM873-2
OI   CVCL_C286 ! WM873-3
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 24
//
ID   WM862
AC   CVCL_RN54
SY   WM-862; WM 862
DR   Wikidata; Q54994328
RX   PubMed=2253310;
CC   Part of: Wistar Institute melanoma cell line collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN52 ! WM811M
OI   CVCL_RN53 ! WM811P
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 4
//
ID   WM873-1
AC   CVCL_C284
SY   WM-873-1; WM 873-1; WML-873-1
DR   cancercelllines; CVCL_C284
DR   Rockland; WM873-1-01-0001
DR   Wikidata; Q54994329
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 8,12
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 22,23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L030 ! WM740V
OI   CVCL_C283 ! WM858
OI   CVCL_C285 ! WM873-2
OI   CVCL_C286 ! WM873-3
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 20
//
ID   WM873-2
AC   CVCL_C285
SY   WM-873-2; WM 873-2; WML-873-2
DR   cancercelllines; CVCL_C285
DR   Rockland; WM873-2-01-0001
DR   Wikidata; Q54994331
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from autologous cell lines WM740V; WM858; WM873-1).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 8
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 29,32.2
ST   D2S1338: 22,23
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   TH01: 6,8
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L030 ! WM740V
OI   CVCL_C283 ! WM858
OI   CVCL_C284 ! WM873-1
OI   CVCL_C286 ! WM873-3
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 22
//
ID   WM873-3
AC   CVCL_C286
SY   WM-873-3; WM 873-3; WML-873-3
DR   cancercelllines; CVCL_C286
DR   Wikidata; Q54994332
RX   PubMed=2253310;
RX   PubMed=3856042;
RX   PubMed=4053039;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from autologous cell lines WM740V; WM858; WM873-1).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L030 ! WM740V
OI   CVCL_C283 ! WM858
OI   CVCL_C284 ! WM873-1
OI   CVCL_C285 ! WM873-2
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   WM88
AC   CVCL_6805
SY   WM-88; WM 88; WC00123
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987992
DR   cancercelllines; CVCL_6805
DR   Cell_Model_Passport; SIDM01768
DR   Coriell; WC00123
DR   Cosmic; 1155563
DR   Cosmic; 1303080
DR   Cosmic; 1669265
DR   DepMap; ACH-000899
DR   GEO; GSM109046
DR   GEO; GSM188065
DR   GEO; GSM188117
DR   GEO; GSM188190
DR   GEO; GSM188205
DR   GEO; GSM188212
DR   GEO; GSM188236
DR   GEO; GSM188266
DR   GEO; GSM188281
DR   GEO; GSM188290
DR   GEO; GSM188325
DR   GEO; GSM887739
DR   GEO; GSM888834
DR   GEO; GSM952589
DR   IARC_TP53; 30189
DR   LiGeA; CCLE_583
DR   PharmacoDB; WM88_1665_2019
DR   Progenetix; CVCL_6805
DR   Rockland; WM88-01-0001
DR   SKY/M-FISH/CGH; 4948
DR   Wikidata; Q54994333
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=22460905;
RX   PubMed=24576830;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*11:01,23:01; B*35:01,44:03; C*04:01,04:01; DQA1*01:02,01:02; DQB1*05:01,06:02; DRB1*01:01,15:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=24576830; DepMap=ACH-000899; Wistar).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=3.54%; Native American=0%; East Asian, North=3.99%; East Asian, South=0%; South Asian=0%; European, North=55.46%; European, South=37.01% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X,Y->X.
CC   Discontinued: Coriell; WC00123; probable.
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,13
ST   D16S539: 11,13
ST   D18S51: 15,19
ST   D19S433: 12,13
ST   D21S11: 29,30
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   D8S1179: 13,15
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 12
ST   vWA: 18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 34
//
ID   WM9
AC   CVCL_6806
SY   WM-9; WM 9; WC00056
DR   BTO; BTO_0003438
DR   cancercelllines; CVCL_6806
DR   Coriell; WC00056
DR   Cosmic; 686408
DR   GEO; GSM186499
DR   GEO; GSM186500
DR   GEO; GSM952590
DR   IARC_TP53; 24990
DR   Progenetix; CVCL_6806
DR   Rockland; WM9-01-0001
DR   Wikidata; Q54994339
RX   PubMed=286328;
RX   PubMed=2068080;
RX   PubMed=3020539;
RX   PubMed=4053039;
RX   PubMed=8342600;
RX   PubMed=39175042;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: D8S1179: 12,13->12,13,14.
CC   Discontinued: Coriell; WC00056; probable.
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 11,14
ST   D18S51: 13
ST   D19S433: 12,15
ST   D21S11: 29
ST   D2S1338: 24,25
ST   D3S1358: 14,17
ST   D5S818: 9,11
ST   D7S820: 9,11
ST   D8S1179: 12,13,14
ST   FGA: 20,25
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 27
//
ID   WM9 R
AC   CVCL_E3AH
RX   PubMed=39175042;
CC   Selected for resistance to: ChEBI; CHEBI_90851; Cobimetinib (Cotellic).
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6806 ! WM9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WM9 RL
AC   CVCL_E8FY
RX   PubMed=31877948;
CC   Selected for resistance to: ChEBI; CHEBI_63637; Vemurafenib (Zelboraf; PLX4032).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6806 ! WM9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   WM9-HmR
AC   CVCL_VS30
SY   WM-9-HmR
DR   cancercelllines; CVCL_VS30
DR   Wikidata; Q98134962
RX   DOI=10.1111/j.1755-148X.2009.00641.x;
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Left axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6806 ! WM9
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 11
//
ID   WM902B
AC   CVCL_6807
SY   WM-902B; WM 902B; WM 902 B; WML 902B; WM902; WC00083
DR   BTO; BTO_0005780
DR   cancercelllines; CVCL_6807
DR   Coriell; WC00083
DR   Cosmic; 686398
DR   Cosmic; 972273
DR   Cosmic; 1155282
DR   Cosmic; 1155553
DR   Cosmic; 1187581
DR   Cosmic; 2163812
DR   Cosmic; 2838886
DR   ESTDAB; ESTDAB-085
DR   GDSC; 1240227
DR   GEO; GSM186501
DR   GEO; GSM186502
DR   GEO; GSM952591
DR   PharmacoDB; WM902B_1674_2019
DR   Progenetix; CVCL_6807
DR   Rockland; WM902B-01-0001
DR   Wikidata; Q54994340
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=4053039;
RX   PubMed=15592718;
RX   PubMed=18632627;
RX   PubMed=18790768;
RX   PubMed=21156289;
RX   PubMed=23851445;
RX   PubMed=27500726;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   HLA typing: A*01:01,29:01; B*07:02,08:01; C*07:01:01,15:05; DPB1*04:01,02:01:02; DQB1*03:01:01,04:02; DRB1*08:01,11:01 (PubMed=15592718).
CC   Sequence variation: Gene deletion; HGNC; HGNC:9588; PTEN; Zygosity=Hemizygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=18632627; PubMed=21156289; PubMed=23851445; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Leu (c.71G>T); ClinVar=VCV000376377; Zygosity=Unspecified (PubMed=21156289; PubMed=23851445; Wistar).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: Coriell; WC00083; probable.
CC   Discontinued: ESTDAB; ESTDAB-085; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 11,13
ST   D19S433: 12,13
ST   D21S11: 28,30
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,14
ST   FGA: 19
ST   TH01: 6,8
ST   TPOX: 8,9
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   WM902B-BR
AC   CVCL_VK52
SY   WM902B-R; WM902-BR
DR   cancercelllines; CVCL_VK52
DR   Cosmic; 2838887
DR   Wikidata; Q98134964
RX   PubMed=21156289;
RX   PubMed=27500726;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Selected for resistance to: ChEBI; CHEBI_131882; SB-590885.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21156289).
CC   Sequence variation: Mutation; HGNC; HGNC:1773; CDK4; Simple; p.Arg24Leu (c.71G>T); ClinVar=VCV000376377; Zygosity=Unspecified (PubMed=21156289).
CC   Sequence variation: Mutation; HGNC; HGNC:11355; STAG2; Simple; p.Lys1083Ter (c.3247A>T); Zygosity=Unspecified (PubMed=27500726).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6807 ! WM902B
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   WM911
AC   CVCL_RN41
SY   WM-911; WM 911
DR   Wikidata; Q54994341
RX   PubMed=4053039;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   WM918
AC   CVCL_RN42
SY   WM-918; WM 918
DR   Wikidata; Q54994342
RX   PubMed=4053039;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   WM98-1
AC   CVCL_L073
SY   WM-98-1; WM 98-1; 98.1
DR   BTO; BTO_0003712
DR   Wikidata; Q54994343
RX   PubMed=2253310;
RX   PubMed=4053039;
RX   PubMed=7646526;
RX   PubMed=8688321;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RN39 ! WM98-2
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 12
//
ID   WM98-2
AC   CVCL_RN39
SY   WM-98-2; WM 98-2
DR   Wikidata; Q54994344
RX   PubMed=4053039;
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L073 ! WM98-1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   WM983A
AC   CVCL_6808
SY   WM-983A; WM 983A; WM983-A; WC00048
DR   cancercelllines; CVCL_6808
DR   Cell_Model_Passport; SIDM01396
DR   Coriell; WC00048
DR   Cosmic; 686405
DR   Cosmic; 928685
DR   Cosmic; 1155272
DR   Cosmic; 1155565
DR   Cosmic; 1155569
DR   Cosmic; 1303081
DR   GEO; GSM109047
DR   GEO; GSM185208
DR   GEO; GSM185209
DR   GEO; GSM186503
DR   GEO; GSM186504
DR   Progenetix; CVCL_6808
DR   Rockland; WM983A-01-0001
DR   Wikidata; Q54994345
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=18790768;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: Amelogenin: X,Y->X, CSF1PO: 10,11->11, D13S317: 11,12->12, D5S818: 10,11->11 and D7S820: 10,11->11.
CC   Discontinued: Coriell; WC00048; probable.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 10,14
ST   D21S11: 29,32.2
ST   D2S1338: 25,27
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 8,13
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6809 ! WM983B
OI   CVCL_A338 ! WM983C
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   WM983B
AC   CVCL_6809
SY   WM-983B; WM 983B; WM983-B; WM-983/B; WC00066
DR   BTO; BTO_0005042
DR   ArrayExpress; E-MTAB-2770
DR   BioGRID_ORCS_Cell_line; 441
DR   BioSample; SAMN10987974
DR   cancercelllines; CVCL_6809
DR   Cell_Model_Passport; SIDM01397
DR   Coriell; WC00066
DR   Cosmic; 686406
DR   Cosmic; 1155557
DR   Cosmic; 1303082
DR   DepMap; ACH-000765
DR   GEO; GSM109048
DR   GEO; GSM887740
DR   GEO; GSM888835
DR   GEO; GSM952592
DR   IARC_TP53; 30190
DR   LiGeA; CCLE_332
DR   PharmacoDB; WM983B_1666_2019
DR   Progenetix; CVCL_6809
DR   Rockland; WM983B-01-0001
DR   Wikidata; Q54994346
RX   PubMed=2068080;
RX   PubMed=2253310;
RX   PubMed=16827748;
RX   PubMed=18632627;
RX   PubMed=21156289;
RX   PubMed=22460905;
RX   PubMed=23285177;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   HLA typing: A*01:01,29:02; B*14:02,37:01; C*06:02,08:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=16827748; PubMed=18632627; PubMed=21156289; DepMap=ACH-000765; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Phe (c.832_833CC>TT); Zygosity=Homozygous (DepMap=ACH-000765).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.75%; Native American=0%; East Asian, North=5.11%; East Asian, South=0%; South Asian=5.18%; European, North=22.68%; European, South=64.28% (PubMed=30894373).
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: deletion of D18S51: 14.
CC   Discontinued: Coriell; WC00066; probable.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11,12
ST   D19S433: 10,14
ST   D21S11: 29,31.2
ST   D2S1338: 25,27
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 8,13
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6808 ! WM983A
OI   CVCL_A338 ! WM983C
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 33
//
ID   WM983B-BR
AC   CVCL_AP81
SY   WM983B BR; WM983BBR; WM983B-R
DR   cancercelllines; CVCL_AP81
DR   Rockland; WM983BBR-01-0001
DR   Wikidata; Q54994347
RX   PubMed=21156289;
RX   PubMed=23285177;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_131882; SB-590885.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=21156289; Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Phe (c.832_833CC>TT); Zygosity=Homozygous (from parent cell line).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Inguinal lymph node; UBERON=UBERON_0001542.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6809 ! WM983B
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 17
//
ID   WM983C
AC   CVCL_A338
SY   WM-983C; WM 983C
DR   cancercelllines; CVCL_A338
DR   Cosmic; 1155556
DR   Cosmic; 1187585
DR   Cosmic; 1303083
DR   GEO; GSM109049
DR   GEO; GSM188069
DR   GEO; GSM188121
DR   GEO; GSM188194
DR   GEO; GSM188209
DR   GEO; GSM188214
DR   GEO; GSM188237
DR   GEO; GSM188267
DR   GEO; GSM188285
DR   GEO; GSM188294
DR   GEO; GSM188326
DR   Progenetix; CVCL_A338
DR   Rockland; WM983C-01-0001
DR   SKY/M-FISH/CGH; 4949
DR   Wikidata; Q54994348
RX   PubMed=2253310;
RX   PubMed=16827748;
RX   PubMed=18632627;
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): Wistar
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 14
ST   D19S433: 10,14
ST   D21S11: 29,31.2
ST   D2S1338: 25,27
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11
ST   D8S1179: 8,13
ST   FGA: 20,23
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6808 ! WM983A
OI   CVCL_6809 ! WM983B
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   WM989
AC   CVCL_0B84
DR   cancercelllines; CVCL_0B84
DR   Rockland; WM989-01-0001
DR   Wikidata; Q54994349
WW   Info; Wistar; -; https://www.wistar.org/our-scientists/meenhard-herlyn
CC   Part of: Wistar Institute melanoma cell line collection.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (Wistar).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (Wistar).
CC   Omics: Transcriptomics; Microarray.
CC   Caution: The reported STR profile from Wistar of this cell line was changed at one point between February 2016 when we retrieved them and entered them in Cellosaurus and May 2018. The major changes were: deletion of CSF1PO: 10,12, D13S317: 11,13->11, D18S51: 10,13->13,15, D19S433: 13->12,13, D21S11: 28->28,31.2, D3S1358: 18->17, deletion of D7S820: 9,10, FGA: 20->23 and TH01: 9->5,9.
ST   Source(s): Wistar
ST   Amelogenin: X
ST   D13S317: 11
ST   D16S539: 13
ST   D18S51: 13,15
ST   D19S433: 12,13
ST   D21S11: 28,31.2
ST   D2S1338: 18,19
ST   D3S1358: 17
ST   D5S818: 12,15
ST   D8S1179: 13,14
ST   FGA: 23
ST   TH01: 5,9
ST   TPOX: 8,10
ST   vWA: 14,15
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 15
//
ID   WMab-1
AC   CVCL_D3ED
DR   Wikidata; Q127384714
RX   PubMed=23524262;
WW   Provider; TUAB; -; http://www.med-tohoku-antibody.com/topics/001_paper_antibody_PDIS.htm
CC   Part of: Tohoku University Antibody Bank hybridoma collection.
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: UniProtKB; P48735; Human IDH2 (Note=With p.Arg172Trp).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   WMM1175
AC   CVCL_W753
SY   WMM 1175
DR   cancercelllines; CVCL_W753
DR   Cosmic; 1102380
DR   Wikidata; Q54994350
RX   PubMed=10338330;
RX   PubMed=11595726;
RX   PubMed=15945100;
RX   PubMed=23455323;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=15945100).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000013899; Zygosity=Unspecified (PubMed=23455323).
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 12
//
ID   WMM1215
AC   CVCL_W754
DR   cancercelllines; CVCL_W754
DR   Cosmic; 929201
DR   Wikidata; Q54994351
RX   PubMed=10338330;
RX   PubMed=23455323;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23455323).
CC   Sequence variation: Mutation; HGNC; HGNC:8803; PDGFRA; Simple; p.Asp842Val (c.2525A>T); ClinVar=VCV000013543; Zygosity=Unspecified (PubMed=23455323).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 9
//
ID   WMN
AC   CVCL_A1FT
DR   Cosmic; 850213
DR   Wikidata; Q102115105
RX   PubMed=7757991;
RX   PubMed=8344493;
RX   PubMed=8402660;
RX   PubMed=9563901;
RX   PubMed=9787181;
RX   PubMed=10567774;
CC   Doubling time: 24 hours (PubMed=8402660).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   WMP-1
AC   CVCL_C853
SY   WMP1
DR   Wikidata; Q54994352
RX   PubMed=7606923;
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: WMP/PasDnJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   24W
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 10
//
ID   WMP-2
AC   CVCL_2241
SY   WMP2
DR   CLO; CLO_0009620
DR   DSMZ; ACC-453
DR   DSMZCellDive; ACC-453
DR   Wikidata; Q54994353
RX   PubMed=7606923;
RX   PubMed=11124532;
RX   PubMed=16391817;
CC   Doubling time: ~30-40 hours (DSMZ=ACC-453).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Breed/subspecies: WMP/PasDnJ.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   24W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   WMPa
AC   CVCL_T689
SY   WMPA; Wisconsin-Minnesota Pronephros, strain A
DR   Wikidata; Q54994354
RX   DOI=10.3354/dao027001;
RX   PubMed=221384;
RX   PubMed=1087310;
RX   PubMed=1429360;
RX   PubMed=4545299;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic kidney, pronephros; UBERON=UBERON_0002120.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
SX   Sex unspecified
AG   Shumway stage 24 embryo
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 9
//
ID   WMPa/V208
AC   CVCL_D6A0
SY   WMPA/V208
DR   Wikidata; Q127384715
RX   PubMed=221384;
RX   PubMed=1087310;
CC   Group: Amphibian cell line.
CC   Virology: Experimentally infected with ranid herpesvirus 1 (RaHV-1) (PubMed=221384; PubMed=1087310).
CC   Derived from site: In situ; Embryonic kidney, pronephros; UBERON=UBERON_0002120.
OX   NCBI_TaxID=8404; ! Lithobates pipiens (Northern leopard frog)
HI   CVCL_T689 ! WMPa
SX   Sex unspecified
AG   Shumway stage 24 embryo
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   WMUi001-A
AC   CVCL_YX75
SY   TAD-hiPSC 2-2
DR   hPSCreg; WMUi001-A
DR   SKIP; SKIP005688
DR   Wikidata; Q98134968
RX   PubMed=32062133;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2203; COL4A2; Simple; p.Arg131Met (c.392G>T); Zygosity=Heterozygous (PubMed=32062133).
CC   Derived from site: In situ; Aorta, smooth muscle; UBERON=UBERON_0004178.
DI   NCIt; C50461; Aortic dissection
DI   ORDO; Orphanet_91387; Familial thoracic aortic aneurysm and aortic dissection
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   WMUi002-A
AC   CVCL_YX76
SY   TAZ-UiPSC
DR   hPSCreg; WMUi002-A
DR   Wikidata; Q98134970
RX   PubMed=32619718;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11577; TAFAZZIN; Simple; p.Asp173Thrfs*11 (c.517delG); ClinVar=VCV001704478; Zygosity=Hemizygous (PubMed=32619718).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=32619718
ST   Amelogenin: X,Y
ST   D12S391: 17,20
ST   D13S317: 9,11
ST   D16S539: 10,13
ST   D18S51: 18,20
ST   D19S433: 14,15.2
ST   D21S11: 30,33.2
ST   D2S441: 10,11
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D6S1043: 19
ST   D7S820: 11
ST   D8S1179: 13,16
ST   FGA: 21,22
ST   Penta E: 12,20
ST   vWA: 16
DI   NCIt; C84585; Barth syndrome
DI   ORDO; Orphanet_111; Barth syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   WMUi003-A
AC   CVCL_A1XL
SY   502-RP-i01A
DR   BioSamples; SAMEA6907389
DR   hPSCreg; WMUi003-A
DR   Wikidata; Q105511752
RX   PubMed=33207307;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:29326; SLC7A14; Simple; p.Gly330Arg (c.988G>A); ClinVar=VCV000126446; Zygosity=Homozygous (PubMed=33207307).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi004-A
AC   CVCL_A1XM
SY   502-RP-i01B
DR   BioSamples; SAMEA6907393
DR   hPSCreg; WMUi004-A
DR   Wikidata; Q105511754
RX   PubMed=33207307;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:29326; SLC7A14; Simple; p.Gly330Arg (c.988G>A); ClinVar=VCV000126446; Zygosity=Heterozygous (PubMed=33207307).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi005-A
AC   CVCL_A1XN
SY   502-RP-i01C
DR   BioSamples; SAMEA6907395
DR   hPSCreg; WMUi005-A
DR   Wikidata; Q105511757
RX   PubMed=33207307;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:29326; SLC7A14; Simple; p.Gly330Arg (c.988G>A); ClinVar=VCV000126446; Zygosity=Heterozygous (PubMed=33207307).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi006-A
AC   CVCL_A5QM
DR   hPSCreg; WMUi006-A
DR   Wikidata; Q107117475
CC   From: Wenzhou Medical University; Wenzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   WMUi013-A
AC   CVCL_A4EM
SY   iPS-Cas9; WMUi006-A
DR   hPSCreg; WMUi013-A
DR   Wikidata; Q105511759
RX   PubMed=33207306;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Characteristics: Using CRISPR/Cas9 a HA/L-TetOn-Cas9-CMV-PuroR-2A-HA/R construct was introduced in the AAVS1 safe harbor locus (PubMed=33207306).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   WMUi014-A
AC   CVCL_A4XY
SY   X-ALD-UiPSCs
DR   hPSCreg; WMUi014-A
DR   Wikidata; Q107117476
RX   PubMed=33472124;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; c.2013insA; Zygosity=Hemizygous (PubMed=33472124).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi015-A
AC   CVCL_A1XT
SY   X-LAS-UiPSC
DR   hPSCreg; WMUi015-A
DR   Wikidata; Q105511761
RX   PubMed=33202306;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2207; COL4A5; Simple; p.Gly1433Val (c.4298G>T); ClinVar=VCV000024724; Zygosity=Hemizygous (PubMed=33202306).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C34842; Alport syndrome
DI   ORDO; Orphanet_63; Alport syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi016-A
AC   CVCL_A4YB
SY   X-Dent-UiPSC
DR   hPSCreg; WMUi016-A
DR   Wikidata; Q107117477
RX   PubMed=33545640;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2023; CLCN5; Simple; p.Arg718Ter (c.2152C>T); ClinVar=VCV000011797; Zygosity=Hemizygous (PubMed=33545640).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C123260; Dent disease
DI   ORDO; Orphanet_93622; Dent disease type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi017-A
AC   CVCL_A4XX
SY   X-RSY-UiPSC
DR   hPSCreg; WMUi017-A
DR   Wikidata; Q107117478
RX   PubMed=33477035;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9330; PQBP1; Simple; p.Pro609Ala (c.1825C>G); Zygosity=Hemizygous (PubMed=33477035).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C165533; Renpenning syndrome
DI   ORDO; Orphanet_3242; Renpenning syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi018-A
AC   CVCL_A4XZ
SY   ABS-UiPSCs
DR   hPSCreg; WMUi018-A
DR   Wikidata; Q107117479
RX   PubMed=33631521;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9208; POR; Simple; p.Arg454His (c.1361G>A) (p.Arg457His, c.1370G>A); ClinVar=VCV000016907; Zygosity=Homozygous (PubMed=33631521).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C178415; Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis
DI   ORDO; Orphanet_63269; Antley-Bixler syndrome with genital anomaly and disorder of steroidogenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi019-A
AC   CVCL_A4YA
SY   BS-UiPSCs
DR   hPSCreg; WMUi019-A
DR   Wikidata; Q107117481
RX   PubMed=33607471;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10910; SLC12A1; Simple; p.Ala244Asp (c.731C>A); Zygosity=Homozygous (PubMed=33607471).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C178412; Bartter syndrome, type 1
DI   ORDO; Orphanet_620217; Bartter syndrome type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 6
//
ID   WMUi020-A
AC   CVCL_A5QJ
SY   BAV-TAA-hiPSC 12-1; BAV-TAA-hiPSC-12-1
DR   BioSamples; SAMEA8172010
DR   hPSCreg; WMUi020-A
DR   Wikidata; Q107117482
RX   PubMed=33631418;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:17985; ROBO4; Simple; p.Gln54Arg (c.161A>G); ClinVar=VCV001277602; Zygosity=Heterozygous (PubMed=33631418).
CC   Derived from site: In situ; Thoracic aorta, smooth muscle; UBERON=UBERON_8480002.
DI   NCIt; C128803; Bicuspid aortic valve
DI   NCIt; C27001; Thoracic aortic aneurysm
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 8
//
ID   WMUi021-A
AC   CVCL_A5GL
SY   GS-UiPSC
DR   hPSCreg; WMUi021-A
DR   Wikidata; Q107117483
RX   PubMed=33735743;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10912; SLC12A3; Simple; p.Thr60Met (c.179C>T); ClinVar=VCV000101514; Zygosity=Homozygous (PubMed=33735743).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84730; Gitelman syndrome
DI   ORDO; Orphanet_358; Gitelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi022-A
AC   CVCL_A5QK
SY   gxl3811724
DR   hPSCreg; WMUi022-A
DR   Wikidata; Q107117484
RX   PubMed=33901818;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9829; RAF1; Simple; p.Ser257Leu (c.770C>T); ClinVar=VCV000013957; Zygosity=Heterozygous (PubMed=33901818).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84820; LEOPARD syndrome
DI   ORDO; Orphanet_500; Noonan syndrome with multiple lentigines
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi023-A
AC   CVCL_A5QL
SY   MFS-iPSC-2021-02
DR   BioSamples; SAMEA8359409
DR   hPSCreg; WMUi023-A
DR   Wikidata; Q107117485
CC   From: Wenzhou Medical University; Wenzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 05-10-23; Version: 4
//
ID   WMUi031-A
AC   CVCL_A7KS
SY   LS-UiPSC
DR   hPSCreg; WMUi031-A
DR   Wikidata; Q107117486
RX   PubMed=33765594;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8108; OCRL; Simple; p.Met876Asnfs (c.2626dupA); Zygosity=Hemizygous (PubMed=33765594).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84940; Oculocerebrorenal syndrome
DI   ORDO; Orphanet_534; Oculocerebrorenal syndrome of Lowe
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WMUi032-A
AC   CVCL_C0J8
DR   BioSamples; SAMEA13317175
DR   hPSCreg; WMUi032-A
DR   Wikidata; Q112930569
RX   PubMed=35489268;
CC   From: Wenzhou Medical University; Wenzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12496; UBE3A; Simple; p.Asp583Gly (c.1748A>G) (p.Asp563Gly, c.1688A>G); ClinVar=VCV000160209; Zygosity=Heterozygous (PubMed=35489268).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_411511; Angelman syndrome due to a point mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WN-R
AC   CVCL_0I64
DR   CCLV; CCLV-RIE 0755
DR   Wikidata; Q54994356
RX   PubMed=19941903;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9902; ! Bison bonasus (European bison)
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 5
//
ID   WN10-1H9
AC   CVCL_A0NP
DR   Wikidata; Q108821518
RX   Patent=US20210188958;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18316.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; B0F9T2; Trichinella spiralis Ts-WN10.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   WNSs 239F1A8
AC   CVCL_XB57
SY   WNSs239F1A8
DR   CCRID; 4201PAT-CCTCC00211
DR   Wikidata; Q98134972
RX   Patent=US7732132;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200718.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P89253; Watermelon silver mottle virus (WSMoV) nonstructural protein NSs.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6971 ! FOX-NY
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   Wnt-LIGHT
AC   CVCL_C8QV
SY   WNT-LIGHT
DR   Wikidata; Q123033927
RX   PubMed=32268014;
CC   Characteristics: Responds to activation of the canonical Wnt signaling pathway by increasing expression of firefly luciferase. Luciferase reporter gene expression is under the control of a promoter with 7 LEF/TCF binding sites (PubMed=32268014).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0462 ! NCTC clone 929
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   Wo Fel
AC   CVCL_3431
DR   CLO; CLO_0009621
DR   ATCC; CRL-1273
DR   Wikidata; Q54994357
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34568; Ehlers-Danlos syndrome
DI   ORDO; Orphanet_98249; Ehlers-Danlos syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   Wo Jo
AC   CVCL_3432
DR   CLO; CLO_0009622
DR   ATCC; CRL-1247
DR   Wikidata; Q54994358
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26837; Osteogenesis imperfecta
DI   ORDO; Orphanet_666; Osteogenesis imperfecta
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   WO-E
AC   CVCL_0C30
DR   Wikidata; Q54994360
RX   PubMed=7736387;
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   WOL-1
AC   CVCL_F848
DR   Wikidata; Q54994361
RX   PubMed=10393935;
CC   Characteristics: IL7 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Stromal cell of bone marrow; CL=CL_0010001.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Adult
CA   Stromal cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 7
//
ID   Wolf-2010-11
AC   CVCL_A9L7
DR   Wikidata; Q102115106
RX   PubMed=25422446;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Ala126Thr (c.376G>A); ClinVar=VCV000372583; Zygosity=Heterozygous (PubMed=25422446).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp613Ter (c.1839G>A); ClinVar=VCV000349320; Zygosity=Heterozygous (PubMed=25422446).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   Wolf-2010-5
AC   CVCL_A9L8
DR   Wikidata; Q102115107
RX   PubMed=25422446;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.His313Tyr (c.937C>T); ClinVar=VCV000290817; Zygosity=Heterozygous (PubMed=25422446).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   Wolf-2010-5-MO
AC   CVCL_A9L9
DR   Wikidata; Q102115109
RX   PubMed=25422446;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   Wolf-2010-9-MO
AC   CVCL_A9M0
DR   Wikidata; Q102115110
RX   PubMed=25422446;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   Wolf-2012-13-FA
AC   CVCL_A9M1
DR   Wikidata; Q102115111
RX   PubMed=25422446;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   WON,C
AC   CVCL_E878
SY   WON, C
DR   dbMHC; 49068
DR   ECACC; 94082295
DR   IHW; IHW09195
DR   IPD-IMGT/HLA; 11736
DR   Wikidata; Q54994362
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*19,26; B*15:25,40; C*04,07; DPB1*02:01:02,16:01; DQA1*01:03,05:01; DQB1*03:01,06:01; DRB1*12:01,08:03; DRB3*02:02 (IPD-IMGT/HLA=11736).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WON,I
AC   CVCL_E879
SY   WON, I; WON, 1; TER238; TER-238; Ter 238; TER412; TER-412; Ter 412; TER514; TER-514; Ter-514; Ter 514; Extract 126
DR   dbMHC; 49069
DR   ECACC; 94082294
DR   IHW; IHW09194
DR   IPD-IMGT/HLA; 11735
DR   Wikidata; Q54994363
RX   PubMed=8307784;
RX   PubMed=30844424;
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/335cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX386F.pdf
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*34:01; B*40:02,56:01; C*01:02,15:02:01; DPB1*02:01:02,05:01; DQA1*01:04,01:03; DQB1*05:03:01; DRB1*08:03:02,14:08; DRB3*02:02 (IPD-IMGT/HLA=11735).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   WON,M
AC   CVCL_E880
SY   WON, M
DR   dbMHC; 49070
DR   ECACC; 94082293
DR   IHW; IHW09193
DR   IPD-IMGT/HLA; 11569
DR   Wikidata; Q54994364
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*24:02,34:01; B*15:25,56; C*04,07; DPA1*01:03:01,02:02:02; DPB1*16:01,22:01; DQA1*01:03; DQB1*06:01; DRB1*08:03 (IPD-IMGT/HLA=11569).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   WON,PY
AC   CVCL_E881
SY   WON, PY
DR   dbMHC; 49071
DR   ECACC; 94082256
DR   IHW; IHW09156
DR   IPD-IMGT/HLA; 11699
DR   Wikidata; Q54994365
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*33; B*58:01; C*03:02; DPB1*04:01; DQA1*05:01; DQB1*02:01; DRB1*03:01; DRB3*02:02 (IPD-IMGT/HLA=11699).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WOO,EM
AC   CVCL_E882
SY   WOO, EM
DR   dbMHC; 49072
DR   ECACC; 94082221
DR   IHW; IHW09122
DR   IPD-IMGT/HLA; 11666
DR   Wikidata; Q54994366
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   Population: Aboriginal Australian.
CC   HLA typing: A*03,24; B*07,40; C*07:02,02:02:02; DPB1*04:01,05:01; DQA1*01:04,01:02; DQB1*05:03,06:02; DRB1*15:01,14:EK; DRB3*02:02; DRB5*01:01 (IPD-IMGT/HLA=11666).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   Wood
AC   CVCL_B6PV
DR   Rockland; CB-0401
DR   Wikidata; Q112041941
WW   Info; Cellaria; -; https://web.archive.org/web/20230129053652/https://cellariainc.com/product/wood-cell-model/
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Glu424Gln (c.1270G>C); ClinVar=VCV001352477; Zygosity=Heterozygous (Cellaria).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): Cellaria
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,14
ST   D16S539: 12,13
ST   D18S51: 13,15
ST   D21S11: 29,31
ST   D3S1358: 14,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 12,13
ST   FGA: 24,26
ST   Penta D: 11,13
ST   Penta E: 13,14
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 18
DI   NCIt; C7688; Invasive breast ductal carcinoma and lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65-69Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   WoodTad-Bone
AC   CVCL_A0WI
DR   Wikidata; Q108821519
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Bone, hindlimb; UBERON=UBERON_0003464.
OX   NCBI_TaxID=45438; ! Lithobates sylvaticus (Wood frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   WoodTad-HE1
AC   CVCL_A0WH
DR   Wikidata; Q108821520
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Cephalic region; UBERON=UBERON_0007811.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=45438; ! Lithobates sylvaticus (Wood frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   WoodTad-rpe
AC   CVCL_A0WJ
DR   Wikidata; Q108821521
RX   PubMed=31172374;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Eye, retina, retinal pigment epithelium; UBERON=UBERON_0001782.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=45438; ! Lithobates sylvaticus (Wood frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   WOP
AC   CVCL_3433
SY   WOP 3027
DR   CLO; CLO_0009623
DR   CLDB; cl4970
DR   ICLC; ATL99011
DR   Wikidata; Q54994367
RX   PubMed=2987528;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03073; Murine polyomavirus (strain A2) (MPyV) large T antigen.
CC   Transformant: NCBI_TaxID; 10636; Murine polyomavirus (strain A2) (MPyV).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: NIH Swiss.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0594 ! NIH 3T3
SX   Male
AG   Embryo
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   WoWe
AC   CVCL_LC74
DR   cancercelllines; CVCL_LC74
DR   GEO; GSM1904848
DR   Progenetix; CVCL_LC74
DR   Wikidata; Q54994368
RX   PubMed=23563200;
RX   PubMed=30873613;
CC   Doubling time: 7 days (PubMed=30873613).
CC   Transformant: NCBI_TaxID; 493803; Merkel cell polyomavirus (MCPyV).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Lower limb, skin; UBERON=UBERON_0003532.
ST   Source(s): PubMed=30873613
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D18S51: 16,24
ST   D21S11: 30,32
ST   D3S1358: 16
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 21,25
ST   Penta D: 12,13
ST   Penta E: 12,16
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 15,18
DI   NCIt; C9231; Merkel cell carcinoma
DI   ORDO; Orphanet_79140; Cutaneous neuroendocrine carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 9
//
ID   WP [Human B-cell IHW]
AC   CVCL_F820
SY   Extract 225; Extract 408
DR   IPD-IMGT/HLA; 11819
DR   Wikidata; Q54994369
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/330cx.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02:30,03:01; B*35:01,38:01; C*04:01,12:03; DRB1*01:01,13:01 (IPD-IMGT/HLA=11819).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   WP [Human diffuse large B-cell lymphoma]
AC   CVCL_ZC29
DR   Wikidata; Q98134974
RX   PubMed=29416618;
RX   PubMed=30165192;
DI   NCIt; C36081; Diffuse large B-cell lymphoma activated B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 3
//
ID   WPE-int
AC   CVCL_K282
DR   BTO; BTO_0006000
DR   ATCC; CRL-2888
DR   BioSample; SAMN03471697
DR   Wikidata; Q54994370
RX   PubMed=16351690;
CC   Population: Caucasian.
CC   Doubling time: ~52 hours (ATCC=CRL-2888).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: WPE1-7-1; BioSample=SAMN03471697.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2888
ST   Amelogenin: X
ST   CSF1PO: 13,14
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   WPE-stem
AC   CVCL_K283
DR   ATCC; CRL-2887
DR   BioSample; SAMN03471813
DR   Wikidata; Q54994371
RX   PubMed=16351690;
CC   Population: Caucasian.
CC   Doubling time: ~24 hours (ATCC=CRL-2887).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2887
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 8,14
ST   D16S539: 9,11
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
ID   WPE1-NA22
AC   CVCL_3810
SY   WPE1NA22
DR   CLO; CLO_0009624
DR   ATCC; CRL-2849
DR   BioSample; SAMN03471802
DR   cancercelllines; CVCL_3810
DR   Cell_Model_Passport; SIDM01932
DR   DepMap; ACH-001422
DR   GEO; GSM827392
DR   Progenetix; CVCL_3810
DR   Wikidata; Q54994372
RX   PubMed=11304724;
RX   PubMed=15643173;
RX   PubMed=20215515;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: ~32 hours (ATCC=CRL-2849).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2849; DepMap=ACH-001422
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   WPE1-NB11
AC   CVCL_3811
DR   CLO; CLO_0009625
DR   ATCC; CRL-2851
DR   cancercelllines; CVCL_3811
DR   GEO; GSM827394
DR   Progenetix; CVCL_3811
DR   Wikidata; Q54994373
RX   PubMed=11304724;
RX   PubMed=15643173;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Doubling time: ~29 hours (ATCC=CRL-2851).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2851
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   WPE1-NB14
AC   CVCL_3812
SY   WPE-1/NB14
DR   CLO; CLO_0009626
DR   ATCC; CRL-2850
DR   cancercelllines; CVCL_3812
DR   GEO; GSM827570
DR   Progenetix; CVCL_3812
DR   Wikidata; Q54994374
RX   PubMed=11304724;
RX   PubMed=15643173;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Doubling time: ~38 hours (ATCC=CRL-2850).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2850
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   WPE1-NB26
AC   CVCL_3813
DR   CLO; CLO_0009627
DR   ATCC; CRL-2852
DR   cancercelllines; CVCL_3813
DR   GEO; GSM648825
DR   GEO; GSM827395
DR   Progenetix; CVCL_3813
DR   Wikidata; Q54994375
RX   PubMed=11304724;
RX   PubMed=15643173;
RX   PubMed=16471037;
RX   PubMed=20215515;
CC   Population: Caucasian.
CC   Doubling time: ~29 hours (ATCC=CRL-2852).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2852
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   WPE1-NB26-64
AC   CVCL_K284
DR   ATCC; CRL-2889
DR   Wikidata; Q54994376
RX   PubMed=16471037;
CC   Population: Caucasian.
CC   Characteristics: Established from WPE1-NB26 cells that formed subcutaneous tumors following cell injection in athymic mice.
CC   Doubling time: ~19 hours (ATCC=CRL-2889).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2889
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3813 ! WPE1-NB26
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   WPE1-NB26-65
AC   CVCL_K285
DR   ATCC; CRL-2890
DR   Wikidata; Q54994377
RX   PubMed=16471037;
CC   Population: Caucasian.
CC   Characteristics: Established from WPE1-NB26 cells that formed subcutaneous tumors following cell injection in athymic mice.
CC   Doubling time: ~23 hours (ATCC=CRL-2890).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Prostate, epithelium; UBERON=UBERON_0000428.
CC   Cell type: Epithelial cell of prostate; CL=CL_0002231.
ST   Source(s): ATCC=CRL-2890
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 14
ST   D16S539: 9,11
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 25
ST   Penta D: 10,13
ST   Penta E: 5,12
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3813 ! WPE1-NB26
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 15
//
ID   WPF22
AC   CVCL_W044
DR   Wikidata; Q54994378
RX   PubMed=24556363;
CC   Group: Endangered species/breed cell line.
CC   Doubling time: 30.2 hours (PubMed=24556363).
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Wuzhishan miniature pig; VBO=VBO_0012869.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 10-09-24; Version: 11
//
ID   WPMY-1
AC   CVCL_3814
SY   WPMY1; WPM-Y.1
DR   BTO; BTO_0003708
DR   CLO; CLO_0009628
DR   ATCC; CRL-2854
DR   BioSample; SAMN03471803
DR   CCRID; 3101HUMGNHu36
DR   CCRID; 4201HUM-CCTCC00627
DR   CLS; 305083
DR   Wikidata; Q54994379
RX   PubMed=10383888;
RX   PubMed=18462435;
CC   Population: Caucasian.
CC   Doubling time: ~38 hours (ATCC=CRL-2854).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pRSV-T).
CC   Derived from site: In situ; Prostate, stroma; UBERON=UBERON_0004184.
CC   Cell type: Stromal cell of prostate; CL=CL_0002622.
ST   Source(s): ATCC=CRL-2854
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 8,14
ST   D16S539: 9
ST   D18S51: 14,16
ST   D19S433: 13
ST   D21S11: 29,31
ST   D2S1338: 17,20
ST   D3S1358: 15,16
ST   D5S818: 12,15
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 24,25
ST   Penta D: 10,13
ST   Penta E: 5
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3791 ! RWPE-1
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   WR Di-1
AC   CVCL_Z814
SY   WR-Di-1; WR-72-Di-1
DR   DGRC; 207
DR   FlyBase_Cell_line; FBtc0000207
DR   Wikidata; Q54994386
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: ~2 days (DGRC=207).
OX   NCBI_TaxID=7250; ! Drosophila immigrans (Fruit fly)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WR Dv-1
AC   CVCL_Z815
SY   WR-Dv-1; WR-75-Dv-1; WR75-Dv-1
DR   DGRC; 40
DR   FlyBase_Cell_line; FBtc0000040
DR   Wikidata; Q54994387
RX   CelloPub=CLPUB00496;
RX   DOI=10.1016/B978-012229460-0/50004-X;
CC   Group: Insect cell line.
CC   Doubling time: 26-32 hours (Note=Depending on growth medium) (DGRC=40).
OX   NCBI_TaxID=7244; ! Drosophila virilis (Fruit fly)
SX   Sex unspecified
AG   First instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   WR001
AC   CVCL_VL92
DR   Wikidata; Q98134976
RX   PubMed=450131;
RX   PubMed=7301938;
CC   From: Nissley, S. Peter; National Cancer Institute; Bethesda; USA.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C9460; Cockayne syndrome
DI   ORDO; Orphanet_191; Cockayne syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 7
//
ID   WR002
AC   CVCL_W060
SY   WR2
DR   Wikidata; Q54994388
RX   PubMed=2502918;
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR004
AC   CVCL_W061
SY   WR4
DR   Wikidata; Q54994390
RX   PubMed=2502918;
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR005
AC   CVCL_W062
SY   WR5
DR   Wikidata; Q54994391
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR010
AC   CVCL_W063
SY   WR10
DR   Wikidata; Q54994392
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Lys88Profs*23 (c.258_261dupCCGA); ClinVar=VCV000018299; Zygosity=Heterozygous; Note=APRT*Q0 allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   WR011
AC   CVCL_W064
SY   WR11
DR   Wikidata; Q54994393
RX   PubMed=2502918;
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Lys88Profs*23 (c.258_261dupCCGA); ClinVar=VCV000018299; Zygosity=Homozygous; Note=APRT*Q0 allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR012
AC   CVCL_W065
SY   WR12
DR   Wikidata; Q54994394
RX   PubMed=2502918;
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR015
AC   CVCL_W066
SY   WR15
DR   Wikidata; Q54994395
RX   PubMed=2502918;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Lys88Profs*23 (c.258_261dupCCGA); ClinVar=VCV000018299; Zygosity=Homozygous; Note=APRT*Q0 allele (PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR016
AC   CVCL_W067
SY   WR16
DR   Wikidata; Q54994396
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR017
AC   CVCL_W068
SY   WR17
DR   Wikidata; Q54994397
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Lys88Profs*23 (c.258_261dupCCGA); ClinVar=VCV000018299; Zygosity=Heterozygous; Note=APRT*Q0 allele (PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   WR020
AC   CVCL_W069
SY   WR20
DR   Wikidata; Q54994399
RX   PubMed=3343350;
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350; PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR035
AC   CVCL_W070
SY   WR35
DR   Wikidata; Q54994400
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Heterozygous; Note=APRT*J allele (PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   WR036
AC   CVCL_W071
SY   WR36
DR   Wikidata; Q54994402
RX   PubMed=3488062;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Heterozygous; Note=APRT*J allele (PubMed=3488062).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   WR063
AC   CVCL_W072
SY   WR63
DR   Wikidata; Q54994403
RX   PubMed=3343350;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   WR064
AC   CVCL_W073
SY   WR64
DR   Wikidata; Q54994404
RX   PubMed=3343350;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Heterozygous; Note=APRT*J allele (PubMed=3343350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   WR067
AC   CVCL_W074
SY   WR67
DR   Wikidata; Q54994405
RX   PubMed=2502918;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WR077
AC   CVCL_W075
SY   WR77
DR   Wikidata; Q54994406
RX   PubMed=2502918;
RX   PubMed=3343350;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Met136Thr (c.407T>C); ClinVar=VCV000018296; Zygosity=Homozygous; Note=APRT*J allele (PubMed=3343350).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   WR081
AC   CVCL_W076
SY   WR81
DR   Wikidata; Q54994407
RX   PubMed=2502918;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WR083
AC   CVCL_W077
SY   WR83
DR   Wikidata; Q54994408
RX   PubMed=2502918;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WR1
AC   CVCL_C5QH
SY   mAb-WR1
DR   Wikidata; Q116050798
RX   PubMed=25069865;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_46577; Dextrofloxacin ((R)-ofloxacin).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 19-12-24; Version: 3
//
ID   WR19L
AC   CVCL_4338
SY   WR 19L; WR 19L.1
DR   CLO; CLO_0009629
DR   ATCC; TIB-52
DR   ECACC; 95050414
DR   Wikidata; Q54994409
RX   PubMed=212198;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5415 ! WR19M.1
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   WR19M.1
AC   CVCL_5415
SY   WR 19M.1; WR 19M
DR   CLO; CLO_0009630
DR   ATCC; TIB-70
DR   Wikidata; Q54994410
RX   PubMed=212198;
RX   PubMed=3792703;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_4338 ! WR19L
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   WR21
AC   CVCL_3623
DR   CLO; CLO_0009631
DR   ATCC; CRL-2189
DR   Wikidata; Q54994411
RX   PubMed=7803707;
CC   Genetic integration: Method=Transgenic mouse; Gene=HGNC; HGNC:5173; HRAS (Note=With p.Gly12Val).
CC   Breed/subspecies: (C57BL/6 x SJL)-Tg(Wap-HRAS)69Lln Chr YSJL/J.
DI   NCIt; C23140; Carcinoma of the mouse salivary glands
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 9
//
ID   WR216
AC   CVCL_5606
DR   CLO; CLO_0050975
DR   BioSample; SAMN03472279
DR   RCB; RCB0520
DR   Wikidata; Q54994412
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:626; APRT; Simple; p.Lys88Profs*23 (c.258_261dupCCGA); ClinVar=VCV000018299; Zygosity=Homozygous; Note=APRT*Q0 allele (RCB=RCB0520).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB0520
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 14
DI   NCIt; C121564; Adenine phosphoribosyltransferase deficiency
DI   ORDO; Orphanet_976; Adenine phosphoribosyltransferase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   WR73-Gm-1
AC   CVCL_WM12
DR   Wikidata; Q98134978
RX   CelloPub=CLPUB00496;
RX   PubMed=915617;
CC   Group: Insect cell line.
OX   NCBI_TaxID=37546; ! Glossina morsitans morsitans (Savannah tsetse fly)
SX   Sex unspecified
AG   Third instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 3
//
ID   WRC
AC   CVCL_4339
DR   CLO; CLO_0009632
DR   CLDB; cl4729
DR   ECACC; 88031148
DR   Wikidata; Q54994413
CC   Virology: Supports the growth of HSV, PRV and vaccinia viruses (ECACC=88031148).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_3537 ! LLC-WRC 256
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   Wrh-f2
AC   CVCL_ZJ78
DR   Wikidata; Q98134980
RX   PubMed=32433581;
CC   Characteristics: Has a low degree of diferentiation, a high degree of malignancy and a high metastasis potential which can lead to typical pulmonary metastasis (PubMed=32433581).
CC   Karyotypic information: Hypertetraploid karyotype (PubMed=32433581).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Transformant: ChEBI; CHEBI_76326; N-nitrosomorpholine (NMOR).
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   Wrh-s2
AC   CVCL_ZJ79
DR   Wikidata; Q98134982
RX   PubMed=32433581;
CC   Characteristics: Poorly diferentiated cell with a relatively low metastasis potential and a low incidence of pulmonary metastasis (PubMed=32433581).
CC   Karyotypic information: Hyperdiploid karyotype (PubMed=32433581).
CC   Transformant: ChEBI; CHEBI_34873; N-nitrosodiethylamine (Diethylnitrosamine; DEN).
CC   Transformant: ChEBI; CHEBI_76326; N-nitrosomorpholine (NMOR).
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   1M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   WRL 68
AC   CVCL_0581
AS   CVCL_D685
SY   WRL-68; WRL68
DR   BTO; BTO_0002584
DR   CLO; CLO_0009633
DR   EFO; EFO_0022716
DR   MCCL; MCC:0000487
DR   CLDB; cl4730
DR   ATCC; CL-48
DR   BCRC; 60338
DR   BioSample; SAMN03151767
DR   ChEMBL-Cells; CHEMBL3307993
DR   ChEMBL-Targets; CHEMBL612587
DR   ECACC; 89121403
DR   IZSLER; BS CL 173
DR   PubChem_Cell_line; CVCL_0581
DR   Wikidata; Q54994415
RX   Patent=CA999546A;
RX   Patent=US3935066;
RX   PubMed=7522099;
RX   PubMed=8389256;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=20143388). Originally thought to be a hepatic fetal epithelial cell line.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00351.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-48.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Misspelling: CL-48; Note=Based on the ATCC catalog number.
CC   Discontinued: BCRC; 60338; true.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): ATCC=CL-48; ECACC=89121403
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3 (ATCC=CL-48)
ST   D13S317: 12,14 (ECACC=89121403)
ST   D16S539: 9,10
ST   D18S51: 16
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   WRL-LFBK-alphavbeta6
AC   CVCL_C4XX
SY   WRL-LFBK-avb6
DR   Wikidata; Q116050799
RX   PubMed=34458357;
CC   Problematic cell line: Misidentified. Grand-parent cell line (LF-BK) was originally thought to be of bovine origin but originates from pig.
CC   Virology: Treatment of the parent cell line with the aromatic cationic compound DB772 has cured the cell line from bovine viral diarrhea virus (BVDV) infection (PubMed=34458357).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30323; Bovine ITGAV.
CC   Genetic integration: Method=Transduction; Gene=VGNC; VGNC:30331; Bovine ITGB6.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
HI   CVCL_RX27 ! LFBK-alphaVbeta6
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 7
//
ID   WRLS1
AC   CVCL_4W86
DR   Wikidata; Q54994416
RX   PubMed=23111106;
CC   Problematic cell line: Contaminated. Parent cell line (WRL-68) has been shown to be a HeLa derivative.
CC   Population: African American.
CC   Selected for resistance to: ChEBI; CHEBI_50924; Sorafenib (Nexavar).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0581 ! WRL 68
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 13
//
ID   WRO
AC   CVCL_0582
AS   CVCL_1663
SY   WRO82-1; WRO 82-1; WRO-82; WRO82; UCLA RO 82-W-1; UCLA RO-82W-1; UCLA RO82W1; RO82W1; RO 82 W-1; RO82-W-1; RO82W-1; RO82
DR   BTO; BTO_0004772
DR   CLO; CLO_0008860
DR   MCCL; MCC:0000488
DR   CLDB; cl4167
DR   CLDB; cl4902
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-3610
DR   cancercelllines; CVCL_0582
DR   Cell_Model_Passport; SIDM00218
DR   ChEMBL-Cells; CHEMBL3308779
DR   ChEMBL-Targets; CHEMBL1075565
DR   Cosmic; 684194
DR   Cosmic; 685606
DR   Cosmic; 849971
DR   Cosmic; 886554
DR   Cosmic; 918181
DR   Cosmic; 928830
DR   Cosmic; 930083
DR   Cosmic; 931244
DR   Cosmic; 990535
DR   Cosmic; 1005459
DR   Cosmic; 1094762
DR   Cosmic; 1152113
DR   Cosmic; 1155332
DR   Cosmic; 1161614
DR   Cosmic; 1162842
DR   Cosmic; 1280051
DR   Cosmic; 1699415
DR   Cosmic; 2319849
DR   Cosmic-CLP; 930083
DR   DepMap; ACH-001384
DR   ECACC; 92030502
DR   EGA; EGAS00001000978
DR   GDSC; 930083
DR   GEO; GSM827437
DR   GEO; GSM1670384
DR   IARC_TP53; 2130
DR   IARC_TP53; 27230
DR   ICLC; HTL98002
DR   LINCS_LDP; LCL-1680
DR   Lonza; 1209
DR   PharmacoDB; RO82W1_1322_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_0582
DR   PubChem_Cell_line; CVCL_0582
DR   TOKU-E; 4066
DR   Wikidata; Q54994417
RX   PubMed=2551628;
RX   PubMed=2570483;
RX   PubMed=8423216;
RX   PubMed=9348181;
RX   PubMed=11439348;
RX   PubMed=14522906;
RX   PubMed=16778181;
RX   PubMed=17804723;
RX   PubMed=18713817;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=23162534;
RX   PubMed=25675381;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Caucasian.
CC   Doubling time: 4 days (PubMed=2570483).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23162534).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Homozygous (PubMed=8423216; PubMed=14522906; Cosmic-CLP=930083; DepMap=ACH-001384).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=2.33%; Native American=0%; East Asian, North=1.32%; East Asian, South=3.34%; South Asian=7.27%; European, North=24%; European, South=61.74% (PubMed=30894373).
CC   Derived from site: Metastatic; Not specified.
ST   Source(s): Cosmic-CLP=930083; DepMap=ACH-001384; ICLC=HTL98002
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11,12 (DepMap=ACH-001384; ICLC=HTL98002)
ST   D16S539: 12 (Cosmic-CLP=930083)
ST   D18S51: 10,13
ST   D21S11: 29
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 8,12
ST   D8S1179: 11,16
ST   FGA: 22.2,23
ST   Penta D: 10
ST   Penta E: 19,20
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,19 (Cosmic-CLP=930083; DepMap=ACH-001384)
ST   vWA: 16,21 (ICLC=HTL98002)
DI   NCIt; C8054; Thyroid gland follicular carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   Ws-HMG
AC   CVCL_U700
SY   WS-HMG
DR   ATCC; CRL-1253
DR   Wikidata; Q54994418
RX   PubMed=4083156;
CC   Discontinued: ATCC; CRL-1253; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   WS0101
AC   CVCL_A7BT
DR   Wikidata; Q107117487
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS0701
AC   CVCL_A7CL
DR   Wikidata; Q107117488
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS0702
AC   CVCL_A7CM
DR   Wikidata; Q107117489
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS0801
AC   CVCL_A7CN
DR   Wikidata; Q107117490
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS1
AC   CVCL_2766
SY   WS-1; WT-Fibr2
DR   CLO; CLO_0009634
DR   EFO; EFO_0022403
DR   CLDB; cl4732
DR   ATCC; CRL-1502
DR   BCRC; 60300
DR   BioSample; SAMN03471371
DR   CLS; 300344
DR   ECACC; 88021104
DR   GEO; GSM1053952
DR   GEO; GSM1053953
DR   GEO; GSM1053954
DR   GEO; GSM1053979
DR   GEO; GSM1053980
DR   GEO; GSM1053981
DR   Wikidata; Q54994419
RX   PubMed=721103;
RX   PubMed=1383811;
RX   PubMed=3724780;
RX   PubMed=23225669;
CC   Population: African American.
CC   Senescence: Senesces at 67 PDL (ATCC=CRL-1502).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: CLS; 300344; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1502; ECACC=88021104
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 15,19
ST   D19S433: 11,14
ST   D21S11: 28,29
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 13
ST   D7S820: 9,10
ST   D8S1179: 12,13
ST   FGA: 22,27
ST   Penta D: 12
ST   Penta E: 11,12
ST   TH01: 8,10
ST   TPOX: 8,9
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12FW
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   WS1-CLS
AC   CVCL_6211
DR   CLS; 300378
DR   Wikidata; Q54994420
CC   Population: Caucasian.
CC   Derived from site: In situ; Foot, skin; UBERON=UBERON_0001513.
ST   Source(s): CLS=300378
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D18S51: 12,17
ST   D21S11: 29,31.2
ST   D3S1358: 15,18
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13
ST   FGA: 20,23
ST   Penta D: 9,13
ST   Penta E: 12,20
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C5585; Skin sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 13
//
ID   WS10001
AC   CVCL_A7FC
DR   Wikidata; Q107117491
RX   PubMed=10543396;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Homozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10101
AC   CVCL_A7CH
DR   Wikidata; Q107117492
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10201
AC   CVCL_A7CC
DR   Wikidata; Q107117493
RX   PubMed=9365237;
RX   PubMed=9503605;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10402
AC   CVCL_A7BY
DR   Wikidata; Q107117494
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10501
AC   CVCL_A7CD
DR   Wikidata; Q107117495
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10801
AC   CVCL_A7CI
DR   Wikidata; Q107117496
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10901
AC   CVCL_A7CE
DR   Wikidata; Q107117497
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated as originating from a 60 year old female in PubMed=9365237 and from a 43 year old female in PubMed=10543396.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS10KO
AC   CVCL_A7PT
SY   Werner Syndrome 10 KObe
DR   Wikidata; Q107117498
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 17 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS10S
AC   CVCL_A7PH
DR   Wikidata; Q107117501
RX   PubMed=4083156;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WS11001
AC   CVCL_A7BV
DR   Wikidata; Q107117502
RX   PubMed=9365237;
RX   PubMed=9503605;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS11201
AC   CVCL_A7CF
DR   Wikidata; Q107117503
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys168Alafs*10 (c.502_503delAA) (c.733_734delAA); ClinVar=VCV000403979; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated as originating from a 49 year old female in PubMed=9365237 and from a 48 year old male in PubMed=10543396.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS11301
AC   CVCL_A7CJ
DR   Wikidata; Q107117504
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS11601
AC   CVCL_A7CK
DR   Wikidata; Q107117505
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS11701
AC   CVCL_A7FM
DR   Wikidata; Q107117506
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; c.3460-7T>A (IVS29-7T>A); ClinVar=VCV000647377; Zygosity=Homozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WS11801
AC   CVCL_A7CQ
DR   Wikidata; Q107117507
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS11901
AC   CVCL_A7CR
DR   Wikidata; Q107117508
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS11KO
AC   CVCL_A7PI
SY   Werner Syndrome 11 KObe
DR   Wikidata; Q107117509
RX   PubMed=4083156;
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 26 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS12001
AC   CVCL_A7FN
DR   Wikidata; Q107117510
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Tyr463Ter (c.1389T>A) (c.1620T>A); Zygosity=Homozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS12101
AC   CVCL_A7FH
DR   Wikidata; Q107117511
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS12301
AC   CVCL_A7CS
DR   Wikidata; Q107117512
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS12701
AC   CVCL_A7FI
DR   Wikidata; Q107117513
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS12KO
AC   CVCL_A7PU
SY   Werner Syndrome 12 KObe
DR   Wikidata; Q107117515
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 28 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS13corr
AC   CVCL_A9L0
DR   Wikidata; Q102115113
RX   PubMed=32321868;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple_corrected; p.Leu200Argfs*87 (c.599delT); ClinVar=VCV002203514; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32321868).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Glu752Ter (c.2254G>T); ClinVar=VCV000215399; Zygosity=Heterozygous (PubMed=32321868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9K9 ! WS13unedit
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   WS13unedit
AC   CVCL_A9K9
SY   Wolf-2010-13
DR   Wikidata; Q102115114
RX   PubMed=25422446;
RX   PubMed=32321868;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Leu200Argfs*87 (c.599delT); ClinVar=VCV002203514; Zygosity=Heterozygous (PubMed=25422446; PubMed=32321868).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Glu752Ter (c.2254G>T); ClinVar=VCV000215399; Zygosity=Heterozygous (PubMed=25422446; PubMed=32321868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   WS14101
AC   CVCL_A7FJ
DR   Wikidata; Q107117516
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS17-c1
AC   CVCL_RI92
DR   SKIP; SKIP001237
DR   Wikidata; Q54994421
RX   PubMed=27509850;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI93 ! WS17-c2
OI   CVCL_RI94 ! WS17-c4
SX   Male
AG   9Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS17-c2
AC   CVCL_RI93
DR   SKIP; SKIP001236
DR   Wikidata; Q54994422
RX   PubMed=27509850;
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI92 ! WS17-c1
OI   CVCL_RI94 ! WS17-c4
SX   Male
AG   9Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS17-c4
AC   CVCL_RI94
DR   SKIP; SKIP001238
DR   Wikidata; Q54994423
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI92 ! WS17-c1
OI   CVCL_RI93 ! WS17-c2
SX   Male
AG   9Y8M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS1KO
AC   CVCL_A7PJ
SY   Werner Syndrome 1 KObe
DR   Wikidata; Q107117517
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 10 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS1TKB
AC   CVCL_J710
DR   CLO; CLO_0050654
DR   BioSample; SAMN03472305
DR   RCB; RCB0409
DR   Wikidata; Q54994424
CC   Population: Japanese.
CC   Senescence: Senesces at 12-13 PDL (RCB=RCB0409).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0409
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J711 ! WS1TKB2
SX   Male
AG   56Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 15
//
ID   WS1TKB2
AC   CVCL_J711
DR   CLO; CLO_0050655
DR   RCB; RCB0433
DR   Wikidata; Q54994425
CC   Population: Japanese.
CC   Senescence: Senesces at 12-13 PDL (RCB=RCB0433).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0433
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J710 ! WS1TKB
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
ID   WS2101
AC   CVCL_A7BU
DR   Wikidata; Q107117518
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS23702
AC   CVCL_A7BW
DR   Wikidata; Q107117519
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS23703
AC   CVCL_A7BX
DR   Wikidata; Q107117520
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Caution: Indicated as originating from a 51 year old male in PubMed=9365237 and from a 39 year old male in PubMed=10543396.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS24002
AC   CVCL_A7BZ
DR   Wikidata; Q107117521
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS25-c1
AC   CVCL_RI95
DR   SKIP; SKIP001239
DR   Wikidata; Q54994426
RX   PubMed=27509850;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI96 ! WS25-c3
OI   CVCL_RI97 ! WS25-c4
SX   Female
AG   13Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS25-c3
AC   CVCL_RI96
DR   SKIP; SKIP001240
DR   Wikidata; Q54994427
RX   PubMed=27509850;
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI95 ! WS25-c1
OI   CVCL_RI97 ! WS25-c4
SX   Female
AG   13Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS25-c4
AC   CVCL_RI97
DR   SKIP; SKIP001241
DR   Wikidata; Q54994428
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI95 ! WS25-c1
OI   CVCL_RI96 ! WS25-c3
SX   Female
AG   13Y7M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   WS25401
AC   CVCL_A7FP
DR   Wikidata; Q107117522
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Ala1306Serfs*13 (c.3915dupA) (c.4146insA); ClinVar=VCV000005448; Zygosity=Homozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS2KO
AC   CVCL_A7PK
SY   Werner Syndrome 2 KObe
DR   Wikidata; Q107117523
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WS2RGB
AC   CVCL_T329
DR   CLO; CLO_0050696
DR   BioSample; SAMN03472337
DR   RCB; GMC0006
DR   RCB; RCB0154
DR   Wikidata; Q54994429
RX   PubMed=1471614;
CC   Population: Japanese.
CC   Senescence: Senesces at 16.2 PDL (RCB=GMC0006).
CC   Discontinued: RCB; RCB0154; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=GMC0006
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 13
//
ID   WS2TKB
AC   CVCL_J712
SY   WS2
DR   CLO; CLO_0050653
DR   BioSample; SAMN03472304
DR   RCB; RCB0407
DR   Wikidata; Q54994432
CC   Population: Japanese.
CC   Senescence: Senesces at 12-15 PDL (RCB=RCB0407).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=RCB0407
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 14
//
ID   WS3KO
AC   CVCL_A7PL
SY   Werner Syndrome 3 KObe
DR   Wikidata; Q107117524
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 11 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS3RGB
AC   CVCL_T330
DR   CLO; CLO_0050699
DR   BioSample; SAMN03472338
DR   RCB; GMC0007
DR   RCB; RCB0155
DR   Wikidata; Q54994433
RX   PubMed=1471614;
CC   Population: Japanese.
CC   Senescence: Senesces at 33.5 PDL (RCB=GMC0007).
CC   Discontinued: RCB; RCB0155; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=GMC0007
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 12
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 13
//
ID   WS4corr
AC   CVCL_A9K6
DR   Wikidata; Q102115116
RX   PubMed=32321868;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp371Ter (c.1112G>A); ClinVar=VCV001709531; Zygosity=Heterozygous (PubMed=32321868).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple_corrected; p.Arg629Trp (c.1885C>T); ClinVar=VCV001071979; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32321868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9K5 ! WS4unedit
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   WS4corr-B
AC   CVCL_A9K7
DR   Wikidata; Q102115117
RX   PubMed=32321868;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp371Ter (c.1112G>A); ClinVar=VCV001709531; Zygosity=Heterozygous (PubMed=32321868).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple_corrected; p.Arg629Trp (c.1885C>T); ClinVar=VCV001071979; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=32321868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9K5 ! WS4unedit
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   WS4KO
AC   CVCL_A7PM
SY   Werner Syndrome 4 KObe
DR   Wikidata; Q107117525
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 13 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS4unedit
AC   CVCL_A9K5
DR   Wikidata; Q102115118
RX   PubMed=32321868;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp371Ter (c.1112G>A); ClinVar=VCV001709531; Zygosity=Heterozygous (PubMed=32321868).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Arg629Trp (c.1885C>T); ClinVar=VCV001071979; Zygosity=Heterozygous (PubMed=32321868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   WS5801
AC   CVCL_A7BR
DR   Wikidata; Q107117527
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS5802
AC   CVCL_A7FK
DR   Wikidata; Q107117528
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS5KO
AC   CVCL_A7PN
SY   Werner Syndrome 5 KObe
DR   Wikidata; Q107117529
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 28 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS6104
AC   CVCL_A7FD
DR   Wikidata; Q107117530
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS6201
AC   CVCL_A7CP
DR   Wikidata; Q107117531
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Glu1149Glyfs (c.3446delA) (c.3677delA); ClinVar=VCV003595545; Zygosity=Homozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 6
//
ID   WS6401
AC   CVCL_A7FL
DR   Wikidata; Q107117532
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg1305Ter (c.3913C>T) (c.4144C>T); ClinVar=VCV000005444; Zygosity=Heterozygous (PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS6501
AC   CVCL_A7BS
DR   Wikidata; Q107117533
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=9365237; PubMed=10543396).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS6801
AC   CVCL_A7BQ
DR   Wikidata; Q107117534
RX   PubMed=9365237;
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS6KO
AC   CVCL_A7PP
SY   Werner Syndrome 6 KObe
DR   Wikidata; Q107117535
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 19 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS6RGB
AC   CVCL_T331
DR   CLO; CLO_0050694
DR   BioSample; SAMN03472353
DR   RCB; GMC0009
DR   RCB; RCB0387
DR   Wikidata; Q54994434
CC   Population: Japanese.
CC   Senescence: Senesces at 22 PDL (RCB=GMC0009).
CC   Discontinued: RCB; RCB0387; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): RCB=GMC0009
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 10
ST   D16S539: 9,10
ST   D5S818: 7,10
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 13
//
ID   WS77-c1
AC   CVCL_RI98
DR   SKIP; SKIP001242
DR   Wikidata; Q54994435
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI99 ! WS77-c4
OI   CVCL_RJ00 ! WS77-c5
SX   Female
AG   8Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS77-c4
AC   CVCL_RI99
DR   SKIP; SKIP001243
DR   Wikidata; Q54994436
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI98 ! WS77-c1
OI   CVCL_RJ00 ! WS77-c5
SX   Female
AG   8Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   WS77-c5
AC   CVCL_RJ00
DR   SKIP; SKIP001244
DR   Wikidata; Q54994437
RX   PubMed=27509850;
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RI98 ! WS77-c1
OI   CVCL_RI99 ! WS77-c4
SX   Female
AG   8Y1M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS79-c2
AC   CVCL_RJ01
DR   SKIP; SKIP001245
DR   Wikidata; Q54994438
RX   PubMed=27509850;
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ02 ! WS79-c3
OI   CVCL_RJ03 ! WS79-c5
SX   Male
AG   13Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 7
//
ID   WS79-c3
AC   CVCL_RJ02
DR   SKIP; SKIP001246
DR   Wikidata; Q54994439
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ01 ! WS79-c2
OI   CVCL_RJ03 ! WS79-c5
SX   Male
AG   13Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   WS79-c5
AC   CVCL_RJ03
DR   SKIP; SKIP001247
DR   Wikidata; Q54994440
RX   PubMed=27509850;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
DI   NCIt; C85232; Williams syndrome
DI   ORDO; Orphanet_904; Williams syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_RJ01 ! WS79-c2
OI   CVCL_RJ02 ! WS79-c3
SX   Male
AG   13Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   WS7KO
AC   CVCL_A7PQ
SY   Werner Syndrome 7 KObe
DR   Wikidata; Q107117536
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WS8901
AC   CVCL_A7FE
DR   Wikidata; Q107117537
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS8KO
AC   CVCL_A7PR
SY   Werner Syndrome 8 KObe
DR   Wikidata; Q107117538
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 19 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS9001
AC   CVCL_A7FF
DR   Wikidata; Q107117539
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS9101
AC   CVCL_A7CA
DR   Wikidata; Q107117541
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS9401
AC   CVCL_A7FG
DR   Wikidata; Q107117542
RX   PubMed=10543396;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   WS9601
AC   CVCL_A7CG
DR   Wikidata; Q107117543
RX   PubMed=9365237;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS9801
AC   CVCL_A7CB
DR   Wikidata; Q107117544
RX   PubMed=9365237;
RX   PubMed=9503605;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous (PubMed=9365237).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 19-12-24; Version: 5
//
ID   WS9KO
AC   CVCL_A7PS
SY   Werner Syndrome 9 KObe
DR   Wikidata; Q107117545
RX   PubMed=4083160;
CC   Population: Japanese.
CC   Senescence: Senesces at 12 PDL (PubMed=4083160).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 6
//
ID   WS9unedit
AC   CVCL_A9K8
SY   Wolf-2010-09; Wolf-2010-9
DR   Wikidata; Q102115119
RX   PubMed=25422446;
RX   PubMed=32321868;
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Ala126Thr (c.376G>A); ClinVar=VCV000372583; Zygosity=Heterozygous (PubMed=25422446; PubMed=32321868).
CC   Sequence variation: Mutation; HGNC; HGNC:12762; WFS1; Simple; p.Trp613Ter (c.1839G>A); ClinVar=VCV000349320; Zygosity=Heterozygous (PubMed=25422446; PubMed=32321868).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C35133; Wolfram syndrome
DI   ORDO; Orphanet_3463; Wolfram syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   WSB
AC   CVCL_J514
SY   Mel-WSB
DR   cancercelllines; CVCL_J514
DR   Cosmic; 889041
DR   Cosmic; 928704
DR   Cosmic; 1211151
DR   GEO; GSM170983
DR   Wikidata; Q54994441
RX   PubMed=8980186;
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17516929;
RX   PubMed=23039341;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 18
//
ID   WSBM
AC   CVCL_R928
SY   White Sturgeon Body Muscle
DR   Wikidata; Q54994442
RX   PubMed=15801167;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   WSCU01 iPS#02
AC   CVCL_IN40
SY   WSCU01 #02; WSCU01-derived iPSC clone 02
DR   Wikidata; Q54994443
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN41 ! WSCU01 iPS#13
OI   CVCL_IN42 ! WSCU01 iPS#14
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   WSCU01 iPS#13
AC   CVCL_IN41
SY   WSCU01 #13; WSCU01-derived iPSC clone 13
DR   Wikidata; Q54994444
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN40 ! WSCU01 iPS#02
OI   CVCL_IN42 ! WSCU01 iPS#14
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   WSCU01 iPS#14
AC   CVCL_IN42
SY   WSCU01 #14; WSCU01-derived iPSC clone 14
DR   Wikidata; Q54994445
RX   PubMed=25390333;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Arg369Ter (c.1105C>T) (c.1336C>T); ClinVar=VCV000005449; Zygosity=Heterozygous (PubMed=25390333).
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=25390333).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_IN40 ! WSCU01 iPS#02
OI   CVCL_IN41 ! WSCU01 iPS#13
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 13
//
ID   WSF
AC   CVCL_R929
SY   White Sturgeon Fin
DR   Wikidata; Q54994446
RX   PubMed=15801167;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   WSG-R
AC   CVCL_0I77
DR   CCLV; CCLV-RIE 0378
DR   Wikidata; Q54994448
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal brain; UBERON=UBERON_0006238.
CC   Breed/subspecies: Wild boar.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 7
//
ID   WSGO
AC   CVCL_R930
SY   White Sturgeon Gonad
DR   Wikidata; Q54994449
RX   PubMed=9676244;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R932 ! WSHO
OI   CVCL_R934 ! WSLV
OI   CVCL_R935 ! WSNV
OI   CVCL_R936 ! WSSB
SX   Male
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   WSH-1
AC   CVCL_R931
SY   White Sturgeon Heart-1
DR   Wikidata; Q54994450
RX   DOI=10.1577/1548-8659(1991)120<0528:TCLFWS>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R937 ! WSS-2
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   WSHO
AC   CVCL_R932
SY   White Sturgeon Hematopoeitic Organ
DR   Wikidata; Q54994451
RX   PubMed=9676244;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Meningeal myeloid tissue; UBERON=UBERON_8480038.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R930 ! WSGO
OI   CVCL_R934 ! WSLV
OI   CVCL_R935 ! WSNV
OI   CVCL_R936 ! WSSB
SX   Male
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   WSHST
AC   CVCL_R933
SY   White Sturgeon Head Soft Tissue
DR   Wikidata; Q54994452
RX   PubMed=15801167;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Head, hypodermis; UBERON=UBERON_0000033+UBERON_0002072.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
SX   Sex unspecified
AG   Fry
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   WSI
AC   CVCL_B7M5
DR   Wikidata; Q112930570
RX   PubMed=10395672;
CC   Sequence variation: Mutation; HGNC; HGNC:9986; RFX5; Simple; p.Gln321Ter (c.961C>T); Zygosity=Heterozygous (PubMed=10395672).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   WSL-R
AC   CVCL_0I66
SY   WSL-Bu; WSL-R-HP; WSL
DR   CCLV; CCLV-RIE 0379
DR   Wikidata; Q54994453
RX   PubMed=19941903;
RX   PubMed=24793370;
RX   PubMed=28871180;
RX   PubMed=34737324;
CC   Selected for resistance to: ChEBI; CHEBI_472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: Wild boar.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 19-12-24; Version: 9
//
ID   WSLV
AC   CVCL_R934
SY   White Sturgeon LiVer
DR   Wikidata; Q54994454
RX   PubMed=9676244;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R930 ! WSGO
OI   CVCL_R932 ! WSHO
OI   CVCL_R935 ! WSNV
OI   CVCL_R936 ! WSSB
SX   Male
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   WSN
AC   CVCL_9881
DR   Wikidata; Q54994455
RX   DOI=10.1007/0-306-46872-7_2;
RX   PubMed=7579408;
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y9M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 9
//
ID   WSNV
AC   CVCL_R935
DR   Wikidata; Q54994456
RX   PubMed=9676244;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R930 ! WSGO
OI   CVCL_R932 ! WSHO
OI   CVCL_R934 ! WSLV
OI   CVCL_R936 ! WSSB
SX   Male
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   WSS-1
AC   CVCL_2767
SY   WS-1
DR   BTO; BTO_0004920
DR   CLO; CLO_0009635
DR   ATCC; CRL-2029
DR   BioSample; SAMN03471421
DR   Wikidata; Q54994457
RX   PubMed=1336119;
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61855; Gabra1.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61966; Gabrg2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 28285; Human adenovirus C serotype 5.
CC   Derived from site: In situ; Fetal kidney; UBERON=UBERON_0002113.
ST   Source(s): ATCC=CRL-2029
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,14
ST   D16S539: 9,13
ST   D18S51: 17,18
ST   D19S433: 15,18
ST   D21S11: 28,30.2
ST   D2S1338: 19
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,14
ST   FGA: 23
ST   Penta D: 9,10
ST   Penta E: 7,15
ST   TH01: 7,9.3
ST   TPOX: 11
ST   vWA: 16,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0045 ! HEK293
SX   Female
AG   Fetus
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 19
//
ID   WSS-2
AC   CVCL_R937
SY   White Sturgeon Spleen-2
DR   Wikidata; Q54994459
RX   DOI=10.1577/1548-8659(1991)120<0528:TCLFWS>2.3.CO;2;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R931 ! WSH-1
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   WSSB
AC   CVCL_R936
SY   White Sturgeon Swim Bladder
DR   Wikidata; Q54994460
RX   PubMed=9676244;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Swim bladder; UBERON=UBERON_0006860.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
OI   CVCL_R930 ! WSGO
OI   CVCL_R932 ! WSHO
OI   CVCL_R934 ! WSLV
OI   CVCL_R935 ! WSNV
SX   Male
AG   Yearling
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   WSSK-1
AC   CVCL_S954
SY   WSSK; White Sturgeon SKin-1
DR   Wikidata; Q54994461
RX   DOI=10.3354/dao011049;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=7904; ! Acipenser transmontanus (White sturgeon)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 10
//
ID   WSSV-3B7
AC   CVCL_XB56
DR   Wikidata; Q98134985
RX   Patent=CN103497250B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201398.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 5
//
ID   WSSV-K1
AC   CVCL_XB91
DR   CCRID; 4201PAT-CCTCC00491
DR   Wikidata; Q98134987
RX   Patent=CN104360068A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014160.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   WSSV-K2
AC   CVCL_XB92
DR   CCRID; 4201PAT-CCTCC00492
DR   Wikidata; Q98134990
RX   Patent=CN104360068A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014161.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: White spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   WSSV-R
AC   CVCL_XY55
DR   Wikidata; Q98134992
RX   Patent=CN1322009C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200418.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Penaeus chinensis receptor for white spot syndrome virus.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 6
//
ID   WSU-1
AC   CVCL_HG33
SY   WSU1
DR   GEO; GSM1985
DR   Wikidata; Q54994462
RX   PubMed=10676951;
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 5
//
ID   WSU-ALCL
AC   CVCL_A036
DR   BioSample; SAMN03151623
DR   cancercelllines; CVCL_A036
DR   Cosmic; 1086369
DR   Wikidata; Q54994463
RX   CelloPub=CLPUB00128;
RX   PubMed=8558920;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=12592342; PubMed=20143388). Originally thought to originate from a malignant pleural effusion of a 18 year old patient with primary refractory anaplastic large cell lymphoma.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00284.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:13222; BCL11B + HGNC; HGNC:2488; NKX2-5; Name(s)=NKX2.5-BCL11B (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:16712; FBXW7; Simple; p.Arg465Cys (c.1393C>T); ClinVar=VCV000376414; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3765; FLT3; Simple; p.Ala627Thr (c.1879G>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1593_Arg1594insProArgLeuProHisAsnSerSerPheHisPheLeu (c.4780_4781ins36); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Pro2412Thr (c.7234C>A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0207 ! CCRF-CEM
SX   Female
AG   3Y11M
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 29
//
ID   WSU-AML
AC   CVCL_5607
DR   Wikidata; Q54994464
RX   PubMed=28109323;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/wsu-heme-onc-cell-lines
CC   Sequence variation: Gene fusion; HGNC; HGNC:1537; CBFA2T3 + HGNC; HGNC:29450; GLIS2; Name(s)=CBFA2T3-GLIS2, ETO2-GLIS2 (PubMed=28109323).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   WSU-BL
AC   CVCL_M552
DR   Wikidata; Q54994465
RX   DOI=10.1111/j.1749-6632.1989.tb16491.x;
RX   PubMed=2527086;
CC   Virology: EBV-negative.
CC   Doubling time: 19 hours (PubMed=2527086).
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number WSU-BL.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7954; Adult Burkitt leukemia
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 15
//
ID   WSU-CLL
AC   CVCL_A049
DR   BioSample; SAMN03151907
DR   cancercelllines; CVCL_A049
DR   Wikidata; Q29958010
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8558918;
RX   PubMed=12200708;
RX   PubMed=12592342;
RX   PubMed=20143388;
RX   PubMed=24923861;
WW   Info; ICLAC; -; https://iclac.org/education/wsu-cll/
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a Reh derivative (PubMed=12200708; PubMed=12592342; PubMed=20143388; PubMed=24923861). Originally thought to originate from a 68 year old male patient with chronic lymphocytic leukemia.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00285.
CC   Sequence variation: Gene fusion; HGNC; HGNC:3495; ETV6 + HGNC; HGNC:10471; RUNX1; Name(s)=ETV6-RUNX1, TEL-AML1 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Arg173Cys (c.517C>T); ClinVar=VCV000189500; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80334; B lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1) ETV6-RUNX1
DI   ORDO; Orphanet_585929; B-lymphoblastic leukemia/lymphoma with t(12;21)(p13.2;q22.1)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1650 ! Reh
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   WSU-DLCL
AC   CVCL_M580
DR   ABM; T8232
DR   Cosmic; 1086347
DR   DSMZ; ACC-779
DR   DSMZCellDive; ACC-779
DR   Wikidata; Q54994466
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1540884;
RX   PubMed=8558920;
CC   Doubling time: 20 hours (PubMed=1540884); ~48-72 hours (DSMZ=ACC-779).
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number WSU-DLCL.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): DSMZ=ACC-779
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D18S51: 14,17.2
ST   D19S433: 14
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 8,12
ST   D8S1179: 13,14
ST   FGA: 18
ST   Penta D: 9,10
ST   Penta E: 11
ST   TH01: 8,9.3
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   WSU-DLCL2
AC   CVCL_1902
SY   WSU-DLCL-2; WSU-DLCL(2); WSUDLCL2
DR   CLO; CLO_0037068
DR   EFO; EFO_0006775
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473225
DR   BioSample; SAMN10989570
DR   cancercelllines; CVCL_1902
DR   Cell_Model_Passport; SIDM00413
DR   Cosmic; 1329090
DR   Cosmic; 1629937
DR   Cosmic; 1714159
DR   Cosmic-CLP; 1331050
DR   DepMap; ACH-000534
DR   DSMZ; ACC-575
DR   DSMZCellDive; ACC-575
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   EGA; EGAS00001002554
DR   GDSC; 1331050
DR   GEO; GSM274708
DR   GEO; GSM887741
DR   GEO; GSM888836
DR   GEO; GSM1035308
DR   GEO; GSM1670582
DR   IARC_TP53; 28232
DR   LiGeA; CCLE_593
DR   LINCS_LDP; LCL-1954
DR   PharmacoDB; WSUDLCL2_1675_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1902
DR   Wikidata; Q54994467
RX   PubMed=9607591;
RX   PubMed=19358282;
RX   PubMed=22460905;
RX   PubMed=23699601;
RX   PubMed=25355872;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26727417;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30285677;
RX   PubMed=30629668;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31160637;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/wsu-heme-onc-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11585.
CC   Population: Caucasian.
CC   Doubling time: 18 hours (PubMed=9607591); ~50-70 hours (DSMZ=ACC-575).
CC   HLA typing: A*24/29; C*12/15 (PubMed=25960936).
CC   HLA typing: A*02:01,29:02; B*27:07,44:03; C*15:02,15:02 (PubMed=26589293).
CC   HLA typing: A*02:01:01,29:02:01; B*27:07:01,44:03:01; C*15:02:01,16:01:01; DPA1*01:03:01,01:03:01; DPB1*04:01:01,04:02:01; DQA1*04:01:01,05:05:01; DQB1*03:01:01,04:02:01; DRA*01:01:01,01:02:02; DRB1*11:01:01,08:01:01 (DSMZCellDive=ACC-575).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:3527; EZH2; Simple; p.Tyr646Phe (c.1937A>T) (Y641F); ClinVar=VCV000076768; Zygosity=Heterozygous (Cosmic-CLP=1331050; DepMap=ACH-000534).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=1331050; DepMap=ACH-000534).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq virome analysis.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.21%; Native American=0%; East Asian, North=2.12%; East Asian, South=0%; South Asian=0%; European, North=66.4%; European, South=31.27% (PubMed=30894373).
CC   Misspelling: WSU-DCL2; GEO=GSM1374991.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=1331050; DSMZ=ACC-575; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 11,14
ST   D16S539: 10,13
ST   D18S51: 15,16
ST   D19S433: 12
ST   D21S11: 29,32.2
ST   D2S1338: 22,25
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 10,12
ST   D8S1179: 12,13
ST   FGA: 22
ST   Penta D: 10,13
ST   Penta E: 14,19
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   WSU-FSCCL
AC   CVCL_1903
SY   WSUFSCCL
DR   EFO; EFO_0006776
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03472504
DR   DepMap; ACH-001708
DR   DSMZ; ACC-612
DR   DSMZCellDive; ACC-612
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM1308987
DR   GEO; GSM1308988
DR   GEO; GSM1308989
DR   GEO; GSM1308990
DR   PharmacoDB; WSUFSCCL_1676_2019
DR   Wikidata; Q54994468
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8221615;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/wsu-heme-onc-cell-lines
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: ~26 hours (PubMed=8221615); ~20-30 hours (DSMZ=ACC-612).
CC   HLA typing: A*02:01,02:01; B*27:05,44:02; C*01:02,05:01; DQA1*02:01,03:02; DQB1*03:02,03:02; DRB1*04:04,07:01 (PubMed=26589293).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-612; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 11,13
ST   D18S51: 13,14
ST   D19S433: 14
ST   D21S11: 30
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 12,14
ST   FGA: 22,24
ST   Penta D: 9,13
ST   Penta E: 7,12
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 18,20
DI   NCIt; C3465; Grade 1 follicular lymphoma
DI   ORDO; Orphanet_545; Follicular lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 30
//
ID   WSU-HN11
AC   CVCL_AX28
SY   Wayne State University-Head and Neck 11
DR   Wikidata; Q54994469
RX   PubMed=7705939;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   WSU-HN12
AC   CVCL_5518
SY   HN12; HN-12; Wayne State University-Head and Neck 12
DR   BTO; BTO_0005040
DR   ABM; T8292
DR   ChEMBL-Cells; CHEMBL4483183
DR   Cosmic; 922079
DR   Cosmic; 2043897
DR   Cosmic; 2296297
DR   Cosmic; 2513908
DR   PubChem_Cell_line; CVCL_5518
DR   Wikidata; Q54994470
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9049184;
RX   PubMed=9389571;
RX   PubMed=25275298;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Doubling time: 24-36 hours (ABM=T8292).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.672+1G>A; ClinVar=VCV000216078; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=9049184).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25275298
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 32,33.2
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 13
ST   FGA: 20,26
ST   Penta D: 9,10
ST   Penta E: 7
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5515 ! WSU-HN4
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   WSU-HN13
AC   CVCL_5519
SY   HN13; Wayne State University-Head and Neck 13
DR   ChEMBL-Cells; CHEMBL4295445
DR   ChEMBL-Targets; CHEMBL4296511
DR   Cosmic; 922088
DR   Cosmic; 2296298
DR   Cosmic; 2513909
DR   PubChem_Cell_line; CVCL_5519
DR   Wikidata; Q54994471
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9049184;
RX   PubMed=9389571;
RX   PubMed=25275298;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val173Leu (c.517G>T); ClinVar=VCV000376668; Zygosity=Unspecified (PubMed=25275298).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=25275298
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 12
ST   D18S51: 14,15
ST   D21S11: 31.2
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 9,10
ST   D8S1179: 13,15
ST   FGA: 21,26
ST   Penta D: 9,11
ST   Penta E: 12,14
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   WSU-HN14
AC   CVCL_AX29
SY   Wayne State University-Head and Neck 14
DR   Wikidata; Q54994472
RX   PubMed=7705939;
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   WSU-HN17
AC   CVCL_5520
SY   HN17; Wayne State University-Head and Neck 17
DR   Cosmic; 922089
DR   Wikidata; Q54994473
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9049184;
RX   PubMed=9389571;
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AX30 ! WSU-HN18
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   WSU-HN18
AC   CVCL_AX30
SY   Wayne State University-Head and Neck 18
DR   Wikidata; Q54994478
RX   PubMed=7705939;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5520 ! WSU-HN17
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   WSU-HN19
AC   CVCL_5521
SY   HN19; Wayne State University-Head and Neck 19
DR   Cosmic; 922090
DR   Wikidata; Q54994479
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9389571;
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C34447; Head and neck squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 12
//
ID   WSU-HN22
AC   CVCL_5522
SY   HN22; Wayne State University-Head and Neck 22
DR   Cosmic; 922081
DR   Wikidata; Q54994480
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9389571;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5517 ! WSU-HN8
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 10
//
ID   WSU-HN24
AC   CVCL_AX31
SY   Wayne State University-Head and Neck 24
DR   Wikidata; Q54994481
RX   PubMed=7705939;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   WSU-HN25
AC   CVCL_AX32
SY   Wayne State University-Head and Neck 25
DR   Wikidata; Q54994482
RX   PubMed=7705939;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   WSU-HN26
AC   CVCL_5523
SY   HN26; Wayne State University-Head and Neck 26
DR   Cosmic; 922082
DR   Wikidata; Q54994483
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9049184;
RX   PubMed=9389571;
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5524 ! WSU-HN27
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   WSU-HN27
AC   CVCL_5524
SY   HN27; Wayne State University-Head and Neck 27
DR   Cosmic; 922083
DR   Wikidata; Q54994484
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9389571;
CC   Derived from site: Metastatic; Larynx; UBERON=UBERON_0001737.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5523 ! WSU-HN26
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   WSU-HN28
AC   CVCL_AX33
SY   Wayne State University-Head and Neck 28
DR   Wikidata; Q54994485
RX   PubMed=7705939;
DI   NCIt; C4943; Pyriform fossa squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 21-03-23; Version: 6
//
ID   WSU-HN3
AC   CVCL_W196
SY   HN3; Wayne State University-Head and Neck 3
DR   Cosmic; 922086
DR   Wikidata; Q54994486
RX   PubMed=7705939;
RX   PubMed=8001221;
DI   NCIt; C4041; Floor of mouth squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 21-03-23; Version: 8
//
ID   WSU-HN30
AC   CVCL_5525
SY   HN30; HN-30; Wayne State University-Head and Neck 30
DR   BTO; BTO_0005039
DR   Cosmic; 922084
DR   Cosmic; 2131844
DR   Cosmic; 2296299
DR   GEO; GSM1643583
DR   Wikidata; Q54994487
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9049184;
RX   PubMed=9389571;
RX   PubMed=21868764;
RX   PubMed=25275298;
RX   PubMed=26754630;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/25024/
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
ST   Source(s): PubMed=21868764; PubMed=25275298
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11 (PubMed=25275298)
ST   D13S317: 11,12 (PubMed=21868764)
ST   D16S539: 11,12
ST   D18S51: 13,16
ST   D21S11: 28
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10
ST   D8S1179: 15,17
ST   FGA: 20,24
ST   Penta D: 2.2
ST   Penta E: 8,12
ST   TH01: 7,9
ST   TPOX: 6,11
ST   vWA: 15,18
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5526 ! WSU-HN31
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   WSU-HN31
AC   CVCL_5526
SY   HN31; Wayne State University-Head and Neck 31
DR   Cosmic; 922085
DR   Cosmic; 2043893
DR   Cosmic; 2131845
DR   Cosmic; 2439754
DR   Wikidata; Q54994488
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9389571;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Provider; AHNS; -; https://www.ahns.info/view/research-cell-lines-view/entry/25024/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 11,12
ST   D5S818: 12,13
ST   D7S820: 10
ST   TH01: 7,9
ST   TPOX: 6,11
ST   vWA: 15,18
DI   NCIt; C102872; Pharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5525 ! WSU-HN30
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   WSU-HN4
AC   CVCL_5515
SY   HN4; Wayne State University-Head and Neck 4
DR   Cosmic; 922078
DR   Cosmic; 2043894
DR   Cosmic; 2131846
DR   Cosmic; 2513906
DR   Wikidata; Q54994489
RX   PubMed=7705939;
RX   PubMed=8001221;
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5518 ! WSU-HN12
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
ID   WSU-HN6
AC   CVCL_5516
SY   HN6; Wayne State University-Head and Neck 6
DR   Cosmic; 922087
DR   Cosmic; 2043895
DR   Cosmic; 2296295
DR   Cosmic; 2513907
DR   Wikidata; Q54994490
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9049184;
RX   PubMed=9389571;
RX   PubMed=25275298;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Leu (c.536A>T); ClinVar=VCV000376608; Zygosity=Unspecified (PubMed=9049184; PubMed=25275298).
CC   Omics: Genomics; Whole exome sequencing.
ST   Source(s): PubMed=25275298
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 13
ST   D16S539: 10,12
ST   D18S51: 13
ST   D21S11: 32.2,33.2
ST   D3S1358: 18
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21,25
ST   Penta D: 9
ST   Penta E: 8,14
ST   TH01: 6,9
ST   TPOX: 8,10
ST   vWA: 18,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   WSU-HN8
AC   CVCL_5517
SY   HN8; Wayne State University-Head and Neck 8
DR   cancercelllines; CVCL_5517
DR   Cosmic; 922080
DR   Cosmic; 2296296
DR   Wikidata; Q54994491
RX   PubMed=7705939;
RX   PubMed=8001221;
RX   PubMed=9389571;
RX   PubMed=25275298;
CC   Part of: OPC-22 oral and pharyngeal cancer cell line panel.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Unspecified (PubMed=25275298).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=25275298
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 13
ST   D16S539: 9,12
ST   D18S51: 13,19
ST   D21S11: 30
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 8
ST   D8S1179: 11,12
ST   FGA: 22
ST   Penta D: 15
ST   Penta E: 5,13
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5522 ! WSU-HN22
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   WSU-NHL
AC   CVCL_1793
SY   WSU-NHL-1; WSUNHL
DR   CLO; CLO_0009636
DR   EFO; EFO_0006777
DR   CLDB; cl4734
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03470898
DR   BioSample; SAMN03473486
DR   cancercelllines; CVCL_1793
DR   Cell_Model_Passport; SIDM00412
DR   ChEMBL-Cells; CHEMBL3308281
DR   ChEMBL-Targets; CHEMBL2366193
DR   Cosmic; 798674
DR   Cosmic; 909785
DR   Cosmic; 994177
DR   Cosmic; 1086348
DR   Cosmic; 1945197
DR   Cosmic; 2276344
DR   Cosmic-CLP; 909785
DR   DepMap; ACH-001709
DR   DSMZ; ACC-58
DR   DSMZCellDive; ACC-58
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909785
DR   GEO; GSM380153
DR   GEO; GSM552470
DR   GEO; GSM1035307
DR   GEO; GSM1374992
DR   GEO; GSM1670583
DR   GEO; GSM3150259
DR   IARC_TP53; 21272
DR   LINCS_LDP; LCL-1955
DR   PharmacoDB; WSUNHL_1677_2019
DR   PRIDE; PXD012087
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1793
DR   PubChem_Cell_line; CVCL_1793
DR   Wikidata; Q54994492
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3143865;
RX   PubMed=7849311;
RX   PubMed=8558920;
RX   PubMed=19278952;
RX   PubMed=20164919;
RX   PubMed=20628145;
RX   PubMed=23292937;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: MD Anderson Cell Lines Project.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11584.
CC   Population: Caucasian.
CC   Doubling time: 57 hours (PubMed=3143865); ~45 hours (DSMZ=ACC-58).
CC   HLA typing: A*02:01,02:01; B*44:02,44:02; C*05:01,07:04 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-high) (PubMed=31068700; Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (Cosmic-CLP=909785).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.04%; East Asian, North=0%; East Asian, South=0.46%; South Asian=3.25%; European, North=71.53%; European, South=24.73% (PubMed=30894373).
CC   Caution: Was originally classified as originating from a follicular lymphoma.
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number WSU-NHL.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Cosmic-CLP=909785; DepMap=ACH-001709; DSMZ=ACC-58; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11 (Cosmic-CLP=909785; DepMap=ACH-001709; DSMZ=ACC-58)
ST   CSF1PO: 11,13 (PubMed=25877200)
ST   D13S317: 8,10,11 (DepMap=ACH-001709; PubMed=25877200)
ST   D13S317: 8,11 (Cosmic-CLP=909785; DSMZ=ACC-58)
ST   D16S539: 10,11,12 (DepMap=ACH-001709; PubMed=25877200)
ST   D16S539: 11,12 (Cosmic-CLP=909785; DSMZ=ACC-58)
ST   D18S51: 15
ST   D19S433: 13,14,15,15.2 (PubMed=25877200)
ST   D19S433: 14,15 (DSMZ=ACC-58)
ST   D21S11: 26,30,31,31.2,32.2 (PubMed=25877200)
ST   D21S11: 26,32.2 (DepMap=ACH-001709; DSMZ=ACC-58)
ST   D2S1338: 17,23
ST   D3S1358: 14,15
ST   D5S818: 10,11,12 (PubMed=25877200)
ST   D5S818: 11,12 (Cosmic-CLP=909785; DepMap=ACH-001709; DSMZ=ACC-58)
ST   D7S820: 10,12
ST   D8S1179: 9,12,13,14 (PubMed=25877200)
ST   D8S1179: 9,14 (DepMap=ACH-001709; DSMZ=ACC-58)
ST   FGA: 19,20
ST   Penta D: 9,10,14 (PubMed=25877200)
ST   Penta D: 9,14 (DepMap=ACH-001709; DSMZ=ACC-58)
ST   Penta E: 5,11,12,13 (PubMed=25877200)
ST   Penta E: 5,12 (DepMap=ACH-001709; DSMZ=ACC-58)
ST   TH01: 6,9 (DSMZ=ACC-58)
ST   TH01: 8,9 (DepMap=ACH-001709)
ST   TH01: 9 (Cosmic-CLP=909785; PubMed=25877200)
ST   TPOX: 8,9,10,11 (PubMed=25877200)
ST   TPOX: 9,10 (Cosmic-CLP=909785; DepMap=ACH-001709; DSMZ=ACC-58)
ST   vWA: 16 (Cosmic-CLP=909785; DepMap=ACH-001709; DSMZ=ACC-58)
ST   vWA: 16,17,19 (PubMed=25877200)
DI   NCIt; C36080; Diffuse large B-cell lymphoma germinal center B-cell type
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 45
//
ID   WSU-Pre-B-ALL
AC   CVCL_5608
SY   WSU-preAll
DR   Wikidata; Q54994493
CC   Discontinued: BioIVT/Asterand Bioscience; Catalog number WSU-Pre-B-ALL.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C8644; B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 15
//
ID   WSU-WM
AC   CVCL_5609
SY   WM-WSU
DR   Cosmic; 1762458
DR   Wikidata; Q54994494
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8499639;
RX   PubMed=18650470;
RX   PubMed=22950966;
WW   Provider; BioIVT/Asterand; -; https://bioivt.com/wsu-heme-onc-cell-lines
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11586.
CC   Doubling time: ~16 hours (PubMed=8499639).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C80307; Waldenstrom macroglobulinemia
DI   ORDO; Orphanet_33226; Waldenstrom macroglobulinemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   WT 1-DP-hiPSC
AC   CVCL_YT63
DR   Wikidata; Q98134993
RX   PubMed=31768763;
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9
ST   D16S539: 13
ST   D18S51: 14,20
ST   D21S11: 31,31.2
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 12,13
ST   FGA: 21,24
ST   Penta D: 9,13
ST   Penta E: 11,17
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   WT 10-7
AC   CVCL_V443
DR   ATCC; CRL-2834
DR   Wikidata; Q54994495
RX   PubMed=12734101;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-2834; true.
CC   Derived from site: In situ; Kidney, distal tubule; Note=From a cyst; UBERON=UBERON_0004135.
CC   Cell type: Epithelial cell of distal tubule; CL=CL_0002305.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V442 ! TS 10-7
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   WT 2-DP-hiPSC
AC   CVCL_YT64
DR   Wikidata; Q98134995
RX   PubMed=31768763;
CC   Caution: Indicated as originating from a female donor in table 1 and from having an amelogenin X,Y marker in figure 8.
CC   Derived from site: In situ; Tooth, dental pulp; UBERON=UBERON_0001754.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 10,11
ST   D18S51: 16,18
ST   D21S11: 29,30
ST   D3S1358: 15,18
ST   D5S818: 11
ST   D7S820: 10,13
ST   D8S1179: 12,14
ST   FGA: 23,24
ST   Penta D: 10,13
ST   Penta E: 11,12
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   WT 3-PBMC-hiPSC
AC   CVCL_YT65
DR   Wikidata; Q98134997
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 10
ST   D18S51: 12,14
ST   D21S11: 30,30.2
ST   D3S1358: 16
ST   D5S818: 10,14
ST   D7S820: 10,11
ST   D8S1179: 11,13
ST   FGA: 25,26
ST   Penta D: 9,11
ST   Penta E: 10,19
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   WT 4-PBMC-hiPSC
AC   CVCL_YT66
DR   Wikidata; Q98135000
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D18S51: 14,15
ST   D21S11: 29,30
ST   D3S1358: 12,16
ST   D5S818: 11
ST   D7S820: 10,11
ST   D8S1179: 12,15
ST   FGA: 25
ST   Penta D: 12,14
ST   Penta E: 16,18
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   WT 5-PBMC-hiPSC
AC   CVCL_YT67
DR   Wikidata; Q98135002
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D18S51: 13,15
ST   D21S11: 28,30
ST   D3S1358: 15,17
ST   D5S818: 10,14
ST   D7S820: 12
ST   D8S1179: 14,15
ST   FGA: 22,26
ST   Penta D: 11,13
ST   Penta E: 15,17
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   WT 6-PBMC-hiPSC
AC   CVCL_YT68
DR   Wikidata; Q98135004
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D21S11: 29,33.2
ST   D3S1358: 16,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 14,16
ST   FGA: 25
ST   Penta D: 10,12
ST   Penta E: 16,18
ST   TH01: 9,9.3
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   WT 7-PBMC-hiPSC
AC   CVCL_YT69
DR   Wikidata; Q98135007
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,9
ST   D16S539: 11
ST   D18S51: 11,14
ST   D21S11: 29,30
ST   D3S1358: 16,17
ST   D5S818: 10,12
ST   D7S820: 12
ST   D8S1179: 12,14
ST   FGA: 21,23
ST   Penta D: 10,12
ST   Penta E: 11,15
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   WT 8-PBMC-hiPSC
AC   CVCL_YT70
DR   Wikidata; Q98135009
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31768763
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 14
ST   D21S11: 29,31.2
ST   D3S1358: 15,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 10,13
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   WT 9-12
AC   CVCL_K230
DR   ATCC; CRL-2833
DR   Wikidata; Q54994496
RX   PubMed=12734101;
CC   Doubling time: ~38 hours (ATCC=CRL-2833).
CC   Transformant: Ad-SV40 hybrid virus.
CC   Derived from site: In situ; Kidney; Note=From a cyst; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): ATCC=CRL-2833
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13
ST   D19S433: 15,15.2
ST   D21S11: 29
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 14
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V444 ! TS 9-7
OI   CVCL_K231 ! WT 9-7
OI   CVCL_V445 ! WT 9-9
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 02-05-24; Version: 12
//
ID   WT 9-7
AC   CVCL_K231
SY   WT97
DR   ATCC; CRL-2830
DR   BioSample; SAMN03471799
DR   Wikidata; Q54994497
RX   PubMed=12734101;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Doubling time: ~26 hours (ATCC=CRL-2830).
CC   Transformant: Ad-SV40 hybrid virus.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: In situ; Kidney, proximal tubule; Note=From a cyst; UBERON=UBERON_0004134.
CC   Cell type: Epithelial cell of proximal tubule; CL=CL_0002306.
ST   Source(s): ATCC=CRL-2830
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D18S51: 13,14
ST   D19S433: 15,15.2
ST   D21S11: 29
ST   D2S1338: 17,24
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 9,13
ST   Penta E: 5,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V444 ! TS 9-7
OI   CVCL_V445 ! WT 9-9
OI   CVCL_K230 ! WT 9-12
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   WT 9-9
AC   CVCL_V445
DR   ATCC; CRL-2832
DR   Wikidata; Q54994498
RX   PubMed=12734101;
CC   Transformant: Ad-SV40 hybrid virus.
CC   Discontinued: ATCC; CRL-2832; true.
CC   Derived from site: In situ; Kidney, distal tubule; Note=From a cyst; UBERON=UBERON_0004135.
CC   Cell type: Epithelial cell of distal tubule; CL=CL_0002305.
ST   Source(s): ATCC=CRL-2832
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 19
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V444 ! TS 9-7
OI   CVCL_K231 ! WT 9-7
OI   CVCL_K230 ! WT 9-12
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 10
//
ID   WT 9-PBMC-hiPSC
AC   CVCL_YT71
DR   Wikidata; Q98135011
RX   PubMed=31768763;
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   Wt MEFs
AC   CVCL_L690
DR   ATCC; CRL-2991
DR   Wikidata; Q54994499
RX   PubMed=12527753;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10-11FD
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   WT SV40 MEF
AC   CVCL_U630
DR   ATCC; CRL-2907
DR   Wikidata; Q54994500
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Embryo
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   WT-1
AC   CVCL_VU16
DR   Millipore; SCC255
DR   Wikidata; Q98135013
RX   PubMed=10574950;
RX   PubMed=28494871;
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Brown adipose tissue; UBERON=UBERON_0001348.
CC   Cell type: Preadipocyte; CL=CL_0002334.
CC   Breed/subspecies: FVB.
ST   Source(s): Millipore=SCC255
ST   Mouse STR 1-1: 10
ST   Mouse STR 1-2: 13
ST   Mouse STR 2-1: 9
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 19.3,20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 17
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 29
ST   Mouse STR 8-1: 15.3
ST   Mouse STR 11-2: 14
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 15.2,16.2
ST   Mouse STR 15-3: 20.3
ST   Mouse STR 17-2: 12,15
ST   Mouse STR 18-3: 16,18
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 26
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   <1D
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 11
//
ID   WT-126 C5
AC   CVCL_YL15
DR   Wikidata; Q98135015
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HA44 ! WT-126 C8
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   WT-126 C8
AC   CVCL_HA44
DR   GEO; GSM1153513
DR   Wikidata; Q54994502
RX   Patent=US9696297;
RX   PubMed=21074045;
RX   PubMed=24153179;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YL15 ! WT-126 C5
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   WT-2-hiPSC
AC   CVCL_A4HK
SY   WT-2
DR   SKIP; SKIP003140
DR   Wikidata; Q105511762
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WT-31
AC   CVCL_CW51
SY   WT31
DR   Wikidata; Q54994503
RX   PubMed=2410507;
RX   PubMed=2809225;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human T-cell receptor alpha/beta-1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 5
//
ID   WT-33 C1
AC   CVCL_HA45
SY   WT-33 iPSC-1
DR   GEO; GSM1153509
DR   GEO; GSM1153510
DR   Wikidata; Q54994504
RX   Patent=US9696297;
RX   PubMed=21074045;
RX   PubMed=24153179;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   WT-9
AC   CVCL_HA46
DR   GEO; GSM1153512
DR   Wikidata; Q54994505
RX   PubMed=24153179;
CC   Population: Asian.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1P27 ! GM22159
SX   Male
AG   1D
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   WT-ADRC-40
AC   CVCL_HA43
SY   WT-ADRC40; ADRC-40; ADRC40
DR   GEO; GSM1153501
DR   GEO; GSM1153507
DR   Wikidata; Q54994506
RX   Patent=US9696297;
RX   PubMed=21074045;
RX   PubMed=24153179;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   WT-AG09319 C1
AC   CVCL_YL21
SY   iPSC-WT clone 1
DR   GEO; GSM525418
DR   GEO; GSM525419
DR   GEO; GSM525420
DR   Wikidata; Q98135017
RX   Patent=US9696297;
RX   PubMed=21074045;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L243 ! AG09319
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 6
//
ID   WT-AG09319 C2
AC   CVCL_ZM11
SY   iPSC-WT clone 2
DR   GEO; GSM525421
DR   GEO; GSM525422
DR   GEO; GSM525423
DR   Wikidata; Q98135019
RX   PubMed=21074045;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L243 ! AG09319
SX   Female
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 5
//
ID   WT-CLS1
AC   CVCL_5904
SY   CLS1
DR   CLS; 300379
DR   Cosmic; 1314022
DR   Wikidata; Q54994507
RX   DOI=10.1002/cnr2.1110;
RX   PubMed=20106868;
CC   Problematic cell line: Misclassified. Originally thought to be a Wilms tumor cell line but is a kidney rhabdoid tumor cell line (DOI=10.1002/cnr2.1110).
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Gln318Ter (c.952C>T); Zygosity=Hemizygous (DOI=10.1002/cnr2.1110).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CLS=300379
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D21S11: 30,31.2
ST   D3S1358: 14,19
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13,14
ST   FGA: 22,25
ST   Penta D: 9
ST   Penta E: 9,12
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   WT-E
AC   CVCL_0C31
DR   Wikidata; Q54994508
RX   PubMed=7736387;
RX   PubMed=10100721;
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   WT-hiPSC 1
AC   CVCL_A4HF
SY   WT1
DR   SKIP; SKIP003137
DR   Wikidata; Q105511765
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HG ! WT-hiPSC 2
OI   CVCL_A4HH ! WT-hiPSC 3
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WT-hiPSC 2
AC   CVCL_A4HG
SY   WT2
DR   SKIP; SKIP003138
DR   Wikidata; Q105511767
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HF ! WT-hiPSC 1
OI   CVCL_A4HH ! WT-hiPSC 3
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WT-hiPSC 3
AC   CVCL_A4HH
SY   WT3
DR   SKIP; SKIP003139
DR   Wikidata; Q105511772
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HF ! WT-hiPSC 1
OI   CVCL_A4HG ! WT-hiPSC 2
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WT-iPS 3F-1
AC   CVCL_W316
DR   Wikidata; Q54994510
RX   PubMed=22405424;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WT-iPS 4F-1
AC   CVCL_W317
DR   Wikidata; Q54994511
RX   PubMed=22405424;
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 7
//
ID   WT-iPSC#1
AC   CVCL_A4WE
DR   Wikidata; Q107117546
RX   PubMed=31151050;
CC   From: University of Bordeaux; Bordeaux; France.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4WF ! WT-iPSC#2
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WT-iPSC#2
AC   CVCL_A4WF
DR   Wikidata; Q107117547
RX   PubMed=31151050;
CC   From: University of Bordeaux; Bordeaux; France.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4WE ! WT-iPSC#1
SX   Male
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WT-iPSC1
AC   CVCL_GQ07
DR   SKIP; SKIP001285
DR   Wikidata; Q54994512
RX   PubMed=27558599;
CC   From: Department of Dermatology, Jikei University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Miscellaneous: Donor identity for WT-iPSC1, WT-iPSC2 and WT-iPSC4 from personal communication of Itoh, Munenari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ08 ! WT-iPSC2
OI   CVCL_GQ09 ! WT-iPSC4
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   WT-iPSC2
AC   CVCL_GQ08
DR   Wikidata; Q54994513
RX   PubMed=27558597;
CC   From: Department of Dermatology, Jikei University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Miscellaneous: Donor identity for WT-iPSC1, WT-iPSC2 and WT-iPSC4 from personal communication of Itoh, Munenari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ07 ! WT-iPSC1
OI   CVCL_GQ09 ! WT-iPSC4
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   WT-iPSC4
AC   CVCL_GQ09
DR   Wikidata; Q54994514
RX   PubMed=27558598;
CC   From: Department of Dermatology, Jikei University School of Medicine; Tokyo; Japan.
CC   Population: Japanese.
CC   Miscellaneous: Donor identity for WT-iPSC1, WT-iPSC2 and WT-iPSC4 from personal communication of Itoh, Munenari.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_GQ07 ! WT-iPSC1
OI   CVCL_GQ08 ! WT-iPSC2
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 9
//
ID   WT-Pe.1
AC   CVCL_M844
DR   Wikidata; Q54994515
RX   PubMed=18558285;
CC   Doubling time: ~65 hours (PubMed=18558285).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   WT-R
AC   CVCL_0I65
DR   CCLV; CCLV-RIE 0728
DR   Wikidata; Q54994516
OX   NCBI_TaxID=9902; ! Bison bonasus (European bison)
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 21-03-23; Version: 3
//
ID   WT.5
AC   CVCL_B0KS
DR   Wikidata; Q108821522
RX   PubMed=7690324;
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: UniProtKB; G3V8L7; Rat Itgam/Cd11b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_J288 ! PAI
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   WT:CS3
AC   CVCL_Z880
SY   WT-CS3
DR   FlyBase_Cell_line; FBtc9000055
DR   Wikidata; Q54994517
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=3919453;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WT:CS5
AC   CVCL_Z881
SY   WT-CS5
DR   FlyBase_Cell_line; FBtc9000056
DR   Wikidata; Q54994518
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=3919453;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WT:LM6
AC   CVCL_Z882
SY   WT-LM6
DR   FlyBase_Cell_line; FBtc9000057
DR   Wikidata; Q54994519
RX   DOI=10.1016/B978-012229460-0/50004-X;
RX   PubMed=3919453;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7227; ! Drosophila melanogaster (Fruit fly)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WT#20G
AC   CVCL_A4QE
DR   SKIP; SKIP000917
DR   Wikidata; Q105511774
RX   PubMed=22142803;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QD ! WT#5J
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WT#5J
AC   CVCL_A4QD
DR   SKIP; SKIP000916
DR   Wikidata; Q105511776
RX   PubMed=22142803;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Keratinocyte; CL=CL_0000312.
DI   NCIt; C40407; Kidney Wilms tumor
DI   ORDO; Orphanet_654; Nephroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4QE ! WT#20G
SX   Sex unspecified
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   WT(MEF) SV40-immortalized
AC   CVCL_A7BM
SY   WT(MEF)
DR   RCB; RCB4717
DR   Wikidata; Q107117548
RX   PubMed=27633668;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C57BL/6J.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   13-14FD
CA   Transformed cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WT1-iPS
AC   CVCL_ZA05
SY   CRL2429-iPS clone 11; C11
DR   GEO; GSM1053967
DR   GEO; GSM1053968
DR   GEO; GSM1053969
DR   GEO; GSM1053985
DR   GEO; GSM1053986
DR   GEO; GSM1053987
DR   Wikidata; Q98135021
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   WT1-iPSC
AC   CVCL_A4SF
SY   WT1
DR   SKIP; SKIP003043
DR   Wikidata; Q107117549
RX   PubMed=29374141;
CC   Derived from site: In situ; Foreskin, skin, dermis; UBERON=UBERON_0001471+UBERON_0002067.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WT100
AC   CVCL_E919
SY   WT-100; GM08602
DR   BTO; BTO_0004551
DR   CLO; CLO_0010610
DR   BioSample; SAMN00798102
DR   CLS; 302139
DR   Coriell; GM08602
DR   IPD-IMGT/HLA; 13141
DR   Wikidata; Q54994525
RX   CelloPub=CLPUB00447;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: DRB1*01:01 (IPD-IMGT/HLA=13141).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 19
//
ID   WT100BIS
AC   CVCL_E883
SY   WT100 BIS; WT-100BIS
DR   dbMHC; 49073
DR   ECACC; 88052006
DR   IHW; IHW09006
DR   IPD-IMGT/HLA; 11652
DR   Wikidata; Q54994526
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*11:01:01:01; B*35:01:01:02; C*04:01:01:01; DPA1*02:01:01; DPB1*01:01:01; DQA1*01:01; DQB1*05:01:01; DRA*01:01; DRB1*01:01:01; DRB6*01:01 (IPD-IMGT/HLA=11652).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   WT145
AC   CVCL_A2HM
DR   Wikidata; Q105511778
RX   PubMed=12644300;
RX   PubMed=23681781;
RX   PubMed=24239860;
CC   Doubling time: 15.8 hours (Note=Non-treated), 45.9 hours (Note=1,25D3 treated) (PubMed=12644300).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   WT17
AC   CVCL_F522
SY   GM08599
DR   CLO; CLO_0010591
DR   Coriell; GM08599
DR   Wikidata; Q54994527
RX   CelloPub=CLPUB00447;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*03; B*35; C*w04 (Coriell=GM08599).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 13
//
ID   WT2-iPS
AC   CVCL_ZA06
SY   CRL1502-iPS clone 32; C32; hiPSC-CRL1502 clone C32; iPS cell line CRL1502 (clone C32)
DR   GEO; GSM1053988
DR   GEO; GSM1053989
DR   GEO; GSM1053990
DR   Wikidata; Q98135023
RX   PubMed=23225669;
RX   PubMed=26444236;
RX   PubMed=27120161;
RX   PubMed=29503086;
CC   Population: African American.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2766 ! WS1
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   WT2-iPSC
AC   CVCL_A4SG
SY   WT2
DR   SKIP; SKIP003044
DR   Wikidata; Q107117550
RX   PubMed=29374141;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WT20
AC   CVCL_F524
SY   GM08067
DR   CLO; CLO_0010026
DR   Coriell; GM08067
DR   Wikidata; Q54994528
RX   CelloPub=CLPUB00447;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*w30; B*18; C*w05 (Coriell=GM08067).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 14
//
ID   WT24
AC   CVCL_E884
SY   WT 24
DR   dbMHC; 49074
DR   IHW; IHW09015
DR   IPD-IMGT/HLA; 11651
DR   Wikidata; Q54994529
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*02:01:01:01; B*27:05:02; C*02:02:02:01; DPA1*01; DPB1*03:01:01; DQB1*05:02:01; DRB1*16:01:01 (IPD-IMGT/HLA=11651).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 18
//
ID   WT276
AC   CVCL_A2HN
DR   Wikidata; Q105511780
RX   PubMed=12644300;
CC   Doubling time: 13.3 hours (Note=Non-treated), 17.5 hours (Note=1,25D3 treated) (PubMed=12644300).
CC   Transformant: ChEBI; CHEBI_254496; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: C57BL/6J.
DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   6-8M
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   WT3
AC   CVCL_RK81
DR   SKIP; SKIP001700
DR   Wikidata; Q54994530
RX   PubMed=28089908;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   WT3-iPS
AC   CVCL_ZA07
SY   CRL2429-iPS clone 16; C16
DR   GEO; GSM1053943
DR   GEO; GSM1053944
DR   GEO; GSM1053945
DR   Wikidata; Q98135025
RX   PubMed=23225669;
CC   Population: Caucasian.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2769 ! CCD-1112Sk
SX   Male
AG   <1M
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   WT3-iPSC
AC   CVCL_A4SH
SY   WT3
DR   SKIP; SKIP003045
DR   Wikidata; Q107117551
RX   PubMed=29374141;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   WT4-iPS
AC   CVCL_ZA08
SY   CRL1502-iPS clone 29; C29
DR   GEO; GSM1053946
DR   GEO; GSM1053947
DR   GEO; GSM1053948
DR   Wikidata; Q98135027
RX   PubMed=23225669;
CC   Population: African American.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2766 ! WS1
SX   Female
AG   12FW
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   WT46
AC   CVCL_E885
SY   GM08068
DR   CLO; CLO_0010027
DR   Coriell; GM08068
DR   dbMHC; 49075
DR   IHW; IHW09305
DR   IPD-IMGT/HLA; 11571
DR   Wikidata; Q54994531
RX   CelloPub=CLPUB00447;
RX   PubMed=2437021;
RX   PubMed=6200433;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*32:01; B*44:02; C*05:01; DPB1*16:01:01; DQA1*01:02:01:01; DQB1*06:04; DRB1*13:02:01:01; DRB3*03:01:01 (IPD-IMGT/HLA=11571).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   WT47
AC   CVCL_E886
SY   WT 47
DR   EFO; EFO_0022360
DR   dbMHC; 49076
DR   ECACC; 88052063
DR   IHW; IHW09063
DR   IPD-IMGT/HLA; 11572
DR   Wikidata; Q54994533
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*32:01:01:01; B*44:02:01:01; C*05:01:01:02; DPA1*01; DPB1*16:01:01; DQA1*01:02:01; DQB1*06:04:01; DRA*01:02; DRB1*13:02:01; DRB3*03:01 (IPD-IMGT/HLA=11572).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 19
//
ID   WT49
AC   CVCL_2242
SY   WT-49; TER98; TER180; GM03098; GM3098; GM03098A
DR   CLO; CLO_0013483
DR   Coriell; GM03098
DR   dbMHC; 49077
DR   ECACC; 86052108
DR   IHW; IHW09285
DR   IPD-IMGT/HLA; 11573
DR   Wikidata; Q54994534
RX   CelloPub=CLPUB00447;
RX   PubMed=6200433;
RX   PubMed=9234496;
RX   PubMed=28360230;
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*02:05:01; B*58:01:01; C*07:18; DPA1*01:03; DPB1*04:01; DQA1*05:01; DQB1*02:01:01; DRB1*03:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=11573).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Misspelling: GM3908; PubMed=6200433.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
ID   WT51
AC   CVCL_E887
SY   WT-51; WT 51; GM03103; GM3103; GM03103A
DR   BTO; BTO_0004497
DR   CLO; CLO_0013564
DR   BioSample; SAMN00808251
DR   CLS; 302141
DR   Coriell; GM03103
DR   dbMHC; 49078
DR   ECACC; 86052110
DR   IHW; IHW09029
DR   IPD-IMGT/HLA; 11574
DR   Wikidata; Q54994535
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=6200433;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*23:01:01:01; B*14:01:01; C*08:02:01:02; DPA1*01:03; DPB1*02:01:02/02:01:19; DQA1*03:01; DQB1*03:02:01; DRA*01:01; DRB1*04:01:01; DRB4*01:01 (IPD-IMGT/HLA=11574).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): CLS=302141
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D18S51: 12,14
ST   D21S11: 30.2,32.2
ST   D3S1358: 15
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 11,12
ST   FGA: 24,25
ST   Penta D: 13
ST   Penta E: 7,13
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 25
//
ID   WT52
AC   CVCL_E888
SY   GM08603
DR   CLO; CLO_0010609
DR   Coriell; GM08603
DR   dbMHC; 49079
DR   IHW; IHW09306
DR   IPD-IMGT/HLA; 11575
DR   Wikidata; Q54994536
RX   CelloPub=CLPUB00447;
RX   PubMed=2437021;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*11; B*55; C*22; DPB1*04:01; DQB1*05:03:01:01; DRB1*14:01; DRB3*01:01 (IPD-IMGT/HLA=11575).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 18
//
ID   WT8
AC   CVCL_E889
SY   WT 8
DR   dbMHC; 49080
DR   IHW; IHW09017
DR   IPD-IMGT/HLA; 11650
DR   Wikidata; Q54994537
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8813743;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Caucasian; Italian.
CC   HLA typing: A*03:01:01:01; B*07:02:01:01; C*07:02:01:03; DPA1*01; DPB1*02:01:02/02:01:19,04:01:01; DQA1*01:02:01; DQB1*06:02:01; DRA*01:02; DRB1*15:01:01; DRB5*01:01; DRB6*02:01 (IPD-IMGT/HLA=11650).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   WT87
AC   CVCL_F523
SY   GM08601
DR   CLO; CLO_0010593
DR   BioSample; SAMN00798100
DR   Coriell; GM08601
DR   Wikidata; Q54994538
RX   CelloPub=CLPUB00447;
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*02; B*w16 (Coriell=GM08601).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 14
//
ID   WTB6
AC   CVCL_VM30
DR   Wikidata; Q98135029
RX   PubMed=24509632;
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 21-03-23; Version: 3
//
ID   WTC CRISPRi HOPX g1
AC   CVCL_VQ27
DR   Wikidata; Q98135031
RX   PubMed=30290179;
CC   Population: Japanese.
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB-P2A-mCherry was introduced in the AAVS1 safe harbor locus.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24961; HOPX.
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM38 ! CRISPRi Gen1C 5
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 15
//
ID   WTC CRISPRi HOPX g4
AC   CVCL_VQ28
DR   Wikidata; Q98135034
RX   PubMed=30290179;
CC   Population: Japanese.
CC   Characteristics: Cell line with Dox-inducible CRISPR interference (CRISPRi).
CC   Characteristics: Using TALEN a construct containing a rtTA+TRE3G promoter and dCas9-KRAB-P2A-mCherry was introduced in the AAVS1 safe harbor locus.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:24961; HOPX.
CC   Genetic integration: Method=TALEN; Gene=FPbase; ZERB6; mCherry (Note=Red fluorescent protein derived from drFP583 (dsRed)).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P06492; Human herpesvirus 1 (HHV-1) VP16 (UL28) (Note=With p.Met1_Arg360del).
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VM38 ! CRISPRi Gen1C 5
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 15
//
ID   WTC dual tagged FBL-mEGFP/NPM1-mTagRFPT-cl18
AC   CVCL_WM16
SY   AICS-0084-018; AICSi002-A-38; UCSFi001-A-38
DR   BioSamples; SAMEA6348732
DR   Coriell; AICS-0084-018
DR   hPSCreg; UCSFi001-A-38
DR   Wikidata; Q98135036
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 FBL has been endogenously tagged in one allele at the C-terminus with mEGFP and NPM1 has been endogenously tagged in one allele at the C-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   WTC dual tagged SEC61B-mEGFP/LMNB1-mTagRFPT-cl36
AC   CVCL_UK02
SY   AICS-0059-036; AICSi002-A-33; UCSFi001-A-33
DR   BioSamples; SAMEA6348727
DR   Coriell; AICS-0059-036
DR   hPSCreg; UCSFi001-A-33
DR   Wikidata; Q98135038
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 SEC61B has been endogenously tagged in one allele at the N-terminus with mEGFP and LMNB1 has been endogenously tagged in one allele at the N-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 13
//
ID   WTC dual tagged TOMM20-mEGFP/mTagRFPT-TUBA1B-cl79
AC   CVCL_A8RS
SY   AICS-0078-079; AICSi002-A-55; UCSFi001-A-55
DR   BioSamples; SAMEA9114810
DR   Coriell; AICS-0078-079
DR   hPSCreg; UCSFi001-A-55
DR   Wikidata; Q108821523
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TOMM20 has been endogenously tagged in one allele at the C-terminus with mEGFP and TUBA1AB has been endogenously tagged in one allele at the N-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   WTC EGFP-PXN-cl50
AC   CVCL_IR30
SY   AICS-0005-050; AICS0005; AICS-0005; PXN cl. 50; AICSi002-A-1; UCSFi001-A-1
DR   BioSamples; SAMEA5843919
DR   Coriell; AICS-0005
DR   hPSCreg; UCSFi001-A-1
DR   Wikidata; Q54994539
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 PXN has been endogenously tagged in one allele at the C-terminus with EGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 17
//
ID   WTC FBL-mEGFP/NPM1-mTagRFPT/CLYBL-dCas9-TagBFP-KRAB-cl61
AC   CVCL_YU29
SY   AICS-0089-061; AICSi002-A-39; UCSFi001-A-39
DR   BioSamples; SAMEA7655481
DR   Coriell; AICS-0089-061
DR   hPSCreg; UCSFi001-A-39
DR   Wikidata; Q98135041
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 FBL has been endogenously tagged in one allele at the C-terminus with mEGFP, NPM1 has been endogenously tagged in one allele at the C-terminus with mTagRFP-T and a dCas9-TagBFP-KRAB construct is expressed from a CAGGS promoter edited into the 2nd intron of the CLYBL safe harbor.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 12
//
ID   WTC FBL-mEGFP/NPM1-mTagRFP-T/UBTF-HaloTag-cl147
AC   CVCL_ZX20
SY   AICS-0086-147; AICSi002-A-42; UCSFi001-A-42
DR   BioSamples; SAMEA7851601
DR   Coriell; AICS-0086-147
DR   hPSCreg; UCSFi001-A-42
DR   Wikidata; Q102115120
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 FBL has been endogenously tagged in one allele at the C-terminus with mEGFP, NPM1 has been endogenously tagged in one allele at the C-terminus with mTagRFP-T and UBTF has been endogenously tagged in one allele at the N-terminus with a HaloTag.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; P0A3G2; Rhodococcus rhodochrous dhaA (Note=Mutated = HaloTag).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 11
//
ID   WTC-CLYBL-dCas9-TagBFP-KRAB-cl391
AC   CVCL_A5ET
SY   AICS-0090-391; AICSi002-A-45; UCSFi001-A-45
DR   BioSamples; SAMEA7851604
DR   Coriell; AICS-0090-391
DR   hPSCreg; UCSFi001-A-45
DR   Wikidata; Q107117553
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 a dCas9-TagBFP-KRAB construct is expressed from a CAGGS promoter edited into the 2nd intron of the CLYBL safe harbor.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; BFJKS; TagBFP (Note=Blue fluorescent protein derived from eqFP578).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=UniProtKB; Q99ZW2; Streptomyces pyogenes Cas9 (Note=With p.Asp10Ala and p.His840Ala and KRAB domain = dCas9-KRAB).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 9
//
ID   WTC-DMD-mEGFP-cl96
AC   CVCL_A5ES
SY   AICS-0063-096; AICSi002-A-44; UCSFi001-A-44
DR   BioSamples; SAMEA7851603
DR   Coriell; AICS-0063-096
DR   hPSCreg; UCSFi001-A-44
DR   Wikidata; Q107117554
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 DMD has been endogenously tagged in one allele at the C-terminus with mEGFP (Coriell=AICS-0063-096).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 10
//
ID   WTC-mEGFP-ACTB-cl184
AC   CVCL_JM16
SY   ACTB-GFP WTC; AICS-0016-184; AICS0016; AICS-0016; ACTB1 cl. 184; AICSi002-A-3; UCSFi001-A-3
DR   BioSamples; SAMEA6298548
DR   Coriell; AICS-0016
DR   hPSCreg; UCSFi001-A-3
DR   Wikidata; Q54994540
RX   PubMed=28814507;
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 ACTB has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 15
//
ID   WTC-mEGFP-ACTN2-cl85
AC   CVCL_WM14
SY   AICS-0075-085; AICSi002-A-4; UCSFi001-A-4
DR   BioSamples; SAMEA6298549
DR   Coriell; AICS-0075-085
DR   hPSCreg; UCSFi001-A-4
DR   Wikidata; Q98135043
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 ACTN2 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-ATP2A2-cl51
AC   CVCL_UD14
SY   ATP2A2-GFP WTC; AICS-0046-051; AICSi002-A-30; UCSFi001-A-30
DR   BioSamples; SAMEA6348724
DR   Coriell; AICS-0046-051
DR   hPSCreg; UCSFi001-A-30
DR   Wikidata; Q98135045
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 ATP2A2 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-CDH1-cl32
AC   CVCL_D0N2
SY   AICS-0014-032; AICSi002-A-66; UCSFi001-A-66
DR   BioSamples; SAMEA110219754
DR   Coriell; AICS-0014-032
DR   hPSCreg; UCSFi001-A-66
DR   Wikidata; Q123033928
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 CDH1 has been endogenously tagged in both alleles at the C-terminus with mEGFP (Coriell=AICS-0014-032).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   WTC-mEGFP-CDH1-cl35
AC   CVCL_D0N3
SY   AICS-0014-035; AICSi002-A-67; UCSFi001-A-67
DR   BioSamples; SAMEA110221455
DR   Coriell; AICS-0014-035
DR   hPSCreg; UCSFi001-A-67
DR   Wikidata; Q123033929
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 CDH1 has been endogenously tagged in one allele at the C-terminus with mEGFP (Coriell=AICS-0014-035).
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   WTC-mEGFP-CTCF-cl20
AC   CVCL_A8SR
SY   AICS-0099-020; AICSi002-A-57; UCSFi001-A-57
DR   BioSamples; SAMEA9114812
DR   Coriell; AICS-0099-020
DR   hPSCreg; UCSFi001-A-57
DR   Wikidata; Q108821524
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 CTCF has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   WTC-mEGFP-CTNNB1-cl67
AC   CVCL_VK86
SY   AICS-0058-067; AICSi002-A-25; UCSFi001-A-25
DR   BioSamples; SAMEA6343703
DR   Coriell; AICS-0058-067
DR   hPSCreg; UCSFi001-A-25
DR   Wikidata; Q98135047
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 CTNNB1 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-DCP1A-cl124
AC   CVCL_C6T4
SY   AICS-0083-124; AICSi002-A-70; UCSFi001-A-70
DR   BioSamples; SAMEA111560210
DR   Coriell; AICS-0083-124
DR   hPSCreg; UCSFi001-A-70
DR   Wikidata; Q117705010
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 DCP1A has been endogenously tagged in one allele with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   WTC-mEGFP-DCP1A-cl5
AC   CVCL_C6T3
SY   AICS-0083-005; AICSi002-A-69; UCSFi001-A-69
DR   BioSamples; SAMEA111560209
DR   Coriell; AICS-0083-005
DR   hPSCreg; UCSFi001-A-69
DR   Wikidata; Q117705011
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 DCP1A has been endogenously tagged in both alleles with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   WTC-mEGFP-DSP-cl65
AC   CVCL_IR31
SY   AICS-0017-065; AICS0017; AICS-0017; DSP cl. 65; AICSi002-A-7; UCSFi001-A-7
DR   BioSamples; SAMEA6324702
DR   Coriell; AICS-0017
DR   hPSCreg; UCSFi001-A-7
DR   Wikidata; Q54994541
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 DSP has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 16
//
ID   WTC-mEGFP-EZH2-cl18
AC   CVCL_A6XI
SY   AICS-0095-018; AICSi002-A-46; UCSFi001-A-46
DR   BioSamples; SAMEA8714190
DR   Coriell; AICS-0095-018
DR   hPSCreg; UCSFi001-A-46
DR   Wikidata; Q107117555
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 EZH2 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   WTC-mEGFP-FBL-cl6
AC   CVCL_JM17
SY   AICS-0014-006; AICS0014; AICS-0014; FBL cl. 6; AICSi002-A-9; UCSFi001-A-9
DR   BioSamples; SAMEA6324704
DR   Coriell; AICS-0014
DR   hPSCreg; UCSFi001-A-9
DR   Wikidata; Q54994543
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 FBL has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 15
//
ID   WTC-mEGFP-FUS-cl69
AC   CVCL_UK05
SY   WTC-FUS-mEGFP-cl69; AICS-0080-069; AICSi002-A-35; UCSFi001-A-35
DR   BioSamples; SAMEA6348729
DR   Coriell; AICS-0080-069
DR   hPSCreg; UCSFi001-A-35
DR   Wikidata; Q98135049
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 FUS has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-G3BP1-cl1
AC   CVCL_B6E3
SY   AICS-0082-001; AICSi002-A-63; UCSFi001-A-63
DR   BioSamples; SAMEA12130333
DR   Coriell; AICS-0082-001
DR   hPSCreg; UCSFi001-A-63
DR   Wikidata; Q112041942
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 G3BP1 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 7
//
ID   WTC-mEGFP-GJA1-cl16
AC   CVCL_VK83
SY   AICS-0053-016; AICSi002-A-22; UCSFi001-A-22
DR   BioSamples; SAMEA6343700
DR   Coriell; AICS-0053-016
DR   hPSCreg; UCSFi001-A-22
DR   Wikidata; Q98135052
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 GJA1 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-HIST1H2BJ-cl36
AC   CVCL_UD17
SY   AICS-0061-036; AICSi002-A-28; UCSFi001-A-28
DR   BioSamples; SAMEA6348722
DR   Coriell; AICS-0061-036
DR   hPSCreg; UCSFi001-A-28
DR   Wikidata; Q98135054
RX   PubMed=37676985;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 HIST1H2BJ has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-LAMP1-cl37
AC   CVCL_LK42
SY   AICS-0022-037; AICS-0022; AICSi002-A-13; UCSFi001-A-13
DR   BioSamples; SAMEA6324708
DR   Coriell; AICS-0022-037
DR   hPSCreg; UCSFi001-A-13
DR   Wikidata; Q54994544
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 LAMP1 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-LMNB1-cl210
AC   CVCL_IR32
SY   AICS-0013-210; AICS0013; AICS-0013; LMNB1 cl. 210; AICSi002-A-6; UCSFi001-A-6
DR   BioSamples; SAMEA6306320
DR   Coriell; AICS-0013
DR   hPSCreg; UCSFi001-A-6
DR   Wikidata; Q54994545
RX   PubMed=28814507;
RX   PubMed=30199041;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 LMNB1 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 16
//
ID   WTC-mEGFP-MAP1LC3B-cl22
AC   CVCL_VK78
SY   AICS-0030-022; AICSi002-A-18; UCSFi001-A-18
DR   BioSamples; SAMEA6324713
DR   Coriell; AICS-0030-022
DR   hPSCreg; UCSFi001-A-18
DR   Wikidata; Q98135056
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 MAP1LC3B has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-MYH10-cl80
AC   CVCL_JM15
SY   MYH10-GFP WTC; AICS-0024-080; AICS0024; AICS-0024; MYH10 cl. 80; AICSi002-A-11; UCSFi001-A-11
DR   BioSamples; SAMEA6324706
DR   Coriell; AICS-0024
DR   hPSCreg; UCSFi001-A-11
DR   Wikidata; Q54994546
RX   PubMed=28814507;
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 MYH10 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   WTC-mEGFP-MYL2-cl27
AC   CVCL_UK03
SY   MYL2-GFP WTC; AICS-0060-027; AICSi002-A-32; UCSFi001-A-32
DR   BioSamples; SAMEA6348726
DR   Coriell; AICS-0060-027
DR   hPSCreg; UCSFi001-A-32
DR   Wikidata; Q98135058
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 MYL2 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-MYL7-cl3
AC   CVCL_UD15
SY   MYL7-GFP WTC; AICS-0052-003; AICS-0052 cl.3; WTC11-MYL7eGFP; AICSi002-A-29; UCSFi001-A-29
DR   BioSamples; SAMEA6348723
DR   Coriell; AICS-0052-003
DR   hPSCreg; UCSFi001-A-29
DR   Wikidata; Q98135061
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 MYL7 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 13
//
ID   WTC-mEGFP-NPM1-cl50
AC   CVCL_VK85
SY   AICS-0057-050; AICSi002-A-24; UCSFi001-A-24
DR   BioSamples; SAMEA6343702
DR   Coriell; AICS-0057-050
DR   hPSCreg; UCSFi001-A-24
DR   Wikidata; Q98135064
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 NPM1 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-NUP153-cl88
AC   CVCL_UD18
SY   AICS-0069-088; AICSi002-A-31; UCSFi001-A-31
DR   BioSamples; SAMEA6348725
DR   Coriell; AICS-0069-088
DR   hPSCreg; UCSFi001-A-31
DR   Wikidata; Q98135066
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 NUP153 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-PCNA-cl83
AC   CVCL_A8RT
SY   AICS-0088-083; AICSi002-A-56; UCSFi001-A-56
DR   BioSamples; SAMEA9114811
DR   Coriell; AICS-0088-083
DR   hPSCreg; UCSFi001-A-56
DR   Wikidata; Q108821525
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 PCNA has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 10-04-25; Version: 8
//
ID   WTC-mEGFP-POLR2A-cl74
AC   CVCL_A6XH
SY   AICS-0096-074; AICSi002-A-47; UCSFi001-A-47
DR   BioSamples; SAMEA8714191
DR   Coriell; AICS-0096-074
DR   hPSCreg; UCSFi001-A-47
DR   Wikidata; Q107117556
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 POLR2A has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   WTC-mEGFP-RAB5A-cl13
AC   CVCL_VK81
SY   AICS-0040-013; AICSi002-A-20; UCSFi001-A-20
DR   BioSamples; SAMEA6324715
DR   Coriell; AICS-0040-013
DR   hPSCreg; UCSFi001-A-20
DR   Wikidata; Q98135071
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 RAB5A has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-RAB5A-cl35
AC   CVCL_VK82
SY   AICS-0040-035; AICSi002-A-21; UCSFi001-A-21
DR   BioSamples; SAMEA6343699
DR   Coriell; AICS-0040-035
DR   hPSCreg; UCSFi001-A-21
DR   Wikidata; Q98135074
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 RAB5A has been endogenously tagged in both alleles at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-Safe harbor locus (AAVS1)-cl28
AC   CVCL_WM17
SY   AICS-0036-028; AICS0036-028; AICSi002-A-36; UCSFi001-A-36
DR   BioSamples; SAMEA6348730
DR   Coriell; AICS-0036-028
DR   hPSCreg; UCSFi001-A-36
DR   Wikidata; Q98135076
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 mEGFP under the control of a CAG promoter was integrated into one allele of the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 13
//
ID   WTC-mEGFP-Safe harbor locus (AAVS1)-cl6
AC   CVCL_JM19
SY   AICS-0036-006; AICS0036; AICS-0036; AICS0036-006; AICSi002-A-12; UCSFi001-A-12
DR   BioSamples; SAMEA6324707
DR   Coriell; AICS-0036-006
DR   hPSCreg; UCSFi001-A-12
DR   Wikidata; Q54994547
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 mEGFP under the control of a CAG promoter was integrated into one allele of the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 17
//
ID   WTC-mEGFP-SEC61B-cl55
AC   CVCL_JM14
SY   AICS-0010-055; AICS0010; AICS-0010; SEC61B cl. 55; AICSi002-A-8; UCSFi001-A-8
DR   BioSamples; SAMEA6324703
DR   Coriell; AICS-0010
DR   hPSCreg; UCSFi001-A-8
DR   Wikidata; Q54994548
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 SEC61B has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   WTC-mEGFP-SLC25A17-cl115
AC   CVCL_VK79
SY   AICS-0033-115; AICSi002-A-19; UCSFi001-A-19
DR   BioSamples; SAMEA6324714
DR   Coriell; AICS-0033-115
DR   hPSCreg; UCSFi001-A-19
DR   Wikidata; Q98135078
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 SLC25A17 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-SMC1A-cl9
AC   CVCL_UK04
SY   WTC-SMC1A-mEGFP-cl9; AICS-0068-009; AICSi002-A-34; UCSFi001-A-34
DR   BioSamples; SAMEA6348728
DR   Coriell; AICS-0068-009
DR   hPSCreg; UCSFi001-A-34
DR   Wikidata; Q98135080
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 SMC1A has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-SON-cl24
AC   CVCL_YU30
SY   AICS-0094-024; AICSi002-A-40; UCSFi001-A-40
DR   BioSamples; SAMEA7743699
DR   Coriell; AICS-0094-024
DR   hPSCreg; UCSFi001-A-40
DR   Wikidata; Q98135082
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 SON has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   WTC-mEGFP-SOX2-cl26
AC   CVCL_WM15
SY   AICS-0074-026; AICSi002-A-37; UCSFi001-A-37
DR   BioSamples; SAMEA6348731
DR   Coriell; AICS-0074-026
DR   hPSCreg; UCSFi001-A-37
DR   Wikidata; Q98135085
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 SOX2 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-ST6GAL1-cl1
AC   CVCL_LK46
SY   AICS-0025-001; AICSi002-A-14; UCSFi001-A-14
DR   BioSamples; SAMEA6324709
DR   Coriell; AICS-0025-001
DR   hPSCreg; UCSFi001-A-14
DR   Wikidata; Q54994549
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 ST6GAL1 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-ST6GAL1-cl44
AC   CVCL_LK43
SY   AICS-0025-044; AICSi002-A-15; UCSFi001-A-15
DR   BioSamples; SAMEA6324710
DR   Coriell; AICS-0025-044
DR   hPSCreg; UCSFi001-A-15
DR   Wikidata; Q54994550
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 ST6GAL1 has been endogenously tagged in both alleles at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   WTC-mEGFP-TERF2-cl25
AC   CVCL_A7MD
SY   AICS-0093-025; AICSi002-A-48; UCSFi001-A-48
DR   BioSamples; SAMEA8714192
DR   Coriell; AICS-0093-025
DR   hPSCreg; UCSFi001-A-48
DR   Wikidata; Q107117557
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TERF2 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 8
//
ID   WTC-mEGFP-TJP1-cl20
AC   CVCL_JM18
SY   AICS-0023-020; AICS0023; AICS-0023; TJP1 cl. 20; AICSi002-A-10; UCSFi001-A-10
DR   BioSamples; SAMEA6324705
DR   Coriell; AICS-0023
DR   hPSCreg; UCSFi001-A-10
DR   Wikidata; Q54994551
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TJP1 has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 14
//
ID   WTC-mEGFP-TNNI1-cl172
AC   CVCL_VK80
SY   TNNI1-GFP WTC; AICS-0037-172; AICSi002-A-26; UCSFi001-A-26
DR   BioSamples; SAMEA6348720
DR   Coriell; AICS-0037-172
DR   hPSCreg; UCSFi001-A-26
DR   Wikidata; Q98135087
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TNNI1 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-TOMM20-cl27
AC   CVCL_IR33
SY   AICS-0011-027; AICS0011; AICS-0011; TOMM20 cl. 27; AICSi002-A-5; UCSFi001-A-5
DR   BioSamples; SAMEA6306319
DR   Coriell; AICS-0011
DR   hPSCreg; UCSFi001-A-5
DR   Wikidata; Q54994552
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TOMM20 has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 16
//
ID   WTC-mEGFP-TTN-cl39
AC   CVCL_UD16
SY   TTN-GFP WTC; AICS-0048-039; AICSi002-A-27; UCSFi001-A-27
DR   BioSamples; SAMEA6348721
DR   Coriell; AICS-0048-039
DR   hPSCreg; UCSFi001-A-27
DR   Wikidata; Q98135089
RX   PubMed=34019794;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TTN has been endogenously tagged in one allele at the C-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 10-04-25; Version: 11
//
ID   WTC-mEGFP-TUBA1B-cl105
AC   CVCL_IR34
SY   AICS-0012-105; AICS0012; AICS-0012; TUBA1B cl. 105; AICSi002-A-2; UCSFi001-A-2
DR   BioSamples; SAMEA6298547
DR   Coriell; AICS-0012
DR   hPSCreg; UCSFi001-A-2
DR   Wikidata; Q54994553
RX   PubMed=28814507;
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TUBA1B has been endogenously tagged in one allele at the N-terminus with mEGFP.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 16
//
ID   WTC-mTagRFPT-CAAX-Safe harbor locus (AAVS1)-cl91
AC   CVCL_VK84
SY   AICS-0054-091; AICSi002-A-23; UCSFi001-A-23
DR   BioSamples; SAMEA6343701
DR   Coriell; AICS-0054-091
DR   hPSCreg; UCSFi001-A-23
DR   Wikidata; Q98135091
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 the CAAX domain of KRAS tagged with mTagRFP-T under the control of a CAG promoter was integrated at the AAVS1 safe harbor locus.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 14
//
ID   WTC-mTagRFPT-CETN2-cl19
AC   CVCL_LK45
SY   AICS-0032-019; AICS-0032; AICSi002-A-17; UCSFi001-A-17
DR   BioSamples; SAMEA6324712
DR   Coriell; AICS-0032-019
DR   hPSCreg; UCSFi001-A-17
DR   Wikidata; Q54994554
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 CETN2 has been endogenously tagged in one allele at the N-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   WTC-mTagRFPT-LMNB1-cl62
AC   CVCL_ZX21
SY   AICS-0034-062; AICSi002-A-41; UCSFi001-A-41
DR   BioSamples; SAMEA7743700
DR   Coriell; AICS-0034-062
DR   hPSCreg; UCSFi001-A-41
DR   Wikidata; Q102115122
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 LMNB1 has been endogenously tagged in one allele at the N-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   WTC-mTagRFPT-TUBA1B-cl35
AC   CVCL_LK44
SY   AICS-0031-035; AICS-0031; AICSi002-A-16; UCSFi001-A-16
DR   BioSamples; SAMEA6324711
DR   Coriell; AICS-0031-035
DR   hPSCreg; UCSFi001-A-16
DR   Wikidata; Q54994555
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
WW   Info; Allen Institute; -; https://www.allencell.org/genomics.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TUBA1B has been endogenously tagged in one allele at the N-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; LF3LJ; TagRFP-T (Note=Red fluorescent protein derived from eqFP578).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 12
//
ID   WTC-TFAM-mEGFP-cl31
AC   CVCL_ZX22
SY   AICS-0087-031; AICSi002-A-43; UCSFi001-A-43
DR   BioSamples; SAMEA7851602
DR   Coriell; AICS-0087-031
DR   hPSCreg; UCSFi001-A-43
DR   Wikidata; Q102115123
WW   Info; Allen Institute; -; https://www.allencell.org/cell-catalog.html
CC   Part of: Allen Cell Collection.
CC   Population: Japanese.
CC   Characteristics: Using CRISPR/Cas9 TFAM has been endogenously tagged in one allele at the C-terminus with mTagRFP-T.
CC   Genetic integration: Method=CRISPR/Cas9; Gene=FPbase; QKFJN; mEGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 9
//
ID   WTC11 AAVS1-NEUROG2 SYNJ1-KO
AC   CVCL_E1HU
SY   SYNJ1 KO WTC11; SJ1 KO iPSC
RX   PubMed=38635628;
CC   Population: Japanese.
CC   Characteristics: Using TALEN a PuroR-CAG-rtTA3G-NEUROG2 construct was introduced in both alleles of the AAVS1 safe harbor locus thus providing doxycycline-inducible expression of NEUROG2/NGN2 (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:11503; SYNJ1.
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:13805; NEUROG2.
CC   Genetic integration: Method=TALEN; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C7XJ ! Pre-i3Neuron NGN2 iPSC clone 1
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   WTC11 HOPX-NLS-eGFP
AC   CVCL_VM46
DR   Wikidata; Q98135094
RX   PubMed=30290179;
CC   Population: Japanese.
CC   Characteristics: Using TALEN, a conditionally expressed HOPX-NLS-eGFP construct was introduced in the AAVS1 safe harbor locus (PubMed=30290179).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=TALEN; Gene=HGNC; HGNC:24961; HOPX.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
ID   WTC11 NLS-eGFP
AC   CVCL_VM47
DR   Wikidata; Q98135096
RX   PubMed=30290179;
CC   Population: Japanese.
CC   Characteristics: Using TALEN, a conditionally expressed NLS-eGFP construct was introduced in the AAVS1 safe harbor locus (PubMed=30290179).
CC   Genetic integration: Method=TALEN; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   WTC11_RB1KO#1
AC   CVCL_A9N8
SY   WTC11_RB1KO clone 1
DR   Wikidata; Q102115124
RX   PubMed=32277725;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   WTC11_RB1KO#4
AC   CVCL_A9N9
SY   WTC11_RB1KO clone 4
DR   Wikidata; Q102115125
RX   PubMed=32277725;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:9884; RB1.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y803 ! GM25256
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   WTH-1
AC   CVCL_A0TT
DR   Wikidata; Q108821526
RX   PubMed=20927351;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q63493; Rat Cd1d (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   WTH-2
AC   CVCL_A0TU
DR   Wikidata; Q108821527
RX   PubMed=20927351;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; Q63493; Rat Cd1d (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   WTK-1
AC   CVCL_6742
SY   WTK1
DR   BTO; BTO_0003706
DR   IARC_TP53; 15513
DR   Wikidata; Q54994556
RX   PubMed=7744731;
RX   PubMed=10397247;
RX   PubMed=11221843;
RX   PubMed=11566342;
RX   PubMed=20673130;
RX   PubMed=22525470;
RX   PubMed=26774668;
CC   Group: Space-flown cell line (cellonaut).
CC   Population: Caucasian.
CC   Doubling time: 12.7 hours (PubMed=7744731).
CC   Sequence variation: Mutation; HGNC; HGNC:11272; SPTA1; Simple; p.Ser1163Ala (c.3487T>G); ClinVar=VCV000258929; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11830; TK1; Simple; p.Ala78Argfs*27 (c.231insC); Zygosity=Heterozygous (PubMed=11221843).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Met237Ile (c.711G>A); ClinVar=VCV000142714; Zygosity=Homozygous (PubMed=7744731; PubMed=11221843; PubMed=22525470).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Omics: Transcriptomics; RNAseq.
CC   Anecdotal: Have been flown in space on the ISS in 2008-2009 to study the biological effects of space radiations, microgravity and the space environment on the expression of TP53-regulated genes (PubMed=20673130).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C97074; Hereditary spherocytosis
DI   ORDO; Orphanet_822; Hereditary spherocytosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2761 ! WIL2 NS
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   WTR-L1
AC   CVCL_XB59
SY   WTRL1
DR   CCRID; 5301RAT-KCB84002ZJ
DR   KCB; KCB 84002ZJ
DR   Wikidata; Q98135097
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 7
//
ID   WTSIi018-B-13
AC   CVCL_D6KR
SY   KOLF2-C1 ATM R35; PEIi019-A-13
DR   BioSamples; SAMEA114503744
DR   hPSCreg; WTSIi018-B-13
DR   Wikidata; Q127384716
RX   PubMed=37976651;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple_edited; p.Arg35Ter (c.103C>T); ClinVar=VCV000003025; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37976651).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S58 ! HPSI0114i-kolf_2-C1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   WTSIi018-B-14
AC   CVCL_D6KS
SY   KOLF2-C1 ATM K3016Q; PEIi019-A-14
DR   BioSamples; SAMEA115039273
DR   hPSCreg; WTSIi018-B-14
DR   Wikidata; Q127384717
RX   PubMed=37976651;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple_edited; p.Lys3016Gln (c.9046A>C); Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37976651).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S58 ! HPSI0114i-kolf_2-C1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   WTSIi018-B-15
AC   CVCL_D6KT
SY   KOLF2-C1 ATM L1465P; PEIi019-A-15
DR   BioSamples; SAMEA115039274
DR   hPSCreg; WTSIi018-B-15
DR   Wikidata; Q127384718
RX   PubMed=37976651;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple_edited; p.Leu1465Pro (c.4394T>C); ClinVar=VCV000181996; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37976651).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S58 ! HPSI0114i-kolf_2-C1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   WTSIi018-B-16
AC   CVCL_D6KU
SY   KOLF2-C1 ATM A3054V; PEIi019-A-16
DR   BioSamples; SAMEA115039275
DR   hPSCreg; WTSIi018-B-16
DR   Wikidata; Q127384720
RX   PubMed=37976651;
CC   From: Paul Ehrlich Institute; Langen; Germany.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:795; ATM; Simple_edited; p.Ala3054Val (c.9161C>T); ClinVar=VCV000479082; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=37976651).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2887; Ataxia telangiectasia syndrome
DI   ORDO; Orphanet_100; Ataxia telangiectasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9S58 ! HPSI0114i-kolf_2-C1
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   WTSIi018-B-19
AC   CVCL_D6RH
SY   DU325; IUFi019-A-19
DR   BioSamples; SAMEA115295914
DR   hPSCreg; WTSIi018-B-19
RX   PubMed=38518401;
CC   From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:132; ACTB (Note=1 of 2 alleles).
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38518401
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,22
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D1S1656: 14,18.3
ST   D21S11: 31,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D6S1043: 12,20
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 12,15
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WTSIi018-B-20
AC   CVCL_D6RI
SY   DU326; IUFi019-A-20
DR   BioSamples; SAMEA115295915
DR   hPSCreg; WTSIi018-B-20
RX   PubMed=38518401;
CC   From: Leibniz Research Institute for Environmental Medicine; Dusseldorf; Germany.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:132; ACTB.
CC   Sequence variation: Mutation; HGNC; HGNC:18037; ARID2; Simple_corrected; p.Pro197Hisfs*12 (c.590_608delCTAAAATCATCACTTTACT); Zygosity=Heterozygous; Note=By CRISPR/Cas9 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; c.3526-1G>A; Zygosity=Heterozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2201; COL3A1; Simple; p.Gly1176Ser (c.3526G>A); Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=38518401
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 18,22
ST   D13S317: 9,10
ST   D16S539: 9,13
ST   D18S51: 12,17
ST   D19S433: 14,15
ST   D1S1656: 14,18.3
ST   D21S11: 31,32.2
ST   D2S1338: 17,19
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D6S1043: 12,20
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 21
ST   Penta D: 12,15
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5P3 ! KOLF2.1J
SX   Male
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   WTSIi227-A-1
AC   CVCL_VN07
SY   WETU LRP2 KO; BIHi228-A-1
DR   BioSamples; SAMEA4861651
DR   hPSCreg; WTSIi227-A-1
DR   Wikidata; Q98135099
CC   From: Berlin Institute of Health; Berlin; Germany.
CC   Population: Caucasian; British.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:6694; LRP2.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_AI06 ! HPSI1113i-wetu_2
SX   Female
AG   55-59Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   WTSIi253-A-2
AC   CVCL_C1XT
SY   UMANi254-A-2
DR   hPSCreg; WTSIi253-A-2
DR   Wikidata; Q114313242
RX   PubMed=35933957;
CC   From: University of Manchester; Manchester; United Kingdom.
CC   Population: Caucasian; British.
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple_edited; p.Ser192Tyr (c.575C>A); ClinVar=VCV000003778; Zygosity=Homozygous; Note=By CRISPR/Cas9 (PubMed=35933957).
CC   Sequence variation: Mutation; HGNC; HGNC:12442; TYR; Simple; p.Arg402Gln (c.1205G>A); ClinVar=VCV000003779; Zygosity=Homozygous (PubMed=35933957).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C168731; Oculocutaneous albinism type 1A
DI   ORDO; Orphanet_79431; Oculocutaneous albinism type 1A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_EE95 ! HPSI0514i-letw_5
SX   Male
AG   70-74Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   WU E-14
AC   CVCL_F812
SY   WUE-14; 29CE12-1
DR   CLO; CLO_0009637
DR   ATCC; CRL-2255
DR   Wikidata; Q54994557
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   WU E-4
AC   CVCL_F813
SY   WUE-4; 1506 A1.4
DR   CLO; CLO_0009638
DR   ATCC; CRL-2247
DR   Wikidata; Q54994558
RX   PubMed=2466929;
RX   PubMed=3973009;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   WU E-7
AC   CVCL_2G80
SY   WU-E-7
DR   Wikidata; Q54994559
RX   PubMed=2466929;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P02649; Human APOE.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 4
//
ID   WU-10A4-B9
AC   CVCL_C8IC
DR   Wikidata; Q123033933
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   WU-3C9-B11
AC   CVCL_C8ID
DR   Wikidata; Q123033935
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   WU-5H6-D6
AC   CVCL_C8IE
DR   Wikidata; Q123033936
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   WU-8F5-E7
AC   CVCL_C8IF
DR   Wikidata; Q123033937
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   WU-9E1-G2
AC   CVCL_C8IG
DR   Wikidata; Q123033938
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P56747; Human CLDN6.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   WU-CcE-1
AC   CVCL_Z976
SY   CcE-1
DR   Wikidata; Q54994560
RX   PubMed=20471390;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=749652; ! Chrysodeixis chalcites (Golden twin-spot moth)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WU-TSC-1
AC   CVCL_C0YU
SY   Wuhan University-Tongue Squamous Carcinoma-1
DR   CCRID; 4201PAT-CCTCC01850
DR   Wikidata; Q114313244
RX   DOI=10.13701/j.cnki.kqyxyj.2022.04.013;
RX   Patent=CN113493769A;
RX   PubMed=36611830;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021161.
CC   Population: Chinese.
CC   Doubling time: 51.15 hours (DOI=10.13701/j.cnki.kqyxyj.2022.04.013).
CC   Misspelling: WU-TSC; CCRID=4201PAT-CCTCC01850.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): DOI=10.13701/j.cnki.kqyxyj.2022.04.013; PubMed=36611830
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 16,22
ST   D13S317: 9,12
ST   D16S539: 12,13
ST   D18S51: 14,16
ST   D19S433: 13,13.2
ST   D21S11: 31
ST   D2S1338: 19,22
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 13,19
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 15,20
ST   TH01: 7,8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   WUi001-A
AC   CVCL_D6K7
DR   hPSCreg; WUi001-A
DR   Wikidata; Q127384722
RX   PubMed=38181637;
CC   From: Westlake University; Hangzhou; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   WUi002-A
AC   CVCL_D6K8
DR   hPSCreg; WUi002-A
DR   Wikidata; Q127384723
RX   PubMed=38181637;
CC   From: Westlake University; Hangzhou; China.
CC   Population: Asian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   WUMi001-A
AC   CVCL_C1TJ
DR   BioSamples; SAMEA13298579
DR   hPSCreg; WUMi001-A
DR   Wikidata; Q114313245
CC   From: Medical University of Warsaw; Warsaw; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   WUMi002-A
AC   CVCL_C1TK
DR   BioSamples; SAMEA13298706
DR   hPSCreg; WUMi002-A
DR   Wikidata; Q114313246
CC   From: Medical University of Warsaw; Warsaw; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   WUMi003-A
AC   CVCL_C1TL
DR   BioSamples; SAMEA13298724
DR   hPSCreg; WUMi003-A
DR   Wikidata; Q114313247
CC   From: Medical University of Warsaw; Warsaw; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   WUMi004-A
AC   CVCL_C1TM
DR   hPSCreg; WUMi004-A
DR   Wikidata; Q114313248
CC   From: Medical University of Warsaw; Warsaw; Poland.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   WUR-GeoBa-1
AC   CVCL_D4A4
DR   Wikidata; Q127384724
RX   DOI=10.18174/540280;
RX   PubMed=37031251;
CC   Senescence: Can undergo at least 98 PDL in OpM1 medium (PubMed=37031251).
CC   Doubling time: ~0.5 hours (Note=In OpM1 medium), ~1 hour (Note=In M1 medium) (PubMed=37031251).
CC   Anecdotal: First sponge cell line, established in 2021.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species 5 letter code.
OX   NCBI_TaxID=519541; ! Geodia barretti (Barrett's horny sponge)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 30-01-24; Last updated: 27-11-25; Version: 4
//
ID   WUZH1
AC   CVCL_E890
SY   WUZHI
DR   dbMHC; 49081
DR   IHW; IHW09459
DR   IPD-IMGT/HLA; 26054
DR   Wikidata; Q54994561
RX   PubMed=30844424;
CC   Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC   Population: Chinese.
CC   HLA typing: A*02:53N,11:01:01; B*37:01,58:01; C*03:02,06:02; DPB1*02:01:02,04:01:01; DQB1*02:01,05:01:01; DRB1*03:01:01,10:01:01; DRB3*02:02:01 (IPD-IMGT/HLA=26054).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   WVB-Pcr-02
AC   CVCL_Z953
DR   ICLDB; wvb-pcr-02
DR   Wikidata; Q54994562
RX   DOI=10.14188/j.1671-8836.1997.02.019;
CC   Group: Insect cell line.
CC   Doubling time: 60-64 hours (DOI=10.14188/j.1671-8836.1997.02.019).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=7127; ! Samia cynthia (Ailanthus silkmoth)
SX   Female
AG   Pupal stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   WW
AC   CVCL_U798
DR   cancercelllines; CVCL_U798
DR   Cosmic; 889042
DR   Cosmic; 928722
DR   GEO; GSM228379
DR   Progenetix; CVCL_U798
DR   Wikidata; Q54994563
RX   PubMed=1697409;
RX   PubMed=9354451;
RX   PubMed=15048078;
RX   PubMed=17363583;
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=9354451; PubMed=17363583).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=15048078; PubMed=17363583).
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 17
//
ID   WW0008
AC   CVCL_8Z01
DR   ECACC; 89060702
DR   Wikidata; Q54994564
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 89060702; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   WW0240
AC   CVCL_8Z02
DR   ECACC; 95080208
DR   Wikidata; Q54994565
CC   Part of: ECACC chromosomal abnormality collection.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 95080208; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y8M
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   WW1
AC   CVCL_N782
DR   Wikidata; Q54994566
RX   PubMed=7638196;
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 7
//
ID   WW165
AC   CVCL_G321
DR   cancercelllines; CVCL_G321
DR   Cosmic; 1197385
DR   Cosmic; 1548845
DR   Wikidata; Q54994575
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=26214590;
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   WW6
AC   CVCL_N783
SY   ES-WW6
DR   EFO; EFO_0005915
DR   ATCC; CRL-2239
DR   ENCODE; ENCBS120ENC
DR   ENCODE; ENCBS121ENC
DR   ENCODE; ENCBS134ZWP
DR   ENCODE; ENCBS480DYF
DR   GEO; GSM1014159
DR   GEO; GSM1014160
DR   Wikidata; Q54994576
RX   PubMed=7638196;
CC   Part of: ENCODE project mouse cell lines.
CC   Discontinued: ATCC; CRL-2239; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   WWAI
AC   CVCL_F821
DR   IPD-IMGT/HLA; 11577
DR   Wikidata; Q54994577
CC   Part of: International Histocompatibility Workshop cell lines.
CC   Population: African American.
CC   HLA typing: A*34:02:01:01 (IPD-IMGT/HLA=11577).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 05-10-23; Version: 11
//
ID   WWX-GEEC03
AC   CVCL_A9LZ
DR   CCRID; 4201PAT-CCTCC00472
DR   Wikidata; Q108821528
RX   Patent=CN104152403B;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2014137.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8844; ! Anser anser anser (Western greylag goose)
AG   Embryo
CA   Finite cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
ID   WX310
AC   CVCL_3434
DR   CLO; CLO_0009639
DR   CLDB; cl4736
DR   ECACC; 85022818
DR   Wikidata; Q54994578
DI   NCIt; C23988; Mouse neoplasms
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   Wx67
AC   CVCL_A742
SY   WX67
DR   Cosmic; 687461
DR   Wikidata; Q54994579
RX   PubMed=12068308;
RX   PubMed=29732388;
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 7
//
ID   WY005
AC   CVCL_F407
DR   CLO; CLO_0051099
DR   RCB; HSC0072
DR   Wikidata; Q54994580
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY020
AC   CVCL_F408
DR   CLO; CLO_0051097
DR   RCB; HSC0069
DR   Wikidata; Q54994582
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY034
AC   CVCL_F409
DR   CLO; CLO_0051118
DR   RCB; HSC0095
DR   Wikidata; Q54994583
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY035
AC   CVCL_F410
DR   CLO; CLO_0051103
DR   RCB; HSC0076
DR   Wikidata; Q54994584
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY036
AC   CVCL_F411
DR   CLO; CLO_0051104
DR   RCB; HSC0077
DR   Wikidata; Q54994585
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY037
AC   CVCL_F412
DR   CLO; CLO_0051105
DR   RCB; HSC0078
DR   Wikidata; Q54994586
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY038
AC   CVCL_F413
DR   CLO; CLO_0051106
DR   RCB; HSC0079
DR   Wikidata; Q54994587
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY039
AC   CVCL_F414
DR   CLO; CLO_0051114
DR   RCB; HSC0090
DR   Wikidata; Q54994588
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY040
AC   CVCL_F415
DR   CLO; CLO_0051107
DR   RCB; HSC0080
DR   Wikidata; Q54994589
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY043
AC   CVCL_F416
DR   CLO; CLO_0051070
DR   RCB; HSC0035
DR   Wikidata; Q54994590
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY046
AC   CVCL_F417
DR   CLO; CLO_0051108
DR   RCB; HSC0081
DR   Wikidata; Q54994591
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   WY047
AC   CVCL_F418
DR   CLO; CLO_0051110
DR   RCB; HSC0084
DR   Wikidata; Q54994592
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY048
AC   CVCL_F419
DR   CLO; CLO_0051109
DR   RCB; HSC0082
DR   Wikidata; Q54994593
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY049
AC   CVCL_F420
DR   CLO; CLO_0051101
DR   RCB; HSC0074
DR   Wikidata; Q54994594
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY050
AC   CVCL_F421
DR   CLO; CLO_0051074
DR   RCB; HSC0042
DR   Wikidata; Q54994595
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY051
AC   CVCL_F422
DR   CLO; CLO_0051167
DR   RCB; HSC0130
DR   Wikidata; Q54994596
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY053
AC   CVCL_F423
DR   CLO; CLO_0051159
DR   RCB; HSC0122
DR   Wikidata; Q54994598
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY054
AC   CVCL_F424
DR   CLO; CLO_0051168
DR   RCB; HSC0132
DR   Wikidata; Q54994599
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY055
AC   CVCL_F425
DR   CLO; CLO_0051160
DR   RCB; HSC0123
DR   Wikidata; Q54994601
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY057
AC   CVCL_F426
DR   CLO; CLO_0051075
DR   RCB; HSC0043
DR   Wikidata; Q54994602
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY058
AC   CVCL_F427
DR   CLO; CLO_0051079
DR   RCB; HSC0048
DR   Wikidata; Q54994603
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY059
AC   CVCL_F428
DR   CLO; CLO_0051089
DR   RCB; HSC0059
DR   Wikidata; Q54994604
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY064
AC   CVCL_F429
DR   CLO; CLO_0051085
DR   RCB; HSC0054
DR   Wikidata; Q54994605
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY065
AC   CVCL_F430
DR   CLO; CLO_0051086
DR   RCB; HSC0055
DR   Wikidata; Q54994606
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY071
AC   CVCL_F431
DR   CLO; CLO_0051180
DR   RCB; HSC0091
DR   Wikidata; Q54994607
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY072
AC   CVCL_F432
DR   CLO; CLO_0051132
DR   RCB; HSC0083
DR   Wikidata; Q54994608
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY073
AC   CVCL_F433
DR   CLO; CLO_0051113
DR   RCB; HSC0089
DR   Wikidata; Q54994609
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY074
AC   CVCL_F434
DR   CLO; CLO_0051111
DR   RCB; HSC0086
DR   Wikidata; Q54994610
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY075
AC   CVCL_F435
DR   CLO; CLO_0051115
DR   RCB; HSC0092
DR   Wikidata; Q54994611
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY076
AC   CVCL_F436
DR   CLO; CLO_0051112
DR   RCB; HSC0088
DR   Wikidata; Q54994612
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY077
AC   CVCL_F437
DR   CLO; CLO_0051179
DR   RCB; HSC0087
DR   Wikidata; Q54994614
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY078
AC   CVCL_F438
SY   WY-078
DR   CLO; CLO_0051066
DR   RCB; HSC0031
DR   Wikidata; Q54994615
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY080
AC   CVCL_F439
DR   CLO; CLO_0051073
DR   RCB; HSC0040
DR   Wikidata; Q54994616
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY083
AC   CVCL_F440
DR   CLO; CLO_0051337
DR   RCB; HSC0063
DR   Wikidata; Q54994617
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY084
AC   CVCL_6E41
DR   Wikidata; Q54994618
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 10
//
ID   WY086
AC   CVCL_F441
DR   CLO; CLO_0051095
DR   RCB; HSC0067
DR   Wikidata; Q54994631
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY090
AC   CVCL_LK57
DR   Wikidata; Q54994632
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 8
//
ID   WY091
AC   CVCL_F442
DR   CLO; CLO_0051094
DR   RCB; HSC0066
DR   Wikidata; Q54994633
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY092
AC   CVCL_F443
DR   CLO; CLO_0051096
DR   RCB; HSC0068
DR   Wikidata; Q54994634
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   WY102
AC   CVCL_F444
DR   CLO; CLO_0051080
DR   RCB; HSC0049
DR   Wikidata; Q54994635
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Colombian; native South American; Wayuu.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   WYUi001-A
AC   CVCL_C0IF
SY   iPSC63
DR   BioSamples; SAMEA13293330
DR   hPSCreg; WYUi001-A
DR   Wikidata; Q112930571
RX   PubMed=35358830;
RX   PubMed=36868040;
CC   From: Wuyi University; Jiangmen; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:15782; ARHGAP11B.
CC   Caution: The original paper (PubMed=35358830) was retracted (PubMed=36868040) and it is indicated that 'new information that has come to the attention of the authors regarding the extent of the editing in the generated iPSC line'. They will submit a new paper that 'will include all corrected and updated details with respect to their edited iPSC line'.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   WYUi002-A
AC   CVCL_D0PZ
SY   RANGRF-/- iPSC; UH-10
DR   BioSamples; SAMEA112815116
DR   hPSCreg; WYUi002-A
DR   Wikidata; Q123033939
RX   PubMed=37327621;
CC   From: Wuyi University; Jiangmen; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:17679; RANGRF.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   WYUi003-A
AC   CVCL_D6K9
DR   BioSamples; SAMEA115043960
DR   hPSCreg; WYUi003-A
DR   Wikidata; Q127384725
CC   From: Wuyi University; Jiangmen; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   X-01
AC   CVCL_C656
DR   Wikidata; Q54994636
RX   PubMed=21338948;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   X-02
AC   CVCL_C657
DR   Wikidata; Q54994637
RX   PubMed=21338948;
CC   From: Shanghai Institutes for Biological Sciences; Shanghai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-09-24; Version: 9
//
ID   X-376
AC   CVCL_RL99
DR   Cosmic; 787489
DR   Cosmic; 975315
DR   Wikidata; Q54994638
RX   PubMed=2538682;
DI   NCIt; C3171; Acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 4
//
ID   X.14
AC   CVCL_D6UB
RX   PubMed=6332057;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Chicken cortical thymocytes 65 kDa antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   X1/5
AC   CVCL_2768
SY   HtTA-1 clone X1/5
DR   CLO; CLO_0009640
DR   CLDB; cl4737
DR   ECACC; 95051229
DR   Wikidata; Q54994639
RX   PubMed=1319065;
CC   Population: African American.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P04483; Escherichia coli Tn10 tetR.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2523 ! HtTA-1
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   X16C8.5
AC   CVCL_0208
SY   X16C
DR   CLO; CLO_0009641
DR   ATCC; TIB-209
DR   Wikidata; Q54994640
RX   PubMed=310843;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: 18 hours (PubMed=310843).
CC   Breed/subspecies: BALB/cAnN.
DI   NCIt; C134780; Mouse reticulum cell sarcoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   >15M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   X19
AC   CVCL_CW58
DR   Wikidata; Q54994641
RX   PubMed=2415533;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00610; Human CLTC.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 13-07-16; Last updated: 21-03-23; Version: 4
//
ID   X22
AC   CVCL_F814
DR   CLO; CLO_0009642
DR   ATCC; CRL-2228
DR   Wikidata; Q54994642
RX   PubMed=2415533;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q00610; Human CLTC (Note=Also reacts with other species).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   X25-4
AC   CVCL_BW59
DR   Wikidata; Q54994644
RX   PubMed=218224;
RX   PubMed=223286;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW60 ! X25-6
OI   CVCL_BW61 ! X25-9
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   X25-6
AC   CVCL_BW60
DR   Wikidata; Q54994645
RX   PubMed=218224;
RX   PubMed=223286;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW59 ! X25-4
OI   CVCL_BW61 ! X25-9
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   X25-9
AC   CVCL_BW61
DR   Wikidata; Q54994646
RX   PubMed=218224;
RX   PubMed=223286;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_BW59 ! X25-4
OI   CVCL_BW60 ! X25-6
AG   <1D
CA   Transformed cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   X3C-5
AC   CVCL_UM88
DR   Wikidata; Q98135101
RX   PubMed=3402430;
CC   Characteristics: Derived from the third passage of a nude mouse xenograft.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   X4-MaRBLE
AC   CVCL_E8AV
SY   HPB-Ma/LTR-FL/CMV-RL
RX   PubMed=17182760;
CC   Population: Japanese.
CC   Characteristics: Reporter cell line to measure HIV-1 infectivity and thus evaluate susceptibility to anti-HIV-1 drugs (PubMed=17182760).
CC   Characteristics: Transfected with two constructs. 1) 53LTRN-lucneoR#1 which contains the HIV-1 strain HXB2 LTR driving the expression of a Luc-DsRed fusion protein. This allows HIV-1 replication to be quantitatively evaluated by using luciferase activity when the LTR is activated by Tat, and the DsRed gene allows HIV-1 infected cells to be identified by red fluorescence. 2) pRenillaPac where Renilla luciferase is under the control of a CMV promoter and is used to monitor cell numbers and viability (PubMed=17182760).
CC   Virology: Infected with Moloney murine leukemia virus (MoMuLV) from MiCl1 (S+L-) (Cellosaurus=CVCL_3405) cells (from parent cell line).
CC   Virology: Susceptible to infection by CXCR4-tropic HIV-1 strains (example HXB2) (PubMed=17182760).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1539; CBFB + HGNC; HGNC:29824; MYL11; Name(s)=CBFB-MYL11, CBFB-MYLPF (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Leu1574Pro (c.4721T>C); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7881; NOTCH1; Simple; p.Asp2442fs*39 (c.7326_7326insGGGCCGTGGACG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys124Ter (c.372C>A); ClinVar=VCV000458537; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=FPbase; EGE3L; DsRed (Note=drFP583, red fluorescent protein from Discosoma sp.).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P27652; Renilla reniformis renilla-type luciferase.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E8AT ! HPB-Ma
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   X50-7
AC   CVCL_8277
DR   Wikidata; Q54994648
RX   Patent=US5178999;
RX   PubMed=218224;
RX   PubMed=223286;
RX   PubMed=3033285;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   <1D
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   X50-7.8
AC   CVCL_J031
DR   Wikidata; Q54994649
RX   Patent=US5178999;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-9694.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8277 ! X50-7
AG   <1D
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   X5563
AC   CVCL_H719
SY   X-5563; x5563
DR   ChEMBL-Cells; CHEMBL3307487
DR   ChEMBL-Targets; CHEMBL614250
DR   PubChem_Cell_line; CVCL_H719
DR   TKG; TKG 0174
DR   Wikidata; Q54994650
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C3H/He.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   X63-omIL-2
AC   CVCL_Y272
SY   X63/OMIL2; XR63-IL2
DR   BCRJ; 0250
DR   Wikidata; Q54994651
RX   PubMed=2831066;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96548; Il2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 7
//
ID   X63-omIL-3
AC   CVCL_M352
SY   X63/OMIL3; XR63-IL3
DR   BCRJ; 0251
DR   ChEMBL-Cells; CHEMBL3307917
DR   ChEMBL-Targets; CHEMBL614312
DR   PubChem_Cell_line; CVCL_M352
DR   Wikidata; Q54994652
RX   PubMed=2831066;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96552; Il3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 11
//
ID   X63-omIL-4
AC   CVCL_Y273
SY   X63/OMIL4; XR63-IL4
DR   BCRJ; 0252
DR   Wikidata; Q54994653
RX   PubMed=2831066;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96556; Il4.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 7
//
ID   X63-omIL-5
AC   CVCL_Y274
SY   X63/OMIL5; XR63-IL5
DR   BCRJ; 0253
DR   Wikidata; Q54994654
RX   PubMed=2831066;
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:96557; Il5.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 07-11-14; Last updated: 14-08-25; Version: 7
//
ID   X9
AC   CVCL_II79
DR   ATCC; CRL-3282
DR   Wikidata; Q54994656
RX   PubMed=22796012;
CC   Derived from site: In situ; Inguinal fat pad, adipose tissue; UBERON=UBERON_0010410+UBERON_0001013.
CC   Cell type: Beige adipocyte; CL=CL_0001070.
CC   Breed/subspecies: 129S6/SvEvTac.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   7-9W
CA   Spontaneously immortalized cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 6
//
ID   XA325.1
AC   CVCL_C5Z6
DR   Wikidata; Q116050807
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.10
AC   CVCL_C5ZA
DR   Wikidata; Q116050808
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.16
AC   CVCL_C5WQ
DR   Wikidata; Q116050809
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.2
AC   CVCL_C5Z7
DR   Wikidata; Q116050810
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.4
AC   CVCL_C5Z8
DR   Wikidata; Q116050811
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.5
AC   CVCL_C5WR
DR   Wikidata; Q116050812
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.6
AC   CVCL_C5Z5
DR   Wikidata; Q116050813
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XA325.7
AC   CVCL_C5Z9
DR   Wikidata; Q116050814
RX   PubMed=34809742;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; Q01638; Human IL1RL1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   XACHi001-A
AC   CVCL_WZ29
DR   hPSCreg; XACHi001-A
DR   Wikidata; Q98135103
RX   PubMed=31382203;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Ala1855Asp (c.5564C>A); Zygosity=Heterozygous (PubMed=31382203).
CC   Sequence variation: Mutation; HGNC; HGNC:10582; SCN10A; Simple; p.Gln1362His (c.4086G>T); Zygosity=Heterozygous (PubMed=31382203).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=31382203
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D12S391: 20
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 13,14
ST   D19S433: 14,14.2
ST   D1S1656: 16
ST   D21S11: 29,32.2
ST   D2S1338: 20,23
ST   D3S1358: 15
ST   D5S818: 12
ST   D6S1043: 14,19
ST   D7S820: 10,12
ST   D8S1179: 13
ST   FGA: 22,23
ST   Penta D: 10,12
ST   Penta E: 12,16
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,19
DI   NCIt; C123414; Catecholaminergic polymorphic ventricular tachycardia type 1
DI   ORDO; Orphanet_3286; Catecholaminergic polymorphic ventricular tachycardia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4M
CA   Induced pluripotent stem cell
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 7
//
ID   XACHi002-A
AC   CVCL_YM75
DR   hPSCreg; XACHi002-A
DR   Wikidata; Q98135105
RX   PubMed=31743840;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg608Ter (c.1822C>T); ClinVar=VCV000972803; Zygosity=Heterozygous (PubMed=31743840).
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu888Ter (c.2662G>T); ClinVar=VCV000578595; Zygosity=Heterozygous (PubMed=31743840).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84734; Glycogen storage disease type II
DI   ORDO; Orphanet_365; Glycogen storage disease due to acid maltase deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   XACHi003-A
AC   CVCL_YM76
DR   hPSCreg; XACHi003-A
DR   Wikidata; Q98135107
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   XACHi004-A
AC   CVCL_YM77
DR   BioSamples; SAMEA111507229
DR   hPSCreg; XACHi004-A
DR   Wikidata; Q98135109
RX   PubMed=36335801;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10484; RYR2; Simple; p.Val4880Ile (c.14638G>A); ClinVar=VCV001439521; Zygosity=Heterozygous (PubMed=36335801).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   XACHi005-A
AC   CVCL_YM78
DR   hPSCreg; XACHi005-A
DR   Wikidata; Q98135113
RX   PubMed=36240644;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Glu888Ter (c.2662G>T); ClinVar=VCV000578595; Zygosity=Heterozygous (PubMed=36240644).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   XACHi006-A
AC   CVCL_YM79
DR   hPSCreg; XACHi006-A
DR   Wikidata; Q98135115
RX   PubMed=36240644;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4065; GAA; Simple; p.Arg608Ter (c.1822C>T); ClinVar=VCV000972803; Zygosity=Heterozygous (PubMed=36240644).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 6
//
ID   XACHi007-A
AC   CVCL_YM80
SY   P1
DR   hPSCreg; XACHi007-A
DR   SKIP; SKIP005748
DR   Wikidata; Q98135117
RX   PubMed=32344329;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6240; KCNE1; Simple; p.Asp76Asn (c.226G>A); ClinVar=VCV000013477; Zygosity=Heterozygous (PubMed=32344329).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172094; Long QT syndrome 5
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8M
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   XACHi008-A
AC   CVCL_YM81
SY   P2
DR   hPSCreg; XACHi008-A
DR   SKIP; SKIP005747
DR   Wikidata; Q98135120
RX   PubMed=32344329;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6240; KCNE1; Simple; p.Asp76Asn (c.226G>A); ClinVar=VCV000013477; Zygosity=Heterozygous (PubMed=32344329).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172094; Long QT syndrome 5
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   XACHi009-A
AC   CVCL_YM82
SY   P3
DR   hPSCreg; XACHi009-A
DR   SKIP; SKIP005746
DR   Wikidata; Q98135122
RX   PubMed=32344329;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6240; KCNE1; Simple; p.Asp76Asn (c.226G>A); ClinVar=VCV000013477; Zygosity=Heterozygous (PubMed=32344329).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172094; Long QT syndrome 5
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 8
//
ID   XACHi010-A
AC   CVCL_ZB26
SY   P1
DR   hPSCreg; XACHi010-A
DR   Wikidata; Q98135124
RX   PubMed=32707487;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1243; C1QBP; Simple; p.Leu275Phe (c.823C>T); ClinVar=VCV000441245; Zygosity=Homozygous (PubMed=32707487).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   XACHi011-A
AC   CVCL_ZB27
SY   P2
DR   hPSCreg; XACHi011-A
DR   Wikidata; Q98135126
RX   PubMed=32707487;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:1243; C1QBP; Simple; p.Leu275Phe (c.823C>T); ClinVar=VCV000441245; Zygosity=Heterozygous (PubMed=32707487).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C174440; Combined oxidative phosphorylation deficiency 33
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 6
//
ID   XACHi012-A
AC   CVCL_A8WL
DR   hPSCreg; XACHi012-A
DR   Wikidata; Q108821529
RX   PubMed=34088017;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ile145Serfs*92 (c.431delC); Zygosity=Heterozygous (PubMed=34088017).
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Trp392Ter (c.1175G>A) (p.Trp265Ter, c.794G>A); ClinVar=VCV000405268; Zygosity=Heterozygous (PubMed=34088017).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34088017
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 17,21
ST   D13S317: 8,12
ST   D16S539: 9
ST   D18S51: 15,17
ST   D19S433: 14,15.2
ST   D1S1656: 16,17
ST   D21S11: 30,32.2
ST   D2S1338: 18,21
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D6S1043: 18,20
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 20,22.2
ST   Penta D: 8.2,12
ST   Penta E: 11,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C84793; Jervell and Lange Nielsen syndrome
DI   ORDO; Orphanet_90647; Jervell and Lange-Nielsen syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   XACHi013-A
AC   CVCL_A8WM
DR   hPSCreg; XACHi013-A
DR   Wikidata; Q108821530
RX   PubMed=34088017;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Trp392Ter (c.1175G>A) (p.Trp265Ter, c.794G>A); ClinVar=VCV000405268; Zygosity=Heterozygous (PubMed=34088017).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34088017
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,21
ST   D13S317: 10,12
ST   D16S539: 9
ST   D18S51: 13,17
ST   D19S433: 14
ST   D1S1656: 16
ST   D21S11: 29,30
ST   D2S1338: 18,23
ST   D3S1358: 14,17
ST   D5S818: 11
ST   D6S1043: 13,20
ST   D7S820: 12
ST   D8S1179: 13,16
ST   FGA: 20,23
ST   Penta D: 8,12
ST   Penta E: 11,13
ST   TH01: 9
ST   TPOX: 7
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   XACHi014-A
AC   CVCL_A8WN
DR   hPSCreg; XACHi014-A
DR   Wikidata; Q108821531
RX   PubMed=34088017;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Ile145Serfs*92 (c.431delC); Zygosity=Heterozygous (PubMed=34088017).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=34088017
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 17,24
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 15,16
ST   D19S433: 13,15.2
ST   D1S1656: 15,17
ST   D21S11: 30,32.2
ST   D2S1338: 21,26
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 11,12
ST   D8S1179: 14,15
ST   FGA: 22.2,23
ST   Penta D: 11,12
ST   Penta E: 13,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   XACHi015-A
AC   CVCL_B0GT
DR   hPSCreg; XACHi015-A
DR   Wikidata; Q108821532
RX   PubMed=34438161;
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Pro605Leu (c.1814C>T); ClinVar=VCV000067284; Zygosity=Heterozygous (PubMed=34438161).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   XACHi016-A
AC   CVCL_B5GS
DR   hPSCreg; XACHi016-A
DR   Wikidata; Q110434409
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   XACHi017-A
AC   CVCL_B5GT
DR   hPSCreg; XACHi017-A
DR   Wikidata; Q110434410
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   XACHi018-A
AC   CVCL_C1WQ
DR   hPSCreg; XACHi018-A
DR   Wikidata; Q114313249
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   XACHi019-A
AC   CVCL_C1WR
DR   hPSCreg; XACHi019-A
DR   Wikidata; Q114313250
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   XACHi020-A
AC   CVCL_C1WS
DR   hPSCreg; XACHi020-A
DR   Wikidata; Q114313253
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   XACHi021-A
AC   CVCL_C1WT
DR   hPSCreg; XACHi021-A
DR   Wikidata; Q114313256
CC   From: Children's Research Institute of Shaanxi province, Xi'an Key Laboratory of Children's Health and Diseases; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 21-03-23; Version: 3
//
ID   XB-2
AC   CVCL_3624
SY   XB2; XB
DR   CLO; CLO_0009644
DR   ATCC; CL-177
DR   BCRC; 60546
DR   IZSLER; BS CL 128
DR   Wikidata; Q54994657
RX   Patent=US4016036;
RX   PubMed=730781;
RX   PubMed=1052770;
RX   PubMed=1690090;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CL-177.
CC   Breed/subspecies: CXBGB/By.
DI   NCIt; C129859; Mouse teratocarcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   XB691
AC   CVCL_C0Q2
DR   Wikidata; Q112930572
RX   PubMed=6861277;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8354; ! Xenopus borealis (Kenyan clawed frog)
SX   Sex unspecified
AG   NF stage 35 tadpole
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   XB693
AC   CVCL_C0Q3
SY   Xb693; XB 693 C
DR   Wikidata; Q112930573
RX   DOI=10.1515/9783112315958-071;
RX   PubMed=3758199;
RX   PubMed=6861277;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8354; ! Xenopus borealis (Kenyan clawed frog)
SX   Sex unspecified
AG   NF stage 35 tadpole
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   XB693T
AC   CVCL_C0Q4
SY   Xb693T; XB 693 T; XB693-M1
DR   Wikidata; Q112930574
RX   DOI=10.1515/9783112315958-071;
RX   PubMed=3758199;
RX   PubMed=6861277;
CC   Group: Amphibian cell line.
CC   Characteristics: Tumorigenic.
CC   Karyotypic information: Hypotetraploid with a modal chromosome number of 62 (PubMed=6861277).
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
OX   NCBI_TaxID=8354; ! Xenopus borealis (Kenyan clawed frog)
HI   CVCL_C0Q3 ! XB693
SX   Sex unspecified
AG   NF stage 35 tadpole
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 4
//
ID   XB694
AC   CVCL_UJ64
DR   Wikidata; Q98135128
RX   CelloPub=CLPUB00460;
RX   PubMed=6861277;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8354; ! Xenopus borealis (Kenyan clawed frog)
SX   Sex unspecified
AG   NF stage 35 tadpole
CA   Spontaneously immortalized cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 4
//
ID   XC
AC   CVCL_1891
DR   BTO; BTO_0005227
DR   CLO; CLO_0009645
DR   CLO; CLO_0050824
DR   CLDB; cl4738
DR   CLDB; cl4739
DR   CLDB; cl4740
DR   CLDB; cl4741
DR   CLDB; cl4742
DR   ATCC; CCL-165
DR   ATCC; CRL-6603
DR   BCRC; 60098
DR   ChEMBL-Cells; CHEMBL3307251
DR   ChEMBL-Targets; CHEMBL612812
DR   DSMZ; ACC-118
DR   DSMZCellDive; ACC-118
DR   ECACC; 88120601
DR   ICLC; ATL96013
DR   IZSLER; BS TCL 66
DR   JCRB; IFO50017
DR   PubChem_Cell_line; CVCL_1891
DR   RCB; RCB1831
DR   Wikidata; Q54994658
RX   PubMed=169030;
RX   PubMed=4186808;
RX   PubMed=4343952;
RX   PubMed=4361813;
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Transformant: NCBI_TaxID; 11888; Rous sarcoma virus (strain Prague C).
CC   Discontinued: ATCC; CRL-6603; true.
CC   Breed/subspecies: White-Weston.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   XC-v
AC   CVCL_D623
DR   BTO; BTO_0005229
DR   Wikidata; Q54994659
RX   PubMed=4359877;
CC   Breed/subspecies: White-Weston.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1891 ! XC
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 7
//
ID   XC1.5/51
AC   CVCL_3625
DR   CLO; CLO_0009646
DR   ATCC; TIB-16
DR   Wikidata; Q54994661
RX   PubMed=8157994;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: C3H.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3493 ! C1.18.4
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 9
//
ID   XCIII-1F8-D7
AC   CVCL_U049
SY   P-1
DR   ECACC; 08041723
DR   Wikidata; Q54994662
RX   PubMed=2450920;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   XCIII-3D8-D8
AC   CVCL_U050
SY   P-2
DR   ECACC; 08041724
DR   Wikidata; Q54994663
RX   PubMed=2450920;
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 5
//
ID   XCIV-1H2-A8
AC   CVCL_U051
SY   T-11
DR   ECACC; 08041728
DR   Wikidata; Q54994665
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   XCL-1
AC   CVCL_WM82
SY   XCL1; XCLi001-A; XCLi004-A-1; CRMi003-A-1
DR   BioSamples; SAMEA5728498
DR   hPSCreg; CRMi003-A-1
DR   Wikidata; Q98135131
RX   PubMed=25777362;
RX   PubMed=26254731;
WW   Provider; XCell Science; -; http://www.xcellscience.com/control-lines/xcl/xcl-1-ipsc
CC   From: XCell Science, Inc.; Novato; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E71 ! NCRM-1
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 8
//
ID   XCL-5
AC   CVCL_WM83
DR   Wikidata; Q98135133
RX   PubMed=25777362;
CC   From: XCell Science, Inc.; Novato; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E75 ! NCRM-5
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   XCL-6
AC   CVCL_WM84
DR   Wikidata; Q98135134
WW   Provider; XCell Science; -; http://www.xcellscience.com/xcl-6-ipscs
CC   From: XCell Science, Inc.; Novato; USA.
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1E76 ! NCRM-6
SX   Female
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 10-04-25; Version: 5
//
ID   XCp
AC   CVCL_7229
DR   CLO; CLO_0009648
DR   CLDB; cl4744
DR   Wikidata; Q54994666
CC   Breed/subspecies: White-Weston.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_1891 ! XC
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 5
//
ID   XD
AC   CVCL_D5GV
DR   Wikidata; Q127384726
RX   PubMed=5831248;
RX   PubMed=16665994;
RX   PubMed=24263944;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Xanthi.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
CA   Spontaneously immortalized cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   XD-6
AC   CVCL_E1GQ
DR   BTO; BTO_0002055
RX   DOI=10.1093/oxfordjournals.pcp.a075547;
RX   DOI=10.1266/jjg.47.53;
CC   Group: Plant cell line.
CC   Characteristics: Retains the capacity to form shoots after long periods of subculturing (DOI=10.1266/jjg.47.53).
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Xanthi.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GV ! XD
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   XD-6S
AC   CVCL_E1GR
RX   DOI=10.15281/jplantres1887.82.417;
CC   Group: Plant cell line.
CC   Derived from site: In situ; Stem; PO=PO_0009047.
CC   Breed/subspecies: Cultivar Xanthi.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_D5GV ! XD
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 10-09-24; Version: 1
//
ID   XDCMHi001-A
AC   CVCL_WT97
DR   BioSamples; SAMEA5070575
DR   hPSCreg; XDCMHi001-A
DR   SKIP; SKIP005796
DR   Wikidata; Q98135136
RX   PubMed=32388440;
CC   From: Xiaoshan District Chinese Medicine Hospital; Hangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Tyr570Cys (c.1709A>G); Zygosity=Heterozygous (PubMed=32388440).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84564; Ankylosing spondylitis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 9
//
ID   XDP-1
AC   CVCL_VZ77
SY   XeroDerma Pigmentosum-1
DR   IBRC; C10407
DR   Wikidata; Q98135138
CC   Population: Iranian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   Xela DS2
AC   CVCL_C0XN
SY   Xenopus laevis Dorsal Skin 2
DR   Wikidata; Q114313259
RX   PubMed=32526291;
RX   PubMed=35492210;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Dorsal, skin; UBERON=UBERON_3010006.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   Xela VS2
AC   CVCL_C0XP
SY   Xenopus laevis Ventral Skin 2
DR   Wikidata; Q114313260
RX   PubMed=32526291;
RX   PubMed=35492210;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Ventral, skin; UBERON=UBERON_3010010.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   XEM1
AC   CVCL_GR61
DR   Wikidata; Q54994667
RX   PubMed=1441600;
RX   PubMed=1692605;
RX   PubMed=8236270;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2458; Cyp1a1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V36 ! V79MZ
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   XEMd-NH
AC   CVCL_GR64
SY   XEMd.NH
DR   Wikidata; Q54994670
RX   PubMed=1441600;
RX   PubMed=1793487;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 2459; Cyp1a2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_4V38 ! V79NH
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 26-09-16; Last updated: 14-08-25; Version: 11
//
ID   XF
AC   CVCL_6E64
SY   Xenopus Fibroblast
DR   Wikidata; Q54994672
RX   PubMed=1811155;
RX   PubMed=2335521;
CC   Group: Amphibian cell line.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   XF 498
AC   CVCL_8928
SY   XF-498; XF498
DR   BTO; BTO_0003414
DR   ChEMBL-Cells; CHEMBL3308037
DR   ChEMBL-Targets; CHEMBL613533
DR   NCI-DTP; XF 498
DR   PubChem_Cell_line; CVCL_8928
DR   Wikidata; Q54994673
RX   PubMed=2041050;
WW   Info; NCI DTP; NCI-60 additional lines; https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   XF11.1D8
AC   CVCL_B0XX
DR   Wikidata; Q110434411
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3030.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF11.1F8
AC   CVCL_B0XY
DR   Wikidata; Q110434414
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3150.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF11.1G8
AC   CVCL_B0XZ
DR   Wikidata; Q110434415
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3027.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF11.4C4
AC   CVCL_B0Y0
DR   Wikidata; Q110434416
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3028.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF11.4D10
AC   CVCL_B0Y1
DR   Wikidata; Q110434417
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3026.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF11.5H1
AC   CVCL_B0Y2
DR   Wikidata; Q110434418
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3029.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF22.3C9.6
AC   CVCL_B0Y3
DR   Wikidata; Q110434419
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3702.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF22.9E6
AC   CVCL_B0Y4
DR   Wikidata; Q110434420
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3859.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF27/28.7D5
AC   CVCL_B0Y5
DR   Wikidata; Q110434421
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4049.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF27/28.18B5
AC   CVCL_B0Y6
DR   Wikidata; Q110434422
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4050.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF27/28.25G10
AC   CVCL_B0Y7
DR   Wikidata; Q110434423
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4051.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF27/28.36A12
AC   CVCL_B0Y8
DR   Wikidata; Q110434424
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4052.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF27/28.36F11
AC   CVCL_B0Y9
DR   Wikidata; Q110434425
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4053.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF27/28.43E2
AC   CVCL_B0YA
SY   XF27/28/CCR5 43E2-AA
DR   Wikidata; Q110434426
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-4054.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 02-05-24; Version: 5
//
ID   XF27/28.55G4
AC   CVCL_B0YB
DR   Wikidata; Q110434427
RX   Patent=US7862818;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF3.10B8
AC   CVCL_B0YC
DR   Wikidata; Q110434428
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3151.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF3.5F1
AC   CVCL_B0YD
DR   Wikidata; Q110434430
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3147.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XF3.6A2
AC   CVCL_B0YE
DR   Wikidata; Q110434431
RX   Patent=US7862818;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-3148.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P51681; Human CCR5/CD195.
CC   Miscellaneous: As the immunized splenic B-cells are from Xenomouse mice the produced mAB is of human origin.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 4
//
ID   XFiPS-F44-3F-1
AC   CVCL_C106
SY   XF-iPSF44-3F-1; iPSXFII+III-1; ESi031-A
DR   BioSamples; SAMEA7781668
DR   hPSCreg; ESi031-A
DR   SKIP; SKIP002414
DR   Wikidata; Q54994674
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_XFiPS-F44-3F-1_vfinal_FIRMA.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/XFiPS-F44-3F-1.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_XFiPS-F44-3F-1.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V191 ! FiPS-3F-1
OI   CVCL_9S07 ! FiPS-4F-7
OI   CVCL_9S08 ! FiPS-4F-8
OI   CVCL_C107 ! XFiPS-F44-3F-2
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   XFiPS-F44-3F-2
AC   CVCL_C107
SY   XF-iPSF44-3F-2; iPSXFII+III-2; ESi032-A
DR   BioSamples; SAMEA6425541
DR   hPSCreg; ESi032-A
DR   SKIP; SKIP002415
DR   Wikidata; Q54994675
WW   Info; P-CMR[C]; -; https://p-cmrc.cat/wp-content/uploads/2020/06/Documento_Deposito_Lineas_XFiPS-F44-3F-2_vfinal.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880364/XFiPS-F44-3F-2.pdf
WW   Provider; BNLC; -; https://www.isciii.es/documents/20119/880377/Anexo_XFiPSF44-3F-2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Foreskin, skin; UBERON=UBERON_0001471.
CC   Cell type: Fibroblast of foreskin; CL=CL_1001608.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V191 ! FiPS-3F-1
OI   CVCL_9S07 ! FiPS-4F-7
OI   CVCL_9S08 ! FiPS-4F-8
OI   CVCL_C106 ! XFiPS-F44-3F-1
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   XG-1
AC   CVCL_4797
SY   XG1; XG 1
DR   ArrayExpress; E-TABM-937
DR   cancercelllines; CVCL_4797
DR   Cosmic; 742957
DR   Cosmic; 2081411
DR   Cosmic; 2367276
DR   Cosmic; 2809768
DR   IARC_TP53; 28500
DR   Wikidata; Q54994677
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1753108;
RX   PubMed=7504521;
RX   PubMed=8204890;
RX   PubMed=10087940;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=21173094;
RX   PubMed=30545397;
RX   PubMed=32123307;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=XG-1
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   Characteristics: Produces IgA kappa.
CC   HLA typing: A*02:01,29; B*40,44; C*02:02,16:01 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Arg (c.34G>C); ClinVar=VCV000040469; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Asn (c.376T>A); ClinVar=VCV000428871; Zygosity=Unspecified (PubMed=1373872; PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   XG-10
AC   CVCL_HX11
SY   XG10
DR   ArrayExpress; E-TABM-1088
DR   Cosmic; 2809774
DR   IARC_TP53; 28491
DR   Wikidata; Q54994695
RX   PubMed=10557056;
RX   PubMed=19718049;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*01,24; B*14,51; C*08,14 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   XG-11
AC   CVCL_HX12
SY   XG11
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_HX12
DR   Cosmic; 2809775
DR   IARC_TP53; 28502
DR   Wikidata; Q54994696
RX   PubMed=19718049;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02,26; B*18,38; C*07,12 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 16
//
ID   XG-12
AC   CVCL_HX13
SY   XG12
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_HX13
DR   IARC_TP53; 28493
DR   Wikidata; Q54994697
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   XG-13
AC   CVCL_HX14
SY   XG13
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_HX14
DR   IARC_TP53; 28511
DR   Wikidata; Q54994699
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   XG-14
AC   CVCL_HX15
SY   XG14
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_HX15
DR   IARC_TP53; 28512
DR   Wikidata; Q54994700
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig kappa.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 15
//
ID   XG-16
AC   CVCL_HX16
SY   XG16
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_HX16
DR   Cosmic; 2809776
DR   IARC_TP53; 28499
DR   Wikidata; Q54994701
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig kappa.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02,29; B*40,49; C*02,07 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000375871; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr220Cys (c.659A>G); ClinVar=VCV000127819; Zygosity=Unspecified (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 16
//
ID   XG-19
AC   CVCL_HX17
SY   XG19
DR   ArrayExpress; E-TABM-1088
DR   IARC_TP53; 28494
DR   Wikidata; Q54994703
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   XG-2
AC   CVCL_4798
SY   XG2; XG 2
DR   ArrayExpress; E-TABM-937
DR   cancercelllines; CVCL_4798
DR   Cosmic; 742959
DR   Cosmic; 2081412
DR   Cosmic; 2367291
DR   Cosmic; 2809769
DR   IARC_TP53; 28497
DR   Wikidata; Q54994704
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1753108;
RX   PubMed=7504521;
RX   PubMed=8204890;
RX   PubMed=10557056;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=21173094;
RX   PubMed=30545397;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: IL6 dependent.
CC   Characteristics: Produces IgG lambda.
CC   HLA typing: A*01,29; B*08,44; C*07,16:01 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys176Tyr (c.527G>A); ClinVar=VCV000186451; Zygosity=Unspecified (PubMed=1373872; PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 28
//
ID   XG-20
AC   CVCL_HX18
SY   XG20
DR   ArrayExpress; E-TABM-1088
DR   Wikidata; Q54994705
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 10
//
ID   XG-21
AC   CVCL_HX19
SY   XG21
DR   ArrayExpress; E-TABM-1088
DR   IARC_TP53; 28507
DR   Wikidata; Q54994706
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   XG-24
AC   CVCL_HX20
SY   XG24
DR   ArrayExpress; E-TABM-1088
DR   IARC_TP53; 28515
DR   Wikidata; Q54994708
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 13
//
ID   XG-3
AC   CVCL_4799
SY   XG3; XG 3; XG-3P; XG3P
DR   ArrayExpress; E-TABM-937
DR   cancercelllines; CVCL_4799
DR   Cosmic; 742960
DR   Cosmic; 2809770
DR   IARC_TP53; 28498
DR   Wikidata; Q54994710
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1753108;
RX   PubMed=8204890;
RX   PubMed=10936422;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02,32; B*35,44; C*04,05 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_HX21 ! XG-3E
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   XG-3E
AC   CVCL_HX21
SY   XG3E
DR   cancercelllines; CVCL_HX21
DR   Wikidata; Q54994711
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8204890;
RX   PubMed=10936422;
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (from autologous cell line XG-3).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_4799 ! XG-3
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 14-08-25; Version: 14
//
ID   XG-4
AC   CVCL_4800
SY   XG4; XG 4
DR   ArrayExpress; E-TABM-937
DR   cancercelllines; CVCL_4800
DR   Cosmic; 742961
DR   IARC_TP53; 364
DR   Wikidata; Q54994712
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1753108;
RX   PubMed=8204890;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=21173094;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG kappa.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg181Cys (c.541C>T); ClinVar=VCV000142624; Zygosity=Heterozygous (PubMed=1373872; PubMed=21173094).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 23
//
ID   XG-5
AC   CVCL_4801
SY   XG5; XG 5
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_4801
DR   Cosmic; 742962
DR   Cosmic; 2809771
DR   IARC_TP53; 365
DR   Wikidata; Q54994713
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1373872;
RX   PubMed=1753108;
RX   PubMed=7504521;
RX   PubMed=8204890;
RX   PubMed=10557056;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=16956823;
RX   PubMed=21173094;
RX   PubMed=30545397;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces Ig lambda.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02:01; B*44,49; C*05:01,07 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=1373872; PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 25
//
ID   XG-6
AC   CVCL_A771
SY   XG6; XG 6
DR   ArrayExpress; E-TABM-1088
DR   Cosmic; 2081413
DR   Cosmic; 2367259
DR   Cosmic; 2809772
DR   IARC_TP53; 28492
DR   Lonza; 94
DR   Wikidata; Q54994714
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8204890;
RX   PubMed=10557056;
RX   PubMed=10583232;
RX   PubMed=10936422;
RX   PubMed=16956823;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=21173094;
RX   PubMed=30545397;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgG lambda.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02; B*15,37; C*03:03,06:02 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 24
//
ID   XG-7
AC   CVCL_A772
SY   XG7; XG 7
DR   ArrayExpress; E-TABM-1088
DR   cancercelllines; CVCL_A772
DR   Cosmic; 2081414
DR   Cosmic; 2367269
DR   Cosmic; 2809773
DR   IARC_TP53; 28519
DR   Wikidata; Q54994716
RX   CelloPub=CLPUB00604;
RX   DOI=10.1007/0-306-46877-8_4;
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8204890;
RX   PubMed=10557056;
RX   PubMed=10936422;
RX   PubMed=11429052;
RX   PubMed=16956823;
RX   PubMed=17229644;
RX   PubMed=17692805;
RX   PubMed=18647998;
RX   PubMed=21173094;
RX   PubMed=30545397;
RX   PubMed=32123307;
WW   Info; Keats Lab; -; https://www.keatslab.org/myeloma-cell-lines
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: IL6 dependent.
CC   HLA typing: A*02:01,24; B*07,40; C*02:02,07 (Direct_author_submission).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Cys (c.34G>T); ClinVar=VCV000012578; Zygosity=Unspecified (PubMed=21173094).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=21173094).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA typing from personal communication of Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 26
//
ID   XG-8
AC   CVCL_A773
SY   XG8; XG 8
DR   Wikidata; Q54994717
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8204890;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA lambda.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   XG-9
AC   CVCL_A774
SY   XG9; XG 9
DR   Wikidata; Q54994718
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=8204890;
RX   PubMed=10936422;
CC   Characteristics: Produces IgA kappa.
CC   Characteristics: IL6 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 16
//
ID   XG69
AC   CVCL_C0XL
SY   Xenopus Glia 69
DR   Wikidata; Q114313261
RX   PubMed=35377941;
CC   Group: Amphibian cell line.
CC   Doubling time: 60.59 hours (Note=At 5th passage), 60.35 hours (Note=At 20th passage) (PubMed=35377941).
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Muller glia; CL=CL_0000636.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   3-5Y
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 10-09-24; Version: 5
//
ID   XGC-1
AC   CVCL_ZU62
DR   Wikidata; Q98135141
RX   PubMed=32943986;
CC   Population: Chinese.
CC   Doubling time: ~48 hours (PubMed=32943986).
CC   Karyotypic information: Has lost chromosome Y.
CC   Derived from site: In situ; Stomach, fundus; UBERON=UBERON_0001160.
ST   Source(s): PubMed=32943986
ST   Amelogenin: X,Y
ST   CSF1PO: 11,13
ST   D13S317: 9,11
ST   D16S539: 11,12
ST   D21S11: 29
ST   D5S818: 10,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C8398; Gastric fundus carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XGC-2
AC   CVCL_HA22
DR   Wikidata; Q54994720
RX   PubMed=27633271;
CC   Population: Chinese.
CC   Doubling time: ~60 hours (PubMed=27633271).
CC   Derived from site: In situ; Stomach, cardia; UBERON=UBERON_0001162.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 7
//
ID   XGC9811
AC   CVCL_0U26
SY   XGC-9811; GC9811; 9811
DR   Wikidata; Q54994721
RX   DOI=10.3321/j.issn:1000-2790.2003.10.004;
RX   DOI=10.3969/j.issn.1001-5949.2008.05.004;
RX   PubMed=16458253;
RX   PubMed=17404872;
CC   Population: Chinese.
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 8
//
ID   XGC9811-L
AC   CVCL_0U27
SY   XGC-9811L
DR   Wikidata; Q54994722
RX   DOI=10.3969/j.issn.1001-5949.2008.05.004;
RX   PubMed=16458253;
CC   Population: Chinese.
CC   Characteristics: Metastatic to liver. Obtained from liver metastic nodules in nude mice injected in the tail vein with the parent cell line (PubMed=16458253).
CC   Omics: Proteomics; 2DE.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0U26 ! XGC9811
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 7
//
ID   XGL
AC   CVCL_DR23
DR   CCRID; 5301FIS-KCB83002ZJ
DR   KCB; KCB 83002ZJ
DR   Wikidata; Q54994723
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
OX   NCBI_TaxID=749193; ! Cyprinus carpio var. singuonensis (Xingguo red carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 11
//
ID   XH1 [Human cervical carcinoma]
AC   CVCL_T292
DR   Wikidata; Q54994724
RX   PubMed=1911212;
RX   PubMed=35692560;
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 05-10-23; Version: 10
//
ID   XH1 [Human iPSC]
AC   CVCL_VG19
DR   SKIP; SKIP000889
DR   Wikidata; Q54994725
RX   PubMed=19838014;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DP59 ! HDF1388
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   XH1a
AC   CVCL_JF77
DR   Wikidata; Q54994726
RX   PubMed=1911212;
CC   Doubling time: 16.2 hours (PubMed=1911212).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T292 ! XH1 [Human cervical carcinoma]
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   XH1b
AC   CVCL_JF78
DR   Wikidata; Q54994727
RX   PubMed=1911212;
CC   Doubling time: 21.6 hours (PubMed=1911212).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_T292 ! XH1 [Human cervical carcinoma]
SX   Female
AG   32Y
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 05-10-23; Version: 7
//
ID   XIII-3E6-B11
AC   CVCL_U043
SY   B-16; B16
DR   Wikidata; Q54994728
RX   PubMed=3826486;
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania braziliensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   XIII-3H6-A12
AC   CVCL_U042
SY   B-12; B12
DR   Wikidata; Q54994729
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania brazilensis.
CC   Monoclonal antibody target: Leishmania panamensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   XIV-2A5-A10
AC   CVCL_U044
SY   B-18; B18
DR   Wikidata; Q54994730
RX   PubMed=3826486;
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania braziliensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 14-08-25; Version: 7
//
ID   XJHi001-A
AC   CVCL_D0Q0
SY   iPS131-1
DR   BioSamples; SAMEA113537076
DR   hPSCreg; XJHi001-A
DR   Wikidata; Q123033940
RX   PubMed=37801747;
CC   From: Xijing Hospital; Xi'an; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3778; FN1; Simple; c.5888-1G>C; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=37801747).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187984; Glomerulopathy with fibronectin deposits-2
DI   ORDO; Orphanet_84090; Fibronectin glomerulopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   XJHi002-A
AC   CVCL_D0Q1
DR   hPSCreg; XJHi002-A
DR   Wikidata; Q123033941
CC   From: Xijing Hospital; Xi'an; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   XL-177
AC   CVCL_T684
SY   XL177
DR   Kerafast; EMU036
DR   Wikidata; Q54994732
RX   PubMed=562840;
RX   PubMed=1811155;
RX   PubMed=2416614;
RX   PubMed=8327476;
RX   PubMed=8793614;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   XL-2
AC   CVCL_2H45
DR   Wikidata; Q54994734
RX   PubMed=26134302;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   XL-2sci
AC   CVCL_2H46
DR   Wikidata; Q54994735
RX   PubMed=26134302;
CC   Population: Chinese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2H45 ! XL-2
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   XL-i-20
AC   CVCL_E6HU
RX   PubMed=38848883;
CC   Population: Chinese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Face, skin, sebaceous gland; UBERON=UBERON_0003487.
CC   Cell type: Sebocyte; CL=CL_0000317.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Telomerase immortalized cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   Xl1
AC   CVCL_6E60
SY   Xenopus laevis 1
DR   Wikidata; Q54994736
RX   PubMed=23054192;
CC   Group: Amphibian cell line.
CC   Characteristics: Can mineralize their extracellular matrix upon addition of an inorganic phosphate donor and vitamin C (PubMed=23054192).
CC   Doubling time: 3-4 days (PubMed=23054192).
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Adult stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   XL110
AC   CVCL_T702
DR   Wikidata; Q54994737
RX   PubMed=1811155;
RX   PubMed=2335521;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 12
//
ID   XL177 lacZ clone 1.18
AC   CVCL_C0N8
DR   Wikidata; Q112930575
RX   PubMed=8793614;
CC   Group: Amphibian cell line.
CC   Characteristics: The expression of the lacZ gene is under the control of a constitutively active Xenopus EF1a promoter (PubMed=8793614).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_T684 ! XL-177
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   XL177 lacZ clone 2.1
AC   CVCL_C0N9
DR   Wikidata; Q112930576
RX   PubMed=8793614;
CC   Group: Amphibian cell line.
CC   Characteristics: The expression of the lacZ gene is under the control of a constitutively active Xenopus EF1a promoter (PubMed=8793614).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_T684 ! XL-177
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   XL177 lacZ clone 2.14
AC   CVCL_C0NA
DR   Wikidata; Q112930577
RX   PubMed=8793614;
CC   Group: Amphibian cell line.
CC   Characteristics: The expression of the lacZ gene is under the control of a constitutively active Xenopus EF1a promoter (PubMed=8793614).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_T684 ! XL-177
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   XL177 lacZ clone 2.5
AC   CVCL_C0NB
DR   Wikidata; Q112930578
RX   PubMed=8793614;
CC   Group: Amphibian cell line.
CC   Characteristics: The expression of the lacZ gene is under the control of a constitutively active Xenopus EF1a promoter (PubMed=8793614).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_T684 ! XL-177
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   XL2
AC   CVCL_6743
DR   Wikidata; Q54994738
RX   PubMed=1811155;
RX   PubMed=7239540;
CC   Group: Amphibian cell line.
CC   Doubling time: 39 hours (PubMed=7239540).
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   XL58
AC   CVCL_C0NC
SY   XL-58
DR   Kerafast; EMU038
DR   Wikidata; Q112930579
RX   PubMed=8052658;
RX   PubMed=16102758;
CC   Group: Amphibian cell line.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 21-03-23; Version: 3
//
ID   XL58-TRE-Luc
AC   CVCL_C0ND
DR   Wikidata; Q112930580
RX   PubMed=16102758;
RX   PubMed=16179385;
CC   Group: Amphibian cell line.
CC   Biotechnology: Used in a thyroid hormone (TH) inducible primary screening assay for the identification and assessment of chemicals that interfere with the TH-signalling pathway within target cells (PubMed=16179385).
CC   Characteristics: Expression of luciferase is under the control of Xenopus T3-response elements (TREs). Expression of EGFP is under the control of the CMV promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_C0NC ! XL58
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   XLA-07
AC   CVCL_J033
SY   Xuanwei Lung Adenocarcinoma-07
DR   Wikidata; Q54994739
RX   PubMed=22883674;
CC   Population: Chinese.
CC   Doubling time: 46.7 hours (PubMed=22883674).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   XLC002
AC   CVCL_IS77
SY   QualiCell Human Embryonic Stem Cell-XLC002
DR   Wikidata; Q54994740
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00009.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC004
AC   CVCL_IS78
SY   QualiCell Human Embryonic Stem Cell-XLC004
DR   Wikidata; Q54994741
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00002.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC007
AC   CVCL_IS79
SY   QualiCell Human Embryonic Stem Cell-XLC007
DR   Wikidata; Q54994743
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00005.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC009
AC   CVCL_IS80
SY   QualiCell Human Embryonic Stem Cell-XLC009
DR   Wikidata; Q54994759
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00021.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC011
AC   CVCL_IS81
SY   QualiCell Human Embryonic Stem Cell-XLC011
DR   Wikidata; Q54994761
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00018.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC012
AC   CVCL_IS82
SY   QualiCell Human Embryonic Stem Cell-XLC012
DR   Wikidata; Q54994762
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00010.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC013
AC   CVCL_IS83
SY   QualiCell Human Embryonic Stem Cell-XLC013
DR   Wikidata; Q54994763
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00001.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC015
AC   CVCL_IS84
SY   QualiCell Human Embryonic Stem Cell-XLC015
DR   Wikidata; Q54994764
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00014.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC016
AC   CVCL_IS85
SY   QualiCell Human Embryonic Stem Cell-XLC016
DR   Wikidata; Q54994765
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00004.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC017
AC   CVCL_IS86
SY   QualiCell Human Embryonic Stem Cell-XLC017
DR   Wikidata; Q54994768
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00020.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC018
AC   CVCL_IS87
SY   QualiCell Human Embryonic Stem Cell-XLC018
DR   Wikidata; Q54994769
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00003.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC020
AC   CVCL_IS88
SY   QualiCell Human Embryonic Stem Cell-XLC020
DR   Wikidata; Q54994770
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00008.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC021
AC   CVCL_IS89
SY   QualiCell Human Embryonic Stem Cell-XLC021
DR   Wikidata; Q54994771
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00016.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC023
AC   CVCL_IS90
SY   QualiCell Human Embryonic Stem Cell-XLC023
DR   Wikidata; Q54994772
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00011.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC025
AC   CVCL_IS91
SY   QualiCell Human Embryonic Stem Cell-XLC025
DR   Wikidata; Q54994774
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00013.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC027
AC   CVCL_IS92
SY   QualiCell Human Embryonic Stem Cell-XLC027
DR   Wikidata; Q54994775
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00015.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC029
AC   CVCL_IS93
SY   QualiCell Human Embryonic Stem Cell-XLC029
DR   Wikidata; Q54994776
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00007.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC030
AC   CVCL_IS94
SY   QualiCell Human Embryonic Stem Cell-XLC030
DR   Wikidata; Q54994777
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00019.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC033
AC   CVCL_IS95
SY   QualiCell Human Embryonic Stem Cell-XLC033
DR   Wikidata; Q54994778
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00017.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC034
AC   CVCL_IS96
SY   QualiCell Human Embryonic Stem Cell-XLC034
DR   Wikidata; Q54994779
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00012.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC038
AC   CVCL_IS97
SY   QualiCell Human Embryonic Stem Cell-XLC038
DR   Wikidata; Q54994780
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00006.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC041
AC   CVCL_IS98
SY   QualiCell Human Embryonic Stem Cell-XLC041
DR   Wikidata; Q54994781
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00022.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC042
AC   CVCL_IS99
SY   QualiCell Human Embryonic Stem Cell-XLC042
DR   Wikidata; Q54994782
WW   Provider; Creative Bioarray; CSC-C00034; https://web.archive.org/web/20160708222836/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC042-CSC-C00034-item-2684.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00034.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC044
AC   CVCL_IT00
SY   QualiCell Human Embryonic Stem Cell-XLC044
DR   Wikidata; Q54994783
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00026.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC046
AC   CVCL_IT01
SY   QualiCell Human Embryonic Stem Cell-XLC046
DR   Wikidata; Q54994784
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00024.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC048
AC   CVCL_IT02
SY   QualiCell Human Embryonic Stem Cell-XLC048
DR   Wikidata; Q54994785
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00028.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC049
AC   CVCL_IT03
SY   QualiCell Human Embryonic Stem Cell-XLC049
DR   Wikidata; Q54994786
WW   Provider; Creative Bioarray; CSC-C00030; https://web.archive.org/web/20160709040147/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC049-CSC-C00030-item-2680.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00030.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC050
AC   CVCL_IT04
SY   QualiCell Human Embryonic Stem Cell-XLC050
DR   Wikidata; Q54994787
WW   Provider; Creative Bioarray; CSC-C00033; https://web.archive.org/web/20160709043811/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC050-CSC-C00033-item-2683.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00033.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC051
AC   CVCL_IT05
SY   QualiCell Human Embryonic Stem Cell-XLC051
DR   Wikidata; Q54994788
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00027.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC052
AC   CVCL_IT06
SY   QualiCell Human Embryonic Stem Cell-XLC052
DR   Wikidata; Q54994789
WW   Provider; Creative Bioarray; CSC-C00032; https://web.archive.org/web/20160708222727/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC052-CSC-C00032-item-2682.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00032.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC053
AC   CVCL_IT07
SY   QualiCell Human Embryonic Stem Cell-XLC053
DR   Wikidata; Q54994791
WW   Provider; Creative Bioarray; CSC-C00035; https://web.archive.org/web/20160708213248/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC053-CSC-C00035-item-2685.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00035.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC054
AC   CVCL_IT08
SY   QualiCell Human Embryonic Stem Cell-XLC054
DR   Wikidata; Q54994792
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00023.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC055
AC   CVCL_IT09
SY   QualiCell Human Embryonic Stem Cell-XLC055
DR   Wikidata; Q54994794
WW   Provider; Creative Bioarray; CSC-C00029; http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC055-CSC-C00029-item-2679.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00029.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC056
AC   CVCL_IT10
SY   QualiCell Human Embryonic Stem Cell-XLC056
DR   Wikidata; Q54994795
WW   Provider; Creative Bioarray; CSC-C00037; https://web.archive.org/web/20160709003215/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC056-CSC-C00037-item-2687.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00037.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC057
AC   CVCL_IT11
SY   QualiCell Human Embryonic Stem Cell-XLC057
DR   Wikidata; Q54994796
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00025.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 6
//
ID   XLC060
AC   CVCL_IT12
SY   QualiCell Human Embryonic Stem Cell-XLC060
DR   Wikidata; Q54994797
WW   Provider; Creative Bioarray; CSC-C00031; https://web.archive.org/web/20160708233020/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC060-CSC-C00031-item-2681.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00031.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC061
AC   CVCL_IT13
SY   QualiCell Human Embryonic Stem Cell-XLC061
DR   Wikidata; Q54994798
WW   Provider; Creative Bioarray; CSC-C00036; https://web.archive.org/web/20160709000856/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC061-CSC-C00036-item-2686.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00036.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC064
AC   CVCL_IT14
SY   QualiCell Human Embryonic Stem Cell-XLC064
DR   Wikidata; Q54994799
WW   Provider; Creative Bioarray; CSC-C00042; https://web.archive.org/web/20160709001236/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC064-CSC-C00042-item-2692.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00042.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC065
AC   CVCL_IT15
SY   QualiCell Human Embryonic Stem Cell-XLC065
DR   Wikidata; Q54994800
WW   Provider; Creative Bioarray; CSC-C00039; https://web.archive.org/web/20160709034600/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC065-CSC-C00039-item-2689.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00039.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC068
AC   CVCL_IT16
SY   QualiCell Human Embryonic Stem Cell-XLC068
DR   Wikidata; Q54994801
WW   Provider; Creative Bioarray; CSC-C00046; https://web.archive.org/web/20160709040140/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC068-CSC-C00046-item-2696.htm
CC   From: Creative Bioarray; New York; USA.
CC   Characteristics: Has Lox sites for Cre-mediated gene insertion and constitutive transgene expression (Creative Bioarray=CSC-C00046).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00046.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   XLC069
AC   CVCL_IT17
SY   QualiCell Human Embryonic Stem Cell-XLC069
DR   Wikidata; Q54994802
WW   Provider; Creative Bioarray; CSC-C00043; https://web.archive.org/web/20160709044236/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC069-CSC-C00043-item-2693.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00043.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC070
AC   CVCL_IT18
SY   QualiCell Human Embryonic Stem Cell-XLC070
DR   Wikidata; Q54994803
WW   Provider; Creative Bioarray; CSC-C00040; https://web.archive.org/web/20160709043814/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC070-CSC-C00040-item-2690.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00040.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC072
AC   CVCL_IT19
SY   QualiCell Human Embryonic Stem Cell-XLC072
DR   Wikidata; Q54994804
WW   Provider; Creative Bioarray; CSC-C00044; https://web.archive.org/web/20160709043934/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC072-CSC-C00044-item-2694.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00044.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC073
AC   CVCL_IT20
SY   QualiCell Human Embryonic Stem Cell-XLC073
DR   Wikidata; Q54994824
WW   Provider; Creative Bioarray; CSC-C00047; https://web.archive.org/web/20160708223103/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC073-CSC-C00047-item-2697.htm
CC   From: Creative Bioarray; New York; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00047.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   XLC074
AC   CVCL_IT21
SY   QualiCell Human Embryonic Stem Cell-XLC074
DR   Wikidata; Q54994825
WW   Provider; Creative Bioarray; CSC-C00038; https://web.archive.org/web/20160709014231/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC074--item-2688.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00038.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC076
AC   CVCL_IT22
SY   QualiCell Human Embryonic Stem Cell-XLC076
DR   Wikidata; Q54994826
WW   Provider; Creative Bioarray; CSC-C00051; https://web.archive.org/web/20160708223644/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC076-CSC-C00051-item-2701.htm
CC   From: Creative Bioarray; New York; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00051.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   XLC077
AC   CVCL_IT23
SY   QualiCell Human Embryonic Stem Cell-XLC077
DR   Wikidata; Q54994827
WW   Provider; Creative Bioarray; CSC-C00041; https://web.archive.org/web/20160709030715/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC077-CSC-C00041-item-2691.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00041.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 7
//
ID   XLC080
AC   CVCL_IT24
SY   QualiCell Human Embryonic Stem Cell-XLC080
DR   Wikidata; Q54994828
WW   Provider; Creative Bioarray; CSC-C00045; https://web.archive.org/web/20160708234256/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC080-CSC-C00045-item-2695.htm
CC   From: Creative Bioarray; New York; USA.
CC   Characteristics: Has a EGFP-POU5F1 knock-in (Creative Bioarray=CSC-C00045).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00045.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   XLC081
AC   CVCL_IT25
SY   QualiCell Human Embryonic Stem Cell-XLC081; CBe002-A
DR   hPSCreg; CBe002-A
DR   Wikidata; Q54994830
WW   Provider; Creative Bioarray; CSC-C00052; https://web.archive.org/web/20160709044355/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC081-CSC-C00052-item-2702.htm
CC   From: Creative Bioarray; New York; USA.
CC   Characteristics: A GFP cassette is inserted to the OLIG2 locus via homologous recombination.
CC   Genetic integration: Method=Homologous recombination; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Discontinued: hPSCreg; CBe002-A; true.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00052.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9726 ! BG01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   XLC083
AC   CVCL_IT26
SY   QualiCell Human Embryonic Stem Cell-XLC083
DR   Wikidata; Q54994831
WW   Provider; Creative Bioarray; CSC-C00049; https://web.archive.org/web/20160709045729/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC083-CSC-C00049-item-2699.htm
CC   From: Creative Bioarray; New York; USA.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00049.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 8
//
ID   XLC088
AC   CVCL_IT27
SY   QualiCell Human Embryonic Stem Cell-XLC088
DR   Wikidata; Q54994832
WW   Provider; Creative Bioarray; CSC-C00048; https://web.archive.org/web/20160709044232/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC088-CSC-C00048-item-2698.htm
CC   From: Creative Bioarray; New York; USA.
CC   Characteristics: POU5F1 promoter driving GFP expression and Zeo resistance (Creative Bioarray=CSC-C00048).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00048.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   XLC090
AC   CVCL_IT28
SY   QualiCell Human Embryonic Stem Cell-XLC090
DR   Wikidata; Q54994833
WW   Provider; Creative Bioarray; CSC-C00050; https://web.archive.org/web/20160709034556/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC090-CSC-C00050-item-2700.htm
CC   From: Creative Bioarray; New York; USA.
CC   Characteristics: Cardiac specific troponin T promoter driving GFP expression and Zeo resistance (Creative Bioarray=CSC-C00050).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00050.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   XLC211
AC   CVCL_E8AC
SY   QualiCell Mouse Embryonic Stem Cell-XLC211
WW   Provider; Creative Bioarray; CSC-C00182; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC211-CSC-C00182-item-2805.htm
CC   Karyotypic information: 40,XY [17]; 39,X [4]; 40,XY,add(1)(H6),add(8)(A1) [2]; 40,XY,add(1)(H6) [1] (Creative Bioarray=CSC-C00182).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC223
AC   CVCL_E8A7
SY   QualiCell Mouse Embryonic Stem Cell-XLC223
WW   Provider; Creative Bioarray; CSC-C00177; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC223-CSC-C00177-item-2800.htm
CC   Karyotypic information: 40,XY [24]; 41,XY,+1 [1] (Creative Bioarray=CSC-C00177).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC224
AC   CVCL_E8A1
SY   QualiCell Mouse Embryonic Stem Cell-XLC224
WW   Provider; Creative Bioarray; CSC-C00171; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC224-CSC-C00171-item-2794.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC230
AC   CVCL_E8AA
SY   QualiCell Mouse Embryonic Stem Cell-XLC230
WW   Provider; Creative Bioarray; CSC-C00180; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC230-CSC-C00180-item-2803.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC231
AC   CVCL_E8AH
SY   QualiCell Mouse Embryonic Stem Cell-XLC231
WW   Provider; Creative Bioarray; CSC-C00187; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC231-CSC-C00187-item-2810.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC242
AC   CVCL_E8AE
SY   QualiCell Mouse Embryonic Stem Cell-XLC242
WW   Provider; Creative Bioarray; CSC-C00184; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC242-CSC-C00184-item-2807.htm
CC   Karyotypic information: 40,XY,?add(12)(?B) [7]; 39,X,?add(12)(?B) [2]; 41,XY,+11,?add(12)(?B)[1] (Creative Bioarray=CSC-C00184).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC243
AC   CVCL_E7ZZ
SY   QualiCell Mouse Embryonic Stem Cell-XLC243
WW   Provider; Creative Bioarray; CSC-C00169; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC243-CSC-C00169-item-2792.htm
CC   Karyotypic information: 40,XY,add(12)(A1->B::?) (Creative Bioarray=CSC-C00169).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC262
AC   CVCL_E8A5
SY   QualiCell Mouse Embryonic Stem Cell-XLC262
WW   Provider; Creative Bioarray; CSC-C00175; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC262-CSC-C00175-item-2798.htm
CC   Karyotypic information: 40,XY[24]; 40,X,dup(Y) [1] (Creative Bioarray=CSC-C00175).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC283
AC   CVCL_E8AG
SY   QualiCell Mouse Embryonic Stem Cell-XLC283
WW   Provider; Creative Bioarray; CSC-C00186; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC283-CSC-C00186-item-2809.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC288
AC   CVCL_E8A6
SY   QualiCell Mouse Embryonic Stem Cell-XLC288
WW   Provider; Creative Bioarray; CSC-C00176; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC288-CSC-C00176-item-2799.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC290
AC   CVCL_E8A0
SY   QualiCell Mouse Embryonic Stem Cell-XLC290
WW   Provider; Creative Bioarray; CSC-C00170; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC290-CSC-C00170-item-2793.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC303
AC   CVCL_IT52
SY   XLC-303; CBi002-A
DR   BioSamples; SAMEA103988342
DR   hPSCreg; CBi002-A
DR   SKIP; SKIP002904
DR   Wikidata; Q54994834
WW   Provider; Creative Bioarray; CSC-C00122; https://web.archive.org/web/20200927132822/http://www.creative-bioarray.com/QualiCell-Induced-Pluripotent-Stem-Cell-XLC303-CSC-C00122-item-2745.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00122.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 5
//
ID   XLC321
AC   CVCL_E7ZY
SY   QualiCell Mouse Embryonic Stem Cell-XLC321
WW   Provider; Creative Bioarray; CSC-C00168; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC321-CSC-C00168-item-2791.htm
CC   Karyotypic information: 40,XY [21]; 39,X [2] (Creative Bioarray=CSC-C00168).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC331
AC   CVCL_E8A3
SY   QualiCell Mouse Embryonic Stem Cell-XLC331
WW   Provider; Creative Bioarray; CSC-C00173; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC331-CSC-C00173-item-2796.htm
CC   Karyotypic information: 40,XY [45/50]; 39,X [3] (Creative Bioarray=CSC-C00173).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC340
AC   CVCL_E8AB
SY   QualiCell Mouse Embryonic Stem Cell-XLC340
WW   Provider; Creative Bioarray; CSC-C00181; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC340-CSC-C00181-item-2804.htm
CC   Karyotypic information: 40,XY [45/50]; 41,XYY[2]; 39,X [1] (Creative Bioarray=CSC-C00181).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC348
AC   CVCL_IT53
SY   XLC-348; CBi001-A
DR   BioSamples; SAMEA4458267
DR   hPSCreg; CBi001-A
DR   SKIP; SKIP002879
DR   Wikidata; Q54994835
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00123.
DI   NCIt; C3362; Schizophrenia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 5
//
ID   XLC349
AC   CVCL_E7ZX
SY   QualiCell Mouse Embryonic Stem Cell-XLC349
WW   Provider; Creative Bioarray; CSC-C00167; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC349-CSC-C00167-item-2790.htm
CC   Karyotypic information: 40,XY [46]; 39,X [1]; 41,XYY [2] (Creative Bioarray=CSC-C00167).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC353
AC   CVCL_E8A9
SY   QualiCell Mouse Embryonic Stem Cell-XLC353
WW   Provider; Creative Bioarray; CSC-C00179; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC353-CSC-C00179-item-2802.htm
CC   Karyotypic information: 40,XY [48]; 39,X[1]; 40,XY,i(6) [1] (Creative Bioarray=CSC-C00179).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC375
AC   CVCL_E8A4
SY   QualiCell Mouse Embryonic Stem Cell-XLC375
WW   Provider; Creative Bioarray; CSC-C00174; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC375-CSC-C00174-item-2797.htm
CC   Karyotypic information: 40,XY [24]; 41,XY,+1 [1] (Creative Bioarray=CSC-C00174).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC377
AC   CVCL_E7ZW
SY   QualiCell Mouse Embryonic Stem Cell-XLC377
WW   Provider; Creative Bioarray; CSC-C00166; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC377-CSC-C00166-item-2789.htm
CC   Karyotypic information: 40,XY [47]; 41,XY,+11 [2]; 39,X [1] (Creative Bioarray=CSC-C00166).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC379
AC   CVCL_E8A2
SY   QualiCell Mouse Embryonic Stem Cell-XLC379
WW   Provider; Creative Bioarray; CSC-C00172; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC379-CSC-C00172-item-2795.htm
CC   Karyotypic information: 40,XY [16]; 39,X [7]; 42,XY,+1,+8 [2] (Creative Bioarray=CSC-C00172).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC382
AC   CVCL_E8AF
SY   QualiCell Mouse Embryonic Stem Cell-XLC382
WW   Provider; Creative Bioarray; CSC-C00185; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC382-CSC-C00185-item-2808.htm
CC   Karyotypic information: 40,XY [40]; 41,XY,+8 [4] (Creative Bioarray=CSC-C00185).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC385
AC   CVCL_E8A8
SY   QualiCell Mouse Embryonic Stem Cell-XLC385
WW   Provider; Creative Bioarray; CSC-C00178; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC385-CSC-C00178-item-2801.htm
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC393
AC   CVCL_E8AD
SY   QualiCell Mouse Embryonic Stem Cell-XLC393
WW   Provider; Creative Bioarray; CSC-C00183; https://www.creative-bioarray.com/QualiCell%C2%AE-Mouse-Embryonic-Stem-Cell-XLC393-CSC-C00183-item-2806.htm
CC   Karyotypic information: 40,XY [24]; 41,XY,+12 [1] (Creative Bioarray=CSC-C00183).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XLC449
AC   CVCL_IT29
SY   QualiCell Human Embryonic Stem Cell-XLC449; CBe001-A
DR   hPSCreg; CBe001-A
DR   Wikidata; Q54994836
WW   Provider; Creative Bioarray; CSC-C00317; https://web.archive.org/web/20160708230046/http://www.creative-bioarray.com/QualiCell-Human-Embryonic-Stem-Cell-XLC449-CSC-C00317-item-2873.htm
CC   From: Creative Bioarray; New York; USA.
CC   Discontinued: hPSCreg; CBe001-A; true.
CC   Discontinued: Creative Bioarray; Catalog number CSC-C00317.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 9
//
ID   XLI-ND
AC   CVCL_E891
SY   Extract 341
DR   dbMHC; 49082
DR   ECACC; 94022554
DR   IHW; IHW09220
DR   IPD-IMGT/HLA; 11580
DR   Wikidata; Q54994837
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Chinese.
CC   HLA typing: A*02:10,30:01; B*13:02,40:06:01:01; C*06:02,08:01; DPA1*02:01,02:02; DPB1*17:01,19:01; DQB1*02,03:03; DRB1*07:01:01,09:01:02; DRB4*01:03:01:01,01:03:02 (IPD-IMGT/HLA=11580).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   XLIV-5A2-B9
AC   CVCL_U045
SY   B-19; B19
DR   Wikidata; Q54994838
RX   PubMed=8734946;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: Leishmania guyanensis.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 6
//
ID   XLK-WG
AC   CVCL_5655
SY   XLKWG; Xenopus Laevis Kidney-Wu & Gall
DR   CLO; CLO_0009649
DR   ATCC; CRL-2527
DR   Wikidata; Q54994839
RX   PubMed=9566968;
RX   PubMed=19799885;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Female
AG   Adult stage
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   XLK2
AC   CVCL_H009
SY   XlK2; XLK-2; XlK-2; XL-K2; Xl K2; Xenopus Laevis Kidney 2
DR   Wikidata; Q54994840
RX   PubMed=2342463;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
ID   XLT-15
AC   CVCL_6744
SY   XLT15; Xenopus Laevis Tadpole-15
DR   BTO; BTO_0001956
DR   Kerafast; EMU035
DR   Wikidata; Q54994841
RX   PubMed=9030578;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Tail; UBERON=UBERON_0002415.
CC   Cell type: Myoblast; CL=CL_0000056.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   XM
AC   CVCL_R938
SY   Xiphophorus Melanoma
DR   Wikidata; Q54994842
RX   PubMed=18377217;
CC   Group: Fish cell line.
CC   Doubling time: ~72 hours (PubMed=18377217).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
DI   NCIt; C134575; Xiphophorus melanoma
OX   NCBI_TaxID=1075644; ! Xiphophorus hellerii x Xiphophorus maculatus (Hybrid swordtail)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   XMDYYYi001-A
AC   CVCL_A1ZV
SY   BDU-iPSCs
DR   BioSamples; SAMEA7683945
DR   hPSCreg; XMDYYYi001-A
DR   Wikidata; Q105511782
RX   PubMed=33799273;
CC   From: Department of Neurology, The First Affiliated Hospital of Xiamen University; Xiamen; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex2-19dup; Zygosity=Hemizygous (PubMed=33799273).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84587; Becker's muscular dystrophy
DI   ORDO; Orphanet_98895; Becker muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   XMG1.2
AC   CVCL_2H37
SY   XMG 1.2; XMG-1.2
DR   BCRJ; 0249
DR   Wikidata; Q54994844
RX   PubMed=2960769;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P01580; Mouse Ifng.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 5
//
ID   XMMBR-B14
AC   CVCL_JX93
DR   Wikidata; Q54994845
RX   Patent=US4853464;
RX   Patent=US4925922;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9308.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human CEA/NCA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
ID   XMMBR-B55
AC   CVCL_XH49
DR   Wikidata; Q98135143
RX   Patent=WO1989001153A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9485.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 19-12-19; Last updated: 21-03-23; Version: 4
//
ID   XMMCO-228
AC   CVCL_JX92
DR   Wikidata; Q54994846
RX   Patent=US4925922;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9174.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06731; Human CEACAM5/CEA/CD66e.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 5
//
ID   XMMCO-791
AC   CVCL_F815
SY   791
DR   CLO; CLO_0009650
DR   ATCC; HB-9173
DR   Wikidata; Q54994847
RX   DOI=10.3390/antib1010039;
RX   Patent=US4708862;
RX   Patent=US4925922;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9173.
CC   Biotechnology: Was used to produce monoclonal antibody MoAb 791T which when conjugated to ricin chain A produces XomaZyme-791 (79IT/36-RTA). XomaZyme-791 was evaluated in two phase 1 clinical trials to treat patients with metastatic colorectal carcinoma (DOI=10.3390/antib1010039).
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Human colorectal tumour-associated antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   XMMEN-J5D
AC   CVCL_A0EG
DR   ATCC; HB-9083
DR   Wikidata; Q108821533
RX   Patent=US5484591;
RX   Patent=WO1988008135A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9083.
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMEN-LY1
AC   CVCL_A0EH
DR   ATCC; HB-9082
DR   Wikidata; Q108821534
RX   Patent=US5484591;
RX   Patent=WO1988008135A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9082.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Salmonella minnesota R595 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMEN-LY2
AC   CVCL_A0EI
DR   Wikidata; Q108821535
RX   Patent=US5484591;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Salmonella minnesota R595 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMEN-OE5
AC   CVCL_F816
SY   AAB-647; AAB647
DR   CLO; CLO_0009651
DR   ATCC; HB-9081
DR   Wikidata; Q54994848
RX   Patent=US5484591;
RX   Patent=WO1988008135A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9081.
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   XMMLY-H65
AC   CVCL_B0H4
SY   H65
DR   Wikidata; Q108821536
RX   Patent=WO1989006967A1;
RX   PubMed=6609971;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9286.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P06127; Human CD5.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMME-001
AC   CVCL_F817
SY   IND1
DR   CLO; CLO_0009652
DR   ATCC; HB-8759
DR   Wikidata; Q54994849
RX   DOI=10.3390/antib1010039;
RX   Patent=US4590071;
RX   PubMed=6609971;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8759.
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was conjugated to a ricin chain A to produce XomaZyme-Mel (XMMME-001-RTA) which was evaluated in several clinical trials for metastatic melanoma patients (DOI=10.3390/antib1010039).
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma tumor specific HMW antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   XMMME-002
AC   CVCL_F818
SY   IND2
DR   CLO; CLO_0009653
DR   Wikidata; Q54994850
RX   Patent=US4590071;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8760.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Human melanoma tumor specific HMW antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   XMMPS-605
AC   CVCL_A0EJ
DR   Wikidata; Q108821537
RX   Patent=US5484591;
RX   Patent=WO1988008135A1;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8909.
CC   Monoclonal antibody isotype: IgG2.
CC   Monoclonal antibody target: Pseudomonas aeruginosa (strain PAC 605) core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 4
//
ID   XMMPS-OP1
AC   CVCL_A0EK
SY   PIC9.1.1
DR   Wikidata; Q108821538
RX   Patent=WO1988008135A1;
RX   PubMed=2427453;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9384.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 1 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMPS-OP2
AC   CVCL_A0EL
DR   Wikidata; Q108821539
RX   Patent=US5484591;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 2 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMPS-OP3
AC   CVCL_A0MH
DR   Wikidata; Q108821540
RX   Patent=US5484591;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 3 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMPS-OP4
AC   CVCL_A0MI
DR   Wikidata; Q108821541
RX   Patent=US5484591;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 4 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XMMPS-OP7
AC   CVCL_A0MJ
DR   Wikidata; Q108821542
RX   Patent=US5484591;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: Pseudomonas aeruginosa Fisher type 7 core lipopolysaccharide (LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   XP-1
AC   CVCL_Z271
SY   Xylotrechus Pyrrhoderus-1
DR   Wikidata; Q54994851
RX   PubMed=10614871;
RX   PubMed=18946707;
CC   Group: Insect cell line.
CC   Doubling time: 5 days (PubMed=10614871).
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=1191636; ! Xylotrechus pyrrhoderus (Longhorned beetle)
SX   Sex unspecified
AG   Larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   XP-CS2
AC   CVCL_L455
SY   XP-CS-2; GM03248; GM 3248; GM3248; GM03248A
DR   CLO; CLO_0016747
DR   BioSample; SAMN00808323
DR   Coriell; GM03248
DR   JCRB; KURB1383
DR   JCRB; KURB1384
DR   JCRB; KURB1385
DR   Wikidata; Q54837972
RX   CelloPub=CLPUB00447;
RX   PubMed=1372108;
RX   PubMed=1702221;
RX   PubMed=3341805;
RX   PubMed=3922833;
RX   PubMed=6096450;
RX   PubMed=7585650;
RX   PubMed=7825573;
RX   PubMed=8823375;
RX   PubMed=26184184;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly602Asp (c.1805G>A); ClinVar=VCV002138306; Zygosity=Heterozygous (PubMed=7585650; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L456 ! XP-CS2 LCL
OI   CVCL_XG02 ! XPCS2VI
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   XP-CS2 LCL
AC   CVCL_L456
SY   GM03249; GM 3249; GM3249
DR   CLO; CLO_0016701
DR   BioSample; SAMN00808324
DR   Coriell; GM03249
DR   Wikidata; Q54837973
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly602Asp (c.1805G>A); ClinVar=VCV002138306; Zygosity=Heterozygous (Coriell=GM03249).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L455 ! XP-CS2
OI   CVCL_XG02 ! XPCS2VI
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   XP0006
AC   CVCL_8Z03
DR   ECACC; 03060734
DR   Wikidata; Q54994853
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03060734; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   XP0007
AC   CVCL_8Z04
DR   ECACC; 03060735
DR   Wikidata; Q54994854
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03060735; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   XP0008
AC   CVCL_8Z05
DR   ECACC; 00306116
DR   Wikidata; Q54994856
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C110940; Panhypopituitarism
DI   ORDO; Orphanet_90695; Panhypopituitarism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8Z10 ! XP0013
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   XP0009
AC   CVCL_8Z06
DR   ECACC; 03061162
DR   Wikidata; Q54994857
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C110940; Panhypopituitarism
DI   ORDO; Orphanet_90695; Panhypopituitarism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   XP0010
AC   CVCL_8Z07
DR   ECACC; 03081426
DR   Wikidata; Q54994858
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03081426; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   XP0011
AC   CVCL_8Z08
DR   ECACC; 03081427
DR   Wikidata; Q54994859
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C110940; Panhypopituitarism
DI   ORDO; Orphanet_90695; Panhypopituitarism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   XP0012
AC   CVCL_8Z09
DR   ECACC; 03082243
DR   Wikidata; Q54994861
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: ECACC; 03082243; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 9
//
ID   XP0013
AC   CVCL_8Z10
DR   ECACC; 03082244
DR   Wikidata; Q54994862
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C110940; Panhypopituitarism
DI   ORDO; Orphanet_90695; Panhypopituitarism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8Z05 ! XP0008
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   XP0014
AC   CVCL_8Z11
DR   ECACC; 03082351
DR   Wikidata; Q54994863
CC   Part of: ECACC chromosomal abnormality collection.
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C110940; Panhypopituitarism
DI   ORDO; Orphanet_90695; Panhypopituitarism
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   XP01RJ
AC   CVCL_ZP84
SY   Xeroderma Pigmentosum 01 Rio de Janeiro
DR   Wikidata; Q98135145
RX   PubMed=23255472;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala28Asp (c.83C>A); ClinVar=VCV000041495; Zygosity=Heterozygous (PubMed=23255472).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Trp968Cys (c.2904G>C); ClinVar=VCV000041496; Zygosity=Heterozygous (PubMed=23255472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP02RJ
AC   CVCL_ZP85
SY   Xeroderma Pigmentosum 02 Rio de Janeiro
DR   Wikidata; Q98135148
RX   PubMed=23255472;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala28Asp (c.83C>A); ClinVar=VCV000041495; Zygosity=Heterozygous (PubMed=23255472).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Trp968Cys (c.2904G>C); ClinVar=VCV000041496; Zygosity=Heterozygous (PubMed=23255472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP100BR
AC   CVCL_ZU90
SY   Xeroderma Pigmentosum 100 BRighton
DR   Wikidata; Q98135150
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; c.457-2A>C; ClinVar=VCV000872377; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   62Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP100MA
AC   CVCL_ZQ95
SY   Xeroderma Pigmentosum 100 MAnnheim
DR   Wikidata; Q98135153
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP100TMA
AC   CVCL_1F45
SY   Xeroderma Pigmentosum Turkey MAlatya 100; GM15709
DR   CLO; CLO_0027669
DR   Coriell; GM15709
DR   Wikidata; Q54848147
RX   PubMed=14662655;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-9T>A (IVS3-9T>A); ClinVar=VCV000000260; Zygosity=Homozygous (PubMed=14662655; PubMed=16081512).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F46 ! XP100TMA LCL
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XP100TMA LCL
AC   CVCL_1F46
SY   Xeroderma Pigmentosum Turkey MAlatya 100 LCL; GM15710
DR   CLO; CLO_0027670
DR   Coriell; GM15710
DR   Wikidata; Q54848148
RX   PubMed=14662655;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-9T>A (IVS3-9T>A); ClinVar=VCV000000260; Zygosity=Homozygous (Coriell=GM15710).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F45 ! XP100TMA
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XP101BR
AC   CVCL_ZU91
SY   Xeroderma Pigmentosum 101 BRighton
DR   Wikidata; Q98135155
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ile290Asn (c.869T>A); Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP101LO
AC   CVCL_ZN33
SY   XP 101 LO; Xeroderma Pigmentosum 101 LOndon
DR   Wikidata; Q98135157
RX   PubMed=504548;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP101OS
AC   CVCL_UH37
SY   Xeroderma Pigmentosum 101 OSaka
DR   JCRB; KURB1090
DR   JCRB; KURB1091
DR   Wikidata; Q98135159
RX   PubMed=1814424;
RX   PubMed=2570806;
RX   PubMed=3834095;
RX   PubMed=9580660;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Ile225Met (c.675A>G) (I214M); Zygosity=Heterozygous (PubMed=9580660).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Gly513Arg (c.1537G>A) (G502R); Zygosity=Heterozygous (PubMed=9580660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   XP101TMA
AC   CVCL_1F49
SY   Xeroderma Pigmentosum Turkey MAlatya 101; GM15715
DR   CLO; CLO_0027675
DR   Coriell; GM15715
DR   Wikidata; Q54848151
RX   PubMed=14662655;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-9T>A (IVS3-9T>A); ClinVar=VCV000000260; Zygosity=Homozygous (PubMed=14662655).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F50 ! XP101TMA LCL
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XP101TMA LCL
AC   CVCL_1F50
SY   Xeroderma Pigmentosum Turkey MAlatya 101 LCL; GM15716
DR   CLO; CLO_0027676
DR   Coriell; GM15716
DR   Wikidata; Q54848152
RX   PubMed=14662655;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-9T>A (IVS3-9T>A); ClinVar=VCV000000260; Zygosity=Homozygous (Coriell=GM15716).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F49 ! XP101TMA
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XP101TO
AC   CVCL_ZM20
SY   Xeroderma Pigmentosum 101 TOkyo
DR   JCRB; KURB1373
DR   Wikidata; Q98135161
RX   PubMed=7000335;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP102BR
AC   CVCL_ZU92
SY   Xeroderma Pigmentosum 102 BRighton
DR   Wikidata; Q98135163
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Thr371fs (c.1111delA); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; Ex1del; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP102LO
AC   CVCL_WX47
SY   Xeroderma Pigmentosum 102 LOndon
DR   Wikidata; Q98135165
RX   PubMed=3347209;
RX   PubMed=4066782;
RX   PubMed=6947227;
RX   PubMed=7585650;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=7585650).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=7585650).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=7585650).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS55 ! XP59BR
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   XP102MA
AC   CVCL_ZQ96
SY   Xeroderma Pigmentosum 102 MAnnheim
DR   Wikidata; Q98135167
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP102TO
AC   CVCL_ZM21
SY   Xeroderma Pigmentosum 102 TOkyo
DR   JCRB; KURB1374
DR   Wikidata; Q98135169
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP103BR
AC   CVCL_ZR84
SY   Xeroderma Pigmentosum 103 BRighton
DR   Wikidata; Q98135170
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP103MA
AC   CVCL_ZR15
SY   Xeroderma Pigmentosum 103 MAnnheim
DR   Wikidata; Q98135172
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP103TO
AC   CVCL_ZM22
SY   Xeroderma Pigmentosum 103 TOkyo
DR   JCRB; KURB1375
DR   Wikidata; Q98135174
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP104BR
AC   CVCL_ZU93
SY   Xeroderma Pigmentosum 104 BRighton
DR   Wikidata; Q98135177
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.His46Metfs*5 (c.136delC); ClinVar=VCV001322832; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP104LO
AC   CVCL_ZU94
SY   Xeroderma Pigmentosum 104 London
DR   Wikidata; Q98135180
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; c.718+1C>A; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   47Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP104TO
AC   CVCL_ZM23
SY   Xeroderma Pigmentosum 104 TOkyo
DR   JCRB; KURB1376
DR   Wikidata; Q98135182
RX   PubMed=2778352;
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP105BE
AC   CVCL_M317
SY   Xeroderma Pigmentosum 105 BEthesda; GM16467
DR   CLO; CLO_0017826
DR   Coriell; GM16467
DR   Wikidata; Q54848583
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Homozygous (PubMed=16081512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP105BR
AC   CVCL_ZU95
SY   Xeroderma Pigmentosum 105 BRighton
DR   Wikidata; Q98135185
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Arg239Ile (c.716G>T); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Pro357Leu (c.1070C>T); ClinVar=VCV000304927; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP106LO
AC   CVCL_ZN34
SY   XP 106 LO; Xeroderma Pigmentosum 106 LOndon
DR   Wikidata; Q98135187
RX   PubMed=504548;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP107BR
AC   CVCL_ZU96
SY   Xeroderma Pigmentosum 107 BRighton
DR   Wikidata; Q98135189
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr585Cys (c.1754A>G); ClinVar=VCV002581665; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   XP107LO
AC   CVCL_ZN35
SY   XP 107 LO; Xeroderma Pigmentosum 107 LOndon
DR   Wikidata; Q98135191
RX   PubMed=1372096;
RX   PubMed=1372100;
RX   PubMed=7825573;
RX   PubMed=9238033;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS44 ! XP107LO LCL
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP107LO LCL
AC   CVCL_ZS44
SY   Xeroderma Pigmentosum 107 LOndon LCL; LB98; 98
DR   Wikidata; Q98135193
RX   PubMed=1372096;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (from autologous cell line XP107LO).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from autologous cell line XP107LO).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN35 ! XP107LO
SX   Male
AG   5Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP107MA
AC   CVCL_ZQ97
SY   Xeroderma Pigmentosum 107 MAnnheim
DR   Wikidata; Q98135195
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP107TO
AC   CVCL_ZW22
SY   Xeroderma Pigmentosum 107 TOkyo
DR   Wikidata; Q102115126
RX   PubMed=1814424;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   XP108LO
AC   CVCL_L468
SY   XP 108 LO; Xeroderma Pigmentosum 108 LOndon; GM00936; GM-936; GM 0936; GM936
DR   CLO; CLO_0029540
DR   Coriell; GM00936
DR   JCRB; KURB1074
DR   Wikidata; Q54836546
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=504548;
RX   PubMed=1372108;
RX   PubMed=3010096;
RX   PubMed=6492896;
RX   PubMed=7163956;
CC   Senescence: Senesces at 13 PDL (PubMed=6492896).
CC   Derived from site: In situ; Umbilical cord; UBERON=UBERON_0002331.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22FW
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   XP109BR
AC   CVCL_ZU97
SY   Xeroderma Pigmentosum 109 BRighton
DR   Wikidata; Q98135198
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP10BE
AC   CVCL_U666
SY   Xeroderma Pigmentosum 10 BEthesda; Gor Do; GOR DO
DR   ATCC; CRL-1204
DR   Wikidata; Q54871612
RX   PubMed=273925;
RX   PubMed=1383811;
RX   PubMed=4811796;
CC   Discontinued: ATCC; CRL-1204; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   XP10BR
AC   CVCL_ZN56
SY   Xeroderma Pigmentosum 10 BRighton
DR   Wikidata; Q98135201
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 16,19
ST   D21S11: 30,33.2
ST   D8S1179: 12,14
ST   FGA: 24,26
ST   TH01: 6,8
ST   vWA: 16,17
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP10CA
AC   CVCL_0J77
SY   Xeroderma Pigmentosum 10 CAiro; AG03961; AG3961
DR   CLO; CLO_0036955
DR   Coriell; AG03961
DR   Wikidata; Q54609790
RX   CelloPub=CLPUB00597;
RX   PubMed=7252263;
RX   PubMed=7326997;
CC   Population: Egyptian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   XP10CA iPSC
AC   CVCL_D3AN
SY   AG29051; AG29051*B
DR   Coriell; AG29051
DR   Wikidata; Q127384727
CC   Population: Egyptian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0J77 ! XP10CA
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   XP10MA
AC   CVCL_ZR31
SY   Xeroderma Pigmentosum 10 MAnnheim
DR   Wikidata; Q98135203
RX   PubMed=2054785;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP10OS
AC   CVCL_9S67
SY   Xeroderma Pigmentosum 10 OSaka
DR   JCRB; KURB1320
DR   Wikidata; Q54994864
RX   PubMed=832273;
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   XP10PV
AC   CVCL_RU33
SY   Xeroderma Pigmentosum 10 PaVia
DR   CLO; CLO_0009654
DR   CLDB; cl4748
DR   Wikidata; Q54994866
RX   PubMed=10766188;
RX   PubMed=11511294;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   XP10SE
AC   CVCL_ZM70
SY   Xeroderma Pigmentosum 10 SEndai
DR   JCRB; KURB1359
DR   Wikidata; Q98135205
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP10TA
AC   CVCL_ZP01
SY   Xeroderma Pigmentosum 10 Tel Aviv
DR   Wikidata; Q98135207
RX   PubMed=18368133;
CC   Population: Jewish; Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Trp174Cys (c.522G>T); Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP10TO
AC   CVCL_ZM19
SY   Xeroderma Pigmentosum 10 TOkyo
DR   JCRB; KURB1076
DR   JCRB; KURB1077
DR   Wikidata; Q98135209
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP110BR
AC   CVCL_ZP89
SY   Xeroderma Pigmentosum 110 BRighton
DR   Wikidata; Q98135210
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Phe247fs (c.738delC); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg356Ter (c.1066C>T); ClinVar=VCV001459259; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP111BR
AC   CVCL_ZR85
SY   Xeroderma Pigmentosum 111 BRighton
DR   Wikidata; Q98135212
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln85Ter (c.253C>T); ClinVar=VCV001193397; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP111LO
AC   CVCL_ZN36
SY   Xeroderma Pigmentosum 111 LOndon
DR   Wikidata; Q98135214
RX   PubMed=1372100;
RX   PubMed=9238033;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP112BR
AC   CVCL_ZU98
SY   Xeroderma Pigmentosum 112 BRighton
DR   Wikidata; Q98135216
RX   PubMed=26884178;
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Trp603Ter (c.1808G>A); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2420+2T>C; ClinVar=VCV000963704; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP112MA
AC   CVCL_ZQ98
SY   Xeroderma Pigmentosum 112 MAnnheim
DR   Wikidata; Q98135218
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP114MA
AC   CVCL_ZQ99
SY   Xeroderma Pigmentosum 114 MAnnheim
DR   Wikidata; Q98135220
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP115BR
AC   CVCL_ZU99
SY   Xeroderma Pigmentosum 115 BRighton
DR   Wikidata; Q98135222
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Met383fs (c.1149delG); Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP115KO
AC   CVCL_ZM55
SY   Xeroderma Pigmentosum 115 KOrea
DR   Wikidata; Q98135224
RX   PubMed=29330851;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:47; ABCB6; Simple; p.Asn467Ser (c.1400A>G); Zygosity=Heterozygous (PubMed=29330851).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Homozygous (PubMed=29330851).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173131; Dyschromatosis universalis hereditaria
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_241; Dyschromatosis universalis hereditaria
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP115LO 1
AC   CVCL_ZP87
SY   Xeroderma Pigmentosum 115 LOndon 1; GM02111; GM2111
DR   Coriell; GM02111
DR   Wikidata; Q98135225
RX   PubMed=6947227;
RX   PubMed=7059984;
RX   PubMed=7263770;
RX   PubMed=7326997;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln373Ter (c.1117C>T); ClinVar=VCV000005890; Zygosity=Homozygous (from autologous cell line XP115LO 2).
CC   Discontinued: Coriell; GM02111; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7358 ! XP115LO 2
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP115LO 2
AC   CVCL_7358
SY   Xeroderma Pigmentosum 115 LOndon 2; GM02359; GM2359
DR   CLO; CLO_0033108
DR   BioSample; SAMN00807735
DR   Coriell; GM02359
DR   Wikidata; Q54837457
RX   CelloPub=CLPUB00447;
RX   PubMed=3010096;
RX   PubMed=6492896;
RX   PubMed=7326997;
RX   PubMed=10398605;
RX   PubMed=10655550;
RX   PubMed=17409408;
RX   PubMed=26884178;
CC   Population: Iranian.
CC   Senescence: Senesces at 28 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln373Ter (c.1117C>T); ClinVar=VCV000005890; Zygosity=Homozygous (PubMed=10398605; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZP87 ! XP115LO 1
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   XP115LO 2 hTERT
AC   CVCL_ZS67
SY   hTERT-GM02359; GM02359-hTERT; hTERT-XPV; XP115LO.hTERT
DR   Wikidata; Q98135228
RX   PubMed=10655550;
RX   PubMed=17409408;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln373Ter (c.1117C>T); ClinVar=VCV000005890; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7358 ! XP115LO 2
SX   Male
AG   25Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 9
//
ID   XP115MA
AC   CVCL_ZR00
SY   Xeroderma Pigmentosum 115 MAnnheim
DR   Wikidata; Q98135230
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP116BR
AC   CVCL_ZR86
SY   Xeroderma Pigmentosum 116 BRighton
DR   Wikidata; Q98135231
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP117BR
AC   CVCL_ZV00
SY   Xeroderma Pigmentosum 117 BRighton
DR   Wikidata; Q98135233
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.299+2delT; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gly810Alafs*9 (c.2429_2441del13); Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP118BR
AC   CVCL_ZV01
SY   Xeroderma Pigmentosum 118 BRighton
DR   Wikidata; Q98135235
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Leu615fs (c.1842delT); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala795Thr (c.2383G>A); ClinVar=VCV000883461; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP119BR
AC   CVCL_ZV02
SY   Xeroderma Pigmentosum 119 BRighton
DR   Wikidata; Q98135237
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu585Ter (c.1753G>T); ClinVar=VCV003774945; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala818Val (c.2453C>T); ClinVar=VCV000996657; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   XP11BE
AC   CVCL_U690
SY   Xeroderma Pigmentosum 11 BEthesda; CS4BE; XP-CS-1; Po Co
DR   ATCC; CRL-1199
DR   Wikidata; Q54947691
RX   PubMed=837385;
RX   PubMed=1034206;
RX   PubMed=2175267;
RX   PubMed=4066782;
RX   PubMed=4811796;
RX   PubMed=9012405;
RX   PubMed=9579555;
RX   PubMed=15572672;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe270Ter (c.807_808delTT); Zygosity=Heterozygous (from autologous cell line XP11BE LCL).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln739fs*42 (c.2218-6C>A) (IVS14-6C>A); Zygosity=Heterozygous (from autologous cell line XP11BE LCL).
CC   Discontinued: ATCC; CRL-1199; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L460 ! XP11BE LCL
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   XP11BE LCL
AC   CVCL_L460
SY   Xeroderma Pigmentosum 11 BEthesda LCL; CS4BE LCL; XP-CS-1 LCL; GM02252; GM-2252; GM 2252; GM2252; GM02252A
DR   CLO; CLO_0032152
DR   BioSample; SAMN00807634
DR   Coriell; GM02252
DR   JCRB; KURB1044
DR   Wikidata; Q54837392
RX   CelloPub=CLPUB00447;
RX   PubMed=1702221;
RX   PubMed=6096450;
RX   PubMed=8327515;
RX   PubMed=11841555;
RX   PubMed=16947863;
CC   Population: Caucasian.
CC   HLA typing: A*w24,w32; B*12,w40 (Coriell=GM02252).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe270Ter (c.807_808delTT); Zygosity=Heterozygous (PubMed=16947863).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln739fs*42 (c.2218-6C>A) (IVS14-6C>A); Zygosity=Heterozygous (PubMed=16947863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U690 ! XP11BE
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   XP11BR
AC   CVCL_W049
SY   XP11 BR; Xeroderma Pigmentosum 11 BRighton
DR   Wikidata; Q54994867
RX   PubMed=1372096;
RX   PubMed=1372100;
RX   PubMed=10022907;
RX   PubMed=11773631;
RX   PubMed=18079351;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gly263Val (c.788G>T); dbSNP=rs1413703153; Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2556 ! XP11BR LCL
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   XP11BR LCL
AC   CVCL_2556
SY   Xeroderma Pigmentosum 11 BRighton LCL; LB205; 205
DR   ECACC; 98062329
DR   Wikidata; Q54902045
RX   PubMed=1372096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gly263Val (c.788G>T); dbSNP=rs1413703153; Zygosity=Homozygous (from autologous cell line XP11BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W049 ! XP11BR
SX   Male
AG   62Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   XP11CA
AC   CVCL_X782
SY   Xeroderma Pigmentosum 11 CAiro; AG03962; AG3962
DR   CLO; CLO_0034759
DR   Coriell; AG03962
DR   Wikidata; Q54609895
RX   CelloPub=CLPUB00597;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 10
//
ID   XP11KO
AC   CVCL_ZM33
SY   Xeroderma Pigmentosum 11 KObe
DR   Wikidata; Q98135239
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP11KY
AC   CVCL_ZQ40
SY   Xeroderma Pigmentosum 11 KYoto
DR   Wikidata; Q98135241
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP11MA
AC   CVCL_ZQ79
SY   Xeroderma Pigmentosum 11 MAnnheim
DR   Wikidata; Q98135244
RX   PubMed=2054785;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP11OS
AC   CVCL_ZM86
SY   Xeroderma Pigmentosum 11 OSaka
DR   Wikidata; Q98135246
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP11PV
AC   CVCL_RU34
SY   Xeroderma Pigmentosum 11 PaVia
DR   CLO; CLO_0009655
DR   CLDB; cl4749
DR   Wikidata; Q54994868
RX   PubMed=8823375;
RX   PubMed=19329487;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   XP11RO
AC   CVCL_ZR52
SY   Xeroderma Pigmentosum 11 ROtterdam
DR   Wikidata; Q98135247
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP11SE
AC   CVCL_ZM71
SY   Xeroderma Pigmentosum 11 SEndai
DR   JCRB; KURB1360
DR   Wikidata; Q98135251
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP11TU
AC   CVCL_ZQ34
SY   Xeroderma Pigmentosum 11 TUnisia
DR   JCRB; KURB1207
DR   Wikidata; Q98135254
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP120BR
AC   CVCL_ZV03
SY   Xeroderma Pigmentosum 120 BRighton
DR   Wikidata; Q98135255
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu585Ter (c.1753G>T); ClinVar=VCV003774945; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala818Val (c.2453C>T); ClinVar=VCV000996657; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   XP121BR
AC   CVCL_ZR87
SY   Xeroderma Pigmentosum 121 BRighton
DR   Wikidata; Q98135257
RX   PubMed=26743599;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP123TMA LCL
AC   CVCL_1F55
SY   Xeroderma Pigmentosum Turkey MAlatya 123 LCL; GM15723
DR   CLO; CLO_0027679
DR   Coriell; GM15723
DR   Wikidata; Q54848159
RX   PubMed=14662655;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-24A>G (IVS3-24A>G); ClinVar=VCV000000261; Zygosity=Homozygous (PubMed=14662655).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XP124LO
AC   CVCL_ZN37
SY   Xeroderma Pigmentosum 124 LOndon
DR   Wikidata; Q98135260
RX   PubMed=1372100;
RX   PubMed=3620347;
RX   PubMed=9096355;
RX   PubMed=11841555;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala792Val (c.2375C>T) (2572C>T); ClinVar=VCV000016567; Zygosity=Heterozygous (from autologous cell line XP124LO LCL).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu960Ter (c.2878G>T) (3075G>T); ClinVar=VCV000016566; Zygosity=Heterozygous (from autologous cell line XP124LO LCL).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZP64 ! XP124LO LCL
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP124LO LCL
AC   CVCL_ZP64
SY   Xeroderma Pigmentosum 124 LOndon LCL; XPG82; LB82
DR   Wikidata; Q98135262
RX   PubMed=9096355;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala792Val (c.2375C>T) (2572C>T); ClinVar=VCV000016567; Zygosity=Heterozygous (PubMed=9096355).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu960Ter (c.2878G>T) (3075G>T); ClinVar=VCV000016566; Zygosity=Heterozygous (PubMed=9096355).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN37 ! XP124LO
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP125LO
AC   CVCL_W053
SY   Xeroderma Pigmentosum 125 LOndon
DR   Wikidata; Q54994879
RX   PubMed=1372100;
RX   PubMed=3620347;
RX   PubMed=9096355;
RX   PubMed=11841555;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala792Val (c.2375C>T) (2572C>T); ClinVar=VCV000016567; Zygosity=Heterozygous (from autologous cell line XP125LO LCL).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu960Ter (c.2878G>T) (3075G>T); ClinVar=VCV000016566; Zygosity=Heterozygous (from autologous cell line XP125LO LCL).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2572 ! XP125LO LCL
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   XP125LO LCL
AC   CVCL_2572
SY   Xeroderma Pigmentosum 125 LOndon LCL; XPG83; XPG 83; LB83
DR   ECACC; 98062328
DR   Wikidata; Q54902092
RX   PubMed=7951246;
RX   PubMed=8327515;
RX   PubMed=8483504;
RX   PubMed=8483505;
RX   PubMed=9096355;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala792Val (c.2375C>T) (2572C>T); ClinVar=VCV000016567; Zygosity=Heterozygous (PubMed=7951246).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu960Ter (c.2878G>T) (3075G>T); ClinVar=VCV000016566; Zygosity=Heterozygous (PubMed=7951246).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W053 ! XP125LO
SX   Female
AG   15Y
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   XP126LO
AC   CVCL_ZP19
SY   Xeroderma Pigmentosum 126 LOndon
DR   Wikidata; Q98135264
RX   PubMed=8797827;
RX   PubMed=9579555;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Thr770Profs*46 (c.2304_2307delTCTC) (2281del4); ClinVar=VCV000016579; Zygosity=Heterozygous (PubMed=8797827).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Heterozygous (PubMed=8797827).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP127VI
AC   CVCL_ZP99
SY   Xeroderma Pigmentosum 127 VIllejuif
DR   Wikidata; Q98135265
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359Valfs*32 (c.1075_1244del170) (Ex10del); Zygosity=Homozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr364fs (c.1091dupC) (Fs364); Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   49Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP129
AC   CVCL_VP51
DR   Wikidata; Q98135268
RX   PubMed=1549511;
RX   PubMed=2823132;
RX   PubMed=3118197;
RX   PubMed=8464385;
CC   Population: Palestinian.
CC   Characteristics: Revertant in term of the XP12RO phenotype.
CC   Selected for resistance to: NCIt; C17231; Ultraviolet radiation.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Gly (c.619C>G); Zygosity=Unspecified (PubMed=8464385).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VP50 ! XP12RO
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   XP12BE
AC   CVCL_F119
SY   XP12 BE; Xeroderma Pigmentosum 12 BEthesda; Jay Tim; Jay-Tim; JayTim; GM05509; GM 5509; GM5509; GM 5509B; GM05509A
DR   CLO; CLO_0024800
DR   ATCC; CRL-1223
DR   Coriell; GM05509
DR   Wikidata; Q54839029
RX   CelloPub=CLPUB00447;
RX   PubMed=273925;
RX   PubMed=450131;
RX   PubMed=643622;
RX   PubMed=656543;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2065254;
RX   PubMed=2657812;
RX   PubMed=3724780;
RX   PubMed=4811796;
RX   PubMed=7161312;
RX   PubMed=7273335;
RX   PubMed=7374661;
RX   PubMed=7471105;
RX   PubMed=8595429;
RX   PubMed=8643543;
RX   PubMed=8823375;
RX   PubMed=9671271;
RX   PubMed=15744458;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.507-1G>T (IVS3-1G>T); Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=8595429; PubMed=9671271).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (PubMed=9671271; Coriell=GM05509).
CC   Discontinued: ATCC; CRL-1223; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F117 ! XP12BE LCL
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   XP12BE LCL
AC   CVCL_F117
SY   Xeroderma Pigmentosum 12 BEthesda LCL; GM02250; GM2250; GM 2250; GM02250A; GM2250A; GM02250D; GM02250E
DR   CLO; CLO_0032150
DR   BioSample; SAMN00807632
DR   Coriell; GM02250
DR   Wikidata; Q54837391
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
RX   PubMed=6096450;
RX   PubMed=6809308;
RX   PubMed=8327515;
RX   PubMed=8483505;
RX   PubMed=8823375;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.507-1G>T (IVS3-1G>T); Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM02250).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM02250).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F119 ! XP12BE
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 23
//
ID   XP12BESV
AC   CVCL_F118
SY   XP12BE (SV40); GM04429; GM4429; GM4429A; GM04429E
DR   CLO; CLO_0019690
DR   Coriell; GM04429
DR   Wikidata; Q54838526
RX   CelloPub=CLPUB00447;
RX   PubMed=6684957;
RX   PubMed=7519740;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.507-1G>T (IVS3-1G>T); Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM04429).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM04429).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F119 ! XP12BE
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 24
//
ID   XP12BR
AC   CVCL_ZP10
SY   Xeroderma Pigmentosum 12 BRighton
DR   Wikidata; Q98135270
RX   PubMed=19179371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP12CA
AC   CVCL_X783
SY   Xeroderma Pigmentosum 12 CAiro; AG03963; AG3963
DR   CLO; CLO_0034760
DR   Coriell; AG03963
DR   Wikidata; Q54609898
RX   CelloPub=CLPUB00597;
RX   PubMed=6492896;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   XP12HM
AC   CVCL_ZQ70
SY   Xeroderma Pigmentosum 12 HamaMatsu
DR   Wikidata; Q98135273
RX   PubMed=20574439;
RX   PubMed=27603812;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=20574439; PubMed=27603812).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP12KO
AC   CVCL_ZM37
SY   Xeroderma Pigmentosum 12 KObe
DR   Wikidata; Q98135275
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP12MA
AC   CVCL_ZR01
SY   Xeroderma Pigmentosum 12 MAnnheim
DR   Wikidata; Q98135278
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP12OS
AC   CVCL_ZM87
SY   Xeroderma Pigmentosum 12 OSaka
DR   JCRB; KURB1321
DR   Wikidata; Q98135280
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP12PV
AC   CVCL_RU35
SY   Xeroderma Pigmentosum 12 PaVia
DR   CLO; CLO_0009656
DR   CLDB; cl4750
DR   Wikidata; Q54994880
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   XP12RO
AC   CVCL_VP50
SY   XP12RO-SV40; XP12RO(SV40); XP12ROSV
DR   Wikidata; Q98135282
RX   PubMed=1372102;
RX   PubMed=1549511;
RX   PubMed=1702221;
RX   PubMed=2823132;
RX   PubMed=3118197;
RX   PubMed=4436596;
RX   PubMed=6256643;
RX   PubMed=6307543;
RX   PubMed=7163956;
RX   PubMed=7273335;
RX   PubMed=7519740;
RX   PubMed=7671243;
RX   PubMed=8055625;
RX   PubMed=8464385;
RX   PubMed=9415314;
RX   PubMed=10334196;
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Homozygous (PubMed=1372102; PubMed=8464385).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 10
//
ID   XP12ROB4
AC   CVCL_VP52
DR   Wikidata; Q98135285
RX   PubMed=10334196;
CC   Population: Palestinian.
CC   Characteristics: Combines defects in three DNA repair functions: MGMT, MMR and NER. Does not express MSH2.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Homozygous (from parent cell line).
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_VP50 ! XP12RO
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 07-09-18; Last updated: 19-12-24; Version: 9
//
ID   XP12SE
AC   CVCL_U870
SY   Xeroderma Pigmentosum 12 SEndai
DR   JCRB; KURB1042
DR   Wikidata; Q54994882
RX   PubMed=202381;
RX   PubMed=832273;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8767 ! XP12SE LCL
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   XP12SE LCL
AC   CVCL_8767
SY   Xeroderma Pigmentosum 12 SEndai LCL; XPL 12; XPL12
DR   Wikidata; Q54995020
RX   PubMed=202381;
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U870 ! XP12SE
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   XP12SF
AC   CVCL_ZR53
SY   Xeroderma Pigmentosum 12 San Fransisco
DR   Wikidata; Q98135287
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP12TA
AC   CVCL_7652
SY   Xeroderma Pigmentosum 12 Tel Aviv; GM16684
DR   CLO; CLO_0017452
DR   Coriell; GM16684
DR   Wikidata; Q54848696
RX   PubMed=11121128;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Homozygous (PubMed=11121128).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   XP12TU
AC   CVCL_ZQ35
SY   Xeroderma Pigmentosum 12 TUnisia
DR   JCRB; KURB1208
DR   Wikidata; Q98135289
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP130LO
AC   CVCL_ZN38
SY   Xeroderma Pigmentosum 130 LOndon
DR   Wikidata; Q98135291
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP131MA
AC   CVCL_V276
SY   Xeroderma Pigmentosum 131 MAnnheim; GM21153
DR   CLO; CLO_0015858
DR   Coriell; GM21153
DR   Wikidata; Q54851704
RX   PubMed=10954218;
RX   PubMed=16947863;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Asp474Glufs*2 (c.1421dupA); ClinVar=VCV000134130; Zygosity=Heterozygous (PubMed=16947863).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln739fs*42 (c.2218-6C>A) (IVS14-6C>A); Zygosity=Heterozygous (PubMed=16947863).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   XP132BE
AC   CVCL_M319
SY   Xeroderma Pigmentosum 132 BEthesda; GM16693
DR   CLO; CLO_0018458
DR   Coriell; GM16693
DR   Wikidata; Q54848709
CC   Population: Honduran.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (Coriell=GM16693).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M318 ! XP132BE LCL
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP132BE LCL
AC   CVCL_M318
SY   Xeroderma Pigmentosum 132 BEthesda LCL; GM16692
DR   CLO; CLO_0018455
DR   Coriell; GM16692
DR   Wikidata; Q54848707
RX   PubMed=16081512;
CC   Population: Honduran.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (Coriell=GM16692).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M319 ! XP132BE
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   XP135LO
AC   CVCL_ZN39
SY   Xeroderma Pigmentosum 135 LOndon
DR   Wikidata; Q98135292
RX   PubMed=1372100;
RX   PubMed=9238033;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (PubMed=9238033; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP136LO
AC   CVCL_ZV04
SY   Xeroderma Pigmentosum 136 London
DR   Wikidata; Q98135294
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Val9Phe (c.25G>T); ClinVar=VCV000910499; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; c.490+3A>G; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   54Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP139DC
AC   CVCL_ZP04
DR   Wikidata; Q98135298
RX   PubMed=18368133;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359Valfs*32 (c.1075_1244del170) (Ex10del); Zygosity=Heterozygous (PubMed=18368133).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr569Argfs*10 (c.1706_1707delCA); Zygosity=Heterozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP13BE
AC   CVCL_U670
SY   Xeroderma Pigmentosum 13 BEthesda; Pe Hay; PeHay
DR   ATCC; CRL-1258
DR   Wikidata; Q54946874
RX   PubMed=225015;
RX   PubMed=273925;
RX   PubMed=656543;
RX   PubMed=4811796;
CC   Discontinued: ATCC; CRL-1258; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 11
//
ID   XP13BR
AC   CVCL_ZP11
SY   Xeroderma Pigmentosum 13 BRighton
DR   Wikidata; Q98135300
RX   PubMed=19179371;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP13CA
AC   CVCL_V266
SY   Xeroderma Pigmentosum 13 CAiro; AG03964; AG3964; GM03964; GM3964
DR   CLO; CLO_0034763
DR   Coriell; AG03964
DR   Coriell; GM03964
DR   Wikidata; Q54609899
RX   CelloPub=CLPUB00597;
RX   PubMed=7163956;
RX   PubMed=7252263;
RX   PubMed=9671271;
CC   Population: Egyptian.
CC   Discontinued: Coriell; GM03964; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 12
//
ID   XP13KY
AC   CVCL_ZQ41
SY   Xeroderma Pigmentosum 13 Kyoto
DR   Wikidata; Q98135302
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP13MA
AC   CVCL_ZR24
SY   Xeroderma Pigmentosum 13 MAnnheim
DR   Wikidata; Q98135305
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP13NA
AC   CVCL_ZS37
SY   Xeroderma Pigmentosum 13 NAgoya
DR   JCRB; KURB1103
DR   Wikidata; Q98135307
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP13OS
AC   CVCL_ZM88
SY   Xeroderma Pigmentosum 13 OSaka
DR   JCRB; KURB1322
DR   Wikidata; Q98135309
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP13PV
AC   CVCL_RU36
SY   Xeroderma Pigmentosum 13 PaVia
DR   CLO; CLO_0009657
DR   CLDB; cl4751
DR   Wikidata; Q54994883
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Ala109Argfs*5 (c.321_322insAA); Zygosity=Heterozygous (PubMed=10766188).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Trp690Ser (c.2069G>C); Zygosity=Heterozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   XP13SE
AC   CVCL_ZM72
SY   Xeroderma Pigmentosum 13 SEndai
DR   JCRB; KURB1361
DR   Wikidata; Q98135311
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP13TU
AC   CVCL_ZQ36
SY   Xeroderma Pigmentosum 13 TUnisia
DR   JCRB; KURB1209
DR   Wikidata; Q98135313
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP14BE
AC   CVCL_U671
SY   Xeroderma Pigmentosum 14 BEthesda; Te Jes
DR   ATCC; CRL-1311
DR   Wikidata; Q54972005
RX   CelloPub=CLPUB00565;
RX   PubMed=4811796;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS6-13_-21del9; Zygosity=Homozygous (CelloPub=CLPUB00565).
CC   Discontinued: ATCC; CRL-1311; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F326 ! XP14BE LCL
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 10
//
ID   XP14BE LCL
AC   CVCL_F326
SY   Xeroderma Pigmentosum 14 BEthesda LCL; GM14701
DR   CLO; CLO_0031988
DR   Coriell; GM14701
DR   Wikidata; Q54847415
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS6-13_-21del9; Zygosity=Homozygous (from autologous cell line XP14BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U671 ! XP14BE
SX   Male
AG   71Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   XP14BR.1
AC   CVCL_ZN23
SY   Xeroderma Pigmentosum 14 BRighton 1; 86/0029
DR   Wikidata; Q98135315
RX   PubMed=1571258;
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg718Ter (c.2152C>T); ClinVar=VCV000551486; Zygosity=Unspecified (from autologous cell line XP14BR.2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F629 ! XP14BR.2
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP14BR.2
AC   CVCL_F629
SY   Xeroderma Pigmentosum 14 BRighton 2; GM16092
DR   CLO; CLO_0018856
DR   Coriell; GM16092
DR   Wikidata; Q54848316
RX   PubMed=10766188;
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg718Ter (c.2152C>T); ClinVar=VCV000551486; Zygosity=Unspecified (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN23 ! XP14BR.1
SX   Female
AG   14-15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 12
//
ID   XP14BRneo17
AC   CVCL_F630
SY   GM16093
DR   CLO; CLO_0018854
DR   Coriell; GM16093
DR   Wikidata; Q54848317
RX   PubMed=16714754;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg718Ter (c.2152C>T); ClinVar=VCV000551486; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F629 ! XP14BR.2
SX   Female
AG   14-15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 17
//
ID   XP14CA
AC   CVCL_X784
SY   Xeroderma Pigmentosum 14 CAiro; AG03965; AG3965
DR   CLO; CLO_0034764
DR   Coriell; AG03965
DR   Wikidata; Q54609901
RX   CelloPub=CLPUB00597;
RX   PubMed=6492896;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 11
//
ID   XP14MA
AC   CVCL_ZR25
SY   Xeroderma Pigmentosum 14 MAnnheim
DR   Wikidata; Q98135317
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP14NA
AC   CVCL_ZQ28
SY   Xeroderma Pigmentosum 14 NAgoya
DR   JCRB; KURB1313
DR   Wikidata; Q98135319
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP14OS
AC   CVCL_ZM89
SY   Xeroderma Pigmentosum 14 OSaka
DR   JCRB; KURB1323
DR   Wikidata; Q98135321
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP14PV
AC   CVCL_RU37
SY   Xeroderma Pigmentosum 14 PaVia
DR   CLO; CLO_0009658
DR   CLDB; cl4752
DR   Wikidata; Q54994884
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   XP14SE
AC   CVCL_ZM73
SY   Xeroderma Pigmentosum 14 SEndai
DR   JCRB; KURB1362
DR   Wikidata; Q98135323
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP14TO
AC   CVCL_ZM18
SY   Xeroderma Pigmentosum 14 TOkyo
DR   JCRB; KURB1066
DR   Wikidata; Q98135326
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP14VI
AC   CVCL_ZR67
SY   Xeroderma Pigmentosum 14 VIllejuif; AS143
DR   JCRB; KURB1231
DR   Wikidata; Q98135328
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP15BE
AC   CVCL_U673
SY   Xeroderma Pigmentosum 15 BEthesda; Me Kam; MeKam
DR   ATCC; CRL-1279
DR   BCRC; 60152
DR   Wikidata; Q54904893
RX   PubMed=4811796;
CC   Population: Pacific; Hawaiian.
CC   Caution: From a male patient according to PubMed=4811796 and from a female patient according to ATCC CRL-1279.
CC   Discontinued: ATCC; CRL-1279; true.
CC   Discontinued: BCRC; 60152; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M999 ! XP15BE LCL
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   XP15BE LCL
AC   CVCL_M999
SY   Xeroderma Pigmentosum 15 BEthesda LCL; GM02545; GM17385
DR   CLO; CLO_0012169
DR   CLO; CLO_0033443
DR   Coriell; GM02545
DR   Coriell; GM17385
DR   Wikidata; Q54837541
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Pacific; Hawaiian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U673 ! XP15BE
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   XP15BR
AC   CVCL_ZN28
SY   Xeroderma Pigmentosum 15 BRighton
DR   Wikidata; Q98135330
RX   PubMed=16714754;
RX   PubMed=18079351;
RX   PubMed=19179371;
RX   PubMed=21566739;
RX   PubMed=22466610;
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Val90Lysfs*15 (c.266_267dupAA); ClinVar=VCV000524023; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP15CA
AC   CVCL_YP24
SY   Xeroderma Pigmentosum 15 CAiro; AG04317; AG4317
DR   Coriell; AG04317
DR   Wikidata; Q93314489
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Discontinued: Coriell; AG04317; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   XP15KY
AC   CVCL_ZQ42
SY   Xeroderma Pigmentosum 15 KYoto
DR   Wikidata; Q98135333
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP15MA
AC   CVCL_ZQ80
SY   Xeroderma Pigmentosum 15 MAnnheim
DR   Wikidata; Q98135335
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP15NA
AC   CVCL_ZQ29
SY   Xeroderma Pigmentosum 15 NAgoya
DR   JCRB; KURB1314
DR   Wikidata; Q98135337
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP15OS
AC   CVCL_9S68
SY   Xeroderma Pigmentosum 15 OSaka
DR   JCRB; KURB1326
DR   Wikidata; Q54994885
RX   PubMed=832273;
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   XP15PV
AC   CVCL_RU38
SY   Xeroderma Pigmentosum 15 PaVia
DR   CLO; CLO_0009659
DR   CLDB; cl4753
DR   Wikidata; Q54994886
RX   PubMed=9238033;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Homozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XP15SE
AC   CVCL_U869
SY   Xeroderma Pigmentosum 15 SEndai
DR   JCRB; KURB1363
DR   Wikidata; Q54994888
RX   PubMed=202381;
RX   PubMed=832273;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8768 ! XP15SE LCL
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   XP15SE LCL
AC   CVCL_8768
SY   Xeroderma Pigmentosum 15 SEndai LCL; XPL 15; XPL15
DR   JCRB; KURB1280
DR   RCB; RCB1910
DR   TKG; TKG 0310
DR   Wikidata; Q54995021
RX   PubMed=202381;
RX   PubMed=1906129;
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: RCB; RCB1910; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U869 ! XP15SE
SX   Male
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   XP161BE
AC   CVCL_ZN99
SY   Xeroderma Pigmentosum 161 BEthesda
DR   Wikidata; Q98135338
RX   PubMed=18368133;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asp360Glyfs*32 (c.1078dupG) (c.1078_1079dupG); ClinVar=VCV001696282; Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP164BE
AC   CVCL_ZP00
SY   Xeroderma Pigmentosum 164 BEthesda
DR   Wikidata; Q98135340
RX   PubMed=18368133;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asp360Glyfs*32 (c.1078dupG) (c.1078_1079dupG); ClinVar=VCV001696282; Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP165MA
AC   CVCL_4T40
DR   Wikidata; Q54994889
RX   PubMed=23370536;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   XP16BE
AC   CVCL_U676
SY   Xeroderma Pigmentosum 16 BEthesda; Jo Vid
DR   ATCC; CRL-1307
DR   Wikidata; Q54899025
CC   Discontinued: ATCC; CRL-1307; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   XP16BR
AC   CVCL_ZN29
SY   Xeroderma Pigmentosum 16 BRighton
DR   Wikidata; Q98135344
RX   PubMed=9238033;
RX   PubMed=18079351;
RX   PubMed=21566739;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=9238033; PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=9238033; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP16CA
AC   CVCL_YP25
SY   Xeroderma Pigmentosum 16 CAiro; AG04318; AG4318
DR   Coriell; AG04318
DR   Wikidata; Q93314491
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Discontinued: Coriell; AG04318; probable.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   XP16KO-I
AC   CVCL_ZM38
SY   XP16KO; Xeroderma Pigmentosum 16 KObe-I
DR   Wikidata; Q98135346
RX   PubMed=1986275;
RX   PubMed=7240788;
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZM44 ! XP16KO-II
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP16KO-II
AC   CVCL_ZM44
SY   Xeroderma Pigmentosum 16 KObe-II
DR   Wikidata; Q98135347
RX   PubMed=1986275;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZM38 ! XP16KO-I
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP16MA
AC   CVCL_ZQ81
SY   Xeroderma Pigmentosum 16 MAnnheim
DR   Wikidata; Q98135349
RX   PubMed=2054785;
RX   PubMed=7165374;
CC   Caution: Said to originate from a female patient in PubMed=2054785 and from a male patient in PubMed=7165374.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP16NA
AC   CVCL_ZQ43
SY   Xeroderma Pigmentosum 16 NAgoya
DR   Wikidata; Q98135351
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP16OS
AC   CVCL_ZM90
SY   Xeroderma Pigmentosum 16 OSaka
DR   JCRB; KURB1328
DR   Wikidata; Q98135353
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP16PV
AC   CVCL_RU39
SY   Xeroderma Pigmentosum 16 PaVia
DR   CLO; CLO_0009660
DR   CLDB; cl4754
DR   Wikidata; Q54994890
RX   PubMed=7671243;
RX   PubMed=9238033;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Homozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XP16RO
AC   CVCL_ZR54
SY   Xeroderma Pigmentosum 16 ROtterdam
DR   Wikidata; Q98135356
RX   PubMed=4778857;
RX   PubMed=4842087;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP16SE
AC   CVCL_ZM74
SY   Xeroderma Pigmentosum 16 SEndai
DR   JCRB; KURB1181
DR   Wikidata; Q98135358
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP16VI
AC   CVCL_ZR32
SY   Xeroderma Pigmentosum 16 VIllejuif
DR   Wikidata; Q98135360
RX   PubMed=9415314;
RX   PubMed=16081512;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Homozygous (PubMed=16081512).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP17BE
AC   CVCL_3815
SY   Xeroderma Pigmentosum 17 BEthesda; GM10428; GM 10428
DR   CLO; CLO_0009661
DR   CLO; CLO_0028646
DR   ATCC; CRL-1360
DR   BioSample; SAMN00800013
DR   BioSample; SAMN03471356
DR   Coriell; GM10428
DR   Wikidata; Q54994891
RX   CelloPub=CLPUB00447;
RX   PubMed=273925;
RX   PubMed=1372108;
RX   PubMed=18470933;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Asp681Asn (c.2041G>A); ClinVar=VCV000016787; Zygosity=Heterozygous (PubMed=18470933).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=18470933).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): ATCC=CRL-1360
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 13,14
ST   D21S11: 28,30
ST   D2S1338: 16,19
ST   D3S1358: 14,16
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 11,14
ST   FGA: 22
ST   Penta D: 11,13
ST   Penta E: 13,14
ST   TH01: 6,7
ST   TPOX: 9,11
ST   vWA: 15,19
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L778 ! XP17BE LCL
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   XP17BE LCL
AC   CVCL_L778
SY   Xeroderma Pigmentosum 17 BEthesda LCL; GM02253; GM-2253; GM 2253; GM2253; GM02253D; GM02253E
DR   CLO; CLO_0032159
DR   BioSample; SAMN00807636
DR   Coriell; GM02253
DR   Wikidata; Q54837393
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
RX   PubMed=6096450;
RX   PubMed=7519740;
RX   PubMed=9025096;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Asp681Asn (c.2041G>A); ClinVar=VCV000016787; Zygosity=Heterozygous (from autologous cell line XP17BE).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from autologous cell line XP17BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3815 ! XP17BE
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 24
//
ID   XP17BR
AC   CVCL_ZV05
SY   Xeroderma Pigmentosum 17 BRighton
DR   Wikidata; Q98135362
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   23Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP17CA
AC   CVCL_0J82
SY   Xeroderma Pigmentosum 17 CAiro; AG04316; AG4316; AG04316A
DR   CLO; CLO_0034790
DR   Coriell; AG04316
DR   Wikidata; Q54609959
RX   CelloPub=CLPUB00597;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 10
//
ID   XP17HM
AC   CVCL_ZQ66
SY   Xeroderma Pigmentosum 17 HamaMatsu
DR   Wikidata; Q98135364
RX   PubMed=20574439;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=20574439).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg231Lysfs*15 (c.689dupT) (690insT); ClinVar=VCV001457431; Zygosity=Heterozygous (PubMed=20574439).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP17KO
AC   CVCL_ZM39
SY   Xeroderma Pigmentosum 17 KObe
DR   Wikidata; Q98135366
RX   PubMed=7240788;
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP17MA
AC   CVCL_ZR02
SY   Xeroderma Pigmentosum 17 MAnnheim
DR   Wikidata; Q98135368
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP17OS
AC   CVCL_ZM91
SY   Xeroderma Pigmentosum 17 OSaka
DR   JCRB; KURB1329
DR   Wikidata; Q98135369
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP17PV
AC   CVCL_RU40
SY   Xeroderma Pigmentosum 17 PaVia
DR   CLO; CLO_0009662
DR   CLDB; cl4755
DR   Wikidata; Q54994892
RX   PubMed=7585650;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=7585650).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=7585650).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   XP17SE
AC   CVCL_W724
SY   Xeroderma Pigmentosum 17 SEndai
DR   Wikidata; Q54994893
RX   PubMed=202381;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8769 ! XP17SE LCL
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   XP17SE LCL
AC   CVCL_8769
SY   Xeroderma Pigmentosum 17 SEndai LCL; XPL 17; XPL17
DR   CLO; CLO_0051020
DR   BioSample; SAMN03471955
DR   FANTOM5_SSTAR; 10563-108A5
DR   RCB; RCB2286
DR   TKG; TKG 0311
DR   Wikidata; Q54995022
RX   PubMed=202381;
RX   PubMed=1906129;
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): RCB=RCB2286; TKG=TKG 0311
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 11
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 8,11
ST   TH01: 6,7
ST   TPOX: 11
ST   vWA: 15,17
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W724 ! XP17SE
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   XP17SF
AC   CVCL_ZR55
SY   Xeroderma Pigmentosum 17 San Fransisco
DR   Wikidata; Q98135371
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP183MA
AC   CVCL_V274
SY   Xeroderma Pigmentosum 183 MAnnheim; GM21072
DR   CLO; CLO_0015394
DR   Coriell; GM21072
DR   Wikidata; Q54851623
RX   PubMed=16947863;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln545Ter (c.1633C>T); ClinVar=VCV000016588; Zygosity=Heterozygous (PubMed=16947863).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln739fs*42 (c.2218-6C>A) (IVS14-6C>A); Zygosity=Heterozygous (PubMed=16947863).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   XP18BR
AC   CVCL_ZM76
SY   Xeroderma Pigmentosum 18 BRighton
DR   JCRB; KURB1232
DR   Wikidata; Q98135373
RX   PubMed=14688028;
RX   PubMed=16164424;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP18KY
AC   CVCL_ZQ44
SY   Xeroderma Pigmentosum 18 KYoto
DR   Wikidata; Q98135376
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP18MA
AC   CVCL_ZR03
SY   Xeroderma Pigmentosum 18 MAnnheim
DR   Wikidata; Q98135380
RX   PubMed=2054785;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP18OS
AC   CVCL_JH24
SY   Xeroderma Pigmentosum 18 OSaka
DR   JCRB; JCRB3027
DR   JCRB; KURB1234
DR   JCRB; KURB1330
DR   Wikidata; Q54994894
RX   PubMed=832273;
RX   PubMed=7947212;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Tyr116Ter (c.348T>A); ClinVar=VCV000000997; Zygosity=Homozygous (PubMed=7947212).
CC   Discontinued: JCRB; KURB1234; probable.
CC   Discontinued: JCRB; KURB1330; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3027
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6M
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 11
//
ID   XP18OSHM
AC   CVCL_ZM56
SY   Xeroderma Pigmentosum 18 OSaka Heterozygote Mother
DR   JCRB; KURB1331
DR   Wikidata; Q98135382
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Tyr116Ter (c.348T>A); ClinVar=VCV000000997; Zygosity=Heterozygous (from familial inference of XP18OS).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP18PV
AC   CVCL_RU41
SY   Xeroderma Pigmentosum 18 PaVia
DR   CLO; CLO_0009663
DR   CLDB; cl4756
DR   Wikidata; Q54994895
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   XP18SE
AC   CVCL_U866
SY   Xeroderma Pigmentosum 18 SEndai
DR   JCRB; KURB1182
DR   Wikidata; Q54994897
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U865 ! XP18SE LCL
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   XP18SE LCL
AC   CVCL_U865
SY   Xeroderma Pigmentosum 18 SEndai LCL; XPL 18; XPL18
DR   Wikidata; Q54995023
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U866 ! XP18SE
SX   Male
AG   18Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   XP19BE
AC   CVCL_H143
SY   Xeroderma Pigmentosum 19 BEthesda; XP1WI; GM01630; GM-1630; GM 1630; GM1630
DR   CLO; CLO_0031500
DR   BioSample; SAMN00806993
DR   Coriell; GM01630
DR   JCRB; KURB1027
DR   Wikidata; Q54836965
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2065254;
RX   PubMed=6947227;
RX   PubMed=9671271;
RX   PubMed=15572672;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Homozygous; Note=Also produces mis-splicing (PubMed=9671271; Coriell=GM01630).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H144 ! XP19BE LCL
SX   Male
AG   3Y6M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   XP19BE LCL
AC   CVCL_H144
SY   Xeroderma Pigmentosum 19 BEthesda LCL; XP1WI LCL; GM02344; GM-2344; GM02344A
DR   CLO; CLO_0033114
DR   BioSample; SAMN00807725
DR   Coriell; GM02344
DR   Wikidata; Q54837451
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Homozygous; Note=Also produces mis-splicing (Coriell=GM02344).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H143 ! XP19BE
SX   Male
AG   3Y6M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   XP19BR
AC   CVCL_ZW25
SY   Xeroderma Pigmentosum 19 BRighton
DR   JCRB; KURB1233
DR   Wikidata; Q102115127
RX   PubMed=21566739;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   XP19HO
AC   CVCL_ZR56
SY   Xeroderma Pigmentosum 19 HOuston
DR   Wikidata; Q98135384
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP19KO
AC   CVCL_ZM40
SY   Xeroderma Pigmentosum 19 KObe
DR   Wikidata; Q98135385
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP19KY
AC   CVCL_ZQ45
SY   Xeroderma Pigmentosum 19 KYoto
DR   Wikidata; Q98135387
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP19MA
AC   CVCL_ZR04
SY   Xeroderma Pigmentosum 19 MAnnheim
DR   Wikidata; Q98135390
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP19OS
AC   CVCL_ZM92
SY   Xeroderma Pigmentosum 19 OSaka
DR   JCRB; KURB1332
DR   Wikidata; Q98135393
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP19PV
AC   CVCL_RU42
SY   Xeroderma Pigmentosum 19 PaVia
DR   CLO; CLO_0009664
DR   CLDB; cl4757
DR   Wikidata; Q54994898
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Heterozygous (PubMed=10766188).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln368Argfs*6 (c.1103_1104delAA) (delAA1208-1209); ClinVar=VCV000267279; Zygosity=Heterozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   XP19SE
AC   CVCL_U867
SY   Xeroderma Pigmentosum 19 SEndai
DR   JCRB; KURB1183
DR   Wikidata; Q54994899
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8770 ! XP19SE LCL
SX   Male
AG   49Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 8
//
ID   XP19SE LCL
AC   CVCL_8770
SY   Xeroderma Pigmentosum 19 SEndai LCL; XPL 19; XPL19
DR   CLO; CLO_0050493
DR   BioSample; SAMN03471924
DR   RCB; RCB2539
DR   TKG; TKG 0312
DR   Wikidata; Q54995024
RX   PubMed=1906129;
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2539
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 10,13
ST   D7S820: 8,14
ST   TH01: 5,6
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U867 ! XP19SE
SX   Male
AG   49Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   XP1AA
AC   CVCL_L464
SY   GM03176; GM3176
DR   CLO; CLO_0013538
DR   BioSample; SAMN00808274
DR   Coriell; GM03176
DR   JCRB; KURB1062
DR   Wikidata; Q54837906
RX   CelloPub=CLPUB00447;
RX   PubMed=2570806;
RX   PubMed=6492896;
RX   PubMed=7059984;
RX   PubMed=7163956;
CC   Population: Indian.
CC   Senescence: Senesces at 21 PDL (PubMed=6492896).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   XP1AB
AC   CVCL_ZQ05
SY   Xeroderma Pigmentosum 1 ABerdeen
DR   Wikidata; Q98135395
RX   PubMed=11773631;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ser548Ter (c.1643C>A); Zygosity=Heterozygous (PubMed=11773631).
CC   Caution: The p.Ser548Ter (c.1643C>A) variant is incorrectly reported as p.Thr548Ter (c.1543C>A) in PubMed=11773631.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   51Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1AS
AC   CVCL_ZM57
SY   Xeroderma Pigmentosum 1 ASahikawa
DR   JCRB; KURB1249
DR   Wikidata; Q98135398
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1BE
AC   CVCL_H686
SY   Xeroderma Pigmentosum 1 BEthesda; Fo Leg; GM10881; GM10881B
DR   CLO; CLO_0023418
DR   ATCC; CRL-1170
DR   BioSample; SAMN00800310
DR   Coriell; GM10881
DR   Wikidata; Q54844715
RX   CelloPub=CLPUB00447;
RX   PubMed=273925;
RX   PubMed=1383811;
RX   PubMed=3724780;
RX   PubMed=4811796;
RX   PubMed=26184184;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys431Argfs*6 (c.1292_1293delAA) (1132_1133delAA); ClinVar=VCV000000256; Zygosity=Hemizygous or homozygous (PubMed=26184184).
CC   Discontinued: ATCC; CRL-1170; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H685 ! XP1BE LCL
SX   Female
AG   27Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   XP1BE LCL
AC   CVCL_H685
SY   Xeroderma Pigmentosum 1 BEthesda LCL; GM02246; GM-2246; GM2246; GM2246A; GM02246B
DR   CLO; CLO_0032149
DR   BioSample; SAMN00807626
DR   Coriell; GM02246
DR   Wikidata; Q54837388
RX   CelloPub=CLPUB00447;
RX   PubMed=1702221;
RX   PubMed=2805228;
RX   PubMed=8327515;
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys431Argfs*6 (c.1292_1293delAA) (1132_1133delAA); ClinVar=VCV000000256; Zygosity=Hemizygous or homozygous (from autologous cell line XP1BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H686 ! XP1BE
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   XP1BP
AC   CVCL_ZQ46
DR   Wikidata; Q98135400
RX   PubMed=2778352;
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1BR
AC   CVCL_M285
SY   Xeroderma Pigmentosum 1 BRighton; GM03615; GM 3615; GM3615
DR   CLO; CLO_0017190
DR   Coriell; GM03615
DR   JCRB; JCRB3064
DR   JCRB; KURB1067
DR   JCRB; KURB1068
DR   Wikidata; Q54838158
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=1372108;
RX   PubMed=3347209;
RX   PubMed=4066782;
RX   PubMed=6492896;
RX   PubMed=6947227;
RX   PubMed=7059984;
RX   PubMed=7471106;
RX   PubMed=8055625;
RX   PubMed=9012405;
RX   PubMed=9238033;
RX   PubMed=11219864;
RX   PubMed=14688028;
RX   PubMed=15572672;
RX   PubMed=18079351;
CC   Senescence: Senesces at 26 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (PubMed=9238033).
CC   Discontinued: JCRB; KURB1068; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3064
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10,12
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 21
//
ID   XP1CA
AC   CVCL_L767
SY   Xeroderma Pigmentosum 1 CAiro; XP1EG; GM02990; GM2990; GM 2990
DR   CLO; CLO_0012589
DR   BioSample; SAMN00808198
DR   Coriell; GM02990
DR   Wikidata; Q54837790
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2897722;
RX   PubMed=6442144;
RX   PubMed=6684957;
RX   PubMed=6947227;
RX   PubMed=7252263;
RX   PubMed=9671271;
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Thr125Ilefs*15 (c.374delC); ClinVar=VCV000267186; Zygosity=Homozygous (PubMed=9671271; Coriell=GM02990).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   XP1CB
AC   CVCL_ZR98
SY   Xeroderma Pigmentosum 1 CamBridge
DR   Wikidata; Q98135402
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP1CBJ
AC   CVCL_ZS33
SY   Xeroderma Pigmentosum 1 China BeiJing
DR   JCRB; KURB1259
DR   Wikidata; Q98135404
RX   PubMed=9536236;
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1CH [XP-V Caucasian]
AC   CVCL_ZP88
DR   Wikidata; Q98135407
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Phe247fs (c.738delC); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg356Ter (c.1066C>T); ClinVar=VCV001459259; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   XP1CH [XP-V Cherevan]
AC   CVCL_7372
SY   Xeroderma Pigmentosum 1 CHerevan; GM03055; GM3055
DR   CLO; CLO_0013505
DR   BioSample; SAMN00808230
DR   Coriell; GM03055
DR   Wikidata; Q54837843
RX   CelloPub=CLPUB00447;
RX   PubMed=7326997;
RX   PubMed=10398605;
CC   Population: Caucasian; Russian Armenian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Val125Ter (c.376C>T); Zygosity=Homozygous (PubMed=10398605).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   XP1CNX
AC   CVCL_ZS34
SY   Xeroderma Pigmentosum 1 China Ning Xia
DR   JCRB; KURB1260
DR   Wikidata; Q98135409
RX   PubMed=9536236;
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1CTA
AC   CVCL_ZS32
SY   Xeroderma Pigmentosum 1 China TAiwan
DR   JCRB; KURB1261
DR   Wikidata; Q98135411
RX   PubMed=1941768;
RX   PubMed=9457909;
CC   Population: Chinese; Taiwan.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y7M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1DU
AC   CVCL_ZN31
SY   Xeroderma Pigmentosum 1 DUndee
DR   Wikidata; Q98135413
RX   PubMed=1372096;
RX   PubMed=1372100;
RX   PubMed=9238033;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Trp (c.1846C>T); ClinVar=VCV000016788; Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS43 ! XP1DU LCL
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1DU LCL
AC   CVCL_ZS43
SY   Xeroderma Pigmentosum 1 DUndee LCL; LB103; 103
DR   Wikidata; Q98135416
RX   PubMed=1372096;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Trp (c.1846C>T); ClinVar=VCV000016788; Zygosity=Heterozygous (from autologous cell line XP1DU).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from autologous cell line XP1DU).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN31 ! XP1DU
SX   Female
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP1EH
AC   CVCL_ZP79
SY   Xeroderma Pigmentosum 1 EHime
DR   JCRB; KURB1022
DR   Wikidata; Q98135418
RX   PubMed=1814424;
RX   PubMed=2778352;
RX   PubMed=7905727;
RX   PubMed=8101209;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1EHF
AC   CVCL_ZW28
SY   Xeroderma Pigmentosum 1 EHime Father
DR   Wikidata; Q102115128
RX   PubMed=8101209;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (from familial inference of XP1EH).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   XP1EHM
AC   CVCL_ZW29
SY   Xeroderma Pigmentosum 1 EHime Mother
DR   Wikidata; Q102115129
RX   PubMed=8101209;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (from familial inference of XP1EH).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   XP1FI
AC   CVCL_ZQ48
DR   Wikidata; Q98135421
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1HEF
AC   CVCL_ZS14
SY   Xeroderma Pigmentosum 1 HElsinki Finland
DR   Wikidata; Q98135423
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1HM
AC   CVCL_ZQ49
SY   Xeroderma Pigmentosum 1 HamaMatsu
DR   Wikidata; Q98135427
RX   PubMed=2778352;
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1JO
AC   CVCL_M279
SY   Xeroderma Pigmentosum 1 JOhannesburg; GM02024; GM-2024; GM2024
DR   CLO; CLO_0032315
DR   BioSample; SAMN00807398
DR   Coriell; GM02024
DR   Wikidata; Q54837243
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African; Zulu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   XP1JTO
AC   CVCL_C3QP
SY   Xeroderma Pigmentosum 1 Japan TOkyo-I
DR   JCRB; KURB1225
DR   Wikidata; Q116050823
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   XP1KA
AC   CVCL_ZS73
SY   Xeroderma Pigmentosum 1 KAnazawa
DR   JCRB; KURB1269
DR   Wikidata; Q98135429
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1KC
AC   CVCL_M277
SY   Xeroderma Pigmentosum 1 Kansas City; GM01295; GM-1295; GM 1295; GM1295
DR   CLO; CLO_0030923
DR   BioSample; SAMN00803782
DR   Coriell; GM01295
DR   Wikidata; Q54836749
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1372108;
RX   PubMed=3010096;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   XP1KG
AC   CVCL_ZQ50
DR   JCRB; KURB1030
DR   Wikidata; Q98135432
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1KN
AC   CVCL_ZQ51
DR   Wikidata; Q98135434
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1KO
AC   CVCL_ZN13
SY   Xeroderma Pigmentosum 1 KObe
DR   Wikidata; Q98135435
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1KR
AC   CVCL_ZQ31
DR   Wikidata; Q98135437
RX   PubMed=8105686;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP1KS
AC   CVCL_D5J3
DR   JCRB; KURB1178
DR   Wikidata; Q127384728
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Finite cell line
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   XP1KU
AC   CVCL_ZR73
SY   XP1KUR; Xeroderma Pigmentosum 1 KUrashiki
DR   JCRB; KURB2886
DR   JCRB; KURB2888
DR   JCRB; KURB2889
DR   Wikidata; Q98135440
RX   PubMed=2570806;
CC   Population: Japanese.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   XP1KU clone-14
AC   CVCL_ZR74
SY   XP1KU cl-14; Xeroderma Pigmentosum 1 KUrashiki clone-14
DR   Wikidata; Q98135443
RX   PubMed=2570806;
CC   Population: Japanese.
CC   Characteristics: UV-resistant.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZR73 ! XP1KU
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   XP1KU clone-2
AC   CVCL_ZR75
SY   XP1KU cl-2; Xeroderma Pigmentosum 1 KUrashiki clone-2
DR   Wikidata; Q98135445
RX   PubMed=2570806;
CC   Population: Japanese.
CC   Characteristics: UV-sensitive.
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZR73 ! XP1KU
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   XP1KU-14(SV)
AC   CVCL_ZR76
SY   XP1Ku-14(SV)
DR   JCRB; KURB2891
DR   Wikidata; Q98135448
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZR74 ! XP1KU clone-14
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   XP1KU-2(SV)
AC   CVCL_ZR77
SY   XP1Ku-2(SV)
DR   JCRB; KURB2890
DR   Wikidata; Q98135450
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Chest, skin; UBERON=UBERON_0001868.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZR75 ! XP1KU clone-2
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-09-24; Version: 8
//
ID   XP1KUHM
AC   CVCL_ZR78
SY   XP1KuHM; Xeroderma Pigmentosum 1 KUrashiki Heterozygote Mother
DR   JCRB; KURB2892
DR   Wikidata; Q98135452
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1KUHF
AC   CVCL_ZR79
SY   XP1KuHF; Xeroderma Pigmentosum 1 KUrashiki Heterozygote Father
DR   JCRB; KURB2893
DR   Wikidata; Q98135454
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1KY
AC   CVCL_JM13
SY   Xeroderma Pigmentosum 1 KYoto
DR   JCRB; KURB1273
DR   Wikidata; Q54994900
RX   PubMed=2451128;
RX   PubMed=3185589;
RX   PubMed=7000335;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 7
//
ID   XP1LO
AC   CVCL_U674
SY   Xeroderma Pigmentosum 1 LOndon; Re Ko
DR   ATCC; CRL-1202
DR   Wikidata; Q54949567
RX   PubMed=273925;
RX   PubMed=2065254;
CC   Discontinued: ATCC; CRL-1202; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   XP1MA
AC   CVCL_ZR22
SY   Xeroderma Pigmentosum 1 MAnnheim
DR   JCRB; KURB1282
DR   Wikidata; Q98135456
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
RX   PubMed=14705792;
CC   Population: Caucasian; Italian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359Valfs*32 (c.1075_1244del170) (Ex10del); Zygosity=Homozygous (PubMed=14705792).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   XP1MG
AC   CVCL_XE09
DR   JCRB; KURB1001
DR   Wikidata; Q98135459
RX   PubMed=2778352;
RX   PubMed=7905727;
RX   PubMed=9025096;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 10
//
ID   XP1MI 1
AC   CVCL_U763
SY   Xeroderma Pigmentosum 1 Miami 1; XPBHBE
DR   ATCC; CRL-1333
DR   Wikidata; Q54994979
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro334His (c.1001C>A); ClinVar=VCV000000253; Zygosity=Homozygous (from autologous cell line XP1MI 2).
CC   Discontinued: ATCC; CRL-1333; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7351 ! XP1MI 2
OI   CVCL_F029 ! XP1MI LCL
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   XP1MI 2
AC   CVCL_7351
SY   Xeroderma Pigmentosum 1 Miami 2; GM02096; GM-2096; GM 2096; GM2096
DR   CLO; CLO_0031821
DR   BioSample; SAMN00807484
DR   Coriell; GM02096
DR   Wikidata; Q54837300
RX   CelloPub=CLPUB00447;
RX   PubMed=3003928;
RX   PubMed=6492896;
RX   PubMed=7389185;
RX   PubMed=18809580;
RX   PubMed=23665875;
CC   Population: African American.
CC   Senescence: Senesces at 24 PDL (PubMed=3003928; PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro334His (c.1001C>A); ClinVar=VCV000000253; Zygosity=Homozygous (PubMed=18809580).
CC   Omics: Variations; CNV analysis.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U763 ! XP1MI 1
OI   CVCL_F029 ! XP1MI LCL
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   XP1MI LCL
AC   CVCL_F029
SY   Xeroderma Pigmentosum 1 Miami LCL; GM02634
DR   CLO; CLO_0015033
DR   Coriell; GM02634
DR   Wikidata; Q54837594
RX   CelloPub=CLPUB00447;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro334His (c.1001C>A); ClinVar=VCV000000253; Zygosity=Homozygous (from autologous cell line XP1MI 2).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U763 ! XP1MI 1
OI   CVCL_7351 ! XP1MI 2
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 17
//
ID   XP1MY
AC   CVCL_ZS25
DR   JCRB; KURB1301
DR   Wikidata; Q98135461
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1NA
AC   CVCL_ZN15
SY   Xeroderma Pigmentosum 1 NAgoya
DR   Wikidata; Q98135464
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1NBi
AC   CVCL_M232
SY   Xeroderma Pigmentosum 1 NairoBi; GM00523; GM-523; GM523; GM00523A
DR   CLO; CLO_0025931
DR   Coriell; GM00523
DR   Wikidata; Q54836289
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African; Kikuyu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   XP1NE
AC   CVCL_J997
SY   Xeroderma Pigmentosum 1 NEwscastle; GM00436; GM-436; GM 0436; GM436
DR   CLO; CLO_0026114
DR   Coriell; GM00436
DR   Wikidata; Q54836220
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1372096;
RX   PubMed=1372108;
RX   PubMed=7825573;
RX   PubMed=9238033;
RX   PubMed=18079351;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly47Arg (c.139G>A); ClinVar=VCV001176084; Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS45 ! XP1NE LCL
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   XP1NE LCL
AC   CVCL_ZS45
SY   Xeroderma Pigmentosum 1 NEwscastle LCL; LB 309; LB309; 309
DR   Wikidata; Q98135465
RX   PubMed=1372096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly47Arg (c.139G>A); ClinVar=VCV001176084; Zygosity=Heterozygous (from autologous cell line XP1NE).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (from autologous cell line XP1NE).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (from autologous cell line XP1NE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_J997 ! XP1NE
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   XP1NI
AC   CVCL_ZQ52
DR   Wikidata; Q98135467
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZQ65 ! XP1Ni(EB-L)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1Ni(EB-L)
AC   CVCL_ZQ65
DR   JCRB; KURB1315
DR   Wikidata; Q98135469
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from autologous cell line XP1NI).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZQ52 ! XP1NI
SX   Male
AG   17Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1NO
AC   CVCL_ZV06
DR   Wikidata; Q98135471
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ser51Glufs*3 (c.149dupT); ClinVar=VCV000631984; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP1NY
AC   CVCL_ZP91
DR   Wikidata; Q98135473
RX   PubMed=837385;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1OS
AC   CVCL_ZM79
SY   Xeroderma Pigmentosum 1 OSaka
DR   JCRB; KURB1316
DR   Wikidata; Q98135475
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1PD
AC   CVCL_L758
SY   GM02009; GM-2009; GM2009
DR   CLO; CLO_0032301
DR   BioSample; SAMN00807380
DR   Coriell; GM02009
DR   JCRB; KURB1028
DR   Wikidata; Q54837234
RX   CelloPub=CLPUB00447;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=3010096;
RX   PubMed=3030788;
RX   PubMed=9671271;
RX   PubMed=26184184;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Cys108Phe (c.323G>T); ClinVar=VCV000000993; Zygosity=Heterozygous (PubMed=9671271; PubMed=26184184).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Leu117Glufs*4 (c.349_353delCTTAT) (349del5); ClinVar=VCV000000994; Zygosity=Heterozygous (PubMed=9671271; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   XP1PO
AC   CVCL_F506
SY   GM05424; GM 5424; GM5424
DR   CLO; CLO_0024796
DR   Coriell; GM05424
DR   JCRB; KURB1069
DR   JCRB; KURB1070
DR   Wikidata; Q54839016
RX   CelloPub=CLPUB00447;
RX   PubMed=1372108;
RX   PubMed=2570806;
RX   PubMed=7163956;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   XP1PR
AC   CVCL_ZR81
DR   Wikidata; Q98135476
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP1PW
AC   CVCL_L930
SY   GM00510; GM0510; GM-510
DR   CLO; CLO_0025939
DR   Coriell; GM00510
DR   JCRB; KURB1057
DR   Wikidata; Q54836278
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6622549;
CC   Population: Arab.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 14
//
ID   XP1RO
AC   CVCL_ZP95
SY   Xeroderma Pigmentosum 1 ROtterdam
DR   Wikidata; Q98135478
RX   PubMed=4778857;
RX   PubMed=10385124;
RX   PubMed=11773631;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Trp297Ter (c.890G>A); ClinVar=VCV000005888; Zygosity=Heterozygous (PubMed=10385124).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Unexplicit; Large deletion; Zygosity=Heterozygous (PubMed=10385124).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1SA [Salisbury]
AC   CVCL_ZR80
SY   Xeroderma Pigmentosum 1 SAlisbury
DR   Wikidata; Q98135482
RX   PubMed=16947863;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (PubMed=16947863).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Arg425Ter (c.1273C>T); ClinVar=VCV000016585; Zygosity=Heterozygous (PubMed=16947863).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3966; Xeroderma pigmentosum, complementation group B
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1SA [Santiago]
AC   CVCL_X781
SY   Xeroderma Pigmentosum 1 SAntiago; AG02872; AG2872
DR   CLO; CLO_0037009
DR   BioSamples; SAME58122
DR   Coriell; AG02872
DR   Wikidata; Q54609713
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   PubMed=7253718;
CC   Population: Chilean.
CC   Derived from site: In situ; Sacrum, skin; UBERON=UBERON_8480024.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   24Y
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 29-06-23; Version: 13
//
ID   XP1SA [Sapporo]
AC   CVCL_JG70
SY   Xeroderma Pigmentosum 1 SApporo
DR   JCRB; KURB1122
DR   Wikidata; Q54994901
RX   PubMed=7830260;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 9
//
ID   XP1SE [Sendai]
AC   CVCL_ZM62
SY   Xeroderma Pigmentosum 1 SEndai
DR   Wikidata; Q98135484
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   38Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1SE [Seoul]
AC   CVCL_ZN95
SY   Xeroderma Pigmentosum 1 SEoul
DR   Wikidata; Q98135487
RX   PubMed=18368133;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP1SF
AC   CVCL_M293
SY   Xeroderma Pigmentosum 1 San Fransisco; GM06090; GM17013
DR   CLO; CLO_0018027
DR   CLO; CLO_0023614
DR   Coriell; GM06090
DR   Coriell; GM17013
DR   Wikidata; Q54842157
RX   CelloPub=CLPUB00447;
RX   PubMed=10398605;
CC   Part of: Human variation panel.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln23Ter (c.67C>T); Zygosity=Homozygous (PubMed=10398605).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP1SH
AC   CVCL_ZV07
DR   Wikidata; Q98135488
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu149Lysfs*18 (c.441_442GA[2]) (c.444_445delAG) (c.445_446delGA) (GA444,445 del-2); ClinVar=VCV000557065; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Leu779fs (c.2336delT); Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   27Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1TA
AC   CVCL_ZQ20
SY   Xeroderma Pigmentosum 1 Tel Aviv
DR   Wikidata; Q98135490
RX   PubMed=11121128;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP1TS
AC   CVCL_UH40
DR   JCRB; KURB1086
DR   Wikidata; Q98135492
RX   PubMed=9580660;
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Val605_Gly611del (c.1812_1832del); Zygosity=Hemizygous or homozygous (PubMed=9580660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 8
//
ID   XP1TUF
AC   CVCL_ZS16
SY   Xeroderma Pigmentosum 1 TUrku Finland
DR   Wikidata; Q98135494
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gly95Arg (c.283G>A); Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP1UTSW
AC   CVCL_ZP83
SY   S05-5125
DR   Wikidata; Q98135496
RX   PubMed=17079196;
RX   PubMed=17084680;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=17079196; PubMed=17084680).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gly810Alafs*9 (c.2429_2441del13); Zygosity=Heterozygous (PubMed=17079196; PubMed=17084680).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP1WA
AC   CVCL_M278
SY   GM02004; GM-2004; GM2004
DR   CLO; CLO_0032296
DR   BioSample; SAMN00807374
DR   Coriell; GM02004
DR   Wikidata; Q54837230
RX   CelloPub=CLPUB00447;
RX   PubMed=7163956;
RX   PubMed=26184184;
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 16
//
ID   XP1YO
AC   CVCL_ZN14
SY   Xeroderma Pigmentosum 1 YOnago
DR   JCRB; KURB1379
DR   Wikidata; Q98135498
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP202BA LCL
AC   CVCL_ZU56
DR   Wikidata; Q98135500
RX   PubMed=16990803;
CC   Population: Guatemalan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg314Glyfs*10 (c.940delC) (C940del-1); ClinVar=VCV003588617; Zygosity=Homozygous (PubMed=16990803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   XP202DC
AC   CVCL_ZP22
DR   Wikidata; Q98135502
RX   CelloPub=CLPUB00562;
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; c.604-26G>A; Zygosity=Heterozygous (CelloPub=CLPUB00562).
CC   Sequence variation: Mutation; HGNC; HGNC:3433; ERCC1; Simple; p.Lys226Ter (c.676A>T); ClinVar=VCV000264678; Zygosity=Heterozygous (CelloPub=CLPUB00562).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15-37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP207SF
AC   CVCL_ZU54
SY   Xeroderma Pigmentosum 207 San Fransisco
DR   Wikidata; Q98135504
RX   PubMed=16990803;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Asp121Alafs*26 (c.362delA) (A362del-1); ClinVar=VCV002679647; Zygosity=Heterozygous (from autologous cell line XP207SF LCL).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu149Lysfs*18 (c.441_442GA[2]) (c.444_445delAG) (c.445_446delGA) (GA444,445 del-2); ClinVar=VCV000557065; Zygosity=Heterozygous (from autologous cell line XP207SF LCL).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU55 ! XP207SF LCL
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   XP207SF LCL
AC   CVCL_ZU55
SY   Xeroderma Pigmentosum 207 San Fransisco LCL
DR   Wikidata; Q98135506
RX   PubMed=16990803;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Asp121Alafs*26 (c.362delA) (A362del-1); ClinVar=VCV002679647; Zygosity=Heterozygous (PubMed=16990803).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu149Lysfs*18 (c.441_442GA[2]) (c.444_445delAG) (c.445_446delGA) (GA444,445 del-2); ClinVar=VCV000557065; Zygosity=Heterozygous (PubMed=16990803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZU54 ! XP207SF
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   XP20BE
AC   CVCL_V577
SY   Xeroderma Pigmentosum 20 BEthesda; AG08803
DR   CLO; CLO_0031381
DR   Coriell; AG08803
DR   Wikidata; Q54742529
RX   CelloPub=CLPUB00597;
RX   PubMed=8823375;
RX   PubMed=9447232;
RX   PubMed=11841555;
RX   PubMed=12060391;
RX   PubMed=15572672;
RX   PubMed=18079351;
RX   PubMed=19179371;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu11Ter (c.31G>T); Zygosity=Heterozygous (from autologous cell line XP20BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V576 ! XP20BE LCL
SX   Male
AG   1Y5M
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   XP20BE LCL
AC   CVCL_V576
SY   Xeroderma Pigmentosum 20 BEthesda LCL; AG08802
DR   CLO; CLO_0031382
DR   Coriell; AG08802
DR   Wikidata; Q54742488
RX   CelloPub=CLPUB00597;
RX   PubMed=8823375;
RX   PubMed=9447232;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Glu11Ter (c.31G>T); Zygosity=Heterozygous (PubMed=9447232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V577 ! XP20BE
SX   Male
AG   1Y5M
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 14
//
ID   XP20BR
AC   CVCL_ZR89
SY   Xeroderma Pigmentosum 20 BRighton
DR   Wikidata; Q98135509
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP20KO
AC   CVCL_ZM41
SY   Xeroderma Pigmentosum 20 KObe
DR   Wikidata; Q98135511
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP20MA
AC   CVCL_M294
SY   Xeroderma Pigmentosum 20 MAnnheim; GM09653
DR   CLO; CLO_0026470
DR   Coriell; GM09653
DR   JCRB; KURB1108
DR   JCRB; KURB1109
DR   Wikidata; Q54843930
RX   CelloPub=CLPUB00447;
RX   PubMed=2054785;
RX   PubMed=2175267;
RX   PubMed=2570806;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   XP20OS
AC   CVCL_ZM93
SY   Xeroderma Pigmentosum 20 OSaka
DR   JCRB; KURB1179
DR   Wikidata; Q98135513
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP20PV
AC   CVCL_ZM12
SY   Xeroderma Pigmentosum 20 PaVia
DR   Wikidata; Q98135516
RX   PubMed=9584159;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP20RO
AC   CVCL_ZR57
SY   Xeroderma Pigmentosum 20 ROtterdam
DR   JCRB; KURB1065
DR   Wikidata; Q98135517
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP20SE
AC   CVCL_ZS49
SY   Xeroderma Pigmentosum 20 SEndai
DR   Wikidata; Q98135521
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8771 ! XP20SE LCL
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP20SE LCL
AC   CVCL_8771
SY   Xeroderma Pigmentosum 20 SEndai LCL; XPL 20; XPL20
DR   CLO; CLO_0050477
DR   BioSample; SAMN03471956
DR   RCB; RCB2287
DR   TKG; TKG 0313
DR   Wikidata; Q54995025
RX   PubMed=1906129;
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2287; TKG=TKG 0313
ST   Amelogenin: X,Y
ST   CSF1PO: 13,14
ST   D13S317: 12,14
ST   D16S539: 10,13
ST   D5S818: 9,12
ST   D7S820: 11,12
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS49 ! XP20SE
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   XP211BA LCL
AC   CVCL_ZU57
DR   Wikidata; Q98135522
RX   PubMed=16990803;
CC   Population: Guatemalan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg314Glyfs*10 (c.940delC) (C940del-1); ClinVar=VCV003588617; Zygosity=Heterozygous (PubMed=16990803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   XP212BA LCL
AC   CVCL_ZU58
DR   Wikidata; Q98135524
RX   PubMed=16990803;
CC   Population: Guatemalan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg314Glyfs*10 (c.940delC) (C940del-1); ClinVar=VCV003588617; Zygosity=Heterozygous (PubMed=16990803).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 7
//
ID   XP218BE LCL
AC   CVCL_M325
SY   Xeroderma Pigmentosum 218 BEthesda LCL; GM17571
DR   CLO; CLO_0013033
DR   Coriell; GM17571
DR   Wikidata; Q54848971
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   XP21BE
AC   CVCL_M296
SY   Xeroderma Pigmentosum 21 BEthesda; GM09943
DR   CLO; CLO_0029754
DR   Coriell; GM09943
DR   Wikidata; Q54844130
RX   CelloPub=CLPUB00447;
RX   PubMed=12665480;
RX   PubMed=18955168;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Met1Arg (c.2T>G); ClinVar=VCV001066146; Zygosity=Homozygous (PubMed=18955168).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M295 ! XP21BE LCL
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP21BE LCL
AC   CVCL_M295
SY   Xeroderma Pigmentosum 21 BEthesda LCL; GM09942
DR   CLO; CLO_0029757
DR   Coriell; GM09942
DR   Wikidata; Q54844129
RX   CelloPub=CLPUB00447;
RX   PubMed=9804340;
RX   PubMed=18955168;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Met1Arg (c.2T>G); ClinVar=VCV001066146; Zygosity=Homozygous (PubMed=18955168).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M296 ! XP21BE
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP21BR
AC   CVCL_ZV08
SY   Xeroderma Pigmentosum 21 BRighton
DR   Wikidata; Q98135526
RX   PubMed=26884178;
CC   Population: Middle Eastern.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000550020; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   39Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP21HM
AC   CVCL_ZQ67
SY   Xeroderma Pigmentosum 21 HamaMatsu
DR   Wikidata; Q98135528
RX   PubMed=20574439;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=20574439).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Thr260Ilefs*8 (c.779delCinsTTCTT) (779insTT) (780insTT); Zygosity=Heterozygous (PubMed=20574439).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP21KO
AC   CVCL_ZM42
SY   Xeroderma Pigmentosum 21 KObe
DR   Wikidata; Q98135530
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP21MA
AC   CVCL_ZR26
SY   Xeroderma Pigmentosum 21 MAnnheim
DR   Wikidata; Q98135532
RX   PubMed=2054785;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP21OS
AC   CVCL_ZM94
SY   Xeroderma Pigmentosum 21 OSaka
DR   JCRB; KURB1119
DR   JCRB; KURB1120
DR   Wikidata; Q98135535
RX   PubMed=832273;
RX   PubMed=7830260;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP21PV
AC   CVCL_RU43
SY   Xeroderma Pigmentosum 21 PaVia
DR   CLO; CLO_0009665
DR   CLDB; cl4758
DR   Wikidata; Q54994902
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   XP21RO
AC   CVCL_M276
SY   Xeroderma Pigmentosum 21 ROtterdam; GM00709; GM-709; GM00709A
DR   CLO; CLO_0028891
DR   Coriell; GM00709
DR   Wikidata; Q54836401
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4778857;
RX   PubMed=6096694;
RX   PubMed=7825573;
RX   PubMed=9804340;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000550020; Zygosity=Homozygous (from familial inference of XP4RO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP21SE LCL
AC   CVCL_ZS50
SY   Xeroderma Pigmentosum 21 SEndai LCL; XPL 21; XPL21
DR   Wikidata; Q98135538
RX   PubMed=6529424;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   XP221BE
AC   CVCL_L971
SY   Xeroderma Pigmentosum 221 BEthesda; GM16802
DR   CLO; CLO_0018404
DR   Coriell; GM16802
DR   Wikidata; Q54848753
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L970 ! XP221BE LCL
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   XP221BE LCL
AC   CVCL_L970
SY   Xeroderma Pigmentosum 221 BEthesda LCL; GM16801
DR   CLO; CLO_0018396
DR   BioSample; SAMN00804703
DR   Coriell; GM16801
DR   Wikidata; Q54848751
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L971 ! XP221BE
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   XP224BE
AC   CVCL_ZP03
SY   Xeroderma Pigmentosum 224 BEthesda; GM16818
DR   Coriell; GM16818
DR   Wikidata; Q98135540
RX   PubMed=18368133;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ser51Glufs*3 (c.149dupT); ClinVar=VCV000631984; Zygosity=Heterozygous (PubMed=18368133).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys220Glu (c.658A>G); Zygosity=Heterozygous (PubMed=18368133).
CC   Discontinued: Coriell; GM16818; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP226BA
AC   CVCL_ZU53
DR   Wikidata; Q98135542
RX   PubMed=27543334;
CC   Population: Guatemalan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg314Glyfs*10 (c.940delC) (C940del-1); ClinVar=VCV003588617; Zygosity=Homozygous (PubMed=27543334).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   XP22BE
AC   CVCL_ZN55
SY   Xeroderma Pigmentosum 22 BEthesda
DR   Wikidata; Q98135543
RX   PubMed=9804340;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2033+2T>G (IVS9+2T>G); ClinVar=VCV000000257; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=9804340).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M309 ! XP22BE LCL
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP22BE LCL
AC   CVCL_M309
SY   Xeroderma Pigmentosum 22 BEthesda LCL; GM13817; GM17090
DR   CLO; CLO_0014523
DR   CLO; CLO_0033592
DR   BioSample; SAMN00802652
DR   Coriell; GM13817
DR   Coriell; GM17090
DR   Wikidata; Q54846816
RX   PubMed=9804340;
CC   Part of: Human variation panel.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2033+2T>G (IVS9+2T>G); ClinVar=VCV000000257; Zygosity=Homozygous; Note=Splice donor mutation (Coriell=GM17090).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN55 ! XP22BE
SX   Male
AG   4Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   XP22BR
AC   CVCL_ZV09
SY   Xeroderma Pigmentosum 22 BRighton
DR   Wikidata; Q98135546
RX   PubMed=26884178;
CC   Population: Middle Eastern.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000550020; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP22KO
AC   CVCL_ZM43
SY   Xeroderma Pigmentosum 22 KObe
DR   Wikidata; Q98135548
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP22KY
AC   CVCL_ZQ53
SY   Xeroderma Pigmentosum 22 KYoto
DR   Wikidata; Q98135551
RX   PubMed=7905727;
RX   PubMed=8101209;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP22MA
AC   CVCL_ZR27
SY   Xeroderma Pigmentosum 22 MAnnheim
DR   Wikidata; Q98135553
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP22OS
AC   CVCL_ZM95
SY   Xeroderma Pigmentosum 22 OSaka
DR   JCRB; KURB1333
DR   Wikidata; Q98135554
RX   PubMed=7947212;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7947212).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP22PV
AC   CVCL_RU44
SY   Xeroderma Pigmentosum 22 PaVia
DR   CLO; CLO_0009666
DR   CLDB; cl4759
DR   Wikidata; Q54994903
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   XP22SE LCL
AC   CVCL_ZS51
SY   Xeroderma Pigmentosum 22 SEndai LCL; XPL 22; XPL22
DR   Wikidata; Q98135556
RX   PubMed=6529424;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   XP22VI
AC   CVCL_ZN43
SY   Xeroderma Pigmentosum 22 VIllejuif
DR   Wikidata; Q98135558
RX   PubMed=9238033;
RX   PubMed=14688028;
RX   PubMed=18676829;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP233VI
AC   CVCL_ZN46
SY   Xeroderma Pigmentosum 233 VIllejuif
DR   Wikidata; Q98135560
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP23BE
AC   CVCL_X828
SY   Xeroderma Pigmentosum 23 BEthesda; AG10032
DR   CLO; CLO_0021880
DR   Coriell; AG10032
DR   Wikidata; Q54743196
RX   CelloPub=CLPUB00597;
RX   PubMed=16081512;
RX   PubMed=16714754;
RX   PubMed=18079351;
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=16081512).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X829 ! XP23BE LCL
SX   Male
AG   21Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   XP23BE iPSC
AC   CVCL_C7PD
SY   AG28409; AG28409*B
DR   Coriell; AG28409
DR   Wikidata; Q117705021
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_X828 ! XP23BE
SX   Male
AG   21Y4M
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 3
//
ID   XP23BE LCL
AC   CVCL_X829
SY   Xeroderma Pigmentosum 23 BEthesda LCL; AG10033
DR   CLO; CLO_0021881
DR   Coriell; AG10033
DR   Wikidata; Q54743198
RX   CelloPub=CLPUB00597;
RX   PubMed=18368133;
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=AG10033).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X828 ! XP23BE
SX   Male
AG   21Y4M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   XP23CA
AC   CVCL_V267
SY   Xeroderma Pigmentosum 23 CAiro; AG06929; AG6929
DR   CLO; CLO_0035477
DR   Coriell; AG06929
DR   Wikidata; Q54740455
RX   CelloPub=CLPUB00597;
RX   PubMed=9671271;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=9671271; Coriell=AG06929).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   XP23MA
AC   CVCL_ZR28
SY   Xeroderma Pigmentosum 23 MAnnheim
DR   Wikidata; Q98135564
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP23OS
AC   CVCL_UH39
SY   Xeroderma Pigmentosum 23 OSaka
DR   JCRB; KURB1087
DR   JCRB; KURB1088
DR   Wikidata; Q98135566
RX   PubMed=3834095;
RX   PubMed=4066782;
RX   PubMed=6492896;
RX   PubMed=9580660;
RX   PubMed=20221251;
CC   Population: Japanese.
CC   Senescence: Senesces at 17 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Glu456Glyfs*8 (c.1364dupA); Zygosity=Hemizygous or homozygous (PubMed=9580660).
CC   Misspelling: XP230S; Note=Occasionally.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   XP23PV
AC   CVCL_RU45
SY   Xeroderma Pigmentosum 23 PaVia
DR   CLO; CLO_0009667
DR   CLDB; cl4760
DR   Wikidata; Q54994905
RX   PubMed=9584159;
RX   PubMed=12812979;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Unexplicit; IVS7+1G>T (c.703_1023del321) (p.Leu235_Lys341del); Zygosity=Homozygous; Note=Splice donor mutation (PubMed=12812979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 10
//
ID   XP23SE LCL
AC   CVCL_ZS52
SY   Xeroderma Pigmentosum 23 SEndai LCL; XPL 23; XPL23
DR   Wikidata; Q98135568
RX   PubMed=6529424;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   XP23VI
AC   CVCL_ZN44
SY   Xeroderma Pigmentosum 23 VIllejuif
DR   Wikidata; Q98135570
RX   PubMed=9238033;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP24BE
AC   CVCL_M302
SY   Xeroderma Pigmentosum 24 BEthesda; GM11638
DR   CLO; CLO_0021324
DR   Coriell; GM11638
DR   Wikidata; Q54845210
RX   PubMed=18955168;
CC   Population: Caucasian; Hungarian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg155Ter (c.463C>T); ClinVar=VCV000496268; Zygosity=Heterozygous (Coriell=GM11638).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>G (IVS5.1-2A>G); ClinVar=VCV000550100; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM11638).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M301 ! XP24BE LCL
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 19
//
ID   XP24BE LCL
AC   CVCL_M301
SY   Xeroderma Pigmentosum 24 BEthesda LCL; GM11637
DR   CLO; CLO_0021323
DR   Coriell; GM11637
DR   Wikidata; Q54845208
RX   PubMed=16081512;
CC   Population: Caucasian; Hungarian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg155Ter (c.463C>T); ClinVar=VCV000496268; Zygosity=Heterozygous (PubMed=16081512).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>G (IVS5.1-2A>G); ClinVar=VCV000550100; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=16081512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M302 ! XP24BE
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 21
//
ID   XP24BR
AC   CVCL_ZP51
SY   Xeroderma Pigmentosum 24 BRighton
DR   Wikidata; Q98135572
RX   PubMed=20221251;
RX   PubMed=21566739;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg589Trp (c.1765C>T); ClinVar=VCV000055829; Zygosity=Heterozygous (PubMed=20221251; PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Heterozygous (PubMed=20221251; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP24HM
AC   CVCL_ZQ71
SY   Xeroderma Pigmentosum 24 HamaMatsu
DR   Wikidata; Q98135575
RX   PubMed=20574439;
RX   PubMed=27603812;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=20574439; PubMed=27603812).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP24KO
AC   CVCL_F514
SY   Xeroderma Pigmentosum 24 KObe
DR   JCRB; JCRB3012
DR   JCRB; KURB1081
DR   Wikidata; Q54994906
RX   PubMed=1376435;
RX   PubMed=1702221;
RX   PubMed=3341805;
RX   PubMed=3922833;
RX   PubMed=3974603;
RX   PubMed=4011712;
RX   PubMed=10771487;
RX   PubMed=22466610;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Lys123Ter (c.367A>T); ClinVar=VCV000031569; Zygosity=Homozygous (PubMed=22466610).
CC   Omics: Genomics; Whole exome sequencing.
CC   Discontinued: JCRB; KURB1081; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173107; UV-sensitive syndrome 3
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 16
//
ID   XP24KY
AC   CVCL_UH41
SY   Xeroderma Pigmentosum 24 KYoto
DR   JCRB; JCRB3074
DR   JCRB; KURB1089
DR   Wikidata; Q98135578
RX   PubMed=9580660;
RX   PubMed=20221251;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg454Trp (c.1360A>T) (R443W); Zygosity=Heterozygous (PubMed=9580660).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Asn537Argfs*8 (c.1608_1617del); Zygosity=Heterozygous (PubMed=9580660).
CC   Discontinued: JCRB; KURB1089; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3074
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,12
ST   D5S818: 10,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   XP24MA
AC   CVCL_ZR29
SY   Xeroderma Pigmentosum 24 MAnnheim
DR   Wikidata; Q98135580
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7059984;
RX   PubMed=7161312;
RX   PubMed=7165374;
RX   PubMed=14705792;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys220fs (c.661_764del); Zygosity=Homozygous (PubMed=14705792).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   XP24OS
AC   CVCL_ZM96
SY   Xeroderma Pigmentosum 24 OSaka
DR   JCRB; KURB1180
DR   Wikidata; Q98135582
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP24PV
AC   CVCL_RU46
SY   Xeroderma Pigmentosum 24 PaVia
DR   CLO; CLO_0009668
DR   CLDB; cl4761
DR   Wikidata; Q54994908
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
ID   XP24SE LCL
AC   CVCL_8772
SY   Xeroderma Pigmentosum 24 SEndai LCL; XPL 24; XPL24
DR   CLO; CLO_0051021
DR   BioSample; SAMN03471925
DR   RCB; RCB2540
DR   TKG; TKG 0314
DR   Wikidata; Q54995026
RX   PubMed=6529424;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB2540
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 10,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 16
//
ID   XP24VI
AC   CVCL_ZR33
SY   Xeroderma Pigmentosum 24 VIllejuif
DR   Wikidata; Q98135584
RX   PubMed=9415314;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   5Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP25BE
AC   CVCL_M288
SY   Xeroderma Pigmentosum 25 BEthesda; GM04489; KR04489
DR   CLO; CLO_0019667
DR   BioSample; SAMN00795295
DR   Coriell; GM04489
DR   Wikidata; Q54838536
RX   PubMed=18955168;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2251-1_-2delAG (IVS11-1_IVS11-2delAG); Zygosity=Homozygous (Coriell=GM04489).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS11-6_IVS11-7insCC; Zygosity=Homozygous (Coriell=GM04489).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M289 ! XP25BE LCL
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP25BE LCL
AC   CVCL_M289
SY   Xeroderma Pigmentosum 25 BEthesda LCL; GM04490; KR04490
DR   CLO; CLO_0019668
DR   BioSample; SAMN00795297
DR   Coriell; GM04490
DR   Wikidata; Q54838537
RX   PubMed=16081512;
CC   Population: African American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS11-1_IVS11-2delAG; Zygosity=Homozygous (PubMed=16081512).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS11-6_IVS11-7insCC; Zygosity=Homozygous (PubMed=16081512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M288 ! XP25BE
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP25KO
AC   CVCL_ZM25
SY   Xeroderma Pigmentosum 25 KObe
DR   Wikidata; Q98135586
RX   PubMed=3341805;
RX   PubMed=3834095;
RX   PubMed=3922833;
RX   PubMed=4011712;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP25OS
AC   CVCL_ZM97
SY   Xeroderma Pigmentosum 25 OSaka
DR   JCRB; KURB1034
DR   Wikidata; Q98135588
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP25PV
AC   CVCL_ZM13
SY   Xeroderma Pigmentosum 25 PaVia
DR   Wikidata; Q98135590
RX   PubMed=9584159;
RX   PubMed=12812979;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Asp307Tyr (c.919G>T); ClinVar=VCV000008790; Zygosity=Homozygous (PubMed=12812979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP25RO
AC   CVCL_F493
SY   XP-25; Xeroderma Pigmentosum 25 ROtterdam; GM00710; GM-710; GM0710; GM710; GM 0710A; GM710A; GM00710A
DR   CLO; CLO_0028892
DR   ATCC; CRL-1261
DR   Coriell; GM00710
DR   JCRB; KURB1039
DR   Wikidata; Q54836402
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=643622;
RX   PubMed=837385;
RX   PubMed=1034206;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=4436596;
RX   PubMed=4778857;
RX   PubMed=4842087;
RX   PubMed=6096694;
RX   PubMed=6622549;
RX   PubMed=7161312;
RX   PubMed=8317483;
RX   PubMed=8643543;
RX   PubMed=9671271;
RX   PubMed=15450399;
RX   PubMed=22282976;
RX   PubMed=30165384;
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Homozygous (PubMed=1372102; PubMed=9671271; Coriell=GM00710).
CC   Discontinued: ATCC; CRL-1261; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   XP25SE LCL
AC   CVCL_ZS53
SY   Xeroderma Pigmentosum 25 SEndai LCL; XPL 25; XPL25
DR   Wikidata; Q98135591
RX   PubMed=6529424;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   XP25TA
AC   CVCL_F222
SY   GM16685; KR04047
DR   CLO; CLO_0017453
DR   Coriell; GM16685
DR   Wikidata; Q54848697
RX   PubMed=11121128;
RX   PubMed=16081512;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Homozygous (PubMed=11121128).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 16
//
ID   XP26BE
AC   CVCL_M300
SY   Xeroderma Pigmentosum 26 BEthesda; GM11636
DR   CLO; CLO_0021321
DR   BioSample; SAMN00800764
DR   Coriell; GM11636
DR   Wikidata; Q54845207
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M299 ! XP26BE LCL
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 11
//
ID   XP26BE LCL
AC   CVCL_M299
SY   Xeroderma Pigmentosum 26 BEthesda LCL; GM11635
DR   CLO; CLO_0021319
DR   Coriell; GM11635
DR   Wikidata; Q54845206
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M300 ! XP26BE
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   XP26BR
AC   CVCL_ZP52
SY   Xeroderma Pigmentosum 26 BRighton
DR   Wikidata; Q98135593
RX   PubMed=20221251;
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Homozygous (PubMed=20221251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP26KO
AC   CVCL_ZM28
SY   Xeroderma Pigmentosum 26 KObe
DR   Wikidata; Q98135595
RX   PubMed=3974603;
RX   PubMed=4011712;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   XP26KY
AC   CVCL_ZQ54
SY   Xeroderma Pigmentosum 26 KYoto
DR   Wikidata; Q98135597
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP26MA
AC   CVCL_ZR30
SY   Xeroderma Pigmentosum 26 MAnnheim
DR   Wikidata; Q98135601
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP26OS
AC   CVCL_ZM98
SY   Xeroderma Pigmentosum 26 OSaka
DR   JCRB; KURB1334
DR   Wikidata; Q98135603
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP26PV
AC   CVCL_ZN53
SY   Xeroderma Pigmentosum 26 PaVia
DR   Wikidata; Q98135604
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP26RO
AC   CVCL_JB72
AS   CVCL_B6J8
SY   Xeroderma Pigmentosum 26 ROtterdam; GM00518; GM0518; GM-518; GM 518
DR   Coriell; GM00518
DR   Wikidata; Q54836284
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=4436596;
RX   PubMed=4778857;
RX   PubMed=6087472;
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Homozygous (from familial inference of XP25RO).
CC   Discontinued: Coriell; GM00518; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 19-12-24; Version: 12
//
ID   XP26SE LCL
AC   CVCL_ZS54
SY   Xeroderma Pigmentosum 26 SEndai LCL; XPL 26; XPL26
DR   Wikidata; Q98135606
RX   PubMed=6529424;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   XP26VI
AC   CVCL_ZN45
SY   Xeroderma Pigmentosum 26 VIllejuif
DR   Wikidata; Q98135608
RX   PubMed=9238033;
RX   PubMed=14688028;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP27KO
AC   CVCL_ZM26
SY   Xeroderma Pigmentosum 27 KObe
DR   Wikidata; Q98135610
RX   PubMed=3834095;
RX   PubMed=4011712;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP27MA
AC   CVCL_ZR21
SY   Xeroderma Pigmentosum 27 MAnnheim
DR   Wikidata; Q98135613
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP27OS
AC   CVCL_9S69
SY   Xeroderma Pigmentosum 27 OSaka
DR   JCRB; KURB1335
DR   Wikidata; Q54994912
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=1372102; PubMed=1702221).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Heterozygous (PubMed=1372102; PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 10
//
ID   XP27PV
AC   CVCL_ZM14
SY   Xeroderma Pigmentosum 27 PaVia
DR   Wikidata; Q98135614
RX   PubMed=12812979;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Lys244Terfs (c.901_904delAAAG); Zygosity=Homozygous (PubMed=12812979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP27TU
AC   CVCL_ZQ37
SY   Xeroderma Pigmentosum 27 TUnisia
DR   Wikidata; Q98135616
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP28BR
AC   CVCL_ZV10
SY   Xeroderma Pigmentosum 28 BRighton
DR   Wikidata; Q98135618
RX   PubMed=26884178;
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu726Profs*67 (c.2176_2192del17); ClinVar=VCV002679642; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP28KO
AC   CVCL_ZM27
SY   Xeroderma Pigmentosum 28 KObe
DR   Wikidata; Q98135621
RX   PubMed=3834095;
RX   PubMed=4011712;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP28MA
AC   CVCL_ZQ83
SY   Xeroderma Pigmentosum 28 MAnnheim
DR   Wikidata; Q98135624
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP28OS
AC   CVCL_ZM99
SY   Xeroderma Pigmentosum 28 OSaka
DR   JCRB; KURB1338
DR   Wikidata; Q98135627
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP28VI
AC   CVCL_ZP98
SY   Xeroderma Pigmentosum 28 VIllejuif
DR   Wikidata; Q98135628
RX   PubMed=11773631;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359Valfs*32 (c.1075_1244del170) (Ex10del); Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr364fs (c.1091dupC) (Fs364); Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP29BE
AC   CVCL_M298
SY   Xeroderma Pigmentosum 29 BEthesda; GM11613
DR   CLO; CLO_0021180
DR   Coriell; GM11613
DR   Wikidata; Q54845191
RX   PubMed=19934020;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gln452Ter (c.1354C>T); ClinVar=VCV001455083; Zygosity=Heterozygous (PubMed=19934020).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=19934020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M297 ! XP29BE LCL
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP29BE LCL
AC   CVCL_M297
SY   Xeroderma Pigmentosum 29 BEthesda LCL; GM11612
DR   CLO; CLO_0021181
DR   Coriell; GM11612
DR   Wikidata; Q54845190
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gln452Ter (c.1354C>T); ClinVar=VCV001455083; Zygosity=Heterozygous (from autologous cell line XP29BE).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from autologous cell line XP29BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M298 ! XP29BE
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP29BR
AC   CVCL_ZV11
SY   Xeroderma Pigmentosum 29 BRighton
DR   Wikidata; Q98135631
RX   PubMed=26884178;
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2033+5G>A; ClinVar=VCV000554256; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP29MA
AC   CVCL_ZR19
SY   Xeroderma Pigmentosum 29 MAnnheim
DR   Wikidata; Q98135634
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=6862680;
RX   PubMed=7165374;
CC   Doubling time: 4.3 days (PubMed=6862680).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP29MAmal
AC   CVCL_E7FB
RX   PubMed=6862680;
CC   Characteristics: Tumorigenic. Gives rise to fibrosarcomas in BALB/c nu/nu mice. Compared to the parent cell line shows a drastically higher DNA repair capacity (PubMed=6862680).
CC   Doubling time: 1.3 days (PubMed=6862680).
CC   Karyotypic information: Near tetraploid karyotype (PubMed=6862680).
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZR19 ! XP29MA
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XP29OS
AC   CVCL_ZN00
SY   Xeroderma Pigmentosum 29 OSaka
DR   JCRB; KURB1339
DR   Wikidata; Q98135635
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2AS
AC   CVCL_ZM58
SY   Xeroderma Pigmentosum 2 ASahikawa
DR   JCRB; KURB1250
DR   Wikidata; Q98135637
RX   PubMed=7830260;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2BE
AC   CVCL_F491
SY   Xeroderma Pigmentosum 2 BEthesda; Ja Ar; GM00677; GM-677; GM 677; GM677; GM0677
DR   CLO; CLO_0028918
DR   ATCC; CRL-1166
DR   Coriell; GM00677
DR   JCRB; KURB1055
DR   Wikidata; Q54836386
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=4811796;
RX   PubMed=6492896;
RX   PubMed=6947227;
RX   PubMed=7163956;
RX   PubMed=7264357;
CC   Population: Caucasian.
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Homozygous (from familial inference of XP8BE; XP9BE).
CC   Discontinued: ATCC; CRL-1166; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 22
//
ID   XP2BI
AC   CVCL_M223
SY   Xeroderma Pigmentosum 2 BIrmingham; GM03021; GM03021A; GM3021; GM3021A; GM03021B
DR   CLO; CLO_0012552
DR   Coriell; GM03021
DR   JCRB; KURB1104
DR   JCRB; KURB1105
DR   Wikidata; Q54837809
RX   CelloPub=CLPUB00447;
RX   PubMed=492197;
RX   PubMed=2175267;
RX   PubMed=2570806;
RX   PubMed=3010096;
RX   PubMed=3030788;
RX   PubMed=3341805;
RX   PubMed=3347209;
RX   PubMed=3922833;
RX   PubMed=4031543;
RX   PubMed=4066782;
RX   PubMed=6307543;
RX   PubMed=7067035;
RX   PubMed=7301938;
RX   PubMed=8317483;
RX   PubMed=8823375;
RX   PubMed=9584159;
RX   PubMed=11219864;
RX   PubMed=11841555;
RX   PubMed=18079351;
RX   PubMed=26184184;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Arg372Thrfs*5 (c.1115_1118delGGAA); ClinVar=VCV000016574; Zygosity=Heterozygous (PubMed=11841555).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Leu858Pro (c.2573T>C); ClinVar=VCV000016573; Zygosity=Heterozygous (PubMed=11841555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   XP2CA
AC   CVCL_L768
SY   Xeroderma Pigmentosum 2 CAiro; GM02991; GM2991
DR   CLO; CLO_0012580
DR   BioSample; SAMN00808199
DR   Coriell; GM02991
DR   Wikidata; Q54837791
RX   PubMed=7252263;
RX   PubMed=9671271;
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Thr125Ilefs*15 (c.374delC); ClinVar=VCV000267186; Zygosity=Homozygous (PubMed=9671271; Coriell=GM02991).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   XP2CH
AC   CVCL_L779
SY   Xeroderma Pigmentosum 2 CHerevan; GM03053; GM3053
DR   CLO; CLO_0013499
DR   BioSample; SAMN00808228
DR   Coriell; GM03053
DR   Wikidata; Q54837840
RX   CelloPub=CLPUB00447;
RX   PubMed=7326997;
RX   PubMed=10398605;
CC   Population: Caucasian; Russian Armenian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Val125Ter (c.376C>T); Zygosity=Homozygous (PubMed=10398605).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   XP2CNX
AC   CVCL_ZS35
SY   Xeroderma Pigmentosum 2 China Ning Xia
DR   Wikidata; Q98135639
RX   PubMed=9536236;
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2DF
AC   CVCL_ZW23
SY   Xeroderma Pigmentosum 2 DusseldorF
DR   Wikidata; Q102115131
RX   PubMed=21566739;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   21Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   XP2DU
AC   CVCL_ZN32
SY   Xeroderma Pigmentosum 2 DUndee
DR   Wikidata; Q98135641
RX   PubMed=11773631;
RX   PubMed=18079351;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys70Serfs*30 (c.207delG); ClinVar=VCV000005892; Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   44Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP2HM
AC   CVCL_ZQ23
SY   Xeroderma Pigmentosum 2 HamaMatsu
DR   Wikidata; Q98135643
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Tyr116Ter (c.348T>A); ClinVar=VCV000000997; Zygosity=Heterozygous (PubMed=7905727).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP2JO skin
AC   CVCL_M282
SY   Xeroderma Pigmentosum 1 JOhannesburg skin; GM02035; GM-2035; GM2035
DR   CLO; CLO_0032570
DR   BioSample; SAMN00807412
DR   Coriell; GM02035
DR   Wikidata; Q54837254
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African; Zulu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M280 ! XP2JO tongue
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   XP2JO tongue
AC   CVCL_M280
SY   Xeroderma Pigmentosum 1 JOhannesburg tongue; GM02032; GM-2032; GM2032
DR   CLO; CLO_0032571
DR   BioSample; SAMN00807406
DR   Coriell; GM02032
DR   JCRB; KURB1060
DR   Wikidata; Q54837251
RX   CelloPub=CLPUB00447;
CC   Population: African; Zulu.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M282 ! XP2JO skin
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   XP2KA
AC   CVCL_M290
SY   Xeroderma Pigmentosum 2 KAnazawa; GM05293
DR   CLO; CLO_0024948
DR   Coriell; GM05293
DR   JCRB; JCRB3016
DR   JCRB; KURB1045
DR   JCRB; KURB1046
DR   Wikidata; Q54838958
RX   CelloPub=CLPUB00447;
RX   PubMed=3834095;
RX   PubMed=3922833;
RX   PubMed=9025096;
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1045; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3016
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 16
//
ID   XP2KY
AC   CVCL_ZQ55
SY   Xeroderma Pigmentosum 2 KYoto
DR   JCRB; KURB1274
DR   Wikidata; Q98135646
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP2LE
AC   CVCL_IM55
SY   Xeroderma Pigmentosum 2 LEningrad; IMG-667 XP2LE; IMG-667
DR   CLO; CLO_0006828
DR   CLDB; cl2760
DR   Wikidata; Q54897558
RX   PubMed=3082051;
RX   PubMed=18079351;
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 12
//
ID   XP2MA
AC   CVCL_ZQ75
SY   Xeroderma Pigmentosum 2 MAnnheim
DR   Wikidata; Q98135648
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP2MO
AC   CVCL_IM53
AS   CVCL_X763
SY   Xeroderma Pigmentosum 2 MOscow; IMG-484 XP2MO; IMG-484; LHC-484; LHC 484; LHC484; AG01952; AG-1952; AG 1952; AG1952
DR   CLO; CLO_0006814
DR   CLO; CLO_0036881
DR   CLDB; cl2746
DR   Coriell; AG01952
DR   Wikidata; Q54609544
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=1212110;
RX   PubMed=7253718;
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 12
//
ID   XP2MY
AC   CVCL_ZS26
DR   JCRB; KURB1302
DR   Wikidata; Q98135651
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2NA
AC   CVCL_ZN16
SY   Xeroderma Pigmentosum 2 NAgoya
DR   Wikidata; Q98135653
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2NBi
AC   CVCL_M231
SY   Xeroderma Pigmentosum 2 NairoBi; GM00522; GM-522; GM522; GM17341
DR   CLO; CLO_0013745
DR   CLO; CLO_0025929
DR   Coriell; GM00522
DR   Coriell; GM17341
DR   Wikidata; Q54836288
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=7163956;
CC   Part of: Human variation panel.
CC   Population: African; Kikuyu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   XP2NE
AC   CVCL_J996
SY   Xeroderma Pigmentosum 2 NEwscastle; GM00435; GM-435; GM 0435; GM0435; GM435; GM00435A
DR   CLO; CLO_0026113
DR   Coriell; GM00435
DR   JCRB; KURB1073
DR   Wikidata; Q54836219
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=837385;
RX   PubMed=1372108;
RX   PubMed=6492896;
RX   PubMed=6684957;
RX   PubMed=7163956;
RX   PubMed=9238033;
RX   PubMed=26184184;
CC   Population: Caucasian.
CC   Senescence: Senesces at 34 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (PubMed=9238033; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   XP2NI
AC   CVCL_ZQ47
DR   Wikidata; Q98135657
RX   PubMed=7905727;
RX   PubMed=8596539;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=7905727; PubMed=8596539).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Glu225Gln (c.673G>C); Zygosity=Heterozygous (PubMed=7905727; PubMed=8596539).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP2OS
AC   CVCL_F510
SY   Xeroderma Pigmentosum 2 OSaka; GM04419; GM 4419
DR   Coriell; GM04419
DR   JCRB; JCRB3048
DR   JCRB; KURB1007
DR   Wikidata; Q54838478
RX   PubMed=832273;
RX   PubMed=967189;
RX   PubMed=1180926;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2039995;
RX   PubMed=6096450;
RX   PubMed=6876478;
RX   PubMed=7000335;
RX   PubMed=7264357;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Misspelling: XP20S; Note=Occasionally.
CC   Discontinued: Coriell; GM04419; probable.
CC   Discontinued: JCRB; KURB1007; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3048
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F512 ! XP2OS LCL
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 25
//
ID   XP2OS LCL
AC   CVCL_F512
SY   Xeroderma Pigmentosum 2 OSaka LCL; GM02345; GM 2345; GM2345; GM2345A; GM02345B; GM2345B; GM17051
DR   CLO; CLO_0014646
DR   CLO; CLO_0033111
DR   BioSample; SAMN00807727
DR   Coriell; GM02345
DR   Coriell; GM17051
DR   Wikidata; Q54837452
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
RX   PubMed=6096450;
RX   PubMed=7519740;
RX   PubMed=8327515;
RX   PubMed=9025096;
RX   PubMed=9584159;
CC   Part of: Human variation panel.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=GM17051).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F510 ! XP2OS
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 24
//
ID   XP2OS SV40-transformed
AC   CVCL_ZN80
SY   XP2OS (SV40); GM04312; GM4312; GM04312A; GM4312A; GM04312B
DR   CLO; CLO_0019549
DR   Coriell; GM04312
DR   Wikidata; Q98135659
RX   CelloPub=CLPUB00447;
RX   PubMed=6684957;
RX   PubMed=7519740;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (Coriell=GM04312).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Could be identical to XP2OS(SV) (Cellosaurus=CVCL_3242).
CC   Misspelling: XP20S (SV40); PubMed=6684957.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F510 ! XP2OS
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 11
//
ID   XP2OS(SV)
AC   CVCL_3242
SY   XP2OS (SV); XP2OS-SV; XP20S-SV40; XP20s(SV40)
DR   JCRB; JCRB0301
DR   JCRB; KURB1008
DR   Wikidata; Q54994913
RX   PubMed=2039995;
RX   PubMed=7000335;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Could be identical to GM04312 (Cellosaurus=CVCL_ZN80).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0301
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 12
ST   D5S818: 11
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F510 ! XP2OS
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 21
//
ID   XP2OS(SV)neo
AC   CVCL_ZR65
DR   Wikidata; Q98135661
RX   PubMed=3795172;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3242 ! XP2OS(SV)
SX   Female
AG   7Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   XP2PD
AC   CVCL_L759
SY   GM02010; GM-2010; GM2010
DR   CLO; CLO_0032300
DR   BioSample; SAMN00807382
DR   Coriell; GM02010
DR   Wikidata; Q54837235
RX   CelloPub=CLPUB00447;
RX   PubMed=9671271;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Cys108Phe (c.323G>T); ClinVar=VCV000000993; Zygosity=Heterozygous (PubMed=9671271; Coriell=GM02010).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Leu117Glufs*4 (c.349_353delCTTAT) (349del5); ClinVar=VCV000000994; Zygosity=Heterozygous (PubMed=9671271; Coriell=GM02010).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   XP2PR
AC   CVCL_ZR82
DR   Wikidata; Q98135664
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP2RO
AC   CVCL_F496
SY   XP-2; Xeroderma Pigmentosum 2 ROtterdam; GM02415; GM-2415; GM 2415; GM2415; GM02415B; GM-1762; GM-708
DR   CLO; CLO_0033096
DR   ATCC; CRL-1259
DR   BioSample; SAMN00807747
DR   Coriell; GM00708
DR   Coriell; GM01762
DR   Coriell; GM02415
DR   JCRB; KURB1079
DR   JCRB; KURB1080
DR   Wikidata; Q54837471
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=837385;
RX   PubMed=1376435;
RX   PubMed=3010096;
RX   PubMed=3030788;
RX   PubMed=3922833;
RX   PubMed=4066782;
RX   PubMed=4778857;
RX   PubMed=4842087;
RX   PubMed=8798680;
RX   PubMed=8823375;
RX   PubMed=9584159;
RX   PubMed=10771487;
RX   PubMed=10777490;
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000008788; Zygosity=Homozygous (PubMed=8798680; PubMed=10777490).
CC   Discontinued: ATCC; CRL-1259; true.
CC   Discontinued: Coriell; GM00708; true.
CC   Discontinued: Coriell; GM01762; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 25
//
ID   XP2SA
AC   CVCL_3243
SY   Xeroderma Pigmentosum 2 SApporo
DR   JCRB; JCRB0305
DR   JCRB; KURB1123
DR   Wikidata; Q54994914
RX   PubMed=1702221;
RX   PubMed=7830260;
RX   PubMed=10385124;
RX   PubMed=10771487;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Virology: Infected with human parvovirus B19 (PubMed=29892436).
CC   Doubling time: 24 hours (JCRB=JCRB0305).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu306Ter (c.916G>T); ClinVar=VCV000005887; Zygosity=Unspecified (PubMed=10385124).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0305
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 18
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   XP2SE
AC   CVCL_ZM63
SY   Xeroderma Pigmentosum 2 SEndai
DR   Wikidata; Q98135665
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2TUF
AC   CVCL_ZS22
SY   Xeroderma Pigmentosum 2 TUrku Finland
DR   Wikidata; Q98135667
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP2YO
AC   CVCL_F598
SY   Xeroderma Pigmentosum 2 YOnago; GM04313; GM04313C; GM04313D
DR   CLO; CLO_0019547
DR   Coriell; GM04313
DR   JCRB; KURB1092
DR   JCRB; KURB1093
DR   Wikidata; Q54994915
RX   CelloPub=CLPUB00447;
RX   PubMed=1702221;
RX   PubMed=1814424;
RX   PubMed=2039995;
RX   PubMed=3834095;
RX   PubMed=8823375;
RX   PubMed=9025096;
RX   PubMed=9579555;
RX   PubMed=9580660;
RX   PubMed=9584159;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Thr567Ala (c.1699A>G) (T556A); Zygosity=Heterozygous (PubMed=9580660).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Val657Glufs*28 (c.1971delT); Zygosity=Heterozygous (PubMed=9580660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   XP2YO(SV)
AC   CVCL_3244
SY   XP2YO-SV; GM08437; GM08437A; GM08437B
DR   CLO; CLO_0010546
DR   BioSample; SAMN00798066
DR   BioSample; SAMN03471615
DR   Coriell; GM08437
DR   JCRB; JCRB0302
DR   JCRB; KURB1094
DR   JCRB; KURB1095
DR   Wikidata; Q54994916
RX   CelloPub=CLPUB00447;
RX   PubMed=1660831;
RX   PubMed=2039995;
RX   PubMed=9025096;
RX   PubMed=14690602;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Thr567Ala (c.1699A>G) (T556A); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Val657Glufs*28 (c.1971delT); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0302
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 11
ST   D5S818: 10,13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 13,17
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F598 ! XP2YO
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 25
//
ID   XP30BE
AC   CVCL_M292
SY   Xeroderma Pigmentosum 30 BEthesda; GM05792; KR05792
DR   CLO; CLO_0024688
DR   Coriell; GM05792
DR   Wikidata; Q54841940
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln368Argfs*6 (c.1103_1104delAA) (delAA1208-1209); ClinVar=VCV000267279; Zygosity=Heterozygous (Coriell=GM05792).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (Coriell=GM05792).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M291 ! XP30BE LCL
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   XP30BE LCL
AC   CVCL_M291
SY   Xeroderma Pigmentosum 30 BEthesda LCL; GM05791
DR   CLO; CLO_0024663
DR   Coriell; GM05791
DR   Wikidata; Q54841939
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Gln368Argfs*6 (c.1103_1104delAA) (delAA1208-1209); ClinVar=VCV000267279; Zygosity=Heterozygous (Coriell=GM05791).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (Coriell=GM05791).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M292 ! XP30BE
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
ID   XP30BR
AC   CVCL_ZV12
SY   Xeroderma Pigmentosum 30 BRighton
DR   Wikidata; Q98135669
RX   PubMed=26884178;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Phe610Leufs*90 (c.1827delC); ClinVar=VCV002720662; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 9
//
ID   XP30MA
AC   CVCL_ZR20
SY   Xeroderma Pigmentosum 30 MAnnheim
DR   Wikidata; Q98135671
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=6862680;
RX   PubMed=7165374;
CC   Derived from site: In situ; Hip, skin; UBERON=UBERON_0001554.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP30OS
AC   CVCL_ZN01
SY   Xeroderma Pigmentosum 30 OSaka
DR   JCRB; KURB1012
DR   Wikidata; Q98135674
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP30RO
AC   CVCL_7395
AS   CVCL_G334; CVCL_IM58
SY   XP3ORO; XP-V XP30RO; XP-V (XP30RO); GM03617; GM03617A; GM3617; IMG-991 XP3ORO; IMG-991
DR   BTO; BTO_0004753
DR   CLO; CLO_0006939
DR   CLO; CLO_0017188
DR   CLDB; cl2871
DR   Coriell; GM03617
DR   Wikidata; Q54994917
RX   CelloPub=CLPUB00447;
RX   PubMed=837385;
RX   PubMed=1214825;
RX   PubMed=4778857;
RX   PubMed=6096694;
RX   PubMed=6947227;
RX   PubMed=7067035;
RX   PubMed=7326997;
RX   PubMed=7471106;
RX   PubMed=7565859;
RX   PubMed=10022907;
RX   PubMed=10385124;
RX   PubMed=10398605;
RX   PubMed=11773631;
RX   PubMed=16520097;
CC   Population: Lebanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ala35fs (c.104_116del); Zygosity=Homozygous (PubMed=10385124; PubMed=10398605).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 26
//
ID   XP30VI
AC   CVCL_ZR34
SY   Xeroderma Pigmentosum 30 VIllejuif
DR   Wikidata; Q98135676
RX   PubMed=9415314;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP314VI
AC   CVCL_ZR35
SY   Xeroderma Pigmentosum 314 VIllejuif
DR   Wikidata; Q98135679
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Heterozygous (PubMed=16081512).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP31BE
AC   CVCL_M308
SY   Xeroderma Pigmentosum 31 BEthesda; GM13155
DR   CLO; CLO_0013622
DR   BioSample; SAMN00802153
DR   Coriell; GM13155
DR   Wikidata; Q54846353
RX   PubMed=18368133;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; c.764+1G>C; Zygosity=Hemizygous; Note=Splice donor mutation (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M307 ! XP31BE LCL
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP31BE LCL
AC   CVCL_M307
SY   Xeroderma Pigmentosum 31 BEthesda LCL; GM13154
DR   CLO; CLO_0013627
DR   BioSample; SAMN00802151
DR   Coriell; GM13154
DR   Wikidata; Q54846352
RX   PubMed=18368133;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; c.764+1G>C; Zygosity=Hemizygous; Note=Splice donor mutation (from autologous cell line XP31BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M308 ! XP31BE
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP31KO
AC   CVCL_ZS94
SY   XP31Ko; Xeroderma Pigmentosum 31 KObe
DR   Wikidata; Q98135681
RX   PubMed=4031543;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP31MA
AC   CVCL_ZQ72
SY   Xeroderma Pigmentosum 31 MAnnheim
DR   Wikidata; Q98135684
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP31OS
AC   CVCL_ZN02
SY   Xeroderma Pigmentosum 31 OSaka
DR   JCRB; KURB1121
DR   Wikidata; Q98135687
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP31TO
AC   CVCL_ZN66
SY   Xeroderma Pigmentosum 31 TOkyo
DR   Wikidata; Q98135689
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP329BE
AC   CVCL_ZP74
SY   Xeroderma Pigmentosum 329 BEthesda; JA1356
DR   Wikidata; Q98135690
RX   PubMed=18955168;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Met1Arg (c.2T>G); ClinVar=VCV001066146; Zygosity=Homozygous (PubMed=18955168).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP32BE
AC   CVCL_M306
SY   Xeroderma Pigmentosum 32 BEthesda; GM13142
DR   CLO; CLO_0013669
DR   BioSample; SAMN00802145
DR   Coriell; GM13142
DR   Wikidata; Q54846349
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M305 ! XP32BE LCL
SX   Male
AG   42Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   XP32BE LCL
AC   CVCL_M305
SY   Xeroderma Pigmentosum 32 BEthesda LCL; GM13141
DR   CLO; CLO_0013670
DR   BioSample; SAMN00802143
DR   Coriell; GM13141
DR   Wikidata; Q54846348
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M306 ! XP32BE
SX   Male
AG   42Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   XP32BR
AC   CVCL_ZP53
SY   Xeroderma Pigmentosum 32 BRighton
DR   Wikidata; Q98135693
RX   PubMed=20221251;
RX   PubMed=26884178;
RX   PubMed=30165384;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Pro379Ser (c.1135C>T); ClinVar=VCV000134148; Zygosity=Heterozygous (PubMed=20221251; PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg589Trp (c.1765C>T); ClinVar=VCV000055829; Zygosity=Heterozygous (PubMed=20221251; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP32MA
AC   CVCL_ZQ73
SY   Xeroderma Pigmentosum 32 MAnnheim
DR   Wikidata; Q98135695
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP32OS
AC   CVCL_ZN03
SY   Xeroderma Pigmentosum 32 OSaka
DR   JCRB; KURB1340
DR   JCRB; KURB1341
DR   Wikidata; Q98135697
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP32TO
AC   CVCL_ZN75
SY   Xeroderma Pigmentosum 32 TOkyo
DR   Wikidata; Q98135699
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP33BE
AC   CVCL_M304
SY   Xeroderma Pigmentosum 33 BEthesda; GM13036
DR   CLO; CLO_0014035
DR   BioSample; SAMN00802038
DR   Coriell; GM13036
DR   Wikidata; Q54846277
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M303 ! XP33BE LCL
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   XP33BE LCL
AC   CVCL_M303
SY   Xeroderma Pigmentosum 33 BEthesda LCL; GM13035
DR   CLO; CLO_0014036
DR   BioSample; SAMN00802036
DR   Coriell; GM13035
DR   Wikidata; Q54846276
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M304 ! XP33BE
SX   Female
AG   31Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 13
//
ID   XP33BR
AC   CVCL_V273
SY   Xeroderma Pigmentosum 33 BRighton; GM21071
DR   CLO; CLO_0015393
DR   Coriell; GM21071
DR   Wikidata; Q54851622
RX   PubMed=16947863;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (PubMed=16947863).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Arg425Ter (c.1273C>T); ClinVar=VCV000016585; Zygosity=Heterozygous (PubMed=16947863).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3966; Xeroderma pigmentosum, complementation group B
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V275 ! XP33BR LCL
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   XP33BR LCL
AC   CVCL_V275
SY   Xeroderma Pigmentosum 33 BRighton LCL; GM21148
DR   CLO; CLO_0015848
DR   Coriell; GM21148
DR   Wikidata; Q54851701
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (Coriell=GM21148).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Arg425Ter (c.1273C>T); ClinVar=VCV000016585; Zygosity=Heterozygous (Coriell=GM21148).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3966; Xeroderma pigmentosum, complementation group B
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_V273 ! XP33BR
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   XP33MA
AC   CVCL_ZR05
SY   Xeroderma Pigmentosum 33 MAnnheim
DR   Wikidata; Q98135702
RX   PubMed=2054785;
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP33OS
AC   CVCL_ZN04
SY   Xeroderma Pigmentosum 33 OSaka
DR   JCRB; KURB1342
DR   Wikidata; Q98135704
RX   PubMed=2570806;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP33TU
AC   CVCL_ZQ38
SY   Xeroderma Pigmentosum 33 TUnisia
DR   JCRB; KURB1224
DR   Wikidata; Q98135707
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP34BE
AC   CVCL_M321
SY   Xeroderma Pigmentosum 34 BEthesda; GM16955
DR   CLO; CLO_0018076
DR   Coriell; GM16955
DR   Wikidata; Q54848814
RX   PubMed=18470933;
RX   PubMed=19934020;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile199Profs*52 (c.594_595insCCCCCCAG) (199insPP); Zygosity=Heterozygous (PubMed=18470933; PubMed=19934020).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=18470933; PubMed=19934020).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M320 ! XP34BE LCL
SX   Male
AG   23Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP34BE LCL
AC   CVCL_M320
SY   Xeroderma Pigmentosum 34 BEthesda LCL; GM16954
DR   CLO; CLO_0018115
DR   Coriell; GM16954
DR   Wikidata; Q54848813
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile199Profs*52 (c.594_595insCCCCCCAG) (199insPP); Zygosity=Heterozygous (from autologous cell line XP34BE).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from autologous cell line XP34BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M321 ! XP34BE
SX   Male
AG   23Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP34BR
AC   CVCL_ZN30
SY   Xeroderma Pigmentosum 34 BRighton
DR   Wikidata; Q98135708
RX   PubMed=18079351;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala818Val (c.2453C>T); ClinVar=VCV000996657; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Thr863fs (c.2586_2587delTA); Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP34MA
AC   CVCL_ZR16
SY   Xeroderma Pigmentosum 34 MAnnheim
DR   Wikidata; Q98135710
RX   PubMed=2054785;
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP34OS
AC   CVCL_ZN05
SY   Xeroderma Pigmentosum 34 OSaka
DR   JCRB; KURB1343
DR   Wikidata; Q98135715
RX   PubMed=7947212;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7947212).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP35BE
AC   CVCL_M323
SY   Xeroderma Pigmentosum 35 BEthesda; GM16957
DR   CLO; CLO_0018072
DR   Coriell; GM16957
DR   Wikidata; Q54848816
RX   PubMed=18470933;
RX   PubMed=19934020;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile199Profs*52 (c.594_595insCCCCCCAG) (199insPP); Zygosity=Heterozygous (PubMed=18470933; PubMed=19934020).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=18470933; PubMed=19934020).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M322 ! XP35BE LCL
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   XP35BE LCL
AC   CVCL_M322
SY   Xeroderma Pigmentosum 35 BEthesda LCL; GM16956
DR   CLO; CLO_0018073
DR   Coriell; GM16956
DR   Wikidata; Q54848815
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ile199Profs*52 (c.594_595insCCCCCCAG) (199insPP); Zygosity=Heterozygous (from autologous cell line XP35BE).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (from autologous cell line XP35BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M323 ! XP35BE
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP35BR
AC   CVCL_ZV13
SY   Xeroderma Pigmentosum 35 BRighton
DR   Wikidata; Q98135717
RX   PubMed=26884178;
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu726Profs*67 (c.2176_2192del17); ClinVar=VCV002679642; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP35MA
AC   CVCL_ZR17
SY   Xeroderma Pigmentosum 35 MAnnheim
DR   Wikidata; Q98135719
RX   PubMed=2054785;
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP35OS
AC   CVCL_3247
SY   Xeroderma Pigmentosum 35 OSaka
DR   JCRB; JCRB0304
DR   JCRB; KURB1164
DR   JCRB; KURB1344
DR   JCRB; KURB1345
DR   Wikidata; Q54994919
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2570806;
RX   PubMed=3814505;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0304
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,10
ST   D16S539: 9,10
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   XP35OS(SVT)
AC   CVCL_4Y31
DR   JCRB; KURB1165
DR   Wikidata; Q54994920
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3247 ! XP35OS
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 14
//
ID   XP35TO
AC   CVCL_ZN76
SY   Xeroderma Pigmentosum 35 TOkyo
DR   Wikidata; Q98135721
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP36BR
AC   CVCL_ZQ02
SY   Xeroderma Pigmentosum 36 BRighton
DR   Wikidata; Q98135723
RX   PubMed=11773631;
RX   PubMed=26884178;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg111His (c.332G>A); ClinVar=VCV001331405; Zygosity=Heterozygous (PubMed=11773631; PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr408Leufs*36 (c.1222_1225delACTT) (Fs407); ClinVar=VCV002431387; Zygosity=Heterozygous (PubMed=11773631; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   48Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP36MA
AC   CVCL_ZR06
SY   Xeroderma Pigmentosum 36 MAnnheim
DR   Wikidata; Q98135726
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP36OS
AC   CVCL_ZN06
SY   Xeroderma Pigmentosum 36 OSaka
DR   JCRB; KURB1346
DR   Wikidata; Q98135727
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from familial inference of XP35OS).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP377BE
AC   CVCL_ZS41
SY   Xeroderma Pigmentosum 377 BEthesda
DR   Wikidata; Q98135729
RX   CelloPub=CLPUB00565;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS6-13_-21del9; Zygosity=Homozygous (CelloPub=CLPUB00565).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP37BR
AC   CVCL_ZQ06
SY   Xeroderma Pigmentosum 37 BRighton
DR   Wikidata; Q98135731
RX   PubMed=11773631;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Pro556fs (c.1668dupC) (Fs556); Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   69Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP37OS
AC   CVCL_ZN07
SY   Xeroderma Pigmentosum 37 OSaka
DR   JCRB; KURB1347
DR   Wikidata; Q98135733
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP37RO
AC   CVCL_ZP94
SY   Xeroderma Pigmentosum 37 ROtterdam
DR   Wikidata; Q98135737
RX   PubMed=11773631;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP38BE
AC   CVCL_ZN97
SY   Xeroderma Pigmentosum 38 BEthesda; AG02592; AG2592
DR   Coriell; AG02592
DR   Wikidata; Q98135739
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
RX   PubMed=18368133;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asp360Glyfs*32 (c.1078dupG) (c.1078_1079dupG); ClinVar=VCV001696282; Zygosity=Homozygous (PubMed=18368133).
CC   Discontinued: Coriell; AG02592; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS46 ! XP38BE LCL
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP38BE LCL
AC   CVCL_ZS46
SY   Xeroderma Pigmentosum 38 BEthesda LCL; AG02593; AG2593
DR   Coriell; AG02593
DR   Wikidata; Q98135742
RX   CelloPub=CLPUB00387;
RX   PubMed=7253718;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asp360Glyfs*32 (c.1078dupG) (c.1078_1079dupG); ClinVar=VCV001696282; Zygosity=Homozygous (from autologous cell line XP38BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; AG02593; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN97 ! XP38BE
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP38KO
AC   CVCL_ZM52
SY   Xeroderma Pigmentosum 38 KObe
DR   Wikidata; Q98135743
RX   PubMed=3834095;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP38OS
AC   CVCL_ZN08
SY   Xeroderma Pigmentosum 38 OSaka
DR   JCRB; KURB1348
DR   Wikidata; Q98135745
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP39BE
AC   CVCL_ZN98
SY   Xeroderma Pigmentosum 39 BEthesda; KR05822
DR   Wikidata; Q98135747
RX   PubMed=18368133;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asp360Glyfs*32 (c.1078dupG) (c.1078_1079dupG); ClinVar=VCV001696282; Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP39BR
AC   CVCL_ZV14
SY   Xeroderma Pigmentosum 39 BRighton
DR   Wikidata; Q98135749
RX   PubMed=26884178;
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu726Profs*67 (c.2176_2192del17); ClinVar=VCV002679642; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP39MA
AC   CVCL_ZR07
SY   Xeroderma Pigmentosum 39 MAnnheim
DR   Wikidata; Q98135751
RX   PubMed=2054785;
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP39OS
AC   CVCL_3248
SY   Xeroderma Pigmentosum 39 OSaka
DR   JCRB; JCRB0326
DR   JCRB; KURB1013
DR   Wikidata; Q54994921
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2570806;
RX   PubMed=3814505;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=1372102).
CC   Discontinued: JCRB; KURB1013; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0326
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 20
//
ID   XP39OS(SVT)
AC   CVCL_4Y32
DR   JCRB; KURB1014
DR   Wikidata; Q54994922
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3248 ! XP39OS
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 13
//
ID   XP39OSTERT
AC   CVCL_3249
SY   XP39OS hTERT
DR   BioSample; SAMN03472494
DR   JCRB; JCRB1057
DR   JCRB; KURB1015
DR   JCRB; NIHS0307
DR   Wikidata; Q54994923
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; KURB1015; probable.
CC   Discontinued: JCRB; NIHS0307; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1057
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3248 ! XP39OS
SX   Female
AG   12Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 22
//
ID   XP39R
AC   CVCL_9S66
DR   JCRB; JCRB1755
DR   Wikidata; Q54994925
RX   PubMed=26090552;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1755
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3248 ! XP39OS
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   XP3BE
AC   CVCL_F494
SY   Xeroderma Pigmentosum 3 BEthesda; Le Mas; GM00030; GM-30; GM 0030; GM0030; GM30A; GM00030A
DR   CLO; CLO_0025191
DR   ATCC; CRL-1189
DR   Coriell; GM00030
DR   JCRB; KURB1056
DR   Wikidata; Q54835984
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=3010096;
RX   PubMed=4811796;
RX   PubMed=6096450;
RX   PubMed=26184184;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.621_622ins83 (XPCins83); ClinVar=VCV000000254; Zygosity=Unspecified (PubMed=26184184).
CC   Discontinued: ATCC; CRL-1189; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F495 ! XP3BE LCL
SX   Male
AG   24Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   XP3BE LCL
AC   CVCL_F495
SY   Xeroderma Pigmentosum 3 BEthesda LCL; GM02248; GM-2248; GM 2248; GM2248; GM02248B
DR   CLO; CLO_0032155
DR   BioSample; SAMN00807628
DR   Coriell; GM02248
DR   Wikidata; Q54837389
RX   CelloPub=CLPUB00447;
RX   PubMed=2805228;
RX   PubMed=6096450;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.621_622ins83 (XPCins83); ClinVar=VCV000000254; Zygosity=Unspecified (Coriell=GM02248).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F494 ! XP3BE
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 20
//
ID   XP3BR
AC   CVCL_M286
SY   Xeroderma Pigmentosum 3 BRighton; GM03616; GM3616
DR   CLO; CLO_0017187
DR   Coriell; GM03616
DR   Wikidata; Q54838159
RX   CelloPub=CLPUB00447;
RX   PubMed=1702221;
RX   PubMed=2175267;
RX   PubMed=2973075;
RX   PubMed=6307543;
RX   PubMed=6492896;
RX   PubMed=6600729;
RX   PubMed=7067035;
RX   PubMed=11219864;
RX   PubMed=11841555;
RX   PubMed=15572672;
RX   PubMed=18079351;
RX   PubMed=23370536;
CC   Senescence: Senesces at 17 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Asp499Ilefs*23 (c.1494delA); ClinVar=VCV000016575; Zygosity=Heterozygous (PubMed=11841555).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Lys917Asnfs*64 (c.2751delA); ClinVar=VCV000016576; Zygosity=Heterozygous (PubMed=11841555).
CC   Caution: Could be identical to IMG-990 XP3Br2 (Cellosaurus=CVCL_IM57).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZP69 ! XP3BR LCL
SX   Male
AG   6-7Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   XP3BR LCL
AC   CVCL_ZP69
SY   Xeroderma Pigmentosum 3 BRighton; LBL463; LB463; 463
DR   Wikidata; Q98135753
RX   PubMed=11841555;
RX   PubMed=15572672;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Asp499Ilefs*23 (c.1494delA); ClinVar=VCV000016575; Zygosity=Heterozygous (PubMed=11841555).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Lys917Asnfs*64 (c.2751delA); ClinVar=VCV000016576; Zygosity=Heterozygous (PubMed=11841555).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M286 ! XP3BR
SX   Male
AG   6-7Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP3CA
AC   CVCL_L769
SY   Xeroderma Pigmentosum 3 CAiro; GM02992; GM2292
DR   CLO; CLO_0012582
DR   BioSample; SAMN00808200
DR   Coriell; GM02992
DR   Wikidata; Q54837792
RX   CelloPub=CLPUB00447;
RX   PubMed=1383811;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   XP3CNX
AC   CVCL_ZS36
SY   Xeroderma Pigmentosum 3 China Ning Xia
DR   Wikidata; Q98135754
RX   PubMed=9536236;
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3DU
AC   CVCL_ZP93
SY   Xeroderma Pigmentosum 3 DUndee
DR   Wikidata; Q98135756
RX   PubMed=11773631;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys70Serfs*30 (c.207delG); ClinVar=VCV000005892; Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP3EH
AC   CVCL_ZP80
SY   Xeroderma Pigmentosum 3 EHime
DR   JCRB; KURB1023
DR   Wikidata; Q98135760
RX   PubMed=7000335;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3GO
AC   CVCL_ZP02
DR   Wikidata; Q98135762
RX   DOI=10.1055/s-2003-822252;
RX   PubMed=18368133;
CC   Population: Caucasian; German.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Val221Profs*2 (c.661_764del104) (Ex6del); Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP3HM [XP-A]
AC   CVCL_ZQ56
SY   Xeroderma Pigmentosum 3 HamaMatsu
DR   Wikidata; Q98135764
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Caution: Two different patients and fibroblast cell lines seem to have been given the same designation: XPH3M, one is a XP-A (Cellosaurus=CVCL_ZQ56) the other a XP-G (Cellosaurus=CVCL_ZS95).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP3HM [XP-G]
AC   CVCL_ZS95
SY   Xeroderma Pigmentosum 3 HamaMatsu
DR   Wikidata; Q98135765
RX   PubMed=22417308;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Leu65Pro (c.194T>C); Zygosity=Homozygous (PubMed=22417308).
CC   Caution: Two different patients and fibroblast cell lines seem to have been given the same designation: XPH3M, one is a XP-A (Cellosaurus=CVCL_ZQ56) the other a XP-G (Cellosaurus=CVCL_ZS95).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP3JO
AC   CVCL_L760
SY   Xeroderma Pigmentosum 3 JOhannesburg; GM02033; GM-2033; GM2033
DR   CLO; CLO_0032572
DR   BioSample; SAMN00807408
DR   Coriell; GM02033
DR   Wikidata; Q54837252
RX   CelloPub=CLPUB00447;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=9671271;
CC   Population: African; Zulu.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg130Lys (c.389G>A); ClinVar=VCV000551153; Zygosity=Homozygous; Note=Affects splicing (PubMed=9671271; Coriell=GM02033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   XP3KA
AC   CVCL_JG85
SY   Xeroderma Pigmentosum 3 KAnazawa
DR   JCRB; JCRB3019
DR   JCRB; KURB1047
DR   JCRB; KURB3010
DR   Wikidata; Q54994926
RX   PubMed=3834095;
RX   PubMed=3922833;
RX   PubMed=4031543;
RX   PubMed=6481688;
CC   Population: Japanese.
CC   Discontinued: JCRB; KURB1047; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3019
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WD01 ! XP3KA(L)
OI   CVCL_3254 ! XPL3KA
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 11
//
ID   XP3KA(L)
AC   CVCL_WD01
DR   JCRB; KURB1048
DR   Wikidata; Q98135766
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JG85 ! XP3KA
OI   CVCL_3254 ! XPL3KA
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   XP3KG
AC   CVCL_ZQ57
DR   Wikidata; Q98135767
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   0-1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP3KO
AC   CVCL_ZM34
SY   Xeroderma Pigmentosum 3 KObe
DR   JCRB; KURB1271
DR   Wikidata; Q98135770
RX   PubMed=832273;
RX   PubMed=967189;
RX   PubMed=7259973;
RX   PubMed=7264357;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3KR
AC   CVCL_L777
SY   GM05292; GM5292
DR   CLO; CLO_0024952
DR   Coriell; GM05292
DR   JCRB; JCRB3044
DR   JCRB; KURB1031
DR   Wikidata; Q54838957
RX   CelloPub=CLPUB00447;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=7905727;
RX   PubMed=9671271;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=1372102; PubMed=7905727; PubMed=9671271).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Heterozygous (PubMed=1372102; PubMed=7905727; PubMed=9671271).
CC   Donor information: Established from monozygotic twin of XP4KR (Cellosaurus=CVCL_ZQ22).
CC   Discontinued: JCRB; KURB1031; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3044
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 13
ST   D7S820: 9,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 19
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 22
//
ID   XP3KY
AC   CVCL_ZQ58
SY   Xeroderma Pigmentosum 3 KYoto
DR   JCRB; KURB1275
DR   Wikidata; Q98135771
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3LE [Leeds]
AC   CVCL_ZS56
SY   Xeroderma Pigmentosum 3 LEeds
DR   Wikidata; Q98135774
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP3LE [Leningrad]
AC   CVCL_IM54
AS   CVCL_X762
SY   Xeroderma Pigmentosum 3 LEningrad; IMG-638 XP3LE; IMG-638; LHC 638; LHC638; AG01951; AG-1951; AG 1951; AG1951
DR   CLO; CLO_0006821
DR   CLO; CLO_0036880
DR   CLDB; cl2753
DR   Coriell; AG01951
DR   Wikidata; Q54609542
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00597;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=3082051;
RX   PubMed=7253718;
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 12
//
ID   XP3MA
AC   CVCL_ZQ76
SY   Xeroderma Pigmentosum 3 MAnnheim
DR   JCRB; KURB1107
DR   Wikidata; Q98135776
RX   PubMed=2054785;
RX   PubMed=2175267;
RX   PubMed=3182904;
RX   PubMed=7165374;
CC   Caution: Said to originate from a female patient in PubMed=2054785 and from a male patient in PubMed=7165374.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP3MO
AC   CVCL_IM56
SY   Xeroderma Pigmentosum 3 MOscow; IMG-730 XP3MO; IMG-730
DR   CLO; CLO_0006851
DR   CLDB; cl2783
DR   Wikidata; Q54897560
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP3MY
AC   CVCL_ZS27
DR   JCRB; KURB1303
DR   Wikidata; Q98135778
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3NA
AC   CVCL_ZN17
SY   Xeroderma Pigmentosum 3 NAgoya
DR   Wikidata; Q98135779
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3NE
AC   CVCL_L754
SY   Xeroderma Pigmentosum 3 NEwscastle; GM00434; GM-434; GM 0434; GM0434; GM434
DR   CLO; CLO_0026112
DR   Coriell; GM00434
DR   Wikidata; Q54836218
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=837385;
RX   PubMed=1034206;
RX   PubMed=1372108;
RX   PubMed=2987007;
RX   PubMed=3003928;
RX   PubMed=3030788;
RX   PubMed=6096694;
RX   PubMed=7825573;
RX   PubMed=8823375;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Homozygous (from familial inference of XP2NE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   XP3OS
AC   CVCL_3245
AS   CVCL_F511
SY   Xeroderma Pigmentosum 3 OSaka; GM04314; GM04314B; GM4314
DR   CLO; CLO_0019557
DR   Coriell; GM04314
DR   GEO; GSM1338611
DR   JCRB; JCRB0303
DR   JCRB; KURB1002
DR   JCRB; KURB1003
DR   JCRB; KURB1004
DR   Wikidata; Q54994928
RX   CelloPub=CLPUB00447;
RX   PubMed=832273;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2570806;
RX   PubMed=7000335;
RX   PubMed=7830260;
RX   PubMed=9671271;
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221; PubMed=9671271; PubMed=27197874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Misspelling: XP30S; Note=Occasionally.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0303; PubMed=27197874
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 14,17
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   XP3OS iPS
AC   CVCL_QW49
SY   XP3OS iPS1; XPAiPS-O1
DR   GEO; GSM1338612
DR   Wikidata; Q54994937
RX   PubMed=27197874;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=27197874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27197874
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 13
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 14,17
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3245 ! XP3OS
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 13
//
ID   XP3OS(SVT)
AC   CVCL_3246
DR   BioSample; SAMN03472492
DR   JCRB; JCRB1055
DR   JCRB; KURB1005
DR   JCRB; NIHS0304
DR   Wikidata; Q54994938
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Discontinued: JCRB; NIHS0304; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1055
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3245 ! XP3OS
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 27
//
ID   XP3OSHF
AC   CVCL_RZ97
SY   Xeroderma Pigmentosum 3 OSaka Heterozygote Father
DR   JCRB; JCRB3049
DR   JCRB; KURB1010
DR   Wikidata; Q54994939
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (from familial inference of XP3OS).
CC   Discontinued: JCRB; KURB1010; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3049
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D5S818: 10
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 11,12
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   XP3OSHM
AC   CVCL_RZ98
SY   Xeroderma Pigmentosum 3 OSaka Heterozygote Mother
DR   JCRB; JCRB3050
DR   JCRB; KURB1011
DR   Wikidata; Q54994941
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (from familial inference of XP3OS).
CC   Discontinued: JCRB; KURB1011; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3050
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 9
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   XP3R
AC   CVCL_9S65
DR   JCRB; JCRB1741
DR   Wikidata; Q54994942
RX   PubMed=26090552;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1741
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   TH01: 7
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3245 ! XP3OS
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 13
//
ID   XP3RO
AC   CVCL_ZR58
SY   Xeroderma Pigmentosum 3 ROtterdam
DR   Wikidata; Q98135783
RX   PubMed=4778857;
RX   PubMed=4842087;
RX   PubMed=8798680;
RX   PubMed=10777490;
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000008788; Zygosity=Homozygous (PubMed=8798680; PubMed=10777490).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F497 ! XP3RO LCL
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP3RO LCL
AC   CVCL_F497
SY   Xeroderma Pigmentosum 3 ROtterdam LCL; GM02450; GM2450; GM 2450; GM2450D; GM02450E; GM02450F
DR   CLO; CLO_0033327
DR   BioSample; SAMN00807789
DR   Coriell; GM02450
DR   Wikidata; Q54837501
RX   CelloPub=CLPUB00447;
RX   PubMed=1376435;
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000008788; Zygosity=Homozygous (from autologous cell line XP3RO).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZR58 ! XP3RO
SX   Female
AG   30Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   XP3SA
AC   CVCL_ZM59
SY   Xeroderma Pigmentosum 3 SApporo
DR   JCRB; KURB1354
DR   Wikidata; Q98135785
RX   PubMed=7830260;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3SE
AC   CVCL_ZM64
SY   Xeroderma Pigmentosum 3 SEndai
DR   JCRB; KURB1357
DR   Wikidata; Q98135787
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3TA
AC   CVCL_ZQ21
SY   Xeroderma Pigmentosum 3 Tel Aviv
DR   Wikidata; Q98135789
RX   PubMed=11121128;
RX   PubMed=12060391;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP3TUF
AC   CVCL_ZS19
SY   Xeroderma Pigmentosum 3 TUrku Finland
DR   Wikidata; Q98135793
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP3YO
AC   CVCL_M284
SY   Xeroderma Pigmentosum 3 YOnago; GM03542; GM3542; GM03542C
DR   CLO; CLO_0017310
DR   BioSample; SAMN00808443
DR   Coriell; GM03542
DR   JCRB; JCRB3039
DR   JCRB; KURB1100
DR   JCRB; KURB1101
DR   Wikidata; Q54838121
RX   CelloPub=CLPUB00387;
RX   CelloPub=CLPUB00447;
RX   PubMed=1814424;
RX   PubMed=3010096;
RX   PubMed=3834095;
RX   PubMed=3922833;
RX   PubMed=4031543;
RX   PubMed=9025096;
RX   PubMed=9580660;
RX   PubMed=26184184;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg490Gln (c.1469G>A) (R479Q); ClinVar=VCV001723249; Zygosity=Heterozygous (PubMed=9580660).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Leu608Pro (c.1823T>C) (L599P); Zygosity=Heterozygous (PubMed=9580660).
CC   Discontinued: JCRB; KURB1101; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3039
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,11
ST   D16S539: 10,11
ST   D5S818: 10
ST   D7S820: 8,11
ST   TH01: 6,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 20
//
ID   XP40BE LCL
AC   CVCL_L933
SY   Xeroderma Pigmentosum 40 BEthesda LCL; GM13295
DR   CLO; CLO_0013329
DR   BioSample; SAMN00802268
DR   Coriell; GM13295
DR   Wikidata; Q54846428
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   XP40GO
AC   CVCL_4T42
DR   Wikidata; Q54994943
RX   PubMed=23370536;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 6
//
ID   XP40KO
AC   CVCL_ZM54
SY   Xeroderma Pigmentosum 40 KObe
DR   JCRB; KURB1063
DR   Wikidata; Q98135795
RX   PubMed=3834095;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP40MA
AC   CVCL_ZR08
SY   Xeroderma Pigmentosum 40 MAnnheim
DR   Wikidata; Q98135798
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP40OS
AC   CVCL_3250
SY   Xeroderma Pigmentosum 40 OSaka
DR   BioSample; SAMN03793112
DR   GEO; GSM1338613
DR   JCRB; JCRB0327
DR   JCRB; KURB1168
DR   JCRB; KURB1169
DR   Wikidata; Q54994945
RX   PubMed=3814505;
RX   PubMed=3834095;
RX   PubMed=6481688;
RX   PubMed=26697316;
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0327
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D5S818: 10,13,14
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   XP40OS iPS
AC   CVCL_CV31
SY   XP40OS iPS2
DR   GEO; GSM1338614
DR   Wikidata; Q54994946
RX   PubMed=26697316;
CC   Population: Japanese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3250 ! XP40OS
SX   Male
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 10
//
ID   XP40OSTERT
AC   CVCL_3251
DR   BioSample; SAMN03472495
DR   JCRB; JCRB1058
DR   JCRB; NIHS0308
DR   Wikidata; Q54994948
CC   Population: Japanese.
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Discontinued: JCRB; NIHS0308; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1058
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D5S818: 10,14
ST   D7S820: 10,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3250 ! XP40OS
SX   Male
AG   30Y
CA   Telomerase immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   XP41MA
AC   CVCL_ZR18
SY   Xeroderma Pigmentosum 41 MAnnheim
DR   Wikidata; Q98135801
RX   PubMed=2054785;
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP41OS
AC   CVCL_ZN09
SY   Xeroderma Pigmentosum 41 OSaka
DR   JCRB; KURB1037
DR   Wikidata; Q98135803
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP42HM
AC   CVCL_ZQ68
SY   Xeroderma Pigmentosum 42 HamaMatsu
DR   Wikidata; Q98135806
RX   PubMed=20574439;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=20574439).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Thr260Ilefs*8 (c.779delCinsTTCTT) (779insTT) (780insTT); Zygosity=Heterozygous (PubMed=20574439).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP42MA
AC   CVCL_ZR13
SY   Xeroderma Pigmentosum 42 MAnnheim
DR   Wikidata; Q98135808
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP42OS
AC   CVCL_ZN10
SY   Xeroderma Pigmentosum 42 OSaka
DR   JCRB; KURB1038
DR   Wikidata; Q98135811
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12-13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP42RO
AC   CVCL_ZP20
SY   Xeroderma Pigmentosum 42 ROtterdam
DR   Wikidata; Q98135814
RX   PubMed=9579555;
RX   PubMed=20221251;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Homozygous (PubMed=9579555).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP42RO-hTERT
AC   CVCL_ZP58
DR   Wikidata; Q98135818
RX   PubMed=30165384;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP20 ! XP42RO
SX   Male
AG   62Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP43HM
AC   CVCL_ZQ69
SY   Xeroderma Pigmentosum 43 HamaMatsu
DR   Wikidata; Q98135821
RX   PubMed=20574439;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=20574439).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Thr260Ilefs*8 (c.779delCinsTTCTT) (779insTT) (780insTT); Zygosity=Heterozygous (PubMed=20574439).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP43KO
AC   CVCL_ZM24
SY   Xeroderma Pigmentosum 43 KObe
DR   Wikidata; Q98135824
RX   PubMed=3341805;
RX   PubMed=9238033;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Asp234Asn (c.700G>A); Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg601Leu (c.1802G>T); Zygosity=Heterozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP43MA
AC   CVCL_ZQ84
SY   Xeroderma Pigmentosum 43 MAnnheim
DR   Wikidata; Q98135827
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP43OS
AC   CVCL_ZN11
SY   Xeroderma Pigmentosum 43 OSaka
DR   JCRB; KURB1349
DR   Wikidata; Q98135829
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP43TO
AC   CVCL_ZM15
SY   Xeroderma Pigmentosum 43 TOkyo
DR   Wikidata; Q98135833
RX   PubMed=1376435;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP44MA
AC   CVCL_ZQ85
SY   Xeroderma Pigmentosum 44 MAnnheim
DR   Wikidata; Q98135836
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP44OS
AC   CVCL_ZN12
SY   Xeroderma Pigmentosum 44 OSaka
DR   JCRB; KURB1352
DR   Wikidata; Q98135838
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP44RO
AC   CVCL_M221
SY   Xeroderma Pigmentosum 44 ROtterdam
DR   Wikidata; Q54994949
RX   PubMed=2645048;
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8013 ! XP44RO(Mel)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 10
//
ID   XP44RO(Mel)
AC   CVCL_8013
SY   XP44RO(MEL); GM13030
DR   CLO; CLO_0014031
DR   BioSample; SAMN00802030
DR   Coriell; GM13030
DR   Wikidata; Q54994952
RX   PubMed=2645048;
CC   Derived from site: Metastatic; Testis; UBERON=UBERON_0000473.
DI   NCIt; C3224; Melanoma
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M221 ! XP44RO
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   XP45MA
AC   CVCL_E7FC
SY   Xeroderma Pigmentosum 45 MAnnheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XP45TA
AC   CVCL_ZR72
SY   Xeroderma Pigmentosum 45 Tel Aviv
DR   Wikidata; Q98135841
RX   PubMed=12060391;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP46HM
AC   CVCL_ZQ64
SY   Xeroderma Pigmentosum 46 HamaMatsu
DR   Wikidata; Q98135843
RX   PubMed=27603812;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gly176Aspfs*6 (c.529G>A); Zygosity=Homozygous; Note=Causes aberrant splicing (PubMed=27603812).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP46MA
AC   CVCL_ZR09
SY   Xeroderma Pigmentosum 46 MAnnheim
DR   Wikidata; Q98135848
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP47MA
AC   CVCL_ZR10
SY   Xeroderma Pigmentosum 47 MAnnheim
DR   Wikidata; Q98135850
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP49BR
AC   CVCL_ZR90
SY   Xeroderma Pigmentosum 49 BRighton
DR   Wikidata; Q98135853
RX   PubMed=26743599;
CC   Population: Afghan.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP4BE
AC   CVCL_U668
SY   Xeroderma Pigmentosum 4 BEthesda; Wo Mec; WoMec
DR   ATCC; CRL-1162
DR   Wikidata; Q54994359
RX   PubMed=225015;
RX   PubMed=273925;
RX   PubMed=503099;
RX   PubMed=656543;
RX   PubMed=837385;
RX   PubMed=3932847;
RX   PubMed=4811796;
RX   PubMed=6409440;
RX   PubMed=6947227;
RX   PubMed=7273335;
RX   PubMed=10385124;
RX   PubMed=11773631;
RX   PubMed=17409408;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Phe18Serfs*12 (c.52_55delTTTG) (del 289-292); ClinVar=VCV000005885; Zygosity=Unspecified (PubMed=10385124).
CC   Discontinued: ATCC; CRL-1162; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 13
//
ID   XP4BR
AC   CVCL_WX46
SY   Xeroderma Pigmentosum 4 BRighton
DR   Wikidata; Q98135855
RX   PubMed=3347209;
RX   PubMed=4066782;
RX   PubMed=7471106;
RX   PubMed=10766188;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Ser225Glnfs*45 (c.671insT); Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   XP4CA
AC   CVCL_L770
SY   Xeroderma Pigmentosum 4 CAiro; GM02993; GM2993
DR   CLO; CLO_0012577
DR   BioSample; SAMN00808201
DR   Coriell; GM02993
DR   Wikidata; Q54837794
RX   CelloPub=CLPUB00447;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 13
//
ID   XP4DF
AC   CVCL_ZW24
SY   Xeroderma Pigmentosum 4 DusseldorF
DR   Wikidata; Q102115132
RX   PubMed=21566739;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   66Y
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   XP4EH
AC   CVCL_ZP81
SY   Xeroderma Pigmentosum 4 EHime
DR   JCRB; KURB1024
DR   Wikidata; Q98135858
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4JO
AC   CVCL_L764
SY   Xeroderma Pigmentosum 4 JOhannesburg; GM02090; GM-2090; GM2090; GM17343
DR   CLO; CLO_0013734
DR   CLO; CLO_0031826
DR   BioSample; SAMN00807474
DR   Coriell; GM02090
DR   Coriell; GM17343
DR   Wikidata; Q54837294
RX   CelloPub=CLPUB00447;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=6492896;
RX   PubMed=9671271;
CC   Part of: Human variation panel.
CC   Population: African; Zulu.
CC   Senescence: Senesces at 24 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg130Lys (c.389G>A); ClinVar=VCV000551153; Zygosity=Homozygous; Note=Affects splicing (PubMed=9671271; Coriell=GM02090).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 23
//
ID   XP4JTO-I
AC   CVCL_ZM49
SY   XP4TO; Xeroderma Pigmentosum 5 Japan TOkyo-I
DR   JCRB; KURB1369
DR   Wikidata; Q98135861
RX   PubMed=832273;
RX   PubMed=7240788;
CC   Population: Japanese.
CC   Derived from site: In situ; Elbow, skin; UBERON=UBERON_0001517.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZM50 ! XP4JTO-II
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4JTO-II
AC   CVCL_ZM50
SY   Xeroderma Pigmentosum 5 Japan TOkyo-II
DR   Wikidata; Q98135863
RX   PubMed=7240788;
CC   Population: Japanese.
CC   Derived from site: In situ; Elbow, skin; UBERON=UBERON_0001517.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZM49 ! XP4JTO-I
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4KA
AC   CVCL_ZM53
SY   Xeroderma Pigmentosum 4 KAnazawa
DR   JCRB; KURB1050
DR   JCRB; KURB1051
DR   Wikidata; Q98135866
RX   PubMed=3834095;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4KG
AC   CVCL_ZQ59
DR   Wikidata; Q98135868
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP4KO
AC   CVCL_ZM29
SY   Xeroderma Pigmentosum 4 KObe
DR   Wikidata; Q98135871
RX   PubMed=967189;
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4KR
AC   CVCL_ZQ22
DR   JCRB; KURB1032
DR   Wikidata; Q98135873
RX   PubMed=7905727;
RX   PubMed=8105686;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Heterozygous (PubMed=7905727).
CC   Donor information: Established from monozygotic twin of XP3KR (Cellosaurus=CVCL_L777).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP4KY
AC   CVCL_ZQ60
SY   Xeroderma Pigmentosum 4 KYoto
DR   JCRB; KURB1276
DR   Wikidata; Q98135877
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4LE
AC   CVCL_ZV15
SY   Xeroderma Pigmentosum 4 LEeds
DR   Wikidata; Q98135880
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu726Profs*67 (c.2176_2192del17); ClinVar=VCV002679642; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP4LO
AC   CVCL_L757
SY   Xeroderma Pigmentosum 4 LOndon; GM00544; GM-544; GM0544; GM 544; GM544; GM00544B; GM544B
DR   CLO; CLO_0026048
DR   Coriell; GM00544
DR   Wikidata; Q54836302
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=837385;
RX   PubMed=1214825;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=4066782;
RX   PubMed=4778857;
RX   PubMed=6492896;
RX   PubMed=6947227;
RX   PubMed=7067035;
RX   PubMed=7161312;
RX   PubMed=7360141;
RX   PubMed=7471106;
RX   PubMed=7671243;
RX   PubMed=7825573;
RX   PubMed=9671271;
RX   PubMed=11219864;
RX   PubMed=14688028;
RX   PubMed=18079351;
RX   PubMed=18470933;
RX   PubMed=26184184;
CC   Senescence: Senesces at 21 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.468_469delAA; Zygosity=Homozygous (PubMed=9671271; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 22
//
ID   XP4MA
AC   CVCL_ZQ90
SY   Xeroderma Pigmentosum 4 MAnnheim
DR   Wikidata; Q98135882
RX   PubMed=2054785;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4MO
AC   CVCL_IM47
SY   Xeroderma Pigmentosum 4 MOscow; IMG-1021 XP4MO; IMG-1021
DR   CLO; CLO_0006714
DR   CLDB; cl2646
DR   Wikidata; Q54897549
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP4MY
AC   CVCL_ZS28
DR   JCRB; KURB1304
DR   Wikidata; Q98135885
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4NA
AC   CVCL_ZN18
SY   Xeroderma Pigmentosum 4 NAgoya
DR   JCRB; KURB1308
DR   Wikidata; Q98135888
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4OS
AC   CVCL_ZM80
SY   Xeroderma Pigmentosum 4 OSaka
DR   Wikidata; Q98135891
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4PA
AC   CVCL_ZP32
DR   Wikidata; Q98135894
RX   PubMed=3029584;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (from child cell line XP4PA(SV)).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP4PA(SV)
AC   CVCL_6E33
SY   XP4PA-SV; XP4PA-SVwt; XP4PA-SV40; XP4PALas
DR   JCRB; KURB1064
DR   Wikidata; Q54994957
RX   PubMed=1660831;
RX   PubMed=3029584;
RX   PubMed=8298653;
RX   PubMed=9012405;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (PubMed=8298653).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   XP4PA-SE1
AC   CVCL_F627
SY   GM16247
DR   CLO; CLO_0019445
DR   Coriell; GM16247
DR   Wikidata; Q54994953
RX   PubMed=10681431;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12816; XPC.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F625 ! XP4PA-SV-EB
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   XP4PA-SE2
AC   CVCL_F628
SY   GM16248
DR   CLO; CLO_0019446
DR   Coriell; GM16248
DR   Wikidata; Q54994955
RX   PubMed=10681431;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:12816; XPC.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F625 ! XP4PA-SV-EB
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   XP4PA-SV-EB
AC   CVCL_F625
SY   GM15983
DR   CLO; CLO_0018741
DR   Coriell; GM15983
DR   Wikidata; Q54994956
RX   PubMed=1660831;
RX   PubMed=10681431;
RX   PubMed=14662655;
RX   PubMed=18955168;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (c.1643_1644delTG) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P03211; Epstein-Barr virus (strain B95-8) EBNA1.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6E33 ! XP4PA(SV)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   XP4RO
AC   CVCL_U695
SY   XP-4; Xeroderma Pigmentosum 4 ROtterdam
DR   ATCC; CRL-1260
DR   Wikidata; Q54994852
RX   PubMed=273925;
RX   PubMed=837385;
RX   PubMed=1034206;
RX   PubMed=1383811;
RX   PubMed=4436596;
RX   PubMed=4778857;
RX   PubMed=7471106;
RX   PubMed=10766188;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg220Ter (c.658C>T); ClinVar=VCV000550020; Zygosity=Homozygous (PubMed=10766188).
CC   Discontinued: ATCC; CRL-1260; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   XP4SA
AC   CVCL_ZM60
SY   Xeroderma Pigmentosum 4 SApporo
DR   JCRB; KURB1355
DR   Wikidata; Q98135896
RX   PubMed=7830260;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4SE
AC   CVCL_ZM65
SY   Xeroderma Pigmentosum 4 SEndai
DR   Wikidata; Q98135898
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP4SL
AC   CVCL_F492
SY   GM00673; GM-673
DR   CLO; CLO_0028858
DR   Coriell; GM00673
DR   Wikidata; Q54836384
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Homozygous (from familial inference of XP8BE; XP9BE).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   XP4TUF
AC   CVCL_ZS23
SY   Xeroderma Pigmentosum 4 TUrku Finland
DR   Wikidata; Q98135900
RX   PubMed=18079351;
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP51BR
AC   CVCL_ZV16
SY   Xeroderma Pigmentosum 51 BRighton
DR   Wikidata; Q98135904
RX   PubMed=26884178;
CC   Population: Middle Eastern.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2251-1G>C; ClinVar=VCV000190213; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   23Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP51RO
AC   CVCL_ZP55
SY   Xeroderma Pigmentosum 51 ROtterdam; XFE
DR   Wikidata; Q98135908
RX   PubMed=17183314;
RX   PubMed=20221251;
CC   Population: Afghan.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg153Pro (c.458G>C); ClinVar=VCV000016581; Zygosity=Homozygous (PubMed=17183314; PubMed=20221251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173111; XFE progeroid syndrome
DI   ORDO; Orphanet_363245; Genetic progeroid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP51RO-hTERT
AC   CVCL_ZP56
DR   Wikidata; Q98135910
RX   PubMed=14690602;
CC   Population: Afghan.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg153Pro (c.458G>C); ClinVar=VCV000016581; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173111; XFE progeroid syndrome
DI   ORDO; Orphanet_363245; Genetic progeroid syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP55 ! XP51RO
SX   Male
AG   15Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP51VI
AC   CVCL_ZQ07
SY   Xeroderma Pigmentosum 51 VIllejuif
DR   Wikidata; Q98135911
RX   PubMed=11773631;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys163fs (Ex5del) (Fs163); Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP52HM
AC   CVCL_ZS96
SY   Xeroderma Pigmentosum 52 HamaMatsu
DR   Wikidata; Q98135913
RX   PubMed=17951140;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP52MA
AC   CVCL_ZQ91
SY   Xeroderma Pigmentosum 52 MAnnheim
DR   Wikidata; Q98135917
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP52RO
AC   CVCL_ZQ08
SY   Xeroderma Pigmentosum 52 ROtterdam
DR   Wikidata; Q98135920
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg356Ter (c.1066C>T); ClinVar=VCV001459259; Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   56Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP53BR
AC   CVCL_ZR91
SY   Xeroderma Pigmentosum 53 BRighton
DR   Wikidata; Q98135923
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP53RO
AC   CVCL_ZQ09
SY   Xeroderma Pigmentosum 53 ROtterdam
DR   Wikidata; Q98135925
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gly295fs (c.882dupT) (Fs294); Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg356Ter (c.1066C>T); ClinVar=VCV001459259; Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys163fs (Ex5del) (Fs163); Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 10
//
ID   XP54BE
AC   CVCL_M326
SY   Xeroderma Pigmentosum 54 BEthesda; GM17861
DR   CLO; CLO_0016463
DR   Coriell; GM17861
DR   Wikidata; Q54849291
RX   PubMed=16081512;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys692Ter (c.2074A>T); ClinVar=VCV000496267; Zygosity=Heterozygous (PubMed=16081512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP54MA
AC   CVCL_ZQ74
SY   Xeroderma Pigmentosum 54 MAnnheim
DR   Wikidata; Q98135928
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP54PV
AC   CVCL_ZV17
SY   Xeroderma Pigmentosum 54 PaVia
DR   Wikidata; Q98135930
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Lys217Glufs*3 (c.648_649delGA); ClinVar=VCV000374933; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP54TO
AC   CVCL_ZN77
SY   Xeroderma Pigmentosum 54 TOkyo
DR   Wikidata; Q98135933
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP55BR
AC   CVCL_ZV18
SY   Xeroderma Pigmentosum 55 BRighton
DR   Wikidata; Q98135935
RX   PubMed=26884178;
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; c.264+1delG; ClinVar=VCV002636488; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP55MA
AC   CVCL_ZR11
SY   Xeroderma Pigmentosum 55 MAnnheim
DR   Wikidata; Q98135939
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP56BR
AC   CVCL_ZV19
SY   Xeroderma Pigmentosum 56 BRighton
DR   Wikidata; Q98135942
RX   PubMed=26884178;
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; c.264+1delG; ClinVar=VCV002636488; Zygosity=Homozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP56MA
AC   CVCL_E7FD
SY   Xeroderma Pigmentosum 56 MAnnheim
RX   PubMed=3182904;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   XP56RO
AC   CVCL_ZQ10
SY   Xeroderma Pigmentosum 56 ROtterdam
DR   Wikidata; Q98135945
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Trp297Ter (c.890G>A); ClinVar=VCV000005888; Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys163fs (Ex5del) (Fs163); Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   25Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 9
//
ID   XP57BR
AC   CVCL_ZR92
SY   Xeroderma Pigmentosum 57 BRighton
DR   Wikidata; Q98135947
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Bangladeshi.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Met214Asnfs*7 (c.640dupA); ClinVar=VCV001805601; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP57RO
AC   CVCL_ZQ11
SY   Xeroderma Pigmentosum 57 ROtterdam
DR   Wikidata; Q98135950
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg361Ser (c.1083G>T) (G1083T); Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   57Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP58BR
AC   CVCL_ZS57
SY   Xeroderma Pigmentosum 58 BRighton
DR   Wikidata; Q98135953
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP58RO
AC   CVCL_ZQ12
SY   Xeroderma Pigmentosum 58 ROtterdam
DR   Wikidata; Q98135955
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP58TO
AC   CVCL_ZN27
SY   Xeroderma Pigmentosum 58 TOkyo
DR   Wikidata; Q98135959
RX   PubMed=3922833;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP59BR
AC   CVCL_ZS55
SY   Xeroderma Pigmentosum 59 BRighton
DR   Wikidata; Q98135961
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_WX47 ! XP102LO
SX   Female
AG   53Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP59RO
AC   CVCL_ZQ13
SY   Xeroderma Pigmentosum 59 ROtterdam
DR   Wikidata; Q98135964
RX   PubMed=11773631;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP59TO
AC   CVCL_ZM30
SY   Xeroderma Pigmentosum 59 TOkyo
DR   JCRB; KURB1078
DR   Wikidata; Q98135967
RX   PubMed=3341805;
RX   PubMed=3922833;
RX   PubMed=4031543;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP5BE
AC   CVCL_U762
SY   XP5 BE; Xeroderma Pigmentosum 5 BEthesda; Be Wen; BeWen
DR   ATCC; CRL-1160
DR   JCRB; KURB1071
DR   Wikidata; Q54994958
RX   PubMed=273925;
RX   PubMed=643622;
RX   PubMed=656543;
RX   PubMed=837385;
RX   PubMed=1372108;
RX   PubMed=4811796;
RX   PubMed=22282976;
CC   Population: Caucasian.
CC   Discontinued: ATCC; CRL-1160; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 11
//
ID   XP5BI
AC   CVCL_ZQ03
SY   Xeroderma Pigmentosum 5 BIrmingham
DR   Wikidata; Q98135971
RX   PubMed=11773631;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr122Pro (c.364A>C); Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr408Leufs*36 (c.1222_1225delACTT) (Fs407); ClinVar=VCV002431387; Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP5CA
AC   CVCL_L771
SY   Xeroderma Pigmentosum 5 CAiro; GM02994; GM2994; GM17378
DR   CLO; CLO_0012578
DR   CLO; CLO_0013699
DR   BioSample; SAMN00808202
DR   Coriell; GM02994
DR   Coriell; GM17378
DR   Wikidata; Q54837795
RX   CelloPub=CLPUB00447;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=3030788;
RX   PubMed=6492896;
RX   PubMed=6684957;
RX   PubMed=7163956;
RX   PubMed=7252263;
RX   PubMed=8595429;
RX   PubMed=9671271;
CC   Part of: Human variation panel.
CC   Population: Egyptian.
CC   Senescence: Senesces at 17 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.507-2A>G (IVS3-2A>G); Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=8595429).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 22
//
ID   XP5EH
AC   CVCL_ZP82
SY   Xeroderma Pigmentosum 5 EHime
DR   JCRB; KURB1025
DR   Wikidata; Q98135974
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5GO
AC   CVCL_ZP77
DR   Wikidata; Q98135976
RX   PubMed=16794584;
CC   Population: Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys642Ilefs*20 (c.1923_1934delins25); Zygosity=Homozygous (PubMed=16794584).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP5JO
AC   CVCL_L765
SY   Xeroderma Pigmentosum 5 JOhannesburg; GM02091; GM-2091; GM2091
DR   CLO; CLO_0031825
DR   BioSample; SAMN00807476
DR   Coriell; GM02091
DR   JCRB; KURB1029
DR   Wikidata; Q54837296
RX   CelloPub=CLPUB00447;
RX   PubMed=9671271;
CC   Population: African; Zulu.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg130Lys (c.389G>A); ClinVar=VCV000551153; Zygosity=Homozygous; Note=Affects splicing (PubMed=9671271).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   XP5JTO
AC   CVCL_ZM51
SY   XP5TO; XP5; Xeroderma Pigmentosum 5 Japan TOkyo
DR   JCRB; KURB1124
DR   Wikidata; Q98135979
RX   PubMed=832273;
RX   PubMed=7240788;
RX   PubMed=7264357;
CC   Population: Japanese.
CC   Derived from site: In situ; Elbow, skin; UBERON=UBERON_0001517.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5KA
AC   CVCL_ZS71
SY   Xeroderma Pigmentosum 5 KAnazawa
DR   JCRB; KURB1116
DR   Wikidata; Q98135981
RX   PubMed=17409408;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5KO
AC   CVCL_ZM32
SY   Xeroderma Pigmentosum 5 KObe
DR   Wikidata; Q98135984
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5KY
AC   CVCL_ZQ61
SY   Xeroderma Pigmentosum 5 KYoto
DR   JCRB; KURB1277
DR   Wikidata; Q98135987
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5MA
AC   CVCL_M283
SY   Xeroderma Pigmentosum 5 MAnnheim; GM03379; GM3379
DR   CLO; CLO_0016680
DR   BioSample; SAMN00808379
DR   Coriell; GM03379
DR   Wikidata; Q54838036
RX   CelloPub=CLPUB00447;
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=6492896;
RX   PubMed=7165374;
RX   PubMed=7263770;
RX   PubMed=7326997;
RX   PubMed=10398605;
CC   Population: Caucasian; German.
CC   Senescence: Senesces at 19 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys220fs (c.661_764del); Zygosity=Homozygous (PubMed=10398605).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   86Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 18
//
ID   XP5MO
AC   CVCL_IM48
SY   Xeroderma Pigmentosum 5 MOscow; IMG-1024 XP5MO; IMG-1025
DR   CLO; CLO_0006716
DR   CLDB; cl2648
DR   Wikidata; Q54897550
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP5MY
AC   CVCL_ZS29
DR   JCRB; KURB1305
DR   Wikidata; Q98135990
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5OS
AC   CVCL_ZM81
SY   Xeroderma Pigmentosum 5 OSaka
DR   JCRB; KURB1118
DR   Wikidata; Q98135992
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5PD
AC   CVCL_L763
SY   GM02062; GM-2062; GM2062
DR   CLO; CLO_0032532
DR   BioSample; SAMN00807448
DR   Coriell; GM02062
DR   Wikidata; Q54837279
RX   CelloPub=CLPUB00447;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=6492896;
RX   PubMed=9671271;
CC   Senescence: Senesces at 36 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (PubMed=9671271; Coriell=GM02062).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg211Ter (c.631C>T); ClinVar=VCV000551809; Zygosity=Heterozygous (PubMed=9671271; Coriell=GM02062).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 23
//
ID   XP5PV
AC   CVCL_RU47
SY   Xeroderma Pigmentosum 5 PaVia
DR   CLO; CLO_0009669
DR   CLDB; cl4762
DR   Wikidata; Q54994909
RX   PubMed=9584159;
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Ala109Argfs*5 (c.321_322insAA); Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XP5RO
AC   CVCL_ZR59
SY   Xeroderma Pigmentosum 5 ROtterdam
DR   Wikidata; Q98135995
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5SA
AC   CVCL_ZM61
SY   Xeroderma Pigmentosum 5 SApporo
DR   JCRB; KURB1356
DR   Wikidata; Q98135997
RX   PubMed=7830260;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5SE
AC   CVCL_U871
SY   Xeroderma Pigmentosum 5 SEndai
DR   JCRB; KURB1358
DR   Wikidata; Q54994959
RX   PubMed=202381;
RX   PubMed=832273;
RX   PubMed=6865988;
RX   PubMed=11219864;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8773 ! XP5SE LCL
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   XP5SE LCL
AC   CVCL_8773
SY   Xeroderma Pigmentosum 5 SEndai LCL; XPL 5; XPL5
DR   CLO; CLO_0050476
DR   BioSample; SAMN03472081
DR   RCB; RCB1875
DR   TKG; TKG 0309
DR   Wikidata; Q54995028
RX   PubMed=202381;
RX   PubMed=6529424;
RX   PubMed=6865988;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): RCB=RCB1875; TKG=TKG 0309
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 10,11
ST   D5S818: 13
ST   D7S820: 11,12
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U871 ! XP5SE
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 17
//
ID   XP5TU
AC   CVCL_ZQ32
SY   Xeroderma Pigmentosum 5 TUnisia
DR   Wikidata; Q98136000
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP5TUF
AC   CVCL_ZS15
SY   Xeroderma Pigmentosum 5 TUrku Finland
DR   Wikidata; Q98136002
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP62BR
AC   CVCL_ZS58
SY   Xeroderma Pigmentosum 62 BRighton
DR   Wikidata; Q98136005
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP62RO
AC   CVCL_ZP54
SY   Xeroderma Pigmentosum 62 ROtterdam
DR   Wikidata; Q98136008
RX   PubMed=20221251;
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg799Trp (c.2395C>T) (R788W); ClinVar=VCV000016580; Zygosity=Homozygous (PubMed=20221251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP62VI
AC   CVCL_ZP96
SY   Xeroderma Pigmentosum 62 VIllejuif
DR   Wikidata; Q98136010
RX   PubMed=11773631;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359Valfs*32 (c.1075_1244del170) (Ex10del); Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP63BR
AC   CVCL_ZV20
SY   Xeroderma Pigmentosum 63 BRighton
DR   Wikidata; Q98136013
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys70Serfs*30 (c.207delG); ClinVar=VCV000005892; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP64BR
AC   CVCL_ZV21
SY   Xeroderma Pigmentosum 64 BRighton
DR   Wikidata; Q98136018
RX   PubMed=26884178;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Tyr146Ter (c.437dupA); Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   55Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP65BE
AC   CVCL_M316
SY   Xeroderma Pigmentosum 65 BEthesda; GM16398
DR   CLO; CLO_0019512
DR   Coriell; GM16398
DR   Wikidata; Q54848508
RX   PubMed=12060391;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Gln136Ter (c.406C>T) (C603T); ClinVar=VCV000016578; Zygosity=Heterozygous (PubMed=12060391).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala874Thr (c.2620G>A) (G2817A); ClinVar=VCV000016577; Zygosity=Heterozygous (PubMed=12060391).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M310 ! XP65BE LCL
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   XP65BE LCL
AC   CVCL_M310
SY   Xeroderma Pigmentosum 65 BEthesda LCL; GM16024
DR   CLO; CLO_0018762
DR   Coriell; GM16024
DR   Wikidata; Q54848307
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Gln136Ter (c.406C>T) (C603T); ClinVar=VCV000016578; Zygosity=Heterozygous (from autologous cell line XP65BE).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala874Thr (c.2620G>A) (G2817A); ClinVar=VCV000016577; Zygosity=Heterozygous (from autologous cell line XP65BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M316 ! XP65BE
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   XP664VI
AC   CVCL_ZR36
SY   Xeroderma Pigmentosum 664 VIllejuif
DR   Wikidata; Q98136021
RX   PubMed=16081512;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Homozygous (PubMed=16081512).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP665VI
AC   CVCL_ZR37
SY   Xeroderma Pigmentosum 665 VIllejuif
DR   Wikidata; Q98136023
RX   PubMed=16081512;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Homozygous (from familial inference of XP664VI).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP66TU
AC   CVCL_ZV22
DR   Wikidata; Q98136026
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Leu309_313del (c.924_938del15); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Ala341Ser (c.1021G>T); Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP67BR
AC   CVCL_ZV23
SY   Xeroderma Pigmentosum 67 BRighton
DR   Wikidata; Q98136028
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Leu461Val (c.1381C>G); ClinVar=VCV000016779; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg511Gln (c.1532G>A); Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Ala717Gly (c.2150C>G) (p.Val716_Arg730del); ClinVar=VCV000134102; Zygosity=Heterozygous; Note=Creates a cryptic donor splice site (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   65Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP67TMA
AC   CVCL_1F33
SY   Xeroderma Pigmentosum Turkey MAlatya 67; GM14867
DR   CLO; CLO_0031923
DR   Coriell; GM14867
DR   Wikidata; Q54847483
RX   PubMed=11511294;
RX   PubMed=16081512;
RX   PubMed=18809580;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Homozygous (PubMed=11511294; PubMed=18809580).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XP67TO
AC   CVCL_ZN86
SY   Xeroderma Pigmentosum 67 TOkyo
DR   Wikidata; Q98136031
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Tyr116Ter (c.348T>A); ClinVar=VCV000000997; Zygosity=Heterozygous (PubMed=1372102; PubMed=1702221).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=1372102; PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP68TMA
AC   CVCL_1F34
SY   Xeroderma Pigmentosum Turkey MAlatya 68; GM14869
DR   CLO; CLO_0031924
DR   Coriell; GM14869
DR   Wikidata; Q54847484
RX   PubMed=11511294;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Homozygous (PubMed=11511294).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XP69TMA
AC   CVCL_1F36
SY   Xeroderma Pigmentosum Turkey MAlatya 69; GM14871; GM14871A
DR   CLO; CLO_0031926
DR   Coriell; GM14871
DR   Wikidata; Q54847486
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr430Ter (c.1290_1295delTAAAGA) (p.Tyr430_Glu432delinsTer) (1395_1400delTAAAGA); ClinVar=VCV000940041; Zygosity=Homozygous (Coriell=GM14871).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F35 ! XP69TMA LCL
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XP69TMA LCL
AC   CVCL_1F35
SY   Xeroderma Pigmentosum Turkey MAlatya 69 LCL; GM14870; GM14870A
DR   CLO; CLO_0031925
DR   Coriell; GM14870
DR   Wikidata; Q54847485
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr430Ter (c.1290_1295delTAAAGA) (p.Tyr430_Glu432delinsTer) (1395_1400delTAAAGA); ClinVar=VCV000940041; Zygosity=Homozygous (Coriell=GM14870).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F36 ! XP69TMA
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XP6BE
AC   CVCL_F599
AS   CVCL_U683
SY   XP6 BE; Xeroderma Pigmentosum 6 BEthesda; Cay Wen; GM10430; GM 10430
DR   CLO; CLO_0028648
DR   ATCC; CRL-1157
DR   BioSample; SAMN00800015
DR   Coriell; GM10430
DR   Wikidata; Q54844449
RX   CelloPub=CLPUB00447;
RX   PubMed=273925;
RX   PubMed=643622;
RX   PubMed=1372108;
RX   PubMed=3922833;
RX   PubMed=4811796;
RX   PubMed=6409440;
RX   PubMed=30165384;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (Coriell=GM10430).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly36_Arg61del; Zygosity=Heterozygous (Coriell=GM10430).
CC   Discontinued: ATCC; CRL-1157; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 21
//
ID   XP6BE(SV)
AC   CVCL_F505
SY   GM08207; GM08207B; GM-08207B; GM 8207; XP6BE(SV40); XP6BE-SV; XP6BESV
DR   CLO; CLO_0010128
DR   Coriell; GM08207
DR   Wikidata; Q54843101
RX   CelloPub=CLPUB00447;
RX   PubMed=1372108;
RX   PubMed=7563073;
RX   PubMed=7585650;
RX   PubMed=7671243;
RX   PubMed=8033104;
RX   PubMed=8055625;
RX   PubMed=8824772;
RX   PubMed=9012405;
RX   PubMed=9025096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=7585650; Coriell=GM08207).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly36_Arg61del; Zygosity=Heterozygous (PubMed=7585650; Coriell=GM08207).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F599 ! XP6BE
SX   Female
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 22
//
ID   XP6BI
AC   CVCL_ZS59
SY   Xeroderma Pigmentosum 6 BIrmingham
DR   Wikidata; Q98136035
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP6BR
AC   CVCL_ZN51
SY   Xeroderma Pigmentosum 6 BRighton
DR   Wikidata; Q98136037
RX   PubMed=1372096;
RX   PubMed=1372100;
RX   PubMed=1911321;
RX   PubMed=7825573;
RX   PubMed=10766188;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Thr808Valfs*48 (c.2421_2604del184); Zygosity=Heterozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2558 ! XP6BR LCL
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP6BR LCL
AC   CVCL_2558
SY   Xeroderma Pigmentosum 6 BRighton LCL; LB253; 253
DR   ECACC; 98062330
DR   Wikidata; Q54902053
RX   PubMed=1372096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Thr808Valfs*48 (c.2421_2604del184); Zygosity=Heterozygous (from autologous cell line XP6BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): ECACC=98062330
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,13
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN51 ! XP6BR
SX   Male
AG   67Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   XP6CA
AC   CVCL_F507
SY   Xeroderma Pigmentosum 6 CAiro; GM02995; GM 2995; GM2995
DR   CLO; CLO_0012586
DR   BioSample; SAMN00808203
DR   Coriell; GM02995
DR   Wikidata; Q54837796
RX   CelloPub=CLPUB00447;
RX   PubMed=2897722;
RX   PubMed=6442144;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   XP6DU
AC   CVCL_M287
SY   Xeroderma Pigmentosum 6 DUndee; GM03618; GM3618
DR   CLO; CLO_0017196
DR   Coriell; GM03618
DR   Wikidata; Q54838160
RX   CelloPub=CLPUB00447;
RX   PubMed=7326997;
RX   PubMed=10022907;
RX   PubMed=10398605;
RX   PubMed=11773631;
RX   PubMed=18079351;
RX   PubMed=26884178;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys70Serfs*30 (c.207delG); ClinVar=VCV000005892; Zygosity=Heterozygous (PubMed=10398605; PubMed=11773631; PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Heterozygous (PubMed=10398605; PubMed=11773631; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP6EH
AC   CVCL_ZS40
SY   Xeroderma Pigmentosum 6 EHime
DR   JCRB; KURB1016
DR   JCRB; KURB1017
DR   Wikidata; Q98136040
RX   PubMed=2778352;
RX   PubMed=7905727;
RX   PubMed=8101209;
RX   PubMed=8596539;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP6EHF
AC   CVCL_ZW26
SY   Xeroderma Pigmentosum 6 EHime Father
DR   JCRB; KURB1019
DR   Wikidata; Q102115133
RX   PubMed=8101209;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (from familial inference of XP6EH).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   XP6EHM
AC   CVCL_ZW27
SY   Xeroderma Pigmentosum 6 EHime Mother
DR   JCRB; KURB1021
DR   Wikidata; Q102115134
RX   PubMed=8101209;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (from familial inference of XP6EH).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   XP6GO
AC   CVCL_ZP78
DR   Wikidata; Q98136042
RX   PubMed=16794584;
CC   Population: Iraqi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys642Ilefs*20 (c.1923_1934delins25); Zygosity=Homozygous (PubMed=16794584).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP6JO
AC   CVCL_M233
SY   Xeroderma Pigmentosum 6 JOhannesburg; GM02476; GM17344
DR   CLO; CLO_0013735
DR   CLO; CLO_0033207
DR   Coriell; GM02476
DR   Coriell; GM17344
DR   Wikidata; Q54837512
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: African; Zulu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   XP6KO
AC   CVCL_ZM31
SY   Xeroderma Pigmentosum 6 KObe
DR   Wikidata; Q98136045
RX   PubMed=3341805;
RX   PubMed=3922833;
RX   PubMed=4011712;
RX   PubMed=4031543;
RX   PubMed=7259973;
RX   PubMed=7300843;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP6MA
AC   CVCL_ZR23
SY   Xeroderma Pigmentosum 6 MAnnheim
DR   Wikidata; Q98136047
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP6MO
AC   CVCL_IM49
SY   Xeroderma Pigmentosum 6 MOscow; IMG-1028 XP6MO; IMG-1028
DR   CLO; CLO_0006719
DR   CLDB; cl2651
DR   Wikidata; Q54897551
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP6MY
AC   CVCL_ZS30
DR   JCRB; KURB1235
DR   JCRB; KURB1236
DR   Wikidata; Q98136050
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP6NA
AC   CVCL_ZQ24
SY   Xeroderma Pigmentosum 6 NAgoya
DR   JCRB; KURB1033
DR   Wikidata; Q98136053
RX   PubMed=7000335;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP6OS
AC   CVCL_ZM82
SY   Xeroderma Pigmentosum 6 OSaka
DR   Wikidata; Q98136056
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP6RO
AC   CVCL_ZR60
SY   Xeroderma Pigmentosum 6 ROtterdam
DR   Wikidata; Q98136059
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP6SE
AC   CVCL_ZM66
SY   Xeroderma Pigmentosum 6 SEndai
DR   Wikidata; Q98136061
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP6TO
AC   CVCL_9S70
SY   Xeroderma Pigmentosum 6 TOkyo
DR   JCRB; KURB1370
DR   Wikidata; Q54994961
RX   PubMed=273925;
RX   PubMed=832273;
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   7Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 11
//
ID   XP6TUF
AC   CVCL_ZS17
SY   Xeroderma Pigmentosum 6 TUrku Finland
DR   Wikidata; Q98136064
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP70BR
AC   CVCL_ZV24
SY   Xeroderma Pigmentosum 70 BRighton
DR   Wikidata; Q98136067
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; c.816-2A>G; ClinVar=VCV000631814; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP70MA
AC   CVCL_ZQ86
SY   Xeroderma Pigmentosum 70 MAnnheim
DR   Wikidata; Q98136069
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP70TMA
AC   CVCL_AK74
SY   Xeroderma Pigmentosum Turkey MAlatya 70; GM15697
DR   CLO; CLO_0027655
DR   Coriell; GM15697
DR   Wikidata; Q54848133
RX   PubMed=18368133;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK75 ! XP70TMA LCL
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   XP70TMA LCL
AC   CVCL_AK75
SY   Xeroderma Pigmentosum Turkey MAlatya 70 LCL; GM15698
DR   CLO; CLO_0027666
DR   Coriell; GM15698
DR   Wikidata; Q54848134
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (from autologous cell line XP70TMA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK74 ! XP70TMA
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   XP70TO
AC   CVCL_F513
SY   Xeroderma Pigmentosum 70 TOkyo
DR   JCRB; JCRB3013
DR   JCRB; JCRB3014
DR   JCRB; KURB1082
DR   JCRB; KURB1083
DR   Wikidata; Q54994962
RX   PubMed=1376435;
RX   PubMed=10771487;
RX   PubMed=22466610;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:29304; UVSSA; Simple; p.Lys123Ter (c.367A>T); ClinVar=VCV000031569; Zygosity=Homozygous (PubMed=22466610).
CC   Discontinued: JCRB; KURB1082; probable.
CC   Discontinued: JCRB; KURB1083; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB3013; JCRB=JCRB3014
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D18S51: 12,14
ST   D21S11: 29
ST   D3S1358: 15,17
ST   D5S818: 11,13
ST   D7S820: 8,10
ST   D8S1179: 12,13
ST   FGA: 19,23
ST   Penta D: 9,10
ST   Penta E: 18,21
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C173107; UV-sensitive syndrome 3
DI   ORDO; Orphanet_178338; UV-sensitive syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   XP71BR
AC   CVCL_ZV25
SY   Xeroderma Pigmentosum 71 BRighton
DR   Wikidata; Q98136072
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; c.816-2A>G; ClinVar=VCV000631814; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP71TMA
AC   CVCL_AK70
SY   Xeroderma Pigmentosum Turkey MAlatya 71; GM14875
DR   CLO; CLO_0032069
DR   Coriell; GM14875
DR   Wikidata; Q54847487
RX   PubMed=18368133;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   XP72BR
AC   CVCL_ZV26
SY   Xeroderma Pigmentosum 72 BRighton
DR   Wikidata; Q98136075
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Pro379Ser (c.1135C>T); ClinVar=VCV000134148; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP72MA
AC   CVCL_4T41
SY   Xeroderma Pigmentosum 72 MAnnheim
DR   Wikidata; Q54994963
RX   PubMed=23370536;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 22-09-15; Last updated: 29-06-23; Version: 7
//
ID   XP72TMA
AC   CVCL_1F38
SY   Xeroderma Pigmentosum Turkey MAlatya 72; GM14877
DR   CLO; CLO_0032070
DR   Coriell; GM14877
DR   Wikidata; Q54847489
RX   PubMed=14662655;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-24A>G (IVS3-24A>G); ClinVar=VCV000000261; Zygosity=Homozygous (PubMed=14662655).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F37 ! XP72TMA LCL
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XP72TMA LCL
AC   CVCL_1F37
SY   Xeroderma Pigmentosum Turkey MAlatya 72 LCL; GM14876; GM14876A
DR   CLO; CLO_0032071
DR   Coriell; GM14876
DR   Wikidata; Q54847488
RX   PubMed=14662655;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-24A>G (IVS3-24A>G); ClinVar=VCV000000261; Zygosity=Homozygous (Coriell=GM14876).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F38 ! XP72TMA
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XP73BR
AC   CVCL_ZS60
SY   Xeroderma Pigmentosum 73 BRighton
DR   Wikidata; Q98136078
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP73TMA
AC   CVCL_1F40
SY   Xeroderma Pigmentosum Turkey MAlatya 73; GM14879
DR   CLO; CLO_0032072
DR   Coriell; GM14879
DR   Wikidata; Q54847491
RX   PubMed=14662655;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-24A>G (IVS3-24A>G); ClinVar=VCV000000261; Zygosity=Homozygous (PubMed=14662655).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F39 ! XP73TMA LCL
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XP73TMA LCL
AC   CVCL_1F39
SY   Xeroderma Pigmentosum Turkey MAlatya 73 LCL; GM14878; GM14878A
DR   CLO; CLO_0032073
DR   Coriell; GM14878
DR   Wikidata; Q54847490
RX   PubMed=14662655;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-24A>G (IVS3-24A>G); ClinVar=VCV000000261; Zygosity=Homozygous (Coriell=GM14878).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F40 ! XP73TMA
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XP74MA
AC   CVCL_ZQ87
SY   Xeroderma Pigmentosum 74 MAnnheim
DR   Wikidata; Q98136080
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP74TMA
AC   CVCL_AK71
SY   Xeroderma Pigmentosum Turkey MAlatya 74; GM14881
DR   CLO; CLO_0032075
DR   Coriell; GM14881
DR   Wikidata; Q54847492
CC   Population: Turkish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   16Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   XP75TMA
AC   CVCL_AK73
SY   Xeroderma Pigmentosum Turkey MAlatya 75; GM14883
DR   CLO; CLO_0032077
DR   Coriell; GM14883
DR   Wikidata; Q54847494
CC   Population: Turkish.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK72 ! XP75TMA LCL
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   XP75TMA LCL
AC   CVCL_AK72
SY   Xeroderma Pigmentosum Turkey MAlatya 75 LCL; GM14882; GM14882A
DR   CLO; CLO_0032074
DR   Coriell; GM14882
DR   Wikidata; Q54847493
CC   Population: Turkish.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK73 ! XP75TMA
SX   Male
AG   11Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 10
//
ID   XP75TO
AC   CVCL_ZN85
SY   Xeroderma Pigmentosum 75 TOkyo
DR   Wikidata; Q98136084
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=1372102; PubMed=1702221).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Heterozygous (PubMed=1372102; PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP75VI
AC   CVCL_ZP97
SY   Xeroderma Pigmentosum 75 VIllejuif
DR   Wikidata; Q98136087
RX   PubMed=11773631;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359Valfs*32 (c.1075_1244del170) (Ex10del); Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   17Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP76BR
AC   CVCL_ZS61
SY   Xeroderma Pigmentosum 76 BRighton
DR   Wikidata; Q98136089
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP77BR
AC   CVCL_ZS62
SY   Xeroderma Pigmentosum 77 BRighton
DR   Wikidata; Q98136091
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP77MA
AC   CVCL_ZQ88
SY   Xeroderma Pigmentosum 77 MAnnheim
DR   Wikidata; Q98136094
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP78BR
AC   CVCL_ZS63
SY   Xeroderma Pigmentosum 78 BRighton
DR   Wikidata; Q98136097
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP78TO
AC   CVCL_ZN89
SY   Xeroderma Pigmentosum 78 TOkyo
DR   Wikidata; Q98136100
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Tyr116Ter (c.348T>A); ClinVar=VCV000000997; Zygosity=Heterozygous (PubMed=1372102).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP79MA
AC   CVCL_ZQ89
SY   Xeroderma Pigmentosum 79 MAnnheim
DR   Wikidata; Q98136102
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7BE
AC   CVCL_U669
SY   XP7 BE; Xeroderma Pigmentosum 7 BEthesda; Te Ko; TeKo; GM02590
DR   ATCC; CRL-1200
DR   Coriell; GM02590
DR   JCRB; KURB1072
DR   Wikidata; Q54972006
RX   PubMed=273925;
RX   PubMed=643622;
RX   PubMed=1372108;
RX   PubMed=4811796;
RX   PubMed=6492896;
RX   PubMed=7273335;
CC   Population: Caucasian.
CC   Senescence: Senesces at 26 PDL (PubMed=6492896).
CC   Discontinued: ATCC; CRL-1200; true.
CC   Discontinued: Coriell; GM02590; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_7359 ! XP7BE LCL
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 12
//
ID   XP7BE LCL
AC   CVCL_7359
SY   Xeroderma Pigmentosum 7 BEthesda LCL; GM02485; GM02485A; GM2485A; GM02485B
DR   CLO; CLO_0033209
DR   Coriell; GM02485
DR   Wikidata; Q54837514
RX   CelloPub=CLPUB00447;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U669 ! XP7BE
SX   Female
AG   14Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 17
//
ID   XP7BR
AC   CVCL_ZQ01
SY   Xeroderma Pigmentosum 7 BRighton
DR   Wikidata; Q98136104
RX   PubMed=10022907;
RX   PubMed=11773631;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu77del (c.222_224TCT[1]) (c.225_227delTCT) (L75del); ClinVar=VCV000005893; Zygosity=Heterozygous (PubMed=11773631).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ile255fs (Fs255); Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   60Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XP7CA
AC   CVCL_L774
SY   Xeroderma Pigmentosum 7 CAiro; GM02997; GM2997
DR   CLO; CLO_0012584
DR   BioSample; SAMN00808205
DR   Coriell; GM02997
DR   Wikidata; Q54837799
RX   CelloPub=CLPUB00447;
RX   PubMed=3030788;
RX   PubMed=6492896;
RX   PubMed=7059984;
RX   PubMed=7252263;
RX   PubMed=27543334;
CC   Population: Egyptian.
CC   Senescence: Senesces at 22 PDL (PubMed=6492896).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
ID   XP7DU
AC   CVCL_ZQ00
SY   Xeroderma Pigmentosum 7 DUndee
DR   Wikidata; Q98136107
RX   PubMed=10022907;
RX   PubMed=11773631;
CC   Population: Caucasian; Scottish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Thr408Leufs*36 (c.1222_1225delACTT) (Fs407); ClinVar=VCV002431387; Zygosity=Heterozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP7KA
AC   CVCL_UH38
SY   Xeroderma Pigmentosum 7 KAnazawa
DR   JCRB; KURB1102
DR   Wikidata; Q98136109
RX   PubMed=9025096;
RX   PubMed=9580660;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Glu502Lys (c.1504G>A) (E491K); Zygosity=Heterozygous (PubMed=9580660).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Ile529Thr (c.1586T>C) (I518T); Zygosity=Heterozygous (PubMed=9580660).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 11
//
ID   XP7MA
AC   CVCL_ZQ77
SY   Xeroderma Pigmentosum 7 MAnnheim
DR   Wikidata; Q98136111
RX   PubMed=2054785;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7MO
AC   CVCL_IM50
SY   Xeroderma Pigmentosum 7 MOscow; IMG-1080 XP7MO; IMG-1080
DR   CLO; CLO_0006736
DR   CLDB; cl2668
DR   Wikidata; Q54897553
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP7MY
AC   CVCL_ZS31
DR   JCRB; KURB1306
DR   Wikidata; Q98136115
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7NA
AC   CVCL_ZQ25
SY   Xeroderma Pigmentosum 7 NAgoya
DR   JCRB; KURB1310
DR   Wikidata; Q98136118
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7NE
AC   CVCL_ZN52
SY   Xeroderma Pigmentosum 7 NEwscastle
DR   Wikidata; Q98136121
RX   PubMed=1372096;
RX   PubMed=18079351;
RX   PubMed=20221251;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Pro379Ser (c.1135C>T); ClinVar=VCV000134148; Zygosity=Heterozygous (PubMed=20221251).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZS42 ! XP7NE LCL
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP7NE LCL
AC   CVCL_ZS42
SY   Xeroderma Pigmentosum 7 NEwscastle LCL; LB313; 313
DR   Wikidata; Q98136123
RX   PubMed=1372096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Pro379Ser (c.1135C>T); ClinVar=VCV000134148; Zygosity=Heterozygous (from autologous cell line XP7NE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3968; Xeroderma pigmentosum, complementation group F
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZN52 ! XP7NE
SX   Male
AG   28Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP7OS
AC   CVCL_ZM83
SY   Xeroderma Pigmentosum 7 OSaka
DR   JCRB; KURB1317
DR   Wikidata; Q98136126
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7RO
AC   CVCL_ZR61
SY   Xeroderma Pigmentosum 7 ROtterdam
DR   Wikidata; Q98136129
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7SE
AC   CVCL_ZM67
SY   Xeroderma Pigmentosum 7 SEndai
DR   JCRB; KURB1040
DR   Wikidata; Q98136131
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP7TA
AC   CVCL_ZP90
SY   Xeroderma Pigmentosum 7 Tel Aviv
DR   Wikidata; Q98136133
RX   PubMed=837385;
RX   PubMed=1214825;
RX   PubMed=4778857;
RX   PubMed=6947227;
RX   PubMed=7471106;
RX   PubMed=10385124;
RX   PubMed=11773631;
WW   Info; Thermo Fisher; -; https://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/x/cell-lines-detail-338.html
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Leu178Profs*2 (c.533_534delTT) (del 770-771); ClinVar=VCV000005886; Zygosity=Unspecified (PubMed=10385124).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 8
//
ID   XP7TO
AC   CVCL_9S71
SY   Xeroderma Pigmentosum 7 TOkyo
DR   JCRB; KURB1043
DR   Wikidata; Q54994964
RX   PubMed=832273;
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 12
//
ID   XP7TUF
AC   CVCL_ZS20
SY   Xeroderma Pigmentosum 7 TUrku Finland
DR   Wikidata; Q98136136
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP80BR
AC   CVCL_ZR93
SY   Xeroderma Pigmentosum 80 BRighton
DR   Wikidata; Q98136138
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Cys105Tyr (c.314G>A); ClinVar=VCV002242179; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP80TO
AC   CVCL_DE29
SY   Xeroderma Pigmentosum 80 TOkyo
DR   JCRB; KURB1084
DR   Wikidata; Q54994968
RX   PubMed=1376435;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   XP81BR
AC   CVCL_ZR94
SY   Xeroderma Pigmentosum 81 BRighton
DR   Wikidata; Q98136141
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: African; Somali.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Cys105Tyr (c.314G>A); ClinVar=VCV002242179; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP81TO
AC   CVCL_DE30
SY   Xeroderma Pigmentosum 81 TOkyo
DR   JCRB; KURB1085
DR   Wikidata; Q54994969
RX   PubMed=1376435;
RX   PubMed=12812979;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   XP82BR
AC   CVCL_ZV27
SY   Xeroderma Pigmentosum 82 BRighton
DR   Wikidata; Q98136144
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Asp132fs (c.395_398delATTG); ClinVar=VCV000916576; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; Ex14-15del; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP82DC
AC   CVCL_M312
SY   GM16181
DR   CLO; CLO_0019815
DR   Coriell; GM16181
DR   Wikidata; Q54848345
RX   PubMed=12060391;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Gln16Ter (c.46C>T); Zygosity=Heterozygous (PubMed=12060391).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Val869Glyfs*11 (c.2606_2607delTG) (c.2604_2605TG[1]) (2801delTG); ClinVar=VCV001065165; Zygosity=Heterozygous (PubMed=12060391).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5-6Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP82TO
AC   CVCL_UH36
SY   Xeroderma Pigmentosum 82 TOkyo
DR   Wikidata; Q98136147
RX   PubMed=8798680;
RX   PubMed=9584159;
RX   PubMed=10771487;
RX   PubMed=10777490;
RX   PubMed=12812979;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Lys244Glu (c.730A>G); ClinVar=VCV000008787; Zygosity=Homozygous (PubMed=8798680; PubMed=10777490).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 13-11-18; Last updated: 19-12-24; Version: 10
//
ID   XP83BR
AC   CVCL_ZS64
SY   Xeroderma Pigmentosum 83 BRighton
DR   Wikidata; Q98136149
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP84BR
AC   CVCL_ZV28
SY   Xeroderma Pigmentosum 84 BRighton
DR   Wikidata; Q98136153
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3966; Xeroderma pigmentosum, complementation group B
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP84TO
AC   CVCL_ZN91
SY   Xeroderma Pigmentosum 84 TOkyo
DR   Wikidata; Q98136156
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP85BR
AC   CVCL_ZV29
SY   Xeroderma Pigmentosum 85 BRighton
DR   Wikidata; Q98136158
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; c.490+3A>G; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ala264Pro (c.790G>C); Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   62Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP86BE
AC   CVCL_M313
SY   Xeroderma Pigmentosum 86 BEthesda; GM16370
DR   CLO; CLO_0019419
DR   Coriell; GM16370
DR   Wikidata; Q54848482
RX   CelloPub=CLPUB00563;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Homozygous; Note=Splice donor mutation (CelloPub=CLPUB00563).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M324 ! XP86BE LCL
SX   Female
AG   47Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 14
//
ID   XP86BE LCL
AC   CVCL_M324
SY   Xeroderma Pigmentosum 86 BEthesda LCL; GM17422
DR   CLO; CLO_0012339
DR   Coriell; GM17422
DR   Wikidata; Q54848860
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS2+1G>A; Zygosity=Homozygous; Note=Splice donor mutation (from autologous cell line XP86BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M313 ! XP86BE
SX   Female
AG   48Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 16
//
ID   XP86VI
AC   CVCL_ZQ04
SY   Xeroderma Pigmentosum 86 VIllejuif
DR   Wikidata; Q98136161
RX   PubMed=11773631;
CC   Population: Algerian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln521Ter (c.1561C>T); ClinVar=VCV001333587; Zygosity=Homozygous (PubMed=11773631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   86Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP87BE
AC   CVCL_M314
SY   Xeroderma Pigmentosum 87 BEthesda; GM16381
DR   CLO; CLO_0019404
DR   BioSample; SAMN00804500
DR   Coriell; GM16381
DR   Wikidata; Q54848489
RX   PubMed=16081512;
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu141Leufs*6 (c.420_423delTGAG) (p.Ser140fs*146) (525_528delTGAG); ClinVar=VCV000550638; Zygosity=Heterozygous (PubMed=16081512).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys522Ter (c.1564A>T); ClinVar=VCV000549952; Zygosity=Heterozygous (PubMed=16081512).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M315 ! XP87BE LCL
SX   Male
AG   14Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   XP87BE LCL
AC   CVCL_M315
SY   Xeroderma Pigmentosum 87 BEthesda LCL; GM16385
DR   CLO; CLO_0019398
DR   BioSample; SAMN00804506
DR   Coriell; GM16385
DR   Wikidata; Q54848494
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu141Leufs*6 (c.420_423delTGAG) (p.Ser140fs*146) (525_528delTGAG); ClinVar=VCV000550638; Zygosity=Heterozygous (Coriell=GM16385).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys522Ter (c.1564A>T); ClinVar=VCV000549952; Zygosity=Heterozygous (Coriell=GM16385).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M314 ! XP87BE
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 18
//
ID   XP87BR
AC   CVCL_ZV30
SY   Xeroderma Pigmentosum 87 BRighton
DR   Wikidata; Q98136163
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Val623Glyfs*26 (c.1867dupG); ClinVar=VCV001363277; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 9
//
ID   XP87TO
AC   CVCL_ZN92
SY   Xeroderma Pigmentosum 87 TOkyo
DR   Wikidata; Q98136165
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP88BR
AC   CVCL_ZR95
SY   Xeroderma Pigmentosum 88 BRighton
DR   Wikidata; Q98136168
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP89BR
AC   CVCL_ZR96
SY   Xeroderma Pigmentosum 89 BRighton
DR   Wikidata; Q98136170
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP89BR-S
AC   CVCL_ZR97
SY   Xeroderma Pigmentosum 89 BRighton-S
DR   Wikidata; Q98136173
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP89MA
AC   CVCL_ZR14
SY   Xeroderma Pigmentosum 89 MAnnheim
DR   Wikidata; Q98136176
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP89TO
AC   CVCL_ZM16
SY   Xeroderma Pigmentosum 89 TOkyo
DR   Wikidata; Q98136178
RX   PubMed=1376435;
RX   PubMed=8798680;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP8BE
AC   CVCL_F487
SY   Xeroderma Pigmentosum 8 BEthesda; Pe Ar; PeAr; GM00671; GM-671; GM 671; GM0671; GM671
DR   CLO; CLO_0028860
DR   ATCC; CRL-1158
DR   Coriell; GM00671
DR   JCRB; KURB1058
DR   Wikidata; Q54836383
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=4811796;
RX   PubMed=6492896;
RX   PubMed=7059984;
RX   PubMed=15572672;
CC   Population: Caucasian.
CC   Senescence: Senesces at 24 PDL (PubMed=6492896).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Homozygous (from autologous cell line XP8BE LCL).
CC   Donor information: Established from monozygotic twin of XP9BE (Cellosaurus=CVCL_F489).
CC   Discontinued: ATCC; CRL-1158; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F488 ! XP8BE LCL
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 21
//
ID   XP8BE LCL
AC   CVCL_F488
SY   Xeroderma Pigmentosum 8 BEthesda LCL; GM02249; GM02249C; GM2249
DR   CLO; CLO_0032156
DR   BioSample; SAMN00807630
DR   Coriell; GM02249
DR   Wikidata; Q54837390
RX   CelloPub=CLPUB00447;
RX   PubMed=8483505;
RX   PubMed=18809580;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Homozygous (PubMed=18809580).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F487 ! XP8BE
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   XP8BR
AC   CVCL_W051
SY   Xeroderma Pigmentosum 8 BRighton
DR   Wikidata; Q54994971
RX   PubMed=1372100;
RX   PubMed=7825573;
RX   PubMed=18079351;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg669Glyfs*40 (c.2005delA); ClinVar=VCV000445466; Zygosity=Heterozygous (PubMed=7825573).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly675Arg (c.2023G>C); ClinVar=VCV002675053; Zygosity=Heterozygous (PubMed=7825573).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2560 ! XP8BR LCL
SX   Male
AG   1Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 27-11-25; Version: 14
//
ID   XP8BR LCL
AC   CVCL_2560
SY   Xeroderma Pigmentosum 8 BRighton LCL; LB316; 316
DR   ECACC; 98062333
DR   Wikidata; Q54902058
RX   PubMed=7825573;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg669Glyfs*40 (c.2005delA); ClinVar=VCV000445466; Zygosity=Heterozygous (from autologous cell line XP8BR).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly675Arg (c.2023G>C); ClinVar=VCV002675053; Zygosity=Heterozygous (from autologous cell line XP8BR).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W051 ! XP8BR
SX   Male
AG   1Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 17
//
ID   XP8CA
AC   CVCL_L773
SY   Xeroderma Pigmentosum 8 CAiro; IMG-819 XP8CA; IMG-819; GM02996; GM2996
DR   CLO; CLO_0006885
DR   CLO; CLO_0012587
DR   CLDB; cl2817
DR   BioSample; SAMN00808204
DR   Coriell; GM02996
DR   JCRB; KURB1061
DR   Wikidata; Q54837798
RX   CelloPub=CLPUB00447;
RX   PubMed=2175267;
RX   PubMed=7252263;
RX   PubMed=15744458;
CC   Population: Egyptian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Homozygous (PubMed=15744458).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1M3W
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 18
//
ID   XP8KO
AC   CVCL_ZM35
SY   Xeroderma Pigmentosum 8 KObe
DR   Wikidata; Q98136181
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP8LO
AC   CVCL_ZN87
SY   Xeroderma Pigmentosum 8 LOndon
DR   ATCC; CRL-1376
DR   Wikidata; Q98136185
RX   DOI=10.1007/978-1-4757-5016-4_9;
RX   PubMed=273925;
RX   PubMed=1034206;
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=2065254;
RX   PubMed=3724780;
CC   Discontinued: ATCC; CRL-1376; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2-3Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 6
//
ID   XP8MA
AC   CVCL_ZQ78
SY   Xeroderma Pigmentosum 8 MAnnheim
DR   Wikidata; Q98136188
RX   PubMed=2054785;
RX   PubMed=3182904;
RX   PubMed=7161312;
RX   PubMed=7165374;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 10-04-25; Version: 6
//
ID   XP8MO
AC   CVCL_IM51
SY   Xeroderma Pigmentosum 8 MOscow; IMG-1217 XP8MO; IMG-1217
DR   CLO; CLO_0006772
DR   CLDB; cl2704
DR   Wikidata; Q54897554
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP8MY
AC   CVCL_ZQ62
DR   JCRB; KURB1307
DR   Wikidata; Q98136191
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP8NA
AC   CVCL_ZQ26
SY   Xeroderma Pigmentosum 8 NAgoya
DR   JCRB; KURB1311
DR   Wikidata; Q98136194
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP8OS
AC   CVCL_ZM84
SY   Xeroderma Pigmentosum 8 OSaka
DR   JCRB; KURB1318
DR   Wikidata; Q98136196
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP8SE
AC   CVCL_ZM68
SY   Xeroderma Pigmentosum 8 SEndai
DR   JCRB; KURB1041
DR   Wikidata; Q98136199
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP8TO
AC   CVCL_ZM77
SY   Xeroderma Pigmentosum 8 TOkyo
DR   JCRB; KURB1371
DR   Wikidata; Q98136202
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP8TU
AC   CVCL_ZQ33
SY   Xeroderma Pigmentosum 8 TUnisia
DR   Wikidata; Q98136205
RX   PubMed=8105686;
CC   Population: Tunisian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=8105686).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   35Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP8TUF
AC   CVCL_ZS18
SY   Xeroderma Pigmentosum 8 TUrku Finland
DR   Wikidata; Q98136208
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP90MA
AC   CVCL_ZR12
SY   Xeroderma Pigmentosum 90 MAnnheim
DR   Wikidata; Q98136209
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP91TMA
AC   CVCL_ZN96
SY   Xeroderma Pigmentosum Turkey MAlatya 91; GM15700
DR   Coriell; GM15700
DR   Wikidata; Q98136212
RX   PubMed=18368133;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (PubMed=18368133).
CC   Discontinued: Coriell; GM15700; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP92TMA
AC   CVCL_ZN94
SY   Xeroderma Pigmentosum Turkey MAlatya 92; GM15713
DR   Coriell; GM15713
DR   Wikidata; Q98136214
RX   PubMed=18368133;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (PubMed=18368133).
CC   Discontinued: Coriell; GM15713; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP93BR
AC   CVCL_ZS65
SY   Xeroderma Pigmentosum 93 BRighton
DR   Wikidata; Q98136217
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg415Ter (c.1243C>T) (C1348T); ClinVar=VCV000438623; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP93TO
AC   CVCL_ZM17
SY   Xeroderma Pigmentosum 93 TOkyo
DR   Wikidata; Q98136219
RX   PubMed=1376435;
RX   PubMed=8798680;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP94BR
AC   CVCL_ZV31
SY   Xeroderma Pigmentosum 94 BRighton
DR   Wikidata; Q98136222
RX   PubMed=26884178;
CC   Population: Sri Lankan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg293Ter (c.877C>T); ClinVar=VCV000554485; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP95BR
AC   CVCL_ZV32
SY   Xeroderma Pigmentosum 95 BRighton
DR   Wikidata; Q98136224
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.2033+5G>A; ClinVar=VCV000554256; Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP95MA
AC   CVCL_ZQ92
SY   Xeroderma Pigmentosum 95 MAnnheim
DR   Wikidata; Q98136227
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP95TO
AC   CVCL_4Y29
SY   Xeroderma Pigmentosum 95 TOkyo
DR   Wikidata; Q54994972
RX   PubMed=1376435;
RX   PubMed=8798680;
RX   PubMed=9539981;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
ID   XP96TA
AC   CVCL_M311
SY   Xeroderma Pigmentosum 96 Tel Aviv; GM16180
DR   CLO; CLO_0019814
DR   Coriell; GM16180
DR   Wikidata; Q54848343
RX   PubMed=12060391;
RX   PubMed=26184184;
CC   Population: Palestinian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Leu308Serfs*12 (c.922_923delTC) (1116delTC); ClinVar=VCV000929130; Zygosity=Homozygous (PubMed=12060391; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 17
//
ID   XP96TO
AC   CVCL_ZN90
SY   Xeroderma Pigmentosum 96 TOkyo
DR   Wikidata; Q98136229
RX   PubMed=1372102;
RX   PubMed=1702221;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP97BR
AC   CVCL_ZV33
SY   Xeroderma Pigmentosum 97 BRighton
DR   Wikidata; Q98136231
RX   PubMed=26884178;
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; c.1378-26_1383del32; Zygosity=Heterozygous (PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Heterozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   34Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP98BR
AC   CVCL_ZV34
SY   Xeroderma Pigmentosum 98 BRighton
DR   Wikidata; Q98136234
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:2718; DDB2; Simple; p.Trp54Ter (c.161G>A); Zygosity=Homozygous (PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP98MA
AC   CVCL_ZQ93
SY   Xeroderma Pigmentosum 98 MAnnheim
DR   Wikidata; Q98136237
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP98TMA
AC   CVCL_1F47
SY   Xeroderma Pigmentosum Turkey MAlatya 98; GM15711
DR   CLO; CLO_0027671
DR   Coriell; GM15711
DR   Wikidata; Q54848149
RX   PubMed=18368133;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F48 ! XP98TMA LCL
SX   Female
AG   29Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   XP98TMA LCL
AC   CVCL_1F48
SY   Xeroderma Pigmentosum Turkey MAlatya 98 LCL; GM15712
DR   CLO; CLO_0027672
DR   Coriell; GM15712
DR   Wikidata; Q54848150
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Homozygous (from autologous cell line XP98TMA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F47 ! XP98TMA
SX   Female
AG   29Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XP99MA
AC   CVCL_ZQ94
SY   Xeroderma Pigmentosum 99 MAnnheim
DR   Wikidata; Q98136240
RX   PubMed=2054785;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9BE
AC   CVCL_F489
SY   Xeroderma Pigmentosum 9 BEthesda; Ge Ar; GeAr; GM00676; GM-676; GM 0676; GM0676
DR   CLO; CLO_0028916
DR   ATCC; CRL-1161
DR   Coriell; GM00676
DR   JCRB; KURB1059
DR   Wikidata; Q54836385
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=273925;
RX   PubMed=4811796;
RX   PubMed=6096450;
RX   PubMed=16990803;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Homozygous (from familial inference of XP8BE).
CC   Donor information: Established from monozygotic twin of XP8BE (Cellosaurus=CVCL_F487).
CC   Discontinued: ATCC; CRL-1161; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F490 ! XP9BE LCL
SX   Male
AG   15Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 19
//
ID   XP9BE LCL
AC   CVCL_F490
SY   Xeroderma Pigmentosum 9 BEthesda LCL; GM02498; GM 2498; GM2498; GM02498B
DR   CLO; CLO_0033233
DR   Coriell; GM02498
DR   Wikidata; Q54837522
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
RX   PubMed=7519740;
RX   PubMed=16990803;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val696_Val697insVal (c.2092_2093insGTG); Zygosity=Homozygous (from autologous cell line XP9BE).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_F489 ! XP9BE
SX   Male
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   XP9BI
AC   CVCL_ZR83
SY   Xeroderma Pigmentosum 9 BIrmingham
DR   Wikidata; Q98136243
RX   PubMed=26743599;
RX   PubMed=26884178;
CC   Population: Pakistani.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.555+8A>G; ClinVar=VCV000852033; Zygosity=Homozygous (PubMed=26743599; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP9BR
AC   CVCL_ZN57
SY   Xeroderma Pigmentosum 9 BRighton
DR   Wikidata; Q98136245
RX   PubMed=11416159;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=11416159
ST   Amelogenin: X,Y
ST   D18S51: 15,16
ST   D21S11: 27,32.2
ST   D8S1179: 12
ST   FGA: 22,24
ST   TH01: 6,9.3
ST   vWA: 14,17
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9CA
AC   CVCL_YP23
SY   Xeroderma Pigmentosum 9 CAiro; AG03960; AG3960
DR   Coriell; AG03960
DR   Wikidata; Q93314328
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Discontinued: Coriell; AG03960; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 5
//
ID   XP9KO
AC   CVCL_ZM36
SY   Xeroderma Pigmentosum 9 KObe
DR   Wikidata; Q98136248
RX   PubMed=7259973;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9KY
AC   CVCL_ZQ63
SY   Xeroderma Pigmentosum 9 KYoto
DR   Wikidata; Q98136250
RX   PubMed=2778352;
RX   PubMed=7905727;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=7905727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XP9MA
AC   CVCL_ZN41
DR   Wikidata; Q98136253
RX   PubMed=2054785;
RX   PubMed=7165374;
RX   PubMed=9238033;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Homozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XP9MO
AC   CVCL_IM52
SY   Xeroderma Pigmentosum 9 MOscow; IMG-1247 XP9MO; IMG-1247
DR   CLO; CLO_0006779
DR   CLDB; cl2711
DR   Wikidata; Q54897555
CC   From: MWCMG, Russian Academy of Medical Sciences; Moscow; Russia.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 11
//
ID   XP9NA
AC   CVCL_ZQ27
SY   Xeroderma Pigmentosum 9 NAgoya
DR   JCRB; KURB1312
DR   Wikidata; Q98136256
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9OS
AC   CVCL_ZM85
SY   Xeroderma Pigmentosum 9 OSaka
DR   JCRB; KURB1319
DR   Wikidata; Q98136258
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9PV
AC   CVCL_RU48
SY   Xeroderma Pigmentosum 9 PaVia
DR   CLO; CLO_0009670
DR   CLDB; cl4763
DR   Wikidata; Q54994973
RX   PubMed=10766188;
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg753fs*13 (c.2257delC); Zygosity=Homozygous (PubMed=10766188).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XP9RO
AC   CVCL_ZR62
SY   Xeroderma Pigmentosum 9 ROtterdam
DR   Wikidata; Q98136260
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9SE
AC   CVCL_ZM69
SY   Xeroderma Pigmentosum 9 SEndai
DR   Wikidata; Q98136263
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9TO
AC   CVCL_ZM78
SY   Xeroderma Pigmentosum 9 TOkyo
DR   JCRB; KURB1372
DR   Wikidata; Q98136266
RX   PubMed=832273;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XP9TUF
AC   CVCL_ZS21
SY   Xeroderma Pigmentosum 9 TUrku Finland
DR   Wikidata; Q98136268
RX   PubMed=18567921;
CC   Population: Caucasian; Finnish.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg228Ter (c.682C>T); ClinVar=VCV000000995; Zygosity=Homozygous (PubMed=18567921).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XPA-1
AC   CVCL_9502
SY   XPA1; PX-184; PX184; PXA184
DR   Cosmic; 1198218
DR   Wikidata; Q54994974
RX   PubMed=14520411;
RX   PubMed=16912165;
RX   PubMed=20037478;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   XPA-2
AC   CVCL_9503
SY   XPA2; PX-196; PX196; PXA196
DR   Wikidata; Q54994975
RX   PubMed=14520411;
RX   PubMed=16912165;
RX   PubMed=20037478;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   XPA-3
AC   CVCL_9504
SY   XPA3; XPa3; PX-154; PX154
DR   Cosmic; 1198219
DR   Wikidata; Q54994976
RX   PubMed=14520411;
RX   PubMed=16912165;
RX   PubMed=20037478;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   XPA-4
AC   CVCL_9505
SY   XPA4; XPa4
DR   Cosmic; 1198220
DR   Wikidata; Q54994978
RX   PubMed=20037478;
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 9
//
ID   XPA7A3A
AC   CVCL_ZQ14
DR   Wikidata; Q98136270
RX   PubMed=3010096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Cys108Phe (c.323G>T); ClinVar=VCV000000993; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Leu117Glufs*4 (c.349_353delCTTAT) (349del5); ClinVar=VCV000000994; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L758 ! XP1PD
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   XPA7A6B
AC   CVCL_ZQ15
DR   Wikidata; Q98136273
RX   PubMed=3010096;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Cys108Phe (c.323G>T); ClinVar=VCV000000993; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Leu117Glufs*4 (c.349_353delCTTAT) (349del5); ClinVar=VCV000000994; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L758 ! XP1PD
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   XPCS1BA
AC   CVCL_V271
SY   XP1BA; Xeroderma Pigmentosum/Cockayne Syndrome 1 BAsel; GM13025
DR   CLO; CLO_0014000
DR   BioSample; SAMN00802022
DR   Coriell; GM13025
DR   Wikidata; Q54846268
RX   PubMed=8317483;
RX   PubMed=8408834;
RX   PubMed=9012405;
RX   PubMed=16947863;
RX   PubMed=18079351;
RX   PubMed=26184184;
RX   PubMed=30165384;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (PubMed=16947863; PubMed=26184184).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (PubMed=16947863; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 15
//
ID   XPCS1BA(SV)
AC   CVCL_ZP29
DR   Wikidata; Q98136277
RX   PubMed=9012405;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V271 ! XPCS1BA
SX   Male
AG   39Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPCS1BD
AC   CVCL_ZU89
SY   95RD112
DR   Wikidata; Q98136279
RX   PubMed=11841555;
RX   PubMed=15572672;
CC   Population: Caucasian; Spanish.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; c.673-1G>A (G870A); dbSNP=rs1256618339; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=15572672).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Cys529Ser (c.1586G>C) (G1783C); ClinVar=VCV000129010; Zygosity=Homozygous (PubMed=15572672).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPCS1CD
AC   CVCL_ZP66
DR   Wikidata; Q98136281
RX   PubMed=23623389;
RX   PubMed=30165384;
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Cys236Arg (c.706T>C); ClinVar=VCV000055827; Zygosity=Heterozygous (PubMed=23623389).
CC   Sequence variation: Mutation; HGNC; HGNC:3436; ERCC4; Simple; p.Arg589Trp (c.1765C>T); ClinVar=VCV000055829; Zygosity=Heterozygous (PubMed=23623389).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   11Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPCS1LV
AC   CVCL_F620
SY   Xeroderma Pigmentosum/Cockayne Syndrome 2 LeuVen; GM13371
DR   CLO; CLO_0012851
DR   BioSample; SAMN00802338
DR   Coriell; GM13371
DR   Wikidata; Q54846485
RX   PubMed=8317483;
RX   PubMed=9096355;
RX   PubMed=11841555;
CC   Population: Caucasian; Flemish.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ser659Valfs*1 (c.1975delA) (2172delA); ClinVar=VCV001696064; Zygosity=Homozygous (PubMed=9096355).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 16
//
ID   XPCS1LV SV40
AC   CVCL_F622
SY   GM14931
DR   CLO; CLO_0030502
DR   BioSample; SAMN00803961
DR   Coriell; GM14931
DR   Wikidata; Q54847525
RX   PubMed=18079351;
CC   Population: Caucasian; Flemish.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ser659Valfs*1 (c.1975delA) (2172delA); ClinVar=VCV001696064; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F620 ! XPCS1LV
SX   Female
AG   5Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 17
//
ID   XPCS1RO
AC   CVCL_ZP68
SY   Xeroderma Pigmentosum/Cockayne Syndrome 1 ROtterdam; 94RD27
DR   Wikidata; Q98136284
RX   PubMed=9096355;
RX   PubMed=9716445;
RX   PubMed=11841555;
CC   Population: Caucasian; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Gly926Profs (c.2775delT) (2972delT); ClinVar=VCV000016568; Zygosity=Unspecified (PubMed=9096355).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7M
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPCS1RO hTERT
AC   CVCL_ZV78
DR   Wikidata; Q98136286
RX   PubMed=30165384;
CC   Population: Caucasian; Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Gly926Profs (c.2775delT) (2972delT); ClinVar=VCV000016568; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP68 ! XPCS1RO
SX   Male
AG   7M
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XPCS2BA
AC   CVCL_V272
SY   XP2BA; Xeroderma Pigmentosum/Cockayne Syndrome 2 BAsel; GM13026
DR   CLO; CLO_0013998
DR   EFO; EFO_0022698
DR   BioSample; SAMN00802024
DR   Coriell; GM13026
DR   Wikidata; Q54846269
RX   PubMed=8408834;
RX   PubMed=9584159;
RX   PubMed=10332046;
RX   PubMed=16947863;
RX   PubMed=18079351;
RX   PubMed=26184184;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (PubMed=16947863; PubMed=26184184).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (PubMed=16947863; PubMed=26184184).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 16
//
ID   XPCS2BASV
AC   CVCL_ZP38
DR   Wikidata; Q98136289
RX   PubMed=9415314;
RX   PubMed=10332046;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_V272 ! XPCS2BA
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPCS2BASV pTTD6VI-transfected Cl-14
AC   CVCL_ZP40
SY   Cl-14
DR   Wikidata; Q98136292
RX   PubMed=10332046;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3435; ERCC3 (Note=With p.Thr119Pro).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP38 ! XPCS2BASV
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   XPCS2BASV pTTD6VI-transfected Cl-19
AC   CVCL_ZP41
SY   Cl-19
DR   Wikidata; Q98136294
RX   PubMed=10332046;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3435; ERCC3 (Note=With p.Thr119Pro).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP38 ! XPCS2BASV
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   XPCS2BASV pTTD6VI-transfected Cl-5
AC   CVCL_ZP39
SY   Cl-5
DR   Wikidata; Q98136296
RX   PubMed=10332046;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3435; ERCC3 (Note=With p.Thr119Pro).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZP38 ! XPCS2BASV
SX   Male
AG   36Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   XPCS2LV
AC   CVCL_F619
SY   Xeroderma Pigmentosum/Cockayne Syndrome 2 LeuVen; GM13370
DR   CLO; CLO_0012846
DR   BioSample; SAMN00802336
DR   Coriell; GM13370
DR   Wikidata; Q54846484
RX   PubMed=8317483;
RX   PubMed=9096355;
RX   PubMed=11841555;
RX   PubMed=18079351;
CC   Population: Caucasian; Flemish.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Arg263Ter (c.787C>T) (984C>T); ClinVar=VCV000016570; Zygosity=Heterozygous (PubMed=9096355).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ser659Valfs*1 (c.1975delA) (2172delA); ClinVar=VCV001696064; Zygosity=Heterozygous (PubMed=9096355).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   1Y8M
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   XPCS2LV SV40
AC   CVCL_F621
SY   GM14930
DR   CLO; CLO_0030505
DR   BioSample; SAMN00803959
DR   Coriell; GM14930
DR   Wikidata; Q54847524
CC   Population: Caucasian; Flemish.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Arg263Ter (c.787C>T) (984C>T); ClinVar=VCV000016570; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ser659Valfs*1 (c.1975delA) (2172delA); ClinVar=VCV001696064; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C156031; Xeroderma pigmentosum-Cockayne syndrome complex
DI   ORDO; Orphanet_220295; Xeroderma pigmentosum-Cockayne syndrome complex
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_F619 ! XPCS2LV
SX   Male
AG   1Y8M
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 18
//
ID   XPCS2VI
AC   CVCL_XG02
SY   XP-CS2VI; Xeroderma Pigmentosum/Cockayne Syndrome 2 VIllejuif
DR   Wikidata; Q98136299
RX   PubMed=8055625;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly602Asp (c.1805G>A); ClinVar=VCV002138306; Zygosity=Heterozygous (from autologous cell lines XP-CS2; XP-CS2 LCL).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L455 ! XP-CS2
OI   CVCL_L456 ! XP-CS2 LCL
SX   Male
AG   >5Y
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   XPCS2VILas
AC   CVCL_XG03
SY   XP-CS2VILas
DR   Wikidata; Q98136301
RX   PubMed=8055625;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gly602Asp (c.1805G>A); ClinVar=VCV002138306; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pLASwt).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_XG02 ! XPCS2VI
SX   Male
AG   >5Y
CA   Transformed cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 12
//
ID   XPCSH4BA
AC   CVCL_1F28
SY   Xeroderma Pigmentosum/Cockayne Syndrome Heterozygote 4 BAsel; GM13027
DR   CLO; CLO_0014004
DR   BioSample; SAMN00802026
DR   Coriell; GM13027
DR   Wikidata; Q54846270
RX   PubMed=16947863;
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Lys157insThrSerAspSerTer (c.471+1G>A); ClinVar=VCV000016589; Zygosity=Heterozygous (PubMed=16947863).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   XPCSH5BA
AC   CVCL_1F29
SY   Xeroderma Pigmentosum/Cockayne Syndrome Heterozygote 5 BAsel; GM13028
DR   CLO; CLO_0014002
DR   BioSample; SAMN00802028
DR   Coriell; GM13028
DR   Wikidata; Q54846271
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe99Ser (c.296T>C); ClinVar=VCV000016583; Zygosity=Heterozygous (Coriell=GM13028).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XPEMB-1
AC   CVCL_3252
SY   XPEMB1; Xeroderma Pigmentosum EMBryo-1
DR   GEO; GSM1338615
DR   JCRB; JCRB0325
DR   Wikidata; Q54994981
RX   PubMed=1372102;
RX   PubMed=1702221;
RX   PubMed=27197874;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=1702221; PubMed=27197874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB0325
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 11,12
ST   D5S818: 11,12
ST   D7S820: 11,14
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Fetus
CA   Finite cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   XPEMB-1 iPS
AC   CVCL_RX70
SY   XPEMB-1 iPS3; XPAiPS-E3
DR   GEO; GSM1338616
DR   Wikidata; Q54994982
RX   PubMed=27197874;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.390-1G>C (IVS3-1G>C); ClinVar=VCV000264684; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=27197874).
CC   Omics: Genomics; Whole exome sequencing.
CC   Misspelling: EPEMB-1 iPS3; GEO=GSM1338616.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3252 ! XPEMB-1
SX   Sex unspecified
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 12
//
ID   XPET6/1
AC   CVCL_4Y30
DR   Wikidata; Q54994983
RX   PubMed=9539981;
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114771; Xeroderma pigmentosum, complementation group E
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_4Y29 ! XP95TO
CA   Transformed cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 12
//
ID   XPG415A
AC   CVCL_ZQ16
DR   Wikidata; Q98136304
RX   PubMed=3010096;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Arg372Thrfs*5 (c.1115_1118delGGAA); ClinVar=VCV000016574; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Leu858Pro (c.2573T>C); ClinVar=VCV000016573; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3969; Xeroderma pigmentosum, complementation group G
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M223 ! XP2BI
SX   Female
AG   17Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
ID   XPH102TMA
AC   CVCL_1F51
SY   Xeroderma Pigmentosum Heterozygote 102 Turkey MAlatya; GM15717
DR   CLO; CLO_0027677
DR   Coriell; GM15717
DR   Wikidata; Q54848153
RX   PubMed=14662655;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-9T>A (IVS3-9T>A); ClinVar=VCV000000260; Zygosity=Heterozygous (PubMed=14662655).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F52 ! XPH102TMA LCL
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XPH102TMA LCL
AC   CVCL_1F52
SY   Xeroderma Pigmentosum Heterozygote 102 Turkey MAlatya LCL; GM15718
DR   CLO; CLO_0027678
DR   Coriell; GM15718
DR   Wikidata; Q54848154
RX   PubMed=14662655;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.413-9T>A (IVS3-9T>A); ClinVar=VCV000000260; Zygosity=Heterozygous (Coriell=GM15718).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F51 ! XPH102TMA
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPH103BE LCL
AC   CVCL_1F56
SY   Xeroderma Pigmentosum Heterozygote 103 BEthesda LCL; GM16023
DR   CLO; CLO_0018811
DR   Coriell; GM16023
DR   Wikidata; Q54848306
RX   PubMed=12060391;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Ala874Thr (c.2620G>A) (G2817A); ClinVar=VCV000016577; Zygosity=Heterozygous (PubMed=12060391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   43Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   XPH104BE LCL
AC   CVCL_1F62
SY   Xeroderma Pigmentosum Heterozygote 104 BEthesda LCL; GM16464
DR   CLO; CLO_0017823
DR   Coriell; GM16464
DR   Wikidata; Q54848580
RX   PubMed=12060391;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Gln136Ter (c.406C>T) (C603T); ClinVar=VCV000016578; Zygosity=Heterozygous (PubMed=12060391).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 12
//
ID   XPH106BE LCL
AC   CVCL_1F63
SY   Xeroderma Pigmentosum Heterozygote 106 BEthesda LCL; GM16468
DR   CLO; CLO_0017827
DR   Coriell; GM16468
DR   Wikidata; Q54848584
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Heterozygous (PubMed=16081512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XPH107BE LCL
AC   CVCL_1F64
SY   Xeroderma Pigmentosum Heterozygote 107 BEthesda LCL; GM16469
DR   CLO; CLO_0017828
DR   Coriell; GM16469
DR   Wikidata; Q54848585
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Heterozygous (PubMed=16081512).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XPH10PV
AC   CVCL_RU49
SY   Xeroderma Pigmentosum Heterozygote 10 PaVia
DR   CLO; CLO_0009671
DR   CLDB; cl4764
DR   Wikidata; Q54994984
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Heterozygous (from familial inference of XP15PV; XP16PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XPH10RO
AC   CVCL_ZR46
SY   Xeroderma Pigmentosum Heterozygote 10 ROtterdam
DR   Wikidata; Q98136307
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XPH11PV
AC   CVCL_RU50
SY   Xeroderma Pigmentosum Heterozygote 11 PaVia
DR   CLO; CLO_0009672
DR   CLDB; cl4765
DR   Wikidata; Q54994986
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH12PV
AC   CVCL_RU51
SY   Xeroderma Pigmentosum Heterozygote 12 PaVia
DR   CLO; CLO_0009673
DR   CLDB; cl4766
DR   Wikidata; Q54994988
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Heterozygous (from familial inference of XP17PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   XPH130BE
AC   CVCL_1F26
SY   Xeroderma Pigmentosum Heterozygote 130 BEthesda; GM11615
DR   CLO; CLO_0021178
DR   Coriell; GM11615
DR   Wikidata; Q54845193
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F25 ! XPH130BE LCL
SX   Female
AG   41Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   XPH130BE LCL
AC   CVCL_1F25
SY   Xeroderma Pigmentosum Heterozygote 130 BEthesda LCL; GM11614
DR   CLO; CLO_0021179
DR   Coriell; GM11614
DR   Wikidata; Q54845192
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F26 ! XPH130BE
SX   Female
AG   41Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   XPH133BE
AC   CVCL_1F66
SY   Xeroderma Pigmentosum Heterozygote 133 BEthesda; GM16691
DR   CLO; CLO_0018456
DR   Coriell; GM16691
DR   Wikidata; Q54848705
CC   Population: Honduran.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (Coriell=GM16691).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F65 ! XPH133BE LCL
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XPH133BE LCL
AC   CVCL_1F65
SY   Xeroderma Pigmentosum Heterozygote 133 BEthesda LCL; GM16690
DR   CLO; CLO_0018453
DR   Coriell; GM16690
DR   Wikidata; Q54848704
RX   PubMed=16081512;
CC   Population: Honduran.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (Coriell=GM16690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F66 ! XPH133BE
SX   Female
AG   32Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPH134BE
AC   CVCL_L461
SY   Xeroderma Pigmentosum Heterozygote 134 BEthesda; XP-CS-HF-1; GM01854; GM-1854; GM 1854
DR   CLO; CLO_0031424
DR   BioSample; SAMN00807225
DR   Coriell; GM01854
DR   Wikidata; Q54837127
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln739fs*42 (c.2218-6C>A) (IVS14-6C>A); Zygosity=Heterozygous (from autologous cell line XPH134BE LCL).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L462 ! XPH134BE LCL
SX   Female
AG   64Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   XPH134BE LCL
AC   CVCL_L462
SY   Xeroderma Pigmentosum Heterozygote 134 BEthesda LCL; XP-CS-HF-1 LCL; GM01855; GM-1855; GM 1855; GM1855
DR   CLO; CLO_0031402
DR   BioSample; SAMN00807227
DR   Coriell; GM01855
DR   Wikidata; Q54837128
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
RX   PubMed=16947863;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Gln739fs*42 (c.2218-6C>A) (IVS14-6C>A); Zygosity=Heterozygous (PubMed=16947863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L461 ! XPH134BE
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   XPH135BE LCL
AC   CVCL_L463
SY   Xeroderma Pigmentosum Heterozygote 135 BEthesda LCL; GM11394
DR   CLO; CLO_0026092
DR   Coriell; GM11394
DR   Wikidata; Q54845054
RX   CelloPub=CLPUB00447;
RX   PubMed=16947863;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3435; ERCC3; Simple; p.Phe270Ter (c.807_808delTT); Zygosity=Heterozygous (PubMed=16947863).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Transformed cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   XPH136BE LCL
AC   CVCL_1F31
SY   Xeroderma Pigmentosum Heterozygote 136 BEthesda LCL; GM13038
DR   CLO; CLO_0014042
DR   BioSample; SAMN00802042
DR   Coriell; GM13038
DR   Wikidata; Q54846279
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   XPH137BE LCL
AC   CVCL_1F30
SY   Xeroderma Pigmentosum Heterozygote 137 BEthesda LCL; GM13037
DR   CLO; CLO_0014032
DR   BioSample; SAMN00802040
DR   Coriell; GM13037
DR   Wikidata; Q54846278
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   XPH13PV
AC   CVCL_RU52
SY   Xeroderma Pigmentosum Heterozygote 13 PaVia
DR   CLO; CLO_0009674
DR   CLDB; cl4767
DR   Wikidata; Q54994989
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH14PV
AC   CVCL_RU53
SY   Xeroderma Pigmentosum Heterozygote 14 PaVia
DR   CLO; CLO_0009675
DR   CLDB; cl4768
DR   Wikidata; Q54994990
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Heterozygous (from familial inference of XP18PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XPH14RO
AC   CVCL_ZR47
SY   Xeroderma Pigmentosum Heterozygote 14 ROtterdam
DR   Wikidata; Q98136310
RX   PubMed=4778857;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Heterozygous (from familial inference of XP12RO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XPH15PV
AC   CVCL_RU54
SY   Xeroderma Pigmentosum Heterozygote 15 PaVia
DR   CLO; CLO_0009676
DR   CLDB; cl4769
DR   Wikidata; Q54994992
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Heterozygous (from familial inference of XP18PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XPH15RO
AC   CVCL_ZR48
SY   Xeroderma Pigmentosum Heterozygote 15 ROtterdam
DR   Wikidata; Q98136312
RX   PubMed=4778857;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Heterozygous (from familial inference of XP12RO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XPH16PV
AC   CVCL_RU55
SY   Xeroderma Pigmentosum Heterozygote 16 PaVia
DR   CLO; CLO_0009677
DR   CLDB; cl4770
DR   Wikidata; Q54995003
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH17PV
AC   CVCL_RU56
SY   Xeroderma Pigmentosum Heterozygote 17 PaVia
DR   CLO; CLO_0009678
DR   CLDB; cl4771
DR   Wikidata; Q54995004
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH17RO
AC   CVCL_ZR49
SY   Xeroderma Pigmentosum Heterozygote 17 ROtterdam
DR   Wikidata; Q98136316
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XPH18PV
AC   CVCL_RU57
SY   Xeroderma Pigmentosum Heterozygote 18 PaVia
DR   CLO; CLO_0009679
DR   CLDB; cl4772
DR   Wikidata; Q54995005
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH19PV
AC   CVCL_RU58
SY   Xeroderma Pigmentosum Heterozygote 19 PaVia
DR   CLO; CLO_0009680
DR   CLDB; cl4773
DR   Wikidata; Q54995007
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH1AA
AC   CVCL_L466
SY   GM03178
DR   CLO; CLO_0013409
DR   BioSample; SAMN00808276
DR   Coriell; GM03178
DR   Wikidata; Q54837908
RX   CelloPub=CLPUB00447;
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   XPH1CH
AC   CVCL_L926
SY   Xeroderma Pigmentosum Heterozygote 1 CHerevan; GM03054; GM3054
DR   CLO; CLO_0013506
DR   BioSample; SAMN00808229
DR   Coriell; GM03054
DR   Wikidata; Q54837841
RX   CelloPub=CLPUB00447;
RX   PubMed=7326997;
CC   Population: Caucasian; Russian Armenian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Val125Ter (c.376C>T); Zygosity=Heterozygous (from familial inference of XP2CH).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 14
//
ID   XPH1PV
AC   CVCL_RU59
SY   Xeroderma Pigmentosum Heterozygote 1 PaVia
DR   CLO; CLO_0009681
DR   CLDB; cl4774
DR   Wikidata; Q54995008
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg753fs*13 (c.2257delC); Zygosity=Heterozygous (from familial inference of XP9PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   XPH206BE LCL
AC   CVCL_1F27
SY   Xeroderma Pigmentosum Heterozygote 206 BEthesda LCL; GM11639
DR   CLO; CLO_0021326
DR   Coriell; GM11639
DR   Wikidata; Q54845211
RX   PubMed=16081512;
CC   Population: Caucasian; Hungarian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg155Ter (c.463C>T); ClinVar=VCV000496268; Zygosity=Heterozygous (Coriell=GM11639).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPH207BE LCL
AC   CVCL_1F32
SY   Xeroderma Pigmentosum Heterozygote 207 BEthesda LCL; GM13296
DR   CLO; CLO_0013324
DR   BioSample; SAMN00802269
DR   Coriell; GM13296
DR   Wikidata; Q54846429
RX   PubMed=16081512;
CC   Population: Caucasian; Hungarian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>G (IVS5.1-2A>G); ClinVar=VCV000550100; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM13296).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   XPH20PV
AC   CVCL_RU60
SY   Xeroderma Pigmentosum Heterozygote 20 PaVia
DR   CLO; CLO_0009682
DR   CLDB; cl4775
DR   Wikidata; Q54995009
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH26TA
AC   CVCL_F223
SY   Xeroderma Pigmentosum Heterozygote 26 Tel Aviv; GM16686; KR04048
DR   CLO; CLO_0017454
DR   Coriell; GM16686
DR   Wikidata; Q54848698
RX   PubMed=11121128;
RX   PubMed=16081512;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Heterozygous (PubMed=11121128).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   XPH27RO
AC   CVCL_ZR50
SY   Xeroderma Pigmentosum Heterozygote 27 ROtterdam
DR   Wikidata; Q98136318
RX   PubMed=4778857;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Heterozygous (from familial inference of XP25RO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XPH27TA
AC   CVCL_F224
SY   Xeroderma Pigmentosum Heterozygote 27 Tel Aviv; GM16687; KR04049
DR   CLO; CLO_0017466
DR   Coriell; GM16687
DR   Wikidata; Q54848700
RX   PubMed=11121128;
RX   PubMed=16081512;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr189Serfs*10 (c.564_565AT[1]) (del AT 669-670); ClinVar=VCV000000258; Zygosity=Heterozygous (PubMed=11121128).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   XPH288BE
AC   CVCL_1F70
SY   Xeroderma Pigmentosum Heterozygote 288 BEthesda; GM16951
DR   CLO; CLO_0018110
DR   Coriell; GM16951
DR   Wikidata; Q54848809
CC   Population: Caucasian.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F69 ! XPH288BE LCL
SX   Female
AG   49Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 8
//
ID   XPH288BE LCL
AC   CVCL_1F69
SY   Xeroderma Pigmentosum Heterozygote 288 BEthesda LCL; GM16950
DR   CLO; CLO_0018112
DR   Coriell; GM16950
DR   Wikidata; Q54848808
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F70 ! XPH288BE
SX   Female
AG   49Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   XPH28RO
AC   CVCL_ZR51
SY   Xeroderma Pigmentosum Heterozygote 28 ROtterdam
DR   Wikidata; Q98136321
RX   PubMed=4778857;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Arg207Ter (c.619C>T); ClinVar=VCV000000996; Zygosity=Heterozygous (from familial inference of XP25RO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XPH291BE LCL
AC   CVCL_1F16
SY   Xeroderma Pigmentosum Heterozygote 291 BEthesda LCL; GM04237; GM04237A
DR   CLO; CLO_0019475
DR   Coriell; GM04237
DR   Wikidata; Q54838449
RX   CelloPub=CLPUB00447;
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   XPH292BE LCL
AC   CVCL_1F17
SY   Xeroderma Pigmentosum Heterozygote 292 BEthesda LCL; GM04238
DR   CLO; CLO_0019482
DR   Coriell; GM04238
DR   Wikidata; Q54838450
RX   CelloPub=CLPUB00447;
RX   PubMed=16081512;
CC   Population: Caucasian.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 12
//
ID   XPH294BE
AC   CVCL_X830
SY   Xeroderma Pigmentosum Heterozygote 294 BEthesda; AG10034
DR   CLO; CLO_0021886
DR   Coriell; AG10034
DR   Wikidata; Q54743200
RX   CelloPub=CLPUB00597;
RX   PubMed=16081512;
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG10034).
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X831 ! XPH294BE LCL
SX   Female
AG   45Y4M
CA   Finite cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 15
//
ID   XPH294BE LCL
AC   CVCL_X831
SY   Xeroderma Pigmentosum Heterozygote 294 BEthesda LCL; AG10035
DR   CLO; CLO_0021887
DR   Coriell; AG10035
DR   Wikidata; Q54743202
RX   CelloPub=CLPUB00597;
CC   Population: Native North American.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; c.622-2A>C (IVS5.1-2A>C); ClinVar=VCV000190209; Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=AG10035).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_X830 ! XPH294BE
SX   Female
AG   45Y4M
CA   Transformed cell line
DT   Created: 05-09-14; Last updated: 19-12-24; Version: 16
//
ID   XPH298BE LCL
AC   CVCL_HJ82
SY   Xeroderma Pigmentosum Heterozygote 298 BEthesda LCL; GM15451
DR   Coriell; GM15451
DR   Wikidata; Q54847956
RX   PubMed=16081512;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 8
//
ID   XPH2AA
AC   CVCL_L467
SY   GM03179
DR   CLO; CLO_0013416
DR   BioSample; SAMN00808277
DR   Coriell; GM03179
DR   Wikidata; Q54837909
RX   CelloPub=CLPUB00447;
CC   Population: Indian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   32Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 11
//
ID   XPH2JO
AC   CVCL_M281
SY   Xeroderma Pigmentosum Heterozygote 2 JOhannesburg; GM02034; GM-2034; GM2034
DR   CLO; CLO_0032569
DR   BioSample; SAMN00807410
DR   Coriell; GM02034
DR   Wikidata; Q54837253
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
CC   Population: African; Zulu.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 14
//
ID   XPH2PV
AC   CVCL_RU61
SY   Xeroderma Pigmentosum Heterozygote 2 PaVia
DR   CLO; CLO_0009683
DR   CLDB; cl4776
DR   Wikidata; Q54995010
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Heterozygous (from familial inference of XP10PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   XPH310BE LCL
AC   CVCL_1F18
SY   Xeroderma Pigmentosum Heterozygote 310 BEthesda LCL; GM04491; KR04491
DR   CLO; CLO_0019669
DR   BioSample; SAMN00795299
DR   Coriell; GM04491
DR   Wikidata; Q54838538
RX   PubMed=16081512;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS11-1_IVS11-2delAG; Zygosity=Heterozygous (Coriell=GM04491).
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Unexplicit; IVS11-6_IVS11-7insCC; Zygosity=Heterozygous (Coriell=GM04491).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XPH311BE LCL
AC   CVCL_1F80
SY   Xeroderma Pigmentosum Heterozygote 311 BEthesda LCL; GM17860
DR   CLO; CLO_0016464
DR   Coriell; GM17860
DR   Wikidata; Q54849289
RX   PubMed=16081512;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys692Ter (c.2074A>T); ClinVar=VCV000496267; Zygosity=Heterozygous (Coriell=GM17860).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XPH312BE LCL
AC   CVCL_1F79
SY   Xeroderma Pigmentosum Heterozygote 312 BEthesda LCL; GM17858
DR   CLO; CLO_0016465
DR   Coriell; GM17858
DR   Wikidata; Q54849288
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 10
//
ID   XPH395BE
AC   CVCL_ZP75
SY   Xeroderma Pigmentosum Heterozygote 395 BEthesda; JA1357
DR   Wikidata; Q98136323
RX   PubMed=18955168;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Met1Arg (c.2T>G); ClinVar=VCV001066146; Zygosity=Heterozygous (PubMed=18955168).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPH396BE
AC   CVCL_ZP76
SY   Xeroderma Pigmentosum Heterozygote 396 BEthesda; JA1358
DR   Wikidata; Q98136326
RX   PubMed=18955168;
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Met1Arg (c.2T>G); ClinVar=VCV001066146; Zygosity=Heterozygous (PubMed=18955168).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPH3PV
AC   CVCL_RU62
SY   Xeroderma Pigmentosum Heterozygote 3 PaVia
DR   CLO; CLO_0009684
DR   CLDB; cl4777
DR   Wikidata; Q54995011
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Heterozygous (from familial inference of XP10PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   XPH4CA
AC   CVCL_L775
SY   Xeroderma Pigmentosum Heterozygote 4 CAiro; GM02998; GM17379
DR   CLO; CLO_0012585
DR   CLO; CLO_0013700
DR   BioSample; SAMN00808206
DR   Coriell; GM02998
DR   Coriell; GM17379
DR   Wikidata; Q54837800
RX   CelloPub=CLPUB00447;
CC   Part of: Human variation panel.
CC   Population: Egyptian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 12
//
ID   XPH4PV
AC   CVCL_RU63
SY   Xeroderma Pigmentosum Heterozygote 4 PaVia
DR   CLO; CLO_0009685
DR   CLDB; cl4778
DR   Wikidata; Q54995012
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Heterozygous (from familial inference of XP12PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XPH5PV
AC   CVCL_RU64
SY   Xeroderma Pigmentosum Heterozygote 5 PaVia
DR   CLO; CLO_0009686
DR   CLDB; cl4779
DR   Wikidata; Q54995013
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Pro43Glnfs*36 (c.128delC); ClinVar=VCV000551235; Zygosity=Heterozygous (from familial inference of XP12PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XPH6PV
AC   CVCL_RU65
SY   Xeroderma Pigmentosum Heterozygote 6 PaVia
DR   CLO; CLO_0009687
DR   CLDB; cl4780
DR   Wikidata; Q54995014
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH7PV
AC   CVCL_RU66
SY   Xeroderma Pigmentosum Heterozygote 7 PaVia
DR   CLO; CLO_0009688
DR   CLDB; cl4781
DR   Wikidata; Q54995015
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH88BE
AC   CVCL_1F58
SY   Xeroderma Pigmentosum Heterozygote 88 BEthesda; GM16380
DR   CLO; CLO_0019401
DR   BioSample; SAMN00804498
DR   Coriell; GM16380
DR   Wikidata; Q54848488
RX   PubMed=16081512;
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys522Ter (c.1564A>T); ClinVar=VCV000549952; Zygosity=Heterozygous (Coriell=GM16380).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F60 ! XPH88BE LCL
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XPH88BE LCL
AC   CVCL_1F60
SY   Xeroderma Pigmentosum Heterozygote 88 BEthesda LCL; GM16384
DR   CLO; CLO_0019396
DR   BioSample; SAMN00804504
DR   Coriell; GM16384
DR   Wikidata; Q54848493
CC   Population: Jewish; Ashkenazi.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Lys522Ter (c.1564A>T); ClinVar=VCV000549952; Zygosity=Heterozygous (Coriell=GM16384).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F58 ! XPH88BE
SX   Male
AG   45Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XPH89BE
AC   CVCL_1F57
SY   Xeroderma Pigmentosum Heterozygote 89 BEthesda; GM16379
DR   CLO; CLO_0019415
DR   BioSample; SAMN00804496
DR   Coriell; GM16379
DR   Wikidata; Q54848487
RX   PubMed=16081512;
CC   Population: Jewish; Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu141Leufs*6 (c.420_423delTGAG) (p.Ser140fs*146) (525_528delTGAG); ClinVar=VCV000550638; Zygosity=Heterozygous (Coriell=GM16379).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F59 ! XPH89BE LCL
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 14
//
ID   XPH89BE LCL
AC   CVCL_1F59
SY   Xeroderma Pigmentosum Heterozygote 89 BEthesda LCL; GM16383
DR   CLO; CLO_0019400
DR   Coriell; GM16383
DR   Wikidata; Q54848492
CC   Population: Jewish; Sephardic.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Glu141Leufs*6 (c.420_423delTGAG) (p.Ser140fs*146) (525_528delTGAG); ClinVar=VCV000550638; Zygosity=Heterozygous (Coriell=GM16383).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Discontinued: Coriell; GM16383; probable.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F57 ! XPH89BE
SX   Female
AG   40Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPH8PV
AC   CVCL_RU67
SY   Xeroderma Pigmentosum Heterozygote 8 PaVia
DR   CLO; CLO_0009689
DR   CLDB; cl4782
DR   Wikidata; Q54995016
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   56Y
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   XPH8RO
AC   CVCL_ZR99
SY   Xeroderma Pigmentosum Heterozygote 8 ROtterdam
DR   Wikidata; Q98136328
RX   PubMed=4778857;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   XPH90BE LCL
AC   CVCL_1F61
SY   Xeroderma Pigmentosum Heterozygote 90 BEthesda LCL; GM16386
DR   CLO; CLO_0019392
DR   Coriell; GM16386
DR   Wikidata; Q54848495
CC   Population: Jewish; Ashkenazi/Sephardic.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   9Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 29-06-23; Version: 11
//
ID   XPH93TMA LCL
AC   CVCL_1F41
SY   Xeroderma Pigmentosum Heterozygote 93 Turkey MAlatya LCL; GM15702
DR   CLO; CLO_0027668
DR   Coriell; GM15702
DR   Wikidata; Q54848135
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr430Ter (c.1290_1295delTAAAGA) (p.Tyr430_Glu432delinsTer) (1395_1400delTAAAGA); ClinVar=VCV000940041; Zygosity=Heterozygous (Coriell=GM15702).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPH94TMA LCL
AC   CVCL_1F42
SY   Xeroderma Pigmentosum Heterozygote 94 Turkey MAlatya LCL; GM15704
DR   CLO; CLO_0027664
DR   Coriell; GM15704
DR   Wikidata; Q54848142
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Tyr430Ter (c.1290_1295delTAAAGA) (p.Tyr430_Glu432delinsTer) (1395_1400delTAAAGA); ClinVar=VCV000940041; Zygosity=Heterozygous (Coriell=GM15704).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPH95TMA
AC   CVCL_AK76
SY   Xeroderma Pigmentosum Heterozygote 95 Turkey MAlatya; GM15705
DR   CLO; CLO_0027665
DR   Coriell; GM15705
DR   Wikidata; Q54848143
RX   PubMed=18368133;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Heterozygous (PubMed=18368133).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK77 ! XPH95TMA LCL
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 10
//
ID   XPH95TMA LCL
AC   CVCL_AK77
SY   Xeroderma Pigmentosum Heterozygote 95 Turkey MAlatya LCL; GM15706
DR   CLO; CLO_0027660
DR   Coriell; GM15706
DR   Wikidata; Q54848144
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln152Ter (c.454C>T); Zygosity=Heterozygous (from autologous cell line XPH95TMA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_AK76 ! XPH95TMA
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 12
//
ID   XPH96TMA
AC   CVCL_1F43
SY   Xeroderma Pigmentosum Heterozygote 96 Turkey MAlatya; GM15707
DR   CLO; CLO_0027663
DR   Coriell; GM15707
DR   Wikidata; Q54848145
RX   PubMed=11511294;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Heterozygous (PubMed=11511294).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F44 ! XPH96TMA LCL
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XPH96TMA LCL
AC   CVCL_1F44
SY   Xeroderma Pigmentosum Heterozygote 96 Turkey MAlatya LCL; GM15708
DR   CLO; CLO_0027658
DR   Coriell; GM15708
DR   Wikidata; Q54848146
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Heterozygous (Coriell=GM15708).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F43 ! XPH96TMA
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XPH97TMA
AC   CVCL_1F53
SY   Xeroderma Pigmentosum Heterozygote 97 Turkey MAlatya; GM15721
DR   CLO; CLO_0027673
DR   Coriell; GM15721
DR   Wikidata; Q54848155
RX   PubMed=11511294;
RX   PubMed=16081512;
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Heterozygous (PubMed=11511294).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F54 ! XPH97TMA LCL
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 13
//
ID   XPH97TMA LCL
AC   CVCL_1F54
SY   Xeroderma Pigmentosum Heterozygote 97 Turkey MAlatya LCL; GM15722
DR   CLO; CLO_0027674
DR   Coriell; GM15722
DR   Wikidata; Q54848157
CC   Population: Turkish.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Arg579Ter (c.1735C>T); ClinVar=VCV000000259; Zygosity=Heterozygous (Coriell=GM15722).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F53 ! XPH97TMA
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XPH9PV
AC   CVCL_RU68
SY   Xeroderma Pigmentosum Heterozygote 9 PaVia
DR   CLO; CLO_0009690
DR   CLDB; cl4783
DR   Wikidata; Q54995017
CC   From: Istituto di Genetica Biochimica ed Evoluzionistica (IGBE); Pavia; Italy.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Gln (c.2048G>A); ClinVar=VCV000264679; Zygosity=Heterozygous (from familial inference of XP15PV; XP16PV).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   XPHF01RJ
AC   CVCL_ZP86
SY   Xeroderma Pigmentosum Heterozygote Female 01 Rio de Janeiro
DR   Wikidata; Q98136331
RX   PubMed=23255472;
CC   Sequence variation: Mutation; HGNC; HGNC:3437; ERCC5; Simple; p.Trp968Cys (c.2904G>C); ClinVar=VCV000041496; Zygosity=Heterozygous (PubMed=23255472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   XPHF12BE
AC   CVCL_1F19
SY   Xeroderma Pigmentosum Heterozygote Female 12 BEthesda; GM05510; GM5510; GM 5510
DR   CLO; CLO_0024801
DR   Coriell; GM05510
DR   Wikidata; Q54839030
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
RX   PubMed=7519740;
RX   PubMed=9671271;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM05510).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F20 ! XPHF12BE LCL
SX   Female
AG   44Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 16
//
ID   XPHF12BE LCL
AC   CVCL_1F20
SY   Xeroderma Pigmentosum Heterozygote Female 12 BEthesda LCL; GM05511; GM 5511; GM05511B
DR   CLO; CLO_0024799
DR   Coriell; GM05511
DR   Wikidata; Q54839031
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM05511).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F19 ! XPHF12BE
SX   Female
AG   44Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 19
//
ID   XPHF1WI
AC   CVCL_U664
SY   GM01631; GM-1631; GM1631
DR   CLO; CLO_0031501
DR   BioSample; SAMN00806995
DR   Coriell; GM01631
DR   Wikidata; Q54836966
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=6947227;
RX   PubMed=9671271;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM01631).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U665 ! XPHF1WI LCL
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 17
//
ID   XPHF1WI LCL
AC   CVCL_U665
SY   GM07689
DR   CLO; CLO_0016370
DR   Coriell; GM07689
DR   Wikidata; Q54842865
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM07689).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_U664 ! XPHF1WI
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 18
//
ID   XPHF4LO
AC   CVCL_WY87
SY   Xeroderma Pigmentosum Heterozygote Father 4 LOndon
DR   Wikidata; Q98136333
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=6947227;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.468_469delAA; Zygosity=Heterozygous (from familial inference of XP4LO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   XPHF662VI
AC   CVCL_ZR38
SY   Xeroderma Pigmentosum Heterozygote Father 662 VIllejuif
DR   Wikidata; Q98136336
RX   PubMed=16081512;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (from familial inference of XP664VI; XP665VI).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPHM12BE
AC   CVCL_1F21
SY   Xeroderma Pigmentosum Heterozygote Male 12 BEthesda; GM05568; GM5568; GM 5568
DR   CLO; CLO_0024551
DR   Coriell; GM05568
DR   Wikidata; Q54841876
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
RX   PubMed=9671271;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.507-1G>T (IVS3-1G>T); Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM05568).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F22 ! XPHM12BE LCL
SX   Male
AG   47Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 15
//
ID   XPHM12BE LCL
AC   CVCL_1F22
SY   Xeroderma Pigmentosum Heterozygote Male 12 BEthesda LCL; GM05569; GM 5569; GM05569A
DR   CLO; CLO_0024549
DR   Coriell; GM05569
DR   Wikidata; Q54841877
RX   CelloPub=CLPUB00447;
RX   PubMed=6096450;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.507-1G>T (IVS3-1G>T); Zygosity=Heterozygous; Note=Splice acceptor mutation (Coriell=GM05569).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F21 ! XPHM12BE
SX   Male
AG   47Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   XPHM1WI
AC   CVCL_1F08
SY   GM01632; GM-1632; GM1632
DR   CLO; CLO_0031496
DR   BioSample; SAMN00806997
DR   Coriell; GM01632
DR   Wikidata; Q54836967
RX   CelloPub=CLPUB00447;
RX   DOI=10.5962/bhl.title.4090;
RX   PubMed=9671271;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM01632).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F23 ! XPHM1WI LCL
SX   Female
AG   25Y
CA   Finite cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 17
//
ID   XPHM1WI LCL
AC   CVCL_1F23
SY   GM07690
DR   CLO; CLO_0016369
DR   Coriell; GM07690
DR   Wikidata; Q54842866
RX   CelloPub=CLPUB00447;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; p.Gln185His (c.555G>C); ClinVar=VCV000550646; Zygosity=Heterozygous; Note=Also produces mis-splicing (Coriell=GM07690).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1F08 ! XPHM1WI
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 08-07-15; Last updated: 19-12-24; Version: 18
//
ID   XPHM4LO
AC   CVCL_WY88
SY   Xeroderma Pigmentosum Heterozygote Mother 4 LOndon
DR   Wikidata; Q98136338
RX   DOI=10.1007/978-1-4757-1117-2_12;
RX   PubMed=6947227;
CC   Sequence variation: Mutation; HGNC; HGNC:12814; XPA; Simple; c.468_469delAA; Zygosity=Heterozygous (from familial inference of XP4LO).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   XPHM663VI
AC   CVCL_ZR39
SY   Xeroderma Pigmentosum Heterozygote Mother 663 VIllejuif
DR   Wikidata; Q98136341
RX   PubMed=16081512;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:12816; XPC; Simple; p.Val548Alafs*25 (c.1639_1640TG[2]) (1744_1745delTG); ClinVar=VCV000000262; Zygosity=Heterozygous (from familial inference of XP664VI; XP665VI).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPJCLO
AC   CVCL_ZN40
DR   Wikidata; Q98136344
RX   PubMed=7825573;
RX   PubMed=9238033;
RX   PubMed=18079351;
RX   PubMed=26884178;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Gln645Aspfs*3 (c.1933_1934delCA); ClinVar=VCV002736906; Zygosity=Heterozygous (PubMed=9238033; PubMed=26884178).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg683Trp (c.2047C>T); ClinVar=VCV000016793; Zygosity=Heterozygous (PubMed=9238033; PubMed=26884178).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 27-11-25; Version: 10
//
ID   XPKABE
AC   CVCL_U793
SY   Te Ger
DR   ATCC; CRL-1275
DR   Wikidata; Q54972004
RX   PubMed=273925;
RX   PubMed=1372108;
CC   Discontinued: ATCC; CRL-1275; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   9Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   XPKFSF
AC   CVCL_U689
SY   HT 709A
DR   ATCC; CRL-1206
DR   Wikidata; Q54896495
RX   PubMed=273925;
CC   Discontinued: ATCC; CRL-1206; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 9
//
ID   XPKMSF
AC   CVCL_U764
SY   XPKM
DR   ATCC; CRL-1203
DR   Wikidata; Q54995019
RX   PubMed=4811796;
CC   Discontinued: ATCC; CRL-1203; true.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Finite cell line
DT   Created: 16-04-14; Last updated: 02-05-24; Version: 9
//
ID   XPL15OS
AC   CVCL_3253
DR   JCRB; JCRB0307
DR   JCRB; KURB1281
DR   Wikidata; Q54995029
RX   PubMed=29892436;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0307
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,10
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 12
ST   TH01: 8,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3965; Xeroderma pigmentosum, complementation group A
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 14
//
ID   XPL1KM
AC   CVCL_ZQ30
DR   Wikidata; Q98136347
RX   PubMed=7000335;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3452; Xeroderma pigmentosum
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   XPL3KA
AC   CVCL_3254
DR   JCRB; JCRB0306
DR   Wikidata; Q54995030
RX   PubMed=2805228;
RX   PubMed=29892436;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB0306
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8,13
ST   D16S539: 10,11
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_JG85 ! XP3KA
OI   CVCL_WD01 ! XP3KA(L)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 15
//
ID   XPLA-Be
AC   CVCL_ZN42
SY   XPLABE
DR   Wikidata; Q98136349
RX   PubMed=2913963;
RX   PubMed=9238033;
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Tyr542Cys (c.1625A>G); Zygosity=Heterozygous (PubMed=9238033).
CC   Sequence variation: Mutation; HGNC; HGNC:3434; ERCC2; Simple; p.Arg616Pro (c.1847G>C); ClinVar=VCV000329508; Zygosity=Heterozygous (PubMed=9238033).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Finite cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   XPML17
AC   CVCL_F907
DR   Wikidata; Q54995031
RX   PubMed=202381;
RX   PubMed=1906129;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   XPPHBE
AC   CVCL_AK35
SY   GM02449; GM02449B; GM02449C
DR   CLO; CLO_0033324
DR   BioSample; SAMN00807787
DR   Coriell; GM02449
DR   Wikidata; Q54837500
RX   CelloPub=CLPUB00447;
RX   PubMed=10398605;
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Asn359fs (c.1078insG); Zygosity=Heterozygous (PubMed=10398605).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Transformed cell line
DT   Created: 02-05-16; Last updated: 19-12-24; Version: 13
//
ID   XPPL17
AC   CVCL_F908
DR   Wikidata; Q54995032
RX   PubMed=202381;
RX   PubMed=1906129;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   XPTS-1
AC   CVCL_9U60
DR   Wikidata; Q54995033
RX   PubMed=21575431;
RX   PubMed=22932480;
CC   Population: Chinese.
CC   Doubling time: 22 hours (PubMed=21575431).
CC   Misspelling: XTPS-1; PubMed=22932480; Note=Everywhere in the paper including in the title.
DI   NCIt; C6645; Infantile hemangioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 9
//
ID   XPV10HM
AC   CVCL_A1ZI
SY   Xeroderma Pigmentosum Variant HamaMatsu 10
DR   Wikidata; Q105511784
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV11HM
AC   CVCL_A1ZJ
SY   Xeroderma Pigmentosum Variant HamaMatsu 11
DR   Wikidata; Q105511788
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu306Ter (c.916G>T); ClinVar=VCV000005887; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV12HM
AC   CVCL_A1ZK
SY   Xeroderma Pigmentosum Variant HamaMatsu 12
DR   Wikidata; Q105511790
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln554fs*31 (c.1661delA); Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV1HM
AC   CVCL_A1ZC
SY   Xeroderma Pigmentosum Variant HamaMatsu 1
DR   Wikidata; Q105511792
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV1KO
AC   CVCL_A1ZL
SY   Xeroderma Pigmentosum Variant KObe 1
DR   Wikidata; Q105511794
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Heterozygous (PubMed=17344931).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu306Ter (c.916G>T); ClinVar=VCV000005887; Zygosity=Heterozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV2HM
AC   CVCL_A1ZD
SY   Xeroderma Pigmentosum Variant HamaMatsu 2
DR   Wikidata; Q105511796
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Arg356Ter (c.1066C>T); ClinVar=VCV001459259; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   XPV2KO
AC   CVCL_A1ZM
SY   Xeroderma Pigmentosum Variant KObe 2
DR   Wikidata; Q105511798
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV3HM
AC   CVCL_A1ZE
SY   Xeroderma Pigmentosum Variant HamaMatsu 3
DR   Wikidata; Q105511801
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   XPV3KO
AC   CVCL_A1ZN
SY   Xeroderma Pigmentosum Variant KObe 3
DR   Wikidata; Q105511803
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ala117Pro (c.349G>C); Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV4KO
AC   CVCL_A1ZP
SY   Xeroderma Pigmentosum Variant KObe 4
DR   Wikidata; Q105511806
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ser242Ter (c.725C>G); ClinVar=VCV000264680; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV5KO
AC   CVCL_A1ZQ
SY   Xeroderma Pigmentosum Variant KObe 5
DR   Wikidata; Q105511808
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV6HM
AC   CVCL_A1ZF
SY   Xeroderma Pigmentosum Variant HamaMatsu 6
DR   Wikidata; Q105511811
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ser242Ter (c.725C>G); ClinVar=VCV000264680; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV6KO
AC   CVCL_A1ZR
SY   Xeroderma Pigmentosum Variant KObe 6
DR   Wikidata; Q105511814
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu306Ter (c.916G>T); ClinVar=VCV000005887; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV7HM
AC   CVCL_A1ZG
SY   Xeroderma Pigmentosum Variant HamaMatsu 7
DR   Wikidata; Q105511816
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Glu164Ter (c.490G>T); ClinVar=VCV000225444; Zygosity=Homozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPV7KO
AC   CVCL_A1ZS
SY   Xeroderma Pigmentosum Variant KObe 7
DR   Wikidata; Q105511818
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   48Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   XPV8HM
AC   CVCL_A1ZH
SY   Xeroderma Pigmentosum Variant HamaMatsu 8
DR   Wikidata; Q105511821
RX   PubMed=17344931;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Ser242Ter (c.725C>G); ClinVar=VCV000264680; Zygosity=Heterozygous (PubMed=17344931).
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Lys589Thr (c.1766A>C); ClinVar=VCV000005895; Zygosity=Heterozygous (PubMed=17344931).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   39Y
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   XPVAR-1
AC   CVCL_ZQ17
SY   XPvar-1
DR   Wikidata; Q98136352
RX   PubMed=3010096;
CC   Population: Iranian.
CC   Sequence variation: Mutation; HGNC; HGNC:9181; POLH; Simple; p.Gln373Ter (c.1117C>T); ClinVar=VCV000005890; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSVori-).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C141367; Xeroderma pigmentosum variant type
DI   ORDO; Orphanet_90342; Xeroderma pigmentosum variant
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_7358 ! XP115LO 2
SX   Male
AG   25Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   XQH
AC   CVCL_J129
DR   cancercelllines; CVCL_J129
DR   Wikidata; Q54995034
RX   Patent=US5976860;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11864.
CC   Population: Caucasian.
CC   Characteristics: Infected with Ehrlichia.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 22
//
ID   XR-1
AC   CVCL_K253
SY   CHO XR-1; CHO.XR-1; GM16147
DR   CLO; CLO_0019811
DR   CLO; CLO_0050426
DR   Coriell; GM16147
DR   RCB; RCB2331
DR   Wikidata; Q54995035
RX   PubMed=2164147;
RX   PubMed=6836453;
RX   PubMed=10047779;
CC   Characteristics: Both alleles of Xrcc4 are deleted in this cell line.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_K254 ! CHO 4364
SX   Female
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 30-01-24; Version: 10
//
ID   XR-C1
AC   CVCL_S146
SY   XRC-1; XRC1; GM16135
DR   CLO; CLO_0018814
DR   Coriell; GM16135
DR   Wikidata; Q54995038
RX   PubMed=9628911;
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D898 ! CHO-9
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 11
//
ID   XR-V10B
AC   CVCL_F517
DR   Wikidata; Q54995040
RX   PubMed=9742232;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   XR-V11B
AC   CVCL_F518
DR   Wikidata; Q54995041
RX   PubMed=9742232;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   XR-V12B
AC   CVCL_F519
DR   Wikidata; Q54995042
RX   PubMed=9742232;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   XR-V13B
AC   CVCL_F520
DR   Wikidata; Q54995043
RX   PubMed=9742232;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 13
//
ID   XR-V15B
AC   CVCL_3271
SY   GM16144
DR   CLO; CLO_0009694
DR   CLO; CLO_0018891
DR   CLO; CLO_0051580
DR   ATCC; CRL-2349
DR   Coriell; GM16144
DR   RCB; RCB2339
DR   Wikidata; Q54995044
RX   PubMed=2460764;
RX   PubMed=8657125;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q60449; Xrcc5; Simple; p.Ala372_Glu417del46 (c.1114_1251del138); Zygosity=Unspecified (PubMed=8657125).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   XR-V16B
AC   CVCL_F521
SY   GM16145
DR   CLO; CLO_0018890
DR   Coriell; GM16145
DR   Wikidata; Q54995045
RX   PubMed=9742232;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   XR-V9B
AC   CVCL_HM60
DR   Wikidata; Q54995046
RX   PubMed=1438689;
RX   PubMed=8657125;
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q60449; Xrcc5; Simple; p.Ile267_Gln350del84 (c.799_1050del252); Zygosity=Unspecified (PubMed=8657125).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_6296 ! V79B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 11
//
ID   XR-V9B-4
AC   CVCL_8651
DR   CLO; CLO_0051581
DR   RCB; RCB2338
DR   Wikidata; Q54995047
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Leu133Gln (c.398T>A); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; O09185; Tp53; Simple; p.Cys135Trp (c.405C>G); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q60449; Xrcc5; Simple; p.Ile267_Gln350del84 (c.799_1050del252); Zygosity=Unspecified (from parent cell line).
CC   Transformant: ChEBI; CHEBI_23995; N-ethyl-N-nitrosourea (ENU).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HM60 ! XR-V9B
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 15
//
ID   XR1
AC   CVCL_T691
SY   Xenopus Retina 1
DR   Wikidata; Q54995048
RX   DOI=10.1006/ncmn.1993.1060;
RX   PubMed=2659410;
RX   PubMed=3257022;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
ID   XR8
AC   CVCL_T692
SY   Xenopus retina 8
DR   Wikidata; Q54995060
RX   PubMed=2659410;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   XR9
AC   CVCL_T693
SY   Xenopus retina 9
DR   Wikidata; Q54995061
RX   PubMed=2659410;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, retina; UBERON=UBERON_0003072.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   XRpe1
AC   CVCL_T694
SY   Xenopus Retinal pigment epithelium 1
DR   Wikidata; Q54995063
RX   DOI=10.1006/ncmn.1993.1060;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, optic cup, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   XRpe2
AC   CVCL_T695
SY   Xenopus Retinal pigment epithelium 2
DR   Wikidata; Q54995064
RX   DOI=10.1006/ncmn.1993.1060;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, optic cup, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   XRpe4
AC   CVCL_T696
SY   Xenopus Retinal pigment epithelium 4
DR   Wikidata; Q54995065
RX   DOI=10.1006/ncmn.1993.1060;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, optic cup, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   XRpe5
AC   CVCL_T697
SY   Xenopus Retinal pigment epithelium 5
DR   Wikidata; Q54995066
RX   DOI=10.1006/ncmn.1993.1060;
CC   Group: Amphibian cell line.
CC   Derived from site: In situ; Embryonic eye, optic cup, retinal pigment epithelium; UBERON=UBERON_0005424.
CC   Cell type: Retinal pigment epithelial cell; CL=CL_0002586.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Early tailbud stage
CA   Spontaneously immortalized cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 11
//
ID   XS20
AC   CVCL_AV87
DR   Wikidata; Q54995067
RX   PubMed=7490479;
RX   PubMed=7636305;
RX   PubMed=7876542;
CC   Derived from site: In situ; Trunk, skin, epidermis; UBERON=UBERON_0001085+UBERON_0001003.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 7
//
ID   XS52
AC   CVCL_K270
DR   Wikidata; Q54995068
RX   PubMed=7490479;
RX   PubMed=7636305;
RX   PubMed=7876542;
CC   Derived from site: In situ; Trunk, skin, epidermis; UBERON=UBERON_0001085+UBERON_0001003.
CC   Cell type: Dendritic cell; CL=CL_0000451.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   <1D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 9
//
ID   XS63
AC   CVCL_3626
DR   CLO; CLO_0009695
DR   ATCC; TIB-17
DR   Wikidata; Q54995069
RX   PubMed=5439579;
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C125417; Mouse multiple myeloma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   XT67E1
AC   CVCL_AS08
SY   XT
DR   GEO; GSM397402
DR   GEO; GSM397403
DR   GEO; GSM397404
DR   GEO; GSM397405
DR   GEO; GSM397406
DR   GEO; GSM397407
DR   Wikidata; Q54995071
RX   PubMed=8538762;
RX   PubMed=19581487;
RX   PubMed=23850244;
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; DNA methylation analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: PGK x 129P2/Ola/Hsd.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_AS07 ! PGK12.1
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 02-05-16; Last updated: 10-04-25; Version: 9
//
ID   XTC-2
AC   CVCL_5610
SY   LSTM-XL-2; XTC-YF; XTC; Xenopus Tadpole Carcass-2
DR   CLO; CLO_0050158
DR   Kerafast; EMU039
DR   RCB; RCB0771
DR   Wikidata; Q54995074
RX   DOI=10.17037/PUBS.04656048;
RX   PubMed=1811155;
RX   PubMed=2318264;
RX   PubMed=4708349;
RX   PubMed=8052658;
RX   PubMed=33389257;
WW   Info; Xenbase; -; https://wiki.xenbase.org/xenwiki/index.php?title=Tissue_culture_of_Xenopus_cell_lines_S3,_XTC_(Stukenberg_lab)
CC   Group: Amphibian cell line.
CC   Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257).
CC   Doubling time: ~24 hours (DOI=10.17037/PUBS.04656048).
CC   Karyotypic information: Diploid karyotype (PubMed=4708349).
CC   Caution: According to RCB RCB0771 XTC-YF and XTC-2 are identical.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 16
//
ID   XTC-2 BirAV5
AC   CVCL_C0NH
SY   XTC-2 [BirAV5]; XTC-2[pEF-BirAV5]
DR   Kerafast; EMU040
DR   Wikidata; Q112930581
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses C-terminal V5-tagged birA under the control of the human EF1a promoter.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_5610 ! XTC-2
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   XTC-2 BirAV5-FLBIO-xKLF9
AC   CVCL_C0NI
SY   XTC-2 [BirAV5-FLBIO-xKLF9]; XTC-2[BirAV5-FLBIO-xKLF9]
DR   Kerafast; EMU041
DR   Wikidata; Q112930582
CC   Group: Amphibian cell line.
CC   Characteristics: Expresses C-terminal V5-tagged birA under the control of the human EF1a promoter and a N-terminal FLBIO (FLAG tag and biotin ligase recognition peptide) Xenopus Klf9 fusion protein.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P06709; Escherichia coli birA (Note=With a C-terminal V5 tag).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q91632; Xenopus laevis Klf9 (Note=With a N-terminal FLBIO tag).
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_C0NH ! XTC-2 BirAV5
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 9
//
ID   XTC-GTX-11
AC   CVCL_VQ56
SY   GTX-11
DR   Wikidata; Q98136355
RX   PubMed=1811155;
RX   PubMed=2113616;
RX   PubMed=2318264;
CC   Group: Amphibian cell line.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
HI   CVCL_5610 ! XTC-2
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   XTC.UC1
AC   CVCL_9916
SY   XTC-UC1; XTC-1; XTC1; XTC
DR   cancercelllines; CVCL_9916
DR   Cosmic; 1084281
DR   Cosmic; 1162844
DR   Cosmic; 2036689
DR   Cosmic; 2328761
DR   Wikidata; Q54995073
RX   PubMed=9669284;
RX   PubMed=11349830;
RX   PubMed=16646677;
RX   PubMed=16778181;
RX   PubMed=17725429;
RX   PubMed=19087340;
RX   PubMed=26354775;
RX   PubMed=29066502;
RX   PubMed=31443247;
RX   PubMed=36599897;
CC   Characteristics: Has a near-homozygous genome (NHG) (PubMed=29066502).
CC   Doubling time: 103 +- 6.7 hours (PubMed=9669284).
CC   Sequence variation: Mutation; HGNC; HGNC:7427; MT-CYB; Simple; p.Glu271Lys (m.15557G>A); ClinVar=VCV000693906; Zygosity=Heteroplasmic; Note=In 70.3% (PubMed=16778181).
CC   Sequence variation: Mutation; HGNC; HGNC:7455; MT-ND1; Simple; p.Gly101Ter (m.3571insC); Zygosity=Heteroplasmic; Note=In 94.3% (PubMed=16778181).
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Simple; p.Val380Leu (c.1138G>C); ClinVar=VCV000041221; Zygosity=Homozygous; Note=Germline (PubMed=26354775).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro151Thr (c.451C>A); ClinVar=VCV000012369; Zygosity=Homozygous (PubMed=31443247).
CC   Omics: Genomics; Mitochondrial genome sequencing.
CC   Omics: Metabolomics.
CC   Miscellaneous: STR profile from personal communication of Marlow, Laura A.
CC   Derived from site: Metastatic; Breast; UBERON=UBERON_0000310.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 12
ST   D18S51: 13,17
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 12
ST   FGA: 24.2
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C4946; Thyroid gland Hurthle cell carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   XTH-2
AC   CVCL_1892
SY   XTH; Xenopus Tadpole Heart-2
DR   CLO; CLO_0009696
DR   CLDB; cl4785
DR   DSMZ; ACC-190
DR   DSMZCellDive; ACC-190
DR   Wikidata; Q54995075
RX   CelloPub=CLPUB00129;
RX   PubMed=3091251;
CC   Group: Amphibian cell line.
CC   Doubling time: ~10-12 days (DSMZ=ACC-190).
CC   Derived from site: In situ; Heart; UBERON=UBERON_0000948.
CC   Cell type: Cardiac endothelial cell; CL=CL_0010008.
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Sex unspecified
AG   Tadpole stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   XTK0
AC   CVCL_7228
DR   CLO; CLO_0009697
DR   CLDB; cl4786
DR   Wikidata; Q54995076
RX   PubMed=6278782;
CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HHV-2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
HI   CVCL_3256 ! XTK2
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   XTK1
AC   CVCL_3255
DR   CLO; CLO_0009698
DR   CLDB; cl4787
DR   Wikidata; Q54995077
RX   PubMed=6278782;
CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HHV-2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 10
//
ID   XTK2
AC   CVCL_3256
SY   XTK-2
DR   CLO; CLO_0009699
DR   CLDB; cl4788
DR   Wikidata; Q54995078
RX   PubMed=6278782;
CC   Transformant: NCBI_TaxID; 10310; Human herpesvirus 2 (HHV-2).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
OX   NCBI_TaxID=10036; ! Mesocricetus auratus (Golden hamster)
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 13
//
ID   XTN-10
AC   CVCL_C0N6
SY   Xenopus Tropicalis Nigerian-10
DR   Wikidata; Q112930583
RX   PubMed=35857907;
CC   Group: Amphibian cell line.
CC   Doubling time: 23.6 hours (PubMed=35857907).
CC   Karyotypic information: Diploid karyotype (PubMed=35857907).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Nigerian St.549; VBO=VBO_0017490.
OX   NCBI_TaxID=8364; ! Xenopus tropicalis (Western clawed frog)
SX   Sex unspecified
AG   NF stage 19
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   XTN-12
AC   CVCL_C0N7
SY   Xenopus Tropicalis Nigerian-12
DR   Wikidata; Q112930584
RX   PubMed=35857907;
CC   Group: Amphibian cell line.
CC   Doubling time: 21.7 hours (PubMed=35857907).
CC   Karyotypic information: Diploid karyotype (PubMed=35857907).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Nigerian St.549; VBO=VBO_0017490.
OX   NCBI_TaxID=8364; ! Xenopus tropicalis (Western clawed frog)
SX   Sex unspecified
AG   NF stage 19
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   XTN-6
AC   CVCL_C0N4
SY   Xenopus Tropicalis Nigerian-6
DR   Wikidata; Q112930585
RX   PubMed=35857907;
CC   Group: Amphibian cell line.
CC   Doubling time: 24.0 hours (PubMed=35857907).
CC   Karyotypic information: Diploid [56]; diploid with trisomy of chromosome 8 [93]; tetraploid [28] (PubMed=35857907).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Nigerian St.549; VBO=VBO_0017490.
OX   NCBI_TaxID=8364; ! Xenopus tropicalis (Western clawed frog)
SX   Sex unspecified
AG   NF stage 19
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   XTN-8
AC   CVCL_C0N5
SY   Xenopus Tropicalis Nigerian-8
DR   Wikidata; Q112930586
RX   PubMed=35857907;
CC   Group: Amphibian cell line.
CC   Doubling time: 24.5 hours (PubMed=35857907).
CC   Karyotypic information: Diploid karyotype (PubMed=35857907).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: Nigerian St.549; VBO=VBO_0017490.
OX   NCBI_TaxID=8364; ! Xenopus tropicalis (Western clawed frog)
SX   Sex unspecified
AG   NF stage 19
CA   Spontaneously immortalized cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 7
//
ID   XTR-3 BSAgB
AC   CVCL_UZ87
SY   XTR-3BSAGB
DR   Wikidata; Q98136357
RX   PubMed=6548703;
CC   Group: Human/rodent somatic cell hybrid.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybrid cell line
DT   Created: 25-02-19; Last updated: 21-03-23; Version: 3
//
ID   XTUU 139/30
AC   CVCL_9V36
DR   Wikidata; Q54995079
RX   PubMed=1335463;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   XTUU D10
AC   CVCL_9V37
DR   Wikidata; Q54995080
RX   PubMed=1335463;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybrid cell line
DT   Created: 23-02-16; Last updated: 21-03-23; Version: 5
//
ID   XTY
AC   CVCL_5611
DR   CLO; CLO_0050157
DR   RCB; RCB0770
DR   Wikidata; Q54995082
RX   PubMed=1737584;
CC   Group: Amphibian cell line.
CC   Doubling time: 75.5 hours (PubMed=1737584).
CC   Derived from site: In situ; Back, hypodermis; UBERON=UBERON_0001137+UBERON_0002072.
DI   NCIt; C134574; Xenopus neoplasm
OX   NCBI_TaxID=8355; ! Xenopus laevis (African clawed frog)
SX   Female
AG   Adult stage
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 12
//
ID   XVI E6E6G10
AC   CVCL_F819
DR   CLO; CLO_0009700
DR   ATCC; HB-9496
DR   Wikidata; Q54995084
RX   Patent=US4816417;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9496.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; A3RGC1; Pig VDR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   XWHNi001-A
AC   CVCL_B5GR
DR   BioSamples; SAMEA10329923
DR   hPSCreg; XWHNi001-A
DR   Wikidata; Q110434432
RX   PubMed=35149456;
CC   From: Department of Neurology, Xuan Wu Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Homozygous (PubMed=35149456).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=35149456
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 15,18
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 15,22
ST   D19S433: 14,15.2
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D2S441: 11
ST   D3S1358: 16
ST   D5S818: 11
ST   D6S1043: 17,19
ST   D7S820: 11,13
ST   D8S1179: 12,13
ST   FGA: 20,23
ST   Penta D: 6,9
ST   Penta E: 12,20
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   XWHNi002-A
AC   CVCL_D0Q2
DR   BioSamples; SAMEA112859424
DR   hPSCreg; XWHNi002-A
DR   Wikidata; Q123033943
RX   PubMed=37356183;
CC   From: Department of Neurology, Xuan Wu Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=37356183).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   XWHNi003-A
AC   CVCL_D0Q3
DR   BioSamples; SAMEA114192046
DR   hPSCreg; XWHNi003-A
DR   Wikidata; Q123033944
CC   From: Department of Neurology, Xuan Wu Hospital; Beijing; China.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   XWHNi004-A
AC   CVCL_D0Q4
DR   BioSamples; SAMEA114216499
DR   hPSCreg; XWHNi004-A
DR   Wikidata; Q123033945
RX   PubMed=38552354;
CC   From: Department of Neurology, Xuan Wu Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:613; APOE; Simple; p.Cys130Arg (c.388T>C); ClinVar=VCV000017864; Zygosity=Homozygous; Note=ApoE4 allele (PubMed=38552354).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38552354
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D12S391: 17,22
ST   D13S317: 8,10
ST   D16S539: 9,13
ST   D18S51: 13,21
ST   D19S433: 14
ST   D21S11: 29,31
ST   D2S1338: 19,25
ST   D2S441: 10,12
ST   D3S1358: 17,18
ST   D5S818: 10,12
ST   D6S1043: 13,18
ST   D7S820: 11
ST   D8S1179: 15
ST   FGA: 24
ST   Penta D: 10,12
ST   Penta E: 13,18
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 18,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 4
//
ID   XWLC-05
AC   CVCL_IQ71
SY   XuanWei Lung Cancer-05
DR   Wikidata; Q54995085
RX   PubMed=17222362;
RX   PubMed=29115620;
CC   Population: Chinese.
CC   Doubling time: 32.8 hours (PubMed=17222362).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 29-06-23; Version: 7
//
ID   XX406
AC   CVCL_F543
SY   TER269; TER-269; Ter 269; TER433; TER-433; Ter 433; TER516; TER-516; Ter-516; Ter 516; Extract 165; Extract 250
DR   IPD-IMGT/HLA; 11581
DR   Wikidata; Q54995087
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/346cx.pdf
WW   Info; UCLA International Cell Exchange; -; https://www.uclahealth.org/sites/default/files/documents/CX387_final_rev.pdf
CC   Part of: International Histocompatibility Workshop cell lines.
CC   HLA typing: A*11:01,24:02; B*48:01,27:06; C*01:02,08:01; DPB1*01:01,05:01; DQA1*01:02,05; DQB1*05:02,03:01; DRB1*15:02,13:13; DRB5*01:01 (IPD-IMGT/HLA=11581).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   XXMUFAi001-A
AC   CVCL_E8YH
DR   BioSamples; SAMEA115758137
DR   hPSCreg; XXMUFAi001-A
RX   PubMed=39709756;
CC   From: The First Affiliated Hospital of Xinxiang Medical University; Xinxiang; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Lys897Thr (c.2690A>C); ClinVar=VCV000067427; Zygosity=Heterozygous (PubMed=39709756).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   XXMUFAi002-A
AC   CVCL_E8YI
DR   hPSCreg; XXMUFAi002-A
CC   From: The First Affiliated Hospital of Xinxiang Medical University; Xinxiang; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   XYAM-1
AC   CVCL_C0WU
SY   XiangYa Acral Melanoma-1
DR   Wikidata; Q114313262
RX   PubMed=34097822;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Heel, skin; UBERON=UBERON_0015873.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   XYAM-2
AC   CVCL_C0WV
SY   XiangYa Acral Melanoma-2
DR   Wikidata; Q114313263
RX   PubMed=34097822;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Finger, thumb, skin; UBERON=UBERON_0003533.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   XYAM-3
AC   CVCL_C0WW
SY   XiangYa Acral Melanoma-3
DR   Wikidata; Q114313265
RX   PubMed=34097822;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Heel, skin; UBERON=UBERON_0015873.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   XYAM-4
AC   CVCL_C0WX
SY   XiangYa Acral Melanoma-4
DR   Wikidata; Q114313266
RX   PubMed=34097822;
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Heel, skin; UBERON=UBERON_0015873.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 5
//
ID   XYFMGC02A
AC   CVCL_RZ67
DR   Wikidata; Q54995089
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   XYFMGC05H
AC   CVCL_RZ72
DR   Wikidata; Q54995097
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   XYFMGC07K
AC   CVCL_RZ74
DR   JCRB; JCRB1750
DR   Wikidata; Q54995099
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1750
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 12,13
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   9Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGC08L
AC   CVCL_RZ75
DR   Wikidata; Q54995101
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   XYFMGC10S
AC   CVCL_RZ77
DR   JCRB; JCRB1754
DR   Wikidata; Q54995103
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1754
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,14
ST   D16S539: 11,13
ST   D5S818: 10,11
ST   D7S820: 9,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   XYFMGC28C
AC   CVCL_RZ83
DR   Wikidata; Q54995109
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   17Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   XYFMGC44W
AC   CVCL_RZ84
DR   JCRB; JCRB1753
DR   Wikidata; Q54995122
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1753
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 11
ST   D16S539: 8,12
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 18,19
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   17Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   XYFMGC50H
AC   CVCL_RZ85
DR   JCRB; JCRB1747
DR   Wikidata; Q54995123
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1747
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 10,13
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 10,11
ST   vWA: 14,17
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG01A
AC   CVCL_RZ66
DR   JCRB; JCRB1738
DR   Wikidata; Q54995088
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1738
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   13Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG03D
AC   CVCL_RZ68
DR   JCRB; JCRB1744
DR   Wikidata; Q54995091
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1744
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,14
ST   D16S539: 9,10
ST   D5S818: 12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   49Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG04D
AC   CVCL_RZ69
DR   JCRB; JCRB1760
DR   Wikidata; Q54995093
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1760
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   XYFMGG04DM
AC   CVCL_RZ70
DR   JCRB; JCRB1756
DR   Wikidata; Q54995095
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1756
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 11,13
ST   D5S818: 11,12
ST   D7S820: 8,11
ST   TH01: 9.3
ST   TPOX: 11
ST   vWA: 16,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG04DP
AC   CVCL_RZ71
DR   JCRB; JCRB1757
DR   Wikidata; Q54995096
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1757
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,13
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 12
ST   TH01: 7,10
ST   TPOX: 8
ST   vWA: 17,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG06K
AC   CVCL_RZ73
DR   JCRB; JCRB1748
DR   Wikidata; Q54995098
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1748
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 12,13
ST   D16S539: 9,12
ST   D5S818: 9,10
ST   D7S820: 8,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   2Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   XYFMGG09R
AC   CVCL_RZ76
DR   Wikidata; Q54995102
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   XYFMGG16M
AC   CVCL_RZ78
DR   JCRB; JCRB1752
DR   Wikidata; Q54995104
RX   PubMed=8353496;
RX   PubMed=29330774;
CC   Sequence variation: Mutation; HGNC; HGNC:11311; SRY; Simple; p.Arg62Gly (c.184C>G); Zygosity=Hemizygous (PubMed=8353496).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1752
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D5S818: 13
ST   D7S820: 11,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14,19
DI   NCIt; C128188; 46,XY sex reversal 1
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   41Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   XYFMGG18B
AC   CVCL_RZ79
DR   JCRB; JCRB1743
DR   Wikidata; Q54995105
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1743
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,13
ST   D16S539: 9,13
ST   D5S818: 12,13
ST   D7S820: 9
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   17Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG19M
AC   CVCL_RZ80
DR   JCRB; JCRB1751
DR   Wikidata; Q54995106
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1751
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 9
ST   TH01: 6,8
ST   TPOX: 11
ST   vWA: 19
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   17Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   XYFMGG23G
AC   CVCL_RZ81
DR   JCRB; JCRB1745
DR   Wikidata; Q54995107
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1745
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,9
ST   TH01: 6,9.3
ST   TPOX: 9,11
ST   vWA: 15,17
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   24Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 7
//
ID   XYFMGG24K
AC   CVCL_RZ82
DR   JCRB; JCRB1746
DR   Wikidata; Q54995108
RX   PubMed=29330774;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): JCRB=JCRB1746
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 12,14
ST   D16S539: 10,13
ST   D5S818: 11
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 9,10
ST   vWA: 16,18
DI   NCIt; C120198; 46,XY gonadal dysgenesis
DI   ORDO; Orphanet_242; 46,XY complete gonadal dysgenesis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   25Y
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 02-05-24; Version: 8
//
ID   Y-17
AC   CVCL_E991
DR   CLO; CLO_0009704
DR   ATCC; HB-179
DR   Wikidata; Q54995124
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   Y-1K
AC   CVCL_8774
DR   Wikidata; Q54995125
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7918028;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: ~62 hours (PubMed=7918028).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=7918028; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   Y-3
AC   CVCL_E990
DR   CLO; CLO_0009705
DR   ATCC; HB-176
DR   Wikidata; Q54995127
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 4
//
ID   Y-3P
AC   CVCL_E989
SY   Y3P
DR   CLO; CLO_0009708
DR   ATCC; HB-183
DR   Wikidata; Q54995128
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 21-03-23; Version: 5
//
ID   Y-79
AC   CVCL_1893
SY   Y79; GM01232; GM01232E
DR   BTO; BTO_0002920
DR   CLO; CLO_0009709
DR   CLO; CLO_0030277
DR   CLO; CLO_0051564
DR   EFO; EFO_0002392
DR   CLDB; cl4796
DR   CLDB; cl4797
DR   CLDB; cl4798
DR   CLDB; cl4984
DR   AddexBio; C0029001/4898
DR   ArrayExpress; E-MTAB-38
DR   ATCC; HTB-18
DR   BCRC; 60422
DR   BCRJ; 0380
DR   BioSample; SAMN00803744
DR   BioSample; SAMN01821607
DR   BioSample; SAMN03472733
DR   BioSample; SAMN03473388
DR   cancercelllines; CVCL_1893
DR   Cell_Model_Passport; SIDM01395
DR   ChEMBL-Cells; CHEMBL3308054
DR   ChEMBL-Targets; CHEMBL613820
DR   CLS; 300382
DR   Coriell; GM01232
DR   Cosmic; 688120
DR   Cosmic; 808507
DR   Cosmic; 1071899
DR   Cosmic; 1176623
DR   DepMap; ACH-001295
DR   DSMZ; ACC-246
DR   DSMZCellDive; ACC-246
DR   ECACC; 86093003
DR   FANTOM5_SSTAR; 10475-106I7
DR   GEO; GSM1250686
DR   GEO; GSM1250688
DR   GEO; GSM1486288
DR   GEO; GSM2043882
DR   IBRC; C11182
DR   ICLC; HTL99029
DR   IGRhCellID; Y79
DR   JCRB; JCRB3020
DR   JCRB; KURB2684
DR   NCBI_Iran; C201
DR   Progenetix; CVCL_1893
DR   PubChem_Cell_line; CVCL_1893
DR   RCB; RCB0427
DR   RCB; RCB1645
DR   Ubigene; YC-B015
DR   Wikidata; Q54995129
RX   CelloPub=CLPUB00447;
RX   DOI=10.3969/j.issn.1673-713X.2017.04.002;
RX   DOI=10.5005/jp-journals-10082-02230;
RX   DOI=10.5795/jjscc.24.451;
RX   PubMed=679190;
RX   PubMed=1679230;
RX   PubMed=2917337;
RX   PubMed=3413073;
RX   PubMed=3518877;
RX   PubMed=4135597;
RX   PubMed=6167750;
RX   PubMed=6351622;
RX   PubMed=7499444;
RX   PubMed=7689221;
RX   PubMed=18036396;
RX   PubMed=18799932;
RX   PubMed=19686387;
RX   PubMed=20215515;
RX   PubMed=21697133;
RX   PubMed=23498719;
RX   PubMed=25326674;
RX   PubMed=27050416;
RX   PubMed=27115612;
RX   PubMed=29162051;
RX   PubMed=29192327;
RX   PubMed=30584916;
RX   PubMed=32123578;
RX   PubMed=32143590;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Doubling time: 52 hours (PubMed=4135597); 47 hours (PubMed=25326674); 24-28 hours (DOI=10.5005/jp-journals-10082-02230); ~40 hours (DSMZ=ACC-246).
CC   HLA typing: A*02:01:01; B*40:01:02,51:01:01; C*03:04:01,12:03:01; DPB1*03:01,04:01; DQA1*01:01:01,01:02:01; DQB1*05:01:01,06:04:01; DRB1*01:01:01,13:02:01 (CLS=300382).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (PubMed=3413073; PubMed=25326674).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (PubMed=3413073; PubMed=25326674).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Anecdotal: Named Y-79 because it was the result of the 79th attempt of a group at Yale to establish a retinoblastoma cell line.
CC   Discontinued: JCRB; KURB2684; probable.
CC   Discontinued: RCB; RCB0427; true.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
ST   Source(s): AddexBio=C0029001/4898; ATCC=HTB-18; CLS=300382; DepMap=ACH-001295; DSMZ=ACC-246; ECACC=86093003; ICLC=HTL99029; JCRB=JCRB3020; RCB=RCB1645
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 13,14
ST   D18S51: 13,16
ST   D19S433: 13
ST   D21S11: 30,32
ST   D2S1338: 20
ST   D3S1358: 15,16
ST   D5S818: 11 (ICLC=HTL99029)
ST   D5S818: 11,12 (AddexBio=C0029001/4898; ATCC=HTB-18; CLS=300382; DepMap=ACH-001295; DSMZ=ACC-246; ECACC=86093003; JCRB=JCRB3020; RCB=RCB1645)
ST   D7S820: 8,9
ST   D8S1179: 13,16
ST   FGA: 20,22 (ATCC=HTB-18; DepMap=ACH-001295; DSMZ=ACC-246)
ST   FGA: 22 (CLS=300382)
ST   Penta D: 12
ST   Penta E: 13,18
ST   TH01: 6 (JCRB=JCRB3020)
ST   TH01: 6,9.3 (AddexBio=C0029001/4898; ATCC=HTB-18; CLS=300382; DepMap=ACH-001295; ECACC=86093003; ICLC=HTL99029; RCB=RCB1645)
ST   TH01: 6,10 (DSMZ=ACC-246)
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 42
//
ID   Y-79 CDDP-R
AC   CVCL_B7IF
SY   Y-79 cisplatin-resistant; Y-79 CisPt
DR   Wikidata; Q112930587
RX   PubMed=29192327;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Y-79 Eto-R
AC   CVCL_B7IG
SY   Y-79 etoposide-resistant; Y-79 Etop
DR   Wikidata; Q112930588
RX   PubMed=29192327;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   Y-AK
AC   CVCL_JH33
DR   Wikidata; Q54995131
RX   PubMed=405267;
CC   Doubling time: 24-29 hours (PubMed=405267).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: AKR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   Y-CH
AC   CVCL_JH34
DR   Wikidata; Q54995132
RX   PubMed=405267;
CC   Doubling time: 24-29 hours (PubMed=405267).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: C3H.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   Y-DD
AC   CVCL_JH35
DR   Wikidata; Q54995133
RX   PubMed=405267;
CC   Doubling time: 24-29 hours (PubMed=405267).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Breed/subspecies: DDD.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   14-18FD
CA   Spontaneously immortalized cell line
DT   Created: 15-05-17; Last updated: 29-06-23; Version: 5
//
ID   Y-iPSC-12
AC   CVCL_LI28
SY   Young-iPSC-12
DR   GEO; GSM2452094
DR   Wikidata; Q54995135
RX   PubMed=28846095;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 6
//
ID   Y-iPSC-4
AC   CVCL_LI29
SY   Young-iPSC-4
DR   GEO; GSM2452095
DR   Wikidata; Q54995137
RX   PubMed=28846095;
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: C57BL/6 x CBA.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 10-04-25; Version: 6
//
ID   Y-MESO-11B
AC   CVCL_A1JY
DR   Wikidata; Q102115135
CC   Population: Japanese.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   Y-MESO-12
AC   CVCL_5178
DR   cancercelllines; CVCL_5178
DR   Cosmic; 2759216
DR   GEO; GSM552526
DR   GEO; GSM850303
DR   Progenetix; CVCL_5178
DR   RCB; RCB5667
DR   Wikidata; Q54995138
RX   PubMed=17270034;
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Homozygous (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: No history of asbestos exposure (PubMed=17270034).
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Y-MESO-14
AC   CVCL_5179
SY   Y-Meso-14
DR   cancercelllines; CVCL_5179
DR   Cosmic; 2759219
DR   GEO; GSM552527
DR   GEO; GSM850302
DR   Progenetix; CVCL_5179
DR   RCB; RCB5668
DR   Wikidata; Q54995139
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (PubMed=21245096).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Lys116Glyfs*5 (c.349_359del11); Zygosity=Unspecified (PubMed=26011428).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000457921; Zygosity=Unspecified (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Y-MESO-14/hPDPN
AC   CVCL_D2U3
DR   Wikidata; Q127384730
RX   PubMed=25080943;
RX   PubMed=28387591;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Lys116Glyfs*5 (c.349_359del11); Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000457921; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:29602; PDPN.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5179 ! Y-MESO-14
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   Y-MESO-21
AC   CVCL_5180
DR   cancercelllines; CVCL_5180
DR   Cosmic; 2759221
DR   GEO; GSM552528
DR   GEO; GSM850288
DR   Progenetix; CVCL_5180
DR   Wikidata; Q54995140
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Y-MESO-22
AC   CVCL_5181
DR   cancercelllines; CVCL_5181
DR   Cosmic; 2759217
DR   GEO; GSM552529
DR   GEO; GSM850289
DR   Progenetix; CVCL_5181
DR   RCB; RCB5669
DR   Wikidata; Q54995141
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Homozygous (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Y-MESO-25
AC   CVCL_5182
DR   cancercelllines; CVCL_5182
DR   Cosmic; 2759218
DR   GEO; GSM552530
DR   GEO; GSM850290
DR   Progenetix; CVCL_5182
DR   RCB; RCB5670
DR   Wikidata; Q54995142
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Unexplicit; Ex13-17del; Zygosity=Homozygous (PubMed=26011428).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; c.532_571del40; Zygosity=Unspecified (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   Y-MESO-26B
AC   CVCL_5183
DR   cancercelllines; CVCL_5183
DR   Cosmic; 2759228
DR   GEO; GSM552531
DR   GEO; GSM850291
DR   Progenetix; CVCL_5183
DR   RCB; RCB5671
DR   Wikidata; Q54995144
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Homozygous (PubMed=21245096).
CC   Sequence variation: Mutation; HGNC; HGNC:6515; LATS2; Simple; p.Tyr649Ter (c.1947G>C); Zygosity=Unspecified (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C27779; Lymphohistiocytoid mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A1KA ! Y-MESO-26C
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Y-MESO-26C
AC   CVCL_A1KA
DR   Wikidata; Q102115136
CC   Population: Japanese.
DI   NCIt; C27779; Lymphohistiocytoid mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5183 ! Y-MESO-26B
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   Y-MESO-27
AC   CVCL_5184
DR   cancercelllines; CVCL_5184
DR   Cosmic; 2759222
DR   GEO; GSM552533
DR   GEO; GSM850292
DR   Progenetix; CVCL_5184
DR   RCB; RCB5672
DR   Wikidata; Q54995145
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:6515; LATS2; Zygosity=Homozygous (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): RCB=RCB5672
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 9,10
ST   vWA: 19,20
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 19
//
ID   Y-MESO-28
AC   CVCL_5185
DR   cancercelllines; CVCL_5185
DR   Cosmic; 2759224
DR   GEO; GSM552534
DR   GEO; GSM850293
DR   Progenetix; CVCL_5185
DR   RCB; RCB5673
DR   Wikidata; Q54995146
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:17795; SAV1; Zygosity=Homozygous (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Y-MESO-29
AC   CVCL_5186
DR   cancercelllines; CVCL_5186
DR   Cosmic; 2759233
DR   GEO; GSM552535
DR   GEO; GSM850294
DR   Progenetix; CVCL_5186
DR   RCB; RCB5674
DR   Wikidata; Q54995148
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   Y-MESO-30
AC   CVCL_5187
DR   cancercelllines; CVCL_5187
DR   Cosmic; 2759226
DR   GEO; GSM552536
DR   GEO; GSM850295
DR   Progenetix; CVCL_5187
DR   RCB; RCB5675
DR   Wikidata; Q54995149
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6515; LATS2; Simple; c.2652_2665+111del125; Zygosity=Unspecified (PubMed=21245096).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): RCB=RCB5675
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 7,8
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 18
//
ID   Y-MESO-32
AC   CVCL_M203
DR   Wikidata; Q54995150
RX   PubMed=22286761;
CC   Population: Japanese.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   Y-MESO-37
AC   CVCL_M204
DR   Wikidata; Q54995151
RX   PubMed=22286761;
CC   Population: Japanese.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   Y-MESO-38
AC   CVCL_A1JZ
DR   Wikidata; Q102115137
CC   Population: Japanese.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   79Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   Y-MESO-43
AC   CVCL_M205
DR   Wikidata; Q54995152
RX   PubMed=22286761;
CC   Population: Japanese.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 8
//
ID   Y-MESO-45
AC   CVCL_M206
DR   Wikidata; Q54995153
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 9
//
ID   Y-MESO-48
AC   CVCL_RP11
DR   Wikidata; Q54995154
RX   PubMed=26011428;
CC   Population: Japanese.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   Y-MESO-61
AC   CVCL_RP12
DR   Wikidata; Q54995155
RX   PubMed=26011428;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Pro195Phefs*5 (c.580_581ins40); Zygosity=Unspecified (PubMed=26011428).
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 7
//
ID   Y-MESO-72
AC   CVCL_RP13
DR   Wikidata; Q54995157
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   Y-MESO-76
AC   CVCL_RP14
DR   Wikidata; Q54995158
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 21-03-23; Version: 5
//
ID   Y-MESO-8A
AC   CVCL_5188
SY   Y-meso 8A
DR   IARC_TP53; 24550
DR   RCB; RCB5664
DR   Wikidata; Q54995159
RX   PubMed=16630136;
RX   PubMed=17270034;
CC   Population: Japanese.
CC   Characteristics: While the primary tumor is biphasic this cell line shows epithelioid morphology.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Omics: Variations; Array-based CGH.
CC   Donor information: No history of asbestos exposure (PubMed=16630136).
CC   Misspelling: ACC-MESO-8A; IARC_TP53=24550.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB5664
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5189 ! Y-MESO-8D
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Y-MESO-8D
AC   CVCL_5189
DR   cancercelllines; CVCL_5189
DR   Cosmic; 2759225
DR   GEO; GSM552524
DR   GEO; GSM850287
DR   IARC_TP53; 24551
DR   Progenetix; CVCL_5189
DR   RCB; RCB5665
DR   Wikidata; Q54995160
RX   PubMed=16630136;
RX   PubMed=17270034;
RX   PubMed=21245096;
RX   PubMed=26011428;
CC   Population: Japanese.
CC   Characteristics: While the primary tumor is biphasic this cell line shows sarcomatoid morphology.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=16630136).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Donor information: No history of asbestos exposure (PubMed=16630136).
CC   Misspelling: ACC-MESO-8D; IARC_TP53=24551.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): RCB=RCB5665
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,9
ST   D16S539: 12
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5188 ! Y-MESO-8A
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 22
//
ID   Y-MESO-9
AC   CVCL_5190
DR   cancercelllines; CVCL_5190
DR   Cosmic; 2759215
DR   GEO; GSM552525
DR   GEO; GSM850301
DR   Progenetix; CVCL_5190
DR   RCB; RCB5666
DR   Wikidata; Q54995161
RX   PubMed=17270034;
RX   PubMed=19380521;
RX   PubMed=21245096;
RX   PubMed=22286761;
RX   PubMed=26011428;
RX   PubMed=28553954;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:950; BAP1; Simple; p.Phe678Leufs*37 (c.2035_2036del2); Zygosity=Unspecified (PubMed=26011428).
CC   Sequence variation: Mutation; HGNC; HGNC:7773; NF2; Simple; p.Tyr177fs (c.527_528delTG); Zygosity=Unspecified (PubMed=21245096).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
ST   Source(s): RCB=RCB5666
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10
ST   D16S539: 9
ST   D5S818: 9,12
ST   D7S820: 9,10
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Y-ML-1B
AC   CVCL_4779
DR   cancercelllines; CVCL_4779
DR   IARC_TP53; 17883
DR   RCB; RCB5394
DR   Wikidata; Q54995162
RX   PubMed=12377411;
RX   PubMed=38639832;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Y-ML-1B
CC   Population: Japanese.
CC   Characteristics: Expresses high levels of CSF2, CSF3, IL6 and IL8 (PubMed=12377411).
CC   Doubling time: 19 hours (PubMed=12377411).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu204Ter (c.610G>T); ClinVar=VCV000977783; Zygosity=Unspecified (PubMed=12377411).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C4450; Lung large cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   Y.I.
AC   CVCL_E892
SY   YI
DR   dbMHC; 49086
DR   ECACC; 94061620
DR   IHW; IHW09352
DR   IPD-IMGT/HLA; 11583
DR   Wikidata; Q54995163
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Japanese.
CC   HLA typing: A*24:02,26:02; B*40:02,52:01; C*03:03,12:02; DPB1*02:01,05:01; DQB1*03:03,05:03:01; DRB1*09:01,14:05 (IPD-IMGT/HLA=11583).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   Y0
AC   CVCL_2783
SY   YO; YB2/3.0Ag30
DR   CLO; CLO_0009715
DR   CLDB; cl4804
DR   ECACC; 85110501
DR   NCBI_Iran; C133
DR   Wikidata; Q54995164
RX   PubMed=22358559;
CC   Group: Hybridoma fusion partner cell line.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
ID   Y03
AC   CVCL_ZD55
DR   Wikidata; Q98136359
RX   PubMed=8105609;
CC   Population: Mexican.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Y06
AC   CVCL_ZD56
DR   Wikidata; Q98136362
RX   PubMed=8105609;
CC   Population: Mexican.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Y1
AC   CVCL_0585
SY   Y-1; Y 1; Clone Y-1; Clone Y1; GM05384
DR   BTO; BTO_0000046
DR   CLO; CLO_0009701
DR   CLO; CLO_0024853
DR   CLO; CLO_0051608
DR   MCCL; MCC:0000491
DR   CLDB; cl4789
DR   CLDB; cl4791
DR   CLDB; cl4792
DR   CLDB; cl4793
DR   ATCC; CCL-79
DR   BCRC; 60363
DR   BCRJ; 0254
DR   CCRID; 3101MOUTCM20
DR   ChEMBL-Cells; CHEMBL3307727
DR   ChEMBL-Targets; CHEMBL614872
DR   CLS; 400477
DR   Coriell; GM05384
DR   ECACC; 85051002
DR   ECACC; 85062807
DR   IZSLER; BS TCL 67
DR   JCRB; JCRB9056
DR   NCBI_Iran; C199
DR   PubChem_Cell_line; CVCL_0585
DR   RCB; RCB0533
DR   Wikidata; Q54995165
RX   CelloPub=CLPUB00447;
RX   DOI=10.1007/BF02618370;
RX   PubMed=423792;
RX   PubMed=5930699;
RX   PubMed=15541570;
RX   PubMed=25277546;
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/Y1_adrenocortical_cell
CC   Doubling time: ~30-40 hours (PubMed=423792).
CC   Omics: Variations; SNP array analysis.
CC   Discontinued: ECACC; 85051002; true.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_5F74 ! Y6
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 29
//
ID   Y1-8BrcAMPr-1
AC   CVCL_5G24
SY   8BrcAMPr-1
DR   Wikidata; Q54995166
RX   PubMed=200506;
RX   PubMed=215599;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-BS1
AC   CVCL_W154
SY   Y1BS1
DR   BTO; BTO_0004236
DR   Wikidata; Q54995167
RX   PubMed=423792;
RX   PubMed=2713387;
RX   PubMed=6270152;
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0585 ! Y1
SX   Male
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   Y1-Cyc-101
AC   CVCL_5G15
SY   Cyc-101; Cyc 101
DR   Wikidata; Q54995168
RX   PubMed=221910;
RX   PubMed=6270152;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Cyc-102
AC   CVCL_5G16
SY   Cyc-102; Cyc 102
DR   Wikidata; Q54995177
RX   PubMed=221910;
RX   PubMed=6270152;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Cyc-103
AC   CVCL_5G17
SY   Cyc-103; Cyc 103
DR   Wikidata; Q54995179
RX   PubMed=221910;
RX   PubMed=6270152;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Forsk-10r-1
AC   CVCL_5G18
SY   Forsk-10r-1
DR   Wikidata; Q54995180
RX   PubMed=6538878;
CC   Selected for resistance to: ChEBI; CHEBI_42471; Forskolin.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Forsk-10r-6
AC   CVCL_5G19
SY   Forsk-10r-6; 10r6
DR   Wikidata; Q54995181
RX   PubMed=6538878;
RX   PubMed=15541570;
CC   Selected for resistance to: ChEBI; CHEBI_42471; Forskolin.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Forsk-10r-9
AC   CVCL_5G20
SY   Forsk-10r-9; 10r9
DR   Wikidata; Q54995183
RX   PubMed=6538878;
RX   PubMed=15541570;
CC   Selected for resistance to: ChEBI; CHEBI_42471; Forskolin.
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-HGPRT-
AC   CVCL_5G26
DR   Wikidata; Q54995185
RX   PubMed=198663;
RX   PubMed=6270152;
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_0585 ! Y1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Kin-2
AC   CVCL_5G21
SY   Kin-2; Kin 2
DR   Wikidata; Q54995186
RX   PubMed=221910;
RX   PubMed=6270152;
RX   PubMed=8388994;
RX   PubMed=15541570;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Kin-7
AC   CVCL_5G22
SY   Kin-7; Kin 7
DR   Wikidata; Q54995187
RX   PubMed=221910;
RX   PubMed=6270152;
RX   PubMed=8388994;
RX   PubMed=15541570;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y1-Kin-8
AC   CVCL_5G23
SY   Kin-8; Kin 8
DR   Wikidata; Q54995188
RX   PubMed=221910;
RX   PubMed=6270152;
RX   PubMed=8388994;
RX   PubMed=15541570;
CC   Selected for resistance to: ChEBI; CHEBI_64211; 8-bromo-3',5'-cyclic AMP (8-bromoadenosine 3',5'-cyclic monophosphate; 8-Br-cAMP).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_W154 ! Y1-BS1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 7
//
ID   Y11
AC   CVCL_C5EY
DR   Wikidata; Q116050828
RX   PubMed=21707364;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q61453; Rat Il17a.
CC   Caution: The title of publication PubMed=21707364 mentions that the mAB is against mouse IL-17 but the text indicates it was raised against rat IL-17.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
ID   Y12
AC   CVCL_B4H6
DR   Wikidata; Q110434433
RX   PubMed=2295704;
RX   PubMed=6180012;
RX   PubMed=6789322;
CC   Monoclonal antibody isotype: IgG2b, kappa (PubMed=6180012); IgG3, kappa (PubMed=2295704).
CC   Monoclonal antibody target: UniProtKB; P27048; Mouse Snrpb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   Y13-238
AC   CVCL_8982
DR   CLO; CLO_0009702
DR   ABCD; ABCD_AF801
DR   ATCC; CRL-1741
DR   ECACC; 89111411
DR   Wikidata; Q54995189
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   Y13-259
AC   CVCL_8983
DR   CLO; CLO_0009703
DR   ATCC; CRL-1742
DR   ECACC; 89111412
DR   Wikidata; Q54995190
CC   Monoclonal antibody isotype: IgG1.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 6
//
ID   Y16
AC   CVCL_5416
SY   Y-16
DR   Wikidata; Q54995191
RX   PubMed=2265612;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Y16
CC   Characteristics: IL5 dependent.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Pre-B cell; CL=CL_0000817.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Factor-dependent cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 9
//
ID   Y17
AC   CVCL_ZD57
DR   Wikidata; Q98136365
RX   PubMed=8105609;
CC   Population: Mexican.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11909; Human T-lymphotropic virus 2 (HTLV-2).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   Y1A3
AC   CVCL_C5HM
DR   Wikidata; Q116050829
RX   PubMed=8985754;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Y1F2
AC   CVCL_C5HN
DR   Wikidata; Q116050830
RX   PubMed=8985754;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Y2
AC   CVCL_B4H5
DR   Wikidata; Q110434434
RX   Patent=US4564597;
RX   PubMed=2295704;
RX   PubMed=6180012;
RX   PubMed=6789322;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8050.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P27048; Mouse Snrpb.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   Y2H8
AC   CVCL_C5HP
DR   Wikidata; Q116050831
RX   PubMed=8985754;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Y3-Ag 1.2.3
AC   CVCL_4342
SY   Y3.AG.1.2.3; Y3-Ag1.2.3; Y3-Ag1,2,3; Y3Ag1.2.3; Y-3-Ag 1.2.3; 210-RC Y3-Ag 1,2,3; 210RCY3-Ag1.2.3; 210RCY3-Ag123; Y3-Ag123; Y3; Y3M
DR   CLO; CLO_0009706
DR   CLO; CLO_0009707
DR   CLDB; cl4794
DR   CLDB; cl4795
DR   ATCC; CRL-1631
DR   CCRID; 3101RATTCR10
DR   CLS; 305207
DR   ECACC; 85110502
DR   JCRB; JCRB9091
DR   TKG; TKG 0283
DR   Wikidata; Q54995192
RX   CelloPub=CLPUB00609;
RX   Patent=US4350683;
RX   PubMed=310519;
RX   PubMed=22358559;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-78.
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Cell type: Plasma cell; CL=CL_0000786.
CC   Breed/subspecies: LOU/C; RS=RS_0000563.
DI   NCIt; C125416; Rat multiple myeloma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 20
//
ID   Y3D7
AC   CVCL_C5HQ
DR   Wikidata; Q116050832
RX   PubMed=8985754;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Y3G3
AC   CVCL_C5HR
DR   Wikidata; Q116050833
RX   PubMed=8985754;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Y5D5
AC   CVCL_C5HS
DR   Wikidata; Q116050834
RX   PubMed=8985754;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P08515; Schistosoma japonicum glutathione S-transferase class-mu 26 kDa isozyme (GST).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 3
//
ID   Y6
AC   CVCL_5F74
SY   Y-6
DR   Wikidata; Q54995193
RX   PubMed=4311571;
RX   PubMed=6270152;
RX   PubMed=7588376;
RX   PubMed=15541570;
CC   Doubling time: 76.8 hours (PubMed=4311571).
CC   Derived from site: In situ; Adrenal gland; UBERON=UBERON_0002369.
CC   Breed/subspecies: LAF1.
DI   NCIt; C22992; Mouse adrenal cortical carcinoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_0585 ! Y1
SX   Male
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 6
//
ID   Y79-6
AC   CVCL_VA40
SY   Y79c6
DR   Wikidata; Q54995194
RX   PubMed=1682862;
RX   PubMed=2751270;
RX   PubMed=2946282;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Misspelling: V79c6; PubMed=2946282.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   Y79-Luc
AC   CVCL_ZF06
DR   Wikidata; Q98136368
RX   PubMed=27050416;
CC   Population: Caucasian.
CC   Characteristics: Expression of luciferase is under the control of the CMV promoter.
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   Y79/EDR
AC   CVCL_A5SR
DR   Wikidata; Q107117559
RX   DOI=10.3969/j.issn.1673-713X.2017.04.002;
RX   PubMed=32143590;
CC   Population: Caucasian.
CC   Doubling time: 14.5 hours (DOI=10.3969/j.issn.1673-713X.2017.04.002).
CC   Selected for resistance to: ChEBI; CHEBI_4911; Etoposide (VP-16).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; Ex2-6del; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9884; RB1; Unexplicit; IVS20+1G>A; Zygosity=Heterozygous (from parent cell line).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Eye, globe; UBERON=UBERON_0010230.
DI   NCIt; C7541; Retinoblastoma
DI   ORDO; Orphanet_790; Retinoblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1893 ! Y-79
SX   Female
AG   2Y6M
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 10-04-25; Version: 7
//
ID   Y8-10C2
AC   CVCL_2Z37
SY   Sa-11; Sa11; WC00004
DR   CLO; CLO_0013430
DR   BioSamples; SAME17761
DR   Coriell; WC00004
DR   Wikidata; Q54995195
RX   PubMed=6163993;
RX   PubMed=9712021;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P03452; Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) hemagglutinin (HA).
CC   Discontinued: Coriell; WC00004; probable.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3411 ! P3X63Ag8
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 14-08-25; Version: 8
//
ID   Y9-iPSC
AC   CVCL_DD56
SY   Y09-iPSC
DR   Wikidata; Q54995196
RX   PubMed=25843045;
RX   PubMed=27191603;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=27191603
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 11
ST   D21S11: 28
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_DD55 ! ND34791
SX   Female
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 7
//
ID   YAA
AC   CVCL_8466
DR   BioSample; SAMN03151986
DR   cancercelllines; CVCL_8466
DR   Wikidata; Q54995197
RX   PubMed=9067707;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00286.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 27
//
ID   YAC-1
AC   CVCL_2244
SY   Yac-1; YAC
DR   BTO; BTO_0006063
DR   CLO; CLO_0009710
DR   CLO; CLO_0050173
DR   CLO; CLO_0050187
DR   CLDB; cl4800
DR   CLDB; cl4801
DR   CLDB; cl4802
DR   CLDB; cl4803
DR   ATCC; TIB-160
DR   BCRC; 60147
DR   BCRJ; 0255
DR   BioSample; SAMN11397655
DR   CCRID; 1101MOU-PUMC000089
DR   CCRID; 3101MOUTCM28
DR   CCRID; 4201MOU-CCTCC00001
DR   CCTCC; GDC0001
DR   ChEMBL-Cells; CHEMBL3308419
DR   ChEMBL-Targets; CHEMBL612814
DR   CLS; 400383
DR   DSMZ; ACC-96
DR   DSMZCellDive; ACC-96
DR   ECACC; 86022801
DR   IZSLER; BS TCL 243
DR   KCB; KCB 93031YJ
DR   KCLB; 40160
DR   NCBI_Iran; C552
DR   NCI-DTP; YAC
DR   PubChem_Cell_line; CVCL_2244
DR   RCB; RCB1165
DR   RCB; RCB2799
DR   TKG; TKG 0387
DR   Wikidata; Q54995198
RX   PubMed=75945;
RX   PubMed=1234049;
RX   PubMed=31220119;
WW   Info; -; -; https://web.archive.org/web/20141104152245/http://www2.kumc.edu/soalab/LabLinks/cell%20lines/yac1.htm
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=YAC-1
CC   Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981).
CC   Doubling time: ~20 hours (DSMZ=ACC-96).
CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
CC   Breed/subspecies: A/Sn.
ST   Source(s): PubMed=31220119
ST   Mouse STR 1-1: 11
ST   Mouse STR 1-2: 17,18
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 21.3
ST   Mouse STR 5-5: 16
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 12
ST   Mouse STR 7-1: 25.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 15
ST   Mouse STR 12-1: 16
ST   Mouse STR 13-1: 16.2,17.2
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 18
ST   Mouse STR 19-2: 12,13
ST   Mouse STR X-1: 26
DI   NCIt; C21602; Mouse lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
ID   YACL95
AC   CVCL_D4A3
DR   Wikidata; Q127384732
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=28569787).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   <1Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   YaFuSS
AC   CVCL_L809
DR   Cosmic; 1319810
DR   GEO; GSM2887620
DR   GEO; GSM2887621
DR   Wikidata; Q54995201
RX   PubMed=15814652;
RX   PubMed=27353471;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=15814652).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C6534; Monophasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   28Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 16
//
ID   YAHKMUi001-A
AC   CVCL_WU87
DR   hPSCreg; YAHKMUi001-A
DR   SKIP; SKIP005605
DR   Wikidata; Q98136371
RX   PubMed=31869684;
CC   From: Yan'an Affiliated Hospital of Kunming Medical University; Kunming; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:11592; TBX1; Simple; p.Gly310Ser (c.928G>A); ClinVar=VCV000007564; Zygosity=Heterozygous (PubMed=31869684).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84505; Tetralogy of Fallot
DI   ORDO; Orphanet_3303; Tetralogy of Fallot
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 19-12-24; Version: 10
//
ID   Yak-2
AC   CVCL_WI05
DR   CCRID; 5301BOV-KCB04003ZJ
DR   KCB; KCB 200403ZJ
DR   Wikidata; Q98136373
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30521; ! Bos mutus grunniens (Wild yak)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 9
//
ID   Yak-BL
AC   CVCL_7212
SY   Yak
DR   Wikidata; Q54995202
RX   PubMed=9882297;
CC   Population: African.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   YAM-P
AC   CVCL_F445
DR   CLO; CLO_0051139
DR   RCB; HSC0006
DR   Wikidata; Q54995203
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAM-RTK1
AC   CVCL_8014
SY   YAM-RTK-1; YAM-RTI
DR   Cosmic; 801770
DR   Wikidata; Q54995204
RX   PubMed=11921280;
RX   PubMed=12210830;
RX   PubMed=14662021;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11103; SMARCB1; Simple; p.Pro173Ser (c.517C>T); Zygosity=Unspecified (PubMed=11921280).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 13
//
ID   Yamada
AC   CVCL_FA16
DR   Wikidata; Q54995205
RX   PubMed=21908323;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Misidentified. Originally thought to be an osteosarcoma cell line of dog origin but found to be from mouse (PubMed=21908323).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00445.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   Yamane
AC   CVCL_DN30
DR   GEO; GSM1974801
DR   Wikidata; Q54995206
RX   PubMed=27197945;
CC   Part of: FACC canine tumor cell line panel.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
ST   Source(s): PubMed=27197945
ST   Dog FHC2010: 227
ST   Dog FHC2054: 151
ST   Dog FHC2079: 275
ST   Dog PEZ1: 119,123
ST   Dog PEZ3: 121,131
ST   Dog PEZ5: 103
ST   Dog PEZ6: 172
ST   Dog PEZ8: 228
ST   Dog PEZ12: 270
ST   Dog PEZ20: 176
DI   NCIt; C120045; Canine osteosarcoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 8
//
ID   Yamato-SS
AC   CVCL_6C44
SY   YAMATO; Yamato
DR   EFO; EFO_0022538
DR   cancercelllines; CVCL_6C44
DR   Cell_Model_Passport; SIDM01410
DR   DepMap; ACH-001277
DR   GEO; GSM2887616
DR   GEO; GSM2887617
DR   PharmacoDB; YAMATO_1678_2019
DR   RCB; RCB3577
DR   Wikidata; Q54995208
RX   PubMed=20518020;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:11340; SS18 + HGNC; HGNC:11335; SSX1; Name(s)=SS18-SSX1 (PubMed=20518020; DepMap=ACH-001277).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (DepMap=ACH-001277).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB3577
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 9,12
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C4279; Biphasic synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   30Y
CA   Cancer cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 21
//
ID   YAMB-1
AC   CVCL_A292
SY   YAM-B1; YAManashi-B-1
DR   Wikidata; Q54995209
RX   PubMed=9529133;
RX   PubMed=10942233;
RX   PubMed=20519628;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 11
//
ID   YAMB-3
AC   CVCL_A293
SY   YAManashi-B-3
DR   Wikidata; Q54995210
RX   PubMed=20519628;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   YAMB-4
AC   CVCL_A294
SY   YAManashi-B-4
DR   Wikidata; Q54995212
RX   PubMed=20519628;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   YAMB-9
AC   CVCL_A295
SY   YAMB9; YAManashi-B-9
DR   Wikidata; Q54995213
RX   PubMed=20519628;
RX   PubMed=28569787;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 11
//
ID   YAMC
AC   CVCL_6E40
SY   Young Adult Mouse Colon
DR   ABM; T0567
DR   Wikidata; Q54995214
RX   PubMed=7678459;
RX   PubMed=25277546;
CC   Genetic integration: Method=Transgenic mouse; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=tsA58).
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   18-21D
CA   Conditionally immortalized cell line
DT   Created: 23-02-16; Last updated: 14-08-25; Version: 12
//
ID   YAMCL-95
AC   CVCL_A2BL
SY   YAMCL95; YAManashi-CL-95
DR   cancercelllines; CVCL_A2BL
DR   IARC_TP53; 28416
DR   Wikidata; Q105511823
RX   PubMed=20575032;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136His (c.408A>T); ClinVar=VCV000482213; Zygosity=Unspecified (PubMed=20575032).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23.3) MLL rearranged
DI   ORDO; Orphanet_585918; B-lymphoblastic leukemia/lymphoma with t(v;11q23.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 7
//
ID   YAML 501.4
AC   CVCL_J777
DR   ECACC; 11060812
DR   Wikidata; Q54995216
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YAML 555.6
AC   CVCL_J778
DR   ECACC; 11060816
DR   Wikidata; Q54995217
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   YAML 568.4
AC   CVCL_A9LM
DR   Wikidata; Q108821543
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YAMN-73
AC   CVCL_8015
SY   YAMN73; YAManashi-N-73
DR   cancercelllines; CVCL_8015
DR   IARC_TP53; 28426
DR   Wikidata; Q54995218
RX   PubMed=10360377;
RX   PubMed=10942233;
RX   PubMed=12506034;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10942233; PubMed=12506034).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   2Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 18
//
ID   YAMN-74
AC   CVCL_W272
SY   YAMN74; YAManashi-N-74
DR   Wikidata; Q54995220
RX   PubMed=10360377;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Gln188Profs*5 (c.562dup); Zygosity=Heterozygous (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   15Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 9
//
ID   YAMN-90R
AC   CVCL_A079
SY   YAMN-90; YAMN90R; YAMN90; YAManashi-N-90 Relapse
DR   cancercelllines; CVCL_A079
DR   IARC_TP53; 28420
DR   Wikidata; Q54995221
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Arg820Trp (c.2458C>T); dbSNP=rs745957331; Zygosity=Heterozygous (PubMed=35124168).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   YAMN-91
AC   CVCL_8016
SY   YAMN91; YAManashi-N-91
DR   IARC_TP53; 28428
DR   Wikidata; Q54995222
RX   PubMed=12506034;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=12506034).
DI   NCIt; C68659; Childhood B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   4Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 14
//
ID   YAMN-92
AC   CVCL_A080
SY   YAMN92; YAManashi-N-92
DR   cancercelllines; CVCL_A080
DR   IARC_TP53; 28421
DR   Wikidata; Q54995223
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=28569787;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=28569787; PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Leu194Arg (c.581T>G); ClinVar=VCV000376633; Zygosity=Unspecified (PubMed=20575032).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   YAMN-93
AC   CVCL_D3Z7
SY   YAMN93; YAManashi-N-93
DR   Wikidata; Q127384733
RX   CelloPub=CLPUB00755;
RX   PubMed=29786757;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   NCIt; C2993; Down syndrome
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
DI   ORDO; Orphanet_870; Down syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   YAMN-96
AC   CVCL_D3ZY
SY   YAMN96; YAManashi-N-96
DR   Wikidata; Q127384735
RX   PubMed=35124168;
CC   Population: Japanese.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   YAMRT
AC   CVCL_EJ26
DR   Cosmic; 2144787
DR   Wikidata; Q54995224
RX   PubMed=24418192;
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C8715; Rhabdoid tumor of the kidney
DI   ORDO; Orphanet_69077; Rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 6
//
ID   YAMT-12
AC   CVCL_A081
DR   Wikidata; Q54995236
RX   PubMed=20519628;
CC   Miscellaneous: Only mentioned as a T-ALL cell line in PubMed=20519628.
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 14
//
ID   YAN3102
AC   CVCL_F446
DR   CLO; CLO_0051166
DR   RCB; HSC0128
DR   Wikidata; Q54995237
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3103
AC   CVCL_F447
DR   CLO; CLO_0051164
DR   RCB; HSC0124
DR   Wikidata; Q54995238
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3119
AC   CVCL_F448
DR   CLO; CLO_0051052
DR   RCB; HSC0010
DR   Wikidata; Q54995240
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   10Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3136
AC   CVCL_F449
DR   CLO; CLO_0051175
DR   RCB; HSC0136
DR   Wikidata; Q54995241
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3140
AC   CVCL_F450
DR   CLO; CLO_0051053
DR   RCB; HSC0011
DR   Wikidata; Q54995242
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3141
AC   CVCL_F451
DR   CLO; CLO_0051060
DR   RCB; HSC0022
DR   Wikidata; Q54995243
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3142
AC   CVCL_F452
DR   CLO; CLO_0051051
DR   RCB; HSC0008
DR   Wikidata; Q54995245
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3143
AC   CVCL_F453
DR   CLO; CLO_0051054
DR   RCB; HSC0012
DR   Wikidata; Q54995247
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YAN3150
AC   CVCL_F454
DR   CLO; CLO_0051055
DR   RCB; HSC0014
DR   Wikidata; Q54995248
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YAN3152
AC   CVCL_F455
DR   CLO; CLO_0051087
DR   RCB; HSC0057
DR   Wikidata; Q54995249
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3154
AC   CVCL_F456
DR   CLO; CLO_0051063
DR   RCB; HSC0025
DR   Wikidata; Q54995250
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   55Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3161
AC   CVCL_F457
DR   CLO; CLO_0051057
DR   RCB; HSC0018
DR   Wikidata; Q54995251
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3191
AC   CVCL_F458
DR   CLO; CLO_0051144
DR   RCB; HSC0019
DR   Wikidata; Q54995252
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YAN3206
AC   CVCL_F459
DR   CLO; CLO_0051093
DR   RCB; HSC0065
DR   Wikidata; Q54995253
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3241
AC   CVCL_F460
DR   CLO; CLO_0051120
DR   RCB; HSC0099
DR   Wikidata; Q54995254
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3242
AC   CVCL_F461
DR   CLO; CLO_0051067
DR   RCB; HSC0032
DR   Wikidata; Q54995256
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   37Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3244
AC   CVCL_F462
DR   CLO; CLO_0051116
DR   RCB; HSC0093
DR   Wikidata; Q54995257
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3245
AC   CVCL_F463
DR   CLO; CLO_0051056
DR   RCB; HSC0015
DR   Wikidata; Q54995258
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3252
AC   CVCL_F464
DR   CLO; CLO_0051058
DR   RCB; HSC0020
DR   Wikidata; Q54995259
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3255
AC   CVCL_F465
DR   CLO; CLO_0051165
DR   RCB; HSC0129
DR   Wikidata; Q54995260
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3259
AC   CVCL_F466
DR   CLO; CLO_0051126
DR   RCB; HSC0104
DR   Wikidata; Q54995261
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3260
AC   CVCL_F467
DR   CLO; CLO_0051158
DR   RCB; HSC0121
DR   Wikidata; Q54995262
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3261
AC   CVCL_F468
DR   CLO; CLO_0051061
DR   RCB; HSC0023
DR   Wikidata; Q54995263
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3264
AC   CVCL_F469
DR   CLO; CLO_0051062
DR   RCB; HSC0024
DR   Wikidata; Q54995265
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3265
AC   CVCL_F470
DR   CLO; CLO_0051147
DR   RCB; HSC0030
DR   Wikidata; Q54995266
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   YAN3268
AC   CVCL_F471
DR   CLO; CLO_0051059
DR   RCB; HSC0021
DR   Wikidata; Q54995267
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YAN3269
AC   CVCL_F472
DR   CLO; CLO_0051122
DR   RCB; HSC0098
DR   Wikidata; Q54995268
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3270
AC   CVCL_F473
DR   CLO; CLO_0051125
DR   RCB; HSC0103
DR   Wikidata; Q54995270
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3273
AC   CVCL_F474
DR   CLO; CLO_0051128
DR   RCB; HSC0110
DR   Wikidata; Q54995271
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   21Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3274
AC   CVCL_F475
DR   CLO; CLO_0051121
DR   RCB; HSC0100
DR   Wikidata; Q54995272
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3275
AC   CVCL_F476
DR   CLO; CLO_0051117
DR   RCB; HSC0094
DR   Wikidata; Q54995273
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   12Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YAN3280
AC   CVCL_F477
DR   CLO; CLO_0051065
DR   RCB; HSC0029
DR   Wikidata; Q54995275
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3285
AC   CVCL_F478
DR   CLO; CLO_0051090
DR   RCB; HSC0060
DR   Wikidata; Q54995276
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3286
AC   CVCL_F479
DR   CLO; CLO_0051064
DR   RCB; HSC0026
DR   Wikidata; Q54995277
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   YAN3301
AC   CVCL_F480
DR   CLO; CLO_0051050
DR   RCB; HSC0005
DR   Wikidata; Q54995278
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Venezuelan; native South American.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   27Y
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 14
//
ID   Yana-1
AC   CVCL_A1RH
SY   Yana-I
DR   Wikidata; Q105511825
RX   PubMed=2820081;
CC   Population: Japanese.
CC   Characteristics: IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   Yana-2
AC   CVCL_A1RI
SY   Yana-II
DR   Wikidata; Q105511829
RX   PubMed=2820081;
CC   Population: Japanese.
CC   Characteristics: Not IL2 dependent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
DI   ORDO; Orphanet_86875; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1RH ! Yana-1
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   YAP
AC   CVCL_8467
DR   BioSample; SAMN03151987
DR   cancercelllines; CVCL_8467
DR   Wikidata; Q54995280
RX   PubMed=8738564;
RX   PubMed=12592342;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a U-937 derivative (PubMed=12592342; PubMed=20143388). Was originally thought to originate from the peripheral blood monocytes of a 42 year old male Japanese patient with psoriasis vulgaris.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00287.
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16063; MLLT10 + HGNC; HGNC:15514; PICALM; Name(s)=PICALM-MLLT10, CALM-AF10 (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Gly129fs*51 (c.387_388insCGCC); Zygosity=Hemizygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Gly60Arg (c.178G>C); ClinVar=VCV000372590; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; c.559+1G>A (p.Val173Trpfs*59); ClinVar=VCV000428908; Zygosity=Homozygous; Note=Splice donor mutation (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:12796; WT1; Simple; p.Arg301Ter (c.901C>T) (p.Arg352Ter, c.1054C>T) (p.Arg374Ter, c.1120C>T); ClinVar=VCV000449416; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C8263; Adult acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0007 ! U-937
SX   Male
AG   37Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 28
//
ID   YAPC
AC   CVCL_1794
DR   CLO; CLO_0009711
DR   EFO; EFO_0006778
DR   ArrayExpress; E-MTAB-38
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 342
DR   BioSample; SAMN03472904
DR   BioSample; SAMN03473329
DR   BioSample; SAMN10988032
DR   cancercelllines; CVCL_1794
DR   Cell_Model_Passport; SIDM00411
DR   ChEMBL-Cells; CHEMBL3307253
DR   ChEMBL-Targets; CHEMBL612815
DR   Cosmic; 909904
DR   Cosmic; 2046537
DR   Cosmic; 2434108
DR   Cosmic-CLP; 909904
DR   DepMap; ACH-000332
DR   DSMZ; ACC-382
DR   DSMZCellDive; ACC-382
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909904
DR   GEO; GSM887742
DR   GEO; GSM888837
DR   GEO; GSM1670584
DR   IARC_TP53; 27267
DR   IGRhCellID; YAPC
DR   LiGeA; CCLE_222
DR   LINCS_LDP; LCL-1792
DR   PharmacoDB; YAPC_1679_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1794
DR   PubChem_Cell_line; CVCL_1794
DR   Wikidata; Q54995282
RX   PubMed=9533774;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25167228;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=26216984;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=29444439;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=YAPC
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: NCI RAS program mutant KRAS cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~48 hours (DSMZ=ACC-382).
CC   HLA typing: A*24:02,24:02; B*35:01,52:01; C*12:02,12:02 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000012583; Zygosity=Heterozygous (Cosmic-CLP=909904; DepMap=ACH-000332).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Homozygous (Cosmic-CLP=909904; DepMap=ACH-000332).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Metabolomics.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.82%; East Asian, North=85.11%; East Asian, South=13.9%; South Asian=0.15%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Misspelling: YPAC; ArrayExpress=E-MTAB-38; Note=Also in an EFO entry (EFO_0002393) now obsoleted.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=909904; DSMZ=ACC-382; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13
ST   D21S11: 31,31.2
ST   D2S1338: 18,24
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 9,11
ST   D8S1179: 13,15
ST   FGA: 21,22
ST   Penta D: 10,13
ST   Penta E: 5,19.4 (PubMed=25877200)
ST   Penta E: 5,20 (DSMZ=ACC-382)
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,17 (Cosmic-CLP=909904)
ST   vWA: 17 (DSMZ=ACC-382; PubMed=25877200)
DI   NCIt; C207229; Pancreatic carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 43
//
ID   YAR
AC   CVCL_2192
DR   dbMHC; 49083
DR   ECACC; 95042721
DR   IHW; IHW09026
DR   IPD-IMGT/HLA; 11587
DR   Wikidata; Q54995284
RX   DOI=10.1007/978-1-4612-3552-1_2;
RX   DOI=10.1007/978-1-4612-3552-1_4;
RX   DOI=10.1007/978-1-4612-3552-1_5;
RX   DOI=10.1007/978-1-4612-3552-1_6;
RX   DOI=10.1007/978-1-4612-3552-1_7;
RX   PubMed=8307784;
RX   PubMed=8813743;
RX   PubMed=28360230;
RX   PubMed=29171935;
RX   PubMed=30844424;
CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC   Population: Jewish; Ashkenazi.
CC   HLA typing: A*26:01:01:01; B*38:01:01; C*12:03:01:01; DPA1*01:03; DPB1*04:01:01; DQA1*03:01; DQB1*03:02:01; DRA*01:01; DRB1*04:02:01; DRB4*01:01 (IPD-IMGT/HLA=11587).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; MHC region sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   Yazd1
AC   CVCL_YN97
DR   Wikidata; Q98136376
RX   PubMed=31970311;
CC   From: Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences; Yazd; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   Yazd2
AC   CVCL_YN98
DR   Wikidata; Q98136378
RX   PubMed=31970311;
CC   From: Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences; Yazd; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   Yazd3
AC   CVCL_YN99
DR   Wikidata; Q98136381
RX   PubMed=31970311;
CC   From: Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences; Yazd; Iran.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex ambiguous
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 4
//
ID   YB2/0
AC   CVCL_8984
SY   YB2/O; YB2-0; YB2/3HL.P2.G11.16Ag.20; YB2/3.0 Ag.20; YB2/3.0.Ag.20; YB2/3.0 Ag20; YB2/3.0Ag20; Y.B2/3.0Ag20
DR   CLO; CLO_0009712
DR   ATCC; CRL-1662
DR   Wikidata; Q54995286
RX   CelloPub=CLPUB00609;
RX   Patent=US4472500;
RX   PubMed=6811596;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-126.
CC   Characteristics: Does not secrete immunoglobulins (non-producing) (Patent=US4472500; PubMed=6811596).
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E9V5 ! YB2/3HL
CA   Hybrid cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 12
//
ID   YB2/0 myc-mCCR8
AC   CVCL_E6IX
RX   PubMed=11123295;
RX   PubMed=14573924;
CC   Selected for resistance to: ChEBI; CHEBI_63486; 8-azaguanine.
CC   Genetic integration: Method=Transfection; Gene=MGI; MGI:1201402; Ccr8 (Note=With a N-terminal Myc tag).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybrid cell line
DT   Created: 10-04-25; Last updated: 14-08-25; Version: 2
//
ID   YB2/39-1 1-1
AC   CVCL_E9V4
RX   PubMed=6161872;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01024; Human C3.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YB2/3HL
AC   CVCL_E9V5
SY   YB2/3 HL; YB2/3(HL); 39-11-1-7
RX   PubMed=6161872;
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; P01024; Human C3.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_E9V4 ! YB2/39-1 1-1
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YB2/4HLK
AC   CVCL_E9V6
SY   YB2/4 HLK; YB2/4(HLK); 42-5-1
RX   PubMed=6161872;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P01024; Human C3.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YB2/9HLK
AC   CVCL_E9V7
SY   YB2/9 HLK; YB2/9(HLK); 90-5-20
RX   PubMed=6161872;
CC   Monoclonal antibody isotype: IgG, kappa.
CC   Monoclonal antibody target: UniProtKB; P01024; Human C3.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YB3.E7
AC   CVCL_F0L2
RX   PubMed=3866115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human unknown protein.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YB5.B8
AC   CVCL_F0L0
RX   PubMed=1708291;
RX   PubMed=3866115;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P10721; Human KIT/CD117.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YBB-190
AC   CVCL_KR77
DR   Wikidata; Q54995303
RX   PubMed=3171697;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   YBC-058
AC   CVCL_KR78
DR   Wikidata; Q54995305
RX   PubMed=3171697;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   YBC-122
AC   CVCL_KR79
DR   Wikidata; Q54995306
RX   PubMed=3171697;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   YBD-047
AC   CVCL_KR80
DR   Wikidata; Q54995308
RX   PubMed=3171697;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   YBLi001-A
AC   CVCL_D0Q5
SY   YBL/IPSC01/CONTROL
DR   BioSamples; SAMEA112638602
DR   hPSCreg; YBLi001-A
DR   Wikidata; Q123033946
RX   PubMed=36905819;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36905819
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 10
ST   D16S539: 10,13
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 32.2
ST   D2S1338: 18,23
ST   D3S1358: 16
ST   D5S818: 10,12
ST   D7S820: 8,10
ST   D8S1179: 10,14
ST   FGA: 20,21
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YBLi002-A
AC   CVCL_D0Q6
SY   YBL/IPSC02/CONTROL; YBL/IPSC002/CONTROL
DR   BioSamples; SAMEA112638603
DR   hPSCreg; YBLi002-A
DR   Wikidata; Q123033947
RX   PubMed=36905819;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36905819
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,11
ST   D16S539: 11,13
ST   D18S51: 17,19
ST   D19S433: 13,14
ST   D21S11: 32.2
ST   D2S1338: 18,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 11,12
ST   D8S1179: 10,14
ST   FGA: 18,23
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 17,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YBLi003-A
AC   CVCL_D0Q7
SY   YBL/IPSC05/CONTROL
DR   BioSamples; SAMEA112638606
DR   hPSCreg; YBLi003-A
DR   Wikidata; Q123033948
RX   PubMed=36905819;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=36905819
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 16,20
ST   D19S433: 15,15.2
ST   D21S11: 28
ST   D2S1338: 18,22
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 11,12
ST   FGA: 21,23
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YBLi004-A
AC   CVCL_D0Q8
SY   YBL/SH/2018/0062
DR   BioSamples; SAMEA112910433
DR   hPSCreg; YBLi004-A
DR   Wikidata; Q123033949
RX   PubMed=38547666;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=38547666
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 12
ST   D16S539: 9,13
ST   D18S51: 14,15
ST   D19S433: 13,15
ST   D21S11: 28,30
ST   D2S1338: 23,24
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   D8S1179: 13
ST   FGA: 23,25
ST   TH01: 9
ST   TPOX: 11
ST   vWA: 14,17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 02-05-24; Version: 3
//
ID   YBLi005-A
AC   CVCL_D0Q9
SY   YBL/OS/2021/00196
DR   BioSamples; SAMEA112910436
DR   hPSCreg; YBLi005-A
DR   Wikidata; Q123033951
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YBLi006-A
AC   CVCL_D0QA
SY   YBL/PH/2022/0025
DR   BioSamples; SAMEA112910788
DR   hPSCreg; YBLi006-A
DR   Wikidata; Q123033952
RX   PubMed=37290137;
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Pro871Leu (c.2612C>T); ClinVar=VCV000041812; Zygosity=Heterozygous (PubMed=37290137).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu1038Gly (c.3113A>G); ClinVar=VCV000041815; Zygosity=Heterozygous (PubMed=37290137).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Lys1183Arg (c.3548A>G); ClinVar=VCV000041818; Zygosity=Heterozygous (PubMed=37290137).
CC   Sequence variation: Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Ser1613Gly (c.4837A>G); ClinVar=VCV000041827; Zygosity=Heterozygous (PubMed=37290137).
CC   Sequence variation: Mutation; HGNC; HGNC:25568; FANCI; Simple; p.Gly27Val (c.80G>T); Zygosity=Heterozygous (PubMed=37290137).
CC   Sequence variation: Mutation; HGNC; HGNC:25568; FANCI; Simple; p.Ala86Val (c.257C>T); ClinVar=VCV000257484; Zygosity=Heterozygous (PubMed=37290137).
CC   Sequence variation: Mutation; HGNC; HGNC:25568; FANCI; Simple; p.Cys742Ser (c.2225G>C); ClinVar=VCV000257482; Zygosity=Heterozygous (PubMed=37290137).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C36100; BRCA1 syndrome
DI   ORDO; Orphanet_227535; Hereditary breast cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 27-11-25; Version: 5
//
ID   YBLi007-A
AC   CVCL_D6KA
SY   YBL/SH/2018/0067
DR   BioSamples; SAMEA115028791
DR   hPSCreg; YBLi007-A
DR   Wikidata; Q127384736
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   YBLi008-A
AC   CVCL_D6KB
SY   YBL/SH/2018/0050
DR   BioSamples; SAMEA115028793
DR   hPSCreg; YBLi008-A
DR   Wikidata; Q127384737
CC   From: Yashraj Biotechnology Ltd; Navi Mumbai; India.
CC   Population: Indian.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 10-09-24; Version: 2
//
ID   YBM
AC   CVCL_XZ91
DR   KCB; KCB 84005
DR   Wikidata; Q98136384
RX   PubMed=14984102;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=61452; ! Neofelis nebulosa (Clouded leopard)
SX   Male
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   YBM 15.1.6
AC   CVCL_G181
SY   YBM15.1.6
DR   ECACC; 89040602
DR   Wikidata; Q54995309
RX   PubMed=3330997;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YBM 29.2.1
AC   CVCL_G182
SY   YBM29.2.1
DR   ECACC; 11060806
DR   Wikidata; Q54995310
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YBM 5.10.4
AC   CVCL_G183
SY   YBM5.10.4
DR   ECACC; 11060805
DR   Wikidata; Q54995311
RX   PubMed=3330997;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P24807; Mouse Cd24.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YBM 6.1.10
AC   CVCL_G184
SY   YBM6.1.10
DR   ECACC; 89040601
DR   Wikidata; Q54995312
RX   PubMed=3330997;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P05555; Mouse Itgam/Cd11b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YBM-209
AC   CVCL_KR81
DR   Wikidata; Q54995314
RX   PubMed=3171697;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   YBT-5
AC   CVCL_YJ20
DR   Wikidata; Q98136386
RX   PubMed=31701557;
CC   Population: Chinese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9 (PubMed=31701557).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): PubMed=31701557
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,20
ST   D13S317: 8,12
ST   D16S539: 12,13
ST   D18S51: 13,20
ST   D19S433: 15,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 14,17
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 21,24
ST   vWA: 14,19
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 9
//
ID   YBY-088
AC   CVCL_KR82
DR   Wikidata; Q54995315
RX   PubMed=3171697;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 3
//
ID   YCC-1
AC   CVCL_9646
SY   YCC1
DR   EFO; EFO_0002876
DR   cancercelllines; CVCL_9646
DR   Cosmic; 1482082
DR   GEO; GSM552378
DR   GEO; GSM562409
DR   GEO; GSM1237682
DR   GEO; GSM1237707
DR   Progenetix; CVCL_9646
DR   Wikidata; Q54995316
RX   PubMed=10402490;
RX   PubMed=18804159;
RX   PubMed=18922971;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 40 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCC-11
AC   CVCL_9648
SY   YCC11
DR   EFO; EFO_0002878
DR   cancercelllines; CVCL_9648
DR   Cosmic; 1482084
DR   GEO; GSM552380
DR   GEO; GSM562412
DR   GEO; GSM1237683
DR   GEO; GSM1237708
DR   Progenetix; CVCL_9648
DR   Wikidata; Q54995322
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=18804159;
RX   PubMed=18922971;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 38 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCC-16
AC   CVCL_9649
SY   YCC16
DR   EFO; EFO_0002879
DR   cancercelllines; CVCL_9649
DR   GEO; GSM552381
DR   GEO; GSM562413
DR   GEO; GSM1237684
DR   GEO; GSM1237709
DR   Progenetix; CVCL_9649
DR   Wikidata; Q54995324
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=18804159;
RX   PubMed=18922971;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCC-17
AC   CVCL_X027
SY   YCC17
DR   GEO; GSM552382
DR   Wikidata; Q54995325
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 25 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 8
//
ID   YCC-18
AC   CVCL_9650
SY   YCC18
DR   GEO; GSM552383
DR   Wikidata; Q54995326
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 30 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   YCC-19
AC   CVCL_9651
SY   YCC19
DR   GEO; GSM552384
DR   Wikidata; Q54995327
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   YCC-2
AC   CVCL_9652
SY   YCC2
DR   cancercelllines; CVCL_9652
DR   GEO; GSM552385
DR   GEO; GSM562414
DR   GEO; GSM1237685
DR   GEO; GSM1237710
DR   Progenetix; CVCL_9652
DR   Wikidata; Q54995329
RX   PubMed=10402490;
RX   PubMed=18804159;
RX   PubMed=18922971;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 43 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCC-20
AC   CVCL_9653
SY   YCC20
DR   GEO; GSM552386
DR   Wikidata; Q54995330
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 31 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   YCC-21
AC   CVCL_9654
SY   YCC21
DR   cancercelllines; CVCL_9654
DR   GEO; GSM2267433
DR   Progenetix; CVCL_9654
DR   Wikidata; Q54995332
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 25 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   YCC-22
AC   CVCL_9655
SY   YCC22
DR   cancercelllines; CVCL_9655
DR   GEO; GSM2267434
DR   Progenetix; CVCL_9655
DR   Wikidata; Q54995333
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 26 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 11
//
ID   YCC-23
AC   CVCL_9656
SY   YCC23
DR   Wikidata; Q54995334
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 37 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 10
//
ID   YCC-25
AC   CVCL_D2Y4
SY   YCC25
DR   Wikidata; Q127384738
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 60 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   36Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-26
AC   CVCL_D2Y5
SY   YCC26
DR   Wikidata; Q127384739
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 45 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   70Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-27
AC   CVCL_D2Y6
SY   YCC27
DR   Wikidata; Q127384741
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 38 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   70Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-28
AC   CVCL_D2Y3
SY   YCC28
DR   Wikidata; Q127384742
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 29 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   53Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-29
AC   CVCL_D2XU
SY   YCC29
DR   Wikidata; Q127384744
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 37 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   36Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-3
AC   CVCL_9657
SY   YCC3
DR   EFO; EFO_0002880
DR   cancercelllines; CVCL_9657
DR   Cosmic; 1482083
DR   GEO; GSM552387
DR   GEO; GSM562415
DR   GEO; GSM1237686
DR   GEO; GSM1237711
DR   GEO; GSM1250890
DR   GEO; GSM1250891
DR   GEO; GSM1250892
DR   GEO; GSM1250893
DR   GEO; GSM2267435
DR   IARC_TP53; 310
DR   Progenetix; CVCL_9657
DR   Wikidata; Q54995335
RX   PubMed=1676761;
RX   PubMed=10402490;
RX   PubMed=18804159;
RX   PubMed=18922971;
RX   PubMed=25343454;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 34 hours (PubMed=29435981).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (PubMed=1676761).
CC   Omics: Genomics; ChIP-seq; GATA4.
CC   Omics: Genomics; ChIP-seq; GATA6.
CC   Omics: Genomics; ChIP-seq; KLF5.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 21
//
ID   YCC-3/CV
AC   CVCL_E2W6
RX   PubMed=18922971;
CC   Population: Korean.
CC   Characteristics: Control cell line for YCC-3/TP (Cellosaurus=CVCL_9659).
CC   Doubling time: 37 hours (PubMed=18922971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9657 ! YCC-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 3
//
ID   YCC-3/R
AC   CVCL_9658
DR   cancercelllines; CVCL_9658
DR   Wikidata; Q54995336
RX   PubMed=20661724;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9657 ! YCC-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 16
//
ID   YCC-3/TP
AC   CVCL_9659
DR   cancercelllines; CVCL_9659
DR   Wikidata; Q54995337
RX   PubMed=18922971;
CC   Population: Korean.
CC   Doubling time: 32 hours (PubMed=18922971).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg175His (c.524G>A); ClinVar=VCV000012374; Zygosity=Unspecified (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:3148; TYMP.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9657 ! YCC-3
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 19
//
ID   YCC-30
AC   CVCL_D2Y2
SY   YCC30
DR   Wikidata; Q127384745
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 36 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   41Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-31
AC   CVCL_D2Y1
SY   YCC31
DR   Wikidata; Q127384746
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Characteristics: MET-amplified, contains 12-13 copies of the gene (PubMed=29435981).
CC   Doubling time: 34 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   31Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-32
AC   CVCL_D2XX
SY   YCC32
DR   Wikidata; Q127384747
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 32 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   52Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-33
AC   CVCL_D2XY
SY   YCC33
DR   Wikidata; Q127384748
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 33 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   44Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-34
AC   CVCL_D2XV
SY   YCC34
DR   Wikidata; Q127384749
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Characteristics: MET-amplified, contains 18-19 copies of the gene (PubMed=29435981).
CC   Doubling time: 35 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   55Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-36
AC   CVCL_D2XW
SY   YCC36
DR   Wikidata; Q127384752
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 32 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C5250; Gastric signet ring cell adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   70Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-38
AC   CVCL_D2XZ
SY   YCC38
DR   Wikidata; Q127384754
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 25 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
AG   33Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-04-25; Version: 3
//
ID   YCC-4
AC   CVCL_9660
SY   YCC4
DR   Wikidata; Q54995339
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   YCC-42
AC   CVCL_D2Y0
SY   YCC42
DR   Wikidata; Q127384756
RX   DOI=10.1158/1538-7445.AM2016-139;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   YCC-5
AC   CVCL_9661
SY   YCC5
DR   Wikidata; Q54995340
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
//
ID   YCC-6
AC   CVCL_9662
SY   YCC6
DR   EFO; EFO_0002881
DR   cancercelllines; CVCL_9662
DR   GEO; GSM552388
DR   GEO; GSM562410
DR   GEO; GSM1237687
DR   GEO; GSM1237712
DR   Progenetix; CVCL_9662
DR   Wikidata; Q54995342
RX   PubMed=18804159;
RX   PubMed=18922971;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 48 hours (PubMed=29435981).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Arg1382Ter (c.4144C>T); ClinVar=VCV000188266; Zygosity=Unspecified (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
ID   YCC-7
AC   CVCL_9663
SY   YCC7
DR   EFO; EFO_0002882
DR   cancercelllines; CVCL_9663
DR   GEO; GSM552389
DR   GEO; GSM562398
DR   GEO; GSM1237688
DR   GEO; GSM1237713
DR   GEO; GSM2267436
DR   Progenetix; CVCL_9663
DR   Wikidata; Q54995343
RX   PubMed=10402490;
RX   PubMed=18804159;
RX   PubMed=18922971;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   YCC-9
AC   CVCL_9664
SY   YCC9
DR   cancercelllines; CVCL_9664
DR   GEO; GSM552390
DR   GEO; GSM562411
DR   GEO; GSM1237689
DR   GEO; GSM1237714
DR   Progenetix; CVCL_9664
DR   Wikidata; Q54995344
RX   PubMed=18922971;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Doubling time: 35 hours (PubMed=29435981).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 14
//
ID   YCCEL1
AC   CVCL_9647
AS   CVCL_L440
SY   YCC-10; YCC10
DR   EFO; EFO_0002877
DR   cancercelllines; CVCL_9647
DR   GEO; GSM552379
DR   GEO; GSM562399
DR   Progenetix; CVCL_9647
DR   Wikidata; Q54995318
RX   DOI=10.1158/1538-7445.AM2016-139;
RX   PubMed=18804159;
RX   PubMed=23175241;
RX   PubMed=25787276;
RX   PubMed=26889033;
RX   PubMed=29435981;
CC   From: Yonsei Cancer Center; Seoul; South Korea.
CC   Population: Korean.
CC   Virology: Contains a complete EBV genome (strain YCCEL1) which has been sequenced (PubMed=25787276; PubMed=26889033).
CC   Doubling time: 50 hours (PubMed=29435981).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.His58Leu; Zygosity=Unspecified (PubMed=29435981).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCMi001-A
AC   CVCL_ZB28
DR   hPSCreg; YCMi001-A
DR   Wikidata; Q98136388
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Unexplicit; Ex8-22del; Zygosity=Hemizygous (from autologous cell line YCMi001-B).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A9YX ! YCMi001-B
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   YCMi001-B
AC   CVCL_A9YX
SY   Del-iPSC-Epi6; HA patient iPSC
DR   BioSamples; SAMEA7211857
DR   hPSCreg; YCMi001-B
DR   Wikidata; Q102115138
RX   PubMed=31105049;
RX   PubMed=32798916;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Unexplicit; Ex8-22del; Zygosity=Hemizygous (PubMed=31105049; PubMed=32798916).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZB28 ! YCMi001-A
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   YCMi001-B-1
AC   CVCL_A9YY
DR   hPSCreg; YCMi001-B-1
DR   Wikidata; Q102115140
RX   PubMed=32798916;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3546; F8; Unexplicit_corrected; Ex8-22del; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=32798916).
CC   Derived from site: In situ; Adipose tissue; UBERON=UBERON_0001013.
CC   Cell type: Mesenchymal stem cell of adipose tissue; CL=CL_0002570.
DI   NCIt; C27146; Hemophilia A
DI   ORDO; Orphanet_98878; Hemophilia A
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A9YX ! YCMi001-B
SX   Male
AG   44Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   YCMi002-A
AC   CVCL_A1ND
SY   F7epi7
DR   BioSamples; SAMEA8714264
DR   hPSCreg; YCMi002-A
DR   Wikidata; Q102115141
RX   PubMed=33038747;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3544; F7; Simple; p.Cys115Ter (c.345C>A); Zygosity=Heterozygous (PubMed=33038747).
CC   Sequence variation: Mutation; HGNC; HGNC:3544; F7; Simple; p.Gln426Ter (c.1276C>T); Zygosity=Heterozygous (PubMed=33038747).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C98939; Hereditary factor VII deficiency
DI   ORDO; Orphanet_327; Congenital factor VII deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   YCMi003-A
AC   CVCL_A8NX
SY   YCMi003-hDCM003-A
DR   BioSamples; SAMEA9393124
DR   hPSCreg; YCMi003-A
DR   Wikidata; Q108821544
RX   PubMed=34438160;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Karyotypic information: 47,XYY (PubMed=34438160).
CC   Sequence variation: Mutation; HGNC; HGNC:6636; LMNA; Simple; p.Asp364His (c.1090G>C); Zygosity=Heterozygous (PubMed=34438160).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C165596; Dilated cardiomyopathy-1A
DI   ORDO; Orphanet_300751; Familial dilated cardiomyopathy with conduction defect due to LMNA mutation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   YCMi004-A
AC   CVCL_A0JS
SY   YCMi004-hDCM004-A
DR   BioSamples; SAMEA9405922
DR   hPSCreg; YCMi004-A
DR   Wikidata; Q108821545
RX   PubMed=34952434;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg23351Ter (c.70051C>T); ClinVar=VCV000405145; Zygosity=Heterozygous (PubMed=34952434).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   YCMi005-A
AC   CVCL_A0JT
SY   YCMi005-hDCM005-A
DR   BioSamples; SAMEA9903714
DR   hPSCreg; YCMi005-A
DR   Wikidata; Q108821547
RX   PubMed=35176663;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:12010; TPM1; Simple; p.Glu192Lys (c.574G>A); ClinVar=VCV000031882; Zygosity=Heterozygous (PubMed=35176663).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C182076; Familial hypertrophic cardiomyopathy type 3
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   YCMi006-A
AC   CVCL_B6RI
DR   BioSamples; SAMEA12870538
DR   hPSCreg; YCMi006-A
DR   Wikidata; Q112041943
RX   PubMed=35917599;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:129; ACTA1; Simple; p.Ile343Met (c.1029C>G); ClinVar=VCV001306956; Zygosity=Heterozygous (PubMed=35917599).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34449; Hypertrophic cardiomyopathy
DI   ORDO; Orphanet_217569; Hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 19-12-24; Version: 6
//
ID   YCMi007-A
AC   CVCL_C1TI
SY   YCMi007-hDCM007-A
DR   BioSamples; SAMEA110188890
DR   hPSCreg; YCMi007-A
DR   Wikidata; Q114313267
RX   PubMed=36801602;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Arg205Trp (c.613C>T); ClinVar=VCV000180554; Zygosity=Heterozygous (PubMed=36801602).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198599; Dilated cardiomyopathy-1D
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 5
//
ID   YCMi008-A
AC   CVCL_C7RD
DR   hPSCreg; YCMi008-A
DR   Wikidata; Q123033954
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 30-01-24; Version: 2
//
ID   YCMi009-A
AC   CVCL_D0QB
SY   YCMi009-hDCM009-A
DR   BioSamples; SAMEA114466249
DR   hPSCreg; YCMi009-A
DR   Wikidata; Q123033955
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:3756; FLNC; Simple; p.Asp668Gly (c.2003A>G); Zygosity=Heterozygous (hPSCreg=YCMi009-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C183309; Familial restrictive cardiomyopathy 5
DI   ORDO; Orphanet_75249; Familial isolated restrictive cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YCMi010-A
AC   CVCL_D2XT
DR   BioSamples; SAMEA114492644
DR   hPSCreg; YCMi010-A
DR   Wikidata; Q127384758
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:28472; TMEM43; Simple; c.443-2A>G; Zygosity=Heterozygous; Note=Splice acceptor mutation (hPSCreg=YCMi010-A).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C173470; Familial arrhythmogenic right ventricular dysplasia 5
DI   ORDO; Orphanet_217656; Familial isolated arrhythmogenic right ventricular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   YCR
AC   CVCL_BT07
SY   YCRL1; Yellow-Checked Rat cell line
DR   CCRID; 5301MAM-KCB88001ZJ
DR   KCB; KCB 88001ZJ
DR   Wikidata; Q29580661
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=69074; ! Rattus flavipectus (Yellow-breasted rat)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 9
//
ID   YCR-1
AC   CVCL_A397
SY   Yokohama City Renal-1
DR   Cosmic; 849377
DR   Wikidata; Q54995346
RX   PubMed=3528602;
RX   PubMed=11146448;
CC   Population: Japanese.
CC   Doubling time: 26.5 hours (PubMed=3528602).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 10
//
ID   YCU-AML1
AC   CVCL_A2GG
SY   Yokohama City University-Acute Myeloid Leukemia 1
DR   Wikidata; Q105511831
RX   PubMed=33163905;
CC   Population: Japanese.
CC   Karyotypic information: Monosomy of chromosome 7 (PubMed=33163905).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C82426; Acute myeloid leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2) GATA2, MECOM
DI   ORDO; Orphanet_402020; Acute myeloid leukemia with inv3(q21;q26.2) or t(3;3)(q21;q26.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 4
//
ID   YCU-AML2
AC   CVCL_E7AL
SY   Yokohama City University-Acute Myeloid Leukemia 2
RX   PubMed=39891826;
CC   Population: Japanese.
CC   Doubling time: 3-4 days (PubMed=39891826).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=39891826).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=39891826).
CC   Sequence variation: Gene fusion; HGNC; HGNC:7132; KMT2A + HGNC; HGNC:7136; MLLT3; Name(s)=KMT2A-MLLT3, MLL-MLLT3, MLL-AF9; Note=KMT2A intron 8 fused to MLLT3 intron 4 (PubMed=39891826).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ala (c.35G>C); ClinVar=VCV000045122; Zygosity=Homozygous (PubMed=39891826).
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9163; Childhood acute monocytic leukemia
DI   ORDO; Orphanet_514; Acute monoblastic/monocytic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   5Y
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
ID   YCU-H891
AC   CVCL_8017
SY   YCU H891
DR   Cosmic; 1136975
DR   Cosmic; 1556186
DR   Wikidata; Q54995348
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26780976; PubMed=26781072). Originally thought to originate from an hypopharyngeal squamous cell carcinoma.
CC   Population: African American.
CC   Doubling time: 11.08 hours (PubMed=21362583).
CC   HLA typing: A*68:02 (Direct_author_submission).
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 12,13.3
ST   D16S539: 9,10
ST   D18S51: 16
ST   D21S11: 27,28
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 20
//
ID   YCU-L891
AC   CVCL_8018
SY   YCU L891
DR   Cosmic; 1136977
DR   Cosmic; 1556187
DR   Wikidata; Q54995350
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
CC   Population: Japanese.
CC   Doubling time: 16.58 hours (PubMed=21362583).
CC   HLA typing: A*24:02 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Misspelling: KCC L891; PubMed=21362583.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 8
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 9,15
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8023 ! YCU-T891
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   YCU-M862
AC   CVCL_8019
SY   YCU M862
DR   Cosmic; 1136972
DR   Cosmic; 1556182
DR   GEO; GSM1643587
DR   Wikidata; Q54995352
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 12.12 hours (PubMed=21362583).
CC   HLA typing: A*24:02,33:03 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 18
ST   D21S11: 29,31
ST   D3S1358: 18
ST   D5S818: 12,13
ST   D7S820: 8
ST   D8S1179: 12
ST   FGA: 22
ST   Penta D: 10
ST   Penta E: 16
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   YCU-M911
AC   CVCL_8020
SY   YCU M911
DR   Cosmic; 1136974
DR   Cosmic; 1556197
DR   Wikidata; Q54995353
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 10.09 hours (PubMed=21362583).
CC   HLA typing: A*02:01,24:02 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 13
ST   D13S317: 12
ST   D16S539: 11,13
ST   D18S51: 15,23
ST   D21S11: 28.2
ST   D3S1358: 13,16
ST   D5S818: 13
ST   D7S820: 11
ST   D8S1179: 13,15
ST   FGA: 23
ST   Penta D: 10
ST   Penta E: 18
ST   TH01: 7
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C8181; Oropharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_500478; Squamous cell carcinoma of the oropharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   YCU-MS861
AC   CVCL_8021
SY   YCU MS861
DR   Cosmic; 1136970
DR   Cosmic; 1556183
DR   GEO; GSM1643586
DR   Wikidata; Q54995355
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 16.64 hours (PubMed=21362583).
CC   HLA typing: A*24:02,26:01 (Direct_author_submission).
CC   Omics: Transcriptomics; Microarray.
CC   Miscellaneous: Age of donor, HLA typing and STR profile from personal communication of Sano, Daisuke.
CC   Misspelling: KCC MS861; PubMed=21362583.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 11,13
ST   D18S51: 13
ST   D21S11: 31
ST   D3S1358: 17
ST   D5S818: 10,12
ST   D7S820: 11
ST   D8S1179: 10,11
ST   FGA: 22,24
ST   Penta D: 10
ST   Penta E: 5
ST   TH01: 7,8
ST   TPOX: 11
ST   vWA: 14,16
DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma
DI   ORDO; Orphanet_500464; Squamous cell carcinoma of the nasal cavity and paranasal sinuses
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   51Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 15
//
ID   YCU-OR891
AC   CVCL_8022
SY   YCU OR891
DR   Cosmic; 1136962
DR   Cosmic; 1556189
DR   Wikidata; Q54995356
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 24.60 hours (PubMed=21362583).
CC   HLA typing: A*02:01,26:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,10
ST   D16S539: 9,14
ST   D18S51: 14,15
ST   D21S11: 29,33.2
ST   D3S1358: 16
ST   D5S818: 12,13
ST   D7S820: 10,12
ST   D8S1179: 10,14
ST   FGA: 21,22
ST   Penta D: 10
ST   Penta E: 13,19.4
ST   TH01: 6,7
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   YCU-T891
AC   CVCL_8023
SY   YCU T891
DR   Cosmic; 1136968
DR   Cosmic; 1556188
DR   Wikidata; Q54995357
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26780976;
RX   PubMed=26781072;
CC   Problematic cell line: Contaminated. YCU-L891 and YCU-T891 have been shown to be identical (PubMed=26780976; PubMed=26781072).
CC   Population: Japanese.
CC   Doubling time: 14.93 hours (PubMed=21362583).
CC   HLA typing: A*24:02 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,13
ST   D16S539: 8
ST   D18S51: 15,16
ST   D21S11: 30
ST   D3S1358: 18
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 14,15
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 9,15
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,19
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8018 ! YCU-L891
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 16
//
ID   YCU-T892
AC   CVCL_8024
SY   YCU T892
DR   Cosmic; 1136969
DR   Cosmic; 1556190
DR   GEO; GSM1643584
DR   Wikidata; Q54995359
RX   PubMed=18097577;
RX   PubMed=21362583;
RX   PubMed=21631644;
RX   PubMed=26754630;
CC   Population: Japanese.
CC   Doubling time: 18.24 hours (PubMed=21362583).
CC   HLA typing: A*29:01 (Direct_author_submission).
CC   Miscellaneous: HLA typing and STR profile from personal communication of Sano, Daisuke.
ST   Source(s): Direct_author_submission
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11
ST   D16S539: 9
ST   D18S51: 14
ST   D21S11: 30,33.2
ST   D3S1358: 16
ST   D5S818: 8
ST   D7S820: 8
ST   D8S1179: 13,14
ST   FGA: 25
ST   Penta D: 9,13
ST   Penta E: 12,14
ST   TH01: 9
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   YCUB-1
AC   CVCL_D3ZD
SY   YCUB1; YcuB1; Yokohama City University BCP-ALL-1
DR   Wikidata; Q127384760
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Ser395Arg (c.1185C>G); Zygosity=Homozygous (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   YCUB-2
AC   CVCL_A082
SY   YCUB2; YcuB2; Yokohama City University BCP-ALL-2
DR   DSMZ; ACC-961
DR   IARC_TP53; 28430
DR   Wikidata; Q54995372
RX   PubMed=11417493;
RX   PubMed=19157546;
RX   PubMed=20147975;
RX   PubMed=20519628;
RX   PubMed=20575032;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=32144432;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: ~24 hours (DSMZ=ACC-961).
CC   Sequence variation: Gene fusion; HGNC; HGNC:4977; HLF + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-HLF, E2A-HLF (PubMed=11417493).
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Ser395Arg (c.1185C>G); Zygosity=Homozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-961
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,11
ST   D16S539: 9
ST   D18S51: 13
ST   D19S433: 13
ST   D21S11: 29,33.2
ST   D2S1338: 20,23
ST   D3S1358: 17,18
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 11
ST   Penta E: 11,16
ST   TH01: 7,8
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C199241; B acute lymphoblastic leukemia with TCF3-HLF rearrangement
DI   ORDO; Orphanet_641375; B-lymphoblastic leukemia/lymphoma with t(17;19)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 15
//
ID   YCUB-4
AC   CVCL_A083
SY   YCUB4; YcuB4; Yokohama City University BCP-ALL-4
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   DSMZ; ACC-962
DR   Wikidata; Q54995373
RX   PubMed=19157546;
RX   PubMed=29786757;
RX   PubMed=32144432;
RX   PubMed=34940123;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (DSMZ=ACC-962).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1008; BCL9 + HGNC; HGNC:6997; MEF2D; Name(s)=MEF2D-BCL9; Note=MEF2D exon5/BCL9 exon 9 fusion (PubMed=34940123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-962
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 31,33.2
ST   D2S1338: 17,22
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 16
ST   FGA: 25,26
ST   Penta D: 10,11
ST   Penta E: 17,21
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A084 ! YCUB-4R
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCUB-4R
AC   CVCL_A084
SY   YCUB4R; Yokohama City University BCP-ALL-4 Relapse
DR   ArrayExpress; E-MTAB-11038
DR   ArrayExpress; E-MTAB-11039
DR   DSMZ; ACC-963
DR   Wikidata; Q54995374
RX   PubMed=19157546;
RX   PubMed=34940123;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (DSMZ=ACC-963).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=34940123).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1008; BCL9 + HGNC; HGNC:6997; MEF2D; Name(s)=MEF2D-BCL9; Note=MEF2D exon5/BCL9 exon 9 fusion (PubMed=34940123).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-963
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 17,18
ST   D19S433: 13,14
ST   D21S11: 31,33.2
ST   D2S1338: 17,22
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   D8S1179: 16
ST   FGA: 25,26
ST   Penta D: 10,11
ST   Penta E: 17,21
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A083 ! YCUB-4
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 15
//
ID   YCUB-5
AC   CVCL_A085
SY   YCUB5; YcuB5; Yokohama City University BCP-ALL-5
DR   DSMZ; ACC-964
DR   Wikidata; Q54995375
RX   PubMed=19157546;
RX   PubMed=29786757;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: ~72 hours (DSMZ=ACC-964).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14281; CRLF2 + HGNC; HGNC:15524; P2RY8; Name(s)=P2RY8-CRLF2; Note=P2RY8 exon 1 fused to CRLF2 exon 1 (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:6192; JAK2; Simple; p.Arg683Ile (c.2048G>T); Zygosity=Unspecified (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Unspecified (PubMed=29786757).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): DSMZ=ACC-964
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 13,15
ST   D19S433: 12
ST   D21S11: 30,30.2
ST   D2S1338: 18,23
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 9,11
ST   D8S1179: 14,16
ST   FGA: 20,21
ST   Penta D: 9,14
ST   Penta E: 11,17
ST   TH01: 6,9
ST   TPOX: 8,12
ST   vWA: 16
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A086 ! YCUB-5R
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 13
//
ID   YCUB-5R
AC   CVCL_A086
SY   YCUB5R; Yokohama City University BCP-ALL-5 Relapse
DR   Wikidata; Q54995377
RX   PubMed=19157546;
CC   Population: Japanese.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A085 ! YCUB-5
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 30-01-24; Version: 11
//
ID   YCUB-6
AC   CVCL_A087
SY   YCUB6; YcuB6; Yokohama City University BCP-ALL-6
DR   DSMZ; ACC-966
DR   Wikidata; Q54995379
RX   PubMed=19157546;
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=32144432;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Doubling time: ~3-4 days (DSMZ=ACC-966).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Omics: Phenotyping; Drug screening.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-966
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 14,16
ST   D19S433: 14,16
ST   D21S11: 29,32.2
ST   D2S1338: 20,24
ST   D3S1358: 12,17
ST   D5S818: 13,14
ST   D7S820: 11
ST   D8S1179: 14
ST   FGA: 22,24
ST   Penta D: 12,13
ST   Penta E: 8,10
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   12Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 14
//
ID   YCUB-7
AC   CVCL_D3Z9
SY   YCUB7; YcuB7; Yokohama City University BCP-ALL-7
DR   Wikidata; Q127384762
RX   PubMed=29786757;
RX   PubMed=32144432;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:7978; NR3C1; Simple; p.Ser599Phe (c.1796C>T) (p.Ser600Phe, c.1799C>T); Zygosity=Homozygous (PubMed=35124168).
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   10-20Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   YCUB-8
AC   CVCL_D3Z8
SY   YCUB8; YcuB8; Yokohama City University BCP-ALL-8
DR   Wikidata; Q127384764
RX   PubMed=29786757;
RX   PubMed=31305009;
RX   PubMed=32144432;
RX   PubMed=35124168;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:8632; PBX1 + HGNC; HGNC:11633; TCF3; Name(s)=TCF3-PBX1, E2A-PBX1 (PubMed=29786757).
CC   Sequence variation: Mutation; HGNC; HGNC:12766; NSD2; Simple; p.Glu1099Lys (c.3295G>A); ClinVar=VCV000638278; Zygosity=Heterozygous (PubMed=35124168).
CC   Omics: Phenotyping; Drug screening.
DI   NCIt; C80347; B acute lymphoblastic leukemia with t(1;19)(q23;p13.3) E2A-PBX1 (TCF3-PBX1)
DI   ORDO; Orphanet_585956; B-lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   YCUS-5
AC   CVCL_N853
SY   Yokohama City University Sarcoma-5
DR   Wikidata; Q54995380
RX   PubMed=10398195;
RX   PubMed=16557275;
CC   Population: Japanese.
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   3Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 21-03-23; Version: 9
//
ID   YD-10B
AC   CVCL_8929
SY   YD10B
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987734
DR   cancercelllines; CVCL_8929
DR   Cell_Model_Passport; SIDM01782
DR   DepMap; ACH-000723
DR   GEO; GSM887743
DR   GEO; GSM888838
DR   IARC_TP53; 21618
DR   KCLB; 60503
DR   LiGeA; CCLE_770
DR   PharmacoDB; YD10B_1680_2019
DR   Progenetix; CVCL_8929
DR   Wikidata; Q54995381
RX   PubMed=16264262;
RX   PubMed=17404023;
RX   PubMed=22460905;
RX   PubMed=23708675;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Korean.
CC   Doubling time: 25.3 hours (PubMed=16264262).
CC   HLA typing: A*02:06,33:03; B*51:01,58:01; C*03:02,14:02 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Glu88Ter (c.262G>T); ClinVar=VCV000376305; Zygosity=Heterozygous (DepMap=ACH-000723).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Trp110Ter (c.330G>A) (p.Gly125Arg, c.373G>A); ClinVar=VCV000376303; Zygosity=Heterozygous (DepMap=ACH-000723).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr236Ter (c.708C>A); Zygosity=Homozygous (PubMed=16264262; DepMap=ACH-000723).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=62.45%; East Asian, South=36.59%; South Asian=0%; European, North=0%; European, South=0.96% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): KCLB=60503; PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8,9 (KCLB=60503)
ST   D13S317: 9 (PubMed=16264262)
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 30,32
ST   D3S1358: 17
ST   D5S818: 11,13
ST   D7S820: 11
ST   D8S1179: 11
ST   DXS101: 22
ST   DYS391: 10
ST   FGA: 23
ST   Penta D: 8,9
ST   Penta E: 5,8
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 18,19 (KCLB=60503)
ST   vWA: 18,19,20 (PubMed=16264262)
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 32
//
ID   YD-15
AC   CVCL_8930
SY   YD15
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10987726
DR   cancercelllines; CVCL_8930
DR   Cell_Model_Passport; SIDM01411
DR   DepMap; ACH-000836
DR   GEO; GSM887744
DR   GEO; GSM888839
DR   IARC_TP53; 21619
DR   KCLB; 60504
DR   LiGeA; CCLE_509
DR   PharmacoDB; YD15_1681_2019
DR   Progenetix; CVCL_8930
DR   Wikidata; Q54995383
RX   PubMed=16264262;
RX   PubMed=21496182;
RX   PubMed=22460905;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Korean.
CC   Doubling time: 19.8 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Ala (c.773A>C); ClinVar=VCV000458563; Zygosity=Homozygous (PubMed=16264262; DepMap=ACH-000836).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.84%; Native American=1.03%; East Asian, North=65.12%; East Asian, South=31.39%; South Asian=0%; European, North=0%; European, South=1.62% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): KCLB=60504; PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 14,19
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L078 ! YD-15M
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   YD-15M
AC   CVCL_L078
SY   YD15M
DR   KCLB; 60505
DR   Wikidata; Q54995384
RX   PubMed=16264262;
CC   Population: Korean.
CC   Doubling time: 20.8 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu258Ala (c.773A>C); ClinVar=VCV000458563; Zygosity=Unspecified (PubMed=16264262).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): KCLB=60505; PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,12
ST   D18S51: 14
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 12,13
ST   D8S1179: 15
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 14,19
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 15
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8930 ! YD-15
SX   Male
AG   39Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 20
//
ID   YD-17
AC   CVCL_L081
SY   YD17
DR   IARC_TP53; 21620
DR   Wikidata; Q54995385
RX   PubMed=16264262;
CC   Population: Korean.
CC   Doubling time: 29.2 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16264262).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 28,31
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L082 ! YD-17M
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 16
//
ID   YD-17M
AC   CVCL_L082
SY   YD17M
DR   Wikidata; Q54995386
RX   PubMed=16264262;
CC   Population: Korean.
CC   Doubling time: 19.6 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16264262).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D21S11: 28,31
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 13,15
ST   FGA: 24
ST   Penta D: 9,13
ST   Penta E: 5,12
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L081 ! YD-17
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 17
//
ID   YD-1C4-A4
AC   CVCL_C8IH
DR   Wikidata; Q123033956
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95484; Human CLDN9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YD-38
AC   CVCL_L083
SY   YD38
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988077
DR   cancercelllines; CVCL_L083
DR   Cell_Model_Passport; SIDM01412
DR   DepMap; ACH-000762
DR   GEO; GSM887745
DR   GEO; GSM888840
DR   IARC_TP53; 21621
DR   IARC_TP53; 30220
DR   KCLB; 60508
DR   LiGeA; CCLE_758
DR   PharmacoDB; YD38_1682_2019
DR   Progenetix; CVCL_L083
DR   Wikidata; Q54995388
RX   PubMed=16264262;
RX   PubMed=22460905;
RX   PubMed=28053903;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Korean.
CC   Doubling time: 21.6 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly199Ter (c.595G>T); ClinVar=VCV000634672; Zygosity=Homozygous (DepMap=ACH-000762).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.56%; East Asian, North=61.56%; East Asian, South=37.62%; South Asian=0%; European, North=0%; European, South=0.26% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, gingiva; UBERON=UBERON_0001828.
ST   Source(s): KCLB=60508; PubMed=16264262
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 12,13
ST   D18S51: 14
ST   D21S11: 30,31
ST   D3S1358: 16
ST   D5S818: 14
ST   D7S820: 10,11
ST   D8S1179: 14
ST   FGA: 22,25
ST   Penta D: 8,12
ST   Penta E: 12,19
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C129857; Gingival squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 29
//
ID   YD-39
AC   CVCL_B482
SY   YD39
DR   Wikidata; Q54995391
RX   PubMed=22621906;
RX   PubMed=22776128;
CC   Population: Korean.
CC   Doubling time: 23.8 +- 2.1 hours (PubMed=22621906).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro27_Ser37del; Zygosity=Unspecified (PubMed=22776128).
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 11
//
ID   YD-4E9-A2
AC   CVCL_C8II
DR   Wikidata; Q123033958
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95484; Human CLDN9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YD-6F9-H2
AC   CVCL_C8IJ
DR   Wikidata; Q123033959
RX   PubMed=23864633;
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; O95484; Human CLDN9.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YD-8
AC   CVCL_L079
SY   YD8
DR   ArrayExpress; E-MTAB-2770
DR   BioSample; SAMN10988082
DR   Cell_Model_Passport; SIDM01413
DR   DepMap; ACH-000630
DR   GEO; GSM887746
DR   GEO; GSM888841
DR   IARC_TP53; 21616
DR   KCLB; 60501
DR   LiGeA; CCLE_283
DR   PharmacoDB; YD8_1683_2019
DR   Progenetix; CVCL_L079
DR   Wikidata; Q54995393
RX   PubMed=16264262;
RX   PubMed=22460905;
RX   PubMed=23708675;
RX   PubMed=26589293;
RX   PubMed=28053903;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Korean.
CC   Doubling time: 29.3 hours (PubMed=16264262).
CC   HLA typing: A*31:01,31:01; B*15:01,40:02; C*03:04,03:04 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly138Val (c.413G>T); Zygosity=Heterozygous (DepMap=ACH-000630).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273His (c.818G>A); ClinVar=VCV000012366; Zygosity=Homozygous (PubMed=16264262; DepMap=ACH-000630).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0.59%; East Asian, North=62.69%; East Asian, South=35.7%; South Asian=0%; European, North=0%; European, South=1.01% (PubMed=30894373).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): KCLB=60501; PubMed=16264262
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D18S51: 15,16
ST   D21S11: 29,30
ST   D3S1358: 15,16 (PubMed=16264262)
ST   D3S1358: 15.2 (KCLB=60501)
ST   D5S818: 12
ST   D7S820: 10,13
ST   D8S1179: 13,16
ST   FGA: 24
ST   Penta D: 13
ST   Penta E: 12,15
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   46Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-04-25; Version: 31
//
ID   YD-9
AC   CVCL_L080
SY   YD9
DR   IARC_TP53; 21617
DR   KCLB; 60502
DR   Wikidata; Q54995394
RX   PubMed=16264262;
RX   PubMed=28053903;
CC   Population: Korean.
CC   Doubling time: 33.4 hours (PubMed=16264262).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=16264262).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): KCLB=60502; PubMed=16264262
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 12,13
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 11,12
ST   D8S1179: 11,13
ST   FGA: 25
ST   Penta D: 9
ST   Penta E: 15,17
ST   TH01: 6
ST   TPOX: 8,9
ST   vWA: 14,19
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 19-12-24; Version: 19
//
ID   YDK-04
AC   CVCL_6F17
SY   YADK-04
DR   Wikidata; Q54995200
RX   Patent=RU2335537;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 63.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
HI   CVCL_M729 ! CG-91
SX   Female
AG   3D
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 5
//
ID   YDOV-105
AC   CVCL_A1KE
SY   YongDong OVarian-105
DR   GEO; GSM4013287
DR   Wikidata; Q102115142
RX   PubMed=19188485;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   YDOV-13
AC   CVCL_A1KF
SY   YongDong OVarian-13
DR   GEO; GSM4013286
DR   Wikidata; Q102115143
RX   PubMed=19188485;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4270; Malignant ovarian Brenner tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   YDOV-139
AC   CVCL_A1KB
SY   YongDong OVarian-139
DR   GEO; GSM4013280
DR   GEO; GSM4013281
DR   Wikidata; Q102115144
RX   PubMed=19188485;
RX   PubMed=20596667;
RX   PubMed=24164300;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Doubling time: 120 hours (PubMed=20596667).
CC   HLA typing: A*24,31; B*07,35; C*03,07; DRB1*01,15 (PubMed=20596667).
CC   Omics: Proteomics; 2DE.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=20596667
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D3S1358: 16
ST   D5S818: 12
ST   D7S820: 11
ST   FGA: 22
ST   TH01: 7
ST   TPOX: 6,9
ST   vWA: 17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   YDOV-151
AC   CVCL_A1KC
SY   YongDong OVarian-151
DR   ABM; T8070
DR   GEO; GSM4013288
DR   Wikidata; Q102115145
RX   PubMed=19188485;
RX   PubMed=19478469;
RX   PubMed=20596667;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Doubling time: 19 hours (PubMed=19478469).
CC   HLA typing: A*38,38; B*58,58; C*03,03; DRB1*03,04 (PubMed=19478469).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=20596667
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 12
ST   D3S1358: 15,16
ST   D5S818: 12
ST   D7S820: 11,12
ST   FGA: 25
ST   TH01: 8,9
ST   TPOX: 6
ST   vWA: 17
DI   NCIt; C4026; Ovarian mucinous cystadenocarcinoma
DI   ORDO; Orphanet_398961; Mucinous adenocarcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   YDOV-157
AC   CVCL_W954
SY   YongDong OVarian-157
DR   GEO; GSM4013282
DR   GEO; GSM4013283
DR   Wikidata; Q54995396
RX   PubMed=18682896;
RX   PubMed=19188485;
RX   PubMed=20596667;
RX   PubMed=24164300;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Doubling time: 102 hours (PubMed=18682896).
CC   Omics: Proteomics; 2DE.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=20596667
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 9
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   FGA: 20,23
ST   TH01: 8,9
ST   TPOX: 12
ST   vWA: 17
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-04-25; Version: 11
//
ID   YDOV-161
AC   CVCL_A1KD
SY   YongDong OVarian-161
DR   GEO; GSM4013284
DR   GEO; GSM4013285
DR   Wikidata; Q102115146
RX   PubMed=19188485;
RX   PubMed=24164300;
RX   PubMed=31615043;
CC   Population: Korean.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
ID   YEL-13
AC   CVCL_R989
SY   YEL13; Yamame Embryonal Liver-13
DR   Wikidata; Q54995397
RX   CelloPub=CLPUB00130;
RX   DOI=10.2331/suisan.54.1881;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Embryonic liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=8020; ! Oncorhynchus masou (Cherry salmon)
SX   Sex unspecified
AG   Embryo
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 27-11-25; Version: 10
//
ID   YEO,AM
AC   CVCL_E893
SY   YEO, AM
DR   dbMHC; 49084
DR   IHW; IHW09137
DR   IPD-IMGT/HLA; 11680
DR   Wikidata; Q54995398
RX   PubMed=8307784;
RX   PubMed=30844424;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*03; B*44:02; DPB1*04:01; DQA1*01:02,03; DQB1*03:01,06:02; DRB1*15:01,04:01; DRB4*01:01; DRB5*01:01 (IPD-IMGT/HLA=11680).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   YES-1
AC   CVCL_E321
SY   YES1
DR   cancercelllines; CVCL_E321
DR   GEO; GSM301574
DR   Progenetix; CVCL_E321
DR   Wikidata; Q54995399
RX   DOI=10.5833/jjgs.27.1885;
RX   PubMed=1770930;
RX   PubMed=1819237;
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=11115554;
RX   PubMed=18575732;
RX   PubMed=18973137;
RX   PubMed=20515944;
CC   Population: Japanese.
CC   Doubling time: 35.2 hours (PubMed=1770930); 82.1 hours (DOI=10.5833/jjgs.27.1885).
CC   HLA typing: A*02,01; B*15,11; C*03 (PubMed=18575732).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
ID   YES-2
AC   CVCL_E322
SY   YES 2; YES2
DR   cancercelllines; CVCL_E322
DR   Cosmic; 2395009
DR   GEO; GSM301575
DR   Progenetix; CVCL_E322
DR   Wikidata; Q54995400
RX   CelloPub=CLPUB00005;
RX   DOI=10.5833/jjgs.27.1885;
RX   PubMed=1770930;
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=11115554;
RX   PubMed=18575732;
RX   PubMed=18973137;
RX   PubMed=20515944;
RX   PubMed=21191746;
CC   Population: Japanese.
CC   Doubling time: 22.9 hours (PubMed=1770930); 67.2 hours (DOI=10.5833/jjgs.27.1885); 23.7 hours (Note=At 102th passage) (CelloPub=CLPUB00005).
CC   HLA typing: A*24; B*01,40; C*03,07 (PubMed=18575732).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 17
//
ID   YES-2CSC
AC   CVCL_S526
SY   YES-2 Cancer Stem Cells
DR   Wikidata; Q54995401
RX   PubMed=23983818;
CC   Population: Japanese.
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_E322 ! YES-2
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
ID   YES-3
AC   CVCL_E323
DR   Wikidata; Q54995402
RX   DOI=10.5833/jjgs.27.1885;
RX   PubMed=1770930;
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=18575732;
RX   PubMed=20515944;
CC   Population: Japanese.
CC   Doubling time: 61.0 hours (PubMed=1770930); 49.2 hours (DOI=10.5833/jjgs.27.1885).
CC   HLA typing: A*04,24; B*01,15; C*01 (PubMed=18575732).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 11
//
ID   YES-4
AC   CVCL_S528
SY   Yes-4; YES4
DR   Wikidata; Q54995403
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=10778992;
RX   PubMed=18575732;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*01,39; C*07 (PubMed=18575732).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   YES-5
AC   CVCL_S529
SY   YES5
DR   Wikidata; Q54995404
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=18575732;
RX   PubMed=20515944;
CC   Population: Japanese.
CC   HLA typing: A*01,02; B*11,15; C*03 (PubMed=18575732).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 9
//
ID   YES-6
AC   CVCL_S530
SY   Yes-6; YES6
DR   Wikidata; Q54995407
RX   PubMed=8590302;
RX   PubMed=8974001;
RX   PubMed=10778992;
RX   PubMed=11115554;
RX   PubMed=18575732;
RX   PubMed=20515944;
RX   PubMed=26317542;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*01,15; C*03,04 (PubMed=18575732).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 10
//
ID   YES-6-Rf
AC   CVCL_C0WZ
SY   Yes-6-Rf
DR   Wikidata; Q114313268
RX   PubMed=26317542;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_S530 ! YES-6
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 19-12-24; Version: 4
//
ID   YFC 118.12
AC   CVCL_J779
DR   ECACC; 11072204
DR   Wikidata; Q54995408
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P05107; Human ITGB2/CD18.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YFC 120.5
AC   CVCL_J780
DR   ECACC; 11060808
DR   Wikidata; Q54995409
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   YFE-16
AC   CVCL_RH79
DR   Wikidata; Q54995411
RX   PubMed=26626025;
RX   PubMed=26997647;
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   YFEF
AC   CVCL_9U61
SY   Yak Fetal Ear Fibroblast
DR   Wikidata; Q54995412
RX   PubMed=23161386;
CC   Doubling time: 35 hours (PubMed=23161386).
CC   Derived from site: In situ; Fetal ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=30521; ! Bos mutus grunniens (Wild yak)
OI   CVCL_9U62 ! YFLF
SX   Male
AG   121-150FD
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   YFLF
AC   CVCL_9U62
SY   Yak Fetal Lung Fibroblast
DR   Wikidata; Q54995413
RX   PubMed=23161386;
CC   Doubling time: 30 hours (PubMed=23161386).
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=30521; ! Bos mutus grunniens (Wild yak)
OI   CVCL_9U61 ! YFEF
SX   Male
AG   121-150FD
CA   Finite cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   YFP-SF1
AC   CVCL_F702
DR   Wikidata; Q54995414
RX   PubMed=21959845;
CC   Group: Endangered species/breed cell line.
CC   Group: Cetacean cell line.
CC   Doubling time: 31.45 hours (Note=At 7th passage), 50.24 hours (Note=At 20th passage) (PubMed=21959845).
CC   Derived from site: In situ; Tail lobe, skin; UBERON=UBERON_8480071.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=1706337; ! Neophocaena asiaeorientalis asiaeorientalis (Yangtze finless porpoise)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 11-02-13; Last updated: 10-09-24; Version: 13
//
ID   YG-PLL
AC   CVCL_B7JH
DR   Wikidata; Q112930589
RX   PubMed=34334531;
CC   Population: Japanese.
CC   Characteristics: IL2 and IL4 dependent.
CC   Doubling time: ~35 hours (PubMed=34334531).
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: Metastatic; Left inguinal lymph node; UBERON=UBERON_0001542.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C3184; Adult T-cell leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   YG10003
AC   CVCL_8557
DR   JCRB; JCRB0119
DR   JCRB; NIHS0160
DR   Wikidata; Q54995415
RX   PubMed=8137280;
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; Q00267; Salmonella typhimurium nhoA.
CC   Discontinued: JCRB; NIHS0160; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 11
//
ID   YG10007
AC   CVCL_8558
DR   JCRB; JCRB0120
DR   JCRB; NIHS0161
DR   Wikidata; Q54995416
RX   PubMed=8137280;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7645; NAT1.
CC   Discontinued: JCRB; NIHS0161; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   YG10008
AC   CVCL_8559
DR   JCRB; JCRB0121
DR   JCRB; NIHS0162
DR   Wikidata; Q54995417
RX   PubMed=8137280;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:7646; NAT2.
CC   Discontinued: JCRB; NIHS0162; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0212 ! CHL
SX   Female
AG   1D
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   YGY 016
AC   CVCL_E894
SY   YGY016
DR   dbMHC; 49085
DR   ECACC; 94082290
DR   IHW; IHW09190
DR   IPD-IMGT/HLA; 11732
DR   Wikidata; Q54995419
RX   PubMed=8307784;
CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC   HLA typing: A*02,33; B*35,61; C*03:03,04; DPB1*02:01:02,05:01; DQA1*01:04,05:01; DQB1*03:01,05:03; DRB1*12:01,14:01; DRB3*01:01,02:02 (IPD-IMGT/HLA=11732).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 17
//
ID   YH-13
AC   CVCL_1795
SY   YH13; YH
DR   CLO; CLO_0009906
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 1043
DR   BioSample; SAMN03472800
DR   BioSample; SAMN10987935
DR   cancercelllines; CVCL_1795
DR   Cell_Model_Passport; SIDM00316
DR   CGH-DB; 158-1
DR   ChEMBL-Cells; CHEMBL3308223
DR   ChEMBL-Targets; CHEMBL2366164
DR   Cosmic; 687591
DR   Cosmic; 909905
DR   Cosmic; 2367556
DR   Cosmic-CLP; 909905
DR   DepMap; ACH-000469
DR   EGA; EGAS00001000978
DR   GDSC; 909905
DR   GEO; GSM887747
DR   GEO; GSM888842
DR   GEO; GSM1670585
DR   IARC_TP53; 27268
DR   JCRB; IFO50493
DR   LiGeA; CCLE_419
DR   LINCS_LDP; LCL-1392
DR   PharmacoDB; YH13_1684_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1795
DR   PubChem_Cell_line; CVCL_1795
DR   Wikidata; Q54995420
RX   DOI=10.1007/0-306-46861-1_11;
RX   PubMed=7947440;
RX   PubMed=8145054;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=30971826;
RX   PubMed=31068700;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Population: Japanese.
CC   Doubling time: 30 hours (PubMed=7947440; PubMed=8145054).
CC   HLA typing: A*11:01,24:02; B*35:01,52:01; C*12:02,12:02; DQA1*01:02,05:02; DQB1*05:02,06:11; DRB1*07:01,11:30 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Gln75Glu (c.223C>G); Zygosity=Heterozygous (Cosmic-CLP=909905; DepMap=ACH-000469).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Phe113Val (c.337T>G); ClinVar=VCV000141302; Zygosity=Homozygous (Cosmic-CLP=909905; DepMap=ACH-000469).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; CRISPR screening.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.04%; Native American=0%; East Asian, North=83.27%; East Asian, South=16.69%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Brain, left fronto-parietal lobe.
ST   Source(s): Cosmic-CLP=909905; JCRB=IFO50493
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 9,12
ST   D16S539: 12
ST   D5S818: 10,12
ST   D7S820: 8,12
ST   TH01: 8
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 39
//
ID   YH206
AC   CVCL_B4JQ
DR   Wikidata; Q110434435
RX   Patent=US4990454;
RX   PubMed=2427759;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-2001.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human heavily glycosylated mucin-like antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   YI 328-18
AC   CVCL_E987
SY   YI328-18
DR   CLO; CLO_0009713
DR   ATCC; HB-9306
DR   Wikidata; Q54995421
RX   Patent=US4885358;
RX   PubMed=3805024;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9306.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_138018; Lactogangliotetraosylceramide (LcGg4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 6
//
ID   YI 328-51
AC   CVCL_E988
SY   YI328-51
DR   Wikidata; Q54995423
RX   Patent=US4885358;
RX   PubMed=3805024;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-9307.
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: ChEBI; CHEBI_138018; Lactogangliotetraosylceramide (LcGg4).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 7
//
ID   YJ
AC   CVCL_8931
DR   BioSample; SAMN03151778
DR   cancercelllines; CVCL_8931
DR   Wikidata; Q54995424
RX   PubMed=9737693;
RX   PubMed=12592342;
RX   PubMed=19344951;
RX   PubMed=20143388;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HL-60 derivative (PubMed=12592342; PubMed=19344951; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00288.
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11998; TP53; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:1787; CDKN2A; Simple; p.Arg80Ter (c.238C>T) (p.Pro94Leu, c.281C>T); ClinVar=VCV000009409; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C7961; Adult acute myeloid leukemia with maturation
DI   ORDO; Orphanet_98834; Acute myeloblastic leukemia with maturation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0002 ! HL-60
SX   Female
AG   36Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 29
//
ID   YK
AC   CVCL_ZV98
DR   Wikidata; Q102115147
RX   PubMed=6202402;
CC   Population: Japanese.
DI   NCIt; C8111; Immature ovarian teratoma
DI   ORDO; Orphanet_398987; Malignant teratoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   20Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   YK-M2
AC   CVCL_9919
DR   Cosmic; 975313
DR   Cosmic; 1281363
DR   DSMZ; ACC-949
DR   Wikidata; Q54995434
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3465438;
CC   Population: Japanese.
CC   Doubling time: ~60 hours (PubMed=3465438); ~50 hours (DSMZ=ACC-949).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-949
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D18S51: 13,17
ST   D19S433: 13,15
ST   D21S11: 28,29
ST   D2S1338: 19,23
ST   D3S1358: 14,16
ST   D5S818: 12
ST   D7S820: 11
ST   D8S1179: 12,13
ST   FGA: 24
ST   Penta D: 10,12
ST   Penta E: 17,18
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 16,18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 12
//
ID   YK136
AC   CVCL_C5YY
DR   Wikidata; Q116050837
RX   PubMed=1368752;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P0A3R9; Streptomyces carzinostaticus neocarzinostatin (ncsA).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   YK136H15-56-16
AC   CVCL_C5YZ
DR   Wikidata; Q116050838
RX   PubMed=1368752;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P0A3R9; Streptomyces carzinostaticus neocarzinostatin (ncsA).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5YY ! YK136
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   YK136HNT56
AC   CVCL_C5Z0
DR   Wikidata; Q116050839
RX   PubMed=1368752;
CC   Monoclonal antibody isotype: IgM, lambda.
CC   Monoclonal antibody target: UniProtKB; P0A3R9; Streptomyces carzinostaticus neocarzinostatin (ncsA).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C5YZ ! YK136H15-56-16
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 14-08-25; Version: 4
//
ID   YK6
AC   CVCL_A2XJ
DR   Wikidata; Q105511834
RX   PubMed=31586074;
CC   Population: Korean.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Miscellaneous: Sex assignment derived from omics analysis from personal communication of Hodson, Daniel James.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Follicular dendritic cell; CL=CL_0000442.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Children
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 9
//
ID   YK6-CD40Lg-IL21
AC   CVCL_A2XK
DR   Wikidata; Q105511836
RX   PubMed=31586074;
CC   Population: Korean.
CC   Characteristics: Used as a feeder line to co-culture with human B cells.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11935; CD40LG.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:1773; CDK4 (Note=With p.Arg24Cys).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:6005; IL21.
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88346; Cd8a.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:98834; Trp53 (Note=With p.Leu14_Lys302del = p53DD).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Miscellaneous: Sex assignment derived from omics analysis from personal communication of Hodson, Daniel James.
CC   Derived from site: In situ; Oral cavity, tonsil; UBERON=UBERON_0002372.
CC   Cell type: Follicular dendritic cell; CL=CL_0000442.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A2XJ ! YK6
SX   Male
AG   Children
CA   Telomerase immortalized cell line
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 10
//
ID   YKG-1
AC   CVCL_1796
SY   YKG1
DR   CLO; CLO_0009907
DR   CLO; CLO_0050640
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   BioGRID_ORCS_Cell_line; 391
DR   BioSample; SAMN01821722
DR   BioSample; SAMN03472510
DR   BioSample; SAMN10988288
DR   cancercelllines; CVCL_1796
DR   Cell_Model_Passport; SIDM00315
DR   CGH-DB; 159-1
DR   ChEMBL-Cells; CHEMBL3308093
DR   ChEMBL-Targets; CHEMBL1075612
DR   Cosmic; 687592
DR   Cosmic; 2367557
DR   Cosmic; 2516045
DR   Cosmic-CLP; 687592
DR   DepMap; ACH-000570
DR   EGA; EGAS00001000978
DR   GDSC; 687592
DR   GEO; GSM827215
DR   GEO; GSM887748
DR   GEO; GSM888843
DR   GEO; GSM1670586
DR   IARC_TP53; 27269
DR   JCRB; JCRB0746
DR   LiGeA; CCLE_804
DR   LINCS_LDP; LCL-1361
DR   PharmacoDB; YKG1_1685_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1796
DR   PubChem_Cell_line; CVCL_1796
DR   RCB; RCB2110
DR   TKG; TKG 0453
DR   Wikidata; Q54995435
RX   PubMed=2589023;
RX   PubMed=9290701;
RX   PubMed=16232199;
RX   PubMed=20164919;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=25984343;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: Japanese.
CC   Doubling time: 28 hours (PubMed=25984343).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Trp146_Ser149delinsCys (c.438_446delGGTTGATTC); Zygosity=Heterozygous (Cosmic-CLP=687592).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.57%; Native American=0.77%; East Asian, North=82.14%; East Asian, South=15.9%; South Asian=0%; European, North=0.28%; European, South=0.34% (PubMed=30894373).
CC   Derived from site: In situ; Brain, right temporo-occipital lobe.
ST   Source(s): Cosmic-CLP=687592; JCRB=JCRB0746; RCB=RCB2110; TKG=TKG 0453
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 11
ST   D5S818: 10,11
ST   D7S820: 10,11
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 40
//
ID   YL1/2
AC   CVCL_J781
DR   ECACC; 92092402
DR   Wikidata; Q54995437
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   YLC-KK1
AC   CVCL_L216
DR   Wikidata; Q54995438
RX   PubMed=9290701;
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 21-03-23; Version: 9
//
ID   YM
AC   CVCL_IU39
DR   DSMZ; ACC-948
DR   Wikidata; Q54995439
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9747876;
RX   PubMed=11572760;
RX   PubMed=11821949;
RX   PubMed=12967475;
RX   PubMed=26727417;
CC   Population: Japanese.
CC   Doubling time: 36-48 hours (PubMed=9747876); ~48 hours (DSMZ=ACC-948).
CC   Karyotypic information: Has lost chromosome Y.
CC   Sequence variation: Gene fusion; HGNC; HGNC:990; BCL2 + HGNC; HGNC:5853; IGL; Name(s)=IGL-BCL2 (PubMed=12967475).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1001; BCL6 + HGNC; HGNC:6006; IL21R; Name(s)=BCL6-IL21R (PubMed=11821949; PubMed=12967475).
CC   Miscellaneous: Originally assigned to be from a B-cell non-Hodgkin lymphoma, immunoblastic-type.
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DSMZ=ACC-948
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9,11
ST   D16S539: 9,10
ST   D18S51: 13,14,17
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17,19
ST   D3S1358: 15
ST   D5S818: 12,13
ST   D7S820: 8,11
ST   D8S1179: 12,15
ST   FGA: 24
ST   Penta D: 9,12
ST   Penta E: 5,11
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C8851; Diffuse large B-cell lymphoma
DI   ORDO; Orphanet_544; Diffuse large B-cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 19-12-24; Version: 12
//
ID   YM-1
AC   CVCL_AP55
DR   Wikidata; Q54995440
RX   PubMed=26432330;
CC   Population: Iranian; Turkamans.
CC   Doubling time: 40.66 hours (PubMed=26432330).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): PubMed=26432330
ST   Amelogenin: X
ST   CSF1PO: 9
ST   D13S317: 11
ST   D16S539: 10,12
ST   D18S51: 10,14
ST   D19S433: 14.2,15.2
ST   D21S11: 28
ST   D2S1338: 20,23
ST   D3S1358: 15,16
ST   D5S818: 8
ST   D7S820: 11,12
ST   D8S1179: 12,15
ST   FGA: 24,27
ST   TH01: 8
ST   TPOX: 12
ST   vWA: 16,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 02-05-16; Last updated: 29-06-23; Version: 8
//
ID   YM-PAFR
AC   CVCL_C4CI
DR   ABCD; ABCD_AQ055
DR   Wikidata; Q116050840
RX   Patent=EP0638648A2;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-4722.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P25105; Human PTAFR.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3412 ! P3X63Ag8U.1
CA   Hybridoma
DT   Created: 15-12-22; Last updated: 21-03-23; Version: 2
//
ID   YM21
AC   CVCL_TZ88
SY   YM-21
DR   Wikidata; Q54995441
RX   PubMed=1737336;
RX   PubMed=17511773;
CC   Population: Japanese.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 21-03-23; Version: 5
//
ID   YMB-1
AC   CVCL_2814
SY   YMB1
DR   BTO; BTO_0002404
DR   CLO; CLO_0009923
DR   EFO; EFO_0006779
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03152042
DR   cancercelllines; CVCL_2814
DR   Cell_Model_Passport; SIDM01260
DR   DepMap; ACH-001249
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GEO; GSM827238
DR   GEO; GSM887749
DR   GEO; GSM888844
DR   IARC_TP53; 30191
DR   JCRB; JCRB0823
DR   LINCS_LDP; LCL-1488
DR   PharmacoDB; YMB1_1686_2019
DR   Progenetix; CVCL_2814
DR   Wikidata; Q54995442
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=6534930;
RX   PubMed=9290701;
RX   PubMed=15900046;
RX   PubMed=20215515;
RX   PubMed=22460905;
RX   PubMed=23136038;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=30894373;
RX   PubMed=31068700;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a ZR-75-1 derivative (PubMed=23136038). Originally thought to originate from a 55 year old woman patient with a breast carcinoma.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00391.
CC   Population: Caucasian.
CC   Doubling time: 44 hours (PubMed=6534930).
CC   HLA typing: A*02:01,24:02; B*35:01,35:01; C*04:01,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=15900046).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=1.26%; Native American=0%; East Asian, North=3.7%; East Asian, South=0%; South Asian=0%; European, North=57.42%; European, South=37.62% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): JCRB=JCRB0823
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 38
//
ID   YMB-1-C
AC   CVCL_B372
DR   cancercelllines; CVCL_B372
DR   Wikidata; Q54995443
CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2814 ! YMB-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 18
//
ID   YMB-1-E
AC   CVCL_2815
SY   YMB1-E; YMB1E
DR   BTO; BTO_0002583
DR   EFO; EFO_0006780
DR   ArrayExpress; E-MTAB-2706
DR   BioSample; SAMN03152043
DR   cancercelllines; CVCL_2815
DR   Cell_Model_Passport; SIDM01261
DR   ChEMBL-Cells; CHEMBL3307353
DR   ChEMBL-Targets; CHEMBL614251
DR   Cosmic; 1571791
DR   Cosmic-CLP; 1303911
DR   DepMap; ACH-002208
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001002554
DR   GDSC; 1303911
DR   GEO; GSM1670587
DR   JCRB; JCRB0825
DR   PharmacoDB; YMB1E_1687_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_2815
DR   RCB; RCB1964
DR   TKG; TKG 0440
DR   Wikidata; Q54995446
RX   PubMed=9290701;
RX   PubMed=23136038;
RX   PubMed=25485619;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=35839778;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative (PubMed=23136038).
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00392.
CC   Population: Caucasian.
CC   HLA typing: A*24:18,24:18; B*35:01,35:01; C*04:01,04:01 (PubMed=26589293).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (Cosmic-CLP=1303911; DepMap=ACH-002208).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Lys117Asn (c.351A>T); ClinVar=VCV000375964; Zygosity=Heterozygous (Cosmic-CLP=1303911; DepMap=ACH-002208).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (Cosmic-CLP=1303911; DepMap=ACH-002208).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.06%; Native American=0%; East Asian, North=0%; East Asian, South=0%; South Asian=1.29%; European, North=66.59%; European, South=32.06% (PubMed=30894373).
CC   Discontinued: RCB; RCB1964; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): Cosmic-CLP=1303911; JCRB=JCRB0825; TKG=TKG 0440
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2814 ! YMB-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 36
//
ID   YMB-A
AC   CVCL_0586
DR   MCCL; MCC:0000492
DR   cancercelllines; CVCL_0586
DR   Wikidata; Q54995448
RX   PubMed=11179484;
CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2814 ! YMB-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 18
//
ID   YMB-S
AC   CVCL_D103
DR   cancercelllines; CVCL_D103
DR   Wikidata; Q54995449
RX   PubMed=8144402;
RX   PubMed=11179484;
CC   Problematic cell line: Contaminated. Parent cell line (YMB-1) has been shown to be a ZR-75-1 derivative.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_2814 ! YMB-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   YME4
AC   CVCL_6C73
DR   Wikidata; Q54995450
RX   DOI=10.15114/tr.22.103;
CC   Transformant: NCBI_TaxID; 28282; Adenovirus 12 (Note=E1A).
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: Fischer 344; RS=RS_0000215.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4563 ! 3Y1-B clone 1
SX   Female
AG   Embryo
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 10-04-25; Version: 11
//
ID   YMMK-1
AC   CVCL_WK55
DR   Wikidata; Q98136392
RX   PubMed=18575732;
CC   Population: Japanese.
DI   NCIt; C4872; Breast carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 4
//
ID   Ymnu
AC   CVCL_6F43
DR   Wikidata; Q54995451
RX   PubMed=7733619;
RX   PubMed=7847838;
CC   Transformant: ChEBI; CHEBI_50102; N-methyl-N-nitrosourea (NMU).
CC   Derived from site: In situ; Peritoneum; UBERON=UBERON_0002358.
CC   Cell type: Peritoneal macrophage; CL=CL_0000581.
CC   Breed/subspecies: NMRI.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   6-8W
CA   Transformed cell line
DT   Created: 23-02-16; Last updated: 19-12-24; Version: 8
//
ID   YMU
AC   CVCL_E895
DR   dbMHC; 49087
DR   IHW; IHW09356
DR   IPD-IMGT/HLA; 11592
DR   Wikidata; Q54995452
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*11:01:01; B*48,62; C*04; DRB1*04:07,15:01 (IPD-IMGT/HLA=11592).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   YN
AC   CVCL_Y579
DR   Wikidata; Q54995453
RX   CelloPub=CLPUB00569;
RX   PubMed=3541491;
RX   PubMed=23665679;
RX   PubMed=23882450;
CC   Population: Japanese.
CC   Doubling time: 36.2 hours (Note=At 8th passage), 21.6 hours (Note=At 47th passage) (PubMed=3541491).
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 8
//
ID   YN-1
AC   CVCL_8775
DR   BTO; BTO_0004624
DR   TKG; TKG 0695
DR   Wikidata; Q54995455
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=3476772;
RX   PubMed=7918028;
RX   PubMed=8558913;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: 20-24 hours (PubMed=7918028).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=7918028; PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0695
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,13
ST   D5S818: 9,10
ST   D7S820: 12
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   YN-1-0-A
AC   CVCL_F916
DR   TKG; TKG 0696
DR   Wikidata; Q54995456
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): TKG=TKG 0696
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 11,14
ST   D5S818: 9,10
ST   D7S820: 12
ST   TH01: 9.3,10
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_8775 ! YN-1
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   YN-4
AC   CVCL_5G86
DR   Wikidata; Q54995457
RX   PubMed=6467198;
RX   PubMed=7306960;
RX   PubMed=24259225;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Cell type: Epithelial cell of mammary gland; CL=CL_0002327.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 14-12-15; Last updated: 14-08-25; Version: 6
//
ID   YN1/1.7.4
AC   CVCL_8985
SY   YN1
DR   CLO; CLO_0009714
DR   ATCC; CRL-1878
DR   BCRC; 60411
DR   ECACC; 90110706
DR   Wikidata; Q54995458
RX   PubMed=2981916;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13597; Mouse Icam1/Cd54.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 10
//
ID   YNH
AC   CVCL_XZ94
DR   KCB; KCB 94015
DR   Wikidata; Q98136394
RX   PubMed=14984103;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9796; ! Equus caballus (Horse)
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 5
//
ID   YNH-1
AC   CVCL_1927
DR   BioSample; SAMN03473442
DR   cancercelllines; CVCL_1927
DR   Cosmic; 787488
DR   Cosmic; 975314
DR   Cosmic; 996309
DR   Cosmic; 998745
DR   Cosmic; 1037657
DR   Cosmic; 1106592
DR   Cosmic; 1281364
DR   Cosmic; 1295724
DR   Cosmic; 2089649
DR   DSMZ; ACC-692
DR   DSMZCellDive; ACC-692
DR   RCB; RCB1291
DR   Wikidata; Q54995460
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9096702;
RX   PubMed=10354136;
RX   PubMed=10637496;
RX   PubMed=14504097;
RX   PubMed=16518851;
RX   PubMed=23955599;
CC   Population: Japanese.
CC   Doubling time: 82 hours (PubMed=9096702); ~80 hours (DSMZ=ACC-692).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3446; ERG + HGNC; HGNC:4010; FUS; Name(s)=FUS-ERG, TLS-ERG (PubMed=9096702; PubMed=10354136).
CC   Sequence variation: Mutation; HGNC; HGNC:9644; PTPN11; Simple; p.Glu76Gly (c.227A>G); ClinVar=VCV000013338; Zygosity=Unspecified (PubMed=16518851).
CC   Discontinued: RCB; RCB1291; true.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): DSMZ=ACC-692; Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D10S1248: 12,13
ST   D12S391: 17,20
ST   D13S317: 8,13
ST   D16S539: 9
ST   D18S51: 14,15
ST   D19S433: 14
ST   D1S1656: 17
ST   D21S11: 29,30
ST   D22S1045: 15,16
ST   D2S1338: 20,25
ST   D2S441: 9.1,11
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 11,13
ST   D8S1179: 12,13 (Technion Genomics Center)
ST   D8S1179: 13 (DSMZ=ACC-692)
ST   DYS391: 11
ST   FGA: 19,20
ST   Penta D: 11,12
ST   Penta E: 5,11
ST   TH01: 6,9
ST   TPOX: 11,12
ST   vWA: 14,16
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   46Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 27
//
ID   YNK
AC   CVCL_R990
SY   Yamame Normal Kidney
DR   Wikidata; Q54995461
RX   CelloPub=CLPUB00103;
RX   DOI=10.2331/suisan.44.415;
RX   DOI=10.3147/jsfp.28.27;
RX   DOI=10.3147/jsfp.30.23;
RX   DOI=10.3354/dao001209;
CC   Group: Fish cell line.
CC   Characteristics: Grows at temperatures ranging from 4 to 29 Celsius (DOI=10.2331/suisan.44.415).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8020; ! Oncorhynchus masou (Cherry salmon)
SX   Sex unspecified
AG   1Y
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 10-04-25; Version: 12
//
ID   YO-K
AC   CVCL_6F98
DR   Wikidata; Q54995462
RX   PubMed=15325525;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8255; ! Paralichthys olivaceus (Bastard halibut)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 05-10-23; Version: 8
//
ID   YOCK-13
AC   CVCL_B6ER
DR   Wikidata; Q112041944
RX   PubMed=14693704;
CC   Characteristics: Expresses an insulin variant which is a single-chain modified insulin which is made of the signal sequence of albumin, the A chain followed by short turn-forming heptapeptide (GGGPGKR) and the B chain. This construct does not require pancreas-specific enzymatic processing (PubMed=14693704).
CC   Characteristics: Reversibly immortalized; exposure to tamoxifen induces the expression of the Cre gene that effects Cre/LoxP recombination and excise the TERT gene.
CC   Characteristics: Transduced with three constructs: 1) a retroviral vector SSR#197 (MoMLV/LTR-LoxP-hTERT-IRES-EGFP-LoxP-MoMLV/LTR) expressing hTERT and eGFP flanked by a pair of loxP sites, 2) a plasmid pCAGMerCreMer/Puro that expresses Cre fused to 2 mutant estrogen-receptor ligand-binding domains (MerCreMer) under the control of the CAG promoter and 3) a plasmid vector expressing modified insulin and zeocin resistance genes under the control of the rat L-PK promoter.
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:6081; INS (Note=Engineered variant).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P06956; Escherichia phage P1 cre.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Hepatocyte; CL=CL_0000182.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6EQ ! TTNT-16-3
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   YOL1/34
AC   CVCL_J782
DR   ECACC; 85102247
DR   Wikidata; Q54995464
RX   PubMed=6811596;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P09733; Saccharomyces cerevisiae TUB1 (Note=Also reacts with alpha-tubulins from many species including human, mouse, rat and amoeba).
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_8984 ! YB2/0
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 5
//
ID   Yoruba68IPSC4
AC   CVCL_9999
SY   TFDF1iPSC10
DR   Wikidata; Q54995465
RX   PubMed=20038950;
CC   From: The Scripps Research Institute; La Jolla; USA.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 06-06-12; Last updated: 10-09-24; Version: 9
//
ID   YOS-B
AC   CVCL_H193
DR   Wikidata; Q54995466
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1486031;
RX   PubMed=10071072;
CC   Population: Japanese.
CC   Doubling time: 48 hours (PubMed=1486031).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=1486031; PubMed=10071072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H194 ! YOS-M
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   YOS-M
AC   CVCL_H194
DR   Cosmic; 787509
DR   Wikidata; Q54995467
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1486031;
RX   PubMed=10071072;
RX   PubMed=10576511;
CC   Population: Japanese.
CC   Doubling time: 5-6 days (PubMed=1486031).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (PubMed=1486031; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_H193 ! YOS-B
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 19-12-24; Version: 14
//
ID   Yoshida sarcoma
AC   CVCL_4U54
SY   YS; YOSHIDA; Yoshida ascites sarcoma cell; Ascites sarcoma of Nagasaki strain
DR   BTO; BTO_0001213
DR   NCI-DTP; Yoshida Sarcoma
DR   TKG; TKG 0088
DR   Wikidata; Q54995468
RX   DOI=10.20772/cancersci1907.40.1_1;
RX   PubMed=12979052;
RX   PubMed=14906546;
CC   Miscellaneous: This is not a cell line but a xenograft, it is the parent tumor for many cell lines.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 9
//
ID   Yoshizaki
AC   CVCL_W836
DR   Cosmic; 945373
DR   Wikidata; Q54995469
RX   PubMed=8980248;
CC   Population: Japanese.
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 14-08-25; Version: 6
//
ID   YOU
AC   CVCL_N819
DR   Cosmic; 1656047
DR   Wikidata; Q54995470
RX   PubMed=15274292;
RX   PubMed=22426987;
CC   Derived from site: In situ; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C9350; Peritoneal malignant mesothelioma
DI   ORDO; Orphanet_168811; Malignant peritoneal mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   YP-MEL
AC   CVCL_L217
DR   Wikidata; Q54995472
RX   PubMed=7520166;
RX   PubMed=9290701;
CC   Population: Japanese.
CC   Doubling time: 41 hours (PubMed=7520166).
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   4Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 8
//
ID   YP1067.1.2E12
AC   CVCL_E9TP
DR   DSHB; Anti-AIF1-YP1067.1.2E12
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; P55008; Human AIF1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YP1067.1.4C2
AC   CVCL_E9TQ
DR   DSHB; Anti-AIF1-YP1067.1.4C2
CC   Part of: BRAIN Initiative Cell Census Network (BICCN) hybridoma collection.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P55008; Human AIF1 (Note=Also reacts with mouse).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ypan1
AC   CVCL_ZX67
SY   Ypan-1
DR   Wikidata; Q102115148
RX   PubMed=2454732;
RX   PubMed=4063969;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Human mucin-like antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   Ypan2
AC   CVCL_ZX68
DR   Wikidata; Q102115149
RX   PubMed=4063969;
CC   Monoclonal antibody isotype: IgM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 29-10-20; Last updated: 21-03-23; Version: 3
//
ID   YPBE-1
AC   CVCL_0J55
DR   Wikidata; Q54995473
RX   PubMed=8839795;
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   YPEN-1
AC   CVCL_0587
SY   YPEN1
DR   CLO; CLO_0009716
DR   MCCL; MCC:0000493
DR   ATCC; CRL-2222
DR   Wikidata; Q54995474
RX   PubMed=8900918;
CC   Doubling time: 26 hours (PubMed=8900918).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 14
//
ID   YPEN-2
AC   CVCL_0J52
DR   Wikidata; Q54995475
RX   PubMed=8900918;
CC   Doubling time: 21 hours (PubMed=8900918).
CC   Transformant: Ad12-SV40 hybrid virus.
CC   Derived from site: In situ; Prostate; UBERON=UBERON_0002367.
CC   Cell type: Endothelial cell; CL=CL_0000115.
CC   Breed/subspecies: Copenhagen; RS=RS_0000184.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Male
AG   8W
CA   Transformed cell line
DT   Created: 10-04-15; Last updated: 10-04-25; Version: 10
//
ID   YPF-5
AC   CVCL_KR28
SY   YPF5; Yellow Perch Fin-5
DR   Wikidata; Q54995477
RX   CelloPub=CLPUB00402;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Misspelling: YFP5; PubMed=33053677; Note=In table 1.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=8167; ! Perca flavescens (American yellow perch)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 9
//
ID   YPK-1
AC   CVCL_CZ89
DR   Wikidata; Q54995478
RX   CelloPub=CLPUB00333;
RX   PubMed=17089051;
RX   PubMed=18575732;
CC   Population: Japanese.
CC   Doubling time: 49.3 hours (CelloPub=CLPUB00333).
CC   HLA typing: A*02,24; B*01,46; C*03 (PubMed=18575732).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 9
//
ID   YPK-2
AC   CVCL_WK52
DR   Wikidata; Q98136397
RX   PubMed=18575732;
CC   Population: Japanese.
CC   HLA typing: A*02,24; B*03,39; C*12 (PubMed=18575732).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   YPK-3
AC   CVCL_WK53
DR   Wikidata; Q98136400
RX   PubMed=18575732;
CC   Population: Japanese.
CC   HLA typing: A*01,02; B*13,48; C*03,08 (PubMed=18575732).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   YPK-4
AC   CVCL_WK54
DR   Wikidata; Q98136402
RX   PubMed=18575732;
CC   Population: Japanese.
CC   HLA typing: A*10,26; B*40; C*03 (PubMed=18575732).
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 4
//
ID   YR-2
AC   CVCL_C7SJ
DR   Wikidata; Q123033960
RX   DOI=10.14930/jsma1939.53.537;
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   From: Yamaguchi, Akira; Department of Oral Pathology, Showa University School of Dentistry; Showa; Japan.
CC   Population: Japanese.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 5
//
ID   YR-6
AC   CVCL_C7SK
DR   Wikidata; Q123033961
WW   Info; KAKEN; 01870076; https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-01870076/
CC   Population: Japanese.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 10-04-25; Version: 4
//
ID   YR-A
AC   CVCL_0C32
DR   Cosmic; 2239094
DR   Wikidata; Q54995479
RX   PubMed=9559344;
RX   PubMed=9815546;
CC   Derived from site: Metastatic; Hypodermis; UBERON=UBERON_0002072.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 9
//
ID   YROS-1
AC   CVCL_W630
DR   Wikidata; Q54995481
RX   PubMed=7479367;
CC   Doubling time: 23 hours (PubMed=7479367).
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone, femur; UBERON=UBERON_0000981.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   YROS-2
AC   CVCL_W631
DR   Wikidata; Q54995482
RX   PubMed=7479367;
CC   Doubling time: 39 hours (PubMed=7479367).
CC   Transformant: NCIt; C176700; Phosphorus-32 beta radiation.
CC   Derived from site: In situ; Bone, humerus; UBERON=UBERON_0000976.
CC   Breed/subspecies: Wistar; RS=RS_0000955.
DI   NCIt; C60487; Rat osteosarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 10-04-25; Version: 8
//
ID   YS-1
AC   CVCL_VN81
DR   JCRB; JCRB1522
DR   Wikidata; Q98136405
CC   Characteristics: Tumor infiltrating fibroblasts.
CC   Senescence: Senesces at ~45 PDL (JCRB=JCRB1522).
CC   Doubling time: ~30 hours (Note=Lot 05142019) (JCRB=JCRB1522).
CC   Derived from site: In situ; Stomach; UBERON=UBERON_0000945.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): JCRB=JCRB1522
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 16,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Finite cell line
DT   Created: 07-09-18; Last updated: 02-05-24; Version: 7
//
ID   YS-5Fu-R-TC
AC   CVCL_4U62
SY   YS-5Fu-R
DR   TKG; TKG 0094
DR   TKG; TKG 0655
DR   Wikidata; Q54995483
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   YS-6MP-R-TC
AC   CVCL_4U55
SY   YS-6MP-R
DR   TKG; TKG 0098
DR   TKG; TKG 0656
DR   Wikidata; Q54995501
CC   Selected for resistance to: ChEBI; CHEBI_50667; Mercaptopurine (6-MP).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   YS-DM-R-TC
AC   CVCL_4U56
SY   YS-DM-R
DR   TKG; TKG 0092
DR   TKG; TKG 0657
DR   Wikidata; Q54995502
CC   Selected for resistance to: ChEBI; CHEBI_41977; Daunorubicin (Daunomycin).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   YS-EX-R-TC
AC   CVCL_4U57
SY   YS-EX-R
DR   TKG; TKG 0093
DR   TKG; TKG 0658
DR   Wikidata; Q54995504
CC   Selected for resistance to: ChEBI; CHEBI_4027; Cyclophosphamide (CP; Endoxan).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   YS-G-TC
AC   CVCL_4U58
SY   YS-G
DR   TKG; TKG 0089
DR   TKG; TKG 0688
DR   Wikidata; Q54995505
CC   Selected for resistance to: ChEBI; CHEBI_82354; Nitrogen mustard N-oxide.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   YS-MC-R-TC
AC   CVCL_4U59
SY   YS-MC-R
DR   TKG; TKG 0096
DR   TKG; TKG 0659
DR   Wikidata; Q54995506
CC   Selected for resistance to: ChEBI; CHEBI_27504; Mitomycin C (MMC; MitC).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 8
//
ID   YS-PPB
AC   CVCL_5436
SY   Yolk Sac-Pre-Pro B cells
DR   Wikidata; Q54995508
RX   PubMed=9686589;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=YS-PPB
CC   Derived from site: In situ; Yolk sac; UBERON=UBERON_0001040.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 11
//
ID   YS-TC
AC   CVCL_G359
SY   Yoshida Sarcoma-Tissue Culture
DR   ChEMBL-Cells; CHEMBL3308014
DR   ChEMBL-Targets; CHEMBL612816
DR   PubChem_Cell_line; CVCL_G359
DR   TKG; TKG 0654
DR   Wikidata; Q54995509
RX   PubMed=7829394;
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 8
//
ID   YS-TM-R-TC
AC   CVCL_4U60
SY   YS-TM-R
DR   TKG; TKG 0100
DR   TKG; TKG 0660
DR   Wikidata; Q54995511
CC   Selected for resistance to: ChEBI; CHEBI_34638; Chromomycin A3.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C60505; Rat sarcoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4U54 ! Yoshida sarcoma
CA   Cancer cell line
DT   Created: 22-09-15; Last updated: 19-12-24; Version: 7
//
ID   Ys.T9.1
AC   CVCL_F0G5
SY   Yst9.1
DR   ABCD; ABCD_AW320
RX   PubMed=2474505;
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG2b, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_59342; Brucella sp. O-PS A-antigen (Note=Also reacts with the Yersinia enterocolitica O:9 antigen used for immunization).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ys.T9.2
AC   CVCL_F0G6
SY   Yst9.2
DR   ABCD; ABCD_BF026
RX   PubMed=2474505;
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3, kappa.
CC   Monoclonal antibody target: ChEBI; CHEBI_137206; Brucella O-antigen (Note=Reacts with both Brucella sp. O-PS A and M-antigens. Also reacts with the Yersinia enterocolitica O:9 antigen used for immunization).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ys.T9.3
AC   CVCL_F0G7
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Yersinia enterocolitica O:9 LPS (Note=Also reacts with Brucela abortus LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ys.T9.4
AC   CVCL_F0G8
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Yersinia enterocolitica O:9 LPS (Note=Also reacts with Brucela abortus LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ys.T9.5
AC   CVCL_F0G9
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Yersinia enterocolitica O:9 LPS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ys.T9.6
AC   CVCL_F0GA
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG3.
CC   Monoclonal antibody target: Yersinia enterocolitica O:9 LPS.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   Ys.T9.7
AC   CVCL_F0GB
RX   PubMed=6437982;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Yersinia enterocolitica O:9 LPS (Note=Also reacts with Brucela abortus LPS).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YS001
AC   CVCL_6474
DR   CLO; CLO_0009717
DR   ATCC; CRL-11776
DR   Wikidata; Q54995512
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-11776.
CC   Discontinued: ATCC; CRL-11776; true.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 10
//
ID   YS08
AC   CVCL_4J68
DR   Wikidata; Q54995514
RX   Patent=US7476540;
RX   PubMed=15857173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00123.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human mesenchymal stem cells membrane protein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   YS14
AC   CVCL_4J69
DR   Wikidata; Q54995515
RX   Patent=US7476540;
RX   PubMed=15857173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00124.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human mesenchymal stem cells membrane protein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   YS18
AC   CVCL_4J70
DR   Wikidata; Q54995516
RX   Patent=US7476540;
RX   PubMed=15857173;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00125.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human mesenchymal stem cells membrane protein antigen.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-09-15; Last updated: 21-03-23; Version: 6
//
ID   YS2
AC   CVCL_LC45
DR   JCRB; JCRB1727
DR   Wikidata; Q54995517
RX   PubMed=3391611;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.1845+2T>C; ClinVar=VCV000252070; Zygosity=Homozygous; Note=Splice donor mutation (JCRB=JCRB1727).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1727
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 9
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 10,12
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Finite cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   YS9;22
AC   CVCL_A743
SY   YS9:22; YS9-22; YS 9:22
DR   CGH-DB; 9220-4
DR   Cosmic; 1012129
DR   Wikidata; Q54995518
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7808006;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=10739008;
RX   PubMed=11226526;
RX   PubMed=16408098;
CC   Population: Japanese.
CC   Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (PubMed=7808006; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   23Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 17
//
ID   YSCCC
AC   CVCL_3629
SY   CCC
DR   CLO; CLO_0050859
DR   BioSample; SAMN03472100
DR   Cell_Model_Passport; SIDM01824
DR   DepMap; ACH-001864
DR   RCB; RCB1549
DR   Wikidata; Q54995519
RX   PubMed=21451941;
RX   PubMed=21687941;
RX   PubMed=27231123;
RX   PubMed=31077409;
RX   PubMed=35640676;
RX   PubMed=39026794;
CC   Part of: Biliary tract cancer cell line atlas.
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Japanese.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): DepMap=ACH-001864; RCB=RCB1549
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 12
ST   D16S539: 10,11
ST   D18S51: 14
ST   D21S11: 30
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D7S820: 10,11
ST   D8S1179: 13,16
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 5,18
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   YSCCC-G10
AC   CVCL_QZ46
DR   Cell_Model_Passport; SIDM01928
DR   Wikidata; Q54995520
RX   PubMed=21451941;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3629 ! YSCCC
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   YSCCC-G100
AC   CVCL_QZ47
DR   Cell_Model_Passport; SIDM01929
DR   Wikidata; Q54995522
RX   PubMed=21451941;
CC   Population: Japanese.
CC   Selected for resistance to: ChEBI; CHEBI_175901; Gemcitabine (Gemzar).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_3629 ! YSCCC
SX   Female
AG   70Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
ID   YSCF
AC   CVCL_A2EW
SY   Yangtze Sturgeon Caudal Fin
DR   Wikidata; Q105511838
RX   PubMed=32888116;
CC   Group: Endangered species/breed cell line.
CC   Group: Fish cell line.
CC   Derived from site: In situ; Caudal fin; UBERON=UBERON_4000164.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=62061; ! Acipenser dabryanus (Yangtze sturgeon)
SX   Sex unspecified
AG   Juvenile
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 6
//
ID   YSCHi001-A
AC   CVCL_D0QC
SY   2AMJH
DR   BioSamples; SAMEA113447775
DR   hPSCreg; YSCHi001-A
DR   Wikidata; Q123033962
CC   From: Severance Children's Hospital; Seoul; South Korea.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YSCHi002-A
AC   CVCL_D0QD
SY   2ABWS
DR   BioSamples; SAMEA113484744
DR   hPSCreg; YSCHi002-A
DR   Wikidata; Q123033963
CC   From: Severance Children's Hospital; Seoul; South Korea.
DI   NCIt; C3020; Seizure disorder
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YSCHi003-A
AC   CVCL_D0QE
SY   8AKSW
DR   BioSamples; SAMEA113484986
DR   hPSCreg; YSCHi003-A
DR   Wikidata; Q123033964
CC   From: Severance Children's Hospital; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YSCHi004-A
AC   CVCL_D0QF
DR   BioSamples; SAMEA113485190
DR   hPSCreg; YSCHi004-A
DR   Wikidata; Q123033965
CC   From: Severance Children's Hospital; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   YSK
AC   CVCL_6745
DR   JCRB; JCRB0619
DR   Wikidata; Q54995523
CC   Discontinued: JCRB; JCRB0619; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   Age unspecified
CA   Undefined cell line type
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 9
//
ID   YSK-21
AC   CVCL_E942
DR   IARC_TP53; 16155
DR   Wikidata; Q54995525
RX   PubMed=11550287;
CC   Population: Japanese.
CC   Doubling time: ~48 hours (PubMed=11550287).
CC   Sequence variation: Gene deletion; HGNC; HGNC:12003; TP73; Zygosity=Heterozygous (PubMed=11550287).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asn288Tyr (c.862A>T); Zygosity=Hemizygous (PubMed=11550287).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48-49Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 14
//
ID   YSS37
AC   CVCL_RY61
DR   JCRB; JCRB1730
DR   Wikidata; Q54995526
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; c.1845+2T>C; ClinVar=VCV000252070; Zygosity=Heterozygous; Note=Splice donor mutation (JCRB=JCRB1730).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): JCRB=JCRB1730
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,12
ST   D16S539: 11
ST   D5S818: 9,13
ST   D7S820: 10,13
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 14,18
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Adult
CA   Finite cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   YST-1
AC   CVCL_5192
DR   CLO; CLO_0050136
DR   BioSample; SAMN03472012
DR   RCB; RCB2136
DR   TKG; TKG 0454
DR   Wikidata; Q54995528
RX   PubMed=1980563;
RX   PubMed=9290701;
RX   PubMed=16510576;
RX   PubMed=28556483;
CC   Population: Japanese.
CC   Doubling time: ~40 hours (PubMed=1980563).
CC   Derived from site: In situ; Arm, hypodermis; UBERON=UBERON_0001460+UBERON_0002072.
CC   Cell type: Schwann cell; CL=CL_0002573.
ST   Source(s): PubMed=28556483; RCB=RCB2136; TKG=TKG 0454
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,12
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29,31
ST   D2S1338: 18,19
ST   D3S1358: 16,18
ST   D5S818: 10,11
ST   D7S820: 9,10
ST   D8S1179: 10,15
ST   FGA: 19,24
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C3269; Schwannoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
ID   YSWS-SF
AC   CVCL_IJ28
SY   Yunnan Semi-fine Wool Sheep-Skin Fibroblast
DR   Wikidata; Q54995529
RX   PubMed=24448770;
CC   Doubling time: 26 hours (PubMed=24448770).
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the cell line description.
CC   Derived from site: In situ; Ear, skin; UBERON=UBERON_0001459.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
CC   Breed/subspecies: Yunnan semi-fine wool; VBO=VBO_0017520.
OX   NCBI_TaxID=9940; ! Ovis aries (Sheep)
SX   Male
AG   Age unspecified
CA   Finite cell line
DT   Created: 01-12-16; Last updated: 10-09-24; Version: 9
//
ID   YT
AC   CVCL_1797
SY   YT-0
DR   BTO; BTO_0005228
DR   CLO; CLO_0009718
DR   EFO; EFO_0022423
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-MTAB-7721
DR   ArrayExpress; E-MTAB-7722
DR   BioSample; SAMN03473541
DR   Cell_Model_Passport; SIDM00410
DR   ChEMBL-Cells; CHEMBL3308146
DR   ChEMBL-Targets; CHEMBL2366114
DR   Cosmic; 850219
DR   Cosmic; 946358
DR   Cosmic; 991546
DR   Cosmic; 1012130
DR   Cosmic; 1524828
DR   Cosmic; 1542072
DR   Cosmic; 2390120
DR   Cosmic; 2785211
DR   Cosmic-CLP; 946358
DR   DepMap; ACH-002317
DR   DSMZ; ACC-434
DR   DSMZCellDive; ACC-434
DR   EGA; EGAS00001000978
DR   GDSC; 946358
DR   GEO; GSM236811
DR   GEO; GSM236847
DR   GEO; GSM472010
DR   GEO; GSM1670588
DR   IARC_TP53; 27711
DR   LINCS_LDP; LCL-1913
DR   PharmacoDB; YT_1688_2019
DR   PRIDE; PXD030304
DR   PubChem_Cell_line; CVCL_1797
DR   Wikidata; Q54995532
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=1313126;
RX   PubMed=2578514;
RX   PubMed=3098894;
RX   PubMed=9787181;
RX   PubMed=10803505;
RX   PubMed=16408098;
RX   PubMed=16827800;
RX   PubMed=19194464;
RX   PubMed=20164919;
RX   PubMed=20454443;
RX   PubMed=21052088;
RX   PubMed=25586472;
RX   PubMed=27397505;
RX   PubMed=30894373;
RX   PubMed=31160637;
RX   PubMed=35839778;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=YT
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: LL-100 blood cancer cell line panel.
CC   Population: Japanese.
CC   Doubling time: ~40-50 hours (DSMZ=ACC-434).
CC   HLA typing: A*26:01:01,31:01:02; B*48:01:01,48:01:01; C*01:02:01,08:01:01; DPA1*01:03:01,01:03:01; DPB1*02:01:02,02:01:02; DQA1*01:02:01,01:04:01; DQB1*05:03:01,06:02:01; DRA*01:01:01,01:01:01; DRB1*14:54:01,15:01:01 (DSMZCellDive=ACC-434).
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0.12%; Native American=0.69%; East Asian, North=74.01%; East Asian, South=25.17%; South Asian=0%; European, North=0%; European, South=0% (PubMed=30894373).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
ST   Source(s): Cosmic-CLP=946358; DSMZ=ACC-434
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,11
ST   D16S539: 10,12
ST   D18S51: 14,16
ST   D19S433: 14,15
ST   D21S11: 30,32
ST   D2S1338: 19,20
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 11,12
ST   D8S1179: 13,16
ST   FGA: 22,23
ST   Penta D: 10,11
ST   Penta E: 15
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 17,18,20 (DSMZ=ACC-434)
ST   vWA: 17,20 (Cosmic-CLP=946358)
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 37
//
ID   YT clone 2C2
AC   CVCL_A1JN
SY   YT2C2
DR   Wikidata; Q102115151
RX   PubMed=1313126;
RX   PubMed=3098894;
RX   PubMed=8217217;
RX   PubMed=9573023;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1797 ! YT
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 5
//
ID   YT-1
AC   CVCL_EJ05
SY   YT1
DR   Cosmic; 2024371
DR   Wikidata; Q54995533
RX   PubMed=7911075;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1797 ! YT
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 29-06-23; Version: 8
//
ID   YT-nu
AC   CVCL_H524
SY   YT-NU
DR   ChEMBL-Cells; CHEMBL3307254
DR   ChEMBL-Targets; CHEMBL612817
DR   PubChem_Cell_line; CVCL_H524
DR   Wikidata; Q54995534
RX   PubMed=201151;
RX   PubMed=1240807;
CC   Population: Japanese.
CC   Characteristics: Established from tissue heterotransplanted into nude mice.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Children
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   YT1
AC   CVCL_T024
SY   YT1-hES
DR   Wikidata; Q54995535
RX   PubMed=22287285;
CC   From: Shandong Research Center of Stem Cell Engineering; Yantai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   YT2
AC   CVCL_T025
SY   YT2-hES
DR   Wikidata; Q54995536
RX   PubMed=22287285;
CC   From: Shandong Research Center of Stem Cell Engineering; Yantai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   YT3
AC   CVCL_T026
SY   YT3-hES
DR   Wikidata; Q54995537
RX   PubMed=22287285;
CC   From: Shandong Research Center of Stem Cell Engineering; Yantai; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 7
//
ID   YT803
AC   CVCL_WK74
SY   YT-803
DR   Wikidata; Q98136408
RX   PubMed=9023415;
CC   From: Nomoto, Kikuo; Kyushu University; Fukuoka; Japan.
CC   Population: Japanese.
CC   HLA typing: A*31:01,33:02; B*44:03:01,51:01; C*14:02,14:03 (PubMed=9023415).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 10-09-24; Version: 4
//
ID   YTA 3.1.2
AC   CVCL_J783
DR   ECACC; 89040603
DR   Wikidata; Q54995539
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTA 74.4.4
AC   CVCL_J784
DR   ECACC; 11060804
DR   Wikidata; Q54995540
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q62351; Mouse Tfrc/Cd71.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YTA1
AC   CVCL_B4IM
DR   Wikidata; Q110434436
RX   PubMed=2422659;
RX   PubMed=6206569;
CC   Characteristics: IL2 dependent.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4IL ! STH4
OI   CVCL_B4IN ! YTH3
OI   CVCL_B4IP ! YTH5
SX   Male
AG   29Y
CA   Finite cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   YTA1H
AC   CVCL_B4IQ
DR   Wikidata; Q110434437
RX   PubMed=2422659;
RX   PubMed=6206569;
CC   Characteristics: IL2 independent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B4IM ! YTA1
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   YTC3
AC   CVCL_A1JP
SY   YT-C3
DR   Wikidata; Q102115152
RX   PubMed=1313126;
RX   PubMed=2578514;
RX   PubMed=8217217;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1797 ! YT
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 29-06-23; Version: 6
//
ID   YTF
AC   CVCL_6F99
SY   Yellow Tail Fin
DR   Wikidata; Q54995541
RX   DOI=10.3147/jsfp.29.29;
RX   PubMed=34382581;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Fin; UBERON=UBERON_0008897.
OX   NCBI_TaxID=8161; ! Seriola quinqueradiata (Five-ray yellowtail)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 8
//
ID   YTH 24.5
AC   CVCL_A9LN
DR   Wikidata; Q108821548
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 30.15
AC   CVCL_J785
DR   ECACC; 11060807
DR   Wikidata; Q54995542
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTH 3.2.6
AC   CVCL_A7QP
SY   YTH 3.2
DR   Wikidata; Q107117560
RX   Patent=EP0536807A1;
RX   PubMed=2475570;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P09564; Human CD7.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 470.5
AC   CVCL_T981
DR   ECACC; 11072206
DR   Wikidata; Q54995543
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P61769; Human B2M.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   YTH 5.3
AC   CVCL_A9LP
DR   Wikidata; Q108821549
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 53.1
AC   CVCL_J786
SY   YTH53.1; YTH 53.1.4
DR   ECACC; 11060813
DR   Wikidata; Q54995545
RX   Patent=EP0536807A1;
RX   PubMed=2475570;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13987; Human CD59.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 7
//
ID   YTH 54.12
AC   CVCL_A9LQ
DR   Wikidata; Q108821550
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 65.3
AC   CVCL_A9LR
DR   Wikidata; Q108821551
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 66.9
AC   CVCL_A7QN
SY   YTH 66.9HL
DR   Wikidata; Q107117561
RX   PubMed=2475570;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: UniProtKB; P31358; Human CD52.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 68.2
AC   CVCL_A9LS
DR   Wikidata; Q108821552
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 71.3
AC   CVCL_T982
DR   ECACC; 11072205
DR   Wikidata; Q54995546
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 03-02-14; Last updated: 21-03-23; Version: 4
//
ID   YTH 72.1
AC   CVCL_A9LT
DR   Wikidata; Q108821553
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 75.6
AC   CVCL_A9LU
DR   Wikidata; Q108821554
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 76.3
AC   CVCL_J787
DR   ECACC; 11060815
DR   Wikidata; Q54995547
CC   Monoclonal antibody isotype: IgG2a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   YTH 79.6
AC   CVCL_A9LV
DR   Wikidata; Q108821555
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 80.103
AC   CVCL_J788
DR   ECACC; 11060811
DR   Wikidata; Q54995548
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTH 81.5
AC   CVCL_J789
DR   ECACC; 11072203
DR   Wikidata; Q54995549
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P20701; Human ITGAL/CD11a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YTH 86.10
AC   CVCL_A9LW
DR   Wikidata; Q108821556
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 862.2
AC   CVCL_J790
DR   ECACC; 11060817
DR   Wikidata; Q54995550
CC   Monoclonal antibody isotype: IgG2b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   YTH 89.1
AC   CVCL_J791
DR   ECACC; 11060814
DR   Wikidata; Q54995551
RX   PubMed=2475570;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P02724; Human GYPA/CD235a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YTH 891.1
AC   CVCL_A9LX
DR   Wikidata; Q108821557
RX   PubMed=2414870;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; P08575; Human PTPRC/CD45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   YTH 906.9HL
AC   CVCL_J792
DR   ABCD; ABCD_AA912
DR   ECACC; 11060809
DR   Wikidata; Q54995565
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01589; Human IL2RA/CD25.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YTH 913.12
AC   CVCL_J793
DR   ECACC; 11060810
DR   Wikidata; Q54995566
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10747; Human CD28.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTH3
AC   CVCL_B4IN
DR   Wikidata; Q110434438
RX   PubMed=6206569;
CC   Characteristics: IL2 independent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4IL ! STH4
OI   CVCL_B4IM ! YTA1
OI   CVCL_B4IP ! YTH5
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   YTH5
AC   CVCL_B4IP
DR   Wikidata; Q110434439
RX   PubMed=6206569;
CC   Characteristics: IL2 independent.
CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B4IL ! STH4
OI   CVCL_B4IM ! YTA1
OI   CVCL_B4IN ! YTH3
SX   Male
AG   29Y
CA   Transformed cell line
DT   Created: 16-12-21; Last updated: 29-06-23; Version: 4
//
ID   YTK
AC   CVCL_R991
SY   Yellow Tail Kidney
DR   Wikidata; Q54995569
RX   DOI=10.3147/jsfp.15.201;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=8161; ! Seriola quinqueradiata (Five-ray yellowtail)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   YTM
AC   CVCL_XZ83
DR   KCB; KCB 88022
DR   Wikidata; Q98136410
RX   PubMed=12067210;
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=74864; ! Martes flavigula (Yellow-throated marten)
SX   Female
CA   Finite cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 6
//
ID   YTMLC-90
AC   CVCL_6959
SY   YTMLC 90
DR   Wikidata; Q54995570
RX   PubMed=15207095;
CC   Population: Chinese.
CC   Misspelling: YTLMC-90; Note=Occasionally.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 11
//
ID   YTS
AC   CVCL_D324
DR   Wikidata; Q54995571
RX   PubMed=30054012;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1797 ! YT
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 15
//
ID   YTS 105.18.10
AC   CVCL_J794
DR   ABCD; ABCD_AD460
DR   ECACC; 11060802
DR   Wikidata; Q54995572
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTS 121.5.2
AC   CVCL_J795
DR   ECACC; 87072283
DR   Wikidata; Q54995573
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P13379; Mouse Cd5.
CC   Discontinued: ECACC; 87072283; true.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   YTS 154.7.7.10
AC   CVCL_J796
DR   ECACC; 87072285
DR   Wikidata; Q54995574
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01831; Mouse Thy1/Cd90.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YTS 156.7.7
AC   CVCL_J797
DR   ABCD; ABCD_AD462
DR   ECACC; 89040604
DR   Wikidata; Q54995575
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P10300; Mouse Cd8b.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTS 169.4.2.1
AC   CVCL_J798
DR   ECACC; 87072284
DR   Wikidata; Q54995576
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P01731; Mouse Cd8a.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTS 177.9.6.1
AC   CVCL_J799
DR   ECACC; 11060819
DR   Wikidata; Q54995578
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTS 191.1.1.2
AC   CVCL_J800
DR   ECACC; 87072282
DR   Wikidata; Q54995579
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06332; Mouse Cd4.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YTS 213.1.1
AC   CVCL_J801
DR   ECACC; 11060803
DR   Wikidata; Q54995581
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; P11835; Mouse Itgb2/Cd18.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 6
//
ID   YTS-1
AC   CVCL_6746
SY   YTS1
DR   BTO; BTO_0003554
DR   Wikidata; Q54995582
RX   PubMed=2733301;
RX   PubMed=3573461;
RX   PubMed=29732388;
CC   Population: Japanese.
CC   Doubling time: 20.2-22.5 hours (PubMed=3573461).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   YTS-Eco
AC   CVCL_EG36
SY   YTS/Eco; YTS/eco; YTS ECO; YTS eco; YTSeco
DR   EFO; EFO_0022593
DR   Wikidata; Q54995583
CC   Population: Japanese.
CC   Genetic integration: Method=Transfection/transduction; Gene=MGI; MGI:88117; Slc7a1.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
CC   Cell type: Natural killer cell; CL=CL_0000623.
DI   NCIt; C82217; Natural killer cell lymphoblastic leukemia/lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D324 ! YTS
SX   Male
AG   15Y
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-09-24; Version: 9
//
ID   Yu-1
AC   CVCL_UG16
DR   Wikidata; Q98136413
RX   PubMed=7689139;
CC   Characteristics: IL2 dependent.
CC   Virology: Susceptible to infection by feline immunodeficiency virus (FIV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9685; ! Felis catus (Cat)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 5
//
ID   YU-1070
AC   CVCL_C8U2
SY   Yonsei University-1070
DR   Wikidata; Q123033966
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Lys601Glu (c.1801A>G); ClinVar=VCV000013966; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1073
AC   CVCL_C8U3
SY   Yonsei University-1073
DR   Wikidata; Q123033967
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1074
AC   CVCL_C8U4
SY   Yonsei University-1074
DR   Wikidata; Q123033968
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asp770delinsGlyTyr (c.2308_2309insGTT) (p.Asp770_Asn771insGly) (c.2310_2311insGGT) (D770_N771insG); ClinVar=VCV000177658; Zygosity=Unspecified (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1075
AC   CVCL_C8U5
SY   Yonsei University-1075
DR   Wikidata; Q123033969
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1076
AC   CVCL_C8U6
SY   Yonsei University-1076
DR   Wikidata; Q123033970
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1077
AC   CVCL_C8TD
SY   YU1077; Yonsei University-1077
DR   ArrayExpress; E-MTAB-11342
DR   Wikidata; Q123033971
RX   PubMed=31882684;
RX   PubMed=35933914;
CC   Population: Korean.
CC   Doubling time: 20 +- 0.8 hours (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene deletion; HGNC; HGNC:1788; CDKN2B; Zygosity=Homozygous (PubMed=35933914).
CC   Sequence variation: Gene fusion; HGNC; HGNC:427; ALK + HGNC; HGNC:1316; EML4; Name(s)=EML4-ALK; Note=E6A20 v3 fusion (PubMed=31882684; PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:427; ALK; Simple; p.Gly1202Arg (c.3604G>A); ClinVar=VCV000376134; Zygosity=Heterozygous (PubMed=31882684; PubMed=35933914).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg273Cys (c.817C>T); ClinVar=VCV000043594; Zygosity=Homozygous (PubMed=35933914).
CC   Omics: Genomics; Whole genome sequencing.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1080
AC   CVCL_C8U7
SY   Yonsei University-1080
DR   Wikidata; Q123033972
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1081
AC   CVCL_C8U8
SY   Yonsei University-1081
DR   Wikidata; Q123033974
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:12012; TPM3; Name(s)=TPM3-ROS1 (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1082
AC   CVCL_C8U9
SY   Yonsei University-1082
DR   Wikidata; Q123033975
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1083
AC   CVCL_C8UA
SY   Yonsei University-1083
DR   Wikidata; Q123033976
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1085
AC   CVCL_C8UB
SY   Yonsei University-1085
DR   Wikidata; Q123033977
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Gene fusion; HGNC; HGNC:10261; ROS1 + HGNC; HGNC:11020; SLC34A2; Name(s)=SLC34A2-ROS1 (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1088
AC   CVCL_C8UC
SY   Yonsei University-1088
DR   Wikidata; Q123033978
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1089
AC   CVCL_C8UD
SY   Yonsei University-1089
DR   Wikidata; Q123033979
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1090
AC   CVCL_C8UE
SY   Yonsei University-1090
DR   Wikidata; Q123033980
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1091
AC   CVCL_C8UF
SY   Yonsei University-1091
DR   Wikidata; Q123033981
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1092
AC   CVCL_C8UG
SY   Yonsei University-1092
DR   Wikidata; Q123033982
RX   PubMed=31882684;
RX   PubMed=39874964;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu861Gln (c.2582T>A); ClinVar=VCV000163380; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1093
AC   CVCL_C8UH
SY   Yonsei University-1093
DR   Wikidata; Q123033983
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1094
AC   CVCL_C8UI
SY   Yonsei University-1094
DR   Wikidata; Q123033984
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1095
AC   CVCL_C8UJ
SY   Yonsei University-1095
DR   Wikidata; Q123033985
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1096
AC   CVCL_C8UK
SY   Yonsei University-1096
DR   Wikidata; Q123033986
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1097
AC   CVCL_C8UL
SY   Yonsei University-1097
DR   Wikidata; Q123033987
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Thr790Met (c.2369C>T); ClinVar=VCV000016613; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Cys797Ser (c.2389T>A); ClinVar=VCV000376342; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Unexplicit; Ex19del; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1099
AC   CVCL_C8UM
SY   Yonsei University-1099
DR   Wikidata; Q123033988
RX   PubMed=31882684;
RX   PubMed=39874964;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Gly719Cys (c.2155G>T); ClinVar=VCV000016611; Zygosity=Unspecified (PubMed=31882684).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Ser768Ile (c.2303G>T); ClinVar=VCV000045251; Zygosity=Unspecified (PubMed=31882684).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YU-1152
AC   CVCL_C8UN
SY   Yonsei University-1152
DR   Wikidata; Q123033989
RX   PubMed=31882684;
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Leu858Arg (c.2573T>G); ClinVar=VCV000016609; Zygosity=Unspecified (PubMed=31882684).
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 10-04-25; Version: 4
//
ID   YUAME
AC   CVCL_EI13
DR   cancercelllines; CVCL_EI13
DR   Wikidata; Q54995584
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YUAVEY
AC   CVCL_K001
DR   cancercelllines; CVCL_K001
DR   Wikidata; Q54995585
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   Yub 10F
AC   CVCL_3257
SY   Yub10F
DR   BioSample; SAMN03472454
DR   JCRB; JCRB1116
DR   JCRB; NIHS0420
DR   SKIP; SKIP000333
DR   Wikidata; Q54995587
CC   Senescence: Senesces at 20 PDL (JCRB=JCRB1116).
CC   Discontinued: JCRB; NIHS0420; true.
ST   Source(s): JCRB=JCRB1116
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 8,11
ST   D16S539: 10,13
ST   D5S818: 10
ST   D7S820: 10,11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 13,14
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Yub2498c
AC   CVCL_JG38
DR   JCRB; JCRB1693
DR   Wikidata; Q54995588
ST   Source(s): JCRB=JCRB1693
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y4M
CA   Somatic stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 5
//
ID   Yub2502c
AC   CVCL_JG39
DR   JCRB; JCRB1700
DR   Wikidata; Q54995589
ST   Source(s): JCRB=JCRB1700
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9
ST   D5S818: 10,12
ST   D7S820: 10
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y9M
CA   Somatic stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 5
//
ID   Yub2503c
AC   CVCL_JG41
DR   JCRB; JCRB1704
DR   Wikidata; Q54995590
ST   Source(s): JCRB=JCRB1704
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D5S818: 10,11
ST   D7S820: 11
ST   TH01: 7,9
ST   TPOX: 9,11
ST   vWA: 17
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   1Y6M
CA   Somatic stem cell
DT   Created: 15-05-17; Last updated: 02-05-24; Version: 5
//
ID   Yub2564a
AC   CVCL_B6R2
DR   JCRB; JCRB1859
DR   Wikidata; Q112041945
CC   Derived from site: In situ; Foot, adipose tissue; UBERON=UBERON_0002387+UBERON_0001013.
ST   Source(s): JCRB=JCRB1859
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17
DI   NCIt; C186308; Dactylomegaly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6R5 ! Yub2564c
SX   Female
AG   1Y3M
CA   Somatic stem cell
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 5
//
ID   Yub2564c
AC   CVCL_B6R5
DR   JCRB; JCRB1862
DR   Wikidata; Q112041946
CC   Derived from site: In situ; Foot, toe, cartilage; UBERON=UBERON_0010685.
ST   Source(s): JCRB=JCRB1862
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D13S317: 11,12
ST   D16S539: 9,10
ST   D5S818: 11
ST   D7S820: 10,13
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B6R2 ! Yub2564a
SX   Female
AG   1Y3M
CA   Somatic stem cell
DT   Created: 17-03-22; Last updated: 02-05-24; Version: 5
//
ID   Yub621b
AC   CVCL_3258
DR   BioSample; SAMN03472451
DR   JCRB; JCRB1112
DR   JCRB; NIHS0416
DR   SKIP; SKIP000329
DR   Wikidata; Q54995591
CC   Senescence: Senesces at 20 PDL (JCRB=JCRB1112).
CC   Discontinued: JCRB; NIHS0416; true.
ST   Source(s): JCRB=JCRB1112
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3259 ! Yub621BMC
OI   CVCL_3260 ! Yub621c
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Yub621BMC
AC   CVCL_3259
SY   Yub621_BMC
DR   JCRB; JCRB1113
DR   JCRB; NIHS0417
DR   SKIP; SKIP000330
DR   Wikidata; Q54995592
RX   PubMed=21155951;
CC   Senescence: Senesces at 20 PDL (JCRB=JCRB1113).
CC   Discontinued: JCRB; NIHS0417; true.
ST   Source(s): JCRB=JCRB1113
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3258 ! Yub621b
OI   CVCL_3260 ! Yub621c
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Yub621c
AC   CVCL_3260
DR   JCRB; JCRB1111
DR   JCRB; NIHS0415
DR   SKIP; SKIP000328
DR   Wikidata; Q54995594
CC   Senescence: Senesces at 20 PDL (JCRB=JCRB1111).
CC   Discontinued: JCRB; NIHS0415; true.
ST   Source(s): JCRB=JCRB1111
ST   Amelogenin: X
ST   CSF1PO: 10,14
ST   D13S317: 8,11
ST   D16S539: 11,12
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3258 ! Yub621b
OI   CVCL_3259 ! Yub621BMC
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Yub622
AC   CVCL_3261
DR   BioSample; SAMN03472452
DR   JCRB; JCRB1114
DR   JCRB; NIHS0418
DR   SKIP; SKIP000331
DR   Wikidata; Q54995595
CC   Discontinued: JCRB; NIHS0418; true.
ST   Source(s): JCRB=JCRB1114
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,13
ST   D16S539: 9,12
ST   D5S818: 11,13
ST   D7S820: 11
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Yub623
AC   CVCL_3262
DR   BioSample; SAMN03472453
DR   JCRB; JCRB1115
DR   JCRB; NIHS0419
DR   SKIP; SKIP000332
DR   Wikidata; Q54995597
CC   Senescence: Senesces at 20 PDL (JCRB=JCRB1115).
CC   Discontinued: JCRB; NIHS0419; true.
ST   Source(s): JCRB=JCRB1115
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 9,11
ST   D5S818: 11,13
ST   D7S820: 9.1,11
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 12
//
ID   Yub625
AC   CVCL_3263
DR   BioSample; SAMN03472468
DR   JCRB; JCRB1155
DR   JCRB; NIHS0461
DR   SKIP; SKIP000720
DR   Wikidata; Q54995599
CC   Discontinued: JCRB; NIHS0461; true.
ST   Source(s): JCRB=JCRB1155
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 12
ST   D16S539: 9,10
ST   D5S818: 12,13
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 14,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub631
AC   CVCL_3264
DR   BioSample; SAMN03472469
DR   JCRB; JCRB1156
DR   JCRB; NIHS0462
DR   SKIP; SKIP000721
DR   Wikidata; Q54995600
CC   Discontinued: JCRB; NIHS0462; true.
ST   Source(s): JCRB=JCRB1156
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 9
ST   D5S818: 12,13
ST   D7S820: 8,10
ST   TH01: 6
ST   TPOX: 8,12
ST   vWA: 14,17
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub632
AC   CVCL_3265
DR   BioSample; SAMN03472470
DR   JCRB; JCRB1157
DR   JCRB; NIHS0463
DR   SKIP; SKIP000722
DR   Wikidata; Q54995601
CC   Discontinued: JCRB; NIHS0463; true.
ST   Source(s): JCRB=JCRB1157
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,10
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 8,10
ST   TH01: 6,9
ST   TPOX: 7,8
ST   vWA: 18,19
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub633
AC   CVCL_3266
DR   BioSample; SAMN03472471
DR   JCRB; JCRB1158
DR   JCRB; NIHS0464
DR   SKIP; SKIP000723
DR   Wikidata; Q54995602
RX   PubMed=21155951;
CC   Discontinued: JCRB; NIHS0464; true.
ST   Source(s): JCRB=JCRB1158
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,9
ST   D16S539: 9,12
ST   D5S818: 11
ST   D7S820: 10,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Yub634
AC   CVCL_3267
DR   BioSample; SAMN03472473
DR   JCRB; JCRB1161
DR   JCRB; NIHS0465
DR   SKIP; SKIP000726
DR   Wikidata; Q54995604
RX   PubMed=21155951;
CC   Discontinued: JCRB; NIHS0465; true.
ST   Source(s): JCRB=JCRB1161
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D13S317: 8,12
ST   D16S539: 11,12
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Yub635
AC   CVCL_3268
DR   BioSample; SAMN03472474
DR   JCRB; JCRB1162
DR   JCRB; NIHS0473
DR   SKIP; SKIP000727
DR   Wikidata; Q54995606
RX   PubMed=21155951;
CC   Discontinued: JCRB; NIHS0473; true.
ST   Source(s): JCRB=JCRB1162
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 9,11
ST   D16S539: 9,11
ST   D5S818: 10,11
ST   D7S820: 8,9
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 16,19
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Yub636
AC   CVCL_3269
DR   BioSample; SAMN03472420
DR   JCRB; JCRB1169
DR   JCRB; NIHS0475
DR   SKIP; SKIP002921
DR   Wikidata; Q54995607
CC   Discontinued: JCRB; NIHS0475; true.
ST   Source(s): JCRB=JCRB1169
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,13
ST   D16S539: 9,10
ST   D5S818: 9,11
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub637b
AC   CVCL_3270
SY   Yub637B
DR   BioSample; SAMN03472475
DR   JCRB; JCRB1163
DR   JCRB; NIHS0474
DR   SKIP; SKIP000728
DR   Wikidata; Q54995608
RX   PubMed=21155951;
CC   Discontinued: JCRB; NIHS0474; true.
ST   Source(s): JCRB=JCRB1163
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3240 ! Yub637s
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   Yub637s
AC   CVCL_3240
DR   JCRB; JCRB1173
DR   JCRB; NIHS0476
DR   SKIP; SKIP000731
DR   Wikidata; Q54995609
CC   Discontinued: JCRB; NIHS0476; true.
ST   Source(s): JCRB=JCRB1173
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 8,12
ST   D16S539: 10
ST   D5S818: 10,11
ST   D7S820: 9,12
ST   TH01: 9
ST   TPOX: 9
ST   vWA: 16,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_3270 ! Yub637b
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub642
AC   CVCL_2954
DR   BioSample; SAMN03472421
DR   JCRB; JCRB1172
DR   JCRB; NIHS0477
DR   SKIP; SKIP000730
DR   Wikidata; Q54995610
CC   Discontinued: JCRB; NIHS0477; true.
ST   Source(s): JCRB=JCRB1172
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2824 ! Yub642b
OI   CVCL_2823 ! Yub642p
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub642b
AC   CVCL_2824
DR   JCRB; JCRB1174
DR   JCRB; NIHS0479
DR   SKIP; SKIP000732
DR   Wikidata; Q54995611
CC   Discontinued: JCRB; NIHS0479; true.
ST   Source(s): JCRB=JCRB1174
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2954 ! Yub642
OI   CVCL_2823 ! Yub642p
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 10
//
ID   Yub642p
AC   CVCL_2823
SY   Yub642P
DR   JCRB; JCRB1171
DR   JCRB; NIHS0478
DR   SKIP; SKIP000729
DR   Wikidata; Q54995612
RX   PubMed=21155951;
CC   Discontinued: JCRB; NIHS0478; true.
ST   Source(s): JCRB=JCRB1171
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,10
ST   D16S539: 9,10
ST   D5S818: 10,13
ST   D7S820: 8,11
ST   TH01: 6
ST   TPOX: 10,11
ST   vWA: 16,18
DI   NCIt; C87110; Polydactyly
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2954 ! Yub642
OI   CVCL_2824 ! Yub642b
SX   Male
CA   Somatic stem cell
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 11
//
ID   YUBEL
AC   CVCL_J515
DR   cancercelllines; CVCL_J515
DR   Cosmic; 1548846
DR   Wikidata; Q54995613
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   YubFKT1
AC   CVCL_YZ72
SY   YUBFKT1
DR   Wikidata; Q98136415
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=24131711;
RX   PubMed=26605499;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=187007; ! Miniopterus fuliginosus (Japanese long-fingered bat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   YubFKT2
AC   CVCL_YZ73
DR   Wikidata; Q98136419
RX   PubMed=30718752;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=187007; ! Miniopterus fuliginosus (Japanese long-fingered bat)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 5
//
ID   YUBRUSE
AC   CVCL_K002
DR   Wikidata; Q54995614
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   YUBUNE
AC   CVCL_J516
DR   cancercelllines; CVCL_J516
DR   Cosmic; 1548847
DR   Wikidata; Q54995628
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   YUCAL
AC   CVCL_J532
DR   cancercelllines; CVCL_J532
DR   Wikidata; Q54995629
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUCAS
AC   CVCL_J065
DR   Cosmic; 1548848
DR   Wikidata; Q54995632
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Ile679Aspfs*21 (c.2033dupC); ClinVar=VCV000141513; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   YUCHER
AC   CVCL_J517
DR   cancercelllines; CVCL_J517
DR   Cosmic; 1548849
DR   Wikidata; Q54995633
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YUCHIME
AC   CVCL_EI14
DR   cancercelllines; CVCL_EI14
DR   Wikidata; Q54995635
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys1714Asn (c.5142A>C); ClinVar=VCV000946790; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YUCHUFA
AC   CVCL_K003
DR   cancercelllines; CVCL_K003
DR   Wikidata; Q54995636
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YUCINJ
AC   CVCL_K004
DR   cancercelllines; CVCL_K004
DR   Wikidata; Q54995637
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUCLAT
AC   CVCL_J518
DR   cancercelllines; CVCL_J518
DR   Cosmic; 1548850
DR   Wikidata; Q54995638
RX   PubMed=21543894;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Ser2496Phe (c.7487C>T); ClinVar=VCV000947131; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   YUCLIR
AC   CVCL_J533
DR   Wikidata; Q54995639
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   YUCMi020-A
AC   CVCL_D6RE
DR   BioSamples; SAMEA115111573
DR   hPSCreg; YUCMi020-A
RX   PubMed=38703667;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: East Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:74; ABCG2; Simple; p.Gln126Ter (c.376C>T); ClinVar=VCV000030385; Zygosity=Homozygous; Note=Blood group JR(a-) (PubMed=38703667).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   YUCMi021-A
AC   CVCL_E5E9
DR   hPSCreg; YUCMi021-A
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   YUCMi022-A
AC   CVCL_E5EA
SY   hiPSC-KCNH2_G53S
DR   BioSamples; SAMEA115112794
DR   hPSCreg; YUCMi022-A
RX   PubMed=39454535;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Gly53Ser (c.157G>A); ClinVar=VCV000067214; Zygosity=Heterozygous (PubMed=39454535).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   YUCMi023-A
AC   CVCL_E5EB
DR   hPSCreg; YUCMi023-A
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   YUCMi024-A
AC   CVCL_E5EC
SY   hiPSC-KCNQ1_G245G_2
DR   BioSamples; SAMEA115789097
DR   hPSCreg; YUCMi024-A
RX   PubMed=39388802;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly245Glu (c.734G>A); Zygosity=Heterozygous (PubMed=39388802).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   YUCMi025-A
AC   CVCL_E5ED
SY   hiPSC-KCNQ1_G245G_1
DR   BioSamples; SAMEA115457758
DR   hPSCreg; YUCMi025-A
RX   PubMed=39388802;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Sequence variation: Mutation; HGNC; HGNC:6294; KCNQ1; Simple; p.Gly245Glu (c.734G>A); Zygosity=Heterozygous (PubMed=39388802).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85049; Long QT syndrome 1
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   YUCMi026-A
AC   CVCL_E5E8
DR   hPSCreg; YUCMi026-A
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
ID   YUCOT
AC   CVCL_J066
DR   cancercelllines; CVCL_J066
DR   Cosmic; 1548851
DR   Wikidata; Q54995640
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUCRENA
AC   CVCL_K005
DR   Wikidata; Q54995641
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   YUCYLO
AC   CVCL_EI15
DR   cancercelllines; CVCL_EI15
DR   Wikidata; Q54995642
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YUDAN3
AC   CVCL_J541
SY   YUDAN-3; YUDAN 3
DR   Cosmic; 1020271
DR   Wikidata; Q54995645
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 7
//
ID   YUDATE
AC   CVCL_K006
DR   Wikidata; Q54995646
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   81Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   YUDEDE
AC   CVCL_G322
DR   cancercelllines; CVCL_G322
DR   Wikidata; Q54995647
RX   PubMed=20149136;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pretibial, soft tissue; UBERON=UBERON_8480049+UBERON_0034929.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUDEW
AC   CVCL_J519
DR   cancercelllines; CVCL_J519
DR   Cosmic; 1548880
DR   Cosmic; 2439309
DR   Wikidata; Q54995649
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 15
//
ID   YUDOSO
AC   CVCL_G323
DR   cancercelllines; CVCL_G323
DR   Cosmic; 1548852
DR   Cosmic; 2439312
DR   Wikidata; Q54995650
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   84Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUDUTY
AC   CVCL_K007
DR   cancercelllines; CVCL_K007
DR   Wikidata; Q54995651
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   80Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUFIC
AC   CVCL_G324
DR   cancercelllines; CVCL_G324
DR   Cosmic; 1548853
DR   Cosmic; 2439314
DR   Wikidata; Q54995652
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUFULO
AC   CVCL_G325
DR   cancercelllines; CVCL_G325
DR   Wikidata; Q54995653
RX   PubMed=20149136;
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=20149136).
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   YUGAFFE
AC   CVCL_K008
DR   Wikidata; Q54995654
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   YUGANK
AC   CVCL_K009
DR   cancercelllines; CVCL_K009
DR   Wikidata; Q54995655
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUGASP
AC   CVCL_J520
DR   cancercelllines; CVCL_J520
DR   Cosmic; 1548854
DR   GEO; GSE69933
DR   Wikidata; Q54995657
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   88Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUGATOR
AC   CVCL_EI17
DR   cancercelllines; CVCL_EI17
DR   Cosmic; 2439318
DR   Wikidata; Q54995658
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YUGEK
AC   CVCL_J540
DR   Cosmic; 1548886
DR   Wikidata; Q54995660
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   YUGEN8
AC   CVCL_A744
SY   YUGEN-8; YUGEN 8
DR   cancercelllines; CVCL_A744
DR   Cosmic; 1197387
DR   Cosmic; 1548855
DR   Cosmic; 2439320
DR   Wikidata; Q54995662
RX   PubMed=9177196;
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   YUGLIDE
AC   CVCL_K010
DR   Wikidata; Q54995663
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   YUGOE
AC   CVCL_J067
DR   cancercelllines; CVCL_J067
DR   Cosmic; 1548856
DR   Wikidata; Q54995664
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gly12Val (c.35G>T); ClinVar=VCV000040470; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUHEF
AC   CVCL_G326
DR   Cosmic; 1548857
DR   Wikidata; Q54995665
RX   CelloPub=CLPUB00386;
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln853Ter (c.2557C>T); ClinVar=VCV001318665; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Lys2552Thrfs*2; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from the lung metastatic melanoma cells of Robert V. Heffernan (the 'HEF' in the cell name) who wrote about his successful fight against cancer in an autobiographical book (CelloPub=CLPUB00386).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   YUHEIK
AC   CVCL_J073
DR   Cosmic; 1548858
DR   Wikidata; Q54995666
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 11
//
ID   YUHOIN
AC   CVCL_J521
DR   Cosmic; 1548859
DR   DepMap; ACH-002847
DR   Wikidata; Q54995667
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUHUY
AC   CVCL_G327
DR   cancercelllines; CVCL_G327
DR   Cosmic; 1548860
DR   Wikidata; Q54995668
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20149136).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUKADI
AC   CVCL_K011
DR   cancercelllines; CVCL_K011
DR   Wikidata; Q54995670
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUKARN
AC   CVCL_K012
DR   Wikidata; Q54995671
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   YUKIM
AC   CVCL_G328
DR   cancercelllines; CVCL_G328
DR   Cosmic; 1548861
DR   Cosmic; 2439332
DR   Wikidata; Q54995672
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   71Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUKOLI
AC   CVCL_G329
DR   cancercelllines; CVCL_G329
DR   Cosmic; 1548862
DR   Wikidata; Q54995673
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   YUKSI
AC   CVCL_J068
DR   cancercelllines; CVCL_J068
DR   Cosmic; 1548863
DR   Cosmic; 2439333
DR   Wikidata; Q54995675
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUL-0019
AC   CVCL_C8TI
DR   Wikidata; Q123033990
RX   PubMed=29686424;
RX   PubMed=35820397;
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (PubMed=29686424).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR1
AC   CVCL_C8TJ
DR   Wikidata; Q123033991
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR2
AC   CVCL_C8TK
DR   Wikidata; Q123033992
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR3
AC   CVCL_C8TL
DR   Wikidata; Q123033993
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR4
AC   CVCL_C8TM
DR   Wikidata; Q123033994
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR5
AC   CVCL_C8TN
DR   Wikidata; Q123033996
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR6
AC   CVCL_C8TP
DR   Wikidata; Q123033997
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR7
AC   CVCL_C8TQ
DR   Wikidata; Q123033998
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YUL-PR8
AC   CVCL_C8TR
DR   Wikidata; Q123033999
RX   PubMed=35820397;
CC   Selected for resistance to: ChEBI; CHEBI_195559; Poziotinib (HMB781-36B).
CC   Sequence variation: Mutation; HGNC; HGNC:3236; EGFR; Simple; p.Asn771delinsPheHis (N771delinsFH); Zygosity=Unspecified (from parent cell line).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8TI ! YUL-0019
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   YULAC
AC   CVCL_B483
DR   cancercelllines; CVCL_B483
DR   Cosmic; 1197390
DR   Cosmic; 1548864
DR   Wikidata; Q54995676
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=20149136).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Neck, hypodermis; UBERON=UBERON_0000974+UBERON_0002072.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   YULAPE
AC   CVCL_K013
DR   cancercelllines; CVCL_K013
DR   Wikidata; Q54995677
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   75Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YULAXER
AC   CVCL_K014
DR   cancercelllines; CVCL_K014
DR   Wikidata; Q54995678
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YULIN
AC   CVCL_J522
DR   Cosmic; 1548879
DR   Wikidata; Q54995692
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   YULOCUS
AC   CVCL_EI19
DR   Cosmic; 2439338
DR   Wikidata; Q54995693
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ile (c.34_35GG>AT) (c.34_35delinsAT); Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Gln2239Ter (c.6715C>T); ClinVar=VCV000428972; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   92Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YULOMA
AC   CVCL_K015
DR   cancercelllines; CVCL_K015
DR   Wikidata; Q54995694
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   62Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YULONE
AC   CVCL_J523
DR   cancercelllines; CVCL_J523
DR   Cosmic; 1548865
DR   Cosmic; 2439339
DR   Wikidata; Q54995695
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   79Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 16
//
ID   YULOVY
AC   CVCL_G330
DR   cancercelllines; CVCL_G330
DR   Wikidata; Q54995696
RX   PubMed=20149136;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   83Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUMAC
AC   CVCL_A745
DR   cancercelllines; CVCL_A745
DR   Cosmic; 1197386
DR   Cosmic; 1548866
DR   Wikidata; Q54995698
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 10
ST   D16S539: 11
ST   D18S51: 16,17
ST   D21S11: 30
ST   D3S1358: 15
ST   D5S818: 12
ST   D7S820: 9
ST   D8S1179: 10,12
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 12
ST   vWA: 17,19
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   YUMAG
AC   CVCL_J534
DR   Wikidata; Q54995699
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   YUMC44
AC   CVCL_VG43
SY   Yamaguchi-Ube Medical Center 44
DR   Cosmic; 2758837
DR   Wikidata; Q54995700
RX   PubMed=26870271;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26870271).
CC   Sequence variation: Gene deletion; HGNC; HGNC:7773; NF2; Zygosity=Homozygous (PubMed=26870271).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   YUMC63
AC   CVCL_VG44
SY   Yamaguchi-Ube Medical Center 63
DR   Cosmic; 2758838
DR   Wikidata; Q54995701
RX   PubMed=26870271;
CC   Population: Japanese.
CC   Donor information: No history of asbestos exposure (PubMed=26870271).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   YUMC64
AC   CVCL_VG45
SY   Yamaguchi-Ube Medical Center 64
DR   Cosmic; 2758839
DR   Wikidata; Q54995702
RX   PubMed=26870271;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous (PubMed=26870271).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 7
//
ID   YUMC8
AC   CVCL_VG46
SY   Yamaguchi-Ube Medical Center 8
DR   Cosmic; 2758836
DR   Wikidata; Q54995703
RX   PubMed=26870271;
CC   Population: Japanese.
CC   Donor information: No history of asbestos exposure (PubMed=26870271).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C45663; Pleural sarcomatoid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   YUMINE
AC   CVCL_K016
DR   cancercelllines; CVCL_K016
DR   Wikidata; Q54995704
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUMM1.1
AC   CVCL_JK10
SY   Yale University Mouse Melanoma 1.1
DR   Millipore; SCC224
DR   Wikidata; Q54995705
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC224
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   YUMM1.10
AC   CVCL_JK19
SY   Yale University Mouse Melanoma 1.10
DR   Wikidata; Q54995706
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.11
AC   CVCL_JK20
SY   Yale University Mouse Melanoma 1.11
DR   Wikidata; Q54995707
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.12
AC   CVCL_JK21
SY   Yale University Mouse Melanoma 1.12
DR   Wikidata; Q54995708
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.13
AC   CVCL_JK22
SY   Yale University Mouse Melanoma 1.13
DR   Wikidata; Q54995709
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.14
AC   CVCL_JK23
SY   Yale University Mouse Melanoma 1.14
DR   Wikidata; Q54995710
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.15
AC   CVCL_JK24
SY   Yale University Mouse Melanoma 1.15
DR   Wikidata; Q54995711
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.2
AC   CVCL_JK11
SY   Yale University Mouse Melanoma 1.2
DR   Wikidata; Q54995712
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.3
AC   CVCL_JK12
SY   Yale University Mouse Melanoma 1.3
DR   Millipore; SCC225
DR   Wikidata; Q54995713
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC225
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   YUMM1.4
AC   CVCL_JK13
SY   Yale University Mouse Melanoma 1.4
DR   Millipore; SCC226
DR   Wikidata; Q54995716
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   YUMM1.5
AC   CVCL_JK14
SY   Yale University Mouse Melanoma 1.5
DR   Wikidata; Q54995717
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.6
AC   CVCL_JK15
SY   Yale University Mouse Melanoma 1.6
DR   Wikidata; Q54995718
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.7
AC   CVCL_JK16
SY   Yale University Mouse Melanoma 1.7
DR   ATCC; CRL-3362
DR   Millipore; SCC191
DR   Wikidata; Q54995719
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): CRUK Cambridge RICS
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 9
//
ID   YUMM1.7D4
AC   CVCL_ZL99
SY   Yale University Mouse Melanoma 1.7 clone D4
DR   Millipore; SCC227
DR   Wikidata; Q98136421
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JK16 ! YUMM1.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 5
//
ID   YUMM1.7D5
AC   CVCL_ZM00
SY   Yale University Mouse Melanoma 1.7 clone D5
DR   Millipore; SCC228
DR   Wikidata; Q98136425
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JK16 ! YUMM1.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 02-07-20; Last updated: 21-03-23; Version: 4
//
ID   YUMM1.8
AC   CVCL_JK17
SY   Yale University Mouse Melanoma 1.8
DR   Wikidata; Q54995720
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.9
AC   CVCL_JK18
SY   Yale University Mouse Melanoma 1.9
DR   Wikidata; Q54995722
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.G1
AC   CVCL_JK25
SY   YUMM1.G; Yale University Mouse Melanoma 1.G1
DR   ATCC; CRL-3363
DR   Wikidata; Q54995723
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   YUMM1.G2
AC   CVCL_JK26
SY   Yale University Mouse Melanoma 1.G2
DR   Wikidata; Q54995724
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.G3
AC   CVCL_JK27
SY   Yale University Mouse Melanoma 1.G3
DR   Wikidata; Q54995725
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.G4
AC   CVCL_JK28
SY   Yale University Mouse Melanoma 1.G4
DR   Wikidata; Q54995726
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM1.G5
AC   CVCL_JK29
SY   Yale University Mouse Melanoma 1.G5
DR   Wikidata; Q54995727
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM2.1
AC   CVCL_JK30
SY   Yale University Mouse Melanoma 2.1
DR   Millipore; SCC232
DR   Wikidata; Q54995728
RX   PubMed=27287723;
CC   Characteristics: Has partial Bcat STA/wt recombination.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC232
ST   Mouse STR 1-1: 10,16
ST   Mouse STR 1-2: 13,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2,30
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 26
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 8
//
ID   YUMM2.1R
AC   CVCL_JK31
SY   Yale University Mouse Melanoma 2.1R
DR   Wikidata; Q54995730
RX   PubMed=27287723;
CC   Characteristics: Has full Bcat STA/wt recombination.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   YUMM2.2
AC   CVCL_JK32
SY   Yale University Mouse Melanoma 2.2
DR   Millipore; SCC234
DR   Wikidata; Q54995731
RX   PubMed=27287723;
CC   Characteristics: Has partial Bcat STA/wt recombination.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   YUMM2.2R
AC   CVCL_JK33
SY   Yale University Mouse Melanoma 2.2R
DR   Wikidata; Q54995732
RX   PubMed=27287723;
CC   Characteristics: Has full Bcat STA/wt recombination.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   YUMM3.1
AC   CVCL_JK34
SY   Yale University Mouse Melanoma 3.1
DR   Wikidata; Q54995733
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM3.2
AC   CVCL_JK35
SY   Yale University Mouse Melanoma 3.2
DR   Millipore; SCC235
DR   Wikidata; Q54995734
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   YUMM3.3
AC   CVCL_JK36
SY   Yale University Mouse Melanoma 3.3
DR   ATCC; CRL-3365
DR   Millipore; SCC236
DR   Wikidata; Q54995735
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC236
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   YUMM3.4
AC   CVCL_JK37
SY   Yale University Mouse Melanoma 3.4
DR   Wikidata; Q54995736
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM4.1
AC   CVCL_JK38
SY   Yale University Mouse Melanoma 4.1
DR   ATCC; CRL-3366
DR   Millipore; SCC237
DR   Wikidata; Q54995759
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC237
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 7
//
ID   YUMM4.2
AC   CVCL_JK39
SY   Yale University Mouse Melanoma 4.2
DR   Wikidata; Q54995760
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 4
//
ID   YUMM4.3
AC   CVCL_JK40
SY   Yale University Mouse Melanoma 4.3
DR   Wikidata; Q54995761
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 4
//
ID   YUMM4.4
AC   CVCL_JK41
SY   Yale University Mouse Melanoma 4.4
DR   Wikidata; Q54995762
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 4
//
ID   YUMM5.1
AC   CVCL_JK42
SY   Yale University Mouse Melanoma 5.1
DR   Wikidata; Q54995763
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM5.2
AC   CVCL_JK43
SY   Yale University Mouse Melanoma 5.2
DR   ATCC; CRL-3367
DR   Millipore; SCC240
DR   Wikidata; Q54995765
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC240
ST   Mouse STR 1-1: 17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 9,16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17,18
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16,17
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17,18
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 12,17
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 10-04-25; Version: 7
//
ID   YUMM5.3
AC   CVCL_JK44
SY   Yale University Mouse Melanoma 5.3
DR   Wikidata; Q54995766
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMM5.4
AC   CVCL_JK45
SY   Yale University Mouse Melanoma 5.4
DR   Millipore; SCC241
DR   Wikidata; Q54995767
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 6
//
ID   YUMM6.1
AC   CVCL_JK46
SY   Yale University Mouse Melanoma 6.1
DR   Wikidata; Q54995770
RX   PubMed=27287723;
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (PubMed=27287723).
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 14-08-25; Version: 5
//
ID   YUMMER.G
AC   CVCL_C2VM
SY   Yale University Mouse Melanoma Exposed to Radiation G
DR   Wikidata; Q114313270
RX   DOI=10.1158/1538-7445.AM2019-4622;
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JK25 ! YUMM1.G1
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 4
//
ID   YUMMER1.7
AC   CVCL_A2AX
SY   Yale University Mouse Melanoma Exposed to Radiation 1.7
DR   Wikidata; Q105511840
RX   PubMed=28379630;
CC   Characteristics: The parent cell line was exposed to three rounds of UVB radiation at 1,500 J/m2 to generate a cell line with an increased number of somatic mutations (PubMed=28379630).
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JK16 ! YUMM1.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   YUMMER1.7D4
AC   CVCL_A2BD
DR   Millipore; SCC243
DR   Wikidata; Q105511842
CC   Characteristics: Diploid clone of parent cell line.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2AX ! YUMMER1.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   YUMMER1.7D5
AC   CVCL_A2BC
DR   Millipore; SCC244
DR   Wikidata; Q105511845
CC   Characteristics: Diploid clone of parent cell line.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2AX ! YUMMER1.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
ID   YUMMER1.7 H2B-GFP5
AC   CVCL_A2AY
SY   YUMMER1.7-H2B-GFP
DR   Millipore; SCC245
DR   Wikidata; Q105511847
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4761; H2BC11 (Note=With p.Gly26Asp and p.Ile119Val and fused in frame with eGFP).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6.
ST   Source(s): Millipore=SCC245
ST   Mouse STR 1-1: 16,17
ST   Mouse STR 1-2: 19
ST   Mouse STR 2-1: 16,17
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_A2AX ! YUMMER1.7
SX   Male
AG   Adult
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 7
//
ID   YUMMER1.G1F
AC   CVCL_C2VW
DR   Millipore; SCC246
DR   Wikidata; Q114313271
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a.
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Breed/subspecies: C57BL/6J-Mc1re/J.
ST   Source(s): Millipore=SCC246
ST   Mouse STR 1-1: 10,17
ST   Mouse STR 1-2: 13,19
ST   Mouse STR 2-1: 16
ST   Mouse STR 3-2: 14
ST   Mouse STR 4-2: 20.3
ST   Mouse STR 5-5: 17
ST   Mouse STR 6-4: 18
ST   Mouse STR 6-7: 17
ST   Mouse STR 7-1: 27.2
ST   Mouse STR 8-1: 16
ST   Mouse STR 11-2: 16
ST   Mouse STR 12-1: 17
ST   Mouse STR 13-1: 17
ST   Mouse STR 15-3: 22.3
ST   Mouse STR 17-2: 16
ST   Mouse STR 18-3: 16
ST   Mouse STR 19-2: 13,14
ST   Mouse STR X-1: 27
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C2VM ! YUMMER.G
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 14-08-25; Version: 6
//
ID   YUMMER2.1
AC   CVCL_D0P1
SY   YUMM2.1 UV-clone 2; Yale University Mouse Melanoma Exposed to Radiation 2.1
DR   Wikidata; Q123034000
CC   Characteristics: Has partial Bcat STA/wt recombination (from parent cell line).
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Miscellaneous: Cell line information from personal communication of Comin-Anduix, Begonya.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_JK30 ! YUMM2.1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   YUMMER2.1 B2m-KO
AC   CVCL_D0P2
SY   YUMMER2.1 B2M-KO
DR   Wikidata; Q123034002
CC   Characteristics: Has partial Bcat STA/wt recombination (from parent cell line).
CC   Knockout cell: Method=CRISPR/Cas9; MGI; MGI:88127; B2m.
CC   Knockout cell: Method=KO mouse; MGI; MGI:104738; Cdkn2a (Note=1 of 2 alleles).
CC   Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
CC   Sequence variation: Mutation; MGI; MGI:88190; Braf; Simple; p.Val637Glu (c.1910T>A); Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCIt; C17231; Ultraviolet radiation.
CC   Miscellaneous: Cell line information from personal communication of Comin-Anduix, Begonya.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D0P1 ! YUMMER2.1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   YUMOBER
AC   CVCL_EI20
DR   cancercelllines; CVCL_EI20
DR   Cosmic; 2439344
DR   Wikidata; Q54995771
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   Yumoto
AC   CVCL_B484
SY   YUMOTO
DR   cancercelllines; CVCL_B484
DR   Cosmic; 877464
DR   Cosmic; 1152542
DR   Wikidata; Q54995772
RX   PubMed=9790785;
CC   Characteristics: Established from a nude mouse xenograft (PubMed=9790785).
CC   Doubling time: ~65 hours (PubMed=9790785).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Asp281His (c.841G>C); ClinVar=VCV000376588; Zygosity=Homozygous (PubMed=9790785).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C180841; Human papillomavirus-independent cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 14
//
ID   YUMUT
AC   CVCL_G331
DR   cancercelllines; CVCL_G331
DR   Cosmic; 1548867
DR   Wikidata; Q54995773
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Wrist, soft tissue; UBERON=UBERON_0004452+UBERON_0034929.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   YUNACK
AC   CVCL_EI21
DR   cancercelllines; CVCL_EI21
DR   Wikidata; Q54995774
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YUNIBO
AC   CVCL_J535
DR   cancercelllines; CVCL_J535
DR   Cosmic; 2439350
DR   Wikidata; Q54995775
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   82Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUNIGE
AC   CVCL_J524
DR   Cosmic; 1548868
DR   Wikidata; Q54995776
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   59Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   YUNUFF
AC   CVCL_K017
DR   Wikidata; Q54995777
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 13
//
ID   YUNUVO
AC   CVCL_J525
DR   Cosmic; 1548885
DR   Wikidata; Q54995778
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   YUPAC7
AC   CVCL_EI22
DR   cancercelllines; CVCL_EI22
DR   Cosmic; 2439353
DR   Wikidata; Q54995779
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 10
//
ID   YUPAO
AC   CVCL_J536
DR   Wikidata; Q54995780
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   YUPEET
AC   CVCL_K018
DR   cancercelllines; CVCL_K018
DR   Wikidata; Q54995782
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUPLA
AC   CVCL_J069
DR   cancercelllines; CVCL_J069
DR   Cosmic; 1548869
DR   Cosmic; 2439355
DR   Wikidata; Q54995783
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUPOM
AC   CVCL_EI23
DR   Cosmic; 2439356
DR   Wikidata; Q54995784
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 5
//
ID   YURDE
AC   CVCL_K019
DR   cancercelllines; CVCL_K019
DR   Wikidata; Q54995785
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YURED
AC   CVCL_K020
DR   cancercelllines; CVCL_K020
DR   Wikidata; Q54995786
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Leu972Pro (c.2915T>C); ClinVar=VCV000656765; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YURIF
AC   CVCL_B485
DR   cancercelllines; CVCL_B485
DR   Cosmic; 1197391
DR   Cosmic; 1548870
DR   Cosmic; 2013572
DR   Wikidata; Q54995788
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Thigh, hypodermis; UBERON=UBERON_0000376+UBERON_0002072.
ST   Source(s): Technion Genomics Center
ST   Amelogenin: X,Y
ST   CSF1PO: 10,13
ST   D13S317: 11,14
ST   D16S539: 12
ST   D18S51: 13,16
ST   D21S11: 28,30
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D7S820: 10
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 11,12
ST   Penta E: 11,14
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 15,16
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 24
//
ID   YURKEN
AC   CVCL_K021
DR   cancercelllines; CVCL_K021
DR   Wikidata; Q54995789
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Pro228Ser (c.682C>T); Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 20
//
ID   YUROB
AC   CVCL_B486
DR   cancercelllines; CVCL_B486
DR   Cosmic; 1548871
DR   Cosmic; 2439361
DR   Wikidata; Q54995790
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000012601; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Abdominal wall; UBERON=UBERON_0003697.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   76Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 18
//
ID   YUROL
AC   CVCL_J070
DR   Cosmic; 1548872
DR   Cosmic; 2439364
DR   Wikidata; Q54995791
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   85Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 13
//
ID   YUSAC2
AC   CVCL_A746
SY   YUSAC-2; YUSAC 2; YUSAC
DR   cancercelllines; CVCL_A746
DR   Cosmic; 1197388
DR   Wikidata; Q54995793
RX   PubMed=9177196;
RX   PubMed=20149136;
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20149136).
CC   Derived from site: Metastatic; Neck, hypodermis; UBERON=UBERON_0000974+UBERON_0002072.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 14-08-25; Version: 18
//
ID   YUSAN
AC   CVCL_J526
DR   Cosmic; 1548873
DR   Wikidata; Q54995795
RX   PubMed=21543894;
RX   PubMed=22842228;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C114828; Mucosal melanoma
DI   ORDO; Orphanet_168999; Malignant melanoma of the mucosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   YUSARI
AC   CVCL_K022
DR   cancercelllines; CVCL_K022
DR   Wikidata; Q54995796
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUSEVi005-A
AC   CVCL_QY96
SY   AMN 5 iPSC; AMN 5; SCHI001-A
DR   BioSamples; SAMEA10405028
DR   hPSCreg; SCHI001-A
DR   Wikidata; Q54995797
RX   PubMed=29065337;
RX   PubMed=35042083;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Gly512Ser (c.1534G>A); ClinVar=VCV000585301; Zygosity=Hemizygous (PubMed=29065337).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=29065337
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,11,12,13
ST   D18S51: 12,13,15,18
ST   D19S433: 14,15.2
ST   D21S11: 28,29,31,32.2
ST   D2S1338: 22,23,24
ST   D3S1358: 15,17,18
ST   D5S818: 11,13
ST   D7S820: 11,12
ST   D8S1179: 13,15
ST   FGA: 19,23
ST   Penta D: 9
ST   Penta E: 11,16,18,23
ST   TH01: 6,9
ST   TPOX: 8,9,11
ST   vWA: 14,16,17,20
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 11
//
ID   YUSEVi005-A-1
AC   CVCL_C0EY
SY   AMN 5 corrected; SCHI001-A-1
DR   BioSamples; SAMEA10454450
DR   hPSCreg; SCHI001-A-1
DR   Wikidata; Q112930590
RX   PubMed=35042083;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple_corrected; p.Gly512Ser (c.1534G>A); ClinVar=VCV000585301; Zygosity=Hemizygous; Note=By CRISPR/Cas9 (PubMed=35042083).
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_QY96 ! YUSEVi005-A
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   YUSEVi006-A
AC   CVCL_QY97
SY   AMN 6 iPSC
DR   Wikidata; Q54995798
RX   PubMed=29065337;
CC   From: Yonsei University College of Medicine; Seoul; South Korea.
CC   Population: Korean.
CC   Sequence variation: Mutation; HGNC; HGNC:61; ABCD1; Simple; p.Ile657del (c.1970_1972delTCA) (c.1968_1970delCAT); ClinVar=VCV00125620; Zygosity=Hemizygous (PubMed=29065337).
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=29065337
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 10,12
ST   D16S539: 9,13
ST   D18S51: 13,15
ST   D19S433: 14,15.2
ST   D21S11: 28,29
ST   D2S1338: 23,24
ST   D3S1358: 17,18
ST   D5S818: 11
ST   D7S820: 12
ST   D8S1179: 15
ST   FGA: 19,23
ST   Penta D: 9
ST   Penta E: 16,18
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 16,17
DI   NCIt; C61252; Adrenoleukodystrophy
DI   ORDO; Orphanet_139396; X-linked cerebral adrenoleukodystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 9
//
ID   YUSIK
AC   CVCL_B487
DR   cancercelllines; CVCL_B487
DR   Cosmic; 1548874
DR   Wikidata; Q54995799
RX   PubMed=20149136;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 22
//
ID   YUSIPU
AC   CVCL_EI16
DR   cancercelllines; CVCL_EI16
DR   Cosmic; 2439372
DR   Wikidata; Q54995800
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   YUSIT1
AC   CVCL_A747
SY   YUSIT-1; YUSIT 1; Yusit-1; YUSITI; Yusiti; YUSIT
DR   cancercelllines; CVCL_A747
DR   Cosmic; 1197389
DR   Cosmic; 1921229
DR   Cosmic; 2439373
DR   Wikidata; Q54995802
RX   PubMed=9177196;
RX   PubMed=20149136;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (PubMed=20149136; PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 20
//
ID   YUSIT1-B11
AC   CVCL_R736
DR   cancercelllines; CVCL_R736
DR   Cosmic; 1921231
DR   Wikidata; Q54995803
RX   Patent=US20130231347;
RX   PubMed=22389471;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A747 ! YUSIT1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   YUSIT1-B31
AC   CVCL_R737
DR   cancercelllines; CVCL_R737
DR   Cosmic; 1921232
DR   Wikidata; Q54995804
RX   Patent=US20130231347;
RX   PubMed=22389471;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A747 ! YUSIT1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   YUSIT1-B5
AC   CVCL_R738
DR   cancercelllines; CVCL_R738
DR   Cosmic; 1921230
DR   Wikidata; Q54995805
RX   Patent=US20130231347;
RX   PubMed=22389471;
CC   Selected for resistance to: ChEBI; CHEBI_75045; Dabrafenib (Tafinlar; GSK2118436).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Lys (c.1798_1799delGTinsAA); ClinVar=VCV000375941; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A747 ! YUSIT1
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 15
//
ID   YUSIV
AC   CVCL_G332
DR   Cosmic; 1548875
DR   Cosmic; 2439374
DR   Wikidata; Q54995809
RX   PubMed=20149136;
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Chest; UBERON=UBERON_0001443.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 14
//
ID   YUSTE
AC   CVCL_J527
DR   cancercelllines; CVCL_J527
DR   Cosmic; 1548876
DR   Wikidata; Q54995822
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   66Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUSUBA
AC   CVCL_K023
DR   cancercelllines; CVCL_K023
DR   Wikidata; Q54995823
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   37Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUSWI
AC   CVCL_K024
DR   cancercelllines; CVCL_K024
DR   Wikidata; Q54995824
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Small intestine; UBERON=UBERON_0002108.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUTER
AC   CVCL_K025
DR   cancercelllines; CVCL_K025
DR   Wikidata; Q54995826
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Leu (c.182A>T); ClinVar=VCV000375874; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUTHO
AC   CVCL_J528
DR   Cosmic; 1548881
DR   Wikidata; Q54995827
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   YUTICA
AC   CVCL_J071
DR   cancercelllines; CVCL_J071
DR   Cosmic; 1548877
DR   Cosmic; 2439381
DR   Wikidata; Q54995828
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Pro1667Leu (c.5000C>T); ClinVar=VCV001744236; Zygosity=Unspecified (PubMed=26214590).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUTUR
AC   CVCL_J539
DR   Wikidata; Q54995829
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 9
//
ID   YUVON3
AC   CVCL_G333
SY   YUVON
DR   Cosmic; 1548882
DR   Wikidata; Q54995830
RX   PubMed=20149136;
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 9
//
ID   YUWAGE
AC   CVCL_K026
DR   Wikidata; Q54995831
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Genomics; Whole exome sequencing.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   YUWALI
AC   CVCL_K027
DR   cancercelllines; CVCL_K027
DR   Wikidata; Q54995832
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 19
//
ID   YUWERA
AC   CVCL_J530
DR   Cosmic; 1548883
DR   Wikidata; Q54995834
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 10
//
ID   YUWHIM
AC   CVCL_K028
DR   cancercelllines; CVCL_K028
DR   Wikidata; Q54995836
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 18
//
ID   YUWIM
AC   CVCL_J531
DR   Cosmic; 1548878
DR   Wikidata; Q54995838
RX   PubMed=21543894;
CC   Part of: Yale University (YU) melanoma cell collection.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
ID   YUZAZ
AC   CVCL_EI18
DR   cancercelllines; CVCL_EI18
DR   Cosmic; 2439392
DR   Wikidata; Q54995839
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   YUZEAL
AC   CVCL_K029
DR   cancercelllines; CVCL_K029
DR   Wikidata; Q54995840
RX   PubMed=22842228;
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Arg (c.1798_1799delGTinsAG); ClinVar=VCV000375940; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   78Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 17
//
ID   YUZEST
AC   CVCL_EI24
DR   cancercelllines; CVCL_EI24
DR   Wikidata; Q54995842
RX   PubMed=26214590;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=26214590).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Cancer cell line
DT   Created: 26-09-16; Last updated: 10-04-25; Version: 11
//
ID   YUZOR
AC   CVCL_J072
DR   Cosmic; 1548884
DR   Wikidata; Q54995843
RX   PubMed=21521745;
RX   PubMed=21543894;
RX   PubMed=21569352;
RX   PubMed=23012583;
CC   Part of: Yale University (YU) melanoma cell collection.
CC   Omics: Transcriptomics; Microarray.
DI   NCIt; C4022; Acral lentiginous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 10-04-25; Version: 12
//
ID   YW 62.3.20
AC   CVCL_J091
SY   YW62.3.20
DR   ECACC; 11072202
DR   Wikidata; Q54995844
RX   PubMed=3330997;
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: UniProtKB; P06800; Mouse Ptprc/Cd45.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_4342 ! Y3-Ag 1.2.3
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 5
//
ID   YY-8103
AC   CVCL_WY40
DR   BTO; BTO_0006281
DR   Wikidata; Q98136428
RX   CelloPub=CLPUB00523;
CC   Population: Chinese.
CC   Virology: Susceptible to infection by herpes simplex virus and measles virus (CelloPub=CLPUB00523).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7956; Adult hepatocellular carcinoma
DI   ORDO; Orphanet_210159; Adult hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 8
//
ID   YYXY-M4
AC   CVCL_E9ED
DR   CCRID; 4201PAT-CCTCC02508
DR   CCRID; 4201PAT-CCTCC02647
RX   Patent=CN118546887A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2023217.
CC   Population: Chinese.
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Patent=CN118546887A
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,24
ST   D13S317: 9,12
ST   D16S539: 9,12
ST   D18S51: 16,20
ST   D19S433: 14
ST   D1S1656: 11,15
ST   D21S11: 29,31.2
ST   D2S1338: 23,24
ST   D3S1358: 16,17
ST   D5S818: 9,12
ST   D6S1043: 12,14
ST   D7S820: 11,12
ST   D8S1179: 10,15
ST   FGA: 24,27
ST   Penta D: 9,12
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,19
DI   NCIt; C122687; Cytogenetically normal acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   YZ1
AC   CVCL_JW74
DR   Wikidata; Q54995845
RX   PubMed=20686615;
CC   Population: Caucasian.
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
CC   Cell type: Fibroblast of lung; CL=CL_0002553.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0347 ! IMR-90
SX   Female
AG   16FW
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 05-10-23; Version: 8
//
ID   YZ18
AC   CVCL_F1EI
SY   YZ-18
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZ19
AC   CVCL_F1EJ
SY   YZ-19
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZ20
AC   CVCL_F1EK
SY   YZ-20
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZ21
AC   CVCL_F1EL
SY   YZ-21
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZ22
AC   CVCL_F1EM
SY   YZ-22
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZ23
AC   CVCL_F1EN
SY   YZ-23
DR   ABCD; ABCD_BF052
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120. Also reacts with HIV-1 A and C subtype strains).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZ24
AC   CVCL_F1EP
SY   YZ-24
RX   PubMed=12665517;
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; P05877; HIV-1 isolate MN env (Note=AA 32-513 = gp120. Immunized with a covalently reactive analog of gp120).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
ID   YZI-1S
AC   CVCL_E2WP
DR   BTO; BTO_0002281
RX   DOI=10.1016/S0176-1617(11)81935-8;
RX   PubMed=9808719;
RX   PubMed=12400676;
CC   Group: Plant cell line.
CC   Characteristics: Resistant to the protoporphyrinogen oxidase-inhibiting herbicide S-23142 (DOI=10.1016/S0176-1617(11)81935-8).
CC   Selected for resistance to: ChEBI; CHEBI_231817; S-23142 (N-[4-chloro-2-fluoro-5-propargyloxy]phenyl-3,4,5,6-tetrahydrophthalimide).
CC   Derived from site: In situ; Pith; PO=PO_0006109.
CC   Breed/subspecies: Cultivar Samsun NN.
OX   NCBI_TaxID=4097; ! Nicotiana tabacum (Common tobacco)
HI   CVCL_E2WN ! TN-I
CA   Spontaneously immortalized cell line
DT   Created: 10-09-24; Last updated: 19-12-24; Version: 2
//
ID   YZWJs513
AC   CVCL_C1EF
SY   YZWJ s513
DR   Wikidata; Q114313272
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/YZWJs513_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   YZWJs516
AC   CVCL_C1EG
SY   YZWJ s516
DR   Wikidata; Q114313273
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/YZWJs516_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   YZWJs524
AC   CVCL_C1EH
SY   YZWJ s524
DR   Wikidata; Q114313276
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/YZWJs524_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   YZWJs527
AC   CVCL_C1EI
SY   YZWJ s527
DR   Wikidata; Q114313280
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/YZWJs527_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EJ ! YZWJs531
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   YZWJs531
AC   CVCL_C1EJ
SY   YZWJ s531
DR   Wikidata; Q114313284
RX   PubMed=31497180;
RX   PubMed=36395757;
WW   Provider; CiRA; -; https://www.cira-foundation.or.jp/e/assets/file/provision-of-ips-cells/YZWJs531_en.pdf
CC   Group: Clinical grade pluripotent cell line.
CC   Part of: Japanese HLA-homozygous iPS cell line panel.
CC   From: Center for iPS Cell Research and Application, Kyoto University; Kyoto; Japan.
CC   Population: Japanese.
CC   HLA typing: A*24:02; B*52:01; DRB1*15:02 (CiRA).
CC   Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C1EF ! YZWJs513
OI   CVCL_C1EG ! YZWJs516
OI   CVCL_C1EH ! YZWJs524
OI   CVCL_C1EI ! YZWJs527
OI   CVCL_C1EK ! Ff-WJs513
OI   CVCL_C1EL ! Ff-WJs516
OI   CVCL_C1EM ! Ff-WJs524
OI   CVCL_C1EN ! Ff-WJs527
OI   CVCL_C1EP ! Ff-WJs531
SX   Male
AG   <1D
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 10-04-25; Version: 6
//
ID   Z-119
AC   CVCL_IU88
SY   Z119
DR   ATCC; CRL-3394
DR   Cosmic; 2491094
DR   Wikidata; Q54995847
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8600166;
RX   PubMed=9067587;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15302850;
CC   Population: Latino.
CC   Characteristics: Can be differentiated into dendritic-like cells in culture with a combination of cytokines (IL1B, IL3, IL7, TNF, KITLG and CD40LG) (PubMed=15302850).
CC   Doubling time: 20-30 hours (PubMed=8600166); ~24-36 hours (ATCC=CRL-3394).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8600166; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 16
//
ID   Z-138
AC   CVCL_B077
SY   Z138
DR   EFO; EFO_0005479
DR   ATCC; CRL-3001
DR   BioSample; SAMN03471023
DR   cancercelllines; CVCL_B077
DR   ChEMBL-Cells; CHEMBL4483125
DR   ChEMBL-Targets; CHEMBL4483276
DR   Cosmic; 2078183
DR   Cosmic; 2088021
DR   Cosmic; 2296992
DR   Cosmic; 2756238
DR   GEO; GSM115807
DR   GEO; GSM629502
DR   GEO; GSM629503
DR   GEO; GSM1044974
DR   GEO; GSM1044975
DR   GEO; GSM1044976
DR   GEO; GSM1044977
DR   GEO; GSM1266779
DR   GEO; GSM1266780
DR   GEO; GSM1266787
DR   GEO; GSM1266788
DR   GEO; GSM1266789
DR   GEO; GSM1266790
DR   GEO; GSM1266791
DR   GEO; GSM1266792
DR   GEO; GSM2322624
DR   Lonza; 1605
DR   Progenetix; CVCL_B077
DR   PubChem_Cell_line; CVCL_B077
DR   Wikidata; Q54995848
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=9669839;
RX   PubMed=16183118;
RX   PubMed=16203034;
RX   PubMed=16960149;
RX   PubMed=21746927;
RX   PubMed=24362935;
RX   PubMed=25315077;
RX   PubMed=25688540;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26194763;
RX   PubMed=27697772;
RX   PubMed=29666304;
CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).
CC   Population: Caucasian.
CC   Doubling time: 24 hours (PubMed=25315077).
CC   HLA typing: A*01:01,23:01; B*08:01,44:05; C*02:02,07:06; DQA1*05:01,01:01; DQB1*05:01,02:01; DRB1*03:01,01:01 (PubMed=25960936).
CC   HLA typing: A*01,23; B*08,44; C*02,07 (PubMed=25688540).
CC   Sequence variation: Mutation; HGNC; HGNC:12032; TRAF2; Simple; p.Trp114Ter (c.341G>A); Zygosity=Unspecified (PubMed=24362935).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Miscellaneous: HLA*C loci for PubMed=24362935 was incorrect, modified version submitted by Pellat-Deceunynck, Catherine.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): ATCC=CRL-3001; PubMed=25877200
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,12
ST   D16S539: 11
ST   D18S51: 14,18
ST   D19S433: 12,14
ST   D21S11: 30,32.2
ST   D2S1338: 19
ST   D3S1358: 16
ST   D5S818: 11,13
ST   D7S820: 8
ST   D8S1179: 8,13
ST   FGA: 20,22
ST   Penta D: 13,15
ST   Penta E: 7,18
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,18
DI   NCIt; C4337; Mantle cell lymphoma
DI   ORDO; Orphanet_52416; Mantle cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   70Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 31
//
ID   Z-181
AC   CVCL_IU89
SY   Z181
DR   ATCC; CRL-3395
DR   Cosmic; 2491095
DR   Wikidata; Q54995849
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8600166;
RX   PubMed=9067587;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15302850;
CC   Population: Mexican-American.
CC   Characteristics: Can be differentiated into dendritic-like cells in culture with a combination of cytokines (IL1B, IL3, IL7, TNF, KITLG and CD40LG) (PubMed=15302850).
CC   Doubling time: 30-40 hours (PubMed=8600166); ~24-36 hours (ATCC=CRL-3395).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8600166; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 27-11-25; Version: 16
//
ID   Z-33
AC   CVCL_4796
SY   Z33
DR   ATCC; CRL-3393
DR   Wikidata; Q54995851
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=8751477;
RX   PubMed=10071072;
RX   PubMed=10576511;
RX   PubMed=15302850;
WW   Info; COPE; -; http://www.cells-talk.com/index.php/page/copelibrary?key=Z-33
CC   Population: Caucasian.
CC   Characteristics: Can not be differentiated into dendritic-like cells in culture with any combination of cytokines (PubMed=15302850).
CC   Doubling time: 24-30 hours (PubMed=8751477).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 1 fused to ABL1 exon 2 (e1a2 transcript) (PubMed=8751477; PubMed=10071072; PubMed=10576511).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 23
//
ID   Z-43
AC   CVCL_WG52
DR   Wikidata; Q98136430
RX   PubMed=8382256;
CC   Doubling time: 16 hours (PubMed=8382256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3247; Myelodysplastic syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   84Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 4
//
ID   Z-55
AC   CVCL_WG53
DR   Wikidata; Q98136433
RX   PubMed=8382256;
CC   Doubling time: 12 hours (PubMed=8382256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   80Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   Z-6
AC   CVCL_WG54
DR   Wikidata; Q98136435
RX   PubMed=8382256;
CC   Doubling time: 24 hours (PubMed=8382256).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: T-cell; CL=CL_0000084.
DI   NCIt; C9142; Adult T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   26Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 6
//
ID   Z-HL16C
AC   CVCL_RL03
SY   ZHL16C
DR   Wikidata; Q54995852
RX   PubMed=11503031;
RX   PubMed=17086279;
RX   PubMed=26116706;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=26116706). Originally thought to originate from embryonic lung fibroblasts.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00609.
CC   Population: African American.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=26116706
ST   Amelogenin: X
ST   CSF1PO: 9,10
ST   D12S391: 20,25
ST   D13S317: 13.3
ST   D16S539: 9,10
ST   D18S51: 16,17
ST   D19S433: 13,14
ST   D21S11: 27,28
ST   D2S1338: 17
ST   D3S1358: 15,18
ST   D5S818: 11,12
ST   D6S1043: 18
ST   D7S820: 8,12
ST   D8S1179: 12,13
ST   FGA: 18,21
ST   Penta D: 8,15
ST   Penta E: 7,17
ST   TH01: 7
ST   TPOX: 8,12
ST   vWA: 16,18
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0030 ! HeLa
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 11
//
ID   Z1
AC   CVCL_D3XD
DR   Wikidata; Q127384767
RX   PubMed=37301090;
CC   Group: Reptilian cell line.
CC   Characteristics: Can grow between 33 to 42 Celsius (PubMed=37301090).
CC   Characteristics: Used to reduce Toxoplasma gondii protozoan virulence by serial passaging on this cell line (PubMed=37301090).
CC   Doubling time: 19 hours (PubMed=37301090).
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=303590; ! Cyrtopodion scabrum (Rough-tailed gecko)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Z11
AC   CVCL_RU26
SY   PureStem Z11 progenitor; ACTC194
DR   Wikidata; Q54995853
RX   PubMed=18462054;
WW   Provider; ESI BIO; ES-194; https://web.archive.org/web/20141202101639/http://www.esibio.com/purestemr-z11-progenitor/
CC   From: ESI BIO - BioTime, Inc. (ES Cell International); Alameda; USA.
CC   Senescence: Can undergo >50 PDL (ESI BIO).
CC   Doubling time: ~50 hours (ESI BIO).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9773 ! WA09
SX   Female
AG   Blastocyst stage
CA   Somatic stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 8
//
ID   Z14A7
AC   CVCL_A8VF
DR   Wikidata; Q108821558
RX   Patent=US10808026;
CC   Group: Patented cell line.
CC   Monoclonal antibody isotype: IgG2c.
CC   Monoclonal antibody target: UniProtKB; Q9NRN5; Human OLFML3.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   Z1a
AC   CVCL_JY50
DR   Wikidata; Q54995854
RX   PubMed=2445586;
RX   PubMed=6165588;
RX   PubMed=7690770;
CC   Characteristics: T cell line specific for myelin basic protein.
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   Z1a-p
AC   CVCL_JY51
DR   Wikidata; Q54995856
RX   PubMed=7690770;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_JY50 ! Z1a
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   Z2
AC   CVCL_J056
DR   ECACC; 93022522
DR   Wikidata; Q54995857
CC   Monoclonal antibody isotype: IgG2b.
CC   Monoclonal antibody target: Mouse IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   Z210
AC   CVCL_D3UP
DR   Wikidata; Q127384768
RX   PubMed=8432973;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Z210.1
AC   CVCL_D3UQ
DR   Wikidata; Q127384771
RX   PubMed=8432973;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3UP ! Z210
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Z210.1.7
AC   CVCL_D3UR
DR   Wikidata; Q127384772
RX   PubMed=8432973;
CC   Derived from site: In situ; Thymus, epithelium; UBERON=UBERON_0003846.
CC   Cell type: Medullary thymic epithelial cell; CL=CL_0002365.
CC   Breed/subspecies: BALB/c.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_D3UQ ! Z210.1
SX   Sex unspecified
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Z24
AC   CVCL_HB35
DR   Wikidata; Q54995858
RX   PubMed=1430210;
RX   PubMed=1689731;
RX   PubMed=1750930;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   Z26
AC   CVCL_J057
DR   ECACC; 93022519
DR   Wikidata; Q54995859
RX   PubMed=2177147;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   Z310
AC   CVCL_F753
DR   ABM; T0256
DR   Kerafast; ECC005
DR   Wikidata; Q54995860
RX   PubMed=12470873;
RX   PubMed=17825520;
RX   PubMed=18162136;
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) (Note=pSV3-neo).
CC   Derived from site: In situ; Brain, choroid plexus; UBERON=UBERON_0001886.
CC   Cell type: Epithelial cell of choroid plexus; CL=CL_0000706.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   4-6W
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 14
//
ID   Z34
AC   CVCL_J058
DR   ECACC; 93022521
DR   Wikidata; Q54995862
CC   Monoclonal antibody isotype: IgA.
CC   Monoclonal antibody target: Influenza A virus (strain A/Puerto Rico/8/1934 H1N1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 14-08-25; Version: 5
//
ID   Z41
AC   CVCL_J059
DR   ECACC; 93022520
DR   Wikidata; Q54995863
RX   PubMed=2177147;
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: Mouse IgG2a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 4
//
ID   Z65
AC   CVCL_HB89
DR   Wikidata; Q54995864
RX   PubMed=1430210;
RX   PubMed=1689731;
RX   PubMed=1750930;
RX   PubMed=9184070;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 8
//
ID   ZA
AC   CVCL_D596
DR   cancercelllines; CVCL_D596
DR   CGH-DB; 361-2
DR   Cosmic; 930337
DR   Cosmic; 1046039
DR   Cosmic; 1123029
DR   IARC_TP53; 1108
DR   Wikidata; Q54995865
RX   PubMed=1570156;
RX   PubMed=2228902;
RX   PubMed=2654810;
RX   PubMed=10069537;
RX   PubMed=12632084;
RX   PubMed=17052259;
RX   PubMed=17599052;
RX   PubMed=18097548;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Gly13Arg (c.37G>C); ClinVar=VCV000035554; Zygosity=Unspecified (PubMed=2654810).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly279Glu (c.836G>A); ClinVar=VCV000419454; Zygosity=Unspecified (PubMed=1570156).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4833; Oral cavity squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   76Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 20
//
ID   Zajdela-Hepatoma
AC   CVCL_1D00
SY   ZH-CLS
DR   CLS; 500306
DR   Wikidata; Q54995867
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: Sprague Dawley; RS=RS_0000681.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
SX   Sex unspecified
AG   11M
CA   Cancer cell line
DT   Created: 08-07-15; Last updated: 10-04-25; Version: 12
//
ID   ZBE3
AC   CVCL_A8VY
SY   Zebrafish Blastula Embryo clone 3
DR   Wikidata; Q108821559
RX   PubMed=28833122;
CC   Group: Fish cell line.
CC   Characteristics: Grows at temperatures ranging from 20 to 32 Celsius. The highest growth rate is obtained at 28 Celsius (PubMed=28833122).
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: AB; VBO=VBO_0017495.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Blastula stage
CA   Embryonic stem cell
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   ZC-7901
AC   CVCL_R992
SY   ZC 7901
DR   KCB; KCB 93047YJ
DR   Wikidata; Q54995868
RX   CelloPub=CLPUB00036;
RX   CelloPub=CLPUB00674;
CC   Group: Fish cell line.
CC   Misspelling: ZC-79001; KCB=KCB 93047YJ.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 02-05-24; Version: 12
//
ID   ZC-7901S1
AC   CVCL_R993
DR   Wikidata; Q54995869
RX   CelloPub=CLPUB00036;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Snout; UBERON=UBERON_0006333.
OX   NCBI_TaxID=7959; ! Ctenopharyngodon idella (Grass carp)
HI   CVCL_R992 ! ZC-7901
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 05-10-23; Version: 10
//
ID   ZC.Lu
AC   CVCL_UT90
DR   ATCC; CRL-6533
DR   Wikidata; Q98136438
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6533; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 5
//
ID   ZC.Lu+ZC424
AC   CVCL_UT91
DR   ATCC; CRL-6534
DR   Wikidata; Q98136440
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Infected with a virus isolated from a poxlike lesion on a young sea lion.
CC   Discontinued: ATCC; CRL-6534; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
HI   CVCL_UT90 ! ZC.Lu
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 25-02-19; Last updated: 29-06-23; Version: 6
//
ID   ZC15.K
AC   CVCL_S366
DR   ATCC; CRL-6537
DR   Wikidata; Q54995871
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6537; true.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
OI   CVCL_S331 ! ZC15.Lu
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   ZC15.Lu
AC   CVCL_S331
DR   ATCC; CRL-6606
DR   Wikidata; Q54995872
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Discontinued: ATCC; CRL-6606; true.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
OI   CVCL_S366 ! ZC15.K
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
ID   ZC2.Sk/Mu
AC   CVCL_S367
DR   ATCC; CRL-6536
DR   Wikidata; Q54995886
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   Virology: Possibly infected by seal poxvirus.
CC   Discontinued: ATCC; CRL-6536; true.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=9704; ! Zalophus californianus (California sealion)
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   ZE
AC   CVCL_WJ12
DR   Wikidata; Q98136443
RX   PubMed=21965729;
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C7950; Invasive breast lobular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZEB2
AC   CVCL_6E09
DR   Wikidata; Q54995887
RX   PubMed=15602876;
RX   PubMed=17141029;
RX   PubMed=18399791;
CC   Group: Fish cell line.
CC   Characteristics: Requires feeder cells. Maintenance of ZEB2 depends on the presence of cell line RTS34st (Cellosaurus=CVCL_L016).
CC   Genetic integration: Method=Transgenic fish; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Blastula stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 9
//
ID   ZEB2J
AC   CVCL_6E10
DR   Wikidata; Q47478427
RX   PubMed=18399791;
RX   PubMed=19116758;
RX   PubMed=24357037;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Characteristics: Does not require feeder cells (PubMed=18399791).
CC   Genetic integration: Method=Transgenic fish; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_6E09 ! ZEB2
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 10-09-24; Version: 10
//
ID   ZEC-014
AC   CVCL_VT79
DR   CCRID; 4201PAT-CCTCC00890
DR   Wikidata; Q98136446
RX   Patent=CN106011069A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201689.
CC   Population: Chinese.
CC   Doubling time: ~22 hours (Patent=CN106011069A).
ST   Source(s): Patent=CN106011069A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,23
ST   D13S317: 12
ST   D16S539: 11
ST   D18S51: 15
ST   D19S433: 14
ST   D21S11: 32.2
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 12
ST   D6S1043: 12
ST   D7S820: 8,13
ST   D8S1179: 12,16
ST   FGA: 26
ST   Penta D: 13
ST   Penta E: 17
ST   TH01: 7,9
ST   TPOX: 11
ST   vWA: 14,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-043
AC   CVCL_VT80
DR   CCRID; 4201PAT-CCTCC00891
DR   Wikidata; Q98136449
RX   Patent=CN106011070A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201690.
CC   Population: Chinese.
ST   Source(s): Patent=CN106011070A
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 18
ST   D13S317: 11
ST   D16S539: 10
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 16
ST   D5S818: 9
ST   D6S1043: 18
ST   D7S820: 9,11
ST   D8S1179: 17
ST   FGA: 22
ST   Penta D: 12,14
ST   Penta E: 15
ST   TH01: 6,9
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-056
AC   CVCL_VT81
DR   CCRID; 4201PAT-CCTCC00892
DR   Wikidata; Q98136454
RX   Patent=CN106011068A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201691.
CC   Population: Chinese.
ST   Source(s): Patent=CN106011068A
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D12S391: 18
ST   D13S317: 8
ST   D16S539: 9,13
ST   D18S51: 17
ST   D19S433: 13,15.2
ST   D21S11: 29
ST   D2S1338: 22
ST   D3S1358: 15,17
ST   D5S818: 9
ST   D6S1043: 11,14
ST   D7S820: 11,13
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 12,22
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,15
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-061
AC   CVCL_VT82
DR   CCRID; 4201PAT-CCTCC00893
DR   Wikidata; Q98136458
RX   Patent=CN106222142A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201692.
CC   Population: Chinese.
CC   Doubling time: ~48 hours (Patent=CN106222142A).
ST   Source(s): Patent=CN106222142A
ST   Amelogenin: X,Y
ST   CSF1PO: 9,11
ST   D12S391: 20,22
ST   D13S317: 13
ST   D16S539: 10,12
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D21S11: 32.2
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 10,13
ST   D6S1043: 19
ST   D7S820: 12
ST   D8S1179: 13
ST   FGA: 21,23
ST   Penta D: 10
ST   Penta E: 14,16
ST   TH01: 10
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-118
AC   CVCL_VT83
DR   CCRID; 4201PAT-CCTCC00895
DR   Wikidata; Q98136460
RX   Patent=CN106047814A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201694.
CC   Population: Chinese.
CC   Doubling time: ~52 hours (Patent=CN106047814A).
ST   Source(s): Patent=CN106047814A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 17,19
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 15,21
ST   D19S433: 13,15
ST   D21S11: 30,31
ST   D2S1338: 18,20
ST   D3S1358: 15,17
ST   D5S818: 12
ST   D6S1043: 17,18
ST   D7S820: 10
ST   D8S1179: 14
ST   FGA: 23,25
ST   Penta D: 8,13
ST   Penta E: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-127
AC   CVCL_VT84
DR   CCRID; 4201PAT-CCTCC00886
DR   Wikidata; Q98136463
RX   Patent=CN106190981A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201685.
CC   Population: Chinese.
CC   Doubling time: ~60 hours (Patent=CN106190981A).
ST   Source(s): Patent=CN106190981A
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 19
ST   D13S317: 8
ST   D16S539: 9,12
ST   D18S51: 16
ST   D19S433: 15.2
ST   D21S11: 29
ST   D2S1338: 18,25
ST   D3S1358: 15
ST   D5S818: 9,12
ST   D6S1043: 18,20
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 19
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 14
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   68Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-134
AC   CVCL_VT85
DR   CCRID; 4201PAT-CCTCC00911
DR   Wikidata; Q98136466
RX   Patent=CN105969734A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016108.
CC   Population: Chinese.
CC   Doubling time: ~60 hours (Patent=CN105969734A).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): Patent=CN105969734A
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 21,22
ST   D13S317: 8
ST   D16S539: 10,12
ST   D18S51: 14
ST   D19S433: 15
ST   D21S11: 29,30
ST   D2S1338: 23
ST   D3S1358: 18
ST   D5S818: 15
ST   D6S1043: 20
ST   D7S820: 10,12
ST   D8S1179: 10
ST   FGA: 25
ST   Penta D: 9,13
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 9
//
ID   ZEC-145
AC   CVCL_VT86
DR   CCRID; 4201PAT-CCTCC00887
DR   Wikidata; Q98136468
RX   Patent=CN106011067A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201686.
CC   Population: Chinese.
CC   Doubling time: ~26 hours (Patent=CN106011067A).
ST   Source(s): Patent=CN106011067A
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 18,19,20
ST   D13S317: 14
ST   D16S539: 9,10
ST   D18S51: 15
ST   D19S433: 14,14.2
ST   D21S11: 32.2
ST   D2S1338: 21
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D6S1043: 14,19
ST   D7S820: 12
ST   D8S1179: 13,14
ST   FGA: 24,25
ST   Penta D: 9
ST   Penta E: 11,14
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   66Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-157
AC   CVCL_VT87
DR   CCRID; 4201PAT-CCTCC00894
DR   Wikidata; Q98136471
RX   Patent=CN106047815A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201693.
CC   Population: Chinese.
CC   Doubling time: ~22 hours (Patent=CN106047815A).
ST   Source(s): Patent=CN106047815A
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 19,22
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,20
ST   D7S820: 9,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 15,18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEC-166
AC   CVCL_VT88
DR   CCRID; 4201PAT-CCTCC00888
DR   Wikidata; Q98136474
RX   Patent=CN106190982A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201687.
CC   Population: Chinese.
CC   Doubling time: ~85 hours (Patent=CN106190982A).
CC   Derived from site: In situ; Esophagus; UBERON=UBERON_0001043.
ST   Source(s): Patent=CN106190982A
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 23
ST   D13S317: 9
ST   D16S539: 11,12
ST   D18S51: 16,19
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 20,24
ST   D3S1358: 15
ST   D5S818: 10,11
ST   D6S1043: 11,13,14
ST   D7S820: 10
ST   D8S1179: 10,11
ST   FGA: 22
ST   Penta D: 11
ST   Penta E: 10,12
ST   TH01: 6,9
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 9
//
ID   ZEC-219
AC   CVCL_VT89
DR   CCRID; 4201PAT-CCTCC00889
DR   Wikidata; Q98136476
RX   Patent=CN106047816A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201688.
CC   Population: Chinese.
CC   Doubling time: ~53 hours (Patent=CN106047816A).
ST   Source(s): Patent=CN106047816A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 13
ST   D19S433: 13,14
ST   D21S11: 29
ST   D2S1338: 23
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 11,18
ST   D7S820: 11,12
ST   D8S1179: 15,16
ST   FGA: 23
ST   Penta D: 9
ST   Penta E: 16,19
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 18,21
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
ID   ZEM
AC   CVCL_R818
DR   Wikidata; Q54995889
RX   PubMed=1591622;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   ZEM-2
AC   CVCL_5678
SY   ZEM2
DR   Wikidata; Q54995890
RX   PubMed=7765109;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 11
//
ID   ZEM-2A
AC   CVCL_J060
DR   Wikidata; Q54995891
RX   PubMed=7765109;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_5678 ! ZEM-2
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 10
//
ID   ZEM2S
AC   CVCL_3274
SY   ZEM-2S
DR   CLO; CLO_0009723
DR   ATCC; CRL-2147
DR   BCRC; 60253
DR   CCRID; 4201FIS-CCTCC00161
DR   CCTCC; GDC0161
DR   Wikidata; Q54995892
RX   DOI=10.1007/BF01404818;
RX   DOI=10.1016/S1873-0140(05)80005-0;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_5678 ! ZEM-2
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 14
//
ID   ZEMH
AC   CVCL_R819
DR   Wikidata; Q54995894
RX   PubMed=1591622;
CC   Group: Fish cell line.
CC   Group: Haploid karyotype cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Blastula stage
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   ZEN
AC   CVCL_5417
SY   7-1-144
DR   JCRB; JCRB1311
DR   Wikidata; Q54995896
RX   DOI=10.1021/jf00097a040;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: ChEBI; CHEBI_10106; Zearalenone.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 8
//
ID   Zeng01i-iPSH9
AC   CVCL_AS49
DR   WiCell; zeng01i-ipsh9
DR   Wikidata; Q54995898
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
ST   Source(s): WiCell=zeng01i-ipsh9
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 9
ST   D16S539: 12,13
ST   D18S51: 13
ST   D21S11: 30
ST   D3S1358: 13,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 8,14
ST   FGA: 26,28
ST   Penta D: 11,13
ST   Penta E: 11,14
ST   TH01: 9.3
ST   TPOX: 10,11
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U176 ! NSC-H9
SX   Female
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 8
//
ID   Zeng02i-iPSH14
AC   CVCL_AS50
DR   WiCell; zeng02i-ipsh14
DR   Wikidata; Q54995899
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Neural stem cell; CL=CL_0000047.
ST   Source(s): WiCell=zeng02i-ipsh14
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11
ST   D16S539: 11,13
ST   D18S51: 12,14
ST   D21S11: 30,31
ST   D3S1358: 15,16
ST   D5S818: 11,13
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   FGA: 21
ST   Penta D: 12,13
ST   Penta E: 13,20
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 15,16
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_U174 ! NSC-H14
SX   Male
AG   Blastocyst stage
CA   Induced pluripotent stem cell
DT   Created: 02-05-16; Last updated: 02-05-24; Version: 8
//
ID   ZES1
AC   CVCL_6E11
SY   Zebrafish ES-like 1
DR   Wikidata; Q54995900
RX   PubMed=24967707;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Blastula; UBERON=UBERON_0000307.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Blastula high stage
CA   Embryonic stem cell
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 6
//
ID   ZF13
AC   CVCL_6G00
SY   ZF-13; ZF 13
DR   Wikidata; Q54995901
RX   PubMed=7737359;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Somite stage 20-25
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 6
//
ID   ZF29
AC   CVCL_6G01
SY   ZF-29; ZF 29
DR   Wikidata; Q54995903
RX   PubMed=7737359;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Somite stage 20-25
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 27-11-25; Version: 6
//
ID   ZF4
AC   CVCL_3275
DR   CLO; CLO_0009724
DR   EFO; EFO_0001261
DR   ATCC; CRL-2050
DR   BCRC; 60246
DR   KCB; KCB 2014059YJ
DR   Lonza; 1135
DR   Wikidata; Q54995904
RX   PubMed=18377224;
CC   Group: Fish cell line.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Prim-5 stage
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 12
//
ID   ZFB1
AC   CVCL_6E12
SY   ZebraFish Bone 1
DR   Wikidata; Q54995905
RX   DOI=10.1111/j.1439-0426.2010.01411.x;
RX   PubMed=23909483;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Bone; UBERON=UBERON_0002481.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ZFBK11-97
AC   CVCL_YZ74
SY   ZFB11-97
DR   Wikidata; Q98136479
RX   DOI=10.14943/doctoral.k12177;
RX   PubMed=24131711;
RX   PubMed=26605499;
RX   PubMed=30718752;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Caution: Exact taxonomic provenance is not known. On the basis of habitat and cyb sequence, it could be from Epomophorus anselli, Epomophorus crypturus, Epomophorus gambianus, Epomophorus minimus or Micropteropus pusillus (PubMed=30718752).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=372077; ! Epomophorus gambianus (Gambian epauletted fruit bat)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ZFBK13-76E
AC   CVCL_YZ75
DR   Wikidata; Q98136481
RX   PubMed=29207524;
RX   PubMed=30718752;
RX   PubMed=31940478;
CC   Group: Bat cell line.
CC   Virology: Susceptible to infection by many filoviruses except Ebola virus (EBOV). This is due to specific sequence changes in NPC1 that acts as a receptor for filoviruses (PubMed=31940478).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 5
//
ID   ZFBK15-137RA
AC   CVCL_YZ76
DR   Wikidata; Q98136484
RX   PubMed=30718752;
RX   PubMed=31940478;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9407; ! Rousettus aegyptiacus (Egyptian rousette)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ZFBS13-75A
AC   CVCL_YZ77
DR   Wikidata; Q98136486
RX   PubMed=26605499;
CC   Group: Bat cell line.
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
OX   NCBI_TaxID=77214; ! Eidolon helvum (Straw-colored fruit bat)
CA   Transformed cell line
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ZFF
AC   CVCL_YB65
DR   Wikidata; Q98136489
RX   DOI=10.1046/j.1365-2761.1996.00258.x;
CC   Group: Fish cell line.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 19-12-19; Last updated: 05-10-23; Version: 5
//
ID   ZFiM-1
AC   CVCL_A2ZU
SY   Zebra Fish Muscle-1
DR   NRFC; NRFC069
DR   Wikidata; Q105511849
WW   Provider; NRFC; NRFC069; https://mail.nbfgr.res.in/nrfc/cellline-available.php
CC   Group: Fish cell line.
CC   Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC069.
CC   Derived from site: In situ; Muscle; UBERON=UBERON_0001630.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Age unspecified
CA   Spontaneously immortalized cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 8
//
ID   ZFL
AC   CVCL_3276
SY   ZF-L; ZebraFish Liver; ZLE; Zebrafish Liver Epithelium
DR   CLO; CLO_0009725
DR   ATCC; CRL-2643
DR   BCRC; 60454
DR   BCRJ; 0256
DR   FCS-free; 154-27-282-1-4-3
DR   Wikidata; Q54995906
RX   DOI=10.1007/BF01404818;
RX   PubMed=7994634;
RX   PubMed=24355757;
RX   PubMed=25536407;
RX   PubMed=28587087;
CC   Group: Fish cell line.
CC   Doubling time: 2.54 +- 0.28 days (Note=In L-15-FBS), 6.6 +- 0.43 days (Note=In UltraMEM-ITES) (PubMed=28587087); 72 hours (ATCC=CRL-2643).
CC   Donor information: According to PubMed 7994634 obtained from pooling the livers of three fish, while ATCC mentions 10 individuals (ATCC=CRL-2643; PubMed=7994634).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 21
//
ID   Zfp57+/- clone 6909
AC   CVCL_DR00
DR   Wikidata; Q54995912
RX   PubMed=27345984;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   Zfp57+/- clone 6911
AC   CVCL_DR01
DR   Wikidata; Q54995913
RX   PubMed=27345984;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57 (Note=1 of 2 alleles).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 30-01-24; Version: 7
//
ID   Zfp57-/- clone 406
AC   CVCL_DR02
DR   Wikidata; Q54995907
RX   PubMed=27345984;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   Zfp57-/- clone 631
AC   CVCL_DR03
DR   Wikidata; Q54995909
RX   PubMed=27345984;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   Zfp57-/- clone 634
AC   CVCL_DR04
DR   Wikidata; Q54995911
RX   PubMed=27345984;
CC   Knockout cell: Method=Homologous recombination; MGI; MGI:99204; Zfp57.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Sex unspecified
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 13-07-16; Last updated: 29-06-23; Version: 6
//
ID   ZFTMA
AC   CVCL_4Z52
DR   GEO; GSM1496090
DR   GEO; GSM1496091
DR   GEO; GSM1496092
DR   GEO; GSM1496095
DR   GEO; GSM1496096
DR   GEO; GSM1496097
DR   Wikidata; Q54995915
RX   PubMed=21359817;
RX   PubMed=22922019;
RX   PubMed=26864856;
CC   Group: Bird cell line.
CC   Doubling time: 9.68 hours (Note=At 300 days of culture) (PubMed=21359817).
CC   Karyotypic information: Tetraploid karyotype (PubMed=21359817).
CC   Omics: Transcriptomics; RNAseq.
DI   NCIt; C134785; Zebra finch neoplasm
OX   NCBI_TaxID=59729; ! Taeniopygia guttata (Zebra finch)
SX   Female
AG   Adult
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 10-04-25; Version: 9
//
ID   ZG
AC   CVCL_R820
SY   Zebrafish Gill
DR   Wikidata; Q54995917
RX   PubMed=1591622;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Gill; UBERON=UBERON_0002535.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   ZH-161
AC   CVCL_JZ64
SY   Zurich Hospital-161
DR   Wikidata; Q54995918
RX   PubMed=27313764;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   ZH-305
AC   CVCL_JZ65
SY   Zurich Hospital-305
DR   Wikidata; Q54995919
RX   PubMed=27313764;
CC   Group: Cancer stem cell line.
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 29-06-23; Version: 6
//
ID   Zh1
AC   CVCL_V187
SY   ZZU-hESC-1
DR   Wikidata; Q54995920
RX   PubMed=22711576;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   Zh21
AC   CVCL_V188
SY   ZZU-hESC-21
DR   Wikidata; Q54995921
RX   PubMed=22711576;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 16-04-14; Last updated: 14-08-25; Version: 10
//
ID   ZH68-2A4
AC   CVCL_A0NN
SY   Ts-ZH68-2A4
DR   Wikidata; Q108821560
RX   Patent=US20210155714;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.18317.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; B0F9T9; Trichinella spiralis serine protease Ts-ZH68.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 21-03-23; Version: 3
//
ID   ZHBTc4
AC   CVCL_C715
SY   ZHBTc4-mESC; ZHBTc4 ES
DR   EFO; EFO_0005914
DR   ENCODE; ENCBS071NKO
DR   ENCODE; ENCBS173ENC
DR   ENCODE; ENCBS174ENC
DR   ENCODE; ENCBS175ENC
DR   ENCODE; ENCBS809MFF
DR   ENCODE; ENCBS898AKA
DR   GEO; GSM137761
DR   GEO; GSM137762
DR   GEO; GSM137763
DR   GEO; GSM137764
DR   GEO; GSM137765
DR   GEO; GSM137766
DR   GEO; GSM137767
DR   GEO; GSM137768
DR   GEO; GSM137769
DR   GEO; GSM137770
DR   GEO; GSM137771
DR   GEO; GSM137772
DR   GEO; GSM137773
DR   GEO; GSM137774
DR   GEO; GSM137775
DR   GEO; GSM137776
DR   GEO; GSM137777
DR   GEO; GSM137778
DR   GEO; GSM137779
DR   GEO; GSM137780
DR   GEO; GSM137786
DR   GEO; GSM137787
DR   GEO; GSM137788
DR   GEO; GSM137789
DR   GEO; GSM137790
DR   GEO; GSM137791
DR   GEO; GSM137792
DR   GEO; GSM137793
DR   GEO; GSM137794
DR   GEO; GSM137795
DR   GEO; GSM138138
DR   GEO; GSM138139
DR   GEO; GSM138140
DR   GEO; GSM1014150
DR   GEO; GSM1014152
DR   GEO; GSM1014169
DR   GEO; GSM1385517
DR   RCB; AES0136
DR   Wikidata; Q54995922
RX   PubMed=10742100;
WW   Info; ENCODE; -; http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/ZhBTc4_Stam_protocol.pdf
CC   Part of: ENCODE project mouse cell lines.
CC   Discontinued: RCB; AES0136; probable.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C714 ! ZHTc6
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 16
//
ID   ZHTc6
AC   CVCL_C714
DR   GEO; GSM137781
DR   GEO; GSM137782
DR   GEO; GSM137783
DR   GEO; GSM137784
DR   GEO; GSM137785
DR   GEO; GSM137796
DR   GEO; GSM137797
DR   GEO; GSM137798
DR   GEO; GSM137799
DR   GEO; GSM137800
DR   GEO; GSM137801
DR   GEO; GSM137802
DR   GEO; GSM137803
DR   GEO; GSM137804
DR   GEO; GSM137805
DR   GEO; GSM137806
DR   GEO; GSM137807
DR   GEO; GSM137808
DR   GEO; GSM137809
DR   GEO; GSM137810
DR   GEO; GSM137811
DR   GEO; GSM137812
DR   GEO; GSM137813
DR   GEO; GSM137814
DR   GEO; GSM137815
DR   GEO; GSM137816
DR   GEO; GSM137817
DR   GEO; GSM137818
DR   GEO; GSM137819
DR   GEO; GSM137820
DR   GEO; GSM138141
DR   GEO; GSM138142
DR   GEO; GSM138143
DR   RCB; AES0137
DR   Wikidata; Q54995923
RX   PubMed=10742100;
CC   Discontinued: RCB; AES0137; probable.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
CC   Breed/subspecies: 129P2/Ola.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3987 ! CGR8
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 11
//
ID   ZIPi001-B
AC   CVCL_YR21
SY   ZIP1K2
DR   hPSCreg; ZIPi001-B
DR   Wikidata; Q98136492
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   ZIPi010-A
AC   CVCL_YR18
DR   hPSCreg; ZIPi010-A
DR   Wikidata; Q98136494
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   ZIPi011-A
AC   CVCL_YR19
DR   hPSCreg; ZIPi011-A
DR   Wikidata; Q98136497
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   ZIPi012-A
AC   CVCL_YR20
DR   hPSCreg; ZIPi012-A
DR   Wikidata; Q98136500
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   ZIPi013-A
AC   CVCL_UF43
DR   BioSamples; SAMEA104620792
DR   hPSCreg; ZIPi013-A
DR   Wikidata; Q98136502
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   ZIPi013-B
AC   CVCL_UF44
SY   ZIP13K2
DR   BioSamples; SAMEA104620789
DR   hPSCreg; ZIPi013-B
DR   Wikidata; Q98136505
RX   PubMed=30343101;
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   ZIPi013-C
AC   CVCL_UF45
DR   hPSCreg; ZIPi013-C
DR   Wikidata; Q98136507
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   ZIPi013-D
AC   CVCL_UF46
DR   hPSCreg; ZIPi013-D
DR   Wikidata; Q98136509
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   ZIPi013-E
AC   CVCL_UF47
SY   ZIP13K5
DR   BioSamples; SAMEA4760687
DR   hPSCreg; ZIPi013-E
DR   Wikidata; Q98136512
RX   PubMed=30343101;
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_UF42 ! HDF-f
SX   Female
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 6
//
ID   ZIPi014-A
AC   CVCL_YR35
DR   hPSCreg; ZIPi014-A
DR   Wikidata; Q98136514
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 21-03-23; Version: 3
//
ID   ZIPi015-A
AC   CVCL_A8GQ
DR   hPSCreg; ZIPi015-A
DR   Wikidata; Q107117563
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-B
AC   CVCL_A8GR
DR   hPSCreg; ZIPi015-B
DR   Wikidata; Q107117564
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-C
AC   CVCL_A8GS
DR   hPSCreg; ZIPi015-C
DR   Wikidata; Q107117565
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-D
AC   CVCL_A8GT
DR   hPSCreg; ZIPi015-D
DR   Wikidata; Q107117567
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-E
AC   CVCL_A8GU
DR   hPSCreg; ZIPi015-E
DR   Wikidata; Q107117568
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-F
AC   CVCL_A8GV
DR   hPSCreg; ZIPi015-F
DR   Wikidata; Q107117569
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-G
AC   CVCL_A8GW
DR   hPSCreg; ZIPi015-G
DR   Wikidata; Q107117570
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-H
AC   CVCL_A8GX
DR   hPSCreg; ZIPi015-H
DR   Wikidata; Q107117571
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-I
AC   CVCL_A8GY
DR   hPSCreg; ZIPi015-I
DR   Wikidata; Q107117572
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GZ ! ZIPi015-J
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-J
AC   CVCL_A8GZ
DR   hPSCreg; ZIPi015-J
DR   Wikidata; Q107117573
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_UD58 ! ZIPi015-K
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
ID   ZIPi015-K
AC   CVCL_UD58
SY   AS_ID; ZIP15
DR   hPSCreg; ZIPi015-K
DR   Wikidata; Q98136517
RX   PubMed=30296670;
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C75462; Angelman syndrome
DI   ORDO; Orphanet_72; Angelman syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A8GQ ! ZIPi015-A
OI   CVCL_A8GR ! ZIPi015-B
OI   CVCL_A8GS ! ZIPi015-C
OI   CVCL_A8GT ! ZIPi015-D
OI   CVCL_A8GU ! ZIPi015-E
OI   CVCL_A8GV ! ZIPi015-F
OI   CVCL_A8GW ! ZIPi015-G
OI   CVCL_A8GX ! ZIPi015-H
OI   CVCL_A8GY ! ZIPi015-I
OI   CVCL_A8GZ ! ZIPi015-J
SX   Female
AG   12Y
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 29-06-23; Version: 7
//
ID   ZIPi021-A
AC   CVCL_D0PK
SY   ZIP21 K1
DR   BioSamples; SAMEA113424921
DR   hPSCreg; ZIPi021-A
DR   Wikidata; Q123034003
RX   PubMed=37343429;
CC   From: Zentrum fur Integrative Psychiatrie; Kiel; Germany.
CC   Population: Caucasian.
CC   Cell type: Fibroblast; CL=CL_0000057.
DI   NCIt; C75463; Prader-Willi syndrome
DI   ORDO; Orphanet_739; Prader-Willi syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   4Y6M
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ZIZ-LD-1
AC   CVCL_Z243
DR   ECACC; 93022523
DR   Wikidata; Q54995925
RX   DOI=10.1016/0022-1910(92)90116-U;
CC   Group: Insect cell line.
CC   Discontinued: ECACC; 93022523; true.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 14-08-25; Version: 9
//
ID   ZIZ-LD-1-15
AC   CVCL_Z244
DR   Wikidata; Q54995927
RX   DOI=10.1016/0022-1910(92)90116-U;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
HI   CVCL_Z243 ! ZIZ-LD-1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ZIZ-LD-1-3
AC   CVCL_Z245
DR   Wikidata; Q54995928
RX   DOI=10.1016/0022-1910(92)90116-U;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
HI   CVCL_Z243 ! ZIZ-LD-1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ZIZ-LD-1-4
AC   CVCL_Z246
DR   Wikidata; Q54995929
RX   DOI=10.1016/0022-1910(92)90116-U;
CC   Group: Insect cell line.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=7539; ! Leptinotarsa decemlineata (Colorado potato beetle)
HI   CVCL_Z243 ! ZIZ-LD-1
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 7
//
ID   ZJ-C-hiPSC
AC   CVCL_A4HJ
SY   ZJ-C; ZJ-Corrected-hiPSC
DR   SKIP; SKIP003142
DR   Wikidata; Q105511852
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple_corrected; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4HC ! ZJ-hiPSC 3
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZJ-hiPSC 11
AC   CVCL_A4HE
SY   ZJ11
DR   SKIP; SKIP003136
DR   Wikidata; Q105511854
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HC ! ZJ-hiPSC 3
OI   CVCL_A4HD ! ZJ-hiPSC 6
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZJ-hiPSC 3
AC   CVCL_A4HC
SY   ZJ3
DR   SKIP; SKIP003134
DR   Wikidata; Q105511858
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HD ! ZJ-hiPSC 6
OI   CVCL_A4HE ! ZJ-hiPSC 11
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZJ-hiPSC 6
AC   CVCL_A4HD
SY   ZJ6
DR   SKIP; SKIP003135
DR   Wikidata; Q105511860
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HC ! ZJ-hiPSC 3
OI   CVCL_A4HE ! ZJ-hiPSC 11
SX   Male
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZJB-ATC1
AC   CVCL_XI70
DR   CCRID; 4201PAT-CCTCC01046
DR   Wikidata; Q98136519
RX   Patent=CN107460171B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201753.
CC   Population: Chinese.
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
ST   Source(s): Patent=CN107460171B
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D12S391: 20
ST   D13S317: 9
ST   D16S539: 10
ST   D18S51: 14,15
ST   D19S433: 13.2,14
ST   D21S11: 31,32.2
ST   D2S1338: 18
ST   D3S1358: 15
ST   D5S818: 10,13
ST   D6S1043: 12,19
ST   D7S820: 10,11
ST   D8S1179: 10,13
ST   FGA: 22,23
ST   Penta D: 9,12
ST   Penta E: 11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C3878; Thyroid gland anaplastic carcinoma
DI   ORDO; Orphanet_142; Anaplastic thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   72Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 29-06-23; Version: 9
//
ID   ZJB-ENC1
AC   CVCL_XI65
DR   CCRID; 4201PAT-CCTCC00919
DR   Wikidata; Q98136522
RX   Patent=CN106244554B;
RX   PubMed=31772679;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2016118.
CC   Population: Chinese.
CC   Doubling time: ~43 hours (PubMed=31772679).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): Patent=CN106244554B; PubMed=31772679
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 18,19
ST   D13S317: 10
ST   D16S539: 9,12
ST   D18S51: 12,17
ST   D19S433: 13
ST   D21S11: 30
ST   D2S1338: 20,21
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D6S1043: 14,17
ST   D7S820: 11,12
ST   D8S1179: 10
ST   FGA: 22,26
ST   Penta D: 9,13
ST   Penta E: 14,27
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 17,20
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   58Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 10-04-25; Version: 10
//
ID   ZJBIQ-Chsu-I
AC   CVCL_Z275
DR   ICLDB; zjbiq-chsu-i
DR   Wikidata; Q54900019
RX   PubMed=25381037;
CC   Group: Insect cell line.
CC   Doubling time: ~62 hours (PubMed=25381037).
CC   Misspelling: KLBIQ-Chsu-I; PubMed=25381037; Note=In text of paper but not in abstract.
CC   Derived from site: In situ; Fat body; UBERON=UBERON_0003917.
OX   NCBI_TaxID=168631; ! Chilo suppressalis (Asiatic rice borer moth)
SX   Sex unspecified
AG   Last instar larval stage
CA   Spontaneously immortalized cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 11
//
ID   ZJED0-02
AC   CVCL_B6WF
DR   CCRID; 4201PAT-CCTCC00707
DR   Wikidata; Q112041947
RX   Patent=CN105112375B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201584.
CC   Monoclonal antibody isotype: IgG2a, kappa.
CC   Monoclonal antibody target: UniProtKB; X5H5A9; Zaire ebolavirus (strain Makona) envelope glycoprotein (GP).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 17-03-22; Last updated: 21-03-23; Version: 3
//
ID   ZJLXB-1
AC   CVCL_JX66
DR   CCRID; 4201PAT-CCTCC00171
DR   Wikidata; Q54995930
RX   Patent=CN100455662C;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200518.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Influenza A virus H5N1 hemagglutinin (HA).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 7
//
ID   ZJSHi001-A
AC   CVCL_A9Z5
SY   ZJSHi-KCNB1
DR   BioSamples; SAMEA7462435
DR   hPSCreg; ZJSHi001-A
DR   Wikidata; Q102115153
RX   PubMed=33607466;
CC   From: Department of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6231; KCNB1; Simple; p.Glu330Asp (c.990G>T); Zygosity=Heterozygous (PubMed=33607466).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C175047; Developmental and epileptic encephalopathy 26
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 7
//
ID   ZJSHDPi001-A
AC   CVCL_C8D1
SY   ZJSH-FGF12
DR   hPSCreg; ZJSHDPi001-A
DR   Wikidata; Q123034004
RX   PubMed=37331110;
CC   From: Department of Pediatrics, The Second Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3668; FGF12; Simple; p.Gly112Ser (c.334G>A) (p.Gly50Ser, c.148G>A); ClinVar=VCV000522854; Zygosity=Heterozygous (PubMed=37331110).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201514; Developmental and epileptic encephalopathy 47
DI   ORDO; Orphanet_442835; Non-specific early-onset epileptic encephalopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 29-06-23; Last updated: 19-12-24; Version: 4
//
ID   ZJU-0327
AC   CVCL_XC09
DR   cancercelllines; CVCL_XC09
DR   CCRID; 4201PAT-CCTCC01124
DR   Wikidata; Q98136525
RX   Patent=CN108034636B;
RX   PubMed=30140169;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017173.
CC   Population: Chinese.
CC   Doubling time: 18.7 hours (Patent=CN108034636B).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Asn (c.376T>A); ClinVar=VCV000428871; Zygosity=Unspecified (PubMed=30140169).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   ZJU-0430
AC   CVCL_XE03
DR   CCRID; 4201PAT-CCTCC01127
DR   Wikidata; Q98136527
RX   Patent=CN108048401A;
RX   PubMed=31367188;
CC   Group: Patented cell line.
CC   Problematic cell line: Possibly contaminated. STR profile is 100% identical to that of GBC-SD (Cellosaurus=CVCL_6903).
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017174.
CC   Population: Chinese.
CC   Doubling time: 19.81 hours (PubMed=31367188).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=31367188
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 11,12
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
//
ID   ZJU-0725
AC   CVCL_XC10
DR   cancercelllines; CVCL_XC10
DR   CCRID; 4201PAT-CCTCC01125
DR   Wikidata; Q98136529
RX   Patent=CN108034636B;
RX   PubMed=30140169;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017171.
CC   Population: Chinese.
CC   Doubling time: 57.5 hours (Patent=CN108034636B).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Asn (c.376T>A); ClinVar=VCV000428871; Zygosity=Unspecified (PubMed=30140169).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC11 ! ZJU-1127
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   ZJU-0826
AC   CVCL_XE04
DR   CCRID; 4201PAT-CCTCC01128
DR   Wikidata; Q98136531
RX   Patent=CN108048401A;
RX   PubMed=31359275;
RX   PubMed=35640676;
CC   Group: Patented cell line.
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017175.
CC   Population: Chinese.
CC   Doubling time: 63.84 hours (PubMed=31359275).
CC   Karyotypic information: Near triploid karyotype (PubMed=31359275).
CC   Derived from site: In situ; Extrahepatic bile duct; UBERON=UBERON_0003703.
ST   Source(s): PubMed=31359275
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11,12
ST   D13S317: 8,12
ST   D16S539: 9,11,12,13
ST   D5S818: 11
ST   D7S820: 11,12
ST   TH01: 7,9,10
ST   TPOX: 9,11
ST   vWA: 16,17
DI   NCIt; C36077; Hilar cholangiocarcinoma
DI   ORDO; Orphanet_99978; Klatskin tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 05-10-23; Version: 10
//
ID   ZJU-1125
AC   CVCL_XE05
DR   cancercelllines; CVCL_XE05
DR   CCRID; 4201PAT-CCTCC01129
DR   Wikidata; Q98136534
RX   Patent=CN108048401A;
RX   PubMed=31359275;
RX   PubMed=35640676;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017176.
CC   Population: Chinese.
CC   Doubling time: 44.73 hours (PubMed=31359275).
CC   Karyotypic information: Near triploid karyotype (PubMed=31359275).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Ser (c.403T>A); ClinVar=VCV000376562; Zygosity=Unspecified (PubMed=31359275).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): PubMed=31359275
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 12,13
ST   D5S818: 11,12
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 16
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 11
//
ID   ZJU-1127
AC   CVCL_XC11
DR   cancercelllines; CVCL_XC11
DR   CCRID; 4201PAT-CCTCC01126
DR   Wikidata; Q98136536
RX   Patent=CN108034636B;
RX   PubMed=30140169;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017172.
CC   Population: Chinese.
CC   Doubling time: 18.8 hours (Patent=CN108034636B).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Tyr126Asn (c.376T>A); ClinVar=VCV000428871; Zygosity=Unspecified (PubMed=30140169).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_XC10 ! ZJU-0725
SX   Female
AG   65Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
ID   ZJUCHi001-A
AC   CVCL_VT14
DR   hPSCreg; ZJUCHi001-A
DR   Wikidata; Q98136539
RX   PubMed=30785048;
CC   From: Children's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7225; MPZ; Simple; p.Arg98Cys (c.292C>T); ClinVar=VCV000014175; Zygosity=Heterozygous (PubMed=30785048).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C118782; Charcot-Marie-Tooth disease type 1B
DI   ORDO; Orphanet_101082; Charcot-Marie-Tooth disease type 1B
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 19-12-24; Version: 9
//
ID   ZJUCHi002-A
AC   CVCL_WG63
DR   hPSCreg; ZJUCHi002-A
DR   Wikidata; Q98136541
RX   PubMed=30807887;
CC   From: Children's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16877; MFN2; Simple; p.Pro251Leu (c.752C>T); ClinVar=VCV000637945; Zygosity=Heterozygous (PubMed=30807887).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C150646; Charcot-Marie-Tooth disease type 2A2A
DI   ORDO; Orphanet_99947; Autosomal dominant Charcot-Marie-Tooth disease type 2A2
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 19-12-24; Version: 8
//
ID   ZJUCHi003-A
AC   CVCL_D4ZF
SY   ZJUCHi003
DR   BioSamples; SAMEA113941585
DR   hPSCreg; ZJUCHi003-A
DR   Wikidata; Q127384773
RX   PubMed=38372889;
CC   From: Children's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:6250; KCNH1; Simple; p.Arg357Gln (c.1070G>A); ClinVar=VCV000279981; Zygosity=Heterozygous; Note=De novo mutation (PubMed=38372889).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
ST   Source(s): PubMed=38372889
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D10S1248: 13,14
ST   D12S391: 18,19
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,15
ST   D19S433: 15,16
ST   D1S1656: 16,20.3
ST   D21S11: 28,30
ST   D22S1045: 11,15
ST   D2S1338: 19,24
ST   D2S441: 11
ST   D3S1358: 15,16
ST   D5S818: 7,11
ST   D6S1043: 11,17
ST   D7S820: 11
ST   D8S1179: 10,16
ST   FGA: 19,26
ST   Penta D: 8,13
ST   Penta E: 11,12
ST   SE33: 21,31.2
ST   TH01: 7
ST   TPOX: 8
ST   vWA: 14,16
DI   NCIt; C205647; Zimmermann-Laband syndrome 1
DI   ORDO; Orphanet_3473; Zimmermann-Laband syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 19-12-24; Version: 3
//
ID   ZJUhES-1
AC   CVCL_LI00
DR   Wikidata; Q54995931
RX   PubMed=20973834;
CC   From: College of Life Sciences, Zhejiang University; Hangzhou; China.
CC   Doubling time: 69 hours (PubMed=20973834).
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
ST   Source(s): PubMed=20973834
ST   Amelogenin: X,Y
ST   D13S317: 9,12
ST   D18S51: 14,17
ST   D21S11: 29,30
ST   D3S1358: 15,16
ST   D5S818: 9,11
ST   D7S820: 8,12
ST   D8S1179: 12,15
ST   FGA: 23,27
ST   vWA: 17
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 5
//
ID   ZJUi001-A
AC   CVCL_ZL90
SY   YFL-4; YFL-Urine-iPSC-#4
DR   hPSCreg; ZJUi001-A
DR   Wikidata; Q98136544
RX   PubMed=33039804;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gly166Val (c.497G>T); ClinVar=VCV000448900; Zygosity=Hemizygous (PubMed=33039804).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL91 ! ZJUi001-B
OI   CVCL_ZL92 ! ZJUi001-C
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZJUi001-B
AC   CVCL_ZL91
SY   YFL-11; YFL-Urine-iPSC-#11
DR   hPSCreg; ZJUi001-B
DR   Wikidata; Q98136546
RX   PubMed=33039804;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gly166Val (c.497G>T); ClinVar=VCV000448900; Zygosity=Hemizygous (PubMed=33039804).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL90 ! ZJUi001-A
OI   CVCL_ZL92 ! ZJUi001-C
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZJUi001-C
AC   CVCL_ZL92
SY   YFL-30; YFL-Urine-iPSC-#30
DR   hPSCreg; ZJUi001-C
DR   Wikidata; Q98136549
RX   PubMed=33039804;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gly166Val (c.497G>T); ClinVar=VCV000448900; Zygosity=Hemizygous (PubMed=33039804).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL90 ! ZJUi001-A
OI   CVCL_ZL91 ! ZJUi001-B
SX   Male
AG   4Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZJUi002-A
AC   CVCL_ZL93
SY   ZZC-3; ZZC-Urine-iPSC-#3
DR   hPSCreg; ZJUi002-A
DR   Wikidata; Q98136552
RX   PubMed=33039804;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gly166Val (c.497G>T); ClinVar=VCV000448900; Zygosity=Heterozygous (PubMed=33039804).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL94 ! ZJUi002-B
OI   CVCL_ZL95 ! ZJUi002-C
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZJUi002-B
AC   CVCL_ZL94
SY   ZZC-4; ZZC-Urine-iPSC-#4
DR   hPSCreg; ZJUi002-B
DR   Wikidata; Q98136554
RX   PubMed=33039804;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gly166Val (c.497G>T); ClinVar=VCV000448900; Zygosity=Heterozygous (PubMed=33039804).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL93 ! ZJUi002-A
OI   CVCL_ZL95 ! ZJUi002-C
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZJUi002-C
AC   CVCL_ZL95
SY   ZZC-5; ZZC-Urine-iPSC-#5
DR   hPSCreg; ZJUi002-C
DR   Wikidata; Q98136557
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gly166Val (c.497G>T); ClinVar=VCV000448900; Zygosity=Heterozygous (from autologous cell lines ZJUi002-A; ZJUi002-B).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_ZL93 ! ZJUi002-A
OI   CVCL_ZL94 ! ZJUi002-B
SX   Female
AG   35Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 9
//
ID   ZJUi003-A
AC   CVCL_ZL88
SY   GZW-iPS; GZW Urine-iPS
DR   hPSCreg; ZJUi003-A
DR   SKIP; SKIP005750
DR   Wikidata; Q98136559
RX   PubMed=32534167;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Thr61Serfs*16 (c.180_181del); Zygosity=Heterozygous (PubMed=32534167).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
CC   Cell type: Epithelial cell of kidney; CL=CL_0002518.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   ZJUi004-A
AC   CVCL_ZL89
SY   FXY-iPSC-C9
DR   hPSCreg; ZJUi004-A
DR   Wikidata; Q98136561
RX   PubMed=32916635;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9024; PKP2; Simple; c.2357+1G>A (c.2489+1G>A); ClinVar=VCV000006757; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=32916635).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84571; Arrhythmogenic right ventricular dysplasia
DI   ORDO; Orphanet_293910; Familial isolated arrhythmogenic ventricular dysplasia, right dominant form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 8
//
ID   ZJUi005-A
AC   CVCL_ZE47
SY   ZJU-iPS-PMD-PLP1-001
DR   hPSCreg; ZJUi005-A
DR   SKIP; SKIP005797
DR   Wikidata; Q98136564
RX   PubMed=32402715;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9086; PLP1; Simple; p.Leu146Pro (c.437T>C); Zygosity=Hemizygous (PubMed=32402715).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75487; Pelizaeus-Merzbacher disease
DI   ORDO; Orphanet_702; Pelizaeus-Merzbacher disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   18Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZJUi007-A
AC   CVCL_A8NW
DR   hPSCreg; ZJUi007-A
DR   Wikidata; Q108821562
RX   PubMed=34365103;
CC   From: The First Affiliated Hospital of Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4296; GLA; Simple; p.Trp47Ter (c.140G>A); Zygosity=Hemizygous (PubMed=34365103).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84701; Fabry disease
DI   ORDO; Orphanet_324; Fabry disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 5
//
ID   ZJUi008-A
AC   CVCL_B5GL
DR   hPSCreg; ZJUi008-A
DR   Wikidata; Q110434440
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 21-03-23; Version: 3
//
ID   ZJUi009-A
AC   CVCL_C0IK
SY   ZJULLi001-A
DR   BioSamples; SAMEA9925523
DR   hPSCreg; ZJUi009-A
DR   Wikidata; Q112930591
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Derived from site: In situ; Arm, skin; UBERON=UBERON_0002427.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
ID   ZJUi010-A
AC   CVCL_C0IJ
SY   161103SPYLQTFSDC12; ZJULLi002-A
DR   BioSamples; SAMEA14091364
DR   hPSCreg; ZJUi010-A
DR   Wikidata; Q112930592
RX   PubMed=35569348;
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Tyr652Ter (c.1956C>A); Zygosity=Heterozygous (PubMed=35569348).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ZJUi011-A
AC   CVCL_C0IL
SY   LSYMYH7iPS; LSY-iPSC-C11; ZJULLi003-A
DR   BioSamples; SAMEA14429757
DR   hPSCreg; ZJUi011-A
DR   Wikidata; Q112930593
RX   PubMed=35944310;
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Glu1462Lys (c.4384G>A); ClinVar=VCV000918880; Zygosity=Heterozygous (PubMed=35944310).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 5
//
ID   ZJUi012-A
AC   CVCL_C0IM
SY   ZYLMYBPC3iPS; ZYL-iPSC-C2; ZJULLi004-A
DR   BioSamples; SAMEA14430505
DR   hPSCreg; ZJUi012-A
DR   Wikidata; Q112930594
RX   PubMed=36041398;
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Ala1255Asp (c.3764C>A); ClinVar=VCV000179227; Zygosity=Heterozygous (PubMed=36041398).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   ZJUi013-A
AC   CVCL_C9HU
DR   hPSCreg; ZJUi013-A
DR   Wikidata; Q123034005
RX   PubMed=37890330;
CC   From: Zhejiang University School of Medicine; Hangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:31750; SAMD12; Unexplicit; 5-BP INS, TTTCA(n) repeat expansion, IVS4; ClinVar=VCV000560216; Zygosity=Heterozygous (PubMed=37890330).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C206111; Familial adult myoclonic epilepsy 1
DI   ORDO; Orphanet_86814; Benign adult familial myoclonic epilepsy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 5
//
ID   ZJUi005-A [Wrong name]
AC   CVCL_A0ZZ
SY   WXG-iPSC-C6
DR   Wikidata; Q108821561
RX   PubMed=34298435;
CC   From: Women's Hospital, Zhejiang University School of Medicine; Hangzhou; China.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys2245Tyr (c.6734G>A); ClinVar=VCV000968455; Zygosity=Heterozygous (PubMed=34298435).
CC   Caution: There are 2 cell lines generated by the same group with the same name. This cell line should be renamed.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 19-12-24; Version: 6
//
ID   ZJYYPHi001-A
AC   CVCL_B5GQ
DR   hPSCreg; ZJYYPHi001-A
DR   Wikidata; Q110434441
RX   PubMed=34678660;
CC   From: Yuyao People's Hospital of Zhejiang Province; Yuyao city; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10593; SCN5A; Simple; p.Arg513Cys (c.1537C>T); ClinVar=VCV000201456; Zygosity=Heterozygous (PubMed=34678660).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137959; Long QT syndrome 3
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ZK
AC   CVCL_A5XI
DR   Wikidata; Q107117574
RX   PubMed=1842870;
CC   Population: Japanese.
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ZK-1
AC   CVCL_A5XH
DR   Wikidata; Q107117575
RX   PubMed=6205928;
RX   PubMed=10359046;
RX   PubMed=22575259;
RX   PubMed=23817087;
CC   Population: Japanese.
CC   Doubling time: 26 hours (PubMed=22575259).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
ID   ZK-2
AC   CVCL_A5XP
DR   Wikidata; Q107117576
RX   PubMed=23817087;
CC   Population: Japanese.
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 21-03-23; Version: 4
//
ID   ZK-58
AC   CVCL_9920
SY   ZK58; HOS 58
DR   cancercelllines; CVCL_9920
DR   Cosmic; 1529906
DR   GEO; GSM879224
DR   IARC_TP53; 27033
DR   Progenetix; CVCL_9920
DR   Wikidata; Q54995932
RX   PubMed=9674117;
RX   PubMed=12645653;
RX   PubMed=15150091;
RX   PubMed=19787792;
RX   PubMed=21519327;
RX   PubMed=23144859;
CC   Characteristics: Established from a nude mice xenograft (PubMed=9674117).
CC   Doubling time: ~72 hours (PubMed=21519327).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=19787792).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: In situ; Bone, leg; UBERON=UBERON_0005893.
ST   Source(s): PubMed=19787792
ST   Amelogenin: X,Y
ST   D16S539: 11
ST   D18S51: 15,18
ST   D19S433: 12,14
ST   D21S11: 29,30.2
ST   D2S1338: 25
ST   D3S1358: 16
ST   D5S818: 11
ST   D8S1179: 13,14
ST   FGA: 24
ST   SE33: 24.2
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 19
//
ID   ZK-H
AC   CVCL_W465
DR   Wikidata; Q54995935
RX   DOI=10.4044/joma1947.92.3-4_289;
RX   PubMed=6257373;
CC   Population: Japanese.
CC   Doubling time: 76 hours (PubMed=6257373).
CC   Karyotypic information: 47,XY,+2 (PubMed=6257373).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C7402; Hairy cell leukemia
DI   ORDO; Orphanet_58017; Classic hairy cell leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W466 ! ZK-N
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 11
//
ID   ZK-N
AC   CVCL_W466
DR   Wikidata; Q54995936
RX   DOI=10.4044/joma1947.92.3-4_289;
CC   Population: Japanese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_W465 ! ZK-H
SX   Male
AG   69Y
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 29-06-23; Version: 10
//
ID   ZK1
AC   CVCL_D1KX
SY   ZK-1
DR   ABM; T0676
DR   Wikidata; Q127384774
RX   PubMed=18452625;
CC   Doubling time: 12-16 hours (PubMed=18452625).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1309998; Marco.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98257; Msr1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung; Note=From a bronchoalveolar lavage; UBERON=UBERON_0002048.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: MARCO-/- SR-AI/II-/- (MS-/-).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D1KY ! ZK2
OI   CVCL_D1KZ ! ZK6
SX   Male
AG   9-14W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZK2
AC   CVCL_D1KY
SY   ZK-2
DR   ABM; T0677
DR   Wikidata; Q127384776
RX   PubMed=18452625;
CC   Doubling time: 12-16 hours (PubMed=18452625).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1309998; Marco.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98257; Msr1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung; Note=From a bronchoalveolar lavage; UBERON=UBERON_0002048.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: MARCO-/- SR-AI/II-/- (MS-/-).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D1KX ! ZK1
OI   CVCL_D1KZ ! ZK6
SX   Male
AG   9-14W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZK6
AC   CVCL_D1KZ
SY   ZK-6
DR   ABM; T0678
DR   Wikidata; Q127384778
RX   PubMed=18452625;
CC   Doubling time: 12-16 hours (PubMed=18452625).
CC   Knockout cell: Method=KO mouse; MGI; MGI:1309998; Marco.
CC   Knockout cell: Method=KO mouse; MGI; MGI:98257; Msr1.
CC   Transformant: Recombinant retrovirus J2.
CC   Derived from site: In situ; Lung; Note=From a bronchoalveolar lavage; UBERON=UBERON_0002048.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: MARCO-/- SR-AI/II-/- (MS-/-).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
OI   CVCL_D1KX ! ZK1
OI   CVCL_D1KY ! ZK2
SX   Male
AG   9-14W
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZKOP
AC   CVCL_6756
SY   Zeocin-resistant KOP
DR   CLO; CLO_0050526
DR   RCB; RCB2151
DR   Wikidata; Q54995937
RX   PubMed=16198317;
CC   Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR).
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_6753 ! KOP
SX   Female
AG   12-13FD
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 27-11-25; Version: 14
//
ID   ZKS
AC   CVCL_5905
SY   Zebrafish Kidney Stromal
DR   Wikidata; Q54995938
RX   PubMed=19433857;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
CC   Breed/subspecies: AB; VBO=VBO_0017495.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Age unspecified
CA   Stromal cell line
DT   Created: 04-04-12; Last updated: 10-09-24; Version: 14
//
ID   ZL-114
AC   CVCL_WF97
DR   IBRC; C10195
DR   Wikidata; Q98136566
RX   PubMed=32358742;
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-117
AC   CVCL_WF98
DR   IBRC; C10199
DR   Wikidata; Q98136569
RX   PubMed=32358742;
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   33Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-70
AC   CVCL_WF99
DR   IBRC; C10186
DR   Wikidata; Q98136572
RX   PubMed=32358742;
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-71
AC   CVCL_WG00
DR   IBRC; C10187
DR   Wikidata; Q98136575
RX   PubMed=32358742;
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   40Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-73
AC   CVCL_WG01
DR   IBRC; C10188
DR   Wikidata; Q98136577
RX   PubMed=32358742;
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   24Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-74
AC   CVCL_WG02
DR   IBRC; C10189
DR   Wikidata; Q98136579
RX   PubMed=32358742;
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-76
AC   CVCL_WG03
DR   IBRC; C10221
DR   Wikidata; Q98136585
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C2985; Diabetes mellitus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-77
AC   CVCL_WG04
DR   IBRC; C10184
DR   Wikidata; Q98136587
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL-78
AC   CVCL_WG05
DR   IBRC; C10198
DR   Wikidata; Q98136590
CC   Population: Iranian; Zabolis.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Transformed cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 5
//
ID   ZL34
AC   CVCL_5906
SY   ZL-34
DR   BTO; BTO_0003992
DR   ECACC; 11120713
DR   Wikidata; Q54995955
RX   PubMed=1373705;
RX   PubMed=21729925;
RX   PubMed=23840376;
RX   PubMed=33567673;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 29 hours (PubMed=1373705); 24 hours (PubMed=23840376).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): ECACC=11120713
ST   Amelogenin: X
ST   CSF1PO: 11,13
ST   D13S317: 11,12
ST   D16S539: 11
ST   D5S818: 11
ST   D7S820: 9
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 18,20
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   53Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
ID   ZL5
AC   CVCL_5907
DR   ECACC; 11120715
DR   Wikidata; Q54995957
RX   PubMed=1373705;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 31 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
ST   Source(s): ECACC=11120715
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D13S317: 9,13
ST   D16S539: 12
ST   D5S818: 12
ST   D7S820: 10,11
ST   TH01: 6,9.3
ST   TPOX: 8,11
ST   vWA: 16,17
DI   NCIt; C45665; Pleural biphasic mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 16
//
ID   ZL55
AC   CVCL_5908
DR   ECACC; 12050301
DR   PRIDE; PXD000589
DR   Wikidata; Q54995958
RX   PubMed=1373705;
RX   PubMed=21729925;
RX   PubMed=24207061;
RX   PubMed=25894527;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 38 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Omics: Proteomics; Subcellular; Cell surface.
CC   Derived from site: In situ; Lung, pleura; UBERON=UBERON_0000977.
ST   Source(s): ECACC=12050301
ST   Amelogenin: X
ST   CSF1PO: 9,11
ST   D13S317: 8
ST   D16S539: 12
ST   D5S818: 10,13
ST   D7S820: 7,11
ST   TH01: 6
ST   TPOX: 8
ST   vWA: 15,19
DI   NCIt; C45662; Pleural epithelioid mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
ID   ZL92
AC   CVCL_T735
DR   Wikidata; Q54995959
RX   PubMed=1373705;
CC   From: University Hospital of Zurich; Zurich; Switzerland.
CC   Doubling time: 87 hours (PubMed=1373705).
CC   Transformant: ChEBI; CHEBI_46661; Asbestos.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C7376; Pleural malignant mesothelioma
DI   ORDO; Orphanet_50251; Pleural mesothelioma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 19-12-24; Version: 11
//
ID   ZLI-R
AC   CVCL_A3AR
DR   CCLV; CCLV-RIE 0130
DR   Wikidata; Q105511862
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal oral cavity, lip; UBERON=UBERON_0001833.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
AG   Fetus
CA   Finite cell line
DT   Created: 12-01-21; Last updated: 29-06-23; Version: 5
//
ID   ZLSC-423
AC   CVCL_XB87
DR   CCRID; 4201PAT-CCTCC00896
DR   Wikidata; Q98136593
CC   Group: Patented cell line.
DI   NCIt; C3493; Lung squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   ZLu-R
AC   CVCL_RX01
SY   ZLU-R
DR   CCLV; CCLV-RIE 0120
DR   Wikidata; Q54995961
RX   PubMed=24457147;
RX   PubMed=25565633;
CC   Derived from site: In situ; Fetal lung; UBERON=UBERON_0005597.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Male
AG   Fetus
CA   Finite cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
ID   ZM
AC   CVCL_E896
DR   dbMHC; 49088
DR   IHW; IHW09246
DR   IPD-IMGT/HLA; 11609
DR   Wikidata; Q54995962
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   HLA typing: A*69:01,24:02; B*44:03,49; C*04,06:02; DPB1*04:01,04:02 (IPD-IMGT/HLA=11609).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 15
//
ID   ZM fibroblast
AC   CVCL_B7LG
DR   Wikidata; Q112930595
RX   PubMed=9287230;
RX   PubMed=9536093;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*14 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9287230).
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LH ! ZM LCL
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   ZM LCL
AC   CVCL_B7LH
DR   Wikidata; Q112930596
RX   PubMed=9287230;
RX   PubMed=9536093;
CC   Population: Moroccan.
CC   Sequence variation: Mutation; HGNC; HGNC:9988; RFXAP; Simple; p.Ser123Thrfs*15 (c.368delG) (484delG); ClinVar=VCV000007651; Zygosity=Homozygous (PubMed=9287230).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C171268; Bare lymphocyte syndrome type 2
DI   ORDO; Orphanet_572; Immunodeficiency by defective expression of MHC class II
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B7LG ! ZM fibroblast
AG   Children
CA   Transformed cell line
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 6
//
ID   ZM-FC
AC   CVCL_E897
DR   dbMHC; 49089
DR   ECACC; 94071440
DR   IHW; IHW09349
DR   IPD-IMGT/HLA; 11610
DR   Wikidata; Q54995963
RX   PubMed=30844424;
CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC   Population: Caucasian; Sardinian.
CC   HLA typing: A*02; B*51; C*02:02; DPA1*01:03:01; DPB1*02:01:02,04:02; DQA1*03,05:01; DQB1*03:04,03:01; DRB1*04:03,11 (IPD-IMGT/HLA=11610).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 22-10-12; Last updated: 05-10-23; Version: 16
//
ID   ZM90630
AC   CVCL_VI21
DR   Wikidata; Q54995965
RX   PubMed=9230208;
RX   PubMed=10606667;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Homozygous; Note=Splice acceptor mutation (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3447; Werner syndrome
DI   ORDO; Orphanet_902; Werner syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 11
//
ID   ZM90633
AC   CVCL_VI22
DR   Wikidata; Q54995966
RX   PubMed=9230208;
RX   PubMed=10606667;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 29-06-23; Version: 6
//
ID   ZM90634
AC   CVCL_VI23
DR   Wikidata; Q54995967
RX   PubMed=10606667;
CC   Sequence variation: Mutation; HGNC; HGNC:12791; WRN; Simple; p.Lys1046fs*14 (c.3139-1G>C) (IVS25-1G>C); ClinVar=VCV000005447; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=10606667).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Transformed cell line
DT   Created: 14-05-18; Last updated: 19-12-24; Version: 10
//
ID   ZMA1
AC   CVCL_XB43
SY   ZMA1-4C11
DR   CCRID; 4201PAT-CCTCC00189
DR   Wikidata; Q98136595
RX   Patent=CN100569800C;
RX   PubMed=17097684;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200615.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96S97; Human MYADM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   ZMA6
AC   CVCL_XB44
SY   ZMA6-4H2
DR   CCRID; 4201PAT-CCTCC00190
DR   Wikidata; Q98136598
RX   Patent=CN100569800C;
RX   PubMed=17097684;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200616.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96S97; Human MYADM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   ZMAC-1
AC   CVCL_X750
SY   UIMAC FBAL-A; FBAL-A; ZMAC; Zuckermann MACrophage-1
DR   Wikidata; Q54995968
RX   Patent=US9169465;
RX   PubMed=22648044;
RX   PubMed=33268540;
WW   Info; -; -; https://www.pork.org/research/a-study-on-the-feasibility-of-using-a-porcine-alveolar-macrophage-cell-line-to-produce-a-prrs-modified-live-virus-vaccine/
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-8764.
CC   Characteristics: CSF1 dependent.
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=22648044).
CC   Doubling time: ~72 hours (Patent=US9169465).
CC   Derived from site: In situ; Fetal lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace x Yorkshire x Duroc; VBO=VBO_0001161+VBO_0001212+VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   58FD
CA   Factor-dependent cell line
DT   Created: 05-09-14; Last updated: 10-04-25; Version: 14
//
ID   ZMAC-4
AC   CVCL_A0XV
SY   ZMAC1107-4; Zuckermann MACrophage-4
DR   Wikidata; Q108821563
RX   Patent=US9169465;
RX   PubMed=21191013;
RX   PubMed=32515659;
CC   Characteristics: CSF1 dependent.
CC   Virology: Susceptible to infection by porcine reproductive and respiratory syndrome virus (PRRSV) (PubMed=21191013).
CC   Virology: Supports high level of replication of African swine fever virus attenuated strain OURT88/3 (PubMed=32515659).
CC   Doubling time: 3.9 +- 0.3 days (PubMed=32515659).
CC   Derived from site: In situ; Fetal lung, alveolus; UBERON=UBERON_0005597+UBERON_0002299.
CC   Cell type: Alveolar macrophage; CL=CL_0000583.
CC   Breed/subspecies: Landrace x Yorkshire x Duroc; VBO=VBO_0001161+VBO_0001212+VBO_0001127.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   60FD
CA   Factor-dependent cell line
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 7
//
ID   ZMB5
AC   CVCL_XB45
SY   ZMB5-3F10
DR   CCRID; 4201PAT-CCTCC00191
DR   Wikidata; Q98136601
RX   Patent=CN100569800C;
RX   PubMed=17097684;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200617.
CC   Monoclonal antibody isotype: IgG.
CC   Monoclonal antibody target: UniProtKB; Q96S97; Human MYADM.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 21-03-23; Version: 6
//
ID   ZMTH3
AC   CVCL_RW74
DR   Wikidata; Q54995969
RX   PubMed=14571134;
RX   PubMed=18949014;
RX   PubMed=26774145;
RX   PubMed=28591165;
CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
DI   NCIt; C147073; Canine mammary adenoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Female
AG   Age unspecified
CA   Transformed cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 5
//
ID   ZN-5
AC   CVCL_A0QW
SY   zn-5
DR   Wikidata; Q108821564
CC   From: Trevarrow, Bill; Institute of Neuroscience, University of Oregon; Eugene; USA.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q90460; Danio rerio alcama/cd166a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 4
//
ID   ZN-8
AC   CVCL_A0QX
SY   zn-8
DR   DSHB; ZN-8
DR   Wikidata; Q108821565
CC   From: Trevarrow, Bill; Institute of Neuroscience, University of Oregon; Eugene; USA.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q90460; Danio rerio alcama/cd166a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 23-09-21; Last updated: 10-09-24; Version: 5
//
ID   ZN-R
AC   CVCL_0I67
SY   ZN-R1
DR   CCLV; CCLV-RIE 0105
DR   CCLV; CCLV-RIE 0122
DR   Wikidata; Q54995970
RX   PubMed=19941903;
RX   PubMed=24457147;
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Female
AG   Adult
CA   Finite cell line
DT   Created: 10-04-15; Last updated: 29-06-23; Version: 6
//
ID   ZNHi001-A
AC   CVCL_A7KT
SY   ZNHi001-Pr-A
DR   Wikidata; Q107117578
RX   PubMed=33780728;
CC   From: Zhongnan Hospital of Wuhan University; Wuhan; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg180Cys (c.538C>T) (p.Arg223Cys, c.667C>T); ClinVar=VCV000128081; Zygosity=Heterozygous (PubMed=33780728).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176588; CHEK2-related hereditary cancer predisposition syndrome
DI   NCIt; C4863; Prostate carcinoma
DI   ORDO; Orphanet_1331; Familial prostate cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KU ! ZNHi001-B
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   ZNHi001-B
AC   CVCL_A7KU
SY   ZNHi001-Pr-B
DR   Wikidata; Q107117579
RX   PubMed=33780728;
CC   From: Zhongnan Hospital of Wuhan University; Wuhan; China.
CC   Population: Asian.
CC   Sequence variation: Mutation; HGNC; HGNC:16627; CHEK2; Simple; p.Arg180Cys (c.538C>T) (p.Arg223Cys, c.667C>T); ClinVar=VCV000128081; Zygosity=Heterozygous (PubMed=33780728).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176588; CHEK2-related hereditary cancer predisposition syndrome
DI   NCIt; C4863; Prostate carcinoma
DI   ORDO; Orphanet_1331; Familial prostate cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A7KT ! ZNHi001-A
SX   Male
AG   63Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 27-11-25; Version: 6
//
ID   Znp
AC   CVCL_JY52
SY   ZNP
DR   Wikidata; Q54995971
RX   PubMed=7690770;
CC   Derived from site: In situ; Lymph node; UBERON=UBERON_0000029.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: Lewis; RS=RS_0000121.
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
HI   CVCL_JY50 ! Z1a
SX   Female
AG   3M
CA   Spontaneously immortalized cell line
DT   Created: 22-08-17; Last updated: 10-04-25; Version: 7
//
ID   ZO
AC   CVCL_M694
DR   Wikidata; Q54995973
RX   PubMed=2557656;
RX   PubMed=29533902;
CC   Derived from site: In situ; Pericardial effusion; UBERON=UBERON_0002409.
DI   NCIt; C9357; Hodgkin lymphoma
DI   ORDO; Orphanet_98293; Hodgkin lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 9
//
ID   ZOCi001-A
AC   CVCL_YC90
DR   BioSamples; SAMEA8050678
DR   hPSCreg; ZOCi001-A
DR   SKIP; SKIP005792
DR   Wikidata; Q98136604
RX   PubMed=32387899;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Arg526Ter (c.1576C>T) (R457*); ClinVar=VCV000143167; Zygosity=Heterozygous (PubMed=32387899).
CC   Sequence variation: Mutation; HGNC; HGNC:2343; CRB1; Simple; p.Thr745Met (c.2234C>T) (T676M); ClinVar=VCV000005733; Zygosity=Heterozygous (PubMed=32387899).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 19-12-24; Version: 9
//
ID   ZOCi002-A
AC   CVCL_B5GM
SY   GZZH; ZOCi003-A
DR   hPSCreg; ZOCi002-A
DR   Wikidata; Q110434442
RX   PubMed=34798543;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Arg102Gln (c.305G>A); ClinVar=VCV000009896; Zygosity=Hemizygous (PubMed=34798543).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   7Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 7
//
ID   ZOCi004-A
AC   CVCL_B5GN
SY   WYXI
DR   hPSCreg; ZOCi004-A
DR   Wikidata; Q110434443
RX   PubMed=36270067;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10457; RS1; Simple; p.Glu72Lys (c.214G>A); ClinVar=VCV000009888; Zygosity=Hemizygous (PubMed=36270067).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75483; Juvenile X-linked retinoschisis
DI   ORDO; Orphanet_792; X-linked retinoschisis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 6
//
ID   Zos
AC   CVCL_R779
DR   Wikidata; Q54995974
RX   PubMed=18298897;
CC   Population: Chinese.
CC   Doubling time: 33.65 hours (PubMed=18298897).
CC   Derived from site: In situ; Bone, right distal femur; UBERON=UBERON_0004406.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R780 ! Zos-M
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 10
//
ID   Zos-M
AC   CVCL_R780
DR   Wikidata; Q54995975
RX   PubMed=18298897;
CC   Population: Chinese.
CC   Doubling time: 31.58 hours (PubMed=18298897).
CC   Derived from site: Metastatic; Bone, right femoral head; Note=From a skip lesion; UBERON=UBERON_0006767.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_R779 ! Zos
SX   Male
AG   18Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 12
//
ID   ZOSL-1
AC   CVCL_B0F2
DR   CCRID; 4201PAT-CCTCC01643
DR   Wikidata; Q108821566
RX   Patent=CN112080473B;
RX   PubMed=34221892;
CC   Group: Patented cell line.
CC   Problematic cell line: Probably contaminated. The STR profile is identical to that of the HOS cell line. Originally thought to originate from the lung metastasis of a 12 year old female Chinese osteosarcoma patient.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202088.
CC   Population: Caucasian.
CC   Doubling time: 39.28 +- 3.04 hours (Patent=CN112080473B; PubMed=34221892).
CC   Derived from site: In situ; Bone, right femur; UBERON=UBERON_0000981.
ST   Source(s): Patent=CN112080473B; PubMed=34221892
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 12
ST   D16S539: 10,13
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31.2,32.2
ST   D2S1338: 24,25
ST   D2S441: 10
ST   D3S1358: 15
ST   D5S818: 13
ST   D6S1043: 18
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 24
ST   Penta D: 9,10
ST   Penta E: 7,12
ST   TH01: 6
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0312 ! HOS
SX   Female
AG   13Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
ID   ZP101
AC   CVCL_HA98
DR   Wikidata; Q54995976
RX   PubMed=9016792;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP102
AC   CVCL_HA99
DR   Wikidata; Q54995978
RX   PubMed=9016792;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP103
AC   CVCL_HB00
DR   Wikidata; Q54995980
RX   PubMed=9016792;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP104
AC   CVCL_HB01
DR   Wikidata; Q54995981
RX   PubMed=9184070;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP105
AC   CVCL_HB02
DR   Wikidata; Q54995983
RX   PubMed=9184070;
RX   PubMed=9418886;
RX   PubMed=11330042;
RX   PubMed=17045664;
RX   PubMed=23009329;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Sequence variation: Mutation; UniProtKB; Q920N5; Pex5; Simple; p.Gly343Glu (c.1028G>A) (G298E); Zygosity=Homozygous (PubMed=9418886).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   ZP106
AC   CVCL_HB03
DR   Wikidata; Q54995984
RX   PubMed=9184070;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP107
AC   CVCL_HB04
DR   Wikidata; Q54995985
RX   PubMed=9184070;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP108
AC   CVCL_HB05
DR   Wikidata; Q54995986
RX   PubMed=9184070;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP109
AC   CVCL_HB06
DR   Wikidata; Q54995988
RX   PubMed=9184070;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP110
AC   CVCL_HB07
DR   Wikidata; Q54995989
RX   PubMed=9270878;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP111
AC   CVCL_HB08
DR   Wikidata; Q54995990
RX   PubMed=9270878;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP112
AC   CVCL_HB09
DR   Wikidata; Q54995991
RX   PubMed=9270878;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP113
AC   CVCL_HB10
DR   Wikidata; Q54995994
RX   PubMed=9270878;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP114
AC   CVCL_HB11
DR   Wikidata; Q54995995
RX   PubMed=9270878;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP115
AC   CVCL_HB12
DR   Wikidata; Q54995996
RX   PubMed=9270878;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP116
AC   CVCL_HB13
DR   Wikidata; Q54995997
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP117
AC   CVCL_HB14
DR   Wikidata; Q54995998
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP118
AC   CVCL_HB15
DR   Wikidata; Q54995999
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP119
AC   CVCL_HB16
DR   Wikidata; Q54996000
RX   PubMed=9727033;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP120
AC   CVCL_HB17
DR   Wikidata; Q54996001
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP121
AC   CVCL_U980
SY   ZP-121
DR   BTO; BTO_0003993
DR   Wikidata; Q54996002
RX   PubMed=10222139;
RX   PubMed=16529741;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 12
//
ID   ZP122
AC   CVCL_HA95
DR   Wikidata; Q54996003
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP123
AC   CVCL_HA96
DR   Wikidata; Q54996004
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP124
AC   CVCL_U981
DR   Wikidata; Q54996017
RX   PubMed=10222139;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   ZP125
AC   CVCL_HB33
DR   Wikidata; Q54996018
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP126
AC   CVCL_U982
DR   Wikidata; Q54996020
RX   PubMed=10222139;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   ZP127
AC   CVCL_U983
DR   Wikidata; Q54996021
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 16-04-14; Last updated: 19-12-24; Version: 11
//
ID   ZP128
AC   CVCL_HB18
DR   Wikidata; Q54996022
RX   PubMed=10441330;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP137
AC   CVCL_HA97
DR   Wikidata; Q54996023
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP139
AC   CVCL_HB19
DR   Wikidata; Q54996025
RX   PubMed=9418886;
RX   PubMed=11330042;
RX   PubMed=17045664;
RX   PubMed=23009329;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Sequence variation: Mutation; UniProtKB; Q920N5; Pex5; Simple; p.Gly530Glu (c.1589G>A) (G480E); Zygosity=Homozygous (PubMed=9418886).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   ZP150
AC   CVCL_HB20
DR   Wikidata; Q54996026
RX   PubMed=10441330;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Sequence variation: Mutation; UniProtKB; Q9QYL1; Pex13; Simple; p.Asp265_Lys306del (c.793_918del126); Zygosity=Heterozygous (PubMed=10441330).
CC   Sequence variation: Mutation; UniProtKB; Q9QYL1; Pex13; Simple; p.Ser319Asn (c.956G>A); Zygosity=Heterozygous (PubMed=10441330).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 14
//
ID   ZP151
AC   CVCL_HB21
DR   Wikidata; Q54996028
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP158
AC   CVCL_HB22
DR   Wikidata; Q54996029
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP159
AC   CVCL_HB23
DR   Wikidata; Q54996030
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP160
AC   CVCL_HB24
DR   Wikidata; Q54996032
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP161
AC   CVCL_HB25
DR   Wikidata; Q54996033
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP162
AC   CVCL_HB26
DR   Wikidata; Q54996034
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP163
AC   CVCL_HB27
DR   Wikidata; Q54996035
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP164
AC   CVCL_HB28
DR   Wikidata; Q54996036
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP165
AC   CVCL_HB29
DR   Wikidata; Q54996038
RX   PubMed=9727033;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP166
AC   CVCL_HB30
DR   Wikidata; Q54996039
RX   PubMed=10222139;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP167
AC   CVCL_HB31
DR   Wikidata; Q54996040
RX   PubMed=10222139;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB34 ! CHOTKa
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 10
//
ID   ZP92
AC   CVCL_HB32
DR   Wikidata; Q54996042
RX   PubMed=1430210;
RX   PubMed=9184070;
RX   PubMed=11330042;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 9
//
ID   ZPEG101
AC   CVCL_HB38
DR   Wikidata; Q54996043
RX   PubMed=23009329;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Sequence variation: Mutation; UniProtKB; Q920N5; Pex5; Simple; p.Leu74Profs*14 (c.147dupC); Zygosity=Homozygous (PubMed=23009329).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB36 ! CHOTKaEG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   ZPEG224
AC   CVCL_HB40
DR   Wikidata; Q54996044
RX   PubMed=12054588;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPEG227
AC   CVCL_HB41
DR   Wikidata; Q54996046
RX   PubMed=12054588;
CC   Sequence variation: Mutation; UniProtKB; Q8R537; Pex7; Simple; p.Trp158Ter (c.474G>A); Zygosity=Unspecified (PubMed=12054588).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   ZPEG228
AC   CVCL_HB42
DR   Wikidata; Q54996047
RX   PubMed=12054588;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPEG229
AC   CVCL_HB43
DR   Wikidata; Q54996048
RX   PubMed=12054588;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPEG230
AC   CVCL_HB44
DR   Wikidata; Q54996049
RX   PubMed=12054588;
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPEG231
AC   CVCL_HB45
DR   Wikidata; Q54996050
RX   PubMed=12054588;
CC   Characteristics: Does not express Pex7 mRNA.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 13
//
ID   ZPEG232
AC   CVCL_HB46
DR   Wikidata; Q54996051
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG233
AC   CVCL_HB47
DR   Wikidata; Q54996053
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG234
AC   CVCL_HB48
DR   Wikidata; Q54996054
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG235
AC   CVCL_HB49
DR   Wikidata; Q54996056
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG236
AC   CVCL_HB50
DR   Wikidata; Q54996058
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG237
AC   CVCL_HB51
DR   Wikidata; Q54996059
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG238
AC   CVCL_HB52
DR   Wikidata; Q54996060
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Sequence variation: Mutation; UniProtKB; Q9JJK3; Pex3; Simple; p.Asn7Glufs*32 (c.18dupG); Zygosity=Homozygous (PubMed=18543353).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   ZPEG239
AC   CVCL_HB53
DR   Wikidata; Q54996061
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Sequence variation: Mutation; UniProtKB; Q06438; Pex2; Simple; p.Glu201Ter (c.601G>T); Zygosity=Homozygous (PubMed=18543353).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   ZPEG240
AC   CVCL_HB54
DR   Wikidata; Q54996063
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG241
AC   CVCL_HB55
DR   Wikidata; Q54996065
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG242
AC   CVCL_HB56
DR   Wikidata; Q54996066
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG243
AC   CVCL_HB57
DR   Wikidata; Q54996067
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG244
AC   CVCL_HB58
DR   Wikidata; Q54996068
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG245
AC   CVCL_HB59
DR   Wikidata; Q54996087
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG246
AC   CVCL_HB60
DR   Wikidata; Q54996088
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG247
AC   CVCL_HB61
DR   Wikidata; Q54996089
RX   PubMed=18543353;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_132982; Acridine half-mustard dihydrochloride (6-chloro-9-[3-(2-chloroethylamino)propylamino]-2-methoxyacridine dihydrochloride; Acridine mutagen ICR 191).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 12
//
ID   ZPEG252
AC   CVCL_HB39
DR   Wikidata; Q54996092
RX   PubMed=16723118;
CC   Sequence variation: Mutation; UniProtKB; A0A061IQK5; Pex1; Simple; p.Gly569Glu (c.1706G>A) (Gly606Glu; G1817A); Zygosity=Homozygous (PubMed=16723118).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB37 ! CHOTKaEG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 16
//
ID   ZPG101
AC   CVCL_HB64
DR   Wikidata; Q54996093
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG102
AC   CVCL_HB65
DR   Wikidata; Q54996094
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG103
AC   CVCL_HB66
DR   Wikidata; Q54996095
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG113
AC   CVCL_HB67
DR   Wikidata; Q54996096
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG115
AC   CVCL_HB68
DR   Wikidata; Q54996097
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG117
AC   CVCL_HB69
DR   Wikidata; Q54996100
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG118
AC   CVCL_HB70
DR   Wikidata; Q54996101
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB62 ! CHOTKaG1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG203
AC   CVCL_HB71
DR   Wikidata; Q54996103
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG205
AC   CVCL_HB72
DR   Wikidata; Q54996104
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG206
AC   CVCL_HB73
DR   Wikidata; Q54996105
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG207
AC   CVCL_HB74
DR   Wikidata; Q54996107
RX   PubMed=10222140;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG208
AC   CVCL_HB75
DR   Wikidata; Q54996109
RX   PubMed=10222140;
RX   PubMed=17045664;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG209
AC   CVCL_HB76
DR   Wikidata; Q54996110
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPG210
AC   CVCL_HB77
DR   Wikidata; Q54996111
RX   PubMed=10222140;
CC   Characteristics: Selected using the 9-(1'-pyrene)nonanol/ultraviolet (P9OH/UV) method. P9OH acts as a photosensitizer. Normal cells which can incorporate the fluorescent fatty alcohol into lipids are killed by UV, but mutants who incorporate P9OH poorly are less susceptible to photosensitized killing.
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; 1XF1B; GFP (Note=avGFP; original A.victoria green fluorescent protein).
CC   Genetic integration: Method=Transfection/transduction; Gene=RGD; 61814; Pex2.
CC   Transformant: ChEBI; CHEBI_21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_HB63 ! CHOTKaG2
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 01-12-16; Last updated: 10-04-25; Version: 11
//
ID   ZPKLBIQ-BPH
AC   CVCL_C2TT
SY   BPH; Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine-Brown PlantHopper
DR   ICLDB; bph
DR   Wikidata; Q114313288
RX   PubMed=24399256;
CC   Group: Insect cell line.
CC   Miscellaneous: As no cell line name was provided in the paper, we assigned the name based on the abbreviation of the institution and the species.
CC   Derived from site: In situ; Whole embryo; UBERON=UBERON_0000922.
OX   NCBI_TaxID=108931; ! Nilaparvata lugens (Brown planthopper)
SX   Sex unspecified
AG   Embryonic stage
CA   Spontaneously immortalized cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
ID   ZPR-1
AC   CVCL_B7NJ
SY   zpr-1; FRet 43; Fret43
DR   Wikidata; Q112930597
RX   PubMed=2401210;
WW   Info; ZFIN; -; https://zfin.org/ZDB-ATB-081002-43
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: UniProtKB; Q6DH07; Danio rerio arr3a.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Hybridoma
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 4
//
ID   ZQNK-29
AC   CVCL_4U93
DR   Wikidata; Q54996112
RX   Patent=CN102876632B;
RX   PubMed=26299072;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201278.
CC   Population: Chinese.
CC   Doubling time: 35.6 hours (PubMed=26299072).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C4684; Nasal type extranodal NK/T-cell lymphoma
DI   ORDO; Orphanet_86879; Extranodal nasal NK/T cell lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 12
//
ID   ZQXZBio iHUVEC
AC   CVCL_F0BB
SY   ZQXZBio immortalized HUVEC
WW   Provider; ZQXZBio; ZQ1099; https://www.zqxzbio.com/Index/p_more/pid/6998.html
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Umbilical vein; UBERON=UBERON_0002066.
CC   Cell type: Endothelial cell of umbilical vein; CL=CL_0002618.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ZQXZBio iRMEC
AC   CVCL_F0BC
SY   ZQXZBio immortalized RMEC
WW   Provider; ZQXZBio; ZQY015; https://www.zqxzbio.com/Index/p_more/pid/2952.html
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P03070; Simian virus 40 (SV40) large T antigen.
CC   Miscellaneous: Sex and age of donor from personal communication of ZQXZBio.
CC   Derived from site: In situ; Eye, retina; UBERON=UBERON_0000966.
CC   Cell type: Retinal endothelial cell; CL=CL_0002585.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Fetus
CA   Transformed cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
ID   ZR-75-1
AC   CVCL_0588
SY   Zr-75-1; ZR751; ZR75-1; ZR75.1; ZR75_1
DR   BTO; BTO_0003136
DR   CLO; CLO_0009727
DR   EFO; EFO_0001262
DR   MCCL; MCC:0000494
DR   CLDB; cl4817
DR   CLDB; cl4818
DR   CLDB; cl4819
DR   CLDB; cl4820
DR   CLDB; cl4821
DR   CLDB; cl4946
DR   AddexBio; C0006011/4901
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   ATCC; CRL-1500
DR   BCRC; 60055
DR   BioGRID_ORCS_Cell_line; 339
DR   BioSample; SAMN01821608
DR   BioSample; SAMN03471337
DR   BioSample; SAMN05292440
DR   BioSample; SAMN10988134
DR   cancercelllines; CVCL_0588
DR   CancerTools; 154547
DR   CCRID; 1101HUM-PUMC000090
DR   CCRID; 3101HUMTCHu126
DR   Cell_Model_Passport; SIDM00314
DR   ChEMBL-Cells; CHEMBL3307615
DR   ChEMBL-Targets; CHEMBL614393
DR   CLS; 300163
DR   Cosmic; 687503
DR   Cosmic; 755295
DR   Cosmic; 871152
DR   Cosmic; 877452
DR   Cosmic; 894094
DR   Cosmic; 904398
DR   Cosmic; 934532
DR   Cosmic; 944296
DR   Cosmic; 979717
DR   Cosmic; 991333
DR   Cosmic; 997927
DR   Cosmic; 1010919
DR   Cosmic; 1044205
DR   Cosmic; 1046930
DR   Cosmic; 1047720
DR   Cosmic; 1136344
DR   Cosmic; 1152530
DR   Cosmic; 1175836
DR   Cosmic; 1287904
DR   Cosmic; 1289421
DR   Cosmic; 1309006
DR   Cosmic; 1326279
DR   Cosmic; 1523772
DR   Cosmic; 1524343
DR   Cosmic; 1571792
DR   Cosmic; 1603229
DR   Cosmic; 1609464
DR   Cosmic; 2165028
DR   Cosmic; 2301536
DR   Cosmic; 2318372
DR   Cosmic; 2361354
DR   Cosmic; 2668279
DR   Cosmic; 2750519
DR   Cosmic; 2787556
DR   DepMap; ACH-000097
DR   ECACC; 87012601
DR   EGA; EGAS00001000610
DR   GEO; GSM73744
DR   GEO; GSM115120
DR   GEO; GSM155214
DR   GEO; GSM217613
DR   GEO; GSM274660
DR   GEO; GSM344360
DR   GEO; GSM344410
DR   GEO; GSM350508
DR   GEO; GSM378142
DR   GEO; GSM383804
DR   GEO; GSM383805
DR   GEO; GSM383806
DR   GEO; GSM388216
DR   GEO; GSM421897
DR   GEO; GSM481332
DR   GEO; GSM783956
DR   GEO; GSM844725
DR   GEO; GSM845400
DR   GEO; GSM847449
DR   GEO; GSM847509
DR   GEO; GSM887750
DR   GEO; GSM888845
DR   GEO; GSM1008921
DR   GEO; GSM1053721
DR   GEO; GSM1172908
DR   GEO; GSM1173004
DR   GEO; GSM1215256
DR   GEO; GSM1238137
DR   GEO; GSM1374993
DR   GEO; GSM1374994
DR   GEO; GSM1374995
DR   GEO; GSM1401648
DR   GEO; GSM1556182
DR   GEO; GSM1556183
DR   GEO; GSM1556184
DR   GEO; GSM1556185
DR   GEO; GSM1556186
DR   GEO; GSM1664567
DR   GEO; GSM2258740
DR   GEO; GSM2258741
DR   GEO; GSM2258742
DR   GEO; GSM2258743
DR   GEO; GSM2258744
DR   GEO; GSM2258745
DR   GEO; GSM2258746
DR   GEO; GSM2258747
DR   GEO; GSM2258748
DR   GEO; GSM2258749
DR   GEO; GSM2258750
DR   GEO; GSM2258751
DR   GEO; GSM2258752
DR   GEO; GSM2258753
DR   GEO; GSM2258754
DR   GEO; GSM2258755
DR   GEO; GSM2258756
DR   GEO; GSM2258757
DR   GEO; GSM2258956
DR   GEO; GSM2258957
DR   GEO; GSM2258958
DR   IARC_TP53; 21111
DR   IBRC; C10099
DR   ICLC; HTL99006
DR   IPD-IMGT/HLA; 12334
DR   IZSLER; BS TCL 75
DR   KCB; KCB 2010136YJ
DR   KCLB; 21500
DR   LiGeA; CCLE_225
DR   LINCS_HMS; 50574
DR   LINCS_LDP; LCL-1321
DR   PharmacoDB; ZR751_1689_2019
DR   PRIDE; PXD001327
DR   PRIDE; PXD005390
DR   Progenetix; CVCL_0588
DR   PubChem_Cell_line; CVCL_0588
DR   RCB; RCB1906
DR   SLKBase; 3633
DR   TKG; TKG 0189
DR   Wikidata; Q54996114
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   DOI=10.25904/1912/1434;
RX   PubMed=688225;
RX   PubMed=1911442;
RX   PubMed=3335022;
RX   PubMed=6582512;
RX   PubMed=7902062;
RX   PubMed=10862037;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11343771;
RX   PubMed=12353263;
RX   PubMed=12800145;
RX   PubMed=15677628;
RX   PubMed=15767549;
RX   PubMed=16397213;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=17334996;
RX   PubMed=18516279;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=19727395;
RX   PubMed=20070913;
RX   PubMed=21378333;
RX   PubMed=22460905;
RX   PubMed=22585861;
RX   PubMed=23601657;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=24389870;
RX   PubMed=25238572;
RX   PubMed=25485619;
RX   PubMed=25699542;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=26589293;
RX   PubMed=26759240;
RX   PubMed=27378269;
RX   PubMed=28196595;
RX   PubMed=28287265;
RX   PubMed=28889351;
RX   PubMed=29273624;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31978347;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/morphology-of-atcc-crl-1500
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/zr-75-1.htm
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
WW   Info; Synapse; PS-ON; https://www.synapse.org/#!Synapse:syn31544564
WW   Info; Wikipedia; -; https://en.wikipedia.org/wiki/ZR-75-1
WW   Provider; Altogen; Xenograft model; https://altogenlabs.com/xenograft-models/breast-cancer-xenograft/zr-75-1-xenograft-model/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JFCR45 cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: KuDOS 95 cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Doubling time: 80 hours (Note=At 40th passage) (PubMed=688225); 79 hours (PubMed=24389870); ~54 hours (PBCF); 70.09 hours (JWGray panel).
CC   HLA typing: A*24/11,11; B*35:01; C*04:01,04:01; DQB1*05:01,05:01; DRB1*01:01,13:03 (PubMed=25960936).
CC   HLA typing: A*11:01,24:02; B*35:01,35:01; C*04:01,04:01 (PubMed=26589293).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (DepMap=ACH-000097).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (PubMed=19593635; DepMap=ACH-000097).
CC   Omics: Genomics; ChIP-seq; H2BK120ub.
CC   Omics: Genomics; ChIP-seq; H3K23ac.
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K36me3.
CC   Omics: Genomics; ChIP-seq; H3K4me1.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Genomics; ChIP-seq; H3K79me2.
CC   Omics: Genomics; ChIP-seq; H3K9ac.
CC   Omics: Genomics; ChIP-seq; H3K9me3.
CC   Omics: Genomics; ChIP-seq; H4K8ac.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; PTM; Glycoproteome.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Transcriptomics; Serial analysis of gene expression (SAGE).
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=1.23%; East Asian, South=0%; South Asian=0.14%; European, North=65.96%; European, South=32.67% (PubMed=30894373).
CC   Anecdotal: Used in a study utilising the fruit fly's olfactory system to detect cancer cells (PubMed=24389870).
CC   Discontinued: RCB; RCB1906; true.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): AddexBio=C0006011/4901; ATCC=CRL-1500; CCRID; CLS=300163; ECACC=87012601; KCLB=21500; PubMed=25877200; PubMed=28889351; Technion Genomics Center
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D10S1248: 16
ST   D12S391: 21
ST   D13S317: 9
ST   D16S539: 11
ST   D18S51: 13,14
ST   D19S433: 13,14
ST   D1S1656: 14.3,16.3
ST   D21S11: 31
ST   D22S1045: 15
ST   D2S1338: 16,25
ST   D2S441: 11,15
ST   D3S1358: 15,16
ST   D5S818: 13
ST   D7S820: 10 (KCLB=21500)
ST   D7S820: 10,11 (AddexBio=C0006011/4901; ATCC=CRL-1500; CCRID; CLS=300163; ECACC=87012601; PubMed=25877200; PubMed=28889351; Technion Genomics Center)
ST   D8S1179: 11,13
ST   FGA: 20,22
ST   Penta D: 14
ST   Penta E: 7,14
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 47
//
ID   ZR-75-1 AKT1 pool B
AC   CVCL_E4WR
SY   ZR-AKT1 pool B
DR   CancerTools; 154623
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:391; AKT1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 AKT2 pool B
AC   CVCL_E4WS
SY   ZR-AKT2 pool B
DR   CancerTools; 154624
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:392; AKT2.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 BCAR1 clone 4A12
AC   CVCL_E4WT
SY   ZR-75-1 BCAR1 [4A12]
DR   CancerTools; 154621
RX   PubMed=10639512;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:971; BCAR1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 BCAR3 clone B3-10
AC   CVCL_E4WU
SY   ZR-75-1 BCAR3 [B3-10]
DR   CancerTools; 154622
RX   PubMed=9582273;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:973; BCAR3.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 BCAR4 clone 2A
AC   CVCL_E4WV
SY   ZR-BCAR4 2A
DR   CancerTools; 154625
RX   PubMed=16778085;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:22170; BCAR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 BCAR4 clone 2B
AC   CVCL_E4WW
SY   ZR-BCAR4 2B
DR   CancerTools; 154626
RX   PubMed=16778085;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:22170; BCAR4.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 GDC-0941-resistant
AC   CVCL_A1FN
DR   cancercelllines; CVCL_A1FN
DR   Cosmic; 2787557
DR   Wikidata; Q102115154
RX   PubMed=26759240;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_65326; Pictrelisib (Pictilisib; GDC-0941).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:8976; PIK3CB; Simple; p.Asp1067Tyr (c.3199G>T); Zygosity=Heterozygous; Note=Responsible for pictrelisib resistance (PubMed=26759240).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 9
//
ID   ZR-75-1 GRB7 clone 3
AC   CVCL_E4WX
SY   ZR-GRB7 (3)
DR   CancerTools; 154627
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4567; GRB7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 GRB7 clone 4
AC   CVCL_E4WY
SY   ZR-GRB7 (4)
DR   CancerTools; 154642
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4567; GRB7.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 HRAS pool A
AC   CVCL_E4WZ
SY   ZR-HRAS pool A
DR   CancerTools; 154630
RX   PubMed=19966015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 HRAS pool B
AC   CVCL_E4X0
SY   ZR-HRAS pool B
DR   CancerTools; 154631
RX   PubMed=19966015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 HygroR clone ZH2D2
AC   CVCL_E4X1
RX   PubMed=9259413;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ZR-75-1 HygroR clone ZH3D7
AC   CVCL_E4X2
SY   ZR-75-1 HygroR [ZH3D7]
DR   CancerTools; 154620
RX   PubMed=9259413;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 10-04-25; Version: 2
//
ID   ZR-75-1 IX-10
AC   CVCL_E4KZ
SY   ZR-75-1 [IX-10]
DR   CancerTools; 154549
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are PSME4 and ZC3HDC5 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 IX-23
AC   CVCL_E4L0
SY   ZR-75-1 [IX-23]
DR   CancerTools; 154550
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are JDP2 and RHOBTB3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 IX-6
AC   CVCL_E4L1
SY   ZR-75-1 [IX-6]
DR   CancerTools; 154551
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are MAP7 and LOC440474 (unknown gene locus) (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 PDGFRA clone 21
AC   CVCL_E4X3
SY   ZR-PDGFRA 21
DR   CancerTools; 154632
RX   PubMed=19966015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8803; PDGFRA.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 PDGFRA clone 30
AC   CVCL_E4X4
SY   ZR-PDGFRA 30
DR   CancerTools; 154633
RX   PubMed=19966015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:8804; PDGFRB.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 PDGFRB clone 4147
AC   CVCL_E4X5
SY   ZR-PDGFRB (4147)
DR   CancerTools; 154634
RX   PubMed=19966015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:5173; HRAS.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 RAF1 clone T2
AC   CVCL_E4X6
SY   ZR-RAF1 (T2)
DR   CancerTools; 154635
RX   PubMed=19966015;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:9829; RAF1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 shPARG
AC   CVCL_RA95
SY   shPARG ZR-75-1
DR   cancercelllines; CVCL_RA95
DR   Wikidata; Q54996115
RX   PubMed=29166620;
CC   Population: Caucasian.
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:8605; PARG.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 12
//
ID   ZR-75-1 shWDR12-4
AC   CVCL_YJ29
DR   cancercelllines; CVCL_YJ29
DR   Wikidata; Q98136608
RX   CelloPub=CLPUB00550;
CC   Population: Caucasian.
CC   Doubling time: 23-37 hours (CelloPub=CLPUB00550).
CC   Knockout cell: Method=shRNA knockdown; HGNC; HGNC:14098; WDR12.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): CelloPub=CLPUB00550
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   ZR-75-1 Tam1
AC   CVCL_A4AL
DR   ATCC; CRL-3438
DR   cancercelllines; CVCL_A4AL
DR   Wikidata; Q105511864
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~1 week (ATCC=CRL-3438).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-3438
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 9
ST   D16S539: 11
ST   D5S818: 13
ST   D7S820: 10,11
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 16,18
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   ZR-75-1 Tam2
AC   CVCL_A4AM
DR   ATCC; CRL-3439
DR   cancercelllines; CVCL_A4AM
DR   Wikidata; Q105511866
RX   PubMed=27378269;
CC   Population: Caucasian.
CC   Doubling time: ~1 week (ATCC=CRL-3439).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 10-04-25; Version: 9
//
ID   ZR-75-1 VIII-11
AC   CVCL_E4L2
SY   ZR-75-1 [VIII-11]
DR   CancerTools; 154552
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are CAPN8 and ZFAND6 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-12
AC   CVCL_E4L3
SY   ZR-75-1 [VIII-12]
DR   CancerTools; 154553
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are FGF19 and MAP7 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-16
AC   CVCL_E4L4
SY   ZR-75-1 [VIII-16]
DR   CancerTools; 154554
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is TRERF1/BCAR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-17
AC   CVCL_E4L5
SY   ZR-75-1 [VIII-17]
DR   CancerTools; 154555
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are FOSL2 and ZADH2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-18
AC   CVCL_E4L6
SY   ZR-75-1 [VIII-18]
DR   CancerTools; 154556
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are BNIP3L, FSTL5, RAP2C, RPL6P14, SRD5AP1, TRPS1 and ZBTB38 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-20
AC   CVCL_E4L7
SY   ZR-75-1 [VIII-20]
DR   CancerTools; 154557
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are ICE2, LARP1 and NEDD8 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-21
AC   CVCL_E4L8
SY   ZR-75-1 [VIII-21]; ZR-75-1 VIII21
DR   CancerTools; 154558
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-22
AC   CVCL_E4L9
SY   ZR-75-1 [VIII-22]
DR   CancerTools; 154559
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are LINC00472, NUCKS1 and VIPR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-24
AC   CVCL_E4LA
SY   ZR-75-1 [VIII-24]; ZR-75-1 VIII24
DR   CancerTools; 154560
RX   PubMed=8413311;
RX   PubMed=9259413;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is TRERF1/BCAR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 VIII-5
AC   CVCL_E4LB
SY   ZR-75-1 [VIII-5]
DR   CancerTools; 154561
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is TRERF1/BCAR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-10
AC   CVCL_E4LC
SY   ZR-75-1 [X-10]
DR   CancerTools; 154562
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are ANKS4B, HNF4G and KCNMA1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-3
AC   CVCL_E4LD
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are MAP7 and SAT1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-4
AC   CVCL_E4LE
SY   ZR-75-1 [X-4]
DR   CancerTools; 154563
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is LPP (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-5
AC   CVCL_E4LF
SY   ZR-75-1 [X-5]
DR   CancerTools; 154564
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are CHCHD3P1 and HK1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-6
AC   CVCL_E4LG
SY   ZR-75-1 [X-6]
DR   CancerTools; 154565
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are DIPK2A, MDM4 and SERTAD3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-7
AC   CVCL_E4LH
SY   ZR-75-1 [X-7]
DR   CancerTools; 154566
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are LINC01684 and SLC11A2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 X-8
AC   CVCL_E4LI
SY   ZR-75-1 [X-8]
DR   CancerTools; 154567
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-13
AC   CVCL_E4LJ
SY   ZR-75-1 [XI-13]; ZR-75-1 XI13
DR   CancerTools; 154568
RX   PubMed=8413311;
RX   PubMed=10639512;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=8413311; PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-14
AC   CVCL_E4LK
SY   ZR-75-1 [XI-14]; ZR-75-1 XI14
DR   CancerTools; 154569
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-15
AC   CVCL_E4LL
SY   ZR-75-1 [XI-15]
DR   CancerTools; 154570
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is MRC1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-16
AC   CVCL_E4LM
SY   ZR-75-1 [XI-16]; ZR-75-1 XI16
DR   CancerTools; 154571
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-17
AC   CVCL_E4LN
SY   ZR-75-1 [XI-17]
DR   CancerTools; 154572
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is GRB7 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-18
AC   CVCL_E4LP
SY   ZR-75-1 [XI-18]
DR   CancerTools; 154573
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-19
AC   CVCL_E4LQ
SY   ZR-75-1 [XI-19]
DR   CancerTools; 154574
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are HPS5 and PAWR (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-20
AC   CVCL_E4LR
SY   ZR-75-1 [XI-20]
DR   CancerTools; 154575
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are HPS5, PAWR and POU3F1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-21
AC   CVCL_E4LS
SY   ZR-75-1 [XI-21]; ZR-75-1 XI21
DR   CancerTools; 154576
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-22
AC   CVCL_E4LT
SY   ZR-75-1 [XI-22]
DR   CancerTools; 154577
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are BMF, HEXIM2, MDS1 and SLC6A9 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-27
AC   CVCL_E4LU
SY   ZR-75-1 [XI-27]
DR   CancerTools; 154578
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is ENTPD5 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-30
AC   CVCL_E4LV
SY   ZR-75-1 [XI-30]
DR   CancerTools; 154579
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are GSE1, MKNK2, PRPF4 and WDR31 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-31
AC   CVCL_E4LW
SY   ZR-75-1 [XI-31]
DR   CancerTools; 154580
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-32
AC   CVCL_E4LX
SY   ZR-75-1 [XI-32]
DR   CancerTools; 154581
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-33
AC   CVCL_E4LY
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are NISCH and PTGR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-35
AC   CVCL_E4LZ
SY   ZR-75-1 [XI-35]
DR   CancerTools; 154582
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are NCOR2 and STARD4 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-36
AC   CVCL_E4M0
SY   ZR-75-1 [XI-36]
DR   CancerTools; 154583
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-38
AC   CVCL_E4M1
SY   ZR-75-1 [XI-38]
DR   CancerTools; 154584
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-39
AC   CVCL_E4M2
SY   ZR-75-1 [XI-39]
DR   CancerTools; 154585
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XI-41
AC   CVCL_E4M3
SY   ZR-75-1 [XI-41]
DR   CancerTools; 154586
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-1
AC   CVCL_E4M4
SY   ZR-75-1 [XII-1]
DR   CancerTools; 154587
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are CITED2 and MSH3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-10
AC   CVCL_E4M5
SY   ZR-75-1 [XII-10]
DR   CancerTools; 154588
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are GSE1, KIAA0040, ROGDI and TPBG (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-11
AC   CVCL_E4M6
SY   ZR-75-1 [XII-11]
DR   CancerTools; 154589
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is GLT8D1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-12
AC   CVCL_E4M7
SY   ZR-75-1 [XII-12]
DR   CancerTools; 154590
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is EGFR (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-13
AC   CVCL_E4M8
SY   ZR-75-1 [XII-13]; ZR-75-1 XII13
DR   CancerTools; 154591
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-14
AC   CVCL_E4M9
SY   ZR-75-1 [XII-14]
DR   CancerTools; 154592
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are AKT1 and AKT2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-2
AC   CVCL_E4MA
SY   ZR-75-1 [XII-2]
DR   CancerTools; 154593
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are CHCHD3P1 and PTPN12 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-4
AC   CVCL_E4MB
SY   ZR-75-1 [XII-4]
DR   CancerTools; 154594
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are MSX2, POLR1F and SEMA3F (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-6
AC   CVCL_E4MC
SY   ZR-75-1 [XII-6]
DR   CancerTools; 154595
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are LUC7L and SRC (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-7
AC   CVCL_E4MD
SY   ZR-75-1 [XII-7]
DR   CancerTools; 154596
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is EGFR (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-8
AC   CVCL_E4ME
SY   ZR-75-1 [XII-8]
DR   CancerTools; 154597
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is ADRA2A (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XII-9
AC   CVCL_E4MF
SY   ZR-75-1 [XII-9]
DR   CancerTools; 154598
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-10
AC   CVCL_E4MG
SY   ZR-75-1 [XIV-10]
DR   CancerTools; 154599
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is CFTR (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-15
AC   CVCL_E4MH
SY   ZR-75-1 [XIV-15]
DR   CancerTools; 154600
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is MSX2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-16
AC   CVCL_E4MI
SY   ZR-75-1 [XIV-16]
DR   CancerTools; 154601
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are LDLR and TLE3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-17
AC   CVCL_E4MJ
SY   ZR-75-1 [XIV-17]
DR   CancerTools; 154602
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are AP2S1 and KPNA3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-2
AC   CVCL_E4MK
SY   ZR-75-1 [XIV-2]
DR   CancerTools; 154603
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is AKT2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-22
AC   CVCL_E4ML
SY   ZR-75-1 [XIV-22]
DR   CancerTools; 154604
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are MRPS14 and NCOR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-26
AC   CVCL_E4MM
SY   ZR-75-1 [XIV-26]
DR   CancerTools; 154605
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is ABCA7 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-31
AC   CVCL_E4MN
SY   ZR-75-1 [XIV-31]
DR   CancerTools; 154606
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is NCOR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-32
AC   CVCL_E4MP
SY   ZR-75-1 [XIV-32]
DR   CancerTools; 154607
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is CITED2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-34
AC   CVCL_E4MQ
SY   ZR-75-1 [XIV-34]
DR   CancerTools; 154608
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is MEIS1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-36
AC   CVCL_E4MR
SY   ZR-75-1 [XIV-36]
DR   CancerTools; 154609
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is RPL7P6 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-37
AC   CVCL_E4MS
SY   ZR-75-1 [XIV-37]
DR   CancerTools; 154610
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is QKI (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-39
AC   CVCL_E4MT
SY   ZR-75-1 [XIV-39]
DR   CancerTools; 154611
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is QKI (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-42
AC   CVCL_E4MU
SY   ZR-75-1 [XIV-42]
DR   CancerTools; 154612
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are MIDN and RPA2P2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-43
AC   CVCL_E4MV
SY   ZR-75-1 [XIV-43]
DR   CancerTools; 154613
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is AKT1 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-5
AC   CVCL_E4MW
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are HADHB and GRHL2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-50
AC   CVCL_E4MX
SY   ZR-75-1 [XIV-50]
DR   CancerTools; 154614
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is CITED2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-51
AC   CVCL_E4MY
SY   ZR-75-1 [XIV-51]
DR   CancerTools; 154615
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are NCOR2 and SPINK4 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-55
AC   CVCL_E4MZ
SY   ZR-75-1 [XIV-55]
DR   CancerTools; 154616
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-57
AC   CVCL_E4N0
SY   ZR-75-1 [XIV-57]
DR   CancerTools; 154617
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is NCOR2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-6
AC   CVCL_E4N1
SY   ZR-75-1 [XIV-6]
DR   CancerTools; 154618
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is BCAR3 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 XIV-9
AC   CVCL_E4N2
SY   ZR-75-1 [XIV-9]
DR   CancerTools; 154619
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Gene likely to be responsible to resistance in this cell line is HGD (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 ZN11B
AC   CVCL_E4N3
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are ANXA13, ETNK2, NCOR2, PIP5K1A and PRICKLE2 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 ZN1E
AC   CVCL_E4N4
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 ZN2A
AC   CVCL_E4N5
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 ZN3B
AC   CVCL_E4N6
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Characteristics: Genes likely to be responsible to resistance in this cell line are NME1, PEX2 and SPAG8 (PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1 ZN5B
AC   CVCL_E4N7
RX   PubMed=8413311;
RX   PubMed=18351453;
CC   Population: Caucasian.
CC   Characteristics: Infected with an amphotropic defective murine retrovirus. Retroviral insertion was used in order to identify genes responsible for estrogen-independence and thus tamoxifen resistant (PubMed=8413311; PubMed=18351453).
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 19-12-24; Last updated: 14-08-25; Version: 3
//
ID   ZR-75-1-Dox
AC   CVCL_UJ20
SY   Zr-75-1-Dox
DR   cancercelllines; CVCL_UJ20
DR   Wikidata; Q98136613
RX   PubMed=7902062;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; PTM; Poly-ADP-ribosylation.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-04-25; Version: 10
//
ID   ZR-75-1/GFP
AC   CVCL_JY90
DR   cancercelllines; CVCL_JY90
DR   Cell_Biolabs; AKR-210
DR   Wikidata; Q54996116
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP).
CC   Discontinued: Cell_Biolabs; AKR-210; probable.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 22-08-17; Last updated: 19-12-24; Version: 12
//
ID   ZR-75-27
AC   CVCL_5612
DR   Wikidata; Q54996118
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=688225;
CC   Population: African American.
CC   Doubling time: 144 hours (Note=At 14th passage) (PubMed=688225).
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_1661 ! ZR-75-30
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 16
//
ID   ZR-75-30
AC   CVCL_1661
SY   ZR75-30; ZR7530; ZR 7530
DR   BTO; BTO_0004915
DR   CLO; CLO_0009728
DR   EFO; EFO_0001263
DR   CLDB; cl4822
DR   CLDB; cl4823
DR   CLDB; cl4824
DR   ArrayExpress; E-MTAB-783
DR   ArrayExpress; E-MTAB-2706
DR   ArrayExpress; E-MTAB-2770
DR   ArrayExpress; E-MTAB-3610
DR   ArrayExpress; E-TABM-157
DR   ATCC; CRL-1504
DR   BCRC; 60056
DR   BioSample; SAMN03471856
DR   BioSample; SAMN10988534
DR   cancercelllines; CVCL_1661
DR   CCRID; 1101HUM-PUMC000240
DR   CCRID; 3101HUMTCHu203
DR   CCTCC; GDC0054
DR   Cell_Model_Passport; SIDM00971
DR   ChEMBL-Cells; CHEMBL3308094
DR   ChEMBL-Targets; CHEMBL1075613
DR   Cosmic; 687504
DR   Cosmic; 871160
DR   Cosmic; 877444
DR   Cosmic; 894095
DR   Cosmic; 904399
DR   Cosmic; 909907
DR   Cosmic; 921977
DR   Cosmic; 949194
DR   Cosmic; 979716
DR   Cosmic; 1046953
DR   Cosmic; 1047719
DR   Cosmic; 1136346
DR   Cosmic; 1152523
DR   Cosmic; 1287913
DR   Cosmic; 1289422
DR   Cosmic; 1571790
DR   Cosmic; 1603230
DR   Cosmic; 2165016
DR   Cosmic-CLP; 909907
DR   DepMap; ACH-000828
DR   ECACC; 88113004
DR   EGA; EGAS00001000610
DR   EGA; EGAS00001000978
DR   GDSC; 909907
DR   GEO; GSM69200
DR   GEO; GSM73747
DR   GEO; GSM115121
DR   GEO; GSM217611
DR   GEO; GSM219946
DR   GEO; GSM274678
DR   GEO; GSM344379
DR   GEO; GSM344429
DR   GEO; GSM350533
DR   GEO; GSM421898
DR   GEO; GSM783957
DR   GEO; GSM844726
DR   GEO; GSM844727
DR   GEO; GSM847450
DR   GEO; GSM847510
DR   GEO; GSM887751
DR   GEO; GSM888846
DR   GEO; GSM984235
DR   GEO; GSM1053719
DR   GEO; GSM1172909
DR   GEO; GSM1173005
DR   GEO; GSM1238138
DR   GEO; GSM1401666
DR   GEO; GSM1661991
DR   GEO; GSM1670589
DR   IARC_TP53; 21112
DR   LiGeA; CCLE_237
DR   LINCS_HMS; 50575
DR   LINCS_LDP; LCL-1322
DR   PharmacoDB; ZR7530_1690_2019
DR   PRIDE; PXD030304
DR   Progenetix; CVCL_1661
DR   PubChem_Cell_line; CVCL_1661
DR   SLKBase; 3628
DR   Wikidata; Q54996119
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=688225;
RX   PubMed=3335022;
RX   PubMed=10969801;
RX   PubMed=11044355;
RX   PubMed=11414198;
RX   PubMed=12836015;
RX   PubMed=16397213;
RX   PubMed=16417655;
RX   PubMed=16541312;
RX   PubMed=17157791;
RX   PubMed=19582160;
RX   PubMed=19593635;
RX   PubMed=20070913;
RX   PubMed=20164919;
RX   PubMed=22460905;
RX   PubMed=23151021;
RX   PubMed=23260012;
RX   PubMed=23601657;
RX   PubMed=24009699;
RX   PubMed=24094812;
RX   PubMed=24176112;
RX   PubMed=25485619;
RX   PubMed=25877200;
RX   PubMed=25960936;
RX   PubMed=25984343;
RX   PubMed=26589293;
RX   PubMed=27397505;
RX   PubMed=28196595;
RX   PubMed=30894373;
RX   PubMed=31068700;
RX   PubMed=31395879;
RX   PubMed=35839778;
WW   Info; LINCS; ICBP43; https://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
WW   Info; Pawefish; -; https://www.cellosaurus.org/pawefish/BreastCellLineDescriptions/ZR-75-30.html
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: COSMIC cell lines project.
CC   Part of: ICBP43 breast cancer cell line panel.
CC   Part of: JWGray breast cancer cell line panel.
CC   Part of: MD Anderson Cell Lines Project.
CC   Part of: TCGA-110-CL cell line panel.
CC   Population: African American.
CC   Doubling time: 110 hours (Note=At 17th passage) (PubMed=688225); 60 hours (PubMed=25984343); ~110 hours (ATCC=CRL-1504); 324.46 hours (JWGray panel).
CC   HLA typing: A*03,23; B*07,35; DQB1*04:02,05:01:01; DRB1*01:01,03:02:01 (PubMed=12836015).
CC   HLA typing: A*03:01,23:01; B*07:02,35:08; C*04:01,07:02; DQB1*06:04,06:04 (PubMed=25960936).
CC   HLA typing: A*03:01,23:01; B*07:02,35:01; C*04:01,07:02 (PubMed=26589293).
CC   Microsatellite instability: Instable (MSI-low) (Sanger).
CC   Sequence variation: Gene fusion; HGNC; HGNC:622; APPBP2 + HGNC; HGNC:24280; PHF20L1; Name(s)=APPBP2-PHF20L1; Note=In frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:17399; ARHGAP32 + HGNC; HGNC:17312; TIMM23; Name(s)=TIMM23-ARHGAP32; Note=Out of frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14347; BCAS3 + HGNC; HGNC:3430; ERBB2; Name(s)=ERBB2-BCAS3; Note=Out of frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:14347; BCAS3 + HGNC; HGNC:5120; HOXB9; Name(s)=BCAS3-HOXB9 (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2191; COL14A1 + HGNC; HGNC:15605; SKAP1; Name(s)=COL14A1-SKAP1; Note=In frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:25989; CWC25 + HGNC; HGNC:19143; USP32; Name(s)=USP32-CWC25, USP32-CCDC49; Note=Out of frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:2746; DDX5 + HGNC; HGNC:22953; DEPTOR; Name(s)=DDX5-DEPTOR; Note=In frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3357; ENPP2 + HGNC; HGNC:9069; PLEC; Name(s)=PLEC-ENPP2, PLEC1-ENPP2; Note=In frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:6513; LASP1 + HGNC; HGNC:12340; TRPS1; Name(s)=TRPS1-LASP1; Note=In frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8001; NRIP1 + HGNC; HGNC:11805; TIAM1; Name(s)=TIAM1-NRIP1; Note=In frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:8153; OPRD1 + HGNC; HGNC:13055; ZMYM4; Name(s)=ZMYM4-OPRD1; Note=Out of frame (PubMed=23260012).
CC   Sequence variation: Gene fusion; HGNC; HGNC:12929; PCGF2 + HGNC; HGNC:29259; TAOK1; Name(s)=TAOK1-PCGF2; Note=In frame (PubMed=23260012).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Ile326Thr (c.977T>C); ClinVar=VCV000424419; Zygosity=Heterozygous (PubMed=19593635).
CC   Sequence variation: Mutation; HGNC; HGNC:1748; CDH1; Simple; p.Glu243Ter (c.727G>T); Zygosity=Homozygous (PubMed=19593635).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Glycomics; N-glycan profiling.
CC   Omics: Phenotyping; Drug screening.
CC   Omics: Phenotyping; shRNA library screening.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Proteomics; Quantitative.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; miRNA profiling; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; Array-based CGH.
CC   Omics: Variations; CNV analysis.
CC   Omics: Variations; SNP array analysis.
CC   Genome ancestry: African=71.64%; Native American=0.74%; East Asian, North=3.41%; East Asian, South=0%; South Asian=0%; European, North=9.83%; European, South=14.38% (PubMed=30894373).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): ATCC=CRL-1504; CCRID; Cosmic-CLP=909907; ECACC=88113004; PubMed=25877200
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 10,11
ST   D16S539: 9
ST   D18S51: 17
ST   D19S433: 13.2,14.2
ST   D21S11: 31
ST   D2S1338: 17,22
ST   D3S1358: 15,18
ST   D5S818: 12,13
ST   D7S820: 11,12
ST   D8S1179: 13,14
ST   FGA: 22
ST   Penta D: 2.2,10
ST   Penta E: 5,7
ST   TH01: 8,9
ST   TPOX: 10,11
ST   vWA: 18,19
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_5612 ! ZR-75-27
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 46
//
ID   ZR-75-9a1
AC   CVCL_5613
DR   cancercelllines; CVCL_5613
DR   Wikidata; Q54996121
RX   PubMed=2713239;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_41774; Tamoxifen.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 19
//
ID   ZR-75-B
AC   CVCL_5614
SY   ZR75-B; ZR-75B; ZR-75b; ZR75B
DR   CLO; CLO_0009924
DR   EFO; EFO_0001264
DR   ArrayExpress; E-TABM-157
DR   ArrayExpress; E-TABM-244
DR   cancercelllines; CVCL_5614
DR   Cosmic; 1136345
DR   Cosmic; 1176641
DR   DepMap; ACH-002331
DR   GEO; GSM1053730
DR   GEO; GSM1172910
DR   GEO; GSM1173006
DR   GEO; GSM1215271
DR   LINCS_HMS; 51096
DR   LINCS_LDP; LCL-2077
DR   PharmacoDB; ZR75B_1691_2019
DR   Wikidata; Q54996122
RX   PubMed=6178756;
RX   PubMed=8562478;
RX   PubMed=9815641;
RX   PubMed=17157791;
RX   PubMed=18516279;
RX   PubMed=24094812;
RX   PubMed=24162158;
RX   PubMed=24176112;
RX   PubMed=25960936;
WW   Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: JWGray breast cancer cell line panel.
CC   Population: Caucasian.
CC   Doubling time: 30.5 hours (PubMed=8562478; PubMed=9815641); 44.80 hours (JWGray panel).
CC   HLA typing: B*35:01,35:01; C*04:01,04:01; DQB1*05:01,05:01 (PubMed=25960936).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Genomics; DNA methylation analysis.
CC   Omics: Genomics; Whole exome sequencing.
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Transcriptomics; RNAseq.
CC   Omics: Variations; SNP array analysis.
CC   Misspelling: ZRB75; Note=Occasionally.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 31
//
ID   ZR-78
AC   CVCL_8025
SY   ZR78
DR   BTO; BTO_0004916
DR   Wikidata; Q54996124
RX   PubMed=3460088;
CC   Characteristics: Deficient in plasmalogen biosynthesis and peroxisome assembly (PubMed=3460088).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   ZR-78.1
AC   CVCL_8026
DR   BTO; BTO_0004917
DR   Wikidata; Q54996125
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_8025 ! ZR-78
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   ZR-82
AC   CVCL_8027
DR   BTO; BTO_0004918
DR   Wikidata; Q54996126
RX   PubMed=3460088;
RX   PubMed=9114014;
CC   Characteristics: Deficient in plasmalogen biosynthesis and peroxisome assembly (PubMed=3460088).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
ID   ZR-87
AC   CVCL_8028
DR   Wikidata; Q54996127
RX   PubMed=3460088;
CC   Characteristics: Deficient in plasmalogen biosynthesis and peroxisome assembly (PubMed=3460088).
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_0214 ! CHO-K1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 10
//
ID   ZR/HERc 1A
AC   CVCL_D3W9
SY   ZR-HERc 1A
DR   CancerTools; 154628
DR   Wikidata; Q127384780
RX   PubMed=1516065;
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR under the control of HSV-1 TK promoter (PubMed=1516065).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   ZR/HERc 1D
AC   CVCL_D3WA
SY   ZR-HERc 1D
DR   Wikidata; Q127384782
RX   PubMed=1516065;
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR under the control of HSV-1 TK promoter (PubMed=1516065).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   ZR/HERc 1E
AC   CVCL_D3WB
SY   ZR-HERc 1E
DR   Wikidata; Q127384783
RX   PubMed=1516065;
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR under the control of HSV-1 TK promoter (PubMed=1516065).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   ZR/HERc 1F
AC   CVCL_D3WC
SY   ZR-HERc 1F
DR   CancerTools; 154629
DR   Wikidata; Q127384786
RX   PubMed=1516065;
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR under the control of HSV-1 TK promoter (PubMed=1516065).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   ZR/HERc 1G
AC   CVCL_D3WD
SY   ZR-HERc 1G
DR   Wikidata; Q127384788
RX   PubMed=1516065;
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR under the control of HSV-1 TK promoter (PubMed=1516065).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   ZR/HERc 2B
AC   CVCL_D3WE
SY   ZR-HERc 2B
DR   Wikidata; Q127384790
RX   PubMed=1516065;
CC   Population: Caucasian.
CC   Characteristics: Expresses EGFR under the control of HSV-1 TK promoter (PubMed=1516065).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:3236; EGFR.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 14-08-25; Version: 4
//
ID   ZR75-1 25DOCR
AC   CVCL_4Y42
DR   cancercelllines; CVCL_4Y42
DR   Wikidata; Q54996129
RX   PubMed=25312014;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   ZR75-1 25PACR
AC   CVCL_4Y44
DR   cancercelllines; CVCL_4Y44
DR   Wikidata; Q54996130
RX   PubMed=25312014;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   ZR75-1 50DOCR
AC   CVCL_4Y43
DR   cancercelllines; CVCL_4Y43
DR   Wikidata; Q54996132
RX   PubMed=25312014;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_4672; Docetaxel anhydrous (Taxotere).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   ZR75-1 50PACR
AC   CVCL_4Y45
DR   cancercelllines; CVCL_4Y45
DR   Wikidata; Q54996135
RX   PubMed=25312014;
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 19-12-24; Version: 12
//
ID   ZR75-LTED
AC   CVCL_YX86
SY   ZR75 LTED; ZR75-Long Term Estrogen-Deprived
DR   cancercelllines; CVCL_YX86
DR   Wikidata; Q98136617
RX   PubMed=26116361;
CC   Population: Caucasian.
CC   Characteristics: Derived from parent cell line by long-term culture in the presence of RPMI 1640 medium containing 10% dextran charcoal stripped serum (DCC) (PubMed=26116361).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 10-04-25; Version: 10
//
ID   ZR75.1 A3
AC   CVCL_YX82
DR   cancercelllines; CVCL_YX82
DR   Wikidata; Q98136621
RX   PubMed=20386540;
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:2594; CYP19A1.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   ZR75B Ad120
AC   CVCL_ZZ26
DR   cancercelllines; CVCL_ZZ26
DR   Wikidata; Q102115155
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 47.8 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5614 ! ZR-75-B
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ZR75B Ad24
AC   CVCL_ZZ27
DR   cancercelllines; CVCL_ZZ27
DR   Wikidata; Q102115156
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 41.3 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5614 ! ZR-75-B
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ZR75B Tx10
AC   CVCL_ZZ28
DR   cancercelllines; CVCL_ZZ28
DR   Wikidata; Q102115157
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 34.1 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5614 ! ZR-75-B
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ZR75B Tx40
AC   CVCL_ZZ29
DR   cancercelllines; CVCL_ZZ29
DR   Wikidata; Q102115158
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 43.5 hours (PubMed=8562478; PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_45863; Paclitaxel (Taxol).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5614 ! ZR-75-B
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ZR75B Vb10
AC   CVCL_ZZ30
DR   cancercelllines; CVCL_ZZ30
DR   Wikidata; Q102115159
RX   PubMed=8562478;
RX   PubMed=9815641;
CC   Population: Caucasian.
CC   Doubling time: 38.2 hours (PubMed=9815641).
CC   Selected for resistance to: ChEBI; CHEBI_27375; Vincaleukoblastine (Vinblastine).
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_5614 ! ZR-75-B
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 8
//
ID   ZR75T
AC   CVCL_IW49
DR   cancercelllines; CVCL_IW49
DR   Wikidata; Q54996136
RX   PubMed=8430082;
RX   PubMed=28196595;
WW   Info; MCLP; -; https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Population: Caucasian.
CC   Sequence variation: Mutation; HGNC; HGNC:5173; HRAS; Simple; p.Glu162Lys (c.484G>A); ClinVar=VCV001034833; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:9588; PTEN; Simple; p.Leu108Arg (c.323T>G); Zygosity=Homozygous (from parent cell line).
CC   Omics: Proteomics; Expression; Reverse-phase protein array.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0588 ! ZR-75-1
SX   Female
AG   63Y
CA   Cancer cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 12
//
ID   ZS-1
AC   CVCL_9R46
SY   ADOL ZS-1 1/31/13
DR   Wikidata; Q54996137
RX   Patent=US9340815;
CC   Group: Bird cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-121623.
CC   Derived from site: In situ; Embryo; UBERON=UBERON_0000922.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: East Lansing Line 0.TVB*S1.
OX   NCBI_TaxID=9031; ! Gallus gallus (Chicken)
SX   Sex unspecified
AG   10FD
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 02-05-24; Version: 9
//
ID   ZSM
AC   CVCL_F481
DR   CLO; CLO_0051136
DR   RCB; HSC0001
DR   Wikidata; Q54996141
RX   PubMed=21383383;
CC   Part of: Sonoda-Tajima cell collection.
CC   Population: Chinese.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Transformed cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 13
//
ID   ZSPHARi001-A
AC   CVCL_C0F6
DR   hPSCreg; ZSPHARi001-A
DR   Wikidata; Q112930598
RX   PubMed=35121199;
CC   From: Zhongshan Hospital of Fudan University; Shanghai; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; c.2992+2T>G; ClinVar=VCV001048002; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35121199).
CC   Sequence variation: Mutation; HGNC; HGNC:2214; COL7A1; Simple; p.Gly2680Ser (c.8038G>A); ClinVar=VCV001075764; Zygosity=Heterozygous (PubMed=35121199).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C156446; Epidermolysis bullosa dystrophica, autosomal recessive
DI   ORDO; Orphanet_79408; Autosomal recessive generalized dystrophic epidermolysis bullosa, severe form
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 19-12-24; Version: 7
//
ID   ZSPHARi002-A
AC   CVCL_D0G2
DR   hPSCreg; ZSPHARi002-A
DR   Wikidata; Q123034006
CC   From: Zhongshan Hospital of Fudan University; Shanghai; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
ID   ZSSJ
AC   CVCL_6E22
DR   Wikidata; Q47478471
RX   PubMed=19116758;
RX   PubMed=33053677;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Spleen; UBERON=UBERON_0002106.
CC   Cell type: Epithelial cell; CL=CL_0000066.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Sex unspecified
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 23-02-16; Last updated: 29-06-23; Version: 7
//
ID   ZSSYe001-A
AC   CVCL_YP14
SY   H1-DAPK1-KOF-C15
DR   BioSamples; SAMEA8325241
DR   hPSCreg; ZSSYe001-A
DR   SKIP; SKIP005599
DR   Wikidata; Q98136625
RX   PubMed=31978714;
CC   From: Sun Yat-sen University Third Affiliated Hospital; Guangzhou; China.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:2674; DAPK1.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9771 ! WA01
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 12-03-20; Last updated: 19-12-24; Version: 7
//
ID   ZSYYDNi001-A
AC   CVCL_B5GP
SY   ZSYYDN-DMD-001
DR   hPSCreg; ZSYYDNi001-A
DR   Wikidata; Q110434444
RX   PubMed=34619646;
CC   From: Department of Neurology, Sun Yat-sen University First Affiliated Hospital; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Unexplicit; Ex51del; Zygosity=Hemizygous (PubMed=34619646).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 19-12-24; Version: 5
//
ID   ZSZOCi001-A
AC   CVCL_D0QH
DR   BioSamples; SAMEA113541684
DR   hPSCreg; ZSZOCi001-A
DR   Wikidata; Q123034007
RX   PubMed=37269665;
CC   From: Zhongshan Ophthalmic Center, Sun Yat-sen University; Guangzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2195; COL18A1; Simple; c.3929-2637_4461+597delinsTC; Zygosity=Heterozygous (PubMed=37269665).
CC   Sequence variation: Mutation; HGNC; HGNC:2195; COL18A1; Simple; c.4259-28_4265del; Zygosity=Heterozygous (PubMed=37269665).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C201594; Knobloch syndrome 1
DI   ORDO; Orphanet_1571; Knobloch syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
ID   Zt/#1
AC   CVCL_D3UI
DR   Wikidata; Q127384791
RX   PubMed=21749705;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Zt/c1
AC   CVCL_D3UJ
DR   Wikidata; Q127384793
RX   PubMed=16880737;
RX   PubMed=21749705;
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Zt/f2
AC   CVCL_D3UK
DR   Wikidata; Q127384795
RX   PubMed=21749705;
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
CC   Misspelling: Zf/f2; Note=In Cellosaurus releases 48 to 50.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
ID   Zt/g4
AC   CVCL_D3UL
DR   Wikidata; Q127384796
RX   PubMed=16880737;
RX   PubMed=21749705;
CC   Biotechnology: The monoclonal antibody produced by this hybridoma was used to prepare a humanized monomethyl auristatin E conjugated (Zt/g4-MMAE) therapeutic antibody whcih is evaluated for the treatment of pancreatic cancer.
CC   Monoclonal antibody isotype: IgG1, lambda.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   Zt/g9
AC   CVCL_D3UM
DR   Wikidata; Q127384797
RX   PubMed=21749705;
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: UniProtKB; Q04912; Human MST1R/CD136.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6
AC   CVCL_DX87
DR   Wikidata; Q127384798
RX   PubMed=12091306;
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Donor information: Established from a spontaneous tumor-like hypertrophied testis (PubMed=12091306).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-1
AC   CVCL_DX88
DR   ABM; T2600
DR   Wikidata; Q127384800
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-10
AC   CVCL_DX97
DR   ABM; T2609
DR   Wikidata; Q127384802
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-11
AC   CVCL_DX98
DR   ABM; T2610
DR   Wikidata; Q127384804
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-12
AC   CVCL_DX99
DR   ABM; T2611
DR   Wikidata; Q127384807
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Characteristics: Stimulates the differentiation of spermatogonia into sperm (PubMed=14991734).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-2
AC   CVCL_DX89
DR   ABM; T2601
DR   Wikidata; Q127384809
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Characteristics: Stimulates the proliferation of spermatogonia (PubMed=14991734).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-3
AC   CVCL_DX90
DR   ABM; T2602
DR   Wikidata; Q127384811
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-4
AC   CVCL_DX91
DR   ABM; T2603
DR   Wikidata; Q127384812
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-5
AC   CVCL_DX92
DR   ABM; T2604
DR   Wikidata; Q127384814
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-6
AC   CVCL_DX93
DR   ABM; T2605
DR   Wikidata; Q127384815
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-7
AC   CVCL_DX94
DR   ABM; T2606
DR   Wikidata; Q127384817
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-8
AC   CVCL_DX95
DR   ABM; T2607
DR   Wikidata; Q127384819
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZtA6-9
AC   CVCL_DX96
DR   ABM; T2608
DR   Wikidata; Q127384821
RX   PubMed=14991734;
CC   Group: Fish cell line.
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Breed/subspecies: alb/alb-1.
OX   NCBI_TaxID=7955; ! Danio rerio (Zebrafish)
HI   CVCL_DX87 ! ZtA6
SX   Male
AG   Adult
CA   Spontaneously immortalized cell line
DT   Created: 30-01-24; Last updated: 10-09-24; Version: 2
//
ID   ZUB1
AC   CVCL_XB16
DR   CCRID; 4201PAT-CCTCC00163
DR   Wikidata; Q98136629
RX   Patent=CN100381468C;
RX   PubMed=17063545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200510.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   ZUB4
AC   CVCL_XB17
DR   CCRID; 4201PAT-CCTCC00164
DR   Wikidata; Q98136633
RX   Patent=CN100398561C;
RX   PubMed=17063545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200511.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   ZUC3
AC   CVCL_XB18
DR   CCRID; 4201PAT-CCTCC00165
DR   Wikidata; Q98136638
RX   Patent=CN100398563C;
RX   PubMed=17063545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200512.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human antigen on mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   ZUE12
AC   CVCL_XB19
DR   CCRID; 4201PAT-CCTCC00166
DR   Wikidata; Q98136643
RX   Patent=CN100398560C;
RX   PubMed=17063545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200514.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   ZUF10
AC   CVCL_XB20
DR   CCRID; 4201PAT-CCTCC00167
DR   Wikidata; Q98136646
RX   Patent=CN100398562C;
RX   PubMed=17063545;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200513.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human antigen on mesenchymal stem cells.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 06-09-19; Last updated: 10-04-25; Version: 7
//
ID   ZW-C-hiPSC
AC   CVCL_A4HI
SY   ZW-C; ZW-Corrected-hiPSC
DR   SKIP; SKIP003141
DR   Wikidata; Q105511869
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple_corrected; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous; Note=By CRISPR/Cas9 (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A4HB ! ZW-hiPSC 12
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZW-hiPSC 12
AC   CVCL_A4HB
SY   ZW12
DR   SKIP; SKIP003133
DR   Wikidata; Q105511871
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GZ ! ZW-hiPSC 6
OI   CVCL_A4HA ! ZW-hiPSC 9
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZW-hiPSC 6
AC   CVCL_A4GZ
SY   ZW6
DR   SKIP; SKIP003131
DR   Wikidata; Q105511873
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4HA ! ZW-hiPSC 9
OI   CVCL_A4HB ! ZW-hiPSC 12
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZW-hiPSC 9
AC   CVCL_A4HA
SY   ZW9
DR   SKIP; SKIP003132
DR   Wikidata; Q105511875
RX   PubMed=29452156;
CC   From: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University; Shanghai; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; HGNC:9386; PRKAG2; Simple; p.Arg302Gln (c.905G>A); ClinVar=VCV000006846; Zygosity=Heterozygous (PubMed=29452156).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C177249; Familial hypertrophic cardiomyopathy type 6
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_A4GZ ! ZW-hiPSC 6
OI   CVCL_A4HB ! ZW-hiPSC 12
SX   Male
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 6
//
ID   ZWG1-Fib
AC   CVCL_WB13
SY   ZellWeGer syndrome 1-Fibroblast
DR   IBRC; C10507
DR   Wikidata; Q98136651
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   2M
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   ZWG2-Fib
AC   CVCL_WB14
SY   ZellWeGer syndrome 2-Fibroblast
DR   IBRC; C10510
DR   Wikidata; Q98136655
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85239; Zellweger syndrome
DI   ORDO; Orphanet_912; Zellweger syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Finite cell line
DT   Created: 24-05-19; Last updated: 29-06-23; Version: 7
//
ID   ZX2021H
AC   CVCL_B6ZD
SY   TJYK-ZLL-01
DR   cancercelllines; CVCL_B6ZD
DR   CCRID; 4201PAT-CCTCC01828
DR   Wikidata; Q112041948
RX   Patent=CN113817684B;
RX   PubMed=35297208;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2021215.
CC   Population: Chinese.
CC   Doubling time: ~29.8 hours (PubMed=35297208).
CC   Sequence variation: Mutation; HGNC; HGNC:1097; BRAF; Simple; p.Asp22Asn (c.64G>A); ClinVar=VCV000040335; Zygosity=Unspecified (PubMed=35297208).
CC   Sequence variation: Mutation; HGNC; HGNC:7765; NF1; Simple; p.Cys2134Tyrfs*8 (c.6401_6402delGT) (p.L2133fs, c.6398_6399del); ClinVar=VCV000818199; Zygosity=Unspecified (PubMed=35297208).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Arg (c.536A>G); ClinVar=VCV000376606; Zygosity=Unspecified (PubMed=35297208).
CC   Derived from site: Metastatic; Cervical lymph node; UBERON=UBERON_0002429.
ST   Source(s): Patent=CN113817684B; PubMed=35297208
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 20
ST   D13S317: 9,11
ST   D16S539: 9,12
ST   D18S51: 14,16
ST   D19S433: 13,15.2
ST   D21S11: 31
ST   D2S1338: 19
ST   D2S441: 10
ST   D3S1358: 16
ST   D5S818: 9
ST   D6S1043: 14
ST   D7S820: 8,12
ST   D8S1179: 13
ST   FGA: 19,21
ST   Penta D: 12
ST   Penta E: 13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   42Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 8
//
ID   ZYM-SVEC01
AC   CVCL_A8QJ
DR   CCRID; 4201PAT-CCTCC00258
DR   Wikidata; Q108821567
RX   Patent=CN101613674A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C200841.
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Klebsiella pneumoniae transposon Tn5 neo.
CC   Derived from site: In situ; Vein; UBERON=UBERON_0001638.
CC   Cell type: Endothelial cell of vein; CL=CL_0002543.
OX   NCBI_TaxID=9823; ! Sus scrofa (Pig)
SX   Sex unspecified
AG   Age unspecified
CA   Telomerase immortalized cell line
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 7
//
ID   ZYXY-M1
AC   CVCL_B6YP
DR   CCRID; 4201PAT-CCTCC01831
DR   Wikidata; Q112041949
RX   Patent=CN113046319B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202144.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Patent=CN113046319B
ST   Amelogenin: X,Y
ST   CSF1PO: 10,11
ST   D12S391: 21,22
ST   D13S317: 9,12
ST   D16S539: 11,13
ST   D18S51: 12,19
ST   D19S433: 13,15.2
ST   D1S1656: 15,16
ST   D21S11: 30,32
ST   D2S1338: 19,23
ST   D3S1358: 16,17
ST   D5S818: 12,13
ST   D6S1043: 14,18
ST   D7S820: 10,11
ST   D8S1179: 10,11
ST   FGA: 22,23
ST   Penta D: 10,13
ST   Penta E: 12
ST   TH01: 7,9
ST   TPOX: 8,9
ST   vWA: 18
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
ID   ZYXY-M1 luc
AC   CVCL_B6YQ
DR   Wikidata; Q112041950
RX   Patent=CN113046319B;
CC   Population: Chinese.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P33967; Bacillus cereus Bsr.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C9154; Adult acute myeloid leukemia
DI   ORDO; Orphanet_519; Acute myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B6YP ! ZYXY-M1
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 14-08-25; Version: 8
//
ID   ZYXY-M2
AC   CVCL_B6YM
DR   CCRID; 4201PAT-CCTCC01830
DR   Wikidata; Q112041951
RX   DOI=10.1182/blood-2021-152639;
RX   Patent=CN113549597B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202145.
CC   Population: Chinese.
CC   Doubling time: 48-72 hours (DOI=10.1182/blood-2021-152639).
CC   Karyotypic information: 47,XY,+12 [1]; 48,XY,+12,+9 [9] (DOI=10.1182/blood-2021-152639).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): Patent=CN113549597B
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D12S391: 17,19
ST   D13S317: 8,9
ST   D16S539: 11,13
ST   D18S51: 14,16
ST   D19S433: 14
ST   D1S1656: 13,17
ST   D21S11: 29
ST   D2S1338: 23,25
ST   D3S1358: 16,17
ST   D5S818: 10,14
ST   D6S1043: 11,14
ST   D7S820: 10,12
ST   D8S1179: 14,15
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 14,15
ST   TH01: 7,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C2862; Primary myelofibrosis
DI   ORDO; Orphanet_824; Primary myelofibrosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
ID   ZYXY-T1
AC   CVCL_B6YT
DR   CCRID; 4201PAT-CCTCC01826
DR   Wikidata; Q112041952
RX   Patent=CN112877290B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC 202143.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): Patent=CN112877290B
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 19,21
ST   D13S317: 9
ST   D16S539: 8,11
ST   D18S51: 14,19
ST   D19S433: 13,13.2
ST   D1S1656: 17.3,18.3
ST   D21S11: 30,31
ST   D2S1338: 23
ST   D3S1358: 14,17
ST   D5S818: 10,13
ST   D6S1043: 13
ST   D7S820: 12,13
ST   D8S1179: 13,14
ST   FGA: 23,24
ST   Penta D: 10,11
ST   Penta E: 15,19
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 14,15
DI   NCIt; C130043; Early T acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 4
//
ID   ZZ-R 127
AC   CVCL_5418
SY   ZZ-R
DR   CCLV; CCLV-RIE 0127
DR   Wikidata; Q54996143
RX   PubMed=19656987;
RX   PubMed=19941903;
RX   PubMed=26082457;
RX   PubMed=27795464;
RX   PubMed=32851014;
RX   PubMed=34737324;
CC   Virology: Susceptible to infection by foot-and-mouth disease virus.
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 15
//
ID   ZZ-R MVV infected
AC   CVCL_C5B7
SY   ZZR-20
DR   Wikidata; Q116050849
RX   PubMed=27795464;
CC   Virology: Persently infected by maedi visna virus (MVV) (PubMed=27795464).
CC   Derived from site: In situ; Fetal oral cavity, tongue; UBERON=UBERON_0010056.
OX   NCBI_TaxID=9925; ! Capra hircus (Goat)
HI   CVCL_5418 ! ZZ-R 127
SX   Sex unspecified
AG   Fetus
CA   Spontaneously immortalized cell line
DT   Created: 15-12-22; Last updated: 29-06-23; Version: 3
//
ID   ZZUCSBi001-A
AC   CVCL_D6NK
DR   BioSamples; SAMEA114531319
DR   hPSCreg; ZZUCSBi001-A
RX   PubMed=38335661;
CC   From: Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   ZZUCSBi002-A
AC   CVCL_D6NL
DR   hPSCreg; ZZUCSBi002-A
CC   From: Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 10-09-24; Last updated: 14-08-25; Version: 2
//
ID   ZZUi001-A
AC   CVCL_VE18
SY   LC-fb001-iPSC
DR   hPSCreg; ZZUi001-A
DR   SKIP; SKIP003089
DR   Wikidata; Q54996144
RX   PubMed=29246575;
CC   Problematic cell line: Probably misidentified. This cell line is said to originate from the same individual as ZZUi002-A but the STR profiles of these two cell lines are completely different.
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Caution: The STR value for D5S818 in PubMed=29246575 is incorrectly reported as 19,20.
CC   Cell type: Fibroblast; CL=CL_0000057.
ST   Source(s): PubMed=29246575
ST   D13S317: 14
ST   D16S539: 5
ST   D19S433: 14
ST   D21S11: 31
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D8S1179: 16,19
ST   TH01: 7
ST   vWA: 19,20
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 10
//
ID   ZZUi002-A
AC   CVCL_VE19
SY   Ctrl-fb001-iPSC
DR   hPSCreg; ZZUi002-A
DR   SKIP; SKIP003087
DR   Wikidata; Q54996145
RX   PubMed=29246575;
CC   Problematic cell line: Probably misidentified. This cell line is said to originate from the same individual as ZZUi001-A but the STR profiles of these two cell lines are completely different.
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29246575
ST   D13S317: 9,14
ST   D19S433: 16.2
ST   D21S11: 31.2,33
ST   D3S1358: 16,18
ST   D5S818: 8,9
ST   D8S1179: 18,19
ST   TH01: 6,9
ST   TPOX: 10
ST   vWA: 18,22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   64Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 8
//
ID   ZZUi003-A
AC   CVCL_LI39
SY   PD-001-iPSC
DR   hPSCreg; ZZUi003-A
DR   Wikidata; Q54996165
RX   PubMed=28925360;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=28925360
ST   D13S317: 9,15
ST   D19S433: 14
ST   D21S11: 32,34.2
ST   D3S1358: 15,17
ST   D5S818: 8
ST   D8S1179: 16
ST   TH01: 7,9
ST   TPOX: 6,12
ST   vWA: 21
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 15-11-17; Last updated: 14-08-25; Version: 9
//
ID   ZZUi004-A
AC   CVCL_LE97
SY   ZZU-iPS-SCA3-001; LBK-SCA3-4-2
DR   BioSamples; SAMEA104388090
DR   hPSCreg; ZZUi004-A
DR   SKIP; SKIP003147
DR   Wikidata; Q54996166
RX   PubMed=29444500;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[76]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=29444500).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
ST   Source(s): PubMed=29444500
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D13S317: 8,12
ST   D16S539: 12
ST   D21S11: 28,31
ST   D5S818: 11,12
ST   D7S820: 8,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 16,20
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 15
//
ID   ZZUi005-A
AC   CVCL_LE98
SY   ZZU-iPS-PD-RAB39b-001
DR   BioSamples; SAMEA104388410
DR   hPSCreg; ZZUi005-A
DR   Wikidata; Q53996684
RX   PubMed=29128816;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16499; RAB39B; Simple; p.Glu179fs*48 (c.536dupA); Zygosity=Hemizygous (PubMed=29128816).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29128816
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D21S11: 29
ST   D5S818: 11,12
ST   D7S820: 10,11
ST   TH01: 9
ST   TPOX: 8,9
ST   vWA: 16,19
DI   NCIt; C184991; Waisman syndrome
DI   ORDO; Orphanet_2379; Early-onset parkinsonism-intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   21Y
CA   Induced pluripotent stem cell
DT   Created: 22-08-17; Last updated: 14-08-25; Version: 13
//
ID   ZZUi006-A
AC   CVCL_VE20
SY   ZZU-iPS-DM1-DMPK-001; ZZU-iPS-DM1-001
DR   BioSamples; SAMEA104491350
DR   hPSCreg; ZZUi006-A
DR   SKIP; SKIP005544
DR   Wikidata; Q54996168
RX   PubMed=30216892;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   47Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 11
//
ID   ZZUi007-A
AC   CVCL_VL50
SY   ZZU-iPS-PD-CHCHD2-001
DR   BioSamples; SAMEA4760684
DR   hPSCreg; ZZUi007-A
DR   Wikidata; Q98136659
RX   PubMed=30237140;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:21645; CHCHD2; Simple; p.Thr61Ile (c.182C>T); ClinVar=VCV000218882; Zygosity=Heterozygous (PubMed=30237140).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C205643; Parkinson disease 22, autosomal dominant
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 07-09-18; Last updated: 14-08-25; Version: 12
//
ID   ZZUi008-A
AC   CVCL_VQ67
SY   DMD-CV-iPSCs
DR   hPSCreg; ZZUi008-A
DR   Wikidata; Q98136663
RX   PubMed=30172907;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2928; DMD; Simple; p.Gln1528Argfs*18 (c.4583delA); Zygosity=Hemizygous (PubMed=30172907).
CC   Derived from site: In situ; Chorionic villus; UBERON=UBERON_0007106.
ST   Source(s): PubMed=30172907
ST   Amelogenin: X,Y
ST   CSF1PO: 13
ST   D12S391: 18,23
ST   D13S317: 8,13
ST   D16S539: 9,12
ST   D18S51: 22
ST   D19S433: 15,16
ST   D21S11: 31.2,32.2
ST   D2S1338: 24
ST   D3S1358: 16,18
ST   D5S818: 10,13
ST   D6S1043: 13,14
ST   D7S820: 10,11
ST   D8S1179: 14,16
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 12,16
ST   TH01: 9,9.3
ST   TPOX: 8,11
ST   vWA: 14
DI   NCIt; C75482; Duchenne muscular dystrophy
DI   ORDO; Orphanet_98896; Duchenne muscular dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   13FW
CA   Induced pluripotent stem cell
DT   Created: 13-11-18; Last updated: 14-08-25; Version: 10
//
ID   ZZUi009-A
AC   CVCL_RY09
SY   ZZU-iPS-AD-PSEN1-001; ZZU-iPS-AD-PS1-001
DR   BioSamples; SAMEA104491590
DR   hPSCreg; ZZUi009-A
DR   SKIP; SKIP003011
DR   Wikidata; Q54996169
RX   PubMed=29304399;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:9508; PSEN1; Simple; p.His214Arg (c.641A>G); Zygosity=Heterozygous (PubMed=29304399).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C123412; Alzheimer's disease 3
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 13
//
ID   ZZUi010-A
AC   CVCL_QZ49
SY   ZZU-iPS-AD-APP-001
DR   BioSamples; SAMEA104494110
DR   hPSCreg; ZZUi010-A
DR   Wikidata; Q54996171
RX   PubMed=29156377;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=29156377).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=29156377
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 10,13
ST   D16S539: 9,12
ST   D21S11: 30,34.2
ST   D5S818: 9,11
ST   D7S820: 11
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 14-08-25; Version: 14
//
ID   ZZUi011-A
AC   CVCL_VE21
SY   ZZU-iPS-Normal-001
DR   BioSamples; SAMEA104620781
DR   hPSCreg; ZZUi011-A
DR   SKIP; SKIP003219
DR   Wikidata; Q54996173
RX   PubMed=29574173;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 14-05-18; Last updated: 14-08-25; Version: 9
//
ID   ZZUi012-A
AC   CVCL_UL86
SY   ZZUi0012-A; ZZU-iPS-PFBC-SLC20A2-001
DR   BioSamples; SAMEA4966483
DR   hPSCreg; ZZUi012-A
DR   SKIP; SKIP005535
DR   Wikidata; Q98136669
RX   PubMed=30776674;
RX   PubMed=31439445;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10947; SLC20A2; Simple; p.Val205Met (c.613G>A); ClinVar=VCV002169534; Zygosity=Heterozygous (PubMed=30776674).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C129973; Idiopathic basal ganglia calcification 1
DI   ORDO; Orphanet_1980; Bilateral striopallidodentate calcinosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 12
//
ID   ZZUi013-A
AC   CVCL_UL87
SY   ZZUi0013-A; ZZU-iPS-AD-MEOX2-001
DR   BioSamples; SAMEA5043219
DR   hPSCreg; ZZUi013-A
DR   SKIP; SKIP005541
DR   Wikidata; Q98136673
RX   PubMed=30616143;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7014; MEOX2; Simple; p.His80del (c.228_230delCCA); Zygosity=Heterozygous (PubMed=30616143).
CC   Derived from site: In situ; Forearm, skin; UBERON=UBERON_0003403.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C2866; Alzheimer's disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 25-02-19; Last updated: 14-08-25; Version: 11
//
ID   ZZUi014-A
AC   CVCL_WN18
SY   ZZUi0014-A; ZZU-iPS-SCA3-002
DR   BioSamples; SAMEA5746310
DR   hPSCreg; ZZUi014-A
DR   SKIP; SKIP005565
DR   Wikidata; Q98136677
RX   PubMed=31639609;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[64]; Zygosity=Heterozygous; Note=The other allele has 14 repeats (PubMed=31639609).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 24-05-19; Last updated: 14-08-25; Version: 12
//
ID   ZZUi015-A
AC   CVCL_WT74
SY   ZZU-iPS-DM1-002
DR   BioSamples; SAMEA8913276
DR   hPSCreg; ZZUi015-A
DR   Wikidata; Q98136682
RX   PubMed=34915310;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:2933; DMPK; Repeat_expansion; c.*224CTG[>50] (c.*224CTG[(51_?)]); ClinVar=VCV000005049; Zygosity=Homozygous (PubMed=34915310).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84679; Dystrophia myotonica 1
DI   ORDO; Orphanet_273; Steinert myotonic dystrophy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 10
//
ID   ZZUi016-A
AC   CVCL_YB83
SY   ZZUi0016-A; ZZU-iPS-Normal-002
DR   BioSamples; SAMEA6114042
DR   hPSCreg; ZZUi016-A
DR   SKIP; SKIP005693
DR   Wikidata; Q98136686
RX   PubMed=32007761;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   ZZUi017-A
AC   CVCL_YB84
SY   ZZUi0017-A; ZZU-iPS-SCA6-001
DR   BioSamples; SAMEA6162960
DR   hPSCreg; ZZUi017-A
DR   SKIP; SKIP005817
DR   Wikidata; Q98136691
RX   PubMed=32791484;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[25] (c.6937CAG[25]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous; Note=The non-expanded allele has p.Gln2313[13] (PubMed=32791484).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   ZZUi018-A
AC   CVCL_YM36
SY   ZZUi0018-A; ZZU-iPS-SCA6-002
DR   BioSamples; SAMEA6551739
DR   hPSCreg; ZZUi018-A
DR   SKIP; SKIP005738
DR   Wikidata; Q98136695
RX   PubMed=32229428;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:1388; CACNA1A; Repeat_expansion; p.Gln2313[25] (c.6937CAG[25]) (c.6937CAG[(21_30)]); ClinVar=VCV000562099; Zygosity=Heterozygous; Note=The non-expanded allele has p.Gln2313[14] (PubMed=32229428).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C142838; Spinocerebellar ataxia type 6
DI   ORDO; Orphanet_98758; Spinocerebellar ataxia type 6
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   31Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   ZZUi019-A
AC   CVCL_A3ZG
SY   ZZU-iPS-Normal-002
DR   BioSamples; SAMEA7762071
DR   hPSCreg; ZZUi019-A
DR   Wikidata; Q105511877
RX   PubMed=33740644;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUi020-A
AC   CVCL_A3ZH
SY   ZZU-iPS-PD-NOTCH2NLC-001
DR   hPSCreg; ZZUi020-A
DR   Wikidata; Q105511879
RX   PubMed=33626493;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=51 GGC repeats (PubMed=33626493).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C26845; Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUi021-A
AC   CVCL_A3ZI
SY   ZZU-iPS-SCA19-KCND3-001; ZZUi0021-SCA19-KCND3-001
DR   BioSamples; SAMEA7807669
DR   hPSCreg; ZZUi021-A
DR   Wikidata; Q105511882
RX   PubMed=34087979;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6239; KCND3; Simple; p.Thr377Met (c.1130C>T); ClinVar=VCV000626319; Zygosity=Heterozygous (PubMed=34087979).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C163756; Spinocerebellar ataxia type 19/22
DI   ORDO; Orphanet_98772; Spinocerebellar ataxia type 19/22
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   23Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUi022-A
AC   CVCL_A3ZJ
SY   ZZU-PKD-PRRT2 iPSC
DR   hPSCreg; ZZUi022-A
DR   Wikidata; Q105511884
RX   PubMed=33550051;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:30500; PRRT2; Simple; p.Gln179Ter (c.535C>T); ClinVar=VCV001352762; Zygosity=Heterozygous (PubMed=33550051).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C178413; Episodic kinesigenic dyskinesia-1
DI   ORDO; Orphanet_98809; Paroxysmal kinesigenic dyskinesia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUi023-A
AC   CVCL_A3ZK
SY   ZZU-iPS-Normal-003
DR   hPSCreg; ZZUi023-A
DR   Wikidata; Q105511886
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 4
//
ID   ZZUi024-A
AC   CVCL_A3ZL
SY   ZZUi0024-A; ZZU-iPS-AD-APP-002
DR   BioSamples; SAMEA7873750
DR   hPSCreg; ZZUi024-A
DR   Wikidata; Q105511888
RX   PubMed=33652304;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:620; APP; Simple; p.Val717Ile (c.2149G>A); ClinVar=VCV000018088; Zygosity=Heterozygous (PubMed=33652304).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C146894; Alzheimer's disease 1
DI   ORDO; Orphanet_1020; Early-onset autosomal dominant Alzheimer disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUi026-A
AC   CVCL_A3ZM
SY   ZZUi0026-A; ZZU-iPS-SCA3-003
DR   BioSamples; SAMEA7976386
DR   hPSCreg; ZZUi026-A
DR   Wikidata; Q105511892
RX   PubMed=34087977;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[80]; Zygosity=Heterozygous (PubMed=34087977).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUi027-A
AC   CVCL_A5GT
SY   ZZU-iPS-RAB39B-002; ZZU-iPS-PD-RAB39b-002
DR   BioSamples; SAMEA8152173
DR   hPSCreg; ZZUi027-A
DR   Wikidata; Q107117580
RX   PubMed=34247111;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:16499; RAB39B; Simple; p.Glu179fs*48 (c.536dupA); Zygosity=Hemizygous (PubMed=34247111).
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C184991; Waisman syndrome
DI   ORDO; Orphanet_2379; Early-onset parkinsonism-intellectual disability syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   ZZUi028-A
AC   CVCL_A4YJ
SY   ZZU-iPS-Normal-005
DR   BioSamples; SAMEA8152175
DR   hPSCreg; ZZUi028-A
DR   Wikidata; Q107117581
RX   PubMed=34088010;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUi029-A
AC   CVCL_A5GU
DR   hPSCreg; ZZUi029-A
DR   Wikidata; Q107117582
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   ZZUi030-A
AC   CVCL_B0FN
SY   ZZU-iPS-SPG7-001
DR   BioSamples; SAMEA9405883
DR   hPSCreg; ZZUi030-A
DR   Wikidata; Q108821568
RX   PubMed=34509920;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11237; SPG7; Simple; p.Arg398Ter (c.1192C>T); ClinVar=VCV000545964; Zygosity=Heterozygous (PubMed=34509920).
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C181657; Spastic paraplegia 7
DI   ORDO; Orphanet_99013; Spastic paraplegia type 7
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   56Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUi031-A
AC   CVCL_B0FP
SY   ZZU-iPS-Normal-006
DR   BioSamples; SAMEA9652838
DR   hPSCreg; ZZUi031-A
DR   Wikidata; Q108821569
RX   PubMed=34856467;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Leg, skin, dermis; UBERON=UBERON_0001511+UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   ZZUi032-A
AC   CVCL_B0FQ
SY   ZZU-iPS-Normal-007
DR   BioSamples; SAMEA9726460
DR   hPSCreg; ZZUi032-A
DR   Wikidata; Q108821570
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Induced pluripotent stem cell
DT   Created: 23-09-21; Last updated: 14-08-25; Version: 5
//
ID   ZZUi033-A
AC   CVCL_B5G6
SY   ZZU-iPS-L1-001
DR   hPSCreg; ZZUi033-A
DR   Wikidata; Q110434445
RX   PubMed=35042084;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6470; L1CAM; Simple; p.Ile219Val (c.655A>G); Zygosity=Hemizygous (PubMed=35042084).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35042084
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 8,12
ST   D16S539: 10,11
ST   D21S11: 29,30
ST   D5S818: 9,11
ST   D7S820: 8,13
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C129930; MASA syndrome
DI   ORDO; Orphanet_2466; MASA syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   6Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUi034-A
AC   CVCL_B5G7
SY   Healthy control 2
DR   hPSCreg; ZZUi034-A
DR   Wikidata; Q110434447
RX   PubMed=35462158;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUi035-A
AC   CVCL_B5G8
DR   hPSCreg; ZZUi035-A
DR   Wikidata; Q110434448
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
DI   NCIt; C4044; Laryngeal squamous cell carcinoma
DI   ORDO; Orphanet_494550; Squamous cell carcinoma of the larynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 4
//
ID   ZZUi036-A
AC   CVCL_C0IH
SY   ZZU-iPS-NIID-NOTCH2NLC-001
DR   BioSamples; SAMEA13855334
DR   hPSCreg; ZZUi036-A
DR   Wikidata; Q112930599
RX   PubMed=35772299;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:53924; NOTCH2NLC; Simple; c.-164GGC[(66_517)]; ClinVar=VCV000691867; Zygosity=Heterozygous; Note=93 GGC repeats (PubMed=35772299).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C122655; Neuronal intranuclear inclusion disease
DI   ORDO; Orphanet_2289; Neuronal intranuclear inclusion disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   ZZUi037-A
AC   CVCL_C9HT
SY   ZZU-iPS-SCA3-004
DR   BioSamples; SAMEA116324564
DR   hPSCreg; ZZUi037-A
DR   Wikidata; Q123034008
RX   PubMed=39603094;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[69]; Zygosity=Heterozygous; Note=The other allele has 21 repeats (PubMed=39603094).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   14Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 3
//
ID   ZZUNEUi001-A
AC   CVCL_WT73
DR   BioSamples; SAMEA5309462
DR   hPSCreg; ZZUNEUi001-A
DR   SKIP; SKIP005791
DR   Wikidata; Q98136699
RX   PubMed=32361313;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   38Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 14-08-25; Version: 9
//
ID   ZZUNEUi002-A
AC   CVCL_YB85
DR   BioSamples; SAMEA6171393
DR   hPSCreg; ZZUNEUi002-A
DR   SKIP; SKIP005862
DR   Wikidata; Q98136703
RX   PubMed=32650241;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7106; ATXN3; Repeat_expansion; c.892CAG[84]; Zygosity=Heterozygous (PubMed=32650241).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84830; Spinocerebellar ataxia type 3
DI   ORDO; Orphanet_98757; Spinocerebellar ataxia type 3
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   22Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   ZZUNEUi003-A
AC   CVCL_YB86
DR   BioSamples; SAMEA6145610
DR   hPSCreg; ZZUNEUi003-A
DR   SKIP; SKIP005583
DR   Wikidata; Q98136708
RX   PubMed=31783295;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Arg778Leu (c.2333G>T); ClinVar=VCV000003852; Zygosity=Homozygous (PubMed=31783295).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   ZZUNEUi004-A
AC   CVCL_YB87
DR   BioSamples; SAMEA6154496
DR   hPSCreg; ZZUNEUi004-A
DR   SKIP; SKIP005793
DR   Wikidata; Q98136711
RX   PubMed=32113134;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Pro992Leu (c.2975C>T); ClinVar=VCV000188831; Zygosity=Homozygous (PubMed=32113134).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 10
//
ID   ZZUNEUi005-A
AC   CVCL_YB88
DR   BioSamples; SAMEA6712335
DR   hPSCreg; ZZUNEUi005-A
DR   Wikidata; Q98136715
RX   PubMed=32745714;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:870; ATP7B; Simple; p.Pro992Leu (c.2975C>T); ClinVar=VCV000188831; Zygosity=Homozygous (PubMed=32745714).
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
DI   NCIt; C84756; Hepatolenticular degeneration
DI   ORDO; Orphanet_905; Wilson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 9
//
ID   ZZUNEUi006-A
AC   CVCL_YB89
SY   U001A
DR   hPSCreg; ZZUNEUi006-A
DR   Wikidata; Q98136720
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 5
//
ID   ZZUNEUi007-A
AC   CVCL_YB90
DR   hPSCreg; ZZUNEUi007-A
DR   SKIP; SKIP005644
DR   Wikidata; Q98136724
RX   PubMed=31931472;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg663His (c.1988G>A); ClinVar=VCV000042875; Zygosity=Heterozygous (PubMed=31931472).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 19-12-19; Last updated: 14-08-25; Version: 11
//
ID   ZZUNEUi008-A
AC   CVCL_YM34
SY   FLNA-M28I-iPSC
DR   hPSCreg; ZZUNEUi008-A
DR   SKIP; SKIP005772
DR   Wikidata; Q98136728
RX   PubMed=32592953;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3754; FLNA; Simple; p.Met28Ile (c.84G>A); ClinVar=VCV000641298; Zygosity=Hemizygous (PubMed=32592953).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C173469; X-linked cardiac valvular dysplasia
DI   ORDO; Orphanet_555877; FLNA-related X-linked myxomatous valvular dysplasia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 10
//
ID   ZZUNEUi009-A
AC   CVCL_YM35
DR   hPSCreg; ZZUNEUi009-A
DR   Wikidata; Q98136730
RX   PubMed=33730648;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   28Y
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 14-08-25; Version: 7
//
ID   ZZUNEUi010-A
AC   CVCL_YZ98
SY   CMF001-A
DR   BioSamples; SAMEA6878129
DR   hPSCreg; ZZUNEUi010-A
DR   Wikidata; Q98136733
RX   PubMed=33093822;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:4010; FUS; Simple; p.Gly504Argfs*12 (c.1509dupA) (p.Arg503fs); ClinVar=VCV000933229; Zygosity=Heterozygous; Note=De novo mutation (PubMed=33093822).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33093822
ST   Amelogenin: X
ST   CSF1PO: 10,12
ST   D12S391: 17,18
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 15
ST   D19S433: 13,15.2
ST   D1S1656: 16,18.3
ST   D21S11: 30,32
ST   D2S1338: 19,25
ST   D3S1358: 17
ST   D5S818: 11
ST   D6S1043: 12,13
ST   D7S820: 10,11
ST   D8S1179: 12,14
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 17,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 17,19
DI   NCIt; C168750; Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia
DI   ORDO; Orphanet_275872; Frontotemporal dementia with motor neuron disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 10
//
ID   ZZUNEUi011-A
AC   CVCL_ZM03
DR   hPSCreg; ZZUNEUi011-A
DR   Wikidata; Q98136735
RX   PubMed=33383407;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   27Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi012-A
AC   CVCL_ZM04
DR   hPSCreg; ZZUNEUi012-A
DR   Wikidata; Q98136738
RX   PubMed=33418203;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi013-A
AC   CVCL_A9YL
SY   MYH6-G3755A-iPSC
DR   hPSCreg; ZZUNEUi013-A
DR   Wikidata; Q102115163
RX   PubMed=33385793;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7576; MYH6; Simple; p.Arg1252Gln (c.3755G>A); ClinVar=VCV001308556; Zygosity=Heterozygous (PubMed=33385793).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C176899; Familial hypertrophic cardiomyopathy type 14
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   41Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 27-11-25; Version: 8
//
ID   ZZUNEUi014-A
AC   CVCL_A9YM
SY   SERPINC1-W27X-iPSC
DR   hPSCreg; ZZUNEUi014-A
DR   Wikidata; Q102115164
RX   PubMed=34973562;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:775; SERPINC1; Simple; p.Trp27Ter (c.80G>A); Zygosity=Heterozygous (PubMed=34973562).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C98815; Antithrombin III deficiency
DI   ORDO; Orphanet_82; Hereditary thrombophilia due to congenital antithrombin deficiency
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 14-08-25; Version: 7
//
ID   ZZUNEUi015-A
AC   CVCL_A4ZQ
DR   hPSCreg; ZZUNEUi015-A
DR   Wikidata; Q107117583
RX   PubMed=33607470;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:17574; ALPK3; Simple; p.Thr136Ile (c.407C>T) (p.Thr338Ile, c.1013C>T); ClinVar=VCV000389853; Zygosity=Heterozygous (PubMed=33607470).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179054; Familial hypertrophic cardiomyopathy type 27
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUNEUi016-A
AC   CVCL_A4ZR
DR   hPSCreg; ZZUNEUi016-A
DR   Wikidata; Q107117584
RX   PubMed=33636496;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Ala355Thr (c.1063G>A); ClinVar=VCV000042820; Zygosity=Heterozygous (PubMed=33636496).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
ST   Source(s): PubMed=33636496
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 16,18
ST   D13S317: 8,9
ST   D16S539: 10,12
ST   D18S51: 14,16
ST   D19S433: 13,14
ST   D21S11: 29,33.2
ST   D2S1338: 18
ST   D3S1358: 15,16
ST   D5S818: 10,12
ST   D6S1043: 18,19
ST   D7S820: 10
ST   D8S1179: 10,16
ST   FGA: 22,25
ST   Penta D: 9,11
ST   Penta E: 13,20
ST   TH01: 9
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   8Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   ZZUNEUi017-A
AC   CVCL_A4ZS
DR   hPSCreg; ZZUNEUi017-A
DR   Wikidata; Q107117585
RX   PubMed=33610015;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Glu12513fs (c.37537delG); Zygosity=Heterozygous (PubMed=33610015).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   20Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi018-A
AC   CVCL_A4ZT
DR   hPSCreg; ZZUNEUi018-A
DR   Wikidata; Q107117586
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 4
//
ID   ZZUNEUi019-A
AC   CVCL_A4ZU
DR   hPSCreg; ZZUNEUi019-A
DR   Wikidata; Q107117587
RX   PubMed=33540281;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:10259; RORB; Simple; c.94-1G>A; ClinVar=VCV001683646; Zygosity=Heterozygous; Note=Splice acceptor mutation (PubMed=33540281).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C179067; Susceptibility to idiopathic generalized epilepsy-15
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   5Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 7
//
ID   ZZUNEUi020-A
AC   CVCL_A4UN
SY   MYH7-R719Q-iPSC
DR   hPSCreg; ZZUNEUi020-A
DR   Wikidata; Q107117588
RX   PubMed=33453578;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7577; MYH7; Simple; p.Arg719Gln (c.2156G>A); ClinVar=VCV000014107; Zygosity=Heterozygous (PubMed=33453578).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C172092; Familial hypertrophic cardiomyopathy type 1
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   15Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi021-A
AC   CVCL_A6IY
SY   TNNT2-C418T-iPSC
DR   hPSCreg; ZZUNEUi021-A
DR   Wikidata; Q107117589
RX   PubMed=34929444;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:11949; TNNT2; Simple; p.Arg140Cys (c.418C>T); ClinVar=VCV000043636; Zygosity=Heterozygous (PubMed=34929444).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C142892; Familial hypertrophic cardiomyopathy type 2
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   25Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 8
//
ID   ZZUNEUi022-A
AC   CVCL_A6IX
DR   hPSCreg; ZZUNEUi022-A
DR   Wikidata; Q107117590
RX   PubMed=33529980;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Urine; UBERON=UBERON_0001088.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 5
//
ID   ZZUNEUi023-A
AC   CVCL_B5ES
DR   hPSCreg; ZZUNEUi023-A
DR   Wikidata; Q110434449
RX   PubMed=34883393;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Kazakh.
CC   Sequence variation: Mutation; HGNC; HGNC:12403; TTN; Simple; p.Arg26562Ter (c.79684C>T); ClinVar=VCV000222861; Zygosity=Heterozygous (PubMed=34883393).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C182078; Dilated cardiomyopathy-1G
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   43Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi024-A
AC   CVCL_B5ET
DR   hPSCreg; ZZUNEUi024-A
DR   Wikidata; Q110434450
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 4
//
ID   ZZUNEUi025-A
AC   CVCL_B5EU
DR   hPSCreg; ZZUNEUi025-A
DR   Wikidata; Q110434451
RX   PubMed=35257994;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; c.772+1G>A; ClinVar=VCV000042790; Zygosity=Heterozygous; Note=Splice donor mutation (PubMed=35257994).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   52Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 14-08-25; Version: 7
//
ID   ZZUNEUi026-A
AC   CVCL_B7T1
DR   BioSamples; SAMEA14300442
DR   hPSCreg; ZZUNEUi026-A
DR   Wikidata; Q112930600
RX   PubMed=35567849;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:12665; VCL; Simple; p.Met209Leu (c.625A>T); ClinVar=VCV000488174; Zygosity=Heterozygous (PubMed=35567849).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C187983; Dilated cardiomyopathy-1W
DI   ORDO; Orphanet_154; Familial isolated dilated cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   65Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi027-A
AC   CVCL_B7T2
DR   BioSamples; SAMEA14328246
DR   hPSCreg; ZZUNEUi027-A
DR   Wikidata; Q112930601
RX   PubMed=35700634;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6251; KCNH2; Simple; p.Tyr43Cys (c.128A>G); ClinVar=VCV000067182; Zygosity=Heterozygous (PubMed=35700634).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C137957; Long QT syndrome 2
DI   ORDO; Orphanet_101016; Romano-Ward syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi028-A
AC   CVCL_B7T3
DR   BioSamples; SAMEA14509782
DR   hPSCreg; ZZUNEUi028-A
DR   Wikidata; Q112930602
RX   PubMed=35772297;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:7551; MYBPC3; Simple; p.Arg502Trp (c.1504C>T); ClinVar=VCV000042540; Zygosity=Heterozygous (PubMed=35772297).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C133725; Familial hypertrophic cardiomyopathy type 4
DI   ORDO; Orphanet_99739; Rare familial disorder with hypertrophic cardiomyopathy
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   19Y
CA   Induced pluripotent stem cell
DT   Created: 23-06-22; Last updated: 14-08-25; Version: 6
//
ID   ZZUNEUi029-A
AC   CVCL_C9HS
DR   BioSamples; SAMEA113550133
DR   hPSCreg; ZZUNEUi029-A
DR   Wikidata; Q123034009
RX   PubMed=37586167;
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6547; LDLR; Simple; p.Glu208Lys (c.622G>A) (E167K); ClinVar=VCV000251328; Zygosity=Heterozygous (PubMed=37586167).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C123416; Hyperlipoproteinemia, type IIa
DI   ORDO; Orphanet_391665; Homozygous familial hypercholesterolemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   34Y
CA   Induced pluripotent stem cell
DT   Created: 05-10-23; Last updated: 14-08-25; Version: 4
//
ID   ZZUNEUi030-A
AC   CVCL_D6KC
DR   hPSCreg; ZZUNEUi030-A
DR   Wikidata; Q127384824
CC   From: The First Affiliated Hospital of Zhengzhou University; Zhengzhou; China.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Induced pluripotent stem cell
DT   Created: 02-05-24; Last updated: 14-08-25; Version: 3
//
ID   ZZUPMCi001-A
AC   CVCL_B5ER
DR   hPSCreg; ZZUPMCi001-A
DR   Wikidata; Q110434452
RX   PubMed=34864221;
CC   From: Precision Medicine Center, Zhengzhou University; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:8617; PAX3; Simple; p.Gly42Alafs*68 (c.123delG); ClinVar=VCV001048553; Zygosity=Heterozygous (PubMed=34864221).
CC   Omics: Genomics; Whole exome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C75008; Waardenburg syndrome type 1
DI   ORDO; Orphanet_3440; Waardenburg syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   29Y
CA   Induced pluripotent stem cell
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
ID   ZZUSAHi001-A
AC   CVCL_ZB29
SY   KCNA5-V259I-iPSC
DR   hPSCreg; ZZUSAHi001-A
DR   SKIP; SKIP005861
DR   Wikidata; Q98136741
RX   PubMed=32721895;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:6224; KCNA5; Simple; p.Val259Ile (c.775G>A); ClinVar=VCV002917091; Zygosity=Heterozygous (PubMed=32721895).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C50466; Atrial fibrillation
DI   ORDO; Orphanet_334; Familial atrial fibrillation
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   57Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 7
//
ID   ZZUSAHi002-A
AC   CVCL_ZB30
DR   hPSCreg; ZZUSAHi002-A
DR   Wikidata; Q98136743
RX   PubMed=32911326;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   32Y
CA   Induced pluripotent stem cell
DT   Created: 02-07-20; Last updated: 29-06-23; Version: 4
//
ID   ZZUSAHi003-A
AC   CVCL_A3ZF
DR   hPSCreg; ZZUSAHi003-A
DR   Wikidata; Q105511894
RX   PubMed=33450697;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:3603; FBN1; Simple; p.Cys980Tyr (c.2939G>A); Zygosity=Heterozygous (PubMed=33450697).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C34807; Marfan syndrome
DI   ORDO; Orphanet_558; Marfan syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   26Y
CA   Induced pluripotent stem cell
DT   Created: 12-01-21; Last updated: 19-12-24; Version: 5
//
ID   ZZUSAHi004-A
AC   CVCL_C6U7
DR   BioSamples; SAMEA111442306
DR   hPSCreg; ZZUSAHi004-A
DR   Wikidata; Q123034010
RX   PubMed=36395689;
CC   From: Zhengzhou University Second Affiliated Hospital; Zhengzhou; China.
CC   Population: Chinese; Han.
CC   Sequence variation: Mutation; HGNC; HGNC:379; AKAP9; Simple; p.Gln1341Lys (c.4021C>A); Zygosity=Heterozygous (PubMed=36395689).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C192195; Long QT syndrome 11
DI   ORDO; Orphanet_768; Familial long QT syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   3Y
CA   Induced pluripotent stem cell
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
ID   __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
AC   CVCL_3449
DR   Wikidata; Q54996174
RX   PubMed=9809040;
CC   Population: Caucasian.
CC   Derived from site: In situ; Colon; UBERON=UBERON_0001155.
CC   Cell type: Epithelial cell of colon; CL=CL_0011108.
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 02-05-24; Version: 11
//
